<SEC-DOCUMENT>0001493152-24-047703.txt : 20241126
<SEC-HEADER>0001493152-24-047703.hdr.sgml : 20241126
<ACCEPTANCE-DATETIME>20241126064020
ACCESSION NUMBER:		0001493152-24-047703
CONFORMED SUBMISSION TYPE:	S-1/A
PUBLIC DOCUMENT COUNT:		140
FILED AS OF DATE:		20241126
DATE AS OF CHANGE:		20241126

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Algorhythm Holdings, Inc.
		CENTRAL INDEX KEY:			0000923601
		STANDARD INDUSTRIAL CLASSIFICATION:	PHONOGRAPH RECORDS & PRERECORDED AUDIO TAPES & DISKS [3652]
		ORGANIZATION NAME:           	04 Manufacturing
		IRS NUMBER:				953795478
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-1/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-283178
		FILM NUMBER:		241498114

	BUSINESS ADDRESS:	
		STREET 1:		6301 NW 5TH WAY, STE 2900
		CITY:			FORT LAUDERDALE
		STATE:			FL
		ZIP:			33309
		BUSINESS PHONE:		(954) 596-1000

	MAIL ADDRESS:	
		STREET 1:		6301 NW 5TH WAY, STE 2900
		CITY:			FORT LAUDERDALE
		STATE:			FL
		ZIP:			33309

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SINGING MACHINE CO INC
		DATE OF NAME CHANGE:	19940523
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-1/A
<SEQUENCE>1
<FILENAME>forms-1a.htm
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:us-roles="http://fasb.org/us-roles/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:RIME="http://algoholdings.com/20240930">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02D_US%2DGAAP%2D2024 -->
<!-- Field: Set; Name: xdx; ID: xdx_03B_RIME_algoholdings.com_20240930 -->
<!-- Field: Set; Name: xdx; ID: xdx_040_20240101_20240930 -->
<!-- Field: Set; Name: xdx; ID: xdx_055_edei%2D%2DAmendmentFlag_true -->
<!-- Field: Set; Name: xdx; ID: xdx_054_edei%2D%2DEntityCentralIndexKey_0000923601 -->
<!-- Field: Set; Name: xdx; ID: xdx_077_XDX_Z%2D%2D\2024 OPERATIONS\EDGAR\11 NOVEMBER\ALGORHYTHM HOLDINGS, INC\11%2D20%2D2024\Form S%2D1A\Draft\Production\forms%2D1a.xdx -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_069_Pure_4_xbrli%2D%2Dpure -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_sqft_0_utr%2D%2Dsqft -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2024-01-01to2024-09-30" id="Fact000003" name="dei:AmendmentFlag">true</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2024-01-01to2024-09-30" id="Fact000004" name="dei:EntityCentralIndexKey">0000923601</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2024-01-01to2024-09-30" id="xdx2ixbrl0011" name="dei:DocumentType">S-1/A</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:DueFromBanks" contextRef="AsOf2023-12-31" id="xdx2ixbrl0052" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2023-12-31" id="xdx2ixbrl0085" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2023-12-31" id="xdx2ixbrl0088" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RIME:CustomerPrepayments" contextRef="AsOf2024-09-30" id="xdx2ixbrl0114" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShortTermBorrowings" contextRef="AsOf2023-12-31" id="xdx2ixbrl0121" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NotesPayableCurrent" contextRef="AsOf2023-12-31_us-gaap_NonrelatedPartyMember" id="xdx2ixbrl0124" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NotesPayableCurrent" contextRef="AsOf2023-12-31_us-gaap_RelatedPartyMember" id="xdx2ixbrl0127" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NotesPayableCurrent" contextRef="AsOf2023-12-31_us-gaap_RelatedPartyMember" id="xdx2ixbrl0130" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:OtherLiabilitiesNoncurrent" contextRef="AsOf2024-09-30" id="xdx2ixbrl0141" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:LongTermNotesPayable" contextRef="AsOf2023-12-31_us-gaap_RelatedPartyMember" id="xdx2ixbrl0145" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2024-09-30" id="xdx2ixbrl0147" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="AsOf2024-09-30" id="xdx2ixbrl0162" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="AsOf2023-12-31" id="xdx2ixbrl0163" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2024-09-30" id="xdx2ixbrl0168" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2023-12-31" id="xdx2ixbrl0169" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:MinorityInterest" contextRef="AsOf2023-12-31" id="xdx2ixbrl0219" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:GainLossOnTerminationOfLease" contextRef="From2023-07-012023-09-30" id="xdx2ixbrl0258" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:GainLossOnTerminationOfLease" contextRef="From2023-01-012023-09-30" id="xdx2ixbrl0260" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:GainLossOnDispositionOfAssets1" contextRef="From2024-07-012024-09-30" id="xdx2ixbrl0282" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:GainLossOnDispositionOfAssets1" contextRef="From2024-01-01to2024-09-30" id="xdx2ixbrl0284" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RIME:GainFromEmployeeRetentionCreditProgramRefund" contextRef="From2024-07-012024-09-30" id="xdx2ixbrl0307" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RIME:GainFromEmployeeRetentionCreditProgramRefund" contextRef="From2023-07-012023-09-30" id="xdx2ixbrl0308" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RIME:GainFromEmployeeRetentionCreditProgramRefund" contextRef="From2024-01-01to2024-09-30" id="xdx2ixbrl0309" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2024-07-012024-09-30" id="xdx2ixbrl0327" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2023-07-012023-09-30" id="xdx2ixbrl0328" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2024-01-01to2024-09-30" id="xdx2ixbrl0329" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2023-07-012023-09-30" id="xdx2ixbrl0338" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2023-01-012023-09-30" id="xdx2ixbrl0340" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-06-30_us-gaap_ReceivablesFromStockholderMember" id="xdx2ixbrl0391" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-06-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0392" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0398" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2024-07-012024-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0399" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2024-07-012024-09-30_us-gaap_ReceivablesFromStockholderMember" id="xdx2ixbrl0400" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2024-07-012024-09-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0408" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2024-07-012024-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0409" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation" contextRef="From2024-07-012024-09-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0417" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation" contextRef="From2024-07-012024-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0418" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2024-07-012024-09-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0426" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2024-07-012024-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0427" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0432" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" contextRef="From2024-07-012024-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0433" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" contextRef="From2024-07-012024-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0436" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0439" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2024-07-012024-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0443" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-09-30_us-gaap_ReceivablesFromStockholderMember" id="xdx2ixbrl0448" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-06-30_us-gaap_ReceivablesFromStockholderMember" id="xdx2ixbrl0457" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-06-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0458" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0464" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-07-012023-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0465" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-07-012023-09-30_us-gaap_ReceivablesFromStockholderMember" id="xdx2ixbrl0466" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-07-012023-09-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0467" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation" contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0471" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation" contextRef="From2023-07-012023-09-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0474" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation" contextRef="From2023-07-012023-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0475" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0478" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2023-07-012023-09-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0481" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2023-07-012023-09-30" id="xdx2ixbrl0483" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-09-30_us-gaap_ReceivablesFromStockholderMember" id="xdx2ixbrl0487" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-09-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0488" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-12-31_us-gaap_ReceivablesFromStockholderMember" id="xdx2ixbrl0496" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-12-31_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0497" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2024-01-012024-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0503" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2024-01-012024-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0504" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2024-01-012024-09-30_us-gaap_ReceivablesFromStockholderMember" id="xdx2ixbrl0505" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2024-01-012024-09-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0513" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2024-01-012024-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0514" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation" contextRef="From2024-01-012024-09-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0522" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation" contextRef="From2024-01-012024-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0523" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2024-01-012024-09-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0531" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2024-01-012024-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0532" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" contextRef="From2024-01-012024-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0537" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" contextRef="From2024-01-012024-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0538" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" contextRef="From2024-01-012024-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0541" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2024-01-012024-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0544" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-09-30_us-gaap_ReceivablesFromStockholderMember" id="xdx2ixbrl0553" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-12-31_us-gaap_ReceivablesFromStockholderMember" id="xdx2ixbrl0562" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-12-31_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0563" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-12-31_us-gaap_ReceivablesFromStockholderMember" id="xdx2ixbrl0571" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-12-31_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0572" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-01-012023-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0578" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-01-012023-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0579" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-01-012023-09-30_us-gaap_ReceivablesFromStockholderMember" id="xdx2ixbrl0580" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-01-012023-09-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0581" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-01-012023-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0585" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-01-012023-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0586" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-01-012023-09-30_us-gaap_ReceivablesFromStockholderMember" id="xdx2ixbrl0587" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-01-012023-09-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0588" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-01-012023-09-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0595" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-01-012023-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0596" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RIME:StockIssuedDuringPeriodValueSaleOfCommonStockWarrants" contextRef="From2023-01-012023-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0601" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RIME:StockIssuedDuringPeriodValueSaleOfCommonStockWarrants" contextRef="From2023-01-012023-09-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0604" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RIME:StockIssuedDuringPeriodValueSaleOfCommonStockWarrants" contextRef="From2023-01-012023-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0605" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation" contextRef="From2023-01-012023-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0610" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation" contextRef="From2023-01-012023-09-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0613" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation" contextRef="From2023-01-012023-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0614" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-09-30_us-gaap_ReceivablesFromStockholderMember" id="xdx2ixbrl0619" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-09-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0620" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-09-30_us-gaap_ReceivablesFromStockholderMember" id="xdx2ixbrl0628" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-09-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0629" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="From2023-01-012023-09-30" id="xdx2ixbrl0651" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RIME:ProvisionForInventoryObsolescence" contextRef="From2024-01-01to2024-09-30" id="xdx2ixbrl0656" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RIME:GainOnTerminationOfOperatingLease" contextRef="From2023-01-012023-09-30" id="xdx2ixbrl0663" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" contextRef="From2024-01-01to2024-09-30" id="xdx2ixbrl0665" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2024-01-01to2024-09-30" id="xdx2ixbrl0674" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RIME:PaymentOfEarlyTerminationFeeOnOperatingLeaseTerminationSettlement" contextRef="From2023-01-012023-09-30" id="xdx2ixbrl0732" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProceedsFromPreviousAcquisition" contextRef="From2023-01-012023-09-30" id="xdx2ixbrl0744" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" contextRef="From2024-01-01to2024-09-30" id="xdx2ixbrl0746" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:RepaymentsOfOtherDebt" contextRef="From2023-01-012023-09-30" id="xdx2ixbrl0789" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProceedsFromRepaymentsOfLinesOfCredit" contextRef="From2024-01-01to2024-09-30" id="xdx2ixbrl0791" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssued1" contextRef="From2023-01-012023-09-30" id="xdx2ixbrl0822" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:CapitalLeaseObligationsIncurred" contextRef="From2024-01-01to2024-09-30" id="xdx2ixbrl0824" unitRef="USD" xs:nil="true"/>
  <ix:nonNumeric contextRef="From2024-03-282024-03-28_us-gaap_RevolvingCreditFacilityMember" id="xdx2ixbrl1051" name="us-gaap:DebtInstrumentTerm">P2Y</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2024-09-30" id="xdx2ixbrl1204" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2024-07-012024-09-30" id="xdx2ixbrl1334" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2023-07-012023-09-30" id="xdx2ixbrl1336" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-07-012023-09-30_custom_LogisticsServicesMember" id="xdx2ixbrl1370" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-01-012023-09-30_custom_LogisticsServicesMember" id="xdx2ixbrl1372" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ContractWithCustomerRefundLiabilityCurrent" contextRef="AsOf2023-03-31" id="xdx2ixbrl1566" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="AsOf2023-12-31" id="xdx2ixbrl1592" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="AsOf2023-03-31" id="xdx2ixbrl1593" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2023-12-31" id="xdx2ixbrl1598" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2023-03-31" id="xdx2ixbrl1599" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:CommonStockShareSubscribedButUnissuedSubscriptionsReceivable" contextRef="AsOf2023-12-31" id="xdx2ixbrl1639" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:GainLossOnDispositionOfAssets1" contextRef="From2022-04-012023-03-31" id="xdx2ixbrl1688" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:GainLossOnDispositionOfAssets1" contextRef="From2021-04-012022-03-31" id="xdx2ixbrl1689" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RIME:GainFromRelatedPartyDebt" contextRef="From2023-04-012023-12-31" id="xdx2ixbrl1691" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RIME:GainFromRelatedPartyDebt" contextRef="From2022-04-012023-03-31" id="xdx2ixbrl1692" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RIME:GainFromPaycheckProtectionPlanLoanForgiveness" contextRef="From2023-04-012023-12-31" id="xdx2ixbrl1695" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RIME:GainFromPaycheckProtectionPlanLoanForgiveness" contextRef="From2022-04-012023-03-31" id="xdx2ixbrl1696" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RIME:GainFromEmployeeRetentionCreditProgramRefund" contextRef="From2023-04-012023-12-31" id="xdx2ixbrl1699" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RIME:GainFromEmployeeRetentionCreditProgramRefund" contextRef="From2021-04-012022-03-31" id="xdx2ixbrl1701" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RIME:GainFromSettlementOfAccountsPayable" contextRef="From2023-04-012023-12-31" id="xdx2ixbrl1703" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="From2023-04-012023-12-31" id="xdx2ixbrl1707" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="From2021-04-012022-03-31" id="xdx2ixbrl1709" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2023-04-012023-12-31" id="xdx2ixbrl1723" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AmortizationOfFinancingCosts" contextRef="From2023-04-012023-12-31" id="xdx2ixbrl1779" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="From2023-04-012023-12-31" id="xdx2ixbrl1807" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="From2023-04-012023-12-31" id="xdx2ixbrl1811" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="From2021-04-012022-03-31" id="xdx2ixbrl1813" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RIME:GainFromPaycheckProtectionPlanLoanForgiveness" contextRef="From2023-04-012023-12-31" id="xdx2ixbrl1815" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RIME:GainFromPaycheckProtectionPlanLoanForgiveness" contextRef="From2022-04-012023-03-31" id="xdx2ixbrl1816" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RIME:GainFromRelatedPartyDebt" contextRef="From2023-04-012023-12-31" id="xdx2ixbrl1819" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RIME:GainFromRelatedPartyDebt" contextRef="From2022-04-012023-03-31" id="xdx2ixbrl1820" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RIME:GainFromSettlementOfAccountsPayable" contextRef="From2023-04-012023-12-31" id="xdx2ixbrl1823" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseDueFromAffiliates" contextRef="From2023-04-012023-12-31" id="xdx2ixbrl1839" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInDueToRelatedParties" contextRef="From2023-04-012023-12-31" id="xdx2ixbrl1863" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInDueToRelatedParties" contextRef="From2021-04-012022-03-31" id="xdx2ixbrl1865" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" contextRef="From2022-04-012023-03-31" id="xdx2ixbrl1868" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" contextRef="From2022-04-012023-03-31" id="xdx2ixbrl1896" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" contextRef="From2021-04-012022-03-31" id="xdx2ixbrl1897" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RIME:PaymentOfRedemptionAndRetirementOfTreasuryStock" contextRef="From2023-04-012023-12-31" id="xdx2ixbrl1911" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RIME:PaymentOfRedemptionAndRetirementOfTreasuryStock" contextRef="From2022-04-012023-03-31" id="xdx2ixbrl1912" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RIME:ProceedsFromCollectionOfSubscriptionsReceivable" contextRef="From2022-04-012023-03-31" id="xdx2ixbrl1916" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RIME:ProceedsFromCollectionOfSubscriptionsReceivable" contextRef="From2021-04-012022-03-31" id="xdx2ixbrl1917" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProceedsFromRepaymentsOfLinesOfCredit" contextRef="From2023-04-012023-12-31" id="xdx2ixbrl1919" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:RepaymentsOfSubordinatedDebt" contextRef="From2023-04-012023-12-31" id="xdx2ixbrl1923" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RIME:PaymentOfDeferredFinancingCharges" contextRef="From2023-04-012023-12-31" id="xdx2ixbrl1927" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RIME:PaymentOfEarlyTerminationFeesOnRevolvingLinesOfCredit" contextRef="From2023-04-012023-12-31" id="xdx2ixbrl1931" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RIME:PaymentOfEarlyTerminationFeesOnRevolvingLinesOfCredit" contextRef="From2021-04-012022-03-31" id="xdx2ixbrl1933" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="From2023-04-012023-12-31" id="xdx2ixbrl1939" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="From2022-04-012023-03-31" id="xdx2ixbrl1940" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RIME:ProceedsFromExerciseOfCommonStockWarrants" contextRef="From2023-04-012023-12-31" id="xdx2ixbrl1943" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RIME:ProceedsFromExerciseOfCommonStockWarrants" contextRef="From2021-04-012022-03-31" id="xdx2ixbrl1945" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProceedsFromWarrantExercises" contextRef="From2023-04-012023-12-31" id="xdx2ixbrl1947" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProceedsFromWarrantExercises" contextRef="From2021-04-012022-03-31" id="xdx2ixbrl1949" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations" contextRef="From2023-04-012023-12-31" id="xdx2ixbrl1951" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:IncomeTaxesPaidNet" contextRef="From2023-04-012023-12-31" id="xdx2ixbrl1979" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:IncomeTaxesPaidNet" contextRef="From2021-04-012022-03-31" id="xdx2ixbrl1981" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:CapitalLeaseObligationsIncurred" contextRef="From2023-04-012023-12-31" id="xdx2ixbrl1987" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RIME:IssuanceOfCommonStockAndWarrantsForOfferingCosts" contextRef="From2023-04-012023-12-31" id="xdx2ixbrl1991" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-03-31_us-gaap_ReceivablesFromStockholderMember" id="xdx2ixbrl2001" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-04-012022-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl2007" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-04-012022-03-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl2008" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-04-012022-03-31_us-gaap_ReceivablesFromStockholderMember" id="xdx2ixbrl2009" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2021-04-012022-03-31_us-gaap_ReceivablesFromStockholderMember" id="xdx2ixbrl2015" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2021-04-012022-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl2016" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="From2021-04-012022-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl2021" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="From2021-04-012022-03-31_us-gaap_ReceivablesFromStockholderMember" id="xdx2ixbrl2023" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="From2021-04-012022-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl2024" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" contextRef="From2021-04-012022-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl2027" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" contextRef="From2021-04-012022-03-31_us-gaap_ReceivablesFromStockholderMember" id="xdx2ixbrl2029" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" contextRef="From2021-04-012022-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl2030" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2021-04-012022-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl2033" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2021-04-012022-03-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl2034" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2021-04-012022-03-31_us-gaap_ReceivablesFromStockholderMember" id="xdx2ixbrl2035" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2021-04-012022-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl2036" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2021-04-012022-03-31" id="xdx2ixbrl2037" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:TreasuryStockRetiredCostMethodAmount" contextRef="From2021-04-012022-03-31_us-gaap_ReceivablesFromStockholderMember" id="xdx2ixbrl2043" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2021-04-012022-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl2049" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2021-04-012022-03-31_us-gaap_ReceivablesFromStockholderMember" id="xdx2ixbrl2051" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2021-04-012022-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl2052" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2021-04-012022-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl2057" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2021-04-012022-03-31_us-gaap_ReceivablesFromStockholderMember" id="xdx2ixbrl2059" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2021-04-012022-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl2060" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-03-31_us-gaap_ReceivablesFromStockholderMember" id="xdx2ixbrl2067" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-04-012023-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl2073" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-04-012023-03-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl2074" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-04-012023-03-31_us-gaap_ReceivablesFromStockholderMember" id="xdx2ixbrl2075" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-04-012023-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl2082" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" contextRef="From2022-04-012023-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl2087" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" contextRef="From2022-04-012023-03-31_us-gaap_ReceivablesFromStockholderMember" id="xdx2ixbrl2089" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" contextRef="From2022-04-012023-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl2090" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RIME:StockIssuedDuringPeriodValueExerciseOfPrefundedAndCommonWarrants" contextRef="From2022-04-012023-03-31_us-gaap_ReceivablesFromStockholderMember" id="xdx2ixbrl2095" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RIME:StockIssuedDuringPeriodValueExerciseOfPrefundedAndCommonWarrants" contextRef="From2022-04-012023-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl2096" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2022-04-012023-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl2101" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2022-04-012023-03-31_us-gaap_ReceivablesFromStockholderMember" id="xdx2ixbrl2103" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2022-04-012023-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl2104" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2022-04-012023-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl2109" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2022-04-012023-03-31_us-gaap_ReceivablesFromStockholderMember" id="xdx2ixbrl2111" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2022-04-012023-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl2112" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RIME:StockIssuedDuringPeriodValueReverseStockSplits" contextRef="From2022-04-012023-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl2115" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RIME:StockIssuedDuringPeriodValueReverseStockSplits" contextRef="From2022-04-012023-03-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl2116" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RIME:StockIssuedDuringPeriodValueReverseStockSplits" contextRef="From2022-04-012023-03-31_us-gaap_ReceivablesFromStockholderMember" id="xdx2ixbrl2117" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RIME:StockIssuedDuringPeriodValueReverseStockSplits" contextRef="From2022-04-012023-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl2118" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RIME:StockIssuedDuringPeriodValueReverseStockSplits" contextRef="From2022-04-012023-03-31" id="xdx2ixbrl2119" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-04-012023-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl2139" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-04-012023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl2140" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-04-012023-12-31_us-gaap_ReceivablesFromStockholderMember" id="xdx2ixbrl2141" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-04-012023-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl2145" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-04-012023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl2146" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-04-012023-12-31_us-gaap_ReceivablesFromStockholderMember" id="xdx2ixbrl2147" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RIME:StockIssuedDuringPeriodValueIssuanceOfCommonStockAtMarketOffering" contextRef="From2023-04-012023-12-31_us-gaap_ReceivablesFromStockholderMember" id="xdx2ixbrl2153" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RIME:StockIssuedDuringPeriodValueIssuanceOfCommonStockAtMarketOffering" contextRef="From2023-04-012023-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl2154" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RIME:StockIssuedDuringPeriodValueIssuanceOfCommonStockPrivatePlacement" contextRef="From2023-04-012023-12-31_us-gaap_ReceivablesFromStockholderMember" id="xdx2ixbrl2161" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RIME:StockIssuedDuringPeriodValueIssuanceOfCommonStockPrivatePlacement" contextRef="From2023-04-012023-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl2162" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" contextRef="From2023-04-012023-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl2167" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" contextRef="From2023-04-012023-12-31_us-gaap_ReceivablesFromStockholderMember" id="xdx2ixbrl2169" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" contextRef="From2023-04-012023-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl2170" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2023-04-012023-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl2173" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2023-04-012023-12-31_us-gaap_ReceivablesFromStockholderMember" id="xdx2ixbrl2175" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2023-04-012023-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl2176" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" contextRef="From2023-04-012023-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl2179" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" contextRef="From2023-04-012023-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl2181" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" contextRef="From2023-04-012023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl2182" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" contextRef="From2023-04-012023-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl2184" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_us-gaap_ReceivablesFromStockholderMember" id="xdx2ixbrl2189" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_us-gaap_ReceivablesFromStockholderMember" id="xdx2ixbrl2197" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-12-31_custom_WarehouseEquipmentMember" id="xdx2ixbrl2305" unitRef="USD" xs:nil="true"/>
  <ix:nonNumeric contextRef="From2024-03-282024-03-28_us-gaap_SubsequentEventMember_us-gaap_RevolvingCreditFacilityMember" id="xdx2ixbrl2341" name="us-gaap:DebtInstrumentTerm">P2Y</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2023-04-012023-12-31_us-gaap_StockOptionMember" id="xdx2ixbrl2545" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2023-04-012023-12-31_us-gaap_StockOptionMember" id="xdx2ixbrl2547" unitRef="USDPShares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2023-04-012023-12-31_us-gaap_StockOptionMember" id="xdx2ixbrl2557" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="From2023-04-012023-12-31_us-gaap_StockOptionMember" id="xdx2ixbrl2559" unitRef="USDPShares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2022-04-012023-03-31_us-gaap_StockOptionMember" id="xdx2ixbrl2561" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="From2022-04-012023-03-31_us-gaap_StockOptionMember" id="xdx2ixbrl2563" unitRef="USDPShares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants" contextRef="From2023-04-012023-12-31" id="xdx2ixbrl2654" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants" contextRef="From2022-04-012023-03-31" id="xdx2ixbrl2655" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:CurrentFederalTaxExpenseBenefit" contextRef="From2023-04-012023-12-31" id="xdx2ixbrl2795" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" contextRef="From2023-04-012023-12-31" id="xdx2ixbrl2799" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" contextRef="From2022-04-012023-03-31" id="xdx2ixbrl2800" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" contextRef="From2021-04-012022-03-31" id="xdx2ixbrl2801" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RIME:CurrentOtherTaxExpenseBenefit" contextRef="From2023-04-012023-12-31" id="xdx2ixbrl2803" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RIME:CurrentOtherTaxExpenseBenefit" contextRef="From2021-04-012022-03-31" id="xdx2ixbrl2805" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:CurrentForeignTaxExpenseBenefit" contextRef="From2023-04-012023-12-31" id="xdx2ixbrl2807" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:CurrentForeignTaxExpenseBenefit" contextRef="From2021-04-012022-03-31" id="xdx2ixbrl2809" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:CurrentFederalStateAndLocalTaxExpenseBenefit" contextRef="From2023-04-012023-12-31" id="xdx2ixbrl2811" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" contextRef="From2023-04-012023-12-31" id="xdx2ixbrl2815" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" contextRef="From2023-04-012023-12-31" id="xdx2ixbrl2819" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit" contextRef="From2023-04-012023-12-31" id="xdx2ixbrl2823" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2023-04-012023-12-31" id="xdx2ixbrl2827" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:DeferredTaxAssetsLiabilitiesNet" contextRef="AsOf2023-12-31" id="xdx2ixbrl2881" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:DeferredTaxAssetsLiabilitiesNet" contextRef="AsOf2023-03-31" id="xdx2ixbrl2882" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RIME:IncomeTaxReconciliationChangeInPermanentDifferencesERCIncome" contextRef="From2023-04-012023-12-31" id="xdx2ixbrl2898" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RIME:IncomeTaxReconciliationChangeInPermanentDifferencesERCIncome" contextRef="From2021-04-012022-03-31" id="xdx2ixbrl2900" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RIME:IncomeTaxReconciliationChangeInExpirationOfNetOpretaingLossCarryforward" contextRef="From2022-04-012023-03-31" id="xdx2ixbrl2907" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RIME:IncomeTaxReconciliationChangeInExpirationOfNetOpretaingLossCarryforward" contextRef="From2021-04-012022-03-31" id="xdx2ixbrl2908" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2023-04-012023-12-31" id="xdx2ixbrl2918" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-04-012023-03-31_custom_OthersMember" id="xdx2ixbrl2977" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2023-04-012023-12-31" id="xdx2ixbrl3079" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-04-012023-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl3162" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-04-012023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl3163" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-04-012023-12-31_us-gaap_ReceivablesFromStockholderMember" id="xdx2ixbrl3164" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-04-012023-12-31_us-gaap_ReceivablesFromStockholderMember" id="xdx2ixbrl3170" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-04-012023-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl3171" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2023-04-012023-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl3176" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2023-04-012023-12-31_us-gaap_ReceivablesFromStockholderMember" id="xdx2ixbrl3178" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2023-04-012023-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl3179" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" contextRef="From2023-04-012023-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl3182" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2023-04-012023-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl3184" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2023-04-012023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl3185" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2023-04-012023-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl3187" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesOther" contextRef="From2023-04-012023-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl3190" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_us-gaap_ReceivablesFromStockholderMember" id="xdx2ixbrl3194" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-03-31_us-gaap_ReceivablesFromStockholderMember" id="xdx2ixbrl3202" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-03-31_us-gaap_ReceivablesFromStockholderMember" id="xdx2ixbrl3210" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-04-012022-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl3216" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-04-012022-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl3217" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-04-012022-12-31_us-gaap_ReceivablesFromStockholderMember" id="xdx2ixbrl3218" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-04-012022-12-31_us-gaap_ReceivablesFromStockholderMember" id="xdx2ixbrl3224" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-04-012022-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl3225" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2022-04-012022-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl3230" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2022-04-012022-12-31_us-gaap_ReceivablesFromStockholderMember" id="xdx2ixbrl3232" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2022-04-012022-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl3233" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2022-04-012022-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl3238" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2022-04-012022-12-31_us-gaap_ReceivablesFromStockholderMember" id="xdx2ixbrl3240" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2022-04-012022-12-31" id="xdx2ixbrl3242" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_us-gaap_ReceivablesFromStockholderMember" id="xdx2ixbrl3248" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_us-gaap_ReceivablesFromStockholderMember" id="xdx2ixbrl3256" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RIME:RefundDueFromCustomer" contextRef="AsOf2022-12-31_custom_SemiCabIncMember" id="xdx2ixbrl3275" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:LoansPayableCurrent" contextRef="AsOf2022-12-31_custom_SemiCabIncMember" id="xdx2ixbrl3308" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ContractWithCustomerRefundLiabilityCurrent" contextRef="AsOf2022-12-31_custom_SemiCabIncMember" id="xdx2ixbrl3311" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RIME:ProvisionForLegalLiability" contextRef="AsOf2022-12-31_custom_SemiCabIncMember" id="xdx2ixbrl3329" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="AsOf2022-12-31_custom_SemiCabIncMember" id="xdx2ixbrl3332" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember" id="xdx2ixbrl3385" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2022-01-012022-12-31_custom_SemiCabIncMember" id="xdx2ixbrl3386" unitRef="USD" xs:nil="true"/>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="rime-20240930.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2024-01-01to2024-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_dei_BusinessContactMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_us-gaap_NonrelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_NonrelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_us-gaap_RelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_RelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_us-gaap_NonrelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_us-gaap_RelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-012023-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012023-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012022-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_ReceivablesFromStockholderMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ReceivablesFromStockholderMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_ReceivablesFromStockholderMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ReceivablesFromStockholderMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_ReceivablesFromStockholderMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ReceivablesFromStockholderMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_ReceivablesFromStockholderMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ReceivablesFromStockholderMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31_us-gaap_ReceivablesFromStockholderMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ReceivablesFromStockholderMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_us-gaap_ReceivablesFromStockholderMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ReceivablesFromStockholderMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_us-gaap_ReceivablesFromStockholderMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ReceivablesFromStockholderMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30_us-gaap_ReceivablesFromStockholderMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ReceivablesFromStockholderMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_us-gaap_ReceivablesFromStockholderMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ReceivablesFromStockholderMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_us-gaap_ReceivablesFromStockholderMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ReceivablesFromStockholderMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_us-gaap_ReceivablesFromStockholderMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ReceivablesFromStockholderMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012022-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012022-03-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012022-03-31_us-gaap_ReceivablesFromStockholderMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ReceivablesFromStockholderMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012022-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012023-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012023-03-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012023-03-31_us-gaap_ReceivablesFromStockholderMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ReceivablesFromStockholderMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012023-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-012023-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-012023-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-012023-12-31_us-gaap_ReceivablesFromStockholderMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ReceivablesFromStockholderMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-012023-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_us-gaap_ReceivablesFromStockholderMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ReceivablesFromStockholderMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_us-gaap_ReceivablesFromStockholderMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ReceivablesFromStockholderMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-06-262024-06-26_custom_AtTheMarketSalesAgreementMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:AtTheMarketSalesAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-06-26</xbrli:startDate>
        <xbrli:endDate>2024-06-26</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-06-262024-06-26_custom_AtTheMarketSalesAgreementAmendmentOneMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:AtTheMarketSalesAgreementAmendmentOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-06-26</xbrli:startDate>
        <xbrli:endDate>2024-06-26</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-06-262024-06-26_custom_AtTheMarketSalesAgreementAmendmentTwoMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:AtTheMarketSalesAgreementAmendmentTwoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-06-26</xbrli:startDate>
        <xbrli:endDate>2024-06-26</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30_custom_AtTheMarketSalesAgreementMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:AtTheMarketSalesAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_custom_AtTheMarketSalesAgreementMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:AtTheMarketSalesAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-10-012024-11-18_us-gaap_SubsequentEventMember_custom_AtTheMarketSalesAgreementMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:AtTheMarketSalesAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-10-01</xbrli:startDate>
        <xbrli:endDate>2024-11-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-032024-07-03_custom_AssetPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:AssetPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-03</xbrli:startDate>
        <xbrli:endDate>2024-07-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-07-03_custom_SemiCabLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">RIME:SemiCabLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-07-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-032024-07-03_custom_SemiCabLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RIME:SemiCabLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-03</xbrli:startDate>
        <xbrli:endDate>2024-07-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-08-23_custom_LeaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:LeaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-08-23</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-04-012024-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-04-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-09-252024-09-25_custom_SettlementAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SettlementAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-09-25</xbrli:startDate>
        <xbrli:endDate>2024-09-25</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-10-252024-10-25_custom_SettlementAgreementMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SettlementAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-10-25</xbrli:startDate>
        <xbrli:endDate>2024-10-25</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30_custom_SettlementAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SettlementAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_custom_SettlementAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SettlementAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-10-22_us-gaap_PrivatePlacementMember_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-10-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-10-222024-10-22_us-gaap_PrivatePlacementMember_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-10-22</xbrli:startDate>
        <xbrli:endDate>2024-10-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-03-28_us-gaap_RevolvingCreditFacilityMember_custom_LoanAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:LoanAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-03-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-10-172024-10-17_us-gaap_RevolvingCreditFacilityMember_us-gaap_SubsequentEventMember_custom_LoanAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:LoanAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-10-17</xbrli:startDate>
        <xbrli:endDate>2024-10-17</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-11-01_custom_StockRepurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:StockRepurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-11-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-11-202023-11-20_us-gaap_PrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-11-20</xbrli:startDate>
        <xbrli:endDate>2023-11-20</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-11-20_us-gaap_PrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-11-20</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-08-232023-08-23_custom_LeaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:LeaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-08-23</xbrli:startDate>
        <xbrli:endDate>2023-08-23</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-02-152023-02-15_custom_ATMOfferingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">RIME:ATMOfferingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-02-15</xbrli:startDate>
        <xbrli:endDate>2023-02-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-012023-12-31_custom_ATMOfferingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">RIME:ATMOfferingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012023-03-31_custom_ATMOfferingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">RIME:ATMOfferingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_RetainedEarningsMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-032024-07-03_custom_SemiCabLLCMember249477656">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">RIME:SemiCabLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-03</xbrli:startDate>
        <xbrli:endDate>2024-07-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-032024-07-03_custom_TwoThousandTwentyFourMember_custom_AjeshKapoorMember_custom_EmploymentAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">RIME:TwoThousandTwentyFourMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:AjeshKapoorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:EmploymentAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-03</xbrli:startDate>
        <xbrli:endDate>2024-07-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-032024-07-03_custom_TwoThousandTwentyFiveMember_custom_AjeshKapoorMember_custom_EmploymentAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">RIME:TwoThousandTwentyFiveMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:AjeshKapoorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:EmploymentAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-03</xbrli:startDate>
        <xbrli:endDate>2024-07-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-032024-07-03_custom_SubsequentYearsMember_custom_AjeshKapoorMember_custom_EmploymentAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">RIME:SubsequentYearsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:AjeshKapoorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:EmploymentAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-03</xbrli:startDate>
        <xbrli:endDate>2024-07-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-032024-07-03_custom_TwoThousandTwentyFourMember_custom_VivekSehgalKapoorMember_custom_EmploymentAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">RIME:TwoThousandTwentyFourMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:VivekSehgalKapoorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:EmploymentAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-03</xbrli:startDate>
        <xbrli:endDate>2024-07-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-032024-07-03_custom_TwoThousandTwentyFiveMember_custom_VivekSehgalKapoorMember_custom_EmploymentAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">RIME:TwoThousandTwentyFiveMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:VivekSehgalKapoorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:EmploymentAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-03</xbrli:startDate>
        <xbrli:endDate>2024-07-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-032024-07-03_custom_TwoThousandTwentySixMember_custom_VivekSehgalKapoorMember_custom_EmploymentAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">RIME:TwoThousandTwentySixMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:VivekSehgalKapoorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:EmploymentAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-03</xbrli:startDate>
        <xbrli:endDate>2024-07-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-032024-07-03_custom_TwoThousandTwentySevenMember_custom_VivekSehgalKapoorMember_custom_EmploymentAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">RIME:TwoThousandTwentySevenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:VivekSehgalKapoorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:EmploymentAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-03</xbrli:startDate>
        <xbrli:endDate>2024-07-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-032024-07-03_custom_TwoThousandTwentyEightMember_custom_VivekSehgalKapoorMember_custom_EmploymentAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">RIME:TwoThousandTwentyEightMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:VivekSehgalKapoorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:EmploymentAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-03</xbrli:startDate>
        <xbrli:endDate>2024-07-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-032024-07-03_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-03</xbrli:startDate>
        <xbrli:endDate>2024-07-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-07-03">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-07-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-032024-07-03">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-03</xbrli:startDate>
        <xbrli:endDate>2024-07-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-07-03_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-07-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-07-03_custom_AlgorhythmHoldingsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">RIME:AlgorhythmHoldingsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-07-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-032024-07-03_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-03</xbrli:startDate>
        <xbrli:endDate>2024-07-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-032024-07-03_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-03</xbrli:startDate>
        <xbrli:endDate>2024-07-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-07-03_custom_SemiCabIncMember249477843">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-07-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-07-03_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-07-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-07-03_us-gaap_TradeNamesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-07-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-07-03_us-gaap_DevelopedTechnologyRightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-07-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-03-28_us-gaap_RevolvingCreditFacilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-03-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_us-gaap_RevolvingCreditFacilityMember_us-gaap_RelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_us-gaap_RevolvingCreditFacilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-03-282024-03-28_us-gaap_RevolvingCreditFacilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-28</xbrli:startDate>
        <xbrli:endDate>2024-03-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-03-282024-03-28_us-gaap_RevolvingCreditFacilityMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-28</xbrli:startDate>
        <xbrli:endDate>2024-03-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30_us-gaap_RevolvingCreditFacilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_us-gaap_RevolvingCreditFacilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-10-172024-10-17_us-gaap_RevolvingCreditFacilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-10-17</xbrli:startDate>
        <xbrli:endDate>2024-10-17</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-10-14_us-gaap_RevolvingCreditFacilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-10-14</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-10-142022-10-14_us-gaap_RevolvingCreditFacilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-10-14</xbrli:startDate>
        <xbrli:endDate>2022-10-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_us-gaap_RevolvingCreditFacilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_us-gaap_RevolvingCreditFacilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-10-14_custom_RevolvingLoanAmendmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">RIME:RevolvingLoanAmendmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-10-14</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-08-30_custom_RevolvingLoanAmendmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">RIME:RevolvingLoanAmendmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-08-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-03-22_custom_AgileCapilalFundingllcMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">RIME:AgileCapilalFundingllcMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-03-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-03-222024-03-22_custom_AgileCapilalFundingllcMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">RIME:AgileCapilalFundingllcMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-22</xbrli:startDate>
        <xbrli:endDate>2024-03-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_custom_AgileCapilalFundingllcMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">RIME:AgileCapilalFundingllcMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-05-08_custom_CedarAdvancellcMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">RIME:CedarAdvancellcMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-05-08</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-05-082024-05-08_custom_CedarAdvancellcMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">RIME:CedarAdvancellcMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-05-08</xbrli:startDate>
        <xbrli:endDate>2024-05-08</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_custom_CedarAdvancellcMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">RIME:CedarAdvancellcMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-03-22_custom_SemiCabInvestorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">RIME:SemiCabInvestorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-03-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-03-28_us-gaap_RevolvingCreditFacilityMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-03-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-03-282024-03-28_us-gaap_SubsequentEventMember_us-gaap_RevolvingCreditFacilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-28</xbrli:startDate>
        <xbrli:endDate>2024-03-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-16_custom_TwoYearCreditAndSecurityAgreementMember_us-gaap_RevolvingCreditFacilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:TwoYearCreditAndSecurityAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-16</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-16_custom_TwoYearLoanAndSecurityAgreementMember_us-gaap_RevolvingCreditFacilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:TwoYearLoanAndSecurityAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-16</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-012023-12-31_custom_CreditAndSecurityAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:CreditAndSecurityAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-12-31_custom_CreditAndSecurityAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:CreditAndSecurityAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012023-03-31_custom_CreditAndSecurityAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:CreditAndSecurityAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012022-03-31_custom_CreditAndSecurityAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:CreditAndSecurityAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30_us-gaap_RelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_us-gaap_RelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_custom_AjeshKapoorOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">RIME:AjeshKapoorOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_custom_AjeshKapoorOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">RIME:AjeshKapoorOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_custom_AjeshKapoorTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">RIME:AjeshKapoorTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_custom_AjeshKapoorTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">RIME:AjeshKapoorTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_custom_VivekSeghalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">RIME:VivekSeghalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_custom_VivekSeghalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">RIME:VivekSeghalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_custom_AjeshKapoorThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">RIME:AjeshKapoorThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_custom_AjeshKapoorThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">RIME:AjeshKapoorThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_custom_AjeshKapoorFourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">RIME:AjeshKapoorFourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_custom_AjeshKapoorFourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">RIME:AjeshKapoorFourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-05-18">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-05-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-05-182023-05-18">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-18</xbrli:startDate>
        <xbrli:endDate>2023-05-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-06-012024-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-06-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-05-182024-05-18_custom_SettlementSumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">RIME:SettlementSumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-05-18</xbrli:startDate>
        <xbrli:endDate>2024-05-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-05-202024-05-20_custom_InitialPaymentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">RIME:InitialPaymentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-05-20</xbrli:startDate>
        <xbrli:endDate>2024-05-20</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-06-032024-06-03_custom_SecondPaymentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">RIME:SecondPaymentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-06-03</xbrli:startDate>
        <xbrli:endDate>2024-06-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-04-30_custom_AdditionalPaymentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">RIME:AdditionalPaymentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-03-28_custom_BlueYonderIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:BlueYonderIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-03-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-06-212023-06-21_custom_BlueYonderIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:BlueYonderIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-06-21</xbrli:startDate>
        <xbrli:endDate>2023-06-21</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-07-01_custom_BlueYonderIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:BlueYonderIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-07-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-10-012024-10-01_custom_BlueYonderIncMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:BlueYonderIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-10-01</xbrli:startDate>
        <xbrli:endDate>2024-10-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-01-01_custom_BlueYonderIncMember_srt_ScenarioForecastMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:BlueYonderIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-01-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_custom_BlueYonderIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:BlueYonderIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-07-01_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-07-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-21_us-gaap_DirectorsAndOfficersLiabilityInsuranceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis">us-gaap:DirectorsAndOfficersLiabilityInsuranceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-21</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-212023-12-21_us-gaap_DirectorsAndOfficersLiabilityInsuranceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis">us-gaap:DirectorsAndOfficersLiabilityInsuranceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-21</xbrli:startDate>
        <xbrli:endDate>2023-12-21</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-03-282020-03-28_custom_ServiceContractAndAgreementMember_custom_SemiCabIncMember_custom_PerYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:ServiceContractAndAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">RIME:PerYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-03-28</xbrli:startDate>
        <xbrli:endDate>2020-03-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-03-282020-03-28_custom_ServiceContractAndAgreementMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:ServiceContractAndAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-03-28</xbrli:startDate>
        <xbrli:endDate>2020-03-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-06-212023-06-21_custom_ServiceContractAndAgreementMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:ServiceContractAndAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-06-21</xbrli:startDate>
        <xbrli:endDate>2023-06-21</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-03-282020-03-28_custom_ServiceContractAndAgreementMember_custom_SemiCabIncMember_custom_DueOnJulyOneTwoThousandTwentyFourMember_custom_TwoSeparateMilestonePaymentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:ServiceContractAndAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">RIME:DueOnJulyOneTwoThousandTwentyFourMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">RIME:TwoSeparateMilestonePaymentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-03-28</xbrli:startDate>
        <xbrli:endDate>2020-03-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-03-282020-03-28_custom_ServiceContractAndAgreementMember_custom_SemiCabIncMember_custom_DueOnJulyOneTwoThousandTwentyFourMember_custom_FirstMilestonePaymentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:ServiceContractAndAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">RIME:DueOnJulyOneTwoThousandTwentyFourMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">RIME:FirstMilestonePaymentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-03-28</xbrli:startDate>
        <xbrli:endDate>2020-03-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-03-282020-03-28_custom_ServiceContractAndAgreementMember_custom_SemiCabIncMember_custom_OctoberOneTwoThousandTwentyFourMember_custom_SecondMilestonePaymentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:ServiceContractAndAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">RIME:OctoberOneTwoThousandTwentyFourMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">RIME:SecondMilestonePaymentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-03-28</xbrli:startDate>
        <xbrli:endDate>2020-03-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-03-282020-03-28_custom_ServiceContractAndAgreementMember_custom_SemiCabIncMember_custom_JanuaryOneTwoThousandTwentyFiveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:ServiceContractAndAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">RIME:JanuaryOneTwoThousandTwentyFiveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-03-28</xbrli:startDate>
        <xbrli:endDate>2020-03-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-03-31_custom_ServiceContractAndAgreementMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:ServiceContractAndAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-05-282024-05-28_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-05-28</xbrli:startDate>
        <xbrli:endDate>2024-05-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-03-312024-03-31_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-31</xbrli:startDate>
        <xbrli:endDate>2024-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-10-01_custom_OperatingLeaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:OperatingLeaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-10-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-10-012017-10-01_custom_OperatingLeaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:OperatingLeaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-10-01</xbrli:startDate>
        <xbrli:endDate>2017-10-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-02-222024-02-22_custom_OperatingLeaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:OperatingLeaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-02-22</xbrli:startDate>
        <xbrli:endDate>2024-02-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-08-23_custom_OperatingLeaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:OperatingLeaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-08-23</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-09-252024-09-25_custom_OperatingLeaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:OperatingLeaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-09-25</xbrli:startDate>
        <xbrli:endDate>2024-09-25</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-02-202024-02-22_custom_OperatingLeaseAgreementMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:OperatingLeaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-02-20</xbrli:startDate>
        <xbrli:endDate>2024-02-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-08-232023-08-23_custom_OperatingLeaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:OperatingLeaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-08-23</xbrli:startDate>
        <xbrli:endDate>2023-08-23</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-10-15_custom_OperatingLeaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:OperatingLeaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-10-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-10-152022-10-15_custom_OperatingLeaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:OperatingLeaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-10-15</xbrli:startDate>
        <xbrli:endDate>2022-10-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_custom_TwoThousandTwentyTwoPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">RIME:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30_custom_TwoThousandTwentyTwoPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">RIME:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_custom_TwoThousandTwentyTwoPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">RIME:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_custom_TwoThousandTwentyTwoPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">RIME:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_custom_TwoThousandTwentyTwoPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">RIME:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30_custom_TwoThousandTwentyTwoPlanMember_us-gaap_GeneralAndAdministrativeExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">RIME:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_custom_TwoThousandTwentyTwoPlanMember_us-gaap_GeneralAndAdministrativeExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">RIME:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_us-gaap_GeneralAndAdministrativeExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_custom_ExercisePriceRangeOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">RIME:ExercisePriceRangeOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_custom_ExercisePriceRangeTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">RIME:ExercisePriceRangeTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_ExercisePriceRangeOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">RIME:ExercisePriceRangeOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_ExercisePriceRangeTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">RIME:ExercisePriceRangeTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30_us-gaap_EmployeeStockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_us-gaap_EmployeeStockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_us-gaap_EmployeeStockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_us-gaap_EmployeeStockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-012023-12-31_us-gaap_EmployeeStockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-012023-12-31_custom_CommonStockWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">RIME:CommonStockWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012023-03-31_us-gaap_EmployeeStockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012023-03-31_custom_CommonStockWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">RIME:CommonStockWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012022-03-31_custom_PreFundedWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">RIME:PreFundedWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012022-03-31_us-gaap_EmployeeStockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012022-03-31_custom_OptionsAndWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">RIME:OptionsAndWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_DomesticCountryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_us-gaap_DomesticCountryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_InternalRevenueServiceIRSMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_StateAndLocalJurisdictionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_us-gaap_StateAndLocalJurisdictionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30_custom_ClassicKaraokeMachinesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:ClassicKaraokeMachinesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_custom_ClassicKaraokeMachinesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:ClassicKaraokeMachinesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_custom_ClassicKaraokeMachinesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:ClassicKaraokeMachinesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_custom_ClassicKaraokeMachinesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:ClassicKaraokeMachinesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30_custom_LicensedProductsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:LicensedProductsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_custom_LicensedProductsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:LicensedProductsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_custom_LicensedProductsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:LicensedProductsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_custom_LicensedProductsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:LicensedProductsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30_custom_KidsYouthElectronicsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:KidsYouthElectronicsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_custom_KidsYouthElectronicsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:KidsYouthElectronicsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_custom_KidsYouthElectronicsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:KidsYouthElectronicsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_custom_KidsYouthElectronicsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:KidsYouthElectronicsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30_custom_MicrophonesAndAccessoriesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:MicrophonesAndAccessoriesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_custom_MicrophonesAndAccessoriesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:MicrophonesAndAccessoriesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_custom_MicrophonesAndAccessoriesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:MicrophonesAndAccessoriesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_custom_MicrophonesAndAccessoriesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:MicrophonesAndAccessoriesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30_custom_MusicSubscriptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:MusicSubscriptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_custom_MusicSubscriptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:MusicSubscriptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_custom_MusicSubscriptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:MusicSubscriptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_custom_MusicSubscriptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:MusicSubscriptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30_custom_LogisticsServicesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:LogisticsServicesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_custom_LogisticsServicesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:LogisticsServicesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_custom_LogisticsServicesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:LogisticsServicesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_custom_LogisticsServicesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:LogisticsServicesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-012023-12-31_custom_KaraokeMachinesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:KaraokeMachinesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012023-03-31_custom_KaraokeMachinesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:KaraokeMachinesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012022-03-31_custom_KaraokeMachinesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:KaraokeMachinesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-012023-12-31_custom_LicensedProductsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:LicensedProductsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012023-03-31_custom_LicensedProductsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:LicensedProductsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012022-03-31_custom_LicensedProductsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:LicensedProductsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-012023-12-31_custom_KidsYouthElectronicsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:KidsYouthElectronicsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012023-03-31_custom_KidsYouthElectronicsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:KidsYouthElectronicsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012022-03-31_custom_KidsYouthElectronicsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:KidsYouthElectronicsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-012023-12-31_custom_MicrophonesAndAccessoriesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:MicrophonesAndAccessoriesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012023-03-31_custom_MicrophonesAndAccessoriesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:MicrophonesAndAccessoriesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012022-03-31_custom_MicrophonesAndAccessoriesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:MicrophonesAndAccessoriesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-012023-12-31_custom_MusicSubscriptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:MusicSubscriptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012023-03-31_custom_MusicSubscriptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:MusicSubscriptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012022-03-31_custom_MusicSubscriptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:MusicSubscriptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30_srt_NorthAmericaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_srt_NorthAmericaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_srt_NorthAmericaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_srt_NorthAmericaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30_country_AU">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_country_AU">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_country_AU">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_country_AU">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30_srt_EuropeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_srt_EuropeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_srt_EuropeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_srt_EuropeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_ThreeCustomersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:ThreeCustomersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-312023-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_FourCustomersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:FourCustomersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-31</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30_custom_SalesRevenueMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">RIME:SalesRevenueMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:CustomerOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30_custom_SalesRevenueMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomersTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">RIME:SalesRevenueMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:CustomersTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30_custom_SalesRevenueMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomersThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">RIME:SalesRevenueMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:CustomersThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_custom_SalesRevenueMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">RIME:SalesRevenueMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:CustomerOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_custom_SalesRevenueMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomersTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">RIME:SalesRevenueMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:CustomersTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_custom_SalesRevenueMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomersThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">RIME:SalesRevenueMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:CustomersThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_custom_SalesRevenueMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">RIME:SalesRevenueMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:CustomerOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_custom_SalesRevenueMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomersTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">RIME:SalesRevenueMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:CustomersTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_custom_SalesRevenueMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomersThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">RIME:SalesRevenueMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:CustomersThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_custom_SalesRevenueMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomersFourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">RIME:SalesRevenueMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:CustomersFourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_custom_SalesRevenueMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">RIME:SalesRevenueMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:CustomerOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_custom_SalesRevenueMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomersTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">RIME:SalesRevenueMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:CustomersTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_custom_SalesRevenueMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomersThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">RIME:SalesRevenueMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:CustomersThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-012023-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_FourCustomersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:FourCustomersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012023-03-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_ThreeCustomersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:ThreeCustomersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012022-03-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_FourCustomersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:FourCustomersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-012023-12-31_custom_SalesRevenueMember_custom_ThreeCustomersMember_custom_CustomersConcentrationRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">RIME:SalesRevenueMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">RIME:ThreeCustomersMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:CustomersConcentrationRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-12-31_custom_SalesRevenueMember_custom_ThreeCustomersMember_custom_CustomersConcentrationRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">RIME:SalesRevenueMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">RIME:ThreeCustomersMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:CustomersConcentrationRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012023-03-31_custom_SalesRevenueMember_custom_ThreeCustomersMember_custom_CustomersConcentrationRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">RIME:SalesRevenueMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">RIME:ThreeCustomersMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:CustomersConcentrationRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012022-03-31_custom_SalesRevenueMember_custom_ThreeCustomersMember_custom_CustomersConcentrationRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">RIME:SalesRevenueMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">RIME:ThreeCustomersMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:CustomersConcentrationRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-012023-12-31_custom_SalesRevenueMember_custom_CustomersOneMember_custom_CustomersConcentrationRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">RIME:SalesRevenueMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">RIME:CustomersOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:CustomersConcentrationRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-012023-12-31_custom_SalesRevenueMember_custom_CustomersTwoMember_custom_CustomersConcentrationRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">RIME:SalesRevenueMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">RIME:CustomersTwoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:CustomersConcentrationRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-012023-12-31_custom_SalesRevenueMember_custom_CustomersThreeMember_custom_CustomersConcentrationRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">RIME:SalesRevenueMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">RIME:CustomersThreeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:CustomersConcentrationRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-12-31_custom_SalesRevenueMember_custom_CustomersOneMember_custom_CustomersConcentrationRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">RIME:SalesRevenueMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">RIME:CustomersOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:CustomersConcentrationRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-12-31_custom_SalesRevenueMember_custom_CustomersTwoMember_custom_CustomersConcentrationRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">RIME:SalesRevenueMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">RIME:CustomersTwoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:CustomersConcentrationRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012023-03-31_custom_SalesRevenueMember_custom_CustomersOneMember_custom_CustomersConcentrationRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">RIME:SalesRevenueMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">RIME:CustomersOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:CustomersConcentrationRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012023-03-31_custom_SalesRevenueMember_custom_CustomersTwoMember_custom_CustomersConcentrationRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">RIME:SalesRevenueMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">RIME:CustomersTwoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:CustomersConcentrationRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012022-03-31_custom_SalesRevenueMember_custom_CustomersOneMember_custom_CustomersConcentrationRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">RIME:SalesRevenueMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">RIME:CustomersOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:CustomersConcentrationRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012022-03-31_custom_SalesRevenueMember_custom_CustomersTwoMember_custom_CustomersConcentrationRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">RIME:SalesRevenueMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">RIME:CustomersTwoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:CustomersConcentrationRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012022-03-31_custom_SalesRevenueMember_custom_CustomersThreeMember_custom_CustomersConcentrationRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">RIME:SalesRevenueMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">RIME:CustomersThreeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:CustomersConcentrationRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-012023-12-31_custom_PurchasesMember_us-gaap_GeographicConcentrationRiskMember_custom_RepublicOfChinaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">RIME:PurchasesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:RepublicOfChinaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012023-03-31_custom_PurchasesMember_us-gaap_GeographicConcentrationRiskMember_custom_RepublicOfChinaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">RIME:PurchasesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:RepublicOfChinaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012022-03-31_custom_PurchasesMember_us-gaap_GeographicConcentrationRiskMember_custom_RepublicOfChinaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">RIME:PurchasesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:RepublicOfChinaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-012023-12-31_custom_RepublicOfChinaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">RIME:RepublicOfChinaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_FourMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:FourMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_FourMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:FourMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_FourMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:FourMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_FourMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:FourMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_us-gaap_RelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_us-gaap_RelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_custom_StingrayMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">RIME:StingrayMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_StingrayMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">RIME:StingrayMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_custom_SMCBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">RIME:SMCBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30_custom_SMCBMember_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">RIME:SMCBMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-012023-12-31_custom_StingrayMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">RIME:StingrayMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-12-31_custom_StingrayMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">RIME:StingrayMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012023-03-31_custom_StingrayMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">RIME:StingrayMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012022-03-31_custom_StingrayMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">RIME:StingrayMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_custom_StingrayMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">RIME:StingrayMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_custom_AultAllianceIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">RIME:AultAllianceIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_AjeshKapoorMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">RIME:AjeshKapoorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_AjeshKapoorMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">RIME:AjeshKapoorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_custom_AjeshKapoorMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">RIME:AjeshKapoorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-10-22_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-10-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-10-222024-10-22_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-10-22</xbrli:startDate>
        <xbrli:endDate>2024-10-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-10-222024-10-22_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-10-22</xbrli:startDate>
        <xbrli:endDate>2024-10-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-10-242024-10-24_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-10-24</xbrli:startDate>
        <xbrli:endDate>2024-10-24</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-10-24_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-10-24</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-11-01_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-11-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_ComputerAndOfficeEquipmentMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">RIME:ComputerAndOfficeEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_ComputerAndOfficeEquipmentMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">RIME:ComputerAndOfficeEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_ComputerAndOfficeEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">RIME:ComputerAndOfficeEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_custom_ComputerAndOfficeEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">RIME:ComputerAndOfficeEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_FurnitureAndFixturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_us-gaap_FurnitureAndFixturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_WarehouseEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">RIME:WarehouseEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_custom_WarehouseEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">RIME:WarehouseEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_MoldsAndToolingMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">RIME:MoldsAndToolingMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_MoldsAndToolingMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">RIME:MoldsAndToolingMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_MoldsAndToolingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">RIME:MoldsAndToolingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_custom_MoldsAndToolingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">RIME:MoldsAndToolingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-112022-04-12_custom_TwoThousandTwentyTwoPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">RIME:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-11</xbrli:startDate>
        <xbrli:endDate>2022-04-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012023-03-31_custom_TwoThousandTwentyTwoPlanMember_srt_DirectorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">RIME:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012023-03-31_custom_TwoThousandTwentyTwoPlanMember_srt_DirectorMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">RIME:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012023-03-31_custom_TwoThousandTwentyTwoPlanMember_srt_DirectorMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">RIME:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012023-03-31_custom_TwoThousandTwentyTwoPlanMember_srt_OfficerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">RIME:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:OfficerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012023-03-31_custom_TwoThousandTwentyTwoPlanMember_srt_OfficerMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">RIME:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:OfficerMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012023-03-31_custom_TwoThousandTwentyTwoPlanMember_srt_OfficerMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">RIME:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:OfficerMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012023-03-31_custom_TwoThousandTwentyTwoPlanMember_custom_EmployeeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">RIME:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:EmployeeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012023-03-31_custom_TwoThousandTwentyTwoPlanMember_custom_EmployeeMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">RIME:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:EmployeeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012023-03-31_custom_TwoThousandTwentyTwoPlanMember_custom_EmployeeMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">RIME:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:EmployeeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012022-03-31_srt_BoardOfDirectorsChairmanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012022-03-31_srt_BoardOfDirectorsChairmanMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012022-03-31_srt_BoardOfDirectorsChairmanMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012023-03-31_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012023-03-31_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012022-03-31_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012022-03-31_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012023-03-31_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012022-03-31_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-04-012021-03-31_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-04-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-012023-12-31_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_SixCurrentAndThreeFormerDirectorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:SixCurrentAndThreeFormerDirectorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_srt_OfficerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:OfficerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_EmployeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:EmployeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-232022-05-23_custom_UnderwritingAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:UnderwritingAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-23</xbrli:startDate>
        <xbrli:endDate>2022-05-23</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-05-23_custom_UnderwritingAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:UnderwritingAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-05-23</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-05-23_custom_UnderwritingAgreementMember_us-gaap_MeasurementInputExercisePriceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:UnderwritingAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-05-23</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-05-23_custom_UnderwritingAgreementMember_us-gaap_MeasurementInputExpectedTermMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:UnderwritingAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-05-23</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-05-23_custom_UnderwritingAgreementMember_us-gaap_MeasurementInputPriceVolatilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:UnderwritingAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-05-23</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-05-23_custom_UnderwritingAgreementMember_us-gaap_MeasurementInputExpectedDividendRateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:UnderwritingAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-05-23</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-05-23_custom_UnderwritingAgreementMember_us-gaap_MeasurementInputRiskFreeInterestRateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:UnderwritingAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-05-23</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-012021-08-05_custom_RedemptionAgreementMember_custom_KonceptsandTreasureGreenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:RedemptionAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:KonceptsandTreasureGreenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-01</xbrli:startDate>
        <xbrli:endDate>2021-08-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-082021-08-10_custom_KonceptsandTreasureGreenMember_custom_RedemptionAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:KonceptsandTreasureGreenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:RedemptionAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-08</xbrli:startDate>
        <xbrli:endDate>2021-08-10</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-08-05_custom_PurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:PurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-08-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-08-05_custom_PreFundedWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">RIME:PreFundedWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-08-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-08-05_us-gaap_PrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-08-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-07-06_us-gaap_PrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-07-06</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-07-06">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-07-06</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-07-06_custom_AGPWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">RIME:AGPWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-07-06</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-07-06">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-07-06</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-12-31_us-gaap_PrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-012023-12-31_srt_NorthAmericaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012023-03-31_srt_NorthAmericaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012022-03-31_srt_NorthAmericaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-012023-12-31_country_AU">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012023-03-31_country_AU">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012022-03-31_country_AU">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-012023-12-31_custom_EuropeAndUnitedKingdomMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">RIME:EuropeAndUnitedKingdomMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012023-03-31_custom_EuropeAndUnitedKingdomMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">RIME:EuropeAndUnitedKingdomMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012022-03-31_custom_EuropeAndUnitedKingdomMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">RIME:EuropeAndUnitedKingdomMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-012023-12-31_custom_OthersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">RIME:OthersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012023-03-31_custom_OthersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">RIME:OthersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012022-03-31_custom_OthersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">RIME:OthersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-12-31_us-gaap_ReceivablesFromStockholderMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ReceivablesFromStockholderMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_srt_MinimumMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_srt_MaximumMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-05-182023-05-18_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-18</xbrli:startDate>
        <xbrli:endDate>2023-05-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-05-182023-05-18_custom_SemiCabIncMember_custom_EqualInstallmentsForThirteenMonthsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RIME:EqualInstallmentsForThirteenMonthsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-18</xbrli:startDate>
        <xbrli:endDate>2023-05-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-05-18_custom_SemiCabIncMember_custom_EqualInstallmentsForThirteenMonthsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RIME:EqualInstallmentsForThirteenMonthsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-05-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-05-182024-05-18_custom_SettlementAgreementMember_custom_TwelveInstallmentsMember_us-gaap_SubsequentEventMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SettlementAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RIME:TwelveInstallmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-05-18</xbrli:startDate>
        <xbrli:endDate>2024-05-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-05-182024-05-18_custom_SettlementAgreementMember_custom_FirstPaymentMember_custom_DueAndPaidOnMayTwentyTwoThousandTwentyFourMember_us-gaap_SubsequentEventMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SettlementAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RIME:FirstPaymentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">RIME:DueAndPaidOnMayTwentyTwoThousandTwentyFourMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-05-18</xbrli:startDate>
        <xbrli:endDate>2024-05-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-05-182024-05-18_custom_SettlementAgreementMember_custom_SecondPaymentMember_custom_DueOnJuneThreeTwoThousandTwentyFourMember_us-gaap_SubsequentEventMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SettlementAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RIME:SecondPaymentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">RIME:DueOnJuneThreeTwoThousandTwentyFourMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-05-18</xbrli:startDate>
        <xbrli:endDate>2024-05-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-05-182024-05-18_custom_SettlementAgreementMember_custom_TenMonthlyPaymentsMember_custom_DueOnJulyOneTwoThousandTwentyFourMember_us-gaap_SubsequentEventMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SettlementAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RIME:TenMonthlyPaymentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">RIME:DueOnJulyOneTwoThousandTwentyFourMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-05-18</xbrli:startDate>
        <xbrli:endDate>2024-05-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-03-22_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-03-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-03-222024-03-22_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-22</xbrli:startDate>
        <xbrli:endDate>2024-03-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-03-222024-03-22_custom_WeeklyPaymentsForWeeksMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RIME:WeeklyPaymentsForWeeksMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-22</xbrli:startDate>
        <xbrli:endDate>2024-03-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-05-08_custom_SemiCabIncMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-05-08</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-05-082024-05-08_custom_SemiCabIncMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-05-08</xbrli:startDate>
        <xbrli:endDate>2024-05-08</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-05-082024-05-08_custom_WeeklyPaymentsMember_custom_SemiCabIncMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RIME:WeeklyPaymentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-05-08</xbrli:startDate>
        <xbrli:endDate>2024-05-08</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-102021-07-10_custom_SixShareholderLoanAgreementsMember_custom_AjeshKapoorMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SixShareholderLoanAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:AjeshKapoorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-10</xbrli:startDate>
        <xbrli:endDate>2021-07-10</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-07-10_custom_SixShareholderLoanAgreementsMember_custom_AjeshKapoorMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SixShareholderLoanAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:AjeshKapoorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-07-10</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-272021-08-27_custom_SixShareholderLoanAgreementsMember_custom_AjeshKapoorMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SixShareholderLoanAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:AjeshKapoorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-27</xbrli:startDate>
        <xbrli:endDate>2021-08-27</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-08-27_custom_SixShareholderLoanAgreementsMember_custom_AjeshKapoorMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SixShareholderLoanAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:AjeshKapoorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-08-27</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-172023-04-17_custom_SixShareholderLoanAgreementsMember_custom_VivekSehgalMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SixShareholderLoanAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:VivekSehgalMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-17</xbrli:startDate>
        <xbrli:endDate>2023-04-17</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-17_custom_SixShareholderLoanAgreementsMember_custom_VivekSehgalMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SixShareholderLoanAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:VivekSehgalMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-17</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-05-052023-05-05_custom_SixShareholderLoanAgreementsMember_custom_AjeshKapoorMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SixShareholderLoanAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:AjeshKapoorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-05</xbrli:startDate>
        <xbrli:endDate>2023-05-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-05-05_custom_SixShareholderLoanAgreementsMember_custom_AjeshKapoorMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SixShareholderLoanAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:AjeshKapoorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-05-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-05-082023-05-08_custom_SixShareholderLoanAgreementsMember_custom_JaganReddyMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SixShareholderLoanAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:JaganReddyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-08</xbrli:startDate>
        <xbrli:endDate>2023-05-08</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-05-08_custom_SixShareholderLoanAgreementsMember_custom_JaganReddyMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SixShareholderLoanAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:JaganReddyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-05-08</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-05-172023-05-17_custom_SixShareholderLoanAgreementsMember_custom_AjeshKapoorMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SixShareholderLoanAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:AjeshKapoorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-17</xbrli:startDate>
        <xbrli:endDate>2023-05-17</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-05-17_custom_SixShareholderLoanAgreementsMember_custom_AjeshKapoorMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SixShareholderLoanAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:AjeshKapoorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-05-17</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-03-31_srt_MinimumMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-03-31_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-03-31_srt_MinimumMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-03-31_srt_MaximumMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:SudhirNarasimhamurthyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:SudhirNarasimhamurthyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:SudhirNarasimhamurthyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:SudhirNarasimhamurthyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:SudhirNarasimhamurthyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:SudhirNarasimhamurthyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_KadandaleSrinivasSudheerMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:KadandaleSrinivasSudheerMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_KadandaleSrinivasSudheerMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:KadandaleSrinivasSudheerMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_KadandaleSrinivasSudheerMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:KadandaleSrinivasSudheerMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_KadandaleSrinivasSudheerMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:KadandaleSrinivasSudheerMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_KadandaleSrinivasSudheerMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:KadandaleSrinivasSudheerMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_KadandaleSrinivasSudheerMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:KadandaleSrinivasSudheerMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_VivekSehgalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:VivekSehgalMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_VivekSehgalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:VivekSehgalMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_VivekSehgalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:VivekSehgalMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_VivekSehgalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:VivekSehgalMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_VivekSehgalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:VivekSehgalMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_VivekSehgalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:VivekSehgalMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_RajivSaxenaMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:RajivSaxenaMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_RajivSaxenaMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:RajivSaxenaMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_HarshaBhatMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:HarshaBhatMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_HarshaBhatMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:HarshaBhatMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_HarshaBhatMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:HarshaBhatMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_HarshaBhatMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:HarshaBhatMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_HarshaBhatMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:HarshaBhatMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_HarshaBhatMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:HarshaBhatMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_JaganReddyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:JaganReddyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_JaganReddyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:JaganReddyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_JaganReddyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:JaganReddyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_JaganReddyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:JaganReddyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_JaganReddyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:JaganReddyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_JaganReddyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:JaganReddyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:SiddayyaSGanjalMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:SiddayyaSGanjalMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:SiddayyaSGanjalMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:SiddayyaSGanjalMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:SiddayyaSGanjalMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:SiddayyaSGanjalMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_SunilAroraMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:SunilAroraMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_SunilAroraMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:SunilAroraMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_RajivVirmaniMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:RajivVirmaniMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_RajivVirmaniMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:RajivVirmaniMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_SudhindraShenoyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:SudhindraShenoyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_SudhindraShenoyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:SudhindraShenoyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_SudhindraShenoyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:SudhindraShenoyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_SudhindraShenoyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:SudhindraShenoyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_SudhindraShenoyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:SudhindraShenoyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_SudhindraShenoyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:SudhindraShenoyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_AntonySunilMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:AntonySunilMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_AntonySunilMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:AntonySunilMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_AntonySunilMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:AntonySunilMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_AntonySunilMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:AntonySunilMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_AntonySunilMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:AntonySunilMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_AntonySunilMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:AntonySunilMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_TuleekaNandyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:TuleekaNandyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_TuleekaNandyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:TuleekaNandyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_TuleekaNandyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:TuleekaNandyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_TuleekaNandyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:TuleekaNandyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_RobelAtnafuMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:RobelAtnafuMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_RobelAtnafuMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:RobelAtnafuMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_GuyPrimusMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:GuyPrimusMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_GuyPrimusMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:GuyPrimusMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_SamarthaGowdaMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:SamarthaGowdaMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_SamarthaGowdaMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:SamarthaGowdaMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_AlexandraAielloMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:AlexandraAielloMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_AlexandraAielloMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:AlexandraAielloMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_StephenCabralMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:StephenCabralMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_StephenCabralMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:StephenCabralMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_JonahPetiPerrinMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:JonahPetiPerrinMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_JonahPetiPerrinMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:JonahPetiPerrinMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_BryanNellaMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:BryanNellaMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_BryanNellaMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:BryanNellaMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_MarkSinkMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:MarkSinkMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_MarkSinkMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:MarkSinkMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_KoustavChoudhuriMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:KoustavChoudhuriMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_KoustavChoudhuriMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:KoustavChoudhuriMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_StockOptionMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-03-31_custom_FoundersMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:FoundersMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-22_custom_SAFEAgreementsMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-03-31_custom_SAFEAgreementsMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-03-31_custom_SAFEAgreementsMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-122023-04-22_custom_FortyFourSAFEAgreementsMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:FortyFourSAFEAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-12</xbrli:startDate>
        <xbrli:endDate>2023-04-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-22_custom_FortyFourSAFEAgreementsMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:FortyFourSAFEAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-122023-04-22_custom_FortyFourSAFEAgreementsMember_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:FortyFourSAFEAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-12</xbrli:startDate>
        <xbrli:endDate>2023-04-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-10-252023-04-22_custom_SAFEOneMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-10-25</xbrli:startDate>
        <xbrli:endDate>2023-04-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-22_custom_SAFEOneMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-10-252023-04-22_custom_SAFEThirtyEightMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEThirtyEightMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-10-25</xbrli:startDate>
        <xbrli:endDate>2023-04-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-22_custom_SAFEThirtyEightMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEThirtyEightMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-10-252023-04-22_custom_SAFEFortyOneMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEFortyOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-10-25</xbrli:startDate>
        <xbrli:endDate>2023-04-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-22_custom_SAFEFortyOneMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEFortyOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-10-252023-04-22_custom_SAFEFortyTwoMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEFortyTwoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-10-25</xbrli:startDate>
        <xbrli:endDate>2023-04-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-22_custom_SAFEFortyTwoMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEFortyTwoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-10-252023-04-22_custom_SAFEFortyFourMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEFortyFourMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-10-25</xbrli:startDate>
        <xbrli:endDate>2023-04-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-22_custom_SAFEFortyFourMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEFortyFourMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-10-252023-04-22_custom_SAFEFortyThreeMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEFortyThreeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-10-25</xbrli:startDate>
        <xbrli:endDate>2023-04-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-22_custom_SAFEFortyThreeMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEFortyThreeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-22_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-122023-04-22_custom_SAFEFortyMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEFortyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-12</xbrli:startDate>
        <xbrli:endDate>2023-04-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-22_custom_SAFEFortyMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEFortyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-122023-04-22_custom_SAFEThirtyNineMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEThirtyNineMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-12</xbrli:startDate>
        <xbrli:endDate>2023-04-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-22_custom_SAFEThirtyNineMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEThirtyNineMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-122023-04-22_custom_SAFETenMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFETenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-12</xbrli:startDate>
        <xbrli:endDate>2023-04-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-22_custom_SAFETenMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFETenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-122023-04-22_custom_SAFEElevenMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEElevenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-12</xbrli:startDate>
        <xbrli:endDate>2023-04-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-22_custom_SAFEElevenMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEElevenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-122023-04-22_custom_SAFETwelveMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFETwelveMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-12</xbrli:startDate>
        <xbrli:endDate>2023-04-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-22_custom_SAFETwelveMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFETwelveMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-122023-04-22_custom_SAFEThirteenMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEThirteenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-12</xbrli:startDate>
        <xbrli:endDate>2023-04-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-22_custom_SAFEThirteenMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEThirteenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-122023-04-22_custom_SAFEFourteenMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEFourteenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-12</xbrli:startDate>
        <xbrli:endDate>2023-04-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-22_custom_SAFEFourteenMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEFourteenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-122023-04-22_custom_SAFEFifteenMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEFifteenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-12</xbrli:startDate>
        <xbrli:endDate>2023-04-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-22_custom_SAFEFifteenMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEFifteenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-122023-04-22_custom_SAFESixteenMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFESixteenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-12</xbrli:startDate>
        <xbrli:endDate>2023-04-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-22_custom_SAFESixteenMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFESixteenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-122023-04-22_custom_SAFESeventeenMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFESeventeenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-12</xbrli:startDate>
        <xbrli:endDate>2023-04-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-22_custom_SAFESeventeenMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFESeventeenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-122023-04-22_custom_SAFEEighteenMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEEighteenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-12</xbrli:startDate>
        <xbrli:endDate>2023-04-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-22_custom_SAFEEighteenMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEEighteenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-122023-04-22_custom_SAFENineteenMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFENineteenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-12</xbrli:startDate>
        <xbrli:endDate>2023-04-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-22_custom_SAFENineteenMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFENineteenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-122023-04-22_custom_SAFETwoMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFETwoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-12</xbrli:startDate>
        <xbrli:endDate>2023-04-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-22_custom_SAFETwoMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFETwoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-122023-04-22_custom_SAFETwentyMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFETwentyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-12</xbrli:startDate>
        <xbrli:endDate>2023-04-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-22_custom_SAFETwentyMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFETwentyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-122023-04-22_custom_SAFETwentyOneMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFETwentyOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-12</xbrli:startDate>
        <xbrli:endDate>2023-04-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-22_custom_SAFETwentyOneMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFETwentyOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-122023-04-22_custom_SAFETwentyTwoMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFETwentyTwoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-12</xbrli:startDate>
        <xbrli:endDate>2023-04-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-22_custom_SAFETwentyTwoMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFETwentyTwoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-122023-04-22_custom_SAFETwentyFourMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFETwentyFourMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-12</xbrli:startDate>
        <xbrli:endDate>2023-04-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-22_custom_SAFETwentyFourMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFETwentyFourMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-122023-04-22_custom_SAFEThreeMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEThreeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-12</xbrli:startDate>
        <xbrli:endDate>2023-04-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-22_custom_SAFEThreeMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEThreeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-122023-04-22_custom_SAFEFourMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEFourMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-12</xbrli:startDate>
        <xbrli:endDate>2023-04-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-22_custom_SAFEFourMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEFourMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-122023-04-22_custom_SAFEFortyFiveMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEFortyFiveMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-12</xbrli:startDate>
        <xbrli:endDate>2023-04-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-22_custom_SAFEFortyFiveMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEFortyFiveMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-122023-04-22_custom_SAFESixMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFESixMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-12</xbrli:startDate>
        <xbrli:endDate>2023-04-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-22_custom_SAFESixMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFESixMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-122023-04-22_custom_SAFESevenMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFESevenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-12</xbrli:startDate>
        <xbrli:endDate>2023-04-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-22_custom_SAFESevenMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFESevenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-122023-04-22_custom_SAFEEightMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEEightMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-12</xbrli:startDate>
        <xbrli:endDate>2023-04-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-22_custom_SAFEEightMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEEightMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-122023-04-22_custom_SAFENineMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFENineMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-12</xbrli:startDate>
        <xbrli:endDate>2023-04-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-22_custom_SAFENineMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFENineMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-122023-04-22_custom_SAFEFiveMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEFiveMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-12</xbrli:startDate>
        <xbrli:endDate>2023-04-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-22_custom_SAFEFiveMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEFiveMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-122023-04-22_custom_SAFETwentyFiveMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFETwentyFiveMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-12</xbrli:startDate>
        <xbrli:endDate>2023-04-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-22_custom_SAFETwentyFiveMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFETwentyFiveMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-122023-04-22_custom_SAFETwentySixMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFETwentySixMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-12</xbrli:startDate>
        <xbrli:endDate>2023-04-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-22_custom_SAFETwentySixMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFETwentySixMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-122023-04-22_custom_SAFETwentySevenMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFETwentySevenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-12</xbrli:startDate>
        <xbrli:endDate>2023-04-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-22_custom_SAFETwentySevenMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFETwentySevenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-122023-04-22_custom_SAFETwentyEightMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFETwentyEightMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-12</xbrli:startDate>
        <xbrli:endDate>2023-04-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-22_custom_SAFETwentyEightMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFETwentyEightMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-122023-04-22_custom_SAFETwentyNineMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFETwentyNineMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-12</xbrli:startDate>
        <xbrli:endDate>2023-04-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-22_custom_SAFETwentyNineMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFETwentyNineMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-122023-04-22_custom_SAFEThirtyMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEThirtyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-12</xbrli:startDate>
        <xbrli:endDate>2023-04-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-22_custom_SAFEThirtyMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEThirtyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-122023-04-22_custom_SAFEThirtyOneMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEThirtyOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-12</xbrli:startDate>
        <xbrli:endDate>2023-04-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-22_custom_SAFEThirtyOneMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEThirtyOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-122023-04-22_custom_SAFEThirtyTwoMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEThirtyTwoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-12</xbrli:startDate>
        <xbrli:endDate>2023-04-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-22_custom_SAFEThirtyTwoMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEThirtyTwoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-122023-04-22_custom_SAFEThirtyThreeMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEThirtyThreeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-12</xbrli:startDate>
        <xbrli:endDate>2023-04-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-22_custom_SAFEThirtyThreeMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEThirtyThreeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-122023-04-22_custom_SAFEThirtyFourMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEThirtyFourMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-12</xbrli:startDate>
        <xbrli:endDate>2023-04-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-22_custom_SAFEThirtyFourMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEThirtyFourMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-122023-04-22_custom_SAFEThirtyFiveMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEThirtyFiveMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-12</xbrli:startDate>
        <xbrli:endDate>2023-04-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-22_custom_SAFEThirtyFiveMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEThirtyFiveMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-122023-04-22_custom_SAFEThirtySixMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEThirtySixMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-12</xbrli:startDate>
        <xbrli:endDate>2023-04-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-22_custom_SAFEThirtySixMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEThirtySixMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-122023-04-22_custom_SAFEThirtySevenMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEThirtySevenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-12</xbrli:startDate>
        <xbrli:endDate>2023-04-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-22_custom_SAFEThirtySevenMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEThirtySevenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-122023-04-22_custom_SAFEFortySixMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEFortySixMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-12</xbrli:startDate>
        <xbrli:endDate>2023-04-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-22_custom_SAFEFortySixMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEFortySixMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-122023-04-22_custom_SAFEFiftyMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEFiftyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-12</xbrli:startDate>
        <xbrli:endDate>2023-04-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-22_custom_SAFEFiftyMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEFiftyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-122023-04-22_custom_SAFEFortyEightMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEFortyEightMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-12</xbrli:startDate>
        <xbrli:endDate>2023-04-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-22_custom_SAFEFortyEightMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEFortyEightMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-122023-04-22_custom_SAFEFortySevenMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEFortySevenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-12</xbrli:startDate>
        <xbrli:endDate>2023-04-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-22_custom_SAFEFortySevenMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEFortySevenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-122023-04-22_custom_SAFEFortyNineMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEFortyNineMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-12</xbrli:startDate>
        <xbrli:endDate>2023-04-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-22_custom_SAFEFortyNineMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEFortyNineMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-122023-04-22_custom_SAFEFiftyOneMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEFiftyOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-12</xbrli:startDate>
        <xbrli:endDate>2023-04-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-22_custom_SAFEFiftyOneMember_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEFiftyOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-22_custom_SemiCabIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000923601</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="sqft">
      <xbrli:measure>utr:sqft</xbrli:measure>
    </xbrli:unit>
  <ix:relationship fromRefs="Fact002581" toRefs="Footnote002610"/>
  <ix:relationship fromRefs="Fact002583" toRefs="Footnote002610"/>
  <ix:relationship fromRefs="Fact002585" toRefs="Footnote002610"/>
  <ix:relationship fromRefs="Fact002587" toRefs="Footnote002610"/>
  <ix:relationship fromRefs="Fact002589" toRefs="Footnote002610"/>
  <ix:relationship fromRefs="Fact002591" toRefs="Footnote002610"/>
  <ix:relationship fromRefs="Fact002593" toRefs="Footnote002610"/>
  <ix:relationship fromRefs="Fact002595" toRefs="Footnote002610"/>
  <ix:relationship fromRefs="Fact002597" toRefs="Footnote002610"/>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Registration
No. 333-283178</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 14pt"><b>Amendment
No. 1 to</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_906_edei--DocumentType_dxL_c20240101__20240930_zZiQT8uq7128" title="::XDX::S-1%2FA"><span style="-sec-ix-hidden: xdx2ixbrl0011">S-1</span></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>REGISTRATION
STATEMENT UNDER THE SECURITIES ACT OF 1933</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: small-caps 18pt Times New Roman, Times, Serif"><b><span id="xdx_90D_edei--EntityRegistrantName_c20240101__20240930_zPmmz4jAb6gh"><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" id="Fact000012" name="dei:EntityRegistrantName">ALGORHYTHM
HOLDINGS, INC.</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of registrant as specified in its charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_903_edei--EntityIncorporationStateCountryCode_c20240101__20240930_z0HeFe1fTQJi"><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" format="ixt-sec:stateprovnameen" id="Fact000013" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3652</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90E_edei--EntityTaxIdentificationNumber_c20240101__20240930_zLhguFZYHfoc"><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" id="Fact000014" name="dei:EntityTaxIdentificationNumber">95-3795478</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
    or Other Jurisdiction of<br/>
    Incorporation or Organization)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Primary
    Standard Industrial <br/>
    Classification Code Number)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S.
    Employer<br/>
    Identification No.)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_904_edei--EntityAddressAddressLine1_c20240101__20240930_zGAqufTca5t4"><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" id="Fact000015" name="dei:EntityAddressAddressLine1">6301 NW 5<sup>th</sup> Way</ix:nonNumeric></span>, <span id="xdx_902_edei--EntityAddressAddressLine2_c20240101__20240930_zcFL7byraTni"><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" id="Fact000016" name="dei:EntityAddressAddressLine2">Suite 2900</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_906_edei--EntityAddressCityOrTown_c20240101__20240930_zhgc1UoEgBAj"><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" id="Fact000017" name="dei:EntityAddressCityOrTown">Fort
Lauderdale</ix:nonNumeric></span>, <span id="xdx_905_edei--EntityAddressStateOrProvince_c20240101__20240930_zYBbrOU3u4oa"><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" id="Fact000018" name="dei:EntityAddressStateOrProvince">FL</ix:nonNumeric></span> <span id="xdx_909_edei--EntityAddressPostalZipCode_c20240101__20240930_zf3dd30BvV3i"><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" id="Fact000019" name="dei:EntityAddressPostalZipCode">33309</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90B_edei--CityAreaCode_c20240101__20240930_zTWC5JKxD2N7"><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" id="Fact000020" name="dei:CityAreaCode">(954)</ix:nonNumeric></span>
<span id="xdx_905_edei--LocalPhoneNumber_c20240101__20240930_z3yrPvdcxFO2"><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" id="Fact000021" name="dei:LocalPhoneNumber">596-1000</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address,
including zip code, and telephone number, including area code, of registrant&#8217;s principal executive offices)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90A_edei--ContactPersonnelName_c20240101__20240930__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_z3ehaYQPnLA1"><ix:nonNumeric contextRef="From2024-01-012024-09-30_dei_BusinessContactMember" id="Fact000022" name="dei:ContactPersonnelName">Gary
Atkinson</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Chief
Executive Officer </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Algorhythm
Holdings, Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_903_edei--EntityAddressAddressLine1_c20240101__20240930__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zCUZMqBIkJ7"><ix:nonNumeric contextRef="From2024-01-012024-09-30_dei_BusinessContactMember" id="Fact000023" name="dei:EntityAddressAddressLine1">6301
NW 5<sup>th</sup> Way</ix:nonNumeric></span>, <span id="xdx_903_edei--EntityAddressAddressLine2_c20240101__20240930__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_ze7kIqqY39Db"><ix:nonNumeric contextRef="From2024-01-012024-09-30_dei_BusinessContactMember" id="Fact000024" name="dei:EntityAddressAddressLine2">Suite 2900</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_908_edei--EntityAddressCityOrTown_c20240101__20240930__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zo56zLW6AHAa"><ix:nonNumeric contextRef="From2024-01-012024-09-30_dei_BusinessContactMember" id="Fact000025" name="dei:EntityAddressCityOrTown">Fort
Lauderdale</ix:nonNumeric></span>, <span id="xdx_907_edei--EntityAddressStateOrProvince_c20240101__20240930__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zfhXBJL54cze"><ix:nonNumeric contextRef="From2024-01-012024-09-30_dei_BusinessContactMember" id="Fact000026" name="dei:EntityAddressStateOrProvince">FL</ix:nonNumeric></span> <span id="xdx_902_edei--EntityAddressPostalZipCode_c20240101__20240930__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zwbGZHX4Eld3"><ix:nonNumeric contextRef="From2024-01-012024-09-30_dei_BusinessContactMember" id="Fact000027" name="dei:EntityAddressPostalZipCode">33309</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90E_edei--CityAreaCode_c20240101__20240930__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zYYQGBTMwog8"><ix:nonNumeric contextRef="From2024-01-012024-09-30_dei_BusinessContactMember" id="Fact000028" name="dei:CityAreaCode">(954)</ix:nonNumeric></span>
<span id="xdx_905_edei--LocalPhoneNumber_c20240101__20240930__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zto5AOwAFxd5"><ix:nonNumeric contextRef="From2024-01-012024-09-30_dei_BusinessContactMember" id="Fact000029" name="dei:LocalPhoneNumber">596-1000</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name,
address, including zip code, and telephone number, including area code, of agent for service)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Copies
to</span>:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 49%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gregory
                                            Sichenzia, Esq.</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Marcelle
    S. Balcombe, Esq.</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sichenzia
    Ross Ference Carmel LLP</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1185
    Avenue of the Americas, 31<sup>st</sup> Floor</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>New
    York, NY 10036</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Telephone:
    (212) 930-9700</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 49%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Joseph
                                            M. Lucosky, Esq.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Scott E. Linsky, Esq. </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Lucosky Brookman LLP</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>101 Wood Avenue South, 5th Floor</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Woodbridge, NJ 08830</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Tel. No.: (732) 395-4400</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Fax No.: (732) 395-4401</b></p>
<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approximate
date of commencement of proposed sale to the public: <b>As soon as practicable after the effective date of this Registration Statement.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the
Securities Act of 1933 check the following box. &#9746;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the
following box and list the Securities Act registration statement number of the earlier effective registration statement for the same
offering. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the
Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the
Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting
company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer&#8221; and &#8220;smaller reporting company&#8221;
in Rule 12b-2 of the Exchange Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large
    accelerated filer &#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated
    filer &#9744;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_edei--EntityFilerCategory_c20240101__20240930_zeENiL22pco8"><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" format="ixt-sec:entityfilercategoryen" id="Fact000030" name="dei:EntityFilerCategory">Non-accelerated
    filer</ix:nonNumeric></span> &#9746;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Smaller
    reporting company <span id="xdx_904_edei--EntitySmallBusiness_c20240101__20240930_za0xN8b2UOWi"><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" format="ixt:booleantrue" id="Fact000031" name="dei:EntitySmallBusiness">&#9746;</ix:nonNumeric></span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
    growth company <span id="xdx_902_edei--EntityEmergingGrowthCompany_c20240101__20240930_zZHtrgy9qyBh"><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" format="ixt:booleanfalse" id="Fact000032" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided to Section 7(a)(2)(B) of the Securities Act. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
Registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the
Registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become effective
in accordance with Section 8(a) of the Securities Act of 1933 or until the Registration Statement shall become effective on such date
as the Commission acting pursuant to said Section 8(a), may determine.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 4pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>EXPLANATORY
NOTE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_98A_edei--AmendmentDescription_c20240101__20240930_gBFAD-NLB_zdf9x7pKaGSg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" continuedAt="ConU000035-01" id="Fact000035" name="dei:AmendmentDescription">This
registration statement contains two prospectuses, as set forth below.</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<div id="xdx_C0E_gBFAD-NLB_zHZafZeNdIAi"><ix:continuation continuedAt="ConU000035-02" id="ConU000035-01"><table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Public
    Offering Prospectus</span></i>. A prospectus to be used for the public offering (the &#8220;Public Offering Prospectus&#8221;) of up
    to 43,478,261 shares of common stock of Algorhythm Holdings, Inc. (the &#8220;Company&#8221;) or pre-funded warrants in lieu
    thereof, 43,478,261 Series A warrants (the &#8220;Series A Warrants&#8221;) and 43,478,261 Series B warrants (together
    with the Series A Warrants, the &#8220;Warrants&#8221;) with such securities being placed and sold through the placement agent named
    on the cover page of the Public Offering Prospectus. The Public Offering Prospectus also relates to the shares issuable upon the
    exercise of the Warrants, and the pre-funded warrants.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Resale
    Prospectus</span></i>. A prospectus to be used for the resale by the selling stockholders (the &#8220;Selling Stockholders&#8221; set
    forth in the section of the resale prospectus (the &#8220;Resale Prospectus&#8221;) entitled &#8220;Selling Stockholders&#8221; of
    an aggregate of 2,840,344 shares of common stock.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.2in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Resale Prospectus is substantively identical to the Public Offering Prospectus, except for the following principal points:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">they
    contain different outside and inside front covers and back covers;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.35in; text-indent: -0.2in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">they
    contain different &#8220;<i>Offering</i>&#8221; sections in the &#8220;<i>Prospectus Summary</i>&#8221; section beginning on page
    Altr 2;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">they
    contain different &#8220;<i>Use of Proceeds</i>&#8221; sections on page Altr 9;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.35in; text-indent: -0.2in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    &#8220;<i>Capitalization</i>&#8221; and &#8220;<i>Dilution</i>&#8221; sections from the Public Offering Prospectus are deleted from
    the Resale Prospectus;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    &#8220;<i>Selling Stockholders</i>&#8221; section is included in the Resale Prospectus;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.35in; text-indent: -0.2in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    &#8220;<i>Plan of Distribution</i>&#8221; section from the Public Offering Prospectus is deleted from the Resale Prospectus and a
    &#8220;<i>Selling Stockholder Plan of Distribution</i>&#8221; is inserted in its place in the Resale Prospectus; and</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    &#8220;<i>Legal Matters</i>&#8221; section in the Resale Prospectus on page Altr 12 deletes the reference to counsel for the
    placement agent. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has included in this registration statement a set of alternate pages after the back cover page of the Public Offering Prospectus
(the &#8220;Alternate Pages&#8221;) to reflect the foregoing differences in the Resale Prospectus as compared to the Public Offering
Prospectus. The Public Offering Prospectus will exclude the Alternate Pages and will be used for the public offering by the Company.
The Resale Prospectus will be substantively identical to the Public Offering Prospectus except for the addition or substitution of the
Alternate Pages, and such other changes as may be necessary to clarify references to the public offering or the resale offering and will
be used for the resale offering by the Selling Stockholders.</span></p>

</ix:continuation></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_C0F_gBFAD-NLB_zZ5TMbBvqoL6"><ix:continuation id="ConU000035-02">&#160;</ix:continuation></span></span></p>


<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><b>THE
INFORMATION IN THIS PRELIMINARY PROSPECTUS IS NOT COMPLETE AND MAY BE CHANGED. THESE SECURITIES MAY NOT BE SOLD UNTIL THE REGISTRATION
STATEMENT FILED WITH THE SECURITIES AND EXCHANGE COMMISSION IS DECLARED EFFECTIVE. THIS PRELIMINARY PROSPECTUS IS NOT AN OFFER TO SELL
THESE SECURITIES AND WE ARE NOT SOLICITING AN OFFER TO BUY THESE SECURITIES IN ANY STATE OR OTHER JURISDICTION WHERE THE OFFER OR SALE
IS NOT PERMITTED.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><b>PRELIMINARY
    PROSPECTUS</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><b>SUBJECT
    TO COMPLETION</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><b>DATED
    NOVEMBER 25, 2024</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PRELIMINARY
PROSPECTUS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Up
to 43,478,261 Shares of Common Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Up
to 43,478,261 Pre-Funded Warrants to Purchase Shares of Common Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Up
to 43,478,261 Series A Warrants to Purchase Shares of Common Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Up
to 43,478,261 Series B Warrants to Purchase Shares of Common Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Up
to 130,434,783 Shares of Common Stock Underlying the Series A Warrants, Series B</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Warrants,
and Pre-Funded Warrants</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img src="forms-1_001.jpg" alt=""/></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Algorhythm
Holdings, Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Algorhythm
Holdings, Inc. (the &#8220;Company,&#8221; &#8220;Algorhythm,&#8221; the &#8220;registrant,&#8221; &#8220;we,&#8221; &#8220;our&#8221;
or &#8220;us&#8221;) is offering up to 43,478,261 shares of the Company&#8217;s common stock, together with Series A warrants
to purchase up to 43,478,261 shares of common stock (the &#8220;Series A Warrants&#8221;) and Series B warrants to purchase up
to 43,478,261 shares of common stock (the &#8220;Series B Warrants&#8221; and, together with the Series A Warrants, the &#8220;Warrants&#8221;).
Each share of our common stock, or a pre-funded warrant in lieu thereof, is being sold together with a Series A Warrant to purchase one
share of our common stock and a Series B Warrant to purchase one share of our common stock. The shares of common stock and Warrants are
immediately separable and will be issued separately in this offering but must be purchased together in this offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
assumed public offering price for each share of common stock and accompanying Warrants is $0.23, which was the last reported sale
price of our common stock on The Nasdaq Capital Market on November 20, 2024. The Series A Warrants will have an exercise price
of $&#160;&#160; per share (at least &#160;&#160;&#160;% of the Minimum Price as defined by the rules of The Nasdaq Stock
Market LLC (&#8220;Nasdaq&#8221;)) and will be exercisable beginning on the date of the approval by the stockholders of the Company
(the &#8220;Initial Exercise Date&#8221; or &#8220;Effective Shareholder Approval Date&#8221; or Initial Exercise Date) of the issuance
of shares upon exercise of the Warrants, among other things (the &#8220;Shareholder Approval&#8221;). The Series A Warrants will expire
on the five-year anniversary of the Initial Exercise Date. The Series B Warrants will have an exercise price of $&#160;&#160;&#160;
per share (and shall not exceed 200% of the Minimum Price as defined by the rules of Nasdaq) and will be exercisable beginning on
the Effective Shareholder Approval Date. The Series B Warrants will expire on the two and one-half year anniversary of the Initial Exercise
Date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the alternate cashless exercise option of the Series B Warrants, a holder of the Series B Warrant has the right to receive an
aggregate number of shares equal to the product of (x) the aggregate number of shares of common stock that would be issuable upon a cash
exercise of the Series B Warrant and (y) 1. The Series A Warrants will provide for an adjustment to the exercise price and number
of shares underlying the Series A Warrants upon our issuance of our common stock or common stock equivalents at a price per share that
is less than the exercise price of the Series A Warrant, subject to certain exceptions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the 4th
trading day after the Effective Shareholder Approval Date, the Warrants&#8217; exercise price will be reset to a price equal to the
lower of (i) the exercise price then in effect and (ii) the greater of (a) the lowest daily VWAP during the period commencing
on the first trading day prior to the Effective Shareholder Approval Date and ending following the close of trading on the fourth
trading day thereafter and (b) the floor price then in effect as set forth in the Warrants, and the number of shares issuable
upon exercise will be increased such that the aggregate exercise price of the Warrants on the issuance date for the shares of common
stock underlying the Warrants then outstanding shall remain unchanged.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
reduction to the exercise prices of the Series A Warrants and the Series B Warrants and resulting increase in the shares of common stock
underlying the Warrants will be subject to a floor price equal to 50% of the Minimum Price as defined by the rules of The Nasdaq Stock
Market, LLC (&#8220;Nasdaq&#8221;) prior to the Effective Shareholder Approval Date, and 20% of the Minimum Price beginning on the Effective
Shareholder Approval Date. Following the Effective Shareholder Approval Date, the exercise price reduction and adjustment provisions
with respect to underlying shares of common stock in the Warrants described above will be effected using the reduced floor price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
common stock is listed on The Nasdaq Capital Market under the symbol &#8220;RIME.&#8221; The last reported sale price of our common stock
on The Nasdaq Capital Market on November 20, 2024 was $0.23 per share. The actual public offering price per each set of
a share of common stock and accompanying Warrants in this offering will be determined between us, Univest Securities, LLC (the &#8220;placement
agent&#8221;) and the investors in this offering at the time of pricing and may reflect a discount to the current market price for our
common stock. Therefore, the recent market price used throughout this preliminary prospectus as a basis for an assumed public offering
price per share of common stock and accompanying Warrants may not be indicative of the final offering price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have engaged Univest Securities, LLC to act as our exclusive placement agent in connection with this offering. The placement agent has
agreed to use its best efforts to arrange for the sale of the securities offered by this prospectus. The placement agent is not purchasing
or selling any of the securities we are offering and the placement agent is not required to arrange the purchase or sale of any specific
number or dollar amount of securities. We have agreed to pay to the placement agent the placement agent fees set forth in the table below,
which assumes that we sell all of the securities offered by this prospectus. There is no arrangement for funds to be received in escrow,
trust or similar arrangement. There is no minimum offering requirement as a condition of closing of this offering. Because there is no
minimum offering amount required as a condition to closing this offering, we may sell fewer than all of the securities offered hereby,
which may significantly reduce the amount of proceeds received by us, and investors in this offering will not receive a refund in the
event that we do not sell an amount of securities sufficient to pursue our business goals described in this prospectus. See &#8220;<i>Risk
Factors</i>&#8221; at page 9. We will bear all costs associated with the offering. See &#8220;<i>Plan of Distribution</i>&#8221; on
page 68 of this prospectus for more information regarding these arrangements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are also offering to each purchaser of shares that would otherwise result in the purchaser&#8217;s beneficial ownership exceeding 4.99%
of our outstanding common stock immediately following the consummation of this offering, the opportunity to purchase pre-funded warrants
each in lieu of one share of common stock, each a &#8220;Pre-Funded Warrant&#8221;). Subject to limited exceptions, a holder of Pre-Funded
Warrants will not have the right to exercise any portion of its Pre-Funded Warrants if the holder, together with its affiliates, would
beneficially own in excess of 4.99% (or, at the election of the holder, such limit may be increased to up to 9.99% on at least 61 days&#8217;
notice) of the number of common stock outstanding immediately after giving effect to such exercise. Each Pre-Funded Warrant will be exercisable
for one share of common stock. The purchase price of each Pre-Funded Warrant will be equal to the price per share minus $0.01, and the
remaining exercise price of each Pre-Funded Warrant will equal $0.01 per share. The Pre-Funded Warrants will be immediately exercisable
(subject to the beneficial ownership limitation) and may be exercised at any time until all of the Pre-Funded Warrants are exercised
in full. For each share we sell (without regard to any limitation on exercise set forth therein), the number of shares we are offering
will be decreased on a one-for-one basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is no established public trading market for the Warrants or the Pre-Funded Warrants, and we do not intend to list the Warrants or the
Pre-Funded Warrants on any national securities exchange or trading system. Without an active trading market, the liquidity of the Warrants
and the Pre-Funded Warrants will be limited. We anticipate that the shares of our common stock to be issued upon exercise of the Warrants
and the Pre-Funded Warrants will trade on The Nasdaq Capital Market. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will have one closing for all the securities purchased in this offering. The offering will terminate upon the completion of a single
closing, which is expected to occur on or about &#160;&#160;&#160;&#160;, 2024. The public offering price per share (or Pre-Funded
Warrant) and the accompanying Warrants will be fixed for the duration of this offering. The termination of our offering will not affect
the offering by the Selling Stockholders described elsewhere in this prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may sell fewer than all securities offered hereby, which may significantly reduce the amount of proceeds received by us, and investors
in this offering will not receive a refund if we do not sell all of the securities offered hereby. We have not established an escrow
account in conjunction with this offering. Because there is no escrow account and no minimum number of securities or amount of proceeds,
investors could be in a position where they have invested in us, but we have not raised sufficient proceeds in this offering to adequately
fund the intended uses of the proceeds as described in this prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the selling stockholders (the &#8220;Selling Stockholders&#8221;) are offering an aggregate of 2,840,344 shares of common
stock to be sold pursuant to a separate resale prospectus (the &#8220;Resale Prospectus&#8221;) included in the registration statement
of which this prospectus forms a part. We will not receive any proceeds from the sale or other disposition of shares by the Selling Stockholders.
The Selling Stockholders will bear all commissions and discounts, if any, attributable to the sale or other disposition of the shares.
We will bear all costs, expenses and fees in connection with the registration of the Selling Stockholders&#8217; shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Investing
in the Securities involves a high degree of risk. See &#8220;<i>Risk Factors</i>&#8221; beginning on page 9</b> <b>of this prospectus
for a discussion of information that should be considered in connection with an investment in our common stock.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Neither
the Securities and Exchange Commission (&#8220;SEC&#8221;) nor any state securities commission has approved or disapproved of these securities
or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Per
    Share of Common Stock and Warrants</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Per
    Pre-Funded Warrant and Warrants</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 52%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public
    offering price</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 12%">&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 12%">&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 12%">&#160;&#160;&#160;&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Placement
    agent fees<sup>(1)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proceeds,
    before expenses, to us<sup>(2)(3)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    the placement agent fee of 7%. Does not include a non-accountable expense of 1% and reimbursement of the placement agent for out
    of pocket fees, costs and expenses incurred, including costs of the escrow or clearing agent not to exceed the amount of $12,900.
    </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For more information about the compensation
    to be received by the placement agent, see &#8220;<i>Plan of Distribution</i>.&#8221;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
    there is no minimum number of securities or amount of proceeds required as a condition to closing in this offering, the actual public
    offering amount, placement agent fees and proceeds to us, if any, are not presently determinable and may be substantially less than
    the total maximum offering amounts set forth above. For more information, see &#8220;<i>Plan of Distribution</i>.&#8221;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    amount of offering proceeds to us presented in this table does not give effect to any exercise of the Warrants or the Pre-Funded
    Warrants.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
delivery to purchasers of securities in this offering is expected to be made on or about &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;,
2024, subject to satisfaction of certain customary closing conditions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Sole
Placement Agent</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 16pt"><b>Univest
Securities, LLC</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
date of this prospectus is &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;,
2024</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TABLE
OF CONTENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ap_001">ABOUT THIS PROSPECTUS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ap_002">MARKET DATA</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ap_003">PROSPECTUS SUMMARY</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ap_004">SUMMARY OF THE OFFERING</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ap_005">RISK FACTORS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ap_006">SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ap_007">USE OF PROCEEDS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ap_008">MARKET FOR COMMON EQUITY AND RELATED STOCKHOLDER MATTERS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ap_009">DIVIDEND POLICY</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ap_010">CAPITALIZATION</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ap_011">DILUTION</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ap_012">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">34</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#alp_001">BUSINESS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#alp_002">MANAGEMENT</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">48</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#alp_003">EXECUTIVE COMPENSATION</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">53</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#alp_004">PRINCIPAL STOCKHOLDERS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">58</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#alp_005">CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">59</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#alp_006">DESCRIPTION OF SECURITIES</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">60</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#alp_007">PLAN OF DISTRIBUTION</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">66</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#alp_008">EXPERTS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">69</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#alp_009">LEGAL MATTERS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">69</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#alp_010">WHERE YOU CAN FIND MORE INFORMATION</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">69</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#alp_011">INDEX TO FINANCIAL STATEMENTS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-1</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>You
should rely only on the information contained in this prospectus or any prospectus supplement or amendment. Neither we, nor the placement
agent, have authorized any other person to provide you with information that is different from, or adds to, that contained in this prospectus.
If anyone provides you with different or inconsistent information, you should not rely on it. Neither we nor the placement agent take
responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. You should
assume that the information contained in this prospectus or any free writing prospectus is accurate only as of the date of this prospectus,
regardless of the time of delivery of this prospectus or of any sale of our securities. Our business, financial condition, results of
operations and prospects may have changed since that date. We are not making an offer of any securities in any jurisdiction in which
such offer is unlawful.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>No
action is being taken in any jurisdiction outside the United States to permit a public offering of our securities or possession or distribution
of this prospectus in that jurisdiction. Persons who come into possession of this prospectus in jurisdictions outside the United States
are required to inform themselves about and to observe any restrictions as to this public offering and the distribution of this prospectus
applicable to that jurisdiction.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 5; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: small-caps 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: small-caps 10pt Times New Roman, Times, Serif"><b><span id="ap_001"></span>ABOUT
THIS PROSPECTUS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Throughout
this prospectus, unless otherwise designated or the context suggests otherwise,</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
    references to the &#8220;Company,&#8221; &#8220;Algorhythm,&#8221; the &#8220;registrant,&#8221; &#8220;we,&#8221; &#8220;our&#8221;
    or &#8220;us&#8221; in this prospectus mean Algorhythm Holdings, Inc. and its wholly owned subsidiaries;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.35in; text-indent: -0.2in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;year&#8221;
    or &#8220;fiscal year&#8221; means the year ending December 31; and</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.35in; text-indent: -0.2in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
    dollar or $ references, when used in this prospectus, refer to United States dollars.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: small-caps 10pt Times New Roman, Times, Serif"><b><span id="ap_002"></span>MARKET
DATA</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Market
data and certain industry data and forecasts used throughout this prospectus were obtained from internal company surveys, market research,
consultant surveys, publicly available information, reports of governmental agencies and industry publications and surveys. Industry
surveys, publications, consultant surveys and forecasts generally state that the information contained therein has been obtained from
sources believed to be reliable, but the accuracy and completeness of such information is not guaranteed. To our knowledge, certain third-party
industry data that includes projections for future periods does not take into account the effects of certain events such as the impact
of the war in Ukraine and Israel, any possible recession may have on the sales of our products and any future outbreaks of coronavirus
(COVID-19). Accordingly, those third-party projections may be overstated and should not be given undue weight. Forecasts are particularly
likely to be inaccurate, especially over long periods of time. In addition, we do not necessarily know what assumptions regarding general
economic growth were used in preparing the forecasts we cite. Statements as to our market position are based on the most currently available
data. Any website references (URLs) in this prospectus are inactive textual references only and are not active hyperlinks. Therefore,
such website references and information accessible from the websites do not constitute a part of, and is not incorporated by reference
into, the registration statement of which this prospectus forms a part. While we are not aware of any misstatements regarding the industry
data presented in this prospectus, our estimates involve risks and uncertainties and are subject to change based on various factors,
including those discussed under the heading &#8220;<i>Risk Factors</i>&#8221; in this prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ap_003"></span>PROSPECTUS
SUMMARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>This
summary highlights selected information from this prospectus and does not contain all of the information that you need to consider in
making your investment decision. You should carefully read the entire prospectus, the applicable prospectus supplement and any related
free writing prospectus, including the risks of investing in our securities discussed under the heading &#8220;Risk Factors&#8221; contained
in the applicable prospectus supplement and any related free writing prospectus.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
operations include our wholly owned subsidiaries, SMC Logistics, Inc., a California corporation (&#8220;SMCL&#8221;), SMC-Music, Inc.,
a Florida corporation (&#8220;SMCM&#8221;), SMC (HK) Limited, a Hong Kong company (&#8220;SMH&#8221;), The Singing Machine Company, Inc.,
a Delaware corporation (&#8220;Singing Machine&#8221;), MICS Hospitality Holdings, Inc., a Delaware corporation (&#8220;MICS Hospitality&#8221;),
MICS Hospitality Management, LLC, a Delaware limited liability company (&#8220;MICS Hospitality Management&#8221;), MICS Nomad, LLC,
a Delaware limited liability company (&#8220;MICS NY&#8221;) and SemiCab Holdings, LLC, a Nevada limited liability company (&#8220;SemiCab&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Overview</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Algorhythm
Holdings, Inc. is an AI technology and consumer electronics holding company with two primary business units &#8211; SemiCab and Singing
Machine. SemiCab is an AI enabled global software logistics business operated through our subsidiary SemiCab Holdings. Singing Machine
is a worldwide leader in the home karaoke consumer products market that designs and distributes karaoke products globally to retailers
and ecommerce partners.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Consumer
Electronics </i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
engage in the development, marketing, and sale of consumer karaoke audio equipment, accessories, and musical recordings. We believe we
are a leading global karaoke and music entertainment company that specializes in the design and production of quality karaoke and music
enabled consumer products for adults and children. Our products are among the most widely available karaoke products in the world. Our
mission is to &#8220;create joy through music.&#8221; To deliver on this mission, we are focused on the following multi-prong approach:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    the short-term, improve profitability by optimizing operations and continue to expand gross margins; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    the mid-to-long-term, continue to expand into new verticals including automotive and connected-TV devices and grow our global distribution
    for our consumer karaoke products.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>AI
Logistics </i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SemiCab
is a cloud-based Collaborative Transportation Platform built to achieve the scalability required to predict and optimize millions of
loads and hundreds of thousands of trucks. To orchestrate collaboration across manufacturers, retailers, distributors, and their carriers,
SemiCab uses real-time data from API-based load tendering and pre-built integrations with TMS and ELD partners. To build fully loaded
round trips, SemiCab uses AI/ML techniques and advanced predictive optimization models. On the SemiCab platform, shippers pay less and
carriers make more while not having to change a thing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
2020, SemiCab has enabled major retailers, brands and transportation providers to address their transportation needs globally. SemiCab&#8217;s
Orchestrated Collaboration&#8482; AI model has proven to increase transportation capacity, improve asset utilization, reduce empty miles,
lower logistics costs, and provide visibility into the entire transportation network. Models show the technology has the capability of
saving shippers tens of billions of dollars annually through optimization. Further, SemiCab&#8217;s technology also has the potential
to play a key role in the improved sustainability model globally. Based on its proven ability to improve truck utilization rates from
65% to over 90%, this results in a dramatic reduction in the carbon footprint of the industry. The optimization of existing truck utilization
can add approximately 30% more trucking capacity without adding more trucks, drivers or driven miles which addresses common problems
plaguing the industry like severe driver shortage and road congestion. Trucking optimization could also eliminate approximately 25% of
CO2 emissions attributable to road freight.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 7; Options: NewSection -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Change
in Fiscal Year </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
2023, our Board of Directors approved a change in our fiscal year end from March 31 to December 31.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
and Symbol Change</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
September 5, 2024, our Certificate of Incorporation was amended to effect a change in the name of the Company from &#8220;The Singing
Machine Company, Inc.&#8221; to &#8220;Algorhythm Holdings, Inc.&#8221; In addition, effective September 8, 2024, the Company&#8217;s
ticker symbol was changed from &#8220;MICS&#8221; to &#8220;RIME.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Recent
Events and Developments</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Oxford
Credit Facility</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 28, 2024, the Company and Oxford Commercial Finance, a Michigan banking corporation, (referred to as &#8220;Oxford&#8221;) entered
into a Loan Agreement (the &#8220;Loan Agreement&#8221;) and related Revolving Credit Note (the &#8220;Note&#8221;) for a $2 million
revolving line of credit (the &#8220;Oxford Line of Credit&#8221;). On October 17, 2024, the Company terminated the Loan Agreement and
the Note. As of the date of termination, the Company had no outstanding amounts owed to Oxford and paid a termination fee of $40,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>ATM
Offering June 2024</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 26, 2024, the Company entered into an At-The-Market Issuance Sales Agreement (the &#8220;Sales Agreement&#8221;) with Ascendiant
Capital markets, LLC, as sales agent (the &#8220;Agent&#8221;), pursuant to which the Company could offer and sell, from time to time,
through the Agent (the &#8220;ATM Offering&#8221;), up to approximately $1,100,000 in shares of the Company&#8217;s common stock. On
July 8, 2024, the Company entered into the First Amendment to the Sales Agreement (the &#8220;Amendment&#8221;) to increase the number
of shares to be sold in the ATM Offering to $2,020,000. On August 9, 2024, the Company entered into the Second Amendment to the Sales
Agreement (the &#8220;Amendment&#8221;) to increase the number of shares to be sold in the ATM Offering to $3,100,000. Pursuant to the
agreement, the Agent was paid $30,000 in fees to cover legal and administrative expenses and will receive an amount equal to 3% of the
gross proceeds from each sale of the Company&#8217;s share of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Through
the date of this prospectus, the Company has sold 3,835,500 shares of common stock under the Sales Agreement and received net proceeds
of approximately $2,975,615 after payment of brokerage commissions and administrative fees to the agent of approximately $123,045.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Asset
Purchase</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 11, 2024, the Company and its wholly owned subsidiary SemiCab Holdings, LLC, a Nevada limited liability company (&#8220;SemiCab
LLC&#8221; and collectively with the Company, the &#8220;Buyer&#8221;), SemiCab, Inc., a Delaware corporation (&#8220;SemiCab&#8221;
or the &#8220;Seller&#8221;), Ajesh Kapoor and Vivek Sehgal entered into an asset purchase agreement (the &#8220;Asset Purchase Agreement&#8221;)
pursuant to which the Seller agreed to sell and assign to the Company, and the Company agreed to purchase and assume from the Seller,
substantially all the assets, and certain specified liabilities relating to the business of the Seller. Subject to certain exceptions
set forth in the Asset Purchase Agreement, the parties agreed that the Buyer will not assume the liabilities of the Seller.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 3, 2024, the parties closed on the transactions contemplated by the Asset Purchase Agreement and the Company issued to the Seller
(i) 641,806 shares of the Company&#8217;s common stock (ii) a twenty percent (20%) membership interest in SemiCab LLC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the asset acquisition agreement, the Company and Seller entered into an option agreement (the &#8220;Option Agreement&#8221;), granting
the Buyer the right to acquire all of the issued and outstanding capital securities of SMCB Solutions Private Limited, a wholly owned
subsidiary of the Seller, in consideration for 320,903 shares of common stock of the Company. The Company has not yet exercised the option.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 8 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Hospitality
Lease</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 23, 2023, MICS NY entered into an Agreement of Lease (the &#8220;Lease Agreement&#8221;) with OAC 111 Flatiron, LLC and OAC Adelphi,
LLC (the &#8220;Landlord&#8221;), pursuant to which MICS NY agreed to lease approximately 10,000 square feet of ground floor retail space
and a portion of the basement underneath the ground floor retail space in the property located at 111 West 24<sup>th</sup> Street, New
York, New York (the &#8220;Premises&#8221;). It was the Company&#8217;s intention to use the Premises as a new karaoke venue, offering
immersive karaoke technology and audio-visual capabilities, with restaurant and bar offerings however due to lack of funding, the Company
initiated termination of the lease in March.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 26, 2024, OAC 111 Flatiron, LLC and OAC Adelphi, LLC (the &#8220;Landlord&#8221;), filed a civil action in the Supreme Court of
the State of New York against MICS Nomad LLC, a subsidiary of the Company (&#8220;MICS NY&#8221;), and the Company (&#8220;the Defendants&#8221;)
for alleged breach of lease, seeking monetary damages including unpaid rent, future unpaid rent, and other expenses related to the lease.
The complaint alleges the Defendants breached the lease in various material respects.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 25, 2024, the Company entered into a Settlement Agreement for a full release and dismissal of the complaint within 5 business
days of the Company&#8217;s payment of $250,000. The Company made full payment on October 25, 2024 and the Landlord filed a discontinuance
with prejudice on October 29, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Private
Placement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 22, 2024, the Company entered into a Securities Purchase Agreement (the &#8220;SPA&#8221;) with the Selling Stockholders pursuant
to which we sold, in a private placement (the &#8220;Private Placement&#8221;), secured notes with an aggregate principal amount of $2,352,941
(the &#8220;Notes&#8221;), and received proceeds before expenses of $2,000,000. As consideration for entering into the SPA, we issued
a total of 2,299,998 shares of common stock of the Company to the Selling Stockholders on October 24, 2024. The Selling Stockholders&#8217;
resale of these shares is being registered on the registration statement of which this prospectus forms a part.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Amended Bylaws</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On October 18, 2024, the
Company amended its Amended By-laws (the &#8220;By-law Amendment&#8221;), for the purpose of reducing the quorum required to hold meetings
of the stockholders of the Company (the &#8220;Quorum Requirement&#8221;). The By-law Amendment reduced the Quorum Requirement from a
majority to thirty-three and one-third percent (33 1/3%) of the voting power of the shares of stock issued and outstanding and entitled
to vote at the meeting. The By-law Amendment was approved by the Board of Directors of the Company on October 18, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Share
Repurchase</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 1, 2024, the Company entered into a Stock Repurchase Agreement (the &#8220;Repurchase Agreement&#8221;) with Regalia Ventures
LLC, a Delaware limited liability company (the &#8220;Seller&#8221;), pursuant to which the Company agreed to repurchase from the Seller
an aggregate of 1,098,901 issued and outstanding shares of common stock, par value $0.01 per share, of the Company (the &#8220;Shares&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
shares of common stock to be repurchased were originally issued to the Seller on November 21, 2023, pursuant to a certain stock purchase
agreement, dated November 20, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the terms of the Repurchase Agreement, the Company has agreed to repurchase from the Seller, and the Seller has agreed to sell,
assign and transfer to the Company, all of the Seller&#8217;s right, title and interest in and to the Shares, at a price per Share
equal to the higher of: (1) the closing price of the common stock on the last trading day immediately preceding the date of the
Repurchase Agreement; or (2) the highest volume weighted average price (VWAP) of the common stock during a pricing period of ten
(10) consecutive trading days prior to the date of the Repurchase Agreement per share (the &#8220;Purchase Price&#8221;), and the
Company shall issue to the Seller a promissory note in the principal amount equal to the Purchase Price, substantially in the form
attached to the Repurchase Agreement as Exhibit A (the &#8220;Note&#8221;), and subject to terms and conditions
therein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
obligations of each of the Company and the Seller to consummate the closing are conditioned upon the (i) issuance by the Company to the
Seller the Note evidencing the Purchase Price and (ii) the Seller&#8217;s delivery to the Company of executed stock power with a medallion
signature guarantee. As of the date of this prospectus, the transaction contemplated by the Repurchase Agreement has not yet closed.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Our
Resale Offering</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Selling Stockholders will be selling through the Resale Prospectus a total of 2,840,344 shares of common stock. We will not receive
any proceeds from the sales by the Selling Stockholders of the securities set forth in the Resale Prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Resale Prospectus is substantively identical to the Public Offering Prospectus, except for the following principal points:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">they
    contain different outside and inside front covers and back covers;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35in; text-indent: -0.2in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">they
    contain different &#8220;<i>Offering</i>&#8221; sections in the &#8220;<i>Prospectus Summary</i>&#8221; section beginning on page
    Altr 2;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35in; text-indent: -0.2in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">they
    contain different &#8220;<i>Use of Proceeds</i>&#8221; sections on page Altr 9;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    &#8220;<i>Capitalization</i>&#8221; and &#8220;<i>Dilution</i>&#8221; sections from the Public Offering Prospectus are deleted from
    the Resale Prospectus;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35in; text-indent: -0.2in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    &#8220;<i>Selling Stockholders</i>&#8221; section is included in the Resale Prospectus;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35in; text-indent: -0.2in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    &#8220;<i>Plan of Distribution</i>&#8221; section from the Public Offering Prospectus is deleted from the Resale Prospectus and a
    &#8220;<i>Selling Stockholder Plan of Distribution</i>&#8221; is inserted in its place in the Resale Prospectus; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    &#8220;<i>Legal Matters</i>&#8221; section in the Resale Prospectus on page Altr 12 deletes the reference to counsel for the
    placement agent.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<!-- Field: Page; Sequence: 9 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Summary
Risk Factors</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
business is subject to a number of risks. You should be aware of these risks before making an investment decision. These risks are summarized
and discussed more fully in the &#8220;<i>Risk Factors</i>&#8221; section of this prospectus. This offering and the ownership of our
common stock is subject to a number of risks. You should be aware of these risks before making an investment decision. These risks are
discussed more fully in the &#8220;<i>Risk Factors</i>&#8221; section of this prospectus. These risks include, among others, that:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Risks
Related to this Offering and the Ownership of Our Securities</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchasers
                                            in this offering will suffer immediate dilution.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                            may experience future dilution as a result of future equity offerings or acquisitions.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
                                            management will have broad discretion over the use of the net proceeds from this offering.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
                                            common stock may be affected by limited trading volume and price fluctuations, which could
                                            adversely impact the value of the Securities.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FINRA
                                            sales practice requirements may limit a stockholder&#8217;s ability to buy and sell our securities.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
                                            investment in our securities is speculative, and there can be no assurance of any return
                                            on any such investment.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            may need, but be unable, to obtain additional funding on satisfactory terms, which could
                                            dilute our stockholders or impose burdensome financial restrictions on our business.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            have identified material weaknesses in our internal control over financial reporting. Failure
                                            to maintain effective internal controls could cause our investors to lose confidence in us
                                            and adversely affect the market price of our common stock. If our internal controls are not
                                            effective, we may not be able to accurately report our financial results or prevent fraud.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            requirements of being a public company may strain our resources, divert management&#8217;s
                                            attention and affect our results of operations.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            we are not able to comply with the applicable continued listing requirements or standards
                                            of The NASDAQ Capital Market, The NASDAQ Capital Market could delist and adversely affect
                                            the market price and liquidity of our common stock.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
                                            laws, regulations, and standards relating to corporate governance and public disclosure may
                                            create uncertainty for public companies, increase legal and financial compliance costs and
                                            make some activities more time consuming.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                                            a &#8220;smaller reporting company&#8221; under applicable law, we are subject to lessened
                                            disclosure requirements, which could leave our stockholders without information or rights
                                            available to stockholders of more mature companies.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            currently do not intend to declare dividends on our common stock in the foreseeable future
                                            and, as a result, your returns on your investment may depend solely on the appreciation of
                                            our common stock.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                            should consult your own independent tax advisor regarding any tax matters arising with respect
                                            to the securities offered in connection with this offering.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            may be subject to securities litigation, which is expensive and could divert our management&#8217;s
                                            attention.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            may be unable to repay our indebtedness under the secured notes, and any default could harm
                                            our financial condition and could lead to us losing our collateralized assets.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 10 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Risks
Related to the Warrants and Pre-Funded Warrants</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
                                            is no public market for the Warrants and the Pre-Funded Warrants.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lack
                                            of voting rights.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
                                            and conversion dilution.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            the Warrants are deemed to be non-compliant with Nasdaq rules, we may be required to amend
                                            the terms of the Warrants, and could be subject to delisting.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adjustments
                                            to the terms of Pre-Funded Warrants.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Warrants are not exercisable until shareholder approval is obtained, and, in certain cases,
                                            may be redeemed by us prior to their expiration.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            the Series B Warrants are exercised by way of an alternative cashless exercise, investors
                                            may suffer substantial dilution.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Warrants and the Pre-Funded Warrants have beneficial ownership limitations.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            will not receive any meaningful amount of additional funds upon the exercise of the Pre-Funded
                                            Warrants.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            may not receive any additional funds upon the exercise of the Series B Warrants.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Risks
Related to Our Company and Financial Condition</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            may encounter difficulties accessing capital.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            have incurred significant losses, have limited cash on hand and there is substantial doubt
                                            as to our ability to continue as a going concern.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            may need to raise additional capital to fund our operations in furtherance of our business
                                            plan.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            are heavily dependent on our senior management, and a loss of a member of our senior management
                                            team could cause our stock price to suffer.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Risks
Related to the Development, Manufacturing, and Shipping of Our Products</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            we are unable to develop new karaoke products, our revenues may not continue to grow.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
                                            products are shipped from China and any disruptions of shipping could prevent of delay our
                                            customer&#8217; receipt of inventory.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
                                            manufacturing operations are located in the People&#8217;s Republic of China, subjecting
                                            us to risks common in international operations. if there is any problem with the manufacturing
                                            process, our revenues and net profitability may be reduced.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            depend on third party suppliers for parts for our karaoke machines and related products,
                                            and if we cannot obtain supplies as needed, our operations will be severely damaged.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            depend on the ability of our suppliers to manufacture our products without infringing, misappropriating
                                            of otherwise violating the intellectual property of proprietary rights of others in manufacturing
                                            our products.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 11 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Risks
Related to our Karaoke Business and Industry</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 20.25pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes
                                            in government regulations relating to international tariffs could significantly reduce our
                                            revenues, product cost and profitability.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 20.25pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            small number of our customers account for a substantial portion of our revenues, and the
                                            loss of one or more of these key customers could significantly reduce our revenues and cash
                                            flow.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 20.25pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            are subject to the risk that some of our large customers may return karaoke products that
                                            they have purchased from us and if this happens, it would reduce our revenues and profitability.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 20.25pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            are subject to pressure from our customers relating to price reduction and financial incentives
                                            and if we are pressured to make these concessions to our customers, it will reduce our revenues
                                            and profitability.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 20.25pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            experience difficulty forecasting the demand for our karaoke products and if we do not accurately
                                            forecast demand, our revenues, net income and cash flow may be affected.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 20.25pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            are subject to the costs and risks of carrying inventory for our customers and if we have
                                            too much inventory, it will affect our cash flow for operations.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 20.25pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            are subject to insurance risk of loss for goods damaged while in transit from the manufacturer
                                            to the customer and our warehouse.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 20.25pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
                                            business is seasonal and therefore our annual operating results will depend, in large part,
                                            on our sales during the relatively brief holiday season.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 20.25pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consumer
                                            discretionary spending may affect karaoke purchases and is affected by various economic conditions
                                            and changes.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 20.25pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            do not have our own warehouse or distribution facilities but rely on a third-party logistics
                                            provider responsible for warehousing and fulfilling our orders. If our third-party provider
                                            experiences disruptions to the operation of its distribution centers, it could have a material
                                            adverse effect on our business, financial condition and results of operations.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 20.25pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
                                            production costs may increase if we are required to make purchases using the Chinese Yuan
                                            instead of the U.S. dollar.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 20.25pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
                                            profit margin may be decreased due to increased prices of raw materials, shipping costs and
                                            costs associated with production.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 20.25pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            we are unable to compete in the karaoke products category, our revenues and net profitability
                                            will be reduced.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 20.25pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Many
                                            of our competitors are larger and have greater financial and other resources than we do.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 20.25pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            we ship products that contain defects, the market acceptance of our products and our reputation
                                            will be harmed and our customers could seek to recover their damages from us.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Risks
Related to our Logistics Business</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            transportation industry historically has experienced cyclical fluctuations in financial results
                                            due to economic recessions, downturns in business cycles of SemiCab&#8217;s customers, interest
                                            rate fluctuations, currency fluctuations, and other economic factors beyond SemiCab&#8217;s
                                            control.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SemiCab
                                            faces substantial industry competition.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SemiCab
                                            relies on technology to operate its business.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SemiCab&#8217;s
                                            international operations subject it to operational, financial, and data privacy risks.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SemiCab&#8217;s
                                            ability to appropriately staff and retain employees is important to its business model.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SemiCab
                                            uses, and may continue to expand its use of, machine learning and artificial intelligence
                                            (&#8220;AI&#8221;) technologies to deliver its services and operate its business.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SemiCab&#8217;s
                                            business is dependent on a small number of customers.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SemiCab
                                            is subject to claims arising from its transportation operations.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SemiCab&#8217;s
                                            business depends upon compliance with numerous government regulations.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 12 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Risks
Related To Our Intellectual Property</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 20.25pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            primarily rely on trade secret protection and non-disclosure agreements to protect our proprietary
                                            information, which may not be effective.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 20.25pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            may be forced to litigate to enforce or defend our intellectual property rights, or the intellectual
                                            property rights of our licensors.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 20.25pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            may not be able to protect our intellectual property rights throughout the world.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>General
Risk Factors</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 20.25pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
                                            information technology systems or data, or those of our service providers or customers or
                                            users could be subject to cyber-attacks or other security incidents, which could result in
                                            data breaches, intellectual property theft, claims, litigation, regulatory investigations,
                                            significant liability, reputational damage and other adverse consequences.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 20.25pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
                                            business, financial condition and results of operations may be materially adversely affected
                                            by any negative impact on the global economy and capital markets resulting from the conflict
                                            in Ukraine or any other geopolitical tensions.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 20.25pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">High
                                            inflation and unfavorable economic conditions could negatively affect our operations and
                                            results.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 20.25pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            are exposed to the credit risk of our customers, who are experiencing financial difficulties,
                                            and if these customers are unable to pay us, our revenues and profitability will be reduced.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 20.25pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            may have trouble hiring additional qualified personnel.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 20.25pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            failure of our information technology systems could significantly disrupt the operation of
                                            our business.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 20.25pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            are subject to various claims and legal actions arising in the ordinary course of our business.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 20.25pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
                                            charter provides limitations of director liability and indemnification of directors and officers
                                            and employees.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 20.25pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            our accounting controls and procedures are circumvented or otherwise fail to achieve their
                                            intended purposes, our business could be seriously harmed.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 20.25pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            requirements of being a public company may strain our resources, divert management&#8217;s
                                            attention and affect our ability to attract and retain qualified board members.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Our
Corporate Information</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
were incorporated under the laws of the State of Delaware in 1994. Our principal business address is 6301 NW 5<sup>th</sup> Way, Suite
2900, Fort Lauderdale, FL 33309, and our telephone number is (954) 596-1000. We maintain our corporate website at <i>https://ir.algoholdings.com/
</i>(this website address is not intended to function <i>as a hyperlink and the information contained on our website is not intended
to be a part of this prospectus).</i> Information on our website does not constitute a part of, nor is it incorporated in any way, into
this prospectus and should not be relied upon in connection with making an investment decision. We make available free of charge on https://ir.algoholdings.com/investor-filings#/
our annual, quarterly, and current reports, and amendments to those reports if any, as soon as reasonably practical after we electronically
file such material with, or furnish it to, the SEC. We may from time to time provide important disclosures to investors by posting them
in the Investor Relations section of our website.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
common stock is quoted on the Nasdaq under the symbol &#8220;RIME&#8221;. We file annual, quarterly, and current reports, proxy statements
and other information with the U.S. Securities Exchange Commission (the &#8220;SEC&#8221;) and are subject to the requirements of the
Securities and Exchange Act of 1934, as amended (the Exchange Act). These filings are available to the public on the Internet at the
SEC&#8217;s website at http://www.sec.gov.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 13 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ap_004"></span>SUMMARY
OF THE OFFERING</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 22%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
    offered by us</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 76%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Up
    to 43,478,261 shares of common stock on a &#8220;best efforts&#8221; basis.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants
    offered by us</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Series A Warrants and Series B Warrants will become exercisable beginning on the Initial
                                            Exercise Date at an exercise price of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
                                            (the Series B Warrants shall not exceed 200% of the Minimum Price as defined by the rules
                                            of Nasdaq). The Series A Warrants will expire on the five-year anniversary of the Initial
                                            Exercise Date and the Series B Warrants will expire on the two and one-half year anniversary
                                            of the Initial Exercise Date. The Warrants include certain mechanisms including (i) the alternative
                                            cashless exercise option. in the Series B Warrants, and (ii) certain anti-dilution
                                            provisions in the Series A Warrants. See &#8220;<i>Description of Securities-Warrants</i>.&#8221;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Warrants may be redeemed by the Company, in whole or in part, at a price of $0.01 per Warrant, by giving not less than thirty (30)
    days&#8217; prior notice to the holders of such Warrants at any time after the date on which (i) the daily volume weighted average
    trading price of the common stock of the Company exceeds $&#160;&#160;&#160; for ten (10) consecutive trading days and (ii) the average daily trading volume of
    the shares of the common stock for such ten (10)-trading day period exceeds $150,000 of shares, as determined in accordance with
    the terms of the Warrants.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    shares of common stock or the Pre-Funded Warrants, as applicable, sold in this offering and the accompanying Warrants, can only be
    purchased together in this offering but will be issued separately and will be immediately separable upon issuance. This offering
    also relates to the offering of the shares of common stock issuable upon exercise of the Warrants. The exercise price and number
    of shares of common stock issuable upon exercise will be subject to certain further adjustments as described herein. See &#8220;<i>Description
    of Securities</i>.&#8221;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    are also registering the issuance of (i) the 43,478,261 shares of our common stock underlying the Series A Warrants and (ii)
    the 43,478,261 shares of our common stock underlying the Series B Warrants.</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-Funded
    Warrants offered by us</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    are also offering the opportunity to purchase, if the purchaser so chooses and in lieu of shares, up to 43,478,261 Pre-Funded
    Warrants to purchasers whose purchase of shares in this offering would otherwise result in the purchaser, together with its affiliates
    and certain related parties, beneficially owning more than 4.99% (or, at the election of the purchaser, 9.99%) of our outstanding
    common stock immediately following the consummation of this offering. Each Pre-Funded Warrant is exercisable for one share of common
    stock. The purchase price of each Pre-Funded Warrant is equal to the price per share being sold to the public in this offering, minus
    $0.01, and the exercise price of each Pre-Funded Warrant is $0.01 per share. The Pre-Funded Warrants will be immediately exercisable
    and may be exercised at any time until all of the Pre-Funded Warrants are exercised in full. For each Pre-Funded Warrant we sell,
    the number of shares we are offering will be decreased on a one-for-one basis. This offering also relates to the shares of common
    stock issuable upon exercise of any Pre-Funded Warrants sold in this offering.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    stock outstanding prior to the offering<sup>(1)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,215,176
    shares.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    stock to be outstanding after the offering</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">57,693,437
    </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(assuming no sale of any Pre-Funded Warrants
    and none of the Warrants issued in this offering are exercised). To the extent Pre-Funded Warrants are sold, the number of shares
    of common stock sold in this offering will be reduced on a one-for-one basis.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Use
    of proceeds</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We estimate the net proceeds from this offering to
us will be approximately $8,880,000, assuming 100% of the securities offered in this offering are sold at an assumed public offering
price of $0.23 per share and accompanying Warrants, which is the last reported sale price of our common stock on The Nasdaq Capital
Market on November 20, 2024, and after deducting the estimated placement agent fees and expected offering expenses payable by
us.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">We intend to use the net proceeds
    from this offering for working capital and other general corporate purposes and to repay the principal amount of $2,352,941 in
    outstanding senior secured notes of the Company. <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
    &#8220;<i>Use of Proceeds</i>&#8221; beginning on page 31.</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Listing
    symbol</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    common stock is listed on The Nasdaq Capital Market under the symbol &#8220;RIME.&#8221; There is no established public trading market
    for the Warrants or the Pre-Funded Warrants, and we do not intend to list these securities on any national securities exchange or
    trading system. Without an active trading market, the liquidity of the Warrants and the Pre-Funded Warrants will be limited.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assumed
    offering price</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$0.23
    </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share, the closing price of our common stock
    on November 20, 2024, as reported by The Nasdaq Capital Market.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transfer
    agent</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Continental
    Stock Transfer &amp; Trust Company</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk
    factors</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
    should carefully consider the information set forth in this prospectus and, in particular, the specific factors set forth in the
    &#8220;<i>Risk Factors</i>&#8221; section beginning on page 9 of this prospectus before deciding whether or not to invest in shares
    of our common stock.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
As of November 20, 2024 and excludes:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">107,261
                                            shares of common stock issuable upon the exercise of outstanding stock options with a weighted-average
                                            exercise price of $8.07 per share;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">63,453
                                            </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
                                            of common stock reserved for future issuance under our 2022 Equity Incentive Plan; and</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">902,113
                                            shares of common stock issuable upon exercise of warrants to purchase common stock with a
                                            weighted-average exercise price of $3.20 per share.</span></td></tr></table>

<p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>


<!-- Field: Page; Sequence: 14 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ap_005"></span>RISK
FACTORS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Investing
in our securities involves a high degree of risk. Before investing in our securities, you should carefully consider the risks described
below. Each of these risk factors, either alone or taken together, could adversely affect our business, operating results and financial
condition, as well as adversely affect the value of an investment in our common stock. There may be additional risks that we do not presently
know of or that we currently believe are immaterial, which could also impair our business and financial position. If any of the events
described below were to occur, our financial condition, our ability to access capital resources, our results of operations and/or our
future growth prospects could be materially and adversely affected and the market price of our common stock could decline. As a result,
you could lose some or all of any investment you may make in our common stock.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
Related to this Offering and the Ownership of Our Securities</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Purchasers
in this offering will suffer immediate dilution.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you purchase securities in this offering, the value of your shares based on our pro forma net tangible book value will immediately be
less than the offering price you paid. This reduction in the value of your equity is known as dilution. At an assumed public offering
price of $0.23 per share and assuming no sale of any Pre-Funded Warrants and none of the Warrants issued in this offering are
exercised, purchasers of shares in this offering will experience immediate dilution of approximately $0.10 per share, representing
the difference between the assumed public offering price per share in this offering and our pro forma as adjusted net tangible book value
per share as of September 30, 2024, after giving effect to the pro forma adjustments and after deducting estimated offering expenses,
including placement agent fees, payable by us. See &#8220;<i>Dilution</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>You
may experience future dilution as a result of future equity offerings or acquisitions.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to raise additional capital, we may in the future offer additional shares of our common stock or other securities convertible into
or exchangeable for our common stock at prices that may not be the same as the price per share in this offering. We may sell shares or
other securities in any future offering at a price per share that is less than the price per share paid by investors in this offering,
and investors purchasing shares or other securities in the future could have rights superior to existing stockholders. The price per
share at which we sell additional shares of our common stock, or securities convertible or exchangeable into our common stock, in future
transactions or acquisitions may be higher or lower than the price per share paid by investors in this offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
management will have broad discretion over the use of the net proceeds from this offering.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
offering grants our management broad discretion in the application of the net proceeds. There are no contractual restrictions on how
the management can allocate the net proceeds from this offering, which may be used at their discretion for general corporate purposes,
including but not limited to, working capital, operational expenses, expansion of our business, and repayment of debt. While management
intends to use the net proceeds in a manner that furthers our business objectives and maximizes the value for our investors, investors
will have limited visibility into the specific uses of the net proceeds. This wide-ranging discretion allows management to allocate funds
to areas that investors might not deem a priority or in their best interest. Consequently, the success of the investment is substantially
dependent on the judgment of our management with regard to the application of the net proceeds. Investors should be aware that the broad
discretion in the use of proceeds increases the risk of their investment, as it may reduce the ability to assess the viability and potential
return of the investment. See &#8220;<i>Use of Proceeds</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
common stock may be affected by limited trading volume and price fluctuations, which could adversely impact the value of the Securities.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
our common stock is traded on The Nasdaq Capital Market, the volume of trading has historically been limited. Our average daily trading
volume of our shares from January 1, 2024 to September 30, 2024 was approximately 240,109 shares. Thinly traded stock can
be more volatile than stock trading in a more active public market. We cannot predict whether and to what the extent to which an active
public market for our common stock will develop or be sustained. Therefore, a holder of our common stock who wishes to sell his or her
shares may not be able to do so immediately or at an acceptable price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, our common stock has experienced, and is likely to experience, significant price and volume fluctuations in the future, which
could adversely affect the market prices of our common stock without regard to our operating performance. In addition, we believe that
factors such as quarterly fluctuations in our financial results and changes in the overall economy or the condition of the financial
markets could cause the market prices of our common stock to fluctuate substantially. These fluctuations may also cause short sellers
to periodically enter the market in the belief that we will have poor results in the future. We cannot predict the actions of market
participants and, therefore, can offer no assurances that the market for our common stock will be stable or appreciate over time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 15 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>FINRA
sales practice requirements may limit a stockholder&#8217;s ability to buy and sell our securities.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
June 30, 2020, the SEC implemented Regulation Best Interest requiring that &#8220;A broker, dealer, or a natural person who is an associated
person of a broker or dealer, when making a recommendation of any securities transaction or investment strategy involving securities
(including account recommendations) to a retail customer, shall act in the best interest of the retail customer at the time the recommendation
is made, without placing the financial or other interest of the broker, dealer, or natural person who is an associated person of a broker
or dealer making the recommendation ahead of the interest of the retail customer.&#8221; This is a significantly higher standard for
broker-dealers to recommend securities to retail customers than before under prior suitability rules of the Financial Industry Regulatory
Authority, Inc. (&#8220;FINRA&#8221;). FINRA suitability rules do still apply to institutional investors and require that in recommending
an investment to a customer, a broker-dealer must have reasonable grounds for believing that the investment is suitable for that customer.
Prior to recommending securities to their customers, broker-dealers must make reasonable efforts to obtain information about the customer&#8217;s
financial status, tax status, investment objectives and other information, and, for retail customers, determine that the investment is
in the customer&#8217;s &#8220;best interest,&#8221; and meet other SEC requirements. Both SEC Regulation Best Interest and FINRA&#8217;s
suitability requirements may make it more difficult for broker-dealers to recommend that their customers buy speculative, low-priced
securities. They may affect investing in our common stock, which may have the effect of reducing the level of trading activity in our
securities. As a result, fewer broker-dealers may be willing to make a market in our common stock, reducing a stockholder&#8217;s ability
to resell shares of our common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>An
investment in our securities is speculative, and there can be no assurance of any return on any such investment.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investors
are cautioned that an investment in the securities offered hereby is highly speculative and involves a significant degree of risk. The
success of our business and the ability to achieve our business goals and objectives, as outlined in this prospectus, are subject to
numerous uncertainties, contingencies and risks. As such, there is no assurance that investors will realize a return on their investment
or that they will not lose their entire investment. Potential investors should carefully consider whether such a speculative investment
is suitable for their financial situation and investment objectives before purchasing securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may need, but be unable, to obtain additional funding on satisfactory terms, which could dilute our stockholders or impose burdensome
financial restrictions on our business.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have relied upon cash from financing activities, and, in the future, we hope to rely on revenues generated from operations to fund the
cash requirements of our activities. However, there can be no assurance that we will be able to generate significant cash from our operating
activities in the future. Future financing may not be available on a timely basis, in sufficient amounts or on terms acceptable to us,
if at all. Any debt financing or other financing of securities senior to the common stock will likely include financial and other covenants
that will restrict our flexibility. Any failure to comply with these covenants would have a material adverse effect on our business,
prospects, financial condition and results of operations because we could lose our existing sources of funding, and our ability to secure
new sources of funding could be impaired.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 16 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
have identified material weaknesses in our internal control over financial reporting. Failure to maintain effective internal controls
could cause our investors to lose confidence in us and adversely affect the market price of our common stock. If our internal controls
are not effective, we may not be able to accurately report our financial results or prevent fraud.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
404 of the Sarbanes-Oxley Act of 2002, or Section 404, requires that we maintain internal control over financial reporting that meets
applicable standards. We may err in the design or operation of our controls, and all internal control systems, no matter how well designed
and operated, can provide only reasonable assurance that the objectives of the control system are met. Because there are inherent limitations
in all control systems, there can be no assurance that all control issues have been or will be detected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
we disclosed in our Transition Report on Form 10-KT for the nine-month period ended December 31, 2023, we disclose that our management
has assessed and identified several material weaknesses in our internal controls over financial reporting (&#8220;ICFR&#8221;) and concluded
that our IFCR was not effective as of December 31, 2023. The material weaknesses included our lack of sufficient resources in our accounting
department restricting our ability to (i) review and approve certain material journal entries which increases the likelihood that a material
misstatement of interim or annual financial statements might not be prevented, (ii) review certain material reconciliations related to
financial reporting in a timely manner and (iii) establish a three-way match of documents or other controls precise enough to detect
a material misstatement in revenue.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
we have taken several steps to remediate the material weaknesses in our IFCR and continue to do so, there can be no assurances given
that our actions will be effective. Any continued failure of our internal control over financial reporting could have a material adverse
effect on our stated results of operations and harm our reputation. If we are unable to implement these changes effectively or efficiently,
it could harm our operations, financial reporting or financial results and could result in an adverse opinion on internal controls from
our independent auditors. Furthermore, investor perceptions of our Company may suffer, and this could cause a decline in the market price
of our common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
the expenses incurred by public companies generally for reporting and corporate governance purposes have been increasing. These increased
costs will require us to divert a significant amount of money that we could otherwise use to develop our business. If we are unable to
satisfy our obligations as a public company, we could be subject to delisting of our common stock, fines, sanctions and other regulatory
action and potentially civil litigation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
requirements of being a public company may strain our resources, divert management&#8217;s attention and affect our results of operations.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a public company in the United States, we face increased legal, accounting, administrative and other costs and expenses. We are subject
to the reporting requirements of the Exchange Act and the Sarbanes-Oxley Act of 2002 (the &#8220;Sarbanes Oxley-Act&#8221;). The Exchange
Act requires, among other things, that we file annual, quarterly and current reports with respect to our business and financial condition.
The Sarbanes- Oxley Act requires, among other things, that we maintain effective disclosure controls and procedures and internal control
over financial reporting. For example, Section 404 requires that our management report on the effectiveness of our internal controls
structure and procedures for financial reporting. Section 404 compliance may divert internal resources and will take a significant amount
of time and effort to complete. If we fail to maintain compliance under Section 404, we could be subject to sanctions or investigations
by Nasdaq, the SEC, or other regulatory authorities. Furthermore, investor perceptions of our Company may suffer, and this could cause
a decline in the market price of our common stock. Any continued failure of our internal control over financial reporting could have
a material adverse effect on our stated results of operations and harm our reputation. If we are unable to implement these changes effectively
or efficiently, it could harm our operations, financial reporting or financial results and could result in an adverse opinion on internal
controls from our independent auditors. We may need to hire a number of additional employees with public accounting and disclosure experience
in order to meet our ongoing obligations as a public company, particularly if we become fully subject to Section 404 and its auditor
attestation requirements, which will increase costs, and evaluate the costs of our current service providers. We expect these rules and
regulations to increase our legal and financial compliance costs and to make some activities more time- consuming and costly, although
we are currently unable to estimate these costs with any degree of certainty. A number of those requirements will require us to carry
out activities we have not done previously. Our management team and other personnel will need to devote a substantial amount of time
to new compliance initiatives and to meeting the obligations that are associated with being a public company, which may divert attention
from other business concerns, which could have a material adverse effect on our business, financial condition and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
the expenses incurred by public companies generally for reporting and corporate governance purposes have been increasing. These increased
costs will require us to divert a significant amount of money that we could otherwise use to develop our business. If we are unable to
satisfy our obligations as a public company, we could be subject to delisting of our common stock, fines, sanctions and other regulatory
action and potentially civil litigation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 17 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
we are not able to comply with the applicable continued listing requirements or standards of The NASDAQ Capital Market, The NASDAQ Capital
Market could delist and adversely affect the market price and liquidity of our common stock.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
common stock is currently traded on The NASDAQ Capital Market under the symbol &#8220;RIME&#8221;. If we fail to meet any of the continued
listing standards of The NASDAQ Capital Market, our common stock will be delisted from The NASDAQ Capital Market.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
continued listing standards include specifically enumerated criteria, such as a $1.00 minimum closing bid price and a requirement that
we maintain stockholder&#8217;s equity of at least $2,500,000. On August 26, 2024, we received a letter from The NASDAQ Stock Market
advising that the Company did not meet the minimum $1.00 per share bid price requirement for continued inclusion on The NASDAQ Capital
Market pursuant to NASDAQ Marketplace Listing Rule 5550(a)(2). To demonstrate compliance with this requirement, the closing bid price
of our common stock needs to be at least $1.00 per share for a minimum of 10 consecutive business days before February 24, 2025. In order
to satisfy this requirement, the Company intends to continue actively monitoring the bid price for its common stock between now and February
24, 2025 and will consider available options to resolve the deficiency and regain compliance with the minimum bid price requirement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition on August 26, 2024, we received a letter from The NASDAQ Stock Market indicating that the Company&#8217;s stockholders&#8217;
equity as reported in our Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2024 (the &#8220;Form 10-Q&#8221;), did
not satisfy the continued listing requirement under Nasdaq Listing Rule 5550(b)(1) (the &#8220;Listing Rule&#8221;), which requires that
a listed company&#8217;s stockholders&#8217; equity be at least $2,500,000 (the &#8220;Stockholders&#8217; Equity Requirement&#8221;).
As reported in its Form 10-Q, the Company&#8217;s stockholders&#8217; equity as of June 30, 2024 was ($872,000). Pursuant to the
Nasdaq Listing Rule and instructions from Nasdaq, the Company submitted a plan to regain compliance with the Listing Rule and was given
an extension until November 14, 2024 to evidence compliance through a public filing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">On November
13, 2024, the Company filed a Form 8-K stating that it believed it regained compliance with the Equity Rule. As reported in our
Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2024, the Company reported stockholders&#8217; equity of
approximately $2.7&#160;million. On November 22, 2024, the Company received a letter from The NASDAQ Stock Market indicating that
based on the Form 8-K filed on November 13, 2024, the Staff has determined that the Company is in compliance with the Listing Rule.
NASDAQ has advised the Company that it will continue to monitor the Company&#8217;s ongoing compliance with the stockholders&#8217;
equity requirement and, if at the time of its next periodic report the Company does not evidence compliance, that it may be subject
to delisting.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>New
laws, regulations, and standards relating to corporate governance and public disclosure may create uncertainty for public companies,
increase legal and financial compliance costs and make some activities more time consuming.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
laws, regulations and standards are subject to varying interpretations, in many cases due to their lack of specificity, and, as a result,
may evolve over time as new guidance is provided by the courts and other bodies. This could result in continuing uncertainty regarding
compliance matters and higher costs necessitated by ongoing revisions to disclosure and governance practices. If our efforts to comply
with new laws, regulations, and standards differ from the activities intended by regulatory or governing bodies due to ambiguities related
to their application and practice, regulatory authorities may initiate legal proceedings against us, and our business may be adversely
affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>As
a &#8220;smaller reporting company&#8221; under applicable law, we are subject to lessened disclosure requirements, which could leave
our stockholders without information or rights available to stockholders of more mature companies.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a &#8220;smaller reporting company&#8221; as defined in Rule 12b-2 of the Exchange Act. As a smaller reporting company, we are permitted
to comply with reduced disclosure obligations in our SEC filings compared to larger public companies. This includes, but is not limited
to, simplified executive compensation disclosures, reduced financial statement requirements, and less stringent narrative disclosure
obligations. While these scaled disclosure requirements may reduce the burden on us and provide some cost savings, investors should be
aware that they may also receive less information about the Company than they would from a larger public reporting company. The designation
as a smaller reporting company and the accompanying reduced disclosure requirements could make it more difficult for investors to fully
assess the value and risks of an investment in our securities. Consequently, the designation as a smaller reporting company under the
SEC rules increases the risk to investors, as it may limit the amount of publicly available information to assess the Company&#8217;s
performance, prospects, and financial health. Potential investors should consider the implications of these reduced disclosure requirements
when making an investment decision.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 18 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
currently do not intend to declare dividends on our common stock in the foreseeable future and, as a result, your returns on your investment
may depend solely on the appreciation of our common stock.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have never declared or paid any cash dividends on our common stock, and we currently do not anticipate declaring or paying any cash dividends
in the foreseeable future. Instead, we plan to retain all available funds and any future earnings to support operations and finance the
growth and development of our business. This reinvestment strategy means that investors should not expect to receive any return on their
investment through dividend payments. Consequently, any return on investment will likely depend on the appreciation of the price of our
common stock, which may never occur. Investors should be aware that the possibility of a lack of dividend income can significantly reduce
the potential for income from their investment in our Company, and the only opportunity for achieving a return on their investment may
be through the sale of their shares at a price greater than their purchase price, which may not be possible. This risk is compounded
by the market&#8217;s volatile nature and the speculative nature of our business, which may not lead to sufficient profits or operational
cash flows to enable dividend payments in the future. Potential investors should carefully consider the long-term nature of an investment
in our company, given our intention not to pay dividends and the consequent requirement for investors to seek returns through other means,
such as capital appreciation, which may not materialize.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>You
should consult your own independent tax advisor regarding any tax matters arising with respect to the securities offered in connection
with this offering.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Participation
in this offering could result in various tax-related consequences for investors. All prospective purchasers of the resold securities
are advised to consult their own independent tax advisors regarding the U.S. federal, state, local and non-U.S. tax consequences relevant
to the purchase, ownership and disposition of the resold securities in their particular situations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may be subject to securities litigation, which is expensive and could divert our management&#8217;s attention.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
market price of our securities may be volatile, and in the past companies that have experienced volatility in the market price of their
securities have been subject to securities class action litigation. We may be the target of this type of litigation in the future. Securities
litigation against us could result in substantial costs and divert our management&#8217;s attention from other business concerns.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may be unable to repay our indebtedness under the secured notes, and any default could harm our financial condition and could lead to
us losing our collateralized assets.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
October 2024, pursuant to a Securities Purchase Agreement, we issued Senior Secured Notes (the &#8220;Notes&#8221;) to the Selling Stockholders.
The Notes have an aggregate principal amount of $2,352,941 with an original issue discount of 15%, and rank senior to any other Company
indebtedness and our capital stock in the event of a liquidation, including the securities being offered hereby. Concurrently with issuing
the Notes, the Company and our wholly-owned subsidiaries entered into a Guarantee Agreement under which our wholly-owned subsidiaries
guaranteed all of the obligations under the Notes. The Notes will mature on February 24, 2025. We further granted the Selling Stockholders
a first lien and continuing first priority security interest in all of our and our subsidiaries&#8217; assets as collateral for the Notes.
While the Notes are outstanding, the Company agreed to certain restrictive covenants, including covenants providing that the Company
and its subsidiaries are not permitted to incur any indebtedness, create any other liens or security interests on property or assets,
make payments on any other indebtedness, change its business, or license our intellectual property, unless the Selling Stockholders give
their prior written consent, which restrictions could materially adversely impact our operations and prevent or delay the execution of
our business plan, strategic transactions or capital raising efforts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may be unable to repay our indebtedness under the Notes. If we default on the Notes, we will be subject to a 14% interest rate, and the
Selling Stockholders may seek to exercise their security interest in our pledged collateral. If the Selling Stockholders seek to foreclose
on their security interest in our pledged collateral, we may lose some or all of our assets, which could cause severe interruptions in
our business practices or temporarily or permanently suspend our business operations. Our failure to repay the Notes and the consequences
therefrom may negatively impact our financial condition and business operations and, in turn, your investment in us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 19 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
Related to the Warrants and Pre-Funded Warrants</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>There
is no public market for the Warrants and the Pre-Funded Warrants.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrants and the Pre-Funded Warrants offered in this offering are not and will not be listed on any securities exchange. Also, we do
not intend to apply to have the Warrants and the Pre-Funded Warrants listed on any securities exchange. Consequently, there is no public
trading market for the warrants, and we do not expect a market to develop. Accordingly, investors may find it difficult to dispose of,
or to obtain accurate quotations as to the market value of, the warrants. This lack of a trading market could result in investors being
unable to liquidate their investment in the warrants or to sell them at a price that reflects their value. The absence of a public market
for these securities could also reduce the liquidity and market price of our common stock to which these warrants are exercisable. Investors
should be prepared to bear the risk of investment in the Warrants and the Pre-Funded Warrants indefinitely.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Lack
of voting rights.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders
of the Warrants and the Pre-Funded Warrants will not have the same voting rights as those associated with our common stock and may have
no voting rights with respect to the shares underlying the warrants until such shares are acquired upon exercise of the warrants. As
a result, if such holders do not exercise their warrants, they will not have any influence over matters requiring stockholder approval
during the period they hold the Warrants and Pre-Funded Warrants, as applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Exercise
and conversion dilution.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
exercise of the Warrants and the Pre-Funded Warrants will increase the number of shares of common stock issued and outstanding, which
will dilute the ownership interests of existing stockholders. The amount of dilution, or the reduction in value to existing shares of
common stock, is determined by the amount of shares ultimately obtained upon the exercise of the warrants relative to the number of shares
of common stock outstanding at the time of exercise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
the Warrants are deemed to be non-compliant with Nasdaq rules, we may be required to amend the terms of the Warrants, and could be subject
to delisting.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
the Company believes the Warrants are compliant with the rules and regulations of Nasdaq, the Company cannot provide any guarantee that
the Warrants or, based on the Warrants, this offering are compliant with such rules and regulations, and Nasdaq may require amendment
to the terms of the Warrants in order to comply with its rules and regulations including terms that are less favorable to the investors
in this offering. Additionally, if we are unable to adequately address Nasdaq rules, our common stock could be subject to delisting from
Nasdaq, which would materially adversely affect our liquidity and investors&#8217; investment in our securities. See the risk factor
titled &#8220;<i>We may not be able to continue to satisfy listing requirements of Nasdaq to maintain a listing of our common stock</i>.&#8221;
on page 9.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Adjustments
to the terms of Pre-Funded Warrants.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms of the Pre-Funded Warrants, including the exercise price and the number of shares of common stock issuable upon exercise, may be
adjusted in certain circumstances, including in the event of stock dividends, stock splits, and similar transactions. While adjustments
are generally intended to prevent dilution for holders of Pre-Funded Warrants, there is no assurance that such adjustments will fully
protect the value of the Pre-Funded Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 20 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
Warrants are not exercisable until shareholder approval is obtained and, in certain cases, may be redeemed by us prior to their expiration.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Series A Warrants and the Series B Warrants are not exercisable unless and until the Warrant Shareholder Approval is obtained from our
stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
adjustments to the exercise price of the Warrants will be subject to a floor price equal to 50% of the Nasdaq Minimum Price prior to
the Effective Shareholder Approval Date, and 20% of the Nasdaq Minimum Price beginning on the Effective Shareholder Approval Date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
we may redeem such Warrants for a nominal price upon 30 days&#8217; prior notice to holders of the Warrants in certain circumstances.
In the event that the trading price of the common stock is then lower than the applicable exercise price, or if the trading price of
the common stock decreases to below the applicable exercise price due to large amounts of investors exercising their Warrants at such
time, or the market&#8217;s expectation that such exercises will occur, then the Warrants may be &#8220;out-of-the-money&#8221; and you
may choose not to exercise them prior to redemption by us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
the Series B Warrants are exercised by way of an alternative cashless exercise, investors may suffer substantial dilution.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Series B Warrants are exercised by way of an alternative cashless exercise, assuming receipt of Shareholder Approval, such exercising
holder will receive approximately three shares of common stock for each Series B Warrant they exercise, without any cash payment to us.
Such issuance will result in substantial dilution to stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
Warrants and the Pre-Funded Warrants have beneficial ownership limitations.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
investment in our Warrants and Pre-Funded Warrants involves a significant risk due to the 4.99% (or 9.99% if the investor so elects)
beneficial ownership limitation. The terms of the Warrants and the Pre-Funded Warrants prohibit any single holder from exercising the
warrants if such exercise would result in the holder beneficially owning more than 4.99% (or 9.99% if the investor so elects) of our
outstanding common stock immediately after the exercise, as elected by the holder at the time of issuance of the warrants. This limitation
may also hinder the holder&#8217;s ability to sell or exercise the Warrants or the Pre-Funded Warrants when it may be most advantageous
to do so, which could affect the value of their investment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
will not receive any meaningful amount of additional funds upon the exercise of the Pre-Funded Warrants.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Pre-Funded Warrant will be exercisable and will have no expiration date and by means of payment of the nominal cash purchase price upon
exercise. Accordingly, we will not receive any or any meaningful additional funds upon the exercise of the Pre-Funded Warrant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may not receive any additional funds upon the exercise of the Series B Warrants.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we receive Shareholder Approval, the Series B Warrants may be exercised by way of an alternative cashless exercise, in which case the
holder would not pay a cash purchase price upon exercise, but instead would receive upon such exercise the number of shares equal to
the product of (x) the aggregate number of shares of common stock that would be issuable upon a cashless exercise of the Series B Warrants
and (y) 1.0. Accordingly, we will likely not receive any additional funds upon the exercise of the Series B Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
Related to Our Company and Financial Condition</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may encounter difficulties accessing capital.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have historically been reliant on third party working capital debt providers, and on periodic equity capital transactions to supplement
our access to capital. Under certain circumstances, including the maintenance of our Nasdaq listing status, governmental regulatory compliance
and other conditions, we may or may not continue to have access to either debt or equity capital. In the event of a loss of access to
capital, there are no assurances that the Company will be able to continue to operate without material changes to its cost structure
or revenue composition. There are also no assurances that even with such changes, that the Company could otherwise self-fund its ongoing
operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 21 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
have incurred significant losses, have limited cash on hand and there is substantial doubt as to our ability to continue as a going concern.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">The Company
incurred net losses of approximately $7,292,000 and $5,348,000 for the nine months ended September 30,
2024 and 2023, respectively. In addition, the Company had accumulated deficits of approximately $33,206,000 and $25,915,000
as of September 30, 2024 and December 31, 2023, respectively, and net cash used in operating activities was $7,069,000
and net cash provided by $760,000 for the nine month periods ended September 30, 2024 and 2023, respectively.
As of September 30, 2024, the Company&#8217;s unrestricted cash balance was $621,000. Based on cash flow projections
from operating and financing activities and the existing balance of cash, management is of the opinion that the Company has
insufficient funds to sustain operations for at least one year after the date of this report, and it may not be able to meet its
payment obligations from operations and related commitments, if the Company is not able to obtain outside financing to allow the
Company to continue as a going concern. Based on these factors, the Company has substantial doubt that it will continue as a going
concern for the twelve months following the issuance date of the financial statements included elsewhere in this report.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s plan to alleviate the going concern issue is to increase revenue while controlling operating costs and expenses and obtaining
funds from outside sources of financing to generate positive financing cash flows. While management is optimistic about its ability to
raise funds to fund operations for at least one year after the date of this report, there can be no assurance that any such measures
will be successful. The Company&#8217;s ability to raise additional funds will depend, in part, on the success of our product development
activities, and other events or conditions that may affect the share value or prospects, as well as factors related to financial, economic
and market conditions, many of which are beyond our control. There can be no assurances that sufficient funds will be available to us
when required or on acceptable terms, if at all. Accordingly, management has concluded that these plans do not alleviate substantial
doubt about the Company&#8217;s ability to continue as a going concern. Our failure to achieve or maintain profitability could negatively
impact the value of our common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may need to raise additional capital to fund our operations in furtherance of our business plan.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
incurred a net loss of approximately $7,292,000 during the nine months ended September 30, 2024, and had a net loss
of approximately $6,398,000 during the nine-month transition period ended December 31, 2023. If we are unable to achieve profitable operations,
we may need to raise additional capital to fund our operations in the furtherance of our business plan. Any proposed financing may include
shares of common stock, shares of preferred stock, warrants to purchase shares of common stock or preferred stock, debt securities, units
consisting of the foregoing securities, equity investments from strategic development partners or some combination of each. Any additional
equity financing may be financially dilutive to, and will be dilutive from an ownership perspective to, our stockholders, and such dilution
may be significant based upon the size of such financing. Additionally, we cannot assure that such funding will be available on a timely
basis, in needed quantities, or on terms favorable to us, if at all.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
are heavily dependent on our senior management, and a loss of a member of our senior management team could cause our stock price to suffer.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we lose the services of Gary Atkinson, our Chief Executive Officer, or Bernardo Melo, our Chief Revenue Officer, we may not be able to
find appropriate replacements on a timely basis, and our business could be adversely affected. Messrs. Atkinson and Melo have worked
at our company for 15 and 20 years, respectively, and are primarily responsible for all our day-to-day operations. Our existing operations
and continued future development depend to a significant extent upon the performance and active participation of these individuals. Although
we have entered into employment agreements with Messrs. Atkinson and Melo, we cannot guarantee that we will be successful in retaining
the services of these individuals. If we were to lose any of these individuals, we may not be able to find appropriate replacements on
a timely basis and our financial condition and results of operations could be materially adversely affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left">&#160;</p>

<!-- Field: Page; Sequence: 22 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
Related to the Development, Manufacturing, and Shipping of Our Products</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
we are unable to develop new karaoke products, our revenues may not continue to grow.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
karaoke industry is characterized by rapid technological change, frequent new product introductions and enhancements and ongoing customer
demands for greater performance. In addition, the average selling price of any karaoke machine has historically decreased over its life,
and we expect that trend to continue. As a result, our products may not be competitive if we fail to introduce new products or product
enhancements that meet evolving customer demands. The development of new products is complex, and we may not be able to complete development
in a timely manner. To introduce products on a timely basis, we must:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">accurately
    define and design new products to meet market demand; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">design
    features that continue to differentiate our products from those of our competitors; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">transition
    our products to new manufacturing process technologies; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">identify
    emerging technological trends in our target markets; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">anticipate
    changes in end-user preferences with respect to our customers&#8217; products; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">bring
    products to market on a timely basis at competitive prices; and </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">respond
    effectively to technological changes or product announcements by others. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that we will need to continue to enhance our karaoke machines and develop new machines to keep pace with competitive and technological
developments and to achieve market acceptance for our products. At the same time, we need to identify and develop other products which
may be different from karaoke machines.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
products are shipped from China and any disruptions of shipping could prevent of delay our customer&#8217; receipt of inventory.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
rely principally on a limited number of contract ocean carriers to ship substantially all of our karaoke products that we import to our
outsourced warehouse facility in Chino, California. Retailers that take delivery of our products in China rely on a variety of carriers
to import those products. Any disruptions in shipping, whether in California or China, caused by labor strikes, other labor disputes,
terrorism, and international incidents may prevent or delay our customers&#8217; receipt of inventory. If our customers do not receive
their inventory on a timely basis, they may cancel their orders or return products to us. Consequently, our revenues and net income would
be reduced, and our results of operations would be adversely affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
manufacturing operations are located in the People&#8217;s Republic of China, subjecting us to risks common in international operations.
if there is any problem with the manufacturing process, our revenues and net profitability may be reduced.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
currently use several contract manufacturers in China to manufacture all our karaoke products. Our arrangements with these contract manufacturers
are subject to the risks of doing business abroad, such as import duties, trade restrictions, work stoppages, and foreign currency fluctuations,
limitations on the repatriation of earnings and political instability, which could have an adverse impact on our margins. Furthermore,
we have limited control over the manufacturing processes. As a result, any difficulties encountered by our third-party manufacturers
that result in product defects, production delays, cost overruns or the inability to fulfill orders on a timely basis could adversely
affect our revenues, profitability and cash flow. Also, since we do not have written agreements with any of these contract manufacturers,
we are subject to additional uncertainty if the contract manufacturers do not deliver products to us on a timely basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
depend on third party suppliers for parts for our karaoke machines and related products, and if we cannot obtain supplies as needed,
our operations will be severely damaged.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
growth and ability to meet customer demand depends in part on our capability to obtain timely deliveries of karaoke machines and our
electronic products. We rely on third party suppliers to produce the parts and materials that are used to manufacture and produce these
products. If our suppliers are unable to provide our factories with the parts and supplies, they we will be unable to produce our products.
There has been recent worldwide volatility in the supply of electronic chips due to the increased demand for semiconductors and we are
currently competing with large companies to obtain these parts and could see production and shipment delays. We cannot guarantee that
we will be able to purchase the parts we need at reasonable prices or in a timely fashion. If we are unable to anticipate any shortages
of parts and materials in the future, we may experience severe production problems and delivery delays, which would impact our sales.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left">&#160;</p>

<!-- Field: Page; Sequence: 23 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
depend on the ability of our suppliers to manufacture our products without infringing, misappropriating of otherwise violating the intellectual
property of proprietary rights of others in manufacturing our products.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
source our products from a variety of contract manufacturers. We buy finished goods from our suppliers and generally do not source raw
materials and parts for manufacturing and assembly into the final product. We rely on our contract manufacturers&#8217; ability to secure
injected plastic, wood cabinets, integrated circuits, display panels, speaker drivers, and other components that are necessary for assembly
into our final products. While we are not responsible for sourcing raw materials, we rely on these suppliers to have all required licenses
or proprietary rights to the materials that are incorporated into the final product. In addition, we rely on the representations of our
contract manufacturers that they are using materials and components that meet all necessary legal, safety, and compliance requirements.
If our suppliers do not have the proper licenses or rights or are not in compliance with all regulatory requirements, we may be named
a party or be subject to claims, including claims of infringement or violating the intellectual property or proprietary rights of third
parties with respect to our products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
Related To Our Karaoke Business And Industry</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Changes
in government regulations relating to international tariffs could significantly reduce our revenues, product cost and profitability.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S.
government administration and members of the U.S. Congress have made public statements indicating possible significant changes in U.S.
trade policy and have taken certain actions that may impact U.S. trade, including imposing tariffs on certain goods imported into the
United States. Any changes in U.S. trade policy could trigger retaliatory actions by affected countries, resulting in &#8220;trade wars,&#8221;
and increased costs for goods imported into the United States. All of our products are manufactured and imported from China. However,
only our microphone products are currently subject to 7.5% tariffs currently in place. Should the government decide to expand its list
of products to include our karaoke products that would subject our products to tariffs in the future, there could be a significant increase
in the landed cost of our products. If we are unable to mitigate these increased costs through price increases, we could experience reductions
in revenues, gross profit margin and results from operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>A
small number of our customers account for a substantial portion of our revenues, and the loss of one or more of these key customers could
significantly reduce our revenues and cash flow.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
rely on a few large customers to provide a substantial portion of our revenues. Sales to our top three customers together comprised
approximately 81%, 69% and 72% of our net sales for our nine-month transition period ended December 31, 2023, and the fiscal
year ended March 31, 2023, and 2022, respectively. In our transition period ended December 31, 2023, revenues from three of these customers
represented 48%, 21% and 12% of total net sales. In our fiscal year ended March 31, 2023, revenues from two of these customers represented
greater than 10% of net sales, at 48% and 21% of total net sales. We do not have long-term contractual arrangements with any of our customers
and they can cancel their orders at any time prior to delivery. A substantial reduction in or termination of orders from any of our largest
customers would decrease our revenues and cash flow.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
are subject to the risk that some of our large customers may return karaoke products that they have purchased from us and if this happens,
it would reduce our revenues and profitability. </i></b>The Company receives significant returns from many of our customers and may be
subject to future returns.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
return of products is due to a variety of reasons including defective units, customers&#8217; overstock and buyer&#8217;s remorse. Our
factories charge customary repair and freight costs, which increase our expenses and reduce profitability. If any of our customers were
to increase the volume of their returned karaoke products to us, it would reduce our revenues and profitability.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 24 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
are subject to pressure from our customers relating to price reduction and financial incentives and if we are pressured to make these
concessions to our customers, it will reduce our revenues and profitability.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
there is intense competition in the karaoke industry, we are subject to pricing pressure from our customers. Many of our customers have
demanded that we lower our prices to remain competitive with other sellers in the karaoke product market. If we do not meet our customers&#8217;
demands to lower our regular prices, we will not sell as many karaoke products. We are also subject to pressure from our customers regarding
certain financial incentives, such as return credits or large cooperative (&#8220;co-op&#8221;) promotion incentives, which effectively
reduce our net sales and profit. We gave co-op promotion incentives of approximately $2,600,000 and $2,300,000 for the nine-month transition
period ended December 31, 2023, and during our fiscal year ended March 31, 2023, respectively. We have historically offered co-op promotion
incentives to our customers because it is standard practice in the retail industry.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
experience difficulty forecasting the demand for our karaoke products and if we do not accurately forecast demand, our revenues, net
income and cash flow may be affected.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
of our reliance on manufacturers in China for our machine production, our production lead times range from one to four months. Therefore,
we must commit to production in advance of customers&#8217; orders. It is difficult to forecast customer demand because we do not have
any scientific or quantitative method to predict this demand. Our forecasting is based on management&#8217;s general expectations about
customer demand, the general strength of the retail market and management&#8217;s historical experiences. In past years we have overestimated
demand for our products, which led to excess inventory in some of our products and caused liquidity problems that adversely affected
our revenues, net income and cash flow.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
are subject to the costs and risks of carrying inventory for our customers and if we have too much inventory, it will affect our cash
flow for operations.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Many
of our customers place orders with us several months prior to the holiday season, but they schedule delivery two or three weeks before
the holiday season begins. As such, we are subject to the risks and costs of carrying inventory during the time period between the placement
of the order and the delivery date, which reduces our cash flow. As of December 31, 2023, and March 31, 2023, we had approximately $6,872,000
in inventory as compared to approximately $9,085,000 in inventory as of March 31, 2023. If we are unable to sell excess inventory in
the future at historical or greater margins, our cash flow for operations will be negatively impacted.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
are subject to insurance risk of loss for goods damaged while in transit from the manufacturer to the customer and our warehouse.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
of our goods are manufactured in China and are transported to customers and our warehouse in California via ocean vessel. As such, we
are subject to damage that may occur to these goods when they are in transit to customers or our warehouse. Should substantial damage
incur while goods are in transit, we could experience a significant loss of revenue, inventory and incur significant out of pocket expenses
associated with destruction of the damaged goods, which could cause a significant loss from operations and reduction in cash flow. While
we have taken significant measures to prevent damage incidents there can be no guarantee of damage incidents occurring in the future.
We have obtained insurance coverage for goods that are shipped direct import to our customers whose shipping terms are FOB shipping point
and for goods in transit to our California warehouse however, certain exclusions have been added that may prevent insurance coverage
of certain damaged incidents in the future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
business is seasonal and therefore our annual operating results will depend, in large part, on our sales during the relatively brief
holiday season.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales
of consumer electronics and toy products in the retail channel are highly seasonal, with a majority of retail sales occurring during
the period from September through December in anticipation of the holiday season, which includes Christmas. A substantial majority of
our sales occur during our fiscal quarter ending September 30 and our fiscal quarter ending December 31. Sales in these two quarters,
combined, accounted for approximately 91% and 62% of net sales in the nine-month transition period ended December 31, 2023, and our fiscal
year ended March 31, 2023, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 25 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Consumer
discretionary spending may affect karaoke purchases and is affected by various economic conditions and changes. </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchases
of karaoke machines and music are considered discretionary for consumers. Our success will therefore be influenced by a number of economic
factors affecting discretionary and consumer spending, such as employment levels, business, interest rates, and taxation rates, all of
which are not under our control. Additionally, other extraordinary events such as terrorist attacks or military engagements, which adversely
affect the retail environment may restrict consumer spending and thereby adversely affect our sales growth and profitability.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
do not have our own warehouse or distribution facilities but rely on a third-party logistics provider responsible for warehousing and
fulfilling our orders. If our third-party provider experiences disruptions to the operation of its distribution centers, it could have
a material adverse effect on our business, financial condition and results of operations.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
lease to our warehouse located in Ontario, California expired on August 31, 2023. We did not renew the lease and instead signed a service
agreement with a third-party logistics company to provide domestic and Canadian warehousing services effective September 1, 2023. We
rely on a logistics company for warehousing and fulfillment of our orders. All of our merchandise is shipped from our suppliers to one
of our provider&#8217;s distribution facilities and then packaged and shipped from our distribution facilities to our customers. The
success of our business depends on our timely receipt of merchandise so we can continuously bring new, on-trend products online for sale.
The success of our business also depends on customer orders being timely processed and delivered to meet promised delivery dates and
satisfy our customers. The efficient flow of our merchandise requires that we have adequate capacity and uninterrupted service in our
distribution facilities to support both our current level of operations. Upgrading our existing arrangement or transferring our operations
to another third-party provider, if necessary, will require us to incur additional costs, which could be significant, and may require
us to obtain additional financing. Our failure to provide adequate order fulfillment, secure additional distribution capacity when necessary
or retain a suitable third-party logistics provider could increase our costs, which in turn could have a material adverse effect on our
business, financial condition and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, if our current provider encounters difficulties associated with its distribution facilities or if they were to shut down or
be unable to operate for any reason, including because of fire, natural disaster, power outage or other event, we could face inventory
shortages, resulting in &#8220;out-of-stock&#8221; conditions on our website, and delays in shipments, resulting in significantly higher
costs and longer lead times distributing our merchandise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
production costs may increase if we are required to make purchases using the Chinese Yuan instead of the U.S. dollar.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
our consumer electronic products are currently manufactured in China. During the nine-month transition period ended December 31, 2023,
the Chinese local currency had no material effect on us as all of our purchases are denominated in U.S. currency. However, in the event
our purchases are required to be made in Chinese local currency, the Yuan, we will be subject to the risks involved in foreign exchange
rates. In the future the value of the Yuan may depend largely on the Chinese government&#8217;s policies and China&#8217;s domestic and
international economic and political developments. As a result, our production costs may increase if we are required to make purchases
using the Yuan instead of the U.S. dollar and the value of the Yuan increases over time. Any significant increase in the cost of manufacturing
our products would have a material adverse effect on our business and results of operations. We sell our product to Canadian customers
some of whom require us to invoice them in Canadian Dollars. We are subject to risks involved in the exchange rate between the Canadian
and US dollar. However, the exchange rate has been stable during our nine-month transition period ended December 31, 2023, and the associated
exchange rates did not have a material impact on our financial results. Should the exchange rate between the Canadian and US Dollar become
more volatile and sales to Canadian customers increase, there could be a material adverse effect on our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
profit margin may be decreased due to increased prices of raw materials, shipping costs and costs associated with production.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fluctuation
in the price of oil, electronic chip components and shipping costs have and will continue to affect us in connection with the sourcing
and delivery of raw materials and services. These issues are common to all companies in the same type of business and if we are not able
to negotiate lower costs, reduce other expenses, or pass on some or all of these price increases to our customers, our profit margin
may be decreased.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<!-- Field: Page; Sequence: 26 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
we are unable to compete in the karaoke products category, our revenues and net profitability will be reduced. </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
major competitors for karaoke machines and related products are Singsation&#174;, Singtrix&#174;, eKids&#174;, Bonaok, Karaoke USA&#8482;,
Ion&#174; Audio, licensed property karaoke products and other consumer electronics companies. We believe that competition for karaoke
machines is based primarily on price, product features, reputation, delivery times, and customer support. To the extent that we lower
prices to attempt to enhance or retain market share, we may adversely impact our operating margins. Conversely, if we opt not to match
competitor&#8217;s price reductions we may lose market share, resulting in decreased volume and revenue. To the extent our leading competitors
reduce prices on their karaoke machines, we must remain flexible to reduce our prices. If we are forced to reduce our prices, it will
result in lower margins and reduced profitability. Because of intense competition in the karaoke industry in the United States during
our fiscal year ended March 31, 2023, and the nine-month transition period ended December 31, 2023, we expect that the intense pricing
pressure in the low end of the market will continue in the karaoke market in the United States in our fiscal year ending December 31,
2024. In addition, we must compete with all the other existing forms of entertainment including, but not limited to: motion pictures,
video arcade games, home video games, theme parks, nightclubs, television, prerecorded tapes, CD&#8217;s, and DVD&#8217;s and streaming
video.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Many
of our competitors are larger and have greater financial and other resources than we do.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
products compete and will compete with similar if not identical products produced by our competitors. These competitive products could
be marketed by well-established, successful companies that possess greater financial, marketing, distribution personnel, and other resources
than we do. Using said resources, these companies can implement extensive advertising and promotional campaigns, both generally and in
response to specific marketing efforts by competitors. They can introduce new products to new markets more rapidly. In certain instances,
competitors with greater financial resources may be able to enter a market in direct competition with us, offering attractive marketing
tools to encourage the sale of products that compete with our products or present cost features that consumers may find attractive.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
we ship products that contain defects, the market acceptance of our products and our reputation will be harmed and our customers could
seek to recover their damages from us.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
products are complex, and despite extensive testing, may contain defects or undetected errors or failures that may become apparent only
after our products have been shipped to our customers or after product features or new versions are released. Any such defect, error
or failure could result in failure of market acceptance of our products or damage to our reputation or relations with our customers,
resulting in substantial costs for us and our customers as well as the cancellation of orders, warranty costs and product returns. In
addition, any defects, errors, misuse of our products or other potential problems within or out of our control that may arise from the
use of our products could result in financial or other damages to our customers. Our customers could seek to have us pay for these losses.
Although we maintain product liability insurance, it may not be adequate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
Related to our Logistics Business</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
transportation industry historically has experienced cyclical fluctuations in financial results due to economic recessions, downturns
in business cycles of SemiCab&#8217;s customers, interest rate fluctuations, currency fluctuations, and other economic factors beyond
SemiCab&#8217;s control.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
Decrease in freight volumes: A reduction in overall freight volumes in the marketplace may reduce opportunities for growth. The market
may be impacted by supply chain disruptions or overall economic conditions. In addition, if a downturn in SemiCab&#8217;s customers&#8217;
business cycles causes a reduction in the volumes of freight shipped by those customers, SemiCab&#8217;s operating results could be adversely
affected. During 2022 and 2023, SemiCab experienced a decline in volumes as shippers struggled with elevated inventory levels and consumer
demand was negatively impacted by inflation and macroeconomic uncertainty. These volume declines have also driven declining freight rates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 27 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
Credit risk and working capital: Some of SemiCab&#8217;s customers may face economic difficulties and may not be able to pay for services
rendered by SemiCab, and some may go out of business. In addition, some customers may take longer to pay or become unable to pay, which
may cause working capital needs to increase.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
Transportation provider failures: A significant number of SemiCab&#8217;s contracted transportation providers may go out of business,
which would result in SemiCab being unable to secure sufficient equipment or other transportation services to meet its commitments to
its customers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
Expense management: SemiCab may not be able to appropriately adjust its expenses to changing market demands. In periods of rapid change,
it may be difficult to match its staffing levels to its business needs. Higher carrier prices may result in decreased adjusted gross
profit margin and increases in working capital. Carriers can be expected to charge higher prices if market conditions warrant or to cover
higher operating expenses. SemiCab&#8217;s adjusted gross profits and income from operations may decrease if SemiCab is unable to increase
its pricing to its customers. Increased demand for over the road transportation services and changes in regulations may reduce available
capacity and increase motor carrier pricing. In the event market conditions change and its contracted rates are below market rates, SemiCab
may be required to provide transportation services at a loss. As its volumes increase or SemiCab increases freight rates charged to its
customers, the resulting increase in revenues may increase its working capital needs due to its business model, which generally has a
higher length of days sales outstanding than days payables outstanding. Changing fuel costs and interruptions of fuel supplies may have
an impact on its adjusted gross profit margin. In its truckload transportation business, fluctuating fuel prices may result in a decreased
adjusted gross profit margin. While its different pricing arrangements with customers and contracted motor carriers make it very difficult
to measure the precise impact, SemiCab believes fuel costs essentially act as a pass-through cost to its truckload business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SemiCab&#8217;s
dependence on third parties to provide equipment and services may impact the delivery and quality of its transportation and logistics
services. SemiCab depends on independent third parties to provide trucking services and to report certain events to them, including but
not limited to, shipment status information and freight claims. These independent third parties may not fulfill their obligations to
SemiCab, or SemiCab&#8217;s relationship with these parties may change, which may prevent SemiCab from meeting its commitments to its
customers. SemiCab&#8217;s reliance on these third parties also could cause delays in reporting certain events, including recognizing
claims. In addition, if SemiCab is unable to secure sufficient equipment or other transportation services from third parties to meet
its commitments to its customers, its operating results could be materially and adversely affected, and its customers could switch to
its competitors temporarily or permanently.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Many
of these risks are beyond SemiCab&#8217;s control, including:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">equipment
    and driver shortages in the transportation industry, particularly among contracted motor carriers;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in regulations impacting transportation;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">disruption
    in the supply or cost of fuel;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    introduction of alternative means of transporting freight; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">unanticipated
    changes in freight markets.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>SemiCab
faces substantial industry competition.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Competition
in the digital freight industry is intense and broad-based. SemiCab competes with traditional and non-traditional logistics companies,
including transportation providers that own equipment, third-party freight brokers, technology matching services, internet freight brokers,
carriers offering logistics services, and on-demand transportation service providers. In addition, customers can bring in-house some
of the services SemiCab provides to them. Increased competition could reduce its market opportunity and create downward pressure on freight
rates. Continued rate pressure may adversely affect SemiCab&#8217;s adjusted gross profits and income from operations. In the event market
conditions change and SemiCab&#8217;s contracted rates are below market rates, it may be required to provide transportation services
at a loss.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SemiCab
earnings may be affected by seasonal changes or significant disruptions in the transportation industry. Results of operations for the
industry generally show a seasonal pattern as customers reduce shipments during and after the winter holiday season. SemiCab believes
this historical pattern has been the result of, or influenced by, numerous factors, including national holidays, weather patterns, consumer
demand, economic conditions, and other similar and subtle forces. Although seasonal changes in the transportation industry have not had
a significant impact on its cash flow or results of operations, SemiCab expects this trend to continue, and it cannot guarantee it will
not adversely impact SemiCab in the future. The transportation industry may also be significantly impacted by disruptions such as the
availability of transportation equipment, as well as factors such as labor shortages, fuel prices, shifts in consumer demand toward more
locally sourced products, and regulatory changes. These disruptions may impact the growth rates within the global logistics industry
and SemiCab&#8217;s ability to provide transportation services for its customers, each of which may adversely impact its results of operations
and operating cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 28 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>SemiCab
relies on technology to operate its business</i></b>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SemiCab
has internally developed the majority of its operating systems and also relies on technology provided by third parties. Its continued
success is dependent on its systems continuing to operate and to meet the changing needs of its customers and users. The continued automation
of existing processes and usage of third-party technology and cloud network capacity will require adaptation and adjustments that may
increase its exposure to cybersecurity risks and system availability reliance. SemiCab relies on its technology staff and third-party
vendors to successfully implement changes to, and to maintain, its operating systems in an efficient manner. If SemiCab fails to maintain,
protect, and enhance its operating systems, it may be at a competitive disadvantage and lose customers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
demonstrated by recent material and high-profile data security breaches, computer malware, viruses, computer hacking, and phishing attacks
have become more prevalent, and may occur on SemiCab&#8217;s and operating systems. SemiCab cannot guarantee future attacks will have
little to no impact on its business. Furthermore, given the interconnected nature of the supply chain and its significant presence in
the industry, it may be an attractive target for such attacks. The insurance coverage held by SemiCab&#8217;s currently have in place
may not apply to a particular loss or it may not be sufficient to cover all liabilities to which we may be subject. A loss for which
SemiCab is not adequately insured could materially affect its financial results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Though
it is difficult to determine what, if any, harm may directly result from any specific interruption or attack, a significant impact on
the performance, reliability, security, and availability of SemiCab&#8217;s operating systems and technical infrastructure to the satisfaction
of its users may harm its reputation, impair its ability to retain existing customers or attract new customers, and expose it to legal
claims and government action, each of which could have a material adverse impact on its financial condition, results of operations, and
growth prospects.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>SemiCab&#8217;s
international operations subject it to operational, financial, and data privacy risks</i></b>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SemiCab
provides services within foreign countries on an increasing basis. Its business outside of the U.S. is subject to various risks, including:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">difficulties
    in managing or overseeing foreign operations and agents;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">limitations
    on the repatriation of funds because of foreign exchange controls;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">foreign
    currency fluctuations;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">different
    liability standards;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">intellectual
    property laws of countries that do not protect its intellectual property rights, including but not limited to, its proprietary information
    systems, to the same extent as the laws of the U.S.;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">issues
    related to non-compliance with laws, rules, and regulations in the countries in which it operates including the U.S. Foreign Corrupt
    Practices Act and similar regulations. Failure to comply could result in reputational harm, substantial penalties, and operational
    restrictions; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">global
    laws and regulations regarding the collection, use, processing, and transfer of personal information may impact its services by imposing
    restrictions on processing, increase legal claim liability, and increase regulatory scrutiny and fines. These requirements continue
    to evolve and vary by region and regime, which increases the risk of noncompliance and impacts operations, including additional expenses
    and resources necessary to manage compliant operations.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
occurrence or consequences of any of these factors may restrict its ability to operate in the affected region and/or decrease the profitability
of its operations in that region.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign
currency fluctuations could result in currency exchange gains or losses or could affect the book value of its assets and liabilities.
Furthermore, SemiCab may experience unanticipated changes to its income tax liabilities resulting from changes in geographical income
mix and changing international tax legislation. If SemiCab does not correctly anticipate changes in international economic and political
conditions, it may not be able to alter its business practices in time to avoid adverse effects.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 29 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>SemiCab&#8217;s
ability to appropriately staff and retain employees is important to its business model</i></b>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SemiCab&#8217;s
continued success depends upon its ability to attract and retain motivated logistics and technology professionals. In periods of rapid
change, it may be more difficult to match its staffing level to its business needs. SemiCab cannot guarantee it will be able to continue
to hire and retain a sufficient number of qualified personnel. In addition, macroeconomic factors impacting the labor market may result
in higher costs to hire and retain qualified personnel. Because of its highly experienced employee base, its employees are attractive
targets for new and existing competitors. Continued success depends in large part on its ability to develop successful employees into
managers and architects.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>SemiCab
uses, and may continue to expand its use of, machine learning and artificial intelligence (&#8220;AI&#8221;) technologies to deliver
its services and operate its business.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
SemiCab fails to successfully integrate AI into its platform and business processes, or if it fails to keep pace with rapidly evolving
AI technological developments, including attracting and retaining talented AI developers and programmers and cybersecurity personnel,
it may face a competitive disadvantage. At the same time, the use or offering of AI technologies may result in new or expanded risks
and liabilities, including enhanced government or regulatory scrutiny, litigation, privacy and compliance issues, ethical concerns, confidentiality,
reputational harm, and security risks. It is not possible to predict all of the risks related to the use of AI and changes in laws, rules,
directives, and regulations governing the use of AI may adversely affect the ability to develop and use AI or subject SemiCab to legal
liability. The cost of complying with laws and regulations governing AI could be significant and would increase operating expenses, which
could adversely affect its business, financial condition, and results of operations. Further, market demand and acceptance of AI technologies
are uncertain, there may be challenges to further incorporate AI into SemiCab&#8217;s processes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>SemiCab&#8217;s
business is dependent on a small number of customers</i></b><i>.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SemiCab
derives a significant portion of its total revenues from a small number of customers. During 2023, SemiCab&#8217;s top 5 customers based
on total revenue comprised approximately 99 percent of its consolidated total revenues. Its largest customer comprised approximately
37 percent of its consolidated total revenues. The sudden loss of major customers could materially and adversely affect its operating
results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>SemiCab
is subject to claims arising from its transportation operations</i></b>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SemiCab
uses the services of thousands of third-party transportation companies in connection with its transportation operations. From time to
time, the drivers employed and engaged by the motor carriers with which SemiCab contracts with are involved in accidents, which may result
in serious personal injuries. The resulting types and/or amounts of damages may be excluded by or exceed the amount of insurance coverage
maintained by the contracted motor carrier. SemiCab contractually requires all motor carriers it works with to carry at least $1,000,000
in automobile liability insurance. SemiCab also requires all contracted motor carriers to maintain workers compensation and other insurance
coverage as required by law. Most contracted motor carriers have insurance exceeding these minimum requirements, as well as cargo insurance
in varying policy amounts. Although these drivers are not employees of SemiCab and all of these drivers are employees, owner-operators,
or independent contractors working for the contracted motor carriers, from time to time, claims may be asserted against SemiCab for its
actions or for SemiCab&#8217;s actions in retaining them. Claims against SemiCab may exceed the amount of its insurance coverage or may
not be covered by insurance at all. A material increase in the frequency or severity of accidents, liability claims, workers&#8217; compensation
claims, or unfavorable resolutions of claims could materially and adversely affect its operating results. In addition, significant increases
in insurance costs or the inability to purchase insurance as a result of these claims could reduce its profitability. SemiCab&#8217;s
involvement in the transportation of certain goods, including but not limited to, hazardous materials, could also increase its exposure
in the event one of its contracted motor carriers is involved in an accident resulting in injuries or contamination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
its customer contracts, SemiCab may agree to assume cargo liability up to a stated maximum. Although SemiCab is not legally liable for
loss or damage to its customers&#8217; cargo, from time to time, claims may be asserted against SemiCab for cargo losses. SemiCab maintains
a broad contingent cargo liability insurance policy to help protect it against catastrophic losses that may not be recovered from the
responsible contracted carrier. SemiCab also carries various liability insurance policies, including automobile and general liability.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 30 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>SemiCab&#8217;s
business depends upon compliance with numerous government regulations</i></b>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SemiCab&#8217;s
operations may be regulated and licensed by various federal, state, and local transportation agencies in the U.S. and similar governmental
agencies in foreign countries in which its operates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SemiCab
is subject to licensing and regulation as a property freight broker and is licensed by the DOT to arrange for the transportation of property
by motor vehicle. The DOT prescribes qualifications for acting in this capacity, including certain surety bonding requirements. SemiCab
also has and maintains other licenses as required by law. SemiCab&#8217;s failure to maintain required permits or licenses, or to comply
with applicable regulations, could result in substantial fines or revocation of its operating permits and licenses</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legislative
or regulatory changes can affect the economics of the transportation industry by requiring changes in operating practices or influencing
the demand for, and the cost of providing, transportation services. SemiCab may experience an increase in operating costs, such as security
costs, as a result of governmental regulations that have been or will be adopted in response to terrorist activities and potential terrorist
activities. No assurances can be given that SemiCab will be able to pass these increased costs on to its customers in the form of rate
increases or surcharges, and its operations and profitability may be materially and adversely affected as a result.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
Related To Our Intellectual Property</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
primarily rely on trade secret protection and non-disclosure agreements to protect our proprietary information, which may not be effective.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
currently rely on trade secret protection and non-disclosure agreements with our employees, consultants and third parties to protect
our confidential and proprietary information. If we do not protect our intellectual property and other confidential information adequately,
competitors may be able to use our proprietary technologies and information and thereby erode any competitive advantages they provide
us with.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will be able to protect our proprietary rights from unauthorized use by third parties only to the extent these rights are effectively
maintained as confidential. We expect to rely primarily on trade secret and contractual protections for our confidential and proprietary
information and we have taken security measures we believe are appropriate to protect this information. These measures, however, may
not provide adequate protection for our trade secrets, know-how or other confidential information. We seek to protect our proprietary
information by, among other things, entering into confidentiality agreements with employees, consultants and other third parties. These
confidentiality agreements may not sufficiently safeguard our trade secrets and other confidential information and may not provide adequate
remedies in the event of unauthorized use or disclosure of this information. Enforcing a claim that a party illegally disclosed or misappropriated
a trade secret or other proprietary information could be difficult, expensive, and time-consuming and the outcome could be unpredictable.
In addition, trade secrets or other confidential information could otherwise become known or be independently developed by others in
a manner that could prevent legal recourse by us. If any of our trade secrets or other confidential or proprietary information were disclosed
or misappropriated or if any such information was independently developed by a competitor, our competitive position could be harmed,
and our business could suffer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may be forced to litigate to enforce or defend our intellectual property rights, or the intellectual property rights of our licensors.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may be forced to litigate to enforce or defend our intellectual property rights against infringement and unauthorized use by competitors.
In so doing, we may place our intellectual property at risk of being invalidated, held unenforceable, or narrowed in scope. Further,
an adverse result in any litigation or defense proceedings may place pending applications at risk of non-issuance. In addition, if any
licensor fails to enforce or defend its intellectual property rights, this may adversely affect our ability to develop and commercialize
our products that including licensing deals, as well as our ability to prevent competitors from making, using, and selling competing
products. Any such litigation could be very costly and could distract our management from focusing on operating our business. The existence
or outcome of any such litigation could harm our business, results of operations and financial condition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
because of the substantial amount of discovery required in connection with intellectual property litigation, there is a risk that some
of our confidential and proprietary information could be compromised by disclosure during this type of litigation. In addition, there
could be public announcements of the results of hearings, motions or other interim proceedings or developments. If securities analysts
or investors perceive these results to be negative, it could have a material adverse effect on the price of our common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left">&#160;</p>

<!-- Field: Page; Sequence: 31 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may not be able to protect our intellectual property rights throughout the world.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filing,
prosecuting, and defending intellectual property rights on our products throughout the world is prohibitively expensive. Competitors
may use our technologies in jurisdictions where we have not obtained intellectual property rights to develop their own products and,
further, may export otherwise infringing products to territories where we have intellectual property rights, but where enforcement is
not as strong as that in the U.S. These products may compete with our products in jurisdictions where we do not have any issued or licensed
patents and our patent claims or other intellectual property rights may not be effective or sufficient to prevent them from competing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Many
companies have encountered significant problems in protecting and defending intellectual property rights in foreign jurisdictions. The
legal systems of certain countries, particularly certain developing countries, do not favor the enforcement of patents and other intellectual
property protection, which could make it difficult for us to stop the infringement of our patents or marketing of competing products
in violation of our proprietary rights generally. Proceedings to enforce our patent rights in foreign jurisdictions could result in substantial
cost and divert our efforts and attention from other aspects of our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>General
Risk Factors</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
information technology systems or data, or those of our service providers or customers or users could be subject to cyber-attacks or
other security incidents, which could result in data breaches, intellectual property theft, claims, litigation, regulatory investigations,
significant liability, reputational damage and other adverse consequences.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
ever-evolving threat landscape makes data security and privacy a critical priority. Our technology team and third-party vendors have
experience and expertise supporting mitigation of the potential cyber-attacks facing our organization and vulnerabilities facing our
technology infrastructure and potential cyber-attacks. All employees have access to cybersecurity training.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
maintain processes for key risk identification, mitigation efforts, and day-to-day management of risks, including cybersecurity risks.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
it is difficult to determine the potential impacts from a cyber-attack or other security incident, we may experience negative impacts
such as reputational harm, inability to retain existing customers or attract new customers, exposure to legal claims and government action,
among others. We cannot guarantee future attacks will have little to no impact on our business. In particular, given the interconnected
nature of the supply chain and our significant presence in the industry, the Company&#8217;s subsidiary, SemiCab, believes it may be
an attractive target for such attacks. The impact of a cyber-attack or other security incident may have a material adverse impact on
our financial condition, results of operations, availability of our systems, and growth prospects, which makes cybersecurity risk management
of critical importance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
primarily rely on technology provided by third parties, with the exception of SemiCab that has internally developed the majority of its
line of business applications. We have processes in place to oversee and identify risks from cyber-attack threats associated with the
use of third-party technology including third-party risk management, and process and partner intake risk assessments. These processes
help mitigate the risks associated with utilizing external technology platforms and help prevent disruptions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
we have processes and programs in place to meet our global compliance obligations and work with our employees and teams across the globe
to ensure security and data protection principles are integrated into the way we conduct our business, there can be no assurance that
our operations may not be subject to successful breaches, employee malfeasance, or human or technological error which could result in,
for example, unauthorized access to, disclosure, modification, misuse, loss, or destruction of company, customer, or other third party
data or systems; theft of sensitive, regulated, or confidential data including personal information and intellectual property; the loss
of access to critical data or systems through ransomware, destructive attacks or other means; and business delays, service or system
disruptions or denials of service.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<!-- Field: Page; Sequence: 32 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
business, financial condition and results of operations may be materially adversely affected by any negative impact on the global economy
and capital markets resulting from the conflict in Ukraine or any other geopolitical tensions.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S.
and global markets are experiencing volatility and disruption following the escalation of geopolitical tensions and the start of the
military conflict between Russia and Ukraine. On February 24, 2022, a full-scale military invasion of Ukraine by Russian troops was reported.
Although the length and impact of the ongoing military conflict is highly unpredictable, the conflict in Ukraine could lead to market
disruptions, including significant volatility in credit and capital markets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Russia&#8217;s
military interventions in Ukraine have led to sanctions and other penalties being levied by the U.S., European Union and other countries
against Russia. Additional potential sanctions and penalties have also been proposed and/or threatened. Russian military actions and
the resulting sanctions could adversely affect the global economy and financial markets. In addition, the invasion of Ukraine and the
resulting sanctions imposed on Russia have resulted in increased volatility in the financial markets and the markets for certain commodities
including oil, which may significantly impact the manufacturers that we rely on but is not expected to have any direct impact on us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
the conflict in the Middle East between Israel and the government of Hamas in Gaza has caused disruptions in shipping lanes in the Red
Sea where some major cargo lines have opted to route their vessels away from the region which has increased the time required to reach
their destinations as well as increased time for vessels to return to their port of origin with empty containers. Continued shipping
line disruptions and delays may impact the availability and cost of shipping containers during peak shipping season.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
we have not experienced any direct impact from the conflicts in the Ukraine and the Middle East, the extent and duration of the military
action, sanctions and resulting market and shipping lane disruptions are impossible to predict but could be substantial and could adversely
affect our operating results as they impact the global economy in the future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>High
inflation and unfavorable economic conditions could negatively affect our operations and results.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unfavorable
global or regional economic conditions may be triggered by numerous developments beyond our control, including inflation, geopolitical
events, health crises such as the COVID-19 pandemic, and other events that trigger economic volatility on a global or regional basis.
Those types of unfavorable economic conditions could adversely affect our business and financial results. In particular, a significant
deterioration in economic conditions, including economic slowdowns or recessions, increased unemployment levels, inflationary pressures
or disruptions to credit and capital markets, could lead to decreased consumer confidence and consumer spending more generally, thus
reducing consumer demand for our products. For example, in 2022 and 2023, the United States experienced a rapid increase in inflation
levels of approximately 6.5% year-over year in 2022 and approximately 4.0% year-over-year in 2023. Such heightened inflationary levels
may negatively impact consumer disposable income and discretionary spending and, in turn, reduce consumer demand for our products and
increase our costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
are exposed to the credit risk of our customers, who are experiencing financial difficulties, and if these customers are unable to pay
us, our revenues and profitability will be reduced.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
sell products to retailers, including national chains, warehouse clubs, department stores, lifestyle merchants, specialty stores, and
direct mail catalogs and showrooms. Deterioration in the financial condition of our customers could result in bad debt expense to us
and have a material adverse effect on our revenues and future profitability.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 33 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may have trouble hiring additional qualified personnel.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
we expand our product development and marketing activities, we will need to hire additional personnel and could experience difficulties
attracting and retaining qualified employees. Competition for qualified personnel could be intense due to the limited number of individuals
who possess the skills and experience required by such an industry. We may not be able to afford, attract and retain quality personnel
on favorable terms, or at all. In addition, to the extent we hire personnel from competitors, we may be subject to allegations that such
personnel have been improperly solicited or that they have divulged proprietary or other confidential information, or that their former
employers own their product or service ideas. Any of these difficulties could have a material adverse effect on our business, results
of operations and financial condition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
failure of our information technology systems could significantly disrupt the operation of our business.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Like
any other business, we rely on e-mail and other digital communications methods as part of our normal operations. As such, our internal
computer systems and servers could fail or suffer security breaches, possibly resulting in a material disruption to our operations. The
secure operation of our IT networks and systems as well as the secure processing and maintenance of information is critical to our operations
and business strategy. Our ability to execute our business plan and to comply with regulatory requirements with respect to data control
and data integrity depends, in part, on the continued and uninterrupted performance of our information technology systems, or IT systems.
These systems are vulnerable to damage from a variety of sources, including telecommunications or network failures, malicious human acts
and natural disasters. Moreover, despite network security and back-up measures, some of our servers are potentially vulnerable to physical
or electronic break-ins, computer viruses and similar disruptive problems. Despite the precautionary measures we have taken to prevent
unanticipated problems that could affect our IT systems, there are no assurances that electronic break-ins, computer viruses and similar
disruptive problems, and/or sustained or repeated system failures or problems arising during the upgrade of any of our IT systems that
interrupt our ability to generate and maintain data will not occur. The occurrence of any of the foregoing with respect to our IT systems
could have a material adverse effect on our business, results of operations or financial condition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
are subject to various claims and legal actions arising in the ordinary course of our business.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to various claims and legal actions arising in the ordinary course of our business. Any such litigation could be very costly
and could distract our management from focusing on operating our business. The existence of any such litigation could harm our business,
results of operations and financial condition. Results of actual and potential litigation are inherently uncertain. An unfavorable result
in a legal proceeding could adversely affect our reputation, financial condition and operating results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to the U.S. Foreign Corrupt Practices Act and other anti-corruption laws, as well as export control laws, customs laws, sanctions
laws and other laws governing our anticipated operations. If we fail to comply with these laws, we could be subject to civil or criminal
penalties, other remedial measures, and legal expenses, which could adversely affect our business, results of operations and financial
condition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
operations are subject to certain anti-corruption laws, including the U.S. Foreign Corrupt Practices Act (&#8220;FCPA&#8221;), and other
anti-corruption laws that apply in countries where we do business. The FCPA and other anti-corruption laws generally prohibit us and
our employees and intermediaries from bribing, being bribed or making other prohibited payments to government officials or other persons
to obtain or retain business or gain some other business advantage. We and our commercial partners operate in several jurisdictions that
pose a high risk of potential FCPA violations and we participate in collaborations and relationships with third parties whose actions
could potentially subject us to liability under the FCPA or local anti-corruption laws. In addition, we cannot predict the nature, scope,
or effect of future regulatory requirements to which our international operations might be subject or the manner in which existing laws
might be administered or interpreted.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are also subject to other laws and regulations governing our international operations, including regulations administered in the U.S.
and in the EU, including applicable export control regulations, economic sanctions on countries and persons, customs requirements and
currency exchange regulations (collectively, &#8220;Trade Control Laws&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
can be no assurance that we are completely effective in ensuring our compliance with all applicable anticorruption laws, including the
FCPA or other legal requirements, such as Trade Control Laws. Any investigation of potential violations of the FCPA, other anti-corruption
laws or Trade Control Laws by the United States, the European Union or other authorities could have an adverse impact on our reputation,
our business, results of operations and financial condition. Furthermore, should we be found not to be in compliance with the FCPA, other
anti-corruption laws or Trade Control Laws, we may be subject to criminal and civil penalties, disgorgement and other sanctions and remedial
measures, as well as the accompanying legal expenses, any of which could have a material adverse effect on our reputation and liquidity,
as well as on our business, results of operations and financial condition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 34 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
charter provides limitations of director liability and indemnification of directors and officers and employees.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
certificate of incorporation limits the liability of directors to the maximum extent permitted by Delaware law. Delaware law provides
that directors of a corporation will not be personally liable for monetary damages for breach of their fiduciary duties as directors,
except for liability for any:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">breach
    of their duty of loyalty to us or our stockholders;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">act
    or omission not in good faith or that involves intentional misconduct or a knowing violation of law;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">unlawful
    payments of dividends or unlawful stock repurchases, or redemptions as provided in Section 174 of the Delaware General Corporation
    Law; or</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">transaction
    from which the directors derived an improper personal benefit.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
limitations of liability do not apply to liabilities arising under the federal or state securities laws and do not affect the availability
of equitable remedies such as injunctive relief or rescission.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
bylaws provide that we will indemnify our directors, officers and employees to the fullest extent permitted by law. Our bylaws also provide
that we are obligated to advance expenses incurred by a director or officer in advance of the final disposition of any action or proceeding.
We believe that these provisions are necessary to attract and retain qualified persons as directors and officers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
limitation of liability in our certificate of incorporation and bylaws may discourage stockholders from bringing a lawsuit against directors
for breach of their fiduciary duties. They may also reduce the likelihood of derivative litigation against directors and officers, even
though an action, if successful, might provide a benefit to us and our stockholders. Our results of operations and financial condition
may be harmed to the extent we pay the costs of settlement and damage awards against directors and officers pursuant to these indemnification
provisions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
our accounting controls and procedures are circumvented or otherwise fail to achieve their intended purposes, our business could be seriously
harmed.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
evaluate our disclosure controls and procedures as of the end of each fiscal quarter, and annually review and evaluate our internal control
over financial reporting in order to comply with the Commission&#8217;s rules relating to internal control over financial reporting adopted
pursuant to the Sarbanes-Oxley Act of 2002. Because of its inherent limitations, internal control over financial reporting may not prevent
or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls
may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
If we fail to maintain effective internal control over financial reporting or our management does not timely assess the adequacy of such
internal control, we may be subject to regulatory sanctions, and our reputation may decline.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have performed an evaluation under the supervision and with the participation of our management, including our principal executive officer
and principal financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures as of the
end of the most recent period covered by this report. Based on our evaluation, our chief executive officer and chief financial officer
concluded that our disclosure controls and procedures were not effective at a reasonable assurance level due to the material weaknesses
described below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 35 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
material weakness is a deficiency, or a combination of deficiencies, within the meaning of Public Company Accounting Oversight Board
(&#8220;PCAOB&#8221;) Audit Standard No. 5, in internal control over financial reporting, such that there is a reasonable possibility
that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis. Management
has identified the following material weaknesses which has caused management to conclude that as of December 31, 2023, our internal control
over financial reporting was not effective at a reasonable assurance level.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not have sufficient resources in our accounting function, which restricts our ability review material account reconciliations and
certain material journal entries related to financial reporting, including fair value estimates, in a timely manner. In addition, there
is no three-way match or other established control over occurrence of revenue that is precise enough to detect a material misstatement
in revenue. Due to our size and nature, segregation of all conflicting duties including review of certain journal entries, reconciliations
and three-way match of documents may not always be possible and may not be economically feasible. However, to the extent possible, the
initiation of transactions, review and reconciliation of transactions and calculations should be performed by separate individuals and
a more precise process regarding the three way match of documents needs to be established.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are currently working to improve and simplify our internal processes and implement enhanced controls to address the material weaknesses
in our internal control over financial reporting, document matching and to remedy the ineffectiveness of our disclosure controls and
procedures. These material weaknesses will not be totally remediated until the applicable remediated controls are operating for a sufficient
period of time and management has concluded, through testing, that these controls are operating effectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
requirements of being a public company may strain our resources, divert management&#8217;s attention and affect our ability to attract
and retain qualified board members.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a public company and subject to the reporting requirements of the Exchange Act, and the Sarbanes-Oxley Act of 2002. The Exchange
Act requires, among other things, that we file annual, quarterly and current reports with respect to our business and financial condition.
The Sarbanes-Oxley Act requires, among other things, that we maintain effective disclosure controls and procedures and internal controls
for financial reporting. For example, Section 404 of the Sarbanes-Oxley Act requires that our management report on the effectiveness
of our internal controls structure and procedures for financial reporting. Section 404 compliance may divert internal resources and will
take a significant amount of time and effort to complete. If we fail to maintain compliance under Section 404, or if our internal control
over financial reporting continues to not be effective as defined under Section 404, we could be subject to sanctions or investigations
by the Nasdaq Stock Market, the SEC, or other regulatory authorities. Furthermore, investor perceptions of our company may suffer, and
this could cause a decline in the market price of our common stock. Any failure of our internal controls could have a material adverse
effect on our stated results of operations and harm our reputation. If we are unable to implement these changes effectively or efficiently,
it could harm our operations, financial reporting or financial results and could result in an adverse opinion on internal controls from
our independent auditors. We may need to hire a number of additional employees with public accounting and disclosure experience in order
to meet our ongoing obligations as a public company, particularly if we become fully subject to Section 404 and its auditor attestation
requirements, which will increase costs. Our management team and other personnel will need to devote a substantial amount of time to
new compliance initiatives and to meeting the obligations that are associated with being a public company, which may divert attention
from other business concerns, which could have a material adverse effect on our business, financial condition and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 36 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: small-caps 10pt Times New Roman, Times, Serif"><b><span id="ap_006"></span>SPECIAL
NOTE REGARDING FORWARD-LOOKING STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus contains &#8220;forward-looking statements.&#8221; Forward-looking statements reflect the current view about future events.
When used in this prospectus, the words &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221;
&#8220;future,&#8221; &#8220;intend,&#8221; &#8220;plan&#8221; or the negative of these terms and similar expressions, as they relate
to us or our management, identify forward-looking statements. Such statements, include, but are not limited to, statements contained
in this prospectus relating to our business strategy, our future operating results and liquidity and capital resources outlook. Forward-looking
statements are based on our current expectations and assumptions regarding our business, the economy and other future conditions. Because
forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that
are difficult to predict. Our actual results may differ materially from those contemplated by the forward-looking statements. They are
neither statements of historical fact nor guarantees of assurance of future performance. We caution you therefore against relying on
any of these forward-looking statements. Important factors that could cause actual results to differ materially from those in the forward-looking
statements include, without limitation:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    ability to raise sufficient capital from this offering;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to attract and retain management;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    growth strategies;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">anticipated
    trends in our business;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    future results of operations;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to incorporate new and changing technologies</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    willingness to develop technological innovation;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    liquidity and ability to finance our development activities;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    impact from ownership if we are a controlled company;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    impact of inflation and other pricing pressures;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    impact of government regulation;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">planned
    capital expenditures (including the amount and nature thereof);</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    financial position, business strategy and other plans and objectives for future operations;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">competition;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    ability of our management team to execute its plans and meet our goals;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">general
    economic conditions, whether internationally, nationally or in the regional and local market areas in which we are doing business,
    that may be less favorable than expected; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">other
    economic, competitive, governmental (including new tariffs), legislative, regulatory, geopolitical and technological factors that
    may negatively impact our business, operations and pricing.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">other
    factors (including the risks contained in the section of this prospectus entitled &#8220;<i>Risk Factors</i>&#8221;) relating to
    our industry, our operations and results of operations and the securities being offered hereby.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Should
one or more of these risks or uncertainties materialize, or should the underlying assumptions prove incorrect, actual results may differ
significantly from those anticipated, believed, estimated, expected, intended or planned.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Factors
or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of
them. We cannot guarantee future results, levels of activity, performance or achievements. Except as required by applicable law, including
the securities laws of the United States, we do not intend to update any of the forward-looking statements to conform these statements
to actual results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: small-caps 10pt Times New Roman, Times, Serif"><b><span id="ap_007"></span>USE
OF PROCEEDS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We estimate that the net proceeds to us from this offering will be $8,880,000 after deducting placement agent fees
and other estimated offering expenses payable by us for this offering assuming that we sell 100% of the securities offered in this offering
(or approximately $$6,580,000, $4,280,000 and $1,980,000 million if we sell 75%, 50% and 25% of the securities offered in this offering,
respectively).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
intend to use the net proceeds from this offering for working capital and other general corporate purposes and to repay the principal
amount of $2,352,941 in outstanding senior secured notes of the Company. The senior notes mature on January 22, 2025, and upon the occurrence
of an event of default, as defined in the senior secured notes, bears interest as the rate of 14% per annum. Pursuant to the terms of
the senior notes, we are required to apply 100% of the net proceeds of this offering to repay the senior secured notes. </span>The Company
intends to apply the net proceeds to the repayment of the senior secured notes and apply any remaining proceeds to working capital and
other general corporate purposes.</p>

<p style="margin: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investors
must rely on the judgment of our management, who will have broad discretion regarding the application of the proceeds of this offering.
The amounts and timing of our actual expenditures will depend upon numerous factors, including market conditions, cash generated by our
operations (if any), business developments and the rate of our growth. We may find it necessary or advisable to use portions of the proceeds
of this offering for other purposes. Pending these uses, we intend to invest the net proceeds of this offering in a money market or other
interest-bearing account.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 37 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: small-caps 10pt Times New Roman, Times, Serif"><b><span id="ap_008"></span>MARKET
FOR COMMON EQUITY AND RELATED STOCKHOLDER MATTERS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
common stock is listed on The Nasdaq Capital Market under the symbol &#8220;RIME.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of November 20, 2024, 14,215,176 shares of our common stock were issued and outstanding and were held by 34 stockholders
of record.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
also have outstanding:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">70,252
                                            </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
                                            of common stock issuable upon the exercise of outstanding stock options with a weighted-average
                                            exercise price of $8.07 per share;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">63,453
                                            </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
                                            of common stock reserved for future issuance under our 2022 Equity Incentive Plan; and</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">902,113
                                            shares of common stock issuable upon exercise of warrants to purchase common stock with a
                                            weighted-average exercise price of $3.20 per share.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ap_009"></span>DIVIDEND
POLICY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have not declared any cash dividends since inception and we do not anticipate paying any dividends in the foreseeable future. Instead,
we anticipate that all of our earnings will be used to provide working capital, to support our operations, and to finance the growth
and development of our business. The payment of dividends is within the discretion of the Board and will depend on our earnings, capital
requirements, financial condition, prospects, applicable Delaware law, which provides that dividends are only payable out of surplus
or current net profits, and other factors our Board might deem relevant. There are no restrictions that currently limit our ability to
pay dividends on our common stock other than those generally imposed by applicable state law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: small-caps 10pt Times New Roman, Times, Serif"><b><span id="ap_010"></span>CAPITALIZATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth our consolidated cash and capitalization, as of September 30, 2024. Such information is set forth on
the following basis:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">on
    an actual basis;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">on
    a pro forma basis giving effect to the sale and issuance of senior secured notes with an aggregate principal amount of
    $<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,352,941 and an aggregate of </span> 4,462,421
    shares of common stock prior to the date of this prospectus; and</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">on
    a pro forma as adjusted basis giving effect to the sale of 43,478,261 shares of common stock by us in this public offering
    (assuming no sale of any Pre-Funded Warrants and none of the Warrants issued in this offering are exercised and 100% of the securities
    offered in this offering are sold) at an assumed public offering price of $0.23 per share, which was the last reported sale
    price of our common stock on The Nasdaq Capital Market on November 20, 2024, after deducting estimated placement agent fees
    and other estimated offering expenses payable by us.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
should read the following table in conjunction with &#8220;<i>Use of Proceeds</i>,&#8221; &#8220;<i>Management&#8217;s Discussion and
Analysis of Financial Condition and Results of Operations</i>&#8221; and our financial statements and related notes included in this
prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
pro forma as adjusted information set forth below is illustrative only and will be adjusted based on the actual public offering price
and other terms of this offering determined at pricing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; text-align: center">As of September 30, 2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center; padding-bottom: 1pt">&#160;</td><td style="text-align: center; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center">Actual</td><td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center">Pro
                                            Forma (1)</td><td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center">Pro
                                            Forma As Adjusted (1)</td><td style="padding-bottom: 1pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left; padding-bottom: 2.5pt">Cash and cash equivalents</td><td style="width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 14%; text-align: right">621,000</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 14%; text-align: right">3,768,000</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 14%; text-align: right">12,653,000</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Total Indebtedness</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,003,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,356,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,356,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stockholders&#8217; equity:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Common stock, 11,079,678 issued and 9,752,755 shares outstanding at September 30, 2024; 14,215,176 issued and outstanding
    pro forma; and 57,693,437 issued and outstanding as adjusted (unaudited)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">98,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">143,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">578,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Additional Paid-in Capital</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">35,995,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">38,265,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">47,830,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accumulated deficit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(33,206,000</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(34,374,000</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(34,374,000</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Non-controlling interest</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(148,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(148,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(148,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Total stockholders&#8217; equity</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,739,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,886,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">13,886,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total Capitalization</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,742,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">7,242,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">17,242,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify">(1) <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information above excludes:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">70,252
    shares of common stock issuable upon the exercise of outstanding stock options with a weighted-average exercise price of $8.07 per
    share;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">63,453
    </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock reserved for future issuance
    under our 2022 Equity Incentive Plan; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">902,113
    shares of common stock issuable upon exercise of warrants to purchase common stock with a weighted-average exercise price of $3.20
    per share.</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 38 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: small-caps 10pt Times New Roman, Times, Serif"><b><span id="ap_011"></span>DILUTION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchasers
of our common stock in this offering will experience an immediate and substantial dilution in the pro forma net tangible book value of
their shares of common stock. Dilution in pro forma net tangible book value represents the difference between the public offering price
per share and the pro forma as adjusted net tangible book value per share of our common stock immediately after the offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
historical net tangible book value (deficit) of our common stock as of September 30, 2024 was $(1,971,000) or $(0.20)
per share. Historical net tangible book value per share of our common stock represents our total tangible assets (total assets less
intangible assets) less total liabilities divided by the number of shares of common stock outstanding as of that date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
giving effect to the issuance of an aggregate of 4,462,421 shares of common stock from September 30, 2024 until the
date of this prospectus, our pro forma net tangible book value as of September 30, 2024 would have been $(1,176,941)
or approximately $(0.08) per share of our common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
giving further effect to the sale of a total of 43,478,261 shares in this offering at an assumed public offering price of $0.23
per share, which was the last reported sale price of our common stock on The Nasdaq Capital Market on November 20, 2024 (assuming
no sale of any Pre-Funded Warrants and none of the Warrants issued in this offering are exercised and 100% of the securities offered
in this offering are sold), less placement agent fees and other expenses of $1,120,000 for net proceeds of $8,880,000, our pro forma as adjusted net tangible book value as of September 30, 2024 would have
been $7,708,059 or $0.13 per share of our common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
represents an immediate increase in the pro forma net tangible book value per share of $0.22 to the existing stockholders and
an immediate dilution in pro forma net tangible book value per share of $0.10 to new investors who purchase shares of common stock
in the offering. The following table illustrates this per share dilution to new investors:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; font-size: 10pt; text-align: justify; padding-bottom: 1pt">Public offering price per share</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; width: 16%; text-align: right">&#160;</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 16%; font-size: 10pt; text-align: right">0.23</td><td style="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: justify; padding-bottom: 1pt">Historical net tangible book value per share as of September
    30, 2024</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(0.20</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"/><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: justify; padding-bottom: 1pt">Increase per share attributable to the pro forma adjustments
    described above</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">0.12</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"/><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: justify; padding-bottom: 1pt">Pro forma net tangible book value per share as of September
    30, 2024</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(0.08</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: justify; padding-bottom: 1pt">Increase in in pro forma net tangible book value per share
    after giving effect to this offering</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">0.22</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"/><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: justify; padding-bottom: 1pt">Pro forma as adjusted net tangible book value per share
    as of September 30, 2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">0.13</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: justify; padding-bottom: 1pt">Dilution in net tangible book value per share to new investors</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">0.10</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
above discussion and table are based on shares of our </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">common
stock <span style="background-color: white">outstanding as of September  30, 2024 and </span>excludes:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt">70,252
shares of common stock issuable upon the exercise of outstanding stock options with a weighted-average exercise price of $8.07 per share;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt">63,453
shares of common stock reserved for future issuance under our 2022 Equity Incentive Plan; and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt">902,113
shares of common stock issuable upon exercise of warrants to purchase common stock with a weighted-average exercise price of $3.20 per
share.</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
completion of this offering without giving effect to the exercise of the Warrants and assuming no sale of any Pre-Funded Warrants, our
existing stockholders would own approximately 25% and our new investors would own approximately 75% of the total number
of shares of our common stock outstanding after this offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the extent that outstanding options or warrants are exercised, you will experience further dilution. In addition, we may choose to raise
additional capital due to market conditions or strategic considerations even if we believe we have sufficient funds for our current or
future operating plans. To the extent that additional capital is raised through the sale of equity or convertible debt securities, the
issuance of these securities may result in further dilution to our stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
dilution information set forth in the table above is illustrative only and will be adjusted based on the actual public offering price
and other terms of this offering determined at pricing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Capitalization
Table</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Shares Purchased</td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Total Consideration</td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Average Price</td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Number</td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Percent</td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Amount</td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Percent</td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Per Share</td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Existing stockholders</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">14,215,176</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">24.64</td><td style="font-size: 10pt; text-align: left">%</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">35,995,000</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">78.26</td><td style="font-size: 10pt; text-align: left">%</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">2.53</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">New Investors</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">43,478,261</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">75.36</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">%</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">10,000,000</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">21.74</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">%</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">0.23</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">57,693,437</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">100</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">%</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">45,995,000</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">100</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">%</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">0.80</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 39 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ap_012"></span>MANAGEMENT&#8217;S
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>This
Quarterly Report on Form 10-Q contains forward-looking statements that involve a number of risks and uncertainties. Words such as &#8220;anticipates,&#8221;
&#8220;expects,&#8221; &#8220;intends,&#8221; &#8220;goals,&#8221; &#8220;plans,&#8221; &#8220;believes,&#8221; &#8220;seeks,&#8221;
&#8220;estimates,&#8221; &#8220;continues,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; &#8220;should,&#8221; &#8220;could,&#8221;
and variations of such words and similar expressions are intended to identify such forward-looking statements. In addition, any statements
that refer to projections of our future financial performance, our anticipated growth and trends in our businesses, uncertain events
or assumptions, and other characterizations of future events or circumstances are forward-looking statements. Such statements are based
on management&#8217;s expectations as of the date of this filing and involve many risks and uncertainties that could cause our actual
results to differ materially from those expressed or implied in our forward-looking statements. Such risks and uncertainties include
those described throughout this report and our Transition Report on Form 10-KT for the nine months period ended December 31, 2023, particularly
the &#8220;Risk Factors&#8221; sections of such reports. Given these risks and uncertainties, readers are cautioned not to place undue
reliance on such forward-looking statements. Readers are urged to carefully review and consider the various disclosures made in this
Form 10-Q and in other documents we file from time to time with the Securities and Exchange Commission (the &#8220;SEC&#8221;) that disclose
risks and uncertainties that may affect our business. The forward-looking statements in this Form 10-Q are made as of the date of this
filing, and we do not undertake, and expressly disclaim any duty to update such statements, whether as a result of new information, new
developments or otherwise, except to the extent that disclosure may be required by law.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>You
should read the following management&#8217;s discussion and analysis of financial condition and results of operations in conjunction
with our unaudited condensed consolidated financial statements and notes thereto included in Part I, Item 1 of this Quarterly Report
on Form 10-Q and with our audited financial statements and related notes thereto and Management&#8217;s Discussion and Analysis of Financial
Condition and Results of Operations included in our Transition Report on Form 10-KT, filed with the SEC on April 15, 2024.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>In
this Quarterly Report, unless the context requires otherwise, references to the &#8220;Company,&#8221; &#8220;Algorhythm,&#8221; &#8220;we,&#8221;
&#8220;our company&#8221; and &#8220;us&#8221; refer to Algorhythm Holdings, Inc., a Delaware corporation, as well as our wholly owned
subsidiaries; SMC Logistics, Inc., a California corporation (&#8220;SMCL&#8221;), SMC-Music, Inc., a Florida corporation (&#8220;SMCM&#8221;),
SMC (HK) Limited, a Hong Kong company (&#8220;SMH&#8221;), The Singing Machine Company, Inc., a Delaware corporation (&#8220;Singing
Machine&#8221;), MICS Hospitality Holdings, Inc., a Delaware corporation (&#8220;MICS Hospitality&#8221;), MICS Hospitality Management,
LLC, a Delaware limited liability company (&#8220;MICS Hospitality Management&#8221;), MICS Nomad, LLC, a Delaware limited liability
company (&#8220;MICS NY&#8221;) and SemiCab Holdings, LLC, a Nevada limited liability company (&#8220;SemiCab&#8221;).</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
objective of this Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operation is to allow investors to
view our company from management&#8217;s perspective, considering items that would have a material impact on future operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Overview</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Algorhythm
Holdings, Inc. (f/k/a The Singing machine Company, Inc.) (the &#8220;Company&#8221;) is a holding company for an AI enabled software
logistics business operated through our SemiCab Holding subsidiary and a home karaoke consumer products company that designs and distributes
karaoke products globally to retailers and ecommerce partners through our Singing Machine subsidiary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
operations include our wholly owned subsidiaries, SMC Logistics, Inc., a California corporation (&#8220;SMCL&#8221;), SMC-Music, Inc.,
a Florida corporation (&#8220;SMCM&#8221;), SMC (HK) Limited, a Hong Kong company (&#8220;SMH&#8221;), MICS Hospitality Holdings, Inc.,
a Delaware corporation (&#8220;MICS Hospitality&#8221;), MICS Hospitality Management, LLC, a Delaware limited liability company (&#8220;MICS
Hospitality Management&#8221;), MICS Nomad, LLC, a Delaware limited liability company (&#8220;MICS NY&#8221;) and SemiCab Holdings, LLC,
a Nevada limited liability company (&#8220;SemiCab&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 40 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Singing
Machine is primarily engaged in the development, marketing, and sale of consumer karaoke audio equipment, accessories, and musical recordings.
We are a global karaoke and music entertainment company that specializes in the design and production of quality karaoke and music enabled
consumer products for adults and children.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SemiCab
is a cloud-based collaborative transportation platform built to achieve the scalability required to predict and optimize full-truckload
transportation at enterprise-scale. To orchestrate collaboration across manufacturers, retailers, distributors, and their carriers, SemiCab
uses real-time data from API-based load tendering and pre-built integrations with TMS and ELD partners. To build fully loaded round trips,
SemiCab uses AI/ML techniques and advanced predictive optimization models.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Recent
Developments</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Name
and Symbol Change</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
September 5, 2024, our Certificate of Incorporation was amended to effect a change in the name of the Company from &#8220;The Singing
Machine Company, Inc.&#8221; to &#8220;Algorhythm Holdings, Inc.&#8221; In addition, effective September 8, 2024, the Company&#8217;s
ticker symbol was changed from &#8220;MICS&#8221; to &#8220;RIME.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Change
in Fiscal Year</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
2023, our Board of Directors approved a change in our fiscal year end from March 31 to December 31. Our results of operations, cash flows,
and all transactions impacting shareholders&#8217; equity presented in this Quarterly Report on Form 10-Q as of September 30, 2024 are
for the three and nine month periods ended September 30, 2024 and 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>ATM
Offering</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 26, 2024, the Company entered into an At-The-Market Issuance Sales Agreement (the &#8220;Sales Agreement&#8221;) with Ascendiant
Capital markets, LLC, as sales agent (the &#8220;Agent&#8221;), pursuant to which the Company could offer and sell, from time to time,
through the Agent (the &#8220;ATM Offering&#8221;), up to approximately $1,100,000 in shares of the Company&#8217;s common stock. <span style="background-color: white">On
July 8, 2024, the Company entered into the First Amendment to the Sales Agreement (the &#8220;Amendment&#8221;) to increase the number
of shares to be sold in the ATM Offering to $2,020,000.</span> On August 9, 2024, the Company entered into the Second Amendment to the
Sales Agreement (the &#8220;Amendment&#8221;) to increase the number of shares to be sold in the ATM Offering to $3,100,000. Pursuant
to the agreement, the Agent was paid $30,000 in fees to cover legal and administrative expenses and will receive an amount equal to 3%
of the gross proceeds from each sale of the Company&#8217;s share of common stock. For the three and nine months ended September 30,
2024, the Company sold 1,673,077 shares of common stock under the ATM offering and received net proceeds of approximately $1,489,000
after payment of legal and accounting fees, brokerage commissions, and administrative fees to the agent of approximately $189,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsequent
to September 30, 2024 and through November 22, 2024 (the last trading day prior to filing), the Company sold 2,162,423 shares of common
stock under the ATM offering, and received net proceeds of approximately $1,372,000 after payment of brokerage commissions and administrative
fees to the agent of approximately $42,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Asset
Purchase</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 11, 2024, the Company and its wholly owned subsidiary SemiCab Holdings, LLC, a Nevada limited liability company (&#8220;SemiCab
LLC&#8221; and collectively with the Company, the &#8220;Buyer&#8221;), SemiCab, Inc., a Delaware corporation (&#8220;SemiCab&#8221;
or the &#8220;Seller&#8221;), Ajesh Kapoor and Vivek Sehgal entered into an asset purchase agreement (the &#8220;Asset Purchase Agreement&#8221;)
pursuant to which the Seller agreed to sell and assign to the Company, and the Company agreed to purchase and assume from the Seller,
substantially all the assets, and certain specified liabilities relating to the business of the Seller. Subject to certain exceptions
set forth in the Asset Purchase Agreement, the parties agreed that the Buyer will not assume the liabilities of the Seller. SemiCab is
an artificial intelligence, cloud-based collaborative transportation platform built to achieve the scalability required to predict and
optimize semi-tractor trailer load efficiency.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 3, 2024, the parties closed on the asset purchase whereby the Company issued to the Seller (i) 641,806 shares of the Company&#8217;s
common stock (ii) a twenty percent (20%) membership interest in SemiCab LLC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 41 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the asset acquisition agreement, the Company and Seller entered into an option agreement (the &#8220;Option Agreement&#8221;), granting
the Buyer the right to acquire all of the issued and outstanding capital securities of SMCB Solutions Private Limited (&#8220;SMCB&#8221;),
a wholly owned subsidiary of the Seller, in consideration for 320,903 shares of common stock of the Company. The Option Agreement has
not been exercised through the date of this filing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Hospitality
Lease</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 23, 2023, MICS NY entered into an Agreement of Lease (the &#8220;Lease Agreement&#8221;) with OAC 111 Flatiron, LLC and OAC Adelphi,
LLC (the &#8220;Landlord&#8221;), pursuant to which MICS NY agreed to lease approximately 10,000 square feet of ground floor retail space
and a portion of the basement underneath the ground floor retail space in the property located at 111 West 24<sup>th</sup> Street, New
York, New York (the &#8220;Premises&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the three months ended June 30, 2024, the Company abandoned its plans to continue use of the leased space and exercised its early termination
provision of the Lease Agreement which was not accepted by the Landlord. Due to the abandonment of the lease, all assets related to the
lease were impaired. Assets including security deposits, rent deposits and right of use assets of approximately $3,878,000 were written
off during the three months ended June 30, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 26, 2024, OAC 111 Flatiron, LLC and OAC Adelphi, LLC (the &#8220;Landlord&#8221;), filed a civil action in the Supreme Court of
the State of New York against MICS Nomad LLC, a subsidiary of the Company (&#8220;MICS NY&#8221;), and the Company (&#8220;the Defendants&#8221;)
for alleged breach of lease, seeking monetary damages including unpaid rent, future unpaid rent, and other expenses related to the lease.
The complaint alleges the Defendants breached the lease in various material respects.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 25, 2024, the Company entered into a Settlement Agreement for a full release and dismissal of the complaint within 5 business
days of the Company&#8217;s payment of $250,000. Pursuant to the Settlement Agreement, the Company made the first payment of $150,000
was made on September 25, 2024 and a final payment of $100,000 was due and paid on October 25, 2024. On October 29, 2024 the Landlord
filed a discontinuance with prejudice.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result of the settlement, during the three months ended September 30, 2024, the Company wrote off the remaining operating lease liability
on the Lease Agreement and recognized a gain on early termination of the operating lease of approximately $3,874,000. For the nine months
ended September 30, 2024 the Company recognized a loss on early termination of the operating lease of $4,000 which includes the $250,000
termination settlement expense. The net loss on early termination of the Lease Agreement was recorded as a component of operating expenses
in the accompanying condensed consolidated statements of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Private
Placement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 22, 2024, the Company entered into a Securities Purchase Agreement (the &#8220;SPA&#8221;) with investors pursuant to which we
sold, in a private placement (the &#8220;Private Placement&#8221;), secured notes with an aggregate principal amount of $2,352,941 (the
&#8220;Notes&#8221;), for cash proceeds of $2,000,000, net of original issue discount of $352,941. As consideration for entering into
the SPA, we issued a total of 2,299,998 shares of common stock of the Company to the investors on October 24, 2024 (See Note 17).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Oxford
Credit Facility</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 28, 2024, the Company and Oxford Commercial Finance, a Michigan banking corporation, (referred to as &#8220;Oxford&#8221;) entered
into a Loan Agreement (the &#8220;Loan Agreement&#8221;) and related Revolving Credit Note (the &#8220;Note&#8221;) for a $2,000,000
revolving line of credit (the &#8220;Oxford Line of Credit&#8221;). On October 17, 2024, the Company terminated the Loan Agreement and
the Note. As of the date of termination, the Company had no outstanding amounts owed to Oxford and paid a termination fee of $40,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 42 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Amended
Bylaws</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 18, 2024, the Company amended its Amended By-laws (the &#8220;By-law Amendment&#8221;), for the purpose of reducing the quorum
required to hold meetings of the stockholders of the Company (the &#8220;Quorum Requirement&#8221;). The By-law Amendment reduced the
Quorum Requirement from a majority to thirty-three and one-third percent (33 1/3%) of the voting power of the shares of stock issued
and outstanding and entitled to vote at the meeting. The By-law Amendment was approved by the Board of Directors of the Company on October
18, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Share
Repurchase</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 1, 2024, the Company entered into a Stock Repurchase Agreement (the &#8220;Repurchase Agreement&#8221;) with Regalia Ventures
LLC, a Delaware limited liability company (the &#8220;Seller&#8221;), pursuant to which the Company agreed to repurchase from the Seller
an aggregate of 1,098,901 issued and outstanding shares of common stock, par value $0.01 per share, of the Company (the &#8220;Shares&#8221;).
Pursuant to the terms of the Repurchase Agreement, the Company has agreed to repurchase from the Seller, and the Seller has agreed to
sell, assign and transfer to the Company, all of the Seller&#8217;s right, title and interest in and to the Shares, at a price per Share
equal to the higher of: (1) the closing price of the common stock on the last trading day immediately preceding the date of the Repurchase
Agreement; or (2) the highest volume weighted average price (VWAP) of the common stock during a pricing period of ten (10) consecutive
trading days prior to the date of the Repurchase Agreement per share (the &#8220;Purchase Price&#8221;), and the Company shall issue
to the Seller a promissory note in the principal amount equal to the Purchase Price, substantially in the form attached to the Repurchase
Agreement as Exhibit A (the &#8220;Note&#8221;), and subject to terms and conditions therein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
shares of common stock to be repurchased were originally issued to the Seller on November 21, 2023, pursuant to a certain stock purchase
agreement, dated November 20, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">As of the date of this filing, the
repurchase of the shares has not yet closed.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Results
of Operations</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth, for the periods indicated, certain items related to our consolidated statements of operations as a percentage
of net sales as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For
    the Three Months Ended</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For
    the Nine Months Ended</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">September
    30, 2024</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">September
    30, 2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">September
    30, 2024</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">September
    30, 2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; width: 40%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net
    Sales</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">100.0</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">100.0</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">100.0</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">100.0</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Cost
    of Goods Sold</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">77.6</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">76.6</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">79.3</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">75.6</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Operating
    Expenses</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">10.5</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">22.8</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">67.1</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">44.8</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Income
    (Loss) from Operations</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">11.8</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.6</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-<span style="font-family: Times New Roman, Times, Serif">46.4</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-20.4</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Other
    (Expenses) Income, Net</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-<span style="font-family: Times New Roman, Times, Serif">2.7</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-0.1</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-2.1</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.9</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Income
    (Loss) Before Income Tax Provision</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">9.1</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.5</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-48.5</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-17.5</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Income
    Tax Provision</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.0</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.0</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.0</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-6.8</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net
    Income (Loss)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">9.1</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.5</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-48.5</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-24.3</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Three
Months Ended September 30, 2024 Compared to the Three Months Ended September 30, 2023</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Net
Sales</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
sales for the three months ended September 30, 2024, decreased to approximately $10,622,000 from approximately $15,931,000 representing
a decrease of approximately $5,309,000 as compared to the three months ended September 30, 2023. The decrease was primarily due to lower
overall sell-through results during the prior year holiday season, mostly with our largest customer, Walmart, which in turn reduced their
forecast for the upcoming holiday season resulting in decreased stock purchases.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Gross
Profit</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gross
profit for the three months ended September 30, 2024 decreased to approximately $2,375,000 from approximately $3,734,000 representing
a decrease of approximately $1,359,000 as compared to the three months ended September 30, 2023. The decrease in gross profit was primarily
due to the decrease in net sales as described above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 43 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Operating
Expenses</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the three months ended September 30, 2024, total operating expenses decreased to approximately $1,118,000, compared to approximately
$3,628,000 during the three months ended September 30, 2023. This represents a decrease in total operating expenses of approximately
$2,510,000 from the three months ended September 30, 2023. The Company wrote off the remaining operating lease liability on the hospitality
Lease Agreement due to a termination Settlement Agreement and recognized a gain on early termination of the operating lease of approximately
$3,874,000 as the related right of use asset had already been written off as impaired in the previous quarter. Selling expenses decreased
by approximately $516,000 of variable and discretionary selling expenses commensurate with the decrease in net sales as described above.
These decreases in operating expenses were offset by increases in stock-based consulting expenses of approximately $426,000 and increased
third-party logistics costs of approximately $213,000 associated with the closing of the Company&#8217;s logistics warehouse in the prior
year. In addition, there was an increase in operating expenses of approximately $816,000 related to the asset acquisition agreement of
SemiCab.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Other
Expenses (Income)</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
expenses consisted of interest expense of approximately $283,000 for the three months ended September 30, 2024, as compared to interest
expense of approximately $53,000 for the three months ended September 30, 2023. The increase in interest expense of approximately $230,000
was primarily due to interest incurred on debt from the recently acquired asset purchase of SemiCab. There was a gain on the disposal
of warehouse equipment of approximately $44,000 associated with the closing of the logistics facility in California during the three
months ended September 30, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Income
Taxes</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the three months ended September 30, 2024 and 2023 the Company did not recognize any income tax provision. The Company is not recognizing
any tax provision for the three months ended September 30, 2024 as the Company is not forecasting any taxable income for the current
year and had a loss before income tax benefit in the previous year. The Company&#8217;s income tax expense differs for the expected tax
benefit based on statutory rates primarily due history of losses and forecasts that suggest the Company will not be able to utilize any
deferred tax assets in the future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Nine
Months Ended September 30, 2024 Compared to the Nine Months Ended September 30, 2023</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Net
Sales</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
sales for the nine months ended September 30, 2024, decreased to approximately $15,488,000 from approximately $21,939,000 representing
a decrease of approximately $6,451,000 as compared to the nine months ended September 30, 2023. The decrease was primarily due to lower
overall sell-through results during the prior year holiday season, mostly with our largest customer, Walmart, which in turn reduced their
forecast for the upcoming holiday season resulting in decreased stock purchases.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Gross
Profit</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gross
profit for the nine months ended September 30, 2024 decreased to approximately $3,201,000 from approximately $5,357,000 representing
a decrease of approximately $2,156,000 as compared to the nine months ended September 30, 2023. The decrease in gross profit was primarily
due to the decrease in net sales as described above. Gross margins for the nine months ended September 30, 2024 were 20.7%, as compared
to 24.4% for the nine months ended September 30, 2023. The primary reason for the decrease in gross profit margin was due to a product
mix of excess inventory that was sold at margins significantly lower than current active products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 44 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Operating
Expenses</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the nine months ended September 30, 2024, total operating expenses increased to approximately $10,386,000 compared to approximately $9,829,000
during the nine months ended September 30, 2023. This represents an increase in total operating expenses of approximately $557,000 for
the nine months ended September 30, 2023. The increase in total operating expenses was primarily due to an increase in stock-based consulting
expenses of approximately $426,000 and an increase in operating expenses of approximately $816,000 related to the asset acquisition agreement
of SemiCab. These increases were offset by a decrease in variable and discretionary selling expenses of approximately $596,000 commensurate
with the decrease in net sales as described above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Other
(Expenses) Income, net</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
expenses, net increased to approximately $328,000 for the nine months ended September 30, 2024 as compared to other income, net of approximately
$626,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
was interest expense of approximately $328,000 for the nine months ended September 30, 2024 as compared to interest expense of approximately
$122,000. The increase in interest expense of approximately $206,000 was primarily due to interest incurred on debt from the recently
acquired asset purchase of SemiCab. During the nine months ended September 30, 2023, there was a refund of approximately $704,000 from
the Employee Retention Credit program and a gain on the disposal of warehouse equipment of approximately $44,000 associated with the
closing of the logistics facility in California.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Income
Taxes</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the nine months ended September 30, 2024, the Company did not recognize any income tax provision as the Company is not forecasting any
taxable income for the current year. The Company&#8217;s income tax provision for the nine months ended September 30, 2023, was approximately
$1,502,000 as the Company recognized a full valuation allowance on all of its deferred tax assets based on the recent history of losses
and forecasts that suggested the Company would not be able to utilize the deferred tax assets in the future. The Company&#8217;s income
tax expense differs for the expected tax benefit/expense based on statutory rates primarily due to full valuation allowance for all of
its subsidiaries for the nine months ended September 30, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Liquidity
and Capital Resources</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company incurred a net loss of approximately $7,247,000 for the nine-month period ended September 30, 2024, and has a history of recurring
losses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 30, 2024, we had cash on hand of approximately $621,000 as compared to approximately $6,703,000 on December 31, 2023. The decrease
in cash on hand of approximately $6,082,000 from December 31, 2023, was primarily due to approximately $7,069,000 used in operations.
We advanced approximately $776,000 to SMCB for prepaid services under a service agreement (See Note 5). There was a decrease in refunds
due to customers of approximately $1,968,000 which included payment of approximately $768,000 to one major customer for refunds due for
overstock returned by the customer in the prior year. There was a seasonal increase in reserves for sales returns of approximately $1,180,000.
These uses of cash were offset by proceeds of approximately $1,489,000 for the sale of its common stock and a decrease in trade and related
party accounts receivable of approximately $3,158,000. As of September 30, 2024, we had deficit working capital of approximately $2,082,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 30, 2023, we had cash on hand of approximately $3,213,000 as compared to $2,795,000 as of December 31, 2022. The increase in
cash on hand of approximately $418,000 was primarily due to approximately $760,000 provided by operating activities primarily due to
peak seasonal increases of accounts payable of approximately $10,442,000 primarily due to factory vendors offset by seasonal increases
in accounts receivable of approximately $3,982,000, inventories or approximately $3,424,000 accrued expenses related to seasonal accruals
for estimated returned goods and co-op incentive program expenses, approximately $1,132,000. Net cash used investing activities for the
purchase of molds and tooling was approximately $163,000. Net cash used in financing activities was approximately $234,000. While the
Company received proceeds from the exercise of common stock warrants and issuance of common stock (net of offering costs) of approximately
$1,640,000, this increase in financing activities was offset by repayment of revolving credit lines of credit and other debt of approximately
$1,874,000 during the nine months ended September 30, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 45 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
previously reported on Form 8-K filed on August 30, 2024, on August 26, 2024, the Company received a notice from The Nasdaq Stock Market
LLC (&#8220;NASDAQ&#8221;) indicating that its stockholders&#8217; equity as reported in its Quarterly Report on Form 10-Q for the quarterly
period ended June 30, 2024 did not meet the minimum of $2,500,000 in stockholders&#8217; equity required by NASDAQ Listing Rule 5550(b)(1)
(the &#8220;Equity Rule&#8221;) for continued listing, or the alternatives of market value of listed securities or net income from continuing
operations. Pursuant to the Equity Rule, the Company submitted a plan to regain compliance with the Equity Rule.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 13, 2024, the Company filed a Form 8-K stating that it believed it regained compliance with the Equity Rule. As disclosed herein,
the Company reported stockholders&#8217; equity of approximately $2.7 million.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NASDAQ
has advised the Company that it will continue to monitor the Company&#8217;s ongoing compliance with the stockholders&#8217; equity requirement
and, if at the time of its next periodic report the Company does not evidence compliance, that it may be subject to delisting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on cash flow projections from operating and financing activities and the existing balance of cash, management is of the opinion that
the Company has insufficient funds to sustain operations for at least one year after the date of this report, and it may not be able
to meet its payment obligations from operations and related commitments, if the Company is not able to obtain outside financing to allow
the Company to continue as a going concern. Based on these factors, the Company has substantial doubt that it will continue as a going
concern for the twelve months following the issuance date of the financial statements included elsewhere in this report.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s plan to alleviate the going concern issue is to increase revenue while controlling operating costs and expenses and obtaining
funds from outside sources of financing to generate positive financing cash flows. While management is optimistic about its ability to
raise funds to fund operations for at least one year after the date of this report, there can be no assurance that any such measures
will be successful.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s ability to raise additional funds will depend, in part, on the success of our product development activities, and other
events or conditions that may affect the share value or prospects, as well as factors related to financial, economic and market conditions,
many of which are beyond our control. There can be no assurances that sufficient funds will be available to us when required or on acceptable
terms, if at all. Accordingly, management has concluded that these plans do not alleviate substantial doubt about the Company&#8217;s
ability to continue as a going concern. Our failure to achieve or maintain profitability could negatively impact the value of our common
stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Critical
Accounting Estimates</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
interim financial statements were prepared in accordance with United States generally accepted accounting principles, which require management
to make subjective decisions, assessments and estimates about the effect of matters that are inherently uncertain. As the number of variables
and assumptions affecting the judgement increases such judgements become even more subjective. While management believes that its assumptions
are reasonable and appropriate, actual results may be materially different than estimated. The critical accounting estimates and assumptions
have not materially changed from those identified in our Transition Report for the period ended December 31, 2023.</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 46 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="alp_001"></span><b>BUSINESS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
operations include our wholly owned subsidiaries, SMC Logistics, Inc., a California corporation (&#8220;SMCL&#8221;), SMC-Music, Inc.,
a Florida corporation (&#8220;SMCM&#8221;), SMC (HK) Limited, a Hong Kong company (&#8220;SMH&#8221;), The Singing Machine Company, Inc.,
a Delaware corporation (&#8220;Singing Machine&#8221;), MICS Hospitality Holdings, Inc., a Delaware corporation (&#8220;MICS Hospitality&#8221;),
MICS Hospitality Management, LLC, a Delaware limited liability company (&#8220;MICS Hospitality Management&#8221;), MICS Nomad, LLC,
a Delaware limited liability company (&#8220;MICS NY&#8221;) and SemiCab Holdings, LLC, a Nevada limited liability company (&#8220;SemiCab&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Overview</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Algorhythm
Holdings, Inc. is an AI technology and consumer electronics holding company with two primary business units &#8211; SemiCab and Singing
Machine. SemiCab is an AI enabled global software logistics business operated through our subsidiary SemiCab Holdings. Singing Machine
is a worldwide leader in the home karaoke consumer products market that designs and distributes karaoke products globally to retailers
and ecommerce partners.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Consumer
Electronics </i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
engage in the development, marketing, and sale of consumer karaoke audio equipment, accessories, and musical recordings. We believe we
are a leading global karaoke and music entertainment company that specializes in the design and production of quality karaoke and music
enabled consumer products for adults and children. Our products are among the most widely available karaoke products in the world. Our
mission is to &#8220;create joy through music.&#8221; To deliver on this mission, we are focused on the following multi-prong approach:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    the short-term, improve profitability by optimizing operations and continue to expand gross margins; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    the mid-to-long-term, continue to expand into new verticals including automotive and connected-TV devices and grow our global distribution
    for our consumer karaoke products.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>AI
Logistics </i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SemiCab
is a cloud-based Collaborative Transportation Platform built to achieve the scalability required to predict and optimize millions of
loads and hundreds of thousands of trucks. To orchestrate collaboration across manufacturers, retailers, distributors, and their carriers,
SemiCab uses real-time data from API-based load tendering and pre-built integrations with TMS and ELD partners. To build fully loaded
round trips, SemiCab uses AI/ML techniques and advanced predictive optimization models. On the SemiCab platform, shippers pay less and
carriers make more while not having to change a thing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
2020, SemiCab has enabled major retailers, brands and transportation providers to address their transportation needs globally. SemiCab&#8217;s
Orchestrated Collaboration&#8482; AI model has proven to increase transportation capacity, improve asset utilization, reduce empty miles,
lower logistics costs, and provide visibility into the entire transportation network. Models show the technology has the capability of
saving shippers tens of billions of dollars annually through optimization. Further, SemiCab&#8217;s technology also has the potential
to play a key role in the improved sustainability model globally. Based on its proven ability to improve truck utilization rates from
65% to over 90%, this results in a dramatic reduction in the carbon footprint of the industry. The optimization of existing truck utilization
can add approximately 30% more trucking capacity without adding more trucks, drivers or driven miles which addresses common problems
plaguing the industry like severe driver shortage and road congestion. Trucking optimization could also eliminate approximately 25% of
CO2 emissions attributable to road freight.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 47 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Change
in Fiscal Year </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
2023, our Board of Directors approved a change in our fiscal year end from March 31 to December 31.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
and Symbol Change</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
September 5, 2024, our Certificate of Incorporation was amended to effect a change in the name of the Company from &#8220;The Singing
Machine Company, Inc.&#8221; to &#8220;Algorhythm Holdings, Inc.&#8221; In addition, effective September 8, 2024, the Company&#8217;s
ticker symbol was changed from &#8220;MICS&#8221; to &#8220;RIME.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Recent
Events and Developments</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Oxford
Credit Facility</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 28, 2024, the Company and Oxford Commercial Finance, a Michigan banking corporation, (referred to as &#8220;Oxford&#8221;) entered
into a Loan Agreement (the &#8220;Loan Agreement&#8221;) and related Revolving Credit Note (the &#8220;Note&#8221;) for a $2 million
revolving line of credit (the &#8220;Oxford Line of Credit&#8221;). On October 17, 2024, the Company terminated the Loan Agreement and
the Note. As of the date of termination, the Company had no outstanding amounts owed to Oxford and paid a termination fee of $40,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>ATM
Offering June 2024</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 26, 2024, the Company entered into an At-The-Market Issuance Sales Agreement (the &#8220;Sales Agreement&#8221;) with Ascendiant
Capital markets, LLC, as sales agent (the &#8220;Agent&#8221;), pursuant to which the Company could offer and sell, from time to time,
through the Agent (the &#8220;ATM Offering&#8221;), up to approximately $1,100,000 in shares of the Company&#8217;s common stock. On
July 8, 2024, the Company entered into the First Amendment to the Sales Agreement (the &#8220;Amendment&#8221;) to increase the number
of shares to be sold in the ATM Offering to $2,020,000. On August 9, 2024, the Company entered into the Second Amendment to the Sales
Agreement (the &#8220;Amendment&#8221;) to increase the number of shares to be sold in the ATM Offering to $3,100,000. Pursuant to the
agreement, the Agent was paid $30,000 in fees to cover legal and administrative expenses and will receive an amount equal to 3% of the
gross proceeds from each sale of the Company&#8217;s share of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Through
the date of this prospectus, the Company has sold 3,835,500 shares of common stock under the Sales Agreement and received net proceeds
of approximately $2,975,615 after payment of brokerage commissions and administrative fees to the agent of approximately $123,045.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Asset
Purchase</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 11, 2024, the Company and its wholly owned subsidiary SemiCab Holdings, LLC, a Nevada limited liability company (&#8220;SemiCab
LLC&#8221; and collectively with the Company, the &#8220;Buyer&#8221;), SemiCab, Inc., a Delaware corporation (&#8220;SemiCab&#8221;
or the &#8220;Seller&#8221;), Ajesh Kapoor and Vivek Sehgal entered into an asset purchase agreement (the &#8220;Asset Purchase Agreement&#8221;)
pursuant to which the Seller agreed to sell and assign to the Company, and the Company agreed to purchase and assume from the Seller,
substantially all the assets, and certain specified liabilities relating to the business of the Seller. Subject to certain exceptions
set forth in the Asset Purchase Agreement, the parties agreed that the Buyer will not assume the liabilities of the Seller.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 3, 2024, the parties closed on the transactions contemplated by the Asset Purchase Agreement and the Company issued to the Seller
(i) 641,806 shares of the Company&#8217;s common stock (ii) a twenty percent (20%) membership interest in SemiCab LLC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the asset acquisition agreement, the Company and Seller entered into an option agreement (the &#8220;Option Agreement&#8221;), granting
the Buyer the right to acquire all of the issued and outstanding capital securities of SMCB Solutions Private Limited, a wholly owned
subsidiary of the Seller, in consideration for 320,903 shares of common stock of the Company. The Company has not yet exercised the option.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 48 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Hospitality
Lease</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 23, 2023, MICS NY entered into an Agreement of Lease (the &#8220;Lease Agreement&#8221;) with OAC 111 Flatiron, LLC and OAC Adelphi,
LLC (the &#8220;Landlord&#8221;), pursuant to which MICS NY agreed to lease approximately 10,000 square feet of ground floor retail space
and a portion of the basement underneath the ground floor retail space in the property located at 111 West 24<sup>th</sup> Street, New
York, New York (the &#8220;Premises&#8221;). It was the Company&#8217;s intention to use the Premises as a new karaoke venue, offering
immersive karaoke technology and audio-visual capabilities, with restaurant and bar offerings however due to lack of funding, the Company
initiated termination of the lease in March.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 26, 2024, OAC 111 Flatiron, LLC and OAC Adelphi, LLC (the &#8220;Landlord&#8221;), filed a civil action in the Supreme Court of
the State of New York against MICS Nomad LLC, a subsidiary of the Company (&#8220;MICS NY&#8221;), and the Company (&#8220;the Defendants&#8221;)
for alleged breach of lease, seeking monetary damages including unpaid rent, future unpaid rent, and other expenses related to the lease.
The complaint alleges the Defendants breached the lease in various material respects.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 25, 2024, the Company entered into a Settlement Agreement for a full release and dismissal of the complaint within 5 business
days of the Company&#8217;s payment of $250,000. The Company made full payment on October 25, 2024 and the Landlord filed a discontinuance
with prejudice on October 29, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Private
Placement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 22, 2024, the Company entered into a Securities Purchase Agreement (the &#8220;SPA&#8221;) with the Selling Stockholders pursuant
to which we sold, in a private placement (the &#8220;Private Placement&#8221;), secured notes with an aggregate principal amount of $2,352,941
(the &#8220;Notes&#8221;), and received proceeds before expenses of $2,000,000. As consideration for entering into the SPA, we issued
a total of 2,299,998 shares of common stock of the Company to the Selling Stockholders on October 24, 2024. The Selling Stockholders&#8217;
resale of these shares is being registered on the registration statement of which this prospectus forms a part.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><i>Amended Bylaws</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">On October 18, 2024,
the Company amended its Amended By-laws (the &#8220;By-law Amendment&#8221;), for the purpose of reducing the quorum required to hold
meetings of the stockholders of the Company (the &#8220;Quorum Requirement&#8221;). The By-law Amendment reduced the Quorum Requirement
from a majority to thirty-three and one-third percent (33 1/3%) of the voting power of the shares of stock issued and outstanding and
entitled to vote at the meeting. The By-law Amendment was approved by the Board of Directors of the Company on October 18, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Share
Repurchase</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 1, 2024, the Company entered into a Stock Repurchase Agreement (the &#8220;Repurchase Agreement&#8221;) with Regalia Ventures
LLC, a Delaware limited liability company (the &#8220;Seller&#8221;), pursuant to which the Company agreed to repurchase from the Seller
an aggregate of 1,098,901 issued and outstanding shares of common stock, par value $0.01 per share, of the Company (the &#8220;Shares&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
shares of common stock to be repurchased were originally issued to the Seller on November 21, 2023, pursuant to a certain stock purchase
agreement, dated November 20, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to the terms of the Repurchase Agreement, the
Company has agreed to repurchase from the Seller, and the Seller has agreed to sell, assign and transfer to the Company, all of the Seller&#8217;s
right, title and interest in and to the Shares, at a price per Share equal to the higher of: (1) the closing price of the common stock
on the last trading day immediately preceding the date of the Repurchase Agreement; or (2) the highest volume weighted average price
(VWAP) of the common stock during a pricing period of ten (10) consecutive trading days prior to the date of the Repurchase Agreement
per share (the &#8220;Purchase Price&#8221;), and the Company shall issue to the Seller a promissory note in the principal amount equal
to the Purchase Price, substantially in the form attached to the Repurchase Agreement as Exhibit A (the &#8220;Note&#8221;), and subject
to terms and conditions therein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
obligations of each of the Company and the Seller to consummate the closing are conditioned upon the (i) issuance by the Company to the
Seller the Note evidencing the Purchase Price and (ii) the Seller&#8217;s delivery to the Company of executed stock power with a medallion
signature guarantee. As of the date of this prospectus, the transaction contemplated by the Repurchase Agreement has not yet closed.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Our
Product Portfolio</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
karaoke products are sold directly to distributors and retail customers and our transportation services are sold to shippers and brokers.
Our portfolio of owned and licensed brands and products are organized into the following categories:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Karaoke</i></b>-
including our flagship brand Singing Machine, our karaoke line is driven by products at affordable price points that we believe deliver
great value to our customers. All of our karaoke products are Bluetooth&#174; enabled to allow access to digital music content via our
mobile apps available on iOS and Android platforms. Our core karaoke line offers advanced features, including but not limited to, enabling
customers to output video to a TV screen, correcting singer&#8217;s pitch in real-time with our proprietary PitchLab&#8482; technology,
streaming karaoke content directly to the machine via WiFi, casting karaoke songs from a mobile device to our karaoke machines through
our SingCast&#8482; casting technology, singing duets, and displaying scrolling lyrics in-time with the song. Our products are sold directly
to consumers via our retail channels, ecommerce, our own website, and distributors worldwide. This product category accounted for approximately
83% of our net sales in our nine months ended December 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Licensed
Products</i></b>- including brands such as Carpool Karaoke. In 2019, we entered into a 3-year license agreement with CBS<sup>&#174; </sup>for
its Carpool Karaoke brand, made popular by James Corden on The Late Show with James Corden. We launched an innovative Carpool Karaoke
Microphone that works specifically in the car. This license agreement with CBS expired on September 30, 2022. On February 28, 2023, we
renewed this license agreement for an additional three years. On March 16, 2023, we entered into a three-year license agreement with
Sesame Street Workshop for its Sesame Street brand for karaoke and singalong toy products, effective January 1, 2023. Through this license
agreement, we will be able to develop and offer for sale all the iconic and beloved Sesame Street characters like Elmo, Big Bird, Cookie
Monster, Abby Cadabby, and many more. This product category accounted for less than 2% of our net sales in the nine months ended December
31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 49 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Microphones
and Accessories</i></b>- we currently offer a line of traditional microphone accessories that are compatible with our karaoke machines.
These microphones feature an assortment of colors, come wired or wireless, and may include new features like party lighting and voice
changing effects. We are also seeing growth in portable Bluetooth microphones which are marketed under our Party Machine brand. This
product category accounted for approximately 11% of our net sales in the nine months ended December 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Singing
Machine Kids Youth Electronics</i></b>- including the brand Singing Machine Kids. Our kids&#8217; line of products offers fun music entertainment
features designed specifically for children. Our kids&#8217; products introduce singing and music entertainment for young singers and
offer advanced features, such as voice changing effects, recording, Bluetooth compatibility, and portability. This product category accounted
for approximately 2% of our net sales in the nine months ended December 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Automotive</i></b>-
In January 2023, we announced at the Consumer Electronics Show that we will be entering the connected vehicle karaoke device market in
partnership with Stingray Group, Inc. (&#8220;Stingray&#8221;). We have developed microphone hardware utilizing our PitchLab&#8482; technology
to offer integrated wireless microphones for connection with major automotive brand&#8217;s vehicles. We are currently in discussion
with many automotive brands to offer our products. This product category is new and did not contribute to our net sales in the nine months
ended December 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Music
Subscriptions</i></b>- in conjunction with our premium partner, Stingray, we offer karaoke music subscription services for the iOS and
Android platforms as well as a web-based download store and integrated streaming services for our hardware. We currently offer almost
20,000 licensed karaoke songs in the catalog. This product category accounted for approximately 2% of our net sales in the nine months
ended December 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Transportation
services:</i></b> SemiCab sells transportation services to shippers such as retailers, manufacturers and brands. SemiCab primarily focuses
on full truck load, over the road transportation services. SemiCab&#8217;s services are sold directly to shippers via bids for transportation
services. These awards may be signed for selected number of routes for a pre-determined period of time, normally up to a year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Platform
subscriptions for transportation execution for brokers: </i></b>SemiCab offers a SaaS based platform subscription to logistics brokers
for managing their operations for transportation execution. The subscription primarily covers Shipper management, Carrier management,
Document management, Load operations management, Invoicing, Integration services and Reporting and Analytics.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Platform
subscriptions for transportation optimization for shippers: </i></b>SemiCab offers a SaaS based platform subscription to shippers to
better manage their freight network by creating optimal lane bundles for bidding and optimized execution of loads with better control
over their data and analytics.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Product
Development and Design</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Product
development is a key element of our strategic growth plan. We strive to deliver many new, exciting consumer products to market every
single year to retain our presence as the market-leader in consumer karaoke products. Strategic product development is done in-house
from our corporate headquarters in Fort Lauderdale, FL where we identify new potential categories, features, and price points. Products
are created in conjunction with contract product designers and inventors in collaboration with our contract manufacturers in China to
deliver products that represent tremendous value to our customers. In addition to new products, we always look for ways to improve existing
products to hit more affordable price points or improve features based upon market feedback.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SemiCab
continuously expands and enhances its platform to provide better transportation services to its customers as well as to automate operational
processes. The objective of these additions and enhancements is to build additional functionality and improve or automate existing functions.
This allows SemiCab to be more efficient, lower the costs of operation, provide consistent and reliable services, and reduce potential
human error in its processes targeting the transportation execution and billing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SemiCab
maintains a small, dedicated software development team in India to build, host, maintain and enhance its platform.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 50 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Suppliers
and Manufacturing </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
source our products from a variety of contract manufacturers in southern China. We are not dependent on any one supplier as we use multiple
manufacturers to make our products. We maintain a Hong Kong office that provides us with factory management, sourcing, quality control,
engineering, and product development. We buy finished goods from our suppliers and generally do not source raw materials for manufacturing,
however in limited circumstances where we develop proprietary hardware and software, we will secure the proprietary circuits and provide
them to our contract manufacturers for assembly into the final product. While we are not responsible for sourcing raw materials, we rely
on our contract manufacturers&#8217; ability to secure injected plastic, wood cabinets, integrated circuits, display panels, speaker
drivers, and other components that are necessary for assembly into our final products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
goods are produced by our contract manufacturers and are either shipped via ocean vessels to our distribution center in Ontario, California
or we utilize a direct import program where our retail customers coordinate to pick up the goods FOB China. The direct import program
allows our customers to take advantage of better ocean container rates through bigger volume and allows us to bypass our California warehouse.
We maintain a third-party logistics warehouse in Canada where we sell directly to retail customers and independent channels in Canada.
Historically, most of our customers pick up goods from our warehouse (freight collect).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 31, 2023, the lease at our Ontario, California warehouse facility expired and was not renewed. Instead, we outsourced this business
function by entering into a service agreement with a third-party logistics company to provide domestic and Canadian warehousing services,
effective September 1, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sales
and Marketing</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
products are marketed and sold through our direct sales team, working in conjunction with independent sales representatives that provide
sales and customer support for our retail customers in North America. Sales are recognized upon transfer of title to our customers and
are made utilizing standard credit terms of approximately 60-90 days. Our sales terms indicate that we only accept returns for defective
merchandise, however we have accepted overstock returns from our retail partners in the past.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
seek to expand our direct-to-consumer sales, which we believe will increase overall gross margins and increase brand awareness.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Marketing,
promotion, and consumer engagement are key elements in the youth electronics, toy, and music categories. Historically, a significant
percentage of our promotional spending has been structured as co-op promotion incentives with our large retail partners. We continue
to focus our marketing efforts on growing brand awareness among our target consumer demographic, optimizing marketing investments, and
executing an integrated marketing strategy. We believe an important component of our future growth is based on speaking to the right
customer, with the right content, in the right channel, at the right time. We have implemented online marketing, social media, and digital
analytics tools, which allow us to better measure the performance of our marketing activities, learn from our consumers, and receive
valuable insights into industry and competitor activities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer
service is a critical component of our marketing strategy in the consumer electronics space. We maintain a U.S.-based internal customer
service department within our corporate headquarters that responds to customer inquiries, investigates, and resolves issues, and is available
to assist customers and consumers during business hours.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SemiCab&#8217;s
services are sold through its direct sales team primarily working with shippers, participating in transportation bids and onboarding
shippers and customers to start operations. While the transportation services contracts are signed for longer durations, generally up
to a year, the actual sales are recognized only after the loads from shippers are executed and delivered by us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
platform subscriptions may be sold through resellers, where sales are recognized on a rolling monthly basis aligned with the SaaS revenue
models.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 51 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SemiCab
uses limited marketing and promotions at this time, primarily focused on creating name recognition and visibility through appropriate
social media channels, blogs, and press releases to share industry awards, customer acquisition news and so on.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Competition</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
youth electronics, toy, and music industries have many participants, none of which have a dominant market share, though certain companies
may have disproportionate strength in specific product categories. We compete with a number of different companies in a variety of categories,
although there is no single company that competes with us across all of our product categories. Our largest direct competitors are Singsation<sup>&#174;</sup>,
Singtrix<sup>&#174;</sup>, eKids<sup>&#174;</sup>, Bonaok, Karaoke USA<sup>&#8482;</sup>, and Ion<sup>&#174;</sup> Audio.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
primary methods of competition in the industry consist of brand positioning, product innovation, quality, price, and timely distribution.
Our competitive strengths include our ability to develop innovative new products and features, speed to market, our relationships with
major retailers, and the quality and pricing of our products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SemiCab
operates in a competitive environment. SemiCab competes with traditional and non-traditional logistics companies, including transportation
providers that own equipment, third-party freight brokers, technology matching services, internet freight brokers, carriers offering
logistics services, and on-demand transportation service providers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SemiCab
wins business based on providing reliable services at lower costs and creating an industry-wide network that can operate more efficiently
with less empty miles than the industry norm, thus creating a more sustainable transportation network for the entire industry.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Intellectual
Property</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
rely on a combination of word and design mark trademarks and trade secrets to protect our intellectual property. In certain circumstances,
we will partner with third parties to develop proprietary products, and, where appropriate, we have license agreements related to the
use of third-party innovation in our products. The duration of our trademark registrations varies from country to country. However, trademarks
are generally valid and may be renewed indefinitely as long as they are in use and/or their registrations are properly maintained.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Customers</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
operate across geographically diverse marketplaces, selling our consumer electronics products globally to large, national retailers as
well as independent retailers, on our retailer&#8217;s websites, and our own direct to consumer website. In North America, our customers
include Amazon, Costco, Sam&#8217;s Club, Target and Wal-Mart. Our largest international territories are the U.K. and Australia, where
we sell through international distributors. We also sell to select international retail customers in geographic locations where we do
not have a direct sales presence.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SemiCab
operates in the logistics industry providing contract-based, long-haul, FTL transportation services to any shipper that may require such
services on an ongoing basis. We currently operate in the USA and India. In the USA, our customers include the likes of Staples and Pepsi
and in India our customers include multi-national companies such as Procter &amp; Gamble, Mondelez, Kellanova, Reckitt Benckiser and
Kimberly-Clarke and Indian multi-nationals such as Asian Paints, Godrej and Apollo Tyres. Our platform subscriptions may be sold via
resellers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SemiCab
maintains teams in the US, Philippines and India to provide the transportation services to its customers in the US and India.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales
to our top five customers in the consumer electronics division together comprised approximately 97% and 91% of our net sales for the
nine-month transition period ended December 31, 2023, and 2022, respectively. In the nine months ended December 31, 2023, revenues from
three of these customers represented greater than 10% of net sales, at 48%, 12% and 21% of total net sales. In our fiscal year ended
December 31, 2022, revenues from two of these customers represented greater than 10% of net sales, at 46% and 22% of total net sales.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 52 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have no long-term contracts with these customers, and as a result, our success depends heavily on our customers&#8217; willingness to
purchase and provide floor or shelf space for our products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Seasonality</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do experience heightened seasonal demand for our consumer electronic products, typically beginning in late July, and extending into early
November of each calendar year, which is accounted for in our quarters ended September 30 and December 31. In our nine-month transition
period ended December 31, 2023, and fiscal year ended March 31, 2023, approximately 91% and 62%, respectively, of our net sales shipped
in our quarters ended September 30 and December 31. However, we continually look for products and new categories to reduce our exposure
to seasonality variances.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transportation
demand is seasonal by nature. In the US, freight demand typically increases before the holidays and reduces after the holiday season
is over. The agricultural produce seasons may also affect the freight markets. In India, agricultural and festival seasons drive the
market seasons for freight.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to the seasonality, the transportation industry is cyclic and goes through regular boom and bust cycles as the capacity builds
up when the demand and prices are high and smaller operators go out of business as the supplies build up and depress prices.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Regulatory
Matters</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
of our products is designed to comply with all applicable mandatory and voluntary safety standards. In the United States, these safety
standards are promulgated by federal, state and independent agencies such as the US Consumer Product Safety Commission, ASTM International,
the Federal Communications Commission, and various states Attorney Generals and state regulatory agencies. All of our products are independently
tested by third party laboratories accepted by the Consumer Product Safety Commission to verify compliance to applicable safety standards.
A similar approach is used to design and test products sold internationally.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
transportation industry in the US is regulated by the government, one of the key federal agencies being the Department of Transportation
(DOT). DOT mandates licensing, insurance and service requirements on the operators in this industry.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Human
Capital Resources</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of October 28, 2024, we had 23 employees, with 17 located at our corporate office, and 6 in our office in Hong Kong. Of our employees,
1 was engaged in engineering and product development, 3 in sales and marketing, 8 in customer support or general operations and 11 in
general administration and finance. All but 2 of these employees are employed on a full-time basis. As of October 28, 2024, approximately
61% of our current workforce is female, 39% male, and our average tenure is 5.24 years. None of our employees are represented by a collective
bargaining unit or is a party to a collective bargaining agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of October 28, 2024, SemiCab had 25 employees, with 4 employees in the US and 21 in India.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Properties</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
entered into an operating lease agreement, effective October 1, 2017, for our corporate headquarters located in Fort Lauderdale, Florida
where we lease approximately 6,500 square feet of office space. The lease was amended on February 22, 2024 to extend the lease term for
an additional 14-months. The lease expires on May 31, 2025. The base rent payment is approximately $10,554 per month, subject to annual
adjustments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
entered into an operating lease agreement, effective October 15, 2022, for our administrative office located in Hong Kong where we lease
approximately 1,890 square feet of office space. The lease expires on October 14, 2025. The base rent payment is approximately $4,900
per month for the entire term of the lease.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 53 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that our facilities are well maintained, in substantial compliance with environmental laws and regulations, and adequately covered
by insurance. We also believe that these leased facilities are not unique and could be replaced, if necessary, at the end of the term
of the existing leases.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Legal
Proceedings</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Derivative
Litigation</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 21, 2023, Ault Lending, LLC (&#8220;Ault Lending&#8221;), a wholly owned subsidiary of Ault Alliance, Inc. (&#8220;Ault&#8221;),
one of the Company&#8217;s largest shareholders, filed a derivative shareholder action in Delaware Chancery Court (the &#8220;Complaint&#8221;)
against (i) the Company, (ii) board members, Gary Atkinson, Jay B. Foreman, Harvey Judkowitz, Joseph Kling, Bernardo Melo, and Mathieu
Peloquin, (iii) Stingray Group, Inc. (&#8220;Stingray&#8221;), which is an affiliate of Mr. Peloquin, and (iv) Regalia Ventures, LLC
(&#8220;Regalia&#8221;), which is owned and controlled by Mr. Foreman (collectively the &#8220;Defendants&#8221;) for alleged breach
of fiduciary duty in approving a recent above-market private placement equity transaction. The Complaint alleges the Company, and the
director defendants followed an inadequate process in evaluating the private placement transaction which occurred back in November 2023
and entered into the transaction with an intent to dilute Ault&#8217;s ownership stake in the Company. Ault Lending is seeking the following
relief from the Court: (i) declarations that the defendant directors breached their fiduciary duties, and that Stingray and Regalia aided
and abetted those breaches, (ii) rescinding the Company&#8217;s sales of shares to Stingray and Regalia, and (iii) awarding damages and
attorney&#8217;s fees to Ault Lending. The Defendants have retained Delaware counsel to represent them in this matter and the Company
has filed a motion to dismiss the suit. The Company has Director &amp; Officer liability insurance for up to $5,000,000 with a retention
of $250,000 for derivative claims.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Civil
Action</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 26, 2024, OAC 111 Flatiron, LLC and OAC Adelphi, LLC, filed a civil action in the Supreme Court of the State of New York against
MICS Nomad LLC, a subsidiary of the Company (&#8220;MICS NY&#8221;), and the Company (&#8220;the Defendants&#8221;) for alleged breach
of lease, seeking monetary damages including unpaid rent, future unpaid rent, and other expenses related to the lease. The complaint
alleges the Defendants breached the lease in various material respects.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 25, 2024, the Company entered into a Settlement Agreement for a full release and dismissal of the complaint within 5 business
days of the Company&#8217;s payment of $250,000. The Company made full payment on or around October 25, 2024 and the Landlord filed a
discontinuance with prejudice on October 29, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
than what is disclosed above, we are not a party to, and our property is not the subject of, any pending material legal proceeding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="alp_002"></span>MANAGEMENT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth certain information with respect to our executive officers, directors and significant employees as of the
date of this filing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 34%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Age</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 52%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Position</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gary
    Atkinson</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">43</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer, Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bernardo
    Melo</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">47</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Revenue Officer, Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Richard
    Perez</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">54</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Harvey
    Judkowitz</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">79</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joseph
    Kling</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">94</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mathieu
    Peloquin</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">53</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jay
    B. Foreman</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">62</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 54 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following information sets forth the backgrounds and business experience of our directors and executive officers:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gary
Atkinson</b> joined the Company in January 2008 and served as General Counsel and Corporate Secretary. In November 2009, Mr. Atkinson
was appointed as Interim Chief Executive Officer and was promoted as the Company&#8217;s permanent Chief Executive Officer in May, 2012.
Mr. Atkinson was appointed as a Director of the Company on August 11, 2022. Mr. Atkinson is a licensed attorney in Florida and Georgia.
He graduated from the University of Rochester with a bachelor&#8217;s degree in economics and has been awarded a dual-degree J.D./M.B.A.
from Case Western Reserve University School of Law and Weatherhead School of Management.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Bernardo
Melo</b> has been with the Company since February 2003. Mr. Melo was appointed as Chief Revenue Officer on April 22, 2022, and has served
as the Vice President of Global Sales and Marketing (&#8220;VP of Sales&#8221;) since 2008. Mr. Melo was appointed as a Director of the
Company on July 27, 2022. During his tenure at the Company, Mr. Melo has overseen the sales and operations of the music division as well
as managed the customer service department. Before taking over the responsibility of VP of Sales, Mr. Melo held dual roles with the Company
managing the operations, licensing and sales of the music division while concentrating on hardware sales for the Latin America and Canada
market as well as key U.S. accounts such as Walmart. Prior to joining the Company, Mr. Melo held a consulting role for Rewards Network
formerly Idine. Mr. Melo&#8217;s assignment during his tenure was improving their operational procedures while increasing efficiencies
and lowering operating cost. Mr. Melo also worked at Coverall North America as Director of Sales managing a startup initiative for the
company covering 15 regional office and 40 sales reps across North America focusing on franchise sales. Overall Mr. Melo has over 16
years of sales, marketing, and management experience.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Richard
Perez </b>joined the Company in May of 2023 as Corporate Controller and was appointed as Chief Financial Officer on January 3, 2024.
For the past 28 years Mr. Perez has worked in accounting and operations in various industries, all while achieving positions of increased
responsibility. Culminating with Controller, Director of Accounting, Director of Finance and Chief Financial Officer positions. Mr. Perez
previously served as director of accounting for Spring Footwear from September 2022 through March 2023 and prior to Spring Footwear,
he served as the chief financial officer of True Grade, LLC from June 2020 through August 2022. Mr. Perez also has a vast amount of experience
in the Food &amp; Beverage industry, having worked in the Specialty Seafood &amp; Meat Group for SYSCO corporation as both a Director
of Finance as well as Director of Operations from May 2011 through May 2020. Mr. Perez graduated from Florida Atlantic University with
a bachelor&#8217;s degree in business administration with a major in accounting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Harvey
Judkowitz</b> has served as a Director of the Company since March 29, 2004, and is the chairman of the Audit Committee. He is licensed
as a CPA in New York and Florida. From 1988 to the present date, Mr. Judkowitz has conducted his own CPA practices. He has served as
the Chairman and CEO of UniPro Financial Services, a diversified financial services company up until the company was sold in September
of 2005. He was formerly the President and Chief Operating Officer of Photovoltaic Solar Cells, Inc.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Joseph
Kling</b> was appointed as a Director of the Company on May 9, 2017. Mr. Kling has spent his entire career in the toy industry, most
notably serving as CEO of View-Master, the iconic stereoscopic toy company, which later purchased Ideal Toy from CBS and later became
View-Master Ideal, publicly traded on the Nasdaq. View-Master Ideal later acquired California Plush Toys and the entire group was later
acquired by Tyco Toys in 1989. Mr. Kling later went into private M&amp;A consulting and sat on the board of Russ Berrie &amp; Co (currently
known as Kids Brands, Inc.) for 21 years advising on the acquisition of several toy companies. Mr. Kling has also served on the Board
of Crown Crafts, a large distributor of infant, toddler, and juvenile consumer products and on the board of Lancit Media Entertainment,
a children&#8217;s, and family media production company (formerly listed on the Nasdaq). Notably, Mr. Kling has been involved in many
major toy company acquisitions of brands such as Melissa &amp; Doug and Brio.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Mathieu
Peloquin</b> was appointed as a Director of the Company on December 1, 2021. Mr. Peloquin was appointed Senior Vice-President, Marketing
and Communications at Stingray in 2013 and oversees marketing, communication strategies, content and investor relations. Mr. Peloquin
brings more than 20 years of experience as an expert marketer, strategist, and inspiring leader. Prior to joining Stingray, Mr. Peloquin
was Vice President of Marketing at Transcontinental Media Inc. and Vice President of Transcontinental Media Inc.&#8217;s Digital Marketing
Solutions Group from 2010 to 2013. He also held several executive positions at Reader&#8217;s Digest Magazines Canada Limited and co-founded
Equinox Marketing Services. Mr. Peloquin is a CPA, CMA and holds a Bachelor of Commerce from the School of Management of the Universit&#233;
du Qu&#233;bec &#224; Montr&#233;al.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 55 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Jay
B. Foreman </b>was appointed as Director of the Company on May 23, 2022. Mr. Foreman has been a veteran of the toy industry for over
30 years. Mr. Foreman started his career at Fable Toys as a territory sales rep for the Jersey Shore and within ten years became SVP
for Galoob Toys, where he was primarily responsible for developing the direct import business. He has founded multiple toy companies
over his career, including co-founding Play-By-Play Toy&#8217;s and Novelties and more recently Play Along Toys, a leading toy company,
which was subsequently sold to Jakks Pacific in 2004. Mr. Foreman later went on to found his third start up which became Basic Fun!,
now the makers of Tonka&#8482; trucks, Carebears&#8482;, K&#8217;NEX&#8482;, Lincoln Logs&#8482;, Playhut&#8482;. Mr. Foreman serves
as CEO of Basic Fun!, which role he has had since he founded the company in 2009. He has also served on the boards of directors of the
Toy Association and Licensing Merchandisers association. He currently chairs the Toy Industry trade show committee which is responsible
for the world-famous NY Toy Fair.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Director
Independence</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board is composed of a majority of &#8220;independent directors&#8221; as defined under the rules of Nasdaq. We use the definition of
&#8220;independence&#8221; applied by Nasdaq to make this determination. Nasdaq Listing Rule 5605(a)(2) provides that an &#8220;independent
director&#8221; is a person other than an officer or employee of the company or any other individual having a relationship which, in
the opinion of the Company&#8217;s Board, would interfere with the exercise of independent judgment in carrying out the responsibilities
of a director. The Nasdaq listing rules provide that a director cannot be considered independent if:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    director is, or at any time during the past three (3) years was, an employee of the company;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    director or a family member of the director accepted any compensation from the company in excess of $120,000 during any period of
    twelve (12) consecutive months within the three (3) years preceding the independence determination (subject to certain exemptions,
    including, among other things, compensation for board or board committee service);</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    director or a family member of the director is a partner in, controlling shareholder of, or an executive officer of an entity to
    which the company made, or from which the company received, payments in the current or any of the past three fiscal years that exceed
    5% of the recipient&#8217;s consolidated gross revenue for that year or $200,000, whichever is greater (subject to certain exemptions);</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    director or a family member of the director is employed as an executive officer of an entity where, at any time during the past three
    (3) years, any of the executive officers of the company served on the compensation committee of such other entity; or</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    director or a family member of the director is a current partner of the company&#8217;s outside auditor, or at any time during the
    past three (3) years was a partner or employee of the company&#8217;s outside auditor, and who worked on the company&#8217;s audit.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
such definitions, our Board has undertaken a review of the independence of each director. Based on information provided by each director
concerning his background, employment and affiliations, our Board has determined that Harvey Judkowitz, Joseph Kling, Mathieu Peloquin
and Jay B. Foreman are independent directors of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nomination
Of Directors</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Nominating Committee is responsible for identifying individuals qualified to become directors. The Nominating Committee seeks to identify
director candidates based on input provided by several sources, including (1) the Nominating Committee members, (2) our other directors,
(3) our stockholders, (4) our Chief Executive Officer or Chairman, and (5) third parties such as professional search firms. In evaluating
potential candidates for director, the Nominating Committee considers the entirety of each candidate&#8217;s credentials.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 56 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Qualifications
for consideration as a director nominee may vary according to the particular areas of expertise being sought as a complement to the existing
composition of the Board of Directors. However, at a minimum, candidates for director must possess:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">high
    personal and professional ethics and integrity; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    ability to exercise sound judgment; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    ability to make independent analytical inquiries; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    willingness and ability to devote adequate time and resources to diligently perform Board and committee duties; and </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    appropriate and relevant business experience and acumen. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to these minimum qualifications, the Nominating Committee also takes into account when considering whether to nominate a potential
director candidate the following factors:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">whether
    the person possesses specific industry expertise and familiarity with general issues affecting our business; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">whether
    the person&#8217;s nomination and election would enable the Board to have a member that qualifies as an &#8220;audit committee financial
    expert&#8221; as such term is defined by the Securities and Exchange Commission (the &#8220;SEC&#8221;) in Item 401 of Regulation
    S-K; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">whether
    the person would qualify as an &#8220;independent director&#8221;, as such term is defined in the Nasdaq Stock Market Rules; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    importance of continuity of the existing composition of the Board of Directors to provide long term stability and experienced oversight;
    and </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    importance of diversified Board membership, in terms of both the individuals involved and their various experiences and areas of
    expertise. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Committees
of the Board of Directors</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Audit
Committee</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
members of our Audit Committee are Messrs. Judkowitz, Kling and Foreman, with Mr. Judkowitz serving as the Chairperson. Each of Messrs.
Judkowitz, Kling and Foreman is independent under the rules and regulations of the SEC and the listing standards of the Nasdaq Stock
Market applicable to audit committee members. Our board of directors has determined that Mr. Judkowitz qualifies as an audit committee
financial expert within the meaning of SEC regulations and meets the financial sophistication requirements of the Nasdaq Stock Market.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Audit Committee has the responsibility for, among other things, (i) selecting, retaining and overseeing our independent registered public
accounting firm, (ii) obtaining and reviewing a report by independent auditors that describe the accounting firm&#8217;s internal quality
control, and any materials issues or relationships that may impact the auditors, (iii) reviewing and discussing with the independent
auditors standards and responsibilities, strategy, scope and timing of audits, any significant risks, and results, (iv) ensuring the
integrity of the Company&#8217;s financial statements, (v) reviewing and discussing with the Company&#8217;s independent auditors any
other matters required to be discussed by PCAOB Auditing Standard No. 1301, (vi) reviewing, approving and overseeing any transaction
between the Company and any related person and any other potential conflict of interest situations, (vii) overseeing the Company&#8217;s
internal audit department, (v) reviewing, approving and overseeing related party transactions, and (viii) establishing and overseeing
procedures for the receipt, retention and treatment of complaints received by the Company regarding accounting, internal accounting controls
or auditing matters and the confidential, anonymous submission by Company employees of concerns regarding questionable accounting or
auditing matters. The Audit Committee charter can be found online at https://ir.algoholdings.com/investor-governance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 57 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Compensation
Committee</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
members of our Compensation Committee are Messrs. Judkowitz, Kling and Foreman, with Mr. Kling serving as the Chairperson. Our Compensation
Committee has the responsibility for, among other things, (i) reviewing and approving the chief executive officer&#8217;s compensation
based on an evaluation in light of corporate goals and objectives, (ii) reviewing and recommending to the Board the compensation of all
other executive officers, (iii) reviewing and recommending to the Board incentive compensation plans and equity plans, (iv) reviewing
and discussing with management the Company&#8217;s Compensation Discussion and Analysis and related information to be included in the
Annual Report on Form 10-K and proxy statements, and (v) reviewing and recommending to the Board for approval procedures relating to
Say on Pay Votes. The Compensation Committee charter can be found online at https://ir.algoholdings.com/investor-governance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Nominating
and Corporate Governance Committee </i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
members of our Nominating and Corporate Governance Committee are Messrs. Judkowitz, Kling and Foreman, with Mr. Foreman serving as the
Chairperson. Our Nominating and Corporate Governance Committee has the responsibility relating to assisting the Board in, among other
things, (i) identifying and screening individuals qualified to become members of our board of directors, consistent with criteria approved
by our board of directors, (ii) recommending to the Board the approval of nominees for director, (ii) developing and recommending to
our board of directors a set of corporate governance guidelines, and (iv) overseeing the evaluation of our board of director. The Nominating
and Corporate Governance Committee charter can be found online at https://ir.algoholdings.com/investor-governance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Executive
Committee</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
members of our Executive Committee are Messrs. Foreman, Judkowitz, Peloquin and Atkinson with Mr. Atkinson serving as the Chairperson.
Our Executive Committee has the responsibility for evaluating critical matters on behalf of the full Board of Directors. This includes
but is not limited to: (i) reviewing monthly financial and operational performance of the Company, (ii) reviewing and recommending prospective
capital markets activities, including equity offerings, debt issuances, and other financings, (iii) evaluating and recommending potential
business development activities such as strategic partnerships, joint ventures, mergers, acquisitions, and divestitures, and (iv) other
strategic initiatives.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>No
Family Relationships</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is no family relationship between any director and executive officer or among any directors or executive officers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Involvement
in Certain Legal Proceedings</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as set forth below, our directors and executive officers have not been involved in any of the following events during the past ten years:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    bankruptcy petition filed by or against such person or any business of which such person was a general partner or executive officer
    either at the time of the bankruptcy or within two years prior to that time;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    conviction in a criminal proceeding or being subject to a pending criminal proceeding (excluding traffic violations and other minor
    offenses);</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">being
    subject to any order, judgment, or decree, not subsequently reversed, suspended, or vacated, of any court of competent jurisdiction,
    permanently or temporarily enjoining him from or otherwise limiting his involvement in any type of business, securities or banking
    activities or to be associated with any person practicing in banking or securities activities;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">being
    found by a court of competent jurisdiction in a civil action, the SEC or the CFTC to have violated a Federal or state securities
    or commodities law, and the judgment has not been reversed, suspended, or vacated;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">being
    subject of, or a party to, any Federal or state judicial or administrative order, judgment decree, or finding, not subsequently reversed,
    suspended or vacated, relating to an alleged violation of any Federal or state securities or commodities law or regulation, any law
    or regulation respecting financial institutions or insurance companies, or any law or regulation prohibiting mail or wire fraud or
    fraud in connection with any business entity; or</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">being
    subject of or party to any sanction or order, not subsequently reversed, suspended, or vacated, of any self-regulatory organization,
    any registered entity or any equivalent exchange, association, entity or organization that has disciplinary authority over its members
    or persons associated with a member.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Code
of Ethics</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have adopted a Code of Ethics that applies to our principal executive officer, principal financial officer, and principal accounting
officer. Our Code of Ethics is available on our website at https://ir.algoholdings.com/investor-governance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 58 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span id="alp_003"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>EXECUTIVE
COMPENSATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Summary
Compensation Table </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table provides information regarding the compensation earned by or paid to our named executive officers with respect to the
nine months ended December 31, 2023, and the twelve-month periods ended March 31, 2023 and 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Name and Principal Position</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Period</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Salary</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Bonus</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Share Based Awards</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Other Comp (4)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">TOTAL COMP</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 22%; font-weight: bold; text-align: left">Gary Atkinson (1)</td><td style="width: 2%">&#160;</td>
    <td style="width: 16%">Nine Months Ended December 31, 2023</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">165,385</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">4,142</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">169,527</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: italic; text-align: left">Chief Executive Officer</td><td>&#160;</td>
    <td style="text-align: left">Fiscal Year 2023</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">212,673</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">30,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">58,586</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">6,192</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">307,451</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">Fiscal Year 2022</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">156,075</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">5,339</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">161,414</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Lionel Marquis (2)</td><td>&#160;</td>
    <td>Nine Months Ended December 31, 2023</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">161,538</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">100,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">6,462</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">268,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: italic; text-align: left">Former Chief Financial Officer</td><td>&#160;</td>
    <td style="text-align: left">Fiscal Year 2023</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">181,694</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">240,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">38,419</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">8,111</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">468,224</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">Fiscal Year 2022</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">154,154</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">6,484</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">160,638</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Bernardo Melo (3)</td><td>&#160;</td>
    <td>Nine Months Ended December 31, 2023</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">165,385</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">47,988</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">8,535</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">221,908</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: italic; text-align: left">Chief Revenue Officer</td><td>&#160;</td>
    <td style="text-align: left">Fiscal Year 2023</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">213,019</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">98,166</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">38,419</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">12,447</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">362,051</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">Fiscal Year 2022</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">163,004</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">146,725</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">9,114</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">12,389</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">331,232</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Atkinson earned an annual salary of approximately $213,000 for the twelve months ended March 31, 2023, and approximately $156,000
    for the twelve months ended March 31, 2022.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Marquis earned an annual salary of approximately $182,000 for the twelve months ended March 31, 2023, and approximately $154,000
    for the twelve months ended March 31, 2022. Mr. Marquis&#8217; employment agreement expired on December 31, 2023, and is engaged
    as a consultant to the Company during the transition of the CFO position to Richard Perez. Mr. Marquis also agreed to postpone payment
    of the remaining amount of $40,000 due upon the change control triggered in 2022 until the Form 10KT has been filed.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Melo earned an annual salary of approximately $213,000 for the twelve months ended March 31, 2023, and approximately $163,000 for
    the twelve months ended March 31, 2022.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    compensation consisted of our 401(k)-match benefit.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 59 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding
Option and Stock Awards on December 31, 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth information with respect to outstanding grants of options to purchase our common stock under stock option
awards issued with Board of Directors approval to the named executive officers as of December 31, 2023:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Name and Principal Position</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Securities</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Underlying</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unexercised</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Options (#)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercisable</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Securities</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Underlying</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unexercised</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Options (#)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unexercisable</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Equity Incentive</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Plan Awards:</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Securities</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Underlying</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unexercised</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unearned</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Options (#)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Option</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise Price ($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Option</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expiration Date</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares or Units</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>of Stock That</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Have Not Vested (#)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Market Value of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares or Units of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stock That Have</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Not Vested ($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Equity Incentive</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Plan Awards:</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unearned Shares,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Units or Other</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Rights That Have</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Not Vested (#)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Equity Incentive</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Plan Awards:</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Market or Payout</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Value of Unearned</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares, Units or</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Other Rights That</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Have Not Vested ($)</b></span></p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 13%; text-align: left">Gary Atkinson, CEO - Other stock option awards</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right">1,667</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 7%; text-align: center">N/A</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right">7.20</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 7%; text-align: right">3/31/2026</td><td style="width: 2%">&#160;</td>
    <td style="width: 7%; text-align: center">N/A</td><td style="width: 2%">&#160;</td>
    <td style="width: 7%; text-align: center">N/A</td><td style="width: 2%">&#160;</td>
    <td style="width: 7%; text-align: center">N/A</td><td style="width: 2%">&#160;</td>
    <td style="width: 7%; text-align: center">N/A</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">- Other stock option awards</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,333</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">N/A</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14.10</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right">5/3/2027</td><td>&#160;</td>
    <td style="text-align: center">N/A</td><td>&#160;</td>
    <td style="text-align: center">N/A</td><td>&#160;</td>
    <td style="text-align: center">N/A</td><td>&#160;</td>
    <td style="text-align: center">N/A</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">- Other stock option awards</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13,334</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">N/A</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right">5/24/2032</td><td>&#160;</td>
    <td style="text-align: center">N/A</td><td>&#160;</td>
    <td style="text-align: center">N/A</td><td>&#160;</td>
    <td style="text-align: center">N/A</td><td>&#160;</td>
    <td style="text-align: center">N/A</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">- Other stock option awards</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,667</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">N/A</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8.65</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right">8/16/2032</td><td>&#160;</td>
    <td style="text-align: center">N/A</td><td>&#160;</td>
    <td style="text-align: center">N/A</td><td>&#160;</td>
    <td style="text-align: center">N/A</td><td>&#160;</td>
    <td style="text-align: center">N/A</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Lionel Marquis, CFO - Other stock option awards</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">N/A</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7.20</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right">3/31/2026</td><td>&#160;</td>
    <td style="text-align: center">N/A</td><td>&#160;</td>
    <td style="text-align: center">N/A</td><td>&#160;</td>
    <td style="text-align: center">N/A</td><td>&#160;</td>
    <td style="text-align: center">N/A</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">- Other stock option awards</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,667</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">N/A</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14.10</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right">5/3/2027</td><td>&#160;</td>
    <td style="text-align: center">N/A</td><td>&#160;</td>
    <td style="text-align: center">N/A</td><td>&#160;</td>
    <td style="text-align: center">N/A</td><td>&#160;</td>
    <td style="text-align: center">N/A</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">- Other stock option awards</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">N/A</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right">5/24/2032</td><td>&#160;</td>
    <td style="text-align: center">N/A</td><td>&#160;</td>
    <td style="text-align: center">N/A</td><td>&#160;</td>
    <td style="text-align: center">N/A</td><td>&#160;</td>
    <td style="text-align: center">N/A</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">- Other stock option awards</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">N/A</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8.65</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right">8/16/2032</td><td>&#160;</td>
    <td style="text-align: center">N/A</td><td>&#160;</td>
    <td style="text-align: center">N/A</td><td>&#160;</td>
    <td style="text-align: center">N/A</td><td>&#160;</td>
    <td style="text-align: center">N/A</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Bernardo Melo, Chief Revenue Officer - Other stock option awards</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">833</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">N/A</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.10</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right">6/30/2025</td><td>&#160;</td>
    <td style="text-align: center">N/A</td><td>&#160;</td>
    <td style="text-align: center">N/A</td><td>&#160;</td>
    <td style="text-align: center">N/A</td><td>&#160;</td>
    <td style="text-align: center">N/A</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">- Other stock option awards</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,333</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">N/A</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9.60</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right">8/10/2026</td><td>&#160;</td>
    <td style="text-align: center">N/A</td><td>&#160;</td>
    <td style="text-align: center">N/A</td><td>&#160;</td>
    <td style="text-align: center">N/A</td><td>&#160;</td>
    <td style="text-align: center">N/A</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">- Other stock option awards</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,667</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">N/A</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14.10</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right">5/3/2027</td><td>&#160;</td>
    <td style="text-align: center">N/A</td><td>&#160;</td>
    <td style="text-align: center">N/A</td><td>&#160;</td>
    <td style="text-align: center">N/A</td><td>&#160;</td>
    <td style="text-align: center">N/A</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">- Other stock option awards</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,667</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">N/A</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6.60</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right">12/25/2031</td><td>&#160;</td>
    <td style="text-align: center">N/A</td><td>&#160;</td>
    <td style="text-align: center">N/A</td><td>&#160;</td>
    <td style="text-align: center">N/A</td><td>&#160;</td>
    <td style="text-align: center">N/A</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">- Other stock option awards</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">N/A</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right">5/24/2032</td><td>&#160;</td>
    <td style="text-align: center">N/A</td><td>&#160;</td>
    <td style="text-align: center">N/A</td><td>&#160;</td>
    <td style="text-align: center">N/A</td><td>&#160;</td>
    <td style="text-align: center">N/A</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">- Other stock option awards</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">N/A</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8.65</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right">8/16/2032</td><td>&#160;</td>
    <td style="text-align: center">N/A</td><td>&#160;</td>
    <td style="text-align: center">N/A</td><td>&#160;</td>
    <td style="text-align: center">N/A</td><td>&#160;</td>
    <td style="text-align: center">N/A</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Employment
Agreements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
April 22, 2022, we entered into employment agreements with each of our Chief Executive Officer and Chief Revenue Officer (the &#8220;Employment
Agreements&#8221;). Effective December 28, 2022, we entered into an employment agreement with our former Chief Financial Officer that
expired on December 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
employment agreements for Messrs. Atkinson and Melo are for a term of three years with automatic renewals for successive one-year terms,
unless either party provides notice of its intention not to extend. Mr. Marquis&#8217;s employment agreement terminated on the close
of business on December 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Employment Agreements, as compensation for their service as executives of the Company, the executives will receive: (1) a base
salary per annum (the &#8220;Base Salary&#8221;), set forth below and commensurate benefits, as described in the Employment Agreement;
(2) eligibility, subject to their continued employment with the Company, to earn an annual bonus (the &#8220;Annual Bonus&#8221;); (3)
eligibility, also subject to their continued employment with the Company, to participate in the Company&#8217;s 2023 Equity Incentive
Plan, or any successor plan, subject to the terms of such plan; and (4) entitlement, also subject to the executives&#8217; continued
employment with the Company, to reimbursement for all reasonable and necessary out-of-pocket business, entertainment, and travel expenses
incurred by them in connection with the performance of their duties for the Company and the Company&#8217;s expense reimbursement policies
and procedures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 60 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
executives&#8217; base salaries are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gary
    Atkinson: $215,000, with an automatic increase to $225,000 on the first anniversary of the Employment Agreement.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lionel
    Marquis: $210,000, retired on December 31, 2023. On January 1, 2024, Richard Perez assumed the role of Chief Financial Officer, with
    an at will employment arrangement, and a base salary of $160,000.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bernardo
    Melo: $215,000 with an automatic increase to $225,000 on the first anniversary of the Employment Agreement.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to the payment of accrued amounts due to the executives, the Employment Agreements for Messrs. Atkinson and Melo each provide
for the payment of severance to the Executives in a lump sum payment equal to two times the sum of the executive&#8217;s base salary
and annual bonus for the year in which the termination occurs, in the event of the termination of the Agreement by the Company without
Cause (as defined in the Employment Agreement), or upon the Company&#8217;s election not to renew the Employment Agreement or by the
executive for Good Reason (as defined in the Employment Agreement). The Employment Agreements provide for payments to the executive of
certain amounts in the event of the executive&#8217;s death or disability (as defined in the Employment Agreement).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event Messrs. Atkinson&#8217;s or Melo&#8217;s employment is terminated by the executive for Good Reason (as defined in the Employment
Agreement) on account of its failure to renew the Employment Agreement or without Cause (as defined in the Employment Agreement&#8221;)
within twelve months of a Change in Control (as defined in the Employment Agreement), the executive shall be entitled to receive a lump
sum payment equal to two times the base salary and annual bonus for the year in which the termination takes place.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment
of severance under the Employment Agreement is conditioned upon Messrs. Atkinson&#8217;s and Melo&#8217;s execution of a release in favor
of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Employment Agreements superseded the change of control agreements previously entered into by the Company in January 2014 with each of
its three executive officers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the change of control agreement (&#8220;CIC Agreement&#8221;) entered into by the Company in January 2014 and subsequent to the change
in control of the Company that occurred in August 2022, Mr. Marquis&#8217; employment agreement included acknowledgement by the Company
that he was entitled to receive bonus cash compensation of $400,000. This bonus was paid in accordance with the section in his Employment
Agreement pertaining to the Change in Control Compensation even if terminated by the Company for any reason. Payments were made as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
$200,000 on December 31, 2022;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
$100,000 on April 30, 2023; and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
$100,000 on December 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Executive
Bonus Plan</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 22, 2022, our Board of Directors approved a Bonus Plan (the &#8220;Bonus Plan&#8221;) for our executive officers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Bonus Plan offers a cash bonus, stock options, and stock grants to the executives based on the Company&#8217;s EBITDA at its fiscal year
end. The value of the cash bonus and number of stock options and grants increases based on the Company&#8217;s percentage of net sales.
The Bonus Plan also provides for a one-time option grant to the executives upon the successful listing of the Company&#8217;s shares
of common stock on the Nasdaq Stock Market, LLC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 61 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Director
Compensation </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth with respect to the named director, compensation information inclusive of equity awards and payments made
during the nine months ended December 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Name</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fees Earned or</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Paid in Cash</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stock</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Awards</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(1)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Option</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Awards</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(2)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Non-Equity</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Incentive</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Plan</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nonqualified</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Deferred</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Earnings</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>All Other</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 37%; text-align: left">Harvey Judkowitz</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right">19,500</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right">19,500</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Joseph Kling</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">19,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">19,500</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Jay Foreman</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">19,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">19,500</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Mathieu Peloquin</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">17,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">17,500</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">James Turner (3)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">17,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">17,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Kenneth Cragun (3)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">19,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">19,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Henry Nisser (3)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">16,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">16,000</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Refer
to Note 4 &#8220;Stock Based Compensation&#8221; in the Notes to the Consolidated Financial Statements included elsewhere in this prospectus
for the relevant assumptions used to determine the valuation of our option awards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
As of March 31, 2023, the aggregate number of stock awards held by Messrs. Judkowitz, Kling and Foreman is 12,295 and 1,140, respectively.
The aggregate stock awards held by both Messrs. Foreman and Peloquin is 617.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
As of March 31, 2023, the aggregate number of Company stock options held by Messrs. Judkowitz, Kling and Foreman is 5,669, 4,335, and
1,667, respectively and Messrs. Peloquin, Turner and Cragun is 1,667, 667 and 667, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
On September 5, 2024, Messrs. Turner, Cragun and Nisser resigned from the board of directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the nine months ended December 31, 2023, our compensation package for our non-employee directors consisted of cash payments and reimbursement
of costs and expenses associated with attending our board meetings.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 62 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
compensate our directors as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
    initial grant of 667 stock options with an exercise price determined as the closing price on the day of joining the board. The options
    vest in one year and expire in ten years while they are board members or the lesser of five years or remaining life of the stock
    option once they are no longer board members.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
    annual cash payment of $15,000 for each completed full year of service or prorated for a partial year. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
    annual stock grant of stock equivalent in value to $5,000 for each completed full year of service or prorated for a partial year.
    The stock price at grant will be determined at the closing price on the day of the annual stockholder meeting. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
    annual grant of 1,000 stock options with an exercise price determined as the closing price on the day of the annual stockholder meeting.
    If the annual meeting is held less than 6 months after the board member first joined the board he or she will not receive another
    option grant.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    $1,000 fee for each board meeting and annual meeting attended. Committee meetings and telephone board meetings will be compensated
    for with a $500 fee.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
    expenses are reimbursed for attending board, committee and annual meetings or when their presence at a location away from home is
    requested.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Board
members Gary Atkinson and Bernardo Mello have agreed not to receive any compensation for their services as a board member.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Equity
Incentive Plan</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 12, 2022, the Company&#8217;s Board of Directors approved The Singing Machine Company, Inc. 2022 Equity Incentive Plan, (the&#8221;2022
Plan&#8221;). The 2022 Plan provides for the issuance of equity incentive awards, such as stock options, stock appreciation rights, stock
awards, restricted stock, stock units, performance awards and other stock or cash-based awards collectively, the &#8220;Awards.&#8221;
Awards may be granted under the 2022 Plan to the Company&#8217;s employees, officers, directors, consultants, agents, advisors, and independent
contractors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
maximum number of shares of common stock initially available for issuance under the 2022 Plan was 233,333 shares of common stock and
thereafter an annual increase shall be added as of the first day of the Company&#8217;s fiscal year beginning in 2023, equal to the least
of (i) 5% of the outstanding common stock on a fully diluted basis as of the end of the Company&#8217;s immediately preceding fiscal
year, (ii) 33,334 shares, and (iii) a lesser amount as determined by the Company&#8217;s Board of Directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
shares of common stock subject to stock awards granted under the 2022 Plan that lapse, terminate, expire prior to exercise, are canceled
or are forfeited, shall again become available for issuance under the 2022 Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2022 Plan authorized an aggregate of 300,001 shares of the Company&#8217;s common stock available to the Company&#8217;s employees, officers,
directors, consultants, agents, advisors and independent contractors. As of September 30, 2024, the Company had granted 166,296
shares of common stock and 70,252 common stock options under the 2022 Plan of which 70,252 stock options were vested
leaving 63,453 shares available for issue.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>401(k)
Plan </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
January 1, 2001, we adopted a voluntary 401(k) plan. All employees with at least one year of service are eligible to participate in our
401(k) plan. We make a matching contribution of 100% of salary deferral contributions up to 3% of pay, plus 50% of salary deferral contributions
from 3% to 5% of pay for each payroll period. The amounts charged to earnings for contributions to this plan and administrative costs
during the nine month transition period ended December 31, 2023, and year ended 2022 totaled approximately $46,000 and
$58,000, respectively. The amounts charged to earnings for contributions to this plan and administrative costs during the years ended
March 31, 2023 and 2022 totaled approximately $74,000 and $70,000, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 63 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Securities
Authorized For Issuance Under Equity Compensation Plans</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 12, 2022, our Board of Directors approved the 2022 Plan. The 2022 Plan provides for the issuance of equity incentive awards, such
as stock options, stock appreciation rights, stock awards, restricted stock, stock units, performance awards and other stock or cash-based
awards collectively, the &#8220;Awards.&#8221; Awards may be granted under the 2022 Plan to the Company&#8217;s employees, officers,
directors, consultants, agents, advisors and independent contractors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
maximum number of shares of common stock initially available for issuance under the 2022 Plan is 233,333 shares of common stock and thereafter
an annual increase shall be added as of the first day of the Company&#8217;s fiscal year beginning in 2023, equal to the least of (i)
5% of the outstanding common stock on a fully diluted basis as of the end of the Company&#8217;s immediately preceding fiscal year, (ii)
333,334 shares, and (iii) a lesser amount as determined by the Board of Directors. The shares of common stock subject to stock awards
granted under the 2022 Plan that lapse, terminate, expire prior to exercise, are canceled or are forfeited, shall again become available
for issuance under the 2022 Plan. Effective April 1, 2023, there were 33,334 additional shares that were allotted to the 2022 Plan based
on the annual plan increase. As of the date of filing of our Transition Report, the total shares available for issuance under the 2022
Plan are 165,469.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes our equity compensation plan information as of December 31, 2023:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify">Plan Category</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number of Securities to be</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>issued upon exercise of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>outstanding options, warrants</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>and rights</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted &#8211;average exercise</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>price of outstanding option,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>warrants and rights</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number of securities</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>remaining available for future</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>issuance under equity</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>compensation Plans</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: justify; padding-bottom: 1pt">Equity compensation plans approved by security holders</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; width: 14%; text-align: right">76,752</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 14%; text-align: right">6.31</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; width: 14%; text-align: right">165,469</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">Equity compensation plans not approved by security holders</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1pt">Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">76,752</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">6.31</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">165,469</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="alp_004"></span>PRINCIPAL
STOCKHOLDERS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table provides information with respect to the beneficial ownership of our common stock as of November 20, 2024 by:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
    of our executive officers and directors;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
    of our current directors and executive officers as a group; and</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
    person or entity, or group of persons or entities, known by us to own beneficially more than 5% of our common stock.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have determined beneficial ownership in accordance with the rules and regulations of the SEC, and the information is not necessarily
indicative of beneficial ownership for any other purpose. In general, under these rules a beneficial owner of a security includes any
person who, directly or indirectly, through any contract, arrangement, understanding, relationship or otherwise has or shares voting
power or investment power with respect to such security. A person is also deemed to be a beneficial owner of a security if that person
has the right to acquire beneficial ownership of such security within 60 days of November 20, 2024. Except as indicated by the
footnotes below, we believe, based on information furnished to us, that the persons and entities named in the table below have sole voting
and sole investment power with respect to all shares that they beneficially own, subject to applicable community property laws.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 64 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Percentage
ownership is based on 14,215,176 shares of common stock outstanding as of November 20, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Name of Beneficial Owner</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common Stock</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Beneficially</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Owned</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage of<br/>
 Beneficial</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ownership Prior to</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>this Offering</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage of<br/>
 Beneficial<br/>
</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ownership After<br/>
</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>this Offering</b></span> </td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    </tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; font-style: italic; text-align: left">Directors and Officers:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 46%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gary Atkinson, <i>Chief Executive Officer and Director</i> (1)</span></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">31,985</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td><td style="width: 1%; text-align: left">%</td>
    </tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bernardo Melo, <i>Chief Revenue Officer and Director</i> (1)</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">43,609</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Richard Perez, <i>Chief Financial Officer</i></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Harvey Judkowitz, <i>Director</i> (1)</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">20,548</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joseph Kling, <i>Director</i> (1)</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,052</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mathieu Peloquin, <i>Director</i> (1)</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,284</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jay Foreman, <i>Director</i> (1) (3)</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,149,636</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8.0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">All Executive Officers and Directors as a Group (7 persons)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; font-style: italic; text-align: left">Beneficial owners of more than 5%:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stingray Group Inc. (2)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,643,347</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11.5</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Regalia Ventures (3)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,098,901</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7.7</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*
Represents less than 1%</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    as to the person indicated, the following outstanding stock options to purchase shares of the Company&#8217;s Common Stock issued
    under 2022 Plan and other stock option awards, which will be vested and exercisable within 60 days of the record date: 20,001 options
    held by Gary Atkinson, 23,500 options held by Bernardo Melo, 5,669 options held by Harvey Judkowitz, 4,335 options held by Joseph
    Kling, and 1,667 options held by both Mathieu Peloquin and Jay Foreman.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Eric
    Boyko indirectly controls approximately 57.5% of the combined voting power of Stingray&#8217;s outstanding shares. As a result, Eric
    Boyko may be deemed to share beneficial ownership of the shares of common stock and the Stingray Warrants held by Stingray. The address
    of Stingray Group Inc. is 730 Wellington Street, Montr&#233;al, Qu&#233;bec H3C 1T4. The security holder may not exercise the
    warrants to the extent such exercise would cause the security holder, together with its affiliates, to beneficially own a number
    of shares of common stock which would exceed 4.99% of our then outstanding common stock following such exercise, excluding for purposes
    of such determination shares of common stock issuable upon exercise of such securities which have not been so exercised.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
    upon the Form 4 filed with the Securities and Exchange Commission on August 12, 2024 by Mr. Foreman, which reflects that the shares
    are owned by Regalia Ventures, LLC (&#8220;Regalia&#8221;). Mr. Foreman, the Managing Member of Regalia, is deemed to have voting
    and dispositive power with respect to the securities held by Regalia. The address of Regalia is 301 Yamato Road, Suite 4200, Boca
    Raton, FL 33431.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="alp_005"></span>CERTAIN
RELATIONSHIPS AND RELATED PARTY TRANSACTIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
than as set forth below and compensation arrangements, including employment, and indemnification arrangements, discussed, there have
been no transactions since the beginning of our last fiscal year, in which the amount involved in the transaction exceeded or will exceed
the lesser of $120,000 or one percent of the average of our total assets as at the year-end for the last two completed fiscal years,
and to which any of our directors, executive officers or beneficial holders of more than 5% of our capital stock, or any immediate family
member of, or person sharing the household with, any of these individuals, had or will have a direct or indirect material interest.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.3in"></p>

<!-- Field: Page; Sequence: 65 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Financing</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 20, 2023, the Company entered into a stock purchase agreement (the &#8220;Purchase Agreement&#8221;) with Stingray Group, Inc.
and Regalia Ventures, LLC pursuant to which the Company sold an aggregate of 2,197,802 shares of its common stock at a price of $0.91
per share, representing a 3% premium to the closing price of the Company&#8217;s common stock on November 17, 2023, for gross proceeds
of $2,000,000. One of the Purchasers, Regalia Ventures LLC, is an entity wholly owned by Jay Foreman, one of the Company&#8217;s directors.
Mathieu Peloquin, one of the Company&#8217;s directors is an officer of the other Purchaser, Stingray Group, Inc. Stingray is a shareholder
of the Company and an entity with which the Company has a music subscription sharing agreement with.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Due
To/From Related Parties</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has a music subscription sharing agreement with Stingray. For the transition year ended December 31, 2023, and 2022, the Company
received music subscription revenue of approximately $600,000 and $500,000, respectively. For the three months ended September
30, 2024, and 2023, the amounts earned from the subscription agreement were approximately $218,000 and $156,000, respectively.
For the nine months ended September 30, 2024, and 2023, the amounts earned from the subscription agreement were approximately
$567,000 and $550,000, respectively. These amounts were included as a component of net sales in the accompanying condensed
consolidated statements of operations. On September 30, 2024, the Company had approximately $269,000 due to Stingray.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Review,
Approval or Ratification of Transactions with Related Persons</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that the terms of all of the above transactions are commercially reasonable and no less favorable to us than we could have obtained
from an unaffiliated third party. Our audit committee is charged with the responsibility to review, approve and oversee any transaction
between the Company and any related party and to develop policies and procedures for the Committee&#8217;s approval of related party
transactions. While we do not maintain a written policy with respect to related party transactions, our audit committee and board of
directors routinely reviews potential transactions with those parties we have identified as related parties prior to the consummation
of the transaction. Each transaction is reviewed to determine that a related party transaction is entered into by us with the related
party pursuant to normal competitive negotiation and on terms no more favorable than with an unrelated third party. We also generally
require, unless permitted by law, that all related parties recuse themselves from negotiating and voting on behalf of the Company in
connection with related party transactions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: small-caps 10pt Times New Roman, Times, Serif"><span id="alp_006"></span><b>DESCRIPTION
OF SECURITIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following description of our securities is only a summary and is qualified in its entirety by reference to the actual terms and provisions
of the capital stock contained in our Certificate of Incorporation and our Bylaws.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>General</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
authorized capital stock consists of 100,000,000 shares of common stock, $.01 par value per share, and 1,000,000 shares of preferred
stock, $1.00 par value per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of November 20, 2024, there were 14,215,176 shares of our common stock issued and outstanding held by approximately 37 holders
of record, and no shares of our preferred stock issued and outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Common
Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
certificate of incorporation, as amended (&#8220;Certificate of Incorporation&#8221;) authorize us to issue up to 100,000,000 shares
of common stock, $0.01 par value. Each holder of our common stock is entitled to one (1) vote for each share held of record on all voting
matters we present for a vote of stockholders, including the election of directors. Holders of common stock have no cumulative voting
rights or preemptive rights to purchase or subscribe for any stock or other securities, and there are no conversion rights or redemption
or sinking fund provisions with respect to our common stock. All shares of our common stock are entitled to share equally in dividends
from sources legally available when, and if, declared by our Board of Directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 66 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors is authorized to issue additional shares of common stock not to exceed the amount authorized by the Certificate of
Incorporation, on such terms and conditions and for such consideration as the Board may deem appropriate without further stockholder
action.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event of our liquidation or dissolution, all shares of our common stock are entitled to share equally in our assets available for
distribution to stockholders. However, the rights, preferences and privileges of the holders of our common stock are subject to, and
may be adversely affected by, the rights of the holders of shares of preferred stock that have been issued or shares of preferred stock
that our Board of Directors may decide to issue in the future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Securities
Other than Common Stock Offered in this Offering</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Warrants</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrants will be issued in the respective forms filed as an exhibit to the registration statement of which this prospectus is a part
and the following summary is subject to and qualified in its entirety by the filed exhibits. You should review a copy of each form of
Series A Warrant and Series B Warrant for a complete description of the terms and conditions applicable to the Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a brief summary of the Warrants and is still subject in all respect to the provisions contained in the form of each applicable
Warrant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Duration
and Exercise Price</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Warrant offered hereby has an initial exercise price per share equal to $&#160;&#160; (the Series B Warrants shall not exceed
200% of the Minimum Price as defined by the rules of Nasdaq). The exercise price of the Warrants were determined based on negotiations
with the placement agent and the investors in this offering. The exercise price and number of shares of common stock issuable upon exercise
is subject to appropriate adjustment in the event of certain stock dividends and distributions, stock splits, stock combinations, reclassifications
or similar events affecting our common stock and also upon any distributions of assets, including cash, stock or other property to our
stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrants will be issued separately from the common stock and Pre-Funded Warrants included in this offering. Each share of our common
stock or Pre-Funded Warrant purchased in this offering will include a Series A Warrant and Series B Warrant, each to purchase one share
of our common stock. The Series A Warrants and Series B Warrants will be issued in certificated form only.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Exercisability</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Series A Warrants and the Series B Warrants are not exercisable until the Initial Exercise Date. The Series A Warrants will expire on
the five-year anniversary of the Initial Exercise Date and the Series B Warrants will expire on the two and one-half year anniversary
of the Initial Exercise Date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Warrant will be exercisable, at the option of each holder, in whole or in part, by delivering to us a duly executed exercise notice accompanied
by payment in full of the exercise price in immediately available funds for the number of shares of our common stock purchased upon such
exercise (except in the case of a cashless exercise as discussed below). A holder will not have the right to exercise any portion of
the Series A Warrants or Series B Warrants if the holder (together with its affiliates) would beneficially own in excess of 4.99% of
the number of shares of our common stock outstanding immediately after giving effect to the exercise, as such percentage ownership is
determined in accordance with the terms of the Series A Warrants and Series B Warrants. However, any holder may increase or decrease
such percentage to any other percentage not in excess of 9.99%, provided that any increase in such percentage shall not be effective
until 61 days following notice from the holder to us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 67 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Cashless
Exercise and Alternative Cashless Exercise</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
at the time a holder exercises its Warrant, a registration statement registering the issuance of common stock underlying the Warrant
under the Securities Act is not then effective or available, in lieu of making the cash payment otherwise contemplated to be made to
us upon such exercise in payment of the aggregate exercise price, the holder may elect instead to receive upon such exercise (either
in whole or in part) the number of shares of common stock determined according to a formula set forth in the Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the case of the Series B Warrants, a holder may also effect an &#8220;alternative cashless exercise&#8221; at any time while the Series
B Warrants are outstanding following the Initial Exercise Date. Under the alternate cashless exercise option, the holder of the Series
B Warrant, has the right to receive an aggregate number of shares equal to the product of (x) the aggregate number of shares of common
stock that would be issuable upon a cashless exercise of the Series B Warrant and (y) 1.0.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Company
Redemption Option</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Series A Warrants and Series B Warrants are redeemable by the Company in certain circumstances. Subject to certain exceptions, if, (i)
the daily volume weighted average trading price of the common stock of the Company exceeds $&#160;&#160; for 10 consecutive trading
days and (ii) the average daily trading volume of the shares of the common stock of the Company for such 10-trading day period exceeds
$150,000 of shares, then we may upon 30 days&#8217; notice (a &#8220;Redemption Notice&#8221;), call for redemption or cancellation of
all or any portion of the warrants for which a notice of exercise has not yet been delivered for consideration equal to $0.01 per warrant
share. Any portion of a warrant subject to such Redemption Notice for which a notice of exercise shall not have been received by the
Redemption Date (as hereinafter defined) will be cancelled at 6:30 p.m. (New York City time) on the thirtieth calendar day after
the date the Redemption Notice is sent by the Company (such date and time, the &#8220;Redemption Date&#8221;). Our right to call the
warrants shall be exercised ratably among the holders based on each holders initial purchase of warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Exercise
Price Adjustments</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, and subject to certain exemptions, if we sell, enter into an agreement to sell, or grant any option to purchase, or sell, enter
into an agreement to sell, or grant any right to reprice (excluding Exempt Issuances, as defined in the Placement Agency Agreement),
or otherwise dispose of or issue (or announce any offer, sale, grant or any option to purchase or other disposition) any shares of common
stock, at an effective price per share less than the exercise price of the Series A Warrants then in effect, the exercise price of the
Series A Warrants will be reduced to the lower of such price or the lowest VWAP during the five consecutive trading days immediately
following such dilutive issuance or announcement thereof (subject to a floor price of $&#160; prior to the Effective Shareholder
Approval Date and a floor price of $&#160;&#160; beginning on the Effective Shareholder Approval Date), and the number of shares
issuable upon exercise will be proportionately adjusted such that the aggregate exercise price will remain unchanged.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
the fourth trading day after Shareholder Approval (the &#8220;Reset Date&#8221;), the exercise price of the Series A and
Series B Warrants will be adjusted to equal the lower of (i) the exercise price then in effect and (ii) the greater of (a) the
lowest daily volume weighted average price of the shares of Common Stock during the period commencing on the first trading day after
the Effective Shareholder Approval Date and ending following the close of trading on the fourth trading day thereafter (the &#8220;Reset
Period&#8221;), and (b) if prior to Shareholder Approval, a price equal to 50% of the Nasdaq Minimum Price, or following the Effective
Shareholder Approval Date, a price equal to the 20% of the Nasdaq Minimum Price and the number of shares issuable upon exercise will
be will be increased such that the aggregate exercise price of the Warrants on the issuance date for the shares of common stock underlying
the Warrants then outstanding shall remain unchanged.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 68 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
exercise price and the number of shares issuable upon exercise of the Warrants is subject to appropriate adjustment in the event of stock
splits, stock dividends, recapitalizations, reorganizations, schemes, arrangements or similar events affecting our common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
reduction to the exercise prices of the Series A Warrants and the Series B Warrants and resulting increase in the number of shares of
common stock underlying the Warrants will be subject to a floor price equal to 50% of the Nasdaq Minimum Price as defined by the rules
of Nasdaq prior to the Effective Shareholder Approval Date, and 20% of the Nasdaq Minimum Price beginning on the Effective Shareholder
Approval Date. Following the Effective Shareholder Approval Date, the exercise price reduction and adjustment provisions with respect
to the underlying shares of common stock in the Warrants described above will be effected using the reduced floor price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Fundamental
Transactions</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event we consummate a merger or consolidation with or into another person or other reorganization event in which our common stock
is converted or exchanged for securities, cash or other property, or we sell, lease, license, assign, transfer, convey or otherwise dispose
of all or substantially all of our assets or we or another person acquire 50% or more of our outstanding shares of common stock, then
following such event, the holders of the Warrants will be entitled to receive upon exercise of the Warrants the same kind and amount
of securities, cash or property which the holders would have received had they exercised the Warrants immediately prior to such fundamental
transaction. Any successor to us or surviving entity shall assume the obligations under the Warrants. Additionally, as more fully described
in the Warrants, in the event of certain fundamental transactions, the holders of the Warrants will be entitled to receive consideration
in an amount equal to the Black Scholes value of such Warrants on the date of consummation of such transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Transferability</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to applicable laws, a Warrant may be transferred at the option of the holder upon surrender of the Warrant to us together with the appropriate
instruments of transfer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Exchange
Listing</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is no established trading market for the Warrants. In addition, we do not intend to apply for the listing of the Warrants on any national
securities exchange. Without an active trading market, the liquidity of the Warrants will be limited.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Right
as a Stockholder</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as otherwise provided in the Warrants or by virtue of such holder&#8217;s ownership of shares of our common stock, the holders of the
Warrants do not have the rights or privileges of holders of our common stock, including any voting rights, until they exercise their
Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Waivers
and Adjustments</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to certain exceptions, any terms of the Warrants may be amended or waived with our written consent and the written consent of the holder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Pre-Funded
Warrants</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following summary of certain terms and provisions of the Pre-Funded Warrants that are being offered hereby is not complete and is subject
to, and qualified in its entirety by, the provisions of the Pre-Funded Warrant, the form of which is filed as an exhibit to the registration
statement of which this prospectus forms a part. Prospective investors should carefully review the terms and provisions of the form of
Pre-Funded Warrant for a complete description of the terms and conditions of the Pre-Funded Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"></p>

<!-- Field: Page; Sequence: 69 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Duration
and Exercise Price</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Pre-Funded Warrant offered hereby will have an initial exercise price per share of common stock equal to $0.01. The Pre-Funded Warrants
will be immediately exercisable and will expire when exercised in full. The exercise price and number of shares of common stock issuable
upon exercise is subject to appropriate adjustment in the event of share dividends, share splits, share combinations, reorganizations
or similar events affecting our shares of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Exercisability</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Pre-Funded Warrants will be exercisable, at the option of each holder, in whole or in part, by delivering to us a duly executed exercise
notice accompanied by payment in full for the number of shares of common stock purchased upon such exercise (except in the case of a
cashless exercise as discussed below). A holder (together with its affiliates) may not exercise any portion of the Pre-Funded Warrant
to the extent that the holder would own more than 4.99% (or, at the election of the holder, 9.99%) of the outstanding shares of common
stock immediately after exercise. However, upon notice from the holder to us, the holder may decrease or increase the holder&#8217;s
beneficial ownership limitation, which may not exceed 9.99% of the number of outstanding shares of common stock immediately after giving
effect to the exercise, as such percentage ownership is determined in accordance with the terms of the Pre-Funded Warrants, provided
that any increase in the beneficial ownership limitation will not take effect until 61 days following notice to us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Cashless
Exercise</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
lieu of making the cash payment otherwise contemplated to be made to us upon such exercise in payment of the aggregate exercise price,
the holder may elect instead to receive upon such exercise (either in whole or in part) the number of shares of common stock determined
according to a formula set forth in the Pre-Funded Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Fractional
Shares</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
fractional shares of common stock will be issued upon the exercise of the Pre-Funded Warrants. Rather, at our election, the number of
shares of common stock to be issued will be rounded up to the nearest whole number or we will pay a cash adjustment in an amount equal
to such fraction multiplied by the exercise price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Transferability</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to applicable laws, a Pre-Funded Warrant may be transferred at the option of the holder upon surrender of the Pre-Funded Warrants to
us together with the appropriate instruments of transfer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Trading
Market</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is no established trading market for the Pre-Funded Warrants, and we do not expect an active trading market to develop. We do not intend
to list the Pre-Funded Warrants on any securities exchange or other trading market. Without a trading market, the liquidity of the Pre-Funded
Warrants will be extremely limited. The shares of common stock issuable upon exercise of the Pre-Funded Warrants are currently traded
on Nasdaq.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">No
Rights as a Stockholder</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as otherwise provided in the Pre-Funded Warrants or by virtue of such holder&#8217;s ownership of shares of common stock, the holders
of the Pre-Funded Warrants do not have the rights or privileges of holders of our shares of common stock, including any voting rights,
until such holder exercise their Pre-Funded Warrants. The Pre-Funded Warrants provide that holders have the right to participate in distributions
or dividends paid on our shares of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Warrant
Certificate</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Pre-Funded Warrants will be issued in certificated form.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"></p>

<!-- Field: Page; Sequence: 70 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Other
Securities of the Company Not Being Offered in this Offering</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a description of securities of the Company other than the common stock and Warrants being offered hereby.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Preferred
Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Certificate of Incorporation authorize us to issue up to 1,000,000 shares of preferred stock, $1.00 par value. Our Board of Directors
is authorized, without further action by the stockholders, to issue shares of preferred stock and to fix the designations, number, rights,
preferences, privileges, and restrictions thereof, including dividend rights, conversion rights, voting rights, terms of redemption,
liquidation preferences and sinking fund terms. We believe that the Board of Directors&#8217; power to set the terms of, and our ability
to issue preferred stock, will provide flexibility in connection with possible financing or acquisition transactions in the future. The
issuance of preferred stock, however, could adversely affect the voting power of holders of common stock and decrease the amount of any
liquidation distribution to such holders. The presence of outstanding preferred stock could also have the effect of delaying, deterring,
or preventing a change in control of our Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding
Warrants</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of November 20, 2024, we had 902,113 outstanding warrants with a weighted average exercise price of $3.20 per share, with a weighted
average remaining life of 2 years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding
Options</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of November 20, 2024, we have 107,261 outstanding options with a weighted average exercise price of $8.07 per share, with a weighted
average remaining contractual life of 5.96 years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
203 of the Delaware General Corporation Law</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to the provisions of Section 203 of the DGCL regulating corporate takeovers. This statute prevents certain Delaware corporations,
under certain circumstances, from engaging in a &#8220;business combination&#8221; with:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    stockholder who owns 15% or more of our outstanding voting stock (otherwise known as an &#8220;interested stockholder&#8221;);</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    affiliate of an interested stockholder; or</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    associate of an interested stockholder, for three years following the date that the stockholder became an interested stockholder.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
&#8220;business combination&#8221; includes a merger or sale of more than 10% of our assets. However, the above provisions of Section
203 do not apply if:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    Board approves the transaction that made the stockholder an &#8220;interested stockholder,&#8221; prior to the date of the transaction;
    or</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">after
    the completion of the transaction that resulted in the stockholder becoming an interested stockholder, that stockholder owned at
    least 85% of our voting stock outstanding at the time the transaction commenced, other than statutorily excluded shares of common
    stock.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Transfer
Agent and Registrar</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
transfer agent and registrar for our common stock is Continental Stock Transfer &amp; Trust Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 71 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Listing</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
common stock is listed on The Nasdaq Capital Market under the symbol &#8220;RIME.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b><span id="alp_007"></span>PLAN
OF DISTRIBUTION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have engaged Univest Securities, LLC to act as our exclusive placement agent to solicit offers to purchase the shares of our common stock
(or Pre-Funded Warrants) and accompanying Warrants offered by this prospectus on a best efforts basis. The placement agent is not purchasing
or selling any such securities, nor is it required to arrange for the purchase and sale of any specific number or dollar amount of such
securities, other than to use its &#8220;best efforts&#8221; to arrange for the sale of such securities by us. Therefore, we may not
sell all, or any, of the shares of common stock, or Pre-Funded Warrants, and accompanying Warrants being offered. The terms of this offering
were subject to market conditions and negotiations between us, the placement agent and prospective investors. This is a best-efforts
offering and there is no minimum number of securities or minimum aggregate amount of proceeds that is a condition to the closing of this
offering. The placement agent may retain sub-agents and selected dealers in connection with this offering. We will have one closing for
all the securities purchased in this offering. The combined public offering price per share of common stock, or Pre-Funded Warrant, and
accompanying Warrants will be fixed for the duration of this offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Delivery
of the securities offered hereby is expected to occur on or about December 2, 2024, subject to satisfaction of certain customary
closing conditions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">We
have agreed to pay the placement agent an aggregate fee equal to 7% of the gross proceeds raised in this offering together with a
1% non-accountable expense allowance.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Per Share of <br/> Common <br/> Stock and <br/> Warrants</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Per <br/> Pre-Funded <br/> Warrant and <br/> Warrants</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%">Public offering price</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Placement agent fees<sup>(1)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Non-accountable expense allowance (1%)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proceeds, before expenses, to us<sup>(2)(3)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(1)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    the placement agent fee of 7% of the gross proceeds raised in this offering. Does not include reimbursement by us of the placement
    agent for any incurred out of pocket fees, costs and expenses, including costs of the of the escrow or clearing agent not to exceed
    the amount of $12,900.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(2)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Represents the non-accountable expense allowance of
    1% of the gross proceeds raised in the offering. <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    estimate that the total expenses of this offering, excluding placement agent fees but including reimbursement by us of accountable
    fees, costs and expenses incurred by the placement agent in connection with this offering, will be approximately $0.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(3)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    amount of offering proceeds to us presented in this table does not give effect to any exercise of the Warrants or the Pre-Funded
    Warrants.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assuming
we raise the maximum amount offered of $10,000,000 in proceeds from this offering, we anticipate payment to the placement agent
of not more than $800,000, consisting of $700,000 for the placement agent fee, $100,000 representing the non-accountable
allowance, and up to $12,900 for the reimbursement of accountable fees, costs and expenses of the placement agent which are
payable by us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 72 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Lock-Up
Agreements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
of our directors, officers and certain holders of more than 5% of our voting stock have agreed with the placement agent to be
subject to a lock up period of 90 days following the closing of this offering. This means that, during the applicable lock-up period,
such persons may not offer for sale, contract to sell or sell any shares of our common stock or any securities convertible into, or exercisable
or exchangeable for, shares of our common stock, subject to certain customary exceptions. The placement agent may, in its sole discretion
and without notice, waive the terms of any of these lock-up agreements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In addition, we have agreed, that until 90 days after the Effective Shareholder Approval Date, not to issue, enter
into any agreement to or announce the proposed issuance of any shares of our common stock or any securities convertible into, or exercisable
or exchangeable for, shares of our common stock or file any registration statement, or amendment of supplement thereto, subject to certain
customary exceptions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From the date of the offering until 180 days after the Effective Shareholder Approval Date, the Company is prohibited
from effecting or entering into an agreement to effect any issuance of any shares of our common stock or any securities convertible into,
or exercisable or exchangeable for, shares of our common stock involving a variable rate transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Tail</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have also agreed to pay the placement agent a tail fee equal to the compensation commensurate with the compensation paid or payable to
the placement agent in connection this offering in any subsequent offering of equity, debt and/or equity derivative instruments to any
investor actually introduced by the placement agent to the Company, but unknown to the Company prior to such introduction during the
period between the date of the Placement Agency Agreement and the closing of this offering or termination of the Placement Agency Agreement
other than for cause (defined as a material breach by the placement agent of the Placement Agency Agreement or a material failure to
perform the services contemplated thereby), as applicable, to the extent such subsequent offering is consummated at any time within the
18 month period from the closing date of this offering or termination of the Placement Agency Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
tail fee will not apply if the Placement Agency Agreement is terminated for cause.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 73 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Other
Relationships</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
placement agent and its respective affiliates may in the future engage in investment banking and other commercial dealings in the ordinary
course of business with us or our affiliates. The placement agent may in the future receive customary fees and commissions for these
transactions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the ordinary course of its various business activities, the placement agent and its affiliates may make or hold a broad array of investments
and actively trade debt and equity securities (or related derivative securities) and financial instruments (including bank loans) for
their own account and for the accounts of its customers, and such investment and securities activities may involve securities and/or
instruments of the issuer. The placement agent and its affiliates may also make investment recommendations and/or publish or express
independent research views in respect of such securities or instruments and may at any time hold, or recommend to clients that they acquire,
long and/or short positions in such securities and instruments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Indemnification</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have agreed to indemnify the placement agent against certain liabilities, including certain liabilities arising under the Securities
Act, or to contribute to payments that the placement agent may be required to make for these liabilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Electronic
Offer, Sale and Distribution</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus in electronic format may be made available on websites or through other online services maintained by the placement agent,
or by its affiliates. Other than this prospectus in electronic format, the information on the placement agent&#8217;s website and any
information contained in any other website maintained by the placement agent is not part of this prospectus or the registration statement
of which this prospectus forms a part, has not been approved and/or endorsed by us or the placement agent in its capacity as a placement
agent, and should not be relied upon by investors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 74 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: small-caps 10pt Times New Roman, Times, Serif"><span id="alp_008"></span><b>EXPERTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consolidated financial statements of the Company as of December 31, 2023 and for the nine-month transition period from April 1, 2023
through December 31, 2023, appearing in this prospectus have been audited by Marcum LLP, independent registered public accounting firm,
as set forth in their report thereon, which includes an explanatory paragraph as to the Company&#8217;s ability to continue as a going
concern, appearing elsewhere in this prospectus, and are included in reliance on the report of such firm given upon their authority as
experts in auditing and accounting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">The consolidated balance
sheet of the Company as of March 31, 2023, the related consolidated statements of operations, cash flows and shareholders&#8217; equity
for each of the two years then ended, have been audited by EisnerAmper LLP, independent registered public accounting firm,
as stated in their report which is included herein. Such financial statements have been included herein in reliance on the report
of such firm given upon their authority as experts in accounting and auditing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">The consolidated balance sheets of SemiCab, Inc. as
of December 31, 2023 and the related consolidated statements of operations for the year ended December 31, 2023, have been audited by
Bush &amp; Associates CPA LLC, the independent registered public accounting firm of SemiCab, Inc., as stated in their report which is
included herein.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: small-caps 10pt Times New Roman, Times, Serif"><b><span id="alp_009"></span>LEGAL
MATTERS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
legal matters with respect to the validity of the securities being offered by this prospectus will be passed upon by Sichenzia Ross Ference
Carmel LLP, New York, New York. <span style="background-color: white">The placement agent is being represented by Lucosky Brookman,
LLP, Woodbridge, New Jersey, in connection with this offering.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span id="alp_010"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>WHERE
YOU CAN FIND MORE INFORMATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have filed with the SEC a registration statement on Form S-1 under the Securities Act with respect to the securities offered by this
prospectus. This prospectus, which constitutes a part of the registration statement, does not contain all of the information set forth
in the registration statement, some of which is contained in exhibits to the registration statement as permitted by the rules and regulations
of the SEC. For further information with respect to us and our common stock, we refer you to the registration statement, including the
exhibits filed as a part of the registration statement. Statements contained in this prospectus concerning the contents of any contract
or any other document is not necessarily complete. If a contract or document has been filed as an exhibit to the registration statement,
please see the copy of the contract or document that has been filed. Each statement in this prospectus relating to a contract or document
filed as an exhibit is qualified in all respects by the filed exhibit. You may obtain copies of this information by mail from the Public
Reference Section of the SEC, 100 F Street, N.E., Room 1580, Washington, D.C. 20549, at prescribed rates. You may obtain information
on the operation of the public reference rooms by calling the SEC at 1-800-SEC-0330. The SEC also maintains an Internet website that
contains reports, proxy statements and other information about issuers, like us, that file electronically with the SEC. The address of
that website is <i>www.sec.gov</i>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to the information and reporting requirements of the Exchange Act and, in accordance with this law, are required to file
periodic reports, proxy statements and other information with the SEC. These periodic reports, proxy statements and other information
are available for inspection and copying at the SEC&#8217;s public reference facilities and the website of the SEC referred to above.
We also maintain a website at <i>www.ir.algoholdings.com</i>. You may access these materials free of charge as soon as reasonably practicable
after they are electronically filed with, or furnished to, the SEC. Information contained on our website is not incorporated herein by
references or otherwise a part of this prospectus and the inclusion of our website address in this prospectus is an inactive textual
reference only. <b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 75 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALGORHYTHM HOLDINGS, INC. AND SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span id="alp_011"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INDEX
TO FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TABLE
OF CONTENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Page</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Condensed
    Consolidated Financial Statements for the Nine Months Ended September 30, 2024 and 2023 (Unaudited):</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><a href="#sj_001">Condensed Consolidated Balance Sheets as of September 30, 2024 (Unaudited) and December 31, 2023</a></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-2</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><a href="#sj_002">Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2024 and 2023 (Unaudited)</a></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-3</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><a href="#sj_003">Condensed Consolidated Statements of Stockholders&#8217;(Deficit) Equity for the three and nine months ended September 30, 2024 and 2023 (Unaudited)</a></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-4</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><a href="#sj_004">Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2024 and 2023 (Unaudited)</a></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-5</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><a href="#sj_005">Notes to Condensed Consolidated Financial Statements (Unaudited)</a></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-6</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.1in">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Page</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Consolidated
    Financial Statements for the Nine-Month Period Ended December 31, 2023 and the Fiscal Years Ended March 31, 2023 and 2022:</b></span></td>
    <td><b>&#160;</b></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#f_001">Report of Independent Registered Public Accounting Firm</a> (PCAOB ID:688)</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-21</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#rep2_001">Report of Independent Registered Public Accounting Firm</a> (PCAOB ID:274)</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">F-22</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><a href="#f_002"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated Balance Sheets</span></a></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-23</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><a href="#f_003"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated Statements of Operations</span></a></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-24</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><a href="#f_004"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated Statements of Cash Flows</span></a></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-25</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><a href="#f_005">Consolidated Statements of Shareholders&#8217; Equity</a></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">F-26</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><a href="#f_006"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes to Consolidated Financial Statements</span></a></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-27</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SEMICAB
INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INDEX
TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.1in">&#160;</td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Page</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_003">Report of Independent Registered Public Accounting Firm</a></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-44</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><a href="#a_001">Consolidated
    Balance Sheets as of Years Ended December 31, 2023 and December 31, 2022</a></span></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-45</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><a href="#a_002">Consolidated Statements of Operations for the Years Ended December 31, 2023 and December 31, 2022</a> </span></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-46</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 76; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="sj_001"></span>ALGORHYTHM
HOLDINGS, INC. and SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONDENSED
CONSOLIDATED BALANCE SHEETS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_309_111_zkL3I9FeOqP" summary="xdx: Statement - Condensed Consolidated Balance Sheets" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49C_20240930_zuRZE14XYOtk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">September
    30, 2024</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20231231_zu0TmrSFJdf2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December
    31, 2023</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">(Unaudited)</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--AssetsAbstract_iB_zSbEmg70sDH4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-decoration: underline; font-weight: bold; text-align: center">Assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--AssetsCurrentAbstract_i01B_zb2I3mmE5Lsf" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Current Assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--Cash_i02I_maACz22r_z9g77CaC9Bv9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; padding-left: 10pt">Cash</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2024-09-30" id="Fact000043" format="ixt:numdotdecimal" decimals="0" unitRef="USD">621,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2023-12-31" id="Fact000044" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,703,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--AccountsReceivableNet_i02I_pp0p0_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--NonrelatedPartyMember_maACz22r_zO5ThpwywNUh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Accounts receivable, net of allowances of $<span id="xdx_907_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_c20240930_zT6aOD5QRkqa"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" contextRef="AsOf2024-09-30" id="Fact000048" format="ixt:numdotdecimal" decimals="0" unitRef="USD">266,000</ix:nonFraction>
    </span>and $<span id="xdx_906_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_c20231231_zixURIQ8TE1a"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" contextRef="AsOf2023-12-31" id="Fact000049" format="ixt:numdotdecimal" decimals="0" unitRef="USD">174,000</ix:nonFraction></span>,
    respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableNet" contextRef="AsOf2024-09-30_us-gaap_NonrelatedPartyMember" id="Fact000046" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,330,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableNet" contextRef="AsOf2023-12-31_us-gaap_NonrelatedPartyMember" id="Fact000047" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,308,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--DueFromBanks_i02I_pp0p0_maACz22r_zkPwB2Tth7ak" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Due from Banks</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DueFromBanks" contextRef="AsOf2024-09-30" id="Fact000051" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">22,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0052">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--AccountsReceivableNet_i02I_pp0p0_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_maACz22r_zVOHAj2ND2Ek" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Accounts receivable, related party</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableNet" contextRef="AsOf2024-09-30_us-gaap_RelatedPartyMember" id="Fact000054" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">157,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableNet" contextRef="AsOf2023-12-31_us-gaap_RelatedPartyMember" id="Fact000055" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">269,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--AccountsReceivableNet_i02I_pp0p0_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_maACz22r_zn6Sr4sxYbBe" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
    receivable</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AccountsReceivableNet" contextRef="AsOf2024-09-30_us-gaap_RelatedPartyMember" id="Fact000057" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">157,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AccountsReceivableNet" contextRef="AsOf2023-12-31_us-gaap_RelatedPartyMember" id="Fact000058" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">269,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_407_ecustom--RefundDueFromCustomer_i02I_pp0p0_maACz22r_z1lEXhIPDA73" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Refund due from customer</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--InventoryNet_i02I_pp0p0_maACz22r_zr06V1lDbeMi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Inventory</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2024-09-30" id="Fact000063" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,328,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2023-12-31" id="Fact000064" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,871,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--ReturnsAsset_i02I_maACz22r_zZfuqrg83Vvb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Returns asset</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="RIME:ReturnsAsset" contextRef="AsOf2024-09-30" id="Fact000066" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,081,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="RIME:ReturnsAsset" contextRef="AsOf2023-12-31" id="Fact000067" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,919,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_i02I_maACz22r_zGBlRXtJ7A73" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Prepaid expenses and other current assets</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2024-09-30" id="Fact000069" format="ixt:numdotdecimal" decimals="0" unitRef="USD">867,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2023-12-31" id="Fact000070" format="ixt:numdotdecimal" decimals="0" unitRef="USD">136,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--AssetsCurrent_i02TI_maAz5EF_mtACz22r_zNEDLnA53Ucf" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-left: 20pt">Total Current Assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2024-09-30" id="Fact000072" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,406,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2023-12-31" id="Fact000073" format="ixt:numdotdecimal" decimals="0" unitRef="USD">23,206,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--PropertyPlantAndEquipmentNet_i01I_maAz5EF_zZlgHSr9Ac5a" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Property and equipment, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2024-09-30" id="Fact000075" format="ixt:numdotdecimal" decimals="0" unitRef="USD">318,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2023-12-31" id="Fact000076" format="ixt:numdotdecimal" decimals="0" unitRef="USD">404,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--OperatingLeaseRightOfUseAsset_i01I_maAz5EF_zsCiiuvO4VOb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Operating leases - right of use assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2024-09-30" id="Fact000078" format="ixt:numdotdecimal" decimals="0" unitRef="USD">137,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2023-12-31" id="Fact000079" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,926,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--OtherAssetsNoncurrent_i01I_maAz5EF_z3QA8yBXo6aj" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Other non-current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherAssetsNoncurrent" contextRef="AsOf2024-09-30" id="Fact000081" format="ixt:numdotdecimal" decimals="0" unitRef="USD">41,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherAssetsNoncurrent" contextRef="AsOf2023-12-31" id="Fact000082" format="ixt:numdotdecimal" decimals="0" unitRef="USD">179,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--IntangibleAssetsNetExcludingGoodwill_i01I_maAz5EF_z8x7HjxrCNak" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Intangible assets, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2024-09-30" id="Fact000084" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,356,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0085">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--Goodwill_i01I_maAz5EF_z4jT4gWEHwCk" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 1pt">Goodwill</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2024-09-30" id="Fact000087" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,354,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0088">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--Assets_i01TI_mtAz5EF_z9VhI62LnWtg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 20pt">Total Assets</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2024-09-30" id="Fact000090" format="ixt:numdotdecimal" decimals="0" unitRef="USD">19,612,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2023-12-31" id="Fact000091" format="ixt:numdotdecimal" decimals="0" unitRef="USD">27,715,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--LiabilitiesAndStockholdersEquityAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-decoration: underline; font-weight: bold; text-align: center">Liabilities and Shareholders&#8217; Equity</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--LiabilitiesCurrentAbstract_i01B_zs5EygZCPuM2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Current Liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--AccountsPayableCurrent_i02I_maLCzv8X_zulhpNjBZQPc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Accounts payable</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2024-09-30" id="Fact000099" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,743,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2023-12-31" id="Fact000100" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,616,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--AccruedLiabilitiesCurrent_i02I_maLCzv8X_zea11dh3vOw3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2024-09-30" id="Fact000102" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,303,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2023-12-31" id="Fact000103" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,614,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--NotesPayableCurrent_i02I_maLCzv8X_z5UJbHlne5g4" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Notes payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--LoansPayableCurrent_i02I_maLCzv8X_zfh85JTafOWk" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Loans from affiliates, current portion</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--ContractWithCustomerRefundLiabilityCurrent_i02I_maLCzv8X_zs8ZvRpqGgEh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Refund due to customer</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ContractWithCustomerRefundLiabilityCurrent" contextRef="AsOf2024-09-30" id="Fact000111" format="ixt:numdotdecimal" decimals="0" unitRef="USD">462,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ContractWithCustomerRefundLiabilityCurrent" contextRef="AsOf2023-12-31" id="Fact000112" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,743,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--CustomerPrepayments_i02I_maLCzv8X_zATuJ47xf7L" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Customer prepayments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0114">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="RIME:CustomerPrepayments" contextRef="AsOf2023-12-31" id="Fact000115" format="ixt:numdotdecimal" decimals="0" unitRef="USD">687,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--ReserveForSalesReturns_i02I_maLCzv8X_zUAqVnPXf2wh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Reserve for sales returns</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="RIME:ReserveForSalesReturns" contextRef="AsOf2024-09-30" id="Fact000117" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,212,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="RIME:ReserveForSalesReturns" contextRef="AsOf2023-12-31" id="Fact000118" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,390,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--ShortTermBorrowings_i02I_maLCzv8X_z3WA7CFbfEB9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Merchant cash advances payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShortTermBorrowings" contextRef="AsOf2024-09-30" id="Fact000120" format="ixt:numdotdecimal" decimals="0" unitRef="USD">303,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0121">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--NotesPayableCurrent_i02I_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--NonrelatedPartyMember_maLCzv8X_zBOL9mzmkLsa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Notes payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:NotesPayableCurrent" contextRef="AsOf2024-09-30_us-gaap_NonrelatedPartyMember" id="Fact000123" format="ixt:numdotdecimal" decimals="0" unitRef="USD">50,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0124">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--NotesPayableCurrent_i02I_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_maLCzv8X_zUZqhBzqGEEi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Current portion of notes payable to related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:NotesPayableCurrent" contextRef="AsOf2024-09-30_us-gaap_RelatedPartyMember" id="Fact000126" format="ixt:numdotdecimal" decimals="0" unitRef="USD">265,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0127">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--NotesPayableCurrent_i02I_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_maLCzv8X_zNodIIUaI7uh" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes
    payable</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:NotesPayableCurrent" contextRef="AsOf2024-09-30_us-gaap_RelatedPartyMember" id="Fact000129" format="ixt:numdotdecimal" decimals="0" unitRef="USD">265,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0130">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_409_eus-gaap--OperatingLeaseLiabilityCurrent_i02I_maLCzv8X_zLBNPQMvhbw5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Current portion of operating lease liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2024-09-30" id="Fact000132" format="ixt:numdotdecimal" decimals="0" unitRef="USD">135,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2023-12-31" id="Fact000133" format="ixt:numdotdecimal" decimals="0" unitRef="USD">84,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--OtherLiabilitiesCurrent_i02I_maLCzv8X_zLLAju4ciGOe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Other current liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2024-09-30" id="Fact000135" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2023-12-31" id="Fact000136" format="ixt:numdotdecimal" decimals="0" unitRef="USD">75,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--LiabilitiesCurrent_i02TI_mtLCzv8X_maLzBT3_zFrj4nUHwyQ3" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-left: 20pt">Total Current Liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2024-09-30" id="Fact000138" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16,488,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2023-12-31" id="Fact000139" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16,209,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--OtherLiabilitiesNoncurrent_i01I_maLzBT3_z1uNEQOsBpR7" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Other liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0141">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesNoncurrent" contextRef="AsOf2023-12-31" id="Fact000142" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--LongTermNotesPayable_i01I_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_maLzBT3_zfkWds6yjWma" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Notes payable to related parties, net of current portion</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LongTermNotesPayable" contextRef="AsOf2024-09-30_us-gaap_RelatedPartyMember" id="Fact000144" format="ixt:numdotdecimal" decimals="0" unitRef="USD">385,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0145">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--OperatingLeaseLiabilityNoncurrent_i01I_maLzBT3_z2PtWKtIww36" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Operating lease liabilities, net of current portion</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0147">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2023-12-31" id="Fact000148" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,925,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--LongTermLoansPayable_i01I_maLzBT3_zEL3I9Vyq8th" style="display: none; vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Loans from affiliates, net of current portion</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--Liabilities_i01TI_maLASEz8Cj_mtLzBT3_zumvsHfZ2iWh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt; padding-left: 30pt">Total Liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2024-09-30" id="Fact000153" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16,873,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2023-12-31" id="Fact000154" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,137,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--CommitmentsAndContingenciesAbstract_iB_z07APAeTdxTh" style="display: none; vertical-align: bottom; background-color: White">
    <td>Commitments and Contingencies</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--ProvisionForLegalLiability_i01I_maCACzRbf_zShgUnv8oe5" style="display: none; vertical-align: bottom; background-color: White">
    <td>Provision for legal liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--CommitmentsAndContingencies_iTI_mtCACzRbf_maLASEz8Cj_zTXG0Ix6ELae" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Commitments and Contingencies</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0162">-</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0163">-</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"/><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--StockholdersEquityAbstract_iB_zk0UL1FXHMll" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Shareholders&#8217; (Deficit) Equity</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--PreferredStockValue_i01I_maSEzYkC_zfPMRVG2fjJ5" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Preferred stock, $<span id="xdx_905_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20240930_z7aQX0BfUfUk" title="Preferred stock, par value"><span id="xdx_908_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20231231_zYlSVy9nqQfj" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2024-09-30" id="Fact000171" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2023-12-31" id="Fact000173" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.00</ix:nonFraction></ix:nonFraction></span></span>
    par value; <span id="xdx_90F_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20240930_zTgbvVSHjc01" title="Preferred stock, shares authorized"><span id="xdx_905_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20231231_ziKDHWWLg6kk" title="Preferred stock, shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2024-09-30" id="Fact000175" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2023-12-31" id="Fact000177" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,000,000</ix:nonFraction></ix:nonFraction></span></span>
    shares authorized; <span id="xdx_90B_eus-gaap--PreferredStockSharesIssued_iI_do_c20240930_zUCTCSTIBozl" title="Preferred stock, shares issued"><span id="xdx_906_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20240930_zGaoftbJge6e" title="Preferred stock, shares outstanding"><span id="xdx_900_eus-gaap--PreferredStockSharesIssued_iI_do_c20231231_z3frIQbC1yr1" title="Preferred stock, shares issued"><span id="xdx_90C_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20231231_zJgLINtVz6Wb" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2024-09-30" id="Fact000179" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2024-09-30" id="Fact000181" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2023-12-31" id="Fact000183" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2023-12-31" id="Fact000185" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span> shares
    issued and outstanding</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0168">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0169">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--CommonStockValue_i01I_pp0p0_maSEzYkC_ztrtsX4CAMK2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Common stock $<span id="xdx_90D_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20240930_zfY5JLekqJ76" title="Common stock, par value"><span id="xdx_902_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20231231_zhPHPJBbp7S7" title="Common stock, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2024-09-30" id="Fact000190" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2023-12-31" id="Fact000192" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.01</ix:nonFraction></ix:nonFraction></span></span>
    par value; <span id="xdx_90C_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20240930_zXmM6IpDfzi1" title="Common stock, shares authorized"><span id="xdx_90E_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20231231_zjvy20bN1W2" title="Common stock, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2024-09-30" id="Fact000194" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2023-12-31" id="Fact000196" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">100,000,000</ix:nonFraction></ix:nonFraction></span></span>
    shares authorized; <span id="xdx_906_eus-gaap--CommonStockSharesIssued_iI_pid_c20240930_zZyIV1gVKL0j" title="Common stock, shares issued"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2024-09-30" id="Fact000198" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">11,079,678</ix:nonFraction></span> issued
    and <span id="xdx_904_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20240930_zkYTtQ1lbJw7" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2024-09-30" id="Fact000200" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,752,755</ix:nonFraction></span> shares outstanding
    at September 30, 2024 and <span id="xdx_900_eus-gaap--CommonStockSharesIssued_iI_pid_c20231231_zQtDhv7FQGM3" title="Common stock, shares issued"><span id="xdx_903_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20231231_zKqfeIgAj25l" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2023-12-31" id="Fact000202" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2023-12-31" id="Fact000204" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,418,061</ix:nonFraction></ix:nonFraction></span></span> issued
    and outstanding at December 31, 2023.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2024-09-30" id="Fact000187" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">98,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2023-12-31" id="Fact000188" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">64,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--AdditionalPaidInCapital_i01I_maSEzYkC_zIPJpQwKpPI6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Additional paid-in capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2024-09-30" id="Fact000206" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35,995,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2023-12-31" id="Fact000207" format="ixt:numdotdecimal" decimals="0" unitRef="USD">33,429,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--CommonStockShareSubscribedButUnissuedSubscriptionsReceivable_i01NI_pp0p0_di_msSEzYkC_zCRLbKvclA0i" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Subscriptions receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--RetainedEarningsAccumulatedDeficit_i01I_maSEzYkC_zg5Tmg03xgG2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Accumulated deficit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2024-09-30" id="Fact000212" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">33,206,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2023-12-31" id="Fact000213" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">25,915,000</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_408_eus-gaap--StockholdersEquity_i01TI_mtSEzYkC_maSEIPAzN8Q_zTGcitZHrvv4" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Total Shareholders&#8217; Equity</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31" id="Fact000216" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,578,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--MinorityInterest_i01I_maSEIPAzN8Q_zTcDKMLbBxT" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Non-controlling interest</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:MinorityInterest" contextRef="AsOf2024-09-30" id="Fact000218" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">148,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0219">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_i01TI_pp0p0_maLASEz8Cj_mtSEIPAzN8Q_zmiNCjTWdMi5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; font-weight: bold; text-align: left; padding-left: 20pt">Total Algorhythm Holdings Shareholders&#8217;
    Equity</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-09-30" id="Fact000221" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,739,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-12-31" id="Fact000222" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,578,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--LiabilitiesAndStockholdersEquity_iTI_pp0p0_mtLASEz8Cj_zOeEEUsi3Rme" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 20pt">Total Liabilities and Shareholders&#8217;
    Equity</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2024-09-30" id="Fact000224" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">19,612,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2023-12-31" id="Fact000225" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">27,715,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>See
notes to the condensed consolidated financial statements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 77; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="sj_002"></span><b>ALGORHYTHM
HOLDINGS, INC. and SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONDENSED
CONSOLIDATED STATEMENTS OF OPERATIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_300_113_zlfBS8i7BHp1" summary="xdx: Statement - Condensed Consolidated Statements of Operations" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_49B_20240701__20240930_z2rwiy9ogQs3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    30, 2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_49C_20230701__20230930_z9p66x1hRW7i" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    30, 2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_494_20240101__20240930_z6z1btZaeALb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    30, 2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_498_20230101__20230930_zNE90TiBOwFj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    30, 2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the Three Months Ended</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the Nine Months Ended</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">September 30, 2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">September 30, 2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">September 30, 2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">September 30, 2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_maGPzvz5_zr6IwnnBvdhh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 44%; font-weight: bold; text-align: left">Net Sales</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2024-07-012024-09-30" id="Fact000227" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,622,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2023-07-012023-09-30" id="Fact000228" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,931,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2024-01-01to2024-09-30" id="Fact000229" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,488,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2023-01-012023-09-30" id="Fact000230" format="ixt:numdotdecimal" decimals="0" unitRef="USD">21,939,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--CostOfGoodsAndServicesSold_msGPzvz5_zNnE1L5zkce2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Cost of Goods Sold</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CostOfGoodsAndServicesSold" contextRef="From2024-07-012024-09-30" id="Fact000232" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,247,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CostOfGoodsAndServicesSold" contextRef="From2023-07-012023-09-30" id="Fact000233" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,197,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CostOfGoodsAndServicesSold" contextRef="From2024-01-01to2024-09-30" id="Fact000234" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,287,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CostOfGoodsAndServicesSold" contextRef="From2023-01-012023-09-30" id="Fact000235" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16,582,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--GrossProfit_iT_mtGPzvz5_maOILzFbw_z3kkyhss7Wqa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Gross Profit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2024-07-012024-09-30" id="Fact000237" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,375,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2023-07-012023-09-30" id="Fact000238" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,734,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2024-01-01to2024-09-30" id="Fact000239" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,201,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2023-01-012023-09-30" id="Fact000240" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,357,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--OperatingExpensesAbstract_iB_zoahSqhmlb8j" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Operating Expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--SellingExpense_i01_maOEz7vg_z4aKxwpB0bQ1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Selling expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SellingExpense" contextRef="From2024-07-012024-09-30" id="Fact000247" format="ixt:numdotdecimal" decimals="0" unitRef="USD">653,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SellingExpense" contextRef="From2023-07-012023-09-30" id="Fact000248" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,169,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SellingExpense" contextRef="From2024-01-01to2024-09-30" id="Fact000249" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,830,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SellingExpense" contextRef="From2023-01-012023-09-30" id="Fact000250" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,426,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--GeneralAndAdministrativeExpense_i01_maOEz7vg_zOS2ADKf1hgh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">General and administrative expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2024-07-012024-09-30" id="Fact000252" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,339,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2023-07-012023-09-30" id="Fact000253" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,459,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2024-01-01to2024-09-30" id="Fact000254" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,552,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2023-01-012023-09-30" id="Fact000255" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,403,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--GainLossOnTerminationOfLease_i01N_di_msOEz7vg_zFEnGKnoE4K" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Net (gain) loss on early termination of operating lease</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:GainLossOnTerminationOfLease" contextRef="From2024-07-012024-09-30" id="Fact000257" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,874,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0258">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:GainLossOnTerminationOfLease" contextRef="From2024-01-01to2024-09-30" id="Fact000259" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0260">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--ProductDevelopmentExpense_i01_maOEz7vg_z13RrzDtRAF7" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Product development</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--OperatingExpenses_i01T_mtOEz7vg_msOILzFbw_zAji9EzCsRC3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Total Operating Expenses</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2024-07-012024-09-30" id="Fact000267" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,118,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2023-07-012023-09-30" id="Fact000268" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,628,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2024-01-01to2024-09-30" id="Fact000269" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,386,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2023-01-012023-09-30" id="Fact000270" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,829,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--OperatingIncomeLoss_iT_mtOILzFbw_maILFCOz5Uy_zEDXIU2G9mEl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Income (Loss) from Operations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2024-07-012024-09-30" id="Fact000272" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,257,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2023-07-012023-09-30" id="Fact000273" format="ixt:numdotdecimal" decimals="0" unitRef="USD">106,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2024-01-01to2024-09-30" id="Fact000274" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">7,185,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2023-01-012023-09-30" id="Fact000275" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,472,000</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--NonoperatingIncomeExpenseAbstract_iB_zpnb04of4EA2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Other (Expenses) Income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--GainLossOnDispositionOfAssets1_i01_maNIEzaih_zY6DBWkVW2I2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Gain on disposal of fixed assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0282">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GainLossOnDispositionOfAssets1" contextRef="From2023-07-012023-09-30" id="Fact000283" format="ixt:numdotdecimal" decimals="0" unitRef="USD">44,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0284">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GainLossOnDispositionOfAssets1" contextRef="From2023-01-012023-09-30" id="Fact000285" format="ixt:numdotdecimal" decimals="0" unitRef="USD">44,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--GainFromRelatedPartyDebt_i01_maNIEzaih_zKvU9bHN2D92" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Gain - related party</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--GainFromPaycheckProtectionPlanLoanForgiveness_i01_maNIEzaih_zoX2cvb1ozSj" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Gain from extinguishment of PPP loan forgiveness</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--GainFromSettlementOfAccountsPayable_i01_maNIEzaih_zxmVU16RbA67" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Gain from settlement of accounts payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--GainsLossesOnExtinguishmentOfDebt_i01_maNIEzaih_zy0tGN9ixOa" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Loss from extinguishment of debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--GainFromEmployeeRetentionCreditProgramRefund_i01_maNIEzaih_zP1WCJLDr0Sd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Gain from Employee Retention Credit Program refund</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0307">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0308">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0309">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="RIME:GainFromEmployeeRetentionCreditProgramRefund" contextRef="From2023-01-012023-09-30" id="Fact000310" format="ixt:numdotdecimal" decimals="0" unitRef="USD">704,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--InterestExpenseDebtExcludingAmortization_i01N_di_msNIEzaih_zcm3y9mIJKKg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Interest expense</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:InterestExpenseDebtExcludingAmortization" contextRef="From2024-07-012024-09-30" id="Fact000312" format="ixt:numdotdecimal" decimals="0" unitRef="USD">283,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:InterestExpenseDebtExcludingAmortization" contextRef="From2023-07-012023-09-30" id="Fact000313" format="ixt:numdotdecimal" decimals="0" unitRef="USD">53,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:InterestExpenseDebtExcludingAmortization" contextRef="From2024-01-01to2024-09-30" id="Fact000314" format="ixt:numdotdecimal" decimals="0" unitRef="USD">328,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:InterestExpenseDebtExcludingAmortization" contextRef="From2023-01-012023-09-30" id="Fact000315" format="ixt:numdotdecimal" decimals="0" unitRef="USD">122,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_400_eus-gaap--NonoperatingIncomeExpense_i01T_mtNIEzaih_maILFCOz5Uy_ztUmE9UDqiQa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Total Other (Expenses) Income, net</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2024-07-012024-09-30" id="Fact000317" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">283,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2023-07-012023-09-30" id="Fact000318" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2024-01-01to2024-09-30" id="Fact000319" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">328,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2023-01-012023-09-30" id="Fact000320" format="ixt:numdotdecimal" decimals="0" unitRef="USD">626,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iT_pp0p0_mtILFCOz5Uy_maPLzU15_zNdiuhSUKBab" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Income (Loss) Before Income Tax Benefit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2024-07-012024-09-30" id="Fact000322" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">974,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2023-07-012023-09-30" id="Fact000323" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">97,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2024-01-01to2024-09-30" id="Fact000324" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">7,513,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2023-01-012023-09-30" id="Fact000325" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">3,846,000</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--IncomeTaxExpenseBenefit_iN_di_msPLzU15_zsgW8R3VkCp5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Income Tax Benefit (Provision)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0327">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0328">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0329">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2023-01-012023-09-30" id="Fact000330" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,502,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--ProfitLoss_iT_mtPLzU15_maNILzdkI_zr9sFV7SoS7k" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Consolidated Net Income (Loss)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2024-07-012024-09-30" id="Fact000332" format="ixt:numdotdecimal" decimals="0" unitRef="USD">974,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-07-012023-09-30" id="Fact000333" format="ixt:numdotdecimal" decimals="0" unitRef="USD">97,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2024-01-01to2024-09-30" id="Fact000334" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">7,513,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-01-012023-09-30" id="Fact000335" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">5,348,000</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_iN_di_msNILzdkI_z4adu4v4dIv9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Net (income) loss attributable to non-controlling interest</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2024-07-012024-09-30" id="Fact000337" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">221,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0338">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2024-01-01to2024-09-30" id="Fact000339" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">221,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0340">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--NetIncomeLoss_iT_mtNILzdkI_zhBc55o9zBzk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net Income (Loss) Available to Common Stockholders</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-07-012024-09-30" id="Fact000342" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,195,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-07-012023-09-30" id="Fact000343" format="ixt:numdotdecimal" decimals="0" unitRef="USD">97,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-01-01to2024-09-30" id="Fact000344" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">7,292,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-09-30" id="Fact000345" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">5,348,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--EarningsPerShareAbstract_iB_zLGsnf9HPM26" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Income (Loss) per common share</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Basic and diluted</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_90D_eus-gaap--EarningsPerShareBasic_c20240701__20240930_z3L1GsYEubXh" title="Loss per Common Share Basic" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA"><span id="xdx_90A_eus-gaap--EarningsPerShareDiluted_c20240701__20240930_z6Jkn7VCPwF7" title="Loss per Common Share Diluted" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2024-07-012024-09-30" id="Fact000352" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2024-07-012024-09-30" id="Fact000354" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.13</ix:nonFraction></ix:nonFraction></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_90D_eus-gaap--EarningsPerShareBasic_c20230701__20230930_zvaAygF3Wvmf" title="Loss per Common Share Basic" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA"><span id="xdx_903_eus-gaap--EarningsPerShareDiluted_c20230701__20230930_zopygiRiLzz2" title="Loss per Common Share Diluted" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2023-07-012023-09-30" id="Fact000356" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2023-07-012023-09-30" id="Fact000358" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.03</ix:nonFraction></ix:nonFraction></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_90D_eus-gaap--EarningsPerShareBasic_c20240101__20240930_zVC0kdd4lwsc" title="Loss per Common Share Basic" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA"><span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_c20240101__20240930_zPfgpNedMDee" title="Loss per Common Share Diluted" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2024-01-01to2024-09-30" id="Fact000360" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2024-01-01to2024-09-30" id="Fact000362" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.99</ix:nonFraction></ix:nonFraction></span></span></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_902_eus-gaap--EarningsPerShareBasic_c20230101__20230930_zZWVZzUcHIv2" title="Income (Loss) per common share, Basic" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA"><span id="xdx_902_eus-gaap--EarningsPerShareDiluted_c20230101__20230930_zmPM7rcKkVhi" title="Income (Loss) per common share, Diluted" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2023-01-012023-09-30" id="Fact000364" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2023-01-012023-09-30" id="Fact000366" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">1.44</ix:nonFraction></ix:nonFraction></span></span></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold">Weighted Average Common and Common</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Equivalent Shares:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--EarningsPerShareBasicOtherDisclosuresAbstract_iB_zfimB7mwb09d" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Weighted Average Common and Common Equivalent Shares:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Basic and diluted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240701__20240930_zzhjpk6lgZ37" title="Weighted Average Common and Common Equivalent Shares: Basic" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA"><span id="xdx_903_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240701__20240930_zEHEyOAZ4Fqj" title="Weighted Average Common and Common Equivalent Shares: Diluted" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2024-07-012024-09-30" id="Fact000373" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2024-07-012024-09-30" id="Fact000375" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,095,504</ix:nonFraction></ix:nonFraction></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_901_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230701__20230930_zRwsdUSVEiRc" title="Weighted Average Common and Common Equivalent Shares: Basic" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA"><span id="xdx_902_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230701__20230930_zKfg95dFqUra" title="Weighted Average Common and Common Equivalent Shares: Diluted" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-07-012023-09-30" id="Fact000377" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-07-012023-09-30" id="Fact000379" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,220,259</ix:nonFraction></ix:nonFraction></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_901_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240101__20240930_zH9stXkd3WF6" title="Weighted Average Common and Common Equivalent Shares: Basic" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA"><span id="xdx_90D_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240101__20240930_zCV85f6Rdn3g" title="Weighted Average Common and Common Equivalent Shares: Diluted" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2024-01-01to2024-09-30" id="Fact000381" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2024-01-01to2024-09-30" id="Fact000383" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,341,204</ix:nonFraction></ix:nonFraction></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_903_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230101__20230930_zmThCjSBRnkj" title="Weighted Average Common and Common Equivalent Shares: Basic" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA"><span id="xdx_90F_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230101__20230930_zJg5S4GqjNbd" title="Weighted Average Common and Common Equivalent Shares: Diluted" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-01-012023-09-30" id="Fact000385" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-01-012023-09-30" id="Fact000387" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,726,259</ix:nonFraction></ix:nonFraction></span></span></td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>See
notes to the condensed consolidated financial statements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 78; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="sj_003"></span>ALGORHYTHM
HOLDINGS, INC. and SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONDENSED
CONSOLIDATED STATEMENTS OF SHAREHOLDERS&#8217; (DEFICIT) EQUITY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the Three Months Ended September 30, 2024 and 2023</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Unaudited)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30B_114_ztahqoSCDBte" summary="xdx: Statement - Condensed Consolidated Statements of Shareholders' (Deficit) Equity" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_4B0_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zZ1FPteNRy5l" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_4B5_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_zDbEokvsgXfi" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_4B9_us-gaap--StatementEquityComponentsAxis_us-gaap--ReceivablesFromStockholderMember_zjkNjowrMpnb" style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_4B8_us-gaap--StatementEquityComponentsAxis_us-gaap--NoncontrollingInterestMember_zVpCJk91enWk" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_4B2_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_z9d3Yw5KnD0b" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deficit</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_4BC_zsVfjveyom1d" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Common Stock</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center">Additional Paid in</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center">Non-Controlling</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center">Accumulated</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Capital</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Interest</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Deficit</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_43C_c20240701__20240930_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_zuDExso3UkVj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; font-weight: bold">Balance at June 30, 2024</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--SharesOutstanding_iS_c20240701__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zH5C9ueSITgh" title="Balance, shares" style="width: 6%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-06-30_us-gaap_CommonStockMember" id="Fact000396" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,418,061</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 6%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-06-30_us-gaap_CommonStockMember" id="Fact000389" format="ixt:numdotdecimal" decimals="0" unitRef="USD">64,000</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 6%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-06-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact000390" format="ixt:numdotdecimal" decimals="0" unitRef="USD">33,465,000</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;<span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0391">-</span></span></td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 6%; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0392">-</span></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 6%; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-06-30_us-gaap_RetainedEarningsMember" id="Fact000393" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">34,401,000</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">)</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 6%; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-06-30" id="Fact000394" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">872,000</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--ProfitLoss_z3MU8GFDUzRa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net (loss) income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0398">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0399">-</span></td><td style="text-align: left">&#160;</td><td>&#160;<span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0400">-</span></span></td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2024-07-012024-09-30_us-gaap_NoncontrollingInterestMember" id="Fact000401" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">221,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2024-07-012024-09-30_us-gaap_RetainedEarningsMember" id="Fact000402" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,195,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2024-07-012024-09-30" id="Fact000403" format="ixt:numdotdecimal" decimals="0" unitRef="USD">974,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--StockIssuedDuringPeriodValueNewIssues_z6BXiNNMnXBc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Sale of common stock, net of offering costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240701__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zGqBRD98IaX1" title="Sale of common stock, net of offering costs, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember" id="Fact000412" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,673,077</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember" id="Fact000405" format="ixt:numdotdecimal" decimals="0" unitRef="USD">18,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2024-07-012024-09-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact000406" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,471,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0408">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0409">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2024-07-012024-09-30" id="Fact000410" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,489,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--StockGrantedDuringPeriodValueSharebasedCompensation_zxxoHkN2r50d" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stock based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensation_c20240701__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z9SxYCAjmDdf" title="Stock based compensation, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember" id="Fact000421" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,019,811</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation" contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember" id="Fact000414" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation" contextRef="From2024-07-012024-09-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact000415" format="ixt:numdotdecimal" decimals="0" unitRef="USD">569,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0417">-</span></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0418">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation" contextRef="From2024-07-012024-09-30" id="Fact000419" format="ixt:numdotdecimal" decimals="0" unitRef="USD">579,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_zag9U9RzWUjk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Common stock issued for purchase of SemiCab Inc</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20240701__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zI6n0BnW71o1" title="Common stock issued for purchase of SemiCab Inc, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember" id="Fact000430" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">641,806</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember" id="Fact000423" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2024-07-012024-09-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact000424" format="ixt:numdotdecimal" decimals="0" unitRef="USD">488,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0426">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0427">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2024-07-012024-09-30" id="Fact000428" format="ixt:numdotdecimal" decimals="0" unitRef="USD">494,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_zawlvTtI6f55" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issuance of subsidiary stock to non-controlling interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0432">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0433">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" contextRef="From2024-07-012024-09-30_us-gaap_NoncontrollingInterestMember" id="Fact000435" format="ixt:numdotdecimal" decimals="0" unitRef="USD">74,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0436">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" contextRef="From2024-07-012024-09-30" id="Fact000437" format="ixt:numdotdecimal" decimals="0" unitRef="USD">74,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--StockIssuedDuringPeriodValueOther_zOdt6DYGJ0Xe" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0439">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2024-07-012024-09-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact000440" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2024-07-012024-09-30_us-gaap_NoncontrollingInterestMember" id="Fact000442" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,000</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0443">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2024-07-012024-09-30" id="Fact000444" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_431_c20240701__20240930_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_zHF5cYH74VM8" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Balance at September 30, 2024</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--SharesOutstanding_iE_c20240701__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zUmG1krJXca3" title="Balance, shares" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-09-30_us-gaap_CommonStockMember" id="Fact000453" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,752,755</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-09-30_us-gaap_CommonStockMember" id="Fact000446" format="ixt:numdotdecimal" decimals="0" unitRef="USD">98,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-09-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact000447" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35,995,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0448">-</span></span>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-09-30_us-gaap_NoncontrollingInterestMember" id="Fact000449" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">148,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-09-30_us-gaap_RetainedEarningsMember" id="Fact000450" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">33,206,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-09-30" id="Fact000451" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,739,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Common Stock</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center">Additional Paid in</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center">Non-Controlling</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center">Accumulated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Capital</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Interest</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Deficit</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_438_c20230701__20230930_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_z3dSiPqtNy9c" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; font-weight: bold">Balance at June 30, 2023</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--SharesOutstanding_iS_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zlhqnQy7iwG" title="Balance, shares" style="width: 6%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-06-30_us-gaap_CommonStockMember" id="Fact000462" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,220,259</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 6%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-06-30_us-gaap_CommonStockMember" id="Fact000455" format="ixt:numdotdecimal" decimals="0" unitRef="USD">42,000</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 6%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-06-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact000456" format="ixt:numdotdecimal" decimals="0" unitRef="USD">31,479,000</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;<span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0457">-</span></span></td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 6%; font-weight: bold; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl0458">-</span></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 6%; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-06-30_us-gaap_RetainedEarningsMember" id="Fact000459" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">21,977,000</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">)</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 6%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-06-30" id="Fact000460" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,544,000</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--ProfitLoss_zCBJKpNcBxPg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0464">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0465">-</span></td><td style="text-align: left">&#160;</td><td>&#160;<span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0466">-</span></span></td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0467">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-07-012023-09-30_us-gaap_RetainedEarningsMember" id="Fact000468" format="ixt:numdotdecimal" decimals="0" unitRef="USD">97,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-07-012023-09-30" id="Fact000469" format="ixt:numdotdecimal" decimals="0" unitRef="USD">97,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--StockGrantedDuringPeriodValueSharebasedCompensation_zBErnqNYJzv1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Stock based compensation</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0471">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><ix:nonFraction name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation" contextRef="From2023-07-012023-09-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact000472" format="ixt:numdotdecimal" decimals="0" unitRef="USD">37,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0474">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0475">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><ix:nonFraction name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation" contextRef="From2023-07-012023-09-30" id="Fact000476" format="ixt:numdotdecimal" decimals="0" unitRef="USD">37,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--StockIssuedDuringPeriodValueOther_z42ESswcvJbi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0478">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2023-07-012023-09-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact000479" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"/>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0481">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2023-07-012023-09-30_us-gaap_RetainedEarningsMember" id="Fact000482" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0483">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_43E_c20230701__20230930_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_zxiUDhC545D3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Balance at September 30, 2023</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--SharesOutstanding_iE_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ze4IazF4b3I1" title="Balance, shares" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-09-30_us-gaap_CommonStockMember" id="Fact000492" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,220,259</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-09-30_us-gaap_CommonStockMember" id="Fact000485" format="ixt:numdotdecimal" decimals="0" unitRef="USD">42,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-09-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact000486" format="ixt:numdotdecimal" decimals="0" unitRef="USD">31,515,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;<span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0487">-</span></span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0488">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-09-30_us-gaap_RetainedEarningsMember" id="Fact000489" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">21,879,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-09-30" id="Fact000490" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,678,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the Nine Months Ended September 30, 2024 and 2023</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Unaudited)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Common Stock</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center">Additional Paid in</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center">Non-Controlling</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center">Accumulated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Capital</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Interest</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Deficit</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_431_c20240101__20240930_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_zh6k2ifiXgBe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; font-weight: bold">Balance at December 31, 2023</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--SharesOutstanding_iS_c20240101__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zVC7GUdWpGd8" title="Balance, shares" style="width: 6%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-12-31_us-gaap_CommonStockMember" id="Fact000501" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,418,061</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 6%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-12-31_us-gaap_CommonStockMember" id="Fact000494" format="ixt:numdotdecimal" decimals="0" unitRef="USD">64,000</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 6%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000495" format="ixt:numdotdecimal" decimals="0" unitRef="USD">33,429,000</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%">&#160;<span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0496">-</span></span></td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0497">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 6%; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-12-31_us-gaap_RetainedEarningsMember" id="Fact000498" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">25,915,000</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">)</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 6%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-12-31" id="Fact000499" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,578,000</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--ProfitLoss_zsWUsRh03RR2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0503">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0504">-</span></td><td style="text-align: left">&#160;</td><td>&#160;<span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0505">-</span></span></td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2024-01-012024-09-30_us-gaap_NoncontrollingInterestMember" id="Fact000506" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">221,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2024-01-012024-09-30_us-gaap_RetainedEarningsMember" id="Fact000507" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">7,292,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2024-01-01to2024-09-30" id="Fact000508" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">7,513,000</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_408_eus-gaap--StockIssuedDuringPeriodValueNewIssues_zpgwKreeeJw6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Sale of common stock, net of offering costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240101__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zvVIAJG7lqnb" title="Sale of common stock, net of offering costs, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2024-01-012024-09-30_us-gaap_CommonStockMember" id="Fact000517" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,673,077</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2024-01-012024-09-30_us-gaap_CommonStockMember" id="Fact000510" format="ixt:numdotdecimal" decimals="0" unitRef="USD">18,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2024-01-012024-09-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact000511" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,471,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0513">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0514">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2024-01-01to2024-09-30" id="Fact000515" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,489,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--StockGrantedDuringPeriodValueSharebasedCompensation_zwurTIidOy9d" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stock based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensation_c20240101__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zWE0599X8eBa" title="Stock based compensation, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" contextRef="From2024-01-012024-09-30_us-gaap_CommonStockMember" id="Fact000526" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,019,811</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation" contextRef="From2024-01-012024-09-30_us-gaap_CommonStockMember" id="Fact000519" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation" contextRef="From2024-01-012024-09-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact000520" format="ixt:numdotdecimal" decimals="0" unitRef="USD">606,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0522">-</span></td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0523">-</span></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation" contextRef="From2024-01-01to2024-09-30" id="Fact000524" format="ixt:numdotdecimal" decimals="0" unitRef="USD">616,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_zpCbsZGIEJqd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Common stock issued for purchase of SemiCab Inc</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20240101__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zKxd889kBDZ" title="Common stock issued for purchase of SemiCab Inc, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" contextRef="From2024-01-012024-09-30_us-gaap_CommonStockMember" id="Fact000535" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">641,806</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2024-01-012024-09-30_us-gaap_CommonStockMember" id="Fact000528" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2024-01-012024-09-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact000529" format="ixt:numdotdecimal" decimals="0" unitRef="USD">488,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0531">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0532">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2024-01-01to2024-09-30" id="Fact000533" format="ixt:numdotdecimal" decimals="0" unitRef="USD">494,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_zWPBc9k03Xg6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issuance of subsidiary stock to non-controlling interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0537">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0538">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" contextRef="From2024-01-012024-09-30_us-gaap_NoncontrollingInterestMember" id="Fact000540" format="ixt:numdotdecimal" decimals="0" unitRef="USD">74,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0541">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" contextRef="From2024-01-01to2024-09-30" id="Fact000542" format="ixt:numdotdecimal" decimals="0" unitRef="USD">74,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--StockIssuedDuringPeriodValueOther_zeewVhRANF9j" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0544">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2024-01-012024-09-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact000545" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2024-01-012024-09-30_us-gaap_NoncontrollingInterestMember" id="Fact000547" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2024-01-012024-09-30_us-gaap_RetainedEarningsMember" id="Fact000548" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2024-01-01to2024-09-30" id="Fact000549" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_439_c20240101__20240930_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_znJ5Aj61gxDc" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Balance at September 30, 2024</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--SharesOutstanding_iE_c20240101__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zMJW7bYftt1i" title="Balance, shares" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-09-30_us-gaap_CommonStockMember" id="Fact000558" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,752,755</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-09-30_us-gaap_CommonStockMember" id="Fact000551" format="ixt:numdotdecimal" decimals="0" unitRef="USD">98,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-09-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact000552" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35,995,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;<span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0553">-</span></span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-09-30_us-gaap_NoncontrollingInterestMember" id="Fact000554" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">148,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-09-30_us-gaap_RetainedEarningsMember" id="Fact000555" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">33,206,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-09-30" id="Fact000556" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,739,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"/></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_437_c20230101__20230930_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_zRKU27AsCi88" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold">Balance at December 31, 2022</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--SharesOutstanding_iS_c20230101__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zRPMKZVONvTh" title="Balance, shares" style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-12-31_us-gaap_CommonStockMember" id="Fact000567" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,148,219</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-12-31_us-gaap_CommonStockMember" id="Fact000560" format="ixt:numdotdecimal" decimals="0" unitRef="USD">31,000</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000561" format="ixt:numdotdecimal" decimals="0" unitRef="USD">29,698,000</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;<span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0562">-</span></span></td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0563">-</span></td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-12-31_us-gaap_RetainedEarningsMember" id="Fact000564" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">16,531,000</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-12-31" id="Fact000565" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,198,000</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr id="xdx_43F_c20230101__20230930_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_zFDLVX96zr3e" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_98D_eus-gaap--SharesOutstanding_iS_c20230101__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zid4gUTT93N2" title="Balance, shares" style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-12-31_us-gaap_CommonStockMember" id="Fact000576" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,148,219</ix:nonFraction></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-12-31_us-gaap_CommonStockMember" id="Fact000569" format="ixt:numdotdecimal" decimals="0" unitRef="USD">31,000</ix:nonFraction></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000570" format="ixt:numdotdecimal" decimals="0" unitRef="USD">29,698,000</ix:nonFraction></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span style="-sec-ix-hidden: xdx2ixbrl0571">-</span></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0572">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-12-31_us-gaap_RetainedEarningsMember" id="Fact000573" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">16,531,000</ix:nonFraction></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-12-31" id="Fact000574" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,198,000</ix:nonFraction></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">&#160;</td><td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: right">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--ProfitLoss_zRh02z0Sdepd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0578">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0579">-</span></td><td style="text-align: left">&#160;</td><td>&#160;<span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0580">-</span></span></td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0581">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-01-012023-09-30_us-gaap_RetainedEarningsMember" id="Fact000582" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">5,348,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-01-012023-09-30" id="Fact000583" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">5,348,000</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_405_eus-gaap--ProfitLoss_zZnWTffE9NYh" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net income (loss)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0585">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0586">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span style="-sec-ix-hidden: xdx2ixbrl0587">-</span></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0588">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-01-012023-09-30_us-gaap_RetainedEarningsMember" id="Fact000589" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">5,348,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-01-012023-09-30" id="Fact000590" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">5,348,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
<tr id="xdx_408_eus-gaap--StockIssuedDuringPeriodValueNewIssues_zKc8dPwsiC28" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Sale of common stock, net of offering costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230101__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zOpExvz916wh" title="Sale of common stock, net of offering costs, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-01-012023-09-30_us-gaap_CommonStockMember" id="Fact000599" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,057,810</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-01-012023-09-30_us-gaap_CommonStockMember" id="Fact000592" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-01-012023-09-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact000593" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,629,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0595">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0596">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-01-012023-09-30" id="Fact000597" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,640,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--StockIssuedDuringPeriodValueSaleOfCommonStockWarrants_zBidy14ppbKj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Sale of common stock warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--StockIssuedDuringPeriodSharesSaleOfCommonStockWarrants_c20230101__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zbONEdwwRTpl" title="Sale of common stock warrants, shares" style="text-align: right"><ix:nonFraction name="RIME:StockIssuedDuringPeriodSharesSaleOfCommonStockWarrants" contextRef="From2023-01-012023-09-30_us-gaap_CommonStockMember" id="Fact000608" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">14,230</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0601">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="RIME:StockIssuedDuringPeriodValueSaleOfCommonStockWarrants" contextRef="From2023-01-012023-09-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact000602" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0604">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0605">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="RIME:StockIssuedDuringPeriodValueSaleOfCommonStockWarrants" contextRef="From2023-01-012023-09-30" id="Fact000606" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--StockGrantedDuringPeriodValueSharebasedCompensation_z3Xpeaj477x5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Stock based compensation</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0610">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation" contextRef="From2023-01-012023-09-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact000611" format="ixt:numdotdecimal" decimals="0" unitRef="USD">174,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0613">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0614">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation" contextRef="From2023-01-012023-09-30" id="Fact000615" format="ixt:numdotdecimal" decimals="0" unitRef="USD">174,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_432_c20230101__20230930_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_zbaSUdioQuE4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Balance at September 30, 2023</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--SharesOutstanding_iE_c20230101__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z93q1RuUKwO9" title="Balance, shares" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-09-30_us-gaap_CommonStockMember" id="Fact000624" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,220,259</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-09-30_us-gaap_CommonStockMember" id="Fact000617" format="ixt:numdotdecimal" decimals="0" unitRef="USD">42,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-09-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact000618" format="ixt:numdotdecimal" decimals="0" unitRef="USD">31,515,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;<span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0619">-</span></span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0620">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-09-30_us-gaap_RetainedEarningsMember" id="Fact000621" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">21,879,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-09-30" id="Fact000622" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,678,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr id="xdx_433_c20230101__20230930_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_z0hmzGjKFez6" style="display: none; vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_989_eus-gaap--SharesOutstanding_iE_c20230101__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z9IA5WdWFMOh" title="Balance, shares" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-09-30_us-gaap_CommonStockMember" id="Fact000633" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,220,259</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-09-30_us-gaap_CommonStockMember" id="Fact000626" format="ixt:numdotdecimal" decimals="0" unitRef="USD">42,000</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-09-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact000627" format="ixt:numdotdecimal" decimals="0" unitRef="USD">31,515,000</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span style="-sec-ix-hidden: xdx2ixbrl0628">-</span></span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0629">-</span></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-09-30_us-gaap_RetainedEarningsMember" id="Fact000630" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">21,879,000</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-09-30" id="Fact000631" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,678,000</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>See
notes to the condensed consolidated financial statements.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 79; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="sj_004"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALGORHYTHM
HOLDINGS, INC. and SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONDENSED
CONSOLIDATED STATEMENTS OF CASH FLOWS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_303_112_zeqEp1UbLEc4" summary="xdx: Statement - Condensed Consolidated Statements of Cash Flows" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_49A_20240101__20240930_zLjmFYkhfWnj" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    30, 2024</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_497_20230101__20230930_zI2MzoKSFiog" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    30, 2023</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the Nine Months Ended</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">September 30, 2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">September 30, 2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB_zrdibWrNNDOg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Cash flows from operating activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--ProfitLoss_i01_maNCPBUzIWD_zyidC6W52YXh" style="vertical-align: bottom; background-color: White">
    <td style="width: 60%; text-align: left; padding-left: 10pt">Net loss</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2024-01-01to2024-09-30" id="Fact000638" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">7,513,000</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-01-012023-09-30" id="Fact000639" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">5,348,000</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_403_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_i01B_zBnhIUKiKjl8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Adjustments to reconcile net loss to net cash used in operating activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--Depreciation_i02_maNCPBUzIWD_z6GyObAJV6L9" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt">Depreciation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2024-01-01to2024-09-30" id="Fact000644" format="ixt:numdotdecimal" decimals="0" unitRef="USD">159,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2023-01-012023-09-30" id="Fact000645" format="ixt:numdotdecimal" decimals="0" unitRef="USD">289,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--AmortizationOfFinancingCosts_i02_maNCPBUzIWD_zG2NKDhWqgI7" style="display: none; vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt">Amortization of deferred financing costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--DeferredIncomeTaxExpenseBenefit_i02_maNCPBUzIWD_zmxHMEYHXnu9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt">Amortization of intangible assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="From2024-01-01to2024-09-30" id="Fact000650" format="ixt:numdotdecimal" decimals="0" unitRef="USD">44,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0651">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--ProvisionForEstimatedCostOfReturns_i02N_di_msNCPBUzIWD_zQnfy8pDkiZb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 20pt">Provision for estimated cost of returns</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="RIME:ProvisionForEstimatedCostOfReturns" contextRef="From2024-01-01to2024-09-30" id="Fact000653" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">839,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="RIME:ProvisionForEstimatedCostOfReturns" contextRef="From2023-01-012023-09-30" id="Fact000654" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,095,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--ProvisionForInventoryObsolescence_i02N_di_msNCPBUzIWD_zalIuvMxLGJ" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 20pt">Provision for inventory obsolescence</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0656">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="RIME:ProvisionForInventoryObsolescence" contextRef="From2023-01-012023-09-30" id="Fact000657" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">271,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--ProvisionForDoubtfulAccounts_i02_maNCPBUzIWD_zbPZpfcSs2Ij" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 20pt">Credit losses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProvisionForDoubtfulAccounts" contextRef="From2024-01-01to2024-09-30" id="Fact000659" format="ixt:numdotdecimal" decimals="0" unitRef="USD">92,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProvisionForDoubtfulAccounts" contextRef="From2023-01-012023-09-30" id="Fact000660" format="ixt:numdotdecimal" decimals="0" unitRef="USD">104,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--GainOnTerminationOfOperatingLease_i02N_di_msNCPBUzIWD_zDE8FhlM0std" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 20pt">Gain on termination of operating lease</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="RIME:GainOnTerminationOfOperatingLease" contextRef="From2024-01-01to2024-09-30" id="Fact000662" format="ixt:numdotdecimal" decimals="0" unitRef="USD">246,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0663">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--GainLossOnSaleOfPropertyPlantEquipment_i02N_di_msNCPBUzIWD_zWa6EO9KPw85" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 20pt">Net gain from disposal of property and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0665">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" contextRef="From2023-01-012023-09-30" id="Fact000666" format="ixt:numdotdecimal" decimals="0" unitRef="USD">42,000</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_404_eus-gaap--ShareBasedCompensation_i02_maNCPBUzIWD_z9TDOnJH7Vzf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 20pt">Stock based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2024-01-01to2024-09-30" id="Fact000668" format="ixt:numdotdecimal" decimals="0" unitRef="USD">616,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2023-01-012023-09-30" id="Fact000669" format="ixt:numdotdecimal" decimals="0" unitRef="USD">174,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--OperatingLeaseRightOfUseAssetAmortizationExpense_i02_maNCPBUzIWD_zVnDdWxziRnf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 20pt">Amortization of right of use assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" contextRef="From2024-01-01to2024-09-30" id="Fact000671" format="ixt:numdotdecimal" decimals="0" unitRef="USD">194,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" contextRef="From2023-01-012023-09-30" id="Fact000672" format="ixt:numdotdecimal" decimals="0" unitRef="USD">520,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--AmortizationOfIntangibleAssets_i02_maNCPBUzIWD_zX8fZSSRK4Sh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 20pt">Change in net deferred tax assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0674">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2023-01-012023-09-30" id="Fact000675" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,399,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--GainsLossesOnExtinguishmentOfDebt_i02N_di_msNCPBUzIWD_zp9m4xbx0hcd" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 20pt">Loss on debt extinguishment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--GainFromPaycheckProtectionPlanLoanForgiveness_i02N_di_msNCPBUzIWD_zKNoxLzKmtzk" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 20pt">Paycheck Protection Plan loan forgiveness</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_ecustom--GainFromRelatedPartyDebt_i02N_di_msNCPBUzIWD_zAEMmnJ4JYh5" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 20pt">Gain - related party</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--GainFromSettlementOfAccountsPayable_i02N_di_msNCPBUzIWD_zRuAD1Z6w1N9" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 20pt">Gain from extinguishment of accounts payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--IncreaseDecreaseInOperatingCapitalAbstract_i02B_zqOVe6QGOCGl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Changes in operating assets and liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--IncreaseDecreaseInAccountsReceivable_i03N_di_msNCPBUzIWD_z5GnSt5RRGh5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 20pt">Accounts receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2024-01-01to2024-09-30" id="Fact000692" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,079,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2023-01-012023-09-30" id="Fact000693" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,982,000</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_404_eus-gaap--IncreaseDecreaseDueFromAffiliates_i03N_di_msNCPBUzIWD_zDAcEXqh1ub9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 20pt">Due from banks</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseDueFromAffiliates" contextRef="From2024-01-01to2024-09-30" id="Fact000695" format="ixt:numdotdecimal" decimals="0" unitRef="USD">22,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseDueFromAffiliates" contextRef="From2023-01-012023-09-30" id="Fact000696" format="ixt:numdotdecimal" decimals="0" unitRef="USD">152,000</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40F_eus-gaap--IncreaseDecreaseInAccountsReceivableRelatedParties_i03N_di_msNCPBUzIWD_zM3CRsD3W6Zf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 20pt">Accounts receivable - related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivableRelatedParties" contextRef="From2024-01-01to2024-09-30" id="Fact000698" format="ixt:numdotdecimal" decimals="0" unitRef="USD">303,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivableRelatedParties" contextRef="From2023-01-012023-09-30" id="Fact000699" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">117,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--IncreaseDecreaseInInventories_i03N_di_msNCPBUzIWD_zPWL26K5abZc" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt">Inventories</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInInventories" contextRef="From2024-01-01to2024-09-30" id="Fact000701" format="ixt:numdotdecimal" decimals="0" unitRef="USD">456,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInInventories" contextRef="From2023-01-012023-09-30" id="Fact000702" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,424,000</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40A_eus-gaap--IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_i03N_di_msNCPBUzIWD_ze71jR6hZEAf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 20pt">Prepaid expenses and other current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="From2024-01-01to2024-09-30" id="Fact000704" format="ixt:numdotdecimal" decimals="0" unitRef="USD">718,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="From2023-01-012023-09-30" id="Fact000705" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">87,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--IncreaseDecreaseInOtherNoncurrentAssets_i03N_di_msNCPBUzIWD_zOCghSqOyte4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 20pt">Other non-current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" contextRef="From2024-01-01to2024-09-30" id="Fact000707" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">151,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" contextRef="From2023-01-012023-09-30" id="Fact000708" format="ixt:numdotdecimal" decimals="0" unitRef="USD">248,000</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40D_eus-gaap--IncreaseDecreaseInAccountsPayable_i03_maNCPBUzIWD_zI54eUjSaCHe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 20pt">Accounts payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="From2024-01-01to2024-09-30" id="Fact000710" format="ixt:numdotdecimal" decimals="0" unitRef="USD">394,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="From2023-01-012023-09-30" id="Fact000711" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,442,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--IncreaseDecreaseInAccruedLiabilities_i03_maNCPBUzIWD_zSVZMmc1F2tl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 20pt">Accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedLiabilities" contextRef="From2024-01-01to2024-09-30" id="Fact000713" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">198,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedLiabilities" contextRef="From2023-01-012023-09-30" id="Fact000714" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">486,000</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40E_eus-gaap--IncreaseDecreaseInDueToRelatedParties_i03_maNCPBUzIWD_zwkmoGP5drz6" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 20pt">Due to related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--IncreaseDecreaseInContractWithCustomerLiability_i03_maNCPBUzIWD_zN8RaF7TSaT9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 20pt">Refunds due to customers</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" contextRef="From2024-01-01to2024-09-30" id="Fact000719" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,967,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" contextRef="From2023-01-012023-09-30" id="Fact000720" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,212,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--IncreaseDecreaseInPrepaidsFromCustomers_i03_maNCPBUzIWD_zyVrNXmb9gqe" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 20pt">Prepaids from customers</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--IncreaseDecreaseInReserveForSalesReturns_i03_maNCPBUzIWD_zZnZ5R1FTSG6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 20pt">Reserve for sales returns</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="RIME:IncreaseDecreaseInReserveForSalesReturns" contextRef="From2024-01-01to2024-09-30" id="Fact000725" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,180,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="RIME:IncreaseDecreaseInReserveForSalesReturns" contextRef="From2023-01-012023-09-30" id="Fact000726" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">646,000</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_406_eus-gaap--IncreaseDecreaseInOperatingLeaseLiability_i03_maNCPBUzIWD_zHJa0wVQSiGa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 20pt">Operating lease liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" contextRef="From2024-01-01to2024-09-30" id="Fact000728" format="ixt:numdotdecimal" decimals="0" unitRef="USD">116,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" contextRef="From2023-01-012023-09-30" id="Fact000729" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">622,000</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_404_ecustom--PaymentOfEarlyTerminationFeeOnOperatingLeaseTerminationSettlement_i03_maNCPBUzIWD_z7pc8PuCcd4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Payment of early termination fee on operating lease termination
    settlement</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="RIME:PaymentOfEarlyTerminationFeeOnOperatingLeaseTerminationSettlement" contextRef="From2024-01-01to2024-09-30" id="Fact000731" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">150,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0732">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i01T_maCCERCzbcL_mtNCPBUzIWD_zaAy2e6uVGC9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 30pt">Net cash (used in) provided by operating activities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2024-01-01to2024-09-30" id="Fact000734" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">7,069,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2023-01-012023-09-30" id="Fact000735" format="ixt:numdotdecimal" decimals="0" unitRef="USD">760,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB_zij5IguBFhM7" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Cash flows from investing activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_i01N_di_msNCPBUz5XK_zdlVDi6adJuj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Purchase of property and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2024-01-01to2024-09-30" id="Fact000740" format="ixt:numdotdecimal" decimals="0" unitRef="USD">70,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2023-01-012023-09-30" id="Fact000741" format="ixt:numdotdecimal" decimals="0" unitRef="USD">163,000</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_403_eus-gaap--ProceedsFromPreviousAcquisition_i01_maNCPBUz5XK_z2dIgy5bbmQa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Cash received from purchase of SemiCab Inc</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromPreviousAcquisition" contextRef="From2024-01-01to2024-09-30" id="Fact000743" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0744">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--ProceedsFromSaleOfPropertyPlantAndEquipment_i01_maNCPBUz5XK_zaehj0kRIf9k" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Disposal of property and equipment</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0746">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" contextRef="From2023-01-012023-09-30" id="Fact000747" format="ixt:numdotdecimal" decimals="0" unitRef="USD">55,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--NetCashProvidedByUsedInInvestingActivities_i01T_maCCERCzbcL_mtNCPBUz5XK_zgv5mzYmysf1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 30pt">Net cash used in investing activities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2024-01-01to2024-09-30" id="Fact000749" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">53,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2023-01-012023-09-30" id="Fact000750" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">108,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 30pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB_zHtMnln1wyIa" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Cash flows from financing activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--ProceedsFromIssuanceOfCommonStock_i01_maNCPBUzcFr_zPZIBFIDmYa8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Proceeds from sale of stock, net of offering costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2024-01-01to2024-09-30" id="Fact000755" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,489,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2023-01-012023-09-30" id="Fact000756" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,640,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecustom--PaymentOfRedemptionAndRetirementOfTreasuryStock_i01N_di_msNCPBUzcFr_zOmSQswa90mf" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Payment of redemption and retirement of treasury stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--ProceedsFromCollectionOfSubscriptionsReceivable_i01_maNCPBUzcFr_zyGddE5yFZHh" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Collection of subscriptions receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--RepaymentsOfSubordinatedDebt_i01N_di_msNCPBUzcFr_zpCPnwUmnkj4" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Payment of subordinated note payable - Starlight Marketing Development, Ltd.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--PaymentOfDeferredFinancingCharges_i01N_di_msNCPBUzcFr_zMKLHcvERUC7" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Payment of deferred financing charges</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--PaymentOfEarlyTerminationFeesOnRevolvingLinesOfCredit_i01N_di_msNCPBUzcFr_zxVJwl4Qqxs5" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Payment of early termination fees on revolving lines of credit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--PaymentsOnInstallmentNote_i01N_di_msNCPBUzcFr_z2Cu701H6GP8" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Payments on installment notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--ProceedsFromStockOptionsExercised_i01_maNCPBUzcFr_z9GeEKnvzVU" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Proceeds from exercise of stock options</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--ProceedsFromExerciseOfCommonStockWarrants_i01_maNCPBUzcFr_z1pL60ZfGcVl" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Proceeds from exercise of common stock warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--ProceedsFromWarrantExercises_i01_maNCPBUzcFr_zxHVfIg9V9j7" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Proceeds from exercise of pre-funded warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--RepaymentsOfDebtAndCapitalLeaseObligations_i01N_di_msNCPBUzcFr_zczl64gksgx6" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Payments on finance leases</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--RepaymentsOfOtherDebt_i01N_di_msNCPBUzcFr_zp47iXz42c69" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Payments on merchant cash advances payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:RepaymentsOfOtherDebt" contextRef="From2024-01-01to2024-09-30" id="Fact000788" format="ixt:numdotdecimal" decimals="0" unitRef="USD">327,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0789">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--ProceedsFromRepaymentsOfLinesOfCredit_i01_maNCPBUzcFr_zHouw90qaXwf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Net payment from revolving lines of credit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0791">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:ProceedsFromRepaymentsOfLinesOfCredit" contextRef="From2023-01-012023-09-30" id="Fact000792" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,761,000</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_405_eus-gaap--ProceedsFromPaymentsForOtherFinancingActivities_i01_maNCPBUzcFr_zA8zAqzxwAf" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; padding-left: 10pt">Other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" contextRef="From2024-01-01to2024-09-30" id="Fact000794" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">122,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" contextRef="From2023-01-012023-09-30" id="Fact000795" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">113,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40E_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_maCCERCzbcL_mtNCPBUzcFr_zHFst2wasGl8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 30pt">Net cash provided by (used in) financing activities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2024-01-01to2024-09-30" id="Fact000797" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,040,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2023-01-012023-09-30" id="Fact000798" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">234,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40F_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_iT_mtCCERCzbcL_zhlI3tEcodn8" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Net change in cash</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2024-01-01to2024-09-30" id="Fact000800" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">6,082,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2023-01-012023-09-30" id="Fact000801" format="ixt:numdotdecimal" decimals="0" unitRef="USD">418,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iS_zvRBj0boFdol" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Cash at beginning of year</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2023-12-31" id="Fact000803" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,703,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2022-12-31" id="Fact000804" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,795,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iE_zK08Yyhembbk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Cash at end of period</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2024-09-30" id="Fact000806" format="ixt:numdotdecimal" decimals="0" unitRef="USD">621,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2023-09-30" id="Fact000807" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,213,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--SupplementalCashFlowInformationAbstract_iB_zNtlvP8Yms3l" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Supplemental disclosures of cash flow information:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--InterestPaidNet_i01_zlyvKIKcRS3i" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">Cash paid for interest</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2024-01-01to2024-09-30" id="Fact000812" format="ixt:numdotdecimal" decimals="0" unitRef="USD">320,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2023-01-012023-09-30" id="Fact000813" format="ixt:numdotdecimal" decimals="0" unitRef="USD">80,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--IncomeTaxesPaidNet_i01_zkdK6qaR9NQe" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">Cash paid for income taxes</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--NoncashInvestingAndFinancingItemsAbstract_iB_zRbKXSLRhz6h" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Non-Cash investing and financing cash flow information:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--StockIssued1_i01_zDtyWA3optTh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">Common stock issued for purchase of SemiCab Inc</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockIssued1" contextRef="From2024-01-01to2024-09-30" id="Fact000821" format="ixt:numdotdecimal" decimals="0" unitRef="USD">569,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0822">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--CapitalLeaseObligationsIncurred_i01_zN5jzEVZRm" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">Equipment purchased under capital lease</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0824">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:CapitalLeaseObligationsIncurred" contextRef="From2023-01-012023-09-30" id="Fact000825" format="ixt:numdotdecimal" decimals="0" unitRef="USD">55,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_i01_z0zPyLcYxrTh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">Right of use assets exchanged for lease liabilities</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" contextRef="From2024-01-01to2024-09-30" id="Fact000827" format="ixt:numdotdecimal" decimals="0" unitRef="USD">136,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" contextRef="From2023-01-012023-09-30" id="Fact000828" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,874,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--IssuanceOfCommonStockAndWarrantsForOfferingCosts_i01_zPdDOJDX2qOb" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">Issuance of common stock and warrants for offering costs</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>See
notes to the condensed consolidated financial statements</i></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 80; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="sj_005"></span>ALGORHYTHM
HOLDINGS, INC. and SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September
30, 2024 and 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact000833" name="us-gaap:NatureOfOperations"><p id="xdx_800_eus-gaap--NatureOfOperations_zVQtZY68gGpg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
1 &#8211; <span id="xdx_82F_zx0mRjbNBQk7">NATURE OF BUSINESS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Algorhythm
Holdings, Inc. (f/k/a The Singing machine Company, Inc.) (the &#8220;Company&#8221;) is a holding company for an AI enabled software
logistics business operated through our SemiCab Holding subsidiary and a home karaoke consumer products company that designs and distributes
karaoke products globally to retailers and ecommerce partners through our Singing Machine subsidiary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
operations include our wholly owned subsidiaries, SMC Logistics, Inc., a California corporation (&#8220;SMCL&#8221;), SMC-Music, Inc.,
a Florida corporation (&#8220;SMCM&#8221;), SMC (HK) Limited, a Hong Kong company (&#8220;SMH&#8221;), MICS Hospitality Holdings, Inc.,
a Delaware corporation (&#8220;MICS Hospitality&#8221;), MICS Hospitality Management, LLC, a Delaware limited liability company (&#8220;MICS
Hospitality Management&#8221;), MICS Nomad, LLC, a Delaware limited liability company (&#8220;MICS NY&#8221;) and SemiCab Holdings, LLC,
a Nevada limited liability company (&#8220;SemiCab&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Singing
Machine is primarily engaged in the development, marketing, and sale of consumer karaoke audio equipment, accessories, and musical recordings.
We are a global karaoke and music entertainment company that specializes in the design and production of quality karaoke and music enabled
consumer products for adults and children.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SemiCab
is a cloud-based collaborative transportation platform built to achieve the scalability required to predict and optimize full-truckload
transportation at enterprise-scale. To orchestrate collaboration across manufacturers, retailers, distributors, and their carriers, SemiCab
uses real-time data from API-based load tendering and pre-built integrations with TMS and ELD partners. To build fully loaded round trips,
SemiCab uses AI/ML techniques and advanced predictive optimization models.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact000835" name="RIME:RecentDevelopmentsTextBlock"><p id="xdx_800_ecustom--RecentDevelopmentsTextBlock_zkFtt4U165d6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
2 - <span id="xdx_821_zyI5z6qQrEjb">RECENT DEVELOPMENTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Name
and Symbol Change</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
September 5, 2024, our Certificate of Incorporation was amended to effect a change in the name of the Company from &#8220;The Singing
Machine Company, Inc.&#8221; to &#8220;Algorhythm Holdings, Inc.&#8221; In addition, effective September 8, 2024, the Company&#8217;s
ticker symbol was changed from &#8220;MICS&#8221; to &#8220;RIME.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Change
in Fiscal Year</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
2023, our Board of Directors approved a change in our fiscal year end from March 31 to December 31. Our results of operations, cash flows,
and all transactions impacting shareholders&#8217; equity presented in this Quarterly Report on Form 10-Q as of September 30, 2024 are
for the three and nine month periods ended September 30, 2024 and 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>ATM
Offering</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 26, 2024, the Company entered into an At-The-Market Issuance Sales Agreement (the &#8220;Sales Agreement&#8221;) with Ascendiant
Capital markets, LLC, as sales agent (the &#8220;Agent&#8221;), pursuant to which the Company could offer and sell, from time to time,
through the Agent (the &#8220;ATM Offering&#8221;), up to approximately $<span id="xdx_90F_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20240626__20240626__us-gaap--TypeOfArrangementAxis__custom--AtTheMarketSalesAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zxtaBAya9Lvj" title="Number of stock sold, value"><ix:nonFraction name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" contextRef="From2024-06-262024-06-26_custom_AtTheMarketSalesAgreementMember_us-gaap_CommonStockMember" id="Fact000837" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,100,000</ix:nonFraction></span> in shares of the Company&#8217;s common stock. <span style="background-color: white">On
July 8, 2024, the Company entered into the First Amendment to the Sales Agreement (the &#8220;Amendment&#8221;) to increase the number
of shares to be sold in the ATM Offering to $<span id="xdx_900_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20240626__20240626__us-gaap--TypeOfArrangementAxis__custom--AtTheMarketSalesAgreementAmendmentOneMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zoysTChabrxh" title="Number of stock sold, value"><ix:nonFraction name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" contextRef="From2024-06-262024-06-26_custom_AtTheMarketSalesAgreementAmendmentOneMember_us-gaap_CommonStockMember" id="Fact000839" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,020,000</ix:nonFraction></span>.</span> On August 9, 2024, the Company entered into the Second Amendment to the
Sales Agreement (the &#8220;Amendment&#8221;) to increase the number of shares to be sold in the ATM Offering to $<span id="xdx_90F_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20240626__20240626__us-gaap--TypeOfArrangementAxis__custom--AtTheMarketSalesAgreementAmendmentTwoMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zvJUvUD1rFs7" title="Number of stock sold, value"><ix:nonFraction name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" contextRef="From2024-06-262024-06-26_custom_AtTheMarketSalesAgreementAmendmentTwoMember_us-gaap_CommonStockMember" id="Fact000841" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,100,000</ix:nonFraction></span>. Pursuant
to the agreement, the Agent was paid $<span id="xdx_90B_eus-gaap--LegalFees_c20240626__20240626__us-gaap--TypeOfArrangementAxis__custom--AtTheMarketSalesAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zKfOat8ljuk" title="Legal and administrative expenses"><ix:nonFraction name="us-gaap:LegalFees" contextRef="From2024-06-262024-06-26_custom_AtTheMarketSalesAgreementMember_us-gaap_CommonStockMember" id="Fact000843" format="ixt:numdotdecimal" decimals="0" unitRef="USD">30,000</ix:nonFraction></span> in fees to cover legal and administrative expenses and will receive an amount equal to 3%
of the gross proceeds from each sale of the Company&#8217;s share of common stock. For the three and nine months ended September 30,
2024, the Company sold <span id="xdx_908_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20240701__20240930__us-gaap--TypeOfArrangementAxis__custom--AtTheMarketSalesAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zyUC7RsqduXe" title="Number of shares issued in transaction"><span id="xdx_90D_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20240101__20240930__us-gaap--TypeOfArrangementAxis__custom--AtTheMarketSalesAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zFvQyJtmM7Ti" title="Number of shares issued in transaction"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2024-07-012024-09-30_custom_AtTheMarketSalesAgreementMember_us-gaap_CommonStockMember" id="Fact000845" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2024-01-012024-09-30_custom_AtTheMarketSalesAgreementMember_us-gaap_CommonStockMember" id="Fact000847" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,673,077</ix:nonFraction></ix:nonFraction></span></span> shares of common stock under the ATM offering and received net proceeds of approximately <span id="xdx_90D_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20240701__20240930__us-gaap--TypeOfArrangementAxis__custom--AtTheMarketSalesAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zR2iZTF6Ix6l" title="Net proceeds from sale of common stock"><span id="xdx_907_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20240101__20240930__us-gaap--TypeOfArrangementAxis__custom--AtTheMarketSalesAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zYNNJ7hHnji1" title="Net proceeds from sale of common stock">$<ix:nonFraction name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" contextRef="From2024-07-012024-09-30_custom_AtTheMarketSalesAgreementMember_us-gaap_CommonStockMember" id="Fact000849" format="ixt:numdotdecimal" decimals="0" unitRef="USD"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" contextRef="From2024-01-012024-09-30_custom_AtTheMarketSalesAgreementMember_us-gaap_CommonStockMember" id="Fact000851" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,489,000</ix:nonFraction></ix:nonFraction></span></span>
after payment of legal and accounting fees, brokerage commissions, and administrative fees to the agent of approximately $<span id="xdx_909_eus-gaap--AdministrativeFeesExpense_c20240701__20240930__us-gaap--TypeOfArrangementAxis__custom--AtTheMarketSalesAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zm4Wo2dU9uAl" title="Brokerage commissions and administrative fees"><span id="xdx_90D_eus-gaap--AdministrativeFeesExpense_c20240101__20240930__us-gaap--TypeOfArrangementAxis__custom--AtTheMarketSalesAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zIXp99kXkhu2" title="Brokerage commissions and administrative fees"><ix:nonFraction name="us-gaap:AdministrativeFeesExpense" contextRef="From2024-07-012024-09-30_custom_AtTheMarketSalesAgreementMember_us-gaap_CommonStockMember" id="Fact000853" format="ixt:numdotdecimal" decimals="0" unitRef="USD"><ix:nonFraction name="us-gaap:AdministrativeFeesExpense" contextRef="From2024-01-012024-09-30_custom_AtTheMarketSalesAgreementMember_us-gaap_CommonStockMember" id="Fact000855" format="ixt:numdotdecimal" decimals="0" unitRef="USD">189,000</ix:nonFraction></ix:nonFraction></span></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 81; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALGORHYTHM
                                            HOLDINGS, INC. and SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September
30, 2024 and 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsequent
to September 30, 2024 and through November 18, 2024 (the last trading day prior to filing), the Company sold <span id="xdx_904_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20241001__20241118__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--AtTheMarketSalesAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zbRTlgrIxpG5" title="Number of shares issued in transaction"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2024-10-012024-11-18_us-gaap_SubsequentEventMember_custom_AtTheMarketSalesAgreementMember_us-gaap_CommonStockMember" id="Fact000857" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,162,423</ix:nonFraction></span> shares of common
stock under the ATM offering, and received net proceeds of approximately $<span id="xdx_902_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20241001__20241118__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--AtTheMarketSalesAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zaeijgi8t6S2" title="Net proceeds from sale of common stock"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" contextRef="From2024-10-012024-11-18_us-gaap_SubsequentEventMember_custom_AtTheMarketSalesAgreementMember_us-gaap_CommonStockMember" id="Fact000859" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,372,000</ix:nonFraction></span> after payment of brokerage commissions and administrative
fees to the agent of approximately $<span id="xdx_906_eus-gaap--AdministrativeFeesExpense_c20241001__20241118__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--AtTheMarketSalesAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z21YPIa7Stw8" title="Brokerage commissions and administrative fees"><ix:nonFraction name="us-gaap:AdministrativeFeesExpense" contextRef="From2024-10-012024-11-18_us-gaap_SubsequentEventMember_custom_AtTheMarketSalesAgreementMember_us-gaap_CommonStockMember" id="Fact000861" format="ixt:numdotdecimal" decimals="0" unitRef="USD">42,000</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Asset
Purchase</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 11, 2024, the Company and its wholly owned subsidiary SemiCab Holdings, LLC, a Nevada limited liability company (&#8220;SemiCab
LLC&#8221; and collectively with the Company, the &#8220;Buyer&#8221;), SemiCab, Inc., a Delaware corporation (&#8220;SemiCab&#8221;
or the &#8220;Seller&#8221;), Ajesh Kapoor and Vivek Sehgal entered into an asset purchase agreement (the &#8220;Asset Purchase Agreement&#8221;)
pursuant to which the Seller agreed to sell and assign to the Company, and the Company agreed to purchase and assume from the Seller,
substantially all the assets, and certain specified liabilities relating to the business of the Seller. Subject to certain exceptions
set forth in the Asset Purchase Agreement, the parties agreed that the Buyer will not assume the liabilities of the Seller. SemiCab is
an artificial intelligence, cloud-based collaborative transportation platform built to achieve the scalability required to predict and
optimize semi-tractor trailer load efficiency.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 3, 2024, the parties closed on the asset purchase whereby the Company issued to the Seller (i) <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesPurchaseOfAssets_c20240703__20240703__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember_zFfnE8f1OG65" title="Shares purchase"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets" contextRef="From2024-07-032024-07-03_custom_AssetPurchaseAgreementMember" id="Fact000863" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">641,806</ix:nonFraction></span> shares of the Company&#8217;s
common stock (ii) a twenty percent (<span id="xdx_90A_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20240703__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SemiCabLLCMember_zXK3h5FiFzG" title="Membership percentage"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2024-07-03_custom_SemiCabLLCMember" id="Fact000865" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">20</ix:nonFraction>%</span>) membership interest in SemiCab LLC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the asset acquisition agreement, the Company and Seller entered into an option agreement (the &#8220;Option Agreement&#8221;), granting
the Buyer the right to acquire all of the issued and outstanding capital securities of SMCB Solutions Private Limited (&#8220;SMCB&#8221;),
a wholly owned subsidiary of the Seller, in consideration for <span id="xdx_905_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20240703__20240703__us-gaap--BusinessAcquisitionAxis__custom--SemiCabLLCMember_zyur9xTrqKn2" title="Seller Consideration share"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2024-07-032024-07-03_custom_SemiCabLLCMember" id="Fact000867" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">320,903</ix:nonFraction></span> shares of common stock of the Company. The Option Agreement expired
unexercised.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Hospitality
Lease</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 23, 2023, MICS NY entered into an Agreement of Lease (the &#8220;Lease Agreement&#8221;) with OAC 111 Flatiron, LLC and OAC Adelphi,
LLC (the &#8220;Landlord&#8221;), pursuant to which MICS NY agreed to lease approximately <span id="xdx_90F_eus-gaap--AreaOfLand_iI_pid_usqft_c20230823__us-gaap--TypeOfArrangementAxis__custom--LeaseAgreementMember_zqAWQB20e3v7" title="Lease space"><ix:nonFraction name="us-gaap:AreaOfLand" contextRef="AsOf2023-08-23_custom_LeaseAgreementMember" id="Fact000869" format="ixt:numdotdecimal" decimals="INF" unitRef="sqft">10,000</ix:nonFraction></span> square feet of ground floor retail space
and a portion of the basement underneath the ground floor retail space in the property located at 111 West 24<sup>th</sup> Street, New
York, New York (the &#8220;Premises&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the six months ended June 30, 2024, the Company abandoned its plans to continue use of the leased space and exercised its early termination
provision of the Lease Agreement which was not accepted by the Landlord. Due to the abandonment of the lease, all assets related to the
lease were impaired. Assets including security deposits, rent deposits and right of use assets of approximately $<span id="xdx_907_ecustom--AssetsWriteOff_c20240401__20240630_ztwmvg2LeXnj" title="Written off"><ix:nonFraction name="RIME:AssetsWriteOff" contextRef="From2024-04-012024-06-30" id="Fact000871" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,878,000</ix:nonFraction></span> were written
off during the three months ended June 30, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 26, 2024, OAC 111 Flatiron, LLC and OAC Adelphi, LLC (the &#8220;Landlord&#8221;), filed a civil action in the Supreme Court of
the State of New York against MICS Nomad LLC, a subsidiary of the Company (&#8220;MICS NY&#8221;), and the Company (&#8220;the Defendants&#8221;)
for alleged breach of lease, seeking monetary damages including unpaid rent, future unpaid rent, and other expenses related to the lease.
The complaint alleged the Defendants breached the lease in various material respects.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 25, 2024, the Company entered into a Settlement Agreement for a full release and dismissal of the complaint within 5 business
days of the Company&#8217;s payment of $<span id="xdx_90A_eus-gaap--OperatingLeasePayments_c20240925__20240925__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember_zZ2y4fwF9h9g" title="Lease payments"><ix:nonFraction name="us-gaap:OperatingLeasePayments" contextRef="From2024-09-252024-09-25_custom_SettlementAgreementMember" id="Fact000873" format="ixt:numdotdecimal" decimals="0" unitRef="USD">250,000</ix:nonFraction></span>. Pursuant to the Settlement Agreement, the Company made the first payment of $<span id="xdx_901_ecustom--OperatingLeasePeriodicPayments_c20240925__20240925__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember_zIN3kvZetXY2" title="periodic lease payments"><ix:nonFraction name="RIME:OperatingLeasePeriodicPayments" contextRef="From2024-09-252024-09-25_custom_SettlementAgreementMember" id="Fact000875" format="ixt:numdotdecimal" decimals="0" unitRef="USD">150,000</ix:nonFraction></span>
was made on September 25, 2024 and a final payment of $<span id="xdx_903_ecustom--OperatingLeasePeriodicPayments_c20241025__20241025__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zpvyTYxHrUjl" title="periodic lease payments"><ix:nonFraction name="RIME:OperatingLeasePeriodicPayments" contextRef="From2024-10-252024-10-25_custom_SettlementAgreementMember_us-gaap_SubsequentEventMember" id="Fact000877" format="ixt:numdotdecimal" decimals="0" unitRef="USD">100,000</ix:nonFraction></span> was due and paid on October 25, 2024. On October 29, 2024, the Landlord
filed a discontinuance with prejudice.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result of the settlement, during the three months ended September 30, 2024, the Company wrote off the remaining operating lease liability
on the Lease Agreement and recognized a gain on early termination of the operating lease of approximately $<span id="xdx_909_eus-gaap--GainLossOnTerminationOfLease_c20240701__20240930__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember_zPsQEpDXHU5k" title="Gain loss on termination of operating lease"><ix:nonFraction name="us-gaap:GainLossOnTerminationOfLease" contextRef="From2024-07-012024-09-30_custom_SettlementAgreementMember" id="Fact000879" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,874,000</ix:nonFraction></span>. For the nine months
ended September 30, 2024, the Company recognized a loss on early termination of the operating lease of $<span id="xdx_902_eus-gaap--GainLossOnTerminationOfLease_c20240101__20240930__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember_z7xMssUBS686" title="Gain loss on termination of operating lease"><ix:nonFraction name="us-gaap:GainLossOnTerminationOfLease" contextRef="From2024-01-012024-09-30_custom_SettlementAgreementMember" id="Fact000881" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,000</ix:nonFraction></span> which includes the $<span id="xdx_90D_ecustom--LeaseSettlementExpense_c20240101__20240930__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember_ztKU1jVXs1V8" title="Lease settlement expense"><ix:nonFraction name="RIME:LeaseSettlementExpense" contextRef="From2024-01-012024-09-30_custom_SettlementAgreementMember" id="Fact000883" format="ixt:numdotdecimal" decimals="0" unitRef="USD">250,000</ix:nonFraction></span>
termination settlement expense. The net loss on early termination of the Lease Agreement was recorded as a component of operating expenses
in the accompanying condensed consolidated statements of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 82; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALGORHYTHM
                                            HOLDINGS, INC. and SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September
30, 2024 and 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Private
Placement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 22, 2024, the Company entered into a Securities Purchase Agreement (the &#8220;SPA&#8221;) with investors pursuant to which we
sold, in a private placement (the &#8220;Private Placement&#8221;), secured notes with an aggregate principal amount of $<span id="xdx_90A_eus-gaap--SecuredDebt_iI_c20241022__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zKfClgJze3ic" title="Secured note principal amount"><ix:nonFraction name="us-gaap:SecuredDebt" contextRef="AsOf2024-10-22_us-gaap_PrivatePlacementMember_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember" id="Fact000885" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,352,941</ix:nonFraction></span> (the
&#8220;Notes&#8221;), for cash proceeds of $<span id="xdx_903_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_c20241022__20241022__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z9OW4kOgoNOb" title="Proceeds from private placement"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2024-10-222024-10-22_us-gaap_PrivatePlacementMember_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember" id="Fact000887" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,000,000</ix:nonFraction></span>, net of original issue discount of $<span id="xdx_90D_ecustom--PrivatePlacementIssueDiscount_c20241022__20241022__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z2Pa41ldSTde" title="Private placement issue discount"><ix:nonFraction name="RIME:PrivatePlacementIssueDiscount" contextRef="From2024-10-222024-10-22_us-gaap_PrivatePlacementMember_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember" id="Fact000889" format="ixt:numdotdecimal" decimals="0" unitRef="USD">352,941</ix:nonFraction></span>. As consideration for entering into
the SPA, we issued a total of <span id="xdx_90C_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20241022__20241022__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_znpcyIVaHklf" title="Issuance of stock, shares"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2024-10-222024-10-22_us-gaap_PrivatePlacementMember_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember" id="Fact000891" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,299,998</ix:nonFraction></span> shares of common stock of the Company to the investors on October 24, 2024 (See Note 17).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Oxford
Credit Facility</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 28, 2024, the Company and Oxford Commercial Finance, a Michigan banking corporation, (referred to as &#8220;Oxford&#8221;) entered
into a Loan Agreement (the &#8220;Loan Agreement&#8221;) and related Revolving Credit Note (the &#8220;Note&#8221;) for a $<span id="xdx_907_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_c20240328__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_za8wH2smkprd" title="Revolving credit facility"><ix:nonFraction name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" contextRef="AsOf2024-03-28_us-gaap_RevolvingCreditFacilityMember_custom_LoanAgreementMember" id="Fact000893" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,000,000</ix:nonFraction></span>
revolving line of credit (the &#8220;Oxford Line of Credit&#8221;). On October 17, 2024, the Company terminated the Loan Agreement and
the Note. As of the date of termination, the Company had no outstanding amounts owed to Oxford and paid a termination fee of $<span id="xdx_90F_eus-gaap--LineOfCreditFacilityCommitmentFeeAmount_c20241017__20241017__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_z0YeidNVAw21" title="Credit facility termination fee"><ix:nonFraction name="us-gaap:LineOfCreditFacilityCommitmentFeeAmount" contextRef="From2024-10-172024-10-17_us-gaap_RevolvingCreditFacilityMember_us-gaap_SubsequentEventMember_custom_LoanAgreementMember" id="Fact000895" format="ixt:numdotdecimal" decimals="0" unitRef="USD">40,000</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Share
Repurchase</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 1, 2024, the Company entered into a Stock Repurchase Agreement (the &#8220;Repurchase Agreement&#8221;) with Regalia Ventures
LLC, a Delaware limited liability company (the &#8220;Seller&#8221;), pursuant to which the Company agreed to repurchase from the Seller
an aggregate of <span id="xdx_902_eus-gaap--CommonStockSharesIssued_iI_c20241101__us-gaap--TypeOfArrangementAxis__custom--StockRepurchaseAgreementMember_ziY17tqiNoAi" title="Shares issued"><span id="xdx_902_eus-gaap--CommonStockSharesOutstanding_iI_c20241101__us-gaap--TypeOfArrangementAxis__custom--StockRepurchaseAgreementMember_zA2Air1hO7Xl" title="Shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2024-11-01_custom_StockRepurchaseAgreementMember" id="Fact000897" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2024-11-01_custom_StockRepurchaseAgreementMember" id="Fact000899" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,098,901</ix:nonFraction></ix:nonFraction></span></span> issued and outstanding shares of common stock, par value $<span id="xdx_90C_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20241101__us-gaap--TypeOfArrangementAxis__custom--StockRepurchaseAgreementMember_zTpSErdqPVXh" title="Common stock, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2024-11-01_custom_StockRepurchaseAgreementMember" id="Fact000901" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.01</ix:nonFraction></span> per share, of the Company (the &#8220;Shares&#8221;).
Pursuant to the terms of the Repurchase Agreement, the Company has agreed to repurchase from the Seller, and the Seller has agreed to
sell, assign and transfer to the Company, all of the Seller&#8217;s right, title and interest in and to the Shares, at a price per Share
equal to the higher of: (1) the closing price of the common stock on the last trading day immediately preceding the date of the Repurchase
Agreement; or (2) the highest volume weighted average price (VWAP) of the common stock during a pricing period of ten (10) consecutive
trading days prior to the date of the Repurchase Agreement per share (the &#8220;Purchase Price&#8221;), and the Company shall issue
to the Seller a promissory note in the principal amount equal to the Purchase Price, substantially in the form attached to the Repurchase
Agreement as Exhibit A (the &#8220;Note&#8221;), and subject to terms and conditions therein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
shares of common stock to be repurchased were originally issued to the Seller on November 21, 2023, pursuant to a certain stock purchase
agreement, dated November 20, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the date of this filing, the repurchase of the shares has not yet closed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact000903" name="us-gaap:SubstantialDoubtAboutGoingConcernTextBlock"><p id="xdx_80A_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zySyMsRllmd3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
3 &#8211; <span id="xdx_82D_zcDEgntxp0m1">LIQUIDITY, GOING CONCERN AND MANAGEMENT PLANS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
previously reported on Form 8-K filed on August 30, 2024, on August 26, 2024, the Company received a notice from The Nasdaq Stock Market
LLC (&#8220;NASDAQ&#8221;) indicating that its stockholders&#8217; equity as reported in its Quarterly Report on Form 10-Q for the quarterly
period ended June 30, 2024 did not meet the minimum of $2,500,000 in stockholders&#8217; equity required by NASDAQ Listing Rule 5550(b)(1)
(the &#8220;Equity Rule&#8221;) for continued listing, or the alternatives of market value of listed securities or net income from continuing
operations. Pursuant to the Equity Rule, the Company submitted a plan to regain compliance with the Equity Rule.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 13, 2024, the Company filed a Form 8-K stating that it believed it regained compliance with the Equity Rule. As disclosed herein,
the Company reported stockholders&#8217; equity of approximately $<span id="xdx_906_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iI_pn5n6_c20240930_zRcLXPjwP0Ci" title="Stockholders equity"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-09-30" id="Fact000905" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">2.7</ix:nonFraction></span> million.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NASDAQ
has advised the Company that it will continue to monitor the Company&#8217;s ongoing compliance with the stockholders&#8217; equity requirement
and, if at the time of its next periodic report the Company does not evidence compliance, that it may be subject to delisting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 30, 2024, the Company had cash on hand of approximately $<span id="xdx_90A_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20240930_zizFOQSZoLX6" title="Cash and cash equivalents"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2024-09-30" id="Fact000907" format="ixt:numdotdecimal" decimals="0" unitRef="USD">621,000</ix:nonFraction></span> and deficit working capital of approximately $<span id="xdx_90D_ecustom--WorkingCapital_iI_c20240930_zWBiJaK42awj" title="Working capital deficit"><ix:nonFraction name="RIME:WorkingCapital" contextRef="AsOf2024-09-30" id="Fact000909" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,082,000</ix:nonFraction></span>
which is not sufficient to fund the Company&#8217;s planned operations through one year after the date the consolidated financial statements
are issued. The Company has a recent history of recurring operating losses and decreases in working capital. These factors create substantial
doubt about the Company&#8217;s ability to continue as a going concern for at least one year after the date that the Company&#8217;s
audited consolidated financial statements are issued.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
condensed consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue
as a going concern. Accordingly, the condensed consolidated financial statements have been prepared on a basis that assumes the Company
will continue as a going concern and which contemplates the realization of assets and satisfaction of liabilities and commitments in
the ordinary course of business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
intends to finance operations with future debt or equity financings, however, if and when such financings may occur are uncertain.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
making this assessment management performed a comprehensive analysis of the Company&#8217;s current circumstances including: its financial
position, cash flow and cash usage forecasts, and obligations and debts. Although management has a recent history of successful capital
raises, the analysis used to determine the Company&#8217;s ability as a going concern does not include cash sources outside the Company&#8217;s
direct control that management expects to be available within the next 12 months.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 83; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALGORHYTHM
                                            HOLDINGS, INC. and SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September
30, 2024 and 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact000911" name="us-gaap:SignificantAccountingPoliciesTextBlock"><p id="xdx_802_eus-gaap--SignificantAccountingPoliciesTextBlock_zmwiPQCXS7Pj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
4 - <span id="xdx_82D_zUCr37okDZFd">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact000913" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock"><p id="xdx_842_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_z0xqk8bzKQQg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_864_zfAZcd39HU79" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Basis
of Presentation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying unaudited financial statements for the three months ended September 30, 2024 and 2023 have been prepared in accordance with
accounting principles generally accepted in the United States of America (&#8220;US GAAP&#8221;) applicable to interim financial information
and the requirements of Form 10-Q and Article 8 of Regulation S-X of the Securities and Exchange Commission. Accordingly, they do not
include all of the information and disclosures required by US GAAP for complete consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">In the opinion of management, such
condensed consolidated financial statements include all adjustments (consisting of normal recurring accruals) necessary for the fair
presentation of the condensed consolidated financial position and the condensed consolidated results of operations. The condensed consolidated
results of operations for the periods presented are not necessarily indicative of the results to be expected for the full year. The condensed
consolidated balance sheet as of September 30, 2024 and condensed financial statements information for the three and nine months ended
September 30, 2024 and 2023 are unaudited whereas the condensed consolidated balance sheet as of December 31, 2023 is derived from the
audited consolidated balance sheet as of that date. The condensed consolidated financial statements and notes hereto should be read in
conjunction with the consolidated financial statements and notes thereto included in the Company&#8217;s annual report on Form 10-KT
for the transition period ended December 31, 2023. There have been no changes to our significant accounting policies as disclosed on
the Company&#8217;s annual report on Form 10-KT for the transition period ended December 31, 2023.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact000915" name="us-gaap:ConsolidationPolicyTextBlock"><p id="xdx_848_eus-gaap--ConsolidationPolicyTextBlock_zG652AMbDIuc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span id="xdx_863_zrdDkiVdw3gl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Principles
of Consolidation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company evaluates its business relationships with related parties to identify potential Variable Interest Entities (&#8220;VIEs&#8221;)
under Accounting Standards Codification (&#8220;ASC&#8221;) 810, Consolidation. The Company will consolidate any VIE in which it has
a controlling financial interest and is deemed to be the primary beneficiary. A controlling financial interest has both of the following
characteristics: (1) the power to direct the activities of the VIE that most significantly impact its economic performance; and (2) the
obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE
that could be significant to the VIE. If both characteristics are met, the Company is considered to be the primary beneficiary and therefore
will consolidate that VIE into its consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
prescribed by ASC 810, if the Company holds a variable interest in a VIE but is not the entity&#8217;s primary beneficiary, it shall
disclose its methodology for determining if the Company is the primary beneficiary of the VIE, e.g., significant judgments and assumptions
made. Additional information required includes information about the types of involvement considered significant, and those considered
in the determination of whether the reporting entity is the primary beneficiary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
if the Company provides or intends to provide financial or other support (explicitly or implicitly) to the VIE, when not contractually
required to, the Company shall disclose the type and amount of the support, along with the primary reasons for providing the support.
Both qualitative and quantitative information about the Company&#8217;s involvement with the VIE, shall include the nature, purpose,
size, and activities of the VIE, including how the VIE is financed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact000917" name="us-gaap:BusinessCombinationsPolicy"><p id="xdx_84D_eus-gaap--BusinessCombinationsPolicy_z8Zj4Utlqz7i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_86F_zifn80Cmun6f" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Business
Combinations</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company allocates the purchase price of an acquired business to the tangible and intangible assets acquired and liabilities assumed based
upon their estimated fair values on the acquisition date. Any excess of the purchase price over the fair value of the net assets acquired
is recorded as goodwill. The purchase price allocation process requires management to make significant estimates and assumptions at the
acquisition date with respect to intangible assets. The allocation of the consideration transferred in certain cases may be subject to
revision based on the final determination of fair values during the measurement period, which may be up to one year from the acquisition
date. Direct transaction costs associated with the business combination are expensed as incurred. The Company includes the results of
operations of the business that it has acquired in its consolidated results prospectively from the date of acquisition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact000919" name="us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock"><p id="xdx_841_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zvE70x651AHd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_86E_zdrnLExkCPR8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Goodwill</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company evaluates its goodwill for impairment in accordance with the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued
Accounting Standards Update (&#8220;ASU&#8221;) 350, <i>Intangibles &#8211; Goodwill and Other</i>. Goodwill is recorded when the purchase
price paid for an acquisition exceeds the estimated fair value of the net identified tangible and intangible assets acquired.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company tests the recorded amount of goodwill for impairment on an annual basis on December 31 or more frequently if there are indicators
that the carrying amount of the goodwill exceeds its carried value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact000921" name="us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy"><p id="xdx_845_eus-gaap--GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy_zcM29p0Vadpl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_867_zbvUCXbIw5xh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Intangible
Assets</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company acquired amortizable intangibles assets as part of asset purchase agreements consisting of customer relationships, trade names
and proprietary technology. Such intangibles are amortized over their useful lives on a straight-line basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company reviews intangible assets for impairment whenever events or changes in business circumstances indicate that the carrying amount
of the assets might not be recoverable. Factors that the Company considers in deciding when to perform an impairment review include significant
underperformance of the business in relation to expectations, significant negative industry or economic trends, and significant changes
or planned changes in the use of the assets. If an impairment review is performed to evaluate a long-lived asset for recoverability,
the Company compares forecasts of undiscounted cash flows expected to result from the use and eventual disposition of the long-lived
asset to its carrying value. An impairment loss would be recognized when estimated undiscounted future cash flows expected to result
from the use of an asset are less than its carrying amount. The impairment loss would be based on the excess of the carrying value of
the impaired asset over its fair value, determined based on discounted cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 84; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALGORHYTHM
                                            HOLDINGS, INC. and SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September
30, 2024 and 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact000923" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock"><p id="xdx_849_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_zopZkXAp8v6a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_86C_zixKQwzNxh5g" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Fair
Value Measurements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with ASC 820, Fair Value Measurements and Disclosures, fair value is defined as the exit price, or the amount that would be
received for the sale of an asset or paid to transfer a liability in an orderly transaction between market participants as of the measurement
date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
guidance also establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes
the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs include those that
market participants would use in valuing the asset or liability and are developed based on market data obtained from sources independent
of the Company. Unobservable inputs are inputs that reflect the Company&#8217;s assumptions about the factors that market participants
would use in valuing the asset or liability. The guidance establishes three levels of inputs that may be used to measure fair value:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
                                            1: Quoted market prices in active markets for identical assets or liabilities.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
                                            2: Inputs other than Level 1 that are observable, either directly or indirectly, such as
                                            quoted prices for similar assets or liabilities; quoted prices in markets that are not active;
                                            or model-derived valuations. All significant inputs used in the Company&#8217;s valuations
                                            are observable or can be derived principally from or corroborated with observable market
                                            data for substantially the full term of the assets or liabilities. Level 2 inputs also include
                                            quoted prices that were adjusted for security-specific restrictions which are compared to
                                            output from internally developed models such as a discounted cash flow model.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
                                            3: Unobservable inputs that are supported by little or no market activity and that are significant
                                            to the fair value of the assets or liabilities.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
carrying amounts of financial instruments carried at cost, including cash, accounts receivables and accounts and accounts receivable
&#8211; related party, trade payables advances and notes payables and notes payable &#8211; related party approximate their fair value
due to the short-term maturities of such instruments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
categorization of a financial instrument within the valuation hierarchy is based upon the lowest level of input that is significant to
the fair value measurement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact000925" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock"><p id="xdx_840_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zh67ficBlsJi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>R<span id="xdx_865_zefuG9EEAdg4">ECENT
ACCOUNTING PRONOUNCEMENTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
November 2023, the FASB issued ASU 2023-07, <i>Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures</i>, that
requires disclosure of significant segment expenses that are regularly reviewed by the chief operating decision maker and included within
each reported measure of segment profit or loss. The standard also requires disclosure of the composition of other segment items included
in the measure of segment profit or loss that are not separately disclosed. All disclosure requirements under ASU 2023-07 are also required
for public entities with a single reportable segment. The ASU is effective for the Company&#8217;s Annual Report on Form 10-K for the
year ended December 31, 2024, and subsequent interim periods, with early adoption permitted. The Company is currently evaluating the
impact of adopting this standard on our consolidated financial statements and related disclosures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 85; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALGORHYTHM
                                            HOLDINGS, INC. and SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September
30, 2024 and 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2023, the FASB issued ASU 2023-09, <i>Income Taxes (Topic 740): Improvements to Income Tax Disclosures</i>. ASU 2023-09 is intended
to enhance the usefulness of income tax disclosures by requiring entities to disclose specific rate reconciliations, amount of income
taxes separate by federal and individual tax jurisdictions, and the amount of income or loss from continuing operations before income
tax expense or benefit disaggregated between federal, state and foreign. ASU 2023-09 is effective for the Company for its fiscal year
beginning January 1, 2025, with early adoption permitted. The Company is currently evaluating the impact of adopting this standard on
our consolidated financial statements and related disclosures.</span></p>

</ix:nonNumeric><p id="xdx_856_zundEyYyi8e5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact000927" name="us-gaap:AssetAcquisitionTextBlock"><p id="xdx_80D_eus-gaap--AssetAcquisitionTextBlock_zMHVfCEgdIX6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
5 &#8211; <span id="xdx_827_zfEDbNuQdSbc">ASSET ACQUISITION</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 11, 2024, the Company and its wholly owned subsidiary SemiCab,LLC, SemiCab, Inc., Ajesh Kapoor and Vivek Sehgal entered into the
Asset Purchase Agreement pursuant to which the Seller agreed to sell and assign to the Company, and the Company agreed to purchase and
assume from the Seller, substantially all the assets, and certain specified liabilities relating to the business of the Seller.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white">The Company
decided to acquire SemiCab as part of a strategic plan to diversify its business and reduce its reliance solely on retail and consumer
electronics and strategically focus on growth. The acquisition fit the Company&#8217;s strategic decision to pivot to a holding company
structure.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 3, 2024, the parties completed the Asset Purchase Agreement whereby the Company issued to the Seller (i) <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesPurchaseOfAssets_c20240703__20240703__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember_z8gJnhFSCGJh" title="Shares purchase"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets" contextRef="From2024-07-032024-07-03_custom_AssetPurchaseAgreementMember" id="Fact000929" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">641,806</ix:nonFraction></span> shares of the Company&#8217;s
common stock with a value of approximately <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodValuePurchaseOfAssets_c20240703__20240703__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember_zkKseGqOtZG4" title="Purchase of assets value">$<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets" contextRef="From2024-07-032024-07-03_custom_AssetPurchaseAgreementMember" id="Fact000931" format="ixt:numdotdecimal" decimals="0" unitRef="USD">494,000</ix:nonFraction></span> (ii) a twenty percent (<span id="xdx_90E_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_uPure_c20240703__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SemiCabLLCMember_zWKLnN6wxobe" title="Membership percentage"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2024-07-03_custom_SemiCabLLCMember" id="Fact000933" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">20</ix:nonFraction>%</span>) membership interest in SemiCab LLC. (See Note 2).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the asset acquisition agreement, the Company and Seller entered into an option agreement (the &#8220;Option Agreement&#8221;), granting
the Buyer the right to acquire all of the issued and outstanding capital securities of SMCB Solutions Private Limited (&#8220;SMCB&#8221;),
a wholly owned subsidiary of the Seller, in consideration for <span id="xdx_90F_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20240703__20240703__us-gaap--AssetAcquisitionAxis__custom--SemiCabLLCMember_zKwvxynjL23g" title="Seller Consideration share"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2024-07-032024-07-03_custom_SemiCabLLCMember249477656" id="Fact000935" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">320,903</ix:nonFraction></span> shares of common stock of the Company. As of the date of this filing,
the Option Agreement expired unexercised.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the asset acquisition agreement, effective July 3, 2024, SemiCab, LLC entered into employment agreements (the &#8220;Agreements&#8221;)
with Ajesh Kapoor and Vivek Sehgal Kapoor&#8217;s agreement spans three years with an annual base salary of $<span id="xdx_903_eus-gaap--SalariesAndWages_c20240703__20240703__srt--StatementScenarioAxis__custom--TwoThousandTwentyFourMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementsMember_zlrl9eXOT6Yi" title="Salaries and wages"><ix:nonFraction name="us-gaap:SalariesAndWages" contextRef="From2024-07-032024-07-03_custom_TwoThousandTwentyFourMember_custom_AjeshKapoorMember_custom_EmploymentAgreementsMember" id="Fact000937" format="ixt:numdotdecimal" decimals="0" unitRef="USD">140,000</ix:nonFraction></span> for 2024, $<span id="xdx_90C_eus-gaap--SalariesAndWages_c20240703__20240703__srt--StatementScenarioAxis__custom--TwoThousandTwentyFiveMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementsMember_zQ3IT5o38E12" title="Salaries and wages"><ix:nonFraction name="us-gaap:SalariesAndWages" contextRef="From2024-07-032024-07-03_custom_TwoThousandTwentyFiveMember_custom_AjeshKapoorMember_custom_EmploymentAgreementsMember" id="Fact000939" format="ixt:numdotdecimal" decimals="0" unitRef="USD">240,000</ix:nonFraction></span>
for 2025, and $<span id="xdx_90E_eus-gaap--SalariesAndWages_c20240703__20240703__srt--StatementScenarioAxis__custom--SubsequentYearsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementsMember_zWLBx1Ospq0a" title="Salaries and wages"><ix:nonFraction name="us-gaap:SalariesAndWages" contextRef="From2024-07-032024-07-03_custom_SubsequentYearsMember_custom_AjeshKapoorMember_custom_EmploymentAgreementsMember" id="Fact000941" format="ixt:numdotdecimal" decimals="0" unitRef="USD">300,000</ix:nonFraction></span> for subsequent years, and Sehgal&#8217;s agreement also spans three years with an annual base salary of $<span id="xdx_906_eus-gaap--SalariesAndWages_c20240703__20240703__srt--StatementScenarioAxis__custom--TwoThousandTwentyFourMember__srt--TitleOfIndividualAxis__custom--VivekSehgalKapoorMember__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementsMember_zxuUVyJG3Mdg" title="Salaries and wages"><ix:nonFraction name="us-gaap:SalariesAndWages" contextRef="From2024-07-032024-07-03_custom_TwoThousandTwentyFourMember_custom_VivekSehgalKapoorMember_custom_EmploymentAgreementsMember" id="Fact000943" format="ixt:numdotdecimal" decimals="0" unitRef="USD">105,000</ix:nonFraction></span>
for 2024, $<span id="xdx_90A_eus-gaap--SalariesAndWages_c20240703__20240703__srt--StatementScenarioAxis__custom--TwoThousandTwentyFiveMember__srt--TitleOfIndividualAxis__custom--VivekSehgalKapoorMember__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementsMember_z8a3AnH52brc" title="Salaries and wages"><ix:nonFraction name="us-gaap:SalariesAndWages" contextRef="From2024-07-032024-07-03_custom_TwoThousandTwentyFiveMember_custom_VivekSehgalKapoorMember_custom_EmploymentAgreementsMember" id="Fact000945" format="ixt:numdotdecimal" decimals="0" unitRef="USD">210,000</ix:nonFraction></span> for 2025, $<span id="xdx_90A_eus-gaap--SalariesAndWages_c20240703__20240703__srt--StatementScenarioAxis__custom--TwoThousandTwentySixMember__srt--TitleOfIndividualAxis__custom--VivekSehgalKapoorMember__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementsMember_zbSowXnf3Axb" title="Salaries and wages"><ix:nonFraction name="us-gaap:SalariesAndWages" contextRef="From2024-07-032024-07-03_custom_TwoThousandTwentySixMember_custom_VivekSehgalKapoorMember_custom_EmploymentAgreementsMember" id="Fact000947" format="ixt:numdotdecimal" decimals="0" unitRef="USD">240,000</ix:nonFraction></span> for 2026, $<span id="xdx_907_eus-gaap--SalariesAndWages_c20240703__20240703__srt--StatementScenarioAxis__custom--TwoThousandTwentySevenMember__srt--TitleOfIndividualAxis__custom--VivekSehgalKapoorMember__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementsMember_zvK7JhFkJkt6" title="Salaries and wages"><ix:nonFraction name="us-gaap:SalariesAndWages" contextRef="From2024-07-032024-07-03_custom_TwoThousandTwentySevenMember_custom_VivekSehgalKapoorMember_custom_EmploymentAgreementsMember" id="Fact000949" format="ixt:numdotdecimal" decimals="0" unitRef="USD">270,000</ix:nonFraction></span> for 2027, and $<span id="xdx_90E_eus-gaap--SalariesAndWages_c20240703__20240703__srt--StatementScenarioAxis__custom--TwoThousandTwentyEightMember__srt--TitleOfIndividualAxis__custom--VivekSehgalKapoorMember__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementsMember_zd2IGkiq341k" title="Salaries and wages"><ix:nonFraction name="us-gaap:SalariesAndWages" contextRef="From2024-07-032024-07-03_custom_TwoThousandTwentyEightMember_custom_VivekSehgalKapoorMember_custom_EmploymentAgreementsMember" id="Fact000951" format="ixt:numdotdecimal" decimals="0" unitRef="USD">300,000</ix:nonFraction></span> for 2028. Both executives&#8217; salaries are subject
to annual review by the Board. They are eligible for annual performance-based bonuses contingent on specific goals set by the Board and
will participate in the 2022 Equity Incentive Plan, receiving annual equity issuances and cash-based incentives tied to revenue milestones.
Both are entitled to standard employee benefits, including health insurance and retirement plans.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 86; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALGORHYTHM
                                            HOLDINGS, INC. and SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September
30, 2024 and 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 3, 2024, the (&#8220;Acquisition Date&#8221;), the Company acquired substantially all the assets and assumed certain liabilities
of SemiCab, Inc. in exchange for the purchase price consideration of approximately $<span id="xdx_90F_eus-gaap--AssetAcquisitionConsiderationTransferred_c20240703__20240703__us-gaap--AssetAcquisitionAxis__custom--SemiCabIncMember_ztWenrSpEiKc" title="Asset acquisition purchase price consideration"><ix:nonFraction name="us-gaap:AssetAcquisitionConsiderationTransferred" contextRef="From2024-07-032024-07-03_custom_SemiCabIncMember" id="Fact000953" format="ixt:numdotdecimal" decimals="0" unitRef="USD">983,000</ix:nonFraction></span>. On July 3, 2024, the value of the total
identifiable intangible assets, including goodwill was approximately <span id="xdx_909_eus-gaap--IntangibleAssetsNetIncludingGoodwill_iI_c20240703_zGHnOvGlyX54" title="Identifiable intangible assets  including goodwill">$<ix:nonFraction name="us-gaap:IntangibleAssetsNetIncludingGoodwill" contextRef="AsOf2024-07-03" id="Fact000955" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,754,000</ix:nonFraction></span>, based on the restricted value of SMC common shares on
the date of acquisition. The Company also recognized non-controlling interest at fair value as of the Acquisition Date in the amount
of approximately $<span id="xdx_90B_ecustom--NonControllingInterestAtFairValue_c20240703__20240703_zI0pHU3nzsZ6" title="Non-controlling interest at fair value"><ix:nonFraction name="RIME:NonControllingInterestAtFairValue" contextRef="From2024-07-032024-07-03" id="Fact000957" format="ixt:numdotdecimal" decimals="0" unitRef="USD">74,000</ix:nonFraction></span> representing <span id="xdx_90C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20240703__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SemiCabIncMember_zqwasO0LjYX6" title="Ownership percentage"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2024-07-03_custom_SemiCabIncMember" id="Fact000959" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">20</ix:nonFraction></span>% ownership in SemiCab Holdings, LLC, which is <span id="xdx_90C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20240703__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlgorhythmHoldingsIncMember_z2rWftGzy9j5" title="Ownership percentage"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2024-07-03_custom_AlgorhythmHoldingsIncMember" id="Fact000961" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">80</ix:nonFraction></span>% owned by the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
trade names and developed technology intangible assets were valued using the relief-from-royalty method. The relief-from-royalty method
is one of the methods under the income approach wherein estimates of a company&#8217;s earnings attributable to the intangible asset
are based on the royalty rate the company would have paid for the use of the asset if it did not own it. Royalty payments are estimated
by applying royalty rates of <span id="xdx_90A_ecustom--RoyaltyRate_pid_dp_uPure_c20240703__20240703_zax9QlMBHA1l" title="Royalty rate"><ix:nonFraction name="RIME:RoyaltyRate" contextRef="From2024-07-032024-07-03" id="Fact000963" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.5</ix:nonFraction></span>% to the prospective revenue attributable to the intangible asset. The resulting net annual royalty payments
are then discounted to present value using a discount factor of <span id="xdx_90C_ecustom--DiscountOnRoyaltyRate_pid_dp_uPure_c20240703__20240703_zKVJtg7wctuf" title="Discount on royalty rate"><ix:nonFraction name="RIME:DiscountOnRoyaltyRate" contextRef="From2024-07-032024-07-03" id="Fact000965" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">33</ix:nonFraction></span>%, and the remaining economic life of <span id="xdx_90D_ecustom--RoyaltyTerm_dc_c20240703__20240703_zu7yRrIFFDMi" title="Royalty term"><ix:nonNumeric contextRef="From2024-07-032024-07-03" format="ixt-sec:durwordsen" id="Fact000967" name="RIME:RoyaltyTerm">nine years</ix:nonNumeric></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company determined an estimated fair value of customer relationships using multi-period excess earnings approach utilizing a discounted
cash flow methodology. The analysis included assumptions regarding the growth rate for the development of new businesses, concluding
between <span id="xdx_904_ecustom--GrowthRateOfDevelopmentOfNewBusiness_pid_dp_c20240703__20240703__srt--RangeAxis__srt--MinimumMember_zgz8ADQQa8oc" title="Growth rate of development of new business"><ix:nonFraction name="RIME:GrowthRateOfDevelopmentOfNewBusiness" contextRef="From2024-07-032024-07-03_srt_MinimumMember" id="Fact000969" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8</ix:nonFraction></span>% and <span id="xdx_901_ecustom--GrowthRateOfDevelopmentOfNewBusiness_pid_dp_c20240703__20240703__srt--RangeAxis__srt--MaximumMember_z6imzS83qoid" title="Growth rate of development of new business"><ix:nonFraction name="RIME:GrowthRateOfDevelopmentOfNewBusiness" contextRef="From2024-07-032024-07-03_srt_MaximumMember" id="Fact000971" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">20</ix:nonFraction></span>% organic growth rates for revenue attributable to existing customers. A discount rate of <span id="xdx_90B_ecustom--DiscountRateForWeightedAverageCost_pid_dp_c20240703__20240703_zdwxyxjh8GA5" title="Discount rate for weighted average cost"><ix:nonFraction name="RIME:DiscountRateForWeightedAverageCost" contextRef="From2024-07-032024-07-03" id="Fact000973" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">33</ix:nonFraction></span>% was used for the weighted
average cost of capital analysis, along with the evaluation of the capital expenditure requirements associated with any new initiatives
developed by SemiCab. The purchase accounting for this transaction is provisional and subject
to measurement period adjustments for one year following the date of acquisition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
valuations for the above intangible assets require use of unobservable inputs that are classified as Level 3 on the fair value hierarchy.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
goodwill resulting from this acquisition is tax deductible.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact000975" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"><p id="xdx_893_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_zqfSlXacSIQb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents the allocation of the consideration transferred to the assets acquired and liabilities assumed based on their
fair values:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span id="xdx_8B0_zqB8RjhO6SA" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE
OF CONSIDERATION TRANSFERRED TO THE ASSETS ACQUIRED AND LIABILITIES ASSUMED</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td title="Equity consideration" id="xdx_49E_20240703__us-gaap--BusinessAcquisitionAxis__custom--SemiCabIncMember_zh7pqoAcz5qf" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 74%; text-align: left">Equity consideration</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable_c20240703__20240703__us-gaap--AssetAcquisitionAxis__custom--SemiCabIncMember_zlLgWxDyscff" title="Equity consideration" style="font: 10pt Times New Roman, Times, Serif; width: 22%; text-align: right"><ix:nonFraction name="us-gaap:AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" contextRef="From2024-07-032024-07-03_custom_SemiCabIncMember" id="Fact000977" format="ixt:numdotdecimal" decimals="0" unitRef="USD">494,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">Fair value of non-controlling interest</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98E_ecustom--AssetAcquisitionFairValueOfNonControllingInterest_c20240703__20240703__us-gaap--AssetAcquisitionAxis__custom--SemiCabIncMember_z6LHfTO1zIf" title="Fair value of non-controlling interest" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:AssetAcquisitionFairValueOfNonControllingInterest" contextRef="From2024-07-032024-07-03_custom_SemiCabIncMember" id="Fact000979" format="ixt:numdotdecimal" decimals="0" unitRef="USD">74,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Total Equity Consideration</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--AssetAcquisitionConsiderationTransferredContingentConsideration_c20240703__20240703__us-gaap--AssetAcquisitionAxis__custom--SemiCabIncMember_zo7Ps31BOJhd" title="Total Equity Consideration" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AssetAcquisitionConsiderationTransferredContingentConsideration" contextRef="From2024-07-032024-07-03_custom_SemiCabIncMember" id="Fact000981" format="ixt:numdotdecimal" decimals="0" unitRef="USD">568,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Debt Extinguishment</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_981_ecustom--AssetAcquisitionDebtExtinguishment_c20240703__20240703__us-gaap--AssetAcquisitionAxis__custom--SemiCabIncMember_z02uvR7ZXrRk" title="Debt Extinguishment" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:AssetAcquisitionDebtExtinguishment" contextRef="From2024-07-032024-07-03_custom_SemiCabIncMember" id="Fact000983" format="ixt:numdotdecimal" decimals="0" unitRef="USD">415,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Total Consideration</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_980_eus-gaap--AssetAcquisitionConsiderationTransferred_c20240703__20240703__us-gaap--AssetAcquisitionAxis__custom--SemiCabIncMember_zlZrKZvXompg" title="Total consideration" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AssetAcquisitionConsiderationTransferred" contextRef="From2024-07-032024-07-03_custom_SemiCabIncMember" id="Fact000985" format="ixt:numdotdecimal" decimals="0" unitRef="USD">983,000</ix:nonFraction></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Identifiable net assets acquired:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_iI_ziB7iOrglvn" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Cash and Cash Equivalents</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" contextRef="AsOf2024-07-03_custom_SemiCabIncMember249477843" id="Fact000987" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_iI_zia4FpE3NQVc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accounts receivable</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" contextRef="AsOf2024-07-03_custom_SemiCabIncMember249477843" id="Fact000989" format="ixt:numdotdecimal" decimals="0" unitRef="USD">193,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_iI_zDAJcMob9pAd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Prepaid expenses and other current assets</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" contextRef="AsOf2024-07-03_custom_SemiCabIncMember249477843" id="Fact000991" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_zlTqy723kO5c" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Property and equipment, net</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" contextRef="AsOf2024-07-03_custom_SemiCabIncMember249477843" id="Fact000993" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_iI_z6siHi5SxsMl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Other Non-Current Operating Assets, Net</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" contextRef="AsOf2024-07-03_custom_SemiCabIncMember249477843" id="Fact000995" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCustomerRelationships_iI_zUWvmGbp32t3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Customer Relationships (<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlNJREVSQVRJT04gVFJBTlNGRVJSRUQgVE8gVEhFIEFTU0VUUyBBQ1FVSVJFRCBBTkQgTElBQklMSVRJRVMgQVNTVU1FRCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20240703__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zYg7VmAKamhf"><ix:nonNumeric contextRef="AsOf2024-07-03_us-gaap_CustomerRelationshipsMember" format="ixt-sec:duryear" id="Fact000998" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">9</ix:nonNumeric>
    </span>year estimated useful life)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCustomerRelationships" contextRef="AsOf2024-07-03_custom_SemiCabIncMember249477843" id="Fact000997" format="ixt:numdotdecimal" decimals="0" unitRef="USD">747,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradeName_iI_z7vJ6LJn72h6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Trade Name (<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlNJREVSQVRJT04gVFJBTlNGRVJSRUQgVE8gVEhFIEFTU0VUUyBBQ1FVSVJFRCBBTkQgTElBQklMSVRJRVMgQVNTVU1FRCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90F_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20240703__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_ziXcACBKrHC6"><ix:nonNumeric contextRef="AsOf2024-07-03_us-gaap_TradeNamesMember" format="ixt-sec:duryear" id="Fact001001" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">9</ix:nonNumeric>
    </span>year estimated useful life)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradeName" contextRef="AsOf2024-07-03_custom_SemiCabIncMember249477843" id="Fact001000" format="ixt:numdotdecimal" decimals="0" unitRef="USD">272,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDevelopedTechnology_iI_zUOYy8tjHF41" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Developed Technology (<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlNJREVSQVRJT04gVFJBTlNGRVJSRUQgVE8gVEhFIEFTU0VUUyBBQ1FVSVJFRCBBTkQgTElBQklMSVRJRVMgQVNTVU1FRCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20240703__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DevelopedTechnologyRightsMember_zCx5Qsd9yz8l"><ix:nonNumeric contextRef="AsOf2024-07-03_us-gaap_DevelopedTechnologyRightsMember" format="ixt-sec:duryear" id="Fact001004" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">6</ix:nonNumeric>
    </span>year estimated useful life)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDevelopedTechnology" contextRef="AsOf2024-07-03_custom_SemiCabIncMember249477843" id="Fact001003" format="ixt:numdotdecimal" decimals="0" unitRef="USD">381,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_iNI_di_zodX7BNLMoAd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accounts payable and accrued expenses</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" contextRef="AsOf2024-07-03_custom_SemiCabIncMember249477843" id="Fact001006" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,680,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_40B_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLoansPayable_iI_zMz2R2tKSr3l" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Loans payable Merchant Cash Advances (MCA)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="RIME:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLoansPayable" contextRef="AsOf2024-07-03_custom_SemiCabIncMember249477843" id="Fact001008" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">631,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_408_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt_iNI_di_zkoi1AVl10b8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Note payable</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt" contextRef="AsOf2024-07-03_custom_SemiCabIncMember249477843" id="Fact001010" format="ixt:numdotdecimal" decimals="0" unitRef="USD">50,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_404_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesNotesPayableRelatedParties_iI_znAEmC4h6vsj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Notes payable Related Parties</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="RIME:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesNotesPayableRelatedParties" contextRef="AsOf2024-07-03_custom_SemiCabIncMember249477843" id="Fact001012" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">650,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_400_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_z67ORAU3jxsf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Net assets acquired</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" contextRef="AsOf2024-07-03_custom_SemiCabIncMember249477843" id="Fact001014" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,371,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40E_eus-gaap--Goodwill_iI_z56M72yov2Yk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Estimated Goodwill</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2024-07-03_custom_SemiCabIncMember249477843" id="Fact001016" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,354,000</ix:nonFraction></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AF_zEtY1LGpkYD7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Pro
Forma Information</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
unaudited pro forma financial information below presents the effects of the Asset Purchase Agreement as though it had been completed
on January 1, 2023. The pro forma adjustments are derived from the historically reported transactions of the respective companies. The
pro forma results do not include anticipated combined effects or other expected benefits of the acquisition. The pro forma results for
the nine months ended September 30, 2024 and 2023 reflect the combined performance of the Company and the SemiCab business for that period.
The unaudited pro forma information is based on available data and certain assumptions that the Company believes are reasonable given
the circumstances. However, actual results may differ materially from the assumptions used in the accompanying unaudited pro forma financial
information. This selected unaudited pro forma condensed combined financial information is presented for illustrative purposes only and
is not intended to represent what the actual consolidated results of operations would have been had the acquisition date occurred on
January 1, 2023, nor does it attempt to forecast future consolidated results of operations.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<ix:exclude><!-- Field: Page; Sequence: 87; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>
<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALGORHYTHM
                                            HOLDINGS, INC. and SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September
30, 2024 and 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact001018" name="RIME:ScheduleOfProFormaFinancialInformationTableTextBlock"><p id="xdx_891_ecustom--ScheduleOfProFormaFinancialInformationTableTextBlock_zWwCnqTKNek9" style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="xdx_8BD_z3uB87DL9bu3" style="display: none">SCHEDULE
OF PRO FORMA FINANCIAL INFORMATION</span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_497_20240101__20240930_z3drDoyCCjZd" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_499_20230101__20230930_z71B4uIUAeLi" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Nine Months Ended</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">September
    30, 2024</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">September
    30, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--BusinessAcquisitionsProFormaRevenue_zGU55vatkVmd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left">Net revenue</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><ix:nonFraction name="us-gaap:BusinessAcquisitionsProFormaRevenue" contextRef="From2024-01-01to2024-09-30" id="Fact001020" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16,831,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><ix:nonFraction name="us-gaap:BusinessAcquisitionsProFormaRevenue" contextRef="From2023-01-012023-09-30" id="Fact001021" format="ixt:numdotdecimal" decimals="0" unitRef="USD">26,848,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax_zRTwvKp3syM2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Operating loss from continuing operations</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax" contextRef="From2024-01-01to2024-09-30" id="Fact001023" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">8,093,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax" contextRef="From2023-01-012023-09-30" id="Fact001024" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">6,187,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_400_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_zBIixXJD0Vvd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Net loss</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" contextRef="From2024-01-01to2024-09-30" id="Fact001026" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">8,451,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" contextRef="From2023-01-012023-09-30" id="Fact001027" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">7,164,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

</ix:nonNumeric><p id="xdx_8A3_zO5F9SgOmRfa" style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white">The pro forma results for
the nine months ended September 30, 2023, include a net increase in operating expenses of $<span id="xdx_904_eus-gaap--IncreaseDecreaseInOperatingCapital_c20230101__20230930_z4qK0CSlK5Mb" title="Increase decrease in operating capital"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOperatingCapital" contextRef="From2023-01-012023-09-30" id="Fact001029" format="ixt:numdotdecimal" decimals="0" unitRef="USD">265,000</ix:nonFraction></span>, consisting of legal and accounting
expenses of approximately $<span id="xdx_905_eus-gaap--LegalFees_c20230101__20230930_z6F1WhjiJy07" title="Legal fees"><ix:nonFraction name="us-gaap:LegalFees" contextRef="From2023-01-012023-09-30" id="Fact001031" format="ixt:numdotdecimal" decimals="0" unitRef="USD">215,000</ix:nonFraction></span>&#160;associated with the acquisition of SemiCab and $<span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20230101__20230930_zYDqUrqyMfye" title="Stock issued during period shares acquisitions"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" contextRef="From2023-01-012023-09-30" id="Fact001033" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">50,000</ix:nonFraction></span>&#160;in shares of SMC common stock issued
to Vivek Sehgal as sign-on bonus.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact001035" name="us-gaap:DebtDisclosureTextBlock"><p id="xdx_802_eus-gaap--DebtDisclosureTextBlock_z5HBU13PkCdh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
6 &#8211; <span id="xdx_82A_zC4jtxyBG7Zj">FINANCING</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Oxford
Credit Facility</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 28, 2024, the Company entered into a Loan and Security Agreement (the &#8220;Credit Agreement&#8221;) with Oxford Business Credit
&#8220;Oxford&#8221;), as Lender. The Credit Agreement established a secured asset-backed revolving credit facility which is comprised
of a maximum $<span id="xdx_900_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_c20240328__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_zbETZNnun2y5" title="Revolving credit facility"><ix:nonFraction name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" contextRef="AsOf2024-03-28_us-gaap_RevolvingCreditFacilityMember" id="Fact001037" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,000,000</ix:nonFraction></span> revolving credit facility (&#8220;Credit Facility&#8221;) (&#8220;Revolving Loan Cap&#8221;). Availability under
the Credit Facility is determined monthly by a borrowing base comprised of a percentage of eligible accounts receivable of the Borrowers.
The Company&#8217;s obligations under the Credit Agreement are secured by a continuing security interest in all property of each Loan
Party, subject to certain excluded collateral (as defined in the Credit Agreement). As of September 30, 2024, there was approximately
$<span id="xdx_901_eus-gaap--OtherReceivables_iI_c20240930__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zi86HMiOCY7e" title="Due from Oxford Bank"><ix:nonFraction name="us-gaap:OtherReceivables" contextRef="AsOf2024-09-30_us-gaap_RevolvingCreditFacilityMember_us-gaap_RelatedPartyMember" id="Fact001039" format="ixt:numdotdecimal" decimals="0" unitRef="USD">22,000</ix:nonFraction></span> due from Oxford for cash collections received that exceeded the amount due on the Credit Agreement. As of September 30, 2024,
there were <span id="xdx_909_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_do_c20240930__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_zD9v6RKE6xid" title="Revolving credit facility"><ix:nonFraction name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" contextRef="AsOf2024-09-30_us-gaap_RevolvingCreditFacilityMember" id="Fact001041" format="ixt-sec:numwordsen" decimals="0" unitRef="USD">no</ix:nonFraction></span> funds available for borrowing under the Credit Facility.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Borrowings
under the Credit Facility take the form of base rate loans at interest rates of the Wall Street Journal Prime Rate plus <span id="xdx_90E_eus-gaap--LineOfCreditFacilityInterestRateDuringPeriod_dp_uPure_c20240328__20240328__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_z8W9XVN6ZVR5" title="The Prime Rate"><ix:nonFraction name="us-gaap:LineOfCreditFacilityInterestRateDuringPeriod" contextRef="From2024-03-282024-03-28_us-gaap_RevolvingCreditFacilityMember" id="Fact001043" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">2.5</ix:nonFraction></span>%, but in
any event no less than <span id="xdx_906_eus-gaap--LineOfCreditFacilityInterestRateDuringPeriod_dp_uPure_c20240328__20240328__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember__srt--RangeAxis__srt--MaximumMember_z6rvZ1pGURj9" title="The Prime Rate"><ix:nonFraction name="us-gaap:LineOfCreditFacilityInterestRateDuringPeriod" contextRef="From2024-03-282024-03-28_us-gaap_RevolvingCreditFacilityMember_srt_MaximumMember" id="Fact001045" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10</ix:nonFraction></span>%. The Credit Agreement includes certain covenants which include, but are not limited to restrictions on debt,
asset liens, capital expenditures, formation of new entities and financial covenants. For the three and nine months ended September 30,
2024, the Company incurred interest expense of approximately $<span id="xdx_90B_eus-gaap--InterestExpenseDebt_c20240701__20240930__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_zjqw8BJS3Cn2" title="Interest expense"><ix:nonFraction name="us-gaap:InterestExpenseDebt" contextRef="From2024-07-012024-09-30_us-gaap_RevolvingCreditFacilityMember" id="Fact001047" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,000</ix:nonFraction></span> and $<span id="xdx_90C_eus-gaap--InterestExpenseDebt_c20240101__20240930__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_z5vOgQSpnoY3" title="Interest expense"><ix:nonFraction name="us-gaap:InterestExpenseDebt" contextRef="From2024-01-012024-09-30_us-gaap_RevolvingCreditFacilityMember" id="Fact001049" format="ixt:numdotdecimal" decimals="0" unitRef="USD">66,000</ix:nonFraction></span>, respectively associated with financing costs from the
Credit Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Credit Agreement is for a <span id="xdx_908_eus-gaap--DebtInstrumentTerm_dxL_c20240328__20240328__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_z0ojmNaeWUz1" title="Credit agreement term::XDX::P2Y"><span style="-sec-ix-hidden: xdx2ixbrl1051">two</span></span>-year term that expires on <span id="xdx_909_eus-gaap--LineOfCreditFacilityExpirationDate1_dd_c20240328__20240328__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_zFLDsF5PnHVf" title="Credit agreement expires"><ix:nonNumeric contextRef="From2024-03-282024-03-28_us-gaap_RevolvingCreditFacilityMember" format="ixt:datemonthdayyearen" id="Fact001053" name="us-gaap:LineOfCreditFacilityExpirationDate1">November 28, 2026</ix:nonNumeric></span>, and automatically renews for an additional one-year term on
each anniversary of date of the agreement unless the Company notifies Oxford within 60 days before the anniversary date of its intention
to pay off the Credit Facility and terminate the Credit Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is subject to a two percent (<span id="xdx_90B_ecustom--PercentageOfExitFee_dp_uPure_c20240328__20240328__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_z2MYsdzqnlW1" title="Percentage of exit fee"><ix:nonFraction name="RIME:PercentageOfExitFee" contextRef="From2024-03-282024-03-28_us-gaap_RevolvingCreditFacilityMember" id="Fact001055" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">2</ix:nonFraction></span>%) exit fee (&#8220;Exit Fee&#8221;) of the Revolving Loan Cap if the Company terminates the Credit
Agreement and repays the obligations under Credit Facility prior to the anniversary date of the Credit Agreement. The Exit Fee shall
automatically renew on the two-year anniversary date of the Loan Agreement for an additional one-year period unless the Company notifies
Lender in writing within sixty (60) days before such anniversary date of Borrower&#8217;s intention to pay off this Credit Facility and
terminate the Credit Agreement and all obligations of the Credit Facility are paid in full by such anniversary date. There were
no draws against the Credit Facility since inception of the Credit Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 17, 2024, the Company voluntarily terminated the Credit Agreement. Pursuant to the terms of the Credit Agreement the Company
was obligated to pay a $<span id="xdx_907_eus-gaap--BusinessExitCosts1_c20241017__20241017__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_zFX9RXPuMKRa" title="Exit fee payable on termination of contract"><ix:nonFraction name="us-gaap:BusinessExitCosts1" contextRef="From2024-10-172024-10-17_us-gaap_RevolvingCreditFacilityMember" id="Fact001057" format="ixt:numdotdecimal" decimals="0" unitRef="USD">40,000</ix:nonFraction></span> Exit Fee due to termination prior to the anniversary date of the Credit Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Fifth
Third Bank Asset-backed Revolving Credit Facility</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 14, 2022, the Company entered into a Loan and Security Agreement with Fifth Third Financial Corporation (the &#8220;Credit Agreement&#8221;),
as Lender, replacing the Company&#8217;s credit facilities with Crestmark and IHC that were terminated by the Company on October 13,
2022. The Credit Agreement established a secured asset-backed revolving credit facility which is comprised of a maximum $<span id="xdx_902_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_c20221014__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_zCqs92yslYxi"><ix:nonFraction name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" contextRef="AsOf2022-10-14_us-gaap_RevolvingCreditFacilityMember" id="Fact001058" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,000,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">revolving credit facility (&#8220;Credit
Facility&#8221;). The Credit Facility was terminated on <span id="xdx_904_eus-gaap--LineOfCreditFacilityExpirationDate1_dd_c20221014__20221014__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_zi3QhIbpTsqa"><ix:nonNumeric contextRef="From2022-10-142022-10-14_us-gaap_RevolvingCreditFacilityMember" format="ixt:datemonthdayyearen" id="Fact001059" name="us-gaap:LineOfCreditFacilityExpirationDate1">November
17, 2023</ix:nonNumeric></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. Availability under the Credit
Facility was determined monthly by a borrowing base comprised of a percentage of eligible accounts receivable and eligible inventory
of the Borrowers. The Company&#8217;s obligations under the Credit Agreement are secured by a continuing security interest in all property
of each Loan Party, subject to certain excluded collateral (as defined in the Credit Facility).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Costs
associated with closing of the Credit Agreement of approximately $<span id="xdx_905_eus-gaap--RepaymentsOfLinesOfCredit_c20221014__20221014__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_zn6BzuHVptCg" title="Costs associated with line of credit"><ix:nonFraction name="us-gaap:RepaymentsOfLinesOfCredit" contextRef="From2022-10-142022-10-14_us-gaap_RevolvingCreditFacilityMember" id="Fact001061" format="ixt:numdotdecimal" decimals="0" unitRef="USD">254,000</ix:nonFraction></span> were deferred and being amortized over life of the loan. During
the three months and nine months ended September 30, 2023 the Company incurred approximately $<span id="xdx_903_eus-gaap--AmortizationOfFinancingCosts_c20230701__20230930__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_zpJWNSfwFKE" title="Amortization of deferred financing costs"><ix:nonFraction name="us-gaap:AmortizationOfFinancingCosts" contextRef="From2023-07-012023-09-30_us-gaap_RevolvingCreditFacilityMember" id="Fact001063" format="ixt:numdotdecimal" decimals="0" unitRef="USD">21,000</ix:nonFraction></span> and $<span id="xdx_907_eus-gaap--AmortizationOfFinancingCosts_c20230101__20230930__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_zU2aQni4klSg" title="Amortization of deferred financing costs"><ix:nonFraction name="us-gaap:AmortizationOfFinancingCosts" contextRef="From2023-01-012023-09-30_us-gaap_RevolvingCreditFacilityMember" id="Fact001065" format="ixt:numdotdecimal" decimals="0" unitRef="USD">63,000</ix:nonFraction></span>, respectively associated
with the amortization of deferred financing costs from the Credit Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 88; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALGORHYTHM
                                            HOLDINGS, INC. and SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September
30, 2024 and 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Borrowings
under the Credit Facility took the form of base rate loans at interest rates of the greater of either <span id="xdx_90A_eus-gaap--LineOfCreditFacilityInterestRateDescription_c20221014__20221014__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_z1IGRS2yb2R1" title="Base rates of loan description"><ix:nonNumeric contextRef="From2022-10-142022-10-14_us-gaap_RevolvingCreditFacilityMember" id="Fact001067" name="us-gaap:LineOfCreditFacilityInterestRateDescription">(a) the Prime Rate plus 0.50% or (b) the Secured Overnight Financing Rate (&#8220;SOFR&#8221;) 30-day term rate plus 3%, subject to a minimum of 0.050% in either case.</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the three and nine months ended September 30, 2023, the Company incurred interest expense of approximately $<span id="xdx_903_eus-gaap--InterestAndDebtExpense_c20230701__20230930__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_zTkl2YOWpDY3" title="Interest expense"><ix:nonFraction name="us-gaap:InterestAndDebtExpense" contextRef="From2023-07-012023-09-30_us-gaap_RevolvingCreditFacilityMember" id="Fact001069" format="ixt:numdotdecimal" decimals="0" unitRef="USD">19,000</ix:nonFraction></span> and $<span id="xdx_903_eus-gaap--InterestAndDebtExpense_c20230101__20230930__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_zMatrRXg6Srd" title="Interest expense"><ix:nonFraction name="us-gaap:InterestAndDebtExpense" contextRef="From2023-01-012023-09-30_us-gaap_RevolvingCreditFacilityMember" id="Fact001071" format="ixt:numdotdecimal" decimals="0" unitRef="USD">59,000</ix:nonFraction></span> respectively,
associated with interest and financing costs from the Credit Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 19, 2023, the Company executed a Waiver and First Amendment agreement which provides for a waiver of previous defaults and instituted
new covenants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 30, 2023, the Company entered into a Waiver and Second Amendment (the &#8220;Revolving Loan Amendment&#8221;) to the Credit Agreement.
The Revolving Loan Amendment provides for, among other things, (i) a waiver of all known existing defaults under the Credit Agreement
as of the date of the Revolving Loan Amendment and (ii) the amendment of the definition of &#8220;Borrowing Base&#8221; to reduce from
$<span id="xdx_905_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_c20221014__us-gaap--CreditFacilityAxis__custom--RevolvingLoanAmendmentMember_zBTI0XrSvoJc" title="Revolving credit facility maximum amount"><ix:nonFraction name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" contextRef="AsOf2022-10-14_custom_RevolvingLoanAmendmentMember" id="Fact001073" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,000,000</ix:nonFraction></span> to $<span id="xdx_903_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_c20230830__us-gaap--CreditFacilityAxis__custom--RevolvingLoanAmendmentMember_zpT5JRSt3O43" title="Revolving credit facility maximum amount"><ix:nonFraction name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" contextRef="AsOf2023-08-30_custom_RevolvingLoanAmendmentMember" id="Fact001075" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,000,000</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 17, 2023, the Company voluntarily terminated the Credit Agreement as the Company could not comply with the debt coverage financial
covenant effective September 30, 2023. There was no balance outstanding on the credit agreement as of the termination date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Merchant
Cash Advance payable &#8211; Agile Capital Funding, LLC</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to the acquisition of SemiCab, the Company assumed a Merchant
Cash Advance (&#8220;MCA Financing&#8221;) payable with Agile Capital Funding, LLC (&#8220;Agile&#8221;). On
March 22, 2024, SemiCab entered into a MCA Financing agreement with Agile. The initial
amount borrowed was $<span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_iI_c20240322__us-gaap--ShortTermDebtTypeAxis__custom--AgileCapilalFundingllcMember_zVHMwas78f7j" title="Initial amount borrowed"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2024-03-22_custom_AgileCapilalFundingllcMember" id="Fact001077" format="ixt:numdotdecimal" decimals="0" unitRef="USD">315,000</ix:nonFraction></span>, with net proceeds to the Company in the amount of $<span id="xdx_902_eus-gaap--ProceedsFromShortTermDebt_c20240322__20240322__us-gaap--ShortTermDebtTypeAxis__custom--AgileCapilalFundingllcMember_zGhiRuXtUIEe" title="Net proceeds from short term debt"><ix:nonFraction name="us-gaap:ProceedsFromShortTermDebt" contextRef="From2024-03-222024-03-22_custom_AgileCapilalFundingllcMember" id="Fact001079" format="ixt:numdotdecimal" decimals="0" unitRef="USD">300,000</ix:nonFraction></span>. Repayment terms stipulate weekly payments in
the amount of $<span id="xdx_906_eus-gaap--DebtInstrumentPeriodicPayment_c20240322__20240322__us-gaap--ShortTermDebtTypeAxis__custom--AgileCapilalFundingllcMember_zyxbviYoc9R4" title="Stipulated periodic payment of short term debt"><ix:nonFraction name="us-gaap:DebtInstrumentPeriodicPayment" contextRef="From2024-03-222024-03-22_custom_AgileCapilalFundingllcMember" id="Fact001081" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16,200</ix:nonFraction></span> for weeks, for a total of $<span id="xdx_90B_eus-gaap--RepaymentsOfShortTermDebt_c20240322__20240322__us-gaap--ShortTermDebtTypeAxis__custom--AgileCapilalFundingllcMember_zy77m5cWfili" title="Total short term debt to be repaid"><ix:nonFraction name="us-gaap:RepaymentsOfShortTermDebt" contextRef="From2024-03-222024-03-22_custom_AgileCapilalFundingllcMember" id="Fact001083" format="ixt:numdotdecimal" decimals="0" unitRef="USD">453,600</ix:nonFraction></span> repaid. The effective interest rate for the borrowings is <span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_dp_c20240322__us-gaap--ShortTermDebtTypeAxis__custom--AgileCapilalFundingllcMember_ztwU3tLc9acj" title="Effective Interest rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" contextRef="AsOf2024-03-22_custom_AgileCapilalFundingllcMember" id="Fact001085" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">15</ix:nonFraction></span>%. As September
30, 2024 the amount due on this MCA Financing was approximately $<span id="xdx_905_eus-gaap--ShortTermBorrowings_iI_c20240930__us-gaap--ShortTermDebtTypeAxis__custom--AgileCapilalFundingllcMember_zMer59dkaotf" title="Amount outstanding for Agile Capital Funding,LLC"><ix:nonFraction name="us-gaap:ShortTermBorrowings" contextRef="AsOf2024-09-30_custom_AgileCapilalFundingllcMember" id="Fact001087" format="ixt:numdotdecimal" decimals="0" unitRef="USD">146,500</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Merchant
Cash Advance payable &#8211; Cedar Advance, LLC</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Pursuant to the acquisition of SemiCab, the Company assumed a MCA Financing
payable with Cedar Advance, LLC (&#8220;Cedar&#8221;). On
May 8, 2024, SemiCab entered into an MCA Financing with Cedar. The initial amount borrowed was $<span id="xdx_90C_eus-gaap--DebtInstrumentFaceAmount_iI_c20240508__us-gaap--ShortTermDebtTypeAxis__custom--CedarAdvancellcMember_zVO8oGJdlich" title="Initial amount borrowed"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2024-05-08_custom_CedarAdvancellcMember" id="Fact001089" format="ixt:numdotdecimal" decimals="0" unitRef="USD">215,000</ix:nonFraction></span>, with net proceeds
to the Company in the amount of $<span id="xdx_907_eus-gaap--ProceedsFromShortTermDebt_c20240508__20240508__us-gaap--ShortTermDebtTypeAxis__custom--CedarAdvancellcMember_z1Y9U30HxHM5" title="Net proceeds from short term debt"><ix:nonFraction name="us-gaap:ProceedsFromShortTermDebt" contextRef="From2024-05-082024-05-08_custom_CedarAdvancellcMember" id="Fact001091" format="ixt:numdotdecimal" decimals="0" unitRef="USD">204,250</ix:nonFraction></span>. Repayment terms stipulate weekly payments in the amount of $<span id="xdx_901_eus-gaap--DebtInstrumentPeriodicPayment_c20240508__20240508__us-gaap--ShortTermDebtTypeAxis__custom--CedarAdvancellcMember_z8OXvDjgdSck" title="Stipulated periodic payment of short term debt"><ix:nonFraction name="us-gaap:DebtInstrumentPeriodicPayment" contextRef="From2024-05-082024-05-08_custom_CedarAdvancellcMember" id="Fact001093" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,133</ix:nonFraction></span> for 28 weeks, for a total
of $<span id="xdx_90D_eus-gaap--RepaymentsOfShortTermDebt_c20240508__20240508__us-gaap--ShortTermDebtTypeAxis__custom--CedarAdvancellcMember_zVqczmkpevka" title="Total short term debt to be repaid"><ix:nonFraction name="us-gaap:RepaymentsOfShortTermDebt" contextRef="From2024-05-082024-05-08_custom_CedarAdvancellcMember" id="Fact001095" format="ixt:numdotdecimal" decimals="0" unitRef="USD">311,750</ix:nonFraction></span> repaid. The effective interest rate for the borrowings is <span id="xdx_908_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_dp_c20240508__us-gaap--ShortTermDebtTypeAxis__custom--CedarAdvancellcMember_zvO8TZuqnv12" title="Effective Interest rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" contextRef="AsOf2024-05-08_custom_CedarAdvancellcMember" id="Fact001097" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">18</ix:nonFraction></span>%. As September 30, 2024 the amount due on this MCA Financing
was approximately $<span id="xdx_90F_eus-gaap--ShortTermBorrowings_iI_c20240930__us-gaap--ShortTermDebtTypeAxis__custom--CedarAdvancellcMember_zCpVVaWuplol" title="Amount outstanding for Agile Capital Funding,LLC"><ix:nonFraction name="us-gaap:ShortTermBorrowings" contextRef="AsOf2024-09-30_custom_CedarAdvancellcMember" id="Fact001099" format="ixt:numdotdecimal" decimals="0" unitRef="USD">156,920</ix:nonFraction></span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Loan
Payable SemiCab Investor</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SemiCab
maintains a loan from a SemiCab investor in the amount of $<span id="xdx_90C_eus-gaap--DebtInstrumentFaceAmount_iI_c20240322__us-gaap--ShortTermDebtTypeAxis__custom--SemiCabInvestorMember_zZ0BzEWCRxDc" title="Initial amount borrowed"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2024-03-22_custom_SemiCabInvestorMember" id="Fact001101" format="ixt:numdotdecimal" decimals="0" unitRef="USD">50,000</ix:nonFraction></span>. The loan bears interest at <span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_dp_c20240322__us-gaap--ShortTermDebtTypeAxis__custom--SemiCabInvestorMember_ziiuETZmpLE4" title="Effective Interest rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" contextRef="AsOf2024-03-22_custom_SemiCabInvestorMember" id="Fact001103" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10</ix:nonFraction>%</span> per annum and matured on May 15, 2024
and is unsecured. As of September 30, 2024 the loan had not been paid and is in default. The principal amount due is recorded as a component
of notes payable on the accompanying condensed consolidated balance sheets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact001105" name="us-gaap:LongTermDebtTextBlock"><p id="xdx_808_eus-gaap--LongTermDebtTextBlock_zsaLNMlnhGfc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
7 &#8211; <span id="xdx_827_zR9yHGinEifc">LOANS PAYABLE &#8211; RELATED PARTIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SemiCab
maintains several outstanding affiliate loans from Ajesh Kapoor and Vivek Sehgal, (current employees and original founders of SemiCab)
initially issued by SemiCab Holdings LLC. The notes are unsecured. There was accrued interest payable is approximately $<span id="xdx_902_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20240930_zdbg0bp8AURb" title="Accrued interest payable"><ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2024-09-30" id="Fact001107" format="ixt:numdotdecimal" decimals="0" unitRef="USD">72,000</ix:nonFraction></span> that is
included as a component of accrued expenses on the accompanying condensed consolidated balance sheets. Interest expense on these related
party loans for the three and nine months ended September 30, 2024 was approximately $<span id="xdx_90C_eus-gaap--InterestExpense_c20240701__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zVow8c7l1kVh" title="Interest expense"><span id="xdx_907_eus-gaap--InterestExpense_c20240101__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zKf1wftrmuU8" title="Interest expense"><ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2024-07-012024-09-30_us-gaap_RelatedPartyMember" id="Fact001109" format="ixt:numdotdecimal" decimals="0" unitRef="USD"><ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2024-01-012024-09-30_us-gaap_RelatedPartyMember" id="Fact001111" format="ixt:numdotdecimal" decimals="0" unitRef="USD">28,000</ix:nonFraction></ix:nonFraction></span></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 89; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALGORHYTHM
                                            HOLDINGS, INC. and SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September
30, 2024 and 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact001113" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"><p id="xdx_89D_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_zNxrQIM0BEHi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
specific terms of each loan are summarized in the table below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BE_zZepzgZY38Uh" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE
OF LOAN</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">Issue</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">Maturity</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">Interest</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td colspan="2" id="xdx_49C_20240930_z8QaO2zgqSDi" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Holder</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Date</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Date</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Status</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Rate</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Principal</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 46%; text-align: left">Ajesh Kapoor</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: right"><span id="xdx_905_eus-gaap--DebtInstrumentIssuanceDate1_dd_c20240101__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorOneMember_zAbJ9Nu4bt79"><ix:nonNumeric contextRef="From2024-01-012024-09-30_custom_AjeshKapoorOneMember" format="ixt:datemonthdayyear" id="Fact001114" name="us-gaap:DebtInstrumentIssuanceDate1">7/10/2021</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: right"><span id="xdx_908_eus-gaap--DebtInstrumentMaturityDate_dd_c20240101__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorOneMember_zH86iwv0hNs3"><ix:nonNumeric contextRef="From2024-01-012024-09-30_custom_AjeshKapoorOneMember" format="ixt:datemonthdayyear" id="Fact001115" name="us-gaap:DebtInstrumentMaturityDate">7/10/2026</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 8%">Current</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: right"><span id="xdx_905_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorOneMember_zkzfROuvp3Sh"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2024-09-30_custom_AjeshKapoorOneMember" id="Fact001116" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">9.0</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--NotesPayable_iI_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorOneMember_zDGdI4auNRg3" title="Principal amount" style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: right"><ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2024-09-30_custom_AjeshKapoorOneMember" id="Fact001118" format="ixt:numdotdecimal" decimals="0" unitRef="USD">150,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Ajesh Kapoor</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_eus-gaap--DebtInstrumentIssuanceDate1_dd_c20240101__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorTwoMember_zHfH1bsvae54"><ix:nonNumeric contextRef="From2024-01-012024-09-30_custom_AjeshKapoorTwoMember" format="ixt:datemonthdayyear" id="Fact001119" name="us-gaap:DebtInstrumentIssuanceDate1">8/27/2021</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_eus-gaap--DebtInstrumentMaturityDate_dd_c20240101__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorTwoMember_zZWTAcVYM0Hd"><ix:nonNumeric contextRef="From2024-01-012024-09-30_custom_AjeshKapoorTwoMember" format="ixt:datemonthdayyear" id="Fact001120" name="us-gaap:DebtInstrumentMaturityDate">8/26/2026</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">Current</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorTwoMember_zSoqUWHGGesh"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2024-09-30_custom_AjeshKapoorTwoMember" id="Fact001121" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">9.0</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--NotesPayable_iI_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorTwoMember_zVF13JLSDoK5" title="Principal amount" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2024-09-30_custom_AjeshKapoorTwoMember" id="Fact001123" format="ixt:numdotdecimal" decimals="0" unitRef="USD">235,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Vivek Seghal</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_eus-gaap--DebtInstrumentIssuanceDate1_dd_c20240101__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--VivekSeghalMember_z2KzwxE1Ipwh"><ix:nonNumeric contextRef="From2024-01-012024-09-30_custom_VivekSeghalMember" format="ixt:datemonthdayyear" id="Fact001124" name="us-gaap:DebtInstrumentIssuanceDate1">4/17/2023</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_eus-gaap--DebtInstrumentMaturityDate_dd_c20240101__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--VivekSeghalMember_zpChU2QYiCFc"><ix:nonNumeric contextRef="From2024-01-012024-09-30_custom_VivekSeghalMember" format="ixt:datemonthdayyear" id="Fact001125" name="us-gaap:DebtInstrumentMaturityDate">10/13/2023</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">Default</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_903_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--VivekSeghalMember_zXuIk9wWnLo2"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2024-09-30_custom_VivekSeghalMember" id="Fact001126" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10.0</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--NotesPayable_iI_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--VivekSeghalMember_z5d53GLi5j8j" title="Principal amount" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2024-09-30_custom_VivekSeghalMember" id="Fact001128" format="ixt:numdotdecimal" decimals="0" unitRef="USD">50,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Ajesh Kapoor</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_903_eus-gaap--DebtInstrumentIssuanceDate1_dd_c20240101__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorThreeMember_zj6J3z4YGgq"><ix:nonNumeric contextRef="From2024-01-012024-09-30_custom_AjeshKapoorThreeMember" format="ixt:datemonthdayyear" id="Fact001129" name="us-gaap:DebtInstrumentIssuanceDate1">5/5/2023</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_eus-gaap--DebtInstrumentMaturityDate_dd_c20240101__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorThreeMember_zz0koCJcw2L1"><ix:nonNumeric contextRef="From2024-01-012024-09-30_custom_AjeshKapoorThreeMember" format="ixt:datemonthdayyear" id="Fact001130" name="us-gaap:DebtInstrumentMaturityDate">5/4/2024</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">Default</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorThreeMember_z0zCbAHnh0h4"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2024-09-30_custom_AjeshKapoorThreeMember" id="Fact001131" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10.0</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--NotesPayable_iI_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorThreeMember_zqlhKpIoJK0k" title="Principal amount" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2024-09-30_custom_AjeshKapoorThreeMember" id="Fact001133" format="ixt:numdotdecimal" decimals="0" unitRef="USD">50,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Ajesh Kapoor</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-bottom: 1pt"><span id="xdx_909_eus-gaap--DebtInstrumentIssuanceDate1_dd_c20240101__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorFourMember_zLCkZHT27tu6"><ix:nonNumeric contextRef="From2024-01-012024-09-30_custom_AjeshKapoorFourMember" format="ixt:datemonthdayyear" id="Fact001134" name="us-gaap:DebtInstrumentIssuanceDate1">5/17/2023</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-bottom: 1pt"><span id="xdx_90D_eus-gaap--DebtInstrumentMaturityDate_dd_c20240101__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorFourMember_zetEGTdpidX7"><ix:nonNumeric contextRef="From2024-01-012024-09-30_custom_AjeshKapoorFourMember" format="ixt:datemonthdayyear" id="Fact001135" name="us-gaap:DebtInstrumentMaturityDate">5/16/2024</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">Default</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"><span id="xdx_909_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorFourMember_zLiWcQbjnTma"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2024-09-30_custom_AjeshKapoorFourMember" id="Fact001136" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10.0</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--NotesPayable_iI_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorFourMember_zI3MWIBNpu4a" title="Principal amount" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2024-09-30_custom_AjeshKapoorFourMember" id="Fact001138" format="ixt:numdotdecimal" decimals="0" unitRef="USD">165,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--NotesPayable_iI_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zkSNxspZRSGi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">Amount due as of September 30, 2024</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2024-09-30_us-gaap_RelatedPartyMember" id="Fact001140" format="ixt:numdotdecimal" decimals="0" unitRef="USD">650,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--NotesPayableCurrent_iI_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zzTUD2zbYcS1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Less: Current portion of notes payable
    to related parties</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:NotesPayableCurrent" contextRef="AsOf2024-09-30_us-gaap_RelatedPartyMember" id="Fact001142" format="ixt:numdotdecimal" decimals="0" unitRef="USD">265,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--LongTermNotesPayable_iTI_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zbbTuKSJbwdg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">Notes payable
    to related parties, net of current portion</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:LongTermNotesPayable" contextRef="AsOf2024-09-30_us-gaap_RelatedPartyMember" id="Fact001144" format="ixt:numdotdecimal" decimals="0" unitRef="USD">385,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AC_zQshLb6Rbmlc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact001146" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock"><p id="xdx_806_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zKZ9TthlTebk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
8 - <span id="xdx_821_z6J69pwYLUc3">COMMITMENTS AND CONTINGENCIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Settlement
Agreement &#8211; Efficient Capital Labs, Inc</i>.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 18, 2023 SemiCab entered into a Installment Business Loan Agreement (&#8220;IBLA&#8221;) with a principal balance of $<span id="xdx_906_ecustom--WorkingCapital_c20230518_zoanr5wg0cw7" title="Working capital"><ix:nonFraction name="RIME:WorkingCapital" contextRef="AsOf2023-05-18" id="Fact001148" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,000,000</ix:nonFraction></span> with
Efficient Capital Labs, Inc. (&#8220;ECL&#8221;) to finance working capital and product development. The loan had a <span id="xdx_90D_eus-gaap--DebtInstrumentTerm_dtM_c20230518__20230518_zEbrhORQ7q53" title="Maturity date"><ix:nonNumeric contextRef="From2023-05-182023-05-18" format="ixt-sec:durmonth" id="Fact001150" name="us-gaap:DebtInstrumentTerm">12</ix:nonNumeric></span>-month maturity
date. Repayments were originally scheduled to begin in June 2023, in equal installments of $<span id="xdx_904_eus-gaap--RepaymentsOfDebt_c20230601__20240630_z1xMeZq6nSb5"><ix:nonFraction name="us-gaap:RepaymentsOfDebt" contextRef="From2023-06-012024-06-30" id="Fact001151" format="ixt:numdotdecimal" decimals="0" unitRef="USD">91,667</ix:nonFraction></span> for 13 months, with an interest rate
of <span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20230518_zAeVUxjjjha" title="Interest rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2023-05-18" id="Fact001153" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">17.97</ix:nonFraction></span>%. On May 18, 2024, SemiCab entered into a settlement agreement (&#8220;Settlement&#8221;) with ECL. The terms of repayment are
as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment:
Semicab shall pay to ECL the sum of $<span id="xdx_900_eus-gaap--LitigationSettlementExpense_c20240518__20240518__us-gaap--AwardTypeAxis__custom--SettlementSumMember_z9y9C5tjqpCj" title="Payments of litigation"><ix:nonFraction name="us-gaap:LitigationSettlementExpense" contextRef="From2024-05-182024-05-18_custom_SettlementSumMember" id="Fact001155" format="ixt:numdotdecimal" decimals="0" unitRef="USD">946,666</ix:nonFraction></span>USD (the &#8220;Settlement Sum&#8221;) as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
On or before May 20, 2024, Semicab shall pay ECL $<span id="xdx_90E_eus-gaap--LitigationSettlementExpense_pn2d_c20240520__20240520__us-gaap--AwardTypeAxis__custom--InitialPaymentMember_zIYh4DuuEbN" title="Payments of litigation"><ix:nonFraction name="us-gaap:LitigationSettlementExpense" contextRef="From2024-05-202024-05-20_custom_InitialPaymentMember" id="Fact001157" format="ixt:numdotdecimal" decimals="-2" unitRef="USD">25,000.00</ix:nonFraction></span> USD (the &#8220;Initial Payment&#8221;);</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
On or before June 3, 2024, Semicab shall pay ECL $<span id="xdx_902_eus-gaap--LitigationSettlementExpense_pn2d_c20240603__20240603__us-gaap--AwardTypeAxis__custom--SecondPaymentMember_zlZWQR4WNKkf" title="Payments of litigation"><ix:nonFraction name="us-gaap:LitigationSettlementExpense" contextRef="From2024-06-032024-06-03_custom_SecondPaymentMember" id="Fact001159" format="ixt:numdotdecimal" decimals="-2" unitRef="USD">75,000.00</ix:nonFraction></span> USD (the &#8220;Second Payment&#8221;);</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
On or before the first business day of each of the following ten (10) calendar months, starting July 1, 2024 Semicab shall pay ECL $<span id="xdx_907_eus-gaap--LitigationSettlementExpense_c20240701__20250430__us-gaap--AwardTypeAxis__custom--AdditionalPaymentMember_zusq0o76wl5b" title="Payments of litigation"><ix:nonFraction name="us-gaap:LitigationSettlementExpense" contextRef="From2024-07-012025-04-30_custom_AdditionalPaymentMember" id="Fact001161" format="ixt:numdotdecimal" decimals="0" unitRef="USD">84,666</ix:nonFraction></span>
USD (the &#8220;Additional Payments,&#8221; and each an &#8220;Additional Payment&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 30, 2024 the amount payable on the Settlement is $<span id="xdx_90B_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_iI_c20240930_zWPg9hqGCcAd" title="Settlement amount payable"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrentAndNoncurrent" contextRef="AsOf2024-09-30" id="Fact001163" format="ixt:numdotdecimal" decimals="0" unitRef="USD">578,917</ix:nonFraction></span> and recorded as a component accrued expenses on the accompanying
condensed consolidated balance sheets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Blue
Yonder, Inc. Lawsuit</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the asset purchase agreement with SemiCab, the Company assumed a judgement against SemiCab regarding damages resulting from contract
breach for IT subscription-based services. On March 28, 2020, SemiCab entered into a service contract and agreement with Blue Yonder,
Inc. (&#8220;Blue Yonder&#8221;) for certain IT subscription-based services. The original term of the agreement was for three years,
at a price of $<span id="xdx_90D_ecustom--LossContingencyEstimateOfPossibleLossPerYear_iI_c20200328__dei--LegalEntityAxis__custom--BlueYonderIncMember_zi0JtbEYp8G" title="Loss contingency estimate of possible loss per year"><ix:nonFraction name="RIME:LossContingencyEstimateOfPossibleLossPerYear" contextRef="AsOf2020-03-28_custom_BlueYonderIncMember" id="Fact001165" format="ixt:numdotdecimal" decimals="0" unitRef="USD">100,000</ix:nonFraction></span> per year, for a total of $<span id="xdx_90A_eus-gaap--LossContingencyEstimateOfPossibleLoss_iI_c20200328__dei--LegalEntityAxis__custom--BlueYonderIncMember_zjWKWP9m8Fli" title="Loss contingency estimate of possible loss value"><ix:nonFraction name="us-gaap:LossContingencyEstimateOfPossibleLoss" contextRef="AsOf2020-03-28_custom_BlueYonderIncMember" id="Fact001167" format="ixt:numdotdecimal" decimals="0" unitRef="USD">300,000</ix:nonFraction></span>. On June 21, 2023, Blue Yonder filed a lawsuit claiming damages in the
amount of $<span id="xdx_907_eus-gaap--LossContingencyDamagesSoughtValue_c20230621__20230621__dei--LegalEntityAxis__custom--BlueYonderIncMember_zBZ9PN4w1q26" title="Lawsuit claiming damages in the amount"><ix:nonFraction name="us-gaap:LossContingencyDamagesSoughtValue" contextRef="From2023-06-212023-06-21_custom_BlueYonderIncMember" id="Fact001169" format="ixt:numdotdecimal" decimals="0" unitRef="USD">275,000</ix:nonFraction></span> with the Maricopa County Superior Court in Arizona (&#8220;Lawsuit&#8221;). The suit was found in favor of Blue Yonder
in the amount of $<span id="xdx_90A_eus-gaap--LossContingencyDamagesAwardedValue_c20230621__20230621__dei--LegalEntityAxis__custom--BlueYonderIncMember_zeNSsGDcrRMd" title="Milestone payments"><ix:nonFraction name="us-gaap:LossContingencyDamagesAwardedValue" contextRef="From2023-06-212023-06-21_custom_BlueYonderIncMember" id="Fact001171" format="ixt:numdotdecimal" decimals="0" unitRef="USD">509,119</ix:nonFraction></span>, subject to two separate milestone payments that would otherwise deem the entire balance due satisfied if either
milestone payment is made by the Company. The first milestone payment for $<span id="xdx_90D_eus-gaap--LossContingencyDamagesPaidValue_c20240701__20240701__dei--LegalEntityAxis__custom--BlueYonderIncMember_zFqEklauQcY4" title="First milestone payment"><ix:nonFraction name="us-gaap:LossContingencyDamagesPaidValue" contextRef="From2024-07-012024-07-01_custom_BlueYonderIncMember" id="Fact001173" format="ixt:numdotdecimal" decimals="0" unitRef="USD">175,000</ix:nonFraction></span> and was due on July 1, 2024 and was not made.
In the event this payment is made, the remaining settlement shall be deemed satisfied. If this payment is not made, the Company shall
owe a total of $<span id="xdx_900_eus-gaap--LossContingencyDamagesAwardedValue_c20241001__20241001__dei--LegalEntityAxis__custom--BlueYonderIncMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z28PkGYqoi01" title="Remaining settlement amount"><ix:nonFraction name="us-gaap:LossContingencyDamagesAwardedValue" contextRef="From2024-10-012024-10-01_custom_BlueYonderIncMember_us-gaap_SubsequentEventMember" id="Fact001175" format="ixt:numdotdecimal" decimals="0" unitRef="USD">225,000</ix:nonFraction></span> by October 1, 2024. In the event this payment is made, the remaining settlement shall be deemed satisfied. If
neither payment is made, Blue Yonder shall be entitled to execute the full $<span id="xdx_901_eus-gaap--LossContingencyDamagesAwardedValue_c20250101__20250101__dei--LegalEntityAxis__custom--BlueYonderIncMember__srt--StatementScenarioAxis__srt--ScenarioForecastMember_z01y7RtbvXn6" title="Loss contingency damages awarded value"><ix:nonFraction name="us-gaap:LossContingencyDamagesAwardedValue" contextRef="From2025-01-012025-01-01_custom_BlueYonderIncMember_srt_ScenarioForecastMember" id="Fact001177" format="ixt:numdotdecimal" decimals="0" unitRef="USD">509,119</ix:nonFraction></span> beginning January 1, 2025. As of the date of this
filing, none of the scheduled payments have been made. A liability of $<span id="xdx_906_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_iI_c20240930__dei--LegalEntityAxis__custom--BlueYonderIncMember_z0Yw3fRw2GBa" title="Component of accrued expenses"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrentAndNoncurrent" contextRef="AsOf2024-09-30_custom_BlueYonderIncMember" id="Fact001179" format="ixt:numdotdecimal" decimals="0" unitRef="USD">509,119</ix:nonFraction></span> has been recorded as a component of accrued expenses on
the accompanying condensed consolidated balance sheets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 90; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALGORHYTHM
                                            HOLDINGS, INC. and SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September
30, 2024 and 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Derivative
Action</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 21, 2023, Ault Lending, LLC, a wholly owned subsidiary of Ault Alliance, Inc. (&#8220;Ault&#8221;), one of the Company&#8217;s
largest shareholders, filed a derivative shareholder action in Delaware Chancery Court against the Company, its Directors, and other
Company shareholders (The Stingray Group, Inc. and Regalia Ventures) (&#8220;the Defendants&#8221;) for alleged breach of fiduciary duty
in approving a recent above-market private placement equity transaction. The complaint alleges the Company, and its directors followed
an inadequate process in evaluating the private placement transaction which occurred back in November 2023 and entered into the transaction
with an intent to dilute Ault&#8217;s ownership stake in the Company. The Company filed a motion to dismiss the complaint. Based on the
Company&#8217;s assessment of the facts underlying the claims, the uncertainty of the litigation and the preliminary stage of the case,
the Company cannot reasonably estimate the potential loss or range of loss that may result from this action.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is involved in litigation arising from other matters in the ordinary course of business. The Company is subject to claims, suits
and other proceedings that could result in fines, civil penalties, or other adverse consequences. The Company records a liability when
it believes that it is probable that a loss has been incurred and the amount can be reasonably estimated. If the Company determines that
a loss is reasonably possible and the loss or range of loss can be estimated, the Company discloses the reasonably possible loss. The
Company evaluates developments in its legal matters that could affect the amount of liability that has been previously accrued, and the
matters and related reasonably possible losses disclosed, and makes adjustments as appropriate. Significant judgment is required to determine
both likelihood of there being and the estimated amount of a loss related to such matters.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact001181" name="us-gaap:LesseeOperatingLeasesTextBlock"><p id="xdx_802_eus-gaap--LesseeOperatingLeasesTextBlock_zOlnHNjODPwi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
9 &#8211; <span id="xdx_827_zbQZ3ywRu1gc">OPERATING LEASES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the time of this filing, the Company has operating lease agreements for offices in Florida and Hong Kong.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company entered into an operating lease agreement, effective October 1, 2017, for our corporate headquarters located in Fort Lauderdale,
Florida where we lease approximately <span id="xdx_901_eus-gaap--AreaOfLand_iI_pid_usqft_c20171001__us-gaap--TypeOfArrangementAxis__custom--OperatingLeaseAgreementMember_zZQ9CI6QWpqh" title="Lease space"><ix:nonFraction name="us-gaap:AreaOfLand" contextRef="AsOf2017-10-01_custom_OperatingLeaseAgreementMember" id="Fact001183" format="ixt:numdotdecimal" decimals="INF" unitRef="sqft">6,500</ix:nonFraction></span> square feet of office space which expired on <span id="xdx_904_eus-gaap--LeaseExpirationDate1_dd_c20171001__20171001__us-gaap--TypeOfArrangementAxis__custom--OperatingLeaseAgreementMember_z3llofSlHtEh" title="Lease expiration, date"><ix:nonNumeric contextRef="From2017-10-012017-10-01_custom_OperatingLeaseAgreementMember" format="ixt:datemonthdayyearen" id="Fact001185" name="us-gaap:LeaseExpirationDate1">March 31, 2024</ix:nonNumeric></span>. On February 22, 2024, <span id="xdx_901_eus-gaap--LesseeOperatingLeaseOptionToExtend_c20240222__20240222__us-gaap--TypeOfArrangementAxis__custom--OperatingLeaseAgreementMember_zx0EQbpNl5J" title="Lease extension, description"><ix:nonNumeric contextRef="From2024-02-222024-02-22_custom_OperatingLeaseAgreementMember" id="Fact001187" name="us-gaap:LesseeOperatingLeaseOptionToExtend">the Company
executed a lease extension for 14 months effective April 1, 2024, and expires on May 31, 2025. The base rent on the extension is approximately
$10,000 per month subject to a 3% annual adjustment.</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company entered into an operating lease on August 23, 2023, for approximately <span id="xdx_904_eus-gaap--AreaOfLand_iI_pid_usqft_c20230823__us-gaap--TypeOfArrangementAxis__custom--OperatingLeaseAgreementMember_zP3fgZuw8Tfa" title="Lease space"><ix:nonFraction name="us-gaap:AreaOfLand" contextRef="AsOf2023-08-23_custom_OperatingLeaseAgreementMember" id="Fact001189" format="ixt:numdotdecimal" decimals="INF" unitRef="sqft">10,000</ix:nonFraction></span> square feet of ground floor retail space and a portion
of the basement underneath the ground floor retail space. During the nine months ended September 30, 2024, the Company abandoned its
plans to continue use of the leased space. On September 25, 2024, the Company entered into a Settlement Agreement for a full release
and termination of the Lease Agreement in exchange for Company&#8217;s payment of $<span id="xdx_909_eus-gaap--OperatingLeasePayments_c20240925__20240925__us-gaap--TypeOfArrangementAxis__custom--OperatingLeaseAgreementMember_zkvfwxkBMgvh" title="Operating lease payments"><ix:nonFraction name="us-gaap:OperatingLeasePayments" contextRef="From2024-09-252024-09-25_custom_OperatingLeaseAgreementMember" id="Fact001191" format="ixt:numdotdecimal" decimals="0" unitRef="USD">250,000</ix:nonFraction></span>. (See Note 2).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact001193" name="RIME:ScheduleOfSupplementalInformationRelatedToLeaseTableTextBlock"><p id="xdx_895_ecustom--ScheduleOfSupplementalInformationRelatedToLeaseTableTextBlock_zF3exgsWDJJa" style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Supplemental
balance sheet information related to leases as of September 30, 2024 and December 31, 2023 is as follows:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span><span id="xdx_8B8_zcEQMBbha7gg" style="display: none">SCHEDULE
OF SUPPLEMENTAL INFORMATION RELATED TO LEASES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;&#160;</b>&#160;<b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">Assets:</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20240930_zhpj8U3NHW9g" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">September
    30, 2024</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49C_20231231_zVjcjeS3yFkb" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">December
    31, 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pp0p0_zTnGXcLX8Yab" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left">Operating lease - right-of-use assets</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2024-09-30" id="Fact001195" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">137,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2023-12-31" id="Fact001196" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,926,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--OperatingLeaseLiabilityAbstract_iB_zcnf2xz6jF33" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif">Liabilities</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">Current</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--OperatingLeaseLiabilityCurrent_i01I_pp0p0_zlNcwoHuOZt9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt">Current portion of operating leases</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2024-09-30" id="Fact001201" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">135,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2023-12-31" id="Fact001202" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">84,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--OperatingLeaseLiabilityNoncurrent_i01I_pp0p0_zaOP6csvSWB2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt">Operating lease liabilities, net of
    current portion</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1204">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2023-12-31" id="Fact001205" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,925,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AD_z3JWMDPUr4Lf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact001207" name="us-gaap:LeaseCostTableTextBlock"><p id="xdx_89F_eus-gaap--LeaseCostTableTextBlock_z1pV0GUJUfB1" style="font: bold 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt">Supplemental
statement of operations information related to operating leases is as follows:</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B6_zif9s7e8i4Od" style="display: none">SCHEDULE
OF LEASE TERM AND DISCOUNT RATE</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_490_20240701__20240930_zIaWt9EvW5ea" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Three
    Months Ended September 30, 2024</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20230701__20230930_zkOg9rK0SLy4" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Three
    Months Ended September 30, 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_497_20240101__20240930_zXlYiL5chsM5" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Nine
    Months Ended September 30, 2024</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20230101__20230930_zwFIrEm7eQNk" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Nine
    Months Ended September 30, 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--OperatingLeaseExpense_zMgjefZg42ab" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 44%; text-align: left">Operating lease expense as a component of general
    and administrative expenses</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseExpense" contextRef="From2024-07-012024-09-30" id="Fact001209" format="ixt:numdotdecimal" decimals="0" unitRef="USD">45,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseExpense" contextRef="From2023-07-012023-09-30" id="Fact001210" format="ixt:numdotdecimal" decimals="0" unitRef="USD">279,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseExpense" contextRef="From2024-01-01to2024-09-30" id="Fact001211" format="ixt:numdotdecimal" decimals="0" unitRef="USD">444,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseExpense" contextRef="From2023-01-012023-09-30" id="Fact001212" format="ixt:numdotdecimal" decimals="0" unitRef="USD">762,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--CashFlowOperatingActivitiesLesseeAbstract_iB_zi0QkZuopnX1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Supplemental cash flow information related to operating
    leases is as follows:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Cash paid for amounts included in the measurement of lease
    liabilities:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--OperatingLeasePayments_i01_zlWk7e7NPjg1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt">Operating cash flow paid for operating
    leases</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeasePayments" contextRef="From2024-07-012024-09-30" id="Fact001219" format="ixt:numdotdecimal" decimals="0" unitRef="USD">45,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeasePayments" contextRef="From2023-07-012023-09-30" id="Fact001220" format="ixt:numdotdecimal" decimals="0" unitRef="USD">363,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeasePayments" contextRef="From2024-01-01to2024-09-30" id="Fact001221" format="ixt:numdotdecimal" decimals="0" unitRef="USD">136,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeasePayments" contextRef="From2023-01-012023-09-30" id="Fact001222" format="ixt:numdotdecimal" decimals="0" unitRef="USD">868,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--LeaseCostAbstract_iB_zVeWmJne5YQ6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Lease term and Discount Rate</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt">Weighted average remaining lease term
    (years)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_i01I_dtY_c20240930_zRklYVwN8Rk4" title="Weighted average remaining lease term (months)" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonNumeric contextRef="AsOf2024-09-30" format="ixt-sec:duryear" id="Fact001229" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1">0.8</ix:nonNumeric></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_i01I_dtY_c20230930_zctYiIdy9umd" title="Weighted average remaining lease term (months)" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonNumeric contextRef="AsOf2023-09-30" format="ixt-sec:duryear" id="Fact001231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1">15.1</ix:nonNumeric></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">Weighted average discount rate</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_i01I_dp_uPure_c20240930_zoascLyeW4fc" title="Weighted average discount rate" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" contextRef="AsOf2024-09-30" id="Fact001233" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">9.0</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_i01I_dp_uPure_c20230930_zhUaArmGSe5l" title="Weighted average discount rate" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" contextRef="AsOf2023-09-30" id="Fact001235" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">12.0</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AC_zAoXCi3OAC8b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 91; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALGORHYTHM
                                            HOLDINGS, INC. and SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September
30, 2024 and 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact001237" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock"><p id="xdx_89D_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_z0VHfRfhtwL4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Minimum
future payments under all operating leases as of September 30, 2024, are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b><span id="xdx_8BC_zcqX8rDCZpgj" style="display: none">SCHEDULE
OF OPERATING LEASE MINIMUM FUTURE PAYMENTS</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Payments due by period</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_497_20240930_zHKj1Dre9ynh" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Amount</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_iI_maLOLLPzbAO_zQ6I9RaOBx82" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 80%">2024 (remaining six months)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" contextRef="AsOf2024-09-30" id="Fact001239" format="ixt:numdotdecimal" decimals="0" unitRef="USD">46,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_maLOLLPzbAO_zrNYz1Se4UA" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">2025</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" contextRef="AsOf2024-09-30" id="Fact001241" format="ixt:numdotdecimal" decimals="0" unitRef="USD">94,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_mtLOLLPzbAO_zRAFXg7raWI5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Total minimum future payments</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" contextRef="AsOf2024-09-30" id="Fact001243" format="ixt:numdotdecimal" decimals="0" unitRef="USD">140,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iI_zVxOUgnXjOb2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Less: Interest</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" contextRef="AsOf2024-09-30" id="Fact001245" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--OperatingLeaseLiability_iI_zRgxvCoHTA8e" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">Total operating
    lease liabilities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2024-09-30" id="Fact001247" format="ixt:numdotdecimal" decimals="0" unitRef="USD">135,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A1_zVBIIm1h7ry1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact001249" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock"><p id="xdx_80E_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zG6alrsOQtU9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
10 &#8211; <span id="xdx_824_z8pagMj79AEl">ISSUANCE OF COMMON STOCK</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Equity
Incentive Plan</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 12, 2022, the Board of Directors approved The Singing Machine Company, Inc. 2022 Equity Incentive Plan, or the 2022 Plan. The 2022
Plan provides for the issuance of equity incentive awards, such as stock options, stock appreciation rights, stock awards, restricted
stock, stock units, performance awards and other stock or cash-based awards collectively, the &#8220;Awards.&#8221; Awards may be granted
under the 2022 Plan to the Company&#8217;s employees, officers, directors, consultants, agents, advisors and independent contractors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
were <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20240101__20240930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zisABCkgWfN5" title="Share base compensation issued shares"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20240701__20240930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zYmZnZZSrlZa" title="Share base compensation issued shares"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" contextRef="From2024-01-012024-09-30_custom_TwoThousandTwentyTwoPlanMember" id="Fact001251" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" contextRef="From2024-07-012024-09-30_custom_TwoThousandTwentyTwoPlanMember" id="Fact001253" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">150,943</ix:nonFraction></ix:nonFraction></span></span>
share base compensation awards issued under the 2022 Plan during the three and nine months ended September 30, 2024 with a weighted average grant date fair value of $<span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20240701__20240930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zWCjtrAmtrV4" title="Weighted average grant date fair value"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20240101__20240930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zC5QGhT1F8Jl" title="Weighted average grant date fair value"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2024-07-012024-09-30_custom_TwoThousandTwentyTwoPlanMember" id="Fact001255" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2024-01-012024-09-30_custom_TwoThousandTwentyTwoPlanMember" id="Fact001257" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.55</ix:nonFraction></ix:nonFraction></span></span> per share. There were <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_do_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zWOnrMwWdR3d" title="Share base compensation issued shares"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_do_c20230701__20230930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zeT29ymfHjz2" title="Share base compensation issued shares"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" contextRef="From2023-01-012023-09-30_custom_TwoThousandTwentyTwoPlanMember" id="Fact001259" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" contextRef="From2023-07-012023-09-30_custom_TwoThousandTwentyTwoPlanMember" id="Fact001261" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares">no</ix:nonFraction></ix:nonFraction></span></span>
share base compensation awards issued under the 2022 Plan during the three and nine months ended September 30, 2023. There were <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20240701__20240930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zOw3t9YtHrDd" title="Share base compensation forfeited shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" contextRef="From2024-07-012024-09-30_custom_TwoThousandTwentyTwoPlanMember" id="Fact001263" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,250</ix:nonFraction></span>
and <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20240101__20240930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zdE7JQ8gAsW6" title="Share base compensation forfeited shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" contextRef="From2024-01-012024-09-30_custom_TwoThousandTwentyTwoPlanMember" id="Fact001265" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,500</ix:nonFraction></span>
shares forfeited during the three and nine months ended September 30, 2024, respectively. There were <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_do_c20230701__20230930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zchqtSocrl0g" title="Share base compensation forfeited shares"><span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_do_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zLyXbmnu4QZk" title="Share base compensation forfeited shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" contextRef="From2023-07-012023-09-30_custom_TwoThousandTwentyTwoPlanMember" id="Fact001267" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" contextRef="From2023-01-012023-09-30_custom_TwoThousandTwentyTwoPlanMember" id="Fact001269" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares">no</ix:nonFraction></ix:nonFraction></span></span>
shares forfeited during the three and nine months ended September 30, 2023. As of September 30, 2024, there were <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20240930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zWe8aTwLyFg2" title="Number of shares available to issued"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" contextRef="AsOf2024-09-30_custom_TwoThousandTwentyTwoPlanMember" id="Fact001271" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">63,453</ix:nonFraction></span>
shares available to be issued under the 2022 Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity compensation under the 2022 Plan was approximately $<span id="xdx_905_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_c20240701__20240930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zU3Fq1TyUcEg" title="Equity compensation"><ix:nonFraction name="us-gaap:EmployeeBenefitsAndShareBasedCompensation" contextRef="From2024-07-012024-09-30_custom_TwoThousandTwentyTwoPlanMember_us-gaap_GeneralAndAdministrativeExpenseMember" id="Fact001273" format="ixt:numdotdecimal" decimals="0" unitRef="USD">101,000</ix:nonFraction></span> and
$<span id="xdx_90C_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_c20240101__20240930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zR5IFzmkKCO9" title="Equity compensation"><ix:nonFraction name="us-gaap:EmployeeBenefitsAndShareBasedCompensation" contextRef="From2024-01-012024-09-30_custom_TwoThousandTwentyTwoPlanMember_us-gaap_GeneralAndAdministrativeExpenseMember" id="Fact001275" format="ixt:numdotdecimal" decimals="0" unitRef="USD">138,000</ix:nonFraction></span> during the three and nine months ended September 30, 2024 and was expensed as a component of general administrative expenses
on the accompanying condensed consolidated statements of operations. As
of September 30, 2024, there was an unrecognized expense of approximately $<span id="xdx_907_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_c20240930_zdxlVYPGXUuh" title="Unrecognised expense"><ix:nonFraction name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" contextRef="AsOf2024-09-30" id="Fact001277" format="ixt:numdotdecimal" decimals="0" unitRef="USD">50,000</ix:nonFraction></span> remaining on options currently vesting over time with
an approximate weighted average of <span id="xdx_906_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dc_c20240101__20240930_z3BAvLIP2v1a" title="Weighted average term"><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" format="ixt-sec:durwordsen" id="Fact001279" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">twelve months</ix:nonNumeric></span> remaining until these options are fully vested.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
vested options as of September 30, 2024, had <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_do_c20240930_zqMbKMC4BkHh" title="Vested options intrinsic value"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" contextRef="AsOf2024-09-30" id="Fact001281" format="ixt-sec:numwordsen" decimals="0" unitRef="USD">no</ix:nonFraction></span> intrinsic value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Other
Equity Compensation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">During
the three and nine months ended September 30, 2024, the Company issued <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardGross_c20240101__20240930_zfCdjqI40XQk"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" contextRef="From2024-01-01to2024-09-30" id="Fact001282" format="ixt:numdotdecimal" decimals="0" unitRef="USD">774,528</ix:nonFraction>
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock to three vendors for payment
of consulting services rendered and <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20240101__20240930_zzHpMV3yOXU6"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2024-01-01to2024-09-30" id="Fact001283" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">94,340</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">for restricted shares of common stock to Vivek
Sehgal (a related party) as bonus compensation (See Note 5). The grant date fair value for all of these share issuances was approximately
$<span id="xdx_908_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20240101__20240930__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zSXLZymTeMUl"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2024-01-012024-09-30_us-gaap_GeneralAndAdministrativeExpenseMember" id="Fact001284" format="ixt:numdotdecimal" decimals="0" unitRef="USD">478,000</ix:nonFraction>
</span></span>and were expensed as a component of general and
administrative expenses on the accompanying condensed consolidated statements of operations during the three and nine months ended September
30, 2024. These shares vest immediately but must be held for a minimum of six months in accordance with Securities Exchange Commission
Rule 144.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact001286" name="RIME:WarrantsDisclosureTextBlock"><p id="xdx_801_ecustom--WarrantsDisclosureTextBlock_zqaEvcPXt8Nh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
11 - <span id="xdx_822_zsppuSeBjha3">WARRANTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
warrants issued and outstanding as of September 30, 2024 and December 31, 2023, were <span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20231231_zGakUkBcFVT5"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2023-12-31" id="Fact001287" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">902,113</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
There were no changes in the warrants outstanding during the period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact001289" name="us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"><p id="xdx_890_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zYYHPpTStg96" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 30, 2024, the Company&#8217;s warrants by expiration date were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span id="xdx_8B9_z53HeMr0u9Ue" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE
OF WARRANTS EXPIRATION</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Number of
    <br/>
    Common Warrants</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Exercise
    Price</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Expiration Date</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zZ9riAbr0ne4" title="Number of common warrants" style="font: 10pt Times New Roman, Times, Serif; width: 30%; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2024-09-30_custom_ExercisePriceRangeOneMember" id="Fact001291" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">802,113</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zQOms2NMpzql" title="Warrant exercise price" style="font: 10pt Times New Roman, Times, Serif; width: 30%; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2024-09-30_custom_ExercisePriceRangeOneMember" id="Fact001293" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.80</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32%"><span id="xdx_906_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zAhRqajSZPL5"><ix:nonNumeric contextRef="AsOf2024-09-30_custom_ExercisePriceRangeOneMember" format="ixt:datemonthdayyearen" id="Fact001294" name="us-gaap:WarrantsAndRightsOutstandingMaturityDate">September
    15, 2026</ix:nonNumeric></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zLaBM9JTpt0j" title="Number of common warrants" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2024-09-30_custom_ExercisePriceRangeTwoMember" id="Fact001296" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">100,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">$</td><td id="xdx_987_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zAKLtDoLbeSe" title="Warrant Exercise Price" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2024-09-30_custom_ExercisePriceRangeTwoMember" id="Fact001298" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.00</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span id="xdx_902_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zF2QLVbDK9Ph"><ix:nonNumeric contextRef="AsOf2024-09-30_custom_ExercisePriceRangeTwoMember" format="ixt:datemonthdayyearen" id="Fact001299" name="us-gaap:WarrantsAndRightsOutstandingMaturityDate">May
    23, 2027</ix:nonNumeric></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20240930_z94gW3N03BR7" title="Number of Common Warrants" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2024-09-30" id="Fact001301" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">902,113</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A3_zU5PGS9xsu82" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<ix:exclude><!-- Field: Page; Sequence: 92; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALGORHYTHM
                                            HOLDINGS, INC. and SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September
30, 2024 and 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact001303" name="us-gaap:EarningsPerShareTextBlock"><p id="xdx_80F_eus-gaap--EarningsPerShareTextBlock_zgLzrlm0sfe3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
12 - <span id="xdx_825_zOxH3ZfwUyFc">COMPUTATION OF LOSS PER SHARE</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact001305" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"><p id="xdx_896_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zjxa6pA9SB0j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computation
of basic and dilutive loss per share for the three and nine months ended September 30, 2024 and 2023 are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span id="xdx_8BA_z8u1VjiPbD3h" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE
OF BASIC AND DILUTIVE LOSS PER SHARE</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_499_20240701__20240930_zh24815XKJY7" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">For
    the three months ended September 30, 2024</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_498_20230701__20230930_ziiKRIrQbrTa" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">For
    the three months ended September 30, 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_498_20240101__20240930_zUVz7oKTpjE8" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">For
    the nine months ended September 30, 2024</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49A_20230101__20230930_zUwyUSQWrji4" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">For
    the nine months ended September 30, 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_zMR8qGvPQ0Oh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: left">Net income (loss) available to common stockholders</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2024-07-012024-09-30" id="Fact001307" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,195,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2023-07-012023-09-30" id="Fact001308" format="ixt:numdotdecimal" decimals="0" unitRef="USD">97,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2024-01-01to2024-09-30" id="Fact001309" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">7,292,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2023-01-012023-09-30" id="Fact001310" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">5,348,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Weighted-average common shares outstanding</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240701__20240930_zjKkO8HXtnNg"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2024-07-012024-09-30" id="Fact001311" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,095,504</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230701__20230930_zLd81j8FJH4k"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-07-012023-09-30" id="Fact001312" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,220,259</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240101__20240930_zrFewd9yDsbh"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2024-01-01to2024-09-30" id="Fact001313" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,341,204</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230101__20230930_zKs9K6QYqox3"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-01-012023-09-30" id="Fact001314" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,726,259</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Basic and diluted income (loss)
    per share</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_eus-gaap--EarningsPerShareDiluted_pid_c20240701__20240930_znNJ4haozmeg"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2024-07-012024-09-30" id="Fact001315" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.13</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_eus-gaap--EarningsPerShareDiluted_pid_c20230701__20230930_z2Ttkzw559F8"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2023-07-012023-09-30" id="Fact001316" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.03</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_pid_c20240101__20240930_zSUx8zUrNY85">(<ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2024-01-01to2024-09-30" id="Fact001317" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.99</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_eus-gaap--EarningsPerShareDiluted_pid_c20230101__20230930_zoHdFLPdoQJl">(<ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2023-01-012023-09-30" id="Fact001318" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">1.44</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AA_zVzkdLWCH937" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
net loss per share is based on the weighted average number of shares of common stock outstanding during the period. Diluted net loss
per share reflects the potential dilution assuming shares of common stock were issued upon the exercise of outstanding in-the-money options
and the proceeds thereof were used to purchase shares of the Company&#8217;s common stock at the average market price during the period
using the treasury stock method.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the three and nine months ended September 30, 2024 and 2023, options to purchase <span id="xdx_906_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240701__20240930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zHUcVtTE0vN9" title="Potentially dilutive securities"><span id="xdx_900_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240101__20240930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zveLJGSzuoq6" title="Potentially dilutive securities"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2024-07-012024-09-30_us-gaap_EmployeeStockOptionMember" id="Fact001320" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2024-01-012024-09-30_us-gaap_EmployeeStockOptionMember" id="Fact001322" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">98,178</ix:nonFraction></ix:nonFraction></span></span> and <span id="xdx_908_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230701__20230930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zJ3qTurI64Th" title="Potentially dilutive securities"><span id="xdx_90C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20230930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zbzTFvh5tmxd" title="Potentially dilutive securities"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2023-07-012023-09-30_us-gaap_EmployeeStockOptionMember" id="Fact001324" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2023-01-012023-09-30_us-gaap_EmployeeStockOptionMember" id="Fact001326" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">91,261</ix:nonFraction></ix:nonFraction></span></span> shares of common stock, respectively
and options to purchase <span id="xdx_901_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240101__20240930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zprMrhM6lpa4" title="Potentially dilutive securities"><span id="xdx_903_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20230930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zoT2RYqlWQM5" title="Potentially dilutive securities"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2024-01-012024-09-30_us-gaap_WarrantMember" id="Fact001328" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2023-01-012023-09-30_us-gaap_WarrantMember" id="Fact001330" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">902,113</ix:nonFraction></ix:nonFraction></span></span> common stock warrants for both September 30, 2024 and 2023 were excluded in the calculation of diluted
net loss per share as the result would have been anti-dilutive.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact001332" name="us-gaap:IncomeTaxDisclosureTextBlock"><p id="xdx_802_eus-gaap--IncomeTaxDisclosureTextBlock_zZAI7n5zRZwk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
13 - <span id="xdx_828_zkrkiJ97izB8">INCOME TAXES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the three months ended September 30, 2024 and 2023 the Company did <span id="xdx_908_eus-gaap--IncomeTaxExpenseBenefit_dxL_c20240701__20240930_z4gmrTXfCyZb" title="Income tax (benefit) provision::XDX::-"><span id="xdx_900_eus-gaap--IncomeTaxExpenseBenefit_dxL_c20230701__20230930_zVhSk3kPnPua" title="Income tax (benefit) provision::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl1334"><span style="-sec-ix-hidden: xdx2ixbrl1336">no</span></span></span></span>t recognize income tax provision as the Company is not forecasting
any taxable income for the current year and had a loss before income tax benefit in the previous year. The Company&#8217;s income tax
provision for the nine months ended September 30, 2023, was approximately $<span id="xdx_905_eus-gaap--IncomeTaxExpenseBenefit_c20230101__20230930_zn4DY84d9sle" title="Income Tax (benefit) provision"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2023-01-012023-09-30" id="Fact001338" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,502,000</ix:nonFraction></span> as the Company recognized a valuation reserve of
all of its deferred tax assets based on the recent history of losses and forecasts that suggested the Company would not be able to utilize
the deferred tax assets in the future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s income tax expense differs from the expected tax benefit/expense based on statutory rates primarily due to full valuation
allowance for all of its subsidiaries for the three and nine months ended September 30, 2024 and 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact001340" name="us-gaap:SegmentReportingDisclosureTextBlock"><p id="xdx_80A_eus-gaap--SegmentReportingDisclosureTextBlock_zLcwUk2Rv7ei" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
14 &#8211; <span id="xdx_822_zubLELtErhoc">REVENUE DISAGGREGATION</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company disaggregates revenues by product line and major geographic region as most of its revenue is generated by the sales of karaoke
hardware and the Company has no other material business segments:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact001342" name="us-gaap:DisaggregationOfRevenueTableTextBlock"><p id="xdx_89C_eus-gaap--DisaggregationOfRevenueTableTextBlock_zWgjDe6nNgVk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;Revenue
by product line is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B1_z1QfDZZPjWcj" style="display: none">SCHEDULE
OF REVENUE BY PRODUCT LINE</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; display: none">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left">&#160;</td><td id="xdx_49C_20240701__20240930_zCzew3xSqc4e" style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; display: none">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left">&#160;</td><td id="xdx_49D_20230701__20230930_zjZ5ZFJYFCAh" style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; display: none">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left">&#160;</td><td id="xdx_496_20240101__20240930_zlQrx7BexgF8" style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; display: none">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left">&#160;</td><td id="xdx_492_20230101__20230930_z8GQqm0u6BOa" style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td colspan="5" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Three
                                            Months Ended</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td colspan="5" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Nine
                                            Months Ended</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">Product Line</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">September
                                            30, 2024</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">September
                                            30, 2023</p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">September
                                            30, 2024</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">September
                                            30, 2023</p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--ClassicKaraokeMachinesMember_zvmUzb0BQWy8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 28%; text-align: left">Classic Karaoke Machines</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2024-07-012024-09-30_custom_ClassicKaraokeMachinesMember" id="Fact001344" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,218,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-07-012023-09-30_custom_ClassicKaraokeMachinesMember" id="Fact001345" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,636,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2024-01-012024-09-30_custom_ClassicKaraokeMachinesMember" id="Fact001346" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,521,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-01-012023-09-30_custom_ClassicKaraokeMachinesMember" id="Fact001347" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,363,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--LicensedProductsMember_zcRM22HViYWg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Licensed Products</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2024-07-012024-09-30_custom_LicensedProductsMember" id="Fact001349" format="ixt:numdotdecimal" decimals="0" unitRef="USD">180,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-07-012023-09-30_custom_LicensedProductsMember" id="Fact001350" format="ixt:numdotdecimal" decimals="0" unitRef="USD">36,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2024-01-012024-09-30_custom_LicensedProductsMember" id="Fact001351" format="ixt:numdotdecimal" decimals="0" unitRef="USD">377,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-01-012023-09-30_custom_LicensedProductsMember" id="Fact001352" format="ixt:numdotdecimal" decimals="0" unitRef="USD">32,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--KidsYouthElectronicsMember_zBaA3BsGGST6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Kids Youth Electronics</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2024-07-012024-09-30_custom_KidsYouthElectronicsMember" id="Fact001354" format="ixt:numdotdecimal" decimals="0" unitRef="USD">379,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-07-012023-09-30_custom_KidsYouthElectronicsMember" id="Fact001355" format="ixt:numdotdecimal" decimals="0" unitRef="USD">297,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2024-01-012024-09-30_custom_KidsYouthElectronicsMember" id="Fact001356" format="ixt:numdotdecimal" decimals="0" unitRef="USD">546,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-01-012023-09-30_custom_KidsYouthElectronicsMember" id="Fact001357" format="ixt:numdotdecimal" decimals="0" unitRef="USD">451,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--MicrophonesAndAccessoriesMember_zlifGfjGdIQ3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Microphones and Accessories</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2024-07-012024-09-30_custom_MicrophonesAndAccessoriesMember" id="Fact001359" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,500,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-07-012023-09-30_custom_MicrophonesAndAccessoriesMember" id="Fact001360" format="ixt:numdotdecimal" decimals="0" unitRef="USD">806,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2024-01-012024-09-30_custom_MicrophonesAndAccessoriesMember" id="Fact001361" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,329,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-01-012023-09-30_custom_MicrophonesAndAccessoriesMember" id="Fact001362" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,543,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--MusicSubscriptionsMember_z9JfG6qqdHl4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Music Subscriptions</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2024-07-012024-09-30_custom_MusicSubscriptionsMember" id="Fact001364" format="ixt:numdotdecimal" decimals="0" unitRef="USD">218,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-07-012023-09-30_custom_MusicSubscriptionsMember" id="Fact001365" format="ixt:numdotdecimal" decimals="0" unitRef="USD">156,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2024-01-012024-09-30_custom_MusicSubscriptionsMember" id="Fact001366" format="ixt:numdotdecimal" decimals="0" unitRef="USD">588,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-01-012023-09-30_custom_MusicSubscriptionsMember" id="Fact001367" format="ixt:numdotdecimal" decimals="0" unitRef="USD">550,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--LogisticsServicesMember_zhP1KbZNMlna" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Logistics Services</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2024-07-012024-09-30_custom_LogisticsServicesMember" id="Fact001369" format="ixt:numdotdecimal" decimals="0" unitRef="USD">127,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1370">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2024-01-012024-09-30_custom_LogisticsServicesMember" id="Fact001371" format="ixt:numdotdecimal" decimals="0" unitRef="USD">127,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1372">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--Revenues_z2nmXoH7wJHb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Total Net Sales</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2024-07-012024-09-30" id="Fact001374" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,622,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-07-012023-09-30" id="Fact001375" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,931,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2024-01-01to2024-09-30" id="Fact001376" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,488,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-01-012023-09-30" id="Fact001377" format="ixt:numdotdecimal" decimals="0" unitRef="USD">21,939,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AA_zEwzKYRBIG99" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 93; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALGORHYTHM
HOLDINGS, INC. and SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September
30, 2024 and 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact001379" name="us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock"><p id="xdx_892_eus-gaap--ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_zUw7jGOtOBdj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales
by geographic region for the periods presented are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BA_zyyjRYaDDCrk" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE
OF SALES BY GEOGRAPHICAL REGION</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; display: none">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; display: none">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left">&#160;</td><td id="xdx_496_20240701__20240930_z7UpUTsSdPv8" style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; display: none">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left">&#160;</td><td id="xdx_497_20230701__20230930_zPB2ZINp0KB8" style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; display: none">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left">&#160;</td><td id="xdx_497_20240101__20240930_zatNM73nEHe1" style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; display: none">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left">&#160;</td><td id="xdx_498_20230101__20230930_zyDFJQGqHp6b" style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Three
    Months Ended</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Nine
    Months Ended</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">September
    30, 2024</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">September
    30, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">September
    30, 2024</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">September
    30, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--Revenues_hsrt--StatementGeographicalAxis__srt--NorthAmericaMember_z12ApUNYOplf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 28%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">North
    America</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2024-07-012024-09-30_srt_NorthAmericaMember" id="Fact001381" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,466,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-07-012023-09-30_srt_NorthAmericaMember" id="Fact001382" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,378,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2024-01-012024-09-30_srt_NorthAmericaMember" id="Fact001383" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,208,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-01-012023-09-30_srt_NorthAmericaMember" id="Fact001384" format="ixt:numdotdecimal" decimals="0" unitRef="USD">21,386,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--Revenues_hsrt--StatementGeographicalAxis__country--AU_zeia9sW3VEha" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Australia</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2024-07-012024-09-30_country_AU" id="Fact001386" format="ixt:numdotdecimal" decimals="0" unitRef="USD">50,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-07-012023-09-30_country_AU" id="Fact001387" format="ixt:numdotdecimal" decimals="0" unitRef="USD">263,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2024-01-012024-09-30_country_AU" id="Fact001388" format="ixt:numdotdecimal" decimals="0" unitRef="USD">174,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-01-012023-09-30_country_AU" id="Fact001389" format="ixt:numdotdecimal" decimals="0" unitRef="USD">263,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--Revenues_hsrt--StatementGeographicalAxis__srt--EuropeMember_zLH57oVPdK82" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Europe</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2024-07-012024-09-30_srt_EuropeMember" id="Fact001391" format="ixt:numdotdecimal" decimals="0" unitRef="USD">106,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-07-012023-09-30_srt_EuropeMember" id="Fact001392" format="ixt:numdotdecimal" decimals="0" unitRef="USD">290,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2024-01-012024-09-30_srt_EuropeMember" id="Fact001393" format="ixt:numdotdecimal" decimals="0" unitRef="USD">106,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-01-012023-09-30_srt_EuropeMember" id="Fact001394" format="ixt:numdotdecimal" decimals="0" unitRef="USD">290,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--Revenues_zs8zxZUzacD" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Net Sales</span><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2024-07-012024-09-30" id="Fact001396" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,622,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-07-012023-09-30" id="Fact001397" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,931,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2024-01-01to2024-09-30" id="Fact001398" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,488,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-01-012023-09-30" id="Fact001399" format="ixt:numdotdecimal" decimals="0" unitRef="USD">21,939,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A9_zkuPpWT8a4K9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company selectively participates in a retailer&#8217;s co-op promotion incentives by providing marketing fund allowances to its customers.
As these co-op promotion initiatives are not a distinct good or service and the Company cannot reasonably estimate the fair value of
the benefit it receives from these arrangements, the cost of these allowances at the time they are offered to the customers are recorded
as a reduction to net sales. For the three months ended September 30, 2024 and 2023, co-op promotion incentives were approximately $<span id="xdx_90E_eus-gaap--AdvertisingExpense_c20240701__20240930_zxy9gNy5db17" title="Co-op promotion incentives"><ix:nonFraction name="us-gaap:AdvertisingExpense" contextRef="From2024-07-012024-09-30" id="Fact001401" format="ixt:numdotdecimal" decimals="0" unitRef="USD">908,000</ix:nonFraction></span>
and $<span id="xdx_901_eus-gaap--AdvertisingExpense_c20230701__20230930_zyjuFAXN4SA7" title="Co-op promotion incentives"><ix:nonFraction name="us-gaap:AdvertisingExpense" contextRef="From2023-07-012023-09-30" id="Fact001403" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,637,000</ix:nonFraction></span>, respectively. For the nine months ended September 30, 2024 and 2023, co-op promotion incentives were approximately $<span id="xdx_902_eus-gaap--AdvertisingExpense_c20240101__20240930_z1tFhax3hUzl" title="Co-op promotion incentives"><ix:nonFraction name="us-gaap:AdvertisingExpense" contextRef="From2024-01-01to2024-09-30" id="Fact001405" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,257,000</ix:nonFraction></span>
and $<span id="xdx_904_eus-gaap--AdvertisingExpense_c20230101__20230930_ztc372oC4IN3" title="Co-op promotion incentives"><ix:nonFraction name="us-gaap:AdvertisingExpense" contextRef="From2023-01-012023-09-30" id="Fact001407" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,901,000</ix:nonFraction></span>, respectively. The Company&#8217;s estimated reserve for co-op promotion incentives was approximately $<span id="xdx_907_ecustom--EstimatedReserveOfAdvertisingExpense_c20240101__20240930_zFsA1DcJnyY6" title="Estimated reserve co-op promotion incentives"><ix:nonFraction name="RIME:EstimatedReserveOfAdvertisingExpense" contextRef="From2024-01-01to2024-09-30" id="Fact001409" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,833,000</ix:nonFraction></span> and $<span id="xdx_90A_ecustom--EstimatedReserveOfAdvertisingExpense_c20230101__20231231_zg2LUd5OvLU8" title="Estimated reserve co-op promotion incentives"><ix:nonFraction name="RIME:EstimatedReserveOfAdvertisingExpense" contextRef="From2023-01-012023-12-31" id="Fact001411" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,277,000</ix:nonFraction></span>
as of September 30, 2024 and December 31, 2023, respectively. The estimated reserve for co-op promotions is a component of accrued expenses
on the accompanying condensed consolidated balance sheets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company estimates variable consideration under its return allowance programs for goods returned from the customer whereby a revenue return
reserve is recorded based on historic return amounts, specific events as identified and management estimates. The Company&#8217;s reserve
for sales returns as of September 30, 2024 and December 31, 2023, was approximately $<span id="xdx_903_ecustom--ReserveForSalesReturns_iI_c20240930_zMfVMB75VpFj" title="Reserve for sales returns"><ix:nonFraction name="RIME:ReserveForSalesReturns" contextRef="AsOf2024-09-30" id="Fact001413" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,212,000</ix:nonFraction></span> and $<span id="xdx_90B_ecustom--ReserveForSalesReturns_iI_c20231231_zWOcGJHDikHf" title="Reserve for sales returns"><ix:nonFraction name="RIME:ReserveForSalesReturns" contextRef="AsOf2023-12-31" id="Fact001415" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,390,000</ix:nonFraction></span>, respectively. In conjunction
with the recording of the revenue sales return reserve, the Company estimates the cost of products that are expected to be returned under
its return allowance program whereby the estimated cost of product returns is recorded as an asset. The asset is separately stated as
returns asset on the condensed consolidated balance sheets. The Company&#8217;s estimated cost of returns as of September 30, 2024 and
December 31, 2023, was approximately $<span id="xdx_90B_ecustom--EstimatedCostOfReturns_iI_c20240930_z9a8cZl4L3Yg" title="Estimated costs of returns"><ix:nonFraction name="RIME:EstimatedCostOfReturns" contextRef="AsOf2024-09-30" id="Fact001417" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,081,000</ix:nonFraction></span> and $<span id="xdx_90A_ecustom--EstimatedCostOfReturns_iI_c20231231_zSEFlnJVlJj2" title="Estimated costs of returns"><ix:nonFraction name="RIME:EstimatedCostOfReturns" contextRef="AsOf2023-12-31" id="Fact001419" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,919,000</ix:nonFraction></span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
return program for defective goods is negotiated with each of the Company&#8217;s wholesale customers on a year-to-year basis. Customers
are allowed to return defective goods within a specified period of time after shipment (between six and nine months). The Company does
make occasional exceptions to this return policy and accordingly records a sales return reserve based on historic return amounts, specific
exceptions as identified and management estimates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company records a sales reserve for its return goods programs at the time of sale for estimated sales returns that may occur. The liability
for defective goods is included in the reserve for sales returns on the condensed consolidated balance sheets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact001421" name="us-gaap:ConcentrationRiskDisclosureTextBlock"><p id="xdx_800_eus-gaap--ConcentrationRiskDisclosureTextBlock_zHVwqT1O2d96" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
15 - <span id="xdx_820_zJPDWPODbaIa">CONCENTRATIONS OF CREDIT RISK AND REVENUE</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company derives a majority of its revenues from retailers of products in the United States. The Company&#8217;s allowance for credit
losses is based upon management&#8217;s estimates and historical experience and reflects the fact that accounts receivable is concentrated
with several large customers. At September 30, 2024, <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240101__20240930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ThreeCustomersMember_zHxYTqJcGeY3"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2024-01-012024-09-30_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_ThreeCustomersMember" id="Fact001422" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">70</ix:nonFraction></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
of accounts receivable were due from three customers in North America that individually owed over 10% of total accounts receivable. On
December 31, 2023, </span><span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20231231__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--FourCustomersMember_z8UER6VkXDVf" style="font-size: 10pt"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2023-12-312023-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_FourCustomersMember" id="Fact001423" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">82</ix:nonFraction></span>%
of accounts receivable were due from four customers in North America that individually owed over 10% of total accounts receivable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues
from customers representing greater than 10% of total net sales derived from our top three customers as a percentage of net sales were
<span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240701__20240930__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zNCPa1fwXXRj" title="Concentration of sales risk, percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2024-07-012024-09-30_custom_SalesRevenueMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerOneMember" id="Fact001425" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">41</ix:nonFraction></span>%, <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240701__20240930__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersTwoMember_zOHucgA96QX2" title="Concentration of sales risk, percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2024-07-012024-09-30_custom_SalesRevenueMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomersTwoMember" id="Fact001427" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">20</ix:nonFraction></span>%, and <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240701__20240930__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersThreeMember_zGUixm5jN6gb" title="Concentration of sales risk, percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2024-07-012024-09-30_custom_SalesRevenueMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomersThreeMember" id="Fact001429" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">13</ix:nonFraction></span>% for the three months ended September 30, 2024. Revenues from customers representing greater than 10% of total net sales
derived from three customers as a percentage of net sales were <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230701__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zRC4bYIqY1fc" title="Concentration of sales risk, percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2023-07-012023-09-30_custom_SalesRevenueMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerOneMember" id="Fact001431" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">28</ix:nonFraction></span>%, <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230701__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersTwoMember_zwAfdt9iNDb" title="Concentration of sales risk, percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2023-07-012023-09-30_custom_SalesRevenueMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomersTwoMember" id="Fact001433" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">22</ix:nonFraction></span>% and <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230701__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersThreeMember_z5Chl58wPjX1" title="Concentration of sales risk, percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2023-07-012023-09-30_custom_SalesRevenueMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomersThreeMember" id="Fact001435" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">21</ix:nonFraction></span>% for the three months ended September 30, 2023. Revenues
from customers representing greater than 10% of total net sales derived from our top four customers as a percentage of net sales were
<span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240101__20240930__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerOneMember_z081AlpVUWSd" title="Concentration of sales risk, percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2024-01-012024-09-30_custom_SalesRevenueMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerOneMember" id="Fact001437" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">29</ix:nonFraction></span>%, <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240101__20240930__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersTwoMember_zpeU54RUqyo8" title="Concentration of sales risk, percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2024-01-012024-09-30_custom_SalesRevenueMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomersTwoMember" id="Fact001439" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">27</ix:nonFraction></span>%, <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240101__20240930__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersThreeMember_zd1CX4VBKbQ2" title="Concentration of sales risk, percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2024-01-012024-09-30_custom_SalesRevenueMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomersThreeMember" id="Fact001441" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">15</ix:nonFraction></span>% and <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240101__20240930__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersFourMember_zPfQ7mVT7Zd5" title="Concentration of sales risk, percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2024-01-012024-09-30_custom_SalesRevenueMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomersFourMember" id="Fact001443" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10</ix:nonFraction></span>% for the nine months ended September 30, 2024. Revenues from customers representing greater than 10% of total net
sales derived from our top three customers as a percentage of net sales were <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zAAabSqEP6sh" title="Concentration of sales risk, percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2023-01-012023-09-30_custom_SalesRevenueMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerOneMember" id="Fact001445" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">44</ix:nonFraction></span>%, <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersTwoMember_zTDI49ve7v16" title="Concentration of sales risk, percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2023-01-012023-09-30_custom_SalesRevenueMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomersTwoMember" id="Fact001447" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">13</ix:nonFraction></span>% and <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersThreeMember_z6GHLWXQemZd" title="Concentration of risk, percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2023-01-012023-09-30_custom_SalesRevenueMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomersThreeMember" id="Fact001449" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">12</ix:nonFraction></span>% for the nine months ended September 30,
2023. The loss of any of these customers could have an adverse impact on the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 94; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALGORHYTHM
                                            HOLDINGS, INC. and SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September
30, 2024 and 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact001451" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock"><p id="xdx_808_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zBVfWm7UcGK3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
16 &#8211; <span id="xdx_82A_zpMy1wLIHqOi">RELATED PARTY TRANSACTIONS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Due
To/From Related Parties</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><b><i>Stingray</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stingray
Group, Inc. (&#8220;Stingray&#8221;) is an existing shareholder with board representation. The Company has a music subscription sharing
agreement with Stingray. For the three months ended September 30, 2024, and 2023, the amounts earned from the subscription agreement
were approximately $<span id="xdx_907_eus-gaap--Revenues_c20240701__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zJJjH8r0nBq1" title="Revenue from related parties"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2024-07-012024-09-30_us-gaap_RelatedPartyMember" id="Fact001453" format="ixt:numdotdecimal" decimals="0" unitRef="USD">218,000</ix:nonFraction></span> and $<span id="xdx_904_eus-gaap--Revenues_c20230701__20230930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_z9RiTOnLgGwk" title="Revenue from related parties"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-07-012023-09-30_us-gaap_RelatedPartyMember" id="Fact001455" format="ixt:numdotdecimal" decimals="0" unitRef="USD">156,000</ix:nonFraction></span>, respectively. For the nine months ended September 30, 2024, and 2023, the amounts earned from
the subscription agreement were approximately $<span id="xdx_908_eus-gaap--Revenues_c20240101__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zuNB2Dfyr794" title="Revenue from related parties"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2024-01-012024-09-30_us-gaap_RelatedPartyMember" id="Fact001457" format="ixt:numdotdecimal" decimals="0" unitRef="USD">567,000</ix:nonFraction></span> and $<span id="xdx_90A_eus-gaap--Revenues_c20230101__20230930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zrr1uvSf71v3" title="Revenue from related parties"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-01-012023-09-30_us-gaap_RelatedPartyMember" id="Fact001459" format="ixt:numdotdecimal" decimals="0" unitRef="USD">550,000</ix:nonFraction></span>, respectively. These amounts were included as a component of net
sales in the accompanying condensed consolidated statements of operations. On September 30, 2024, the Company had approximately $<span id="xdx_900_eus-gaap--OtherReceivables_iI_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StingrayMember_zJfiaWl0n5sa" title="Due from related parties"><ix:nonFraction name="us-gaap:OtherReceivables" contextRef="AsOf2024-09-30_custom_StingrayMember" id="Fact001461" format="ixt:numdotdecimal" decimals="0" unitRef="USD">157,000</ix:nonFraction></span>
due from Stingray. On December 31, 2023, the Company had approximately $<span id="xdx_903_eus-gaap--OtherReceivables_iI_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StingrayMember_zPoqAjmRFuck" title="Due from related parties"><ix:nonFraction name="us-gaap:OtherReceivables" contextRef="AsOf2023-12-31_custom_StingrayMember" id="Fact001463" format="ixt:numdotdecimal" decimals="0" unitRef="USD">269,000</ix:nonFraction></span> due from Stingray for music subscription reimbursement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>SMCB</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company determined that SMCB is a VIE as the Company provides financial support to SMCB. While not contractually obligated, SMCB currently
relies on our reimbursement of certain costs under a Services Agreement (&#8220;MSA&#8221;) whereby SMCB agree to provide IT software
development services to support SemiCab&#8217;s US operations. In exchange, under the MSA, the Company grants intellectual property rights
to SMCB to use the software platform in India. Compensation for services is invoiced and paid on a monthly or quarterly basis as agreed
by both parties, with rates subject to periodic review and revision. As a result of this relationship SMCB has been determined to be
a VIE.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the asset acquisition agreement of SemiCab, the Company entered into an option agreement granting the right to acquire all of the
issued and outstanding capital securities of SMCB, however the option agreement expired on August 31, 2024 unexercised.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company further determined that it is not the primary beneficiary of SMCB as the Company does not have the power to direct or control
SMCB&#8217;s significant activities related to its business. Accordingly, the Company has not consolidated SMCB&#8217;s results of operations
and financial position in the accompanying condensed consolidated financials presented for this period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 30, 2024, the Company has advanced approximately $<span id="xdx_90F_eus-gaap--OtherLiabilities_iI_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SMCBMember_zBVvCBdJWnd7" title="Due to related parties"><ix:nonFraction name="us-gaap:OtherLiabilities" contextRef="AsOf2024-09-30_custom_SMCBMember" id="Fact001465" format="ixt:numdotdecimal" decimals="0" unitRef="USD">776,000</ix:nonFraction></span>
to SMCB for estimated prepaid services to be provided by SMCB in accordance with the MSA which are a component of prepaid expenses
and other current assets on the accompanying condensed consolidated balance sheets. During the three months ended September 30,
2024, the Company incurred approximately $<span id="xdx_902_eus-gaap--ProfessionalFees_c20240701__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SMCBMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zZnAwKWBMABb" title="Software support service"><ix:nonFraction name="us-gaap:ProfessionalFees" contextRef="From2024-07-012024-09-30_custom_SMCBMember_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" id="Fact001467" format="ixt:numdotdecimal" decimals="0" unitRef="USD">422,000</ix:nonFraction></span>
in software support services under the MSA.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact001469" name="us-gaap:SubsequentEventsTextBlock"><p id="xdx_803_eus-gaap--SubsequentEventsTextBlock_zn3f20UwLxwa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
17 &#8211; <span id="xdx_82E_zgBcjXTSdma2">SUBSEQUENT EVENTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Securities
Purchase Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 22, 2024, the Company entered into a Securities Purchase Agreement (the &#8220;SPA&#8221;), pursuant to which the Company agreed
to issue and sell to each purchaser (i) an Original Issue Discount Senior Secured Note with a principal amount equal to such purchaser&#8217;s
subscription amount divided by <span id="xdx_907_eus-gaap--SharePrice_iI_c20241022__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zEZHBXI6TvXh" title="Share price"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2024-10-22_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember" id="Fact001471" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.85</ix:nonFraction></span> (each a &#8220;Note&#8221; and collectively, the &#8220;Notes&#8221;), and (ii) a number of shares
of common stock of the Company, par value $<span id="xdx_902_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20241022__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zlZTSjAdp1ig" title="Common stock, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2024-10-22_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember" id="Fact001473" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.01</ix:nonFraction></span> equal to (i) <span id="xdx_904_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20241022__20241022__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zlpqy9VjA3Pa" title="Number of share sold"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2024-10-222024-10-22_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember" id="Fact001475" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,300,000</ix:nonFraction></span> multiplied by (ii) such purchaser&#8217;s subscription amount
divided by (iii) $<span id="xdx_907_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20241022__20241022__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zoXhIDFdnyU8" title="Number of shares sold, value"><ix:nonFraction name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" contextRef="From2024-10-222024-10-22_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember" id="Fact001477" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,000,000</ix:nonFraction></span> (the &#8220;Shares&#8221;) (the transactions contemplated under the SPA, the &#8220;Offering&#8221;).The
aggregate gross proceeds to the Company were approximately $<span id="xdx_90B_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_pn5n6_c20241022__20241022__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zl2FZAMPD5S1" title="Net proceeds"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" contextRef="From2024-10-222024-10-22_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember" id="Fact001479" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">2.0</ix:nonFraction></span> million, before deducting placement agent fees and expenses. The Company
intends to use the net proceeds from the Offering for working capital and other general corporate purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company agreed to certain registration rights with respect to the Shares, as described in the SPA. The Company also granted the purchasers
a right to participate up to an amount of <span id="xdx_90D_ecustom--PercentageOfPurchasersRightToParticipateOnIssuanceCompanyOfCommonStock_dp_c20241022__20241022__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zWsuSWAzHKp3" title="Percentage of purchasers right to participate on issuance company of common stock"><ix:nonFraction name="RIME:PercentageOfPurchasersRightToParticipateOnIssuanceCompanyOfCommonStock" contextRef="From2024-10-222024-10-22_us-gaap_SubsequentEventMember" id="Fact001481" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">20</ix:nonFraction></span>% in any issuance by the Company of common stock or common stock equivalents for cash, subject
to certain exceptions, during the 90 days after the closing of the Offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Univest
Securities LLC served as the placement agent in the Offering and received <span id="xdx_90B_ecustom--PercentageOfGrossProceeds_dp_uPure_c20241022__20241022__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zwhyZEqEsJ5e" title="Percentage of gross proceeds"><ix:nonFraction name="RIME:PercentageOfGrossProceeds" contextRef="From2024-10-222024-10-22_us-gaap_SubsequentEventMember" id="Fact001483" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">7</ix:nonFraction></span>% of the gross proceeds received by the Company and reimbursement
of the legal fees of its counsel.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Offering closed on October 24, 2024. At the closing, the Company issued to the purchasers an aggregate of <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20241024__20241024__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zifBkpKJ3aU9" title="Number of shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2024-10-242024-10-24_us-gaap_SubsequentEventMember" id="Fact001485" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,300,000</ix:nonFraction></span> shares of its common
stock and Notes in the aggregate principal amount of $<span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_iI_c20241024__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zSyE6GH6yrfb" title="Principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2024-10-24_us-gaap_SubsequentEventMember" id="Fact001487" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,352,941</ix:nonFraction></span>for total proceeds of $<span id="xdx_90A_eus-gaap--ProceedsFromIssuanceOfDebt_c20241024__20241024__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zptQhopjOsD3" title="Net proceeds"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfDebt" contextRef="From2024-10-242024-10-24_us-gaap_SubsequentEventMember" id="Fact001489" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,000,000</ix:nonFraction></span> net of original issue discount of $<span id="xdx_90D_eus-gaap--DebtConversionOriginalDebtAmount1_c20241024__20241024__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zk24LJlFQYOl" title="Original issue discount"><ix:nonFraction name="us-gaap:DebtConversionOriginalDebtAmount1" contextRef="From2024-10-242024-10-24_us-gaap_SubsequentEventMember" id="Fact001491" format="ixt:numdotdecimal" decimals="0" unitRef="USD">352,941</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the closing, the Company issued a Note to each purchaser equal to such purchaser&#8217;s subscription amount divided by<span id="xdx_901_eus-gaap--SharePrice_iI_c20241024__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zOVhV4wFOo7f" title="Share price"> <ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2024-10-24_us-gaap_SubsequentEventMember" id="Fact001493" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.85</ix:nonFraction></span>. The Notes
were issued with an original issue discount of <span id="xdx_902_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_dp_c20241024__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z5XsBXUxrc49" title="Original issue discount percentage"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" contextRef="AsOf2024-10-24_us-gaap_SubsequentEventMember" id="Fact001495" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">15</ix:nonFraction></span>%. No interest shall accrue on the Notes unless and until an Event of Default (as defined
in the Notes) has occurred, upon which interest shall accrue at a rate of fourteen percent (<span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20241024__20241024__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zhZ9dAyRbgai" title="Interest accrued rate percentage"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateDuringPeriod" contextRef="From2024-10-242024-10-24_us-gaap_SubsequentEventMember" id="Fact001497" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">14.0</ix:nonFraction></span>%) per annum and shall be computed on
the basis of a three hundred sixty (360)-day year and twelve (12) thirty (30)-day months and shall be payable on the maturity date, which
is ninety (90) days from the issuance date of <span id="xdx_90B_eus-gaap--DebtInstrumentIssuanceDate1_dd_c20241024__20241024__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z7jNeTGUtGfk" title="Issuance date"><ix:nonNumeric contextRef="From2024-10-242024-10-24_us-gaap_SubsequentEventMember" format="ixt:datemonthdayyearen" id="Fact001499" name="us-gaap:DebtInstrumentIssuanceDate1">October 24, 2024</ix:nonNumeric></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Notes also provide for redemption upon a change of control, as such term is defined under the Notes and mandatory redemption upon the
receipt of net proceeds from any offering of equity or debt by the Company. The Company also has the right to prepay the Notes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Notes are secured by a security interest in the assets and property of the Company and its subsidiaries and guaranteed by the Company&#8217;s
subsidiaries, pursuant to the terms of a Guarantee Agreement entered into among the purchasers and the Company and each of its subsidiaries.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Stock
Repurchase Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 1, 2024, the Company entered into Stock Repurchase Agreement (the &#8220;Repurchase Agreement&#8221;) with Regalia Ventures
LLC, a Delaware limited liability company (the &#8220;Seller&#8221;), pursuant to which the Company agreed to repurchase from the Seller
an aggregate of <span id="xdx_906_eus-gaap--CommonStockSharesIssued_iI_c20241101__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zcKURhHgy414" title="Common stock shares issued"><span id="xdx_904_eus-gaap--CommonStockSharesOutstanding_iI_c20241101__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zUig7kzsu433" title="Common stock shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2024-11-01_us-gaap_SubsequentEventMember" id="Fact001501" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2024-11-01_us-gaap_SubsequentEventMember" id="Fact001503" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,098,901</ix:nonFraction></ix:nonFraction></span></span> issued and outstanding shares of common stock, par value $<span id="xdx_909_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20241101__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zHlo0sa1f2C1" title="Common stock par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2024-11-01_us-gaap_SubsequentEventMember" id="Fact001505" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.01</ix:nonFraction></span> per share, of the Company (the &#8220;Shares&#8221;).
The shares of common stock to be repurchased were originally issued to the Seller on November 21, 2023, pursuant to a certain stock purchase
agreement, dated November 20, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
consideration for the transaction contemplated by the Repurchase Agreement (the &#8220;Stock Repurchase&#8221;), when the transaction
closes, the Company has agreed to repurchase from the Seller, and the Seller has agreed to sell, assign and transfer to the Company,
all of the Seller&#8217;s right, title and interest in and to the Shares, at a price per Share equal to the higher of: (1) the closing
price of the common stock on the last trading day immediately preceding the date of the Repurchase Agreement; or (2) the highest volume
weighted average price (VWAP) of the common stock during a pricing period of ten (10) consecutive trading days prior to the date of the
Repurchase Agreement per share (the &#8220;Purchase Price&#8221;), and the Company shall issue to the Seller a promissory note in the
principal amount equal to the Purchase Price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the date of this filing, the repurchase of the shares has not yet closed.</span></p>

</ix:nonNumeric><p id="xdx_816_z1oSrP1CVAwf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 95; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="f_001"></span>REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the Shareholders and Board of Directors of</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Singing Machine Company, Inc.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Opinion
on the Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have audited the accompanying consolidated balance sheet of The Singing Machine Company, Inc. (the &#8220;Company&#8221;) as of December
31, 2023, the related consolidated statements of operations, cash flows, and, shareholders&#8217; equity for the nine month transition
period from April 1, 2023 through December 31, 2023, and the related notes (collectively referred to as the &#8220;financial statements&#8221;).
In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December
31, 2023, and the results of its operations and its cash flows for the period from April 1, 2023 through December 31, 2023, in conformity
with accounting principles generally accepted in the United States of America<b>.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Explanatory
Paragraph &#8211; Going Concern</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As more
fully described in Note 3, the Company has a significant working capital deficiency, has incurred significant losses and needs to raise
additional funds to meet its obligations and sustain its operations. These conditions raise substantial doubt about the Company&#8217;s
ability to continue as a going concern. Management&#8217;s plans in regard to these matters are also described in Note 3. The consolidated
financial statements do not include any adjustments that might result from the outcome of this uncertainty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Basis
for Opinion</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s
financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board
(United States) (&#8220;PCAOB&#8221;) and are required to be independent with respect to the Company in accordance with the U.S. federal
securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company
is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit
we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion
on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or
fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding
the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant
estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides
a reasonable basis for our opinion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Critical
Audit Matters</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
critical audit matters communicated below are matters arising from the current period audit of the financial statements that were communicated
or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial
statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters
does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit
matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Reserve
for Sales Returns:</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
discussed in Note 4 to the consolidated financial statements, the Company estimates the sales value of goods to be returned from our
allowance programs for goods returned from the customer for various reasons, whereby a reserve for sales returns is recorded based on
historic return amounts, specific events as identified and management estimates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
identified management&#8217;s estimate for sales returns as a critical audit matter due to the fact that there was significant judgment
required by management with respect to measurement uncertainty, as the calculation of estimated sales returns includes assumptions such
as historical product returns and margins experience used to predict future returns. This in turn led to a high degree of auditor judgment,
subjectivity and effort in applying the procedures related to those assumptions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Addressing
the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the financial
statements. We obtained an understanding and evaluated the design of controls over the Company&#8217;s estimates for variable consideration.
Our procedures also included, among others, (1) recalculating the sales return reserve based on our review of returns received subsequent
to year end and the net realizable value of the returned goods based on historical sales and margin experience; (2) evaluating the Company&#8217;s
ability to accurately estimate the sales return reserve by comparing historically recorded reserves to the actual amount that was ultimately
claimed by the retailers; and (3) analyzing year over year trends in the reserve in comparison with revenue trends to further evaluate
reasonableness of the estimate and consistency with expectations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
Marcum <span style="font-variant: small-caps">llp</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: small-caps 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>Marcum LLP</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: small-caps 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have served as the Company&#8217;s auditor since 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: small-caps 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>Philadelphia,
Pennsylvania</span><br/>
April 15, 2024</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 96; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="rep2_001"></span>REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the Board of Directors and Shareholders of</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Singing Machine Company, Inc.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Opinion
on the Financial Statements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have audited the accompanying consolidated balance sheet of The Singing Machine Company, Inc. and Subsidiaries (the
&#8220;Company&#8221;) as of March 31, 2023, and the related consolidated statements of operations, cash flows, and
shareholders&#8217; equity for each of the two years then ended, and the related notes (collectively referred to as the
&#8220;financial statements&#8221;). In our opinion, the financial statements present fairly, in all material respects, the
consolidated financial position of the Company as of March 31, 2023, and the consolidated results of their operations and their cash
flows for each of the two years then ended, in conformity with accounting principles generally accepted in the United States of
America.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Basis
for Opinion</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s
financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board
(United States) (&#8220;PCAOB&#8221;) and are required to be independent with respect to the Company in accordance with the U.S. federal
securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company
is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits
we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion
on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error
or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding
the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant
estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits
provide a reasonable basis for our opinion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have served as the Company&#8217;s auditor from 2016 to 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    EisnerAmper LLP</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>EISNERAMPER LLP</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>Iselin, New Jersey</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">July 14, 2023</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<!-- Field: Page; Sequence: 97; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p id="xdx_045_c20230401__20231231_zYCXWJiK5ZYk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="f_002"></span>The
Singing Machine Company, Inc. and Subsidiaries</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONSOLIDATED
BALANCE SHEETS </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_304_111_zjGdOcQNAOc5" summary="xdx: Statement - Condensed Consolidated Balance Sheets" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: italic bold 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20231231_z0xEtRL021Hk" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49C_20230331_zsn0FS9pdDKj" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: italic bold 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--AssetsAbstract_iB_zu7Hde918cWb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-decoration: underline; text-align: center">Assets</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--AssetsCurrentAbstract_i01B_zrRpIWmPl9Ac" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><b>Current Assets</b></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--Cash_i02I_zWppANQ5Tuf8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 60%; text-align: left">Cash</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2023-12-31" id="Fact001513" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,703,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2023-03-31" id="Fact001514" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,895,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--AccountsReceivableNet_i02I_pp0p0_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--NonrelatedPartyMember_zv9rxQHXZEt4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Accounts receivable, net of allowances of $<span id="xdx_907_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_c20231231_z6ZYmHsz3zdk" title="Allowance for doubtful accounts receivable, net"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" contextRef="AsOf2023-12-31" id="Fact001519" format="ixt:numdotdecimal" decimals="0" unitRef="USD">174,000</ix:nonFraction></span> and $<span id="xdx_908_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_c20230331_zL8bCuOGqgig" title="Allowance for doubtful accounts receivable, net"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" contextRef="AsOf2023-03-31" id="Fact001521" format="ixt:numdotdecimal" decimals="0" unitRef="USD">166,000</ix:nonFraction></span>, respectively</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableNet" contextRef="AsOf2023-12-31_us-gaap_NonrelatedPartyMember" id="Fact001516" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,308,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableNet" contextRef="AsOf2023-03-31_us-gaap_NonrelatedPartyMember" id="Fact001517" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,075,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--AccountsReceivableNet_i02I_pp0p0_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zOhhGC9Z2Wad" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Accounts receivable related parties</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableNet" contextRef="AsOf2023-12-31_us-gaap_RelatedPartyMember" id="Fact001523" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">269,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableNet" contextRef="AsOf2023-03-31_us-gaap_RelatedPartyMember" id="Fact001524" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">239,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--AccountsReceivableNet_i02I_pp0p0_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zlmQ4hA1giKb" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; display: none; padding-left: 10pt; text-align: left">Accounts receivable </td><td style="font: 10pt Times New Roman, Times, Serif; display: none">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableNet" contextRef="AsOf2023-12-31_us-gaap_RelatedPartyMember" id="Fact001526" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">269,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; display: none">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableNet" contextRef="AsOf2023-03-31_us-gaap_RelatedPartyMember" id="Fact001527" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">239,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--InventoryNet_i02I_zz6OuGJKAila" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Inventory</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2023-12-31" id="Fact001529" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,871,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2023-03-31" id="Fact001530" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,085,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--ReturnsAsset_i02I_zTEg3X0HlQO7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Returns asset</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:ReturnsAsset" contextRef="AsOf2023-12-31" id="Fact001532" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,919,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:ReturnsAsset" contextRef="AsOf2023-03-31" id="Fact001533" format="ixt:numdotdecimal" decimals="0" unitRef="USD">555,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_i02I_znOQmLTtYWzl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1pt">Prepaid expenses and other current assets</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2023-12-31" id="Fact001535" format="ixt:numdotdecimal" decimals="0" unitRef="USD">136,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2023-03-31" id="Fact001536" format="ixt:numdotdecimal" decimals="0" unitRef="USD">351,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--AssetsCurrent_i02TI_zFQHDZictSQe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left"><b>Total Current Assets</b></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2023-12-31" id="Fact001538" format="ixt:numdotdecimal" decimals="0" unitRef="USD">23,206,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2023-03-31" id="Fact001539" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,200,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--PropertyPlantAndEquipmentNet_i01I_zkZImso8vasl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><b>Property and equipment, net</b></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2023-12-31" id="Fact001541" format="ixt:numdotdecimal" decimals="0" unitRef="USD">404,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2023-03-31" id="Fact001542" format="ixt:numdotdecimal" decimals="0" unitRef="USD">633,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--OperatingLeaseRightOfUseAsset_i01I_zsQPQogNSYW4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><b>Operating leases - right of use assets</b></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2023-12-31" id="Fact001544" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,926,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2023-03-31" id="Fact001545" format="ixt:numdotdecimal" decimals="0" unitRef="USD">561,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--OtherAssetsNoncurrent_i01I_zhxNaMbzCZR" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><b>Other non-current assets</b></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:OtherAssetsNoncurrent" contextRef="AsOf2023-12-31" id="Fact001547" format="ixt:numdotdecimal" decimals="0" unitRef="USD">179,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:OtherAssetsNoncurrent" contextRef="AsOf2023-03-31" id="Fact001548" format="ixt:numdotdecimal" decimals="0" unitRef="USD">255,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--Assets_i01TI_zzEc0zgMGtPl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left; padding-bottom: 2.5pt"><b>Total Assets</b></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2023-12-31" id="Fact001550" format="ixt:numdotdecimal" decimals="0" unitRef="USD">27,715,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2023-03-31" id="Fact001551" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16,649,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--LiabilitiesAndStockholdersEquityAbstract_iB_z1lQUYAcgeag" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-decoration: underline; text-align: center">Liabilities and Shareholders&#8217; Equity</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--LiabilitiesCurrentAbstract_i01B_zbc9ZZfRKgof" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><b>Current Liabilities</b></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--AccountsPayableCurrent_i02I_z6qw7lQcxWj4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Accounts payable</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2023-12-31" id="Fact001559" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,616,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2023-03-31" id="Fact001560" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,769,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--AccruedLiabilitiesCurrent_i02I_zQH1kd3qLFnk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Accrued expenses</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2023-12-31" id="Fact001562" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,614,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2023-03-31" id="Fact001563" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,266,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--ContractWithCustomerRefundLiabilityCurrent_i02I_z0I0TOHOhBxa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Refund due to customer</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ContractWithCustomerRefundLiabilityCurrent" contextRef="AsOf2023-12-31" id="Fact001565" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,743,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1566">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--CustomerPrepayments_i02I_zxTDHeBof5ed" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Customer prepayments</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:CustomerPrepayments" contextRef="AsOf2023-12-31" id="Fact001568" format="ixt:numdotdecimal" decimals="0" unitRef="USD">687,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:CustomerPrepayments" contextRef="AsOf2023-03-31" id="Fact001569" format="ixt:numdotdecimal" decimals="0" unitRef="USD">583,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--ReserveForSalesReturns_i02I_zfcH9SWl2wE9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Reserve for sales returns</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:ReserveForSalesReturns" contextRef="AsOf2023-12-31" id="Fact001571" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,390,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:ReserveForSalesReturns" contextRef="AsOf2023-03-31" id="Fact001572" format="ixt:numdotdecimal" decimals="0" unitRef="USD">900,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--OtherLiabilitiesCurrent_i02I_zQIctxvnlkYk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Other current liabilities</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2023-12-31" id="Fact001574" format="ixt:numdotdecimal" decimals="0" unitRef="USD">75,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2023-03-31" id="Fact001575" format="ixt:numdotdecimal" decimals="0" unitRef="USD">99,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--OperatingLeaseLiabilityCurrent_i02I_zqrzyHahntF5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1pt">Current portion of operating lease liabilities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2023-12-31" id="Fact001577" format="ixt:numdotdecimal" decimals="0" unitRef="USD">84,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2023-03-31" id="Fact001578" format="ixt:numdotdecimal" decimals="0" unitRef="USD">509,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--LiabilitiesCurrent_i02TI_zZEBH0u55NY6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left"><b>Total Current Liabilities</b></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2023-12-31" id="Fact001580" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16,209,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2023-03-31" id="Fact001581" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,126,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--OtherLiabilitiesNoncurrent_i01I_z4QG5D6Dtejf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><b>Other liabilities, net of current portion</b></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesNoncurrent" contextRef="AsOf2023-12-31" id="Fact001583" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesNoncurrent" contextRef="AsOf2023-03-31" id="Fact001584" format="ixt:numdotdecimal" decimals="0" unitRef="USD">104,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--OperatingLeaseLiabilityNoncurrent_i01I_zhkPWrHJRygg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><b>Operating lease liabilities, net of current portion</b></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2023-12-31" id="Fact001586" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,925,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2023-03-31" id="Fact001587" format="ixt:numdotdecimal" decimals="0" unitRef="USD">88,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--Liabilities_i01TI_zlHLgNmBUTU7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left; padding-bottom: 1pt"><b>Total Liabilities</b></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2023-12-31" id="Fact001589" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,137,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2023-03-31" id="Fact001590" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,318,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--CommitmentsAndContingencies_i01TI_zONDHhoEdx3l" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><b>Commitments and Contingencies</b></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1592">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1593">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--StockholdersEquityAbstract_i01B_zvXF0NyLBBi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><b>Shareholders&#8217; Equity</b></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--PreferredStockValue_i02I_zWqcRvwcRhSi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Preferred stock, $<span id="xdx_90A_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20231231_zbxx6TwPXKCb" title="Preferred stock, par value"><span id="xdx_90F_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20230331_zicjv9H1mXN3" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2023-12-31" id="Fact001601" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2023-03-31" id="Fact001603" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.00</ix:nonFraction></ix:nonFraction></span></span> par value; <span id="xdx_907_eus-gaap--PreferredStockSharesAuthorized_iI_c20231231_znn1lcijWQd4" title="Preferred stock, shares authorized"><span id="xdx_905_eus-gaap--PreferredStockSharesAuthorized_iI_c20230331_zPMl6ixu20Ah" title="Preferred stock, shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2023-12-31" id="Fact001605" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2023-03-31" id="Fact001607" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,000,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized; <span id="xdx_901_eus-gaap--PreferredStockSharesIssued_iI_do_c20231231_zgAzyZL6jJu3" title="Preferred stock, shares issued"><span id="xdx_903_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20231231_z2Q1tWtpYIe9" title="Preferred stock, shares outstanding"><span id="xdx_904_eus-gaap--PreferredStockSharesIssued_iI_do_c20230331_zpP5xuFzIegj" title="Preferred stock, shares issued"><span id="xdx_905_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20230331_zBdtFkR8K6O3" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2023-12-31" id="Fact001609" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2023-12-31" id="Fact001611" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2023-03-31" id="Fact001613" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2023-03-31" id="Fact001615" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span> shares issued and outstanding</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1598">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1599">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--CommonStockValue_i02I_pp0p0_zdPkoKcoOl32" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Common stock $<span id="xdx_900_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20231231_zry4E8BvrX28" title="Common stock, par value"><span id="xdx_906_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20230331_zFPDptivusxl" title="Common stock, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2023-12-31" id="Fact001620" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2023-03-31" id="Fact001622" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.01</ix:nonFraction></ix:nonFraction></span></span> par value; <span id="xdx_90E_eus-gaap--CommonStockSharesAuthorized_iI_c20231231_zsCAWO4OiwBa" title="Common stock, shares authorized"><span id="xdx_901_eus-gaap--CommonStockSharesAuthorized_iI_c20230331_zaAB9JyXNqG9" title="Common stock, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2023-12-31" id="Fact001624" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2023-03-31" id="Fact001626" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">100,000,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized; <span id="xdx_90B_eus-gaap--CommonStockSharesIssued_iI_c20231231_z3wa7i7ZAlk7" title="Common stock, shares issued"><span id="xdx_905_eus-gaap--CommonStockSharesOutstanding_iI_c20231231_zbGX7wTVnnmi" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2023-12-31" id="Fact001628" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2023-12-31" id="Fact001630" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,418,061</ix:nonFraction></ix:nonFraction></span></span> issued and outstanding at December 31, 2023 and 3,184,439 issued and <span id="xdx_905_eus-gaap--CommonStockSharesIssued_iI_c20230331_zfOblMEFTNol" title="Common stock, shares issued"><span id="xdx_903_eus-gaap--CommonStockSharesOutstanding_iI_c20230331_zKJdT11Euwid" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2023-03-31" id="Fact001632" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2023-03-31" id="Fact001634" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,167,489</ix:nonFraction></ix:nonFraction></span></span> outstanding at March 31, 2023</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2023-12-31" id="Fact001617" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">64,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2023-03-31" id="Fact001618" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">32,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--AdditionalPaidInCapital_i02I_zaZWdzADarJf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Additional paid-in capital</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2023-12-31" id="Fact001636" format="ixt:numdotdecimal" decimals="0" unitRef="USD">33,429,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2023-03-31" id="Fact001637" format="ixt:numdotdecimal" decimals="0" unitRef="USD">29,822,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--CommonStockShareSubscribedButUnissuedSubscriptionsReceivable_i02NI_pp0p0_di_zSrgOwoLo508" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Subscriptions receivable</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1639">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:CommonStockShareSubscribedButUnissuedSubscriptionsReceivable" contextRef="AsOf2023-03-31" id="Fact001640" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_40F_eus-gaap--RetainedEarningsAccumulatedDeficit_i02I_zM6Bn32Vtps8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1pt">Accumulated deficit</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2023-12-31" id="Fact001642" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">25,915,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2023-03-31" id="Fact001643" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">19,517,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_403_eus-gaap--StockholdersEquity_i02TI_pp0p0_zt3mmk4Do8el" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left; padding-bottom: 1pt"><b>Total Shareholders&#8217; Equity</b></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31" id="Fact001645" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,578,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-31" id="Fact001646" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,331,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--LiabilitiesAndStockholdersEquity_i01TI_pp0p0_z8FaDaGRqp86" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left; padding-bottom: 2.5pt"><b>Total Liabilities and Shareholders&#8217; Equity</b></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2023-12-31" id="Fact001648" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">27,715,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2023-03-31" id="Fact001649" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">16,649,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>See
notes to the consolidated financial statements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 98; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="f_003"></span>The
Singing Machine Company, Inc. and Subsidiaries</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONSOLIDATED
STATEMENTS OF OPERATIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_308_113_zfbMDqlVzs55" summary="xdx: Statement - Condensed Consolidated Statements of Operations" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; display: none">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49A_20230401__20231231_zHMeam0IyEha" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: center">December 31, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_499_20220401__20230331_z8DXwzNOowNe" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: center">March 31, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_490_20210401__20220331_zbiIjShs3Di6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: center">March 31, 2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none; padding-bottom: 1pt">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center">Nine Months Ended</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Years Ended</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zq7fHmV7rQ1c" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; width: 43%; text-align: left">Net Sales</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2023-04-012023-12-31" id="Fact001651" format="ixt:numdotdecimal" decimals="0" unitRef="USD">29,198,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-04-012023-03-31" id="Fact001652" format="ixt:numdotdecimal" decimals="0" unitRef="USD">39,299,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-04-012022-03-31" id="Fact001653" format="ixt:numdotdecimal" decimals="0" unitRef="USD">47,512,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--CostOfGoodsAndServicesSold_zwsMKpJqv8r8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Cost of Goods Sold</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:CostOfGoodsAndServicesSold" contextRef="From2023-04-012023-12-31" id="Fact001655" format="ixt:numdotdecimal" decimals="0" unitRef="USD">23,008,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:CostOfGoodsAndServicesSold" contextRef="From2022-04-012023-03-31" id="Fact001656" format="ixt:numdotdecimal" decimals="0" unitRef="USD">30,090,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:CostOfGoodsAndServicesSold" contextRef="From2021-04-012022-03-31" id="Fact001657" format="ixt:numdotdecimal" decimals="0" unitRef="USD">36,697,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--GrossProfit_iT_zhauGAcAEWgf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Gross Profit</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2023-04-012023-12-31" id="Fact001659" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,190,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2022-04-012023-03-31" id="Fact001660" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,209,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2021-04-012022-03-31" id="Fact001661" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,815,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--OperatingExpensesAbstract_iB_zDtp2aQmVsQ2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Operating Expenses</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--SellingExpense_i01_zjTEpJ4PIltd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Selling expenses</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:SellingExpense" contextRef="From2023-04-012023-12-31" id="Fact001667" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,717,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:SellingExpense" contextRef="From2022-04-012023-03-31" id="Fact001668" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,442,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:SellingExpense" contextRef="From2021-04-012022-03-31" id="Fact001669" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,589,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--GeneralAndAdministrativeExpense_i01_zJQjVpwOQK0b" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1pt">General and administrative expenses</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2023-04-012023-12-31" id="Fact001671" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,616,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2022-04-012023-03-31" id="Fact001672" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,465,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2021-04-012022-03-31" id="Fact001673" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,157,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--OperatingExpenses_i01T_zjyHrV6nVYO4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Total Operating Expenses</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2023-04-012023-12-31" id="Fact001675" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,333,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2022-04-012023-03-31" id="Fact001676" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,907,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2021-04-012022-03-31" id="Fact001677" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,746,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--OperatingIncomeLoss_iT_z70PlvaOrKjf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">(Loss) Income from Operations</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2023-04-012023-12-31" id="Fact001679" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">6,143,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2022-04-012023-03-31" id="Fact001680" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,698,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2021-04-012022-03-31" id="Fact001681" format="ixt:numdotdecimal" decimals="0" unitRef="USD">69,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--NonoperatingIncomeExpenseAbstract_iB" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Other (Expenses) Income</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--GainLossOnDispositionOfAssets1_i01_zxDiKqFqhFyb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Gain on disposal of fixed assets</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:GainLossOnDispositionOfAssets1" contextRef="From2023-04-012023-12-31" id="Fact001687" format="ixt:numdotdecimal" decimals="0" unitRef="USD">44,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1688">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1689">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--GainFromRelatedPartyDebt_i01_z5cn7nBdwuDg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Gain - related party</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1691">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1692">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:GainFromRelatedPartyDebt" contextRef="From2021-04-012022-03-31" id="Fact001693" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--GainFromPaycheckProtectionPlanLoanForgiveness_i01_zUvhqhoLvMK4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Gain from extinguishment of PPP loan forgiveness</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1695">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1696">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:GainFromPaycheckProtectionPlanLoanForgiveness" contextRef="From2021-04-012022-03-31" id="Fact001697" format="ixt:numdotdecimal" decimals="0" unitRef="USD">448,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--GainFromEmployeeRetentionCreditProgramRefund_i01_zUVtxzshyxl3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Gain from Employee Retention Credit Program refund</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1699">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:GainFromEmployeeRetentionCreditProgramRefund" contextRef="From2022-04-012023-03-31" id="Fact001700" format="ixt:numdotdecimal" decimals="0" unitRef="USD">704,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1701">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--GainFromSettlementOfAccountsPayable_i01_zOIg1kL9AxFi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Gain from settlement of accounts payable</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1703">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:GainFromSettlementOfAccountsPayable" contextRef="From2022-04-012023-03-31" id="Fact001704" format="ixt:numdotdecimal" decimals="0" unitRef="USD">48,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:GainFromSettlementOfAccountsPayable" contextRef="From2021-04-012022-03-31" id="Fact001705" format="ixt:numdotdecimal" decimals="0" unitRef="USD">339,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--GainsLossesOnExtinguishmentOfDebt_i01_z6kn3XkKtmRe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Loss from extinguishment of debt</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1707">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="From2022-04-012023-03-31" id="Fact001708" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">183,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1709">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--InterestExpenseDebtExcludingAmortization_i01N_di_zOLKWC7jdRYk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1pt">Interest expense</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:InterestExpenseDebtExcludingAmortization" contextRef="From2023-04-012023-12-31" id="Fact001711" format="ixt:numdotdecimal" decimals="0" unitRef="USD">299,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:InterestExpenseDebtExcludingAmortization" contextRef="From2022-04-012023-03-31" id="Fact001712" format="ixt:numdotdecimal" decimals="0" unitRef="USD">479,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:InterestExpenseDebtExcludingAmortization" contextRef="From2021-04-012022-03-31" id="Fact001713" format="ixt:numdotdecimal" decimals="0" unitRef="USD">580,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_408_eus-gaap--NonoperatingIncomeExpense_i01T_zp5Bx9iM1qDf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Total Other (Expenses) Income, net</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2023-04-012023-12-31" id="Fact001715" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">255,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2022-04-012023-03-31" id="Fact001716" format="ixt:numdotdecimal" decimals="0" unitRef="USD">90,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2021-04-012022-03-31" id="Fact001717" format="ixt:numdotdecimal" decimals="0" unitRef="USD">218,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iT_pp0p0_z8hSLaL07tv9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">(Loss) Income Before Income Tax Benefit</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2023-04-012023-12-31" id="Fact001719" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">6,398,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2022-04-012023-03-31" id="Fact001720" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">3,608,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2021-04-012022-03-31" id="Fact001721" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">287,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--IncomeTaxExpenseBenefit_iN_di_zprYN0RSMzQ6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Income Tax Benefit (Provision)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1723">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2022-04-012023-03-31" id="Fact001724" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,030,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2021-04-012022-03-31" id="Fact001725" format="ixt:numdotdecimal" decimals="0" unitRef="USD">57,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--ProfitLoss_iT_zkXBOxyB5UVa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Net (Loss) Income</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-04-012023-12-31" id="Fact001727" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">6,398,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-04-012023-03-31" id="Fact001728" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,638,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-04-012022-03-31" id="Fact001729" format="ixt:numdotdecimal" decimals="0" unitRef="USD">230,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--EarningsPerShareAbstract_iB" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Loss per Common Share</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--EarningsPerShareBasic_i01_zZgn2Db1QDai" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Basic</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2023-04-012023-12-31" id="Fact001735" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">1.32</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2022-04-012023-03-31" id="Fact001736" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">1.65</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2021-04-012022-03-31" id="Fact001737" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.14</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--EarningsPerShareDiluted_i01_zNo2utdh2fbc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Diluted</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2023-04-012023-12-31" id="Fact001739" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">1.32</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2022-04-012023-03-31" id="Fact001740" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">1.65</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2021-04-012022-03-31" id="Fact001741" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.14</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--EarningsPerShareBasicOtherDisclosuresAbstract_iB_zrxsDXA2JEJ8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Weighted Average Common and Common</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Equivalent Shares:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--EarningsPerShareBasicOtherDisclosuresAbstract_iB_zHAh5Fr6lNCe" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: left">Weighted Average Common and Common Equivalent Shares:</td><td style="font: 10pt Times New Roman, Times, Serif; display: none">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; display: none">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; display: none">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_zrNa98uk6N6k" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Basic</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-04-012023-12-31" id="Fact001751" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,864,540</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2022-04-012023-03-31" id="Fact001752" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,811,872</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2021-04-012022-03-31" id="Fact001753" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,614,506</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_z0m43lertzA5" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; display: none; padding-left: 10pt; text-align: left">Basic </td><td style="font: 10pt Times New Roman, Times, Serif; display: none">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-04-012023-12-31" id="Fact001755" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,864,540</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; display: none">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2022-04-012023-03-31" id="Fact001756" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,811,872</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; display: none">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2021-04-012022-03-31" id="Fact001757" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,614,506</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_zQlvzLKHYKu3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Diluted</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-04-012023-12-31" id="Fact001759" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,864,540</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2022-04-012023-03-31" id="Fact001760" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,811,872</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2021-04-012022-03-31" id="Fact001761" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,623,397</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>See
notes to the consolidated financial statements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 99; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="f_004"></span>The
Singing Machine Company, Inc. and Subsidiaries</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONSOLIDATED
STATEMENTS OF CASH FLOWS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_305_112_zSLbc9GZMDkc" summary="xdx: Statement - Condensed Consolidated Statements of Cash Flows" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" id="xdx_49A_20230401__20231231_zrls0cajnui7" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" id="xdx_499_20220401__20230331_zw8HMAuKYa15" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" id="xdx_490_20210401__20220331_zRHx6u1BEJe2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">For the Nine Months Ended</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">For the Fiscal Years Ended</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB_zGBAnJ006Td3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Cash flows from operating activities</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--ProfitLoss_i01_z0fPw9Gow6Cl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 43%; text-align: left">Net (loss) income</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-04-012023-12-31" id="Fact001767" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">6,398,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-04-012023-03-31" id="Fact001768" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,638,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-04-012022-03-31" id="Fact001769" format="ixt:numdotdecimal" decimals="0" unitRef="USD">230,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_i01B_zQ9DQhVZd6Ld" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Adjustments to reconcile net (loss) income to net cash provided by (used in)
    operating activities:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--Depreciation_i02_zuGDbi9rFEZ" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left">Depreciation</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2023-04-012023-12-31" id="Fact001775" format="ixt:numdotdecimal" decimals="0" unitRef="USD">287,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2022-04-012023-03-31" id="Fact001776" format="ixt:numdotdecimal" decimals="0" unitRef="USD">228,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2021-04-012022-03-31" id="Fact001777" format="ixt:numdotdecimal" decimals="0" unitRef="USD">246,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--AmortizationOfFinancingCosts_i02_zgY6iQK2b22l" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left">Amortization of deferred financing costs</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1779">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AmortizationOfFinancingCosts" contextRef="From2022-04-012023-03-31" id="Fact001780" format="ixt:numdotdecimal" decimals="0" unitRef="USD">47,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AmortizationOfFinancingCosts" contextRef="From2021-04-012022-03-31" id="Fact001781" format="ixt:numdotdecimal" decimals="0" unitRef="USD">45,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--ProvisionForEstimatedCostOfReturns_i02N_di_zBQBOHio1BW8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left">Provision for estimated cost of returns</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="RIME:ProvisionForEstimatedCostOfReturns" contextRef="From2023-04-012023-12-31" id="Fact001783" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,364,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:ProvisionForEstimatedCostOfReturns" contextRef="From2022-04-012023-03-31" id="Fact001784" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">128,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="RIME:ProvisionForEstimatedCostOfReturns" contextRef="From2021-04-012022-03-31" id="Fact001785" format="ixt:numdotdecimal" decimals="0" unitRef="USD">156,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_405_ecustom--ProvisionForInventoryObsolescence_i02N_di_zcTcX2w9q0U8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left">Provision for inventory obsolesence</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:ProvisionForInventoryObsolescence" contextRef="From2023-04-012023-12-31" id="Fact001787" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,798,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:ProvisionForInventoryObsolescence" contextRef="From2022-04-012023-03-31" id="Fact001788" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">536,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="RIME:ProvisionForInventoryObsolescence" contextRef="From2021-04-012022-03-31" id="Fact001789" format="ixt:numdotdecimal" decimals="0" unitRef="USD">272,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_409_eus-gaap--ProvisionForDoubtfulAccounts_i02_zpc5psKTAdRi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left">Credit losses</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ProvisionForDoubtfulAccounts" contextRef="From2023-04-012023-12-31" id="Fact001791" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ProvisionForDoubtfulAccounts" contextRef="From2022-04-012023-03-31" id="Fact001792" format="ixt:numdotdecimal" decimals="0" unitRef="USD">43,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:ProvisionForDoubtfulAccounts" contextRef="From2021-04-012022-03-31" id="Fact001793" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">16,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_409_eus-gaap--GainLossOnSaleOfPropertyPlantEquipment_i02N_di_zRnTaVTCBxp" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left">(Gain) loss from disposal of property and equipment</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" contextRef="From2023-04-012023-12-31" id="Fact001795" format="ixt:numdotdecimal" decimals="0" unitRef="USD">44,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" contextRef="From2022-04-012023-03-31" id="Fact001796" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" contextRef="From2021-04-012022-03-31" id="Fact001797" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--ShareBasedCompensation_i02_zjGJCLuo3j19" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left">Stock based compensation</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2023-04-012023-12-31" id="Fact001799" format="ixt:numdotdecimal" decimals="0" unitRef="USD">110,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2022-04-012023-03-31" id="Fact001800" format="ixt:numdotdecimal" decimals="0" unitRef="USD">382,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2021-04-012022-03-31" id="Fact001801" format="ixt:numdotdecimal" decimals="0" unitRef="USD">44,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--OperatingLeaseRightOfUseAssetAmortizationExpense_i02_zkVIrM0R5qQ8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left">Amortization of right of use assets</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" contextRef="From2023-04-012023-12-31" id="Fact001803" format="ixt:numdotdecimal" decimals="0" unitRef="USD">510,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" contextRef="From2022-04-012023-03-31" id="Fact001804" format="ixt:numdotdecimal" decimals="0" unitRef="USD">718,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" contextRef="From2021-04-012022-03-31" id="Fact001805" format="ixt:numdotdecimal" decimals="0" unitRef="USD">795,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--DeferredIncomeTaxExpenseBenefit_i02_zd4H4qG8wKAg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left">Change in net deferred tax assets</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1807">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="From2022-04-012023-03-31" id="Fact001808" format="ixt:numdotdecimal" decimals="0" unitRef="USD">893,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="From2021-04-012022-03-31" id="Fact001809" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">5,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_407_eus-gaap--GainsLossesOnExtinguishmentOfDebt_i02N_di_z4WRdRgMtB1b" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left">Loss on debt extinguishment</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1811">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="From2022-04-012023-03-31" id="Fact001812" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">183,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1813">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecustom--GainFromPaycheckProtectionPlanLoanForgiveness_i02N_di_z431lnEB9Qhg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left">Paycheck Protection Plan loan forgiveness</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1815">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1816">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="RIME:GainFromPaycheckProtectionPlanLoanForgiveness" contextRef="From2021-04-012022-03-31" id="Fact001817" format="ixt:numdotdecimal" decimals="0" unitRef="USD">448,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_404_ecustom--GainFromRelatedPartyDebt_i02N_di_z1qnPV51Ayya" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left">Gain - related party</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1819">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1820">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="RIME:GainFromRelatedPartyDebt" contextRef="From2021-04-012022-03-31" id="Fact001821" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_404_ecustom--GainFromSettlementOfAccountsPayable_i02N_di_zLCdwlKRKsTi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left">Gain from extinguishment of accounts payable</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1823">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="RIME:GainFromSettlementOfAccountsPayable" contextRef="From2022-04-012023-03-31" id="Fact001824" format="ixt:numdotdecimal" decimals="0" unitRef="USD">48,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="RIME:GainFromSettlementOfAccountsPayable" contextRef="From2021-04-012022-03-31" id="Fact001825" format="ixt:numdotdecimal" decimals="0" unitRef="USD">339,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_40F_eus-gaap--IncreaseDecreaseInOperatingCapitalAbstract_i02B_zsVcS0Z4JVxj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Changes in operating assets and liabilities:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--IncreaseDecreaseInAccountsReceivable_i03N_di_zNKNYjc917S" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left">Accounts receivable</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2023-04-012023-12-31" id="Fact001831" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,241,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2022-04-012023-03-31" id="Fact001832" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">667,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2021-04-012022-03-31" id="Fact001833" format="ixt:numdotdecimal" decimals="0" unitRef="USD">558,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_40F_eus-gaap--IncreaseDecreaseInAccountsReceivableRelatedParties_i03N_di_zxAZInQnQgc9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left">Accounts receivable &#8211; related parties</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivableRelatedParties" contextRef="From2023-04-012023-12-31" id="Fact001835" format="ixt:numdotdecimal" decimals="0" unitRef="USD">30,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivableRelatedParties" contextRef="From2022-04-012023-03-31" id="Fact001836" format="ixt:numdotdecimal" decimals="0" unitRef="USD">87,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivableRelatedParties" contextRef="From2021-04-012022-03-31" id="Fact001837" format="ixt:numdotdecimal" decimals="0" unitRef="USD">64,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_40A_eus-gaap--IncreaseDecreaseDueFromAffiliates_i03N_di_z0XhFHamuWx9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left">Due from banks</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1839">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseDueFromAffiliates" contextRef="From2022-04-012023-03-31" id="Fact001840" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">101,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseDueFromAffiliates" contextRef="From2021-04-012022-03-31" id="Fact001841" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,456,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--IncreaseDecreaseInInventories_i03N_di_zH6e3Zeix9k" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left">Inventories</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInInventories" contextRef="From2023-04-012023-12-31" id="Fact001843" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">415,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInInventories" contextRef="From2022-04-012023-03-31" id="Fact001844" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,858,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInInventories" contextRef="From2021-04-012022-03-31" id="Fact001845" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,244,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_404_eus-gaap--IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_i03N_di_zV6Tff76SXce" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left">Prepaid expenses and other current assets</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="From2023-04-012023-12-31" id="Fact001847" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">215,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="From2022-04-012023-03-31" id="Fact001848" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">78,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="From2021-04-012022-03-31" id="Fact001849" format="ixt:numdotdecimal" decimals="0" unitRef="USD">123,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_409_eus-gaap--IncreaseDecreaseInOtherNoncurrentAssets_i03N_di_zwkqTOkbpUVl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left">Other non-current assets</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" contextRef="From2023-04-012023-12-31" id="Fact001851" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">76,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" contextRef="From2022-04-012023-03-31" id="Fact001852" format="ixt:numdotdecimal" decimals="0" unitRef="USD">38,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" contextRef="From2021-04-012022-03-31" id="Fact001853" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">61,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--IncreaseDecreaseInAccountsPayable_i03_zBshKghPxG4j" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left">Accounts payable</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="From2023-04-012023-12-31" id="Fact001855" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,847,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="From2022-04-012023-03-31" id="Fact001856" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,511,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="From2021-04-012022-03-31" id="Fact001857" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,217,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--IncreaseDecreaseInAccruedLiabilities_i03_zGS4iZzXmaA4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left">Accrued expenses</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedLiabilities" contextRef="From2023-04-012023-12-31" id="Fact001859" format="ixt:numdotdecimal" decimals="0" unitRef="USD">348,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedLiabilities" contextRef="From2022-04-012023-03-31" id="Fact001860" format="ixt:numdotdecimal" decimals="0" unitRef="USD">533,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedLiabilities" contextRef="From2021-04-012022-03-31" id="Fact001861" format="ixt:numdotdecimal" decimals="0" unitRef="USD">77,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--IncreaseDecreaseInDueToRelatedParties_i03_zE0QLvKuqQn" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left">Due to related parties</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1863">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInDueToRelatedParties" contextRef="From2022-04-012023-03-31" id="Fact001864" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">63,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1865">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--IncreaseDecreaseInContractWithCustomerLiability_i03_zxueobGnsECc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left">Refunds due  to customer</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" contextRef="From2023-04-012023-12-31" id="Fact001867" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,743,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1868">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" contextRef="From2021-04-012022-03-31" id="Fact001869" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">139,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_40F_ecustom--IncreaseDecreaseInPrepaidsFromCustomers_i03_ze5QviuKf5Fd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left">Prepaids from customers</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:IncreaseDecreaseInPrepaidsFromCustomers" contextRef="From2023-04-012023-12-31" id="Fact001871" format="ixt:numdotdecimal" decimals="0" unitRef="USD">103,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:IncreaseDecreaseInPrepaidsFromCustomers" contextRef="From2022-04-012023-03-31" id="Fact001872" format="ixt:numdotdecimal" decimals="0" unitRef="USD">485,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="RIME:IncreaseDecreaseInPrepaidsFromCustomers" contextRef="From2021-04-012022-03-31" id="Fact001873" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">47,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_404_ecustom--IncreaseDecreaseInReserveForSalesReturns_i03_z9N3JfxXKUwc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left">Reserve for sales returns</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:IncreaseDecreaseInReserveForSalesReturns" contextRef="From2023-04-012023-12-31" id="Fact001875" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,490,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="RIME:IncreaseDecreaseInReserveForSalesReturns" contextRef="From2022-04-012023-03-31" id="Fact001876" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">90,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:IncreaseDecreaseInReserveForSalesReturns" contextRef="From2021-04-012022-03-31" id="Fact001877" format="ixt:numdotdecimal" decimals="0" unitRef="USD">30,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--IncreaseDecreaseInOperatingLeaseLiability_i03_zYpoWoCeF4Z" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left; padding-bottom: 1pt">Operating lease liabilities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" contextRef="From2023-04-012023-12-31" id="Fact001879" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">462,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" contextRef="From2022-04-012023-03-31" id="Fact001880" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">738,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" contextRef="From2021-04-012022-03-31" id="Fact001881" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">795,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_404_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i03T_zXDjgPW2n9J1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 30pt; text-align: left; padding-bottom: 1pt">Net cash provided by (used in) operating activities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2023-04-012023-12-31" id="Fact001883" format="ixt:numdotdecimal" decimals="0" unitRef="USD">411,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2022-04-012023-03-31" id="Fact001884" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">330,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2021-04-012022-03-31" id="Fact001885" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,012,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_402_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB_zQ3Yeccwp61b" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Cash flows from investing activities</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_i01N_di_zlAmBClbLJ39" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Purchase of property and equipment</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2023-04-012023-12-31" id="Fact001891" format="ixt:numdotdecimal" decimals="0" unitRef="USD">68,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2022-04-012023-03-31" id="Fact001892" format="ixt:numdotdecimal" decimals="0" unitRef="USD">244,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2021-04-012022-03-31" id="Fact001893" format="ixt:numdotdecimal" decimals="0" unitRef="USD">118,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_409_eus-gaap--ProceedsFromSaleOfPropertyPlantAndEquipment_i01_zbNLszMhKT87" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1pt">Disposal of property and equipment</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" contextRef="From2023-04-012023-12-31" id="Fact001895" format="ixt:numdotdecimal" decimals="0" unitRef="USD">54,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1896">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1897">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--NetCashProvidedByUsedInInvestingActivities_i01T_z26rS3SaZlY7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 30pt; text-align: left; padding-bottom: 1pt">Net cash used in investing activities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2023-04-012023-12-31" id="Fact001899" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">14,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2022-04-012023-03-31" id="Fact001900" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">244,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2021-04-012022-03-31" id="Fact001901" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">118,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40F_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB_zgdIXCR80Uc3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Cash flows from financing activities</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--ProceedsFromIssuanceOfCommonStock_i01_zBsGV74M4Rc3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Proceeds from issuance of stock, net of offering costs</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2023-04-012023-12-31" id="Fact001907" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,529,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2022-04-012023-03-31" id="Fact001908" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,393,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2021-04-012022-03-31" id="Fact001909" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,001,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--PaymentOfRedemptionAndRetirementOfTreasuryStock_i01N_di_zDyXQWqT9a1c" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Payment of redemption and retirement of treasury stock</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1911">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1912">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="RIME:PaymentOfRedemptionAndRetirementOfTreasuryStock" contextRef="From2021-04-012022-03-31" id="Fact001913" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,162,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_40D_ecustom--ProceedsFromCollectionOfSubscriptionsReceivable_i01_znOfJ5akpb17" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Collection of subscriptions receivable</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:ProceedsFromCollectionOfSubscriptionsReceivable" contextRef="From2023-04-012023-12-31" id="Fact001915" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1916">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1917">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--ProceedsFromRepaymentsOfLinesOfCredit_i01_z8ER2WNY4Ls3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Net (payment) proceeds from revolving lines of credit</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1919">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:ProceedsFromRepaymentsOfLinesOfCredit" contextRef="From2022-04-012023-03-31" id="Fact001920" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,500,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromRepaymentsOfLinesOfCredit" contextRef="From2021-04-012022-03-31" id="Fact001921" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,435,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--RepaymentsOfSubordinatedDebt_i01N_di_zsugwgNf0ofc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Payment of subordinated note payable - Starlight Marketing Development, Ltd.</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1923">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:RepaymentsOfSubordinatedDebt" contextRef="From2022-04-012023-03-31" id="Fact001924" format="ixt:numdotdecimal" decimals="0" unitRef="USD">353,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:RepaymentsOfSubordinatedDebt" contextRef="From2021-04-012022-03-31" id="Fact001925" format="ixt:numdotdecimal" decimals="0" unitRef="USD">150,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_403_ecustom--PaymentOfDeferredFinancingCharges_i01N_di_zo29puAtGuw3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Payment of deferred financing charges</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1927">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="RIME:PaymentOfDeferredFinancingCharges" contextRef="From2022-04-012023-03-31" id="Fact001928" format="ixt:numdotdecimal" decimals="0" unitRef="USD">254,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="RIME:PaymentOfDeferredFinancingCharges" contextRef="From2021-04-012022-03-31" id="Fact001929" format="ixt:numdotdecimal" decimals="0" unitRef="USD">38,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_40D_ecustom--PaymentOfEarlyTerminationFeesOnRevolvingLinesOfCredit_i01N_di_zg5BJQUpUg13" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Payment of early termination fees on revolving lines of credit</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1931">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="RIME:PaymentOfEarlyTerminationFeesOnRevolvingLinesOfCredit" contextRef="From2022-04-012023-03-31" id="Fact001932" format="ixt:numdotdecimal" decimals="0" unitRef="USD">183,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1933">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--PaymentsOnInstallmentNote_i01N_di_zw8CLc7P0WF5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Payments on installment notes</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="RIME:PaymentsOnInstallmentNote" contextRef="From2023-04-012023-12-31" id="Fact001935" format="ixt:numdotdecimal" decimals="0" unitRef="USD">124,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="RIME:PaymentsOnInstallmentNote" contextRef="From2022-04-012023-03-31" id="Fact001936" format="ixt:numdotdecimal" decimals="0" unitRef="USD">74,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="RIME:PaymentsOnInstallmentNote" contextRef="From2021-04-012022-03-31" id="Fact001937" format="ixt:numdotdecimal" decimals="0" unitRef="USD">68,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_408_eus-gaap--ProceedsFromStockOptionsExercised_i01_zyACRbwtOpyb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Proceeds from exercise of stock options</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1939">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1940">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="From2021-04-012022-03-31" id="Fact001941" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecustom--ProceedsFromExerciseOfCommonStockWarrants_i01_zijymPrxeRGg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Proceeds from exercise of common stock warrants</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1943">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:ProceedsFromExerciseOfCommonStockWarrants" contextRef="From2022-04-012023-03-31" id="Fact001944" format="ixt:numdotdecimal" decimals="0" unitRef="USD">990,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1945">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--ProceedsFromWarrantExercises_i01_zDLahcR4Bpel" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Proceeds from exercise of pre-funded warrants</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1947">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromWarrantExercises" contextRef="From2022-04-012023-03-31" id="Fact001948" format="ixt:numdotdecimal" decimals="0" unitRef="USD">168,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1949">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--RepaymentsOfDebtAndCapitalLeaseObligations_i01N_di_zXyTVxTk9WV2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1pt">Payments on finance leases</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1951">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations" contextRef="From2022-04-012023-03-31" id="Fact001952" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations" contextRef="From2021-04-012022-03-31" id="Fact001953" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_409_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_z7bYJ7FWsMx8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 30pt; text-align: left; padding-bottom: 1pt">Net cash provided by financing activities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2023-04-012023-12-31" id="Fact001955" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,411,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2022-04-012023-03-31" id="Fact001956" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,178,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2021-04-012022-03-31" id="Fact001957" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,024,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_iT_zj9Sl7KnVhhk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Net change in cash</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2023-04-012023-12-31" id="Fact001959" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,808,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2022-04-012023-03-31" id="Fact001960" format="ixt:numdotdecimal" decimals="0" unitRef="USD">604,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2021-04-012022-03-31" id="Fact001961" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,894,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iS_zKr2t1UFcsDe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Cash at beginning of year</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2023-03-31" id="Fact001963" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,895,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2022-03-31" id="Fact001964" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,291,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2021-03-31" id="Fact001965" format="ixt:numdotdecimal" decimals="0" unitRef="USD">397,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iE_zGTT3KI2QL8d" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Cash at end of period</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2023-12-31" id="Fact001967" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,703,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2023-03-31" id="Fact001968" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,895,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2022-03-31" id="Fact001969" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,291,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--SupplementalCashFlowInformationAbstract_iB_z7mCqglBmusa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Supplemental disclosures of cash flow information:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--InterestPaidNet_i01_z3Sw1IBVZNY8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Cash paid for interest</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2023-04-012023-12-31" id="Fact001975" format="ixt:numdotdecimal" decimals="0" unitRef="USD">44,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2022-04-012023-03-31" id="Fact001976" format="ixt:numdotdecimal" decimals="0" unitRef="USD">481,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2021-04-012022-03-31" id="Fact001977" format="ixt:numdotdecimal" decimals="0" unitRef="USD">547,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--IncomeTaxesPaidNet_i01_ztNEY0Ll7lZg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Cash paid for income taxes</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1979">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxesPaidNet" contextRef="From2022-04-012023-03-31" id="Fact001980" format="ixt:numdotdecimal" decimals="0" unitRef="USD">34,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1981">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--NoncashInvestingAndFinancingItemsAbstract_iB_zxT3D5lyqbS1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Non-Cash investing and financing cash flow information:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--CapitalLeaseObligationsIncurred_i01_z4bgtX4cCZ4c" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Equipment purchased under capital lease</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1987">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:CapitalLeaseObligationsIncurred" contextRef="From2022-04-012023-03-31" id="Fact001988" format="ixt:numdotdecimal" decimals="0" unitRef="USD">55,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:CapitalLeaseObligationsIncurred" contextRef="From2021-04-012022-03-31" id="Fact001989" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--IssuanceOfCommonStockAndWarrantsForOfferingCosts_i01_zt5Nmovg97hl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Issuance of common stock and warrants for offering costs</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1991">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:IssuanceOfCommonStockAndWarrantsForOfferingCosts" contextRef="From2022-04-012023-03-31" id="Fact001992" format="ixt:numdotdecimal" decimals="0" unitRef="USD">244,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:IssuanceOfCommonStockAndWarrantsForOfferingCosts" contextRef="From2021-04-012022-03-31" id="Fact001993" format="ixt:numdotdecimal" decimals="0" unitRef="USD">548,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_i01_zhcMTelbO7rg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Right of use assets exchanged for lease liabilities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" contextRef="From2023-04-012023-12-31" id="Fact001995" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,874,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" contextRef="From2022-04-012023-03-31" id="Fact001996" format="ixt:numdotdecimal" decimals="0" unitRef="USD">192,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" contextRef="From2021-04-012022-03-31" id="Fact001997" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>See
notes to the consolidated financial statements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 100; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="f_005"></span>The
Singing Machine Company, Inc. and Subsidiaries</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONSOLIDATED
STATEMENTS OF SHAREHOLDERS&#8217; EQUITY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For
the twelve months ended March 31, 2023 and 2022 and nine months ended December 31, 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_306_114_z4egWyq9Tsf4" summary="xdx: Statement - Condensed Consolidated Statements of Shareholders' (Deficit) Equity" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; display: none">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; display: none">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; display: none">&#160;</td>
    <td colspan="2" id="xdx_4B2_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zHl6CDIBSOhk" style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; display: none">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; display: none">&#160;</td>
    <td colspan="2" id="xdx_4B5_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_z8C2RC9Y3vSh" style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; display: none">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; display: none">&#160;</td>
    <td colspan="2" id="xdx_4BB_us-gaap--StatementEquityComponentsAxis_us-gaap--ReceivablesFromStockholderMember_zHpCaYQxAiL9" style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; display: none">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; display: none">&#160;</td>
    <td colspan="2" id="xdx_4B2_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zp3mRwC1CTV4" style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; display: none">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; display: none">&#160;</td>
    <td colspan="2" id="xdx_4BC_z6xXgf7ABRx5" style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; display: none">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Common Stock</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Additional </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Paid in </b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center">Subscriptions</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center">Accumulated</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Shares</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Amount</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Capital</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Receivable</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Deficit</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Total</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr id="xdx_438_c20210401__20220331_eus-gaap--StockholdersEquity_iS_zRT9MCY4U8Qe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; width: 40%; text-align: left">Balance at March 31, 2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--SharesOutstanding_iS_c20210401__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zTBpAqohVs75" title="Balance, shares" style="font: bold 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-03-31_us-gaap_CommonStockMember" id="Fact002005" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,301,358</ix:nonFraction></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-03-31_us-gaap_CommonStockMember" id="Fact001999" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,000</ix:nonFraction></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-03-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact002000" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,151,000</ix:nonFraction></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2001">-</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 6%; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-03-31_us-gaap_RetainedEarningsMember" id="Fact002002" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">12,254,000</ix:nonFraction></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-03-31" id="Fact002003" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,910,000</ix:nonFraction></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--ProfitLoss_z248zpM0R5zk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Net income</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2007">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2008">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2009">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-04-012022-03-31_us-gaap_RetainedEarningsMember" id="Fact002010" format="ixt:numdotdecimal" decimals="0" unitRef="USD">230,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-04-012022-03-31" id="Fact002011" format="ixt:numdotdecimal" decimals="0" unitRef="USD">230,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--StockIssuedDuringPeriodValueNewIssues_z5kGteamUhxb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Issuance of common stock</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210401__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zg9QXw6TXObg" title="Issuance of common stock, shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2021-04-012022-03-31_us-gaap_CommonStockMember" id="Fact002019" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">550,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2021-04-012022-03-31_us-gaap_CommonStockMember" id="Fact002013" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2021-04-012022-03-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact002014" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,944,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2015">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2016">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2021-04-012022-03-31" id="Fact002017" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,950,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--AdjustmentsToAdditionalPaidInCapitalWarrantIssued_zmQchn7Lr517" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Issuance of pre-funded warrants</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2021">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="From2021-04-012022-03-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact002022" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,882,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2023">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2024">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="From2021-04-012022-03-31" id="Fact002025" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,882,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_iN_di_z1vnOJLjvZF7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Common stock offering costs</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2027">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" contextRef="From2021-04-012022-03-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact002028" format="ixt:numdotdecimal" decimals="0" unitRef="USD">831,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2029">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2030">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" contextRef="From2021-04-012022-03-31" id="Fact002031" format="ixt:numdotdecimal" decimals="0" unitRef="USD">831,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_402_eus-gaap--StockIssuedDuringPeriodValueOther_zVEbpQjPtMBc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Issuance of common stock for stock offering costs</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--StockIssuedDuringPeriodSharesOther_c20210401__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zVV6xYbYVWbf" title="Issuance of common stock for stock offering costs, shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesOther" contextRef="From2021-04-012022-03-31_us-gaap_CommonStockMember" id="Fact002039" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">19,047</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2033">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2034">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2035">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2036">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2037">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--TreasuryStockRetiredCostMethodAmount_iN_di_zx7OiYQ46Cwc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Redemption and retirement of treasury shares</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--TreasuryStockSharesRetired_iN_di_c20210401__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z5ISAB26R6g6" title="Redemption and retirement of treasury shares, shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:TreasuryStockSharesRetired" contextRef="From2021-04-012022-03-31_us-gaap_CommonStockMember" id="Fact002047" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">654,105</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:TreasuryStockRetiredCostMethodAmount" contextRef="From2021-04-012022-03-31_us-gaap_CommonStockMember" id="Fact002041" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:TreasuryStockRetiredCostMethodAmount" contextRef="From2021-04-012022-03-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact002042" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,301,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2043">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:TreasuryStockRetiredCostMethodAmount" contextRef="From2021-04-012022-03-31_us-gaap_RetainedEarningsMember" id="Fact002044" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,855,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:TreasuryStockRetiredCostMethodAmount" contextRef="From2021-04-012022-03-31" id="Fact002045" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,163,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_40B_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensation_zxvtPwtm5eli" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Stock based compensation</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensation_c20210401__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zQaEDUy3gOBf" title="Stock based compensation, shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" contextRef="From2021-04-012022-03-31_us-gaap_CommonStockMember" id="Fact002055" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,242</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2049">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2021-04-012022-03-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact002050" format="ixt:numdotdecimal" decimals="0" unitRef="USD">44,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2051">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2052">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2021-04-012022-03-31" id="Fact002053" format="ixt:numdotdecimal" decimals="0" unitRef="USD">44,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_zZIHOUsxLN09" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Exercise of stock options</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20210401__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z5pa2B4egmj7" title="Exercise of stock options, shares" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2021-04-012022-03-31_us-gaap_CommonStockMember" id="Fact002063" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,667</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2057">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2021-04-012022-03-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact002058" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2059">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2060">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2021-04-012022-03-31" id="Fact002061" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_43A_c20220401__20230331_eus-gaap--StockholdersEquity_iS_z7P3isVEVxPk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Balance at March 31, 2022</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--SharesOutstanding_iS_c20220401__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zPfJCXzNyj4d" title="Balance, shares" style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-03-31_us-gaap_CommonStockMember" id="Fact002071" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,221,209</ix:nonFraction></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-03-31_us-gaap_CommonStockMember" id="Fact002065" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,000</ix:nonFraction></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-03-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact002066" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,903,000</ix:nonFraction></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2067">-</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-03-31_us-gaap_RetainedEarningsMember" id="Fact002068" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">14,879,000</ix:nonFraction></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-03-31" id="Fact002069" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,036,000</ix:nonFraction></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--ProfitLoss_zgR8XGiE4oO4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Net loss</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2073">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2074">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2075">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-04-012023-03-31_us-gaap_RetainedEarningsMember" id="Fact002076" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,638,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-04-012023-03-31" id="Fact002077" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,638,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_408_eus-gaap--StockIssuedDuringPeriodValueNewIssues_zAIizrRv3ZK1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Issuance of common stock</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220401__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zQBXLEcqPL24" title="Issuance of common stock, shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2022-04-012023-03-31_us-gaap_CommonStockMember" id="Fact002085" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,014,230</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-04-012023-03-31_us-gaap_CommonStockMember" id="Fact002079" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-04-012023-03-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact002080" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,026,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-04-012023-03-31_us-gaap_ReceivablesFromStockholderMember" id="Fact002081" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">6,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2082">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-04-012023-03-31" id="Fact002083" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,030,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_iN_di_zk3yaLn1Nyed" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Common stock offering costs</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2087">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" contextRef="From2022-04-012023-03-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact002088" format="ixt:numdotdecimal" decimals="0" unitRef="USD">637,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2089">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2090">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" contextRef="From2022-04-012023-03-31" id="Fact002091" format="ixt:numdotdecimal" decimals="0" unitRef="USD">637,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_401_ecustom--StockIssuedDuringPeriodValueExerciseOfPrefundedAndCommonWarrants_z7ojdt48WTFc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Exercise of pre-funded and common warrants</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_987_ecustom--StockIssuedDuringPeriodSharesExerciseOfPrefundedAndCommonWarrants_pid_c20220401__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zWHoaic8cLv3" title="Exercise of pre-funded warrants, shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:StockIssuedDuringPeriodSharesExerciseOfPrefundedAndCommonWarrants" contextRef="From2022-04-012023-03-31_us-gaap_CommonStockMember" id="Fact002099" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">914,558</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:StockIssuedDuringPeriodValueExerciseOfPrefundedAndCommonWarrants" contextRef="From2022-04-012023-03-31_us-gaap_CommonStockMember" id="Fact002093" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:StockIssuedDuringPeriodValueExerciseOfPrefundedAndCommonWarrants" contextRef="From2022-04-012023-03-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact002094" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,148,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2095">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2096">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:StockIssuedDuringPeriodValueExerciseOfPrefundedAndCommonWarrants" contextRef="From2022-04-012023-03-31" id="Fact002097" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,158,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensation_zkNP010nAkC6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Stock based compensation</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensation_c20220401__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zQOST3obCrs8" title="Stock based compensation, shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" contextRef="From2022-04-012023-03-31_us-gaap_CommonStockMember" id="Fact002107" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">15,803</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2101">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2022-04-012023-03-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact002102" format="ixt:numdotdecimal" decimals="0" unitRef="USD">145,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2103">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2104">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2022-04-012023-03-31" id="Fact002105" format="ixt:numdotdecimal" decimals="0" unitRef="USD">145,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_zV6G1owdLJIe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Employee compensation - stock option</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2109">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2022-04-012023-03-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact002110" format="ixt:numdotdecimal" decimals="0" unitRef="USD">237,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2111">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2112">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2022-04-012023-03-31" id="Fact002113" format="ixt:numdotdecimal" decimals="0" unitRef="USD">237,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--StockIssuedDuringPeriodValueReverseStockSplits_zAxU8Zaotyig" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Other</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--StockIssuedDuringPeriodSharesReverseStockSplits_pid_c20220401__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zPqtveay13hl" title="Rounding of common stock issued due to reverse split, shares" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesReverseStockSplits" contextRef="From2022-04-012023-03-31_us-gaap_CommonStockMember" id="Fact002121" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,688</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2115">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2116">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2117">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2118">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2119">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_431_c20230401__20231231_eus-gaap--StockholdersEquity_iS_zFy5Q73GoU3g" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Balance at March 31, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--SharesOutstanding_iS_c20230401__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zMAryo0QXl7j" title="Balance, shares" style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-03-31_us-gaap_CommonStockMember" id="Fact002129" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,167,488</ix:nonFraction></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-31_us-gaap_CommonStockMember" id="Fact002123" format="ixt:numdotdecimal" decimals="0" unitRef="USD">32,000</ix:nonFraction></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact002124" format="ixt:numdotdecimal" decimals="0" unitRef="USD">29,822,000</ix:nonFraction></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-31_us-gaap_ReceivablesFromStockholderMember" id="Fact002125" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">6,000</ix:nonFraction></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-31_us-gaap_RetainedEarningsMember" id="Fact002126" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">19,517,000</ix:nonFraction></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-31" id="Fact002127" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,331,000</ix:nonFraction></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_432_c20230401__20231231_eus-gaap--StockholdersEquity_iS_zSogdJciyaA8" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: left">Balance</td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--SharesOutstanding_iS_c20230401__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zJ47yS1G3Fh" title="Balance, shares" style="font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-03-31_us-gaap_CommonStockMember" id="Fact002137" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,167,488</ix:nonFraction></td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-31_us-gaap_CommonStockMember" id="Fact002131" format="ixt:numdotdecimal" decimals="0" unitRef="USD">32,000</ix:nonFraction></td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact002132" format="ixt:numdotdecimal" decimals="0" unitRef="USD">29,822,000</ix:nonFraction></td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-31_us-gaap_ReceivablesFromStockholderMember" id="Fact002133" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">6,000</ix:nonFraction></td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: left">)</td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-31_us-gaap_RetainedEarningsMember" id="Fact002134" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">19,517,000</ix:nonFraction></td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: left">)</td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-31" id="Fact002135" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,331,000</ix:nonFraction></td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: left">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--ProfitLoss_zZR3dJVhMcne" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Net loss</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2139">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2140">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2141">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-04-012023-12-31_us-gaap_RetainedEarningsMember" id="Fact002142" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">6,398,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-04-012023-12-31" id="Fact002143" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">6,398,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_40A_eus-gaap--ProfitLoss_zqZv7raRaNZ2" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left">Net income (Ioss)</td><td style="font: 10pt Times New Roman, Times, Serif; display: none">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; display: none">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2145">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; display: none">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2146">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; display: none">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2147">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; display: none">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-04-012023-12-31_us-gaap_RetainedEarningsMember" id="Fact002148" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">6,398,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; display: none">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-04-012023-12-31" id="Fact002149" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">6,398,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left">)</td></tr>
<tr id="xdx_40D_ecustom--StockIssuedDuringPeriodValueIssuanceOfCommonStockAtMarketOffering_znmJj2bCK3Af" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Issuance of common stock - at-the -market offering</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_983_ecustom--StockIssuedDuringPeriodSharesIssuanceOfCommonStockAtMarketOffering_pid_c20230401__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zd0oEfCibN23" title="Issuance of common stock - at-the-market offering, shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:StockIssuedDuringPeriodSharesIssuanceOfCommonStockAtMarketOffering" contextRef="From2023-04-012023-12-31_us-gaap_CommonStockMember" id="Fact002157" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,052,770</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:StockIssuedDuringPeriodValueIssuanceOfCommonStockAtMarketOffering" contextRef="From2023-04-012023-12-31_us-gaap_CommonStockMember" id="Fact002151" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:StockIssuedDuringPeriodValueIssuanceOfCommonStockAtMarketOffering" contextRef="From2023-04-012023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact002152" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,699,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2153">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2154">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:StockIssuedDuringPeriodValueIssuanceOfCommonStockAtMarketOffering" contextRef="From2023-04-012023-12-31" id="Fact002155" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,709,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_ecustom--StockIssuedDuringPeriodValueIssuanceOfCommonStockPrivatePlacement_zuchvHYFkyxe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Issuance of common stock - private placement</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98F_ecustom--StockIssuedDuringPeriodSharesIssuanceOfCommonStockPrivatePlacement_pid_c20230401__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zW1GPLVpZXnb" title="Issuance of common stock - private placement, shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:StockIssuedDuringPeriodSharesIssuanceOfCommonStockPrivatePlacement" contextRef="From2023-04-012023-12-31_us-gaap_CommonStockMember" id="Fact002165" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,197,803</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:StockIssuedDuringPeriodValueIssuanceOfCommonStockPrivatePlacement" contextRef="From2023-04-012023-12-31_us-gaap_CommonStockMember" id="Fact002159" format="ixt:numdotdecimal" decimals="0" unitRef="USD">22,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:StockIssuedDuringPeriodValueIssuanceOfCommonStockPrivatePlacement" contextRef="From2023-04-012023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact002160" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,977,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2161">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2162">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:StockIssuedDuringPeriodValueIssuanceOfCommonStockPrivatePlacement" contextRef="From2023-04-012023-12-31" id="Fact002163" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,999,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_iN_di_zwAw2MAdBXr9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Common stock offering costs</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2167">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" contextRef="From2023-04-012023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact002168" format="ixt:numdotdecimal" decimals="0" unitRef="USD">179,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2169">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2170">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" contextRef="From2023-04-012023-12-31" id="Fact002171" format="ixt:numdotdecimal" decimals="0" unitRef="USD">179,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_409_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensation_zGGTUyA6apfe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Stock based compensation</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensation_c20230401__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zTFvP7ld8gYi" title="Stock based compensation, shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2179">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2173">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2023-04-012023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact002174" format="ixt:numdotdecimal" decimals="0" unitRef="USD">110,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2175">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2176">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2023-04-012023-12-31" id="Fact002177" format="ixt:numdotdecimal" decimals="0" unitRef="USD">110,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--AdjustmentsToAdditionalPaidInCapitalOther_zdaZIjYspaxj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Other</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2181">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2182">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" contextRef="From2023-04-012023-12-31_us-gaap_ReceivablesFromStockholderMember" id="Fact002183" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2184">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" contextRef="From2023-04-012023-12-31" id="Fact002185" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_43A_c20230401__20231231_eus-gaap--StockholdersEquity_iE_z5COtlydEBu8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Balance at December 31, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--SharesOutstanding_iE_c20230401__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zdc1RrzPWWBk" title="Balance, shares" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-12-31_us-gaap_CommonStockMember" id="Fact002193" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,418,061</ix:nonFraction></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_us-gaap_CommonStockMember" id="Fact002187" format="ixt:numdotdecimal" decimals="0" unitRef="USD">64,000</ix:nonFraction></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact002188" format="ixt:numdotdecimal" decimals="0" unitRef="USD">33,429,000</ix:nonFraction></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2189">-</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_us-gaap_RetainedEarningsMember" id="Fact002190" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">25,915,000</ix:nonFraction></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31" id="Fact002191" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,578,000</ix:nonFraction></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_435_c20230401__20231231_eus-gaap--StockholdersEquity_iE_zPFYm4wDj7Qe" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: left; padding-bottom: 2.5pt">Balance</td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--SharesOutstanding_iE_c20230401__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zp4UJf0sR6Qk" title="Balance, shares" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-12-31_us-gaap_CommonStockMember" id="Fact002201" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,418,061</ix:nonFraction></td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_us-gaap_CommonStockMember" id="Fact002195" format="ixt:numdotdecimal" decimals="0" unitRef="USD">64,000</ix:nonFraction></td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact002196" format="ixt:numdotdecimal" decimals="0" unitRef="USD">33,429,000</ix:nonFraction></td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2197">-</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_us-gaap_RetainedEarningsMember" id="Fact002198" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">25,915,000</ix:nonFraction></td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31" id="Fact002199" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,578,000</ix:nonFraction></td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>See
notes to the consolidated financial statements.</i></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 101; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="f_006"></span>THE
SINGING MACHINE COMPANY, INC AND SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
31, 2023, and March 31, 2023 and 2022</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<ix:nonNumeric contextRef="From2023-04-012023-12-31" escape="true" id="Fact002203" name="us-gaap:NatureOfOperations"><p id="xdx_800_eus-gaap--NatureOfOperations_zsL9fKGUJGMi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
1 &#8211; <span id="xdx_82A_zlzsnAE65cha">NATURE OF BUSINESS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are primarily engaged in the development, marketing, and sale of consumer karaoke audio equipment, accessories, and musical recordings.
We believe we are a leading global karaoke and music entertainment company that specializes in the design and production of quality karaoke
and music enabled consumer products for adults and children. Our products are among the most widely available karaoke products in the
world.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
mission is to &#8220;create joy through music.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Singing Machine&#8217;s operations include its wholly owned subsidiaries, SMC Logistics, Inc., a California corporation (&#8220;SMCL&#8221;),
SMC-Music, Inc., a Florida corporation (&#8220;SMCM&#8221;), SMC (HK) Limited, a Hong Kong company (&#8220;SMH&#8221;), MICS Hospitality
Holdings, Inc., a Delaware corporation (&#8220;MICS Hospitality&#8221;), MICS Hospitality Management, LLC, a Delaware limited liability
company (&#8220;MICS Hospitality Management&#8221;) and MICS Nomad, LLC, a Delaware limited liability company (&#8220;MICS NY&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-04-012023-12-31" escape="true" id="Fact002205" name="RIME:RecentDevelopmentsTextBlock"><p id="xdx_800_ecustom--RecentDevelopmentsTextBlock_zMDDr0ulIhw6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
2 - <span id="xdx_82A_zi95aABtW9Vj">RECENT DEVELOPMENTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Change
in Fiscal Year </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
2023, our Board of Directors approved a change in our fiscal year end from March 31 to December 31. Our results of operations, cash
flows, and all transactions impacting shareholders&#8217; equity presented in this Transition Report on Table of Contents Form 10-KT
are for the nine-month period ended December 31, 2023 (&#8220;transition period&#8221;), and our fiscal years 2023 and 2022 are for
the twelve months ended March 31, 2023, and March 31, 2022, unless otherwise noted.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Private
Placement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 20, 2023, the Company entered into an agreement to sell $<span id="xdx_907_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20231120__20231120__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zfixydcjEL85" title="Number of stock sold, value"><ix:nonFraction name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" contextRef="From2023-11-202023-11-20_us-gaap_PrivatePlacementMember" id="Fact002207" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,000,000</ix:nonFraction></span> in common stock through a private placement of common stock
(the &#8220;Private Placement&#8221;). The Private Placement was completed with two Affiliates, (Stingray Group, Inc. and Jay Foreman),
both of which were existing shareholders with Board representation. The Private Placement was completed at $<span id="xdx_90C_eus-gaap--SaleOfStockPricePerShare_iI_c20231120__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zaWldYcI4yJ2" title="Commmon stock share per share"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2023-11-20_us-gaap_PrivatePlacementMember" id="Fact002209" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.91</ix:nonFraction></span> per share of common
stock, with a total of approximately <span id="xdx_90B_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20231120__20231120__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zQ19jELJcLse" title="Number of shares sold"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2023-11-202023-11-20_us-gaap_PrivatePlacementMember" id="Fact002211" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,198,000</ix:nonFraction></span> shares issued. Net proceeds from the transaction were approximately $<span id="xdx_90D_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20231120__20231120__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zU7wJCVwJCGj" title="Proceeds from sale of equity"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" contextRef="From2023-11-202023-11-20_us-gaap_PrivatePlacementMember" id="Fact002213" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,900,000</ix:nonFraction></span>, net of
transaction fees of approximately $<span id="xdx_90E_ecustom--TransactionFees_iI_c20231120__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zmuLUdQlLQGk" title="Transaction fees"><ix:nonFraction name="RIME:TransactionFees" contextRef="AsOf2023-11-20_us-gaap_PrivatePlacementMember" id="Fact002215" format="ixt:numdotdecimal" decimals="0" unitRef="USD">100,000</ix:nonFraction></span>. During the six-month period after the closing date, the purchasers may make a written request
for registration under the Securities Act of all or any portion of the shares purchased.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Hospitality
Lease</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 23, 2023, MICS NY entered into an Agreement of Lease (the &#8220;Lease Agreement&#8221;) with OAC 111 Flatiron, LLC and OAC Adelphi,
LLC (the &#8220;Landlord&#8221;), pursuant to which MICS NY agreed to lease approximately <span id="xdx_904_eus-gaap--AreaOfLand_iI_pid_usqft_c20230823__us-gaap--TypeOfArrangementAxis__custom--LeaseAgreementMember_zC3lWaoT8JV7" title="Lease space"><ix:nonFraction name="us-gaap:AreaOfLand" contextRef="AsOf2023-08-23_custom_LeaseAgreementMember" id="Fact002217" format="ixt:numdotdecimal" decimals="INF" unitRef="sqft">10,000</ix:nonFraction></span> square feet of ground floor retail space
and a portion of the basement underneath the ground floor retail space in the property located at 111 West 24<sup>th</sup> Street, New
York, New York (the &#8220;Premises&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
term of the Lease Agreement is for fifteen (<span id="xdx_90E_eus-gaap--LesseeOperatingLeaseTermOfContract_iI_dtY_c20230823__us-gaap--TypeOfArrangementAxis__custom--LeaseAgreementMember_zTmVGdoOnDe" title="Lease term"><ix:nonNumeric contextRef="AsOf2023-08-23_custom_LeaseAgreementMember" format="ixt-sec:duryear" id="Fact002219" name="us-gaap:LesseeOperatingLeaseTermOfContract">15</ix:nonNumeric></span>) years, or on such an earlier date upon which the term shall expire, be canceled or terminated
pursuant to any of the conditions or covenants of the Lease Agreement. Pursuant to the Lease Agreement, MICS NY is obligated to pay an
initial base rent in the amount of $<span id="xdx_909_eus-gaap--PaymentsForRent_c20230823__20230823__us-gaap--TypeOfArrangementAxis__custom--LeaseAgreementMember_zV4WSxyON0lh" title="Initial base rent"><ix:nonFraction name="us-gaap:PaymentsForRent" contextRef="From2023-08-232023-08-23_custom_LeaseAgreementMember" id="Fact002221" format="ixt:numdotdecimal" decimals="0" unitRef="USD">30,000</ix:nonFraction></span> beginning August 1, 2024, with scheduled increases over the term, as set forth in the Lease
Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
March 2024, the Company initiated the termination of this lease under certain provisions made available under the Lease Agreement. The
Landlord and the Company are in active discussions as to the terms of the lease termination however as of this filing, it is too early
in the negotiation process to estimate any potential loss, if any, related to the lease termination process.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>ATM
Offering</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">On
February 15, 2023, the Company entered into an At-The-Market Issuance Sales Agreement (the &#8220;Sales Agreement&#8221;) with Aegis
Capital Corp, as sales agent (the &#8220;Agent&#8221;), pursuant to which the Company could offer and sell, from time to time,
through the Agent (the &#8220;ATM Offering&#8221;), up to approximately $<span id="xdx_909_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_pp0p0_c20230215__20230215__us-gaap--SubsidiarySaleOfStockAxis__custom--ATMOfferingMember_zWZ0xMZwEGnl" title="Number of stock sold, value"><ix:nonFraction name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" contextRef="From2023-02-152023-02-15_custom_ATMOfferingMember" id="Fact002223" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,800,000</ix:nonFraction></span>
in shares of the Company&#8217;s common stock. For the nine months ended December 31, 2023, and fiscal year ended March 31, 2023,
the Company received net proceeds of approximately $<span id="xdx_901_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20230401__20231231__us-gaap--SubsidiarySaleOfStockAxis__custom--ATMOfferingMember_zcL78nR3yvDi" title="Proceeds from sale of equity"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" contextRef="From2023-04-012023-12-31_custom_ATMOfferingMember" id="Fact002225" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,654,000</ix:nonFraction></span>
and $<span id="xdx_904_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20220401__20230331__us-gaap--SubsidiarySaleOfStockAxis__custom--ATMOfferingMember_zd8C9KHbRXL" title="Proceeds from sale of equity"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" contextRef="From2022-04-012023-03-31_custom_ATMOfferingMember" id="Fact002227" format="ixt:numdotdecimal" decimals="0" unitRef="USD">36,000</ix:nonFraction></span>,
respectively, after payment of brokerage commissions and administrative fees to the agent. As of May 12, 2023, the Company  terminated the Sales Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-04-012023-12-31" escape="true" id="Fact002229" name="us-gaap:SubstantialDoubtAboutGoingConcernTextBlock"><p id="xdx_80A_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zi9CW53dKuY8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
3 &#8211; <span id="xdx_821_zZcFLFmmCccg">LIQUIDITY, GOING CONCERN AND MANAGEMENT PLANS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">As
of December 31, 2023, the Company had cash on hand of approximately $<span id="xdx_904_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20231231_zszztNhTKdXa"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2023-12-31" id="Fact002230" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,703,000</ix:nonFraction> </span>which
is not sufficient to fund the Company&#8217;s planned operations through one year after the date the consolidated financial
statements are issued. The Company has a recent history of recurring operating losses and decreases in working capital. These
factors create substantial doubt about the Company&#8217;s ability to continue as a going concern for at least one year after the
date that the Company&#8217;s audited consolidated financial statements are issued.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The consolidated financial statements do not
include any adjustments that might be necessary if the Company is unable to continue as a going concern. Accordingly, the
consolidated financial statements have been prepared on a basis that assumes the Company will continue as a going concern and which
contemplates the realization of assets and satisfaction of liabilities and commitments in the ordinary course of business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Management
intends to finance operations with future debt or equity financings however, if and when such financings may occur are uncertain.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">In
making this assessment management performed a comprehensive analysis of the Company&#8217;s current circumstances including: its
financial position, cash flow and cash usage forecasts, and obligations and debts. Although management has a recent history of
successful capital raises, the analysis used to determine the Company&#8217;s ability as a going concern does not include cash
sources outside the Company&#8217;s direct control that management expects to be available within the next 12 months.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>


<ix:exclude><!-- Field: Page; Sequence: 102; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
SINGING MACHINE COMPANY, INC AND SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
31, 2023, and March 31, 2023 and 2022</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-04-012023-12-31" escape="true" id="Fact002232" name="us-gaap:SignificantAccountingPoliciesTextBlock"><p id="xdx_804_eus-gaap--SignificantAccountingPoliciesTextBlock_zqNjTthj8LAf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
4 - <span id="xdx_825_z04vsAxtg152">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<ix:nonNumeric contextRef="From2023-04-012023-12-31" escape="true" id="Fact002234" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock"><p id="xdx_84C_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_z3YYmrJUWim1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>BASIS
OF PRESENTATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the
United States of America (&#8220;GAAP&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-04-012023-12-31" escape="true" id="Fact002236" name="us-gaap:ConsolidationPolicyTextBlock"><p id="xdx_847_eus-gaap--ConsolidationPolicyTextBlock_zCa0IWp0mh3i" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PRINCIPLES
OF CONSOLIDATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements include the accounts of the Company and its Hong Kong subsidiary, SMCL, SMCM, SMH, MICS
Hospitality, MICS Hospitality Management and MICS NY. All inter-company accounts and transactions have been eliminated in consolidation
for all periods presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-04-012023-12-31" escape="true" id="Fact002238" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription"><p id="xdx_849_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zVl9t85L9Bml" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RECLASSIFICATION
OF PRIOR YEARS PRESENTATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on
the reported results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-04-012023-12-31" escape="true" id="Fact002240" name="us-gaap:UseOfEstimates"><p id="xdx_841_eus-gaap--UseOfEstimates_zg7Fs5GiIx77" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>USE
OF ESTIMATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions. These estimates and
assumptions affect the reported amounts of assets, liabilities, revenues and expenses. Actual results could differ materially from these
estimates. Estimates are assessed each period and updated to reflect current information. Significant estimates include revenue recognition,
allowance for credit losses, provision for excess and obsolete inventory, reserve for sales returns, accruals relating to litigation,
income taxes and share-based compensation expense.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-04-012023-12-31" escape="true" id="Fact002242" name="us-gaap:TradeAndOtherAccountsReceivablePolicy"><p id="xdx_848_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zKXhm8BV8qe8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ACCOUNTS
RECEIVABLE AND ALLOWANCES FOR EXPECTED CREDIT LOSSES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2016, the FASB issued Accounting Standards Update (&#8220;ASU&#8221;) 2016-13, &#8220;Financial Instruments&#8212;Credit Losses&#8221;
<i>(Topic 326)</i>. This ASU represents a significant change in the current accounting model by requiring immediate recognition of management&#8217;s
estimates of current expected credit losses. Under the prior model, losses were recognized only as they were incurred, which delayed
recognition of expected losses that might not yet have met the threshold of being probable. The amendments in ASU 2016-03 were effective
for our fiscal year beginning April 1, 2023, including interim periods within that fiscal year. We adopted ASU 2016-03 on April 1, 2023,
and the adoption did not have any material effect on our consolidated financial statements and related disclosures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes an allowance for credit losses at the time a receivable is recorded based on its estimate of expected credit losses
and adjusts this estimate over the life of the receivable as needed. The Company evaluates specific identified risks and the aggregation
and risk characteristics of a receivable pool and develops loss rates that reflect historical collections, current forecasts of future
economic conditions over the time horizon the Company is exposed to credit risk, and payment terms or conditions that may materially
affect future forecasts. As needed, amounts are written-off when determined to be uncollectible.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-04-012023-12-31" escape="true" id="Fact002244" name="us-gaap:InventoryPolicyTextBlock"><p id="xdx_84D_eus-gaap--InventoryPolicyTextBlock_zt1zqrGxQzxj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INVENTORY
AND RETURNS ASSET</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory
is comprised primarily of electronic karaoke equipment, microphones, and accessories, and are stated at the lower of cost or net realizable
value, as determined using the first in, first out method. The Company reduces inventory on hand to its net realizable value on an item-by-item
basis when it is apparent that the expected realizable value of an inventory item falls below its original cost. A charge to cost of
sales results when the estimated net realizable value of specific inventory items declines below cost. Management regularly reviews the
Company&#8217;s investment in inventories for such declines in value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the Company reports an estimated amount for the net realizable value of expected future inventory returns (returns asset) related
to the Company&#8217;s defective allowance, overstock, and warranty policies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<ix:exclude><!-- Field: Page; Sequence: 103; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
SINGING MACHINE COMPANY, INC AND SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
31, 2023, and March 31, 2023 and 2022</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-04-012023-12-31" escape="true" id="Fact002246" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"><p id="xdx_841_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zUAAmNvZLnp8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>LONG-LIVED
ASSETS </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company periodically evaluates the carrying value of the unamortized balances of its long-lived assets, including property, equipment
and rental assets, to determine whether impairment of these assets has occurred or whether a revision to the related amortization periods
should be made. If the carrying value of the long-lived asset group exceeds the estimated future undiscounted cash flows, an impairment
loss is recorded based on the amount by which the asset group&#8217;s carrying amount exceeds its fair value. Fair value is determined
based on an evaluation of the assets&#8217; associated discounted future cash flows or appraised value<i>.</i> For the nine months ended
December 31, 2023 and fiscal year ended March 31, 2023, the Company had no impairment loss related to long-lived assets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-04-012023-12-31" escape="true" id="Fact002248" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock"><p id="xdx_84F_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_znvSDpwnKbKl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PROPERTY
AND EQUIPMENT, NET </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and equipment are stated at cost, less accumulated depreciation. Expenditures for repairs and maintenance are charged to expense as incurred.
Depreciation is provided for in amounts sufficient to relate the cost of depreciable assets to their estimated useful lives using straight-line
methods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-04-012023-12-31" escape="true" id="Fact002250" name="us-gaap:LesseeLeasesPolicyTextBlock"><p id="xdx_84F_eus-gaap--LesseeLeasesPolicyTextBlock_zJtEl5F2EXkj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>LEASES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company determines if an arrangement contains a lease at the inception of a contract. Right-of-use assets represent the Company&#8217;s
right to use an underlying asset for the lease term and lease liabilities represent the Company&#8217;s obligation to make lease payments
arising from the lease. Right-of-use assets and lease liabilities are recognized at the commencement date. The liability is equal to
the present value of the remaining minimum lease payments. The asset is based on the liability, subject to certain adjustments. Operating
leases result in straight-line expense (similar to operating leases under the prior accounting standard) while finance leases result
in a front-loaded expense pattern (similar to capital leases under the prior accounting standard). As the interest rate implicit in the
Company&#8217;s operating leases is not readily determinable, the Company utilizes its incremental borrowing rate to discount the lease
payments. The Company utilizes the implicit rate for its finance leases.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-04-012023-12-31" escape="true" id="Fact002252" name="us-gaap:FairValueOfFinancialInstrumentsPolicy"><p id="xdx_84F_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zO1xq9uamRK9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FAIR
VALUE OF FINANCIAL INSTRUMENTS </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
follow Financial Accounting Standards Board (&#8220;FASB&#8221;) Accounting Standards Codification (&#8220;ASC&#8221;) 825, &#8220;Financial
Instruments&#8221;, which requires disclosure of information about the fair value of certain financial instruments for which it is practicable
to estimate that value. For the purposes of this disclosure, the fair value of a financial instrument is the amount at which the instrument
could be exchanged in a current transaction between willing parties, other than in a forced sale or liquidation. The carrying amounts
of the Company&#8217;s short-term financial instruments, including accounts receivable, accounts payable, accrued expenses, refunds due
to customers, customer deposits, other current liabilities and due from related parties approximates fair value due to the relatively
short period to maturity for these instruments. The carrying amounts on other liabilities are approximate to fair value due to their
relatively short period to maturity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-04-012023-12-31" escape="true" id="Fact002254" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock"><p id="xdx_842_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_znmqBVe2Pvf5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>REVENUE
RECOGNITION AND RESERVE FOR SALES RETURNS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes revenue in accordance with FASB ASC 606, &#8220;Revenue from Contracts with Customers&#8221;. All revenue is generated
from contracts with customers. The Company recognizes revenue when the control of the goods sold is transferred to the customer, in an
amount, referred to as the transaction price, that reflects the consideration to which the Company is expected to be entitled in exchange
for those goods. The Company determines revenue recognition utilizing the following five steps: (1) identification of the contract with
a customer, (2) identification of the performance obligations in the contract (promised goods or services that are distinct), (3) determination
of the transaction price, (4) allocation of the transaction price to the performance obligations, and (5) recognition of revenue when,
or as, the Company transfers control of the product or service for each performance obligation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s performance obligations are established when a customer submits a purchase order notification, and the Company
accepts the order. The Company identifies performance obligations as the delivery of the requested product or service in appropriate
quantities and to the location specified in the customer&#8217;s contract and/or purchase order. Revenue from sales of product is
recognized at a point in time when the Company transfers control to the customer, typically at the time when the product is
delivered or shipped, at which time, title passes to the customer and there are no further performance obligations with regards to
the product.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company selectively participates in a retailer&#8217;s co-op promotion incentives to maximize sales of the Company&#8217;s products on
the retail floor or to assist in developing consumer awareness of new product launches, by providing marketing fund allowances to our
customers. As these co-op promotion initiatives are not a distinct good or service and the Company cannot reasonably estimate the fair
value of the benefit it receives from these arrangements, the cost of these allowances at the time they are offered to the customers
are recorded as a reduction to net sales. Co-op promotion incentives were approximately $<span id="xdx_907_eus-gaap--AdvertisingExpense_c20230401__20231231_zetgZ155fVu8" title="Co-op promotion incentives"><ix:nonFraction name="us-gaap:AdvertisingExpense" contextRef="From2023-04-012023-12-31" id="Fact002256" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,600,000</ix:nonFraction></span> during the nine months ended December
31, 2023, $<span id="xdx_908_eus-gaap--AdvertisingExpense_c20220401__20230331_z7p1nzM50py8" title="Co-op promotion incentives" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__"><ix:nonFraction name="us-gaap:AdvertisingExpense" contextRef="From2022-04-012023-03-31" id="Fact002258" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,300,000</ix:nonFraction></span> during fiscal 2023 and $<span id="xdx_905_eus-gaap--AdvertisingExpense_c20210401__20220331_zys9xYLM0WY1" title="Co-op promotion incentives" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__"><ix:nonFraction name="us-gaap:AdvertisingExpense" contextRef="From2021-04-012022-03-31" id="Fact002260" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,000,000</ix:nonFraction></span> during fiscal 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s contracts with customers consist of one performance obligation (the sale of the Company&#8217;s products). The
Company&#8217;s contracts have no financing elements, payment terms are generally less than 120 days and have no further contract
asset or liability obligations once control of goods is transferred to the customer. Revenue is recorded in the amount of
consideration the Company expects to receive for the sale of these goods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Costs
incurred in fulfilling contracts with customers include administrative costs associated with the procurement of goods are included in
general and administrative expenses, in-bound freight costs are included in the cost of goods sold and accrued sales representative commissions
are included in selling expenses in the accompanying consolidated statements of operations as our underlying customer agreements are
less than one year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<ix:exclude><!-- Field: Page; Sequence: 104; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
SINGING MACHINE COMPANY, INC AND SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
31, 2023, and March 31, 2023 and 2022</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
the Company has no overstock return privileges in its vendor agreements with its customers, the Company does accept defective returns,
warranty exchanges and overstock from seasonal customers. The Company estimates the sales value of goods to be returned from our allowance
programs for goods returned from the customer for various reasons, whereby a reserve for sales returns is recorded based on historic
return amounts, specific events as identified and management estimates. The Company&#8217;s reserve for sales returns was approximately
$<span id="xdx_90E_ecustom--ReserveForSalesReturn_iI_c20231231_zUmZ1f0zmEhh" title="Reserve for sales return" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__"><ix:nonFraction name="RIME:ReserveForSalesReturn" contextRef="AsOf2023-12-31" id="Fact002262" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,400,000</ix:nonFraction></span> as of December 31, 2023, and $<span id="xdx_908_ecustom--ReserveForSalesReturn_iI_c20230331_zgqYZZmZeKTg" title="Reserve for sales return" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__"><ix:nonFraction name="RIME:ReserveForSalesReturn" contextRef="AsOf2023-03-31" id="Fact002264" format="ixt:numdotdecimal" decimals="0" unitRef="USD">900,000</ix:nonFraction></span> as of March 31, 2023. The Company estimates the net realizable value of these expected
future sales returns. The net realizable value of these estimated returns is classified as return assets as part of current assets on
the accompanying consolidated financial statements. The Company&#8217;s return assets were approximately $<span id="xdx_905_ecustom--ReturnAssets_iI_c20231231_zlaEnHEG2wQf" title="Return assets" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__"><ix:nonFraction name="RIME:ReturnAssets" contextRef="AsOf2023-12-31" id="Fact002266" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,900,000</ix:nonFraction></span> and $<span id="xdx_90A_ecustom--ReturnAssets_iI_c20230331_zkNePkNTq8s5" title="Return assets" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__"><ix:nonFraction name="RIME:ReturnAssets" contextRef="AsOf2023-03-31" id="Fact002268" format="ixt:numdotdecimal" decimals="0" unitRef="USD">600,000</ix:nonFraction></span> as of
December 31, 2023, and March 31, 2023, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-04-012023-12-31" escape="true" id="Fact002270" name="RIME:ShippingAndHandlingCostsPolicyTextBlock"><p id="xdx_84B_ecustom--ShippingAndHandlingCostsPolicyTextBlock_zCeER69gCcLf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHIPPING
AND HANDLING COSTS </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shipping
and handling activities are performed before the customer obtains control of the goods sold to them and are considered activities to
fulfill the Company&#8217;s promise to transfer the goods. For the nine months ended December 31, 2023, shipping and handling expenses
were approximately $<span id="xdx_901_ecustom--ShippingAndHandlingExpenses_c20230401__20231231_zAD9DO2uvUu3" title="Shipping and handling expenses" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__"><ix:nonFraction name="RIME:ShippingAndHandlingExpenses" contextRef="From2023-04-012023-12-31" id="Fact002272" format="ixt:numdotdecimal" decimals="0" unitRef="USD">600,000</ix:nonFraction></span>. For Fiscal 2023 and 2022 shipping and handling expenses were approximately $<span id="xdx_90D_ecustom--ShippingAndHandlingExpenses_c20220401__20230331_zDKl0hYiF6Pl" title="Shipping and handling expenses" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__"><ix:nonFraction name="RIME:ShippingAndHandlingExpenses" contextRef="From2022-04-012023-03-31" id="Fact002274" format="ixt:numdotdecimal" decimals="0" unitRef="USD">500,000</ix:nonFraction></span> and $<span id="xdx_90B_ecustom--ShippingAndHandlingExpenses_c20210401__20220331_zWcuHtKtohl5" title="Shipping and handling expenses" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__"><ix:nonFraction name="RIME:ShippingAndHandlingExpenses" contextRef="From2021-04-012022-03-31" id="Fact002276" format="ixt:numdotdecimal" decimals="0" unitRef="USD">900,000</ix:nonFraction></span>, respectively.
These expenses are classified as a component of selling expenses in the accompanying consolidated statements of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-04-012023-12-31" escape="true" id="Fact002278" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy"><p id="xdx_845_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zW3YbDrlpx7h" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARE-BASED
COMPENSATION </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has granted stock options and restricted stock units (&#8220;RSUs&#8221;) to employees, non-employee consultants and non-employee
members of our Board of Directors. The Company also has an equity incentive plan which provides for the issuance of equity incentive
awards, such as stock options, stock appreciation rights, stock awards, restricted stock, stock units, performance awards and other stock
or cash-based awards collectively, the &#8220;Awards.&#8221; Awards may be granted under the 2022 Plan to the Company&#8217;s employees,
officers, directors, consultants, agents, advisors and independent contractors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company measures the compensation cost associated with all share-based payments based on grant date fair values. The fair value of each
stock option and stock purchase right is estimated on the date of grant using an option pricing model that meets certain requirements.
The Company generally uses the Black-Scholes option pricing model to estimate the fair value of its stock options and stock purchase
rights. The determination of the fair value of share-based payment awards utilizing the Black-Scholes model is affected by the Company&#8217;s
stock price and several assumptions, including expected volatility, expected term, risk-free interest rate and expected dividends.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
grants of stock options, the Company uses a blend of historical and implied volatility for traded options on its stock to estimate the
expected volatility assumption required in the Black-Scholes model. The Company&#8217;s use of a blended volatility estimates in computing
the expected volatility assumption for stock options is based on its belief that while the implied volatility is representative of expected
future volatility, the historical volatility over the expected term of the award is also an indicator of expected future volatility.
The Company utilizes a blended volatility estimate that consists of implied volatility and historical volatility in order to estimate
the expected volatility assumption of the Black-Scholes model.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
expected term of stock options granted is estimated using historical experience. The risk-free interest rate assumption is based on observed
interest rates appropriate for the expected terms of the Company&#8217;s stock options and stock purchase rights. The dividend yield
assumption is based on the Company&#8217;s history and expectation of no dividend payouts. The Company estimates forfeitures at the time
of grant and revises these estimates, if necessary, in subsequent periods if actual forfeitures differ from those estimates. The Company
estimates its forfeiture rate assumption for all types of share-based compensation awards based on historical forfeiture rates related
to each category of award.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compensation
costs associated with grants of restricted stock units are measured at fair value, which has historically been the closing price of the
Company&#8217;s common stock on the date of grant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes share-based compensation expense over the requisite service period of each individual award, which generally equals
the vesting period, using the straight-line method for awards that contain only service conditions. For awards that contain performance
conditions, the Company recognizes the share-based compensation expense on a straight-line basis for each vesting tranche, when achievement
of that tranche is considered probable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company evaluates the assumptions used to value stock awards at each grant date. If there are any modifications or cancellations of
the underlying unvested securities, the Company may be required to accelerate, increase or cancel any remaining unearned share-based
compensation expense.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-04-012023-12-31" escape="true" id="Fact002280" name="us-gaap:IncomeTaxPolicyTextBlock"><p id="xdx_849_eus-gaap--IncomeTaxPolicyTextBlock_zXx5R89VEUIg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INCOME
TAXES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company follows the provisions of FASB ASC 740 &#8220;Accounting for Income Taxes.&#8221; Under the asset and liability method of ASC
740, deferred tax assets and liabilities are recognized for the future tax consequences attributed to differences between the financial
statement carrying amounts of existing assets and liabilities and their respective tax base. Deferred tax assets and liabilities are
measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to
be recovered or settled. Under ASC 740, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income
in the period that includes the enactment date. If it is more likely than not that some portion of a deferred tax asset will not be realized,
a valuation allowance is recognized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 105; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
SINGING MACHINE COMPANY, INC AND SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
31, 2023, and March 31, 2023 and 2022</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes a liability for uncertain tax positions. An uncertain tax position is defined as a position in a previously filed
tax return or a position expected to be taken in a future tax return that is not based on clear and unambiguous tax law and which is
reflected in measuring current or deferred income tax assets and liabilities for interim or annual periods. The Company may
recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained
on examination by the taxing authorities, based on the technical merits of the position. The Company measures the tax benefits
recognized based on the largest benefit that has a <span id="xdx_90A_eus-gaap--IncomeTaxExaminationLikelihoodOfUnfavorableSettlement_c20230401__20231231_zrx94xkqnTv7"><ix:nonNumeric contextRef="From2023-04-012023-12-31" id="Fact002281" name="us-gaap:IncomeTaxExaminationLikelihoodOfUnfavorableSettlement">greater
than 50% likelihood</ix:nonNumeric></span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of being realized upon
ultimate resolution.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2023, and March 31, 2023, there were no uncertain tax positions that resulted in any adjustment to the Company&#8217;s
provision for income taxes. The Company recognizes interest and penalties related to unrecognized tax benefits in its provision for income
taxes. The Company currently has no liabilities recorded for accrued interest or penalties related to uncertain tax provisions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-04-012023-12-31" escape="true" id="Fact002283" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock"><p id="xdx_84B_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zlsiD5f9UQQb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RECENT
ACCOUNTING PRONOUNCEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2023, the FASB issued ASU 2023-09, <i>Income Taxes (Topic 740): Improvements to Income Tax Disclosures</i>. ASU 2023-09 is intended
to enhance the usefulness of income tax disclosures by requiring entities to disclose specific rate reconciliations, amount of income
taxes separate by federal and individual tax jurisdictions, and the amount of income (loss) from continuing operations before income
tax expense (benefit) disaggregated between federal, state and foreign. ASU 2023-09 is effective for the Company for its fiscal year
beginning January 1, 2025, with early adoption permitted. The Company is currently evaluating the impact of adopting this standard on
our consolidated financial statements and related disclosures.</span></p>

</ix:nonNumeric><p id="xdx_85B_zW76W1xUgLok" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-04-012023-12-31" escape="true" id="Fact002285" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock"><p id="xdx_80F_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_ztYxJTMrb7r3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
5 - <span>PROPERTY AND EQUIPMENT, NET</span> </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_828_zEWoggtyJkS6" style="display: none">PROPERTY
AND EQUIPMENT</span></span></p>

<ix:nonNumeric contextRef="From2023-04-012023-12-31" escape="true" id="Fact002287" name="us-gaap:PropertyPlantAndEquipmentTextBlock"><p id="xdx_890_eus-gaap--PropertyPlantAndEquipmentTextBlock_zTLkenoLXW3g" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of property and equipment is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zAmQk0bKrwej" style="display: none">SCHEDULE
OF PROPERTY AND EQUIPMENT</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">Useful</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">December 31,</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">March 31,</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Life</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48%; text-align: left">Computer and office equipment</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: left"><span id="xdx_904_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerAndOfficeEquipmentMember__srt--RangeAxis__srt--MinimumMember_zZItq5y2jJK9" title="Average useful life (in years)"><ix:nonNumeric contextRef="AsOf2023-12-31_custom_ComputerAndOfficeEquipmentMember_srt_MinimumMember" format="ixt-sec:duryear" id="Fact002289" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">5</ix:nonNumeric></span>-<span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerAndOfficeEquipmentMember__srt--RangeAxis__srt--MaximumMember_zluvefZyvHkg" title="Average useful life (in years)"><ix:nonNumeric contextRef="AsOf2023-12-31_custom_ComputerAndOfficeEquipmentMember_srt_MaximumMember" format="ixt-sec:duryear" id="Fact002291" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">7</ix:nonNumeric></span> years</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerAndOfficeEquipmentMember_zOJy9Ps5K0t7" title="Property and equipment, gross" style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-12-31_custom_ComputerAndOfficeEquipmentMember" id="Fact002293" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">404,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerAndOfficeEquipmentMember_zOOhCwIoh8B1" title="Property and equipment, gross" style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-03-31_custom_ComputerAndOfficeEquipmentMember" id="Fact002295" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">497,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Furniture and fixtures</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zsCYAHHPEDLe" title="Average useful life (in years)"><ix:nonNumeric contextRef="AsOf2023-12-31_us-gaap_FurnitureAndFixturesMember" format="ixt-sec:duryear" id="Fact002297" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">7</ix:nonNumeric></span> years</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zqHbKfyGTJuc" title="Property and equipment, gross" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-12-31_us-gaap_FurnitureAndFixturesMember" id="Fact002299" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">107,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zyk4EUB7BZyc" title="Property and equipment, gross" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-03-31_us-gaap_FurnitureAndFixturesMember" id="Fact002301" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">111,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Warehouse equipment</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_906_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--WarehouseEquipmentMember_zkZk2d4OMzV6" title="Average useful life (in years)"><ix:nonNumeric contextRef="AsOf2023-12-31_custom_WarehouseEquipmentMember" format="ixt-sec:duryear" id="Fact002303" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">7</ix:nonNumeric></span> years</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--WarehouseEquipmentMember_zU1a3Xgvuwmk" title="Property and equipment, gross" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2305">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--WarehouseEquipmentMember_zZEuGuqIRqV1" title="Property and equipment, gross" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-03-31_custom_WarehouseEquipmentMember" id="Fact002307" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">251,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Molds and tooling</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MoldsAndToolingMember__srt--RangeAxis__srt--MinimumMember_zXcDx8A9SzZb" title="Average useful life (in years)"><ix:nonNumeric contextRef="AsOf2023-12-31_custom_MoldsAndToolingMember_srt_MinimumMember" format="ixt-sec:duryear" id="Fact002309" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">3</ix:nonNumeric></span>-<span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MoldsAndToolingMember__srt--RangeAxis__srt--MaximumMember_zUNkbKrTalP5" title="Average useful life (in years)"><ix:nonNumeric contextRef="AsOf2023-12-31_custom_MoldsAndToolingMember_srt_MaximumMember" format="ixt-sec:duryear" id="Fact002311" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">5</ix:nonNumeric></span> years</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MoldsAndToolingMember_zUTKwhQYnkq5" title="Property and equipment, gross" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-12-31_custom_MoldsAndToolingMember" id="Fact002313" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,228,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MoldsAndToolingMember_zL5n6RHOk1b4" title="Property and equipment, gross" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-03-31_custom_MoldsAndToolingMember" id="Fact002315" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,160,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20231231_zlU54n9m8uG6" title="Property and equipment, gross" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-12-31" id="Fact002317" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,739,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230331_zrs7FnVl2VLj" title="Property and equipment, gross" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-03-31" id="Fact002319" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,019,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Less: Accumulated depreciation</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pp0p0_c20231231_zH6PI5nPOcA7" title="Less: Accumulated depreciation" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2023-12-31" id="Fact002321" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,335,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pp0p0_c20230331_z8dczwO11nca" title="Less: Accumulated depreciation" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2023-03-31" id="Fact002323" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,386,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-bottom: 2.5pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-bottom: 2.5pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3p0_c20231231_z4mXyHYNYQZ3" title="Property and equipment, net" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2023-12-31" id="Fact002325" format="ixt:numdotdecimal" decimals="-3" scale="0" unitRef="USD">404,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3p0_c20230331_zbbsJanErv32" title="Property and equipment, net" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2023-03-31" id="Fact002327" format="ixt:numdotdecimal" decimals="-3" scale="0" unitRef="USD">633,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A4_zzdYpgc2Hfta" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
expense for the nine months ended December 31, 2023 was approximately $<span id="xdx_903_eus-gaap--Depreciation_c20230401__20231231_zAZmXlnANDS2" title="Depreciation expense"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2023-04-012023-12-31" id="Fact002329" format="ixt:numdotdecimal" decimals="0" unitRef="USD">287,000</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
expense for both fiscal years ended March 31, 2023, and 2022, was approximately $<span id="xdx_907_eus-gaap--Depreciation_c20220401__20230331_z1M2ij933MBi" title="Depreciation expense"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2022-04-012023-03-31" id="Fact002331" format="ixt:numdotdecimal" decimals="0" unitRef="USD">228,000</ix:nonFraction></span> and $<span id="xdx_900_eus-gaap--Depreciation_c20210401__20220331_zJgXsnYaL1Ca" title="Depreciation expense"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2021-04-012022-03-31" id="Fact002333" format="ixt:numdotdecimal" decimals="0" unitRef="USD">246,000</ix:nonFraction></span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-04-012023-12-31" escape="true" id="Fact002335" name="us-gaap:DebtDisclosureTextBlock"><p id="xdx_802_eus-gaap--DebtDisclosureTextBlock_zoegaCnoZlqf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
6 &#8211; <span id="xdx_828_znhlSSPeKUJ2">FINANCING</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Oxford
Credit Facility</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 28, 2024, the Company entered into a Loan and Security Agreement with Oxford Business Credit (the &#8220;Credit Agreement&#8221;),
as Lender. The Credit Agreement established a secured asset-backed revolving credit facility which is comprised of a maximum $<span id="xdx_90B_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_c20240328__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zQk4m4U3gg33" title="Revolving credit facility"><ix:nonFraction name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" contextRef="AsOf2024-03-28_us-gaap_RevolvingCreditFacilityMember_us-gaap_SubsequentEventMember" id="Fact002337" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,000,000</ix:nonFraction></span>
revolving credit facility (&#8220;Credit Facility&#8221;). Availability under the Credit Facility is determined monthly by a borrowing
base comprised of a percentage of eligible accounts receivable of the Borrowers. The Company&#8217;s obligations under the Credit Agreement
are secured by a continuing security interest in all property of each Loan Party, subject to certain excluded collateral (as defined
in the Credit Agreement).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 106; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
SINGING MACHINE COMPANY, INC AND SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
31, 2023, and March 31, 2023 and 2022</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Borrowings
under the Credit Facility take the form of base rate loans at interest rates of the greater of either (a) the Prime Rate plus <span id="xdx_907_ecustom--LineOfCreditFacilityInterestRate_dp_uPure_c20240328__20240328__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_zpUeUt4O9lV5" title="The Prime Rate"><ix:nonFraction name="RIME:LineOfCreditFacilityInterestRate" contextRef="From2024-03-282024-03-28_us-gaap_SubsequentEventMember_us-gaap_RevolvingCreditFacilityMember" id="Fact002339" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">2.5</ix:nonFraction></span>% The
Credit agreement includes certain covenants which include, but are not limited to restrictions on debt, asset liens, capital expenditures,
formation of new entities and financial covenants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Credit Agreement is for a <span id="xdx_90A_eus-gaap--DebtInstrumentTerm_dxL_c20240328__20240328__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_z8vRwyyYUbrb" title="Credit agreement term::XDX::P2Y"><span style="-sec-ix-hidden: xdx2ixbrl2341">two</span></span>-year term that expires on <span id="xdx_908_eus-gaap--LineOfCreditFacilityExpirationDate1_dd_c20240328__20240328__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_zvE5JZcsnlB5" title="Credit agreement expires"><ix:nonNumeric contextRef="From2024-03-282024-03-28_us-gaap_SubsequentEventMember_us-gaap_RevolvingCreditFacilityMember" format="ixt:datemonthdayyearen" id="Fact002343" name="us-gaap:LineOfCreditFacilityExpirationDate1">November 28, 2026</ix:nonNumeric></span>, and automatically renews for an additional one-year term on
each anniversary of date of the agreement unless the Company notifies Oxford within 60 days before the anniversary date of its intention
to pay off the Credit Facility and terminate the Credit Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is subject to a two percent (<span id="xdx_907_ecustom--PercentageOfExitFee_dp_uPure_c20240328__20240328__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_zrDXecF6lhGe" title="Percentage of exit fee"><ix:nonFraction name="RIME:PercentageOfExitFee" contextRef="From2024-03-282024-03-28_us-gaap_SubsequentEventMember_us-gaap_RevolvingCreditFacilityMember" id="Fact002345" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">2</ix:nonFraction></span>%) Exit Fee if the Company terminates the Credit Agreement and repays the obligations under Credit
Facility prior to the anniversary date of the Credit Agreement. The Exit Fee shall automatically renew on the two-year anniversary date
of the Loan Agreement for an additional one-year period unless the Company notifies Lender in writing within sixty (60) days before such
anniversary date of Borrower&#8217;s intention to pay off this Credit Facility and terminate the Credit Agreement and all obligations
of the Credit Facility are paid in full by such anniversary date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fifth
Third Bank Asset-backed Revolving Credit Facility</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 14, 2022, the Company entered into a Loan and Security Agreement with Fifth Third Financial Corporation (the &#8220;Credit Agreement&#8221;),
as Lender, replacing the Company&#8217;s credit facilities with Crestmark and IHC that were terminated by the Company on October 13,
2022. The Credit Agreement established a secured asset-backed revolving credit facility which is comprised of a maximum $<span id="xdx_902_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_c20221014__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_zj8BYhItFPY5" title="Revolving credit facility maximum amount"><ix:nonFraction name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" contextRef="AsOf2022-10-14_us-gaap_RevolvingCreditFacilityMember" id="Fact002347" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,000,000</ix:nonFraction></span> revolving
credit facility (&#8220;Credit Facility&#8221;). The Credit Facility was terminated on <span id="xdx_904_eus-gaap--LineOfCreditFacilityExpirationDate1_dd_c20221014__20221014__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_zUBMDHAdT2ed" title="Revolving credit facility terminated date"><ix:nonNumeric contextRef="From2022-10-142022-10-14_us-gaap_RevolvingCreditFacilityMember" format="ixt:datemonthdayyearen" id="Fact002349" name="us-gaap:LineOfCreditFacilityExpirationDate1">November 17, 2023</ix:nonNumeric></span>. Availability under the Credit
Facility was determined monthly by a borrowing base comprised of a percentage of eligible accounts receivable and eligible inventory
of the Borrowers. The Company&#8217;s obligations under the Credit Agreement are secured by a continuing security interest in all property
of each Loan Party, subject to certain excluded collateral (as defined in the Credit Agreement).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Costs
associated with closing of the Credit Agreement of approximately $<span id="xdx_902_eus-gaap--RepaymentsOfLinesOfCredit_c20221014__20221014__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_zl2w5WVzF013" title="Costs associated with line of credit"><ix:nonFraction name="us-gaap:RepaymentsOfLinesOfCredit" contextRef="From2022-10-142022-10-14_us-gaap_RevolvingCreditFacilityMember" id="Fact002351" format="ixt:numdotdecimal" decimals="0" unitRef="USD">254,000</ix:nonFraction></span> were deferred and being amortized over life of the loan. During
the nine months ended December 31, 2023, and 2022, the Company incurred amortization expenses of approximately $<span id="xdx_909_eus-gaap--AdjustmentForAmortization_c20230401__20231231_zkE9VC4x4R5k" title="Amortization expense"><ix:nonFraction name="us-gaap:AdjustmentForAmortization" contextRef="From2023-04-012023-12-31" id="Fact002353" format="ixt:numdotdecimal" decimals="0" unitRef="USD">215,000</ix:nonFraction></span> and $<span id="xdx_90D_eus-gaap--AdjustmentForAmortization_c20220401__20221231_z1ylOAExJwd9" title="Amortization expense"><ix:nonFraction name="us-gaap:AdjustmentForAmortization" contextRef="From2022-04-012022-12-31" id="Fact002355" format="ixt:numdotdecimal" decimals="0" unitRef="USD">18,000</ix:nonFraction></span> respectively
associated with the amortization of deferred financing costs from the Credit Agreement. During the fiscal years ended March 31, 2023,
and 2022, the Company incurred amortization expense of approximately $<span id="xdx_906_eus-gaap--AdjustmentForAmortization_c20220401__20230331_zgZgKCRmzEcf" title="Amortization expense"><ix:nonFraction name="us-gaap:AdjustmentForAmortization" contextRef="From2022-04-012023-03-31" id="Fact002357" format="ixt:numdotdecimal" decimals="0" unitRef="USD">39,000</ix:nonFraction></span> and $<span id="xdx_90A_eus-gaap--AdjustmentForAmortization_c20210401__20220331_zLZLz0yNvpQl" title="Amortization expense"><ix:nonFraction name="us-gaap:AdjustmentForAmortization" contextRef="From2021-04-012022-03-31" id="Fact002359" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></span>, respectively, associated with the amortization of
deferred financing costs from the Credit Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Borrowings
under the Credit Facility took the form of base rate loans at interest rates of the greater of either <span id="xdx_907_eus-gaap--LineOfCreditFacilityInterestRateDescription_c20221014__20221014__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_zWOWVwwlxQEc" title="Base rates of loan description"><ix:nonNumeric contextRef="From2022-10-142022-10-14_us-gaap_RevolvingCreditFacilityMember" id="Fact002361" name="us-gaap:LineOfCreditFacilityInterestRateDescription">(a) the Prime Rate plus 0.50% or (b) the Secured Overnight Financing Rate (&#8220;SOFR&#8221;) 30-day term rate plus 3%, subject to a minimum of 0.050% in either case.</ix:nonNumeric></span>
For the nine months ended December 31, 2023, and 2022, the Company incurred interest expense of approximately $<span id="xdx_90A_eus-gaap--InterestAndDebtExpense_c20230401__20231231_zT1dJ4T4Lski" title="Interest expense"><ix:nonFraction name="us-gaap:InterestAndDebtExpense" contextRef="From2023-04-012023-12-31" id="Fact002363" format="ixt:numdotdecimal" decimals="0" unitRef="USD">28,000</ix:nonFraction></span> and $<span id="xdx_900_eus-gaap--InterestAndDebtExpense_c20220401__20221231_zEf4bGqscgW6" title="Interest expense"><ix:nonFraction name="us-gaap:InterestAndDebtExpense" contextRef="From2022-04-012022-12-31" id="Fact002365" format="ixt:numdotdecimal" decimals="0" unitRef="USD">19,000</ix:nonFraction></span>, respectively.
For the fiscal years ended March 31, 2023, and 2022, the Company incurred interest expense of approximately $<span id="xdx_909_eus-gaap--InterestAndDebtExpense_c20220401__20230331_zuIsnGIR9zM" title="Interest expense"><ix:nonFraction name="us-gaap:InterestAndDebtExpense" contextRef="From2022-04-012023-03-31" id="Fact002367" format="ixt:numdotdecimal" decimals="0" unitRef="USD">33,000</ix:nonFraction></span> and $<span id="xdx_90F_eus-gaap--InterestAndDebtExpense_c20210401__20220331_zQSAmhQeeXf2" title="Interest expense"><ix:nonFraction name="us-gaap:InterestAndDebtExpense" contextRef="From2021-04-012022-03-31" id="Fact002369" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 19, 2023, the Company executed a Waiver and First Amendment agreement which provides for a waiver of previous defaults and
instituted new covenants. On November 17, 2023, the Company voluntarily terminated the Credit Agreement as the
Company could not comply with the debt coverage financial covenant effective September 30, 2023. There was no balance outstanding on
the credit agreement as of the termination date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Intercreditor
Revolving Credit Facility Crestmark Bank and Iron Horse Credit</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 16, 2020, the Company entered into a two-year Credit and Security Agreement for a $<span id="xdx_90B_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_c20200616__us-gaap--TypeOfArrangementAxis__custom--TwoYearCreditAndSecurityAgreementMember__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_z2Di9oZsjNdh" title="Line of credit facility, maximum borrowing amount"><ix:nonFraction name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" contextRef="AsOf2020-06-16_custom_TwoYearCreditAndSecurityAgreementMember_us-gaap_RevolvingCreditFacilityMember" id="Fact002371" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,500,000</ix:nonFraction></span> financing facility, with Iron Horse
Credit (&#8220;IHC&#8221;) on eligible accounts receivable and inventory. Also, on June 16, 2020, the Company entered into a two-year
Loan and Security Agreement for a $<span id="xdx_90C_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_c20200616__us-gaap--TypeOfArrangementAxis__custom--TwoYearLoanAndSecurityAgreementMember__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_zSKFgqhR76M3" title="Line of credit facility, maximum borrowing amount"><ix:nonFraction name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" contextRef="AsOf2020-06-16_custom_TwoYearLoanAndSecurityAgreementMember_us-gaap_RevolvingCreditFacilityMember" id="Fact002373" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,000,000</ix:nonFraction></span> financing facility with Crestmark Bank (&#8220;Crestmark&#8221;) on eligible accounts receivable.
For the nine months ended December 31, 2023, and 2022, the Company incurred approximately $<span id="xdx_90E_eus-gaap--AdjustmentForAmortization_c20230401__20231231__us-gaap--TypeOfArrangementAxis__custom--CreditAndSecurityAgreementsMember_zTgv0ThgPB2l" title="Amortization expense"><ix:nonFraction name="us-gaap:AdjustmentForAmortization" contextRef="From2023-04-012023-12-31_custom_CreditAndSecurityAgreementsMember" id="Fact002375" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></span> and $<span id="xdx_904_eus-gaap--AdjustmentForAmortization_c20220401__20221231__us-gaap--TypeOfArrangementAxis__custom--CreditAndSecurityAgreementsMember_z36h7xfRpnNf" title="Amortization expense"><ix:nonFraction name="us-gaap:AdjustmentForAmortization" contextRef="From2022-04-012022-12-31_custom_CreditAndSecurityAgreementsMember" id="Fact002377" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,000</ix:nonFraction></span>, respectively, in amortization
costs for deferred financing charges associated with the credit and security agreements with Crestmark and IHC. The Company also incurred
interest expense of approximately $<span id="xdx_90C_eus-gaap--InterestAndDebtExpense_c20220401__20230331__us-gaap--TypeOfArrangementAxis__custom--CreditAndSecurityAgreementsMember_zG7CviMNZYY1" title="Interest expenses"><ix:nonFraction name="us-gaap:InterestAndDebtExpense" contextRef="From2022-04-012023-03-31_custom_CreditAndSecurityAgreementsMember" id="Fact002379" format="ixt:numdotdecimal" decimals="0" unitRef="USD">400,000</ix:nonFraction></span> and $<span id="xdx_908_eus-gaap--InterestAndDebtExpense_c20210401__20220331__us-gaap--TypeOfArrangementAxis__custom--CreditAndSecurityAgreementsMember_zq3KNQdq2gy8" title="Interest expenses"><ix:nonFraction name="us-gaap:InterestAndDebtExpense" contextRef="From2021-04-012022-03-31_custom_CreditAndSecurityAgreementsMember" id="Fact002381" format="ixt:numdotdecimal" decimals="0" unitRef="USD">500,000</ix:nonFraction></span> for the fiscal years ended March 31, 2023, and 2022, respectively, associated
with the credit and security agreements with Crestmark and IHC.</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 107; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
SINGING MACHINE COMPANY, INC AND SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
31, 2023, and March 31, 2023 and 2022</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-04-012023-12-31" escape="true" id="Fact002383" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock"><p id="xdx_80A_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zIa6MsNQNNqj" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTE
7 - <span id="xdx_824_zJJZMc7y3cr9">COMMITMENTS AND CONTINGENCIES</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Hospitality
Lease</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 23, 2023, MICS NY entered into an Agreement of Lease (the &#8220;Lease Agreement&#8221;) with OAC 111 Flatiron, LLC and OAC Adelphi,
LLC (the &#8220;Landlord&#8221;), pursuant to which MICS NY agreed to lease approximately 10,000 square feet of ground floor retail space
and a portion of the basement underneath the ground floor retail space in the property located at 111 West 24<sup>th</sup> Street, New
York, New York (the &#8220;Premises&#8221;). It was the Company&#8217;s intention to use the Premises as a new karaoke venue, offering
immersive karaoke technology and audio-visual capabilities, with restaurant and bar offerings however due to lack of funding, the Company
initiated termination of the lease in March 2024 (See Note 8 - Operating Leases).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
term of the Lease Agreement is for fifteen (15) years, or on such an earlier date upon which the term shall expire, be canceled, or terminated
pursuant to any of the conditions or covenants of the Lease Agreement. Pursuant to the Lease Agreement, MICS NY is obligated to pay an
initial base rent in the amount of $<span id="xdx_90B_eus-gaap--OperatingLeaseExpense_c20240701__20240701__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zY2Htcevq7v9" title="Operating lease expense"><ix:nonFraction name="us-gaap:OperatingLeaseExpense" contextRef="From2024-07-012024-07-01_us-gaap_SubsequentEventMember" id="Fact002385" format="ixt:numdotdecimal" decimals="0" unitRef="USD">30,000</ix:nonFraction></span> beginning July 1, 2024, with scheduled increases over the term, as set forth in the Lease
Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
March 2024, the Company initiated the termination of this lease under certain provisions made available under the Lease Agreement. The
Landlord and the Company are in active discussions as to the terms of the lease termination however as of this filing, it is too early
in the negotiation process to estimate any potential loss, if any, related to the lease termination process.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Derivative
Litigation</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 21, 2023, Ault Lending, LLC, a wholly owned subsidiary of Ault Alliance, Inc. (&#8220;Ault&#8221;), one of the Company&#8217;s
largest shareholders, filed a derivative shareholder action in Delaware Chancery Court against the Company, its Directors, and other
Company shareholders (The Stingray Group, Inc. and Regalia Ventures) (&#8220;the Defendants&#8221;) for alleged breach of fiduciary duty
in approving a recent above-market private placement equity transaction. The Complaint alleges the Company, and its Directors followed
an inadequate process in evaluating the private placement transaction which occurred back in November 2023 and entered into the transaction
with an intent to dilute Ault&#8217;s ownership stake in the Company. The Defendants have retained Delaware counsel to represent them
in this matter and the Company has filed a motion to dismiss the suit. The Company has Director &amp; Officer liability insurance for
up to $<span id="xdx_90C_ecustom--InsuranceLiabilities_iI_c20231221__us-gaap--ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis__us-gaap--DirectorsAndOfficersLiabilityInsuranceMember_zWY8fcSPZEQ8" title="Insurance liabilities"><ix:nonFraction name="RIME:InsuranceLiabilities" contextRef="AsOf2023-12-21_us-gaap_DirectorsAndOfficersLiabilityInsuranceMember" id="Fact002387" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,000,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">with a retention of $<span id="xdx_904_eus-gaap--MalpracticeInsuranceMaximumCoveragePerIncident_c20231221__20231221__us-gaap--ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis__us-gaap--DirectorsAndOfficersLiabilityInsuranceMember_zP4GhMz6qIV4"><ix:nonFraction name="us-gaap:MalpracticeInsuranceMaximumCoveragePerIncident" contextRef="From2023-12-212023-12-21_us-gaap_DirectorsAndOfficersLiabilityInsuranceMember" id="Fact002388" format="ixt:numdotdecimal" decimals="0" unitRef="USD">250,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">for derivative claims.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
than what is disclosed above, we are not a party to, and our property is not the subject of, any pending material legal proceedings.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-04-012023-12-31" escape="true" id="Fact002390" name="us-gaap:LesseeOperatingLeasesTextBlock"><p id="xdx_802_eus-gaap--LesseeOperatingLeasesTextBlock_z2S3jesDU2Of" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
8 &#8211; <span id="xdx_822_z7PIQGxfbp87">OPERATING LEASES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the time of this filing, the Company has operating lease agreements for offices in Florida and Hong Kong and a retail location in New
York expiring in various years through 2038. The Company entered into an operating lease agreement, effective October 1, 2017, for our
corporate headquarters located in Fort Lauderdale, Florida where we lease approximately <span id="xdx_909_eus-gaap--AreaOfLand_iI_pid_usqft_c20171001__us-gaap--TypeOfArrangementAxis__custom--OperatingLeaseAgreementMember_z5QYnhZlBjAd" title="Lease space"><ix:nonFraction name="us-gaap:AreaOfLand" contextRef="AsOf2017-10-01_custom_OperatingLeaseAgreementMember" id="Fact002392" format="ixt:numdotdecimal" decimals="INF" unitRef="sqft">6,500</ix:nonFraction></span> square feet of office space. The lease
expired on <span id="xdx_901_eus-gaap--LeaseExpirationDate1_dd_c20171001__20171001__us-gaap--TypeOfArrangementAxis__custom--OperatingLeaseAgreementMember_zZPQQUCnUqY3" title="Lease expiration, date"><ix:nonNumeric contextRef="From2017-10-012017-10-01_custom_OperatingLeaseAgreementMember" format="ixt:datemonthdayyearen" id="Fact002394" name="us-gaap:LeaseExpirationDate1">March 31, 2024</ix:nonNumeric></span>. The base rent payment is approximately $<span id="xdx_901_eus-gaap--PaymentsForRent_c20171001__20171001__us-gaap--TypeOfArrangementAxis__custom--OperatingLeaseAgreementMember_ztyn6TshNWF2" title="Base rent payment"><ix:nonFraction name="us-gaap:PaymentsForRent" contextRef="From2017-10-012017-10-01_custom_OperatingLeaseAgreementMember" id="Fact002396" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,950</ix:nonFraction></span> per month, subject to annual adjustments. On February 22, 2024,
<span id="xdx_90D_eus-gaap--LesseeOperatingLeaseOptionToExtend_c20240220__20240222__us-gaap--TypeOfArrangementAxis__custom--OperatingLeaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_znUBhqeiqPDd" title="Lease extension, description"><ix:nonNumeric contextRef="From2024-02-202024-02-22_custom_OperatingLeaseAgreementMember_us-gaap_SubsequentEventMember" id="Fact002398" name="us-gaap:LesseeOperatingLeaseOptionToExtend">the Company executed a lease extension for 14 months effective April 1, 2024, and expires on May 31, 2025. The base rent on the extension
is approximately $<span id="xdx_90E_eus-gaap--PaymentsForRent_c20240220__20240222__us-gaap--TypeOfArrangementAxis__custom--OperatingLeaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z9leSZpZRE72" title="Base rent payment"><ix:nonFraction name="us-gaap:PaymentsForRent" contextRef="From2024-02-202024-02-22_custom_OperatingLeaseAgreementMember_us-gaap_SubsequentEventMember" id="Fact002400" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,553</ix:nonFraction></span> per month subject to a 3% annual adjustment.</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company entered into an operating lease on August 23, 2023, for approximately <span id="xdx_904_eus-gaap--AreaOfLand_iI_pid_usqft_c20230823__us-gaap--TypeOfArrangementAxis__custom--OperatingLeaseAgreementMember_zKLb1vxeC867" title="Lease space"><ix:nonFraction name="us-gaap:AreaOfLand" contextRef="AsOf2023-08-23_custom_OperatingLeaseAgreementMember" id="Fact002402" format="ixt:numdotdecimal" decimals="INF" unitRef="sqft">10,000</ix:nonFraction></span> square feet of ground floor retail space and a portion
of the basement underneath the ground floor retail space. The lease expires <span id="xdx_909_eus-gaap--LeaseExpirationDate1_dd_c20230823__20230823__us-gaap--TypeOfArrangementAxis__custom--OperatingLeaseAgreementMember_zWsj6gYbLEug" title="Lease expiration, date"><ix:nonNumeric contextRef="From2023-08-232023-08-23_custom_OperatingLeaseAgreementMember" format="ixt:datemonthdayyearen" id="Fact002404" name="us-gaap:LeaseExpirationDate1">August 22, 2038</ix:nonNumeric></span>, and the monthly base rent is $<span id="xdx_901_eus-gaap--PaymentsForRent_c20230823__20230823__us-gaap--TypeOfArrangementAxis__custom--OperatingLeaseAgreementMember_zNQPTSZhW5p7" title="Base rent"><ix:nonFraction name="us-gaap:PaymentsForRent" contextRef="From2023-08-232023-08-23_custom_OperatingLeaseAgreementMember" id="Fact002406" format="ixt:numdotdecimal" decimals="0" unitRef="USD">30,000</ix:nonFraction></span>, subject
to annual increases. The lease includes a 11-month free rent period between July 1, 2023, and June 30, 2024 and also includes a $<span id="xdx_906_eus-gaap--TenantImprovements_iI_pp0p0_c20230823__us-gaap--TypeOfArrangementAxis__custom--OperatingLeaseAgreementMember_zvx16rWpdwGk" title="Reimbursement for tenant improvements"><ix:nonFraction name="us-gaap:TenantImprovements" contextRef="AsOf2023-08-23_custom_OperatingLeaseAgreementMember" id="Fact002408" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">700,000</ix:nonFraction></span>
reimbursement for tenant improvements upon completion of construction milestones as defined in the lease. Due to uncertainties as to
whether these milestones will be met timely, the Company has not recorded any amounts related to the tenant improvement allowance in
our consolidated financial statements for the nine months ended December 31, 2023, at lease inception in the balance sheet of our consolidated
financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 31, 2023, our Ontario, California operating lease agreement for our primary warehouse expired. The Company did not renew the lease
and instead transferred all of its warehousing and logistics operations to a third-party logistics facility.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
entered into an operating lease agreement, effective October 15, 2022, for our administrative office located in Hong Kong where we lease
approximately <span id="xdx_903_eus-gaap--AreaOfLand_iI_pid_usqft_c20221015__us-gaap--TypeOfArrangementAxis__custom--OperatingLeaseAgreementMember_zLtdlyRbCAph" title="Lease space"><ix:nonFraction name="us-gaap:AreaOfLand" contextRef="AsOf2022-10-15_custom_OperatingLeaseAgreementMember" id="Fact002410" format="ixt:numdotdecimal" decimals="INF" unitRef="sqft">1,890</ix:nonFraction></span> square feet of office space. The lease expires on <span id="xdx_909_eus-gaap--LeaseExpirationDate1_dd_c20221015__20221015__us-gaap--TypeOfArrangementAxis__custom--OperatingLeaseAgreementMember_zX31giI38MOh" title="Lease expiration, date"><ix:nonNumeric contextRef="From2022-10-152022-10-15_custom_OperatingLeaseAgreementMember" format="ixt:datemonthdayyearen" id="Fact002412" name="us-gaap:LeaseExpirationDate1">October 14, 2025</ix:nonNumeric></span>. The base rent payment is approximately $<span id="xdx_904_eus-gaap--PaymentsForRent_c20221015__20221015__us-gaap--TypeOfArrangementAxis__custom--OperatingLeaseAgreementMember_zvdhvfgd9BLj" title="Base rent payment"><ix:nonFraction name="us-gaap:PaymentsForRent" contextRef="From2022-10-152022-10-15_custom_OperatingLeaseAgreementMember" id="Fact002414" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,900</ix:nonFraction></span>
per month for the entire term of the lease.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 108; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
SINGING MACHINE COMPANY, INC AND SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
31, 2023, and March 31, 2023 and 2022</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease
expense for our operating leases is recognized on a straight-line basis over the lease terms.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<ix:nonNumeric contextRef="From2023-04-012023-12-31" escape="true" id="Fact002416" name="RIME:ScheduleOfSupplementalInformationRelatedToLeaseTableTextBlock"><p id="xdx_895_ecustom--ScheduleOfSupplementalInformationRelatedToLeaseTableTextBlock_zWjmbd3bVcm2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Supplemental
balance sheet information related to leases as of December 31, 2023 and March 31, 2023 is as follows:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span><span id="xdx_8B0_za7kMDxbRY3d" style="display: none">SCHEDULE OF SUPPLEMENTAL INFORMATION RELATED TO LEASES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_49C_20231231_zDcPHGudyeXj" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_498_20230331_zHS0qcvQ2ZEf" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Assets:</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pp0p0_z1RqJbrrnIY7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left">Operating lease - right-of-use assets</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2023-12-31" id="Fact002418" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,926,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2023-03-31" id="Fact002419" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">561,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Liabilities</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--OperatingLeaseLiabilityCurrent_iI_pp0p0_z2SRaJwowWSb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Current portion of operating leases</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2023-12-31" id="Fact002421" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">84,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2023-03-31" id="Fact002422" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">509,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pp0p0_zwkV7Yqg0h92" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Operating lease liabilities, net of current portion</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2023-12-31" id="Fact002424" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,925,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2023-03-31" id="Fact002425" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">88,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AC_zgIRmhowRwrj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-04-012023-12-31" escape="true" id="Fact002427" name="us-gaap:LeaseCostTableTextBlock"><p id="xdx_89F_eus-gaap--LeaseCostTableTextBlock_zOFvpHZmMXH9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Supplemental
statement of operations information related to leases for the nine months ended December 31, 2023 and fiscal year ended March 31, 2023
is as follows:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BD_zMH17NPEuaWc" style="display: none">SCHEDULE OF LEASE TERM AND DISCOUNT RATE</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_49E_20230401__20231231_zWqyUUsNndN5" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_49E_20220401__20230331_zzVpriL4SWkl" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Nine Months Ended</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Fiscal Year Ended</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--OperatingLeaseExpense_zG1MRiSO8EQl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left">Operating lease expense as a component of general and administrative expenses</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseExpense" contextRef="From2023-04-012023-12-31" id="Fact002429" format="ixt:numdotdecimal" decimals="0" unitRef="USD">717,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseExpense" contextRef="From2022-04-012023-03-31" id="Fact002430" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,058,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Supplemental cash flow information related to leases for the nine months ended December 31, 2023 and fiscal year ended March 31, 2023 is as follows:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Cash paid for amounts included in the measurement of lease liabilities:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--OperatingLeasePayments_zdqWnEkPiF56" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Operating cash flow paid for operating leases</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeasePayments" contextRef="From2023-04-012023-12-31" id="Fact002432" format="ixt:numdotdecimal" decimals="0" unitRef="USD">858,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeasePayments" contextRef="From2022-04-012023-03-31" id="Fact002433" format="ixt:numdotdecimal" decimals="0" unitRef="USD">960,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Lease term and Discount Rate</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Weighted average remaining lease term (months)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Operating leases</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtM_c20231231_zKkjermhv1xa" title="Weighted average remaining lease term (months)" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonNumeric contextRef="AsOf2023-12-31" format="ixt-sec:durmonth" id="Fact002435" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1">15.0</ix:nonNumeric></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtM_c20230331_zfICcyELPeRk" title="Weighted average remaining lease term (months)" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonNumeric contextRef="AsOf2023-03-31" format="ixt-sec:durmonth" id="Fact002437" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1">12.4</ix:nonNumeric></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Weighted average discount rate</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Operating leases</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_uPure_c20231231_zpUFwiwx61Pj" title="Weighted average discount rate" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" contextRef="AsOf2023-12-31" id="Fact002439" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">12.0</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_uPure_c20230331_zBY1LEPGSq5g" title="Weighted average discount rate" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" contextRef="AsOf2023-03-31" id="Fact002441" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">6.5</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A9_zVeywgAg1hie" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<ix:nonNumeric contextRef="From2023-04-012023-12-31" escape="true" id="Fact002443" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock"><p id="xdx_89D_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zp4IXSDZzVy1" style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Minimum future payments under all operating leases as of December 31, 2023, are as follows:</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b><span id="xdx_8B3_zrBTJWYRyf78" style="display: none">SCHEDULE
OF OPERATING LEASE MINIMUM FUTURE PAYMENTS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">Payments due by period</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_495_20231231_zeoiT9zTEqfl" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Amount</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_maLOLLPzbAO_zO5vCyfHAU33" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 78%; text-align: left">2024</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" contextRef="AsOf2023-12-31" id="Fact002445" format="ixt:numdotdecimal" decimals="0" unitRef="USD">269,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_maLOLLPzbAO_zTdNecW50r51" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">2025</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" contextRef="AsOf2023-12-31" id="Fact002447" format="ixt:numdotdecimal" decimals="0" unitRef="USD">355,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_maLOLLPzbAO_zTKJSwNDSsnk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">2026</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" contextRef="AsOf2023-12-31" id="Fact002449" format="ixt:numdotdecimal" decimals="0" unitRef="USD">529,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_maLOLLPzbAO_zbN8Kl94jvk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">2027</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" contextRef="AsOf2023-12-31" id="Fact002451" format="ixt:numdotdecimal" decimals="0" unitRef="USD">585,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_maLOLLPzbAO_zo5OU1FlIcmk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">2028</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" contextRef="AsOf2023-12-31" id="Fact002453" format="ixt:numdotdecimal" decimals="0" unitRef="USD">610,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_maLOLLPzbAO_zUA0M4XIYggd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Thereafter</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" contextRef="AsOf2023-12-31" id="Fact002455" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,555,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_mtLOLLPzbAO_zZ7pqYo4GpEl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Total minimum future payments</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" contextRef="AsOf2023-12-31" id="Fact002457" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,903,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iI_zgWxyK52Qum9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Less: interest</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" contextRef="AsOf2023-12-31" id="Fact002459" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,894,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--OperatingLeaseLiability_iI_zVOVB7QGOcuf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Total operating lease liabilities</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2023-12-31" id="Fact002461" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,009,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--OperatingLeaseLiabilityCurrent_iI_zIJhnVEt2fy5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Less: current portion of lease liabilities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2023-12-31" id="Fact002463" format="ixt:numdotdecimal" decimals="0" unitRef="USD">84,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_zHQbvNKnJDIh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Operating lease liabilities, net of current portion</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2023-12-31" id="Fact002465" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,925,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A7_zAEaWhvEnV36" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-04-012023-12-31" escape="true" id="Fact002467" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"><p id="xdx_80D_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_z5GkWyKWz7u9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
9 &#8211; <span id="xdx_82C_zz4hmLHo5Qhg">STOCK COMPENSATION EXPENSE</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>EQUITY
INCENTIVE PLAN</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 12, 2022, the Board of Directors approved The Singing Machine Company, Inc. 2022 Equity Incentive Plan, or the 2022 Plan. The 2022
Plan provides for the issuance of equity incentive awards, such as stock options, stock appreciation rights, stock awards, restricted
stock, stock units, performance awards and other stock or cash-based awards collectively, the &#8220;Awards.&#8221; Awards may be granted
under the 2022 Plan to the Company&#8217;s employees, officers, directors, consultants, agents, advisors and independent contractors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--SaleOfStockDescriptionOfTransaction_c20220411__20220412__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zekDRupXv7Ej" title="Sale of stock description"><ix:nonNumeric contextRef="From2022-04-112022-04-12_custom_TwoThousandTwentyTwoPlanMember" id="Fact002469" name="us-gaap:SaleOfStockDescriptionOfTransaction">The
maximum number of shares of common stock initially available for issuance under the 2022 Plan is 233,334 shares of common stock and
thereafter an annual increase shall be added as of the first day of the Company&#8217;s fiscal year beginning in 2023, equal to the
least of (i) 5% of the outstanding common stock on a fully diluted basis as of the end of the Company&#8217;s immediately preceding
fiscal year, (ii) 33,334 shares, and (iii) a lesser amount as determined by the Board of Directors.</ix:nonNumeric></span> The shares of common stock
subject to stock awards granted under the 2022 Plan that lapse, terminate, expire prior to exercise, are canceled, or are forfeited,
shall again become available for issuance under the 2022 Plan. Shares subject to a stock award under the 2022 Plan shall not again
be made available for issuance or delivery under the 2022 Plan if such shares are (i) shares tendered by a participant or retained
by the Company as full or partial payment to the Company for the exercise or purchase price of an award or (ii) shares used to
satisfy tax withholding obligations in connection with an award.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board of Directors may amend, suspend or terminate the 2022 Plan or a portion of it at any time; however, to the extent required by applicable
law, regulation or stock exchange rule, stockholder approval shall be required for any amendment to the 2022 Plan. The 2022 Plan is scheduled
to terminate automatically in ten (10) years following the earlier of (a) the date the Board of Directors adopted the 2022 Plan and (b)
the date the stockholders approved the 2022 Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<ix:exclude><!-- Field: Page; Sequence: 109; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
SINGING MACHINE COMPANY, INC AND SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
31, 2023, and March 31, 2023 and 2022</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>COMMON
STOCK OPTIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the nine months ended December 31, 2023, the Company did not issue any stock options. During the fiscal years ended March 31, 2023, the
Company issued the following stock options:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fiscal
2023:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the fiscal year ended March 31, 2023, the Company issued <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220401__20230331__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zhYKPx7FRuG7" title="Common stock options grants"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2022-04-012023-03-31_custom_TwoThousandTwentyTwoPlanMember_srt_DirectorMember" id="Fact002471" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,001</ix:nonFraction></span> stock options under the 2022 Plan at an exercise price ranging from $<span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220401__20230331__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__srt--TitleOfIndividualAxis__srt--DirectorMember__srt--RangeAxis__srt--MinimumMember_zfKtS8MEOK35" title="Exercise price"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2022-04-012023-03-31_custom_TwoThousandTwentyTwoPlanMember_srt_DirectorMember_srt_MinimumMember" id="Fact002473" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.35</ix:nonFraction></span>
to $<span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220401__20230331__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__srt--TitleOfIndividualAxis__srt--DirectorMember__srt--RangeAxis__srt--MaximumMember_zBltLXSALflb" title="Exercise price"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2022-04-012023-03-31_custom_TwoThousandTwentyTwoPlanMember_srt_DirectorMember_srt_MaximumMember" id="Fact002475" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">8.11</ix:nonFraction></span> per share to directors as compensation for their service.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the fiscal year ended March 31, 2023, the Company issued <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220401__20230331__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__srt--TitleOfIndividualAxis__srt--OfficerMember_zIirfgi9Svy1" title="Common stock options grants"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2022-04-012023-03-31_custom_TwoThousandTwentyTwoPlanMember_srt_OfficerMember" id="Fact002477" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">37,001</ix:nonFraction> </span>stock
options from the 2022 Plan at an exercise price ranging from $<span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220401__20230331__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__srt--TitleOfIndividualAxis__srt--OfficerMember__srt--RangeAxis__srt--MinimumMember_zrjgVp5Wyuzf" title="Exercise price"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2022-04-012023-03-31_custom_TwoThousandTwentyTwoPlanMember_srt_OfficerMember_srt_MinimumMember" id="Fact002479" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4.00</ix:nonFraction></span>
to $<span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220401__20230331__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__srt--TitleOfIndividualAxis__srt--OfficerMember__srt--RangeAxis__srt--MaximumMember_z0xBID13UDZ6" title="Exercise price"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2022-04-012023-03-31_custom_TwoThousandTwentyTwoPlanMember_srt_OfficerMember_srt_MaximumMember" id="Fact002481" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">8.65</ix:nonFraction></span>
per share to the Company&#8217;s officers as incentive compensation for the successful up-listing of the Company&#8217;s common
stock on the Nasdaq Capital Market and compensation related to their Fiscal 2022 annual incentive plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the fiscal year ended March 31, 2023, the Company issued <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220401__20230331__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__srt--TitleOfIndividualAxis__custom--EmployeeMember_z4xSXPO0ahl4" title="Common stock options grants"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2022-04-012023-03-31_custom_TwoThousandTwentyTwoPlanMember_custom_EmployeeMember" id="Fact002483" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">64,750</ix:nonFraction></span> stock options from the 2022 Plan to all employees (excluding Company
officers) who had one year or more of service to the Company under an Employee Incentive Plan at an exercise price ranging from $<span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220401__20230331__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__srt--TitleOfIndividualAxis__custom--EmployeeMember__srt--RangeAxis__srt--MinimumMember_zN0Y1fCGx21g" title="Exercise price"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2022-04-012023-03-31_custom_TwoThousandTwentyTwoPlanMember_custom_EmployeeMember_srt_MinimumMember" id="Fact002485" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">8.11</ix:nonFraction></span>
to $<span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220401__20230331__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__srt--TitleOfIndividualAxis__custom--EmployeeMember__srt--RangeAxis__srt--MaximumMember_zZe98hshSP07" title="Exercise price"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2022-04-012023-03-31_custom_TwoThousandTwentyTwoPlanMember_custom_EmployeeMember_srt_MaximumMember" id="Fact002487" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">8.65</ix:nonFraction></span> per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employee
stock option compensation expense for the nine months ended December 31, 2023, and in fiscal years ended March 31, 2023, and 2022 includes
the estimated fair value of options granted, amortized on a straight-line basis over the requisite service period for the entire portion
of the award. For the nine months ended December 31, 2023, the stock option expense was approximately $<span id="xdx_90A_eus-gaap--StockOptionPlanExpense_c20230401__20231231_zRDg86rXewH5" title="Stock option expense"><ix:nonFraction name="us-gaap:StockOptionPlanExpense" contextRef="From2023-04-012023-12-31" id="Fact002489" format="ixt:numdotdecimal" decimals="0" unitRef="USD">110,000</ix:nonFraction></span>. For the fiscal years
ended March 31, 2023, and 2022, the stock option expense was approximately $<span id="xdx_90B_eus-gaap--StockOptionPlanExpense_c20220401__20230331_zfc9hwTbnooh" title="Stock option expense"><ix:nonFraction name="us-gaap:StockOptionPlanExpense" contextRef="From2022-04-012023-03-31" id="Fact002491" format="ixt:numdotdecimal" decimals="0" unitRef="USD">237,000</ix:nonFraction></span> and $<span id="xdx_901_eus-gaap--StockOptionPlanExpense_c20210401__20220331_zzGZkuXxuiw3" title="Stock option expense"><ix:nonFraction name="us-gaap:StockOptionPlanExpense" contextRef="From2021-04-012022-03-31" id="Fact002493" format="ixt:numdotdecimal" decimals="0" unitRef="USD">22,000</ix:nonFraction></span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fiscal
2022:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the fiscal year ended March 31, 2022, the Company issued <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210401__20220331__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember_zKGFIfAPybk8" title="Common stock options grants"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2021-04-012022-03-31_srt_BoardOfDirectorsChairmanMember" id="Fact002495" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,001</ix:nonFraction></span> Board approved options three members of our Board of Directors at an exercise
price ranging from $<span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210401__20220331__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember__srt--RangeAxis__srt--MinimumMember_zmfTXfAfdLjd" title="Exercise price"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2021-04-012022-03-31_srt_BoardOfDirectorsChairmanMember_srt_MinimumMember" id="Fact002497" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">8.10</ix:nonFraction></span> and $<span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210401__20220331__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember__srt--RangeAxis__srt--MaximumMember_zOAUKVkhGR0b" title="Exercise price"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2021-04-012022-03-31_srt_BoardOfDirectorsChairmanMember_srt_MaximumMember" id="Fact002499" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">8.70</ix:nonFraction></span> per share pursuant to our annual director compensation plan for the fiscal year ended March 31, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of each option grant was estimated on the date of the grant using the Black-Scholes option-pricing model with the assumptions
outlined below. The expected volatility is based upon the historical volatility of our stock and other contributing factors. The expected
term is based upon observation of actual time elapsed between date of grant and exercise of options for all employees.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the year ended March 31, 2023: expected dividend yield of <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20220401__20230331_zAwJHiDdPak2" title="Stock option, expected dividend yield"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2022-04-012023-03-31" id="Fact002501" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0</ix:nonFraction></span>%, risk-free interest rate between <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20220401__20230331__srt--RangeAxis__srt--MinimumMember_zVvIIspQ1oHe" title="Stock option, risk free interest rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2022-04-012023-03-31_srt_MinimumMember" id="Fact002503" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">2.63</ix:nonFraction></span>% and <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20220401__20230331__srt--RangeAxis__srt--MaximumMember_zEQwQQUSYlxb" title="Stock option, risk free interest rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2022-04-012023-03-31_srt_MaximumMember" id="Fact002505" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">3.21</ix:nonFraction></span>%, respectively, with
    volatility between <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20220401__20230331__srt--RangeAxis__srt--MinimumMember_zCEZh59Ffih7" title="Stock option, volatility"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2022-04-012023-03-31_srt_MinimumMember" id="Fact002507" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">166.1</ix:nonFraction></span>% and <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20220401__20230331__srt--RangeAxis__srt--MaximumMember_zC5exglHaUV" title="Stock option, volatility"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2022-04-012023-03-31_srt_MaximumMember" id="Fact002509" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">196.3</ix:nonFraction></span>%, respectively with an expected term of <span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dc_c20220401__20230331_zjVgIJiZ7k8l" title="Stock option, expected term"><ix:nonNumeric contextRef="From2022-04-012023-03-31" format="ixt-sec:durwordsen" id="Fact002511" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">three years</ix:nonNumeric></span>.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the fiscal year ended March 31, 2022: expected dividend yield of <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20210401__20220331_zNwaweCTsHp8" title="Stock option, expected dividend yield"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2021-04-012022-03-31" id="Fact002513" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0</ix:nonFraction></span>%, risk-free interest rate between <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20210401__20220331__srt--RangeAxis__srt--MinimumMember_zApapyrpAuW6" title="Stock option, risk free interest rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2021-04-012022-03-31_srt_MinimumMember" id="Fact002515" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.43</ix:nonFraction></span>% and <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20210401__20220331__srt--RangeAxis__srt--MaximumMember_zjW8pkHro0Ab" title="Stock option, risk free interest rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2021-04-012022-03-31_srt_MaximumMember" id="Fact002517" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.96</ix:nonFraction></span>%, respectively
    with volatility between <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20210401__20220331__srt--RangeAxis__srt--MinimumMember_zzGMD5kpB1Ql" title="Stock option, volatility"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2021-04-012022-03-31_srt_MinimumMember" id="Fact002519" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">149.5</ix:nonFraction></span>% and <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20210401__20220331__srt--RangeAxis__srt--MaximumMember_zcm7CXKI6d5l" title="Stock option, volatility"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2021-04-012022-03-31_srt_MaximumMember" id="Fact002521" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">157.0</ix:nonFraction></span>% respectively with an expected term of <span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dc_c20210401__20220331_zPjyUS7j10Ii" title="Stock option, expected term"><ix:nonNumeric contextRef="From2021-04-012022-03-31" format="ixt-sec:durwordsen" id="Fact002523" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">three years</ix:nonNumeric></span>.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-04-012023-12-31" escape="true" id="Fact002525" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"><p id="xdx_894_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zwSZRhkkVd2i" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of stock option activity for each of the years presented is summarized below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span id="xdx_8BB_zxjo8GHyYRrc" style="display: none">SUMMARY OF STOCK OPTION ACTIVITY</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Nine Months Ended</p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">December 31, 2023</p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Fiscal Year Ended</p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">March 31, 2023</p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Fiscal Year Ended</p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">March 31, 2022</p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Number of</p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Options</p></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Weighted</p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Average Exercise</p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Price</p></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Weighted</p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Average Contractual</p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Life</p></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Number of</p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Options</p></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Weighted</p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Average Exercise</p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Price</p></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Weighted</p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Average Contractual</p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Life</p></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Number of</p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Options</p></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Weighted</p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Average Exercise</p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Price</p></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Weighted</p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Average Contractual</p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Life</p></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Stock Options:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; width: 28%; text-align: left">Balance at beginning of year</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20230401__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zuSR13e2AEoi" title="Number of Options, Balance at beginning of period" style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2023-03-31_us-gaap_StockOptionMember" id="Fact002527" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">161,427</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20230401__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zM4jL2mKz5ye" title="Weighted Average Exercise Price, Balance at beginning of period" style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2023-03-31_us-gaap_StockOptionMember" id="Fact002529" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">7.90</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: right"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220401__20230331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_z4VT6tWjrgqi" title="Weighted Average contractual life"><ix:nonNumeric contextRef="From2022-04-012023-03-31_us-gaap_StockOptionMember" format="ixt-sec:duryear" id="Fact002531" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">6.6</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220401__20230331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_z8dASt4qV4ne" title="Number of Options, Balance at beginning of period" style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2022-03-31_us-gaap_StockOptionMember" id="Fact002533" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">56,343</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20220401__20230331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zKgXaYCHT0o2" title="Weighted Average Exercise Price, Balance at beginning of period" style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2022-03-31_us-gaap_StockOptionMember" id="Fact002535" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">9.90</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210401__20220331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zWny3OKkJnFk" title="Weighted Average contractual life"><ix:nonNumeric contextRef="From2021-04-012022-03-31_us-gaap_StockOptionMember" format="ixt-sec:duryear" id="Fact002537" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">4.1</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20210401__20220331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zec1i6Kv76M9" title="Number of Options, Balance at beginning of period" style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-03-31_us-gaap_StockOptionMember" id="Fact002539" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">56,010</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20210401__20220331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zjjPY4f494Lk" title="Weighted Average Exercise Price, Balance at beginning of period" style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2021-03-31_us-gaap_StockOptionMember" id="Fact002541" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">9.90</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: right"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20200401__20210331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zt6XjHfdLmUi" title="Weighted Average contractual life"><ix:nonNumeric contextRef="From2020-04-012021-03-31_us-gaap_StockOptionMember" format="ixt-sec:duryear" id="Fact002543" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">5.4</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Granted</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230401__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zUkFlbAFEZug" title="Number of Options, Granted" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2545">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20230401__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zunSwWVnfai3" title="Weighted Average Exercise Price, Granted" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2547">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220401__20230331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zfBOrO3XLqfi" title="Number of Options, Granted" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2022-04-012023-03-31_us-gaap_StockOptionMember" id="Fact002549" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">107,752</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220401__20230331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_z1nbqACPRrm4" title="Weighted Average Exercise Price, Granted" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2022-04-012023-03-31_us-gaap_StockOptionMember" id="Fact002551" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">6.83</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210401__20220331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_z1T5Xzj2wjN7" title="Number of Options, Granted" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2021-04-012022-03-31_us-gaap_StockOptionMember" id="Fact002553" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,667</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210401__20220331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zcgNdOMVzf3d" title="Weighted Average Exercise Price, Granted" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2021-04-012022-03-31_us-gaap_StockOptionMember" id="Fact002555" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">7.80</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Exercised</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20230401__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zPs1yMi1yQV8" title="Number of Options, Exercised" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2557">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20230401__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zApJ6Jrqzn57" title="Weighted Average Exercise Price, Exercised" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2559">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20220401__20230331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zT42hGb2aNR" title="Number of Options, Exercised" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2561">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20220401__20230331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_z37yoMd6Q3Ti" title="Weighted Average Exercise Price, Exercised" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2563">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20210401__20220331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zKwYoyq3KHh7" title="Number of Options, Exercised" style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2021-04-012022-03-31_us-gaap_StockOptionMember" id="Fact002565" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,667</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20210401__20220331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zKk6OPn2Fa7k" title="Weighted Average Exercise Price, Exercised" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="From2021-04-012022-03-31_us-gaap_StockOptionMember" id="Fact002567" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.40</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Forfeited</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20230401__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zM53IbfCe9X3" title="Number of Options, Forfeited" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" contextRef="From2023-04-012023-12-31_us-gaap_StockOptionMember" id="Fact002569" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">47,666</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20230401__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zcSqnMymjpzh" title="Weighted Average Exercise Price, Forfeited" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" contextRef="From2023-04-012023-12-31_us-gaap_StockOptionMember" id="Fact002571" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">7.48</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20220401__20230331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zOaq83fvBo2h" title="Number of Options, Forfeited" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" contextRef="From2022-04-012023-03-31_us-gaap_StockOptionMember" id="Fact002573" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,668</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20220401__20230331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zzIPkkG9V76j" title="Weighted Average Exercise Price, Forfeited" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" contextRef="From2022-04-012023-03-31_us-gaap_StockOptionMember" id="Fact002575" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.63</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20210401__20220331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zMtnNIMFxgt9" title="Number of Options, Forfeited" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" contextRef="From2021-04-012022-03-31_us-gaap_StockOptionMember" id="Fact002577" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">667</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20210401__20220331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zsZN6Kzaabge" title="Weighted Average Exercise Price, Forfeited" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" contextRef="From2021-04-012022-03-31_us-gaap_StockOptionMember" id="Fact002579" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.60</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Balance at end of year *</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20230401__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_fKCop_z6HwM5zINEc7" title="Number of Options, Balance at end of period" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2023-12-31_us-gaap_StockOptionMember" id="Fact002581" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">113,761</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20230401__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_fKCop_zT3QNP0Qe0E1" title="Weighted Average Exercise Price, Balance at end of period" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2023-12-31_us-gaap_StockOptionMember" id="Fact002583" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">8.08</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230401__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_fKCop_zOPu4ZtADzIj" title="Weighted Average contractual life"><ix:nonNumeric contextRef="From2023-04-012023-12-31_us-gaap_StockOptionMember" format="ixt-sec:duryear" id="Fact002585" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">4.2</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20220401__20230331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_fKCop_zD4igbxPj4V7" title="Number of Options, Balance at end of period" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2023-03-31_us-gaap_StockOptionMember" id="Fact002587" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">161,427</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20220401__20230331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_fKCop_z28dSgXsk8W1" title="Weighted Average Exercise Price, Balance at end of period" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2023-03-31_us-gaap_StockOptionMember" id="Fact002589" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">7.90</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span id="xdx_90C_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220401__20230331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_fKCop_zCIRXJCsJF4i" title="Weighted Average contractual life"><ix:nonNumeric contextRef="From2022-04-012023-03-31_us-gaap_StockOptionMember" format="ixt-sec:duryear" id="Fact002591" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">6.6</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20210401__20220331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_fKCop_zBve8WxqYidb" title="Number of Options, Balance at end of period" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2022-03-31_us-gaap_StockOptionMember" id="Fact002593" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">56,343</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20210401__20220331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_fKCop_z2odeywZpLlh" title="Weighted Average Exercise Price, Balance at end of period" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2022-03-31_us-gaap_StockOptionMember" id="Fact002595" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">9.90</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span id="xdx_90A_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210401__20220331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_fKCop_zUxCdhfq8POk" title="Weighted Average contractual life"><ix:nonNumeric contextRef="From2021-04-012022-03-31_us-gaap_StockOptionMember" format="ixt-sec:duryear" id="Fact002597" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">4.1</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Options exercisable at end of year</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20230401__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_z3jhMdDLOEjd" title="Number of Options, exercisable at end of period" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="AsOf2023-12-31_us-gaap_StockOptionMember" id="Fact002599" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">91,261</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20230401__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zPdnz0W0BGpa" title="Weighted Average Exercise Price, Options exercisable at end of period" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="AsOf2023-12-31_us-gaap_StockOptionMember" id="Fact002601" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">8.06</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20220401__20230331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zYb8ze7xDAZ1" title="Number of Options, exercisable at end of period" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="AsOf2023-03-31_us-gaap_StockOptionMember" id="Fact002603" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">53,675</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20220401__20230331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zeZztL05GLB6" title="Weighted Average Exercise Price, Options exercisable at end of period" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="AsOf2023-03-31_us-gaap_StockOptionMember" id="Fact002605" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">9.90</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20210401__20220331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zU3UfCKF5SS4" title="Number of Options, exercisable at end of period" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="AsOf2022-03-31_us-gaap_StockOptionMember" id="Fact002607" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">52,667</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20210401__20220331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zTpFTVGB4XQe" title="Weighted Average Exercise Price, Options exercisable at end of period" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="AsOf2022-03-31_us-gaap_StockOptionMember" id="Fact002609" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">9.90</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font: 10pt Times New Roman, Times, Serif; width: 15pt; text-align: right"><span id="xdx_F03_zMJ9yCxd4dyi" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F11_ztjnMqHqnwl5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote002610" xml:lang="en-US">Total number of
options outstanding as of December 31, 2023, includes <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20231231__srt--TitleOfIndividualAxis__custom--SixCurrentAndThreeFormerDirectorsMember_ziDf0VRBSP8d" title="Option issued" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEVNUExPWUVFIFNUT0NLIE9QVElPTlMgT1VUU1RBTkRJTkcgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2023-12-31_custom_SixCurrentAndThreeFormerDirectorsMember" id="Fact002612" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">23,343</ix:nonFraction></span> options issued to six current and three former directors as compensation,
<span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20231231__srt--TitleOfIndividualAxis__srt--OfficerMember_zlaFmcYLufcb" title="Option issued" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEVNUExPWUVFIFNUT0NLIE9QVElPTlMgT1VUU1RBTkRJTkcgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2023-12-31_srt_OfficerMember" id="Fact002614" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">56,668</ix:nonFraction></span> options issued to Company officers as compensation and <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20231231__srt--TitleOfIndividualAxis__custom--EmployeesMember_zMTAts14yJF3" title="Option issued" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEVNUExPWUVFIFNUT0NLIE9QVElPTlMgT1VUU1RBTkRJTkcgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2023-12-31_custom_EmployeesMember" id="Fact002616" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">33,750</ix:nonFraction></span> options issued to employees as part of an Employee Stock Incentive
Plan.</ix:footnote></span></td>
</tr></table>

</ix:nonNumeric><p id="xdx_8A3_zIYp4RC0vqbi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2023, there was an unrecognized expense of approximately $<span id="xdx_904_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_c20231231_zgCDisISYLPc" title="Unrecognised expense"><ix:nonFraction name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" contextRef="AsOf2023-12-31" id="Fact002618" format="ixt:numdotdecimal" decimals="0" unitRef="USD">122,000</ix:nonFraction></span> remaining on options currently vesting over time with
approximate weighted average of <span id="xdx_905_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dc_c20230401__20231231_z5eipgicKVjg" title="Weighted average term"><ix:nonNumeric contextRef="From2023-04-012023-12-31" format="ixt-sec:durwordsen" id="Fact002620" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">eighteen months</ix:nonNumeric></span> remaining until these options are fully vested.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
vested options as of December 31, 2023, had <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_do_c20231231_z5Y582EQZRv3" title="Vested options"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" contextRef="AsOf2023-12-31" id="Fact002622" format="ixt-sec:numwordsen" decimals="0" unitRef="USD">no</ix:nonFraction></span> intrinsic value. As of December 31, 2023, there were <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20231231_zNn4FSuDIj9a" title="Number of shares available for issuance"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" contextRef="AsOf2023-12-31" id="Fact002624" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">165,469</ix:nonFraction></span> shares under the 2022 Plan
available to be issued.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WARRANTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
warrants issued and outstanding as of December 31, 2023 and March 31, 2023, were <span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20231231_zpFvGKoQgIz3" title="Warrants outstanding"><span id="xdx_904_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20230331_zaAapAmp1i4e" title="Warrants outstanding"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2023-12-31" id="Fact002626" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2023-03-31" id="Fact002628" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">902,113</ix:nonFraction></ix:nonFraction></span></span>.
There were no changes in the warrants outstanding during the period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 110; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
SINGING MACHINE COMPANY, INC AND SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
31, 2023, and March 31, 2023 and 2022</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-04-012023-12-31" escape="true" id="Fact002630" name="us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"><p id="xdx_894_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zAXu7qMU6Qxd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2023, the Company&#8217;s warrants by expiration date were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B2_z4dc31X58bna" style="display: none">SCHEDULE
OF WARRANTS EXPIRATION</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Number of</p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Common</p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Warrants</p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Exercise Price</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Expiration Date</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_z1p7O41GDgqk" title="Number of common warrants" style="font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2023-12-31_custom_ExercisePriceRangeOneMember" id="Fact002632" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">802,113</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zzlnpwNolV4l" title="Warrant Exercise Price" style="font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2023-12-31_custom_ExercisePriceRangeOneMember" id="Fact002634" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.80</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 52%; text-align: left"><span id="xdx_90F_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zeQZylxWsLCl" title="Expiration Date"><ix:nonNumeric contextRef="AsOf2023-12-31_custom_ExercisePriceRangeOneMember" format="ixt:datemonthdayyearen" id="Fact002636" name="us-gaap:WarrantsAndRightsOutstandingMaturityDate">September 15, 2026</ix:nonNumeric></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zUrmgJ8OuzZa" title="Number of common warrants" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2023-12-31_custom_ExercisePriceRangeTwoMember" id="Fact002638" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">100,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">$</td><td id="xdx_980_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_z2GYeW1cdQR6" title="Warrant Exercise Price" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2023-12-31_custom_ExercisePriceRangeTwoMember" id="Fact002640" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.00</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span id="xdx_905_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zvU7gahreCL4" title="Expiration Date"><ix:nonNumeric contextRef="AsOf2023-12-31_custom_ExercisePriceRangeTwoMember" format="ixt:datemonthdayyearen" id="Fact002642" name="us-gaap:WarrantsAndRightsOutstandingMaturityDate">May 23, 2027</ix:nonNumeric></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20231231_zX2rc3VxQHeg" title="Number of common warrants" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2023-12-31" id="Fact002644" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">902,113</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-bottom: 2.5pt">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A0_zc9F3jST1XBg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-04-012023-12-31" escape="true" id="Fact002646" name="us-gaap:EarningsPerShareTextBlock"><p id="xdx_809_eus-gaap--EarningsPerShareTextBlock_zG4iKg7KSqD" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
10 - <span>COMPUTATION OF (LOSS) EARNINGS PER SHARE</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_823_zrvuvKyHQPu4" style="display: none">COMPUTATION
OF LOSS PER SHARE</span>&#160;</span></p>

<ix:nonNumeric contextRef="From2023-04-012023-12-31" escape="true" id="Fact002648" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"><p id="xdx_894_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zkkcrU1UzQx7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computation
of dilutive shares for the nine months ended December 31, 2023 and fiscal years ended March 31, 2023 and 2022 are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B1_zwv1HLg3C7Jd" style="display: none">SCHEDULE
OF BASIC AND DILUTIVE SHARES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_492_20230401__20231231_zMhBsn563Tz9" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Nine months ended</p>
                                               <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">December 31, 2023</p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_499_20220401__20230331_zwsIj5F43kF6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Fiscal year ended</p>
                                               <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">March 31, 2023</p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20210401__20220331_zOYnLVamqU39" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Fiscal year ended</p>
                                               <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">March 31, 2022</p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_zC8SvzUsAmnc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 43%; text-align: left">Basic weighted average common shares outstanding</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-04-012023-12-31" id="Fact002650" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,864,540</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2022-04-012023-03-31" id="Fact002651" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,811,872</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2021-04-012022-03-31" id="Fact002652" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,614,506</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_zA0NI4Fna3t" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Effect of dilutive stock options</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2654">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2655">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants" contextRef="From2021-04-012022-03-31" id="Fact002656" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">8,891</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_zJVYATuS89pb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Diluted weighted average of common shares outstanding</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-04-012023-12-31" id="Fact002658" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,864,540</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2022-04-012023-03-31" id="Fact002659" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,811,872</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2021-04-012022-03-31" id="Fact002660" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,623,397</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A0_z7bKfIsBccWj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
net (loss) income per share is based on the weighted average number of shares of common stock outstanding during the period. Diluted
net (loss) income per share reflects the potential dilution assuming shares of common stock were issued upon the exercise of
outstanding in-the-money options and the proceeds thereof were used to purchase shares of the Company&#8217;s common stock at the
average market price during the period using the treasury stock method. For the nine months ended December 31, 2023, options to
purchase <span id="xdx_903_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230401__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zaRa7ZNjzhsg" title="Potentially dilutive securities"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2023-04-012023-12-31_us-gaap_EmployeeStockOptionMember" id="Fact002662" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">113,761</ix:nonFraction></span>
shares of common stock and <span id="xdx_90D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230401__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--CommonStockWarrantsMember_zAJM7dzAOuSh" title="Potentially dilutive securities"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2023-04-012023-12-31_custom_CommonStockWarrantsMember" id="Fact002664" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">902,113</ix:nonFraction></span>
common stock warrants were excluded in the calculation of diluted net (loss) income per share as the result would have been
anti-dilutive. For the fiscal year ended March 31, 2023, options to purchase <span id="xdx_90E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220401__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zsg8lIyWdJw6" title="Potentially dilutive securities"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2022-04-012023-03-31_us-gaap_EmployeeStockOptionMember" id="Fact002666" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">53,675</ix:nonFraction></span>
shares of common stock and <span id="xdx_909_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220401__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--CommonStockWarrantsMember_zbOFlAyYQ4Dk" title="Potentially dilutive securities"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2022-04-012023-03-31_custom_CommonStockWarrantsMember" id="Fact002668" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">902,113</ix:nonFraction></span>
common stock warrants were excluded in the calculation of diluted net (loss) income per share as the result would have been
anti-dilutive.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the fiscal year ended March 31, 2022, pre-funded warrants to purchase <span id="xdx_903_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210401__20220331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--PreFundedWarrantsMember_zDbzGVgB9NFe" title="Potentially dilutive securities"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2021-04-012022-03-31_custom_PreFundedWarrantsMember" id="Fact002670" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">561,111</ix:nonFraction></span> shares of common stock were included in basic weighted
average shares outstanding as deemed outstanding. Options to purchase <span id="xdx_909_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210401__20220331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_z3fL6IOMWC2h" title="Potentially dilutive securities"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2021-04-012022-03-31_us-gaap_EmployeeStockOptionMember" id="Fact002672" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">8,891</ix:nonFraction></span> shares of common stock were included in the calculation of
diluted net income per share. For the fiscal year ended March 31, 2022, options and warrants to purchase approximately <span id="xdx_900_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210401__20220331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--OptionsAndWarrantsMember_zoEguhA4bOS9" title="Potentially dilutive securities"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2021-04-012022-03-31_custom_OptionsAndWarrantsMember" id="Fact002674" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">56,000</ix:nonFraction></span> shares
of common stock were excluded in the calculation of diluted net (loss) income per share as the result would have been anti-dilutive.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-04-012023-12-31" escape="true" id="Fact002676" name="RIME:IssuanceOfPublicOfferingTextBlock"><p id="xdx_803_ecustom--IssuanceOfPublicOfferingTextBlock_zbLN8k1uirYh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
11 &#8211; <span id="xdx_828_z0aE5XohnvDf">PUBLIC OFFERING AND NASDAQ UPLISTING</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 23, 2022, the Company entered into the Underwriting Agreement with Aegis Capital Corp., who acted as the sole Underwriter, in a firm
commitment underwritten public offering pursuant to which the Company sold to the Underwriter <span id="xdx_902_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20220523__20220523__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_zfDp2eI7R9x3" title="Sale of stock, number of shares issued in transaction"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2022-05-232022-05-23_custom_UnderwritingAgreementMember" id="Fact002678" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,000,000</ix:nonFraction></span> shares of common stock, par value
$<span id="xdx_902_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20220523__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_zBOCML0XZEO5" title="Common stock, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-05-23_custom_UnderwritingAgreementMember" id="Fact002680" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.01</ix:nonFraction></span> per share for gross proceeds of $<span id="xdx_904_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20220523__20220523__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_zdekSTM9f1kf" title="Gross proceeds"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2022-05-232022-05-23_custom_UnderwritingAgreementMember" id="Fact002682" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,000,000</ix:nonFraction></span> prior to deducting underwriting discounts and commissions and other estimated offering
expenses of approximately $<span id="xdx_901_eus-gaap--PaymentsForCommissions_c20220523__20220523__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_zF0zNDjHjaoe" title="Underwriting discounts and commissions and other estimated offering expenses"><ix:nonFraction name="us-gaap:PaymentsForCommissions" contextRef="From2022-05-232022-05-23_custom_UnderwritingAgreementMember" id="Fact002684" format="ixt:numdotdecimal" decimals="0" unitRef="USD">600,000</ix:nonFraction></span>. The price to the public in the offering was $<span id="xdx_90D_eus-gaap--SaleOfStockPricePerShare_iI_c20220523__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_zaFjRu0c4M3h" title="Sale of stock, price per share"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2022-05-23_custom_UnderwritingAgreementMember" id="Fact002686" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4.00</ix:nonFraction></span> per Share, before underwriting discounts and commissions.
The offering closed on May 26, 2022. The Company received net proceeds of approximately <span id="xdx_902_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20220523__20220523__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_ztQFgvfbn5t" title="Net proceeds"><ix:nonFraction name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" contextRef="From2022-05-232022-05-23_custom_UnderwritingAgreementMember" id="Fact002688" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,400,000</ix:nonFraction></span> which was used for working capital.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the terms of the Underwriting Agreement, the Company agreed to issue to the Underwriter warrants to purchase up to <span id="xdx_901_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220523__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_zWnqf8ePdVYi" title="Underwriter warrants to purchase"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2022-05-23_custom_UnderwritingAgreementMember" id="Fact002690" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">100,000</ix:nonFraction></span> shares
of Common Stock representing <span id="xdx_904_ecustom--SaleOfStockPercentage_pid_dp_uPure_c20220523__20220523__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_zsa35ZeGESi3" title="Sale of stock, percentage"><ix:nonFraction name="RIME:SaleOfStockPercentage" contextRef="From2022-05-232022-05-23_custom_UnderwritingAgreementMember" id="Fact002692" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10.0</ix:nonFraction></span>% of the Shares sold in this offering, excluding any Shares sold through the over-allotment option.
The warrants are exercisable for six months from the commencement of sales under the offering, have an exercise price of $<span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220523__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_z7qG3UCt2qw9" title="Exercise price per share"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2022-05-23_custom_UnderwritingAgreementMember" id="Fact002694" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.00</ix:nonFraction></span> per share
and expire <span id="xdx_909_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_c20220523__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_zWsbtxhGBZS1" title="Warrant term"><ix:nonNumeric contextRef="AsOf2022-05-23_custom_UnderwritingAgreementMember" format="ixt-sec:durwordsen" id="Fact002696" name="us-gaap:WarrantsAndRightsOutstandingTerm">five years</ix:nonNumeric></span> from the date of issuance. The Company estimated the fair value of these warrants to be approximately $<span id="xdx_906_eus-gaap--FairValueAdjustmentOfWarrants_pp0p0_c20220523__20220523__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_zdzZOfjpolz" title="Fair value adjustment of warrants"><ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2022-05-232022-05-23_custom_UnderwritingAgreementMember" id="Fact002698" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">244,000</ix:nonFraction></span>
using the Black-Scholes Model based on the following input assumptions: common stock price of $<span id="xdx_906_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220523__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember_zhaLW2eVYTDk" title="Warrant measurement input"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2022-05-23_custom_UnderwritingAgreementMember_us-gaap_MeasurementInputExercisePriceMember" id="Fact002700" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">2.90</ix:nonFraction></span>, expected life of the warrants of
<span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20220523__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_z17ADdJpzU7l" title="Warrant term"><ix:nonNumeric contextRef="AsOf2022-05-23_custom_UnderwritingAgreementMember_us-gaap_MeasurementInputExpectedTermMember" format="ixt-sec:duryear" id="Fact002702" name="us-gaap:WarrantsAndRightsOutstandingTerm">3</ix:nonNumeric></span> years; stock price volatility of <span id="xdx_902_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220523__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zCP8iv4WwsJb" title="Warrant measurement input"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2022-05-23_custom_UnderwritingAgreementMember_us-gaap_MeasurementInputPriceVolatilityMember" id="Fact002704" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">176</ix:nonFraction></span>%; dividend yield of <span id="xdx_90E_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220523__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zRpbMe0Ug4eb" title="Warrant measurement input"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2022-05-23_custom_UnderwritingAgreementMember_us-gaap_MeasurementInputExpectedDividendRateMember" id="Fact002706" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">0</ix:nonFraction></span>%; and the risk-free interest rate of <span id="xdx_900_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220523__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zrt05B5RPxX4" title="Warrant measurement input"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2022-05-23_custom_UnderwritingAgreementMember_us-gaap_MeasurementInputRiskFreeInterestRateMember" id="Fact002708" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">2.63</ix:nonFraction></span>%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 24, 2022, the Company&#8217;s common stock was approved to list on the Nasdaq Capital Market under the symbol &#8220;MICS&#8221;
and began trading on the Nasdaq Capital Market on May 24, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-04-012023-12-31" escape="true" id="Fact002710" name="RIME:AtTheMarketPublicOfferingTextBlock"><p id="xdx_80D_ecustom--AtTheMarketPublicOfferingTextBlock_zBPwJg5r8tR2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
12 &#8211; <span id="xdx_82E_z1zXFm5G0Zvc">ATM OFFERING</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 15, 2023, the Company entered into an At-The-Market Issuance Sales Agreement (the &#8220;Sales Agreement&#8221;) with Aegis
Capital Corp, as sales agent (the &#8220;Agent&#8221;), pursuant to which the Company could offer and sell, from time to time, through
the Agent (the &#8220;ATM Offering&#8221;), up to approximately $<span id="xdx_903_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_pp0p0_c20230215__20230215__us-gaap--SubsidiarySaleOfStockAxis__custom--ATMOfferingMember_z8sylrixdvOg" title="Number of stock sold, value"><ix:nonFraction name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" contextRef="From2023-02-152023-02-15_custom_ATMOfferingMember" id="Fact002712" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,800,000</ix:nonFraction></span> in shares of the Company&#8217;s common stock. For the nine
months ended December 31, 2023, and fiscal year ended March 31, 2023, the Company received net proceeds of approximately $<span id="xdx_90F_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20230401__20231231__us-gaap--SubsidiarySaleOfStockAxis__custom--ATMOfferingMember_z5j0sPe6ajV7" title="Proceeds from sale of equity"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" contextRef="From2023-04-012023-12-31_custom_ATMOfferingMember" id="Fact002714" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,654,000</ix:nonFraction></span> and
$<span id="xdx_907_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20220401__20230331__us-gaap--SubsidiarySaleOfStockAxis__custom--ATMOfferingMember_zmbXx5bjFuh3" title="Proceeds from sale of equity"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" contextRef="From2022-04-012023-03-31_custom_ATMOfferingMember" id="Fact002716" format="ixt:numdotdecimal" decimals="0" unitRef="USD">36,000</ix:nonFraction></span>, respectively, after payment of brokerage commissions and administrative fees to the agent. The ATM Offering was terminated on May 12, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<ix:exclude><!-- Field: Page; Sequence: 111; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
SINGING MACHINE COMPANY, INC AND SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
31, 2023, and March 31, 2023 and 2022</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-04-012023-12-31" escape="true" id="Fact002718" name="RIME:PrivatePlacementTextBlock"><p id="xdx_804_ecustom--PrivatePlacementTextBlock_zEGmTkIFWoac" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
13 &#8211; <span id="xdx_827_zVjf19s2AIXd">PRIVATE PLACEMENT</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 20, 2023, the Company the Company entered into an agreement to sell $<span id="xdx_90F_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20231120__20231120__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zIlmqJmcjBP6" title="Number of stock sold, value"><ix:nonFraction name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" contextRef="From2023-11-202023-11-20_us-gaap_PrivatePlacementMember" id="Fact002720" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,000,000</ix:nonFraction></span> in common stock through a private placement of
common stock (the &#8220;Private Placement&#8221;). The Private Placement was completed with two Affiliates, (Stingray Group, Inc. and
Jay Foreman), both of which were existing shareholders with Board representation. The Private Placement was completed at $<span id="xdx_902_eus-gaap--SaleOfStockPricePerShare_iI_c20231120__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zF8MvgiOJe45" title="Commmon stock share per share"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2023-11-20_us-gaap_PrivatePlacementMember" id="Fact002722" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.91</ix:nonFraction></span> per share
of common stock, with a total of approximately <span id="xdx_901_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20231120__20231120__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zA4yjRNzWoKa" title="Number of stock sold"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2023-11-202023-11-20_us-gaap_PrivatePlacementMember" id="Fact002724" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,198,000</ix:nonFraction></span> shares issued. Net proceeds from the transaction were approximately $<span id="xdx_903_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20231120__20231120__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zIODCkO1j2nc" title="Proceeds from sale of equity"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" contextRef="From2023-11-202023-11-20_us-gaap_PrivatePlacementMember" id="Fact002726" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,900,000</ix:nonFraction></span>,
net of transaction fees of approximately $<span id="xdx_90E_ecustom--TransactionFees_iI_c20231120__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zBW9bXe0xPO7" title="Transaction fees"><ix:nonFraction name="RIME:TransactionFees" contextRef="AsOf2023-11-20_us-gaap_PrivatePlacementMember" id="Fact002728" format="ixt:numdotdecimal" decimals="0" unitRef="USD">100,000</ix:nonFraction></span>. During the six-month period after the closing date, the purchasers may make a written
request for registration under the Securities Act of all or any portion of the shares purchased.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-04-012023-12-31" escape="true" id="Fact002730" name="RIME:StockRedemptionTextBlock"><p id="xdx_805_ecustom--StockRedemptionTextBlock_zv7yitEIiMih" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
14 - <span id="xdx_82C_zOJYSrS3MzGj">AUGUST 2021 STOCK REDEMPTION</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 5, 2021, the Company entered into the Redemption Agreement with koncepts and Treasure Green (former majority shareholders), pursuant
to which the Company redeemed <span id="xdx_903_eus-gaap--StockRedeemedOrCalledDuringPeriodShares_c20210801__20210805__us-gaap--TypeOfArrangementAxis__custom--RedemptionAgreementMember__dei--LegalEntityAxis__custom--KonceptsandTreasureGreenMember_zdillBIFb94g" title="Shares redeemed"><ix:nonFraction name="us-gaap:StockRedeemedOrCalledDuringPeriodShares" contextRef="From2021-08-012021-08-05_custom_RedemptionAgreementMember_custom_KonceptsandTreasureGreenMember" id="Fact002732" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">654,105</ix:nonFraction></span> shares of common stock of the Company. The closing of the transaction set forth in the Redemption
Agreement took place on August 10, 2021, at which time the Redeemed Shares were assigned and transferred back to the Company in consideration
of a payment by the Company of approximately $<span id="xdx_901_eus-gaap--ConversionOfStockAmountIssued1_pn5n6_c20210808__20210810__dei--LegalEntityAxis__custom--KonceptsandTreasureGreenMember__us-gaap--TypeOfArrangementAxis__custom--RedemptionAgreementMember_zXLU89EnUN45" title="Conversion of stock, amount issued"><ix:nonFraction name="us-gaap:ConversionOfStockAmountIssued1" contextRef="From2021-08-082021-08-10_custom_KonceptsandTreasureGreenMember_custom_RedemptionAgreementMember" id="Fact002734" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">7.2</ix:nonFraction> </span>million to koncepts and Treasure Green. The Redeemed Shares were retired and returned
to the unissued authorized capital of the Company. Pursuant to the Redemption Agreement, neither koncepts nor Treasure Green remained
stockholders of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-04-012023-12-31" escape="true" id="Fact002736" name="RIME:AugustTwentyTwentyOnePrivatePlacementTextBlock"><p id="xdx_809_ecustom--AugustTwentyTwentyOnePrivatePlacementTextBlock_zk73zIeNXpC" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
15 &#8211; <span id="xdx_82A_zSd0GOr2ugal">AUGUST 2021 PRIVATE PLACEMENT</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 5, 2021, the Company entered into a securities purchase agreement (the &#8220;Purchase Agreement&#8221;) with large institutional
investors and the strategic investor for private placement of (i) <span id="xdx_903_eus-gaap--CommonStockSharesIssued_iI_pid_c20210805__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember_zQszQ83FBDHl" title="Common stock, shares, issued"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2021-08-05_custom_PurchaseAgreementMember" id="Fact002738" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">550,000</ix:nonFraction></span> shares of its common stock (the &#8220;Shares&#8221;) together
with Common Warrants to purchase up to <span id="xdx_908_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20210805__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember_zOGBglabIYcb" title="Warrants to purchase common stock"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2021-08-05_custom_PurchaseAgreementMember" id="Fact002740" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">550,000</ix:nonFraction></span> shares of common stock with an exercise price of $<span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20210805__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember_zhmhLP6uuLbc" title="Exercise price of warrants"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2021-08-05_custom_PurchaseAgreementMember" id="Fact002742" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.50</ix:nonFraction></span> per share, and (ii) <span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_pid_c20210805__us-gaap--StatementEquityComponentsAxis__custom--PreFundedWarrantsMember_zKwi0Gu6w8Si" title="Class of warrant or right, number of securities called by each warrant or right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" contextRef="AsOf2021-08-05_custom_PreFundedWarrantsMember" id="Fact002744" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">561,111</ix:nonFraction></span> pre-funded
warrants (&#8220;Pre-Funded Warrants&#8221;) with each Pre-Funded Warrant exercisable for one share of common stock at an exercise price
of $<span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20210805__us-gaap--StatementEquityComponentsAxis__custom--PreFundedWarrantsMember_z5nmqbZW8u2b" title="Exercise price of warrants"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2021-08-05_custom_PreFundedWarrantsMember" id="Fact002746" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.01</ix:nonFraction></span> per share, together with Common Warrants to purchase up to <span id="xdx_900_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20210805__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zdAko8gD2IWj" title="Issuance of warrant shares"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2021-08-05_us-gaap_PrivatePlacementMember" id="Fact002748" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">561,111</ix:nonFraction></span> shares of common stock at an exercise price of $<span id="xdx_901_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20210805__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zkpDamcxzt56" title="Exercise price of warrants"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2021-08-05_us-gaap_PrivatePlacementMember" id="Fact002750" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.50</ix:nonFraction></span> per
share (the &#8220;Private Placement&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Common Warrants and Pre-Funded Warrants are collectively referred to as (the &#8220;Warrants&#8221;). The Warrants are exercisable at
any time at the option of the holder, have a term of 5 years from the issuance date and provide for cashless exercise under certain conditions.
The Company determined that the Warrants meet the conditions for equity classification. Shares issuable upon exercise of the Warrants
are hereinafter referred to as the &#8220;Warrant Shares&#8221;. The exercise price and number of the Warrant Shares are subject to anti-dilution
and other adjustments for certain stock dividends, stock splits, subsequent rights offerings, pro rata distributions or certain equity
structure changes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the terms of the Purchase Agreement, on September 3, 2021, the Company filed a registration statement providing for the resale by
the purchasers of the Shares and Warrant Shares sold in the Private Placement, which registration statement became effective on September
15, 2021. Additionally, under the terms of the Purchase Agreement, the Company was obligated to use its reasonable best efforts to submit
an application to have the Company&#8217;s common stock listed on a national exchange by December 31, 2021, and to use its reasonable
best efforts to have the Shares and Warrant Shares listed on such national exchange as soon as practicable following the submission of
such application. As indicated, the Common Stock was approved to list on the Nasdaq Capital Market under the symbol &#8220;MICS&#8221;
and began trading on the Nasdaq Capital Market on May 24, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
closing of the Private Placement took place on August 10, 2021, when the Shares and Warrants were delivered to the purchasers and
funds, in the amount of approximately $<span id="xdx_90C_eus-gaap--ProceedsFromWarrantExercises_c20210808__20210810__dei--LegalEntityAxis__custom--KonceptsandTreasureGreenMember__us-gaap--TypeOfArrangementAxis__custom--RedemptionAgreementMember_zXFTAqhoUydc" title="Proceeds from warrant exercises"><ix:nonFraction name="us-gaap:ProceedsFromWarrantExercises" contextRef="From2021-08-082021-08-10_custom_KonceptsandTreasureGreenMember_custom_RedemptionAgreementMember" id="Fact002752" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,800,000</ix:nonFraction></span>,
were received by the Company. Approximately $<span id="xdx_903_eus-gaap--ConversionOfStockAmountIssued1_c20210808__20210810__dei--LegalEntityAxis__custom--KonceptsandTreasureGreenMember__us-gaap--TypeOfArrangementAxis__custom--RedemptionAgreementMember_zf46bgR4qsre" title="Conversion of stock, amount issued"><ix:nonFraction name="us-gaap:ConversionOfStockAmountIssued1" contextRef="From2021-08-082021-08-10_custom_KonceptsandTreasureGreenMember_custom_RedemptionAgreementMember" id="Fact002754" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,200,000</ix:nonFraction></span>
of the funds was used to execute the Redemption Agreement (See Note 14 &#8211; August 2021 Stock Redemption).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stingray
is part of the group of investors who participated in the Private Placement and have acquired a minority interest in the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Private Placement, on July 6, 2021, the Company entered into a Placement Agency Agreement with A.G.P./Alliance Global
Partners (&#8220;AGP&#8221;), which provided for AGP to serve as the exclusive placement agent, advisor or underwriter (the &#8220;placement
agent services&#8221;). Pursuant to the Placement Agency Agreement, upon closing of the Private Placement, the Company paid AGP placement
fees of approximately $<span id="xdx_909_eus-gaap--PaymentsForRepurchaseOfPrivatePlacement_pn5n6_c20210701__20210706__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zSfjuAhNJ6la"><ix:nonFraction name="us-gaap:PaymentsForRepurchaseOfPrivatePlacement" contextRef="From2021-07-012021-07-06_us-gaap_PrivatePlacementMember" id="Fact002755" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">600,000</ix:nonFraction>
</span></span><span id="xdx_90A_eus-gaap--DerivativeDescriptionOfTerms_c20210701__20210706_zrQlLm8Y9Om9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2021-07-012021-07-06" id="Fact002756" name="us-gaap:DerivativeDescriptionOfTerms">(representing
7% of the gross proceeds raised in the Private Placement excluding proceeds raised from the strategic investor, plus 3.5% of the aggregate
gross proceeds raised from the strategic investor),</ix:nonNumeric></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and
issued AGP warrants to purchase <span id="xdx_905_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20210706__us-gaap--ClassOfWarrantOrRightAxis__custom--AGPWarrantsMember_zWSmk3I0WCM"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2021-07-06_custom_AGPWarrantsMember" id="Fact002757" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">44,445</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of the Company&#8217;s common stock (the
&#8220;Advisor Warrants&#8221;) (representing <span id="xdx_90A_ecustom--AggregateNumberOfShares_iI_pid_dp_uPure_c20210706_z7VXqDZ67cXc"><ix:nonFraction name="RIME:AggregateNumberOfShares" contextRef="AsOf2021-07-06" id="Fact002758" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">5</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
of the aggregate number of Shares and Pre-Funded Warrants sold in the Private Placement, excluding the Shares sold to the strategic investor).
The Advisor Warrants have the same exercise price ($<span id="xdx_900_eus-gaap--SharePrice_iI_pid_c20210706_z4jvEi89V5mb"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2021-07-06" id="Fact002759" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.50</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)
and terms as the Common Warrants issued in the Private Placement. The Company estimated the fair value of the Advisor Warrants to be
approximately $<span id="xdx_901_eus-gaap--EquityFairValueDisclosure_iI_c20210706_zTL6IvK3uL4d"><ix:nonFraction name="us-gaap:EquityFairValueDisclosure" contextRef="AsOf2021-07-06" id="Fact002760" format="ixt:numdotdecimal" decimals="0" unitRef="USD">400,000</ix:nonFraction></span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">using
the Black-Scholes Model based on the following input assumptions: common stock price of $<span id="xdx_90B_ecustom--SharePrice1_iI_c20210706_zdtHJ2Nhqef7"><ix:nonFraction name="RIME:SharePrice1" contextRef="AsOf2021-07-06" id="Fact002761" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">9.90</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
expected life of the warrants of <span id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20210706_zRtNseODzXP2"><ix:nonNumeric contextRef="AsOf2021-07-06" format="ixt-sec:duryear" id="Fact002762" name="us-gaap:WarrantsAndRightsOutstandingTerm">2.5</ix:nonNumeric></span></span>
<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">years; stock price volatility of <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20210701__20210706_zlAYuLDmTNxl"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2021-07-012021-07-06" id="Fact002763" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">168</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%;
dividend yield of <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20210701__20210706_zC3fSB4cE5T6"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2021-07-012021-07-06" id="Fact002764" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%;
and the risk-free interest rate of <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20210701__20210706_zrPYJK9QSeN"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2021-07-012021-07-06" id="Fact002765" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">2.65</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to the placement fees paid to AGP, the Company incurred additional offering costs for direct incremental legal, consulting,
accounting and filing fees related to the Private Placement of approximately $<span id="xdx_90E_eus-gaap--LegalFees_c20220401__20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zcj2kH3dj1nl" title="Legal fees"><ix:nonFraction name="us-gaap:LegalFees" contextRef="From2022-04-012022-12-31_us-gaap_PrivatePlacementMember" id="Fact002767" format="ixt:numdotdecimal" decimals="0" unitRef="USD">400,000</ix:nonFraction></span>
of which one consultant was issued <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20220401__20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zbhW3MNW1d2i" title="Stock issued for restricted shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" contextRef="From2022-04-012022-12-31_us-gaap_PrivatePlacementMember" id="Fact002769" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,905</ix:nonFraction></span>
shares of restricted common stock with an aggregate fair value of approximately $<span id="xdx_905_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardGross_c20220401__20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zzHoiZJpNOPb" title="Stock issued for restricted shares, value"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" contextRef="From2022-04-012022-12-31_us-gaap_PrivatePlacementMember" id="Fact002771" format="ixt:numdotdecimal" decimals="0" unitRef="USD">200,000</ix:nonFraction></span>
and a cash payment of approximately $<span id="xdx_90A_eus-gaap--PaymentsForRepurchaseOfPrivatePlacement_c20220401__20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zKH1tG8nZTLj" title="Cash payment for private placement"><ix:nonFraction name="us-gaap:PaymentsForRepurchaseOfPrivatePlacement" contextRef="From2022-04-012022-12-31_us-gaap_PrivatePlacementMember" id="Fact002773" format="ixt:numdotdecimal" decimals="0" unitRef="USD">100,000</ix:nonFraction></span>.
Total offering costs related to the Private Placement amounted approximately $<span id="xdx_90D_eus-gaap--PaymentsOfStockIssuanceCosts_c20220401__20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zcNcIzRf9hHj" title="Payment of stock issuance expenses"><ix:nonFraction name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="From2022-04-012022-12-31_us-gaap_PrivatePlacementMember" id="Fact002775" format="ixt:numdotdecimal" decimals="0" unitRef="USD">800,000</ix:nonFraction></span>
of which was payment of stock issuance expenses, which is recorded as an offset to additional paid in capital in the accompanying
consolidated statements of shareholders&#8217; equity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-04-012023-12-31" escape="true" id="Fact002777" name="us-gaap:IncomeTaxDisclosureTextBlock"><p id="xdx_800_eus-gaap--IncomeTaxDisclosureTextBlock_zs4A8cVjmsH8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
16 - <span id="xdx_82A_zgbCidzNUWFd">INCOME TAXES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-04-012023-12-31" escape="true" id="Fact002779" name="RIME:ScheduleOfLossBeforeIncomeTaxTableTextBlock"><p id="xdx_89C_ecustom--ScheduleOfLossBeforeIncomeTaxTableTextBlock_zcKIvPBKU3z8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s loss before income taxes for the nine months ended December 31, 2023, and fiscal years ended March 31, 2023, and 2022
is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span id="xdx_8BE_z3CzUrwMDpU2" style="display: none">SCHEDULE OF LOSS BEFORE INCOME TAXES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_491_20230401__20231231_z3gv4sBqTotb" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20220401__20230331_zFivyGNqlKJl" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_492_20210401__20220331_zHzf2VMRhQWe" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">Nine months ended</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Fiscal years ended</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_zwVDB3c5KXVc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 34%; text-align: left">United States</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" contextRef="From2023-04-012023-12-31" id="Fact002781" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">6,173,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" contextRef="From2022-04-012023-03-31" id="Fact002782" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,526,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" contextRef="From2021-04-012022-03-31" id="Fact002783" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">261,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_404_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_zeCEGkZB61cj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Foreign</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" contextRef="From2023-04-012023-12-31" id="Fact002785" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">225,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" contextRef="From2022-04-012023-03-31" id="Fact002786" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">82,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" contextRef="From2021-04-012022-03-31" id="Fact002787" format="ixt:numdotdecimal" decimals="0" unitRef="USD">548,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_zs8t6xUY4trg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss
    before income taxes</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2023-04-012023-12-31" id="Fact002789" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">6,398,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2022-04-012023-03-31" id="Fact002790" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,608,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2021-04-012022-03-31" id="Fact002791" format="ixt:numdotdecimal" decimals="0" unitRef="USD">287,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A9_zartpE47oyA7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-04-012023-12-31" escape="true" id="Fact002793" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"><p id="xdx_89B_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zwnpNk4VM3Al" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
provision for income taxes for the nine months ended December 31, 2023, and fiscal years ended March 31, 2023, and 2022 is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span id="xdx_8BF_z3RkLhSRENai" style="display: none">SCHEDULE OF PROVISION FOR INCOME TAXES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_496_20230401__20231231_zMrKuEIP6l78" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_496_20220401__20230331_zVWJ0jALdzn2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_499_20210401__20220331_zRwAoTfR3pM" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">Nine months ended</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Fiscal years ended</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2022</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Income tax provision:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Current:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--CurrentFederalTaxExpenseBenefit_maCFSALz48L_zePw4gom3VJj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 34%; text-align: left">Federal</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2795">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"><ix:nonFraction name="us-gaap:CurrentFederalTaxExpenseBenefit" contextRef="From2022-04-012023-03-31" id="Fact002796" format="ixt:numdotdecimal" decimals="0" unitRef="USD">109,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"><ix:nonFraction name="us-gaap:CurrentFederalTaxExpenseBenefit" contextRef="From2021-04-012022-03-31" id="Fact002797" format="ixt:numdotdecimal" decimals="0" unitRef="USD">63,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_maCFSALz48L_zJtMCKdI8mt1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">State</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2799">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2800">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2801">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--CurrentOtherTaxExpenseBenefit_maCFSALz48L_z2xFJgRqIO7e" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Other</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2803">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="RIME:CurrentOtherTaxExpenseBenefit" contextRef="From2022-04-012023-03-31" id="Fact002804" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">5,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2805">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--CurrentForeignTaxExpenseBenefit_maCFSALz48L_z4wliGmmM3v9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1pt">Hong Kong</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2807">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:CurrentForeignTaxExpenseBenefit" contextRef="From2022-04-012023-03-31" id="Fact002808" format="ixt:numdotdecimal" decimals="0" unitRef="USD">34,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2809">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--CurrentFederalStateAndLocalTaxExpenseBenefit_iT_mtCFSALz48L_maITEBzBKD_zObMMc8g0sfj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Total current Federal and State</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2811">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:CurrentFederalStateAndLocalTaxExpenseBenefit" contextRef="From2022-04-012023-03-31" id="Fact002812" format="ixt:numdotdecimal" decimals="0" unitRef="USD">138,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:CurrentFederalStateAndLocalTaxExpenseBenefit" contextRef="From2021-04-012022-03-31" id="Fact002813" format="ixt:numdotdecimal" decimals="0" unitRef="USD">63,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Deferred:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_maDFSALzMsp_z5wMSFShEQaj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Federal</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2815">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" contextRef="From2022-04-012023-03-31" id="Fact002816" format="ixt:numdotdecimal" decimals="0" unitRef="USD">686,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" contextRef="From2021-04-012022-03-31" id="Fact002817" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">60,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_40E_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_maDFSALzMsp_zikmZFKcqwX9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1pt">State</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2819">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" contextRef="From2022-04-012023-03-31" id="Fact002820" format="ixt:numdotdecimal" decimals="0" unitRef="USD">206,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" contextRef="From2021-04-012022-03-31" id="Fact002821" format="ixt:numdotdecimal" decimals="0" unitRef="USD">54,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--DeferredFederalStateAndLocalTaxExpenseBenefit_iT_mtDFSALzMsp_maITEBzBKD_zc0coHnpCFEh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Total Deferred Federal and State</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2823">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit" contextRef="From2022-04-012023-03-31" id="Fact002824" format="ixt:numdotdecimal" decimals="0" unitRef="USD">892,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit" contextRef="From2021-04-012022-03-31" id="Fact002825" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">6,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--IncomeTaxExpenseBenefit_iT_mtITEBzBKD_zlOwdZewRqMb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Total income tax provision</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2827">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2022-04-012023-03-31" id="Fact002828" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,030,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2021-04-012022-03-31" id="Fact002829" format="ixt:numdotdecimal" decimals="0" unitRef="USD">57,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A2_zKtIcvYIOfN8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 112; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
SINGING MACHINE COMPANY, INC AND SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
31, 2023, and March 31, 2023 and 2022</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-04-012023-12-31" escape="true" id="Fact002831" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"><p id="xdx_893_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zKyasForL40c" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s net deferred tax assets as of December 31, 2023, and ended March 31, 2023 are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B3_zyy9lBaEuoLj" style="display: none">SCHEDULE
OF DEFERRED TAX ASSETS AND LIABILITIES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" id="xdx_49A_20231231_znTKkDMvVGEk" style="font: 10pt Times New Roman, Times, Serif; text-align: center">December 31,</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" id="xdx_494_20230331_zsJ6V8SEPaQ7" style="font: 10pt Times New Roman, Times, Serif; text-align: center">March 31,</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsDomestic_iI_maDTAGzkTe_zJcF4AE0oCF9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left">NOL Federal Carryforward</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic" contextRef="AsOf2023-12-31" id="Fact002833" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,291,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic" contextRef="AsOf2023-03-31" id="Fact002834" format="ixt:numdotdecimal" decimals="0" unitRef="USD">868,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_iI_maDTAGzkTe_zfbMU0Jdv45i" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">State NOL Carryforward</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" contextRef="AsOf2023-12-31" id="Fact002836" format="ixt:numdotdecimal" decimals="0" unitRef="USD">470,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" contextRef="AsOf2023-03-31" id="Fact002837" format="ixt:numdotdecimal" decimals="0" unitRef="USD">341,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsInventory_iI_maDTAGzkTe_zqMAT95bmnSd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Inventory differences to inventory valuation</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsInventory" contextRef="AsOf2023-12-31" id="Fact002839" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,173,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsInventory" contextRef="AsOf2023-03-31" id="Fact002840" format="ixt:numdotdecimal" decimals="0" unitRef="USD">623,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_iI_maDTAGzkTe_z18znzqFGylg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Stock option compensation expense</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" contextRef="AsOf2023-12-31" id="Fact002842" format="ixt:numdotdecimal" decimals="0" unitRef="USD">159,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" contextRef="AsOf2023-03-31" id="Fact002843" format="ixt:numdotdecimal" decimals="0" unitRef="USD">184,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--DeferredTaxAssetsRightUseOfLiability_iI_maDTAGzkTe_z7MQ7WEw3lse" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Right of use liability</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:DeferredTaxAssetsRightUseOfLiability" contextRef="AsOf2023-12-31" id="Fact002845" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,022,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:DeferredTaxAssetsRightUseOfLiability" contextRef="AsOf2023-03-31" id="Fact002846" format="ixt:numdotdecimal" decimals="0" unitRef="USD">118,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--DeferredTaxAssetsBusinessInterestLimitation_iI_maDTAGzkTe_z04oHutDkea3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Business interest limitation</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:DeferredTaxAssetsBusinessInterestLimitation" contextRef="AsOf2023-12-31" id="Fact002848" format="ixt:numdotdecimal" decimals="0" unitRef="USD">151,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:DeferredTaxAssetsBusinessInterestLimitation" contextRef="AsOf2023-03-31" id="Fact002849" format="ixt:numdotdecimal" decimals="0" unitRef="USD">138,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--DeferredTaxAssetsAllowanceForDoubtFulAccounts_iI_maDTAGzkTe_zg3VHHmlvoMb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Allowance for doubtful accounts</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:DeferredTaxAssetsAllowanceForDoubtFulAccounts" contextRef="AsOf2023-12-31" id="Fact002851" format="ixt:numdotdecimal" decimals="0" unitRef="USD">45,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:DeferredTaxAssetsAllowanceForDoubtFulAccounts" contextRef="AsOf2023-03-31" id="Fact002852" format="ixt:numdotdecimal" decimals="0" unitRef="USD">43,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances_iI_maDTAGzkTe_zwTm6k5Oi3b2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Reserve for estimated returns</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances" contextRef="AsOf2023-12-31" id="Fact002854" format="ixt:numdotdecimal" decimals="0" unitRef="USD">384,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances" contextRef="AsOf2023-03-31" id="Fact002855" format="ixt:numdotdecimal" decimals="0" unitRef="USD">89,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_iI_maDTAGzkTe_zLsHZcgvuira" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Accrued vacation</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" contextRef="AsOf2023-12-31" id="Fact002857" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" contextRef="AsOf2023-03-31" id="Fact002858" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--DeferredTaxAssetsGross_iTI_mtDTAGzkTe_maDTANzmdy_zgDA8p5rs8gh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsGross" contextRef="AsOf2023-12-31" id="Fact002860" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,702,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsGross" contextRef="AsOf2023-03-31" id="Fact002861" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,418,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_msDTANzmdy_zH2zn2oTD532" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Less: valuation allowance</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2023-12-31" id="Fact002863" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,600,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2023-03-31" id="Fact002864" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,104,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40B_eus-gaap--DeferredTaxAssetsNet_iTI_maDTALNzWnn_mtDTANzmdy_zq4JfvbOkoL" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Net deferred tax asset</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsNet" contextRef="AsOf2023-12-31" id="Fact002866" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,102,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsNet" contextRef="AsOf2023-03-31" id="Fact002867" format="ixt:numdotdecimal" decimals="0" unitRef="USD">314,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--DeferredTaxLiabilitiesPropertyPlantAndEquipment_iNI_di_maDTLzkol_zQU1KPUgfPJk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Depreciable and amortizable assets</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" contextRef="AsOf2023-12-31" id="Fact002869" format="ixt:numdotdecimal" decimals="0" unitRef="USD">67,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" contextRef="AsOf2023-03-31" id="Fact002870" format="ixt:numdotdecimal" decimals="0" unitRef="USD">134,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_40C_ecustom--DeferredTaxLiabilitiesRightUseOfAsset_iNI_di_maDTLzkol_zCoA2j3XFaBd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">ROU Asset</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="RIME:DeferredTaxLiabilitiesRightUseOfAsset" contextRef="AsOf2023-12-31" id="Fact002872" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,000,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="RIME:DeferredTaxLiabilitiesRightUseOfAsset" contextRef="AsOf2023-03-31" id="Fact002873" format="ixt:numdotdecimal" decimals="0" unitRef="USD">111,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_403_eus-gaap--DeferredTaxLiabilitiesPrepaidExpenses_iNI_di_maDTLzkol_zlE04no3wyIe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Prepaid expenses</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilitiesPrepaidExpenses" contextRef="AsOf2023-12-31" id="Fact002875" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilitiesPrepaidExpenses" contextRef="AsOf2023-03-31" id="Fact002876" format="ixt:numdotdecimal" decimals="0" unitRef="USD">69,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--DeferredTaxLiabilities_iNTI_di_msDTALNzWnn_mtDTLzkol_zlWlWrLvQpIb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Net deferred tax liability</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilities" contextRef="AsOf2023-12-31" id="Fact002878" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,102,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilities" contextRef="AsOf2023-03-31" id="Fact002879" format="ixt:numdotdecimal" decimals="0" unitRef="USD">314,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTI_mtDTALNzWnn_zIj3UIbrG3df" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2881">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2882">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AC_zzsckDqAScVa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes federal, state and foreign current tax liabilities or assets based on its estimate of taxes payable to or refundable
by tax authorities in the current fiscal year. The Company also recognizes federal, state and foreign deferred tax liabilities or assets
based on the Company&#8217;s estimate of future tax effects attributable to temporary differences and carryforwards. The Company records
a valuation allowance to reduce any deferred tax assets by the amount of any tax benefits that, based on available evidence and judgment,
are not expected to be realized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company performed an analysis in accordance with the provisions of ASC 740, which requires an assessment of both positive and
negative evidence when determining whether it is more likely than not that deferred tax assets are recoverable. The analysis
performed to assess the realizability of the deferred tax assets included an evaluation of the pattern and timing of the reversals
of temporary differences and the length of carryback and carryforward periods available under the applicable federal, state and
foreign laws; and the amount and timing of future taxable income. The Company evaluated the realizability of its deferred tax assets
as of December 31, 2023 and March 31, 2023 in accordance with accounting principles generally accepted in the United States of
America and concluded that valuation allowance against all of our deferred tax assets was necessary based upon the Company&#8217;s
conclusions regarding, among other considerations, the Company&#8217;s recent history of losses and projected earnings for fiscal
year 2024 and in the future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-04-012023-12-31" escape="true" id="Fact002884" name="us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"><p id="xdx_89F_eus-gaap--ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_zXpACVfvQcl4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
actual tax provision differs from the &#8220;expected&#8221; tax for the nine-month transition period ended December 31, 2023, and
the years ended March 31, 2023, and 2022 (computed by applying the U.S. Federal Corporate tax rate of 21 percent to income before
taxes) as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BB_zcJhmqf1s41b" style="display: none">SCHEDULE
OF TAX PROVISION</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20230401__20231231_z8vkNy8O8w6l" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_495_20220401__20230331_zp2XvTg004g7" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_490_20210401__20220331_zQ3piCOGCKQi" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2022</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_maITEBzmuZ_zqhaPji5LA26" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 43%; text-align: left">Statutory federal tax rate</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" contextRef="From2023-04-012023-12-31" id="Fact002886" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,344,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" contextRef="From2022-04-012023-03-31" id="Fact002887" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">758,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" contextRef="From2021-04-012022-03-31" id="Fact002888" format="ixt:numdotdecimal" decimals="0" unitRef="USD">60,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_maITEBzmuZ_znWhJFW0VkI7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Stater tax rate</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" contextRef="From2023-04-012023-12-31" id="Fact002890" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">326,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" contextRef="From2022-04-012023-03-31" id="Fact002891" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">174,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" contextRef="From2021-04-012022-03-31" id="Fact002892" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--IncomeTaxReconciliationChangeInEnactedTaxRate_maITEBzmuZ_zbpaBJyHD3V3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Permanent differences</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" contextRef="From2023-04-012023-12-31" id="Fact002894" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" contextRef="From2022-04-012023-03-31" id="Fact002895" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" contextRef="From2021-04-012022-03-31" id="Fact002896" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecustom--IncomeTaxReconciliationChangeInPermanentDifferencesERCIncome_maITEBzmuZ_z0sxIegNnU8g" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Permanent difference in ERC income</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2898">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="RIME:IncomeTaxReconciliationChangeInPermanentDifferencesERCIncome" contextRef="From2022-04-012023-03-31" id="Fact002899" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">99,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2900">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--IncomeTaxReconciliationForeignIncomeTaxRateDifferential_maITEBzmuZ_zxM7CBG0rctj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Tax rate differential on foreign earnings</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" contextRef="From2023-04-012023-12-31" id="Fact002902" format="ixt:numdotdecimal" decimals="0" unitRef="USD">59,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" contextRef="From2022-04-012023-03-31" id="Fact002903" format="ixt:numdotdecimal" decimals="0" unitRef="USD">21,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" contextRef="From2021-04-012022-03-31" id="Fact002904" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">84,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_404_ecustom--IncomeTaxReconciliationChangeInExpirationOfNetOpretaingLossCarryforward_maITEBzmuZ_z3bxgbF9SVQd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Expiration of net operating loss carryforward</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:IncomeTaxReconciliationChangeInExpirationOfNetOpretaingLossCarryforward" contextRef="From2023-04-012023-12-31" id="Fact002906" format="ixt:numdotdecimal" decimals="0" unitRef="USD">89,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2907">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2908">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_maITEBzmuZ_zDX1hCDEpzVk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Change in valuation allowance</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="From2023-04-012023-12-31" id="Fact002910" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,495,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="From2022-04-012023-03-31" id="Fact002911" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,026,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="From2021-04-012022-03-31" id="Fact002912" format="ixt:numdotdecimal" decimals="0" unitRef="USD">55,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--IncomeTaxReconciliationOtherReconcilingItems_maITEBzmuZ_zzR1Oatq5DS4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Other</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationOtherReconcilingItems" contextRef="From2023-04-012023-12-31" id="Fact002914" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationOtherReconcilingItems" contextRef="From2022-04-012023-03-31" id="Fact002915" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationOtherReconcilingItems" contextRef="From2021-04-012022-03-31" id="Fact002916" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--IncomeTaxExpenseBenefit_iT_mtITEBzmuZ_zX0jsMOAbHnd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax
    provision</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2918">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2022-04-012023-03-31" id="Fact002919" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,030,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2021-04-012022-03-31" id="Fact002920" format="ixt:numdotdecimal" decimals="0" unitRef="USD">57,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A5_znnnZIzJLiE6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 113; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
SINGING MACHINE COMPANY, INC AND SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
31, 2023, and March 31, 2023 and 2022</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
December 31, 2023, and March 31, 2023, the Company had federal tax net operating loss carryforwards in the amount of approximately $<span id="xdx_909_eus-gaap--OperatingLossCarryforwards_iI_c20231231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zJ5oiD2W6Bj" title="Federal tax net operating loss carryforwards"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2023-12-31_us-gaap_DomesticCountryMember" id="Fact002922" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,149,000</ix:nonFraction></span>
and $<span id="xdx_90C_eus-gaap--OperatingLossCarryforwards_iI_c20230331__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zjVbPDDceWL2" title="Federal tax net operating loss carryforwards"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2023-03-31_us-gaap_DomesticCountryMember" id="Fact002924" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,131,000</ix:nonFraction></span>, respectively that begin to expire in the year 2025. The net operating loss carryforward is subject to an IRS Section
382 limitation that limited the amount available to use beginning in Fiscal 2020 to approximately $<span id="xdx_909_eus-gaap--OperatingLossCarryforwards_iI_c20231231__us-gaap--IncomeTaxAuthorityNameAxis__us-gaap--InternalRevenueServiceIRSMember_zh8ZzfUJAkZe" title="Net operating loss"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2023-12-31_us-gaap_InternalRevenueServiceIRSMember" id="Fact002926" format="ixt:numdotdecimal" decimals="0" unitRef="USD">150,000</ix:nonFraction> </span>per year. In addition, the
Company had state tax net operating loss carryforwards of approximately $<span id="xdx_907_eus-gaap--OperatingLossCarryforwards_iI_c20231231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--StateAndLocalJurisdictionMember_z2zZTFLTI0U3" title="Operating loss carryforwards"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2023-12-31_us-gaap_StateAndLocalJurisdictionMember" id="Fact002928" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,453,000</ix:nonFraction></span> and $<span id="xdx_90F_eus-gaap--OperatingLossCarryforwards_iI_c20230331__us-gaap--IncomeTaxAuthorityAxis__us-gaap--StateAndLocalJurisdictionMember_zcn95fYK8YPf" title="Operating loss carryforwards"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2023-03-31_us-gaap_StateAndLocalJurisdictionMember" id="Fact002930" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,238,000</ix:nonFraction></span>, respectively that will begin to expire
beginning in 2024. These tax net operating loss carryforwards may be subject to adjustment based on future changes in ownership.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
December 31, 2023, the Company evaluated the realizability of its deferred tax assets in accordance with GAAP and concluded that a valuation
allowance of approximately $<span id="xdx_90E_eus-gaap--DeferredTaxAssetsValuationAllowance_iI_c20231231_z0JfsW10Zare" title="Deferred tax asset valuation allowance"><ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2023-12-31" id="Fact002932" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,600,000</ix:nonFraction></span> against deferred tax assets is necessary. The recognition of the remaining net deferred
tax asset and corresponding tax benefit is based upon the Company&#8217;s conclusions regarding, among other considerations, the Company&#8217;s
current and anticipated customers, contracts and product introductions, and recent operating results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-04-012023-12-31" escape="true" id="Fact002934" name="us-gaap:SegmentReportingDisclosureTextBlock"><p id="xdx_809_eus-gaap--SegmentReportingDisclosureTextBlock_z4oc9irSX5Ib" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
17 &#8211; <span id="xdx_826_zJf6TZ2q0cba">REVENUE DISAGGREGATION </span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company disaggregates revenues by product line and major geographic region as most of its revenue is generated by the sales of karaoke
hardware and the Company has no other material business segments:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<ix:nonNumeric contextRef="From2023-04-012023-12-31" escape="true" id="Fact002936" name="us-gaap:DisaggregationOfRevenueTableTextBlock"><p id="xdx_896_eus-gaap--DisaggregationOfRevenueTableTextBlock_z5e4ksowGI86" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue
by product line is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BE_z3cwErgWkoab" style="display: none">SCHEDULE
OF REVENUE BY PRODUCT LINE</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_490_20230401__20231231_zcvFlwHSoYL9" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">December 31,2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_495_20220401__20230331_zlXsNzH4TLT2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_495_20210401__20220331_z5WtX8zdZ96k" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2022</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center">Nine Months Ended</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Fiscal Years Ended</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">December 31,2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2022</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-decoration: underline; text-align: left">Product Line</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--KaraokeMachinesMember_z0vcexDTdO97" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 43%; text-align: left">Karaoke Machines</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-04-012023-12-31_custom_KaraokeMachinesMember" id="Fact002938" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,189,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-04-012023-03-31_custom_KaraokeMachinesMember" id="Fact002939" format="ixt:numdotdecimal" decimals="0" unitRef="USD">28,856,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-04-012022-03-31_custom_KaraokeMachinesMember" id="Fact002940" format="ixt:numdotdecimal" decimals="0" unitRef="USD">38,869,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--LicensedProductsMember_zsLnmKlMotNd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Licensed Products</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-04-012023-12-31_custom_LicensedProductsMember" id="Fact002942" format="ixt:numdotdecimal" decimals="0" unitRef="USD">549,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-04-012023-03-31_custom_LicensedProductsMember" id="Fact002943" format="ixt:numdotdecimal" decimals="0" unitRef="USD">95,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-04-012022-03-31_custom_LicensedProductsMember" id="Fact002944" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,645,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--KidsYouthElectronicsMember_zXQuyMEB1F5d" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Kids Youth Electronics</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-04-012023-12-31_custom_KidsYouthElectronicsMember" id="Fact002946" format="ixt:numdotdecimal" decimals="0" unitRef="USD">565,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-04-012023-03-31_custom_KidsYouthElectronicsMember" id="Fact002947" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,872,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-04-012022-03-31_custom_KidsYouthElectronicsMember" id="Fact002948" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,277,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--MicrophonesAndAccessoriesMember_zehC3h1wXjc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Microphones and Accessories</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-04-012023-12-31_custom_MicrophonesAndAccessoriesMember" id="Fact002950" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,283,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-04-012023-03-31_custom_MicrophonesAndAccessoriesMember" id="Fact002951" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,802,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-04-012022-03-31_custom_MicrophonesAndAccessoriesMember" id="Fact002952" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,185,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--MusicSubscriptionsMember_z6b5M8pZNNNg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Music Subscriptions</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-04-012023-12-31_custom_MusicSubscriptionsMember" id="Fact002954" format="ixt:numdotdecimal" decimals="0" unitRef="USD">612,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-04-012023-03-31_custom_MusicSubscriptionsMember" id="Fact002955" format="ixt:numdotdecimal" decimals="0" unitRef="USD">674,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-04-012022-03-31_custom_MusicSubscriptionsMember" id="Fact002956" format="ixt:numdotdecimal" decimals="0" unitRef="USD">536,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--Revenues_z187dA9Sthlj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Total Net Sales</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-04-012023-12-31" id="Fact002958" format="ixt:numdotdecimal" decimals="0" unitRef="USD">29,198,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-04-012023-03-31" id="Fact002959" format="ixt:numdotdecimal" decimals="0" unitRef="USD">39,299,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-04-012022-03-31" id="Fact002960" format="ixt:numdotdecimal" decimals="0" unitRef="USD">47,512,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AD_zJJzZMbCd3Oe" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-04-012023-12-31" escape="true" id="Fact002962" name="us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock"><p id="xdx_890_eus-gaap--ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_zo4TbTIXPNVd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue
by geographic region is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BD_zhNkzveFBU0e" style="display: none">SCHEDULE OF REVENUE BY GEOGRAPHICAL REGION</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_490_20230401__20231231_zNrLZbPbyV8c" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_495_20220401__20230331_zqervhkGBDRc" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_495_20210401__20220331_zb4vNjlif2K4" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">FOR THE NINE MONTHS ENDED</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">FOR THE FISCAL YEARS ENDED</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--Revenues_hsrt--StatementGeographicalAxis__srt--NorthAmericaMember_z3SHp5Gxhxz6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 43%; text-align: left">North America</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-04-012023-12-31_srt_NorthAmericaMember" id="Fact002964" format="ixt:numdotdecimal" decimals="0" unitRef="USD">28,763,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-04-012023-03-31_srt_NorthAmericaMember" id="Fact002965" format="ixt:numdotdecimal" decimals="0" unitRef="USD">38,298,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-04-012022-03-31_srt_NorthAmericaMember" id="Fact002966" format="ixt:numdotdecimal" decimals="0" unitRef="USD">46,396,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--Revenues_hsrt--StatementGeographicalAxis__country--AU_zI0fmWTEjNM4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Australia</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-04-012023-12-31_country_AU" id="Fact002968" format="ixt:numdotdecimal" decimals="0" unitRef="USD">205,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-04-012023-03-31_country_AU" id="Fact002969" format="ixt:numdotdecimal" decimals="0" unitRef="USD">670,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-04-012022-03-31_country_AU" id="Fact002970" format="ixt:numdotdecimal" decimals="0" unitRef="USD">679,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--Revenues_hsrt--StatementGeographicalAxis__custom--EuropeAndUnitedKingdomMember_z2qxcwIIbrjj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Europe and United Kingdom</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-04-012023-12-31_custom_EuropeAndUnitedKingdomMember" id="Fact002972" format="ixt:numdotdecimal" decimals="0" unitRef="USD">226,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-04-012023-03-31_custom_EuropeAndUnitedKingdomMember" id="Fact002973" format="ixt:numdotdecimal" decimals="0" unitRef="USD">331,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-04-012022-03-31_custom_EuropeAndUnitedKingdomMember" id="Fact002974" format="ixt:numdotdecimal" decimals="0" unitRef="USD">359,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--Revenues_hsrt--StatementGeographicalAxis__custom--OthersMember_ztrJtqC9geC2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">All Others</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-04-012023-12-31_custom_OthersMember" id="Fact002976" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2977">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-04-012022-03-31_custom_OthersMember" id="Fact002978" format="ixt:numdotdecimal" decimals="0" unitRef="USD">78,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--Revenues_z1XP4QOH1mTj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Net sales</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-04-012023-12-31" id="Fact002980" format="ixt:numdotdecimal" decimals="0" unitRef="USD">29,198,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-04-012023-03-31" id="Fact002981" format="ixt:numdotdecimal" decimals="0" unitRef="USD">39,299,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-04-012022-03-31" id="Fact002982" format="ixt:numdotdecimal" decimals="0" unitRef="USD">47,512,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A9_zgOtFMZeeo0e" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
geographic area of sales is based primarily on where the product was delivered.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-04-012023-12-31" escape="true" id="Fact002984" name="us-gaap:ConcentrationRiskDisclosureTextBlock"><p id="xdx_800_eus-gaap--ConcentrationRiskDisclosureTextBlock_znfs8FWL4Ul5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
18 - <span id="xdx_82E_zSrhmbvWQBFk">CONCENTRATIONS OF CREDIT RISK AND REVENUE</span> </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
times, the Company maintains cash in United States bank accounts that are more than the Federal Deposit Insurance Corporation insured
amounts. The Company maintains cash balances in foreign financial institutions. The Company regularly monitors the financial stability
of this financial institution and believes that it is not exposed to any significant credit risk in cash and cash equivalents. However,
in March and April 2023, certain U.S. government banking regulators took steps to intervene in the operations of certain financial institutions
due to liquidity concerns, which caused general heightened uncertainties in financial markets. While these events have not had a material
direct impact on the Company&#8217;s operations, if further liquidity and financial stability concerns arise with respect to banks and
financial institutions, either nationally or in specific regions, the Company&#8217;s ability to access cash or enter into new financing
arrangements may be threatened, which could have a material adverse effect on its business, financial condition and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company derives most of its revenues from retailers in the United States. The Company&#8217;s allowance for credit losses is based upon
management&#8217;s estimates and historical experience and reflects the fact that accounts receivable is concentrated with several large
customers. On December 31, 2023, <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230401__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--FourCustomersMember_zdPKSNZ3Ms3c" title="Concentration of sales risk, percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2023-04-012023-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_FourCustomersMember" id="Fact002986" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">82</ix:nonFraction></span>% of accounts receivable were due from four customers in North America that individually owed over
10% of total accounts receivable. On March 31, 2023, <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220401__20230331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ThreeCustomersMember_zcQN8fDaDZW1" title="Concentration of sales risk, percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2022-04-012023-03-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_ThreeCustomersMember" id="Fact002988" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">79</ix:nonFraction></span>% of accounts receivable were due from three customers in North America that individually
owed over 10% of total accounts receivable. On March 31, 2022, <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210401__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--FourCustomersMember_zFSXapnxAiv5" title="Concentration of sales risk, percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2021-04-012022-03-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_FourCustomersMember" id="Fact002990" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">53</ix:nonFraction></span>% of accounts receivable were due from four customers in North America
that individually owed over 10% of total accounts receivable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues
derived from our top three customers for the nine months ended December 31, 2023, and 2022, were <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230401__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__custom--ThreeCustomersMember__srt--MajorCustomersAxis__custom--CustomersConcentrationRiskMember_zOW0Mk4toyx6" title="Concentration of sales risk, percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2023-04-012023-12-31_custom_SalesRevenueMember_custom_ThreeCustomersMember_custom_CustomersConcentrationRiskMember" id="Fact002992" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">81</ix:nonFraction></span>% and <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220401__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__custom--ThreeCustomersMember__srt--MajorCustomersAxis__custom--CustomersConcentrationRiskMember_zozBkQYinFl9" title="Concentration of sales risk, percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2022-04-012022-12-31_custom_SalesRevenueMember_custom_ThreeCustomersMember_custom_CustomersConcentrationRiskMember" id="Fact002994" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">77</ix:nonFraction></span>% of total revenue, respectively.
Revenues derived from our top three customers for the fiscal years ended March 31, 2023, and 2022 were <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220401__20230331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__custom--ThreeCustomersMember__srt--MajorCustomersAxis__custom--CustomersConcentrationRiskMember_zFXh5VZLs1x1" title="Concentration of sales risk, percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2022-04-012023-03-31_custom_SalesRevenueMember_custom_ThreeCustomersMember_custom_CustomersConcentrationRiskMember" id="Fact002996" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">69</ix:nonFraction></span>% and <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210401__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__custom--ThreeCustomersMember__srt--MajorCustomersAxis__custom--CustomersConcentrationRiskMember_zmSuTByUV0x7" title="Concentration of sales risk, percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2021-04-012022-03-31_custom_SalesRevenueMember_custom_ThreeCustomersMember_custom_CustomersConcentrationRiskMember" id="Fact002998" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">72</ix:nonFraction></span>% of total revenue,
respectively. Revenues from customers representing greater than 10% of total net sales were derived from top three customers for the
nine months ended December 31, 2023, and top two customers for the nine months ended December 31, 2022, as percentage of the net sales
were <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230401__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomersOneMember__srt--MajorCustomersAxis__custom--CustomersConcentrationRiskMember_zdGtBbk808Kh" title="Concentration of sales risk, percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2023-04-012023-12-31_custom_SalesRevenueMember_custom_CustomersOneMember_custom_CustomersConcentrationRiskMember" id="Fact003000" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">48</ix:nonFraction></span>%, <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230401__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomersTwoMember__srt--MajorCustomersAxis__custom--CustomersConcentrationRiskMember_zvVJk8ALlRLc" title="Concentration of sales risk, percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2023-04-012023-12-31_custom_SalesRevenueMember_custom_CustomersTwoMember_custom_CustomersConcentrationRiskMember" id="Fact003002" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">21</ix:nonFraction></span>% and <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230401__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomersThreeMember__srt--MajorCustomersAxis__custom--CustomersConcentrationRiskMember_zpe8ODKWIO53" title="Concentration of sales risk, percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2023-04-012023-12-31_custom_SalesRevenueMember_custom_CustomersThreeMember_custom_CustomersConcentrationRiskMember" id="Fact003004" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">12</ix:nonFraction></span>% and <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220401__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomersOneMember__srt--MajorCustomersAxis__custom--CustomersConcentrationRiskMember_z3mQnf61ln43" title="Concentration of sales risk, percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2022-04-012022-12-31_custom_SalesRevenueMember_custom_CustomersOneMember_custom_CustomersConcentrationRiskMember" id="Fact003006" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">46</ix:nonFraction></span>% and, <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220401__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomersTwoMember__srt--MajorCustomersAxis__custom--CustomersConcentrationRiskMember_z0VYpnq06jgc" title="Concentration of sales risk, percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2022-04-012022-12-31_custom_SalesRevenueMember_custom_CustomersTwoMember_custom_CustomersConcentrationRiskMember" id="Fact003008" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">22</ix:nonFraction></span>%, respectively. Revenues from customers representing greater than 10% of total net sales were derived
from our top two customers in Fiscal 2023 and top three customers in Fiscal 2022 as percentage of the net sales were <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220401__20230331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomersOneMember__srt--MajorCustomersAxis__custom--CustomersConcentrationRiskMember_zT7KGAJqPvv9" title="Concentration of sales risk, percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2022-04-012023-03-31_custom_SalesRevenueMember_custom_CustomersOneMember_custom_CustomersConcentrationRiskMember" id="Fact003010" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">48</ix:nonFraction></span>% and <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220401__20230331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomersTwoMember__srt--MajorCustomersAxis__custom--CustomersConcentrationRiskMember_zMLs58p2um1d" title="Concentration of sales risk, percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2022-04-012023-03-31_custom_SalesRevenueMember_custom_CustomersTwoMember_custom_CustomersConcentrationRiskMember" id="Fact003012" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">21</ix:nonFraction></span>% and
<span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210401__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomersOneMember__srt--MajorCustomersAxis__custom--CustomersConcentrationRiskMember_zDmwTLyzkI3d" title="Concentration of sales risk, percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2021-04-012022-03-31_custom_SalesRevenueMember_custom_CustomersOneMember_custom_CustomersConcentrationRiskMember" id="Fact003014" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">37</ix:nonFraction></span>%, <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210401__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomersTwoMember__srt--MajorCustomersAxis__custom--CustomersConcentrationRiskMember_zeeHNC9oX279" title="Concentration of sales risk, percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2021-04-012022-03-31_custom_SalesRevenueMember_custom_CustomersTwoMember_custom_CustomersConcentrationRiskMember" id="Fact003016" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">18</ix:nonFraction></span>%, and <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210401__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomersThreeMember__srt--MajorCustomersAxis__custom--CustomersConcentrationRiskMember_ziPVXjAekhGk" title="Concentration of sales risk, percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2021-04-012022-03-31_custom_SalesRevenueMember_custom_CustomersThreeMember_custom_CustomersConcentrationRiskMember" id="Fact003018" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">17</ix:nonFraction></span>%, respectively. The loss of any of these customers could have an adverse impact on the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 114; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
SINGING MACHINE COMPANY, INC AND SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
31, 2023, and March 31, 2023 and 2022</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is dependent upon foreign companies for the manufacture of all its electronic products. The Company&#8217;s arrangements with
manufacturers are subject to the risk of doing business abroad, such as import duties, trade restrictions, work stoppages, foreign currency
fluctuations, political instability, and other factors, which could have an adverse impact on its business. The Company believes that
the loss of any one or more of their suppliers would not have a long-term material adverse effect because other manufacturers with whom
the Company does business would be able to increase production to fulfill their requirements. However, the loss of certain suppliers
in the short term could adversely affect business until alternative supply arrangements are secured.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the nine months ended December 31, 2023, and fiscal years 2023 and 2022, manufacturers in the People&#8217;s Republic of China accounted
for <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230401__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--GeographicConcentrationRiskMember__srt--MajorCustomersAxis__custom--RepublicOfChinaMember_zq4PtJ0ODRV6" title="Concentration of sales risk, percentage"><span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220401__20230331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--GeographicConcentrationRiskMember__srt--MajorCustomersAxis__custom--RepublicOfChinaMember_zvKD5hLm5NGg" title="Concentration of sales risk, percentage"><span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210401__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--GeographicConcentrationRiskMember__srt--MajorCustomersAxis__custom--RepublicOfChinaMember_zvJ9DP33MIKa" title="Concentration of sales risk, percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2023-04-012023-12-31_custom_PurchasesMember_us-gaap_GeographicConcentrationRiskMember_custom_RepublicOfChinaMember" id="Fact003020" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2022-04-012023-03-31_custom_PurchasesMember_us-gaap_GeographicConcentrationRiskMember_custom_RepublicOfChinaMember" id="Fact003022" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2021-04-012022-03-31_custom_PurchasesMember_us-gaap_GeographicConcentrationRiskMember_custom_RepublicOfChinaMember" id="Fact003024" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span>% of the Company&#8217;s total product purchases, including all the Company&#8217;s hardware purchases. In 2018 <span id="xdx_900_eus-gaap--DebtInstrumentDescription_pid_c20230401__20231231__us-gaap--ConcentrationRiskByTypeAxis__custom--RepublicOfChinaMember_zCksFkuHY0Dk" title="Debt instrument, description"><ix:nonNumeric contextRef="From2023-04-012023-12-31_custom_RepublicOfChinaMember" id="Fact003026" name="us-gaap:DebtInstrumentDescription">the U.S. government-imposed
tariffs of up to 25% on certain goods imported from China. All our products are manufactured and imported from China however, only our
microphones are currently subject to a 7.5% tariff currently in place</ix:nonNumeric></span>. Should the government decide to expand its list of products to
include our karaoke products that would subject our products to tariffs in the future, there could be a significant increase in the landed
cost of our products. If we are unable to mitigate these increased costs through price increases, we could experience reductions in revenues,
gross profit margin and results from operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-04-012023-12-31" escape="true" id="Fact003028" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock"><p id="xdx_805_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zpzov70XlNqd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
19 &#8211; <span id="xdx_826_zIqD0Wxtzpf2">RELATED PARTY TRANSACTIONS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Financing</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 20, 2023, the Company the Company entered into an agreement to sell $<span id="xdx_90C_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20231120__20231120__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zHp8xmDlvEdd" title="Number of stock sold, value"><ix:nonFraction name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" contextRef="From2023-11-202023-11-20_us-gaap_PrivatePlacementMember" id="Fact003030" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,000,000</ix:nonFraction></span> in common stock through a private placement of
common stock (the &#8220;Private Placement&#8221;). The Private Placement was completed with two Affiliates, (Stingray Group, Inc. and
Jay Foreman), both of which were existing shareholders with Board representation (See Note 13 &#8211; November 2023 Private Placement).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Due
To/From Related Parties</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has a music subscription sharing agreement with Stingray. For the transition year ended December 31, 2023, and 2022, the Company
received music subscription revenue of approximately $<span id="xdx_909_eus-gaap--Revenues_c20230401__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StingrayMember_zbGwyH4zwAD7" title="Revenue from related parties"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-04-012023-12-31_custom_StingrayMember" id="Fact003032" format="ixt:numdotdecimal" decimals="0" unitRef="USD">600,000</ix:nonFraction></span> and $<span id="xdx_90C_eus-gaap--Revenues_c20220401__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StingrayMember_zYr9SNNglQt4" title="Revenue from related parties"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-04-012022-12-31_custom_StingrayMember" id="Fact003034" format="ixt:numdotdecimal" decimals="0" unitRef="USD">500,000</ix:nonFraction></span>, respectively. For the fiscal years ended March 31, 2023,
and 2022, this amount was approximately $<span id="xdx_905_eus-gaap--Revenues_c20220401__20230331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StingrayMember_zh4tfxEtKxBe" title="Revenue from related parties"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-04-012023-03-31_custom_StingrayMember" id="Fact003036" format="ixt:numdotdecimal" decimals="0" unitRef="USD">700,000</ix:nonFraction></span> and $<span id="xdx_908_eus-gaap--Revenues_c20210401__20220331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StingrayMember_zRqvXqUDZUGg" title="Revenue from related parties"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-04-012022-03-31_custom_StingrayMember" id="Fact003038" format="ixt:numdotdecimal" decimals="0" unitRef="USD">500,000</ix:nonFraction></span>, respectively. This amount was included as a component of net sales in
the accompanying consolidated statements of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 31, 2023, and March 31, 2023, the Company had approximately $<span id="xdx_906_eus-gaap--OtherReceivables_iI_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StingrayMember_zRMFezJhOQqk" title="Due from related parties"><ix:nonFraction name="us-gaap:OtherReceivables" contextRef="AsOf2023-12-31_custom_StingrayMember" id="Fact003040" format="ixt:numdotdecimal" decimals="0" unitRef="USD">269,000</ix:nonFraction></span> and $<span id="xdx_90C_eus-gaap--OtherReceivables_iI_c20230331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StingrayMember_zqiC6Tg9gLq7" title="Due from related parties"><ix:nonFraction name="us-gaap:OtherReceivables" contextRef="AsOf2023-03-31_custom_StingrayMember" id="Fact003042" format="ixt:numdotdecimal" decimals="0" unitRef="USD">218,000</ix:nonFraction></span>, respectively, due from Stingray for music
subscription reimbursement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
March 31, 2023, the Company had travel and entertainment expense reimbursements due from Ault Alliance, Inc., a former parent company,
of approximately $<span id="xdx_905_eus-gaap--OtherReceivables_iI_c20230331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AultAllianceIncMember_ztpvUOwheBG4" title="Due from related parties"><ix:nonFraction name="us-gaap:OtherReceivables" contextRef="AsOf2023-03-31_custom_AultAllianceIncMember" id="Fact003044" format="ixt:numdotdecimal" decimals="0" unitRef="USD">21,000</ix:nonFraction></span>. There was nothing due to or from Ault Alliance, Inc. on December 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-04-012023-12-31" escape="true" id="Fact003046" name="us-gaap:InsuranceDisclosureTextBlock"><p id="xdx_80C_eus-gaap--InsuranceDisclosureTextBlock_z6jsZOuvGBe6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
20 &#8211; <span id="xdx_827_zXdX0YYy0v1h">DAMAGED GOODS INCIDENT RECOVERY</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the fiscal years ended March 31, 2023 and 2022 we recognized a gain of approximately $<span id="xdx_90E_ecustom--GainFromSettlementOfAccountsPayable_c20220401__20230331_zzEK73FtAMDc" title="Settlement of accounts payable"><ix:nonFraction name="RIME:GainFromSettlementOfAccountsPayable" contextRef="From2022-04-012023-03-31" id="Fact003048" format="ixt:numdotdecimal" decimals="0" unitRef="USD">48,000</ix:nonFraction></span> and $<span id="xdx_900_ecustom--GainFromSettlementOfAccountsPayable_c20210401__20220331_zzcZCRRDYSg6" title="Settlement of accounts payable"><ix:nonFraction name="RIME:GainFromSettlementOfAccountsPayable" contextRef="From2021-04-012022-03-31" id="Fact003050" format="ixt:numdotdecimal" decimals="0" unitRef="USD">339,000</ix:nonFraction></span> as other income on the accompanying
consolidated statements of operations due to settlement of accounts payable by a manufacturer&#8217;s representative of a factory that
caused a damaged goods incident in Fiscal 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 115; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
SINGING MACHINE COMPANY, INC AND SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
31, 2023, and March 31, 2023 and 2022</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-04-012023-12-31" escape="true" id="Fact003052" name="RIME:SupplementalInformationDisclosuresTextBlock"><p id="xdx_806_ecustom--SupplementalInformationDisclosuresTextBlock_zGt64f89haC8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
21 &#8211; <span id="xdx_82D_zUPxBfovsTDj">SUPPLEMENTAL INFORMATION CONDENSED FINANCIAL INFORMATION</span> FOR THE NINE MONTHS ENDED DECEMBER 31, 2023, AND 2022.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
Singing Machine Company, Inc. and Subsidiaries</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONDENSED
CONSOLIDATED STATEMENTS OF OPERATIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For
the nine months ended December 31, 2023 and 2022</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<ix:nonNumeric contextRef="From2023-04-012023-12-31" escape="true" id="Fact003054" name="srt:ScheduleOfCondensedIncomeStatementTableTextBlock"><p id="xdx_894_esrt--ScheduleOfCondensedIncomeStatementTableTextBlock_zRwUdi7R88z1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B2_z6ajTb0E5juc">SCHEDULE
OF CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS&#160;</span></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--IncomeStatementAbstract_pn3n3_zk1596I4Wbc4" summary="xdx: Disclosure - SCHEDULE OF CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_494_20230401__20231231_zUw8GwXOeui" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_490_20220401__20221231_zXvi6m7zAge8" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Nine Months Ended</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">(unaudited)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_maGPzmfg_z9MVSYgGPy5h" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; width: 60%; text-align: left">Net Sales</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2023-04-012023-12-31" id="Fact003058" format="ixt:numdotdecimal" decimals="0" unitRef="USD">29,198,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-04-012022-12-31" id="Fact003059" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35,916,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--CostOfGoodsAndServicesSold_msGPzmfg_zJLNOOQwROW3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Cost of Goods Sold</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:CostOfGoodsAndServicesSold" contextRef="From2023-04-012023-12-31" id="Fact003061" format="ixt:numdotdecimal" decimals="0" unitRef="USD">23,008,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:CostOfGoodsAndServicesSold" contextRef="From2022-04-012022-12-31" id="Fact003062" format="ixt:numdotdecimal" decimals="0" unitRef="USD">27,481,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--GrossProfit_iT_pp0p0_mtGPzmfg_maOILzsGr_za4kC8gX327g" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Gross Profit</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2023-04-012023-12-31" id="Fact003064" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,190,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2022-04-012022-12-31" id="Fact003065" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">8,435,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--OperatingExpenses_pp0p0_msOILzsGr_zE9QVe01jj7h" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Operating Expenses</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2023-04-012023-12-31" id="Fact003067" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">12,333,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2022-04-012022-12-31" id="Fact003068" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,986,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--OperatingIncomeLoss_iT_pp0p0_mtOILzsGr_maILFCOzzC2_zHJguttX6boe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">(Loss) Income from Operations</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2023-04-012023-12-31" id="Fact003070" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">6,143,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2022-04-012022-12-31" id="Fact003071" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">1,551,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--NonoperatingIncomeExpense_pp0p0_maILFCOzzC2_zp1msKve4kq6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Other (Expenses) Income</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2023-04-012023-12-31" id="Fact003073" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">255,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2022-04-012022-12-31" id="Fact003074" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">574,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iT_pp0p0_mtILFCOzzC2_maNILzRTS_ztxzDGaPsQV9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">(Loss) Income Before Income Tax Benefit</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2023-04-012023-12-31" id="Fact003076" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">6,398,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2022-04-012022-12-31" id="Fact003077" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">2,125,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--IncomeTaxExpenseBenefit_iN_pp0p0_di_msNILzRTS_zcGL0bqOzrla" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Income Tax Benefit (Loss)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3079">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2022-04-012022-12-31" id="Fact003080" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">472,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--ProfitLoss_iT_pp0p0_mtNILzRTS_zMycqg2Gmiql" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Net (Loss) Income</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-04-012023-12-31" id="Fact003082" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">6,398,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-04-012022-12-31" id="Fact003083" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">1,653,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--EarningsPerShareAbstract_iB_z7JAa0AK9DI6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Loss per Common Share</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Basic and Diluted</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_eus-gaap--EarningsPerShareBasic_pid_c20230401__20231231_zFisDk6vXfV5" title="Basic" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTkRFTlNFRCBDT05TT0xJREFURUQgU1RBVEVNRU5UUyBPRiBPUEVSQVRJT05TIChEZXRhaWxzKQA_"><span id="xdx_900_eus-gaap--EarningsPerShareDiluted_pid_c20230401__20231231_zrfoP03g4xC9" title="Diluted" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTkRFTlNFRCBDT05TT0xJREFURUQgU1RBVEVNRU5UUyBPRiBPUEVSQVRJT05TIChEZXRhaWxzKQA_">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2023-04-012023-12-31" id="Fact003088" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2023-04-012023-12-31" id="Fact003090" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">1.32</ix:nonFraction></ix:nonFraction></span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_eus-gaap--EarningsPerShareBasic_pid_c20220401__20221231_zigRinIATjdk" title="Basic" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTkRFTlNFRCBDT05TT0xJREFURUQgU1RBVEVNRU5UUyBPRiBPUEVSQVRJT05TIChEZXRhaWxzKQA_"><span id="xdx_906_eus-gaap--EarningsPerShareDiluted_pid_c20220401__20221231_z6xAmVxVcGn1" title="Diluted" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTkRFTlNFRCBDT05TT0xJREFURUQgU1RBVEVNRU5UUyBPRiBPUEVSQVRJT05TIChEZXRhaWxzKQA_">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2022-04-012022-12-31" id="Fact003092" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2022-04-012022-12-31" id="Fact003094" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.61</ix:nonFraction></ix:nonFraction></span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--EarningsPerShareBasicOtherDisclosuresAbstract_iB" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Weighted Average Common and Common</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Equivalent Shares:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--EarningsPerShareBasicOtherDisclosuresAbstract_iB_z4AL99Y9uNWh" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Weighted Average Common and Common Equivalent Shares:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Basic and Diluted</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_904_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20230401__20231231_z62xNBARsPq1" title="Basic" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTkRFTlNFRCBDT05TT0xJREFURUQgU1RBVEVNRU5UUyBPRiBPUEVSQVRJT05TIChEZXRhaWxzKQA_"><span id="xdx_907_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20230401__20231231_znDWmOHXgU81" title="Diluted" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTkRFTlNFRCBDT05TT0xJREFURUQgU1RBVEVNRU5UUyBPRiBPUEVSQVRJT05TIChEZXRhaWxzKQA_"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-04-012023-12-31" id="Fact003102" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-04-012023-12-31" id="Fact003104" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,864,540</ix:nonFraction></ix:nonFraction></span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20220401__20221231_zzFnOlShhQ4g" title="Basic" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTkRFTlNFRCBDT05TT0xJREFURUQgU1RBVEVNRU5UUyBPRiBPUEVSQVRJT05TIChEZXRhaWxzKQA_"><span id="xdx_907_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20220401__20221231_zfWTnrupW0d3" title="Diluted" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTkRFTlNFRCBDT05TT0xJREFURUQgU1RBVEVNRU5UUyBPRiBPUEVSQVRJT05TIChEZXRhaWxzKQA_"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2022-04-012022-12-31" id="Fact003106" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2022-04-012022-12-31" id="Fact003108" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,699,210</ix:nonFraction></ix:nonFraction></span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A4_zwQ08z2eSbPg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<ix:exclude><!-- Field: Page; Sequence: 116; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
SINGING MACHINE COMPANY, INC AND SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
31, 2023, and March 31, 2023 and 2022</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
Singing Machine Company, Inc. and Subsidiaries</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONDENSED
CONSOLIDATED STATEMENTS OF CASH FLOWS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For
the nine months ended December 31, 2023 and 2022 (unaudited)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<ix:nonNumeric contextRef="From2023-04-012023-12-31" escape="true" id="Fact003110" name="srt:ScheduleOfCondensedCashFlowStatementTableTextBlock"><p id="xdx_898_esrt--ScheduleOfCondensedCashFlowStatementTableTextBlock_zzJFFZvUv7P4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B9_zq2esEfyrJUc">SCHEDULE
OF CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</span></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--StatementOfCashFlowsAbstract_pn3n3_z5qt6cR0g2Kd" summary="xdx: Disclosure - SCHEDULE OF CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_494_20230401__20231231_zN3BV2OvRkHe" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20220401__20221231_zWPEFIOYuZP4" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">For the Nine Months Ended</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">(unaudited)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Cash flows from operating activities</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--ProfitLoss_i01_pp0p0_maNCPBUzVoD_zRbqIkluj2xg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 60%; text-align: left">Net loss</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-04-012023-12-31" id="Fact003117" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">6,398,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-04-012022-12-31" id="Fact003118" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">1,653,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_405_eus-gaap--AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_i01_maNCPBUzVoD_z2q9M7Aaj0rc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Adjustments to reconcile net loss to net cash used in operating activities:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" contextRef="From2023-04-012023-12-31" id="Fact003120" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,305,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" contextRef="From2022-04-012022-12-31" id="Fact003121" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">73,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_40C_eus-gaap--IncreaseDecreaseInOperatingCapital_i02N_di_msNCPBUzVoD_zycYRO5ECe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1pt">Changes in operating assets and liabilities:</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOperatingCapital" contextRef="From2023-04-012023-12-31" id="Fact003123" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">5,504,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="letter-spacing: -0.1pt">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOperatingCapital" contextRef="From2022-04-012022-12-31" id="Fact003124" format="ixt:numdotdecimal" decimals="0" unitRef="USD">538,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_405_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i01T_pp0p0_maCCERCzHgo_mtNCPBUzVoD_z5HCjOq13Pf2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left; padding-bottom: 1pt">Net cash provided by (used in) operating activities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2023-04-012023-12-31" id="Fact003126" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">411,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="letter-spacing: -0.1pt">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2022-04-012022-12-31" id="Fact003127" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">2,264,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40E_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Cash flows from investing activities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--NetCashProvidedByUsedInInvestingActivities_i01T_pp0p0_maCCERCzHgo_mtNCPBUzYTF_zu7TLVNtK3H" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left; padding-bottom: 1pt">Net cash used in investing activities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2023-04-012023-12-31" id="Fact003132" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">14,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2022-04-012022-12-31" id="Fact003133" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">149,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40F_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Cash flows from financing activities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_pp0p0_mtNCPBUz2nB_maCCERCzHgo_zNUUYQjGsFo4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left; padding-bottom: 1pt">Net cash provided by financing activities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2023-04-012023-12-31" id="Fact003138" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,411,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2022-04-012022-12-31" id="Fact003139" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,917,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_iT_pp0p0_mtCCERCzHgo_zLQk8dYsgvM2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Net change in cash</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2023-04-012023-12-31" id="Fact003141" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,808,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="letter-spacing: -0.1pt"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2022-04-012022-12-31" id="Fact003142" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">504,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iS_zYLw7ZXMPcnj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Cash at beginning of year</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2023-03-31" id="Fact003144" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,895,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="letter-spacing: -0.1pt"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2022-03-31" id="Fact003145" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,291,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iE_pp0p0" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Cash at end of period</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2023-12-31" id="Fact003147" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,703,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2022-12-31" id="Fact003148" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,795,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AE_zOCpvyu6hNq8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<ix:exclude><!-- Field: Page; Sequence: 117; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
SINGING MACHINE COMPANY, INC AND SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
31, 2023, and March 31, 2023 and 2022</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
Singing Machine Company, Inc. and Subsidiaries</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONDENSED
CONSOLIDATED STATEMENTS OF SHAREHOLDERS&#8217; EQUITY </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For
the nine months ended December 31, 2023 and 2022 (unaudited) </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<ix:nonNumeric contextRef="From2023-04-012023-12-31" escape="true" id="Fact003150" name="us-gaap:ScheduleOfStockholdersEquityTableTextBlock"><p id="xdx_896_eus-gaap--ScheduleOfStockholdersEquityTableTextBlock_zCW1DqARj325" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BE_zvYf1K7G3G04">SCHEDULE
OF CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS&#8217; EQUITY </span><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--StatementOfStockholdersEquityAbstract_pn3n3_zxyrKaMhy6f1" summary="xdx: Disclosure - SCHEDULE OF CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS? EQUITY (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Shares</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B2_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zEtMtgSm2zZ8" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Amount</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B5_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_zAxMPGS8fGRg" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Capital</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4BB_us-gaap--StatementEquityComponentsAxis_us-gaap--ReceivablesFromStockholderMember_zCLULKo1u7T5" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Receivable</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B2_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zuAhdj1FY41h" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Deficit</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4BC_zScqmt4y1DSg" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Total</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Common Stock</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center">Additional Paid in</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center">Subscriptions</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center">Accumulated</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Shares</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Amount</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Capital</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Receivable</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Deficit</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Total</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_430_c20230401__20231231_eus-gaap--StockholdersEquity_iS_z15MFfvx8tte" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; width: 40%; text-align: left">Balance at March 31, 2023</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--SharesOutstanding_iS_c20230401__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zowtBJASZVCh" title="Balance, shares" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-03-31_us-gaap_CommonStockMember" id="Fact003160" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,167,488</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span style="letter-spacing: -0.1pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-31_us-gaap_CommonStockMember" id="Fact003154" format="ixt:numdotdecimal" decimals="0" unitRef="USD">32,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span style="letter-spacing: -0.1pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact003155" format="ixt:numdotdecimal" decimals="0" unitRef="USD">29,822,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-31_us-gaap_ReceivablesFromStockholderMember" id="Fact003156" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">6,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-31_us-gaap_RetainedEarningsMember" id="Fact003157" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">19,517,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-31" id="Fact003158" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,331,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--ProfitLoss_zljSGiBzflMd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Net loss</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3162">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3163">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3164">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-04-012023-12-31_us-gaap_RetainedEarningsMember" id="Fact003165" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">6,398,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-04-012023-12-31" id="Fact003166" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">6,398,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_408_eus-gaap--StockIssuedDuringPeriodValueNewIssues_zuXpPoKfvDuh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Issuance of common stock, net of stock offering costs</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230401__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zHs66oERJF77" title="Issuance of common stock, net of stock offering costs, shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-04-012023-12-31_us-gaap_CommonStockMember" id="Fact003174" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,250,573</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-04-012023-12-31_us-gaap_CommonStockMember" id="Fact003168" format="ixt:numdotdecimal" decimals="0" unitRef="USD">32,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-04-012023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact003169" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,497,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3170">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3171">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-04-012023-12-31" id="Fact003172" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,529,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--ShareBasedCompensation_zAD96sTcLV4c" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Stock based compensation</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensation_c20230401__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zetVtSdvzZK1" title="Stock based compensation ,shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3182">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3176">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2023-04-012023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact003177" format="ixt:numdotdecimal" decimals="0" unitRef="USD">110,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3178">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3179">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2023-04-012023-12-31" id="Fact003180" format="ixt:numdotdecimal" decimals="0" unitRef="USD">110,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--StockIssuedDuringPeriodValueOther_zwMG12wIkAC4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Other</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesOther_c20230401__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zVRpaFXW54eb" title="Other, shares" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3190">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3184">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3185">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2023-04-012023-12-31_us-gaap_ReceivablesFromStockholderMember" id="Fact003186" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3187">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2023-04-012023-12-31" id="Fact003188" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_43A_c20230401__20231231_eus-gaap--StockholdersEquity_iE_z9PBjMd6zXs8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">&#160;Balance at December 31, 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--SharesOutstanding_iE_c20230401__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zoqWMShhrePd" title="Balance, shares" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-12-31_us-gaap_CommonStockMember" id="Fact003198" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,418,061</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_us-gaap_CommonStockMember" id="Fact003192" format="ixt:numdotdecimal" decimals="0" unitRef="USD">64,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact003193" format="ixt:numdotdecimal" decimals="0" unitRef="USD">33,429,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3194">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_us-gaap_RetainedEarningsMember" id="Fact003195" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">25,915,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31" id="Fact003196" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,578,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Common Stock</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center">Additional Paid in</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center">Subscriptions</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center">Accumulated</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Shares</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Amount</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Capital</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Receivable</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Deficit</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Total</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_430_c20220401__20221231_eus-gaap--StockholdersEquity_iS_zycTCV8uqA29" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; width: 40%; text-align: left">Balance at March 31, 2022</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--SharesOutstanding_iS_c20220401__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zdlm0MkAosCh" title="Balance, shares" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-03-31_us-gaap_CommonStockMember" id="Fact003206" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,221,209</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-03-31_us-gaap_CommonStockMember" id="Fact003200" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-03-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact003201" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,903,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right">&#160;&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl3202">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-03-31_us-gaap_RetainedEarningsMember" id="Fact003203" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">14,879,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-03-31" id="Fact003204" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,036,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_436_c20220401__20221231_eus-gaap--StockholdersEquity_iS_zojW5XrXZ977" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Balance, value</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--SharesOutstanding_iS_c20220401__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zwTA0nkfmV2a" title="Balance, shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-03-31_us-gaap_CommonStockMember" id="Fact003214" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,221,209</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-03-31_us-gaap_CommonStockMember" id="Fact003208" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-03-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact003209" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,903,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl3210">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-03-31_us-gaap_RetainedEarningsMember" id="Fact003211" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">14,879,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-03-31" id="Fact003212" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,036,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--ProfitLoss_zkUmFtmEA8h2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Net loss</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3216">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3217">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3218">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-04-012022-12-31_us-gaap_RetainedEarningsMember" id="Fact003219" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,653,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-04-012022-12-31" id="Fact003220" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,653,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_408_eus-gaap--StockIssuedDuringPeriodValueNewIssues_zqnTAwvBYPt5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Issuance of common stock and warrants, net of stock offering costs</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220401__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zJ1CYS2FTsP5" title="Issuance of common stock and warrants, net of stock offering costs, shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2022-04-012022-12-31_us-gaap_CommonStockMember" id="Fact003228" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,909,519</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-04-012022-12-31_us-gaap_CommonStockMember" id="Fact003222" format="ixt:numdotdecimal" decimals="0" unitRef="USD">19,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-04-012022-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact003223" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,489,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3224">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3225">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-04-012022-12-31" id="Fact003226" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,508,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--ShareBasedCompensation_z20q0lgt0B88" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Stock based compensation</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensation_c20220401__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zDSwTyperGsd" title="Stock based compensation ,shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" contextRef="From2022-04-012022-12-31_us-gaap_CommonStockMember" id="Fact003236" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">15,803</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3230">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2022-04-012022-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact003231" format="ixt:numdotdecimal" decimals="0" unitRef="USD">307,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3232">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3233">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2022-04-012022-12-31" id="Fact003234" format="ixt:numdotdecimal" decimals="0" unitRef="USD">307,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--StockIssuedDuringPeriodValueOther_zVfoPv7TlHG9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Other</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--StockIssuedDuringPeriodSharesOther_c20220401__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zqFQDez6fl4" title="Other, shares" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesOther" contextRef="From2022-04-012022-12-31_us-gaap_CommonStockMember" id="Fact003244" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,688</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3238">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2022-04-012022-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact003239" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3240">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2022-04-012022-12-31_us-gaap_RetainedEarningsMember" id="Fact003241" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,000</ix:nonFraction></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3242">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_430_c20220401__20221231_eus-gaap--StockholdersEquity_iE_zuIEPlPLRTZe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Balance at December 31, 2022 (unaudited)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--SharesOutstanding_iE_c20220401__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zVm7Ha1dRStd" title="Balance, shares" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-12-31_us-gaap_CommonStockMember" id="Fact003252" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,148,219</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_us-gaap_CommonStockMember" id="Fact003246" format="ixt:numdotdecimal" decimals="0" unitRef="USD">31,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact003247" format="ixt:numdotdecimal" decimals="0" unitRef="USD">29,698,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3248">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_us-gaap_RetainedEarningsMember" id="Fact003249" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">16,531,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31" id="Fact003250" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,198,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_43D_c20220401__20221231_eus-gaap--StockholdersEquity_iE_z9aej9Q95ur6" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Balance, value</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--SharesOutstanding_iE_c20220401__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zsOmskrUNKS" title="Balance, shares" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-12-31_us-gaap_CommonStockMember" id="Fact003260" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,148,219</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_us-gaap_CommonStockMember" id="Fact003254" format="ixt:numdotdecimal" decimals="0" unitRef="USD">31,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact003255" format="ixt:numdotdecimal" decimals="0" unitRef="USD">29,698,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3256">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_us-gaap_RetainedEarningsMember" id="Fact003257" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">16,531,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31" id="Fact003258" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,198,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8AF_zjOG8MKLoXzl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<ix:exclude><!-- Field: Page; Sequence: 118; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_003"></span>Report
of Independent Registered Public Accounting Firm</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the Shareholder and the Board of Directors of</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SemiCab,
Inc.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Opinion
on the Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have audited the accompanying consolidated balance sheet of SemiCab, Inc. (the &#8220;Company&#8221;) as of December 31, 2023 and 2022,
and the related consolidated statements of operations and comprehensive loss, stockholders&#8217; equity and cash flows for the years
then ended, and the related notes (collectively referred to as the &#8220;financial statements&#8221;). In our opinion, the financial
statements present fairly, in all material respects, the financial position of the Company as of December 31, 2023 and 2022, and the
results of its operations and its cash flows for the years then ended in conformity with accounting principles generally accepted in
the United States of America.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GOING
CONCERN</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying financial statements have been prepared assuming that the Company will continue as a going concern. The Company has suffered
substantial net losses and negative cash flows from operations in recent years and is dependent on debt and equity financing to fund
its operations, all of which raise substantial doubt about the Company&#8217;s ability to continue as a going concern. Management&#8217;s
plans regarding these matters have also been reviewed and considered. The consolidated financial statements do not include any adjustments
that might result from the outcome of this uncertainty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>BASIS
FOR OPINION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on these financial
statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United
States) (&#8220;PCAOB&#8221;) and are required to be independent with respect to the Company in accordance with the U.S. federal securities
laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company
is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits,
we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion
on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or
fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding
the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant
estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides
a reasonable basis for our opinion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Critical
Audit Matters</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Critical
audit matters are matters arising from the current period audit of the financial statements that were communicated or required to be
communicated to the audit committee and that (1) relate to accounts or disclosures that are material to the financial statements and
(2) involved our especially challenging, subjective, or complex judgements. We determined that there are no critical audit matters.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/Bush
&amp; Associates CPA LLC</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have served as the Company&#8217;s auditor since 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Henderson,
Nevada</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
11, 2024</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 119; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p id="xdx_04C_c20230101__20231231_zrvfceZOHjc8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_119_hdei--LegalEntityAxis__custom--SemiCabIncMember_zGg4NCqpbXSb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SemiCab,
Inc. </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_001"></span>CONSOLIDATED
BALANCE SHEETS </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30A_111_zPmv06O0r6Pa" summary="xdx: Statement - Condensed Consolidated Balance Sheets" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_492_20231231_zrE5FecPErqb" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20221231_z8DHPHx0oLB6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--AssetsAbstract_iB_zKIBsk4SAO89" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-decoration: underline; text-align: center">Assets</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--AssetsCurrentAbstract_i01B_zK9yhLCH8r7h" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Current Assets</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--Cash_i02I_zb6S1TMj4vcj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; padding-left: 10pt">Cash</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2023-12-31_custom_SemiCabIncMember" id="Fact003268" format="ixt:numdotdecimal" decimals="0" unitRef="USD">72,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2022-12-31_custom_SemiCabIncMember" id="Fact003269" format="ixt:numdotdecimal" decimals="0" unitRef="USD">881,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--AccountsReceivableNet_i02I_zKQWliMrvw1h" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt">Accounts receivable</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableNet" contextRef="AsOf2023-12-31_custom_SemiCabIncMember" id="Fact003271" format="ixt:numdotdecimal" decimals="0" unitRef="USD">494,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableNet" contextRef="AsOf2022-12-31_custom_SemiCabIncMember" id="Fact003272" format="ixt:numdotdecimal" decimals="0" unitRef="USD">677,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--RefundDueFromCustomer_i02I_zCarpsXD6RFj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt">Refund due from customer</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:RefundDueFromCustomer" contextRef="AsOf2023-12-31_custom_SemiCabIncMember" id="Fact003274" format="ixt:numdotdecimal" decimals="0" unitRef="USD">143,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3275">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_i02I_zI047hNyjXYf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 10pt">Prepaid Expenses and other current assets</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2023-12-31_custom_SemiCabIncMember" id="Fact003277" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2022-12-31_custom_SemiCabIncMember" id="Fact003278" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--AssetsCurrent_i02TI_zJuxdfOibgel" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 20pt">Total Current Assets</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2023-12-31_custom_SemiCabIncMember" id="Fact003280" format="ixt:numdotdecimal" decimals="0" unitRef="USD">714,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2022-12-31_custom_SemiCabIncMember" id="Fact003281" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,566,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--PropertyPlantAndEquipmentNet_i01I_zHyFNFQjvHmi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Property and equipment, net</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2023-12-31_custom_SemiCabIncMember" id="Fact003283" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2022-12-31_custom_SemiCabIncMember" id="Fact003284" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--OtherAssetsNoncurrent_i01I_z0EeEEGUzOJ2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Other non-current assets</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:OtherAssetsNoncurrent" contextRef="AsOf2023-12-31_custom_SemiCabIncMember" id="Fact003286" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:OtherAssetsNoncurrent" contextRef="AsOf2022-12-31_custom_SemiCabIncMember" id="Fact003287" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--Assets_i01TI_z8ZMyA5JgxRb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt; padding-left: 20pt">Total Assets</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2023-12-31_custom_SemiCabIncMember" id="Fact003289" format="ixt:numdotdecimal" decimals="0" unitRef="USD">731,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2022-12-31_custom_SemiCabIncMember" id="Fact003290" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,584,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--LiabilitiesAndStockholdersEquityAbstract_iB_z2iSexEs1oO" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-decoration: underline; text-align: center">Liabilities and Shareholders&#8217; Equity</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--LiabilitiesCurrentAbstract_i01B_zbAZzCqRzV8b" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Current Liabilities</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--AccountsPayableCurrent_i02I_z1i9d2bKJjfj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt">Accounts payable</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2023-12-31_custom_SemiCabIncMember" id="Fact003298" format="ixt:numdotdecimal" decimals="0" unitRef="USD">668,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2022-12-31_custom_SemiCabIncMember" id="Fact003299" format="ixt:numdotdecimal" decimals="0" unitRef="USD">810,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--AccruedLiabilitiesCurrent_i02I_zsOCocUIMzxc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt">Accrued expenses</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2023-12-31_custom_SemiCabIncMember" id="Fact003301" format="ixt:numdotdecimal" decimals="0" unitRef="USD">149,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2022-12-31_custom_SemiCabIncMember" id="Fact003302" format="ixt:numdotdecimal" decimals="0" unitRef="USD">151,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--NotesPayableCurrent_i02I_zgOgEjgiKXa3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt">Notes payable</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:NotesPayableCurrent" contextRef="AsOf2023-12-31_custom_SemiCabIncMember" id="Fact003304" format="ixt:numdotdecimal" decimals="0" unitRef="USD">833,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:NotesPayableCurrent" contextRef="AsOf2022-12-31_custom_SemiCabIncMember" id="Fact003305" format="ixt:numdotdecimal" decimals="0" unitRef="USD">579,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--LoansPayableCurrent_i02I_z8yBfgcYEyh4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt">Loans from affiliates, current portion</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:LoansPayableCurrent" contextRef="AsOf2023-12-31_custom_SemiCabIncMember" id="Fact003307" format="ixt:numdotdecimal" decimals="0" unitRef="USD">315,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3308">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--ContractWithCustomerRefundLiabilityCurrent_i02I_zWHPZlDVxlE4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt">Due to factor</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ContractWithCustomerRefundLiabilityCurrent" contextRef="AsOf2023-12-31_custom_SemiCabIncMember" id="Fact003310" format="ixt:numdotdecimal" decimals="0" unitRef="USD">231,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3311">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--OtherLiabilitiesCurrent_i02I_zoxTabAfqCl8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 10pt">Other current liabilities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2023-12-31_custom_SemiCabIncMember" id="Fact003313" format="ixt:numdotdecimal" decimals="0" unitRef="USD">45,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2022-12-31_custom_SemiCabIncMember" id="Fact003314" format="ixt:numdotdecimal" decimals="0" unitRef="USD">108,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--LiabilitiesCurrent_i02TI_zNvoUx6cSBC3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 20pt">Total Current Liabilities</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2023-12-31_custom_SemiCabIncMember" id="Fact003316" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,241,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2022-12-31_custom_SemiCabIncMember" id="Fact003317" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,648,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--LongTermLoansPayable_i01I_zJGecqNnFaX7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Loans from affiliates, net of current portion</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:LongTermLoansPayable" contextRef="AsOf2023-12-31_custom_SemiCabIncMember" id="Fact003319" format="ixt:numdotdecimal" decimals="0" unitRef="USD">385,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:LongTermLoansPayable" contextRef="AsOf2022-12-31_custom_SemiCabIncMember" id="Fact003320" format="ixt:numdotdecimal" decimals="0" unitRef="USD">385,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--Liabilities_i01TI_z2iisP21K2f6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 20pt">Total Liabilities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2023-12-31_custom_SemiCabIncMember" id="Fact003322" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,626,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2022-12-31_custom_SemiCabIncMember" id="Fact003323" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,033,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--CommitmentsAndContingenciesAbstract_i01B_zaSounIA6tR7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Commitments and Contingencies</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--ProvisionForLegalLiability_i02I_zkIvvdnfpUfa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt">Provision for legal liability</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:ProvisionForLegalLiability" contextRef="AsOf2023-12-31_custom_SemiCabIncMember" id="Fact003328" format="ixt:numdotdecimal" decimals="0" unitRef="USD">275,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3329">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--CommitmentsAndContingencies_i02TI_zmnccElb5Bmc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 20pt">Total Commitments and Contingencies</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="AsOf2023-12-31_custom_SemiCabIncMember" id="Fact003331" format="ixt:numdotdecimal" decimals="0" unitRef="USD">275,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3332">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--StockholdersEquityAbstract_i01B_zIshhRihLkT7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Shareholders&#8217; Equity</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--PreferredStockValue_i02I_zdpWeDq6BjDe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt">Preferred equity</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2023-12-31_custom_SemiCabIncMember" id="Fact003337" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,969,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2022-12-31_custom_SemiCabIncMember" id="Fact003338" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,543,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--RetainedEarningsAccumulatedDeficit_i02I_zc4U46jdpzCl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 10pt">Accumulated deficit</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2023-12-31_custom_SemiCabIncMember" id="Fact003340" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">8,139,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2022-12-31_custom_SemiCabIncMember" id="Fact003341" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">5,992,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_408_eus-gaap--StockholdersEquity_i02TI_z52VlWxqUVJi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 20pt">Total Shareholders&#8217; Equity</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_custom_SemiCabIncMember" id="Fact003343" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,170,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_custom_SemiCabIncMember" id="Fact003344" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">449,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_407_eus-gaap--LiabilitiesAndStockholdersEquity_i01TI_zh8uMqYx0Yu" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt; padding-left: 20pt">Total Liabilities and Shareholders&#8217; Equity</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2023-12-31_custom_SemiCabIncMember" id="Fact003346" format="ixt:numdotdecimal" decimals="0" unitRef="USD">731,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2022-12-31_custom_SemiCabIncMember" id="Fact003347" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,584,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>See
notes to condensed consolidated statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 120; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SemiCab,
Inc. </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_002"></span>CONDENSED
CONSOLIDATED STATEMENTS OF OPERATIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30F_113_zJtpNz3FXg4b" summary="xdx: Statement - Condensed Consolidated Statements of Operations" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49A_20230101__20231231_zCEXlSlfj0Ih" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_494_20220101__20221231_zF3FdCZxDmBh" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Years Ended</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zg3FPhfgl7kk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; width: 60%; text-align: left">Net Revenue</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember" id="Fact003349" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,036,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-01-012022-12-31_custom_SemiCabIncMember" id="Fact003350" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,655,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--CostOfGoodsAndServicesSold_zq51xC47RFmi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">Cost of Revenue</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:CostOfGoodsAndServicesSold" contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember" id="Fact003352" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,853,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:CostOfGoodsAndServicesSold" contextRef="From2022-01-012022-12-31_custom_SemiCabIncMember" id="Fact003353" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,108,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--GrossProfit_iT_zCZYLWrSxx37" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Gross Profit (Loss)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember" id="Fact003355" format="ixt:numdotdecimal" decimals="0" unitRef="USD">183,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2022-01-012022-12-31_custom_SemiCabIncMember" id="Fact003356" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">453,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--OperatingExpensesAbstract_iB_zAjFbtufdk9d" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Operating Expenses</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--SellingExpense_i01_zrhAAMCV0484" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Selling general and administrative expenses</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:SellingExpense" contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember" id="Fact003361" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,333,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:SellingExpense" contextRef="From2022-01-012022-12-31_custom_SemiCabIncMember" id="Fact003362" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,511,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--ProductDevelopmentExpense_i01_zGDS6aa3SYBb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; padding-left: 10pt; text-align: left">Product development</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:ProductDevelopmentExpense" contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember" id="Fact003364" format="ixt:numdotdecimal" decimals="0" unitRef="USD">852,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:ProductDevelopmentExpense" contextRef="From2022-01-012022-12-31_custom_SemiCabIncMember" id="Fact003365" format="ixt:numdotdecimal" decimals="0" unitRef="USD">640,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--OperatingExpenses_i01T_zMpafX2Fbt5l" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">Total Operating Expenses</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember" id="Fact003367" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,185,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2022-01-012022-12-31_custom_SemiCabIncMember" id="Fact003368" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,151,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--OperatingIncomeLoss_iT_za4ce2RczYDl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Loss from Operations</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember" id="Fact003370" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,002,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2022-01-012022-12-31_custom_SemiCabIncMember" id="Fact003371" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,604,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--NonoperatingIncomeExpenseAbstract_iB_zUIlgAQLBRR3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Other Expenses</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--InterestExpenseDebtExcludingAmortization_i01N_di_zprLXpXrW1Aj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; padding-left: 10pt; text-align: left">Interest expense</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:InterestExpenseDebtExcludingAmortization" contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember" id="Fact003376" format="ixt:numdotdecimal" decimals="0" unitRef="USD">145,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:InterestExpenseDebtExcludingAmortization" contextRef="From2022-01-012022-12-31_custom_SemiCabIncMember" id="Fact003377" format="ixt:numdotdecimal" decimals="0" unitRef="USD">63,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_403_eus-gaap--NonoperatingIncomeExpense_i01T_zjtmmPcki4Mg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">Total Other Expenses</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember" id="Fact003379" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">145,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2022-01-012022-12-31_custom_SemiCabIncMember" id="Fact003380" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">63,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iT_zc5Yt981FuBl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Loss Before Income Tax Benefit (Provision)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember" id="Fact003382" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,147,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2022-01-012022-12-31_custom_SemiCabIncMember" id="Fact003383" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,667,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--IncomeTaxExpenseBenefit_iN_di_zSUE7npCtSBh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">Income Tax Benefit (Provision)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3385">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3386">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--ProfitLoss_iT_zLvmfvvdseZ6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">Net Loss</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember" id="Fact003388" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,147,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-01-012022-12-31_custom_SemiCabIncMember" id="Fact003389" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,667,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>See
notes to condensed consolidated statements</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 121; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember" escape="true" id="Fact003391" name="us-gaap:NatureOfOperations"><p id="xdx_801_eus-gaap--NatureOfOperations_zFnSd0WXeqg9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span id="alp_014"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
1 - <span>BASIS OF PRESENTATION</span> </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;<span id="xdx_829_z3u6FIzulgK1">NATURE OF BUSINESS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>OVERVIEW</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
SemiCab, Inc., a Delaware corporation (the &#8220;Company,&#8221; &#8220;SemiCab&#8221;) is primarily engaged in the development, marketing,
and sale of logistics optimization services for enterprise-level dedicated freight and shipping customers in The United States and India.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Basis
of Presentation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States
of America (&#8220;GAAP&#8221;), which contemplate continuation of the Company as a going concern, and assumes continuity of operations,
realization of assets and the satisfaction of liabilities and commitments in the normal course of business. The Company has suffered
substantial net losses and negative cash flows from operations in recent years and is dependent on debt and equity financing to fund
its operations all of which raise substantial doubt about the Company&#8217;s ability to continue as a going concern. Recoverability
of a major portion of the recorded asset amounts shown in the accompanying balance sheet is dependent upon the Company&#8217;s ability
to increase its revenue and meet its financing requirements on a continuing basis and become profitable in its future operations. The
accompanying consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded
assets or the amounts and classification of liabilities that might be necessary should the Company be unable to continue in existence.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember" escape="true" id="Fact003393" name="us-gaap:SubstantialDoubtAboutGoingConcernTextBlock"><p id="xdx_80E_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zY1NS1InFa3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
2 &#8211; <span>GOING CONCERN</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_82D_zmLRHaxfVLM3" style="display: none">LIQUIDITY,
GOING CONCERN AND MANAGEMENT PLANS</span><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s financial statements as of December 31, 2023 and 2022 have been prepared using generally accepted accounting principles
in the United States of America applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities
in the normal course of business. The Company has not yet established an ongoing source of revenue sufficient to cover its operating
costs and allow it to continue as a going concern. The Company has accumulated losses from 2022 to 2023 of $<span id="xdx_90E_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_c20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zzCd79lKYFP4" title="Accumulated losses"><ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2023-12-31_us-gaap_RetainedEarningsMember_custom_SemiCabIncMember" id="Fact003395" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,814,000</ix:nonFraction></span>. These factors
among others raise substantial doubt about the ability of the company to continue as a going concern for a reasonable period of time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to continue as a going concern, the Company will need, among other things, additional capital resources. Management&#8217;s plan
is to obtain such resources for the Company by obtaining capital from management and significant shareholders sufficient to meet its
minimal operating expenses and seeking third party equity and/or debt financing. However, management cannot provide any assurances that
the Company will be successful in accomplishing any of its plans. These financial statements do not include any adjustments related to
the recoverability and classification of assets or the amounts and classification of liabilities that might be necessary should the Company
be unable to continue as a going concern.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember" escape="true" id="Fact003397" name="us-gaap:SignificantAccountingPoliciesTextBlock"><p id="xdx_805_eus-gaap--SignificantAccountingPoliciesTextBlock_zz3tgt0GCdw9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
3 - <span id="xdx_829_z65a3VHgP1y3">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember" escape="true" id="Fact003399" name="us-gaap:ConsolidationPolicyTextBlock"><p id="xdx_84A_eus-gaap--ConsolidationPolicyTextBlock_zt14LqVxqMS1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_z460VSZ58tEi">PRINCIPLES
OF CONSOLIDATION</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements include certain intercompany expenses associated with its wholly owned India subsidiary,
SMCB Solutions Private Limited, the accounts of the Company. All inter-company accounts and transactions have been eliminated in consolidation
for all periods presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember" escape="true" id="Fact003401" name="us-gaap:UseOfEstimates"><p id="xdx_845_eus-gaap--UseOfEstimates_z7bKEnQYdoBc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_860_zbZQlUmRLS03">USE
OF ESTIMATES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SemiCab
makes estimates and assumptions in the ordinary course of business relating to sales collections and allowances, warranty reserves, and
reserves for promotional incentives that may affect the reported amounts of assets and liabilities and of contingent assets and liabilities
at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Future
events and their effects cannot be determined with absolute certainty; therefore, the determination of estimates requires the exercise
of judgment. Historically, past changes to these estimates have not had a material impact on the Company&#8217;s financial statements.
However, circumstances could change which may alter future expectations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<ix:exclude><!-- Field: Page; Sequence: 122; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember" escape="true" id="Fact003403" name="RIME:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountPolicy"><p id="xdx_848_ecustom--ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountPolicy_z1ejGJPCZPgi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_862_zmLkW7LMOPD3">ALLOWANCE
FOR DOUBTFUL ACCOUNTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SemiCab&#8217;s
allowance for doubtful accounts is based on management&#8217;s estimates of the creditworthiness of its customers, current economic conditions
and historical information, and, in the opinion of management, is believed to be in an amount sufficient to respond to normal business
conditions. Management sets 100% reserves for customers in bankruptcy and other allowances based upon historical collection experience.
The Company is subject to chargebacks from customers that are deducted from open invoices and reduce collectability of open invoices.
Should business conditions deteriorate or any major customer default on its obligations to the Company, this allowance may need to be
significantly increased, which would have a negative impact on operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember" escape="true" id="Fact003405" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"><p id="xdx_84D_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zLndMT9h1Rrb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_zIH83l1KnwYc">FOREIGN
CURRENCY TRANSLATION</span> </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for foreign currency transactions pursuant to ASC 830, Foreign Currency Matters (&#8220;ASC 830&#8221;). The functional
currency of the Company is the U.S. dollar, which is the currency of the primary economic environment in which it operates. In accordance
with ASC 830, monetary balances denominated in or linked to foreign currency are stated on the basis of the exchange rates prevailing
at the applicable balance sheet date. For foreign currency transactions included in the statement of operations, the exchange rates applicable
on the relevant transaction dates are used. Gains or losses arising from changes in the exchange rates used in the translation of such
transactions and from the remeasurement of the monetary balance sheet items are recorded as gain (loss) on foreign currency transactions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
functional currency of the India subsidiary is the Indian Rupee. Under ASC 830, all assets and liabilities are translated into U. S.
dollars using the current exchange rate at the end of each fiscal period. Revenues and expenses are translated using the average exchange
rates prevailing throughout the respective periods. All transaction gains and losses from the measurement of monetary balance sheet items
denominated in Indian Rupee are reflected in the statement of operations as appropriate. Translation adjustments are included in accumulated
other comprehensive loss.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember" escape="true" id="Fact003407" name="us-gaap:ConcentrationRiskCreditRisk"><p id="xdx_84F_eus-gaap--ConcentrationRiskCreditRisk_zuOr9O0PwYm5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b><span id="xdx_86E_zcJuM1Yy4mYi">Concentration
of Credit Risk</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
times, the Company maintains cash in United States bank accounts that are in excess of the Federal Deposit Insurance Corporation insured
amounts. The Company maintains cash balances in foreign financial institutions. The amounts at foreign financial institutions at December
31, 2023 and 2022 were approximately $<span id="xdx_90D_eus-gaap--ForeignFinancialInstitutionsActualDeposits_iI_c20231231_za9UvT4LO8nh" title="Foreign financial institutions actual deposits" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__"><ix:nonFraction name="us-gaap:ForeignFinancialInstitutionsActualDeposits" contextRef="AsOf2023-12-31_custom_SemiCabIncMember" id="Fact003409" format="ixt:numdotdecimal" decimals="0" unitRef="USD">58,000</ix:nonFraction></span> and $<span id="xdx_906_eus-gaap--ForeignFinancialInstitutionsActualDeposits_iI_c20221231_zwMgn0t9uMXb" title="Foreign financial institutions actual deposits" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__"><ix:nonFraction name="us-gaap:ForeignFinancialInstitutionsActualDeposits" contextRef="AsOf2022-12-31_custom_SemiCabIncMember" id="Fact003411" format="ixt:numdotdecimal" decimals="0" unitRef="USD">91,000</ix:nonFraction></span>, respectively. The Company regularly monitors the financial stability of this
financial institution and believes that it is not exposed to any significant credit risk in cash and cash equivalents. However, in March
and April 2023, certain U.S. government banking regulators took steps to intervene in the operations of certain financial institutions
due to liquidity concerns, which caused general heightened uncertainties in financial markets. While these events have not had a material
direct impact on the Company&#8217;s operations, if further liquidity and financial stability concerns arise with respect to banks and
financial institutions, either nationally or in specific regions, the Company&#8217;s ability to access cash or enter into new financing
arrangements may be threatened, which could have a material adverse effect on its business, financial condition and results of operations.
Financial instruments, which potentially subject the Company to concentrations of credit risk, consist of accounts receivable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember" escape="true" id="Fact003413" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"><p id="xdx_843_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zBaPdFhl2PSl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86C_zwUgYWEk8UX9">LONG-LIVED
ASSETS</span> </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable. The only meaningful long-lived assets are intangible in nature and under GAAP accounting, not capitalized nor assigned any
long-term accounting value. prior to the proposed transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember" escape="true" id="Fact003415" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock"><p id="xdx_84E_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zzUXSum9Vgah" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_zwN1Jzo3psEk">PROPERTY
AND EQUIPMENT</span> </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and Equipment are stated at cost. Depreciation is provided for in amounts sufficient to relate the cost of depreciable assets to operations
over the estimated service lives, principally using straight-line methods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
estimated useful lives used to compute depreciation and amortization for financial reporting purposes are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember" escape="true" id="Fact003417" name="us-gaap:ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock"><p id="xdx_897_eus-gaap--ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock_z2dJnq9UqxD5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zmYEfXhjCFr5" style="display: none">SCHEDULE
OF ESTIMATED USEFUL LIVES</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify">&#160;</td>
  <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Years</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 70%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
  and Equipment</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 30%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__srt--RangeAxis__srt--MinimumMember_zhbOAT3stvZh" title="Property plant and equipment useful life"><ix:nonNumeric contextRef="AsOf2023-12-31_srt_MinimumMember_custom_SemiCabIncMember" format="ixt-sec:duryear" id="Fact003419" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">3</ix:nonNumeric></span> - <span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__srt--RangeAxis__srt--MaximumMember_zqn6PxRDpa4c" title="Property plant and equipment useful life"><ix:nonNumeric contextRef="AsOf2023-12-31_srt_MaximumMember_custom_SemiCabIncMember" format="ixt-sec:duryear" id="Fact003421" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">5</ix:nonNumeric></span></span></td></tr>
</table>


</ix:nonNumeric><p id="xdx_8A6_zWlb9Wnx0g7h" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 123; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember" escape="true" id="Fact003423" name="RIME:PrepaidExpensesPolicyTextBlock"><p id="xdx_845_ecustom--PrepaidExpensesPolicyTextBlock_zkvjbZ0xjxoj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_867_zagvPAZT0yLk">PREPAID
EXPENSES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid
expenses consist primarily of prepaid services which will be expensed as the services are provided within twelve months. As of December
31, 2023 and 2022, the balances of the prepaids account were $<span id="xdx_90F_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iI_c20231231_z7bl03q6wx8h" title="Prepaid expense" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2023-12-31_custom_SemiCabIncMember" id="Fact003425" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,000</ix:nonFraction></span> and $<span id="xdx_90F_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iI_c20221231_znLDu8J88Lbf" title="Prepaid expense" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2022-12-31_custom_SemiCabIncMember" id="Fact003427" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,000</ix:nonFraction></span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember" escape="true" id="Fact003429" name="us-gaap:FairValueOfFinancialInstrumentsPolicy"><p id="xdx_849_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zHRLmSf1tBl5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_869_zz0MwxDff286">FAIR
VALUE OF FINANCIAL INSTRUMENTS</span> </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
carrying values of financial instruments comprising cash and cash equivalents, payables, and notes payable-related party approximate
fair values due to the short-term maturities of these instruments. The notes payable- related party is considered a level 3 measurement.
As defined in ASC 820, <i>Fair Value Measurements and Disclosures</i>, fair value is the price that would be received to sell an asset
or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). The Company
utilizes market data or assumptions that market participants would use in pricing the asset or liability, including assumptions about
risk and the risks inherent in the inputs to the valuation technique. These inputs can be readily observable, market corroborated, or
generally unobservable. ASC 820 establishes a fair value hierarchy that prioritizes the inputs used to measure fair value. The hierarchy
gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and
the lowest priority to unobservable inputs (Level 3 measurement). This fair value measurement framework applies to both initial and subsequent
measurement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    1:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 92%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quoted
    prices are available in active markets for identical assets or liabilities as of the reporting date.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    2:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pricing
    inputs are other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as
    of the reported date. Level 2 includes those financial instruments that are valued using models or other valuation methodologies.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    3:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pricing
inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally
developed methodologies that result in management&#8217;s best estimate of fair value. The significant unobservable inputs used in the
fair value measurement for nonrecurring fair value measurements of long-lived assets include pricing models, discounted cash flow methodologies
and similar techniques.</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
carrying amounts of the Company&#8217;s short-term financial instruments, including accounts receivable, accounts payable, accrued expenses,
customer deposits, refunds due to customers, and due to related parties approximates fair value due to the relatively short period to
maturity for these instruments. The carrying amounts on the notes payable, finance leases and installment notes approximate fair value
either due to the relatively short period to maturity or the related interest is accrued at a rate similar to market rates. The carrying
amounts on the revolving line of credit approximates fair value due the relatively short period to maturity and related interest accrued
at market rates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember" escape="true" id="Fact003431" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock"><p id="xdx_841_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_z6gJVLCEEyt9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span>REVENUE
RECOGNITION</span> </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_869_ziYHCZqBAts2" style="display: none">REVENUE
RECOGNITION AND RESERVE FOR SALES RETURNS</span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes revenue in accordance with FASB ASC 606, &#8220;Revenue from Contracts with Customers&#8221;. All revenue is generated
from contracts with customers. The Company recognizes revenue when the control of the goods sold is transferred to the customer, in an
amount, referred to as the transaction price, that reflects the consideration to which the Company is expected to be entitled in exchange
for those goods. The Company determines revenue recognition utilizing the following five steps: (1) identification of the contract with
a customer, (2) identification of the performance obligations in the contract (promised goods or services that are distinct), (3) determination
of the transaction price, (4) allocation of the transaction price to the performance obligations, and (5) recognition of revenue when,
or as, the Company transfers control of the product or service for each performance obligation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s contracts with customers consist of one performance obligation (the sale of the Company&#8217;s products). The Company&#8217;s
contracts have no financing elements, payment terms are less than 120 days and have no further contract asset or liability obligations
once control of goods is transferred to the customer. Revenue is recorded in the amount of consideration the Company expects to receive
for the sale of these goods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 124; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Costs
incurred in fulfilling contracts with customers include administrative costs associated with the procurement of goods are included in
general and administrative expenses, in-bound freight costs are included in the cost of goods sold and accrued sales representative commissions
are included in selling expenses in the accompanying consolidated statements of operations as our underlying customer agreements are
less than one year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember" escape="true" id="Fact003433" name="RIME:ShippingAndHandlingCostsPolicyTextBlock"><p id="xdx_84D_ecustom--ShippingAndHandlingCostsPolicyTextBlock_zUMy4fBOf0a2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_862_zJNalzNaVDh9">SHIPPING
AND HANDLING COSTS</span> </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shipping
and handling activities are performed before the customer obtains control of the goods delivered for them and are considered activities
to fulfill the Company&#8217;s promise to transfer the goods. For Fiscal 2023 and 2022 shipping and handling expenses provided by third
party shippers were approximately $<span id="xdx_90F_ecustom--ShippingAndHandlingExpenses_c20230101__20231231_zlhIbVOmmoij" title="Shipping and handling expenses" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__"><ix:nonFraction name="RIME:ShippingAndHandlingExpenses" contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember" id="Fact003435" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,692,000</ix:nonFraction></span> and $<span id="xdx_908_ecustom--ShippingAndHandlingExpenses_c20220101__20221231_zYqwgyDuxhu8" title="Shipping and handling expenses" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__"><ix:nonFraction name="RIME:ShippingAndHandlingExpenses" contextRef="From2022-01-012022-12-31_custom_SemiCabIncMember" id="Fact003437" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,057,000</ix:nonFraction></span>, respectively. These expenses are classified as a component of selling
expenses in the accompanying consolidated statements of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember" escape="true" id="Fact003439" name="us-gaap:CompensationRelatedCostsPolicyTextBlock"><p id="xdx_849_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zi5KOh9YHNHf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86B_z18aPM8fpv76">STOCK-BASED
COMPENSATION</span> </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for share based compensation in accordance with the provisions of ASC 718-10, &#8220;Compensation &#8212; Stock Compensation,&#8221;
which requires measurement of compensation cost for all stock awards at fair value on date of grant and recognition of compensation over
the service period for awards expected to vest. The majority of its share-based compensation arrangements vest over a three year vesting
schedule. The Company expenses its share-based compensation under the ratable method, which treats each vesting tranche as if it were
an individual grant. The fair value of stock options is determined using the Black-Scholes valuation model and requires the input of
certain assumptions. These assumptions include estimating the length of time employees will retain their vested stock options before
exercising them (the &#8220;expected option term&#8221;), the estimated volatility of its common stock price over the option&#8217;s
expected term, the risk-free interest rate over the option&#8217;s expected term, and the Company&#8217;s expected annual dividend yield.
Changes in these subjective assumptions can materially affect the estimate of fair value of stock-based compensation and consequently,
the related amount recognized as an expense in the consolidated statements of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
required under the accounting rules, the Company reviews its valuation assumptions at each grant date and, as a result, the Company is
likely to change its valuation assumptions used to value employee stock-based awards granted in future periods. The values derived from
using the Black-Scholes model are recognized as expense over the service period, net of estimated forfeitures (the number of individuals
that will ultimately not complete their vesting requirements). The estimation of stock awards that will ultimately vest requires significant
judgment. The Company considers many factors when estimating expected forfeitures, including types of awards, employee class, and historical
experience. Actual results, and future changes in estimates, may differ substantially from current estimates. Options and warrants to
outsiders are accounted for under ASC 718.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember" escape="true" id="Fact003441" name="us-gaap:ResearchAndDevelopmentExpensePolicy"><p id="xdx_848_eus-gaap--ResearchAndDevelopmentExpensePolicy_zbNgN3QOxfw7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_z0hSPZtChHU4">RESEARCH
AND DEVELOPMENT COSTS</span> </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
research and development costs are charged to results of operations as incurred. These expenses are shown as a component of general and
administrative expenses in the consolidated statements of operations. For the years ended December 31, 2023 and 2022, these amounts totaled
approximately $<span id="xdx_907_eus-gaap--ResearchAndDevelopmentExpense_c20230101__20231231_z00keplmHzVi" title="Research and development costs" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember" id="Fact003443" format="ixt:numdotdecimal" decimals="0" unitRef="USD">842,000</ix:nonFraction></span> and $<span id="xdx_904_eus-gaap--ResearchAndDevelopmentExpense_c20220101__20221231_zP8VEPPMhMm1" title="Research and development costs" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2022-01-012022-12-31_custom_SemiCabIncMember" id="Fact003445" format="ixt:numdotdecimal" decimals="0" unitRef="USD">640,000</ix:nonFraction></span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember" escape="true" id="Fact003447" name="us-gaap:IncomeTaxPolicyTextBlock"><p id="xdx_849_eus-gaap--IncomeTaxPolicyTextBlock_zTed47CBFWAh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_869_zOUw1hxTBww3">INCOME
TAXES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company follows the provisions of FASB ASC 740 &#8220;Accounting for Income Taxes.&#8221; Under the asset and liability method of ASC
740, deferred tax assets and liabilities are recognized for the future tax consequences attributed to differences between the financial
statement carrying amounts of existing assets and liabilities and their respective tax base. Deferred tax assets and liabilities are
measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to
be recovered or settled. Under ASC 740, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income
in the period that includes the enactment date. If it is more likely than not that some portion of a deferred tax asset will not be realized,
a valuation allowance is recognized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 125; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes a liability for uncertain tax positions. An uncertain tax position is defined as a position in a previously filed
tax return or a position expected to be taken in a future tax return that is not based on clear and unambiguous tax law and which is
reflected in measuring current or deferred income tax assets and liabilities for interim or annual periods. The Company may recognize
the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination
by the taxing authorities, based on the technical merits of the position. The Company measures the tax benefits recognized based on the
largest benefit that has a greater than 50% likelihood of being realized upon ultimate resolution.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of March 31, 2023 and 2022 there were no uncertain tax positions that resulted in any adjustment to the Company&#8217;s provision for
income taxes. The Company recognizes interest and penalties related to unrecognized tax benefits in its provision for income taxes. The
Company currently has no liabilities recorded for accrued interest or penalties related to uncertain tax provisions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember" escape="true" id="Fact003449" name="us-gaap:EarningsPerSharePolicyTextBlock"><p id="xdx_84A_eus-gaap--EarningsPerSharePolicyTextBlock_zAb0q9XUEOti" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_863_zz3yTyIaMu27">COMPUTATION
OF EARNINGS (LOSS) PER SHARE</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable. This is not required.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember" escape="true" id="Fact003451" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock"><p id="xdx_84B_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zSuculTGSwrj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_zSh71TqczAL7">RECENT
ACCOUNTING PRONOUNCEMENTS</span>:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">In
June 2016, the FASB issued ASU 2016-13, &#8220;Financial Instruments&#8212;Credit Losses&#8221; <i>(Topic 326)</i>. This ASU represents
a significant change in the current accounting model by requiring immediate recognition of management&#8217;s estimates of current expected
credit losses. Under the prior model, losses were recognized only as they were incurred, which delayed recognition of expected losses
that might not yet have met the threshold of being probable. </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
amendments in ASU 2016-03 for smaller reporting companies are effective for the Company beginning April 1, 2023, including interim periods
within that fiscal year. The Company adopted ASU 2016-13 on May 1, 2024. The adoption of ASU 2016-13 did not result in any material effects
to the consolidated financial statements or related disclosures.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric></ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember" escape="true" id="Fact003453" name="us-gaap:AccountsAndNontradeReceivableTextBlock"><p id="xdx_80F_eus-gaap--AccountsAndNontradeReceivableTextBlock_zVpryh8ylkhh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
4 &#8211; <span id="xdx_822_zeyZTwlK6GR9">ACCOUNTS RECEIVABLE</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
receivable are carried at original amount less an estimate made for doubtful receivables based on a review of all outstanding amounts
on a monthly basis. Management determines the allowance for doubtful receivables by regularly evaluating individual customer receivables
and considering a customer&#8217;s financial condition, credit history, and current economic conditions. Accounts receivable are written
off when deemed uncollectible. Accounts receivable at December 31, 2023 and 2022 consisted of the following: $<span id="xdx_906_eus-gaap--AccountsReceivableNet_iI_c20231231_zlNbTT3bb76h" title="Accounts receivable, net"><ix:nonFraction name="us-gaap:AccountsReceivableNet" contextRef="AsOf2023-12-31_custom_SemiCabIncMember" id="Fact003455" format="ixt:numdotdecimal" decimals="0" unitRef="USD">494,000</ix:nonFraction></span> and $<span id="xdx_908_eus-gaap--AccountsReceivableNet_iI_c20221231_zU2dKl4oUvqh" title="Accounts receivable, net"><ix:nonFraction name="us-gaap:AccountsReceivableNet" contextRef="AsOf2022-12-31_custom_SemiCabIncMember" id="Fact003457" format="ixt:numdotdecimal" decimals="0" unitRef="USD">677,000</ix:nonFraction></span>, all
due from large, US-based manufacturers for shipping services provided by the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bad
debt expenses (if any) are recorded in selling, general, and administrative expense.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
allowance for doubtful accounts for the years ended December 31, 2023 and 2022 is as follows: This has historically been set at $<span id="xdx_901_eus-gaap--ProvisionForDoubtfulAccounts_c20230101__20231231_zfOdHeazxahe" title="Allowance for doubtful accounts"><span id="xdx_901_eus-gaap--ProvisionForDoubtfulAccounts_c20220101__20221231_zhDsyhw7b8th" title="Allowance for doubtful accounts"><ix:nonFraction name="us-gaap:ProvisionForDoubtfulAccounts" contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember" id="Fact003459" format="ixt:numdotdecimal" decimals="0" unitRef="USD"><ix:nonFraction name="us-gaap:ProvisionForDoubtfulAccounts" contextRef="From2022-01-012022-12-31_custom_SemiCabIncMember" id="Fact003461" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></ix:nonFraction></span></span>, as
the Company has not previously recorded any losses due to bad debt.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember" escape="true" id="Fact003463" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock"><p id="xdx_80B_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_z8UFEgXSL1xf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
5 - <span id="xdx_829_zP6e4Hs3BiIl">PROPERTY AND EQUIPMENT </span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equipment
and leasehold improvements consisted of the following as of December 31: Miscellaneous office equipment, including desktop computers,
laptop computers, and printers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
was $<span id="xdx_905_eus-gaap--Depreciation_c20230101__20231231_zAhYcoIwJFqh" title="Depreciation"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember" id="Fact003465" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,000</ix:nonFraction></span> and $<span id="xdx_90A_eus-gaap--Depreciation_c20220101__20221231_z4Rd6P30Jwp7" title="Depreciation"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2022-01-012022-12-31_custom_SemiCabIncMember" id="Fact003467" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,000</ix:nonFraction></span> for 2023 and 2022, respectively. Amounts are recorded in selling, general, and administrative expenses as well
as in cost of services.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember" escape="true" id="Fact003469" name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"><p id="xdx_80F_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_z2UNyz13Ru0f" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
6 &#8211; <span id="xdx_823_zcUwkXLrXqm2">ACCOUNTS PAYABLE AND ACCRUED EXPENSES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
payable and accrued liabilities consisted of the following as of December 31: $<span id="xdx_908_eus-gaap--AccountsPayableCurrent_iI_c20231231_zGXzS11qlwt3" title="Vendors expenses payable"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2023-12-31_custom_SemiCabIncMember" id="Fact003471" format="ixt:numdotdecimal" decimals="0" unitRef="USD">668,000</ix:nonFraction></span> in vendors expenses payable, primarily for shipping
services, and $<span id="xdx_900_eus-gaap--AccruedLiabilitiesCurrent_iI_c20231231_zdzT7CfE9he8" title="Accrued expenses"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2023-12-31_custom_SemiCabIncMember" id="Fact003473" format="ixt:numdotdecimal" decimals="0" unitRef="USD">149,000</ix:nonFraction></span> in accrued expenses, primarily for accrued payroll and interest expenses payable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 126; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember" escape="true" id="Fact003475" name="RIME:NotePayableAndFinancingArrangementsTextBlock"><p id="xdx_80A_ecustom--NotePayableAndFinancingArrangementsTextBlock_zN22Pp3Pw6p5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
7 &#8211; <span id="xdx_82A_z0pezUGdYowb">NOTES PAYABLE AND FINANING ARRANGEMENTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Efficient
Capital Labs Installment Note &amp; Settlement</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 18, 2023 the Company entered into a financing arrangement with Efficient Capital Labs, Inc. (&#8220;ECL&#8221;) to finance working
capital and product development. The loan had a <span id="xdx_901_eus-gaap--DebtInstrumentMaturityDateDescription_c20230518__20230518__dei--LegalEntityAxis__custom--EfficientCapitalLabsIncMember_ztGUt31qVFR1" title="Maturity date, description"><ix:nonNumeric contextRef="From2023-05-182023-05-18_custom_SemiCabIncMember" id="Fact003477" name="us-gaap:DebtInstrumentMaturityDateDescription">12-month maturity date</ix:nonNumeric></span>. Repayments were originally scheduled to begin in June 2023, in
equal installments of $<span id="xdx_90A_eus-gaap--RepaymentsOfDebt_pp2d_c20230518__20230518__dei--LegalEntityAxis__custom--EfficientCapitalLabsIncMember__us-gaap--DebtInstrumentAxis__custom--EqualInstallmentsForThirteenMonthsMember_zD2EaSEjCYT9" title="Repayment, debt"><ix:nonFraction name="us-gaap:RepaymentsOfDebt" contextRef="From2023-05-182023-05-18_custom_SemiCabIncMember_custom_EqualInstallmentsForThirteenMonthsMember" id="Fact003479" format="ixt:numdotdecimal" decimals="2" unitRef="USD">91,667.67</ix:nonFraction></span> for 13 months, with an interest rate of <span id="xdx_906_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20230518__dei--LegalEntityAxis__custom--EfficientCapitalLabsIncMember__us-gaap--DebtInstrumentAxis__custom--EqualInstallmentsForThirteenMonthsMember_zQ9V9sZX9UMc" title="Interest rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2023-05-18_custom_SemiCabIncMember_custom_EqualInstallmentsForThirteenMonthsMember" id="Fact003481" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">17.97</ix:nonFraction></span>%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 18, 2024, the Company entered into a Settlement Agreement (&#8220;Settlement&#8221;) with ECL. In the Settlement, the Company agreed
to repay a total of $<span id="xdx_905_eus-gaap--RepaymentsOfDebt_pp2d_c20240518__20240518__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember__us-gaap--DebtInstrumentAxis__custom--TwelveInstallmentsMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zKLZ4acK3Bl7" title="Repayment, debt"><ix:nonFraction name="us-gaap:RepaymentsOfDebt" contextRef="From2024-05-182024-05-18_custom_SettlementAgreementMember_custom_TwelveInstallmentsMember_us-gaap_SubsequentEventMember_custom_SemiCabIncMember" id="Fact003483" format="ixt:numdotdecimal" decimals="2" unitRef="USD">946,666.60</ix:nonFraction></span> in 12 installments. The first payment in the amount of $<span id="xdx_909_eus-gaap--RepaymentsOfDebt_c20240518__20240518__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember__us-gaap--DebtInstrumentAxis__custom--FirstPaymentMember__us-gaap--AwardDateAxis__custom--DueAndPaidOnMayTwentyTwoThousandTwentyFourMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_za7rIbSzBCD3" title="Repayment, debt"><ix:nonFraction name="us-gaap:RepaymentsOfDebt" contextRef="From2024-05-182024-05-18_custom_SettlementAgreementMember_custom_FirstPaymentMember_custom_DueAndPaidOnMayTwentyTwoThousandTwentyFourMember_us-gaap_SubsequentEventMember_custom_SemiCabIncMember" id="Fact003485" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,000</ix:nonFraction></span> was due and paid on May 20, 2024. A second
payment in the amount of $<span id="xdx_902_eus-gaap--RepaymentsOfDebt_c20240518__20240518__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember__us-gaap--DebtInstrumentAxis__custom--SecondPaymentMember__us-gaap--AwardDateAxis__custom--DueOnJuneThreeTwoThousandTwentyFourMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zZSHUAGoYguf" title="Repayment, debt"><ix:nonFraction name="us-gaap:RepaymentsOfDebt" contextRef="From2024-05-182024-05-18_custom_SettlementAgreementMember_custom_SecondPaymentMember_custom_DueOnJuneThreeTwoThousandTwentyFourMember_us-gaap_SubsequentEventMember_custom_SemiCabIncMember" id="Fact003487" format="ixt:numdotdecimal" decimals="0" unitRef="USD">75,000</ix:nonFraction></span> is due on June 3, 2024. Thereafter, ten monthly payments are due on the first day of each month starting
on July 1, 2024 in the amount of $<span id="xdx_90C_eus-gaap--RepaymentsOfDebt_pp2d_c20240518__20240518__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember__us-gaap--DebtInstrumentAxis__custom--TenMonthlyPaymentsMember__us-gaap--AwardDateAxis__custom--DueOnJulyOneTwoThousandTwentyFourMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zSnWPftc6NPh" title="Repayment, debt"><ix:nonFraction name="us-gaap:RepaymentsOfDebt" contextRef="From2024-05-182024-05-18_custom_SettlementAgreementMember_custom_TenMonthlyPaymentsMember_custom_DueOnJulyOneTwoThousandTwentyFourMember_us-gaap_SubsequentEventMember_custom_SemiCabIncMember" id="Fact003489" format="ixt:numdotdecimal" decimals="2" unitRef="USD">84,666.66</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shareholder
Notes </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember" escape="true" id="Fact003491" name="us-gaap:ScheduleOfDebtTableTextBlock"><p id="xdx_890_eus-gaap--ScheduleOfDebtTableTextBlock_zjVs3uuodTWd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beginning
in July of 2021, and ending in May of 2023, the Company entered into a total of six shareholder loan agreements with a total of three
shareholders. These notes are all unsecured with limited rights of recourse. The specific terms of each note are summarized on the table
below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span id="xdx_8B6_zpz2rEc3RS87" style="display: none">SCHEDULE OF SPECIFIC TERMS</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif">Date</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Maturity</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Holder</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Principal</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Rate</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Accrued Interest</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Current Balance</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 12%"><span id="xdx_909_eus-gaap--DebtInstrumentIssuanceDate1_c20210710__20210710__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zMxeSg9oDMpc" title="Date"><ix:nonNumeric contextRef="From2021-07-102021-07-10_custom_SixShareholderLoanAgreementsMember_custom_AjeshKapoorMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003493" name="us-gaap:DebtInstrumentIssuanceDate1">7/10/2021</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: center"><span id="xdx_90D_eus-gaap--DebtInstrumentMaturityDate_c20210710__20210710__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zF3FgAPQLLs" title="Maturity"><ix:nonNumeric contextRef="From2021-07-102021-07-10_custom_SixShareholderLoanAgreementsMember_custom_AjeshKapoorMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003495" name="us-gaap:DebtInstrumentMaturityDate">7/10/2026</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: center">Ajesh Kapoor</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pp2d_c20210710__20210710__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zZUUQwVGwcHh" title="Principal" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><ix:nonFraction name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" contextRef="From2021-07-102021-07-10_custom_SixShareholderLoanAgreementsMember_custom_AjeshKapoorMember_custom_SemiCabIncMember" id="Fact003497" format="ixt:numdotdecimal" decimals="2" unitRef="USD">150,000.00</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span id="xdx_908_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20210710__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zvdo8UoOZZx9" title="Rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2021-07-10_custom_SixShareholderLoanAgreementsMember_custom_AjeshKapoorMember_custom_SemiCabIncMember" id="Fact003499" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">9.0</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--DebtInstrumentPeriodicPaymentInterest_pp2d_c20210710__20210710__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zbXg08gQ3suc" title="Accrued Interest" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><ix:nonFraction name="us-gaap:DebtInstrumentPeriodicPaymentInterest" contextRef="From2021-07-102021-07-10_custom_SixShareholderLoanAgreementsMember_custom_AjeshKapoorMember_custom_SemiCabIncMember" id="Fact003501" format="ixt:numdotdecimal" decimals="2" unitRef="USD">36,838.36</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--DebtInstrumentPeriodicPayment_pp2d_c20210710__20210710__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zsCuIFPy3W18" title="Current Balance" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><ix:nonFraction name="us-gaap:DebtInstrumentPeriodicPayment" contextRef="From2021-07-102021-07-10_custom_SixShareholderLoanAgreementsMember_custom_AjeshKapoorMember_custom_SemiCabIncMember" id="Fact003503" format="ixt:numdotdecimal" decimals="2" unitRef="USD">186,838.36</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90E_eus-gaap--DebtInstrumentIssuanceDate1_c20210827__20210827__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_z3zQ7dE44r28" title="Date"><ix:nonNumeric contextRef="From2021-08-272021-08-27_custom_SixShareholderLoanAgreementsMember_custom_AjeshKapoorMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003505" name="us-gaap:DebtInstrumentIssuanceDate1">8/27/2021</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90B_eus-gaap--DebtInstrumentMaturityDate_c20210827__20210827__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_z82UfKP6YOJ5" title="Maturity"><ix:nonNumeric contextRef="From2021-08-272021-08-27_custom_SixShareholderLoanAgreementsMember_custom_AjeshKapoorMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003507" name="us-gaap:DebtInstrumentMaturityDate">8/26/2026</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">Ajesh Kapoor</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98C_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pp2d_c20210827__20210827__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zc0bFz2i6mR2" title="Principal" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" contextRef="From2021-08-272021-08-27_custom_SixShareholderLoanAgreementsMember_custom_AjeshKapoorMember_custom_SemiCabIncMember" id="Fact003509" format="ixt:numdotdecimal" decimals="2" unitRef="USD">235,000.00</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20210827__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zSkUfAtXdMv4" title="Rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2021-08-27_custom_SixShareholderLoanAgreementsMember_custom_AjeshKapoorMember_custom_SemiCabIncMember" id="Fact003511" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">9.0</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_986_eus-gaap--DebtInstrumentPeriodicPaymentInterest_pp2d_c20210827__20210827__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zyMUpXy8YYF9" title="Accrued Interest" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:DebtInstrumentPeriodicPaymentInterest" contextRef="From2021-08-272021-08-27_custom_SixShareholderLoanAgreementsMember_custom_AjeshKapoorMember_custom_SemiCabIncMember" id="Fact003513" format="ixt:numdotdecimal" decimals="2" unitRef="USD">54,932.05</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_984_eus-gaap--DebtInstrumentPeriodicPayment_pp2d_c20210827__20210827__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zZio3ImCnja9" title="Current Balance" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:DebtInstrumentPeriodicPayment" contextRef="From2021-08-272021-08-27_custom_SixShareholderLoanAgreementsMember_custom_AjeshKapoorMember_custom_SemiCabIncMember" id="Fact003515" format="ixt:numdotdecimal" decimals="2" unitRef="USD">289,932.05</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90B_eus-gaap--DebtInstrumentIssuanceDate1_c20230417__20230417__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--VivekSehgalMember_zuBVgiyGuJ15" title="Date"><ix:nonNumeric contextRef="From2023-04-172023-04-17_custom_SixShareholderLoanAgreementsMember_custom_VivekSehgalMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003517" name="us-gaap:DebtInstrumentIssuanceDate1">4/17/2023</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_c20230417__20230417__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--VivekSehgalMember_zL93Kx1OE147" title="Maturity"><ix:nonNumeric contextRef="From2023-04-172023-04-17_custom_SixShareholderLoanAgreementsMember_custom_VivekSehgalMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003519" name="us-gaap:DebtInstrumentMaturityDate">10/16/2023</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">Vivek Sehgal</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98C_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pp2d_c20230417__20230417__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--VivekSehgalMember_zDVy2qwrrGsl" title="Principal" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" contextRef="From2023-04-172023-04-17_custom_SixShareholderLoanAgreementsMember_custom_VivekSehgalMember_custom_SemiCabIncMember" id="Fact003521" format="ixt:numdotdecimal" decimals="2" unitRef="USD">50,000.00</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20230417__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--VivekSehgalMember_zTOgp5Ja2CT5" title="Rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2023-04-17_custom_SixShareholderLoanAgreementsMember_custom_VivekSehgalMember_custom_SemiCabIncMember" id="Fact003523" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10.0</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_980_eus-gaap--DebtInstrumentPeriodicPaymentInterest_pp2d_c20230417__20230417__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--VivekSehgalMember_zJpj5JUzaJu9" title="Accrued Interest" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:DebtInstrumentPeriodicPaymentInterest" contextRef="From2023-04-172023-04-17_custom_SixShareholderLoanAgreementsMember_custom_VivekSehgalMember_custom_SemiCabIncMember" id="Fact003525" format="ixt:numdotdecimal" decimals="2" unitRef="USD">4,794.52</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_983_eus-gaap--DebtInstrumentPeriodicPayment_pp2d_c20230417__20230417__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--VivekSehgalMember_zh9u9wekat1l" title="Current Balance" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:DebtInstrumentPeriodicPayment" contextRef="From2023-04-172023-04-17_custom_SixShareholderLoanAgreementsMember_custom_VivekSehgalMember_custom_SemiCabIncMember" id="Fact003527" format="ixt:numdotdecimal" decimals="2" unitRef="USD">54,794.52</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_905_eus-gaap--DebtInstrumentIssuanceDate1_c20230505__20230505__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zMh3trEJXS61" title="Date"><ix:nonNumeric contextRef="From2023-05-052023-05-05_custom_SixShareholderLoanAgreementsMember_custom_AjeshKapoorMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003529" name="us-gaap:DebtInstrumentIssuanceDate1">5/5/2023</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_907_eus-gaap--DebtInstrumentMaturityDate_c20230505__20230505__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_z7GsuQ7ZTXE6" title="Maturity"><ix:nonNumeric contextRef="From2023-05-052023-05-05_custom_SixShareholderLoanAgreementsMember_custom_AjeshKapoorMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003531" name="us-gaap:DebtInstrumentMaturityDate">5/4/2024</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">Ajesh Kapoor</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_983_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pp2d_c20230505__20230505__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zHucpzqngjnf" title="Principal" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" contextRef="From2023-05-052023-05-05_custom_SixShareholderLoanAgreementsMember_custom_AjeshKapoorMember_custom_SemiCabIncMember" id="Fact003533" format="ixt:numdotdecimal" decimals="2" unitRef="USD">50,000.00</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20230505__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_z9J0SLMyNfyj" title="Rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2023-05-05_custom_SixShareholderLoanAgreementsMember_custom_AjeshKapoorMember_custom_SemiCabIncMember" id="Fact003535" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10.0</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_989_eus-gaap--DebtInstrumentPeriodicPaymentInterest_pp2d_c20230505__20230505__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zBd3J4sMd0gj" title="Accrued Interest" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:DebtInstrumentPeriodicPaymentInterest" contextRef="From2023-05-052023-05-05_custom_SixShareholderLoanAgreementsMember_custom_AjeshKapoorMember_custom_SemiCabIncMember" id="Fact003537" format="ixt:numdotdecimal" decimals="2" unitRef="USD">4,547.95</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_986_eus-gaap--DebtInstrumentPeriodicPayment_pp2d_c20230505__20230505__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zKRkUjy3cc0d" title="Current Balance" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:DebtInstrumentPeriodicPayment" contextRef="From2023-05-052023-05-05_custom_SixShareholderLoanAgreementsMember_custom_AjeshKapoorMember_custom_SemiCabIncMember" id="Fact003539" format="ixt:numdotdecimal" decimals="2" unitRef="USD">54,547.95</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90E_eus-gaap--DebtInstrumentIssuanceDate1_c20230508__20230508__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--JaganReddyMember_zLITNj5tRMZa" title="Date"><ix:nonNumeric contextRef="From2023-05-082023-05-08_custom_SixShareholderLoanAgreementsMember_custom_JaganReddyMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003541" name="us-gaap:DebtInstrumentIssuanceDate1">5/8/2023</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_902_eus-gaap--DebtInstrumentMaturityDate_c20230508__20230508__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--JaganReddyMember_zydI6JVpUaEg" title="Maturity"><ix:nonNumeric contextRef="From2023-05-082023-05-08_custom_SixShareholderLoanAgreementsMember_custom_JaganReddyMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003543" name="us-gaap:DebtInstrumentMaturityDate">5/7/2024</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">Jagan Reddy</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98E_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pp2d_c20230508__20230508__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--JaganReddyMember_z1dk5xlV6Vwg" title="Principal" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" contextRef="From2023-05-082023-05-08_custom_SixShareholderLoanAgreementsMember_custom_JaganReddyMember_custom_SemiCabIncMember" id="Fact003545" format="ixt:numdotdecimal" decimals="2" unitRef="USD">50,000.00</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_906_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20230508__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--JaganReddyMember_zz4lr1bk8xv9" title="Rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2023-05-08_custom_SixShareholderLoanAgreementsMember_custom_JaganReddyMember_custom_SemiCabIncMember" id="Fact003547" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10.0</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_982_eus-gaap--DebtInstrumentPeriodicPaymentInterest_pp2d_c20230508__20230508__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--JaganReddyMember_zf95chdqpBLk" title="Accrued Interest" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:DebtInstrumentPeriodicPaymentInterest" contextRef="From2023-05-082023-05-08_custom_SixShareholderLoanAgreementsMember_custom_JaganReddyMember_custom_SemiCabIncMember" id="Fact003549" format="ixt:numdotdecimal" decimals="2" unitRef="USD">4,506.85</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_985_eus-gaap--DebtInstrumentPeriodicPayment_pp2d_c20230508__20230508__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--JaganReddyMember_zSau5oqdc87g" title="Current Balance" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:DebtInstrumentPeriodicPayment" contextRef="From2023-05-082023-05-08_custom_SixShareholderLoanAgreementsMember_custom_JaganReddyMember_custom_SemiCabIncMember" id="Fact003551" format="ixt:numdotdecimal" decimals="2" unitRef="USD">54,506.85</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_906_eus-gaap--DebtInstrumentIssuanceDate1_c20230517__20230517__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zsEPMwAukQa6" title="Date"><ix:nonNumeric contextRef="From2023-05-172023-05-17_custom_SixShareholderLoanAgreementsMember_custom_AjeshKapoorMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003553" name="us-gaap:DebtInstrumentIssuanceDate1">5/17/2023</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_c20230517__20230517__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zeLWdCc3sYbj" title="Maturity"><ix:nonNumeric contextRef="From2023-05-172023-05-17_custom_SixShareholderLoanAgreementsMember_custom_AjeshKapoorMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003555" name="us-gaap:DebtInstrumentMaturityDate">5/16/2024</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">Ajesh Kapoor</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_980_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pp2d_c20230517__20230517__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zHrzrv6MhQhj" title="Principal" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" contextRef="From2023-05-172023-05-17_custom_SixShareholderLoanAgreementsMember_custom_AjeshKapoorMember_custom_SemiCabIncMember" id="Fact003557" format="ixt:numdotdecimal" decimals="2" unitRef="USD">165,000.00</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20230517__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zNKVAz1OIPvb" title="Rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2023-05-17_custom_SixShareholderLoanAgreementsMember_custom_AjeshKapoorMember_custom_SemiCabIncMember" id="Fact003559" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10.0</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_984_eus-gaap--DebtInstrumentPeriodicPaymentInterest_pp2d_c20230517__20230517__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_z286zhnhOtD3" title="Accrued Interest" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:DebtInstrumentPeriodicPaymentInterest" contextRef="From2023-05-172023-05-17_custom_SixShareholderLoanAgreementsMember_custom_AjeshKapoorMember_custom_SemiCabIncMember" id="Fact003561" format="ixt:numdotdecimal" decimals="2" unitRef="USD">14,465.75</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98E_eus-gaap--DebtInstrumentPeriodicPayment_pp2d_c20230517__20230517__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zxgJ2W2cOTQ6" title="Current Balance" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:DebtInstrumentPeriodicPayment" contextRef="From2023-05-172023-05-17_custom_SixShareholderLoanAgreementsMember_custom_AjeshKapoorMember_custom_SemiCabIncMember" id="Fact003563" format="ixt:numdotdecimal" decimals="2" unitRef="USD">179,465.75</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A5_zSrte5fz5LGf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>MCA-Agile
Capital Funding, LLC</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 22, 2024, the Company entered into a Merchant Cash Advance (&#8220;MCA Financing&#8221;) with Agile Capital Funding, LLC. The initial
amount borrowed was $<span id="xdx_90D_eus-gaap--ShortTermBorrowings_iI_c20240322__dei--LegalEntityAxis__custom--AgileCapitalFundingLLCMember_zPJrmtBqeIZd" title="Initial amount, borrowed"><ix:nonFraction name="us-gaap:ShortTermBorrowings" contextRef="AsOf2024-03-22_custom_SemiCabIncMember" id="Fact003565" format="ixt:numdotdecimal" decimals="0" unitRef="USD">315,000</ix:nonFraction></span>, with net proceeds to the Company in the amount of $<span id="xdx_90C_eus-gaap--ProceedsFromIssuanceOfDebt_c20240322__20240322__dei--LegalEntityAxis__custom--AgileCapitalFundingLLCMember_ztfDwHiB7NTa" title="Net proceeds"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfDebt" contextRef="From2024-03-222024-03-22_custom_SemiCabIncMember" id="Fact003567" format="ixt:numdotdecimal" decimals="0" unitRef="USD">300,000</ix:nonFraction></span>. Repayment terms stipulate weekly payments in
the amount of $<span id="xdx_906_eus-gaap--RepaymentsOfDebt_c20240322__20240322__us-gaap--DebtInstrumentAxis__custom--WeeklyPaymentsForWeeksMember__dei--LegalEntityAxis__custom--AgileCapitalFundingLLCMember_zkIqnUbeukB7" title="Repayment, debt"><ix:nonFraction name="us-gaap:RepaymentsOfDebt" contextRef="From2024-03-222024-03-22_custom_WeeklyPaymentsForWeeksMember_custom_SemiCabIncMember" id="Fact003569" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16,200</ix:nonFraction></span> for weeks, for a total of $<span id="xdx_90A_eus-gaap--RepaymentsOfDebt_c20240322__20240322__dei--LegalEntityAxis__custom--AgileCapitalFundingLLCMember_zWKYumNYiJ98" title="Repayment, debt"><ix:nonFraction name="us-gaap:RepaymentsOfDebt" contextRef="From2024-03-222024-03-22_custom_SemiCabIncMember" id="Fact003571" format="ixt:numdotdecimal" decimals="0" unitRef="USD">453,600</ix:nonFraction></span> repaid. The effective interest rate for the borrowings is <span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_uPure_c20240322__dei--LegalEntityAxis__custom--AgileCapitalFundingLLCMember_z3G1Hwg6XVU2" title="Effective, interest rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" contextRef="AsOf2024-03-22_custom_SemiCabIncMember" id="Fact003573" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">18</ix:nonFraction></span>%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>MCA-Huson
Cedar Advance, LLC</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 8, 2024, the Company entered into an MCA Financing with Cedar Advance, LLC. The initial amount borrowed was $<span id="xdx_90D_eus-gaap--ShortTermBorrowings_iI_c20240508__dei--LegalEntityAxis__custom--HusonCedarAdvanceLLCMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zmsFCSFX66nh" title="Initial amount, borrowed"><ix:nonFraction name="us-gaap:ShortTermBorrowings" contextRef="AsOf2024-05-08_custom_SemiCabIncMember_us-gaap_SubsequentEventMember" id="Fact003575" format="ixt:numdotdecimal" decimals="0" unitRef="USD">215,000</ix:nonFraction></span>, with net proceeds
to the Company in the amount of $<span id="xdx_903_eus-gaap--ProceedsFromIssuanceOfDebt_c20240508__20240508__dei--LegalEntityAxis__custom--AgileCapitalFundingLLCMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zWf6Gw7Kh7sk" title="Net proceeds"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfDebt" contextRef="From2024-05-082024-05-08_custom_SemiCabIncMember_us-gaap_SubsequentEventMember" id="Fact003577" format="ixt:numdotdecimal" decimals="0" unitRef="USD">204,250</ix:nonFraction></span>. Repayment terms stipulate weekly payments in the amount of $<span id="xdx_901_eus-gaap--RepaymentsOfDebt_c20240508__20240508__us-gaap--DebtInstrumentAxis__custom--WeeklyPaymentsMember__dei--LegalEntityAxis__custom--HusonCedarAdvanceLLCMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zvIZ99bgwdBc" title="Repayment, debt"><ix:nonFraction name="us-gaap:RepaymentsOfDebt" contextRef="From2024-05-082024-05-08_custom_WeeklyPaymentsMember_custom_SemiCabIncMember_us-gaap_SubsequentEventMember" id="Fact003579" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,133</ix:nonFraction></span> for 28 weeks, for a total
of $<span id="xdx_904_eus-gaap--RepaymentsOfDebt_c20240508__20240508__dei--LegalEntityAxis__custom--HusonCedarAdvanceLLCMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zyqCIgiTHWP1" title="Repayment, debt"><ix:nonFraction name="us-gaap:RepaymentsOfDebt" contextRef="From2024-05-082024-05-08_custom_SemiCabIncMember_us-gaap_SubsequentEventMember" id="Fact003581" format="ixt:numdotdecimal" decimals="0" unitRef="USD">311,750</ix:nonFraction></span> repaid. The effective interest rate for the borrowings is <span id="xdx_903_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_uPure_c20240508__dei--LegalEntityAxis__custom--AgileCapitalFundingLLCMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z12Z4Wp4lZii" title="Effective, interest rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" contextRef="AsOf2024-05-08_custom_SemiCabIncMember_us-gaap_SubsequentEventMember" id="Fact003583" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">18</ix:nonFraction></span>%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 127; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember" escape="true" id="Fact003585" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock"><p id="xdx_802_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_z1Sc4s1zMWhj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
8 - <span id="xdx_825_zuTW9foaJel9">COMMITMENTS AND CONTINGENCIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 28, 2020 the Company entered into a service contract and agreement with Blue Yonder, Inc. (&#8220;Blue Yonder&#8221;) for certain
IT subscription based services. The original term of the agreement was for three years, at a price of $<span id="xdx_900_eus-gaap--LossContingencyDamagesSoughtValue_c20200328__20200328__us-gaap--TypeOfArrangementAxis__custom--ServiceContractAndAgreementMember__dei--LegalEntityAxis__custom--BlueYonderIncMember__us-gaap--AwardTypeAxis__custom--PerYearMember_zxTJyLDdZEl2" title="Sought, value"><ix:nonFraction name="us-gaap:LossContingencyDamagesSoughtValue" contextRef="From2020-03-282020-03-28_custom_ServiceContractAndAgreementMember_custom_SemiCabIncMember_custom_PerYearMember" id="Fact003587" format="ixt:numdotdecimal" decimals="0" unitRef="USD">100,000</ix:nonFraction></span> per year, for a total
of $<span id="xdx_90B_eus-gaap--LossContingencyDamagesSoughtValue_c20200328__20200328__us-gaap--TypeOfArrangementAxis__custom--ServiceContractAndAgreementMember__dei--LegalEntityAxis__custom--BlueYonderIncMember_zfh0uA2XoVL7" title="Sought value, total"><ix:nonFraction name="us-gaap:LossContingencyDamagesSoughtValue" contextRef="From2020-03-282020-03-28_custom_ServiceContractAndAgreementMember_custom_SemiCabIncMember" id="Fact003589" format="ixt:numdotdecimal" decimals="0" unitRef="USD">300,000</ix:nonFraction></span>. On June 21, 2023, Blue Yonder filed a lawsuit claiming damages in the amount of $<span id="xdx_902_eus-gaap--LossContingencyDamagesSoughtValue_c20230621__20230621__us-gaap--TypeOfArrangementAxis__custom--ServiceContractAndAgreementMember__dei--LegalEntityAxis__custom--BlueYonderIncMember_z0wLk7FoqZv9" title="Damages claimed"><ix:nonFraction name="us-gaap:LossContingencyDamagesSoughtValue" contextRef="From2023-06-212023-06-21_custom_ServiceContractAndAgreementMember_custom_SemiCabIncMember" id="Fact003591" format="ixt:numdotdecimal" decimals="0" unitRef="USD">275,000</ix:nonFraction></span> with the Maricopa County Superior
Court in Arizona (&#8220;Lawsuit&#8221;). The suit was found in favor of Blue Yonder in the amount of $<span id="xdx_905_ecustom--PaymentsForMilestone_c20200328__20200328__us-gaap--TypeOfArrangementAxis__custom--ServiceContractAndAgreementMember__dei--LegalEntityAxis__custom--BlueYonderIncMember__us-gaap--AwardDateAxis__custom--DueOnJulyOneTwoThousandTwentyFourMember__us-gaap--AwardTypeAxis__custom--TwoSeparateMilestonePaymentMember_zUZFK17p3Kye" title="Payments for milestone"><ix:nonFraction name="RIME:PaymentsForMilestone" contextRef="From2020-03-282020-03-28_custom_ServiceContractAndAgreementMember_custom_SemiCabIncMember_custom_DueOnJulyOneTwoThousandTwentyFourMember_custom_TwoSeparateMilestonePaymentMember" id="Fact003593" format="ixt:numdotdecimal" decimals="0" unitRef="USD">509,119</ix:nonFraction></span>, subject to two separate
milestone payments that would otherwise deem the entire balance due satisfied if either milestone payment is made by the Company. The
first milestone payment if for $<span id="xdx_906_ecustom--PaymentsForMilestone_c20200328__20200328__us-gaap--TypeOfArrangementAxis__custom--ServiceContractAndAgreementMember__dei--LegalEntityAxis__custom--BlueYonderIncMember__us-gaap--AwardDateAxis__custom--DueOnJulyOneTwoThousandTwentyFourMember__us-gaap--AwardTypeAxis__custom--FirstMilestonePaymentMember_z8YTp3WxJoU5" title="Remaining settlement"><ix:nonFraction name="RIME:PaymentsForMilestone" contextRef="From2020-03-282020-03-28_custom_ServiceContractAndAgreementMember_custom_SemiCabIncMember_custom_DueOnJulyOneTwoThousandTwentyFourMember_custom_FirstMilestonePaymentMember" id="Fact003595" format="ixt:numdotdecimal" decimals="0" unitRef="USD">175,000</ix:nonFraction></span> and is due on July 1, 2024. In the event this payment is made, the remaining settlement shall
be deemed satisfied. If this payment is not made, the Company shall owe a total of $<span id="xdx_90C_ecustom--PaymentsForMilestone_c20200328__20200328__us-gaap--TypeOfArrangementAxis__custom--ServiceContractAndAgreementMember__dei--LegalEntityAxis__custom--BlueYonderIncMember__us-gaap--AwardDateAxis__custom--OctoberOneTwoThousandTwentyFourMember__us-gaap--AwardTypeAxis__custom--SecondMilestonePaymentMember_zXzVpZbuL0Oi" title="Payments for milestone"><ix:nonFraction name="RIME:PaymentsForMilestone" contextRef="From2020-03-282020-03-28_custom_ServiceContractAndAgreementMember_custom_SemiCabIncMember_custom_OctoberOneTwoThousandTwentyFourMember_custom_SecondMilestonePaymentMember" id="Fact003597" format="ixt:numdotdecimal" decimals="0" unitRef="USD">225,000</ix:nonFraction></span> by October 1, 2024. In the event this payment
is made, the remaining settlement shall be deemed satisfied. If neither payment s made, Blue Yonder shall be entitled to execute the
full $<span id="xdx_909_eus-gaap--PaymentsForLegalSettlements_c20200328__20200328__us-gaap--TypeOfArrangementAxis__custom--ServiceContractAndAgreementMember__dei--LegalEntityAxis__custom--BlueYonderIncMember__us-gaap--AwardDateAxis__custom--JanuaryOneTwoThousandTwentyFiveMember_zFzUDECfAmrb" title="Remaining settlement"><ix:nonFraction name="us-gaap:PaymentsForLegalSettlements" contextRef="From2020-03-282020-03-28_custom_ServiceContractAndAgreementMember_custom_SemiCabIncMember_custom_JanuaryOneTwoThousandTwentyFiveMember" id="Fact003599" format="ixt:numdotdecimal" decimals="0" unitRef="USD">509,119</ix:nonFraction></span> beginning January 1, 2025. As of March 31, 2024, the Company has accrued $<span id="xdx_907_eus-gaap--OtherLiabilitiesCurrent_iI_c20240331__us-gaap--TypeOfArrangementAxis__custom--ServiceContractAndAgreementMember_zuR5Nm4zg1Dk" title="Other current liability"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2024-03-31_custom_ServiceContractAndAgreementMember_custom_SemiCabIncMember" id="Fact003601" format="ixt:numdotdecimal" decimals="0" unitRef="USD">225,000</ix:nonFraction></span> on its balance sheet as an other current
liability to account for the expected payment of this amount required to settle this dispute on or before October 1, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 28, 2024, SemiCab was sued by a Baxter Bailey, collection agency acting on behalf of a domestic freight shipper. The shipper claims
is was underpaid for services rendered, and SemiCab has disputed the claim. The total amount in dispute is approximately $<span id="xdx_90E_ecustom--DisputeAmount_c20240528__20240528_zYFvGN8bXUmj" title="Dispute. amount"><ix:nonFraction name="RIME:DisputeAmount" contextRef="From2024-05-282024-05-28_custom_SemiCabIncMember" id="Fact003603" format="ixt:numdotdecimal" decimals="0" unitRef="USD">93,000</ix:nonFraction></span>. SemiCab
intends to dispute the claim. As such, this litigation has been excluded from liabilities assumed as part of this transaction. $<span id="xdx_900_ecustom--AccruedPotentialLiability_c20240331__20240331_zC34jPhewe5j" title="Accrued, potential liability"><ix:nonFraction name="RIME:AccruedPotentialLiability" contextRef="From2024-03-312024-03-31_custom_SemiCabIncMember" id="Fact003605" format="ixt:numdotdecimal" decimals="0" unitRef="USD">100,000</ix:nonFraction></span>
has been accrued on the March 31, 2024 balance sheet to account for this potential liability.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember" escape="true" id="Fact003607" name="RIME:AccountsReceivableDisclosureTextBlock"><p id="xdx_807_ecustom--AccountsReceivableDisclosureTextBlock_z2TQ6gZjtLQa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
9 - <span id="xdx_822_z9VUFgefS8i7">DUE FROM FACTOR</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
entered into an accounts receivable factoring arrangement with a financial institution (the &#8220;Factor&#8221;) which has been extended
to October 31, 2024 and may be discontinued at that time. Pursuant to the terms of the arrangement, from time to time, we sell to the
Factor a minimum of $<span id="xdx_902_eus-gaap--AccountsReceivableNet_iI_c20240331__srt--RangeAxis__srt--MinimumMember_zMEZ7d7jYdLc" title="Accounts receivable"><ix:nonFraction name="us-gaap:AccountsReceivableNet" contextRef="AsOf2024-03-31_srt_MinimumMember_custom_SemiCabIncMember" id="Fact003609" format="ixt:numdotdecimal" decimals="0" unitRef="USD">150,000</ix:nonFraction></span> per quarter of certain of our accounts receivable balances on a non-recourse basis for credit approved accounts.
The <span id="xdx_902_ecustom--ForeignAndDomesticRateOfAccountsReceivable_c20240101__20240331_zcUMJeQOsJbb" title="Accounts receivable rate, description"><ix:nonNumeric contextRef="From2024-01-012024-03-31_custom_SemiCabIncMember" id="Fact003611" name="RIME:ForeignAndDomesticRateOfAccountsReceivable">Factor remits 35% of the foreign and 75% of the domestic accounts receivable balance</ix:nonNumeric></span> to us (the &#8220;Advance Amount&#8221;), with
the remaining balance, less fees, forwarded to us once the Factor collects the full accounts receivable balance from the customer. In
addition, from time to time, we receive over advances from the Factor. Factoring fees range from <span id="xdx_906_ecustom--AdvanceFeeRate_pid_dp_uPure_c20240101__20240331__srt--RangeAxis__srt--MinimumMember_zM84KYSyuAt7" title="Advance fee, rate"><ix:nonFraction name="RIME:AdvanceFeeRate" contextRef="From2024-01-012024-03-31_srt_MinimumMember_custom_SemiCabIncMember" id="Fact003613" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">2.75</ix:nonFraction></span>% to <span id="xdx_906_ecustom--AdvanceFeeRate_pid_dp_uPure_c20240101__20240331__srt--RangeAxis__srt--MaximumMember_zh6r6lG6zNmh" title="Advance fee, rate"><ix:nonFraction name="RIME:AdvanceFeeRate" contextRef="From2024-01-012024-03-31_srt_MaximumMember_custom_SemiCabIncMember" id="Fact003615" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">15</ix:nonFraction></span>% of the face value of the
invoice factored and are determined by the number of days required for collection of the invoice. We expect to continue to use this factoring
arrangement periodically to assist with our general working capital requirements due to contractual requirements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>LEGAL
MATTERS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 28, 2024, SemiCab was sued by a Baxter Bailey, collection agency acting on behalf of a domestic freight shipper. The shipper claims
is was underpaid for services rendered, and SemiCab has disputed the claim. The total amount in dispute is approximately $<span id="xdx_90C_eus-gaap--LegalFees_c20240528__20240528_zq4v3oh80Beg" title="Dispute, amount"><ix:nonFraction name="us-gaap:LegalFees" contextRef="From2024-05-282024-05-28_custom_SemiCabIncMember" id="Fact003617" format="ixt:numdotdecimal" decimals="0" unitRef="USD">93,000</ix:nonFraction></span>. SemiCab
intends to dispute the claim. As such, this litigation has been excluded from liabilities assumed as part of this transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>LEASES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Operating
Leases</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable. The Company currently utilizes a work-from-home model for its US operations, and a month-to-month shared office space in
Bangalore that expires in June. At that time 100% of the current employees will adopt a work-from-home model.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Finance
Leases</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable. The Company does not have any material financial leases at this time, or any of the periods presented in this Report.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember" escape="true" id="Fact003619" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock"><p id="xdx_809_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zPE0SCL9ZdW" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
10 &#8211; <span id="xdx_82B_zxYWXgk2KtZj">STOCKHOLDERS&#8217; EQUITY</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>EQUITY
INCCENTIVE PLAN</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has maintained an equity incentive plan since 2020. Under this plan, all employees have been eligible to received common stock
options as a part of their performance-based incentive compensation plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<ix:exclude><!-- Field: Page; Sequence: 128; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>COMMON
STOCK OPTIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember" escape="true" id="Fact003621" name="RIME:ScheduleOfStockOptionIssuedTableTextBlock"><p id="xdx_89D_ecustom--ScheduleOfStockOptionIssuedTableTextBlock_zS4MKNLnlLo3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the years ended Dember 31, 2020, 2021 and 2022 the Company issued the following stock options, as shown below. No options were issued
in 2023 or 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span id="xdx_8B5_zQna3u5WPUSa" style="display: none">SCHEDULE OF STOCK OPTION ISSUED
DURING THE YEAR DECEMBER 31, 2020, 2021 AND 2022</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif">Holder</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">Granted Shares</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">Outstanding Awards</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">Grant Date</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">Exercise Price</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">Vesting Start Date</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">Vested Outstanding</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">Unvested</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">Date Fully Vested</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">Board Approval Date</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">Expiration Date</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: left">Sudhir Narasimhamurthy</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zkaVwWdoGg3" title="Granted Shares" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2020-01-012020-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003623" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">180,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zcr2MKz1AwFg" title="Outstanding Awards" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003625" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">180,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span id="xdx_901_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z1PCe2WkmQMa" title="Granted Date"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003627" name="us-gaap:TargetedOrTrackingStockIssuanceDates">09-29-2020</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20201231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zEwHsyzEa6K4" title="Exercise price" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2020-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003629" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.06</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span id="xdx_904_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z5ZXzIUpv5v2" title="Vesting Date"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003631" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate">09-29-2020</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z1y1z4fUkMd9" title="Vested Outstanding" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2020-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003633" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">180,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20201231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zjAJBNToTHb9" title="Unvested" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="AsOf2020-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003635" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">0</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zc9gMLKiRMSi" title="Date Fully Vested"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003637" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate">09-29-2023</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span id="xdx_908_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z6c6IllFXpx7" title="Board Approval Date"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003639" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate">09-28-2020</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zdfXa5VRylw9" title="Expiration Date"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003641" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">09-28-2030</ix:nonNumeric></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Sudhir Narasimhamurthy</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z3uCfygXvbR4" title="Granted Shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2021-01-012021-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003643" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">50,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zQtKppP6tag2" title="Outstanding Awards" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003645" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">50,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_znDPUpqUbYw1" title="Granted Date"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003647" name="us-gaap:TargetedOrTrackingStockIssuanceDates">08-12-2021</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20211231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zjCZBQdsmS37" title="Exercise price" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2021-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003649" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.06</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z5Wb3cLxzFP2" title="Vesting Date"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003651" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate">09-01-2021</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zvRymfYhav79" title="Vested Outstanding" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2021-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003653" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">33,333</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20211231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z430AXwdWbqa" title="Unvested" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="AsOf2021-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003655" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">16,667</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_ztFM8AbGO4z" title="Date Fully Vested"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003657" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate">09-01-2025</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z8DY2FENLkba" title="Board Approval Date"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003659" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate">08-12-2021</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zaVtrIbr1jSa" title="Expiration Date"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003661" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">08-11-2031</ix:nonNumeric></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Sudhir Narasimhamurthy</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zdQxKgnCNhYl" title="Granted Shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2022-01-012022-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003663" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">25,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zpCDH1mvMsFb" title="Outstanding Awards" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2022-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003665" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">25,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zOpcXghoINqd" title="Granted Date"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003667" name="us-gaap:TargetedOrTrackingStockIssuanceDates">05-02-2022</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zkXP0xggFfQ4" title="Exercise price" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2022-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003669" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.05</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zSKiAJqKuqb1" title="Vesting Date"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003671" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate">05-02-2022</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zNyEIkIRBfme" title="Vested Outstanding" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2022-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003673" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">12,500</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zbeugqboZ186" title="Unvested" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="AsOf2022-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003675" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">12,500</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zCJz3cB56Coc" title="Date Fully Vested"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003677" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate">05-02-2026</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zr8EiANorbQf" title="Board Approval Date"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003679" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate">05-02-2022</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z6JDYzFtRMFg" title="Expiration Date"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003681" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">05-01-2032</ix:nonNumeric></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Kadandale Srinivas Sudheer</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zQXre4LkNdsg" title="Granted Shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2020-01-012020-12-31_custom_KadandaleSrinivasSudheerMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003683" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">600,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zZEPsi2Skxqd" title="Outstanding Awards" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-12-31_custom_KadandaleSrinivasSudheerMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003685" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">600,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20200101__20201231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zEog8Y6iMuMb" title="Granted Date"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_KadandaleSrinivasSudheerMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003687" name="us-gaap:TargetedOrTrackingStockIssuanceDates">09-29-2020</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20201231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z8wAPlyTERF9" title="Exercise price" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2020-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003689" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.06</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zZ1kQQCQyof3" title="Vesting Date"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_KadandaleSrinivasSudheerMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003691" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate">09-29-2020</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z19ywhQYgQYa" title="Vested Outstanding" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2020-12-31_custom_KadandaleSrinivasSudheerMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003693" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">600,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20201231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zTe1UbNcWdQk" title="Unvested" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="AsOf2020-12-31_custom_KadandaleSrinivasSudheerMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003695" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">0</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zbxETfbMaBLd" title="Date Fully Vested"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_KadandaleSrinivasSudheerMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003697" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate">09-29-2023</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z7eACM5ED3Ci" title="Board Approval Date"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_KadandaleSrinivasSudheerMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003699" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate">09-28-2020</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z0JG5iPR3Z17" title="Expiration Date"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_KadandaleSrinivasSudheerMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003701" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">09-28-2030</ix:nonNumeric></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Kadandale Srinivas Sudheer</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20211231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_za98zzoEujK9" title="Granted Shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2021-01-012021-12-31_custom_KadandaleSrinivasSudheerMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003703" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">100,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zE3JVBLazA0a" title="Outstanding Awards" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-12-31_custom_KadandaleSrinivasSudheerMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003705" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">100,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90F_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20210101__20211231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z6eOXUUTjNrk" title="Granted Date"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_KadandaleSrinivasSudheerMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003707" name="us-gaap:TargetedOrTrackingStockIssuanceDates">08-12-2021</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20211231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zg6Nmo40glYd" title="Exercise price" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2021-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003709" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.06</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zFeRQu9z9nq" title="Vesting Date"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_KadandaleSrinivasSudheerMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003711" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate">09-01-2021</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z8tDJidvYA8g" title="Vested Outstanding" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2021-12-31_custom_KadandaleSrinivasSudheerMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003713" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">66,666</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20211231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zODHT2K3W2L3" title="Unvested" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="AsOf2021-12-31_custom_KadandaleSrinivasSudheerMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003715" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">33,334</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zJAqgSZbew21" title="Date Fully Vested"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_KadandaleSrinivasSudheerMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003717" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate">09-01-2025</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zMLmVAewjCL5" title="Board Approval Date"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_KadandaleSrinivasSudheerMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003719" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate">08-12-2021</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zU0PUmZ171j1" title="Expiration Date"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_KadandaleSrinivasSudheerMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003721" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">08-11-2031</ix:nonNumeric></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Kadandale Srinivas Sudheer</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zytGZ9hbU7ja" title="Granted Shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2022-01-012022-12-31_custom_KadandaleSrinivasSudheerMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003723" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">50,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zF4FHf7SRPXe" title="Outstanding Awards" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2022-12-31_custom_KadandaleSrinivasSudheerMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003725" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">50,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_904_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z8UbrhZ7O8t1" title="Granted Date"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_KadandaleSrinivasSudheerMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003727" name="us-gaap:TargetedOrTrackingStockIssuanceDates">05-02-2022</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zSYMGd9uqPca" title="Exercise price" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2022-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003729" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.05</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zbDudXMOICq9" title="Vesting Date"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_KadandaleSrinivasSudheerMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003731" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate">05-02-2022</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zhW8YXZAWDZd" title="Vested Outstanding" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2022-12-31_custom_KadandaleSrinivasSudheerMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003733" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">25,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zZRwBgBVHrud" title="Unvested" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="AsOf2022-12-31_custom_KadandaleSrinivasSudheerMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003735" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">25,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z88nzqafXHq3" title="Date Fully Vested"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_KadandaleSrinivasSudheerMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003737" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate">05-02-2026</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_903_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zlGP0zcOyh0i" title="Board Approval Date"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_KadandaleSrinivasSudheerMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003739" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate">05-02-2022</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zCz9iQ9aDTn8" title="Expiration Date"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_KadandaleSrinivasSudheerMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003741" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">05-01-2032</ix:nonNumeric></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Vivek Sehgal</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zRpjmlZTOGX3" title="Granted Shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2020-01-012020-12-31_custom_VivekSehgalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003743" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,000,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zcQvVn88Xlzd" title="Outstanding Awards" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-12-31_custom_VivekSehgalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003745" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,000,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20200101__20201231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zYn1HvGb2uE3" title="Granted Date"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_VivekSehgalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003747" name="us-gaap:TargetedOrTrackingStockIssuanceDates">09-29-2020</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20201231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zwj20RpZTZ3l" title="Exercise price" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2020-12-31_custom_VivekSehgalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003749" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.06</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zcOJJxYF28v4" title="Vesting Date"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_KadandaleSrinivasSudheerMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003751" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate">09-29-2020</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zXMwES9jBJyk" title="Vested Outstanding" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2020-12-31_custom_VivekSehgalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003753" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,000,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20201231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zR4OKdEJGYAe" title="Unvested" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="AsOf2020-12-31_custom_VivekSehgalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003755" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">0</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_903_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zmG35jgQubc4" title="Date Fully Vested"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_VivekSehgalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003757" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate">09-29-2023</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z157ujDnNYy8" title="Board Approval Date"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_VivekSehgalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003759" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate">09-28-2020</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zGq4oFwd78C8" title="Expiration Date"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_VivekSehgalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003761" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">09-28-2030</ix:nonNumeric></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Vivek Sehgal</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20211231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zhGKq280Xs45" title="Granted Shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2021-01-012021-12-31_custom_VivekSehgalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003763" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">200,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zO4iwkQvJbya" title="Outstanding Awards" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-12-31_custom_VivekSehgalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003765" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">200,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90F_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20210101__20211231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zR91Gan7PQ68" title="Granted Date"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_VivekSehgalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003767" name="us-gaap:TargetedOrTrackingStockIssuanceDates">08-12-2021</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20211231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zv711yflLHw9" title="Exercise price" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2021-12-31_custom_VivekSehgalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003769" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.06</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zv58Z1jTHlu2" title="Vesting Date"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_KadandaleSrinivasSudheerMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003771" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate">09-01-2021</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zYD54Fb54DUi" title="Vested Outstanding" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2021-12-31_custom_VivekSehgalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003773" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">133,333</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20211231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zvLyxMREXQyd" title="Unvested" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="AsOf2021-12-31_custom_VivekSehgalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003775" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">66,667</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zDqisXKWh0Ik" title="Date Fully Vested"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_VivekSehgalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003777" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate">09-01-2025</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z6BxPFgVriA2" title="Board Approval Date"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_VivekSehgalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003779" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate">08-12-2021</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zVnMcREQ1i55" title="Expiration Date"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_VivekSehgalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003781" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">08-11-2031</ix:nonNumeric></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Vivek Sehgal</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zDDZm2IDXNL3" title="Granted Shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2022-01-012022-12-31_custom_VivekSehgalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003783" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">100,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zRghaqfb8pch" title="Outstanding Awards" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2022-12-31_custom_VivekSehgalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003785" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">100,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90D_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zEAqpKDIUl87" title="Granted Date"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_VivekSehgalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003787" name="us-gaap:TargetedOrTrackingStockIssuanceDates">05-02-2022</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zqs3KXmqO1ua" title="Exercise price" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2022-12-31_custom_VivekSehgalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003789" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.05</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_901_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zZxxyoqlsdBi" title="Vesting Date"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_KadandaleSrinivasSudheerMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003791" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate">05-02-2022</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zBKaGub0LWD9" title="Vested Outstanding" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2022-12-31_custom_VivekSehgalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003793" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">50,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zfyYDo512rMa" title="Unvested" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="AsOf2022-12-31_custom_VivekSehgalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003795" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">50,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_906_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zGWF9B3Fc3tc" title="Date Fully Vested"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_VivekSehgalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003797" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate">05-02-2026</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zNCmcVOAIY4j" title="Board Approval Date"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_VivekSehgalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003799" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate">05-02-2022</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zMd2fAXZF2Q1" title="Expiration Date"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_VivekSehgalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003801" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">05-01-2032</ix:nonNumeric></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Rajiv Saxena</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__srt--TitleOfIndividualAxis__custom--RajivSaxenaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_znQO4mVSpOjk" title="Granted Shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2020-01-012020-12-31_custom_RajivSaxenaMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003803" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">100,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--RajivSaxenaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zhBE7ZJA66Uh" title="Outstanding Awards" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-12-31_custom_RajivSaxenaMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003805" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">100,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20200101__20201231__srt--TitleOfIndividualAxis__custom--RajivSaxenaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zfqtIuMocDq4" title="Granted Date"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_RajivSaxenaMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003807" name="us-gaap:TargetedOrTrackingStockIssuanceDates">09-29-2020</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20201231__srt--TitleOfIndividualAxis__custom--RajivSaxenaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z0V8spZqH7ca" title="Exercise price" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2020-12-31_custom_RajivSaxenaMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003809" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.06</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_904_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--RajivSaxenaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zOTob9Ez0zb3" title="Vesting Date"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_RajivSaxenaMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003811" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate">09-29-2020</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--RajivSaxenaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zAVzgpY3COkg" title="Vested Outstanding" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2020-12-31_custom_RajivSaxenaMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003813" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">100,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20201231__srt--TitleOfIndividualAxis__custom--RajivSaxenaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zhi2QrpZRBBd" title="Unvested" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="AsOf2020-12-31_custom_RajivSaxenaMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003815" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">0</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--RajivSaxenaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_ztcI3kL5i449" title="Date Fully Vested"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_RajivSaxenaMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003817" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate">09-29-2023</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--RajivSaxenaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zoEfGqJJHtcg" title="Board Approval Date"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_RajivSaxenaMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003819" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate">09-28-2020</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--RajivSaxenaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zXH5b5Qf8pAh" title="Expiration Date"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_RajivSaxenaMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003821" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">09-28-2030</ix:nonNumeric></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Harsha Bhat</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z08HbgZ0X45g" title="Granted Shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2020-01-012020-12-31_custom_HarshaBhatMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003823" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">180,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zbwUA0GCQ80h" title="Outstanding Awards" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-12-31_custom_HarshaBhatMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003825" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">180,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_906_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20200101__20201231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zXXdHjVSoRFj" title="Granted Date"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_HarshaBhatMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003827" name="us-gaap:TargetedOrTrackingStockIssuanceDates">09-29-2020</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20201231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zSUxLUAAlsU4" title="Exercise price" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2020-12-31_custom_HarshaBhatMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003829" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.06</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zoVMaEcY1RVj" title="Vesting Date"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_HarshaBhatMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003831" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate">09-29-2020</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zrzYnC0SL8qb" title="Vested Outstanding" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2020-12-31_custom_HarshaBhatMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003833" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">180,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20201231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zzsVwuUkeghi" title="Unvested" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="AsOf2020-12-31_custom_HarshaBhatMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003835" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">0</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z8sd1sUXMfJ2" title="Date Fully Vested"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_HarshaBhatMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003837" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate">09-29-2023</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zmgIWsiO9eX5" title="Board Approval Date"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_HarshaBhatMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003839" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate">09-28-2020</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z2dyEezFF0Fa" title="Expiration Date"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_HarshaBhatMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003841" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">09-28-2030</ix:nonNumeric></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Harsha Bhat</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20211231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zDsyymcL05z2" title="Granted Shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2021-01-012021-12-31_custom_HarshaBhatMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003843" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">50,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z6wgdxcyHxT1" title="Outstanding Awards" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-12-31_custom_HarshaBhatMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003845" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">50,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20210101__20211231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z9QO3uaAaEOh" title="Granted Date"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_HarshaBhatMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003847" name="us-gaap:TargetedOrTrackingStockIssuanceDates">08-12-2021</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20211231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zaUkaL5fUYPe" title="Exercise price" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2021-12-31_custom_HarshaBhatMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003849" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.06</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_ze5s6G3w3q4f" title="Vesting Date"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_HarshaBhatMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003851" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate">09-01-2021</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zfoMrlWA3YA7" title="Vested Outstanding" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2021-12-31_custom_HarshaBhatMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003853" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">33,333</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20211231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zUgMjGfU0RTi" title="Unvested" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="AsOf2021-12-31_custom_HarshaBhatMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003855" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">16,667</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_za3qr7dQi3Wa" title="Date Fully Vested"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_HarshaBhatMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003857" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate">09-01-2025</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zsnSa1PIg8Te" title="Board Approval Date"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_HarshaBhatMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003859" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate">08-12-2021</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zskswrzDKQ09" title="Expiration Date"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_HarshaBhatMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003861" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">08-11-2031</ix:nonNumeric></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Harsha Bhat</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zNmCBODP5IDj" title="Granted Shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2022-01-012022-12-31_custom_HarshaBhatMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003863" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">25,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zMpSnEP1ymzd" title="Outstanding Awards" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2022-12-31_custom_HarshaBhatMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003865" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">25,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zOzdi7J0AsDh" title="Granted Date"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_HarshaBhatMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003867" name="us-gaap:TargetedOrTrackingStockIssuanceDates">05-02-2022</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zBKdxDK5waRe" title="Exercise price" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2022-12-31_custom_HarshaBhatMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003869" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.05</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zOv44xxlwtEl" title="Vesting Date"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_HarshaBhatMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003871" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate">05-02-2022</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z90kaRIoIGpc" title="Vested Outstanding" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2022-12-31_custom_HarshaBhatMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003873" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">12,500</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zztgEunYXoFa" title="Unvested" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="AsOf2022-12-31_custom_HarshaBhatMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003875" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">12,500</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_903_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zMLrqEeSJIT1" title="Date Fully Vested"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_HarshaBhatMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003877" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate">05-02-2026</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zM7zJ4LAPqY1" title="Board Approval Date"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_HarshaBhatMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003879" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate">05-02-2022</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z7W4b76MIqI5" title="Expiration Date"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_HarshaBhatMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003881" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">05-01-2032</ix:nonNumeric></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Jagan Reddy</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zKxeqlsABfBj" title="Granted Shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2020-01-012020-12-31_custom_JaganReddyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003883" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,000,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zCX04OMzsbj2" title="Outstanding Awards" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-12-31_custom_JaganReddyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003885" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,000,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20200101__20201231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zOBUo3w8GC44" title="Granted Date"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_JaganReddyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003887" name="us-gaap:TargetedOrTrackingStockIssuanceDates">09-29-2020</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20201231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zLcOa2wApEZb" title="Exercise price" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2020-12-31_custom_JaganReddyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003889" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.06</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zKGRKrSA53dl" title="Vesting Date"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_JaganReddyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003891" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate">09-29-2020</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zx3OEy8qgdm1" title="Vested Outstanding" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2020-12-31_custom_JaganReddyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003893" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,000,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20201231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zAjEkAZ5A27l" title="Unvested" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="AsOf2020-12-31_custom_JaganReddyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003895" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">0</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zzqPH1Zy89ud" title="Date Fully Vested"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_JaganReddyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003897" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate">09-29-2023</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zzxwfJY1pVfc" title="Board Approval Date"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_JaganReddyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003899" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate">09-28-2020</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zBJeqN0tpsA5" title="Expiration Date"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_JaganReddyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003901" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">09-28-2030</ix:nonNumeric></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Jagan Reddy</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20211231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z1QNcWlp7339" title="Granted Shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2021-01-012021-12-31_custom_JaganReddyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003903" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">200,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zBOhrCUX2hWh" title="Outstanding Awards" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-12-31_custom_JaganReddyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003905" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">200,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20210101__20211231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z77tWXOWvbQf" title="Granted Date"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_JaganReddyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003907" name="us-gaap:TargetedOrTrackingStockIssuanceDates">08-12-2021</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20211231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zWjsNE1gxH6a" title="Exercise price" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2021-12-31_custom_JaganReddyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003909" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.06</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z3VGSbXqfnHd" title="Vesting Date"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_JaganReddyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003911" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate">09-01-2021</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zJnYSjGUYRq9" title="Vested Outstanding" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2021-12-31_custom_JaganReddyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003913" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">133,333</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20211231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zXigKW9A6dBd" title="Unvested" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="AsOf2021-12-31_custom_JaganReddyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003915" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">66,667</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z2AXveCbVYM1" title="Date Fully Vested"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_JaganReddyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003917" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate">09-01-2025</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zGx1kMBN6qMk" title="Board Approval Date"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_JaganReddyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003919" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate">08-12-2021</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_znMp1jOUxMRi" title="Expiration Date"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_JaganReddyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003921" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">08-11-2031</ix:nonNumeric></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Jagan Reddy</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zWnM7OtIcJl5" title="Granted Shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2022-01-012022-12-31_custom_JaganReddyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003923" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">100,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z3CLUQbelsd5" title="Outstanding Awards" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2022-12-31_custom_JaganReddyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003925" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">100,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zaFrPzj34uy1" title="Granted Date"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_JaganReddyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003927" name="us-gaap:TargetedOrTrackingStockIssuanceDates">05-02-2022</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zx2CNpSmQoI2" title="Exercise price" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2022-12-31_custom_JaganReddyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003929" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.05</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zSms9MSXoam1" title="Vesting Date"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_JaganReddyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003931" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate">05-02-2022</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zdyEfY0hMI0j" title="Vested Outstanding" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2022-12-31_custom_JaganReddyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003933" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">50,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z2XI43Etedgl" title="Unvested" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="AsOf2022-12-31_custom_JaganReddyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003935" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">50,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zTeiOccr6De4" title="Date Fully Vested"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_JaganReddyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003937" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate">05-02-2026</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_901_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zTIQbZj7izOk" title="Board Approval Date"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_JaganReddyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003939" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate">05-02-2022</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zhcIPo9lJrnb" title="Expiration Date"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_JaganReddyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003941" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">05-01-2032</ix:nonNumeric></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Siddayya S Ganjal</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zLtHZXLIYXT2" title="Granted Shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2020-01-012020-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003943" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">180,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zidPZtDo9f2l" title="Outstanding Awards" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003945" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">180,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90D_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z64CelNZxK28" title="Granted Date"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003947" name="us-gaap:TargetedOrTrackingStockIssuanceDates">09-29-2020</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20201231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zZJN9c6A2Xz8" title="Exercise price" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2020-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003949" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.06</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zji5tD9IWLJ7" title="Vesting Date"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003951" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate">09-29-2020</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zEbslEd6W4Uk" title="Vested Outstanding" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2020-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003953" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">180,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20201231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zC47cn7xpmB5" title="Unvested" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="AsOf2020-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003955" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">0</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_903_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z81CfIvqcg07" title="Date Fully Vested"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003957" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate">09-29-2023</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zZhwhGG9ylSl" title="Board Approval Date"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003959" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate">09-28-2020</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zlETeoQnlBD6" title="Expiration Date"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003961" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">09-28-2030</ix:nonNumeric></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Siddayya S Ganjal</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zOeVWgDLd6bd" title="Granted Shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2021-01-012021-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003963" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">50,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zO52qNDAB4j1" title="Outstanding Awards" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003965" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">50,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zQiPa3xVsHL6" title="Granted Date"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003967" name="us-gaap:TargetedOrTrackingStockIssuanceDates">08-12-2021</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20211231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zp1TIwkcXPli" title="Exercise price" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2021-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003969" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.06</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_906_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zi1FCNFDnJ4a" title="Vesting Date"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003971" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate">09-01-2021</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zCxAMtrNrbwi" title="Vested Outstanding" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2021-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003973" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">33,333</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20211231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zODWxdOOSXZ7" title="Unvested" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="AsOf2021-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003975" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">16,667</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zUelF2aoLGV" title="Date Fully Vested"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003977" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate">09-01-2025</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zYRo89dsMIXc" title="Board Approval Date"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003979" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate">08-12-2021</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z26RMcgHAkZ2" title="Expiration Date"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003981" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">08-11-2031</ix:nonNumeric></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Siddayya S Ganjal</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z8GrwY1ZeiA8" title="Granted Shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2022-01-012022-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003983" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">25,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z7PdBfdIQS8f" title="Outstanding Awards" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2022-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003985" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">25,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_901_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zfZ2QJXel0R6" title="Granted Date"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003987" name="us-gaap:TargetedOrTrackingStockIssuanceDates">05-02-2022</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zOLPYJnpSyB4" title="Exercise price" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2022-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003989" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.05</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zDdmnDMrgNB1" title="Vesting Date"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003991" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate">05-02-2022</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z9jAQSeoce1j" title="Vested Outstanding" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2022-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003993" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">12,500</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zEU7k2yN2rrl" title="Unvested" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="AsOf2022-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact003995" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">12,500</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_901_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zmKgANLDQ4C8" title="Date Fully Vested"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003997" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate">05-02-2026</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_903_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zbrXvmpsk0o4" title="Board Approval Date"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact003999" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate">05-02-2022</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zSN3SC32THb8" title="Expiration Date"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004001" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">05-01-2032</ix:nonNumeric></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Sunil Arora</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SunilAroraMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z7m9enW4i5Zi" title="Granted Shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2020-01-012020-12-31_custom_SunilAroraMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004003" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">90,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--SunilAroraMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zsezXG1Sejg5" title="Outstanding Awards" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-12-31_custom_SunilAroraMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004005" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">0</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SunilAroraMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zkoYykwWriM4" title="Granted Date"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_SunilAroraMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004007" name="us-gaap:TargetedOrTrackingStockIssuanceDates">09-29-2020</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20201231__srt--TitleOfIndividualAxis__custom--SunilAroraMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zPcaRvcX5Ww6" title="Exercise price" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2020-12-31_custom_SunilAroraMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004009" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.06</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SunilAroraMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zLPcUvlsIyVc" title="Vesting Date"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_SunilAroraMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004011" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate">09-29-2020</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--SunilAroraMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zP0MdBecOlJ3" title="Vested Outstanding" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2020-12-31_custom_SunilAroraMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004013" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">0</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20201231__srt--TitleOfIndividualAxis__custom--SunilAroraMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zjtyFMbmjjM1" title="Unvested" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="AsOf2020-12-31_custom_SunilAroraMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004015" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">0</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SunilAroraMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_znYKA3dyYKOa" title="Date Fully Vested"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_SunilAroraMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004017" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate">09-29-2023</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SunilAroraMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zfFmNNsb1id8" title="Board Approval Date"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_SunilAroraMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004019" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate">09-28-2020</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SunilAroraMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z5q5eI77xCTf" title="Expiration Date"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_SunilAroraMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004021" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">09-28-2030</ix:nonNumeric></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Rajiv Virmani</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__srt--TitleOfIndividualAxis__custom--RajivVirmaniMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zAvTpweQTCkk" title="Granted Shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2020-01-012020-12-31_custom_RajivVirmaniMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004023" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">500,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--RajivVirmaniMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zsPUxo7rXUVi" title="Outstanding Awards" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-12-31_custom_RajivVirmaniMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004025" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">500,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20200101__20201231__srt--TitleOfIndividualAxis__custom--RajivVirmaniMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zUixUnpBEey" title="Granted Date"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_RajivVirmaniMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004027" name="us-gaap:TargetedOrTrackingStockIssuanceDates">09-29-2020</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20201231__srt--TitleOfIndividualAxis__custom--RajivVirmaniMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zYa1tFm2h7r2" title="Exercise price" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2020-12-31_custom_RajivVirmaniMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004029" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.06</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--RajivVirmaniMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zGdB8F8Vpkw9" title="Vesting Date"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_RajivVirmaniMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004031" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate">09-29-2020</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--RajivVirmaniMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zzuDeP7iTWBh" title="Vested Outstanding" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2020-12-31_custom_RajivVirmaniMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004033" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">500,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20201231__srt--TitleOfIndividualAxis__custom--RajivVirmaniMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_znbKyxGWlMO4" title="Unvested" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="AsOf2020-12-31_custom_RajivVirmaniMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004035" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">0</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--RajivVirmaniMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z1ZhutZcDpOl" title="Date Fully Vested"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_RajivVirmaniMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004037" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate">09-29-2023</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--RajivVirmaniMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zHE0MGI0XA6c" title="Board Approval Date"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_RajivVirmaniMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004039" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate">09-28-2020</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--RajivVirmaniMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zrxbrYtV69t1" title="Expiration Date"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_RajivVirmaniMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004041" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">09-28-2030</ix:nonNumeric></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Sudhindra Shenoy</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zJ4QWiC4caWb" title="Granted Shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2020-01-012020-12-31_custom_SudhindraShenoyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004043" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">180,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zgmeBkw8F8j5" title="Outstanding Awards" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-12-31_custom_SudhindraShenoyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004045" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">180,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zv4BBKrvS86k" title="Granted Date"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_SudhindraShenoyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004047" name="us-gaap:TargetedOrTrackingStockIssuanceDates">09-29-2020</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20201231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z9PEv9VWomrf" title="Exercise price" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2020-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004049" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.06</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zcTu02LTXQD6" title="Vesting Date"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_SudhindraShenoyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004051" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate">09-29-2020</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zED81jMp6uo1" title="Vested Outstanding" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2020-12-31_custom_SudhindraShenoyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004053" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">180,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20201231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zSpk753JhlNa" title="Unvested" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="AsOf2020-12-31_custom_SudhindraShenoyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004055" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">0</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zDYoF6saLzQ6" title="Date Fully Vested"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_SudhindraShenoyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004057" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate">09-29-2023</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zRxbgV6riQIi" title="Board Approval Date"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_SudhindraShenoyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004059" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate">09-28-2020</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zSWz0ilcoDn9" title="Expiration Date"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_SudhindraShenoyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004061" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">09-28-2030</ix:nonNumeric></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Sudhindra Shenoy</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zHiLjzV9s139" title="Granted Shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2021-01-012021-12-31_custom_SudhindraShenoyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004063" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">50,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zqncTIeeYlMi" title="Outstanding Awards" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-12-31_custom_SudhindraShenoyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004065" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">50,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z3Q7dMpXuPQl" title="Granted Date"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_SudhindraShenoyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004067" name="us-gaap:TargetedOrTrackingStockIssuanceDates">08-12-2021</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20211231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zqtXw6he9koe" title="Exercise price" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2021-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004069" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.06</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z3EiXnMZUPVg" title="Vesting Date"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_SudhindraShenoyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004071" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate">09-01-2021</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z4TqSghQCWf5" title="Vested Outstanding" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2021-12-31_custom_SudhindraShenoyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004073" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">33,333</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20211231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zl9Dk6iCfNUc" title="Unvested" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="AsOf2021-12-31_custom_SudhindraShenoyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004075" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">16,667</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z3cBvBXDJ7sc" title="Date Fully Vested"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_SudhindraShenoyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004077" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate">09-01-2025</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zSxBfMKkqZRi" title="Board Approval Date"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_SudhindraShenoyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004079" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate">08-12-2021</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zK2KmCBBBoJ8" title="Expiration Date"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_SudhindraShenoyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004081" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">08-11-2031</ix:nonNumeric></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Sudhindra Shenoy</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zdwYncZrvV59" title="Granted Shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2022-01-012022-12-31_custom_SudhindraShenoyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004083" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">25,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zAJPR9VMuZJg" title="Outstanding Awards" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2022-12-31_custom_SudhindraShenoyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004085" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">25,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90B_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zjD8uIPJTn3j" title="Granted Date"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_SudhindraShenoyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004087" name="us-gaap:TargetedOrTrackingStockIssuanceDates">05-02-2022</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_ztFhqTbEQtJ1" title="Exercise price" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2022-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004089" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.05</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_ztvHTgqFPMv6" title="Vesting Date"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_SudhindraShenoyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004091" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate">05-02-2022</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zN9xWBjDSpSb" title="Vested Outstanding" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2022-12-31_custom_SudhindraShenoyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004093" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">12,500</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z6ZIFhqGT8j9" title="Unvested" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="AsOf2022-12-31_custom_SudhindraShenoyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004095" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">12,500</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zKWPeT8HF9z5" title="Date Fully Vested"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_SudhindraShenoyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004097" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate">05-02-2026</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z8YAQ8UQsU22" title="Board Approval Date"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_SudhindraShenoyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004099" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate">05-02-2022</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zSlZ99QVHP9b" title="Expiration Date"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_SudhindraShenoyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004101" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">05-01-2032</ix:nonNumeric></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Antony Sunil</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zmI8FhHvmypd" title="Granted Shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2020-01-012020-12-31_custom_AntonySunilMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004103" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">90,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zS427y4oyIgh" title="Outstanding Awards" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-12-31_custom_AntonySunilMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004105" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">90,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20200101__20201231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zS4jXqRIxdNa" title="Granted Date"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_AntonySunilMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004107" name="us-gaap:TargetedOrTrackingStockIssuanceDates">09-29-2020</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20201231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zCK1E38zUGB9" title="Exercise price" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2020-12-31_custom_AntonySunilMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004109" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.06</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zUchczNYa5jk" title="Vesting Date"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_AntonySunilMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004111" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate">09-29-2020</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zE9ia44VfIm6" title="Vested Outstanding" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2020-12-31_custom_AntonySunilMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004113" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">90,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20201231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zx8POfK8Rcw6" title="Unvested" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="AsOf2020-12-31_custom_AntonySunilMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004115" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">0</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zRbZddjh8Aue" title="Date Fully Vested"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_AntonySunilMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004117" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate">09-29-2023</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zszioAjv8Bqe" title="Board Approval Date"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_AntonySunilMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004119" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate">09-28-2020</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zDdDEeTDGbhi" title="Expiration Date"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_AntonySunilMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004121" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">09-28-2030</ix:nonNumeric></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Antony Sunil</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20211231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zStQjTpTmw22" title="Granted Shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2021-01-012021-12-31_custom_AntonySunilMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004123" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">50,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zW3X4WBNgYxh" title="Outstanding Awards" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-12-31_custom_AntonySunilMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004125" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">50,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_906_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20210101__20211231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zLfMcMLcTXGh" title="Granted Date"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_AntonySunilMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004127" name="us-gaap:TargetedOrTrackingStockIssuanceDates">08-12-2021</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20211231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zkXLwkFMIA5d" title="Exercise price" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2021-12-31_custom_AntonySunilMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004129" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.06</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zPPj5PC7Ix7c" title="Vesting Date"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_AntonySunilMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004131" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate">09-01-2021</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zliNQG0mUou2" title="Vested Outstanding" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2021-12-31_custom_AntonySunilMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004133" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">33,333</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20211231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zpy0i9DTWivi" title="Unvested" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="AsOf2021-12-31_custom_AntonySunilMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004135" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">16,667</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zf06eLernOX8" title="Date Fully Vested"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_AntonySunilMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004137" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate">09-01-2025</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zMHa6AstZAy7" title="Board Approval Date"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_AntonySunilMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004139" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate">08-12-2021</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z8VDq4AdhNN4" title="Expiration Date"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_AntonySunilMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004141" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">08-11-2031</ix:nonNumeric></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Antony Sunil</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zt6Tew4XYJvg" title="Granted Shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2022-01-012022-12-31_custom_AntonySunilMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004143" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">25,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zqEbpMITIlH1" title="Outstanding Awards" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2022-12-31_custom_AntonySunilMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004145" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">25,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90B_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zjQHGf6zSV6k" title="Granted Date"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_AntonySunilMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004147" name="us-gaap:TargetedOrTrackingStockIssuanceDates">05-02-2022</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zrl3HOXAcou1" title="Exercise price" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2022-12-31_custom_AntonySunilMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004149" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.05</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_903_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zRPrkULN2mnh" title="Vesting Date"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_AntonySunilMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004151" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate">05-02-2022</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zwE2jHb87Abd" title="Vested Outstanding" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2022-12-31_custom_AntonySunilMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004153" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">12,500</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zodw1uxPgGnj" title="Unvested" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="AsOf2022-12-31_custom_AntonySunilMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004155" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">12,500</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_904_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zHnvDmjt5DJk" title="Date Fully Vested"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_AntonySunilMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004157" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate">05-02-2026</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zuQqZZQ4Bec5" title="Board Approval Date"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_AntonySunilMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004159" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate">05-02-2022</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zyH5egEJfptj" title="Expiration Date"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_AntonySunilMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004161" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">05-01-2032</ix:nonNumeric></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Tuleeka Nandy</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20211231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zGeQUPGVcqC9" title="Granted Shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2021-01-012021-12-31_custom_TuleekaNandyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004163" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">15,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zWREe5GJFG32" title="Outstanding Awards" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-12-31_custom_TuleekaNandyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004165" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">0</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20210101__20211231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zPlyc3UbVQ68" title="Granted Date"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_TuleekaNandyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004167" name="us-gaap:TargetedOrTrackingStockIssuanceDates">08-12-2021</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20211231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zyg4qZYrT9Wa" title="Exercise price" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2021-12-31_custom_TuleekaNandyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004169" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.06</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_904_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z9Tm46w78EVl" title="Vesting Date"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_TuleekaNandyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004171" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate">09-01-2021</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zciUSx4cEKVe" title="Vested Outstanding" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2021-12-31_custom_TuleekaNandyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004173" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">0</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20211231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zc5DVfnr44za" title="Unvested" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="AsOf2021-12-31_custom_TuleekaNandyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004175" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">0</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_906_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zk9oh7ar75S1" title="Date Fully Vested"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_TuleekaNandyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004177" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate">09-01-2025</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zqQR8gFyZZEa" title="Board Approval Date"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_TuleekaNandyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004179" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate">08-12-2021</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zCBYtFP5vVA1" title="Expiration Date"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_TuleekaNandyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004181" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">08-11-2031</ix:nonNumeric></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Tuleeka Nandy</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zbzyE7DKx0n5" title="Granted Shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2022-01-012022-12-31_custom_TuleekaNandyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004183" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">15,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zyPGwPl4LmOl" title="Outstanding Awards" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2022-12-31_custom_TuleekaNandyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004185" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">15,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zNOHxOGAM5ql" title="Granted Date"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_TuleekaNandyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004187" name="us-gaap:TargetedOrTrackingStockIssuanceDates">05-02-2022</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zIL7zRdfFmqg" title="Exercise price" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2022-12-31_custom_TuleekaNandyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004189" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.05</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zFT85c9TDdK8" title="Vesting Date"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_TuleekaNandyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004191" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate">05-02-2022</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zS94C0Wmy8v1" title="Vested Outstanding" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2022-12-31_custom_TuleekaNandyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004193" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,500</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zKYh7zntYvEb" title="Unvested" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="AsOf2022-12-31_custom_TuleekaNandyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004195" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,500</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_906_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zB6HsCjNmSfc" title="Date Fully Vested"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_TuleekaNandyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004197" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate">05-02-2026</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_904_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zW0Qw50fnqOg" title="Board Approval Date"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_TuleekaNandyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004199" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate">05-02-2022</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zu3PueADS1Nf" title="Expiration Date"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_TuleekaNandyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004201" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">05-01-2032</ix:nonNumeric></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Robel Atnafu</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20211231__srt--TitleOfIndividualAxis__custom--RobelAtnafuMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zMYN4j4zbw27" title="Granted Shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2021-01-012021-12-31_custom_RobelAtnafuMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004203" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--RobelAtnafuMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zkaOlGc6QBKd" title="Outstanding Awards" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-12-31_custom_RobelAtnafuMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004205" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">0</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_906_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20210101__20211231__srt--TitleOfIndividualAxis__custom--RobelAtnafuMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zCAg44aRCXz9" title="Granted Date"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_RobelAtnafuMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004207" name="us-gaap:TargetedOrTrackingStockIssuanceDates">08-12-2021</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20211231__srt--TitleOfIndividualAxis__custom--RobelAtnafuMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zQlITQRRVHT5" title="Exercise price" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2021-12-31_custom_RobelAtnafuMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004209" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.06</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--RobelAtnafuMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zrgD9NvzmkK5" title="Vesting Date"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_RobelAtnafuMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004211" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate">09-01-2021</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--RobelAtnafuMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zD3QUtoWzBOj" title="Vested Outstanding" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2021-12-31_custom_RobelAtnafuMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004213" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">0</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20211231__srt--TitleOfIndividualAxis__custom--RobelAtnafuMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zmr99hzbrwbb" title="Unvested" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="AsOf2021-12-31_custom_RobelAtnafuMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004215" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">0</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_903_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--RobelAtnafuMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zYaOQ001KYc5" title="Date Fully Vested"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_RobelAtnafuMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004217" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate">09-01-2025</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--RobelAtnafuMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zRYd7sPNM6ne" title="Board Approval Date"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_RobelAtnafuMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004219" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate">08-12-2021</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--RobelAtnafuMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zE0Thm3B4a73" title="Expiration Date"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_RobelAtnafuMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004221" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">08-11-2031</ix:nonNumeric></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Guy Primus</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20211231__srt--TitleOfIndividualAxis__custom--GuyPrimusMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zv7tnKkLurq3" title="Granted Shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2021-01-012021-12-31_custom_GuyPrimusMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004223" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">360,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--GuyPrimusMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z5lsCpiRMGT7" title="Outstanding Awards" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-12-31_custom_GuyPrimusMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004225" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">360,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_904_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20210101__20211231__srt--TitleOfIndividualAxis__custom--GuyPrimusMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z27yWlq2iEZh" title="Granted Date"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_GuyPrimusMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004227" name="us-gaap:TargetedOrTrackingStockIssuanceDates">08-12-2021</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20211231__srt--TitleOfIndividualAxis__custom--GuyPrimusMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z4LI0glhB5K7" title="Exercise price" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2021-12-31_custom_GuyPrimusMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004229" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.06</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--GuyPrimusMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z6R8fWq0gQKb" title="Vesting Date"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_GuyPrimusMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004231" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate">09-01-2021</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--GuyPrimusMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zJHAcSIrs837" title="Vested Outstanding" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2021-12-31_custom_GuyPrimusMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004233" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">240,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20211231__srt--TitleOfIndividualAxis__custom--GuyPrimusMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zshUiCy9NTE" title="Unvested" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="AsOf2021-12-31_custom_GuyPrimusMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004235" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">120,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--GuyPrimusMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z0v50qGwDqbi" title="Date Fully Vested"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_GuyPrimusMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004237" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate">09-01-2025</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--GuyPrimusMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z183fR4njIGi" title="Board Approval Date"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_GuyPrimusMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004239" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate">08-12-2021</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--GuyPrimusMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zNgUaGWfKBNc" title="Expiration Date"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_GuyPrimusMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004241" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">08-11-2031</ix:nonNumeric></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Samartha Gowda</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SamarthaGowdaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zx41vfeTjDK1" title="Granted Shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2022-01-012022-12-31_custom_SamarthaGowdaMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004243" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">15,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--SamarthaGowdaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z5mVmuym9a7e" title="Outstanding Awards" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2022-12-31_custom_SamarthaGowdaMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004245" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">15,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SamarthaGowdaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zA9b1GaOT6Tl" title="Granted Date"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_SamarthaGowdaMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004247" name="us-gaap:TargetedOrTrackingStockIssuanceDates">05-02-2022</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--SamarthaGowdaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zP7eRx49hXbl" title="Exercise price" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2022-12-31_custom_SamarthaGowdaMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004249" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.05</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SamarthaGowdaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zMkuWD2OKVUg" title="Vesting Date"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_SamarthaGowdaMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004251" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate">05-02-2022</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--SamarthaGowdaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z2pjFHsTgYjk" title="Vested Outstanding" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2022-12-31_custom_SamarthaGowdaMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004253" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,500</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--SamarthaGowdaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zOeHdHRImpt4" title="Unvested" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="AsOf2022-12-31_custom_SamarthaGowdaMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004255" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,500</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SamarthaGowdaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z6p852xmFNl8" title="Date Fully Vested"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_SamarthaGowdaMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004257" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate">05-02-2026</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SamarthaGowdaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zRKoBC1L5T74" title="Board Approval Date"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_SamarthaGowdaMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004259" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate">05-02-2022</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SamarthaGowdaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zCrDWd7dOoo2" title="Expiration Date"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_SamarthaGowdaMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004261" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">05-01-2032</ix:nonNumeric></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Alexandra Aiello</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--AlexandraAielloMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zos3ZTwgdgpd" title="Granted Shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2022-01-012022-12-31_custom_AlexandraAielloMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004263" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,500</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--AlexandraAielloMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zkLf5NC3A9F8" title="Outstanding Awards" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2022-12-31_custom_AlexandraAielloMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004265" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,500</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--AlexandraAielloMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zUOXKuHn8bJ2" title="Granted Date"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_AlexandraAielloMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004267" name="us-gaap:TargetedOrTrackingStockIssuanceDates">05-02-2022</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--AlexandraAielloMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zMlDopmU4nMk" title="Exercise price" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2022-12-31_custom_AlexandraAielloMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004269" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.05</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--AlexandraAielloMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zMO4Wx2Wxqsb" title="Vesting Date"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_AlexandraAielloMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004271" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate">05-02-2022</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--AlexandraAielloMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zj0DmFR2Hmfl" title="Vested Outstanding" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2022-12-31_custom_AlexandraAielloMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004273" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,250</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--AlexandraAielloMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zMKrN3i8HUx1" title="Unvested" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="AsOf2022-12-31_custom_AlexandraAielloMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004275" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,250</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--AlexandraAielloMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zZ1BzH0xur41" title="Date Fully Vested"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_AlexandraAielloMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004277" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate">05-02-2026</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--AlexandraAielloMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z4rVg0eKPw0i" title="Board Approval Date"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_AlexandraAielloMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004279" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate">05-02-2022</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--AlexandraAielloMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zMmyOdwnl6bf" title="Expiration Date"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_AlexandraAielloMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004281" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">05-01-2032</ix:nonNumeric></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Stephen Cabral</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--StephenCabralMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zlO4ZVDea3Y4" title="Granted Shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2022-01-012022-12-31_custom_StephenCabralMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004283" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--StephenCabralMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z5AJCEHMgIm8" title="Outstanding Awards" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2022-12-31_custom_StephenCabralMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004285" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">0</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_903_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--StephenCabralMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zKMERKWPDCo2" title="Granted Date"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_StephenCabralMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004287" name="us-gaap:TargetedOrTrackingStockIssuanceDates">05-02-2022</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--StephenCabralMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zpoidDGY1po6" title="Exercise price" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2022-12-31_custom_StephenCabralMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004289" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.05</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--StephenCabralMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_ziPZldaQahO" title="Vesting Date"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_StephenCabralMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004291" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate">05-02-2022</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--StephenCabralMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z7mtBjLCWCOg" title="Vested Outstanding" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2022-12-31_custom_StephenCabralMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004293" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">0</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--StephenCabralMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zvGzB6e10LIj" title="Unvested" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="AsOf2022-12-31_custom_StephenCabralMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004295" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">0</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--StephenCabralMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zuwBeWx1OgTj" title="Date Fully Vested"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_StephenCabralMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004297" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate">05-02-2026</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--StephenCabralMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z06wjmJJL7j" title="Board Approval Date"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_StephenCabralMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004299" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate">05-02-2022</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--StephenCabralMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zf0KWNyJqW24" title="Expiration Date"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_StephenCabralMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004301" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">05-01-2032</ix:nonNumeric></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Jonah Petit-Perrin</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--JonahPetiPerrinMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zjUdsZpRym9c" title="Granted Shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2022-01-012022-12-31_custom_JonahPetiPerrinMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004303" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,500</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--JonahPetiPerrinMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z5ByE1Z1QMa3" title="Outstanding Awards" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2022-12-31_custom_JonahPetiPerrinMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004305" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,500</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--JonahPetiPerrinMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_znNtTB3GQ4m7" title="Granted Date"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_JonahPetiPerrinMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004307" name="us-gaap:TargetedOrTrackingStockIssuanceDates">05-02-2022</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--JonahPetiPerrinMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zBS4tPH6taid" title="Exercise price" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2022-12-31_custom_JonahPetiPerrinMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004309" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.05</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--JonahPetiPerrinMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z1Z9cejRmEwh" title="Vesting Date"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_JonahPetiPerrinMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004311" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate">05-02-2022</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--JonahPetiPerrinMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zee8GqimbV64" title="Vested Outstanding" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2022-12-31_custom_JonahPetiPerrinMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004313" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,250</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--JonahPetiPerrinMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_ziQtB8JotaV4" title="Unvested" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="AsOf2022-12-31_custom_JonahPetiPerrinMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004315" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,250</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--JonahPetiPerrinMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zhtHlmhSqBV1" title="Date Fully Vested"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_JonahPetiPerrinMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004317" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate">05-02-2026</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--JonahPetiPerrinMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zjdz5sN18x0g" title="Board Approval Date"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_JonahPetiPerrinMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004319" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate">05-02-2022</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--JonahPetiPerrinMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z4ipI8GLHwP8" title="Expiration Date"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_JonahPetiPerrinMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004321" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">05-01-2032</ix:nonNumeric></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Bryan Nella</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--BryanNellaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zbPLsMrTyCA2" title="Granted Shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2022-01-012022-12-31_custom_BryanNellaMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004323" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">25,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--BryanNellaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zeur895jwiSe" title="Outstanding Awards" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2022-12-31_custom_BryanNellaMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004325" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">25,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90B_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--BryanNellaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zmLZTBTnQtG2" title="Granted Date"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_BryanNellaMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004327" name="us-gaap:TargetedOrTrackingStockIssuanceDates">05-02-2022</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--BryanNellaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zUc14HjWkwyg" title="Exercise price" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2022-12-31_custom_BryanNellaMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004329" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.05</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--BryanNellaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zONYjSE3kgmd" title="Vesting Date"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_BryanNellaMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004331" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate">05-02-2022</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--BryanNellaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zhwvJLEBGex1" title="Vested Outstanding" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2022-12-31_custom_BryanNellaMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004333" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">12,500</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--BryanNellaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z1WjMt58CFUg" title="Unvested" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="AsOf2022-12-31_custom_BryanNellaMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004335" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">12,500</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--BryanNellaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z96tWHUjxNeg" title="Date Fully Vested"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_BryanNellaMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004337" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate">05-02-2026</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--BryanNellaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zMwCQJm0JADe" title="Board Approval Date"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_BryanNellaMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004339" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate">05-02-2022</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--BryanNellaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zdDDHYmYKT2i" title="Expiration Date"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_BryanNellaMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004341" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">05-01-2032</ix:nonNumeric></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Mark Sink</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--MarkSinkMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zimf9Ch28Wui" title="Granted Shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2022-01-012022-12-31_custom_MarkSinkMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004343" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">25,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--MarkSinkMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zZLocIrhgjk2" title="Outstanding Awards" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2022-12-31_custom_MarkSinkMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004345" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">25,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_906_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--MarkSinkMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zGFaccnau9le" title="Granted Date"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_MarkSinkMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004347" name="us-gaap:TargetedOrTrackingStockIssuanceDates">05-16-2022</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--MarkSinkMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zu7z4rcHGuCc" title="Exercise price" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2022-12-31_custom_MarkSinkMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004349" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.05</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_906_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--MarkSinkMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zabNGQ8A0Kj6" title="Vesting Date"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_MarkSinkMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004351" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate">05-16-2022</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--MarkSinkMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zlle8gf7Tndd" title="Vested Outstanding" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2022-12-31_custom_MarkSinkMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004353" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">12,500</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--MarkSinkMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zTZuKBOkJng2" title="Unvested" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="AsOf2022-12-31_custom_MarkSinkMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004355" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">12,500</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--MarkSinkMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zFMW3LGvFmH1" title="Date Fully Vested"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_MarkSinkMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004357" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate">05-16-2026</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--MarkSinkMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zJLhpuc0V4h" title="Board Approval Date"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_MarkSinkMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004359" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate">05-02-2022</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--MarkSinkMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zvLkBOKkgj1b" title="Expiration Date"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_MarkSinkMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004361" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">05-15-2032</ix:nonNumeric></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Koustav Choudhuri</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--KoustavChoudhuriMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zbh9U6pV5q3c" title="Granted Shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2022-01-012022-12-31_custom_KoustavChoudhuriMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004363" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">17,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--KoustavChoudhuriMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zqKUHN23zawa" title="Outstanding Awards" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2022-12-31_custom_KoustavChoudhuriMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004365" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">17,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--KoustavChoudhuriMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zFze2Pe8pvWc" title="Granted Date"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_KoustavChoudhuriMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004367" name="us-gaap:TargetedOrTrackingStockIssuanceDates">05-16-2022</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--KoustavChoudhuriMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zCR3ZuuzNtj9" title="Exercise price" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2022-12-31_custom_KoustavChoudhuriMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004369" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.05</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--KoustavChoudhuriMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z8f5vWaGbzx2" title="Vesting Date"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_KoustavChoudhuriMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004371" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate">05-16-2022</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--KoustavChoudhuriMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zHFzmum5KYR8" title="Vested Outstanding" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2022-12-31_custom_KoustavChoudhuriMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004373" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">8,500</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--KoustavChoudhuriMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zA3MVoCaVxUa" title="Unvested" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="AsOf2022-12-31_custom_KoustavChoudhuriMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004375" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">8,500</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--KoustavChoudhuriMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z7Qdji6G9dJ3" title="Date Fully Vested"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_KoustavChoudhuriMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004377" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate">05-16-2026</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--KoustavChoudhuriMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z9Z9FMLzPlT6" title="Board Approval Date"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_KoustavChoudhuriMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004379" name="RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate">05-02-2022</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--KoustavChoudhuriMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zHeIwWUKyAG8" title="Expiration Date"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_KoustavChoudhuriMember_us-gaap_StockOptionMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004381" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">05-15-2032</ix:nonNumeric></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif">Total</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zbm3KvbNqxJi" title="Granted Shares" style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2022-01-012022-12-31_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004383" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">11,712,000</ix:nonFraction></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zbFqwBe0pozj" title="Outstanding Awards" style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2022-12-31_us-gaap_StockOptionMember_custom_SemiCabIncMember" id="Fact004385" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">11,597,000</ix:nonFraction></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A7_zOfGtJ9Lfm38" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WARRANTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable. The Company has not issued any form of a warrant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>COMMON
STOCK ISSUANCES </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable other than founders shares in the amount of <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240101__20240331__srt--TitleOfIndividualAxis__custom--FoundersMember_zW90DaQyoT2d" title="Common stock, issuance"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2024-01-012024-03-31_custom_FoundersMember_custom_SemiCabIncMember" id="Fact004387" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">25,000,000</ix:nonFraction></span>. The Company has only used SAFE convertible notes convertible into
preferred equity, and common stock options to date.</span></p>
<!-- Field: Split-Segment; Name: 001 -->
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember" escape="true" id="Fact004389" name="RIME:SafePrivatePlacementsTextBlock"><p id="xdx_80D_ecustom--SafePrivatePlacementsTextBlock_zkMoV0TaqySi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
11 &#8211;<span id="xdx_82E_zqzxCowkNyk7">SAFE PRIVATE PLACEMENTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beginning
on October 25, 2018 through April 22, 2023, the Company entered into a total of 50 separate Simple Agreements for Future Equity (&#8220;SAFE
Agreements&#8221;). 45 distinct counterparties entered into subscription agreements with the Company, investing a total of $<span id="xdx_908_eus-gaap--Investments_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEAgreementsMember_zw8qc4vbx8mb"><ix:nonFraction name="us-gaap:Investments" contextRef="AsOf2023-04-22_custom_SAFEAgreementsMember_custom_SemiCabIncMember" id="Fact004390" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,038,820</ix:nonFraction>
</span>during this period. The terms of these SAFE Agreements varied slightly over the course of this time frame. All of these investments were
made in the form of a private placement under Reg D and were considered exempt from registration at that time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 129; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember" escape="true" id="Fact004392" name="RIME:SafePrivatePlacementsTableTextBlock"><p id="xdx_892_ecustom--SafePrivatePlacementsTableTextBlock_zMdTYM5IwPF4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table below summarizes the first tranche of subscriptions, all with the same terms and conditions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; display: none; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BA_zbXdLJs5wjXa">SCHEDULE
OF FIRST TRANCHE OF SUBSCRIPTIONS</span></span></p>


<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ID</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible
    Holder Name</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue
    Date</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Valuation
    Cap</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Converted
    Date</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 12%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SAFE-1</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 23%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_ecustom--ConvertibleHolderName_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEOneMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zmBU6yAqD2Hi" title="Convertible Holder Name"><ix:nonNumeric contextRef="From2018-10-252023-04-22_custom_SAFEOneMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember" id="Fact004394" name="RIME:ConvertibleHolderName">Ardhendu
    Haldar</ix:nonNumeric></span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_980_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEOneMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zliJ96O3eCyd" title="Principal" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="RIME:InvestmentOfPrincipalAmount" contextRef="AsOf2023-04-22_custom_SAFEOneMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember" id="Fact004396" format="ixt:numdotdecimal" decimals="0" unitRef="USD">250,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 12%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_ecustom--InvestmentIssueDate_dd_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEOneMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zVsRHCePLDrl" title="Issue Date"><ix:nonNumeric contextRef="From2018-10-252023-04-22_custom_SAFEOneMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004398" name="RIME:InvestmentIssueDate">10-25-2018</ix:nonNumeric></span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEOneMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zF51JYfcVegi" title="Valuation Cap"><ix:nonFraction name="RIME:ValuationCapitalOfInvestment" contextRef="AsOf2023-04-22_custom_SAFEOneMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember" id="Fact004400" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,000,000</ix:nonFraction></span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--InvestmentConvertedDate_dd_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEOneMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zhQqLyTc9ISi" title="Converted Date"><ix:nonNumeric contextRef="From2018-10-252023-04-22_custom_SAFEOneMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004402" name="RIME:InvestmentConvertedDate">12-25-2020</ix:nonNumeric></span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SAFE-38</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--ConvertibleHolderName_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyEightMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zsp0Xg3OZ17g" title="Convertible Holder Name"><ix:nonNumeric contextRef="From2018-10-252023-04-22_custom_SAFEThirtyEightMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember" id="Fact004404" name="RIME:ConvertibleHolderName">Praveen
    Kaza</ix:nonNumeric></span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98B_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyEightMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zwKlJexkQVYc" title="Principal" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="RIME:InvestmentOfPrincipalAmount" contextRef="AsOf2023-04-22_custom_SAFEThirtyEightMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember" id="Fact004406" format="ixt:numdotdecimal" decimals="0" unitRef="USD">100,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_ecustom--InvestmentIssueDate_dd_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyEightMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zWVwrA2aR1ll" title="Issue Date"><ix:nonNumeric contextRef="From2018-10-252023-04-22_custom_SAFEThirtyEightMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004408" name="RIME:InvestmentIssueDate">10-25-2018</ix:nonNumeric></span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyEightMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zHCIbpCX9oTh" title="Valuation Cap"><ix:nonFraction name="RIME:ValuationCapitalOfInvestment" contextRef="AsOf2023-04-22_custom_SAFEThirtyEightMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember" id="Fact004410" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,000,000</ix:nonFraction></span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_ecustom--InvestmentConvertedDate_dd_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyEightMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zcY9jTwULxIl" title="Converted Date"><ix:nonNumeric contextRef="From2018-10-252023-04-22_custom_SAFEThirtyEightMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004412" name="RIME:InvestmentConvertedDate">12-25-2020</ix:nonNumeric></span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SAFE-41</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--ConvertibleHolderName_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyOneMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zNbrREaH5yVg" title="Convertible Holder Name"><ix:nonNumeric contextRef="From2018-10-252023-04-22_custom_SAFEFortyOneMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember" id="Fact004414" name="RIME:ConvertibleHolderName">Kurt
    W Mattson</ix:nonNumeric></span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98E_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyOneMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zjQUbNow8tH" title="Principal" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="RIME:InvestmentOfPrincipalAmount" contextRef="AsOf2023-04-22_custom_SAFEFortyOneMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember" id="Fact004416" format="ixt:numdotdecimal" decimals="0" unitRef="USD">50,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecustom--InvestmentIssueDate_dd_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyOneMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zeZsrnt9se8h" title="Issue Date"><ix:nonNumeric contextRef="From2018-10-252023-04-22_custom_SAFEFortyOneMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004418" name="RIME:InvestmentIssueDate">03-27-2019</ix:nonNumeric></span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyOneMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_z7scvcwKhoc2" title="Valuation Cap"><ix:nonFraction name="RIME:ValuationCapitalOfInvestment" contextRef="AsOf2023-04-22_custom_SAFEFortyOneMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember" id="Fact004420" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,000,000</ix:nonFraction></span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecustom--InvestmentConvertedDate_dd_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyOneMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zKL4FKO1Fmnc" title="Converted Date"><ix:nonNumeric contextRef="From2018-10-252023-04-22_custom_SAFEFortyOneMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004422" name="RIME:InvestmentConvertedDate">12-25-2020</ix:nonNumeric></span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SAFE-42</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--ConvertibleHolderName_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyTwoMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_z2dvffhkCpyh" title="Convertible Holder Name"><ix:nonNumeric contextRef="From2018-10-252023-04-22_custom_SAFEFortyTwoMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember" id="Fact004424" name="RIME:ConvertibleHolderName">Wendy
    A Thompson</ix:nonNumeric></span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_986_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyTwoMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zOCnPEcTXJRe" title="Principal" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="RIME:InvestmentOfPrincipalAmount" contextRef="AsOf2023-04-22_custom_SAFEFortyTwoMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember" id="Fact004426" format="ixt:numdotdecimal" decimals="0" unitRef="USD">50,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_ecustom--InvestmentIssueDate_dd_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyTwoMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_z40PYKq7EC3c" title="Issue Date"><ix:nonNumeric contextRef="From2018-10-252023-04-22_custom_SAFEFortyTwoMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004428" name="RIME:InvestmentIssueDate">03-27-2019</ix:nonNumeric></span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyTwoMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zVijYLn5dR3" title="Valuation Cap"><ix:nonFraction name="RIME:ValuationCapitalOfInvestment" contextRef="AsOf2023-04-22_custom_SAFEFortyTwoMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember" id="Fact004430" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,000,000</ix:nonFraction></span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_ecustom--InvestmentConvertedDate_dd_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyTwoMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zOBbF9N3JDhc" title="Converted Date"><ix:nonNumeric contextRef="From2018-10-252023-04-22_custom_SAFEFortyTwoMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004432" name="RIME:InvestmentConvertedDate">12-25-2020</ix:nonNumeric></span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SAFE-44</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--ConvertibleHolderName_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyFourMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zdE9XHWYEDdh" title="Convertible Holder Name"><ix:nonNumeric contextRef="From2018-10-252023-04-22_custom_SAFEFortyFourMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember" id="Fact004434" name="RIME:ConvertibleHolderName">Sonata
    Software North America Inc</ix:nonNumeric></span>.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98A_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyFourMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zVGewTXRhwrb" title="Principal" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="RIME:InvestmentOfPrincipalAmount" contextRef="AsOf2023-04-22_custom_SAFEFortyFourMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember" id="Fact004436" format="ixt:numdotdecimal" decimals="0" unitRef="USD">468,041</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_ecustom--InvestmentIssueDate_dd_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyFourMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zNPuc9NcMVa2" title="Issue Date"><ix:nonNumeric contextRef="From2018-10-252023-04-22_custom_SAFEFortyFourMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004438" name="RIME:InvestmentIssueDate">02-24-2020</ix:nonNumeric></span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyFourMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zmbPCN5pvDx3" title="Valuation Cap"><ix:nonFraction name="RIME:ValuationCapitalOfInvestment" contextRef="AsOf2023-04-22_custom_SAFEFortyFourMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember" id="Fact004440" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,000,000</ix:nonFraction></span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--InvestmentConvertedDate_dd_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyFourMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zRDcr11ljCIl" title="Converted Date"><ix:nonNumeric contextRef="From2018-10-252023-04-22_custom_SAFEFortyFourMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004442" name="RIME:InvestmentConvertedDate">12-25-2020</ix:nonNumeric></span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SAFE-43</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_ecustom--ConvertibleHolderName_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyThreeMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zkUUt1YUMlSf" title="Convertible Holder Name"><ix:nonNumeric contextRef="From2018-10-252023-04-22_custom_SAFEFortyThreeMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember" id="Fact004444" name="RIME:ConvertibleHolderName">THE
    IRA CLUB F/B/O RANJU MAHESHWARI ROTH IRA 2000201</ix:nonNumeric></span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_983_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyThreeMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zUJGoISJZdW4" title="Principal" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="RIME:InvestmentOfPrincipalAmount" contextRef="AsOf2023-04-22_custom_SAFEFortyThreeMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember" id="Fact004446" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_ecustom--InvestmentIssueDate_dd_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyThreeMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_z2hw2WkOElA7" title="Issue Date"><ix:nonNumeric contextRef="From2018-10-252023-04-22_custom_SAFEFortyThreeMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004448" name="RIME:InvestmentIssueDate">06-15-2020</ix:nonNumeric></span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyThreeMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zRWIOgb9n6o6" title="Valuation Cap"><ix:nonFraction name="RIME:ValuationCapitalOfInvestment" contextRef="AsOf2023-04-22_custom_SAFEFortyThreeMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember" id="Fact004450" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,000,000</ix:nonFraction></span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--InvestmentConvertedDate_dd_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyThreeMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zLBBYOIrIXTk" title="Converted Date"><ix:nonNumeric contextRef="From2018-10-252023-04-22_custom_SAFEFortyThreeMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004452" name="RIME:InvestmentConvertedDate">12-25-2020</ix:nonNumeric></span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_984_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zSss5sYwsHj4" title="Principal" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="RIME:InvestmentOfPrincipalAmount" contextRef="AsOf2023-04-22_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember" id="Fact004454" format="ixt:numdotdecimal" decimals="0" unitRef="USD">943,041</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AE_zYrpx0ld86fe" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
total of six investors subscribed for a total of $<span id="xdx_90E_eus-gaap--Investments_iI_c20240331__us-gaap--TypeOfArrangementAxis__custom--SAFEAgreementsMember_zNsFTh2bWTS3" title="Investments"><ix:nonFraction name="us-gaap:Investments" contextRef="AsOf2024-03-31_custom_SAFEAgreementsMember_custom_SemiCabIncMember" id="Fact004456" format="ixt:numdotdecimal" decimals="0" unitRef="USD">943,041</ix:nonFraction></span> was invested at a valuation of $<span id="xdx_904_ecustom--InvestedValuationOfAmount_c20240101__20240331__us-gaap--TypeOfArrangementAxis__custom--SAFEAgreementsMember_zbaKohTz30c2" title="Invested valuation of value"><ix:nonFraction name="RIME:InvestedValuationOfAmount" contextRef="From2024-01-012024-03-31_custom_SAFEAgreementsMember_custom_SemiCabIncMember" id="Fact004458" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,000,000</ix:nonFraction></span>. On December 25, 2020, all of these
SAFE Agreements were converted to preferred equity and the underlying subscription agreements were cancelled. These are the only SAFE
Agreements converted to date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
August 12, 2021 to April 22, 2023, the Company entered into the remaining 44 SAFE Agreements with a total of 39 individual counterparties.
The total amount of capital invested under these subscriptions was $<span id="xdx_90E_ecustom--InvestedValuationOfAmount_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--FortyFourSAFEAgreementsMember_zWF5ApTWeWQa" title="Invested valuation of amount"><ix:nonFraction name="RIME:InvestedValuationOfAmount" contextRef="From2021-08-122023-04-22_custom_FortyFourSAFEAgreementsMember_custom_SemiCabIncMember" id="Fact004460" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,095,779</ix:nonFraction></span>. The primary difference in the terms of this tranche of
capital raised was the valuation placed on the Company, which increased from a valuation of $<span id="xdx_902_eus-gaap--DebtInstrumentFaceAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--FortyFourSAFEAgreementsMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zqKhmi8O6bRd" title="Principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2023-04-22_custom_FortyFourSAFEAgreementsMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember" id="Fact004462" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,000,000</ix:nonFraction></span> under the first tranche to $<span id="xdx_902_ecustom--InvestedValuationOfAmount_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--FortyFourSAFEAgreementsMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheTwoMember_z1Y1jTBvFU4c" title="Invested valuation of amount"><ix:nonFraction name="RIME:InvestedValuationOfAmount" contextRef="From2021-08-122023-04-22_custom_FortyFourSAFEAgreementsMember_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_custom_SemiCabIncMember" id="Fact004464" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35,000,000</ix:nonFraction></span>
under the second tranche. None of the second tranche of SAFE Agreements have been converted, cancelled, or otherwise amended.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 130; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember" escape="true" id="Fact004466" name="us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock"><p id="xdx_898_eus-gaap--InvestmentHoldingsScheduleOfInvestmentsTableTextBlock_zhB1KGs8u75" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table below summarizes the remaining 44 SAFE Agreements, all of which are expected to terminated immediately after closing of the Transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; display: none; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B7_zMmD0PkXOs9b" style="display: none">SUMMARY
OF  TERMINATED IMMEDIATELY AFTER CLOSING OF THE TRANSACTION</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif">ID</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif">Convertible Holder Name</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Principal</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Issue Date</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Valuation Cap</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 15%">SAFE-40</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 29%; text-align: left"><span id="xdx_90A_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyMember_zNnWrhDBldck" title="Convertible Holder Name"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFEFortyMember_custom_SemiCabIncMember" id="Fact004468" name="RIME:ConvertibleHolderName">Sunil Bhatia</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98F_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyMember_zEKBp996pwHi" title="Principal" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><ix:nonFraction name="RIME:InvestmentOfPrincipalAmount" contextRef="AsOf2023-04-22_custom_SAFEFortyMember_custom_SemiCabIncMember" id="Fact004470" format="ixt:numdotdecimal" decimals="0" unitRef="USD">250,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: center"><span id="xdx_902_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyMember_zPaiFTX2BXk8" title="Issue Date"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFEFortyMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004472" name="RIME:InvestmentIssueDate">08-12-2021</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right"><span id="xdx_901_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyMember_zI3TIfkGu0t2" title="Valuation Cap"><ix:nonFraction name="RIME:ValuationCapitalOfInvestment" contextRef="AsOf2023-04-22_custom_SAFEFortyMember_custom_SemiCabIncMember" id="Fact004474" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,000,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-39</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_90D_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyNineMember_z2xekIuZFKYe" title="Convertible Holder Name"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFEThirtyNineMember_custom_SemiCabIncMember" id="Fact004476" name="RIME:ConvertibleHolderName">Pallav Gupta</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98D_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyNineMember_zrn49RYrIbR3" title="Principal" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:InvestmentOfPrincipalAmount" contextRef="AsOf2023-04-22_custom_SAFEThirtyNineMember_custom_SemiCabIncMember" id="Fact004478" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_909_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyNineMember_z96jMvjVktAj" title="Issue Date"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFEThirtyNineMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004480" name="RIME:InvestmentIssueDate">08-12-2021</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyNineMember_zKrr458gx533" title="Valuation Cap"><ix:nonFraction name="RIME:ValuationCapitalOfInvestment" contextRef="AsOf2023-04-22_custom_SAFEThirtyNineMember_custom_SemiCabIncMember" id="Fact004482" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,000,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-10</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_907_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETenMember_zkAQ4JGsh2K9" title="Convertible Holder Name"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFETenMember_custom_SemiCabIncMember" id="Fact004484" name="RIME:ConvertibleHolderName">The Bhardwaj 2003 Revocable Trust</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98A_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETenMember_zxPlTIta7LCg" title="Principal" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:InvestmentOfPrincipalAmount" contextRef="AsOf2023-04-22_custom_SAFETenMember_custom_SemiCabIncMember" id="Fact004486" format="ixt:numdotdecimal" decimals="0" unitRef="USD">200,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90E_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETenMember_zPpAgbPO2igf" title="Issue Date"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFETenMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004488" name="RIME:InvestmentIssueDate">12-31-2021</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETenMember_zvAiK7JMG6Ck" title="Valuation Cap"><ix:nonFraction name="RIME:ValuationCapitalOfInvestment" contextRef="AsOf2023-04-22_custom_SAFETenMember_custom_SemiCabIncMember" id="Fact004490" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35,000,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-11</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_909_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEElevenMember_zx29Iq8xxFvf" title="Convertible Holder Name"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFEElevenMember_custom_SemiCabIncMember" id="Fact004492" name="RIME:ConvertibleHolderName">Praveen Kaza</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_989_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEElevenMember_zDgGtuZ5Xpt2" title="Principal" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:InvestmentOfPrincipalAmount" contextRef="AsOf2023-04-22_custom_SAFEElevenMember_custom_SemiCabIncMember" id="Fact004494" format="ixt:numdotdecimal" decimals="0" unitRef="USD">50,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90C_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEElevenMember_zjMRPuI8Pqei" title="Issue Date"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFEElevenMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004496" name="RIME:InvestmentIssueDate">12-31-2021</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEElevenMember_zuk39vaK0GIi" title="Valuation Cap"><ix:nonFraction name="RIME:ValuationCapitalOfInvestment" contextRef="AsOf2023-04-22_custom_SAFEElevenMember_custom_SemiCabIncMember" id="Fact004498" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35,000,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-12</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_901_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwelveMember_zvucg5fvnDKk" title="Convertible Holder Name"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFETwelveMember_custom_SemiCabIncMember" id="Fact004500" name="RIME:ConvertibleHolderName">Pallav Gupta</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_981_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwelveMember_zM4GJPvEhpF1" title="Principal" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:InvestmentOfPrincipalAmount" contextRef="AsOf2023-04-22_custom_SAFETwelveMember_custom_SemiCabIncMember" id="Fact004502" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_905_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwelveMember_zsihZaL9rFLg" title="Issue Date"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFETwelveMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004504" name="RIME:InvestmentIssueDate">12-31-2021</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90B_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwelveMember_zU3JDnKOLoMg" title="Valuation Cap"><ix:nonFraction name="RIME:ValuationCapitalOfInvestment" contextRef="AsOf2023-04-22_custom_SAFETwelveMember_custom_SemiCabIncMember" id="Fact004506" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35,000,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-13</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_902_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirteenMember_zRj99Hawz5vj" title="Convertible Holder Name"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFEThirteenMember_custom_SemiCabIncMember" id="Fact004508" name="RIME:ConvertibleHolderName">Amit and Anju Bhardwaj</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_987_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirteenMember_zdS4E6YfSQa7" title="Principal" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:InvestmentOfPrincipalAmount" contextRef="AsOf2023-04-22_custom_SAFEThirteenMember_custom_SemiCabIncMember" id="Fact004510" format="ixt:numdotdecimal" decimals="0" unitRef="USD">50,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_900_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirteenMember_zuxmOK3Tw1Vj" title="Issue Date"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFEThirteenMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004512" name="RIME:InvestmentIssueDate">12-31-2021</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90F_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirteenMember_z7gdaPTaMrxh" title="Valuation Cap"><ix:nonFraction name="RIME:ValuationCapitalOfInvestment" contextRef="AsOf2023-04-22_custom_SAFEThirteenMember_custom_SemiCabIncMember" id="Fact004514" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35,000,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-14</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_908_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFourteenMember_zZRo7rH88Jk6" title="Convertible Holder Name"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFEFourteenMember_custom_SemiCabIncMember" id="Fact004516" name="RIME:ConvertibleHolderName">Komal Bajaj</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98C_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFourteenMember_zA4UOoq9A4G1" title="Principal" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:InvestmentOfPrincipalAmount" contextRef="AsOf2023-04-22_custom_SAFEFourteenMember_custom_SemiCabIncMember" id="Fact004518" format="ixt:numdotdecimal" decimals="0" unitRef="USD">50,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_900_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFourteenMember_zKCanzlfUdsg" title="Issue Date"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFEFourteenMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004520" name="RIME:InvestmentIssueDate">12-31-2021</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFourteenMember_zIKvaYNdkdMh" title="Valuation Cap"><ix:nonFraction name="RIME:ValuationCapitalOfInvestment" contextRef="AsOf2023-04-22_custom_SAFEFourteenMember_custom_SemiCabIncMember" id="Fact004522" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35,000,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-15</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90C_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFifteenMember_zj7F5dwItiYc" title="Convertible Holder Name"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFEFifteenMember_custom_SemiCabIncMember" id="Fact004524" name="RIME:ConvertibleHolderName">Goel Trust, Dated Aug 2, 2000</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98E_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFifteenMember_zkgYiXUFZpy1" title="Principal" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:InvestmentOfPrincipalAmount" contextRef="AsOf2023-04-22_custom_SAFEFifteenMember_custom_SemiCabIncMember" id="Fact004526" format="ixt:numdotdecimal" decimals="0" unitRef="USD">100,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_900_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFifteenMember_zYEaBfG2lGlc" title="Issue Date"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFEFifteenMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004528" name="RIME:InvestmentIssueDate">12-31-2021</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90D_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFifteenMember_zPtrjrMBMVR" title="Valuation Cap"><ix:nonFraction name="RIME:ValuationCapitalOfInvestment" contextRef="AsOf2023-04-22_custom_SAFEFifteenMember_custom_SemiCabIncMember" id="Fact004530" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35,000,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-16</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_902_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESixteenMember_zjmnovNVUREh" title="Convertible Holder Name"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFESixteenMember_custom_SemiCabIncMember" id="Fact004532" name="RIME:ConvertibleHolderName">Sanjiva Singh</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98F_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESixteenMember_zPbhZDlGti9i" title="Principal" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:InvestmentOfPrincipalAmount" contextRef="AsOf2023-04-22_custom_SAFESixteenMember_custom_SemiCabIncMember" id="Fact004534" format="ixt:numdotdecimal" decimals="0" unitRef="USD">100,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90B_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESixteenMember_zmtZT7WmxGWd" title="Issue Date"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFESixteenMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004536" name="RIME:InvestmentIssueDate">12-31-2021</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESixteenMember_zeXEnVfzKFOc" title="Valuation Cap"><ix:nonFraction name="RIME:ValuationCapitalOfInvestment" contextRef="AsOf2023-04-22_custom_SAFESixteenMember_custom_SemiCabIncMember" id="Fact004538" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35,000,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-17</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_908_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESeventeenMember_zPT0HF6QbXz2" title="Convertible Holder Name"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFESeventeenMember_custom_SemiCabIncMember" id="Fact004540" name="RIME:ConvertibleHolderName">Rajeev Agarwal</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_986_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESeventeenMember_zWAgY5GiRFPd" title="Principal" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:InvestmentOfPrincipalAmount" contextRef="AsOf2023-04-22_custom_SAFESeventeenMember_custom_SemiCabIncMember" id="Fact004542" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_902_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESeventeenMember_zlWqcPmnUMm1" title="Issue Date"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFESeventeenMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004544" name="RIME:InvestmentIssueDate">12-31-2021</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESeventeenMember_zLISUGvFYJE1" title="Valuation Cap"><ix:nonFraction name="RIME:ValuationCapitalOfInvestment" contextRef="AsOf2023-04-22_custom_SAFESeventeenMember_custom_SemiCabIncMember" id="Fact004546" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35,000,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-18</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_900_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEEighteenMember_zvb6oFeoq7dc" title="Convertible Holder Name"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFEEighteenMember_custom_SemiCabIncMember" id="Fact004548" name="RIME:ConvertibleHolderName">Sanyogita and Sunil Gupta</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_984_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEEighteenMember_zlSZj5xmK85i" title="Principal" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:InvestmentOfPrincipalAmount" contextRef="AsOf2023-04-22_custom_SAFEEighteenMember_custom_SemiCabIncMember" id="Fact004550" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_909_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEEighteenMember_zw4aZodHxbsd" title="Issue Date"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFEEighteenMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004552" name="RIME:InvestmentIssueDate">12-31-2021</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90D_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEEighteenMember_z0zCJl2UxNzh" title="Valuation Cap"><ix:nonFraction name="RIME:ValuationCapitalOfInvestment" contextRef="AsOf2023-04-22_custom_SAFEEighteenMember_custom_SemiCabIncMember" id="Fact004554" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35,000,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-19</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_902_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFENineteenMember_z5gYmgIRZC2j" title="Convertible Holder Name"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFENineteenMember_custom_SemiCabIncMember" id="Fact004556" name="RIME:ConvertibleHolderName">SEM Gaingels Fund I, a series of JMWTX Investments, LP</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_985_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFENineteenMember_zHLtC1f3hJTb" title="Principal" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:InvestmentOfPrincipalAmount" contextRef="AsOf2023-04-22_custom_SAFENineteenMember_custom_SemiCabIncMember" id="Fact004558" format="ixt:numdotdecimal" decimals="0" unitRef="USD">300,279</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_904_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFENineteenMember_zvUnvJTA2m74" title="Issue Date"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFENineteenMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004560" name="RIME:InvestmentIssueDate">12-31-2021</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFENineteenMember_zcTAUrLJsjy3" title="Valuation Cap"><ix:nonFraction name="RIME:ValuationCapitalOfInvestment" contextRef="AsOf2023-04-22_custom_SAFENineteenMember_custom_SemiCabIncMember" id="Fact004562" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35,000,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-2</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_901_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwoMember_ztzlSQofB838" title="Convertible Holder Name"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFETwoMember_custom_SemiCabIncMember" id="Fact004564" name="RIME:ConvertibleHolderName">FVI Fund LLC</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98C_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwoMember_z6Pm4zfQYkv4" title="Principal" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:InvestmentOfPrincipalAmount" contextRef="AsOf2023-04-22_custom_SAFETwoMember_custom_SemiCabIncMember" id="Fact004566" format="ixt:numdotdecimal" decimals="0" unitRef="USD">50,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90F_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwoMember_z7SmG95GTUB7" title="Issue Date"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFETwoMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004568" name="RIME:InvestmentIssueDate">12-31-2021</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwoMember_z7obRtEGSim1" title="Valuation Cap"><ix:nonFraction name="RIME:ValuationCapitalOfInvestment" contextRef="AsOf2023-04-22_custom_SAFETwoMember_custom_SemiCabIncMember" id="Fact004570" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35,000,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-20</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_901_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyMember_zYy69ZruVOce" title="Convertible Holder Name"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFETwentyMember_custom_SemiCabIncMember" id="Fact004572" name="RIME:ConvertibleHolderName">JWass PT Investors, LP - B2</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_987_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyMember_zlKjHaqejOWd" title="Principal" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:InvestmentOfPrincipalAmount" contextRef="AsOf2023-04-22_custom_SAFETwentyMember_custom_SemiCabIncMember" id="Fact004574" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_902_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyMember_zOclF6NkOzk5" title="Issue Date"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFETwentyMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004576" name="RIME:InvestmentIssueDate">12-31-2021</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyMember_zOpn12QWZsu" title="Valuation Cap"><ix:nonFraction name="RIME:ValuationCapitalOfInvestment" contextRef="AsOf2023-04-22_custom_SAFETwentyMember_custom_SemiCabIncMember" id="Fact004578" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35,000,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-21</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_90C_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyOneMember_z9fzyC7DZ3d4" title="Convertible Holder Name"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFETwentyOneMember_custom_SemiCabIncMember" id="Fact004580" name="RIME:ConvertibleHolderName">Medhavi Gupta</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_982_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyOneMember_zdvRuVWHS8D" title="Principal" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:InvestmentOfPrincipalAmount" contextRef="AsOf2023-04-22_custom_SAFETwentyOneMember_custom_SemiCabIncMember" id="Fact004582" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_902_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyOneMember_znwAza1j5Ujc" title="Issue Date"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFETwentyOneMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004584" name="RIME:InvestmentIssueDate">12-31-2021</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyOneMember_znzs75RnW6Cl" title="Valuation Cap"><ix:nonFraction name="RIME:ValuationCapitalOfInvestment" contextRef="AsOf2023-04-22_custom_SAFETwentyOneMember_custom_SemiCabIncMember" id="Fact004586" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35,000,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-22</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_90D_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyTwoMember_z144al2WrGR1" title="Convertible Holder Name"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFETwentyTwoMember_custom_SemiCabIncMember" id="Fact004588" name="RIME:ConvertibleHolderName">Sundeep Sibal</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_988_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyTwoMember_zhtfycm9WdOe" title="Principal" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:InvestmentOfPrincipalAmount" contextRef="AsOf2023-04-22_custom_SAFETwentyTwoMember_custom_SemiCabIncMember" id="Fact004590" format="ixt:numdotdecimal" decimals="0" unitRef="USD">50,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_908_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyTwoMember_zKn85GJ5Z0zi" title="Issue Date"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFETwentyTwoMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004592" name="RIME:InvestmentIssueDate">12-31-2021</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyTwoMember_zPfMSm9t0Xmf" title="Valuation Cap"><ix:nonFraction name="RIME:ValuationCapitalOfInvestment" contextRef="AsOf2023-04-22_custom_SAFETwentyTwoMember_custom_SemiCabIncMember" id="Fact004594" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35,000,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-24</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_901_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyFourMember_zAEqTQvKbuf2" title="Convertible Holder Name"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFETwentyFourMember_custom_SemiCabIncMember" id="Fact004596" name="RIME:ConvertibleHolderName">Jolly Gupta</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98F_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyFourMember_zjmTFdn1ZnFl" title="Principal" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:InvestmentOfPrincipalAmount" contextRef="AsOf2023-04-22_custom_SAFETwentyFourMember_custom_SemiCabIncMember" id="Fact004598" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_908_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyFourMember_zK104COnc0R2" title="Issue Date"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFETwentyFourMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004600" name="RIME:InvestmentIssueDate">12-31-2021</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyFourMember_zfJ9p1jroqjj" title="Valuation Cap"><ix:nonFraction name="RIME:ValuationCapitalOfInvestment" contextRef="AsOf2023-04-22_custom_SAFETwentyFourMember_custom_SemiCabIncMember" id="Fact004602" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35,000,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-3</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_908_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThreeMember_zRjjC2OLq2rk" title="Convertible Holder Name"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFEThreeMember_custom_SemiCabIncMember" id="Fact004604" name="RIME:ConvertibleHolderName">Ashutosh Malaviya</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98B_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThreeMember_zZBAbKZN1IC6" title="Principal" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:InvestmentOfPrincipalAmount" contextRef="AsOf2023-04-22_custom_SAFEThreeMember_custom_SemiCabIncMember" id="Fact004606" format="ixt:numdotdecimal" decimals="0" unitRef="USD">50,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_902_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThreeMember_zm1Tm30R8FY4" title="Issue Date"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFEThreeMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004608" name="RIME:InvestmentIssueDate">12-31-2021</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThreeMember_zKftjrrX15b8" title="Valuation Cap"><ix:nonFraction name="RIME:ValuationCapitalOfInvestment" contextRef="AsOf2023-04-22_custom_SAFEThreeMember_custom_SemiCabIncMember" id="Fact004610" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35,000,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-4</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_905_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFourMember_zG7nyP7UGV85" title="Convertible Holder Name"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFEFourMember_custom_SemiCabIncMember" id="Fact004612" name="RIME:ConvertibleHolderName">Consensia Inc</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98A_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFourMember_z9rqcLReDAC6" title="Principal" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:InvestmentOfPrincipalAmount" contextRef="AsOf2023-04-22_custom_SAFEFourMember_custom_SemiCabIncMember" id="Fact004614" format="ixt:numdotdecimal" decimals="0" unitRef="USD">50,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_903_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFourMember_zUV3DxTSvFXa" title="Issue Date"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFEFourMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004616" name="RIME:InvestmentIssueDate">12-31-2021</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90F_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFourMember_zOM7HbVmx624" title="Valuation Cap"><ix:nonFraction name="RIME:ValuationCapitalOfInvestment" contextRef="AsOf2023-04-22_custom_SAFEFourMember_custom_SemiCabIncMember" id="Fact004618" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35,000,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-45</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_902_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyFiveMember_z8Zwm7gyGDm9" title="Convertible Holder Name"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFEFortyFiveMember_custom_SemiCabIncMember" id="Fact004620" name="RIME:ConvertibleHolderName">Atula Sibal</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_987_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyFiveMember_zWwxjlxJtFG1" title="Principal" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:InvestmentOfPrincipalAmount" contextRef="AsOf2023-04-22_custom_SAFEFortyFiveMember_custom_SemiCabIncMember" id="Fact004622" format="ixt:numdotdecimal" decimals="0" unitRef="USD">50,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90A_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyFiveMember_z1J2fHmUTJZ2" title="Issue Date"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFEFortyFiveMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004624" name="RIME:InvestmentIssueDate">12-31-2021</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyFiveMember_zovVeA5NUiI5" title="Valuation Cap"><ix:nonFraction name="RIME:ValuationCapitalOfInvestment" contextRef="AsOf2023-04-22_custom_SAFEFortyFiveMember_custom_SemiCabIncMember" id="Fact004626" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35,000,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-6</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_904_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESixMember_zAORJfg9xmPk" title="Convertible Holder Name"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFESixMember_custom_SemiCabIncMember" id="Fact004628" name="RIME:ConvertibleHolderName">Ajay Bhatnagar</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98B_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESixMember_zMVvItr25CU3" title="Principal" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:InvestmentOfPrincipalAmount" contextRef="AsOf2023-04-22_custom_SAFESixMember_custom_SemiCabIncMember" id="Fact004630" format="ixt:numdotdecimal" decimals="0" unitRef="USD">100,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_908_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESixMember_zCY7GJBRuXOa" title="Issue Date"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFESixMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004632" name="RIME:InvestmentIssueDate">12-31-2021</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90F_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESixMember_zrmlbLeHoiRe" title="Valuation Cap"><ix:nonFraction name="RIME:ValuationCapitalOfInvestment" contextRef="AsOf2023-04-22_custom_SAFESixMember_custom_SemiCabIncMember" id="Fact004634" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35,000,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-7</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_902_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESevenMember_zsXtuX1hlU3i" title="Convertible Holder Name"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFESevenMember_custom_SemiCabIncMember" id="Fact004636" name="RIME:ConvertibleHolderName">Pankaj Sinha</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_981_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESevenMember_zVEoAVhg3is6" title="Principal" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:InvestmentOfPrincipalAmount" contextRef="AsOf2023-04-22_custom_SAFESevenMember_custom_SemiCabIncMember" id="Fact004638" format="ixt:numdotdecimal" decimals="0" unitRef="USD">50,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90D_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESevenMember_z6qqVZlPTGq2" title="Issue Date"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFESevenMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004640" name="RIME:InvestmentIssueDate">12-31-2021</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESevenMember_zCX9sTubOrif" title="Valuation Cap"><ix:nonFraction name="RIME:ValuationCapitalOfInvestment" contextRef="AsOf2023-04-22_custom_SAFESevenMember_custom_SemiCabIncMember" id="Fact004642" format="ixt:numunitdecimalin" decimals="0" unitRef="USD">35,000,00</ix:nonFraction></span>0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-8</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_908_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEEightMember_z3FLJBYSju17" title="Convertible Holder Name"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFEEightMember_custom_SemiCabIncMember" id="Fact004644" name="RIME:ConvertibleHolderName">Bakulesh Adya</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_982_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEEightMember_za1ogWXLzuG" title="Principal" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:InvestmentOfPrincipalAmount" contextRef="AsOf2023-04-22_custom_SAFEEightMember_custom_SemiCabIncMember" id="Fact004646" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_907_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEEightMember_zUf4NUgc5ltl" title="Issue Date"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFEEightMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004648" name="RIME:InvestmentIssueDate">12-31-2021</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_901_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEEightMember_z0GeTzCjdZ8a" title="Valuation Cap"><ix:nonFraction name="RIME:ValuationCapitalOfInvestment" contextRef="AsOf2023-04-22_custom_SAFEEightMember_custom_SemiCabIncMember" id="Fact004650" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35,000,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-9</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_90D_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFENineMember_zxkc6bd9qW14" title="Convertible Holder Name"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFENineMember_custom_SemiCabIncMember" id="Fact004652" name="RIME:ConvertibleHolderName">Alok Mahajan</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98B_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFENineMember_zTrQ9S5ulMkj" title="Principal" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:InvestmentOfPrincipalAmount" contextRef="AsOf2023-04-22_custom_SAFENineMember_custom_SemiCabIncMember" id="Fact004654" format="ixt:numdotdecimal" decimals="0" unitRef="USD">50,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_906_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFENineMember_zwEodwKJgPy3" title="Issue Date"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFENineMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004656" name="RIME:InvestmentIssueDate">12-31-2021</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFENineMember_zAzDeee9QL8l" title="Valuation Cap"><ix:nonFraction name="RIME:ValuationCapitalOfInvestment" contextRef="AsOf2023-04-22_custom_SAFENineMember_custom_SemiCabIncMember" id="Fact004658" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35,000,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-5</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_901_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFiveMember_zNIRhPwRjDqf" title="Convertible Holder Name"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFEFiveMember_custom_SemiCabIncMember" id="Fact004660" name="RIME:ConvertibleHolderName">BANSAL GARG FAMILY TRUST AMIT BANSAL TRTEE KARUNA GARG TRTEE U/A 11/07/2017</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_980_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFiveMember_zTo0BWVT15Q2" title="Principal" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:InvestmentOfPrincipalAmount" contextRef="AsOf2023-04-22_custom_SAFEFiveMember_custom_SemiCabIncMember" id="Fact004662" format="ixt:numdotdecimal" decimals="0" unitRef="USD">100,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_909_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFiveMember_zqdqxPgiq1Uh" title="Issue Date"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFEFiveMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004664" name="RIME:InvestmentIssueDate">12-31-2021</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_901_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFiveMember_zoiEi4vFMMQ" title="Valuation Cap"><ix:nonFraction name="RIME:ValuationCapitalOfInvestment" contextRef="AsOf2023-04-22_custom_SAFEFiveMember_custom_SemiCabIncMember" id="Fact004666" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35,000,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-25</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_901_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyFiveMember_z87GVP2Kr487" title="Convertible Holder Name"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFETwentyFiveMember_custom_SemiCabIncMember" id="Fact004668" name="RIME:ConvertibleHolderName">Disrupt Fund XVIII, LLC</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_988_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyFiveMember_zpDXoAkIL7gc" title="Principal" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:InvestmentOfPrincipalAmount" contextRef="AsOf2023-04-22_custom_SAFETwentyFiveMember_custom_SemiCabIncMember" id="Fact004670" format="ixt:numdotdecimal" decimals="0" unitRef="USD">50,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_906_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyFiveMember_z2iip7EJy5Zc" title="Issue Date"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFETwentyFiveMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004672" name="RIME:InvestmentIssueDate">01-24-2022</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyFiveMember_zIGi98eBjik8" title="Valuation Cap"><ix:nonFraction name="RIME:ValuationCapitalOfInvestment" contextRef="AsOf2023-04-22_custom_SAFETwentyFiveMember_custom_SemiCabIncMember" id="Fact004674" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35,000,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-26</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_903_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentySixMember_z5qk6UtZVyma" title="Convertible Holder Name"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFETwentySixMember_custom_SemiCabIncMember" id="Fact004676" name="RIME:ConvertibleHolderName">Ajatshatru and Manju Dhawal</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_989_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentySixMember_zwq5d84kJyqj" title="Principal" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:InvestmentOfPrincipalAmount" contextRef="AsOf2023-04-22_custom_SAFETwentySixMember_custom_SemiCabIncMember" id="Fact004678" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90B_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentySixMember_zvXbDAVLuwEb" title="Issue Date"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFETwentySixMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004680" name="RIME:InvestmentIssueDate">01-31-2022</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentySixMember_z3QGORJeh0w7" title="Valuation Cap"><ix:nonFraction name="RIME:ValuationCapitalOfInvestment" contextRef="AsOf2023-04-22_custom_SAFETwentySixMember_custom_SemiCabIncMember" id="Fact004682" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35,000,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-27</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_908_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentySevenMember_zQISQihhra6h" title="Convertible Holder Name"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFETwentySevenMember_custom_SemiCabIncMember" id="Fact004684" name="RIME:ConvertibleHolderName">Mrityunjay Dhawal</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_981_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentySevenMember_zaoVassLtjEc" title="Principal" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:InvestmentOfPrincipalAmount" contextRef="AsOf2023-04-22_custom_SAFETwentySevenMember_custom_SemiCabIncMember" id="Fact004686" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90A_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentySevenMember_z7BJQdSejaS9" title="Issue Date"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFETwentySevenMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004688" name="RIME:InvestmentIssueDate">01-31-2022</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentySevenMember_zBfracneXCt3" title="Valuation Cap"><ix:nonFraction name="RIME:ValuationCapitalOfInvestment" contextRef="AsOf2023-04-22_custom_SAFETwentySevenMember_custom_SemiCabIncMember" id="Fact004690" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35,000,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-28</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_90D_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyEightMember_zs6p2mtqhsyf" title="Convertible Holder Name"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFETwentyEightMember_custom_SemiCabIncMember" id="Fact004692" name="RIME:ConvertibleHolderName">You Sexy Dawg, LLC</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_983_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyEightMember_zDaYJfvx0zr3" title="Principal" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:InvestmentOfPrincipalAmount" contextRef="AsOf2023-04-22_custom_SAFETwentyEightMember_custom_SemiCabIncMember" id="Fact004694" format="ixt:numdotdecimal" decimals="0" unitRef="USD">50,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90F_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyEightMember_zaxRpdVeNIgk" title="Issue Date"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFETwentyEightMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004696" name="RIME:InvestmentIssueDate">01-31-2022</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyEightMember_zxC1LXiYo3fa" title="Valuation Cap"><ix:nonFraction name="RIME:ValuationCapitalOfInvestment" contextRef="AsOf2023-04-22_custom_SAFETwentyEightMember_custom_SemiCabIncMember" id="Fact004698" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35,000,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-29</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_908_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyNineMember_zzINvLOaD5A2" title="Convertible Holder Name"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFETwentyNineMember_custom_SemiCabIncMember" id="Fact004700" name="RIME:ConvertibleHolderName">Elisa deLaet</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_984_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyNineMember_zV3qmc05prX3" title="Principal" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:InvestmentOfPrincipalAmount" contextRef="AsOf2023-04-22_custom_SAFETwentyNineMember_custom_SemiCabIncMember" id="Fact004702" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90D_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyNineMember_zcqM2qkRQRdl" title="Issue Date"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFETwentyNineMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004704" name="RIME:InvestmentIssueDate">01-31-2022</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_904_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyNineMember_zNdG7c4Mgh9i" title="Valuation Cap"><ix:nonFraction name="RIME:ValuationCapitalOfInvestment" contextRef="AsOf2023-04-22_custom_SAFETwentyNineMember_custom_SemiCabIncMember" id="Fact004706" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35,000,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-30</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_90C_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyMember_z9A7xdcWrMck" title="Convertible Holder Name"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFEThirtyMember_custom_SemiCabIncMember" id="Fact004708" name="RIME:ConvertibleHolderName">Ardhendu Haldar</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98A_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyMember_zrWXHC3A6nAc" title="Principal" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:InvestmentOfPrincipalAmount" contextRef="AsOf2023-04-22_custom_SAFEThirtyMember_custom_SemiCabIncMember" id="Fact004710" format="ixt:numdotdecimal" decimals="0" unitRef="USD">100,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90E_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyMember_zx4eM6Tyeixi" title="Issue Date"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFEThirtyMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004712" name="RIME:InvestmentIssueDate">02-28-2022</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyMember_zxHAEZ4L86Rf" title="Valuation Cap"><ix:nonFraction name="RIME:ValuationCapitalOfInvestment" contextRef="AsOf2023-04-22_custom_SAFEThirtyMember_custom_SemiCabIncMember" id="Fact004714" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35,000,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-31</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_90B_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyOneMember_z9s03pEKaLbc" title="Convertible Holder Name"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFEThirtyOneMember_custom_SemiCabIncMember" id="Fact004716" name="RIME:ConvertibleHolderName">Suzanne and Tom Lambert</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98A_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyOneMember_zUSy1B6ET8G8" title="Principal" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:InvestmentOfPrincipalAmount" contextRef="AsOf2023-04-22_custom_SAFEThirtyOneMember_custom_SemiCabIncMember" id="Fact004718" format="ixt:numdotdecimal" decimals="0" unitRef="USD">250,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90D_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyOneMember_zju0awdaGHx9" title="Issue Date"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFEThirtyOneMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004720" name="RIME:InvestmentIssueDate">02-28-2022</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyOneMember_zkh6ooAfsSMf" title="Valuation Cap"><ix:nonFraction name="RIME:ValuationCapitalOfInvestment" contextRef="AsOf2023-04-22_custom_SAFEThirtyOneMember_custom_SemiCabIncMember" id="Fact004722" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35,000,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-32</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_90A_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyTwoMember_zCzp2jV9ZjNh" title="Convertible Holder Name"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFEThirtyTwoMember_custom_SemiCabIncMember" id="Fact004724" name="RIME:ConvertibleHolderName">Nidus Capital Holdings, LLC</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_987_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyTwoMember_zC8z68bxng7l" title="Principal" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:InvestmentOfPrincipalAmount" contextRef="AsOf2023-04-22_custom_SAFEThirtyTwoMember_custom_SemiCabIncMember" id="Fact004726" format="ixt:numdotdecimal" decimals="0" unitRef="USD">250,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_908_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyTwoMember_zDDJO5nh0IJb" title="Issue Date"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFEThirtyTwoMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004728" name="RIME:InvestmentIssueDate">02-28-2022</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyTwoMember_zoKzpsL4Pm31" title="Valuation Cap"><ix:nonFraction name="RIME:ValuationCapitalOfInvestment" contextRef="AsOf2023-04-22_custom_SAFEThirtyTwoMember_custom_SemiCabIncMember" id="Fact004730" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35,000,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-33</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_909_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyThreeMember_za1CM0HpvT88" title="Convertible Holder Name"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFEThirtyThreeMember_custom_SemiCabIncMember" id="Fact004732" name="RIME:ConvertibleHolderName">Compelling Natural Health II, LLC</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_986_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyThreeMember_zV625NkkSqAb" title="Principal" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:InvestmentOfPrincipalAmount" contextRef="AsOf2023-04-22_custom_SAFEThirtyThreeMember_custom_SemiCabIncMember" id="Fact004734" format="ixt:numdotdecimal" decimals="0" unitRef="USD">250,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90A_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyThreeMember_zhEHULcGdxie" title="Issue Date"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFEThirtyThreeMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004736" name="RIME:InvestmentIssueDate">02-28-2022</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyThreeMember_zrlOk9avlmYb" title="Valuation Cap"><ix:nonFraction name="RIME:ValuationCapitalOfInvestment" contextRef="AsOf2023-04-22_custom_SAFEThirtyThreeMember_custom_SemiCabIncMember" id="Fact004738" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35,000,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-34</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_901_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyFourMember_zxbogyxpmin4" title="Convertible Holder Name"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFEThirtyFourMember_custom_SemiCabIncMember" id="Fact004740" name="RIME:ConvertibleHolderName">Birch Hill Capital Group, LLC</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_983_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyFourMember_zjvNqbGpxkxe" title="Principal" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:InvestmentOfPrincipalAmount" contextRef="AsOf2023-04-22_custom_SAFEThirtyFourMember_custom_SemiCabIncMember" id="Fact004742" format="ixt:numdotdecimal" decimals="0" unitRef="USD">250,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_905_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyFourMember_zAy1t63ty99e" title="Issue Date"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFEThirtyFourMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004744" name="RIME:InvestmentIssueDate">02-28-2022</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyFourMember_zraxNBVKnfM2" title="Valuation Cap"><ix:nonFraction name="RIME:ValuationCapitalOfInvestment" contextRef="AsOf2023-04-22_custom_SAFEThirtyFourMember_custom_SemiCabIncMember" id="Fact004746" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35,000,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-35</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_90F_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyFiveMember_zwI3xKp4Nco2" title="Convertible Holder Name"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFEThirtyFiveMember_custom_SemiCabIncMember" id="Fact004748" name="RIME:ConvertibleHolderName">Ingrid P. Maes as Trustee of The IPM Irrevocable Trust dated September 1, 2022</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_989_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyFiveMember_zNZy204xQP7l" title="Principal" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:InvestmentOfPrincipalAmount" contextRef="AsOf2023-04-22_custom_SAFEThirtyFiveMember_custom_SemiCabIncMember" id="Fact004750" format="ixt:numdotdecimal" decimals="0" unitRef="USD">250,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90A_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyFiveMember_zSQoyF6nupMl" title="Issue Date"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFEThirtyFiveMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004752" name="RIME:InvestmentIssueDate">02-28-2022</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyFiveMember_zJbWSxvp90Nd" title="Valuation Cap"><ix:nonFraction name="RIME:ValuationCapitalOfInvestment" contextRef="AsOf2023-04-22_custom_SAFEThirtyFiveMember_custom_SemiCabIncMember" id="Fact004754" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35,000,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-36</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_90C_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtySixMember_ztVM9pdodOB7" title="Convertible Holder Name"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFEThirtySixMember_custom_SemiCabIncMember" id="Fact004756" name="RIME:ConvertibleHolderName">Nattoceuticals, LLC</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_989_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtySixMember_z7ApdaQb37vc" title="Principal" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:InvestmentOfPrincipalAmount" contextRef="AsOf2023-04-22_custom_SAFEThirtySixMember_custom_SemiCabIncMember" id="Fact004758" format="ixt:numdotdecimal" decimals="0" unitRef="USD">250,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_905_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtySixMember_zxEZbdt2Z7j1" title="Issue Date"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFEThirtySixMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004760" name="RIME:InvestmentIssueDate">02-28-2022</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtySixMember_zvYBBuwLA0N4" title="Valuation Cap"><ix:nonFraction name="RIME:ValuationCapitalOfInvestment" contextRef="AsOf2023-04-22_custom_SAFEThirtySixMember_custom_SemiCabIncMember" id="Fact004762" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35,000,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-37</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_905_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtySevenMember_zZRPNNnL8Vm7" title="Convertible Holder Name"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFEThirtySevenMember_custom_SemiCabIncMember" id="Fact004764" name="RIME:ConvertibleHolderName">Pallav Gupta</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98D_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtySevenMember_zH0Gh5Fm4rEe" title="Principal" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:InvestmentOfPrincipalAmount" contextRef="AsOf2023-04-22_custom_SAFEThirtySevenMember_custom_SemiCabIncMember" id="Fact004766" format="ixt:numdotdecimal" decimals="0" unitRef="USD">60,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90A_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtySevenMember_zjBpxNYCNpA" title="Issue Date"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFEThirtySevenMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004768" name="RIME:InvestmentIssueDate">02-28-2022</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtySevenMember_zpcCwMgPJ0Jl" title="Valuation Cap"><ix:nonFraction name="RIME:ValuationCapitalOfInvestment" contextRef="AsOf2023-04-22_custom_SAFEThirtySevenMember_custom_SemiCabIncMember" id="Fact004770" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35,000,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-46</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_905_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortySixMember_z0Il1LOBPbM" title="Convertible Holder Name"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFEFortySixMember_custom_SemiCabIncMember" id="Fact004772" name="RIME:ConvertibleHolderName">Gaingels Semicab LLC</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_985_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortySixMember_zXe3YnldJGN8" title="Principal" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:InvestmentOfPrincipalAmount" contextRef="AsOf2023-04-22_custom_SAFEFortySixMember_custom_SemiCabIncMember" id="Fact004774" format="ixt:numdotdecimal" decimals="0" unitRef="USD">130,500</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_907_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortySixMember_z17TXVfMMkii" title="Issue Date"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFEFortySixMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004776" name="RIME:InvestmentIssueDate">03-21-2023</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortySixMember_zJTaJaq4HfWh" title="Valuation Cap"><ix:nonFraction name="RIME:ValuationCapitalOfInvestment" contextRef="AsOf2023-04-22_custom_SAFEFortySixMember_custom_SemiCabIncMember" id="Fact004778" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35,000,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-50</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_90F_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFiftyMember_zkcNU8cVCKb3" title="Convertible Holder Name"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFEFiftyMember_custom_SemiCabIncMember" id="Fact004780" name="RIME:ConvertibleHolderName">Pankaj Sinha</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98F_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFiftyMember_zi2KO9kkOGtl" title="Principal" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:InvestmentOfPrincipalAmount" contextRef="AsOf2023-04-22_custom_SAFEFiftyMember_custom_SemiCabIncMember" id="Fact004782" format="ixt:numdotdecimal" decimals="0" unitRef="USD">50,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90B_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFiftyMember_zZycYQjTglz3" title="Issue Date"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFEFiftyMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004784" name="RIME:InvestmentIssueDate">04-04-2023</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFiftyMember_zvYcYOEtMBL5" title="Valuation Cap"><ix:nonFraction name="RIME:ValuationCapitalOfInvestment" contextRef="AsOf2023-04-22_custom_SAFEFiftyMember_custom_SemiCabIncMember" id="Fact004786" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35,000,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-48</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_901_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyEightMember_zYF6mij4ytgk" title="Convertible Holder Name"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFEFortyEightMember_custom_SemiCabIncMember" id="Fact004788" name="RIME:ConvertibleHolderName">Lucy Holifield</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_987_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyEightMember_zT8XYsub1pkc" title="Principal" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:InvestmentOfPrincipalAmount" contextRef="AsOf2023-04-22_custom_SAFEFortyEightMember_custom_SemiCabIncMember" id="Fact004790" format="ixt:numdotdecimal" decimals="0" unitRef="USD">70,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_906_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyEightMember_zaWFVEcDEAFf" title="Issue Date"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFEFortyEightMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004792" name="RIME:InvestmentIssueDate">04-14-2023</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyEightMember_zbigYlXvlFvg" title="Valuation Cap"><ix:nonFraction name="RIME:ValuationCapitalOfInvestment" contextRef="AsOf2023-04-22_custom_SAFEFortyEightMember_custom_SemiCabIncMember" id="Fact004794" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35,000,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-47</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_902_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortySevenMember_zEYHNK6zi5Pf" title="Convertible Holder Name"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFEFortySevenMember_custom_SemiCabIncMember" id="Fact004796" name="RIME:ConvertibleHolderName">Corvus Albus LLC</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_986_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortySevenMember_zgs3uoustsvc" title="Principal" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:InvestmentOfPrincipalAmount" contextRef="AsOf2023-04-22_custom_SAFEFortySevenMember_custom_SemiCabIncMember" id="Fact004798" format="ixt:numdotdecimal" decimals="0" unitRef="USD">100,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_909_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortySevenMember_zNhU2aMYEqHa" title="Issue Date"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFEFortySevenMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004800" name="RIME:InvestmentIssueDate">04-19-2023</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortySevenMember_zW3XBIzILQ86" title="Valuation Cap"><ix:nonFraction name="RIME:ValuationCapitalOfInvestment" contextRef="AsOf2023-04-22_custom_SAFEFortySevenMember_custom_SemiCabIncMember" id="Fact004802" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35,000,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-49</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_904_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyNineMember_zexIdYj1LXzg" title="Convertible Holder Name"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFEFortyNineMember_custom_SemiCabIncMember" id="Fact004804" name="RIME:ConvertibleHolderName">David Friedland</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98D_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyNineMember_zAWqjBWO3Cvi" title="Principal" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:InvestmentOfPrincipalAmount" contextRef="AsOf2023-04-22_custom_SAFEFortyNineMember_custom_SemiCabIncMember" id="Fact004806" format="ixt:numdotdecimal" decimals="0" unitRef="USD">50,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90B_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyNineMember_zFXk85gUHVD2" title="Issue Date"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFEFortyNineMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004808" name="RIME:InvestmentIssueDate">04-19-2023</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyNineMember_z5oxexiVv7Y8" title="Valuation Cap"><ix:nonFraction name="RIME:ValuationCapitalOfInvestment" contextRef="AsOf2023-04-22_custom_SAFEFortyNineMember_custom_SemiCabIncMember" id="Fact004810" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35,000,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">SAFE-51</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span id="xdx_90E_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFiftyOneMember_zA1pnuTTL2zd" title="Convertible Holder Name"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFEFiftyOneMember_custom_SemiCabIncMember" id="Fact004812" name="RIME:ConvertibleHolderName">Kapil K Gupta</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_984_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFiftyOneMember_zAXtWhB2dFJ9" title="Principal" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:InvestmentOfPrincipalAmount" contextRef="AsOf2023-04-22_custom_SAFEFiftyOneMember_custom_SemiCabIncMember" id="Fact004814" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><span id="xdx_908_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFiftyOneMember_zhQKwfvu2dNl" title="Issue Date"><ix:nonNumeric contextRef="From2021-08-122023-04-22_custom_SAFEFiftyOneMember_custom_SemiCabIncMember" format="ixt:datemonthdayyear" id="Fact004816" name="RIME:InvestmentIssueDate">04-22-2023</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"><span id="xdx_90A_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFiftyOneMember_zRFGcdWSHWK" title="Valuation Cap"><ix:nonFraction name="RIME:ValuationCapitalOfInvestment" contextRef="AsOf2023-04-22_custom_SAFEFiftyOneMember_custom_SemiCabIncMember" id="Fact004818" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35,000,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">TOTAL</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_989_ecustom--InvestmentOfPrincipalAmount_iI_c20230422_zZM1IaDPyD56" title="Principal" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="RIME:InvestmentOfPrincipalAmount" contextRef="AsOf2023-04-22_custom_SemiCabIncMember" id="Fact004820" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,095,779</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  </table>


</ix:nonNumeric><p id="xdx_8AE_zZxvnaJE3qIk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 131; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember" escape="true" id="Fact004822" name="us-gaap:IncomeTaxDisclosureTextBlock"><p id="xdx_808_eus-gaap--IncomeTaxDisclosureTextBlock_zvGJHFazOHq3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
12- <span id="xdx_82C_zVZbS042zD3f">INCOME TAXES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company files separate tax returns in the United States and India. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember" escape="true" id="Fact004824" name="us-gaap:CompensationAndEmployeeBenefitPlansTextBlock"><p id="xdx_804_eus-gaap--CompensationAndEmployeeBenefitPlansTextBlock_zzSRH9xpIi5h" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
13 - <span id="xdx_827_zXf3uxo7lr86">EMPLOYEE BENEFIT PLANS </span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has a 401(k) plan for its employees to which the Company makes contributions at rates dependent on the level of each employee&#8217;s
contributions. Contributions made by the Company are limited to the maximum allowable for federal income tax purposes. The Company does
not provide any post-employment benefits to retirees.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember" escape="true" id="Fact004826" name="us-gaap:ConcentrationRiskDisclosureTextBlock"><p id="xdx_803_eus-gaap--ConcentrationRiskDisclosureTextBlock_z41cxMIkSk6l" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
14 &#8211; <span>CONCENTRATIONS OF CREDIT RISK, CUSTOMERS, AND SUPPLIERS</span> </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_82A_zmX6yOVKuvE6" style="display: none">CONCENTRATIONS
OF CREDIT RISK AND REVENUE</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company derives a majority of its revenues from enterprise-level customers in the United States. The Company&#8217;s allowance for doubtful
accounts is based upon management&#8217;s estimates and historical experience and reflects the fact that accounts receivable are concentrated
with several large customers. At both December 31, 2023 and 2022, <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--FourMember_zTzp1lWG4aC6" title="Concentration risk percentage"><span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--FourMember_zYj9y70UmWYk" title="Concentration risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2023-01-012023-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_FourMember_custom_SemiCabIncMember" id="Fact004828" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2022-01-012022-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_FourMember_custom_SemiCabIncMember" id="Fact004830" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></ix:nonFraction></span></span>% of accounts receivable were due from four customers in North America,
all of which that individually owed over 10% of total accounts receivable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues
derived from our top four US customers in 2023 and 2022 were <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--FourMember_ziRbky3oJY12" title="Concentration risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2023-01-012023-12-31_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_FourMember_custom_SemiCabIncMember" id="Fact004832" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% and <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--FourMember_z4sOhNOxvzV1" title="Concentration risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2022-01-012022-12-31_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_FourMember_custom_SemiCabIncMember" id="Fact004834" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of total revenue, respectively, all of which represented greater
than 10% of total net sales in both years. The loss of any of these customers could have an adverse impact on the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember" escape="true" id="Fact004836" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock"><p id="xdx_80C_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zRpnRjhHeWVj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
15 &#8211; <span id="xdx_822_zFYfQv2wehN2">RELATED PARTY TRANSACTIONS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DUE
TO/FROM RELATED PARTIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the years ended December 31, 2023 and 2022, the Company owed $<span id="xdx_90F_eus-gaap--OtherReceivables_iI_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorMember_z2L6PZMach09" title="Other receivables"><ix:nonFraction name="us-gaap:OtherReceivables" contextRef="AsOf2023-12-31_custom_AjeshKapoorMember_custom_SemiCabIncMember" id="Fact004838" format="ixt:numdotdecimal" decimals="0" unitRef="USD">712,000</ix:nonFraction></span> and $<span id="xdx_908_eus-gaap--OtherReceivables_iI_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorMember_zkBoktVALhQ6" title="Other receivables"><ix:nonFraction name="us-gaap:OtherReceivables" contextRef="AsOf2022-12-31_custom_AjeshKapoorMember_custom_SemiCabIncMember" id="Fact004840" format="ixt:numdotdecimal" decimals="0" unitRef="USD">385,000</ix:nonFraction></span>, respectively, to Ajesh Kapoor in the form of shareholder
notes. see Note 6 &#8211; Credit Arrangements</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 31, 2023, the Company had approximately $<span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_c20230331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorMember_z7QgPyDMmQhi" title="Principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2023-03-31_custom_AjeshKapoorMember_custom_SemiCabIncMember" id="Fact004842" format="ixt:numdotdecimal" decimals="0" unitRef="USD">712,000</ix:nonFraction></span> in principal plus accrued interest, due to Ajesh Kapoor, the founder and primary
shareholder in SemiCab.</span></p>

</ix:nonNumeric><p id="xdx_815_zMrE5f24KQia" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 132; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: Red; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information in this prospectus is not complete and may be changed. These securities may not be sold until the registration statement
filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and is not soliciting
an offer to buy these securities in any state or other jurisdiction where the offer or sale is not permitted.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PRELIMINARY
    PROSPECTUS</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SUBJECT
    TO COMPLETION</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DATED
    NOVEMBER 25, 2024</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2,840,344
</b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares of Common Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img src="forms-1_003.jpg" alt=""/></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Algorhythm
Holdings, Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus relates to the resale of 2,840,344 shares of common stock, par value $0.01 per share, by the selling stockholders (the
&#8220;Selling Stockholders&#8221;) of Alorhythm Holdings, Inc. We will not receive any proceeds from the sale or other disposition of
shares by the Selling Stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
common stock is listed on The Nasdaq Capital Market under the symbol &#8220;RIME.&#8221; The closing price of our common stock on November
22, 2024 was $0.253 per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
shares sold by the Selling Stockholders will occur at prevailing market prices or in privately negotiated prices. The distribution of
securities offered hereby may be effected in one or more transactions that may take place in ordinary brokers&#8217; transactions, privately
negotiated transactions or through sales to one or more dealers for resale of such securities as principals. Usual and customary or specifically
negotiated brokerage fees or commissions may be paid by the Selling Stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2024, a registration statement under the Securities Act of 1933, as amended
(the &#8220;Securities Act&#8221;) with respect to a public offering of common stock, was declared effective by the Securities and Exchange
Commission (the &#8220;SEC&#8221;). We will receive approximately $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; million in
net proceeds from the offering, which will terminate on , 2024, after payment of placement agent fees and other expenses of the offering
assuming that we sold 100% of the securities offered in the offering (or approximately $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
million, $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; million and $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
million if we sold 75%, 50% and 25% of the securities offered in the primary offering, respectively).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Investing
in our common stock involves a high degree of risk, including the risk of losing your entire investment. See &#8220;<i>Risk Factors</i>&#8221;
beginning on page 9</b> <b>of the primary offering prospectus contained in the registration statement of which this prospectus forms
a part, to read about factors you should consider before buying our common stock.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Neither
the SEC nor any state securities commission nor any other regulatory body has approved or disapproved of these securities or determined
if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
date of this prospectus is &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;,
2024</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 134; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">Altr <!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 0pt; margin-bottom: 0pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>PROSPECTUS
SUMMARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>This
summary highlights selected information from this prospectus and does not contain all of the information that you need to consider in
making your investment decision. You should carefully read the entire prospectus, the applicable prospectus supplement and any related
free writing prospectus, including the risks of investing in our securities discussed under the heading &#8220;Risk Factors&#8221; contained
in the applicable prospectus supplement and any related free writing prospectus.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
operations include our wholly owned subsidiaries, SMC Logistics, Inc., a California corporation (&#8220;SMCL&#8221;), SMC-Music, Inc.,
a Florida corporation (&#8220;SMCM&#8221;), SMC (HK) Limited, a Hong Kong company (&#8220;SMH&#8221;), The Singing Machine Company, Inc.,
a Delaware corporation (&#8220;Singing Machine&#8221;), MICS Hospitality Holdings, Inc., a Delaware corporation (&#8220;MICS Hospitality&#8221;),
MICS Hospitality Management, LLC, a Delaware limited liability company (&#8220;MICS Hospitality Management&#8221;), MICS Nomad, LLC,
a Delaware limited liability company (&#8220;MICS NY&#8221;) and SemiCab Holdings, LLC, a Nevada limited liability company (&#8220;SemiCab&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Overview</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Algorhythm
Holdings, Inc. is an AI technology and consumer electronics holding company with two primary business units &#8211; SemiCab and Singing
Machine. SemiCab is an AI enabled global software logistics business operated through our subsidiary SemiCab Holdings. Singing Machine
is a worldwide leader in the home karaoke consumer products market that designs and distributes karaoke products globally to retailers
and ecommerce partners.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Consumer
Electronics </i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
engage in the development, marketing, and sale of consumer karaoke audio equipment, accessories, and musical recordings. We believe we
are a leading global karaoke and music entertainment company that specializes in the design and production of quality karaoke and music
enabled consumer products for adults and children. Our products are among the most widely available karaoke products in the world. Our
mission is to &#8220;create joy through music.&#8221; To deliver on this mission, we are focused on the following multi-prong approach:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    the short-term, improve profitability by optimizing operations and continue to expand gross margins; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    the mid-to-long-term, continue to expand into new verticals including automotive and connected-TV devices and grow our global distribution
    for our consumer karaoke products.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>AI
Logistics </i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SemiCab
is a cloud-based Collaborative Transportation Platform built to achieve the scalability required to predict and optimize millions of
loads and hundreds of thousands of trucks. To orchestrate collaboration across manufacturers, retailers, distributors, and their carriers,
SemiCab uses real-time data from API-based load tendering and pre-built integrations with TMS and ELD partners. To build fully loaded
round trips, SemiCab uses AI/ML techniques and advanced predictive optimization models. On the SemiCab platform, shippers pay less and
carriers make more while not having to change a thing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
2020, SemiCab has enabled major retailers, brands and transportation providers to address their transportation needs globally. SemiCab&#8217;s
Orchestrated Collaboration&#8482; AI model has proven to increase transportation capacity, improve asset utilization, reduce empty miles,
lower logistics costs, and provide visibility into the entire transportation network. Models show the technology has the capability of
saving shippers tens of billions of dollars annually through optimization. Further, SemiCab&#8217;s technology also has the potential
to play a key role in the improved sustainability model globally. Based on its proven ability to improve truck utilization rates from
65% to over 90%, this results in a dramatic reduction in the carbon footprint of the industry. The optimization of existing truck utilization
can add approximately 30% more trucking capacity without adding more trucks, drivers or driven miles which addresses common problems
plaguing the industry like severe driver shortage and road congestion. Trucking optimization could also eliminate approximately 25% of
CO2 emissions attributable to road freight.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 135; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">Altr <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 0pt; margin-bottom: 0pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Change
in Fiscal Year </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
2023, our Board of Directors approved a change in our fiscal year end from March 31 to December 31.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
and Symbol Change</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
September 5, 2024, our Certificate of Incorporation was amended to effect a change in the name of the Company from &#8220;The Singing
Machine Company, Inc.&#8221; to &#8220;Algorhythm Holdings, Inc.&#8221; In addition, effective September 8, 2024, the Company&#8217;s
ticker symbol was changed from &#8220;MICS&#8221; to &#8220;RIME.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Recent
Events and Developments</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Oxford
Credit Facility</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 28, 2024, the Company and Oxford Commercial Finance, a Michigan banking corporation, (referred to as &#8220;Oxford&#8221;) entered
into a Loan Agreement (the &#8220;Loan Agreement&#8221;) and related Revolving Credit Note (the &#8220;Note&#8221;) for a $2 million
revolving line of credit (the &#8220;Oxford Line of Credit&#8221;). On October 17, 2024, the Company terminated the Loan Agreement and
the Note. As of the date of termination, the Company had no outstanding amounts owed to Oxford and paid a termination fee of $40,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>ATM
Offering June 2024</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 26, 2024, the Company entered into an At-The-Market Issuance Sales Agreement (the &#8220;Sales Agreement&#8221;) with Ascendiant
Capital markets, LLC, as sales agent (the &#8220;Agent&#8221;), pursuant to which the Company could offer and sell, from time to time,
through the Agent (the &#8220;ATM Offering&#8221;), up to approximately $1,100,000 in shares of the Company&#8217;s common stock. On
July 8, 2024, the Company entered into the First Amendment to the Sales Agreement (the &#8220;Amendment&#8221;) to increase the number
of shares to be sold in the ATM Offering to $2,020,000. On August 9, 2024, the Company entered into the Second Amendment to the Sales
Agreement (the &#8220;Amendment&#8221;) to increase the number of shares to be sold in the ATM Offering to $3,100,000. Pursuant to the
agreement, the Agent was paid $30,000 in fees to cover legal and administrative expenses and will receive an amount equal to 3% of the
gross proceeds from each sale of the Company&#8217;s share of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Through
the date of this prospectus, the Company has sold 3,835,500 shares of common stock under the Sales Agreement and received net proceeds
of approximately $2,975,615 after payment of brokerage commissions and administrative fees to the agent of approximately $123,045.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Asset
Purchase</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 11, 2024, the Company and its wholly owned subsidiary SemiCab Holdings, LLC, a Nevada limited liability company (&#8220;SemiCab
LLC&#8221; and collectively with the Company, the &#8220;Buyer&#8221;), SemiCab, Inc., a Delaware corporation (&#8220;SemiCab&#8221;
or the &#8220;Seller&#8221;), Ajesh Kapoor and Vivek Sehgal entered into an asset purchase agreement (the &#8220;Asset Purchase Agreement&#8221;)
pursuant to which the Seller agreed to sell and assign to the Company, and the Company agreed to purchase and assume from the Seller,
substantially all the assets, and certain specified liabilities relating to the business of the Seller. Subject to certain exceptions
set forth in the Asset Purchase Agreement, the parties agreed that the Buyer will not assume the liabilities of the Seller.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 3, 2024, the parties closed on the transactions contemplated by the Asset Purchase Agreement and the Company issued to the Seller
(i) 641,806 shares of the Company&#8217;s common stock (ii) a twenty percent (20%) membership interest in SemiCab LLC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the asset acquisition agreement, the Company and Seller entered into an option agreement (the &#8220;Option Agreement&#8221;), granting
the Buyer the right to acquire all of the issued and outstanding capital securities of SMCB Solutions Private Limited, a wholly owned
subsidiary of the Seller, in consideration for 320,903 shares of common stock of the Company. The Company has not yet exercised the option.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 136; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">Altr <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 0pt; margin-bottom: 0pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Hospitality
Lease</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 23, 2023, MICS NY entered into an Agreement of Lease (the &#8220;Lease Agreement&#8221;) with OAC 111 Flatiron, LLC and OAC Adelphi,
LLC (the &#8220;Landlord&#8221;), pursuant to which MICS NY agreed to lease approximately 10,000 square feet of ground floor retail space
and a portion of the basement underneath the ground floor retail space in the property located at 111 West 24<sup>th</sup> Street, New
York, New York (the &#8220;Premises&#8221;). It was the Company&#8217;s intention to use the Premises as a new karaoke venue, offering
immersive karaoke technology and audio-visual capabilities, with restaurant and bar offerings however due to lack of funding, the Company
initiated termination of the lease in March.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 26, 2024, OAC 111 Flatiron, LLC and OAC Adelphi, LLC (the &#8220;Landlord&#8221;), filed a civil action in the Supreme Court of
the State of New York against MICS Nomad LLC, a subsidiary of the Company (&#8220;MICS NY&#8221;), and the Company (&#8220;the Defendants&#8221;)
for alleged breach of lease, seeking monetary damages including unpaid rent, future unpaid rent, and other expenses related to the lease.
The complaint alleges the Defendants breached the lease in various material respects.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 25, 2024, the Company entered into a Settlement Agreement for a full release and dismissal of the complaint within 5 business
days of the Company&#8217;s payment of $250,000. The Company made full payment on or around October 25, 2024 and the Landlord filed a
discontinuance with prejudice on October 29, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Private
Placement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 22, 2024, the Company entered into a Securities Purchase Agreement (the &#8220;SPA&#8221;) with the Selling Stockholders pursuant
to which we sold, in a private placement (the &#8220;Private Placement&#8221;), secured notes with an aggregate principal amount of $2,352,941
(the &#8220;Notes&#8221;), and received proceeds before expenses of $2,000,000. As consideration for entering into the SPA, we issued
a total of 2,299,998 shares of common stock of the Company to the Selling Stockholders on October 24, 2024. The Selling Stockholders&#8217;
resale of these shares is being registered on the registration statement of which this prospectus forms a part.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><i>Amended Bylaws</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">On
October 18, 2024, the Company amended its Amended By-laws (the &#8220;By-law Amendment&#8221;), for the purpose of reducing the quorum
required to hold meetings of the stockholders of the Company (the &#8220;Quorum Requirement&#8221;). The By-law Amendment reduced the
Quorum Requirement from a majority to thirty-three and one-third percent (33 1/3%) of the voting power of the shares of stock issued
and outstanding and entitled to vote at the meeting. The By-law Amendment was approved by the Board of Directors of the Company on October
18, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><i>Share Repurchase</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">On
November 1, 2024, the Company entered into a Stock Repurchase Agreement (the &#8220;Repurchase Agreement&#8221;) with Regalia Ventures
LLC, a Delaware limited liability company (the &#8220;Seller&#8221;), pursuant to which the Company agreed to repurchase from the Seller
an aggregate of 1,098,901 issued and outstanding shares of common stock, par value $0.01 per share, of the Company (the &#8220;Shares&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">The
shares of common stock to be repurchased were originally issued to the Seller on November 21, 2023, pursuant to a certain stock purchase
agreement, dated November 20, 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">Pursuant
to the terms of the Repurchase Agreement, the Company has agreed to repurchase from the Seller, and the Seller has agreed to sell, assign
and transfer to the Company, all of the Seller&#8217;s right, title and interest in and to the Shares, at a price per Share equal to
the higher of: (1) the closing price of the common stock on the last trading day immediately preceding the date of the Repurchase Agreement;
or (2) the highest volume weighted average price (VWAP) of the common stock during a pricing period of ten (10) consecutive trading days
prior to the date of the Repurchase Agreement per share (the &#8220;Purchase Price&#8221;), and the Company shall issue to the Seller
a promissory note in the principal amount equal to the Purchase Price, substantially in the form attached to the Repurchase Agreement
as Exhibit A (the &#8220;Note&#8221;), and subject to terms and conditions therein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">The
obligations of each of the Company and the Seller to consummate the closing are conditioned upon the (i) issuance by the Company to the
Seller the Note evidencing the Purchase Price and (ii) the Seller&#8217;s delivery to the Company of executed stock power with a medallion
signature guarantee. As of the date of this prospectus, the transaction contemplated by the Repurchase Agreement has not yet closed.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Our
Resale Offering</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
of our stockholders will be selling through the Resale Prospectus a total of 2,840,344 shares of common stock. We will not receive
any proceeds from the sales by the Selling Stockholders of the securities set forth in the Resale Prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Resale Prospectus is substantively identical to the Public Offering Prospectus, except for the following principal points:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">they
    contain different outside and inside front covers and back covers;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">they
    contain different &#8220;<i>Offering</i>&#8221; sections in the &#8220;<i>Prospectus Summary</i>&#8221; section beginning on page
    Altr 2;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">they
    contain different &#8220;<i>Use of Proceeds</i>&#8221; sections on page Altr 9;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    &#8220;<i>Capitalization</i>&#8221; and &#8220;<i>Dilution</i>&#8221; sections from the Public Offering Prospectus are deleted from
    the Resale Prospectus;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: -0.2in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    &#8220;<i>Selling Stockholders</i>&#8221; section is included in the Resale Prospectus;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: -0.2in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    &#8220;<i>Plan of Distribution</i>&#8221; section from the Public Offering Prospectus is deleted from the Resale Prospectus and a
    &#8220;<i>Selling Stockholder Plan of Distribution</i>&#8221; is inserted in its place in the Resale Prospectus; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    &#8220;<i>Legal Matters</i>&#8221; section in the Resale Prospectus on page Altr 12 deletes the reference to counsel for the
    placement agent.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 137; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">Altr <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 0pt; margin-bottom: 0pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Summary
Risk Factors</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
business is subject to a number of risks. You should be aware of these risks before making an investment decision. These risks are summarized
and discussed more fully in the &#8220;<i>Risk Factors</i>&#8221; section of this prospectus. This offering and the ownership of our
common stock is subject to a number of risks. You should be aware of these risks before making an investment decision. These risks are
discussed more fully in the &#8220;<i>Risk Factors</i>&#8221; section of this prospectus. These risks include, among others, that:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Risks
Related to this Offering and the Ownership of Our Securities</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchasers
                                            in this offering will suffer immediate dilution.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                            may experience future dilution as a result of future equity offerings or acquisitions.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
                                            management will have broad discretion over the use of the net proceeds from this offering.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
                                            common stock may be affected by limited trading volume and price fluctuations, which could
                                            adversely impact the value of the Securities.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FINRA
                                            sales practice requirements may limit a stockholder&#8217;s ability to buy and sell our securities.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
                                            investment in our securities is speculative, and there can be no assurance of any return
                                            on any such investment.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            may need, but be unable, to obtain additional funding on satisfactory terms, which could
                                            dilute our stockholders or impose burdensome financial restrictions on our business.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            have identified material weaknesses in our internal control over financial reporting. Failure
                                            to maintain effective internal controls could cause our investors to lose confidence in us
                                            and adversely affect the market price of our common stock. If our internal controls are not
                                            effective, we may not be able to accurately report our financial results or prevent fraud.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            requirements of being a public company may strain our resources, divert management&#8217;s
                                            attention and affect our results of operations.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            we are not able to comply with the applicable continued listing requirements or standards
                                            of The NASDAQ Capital Market, The NASDAQ Capital Market could delist and adversely affect
                                            the market price and liquidity of our common stock.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
                                            laws, regulations, and standards relating to corporate governance and public disclosure may
                                            create uncertainty for public companies, increase legal and financial compliance costs and
                                            make some activities more time consuming.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                                            a &#8220;smaller reporting company&#8221; under applicable law, we are subject to lessened
                                            disclosure requirements, which could leave our stockholders without information or rights
                                            available to stockholders of more mature companies.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            currently do not intend to declare dividends on our common stock in the foreseeable future
                                            and, as a result, your returns on your investment may depend solely on the appreciation of
                                            our common stock.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                            should consult your own independent tax advisor regarding any tax matters arising with respect
                                            to the securities offered in connection with this offering.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            may be subject to securities litigation, which is expensive and could divert our management&#8217;s
                                            attention.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            may be unable to repay our indebtedness under the secured notes, and any default could harm
                                            our financial condition and could lead to us losing our collateralized assets.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 138; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">Altr <!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 0pt; margin-bottom: 0pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Risks
Related to the Warrants and Pre-Funded Warrants</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
                                            is no public market for the Warrants and the Pre-Funded Warrants.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lack
                                            of voting rights.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
                                            and conversion dilution.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            the Warrants are deemed to be non-compliant with Nasdaq rules, we may be required to amend
                                            the terms of the Warrants, and could be subject to delisting.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adjustments
                                            to the terms of Pre-Funded Warrants.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Warrants are not exercisable until shareholder approval is obtained and, in certain cases,
                                            may be redeemed by us prior to their expiration.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            the Series B Warrants are exercised by way of an alternative cashless exercise, investors
                                            may suffer substantial dilution.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Warrants and the Pre-Funded Warrants have beneficial ownership limitations.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            will not receive any meaningful amount of additional funds upon the exercise of the Pre-Funded
                                            Warrants.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            may not receive any additional funds upon the exercise of the Series B Warrants.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Risks
Related to Our Company and Financial Condition</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            may encounter difficulties accessing capital.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            have incurred significant losses, have limited cash on hand and there is substantial doubt
                                            as to our ability to continue as a going concern.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            may need to raise additional capital to fund our operations in furtherance of our business
                                            plan.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            are heavily dependent on our senior management, and a loss of a member of our senior management
                                            team could cause our stock price to suffer.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Risks
Related to the Development, Manufacturing, and Shipping of Our Products</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            we are unable to develop new karaoke products, our revenues may not continue to grow.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
                                            products are shipped from China and any disruptions of shipping could prevent of delay our
                                            customer&#8217; receipt of inventory.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
                                            manufacturing operations are located in the People&#8217;s Republic of China, subjecting
                                            us to risks common in international operations. if there is any problem with the manufacturing
                                            process, our revenues and net profitability may be reduced.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            depend on third party suppliers for parts for our karaoke machines and related products,
                                            and if we cannot obtain supplies as needed, our operations will be severely damaged.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            depend on the ability of our suppliers to manufacture our products without infringing, misappropriating
                                            of otherwise violating the intellectual property of proprietary rights of others in manufacturing
                                            our products.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 139; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">Altr <!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 0pt; margin-bottom: 0pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Risks
Related to our Karaoke Business and Industry</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes
                                            in government regulations relating to international tariffs could significantly reduce our
                                            revenues, product cost and profitability.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            small number of our customers account for a substantial portion of our revenues, and the
                                            loss of one or more of these key customers could significantly reduce our revenues and cash
                                            flow.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            are subject to the risk that some of our large customers may return karaoke products that
                                            they have purchased from us and if this happens, it would reduce our revenues and profitability.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            are subject to pressure from our customers relating to price reduction and financial incentives
                                            and if we are pressured to make these concessions to our customers, it will reduce our revenues
                                            and profitability.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            experience difficulty forecasting the demand for our karaoke products and if we do not accurately
                                            forecast demand, our revenues, net income and cash flow may be affected.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            are subject to the costs and risks of carrying inventory for our customers and if we have
                                            too much inventory, it will affect our cash flow for operations.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            are subject to insurance risk of loss for goods damaged while in transit from the manufacturer
                                            to the customer and our warehouse.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
                                            business is seasonal and therefore our annual operating results will depend, in large part,
                                            on our sales during the relatively brief holiday season.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consumer
                                            discretionary spending may affect karaoke purchases and is affected by various economic conditions
                                            and changes.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            do not have our own warehouse or distribution facilities but rely on a third-party logistics
                                            provider responsible for warehousing and fulfilling our orders. If our third-party provider
                                            experiences disruptions to the operation of its distribution centers, it could have a material
                                            adverse effect on our business, financial condition and results of operations.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
                                            production costs may increase if we are required to make purchases using the Chinese Yuan
                                            instead of the U.S. dollar.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
                                            profit margin may be decreased due to increased prices of raw materials, shipping costs and
                                            costs associated with production.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            we are unable to compete in the karaoke products category, our revenues and net profitability
                                            will be reduced.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Many
                                            of our competitors are larger and have greater financial and other resources than we do.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            we ship products that contain defects, the market acceptance of our products and our reputation
                                            will be harmed and our customers could seek to recover their damages from us.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Risks
Related to our Logistics Business</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            transportation industry historically has experienced cyclical fluctuations in financial results
                                            due to economic recessions, downturns in business cycles of SemiCab&#8217;s customers, interest
                                            rate fluctuations, currency fluctuations, and other economic factors beyond SemiCab&#8217;s
                                            control.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<!-- Field: Page; Sequence: 140; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">Altr <!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 0pt; margin-bottom: 0pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SemiCab
                                            faces substantial industry competition.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SemiCab
                                            relies on technology to operate its business.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SemiCab&#8217;s
                                            international operations subject it to operational, financial, and data privacy risks.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SemiCab&#8217;s
                                            ability to appropriately staff and retain employees is important to its business model.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SemiCab
                                            uses, and may continue to expand its use of, machine learning and artificial intelligence
                                            (&#8220;AI&#8221;) technologies to deliver its services and operate its business.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SemiCab&#8217;s
                                            business is dependent on a small number of customers.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SemiCab
                                            is subject to claims arising from its transportation operations.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SemiCab&#8217;s
                                            business depends upon compliance with numerous government regulations.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Risks
Related To Our Intellectual Property</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            primarily rely on trade secret protection and non-disclosure agreements to protect our proprietary
                                            information, which may not be effective.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            may be forced to litigate to enforce or defend our intellectual property rights, or the intellectual
                                            property rights of our licensors.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            may not be able to protect our intellectual property rights throughout the world.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>General
Risk Factors</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
                                            information technology systems or data, or those of our service providers or customers or
                                            users could be subject to cyber-attacks or other security incidents, which could result in
                                            data breaches, intellectual property theft, claims, litigation, regulatory investigations,
                                            significant liability, reputational damage and other adverse consequences.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
                                            business, financial condition and results of operations may be materially adversely affected
                                            by any negative impact on the global economy and capital markets resulting from the conflict
                                            in Ukraine or any other geopolitical tensions.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">High
                                            inflation and unfavorable economic conditions could negatively affect our operations and
                                            results.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            are exposed to the credit risk of our customers, who are experiencing financial difficulties,
                                            and if these customers are unable to pay us, our revenues and profitability will be reduced.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            may have trouble hiring additional qualified personnel.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            failure of our information technology systems could significantly disrupt the operation of
                                            our business.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            are subject to various claims and legal actions arising in the ordinary course of our business.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
                                            charter provides limitations of director liability and indemnification of directors and officers
                                            and employees.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            our accounting controls and procedures are circumvented or otherwise fail to achieve their
                                            intended purposes, our business could be seriously harmed.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            requirements of being a public company may strain our resources, divert management&#8217;s
                                            attention and affect our ability to attract and retain qualified board members.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Our
Corporate Information</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
were incorporated under the laws of the State of Delaware in 1994. Our principal business address is 6301 NW 5<sup>th</sup> Way, Suite
2900, Fort Lauderdale, FL 33309, and our telephone number is (954) 596-1000. We maintain our corporate website at <i>https://ir.algoholdings.com
</i>(this website address is not intended to function <i>as a hyperlink and the information contained on our website is not intended
to be a part of this prospectus).</i> Information on our website does not constitute a part of, nor is it incorporated in any way, into
this prospectus and should not be relied upon in connection with making an investment decision. We make available free of charge on https://ir.algoholdings.com/investor-filings#/
our annual, quarterly, and current reports, and amendments to those reports if any, as soon as reasonably practical after we electronically
file such material with, or furnish it to, the SEC. We may from time to time provide important disclosures to investors by posting them
in the Investor Relations section of our website.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
common stock is quoted on the Nasdaq under the symbol &#8220;RIME&#8221;. We file annual, quarterly, and current reports, proxy statements
and other information with the U.S. Securities Exchange Commission (the &#8220;SEC&#8221;) and are subject to the requirements of the
Securities and Exchange Act of 1934, as amended (the Exchange Act). These filings are available to the public on the Internet at the
SEC&#8217;s website at http://www.sec.gov.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 141; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">Altr <!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 0pt; margin-bottom: 0pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>The
RESALE offering</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 34%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    stock offered:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 64%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,840,344
    </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
    of common stock outstanding before this offering:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,215,176
    shares</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
    of common stock outstanding after the resale offering:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,215,176
    shares</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
    of common stock outstanding after the resale offering and the primary offering:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">57,693,437
    </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares<sup>(1)</sup></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Use
    of proceeds:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    will not receive any proceeds from the sale of common stock held by the Selling Stockholder being registered in this prospectus.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Listing:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    common stock listed on The Nasdaq Capital Market under the symbol &#8220;RIME.&#8221;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk
    factors:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
    investment in our securities involves a high degree of risk. See &#8220;<i>Risk Factors</i>&#8221; beginning on page 9
    of the primary offering prospectus contained in the registration statement of which this prospectus forms a part, and other information
    included in this prospectus and the registration statement of which this prospectus forms a part, for a discussion of factors you
    should carefully consider before deciding to invest in our common stock.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
As of November 22, 2024 and based upon the shares issued in the primary offering of up to 43,478,261 assumed public offering
price for each share of common stock and accompanying Warrants is $0.23 and excludes:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">107,261
                                            shares of common stock issuable upon the exercise of outstanding stock options with a weighted-average
                                            exercise price of $8.07 per share;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">63,453
                                            </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
                                            of common stock reserved for future issuance under our 2022 Equity Incentive Plan; and</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">902,113
                                            shares of common stock issuable upon exercise of warrants to purchase common stock with a
                                            weighted-average exercise price of $3.20 per share.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>USE
OF PROCEEDS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will not receive any of the proceeds from the sale of the common stock held by the Selling Stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SELLING
STOCKHOLDERS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">On
October 22, 2024, the Company entered into a securities purchase agreement with certain of the Selling Stockholders pursuant to which
we sold, in a private placement, secured notes with an aggregate principal amount of $2,352,941, and received proceeds before expenses
of $2,000,000. As consideration for entering into the SPA, we issued a total of 2,299,998 shares of common stock of the Company to the
Selling Stockholders on October 24, 2024, which shares are included in this prospectus. On August 9, 2024, the Company issued to each of Catalyst
Corporate Solutions and Three Rivers Business Consulting, an aggregate of 540,346 shares of its common stock in consideration for consulting
services to the Company. The shares issued to each of the consultants are included in this prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus relates to the sale or other disposition of up to 2,840,344 shares of our common stock by the Selling Stockholders
and their donees, pledgees, transferees or other successors-in-interest selling shares of common stock or interests in shares of common
stock received after the date of this prospectus from a Selling Stockholder as a gift, pledge, partnership distribution or other transfer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table below sets forth information as of the date of this prospectus, to our knowledge, the Selling Stockholders and other information
regarding the beneficial ownership (as determined under Section 13(d) of the Exchange Act and the rules and regulations thereunder) of
the shares of common stock held by the Selling Stockholders. The second column lists the number of shares of common stock beneficially
owned by the Selling Stockholders, as of [ ], 2024. The third column lists the maximum number of shares of common stock that may be sold
or otherwise disposed of by the Selling Stockholders pursuant to the registration statement of which this prospectus forms a part. The
Selling Stockholders may sell or otherwise dispose of some, all or none of their shares. Pursuant to Rules 13d-3 and 13d-5 of the Exchange
Act, beneficial ownership includes any shares of our common stock as to which a stockholder has sole or shared voting power or investment
power, and also any shares of our common stock which the stockholder has the right to acquire within 60 days.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 142; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">Altr <!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 0pt; margin-bottom: 0pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
percentage of beneficial ownership for the Selling Stockholders is based on shares of common stock outstanding as of the date of this
prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
our knowledge, none of the Selling Stockholders have had any material relationship with us within the past three years. Our knowledge
is based on information provided by the Selling Stockholders in registration statement questionnaires.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
shares of common stock being covered hereby may be sold or otherwise disposed of from time to time during the period the registration
statement of which this prospectus is a part remains effective, by or for the account of the Selling Stockholders. After the date of
effectiveness of the registration statement of which this prospectus forms a part, the Selling Stockholders may have sold or transferred,
in transactions covered by this prospectus, some or all of their common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information
about the Selling Stockholders may change over time. Any changed information will be set forth in an amendment to the registration statement
or supplement to this prospectus, to the extent required by law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td colspan="21" style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Shares Beneficially <br/> Owned as of the date of this <br/> Prospectus</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Shares <br/> Offered <br/> by this</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares Beneficially <br/> Owned After the <br/> Offering<sup>(1)</sup></b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif">Name of Selling Stockholder</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Number</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Percent</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Prospectus</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Number</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Percent</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 35%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">S.H.N Financial Investments Ltd <sup>(2)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">383,333</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">2.7</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">383,333</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bigger Capital Fund, LP.<sup>(3)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">383,333</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2.7</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">383,333</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">L1 Capital Global Opportunities Master Fund<sup>(4)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">383,333</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2.7</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">383,333</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Anson Investments Master Fund LP<sup>(5)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">383,333</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2.7</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">383,333</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Altium Growth Fund, LP<sup>(6)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">383,333</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2.7</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">383,333</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generating Alpha Ltd. <sup>(7)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">383,333</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2.7</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">383,333</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Catalyst Corporate Solutions, LLC<sup>(8)</sup></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">350,000</p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">2.5</p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">350,000</p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Three Rivers Business Consulting LLC<sup>(9)</sup></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">190,346</p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1.3</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">190,346</p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif">Total</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2,840,344</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">20</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2,840,344</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assumes
    the sale of all shares offered pursuant to the primary offering prospectus.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nir
    Shamir and Hadar Shamir have shared power to vote and dispose of the securities help by S.H.N Financial Investments Ltd and may be
    deemed to be the beneficial owners of such shares of common stock. The address of S.H.N Financial Investments Ltd is Arik Einstein
    3, Herzliya, Israel.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
    Bigger, Managing Member of&#160;Bigger Capital Fund, LP may be deemed to have sole voting and dispositive power with respect to the
    shares held by&#160;Bigger Capital Fund, LP. The address of&#160;Bigger Capital Fund, LP is 11700 W Charleston Blvd 170-659. Las
    Vegas, NV 89135.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">David
    Feldman and Joel Arber are the Directors of L1 Capital Global Opportunities Master Fund, Ltd. As such they may be deemed to be beneficial
    owners of such shares of common stock. The business address of L1 Capital Global Opportunities Master Fund., Ltd. is 161A Shedden
    Road, 1 Artillery Court, PO Box 10085, Grand Cayman KY1-1001, Cayman Islands.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Anson
    Advisors Inc and Anson Funds Management LP, the Co-Investment Advisers of Anson Investments Master Fund LP (&#8220;Anson Investments&#8221;),
    hold voting and dispositive power over the common stock held by Anson Investments. Tony Moore is the managing member of Anson Management
    GP LLC, which is the general partner of Anson Funds Management LP. Moez Kassam and Amin Nathoo are directors of Anson Advisors Inc.
    Mr. Moore, Mr. Kassam and Mr. Nathoo each disclaim beneficial ownership of these common stock except to the extent of their pecuniary
    interest therein. The principal business address of Anson is Maples Corporate Services Limited, PO Box 309, Ugland House, Grand Cayman,
    KY1-1104, Cayman Islands.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jacob
    Gottlieb may be deemed to have sole voting and dispositive power with respect to the shares held by&#160;Altium Growth Fund, LP.
    The address of&#160;Altium Growth Fund, LP is 152 West 57th Street, FL 20 New York, NY 10019.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maria
    Cano may be deemed to have sole voting and dispositive power with respect to the shares held by&#160;Generating Alpha Ltd. The address
    of Generating Alpha Ltd. is Hunkins Waterfront Plaza, Suite 556, Main Street, Charlestown, KN0802, Saint Kitts and Nevis.&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">(8)</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Scott Mahoney is the Owner of Catalyst Corporate Solutions,
    LLC and as such may be deemed to be beneficial owner of such shares of common stock. The address of Catalyst Corporate
    Solutions, LLC is 10119 W Lariant Lane, Peoria, AZ 85383.</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">(9)</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Brian Jacobelli is the Sole Member of Three Rivers Business
    Consulting LLC and as such may be deemed to be beneficial owner of such shares of common stock. The address of Three
    Rivers Business Consulting LLC is 23 Overlook Court, Pittsburgh, PA 15222.</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<!-- Field: Page; Sequence: 143; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">Altr <!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 0pt; margin-bottom: 0pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SELLING
STOCKHOLDER <span style="text-transform: uppercase">PLAN OF DISTRIBUTION</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Selling Stockholders may, from time to time, sell any or all of their shares of common stock on any stock exchange, market or trading
facility on which the shares are traded or in private transactions. These sales may be at fixed or negotiated prices. The Selling Stockholders
may use any one or more of the following methods when selling shares:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ordinary
    brokerage transactions and transactions in which the broker-dealer solicits purchasers;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">block
    trades in which the broker-dealer will attempt to sell the shares as agent but may position and resell a portion of the block as
    principal to facilitate the transaction;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">purchases
    by a broker-dealer as principal and resale by the broker-dealer for its account;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    exchange distribution in accordance with the rules of the applicable exchange;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">privately
    negotiated transactions;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">short
    sales effected after the date the registration statement of which this prospectus is a part is declared effective by the SEC;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">broker-dealers
    may agree with the Selling Stockholders to sell a specified number of such shares at a stipulated price per share;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    combination of any such methods of sale; and</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    other method permitted pursuant to applicable law.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Broker-dealers
engaged by the Selling Stockholders may arrange for other brokers-dealers to participate in sales. Broker-dealers may receive commissions
or discounts from the Selling Stockholders (or, if any broker-dealer acts as agent for the purchaser of shares, from the purchaser) in
amounts to be negotiated. The Selling Stockholders do not expect these commissions and discounts to exceed what is customary in the types
of transactions involved. Any profits on the resale of shares of common stock by a broker-dealer acting as principal might be deemed
to be underwriting discounts or commissions under the Securities Act. Discounts, concessions, commissions and similar selling expenses,
if any, attributable to the sale of shares will be borne by a Selling Stockholder. The Selling Stockholders may agree to indemnify any
agent, dealer or broker-dealer that participates in transactions involving sales of the shares if liabilities are imposed on that person
under the Securities Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Selling Stockholders may from time to time pledge or grant a security interest in some or all of the shares of common stock owned by
them and, if they default in the performance of their secured obligations, the pledgees or secured parties may offer and sell the shares
of common stock from time to time under this prospectus after we have filed a supplement to this prospectus under Rule 424(b)(3) or other
applicable provision of the Securities Act supplementing or amending the list of Selling Stockholders to include the pledgee, transferee
or other successors in interest as Selling Stockholders under this prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<!-- Field: Page; Sequence: 144; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">Altr <!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 0pt; margin-bottom: 0pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Selling Stockholders also may transfer the shares of common stock in other circumstances, in which case the transferees, pledgees or
other successors in interest will be the selling beneficial owners for purposes of this prospectus and may sell the shares of common
stock from time to time under this prospectus after we have filed a supplement to this prospectus under Rule 424(b)(3) or other applicable
provision of the Securities Act supplementing or amending the list of Selling Stockholders to include the pledgee, transferee or other
successors in interest as Selling Stockholders under this prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Selling Stockholders and any broker-dealers or agents that are involved in selling the shares of common stock held by the Selling Stockholders
or its transferees, pledgees or other successors in interest may be deemed to be &#8220;underwriters&#8221; within the meaning of the
Securities Act in connection with such sales. In such event, any commissions received by such broker-dealers or agents and any profit
on the resale of the shares of common stock purchased by them may be deemed to be underwriting commissions or discounts under the Securities
Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are required to pay all fees and expenses incident to the registration of the shares of common stock held by the Selling Stockholders.
We have agreed to indemnify the Selling Stockholders against certain losses, claims, damages and liabilities, including liabilities under
the Securities Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Selling Stockholders have advised us that they have not entered into any agreements, understandings or arrangements with any underwriters
or broker-dealers regarding the sale of their shares of common stock, nor is there an underwriter or coordinating broker acting in connection
with a proposed sale of common stock by any Selling Stockholder. If we are notified by any Selling Stockholder that any material arrangement
has been entered into with a broker-dealer for the sale of shares of his, her, or its common stock, if required, we will file a supplement
to this prospectus. If the Selling Stockholders use this prospectus for any sale of their shares of common stock, they will be subject
to the prospectus delivery requirements of the Securities Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to comply with the securities laws of some states, if applicable, the common stock held by the Selling Stockholders or its transferees,
pledgees or other successors in interest may be sold in these jurisdictions only through registered or licensed brokers or dealers. In
addition, in some states the common stock may not be sold unless it has been registered or qualified for sale or an exemption from registration
or qualification requirements becomes available and is complied with.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have advised the Selling Stockholders that the anti-manipulation rules of Regulation M under the Exchange Act may apply to sales of shares
in the market and to the activities of the Selling Stockholders and their affiliates. In addition, to the extent applicable we will make
copies of this prospectus (as it may be supplemented or amended from time to time) available to the Selling Stockholders for the purpose
of satisfying the prospectus delivery requirements of the Securities Act. The Selling Stockholders may indemnify any broker-dealer that
participates in transactions involving the sale of the shares against certain liabilities, including liabilities arising under the Securities
Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have agreed with the Selling Stockholders to keep the registration statement of which this prospectus constitutes a part effective until
the earliest of (1) such time as all of the shares covered by this prospectus have been disposed of pursuant to and in accordance with
the registration statement and (2) the date on which all of the shares may be sold without restriction pursuant to Rule 144 of the Securities
Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>LEGAL
MATTERS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
legal matters with respect to the validity of the securities being offered by this prospectus will be passed upon by Sichenzia Ross Ference
Carmel LLP, New York, New York</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 145; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">Altr <!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 0pt; margin-bottom: 0pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Up
to 43,478,261 Shares of Common Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Up
to 43,478,261 Pre-Funded Warrants to Purchase Shares of Common Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Up
to 43,478,261 Series A Warrants to Purchase Shares of Common Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Up
to 43,478,261 Series B Warrants to Purchase Shares of Common Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Up
to 130,434,783 Shares of Common Stock Underlying the Series A Warrants, Series B</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Warrants,
and Pre-Funded Warrants</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="forms-1a_001.jpg" alt="" style="height: 77px; width: 300px"/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Algorhythm
Holdings, Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PRELIMINARY
PROSPECTUS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Univest
Securities, LLC</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;,
2024</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 146 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 0pt; margin-bottom: 0pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Part
II</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INFORMATION
NOT REQUIRED IN PROSPECTUS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
13. OTHER EXPENSES OF ISSUANCE AND DISTRIBUTION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.35in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth all costs and expenses, other than the estimated placement agent fees and commissions payable by us, in connection
with the offer and sale of the securities being registered. All amounts shown are estimates except for the SEC registration fee and the
FINRA filing fee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.35in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amount</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 80%; text-align: left">SEC registration fee</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">5,338</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">FINRA filing fee</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">5,730</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Legal fees and expenses</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">250,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accounting fees and expenses</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">75,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Transfer agent and registrar fees and expenses</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">5,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Miscellaneous fees and expenses</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">10,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">Total</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">351,068</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.35in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
14. INDEMNIFICATION OF DIRECTORS AND OFFICERS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
102 of the General Company Law of the State of Delaware (&#8220;DGCL&#8221;) permits a Company to eliminate the personal liability of
directors of a Company to the Company or its stockholders for monetary damages for a breach of fiduciary duty as a director, except where
the director breached his duty of loyalty, failed to act in good faith, engaged in intentional misconduct or knowingly violated a law,
authorized the payment of a dividend or approved a stock repurchase in violation of Delaware corporate law or obtained an improper personal
benefit. Our charter provides that no director of the Company shall be personally liable to it or its stockholders for monetary damages
for any breach of fiduciary duty as a director, notwithstanding any provision of law imposing such liability, except to the extent that
the DGCL prohibits the elimination or limitation of liability of directors for breaches of fiduciary duty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 42.85pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
145 of the DGCL provides that a Company has the power to indemnify a director, officer, employee, or agent of the Company, or a person
serving at the request of the Company for another Company, partnership, joint venture, trust or other enterprise in related capacities
against expenses (including attorneys&#8217; fees), judgments, fines and amounts paid in settlement actually and reasonably incurred
by the person in connection with an action, suit or proceeding to which he was or is a party or is threatened to be made a party to any
threatened, ending or completed action, suit or proceeding by reason of such position, if such person acted in good faith and in a manner
he reasonably believed to be in or not opposed to the best interests of the Company, and, in any criminal action or proceeding, had no
reasonable cause to believe his conduct was unlawful, except that, in the case of actions brought by or in the right of the Company,
no indemnification shall be made with respect to any claim, issue or matter as to which such person shall have been adjudged to be liable
to the Company unless and only to the extent that the Court of Chancery or other adjudicating court determines that, despite the adjudication
of liability but in view of all of the circumstances of the case, such person is fairly and reasonably entitled to indemnity for such
expenses which the Court of Chancery or such other court shall deem proper.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a claim is not paid in full by the Company, the claimant may at any time thereafter bring suit against the Company to recover the unpaid
amount of the claim and, if successful in whole or in part, the claimant shall also be entitled to be paid the expense of prosecuting
such claim. It shall be a defense to any such action (other than an action brought to enforce a claim for expenses incurred in defending
any proceeding in advance of its final disposition where any undertaking required by the Bylaws has been tendered to the Company) that
the claimant has not met the standards of conduct which make it permissible under the DGCL for the Company to indemnify the claimant
for the amount claimed, but the burden of proving such defense shall be on the Company. Neither the failure of the Company (including
its board of directors (&#8220;Board&#8221;), legal counsel, or its stockholders) to have made a determination prior to the commencement
of such action that indemnification of the claimant is proper in the circumstances because he or she has met the applicable standard
of conduct set forth in the DGCL, nor an actual determination by the Company (including its Board, legal counsel, or its stockholders)
that the claimant has not met such applicable standard of conduct, shall be a defense to the action or create a presumption that the
claimant has not met the applicable standard of conduct. Indemnification shall include payment by the Company of expenses in defending
an action or proceeding in advance of the final disposition of such action or proceeding upon receipt of an undertaking by the person
indemnified to repay such payment if it is ultimately determined that such person is not entitled to indemnification.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 147; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 0pt; margin-bottom: 0pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
15. RECENT SALES OF UNREGISTERED SECURITIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Set
forth below is information regarding securities issued by us within the last three years from which were not registered under
the Securities Act of 1933, as amended.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="font: 10pt Times New Roman, Times, Serif">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            August 5, 2021, the Company entered into a securities purchase agreement with large institutional
                                            investors and the strategic investor for private placement of (i) 550,000 shares of its common
                                            stock together with common warrants to purchase up to 550,000
                                            shares of common stock with an exercise price of $10.50 per share, and (ii) 561,111 pre-funded
                                            warrants with each pre-funded warrant exercisable for one share of common stock at an exercise
                                            price of $0.01 per share, together with common warrants to purchase up to 561,111 shares
                                            of common stock at an exercise price of $10.50 per share. The closing of the private placement
                                            took place on August 10, 2021, when the shares and warrants were delivered to the purchasers
                                            and funds, in the amount of approximately $9,800,000, were received by the Company.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            November 20, 2023, the Company entered into an agreement to sell $2,000,000 in common stock
                                            through a private placement of common stock. The private placement was completed with two
                                            Affiliates, (Stingray Group, Inc. and Jay Foreman), both of which were existing shareholders
                                            with Board representation. The private placement was completed at $0.91 per share of common
                                            stock, with a total of approximately 2,198,000 shares issued.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">On
                                            August 9, 2024, the Company issued an aggregate of 774,528 shares of restricted common stock
                                            to three consultants pursuant to consulting agreements with the Company.</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            October 22, 2024, the Company entered into a securities purchase agreement with the Selling
                                            Stockholders pursuant to which we sold, in a private placement, secured notes with an aggregate
                                            principal amount of $2,352,941, and received proceeds before expenses of $2,000,000. As consideration
                                            for entering into the securities purchase agreement, we issued a total of 2,299,998
                                            shares of common stock of the Company to the Selling Stockholders on October 24, 2024.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
issuance of the securities listed above was deemed exempt from registration under Section 4(a)(2) of the Securities Act or Regulation
D promulgated thereunder in that the issuance of securities were made to an accredited investor and did not involve a public offering.
The recipient of such securities represented its intention to acquire the securities for investment purposes only and not with a view
to or for sale in connection with any distribution thereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
16. Exhibits and Financial Statement Schedules.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<b><i>Exhibits</i></b>: Reference is made to the Exhibit Index following the signature pages hereto, which Exhibit Index is hereby incorporated
into this Item.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.7in; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No.</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Description</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/923601/000095011600000456/0000950116-00-000456.txt" style="-sec-extract: exhibit">Certificate of Incorporation of the Company filed with the Delaware Secretary of State on February 15, 1994 and amendments through April 14, 1999 (incorporated by reference to Exhibit 3.1 in the Company&#8217;s registration statement on Form SB-2 filed with the SEC on March 7, 2000).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/923601/000111650200500092/0001116502-00-500092-0002.txt" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificate of Amendment to Certificate of Incorporation filed with the Delaware Secretary of State on September 29, 2000 (incorporated by reference to Exhibit 3.1 in the Company&#8217;s Quarterly Report on Form 10-QSB for the period ended September 30, 1999 filed with the SEC on November 14, 2000).</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/923601/000111650201500229/ex3-13.txt" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corrected Certificate of Amendment to Certificate of Incorporation filed with the Delaware Secretary of State on March 27, 2001 (incorporated by reference to Exhibit 3.13 in the Company&#8217;s registration statement on Form SB-2 filed with the SEC on April 11, 2001).</span></a></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 148; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 0pt; margin-bottom: 0pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; width: 0.7in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/923601/000111650201500229/ex3-12.txt" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corrected Certificate of Amendment to Certificate of Incorporation filed with the Delaware Secretary of State on April 4, 2001 (incorporated by referenced to Exhibit 3.12 in the Company&#8217;s registration statement on Form SB-2 filed with the SEC on April 11, 2001).</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.5</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/923601/000149315222019311/ex3-5.htm" style="-sec-extract: exhibit">Certificate of Correction to Corrected Certificate of Amendment to Certificate of Incorporation filed with the Delaware Secretary of State on April 20, 2001 (incorporated by reference to the Company&#8217;s Annual Report on Form 10-K filed with the SEC on July 14, 2022).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.6</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/923601/000149315222019311/ex3-6.htm" style="-sec-extract: exhibit">Certificate of Amendment to the Certificate of Incorporation filed with the Delaware Secretary of State on January 27, 2006 (incorporated by reference to the Company&#8217;s Annual Report on Form 10-K filed with the SEC on July 14, 2022).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.7</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/923601/000149315222019311/ex3-7.htm" style="-sec-extract: exhibit">Certificate for Renewal and Revival of Charter filed with Delaware Secretary of State on September 25, 2012 (incorporated by reference to the Company&#8217;s Annual Report on Form 10-K filed with the SEC on July 14, 2022).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.8</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/923601/000149315222015079/ex3-1.htm" style="-sec-extract: exhibit">Certificate of Amendment of Certificate of Incorporation filed with the Delaware Secretary of State on May 19, 2022 (incorporated by reference to the Company&#8217;s Current Report on Form 8-K filed with the SEC on May 25, 2022).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.9</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/923601/000149315224035205/ex3-1.htm" style="-sec-extract: exhibit">Certificate of Amendment of Certificate of Incorporation filed with the Delaware Secretary of State on August 27, 2024 (incorporated by reference to the Company&#8217;s Current Report on Form 8-K filed with the SEC on September 6, 2024).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.10</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/923601/000111650201500685/ex3-14.txt" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amended By-Laws of the Company (incorporated by reference to Exhibit 3.14 in the Company&#8217;s Annual Report on Form 10-KSB for the year ended March 31, 2001 filed with the SEC on June 29, 2001).</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.11</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/923601/000149315224041797/ex3-1.htm" style="-sec-extract: exhibit">Amendment No. 1 to Amended By-Laws, effective October 18, 2024 (incorporated by reference to the Company&#8217;s Current Report on Form 8-K filed with the SEC on October 21, 2024).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/923601/000149315222019311/ex4-1.htm" style="-sec-extract: exhibit">Description of Registrant&#8217;s Securities (incorporated by reference to the Company&#8217;s Annual Report on Form 10-K filed with the SEC on July 14, 2022).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex4-2.htm">Form of Series A Warrant</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex4-3.htm">Form of Series B Warrant</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex4-4.htm">Form of Pre-Funded Warrant</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex5-1.htm">Opinion of Counsel of Registrant</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/923601/000149315219009954/ex10-8.htm" style="-sec-extract: exhibit">Lease for Lakeside Plaza executive offices dated July 31, 2011 by and between the Company and Lakeside IV, LLC (incorporated by reference to the Company&#8217;s Annual Report on Form 10-K filed with the SEC on July 1, 2019).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/923601/000149315219009954/ex10-9.htm" style="-sec-extract: exhibit">Lease for Ontario, CA warehouse dated January 31, 2013 by and between the Company and Majestic-CCCIV Partners (incorporated by reference to the Company&#8217;s Annual Report on Form 10-K filed with the SEC on July 1, 2019).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/923601/000149315219009954/ex10-10.htm" style="-sec-extract: exhibit">Executive Change of Control Agreement dated January 3, 2014 by and between the Company and Gary Atkinson, Bernardo Melo, and Lionel Marquis (incorporated by reference to the Company&#8217;s Annual Report on Form 10-K filed with the SEC on July 1, 2019).</a></span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 149; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 0pt; margin-bottom: 0pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; width: 0.7in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/923601/000149315220015474/ex10-8.htm" style="-sec-extract: exhibit">First Amendment to Standard Industrial Lease dated June 15, 2020 (incorporated by reference to the Company&#8217;s Annual Report on Form 10-K filed with the SEC on August 13, 2020).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/923601/000149315221019422/ex10-1.htm" style="-sec-extract: exhibit">Stock Redemption Agreement, dated as of August 5, 2021, by and among the Company, Koncepts International, Ltd. and Treasure Green Holdings, Ltd. (incorporated by reference to the Company&#8217;s Current Report on Form 8-K filed with the SEC on August 12, 2021).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/923601/000149315223005442/ex1-1.htm" style="-sec-extract: exhibit">At-The-Market Issuance Sales Agreement, dated February 15, 2023, by and between the Company and Aegis Capital Corp. (incorporated by reference to the Company&#8217;s Current Report on Form 8-K filed with the SEC on February 17, 2023).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.7+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/923601/000149315222010748/ex10-1.htm" style="-sec-extract: exhibit">Employment Agreement by and between the Company and Gary Atkinson (incorporated by reference to the Company&#8217;s Current Report on Form 8-K filed with the SEC on April 22, 2022).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.8+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/923601/000149315222010748/ex10-2.htm" style="-sec-extract: exhibit">Employment Agreement by and between the Company. and Lionel Marquis (incorporated by reference to the Company&#8217;s Current Report on Form 8-K filed with the SEC on April 22, 2022).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.9+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/923601/000149315222010748/ex10-3.htm" style="-sec-extract: exhibit">Employment Agreement by and between the Company and Bernardo Melo (incorporated by reference to the Company&#8217;s Current Report on Form 8-K filed with the SEC on April 22, 2022).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.10</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/923601/000149315222015375/ex10-1.htm" style="-sec-extract: exhibit">Form of Indemnification Agreement to be entered into with the Registrant and each of its officers and directors (incorporated by reference to the Company&#8217;s Current Report on Form 8-K filed with the SEC on May 27, 2022).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.11</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/923601/000149315222028927/ex10-1.htm" style="-sec-extract: exhibit">Credit and Security Agreement by and among the Company, SMC Logistics, Inc. and Fifth Third Bank, dated October 14, 2022 (incorporated by reference to the Company&#8217;s Current Report on Form 8-K filed with the SEC on October 20, 2022).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.12+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/923601/000149315223000820/ex10-1.htm" style="-sec-extract: exhibit">Employment Agreement by and between the Company and Lionel Marquis (incorporated by reference to the Company&#8217;s Current Report on Form 8-K filed with the SEC on January 6, 2023).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.13</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/923601/000149315223019127/ex10-1.htm" style="-sec-extract: exhibit">Waiver and First Amendment to Credit and Security Agreement by and among the Company, SMC Logistics, Inc. and Fifth Third Bank, dated May 19, 2023 (incorporated by reference to the Company&#8217;s Current Report on Form 8-K filed with the SEC on May 25, 2023).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.14</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/923601/000149315223030095/ex10-1.htm" style="-sec-extract: exhibit">Agreement of Lease by and between MICS Nomad, LLC and OAC 111 Flatiron, LLC and OAC Adelphi, LLC, dated August 1, 2023 (incorporated by reference to Exhibit 10.1 in the Company&#8217;s Current Report on Form 8-K filed with the SEC on August 24, 2023).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.15</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/923601/000149315223031486/ex10-1.htm" style="-sec-extract: exhibit">Waiver and Second Amendment to Credit and Security Agreement dated August 30, 2023 (incorporated by reference to Exhibit 10.1 in the Company&#8217;s Current Report on Form 8-K filed with the SEC on September 1, 2023).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.16</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/923601/000149315223042523/ex10-1.htm" style="-sec-extract: exhibit">Form of Stock Purchase Agreement dated November 20, 2023 (incorporated by reference to Exhibit 10.1 in the Company&#8217;s Current Report on Form 8-K filed with the SEC on November 22, 2023).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.17</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/923601/000149315224013045/ex10-1.htm" style="-sec-extract: exhibit">Loan Agreement by and between the Company and Oxford Commercial Finance dated March 28, 2024 (incorporated by reference to Exhibit 10.1 in the Company&#8217;s Current Report on Form 8-K filed with the SEC on April 3, 2024).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.18</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/923601/000149315224013045/ex10-2.htm" style="-sec-extract: exhibit">Revolving Credit Note dated March 28, 2024 (incorporated by reference to Exhibit 10.2 in the Company&#8217;s Current Report on Form 8-K filed with the SEC on April 3, 2024).</a></span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 150; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 0pt; margin-bottom: 0pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; width: 0.7in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.19</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/923601/000149315224013045/ex10-3.htm" style="-sec-extract: exhibit">Security Agreement by and between the Company and Oxford Commercial Finance dated March 28, 2024 (incorporated by reference to Exhibit 10.3 in the Company&#8217;s Current Report on Form 8-K filed with the SEC on April 3, 2024).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.20</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/923601/000149315224023543/ex2-1.htm" style="-sec-extract: exhibit">Asset Purchase Agreement dated June 11, 2024 among the Company, SemiCab, Inc. and SemiCab Holdings, LLC (incorporated by reference to Exhibit 2.1 in the Company&#8217;s Current Report on Form 8-K filed with the SEC on June 12, 2024).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.21</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/923601/000149315224023543/ex10-1.htm" style="-sec-extract: exhibit">Operating Agreement between the Company, SemiCab Holdings, LLC and SemiCab, Inc. (incorporated by reference to Exhibit 10.1 in the Company&#8217;s Current Report on Form 8-K filed with the SEC on June 12, 2024).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.22</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/923601/000149315224025467/ex1-1.htm" style="-sec-extract: exhibit">At-The-Market Issuance Sales Agreement by and between the Company and Ascendiant Capital Markets, LLC, dated June 26, 2024 (incorporated by reference to Exhibit 1.1 in the Company&#8217;s Current Report on Form 8-K filed with the SEC on June 27, 2024).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.23</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/923601/000149315224026286/ex2-2.htm" style="-sec-extract: exhibit">Amendment No. 1 to Asset Purchase Agreement dated July 1, 2024, among the Company, SemiCab, Inc. and SemiCab Holdings, LLC (incorporated by reference to Exhibit 2.2 in the Company&#8217;s Current Report on Form 8-K filed with the SEC on July 5, 2024).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.24</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/923601/000149315224026548/ex10-1.htm" style="-sec-extract: exhibit">Amendment to At-The-Market Issuance Sales Agreement by and between the Company and Ascendiant Capital Markets, LLC, dated July 8, 2024 (incorporated by reference to Exhibit 10.1 in the Company&#8217;s Current Report on Form 8-K filed with the SEC on July 9, 2024).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.25</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/923601/000149315224042405/ex10-1.htm" style="-sec-extract: exhibit">Form of Securities Purchase Agreement entered into between the Company and the investors party thereto (incorporated by reference to Exhibit 10.1 in the Company&#8217;s Current Report on Form 8-K filed with the SEC on October 24, 2024)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.26</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/923601/000149315224042405/ex10-2.htm" style="-sec-extract: exhibit">Form of Original Issue Discount Senior Secured Note issued October 24, 2024 (incorporated by reference to Exhibit 10.2 in the Company&#8217;s Current Report on Form 8-K filed with the SEC on October 24, 2024)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.27</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/923601/000149315224042405/ex10-3.htm" style="-sec-extract: exhibit">Form of Guarantee (incorporated by reference to Exhibit 10.3 in the Company&#8217;s Current Report on Form 8-K filed with the SEC on October 24, 2024)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.28*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex10-28.htm">Form of Securities Purchase Agreement</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top">10.29*</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><a href="ex10-29.htm">Form of Placement Agency Agreement</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/923601/000149315224044853/ex21.htm" style="-sec-extract: exhibit">List
    of subsidiaries of Algorhythm Holdings. Inc. (previously filed)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex23-1.htm">Consent of Marcum LLP</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.2*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex23-2.htm">Consent of EisnerAmper LLP</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.3*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex23-3.htm">Consent of Bush &amp; Associates CPA LLC</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.4*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex5-1.htm">Consent of Counsel to Registrant (included in Exhibit 5.1)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/923601/000149315224044853/forms-1.htm#alp_020" style="-sec-extract: exhibit">Powers
    of Attorney (previously filed)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">107</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/923601/000149315224044853/ex-107.htm" style="-sec-extract: exhibit">Filing
    Fee Table (previously filed)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.INS</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
    XBRL Instance Document. The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within
    the Inline XBRL document.</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; width: 0.7in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.SCH</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
    XBRL Taxonomy Extension Schema Document.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.CAL</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
    XBRL Taxonomy Extension Calculation Linkbase Document.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.DEF</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
    XBRL Taxonomy Extension Definition Linkbase Document.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.LAB</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
    XBRL Taxonomy Extension Label Linkbase Document.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.PRE</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
    XBRL Taxonomy Extension Presentation Linkbase Document.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover
    Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">+</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicates management contract or compensatory plan.</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
  <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed herewith.</span></td></tr>

</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>



<!-- Field: Page; Sequence: 151; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 0pt; margin-bottom: 0pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
17. Undertakings.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned registrant hereby undertakes:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
To include any prospectus required by section 10(a)(3) of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;);</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective
amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration
statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities
offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range
may be reflected in the form of prospectus filed with the Securities and Exchange Commission pursuant to Rule 424(b) if, in the aggregate,
the changes in volume and price represent no more than a 20 percent change in the maximum aggregate offering price set forth in the &#8220;Calculation
of Registration Fee&#8221; table in the effective registration statement; and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or
any material change to such information in the registration statement; provided, however, that paragraphs (1)(i), (1)(ii) and (1)(iii)
above do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports
filed with or furnished to the Securities and Exchange Commission by the registrant pursuant to Section 13 or Section 15(d) of the Securities
Exchange Act of 1934 that are incorporated by reference in the registration statement, or is contained in a form of prospectus filed
pursuant to Rule 424(b) that is part of the registration statement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be
a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed
to be the initial bona fide offering thereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the
termination of the offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)
That, for the purpose of determining liability under the Securities Act to any purchaser:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 32.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)
Each prospectus filed by the registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the
date the filed prospectus was deemed part of and included in the registration statement; and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)
Each prospectus filed pursuant to Rule 424(b) as part of a registration statement relating to an offering, other than registration statements
relying on Rule 430B or other than prospectuses filed in reliance on Rule 430A, shall be deemed to be part of and included in the registration
statement as of the date it is first used after effectiveness. Provided, however, that no statement made in a registration statement
or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into
the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of
sale prior to such first use, supersede or modify any statement that was made in the registration statement or prospectus that was part
of the registration statement or made in any such document immediately prior to such date of first use.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)
That for the purpose of determining liability of the registrant under the Securities Act to any purchaser in the initial distribution
of securities, the undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant
to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities
are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to
the purchaser and will be considered to offer or sell such securities to such purchaser:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule
424;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 152; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 0pt; margin-bottom: 0pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by
the undersigned registrant;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant
or its securities provided by or on behalf of the undersigned registrant; and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insofar
as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of
the registrant pursuant to any charter provision, by law or otherwise, the registrant has been advised that in the opinion of the Securities
and Exchange Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable.
In the event that a claim for indemnification against such liabilities (other than payment by the registrant of expenses incurred or
paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted
by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the
opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question
whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication
of such issue.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned registrant hereby undertakes that:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
For purposes of determining any liability under the Securities Act, the information omitted from the form of prospectus filed as part
of this registration statement in reliance upon Rule 430A and contained in a form of prospectus filed by the registrant pursuant to Rule
424(b)(1) or (4) or 497(h) under the Securities Act shall be deemed to be part of this registration statement as of the time it was declared
effective.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
For the purpose of determining any liability under the Securities Act, each post-effective amendment that contains a form of prospectus
shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at
that time shall be deemed to be the initial bona fide offering thereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 153; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 0pt; margin-bottom: 0pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Act of 1933, the registrant has duly caused this Registration Statement to be signed on its behalf
by the undersigned, thereunto duly authorized in the City of Fort Lauderdale, State of Florida, on November 25, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALGORHYTHM
    HOLDINGS, INC.</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Gary Atkinson </i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gary
    Atkinson</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
    Executive Officer)</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 154; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 0pt; margin-bottom: 0pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities
and on the dates indicated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 24%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 56%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Position</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 16%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Gary Atkinson </i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer, Chairman and Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">November
    25, 2024</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gary
    Atkinson</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
    Executive Officer)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Richard Perez </i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">November
    25, 2024</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Richard
    Perez</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
Financial and Accounting Officer)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    * </i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Revenue Officer and Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">November
    25, 2024</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bernardo
    Melo</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    * </i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">November
    25, 2024</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Harvey
    Judkowitz</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    * </i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">November
    25, 2024</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joseph
    Kling</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    * </i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">November
    25, 2024</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mathieu
    Peloquin</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    * </i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">November
    25, 2024</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jay
    Foreman</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
    <td style="padding-bottom: 1pt; width: 4%">*By:</td>
  <td style="border-bottom: Black 1pt solid; width: 46%"><i>/s/ Gary Atkinson</i></td>
  <td style="padding-bottom: 1pt; width: 50%">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
    <td>&#160;</td>
  <td>Gary Atkinson</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
    <td>&#160;</td>
  <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Attorney-In-Fact</p>
</td>
  <td>&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 155; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>2
<FILENAME>ex4-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
4.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SERIES
A COMMON STOCK PURCHASE WARRANT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ALGORHYTHM
HOLDINGS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
    Shares: [*]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuance
    Date: [&nbsp;&nbsp; ], 2024</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
SERIES A COMMON STOCK PURCHASE WARRANT (&ldquo;<B>Warrant</B>&rdquo;) certifies that, for value received, ______________ or its assigns
(the &ldquo;<B>Holder</B>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter
set forth, at any time on or after the Shareholder Approval Date (as defined below) (such date, the &ldquo;<B>Initial Exercise Date</B>&rdquo;)
and on or prior to 5:00 p.m. (New York, New York time) on the five year anniversary of the Initial Exercise Date, <I>provided</I> that
if such date is not a Trading Day, the immediately following Trading Day (the &ldquo;<B>Termination Date</B>&rdquo;) but not thereafter,
to subscribe for and purchase from Algorhythm Holdings, Inc., a Delaware corporation (the &ldquo;<B>Company</B>&rdquo;), up to ______
shares Common Stock, the (&ldquo;<B>Warrant Shares</B>&rdquo;), subject to adjustment hereunder. The purchase price of one share of Common
Stock under this Warrant shall be equal to the Exercise Price, as defined in <U>Section 2(b)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
1</U>. <U>Definitions</U>. In addition to the terms defined elsewhere in this Warrant, the following terms have the meanings indicated
in this <U>Section 1</U>. Capitalized word and terms used and not otherwise defined herein shall have the meanings set forth in that
certain Securities Purchase Agreement (the &ldquo;<B>Purchase Agreement</B>&rdquo;), dated [ ], 2024, among the Company and the purchasers
signatory thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Adjustment
Period</B>&rdquo; shall have the meaning set forth in <U>Section 3(i)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Affiliate</B>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Alternate
Consideration</B>&rdquo; shall have the meaning set forth in <U>Section 3(d)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Applicable
Price</B>&rdquo; shall have the meaning set forth in <U>Section 3(i)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Attribution
Parties</B>&rdquo; shall have the meaning set forth in <U>Section 2(e)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Base
Share Price</B>&rdquo; shall have the meaning set forth in <U>Section 3(i)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Bid
Price</B>&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (i) if the Common Stock
is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York, New York time) to 4:02 p.m. (New York, New York time)), (ii) if OTCQB or OTCQX is not a Trading Market, the volume weighted
average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (iii) if the Common
Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open
Market (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of
the Common Stock so reported, or (iv) in all other cases, the fair market value of a share of Common Stock as determined by an independent
appraiser selected in good faith by the Holders of a majority in interest of the Warrants then outstanding and reasonably acceptable
to the Company, the fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Black
Scholes Value</B>&rdquo; shall have the meaning set forth in <U>Section 3(d)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Bloomberg</B>&rdquo;
means Bloomberg L.P., or any successor thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Board
of Directors</B>&rdquo; means the board of directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Buy-In</B>&rdquo;
shall have the meaning set forth in <U>Section 2(d)(iv)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Business
Day</B>&rdquo; means any day other than Saturday, Sunday, or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Bylaws</B>&rdquo;
means the Amended and Restated Bylaws of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Certificate
of Incorporation</B>&rdquo; means the Certificate of Incorporation, as amended, of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Common
Stock</B>&rdquo; means the common stock of the Company, par value $0.01 per share, and any other class of securities into which such
securities may hereafter be reclassified or changed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Common
Stock Equivalents</B>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant, or other instrument that
is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Company</B>&rdquo;
shall have the meaning set forth in the Preamble.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Convertible
Securities</B>&rdquo; shall have the meaning set forth in <U>Section 3(i)(1)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Convertible
Securities Shares</B>&rdquo; shall have the meaning set forth in <U>Section 3(i)(1)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Distribution</B>&rdquo;
shall have the meaning set forth in <U>Section 3(c)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>DWAC</B>&rdquo;
shall have the meaning set forth in <U>Section 2(d)(i)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 67.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Dilutive
Issuance</B>&rdquo; shall have the meaning set forth in <U>Section 3(i)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 67.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Exchange
Ac</B>t&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Exercise
Price</B>&rdquo; shall have the meaning set forth in <U>Section 2(b)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Floor
Price</B>&rdquo; means (A) prior to the Shareholder Approval Date, a price equal to $[ ] per share, and (B) effective beginning on the
Shareholder Approval Date, a price equal to $[ ] per share; which in each case shall be appropriately adjusted for any stock dividend,
stock split, stock combination, reclassification or similar event or transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Fundamental
Transaction</B>&rdquo; shall have the meaning set forth in <U>Section 3(d)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Holder</B>&rdquo;
shall have the meaning set forth in the Preamble.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Initial
Exercise Date</B>&rdquo; shall have the meaning set forth in the Preamble.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Issuance
Date</B>&rdquo; means the issuance date of this Warrant as set forth on the first page hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>New
Issuance Price</B>&rdquo; shall have the meaning set forth in <U>Section 3(i)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Notice
of Exercise</B>&rdquo; shall have the meaning set forth in <U>Section 2(a)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Option&rdquo;
</B>means any rights, warrants, or options to subscribe for or purchase Common Stock or Convertible Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Person</B>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof), or other entity of any kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Primary
Security</B>&rdquo; shall have the meaning set forth in <U>Section 3(i)(4)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Purchase
Agreement</B>&rdquo; shall have the meaning set forth in <U>Section 1</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Purchase
Rights</B>&rdquo; shall have the meaning set forth in <U>Section 3(b)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Redemption
Date</B>&rdquo; shall have the meaning set forth in <U>Section 2(f)(ii)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Redemption
Price</B>&rdquo; shall have the meaning set forth in <U>Section 2(f)(ii)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Redemption
Notice</B>&rdquo; shall have the meaning set forth in <U>Section 2(f)(iii)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Redemption
Notice Date</B>&rdquo; shall have the meaning set forth in <U>Section 2(f)(iii)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Registration
Statement</B>&rdquo; means the Company&rsquo;s registration statement on Form S-1, as amended (File No. 333-283178).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Required
Holders</B>&rdquo; shall have the meaning set forth in <U>Section 3(d)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Reset
Date</B>&rdquo; means the fourth (4th) Trading Day following the Shareholder Approval Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Reset
Period</B>&rdquo; means the period commencing on the first Trading Day prior to the Shareholder Approval Date and ending following the
close of trading on the fourth (4th) Trading Day thereafter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Reset
Price</B>&rdquo; means the greater of (i) the lowest daily VWAP during the Reset Period and (ii) the Floor Price in effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>SEC</B>&rdquo;
means the United States Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Secondary
Securities</B>&rdquo; shall have the meaning set forth in <U>Section 3(i)(4)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Securities
Act</B>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Shareholder
Approval</B>&rdquo; means such approval as may be required by the applicable rules and regulations of The Nasdaq Stock Market LLC (or
any successor entity) from the shareholders of the Company with respect to issuance of all of the Warrant Shares upon the exercise of
the Warrants, including, without limitation, to render inapplicable clause (A) of the definition of the Floor Price, thereby giving full
effect to the adjustment to the Exercise Price and/or number of shares of Common Stock underlying the Warrants following any Dilutive
Issuance or Reset Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Shareholder
Approval Date</B>&rdquo; means the Trading Day that Shareholder Approval is received and deemed effective. Notwithstanding anything to
the contrary, such notice shall be deemed to be given by a public filing with the SEC disclosing the effectiveness of the Shareholder
Approval.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Standard
Settlement Period</B>&rdquo; shall have the meaning set forth in <U>Section 2(d)(i)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Subsidiary</B>&rdquo;
means any subsidiary of the Company and shall, where applicable, also include any direct or indirect subsidiary of the Company formed
or acquired after the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Successor
Entity</B>&rdquo; shall have the meaning set forth in <U>Section 3(d)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Termination
Date</B>&rdquo; shall have the meaning set forth in the Preamble.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Trading
Day</B>&rdquo; means a day on which the Trading Market is open for trading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Trading
Market</B>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: The Nasdaq Capital Market, The Nasdaq Global Market, The Nasdaq Global Select Market, the New York Stock Exchange, or the
NYSE American, (or any successors to any of the foregoing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Trading
Value</B>&rdquo; means, with respect to the Company&rsquo;s Common Stock, the daily trading volume on the Company&rsquo;s primary Trading
Market as reported by Bloomberg multiplied by the closing price of the Common Stock on such date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Transfer
Agent</B>&rdquo; means Continental Stock Transfer &amp; Trust Company, the current transfer agent of the Company, with a mailing address
1 State Street, 30th Floor, New York, NY 10004-1561 and a phone number of (212) 509-4000, and any successor transfer agent of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Trigger
Date</B>&rdquo; shall have the meaning set forth in <U>Section 5(a)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Unit</B>&rdquo;
shall have the meaning set forth in <U>Section 3(i)(4)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Valuation
Event</B>&rdquo; shall have the meaning set forth in <U>Section 3(i)(4)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>VWAP</B>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (i) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York, New York time) to 4:02 p.m. (New York, New York time)), (ii) if OTCQB or OTCQX is not a Trading Market, the volume weighted
average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (iii) if the Common
Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open
Market (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of
the Common Stock so reported, or (iv) in all other cases, the fair market value of a share of Common Stock as determined by an independent
appraiser selected in good faith by the holders of a majority in interest of the Warrants then outstanding and reasonably acceptable
to the Company, the fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Warrant
Register</B>&rdquo; shall have the meaning set forth in <U>Section 4(c)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Warrant
Share Delivery Date</B>&rdquo; shall have the meaning set forth in <U>Section 2(d)(i)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Warrant
Shares</B>&rdquo; shall have the meaning set forth in the Preamble.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Warrants</B>&rdquo;
means this Warrant and other Series A Common Stock purchase warrants issued by the Company pursuant to the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
2</U>. <U>Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Exercise of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time
or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed facsimile
copy or PDF copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form attached hereto as <U>Exhibit A</U>
(the &ldquo;<B>Notice of Exercise</B>&rdquo;). Within the earlier of (i) one (1) Trading Day and (ii) such earlier time comprising the
Standard Settlement Period (as defined in <U>Section 2(d)(i)</U> herein) following the date of exercise as aforesaid, the Holder shall
deliver the aggregate Exercise Price for the number of Warrant Shares specified in the applicable Notice of Exercise by wire transfer
or cashier&rsquo;s check drawn on a United States bank unless the cashless exercise procedure specified in <U>Section 2(c)</U> below
is applicable and specified in the attached Notice of Exercise. The Company shall have no obligation to inquire with respect to or otherwise
confirm the authenticity of the signature(s) contained on any Notice of Exercise nor the authority of the person so executing such Notice
of Exercise. No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization)
of any Notice of Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically
surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has
been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading
Days of the date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases
of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant
Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall
maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection
to any Notice of Exercise within one (1) Trading Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this
Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant
Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated
on the face hereof.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Exercise Price</U>. The exercise price per share of Common Stock under this Warrant shall be $[ ], subject to adjustment hereunder
(the &ldquo;<B>Exercise Price</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Cashless Exercise</U>. If and only if at the time of any exercise hereof there is no effective registration statement registering,
or the prospectus contained therein is not available for the issuance of the Warrant Shares to the Holder, then this Warrant may be exercised,
in whole or in part, at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive a number
of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)
= as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of
Exercise is (1) both executed and delivered pursuant to <U>Section 2(a)</U> hereof on a day that is not a Trading Day or (2) both executed
and delivered pursuant to <U>Section 2(a)</U> hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as
defined in Rule 600(b) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) the Bid Price of the
Common Stock on the principal Trading Market as reported by Bloomberg as of the time of the Holder&rsquo;s execution of the applicable
Notice of Exercise if such Notice of Exercise is executed during &ldquo;regular trading hours&rdquo; on a Trading Day and is delivered
within two hours thereafter (including until two hours after the close of &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant
to <U>Section 2(a)</U> hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise
is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to <U>Section 2(a)</U> hereof after the close of
&ldquo;regular trading hours&rdquo; on such Trading Day;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)
= the Exercise Price of this Warrant, as adjusted hereunder; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(X)
= the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such
exercise were by means of a cash exercise rather than a cashless exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised. The Company agrees not
to take any position contrary to this <U>Section 2(c)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Mechanics of Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Delivery of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by
the Transfer Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository
Trust Company through its Deposit or Withdrawal at Custodian system (&ldquo;<B>DWAC</B>&rdquo;) if the Company is then a participant
in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale
of the Warrant Shares by the Holder or (B) this Warrant is being exercised via cashless exercise, and otherwise by physical delivery
of a certificate, registered in the Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant
Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by
the date that is the earlier of (i) one (1) Trading Day after delivery of the Notice of Exercise and the aggregate Exercise Price (other
than in the case of a cashless exercise) to the Company and (ii) the number of days comprising the Standard Settlement Period after the
delivery to the Company of the Notice of Exercise and the aggregate Exercise Price (other than in the case of a cashless exercise) (such
date, the &ldquo;<B>Warrant Share Delivery Date</B>&rdquo;). Upon delivery of the Notice of Exercise, the Holder shall be deemed for
all corporate purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised,
irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price (other than in the
case of a cashless exercise) is received by the Warrant Share Delivery Date. If the Company fails for any reason to deliver to the Holder
the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery Date following payment of the aggregate Exercise Price
by the Holder (other than in the case of cashless exercise is received by the Company by such date), the Company shall pay to the Holder,
in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of
the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the fifth
(5th) Trading Day after the Warrant Share Delivery Date) for each Trading Day after such Warrant Share Delivery Date until such Warrant
Shares are delivered or Holder rescinds such exercise. The Company agrees to maintain a transfer agent that is a participant in the FAST
program so long as this Warrant remains outstanding and exercisable. As used herein, &ldquo;<B>Standard Settlement Period</B>&rdquo;
means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary Trading Market with respect
to the Common Stock as in effect on the date of delivery of the Notice of Exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.5pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
<U>Delivery of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of
a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant
evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in
all other respects be identical with this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
<U>Rescission Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to <U>Section
2(d)(i)</U> by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise by delivering written notice
to the Company at any time prior to the delivery of such Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.5pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
<U>Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to
the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions
of <U>Section 2(d)(i)</U> above pursuant to an exercise on or before the Warrant Share Delivery Date (other than a failure caused by
incorrect or incomplete information provided by the Holder to the Company), and if after such date the Holder is required by its broker
to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares of Common Stock
to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a
&ldquo;<B>Buy-In</B>&rdquo;), then the Company shall (A) <I>provided</I> that if the Common Stock is then listed or quoted on the Trading
Market or any over-the-counter market (including OTC Pink or any successor) such price set forth in (y)(2) of this clause (A) is reasonably
comparable to a market price or prices in purchases and sales of the Common Stock occurring in the market on or close in time to the
Trading Day on which the Holder&rsquo;s purchase occurred taking into account the volume of the Holder&rsquo;s purchase, pay in cash
to the Holder the amount, if any, by which (x) the Holder&rsquo;s total purchase price (including brokerage commissions, if any) for
the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company
was required to deliver to the Holder in connection with the exercise at issue times (2) the price at which the sell order giving rise
to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the portion of the Warrant and equivalent
number of Warrant Shares for which such exercise was not honored (in which case such exercise shall be deemed rescinded) or deliver to
the Holder the number of shares of Common Stock that would have been issued had the Company timely complied with its exercise and delivery
obligations hereunder. For example, if the Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with
respect to an attempted exercise of shares of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000,
under clause (A) of the immediately preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide
the Company written notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence
of the amount of such loss. Nothing herein shall limit a Holder&rsquo;s right to pursue any other remedies available to it hereunder,
at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s
failure to timely deliver shares of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof. The obligation
of the Company to pay compensation for Buy-In under this <U>Section 2(d)(iv)</U> is subject to delivery by the Holder of the aggregate
Exercise Price in accordance with the terms of <U>Section 2(a)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.5pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
<U>No Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company
shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied
by the Exercise Price or round up to the next whole share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)
<U>Charges, Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax
or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company,
and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>,
<U>however</U>, that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when
surrendered for exercise shall be accompanied by the assignment form substantially in the form attached hereto as <U>Exhibit B</U> duly
executed by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer
tax incidental thereto. The Company shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and
all fees to the Depository Trust Company (or another established clearing corporation performing similar functions) required for same-day
electronic delivery of the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)
<U>Closing of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise
of this Warrant, pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.5pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Holder&rsquo;s Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the
right to exercise any portion of this Warrant, pursuant to <U>Section 2</U> or otherwise, to the extent that after giving effect to such
issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and
any other Persons acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<B>Attribution
Parties</B>&rdquo;)), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the
foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties
shall include the number of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is
being made, but shall exclude the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised
portion of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion
of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock
Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the
Holder or any of its Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this <U>Section
2(e)</U>, beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations
promulgated thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation
is in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in
accordance therewith. To the extent that the limitation contained in this <U>Section 2(e)</U> applies, the determination of whether this
Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and
of which portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise
shall be deemed to be the Holder&rsquo;s determination of whether this Warrant is exercisable (in relation to other securities owned
by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable, in each case
subject to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy of such determination
and shall have no liability for exercises of the Warrant that are not in compliance with the Beneficial Ownership Limitation, except
to the extent the Holder relies on a number of outstanding shares of Common Stock that was provided by the Company. In addition, a determination
as to any group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and
regulations promulgated thereunder. For purposes of this <U>Section 2(e)</U>, in determining the number of outstanding shares of Common
Stock, a Holder may rely on the number of outstanding shares of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic
or annual report filed with the SEC, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written
notice by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon the written request
of a Holder, the Company shall within one (1) Trading Day confirm orally and in writing to the Holder the number of shares of Common
Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the
conversion or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since
the date as of which such number of outstanding shares of Common Stock was reported. The &ldquo;<B>Beneficial Ownership Limitation</B>&rdquo;
shall be 4.99% (or, upon election by a Holder prior to the issuance of any Warrants, 9.99%) of the number of shares of Common Stock outstanding
immediately after giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant. The Holder, upon written
notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this <U>Section 2(e)</U>, provided
that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately
after giving effect to the issuance of shares of Common Stock upon exercise of this Warrant held by the Holder and the provisions of
this <U>Section 2(e)</U> shall continue to apply. Any increase in the Beneficial Ownership Limitation will not be effective until the
61<SUP>st</SUP> day after such notice is delivered to the Company. The provisions of this paragraph shall be construed and implemented
in a manner otherwise than in strict conformity with the terms of this <U>Section 2(e)</U> to correct this paragraph (or any portion
hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes
or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall apply
to a successor holder of this Warrant. If the Warrant is unexercisable as a result of the Holder&rsquo;s Beneficial Ownership Limitation,
no alternate consideration is owing to the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Redemption Right</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
Beginning on the Initial Exercise Date, this Warrant may be redeemed at the option of the Company, in whole or in part, by giving not
less than thirty (30) days&rsquo; prior notice, which notice may not be given before, but may be given at any time after the date on
which (i) the VWAP exceeded $[ ] for ten (10) consecutive Trading Days and (ii) the average daily Trading Value of the Common Stock for
such ten (10) Trading Day period referred to in this <U>Section 2(f)(i)</U> exceeded $[150,000].</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
The price at which this Warrant may be redeemed (the &ldquo;<B>Redemption Price</B>&rdquo;) is $0.01 per Warrant Share. On and after
the date upon which such Warrant is redeemed by the Company (the &ldquo;<B>Redemption Date</B>&rdquo;), the Holder of a redeemed Warrant
shall be entitled to payment of the Redemption Price upon surrender of the Warrant to the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
Notice of redemption of this Warrant (the &ldquo;<B>Redemption Notice</B>&rdquo;) shall be given at least thirty (30) days prior to the
Redemption Date (the &ldquo;<B>Redemption Notice Date</B>&rdquo;) by the Company (i) providing notice to the Holder as provided in <U>Section
5(i)</U>, (ii) notifying the Holders of such redemption via publication of a press release and (iii) taking such other steps as may be
required under applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
From and after the Redemption Date, any Warrant Shares noticed for redemption that have not theretofore been exercised by the Holder
shall cease to represent the right to purchase any shares of Common Stock and shall be deemed canceled and void and of no further force
or effect without any further act or deed on the part of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
By acceptance of this Warrant, the Holder undertakes to return the certificate representing any redeemed Warrant to the Company upon
their redemption and to indemnify the Company with respect to any losses, claims, damages, or liabilities arising from the Holder&rsquo;s
failure to return such certificate. In the event the certificate so returned represents a number of Warrant Shares in excess of the number
being redeemed, the Company shall as promptly as practicable issue to the Holder a new certificate in book-entry form for the number
of unredeemed Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)
Notwithstanding anything to the contrary set forth in this Warrant, the Company may not require the cancellation of this Warrant (and
any related Redemption Notice shall be void), unless, from the beginning of the Redemption Notice Date through the Redemption Date, (1)
the Company shall have honored in accordance with the terms of this Warrant all Notices of Exercise delivered by 6:30 p.m. (New York,
New York time) on the Redemption Date, (2) a registration statement shall be effective as to all Warrant Shares and the prospectus thereunder
available for use by the Company for the sale of all such Warrant Shares to the Holder, (3) the Common Stock shall be listed or quoted
for trading on the Trading Market, (4) there is a sufficient number of authorized shares of Common Stock for issuance of all Warrant
Shares, and (5) the issuance of all Warrant Shares subject to a Redemption Notice shall not cause a breach of any provision of <U>Section
2(e)</U> herein. The Company&rsquo;s right to call the Warrants under this <U>Section 2(f)</U> shall be exercised ratably among the Holders
based on each Holder&rsquo;s ownership of outstanding Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
3</U>. <U>Certain Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Stock Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise
makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares
of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the
Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which
the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this <U>Section 3(a)</U> shall become effective immediately after the record
date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after
the effective date in the case of a subdivision, combination or re-classification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Subsequent Rights Offerings</U>. In addition to any adjustments pursuant to <U>Section 3(a)</U> above, if at any time that this Warrant
is outstanding the Company grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or
other property pro rata to all of the record holders of any class of shares of Common Stock (the &ldquo;<B>Purchase Rights</B>&rdquo;),
then the Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the
Holder could have acquired if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant
(without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately
before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the
date as of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights
(provided, however, that, to the extent that the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder
exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent
(or beneficial ownership of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to
such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding
the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Pro Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or
other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital
or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend,
spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<B>Distribution</B>&rdquo;),
at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution
to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable
upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial
Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the
date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>,
<U>however</U>, that, to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder
exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent
(or in the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such
Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result
in the Holder exceeding the Beneficial Ownership Limitation). To the extent that this Warrant has not been partially or completely exercised
at the time of such Distribution, such portion of the Distribution shall be held in abeyance for the benefit of the Holder until the
Holder has exercised this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Fundamental Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or
more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company, directly
or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of
its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer
(whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange
their shares for other securities, cash or property and has been accepted by the holders of greater than 50% of the outstanding Common
Stock or greater than 50% of the voting power of the common equity of the Company, (iv) the Company, directly or indirectly, in one or
more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share
exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property (other
than a stock split or stock dividend), or (v) the Company, directly or indirectly, in one or more related transactions consummates a
stock or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off,
merger or scheme of arrangement (other than a stock split or stock dividend) with another Person or group of Persons whereby such other
Person or group acquires greater than 50% of the outstanding shares of Common Stock or greater than 50% of the voting power of the common
equity of the Company (each a &ldquo;<B>Fundamental Transaction</B>&rdquo;), then, upon any subsequent exercise of this Warrant, the
Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to
the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in <U>Section 2(e)</U>
on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if
it is the surviving corporation, and any additional consideration (the &ldquo;<B>Alternate Consideration</B>&rdquo;) receivable as a
result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is exercisable immediately
prior to such Fundamental Transaction (without regard to any limitation in <U>Section 2(e)</U> on the exercise of this Warrant). For
purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration
based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and
the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value
of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash
or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration
it receives upon any exercise of this Warrant following such Fundamental Transaction. Notwithstanding anything to the contrary, in the
event of a Fundamental Transaction, the Company or any Successor Entity (as defined below) shall, at the Holder&rsquo;s option, exercisable
at any time concurrently with, or within 30 days after, the consummation of the Fundamental Transaction (or, if later, the date of the
public announcement of the applicable Fundamental Transaction), purchase this Warrant from the Holder by paying to the Holder an amount
of cash equal to the Black Scholes Value (as defined below) of the remaining unexercised portion of this Warrant on the date of the consummation
of such Fundamental Transaction; <U>provided</U>, <U>however</U>, that, if the Fundamental Transaction is not within the Company&rsquo;s
control, including not approved by the Board of Directors, the Holder shall only be entitled to receive from the Company or any Successor
Entity the same type or form of consideration (and in the same proportion), at the Black Scholes Value of the unexercised portion of
this Warrant, that is being offered and paid to the holders of Common Stock of the Company in connection with the Fundamental Transaction,
whether that consideration be in the form of cash, stock or any combination thereof, or whether the holders of Common Stock are given
the choice to receive from among alternative forms of consideration in connection with the Fundamental Transaction; <U>provided</U>,
<U>further</U>, that if holders of Common Stock of the Company are not offered or paid any consideration in such Fundamental Transaction,
such holders of Common Stock will be deemed to have received shares of common stock of the Successor Entity (which Successor Entity may
be the Company following such Fundamental Transaction) in such Fundamental Transaction. &ldquo;<B>Black Scholes Value</B>&rdquo; means
the value of this Warrant based on the Black-Scholes Option Pricing Model obtained from the &ldquo;OV&rdquo; function on Bloomberg determined
as of the day of consummation of the applicable Fundamental Transaction for pricing purposes and reflecting (A) a risk-free interest
rate corresponding to the U.S. Treasury rate for a period equal to the time between the date of the public announcement of the applicable
contemplated Fundamental Transaction and the Termination Date, (B) an expected volatility equal to the greater of (1) the 30 day volatility,
(2) the 100 day volatility or (3) the 365 day volatility, each of clauses (1)-(3) as obtained from the HVT function on Bloomberg (determined
utilizing a 365 day annualization factor) as of the Trading Day immediately following the public announcement of the applicable contemplated
Fundamental Transaction, (C) the underlying price per share used in such calculation shall be the greater of (i) the sum of the price
per share being offered in cash, if any, plus the value of any non-cash consideration, if any, being offered in such Fundamental Transaction
and (ii) the VWAP immediately preceding the public announcement of the applicable contemplated Fundamental Transaction (or the consummation
of the applicable Fundamental Transaction, if earlier), (D) the sum of the remaining option time equal to the time between the date of
the public announcement of the applicable contemplated Fundamental Transaction and the Termination Date and (E) a zero cost of borrow.
The payment of the Black Scholes Value will be made by wire transfer of immediately available funds (or such other consideration) within
the later of (i) five Business Days of the Holder&rsquo;s election and (ii) the date of consummation of the Fundamental Transaction.
The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the &ldquo;<B>Successor
Entity</B>&rdquo;) to assume in writing all of the obligations of the Company under this Warrant in accordance with the provisions of
this <U>Section 3(d)</U> pursuant to written agreements in form and substance reasonably satisfactory to the holders of Warrants representing
at least a majority of the shares of Common Stock underlying the Warrants then outstanding without giving effect to any beneficial ownership
limitations (the &ldquo;<B>Required Holders</B>&rdquo;) and approved by the Required Holders (without unreasonable delay) prior to such
Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the
Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which is exercisable for
a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common
Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior
to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock
(but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such
shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting the economic
value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in
form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall be added to the
term &ldquo;Company&rdquo; under this Warrant (so that from and after the occurrence or consummation of such Fundamental Transaction,
each and every provision of this Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo; shall refer instead
to each of the Company and the Successor Entity or Successor Entities, jointly and severally), and the Successor Entity or Successor
Entities, jointly and severally with the Company, may exercise every right and power of the Company prior thereto and the Successor Entity
or Successor Entities shall assume all of the obligations of the Company prior thereto under this Warrant and the other Transaction Documents
with the same effect as if the Company and such Successor Entity or Successor Entities, jointly and severally, had been named as the
Company herein. For the avoidance of doubt, the Holder shall be entitled to the benefits of the provisions of this <U>Section 3(d)</U>
regardless of (i) whether the Company has sufficient authorized shares of Common Stock for the issuance of Warrant Shares and/or (ii)
whether a Fundamental Transaction occurs prior to the Initial Exercise Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Calculations</U>. All calculations under this <U>Section 3</U> shall be made to the nearest cent or the nearest 1/100th of a share,
as the case may be. For purposes of this <U>Section 3</U>, the number of shares of Common Stock deemed to be issued and outstanding as
of a given date shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Notice to Holder</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Adjustment to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this <U>Section 3</U>, the
Company shall promptly deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting
adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment; provided, however,
that the Company may satisfy the notice requirement in this <U>Section 3(f)</U> by filing such information with the Commission on its
Electronic Data Gathering, Analysis, and Retrieval (EDGAR) system pursuant to a Current Report on Form 8-K, Quarterly Report on Form
10-Q or Annual Report on Form 10-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
<U>Notice to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form other
than a stock split or stock dividend) on the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a
redemption of the Common Stock (excluding any granting or issuance of rights to all of the Company&rsquo;s stockholders pursuant to a
stockholder rights plan), (C) the Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe
for or purchase any shares of capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall
be required in connection with any reclassification of the Common Stock, any consolidation or merger to which the Company (or any of
its Subsidiaries) is a party, any sale or transfer of all or substantially all of its assets, or any compulsory share exchange whereby
the Common Stock is converted into other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary
dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by
facsimile or email to the Holder at its last facsimile number or email address as it shall appear upon the Warrant Register of the Company,
at least ten (10) calendar days prior to the applicable record or effective date hereinafter specified, a notice stating (x) the date
on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not
to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions, redemption,
rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share
exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock of record
shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification,
consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver such notice or any defect therein or in
the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice. To the extent that
any notice provided in this Warrant constitutes, or contains, material, non-public information regarding the Company or any of the Subsidiaries,
the Company shall simultaneously file such notice with the SEC pursuant to a Current Report on Form 8-K. The Holder shall remain entitled
to exercise this Warrant during the period commencing on the date of such notice to the effective date of the event triggering such notice
except as may otherwise be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.5pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Voluntary Adjustment By Company</U>. Subject to the rules and regulations of the Trading Market, the Company may at any time during
the term of this Warrant reduce the then current Exercise Price to any amount and for any period of time deemed appropriate by the Company&rsquo;s
Board of Directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>Shareholder Approval</U>. The Company shall hold a meeting of shareholders for, or obtain through written consent, the Shareholder
Approval as soon as practicable following the Issuance Date. After obtaining the Shareholder Approval through such meeting or vote, the
Company shall comply with all applicable rules and regulations of the SEC and applicable state laws and provisions of its Certificate
of Incorporation and Bylaws with respect to the Shareholder Approval, and shall use its best efforts to cause the minimal amount of time
therefor to apply before the Shareholder Approval takes effect in accordance with such rules and regulations, laws, and provisions. Without
limiting the generality of the foregoing, the Company shall prepare and file with the SEC any necessary materials or disclosures with
the SEC with respect to the shareholder vote for Shareholder Approval and shall ensure these materials are provided to shareholders of
the Company as soon as practicable thereafter in accordance with the rules and regulations of the SEC. The Company shall promptly provide
responses to the SEC with respect to any comments received from the SEC regarding these materials filed in accordance with this <U>Section
3(h)</U>, and will take all required actions to facilitate the shareholder vote and use reasonable efforts to ensure Shareholder Approval
is obtained in a timely manner.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Subsequent Equity Sales</U>. If, at any time while this Warrant is outstanding (such period, the &ldquo;<B>Adjustment Period</B>&rdquo;),
the Company issues, sells, enters into an agreement to sell, or grants any option to purchase, or sells, enters into an agreement to
sell, or grants any right to reprice, or otherwise disposes of or issues (or announces any offer, sale, grant, or any option to purchase
or other disposition), or, in accordance with this <U>Section 3(i)</U>, is deemed to have issued or sold, any shares of Common Stock
or Common Stock Equivalents for a consideration per share (the &ldquo;<B>New Issuance Price</B>&rdquo;) less than a price equal to the
Exercise Price in effect immediately prior to such issue or sale or deemed issuance or sale (such Exercise Price then in effect is referred
to as the &ldquo;<B>Applicable Price</B>&rdquo;) (the foregoing a &ldquo;<B>Dilutive Issuance</B>&rdquo;), then simultaneously with the
consummation (or, if earlier, the announcement) of such Dilutive Issuance, the Exercise Price then in effect shall be reduced to an amount
(the &ldquo;<B>New Exercise Price</B>&rdquo;) equal to the lower of (A) the New Issuance Price and (B) the lowest VWAP during the five
(5) consecutive Trading Days immediately following the Dilutive Issuance (such lower price, the &ldquo;<B>Base Share Price</B>&rdquo;)
and the number of Warrant Shares issuable hereunder shall be proportionately increased such that the aggregate Exercise Price of this
Warrant on the Issuance Date for the Warrant Shares then outstanding shall remain unchanged; <I>provided</I> that the Base Share Price
shall not be less than the Floor Price and any adjustment shall be consistent with maintaining equity classification under applicable
accounting guidance. Notwithstanding the foregoing, if one or more Dilutive Issuances occur prior to the Shareholder Approval Date such
that the reduction of the Exercise Price was limited by clause (A) in the definition of the Floor Price, then effective on the Shareholder
Approval Date, the Exercise Price will automatically be reduced to equal the greater of (x) lowest Base Share Price with respect to any
Dilutive Issuance that occurred prior to the Shareholder Approval Date and (B) the Floor Price determined in reference to clause (B)
of the definition of the Floor Price, and in any such event the number of Warrant Shares issuable hereunder shall be increased such that
the aggregate Exercise Price of this Warrant on the Issuance Date for the Warrant Shares then outstanding shall remain unchanged. If
the Company enters into a Variable Rate Transaction (as defined in the Purchase Agreement; <I>provided</I>, that, with respect to a Variable
Rate Transaction that is an equity line of credit or an &ldquo;at-the-market offering&rdquo;, this <U>Section 3(i)</U> shall apply to
any issuances of Common Stock or Common Stock Equivalents thereunder rather than the entry into the agreement with respect thereto),
the Company shall be deemed to have issued shares of Common Stock or Common Stock Equivalents at the lowest possible price, conversion
price, or exercise price at which such securities may be issued, converted, or exercised. Notwithstanding the foregoing, no adjustments
shall be made, paid, or issued under this <U>Section 3(i)</U> in respect of an Exempt Issuance (as defined in the Purchase Agreement).
For the avoidance of doubt, in the event the Exercise Price has been adjusted pursuant to this <U>Section 3(i)</U> and the Dilutive Issuance
that triggered such adjustment does not occur, is not consummated, is unwound, or is canceled after the facts for any reason whatsoever,
in no event shall the Exercise Price be readjusted to the Exercise Price that would have been in effect if such Dilutive Issuance had
not occurred or been consummated. For all purposes of the foregoing, the following shall be applicable:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
<U>Issuance of Options</U>. If, during the Adjustment Period, the Company in any manner grants or sells any Options and the lowest price
per share for which one share of Common Stock is issuable upon the exercise of any such Option or upon conversion, exercise, or exchange
of any convertible securities (&ldquo;<B>Convertible Securities</B>&rdquo;) issuable upon exercise of any such Option (such shares of
Common Stock issuable upon such exercise of any Option or upon conversion, exercise, or exchange of any Convertible Securities, the &ldquo;<B>Convertible
Securities Shares</B>&rdquo;) is less than the Applicable Price, then such shares of Common Stock shall be deemed to be outstanding and
to have been issued and sold by the Company at the time of the granting or sale of such Option for such price per share. For purposes
of this <U>Section 3(i)(1)</U>, the &ldquo;lowest price per share for which one share of Common Stock is issuable upon the exercise of
any such Option or upon conversion, exercise, or exchange of any Convertible Securities issuable upon exercise of any such Option&rdquo;
shall be equal to (A) the sum of (1) the lowest amount of consideration (if any) received or receivable by the Company with respect to
any one Convertible Securities Share upon the granting or sale of such Option, upon exercise of such Option and upon conversion, exercise,
or exchange of any Convertible Security issuable upon exercise of such Option and (2) the lowest exercise price set forth in such Option
for which one Convertible Securities Share is issuable upon the exercise of any such Option or upon conversion, exercise, or exchange
of any Convertible Securities issuable upon exercise of any such Option, minus (B) the sum of all amounts paid or payable to the holder
of such Option (or any other Person), with respect to any one Convertible Securities Share, upon the granting or sale of such Option,
upon exercise of such Option and upon conversion, exercise, or exchange of any Convertible Security issuable upon exercise of such Option
plus the value of any other consideration received or receivable by, or benefit conferred on, the holder of such Option (or any other
Person), with respect to any one Convertible Securities Share. Except as contemplated below, no further adjustment of the Exercise Price
shall be made upon the actual issuance of such Convertible Securities Share or of such Convertible Securities upon the exercise of such
Options or upon the actual issuance of such Convertible Securities Share upon conversion, exercise, or exchange of such Convertible Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
<U>Issuance of Convertible Securities</U>. If, during the Adjustment Period, the Company in any manner issues or sells any Convertible
Securities and the lowest price per share for which one Convertible Securities Share is issuable upon the conversion, exercise, or exchange
thereof is less than the Applicable Price, then such Convertible Securities Share shall be deemed to be outstanding and to have been
issued and sold by the Company at the time of the issuance or sale of such Convertible Securities for such price per share. For the purposes
of this <U>Section 3(i)(2)</U>, the &ldquo;lowest price per share for which one Convertible Securities Share is issuable upon the conversion,
exercise or exchange thereof&rdquo; shall be equal to (A) the sum of (1) the lowest amount of consideration (if any) received or receivable
by the Company with respect to one Convertible Securities Share upon the issuance or sale of the Convertible Security and upon conversion,
exercise, or exchange of such Convertible Security and (2) the lowest conversion price set forth in such Convertible Security for which
one Convertible Securities Share is issuable upon conversion, exercise, or exchange thereof, minus (B) the sum of all amounts paid or
payable to the holder of such Convertible Security (or any other Person), with respect to any one Convertible Securities Share, upon
the issuance or sale of such Convertible Security plus the value of any other consideration received or receivable by, or benefit conferred
on, the holder of such Convertible Security (or any other Person), with respect to any one Convertible Securities Share. Except as contemplated
below, no further adjustment of the Exercise Price shall be made upon the actual issuance of such Convertible Securities Share upon conversion,
exercise, or exchange of such Convertible Securities, and if any such issue or sale of such Convertible Securities is made upon exercise
of any Options for which adjustment of the Exercise Price has been or is to be made pursuant to other provisions of this <U>Section 3(i)(2)</U>,
except as contemplated below, no further adjustment of the Exercise Price shall be made by reason of such issue or sale.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
<U>Change in Option Price or Rate of Conversion</U>. If, during the Adjustment Period, the purchase or exercise price provided for in
any Options, the additional consideration, if any, payable upon the issue, conversion, exercise, or exchange of any Convertible Securities,
or the rate at which any Convertible Securities are convertible into or exercisable or exchangeable for shares of Common Stock increases
or decreases at any time (other than proportional changes in conversion or exercise prices, as applicable, in connection with an event
referred to in <U>Section 3(a)</U>, the Exercise Price in effect at the time of such increase or decrease shall be adjusted to the Exercise
Price which would have been in effect at such time had such Options or Convertible Securities provided for such increased or decreased
purchase price, additional consideration or increased or decreased conversion rate, as the case may be, at the time initially granted,
issued, or sold. For purposes of this <U>Section 3(i)(3)</U>, if the terms of any Option or Convertible Security that was outstanding
as of the date of issuance of this Warrant are increased or decreased in the manner described in the immediately preceding sentence,
then such Option or Convertible Security and the Convertible Securities Share deemed issuable upon exercise, conversion, or exchange
thereof shall be deemed to have been issued as of the date of such increase or decrease. No adjustment pursuant to this <U>Section 3(i)(3)
</U>shall be made if such adjustment would result in an increase of the Exercise Price then in effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)
<U>Calculation of Consideration Received</U>. If any Option or Convertible Security is issued in connection with the issuance or sale
or deemed issuance or sale of any other securities of the Company (the &ldquo;<B>Primary Security</B>,&rdquo; and such Option or Convertible
Security, the &ldquo;<B>Secondary Securities</B>&rdquo; and together with the Primary Security, each a &ldquo;<B>Unit</B>&rdquo;), together
comprising one integrated transaction, the aggregate consideration per share with respect to such Primary Security shall be deemed to
be the lowest of (x) the purchase price of such Unit, (y) if such Primary Security is an Option and/or Convertible Security, the lowest
price per share for which one share of Common Stock is at any time issuable upon the exercise or conversion of the Primary Security in
accordance with <U>Section 3(i)(1)</U> or <U>3(i)(2)</U> above and (z) the lowest VWAP of the shares of Common Stock on any Trading Day
during the five (5) consecutive Trading Days immediately following the consummation (or, if applicable, the announcement) of such Dilutive
Issuance (for the avoidance of doubt, if such public announcement, if applicable, is released prior to the opening of the Principal Market
on a Trading Day, such Trading Day shall be the first Trading Day in such five (5) Trading Day period and if this Warrant is exercised
on any given Exercise Date during any such period, the Holder may elect to earlier end such period (including, solely with respect to
such portion of this Warrant exercised on such applicable Exercise Date)). If any shares of Common Stock, Options, or Convertible Securities
are issued or sold or deemed to have been issued or sold for cash, the consideration received therefor will be deemed to be the net amount
of cash received by the Company therefor. If any shares of Common Stock, Options, or Convertible Securities are issued or sold for a
consideration other than cash, the amount of such consideration received by the Company will be the fair value of such consideration,
except where such consideration consists of publicly traded securities, in which case the amount of consideration received by the Company
for such securities will be the arithmetic average of the VWAPs of such security for each of the five (5) Trading Days immediately preceding
the date of receipt. If any shares of Common Stock, Options, or Convertible Securities are issued to the owners of the non-surviving
entity in connection with any merger in which the Company is the surviving entity, the amount of consideration therefor will be deemed
to be the fair market value of such portion of the net assets and business of the non-surviving entity as is attributable to such shares
of Common Stock, Options or Convertible Securities (as the case may be). The fair market value of any consideration other than cash or
publicly traded securities will be determined jointly by the Company and the Holder. If such parties are unable to reach agreement within
ten (10) days after the occurrence of an event requiring valuation (the &ldquo;<B>Valuation Event</B>&rdquo;), the fair market value
of such consideration will be determined within five (5) Trading Days after the tenth (10th) day following such Valuation Event by an
independent, reputable appraiser jointly selected by the Company and the Holder. The determination of such appraiser shall be final and
binding upon all parties absent manifest error and the fees and expenses of such appraiser shall be borne by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)
<U>Record Date</U>. If, during the Adjustment Period, the Company takes a record of stockholders for the purpose of entitling them (A)
to receive a dividend or other distribution payable in shares of Common Stock, Options, or in Convertible Securities or (B) to subscribe
for or purchase shares of Common Stock, Options, or Convertible Securities, then such record date will be deemed to be the date of the
issue or sale of shares of Common Stock deemed to have been issued or sold upon the declaration of such dividend or the making of such
other distribution or the date of the granting of such right of subscription or purchase (as the case may be).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
<U>Reset</U>. Beginning on the Shareholder Approval Date and ending on the Reset Date, the Exercise Price shall be adjusted to equal
the lower of (i) the Exercise Price then in effect and (ii) the Reset Price determined as of the date of determination. Upon such reset
of the Exercise Price pursuant to this Section 3(k), the number of Warrant Shares issuable hereunder shall be increased such that the
aggregate Exercise Price of this Warrant on the Issuance Date for the Warrant Shares then outstanding shall remain unchanged following
such reset. Notwithstanding the foregoing, if a Holder requests to exercise this Warrant in whole or in part on any given date prior
to the Reset Date, solely with respect to such portion of this Warrant being exercised on such applicable Exercise Date, (a) such applicable
Reset Date shall be deemed to mean the Exercise Date, (b) such applicable Reset Period shall be deemed to have ended on the Trading Day
immediately prior to the Exercise Date and (c) the applicable Reset Price for such exercised Warrants shall be calculated pursuant to
this Section 3(k). For the avoidance of doubt, following the calculation of the Reset Price pursuant to this Section 3(k), the Company&rsquo;s
obligations with regard to such exercised Warrants shall be deemed satisfied and no additional Reset Price shall apply to such exercised
Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
4</U>. <U>Transfer of Warrant</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Transferability</U>. Subject to compliance with any applicable securities laws, this Warrant and all rights hereunder (including,
without limitation, any registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office
of the Company or its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto
as <U>Exhibit B</U> duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon
the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant
or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument
of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant
shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender
this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant
to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the Company assigning this
Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant
Shares without having a new Warrant issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>New Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of
the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by
the Holder or its agent or attorney. Subject to compliance with <U>Section 4(a)</U>, as to any transfer which may be involved in such
division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be
divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the Issuance Date of
this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Warrant Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the
&ldquo;<B>Warrant Register</B>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the
registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder,
and for all other purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
5</U>. <U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Reverse Stock Split</U>. If at any time this Warrant is outstanding and the Company receives notice from the Trading Market that the
Company is failing to satisfy the Trading Market&rsquo;s minimum bid price requirement (the &ldquo;<B>Trigger Date</B>&rdquo;), then
the Company shall use reasonable efforts to obtain the necessary consents and approvals to undertake a reverse stock split after such
Trigger Date and to prior to the effectiveness of any delisting notice issued by the Trading Market, effect such reverse stock split.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>No Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights,
dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in <U>Section 2(d)(i)</U>, except
as expressly set forth in <U>Section 3</U>. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo;
pursuant to <U>Section 2(c)</U> or to receive cash payments pursuant to <U>Section 2(d)(i)</U> and <U>Section 2(d)(iv)</U> herein, in
no event shall the Company be required to net cash settle an exercise of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Loss, Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares,
and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant,
shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the
Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant
or stock certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Saturdays, Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Trading
Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Authorized Shares</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company covenants that, from the Initial Exercise Date and thereafter during the period the Warrant is outstanding, it will reserve from
its authorized and unissued Common Stock a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise
of any purchase rights under this Warrant. The Company further covenants that its issuance of this Warrant shall constitute full authority
to its officers who are charged with the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under
this Warrant. The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as
provided herein without violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the Common
Stock may be listed. The Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase rights represented
by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance
herewith, be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens and charges created by the
Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending
its Certificate of Incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale
of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant,
but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary
or appropriate to protect the rights of Holder as set forth in this Warrant against impairment (it being understood that this Warrant
shall not in any case prevent the Company from effecting any such amendment, reorganization, transfer, consolidation, merger, dissolution,
issuance or sale). Without limiting the generality of the foregoing, the Company will (i) not increase the par value of any Warrant Shares
above the amount payable therefor upon such exercise immediately prior to such increase in par value, (ii) take all such action as may
be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable Warrant Shares upon
the exercise of this Warrant and (iii) use commercially reasonable efforts to obtain all such authorizations, exemptions or consents
from any public regulatory body having jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations under
this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from
any public regulatory body or bodies having jurisdiction thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>(</U>f)
<U>Governing Law; Exclusive Jurisdiction</U>. All questions concerning the construction, validity, enforcement and interpretation of
this Warrant shall be determined in accordance with the provisions of the Purchase Agreement, and any action relating to this Warrant
shall only be brought as provided in the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Restrictions</U>. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered will
have restrictions upon resale imposed by state and federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>Nonwaiver and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall
operate as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies, notwithstanding the fact that
the right to exercise this Warrant terminates on the Termination Date. Without limiting any other provision of this Warrant, if the Company
willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages to the Holder, the
Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable
attorneys&rsquo; fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts due pursuant hereto
or in otherwise enforcing any of its rights, powers or remedies hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Notices</U>. Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall
be delivered in accordance with the notice provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
<U>Limitation of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant
to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of
the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company
or by creditors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
<U>Remedies</U>. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will
be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate
compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to
assert the defense in any action for specific performance that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
<U>Successors and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall
inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns
of the Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and
shall be enforceable by the Holder or holder of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
<U>Amendment and Waiver</U>. Except as otherwise provided herein, the provisions of this Warrant may be amended and the Company may take
any action herein prohibited, or omit to perform any act herein required to be performed by it, only if the Company has obtained the
written consent of the Required Holders. Any such amendment shall apply to all Warrants outstanding and be binding upon all registered
holders of such Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
<U>Severability</U>. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid
under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall
be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining
provisions of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)
<U>Headings</U>. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed
a part of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Page Follows)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Algorhythm
    Holdings, Inc.</B></FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
A</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>NOTICE
OF EXERCISE</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TO:
ALGORHYTHM HOLDINGS, INC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only
if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
Payment shall take the form of (check applicable box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;
in lawful money of the United States; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;
if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in subsection 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrant Shares shall be delivered to the following DWAC Account Number:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Investing Entity:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Investing Entity</I>:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">___________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">____________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">___________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
B</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>ASSIGNMENT
FORM</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares.)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">______________________________________</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">______________________________________</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone
    Number:</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
    Address:</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">______________________________________</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">______________________________________</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
    _______________ __, ______</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Signature: ___________________</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Address: ____________________</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.3
<SEQUENCE>3
<FILENAME>ex4-3.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
4.3</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SERIES
B COMMON STOCK PURCHASE WARRANT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ALGORHYTHM
HOLDINGS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
    Shares: [*]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuance
    Date: [&nbsp;&nbsp; ], 2024</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
SERIES B COMMON STOCK PURCHASE WARRANT (&ldquo;<B>Warrant</B>&rdquo;) certifies that, for value received, ______________ or its assigns
(the &ldquo;<B>Holder</B>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter
set forth, at any time on or after the Shareholder Approval Date (as defined below) (such date, the &ldquo;<B>Initial Exercise Date</B>&rdquo;)
and on or prior to 5:00 p.m. (New York, New York time) on the two and one-half (2.5) year anniversary of the Initial Exercise Date, <I>provided</I> that
if such date is not a Trading Day, the immediately following Trading Day (the &ldquo;<B>Termination Date</B>&rdquo;) but not thereafter,
to subscribe for and purchase from Algorhythm Holdings, Inc., a Delaware corporation (the &ldquo;<B>Company</B>&rdquo;), up to ______
shares Common Stock, the (&ldquo;<B>Warrant Shares</B>&rdquo;), subject to adjustment hereunder. The purchase price of one share of Common
Stock under this Warrant shall be equal to the Exercise Price, as defined in <U>Section 2(b)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
1</U>. <U>Definitions</U>. In addition to the terms defined elsewhere in this Warrant, the following terms have the meanings indicated
in this <U>Section 1</U>. Capitalized word and terms used and not otherwise defined herein shall have the meanings set forth in that
certain Securities Purchase Agreement (the &ldquo;<B>Purchase Agreement</B>&rdquo;), dated [ ], 2024, among the Company and the purchasers
signatory thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Adjustment
Period</B>&rdquo; shall have the meaning set forth in <U>Section 3(i)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Affiliate</B>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Alternate
Consideration</B>&rdquo; shall have the meaning set forth in <U>Section 3(d)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Attribution
Parties</B>&rdquo; shall have the meaning set forth in <U>Section 2(e)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Bid
Price</B>&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (i) if the Common Stock
is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York, New York time) to 4:02 p.m. (New York, New York time)), (ii) if OTCQB or OTCQX is not a Trading Market, the volume weighted
average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (iii) if the Common
Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open
Market (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of
the Common Stock so reported, or (iv) in all other cases, the fair market value of a share of Common Stock as determined by an independent
appraiser selected in good faith by the Holders of a majority in interest of the Warrants then outstanding and reasonably acceptable
to the Company, the fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Black
Scholes Value</B>&rdquo; shall have the meaning set forth in <U>Section 3(d)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Bloomberg</B>&rdquo;
means Bloomberg L.P., or any successor thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Board
of Directors</B>&rdquo; means the board of directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Buy-In</B>&rdquo;
shall have the meaning set forth in <U>Section 2(d)(iv)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Business
Day</B>&rdquo; means any day other than Saturday, Sunday, or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Bylaws</B>&rdquo;
means the Amended and Restated Bylaws of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Certificate
of Incorporation</B>&rdquo; means the Certificate of Incorporation, as amended, of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Common
Stock</B>&rdquo; means the common stock of the Company, par value $0.01 per share, and any other class of securities into which such
securities may hereafter be reclassified or changed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Common
Stock Equivalents</B>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant, or other instrument that
is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Company</B>&rdquo;
shall have the meaning set forth in the Preamble.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Distribution</B>&rdquo;
shall have the meaning set forth in <U>Section 3(c)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>DWAC</B>&rdquo;
shall have the meaning set forth in <U>Section 2(d)(i)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 67.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Exchange
Ac</B>t&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Exercise
Price</B>&rdquo; shall have the meaning set forth in <U>Section 2(b)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Floor
Price</B>&rdquo; means (A) prior to the Shareholder Approval Date, a price equal to $[ ] per share, and (B) effective beginning on the
Shareholder Approval Date, a price equal to $[ ] per share; which in each case shall be appropriately adjusted for any stock dividend,
stock split, stock combination, reclassification or similar event or transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Fundamental
Transaction</B>&rdquo; shall have the meaning set forth in <U>Section 3(d)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Holder</B>&rdquo;
shall have the meaning set forth in the Preamble.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Initial
Exercise Date</B>&rdquo; shall have the meaning set forth in the Preamble.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Issuance
Date</B>&rdquo; means the issuance date of this Warrant as set forth on the first page hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Notice
of Exercise</B>&rdquo; shall have the meaning set forth in <U>Section 2(a)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Person</B>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof), or other entity of any kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Purchase
Agreement</B>&rdquo; shall have the meaning set forth in <U>Section 1</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Purchase
Rights</B>&rdquo; shall have the meaning set forth in <U>Section 3(b)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Redemption
Date</B>&rdquo; shall have the meaning set forth in <U>Section 2(f)(ii)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Redemption
Price</B>&rdquo; shall have the meaning set forth in <U>Section 2(f)(ii)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Redemption
Notice</B>&rdquo; shall have the meaning set forth in <U>Section 2(f)(iii)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Redemption
Notice Date</B>&rdquo; shall have the meaning set forth in <U>Section 2(f)(iii)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Registration
Statement</B>&rdquo; means the Company&rsquo;s registration statement on Form S-1, as amended (File No. 333-283178).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Required
Holders</B>&rdquo; shall have the meaning set forth in <U>Section 3(d)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Reset
Date</B>&rdquo; means the fourth (4th) Trading Day following the Shareholder Approval Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Reset
Period</B>&rdquo; means the period commencing on the first Trading Day prior to the Shareholder Approval Date and ending following the
close of trading on the fourth (4th) Trading Day thereafter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Reset
Price</B>&rdquo; means the greater of (i) the lowest daily VWAP during the Reset Period and (ii) the Floor Price in effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>SEC</B>&rdquo;
means the United States Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Securities
Act</B>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Shareholder
Approval</B>&rdquo; means such approval as may be required by the applicable rules and regulations of The Nasdaq Stock Market LLC
(or any successor entity) from the shareholders of the Company with respect to issuance of all of the Warrant Shares upon the
exercise of the Warrants, including, without limitation, to render inapplicable clause (A) of the definition of the Floor Price,
thereby giving full effect to the alternative cashless exercises pursuant to <U>Section 2(c)</U> hereof and the adjustment to the
Exercise Price and/or number of shares of Common Stock underlying the Warrants following any Reset
Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Shareholder
Approval Date</B>&rdquo; means the Trading Day that Shareholder Approval is received and deemed effective. Notwithstanding anything to
the contrary, such notice shall be deemed to be given by a public filing with the SEC disclosing the effectiveness of the Shareholder
Approval.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Standard
Settlement Period</B>&rdquo; shall have the meaning set forth in <U>Section 2(d)(i)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Subsidiary</B>&rdquo;
means any subsidiary of the Company and shall, where applicable, also include any direct or indirect subsidiary of the Company formed
or acquired after the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Successor
Entity</B>&rdquo; shall have the meaning set forth in <U>Section 3(d)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Termination
Date</B>&rdquo; shall have the meaning set forth in the Preamble.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Trading
Day</B>&rdquo; means a day on which the Trading Market is open for trading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Trading
Market</B>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: The Nasdaq Capital Market, The Nasdaq Global Market, The Nasdaq Global Select Market, the New York Stock Exchange, or the
NYSE American, (or any successors to any of the foregoing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Trading
Value</B>&rdquo; means, with respect to the Company&rsquo;s Common Stock, the daily trading volume on the Company&rsquo;s primary Trading
Market as reported by Bloomberg multiplied by the closing price of the Common Stock on such date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Transfer
Agent</B>&rdquo; means Continental Stock Transfer &amp; Trust Company, the current transfer agent of the Company, with a mailing address
1 State Street, 30th Floor, New York, NY 10004-1561 and a phone number of (212) 509-4000, and any successor transfer agent of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Trigger
Date</B>&rdquo; shall have the meaning set forth in <U>Section 5(a)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>VWAP</B>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (i) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York, New York time) to 4:02 p.m. (New York, New York time)), (ii) if OTCQB or OTCQX is not a Trading Market, the volume weighted
average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (iii) if the Common
Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open
Market (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of
the Common Stock so reported, or (iv) in all other cases, the fair market value of a share of Common Stock as determined by an independent
appraiser selected in good faith by the holders of a majority in interest of the Warrants then outstanding and reasonably acceptable
to the Company, the fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Warrant
Register</B>&rdquo; shall have the meaning set forth in <U>Section 4(c)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Warrant
Share Delivery Date</B>&rdquo; shall have the meaning set forth in <U>Section 2(d)(i)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Warrant
Shares</B>&rdquo; shall have the meaning set forth in the Preamble.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Warrants</B>&rdquo;
means this Warrant and other Series B Common Stock purchase warrants issued by the Company pursuant to the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
2</U>. <U>Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Exercise of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time
or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed facsimile
copy or PDF copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form attached hereto as <U>Exhibit A</U>
(the &ldquo;<B>Notice of Exercise</B>&rdquo;). Within the earlier of (i) one (1) Trading Day and (ii) such earlier time comprising the
Standard Settlement Period (as defined in <U>Section 2(d)(i)</U> herein) following the date of exercise as aforesaid, the Holder shall
deliver the aggregate Exercise Price for the number of Warrant Shares specified in the applicable Notice of Exercise by wire transfer
or cashier&rsquo;s check drawn on a United States bank unless the cashless exercise procedure specified in <U>Section 2(c)</U> below
is applicable and specified in the attached Notice of Exercise. For the avoidance of doubt, any reference to cashless exercise herein shall include a reference to alternative cashless
exercise. The Company shall have no obligation to inquire with respect to or otherwise
confirm the authenticity of the signature(s) contained on any Notice of Exercise nor the authority of the person so executing such Notice
of Exercise. No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization)
of any Notice of Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically
surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has
been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading
Days of the date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases
of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant
Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall
maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection
to any Notice of Exercise within one (1) Trading Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this
Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant
Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated
on the face hereof.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Exercise
Price</U>. The exercise price per share of Common Stock under this Warrant shall be $[ ], subject to adjustment hereunder and shall
not exceed 200% of the Minimum Price as defined by the rules of The Nasdaq Stock Market (the &ldquo;<B>Exercise
Price</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Cashless Exercise</U>. If and only if at the time of any exercise hereof there is no effective registration statement registering,
or the prospectus contained therein is not available for the issuance of the Warrant Shares to the Holder, then this Warrant may be exercised,
in whole or in part, at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive a number
of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)
= as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of
Exercise is (1) both executed and delivered pursuant to <U>Section 2(a)</U> hereof on a day that is not a Trading Day or (2) both executed
and delivered pursuant to <U>Section 2(a)</U> hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as
defined in Rule 600(b) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) the Bid Price of the
Common Stock on the principal Trading Market as reported by Bloomberg as of the time of the Holder&rsquo;s execution of the applicable
Notice of Exercise if such Notice of Exercise is executed during &ldquo;regular trading hours&rdquo; on a Trading Day and is delivered
within two hours thereafter (including until two hours after the close of &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant
to <U>Section 2(a)</U> hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise
is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to <U>Section 2(a)</U> hereof after the close of
&ldquo;regular trading hours&rdquo; on such Trading Day;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)
= the Exercise Price of this Warrant, as adjusted hereunder; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(X)
= the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such
exercise were by means of a cash exercise rather than a cashless exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">Whether or not an
effective registration statement or prospectus is available, the Holder may also effect an &ldquo;alternative cashless exercise&rdquo;
at any time on or after the Shareholder Approval Date. In such event, the aggregate number of Warrant Shares issuable in such alternative
cashless exercise pursuant to any given Notice of Exercise electing to effect an alternative cashless exercise shall equal the product
of (i) the aggregate number of Warrant Shares that would be issuable upon exercise of this Warrant if such exercise were by means of a
cash exercise rather than a cashless exercise, multiplied by (ii) 1.0. Such number of aggregate Warrant Shares issuable in such alternative
cashless exercise shall be proportionally adjusted in the event of any stock split, dividend, reclassification or any other adjustment
provided in <U>Section 3(a)</U> hereof. Notwithstanding anything herein to the contrary, on the Termination Date, this Warrant shall be
automatically exercised via cashless exercise pursuant to this <U>Section 2(c)</U>, <I>provided</I> that the Shareholder Approval Date
shall have occurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
Warrant Shares are issued in any cashless exercise provided for under this <U>Section 2(c)</U>, the parties acknowledge and agree
that in accordance with Section 3(a)(9) of the Securities Act, the Warrant Shares shall take on the registered characteristics of
the Warrants being exercised. The Company agrees not to take any position contrary to this <U>Section 2(c)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Mechanics of Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Delivery of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by
the Transfer Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository
Trust Company through its Deposit or Withdrawal at Custodian system (&ldquo;<B>DWAC</B>&rdquo;) if the Company is then a participant
in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale
of the Warrant Shares by the Holder or (B) this Warrant is being exercised via cashless exercise, and otherwise by physical delivery
of a certificate, registered in the Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant
Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by
the date that is the earlier of (i) one (1) Trading Day after delivery of the Notice of Exercise and the aggregate Exercise Price (other
than in the case of a cashless exercise) to the Company and (ii) the number of days comprising the Standard Settlement Period after the
delivery to the Company of the Notice of Exercise and the aggregate Exercise Price (other than in the case of a cashless exercise) (such
date, the &ldquo;<B>Warrant Share Delivery Date</B>&rdquo;). Upon delivery of the Notice of Exercise, the Holder shall be deemed for
all corporate purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised,
irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price (other than in the
case of a cashless exercise) is received by the Warrant Share Delivery Date. If the Company fails for any reason to deliver to the Holder
the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery Date following payment of the aggregate Exercise Price
by the Holder (other than in the case of cashless exercise is received by the Company by such date), the Company shall pay to the Holder,
in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of
the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the fifth
(5th) Trading Day after the Warrant Share Delivery Date) for each Trading Day after such Warrant Share Delivery Date until such Warrant
Shares are delivered or Holder rescinds such exercise. The Company agrees to maintain a transfer agent that is a participant in the FAST
program so long as this Warrant remains outstanding and exercisable. As used herein, &ldquo;<B>Standard Settlement Period</B>&rdquo;
means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary Trading Market with respect
to the Common Stock as in effect on the date of delivery of the Notice of Exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.5pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
<U>Delivery of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of
a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant
evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in
all other respects be identical with this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
<U>Rescission Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to <U>Section
2(d)(i)</U> by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise by delivering written notice
to the Company at any time prior to the delivery of such Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.5pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
<U>Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to
the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions
of <U>Section 2(d)(i)</U> above pursuant to an exercise on or before the Warrant Share Delivery Date (other than a failure caused by
incorrect or incomplete information provided by the Holder to the Company), and if after such date the Holder is required by its broker
to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares of Common Stock
to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a
&ldquo;<B>Buy-In</B>&rdquo;), then the Company shall (A) <I>provided</I> that if the Common Stock is then listed or quoted on the Trading
Market or any over-the-counter market (including OTC Pink or any successor) such price set forth in (y)(2) of this clause (A) is reasonably
comparable to a market price or prices in purchases and sales of the Common Stock occurring in the market on or close in time to the
Trading Day on which the Holder&rsquo;s purchase occurred taking into account the volume of the Holder&rsquo;s purchase, pay in cash
to the Holder the amount, if any, by which (x) the Holder&rsquo;s total purchase price (including brokerage commissions, if any) for
the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company
was required to deliver to the Holder in connection with the exercise at issue times (2) the price at which the sell order giving rise
to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the portion of the Warrant and equivalent
number of Warrant Shares for which such exercise was not honored (in which case such exercise shall be deemed rescinded) or deliver to
the Holder the number of shares of Common Stock that would have been issued had the Company timely complied with its exercise and delivery
obligations hereunder. For example, if the Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with
respect to an attempted exercise of shares of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000,
under clause (A) of the immediately preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide
the Company written notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence
of the amount of such loss. Nothing herein shall limit a Holder&rsquo;s right to pursue any other remedies available to it hereunder,
at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s
failure to timely deliver shares of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof. The obligation
of the Company to pay compensation for Buy-In under this <U>Section 2(d)(iv)</U> is subject to delivery by the Holder of the aggregate
Exercise Price in accordance with the terms of <U>Section 2(a)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.5pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
<U>No Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company
shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied
by the Exercise Price or round up to the next whole share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)
<U>Charges, Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax
or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company,
and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>,
<U>however</U>, that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when
surrendered for exercise shall be accompanied by the assignment form substantially in the form attached hereto as <U>Exhibit B</U> duly
executed by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer
tax incidental thereto. The Company shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and
all fees to the Depository Trust Company (or another established clearing corporation performing similar functions) required for same-day
electronic delivery of the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)
<U>Closing of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise
of this Warrant, pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.5pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Holder&rsquo;s Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the
right to exercise any portion of this Warrant, pursuant to <U>Section 2</U> or otherwise, to the extent that after giving effect to such
issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and
any other Persons acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<B>Attribution
Parties</B>&rdquo;)), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the
foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties
shall include the number of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is
being made, but shall exclude the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised
portion of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion
of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock
Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the
Holder or any of its Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this <U>Section
2(e)</U>, beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations
promulgated thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation
is in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in
accordance therewith. To the extent that the limitation contained in this <U>Section 2(e)</U> applies, the determination of whether this
Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and
of which portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise
shall be deemed to be the Holder&rsquo;s determination of whether this Warrant is exercisable (in relation to other securities owned
by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable, in each case
subject to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy of such determination
and shall have no liability for exercises of the Warrant that are not in compliance with the Beneficial Ownership Limitation, except
to the extent the Holder relies on a number of outstanding shares of Common Stock that was provided by the Company. In addition, a determination
as to any group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and
regulations promulgated thereunder. For purposes of this <U>Section 2(e)</U>, in determining the number of outstanding shares of Common
Stock, a Holder may rely on the number of outstanding shares of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic
or annual report filed with the SEC, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written
notice by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon the written request
of a Holder, the Company shall within one (1) Trading Day confirm orally and in writing to the Holder the number of shares of Common
Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the
conversion or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since
the date as of which such number of outstanding shares of Common Stock was reported. The &ldquo;<B>Beneficial Ownership Limitation</B>&rdquo;
shall be 4.99% (or, upon election by a Holder prior to the issuance of any Warrants, 9.99%) of the number of shares of Common Stock outstanding
immediately after giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant. The Holder, upon written
notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this <U>Section 2(e)</U>, provided
that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately
after giving effect to the issuance of shares of Common Stock upon exercise of this Warrant held by the Holder and the provisions of
this <U>Section 2(e)</U> shall continue to apply. Any increase in the Beneficial Ownership Limitation will not be effective until the
61<SUP>st</SUP> day after such notice is delivered to the Company. The provisions of this paragraph shall be construed and implemented
in a manner otherwise than in strict conformity with the terms of this <U>Section 2(e)</U> to correct this paragraph (or any portion
hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes
or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall apply
to a successor holder of this Warrant. If the Warrant is unexercisable as a result of the Holder&rsquo;s Beneficial Ownership Limitation,
no alternate consideration is owing to the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Redemption Right</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
Beginning on the Initial Exercise Date, this Warrant may be redeemed at the option of the Company, in whole or in part, by giving not
less than thirty (30) days&rsquo; prior notice, which notice may not be given before, but may be given at any time after the date on
which (i) the VWAP exceeded $[ ] for ten (10) consecutive Trading Days and (ii) the average daily Trading Value of the Common Stock for
such ten (10) Trading Day period referred to in this <U>Section 2(f)(i)</U> exceeded $[150,000].</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
The price at which this Warrant may be redeemed (the &ldquo;<B>Redemption Price</B>&rdquo;) is $0.01 per Warrant Share. On and after
the date upon which such Warrant is redeemed by the Company (the &ldquo;<B>Redemption Date</B>&rdquo;), the Holder of a redeemed Warrant
shall be entitled to payment of the Redemption Price upon surrender of the Warrant to the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
Notice of redemption of this Warrant (the &ldquo;<B>Redemption Notice</B>&rdquo;) shall be given at least thirty (30) days prior to the
Redemption Date (the &ldquo;<B>Redemption Notice Date</B>&rdquo;) by the Company (i) providing notice to the Holder as provided in <U>Section
5(i)</U>, (ii) notifying the Holders of such redemption via publication of a press release and (iii) taking such other steps as may be
required under applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
From and after the Redemption Date, any Warrant Shares noticed for redemption that have not theretofore been exercised by the Holder
shall cease to represent the right to purchase any shares of Common Stock and shall be deemed canceled and void and of no further force
or effect without any further act or deed on the part of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
By acceptance of this Warrant, the Holder undertakes to return the certificate representing any redeemed Warrant to the Company upon
their redemption and to indemnify the Company with respect to any losses, claims, damages, or liabilities arising from the Holder&rsquo;s
failure to return such certificate. In the event the certificate so returned represents a number of Warrant Shares in excess of the number
being redeemed, the Company shall as promptly as practicable issue to the Holder a new certificate in book-entry form for the number
of unredeemed Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)
Notwithstanding anything to the contrary set forth in this Warrant, the Company may not require the cancellation of this Warrant (and
any related Redemption Notice shall be void), unless, from the beginning of the Redemption Notice Date through the Redemption Date, (1)
the Company shall have honored in accordance with the terms of this Warrant all Notices of Exercise delivered by 6:30 p.m. (New York,
New York time) on the Redemption Date, (2) a registration statement shall be effective as to all Warrant Shares and the prospectus thereunder
available for use by the Company for the sale of all such Warrant Shares to the Holder, (3) the Common Stock shall be listed or quoted
for trading on the Trading Market, (4) there is a sufficient number of authorized shares of Common Stock for issuance of all Warrant
Shares, and (5) the issuance of all Warrant Shares subject to a Redemption Notice shall not cause a breach of any provision of <U>Section
2(e)</U> herein. The Company&rsquo;s right to call the Warrants under this <U>Section 2(f)</U> shall be exercised ratably among the Holders
based on each Holder&rsquo;s initial purchase of Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
3</U>. <U>Certain Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Stock Dividends and Splits</U>. In addition to any adjustment provided under <U>Section 2(c)</U>, if the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise
makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares
of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the
Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which
the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this <U>Section 3(a)</U> shall become effective immediately after the record
date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after
the effective date in the case of a subdivision, combination or re-classification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Subsequent Rights Offerings</U>. In addition to any adjustments pursuant to <U>Section 3(a)</U> above, if at any time that this Warrant
is outstanding the Company grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or
other property pro rata to all of the record holders of any class of shares of Common Stock (the &ldquo;<B>Purchase Rights</B>&rdquo;),
then the Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the
Holder could have acquired if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant
(without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately
before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the
date as of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights
(provided, however, that, to the extent that the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder
exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent
(or beneficial ownership of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to
such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding
the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Pro Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or
other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital
or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend,
spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<B>Distribution</B>&rdquo;),
at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution
to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable
upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial
Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the
date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>,
<U>however</U>, that, to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder
exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent
(or in the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such
Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result
in the Holder exceeding the Beneficial Ownership Limitation). To the extent that this Warrant has not been partially or completely exercised
at the time of such Distribution, such portion of the Distribution shall be held in abeyance for the benefit of the Holder until the
Holder has exercised this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Fundamental Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or
more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company, directly
or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of
its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer
(whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange
their shares for other securities, cash or property and has been accepted by the holders of greater than 50% of the outstanding Common
Stock or greater than 50% of the voting power of the common equity of the Company, (iv) the Company, directly or indirectly, in one or
more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share
exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property (other
than a stock split or stock dividend), or (v) the Company, directly or indirectly, in one or more related transactions consummates a
stock or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off,
merger or scheme of arrangement (other than a stock split or stock dividend) with another Person or group of Persons whereby such other
Person or group acquires greater than 50% of the outstanding shares of Common Stock or greater than 50% of the voting power of the common
equity of the Company (each a &ldquo;<B>Fundamental Transaction</B>&rdquo;), then, upon any subsequent exercise of this Warrant, the
Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to
the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in <U>Section 2(e)</U>
on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if
it is the surviving corporation, and any additional consideration (the &ldquo;<B>Alternate Consideration</B>&rdquo;) receivable as a
result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is exercisable immediately
prior to such Fundamental Transaction (without regard to any limitation in <U>Section 2(e)</U> on the exercise of this Warrant). For
purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration
based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and
the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value
of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash
or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration
it receives upon any exercise of this Warrant following such Fundamental Transaction. Notwithstanding anything to the contrary, in the
event of a Fundamental Transaction, the Company or any Successor Entity (as defined below) shall, at the Holder&rsquo;s option, exercisable
at any time concurrently with, or within 30 days after, the consummation of the Fundamental Transaction (or, if later, the date of the
public announcement of the applicable Fundamental Transaction), purchase this Warrant from the Holder by paying to the Holder an amount
of cash equal to the Black Scholes Value (as defined below) of the remaining unexercised portion of this Warrant on the date of the consummation
of such Fundamental Transaction; <U>provided</U>, <U>however</U>, that, if the Fundamental Transaction is not within the Company&rsquo;s
control, including not approved by the Board of Directors, the Holder shall only be entitled to receive from the Company or any Successor
Entity the same type or form of consideration (and in the same proportion), at the Black Scholes Value of the unexercised portion of
this Warrant, that is being offered and paid to the holders of Common Stock of the Company in connection with the Fundamental Transaction,
whether that consideration be in the form of cash, stock or any combination thereof, or whether the holders of Common Stock are given
the choice to receive from among alternative forms of consideration in connection with the Fundamental Transaction; <U>provided</U>,
<U>further</U>, that if holders of Common Stock of the Company are not offered or paid any consideration in such Fundamental Transaction,
such holders of Common Stock will be deemed to have received shares of common stock of the Successor Entity (which Successor Entity may
be the Company following such Fundamental Transaction) in such Fundamental Transaction. &ldquo;<B>Black Scholes Value</B>&rdquo; means
the value of this Warrant based on the Black-Scholes Option Pricing Model obtained from the &ldquo;OV&rdquo; function on Bloomberg determined
as of the day of consummation of the applicable Fundamental Transaction for pricing purposes and reflecting (A) a risk-free interest
rate corresponding to the U.S. Treasury rate for a period equal to the time between the date of the public announcement of the applicable
contemplated Fundamental Transaction and the Termination Date, (B) an expected volatility equal to the greater of (1) the 30 day volatility,
(2) the 100 day volatility or (3) the 365 day volatility, each of clauses (1)-(3) as obtained from the HVT function on Bloomberg (determined
utilizing a 365 day annualization factor) as of the Trading Day immediately following the public announcement of the applicable contemplated
Fundamental Transaction, (C) the underlying price per share used in such calculation shall be the greater of (i) the sum of the price
per share being offered in cash, if any, plus the value of any non-cash consideration, if any, being offered in such Fundamental Transaction
and (ii) the VWAP immediately preceding the public announcement of the applicable contemplated Fundamental Transaction (or the consummation
of the applicable Fundamental Transaction, if earlier), (D) the sum of the remaining option time equal to the time between the date of
the public announcement of the applicable contemplated Fundamental Transaction and the Termination Date and (E) a zero cost of borrow.
The payment of the Black Scholes Value will be made by wire transfer of immediately available funds (or such other consideration) within
the later of (i) five Business Days of the Holder&rsquo;s election and (ii) the date of consummation of the Fundamental Transaction.
The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the &ldquo;<B>Successor
Entity</B>&rdquo;) to assume in writing all of the obligations of the Company under this Warrant in accordance with the provisions of
this <U>Section 3(d)</U> pursuant to written agreements in form and substance reasonably satisfactory to the holders of Warrants representing
at least a majority of the shares of Common Stock underlying the Warrants then outstanding without giving effect to any beneficial ownership
limitations (the &ldquo;<B>Required Holders</B>&rdquo;) and approved by the Required Holders (without unreasonable delay) prior to such
Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the
Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which is exercisable for
a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common
Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior
to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock
(but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such
shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting the economic
value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in
form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall be added to the
term &ldquo;Company&rdquo; under this Warrant (so that from and after the occurrence or consummation of such Fundamental Transaction,
each and every provision of this Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo; shall refer instead
to each of the Company and the Successor Entity or Successor Entities, jointly and severally), and the Successor Entity or Successor
Entities, jointly and severally with the Company, may exercise every right and power of the Company prior thereto and the Successor Entity
or Successor Entities shall assume all of the obligations of the Company prior thereto under this Warrant and the other Transaction Documents
with the same effect as if the Company and such Successor Entity or Successor Entities, jointly and severally, had been named as the
Company herein. For the avoidance of doubt, the Holder shall be entitled to the benefits of the provisions of this <U>Section 3(d)</U>
regardless of (i) whether the Company has sufficient authorized shares of Common Stock for the issuance of Warrant Shares and/or (ii)
whether a Fundamental Transaction occurs prior to the Initial Exercise Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Calculations</U>. All calculations under this <U>Section 3</U> shall be made to the nearest cent or the nearest 1/100th of a share,
as the case may be. For purposes of this <U>Section 3</U>, the number of shares of Common Stock deemed to be issued and outstanding as
of a given date shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Notice to Holder</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Adjustment to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this <U>Section 3</U>, the
Company shall promptly deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting
adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment; provided, however,
that the Company may satisfy the notice requirement in this <U>Section 3(f)</U> by filing such information with the Commission on its
Electronic Data Gathering, Analysis, and Retrieval (EDGAR) system pursuant to a Current Report on Form 8-K, Quarterly Report on Form
10-Q or Annual Report on Form 10-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
<U>Notice to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form other
than a stock split or stock dividend) on the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a
redemption of the Common Stock (excluding any granting or issuance of rights to all of the Company&rsquo;s stockholders pursuant to a
stockholder rights plan), (C) the Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe
for or purchase any shares of capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall
be required in connection with any reclassification of the Common Stock, any consolidation or merger to which the Company (or any of
its Subsidiaries) is a party, any sale or transfer of all or substantially all of its assets, or any compulsory share exchange whereby
the Common Stock is converted into other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary
dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by
facsimile or email to the Holder at its last facsimile number or email address as it shall appear upon the Warrant Register of the Company,
at least ten (10) calendar days prior to the applicable record or effective date hereinafter specified, a notice stating (x) the date
on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not
to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions, redemption,
rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share
exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock of record
shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification,
consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver such notice or any defect therein or in
the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice. To the extent that
any notice provided in this Warrant constitutes, or contains, material, non-public information regarding the Company or any of the Subsidiaries,
the Company shall simultaneously file such notice with the SEC pursuant to a Current Report on Form 8-K. The Holder shall remain entitled
to exercise this Warrant during the period commencing on the date of such notice to the effective date of the event triggering such notice
except as may otherwise be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.5pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Voluntary Adjustment By Company</U>. Subject to the rules and regulations of the Trading Market, the Company may at any time during
the term of this Warrant reduce the then current Exercise Price to any amount and for any period of time deemed appropriate by the Company&rsquo;s
Board of Directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>Shareholder Approval</U>. The Company shall hold a meeting of shareholders for, or obtain through written consent, the Shareholder
Approval as soon as practicable following the Issuance Date. After obtaining the Shareholder Approval through such vote, the
Company shall comply with all applicable rules and regulations of the SEC and applicable state laws and provisions of its Certificate
of Incorporation and Bylaws with respect to the Shareholder Approval, and shall use its best efforts to cause the minimal amount of time
therefor to apply before the Shareholder Approval takes effect in accordance with such rules and regulations, laws, and provisions. Without
limiting the generality of the foregoing, the Company shall prepare and file with the SEC any necessary materials or disclosures with
the SEC with respect to the shareholder vote for Shareholder Approval and shall ensure these materials are provided to shareholders of
the Company as soon as practicable thereafter in accordance with the rules and regulations of the SEC. The Company shall promptly provide
responses to the SEC with respect to any comments received from the SEC regarding these materials filed in accordance with this <U>Section
3(h)</U>, and will use reasonable efforts to facilitate the shareholder vote and ensure Shareholder Approval
is obtained in a timely manner.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Reset</U>. Beginning on the Shareholder Approval Date and ending on the Reset Date, the Exercise Price shall be adjusted to equal
the lower of (i) the Exercise Price then in effect and (ii) the Reset Price determined as of the date of determination. Upon such reset
of the Exercise Price pursuant to this Section 3(j), the number of Warrant Shares issuable hereunder shall be increased such that the
aggregate Exercise Price of this Warrant on the Issuance Date for the Warrant Shares then outstanding shall remain unchanged following
such reset. Notwithstanding the foregoing, if a Holder requests to exercise this Warrant in whole or in part on any given date prior
to the Reset Date, solely with respect to such portion of this Warrant being exercised on such applicable Exercise Date, (a) such applicable
Reset Date shall be deemed to mean the Exercise Date, (b) such applicable Reset Period shall be deemed to have ended on the Trading Day
immediately prior to the Exercise Date and (c) the applicable Reset Price for such exercised Warrants shall be calculated pursuant to
this Section 3(j). For the avoidance of doubt, following the calculation of the Reset Price pursuant to this Section 3(j), the Company&rsquo;s
obligations with regard to such exercised Warrants shall be deemed satisfied and no additional Reset Price shall apply to such exercised
Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
4</U>. <U>Transfer of Warrant</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Transferability</U>. Subject to compliance with any applicable securities laws, this Warrant and all rights hereunder (including,
without limitation, any registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office
of the Company or its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto
as <U>Exhibit B</U> duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon
the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant
or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument
of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant
shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender
this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant
to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the Company assigning this
Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant
Shares without having a new Warrant issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>New Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of
the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by
the Holder or its agent or attorney. Subject to compliance with <U>Section 4(a)</U>, as to any transfer which may be involved in such
division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be
divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the Issuance Date of
this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Warrant Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the
&ldquo;<B>Warrant Register</B>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the
registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder,
and for all other purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
5</U>. <U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Reverse Stock Split</U>. If at any time this Warrant is outstanding and the Company receives notice from the Trading Market that the
Company is failing to satisfy the Trading Market&rsquo;s minimum bid price requirement (the &ldquo;<B>Trigger Date</B>&rdquo;), then
the Company shall use reasonable efforts to obtain the necessary consents and approvals to undertake a reverse stock split after such
Trigger Date and shall, prior to the effectiveness of any delisting notice issued by the Trading Market, effect such reverse stock split.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>No Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights,
dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in <U>Section 2(d)(i)</U>, except
as expressly set forth in <U>Section 3</U>. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo;
pursuant to <U>Section 2(c)</U> or to receive cash payments pursuant to <U>Section 2(d)(i)</U> and <U>Section 2(d)(iv)</U> herein, in
no event shall the Company be required to net cash settle an exercise of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Loss, Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares,
and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant,
shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the
Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant
or stock certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Saturdays, Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Trading
Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Authorized Shares</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company covenants that, from the Initial Exercise Date and thereafter during the period the Warrant is outstanding, it will reserve from
its authorized and unissued Common Stock a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise
of any purchase rights under this Warrant. The Company further covenants that its issuance of this Warrant shall constitute full authority
to its officers who are charged with the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under
this Warrant. The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as
provided herein without violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the Common
Stock may be listed. The Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase rights represented
by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance
herewith, be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens and charges created by the
Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending
its Certificate of Incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale
of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant,
but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary
or appropriate to protect the rights of Holder as set forth in this Warrant against impairment (it being understood that this Warrant
shall not in any case prevent the Company from effecting any such amendment, reorganization, transfer, consolidation, merger, dissolution,
issuance or sale). Without limiting the generality of the foregoing, the Company will (i) not increase the par value of any Warrant Shares
above the amount payable therefor upon such exercise immediately prior to such increase in par value, (ii) take all such action as may
be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable Warrant Shares upon
the exercise of this Warrant and (iii) use commercially reasonable efforts to obtain all such authorizations, exemptions or consents
from any public regulatory body having jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations under
this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from
any public regulatory body or bodies having jurisdiction thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>(</U>f)
<U>Governing Law; Exclusive Jurisdiction</U>. All questions concerning the construction, validity, enforcement and interpretation of
this Warrant shall be determined in accordance with the provisions of the Purchase Agreement, and any action relating to this Warrant
shall only be brought as provided in the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Restrictions</U>. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not utilize cashless exercise, will
have restrictions upon resale imposed by state and federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>Nonwaiver and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall
operate as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies, notwithstanding the fact that
the right to exercise this Warrant terminates on the Termination Date. Without limiting any other provision of this Warrant, if the Company
willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages to the Holder, the
Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable
attorneys&rsquo; fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts due pursuant hereto
or in otherwise enforcing any of its rights, powers or remedies hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Notices</U>. Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall
be delivered in accordance with the notice provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
<U>Limitation of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant
to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of
the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company
or by creditors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
<U>Remedies</U>. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will
be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate
compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to
assert the defense in any action for specific performance that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
<U>Successors and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall
inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns
of the Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and
shall be enforceable by the Holder or holder of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
<U>Amendment and Waiver</U>. Except as otherwise provided herein, the provisions of this Warrant may be amended and the Company may take
any action herein prohibited, or omit to perform any act herein required to be performed by it, only if the Company has obtained the
written consent of the Required Holders. Any such amendment shall apply to all Warrants outstanding and be binding upon all registered
holders of such Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
<U>Severability</U>. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid
under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall
be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining
provisions of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)
<U>Headings</U>. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed
a part of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Page Follows)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Algorhythm
    Holdings, Inc.</B></FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
A</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>NOTICE
OF EXERCISE</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TO:
ALGORHYTHM HOLDINGS, INC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only
if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
Payment shall take the form of (check applicable box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;
in lawful money of the United States; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;
if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in subsection 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrant Shares shall be delivered to the following DWAC Account Number:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Investing Entity:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Investing Entity</I>:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">___________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">____________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">___________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
B</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>ASSIGNMENT
FORM</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares.)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">______________________________________</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">______________________________________</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone
    Number:</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
    Address:</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">______________________________________</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">______________________________________</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
    _______________ __, ______</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Signature: ___________________</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Address: ____________________</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.4
<SEQUENCE>4
<FILENAME>ex4-4.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><B>Exhibit 4.4</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PRE-FUNDED
COMMON STOCK PURCHASE WARRANT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ALGORHYTHM
HOLDINGS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
    Shares: [ ]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial
    Issuance Date: [ ], 2024</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the &ldquo;<B>Warrant</B>&rdquo;) certifies that, for value received, ______________ or its
assigns (the &ldquo;<B>Holder</B>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter
set forth at any time on or after the date hereof (such date, the &ldquo;<B>Initial Exercise Date</B>&rdquo;) until the date this Warrant
is exercised in full (the &ldquo;<B>Termination Date</B>&rdquo;) but not thereafter, to subscribe for and purchase from Algorhythm Holdings,
Inc., a Delaware corporation (the &ldquo;<B>Company</B>&rdquo;), up to ______ shares (the &ldquo;<B>Warrant Shares</B>&rdquo;) of common
stock, par value $0.01 per share, of the Company (&ldquo;<B>Common Stock</B>&rdquo;), subject to adjustment hereunder. The purchase price
of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in <U>Section 2(b)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
1</U>. <U>Definitions</U>. In addition to the terms defined elsewhere in this Warrant, the following terms have the meanings indicated
in this <U>Section 1</U>. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Securities
Purchase Agreement (the &ldquo;<B>Purchase Agreement</B>&rdquo;), dated [ ], 2024, among the Company and the purchasers signatory thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Affiliate</B>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls, or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Alternate
Consideration</B>&rdquo; shall have the meaning set forth in <U>Section 3(d)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Attribution
Parties</B>&rdquo; shall have the meaning set forth in <U>Section 2(e)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Beneficial
Ownership Limitation</B>&rdquo; shall have the meaning set forth in <U>Section 2(e)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Bid
Price</B>&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (i) if the Common Stock
is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York, New York time) to 4:02 p.m. (New York, New York time)), (ii) if OTCQB or OTCQX is not a Trading Market, the volume weighted
average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (iii) if the Common
Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open
Market (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of
the Common Stock so reported, or (iv) in all other cases, the fair market value of a share of Common Stock as determined by an independent
appraiser selected in good faith by the Holders of a majority in interest of the Warrants then outstanding and reasonably acceptable
to the Company, the fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Bloomberg</B>&rdquo;
means Bloomberg L.P., or any successor thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Board
of Directors</B>&rdquo; means the board of directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Business
Day</B>&rdquo; means any day other than Saturday, Sunday, or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 67.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Buy-In</B>&rdquo;
shall have the meaning set forth in <U>Section 2(d)(iv)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Common
Stock</B>&rdquo; shall have the meaning set forth in the Preamble.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Common
Stock Equivalents</B>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant, or other instrument that
is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Company</B>&rdquo;
shall have the meaning set forth in the Preamble.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 67.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Distribution</B>&rdquo;
shall have the meaning set forth in <U>Section 3(c)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 67.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>DWAC</B>&rdquo;
shall have the meaning set forth in <U>Section 2(d)(i)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Exchange
Act</B>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Exercise
Price</B>&rdquo; shall have the meaning set forth in <U>Section 2(b)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Fundamental
Transaction</B>&rdquo; shall have the meaning set forth in <U>Section 3(d)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Holder</B>&rdquo;
shall have the meaning set forth in the Preamble.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 67.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Initial
Exercise Date</B>&rdquo; shall have the meaning set forth in the Preamble.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 67.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Notice
of Exercise</B>&rdquo; shall have the meaning set forth in <U>Section 2(a)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Person</B>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof), or other entity of any kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Placement
Agency Agreement</B>&rdquo; means the placement agency agreement, dated as of [ ], 2024, by and between the Company and Univest Securities,
LLC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Purchase
Agreement</B>&rdquo; shall have the meaning set forth in <U>Section 1</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Purchase
Rights</B>&rdquo; shall have the meaning set forth in <U>Section 3(b)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Registration
Statement</B>&rdquo; means the Company&rsquo;s registration statement on Form S-1, as amended (File No. 333283178).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>SEC</B>&rdquo;
means the United States Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Securities
Act</B>&rdquo; means the Securities Act of 1933 and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Standard
Settlement Period</B>&rdquo; shall have the meaning set forth in <U>Section 2(d)(i)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Subsidiary</B>&rdquo;
means any subsidiary of the Company and shall, where applicable, also include any direct or indirect subsidiary of the Company formed
or acquired after the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Successor
Entity</B>&rdquo; shall have the meaning set forth in <U>Section 3(d)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Termination
Date</B>&rdquo; shall have the meaning set forth in the Preamble.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Trading
Day</B>&rdquo; means a day on which the Trading Market is open for trading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Trading
Market</B>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: The Nasdaq Capital Market, The Nasdaq Global Market, The Nasdaq Global Select Market, the New York Stock Exchange, or the
NYSE American, (or any successors to any of the foregoing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Transfer
Agent</B>&rdquo; means Continental Stock Transfer &amp; Trust Company, the current transfer agent of the Company, with a mailing address
of 1 State Street, 30th Floor, New York, NY 10004-1561 and a phone number of (212) 509-4000, and any successor transfer agent of the
Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>VWAP</B>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (i) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York, New York time) to 4:02 p.m. (New York, New York time)), (ii) if OTCQB or OTCQX is not a Trading Market, the volume weighted
average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (iii) if the Common
Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open
Market (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of
the Common Stock so reported, or (iv) in all other cases, the fair market value of a share of Common Stock as determined by an independent
appraiser selected in good faith by the holders of a majority in interest of the Warrants then outstanding and reasonably acceptable
to the Company, the fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Warrants</B>&rdquo;
means this Warrant and other Pre-Funded Common Stock purchase warrants issued by the Company pursuant to the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Warrant
Register</B>&rdquo; shall have the meaning set forth in <U>Section 4(c)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Warrant
Share Delivery Date</B>&rdquo; shall have the meaning set forth in <U>Section 2(d)(i)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 67.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Warrant
Shares</B>&rdquo; shall have the meaning set forth in the Preamble.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
2</U>. <U>Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">

    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Exercise
    of Warrant</U>. Subject to the terms and conditions hereof, exercise of the purchase rights represented by this Warrant may be made,
    in whole or in part, at any time or times on or after the Initial Exercise Date and on or before the Termination Date by delivery
    to the Company of a duly executed facsimile copy or PDF copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise
    substantially in the form attached hereto as <U>Exhibit A</U> (the &ldquo;<B>Notice of Exercise</B>&rdquo;). Within the earlier of
    (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined in <U>Section 2(d)(i)
    </U>herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the number of
    Warrant Shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States
    bank unless the cashless exercise procedure specified in <U>Section 2(c)</U> below is applicable and specified in the attached Notice
    of Exercise. The Company shall have no obligation to inquire with respect to or otherwise confirm the authenticity of the signature(s)
    contained on any Notice of Exercise nor the authority of the person so executing such Notice of Exercise. No ink-original Notice
    of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise
    be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant
    to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in
    full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading Days of the
    date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases
    of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of
    Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the
    Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver
    any objection to any Notice of Exercise within one (1) Trading Day of receipt of such notice. <B>The Holder and any assignee, by
    acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of
    a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be
    less than the amount stated on the face hereof.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 85.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">

    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Exercise
    Price</U>. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.01 per Warrant Share, was pre-funded
    to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise
    price of $0.01 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant.
    The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under
    any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination
    Date. The remaining unpaid exercise price per share of Common Stock under this Warrant shall be $0.01, subject to adjustment hereunder
    (the &ldquo;<B>Exercise Price</B>&rdquo;).</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">

    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Cashless
    Exercise</U>. This Warrant may be exercised, in whole or in part, at such time by means of a &ldquo;cashless exercise&rdquo; in which
    the Holder shall be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A),
    where:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)
    =</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
    applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of
    Exercise is (1) both executed and delivered pursuant to <U>Section 2(a)</U> hereof on a day that is not a Trading Day or (2) both
    executed and delivered pursuant to <U>Section 2(a)</U> hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo;
    (as defined in Rule 600(b)(68) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) the VWAP
    on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (iii) the VWAP on the date of the applicable
    Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered
    pursuant to <U>Section 2(a)</U> hereof after the close of &ldquo;regular trading hours&rdquo; on such Trading Day;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)
    =</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Exercise Price of this Warrant, as adjusted hereunder; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(X)
    =</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such
    exercise were by means of a cash exercise rather than a cashless exercise.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised. The Company agrees not
to take any position contrary to this <U>Section 2(c)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Mechanics of Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 48.6pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Delivery of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by
the Transfer Agent by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository Trust Company
through its Deposit or Withdrawal at Custodian system (&ldquo;<B>DWAC</B>&rdquo;) if the Company is then a participant in such system
and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant
Shares by the Holder or (B) this Warrant is being exercised via cashless exercise, and otherwise by physical delivery of a certificate,
registered in the Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant Shares to which
the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is
the earliest of (i) one (1) Trading Day after the delivery of the Notice of Exercise to the Company, (ii) one (1) Trading Day after delivery
of the aggregate Exercise Price to the Company, and (iii) the number of days comprising the Standard Settlement Period after the delivery
to the Company of the Notice of Exercise (such date, the &ldquo;<B>Warrant Share Delivery Date</B>&rdquo;) provided that payment of the
aggregate Exercise Price (other than in the instance of a cashless exercise) is received by the Company by such date. Upon delivery of
the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares
with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment
of the aggregate Exercise Price (other than in the case of a cashless exercise) is received by the Warrant Share Delivery Date. If the
Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery
Date, provided that payment of the aggregate Exercise Price (other than in the instance of a cashless exercise) is received by the Company
by such date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares
subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day
(increasing to $20 per Trading Day on the fifth Trading Day after the Warrant Share Delivery Date) for each Trading Day after such Warrant
Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise. The Company agrees to maintain a transfer
agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable. As used herein, &ldquo;<B>Standard
Settlement Period</B>&rdquo; means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary
Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice of Exercise. Notwithstanding the foregoing,
with respect to any Notice(s) of Exercise delivered on or prior to 12:00 p.m. (New York, NY time) on the Initial Exercise Date, which
may be delivered at any time after the time of execution of the Purchase Agreement, the Company agrees to deliver the Warrant Shares
subject to such notice(s) by 4:00 p.m. (New York, NY time) on the Initial Exercise Date and the Initial Exercise Date shall be the Warrant
Share Delivery Date for purposes hereunder, provided that payment of the aggregate Exercise Price (other than in the case of a cashless
exercise) is received by such Warrant Share Delivery Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Delivery of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of
a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant
evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in
all other respects be identical with this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 81pt; text-align: justify; text-indent: 48.6pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.
<U>Rescission Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to <U>Section
2(d)(i)</U> by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.
<U>Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to
the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions
of <U>Section 2(d)(i)</U> above pursuant to an exercise on or before the Warrant Share Delivery Date, (other than a failure caused by
incorrect or incomplete information provided by the Holder to the Company), and if after such date the Holder is required by its broker
to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares of Common Stock
to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a
&ldquo;<B>Buy-In</B>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&rsquo;s
total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained
by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise
at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the
Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in
which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been
issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common
Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of Warrants with an aggregate
sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall
be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder
in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit a Holder&rsquo;s
right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific
performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares of Common Stock upon exercise
of the Warrant as required pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.8in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.
<U>No Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company
shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied
by the Exercise Price or round up to the next whole share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 81pt; text-align: justify; text-indent: 48.6pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi.
<U>Charges, Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax
or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company,
and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>,
<U>however</U>, that in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when
surrendered for exercise shall be accompanied by the assignment form attached hereto as <U>Exhibit B</U> duly executed by the Holder
and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental
thereto. The Company shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the
Depository Trust Company (or another established clearing corporation performing similar functions) required for same-day electronic
delivery of the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vii.
<U>Closing of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise
of this Warrant, pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">

    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Holder&rsquo;s
    Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise
    any portion of this Warrant, pursuant to <U>Section 2</U> or otherwise, to the extent that after giving effect to such issuance after
    exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other
    Persons acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<B>Attribution Parties</B>&rdquo;)),
    would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence,
    the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the
    number of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but
    shall exclude the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion
    of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion
    of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation, any other Common
    Stock Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned
    by the Holder or any of its Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this
    <U>Section 2(e)</U>, beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules
    and regulations promulgated thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that
    such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required
    to be filed in accordance therewith. To the extent that the limitation contained in this <U>Section 2(e)</U> applies, the determination
    of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution
    Parties) and of which portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the submission of
    a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination of whether this Warrant is exercisable (in relation to
    other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is
    exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm
    the accuracy of such determination and shall have no liability for exercises of the Warrant that are not in compliance with the Beneficial
    Ownership Limitation, except to the extent the Holder relies on a number of outstanding shares of Common Stock that was provided
    by the Company. In addition, a determination as to any group status as contemplated above shall be determined in accordance with
    Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, and the Company shall have no obligation
    to verify or confirm the accuracy of such determination and shall have no liability for exercises of the Warrant that are not in
    compliance with the Beneficial Ownership Limitation, except to the extent the Holder relies on the number of outstanding shares of
    Common Stock that was provided by the Company. For purposes of this <U>Section 2(e)</U>, in determining the number of outstanding
    shares of Common Stock, a Holder may rely on the number of outstanding shares of Common Stock as reflected in (A) the Company&rsquo;s
    most recent periodic or annual report filed with the SEC, as the case may be, (B) a more recent public announcement by the Company
    or (C) a more recent written notice by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding.
    Upon the written request of a Holder, the Company shall within one (1) Trading Day confirm orally and in writing to the Holder the
    number of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined
    after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates
    or Attribution Parties since the date as of which such number of outstanding shares of Common Stock was reported. The &ldquo;<B>Beneficial
    Ownership Limitation</B>&rdquo; shall be 4.99% (or, upon election by a Holder prior to the issuance of any Warrants, 9.99%) of the
    number of shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon
    exercise of this Warrant. The Holder, upon written notice to the Company, may increase or decrease the Beneficial Ownership Limitation
    provisions of this <U>Section 2(e)</U>, provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number
    of shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of
    this Warrant held by the Holder and the provisions of this <U>Section 2(e)</U> shall continue to apply. Any increase in the Beneficial
    Ownership Limitation will not be effective until the sixty-first (61st) day after such notice is delivered to the Company. The provisions
    of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this <U>Section
    2(e)</U> to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership
    Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to such limitation.
    The limitations contained in this paragraph shall apply to a successor holder of this Warrant. If the Warrant is unexercisable as
    a result of the Holder&rsquo;s Beneficial Ownership Limitation, no alternate consideration is owing to the Holder.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
3</U>. <U>Certain Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.9in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Stock Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise
makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares
of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the
Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which
the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this <U>Section 3(a) </U>shall become effective immediately after the record
date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after
the effective date in the case of a subdivision, combination or re-classification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Subsequent Rights Offerings</U>. In addition to any adjustments pursuant to <U>Section 3(a)</U> above, if at any time while this Warrant
is outstanding the Company grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or
other property pro rata to all of the record holders of any class of shares of Common Stock (the &ldquo;<B>Purchase Rights</B>&rdquo;),
then the Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the
Holder could have acquired if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant
(without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately
before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the
date as of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights
(<I>provided</I>, <I>however</I>, that to the extent that the Holder&rsquo;s right to participate in any such Purchase Right would result
in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right
to such extent (or beneficial ownership of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase
Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the
Holder exceeding the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Pro Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or
other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital
or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend,
spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<B>Distribution</B>&rdquo;),
at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution
to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable
upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial
Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the
date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>,
<U>however</U>, that to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder exceeding
the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in
the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution
shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder
exceeding the Beneficial Ownership Limitation). To the extent that this Warrant has not been partially or completely exercised at the
time of such Distribution, such portion of the Distribution shall be held in abeyance for the benefit of the Holder until the Holder
has exercised this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Fundamental Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or
more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company, directly
or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of
its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer
(whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange
their shares for other securities, cash or property and has been accepted by the holders of greater than 50% of the outstanding Common
Stock or greater than 50% of the voting power of the common equity of the Company, (iv) the Company, directly or indirectly, in one or
more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share
exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property (other
than a stock split or stock dividend), or (v) the Company, directly or indirectly, in one or more related transactions consummates a
stock or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off,
merger or scheme of arrangement (other than a stock split or stock dividend)) with another Person or group of Persons whereby such other
Person or group acquires greater than 50% of the outstanding shares of Common Stock or greater than 50% of the voting power of the common
equity of the Company (each a &ldquo;<B>Fundamental Transaction</B>&rdquo;), then, upon any subsequent exercise of this Warrant, the
Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to
the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in <U>Section 2(e)</U>
on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if
it is the surviving corporation, and any additional consideration (the &ldquo;<B>Alternate Consideration</B>&rdquo;) receivable as a
result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is exercisable immediately
prior to such Fundamental Transaction (without regard to any limitation in <U>Section 2(e)</U> on the exercise of this Warrant). For
purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration
based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and
the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value
of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash
or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration
it receives upon any exercise of this Warrant following such Fundamental Transaction. The Company shall cause any successor entity in
a Fundamental Transaction in which the Company is not the survivor (the &ldquo;<B>Successor Entity</B>&rdquo;) to assume in writing all
of the obligations of the Company under this Warrant in accordance with the provisions of this <U>Section 3(d)</U> pursuant to written
agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior
to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security
of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which is exercisable
for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common
Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior
to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock
(but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such
shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting the economic
value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in
form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall be added to the
term &ldquo;Company&rdquo; under this Warrant (so that from and after the occurrence or consummation of such Fundamental Transaction,
the provisions of this Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo; shall refer instead to each
of the Company and the Successor Entity, or Successor Entities, jointly and severally), and the Successor Entity or Successor Entities,
jointly and severally with the Company, may exercise every right and power of the Company prior thereto and the Successor Entity or Successor
Entities shall assume all of the obligations of the Company prior thereto under this Warrant and the other Transaction Documents with
the same effect as if the Company and such Successor Entity or Successor Entities, jointly and severally, had been named as the Company
herein. For the avoidance of doubt, the Holder shall be entitled to the benefits of the provisions of this <U>Section 3(d)</U> regardless
of (i) whether the Company has sufficient authorized shares of Common Stock for the issuance of Warrant Shares and/or (ii) whether a
Fundamental Transaction occurs prior to the Initial Exercise Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Calculations</U>. All calculations under this <U>Section 3</U> shall be made to the nearest cent or the nearest 1/100th of a share,
as the case may be. For purposes of this <U>Section 3</U>, the number of shares of Common Stock deemed to be issued and outstanding as
of a given date shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Notice to Holder</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Adjustment to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this <U>Section 3</U>, the
Company shall promptly deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and
any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment;
provided, however, that the Company may satisfy this notice requirement in this <U>Section 3(f)</U> by filing such notice with the SEC
pursuant to a Current Report on Form 8-K, Quarterly Report on Form 10-Q or Annual Report on Form 10-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
<U>Notice to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form other
than a stock split or stock dividend) on the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a
redemption of the Common Stock, (C) the Company shall authorize the granting to all holders of the Common Stock rights or warrants to
subscribe for or purchase any shares of capital stock of any class or of any rights (excluding any granting or issuance of rights to
all of the Company&rsquo;s shareholders pursuant to a shareholder rights plan), (D) the approval of any stockholders of the Company shall
be required in connection with any reclassification of the Common Stock, any consolidation or merger to which the Company is a party,
any sale or transfer of all or substantially all of the assets of the Company, or any compulsory share exchange whereby the Common Stock
is converted into other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation
or winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by facsimile or email to the
Holder at its last facsimile number or email address as it shall appear upon the Warrant Register of the Company, at least twenty (20)
calendar days prior to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record
is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the
date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants
are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected
to become effective or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to
exchange their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation,
merger, sale, transfer or share exchange; provided that the failure to deliver such notice or any defect therein or in the delivery thereof
shall not affect the validity of the corporate action required to be specified in such notice. To the extent that any notice provided
in this Warrant constitutes, or contains, material, non-public information regarding the Company or any of the Subsidiaries, the Company
shall simultaneously file such notice with the SEC pursuant to a Current Report on Form 8-K. The Holder shall remain entitled to exercise
this Warrant during the period commencing on the date of such notice to the effective date of the event triggering such notice except
as may otherwise be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)
<U>Voluntary Adjustment by Company</U>. Subject to the rules and regulations of the Trading Market, the Company may at any time during
the term of this Warrant reduce the then current Exercise Price to any amount and for any period of time deemed appropriate by the Board
of Directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
4</U>. <U>Transfer of Warrant</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Transferability</U>. Subject to compliance with any applicable securities laws, this Warrant and all rights hereunder (including,
without limitation, any registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office
of the Company or its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto
duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer.
Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the
assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall
issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled.
Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company
unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within three
(3) Trading Days of the date on which the Holder delivers an assignment form to the Company assigning this Warrant in full. The Warrant,
if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new
Warrant issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.9in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>New Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of
the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by
the Holder or its agent or attorney. Subject to compliance with <U>Section 4(a)</U>, as to any transfer which may be involved in such
division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be
divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the Initial Exercise
Date of this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.9in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Warrant Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the
&ldquo;<B>Warrant Register</B>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the
registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder,
and for all other purposes, absent actual notice to the contrary.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
5</U>. <U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.9in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>No Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights,
dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in <U>Section 2(d)(i)</U>, except
as expressly set forth in <U>Section 3</U>. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo;
pursuant to <U>Section 2(c)</U> or to receive cash payments pursuant to <U>Section 2(d)(i)</U> and <U>Section 2(d)(iv)</U> herein, in
no event shall the Company be required to net cash settle an exercise of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 40.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Loss, Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares,
and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant,
shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the
Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant
or stock certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 40.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Saturdays, Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Trading
Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 40.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Authorized Shares</U>. The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized
and unissued Common Stock a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase
rights under this Warrant. The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers
who are charged with the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The
Company will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein
without violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be
listed. The Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this
Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith,
be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in
respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 40.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 40.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 40.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending
its Certificate of Incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale
of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant,
but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary
or appropriate to protect the rights of Holder as set forth in this Warrant against impairment (it being understood that this Warrant
shall not in any case prevent the Company from effecting any such amendment, reorganization, transfer, consolidation, merger, dissolution,
issuance or sale). Without limiting the generality of the foregoing, the Company will (i) not increase the par value of any Warrant Shares
above the amount payable therefor upon such exercise immediately prior to such increase in par value, (ii) take all such action as may
be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable Warrant Shares upon
the exercise of this Warrant and (iii) use commercially reasonable efforts to obtain all such authorizations, exemptions or consents
from any public regulatory body having jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations under
this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 40.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
taking any action, which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from
any public regulatory body or bodies having jurisdiction thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Governing Law; Exclusive Jurisdiction</U>. All questions concerning the construction, validity, enforcement and interpretation of
this Warrant shall be determined in accordance with the provisions of the Purchase Agreement, and any action relating to this Warrant
shall only be brought as provided in the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Restrictions</U>. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and
the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)
<U>Nonwaiver and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall
operate as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies, notwithstanding the fact that
the right to exercise this Warrant terminates on the Termination Date. Without limiting any other provision of this Warrant, if the Company
willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages to the Holder, the
Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable
attorneys&rsquo; fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts due pursuant hereto
or in otherwise enforcing any of its rights, powers or remedies hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.9in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h)
<U>Notices</U>. Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall
be delivered in accordance with the notice provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.9in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)
<U>Limitation of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant
to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of
the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company
or by creditors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 31.5pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 31.5pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 31.5pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">j)
<U>Remedies</U>. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will
be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate
compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to
assert the defense in any action for specific performance that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 31.5pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">k)
<U>Successors and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall
inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns
of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall
be enforceable by the Holder or holder of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 31.5pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">l)
<U>Amendment and Waiver</U>. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the
Company, on the one hand, and the Holder or the beneficial owner of this Warrant, on the other hand.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">m)
<U>Severability</U>. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid
under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall
be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining
provisions of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.9in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">n)
<U>Headings</U>. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed
a part of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Page Follows)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Algorhythm holdings, INC.</B></FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 45%">&nbsp;</TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">

    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICE
OF EXERCISE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TO:
ALGORHYTHM HOLDINGS, INC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only
if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
Payment shall take the form of (check applicable box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;
in lawful money of the United States; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 67.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;
if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in subsection 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrant Shares shall be delivered to the following DWAC Account Number:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 67.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 67.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Investing Entity:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Investing Entity</I>:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">___________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">____________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">___________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ASSIGNMENT
FORM</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to exercise the Warrant to purchase
shares.)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">______________________________________</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">______________________________________</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone
    Number:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">______________________________________</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
    Address:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">______________________________________</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
    _______________ __, ______</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Signature: ___________________</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Address: ____________________</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 16; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>5
<FILENAME>ex5-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Exhibit 5.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex5-1_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1in 0pt 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">November
25, 2024</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 279pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Algorhythm
Holdings. Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6301
NW 5<SUP>th</SUP> Way, Suite 2900</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fort
Lauderdale, FL 33309</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RE:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Algorhythm
    Holdings, Inc.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registration
    Statement on Form S-1 (File No.: 333-283178)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ladies
and Gentlemen:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have acted as counsel to Algorhythm Holdings, Inc., a Delaware corporation (the &ldquo;Company&rdquo;), in connection with the preparation
of the Company&rsquo;s registration statement on Form S-1 and the preliminary prospectus forming a part of the registration statement
(the &ldquo;Prospectus&rdquo;), under the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;), initially filed by the
Company with the Securities and Exchange Commission (the &ldquo;Commission&rdquo;) on November 12, 2024, as thereafter amended or supplemented
(the &ldquo;Registration Statement&rdquo;). The Prospectus relates to the registration of the proposed (i) offering of (A) shares of
common stock (the &ldquo;Shares&rdquo;), par value $0.01 per share, of the Company (the &ldquo;Common Stock&rdquo;) or pre-funded warrants
(the &ldquo;Pre-Funded Warrants&rdquo;), each having the right to purchase one share of Common Stock (&ldquo;Pre-Funded Warrant Share&rdquo;),
in lieu of Shares, (B) Series A warrants (the &ldquo;Series A Warrants&rdquo;), each having the right to purchase one share of Common
Stock (the &ldquo;Series A Warrant Shares&rdquo;), and (C) Series B warrants (the &ldquo;Series B Warrants&rdquo; and, together with
the Series A Warrants, the &ldquo;Warrants&rdquo;), each having the right to purchase one share of Common Stock (together with the Series
A Warrant Shares, the &ldquo;Warrant Shares&rdquo;) and (ii) resale from time to time by the selling stockholders of the Company of up
to 2,840,344 shares of Common Stock (the &ldquo;Selling Stockholder Shares&rdquo;). The proposed maximum aggregate offering price of
the Shares or Pre-Funded Warrants in lieu thereof, the Series A Warrant Shares and the Series B Warrant Shares is $10,000,000]. For each
Pre-Funded Warrant the Company sells, the number of Shares offered will be decreased on a one-for-one basis. The Shares, the Pre-Funded
Warrants, the Pre-Funded Warrant Shares, the Warrants, the Warrant Shares, and the Selling Stockholder Shares, are collectively referred
to as the &ldquo;Securities.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with this opinion, we have examined originals or copies (certified or otherwise identified to our satisfaction) of (i) the
Company&rsquo;s Certificate of Incorporation as currently in effect, (ii) the Company&rsquo;s Amended Bylaws as currently in effect,
(iii) the Registration Statement and related Prospectus, (iv) the form of Securities Purchase Agreement; (v) the form of Placement Agency
Agreement, (vi) the form of Pre-Funded Warrant, (vii) the form of Series A Warrant, (viii) the form of Series B Warrant, and (ix) such
corporate records, agreements, documents and other instruments, and such certificates or comparable documents of public officials or
of officers and representatives of the Company, as we have deemed relevant and necessary as a basis for the opinion hereinafter set forth.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
such examination, we have assumed the genuineness of all signatures, the legal capacity of all natural persons, the authenticity of all
documents submitted to us as originals, the conformity to original documents of all documents submitted to us as certified, conformed
or photostatic copies, and the authenticity of the originals of such latter documents. As to certain questions of fact material to this
opinion, we have relied upon certificates or comparable documents of officers and representatives of the Company and have not sought
to independently verify such facts.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">1185
AVENUE OF THE AMERICAS | 31ST FLOOR | NEW YORK, NY | 10036</FONT></P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">T
(212) 930-9700 | F (212) 930-9725 | WWW.SRFC.LAW</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on the foregoing, and subject to the assumptions, qualifications, limitations and exceptions set forth herein, we are of the opinion
that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Shares have been duly authorized by all necessary corporate action on the part of the Company and, when issued and sold in accordance
    with the Registration Statement and the Prospectus and delivered and paid for in accordance with the terms of the Securities Purchase
    Agreement, the Shares will be validly issued, fully paid and nonassessable.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Pre-Funded Warrants have been duly authorized by all necessary corporate action on the part of the Company and, when issued and sold
    in accordance with the Registration Statement and the Prospectus and delivered and paid for in accordance with the terms of the Securities
    Purchase Agreement, the Pre-Funded Warrants will constitute valid and binding obligations of the Company, enforceable against the
    Company in accordance with their terms except as such enforceability may be limited by (i) any applicable bankruptcy, insolvency,
    reorganization, moratorium or similar laws affecting creditors&rsquo; rights generally including, without limitation, fraudulent
    transfer or fraudulent conveyance laws; (ii) public policy considerations, statutes or court decisions that may limit rights to obtain
    exculpation, indemnification or contribution (including, without limitation, indemnification regarding violations of the securities
    laws and indemnification for losses resulting from a judgment for the payment of any amount other than in United States dollars);
    and (iii) general principles of equity (including, without limitation, concepts of materiality, reasonableness, good faith and fair
    dealing) and the availability of equitable remedies (including, without limitation, specific performance and equitable relief), regardless
    of whether considered in a proceeding in equity or at law.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Pre-Funded Warrant Shares have been duly authorized by all necessary corporate action on the part of the Company and, assuming a
    sufficient number of authorized but unissued shares of Common Stock are available for issuance when the Pre-Funded Warrants are exercised,
    the Pre-Funded Warrant Shares, when and if issued upon exercise of the Pre-Funded Warrants in accordance with the terms of the Pre-Funded
    Warrants, will be validly issued, fully paid and nonassessable.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Warrants have been duly authorized by all necessary corporate action on the part of the Company and, when issued and sold in accordance
    with the Registration Statement and the Prospectus and delivered and paid for in accordance with the terms of the Securities Purchase
    Agreement, the Warrants will constitute valid and binding obligations of the Company, enforceable against the Company in accordance
    with their terms except as such enforceability may be limited by (i) any applicable bankruptcy, insolvency, reorganization, moratorium
    or similar laws affecting creditors&rsquo; rights generally including, without limitation, fraudulent transfer or fraudulent conveyance
    laws; (ii) public policy considerations, statutes or court decisions that may limit rights to obtain exculpation, indemnification
    or contribution (including, without limitation, indemnification regarding violations of the securities laws and indemnification for
    losses resulting from a judgment for the payment of any amount other than in United States dollars); and (iii) general principles
    of equity (including, without limitation, concepts of materiality, reasonableness, good faith and fair dealing) and the availability
    of equitable remedies (including, without limitation, specific performance and equitable relief), regardless of whether considered
    in a proceeding in equity or at law.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Warrant Shares have been duly authorized by all necessary corporate action on the part of the Company and, assuming a sufficient
    number of authorized but unissued shares of Common Stock are available for issuance when the Warrants are exercised, the Warrant
    Shares, when and if issued upon exercise of the Warrants in accordance with the terms of the Warrants, will be validly issued, fully
    paid and nonassessable.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Selling Stockholder Shares are validly issued, fully paid and nonassessable.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
opinion expressed herein is limited to the Delaware General Corporation Law and, with respect to the enforceability of the Pre-Funded
Warrants and the Warrants, the laws of the State of New York, and we express no opinion as to the effect on the matters covered by this
letter of the laws of any other jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
assume no obligation to update or supplement any of our opinions to reflect any changes of law or fact that may occur. We hereby consent
to the filing of this letter as an exhibit to the Registration Statement and to the reference to our firm under the caption &ldquo;Legal
Matters&rdquo; in the Prospectus which is a part of the Registration Statement. In giving such consents, we do not thereby admit that
we are in the category of persons whose consent is required under Section 7 of the Securities Act or the Rules and Regulations of the
Commission promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very
    truly yours,</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Sichenzia Ross Ference Carmel LLP</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sichenzia
    Ross Ference Carmel LLP</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">1185
AVENUE OF THE AMERICAS | 31ST FLOOR | NEW YORK, NY | 10036</FONT></P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">T
(212) 930-9700 | F (212) 930-9725 | WWW.SRFC.LAW</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 51.65pt 0 108.05pt; text-indent: -0.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 51.65pt 0 108.05pt; text-indent: -0.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 51.65pt 0 108.05pt; text-indent: -0.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.28
<SEQUENCE>6
<FILENAME>ex10-28.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><B>Exhibit 10.28</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>SECURITIES
PURCHASE AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
SECURITIES PURCHASE AGREEMENT (this &ldquo;<U>Agreement</U>&rdquo;) is entered into and made effective as of [&#9679;], 2024, between
ALGORHYTHM HOLDINGS, INC., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), and each purchaser identified on the signature
pages hereto (each, including its successors and assigns, a &ldquo;<U>Purchaser</U>&rdquo; and collectively the &ldquo;<U>Purchasers</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
subject to the terms and conditions set forth in this Agreement and pursuant to an effective registration statement under the Securities
Act of 1933, as amended (the &ldquo;<U>Securities Act</U>&rdquo;) as to the Shares, the Pre-Funded Warrants, the Series A Warrants, and
the Series B Warrants (each as defined herein) (collectively, the &ldquo;<U>Securities</U>&rdquo;), the Company desires to issue and
sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, the Securities of the Company
as provided in this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOW,
THEREFORE, in consideration of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt
and adequacy of which are hereby acknowledged, the Company and each Purchaser agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
I.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DEFINITIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1
<U>Definitions</U>. In addition to the words and terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following
words and terms have the meanings set forth in this Section 1.1:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Acquiring
Person</U>&rdquo; shall have the meaning ascribed to such term in Section 4.5.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person as such terms are used in and construed under Rule 405 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Agreement</U>&rdquo;
shall have the meaning ascribed to such term in the Preamble.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>BHCA</U>&rdquo;
shall have the meaning ascribed to such term in <U>Section 3.1(ii)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Board
of Directors</U>&rdquo; means the board of directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Business
Day</U>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing</U>&rdquo;
means the closing of the purchase and sale of the Securities pursuant to <U>Section 2.1</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing
Date</U>&rdquo; means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable parties
thereto, and all conditions precedent to (i) the Purchasers&rsquo; obligations to pay the Subscription Amount and (ii) the Company&rsquo;s
obligations to deliver the Securities, in each case, have been satisfied or waived, but in no event later than the first (1st) Trading
Day following the date hereof (or the second (2nd) Trading Day following the date hereof if this Agreement is signed on a day that is
not a Trading Day or after 4:00 p.m. (New York, NY time) and before midnight (New York, NY time) on a Trading Day).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock</U>&rdquo; means the common stock of the Company, par value $0.01 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time shares of Common Stock, including, without limitation, any debt, preferred shares, right, option, warrant or other instrument
that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, shares
of Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Company</U>&rdquo;
shall have the meaning ascribed to such term in the Preamble.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Company
Counsel</U>&rdquo; means Sichenzia Ross Ference Carmel LLP, counsel to the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Control</U>&rdquo;
(including the terms &ldquo;<U>Controlled by</U>&rdquo; and &ldquo;<U>under common Control with</U>&rdquo;) means the possession, directly
or indirectly, of the power to direct or cause the direction of the management and policies of a person, whether through the ownership
of voting securities, as trustee or executor, by contract or otherwise, including the ownership, directly or indirectly, of securities
having the power to elect a majority of the board of directors or similar body governing the affairs of such person or securities that
represent a majority of the outstanding voting securities of such person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Disclosure
Time</U>&rdquo; means, (i) if this Agreement is signed on a day that is not a Trading Day or after 9:00 a.m. (New York, NY time) and
before midnight (New York, NY time) on any Trading Day, 9:01 a.m. (New York, NY time) on the Trading Day immediately following the date
hereof, unless otherwise instructed as to an earlier time by the Placement Agent, and (ii) if this Agreement is signed between midnight
(New York, NY time) and 9:00 a.m. (New York, NY time) on any Trading Day, no later than 9:01 a.m. (New York, NY time) on the date hereof,
unless otherwise instructed as to an earlier time by the Placement Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>DVP</U>&rdquo;
shall have the meaning ascribed to such term in Section 2.1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>DWAC</U>&rdquo;
shall have the meaning ascribed to such term in <U>Section 2.2(a)(ii)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>EDGAR</U>&rdquo;
means the Electronic Data Gathering, Analysis, and Retrieval System.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>ERISA</U>&rdquo;
shall have the meaning ascribed to such term in <U>Section 3.2(j)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Evaluation
Date</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(r).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exempt
Issuance</U>&rdquo; means the issuance of (i) shares of Common Stock, restricted stock units, or options, including the shares of Common
Stock underlying the restricted stock units or options, to employees, officers, directors, or consultants of the Company pursuant to
any stock or option plan duly adopted for such purpose, by a majority of the non-employee members of the Board of Directors or a majority
of the members of a committee of non-employee directors established for such purpose for services rendered to the Company, (ii) Common
Stock issued upon the exercise or exchange of or conversion of any Warrants issued hereunder or Common Stock Purchase Warrants issued
to the Placement Agent in connection with the Offering and/or other securities exercisable or exchangeable for or convertible into shares
of Common Stock issued and outstanding on the date of this Agreement <I>provided</I> that such securities have not been amended since
the date of this Agreement to increase the number of such securities or to decrease the exercise price, exchange price, or conversion
price of such securities (other than in connection with stock splits or combinations or anti-dilution provisions contained therein as
disclosed in the SEC Reports and the Prospectus) or to extend the term of such securities or securities issuable in connection with a
transaction involving the Company and existing stockholders in which the Company offers the existing stockholders the option to exchange
their shares of Common Stock for other securities of the Company, (iii), securities issued pursuant to merger, acquisition, or strategic
transactions approved by a majority of the disinterested directors of the Company, <I>provided</I> that such securities are issued as
&ldquo;restricted securities&rdquo; (as defined in Rule 144) and carry no registration rights that require or permit the filing of any
registration statement in connection therewith during the prohibition period in <U>Section 4.11(a)</U> herein, and <I>provided</I>, <I>further
</I>that any such issuance shall only be to a Person that (or to the equity holders of a Person) which is, itself or through its subsidiaries,
an operating company, or an owner of an asset in a business synergistic with the business of the Company and in which the Company receives
benefits in addition to any investment of funds, but shall not include a transaction in which the Company is issuing securities primarily
for the purpose of raising capital or to an entity whose primary business is investing in securities, (iv) securities for settlement
of outstanding payables or liabilities <I>provided</I> that such securities are issued as &ldquo;restricted securities&rdquo; (as defined
in Rule 144) and carry no registration rights that require or permit the filing of any registration statement in connection therewith
during the prohibition period in <U>Section 4.11(a)</U> herein, and (v) up to $10,000,000 of securities issued to other purchasers pursuant
to the Prospectus concurrently with the Closing at the Per Share Purchase Price, less the aggregate Subscription Amount pursuant to this
Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>FCPA</U>&rdquo;
means the Foreign Corrupt Practices Act of 1977, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Federal
Reserve</U>&rdquo; shall have the meaning ascribed to such term in <U>Section 2.2(a)(ii)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>FTC</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(l).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>GAAP</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(h).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>GDPR</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(nn).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Indebtedness</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(z).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Issuer
Free Writing Prospectus</U>&rdquo; shall have the meaning ascribed to such term in <U>Section 3.1(f)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>IT
Systems and Data</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(mm).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Intellectual
Property Rights</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(o).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Liens</U>&rdquo;
means a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Lock-Up
Agreement</U>&rdquo; means the Lock-Up Agreement, dated as of the date hereof, by and among the Placement Agent and the directors, officers,
and certain 5% stockholders of the Company, substantially in the form of <U>Exhibit A</U> attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Material
Adverse Effect</U>&rdquo; shall have the meaning assigned to such term in Section 3.1(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Material
Permits</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(m).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Misconduct</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(k).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Money
Laundering Laws</U>&rdquo; shall have the meaning ascribed to such term in <U>Section 3.1(jj)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Non-cooperative
Jurisdiction</U>&rdquo; shall have the meaning ascribed to such term in <U>Section 3.2(i)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>OFAC</U>&rdquo;
shall have the meaning ascribed to such term in <U>Section 3.1(gg)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Offering</U>&rdquo;
shall mean the offering of the Securities contemplated by this Agreement and the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Per
Share Purchase Price</U>&rdquo; equals $[&#9679;], subject to adjustment for reverse and forward share splits, share dividends, share
combinations and other similar events with respect to shares of Common Stock that occur after the date of this Agreement and prior to
the Closing; <I>provided</I> that the purchase price per Pre-Funded Warrant shall be the Per Share Purchase Price minus $0.01.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint share company, government (or an agency or subdivision thereof) or other entity of any kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Personal
Data</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(nn).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Placement
Agency Agreement</U>&rdquo; means the Placement Agency Agreement by and between the Company and the Placement Agent dated as of [&#9679;],
2024, as it may be amended from time to time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Placement
Agent</U>&rdquo; means Univest Securities, LLC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Policies</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(nn).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Pre-Funded
Warrants</U>&rdquo; means the Common Stock Purchase Warrants delivered to certain of the Purchasers at the Closing in accordance with
Section 2.2(a)(iii) hereof to the extent any Purchasers elect to receive Pre-Funded Warrants in lieu of Shares, which Pre-Funded Warrants
shall be exercisable into shares of Common Stock and shall be in the form of <U>Exhibit B</U> attached hereto, which Pre-Funded Warrants
shall be exercisable beginning on the Initial Exercise Date (as defined therein) until all of the Pre-Funded Warrants have been exercised,
and shall be exercisable at an exercise price of $0.01 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Preliminary
Prospectus</U>&rdquo; means the preliminary prospectus dated [&#9679;], 2024, filed with the SEC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Pre-Settlement
Period</U>&rdquo; shall have the meaning set forth in <U>Section 5.21</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Pre-Settlement
Shares</U>&rdquo; shall have the meaning set forth in <U>Section 5.21</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Privacy
Laws</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(nn).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Proceeding</U>&rdquo;
means an action, claim, suit, investigation or proceeding (including, without limitation, a preliminary inquiry, an informal investigation
or a partial proceeding, such as a deposition), whether commenced or threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Prospectus</U>&rdquo;
means the final prospectus filed for the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Purchaser</U>&rdquo;
shall have the meaning ascribed to such term in the Preamble.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Purchaser
Party</U>&rdquo; shall have the meaning ascribed to such term in Section 4.8.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Registration
Statement</U>&rdquo; means the effective registration statement on Form S-1 filed with SEC (File No. 333-283178) which registers the
sale of the Securities to the Purchasers, and shall include the Rule 462(b) Registration Statement if applicable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Required
Approvals</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(e).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Rule
144</U>&rdquo; means Rule 144 promulgated by the SEC pursuant to the Securities Act, as such Rule may be amended or interpreted from
time to time, or any similar rule or regulation hereafter adopted by the SEC having substantially the same purpose and effect as such
Rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Rule
424</U>&rdquo; means Rule 424 promulgated by the SEC pursuant to the Securities Act, as such Rule may be amended or interpreted from
time to time, or any similar rule or regulation hereafter adopted by the SEC having substantially the same purpose and effect as such
Rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Rule
462(b) Registration Statement</U>&rdquo; means any registration statement prepared by the Company registering additional Securities,
which was filed with the SEC on or prior to the date hereof and became automatically effective pursuant to Rule 462(b) promulgated by
the SEC pursuant to the Securities Act, if applicable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>SEC</U>&rdquo;
means the Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>SEC
Reports</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(h).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities</U>&rdquo;
means the Shares and the Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Series
A Warrants</U>&rdquo; means the Common Stock Purchase Warrants delivered to the Purchasers at the Closing in accordance with Section
2.2(a)(iii) hereof, which Series A Warrants shall be exercisable into shares of Common Stock and shall be in the form of <U>Exhibit C
</U>attached hereto, which Series A Warrants shall be exercisable beginning on the Initial Exercise Date (as defined therein), have a
term of five years from the Series A Warrants&rsquo; Initial Exercise Date, and shall be exercisable at an exercise price of $[&#9679;]
per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Series
B Warrants</U>&rdquo; means the Common Stock Purchase Warrants delivered to the Purchasers at the Closing in accordance with Section
2.2(a)(iii) hereof, which Series B Warrants shall be exercisable into shares of Common Stock and shall be in the form of <U>Exhibit D
</U>attached hereto, which Series B Warrants shall be exercisable beginning on the Initial Exercise Date (as defined therein), have a
term of two and a half (2.5) years from the Series B Warrants&rsquo; Initial Exercise Date, and shall be exercisable at an exercise price
of $[&#9679;] per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Shareholder
Approval</U>&rdquo; means such approval as may be required by the applicable rules and regulations of The Nasdaq Stock Market LLC (or
any successor entity) from the shareholders of the Company with respect to (i) reduction to the applicable floor price in the Warrants
inapplicable, (ii) adjustment terms in the Warrants, (iii) issuance of all of the Warrant Shares upon the exercise the Warrants in accordance
with their terms (including adjustment provisions set forth therein), and (iv) to consent to any adjustment to the exercise price or
number of shares of Common Stock underlying the Warrants in the event of a Dilutive Issuance and Reset Date (as defined in the Warrants).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Shareholder
Approval Date</U>&rdquo; means the first Trading Day following the Company&rsquo;s notice to the Purchasers of Shareholder Approval,
which notice shall be provided within two Trading Days of the effectiveness Company&rsquo;s receipt of the Shareholder Approval in accordance
with SEC rules and regulations and applicable law and provisions of the Company&rsquo;s Certificate of Incorporation and Bylaws, including
the requirements with respect to filing and mailing a proxy statement on Schedule 14A. Notwithstanding anything to the contrary, such
notice shall be deemed to be given by a public filing with the SEC disclosing the effectiveness of the Shareholder Approval.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Shares</U>&rdquo;
means the shares of Common Stock which are issuable to each Purchaser pursuant to this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Shell
Bank</U>&rdquo; shall have the meaning ascribed to such term in <U>Section 3.2(h)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Short
Sales</U>&rdquo; means all &ldquo;short sales&rdquo; as defined in Rule 200 of Regulation SHO under the Exchange Act (but shall not be
deemed to include locating and/or borrowing shares of Common Stock).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subscription
Amount</U>&rdquo; means, as to each Purchaser, the aggregate amount to be paid for the Shares or Pre-Funded Warrants (in lieu of Shares)
and Warrants purchased hereunder as specified below such Purchaser&rsquo;s name on the signature page of this Agreement and next to the
heading &ldquo;Subscription Amount,&rdquo; in United States dollars and in immediately available funds (minus, if applicable, a Purchaser&rsquo;s
aggregate exercise price of the Pre-Funded Warrants, which amounts shall be paid as and when such Pre-Funded Warrants are exercised for
cash).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subsidiary</U>&rdquo;
of any person means any corporation, partnership, limited liability company, joint stock company, joint venture or other organization
or entity, whether incorporated or unincorporated, which is Controlled by such Person, and shall, where applicable, also include any
direct or indirect subsidiary of the Company formed or acquired after the date of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the principal Trading Market is open for trading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the shares of Common Stock are listed or quoted for trading
on the date in question: the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock Exchange,
or the NYSE American (or any successors to any of the foregoing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transaction
Documents</U>&rdquo; means this Agreement, the Lock-Up Agreements, the Warrants, all exhibits and schedules thereto and hereto and any
other documents or agreements executed in connection with the transactions contemplated hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transfer
Agent</U>&rdquo; means Continental Stock Transfer &amp; Trust Company, the current transfer agent of the Company, with a mailing address
of 1 State Street, 30th Floor, New York, NY 10004-1561 and a phone number of (212) 509-4000, and any successor transfer agent of the
Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Variable
Rate Transaction</U>&rdquo; shall have the meaning ascribed to such term in Section 4.11(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (i) if the shares of Common Stock are then
listed or quoted on a Trading Market, the daily volume weighted average price of a share of Common Stock for such date (or the nearest
preceding date) on the Trading Market on which the shares of Common Stock are then listed or quoted as reported by Bloomberg L.P. (based
on a Trading Day from 9:30 a.m. (New York, NY time) to 4:02 p.m. (New York, NY time)), (ii) if the OTCQB or OTCQX is not a Trading Market,
the volume weighted average price of a share of Common Stock for such date (or the nearest preceding date) on the OTCQB or OTCQX, (iii)
if shares of Common Stock are not then listed or quoted for trading on the OTCQB or OTCQX and if prices for shares of Common Stock are
then reported in the &ldquo;Pink Sheets&rdquo; published by OTC Markets Group, Inc. (or a similar organization or agency succeeding to
its functions of reporting prices), the most recent bid price per share of Common Stock so reported, or (iv) in all other cases, the
fair market value per share of Common Stock as determined by an independent appraiser selected in good faith by the Purchasers of a majority
in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid
by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Warrants</U>&rdquo;
means, collectively, the Pre-Funded Warrants, the Series A Warrants and the Series B Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Warrant
Shares</U>&rdquo; means the shares of Common Stock issuable upon exercise of the Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
II.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PURCHASE
AND SALE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1
<U>Closing</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
On the Closing Date, upon the terms and subject to the conditions set forth herein, substantially concurrent with the execution and delivery
of this Agreement by the parties hereto, the Company agrees to sell, and the Purchasers, severally and not jointly, agree to purchase,
up to an aggregate of $10,000,000 of the Shares and/or the Pre-Funded Warrants and the corresponding Warrants subscribed for by such
Purchaser. Notwithstanding anything herein to the contrary, to the extent that a Purchaser determines, in its sole discretion, that such
Purchaser&rsquo;s Subscription Amount (together with such Purchaser&rsquo;s Affiliates, and any Person acting as a group together with
such Purchaser or any of such Purchaser&rsquo;s Affiliates) would cause such Purchaser&rsquo;s beneficial ownership of the shares of
Common Stock to exceed the Beneficial Ownership Limitation, or as such Purchaser may otherwise choose, such Purchaser may elect to purchase
Pre-Funded Warrants in lieu of the Shares as determined pursuant to <U>Section 2.2(a)</U>. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo;
shall be 4.99% (or, with respect to each Purchaser, at the election of the Purchaser at Closing, 9.99%) of the number of shares of the
Common Stock outstanding immediately after giving effect to the issuance of the Shares on the Closing Date. In each case, the election
to receive Pre-Funded Warrants is solely at the option of the Purchaser. Each Purchaser&rsquo;s Subscription Amount as set forth on the
signature page hereto executed by such Purchaser shall be made available for &ldquo;Delivery Versus Payment&rdquo; (&ldquo;<U>DVP</U>&rdquo;)
settlement with the Company or its designee. The Company shall deliver to each Purchaser its respective Shares, Pre-Funded Warrants,
Series A Warrants and Series B Warrants, as applicable and as indicated on such Purchaser&rsquo;s signature page hereto and determined
based on its respective Subscription Amount and election for Shares and/or Pre-Funded Warrants, and the Company and each Purchaser shall
deliver the other items set forth in <U>Section 2.2</U> deliverable at the Closing. Upon satisfaction of the covenants and conditions
set forth in <U>Sections 2.2</U> and <U>2.3</U>, the Closing shall occur remotely by electronic transfer of the Transaction Documents
and other items deliverable hereunder. Unless otherwise directed by the Placement Agent, settlement of the Shares shall occur via DVP
(i.e., on the Closing Date, the Company shall issue the Securities registered in the Purchasers&rsquo; names and addresses, and the Shares
shall be released by the Transfer Agent directly to the account(s) at the Placement Agent identified by each Purchaser; upon receipt
of such Shares, the Placement Agent shall promptly electronically deliver such Shares to the applicable Purchaser, and payment therefor
shall be made by the Placement Agent (or its clearing firm) by wire transfer to the Company).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Each Purchaser acknowledges that, concurrently with the Closing and pursuant to the Prospectus, the Company may sell up to $10,000,000
of additional Shares or Pre-Funded Warrants in lieu thereof and Warrants to purchasers not party to this Agreement, less the aggregate
Subscription Amount pursuant to this Agreement, and will issue to such purchasers such shares of Common Stock and Warrants or Pre-Funded
Warrants in lieu thereof and Warrants in the same form and at the same Per Share Purchase Price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2
<U>Deliveries</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
On or prior to the Closing Date, the Company shall deliver or cause to be delivered to each Purchaser the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
this Agreement duly executed by the Company;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
a copy of the irrevocable instructions to the Transfer Agent instructing the Transfer Agent to deliver on an expedited basis via The
Depository Trust Company Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) Shares equal to such Purchaser&rsquo;s
Subscription Amount divided by the Per Share Purchase Price (minus the number of shares of Common Stock issuable upon exercise of such
Purchaser&rsquo;s Pre-Funded Warrant, if applicable), registered in the name of such Purchaser;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
duly executed Pre-Funded Warrants, if any, and Warrants issued and registered in the name of such Purchaser, as applicable to such Purchaser;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
a legal opinion of Company Counsel, in a form reasonably acceptable to the Placement Agent;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
a good standing certificate or its equivalent of the Company and each of its active Subsidiaries in each such entity&rsquo;s jurisdiction
of incorporation or formation issued by the relevant competent state or local government authority or registrar of companies or entities
as applicable, dated as of a date within ten (10) days of the Closing Date;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)
a certificate executed by the Chief Executive Officer of the Company, in form and substance reasonably satisfactory to the Placement
Agent;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)
a certificate executed by the Secretary of the Company, in form and substance reasonably satisfactory to the Placement Agent;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)
Lock-up Agreements, in form and substance reasonably acceptable to the Placement Agent, executed by the Company and each officer, director
and greater than five percent (5%) shareholders of the Company;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ix)
the Company&rsquo;s wire instructions, on Company letterhead and executed by the Chief Executive Officer or Chief Financial Officer;
and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)
the Prospectus (which may be delivered in accordance with Rule 172 under the Securities Act).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
On or prior to the Closing Date, each Purchaser shall deliver or cause to be delivered to the Company the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
this Agreement duly executed by such Purchaser; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
such Purchaser&rsquo;s Subscription Amount (minus, if applicable, a Purchasers aggregate exercise price of the Pre-Funded Warrants, which
amounts shall be paid as and when such Pre-Funded Warrants are exercised for cash), which shall be made available for DVP settlement
with the Company or its designees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3
<U>Closing Conditions</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Subject to <U>Section 5.21</U> below, as applicable, the obligations of the Company hereunder in connection with the Closing are subject
to the following conditions being met:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse
Effect, in all respects) when made and on the Closing Date of the representations and warranties of the Purchasers contained herein (unless
such representation or warranty is as of a specific date therein in which case they shall be accurate in all material respects (or, to
the extent representations or warranties are qualified by materiality or Material Adverse Effect, in all respects) as of such date);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
all obligations, covenants and agreements of each Purchaser required to be performed at or prior to the Closing Date shall have been
performed; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
the delivery by each Purchaser of the items set forth in Section 2.2(b) of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Subject to <U>Section 5.21</U> below, as applicable, the respective obligations of the Purchasers hereunder in connection with the Closing
are subject to the following conditions being met:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse
Effect, in all respects) when made and on the Closing Date of the representations and warranties of the Purchasers contained herein (unless
such representation or warranty is as of a specific date therein in which case they shall be accurate in all material respects (or, to
the extent representations or warranties are qualified by materiality or Material Adverse Effect, in all respects) as of such date);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
all obligations, covenants and agreements of the Company required to be performed at or prior to the Closing Date shall have been performed;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
the delivery by the Company of the items set forth in Section 2.2(a) of this Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
the Company shall have set the record date to obtain the Shareholder Approval;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
there shall have been no Material Adverse Effect with respect to the Company since the date of this Agreement and to the Closing Date;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)
the Company will have submitted a Listing of Additional Shares Notification to the Trading Market with respect to the Shares and Warrant
Shares subject to Shareholder Approval with respect to the Warrant Shares e, and from the date of this Agreement to the Closing Date,
trading in the shares of Common Stock shall not have been suspended by the SEC or any Trading Market, and, at any time prior to the Closing
Date, trading in securities generally as reported by Bloomberg L.P. shall not have been suspended or limited, or minimum prices shall
not have been established on securities whose trades are reported by such service, or on any Trading Market, nor shall a banking moratorium
have been declared either by the United States or New York State authorities nor shall there have occurred any material outbreak or escalation
of hostilities or other national or international calamity of such magnitude in its effect on, or any material adverse change in, any
financial market which, in each case, in the reasonable judgment of such Purchaser, makes it impracticable or inadvisable to purchase
the Securities at the Closing; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)
no stop order suspending the effectiveness of the Registration Statement or any post-effective amendment thereto has been issued under
the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
III.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>REPRESENTATIONS
AND WARRANTIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1
<U>Representations and Warranties of the Company</U>. The Company hereby makes the following representations and warranties to each Purchaser
as of the date hereof and as of the Closing Date (unless as of a specific date therein, in which case they shall be accurate as of such
date):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Subsidiaries</U>. All of the direct and indirect Subsidiaries of the Company are set forth in the Registration Statement. The Company
owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and
all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and
free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references
to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Organization and Qualification</U>. The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized,
validly existing and, if applicable under the laws of the jurisdiction in which they are formed, in good standing under the laws of the
jurisdiction of its incorporation or organization, with the requisite power and authority to own and use its properties and assets and
to carry on its business as currently conducted. The Company and each of the Subsidiaries has all necessary authorizations, approvals,
orders, licenses, certificates and permits of and from all governmental regulatory officials and bodies that it needs as of the date
of this Agreement to conduct its business purpose in all material respects as described in the Registration Statement and SEC Reports
and to own or lease its properties. Neither the Company nor any Subsidiary is in violation nor default of any of the provisions of its
respective certificate or articles of incorporation or association, bylaws or other organizational or charter documents. Each of the
Company and the Subsidiaries is duly qualified to conduct business and is in good standing as a foreign corporation or other entity in
each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification necessary, except where
the failure to be so qualified or in good standing, as the case may be, could not have or reasonably be expected to result in: (i) a
material adverse effect on the legality, validity or enforceability of any Transaction Document, (ii) a material adverse effect on the
results of operations, assets, business or condition (financial or otherwise) of the Company and the Subsidiaries, taken as a whole,
or (iii) a material adverse effect on the Company&rsquo;s ability to perform in any material respect on a timely basis its obligations
under any Transaction Document (any of (i), (ii) or (iii), a &ldquo;<U>Material Adverse Effect</U>&rdquo;); <I>provided</I> that a change
in the market price or trading volume of the Common Stock alone shall not be deemed, in and of itself, to constitute a Material Adverse
Effect. No Proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or curtail
such power and authority or qualification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Authorization; Enforcement</U>. The Company has the requisite corporate power and authority to enter into and to consummate the transactions
contemplated by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and thereunder.
The execution and delivery of this Agreement and each of the other Transaction Documents by the Company and the consummation by it of
the transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Company and no
further action is required by the Company, the Board of Directors, or the Company&rsquo;s stockholders in connection herewith or therewith
other than in connection with the Required Approvals. This Agreement and each other Transaction Document to which it is a party has been
(or upon delivery will have been) duly executed by the Company and, when delivered in accordance with the terms hereof and thereof, will
constitute the valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except (i) as
limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application
affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating to the availability of specific performance,
injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable
law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>No Conflicts</U>. The execution, delivery and performance by the Company of this Agreement and the other Transaction Documents to
which it is a party, the issuance and sale of the Securities and the consummation by it of the transactions contemplated hereby and thereby
do not and will not (i) conflict with or violate any provision of the Company&rsquo;s or any Subsidiary&rsquo;s certificate or articles
of incorporation or association, bylaws or other organizational or charter documents, or (ii) conflict with, or constitute a default
(or an event that with notice or lapse of time or both would become a default) under, result in the creation of any Lien upon any of
the properties or assets of the Company or any Subsidiary, or give to others any rights of termination, amendment, anti-dilution or similar
adjustments, acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or
other instrument (evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary
is a party or by which any property or asset of the Company or any Subsidiary is bound or affected, or (iii) subject to the Required
Approvals, conflict with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction
of any court or governmental authority to which the Company or a Subsidiary is subject (including federal and state securities laws and
regulations), or by which any property or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses
(ii) and (iii), such as could not have or reasonably be expected to result in a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Filings, Consents and Approvals</U>. The Company is not required to obtain any consent, waiver, authorization or order of, give any
notice to, or make any filing or registration with, any court or other federal, state, local or other governmental authority or other
Person in connection with the execution, delivery and performance by the Company of the Transaction Documents, other than: (i) the filings
required pursuant to Section 4.4 of this Agreement, (ii) the filing with the SEC of the Prospectus, (iii) application(s) to each applicable
Trading Market for the listing of the Shares and the Warrant Shares for trading thereon in the time and manner required thereby, (iv)
such filings as are required to be made under applicable state securities laws, and (v) the filing and mailing of a proxy statement on
Schedule 14A in connection with the Shareholder Approval (collectively, the &ldquo;<U>Required Approvals</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Issuance of the Securities; Registration</U>. The Shares are duly authorized and, when issued and paid for in accordance with the
applicable Transaction Documents, will be duly and validly issued, fully paid and non-assessable, free and clear of all Liens imposed
by the Company. The Warrants are duly authorized and, when issued and paid for in accordance with the applicable Transaction Documents,
will constitute valid and legally binding obligations of the Company, enforceable against the Company in accordance with their terms.
The Warrant Shares are duly authorized and, when issued in accordance with the terms of the Warrants against payment therefor as provided
therein, will be validly issued, fully paid and non-assessable, free and clear of all Liens imposed by the Company. The Company has reserved
from its duly authorized capital the maximum number of shares of Common Stock issuable pursuant to this Agreement and the Warrants (without
taking into account any limitations on the exercise of the Warrants set forth therein). The Company has prepared and filed the Registration
Statement in conformity with the requirements of the Securities Act, which became effective on [&#9679;], 2024, including the Prospectus,
and such amendments and supplements thereto as may have been required to the date of this Agreement. The Registration Statement is effective
under the Securities Act and no stop order preventing or suspending the effectiveness of the Registration Statement or suspending or
preventing the use of the Preliminary Prospectus or the Prospectus has been issued by the SEC and no Proceedings for that purpose have
been instituted or, to the knowledge of the Company, are threatened by the SEC. The Company, if required by the rules and regulations
of the SEC, shall file the Prospectus with the SEC pursuant to Rule 424(b). At the time the Registration Statement and any amendments
thereto became effective, at the date of this Agreement and at the Closing Date, the Registration Statement and any amendments thereto
conformed and will conform in all material respects to the requirements of the Securities Act and did not and will not contain any untrue
statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein
not misleading; and the Preliminary Prospectus, the Prospectus and any amendments or supplements thereto, at the time the Preliminary
Prospectus and the Prospectus or any amendment or supplement thereto was issued and at the Closing Date, conformed and will conform in
all material respects to the requirements of the Securities Act and did not and will not contain an untrue statement of a material fact
or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they
were made, not misleading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
&ldquo;issuer free writing prospectus&rdquo; (as defined in Rule 433 under the Securities Act) relating to the Securities is hereafter
referred to as an &ldquo;<U>Issuer Free Writing Prospectus</U>.&rdquo; Any reference herein to the Preliminary Prospectus and the Prospectus
shall be deemed to refer to and include the documents incorporated by reference therein as of the date of filing thereof; and any reference
herein to any &ldquo;amendment&rdquo; or &ldquo;supplement&rdquo; with respect to any of the Preliminary Prospectus and the Prospectus
shall be deemed to refer to and include (i) the filing of any document with the Commission incorporated or deemed to be incorporated
therein by reference after the date of filing of such Preliminary Prospectus or Prospectus and (ii) any such document so filed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
references in this Agreement to the Registration Statement, the Preliminary Prospectus, the Prospectus, or any Issuer Free Writing Prospectus,
or any amendments or supplements to any of the foregoing, shall be deemed to include any copy thereof filed with the Commission on EDGAR.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Capitalization</U>. The capitalization of the Company as of the date hereof is as set forth on Schedule 3.1(g) which Schedule 3.1(g)
shall also include the number of shares of Common Stock owned beneficially, and of record, by Affiliates of the Company as of the date
hereof. The Company has not issued any capital stock or Common Stock Equivalents since its most recently filed periodic report under
the Exchange Act, other than pursuant to the exercise of employee stock options or vesting and settlement of restricted stock units under
the Company&rsquo;s stock option or equity incentive plans, the issuance of shares of Common Stock to employees pursuant to any employee
stock purchase plans, and pursuant to the conversion and/or exercise of Common Stock Equivalents outstanding as of the date of the most
recently filed periodic report under the Exchange Act. No Person has any right of first refusal, preemptive right, right of participation,
or any similar right to participate in the transactions contemplated by the Transaction Documents. Except as a result of the purchase
and sale of the Securities and set forth on Schedule 3.1(g), there are no outstanding options, warrants, scrip rights to subscribe to,
calls or commitments of any character whatsoever relating to, or securities, rights or obligations convertible into or exercisable or
exchangeable for, or giving any Person any right to subscribe for or acquire, any shares of Common Stock or Common Stock Equivalents
or the capital stock of any Subsidiary, or contracts, commitments, understandings or arrangements by which the Company or any Subsidiary
is or may become bound to issue additional shares of Common Stock or Common Stock Equivalents or capital stock of any Subsidiary. The
issuance and sale of the Securities will not obligate the Company or any Subsidiary to issue shares of Common Stock or Common Stock Equivalents
or other securities to any Person (other than the Purchasers). There are no outstanding securities or instruments of the Company or any
Subsidiary with any provision that adjusts, and the issuance and sale of the Securities will not result in a right of any holder of Company
securities or instruments to adjust, the exercise, conversion, exchange or reset price under any of such securities or instruments upon
an issuance of securities by the Company or any Subsidiary. There are no outstanding securities or instruments of the Company or any
Subsidiary that contain any redemption or similar provisions, and there are no contracts, commitments, understandings or arrangements
by which the Company or any Subsidiary is or may become bound to redeem a security of the Company or such Subsidiary. The Company does
not have any stock appreciation rights or &ldquo;phantom stock&rdquo; plans or agreements or any similar plan or agreement. All of the
outstanding shares of capital stock of the Company are duly authorized, validly issued, fully paid and nonassessable, have been issued
in compliance with all federal and state securities laws where applicable, and none of such outstanding shares was issued in violation
of any preemptive rights or similar rights to subscribe for or purchase securities. Except for the Required Approvals, no further approval
or authorization of any shareholder, the Board of Directors or others is required for the issuance and sale of the Securities. There
are no shareholders agreements, voting agreements or other similar agreements with respect to the Company&rsquo;s capital stock to which
the Company is a party or, to the knowledge of the Company, between or among any of the Company&rsquo;s shareholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>SEC Reports; Financial Statements</U>. The Company has filed all reports, schedules, forms, statements and other documents required
to be filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof , for
the one (1) year preceding the date of this Agreement (or such shorter period as the Company was required by law or regulation to file
such material) (the foregoing materials, including the exhibits thereto and documents incorporated by reference therein, together with
the Prospectus, being collectively referred to herein as the &ldquo;<U>SEC Reports</U>&rdquo;) on a timely basis or has received a valid
extension of such time of filing and has filed any such SEC Reports prior to the expiration of any such extension. As of their respective
dates, the SEC Reports complied in all material respects with the requirements of the Securities Act and the Exchange Act, as applicable,
and none of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state a material fact required
to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made,
not misleading. The Company has never been an issuer subject to Rule 144(i) under the Securities Act. The financial statements of the
Company included in the SEC Reports comply in all material respects with applicable accounting requirements and the rules and regulations
of the SEC with respect thereto as in effect at the time of filing. Such financial statements have been prepared in accordance with United
States generally accepted accounting principles applied on a consistent basis during the periods involved (&ldquo;<U>GAAP</U>&rdquo;),
except as may be otherwise specified in such financial statements or the notes thereto and except that unaudited financial statements
may not contain all footnotes required by GAAP, and fairly present in all material respects the financial position of the Company and
its consolidated Subsidiaries as of and for the dates thereof and the results of operations and cash flows for the periods then ended,
subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments. The selected financial data set forth
under the caption &ldquo;Selected Financial Data&rdquo; in the SEC Reports fairly present, on the basis stated in such SEC Reports, the
information included therein. The agreements and documents described in the Registration Statement and the SEC Reports conform in all
material aspects to the descriptions thereof contained therein and there are no agreements or other documents required by the Securities
Act and the rules and regulations thereunder to be described in the Registration Statement, the Prospectus or the SEC Reports or to be
filed with the SEC as exhibits to the Registration Statement, that have not been so described or filed. Each agreement or other instrument
(however characterized or described) to which the Company is a party or by which it is or may be bound or affected and (i) that is referred
to in the Registration Statement or the SEC Reports, or (ii) is material to the Company&rsquo;s business, has been duly authorized and
validly executed by the Company, is in full force and effect in all material respects and is enforceable against the Company and, to
the Company&rsquo;s knowledge, the other parties thereto, in accordance with its terms, except (x) as such enforceability may be limited
by bankruptcy, insolvency, reorganization or similar laws affecting creditors&rsquo; rights generally, (y) as enforceability of any indemnification
or contribution provision may be limited under the federal and state securities laws, and (z) that the remedy of specific performance
and injunctive and other forms of equitable relief may be subject to the equitable defenses and to the discretion of the court before
which any proceeding therefore may be brought. None of such agreements or instruments has been assigned by the Company, and neither the
Company nor, to the best of the Company&rsquo;s knowledge, any other party is in default thereunder and, to the best of the Company&rsquo;s
knowledge, no event has occurred that, with the lapse of time or the giving of notice, or both, would constitute a default thereunder.
To the Company&rsquo;s knowledge, performance by the Company of the material provisions of such agreements or instruments will not result
in a violation of any existing applicable law, rule, regulation, judgment, order or decree of any governmental agency or court, domestic
or foreign, having jurisdiction over the Company or any of its assets or businesses, including, without limitation, those relating to
environmental laws and regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Material Changes; Undisclosed Events, Liabilities or Developments</U>. Since the date of the latest audited financial statements included
within the SEC Reports, except as set forth in Schedule 3.1(i), (i) there has been no event, occurrence or development that has had or
that could reasonably be expected to result in a Material Adverse Effect, (ii) the Company has not incurred any liabilities (contingent
or otherwise) other than (A) trade payables and accrued expenses incurred in the ordinary course of business consistent with past practice
and (B) liabilities not required to be reflected in the Company&rsquo;s financial statements pursuant to GAAP or disclosed in filings
made with the SEC, (iii) the Company has not altered its method of accounting, (iv) the Company has not declared or made any dividend
or distribution of cash or other property to its shareholders or purchased, redeemed or made any agreements to purchase or redeem any
shares of its capital stock and (v) the Company has not issued any equity securities to any officer, director or Affiliate, except pursuant
to existing Company stock option or equity incentive plans. The Company does not have pending before the SEC any request for confidential
treatment of information. Except for the issuance of the Securities contemplated by this Agreement or as set forth in Schedule 3.1(i),
no event, liability, fact, circumstance, occurrence or development has occurred or exists or is reasonably expected to occur or exist
with respect to the Company or its Subsidiaries or their respective businesses, prospects, properties, operations, assets or financial
condition that would be required to be disclosed by the Company under applicable securities laws at the time this representation is made
or deemed made that has not been publicly disclosed at least one Trading Day prior to the date that this representation is made.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
<U>Litigation</U>. Except as disclosed in the SEC Reports, there is no Proceeding pending or, to the knowledge of the Company, threatened
against or affecting the Company, any Subsidiary or any of their respective properties before or by any court, arbitrator, governmental
or administrative agency or regulatory authority (federal, state, county, local or foreign) which (i) adversely affects or challenges
the legality, validity or enforceability of any of the Transaction Documents or the Securities or (ii) could, if there were an unfavorable
decision, have or reasonably be expected to result in a Material Adverse Effect. Neither the Company nor any Subsidiary, nor any director
or officer thereof, is or has been the subject of any Proceeding involving a claim of violation of or liability under federal or state
securities laws or a claim of breach of fiduciary duty, which could result in a Material Adverse Effect. There has not been, and to the
knowledge of the Company, there is not pending or contemplated, any investigation by the SEC involving the Company or any current or
former director or officer of the Company. The SEC has not issued any stop order or other order suspending the effectiveness of any registration
statement filed by the Company or any Subsidiary under the Exchange Act or the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
<U>Labor Relations</U>. (1) No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees
of the Company, which could reasonably be expected to result in a Material Adverse Effect. None of the Company&rsquo;s or its Subsidiaries&rsquo;
employees is a member of a union that relates to such employee&rsquo;s relationship with the Company or such Subsidiary, and neither
the Company nor any of its Subsidiaries is a party to a collective bargaining agreement, and the Company and its Subsidiaries believe
that their relationships with their employees are good. (2) No executive officer of the Company or any Subsidiary, to the knowledge of
the Company, is, or is now expected to be, in violation of any material term of any employment contract, confidentiality, disclosure
or proprietary information agreement or non-competition agreement, or any other contract or agreement or any restrictive covenant in
favor of any third party, and the continued employment of each such executive officer does not subject the Company or any of its Subsidiaries
to any liability with respect to any of the foregoing matters. (3) To the Company&rsquo;s knowledge, (a) no allegation of sexual harassment,
sexual misconduct or discrimination, whether such discrimination arises from race, ethnic background, sex, gender status, age or otherwise
(&ldquo;<U>Misconduct</U>&rdquo;) have been made involving any current or former director, officer, employee or independent contractor
of the Company or any of its Subsidiaries, (b) neither the Company nor any of its Subsidiaries have entered into any settlement agreements
related to allegations of Misconduct by any current or former director, officer, employee, or independent contractor of the Company or
any of its Subsidiaries. (4) The Company and its Subsidiaries are in compliance with all applicable U.S. federal, state, local and foreign
laws and regulations relating to employment and employment practices, terms and conditions of employment and wages and hours, except
where the failure to be in compliance could not, individually or in the aggregate, reasonably be expected to have a Material Adverse
Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
<U>Compliance</U>. Neither the Company nor any Subsidiary: (i) is in default under or in violation of (and no event has occurred that
has not been waived that, with notice or lapse of time or both, would result in a default by the Company or any Subsidiary under), nor
has the Company or any Subsidiary received notice of a claim that it is in default under or that it is in violation of, any indenture,
loan or credit agreement or any other agreement or instrument to which it is a party or by which it or any of its properties is bound
(whether or not such default or violation has been waived), (ii) is in violation of any judgment, decree or order of any court, arbitrator
or other governmental authority or (iii) is or has been in violation of any statute, rule, ordinance or regulation of any governmental
authority, including without limitation all foreign, federal, state and local laws relating to the U.S. Federal Trade Commission (&ldquo;<U>FTC</U>&rdquo;),
state unfair trade practice laws and rules and foreign equivalents, taxes, environmental protection, occupational health and safety,
product quality and safety and employment and labor matters, except in each case as could not have or reasonably be expected to result
in a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
<U>Regulatory Permits</U>. The Company and the Subsidiaries possess all certificates, authorizations and permits issued by the appropriate
federal, state, local or foreign regulatory authorities necessary to conduct their respective businesses as described in the SEC Reports,
except where the failure to possess such permits could not reasonably be expected to result in a Material Adverse Effect (&ldquo;<U>Material
Permits</U>&rdquo;), and neither the Company nor any Subsidiary has received any notice of Proceedings relating to the revocation or
modification of any Material Permit. The disclosures in the Registration Statement concerning the effects of federal, state, local and
all foreign regulation on the Company&rsquo;s business as currently contemplated are correct in all material respects. The Company is
and has been in material compliance with any term of any such Material Permits, except for any violations which would not reasonably
be expected to have a Material Adverse Effect. The Company has not received notice of any Proceeding from any governmental authority
or third party alleging that any product, operation or activity is in violation of any applicable laws or regulations or Material Permits
or has any knowledge that any such entity or third party is considering any such Proceeding, nor, to the Company&rsquo;s knowledge, has
there been any material noncompliance with or violation of any applicable laws or regulations by the Company that could reasonably be
expected to require the issuance of any such communication or result in an investigation, corrective action, or enforcement action by
any governmental authority.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
<U>Title to Assets</U>. The Company and the Subsidiaries have good and marketable title in fee simple to all real property owned by them
and good and marketable title in all personal property owned by them that is material to the business of the Company and the Subsidiaries,
in each case free and clear of all Liens, except for (i) Liens as do not materially affect the value of such property and do not materially
interfere with the use made and proposed to be made of such property by the Company and the Subsidiaries and (ii) Liens for the payment
of federal, state or other taxes, for which appropriate reserves have been made therefor in accordance with GAAP and, the payment of
which is neither delinquent nor subject to penalties. Any real property and facilities held under lease by the Company and the Subsidiaries
are held by them under valid, subsisting and enforceable leases with which the Company and the Subsidiaries are in compliance in all
material respects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)
<U>Intellectual Property</U>. The Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks,
trademark applications, service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights
and similar rights necessary or required for use in connection with their respective businesses as described in the SEC Reports and which
the failure to so have could have a Material Adverse Effect (collectively, the &ldquo;<U>Intellectual Property Rights</U>&rdquo;). None
of, and neither the Company nor any Subsidiary has received a notice (written or otherwise) that any of, the Intellectual Property Rights
has expired, terminated or been abandoned, or is expected to expire or terminate or be abandoned, within two (2) years from the date
of this Agreement, except as would not reasonably be expected to have a Material Adverse Effect. Neither the Company nor any Subsidiary
has received, since the date of the latest audited financial statements included within the SEC Reports, a written notice of a claim
or otherwise has any knowledge that the Intellectual Property Rights violate or infringe upon the rights of any Person, except as could
not have or reasonably be expected to not have a Material Adverse Effect. To the knowledge of the Company, all such Intellectual Property
Rights are enforceable and there is no existing infringement by another Person of any of the Intellectual Property Rights. The Company
and its Subsidiaries have taken reasonable security measures to protect the secrecy, confidentiality and value of all of their intellectual
properties, except where failure to do so could not, individually or in the aggregate, reasonably be expected to have a Material Adverse
Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)
<U>Insurance</U>. The Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses
and risks and in such amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged, including,
but not limited to, directors and officers insurance coverage. Neither the Company nor any Subsidiary has any reason to believe that
it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar
insurers as may be necessary to continue its business without a significant increase in cost.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)
<U>Transactions With Affiliates and Employees</U>. Except as set forth in Schedule 3.1(q), none of the executive officers or directors
of the Company or any Subsidiary and, to the knowledge of the Company, none of the employees of the Company or any Subsidiary is presently
a party to any transaction with the Company or any Subsidiary (other than for services as employees, executive officers and directors),
including any contract, agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real
or personal property to or from, providing for the borrowing of money from or lending of money to or otherwise requiring payments to
or from any executive officer, director or such employee or, to the knowledge of the Company, any entity in which any executive officer,
director, or any such employee has a substantial interest or is an officer, director, trustee, shareholder, member or partner, in , in
each case in excess of 1% of the Company&rsquo;s average total assets as of December 31, 2023 and 2022 other than for: (i) payment of
salary or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company and (iii) other employee
benefits, including equity award or option agreements under any equity incentive plan of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)
<U>Sarbanes-Oxley; Internal Accounting Controls</U>. The Company and the Subsidiaries are in material compliance with any and all applicable
requirements of the Sarbanes-Oxley Act of 2002 that are effective as of the date of this Agreement and applicable to the Company and
the Subsidiaries, and any and all applicable rules and regulations promulgated by the SEC thereunder that are effective as of the date
of this Agreement and as of the Closing Date and applicable to the Company and the Subsidiaries. The Company and the Subsidiaries maintain
a system of internal accounting controls sufficient to provide reasonable assurance that: (i) transactions are executed in accordance
with management&rsquo;s general or specific authorizations, (ii) transactions are recorded as necessary to permit preparation of financial
statements in conformity with GAAP and to maintain asset accountability, (iii) access to assets is permitted only in accordance with
management&rsquo;s general or specific authorization, and (iv) the recorded accountability for assets is compared with the existing assets
at reasonable intervals and appropriate action is taken with respect to any differences. The Company and the Subsidiaries have established
disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Company and the Subsidiaries and
designed such disclosure controls and procedures to ensure that information required to be disclosed by the Company in the reports it
files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC&rsquo;s
rules and forms. The Company&rsquo;s certifying officers have evaluated the effectiveness of the Company&rsquo;s disclosure controls
and procedures of the Company and the Subsidiaries as of the end of the period covered by the Company&rsquo;s most recently filed periodic
report under the Exchange Act (such date, the &ldquo;<U>Evaluation Date</U>&rdquo;). The Company presented in its most recently filed
periodic report under the Exchange Act the conclusions of the certifying officers about the effectiveness of the disclosure controls
and procedures based on their evaluations as of the Evaluation Date. Since the Evaluation Date, there have been no changes in the internal
control over financial reporting (as such term is defined in the Exchange Act) of the Company and its Subsidiaries that have materially
affected, or is reasonably likely to materially affect, the internal control over financial reporting of the Company and its Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s)
<U>Certain Fees</U>. Except as set forth in the Prospectus, no brokerage or finder&rsquo;s fees or commissions are or will be payable
by the Company or any Subsidiary to any broker, financial advisor or consultant, finder, placement agent, investment banker, bank or
other Person with respect to the transactions contemplated by the Transaction Documents. Other than for Persons directly engaged by a
Purchaser, if any, the Purchasers shall have no obligation with respect to any fees or with respect to any claims made by or on behalf
of other Persons for fees of a type contemplated in this Section that may be due in connection with the transactions contemplated by
the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t)
<U>Investment Company</U>. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Securities,
will not be or be an Affiliate of, an &ldquo;investment company&rdquo; within the meaning of the Investment Company Act of 1940, as amended.
The Company shall conduct its business in a manner so that it will not become an &ldquo;investment company&rdquo; subject to registration
under the Investment Company Act of 1940, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u)
<U>Registration Rights</U>. Other than the selling stockholders listed in the resale prospectus of the Registration Statement, no Person
has any right to cause the Company or any Subsidiary to effect the registration under the Securities Act of any securities of the Company
or any Subsidiary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
<U>Listing and Maintenance Requirements</U>. The shares of Common Stock are registered pursuant to Section 12(b) or 12(g) of the Exchange
Act, and the Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration
of the shares of Common Stock under the Exchange Act nor has the Company received any notification that the SEC is contemplating terminating
such registration. Except as set forth in Schedule 31.(v), the Company has not, in the twelve (12) months preceding the date of this
Agreement, received notice from any Trading Market on which the shares of Common Stock are or have been listed or quoted to the effect
that the Company is not in compliance with the listing or maintenance requirements of such Trading Market. The Common Stock is currently
eligible for electronic transfer through the Depository Trust Company or another established clearing corporation and the Company is
current in payment of the fees to the Depository Trust Company (or such other established clearing corporation) in connection with such
electronic transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(w)
<U>Application of Takeover Protections</U>. The Company and the Board of Directors have taken all necessary action, if any, in order
to render inapplicable any control share acquisition, business combination, poison pill (including any distribution under a rights agreement)
or other similar anti-takeover provision under the Company&rsquo;s certificate of incorporation (or similar charter documents) or the
laws of its jurisdiction of incorporation that is or could become applicable to the Purchasers as a result of the Purchasers and the
Company fulfilling their obligations or exercising their rights under the Transaction Documents, including without limitation as a result
of the Company&rsquo;s issuance of the Securities and the Purchasers&rsquo; ownership of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)
<U>Disclosure</U>. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents,
the Company confirms that neither it nor any other Person acting on its behalf has provided any of the Purchasers or their agents or
counsel with any information that it believes constitutes or might constitute material, non-public information which is not otherwise
disclosed in the Prospectus. The Company understands and confirms that the Purchasers will rely on the foregoing representation in effecting
transactions in securities of the Company. All of the disclosure furnished by or on behalf of the Company to the Purchasers regarding
the Company and its Subsidiaries, their respective businesses and the transactions contemplated hereby is true and correct in all material
respects and does not contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the
statements made therein, in light of the circumstances under which they were made, not misleading. The press releases disseminated by
the Company during the 12 months preceding the date of this Agreement taken as a whole do not contain any untrue statement of a material
fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of
the circumstances under which they were made and when made, not misleading. The Company acknowledges and agrees that no Purchaser makes
or has made any representations or warranties with respect to the transactions contemplated hereby other than those specifically set
forth in Section 3.2 hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(y)
<U>No Integrated Offering</U>. Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in Section 3.2,
neither the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers
or sales of any security or solicited any offers to buy any security, under circumstances that would cause this Offering of the Securities
to be integrated with prior offerings by the Company for purposes of any applicable shareholder approval provisions of any Trading Market
on which any of the securities of the Company are listed or designated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(z)
<U>Solvency</U>. Except as disclosed in the Preliminary Prospectus or the Prospectus, based on the consolidated financial condition of
the Company as of the Closing Date, after giving effect to the receipt by the Company of the proceeds from the sale of the Securities
hereunder, (i) the fair saleable value of the Company&rsquo;s assets exceeds the amount that will be required to be paid on or in respect
of the Company&rsquo;s existing debts and other liabilities (including known contingent liabilities) as they mature, (ii) the Company&rsquo;s
assets do not constitute unreasonably small capital to carry on its business as now conducted and as proposed to be conducted including
its capital needs taking into account the particular capital requirements of the business conducted by the Company, consolidated and
projected capital requirements and capital availability thereof, and (iii) the current cash flow of the Company, together with the proceeds
the Company would receive, were it to liquidate all of its assets, after taking into account all anticipated uses of the cash, would
be sufficient to pay all amounts on or in respect of its liabilities when such amounts are required to be paid. The Company does not
intend to incur debts beyond its ability to pay such debts as they mature (taking into account the timing and amounts of cash to be payable
on or in respect of its debt). Except as disclosed in the Preliminary Prospectus or the Prospectus, the Company has no knowledge of any
facts or circumstances which lead it to believe that it will file for reorganization or liquidation under the bankruptcy or reorganization
laws of any jurisdiction within one (1) year from the Closing Date. The Preliminary Prospectus and the Prospectus sets forth as of the
date of this Agreement and as of the Closing Date, respectively, all outstanding secured and unsecured Indebtedness of the Company or
any Subsidiary, or for which the Company or any Subsidiary has commitments. For the purposes of this Agreement, &ldquo;<U>Indebtedness</U>&rdquo;
means (x) any liabilities for borrowed money or amounts owed in excess of Fifty Thousand Dollars ($50,000) (other than trade accounts
payable incurred in the ordinary course of business), (y) all guaranties, endorsements and other contingent obligations in respect of
indebtedness of others, whether or not the same are or should be reflected in the Company&rsquo;s consolidated balance sheet (or the
notes thereto), except guaranties by endorsement of negotiable instruments for deposit or collection or similar transactions in the ordinary
course of business; and (z) the present value of any lease payments in excess of One Hundred Thousand Dollars ($100,000) due under leases
required to be capitalized in accordance with GAAP. Neither the Company nor any Subsidiary is in default with respect to any Indebtedness.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(aa)
<U>Tax Status</U>. Except for matters that would not, individually or in the aggregate, have or reasonably be expected to result in a
Material Adverse Effect, the Company and its Subsidiaries each (i) has made or filed all United States federal, state and local income
and franchise taxes and all foreign income and franchise tax returns, reports and declarations required by any jurisdiction to which
it is subject, (ii) has paid all taxes and other governmental assessments and charges that are material in amount, shown or determined
to be due on such returns, reports and declarations and (iii) has set aside on its books provision reasonably adequate for the payment
of all material taxes for periods subsequent to the periods to which such returns, reports or declarations apply. There are no unpaid
taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company or of any
Subsidiary know of no basis for any such claim.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(bb)
<U>Foreign Corrupt Practices</U>. Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary, any
agent or other person acting on behalf of the Company or any Subsidiary, has (i) directly or indirectly, used any funds for unlawful
contributions, gifts, entertainment or other unlawful expenses related to foreign or domestic political activity, (ii) made any unlawful
payment to foreign or domestic government officials or employees or to any foreign or domestic political parties or campaigns from corporate
funds, (iii) failed to disclose fully any contribution made by the Company or any Subsidiary (or made by any person acting on its behalf
of which the Company is aware) which is in violation of law, or (iv) violated in any material respect any provision of FCPA. The Company
has taken reasonable steps to ensure that its accounting controls and procedures are sufficient to cause the Company to comply in all
material respects with the FCPA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(cc)
<U>Accountants</U>. The Company&rsquo;s independent registered public accounting firm is set forth in the Preliminary Prospectus and
the Prospectus. To the knowledge of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange
Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company&rsquo;s Annual Report for
the fiscal year ending December 31, 2024.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(dd)
<U>Acknowledgment Regarding Purchasers&rsquo; Purchase of Securities</U>. The Company acknowledges and agrees that each of the Purchasers
is acting solely in the capacity of an arm&rsquo;s length purchaser with respect to the Transaction Documents and the transactions contemplated
thereby. The Company further acknowledges that no Purchaser is acting as a financial advisor or fiduciary of the Company (or in any similar
capacity) with respect to the Transaction Documents and the transactions contemplated thereby and any advice given by any Purchaser or
any of their respective representatives or agents in connection with the Transaction Documents and the transactions contemplated thereby
is merely incidental to the Purchasers&rsquo; purchase of the Securities. The Company further represents to each Purchaser that the Company&rsquo;s
decision to enter into this Agreement and the other Transaction Documents has been based solely on the independent evaluation of the
transactions contemplated hereby by the Company and its representatives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ee)
<U>Acknowledgement Regarding Purchaser&rsquo;s Trading Activity</U>. Anything in this Agreement or elsewhere herein to the contrary notwithstanding
(except for Sections 3.2(f) and 4.13 hereof), it is understood and acknowledged by the Company that: (i) none of the Purchasers has been
asked by the Company to agree, nor has any Purchaser agreed, to desist from purchasing or selling, long and/or short, securities of the
Company, or &ldquo;derivative&rdquo; securities based on securities issued by the Company or to hold the Securities for any specified
term; (ii) past or future open market or other transactions by any Purchaser, specifically including, without limitation, Short Sales
or &ldquo;derivative&rdquo; transactions, before or after the closing of this or future private placement transactions, may negatively
impact the market price of the Company&rsquo;s publicly-traded securities; (iii) any Purchaser, and counter-parties in &ldquo;derivative&rdquo;
transactions to which any such Purchaser is a party, directly or indirectly, presently may have a &ldquo;short&rdquo; position in the
shares of Common Stock, and (iv) each Purchaser shall not be deemed to have any affiliation with or control over any arm&rsquo;s length
counter-party in any &ldquo;derivative&rdquo; transaction. The Company further understands and acknowledges that (y) one or more Purchasers
may engage in hedging activities at various times during the period that the Securities are outstanding, including, without limitation,
during the periods that the value of the Warrant Shares deliverable with respect to the Securities are being determined, and (z) such
hedging activities (if any) could reduce the value of the existing shareholders&rsquo; equity interests in the Company at and after the
time that the hedging activities are being conducted. The Company acknowledges that such aforementioned hedging activities do not constitute
a breach of any of the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ff)
<U>Regulation M Compliance</U>. The Company has not, and to its knowledge no one acting on its behalf (other than the Placement Agent,
as to which no representation is made) has, (i) taken, directly or indirectly, any action designed to cause or to result in the stabilization
or manipulation of the price of any security of the Company to facilitate the sale or resale of any of the Securities, (ii) sold, bid
for, purchased, or, paid any compensation for soliciting purchases of, any of the Securities, or (iii) paid or agreed to pay to any Person
any compensation for soliciting another to purchase any other securities of the Company, other than, in the case of clauses (ii) and
(iii), compensation paid to the Placement Agent in connection with the placement of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(gg)
<U>Office of Foreign Assets Control</U>. Neither the Company nor any Subsidiary nor, to the Company&rsquo;s knowledge, any director,
officer, agent, employee or Affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the
Office of Foreign Assets Control of the U.S. Treasury Department (&ldquo;<U>OFAC</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(hh)
<U>U.S. Real Property Holding Corporation</U>. The Company is not and has never been a U.S. real property holding corporation within
the meaning of Section 897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon Purchaser&rsquo;s
request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
<U>Bank Holding Company Act</U>. Neither the Company nor any of its Subsidiaries or Affiliates is subject to the Bank Holding Company
Act of 1956, as amended (the &ldquo;<U>BHCA</U>&rdquo;) and to regulation by the Board of Governors of the Federal Reserve System (the
&ldquo;<U>Federal Reserve</U>&rdquo;). Neither the Company nor any of its Subsidiaries or Affiliates owns or controls, directly or indirectly,
five percent (5%) or more of the outstanding shares of any class of voting securities or twenty-five percent (25%) or more of the total
equity of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its
Subsidiaries or Affiliates exercises a controlling influence over the management or policies of a bank or any entity that is subject
to the BHCA and to regulation by the Federal Reserve.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(jj)
<U>Money Laundering</U>. The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance with
applicable financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended,
applicable United States federal and state and foreign money laundering statutes and applicable rules and regulations thereunder (collectively,
the &ldquo;<U>Money Laundering Laws</U>&rdquo;), and no Proceeding by or before any court or governmental agency, authority or body or
any arbitrator involving the Company or any Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge of the
Company or any Subsidiary, threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(kk)
<U>Environmental Laws</U>. The Company and its Subsidiaries (i) are in compliance with all federal, state, local and foreign laws relating
to pollution or protection of human health or the environment (including ambient air, surface water, groundwater, land surface or subsurface
strata), including laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants, contaminants, or
toxic or hazardous substances or wastes (collectively, &ldquo;<U>Hazardous Materials</U>&rdquo;) into the environment, or otherwise relating
to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials, as well
as all authorizations, codes, decrees, demands, or demand letters, injunctions, judgments, licenses, notices or notice letters, orders,
permits, plans or regulations, issued, entered, promulgated or approved thereunder (&ldquo;<U>Environmental Laws</U>&rdquo;); (ii) have
received all permits licenses or other approvals required of them under applicable Environmental Laws to conduct their respective businesses;
and (iii) are in compliance with all terms and conditions of any such permit, license or approval where in each clause (i), (ii) and
(iii), the failure to so comply could be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ll)
<U>Stock Option Plans</U>. Each stock option granted by the Company under the Company&rsquo;s stock option plan was granted (i) in accordance
with the terms of the Company&rsquo;s stock option plan and (ii) with an exercise price at least equal to the fair market value of the
Common Stock on the date such stock option would be considered granted under GAAP and applicable law. No stock option granted under the
Company&rsquo;s stock option plan has been backdated. The Company has not knowingly granted, and there is no and has been no Company
policy or practice to knowingly grant, stock options or awards prior to, or otherwise knowingly coordinate the grant of stock options
or awards with, the release or other public announcement of material information regarding the Company or its Subsidiaries or their financial
results or prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(mm)
<U>Cybersecurity</U>. There has been no security breach or other compromise of or relating to any of the Company&rsquo;s or any Subsidiary&rsquo;s
information technology and computer systems, networks, hardware, software, data (including the data of its respective customers, employees,
suppliers, vendors and any third party data maintained by or on behalf of it), equipment or technology (collectively, &ldquo;<U>IT Systems
and Data</U>&rdquo;) that would reasonably be expected to result in, individually or in the aggregate, a Material Adverse Effect and
(i) the Company and the Subsidiaries have not been notified of, and has no knowledge of any event or condition that would reasonably
be expected to result in, any material security breach or other compromise to its IT Systems and Data; (ii) the Company and the Subsidiaries
are presently in compliance with all applicable laws or statutes and all judgments, orders, rules and regulations of any court or arbitrator
or governmental or regulatory authority, internal policies and contractual obligations relating to the privacy and security of IT Systems
and Data and to the protection of such IT Systems and Data from unauthorized use, access, misappropriation or modification, except as
would not, individually or in the aggregate, have a Material Adverse Effect; (iii) the Company and the Subsidiaries have implemented
and maintained commercially reasonable safeguards to maintain and protect its material confidential information and the integrity, continuous
operation, redundancy and security of all IT Systems and Data; and (iv) the Company and the Subsidiaries have implemented backup and
disaster recovery technology consistent with industry standards and practices.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(nn)
<U>Compliance with Data Privacy Laws</U>. (i) The Company and the Subsidiaries are, and at all times during the last three (3) years
were, in material compliance with all applicable state, federal and foreign data privacy and security laws and regulations, including,
without limitation, the European Union General Data Protection Regulation (&ldquo;<U>GDPR</U>&rdquo;) (EU 2016/679) (collectively, &ldquo;<U>Privacy
Laws</U>&rdquo;); (ii) the Company and the Subsidiaries have in place, comply with, and take appropriate steps reasonably designed to
ensure compliance with their policies and procedures relating to data privacy and security and the collection, storage, use, disclosure,
handling and analysis of Personal Data (as defined below) (the &ldquo;<U>Policies</U>&rdquo;); (iii) the Company provides accurate notice
of its applicable Policies to its customers, employees, third party vendors and representatives as required by the Privacy Laws; and
(iv) applicable Policies provide accurate and sufficient notice of the Company&rsquo;s then-current privacy practices relating to its
subject matter, and do not contain any material omissions of the Company&rsquo;s then-current privacy practices, as required by Privacy
Laws. &ldquo;<U>Personal Data</U>&rdquo; means (i) a natural person&rsquo;s name, street address, telephone number, email address, photograph,
social security number, bank information, or customer or account number; (ii) any information which would qualify as &ldquo;personally
identifying information&rdquo; under the FTC, as amended; (iii) &ldquo;personal data&rdquo; as defined by GDPR; and (iv) any other piece
of information that allows the identification of such natural person, or his or her family, or permits the collection or analysis of
any identifiable data related to an identified person&rsquo;s health or sexual orientation. (i) None of such disclosures made or contained
in any of the Policies have been inaccurate, misleading, or deceptive in violation of any Privacy Laws and (ii) the execution, delivery
and performance of the Transaction Documents will not result in a breach of any Privacy Laws or Policies. Neither the Company nor the
Subsidiaries (i) to the knowledge of the Company, has received written notice of any actual or potential liability of the Company or
the Subsidiaries under, or actual or potential violation by the Company or the Subsidiaries of, any of the Privacy Laws; (ii) is currently
conducting or paying for, in whole or in part, any investigation, remediation or other corrective action pursuant to any regulatory request
or demand pursuant to any Privacy Law; or (iii) is a party to any order, decree, or agreement by or with any court or arbitrator or governmental
or regulatory authority that imposed any obligation or liability under any Privacy Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2
<U>Representations and Warranties of the Purchasers</U>. Each Purchaser, for itself and for no other Purchaser, hereby represents and
warrants as of the date of this Agreement and as of the Closing Date to the Company as follows (unless as of a specific date therein,
in which case they shall be accurate as of such date):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 21pt; text-align: justify; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Organization; Authority</U>. Such Purchaser is either an individual or an entity duly incorporated or formed, validly existing and
in good standing under the laws of the jurisdiction of its incorporation or formation with full right, corporate, partnership, limited
liability company or similar power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents
and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of the Transaction Documents and performance
by such Purchaser of the transactions contemplated by the Transaction Documents have been duly authorized by all necessary corporate,
partnership, limited liability company or similar action, as applicable, on the part of such Purchaser. Each Transaction Document to
which it is a party has been duly executed by such Purchaser, and when delivered by such Purchaser in accordance with the terms hereof,
will constitute the valid and legally binding obligation of such Purchaser, enforceable against it in accordance with its terms, except:
(i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general
application affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating to the availability of specific
performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited
by applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 21pt; text-align: justify; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Understandings or Arrangements</U>. Such Purchaser is acquiring the Securities as principal for its own account and has no direct
or indirect arrangement or understandings with any other persons to distribute or regarding the distribution of such Securities (this
representation and warranty not limiting such Purchaser&rsquo;s right to sell the Securities pursuant to the Registration Statement or
otherwise in compliance with applicable federal and state securities laws). Such Purchaser is acquiring the Securities hereunder in the
ordinary course of its business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 21pt; text-align: justify; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Experience of Such Purchaser</U>. Such Purchaser, either alone or together with its representatives, has such knowledge, sophistication
and experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment
in the Securities, and has so evaluated the merits and risks of such investment. Such Purchaser is able to bear the economic risk of
an investment in the Securities and, at the present time, is able to afford a complete loss of such investment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 21pt; text-align: justify; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Access to Information</U>. Such Purchaser acknowledges that it has had the opportunity to review the Transaction Documents (including
all exhibits and schedules thereto), and the SEC Reports including the Prospectus and, has been afforded, (i) the opportunity to ask
such questions as it has deemed necessary of, and to receive answers from, representatives of the Company concerning the terms and conditions
of the offering of the Securities and the merits and risks of investing in the Securities; (ii) access to information about the Company
and its financial condition, results of operations, business, properties, management and prospects sufficient to enable it to evaluate
its investment; and (iii) the opportunity to obtain such additional information that the Company possesses or can acquire without unreasonable
effort or expense that is necessary to make an informed investment decision with respect to the investment. Such Purchaser acknowledges
and agrees that neither the Placement Agent nor any Affiliate of the Placement Agent has provided such Purchaser with any information
or advice with respect to the Securities nor is such information or advice necessary or desired. Neither the Placement Agent nor any
Affiliate has made or makes any representation as to the Company or the quality of the Securities and the Placement Agent and any Affiliate
may have acquired non-public information with respect to the Company which such Purchaser agrees need not be provided to it. In connection
with the issuance of the Securities to such Purchaser, neither the Placement Agent nor any of its Affiliates has acted as a financial
advisor or fiduciary to such Purchaser.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 21pt; text-align: justify; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Certain Transactions and Confidentiality</U>. Other than consummating the transactions contemplated hereunder, such Purchaser has
not, nor has any Person acting on behalf of or pursuant to any understanding with such Purchaser, directly or indirectly executed any
purchases or sales, including Short Sales, of the securities of the Company during the period commencing as of the time that such Purchaser
first received a term sheet (written or oral) from the Company or any other Person representing the Company setting forth the material
pricing terms of the transactions contemplated hereunder and ending immediately prior to the execution hereof. Notwithstanding the foregoing,
in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of
such Purchaser&rsquo;s assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers
managing other portions of such Purchaser&rsquo;s assets, the representation set forth above shall only apply with respect to the portion
of assets managed by the portfolio manager that made the investment decision to purchase the Securities covered by this Agreement. Other
than to other Persons party to this Agreement or to such Purchaser&rsquo;s representatives, including, without limitation, its officers,
directors, partners, legal and other advisors, employees, agents and Affiliates, such Purchaser has maintained the confidentiality of
all disclosures made to it in connection with this transaction (including the existence and terms of this transaction). Notwithstanding
the foregoing, for the avoidance of doubt, nothing contained herein shall constitute a representation or warranty, or preclude any actions,
with respect to locating or borrowing shares in order to effect Short Sales or similar transactions in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 21pt; text-align: justify; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Ownership of Company Securities</U>. Except as disclosed in writing to the Company as of the date of this Agreement, no Purchaser,
any of its Affiliates, or any other Persons whose beneficial ownership of shares of Common Stock would be aggregated with the Purchaser&rsquo;s
for purposes of Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, including any &ldquo;group&rdquo;
of which the Purchaser is a member, directly or indirectly owns, beneficially or otherwise (including solely with respect to an economic
interest), any of the outstanding shares of Common Stock, or any other shares of capital stock, options, warrants, derivative securities,
rights or any other securities (including any securities convertible into, exchangeable for or that represent the right to receive securities)
of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 21pt; text-align: justify; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Nature of Warrants</U>. The Purchaser acknowledges that the Warrants will not be immediately exercisable upon issuance, that the Purchaser
may only exercise the Warrants beginning on the applicable Initial Exercise Date, and that the Warrants shall be subject to the Company
complying with applicable rules and regulations of the Trading Market including those relating to the Shareholder Approval Date (as defined
in the Warrants). The Purchaser further acknowledges that while the Company believes the Warrants are compliant with the rules and regulations
of the Trading Market, neither the Company nor the Placement Agent provide any representation, warranty or guarantee that the Warrants
or, based on the Warrants, the Offering are compliant with such rules and regulations and that the Trading Market may require amendment
to the terms of the Warrants in order to comply with its rules and regulations, and the Purchaser covenants and agrees to reasonably
cooperate with the Company and the Placement Agent in good faith in connection with any amendment or other action with respect to the
Warrants that may be required by the Trading Market in the event that the Warrants are deemed to be non-compliant with such rules and
regulations by the Trading Market. The Purchaser further acknowledges that the Warrants will not be listed or quoted for trading on any
securities exchange or quotation system and will not be publicly traded.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 21pt; text-align: justify; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>Sanctioned Persons</U>. Purchaser is not owned or controlled by or acting on behalf of (in connection with this Agreement), a Sanctioned
Person. Purchaser is not an institution that accepts currency for deposit and that (i) has no physical presence in the jurisdiction in
which it is incorporated or in which it is operating and (ii) is unaffiliated with a regulated financial group that is subject to consolidated
supervision (a &ldquo;<U>Shell Bank</U>&rdquo;) or providing banking services to a Shell Bank. Purchaser also represents that, to the
extent required by applicable law, it maintains, either directly or through the use of a third-party administrator, policies, and procedures
reasonably designed for the screening of any investors in the Purchaser against Sanctions-related lists of blocked or restricted persons.
Purchaser further represents and warrants that (A) the funds held by Purchaser and used to purchase the Securities were not directly
or indirectly derived from or related to any activities that may contravene U.S. federal, state, or non-U.S. anti-money laundering, anti-corruption,
or Sanctions laws and regulations or activities that may otherwise be deemed criminal and (B) any returns from the Purchaser&rsquo;s
investment will not be used to finance any illegal activities. For purposes of this Agreement, &ldquo;<U>Sanctioned Person</U>&rdquo;
means at any time any person or entity with whom dealings are restricted, prohibited, or sanctionable under any Sanctions (as defined
below), including as a result of being: (I) listed on any Sanctions-related list of designated or blocked or restricted persons; (II)
that is a national of, the government of, or any agency or instrumentality of the government of, or resident in, or organized under the
laws of, a country or territory that is the target of comprehensive Sanctions from time to time (as of the date of this Agreement, Cuba,
Iran, North Korea, Syria, and the Crimea region); or (III) a relationship of ownership, control, or agency with any of the foregoing.
&ldquo;<U>Sanctions</U>&rdquo; means those trade, economic and financial sanctions laws, regulations, embargoes, and restrictive measures
(in each case having the force of law) administered, enacted, or enforced from time to time by (1) the United States (including without
limitation the U.S. Department of the Treasury, Office of Foreign Assets Control, the U.S. Department of State, and the U.S. Department
of Commerce), (2) the European Union and enforced by its member states, (3) the United Nations, and (4) the United Kingdom.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Non-cooperative Jurisdiction</U>. Purchaser is not owned or controlled by or acting on behalf of (in connection with this Agreement),
a person or entity resident in, or whose funds used to purchase the Securities are transferred from or through, a country, territory,
or entity that (i) has been designated as non-cooperative with international anti-money laundering or counter terrorist financing principles
or procedures by the United States or by an intergovernmental group or organization, such as the Financial Action Task Force, of which
the United States is a member; (ii) is the subject of an advisory issued by the Financial Crimes Enforcement Network of the U.S. Department
of the Treasury; or (iii) has been designated by the Secretary of the Treasury under Section 311 of the USA PATRIOT Act as warranting
special measures due to money laundering concerns (any such country or territory, a &ldquo;<U>Non-cooperative Jurisdiction</U>&rdquo;),
or an entity or individual that resides or has a place of business in, or is organized under the laws of, a Non-cooperative Jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 22.5pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
<U>ERISA</U>. If Purchaser is an employee benefit plan that is subject to Title I of the Employee Retirement Income Security Act of 1974,
as amended (&ldquo;<U>ERISA</U>&rdquo;), a plan, an individual retirement account or other arrangement that is subject to section 4975
of the Code or an employee benefit plan that is a governmental plan (as defined in section 3(32) of ERISA), a church plan (as defined
in section 3(33) of ERISA), a non-U.S. plan (as described in section 4(b)(4) of ERISA), or other plan that is not subject to the foregoing
but may be subject to provisions under any other federal, state, local, non-U.S., or other laws or regulations that are similar to such
provisions of ERISA or the Code, or an entity whose underlying assets are considered to include &ldquo;plan assets&rdquo; of any such
plan, account or arrangement subject to the fiduciary or prohibited transaction provisions of ERISA or section 4975 of the Code, Purchaser
represents and warrants that the acquisition and holding of the Securities will not result in a non-exempt prohibited transaction under
ERISA or Section 4975 of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company acknowledges and agrees that the representations contained in this Section 3.2 shall not modify, amend or affect such Purchaser&rsquo;s
right to rely on the Company&rsquo;s representations and warranties contained in this Agreement or any representations and warranties
contained in any other Transaction Document or any other document or instrument executed and/or delivered in connection with this Agreement
or the consummation of the transactions contemplated hereby. Notwithstanding the foregoing, for the avoidance of doubt, nothing contained
herein shall constitute a representation or warranty, or preclude any actions, with respect to locating or borrowing shares in order
to effect Short Sales or similar transactions in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
IV.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OTHER
AGREEMENTS OF THE PARTIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1
<U>Warrant Shares</U>. If all or any portion of the Warrants are exercised at a time when there is an effective registration statement
to cover the issuance or resale of the Warrant Shares or if the Warrants are exercised via cashless exercise, the Warrant Shares issued
pursuant to any such exercise shall be issued free of all legends. If at any time following the date hereof the Registration Statement
(or any subsequent registration statement registering the sale or resale of the Warrant Shares) is not effective or is not otherwise
available for the sale or resale of the Warrant Shares, the Company shall immediately notify the holders of the Warrants in writing that
such registration statement is not then effective and thereafter shall promptly notify such holders when the registration statement is
effective again and available for the sale or resale of the Warrant Shares (it being understood and agreed that the foregoing shall not
limit the ability of the Company to issue, or any Purchaser to sell, any of the Warrant Shares in compliance with applicable federal
and state securities laws). The Company shall use best efforts to keep a registration statement (including the Registration Statement)
registering the issuance or resale of the Warrant Shares effective during the term of the Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2
<U>Furnishing of Information</U>. Until the earliest of the time that (i) no Purchaser owns Securities or (ii) the Warrants have expired,
the Company covenants to use its reasonable efforts to timely file (or obtain extensions in respect thereof and file within the applicable
grace period) all reports required to be filed by the Company after the date hereof pursuant to the Exchange Act even if the Company
is not then subject to the reporting requirements of the Exchange Act except in the event that the Company consummates: (A) any transaction
or series of related transactions as a result of which any Person (together with its Affiliates) acquires then outstanding securities
of the Company representing more than fifty percent (50%) of the voting control of the Company; (B) a merger or reorganization of the
Company with one or more other entities in which the Company is not the surviving entity; or (C) a sale of all or substantially all of
the assets of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3
<U>Integration</U>. The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security
(as defined in Section 2 of the Securities Act) that would be integrated with the offer or sale of the Securities for purposes of the
rules and regulations of any Trading Market such that it would require shareholder approval prior to the closing of such other transaction
unless shareholder approval is obtained before the closing of such subsequent transaction, other than the Shareholder Approval.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4
<U>Securities Laws Disclosure; Publicity</U>. The Company shall (a) by the Disclosure Time, issue a press release disclosing the material
terms of the transactions contemplated hereby, and (b) file a Current Report on Form 8-K, including the Transaction Documents as exhibits
thereto, with the SEC within the time required by the Exchange Act. From and after the issuance of such press release, the Company represents
to the Purchasers that it shall have publicly disclosed all material, non-public information delivered to any of the Purchasers by the
Company or any of its Subsidiaries, or any of their respective officers, directors, employees, Affiliates or agents, including, without
limitation, the Placement Agent, in connection with the transactions contemplated by the Transaction Documents. In addition, effective
upon the issuance of such press release, the Company acknowledges and agrees that any and all confidentiality or similar obligations
under any agreement, whether written or oral, between the Company, any of its Subsidiaries or any of their respective officers, directors,
agents, employees, Affiliates or agents, including, without limitation, the Placement Agent, on the one hand, and any of the Purchasers
or any of their Affiliates on the other hand, shall terminate and be of no further force or effect. The Company understands and confirms
that each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company. The Company and
each Purchaser shall consult with each other in issuing any other press releases with respect to the transactions contemplated hereby,
and neither the Company nor any Purchaser shall issue any such press release nor otherwise make any such public statement without the
prior consent of the Company, with respect to any press release of any Purchaser, or without the prior consent of each Purchaser, with
respect to any press release of the Company, which consent shall not unreasonably be withheld or delayed, except if such disclosure is
required by law, in which case the disclosing party shall promptly provide the other party with prior notice of such public statement
or communication. Notwithstanding the foregoing, the Company shall not publicly disclose the name of any Purchaser, or include the name
of any Purchaser in any filing with the SEC or any regulatory agency or Trading Market, without the prior written consent of such Purchaser,
except (a) as required by federal securities law in connection with the filing of final Transaction Documents with the SEC and (b) to
the extent such disclosure is required by law or Trading Market regulations, in which case the Company shall provide the Purchasers with
prior notice of such disclosure permitted under this clause (b) and reasonably cooperate with such Purchaser regarding such disclosure.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5
<U>Shareholder Rights Plan</U>. No claim will be made or enforced by the Company or, with the consent of the Company, any other Person,
that any Purchaser is an &ldquo;<U>Acquiring Person</U>&rdquo; under any control share acquisition, business combination, poison pill
(including any distribution under a rights agreement) or similar anti-takeover plan or arrangement in effect or hereafter adopted by
the Company, or that any Purchaser could be deemed to trigger the provisions of any such plan or arrangement, by virtue of receiving
Securities under the Transaction Documents or under any other agreement between the Company and the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6
<U>Non-Public Information</U>. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction
Documents, which shall be disclosed pursuant to Section 4.4, the Company covenants and agrees that neither it, nor any other Person acting
on its behalf will provide any Purchaser or its agents or counsel with any information that constitutes, or the Company reasonably believes
constitutes, material non-public information, unless prior thereto such Purchaser shall have consented to the receipt of such information
and agreed with the Company to keep such information confidential. The Company understands and confirms that each Purchaser shall be
relying on the foregoing covenant in effecting transactions in securities of the Company. To the extent that the Company delivers any
material, non-public information to a Purchaser without such Purchaser&rsquo;s consent, the Company hereby covenants and agrees that
such Purchaser shall not have any duty of confidentiality to the Company, any of its Subsidiaries, or any of their respective officers,
directors, agents, employees or Affiliates, or a duty to the Company, any of its Subsidiaries or any of their respective officers, directors,
agents, employees or Affiliates not to trade on the basis of, such material, non-public information, provided that the Purchaser shall
remain subject to applicable law. To the extent that any notice provided pursuant to any Transaction Document constitutes, or contains,
material, non-public information regarding the Company or any Subsidiaries, the Company shall simultaneously file such notice with the
SEC on a Current Report on Form 8-K or shall issue a press release containing such material non-public information. The Company understands
and confirms that each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7
<U>Use of Proceeds</U>. The Company shall use the net proceeds from the sale of the Securities hereunder as set forth in the Registration
Statement, and otherwise as set forth in the Registration Statement shall not use such proceeds: (a) for the satisfaction of any portion
of the Company&rsquo;s debt (other than payment of trade payables in the ordinary course of the Company&rsquo;s business and prior practices),
(b) for the redemption of any shares of Common Stock or Common Stock Equivalents, (c) for the settlement of any outstanding litigation
or (d) in violation of FCPA or OFAC regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8
<U>Indemnification of Purchasers</U>. Subject to the provisions of this Section 4.8, the Company will indemnify and hold each Purchaser
and its directors, officers, shareholders, members, partners, employees and agents (and any other Persons with a functionally equivalent
role of a Person holding such titles notwithstanding a lack of such title or any other title), each Person who controls such Purchaser
(within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, shareholders,
agents, members, partners or employees (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding
a lack of such title or any other title) of such controlling persons (each, a &ldquo;<U>Purchaser Party</U>&rdquo;) harmless from any
and all losses, liabilities, obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts paid in
settlements, court costs and reasonable attorneys&rsquo; fees and costs of investigation that any such Purchaser Party may suffer or
incur as a result of or relating to (i) any breach of any of the representations, warranties, covenants or agreements made by the Company
in this Agreement or in the other Transaction Documents, (ii) any untrue statement or alleged untrue statement of a material fact contained
in the Registration Statement or Prospectus or by any omission or alleged omission to state therein a material fact necessary to make
the statements therein, in light of the circumstances under which they were made, not misleading (other than untrue statements or alleged
untrue statements in, or omissions or alleged omissions from, information relating to a Purchaser Party furnished in writing by or on
behalf of such Purchaser Party expressly for use in the Registration Statement or Prospectus), or (iii) any Proceeding instituted against
the Purchaser Parties in any capacity (including a Purchaser Party&rsquo;s status as an investor), or any of them or their respective
Affiliates, by the Company or any stockholder of the Company who is not an Affiliate of such Purchaser Party, arising out of or relating
to any of the transactions contemplated by the Transaction Documents. For avoidance of doubt, the indemnification provided herein is
intended to and shall also cover, direct claims brought by the Company against the Purchaser Parties; provided, however, that such indemnification
shall not cover any loss, claim, damage or liability to the extent it is finally judicially determined to be attributable to any Purchaser
Party&rsquo;s breach of any of the representations, warranties, covenants or agreements made by such Purchaser Party in any Transaction
Document or any conduct by a Purchaser Party which is finally judicially determined to constitute fraud, gross negligence or willful
misconduct. If any Proceeding shall be brought against any Purchaser Party in respect of which indemnity may be sought pursuant to this
Agreement, such Purchaser Party shall promptly notify the Company in writing, and, except with respect to direct claims brought by the
Company, the Company shall have the right to assume the defense thereof with counsel of its own choosing reasonably acceptable to the
Purchaser Party. Any Purchaser Party shall have the right to employ separate counsel in any such Proceeding and participate in the defense
thereof, but the fees and expenses of such counsel shall be at the expense of such Purchaser Party except to the extent that (i) the
employment thereof has been specifically authorized by the Company in writing, (ii) the Company has failed after a reasonable period
of time to assume such defense and to employ counsel or (iii) in such Proceeding there is, in the reasonable opinion of counsel to the
applicable Purchaser Party (which may be internal counsel), a material conflict on any material issue between the position of the Company
and the position of such Purchaser Party, in which case the Company shall be responsible for the reasonable fees and expenses of no more
than one such separate counsel. The Company will not be liable to any Purchaser Party under this Agreement for any settlement by a Purchaser
Party effected without the Company&rsquo;s prior written consent, which shall not be unreasonably withheld or delayed. In addition, if
any Purchaser Party takes actions to collect amounts due under any Transaction Documents or to enforce the provisions of any Transaction
Documents, then the Company shall pay the cost incurred by such Purchaser Party for such collection, enforcement or action, including,
but not limited to, attorney&rsquo;s fees and disbursements. The indemnification and other payment obligations required by this Section
4.8 shall be made by periodic payments of the amount thereof during the course of the investigation, defense, collection, enforcement
or action, as and when bills are received or are incurred; provided, that if any Purchaser Party is finally judicially determined not
to be entitled to indemnification or payment under this Section 4.8, such Purchaser Party shall promptly reimburse the Company for any
payments that are advanced under this sentence. The indemnity agreements contained herein shall be in addition to any cause of action
or similar right of any Purchaser Party against the Company or others and any liabilities the Company may be subject to pursuant to law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.9
<U>Reservation of Shares of Common Stock</U>. As of the Shareholder Approval Date, , the Company shall have reserved and the Company
shall continue thereafter to reserve and keep available at all times, free of preemptive rights, a sufficient number of shares of Common
Stock for the purpose of enabling the Company to issue the Shares pursuant to this Agreement and Warrant Shares pursuant to any exercise
of the Warrants, including but not limited to, a number of shares of Common Stock sufficient to honor the issuance of the maximum number
of shares of Common Stock issuable assuming exercise in full of the Series B Warrants via an &ldquo;alternative cashless exercise&rdquo;
at the Floor Price (as defined thereunder) under Section 2(c) of the Series B Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.10
<U>Listing of Shares</U>. The Company hereby agrees to use commercially reasonable efforts to maintain the listing or quotation of the
Shares and Warrant Shares on each Trading Market on which any shares of Common Stock are currently listed, and concurrently with the
Closing, the Company shall apply to list or quote all of the Shares and Warrant Shares on such Trading Markets and promptly secure the
listing of all of the Shares and Warrant Shares on such Trading Markets. The Company further agrees, if the Company applies to have the
shares of Common Stock traded on any other Trading Market, it will then include in such application all of the Shares and Warrant Shares,
and will take such other action as is necessary to cause all of the Shares and Warrant Shares to be listed or quoted on such other Trading
Market as promptly as possible. The Company will then take all action reasonably necessary to continue the listing and trading of its
shares of Common Stock on a Trading Market and will comply in all material respects with the Company&rsquo;s reporting, filing and other
obligations under the bylaws or rules of the Trading Market. The Company agrees to maintain the eligibility of the Common Stock for electronic
transfer through the Depository Trust Company or another established clearing corporation, including, without limitation, by timely payment
of fees to the Depository Trust Company or such other established clearing corporation in connection with such electronic transfer. Notwithstanding
the foregoing, this Section 4.10 shall not apply in the event that the Company consummates: (i) any transaction or series of related
transactions as a result of which any Person (together with its Affiliates) acquires then outstanding securities of the Company representing
more than fifty percent (50%) of the voting control of the Company; (ii) a merger or reorganization of the Company with one or more other
entities in which the Company is not the surviving entity; or (iii) a sale of all or substantially all of the assets of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.11
<U>Subsequent Equity Sales</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
From the date hereof until ninety (90) days after the Shareholder Approval Date, neither the Company nor any Subsidiary shall (i) issue,
enter into any agreement to issue or announce the issuance or proposed issuance of any Common Stock or Common Stock Equivalents, or (ii)
file any registration statement or amendment or supplement thereto, other than with respect to the Registration Statement or a registration
statement on Form S-8, except for the Securities issued pursuant hereto or otherwise in connection with the Offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
From the date hereof until one hundred and eighty (180) days after the Shareholder Approval Date, the Company shall be prohibited from
effecting or entering into an agreement to effect any issuance by the Company or any of its Subsidiaries of Common Stock or Common Stock
Equivalents (or a combination of units thereof) involving a Variable Rate Transaction. &ldquo;<U>Variable Rate Transaction</U>&rdquo;
means a transaction in which the Company (i) issues or sells any debt or equity securities that are convertible into, exchangeable or
exercisable for, or include the right to receive additional shares of Common Stock either (A) at a conversion price, exercise price or
exchange rate or other price that is based upon and/or varies with the trading prices of or quotations for the shares of Common Stock
at any time after the initial issuance of such debt or equity securities, or (B) with a conversion, exercise or exchange price that is
subject to being reset at some future date after the initial issuance of such debt or equity security (other than in connection with
a stock split or stock dividend or similar event) or upon the occurrence of specified or contingent events directly or indirectly related
to the business of the Company or the market for the Common Stock or (ii) enters into, or effects a transaction under, any agreement,
including, but not limited to, an equity line of credit or an &ldquo;at-the-market offering&rdquo;, whereby the Company may issue securities
at a future determined price regardless of whether shares pursuant to such agreement have actually been issued and regardless of whether
such agreement is subsequently canceled. The Purchaser shall be entitled to obtain injunctive relief against the Company to preclude
any such issuance, which remedy shall be in addition to any right to collect damages.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Notwithstanding the foregoing, this Section 4.11 shall not apply in respect of an Exempt Issuance, except that no Variable Rate Transaction
shall be an Exempt Issuance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.12
<U>Equal Treatment of Purchasers</U>. No consideration (including any modification of any Transaction Document) shall be offered or paid
to any Person to amend or consent to a waiver or modification of any provision of the Transaction Documents unless the same consideration
is also offered to all of the parties to the Transaction Documents. For clarification purposes, this provision constitutes a separate
right granted to each Purchaser by the Company and negotiated separately by each Purchaser, and is intended for the Company to treat
the Purchasers as a class and shall not in any way be construed as the Purchasers acting in concert or as a group with respect to the
purchase, disposition or voting of Securities or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.13
<U>Certain Transactions and Confidentiality</U>. Each Purchaser, severally and not jointly, covenants that neither it nor any Affiliate
acting on its behalf or pursuant to any understanding with it will execute any purchases or sales, including Short Sales of any of the
Company&rsquo;s securities during the period commencing with the execution of this Agreement and ending at such time that the transactions
contemplated by this Agreement are first publicly announced pursuant to the initial press release as described in Section 4.4. Each Purchaser,
severally and not jointly, covenants that until such time as the transactions contemplated by this Agreement are publicly disclosed by
the Company pursuant to the initial press release as described in Section 4.4, such Purchaser will maintain the confidentiality of the
existence and terms of this transaction. Notwithstanding the foregoing and notwithstanding anything contained in this Agreement to the
contrary, the Company expressly acknowledges and agrees that (i) no Purchaser makes any representation, warranty or covenant hereby that
it will not engage in effecting transactions in any securities of the Company after the time that the transactions contemplated by this
Agreement are first publicly announced pursuant to the initial press release as described in Section 4.4, (ii) no Purchaser shall be
restricted or prohibited from effecting any transactions in any securities of the Company in accordance with applicable securities laws
from and after the time that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press
release as described in Section 4.4 and (iii) no Purchaser shall have any duty of confidentiality or duty not to trade in the securities
of the Company to the Company, any of its Subsidiaries, or any of their respective officers, directors, employees, Affiliates, or agent,
including, without limitation, the Placement Agent after the issuance of the initial press release as described in Section 4.4. Notwithstanding
the foregoing, in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate
portions of such Purchaser&rsquo;s assets and the portfolio managers have no direct knowledge of the investment decisions made by the
portfolio managers managing other portions of such Purchaser&rsquo;s assets, the covenant set forth above shall only apply with respect
to the portion of assets managed by the portfolio manager that made the investment decision to purchase the Securities covered by this
Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.14
<U>Exercise Procedures</U>. The form of Notice of Exercise included in the Warrants sets forth the totality of the procedures required
of the Purchasers in order to exercise the Warrants. No additional legal opinion, other information or instructions shall be required
of the Purchasers to exercise their Warrants. Without limiting the preceding sentences, no ink-original Notice of Exercise shall be required,
nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise form be required in order to
exercise the Warrants. The Company shall honor exercises of the Warrants and shall deliver Warrant Shares in accordance with the terms,
conditions and time periods set forth in the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.15
<U>Lock-Up Agreements</U>. The Company shall not amend, modify, waive or terminate any provision of any of the Lock-Up Agreements except
to extend the term of the lock-up period and shall enforce the provisions of each Lock-Up Agreement in accordance with its terms. If
any party to a Lock-Up Agreement breaches any provision of a Lock-Up Agreement, the Company shall promptly use its reasonable efforts
to seek specific performance of the terms of such Lock-Up Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
V.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>MISCELLANEOUS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1
<U>Termination</U>. This Agreement may be terminated by any Purchaser, as to such Purchaser&rsquo;s obligations hereunder only and without
any effect whatsoever on the obligations between the Company and the other Purchasers, by written notice to the other parties, if the
Closing has not been consummated on or before the fifth (5th) Trading Day following the date hereof; <U>provided</U>, <U>however</U>,
that no such termination will affect the right of any party hereto to sue for any breach by any other party (or parties).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2
<U>Fees and Expenses</U>. Except as expressly set forth in the Transaction Documents to the contrary, each party shall pay the fees and
expenses of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the
negotiation, preparation, execution, delivery and performance of this Agreement. The Company shall pay all Transfer Agent fees (including,
without limitation, any fees required for same-day processing of any instruction letter delivered by the Company and any exercise notice
delivered by a Purchaser), stamp taxes and other taxes and duties levied in connection with the delivery of any Securities to the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3
<U>Entire Agreement</U>. The Transaction Documents, together with the exhibits and schedules thereto, and the Prospectus, contain the
entire understanding of the parties with respect to the subject matter hereof and thereof and supersede all prior agreements and understandings,
oral or written, with respect to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.4
<U>Notices</U>. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in
writing and shall be deemed given and effective on the earliest of: (i) the time of transmission, if such notice or communication is
delivered via facsimile at the facsimile number or email attachment at the email address as set forth on the signature pages attached
hereto at or prior to 5:30 p.m. (New York, NY time) on a Trading Day, (ii) the next Trading Day after the time of transmission, if such
notice or communication is delivered via facsimile at the facsimile number or email attachment at the email address as set forth on the
signature pages attached hereto on a day that is not a Trading Day or later than 5:30 p.m. (New York, NY time) on any Trading Day, (iii)
the second (2nd) Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service or (d) upon
actual receipt by the party to whom such notice is required to be given. The address for such notices and communications shall be as
set forth on the signature pages attached hereto. To the extent that any notice provided pursuant to any Transaction Document constitutes,
or contains, material, non-public information regarding the Company or any Subsidiaries, the Company shall simultaneously file such notice
with the SEC pursuant to a Current Report on Form 8-K or by issuing a press release containing such material non-public information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.5
<U>Amendments; Waivers</U>. No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument
signed, in the case of an amendment, by the Company and Purchasers which purchased at least 50.1% in interest of the Shares based on
the Subscription Amounts hereunder (or, prior to the Closing, the Company and each Purchaser) or, in the case of a waiver, by the party
against whom enforcement of any such waived provision is sought, provided that if any amendment, modification or waiver disproportionately
and adversely impacts a Purchaser (or group of Purchasers), the consent of such disproportionately impacted Purchaser (or group of Purchasers)
shall also be required. No waiver of any default with respect to any provision, condition or requirement of this Agreement shall be deemed
to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement
hereof, nor shall any delay or omission of any party to exercise any right hereunder in any manner impair the exercise of any such right.
Any amendment effected in accordance with this Section 5.5 shall be binding upon each Purchaser and holder of Securities and the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.6
<U>Headings</U>. The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to
limit or affect any of the provisions hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.7
<U>Successors and Assigns</U>. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and
permitted assigns. The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent
of each Purchaser (other than by merger). Any Purchaser may assign any or all of its rights under this Agreement to any Person to whom
such Purchaser assigns or transfers any Securities, provided that such transferee agrees in writing to be bound, with respect to the
transferred Securities, by the provisions of the Transaction Documents that apply to the &ldquo;Purchasers.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.8
<U>Third-Party Beneficiaries</U>. The Placement Agent shall be a third-party beneficiary of the representations and warranties of the
Company in Section 3.1 and the representations and warranties of the Purchasers in Section 3.2. This Agreement is intended for the benefit
of the parties hereto and their respective successors and permitted assigns and is not for the benefit of, nor may any provision hereof
be enforced by, any other Person, except as otherwise set forth in Section 4.8 and this Section 5.8.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.9
<U>Governing Law</U>. All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents
shall be governed by and construed and enforced in accordance with the internal laws of the State of New York. Each party agrees that
all legal Proceedings concerning the interpretations, enforcement and defense of the transactions contemplated by this Agreement and
any other Transaction Documents (whether brought against a party hereto or its respective affiliates, directors, officers, shareholders,
partners, members, employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York.
Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York,
Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby
or discussed herein (including with respect to the enforcement of any of the Transaction Documents), and hereby irrevocably waives, and
agrees not to assert in any Proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such
Proceeding is improper or is an inconvenient venue for such Proceeding. Each party hereby irrevocably waives personal service of process
and consents to process being served in any such Proceeding by mailing a copy thereof via registered or certified mail or overnight delivery
(with evidence of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service
shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any
way any right to serve process in any other manner permitted by law. If any party shall commence an Proceeding to enforce any provisions
of the Transaction Documents, then, in addition to the obligations of the Company under Section 4.8, the prevailing party in such Proceeding
shall be reimbursed by the non-prevailing party for its reasonable attorneys&rsquo; fees and other costs and expenses incurred with the
investigation, preparation and prosecution of such Proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.10
<U>Survival</U>. The representations and warranties contained herein shall survive the Closing and the delivery of the Securities for
the applicable statute of limitations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.11
<U>Execution</U>. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one
and the same agreement and shall become effective when counterparts have been signed by each party and delivered to each other party,
it being understood that the parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission
or by e-mail delivery of a &ldquo;.pdf&rdquo; format data file, such signature shall create a valid and binding obligation of the party
executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or &ldquo;.pdf&rdquo; signature
page were an original thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.12
<U>Severability</U>. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to
be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall
remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially
reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated
by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would
have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared
invalid, illegal, void or unenforceable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.13
<U>Rescission and Withdrawal Right</U>. Notwithstanding anything to the contrary contained in (and without limiting any similar provisions
of) any of the other Transaction Documents, whenever any Purchaser exercises a right, election, demand or option under a Transaction
Document and the Company does not timely perform its related obligations within the periods therein provided, then such Purchaser may
rescind or withdraw, in its sole discretion from time to time upon written notice to the Company, any relevant notice, demand or election
in whole or in part without prejudice to its future actions and rights; <U>provided</U>, <U>however</U>, that in the case of a rescission
of an exercise of an Warrant, the applicable Purchaser shall be required to return any shares of Common Stock subject to any such rescinded
exercise notice concurrently (if such shares were delivered to the applicable Purchaser) with the return to such Purchaser of the aggregate
exercise price paid to the Company for such shares and the restoration of such Purchaser&rsquo;s right to acquire such shares pursuant
to such Purchaser&rsquo;s Warrant (including, issuance of a replacement warrant certificate evidencing such restored right).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.14
<U>Replacement of Securities</U>. If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed,
the Company shall issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation),
or in lieu of and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to
the Company of such loss, theft or destruction. The applicant for a new certificate or instrument under such circumstances shall also
pay any reasonable third-party costs (including customary indemnity) associated with the issuance of such replacement Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.15
<U>Remedies</U>. In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages,
each of the Purchasers and the Company will be entitled to specific performance under the Transaction Documents. The parties agree that
monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations contained in the Transaction
Documents and hereby agree to waive and not to assert in any Proceeding for specific performance of any such obligation the defense that
a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.16
<U>Payment Set Aside</U>. To the extent that the Company makes a payment or payments to any Purchaser pursuant to any Transaction Document
or a Purchaser enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise
or any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged by
or are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other Person under any law (including,
without limitation, any bankruptcy law, state or federal law, common law or equitable cause of action), then to the extent of any such
restoration the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force and effect
as if such payment had not been made or such enforcement or setoff had not occurred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.17
<U>Independent Nature of Purchasers&rsquo; Obligations and Rights</U>. The obligations of each Purchaser under any Transaction Document
are several and not joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the performance
or non-performance of the obligations of any other Purchaser under any Transaction Document. Nothing contained herein or in any other
Transaction Document, and no action taken by any Purchaser pursuant hereto or thereto, shall be deemed to constitute the Purchasers as
a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Purchasers are in any way
acting in concert or as a group with respect to such obligations or the transactions contemplated by the Transaction Documents. Each
Purchaser shall be entitled to independently protect and enforce its rights including, without limitation, the rights arising out of
this Agreement or out of the other Transaction Documents, and it shall not be necessary for any other Purchaser to be joined as an additional
party in any Proceeding for such purpose. Each Purchaser has been represented by its own separate legal counsel in its review and negotiation
of the Transaction Documents. The Company has elected to provide all Purchasers with the same terms and Transaction Documents for the
convenience of the Company and not because it was required or requested to do so by any of the Purchasers. It is expressly understood
and agreed that each provision contained in this Agreement and in each other Transaction Document is between the Company and a Purchaser,
solely, and not between the Company and the Purchasers collectively and not between and among the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.18
<U>Liquidated Damages</U>. The Company&rsquo;s obligations to pay any partial liquidated damages or other amounts owing under the Transaction
Documents is a continuing obligation of the Company and shall not terminate until all unpaid partial liquidated damages and other amounts
have been paid notwithstanding the fact that the instrument or security pursuant to which such partial liquidated damages or other amounts
are due and payable shall have been canceled.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.19
<U>Saturdays, Sundays, Holidays, etc.</U> If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business
Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.20
<U>Construction</U>. The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise
the Transaction Documents and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against
the drafting party shall not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each
and every reference to share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse
and forward share splits, share dividends, share combinations and other similar events with respect to the shares of Common Stock and
Warrants that occur after the date of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.21
<U>Sales During Pre-Settlement Period</U>. Notwithstanding anything herein to the contrary, if at any time on or after the time of execution
of this Agreement by the Company and an applicable Purchaser, through, and including the time immediately prior to a Closing (the &ldquo;<U>Pre-Settlement
Period</U>&rdquo;), such Purchaser sells to any Person all, or any portion, of any Shares to be issued hereunder to such Purchaser at
the Closing (collectively, the &ldquo;<U>Pre-Settlement Shares</U>&rdquo;), such Purchaser shall, automatically hereunder (without any
additional required actions by such Purchaser or the Company), be deemed to be unconditionally bound to purchase, and the Company shall
be deemed unconditionally bound to sell, such Pre-Settlement Shares to such Purchaser at the Closing; provided, that the Company shall
not be required to deliver any Pre-Settlement Shares to such Purchaser prior to the Company&rsquo;s receipt of the purchase price of
such Pre-Settlement Shares hereunder; and provided further that the Company hereby acknowledges and agrees that the forgoing shall not
constitute a representation or covenant by such Purchaser as to whether or not during the Pre-Settlement Period such Purchaser shall
sell any Shares to any Person and that any such decision to sell any Shares by such Purchaser shall be made, in the sole discretion of
such Purchaser, at the time such Purchaser elects to effect any such sale, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.22
<B><U>WAIVER OF JURY TRIAL</U>. <U>IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY,
THE PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY,
IRREVOCABLY AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Pages Follow)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ALGORHYTHM
    HOLDINGS, INC.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Address
    for Notice:</U></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6301
    NW 5<SUP>th</SUP> Way, Suite 2900</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 44%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-left: 10pt; padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fort
    Lauderdale, FL 33309</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gary
    Atkinson</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-Mail:
    gatkinson@algoholdings.com</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fax:(954)
    596-2000</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
a copy to (which shall not constitute notice):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gregory
Sichenzia</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1185
Avenue of the Americas, 31<SUP>st</SUP> Floor</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, New York, 10036</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-Mail:
<U>gsichenzia@srfc.law</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fax:
(212) 930-9725</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SIGNATURE
PAGE FOR PURCHASER FOLLOWS]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[SIGNATURE
PAGE TO SECURITIES PURCHASE AGREEMENT]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[PURCHASER
SIGNATURE PAGES TO <FONT STYLE="text-transform: uppercase">ALGORHYTHM HOLDINGS, inc.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECURITIES
PURCHASE AGREEMENT]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories
as of the date first indicated above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Purchaser: ________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Purchaser</I>: _________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory: _______________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: ________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
Address of Authorized Signatory: _________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Facsimile
Number of Authorized Signatory: __________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address
for Notice to Purchaser (and delivery of Warrants):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address
for Delivery of Applicable Securities to Purchaser (if not same as address for notice):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subscription
Amount: $_________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares:
(if applicable) _________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-Funded
Warrants: (if applicable)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Series
A Warrants: __________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Series
B Warrants: __________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EIN
Number: _______________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[SIGNATURE
PAGE TO SECURITIES PURCHASE AGREEMENT]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 32; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.29
<SEQUENCE>7
<FILENAME>ex10-29.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><B>Exhibit 10.29</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PLACEMENT
AGENCY AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;],
2024</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Univest
Securities, LLC</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">75
Rockefeller Plaza, Suite 18C</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, NY, 10019</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ladies
and Gentlemen:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the terms and conditions of this agreement (this &ldquo;<B>Agreement</B>&rdquo;) and the Transaction Documents (as defined below),
Algorhythm Holdings, Inc. a Delaware corporation (the &ldquo;<B>Company</B>&rdquo;), hereby agrees to offer and sell up to an aggregate
of $10,000,000 of securities of the Company directly to various investors (each, an &ldquo;<B>Investor</B>&rdquo; and collectively, the
&ldquo;<B>Investors</B>&rdquo;) through Univest Securities, LLC, as placement agent (the &ldquo;<B>Placement Agent</B>&rdquo;), in each
case consisting of (i) shares of the Company&rsquo;s common stock, par value $0.01 per share (the <B>&ldquo;Common Stock</B>&rdquo;)
and/or warrants to purchase shares of Common Stock in lieu thereof (the &ldquo;<B>Pre-Funded Warrants</B>&rdquo;) as the applicable Investor
may elect, (ii) Series A warrants to purchase shares of Common Stock (each a &ldquo;<B>Series A Warrant</B>&rdquo; and collectively,
the &ldquo;<B>Series A Warrants</B>&rdquo;), and (iii) Series B warrants to purchase shares of Common Stock (each a &ldquo;<B>Series
B Warrant</B>&rdquo; and collectively, the &ldquo;<B>Series B Warrants</B>,&rdquo; and together with the Pre-Funded Warrants and Series
A Warrants, collectively, the &ldquo;<B>Warrants</B>&rdquo;). The shares of Common Stock underlying the Series A Warrants and the Series
B Warrants are referred to as the &ldquo;<B>Warrant Shares</B>.&rdquo; The Common Stock offered and sold in this Offering is defined
as the &ldquo;<B>Shares</B>.&rdquo; The Shares, the Pre-Funded Warrants, the Series A Warrants, the Series B Warrants and the Warrant
Shares are collectively referred to as the &ldquo;<B>Securities</B>.&rdquo; The documents executed and delivered by the Company and the
Investors in connection with the Offering (as defined below), including, without limitation, a securities purchase agreement to be entered
into between the Company and each Investor (the &ldquo;<B>Purchase Agreement</B>&rdquo;), shall be collectively referred to herein as
the &ldquo;<B>Transaction Documents</B>.&rdquo; The purchase price to the Investors for each Share and accompanying Series A Warrant
and Series B Warrant is $[&#9679;] or for each Pre-Funded Warrant and accompanying Series A Warrant and Series B Warrant is $[&#9679;],
the exercise price for each Warrant Share is $[&#9679;], and the exercise price for each Share issuable upon exercise of each Pre-Funded
Warrant is $0.01.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
anything herein to the contrary, in the event that the Placement Agent determines that any of the terms provided for hereunder do not
comply with a Financial Industry Regulatory Authority (&ldquo;<B>FINRA</B>&rdquo;) rule, including but not limited to FINRA Rule 5110,
then the Company shall agree to amend this Agreement in writing upon the request of the Placement Agent to comply with any such rules;
provided that any such amendments shall not provide for terms that are less favorable to the Company than the terms of this Agreement
or terms are adverse to the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company hereby confirms its agreement with the Placement Agent as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
1. Agreement to Act as Placement Agent</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
On the basis of the representations, warranties and agreements of the Company herein contained, and subject to all the terms and conditions
of this Agreement, the Placement Agent shall be the exclusive placement agent in connection with the offering and sale by the Company
of the Securities pursuant to the Company&rsquo;s registration statement on Form S-1 (File No. 333-283178) (the &ldquo;<B>Registration
Statement</B>&rdquo;) with the terms of such offering (the &ldquo;<B>Offering</B>&rdquo;) to be subject to market conditions and negotiations
between the Company, the Placement Agent and the prospective Investors. The Placement Agent will act on a best efforts basis and the
Company agrees and acknowledges that there is no guarantee of the successful placement of the Securities, or any portion thereof, in
the prospective Offering. Under no circumstances will the Placement Agent or any of its Affiliates (as defined below) be obligated to
underwrite or purchase any of the Securities for its own account or otherwise provide any financing. The Placement Agent shall act solely
as the Company&rsquo;s agent and not as principal. The Placement Agent shall have no authority to bind the Company with respect to any
prospective offer to purchase Securities and the Company shall have the sole right to accept offers to purchase Securities and may reject
any such offer, in whole or in part. Subject to the terms and conditions hereof, payment of the purchase price for, and delivery of,
the Securities shall be made at one closing (the &ldquo;<B>Closing</B>&rdquo; and the date on which the Closing occurs, the &ldquo;<B>Closing
Date</B>&rdquo;). As compensation for services rendered, on the Closing Date, the Company shall pay to the Placement Agent the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
a cash fee equal to seven percent (7%) of the aggregate gross proceeds received by the Company from the sale of the Securities (the &ldquo;<B>Cash
Fee</B>&rdquo;);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
a non-accountable expense allowance equal to one percent (1%) of the gross proceeds received by the Company from the sale of the Securities
at the Closing; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
reimbursement of the Placement Agent&rsquo;s reasonable travel and other out-of-pocket expenses, and any incurred out-of-pocket costs
of the escrow or clearing agent in an amount of up to $12,900.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The term of the Placement Agent&rsquo;s exclusive engagement shall begin on the date hereof and continue until the earlier of (i) the
Closing Date (the &ldquo;<B>Exclusive Term</B>&rdquo;), and (ii) the date the Placement Agent or the Company terminates the engagement
according to the terms of the next sentence (such date, the &ldquo;<B>Termination Date</B>&rdquo; and the period of time during which
this Agreement remains in effect is referred to herein as the &ldquo;<B>Term</B>&rdquo;). The engagement may be terminated at any time
by either party hereto upon seven (7) days written notice to the other party, effective upon receipt of written notice to that effect
by the other party. Unless otherwise provided under this Agreement, the provisions concerning the Company&rsquo;s obligation to pay any
fees actually earned pursuant to <U>Section 1(a)</U> hereof and to pay or reimburse the Placement Agent for any expenses incurred in
accordance with <U>Section 6</U> hereof, the Company&rsquo;s obligations contained in the indemnification provisions, and the provisions
concerning indemnification and contribution contained herein will survive any expiration or termination of this Agreement for any reason.
All fees and expense payments or reimbursements due to the Placement Agent shall be paid by the Company to the Placement Agent on or
before the Termination Date (in the event such fees and expenses are earned or owed as of the Termination Date). Furthermore, the Company
agrees that during the Placement Agent&rsquo;s engagement hereunder, all inquiries from prospective U.S. Investors with respect to the
Offering will be referred to the Placement Agent. Additionally, except as set forth hereunder or otherwise disclosed to the Placement
Agent in writing, the Company represents, warrants and covenants that no brokerage or finder&rsquo;s fees or commissions are or will
be payable by the Company or any subsidiary of the Company to any broker, financial advisor or consultant, finder, placement agent, investment
banker, bank or other third-party with respect to the Offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
services provided by the Placement Agent hereunder are solely for the benefit of the Company and are not intended to confer any rights
upon any persons or entities not a party hereto (including, without limitation, security holders, employees or creditors of the Company)
as against the Placement Agent or its directors, officers, agents and employees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
2. Representations, Warranties and Covenants of the Company</B>. The Company hereby represents and warrants to the Placement Agent that
the following is true and correct as of the date hereof, and will be true and correct as of the Closing Date, and covenants and agrees
as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Securities Law Filings</U>. The Company has filed with the U.S. Securities and Exchange Commission (the &ldquo;<B>SEC</B>&rdquo;)
the Registration Statement under the Securities Act of 1933, as amended (the &ldquo;<B>Securities Act</B>&rdquo;), which was originally
filed on November 12, 2024 and declared effective on [&#9679;], 2024 for the registration of the Securities under the Securities Act.
Following the determination of pricing among the Company and the prospective Investors introduced to the Company by the Placement Agent,
the Company will file with the SEC pursuant to Rules 424(b) and 430A under the Securities Act, and the rules and regulations (the &ldquo;<B>Rules
and Regulations</B>&rdquo;) of the SEC promulgated thereunder, a final prospectus relating to the placement of the Securities, their
respective pricings and the plan of distribution thereof and will advise the Placement Agent of all further information (financial and
other) with respect to the Company required to be set forth therein. Such registration statement, at any given time, including the exhibits
thereto filed at such time, as amended at such time, is hereinafter called the &ldquo;<B>Registration Statement</B>&rdquo;; such prospectus
in the form in which it appears in the Registration Statement at the time of effectiveness is hereinafter called the &ldquo;<B>Preliminary
Prospectus</B>&rdquo;; and the final prospectus, in the form in which it will be filed with the SEC pursuant to Rules 424(b) and/or 430A
(including the Preliminary Prospectus as it may be amended or supplemented) is hereinafter called the &ldquo;<B>Prospectus</B>.&rdquo;
If the Company files any registration statement pursuant to Rule 462(b) of the Securities Act Rules and Regulations, then after such
filing, the term &ldquo;Registration Statement&rdquo; shall include such registration statement filed pursuant to Rule 462(b). Any reference
in this Agreement to the Registration Statement, the Registration Statement, the Preliminary Prospectus or the Prospectus shall be deemed
to refer to and include the documents incorporated by reference therein (the &ldquo;<B>Incorporated Documents</B>&rdquo;), if any, which
were or are filed under the Securities Exchange Act of 1934, as amended (the &ldquo;<B>Exchange Act</B>&rdquo;), at any given time, as
the case may be; and any reference in this Agreement to the terms &ldquo;amend,&rdquo; &ldquo;amendment,&rdquo; or &ldquo;supplement&rdquo;
with respect to the Registration Statement, the Registration Statement, the Preliminary Prospectus or the Prospectus shall be deemed
to refer to and include the filing of any document under the Exchange Act after the date of this Agreement, or the issue date of the
Preliminary Prospectus or the Prospectus, as the case may be, deemed to be incorporated therein by reference. All references in this
Agreement to financial statements and schedules and other information which is &ldquo;contained,&rdquo; &ldquo;included,&rdquo; &ldquo;described,&rdquo;
&ldquo;referenced,&rdquo; &ldquo;set forth,&rdquo; or &ldquo;stated&rdquo; in the Registration Statement, the Preliminary Prospectus
or the Prospectus (and all other references of like import) shall be deemed to mean and include all such financial statements and schedules
and other information which is or is deemed to be incorporated by reference in the Registration Statement, the Preliminary Prospectus
or the Prospectus, as the case may be. As used in this paragraph and elsewhere in this Agreement, &ldquo;<B>Time of Sale Disclosure Package</B>&rdquo;
means the Preliminary Prospectus, any securities purchase agreement between the Company and the Investors, the final terms of the Offering
provided to the Investors (orally or in writing) and any issuer free writing prospectus as defined in Rule 433 of the Securities Act
(each, an &ldquo;<B>Issuer Free Writing Prospectus</B>&rdquo;), if any, that the parties hereto shall hereafter expressly agree in writing
to treat as part of the Time of Sale Disclosure Package. The term &ldquo;<B>any Prospectus</B>&rdquo; shall mean, as the context requires,
the Preliminary Prospectus, the Prospectus, and any supplement to either thereof. The Company has not received any notice that the SEC
has issued or intends to issue a stop order suspending the effectiveness of the Registration Statement or the use of the Preliminary
Prospectus or any prospectus supplement or intends to commence a Proceeding for any such purpose.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Assurances</U>. The Registration Statement, as amended, (and any further documents to be filed with the SEC) contains all exhibits
and schedules as required by the Securities Act. Each of the Registration Statement and any post-effective amendment thereto, at the
time it became effective, complied in all material respects with the Securities Act and the applicable Rules and Regulations and did
not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make
the statements therein not misleading. The Preliminary Prospectus and the Prospectus, each as of its respective date, complies or will
comply in all material respects with the Securities Act and the applicable Rules and Regulations. Each of the Preliminary Prospectus
and the Prospectus, as amended or supplemented, did not and will not contain as of the date thereof any untrue statement of a material
fact or omit to state a material fact necessary in order to make the statements therein, in light of the circumstances under which they
were made, not misleading. The Incorporated Documents, when they were filed with the SEC, conformed in all material respects to the requirements
of the Exchange Act and the applicable Rules and Regulations promulgated thereunder, and none of such documents, when they were filed
with the SEC, contained any untrue statement of a material fact or omitted to state a material fact necessary to make the statements
therein (with respect to Incorporated Documents incorporated by reference in the Preliminary Prospectus or the Prospectus), in light
of the circumstances under which they were made not misleading. No post-effective amendment to the Registration Statement reflecting
any facts or events arising after the date thereof which represent, individually or in the aggregate, a fundamental change in the information
set forth therein is required to be filed with the SEC. Except for this Agreement and the Transaction Documents, there are no documents
required to be filed with the SEC in connection with the transaction contemplated hereby that (x) have not been filed as required pursuant
to the Securities Act or (y) will not be filed within the requisite time period. Except for this Agreement and the Transaction Documents,
there are no contracts or other documents required to be described in the Preliminary Prospectus or the Prospectus, or to be filed as
exhibits or schedules to the Registration Statement, which have not been described or filed as required.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Offering Materials</U>. Neither the Company nor any of its directors and officers has distributed and none of them will distribute,
prior to the Closing Date, any offering material in connection with the offering and sale of the Securities other than the Time of Sale
Disclosure Package.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Subsidiaries</U>. All of the direct and indirect subsidiaries of the Company (the &ldquo;<B>Subsidiaries</B>&rdquo;) are set forth
in the Registration Statement. The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary
free and clear of any liens, charges, security interests, encumbrances, rights of first refusal, preemptive rights or other restrictions
(collectively, &ldquo;<B>Liens</B>&rdquo;), and all of the issued and outstanding shares of capital stock of each Subsidiary are validly
issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Organization and Qualification</U>. The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized,
validly existing and in good standing under the laws of the jurisdiction of its incorporation or organization, with the requisite power
and authority to own and use its properties and assets and to carry on its business as currently conducted. Neither the Company nor any
Subsidiary is in violation nor in default of any of the provisions of its respective certificate or articles of incorporation, bylaws
or other organizational or charter documents. Each of the Company and the Subsidiaries is duly qualified to conduct business and is in
good standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted or property
owned by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as the case may be,
could not have or reasonably be expected to result in: (i) a material adverse effect on the legality, validity or enforceability of this
Agreement, the Transaction Documents or any other agreement or instrument relating to the Offering, (ii) a material adverse effect on
the results of operations, assets, business or condition (financial or otherwise) of the Company and the Subsidiaries, or (iii) a material
adverse effect on the Company&rsquo;s ability to perform in any material respect on a timely basis its obligations under this Agreement
or the transactions contemplated under the Preliminary Prospectus (any of (i), (ii) or (iii), a &ldquo;<B>Material Adverse Effect</B>&rdquo;);
<I>provided</I> that a change in the market price or trading volume of the Common Stock alone shall not be deemed, in and of itself,
to constitute a Material Adverse Effect. No action, claim, suit, investigation or proceeding (including, without limitation, an informal
inquiry), whether commenced or threatened (&ldquo;<B>Proceeding</B>&rdquo;) has been instituted in any such jurisdiction revoking, limiting
or curtailing or seeking to revoke, limit or curtail such power and authority or qualification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Authorization; Enforcement</U>. The Company has the requisite corporate power and authority to enter into and to consummate the transactions
contemplated by this Agreement, the Transaction Documents and the Time of Sale Disclosure Package and otherwise to carry out its obligations
hereunder and thereunder. The execution and delivery of each of this Agreement, the Transaction Documents and the Time of Sale Disclosure
Package by the Company and the consummation by it of the transactions contemplated hereby and thereby and under the Preliminary Prospectus
have been duly authorized by all necessary action on the part of the Company and no further action is required by the Company, the Company&rsquo;s
Board of Directors or the Company&rsquo;s shareholders in connection therewith other than in connection with the Required Approvals (as
defined below). This Agreement and each Transaction Document has been duly executed by the Company and, when delivered in accordance
with the terms hereof, will constitute valid and binding obligations of the Company enforceable against the Company in accordance with
their terms, except (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium
and other laws of general application affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating to
the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution
provisions may be limited by applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>No Conflicts</U>. The execution, delivery and performance by the Company of this Agreement and each Transaction Document and the transactions
contemplated hereby, thereby and pursuant to the Time of Sale Disclosure Package, the issuance and sale of the Securities and the consummation
by it of the transactions contemplated hereby and thereby to which it is a party do not and will not (i) conflict with or violate any
provision of the Company&rsquo;s or any Subsidiary&rsquo;s certificate or articles of incorporation, bylaws or other organizational or
charter documents, or (ii) conflict with, or constitute a default (or an event that with notice or lapse of time or both would become
a default) under, result in the creation of any Lien upon any of the properties or assets of the Company or any Subsidiary, or give to
others any rights of termination, amendment, acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement,
credit facility, debt or other instrument (evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the
Company or any Subsidiary is a party or by which any property or asset of the Company or any Subsidiary is bound or affected, or (iii)
subject to the Required Approvals, conflict with or result in a violation of any law, rule, regulation, order, judgment, injunction,
decree or other restriction of any court or governmental authority to which the Company or a Subsidiary is subject (including federal
and state securities laws and regulations), or by which any property or asset of the Company or a Subsidiary is bound or affected; except
in the case of each of clauses (ii) and (iii), such as could not have or reasonably be expected to result in a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>Filings, Consents and Approvals</U>. The Company is not required to obtain any consent, waiver, authorization or order of, give any
notice to, or make any filing or registration with, any court or other federal, state, local or other governmental authority or other
Person in connection with the execution, delivery and performance by the Company of this Agreement and the transactions contemplated
by the Preliminary Prospectus, other than: (i) the filing with the SEC of the Prospectus and such other filings as are required to be
made under applicable state securities laws, (ii) application(s) to each applicable Trading Market for the listing of the Shares and
the Warrant Shares for trading thereon in the time and manner required thereby, and (iii) the filing and mailing of a proxy statement
on Schedule 14A in connection with the Shareholder Approval (the &ldquo;<B>Required Approvals</B>&rdquo;). &ldquo;<B>Shareholder Approval</B>&rdquo;
means such approval as may be required by the applicable Rules and Regulations of The Nasdaq Capital Market (or any successor entity)
from the shareholders of the Company with respect to the issuance of all of the Shares, the Warrants and the Warrant Shares upon exercise
of the Warrants. As used herein (i) &ldquo;<B>Persons</B>&rdquo; means an individual or corporation, partnership, trust, incorporated
or unincorporated association, joint venture, limited liability company, joint stock company, government (or an agency or subdivision
thereof) or other entity of any kind and (ii) &ldquo;<B>Affiliate</B>&rdquo; means any Person that, directly or indirectly through one
or more intermediaries, controls or is controlled by or is under common control with a Person as such terms are used in and construed
under Rule 405 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Issuance of the Securities; Registration</U>. The Shares are duly authorized and, when issued and paid for in accordance with the
Prospectus, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company. The Warrants
are duly authorized and, when issued and paid for, will constitute valid and legally binding obligations of the Company, enforceable
against the Company in accordance with their terms. The Warrant Shares, when issued in accordance with the terms of the Warrants, respectively,
will be validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company. The Company has reserved from
its duly authorized capital stock the maximum number of shares of Common Stock issuable pursuant to the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
<U>Capitalization</U>. The capitalization of the Company is as set forth in the Registration Statement. The Company has not issued any
capital stock or Common Stock Equivalents since its most recently filed SEC Report (as defined below), other than pursuant to the exercise
of employee stock options or vesting and settlement of restricted stock units under the Company&rsquo;s stock option plans, the issuance
of shares of Common Stock to employees pursuant to any employee stock purchase plans and pursuant to the conversion and/or exercise of
securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire at any time any Common Stock, including,
without limitation, any debt, preferred stock, rights, options, warrants or other instrument that is at any time convertible into or
exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock (&ldquo;Common Stock Equivalents&rdquo;)
outstanding as of the date of the most recently filed periodic report under the Exchange Act. No Person has any right of first refusal,
preemptive right, right of participation, or any similar right to participate in the transactions contemplated by this Agreement and
the transactions contemplated pursuant to the Preliminary Prospectus or the Prospectus. Except as a result of the purchase and sale of
the Securities and except as set forth in the SEC Reports, there are no outstanding options, warrants, scrip rights to subscribe to,
calls or commitments of any character whatsoever relating to, or securities, rights or obligations convertible into or exercisable or
exchangeable for, or giving any Person any right to subscribe for or acquire, any shares of Common Stock or the capital stock of any
Subsidiary, or contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is or may become bound to
issue additional shares of Common Stock or Common Stock Equivalents or capital stock of any Subsidiary,. The issuance and sale of the
Securities will not obligate the Company or any Subsidiary to issue shares of Common Stock or other securities to any Person (other than
the Investors and the Placement Agent) and will not result in a right of any holder of Company securities to adjust the exercise, conversion,
exchange or reset price under any of such securities. There are no outstanding securities or instruments of the Company or any Subsidiary
that contain any redemption or similar provisions, and there are no contracts, commitments, understandings or arrangements by which the
Company or any Subsidiary is or may become bound to redeem a security of the Company or such Subsidiary. The Company does not have any
stock appreciation rights or &ldquo;phantom stock&rdquo; plans or agreements or any similar plan or agreement. All of the outstanding
shares of capital stock of the Company are duly authorized, validly issued, fully paid and nonassessable, have been issued in compliance
with all federal and state securities laws where applicable, and none of such outstanding shares was issued in violation of any preemptive
rights or similar rights to subscribe for or purchase securities. Except for the Required Approvals, no further approval or authorization
of any shareholder, the Board of Directors or others is required for the issuance and sale of the Securities. There are no shareholders
agreements, voting agreements or other similar agreements with respect to the Company&rsquo;s capital stock to which the Company is a
party or, to the knowledge of the Company, between or among any of the Company&rsquo;s shareholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
<U>SEC Reports; Financial Statements</U>. The Company has filed all reports, schedules, forms, statements and other documents required
to be filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the
one (1) year preceding the date hereof (or such shorter period as the Company was required by law or regulation to file such material)
(the foregoing materials, including the exhibits thereto and documents incorporated by reference therein, together with the Preliminary
Prospectus, the Prospectus and any prospectus supplement, being collectively referred to herein as the &ldquo;<B>SEC Reports</B>&rdquo;)
on a timely basis or has received a valid extension of such time of filing and has filed any such SEC Reports prior to the expiration
of any such extension. As of their respective dates, the SEC Reports complied in all material respects with the requirements of the Securities
Act and the Exchange Act, as applicable, and none of the SEC Reports, when filed, contained any untrue statement of a material fact or
omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the
circumstances under which they were made, not misleading. The Company has never been an issuer subject to Rule 144(i) under the Securities
Act. The financial statements of the Company included in the SEC Reports comply in all material respects with applicable accounting requirements
and the rules and regulations of the SEC with respect thereto as in effect at the time of filing. Such financial statements have been
prepared in accordance with United States generally accepted accounting principles applied on a consistent basis during the periods involved
(&ldquo;<B>GAAP</B>&rdquo;), except as may be otherwise specified in such financial statements or the notes thereto and except that unaudited
financial statements may not contain all footnotes required by GAAP, and fairly present in all material respects the financial position
of the Company and its consolidated Subsidiaries as of and for the dates thereof and the results of operations and cash flows for the
periods then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments. The selected financial
data set forth under the caption &ldquo;Selected Financial Data&rdquo; in the SEC Reports fairly present, on the basis stated in such
SEC Reports, the information included therein. The agreements and documents described in the Registration Statement and the SEC Reports
conform in all material aspects to the descriptions thereof contained therein and there are no agreements or other documents required
by the Securities Act and the rules and regulations thereunder to be described in the Registration Statement, the Prospectus or the SEC
Reports or to be filed with the Commission as exhibits to the Registration Statement, that have not been so described or filed. Each
agreement or other instrument (however characterized or described) to which the Company is a party or by which it is or may be bound
or affected and (i) that is referred to in the Registration Statement or the SEC Reports, or (ii) is material to the Company&rsquo;s
business, has been duly authorized and validly executed by the Company, is in full force and effect in all material respects and is enforceable
against the Company and, to the Company&rsquo;s knowledge, the other parties thereto, in accordance with its terms, except (x) as such
enforceability may be limited by bankruptcy, insolvency, reorganization or similar laws affecting creditors&rsquo; rights generally,
(y) as enforceability of any indemnification or contribution provision may be limited under the federal and state securities laws, and
(z) that the remedy of specific performance and injunctive and other forms of equitable relief may be subject to the equitable defenses
and to the discretion of the court before which any proceeding therefore may be brought. None of such agreements or instruments has been
assigned by the Company, and neither the Company nor, to the best of the Company&rsquo;s knowledge, any other party is in default thereunder
and, to the best of the Company&rsquo;s knowledge, no event has occurred that, with the lapse of time or the giving of notice, or both,
would constitute a default thereunder. To the best of the Company&rsquo;s knowledge, performance by the Company of the material provisions
of such agreements or instruments will not result in a violation of any existing applicable law, rule, regulation, judgment, order or
decree of any governmental agency or court, domestic or foreign, having jurisdiction over the Company or any of its assets or businesses,
including, without limitation, those relating to environmental laws and regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
<U>Material Changes; Undisclosed Events, Liabilities or Developments</U>. Since the date of the latest audited financial statements included
within the Preliminary Prospectus or the Prospectus, except as disclosed in the Preliminary Prospectus or the Prospectus, as the case
may be, (i) there has been no event, occurrence or development that has had or that could reasonably be expected to result in a Material
Adverse Effect, (ii) except as disclosed in the SEC Reports, the Company has not incurred any liabilities (contingent or otherwise) other
than (A) trade payables and accrued expenses incurred in the ordinary course of business consistent with past practice, and (B) liabilities
not required to be reflected in the Company&rsquo;s financial statements pursuant to GAAP or disclosed in filings made with the SEC,
(iii) the Company has not altered its method of accounting, (iv) the Company has not declared or made any dividend or distribution of
cash or other property to its shareholders or purchased, redeemed or made any agreements to purchase or redeem any shares of its capital
stock, and (v) the Company has not issued any equity securities to any officer, director or Affiliate, except pursuant to existing Company
equity incentive plans. The Company does not have pending before the SEC any request for confidential treatment of information. Except
for the issuance of the Securities contemplated or disclosed in the Preliminary Prospectus or the Prospectus, no event, liability, fact,
circumstance, occurrence or development has occurred or exists or is reasonably expected to occur or exist with respect to the Company
or its Subsidiaries or their respective businesses, prospects, properties, operations, assets or financial condition that would be required
to be disclosed by the Company under applicable securities laws at the time this representation is made or deemed made that has not been
publicly disclosed at least one (1) Trading Day prior to the date that this representation is made. As used in this Agreement, &ldquo;<B>Trading
Day</B>&rdquo; means a day on which the Trading Market (as defined below) is open for trading. As used in this Agreement, &ldquo;<B>Trading
Market</B>&rdquo; means The Nasdaq Capital Market, the securities exchange on which the Common Stock is listed for trading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
<U>Litigation</U>. Except as disclosed in the SEC Reports, there is no Proceeding pending or, to the knowledge of the Company, threatened
against or affecting the Company, any Subsidiary or any of their respective properties before or by any court, arbitrator, governmental
or administrative agency or regulatory authority (federal, state, county, local or foreign) which (i) adversely affects or challenges
the legality, validity or enforceability of any of this Agreement, the Transaction Documents and the transactions contemplated pursuant
to the Time of Sale Disclosure Package or the Securities or (ii) could, if there were an unfavorable decision, have or reasonably be
expected to result in a Material Adverse Effect. Neither the Company nor any Subsidiary, nor any director or officer thereof, is or has
been the subject of any Proceeding involving a claim of violation of or liability under federal or state securities laws or a claim of
breach of fiduciary duty. There has not been, and to the knowledge of the Company, there is not pending or contemplated, any investigation
or informal inquiry by the SEC or its Staff involving the Company or any current or former director or officer of the Company. The SEC
has not issued any stop order or other order suspending the effectiveness of any registration statement filed by the Company or any Subsidiary
under the Exchange Act or the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
<U>Labor Relations</U>. (1) No material labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of
the employees of the Company, which could reasonably be expected to result in a Material Adverse Effect. None of the Company&rsquo;s
or its Subsidiaries&rsquo; employees is a member of a union that relates to such employee&rsquo;s relationship with the Company or such
Subsidiary, and neither the Company nor any of its Subsidiaries is a party to a collective bargaining agreement, and the Company and
its Subsidiaries believe that their relationships with their employees are good. (2) No executive officer of the Company or any Subsidiary,
to the knowledge of the Company, is, or is now expected to be, in violation of any material term of any employment contract, confidentiality,
disclosure or proprietary information agreement or non-competition agreement, or any other contract or agreement or any restrictive covenant
in favor of any third party, and the continued employment of each such executive officer does not subject the Company or any of its Subsidiaries
to any liability with respect to any of the foregoing matters. (3) To the Company&rsquo;s knowledge, (a) no allegation of sexual harassment,
sexual misconduct or discrimination, whether such discrimination arises from race, ethnic background, sex, gender status, age or otherwise
(&ldquo;<B>Misconduct</B>&rdquo;) have been made involving any current or former director, officer, employee or independent contractor
of the Company or any of its Subsidiaries, (b) neither the Company nor any of its Subsidiaries have entered into any settlement agreements
related to allegations of Misconduct by any current or former director, officer, employee, or independent contractor of the Company or
any of its Subsidiaries. (4) The Company and its Subsidiaries are in compliance with all applicable U.S. federal, state, local, and foreign
laws and regulations relating to employment and employment practices, terms and conditions of employment, and wages and hours, except
where the failure to be in compliance could not, individually or in the aggregate, reasonably be expected to have a Material Adverse
Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)
<U>Compliance</U>. In addition to Section 2(n), neither the Company nor any Subsidiary: (i) is in default under or in violation of (and
no event has occurred that has not been waived that, with notice or lapse of time or both, would result in a default by the Company or
any Subsidiary under), nor has the Company or any Subsidiary received notice of a claim that it is in default under or that it is in
violation of, any indenture, loan, or credit agreement or any other agreement or instrument to which it is a party or by which it or
any of its properties is bound (whether or not such default or violation has been waived), (ii) is in violation of any judgment, decree,
or order of any court, arbitrator, or governmental authority, or (iii) is or has been in violation of any law, statute, rule, ordinance
or regulation of any governmental authority, including without limitation all foreign, federal, state and local laws relating to the
U.S. Food and Drug Administration (&ldquo;<B>FDA</B>&rdquo;) and comparable foreign regulators, the U.S. Federal Trade Commission (&ldquo;<B>FTC</B>&rdquo;),
state unfair trade practice laws and rules and foreign equivalents, taxes, environmental protection, occupational health and safety and
product quality matters, except in each case as could not have or reasonably be expected to result in a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)
<U>Regulatory Permits</U>. The Company and the Subsidiaries possess all certificates, authorizations and permits issued by the appropriate
federal, state, local or foreign regulatory authorities necessary to conduct their respective businesses as described in the Time of
Sale Disclosure Package, except where the failure to possess such permits would not or could not reasonably be expected to result in
a Material Adverse Effect (&ldquo;<B>Material Permits</B>&rdquo;), and neither the Company nor any Subsidiary has received any notice
of Proceedings relating to the revocation or modification of any Material Permit. The disclosures in the Registration Statement concerning
the effects of federal, state, local and all foreign regulation on the Company&rsquo;s business as currently contemplated are correct
in all material respects. The Company is and has been in material compliance with any term of any such Material Permits, except for any
violations which would not reasonably be expected to have a Material Adverse Effect. The Company has not received notice of any Proceeding
from any governmental authority or third party alleging that any Product, operation or activity is in violation of any applicable laws
or regulations or Material Permits or has any knowledge that any such entity or third party is considering any such Proceeding, nor,
to the Company&rsquo;s knowledge, has there been any material noncompliance with or violation of any applicable laws or regulations by
the Company that could reasonably be expected to require the issuance of any such communication or result in an investigation, corrective
action, or enforcement action by any governmental authority.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)
<U>Title to Assets</U>. The Company and the Subsidiaries have good and marketable title in fee simple to all real property owned by them
and good and marketable title in all personal property owned by them that is material to the business of the Company and the Subsidiaries,
in each case free and clear of all Liens, except for Liens as do not materially affect the value of such property and do not materially
interfere with the use made and proposed to be made of such property by the Company and the Subsidiaries and Liens for the payment of
federal, state or other taxes, for which appropriate reserves have been made therefor in accordance with GAAP and, the payment of which
is neither delinquent nor subject to penalties. Any real property and facilities held under lease by the Company and the Subsidiaries
are held by them under valid, subsisting and enforceable leases with which the Company and the Subsidiaries are in compliance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)
<U>Patents and Trademarks</U>. The Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks,
trademark applications, service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights
and similar rights necessary or material for use in connection with their respective businesses as described in the Preliminary Prospectus
and Prospectus and which the failure to so have could have a Material Adverse Effect (collectively, the &ldquo;<B>Intellectual Property
Rights</B>&rdquo;). None of, and neither the Company nor any Subsidiary has received a notice (written or otherwise) that any of, the
Intellectual Property Rights has expired, terminated or been abandoned, or is expected to expire or terminate or be abandoned, within
two (2) years from the date of this Agreement. Neither the Company nor any Subsidiary has received, since the date of the latest audited
financial statements included within the Preliminary Prospectus and the Prospectus, a notice (written or otherwise) of a claim or otherwise
has any knowledge that the Intellectual Property Rights violate or infringe upon the rights of any Person, except as would not have a
Material Adverse Effect. To the knowledge of the Company, all such Intellectual Property Rights are enforceable and there is no existing
infringement by another Person of any of the Intellectual Property Rights. The Company and its Subsidiaries have taken reasonable security
measures to protect the secrecy, confidentiality and value of all of their intellectual properties, except where failure to do so could
not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.</FONT></P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s)
<U>Insurance</U>. The Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses
and risks and in such amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged, including,
but not limited to, directors and officers insurance coverage. Neither the Company nor any Subsidiary has any reason to believe that
it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar
insurers as may be necessary to continue its business without a significant increase in cost.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t)
<U>Transactions With Affiliates and Employees</U>. Except as set forth in the Time of Sale Disclosure Package, none of the executive
officers or directors of the Company or any Subsidiary and, to the knowledge of the Company, none of the employees of the Company or
any Subsidiary is presently a party to any transaction with the Company or any Subsidiary (other than for services as employees, executive
officers and directors), including any contract, agreement or other arrangement providing for the furnishing of services to or by, providing
for rental of real or personal property to or from, providing for the borrowing of money from or lending of money to or otherwise requiring
payments to or from any executive officer, director or such employee or, to the knowledge of the Company, any entity in which any executive
officer, director, or any such employee has a substantial interest or is an officer, director, trustee, shareholder, member or partner,
in each case in excess of one percent (1%) of the Company&rsquo;s average total assets as of December 31, 2023 and 2022 other than for:
(i) payment of salary or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company and
(iii) other employee benefits, including equity award or option agreements under any equity incentive plan or similar of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u)
<U>Sarbanes-Oxley; Internal Accounting Controls</U>. The Company and the Subsidiaries are in compliance with any and all applicable requirements
of the Sarbanes-Oxley Act of 2002 that are effective as of the date hereof, and any and all applicable rules and regulations promulgated
by the SEC thereunder that are effective as of the date hereof and as of the Closing Date. Except as disclosed in the Preliminary Prospectus
or the Prospectus, the Company and the Subsidiaries maintain a system of internal accounting controls sufficient to provide reasonable
assurance that: (i) transactions are executed in accordance with management&rsquo;s general or specific authorizations, (ii) transactions
are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability,
(iii) access to assets is permitted only in accordance with management&rsquo;s general or specific authorization, and (iv) the recorded
accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to
any differences. The Company and the Subsidiaries have established disclosure controls and procedures (as defined in Exchange Act Rules
13a-15(e) and 15d-15(e)) for the Company and the Subsidiaries and designed such disclosure controls and procedures to ensure that information
required to be disclosed by the Company in the reports it files or submits under the Exchange Act is recorded, processed, summarized
and reported, within the time periods specified in the SEC&rsquo;s rules and forms. The Company&rsquo;s certifying officers have evaluated
the effectiveness of the Company&rsquo;s disclosure controls and procedures of the Company and the Subsidiaries as of the end of the
period covered by the Company&rsquo;s most recently filed periodic report under the Exchange Act (such date, the &ldquo;<B>Evaluation
Date</B>&rdquo;). The Company presented in its most recently filed periodic report under the Exchange Act the conclusions of the certifying
officers about the effectiveness of the disclosure controls and procedures based on their evaluations as of the Evaluation Date. Since
the Evaluation Date, there have been no changes in the internal control over financial reporting (as such term is defined in the Exchange
Act) of the Company and its Subsidiaries that have materially affected, or is reasonably likely to materially affect, the internal control
over financial reporting of the Company and its Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
<U>Certain Fees</U>. Except as set forth in the Preliminary Prospectus or the Prospectus, no brokerage or finder&rsquo;s fees or commissions
are or will be payable by the Company to any broker, dealer, financial advisor or consultant, finder, placement agent, investment banker,
bank or other Person with respect to the transactions contemplated by this Agreement and the transactions contemplated pursuant to the
Preliminary Prospectus and the Prospectus. The Investors shall have no obligation with respect to any fees or with respect to any claims
made by or on behalf of other Persons for fees of a type contemplated in this Section 2(v) that may be due in connection with the transactions
contemplated by this Agreement and the transactions contemplated pursuant to the Preliminary Prospectus and the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(w)
<U>Investment Company</U>. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Securities,
will not be or be an Affiliate of, an &ldquo;investment company&rdquo; within the meaning of the Investment Company Act of 1940, as amended.
The Company shall conduct its business in a manner so that it will not become an &ldquo;investment company&rdquo; subject to registration
under the Investment Company Act of 1940, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)
<U>Registration Rights</U>. Except as disclosed in the Preliminary Prospectus or the Prospectus, no Person has any right to cause the
Company or any Subsidiary to effect the registration under the Securities Act of any securities of the Company or any Subsidiary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(y)
<U>Listing and Maintenance Requirements</U>. The Common Stock is registered pursuant to Section 12(b) of the Exchange Act, and the Company
has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration of the Common
Stock under the Exchange Act nor has the Company received any notification that the SEC is contemplating terminating such registration.
Except as disclosed in the Preliminary Prospectus or the Prospectus, the Company has not, in the twelve (12) months preceding the date
hereof, received notice from any Trading Market on which the Common Stock is or has been listed or quoted to the effect that the Company
is not in compliance with the listing or maintenance requirements of such Trading Market. Except as otherwise disclosed in the Prospectus,
the Company is, and has no reason to believe that it will not in the foreseeable future continue to be, in compliance with all such listing
and maintenance requirements. The Common Stock is currently eligible for electronic transfer through the Depository Trust Company or
another established clearing corporation and the Company is current in payment of the fees to the Depository Trust Company (or such other
established clearing corporation) in connection with such electronic transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(z)
<U>Application of Takeover Protections</U>. The Company and its Board of Directors have taken all necessary action, if any, in order
to render inapplicable any control share acquisition, business combination, poison pill (including any distribution under a rights agreement)
or other similar anti-takeover provision under the Company&rsquo;s certificate of incorporation (or similar charter documents) or the
laws of its state of incorporation that is or could become applicable to the Investors as a result of the Investors and the Company fulfilling
their obligations or exercising their rights under this Agreement and the transactions contemplated pursuant to the Preliminary Prospectus,
including without limitation as a result of the Company&rsquo;s issuance of the Securities and the Investors&rsquo; ownership of the
Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(aa)
<U>Disclosure</U>. Except with respect to the material terms and conditions of the transactions contemplated by this Agreement and the
transactions contemplated pursuant to the Preliminary Prospectus and the Prospectus, the Company confirms that neither it nor any other
Person acting on its behalf has provided any of the Investors or their agents or counsel with any information that it believes constitutes
or might constitute material, non-public information which is not otherwise disclosed in the Time of Sale Disclosure Package. The Company
understands and confirms that the Investors will rely on the foregoing representation in effecting transactions in securities of the
Company. All of the disclosure furnished by or on behalf of the Company to the Investors regarding the Company and, its Subsidiaries,
their respective businesses and the transactions contemplated hereby, including the Time of Sale Disclosure Package, does not contain
any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements made therein, in
light of the circumstances under which they were made, not misleading. The press releases disseminated by the Company during the twelve
(12) months preceding the date of this Agreement taken as a whole did not contain, at their respective times of issuance, any untrue
statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements
therein, in light of the circumstances under which they were made and when made, not misleading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(bb)
<U>No Integrated Offering</U>. Neither the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly
or indirectly, made any offers or sales of any security or solicited any offers to buy any security, under circumstances that would cause
this offering of the Securities to be integrated with prior offerings by the Company for purposes of any applicable shareholder approval
provisions of any Trading Market on which any of the securities of the Company are listed or designated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(cc)
<U>Solvency</U>. Except as disclosed in the Preliminary Prospectus or the Prospectus, based on the consolidated financial condition of
the Company as of the Closing Date, after giving effect to the receipt by the Company of the proceeds from the sale of the Securities
hereunder, (i) the fair saleable value of the Company&rsquo;s assets exceeds the amount that will be required to be paid on or in respect
of the Company&rsquo;s existing debts and other liabilities (including known contingent liabilities) as they mature, (ii) the Company&rsquo;s
assets do not constitute unreasonably small capital to carry on its business as now conducted and as proposed to be conducted including
its capital needs taking into account the particular capital requirements of the business conducted by the Company, consolidated and
projected capital requirements and capital availability thereof, and (iii) the current cash flow of the Company, together with the proceeds
the Company would receive, were it to liquidate all of its assets, after taking into account all anticipated uses of the cash, would
be sufficient to pay all amounts on or in respect of its liabilities when such amounts are required to be paid. The Company does not
intend to incur debts beyond its ability to pay such debts as they mature (taking into account the timing and amounts of cash to be payable
on or in respect of its debt). Except as disclosed in the Preliminary Prospectus or the Prospectus, the Company has no knowledge of any
facts or circumstances which lead it to believe that it will file for reorganization or liquidation under the bankruptcy or reorganization
laws of any jurisdiction within one year from each Closing Date. The Time of Sale Disclosure Package discloses as of the date hereof
all outstanding secured and unsecured Indebtedness of the Company or any Subsidiary, or for which the Company or any Subsidiary has commitments.
For the purposes of this Agreement, &ldquo;<U>Indebtedness</U>&rdquo; means (x) any liabilities for borrowed money or amounts owed in
excess of Fifty Thousand Dollars ($50,000) (other than trade accounts payable incurred in the ordinary course of business), (y) all guaranties,
endorsements, and other contingent obligations in respect of indebtedness of others, whether or not the same are or should be reflected
in the Company&rsquo;s consolidated balance sheet (or the notes thereto), except guaranties by endorsement of negotiable instruments
for deposit or collection or similar transactions in the ordinary course of business; and (z) the present value of any lease payments
in excess of One Hundred Thousand Dollars ($100,000) due under leases required to be capitalized in accordance with GAAP. Neither the
Company nor any Subsidiary is in default with respect to any Indebtedness.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(dd)
<U>Tax Status</U>. Except for matters that would not, individually or in the aggregate, have or reasonably be expected to result in a
Material Adverse Effect, the Company and its Subsidiaries (i) has made or filed all United States federal, state and local income and
franchise and all foreign income and franchise tax returns, reports and declarations required by any jurisdiction to which it is subject,
(ii) has paid all taxes and other governmental assessments and charges that are material in amount, shown or determined to be due on
such returns, reports and declarations and (iii) has set aside on its books provision reasonably adequate for the payment of all material
taxes for periods subsequent to the periods to which such returns, reports or declarations apply. There are no unpaid taxes in any material
amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company or of any Subsidiary know of no
basis for any such claim.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ee)
<U>Foreign Corrupt Practices</U>. Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary, any
agent or other person acting on behalf of the Company or any Subsidiary, has (i) directly or indirectly, used any funds for unlawful
contributions, gifts, entertainment or other unlawful expenses related to foreign or domestic political activity, (ii) made any unlawful
payment to foreign or domestic government officials or employees or to any foreign or domestic political parties or campaigns from corporate
funds, (iii) failed to disclose fully any contribution made by the Company or any Subsidiary (or made by any Person acting on its behalf
of which the Company is aware) which is in violation of law, or (iv) violated in any material respect any provision of the Foreign Corrupt
Practices Act of 1977 (the &ldquo;<B>FCPA</B>&rdquo;). The Company has taken reasonable steps to ensure that its accounting controls
and procedures are sufficient to cause the Company to comply in all material respects with the FCPA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ff)Reserved.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(gg)
<U>Stock Option Plans</U>. Each stock option granted by the Company under the Company&rsquo;s stock option plan was granted (i) in accordance
with the terms of the Company&rsquo;s stock option plan and (ii) with an exercise price at least equal to the fair market value of the
Common Stock on the date such stock option would be considered granted under GAAP and applicable law. No stock option granted under the
Company&rsquo;s stock option plan has been backdated. The Company has not knowingly granted, and there is no and has been no Company
policy or practice to knowingly grant, stock options prior to, or otherwise knowingly coordinate the grant of stock options with, the
release or other public announcement of material information regarding the Company or its Subsidiaries or their financial results or
prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(hh)
<U>Accountants</U>. The Company&rsquo;s independent registered public accounting firm is set forth in the Preliminary Prospectus and
the Prospectus. To the knowledge of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange
Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company&rsquo;s Annual Report for
the fiscal year ending December 31, 2024.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
<U>Regulation M Compliance</U>. The Company has not, and to its knowledge no one acting on its behalf (other than the Placement Agent,
as to which no representation is made) has, (i) taken, directly or indirectly, any action designed to cause or to result in the stabilization
or manipulation of the price of any security of the Company to facilitate the sale or resale of any of the Securities, (ii) sold, bid
for, purchased, or, paid any compensation for soliciting purchases of, any of the Securities, or (iii) paid or agreed to pay to any Person
any compensation for soliciting another to purchase any other securities of the Company, other than, in the case of clauses (ii) and
(iii), compensation paid to the Company&rsquo;s placement agent in connection with the placement of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(jj)
<U>Office of Foreign Assets Control</U>. Neither the Company nor any Subsidiary, to the Company&rsquo;s knowledge, any director, officer,
agent, employee or Affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of
Foreign Assets Control of the U.S. Treasury Department.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(kk)
<U>U.S. Real Property Holding Corporation</U>. The Company is not and has never been a U.S. real property holding corporation within
the meaning of Section 897 of the Internal Revenue Code of 1986, and the Company shall so certify upon any Investor&rsquo;s request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ll)
<U>Bank Holding Company Act</U>. Neither the Company nor any of its Subsidiaries or Affiliates is subject to the Bank Holding Company
Act of 1956, as amended (the &ldquo;<B>BHCA</B>&rdquo;) and to regulation by the Board of Governors of the Federal Reserve System (the
&ldquo;<B>Federal Reserve</B>&rdquo;). Neither the Company nor any of its Subsidiaries or Affiliates owns or controls, directly or indirectly,
five percent (5%) or more of the outstanding shares of any class of voting securities or twenty-five percent (25%) or more of the total
equity of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its
Subsidiaries or Affiliates exercises a controlling influence over the management or policies of a bank or any entity that is subject
to the BHCA and to regulation by the Federal Reserve.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(mm)
<U>Money Laundering</U>. The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance with
applicable financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended,
applicable United States federal and state and foreign money laundering statutes and applicable rules and regulations thereunder (collectively,
the &ldquo;<B>Money Laundering Laws</B>&rdquo;), and no Proceeding by or before any court or governmental agency, authority or body or
any arbitrator involving the Company with respect to the Money Laundering Laws is pending or, to the knowledge of the Company, threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(nn)
<U>Certificates</U>. Any certificate signed by an officer of the Company and delivered to the Placement Agent or to Lucosky Brookman
LLP, 101 Wood Avenue South, 5<SUP>th</SUP> Floor, Woodbridge, NJ 08830 (&ldquo;<B>Placement Agent&rsquo;s Counsel</B>&rdquo;) shall be
deemed to be a representation and warranty by the Company to the Placement Agent as to the matters set forth therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(oo)
<U>Reliance</U>. The Company acknowledges that the Placement Agent will rely upon the accuracy and truthfulness of the foregoing representations
and warranties and hereby consents to such reliance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(pp)
<U>Forward-Looking Statements</U>. No forward-looking statements (within the meaning of Section 27A of the Securities Act and Section
21E of the Exchange Act) contained in the Time of Sale Disclosure Package has been made or reaffirmed without a reasonable basis or has
been disclosed other than in good faith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(qq)
<U>Statistical or Market-Related Data</U>. Any statistical, industry-related and market-related data included or incorporated by reference
in the Time of Sale Disclosure Package, are based on or derived from sources that the Company reasonably and in good faith believes to
be reliable and accurate, and such data agree with the sources from which they are derived.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(rr)
<U>FINRA Affiliations</U>. There are no affiliations with any firm that is a member of the FINRA participating in the Offering among
the Company&rsquo;s officers, directors or, to the knowledge of the Company, any 5% or greater shareholder of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ss)
<U>Board of Directors</U>. The Company&rsquo;s Board of Directors is comprised of the persons identified as directors of the Company
in the Preliminary Prospectus or the Prospectus under the section titled &ldquo;Management.&rdquo; The qualifications of the persons
serving as board members and the overall composition of the Board of Directors comply with the Sarbanes-Oxley Act of 2002 and the rules
promulgated thereunder applicable to the Company and the rules of the Trading Market. At least one member of the Board of Directors qualifies
as a &ldquo;financial expert&rdquo; as such term is defined under the Sarbanes-Oxley Act of 2002 and the rules promulgated thereunder
and the rules of the Trading Market. In addition, at least a majority of the persons serving on the Board of Directors qualify as &ldquo;independent&rdquo;
as defined under the rules of the Trading Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(tt)
<U>Cybersecurity</U>. There has been no security breach or other compromise of or relating to any of the Company&rsquo;s or any Subsidiary&rsquo;s
information technology and computer systems, networks, hardware, software, data (including the data of its respective customers, employees,
suppliers, vendors and any third party data maintained by or on behalf of it), equipment or technology (collectively, &ldquo;<B>IT Systems
and Data</B>&rdquo;) that would reasonably be expected to result in, individually or in the aggregate, a Material Adverse Effect and
(i) the Company and the Subsidiaries have not been notified of, and has no knowledge of any event or condition that would reasonably
be expected to result in, any material security breach or other compromise to its IT Systems and Data; (ii) the Company and the Subsidiaries
are presently in compliance with all applicable laws or statutes and all judgments, orders, rules and regulations of any court or arbitrator
or governmental or regulatory authority, internal policies and contractual obligations relating to the privacy and security of IT Systems
and Data and to the protection of such IT Systems and Data from unauthorized use, access, misappropriation or modification, except as
would not, individually or in the aggregate, have a Material Adverse Effect; (iii) the Company and the Subsidiaries have implemented
and maintained commercially reasonable safeguards to maintain and protect its material confidential information and the integrity, continuous
operation, redundancy and security of all IT Systems and Data; and (iv) the Company and the Subsidiaries have implemented backup and
disaster recovery technology consistent with industry standards and practices.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(uu)
<U>Compliance with Data Privacy Laws</U>. (i) The Company and the Subsidiaries are, and at all times during the last three (3) years
were, in material compliance with all applicable state, federal and foreign data privacy and security laws and regulations, including,
without limitation, the European Union General Data Protection Regulation (&ldquo;<B>GDPR</B>&rdquo;) (EU 2016/679) (collectively, &ldquo;<B>Privacy
Laws</B>&rdquo;); (ii) the Company and the Subsidiaries have in place, comply with, and take appropriate steps reasonably designed to
ensure compliance with their policies and procedures relating to data privacy and security and the collection, storage, use, disclosure,
handling and analysis of Personal Data (as defined below) (the &ldquo;<B>Policies</B>&rdquo;); (iii) the Company provides accurate notice
of its applicable Policies to its customers, employees, third party vendors and representatives as required by the Privacy Laws; and
(iv) applicable Policies provide accurate and sufficient notice of the Company&rsquo;s then-current privacy practices relating to its
subject matter, and do not contain any material omissions of the Company&rsquo;s then-current privacy practices, as required by Privacy
Laws. &ldquo;<B>Personal Data</B>&rdquo; means (i) a natural person&rsquo;s name, street address, telephone number, email address, photograph,
social security number, bank information, or customer or account number; (ii) any information which would qualify as &ldquo;personally
identifying information&rdquo; under the FTC, as amended; (iii) &ldquo;personal data&rdquo; as defined by GDPR; and (iv) any other piece
of information that allows the identification of such natural person, or his or her family, or permits the collection or analysis of
any identifiable data related to an identified person&rsquo;s health or sexual orientation. (i) None of such disclosures made or contained
in any of the Policies have been inaccurate, misleading, or deceptive in violation of any Privacy Laws and (ii) the execution, delivery
and performance of the Transaction Documents will not result in a breach of any Privacy Laws or Policies. Neither the Company nor the
Subsidiaries (i) to the knowledge of the Company, has received written notice of any actual or potential liability of the Company or
the Subsidiaries under, or actual or potential violation by the Company or the Subsidiaries of, any of the Privacy Laws; (ii) is currently
conducting or paying for, in whole or in part, any investigation, remediation or other corrective action pursuant to any regulatory request
or demand pursuant to any Privacy Law; or (iii) is a party to any order, decree, or agreement by or with any court or arbitrator or governmental
or regulatory authority that imposed any obligation or liability under any Privacy Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vv)
<U>Environmental Laws</U>. The Company and its Subsidiaries (i) are in compliance with all federal, state, local and foreign laws relating
to pollution or protection of human health or the environment (including ambient air, surface water, groundwater, land surface or subsurface
strata), including laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants, contaminants, or
toxic or hazardous substances or wastes (collectively, &ldquo;<B>Hazardous Materials</B>&rdquo;) into the environment, or otherwise relating
to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials, as well
as all authorizations, codes, decrees, demands, or demand letters, injunctions, judgments, licenses, notices or notice letters, orders,
permits, plans or regulations, issued, entered, promulgated or approved thereunder (&ldquo;<B>Environmental Laws</B>&rdquo;); (ii) have
received all permits licenses or other approvals required of them under applicable Environmental Laws to conduct their respective businesses;
and (iii) are in compliance with all terms and conditions of any such permit, license or approval where in each clause (i), (ii) and
(iii), the failure to so comply could be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
3. Delivery and Payment</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Closing for the Offering</U>. Delivery of and payment for the Securities shall be made at or around [&#9679;] a.m., Eastern time,
on or before the first (1st) Trading Day following the date of the Purchase Agreement. The Closing shall take place remotely by electronic
transfer of the Closing documentation. On the Closing Date, the Company shall issue such amount of Securities sold pursuant to the Purchase
Agreement directly to the accounts designated by the Placement Agent for the applicable Investors and payment shall be made by the Investors
by wire transfer to the Company. At the Closing, the Securities which the Company shall deliver to each Investor shall consist of the
following, as applicable: (i) the number of Shares and/or Pre-Funded Warrants purchased by such Investor, (ii) a Series A Warrant registered
in the name of each Investor to purchase up to an aggregate number of Warrant Shares equal to one hundred percent (100%) of the aggregate
number of such Investor&rsquo;s Shares purchased pursuant to the Offering (on an as-exercised basis without giving effect to any beneficial
ownership limitations in the case of Investors who purchased Pre-Funded Warrants) and (iii) a Series B Warrant registered in the name
of each Investor to purchase up to an aggregate number of Warrant Shares equal to 100% of the aggregate number of such Investor&rsquo;s
Shares purchased pursuant to the Offering (on an as-exercised basis without giving effect to any beneficial ownership limitations in
the case of Investors who purchased Pre-Funded Warrants). Subject to the terms and conditions hereof, at the Closing, payment of the
purchase price for the Securities sold pursuant to the Purchase Agreement shall be made by federal funds wire transfer, against delivery
of the Shares (with the Series A Warrants and the Series B Warrants to follow as provided in the previous sentence), and such Securities
shall be registered in such name or names and shall be in such denominations, as the Placement Agent may request. Deliveries of the documents
with respect to the purchase of the Securities, if any, shall be made at the offices of Placement Agent&rsquo;s Counsel; provided, however,
that the Company shall be deemed to have satisfied its obligations with respect to the delivery of the Series A Warrants and Series B
Warrants by making available a PDF copy of the executed Series A Warrants and Series B Warrants at the Closing and delivering the originals
thereof within five Trading Days of the Closing. All actions taken at the Closing shall be deemed to have occurred simultaneously.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Payment for the Securities</U>. The Securities are being sold to the Investors at the public offering price as set forth in the Prospectus.
The purchase of the Securities by each of the Investors shall be evidenced by the receipt of funds in the account designated by the Company
and the Placement Agent and execution of a Purchase Agreement by each such Investor and the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Delivery of the Shares, Series A Warrants and Series B Warrants</U>. Delivery of the Shares shall be made through the facilities of
The Depository Trust Company unless the Placement Agent shall otherwise instruct. Delivery of the Series A Warrants and the Series B
Warrants shall be made as set forth in Section 3(a) above.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
4. Covenants and Agreements of the Company</B>. The Company further covenants and agrees with the Placement Agent as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Registration Statement Matters</U>. During the Prospectus Delivery Period (as defined below), the Company will advise the Placement
Agent promptly after it receives notice thereof of the time when any amendment to the Registration Statement has been filed or becomes
effective or any supplement to the Prospectus has been filed and will furnish the Placement Agent with copies thereof. During the Prospectus
Delivery Period (as defined in Section 4(c), the Company will file promptly all reports and any definitive proxy or information statements
required to be filed by the Company with the SEC pursuant to Section 13(a), 14 or 15(d) of the Exchange Act subsequent to the date of
any Prospectus. During the Prospectus Delivery Period, the Company will advise the Placement Agent, promptly after it receives notice
thereof (i) of any request by the SEC to amend the Registration Statement or to amend or supplement any Prospectus or for additional
information, and (ii) of the issuance by the SEC of any stop order suspending the effectiveness of the Registration Statement or any
post-effective amendment thereto or any order directed at any Incorporated Document, if any, or any amendment or supplement thereto or
any order preventing or suspending the use of the Preliminary Prospectus or the Prospectus or any prospectus supplement or any amendment
or supplement thereto or any post-effective amendment to the Registration Statement, of the suspension of the qualification of the Securities
for offering or sale in any jurisdiction, of the institution or threatened institution of any Proceeding for any such purpose, or of
any request by the SEC for the amending or supplementing of the Registration Statement or a Prospectus or for additional information.
The Company shall use its best efforts to prevent the issuance of any such stop order or prevention or suspension of such use. If the
SEC shall enter any such stop order or order or notice of prevention or suspension at any time, the Company will use its best efforts
to obtain the lifting of such order at the earliest possible moment, or will file a new registration statement and use its best efforts
to have such new registration statement declared effective as soon as practicable. Additionally, the Company agrees that during the Prospectus
Delivery Period, it shall comply with the provisions of Rules 424(b), 430A, 430B and 430C, as applicable, under the Securities Act, including
with respect to the timely filing of documents thereunder, and will use its reasonable efforts to confirm that any filings made by the
Company under such Rule 424(b) are received in a timely manner by the SEC. The Company covenants and agrees to update the Prospectus
to include all information required to be included therein, including with respect to any SEC Reports that are filed subsequent to the
date of the Prospectus, for the period beginning on the effective date of the Registration Statement and ending on the date on which
no Warrants (including any Pre-Funded Warrants) are outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Blue Sky Compliance</U>. The Company will qualify or register the Offering under the securities laws of applicable jurisdictions (United
States and foreign) as the Placement Agent and the Investors may reasonably request and will make such applications, file such documents,
and furnish such information as may be reasonably required for that purpose, provided the Company shall not be required to qualify as
a foreign corporation or to file a general consent to service of process in any jurisdiction where it is not now so qualified or required
to file such a consent, and <U>provided further</U> that the Company shall not be required to produce any new disclosure statement or
take such action as is necessary for the Offering to be made pursuant to an available exemption from qualification or registration in
applicable jurisdictions. During the Prospectus Delivery Period, the Company will, from time to time, prepare and file such statements,
reports and other documents as are or may be required to continue such qualifications in effect. During the Prospectus Delivery Period,
the Company will advise the Placement Agent promptly of the suspension of the qualification or registration of (or any such exemption
relating to) the Securities for offering, sale or trading in any jurisdiction or any initiation or threat of any Proceeding for any such
purpose, and in the event of the issuance of any order suspending such qualification, registration or exemption, the Company shall use
its best efforts to obtain the withdrawal thereof at the earliest possible moment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Amendments and Supplements to a Prospectus and Other Matters</U>. The Company will comply with the Securities Act and the Exchange
Act, and the rules and regulations of the SEC thereunder, so as to permit the completion of the distribution of the Securities as contemplated
in this Agreement, the Incorporated Documents and any Prospectus. If during the period in which a prospectus is required by law to be
delivered in connection with the distribution of Securities contemplated by the Incorporated Documents or any Prospectus (the &ldquo;<B>Prospectus
Delivery Period</B>&rdquo;), any event shall occur as a result of which, in the judgment of the Company or in the opinion of the Placement
Agent or Placement Agent&rsquo;s Counsel, it becomes necessary to amend or supplement the Incorporated Documents or any Prospectus in
order to make the statements therein, in the light of the circumstances under which they were made, as the case may be, not misleading,
or if it is necessary at any time to amend or supplement the Incorporated Documents or any Prospectus or to file under the Exchange Act
any Incorporated Document to comply with any law, the Company will promptly prepare and file with the SEC, and furnish at its own expense
to the Placement Agent and to dealers, an appropriate amendment to the Registration Statement or supplement to the Registration Statement,
the Incorporated Documents or any Prospectus that is necessary in order to make the statements in the Incorporated Documents and any
Prospectus as so amended or supplemented, in the light of the circumstances under which they were made, as the case may be, not misleading,
or so that the Registration Statement, the Incorporated Documents or any Prospectus, as so amended or supplemented, will comply with
law. Before amending the Registration Statement or supplementing the Incorporated Documents or any Prospectus in connection with the
Offering, the Company will furnish the Placement Agent with a copy of such proposed amendment or supplement and will not file any such
amendment or supplement to which the Placement Agent reasonably objects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Copies of any Amendments and Supplements to a Prospectus</U>. The Company will furnish the Placement Agent, without charge, during
the period beginning on the date hereof and ending on the Closing Date of the Offering, as many copies of any Prospectus or Prospectus
supplement and any amendments and supplements thereto, as the Placement Agent may reasonably request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Free Writing Prospectus</U>. The Company covenants that it will not, unless it obtains the prior written consent of the Placement
Agent, make any offer relating to the Securities that would constitute an Issuer Free Writing Prospectus or that would otherwise constitute
a &ldquo;<B>Free Writing Prospectus</B>&rdquo; (as defined in Rule 405 of the Securities Act) required to be filed by the Company with
the SEC or retained by the Company under Rule 433 of the Securities Act. In the event that the Placement Agent expressly consents in
writing to any such Free Writing Prospectus (a &ldquo;<B>Permitted Free Writing Prospectus</B>&rdquo;), the Company covenants that it
shall (i) treat each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, and (ii) comply with the requirements of
Rule 164 and 433 of the Securities Act applicable to such Permitted Free Writing Prospectus, including in respect of timely filing with
the SEC, legending and record keeping. Notwithstanding anything herein to the contrary, in no event shall the Company make any offer
or communication relating to the Offering which meets the definition of a &ldquo;Free Writing Prospectus&rdquo; while the Company is
an &ldquo;ineligible issuer&rdquo; (as such terms are defined in Rule 405 of the Securities Act) or otherwise in contravention of the
Securities Act and the Rules and Regulations thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Transfer Agent</U>. The Company will maintain, at its expense, a registrar and transfer agent for the Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Earnings Statement</U>. As soon as practicable and in accordance with applicable requirements under the Securities Act, but in any
event not later than 12 months after the Closing Date, the Company will make generally available to its security holders and to the Placement
Agent an earnings statement, covering a period of at least 12 consecutive months beginning after the Closing Date, that satisfies the
provisions of Section 11(a) and Rule 158 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>Periodic Reporting Obligations</U>. During the Prospectus Delivery Period, the Company will duly file, on a timely basis, with the
SEC and the Trading Market all reports and documents required to be filed under the Exchange Act within the time periods and in the manner
required by the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Additional Documents</U><I>. </I>The Company will enter into any subscription, purchase or other customary agreements as the Placement
Agent or the Investors deem necessary or appropriate to consummate the Closing in connection with the Offering, all of which will be
in form and substance reasonably acceptable to the Placement Agent and the Investors. The Company agrees that the Placement Agent may
rely upon the representations and warranties, and applicable covenants set forth in any Transaction Document including the Purchase Agreement
entered into with Investors in connection with the Offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
<U>No Manipulation of Price</U><I>. </I>The Company will not take, directly or indirectly, any action designed to cause or result in,
or that has constituted or might reasonably be expected to constitute, the stabilization or manipulation of the price of any securities
of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
<U>Acknowledgment</U>. The Company acknowledges that any advice given by the Placement Agent to the Company is solely for the benefit
and use of the Board of Directors of the Company and may not be used, reproduced, disseminated, quoted or referred to, without the Placement
Agent&rsquo;s prior written consent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
<U>Announcement of Offering</U>. The Company acknowledges and agrees that the Placement Agent may, subsequent to the Closing, make public
its involvement with the Offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
<U>Reliance on Others</U>. The Company confirms that it will rely on its own counsel and accountants for legal and accounting advice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
<U>Research Matters</U><FONT STYLE="font-variant: small-caps">.</FONT> By entering into this Agreement, the Placement Agent provides
no promise, either explicitly or implicitly, of favorable or continued research coverage of the Company and the Company hereby acknowledges
and agrees that the Placement Agent&rsquo;s selection as the placement agent for the Offering was in no way conditioned, explicitly or
implicitly, on the Placement Agent&rsquo;s providing favorable or any research coverage of the Company. In accordance with FINRA Rule
2711(e), the parties acknowledge and agree that the Placement Agent has not directly or indirectly offered favorable research, a specific
rating or a specific price target, or threatened to change research, a rating or a price target, to the Company or inducement for the
receipt of business or compensation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)
<U>Lock-Up Agreements</U>. The Company shall not amend, modify, waive or terminate any provision of any of the Lock-Up Agreements (as
defined below) except to extend the term of the lock-up period and shall enforce the provisions of each Lock-Up Agreement in accordance
with its terms. If any party to a Lock-Up Agreement breaches any provision of a Lock-Up Agreement, the Company shall promptly use its
best efforts to seek specific performance of the terms of such Lock-Up Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)
<U>Subsequent Equity Sales</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
From the date hereof until ninety (90) days after the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any
agreement to issue or announce the issuance or proposed issuance of any Common Stock or Common Stock Equivalents, except for the securities
issued pursuant hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
From the date hereof until one hundred and eighty (180) days after the Closing Date, the Company shall be prohibited from effecting or
entering into an agreement to effect any issuance by the Company or any of its Subsidiaries of Common Stock or Common Stock Equivalents
(or a combination of units thereof) involving a Variable Rate Transaction. &ldquo;<B>Variable Rate Transaction</B>&rdquo; means a transaction
in which the Company (i) issues or sells any debt or equity securities that are convertible into, exchangeable or exercisable for, or
include the right to receive additional shares of Common Stock either (A) at a conversion price, exercise price or exchange rate or other
price that is based upon and/or varies with the trading prices of or quotations for the Common Stock at any time after the initial issuance
of such debt or equity securities, or (B) with a conversion, exercise or exchange price that is subject to being reset at some future
date after the initial issuance of such debt or equity security or upon the occurrence of specified or contingent events directly or
indirectly related to the business of the Company or the market for the Common Stock or (ii) enters into, or effects a transaction under,
any agreement, including, but not limited to, an equity line of credit or an &ldquo;at-the-market offering&rdquo;, whereby the Company
may issue securities at a future determined price regardless of whether shares pursuant to such agreement have actually been issued and
regardless of whether such agreement is subsequently canceled. The Placement Agent shall be entitled to obtain injunctive relief against
the Company to preclude any such issuance, which remedy shall be in addition to any right to collect damages.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
Notwithstanding the foregoing, Section 4(p)(i) and (ii) shall not apply in respect of an Exempt Issuance. An &ldquo;<B>Exempt Issuance</B>&rdquo;
means the issuance of (A) shares of Common Stock or options or other securities to employees, officers, directors or consultants of the
Company pursuant to any employee benefit plan, equity incentive plan or other employee compensation plan existing on the date hereof
or any stock or option plan duly adopted for such purpose, by a majority of the non-employee members of the Board of Directors or a majority
of the members of a committee of non-employee directors established for such purpose for services rendered to the Company, (B) Common
Stock issued upon the exercise or exchange of or conversion of any Securities issued pursuant to the Securities Purchase Agreement or
Prospectus or this Agreement and/or other securities exercisable or exchangeable for or convertible into shares of Common Stock issued
and outstanding on the date of this Agreement provided that such securities have not been amended since the date of this Agreement to
increase the number of such securities or to decrease the exercise price, exchange price or conversion price of such securities (other
than in connection with stock splits or combinations or anti-dilution provisions contained therein as disclosed in the SEC Reports and
the Prospectus) or to extend the term of such securities, or securities issuable in connection with a transaction involving the Company
and existing stockholders in which the Company offers the existing stockholders the option to exchange their shares of Common Stock for
other securities of the Company, (C) securities issued pursuant to acquisitions or strategic transactions approved by a majority of the
disinterested directors of the Company, provided that such securities are issued as &ldquo;restricted securities&rdquo; (as defined in
Rule 144) and carry no registration rights that require or permit the filing of any registration statement in connection therewith during
the prohibition period in Section 4(p)(i) herein, and provided that any such issuance shall only be to a Person (or to the equityholders
of a Person) which is, itself or through its subsidiaries, an operating company or an owner of an asset in a business synergistic with
the business of the Company and shall provide to the Company additional benefits in addition to the investment of funds, but shall not
include a transaction in which the Company is issuing securities primarily for the purpose of raising capital or to an entity whose primary
business is investing in securities, and (D) the issuance of the Securities in the Offering, and (E) the entry into and/or issuance of
shares of Common Stock pursuant to a Regulation A+ offering with the Placement Agent as sales agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)
<U>Tail Fee</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Tail Fee</U>. The Company and the Placement Agent agree that for a period of eighteen (18) months from (i) the Closing Date of the
Offering or (ii) if the Closing does not occur, the termination of this Agreement by the Company other than for Cause, the Placement
Agent shall be entitled to compensation commensurate with those set forth under Section 1(a) (the &ldquo;<B>Tail Fee</B>&rdquo;), from
the sale of any equity, debt and/or equity derivative instruments to any investor actually introduced by the Placement Agent to the Company,
but unknown to the Company prior to such introduction, during the period between the date of this Agreement and the Closing of the Offering
or the termination of this Agreement, as applicable (each, a &ldquo;<B>Tail Financing</B>&rdquo;), and such Tail Financing is consummated
at any time within the eighteen (18) month period from the Closing Date of the Offering or termination of this Agreement, as applicable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
<U>Termination for Cause</U>. Notwithstanding anything herein to the contrary, in accordance with FINRA Rule 5110(g)(5)(B), this Section
4(q) and the Tail Fee contemplated hereby may be terminated by the Company for &ldquo;Cause&rdquo;, which shall mean a material breach
by the Placement Agent of this Agreement or a material failure by the Placement Agent to provide the services as contemplated by this
Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)
<U>Securities Laws Disclosure; Publicity</U>. The Company shall (i) issue a press release disclosing the material terms of the transactions
contemplated hereby at the date and time agreed upon by the Company and the Placement Agent, and (ii) file a Current Report on Form 8-K,
including the Transaction Documents as exhibits thereto, with the SEC within the time required by the Exchange Act. From and after the
issuance of such press release, the Company represents that it shall have publicly disclosed all material, non-public information delivered
by the Company or any of its Subsidiaries, or any of their respective officers, directors, employees, Affiliates or agents, in connection
with the transactions contemplated by the Transaction Documents. The Company and the Placement Agent shall consult with each other in
issuing any other press releases with respect to the transactions contemplated hereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s)
<U>Shareholder Approval</U>. The Company shall hold an annual or special meeting of stockholders on or prior to the date that is sixty
(60) days following the Closing Date for the purpose of obtaining Shareholder Approval, with the recommendation of the Company&rsquo;s
Board of Directors that such proposals are approved, and the Company shall solicit proxies from its shareholders in connection therewith
in the same manner as all other management proposals in such proxy statement and all management-appointed proxyholders shall vote their
proxies in favor of such proposals. If the Company does not obtain Shareholder Approval at the first meeting, the Company shall use commercially
reasonable efforts to call a meeting every sixty (60) days thereafter to seek Shareholder Approval until the earlier of the Shareholder
Approval Date or the Series A Warrants and Series B Warrants are no longer outstanding. The Company shall set the record date for Shareholder
Approval prior to the Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
5. Conditions of the Obligations of the Placement Agent</B>. The obligations of the Placement Agent hereunder shall be subject to the
accuracy of the representations and warranties on the part of the Company set forth in <U>Section 2</U> hereof, in each case as of the
date hereof and as of the Closing Date as though then made, to the timely performance by each of the Company of its covenants and other
obligations hereunder, and to each of the following additional conditions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Accountants&rsquo; Comfort Letter</U>. On the Closing Date, the Placement Agent shall have received, and the Company shall have caused
to be delivered to the Placement Agent, a letter from Marcum LLP, the independent registered public accounting firm of the Company, and
EisnerAmper LLP, the former independent registered public accounting firm of the Company, addressed to the Placement Agent, dated as
of the Closing Date, in form and substance satisfactory to the Placement Agent..</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Compliance with Registration Requirements; No Stop Order; No Objection from FINRA</U>. Each Prospectus (in accordance with Rule 424(b))
and Free Writing Prospectus if any, shall have been duly filed with the SEC, as appropriate; no stop order suspending the effectiveness
of the Registration Statement or any part thereof shall have been issued and no Proceeding for that purpose shall have been initiated
or threatened by the SEC; no order preventing or suspending the use of any Prospectus shall have been issued and no Proceeding for that
purpose shall have been initiated or threatened by the SEC; no order having the effect of ceasing or suspending the distribution of the
Securities or any other securities of the Company shall have been issued by any securities commission, securities regulatory authority
or stock exchange and no Proceedings for that purpose shall have been instituted or shall be pending or, to the knowledge of the Company,
contemplated by any securities commission, securities regulatory authority or stock exchange; all requests for additional information
on the part of the SEC shall have been complied with; and FINRA shall have raised no objection to the fairness and reasonableness of
the placement terms and arrangements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Corporate Proceedings</U>. All corporate proceedings and other legal matters in connection with this Agreement, the Registration Statement
and each Prospectus, and the registration, sale, and delivery of the Securities, shall have been completed or resolved in a manner reasonably
satisfactory to the Placement Agent&rsquo;s Counsel, and such counsel shall have been furnished with such papers and information as it
may reasonably have requested to enable such counsel to pass upon the matters referred to in this Section 5.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>No Material Adverse Change</U>. Subsequent to the execution and delivery of this Agreement and prior to the Closing Date, in the Placement
Agent&rsquo;s reasonable judgment after consultation with the Company, there shall not have occurred any material adverse change or development
involving a prospective material adverse change in the condition or the business activities, financial or otherwise, of the Company from
the latest dates as of which such condition is set forth in the Registration Statement and Prospectus (each, a &ldquo;<B>Material Adverse
Change</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Opinions of Counsel for the Company</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Placement Agent shall have received on the Closing Date the written opinion of Sichenzia Ross Ference Carmel LLP, legal counsel to the
Company, dated as of the Closing Date and addressed to the Placement Agent, including, without limitation, a negative assurance letter
addressed to the Placement Agent and, in form and substance satisfactory to the Placement Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Officers&rsquo; Certificate</U>. The Placement Agent shall have received on the Closing Date, a certificate of the Company, dated
as of the Closing Date and which may be relied upon by the Placement Agent, signed by the Chief Executive Officer and Chief Financial
Officer of the Company, in their respective capacities as such officers only, in a form satisfactory to the Placement Agent, to the effect
that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
The representations and warranties of the Company in this Agreement are true and correct in all material respects (except such representations
and warranties which are qualified by materiality or by Material Adverse Effect, which shall be true and correct in all respects), as
if made on and as of the Closing Date, and the Company has complied with all the agreements and satisfied all the conditions on its part
to be performed or satisfied at or prior to the Closing Date;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
No stop order suspending the effectiveness of the Registration Statement or the use of any Prospectus has been issued and no Proceedings
for that purpose have been instituted or are pending or, to the Company&rsquo;s knowledge, threatened under the Securities Act; no order
having the effect of ceasing or suspending the distribution of the Securities or any other securities of the Company has been issued
by any securities commission, securities regulatory authority or stock exchange in the United States and no Proceedings for that purpose
have been instituted or are pending or, to the knowledge of the Company, contemplated by any securities commission, securities regulatory
authority or stock exchange in the United States;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
When the Registration Statement became effective, at the time of sale, and at all times subsequent thereto up to the delivery of such
certificate, the Registration Statement and the Incorporated Documents, if any, when such documents became effective or were filed with
the SEC, and any Prospectus, contained all material information required to be included therein by the Securities Act and the Exchange
Act and the applicable rules and regulations of the SEC thereunder, as the case may be, and in all material respects conformed to the
requirements of the Securities Act and the Exchange Act and the applicable rules and regulations of the SEC thereunder, as the case may
be, and the Registration Statement and the Incorporated Documents, if any, and any Prospectus, did not and do not include any untrue
statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein,
in the light of the circumstances under which they were made, not misleading (provided, however, that the preceding representations and
warranties contained in this paragraph (iii) shall not apply to any statements or omissions made in reliance upon and in conformity with
information furnished in writing to the Company by the Placement Agent expressly for use therein) and, since the effective date of the
Registration Statement, there has occurred no event required by the Securities Act and the rules and regulations of the SEC thereunder
to be set forth in the Incorporated Documents which has not been so set forth; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
Subsequent to the respective dates as of which information is given in the Registration Statement, the Incorporated Documents and any
Prospectus, there has not been: (i) any Material Adverse Change; (ii) any transaction that is material to the Company and the Subsidiaries
taken as a whole, except transactions entered into in the ordinary course of business; (iii) any obligation, direct or contingent, that
is material to the Company and the Subsidiaries taken as a whole, incurred by the Company or any Subsidiary, except obligations incurred
in the ordinary course of business; (iv) any material change in the capital stock (except changes thereto resulting from the exercise
of outstanding stock options or warrants) or outstanding indebtedness of the Company or any Subsidiary; (v) any dividend or distribution
of any kind declared, paid or made on the capital stock of the Company; or (vi) any loss or damage (whether or not insured) to the property
of the Company or any Subsidiary which has been sustained or will have been sustained which has a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Chief Financial Officer&rsquo;s Certificate</U>. The Placement Agent shall have received on the Closing Date, a certificate of the
Company, dated as of the Closing Date and which may be relied upon by the Placement Agent, signed by the Chief Financial Officer of the
Company, with respect to certain financial data contained in or incorporated by reference into the Registration Statement, in a form
satisfactory to the Placement Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>Secretary&rsquo;s Certificate</U>. The Placement Agent shall have received on the Closing Date, a certificate of the Company, dated
as of the Closing Date and which may be relied upon by the Placement Agent, signed by the Secretary of the Company, certifying, among
others, (i) that each of the Company&rsquo;s Amended and Restated Certificate of Incorporation and Amendment No. 1 to Amended Bylaws,
and all amendments thereto, is true and complete, has not been modified and is in full force and effect; (ii) that the resolutions of
the Company&rsquo;s Board of Directors relating to the Offering are in full force and effect and have not been modified; (iii) that each
of the Company and its Subsidiaries is in good standing under the laws of the jurisdiction of its incorporation or organization; (iv)
as to the accuracy and completeness of all correspondence between the Company or its counsel and the SEC; and (v) as to the incumbency
of the officers of the Company, in a form reasonably acceptable to the Placement Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Exchange Act Registration and Stock Exchange Listing</U>. The Common Stock (including the Shares and the Warrant Shares) shall be
registered under the Exchange Act and shall be listed on the Trading Market, and the Company shall not have taken any action designed
to terminate, or likely to have the effect of terminating, the registration of the Common Stock under the Exchange Act or delisting or
suspending from trading the Common Stock from the Trading Market, nor shall the Company have received any information suggesting that
the SEC or the Trading Market is contemplating terminating such registration or listing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
<U>Lock-Up Agreement</U>. On or prior to the date of this Agreement, the Company shall also have furnished to the Placement Agent a letter
substantially in the form of <U>Exhibit A</U> hereto (the &ldquo;<B>Lock-Up Agreement</B>&rdquo;) from each executive officer, director
and five percent (5%) shareholder of the Company addressed to the Placement Agent. The Company will use its best efforts to enforce the
terms of each Lock-Up Agreement and will issue stop-transfer instructions to the transfer agent for the Common Stock with respect to
any transaction or contemplated transaction that would constitute a breach of or default under the applicable Lock-Up Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
<U>Shareholder Approval</U>. The Company shall have obtained the Shareholder Approval.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
<U>Additional Documents</U>. On or before the Closing Date, the Placement Agent and Placement Agent&rsquo;s Counsel shall have received
such information and documents as they may reasonably require for the purposes of enabling them to pass upon the issuance and sale of
the Securities as contemplated herein, or in order to evidence the accuracy of any of the representations and warranties, or the satisfaction
of any of the conditions or agreements, herein contained.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any condition specified in this <U>Section 5</U> is not satisfied when and as required to be satisfied, this Agreement may be terminated
by the Placement Agent by notice to the Company at any time on or prior to the Closing Date, which termination shall be without liability
on the part of any party to any other party, except that <U>Section 1(a)</U>, <U>Section 1(b)</U>, <U>Section 6</U> (Payment of Expenses),
<U>Section 7</U> (Indemnification and Contribution) and <U>Section 8</U> (Representations and Indemnities to Survive Delivery) shall
at all times be effective and shall survive such termination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
6. Payment of Fees and Expenses</B>. Subject to compliance with FINRA Rule 5110(f)(2)(D), the Company agrees to pay all costs, fees and
expenses incurred by the Company in connection with the performance of its obligations hereunder and in connection with the transactions
contemplated hereby, including, without limitation: (i) payment to the Placement Agent of its Cash Fee and non-accountable expense allowance
(ii) all expenses incident to the issuance, delivery and qualification of the Securities (including all printing and engraving costs);
(iii) all fees and expenses of the registrar and transfer agent of the Common Stock; (iv) all necessary issue, transfer and other stamp
taxes in connection with the issuance and sale of the Securities; (v) all fees and expenses of the Company&rsquo;s counsel, registered
independent public accounting firm and other advisors; (vi) all costs and expenses incurred in connection with the preparation, printing,
filing, shipping and distribution of the Registration Statement (including financial statements, exhibits, schedules, consents and certificates
of experts), the Preliminary Prospectus, the Prospectus and each Prospectus supplement, if any, and all amendments and supplements thereto,
and this Agreement; (vii) all filing fees, reasonable attorneys&rsquo; fees and expenses incurred by the Company in connection with qualifying
or registering (or obtaining exemptions from the qualification or registration of) all or any part of the Securities for offer and sale
under the state securities or blue sky laws or the securities laws of any other country; (viii) the filing fees incident to the review
and approval by FINRA of the Placement Agent&rsquo;s participation in the offering and distribution of the Securities; (ix) the fees
and expenses associated with including the Shares and Warrant Shares on the Trading Market; (x) all costs and expenses incident to the
travel and accommodation of the Company&rsquo;s employees on the &ldquo;roadshow,&rdquo; if any; (xi) the Placement Agent&rsquo;s closing
costs, including the reimbursement of the out-of-pocket cost of the escrow agent or clearing agent, of up to $12,900; and (xii) all other
fees, costs and expenses referred to in Part II of the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
7. Indemnification and Contribution</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The Company agrees to indemnify and hold harmless the Placement Agent, its Affiliates and each Person controlling the Placement Agent,
and the directors, officers, agents and employees of the Placement Agent, their respective affiliates and each such controlling person
(the Placement Agent, and each such entity or person, an &ldquo;<B>Indemnified Person</B>&rdquo;) from and against any losses, claims,
damages, judgments, assessments, costs and other liabilities (collectively, the &ldquo;<B>Liabilities</B>&rdquo;), and shall reimburse
each Indemnified Person for all fees and expenses (including the reasonable fees and expenses of one counsel for all Indemnified Persons,
except as otherwise expressly provided herein) (collectively, the &ldquo;<B>Expenses</B>&rdquo;) as they are incurred by an Indemnified
Person in investigating, preparing, pursuing or defending any Proceedings, whether or not any Indemnified Person is a party thereto,
(i) caused by, or arising out of or in connection with, any untrue statement or alleged untrue statement of a material fact contained
in the Registration Statement, any Incorporated Document, or any Prospectus or by any omission or alleged omission to state therein a
material fact necessary to make the statements therein, in light of the circumstances under which they were made, not misleading (other
than untrue statements or alleged untrue statements in, or omissions or alleged omissions from, information relating to an Indemnified
Person furnished in writing by or on behalf of such Indemnified Person expressly for use in the Registration Statement, any Incorporated
Document, or any Prospectus) or (ii) otherwise arising out of or in connection with advice or services rendered or to be rendered by
any Indemnified Person pursuant to this Agreement, the transactions contemplated thereby or any Indemnified Person&rsquo;s actions or
inactions in connection with any such advice, services or transactions; <U>provided</U>, <U>however</U>, that, in the case of clause
(ii) only, the Company shall not be responsible for any Liabilities or Expenses of any Indemnified Person that are finally judicially
determined to have resulted solely from such Indemnified Person&rsquo;s (x) gross negligence or willful misconduct in connection with
any of the advice, actions, inactions or services referred to above or (y) use of any offering materials or information concerning the
Company in connection with the offer or sale of the Securities in the Offering which were not authorized for such use by the Company
and which use constitutes gross negligence or willful misconduct. The Company also agrees to reimburse each Indemnified Person for all
Expenses as they are incurred in connection with enforcing such Indemnified Person&rsquo;s rights under this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Upon receipt by an Indemnified Person of actual notice of an Proceeding against such Indemnified Person with respect to which indemnity
may be sought under this Agreement, such Indemnified Person shall promptly notify the Company in writing; provided that failure by any
Indemnified Person so to notify the Company shall not relieve the Company from any liability which the Company may have on account of
this indemnity or otherwise to such Indemnified Person, except to the extent the Company shall have been prejudiced by such failure.
The Company shall, if requested by the Placement Agent, assume the defense of any such Proceeding including the employment of counsel
reasonably satisfactory to the Placement Agent, which counsel may also be counsel to the Company. Any Indemnified Person shall have the
right to employ separate counsel in any such action and participate in the defense thereof, but the fees and expenses of such counsel
shall be at the expense of such Indemnified Person unless: (i) the Company has failed promptly to assume the defense and employ counsel
or (ii) the named parties to any such Proceeding (including any impeded parties) include such Indemnified Person and the Company, and
such Indemnified Person shall have been advised in the reasonable opinion of counsel that there is an actual conflict of interest that
prevents the counsel selected by the Company from representing both the Company (or another client of such counsel) and any Indemnified
Person; provided that the Company shall not in such event be responsible hereunder for the fees and expenses of more than one firm of
separate counsel for all Indemnified Persons in connection with any Proceeding or related Proceedings, in addition to any local counsel.
The Company shall not be liable for any settlement of any Proceeding effected without its written consent (which shall not be unreasonably
withheld). In addition, the Company shall not, without the prior written consent of the Indemnified Person (which shall not be unreasonably
withheld), settle, compromise or consent to the entry of any judgment in or otherwise seek to terminate any pending or threatened Proceeding
in respect of which indemnification or contribution may be sought hereunder (whether or not such Indemnified Person is a party thereto)
unless such settlement, compromise, consent or termination includes an unconditional release of each Indemnified Person from all Liabilities
arising out of such Proceeding for which indemnification or contribution may be sought hereunder. The indemnification required hereby
shall be made by periodic payments of the amount thereof during the course of the investigation or defense, as such expense, loss, damage
or liability is incurred and is due and payable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
In the event that the foregoing indemnity is unavailable to an Indemnified Person other than in accordance with this Agreement, the Company
shall contribute to the Liabilities and Expenses paid or payable by such Indemnified Person in such proportion as is appropriate to reflect
(i) the relative benefits to the Company, on the one hand, and to the Placement Agent and any other Indemnified Person, on the other
hand, of the matters contemplated by this Agreement or (ii) if the allocation provided by the immediately preceding clause is not permitted
by applicable law, not only such relative benefits but also the relative fault of the Company, on the one hand, and the Placement Agent
and any other Indemnified Person, on the other hand, in connection with the matters as to which such Liabilities or Expenses relate,
as well as any other relevant equitable considerations; provided that in no event shall the Company contribute less than the amount necessary
to ensure that all Indemnified Persons, in the aggregate, are not liable for any Liabilities and Expenses in excess of the amount of
fees actually received by the Placement Agent pursuant to this Agreement. For purposes of this paragraph, the relative benefits to the
Company, on the one hand, and to the Placement Agent on the other hand, of the matters contemplated by this Agreement shall be deemed
to be in the same proportion as (a) the total value paid or contemplated to be paid to or received or contemplated to be received by
the Company in the transaction or transactions that are within the scope of this Agreement, whether or not any such transaction is consummated,
bears to (b) the fees paid to the Placement Agent under this Agreement. Notwithstanding the above, no person guilty of fraudulent misrepresentation
within the meaning of Section 11(f) of the Securities Act, as amended, shall be entitled to contribution from a party who was not guilty
of fraudulent misrepresentation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
The Company also agrees that no Indemnified Person shall have any liability (whether direct or indirect, in contract or tort or otherwise)
to the Company for or in connection with advice or services rendered or to be rendered by any Indemnified Person pursuant to this Agreement,
the transactions contemplated thereby or any Indemnified Person&rsquo;s actions or inactions in connection with any such advice, services
or transactions except for Liabilities (and related Expenses) of the Company that are finally judicially determined to have resulted
solely from such Indemnified Person&rsquo;s gross negligence or willful misconduct in connection with any such advice, actions, inactions
or services.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
The reimbursement, indemnity and contribution obligations of the Company set forth herein shall apply to any modification of this Agreement
and shall remain in full force and effect regardless of any termination of, or the completion of any Indemnified Person&rsquo;s services
under or in connection with, this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
8. Representations and Indemnities to Survive Delivery</B>. The respective indemnities, agreements, representations, warranties and other
statements of the Company or any person controlling the Company, of its officers, and of the Placement Agent set forth in or made pursuant
to this Agreement will remain in full force and effect, regardless of any investigation made by or on behalf of the Placement Agent,
the Company, or any of its or their partners, officers or directors or any controlling person, as the case may be, and will survive delivery
of and payment for the Securities sold hereunder and any termination of this Agreement. A successor to the Placement Agent, or to the
Company, its directors or officers or any person controlling the Company, shall be entitled to the benefits of the indemnity, contribution
and reimbursement agreements contained in this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
9. Notices</B>. All communications hereunder shall be in writing and shall be overnight, next business day delivery, hand delivered or
e-mailed and confirmed to the parties hereto as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
to the Placement Agent to the address set forth above, attention: Yi (Edric) Guo, Chief Executive Officer, e-mail: yguo@univest.us</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>With
a copy (which shall not constitute notice) to:</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lucosky
Brookman LLP</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">101
Wood Avenue South, 5<SUP>th</SUP> Floor</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Woodbridge,
NJ 08830</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Telephone:
(732) 395-4400</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Jorge Campos, Esq.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
jcampos@lucbro.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
to the Company:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Algorhythm
Holdings, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3000
NW 109<SUP>th</SUP> Ave</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Miami,
FL 33172</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:
Gary Atkinson</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
[&#9679;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>With
a copy (which shall not constitute notice) to:</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sichenzia
Ross Ference Carmel LLP</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1185
Avenue of the Americas, 31st Floor</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, New York 10036</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:
Gregory Sichenzia, Esq.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fax:
(212) 930-9725</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
gsichenzial@srfc.law</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
party hereto may change the address for receipt of communications by giving written notice to the others.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
10. Successors</B>. This Agreement will inure to the benefit of and be binding upon the parties hereto, and to the benefit of the employees,
officers and directors and controlling persons referred to in Section 7 hereof, and to their respective successors, and personal representative,
and no other person will have any right or obligation hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
11. Partial Unenforceability</B>. The invalidity or unenforceability of any section, paragraph or provision of this Agreement shall not
affect the validity or enforceability of any other section, paragraph or provision hereof. If any Section, paragraph or provision of
this Agreement is for any reason determined to be invalid or unenforceable, there shall be deemed to be made such minor changes (and
only such minor changes) as are necessary to make it valid and enforceable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
12. Governing Law Provisions; Exclusive Jurisdiction</B>. This Agreement and the transactions contemplated hereby shall be governed as
to validity, interpretation, construction, effect and in all other respects by the internal laws of the State of New York. Each of the
Placement Agent and the Company: (i) agrees that any legal suit, action or Proceeding arising out of or relating to this Agreement and/or
the transactions contemplated hereby shall be instituted exclusively in the New York Supreme Court, County of New York, or in the United
States District Court for the Southern District of New York, (ii) waives any objection which it may have or hereafter to the venue of
any such suit, action or Proceeding, and (iii) irrevocably consents to the jurisdiction of the New York Supreme Court, County of New
York, and the United States District Court for the Southern District of New York in any such suit, action or Proceeding. Each of the
Placement Agent and the Company further agrees to accept and acknowledge service of any and all process which may be served in any such
suit, action or Proceeding in the New York Supreme Court, County of New York, or in the United States District Court for the Southern
District of New York and agrees that service of process upon the Company mailed by certified mail to the Company&rsquo;s address shall
be deemed in every respect effective service of process upon the Company, in any such suit, action or Proceeding, and service of process
upon the Placement Agent mailed by certified mail to the Placement Agent&rsquo;s address shall be deemed in every respect effective service
process upon the Placement Agent, in any such suit, action or Proceeding. If either party shall commence an action or Proceeding to enforce
any provision of this Agreement, then the prevailing party in such action or Proceeding shall be reimbursed by the other party for its
reasonable attorney&rsquo;s fees and other costs and expenses incurred with the investigation, preparation and prosecution of such action
or Proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
13. General Provisions</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
This Agreement constitutes the entire agreement of the parties to this Agreement and supersedes all prior written or oral and all contemporaneous
oral agreements, understandings and negotiations with respect to the subject matter hereof. Notwithstanding anything herein to the contrary,
the Engagement Agreement, dated November 8, 2024 (&ldquo;<B>Engagement Agreement</B>&rdquo;), between the Company and the Placement Agent,
shall continue to be effective, and the terms therein shall continue to survive and be enforceable by the Placement Agent in accordance
with its terms, provided that, in the event of a conflict between the terms of the Engagement Agreement and this Agreement, the terms
of this Agreement shall prevail. This Agreement may be executed in two or more counterparts, each one of which shall be an original,
with the same effect as if the signatures thereto and hereto were upon the same instrument. This Agreement may not be amended or modified
unless in writing by all of the parties hereto, and no condition herein (express or implied) may be waived unless waived in writing by
each party whom the condition is meant to benefit. Section headings herein are for the convenience of the parties only and shall not
affect the construction or interpretation of this Agreement. If any provision contained in this Agreement is in conflict with, or inconsistent
with, any provision in that certain Securities Purchase Agreement dated as of [&#9679;], 2024 (the &ldquo;<B>Securities Purchase Agreement</B>&rdquo;),
by and between the Company and the purchasers listed on the signature page thereto, the terms of the Securities Purchase Agreement shall
govern and control.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The Company acknowledges that in connection with the Offering of the Securities: (i) the Placement Agent has acted at arm&rsquo;s length,
is not an agent of, and owes no fiduciary duties to the Company or any other person, (ii) the Placement Agent owes the Company only those
duties and obligations set forth in this Agreement and (iii) the Placement Agent may have interests that differ from those of the Company.
The Company waives to the full extent permitted by applicable law any claims it may have against the Placement Agent arising from an
alleged breach of fiduciary duty in connection with the offering of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<I>The
remainder of this page has been intentionally left blank.</I>]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the foregoing is in accordance with your understanding of our agreement, please sign below whereupon this instrument, along with all
counterparts hereof, shall become a binding agreement in accordance with its terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Algorhythm
    Holdings, Inc.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Gary Atkinson</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gary
    Atkinson</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accepted
and agreed to as of the date first written above:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Univest
    Securities, LLC</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Yi (Edric) Guo</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yi
    (Edric) Guo</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Exhibit
A</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
of Lock-Up Agreement</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Attached]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 23; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>8
<FILENAME>ex23-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
23.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><U>Independent
Registered Public Accounting Firm&rsquo;s Consent</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
consent to the inclusion in this Registration Statement of Algorhythm Holdings, Inc. (f/k/a The Singing Machine Company, Inc.) on
Amendment No. 1 to Form S-1 (File No. 333-283178) of our report dated April 15, 2024, which includes an explanatory paragraph as to
the Algorhythm Holdings, Inc.&rsquo;s ability to continue as a going concern, with respect to our audit of the financial statements
of Algorhythm Holdings, Inc. as of December 31, 2023 and for the nine-month transition period from April 1, 2023 through December
31, 2023, which report appears in the Prospectus, which is part of this Registration Statement. We also consent to the reference to
our Firm under the heading &ldquo;Experts&rdquo; in such Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
Marcum <FONT STYLE="font-variant: small-caps">llp</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Marcum
<FONT STYLE="font-variant: small-caps">llp</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Philadelphia,
Pennsylvania</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">November
25, 2024</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>9
<FILENAME>ex23-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 23.2</B></P>

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Segoe UI, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</B></FONT></P>

<P STYLE="font: 10pt Segoe UI, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Segoe UI, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
consent to the inclusion in Amendment No. 1 to this Registration Statement of Algorhythm Holdings, Inc. (formerly known as The
Singing Machine Company, Inc.) on Form S-1 (No. 333-283178) to be filed on or about November 25, 2024 of our report dated
July 14, 2023, on our audits of the consolidated balance sheet as of March 31, 2023 and the related consolidated statements of operations,
cash flows and shareholders&rsquo; equity for each of the two years then ended. We also consent to the reference to our firm under the
caption &ldquo;Experts&rdquo; in this Registration Statement. </FONT></P>

<P STYLE="font: 10pt Segoe UI, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Segoe UI, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
EisnerAmper LLP</I></FONT></P>

<P STYLE="font: 10pt Segoe UI, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Segoe UI, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EISNERAMPER
LLP</FONT></P>

<P STYLE="font: 10pt Segoe UI, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">West
Palm Beach, Florida</FONT></P>

<P STYLE="margin: 0; font: 10pt/115% Segoe UI, Helvetica, Sans-Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">November
25, 2024</FONT></P>

<P STYLE="font: 10pt/115% Segoe UI, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/115% Segoe UI, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/115% Segoe UI, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.3
<SEQUENCE>10
<FILENAME>ex23-3.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"><B>Exhibit 23.3</B></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex23-3_001.jpg" ALT="">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>forms-1_001.jpg
<TEXT>
begin 644 forms-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  S ,4# 2(  A$! Q$!_\0
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M;F/RV9#\P'M^59'@WP+IW@F*[CT^>XE%RRLWG$'&,], >M6<1SWQR_Y)X?\
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MO\(]$?PK'X?-W>_9H[LW8?<N[<5VXZ8QB@"Q\(/^28:3]9O_ $:]>=_M _\
M(;T;_KW?_P!"KV;PUH%MX7T&VTBTDDD@@W;6E(+'<Q8YQ[FL7QE\.]+\:W=K
M<7]Q<Q-;H440D $$YYR#0!X9XU_Y'71/^O&Q_P#0%KZCK@-4^$NBZMJEK?S7
M=XLEM%#$@5EP1& !GCVKOZ!'S?\ ![_DJLO_ %RG_G7K?Q;_ .28ZS_NQ?\
MHU*;X:^&&D>%_$+:S9W5W).5==LK*5^;KT%=%XCT*W\3:#<Z1=R21P7 4,T9
M 888-QGW% SSGX ?\BGJ?_7]_P"TUHKN/!W@VP\%Z=/96$T\L<TOFL9B"0<
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-223DT44 6Z*** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>forms-1_003.jpg
<TEXT>
begin 644 forms-1_003.jpg
M_]C_X  02D9)1@ ! 0$ 9 !D  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !: 5X# 2(  A$! Q$!_\0
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M599K"_,3$%Q)@J(GQID$)N*Q&(JJ,K.K1PE6=%):.3GSJ7+?K[--K51LU??
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MT$,*<_\ \$^O^#E/]O+XC?M#_L3_ +(FN?"[]DRT^&?C7XM_L\_L[:MK&D>
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MS>:3X'\#^%(]4T)-<\22Z9:SZQJU[?ZU8:1X7TR;3+R^:\O=7TG2[[^BM_\
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M %._^"!'_*'[]AC_ +)AXA_]69XXH"M\%/TA_P"DG[!U_FL_\'7O_*5C2/\
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MZ+/)<SV7A[XG?#K6O"7A?Q'=Z3 '^S:>WC;P5XJMO^$AN/+'VN7P!X9B+*X
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MD^H>&)+^-K*T75'M+EY=3\!^(+2RU@I+?RS7KQ^<ONOBG_@N/^W?XZL!X?\
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M4<;@84)XO#/'99F^+R_,84,+_:=<,5"$#/S=.!D\8&>O3/ !)Z %MH/\<?\
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M"#X. %5E52RG:>0""RO@\5_5K09R^*3\V?Q#?\'EG_'G_P $YO\ K]_:T_\
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M^3Z9'FT>2*)2\DVFO'&HP"SO:E44$\98D!<D D@9!(S_ &V?\&>6DZ;KT?\
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M-C.#C\H?^#5Z&XC_ ."LVD-+;742_P##-'QQ4-/;31+N-_\ #T@!GC5<D!L
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M.0RNL3*RD8(*L>#]:":+M)Z7NDNB^TGUTZ'^@;_P;(_\H>/V=_\ L=?VAO\
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M.N>'?$>@:S9PZCH^N:#K>F3W6F:QH^JZ?<6]]INIZ?=7%E?6<\-S:SRPRH[
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M!TVZOAJ/BRS^P:-=ZE'=6<TWV\D,<8544(B!%2- $2-8QM1$1 JJBK@!0,8
M&.!7\C6H&W@_X-M_VG[BYC0:3IG[4O[1&J:X#$9+2U\-:-_P52US4O$-Q=VR
M*P;2['0;2^N=0A\LPKIT,^]!&&(!;OM_7<_7/PY^V=_P4T\;>&M)^*GA;_@E
M1I5I\,-=TI/$VB^#_'/[:?@3P?\ M+:CX6O;=M0T>2[^&#_"O4_AWX9\::GI
M4MI=?\(+XC^,]F^EWSS:-KNOZ3>PRM%Z-^R/_P %./A;^U)^S/\ M-?M8ZKX
M,\8? WX3_LP?%#X[^"/&P^)$,@\76/ACX >$]'\8>-/%WB?PK::?!?>%=5T[
M3K_4K35_!&_6K[2=1T*\MHM8U19H9C^D\4UM=1P7-M<0W$%Q'#<6\T$L<L4\
M,J*\4T,L999(98V61'C8I(C!E8JW/\_'_!.G7/V=/B-^R7_P64UCXM>*?"EW
M^RGXX_X*)?\ !2&W^*?C*?718>"KKX(^(/#GA?2_B!KDGBG3;B*.T\.3^%;C
M6+N7Q#I]TL4=@7U&TN@GE75 )=>B:7F?1O@/]MO_ (*2_&?P!X6^-WPA_P""
M97@4_"'Q]X;T_P =_#[1_BQ^V[X:^'OQU\3^!/$%DNM^$-3U+P%I'P0\;^!?
M!/B/Q1X=N]+U&+PIK_Q3DDT&ZOAIGB'4["YM[O[/]R?L??M2^$?VQ_@)X2^.
M_@WP]XK\%Q:W?^+/"WBOX=^/M/@TOQU\-/B/\._%>L> _B/\//%]G:7%[:)K
M?A#QEX?UC1YKBRGFL=1@MX-2LY7M;R U\$_#;]F?_@IY^SS\-_!O@W]F+]O#
M]F;]HOX1>%/!OAGPO\)O#W[7_P"R_P"(H_&-G\.M TRVL_!%MJ/Q\_9R^,G@
MBU\8:@?"T.E:3/XQU/X*W%SJBVZ^(KVUU'4KJ[%Q]9_L%?M4Z[^UE\'O%_B'
MQQ\.-*^$WQ>^#OQT^,G[-WQR\#^&_$S^,_!FG?%[X*^+)O#7BO4? GC&XT/P
MU?>)?!GB6-]-\2Z%?ZMX=T;6+:#57TG5+1[W3I[NY :O=JUOQ7JG_FS[CHHH
MH$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !7SY\&?V;/ ?P,\??M*?$7PAJ'BB]UW]J;XP:=\;/B+!K^H:=
M>:9IWBS3/A7\._A!;6?A.WLM(TVXTW0CX8^&?A^YEM-3NM9O7UB?4[E=12TG
MMK&T^@Z* /-?C-\+/#OQS^$'Q5^"?C"YU>S\)?&#X;>.OA;XHN_#]U;V.NVW
MAWX@^%]5\):W<:+>W=GJ-K9ZM!IFL74NFW5S87MO;WJ02S6ES$CP2>,>-?V+
M/@+\2OV2-'_8I^)/A_4_'/P0T7X9^ /A?9V^K:Q<V'B^&R^&&GZ#9^!O%MCX
ML\-KH>HZ'X_\-ZAX:T7Q+I'BOPX-'N]+\26$.J:;'9[%A7ZQHH _)+5/^"6?
MC/Q1X>NOAWXW_P""G_\ P4L\7_"?4],'AW7? ]Y\4/@CH>J^(_"@A2VN/#FM
M_%CPG\ - ^,$T6K62/I^OZY8^.=/\5:U97-ZESKJW%W+<U]I>)_V.?V;_%?[
M*.J?L17WPNT*P_9AU3X4/\%/^%6Z"UYHNEZ;\/1I2:19Z;H]_8W,>KZ;J6FQ
MQ07^G^(;>_&NV^N01:]_:#ZNK7C?3=% 7_S/A?3OV OA=JG[)WCC]C?XY_$?
MX[?M8?"OQ]]JBU?7/VD_B%;^,OBC9V &BS^'K/1_B'X:\/\ @S6;&Y\$:UH&
MG>*/!GB0^?XPT3Q3$-=7Q%/>Q6SV_@A_X)6R>)["Q\"?&O\ ;\_;[_:$^!-O
M)I\&O? ?XI_$KX51>$?B/X?TIH_L_@SXL^,/ 7P8\$_%OXB>$-2CC2#QAHFM
M?$'R?B#9>?IOCI_$&E7^IV-_^L=% 'Q7\)_V#_@M\&?V-O$_[#7@V_\ &T?P
M7\5>&_CQX3N[F\U/0AXNT[1OVA?$/CSQ)XRM]%O]-\-Z=H.G#2+OXA:U:^$8
ME\-R6ND:?:Z3;7-MJ/V262YF^(G[#'P?^)O[&/AO]A;Q!K'CZW^#OA;P3\#O
M 6G:OI.M:/;>/I-%^ &K^!-:\%RWFMW/AZ\TB74+V[^'FAKXAN(_#T,5[!-J
M*V-OILD\$MM]G44!=_K\Q ,$GU_+J>WKS@GO@5\(Z#^R_P# ;]DO]C#XR?!E
MO!WCSXV_ U=)_:6^)7C[X;:QINF?$7QK\1=)^+?B+QU\5OB9X"T;P]I^G>&[
M3Q,^LW/BO7O#_A+PV(8+Z[MYM+TJ74KJ^9[^;[OJ*3JO_ C^(*X/U'8]J /Y
MN?A-\%O^";'C;]G;PEXG\&?\%A?VIM'_ &-=5\$66IVWP0\0_P#!0GP5X4\$
M^$_A2-+C:]^#GBO7]3TZT_:"\$>'?"NC*W@WQ)X.U'XO:;XH\*VME>^$K[5K
M-;2>!?H#_@B[\%?AEKW[%/[2JZ=\+]#TS]E+]KC]K?\ :X^('P5^&6H^$9-!
M\+Z[^R3X\O['X6^ K63P9J5C8O;>"O'O@/PC)JVAZ=>Z?;_VCX)U_2;B>$_;
M69OT7\1?L#?L*>,/'UU\5O%O[%G[)?BCXHWVK1Z_>_$GQ%^SE\'M;\?7FNQ2
M12Q:U=>,=3\&W7B*XU:*6"&6/4I=1>\22&)UF#1H1]56T44"^3#''## J0PQ
M1(L<<,,8V1Q11H L<<:*J(B *JJJJ    =WM?3_(_)KPS_P2P\4?#CPUI/PV
M^#G_  4K_P""B?PM^#7A;3T\.>!OA?IGCSX$^,[7P#X+ME>VTGP1X8\>_$_X
M >-_BC_PC_AC2_(T+PG)KWC77=;\/Z'8:98P:Q(;&"8?=7[,/[,/PJ_9%^$6
MC_!GX06GB!/#UAJ_B7Q5KGB#QCXEU3QIX_\ 'WCSQOKEWXG\<_$3XA^--<FN
I-8\6>-O&7B/4+W6->UF^E DGG2TL+:PTJSL-/M?H6B@+NUNG]>1__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>forms-1a_001.jpg
<TEXT>
begin 644 forms-1a_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !- 2P# 2(  A$! Q$!_\0
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M64G6E7P\\1.,*=5QE_5S.=L1]5=!P2."01R 3CZ@YQT)K\#/ ?[=?[2&N_\
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M$IQHW_V//!FB?MS?\%;OBYX_^)<<?BGPQX(\2_$#XDC2-4CD>SU.#P-XAM?
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MXT^XEFGGE;P]X#\<?'_PWX8MG>XEE?9IGA^STW2;:-2(H;2P@AB1$0"O</\
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MO$Q#! H^S/V*O^5?7_@MP?7XK?L7G'?CXT?"'CZGH/>OGG_@@J=__!7O]B0
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M +K4]6\(WVI:A.0,RWM_>W5U<.3-<7$DK.Y_D5_X.F_^"=O[)7[-_@_]G_\
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M^@:E=6#3QS0I>165]<O:2312Q)<+&QCDVLK?T _\&ZP O?\ @K8!C_E%U\6
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M]I:==^)=TQCT1]0\3:G:6]W]GN9- U8Q_8I?=/\ @C/^P1\2O ?BSQ'^V/\
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MW$6J>,O&>MB";Q/XSUQ83"E_JUS"D,4-K:1EX=+TBS6.PTR%C';H\DEQ//\
M7(3Y@2!QSNQSVX]A^?3J,TNQ>X!].OX=ZO+\BRG+*LJ^$PKC7E'E]O5KUL15
MC%JSC3G7E-PBU=-1Y;K1NVAQ>(_TA/%WQ7RO#Y'QIQ33Q.28?$0Q?]D9/DN4
M<.9=B<525J-?'X?)\/A_[0EA_>EA8XN=2CAJLIXBG0^LS6(IL1>0?;KR 1D$
M8YQUYQCL!TJ1AG'UZ\_Y_/'ZTX #@45ZWGUM;I>R]-#\7Z)+2RLO+^OZT(U!
M4-P<G@<9['GZ?I]>:<N['/4]..1G_(X_E3J*/Z_KL*W].S_00=!GK]/7_/-
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M=X5\7W>E6D_B3P[IWB"V5(-<T[1]9>\L+'5HHXDU&U@BNQ#"9C&H([2BBB@
MHHHH *,#T_SU_GS110 @&/\ (_IBEHHH /\ /^?UH_R:** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ KX&_P""8O@_Q;X#_8C^#GA/QWX5\3>"?%6E
M7?Q2.I^&/%^BZGX<\0Z;'J'QB^(.I:<]_HVKP6NHVB7^F7EIJ-DUQ GVJQNK
M:\A+PS1R-]\$9!'J"/S&*14"G.<GU/\ GI@ 8Z#'N: /S<^+O@CQOJ/_  5!
M_8L\?:=X,\6ZCX"\*_LV?M=Z'XF\;6/A[5;OP?X9USQ+K/P0F\.Z)KOB2"V?
M1]&U;Q!%H^IMHFG:A=6UUJT>E7ILTN!8S^5\I?LU?%BY_P""<WB#]I[]GSX\
M? K]K;5_#WBC]JOXZ?M%?!CXS_ S]DWX]_M/_#GXB_#_ ./WC&7XCQZ1?7W[
M-O@#XH:EX#\=>!=>U;6?#FO>'/'VD>&#J%EIVGZWX?N]9M+ZX-I^YQB!W8)7
M</X>,'.2P[;B2<DC/..E-*;00K%0.<#WXYQCTS]3SF@#\>?V;?"GQ9_:*^*G
M_!1W]J*_^$/Q!^!_@']I_P"#?P-_9U_9_P#"_P =/#.J_#CXN^)]-^!?A;]H
M1=8^*GC;X9:Y;P^(_AGX=\7>*_CPVE>#O#GC.TTKQPVB^$[G7_$/AW05U>PL
M!\G?#?PA\?O'?_!'K]GKX >%?V9_CEH'[3__  3GL_\ @GO>^*_@Y\8/ UY\
M++7XU^,_V)_%OPD\>>,O"OP+^)&LW$_P^^(>C>.K3X6:UIW@7QOH6OW7A][[
M5_#UKXDF\.WU_=VFF_T=J#@\G.3S]!MY]>F?K[5&4SSD\;B??:V>A)QGO^F!
MQ0!^%?[9?[>7BC]H[]CO]H+X*?LF_L=?MR>,OC]\8_V??BKX1L/#/QD_8N_:
M6_9\\#?#1/$?P^U>T\2ZCX^^)'Q7^'/A;P=XAUGPWIMYJMKX;\"?"#6_B5XM
M^)GCJVTGPMX+T^_TS5Y/$^G^L_$_X:?$._\ @W_P1WTK2/AYX\O+SX7_ +17
M[+6M?$33(?"FM3ZI\.O#_AW]F/XE:!KFK^/[2&S>7PE8:!K>H:?HFN7NMK:6
MVG:Q>VVFW,L5W/%$WZ^>6>[L?J>^>_KQQ]/?.5\L9)SG(P<C/' P?7ZGG)SG
MM0%_Z_ _.CPAX)\:6_\ P57^.'Q#NO!WBJ#X>ZK^PE^SSX1TGQY-X?U2+P;J
MGBS1/C?\>M7U?POIWB=K9=)O?$>DZ9K.E:IJNAV]U+J%AIVJ:9>7=O%;7]J\
MO-_$_P !>.[W_@K;^R'\2;#P3XMOOAOX9_8O_:X\*^)?B#:>'=4N?!/AWQ/X
MC^(_[/%_X<\-:YXHBMVT;2=>U^QT/6[S1=*O;J*^U.UT?4YK6"2.RN6B_3Q4
MVG@G'0+V XP /;'UY/-1F/>'7=M^<L"!GYLY4D'*G:RAL$8)'(Y- 'X2_LT?
M&3QI_P $Y]$^+O[,/QB_9-_;,\?1:?\ M"?'OXG?";XK_LX?L[>-?VB?AU\6
M_AY\9_B)J_Q0\/R2ZY\-H-4?X=>-=%N_%>H>$_$?AGXB6WAVQMI])MM9L/$-
M]I=],^G<A^PMX[_:4\<_M$?\%S_B/H?PFT+X=_M):_J7[./B+X*_!?XHZY"+
M;0-9C_8RLO\ A0'AKXWZMX4N]3M-#UGQ%#;>%-8^*FG^&-4URW\&3>(M6\.:
M?K.N2Z$;ZY^\/%G[+W[6OA?XG?%'Q5\ /VZ]0\#>!/BWXKE^(5W\,_C+\"],
M_:&MO /BZ\T?2M$UFR^%WBF]^)?P]U?PK\.=1BT33]6M?AW=0:UINA^(;KQ!
MJ.CW]I:ZW)IMMZU^QY^RB?V8M#^*^M>*_B?KGQS^.?[0_P 4+GXT?'GXT>(_
M#NA>$KKQGXPD\*^&O ?AW1_#WA'P\)-/\&?#WP#X!\%^%O"'@?PA'J6M2Z7I
MVFW%[J&M:MK6KZMJ=V#NK>?_  ;^7ZGXL?$E_P#@FY\6?A_J?C#Q3_P2._;!
M^%_[96M>&YGN--^!7_!-?]J#X4_'/PU\;+P.[/X2_; ^"_PS\*?"5-6T[Q=>
M76HZ=\8X_P!H&+P;-HWVK5]3\5KH][?V\_[O?L?:/\:_#O[*W[/.A?M(ZI<:
MS\>](^#W@'3OB[JE[J5EK&H7OCVT\.6$'B*75-7TZ&WL-6U;[>DJ:KJEI&T&
HH:BES=QS7"S"XE^BS&3GYWY)/!(X/4=>GIZ4")0,$;L=SUQZ4"/_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>ex23-3_001.jpg
<TEXT>
begin 644 ex23-3_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" 2/ X0# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^_')'0D?C
M2$MC@G\S_G^7U'6BB@#'U#2A?R+.]UJ<3ID"*RUC5-,A8$%<NME<E&8 Y!\H
MY8#.WEA'9Z0+21Y([C5"S1-'YESXAUC4L LIVI:7\CV:,0#BY\IKA,E4.,5N
M44 1PJT<4<>^1MB(F9)7E<E1@EI7 >1C@9=@&8Y8C)R9<GU/YFDHH 7)]3^9
MHR?4_F:2B@!<GU/YFC)]3^9I** %R?4_F:,GU/YFDHH 7)]3^9K-OK-[T,CS
M7*1A08Q;7]_I[B0$EF>:PN+:5D(V@(9 ,@Y&"2-&B@#FCX?&TC[9J[@@90^)
M?$D))X.//CU)I$Y[J"2!@Y!-26FBFTD,T<FHF3:5$5QXI\2:A"X( +%;ZZFC
MC9>Q6%R<DY! ST&!Z#\A2X Z "@QA14)<RE)[Z-M[^K9% K10QH2^57!#3RW
M)').#/-^]EZ_?D^8].   VYA6X55=I\*VX>3>7EFV<$<O:2([CG[CYC)Y."!
MF>B@V,>'37@NY;B.>\9)$"K'-K&KW C89!*0W=Q/:C/4'[.I['<0&K8#-CDG
M\S_G^7T'2BB@!<GU/YFC)]3^9I** %R?4_F:,GU/YFDHH 7)]3^9HR?4_F:2
MB@!<GU/YFC)]3^9I** %R?4_F:,GU/YFDHH 7)]3^9HR?4_F:2B@!<GU/YFC
M)]3^9I** %R?4_F:,GU/YFDHH 7)]3^9HR?4_F:2B@!<GU/YFC)]3^9I** %
MR?4_F:,GU/YFDHH 7)]3^9HR?4_F:2B@!<GU/YFC)]3^9I** %R?4_F:,GU/
MYFDHH 7)]3^9HR?4_F:2B@!<GU/YFC)]3^9I** %R?4_F:,GU/YFDHH 7)]3
M^9I*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $.2#C
MKCCZ]C^!Y]?2HXO,\H)= 2/G.8\E> ,8R$/!SVJ6B@! %'W5VKV'OR2<9.,D
M_IGO2T44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 5'*[(N47>=RC;ST) )X]!S^%24$ _P"?\\>W2@ ^7(VDG@[N2<'C
M'7IW_P BBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BCG&<?+G&<\YSCI]??IS10 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% &?Y>H&\F=7M!9D((UD60RY"(),XEV#YP^T^
M6#M(SGK5\=!]!UZ_C2%%;[P!^O\ G^>?:G4 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%(?ZKGV&1N/X#)J+SD-QY"H5(0N6_A905  ]_F!]AGW% $U%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 48'^?\\444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?^"UD<<O[!/CQ))/+1_&OPW0@1/*92WB- (P(RK"0;_-A9FV+-%$&5U8QO\
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M?;7]K%?%_P"PQ^QCX,_8K^#&G?#C0)K+7/%E^YU3X@^.XM.^PW7BOQ!*[O\
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M?$'A32? OQ)T>RU74M'N+?6/ GB/Q#I^LZ'K&G^(]"N-4T$W>H6?Z:$8+#G
M(QGD\@'^9K^.S_@A9^SG_P $!_AQ^WS\7?%'_!.[]K;QY^T5^T.? GQ$U'P!
M\/?&VB?$33O"OP8^"TOB#PAI/C2U^'_B+Q3\&? 5AX^U.TU/5=+T&S\2W_CC
MQ;XBO? %ZHLM/O/L?BWQGK']3?[0?[47[./[*7@:7XG?M+_&[X8? OP(+F6P
MMO$GQ/\ &6B>$K/5M6AL+C4O[!\.PZO=V][XG\23V%G=75GX;\.VNJ:[?1V\
MAL]/G9"!-1\OPQG+;W;:ZK6]KV75/M:]KZ*$[QO)PW:O&2:W:2N[:]&N]TEL
M>\$@=2!]:3([$9[<U^ ^E?\ !SO_ ,$2+V_FLG_;0EL/)NGM8[G5?V<?VJ[/
M3KY4#8O+741\$)K2.SD(S')J,NGR. &$(5@:_9R'X_?!6]^"5Q^T=:_%#P+=
M_ 2+X;W_ ,7V^,5AXBTZ^^'@^%VEZ!<^*=2\>CQ3:33:8?#-CX=L[O5[K5%G
M,,%G;3R2%3$ZJH\S5W"4&VTE)..W:Z6GG^92E%WY91E;7W6GNKK9O?H=Y-XC
MT2T=%N-5BW2ZF='AA53N_M'SF@-H2N3YBR+L)8@9!(YR*WD975)$)*OR,YZ8
M..I."<9QU'0\Y%?Y8?\ P5T_X*]^*?C!_P %6;GXR?L4?\%$OVF[7]DRVE_9
M^/A[4?AOXD^.GPU\&> DT+1O"UE\5H_#'PDU:\\%R>*X1JFGZQXKU4:MX3LX
M_&>LZKJ.AE=3TN"TO;O_ $8OV+_^"C7[%/\ P4*\/^,_$O[''QY\-?&C3/AS
MJ&B:?XYL=.T+QIX.\3^$9_$]M?WGAR77_!GQ$\,^#_%VFZ=K\6EZQ'HVJSZ&
MNEZE>Z'KNGV5Y-?:'JUM9Q.G5I.,YR;@W=Z.,81>RES-*]VDN]C.%6%24HQ:
MO&5MT^;2[:2;=O/_ (8^W:3(]1^=?GC^VW_P52_8+_X)WW?AO3?VO/VC?"_P
MJ\1>,=,?6_"O@2VT+QI\0_B+K6AQS7EFNO)X ^&7AGQCXLT[PU=ZEIVHZ18^
M*]=TO2?"UYJUA?Z;!K+W>G7T=M\O_LY?\'$7_!(7]J/XC^&_A%\//VLM+\._
M$/QEJ9T?PGHGQ<^'GQ/^#NF^(=5<+]@TG3_''Q#\':'\.QK>MW31:;X=\/7O
MBZS\0>)-8GM=&T+2M1U2\M;2;:S:YDFXVO=)M6[W2:M\R^>-^7FC?MS*_I:]
M[^7]+]KZ*A,R@9)(^8)@HS.6/\.Q 6S[ 9)(&.":_)C]H7_@NW_P23_9:^(^
MM?"3XS_ML?#;2?B+X7U#4='\4^&/!?A_XE_&*X\*:_I%W+IVL>&_%E[\&O W
MC_2_#'B;1]0AGL-7\-Z[?6&O:7?6]S9W^G6]S;3Q(H^]\/O?X=?R7E_PPW*,
M5>345W;27WMH_6S(]1^8I:_.S]D3_@K5_P $Z/V[]?N_"'[*O[5_PO\ B?XY
MM?M3I\.KEO$?P[^)NIVMA92:CJ.I^'_AK\5/#_@CQWXGT32[*)Y]5UWPWX?U
M71]+48U"]MF*JWZ)*20"1M)Y*YS@DYQGVIM-:--/L] 34DFFFGLTTT_FKB_F
M?H"3^0KS3XL_&CX._ 3P?<?$/XZ_%GX9_!7P!:7EKIUWXY^+?CSPM\./!]KJ
M%[YIL[&X\3>,=5T;1H;R[$$QMK:2]6><12&)'V-B?XN_$WP7\%/A7\2/C+\2
M=7'A_P"'?PC\!^,/B=X]UTPS7/\ 8W@SP%X<U+Q3XGU06UNKW%RUAHFE7MTM
MO CS3M$(HD=V53_E*66E?M\?\'.7_!2;Q/#INOZ;I!BTWQ7X\T73OB'XGU$?
M!_\ 9%_9UTS7-'TBPTC1M,TZREN]3UJ>XU/PEX?NH?"?AQ?$WQ2^(.H2^*/$
MCZ/X>M?$7B3PI4(<UVWRQBKR=K_)>?E^6YG5J^SY4HN<YNT8JROW;;V2W;U_
M0_T;]-_X+3_\$F]4U@:-#_P48_8X@GDN3:Q7%_\ 'CP)I>FM*I96>76M4U2R
MT2"UW(2MY-J*6KJ5=9RCH3^CWA/Q9X7\=>'='\8>"?$N@>,?"/B/3[?5O#OB
MKPMK&F^(?#>OZ5=H)+;4]$US1[F\TO5=/N$(:"]L+NXMI5YCD85_#GXO_P"#
M*+PC%\+KV/P#_P % /%5]\:[72KN>POO&?P.T/3/A+X@UJ*UDDL=+O="T3QS
MJ7C3P=I&IWJPVEUKD7BCQU>Z#:SRZC%X>\22VPTJ\_);_@AI^WC^T+_P1S_X
M*=7?[ W[3]WXJ\*?!GXC_&23]GGXY?!;5[XZCX>^%WQOUK6;'PO\/?CYX#L[
MJXM["UL-1UC_ (1^P\2^,?"\T/A_XD?!/Q1;>.)[3QC/X3^&TNG5R1<9<LDW
M'5IJSM?H[V^6_P"D^WDFE.BH1EIS1;E:5OM:72=G[VJOV5C_ $D?CM^UG^RW
M^R^OA8_M)?M*? #]GMO&IUO_ (0[_A>?QF^'/PE_X2[_ (1@:0?$O_"*)X_\
M2>'V\0G0#X@T-=:&D+>?V4=:TD7WD'4K,3?*NI_\%E/^"4.C21PWO_!1[]BJ
M1I6V(=+_ &C/ACKL8(,8/FSZ%XAU*"%/WJX>:2-2!(0V(IBG\H__  >V0./%
M'_!-&YV 12Z!^V/;HX*Y>:UU3]EUYDV_?P@N8F5F78QD.W+*X%?]CG_@TC_9
MT_:D_8M_96_:*U7]L+X\^#O'WQ]_9]^$OQN\0:7IW@;X=ZEX+T*[^*O@K1_'
M2>']$T^_M+/7)K;0+37K?1FO[WQ-=3:K<6,VK)#I\-]'IEE*C'E4I2:NVDE&
M^WS0Y5I1G*G&E&=HP=Y-Z<RD[))/MNW;3Y']O_P2_::_9N_:5T?5=?\ V=_V
M@O@G\?=%T*XMK77-7^"?Q5\"_%'3-%N;T2M9VNL7G@?7=;@TNZN1;W'DV^H/
M;S2>1,%0^5)M]P&0.>H'..F>]?Y)_P"VK^S!^TY_P;;?\%*?AEK_ ,#OCC;>
M-]3M?"6@_&7X/_$FUT;4/"$7Q*^'%YX@O] \;?!_XV> [+7+NWFL)]=\,ZKX
M:\6:-IWB74]&\3>%;[PQXUT>]\*^*+TZ#X*_U-?A1^T;\./BG^S'\,OVLAJ<
M/@_X2?$KX"^#?VC$U?Q7<1:=!X8^''C#X=Z=\3?[2\1WDWDV^GPZ'X9U W.L
M7,_DPVJ6MQ)(45#@G#EY6GS*2]UV:VZ?>%.K[3G4H^SG!^]&Z:2>J:?9I-ZV
MUOHNGB?QR_X*;?\ !/3]FCXCW_P@^/O[:'[-_P (_BEI%GI-_K7@#QS\5_"V
MA^*] MM=L8-4T5]?T6>_^UZ')JFDW=EK-A;ZO'97%UHU_IVK11-INH65U/\
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M\G9>F?#]E7QYX",ZVER%^(/@^1 \22@[-<L?+:.*0B*4EQG#MM0!MXVLX/\
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M'*?E.Y #(C?=<!U'0-\PP<FI5@VJJKL" Y"HH5>N2  -J\YS@#CBOY9?&/\
MP<4^)KC7I!\.OV>K%O#T%U-'M\6^(WAU.YM?WGD,5TU)+>.X93$\FR62WWJ\
M2[D?S1]3_LV_\%[_ ($_$WQ'9>"_C5X/UGX*:A>RVMI!XN>:+7?!(O;GS,KJ
M$UN@U#2+8.L8%W<PR6Z+*#(ZA'(_1L?X+>)^7X*>/Q7">82PM*FJTH4*V#Q=
M>G#5RDL'A\95Q'/%)NI"%*511BVH2BKGY]@O%_PNQV-IX/!\99)/$XBHZ%*<
MI5\-1KU8S=-4J>-Q."PN&J3E43A3BL3:I+E]G*:G3E/]^P !@  >U5D^XO\
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MD_\ !<+XF_'7X@_L@^./VD/@M\0/#5S;>+OBM\*/A7?6WPB\/VD_C_4M7O\
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M^'UTG3=0U&:VTGQU\'/'4UC8:%HOCFRL=7U5?#N@:/XG_P"$?T__ %XV&TL
M, *,#V&['UK_ #"_^#O"T:^_X*Z>";#^S]0U=[[]D3X V7]DZ7(L6K:JUU\3
M?C9!_9FF326U\D6I7[2?9;&5[*]6.[EB=[2Z ,$G^GJV-[8QT&?KSG/OZTJC
MYHTI/=\Z?G:UK^9=&*A4KPCI!2@XQZ)RAS.WELEV,3Q%K6E>&M'U77=?UC3=
M T'0M,O=<UWQ#K5[:Z7I&AZ-I,$E_J6KZMJ=[+;V.FZ9IEG;SWNH:A>SP6=E
M9PRW-S+'#%(X_P ?_P#X*&_M4?!'X4?\%:OCA^U3_P $D?B9XL^%G@^3QKK'
MBGX?_$OPD+C0+>+XB?$7PA>Z3\=]3^%.G^([(ZAI_P ,_%VO>)O&2:#I.IZ7
M%I]M9ZQJ">$=.TOP4GA"ULO] [_@Z#7XJ?\ #F/]J"7X8W>K6UI!K?P4/Q2&
MC-<?VA=?".?XO^$;3Q=:[K4&[_L=KRXT.;Q>MNRPR>#8?$$>M%O#KZPC?A9_
MP:;_  #_ ."=7[1O[)?[:?PK^-7PY^$?Q2_:>\?^-M>\"_$SP?XW,E_X_P!1
M_9#UGP)\/CX6_P"$*M[G['>>'/"Y^)8\?3ZMXC^&UU#XJTOQKIGA76O$FO:=
M=:?\+DTR5*%*$ZLTW"-HR2BY;VLW&*;:7DF_*UV3B6Y.%._+9.HIVN[Q:2C'
MS?-=[NRLDV;/_!J%_P $_/V?OB[JWBO_ (*F_$[X^V7[1'[7_A[QA\0-.L_A
M#<^)+W5?%GP"\5^/+_Q?H^J_&CX[7.MWDWBOQI\5OC?HB>*-5\!>(]4>;P=;
M^&M?\6:S)J/C+XFR7-Q\+?Z[_P!D'_@HI^QC^WC>?$VP_9+_ &@?!'QQN_@[
M>:)8?$9/"$'B:W3P]+XDFUZ#P_=)-XDT#0HM;TC7)/#&OC2]=\//J^B7BZ9+
M)#J#I+;M-_F6?MC?"_\ :8_X-VOV_/CQ\'_V<?C=9:KX9^-W[._C[P7X8\37
MEUI.L>*M9_9T^.-MKWAK2K/XFZ#HT^EOX6^-WPM\0Z*-;\.>)8++2-.O?%?A
M71_&VEZ++X)\4:YX!D_JP_X,Y?V1;WX1?L*_%_\ :RUAHEN_VP/BA!I/A&SM
MV6;R/A?^S7?^-/A[IEW=R%@UMJ-_\3]>^+MO)8>4572M(T2_-S,^H&VL7)7B
MZO.I0DXNDE&UHO1I^FEM%YZ[%"JFU2C"SBI>TE>]WTE?=N3NW?7=-)K7^OHC
M((/0@C\Z_&+_ (+W_MZ:I_P3]_X)F_&[XM>#[V#3OC!\2CIW[._P,N90Y-A\
M1OBU::K;7?B>T/ES1'5?AW\-]'^('Q,T6WO+>XTZ_P!:\&Z=INI1-87MR5_9
MUB5&2I &.N #ST)SQGIGMG-?YPO_  >/_MC1?$#]K'X&_L6^&]7BN/#'[,/P
M[N_BE\2[>RO;MO\ B[OQMAM)M$T77; G[*+[P;\)/#_ASQ#H5Q&KS+8?&/58
M68)(HI0CS32[.[](V;_(VK3]G3E+K:T5WE+1*W75[+4^O/\ @S3_ &1;:R^'
MW[6G[9OB;PUH.H1^.?$/AO\ 97^&%_=VFHW7B.T\+^"+&S^(GQTT_P BZL_[
M$N?!'Q"U+Q=\'M)GN8I[R]NM:^%FKZ=<Q6UK;2)>?F3_ ,$[8KK_ ((T?\'-
M%]^S'J-W<Z1\,=>^-WC+]D!D>X74[S4O@O\ M-0Z!XS_ &6VU*^8QB*ZDUS4
M_P!G+6O$=Q,)19FVU>.5FV?:5]<_9Q_X-I_^"ZEG\$? VN?"/]M+X5_LZ^#/
MB?X1\/?$RY^#UI^U3^V%\,-4\-7OQ!\+Z/J]_H_CWP9\./@;>>$+?QWI]E-:
M:!XS&F:EK]I_:6E2V$6N:M96EM=2?E%_P57_ ."3O_!0;_@E[XF^$_QP_:M^
M+?@/XK^+/C=XLUF^\-_&[X9?%7XI?$OQ'8_$WX=6^@:S8_\ ";^)OBUX"\ ^
M,X_%"V+6&J>&=16/78)+/P]>V[ZA8SZ7;6DNJBW4JWJQ<)JT*:C)..UMTHZ-
M:.Z2TMN<?-*-*B_9R3HRC.<N:#44V_:-V?-+F3O)-)O5N]FI?Z/'_!?'Q_\
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MX3TK3M:O]>OM ^+FIZS\,-=TJ\M9=-@ETW4FUFZ31K>ZOA_.1^SS_P $0?\
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MGI<M[X!\!_#2[\UM-\1^)OB5J"V.E^%WM9YM,$5^=?U&[M/#>FZIJEI\$?\
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M?PX\!:UXDUGXCW7AZSTOPYJ_@G7=$G5I)->TZZT.VU29/DW_ (,GY6_X3/\
MX*2V[ M-+X+_ &29BR ;<P:Y^T6L@ !)RS3@KC(PIYZ93=Z4]9-J4;.7G>UM
MVMMKOH5S_OZ<E"$5[*?-[/F]YQLWS<W+=KT23O9ZGX7?\%</V"_@%^S;_P %
MF]7_ &(/V=]#\6?#WX*^)?''[+GA[1]&U;Q1>>*+OPLGQTTCP!)K\7A/Q/XI
M;Q!X@O=%TJ?Q5<#2+CQI=>)=9M]3M[Y-1N]6LDM@_P#H>:1^QO\ L._\$/\
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M'@#XA:UK4-YJ5]XE^(.AZS?!XM3U";2[/^4[_@WD^%?_  2"^*7QM^,&A_\
M!4;7_ UEJ=OX6\%/^S1X>^-7Q)U'X5? /Q!?3WGB1OB7=^*?%UIKGA/1M1\=
MV-M#X'M? WAKQKXML_#NL6>N>*[JQT+Q+XGL])G\/_V[?\$O/%W_  2I_P""
M=_\ P2&\2?M1?LH?$_XN3_L0'QC\1/CCX\^*'QDT;Q-K_P 5K_QR-;\/?!KQ
M!!JOA31O _AZY%]IVI^"?"7P[T;3/#'@ZTT.>/2['5YK^^6^U;Q)=_CY\"?^
M"2G_  ;H?\%L/&'QU^)/[$GCK]I7X,>(_"^KVVH_$3X1_"V^L_A=X:\-7WCN
MXU/5=/\ &WA3X5_&CX7?$)-+\"ZYJMIKNE6WA_P-K&D^"_##Z7-X<T?PUX.L
M&\.I*0E%*I92A&4M)*-FK2;=^R\EKOYHVE";^KR]R4H+6$I*TKQLY)ZM\MKJ
MT7OHT[,7QE_P:^_"7XK_ +6W@W]JO_@E1^W5\)_@;\'?!_C3X>_$/2-#\*W.
MH?M'ZA\%OB9X.UBUUJ/5OAAXPT'XF2OJ&BW5[H]EXBT;P]XU\617^F:I+K&D
MP:Z_A@:78:9_<ICJ,XW.><=-[_ED _GZU_D0_P#!1G]E7XP?\&^7_!0GP_X<
M_93_ &PM?O?'&F?#;PM\:?!?Q-\"Q0> _'OAO1M<\3^([2'X9?&CP;I^K:]X
M:\1PW,G@J&^UGPYK\%_X&^)7@_5M-FUKP7;:=J%QHL?^L7\"_&_B#XF?!'X.
M?$CQ9HMMX:\4_$'X5_#SQQXE\.637+6?A_Q!XL\(Z/K^L:)9O>?Z6UKI.I7]
MS86[7?\ I+16Z&?,I>BHG[K<N925T[6=D[:WU^_5W]"Z+CS5(J'))27.DTXM
MM)J4;:*][M63[WW/Q\_X.6_$^M>$_P#@B3^W+>Z#>SV-Y?Z/\"?"5U<VY*O)
MH/CS]ISX+>#/%%E(592+?5/#.NZMI-P "KQWS1LC(Y6OPX_X,HOA+HT7@#]O
M?X\326ESXBUOQW\%_@[91-'$;[1="\'^&_%GCK5)(I,>;':>*=0\?:2ERA+)
M+-X.M&4*T4A;^J__ (*=?LC-^W;^P%^U9^RE9FR3Q+\7?A/J]GX!N-4NA8Z5
M;_%3PG=V'CSX1W>L7GV:[:TT:S^)OA7PE<ZO<16TTT.G0W4L"&=4(_SG/^#>
MS_@J$G_!(_\ ;2^*_P &?VJK#7OAQ\#/C??6WPI_: @\1:/J-IXC_9\^-GPE
MUSQ%I7A;Q?XI\.OI=UKUG8^%]5U?QG\.OBOX>MK6QU2TM=:T_P 47WVS_A74
M&B:BXING-+>\96Z\J33MU>K3[?<35:C7I2DO=<7%2ULI-MV?175K=7:_1)_Z
MI\B(ZE'7>FXAER02 2 ,C!SG'0@GD=Z\H\0? ;X&^,/&&D?$'Q5\)/A9XI\?
M^')-/ET+QOXF^'W@_P 0>,=#ETJ=;K29-(\4:QHMWKVEOI=RBW.FM8W\)L9T
M26U,3J&KR/QI^W3^QMX"^#,W[0?BW]JC]GO1?@>-)DUBU^+,7QA\!ZEX,UBS
M2!KF%?"NM:-KNH0^+M3U0(+?1=$\+_VMK.O7L]OIVCV%]?W5O:R_P\^ ?^#D
M/_@I1^U[_P %>/A[\)/V)DT;7?V6_BE^T;X8\!?#3]GCQ3\)/"FH:[XB^">E
MSV=CXZ^(GC;QS:^'Q\3/"-U+X)TCQ=\:O$%W#XC;3/A=IXN+/4;?5]%\-74%
M_$8N5[77*FV]5HNG35]$_,UG4A#D3U<Y1C%*TG=ZIVULDM;Z6]6CVS_@]OL9
M6/\ P3+U*.5&@B_X;/TV0X^=;F^_X96OH"JX*LACL+D,205;RP-V\[?O7_@G
MA_P<2_\ !(WX+_L%_L9_!CXA?M*:G\,O''P>_91^#7P^\=^ M6^"7[1/B;4=
M#\;_  T\!:-X+\5Z-:>(_!WPN\5^%-=35=<T+4M8\-SV/B.1-0T34=(EE32)
MYY=*L?@__@]IAO5M/^":$D<BKIB:A^V5'/ R[99-1E@_9@ET^X)VDF..SAU)
M& ,15IAE)=Z&'[V_X)G_ /!N5_P2!^,W_!/G]B[XU_&#]FWQ9\4_BC\:?V:O
M@U\8/B#XS\0_M!_M"^%KK4?%_P 3O .A^-_$-E9>'_A?\3O /@_2_#NC:MK-
MWHWA>TL/#L-^GAVQTPZYJFN:V;_6;[1\OLJ=U+XI;6UWUUZ;+3K?U,%[1XBO
MR.%E&DGS<VFCLK1MKK)MOHU;J?R=?\%D?VZ]5_X+L_\ !1#X4Z9^QA\"?B#J
ML>F^!]'_ &>_@#X7U/3;0?%WXLZK=:WKGC;7_%'B3P]INLZMX:\%Z#8:MK&L
M'3XKC6Y[;P[X"T"\\??$'7]"2_U70?!7]:G_  < _%3PC_P3L_X(.^"/V*-(
M\0I'XZ^)/PN^ 7[$_P -+/2[Z666]\&?";1/ I^+_B$F^\K4KWPT?AQX'O?"
ME]J-RJ7#:I\1/#2WBN]^\+?O#^RY_P $S_V ?V*KVVUO]EW]D;X'_"'Q99Z;
M>:-%\0]#\%V.I_%5M%U$6_\ :6D7/Q8\2_VY\2;S3-2-I;-J%A=^*9K6^D@B
MDNXIG0-7\$G_  =E_M1W/[5G_!2GX1_L9?"71]8\77?[*?A?3_AO!HFAVD.I
M7_BG]H?]I>Y\"^)]7\*^$;;3)[J35[A/#=G\&/"PB86^H#QROB/P_+81/I27
M%V)J<H12M"%WJ]TKMN6CM?335:=;:DE*C3JS<E*K4:2<5RJ[]V*BKWTO>][W
ML[)7M^J__!J-^P,-?_X)R?MA^.?C;X0FF^%/_!1K4]3^#NGQ6^JZ?>2^+O@+
M\,/#OQ2^#7BS4S'IL^H2^&))_B%\0/C%X7LK;Q!#I^O--X6;7UT=O#U]X:U;
M6OR(_P"#<'XL^.?^"</_  6X^('["OQ<UBPTO3_BYK'Q;_8_^)']HZU;:%X:
M;XT? _6/%.O_  H\763:DT8U:^\3:YX0\2?#OX?6,-QYFOR?&RP&F+J%S>:<
MLWN'@C_@T)_X*A:1H&AO:_MI_L^?#F]\NTUJ?PQX<\<_M"I:^&]=D,%]<107
MF@^"=+TZ>_L-10;]5TZWACN;NV%]:RR QS-^-'_!3;_@FC^V=_P1@_:&^ ?C
M7XH?%KPOXZ^(7Q"U*_\ CW\)OCQ\.M4\8:A(?BU\)O'>AZ]KTNL7_CO2--\0
M7/CKPQXEU;P-XQU#5;@:C'J:^*M.NYKV6^-_&A&+=2O>K&<:NL(J$HN+B_=5
MVVF^56;3UV6FIBYN,*+5-Q5!VG)R3?*])72>W,[]N^NW^P..:*^;OV//VD_"
M?[8O[*_[/G[4G@E(+;0/CO\ "7P9\2$TJ&]AU!_#>J^(=&M+GQ'X.OKR#,4N
MK>"O$G]L>$M9"$B+5]%OHNJ-7TC6)Z.^H4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 5^1W_!;T3G_ ()Z_$S[-"9)!XO^&>)%=TDM
MB?&-DHNHV&8T>)V4!YU>(;SM\B<0W,/ZXU^0/_!<LJ/^"=WQ0!?RI!XP^%S6
MSAVC)G'C;3F5"W^I&\!E7[0)(@^UU1;@6\B?9^'"3\0>"$]GQ7D2WMOF%);[
M+YZ=SY+C^:I\"\9SDVE#A3B.3LVI662YD_=:UYKI6^:/XC+O5(?M,22*Z2A8
MGN#$@:,RA6412%6.W:&R7A1D8-E5QBF)>6\-S;,C1B<M+<SJ6WC:5;8IP  5
M ([/U8#O7()<% KRRS;U3:T<J$J2FT!@H9&8%<8SSR<>UP20((2 OS+O(R.=
MZ97.UF*8+8()RASD<8K_ %J671Y:?+.2=H\TE*TE%PB[:*TK.VUKWN?XZ+/*
MU25:<^627LE24:4(J,H\RJU'/VD6W-*,9R47S.+5MD>E^#_(/BOP)+%.P)\8
M^&9X6^T1HJROKMC&'S)D^6C,&/ )4'&,Y'^F%IBE;.Q4@KBQMAM.T;,00#;A
M?E&,=N/3BO\ ,:\%.!XT\&+&0AM?&'A*9H8947>D>OZ=)N>5VB6-/E)8EAL
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MQ/)I\\_YGM;9;?=^HO8TOY$K.ZMW[_?KVOJDGJ?B1_P6Q_X(\K_P5O\ @/\
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M>-K6YBC!U6[A\'> K&ZFAB5O#D@'G+_=Q\Q^\<XZ< 8SUZ?04TKG^)^N0 V
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MXY?!MEJ]Y!#IGBF_\6^&;C6-#U;^RI555"JH1%&U$4 *B#A44# "JN%
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M^W*K1[?&'[.UL/-5F(\6>+)F"/"9'22-O!BJL4<@^SJR-,Y=A(L)B!>I8O\
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MPAJNC*9($FM[;6V:&^\/ZN[!//C.D:O96MP#!*K>69<!F*BO\V;XK?"CQ_\
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M _S_ )Y]O2BBF F!T[>G;\NAHVC_ "3_ (TM% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MK_@H#\:/ '_!-Z^T/5?V>?@W\6?C1^VW^U7^P7^U-HVK?!WQK\1_AKJ_Q#^
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MB9\/(OAA\3OB/X/O?AQX;^*GC_PG?Z=#H_CNTUB^@^&D_@/2)/BEHYU32O'
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M<4 %%&<T4 %%%% !129'O^((_F*6@ HHHH **** "BBDR/?\01_,4 +1110
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MZG_P4[_9.G\/_!76OA9KOQ#_ &C]1_:#^#5U^T7\+O!'[-_PD^('Q:^(>I?
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M:;XVT_P1<ZGH]A9:+K>KZ#J6NZ1;)8ZI 6_'SQ)^SO\ M_Z3^R?X-_9LT?\
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M'9:AI=[<_JA_P3B^'7C&PU[QY\4O$W_!*S]F_P#X)<-K'A/POX1U3PEX#D^
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M\;_'#7_@AH$KI\*-+U>>UO;GQ[_PKOY7^$_[-'_!2#X4?\$7_P!@7]F7P_\
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M?LV>#?C'H$-WX^\-?#/XX_$7XL>$_!7Q-\3^-?"]SX5NYOAIKNJ+X*.O7OQ
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M:A:.+34(23O.49KD<4G>CA:,HMOFTE7J>U4MDIPM&*<TY?J1HW_!4#]DW5/
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M\$Q/VA_$5A9_ME?\%!/CS>^+O@S^T[^S%\.OVS/V4];^+GQ6U7XP_LT?'_\
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MQ_P4+?X^_M<^,_AE^Q=HOCC2/V]?^"9_P4^$UUK&J?M*_"SPEX?_ &;/C_\
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MB)KVHZ_H]AK]YI]K*/"?BR/0^'_:4_X*._L[_LM^+O'/@SQU:?%KQ5JGP?\
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MX.4A.ZO:VKLKWTO)+5)73233LKII\L6W%%%%% PHHHH **** "BBB@ HHHH
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M/QJ^ EEXQ\+?'[5_"7P;^ G@'P/^U#\8_@S\6_B;\>==\=? _P &'X6?LO\
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M7_@A^V!\*M3^!W[17@^\^(/PFUW4=+U/Q%X&7QEX]\&Z-XGDT:5[K3;'Q4/
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MT)X#\!^'M%\;^$_C+^U/9>(=%\0?'[P%\./B)+\6_BOJ7AKP7X-\ ^ ?$">
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M^!GPNUE+KX4^$_B%XX\7?##5O@W^TEXIO/A"Z:U8M>>(/A]XA\:Z-X<UO7O
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M?#Y-%_X*??"CQ5XHM[76/C=XDT[5OA#\1]*_9)\<?M4>'/"LAL_@MK-EXO\
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M^.'[/6@?LN_M?^'/VAOV7O!?Q0\>>&M;_;&DAU[6_P!HSQ=\#?V/$\&>*O\
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MC!Z9&0<_P\=^W;(^E?'WQ_\ V[OV;_V9/BC\(/@Q\8=9^*FG_$GX^76H:?\
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MU.7QAXSO];\::UKGCKQO<QZ)#KVF^"?#_P!__#G]K#X2_%/]HOX_?LM^%/\
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M[0,'C2UT[P=\)OBEXTUCQ!<:OK-U\.]1\<^#O#6K7ME\/[O0/BCJNL_&V_\
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M_@/'8?M$K\-_@Y\?+_\ :?\ AQI9_;#_ &IVU3PS\==0UFU\5/\ $2Q\0/\
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M?,[.2C*I1J2I3C9QE&4(SI3NWRMMP?+)26;_ ,$H/VF/C'^VQ_P3H^"7QO\
MCE+HOAWXU^)[;XO_  Y\>^(_AU:6$6BZAXN^#GQB^)?P+N_B/X2TW7=+OM)M
M3XHN/A^GC2'2]1\/2:#9ZKJ%S8Q:#)H,-O9R?S^W?PC\=?#O_@GK\3)$_:&^
M*_Q2\0:O_P '$7A+P9H6J?'ZP^'_ ([T_1/$OPF_X*X7_P -;'XDZI!\/O!_
MP<\8^,M<\>V>B^&=1^*&D:O\0HM#O9_#5GI7POM_A'H\T]E7]=?PA^$/PU^
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M>\5_%3X4>(?B->?ME_#WP;\,/VDM'\9_&CXZZ_X,^)'A3X;SZ3>?#1SX#O\
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M@OK_ ,:_A[\)=)N?@OX__::_:2^(_P"S-XOE%A\#_AW\-8?&7PM\'7%EX?\
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MXC\.?"/X-_'+3[_S[_\ 9Z^,.B7WCKP/I&H+:Q^#_@+X\M-5T#3/8;/]HO\
MX**6.@_\$Q_#&J?MAQ^-/%'_  5M\)^ OB+97\_A7X+_ +.\?[/@^&W[$4'Q
M;^(GPA^%?Q(G^ /[2-E?ZM^T3\3_ !!X:U:Q\0>/?A%XCU3PQX<\)>+?!/@2
MY\/>-_'N@>//#'Z/?\./?V!7>QOI]'_:*NO$D'[/GB[]EC5_&\_[8G[4I\=>
M-/@%XSDM!J7PJ\?>*U^+*ZKXS\ Z=86TFD>&/ NNS7?@?PII]Q"_A[PUI^IZ
M+X9U'0_:_B5_P2U_8Q^,?[)OPM_8M^*?P^\3>._@K\#9?#UY\%KC7_BA\29_
MBG\*]5\&)>6_@76O!/QD@\46_P 2])U3P1IEX- \.3?\))-#%X8M+'PQJ-OJ
M.@VXT]M9234K1:?/32248MTHU<3.5K-QC4E&IAX\R236'=-N-.5V)148+ENU
M3DI-RE).M*E0BI6=I2@JE.K)1>J]LIZSBTM/_@GOI7[9?A3X:?$[P#^W%\9/
MA%\;_BCX)^/'CC3/ WBCX:^(],\2^,M&^!6MZ7X4\7?"?PA^T3J'A_X+?L\^
M$[GX\Z%H?B*9-<U;P?\ !WP-X>\4>#Y_!'BJ/2#J.LZC>WGYU_L.?'C]J[]M
M7X0?LU_\%&=-_;3L/A%X.\=?M:_$SP+\:?V1OB9X8^#<_P !M$^"47QR^(O[
M.?P\^!7A+6+'X=^&_CAI/[3^H:_8_"'5_"OC/Q)\8[F#QA\3?&6K:;'X2U/P
M!XA\#?#*T_8_]FW]F/X/?LG?#J3X:?!G0=5TW2M3\2ZSXY\8>)?%OBSQ5\1O
MB7\3/B#XC%HGB#XB?%7XH>/=8\1>/?B1XYU:VT[2M*?Q%XMU_5+O3?#.A^&O
M!NA?V5X.\+>&M TGY(\&_P#!'_\ 8$\ ?M/:Q^UKX4^#VJZ5\3-:^)]U\<[K
MPS'\3?B>_P #X?CM?6>H65[\;;;X!-XO_P"%1?\ "T)$U&6\L?$MWX1NSX?U
MZ"S\6>&;71?%UG;Z['.O.Y72CRQLE"/NRC)-^YS*,XU(\T9*5FWRR;C>HW+2
M<&M>;F;3;M[KBTUS)-J47:<;)I6MJU%'XY0?\% _VSO$/_!+SX6_\%MO!_QU
M\>WM[K'[16AP>-_V YO!7P6U'X':O\#?%?[:]Q^R+:_ KPEJEO\ "33OCGX?
M^,/A^PU7POXK'Q7U+XLZU?:A\1[/Q-!>>&G^'NL>'_ 'AB[^U/\ '[_@H+\/
M/@/_ ,%FOV@_"/[?WQ"TZX_X)Q?M6W7_  H?P&?@;^S1-I/BKPA>_!W]EGXN
M7OPO^..IR?"H7_C#X8Z-IWQ.\0>#_AW;> 1\*OB%I=Y=^(?&/Q.^(GQAO;SP
MEI7@;]KM _X)>_L<^%?B/JOQ!\-^!O&&BZ9K?QKLOVF-5^#&G_%WXJP?LXWW
M[2.FZO#KNG_'.;X!IXO'PR_X3JSUJSTOQ!;VZ>'T\'1^,="\-_$)?"G_  L/
MPSX?\6:;R_BK_@DE^QIXX\)_M5>!O%NF_'?7?"?[:WQ T[XF_M):'=_M6?M*
MQZ?\0/%6EO-%;/';6OQ2@A\,Z))HXT?PGJ'ACPM'H_A[5O!?@_P%X0U33;OP
M_P"!_"]AI:?-R24$J<^2?*TW42DZ>7QIJ]57DJ=2AC*O/.+E4^LVJ1YG*$1)
M<S;NX\T+*RB^55<;.=U!J*<X5L-!J,DH.C>+M&,W\!>*/"_COX+?\%&O^"OW
M[2G_  V3\1_!H^%O_!.O]FOXO:!)\9-/^''BS]GWP-I^LV'_  407PMHOC/P
MOX4^#4'Q2?X(_ KQ9X(C^(^B>$OA;XKT#XA>+-?U'QC=^./$'Q0UCQ%%9+R?
M[#_[0G[;GCO]N2/]D;XF_&']I;PWX#^.W_!)B/\ :L\-_$;XV^$OV:-/^.FA
M_'C2OC%X#^$.K?';X6_#70OA[X@\,?!GP-X[T_QP/&N@_L]?'CPUXFU/P??6
M>CZ=XL^%'PPU6V\7?#U_U/\ B)_P2]_9$^+OC(>-_BEX?^*WCS5+S]E]/V0/
M%UCKW[1'Q[_L+XI?!B#PW\2_"%E%\9-)T[XC:?;_ !=\?:7H'QE^*2:-\4/B
M&?$/CW1M=\9WWC73->M/'.F^'_$FC\/\.?\ @C[^Q5\+/'/A'XH^$[#]H2W^
M*?@WX#>-OV:;#XI7'[7W[4[_ !)U'X.>-K6.S/A'7/'-O\7;7Q+J-AX&B477
MPBL_[2@TSX/Z_:Z!XR^&^G>&_&O@OP-XC\,D7-1A&24E%3IIM:QI-XQQBKMM
M.'MJ$H-/FA*$WS-J%VDKSD[<T^65K)1510P46[1BE)-T,2Y)I)JM"*2CSM?D
M[^SG^U3^W1\=/A#_ ,&_.JC]L3QMX,UW]O'PU^TYX8_:;U>#X4_ 3Q/-XJO/
M"'[-WQM^*.D_$3P^GB'X9S-X7^)?A:^\)PMX#02ZE\(+#7K/PUJOC_X/?$SP
MYHNL>"/%>?IO_!03]M'P[\!/&OP(/QZL_$WQ<;_@OSXN_P""2'P^_:A^)2_"
MSX<?$*V^#T/@J7XR>$-:UK4=(^ 'Q$^"[_'#6K2Q7X&Z%XJF_9NUKPM?ZQXE
MT?Q%=?#YM90 ?LAX)_X)._L8?#=OV2(_ ?ASXR>&--_89USQ-XA_9AT*Q_:B
M_:7NM%^'-_XRDD3Q/;/9ZQ\5]3D\5:%K.BW6J>#;SPOXON-=\-OX U[Q#X"7
M2E\):YJ>D7.%+_P1R_X)_P"I_!G]HK]G_P 7?"?Q;\2/A1^U5\4T^.7QH\.?
M%+XW_&[XCWFL_&D21O<?%GPWXG\7?$#5/%?@'XAZE';V%GK7BOP1K6@:MKNE
MZ7IFCZS<7^D6B6)UYH^TKRE%2A4FY4H:0=.//A9*"FDVDXT\0D[6C[51:<6W
M&8Q7LZ47=5(THPJ5&U-SG_M5ZC@VHM_O,/==72<HOG4;_GQX@^)7_!1WX)?$
MKX2_L=?M+?M2?#[1M!_:]_;2^&_@#X<?%[P)XZ\$?$7]JOX.?L[:U^SO^T%\
M0_$?PS\<>+V_9@_9G^&>B^*_C)\6_P!GM/AU^SS\4[3X.>(_&]SX9\1?&;3M
M.UZZ^*7PW\&^,K+Z*_X)E>!KWX;?M[_\%H/ U[X_^('Q.;P]\=OV*[2U\:_%
M'4M'UOQU?Z7+^P7\'KO2-,U[7=$\/^&H-?E\-:7<6?ARTU_5=.N?%VNZ;I=G
MJ_CK7_%GC2]U_P 5ZW]"1?\ !'O]@:Y^ /B']G/Q9\)O$GQ(\)^+?'?@7XI>
M(_'OQ)^+WQ=\8?'^_P#B;\+M/LM&^&7CVS_:(U'QL?C-X;U_X=>'["/PQX&'
MA/QGH&E>%_"EYKWA;2-,MO#_ (J\4Z;K/M'[-G_!/K]EC]DKXF?%GXR?!#P=
MXWT?XH?'?3O!NF_&'QIXR^.?QW^+6K?$7_A -'MM#\+ZOXH7XL_$KQM8ZCXL
MM+"W?[=XVEL_^$PUJXO]5N-8UR^?4[SS2G-05>+BVJM.=.,O=BTI+ R@N57N
MH3PM3FFY*=1UN=QCRN$U.#ERV?*HSIS<4W9RA*NY235F^>-6"5.5XTO9)1OS
MJ4?RL_;*_:)_:O\ @'^VU\??V;[[]J#XC>%_#7[:/['Z>+_^"8NIZ#X8_9NM
MM5\ _MB_#+XC^$O /CC]G/PK#XR^#>K6'CF3XF7GQ(^$NOS:S\57\3S^$OAY
MJWCN33?$_AC4K73_ !;H4?\ P3^_:B_:>_;^\ >#/"J?M$?%KX%?&K]DC]E'
MX@?"']N:R\/^&?V>?%NNZS^W_+\0/B#\ ='O=>M?&OP4\;^&O#.O_#S5/V</
MBK\?9_AKH:^%H9O#_P =_P!GX^+-!O?![_V9X@_<OQW\!OA!\3OB%\&/BOX^
M\ Z!XH^(G[//B'Q5XJ^"WB[4H;C^V/A[KOCCP9JOP_\ %EYHL]O<P(\>N^$]
M9N]/OK#48KW3GN8=*UE+2/7-#T/4M.XKP[^R7\#?!VC_ +2FA>"O#6K^!+/]
MK;XB^)_BS\<+OX?>-/&GP^\1:Y\1?&GP_P#!OPU\4^+_  SXO\$Z_H/BSX=^
M(-9\/>!-"O+C6? .M>'-4@\52:SXQLKRU\2ZWJ.IS\[C+V<HQ=I>RK0A+2\*
MC=;ZO4V][V<<5653FO.3H8-IN%.<):1:YKN.GM:<VKNSBE356%M;1G["$HI-
M<CK8E1Y7-2/YQOAY)^T!^U9XW_X-E/CM\0OVM/V@]*\4?%OX&?&OQKX]MO")
M^#EMX4U+XJV'['7B[7]2^*4WA;Q)\'O%&C77COQOX:\:>+?AMK.J:K;:C9>&
M? =]?6_PGTWX<>)=<\4>)]>\,M_C#^T;^R;\"O\ @LE^VC\$OV@?$/@'3/V?
M/^#@/Q5_PD'P,T[X??"CQ!X*^.WA_P")WQ4_8;^%7Q*\/?%;Q)XZ\&>+O'MC
MIMQX)\<?9?!3_"#Q!\*=8\-:A_PD.J:QJWB^_P!2\(W/P^_H@O?^"47[&%Q\
M*OV9?@M9>%OBQH7P_P#V/O$6O:Y^S_;:)^TE^T/:>*/!.F>*_#^M^$/%7@ _
M$27XG7'Q$U?X8>(O!GB'4_ VH^ -3\4W'AU? DY\#V-I9>$VET>3&U__ ((_
M?L&^*/A7^T#\$O$/P]^*FK_"W]J;XTZ;^T3\>O"%]^U/^U3+9?$/XU:7J4&L
MP^/M0NU^-":II^H7FL:?X=U;5],T:_T[P_K.H^"?A[>:GI%U<> /!\FC=<:E
M)5E*5'FI>VE4G24HP52%3%9=6G"34;.]'"UZ-I\T;U(RLE\.:4O8NG*<I2=&
ME24[:P=.GCH\][\TG[3$TJB:M*+@[:P7-^<7Q_\ VA?VS/ 7BO\ X.-M!\-_
MM:?$G2T_8Y_9(_9S_:>_9%U9_A]^SW?7WP6O-<^$G[3?QH\9> ]*L;SX.R^'
M/%_@_P 4ZW\,++P'>ZO\0=!\4_$.S\"+!]E\:#QQIMOXWD^DO@+\3/VK/ '_
M  4/_9N^%OQ3_:M\3?M#?#?]K/\ X)]_%C]HCQ)X(UOX8?"/P%X+^&7Q?^&'
MCG]GJRL]2^"3>"O"%C\0=&^'FK>'OBOK6D1^"_B=\0/BKXA@:WMM7UOX@>)M
M5\J:U^IO&'_!*?\ 8Y\<W7[3^HZ_I'QTFU7]L[P!X2^%G[36JP_M;?M4QWGQ
M5^'?@>[LYO#OA'4XV^,<EAH^DVNEPZMX/N(_#=EH\M]X \:?$;P)=RR^%?B+
MXTTO7.W\+?\ !._]G#P=\9O@1\?M&E^.,WQ._9N^#\OP'^%.J:_^TQ^T%XHT
M33_A;=V"6&J^&O$WA#Q'\2-3\*>/#K_V30]1\1ZKXTT?7=8U[7?"'@?Q!JM_
M=:SX*\,7VEXPM'25ZGO0O)QY4XQHX^G*-G*3]^I6P-1O=?597?->4W53G=TT
MJ2]GRQBE&5JGM,%+G6B6D:.*BELEB-K)*/PM_P %&_A=\0O&?_!3#_@C7?>'
MOVD_CY\+?#6I_%;]JC23X+^'5U\*6\&Z7XI\-?L8?'[Q##\0X-"\>?";QY;Z
MQX_\0^%[_P 0_"Z\U;Q<?$FG>&?A_J^M1?#/1_ ?C'Q%XC\8:S^4?BWXQ?M+
M?LE? C_@MI^VQ\#/VA-<^'MG^S7_ ,%N->UO4?@CI_PY^%7B+P9\=--\8R?L
M$> _B1X=^+_B/QYX0\8>-X-"O? 7BG^S/ T?P>UKX0ZYX5UB;Q+K^O\ B/QQ
M<:CX.B^'7]/_ .U#^QC\"_VP%^%#?&?3_'#WOP6\<:CX]\ ZW\.OBG\2?A#X
METW4M>\'Z_\ #[Q9H\_BCX7^*/"?B*Z\*^-? WBG7_"/C'P\=42SU_P]JM[I
M5V3:75S%-\^^)O\ @D5^PIXT^&7[2GP9\6_#[XH^(?A=^U[\6],^.W[0_@S4
M_P!J+]J.XTOXB?%C2K^VU.+Q?.Y^,8O-!FO+S3/#C:QI'ABZT;P_K<'@GX>V
M>KZ3>VG@#P?#HN<8\M:A4<4XT:M>I*-DW5A6K9=/D<FKK]WA:]*2?,G&K=)7
M=M)--25FN:%&/NRLTZ4<8G+2VKE7HN+6O-33E?E3/R=_:\_;4_:P\"?%WX\?
M%SX)_'CXE_$GX?\ P!_X*/\ [)?P!\0CP#I'P0T']C7X4_"SQUXQ_9]^$_Q8
M_96^(^F^._!FI?'7XX_M-:IXG^(^L>*?B)XL^&&IW?ACX3P^*/!MAX<^,?P[
M\4^$_'/P0O?MC_@G7\'_ !7X-_X*)?\ !8;Q-K/[17QZ^*%MIO[1?P5\(GPO
M\2;CX0WWANZB\5?L>_LT?&'1M5\_PO\ !_PGXKTJZ^&TOCGQ)\/O &@>'O%.
MC> ;/P#J*#Q#X-\2>.ED\<S^I^.?^")W_!/WXAM\55\2^!_B])8_&+X@^$/C
M'XMT2P_:<_:+TWPY:?'7PA=^$KG_ (:'\+>&[/XG1:%X7_:,\50^!O#FF>-?
MC[I.GP?%OQ%I"^(=-E\7P6_C?QPOB+ZC^&_["W[/GPF_:1^(?[5O@G3_ (BV
M7Q=^*GACP7X8\=-J?QI^,'B/P)KQ\ ^!O"_PQ\.>+;[X:>(O&^J^!KSXC6_P
M\\%>%O"$_P 1K_0[SQE/I&FW@&LQW?B;Q==:]M2DH4Y0E%RG.$Z?M+IVC.&'
MNY7M)_O*,FDDW:K>3CR2C+"K"<YTY4ZG)3C.$Y4N6SFH3KM133:BE"K222?*
MG0LDU/F7YH?ME?\ "[/^'WG[ #? J/X47/C!/V%OVUVFA^,FM^--&\,IHD_Q
M%^ %OJ=SHR>!] UW4=6\36D\NE7<6C7;Z!IU_H]IJK3>(K"^MM.BNOF+Q/\
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MEX1O8XKOP3XK\-7"F5N=^('_  3/_93\;ZG\/M>T71OB?\%-?^%OP)M/V7O
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M\62^'_$.AV6I6'B67P[J]KX>EU2[L9H%_<;]G;]IGX$_M8? WP1^TO\ L_\
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M'B>/QSXFLXKC0_!$?P8^+^H^,-3T+2_A]XJNM&N_[MVCS5HTW.E!R7+B;XC
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M?B!\;?"^DMI?[0?C>TOGA^#7PA\7S>%/"4&M?&;XAZ=K/P>\Y_X*0Z1^W_\
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MV@>#M*U?Q)J$R:?8N[?RS:]X5_81^ _[&?\ P2&^*7A_1_V??"NN_MD_$?\
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M-YTINI2I5'%Q=2E3J.+M>+G"$I1=KI2A)RA)+12A)= HHHK,T"BBB@ HHHH
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M^(]3TG1[OQ/K=_KOC'7+KQ-XN\6^,/'GBW7/B#\0O'/BS7+L1_VAXG\=^/\
MQ/XE\9>()+.UT[2(M7UR\M]"TC1=$AT_2;+U>BBRU\[)ZO5*]D[MII7=M-+N
MU@MMY-M>3:LVM$[M;Z_YE2/3]/A=9(;"RAD3.R2*TMXW3*E#L=(PRY1F4X(R
MI*G@D5*UM;M,EPT$+7$<4D$=PT4;3QPS,CS0I,5,B13/'&TL:L$D9$+ABHQ-
M13\PLOZ\MEYI=$]/(I2:;ITKR236%C-)*<R22V=O(\AP%&]WC+.0H"Y8D[0!
MT  N8/4$@^HXQ^ P/TI:*5EIY;>731;+Y(/Q]==]]=]>NNOW6\:\>_!'P[\2
M?B/\(/B%XI\0>,KBW^"NK:_XJ\,?#VSU:QL/AYK/CO5M';P_H_CGQKIMOI*Z
M_P"*]6\"Z1>Z\/!&A:EXE/@+2]>UQ/'5]X.U7XA>#_AMXL\$^Q,BL22J$E2N
M616.UL;E!8'Y6PNX'(.!D<##Z*+)*R5E=RLOYGRW?K[D=;W2C%)I122LM=-T
MHOS2YK+T]Z3:V;E)M-RDWD+X?T)$N8TT72%CO9_M5Y&NEV"I=W)GEN3<72K;
M@3SFYFFN#+*'D\^627=YCLQ;+X<\/S7.B7DVA:-+=^&3.?#=U+I5A)<^'C=6
M?]G7)T.=[<RZ3Y^GG[#-]@:W,MG_ *-(6@_=ULT466VVVVFVVUMNG:[M:[';
M]?QW^^ROWZW>I"+>!9#,D,*3'.9EAC64[E13^]"ASN6-%;+'*HB\!5Q'#96E
ML6-O;6UONDNYF\BV@A)EU"X^UW\I,4:$R7UU_I-XYRUU<?OIS(_-6J*++M_5
M[_FV_5WWU"W]?*WY:>FFJT(E@A5WD2*))))1/+(L48DDG6W6U$\CA=SS"VC2
MV$K$N+=%A!\L!1GKH>BKK#^(ETC2E\02:;'HTFNKIUHNLR:/#<O>PZ2^J>3]
MN?3(KUWNX[!IS:)<LTZPB1BQU:*=E_6OEUO_ %]P?U_7?YW[[ZD8AC66298X
MUFECBBDF6.,3/' 96A1Y0N]DA,\QB5F*Q&:4H%,C9=M'!PI*G(+*&P2,$\C@
MD$@D8)Z="0744K+LNG1=-NG3I]^X?UY_?N9;Z)HTEQ<7;Z3I;W5W$8+JZ;3K
M-KBZ@: 6IAN)V@,LT)M56U,4C-&;=5@VB(!*L6VGV-G$;>TLK.UMV9F,%M:P
M00EWY=VBBC2,NY^^Q7+?Q9JY119.Z:O?1WUNKW:=[W3;;:=TVV[7=PLON=UY
M-*R:[:::6TT(([:WA8M#!!"Q54)BABB)1,[$8HBEE3<VQ2<+DX R2<R\\-^'
MM0?4Y;_0M%OI-:M-/L-8DO-)T^Z?5K#2I[JYTNRU-Y[>1K^TTVXOKZXT^VNS
M+#93WEU+;I')/*S[5%.W];_=>]@M^._2_KW^9DV>@Z'I]]=:GI^C:38:C?&9
MKV_LM-LK6^O&N+AKNX-W=P0)<7!N+IC<S&61S+<$SN6E):K5GI]CIT"VNGV5
MI86JR7,RVUE;06EN)KRYEO;N806\<<0ENKVXGO+B3;NFNIYIY2TLCN;E%*R[
M+[E?=O>U[7;=KVN[VOJS_A_GW]>E][:7MH4QI]B,8LK(;4$8Q:6XQ&)$E"#$
M?""6**0)]T/'&X&]%8316\$ <0PPPB1S)((8HXA([  NXC50SD  NV6( &<
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MG43$;QM->Z1+E[%IC:M<*LQB\Q0PTJ*+=.EK?+MY+R5EY/6YUOU[_P!?K?\
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MY<,<:;G9MN6)-^BBF 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M[D#\R!_6@ HH;*N%/.59LXQC:5&,9/7=USVZ44 %%%% !1110 4444 %%%%
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MJ^D_!'PQ=>)-9^(^CQ>*EA\7>$->TCPCH'Q$;_P3Q_X*4^.?V^]7T'Q)X?\
M@I\&=,^ _B3X8^./%U]X\^&G[4VJ?%KXH_ OXI^%/%/PSTK2_P!FC]J_X':W
M^SM\);GX'_&[7_#7CKQ'XDFTC2_'?Q&T.SN?AEXML=(UGQ-X<N_#/C?7NE^
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_P!I7^F/]O+]H[PA^RS\&M)^*=U\,K+XU?&V;Q]HWP^_9 ^#T9T&S\6_%/\
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M  O[XL_M0>-#XIT35M3_ &FO^$!\)7\'P!_9/^#7A.#1=8\$?L]_#;X1>"O
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M"?\ I7@#PS\./BA/XH^(NH?"KX7^%_V*Y_&&I:;K'Q'N?$B^);3PYJ/[1/\
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M7&--V_+7_@I9XK_X*(? _P"$>D>-/B)^T_>_$O\ :)^*?B*7PI^R/_P3R_8
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M^"?_ /P3<TWX+>)O@AJVH>'=376_#]_^UU^T)X"\/^&_$/[2MO;:XNC:]/\
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MZAX>\4?M@?$OPKJ%MK/PA^&VJ6>J:'\*?!^K:7^T5\<=*F\(:A\%OAA^T?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MP>T_X%V7P,_9(\;^/_CC\*= A\:WOP;^*/CK]EUO!WQ.\(?"#QWH/AKXC_\
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M"YB64W'B'5O$>KZ[X]UZ\O9$U37+7PK:>$O!_A;YO_:R\;?L^?LC_LC:_P"
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M?^SA^SQX_P!>\0? N#QI>7&NV'BS0/$?CGXE>//V*?A!K>E>)9+7Q0_PWO\
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M2I#*\2YD6.9X)UA<J%E:"948F-]KPQ(SA@#TRKJ>.N0ZH1]<8_K_ "??M_\
M[-7PD@_X(96W[3GQY^%W@3XC?M,_&+Q]_P $[?VJOVB/BMXC^']K\4?'.J_%
MWXO?M._LTV7Q%T[PG?:AH?B7QJG@7PC\//'7B;X!?"?X;^&1<0>'O@+!IOP@
M\/Z3<:'=7FEZCYYXO\1Z_P#LA?M9?\%,/VR/^"=7[/OQ&_9G_8B^$G_!'+XB
M:]XJTG4OV:/B1^RQ^SYXQ_X*.>$_&WB74OAAXH\,_ 7XL^!/AA8>-?%/AKX;
MZ7I5MXV\9^"/ ,GA^STBUU/2/%>N#6/%=K'XBJI%T55=3W?8U*U*:W:G0H1J
MU-%?W56;PT9*_-42:]V5HS3G[6453]Y3A3J0G:T)PJU_94[.^LG3MB91TY:7
M,K\\;2_K_P#M-L+A+,W$ NY(6N4M#+&+I[9'2-[A+<L)F@221$>54,:NZJ6W
M, 9MPR0.<'!QS@CJ/J.X_ 9(Q7X7?L4?\$S?V,?V@/V#?@+\5/CY\#O /Q>_
M:5_:@_9A^'_Q6^-/[6_C7POH6K_M4ZO\4?V@/A/I'BCQSXQ\)?'ZYTUOB?\
M#NZT74?%-Y9_#*P\$>)-"T[X8>'].T#0/!MKI6G:1;PU[_\ &O3_ (D?L]_L
M(_LS?L7:%\4-:\0?M$_&C0_@#_P3\\+_ !H\,6%_HGBD>(KWX;#2?CY^T;X6
MLFU'59="\4?"K]G[X=?';]I/PO9ZKK-_9Q^*/ NB:#JFIW<=Z]U-,TX.4';V
ML:GL>1-.+J<TZ<DJEU%1A5CR-M/FC><6E'D=Q]ZS3]UQ<[VU4$E/F<>_L_?L
MGNXPUD^9?JEG.< G:2&QCY2/7)&/_K&N,U3XC?#_ $3Q3HO@;6?'G@K2/&WB
M6'[3X<\&ZIXIT2P\5Z_;[IT\[1?#UW?0ZOJL6^VN5\VPL[B,M;S@,3$X7\8_
MV5?VK_B=\"O^"47[5MC\0Y'\8?M1?\$D/AE^TK\!?B<?$5EKB_\ "R]?_9&^
M$VI>-?@9\4KE=;U&?Q'KFB_M!_ ;_A3WQ2N->NKP3:QJOC'Q!;17+7-A<2+I
M?\$WOV/_ (%?M0?\$Q?A#XY_:W^'W@K]I_XE?M]?"+P3^TC^U=\2/BQX/\.Z
MOXQ^*?Q"^+OANR\6Z?+<:S:V%G<^%;+X0Z'JNA^ /@AI_@9O#.G?!OPIX*\)
MZ=\,;/PC'H>GK;"3:E*+BXJG1G&]U*:Q%Y4N5:\MH1;J\Z3A+W%SRC45-:V3
M>C<ZE-QZQE22<^:VEG>/LVG>:?,U%./-^W:LSYV[6QP<!N#Z'(X/L:<-W<'V
MPK#GT^8 'OT/0$],&OX@_C!XETWXZ_\ !,[_ ((_^*?VRO#UM^TWXZ^ /_!<
M7X8_L=>,_B5XU^&2_%_XC_&+X3_"G]H+XZ?"*[L=1T2'0/$OC+XDW7Q*\$^!
M_!%A\1?"\5IXGU?XO>+M!;5=9TSQ+XHO88F^^?V5-7^#_@S_ (+UR>!_V5/
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MQ_#/_@BQ^VM\+? /[$_P(\/?ML?L_P#_  H3]@+]M[6/VIO@KH=_^R[XOO\
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M_%7PK\,CPUI/PS\%^)O$G_";>&,_X5_\$G?VM?@9\3/V@/AI\'OV^+_X<?\
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M"^/E[\.O!,NB^ O".L^&_$W[.EM?:=X=L;W5=)MUF&F6WW)\<?V8]/\ C?\
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M&_\ 9LN_VS/VW+KP9^T1^US!^VM\4O$)N_V/X?&>I?&IOB#I?Q=U5M,N[?\
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M_).R[**3;=VRBBBD,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?2+*^U2^L[2?T:*5)HTEC8-'(B2(P((:.10R,""0592""#@@@C@@U_'_ /\
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MAE'UC.%:4HO[7LYV]V*E/UBBBBK **** "BBB@ HHHH **** "BBB@ HHHH
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MI-7;6C37V7=7U5[R=[.^J<I-/5J[M9.Q\8?!#]G/XQ:!^P5\/_V5OCC^T?\
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M&F6$MJNI:1J^FW"0?9=3TW4+&:YM9OI.-!&BHN<*JJ-SO(Q5%"J7DD+.[;0
MSNS,Q&6))I^1C.1CU[44^K>[DTV^K:32O\I2^]]7<5MO[J:79)N+:7:[C%ON
MXKL%%)D>H_,4M PHI,CU'YBEH ***3('4@?C0 M%)D>H_,4I('4@?6@ HI,C
MU'YT9!Z$'\: %HHHR.F>?2@ HHHH **3(ZY&/7-&1ZC\Q0 M%%% !11D'H<T
M9'J* "BDR/4<].:,@=2!^- "T49!Z$&DR/4?G0 M%)D>H_.C(]1^8H 6BDR/
M4?G2Y'J* "B@D#J0/K29'J/SH 6BBB@ HI,CU'YTM !11D>HI,CU'YB@!:*,
M@]"#10 44F1ZC\Q1D=,C/IF@!:*3(Z9&?3-+0 4444 %%)D>HYZ<]:,CID9]
M,T +102!U('UI"0.M "T4F1WX^O%&1ZC\Q0 M%)D>H_.C('4@?C0 M%%&1ZB
M@ HHHH **3(]1^8HR/4?F* %HI,CU'YBC(]1^8H 6BDR.N1CUS1D>H_,4 +1
M1D'H<T4 %%%% !1110 4444 %%%)D#J0/QH 6BBB@ HHHH **** "BBB@ HH
MHH BBGCF!V,"02KKT>-P%9DD0X:-U#*2KJI&Y<C)Q4M95A)-*\SS D$6WDR>
M4L:3(UK!*TT+&1IY59YA#*TZ1.DL+!8PKYK5H **** "BBB@ HHHH **** /
MD7]O;XY^)OV8/V+_ -JK]I+P=IOA_6?%'P&_9Z^+?Q:\/Z-XH&J_V#J^N?#_
M ,':EXLTG3=3DT6[LM3CM;V\T>.V<VEU;2L95VW,&TR#^%)/^#Q7]O%HXYD_
M9>_8MN5DCBG$L5S\:KP,)429E6Z?QY^]DC+M&VXKY4L;0\>7Q_HA>+O!_ACQ
M[X=USP?XTT#1?%GA'Q/H^H>'_$OA?Q)I=CKGA[Q!HFJQI!J.EZSHNJ07>F:G
M87ELKVUQ:WUI<0R0S2J4*NZM\JC_ ()P_P#!/'!#_L%_L7R%BQ9W_9<^!NYM
MQ)^8+X"53C.T<9*@;F9LL0#^&*Y_X/,OVX[.*/S?V6_V2$<S(C!V^,Q4(5=B
M0R_$)P6)7@;V YSG@U*W_!YA^V]\OE?LQ?LCN"H+';\:#ACU S\00< 8/3!S
MP>#7]RO_  [=_P""=ZXV?L$?L5*PZM_PRQ\#CGV 7P,I7G!SN/3\0/\ \$W/
M^"=TI!D_8(_8K9@H4,?V6/@8QP"2 "_@5R ,\+G .3WP #^&T?\ !Y7^W,>O
M[+W[(D8QG?,_QBAC7TWR2?$540'@ L1DD 9) .5J?_!Y;^W;&T+VW[.G[$EJ
MP#Y74+OXP3F3E<>4;;XK6Z)M.=XD5]VY=I 5L_W4K_P3?_X)X1D/#^P3^Q=!
M*O*30_LN? Q)$)!!*$^ FVEE+*>ORL1GG-._X=R_\$^VQYG["_['$N.AD_9?
M^!;$9Z@8\ +UXS0!_!S)_P 'F'[?\DD93X&_L(0EV7<C:=\>;SR06 QL@^-M
MO%<LHY\N/:LO$8*YJ"[_ .#R/_@H\P8V?P/_ &$'09,;CP)\>V9R ?D,;?M)
M6#C((/WB 1AD&-R_WIQ_\$[/V (G1H_V&OV.XS&RM'L_9B^!Z;"IRI4KX#5E
M((!!5E8?PL#@C4'[ W["8VX_8G_9'!0[D(_9Q^#HVO@C>H_X0SY3@GHV<$C=
MSF@#_/\ Y?\ @\S_ ."EEE8B:;X!?L(B?S) (Y? ?Q]C8H&&U]A_:4N6"L"2
MI$S9&,*OW1<L/^#SW_@H6)2MU^S]^PP53.]!X2^.VDQ/D8W1ZA/\>+^!MK$-
MA(9O,4;-T9=7']^5S^P9^PM</NOOV+/V2;N3:JB2?]G#X/R-Y:Y")F3P?*=J
M#A1N  Z**KR_L!?L'WD*VD_[%'[(LUK%M\BVD_9J^#,D4& 2=D<W@R6+!(/*
MQ(5R,4$\M2[=X.-]%U2T[R6N_3M9'\%4O_!YY^W?#&7_ .&??V'WG;Y@D=I\
M=9 >".73XL.BGC 5F0D<CCFJ)_X/,O\ @HBR&XC^ G[!B1$&98?^$>^--Q<I
M&<N(R5_:'@FFG48#?Z)#,[@@VL;DQC^]8_\ !.K]@ _\V.?L>CV'[,7P,Q]>
M?A^QST'7& ..I(O_  3R_8 @=2O[#O['RM&596'[,7P0!### @Q^ XR#GG*,
MA!Y&*!M2>D;7\]OS77Y^1_! /^#S7_@H](S-%\ ?V$47CYY?!WQSRY/88_:*
M4Y P3N XZ9JS:?\ !Y;_ ,%$YIS'/\!?V&#,%!;R_#/[0\49^4LH6./XZ7EH
M"%(W;+A]QR6V.61/[WIO^"?_ .P/.J)+^Q#^R"ZH2RAOV:?@O(JDC!VK+X(D
M5<@#)4 G !..*GM_V"?V$;6,16W[%7[(\"+NVK%^S;\'(U&YF8X2'P9$@!9F
M)PO)))R6)H(Y*^W-3];/[OCO?Y6/X%8_^#S+_@HDRC;\!OV"4XSMD\+_ !H@
M()Y;Y)/VC P))Y)&.<DX()1_^#R[_@HVHEDA^ W[!AD, $:Q>#OCI=B20%R%
M>6V_:+,,:@,"48K)\P8DJR ?WMO_ ,$]?V IF62X_8?_ &/KB95V^?+^S%\$
M6DQW 9O KD ], XQ[\F:/_@GI^P,H/D_L1_LAQ+G)6/]F;X'H"Q ))'_  @)
MR<8&?0"@NTU;FY;:WL[ZZ>>GX]NQ_ /:_P#!Y;_P4S=E<_ G]@S:N3)%_P *
M]_:%0)P0T8FD_:?DB&P_*'%NZ,5RB $$:$'_  >9?\%)KB"2X3X"_L%[8CC+
M>"/CTI[[CM;]HP-QM/.,$<@G.*_OZ7]@G]A:*+R_^&+?V2O+"B,*O[.'P>1=
MG"J"B^#BAP,9"HJ^BJ!BJZ?L$_L'QIL7]B?]D95))*K^S;\'44D]25'@S&<
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M"#'IGYSPHS@5#-_P>>?\%"(RBVOP(_86MUVDR+-X=^/^MLSDX!6X7X[:?Y(
M&#$8YMQ^?S%SMK^^6/\ X)]_L%;QM_8F_9$SS][]F?X)XZ'^YX&C;\G'OD5;
M7_@G]^P:/O?L1?LA.>Q'[-?P:7'MC_A"W_/(^E )32M-Q;_N[6Z=7KOU/X &
M_P"#S[_@H_/YL</P*_8/13O1)Y? /[021H"2BR,__#1MO\H.#E9X>/F$J?>%
M8?\ !YC_ ,%*(O\ FD?[ ,18X!_X5I^T#J@; SRK_M;6RVX&?OEVW_=V_+N'
M^@;;?L(_L,6,R36G[%_[)MK-!('@FM?V<OA!;S0/&V8VCDC\'!E:,@%70HP;
M!4C%;+_L8?L=7 V-^R=^S*R8^=9/@+\*Y RG (P_A3 STR0P]0:!)5$_>Y'&
M][IV=GTM=ZK3\3_/4N/^#S?_ (*81\1?"/\ X)_2D 'CX1_'?&<9X/\ PV,>
M><$ $@Y'!&*L:=_P>7_\%+;Z-FNOA1_P3]L@%)!?X3_'>+$F,HF^3]KNZ!9L
M'@0'I]Y1S7^A/;_L7?L?6D2P6O[*7[--M A8I#!\!OA7%$A=VD<K'%X3C0%I
M&:1B%!+L6;<Q).B?V1_V50FQ/V9/V=T!(RI^"?PW9#@Y&57PY&"<\@]CVH*/
M\[^7_@\L_P""E1CF*_"?_@G]+,DA6('X6?',9CVJ>'?]JC8<L7Y!P.^XYK07
M_@\H_P""E/DQK+\+/^"?!+Q1;XU^%7QR;#NBED+I^U_,H*,2"WV4C(R8E'"_
MZ%8_9"_93R2?V8OV<<DDDCX&_#8$D]2?^*?.2>,GO31^QW^R.DJ3K^RQ^S@D
MT99Q,GP/^&(D#MG=(K_\(MYB,=S$E7R<D$G)- '^>D__  >3?\%)8\8^%O\
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M&.LS0(J6TVJ_#_PE?36X5Y''E2SZ.S(BO*SK&FW:[RN'S(<6!_G'I_P>&_\
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MVNG;6VOST?H!_G4-_P 'A?\ P4E)P?#G[ JJ "K#X3_&-B^<[BVS]JAF4CC
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M L+0D",0&/01/ J;0L9CN!+&H&V7< :WU\ >!4R$\$^$$#8W!?#>BC..F?\
M0.<9./K5W3U6SU7H]5OKLUOKW _S5[C_ (.^?^"G<*">*T_8:D9VP0OP@\<-
M* ,H=ZK^T6)-IQE<C(&W)(-2?\1>_P#P4_EL3-%%^PS#=AUS&_PC\;*3%ARP
M"R?M&9SG8<8)[#DYK_2F_P"$#\%A?+7P?X16,$E8_P#A&='*KG); ^RA>26)
M(4$D\]\M'@#P*!M'@GP@%_NCPUH@7Z8&GXH _P T0_\ !X+_ ,%2$,\1T_\
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M>R6W[##6=ZDPM_*^%?B=[Q6AD17%WID/QYMK^P!Y,37L,*S*-T2R*5<7(O\
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M=MIUT8KR>.%CHGT:;3Z-+=I[-+JTVEU:#JUU6ZZKKJMUIKJD>Q;%]/U/^-*
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M"?&2\\?Z=\(/C?\ "#XKZA\)]?G\*?%/3_AK\2_!?CJ^^&GBBUGU&VN?#?Q
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MQAX7\?\ @/QCI%EX@\(^-O!/B#2?%?A'Q5H.I0K<:=K?AOQ+H%YJ&BZYI%_
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MZ1-/OF2Y86DYC3C&>Z4K*]K*5EW:L[+S=EYAV\W9>;[+N_)7?D?1F#ZG]/\
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MV^R3;LDVNSHI,C_/;V/H>>E&0#C//IW_ "_GZ=Z5UW7W_P!?UKL M%)D>O\
MGK_+G-&1ZCG_ #_2G_7Y_P"3^Y]G8_K^OZWTWT%HI"P'4C/IW_#WI2"!N)4C
M('!Y&3@<YP0._MD]J/Z_7\M0"BDR.F11D>H_.BZ_K[_RU] _K]/ST]=-]!:*
M0D#J1_G_ /6,^F1F@$'H?>@!:*** "BBB@ HHHH **** "BBB@ J*2WBN%99
M3E,C*$C:2 .<'OSC/M4M)@'J ?PH !T'T%+110 4444 %%%% !1110 4444
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M?''P1/I_PM\&VDOA+XS^+%L5\4?%CP_+#HZOI?Q%\0+IFGKK'C&S:+7M1%G
M+J_D"54)4XP<944V_8^][23:4/9JJHJ;:M5493;DY2BZDX)J"IR4U%4DVXSY
M;^T27)!63<G3NXK5TTU"Z2NHJ;3FYJ7Y<_\ !3GQ9\2_!?\ P4Q_X(^ZY\%?
MAUX.^+OQ@MO"'_!4&7P!\+_&GQ-G^#^G^.M6L?V;?AYJ\GAVT\?P^$O',6AZ
MAJ,6FBVL[C5O"VH>'1=20-K5WH4"1^(-*^2?V0OCMI/PI_X)V?LG6?P>_:CL
M/!'B'_@H+_P4[\>?#G]HGXJK\+],\ :G^Q#\:OVB;_XY?'GXN?LX^"/@-\1]
M1^*7A_X1?$CPI\0_!6D_LM_#G3OB?/X]\(VOCKXHZ)\<8M#\<^%M?\->&M?_
M *-_&G[.WP!^)'Q(^'WQC^(7P2^$WCKXM_"5I7^%?Q/\8?#SPEXD^('PU>XF
M^TW#^ O&&L:3>:_X2>XN/W\[Z#J%@\LN'=BRJ1P&N?L/?L7>)[_XO:IXC_9'
M_9DU_5/V@H+*V^/.I:Q\!_A;J5_\:H=,UVR\4::GQ7O+OPK+<?$$Z=XETS3/
M$-C)XKDU:2UUS3-,U>%UU'3K*Y@F,G&U];<T9*]N>F\3#$1IMVNHN<$Y\J4K
MPIKFG2E6I2NI>=K)1Y80BI<L9-2C1K47449>ZY*-6T4[QMS-J,XTYK\S_P#@
MD!J>E?"ZX_X*;>'OB3\:M*\8:YJ'_!9GX]_#S2O'WCC6/AIX?\1_$3Q?)\"/
MV9++PUX=O;;P7HW@?P=J'Q/NM&T@6>JZ#X7\*Z/J.JZQH^L7PT"*Y^VA?VP\
M,^+O"GC?2DU[P5XF\.^,-#.IZEI7]L^%]:TWQ#I/]IZ#JMSHNNZ<-1TFZN[/
M^T-%UBPOM*U:S\[[1INIV5W8WD<-U;S1)X1X6_8K_8Y\"V>C:=X)_9,_9F\(
M:=X=^(_A7XQ>']/\+_ ;X5^'K+0_BYX&T.?POX*^*FC6VD>$[.'2_B/X/\,W
M5UX=\+>-[%(/$OA_0KJYTG2=2M;">6W:']E[]DWX6_LG_#WQI\/?AGHV@:%I
M7Q"^)WCWXK>*++P3X-\*_"KPK'X@\<R6EE]A\*^ _AOIOA[PIX-TG0?">C>&
M?"MFVAV$.MZ])H4GCCQKK7B?XE^)?%WC+7D[-6;E=4Z<4[1L_9QHTE>S]V].
M$IO?W[1UB[B;;E-VMS5)3M=RM&;E.R;LVHOE@K[Q=]+6/Y'?B1-^U!%_P0=^
M/_A.+X(_L[W?[+%]^WC\5YH_B1/^T%XKC^,MEI-M_P %I;Z.XMK7]FVV_8^D
M^'ES%;>-M,GT2VEU;]J"74;7PL__  F%I=V,MGI'P]LOUK^)?[6'[5GCC]O?
MXT>#_A7^TK\#_@MX?_9"_; _99^"GB?]GSXL_&OX<>%--^+7P0^-'P_^ OBO
M7O$6J?"R3]F#X@?'/6_BA\;/%/QVUCX:?LY>+?"/QX\-^#;GQ[X%\$^&+3X;
MOJ5M\0)_BA^L6G_L%?L2:5\#_$W[-&F?LF_L_6/[/?C3Q/#XV\7_  2M_A1X
M,C^%_BCQC!<:%=Q>*_$'@Q=(_L'5_$27/ACPY<KK-_9SZA]HT+29O/\ -L;=
MD[76?V4/V8/$?Q4^'WQU\0_L\?!+7OC;\)M!M/"WPP^,&M?"[P3JWQ/^'WAO
M3CJ)TS0O!_CO4-$N/$^@:5I1UC63I5EIVIP0:8VM:R]BEN^KZFUU$(VI4Z4V
MY<D*47-:2DZ>&PM%O>V]"HK:<T*\KRC*$4JG[U6=6*47+VR47:48QJ8K%5XK
M^9JV(A=W<H3HQY4XR9^&O[,?[2_[<NC?$_\ 8R\0_%?]JOQ=^T%X'^+W[9__
M  5._8N\8?">_P#@5\"_!MWX@\-_LB77[<'BWX3?$Q/$/PX\)^$]7E^.5RW[
M,F@>"]2CT2;PM\*-6\%ZI::7'\,+'QQIGB'XF>-_D/3/VD/BGXI^*'_!(?\
MX*0^(?C;=?M4>+/BW^P;_P %5/VL=(^ ?AZS^$N@_#SX>_$G0/V<O@YXKU/]
MFWX"'P/X(E^+,EMX,U1;[X'>.E^(?Q ^*_BF3QEX C\17]CH'BB_\3Z=>?TT
M^%_V*/V0/!,_PRNO!_[,/P'\+W/P7\5^,_'?PAGT'X6>#-+E^&7C;XC"U7X@
M>+O DEGH\3^%_$GC9;*T7Q5K.CFTO]=%O$-1GN-HIGAK]B7]C7P3\4/^%W>#
M/V2?V9O"OQG;Q?XJ\?GXN^'/@1\*]%^)L?CGQW8W&F^-_&</CO3_  I;^*8?
M%/C.QO;^T\6Z[!JL>J>([>_OH]7NKS[==^:Z?/"*3DG.-%TX5.5*49O"RH3K
MMW;E4E5JSK1;U@H1IKF4Y<E2<)-ITERN?--<S7M(+$*K&E9:0BJ5.G2DDW&;
MDY235.+G_,/XB_;2_P""C7A#]C[QM^TGX2_X*'_!KQ_HWQ,_9U_9"^.WPZCT
MGQ;\!OCI\5_!WQ:\6?M3?"3X/?&S2]*\ ^%_V-_@IX6\._LK^*?!GQIT[POJ
M?A+Q?XCO_CE\.OB[X$BTKPC\0G2_\=7T/W1XP\=?MX_LT?M6_ OX>_&3]M_X
MO_%_X&>'_''[-/P\\;?'#X8?"7]B[4M(G^)G[2?[6?Q.LM%^%G[<?[/>GZ7I
M7QN^%&C_ !B^'?B[X%?L]_ C]H3X!W^E>"/"7BCPXGCKQ+X*@;Q7XEL4_7"S
M_P"">_[!5AX;^)7@ZR_8K_95MO"'QG\1:%XN^+_A&+]GSX3KX6^*/BCPO=WN
MH^&==\?^'SX2.C^+=1\-ZKJ6J:SH%SK=G>-HVN:IJFMZ;]FU;4[Z\N/2?$_[
M+G[-7C?XL^&_CWXS_9_^"_BOXX^#_P"R/^$6^,/B+X8>"M9^)OA__A'9-3F\
M.'2/'.H:)<>)+%O#4VMZW/X<>#44?0)]:UB;1S92ZK?M<:3DISYHTU2BJBFN
M5IM4U"5J5G:,G&<K*<K<T80G-2GSQJ9)34'%N,FXR7.XI>\Y1:F[>\DXQM*G
M!\BO*,.5<DX?SW_![]M3]M7XM?#O]@K]HJ+X^_$6Q\3?MR_MT_M*_L3_ !M_
M9*T3P!\!+^V_91M+32?VJH?"?B7X=MJGPAO?B+H_Q%_8_L/@#X:\>?$2'XQZ
MI\1_#GQ+BUWQCJGC#P]IWA"[\%Z'X>]F_P"":G[6'[5WB+4_V(OB/^UG^UC:
M?$GX=?M9_P#!)CXB?MB?$73O%/PQ^#WP?\#_  :\=? 3Q7^Q_H5[XQT/Q3X4
MTG1-0@TCQ7X0_:%\6>(OBW+XUUW4/#$?B71H/$G@G2OAEX*>S\!:!^RD7['W
M[)]O\0O'WQ;MOV9_@):?%7XJZ'XB\-?$OXEV?PC\!6GC[Q]X?\86EII_B_2/
M%WB^WT&/Q!KUEXMT_3M+L/%,>HZA.?$=GH^BVNLF]@T;2X[3C=4_8,_9#?PN
MOA[PQ^S;\ /"-SI/P,\=_LY>"-5L/@C\+]4C\!?!WXBVFO0>*/AWH/A[7_"V
MJ>&9_A[K%UXDUC4->^'.JZ3>^!_%,E_?6?B30]2L-0O+>7-*U.,5=2BX-S<G
M-S2I.,Z;YW>TYJ,E-OG2J33=X0D[DW*JYV4834UR65H7JPE3FFE=.G3YJ;C&
MZDXPGJY3B7_VL_$F@>)?V'?VF?%OAC6] \2^&/$/[)_QG\1^'O$.E7VF:_X7
M\0Z!JWP>\2ZII&LZ;J-O)>:-K6@:KI\\&H6=]#-=:;J6G3QSQ23VDRN_\R=I
M!XL_X)Z^%?V9_P!A_5K[Q?XQ_8&_;+_:T_X)+_%__@F=\0K@:[\0-/\ @O\
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MB/I.DV'A#5+66'WWQI_P3Q_8,^(_@/X8?"WX@_L9?LO^-_AM\$[/Q!I_P?\
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M(:WX:T35AXM\!G^V]W@GQ-_:%C<?V]X1;_A)?$>[PUJWVS13_;^MYL2=5O\
M[14WS3C-12Y8*'*FXJ2@J;@Y-7U<Z2]K)1<I4JE:G'E<H2C,%RQ:=Y-R<KOH
MYN:DK=8J%27)&ZM4IT9MM1E&?X8_$O\ :._:H^"K?LB?MG>.?VGOB?=_L3_'
M+]HG]I+P]\4/AOH_P$^%>LZQX<^"?[0GA;XB_P##LOQ#X0.E_ 2'XM:%=_\
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MP_M$2>49/CK#\*_ \/Q=D>W\'_\ "O+>>3XAQZ&OBI[NW^'V? -O?-JAO8/
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@""&XBG4/&VY7#%6. 7V.8Y!L.)%,4@\N0.B%7^4_,34]<OX20OH&AS
MM]I#MHNEJRW?E27)E>#[1<7$T_EB>2XNYG,MR[R&-Y &6*-S(S]10 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &/I>GC38
M[2TC:5X+/3XK&%YB9Y5CMW.Q9+R63SYV\IHH1YD()-N[F7<P6MBBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** #GH 2?0>G^2*.>A!!]#Z?Y!HY^;'7RWQ]?EJK9^
M>(<7&[S0[@[NNT,0OX8Z?C0!:HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** #GJ"0?4>G^0*.2<DY. /P&>OJ>3DT44 %%%%
M!1110 4444 %%%% !1110!@>'=<L_$FDZ1KVEW$ESI.MZ/IVLZ9<20BW:\L=
M6L;34K.Y>VDVW=G*UK=1%[:>)'0LWF!6V@;]>9_!K3[S2?A#\)]+U2RN]/U;
M2OAKX&TS5+&^MY;>\L[ZS\,:7:7EI=Q2JKQW-O=6[PS1OA@T;9R%4GTR@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ((H0
MC;R!YA!5V12@=<KY>\%Y"[QHH0.7)V@C ! $]%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 &" #E6#' *Y]"?Z8HKR3X
M">*M7\=? OX+>-=?N8KO7O&/PG^'/BS7;J&WM[.*YUOQ)X/T;6=4N8K.U2.V
MM(KB\OKB2.UMHH[:W61(H$CB1$7UN@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HZ44$
M9!'J,4 5'O(8YDMI)($N9$,D=J9X_M+QKC?(L&?,*1[AO8+A<\FK9!!P<'@'
MCWR._P!*H/I>GR7EOJ,EG;OJ%K#);V]^T2&\B@FV^=$+@CS"DI12ZDX8J#C-
M7\DG).3@#IC@9_Q- !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'DOP+\':U\/O@U\(/ G
MB%+./7/ OPI^'G@S6AIYCETZ36/#?A#0]'U-]-G#O.;%+ZPN8K=92/,B$<P+
M_*3ZU110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4<]<''KCCT^O7CI2'H?H:K7)O//M]D:_9PQ\YC(, %2 &4KDKNVYQVSQGB@
M"U10.@Z]._7\?>B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH *3'^TQ]0SNP]>C,0/R^F*6B@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BDVLQ^4J,#
MG<H;.<XQGIT.?7CKQ@ *Y!()!Z@;1R 1@#@8!'IDY/6@!:*** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!,9_^L2/Y4N,444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444R218D:1\[44
MLV!DA1C)P.3C(Z<]AR10 ^BFHZR*KKT90PSUPPR"1VS_ (CJ*=0 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %-90P(/1D9#QGY6
MQG\>!@G(]0:=10 U5"@   *JJ,#^%1@9]2!QV&,  4ZBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHI#T/T- "Y!Z'-%(^"\93E0&SCIG'&:6@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **@AN
M(KA$EA=98I(HIHY8V$D4D4ZAX9(IH]T$R2(0ZM%*ZE"&SR 9Z "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \D^!?A'5O G
MP<^$7@WQ!=0WFN^"?A9\/_!>L7-E=W%QI]SJOASPII&C:O<6WG+'YJ2ZCITC
M0W$D9G,;')3S)0WK=&.<]3ZGG^?Z^O>B@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MO:L,U;^"?P+^'O[/_A;6/"?PYM-?BLO$OCCQG\3/%.I>*_&'BKQWXD\3>/\
MXA:U-XA\9>*-8\0^,-7UG4VN=9U>XDGCTNRGL_#^B6JV^D>'-(TC1;*RTZWF
M"<;IRDU:LEM;]Y6H5(7^T^14ZCO=I2JRC%*%D5-J2@E%1<?9<S5[R=.&(C*7
M;WO;4X-:2<:49-MH]@HHHJA!1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%'H!U
M/3)P.A/7\*""#AAC.<8.>F,_S% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %1.LK,GER*@!^=6 .Y?8D$@C(^M2T8!ZC-
M !_]<?D<=N**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@"O=))) Z0_ZPE-OX2*S=QG"AC4ZAECA5_OA"&^ORYI?Q((Z$=1V_D:.>
MY)],]L]?Y"@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
; **** "BBB@ HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>ex5-1_001.jpg
<TEXT>
begin 644 ex5-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !/ +T# 2(  A$! Q$!_\0
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MSO\ X: \/?\ 0+U+\D_QK;#SKQC:FKHJ+?0X>T^!/BR:X5+B2QMXB?FD,N[
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>16
<FILENAME>rime-20240930.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWaCE+bP9z5Z82ekhvWBzbana/y4nIZU/kigJvlBW4SsI -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:RIME="http://algoholdings.com/20240930" elementFormDefault="qualified" targetNamespace="http://algoholdings.com/20240930">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://algoholdings.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/BalanceSheets" id="BalanceSheets">
          <link:definition>00000002 - Statement - Condensed Consolidated Balance Sheets</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/BalanceSheetsParenthetical" id="BalanceSheetsParenthetical">
          <link:definition>00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/StatementsOfOperations" id="StatementsOfOperations">
          <link:definition>00000004 - Statement - Condensed Consolidated Statements of Operations</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/StatementsOfShareholdersDeficitEquity" id="StatementsOfShareholdersDeficitEquity">
          <link:definition>00000005 - Statement - Condensed Consolidated Statements of Shareholders' (Deficit) Equity</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/StatementsOfCashFlows" id="StatementsOfCashFlows">
          <link:definition>00000006 - Statement - Condensed Consolidated Statements of Cash Flows</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/NatureOfBusiness" id="NatureOfBusiness">
          <link:definition>00000007 - Disclosure - NATURE OF BUSINESS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/RecentDevelopments" id="RecentDevelopments">
          <link:definition>00000008 - Disclosure - RECENT DEVELOPMENTS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/LiquidityGoingConcernAndManagementPlans" id="LiquidityGoingConcernAndManagementPlans">
          <link:definition>00000009 - Disclosure - LIQUIDITY, GOING CONCERN AND MANAGEMENT PLANS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/SummaryOfSignificantAccountingPolicies" id="SummaryOfSignificantAccountingPolicies">
          <link:definition>00000010 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/AssetAcquisition" id="AssetAcquisition">
          <link:definition>00000011 - Disclosure - ASSET ACQUISITION</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/Financing" id="Financing">
          <link:definition>00000012 - Disclosure - FINANCING</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/LoansPayableRelatedParties" id="LoansPayableRelatedParties">
          <link:definition>00000013 - Disclosure - LOANS PAYABLE &#8211; RELATED PARTIES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
          <link:definition>00000014 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/OperatingLeases" id="OperatingLeases">
          <link:definition>00000015 - Disclosure - OPERATING LEASES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/IssuanceOfCommonStock" id="IssuanceOfCommonStock">
          <link:definition>00000016 - Disclosure - ISSUANCE OF COMMON STOCK</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/Warrants" id="Warrants">
          <link:definition>00000017 - Disclosure - WARRANTS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/ComputationOfLossPerShare" id="ComputationOfLossPerShare">
          <link:definition>00000018 - Disclosure - COMPUTATION OF LOSS PER SHARE</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/IncomeTaxes" id="IncomeTaxes">
          <link:definition>00000019 - Disclosure - INCOME TAXES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/RevenueDisaggregation" id="RevenueDisaggregation">
          <link:definition>00000020 - Disclosure - REVENUE DISAGGREGATION</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/ConcentrationsOfCreditRiskAndRevenue" id="ConcentrationsOfCreditRiskAndRevenue">
          <link:definition>00000021 - Disclosure - CONCENTRATIONS OF CREDIT RISK AND REVENUE</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/RelatedPartyTransactions" id="RelatedPartyTransactions">
          <link:definition>00000022 - Disclosure - RELATED PARTY TRANSACTIONS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/SubsequentEvents" id="SubsequentEvents">
          <link:definition>00000023 - Disclosure - SUBSEQUENT EVENTS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/PropertyAndEquipment" id="PropertyAndEquipment">
          <link:definition>00000024 - Disclosure - PROPERTY AND EQUIPMENT</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/StockCompensationExpense" id="StockCompensationExpense">
          <link:definition>00000025 - Disclosure - STOCK COMPENSATION EXPENSE</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/PublicOfferingAndNasdaqUplisting" id="PublicOfferingAndNasdaqUplisting">
          <link:definition>00000026 - Disclosure - PUBLIC OFFERING AND NASDAQ UPLISTING</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/AtmOffering" id="AtmOffering">
          <link:definition>00000027 - Disclosure - ATM OFFERING</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/PrivatePlacement" id="PrivatePlacement">
          <link:definition>00000028 - Disclosure - PRIVATE PLACEMENT</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/August2021StockRedemption" id="August2021StockRedemption">
          <link:definition>00000029 - Disclosure - AUGUST 2021 STOCK REDEMPTION</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/August2021PrivatePlacement" id="August2021PrivatePlacement">
          <link:definition>00000030 - Disclosure - AUGUST 2021 PRIVATE PLACEMENT</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/DamagedGoodsIncidentRecovery" id="DamagedGoodsIncidentRecovery">
          <link:definition>00000031 - Disclosure - DAMAGED GOODS INCIDENT RECOVERY</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/SupplementalInformationCondensedFinancialInformation" id="SupplementalInformationCondensedFinancialInformation">
          <link:definition>00000032 - Disclosure - SUPPLEMENTAL INFORMATION CONDENSED FINANCIAL INFORMATION</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/AccountsReceivable" id="AccountsReceivable">
          <link:definition>00000033 - Disclosure - ACCOUNTS RECEIVABLE</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/AccountsPayableAndAccruedExpenses" id="AccountsPayableAndAccruedExpenses">
          <link:definition>00000034 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/NotesPayableAndFinaningArrangements" id="NotesPayableAndFinaningArrangements">
          <link:definition>00000035 - Disclosure - NOTES PAYABLE AND FINANING ARRANGEMENTS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/DueFromFactor" id="DueFromFactor">
          <link:definition>00000036 - Disclosure - DUE FROM FACTOR</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/StockholdersEquity" id="StockholdersEquity">
          <link:definition>00000037 - Disclosure - STOCKHOLDERS&#8217; EQUITY</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/SafePrivatePlacements" id="SafePrivatePlacements">
          <link:definition>00000038 - Disclosure - SAFE PRIVATE PLACEMENTS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/EmployeeBenefitPlans" id="EmployeeBenefitPlans">
          <link:definition>00000039 - Disclosure - EMPLOYEE BENEFIT PLANS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/SummaryOfSignificantAccountingPoliciesPolicies" id="SummaryOfSignificantAccountingPoliciesPolicies">
          <link:definition>00000040 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/AssetAcquisitionTables" id="AssetAcquisitionTables">
          <link:definition>00000041 - Disclosure - ASSET ACQUISITION (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/LoansPayableRelatedPartiesTables" id="LoansPayableRelatedPartiesTables">
          <link:definition>00000042 - Disclosure - LOANS PAYABLE &#8211; RELATED PARTIES (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/OperatingLeasesTables" id="OperatingLeasesTables">
          <link:definition>00000043 - Disclosure - OPERATING LEASES (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/WarrantsTables" id="WarrantsTables">
          <link:definition>00000044 - Disclosure - WARRANTS (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/ComputationOfLossPerShareTables" id="ComputationOfLossPerShareTables">
          <link:definition>00000045 - Disclosure - COMPUTATION OF LOSS PER SHARE (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/RevenueDisaggregationTables" id="RevenueDisaggregationTables">
          <link:definition>00000046 - Disclosure - REVENUE DISAGGREGATION (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/PropertyAndEquipmentTables" id="PropertyAndEquipmentTables">
          <link:definition>00000047 - Disclosure - PROPERTY AND EQUIPMENT (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/StockCompensationExpenseTables" id="StockCompensationExpenseTables">
          <link:definition>00000048 - Disclosure - STOCK COMPENSATION EXPENSE (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/August2021PrivatePlacementTables" id="August2021PrivatePlacementTables">
          <link:definition>00000049 - Disclosure - AUGUST 2021 PRIVATE PLACEMENT (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/SupplementalInformationCondensedFinancialInformationTables" id="SupplementalInformationCondensedFinancialInformationTables">
          <link:definition>00000050 - Disclosure - SUPPLEMENTAL INFORMATION CONDENSED FINANCIAL INFORMATION (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/NotesPayableAndFinaningArrangementsTables" id="NotesPayableAndFinaningArrangementsTables">
          <link:definition>00000051 - Disclosure - NOTES PAYABLE AND FINANING ARRANGEMENTS (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/StockholdersEquityTables" id="StockholdersEquityTables">
          <link:definition>00000052 - Disclosure - STOCKHOLDERS&#8217; EQUITY (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/SafePrivatePlacementsTables" id="SafePrivatePlacementsTables">
          <link:definition>00000053 - Disclosure - SAFE PRIVATE PLACEMENTS (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/RecentDevelopmentsDetailsNarrative" id="RecentDevelopmentsDetailsNarrative">
          <link:definition>00000054 - Disclosure - RECENT DEVELOPMENTS (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/LiquidityGoingConcernAndManagementPlansDetailsNarrative" id="LiquidityGoingConcernAndManagementPlansDetailsNarrative">
          <link:definition>00000055 - Disclosure - LIQUIDITY, GOING CONCERN AND MANAGEMENT PLANS (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/ScheduleOfConsiderationTransferredToAssetsAcquiredAndLiabilitiesAssumedDetails" id="ScheduleOfConsiderationTransferredToAssetsAcquiredAndLiabilitiesAssumedDetails">
          <link:definition>00000056 - Disclosure - SCHEDULE OF CONSIDERATION TRANSFERRED TO THE ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/ScheduleOfConsiderationTransferredToAssetsAcquiredAndLiabilitiesAssumedDetailsParenthetical" id="ScheduleOfConsiderationTransferredToAssetsAcquiredAndLiabilitiesAssumedDetailsParenthetical">
          <link:definition>00000057 - Disclosure - SCHEDULE OF CONSIDERATION TRANSFERRED TO THE ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details) (Parenthetical)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/ScheduleOfProFormaFinancialInformationDetails" id="ScheduleOfProFormaFinancialInformationDetails">
          <link:definition>00000058 - Disclosure - SCHEDULE OF PRO FORMA FINANCIAL INFORMATION (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/AssetAcquisitionDetailsNarrative" id="AssetAcquisitionDetailsNarrative">
          <link:definition>00000059 - Disclosure - ASSET ACQUISITION (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/FinancingDetailsNarrative" id="FinancingDetailsNarrative">
          <link:definition>00000060 - Disclosure - FINANCING (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/ScheduleOfLoanDetails" id="ScheduleOfLoanDetails">
          <link:definition>00000061 - Disclosure - SCHEDULE OF LOAN (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/LoansPayableRelatedPartiesDetailsNarrative" id="LoansPayableRelatedPartiesDetailsNarrative">
          <link:definition>00000062 - Disclosure - LOANS PAYABLE &#8211; RELATED PARTIES (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/CommitmentsAndContingenciesDetailsNarrative" id="CommitmentsAndContingenciesDetailsNarrative">
          <link:definition>00000063 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/ScheduleOfSupplementalInformationRelatedToLeasesDetails" id="ScheduleOfSupplementalInformationRelatedToLeasesDetails">
          <link:definition>00000064 - Disclosure - SCHEDULE OF SUPPLEMENTAL INFORMATION RELATED TO LEASES (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/ScheduleOfLeaseTermAndDiscountRateDetails" id="ScheduleOfLeaseTermAndDiscountRateDetails">
          <link:definition>00000065 - Disclosure - SCHEDULE OF LEASE TERM AND DISCOUNT RATE (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/ScheduleOfOperatingLeaseMinimumFuturePaymentsDetails" id="ScheduleOfOperatingLeaseMinimumFuturePaymentsDetails">
          <link:definition>00000066 - Disclosure - SCHEDULE OF OPERATING LEASE MINIMUM FUTURE PAYMENTS (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/OperatingLeasesDetailsNarrative" id="OperatingLeasesDetailsNarrative">
          <link:definition>00000067 - Disclosure - OPERATING LEASES (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/IssuanceOfCommonStockDetailsNarrative" id="IssuanceOfCommonStockDetailsNarrative">
          <link:definition>00000068 - Disclosure - ISSUANCE OF COMMON STOCK (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/ScheduleOfWarrantsExpirationDetails" id="ScheduleOfWarrantsExpirationDetails">
          <link:definition>00000069 - Disclosure - SCHEDULE OF WARRANTS EXPIRATION (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/WarrantsDetailsNarrative" id="WarrantsDetailsNarrative">
          <link:definition>00000070 - Disclosure - WARRANTS (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/ScheduleOfBasicAndDilutiveLossPerShareDetails" id="ScheduleOfBasicAndDilutiveLossPerShareDetails">
          <link:definition>00000071 - Disclosure - SCHEDULE OF BASIC AND DILUTIVE LOSS PER SHARE (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/ComputationOfLossPerShareDetailsNarrative" id="ComputationOfLossPerShareDetailsNarrative">
          <link:definition>00000072 - Disclosure - COMPUTATION OF LOSS PER SHARE (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/IncomeTaxesDetailsNarrative" id="IncomeTaxesDetailsNarrative">
          <link:definition>00000073 - Disclosure - INCOME TAXES (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/ScheduleOfRevenueByProductLineDetails" id="ScheduleOfRevenueByProductLineDetails">
          <link:definition>00000074 - Disclosure - SCHEDULE OF REVENUE BY PRODUCT LINE (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/ScheduleOfSalesByGeographicalRegionDetails" id="ScheduleOfSalesByGeographicalRegionDetails">
          <link:definition>00000075 - Disclosure - SCHEDULE OF SALES BY GEOGRAPHICAL REGION (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/RevenueDisaggregationDetailsNarrative" id="RevenueDisaggregationDetailsNarrative">
          <link:definition>00000076 - Disclosure - REVENUE DISAGGREGATION (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/ConcentrationsOfCreditRiskAndRevenueDetailsNarrative" id="ConcentrationsOfCreditRiskAndRevenueDetailsNarrative">
          <link:definition>00000077 - Disclosure - CONCENTRATIONS OF CREDIT RISK AND REVENUE (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/RelatedPartyTransactionsDetailsNarrative" id="RelatedPartyTransactionsDetailsNarrative">
          <link:definition>00000078 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/SubsequentEventsDetailsNarrative" id="SubsequentEventsDetailsNarrative">
          <link:definition>00000079 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" id="SummaryOfSignificantAccountingPoliciesDetailsNarrative">
          <link:definition>00000080 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/ScheduleOfPropertyAndEquipmentDetails" id="ScheduleOfPropertyAndEquipmentDetails">
          <link:definition>00000081 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/PropertyAndEquipmentDetailsNarrative" id="PropertyAndEquipmentDetailsNarrative">
          <link:definition>00000082 - Disclosure - PROPERTY AND EQUIPMENT (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/SummaryOfStockOptionActivityDetails" id="SummaryOfStockOptionActivityDetails">
          <link:definition>00000083 - Disclosure - SUMMARY OF STOCK OPTION ACTIVITY (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/ScheduleOfEmployeeStockOptionsOutstandingDetailsParenthetical" id="ScheduleOfEmployeeStockOptionsOutstandingDetailsParenthetical">
          <link:definition>00000084 - Disclosure - SCHEDULE OF EMPLOYEE STOCK OPTIONS OUTSTANDING (Details) (Parenthetical)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/ScheduleOfBasicAndDilutiveSharesDetails" id="ScheduleOfBasicAndDilutiveSharesDetails">
          <link:definition>00000085 - Disclosure - SCHEDULE OF BASIC AND DILUTIVE SHARES (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/StockCompensationExpenseDetailsNarrative" id="StockCompensationExpenseDetailsNarrative">
          <link:definition>00000086 - Disclosure - STOCK COMPENSATION EXPENSE (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/PublicOfferingAndNasdaqUplistingDetailsNarrative" id="PublicOfferingAndNasdaqUplistingDetailsNarrative">
          <link:definition>00000087 - Disclosure - PUBLIC OFFERING AND NASDAQ UPLISTING (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/AtmOfferingDetailsNarrative" id="AtmOfferingDetailsNarrative">
          <link:definition>00000088 - Disclosure - ATM OFFERING (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/PrivatePlacementDetailsNarrative" id="PrivatePlacementDetailsNarrative">
          <link:definition>00000089 - Disclosure - PRIVATE PLACEMENT (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/August2021StockRedemptionDetailsNarrative" id="August2021StockRedemptionDetailsNarrative">
          <link:definition>00000090 - Disclosure - AUGUST 2021 STOCK REDEMPTION (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/ScheduleOfLossBeforeIncomeTaxesDetails" id="ScheduleOfLossBeforeIncomeTaxesDetails">
          <link:definition>00000091 - Disclosure - SCHEDULE OF LOSS BEFORE INCOME TAXES (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/ScheduleOfProvisionForIncomeTaxesDetails" id="ScheduleOfProvisionForIncomeTaxesDetails">
          <link:definition>00000092 - Disclosure - SCHEDULE OF PROVISION FOR INCOME TAXES (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" id="ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails">
          <link:definition>00000093 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/ScheduleOfTaxProvisionDetails" id="ScheduleOfTaxProvisionDetails">
          <link:definition>00000094 - Disclosure - SCHEDULE OF TAX PROVISION (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/ScheduleOfRevenueByGeographicalRegionDetails" id="ScheduleOfRevenueByGeographicalRegionDetails">
          <link:definition>00000095 - Disclosure - SCHEDULE OF REVENUE BY GEOGRAPHICAL REGION (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/August2021PrivatePlacementDetailsNarrative" id="August2021PrivatePlacementDetailsNarrative">
          <link:definition>00000096 - Disclosure - AUGUST 2021 PRIVATE PLACEMENT (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/DamagedGoodsIncidentRecoveryDetailsNarrative" id="DamagedGoodsIncidentRecoveryDetailsNarrative">
          <link:definition>00000097 - Disclosure - DAMAGED GOODS INCIDENT RECOVERY (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfOperationsDetails" id="ScheduleOfCondensedConsolidatedStatementsOfOperationsDetails">
          <link:definition>00000098 - Disclosure - SCHEDULE OF CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfCashFlowsDetails" id="ScheduleOfCondensedConsolidatedStatementsOfCashFlowsDetails">
          <link:definition>00000099 - Disclosure - SCHEDULE OF CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfShareholdersEquityDetails" id="ScheduleOfCondensedConsolidatedStatementsOfShareholdersEquityDetails">
          <link:definition>00000100 - Disclosure - SCHEDULE OF CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS? EQUITY (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/ScheduleOfEstimatedUsefulLivesDetails" id="ScheduleOfEstimatedUsefulLivesDetails">
          <link:definition>00000101 - Disclosure - SCHEDULE OF ESTIMATED USEFUL LIVES (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/AccountsReceivableDetailsNarrative" id="AccountsReceivableDetailsNarrative">
          <link:definition>00000102 - Disclosure - ACCOUNTS RECEIVABLE (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/AccountsPayableAndAccruedExpensesDetailsNarrative" id="AccountsPayableAndAccruedExpensesDetailsNarrative">
          <link:definition>00000103 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/ScheduleOfSpecificTermsDetails" id="ScheduleOfSpecificTermsDetails">
          <link:definition>00000104 - Disclosure - SCHEDULE OF SPECIFIC TERMS (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/NotesPayableAndFinaningArrangementsDetailsNarrative" id="NotesPayableAndFinaningArrangementsDetailsNarrative">
          <link:definition>00000105 - Disclosure - NOTES PAYABLE AND FINANING ARRANGEMENTS (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/DueFromFactorDetailsNarrative" id="DueFromFactorDetailsNarrative">
          <link:definition>00000106 - Disclosure - DUE FROM FACTOR (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/ScheduleOfStockOptionIssuedDuringYearDecember3120202021And2022Details" id="ScheduleOfStockOptionIssuedDuringYearDecember3120202021And2022Details">
          <link:definition>00000107 - Disclosure - SCHEDULE OF STOCK OPTION ISSUED DURING THE YEAR DECEMBER 31, 2020, 2021 AND 2022 (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/StockholdersEquityDetailsNarrative" id="StockholdersEquityDetailsNarrative">
          <link:definition>00000108 - Disclosure - STOCKHOLDERS&#8217; EQUITY (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/ScheduleOfFirstTrancheOfSubscriptionsDetails" id="ScheduleOfFirstTrancheOfSubscriptionsDetails">
          <link:definition>00000109 - Disclosure - SCHEDULE OF FIRST TRANCHE OF SUBSCRIPTIONS (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/SummaryOfTerminatedImmediatelyAfterClosingOfTransactionDetails" id="SummaryOfTerminatedImmediatelyAfterClosingOfTransactionDetails">
          <link:definition>00000110 - Disclosure - SUMMARY OF TERMINATED IMMEDIATELY AFTER CLOSING OF THE TRANSACTION (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://algoholdings.com/role/SafePrivatePlacementsDetailsNarrative" id="SafePrivatePlacementsDetailsNarrative">
          <link:definition>00000111 - Disclosure - SAFE PRIVATE PLACEMENTS (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="rime-20240930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="rime-20240930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="rime-20240930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="rime-20240930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
    <import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" />
    <import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd" />
    <import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" />
    <import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd" />
    <element id="RIME_SemiCabIncMember" name="SemiCabIncMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_AtTheMarketSalesAgreementMember" name="AtTheMarketSalesAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_AtTheMarketSalesAgreementAmendmentOneMember" name="AtTheMarketSalesAgreementAmendmentOneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_AtTheMarketSalesAgreementAmendmentTwoMember" name="AtTheMarketSalesAgreementAmendmentTwoMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_AssetPurchaseAgreementMember" name="AssetPurchaseAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_SemiCabLLCMember" name="SemiCabLLCMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_LeaseAgreementMember" name="LeaseAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_SettlementAgreementMember" name="SettlementAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_SecuritiesPurchaseAgreementMember" name="SecuritiesPurchaseAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_LoanAgreementMember" name="LoanAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_StockRepurchaseAgreementMember" name="StockRepurchaseAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_ATMOfferingMember" name="ATMOfferingMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_TwoThousandTwentyFourMember" name="TwoThousandTwentyFourMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_AjeshKapoorMember" name="AjeshKapoorMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_EmploymentAgreementsMember" name="EmploymentAgreementsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_TwoThousandTwentyFiveMember" name="TwoThousandTwentyFiveMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_SubsequentYearsMember" name="SubsequentYearsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_VivekSehgalKapoorMember" name="VivekSehgalKapoorMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_TwoThousandTwentySixMember" name="TwoThousandTwentySixMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_TwoThousandTwentySevenMember" name="TwoThousandTwentySevenMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_TwoThousandTwentyEightMember" name="TwoThousandTwentyEightMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_AlgorhythmHoldingsIncMember" name="AlgorhythmHoldingsIncMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_RevolvingLoanAmendmentMember" name="RevolvingLoanAmendmentMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_AgileCapilalFundingllcMember" name="AgileCapilalFundingllcMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_CedarAdvancellcMember" name="CedarAdvancellcMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_SemiCabInvestorMember" name="SemiCabInvestorMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_TwoYearCreditAndSecurityAgreementMember" name="TwoYearCreditAndSecurityAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_TwoYearLoanAndSecurityAgreementMember" name="TwoYearLoanAndSecurityAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_CreditAndSecurityAgreementsMember" name="CreditAndSecurityAgreementsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_AjeshKapoorOneMember" name="AjeshKapoorOneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_AjeshKapoorTwoMember" name="AjeshKapoorTwoMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_VivekSeghalMember" name="VivekSeghalMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_AjeshKapoorThreeMember" name="AjeshKapoorThreeMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_AjeshKapoorFourMember" name="AjeshKapoorFourMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_SettlementSumMember" name="SettlementSumMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_InitialPaymentMember" name="InitialPaymentMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_SecondPaymentMember" name="SecondPaymentMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_AdditionalPaymentMember" name="AdditionalPaymentMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_BlueYonderIncMember" name="BlueYonderIncMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_ServiceContractAndAgreementMember" name="ServiceContractAndAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_PerYearMember" name="PerYearMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_DueOnJulyOneTwoThousandTwentyFourMember" name="DueOnJulyOneTwoThousandTwentyFourMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_TwoSeparateMilestonePaymentMember" name="TwoSeparateMilestonePaymentMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_FirstMilestonePaymentMember" name="FirstMilestonePaymentMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_OctoberOneTwoThousandTwentyFourMember" name="OctoberOneTwoThousandTwentyFourMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_SecondMilestonePaymentMember" name="SecondMilestonePaymentMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_JanuaryOneTwoThousandTwentyFiveMember" name="JanuaryOneTwoThousandTwentyFiveMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_OperatingLeaseAgreementMember" name="OperatingLeaseAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_TwoThousandTwentyTwoPlanMember" name="TwoThousandTwentyTwoPlanMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_ExercisePriceRangeOneMember" name="ExercisePriceRangeOneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_ExercisePriceRangeTwoMember" name="ExercisePriceRangeTwoMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_CommonStockWarrantsMember" name="CommonStockWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_PreFundedWarrantsMember" name="PreFundedWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_OptionsAndWarrantsMember" name="OptionsAndWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_ClassicKaraokeMachinesMember" name="ClassicKaraokeMachinesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_LicensedProductsMember" name="LicensedProductsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_KidsYouthElectronicsMember" name="KidsYouthElectronicsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_MicrophonesAndAccessoriesMember" name="MicrophonesAndAccessoriesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_MusicSubscriptionsMember" name="MusicSubscriptionsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_LogisticsServicesMember" name="LogisticsServicesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_KaraokeMachinesMember" name="KaraokeMachinesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_ThreeCustomersMember" name="ThreeCustomersMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_FourCustomersMember" name="FourCustomersMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_SalesRevenueMember" name="SalesRevenueMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_CustomerOneMember" name="CustomerOneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_CustomersTwoMember" name="CustomersTwoMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_CustomersThreeMember" name="CustomersThreeMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_CustomersFourMember" name="CustomersFourMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_CustomersConcentrationRiskMember" name="CustomersConcentrationRiskMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_CustomersOneMember" name="CustomersOneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_PurchasesMember" name="PurchasesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_RepublicOfChinaMember" name="RepublicOfChinaMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_FourMember" name="FourMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_StingrayMember" name="StingrayMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_SMCBMember" name="SMCBMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_AultAllianceIncMember" name="AultAllianceIncMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_ComputerAndOfficeEquipmentMember" name="ComputerAndOfficeEquipmentMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_WarehouseEquipmentMember" name="WarehouseEquipmentMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_MoldsAndToolingMember" name="MoldsAndToolingMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_EmployeeMember" name="EmployeeMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_SixCurrentAndThreeFormerDirectorsMember" name="SixCurrentAndThreeFormerDirectorsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_EmployeesMember" name="EmployeesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_UnderwritingAgreementMember" name="UnderwritingAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_RedemptionAgreementMember" name="RedemptionAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_KonceptsandTreasureGreenMember" name="KonceptsandTreasureGreenMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_PurchaseAgreementMember" name="PurchaseAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_AGPWarrantsMember" name="AGPWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_EuropeAndUnitedKingdomMember" name="EuropeAndUnitedKingdomMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_OthersMember" name="OthersMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_EqualInstallmentsForThirteenMonthsMember" name="EqualInstallmentsForThirteenMonthsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_TwelveInstallmentsMember" name="TwelveInstallmentsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_FirstPaymentMember" name="FirstPaymentMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_DueAndPaidOnMayTwentyTwoThousandTwentyFourMember" name="DueAndPaidOnMayTwentyTwoThousandTwentyFourMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_DueOnJuneThreeTwoThousandTwentyFourMember" name="DueOnJuneThreeTwoThousandTwentyFourMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_TenMonthlyPaymentsMember" name="TenMonthlyPaymentsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_WeeklyPaymentsForWeeksMember" name="WeeklyPaymentsForWeeksMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_WeeklyPaymentsMember" name="WeeklyPaymentsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_SixShareholderLoanAgreementsMember" name="SixShareholderLoanAgreementsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_VivekSehgalMember" name="VivekSehgalMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_JaganReddyMember" name="JaganReddyMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_SudhirNarasimhamurthyMember" name="SudhirNarasimhamurthyMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_KadandaleSrinivasSudheerMember" name="KadandaleSrinivasSudheerMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_RajivSaxenaMember" name="RajivSaxenaMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_HarshaBhatMember" name="HarshaBhatMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_SiddayyaSGanjalMember" name="SiddayyaSGanjalMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_SunilAroraMember" name="SunilAroraMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_RajivVirmaniMember" name="RajivVirmaniMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_SudhindraShenoyMember" name="SudhindraShenoyMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_AntonySunilMember" name="AntonySunilMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_TuleekaNandyMember" name="TuleekaNandyMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_RobelAtnafuMember" name="RobelAtnafuMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_GuyPrimusMember" name="GuyPrimusMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_SamarthaGowdaMember" name="SamarthaGowdaMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_AlexandraAielloMember" name="AlexandraAielloMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_StephenCabralMember" name="StephenCabralMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_JonahPetiPerrinMember" name="JonahPetiPerrinMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_BryanNellaMember" name="BryanNellaMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_MarkSinkMember" name="MarkSinkMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_KoustavChoudhuriMember" name="KoustavChoudhuriMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_FoundersMember" name="FoundersMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_SAFEAgreementsMember" name="SAFEAgreementsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_FortyFourSAFEAgreementsMember" name="FortyFourSAFEAgreementsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_SAFEOneMember" name="SAFEOneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_SAFEThirtyEightMember" name="SAFEThirtyEightMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_SAFEFortyOneMember" name="SAFEFortyOneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_SAFEFortyTwoMember" name="SAFEFortyTwoMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_SAFEFortyFourMember" name="SAFEFortyFourMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_SAFEFortyThreeMember" name="SAFEFortyThreeMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_SAFEFortyMember" name="SAFEFortyMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_SAFEThirtyNineMember" name="SAFEThirtyNineMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_SAFETenMember" name="SAFETenMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_SAFEElevenMember" name="SAFEElevenMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_SAFETwelveMember" name="SAFETwelveMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_SAFEThirteenMember" name="SAFEThirteenMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_SAFEFourteenMember" name="SAFEFourteenMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_SAFEFifteenMember" name="SAFEFifteenMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_SAFESixteenMember" name="SAFESixteenMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_SAFESeventeenMember" name="SAFESeventeenMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_SAFEEighteenMember" name="SAFEEighteenMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_SAFENineteenMember" name="SAFENineteenMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_SAFETwoMember" name="SAFETwoMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_SAFETwentyMember" name="SAFETwentyMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_SAFETwentyOneMember" name="SAFETwentyOneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_SAFETwentyTwoMember" name="SAFETwentyTwoMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_SAFETwentyFourMember" name="SAFETwentyFourMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_SAFEThreeMember" name="SAFEThreeMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_SAFEFourMember" name="SAFEFourMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_SAFEFortyFiveMember" name="SAFEFortyFiveMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_SAFESixMember" name="SAFESixMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_SAFESevenMember" name="SAFESevenMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_SAFEEightMember" name="SAFEEightMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_SAFENineMember" name="SAFENineMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_SAFEFiveMember" name="SAFEFiveMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_SAFETwentyFiveMember" name="SAFETwentyFiveMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_SAFETwentySixMember" name="SAFETwentySixMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_SAFETwentySevenMember" name="SAFETwentySevenMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_SAFETwentyEightMember" name="SAFETwentyEightMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_SAFETwentyNineMember" name="SAFETwentyNineMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_SAFEThirtyMember" name="SAFEThirtyMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_SAFEThirtyOneMember" name="SAFEThirtyOneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_SAFEThirtyTwoMember" name="SAFEThirtyTwoMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_SAFEThirtyThreeMember" name="SAFEThirtyThreeMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_SAFEThirtyFourMember" name="SAFEThirtyFourMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_SAFEThirtyFiveMember" name="SAFEThirtyFiveMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_SAFEThirtySixMember" name="SAFEThirtySixMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_SAFEThirtySevenMember" name="SAFEThirtySevenMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_SAFEFortySixMember" name="SAFEFortySixMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_SAFEFiftyMember" name="SAFEFiftyMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_SAFEFortyEightMember" name="SAFEFortyEightMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_SAFEFortySevenMember" name="SAFEFortySevenMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_SAFEFortyNineMember" name="SAFEFortyNineMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_SAFEFiftyOneMember" name="SAFEFiftyOneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_RefundDueFromCustomer" name="RefundDueFromCustomer" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_ReturnsAsset" name="ReturnsAsset" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_CustomerPrepayments" name="CustomerPrepayments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_ReserveForSalesReturns" name="ReserveForSalesReturns" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_CommitmentsAndContingenciesAbstract" name="CommitmentsAndContingenciesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_ProvisionForLegalLiability" name="ProvisionForLegalLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_ProductDevelopmentExpense" name="ProductDevelopmentExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_GainFromRelatedPartyDebt" name="GainFromRelatedPartyDebt" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_GainFromPaycheckProtectionPlanLoanForgiveness" name="GainFromPaycheckProtectionPlanLoanForgiveness" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_GainFromSettlementOfAccountsPayable" name="GainFromSettlementOfAccountsPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_GainFromEmployeeRetentionCreditProgramRefund" name="GainFromEmployeeRetentionCreditProgramRefund" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_StockIssuedDuringPeriodValueSaleOfCommonStockWarrants" name="StockIssuedDuringPeriodValueSaleOfCommonStockWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_StockIssuedDuringPeriodSharesSaleOfCommonStockWarrants" name="StockIssuedDuringPeriodSharesSaleOfCommonStockWarrants" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_StockIssuedDuringPeriodValueExerciseOfPrefundedAndCommonWarrants" name="StockIssuedDuringPeriodValueExerciseOfPrefundedAndCommonWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_StockIssuedDuringPeriodSharesExerciseOfPrefundedAndCommonWarrants" name="StockIssuedDuringPeriodSharesExerciseOfPrefundedAndCommonWarrants" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_StockIssuedDuringPeriodValueReverseStockSplits" name="StockIssuedDuringPeriodValueReverseStockSplits" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_StockIssuedDuringPeriodValueIssuanceOfCommonStockAtMarketOffering" name="StockIssuedDuringPeriodValueIssuanceOfCommonStockAtMarketOffering" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_StockIssuedDuringPeriodSharesIssuanceOfCommonStockAtMarketOffering" name="StockIssuedDuringPeriodSharesIssuanceOfCommonStockAtMarketOffering" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_StockIssuedDuringPeriodValueIssuanceOfCommonStockPrivatePlacement" name="StockIssuedDuringPeriodValueIssuanceOfCommonStockPrivatePlacement" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_StockIssuedDuringPeriodSharesIssuanceOfCommonStockPrivatePlacement" name="StockIssuedDuringPeriodSharesIssuanceOfCommonStockPrivatePlacement" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_ProvisionForEstimatedCostOfReturns" name="ProvisionForEstimatedCostOfReturns" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_ProvisionForInventoryObsolescence" name="ProvisionForInventoryObsolescence" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_GainOnTerminationOfOperatingLease" name="GainOnTerminationOfOperatingLease" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_IncreaseDecreaseInPrepaidsFromCustomers" name="IncreaseDecreaseInPrepaidsFromCustomers" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_IncreaseDecreaseInReserveForSalesReturns" name="IncreaseDecreaseInReserveForSalesReturns" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_PaymentOfEarlyTerminationFeeOnOperatingLeaseTerminationSettlement" name="PaymentOfEarlyTerminationFeeOnOperatingLeaseTerminationSettlement" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_PaymentOfRedemptionAndRetirementOfTreasuryStock" name="PaymentOfRedemptionAndRetirementOfTreasuryStock" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_ProceedsFromCollectionOfSubscriptionsReceivable" name="ProceedsFromCollectionOfSubscriptionsReceivable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_PaymentOfDeferredFinancingCharges" name="PaymentOfDeferredFinancingCharges" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_PaymentOfEarlyTerminationFeesOnRevolvingLinesOfCredit" name="PaymentOfEarlyTerminationFeesOnRevolvingLinesOfCredit" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_PaymentsOnInstallmentNote" name="PaymentsOnInstallmentNote" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_ProceedsFromExerciseOfCommonStockWarrants" name="ProceedsFromExerciseOfCommonStockWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_IssuanceOfCommonStockAndWarrantsForOfferingCosts" name="IssuanceOfCommonStockAndWarrantsForOfferingCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_DisclosureRecentDevelopmentsAbstract" name="DisclosureRecentDevelopmentsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_RecentDevelopmentsTextBlock" name="RecentDevelopmentsTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_DisclosureOperatingLeasesAbstract" name="DisclosureOperatingLeasesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_DisclosureWarrantsAbstract" name="DisclosureWarrantsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_WarrantsDisclosureTextBlock" name="WarrantsDisclosureTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_DisclosurePublicOfferingAndNasdaqUplistingAbstract" name="DisclosurePublicOfferingAndNasdaqUplistingAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_IssuanceOfPublicOfferingTextBlock" name="IssuanceOfPublicOfferingTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_DisclosureAtmOfferingAbstract" name="DisclosureAtmOfferingAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_AtTheMarketPublicOfferingTextBlock" name="AtTheMarketPublicOfferingTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_DisclosurePrivatePlacementAbstract" name="DisclosurePrivatePlacementAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_PrivatePlacementTextBlock" name="PrivatePlacementTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_DisclosureAugust2021StockRedemptionAbstract" name="DisclosureAugust2021StockRedemptionAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_StockRedemptionTextBlock" name="StockRedemptionTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_DisclosureAugust2021PrivatePlacementAbstract" name="DisclosureAugust2021PrivatePlacementAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_AugustTwentyTwentyOnePrivatePlacementTextBlock" name="AugustTwentyTwentyOnePrivatePlacementTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_DisclosureSupplementalInformationCondensedFinancialInformationAbstract" name="DisclosureSupplementalInformationCondensedFinancialInformationAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_SupplementalInformationDisclosuresTextBlock" name="SupplementalInformationDisclosuresTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_DisclosureNotesPayableAndFinaningArrangementsAbstract" name="DisclosureNotesPayableAndFinaningArrangementsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_NotePayableAndFinancingArrangementsTextBlock" name="NotePayableAndFinancingArrangementsTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_DisclosureDueFromFactorAbstract" name="DisclosureDueFromFactorAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_AccountsReceivableDisclosureTextBlock" name="AccountsReceivableDisclosureTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_DisclosureSafePrivatePlacementsAbstract" name="DisclosureSafePrivatePlacementsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_SafePrivatePlacementsTextBlock" name="SafePrivatePlacementsTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_ShippingAndHandlingCostsPolicyTextBlock" name="ShippingAndHandlingCostsPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountPolicy" name="ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountPolicy" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_PrepaidExpensesPolicyTextBlock" name="PrepaidExpensesPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_ScheduleOfProFormaFinancialInformationTableTextBlock" name="ScheduleOfProFormaFinancialInformationTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_ScheduleOfSupplementalInformationRelatedToLeaseTableTextBlock" name="ScheduleOfSupplementalInformationRelatedToLeaseTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_ScheduleOfLossBeforeIncomeTaxTableTextBlock" name="ScheduleOfLossBeforeIncomeTaxTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_ScheduleOfStockOptionIssuedTableTextBlock" name="ScheduleOfStockOptionIssuedTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_SafePrivatePlacementsTableTextBlock" name="SafePrivatePlacementsTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_AssetsWriteOff" name="AssetsWriteOff" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_OperatingLeasePeriodicPayments" name="OperatingLeasePeriodicPayments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_LeaseSettlementExpense" name="LeaseSettlementExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_PrivatePlacementIssueDiscount" name="PrivatePlacementIssueDiscount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_TransactionFees" name="TransactionFees" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_WorkingCapital" name="WorkingCapital" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_AssetAcquisitionFairValueOfNonControllingInterest" name="AssetAcquisitionFairValueOfNonControllingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_AssetAcquisitionDebtExtinguishment" name="AssetAcquisitionDebtExtinguishment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCustomerRelationships" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCustomerRelationships" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradeName" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradeName" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDevelopedTechnology" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDevelopedTechnology" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLoansPayable" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLoansPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesNotesPayableRelatedParties" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesNotesPayableRelatedParties" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_NonControllingInterestAtFairValue" name="NonControllingInterestAtFairValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_RoyaltyRate" name="RoyaltyRate" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_DiscountOnRoyaltyRate" name="DiscountOnRoyaltyRate" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_RoyaltyTerm" name="RoyaltyTerm" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_GrowthRateOfDevelopmentOfNewBusiness" name="GrowthRateOfDevelopmentOfNewBusiness" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_DiscountRateForWeightedAverageCost" name="DiscountRateForWeightedAverageCost" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_PercentageOfExitFee" name="PercentageOfExitFee" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_LineOfCreditFacilityInterestRate" name="LineOfCreditFacilityInterestRate" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_LossContingencyEstimateOfPossibleLossPerYear" name="LossContingencyEstimateOfPossibleLossPerYear" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_InsuranceLiabilities" name="InsuranceLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_PaymentsForMilestone" name="PaymentsForMilestone" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_DisputeAmount" name="DisputeAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_AccruedPotentialLiability" name="AccruedPotentialLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_EstimatedReserveOfAdvertisingExpense" name="EstimatedReserveOfAdvertisingExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_EstimatedCostOfReturns" name="EstimatedCostOfReturns" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_PercentageOfPurchasersRightToParticipateOnIssuanceCompanyOfCommonStock" name="PercentageOfPurchasersRightToParticipateOnIssuanceCompanyOfCommonStock" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_PercentageOfGrossProceeds" name="PercentageOfGrossProceeds" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_ReserveForSalesReturn" name="ReserveForSalesReturn" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_ReturnAssets" name="ReturnAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_ShippingAndHandlingExpenses" name="ShippingAndHandlingExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_SaleOfStockPercentage" name="SaleOfStockPercentage" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_CurrentOtherTaxExpenseBenefit" name="CurrentOtherTaxExpenseBenefit" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_DeferredTaxAssetsRightUseOfLiability" name="DeferredTaxAssetsRightUseOfLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_DeferredTaxAssetsBusinessInterestLimitation" name="DeferredTaxAssetsBusinessInterestLimitation" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_DeferredTaxAssetsAllowanceForDoubtFulAccounts" name="DeferredTaxAssetsAllowanceForDoubtFulAccounts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_DeferredTaxLiabilitiesRightUseOfAsset" name="DeferredTaxLiabilitiesRightUseOfAsset" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_IncomeTaxReconciliationChangeInPermanentDifferencesERCIncome" name="IncomeTaxReconciliationChangeInPermanentDifferencesERCIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_IncomeTaxReconciliationChangeInExpirationOfNetOpretaingLossCarryforward" name="IncomeTaxReconciliationChangeInExpirationOfNetOpretaingLossCarryforward" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_AggregateNumberOfShares" name="AggregateNumberOfShares" nillable="true" xbrli:periodType="instant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_SharePrice1" name="SharePrice1" nillable="true" xbrli:periodType="instant" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_ForeignAndDomesticRateOfAccountsReceivable" name="ForeignAndDomesticRateOfAccountsReceivable" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_AdvanceFeeRate" name="AdvanceFeeRate" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate" nillable="true" xbrli:periodType="duration" type="xbrli:dateItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate" nillable="true" xbrli:periodType="duration" type="xbrli:dateItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate" nillable="true" xbrli:periodType="duration" type="xbrli:dateItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_ConvertibleHolderName" name="ConvertibleHolderName" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_InvestmentOfPrincipalAmount" name="InvestmentOfPrincipalAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_InvestmentIssueDate" name="InvestmentIssueDate" nillable="true" xbrli:periodType="duration" type="xbrli:dateItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_ValuationCapitalOfInvestment" name="ValuationCapitalOfInvestment" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_InvestmentConvertedDate" name="InvestmentConvertedDate" nillable="true" xbrli:periodType="duration" type="xbrli:dateItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_InvestedValuationOfAmount" name="InvestedValuationOfAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RIME_AmortizationOfRightOfUseAssets" name="AmortizationOfRightOfUseAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>17
<FILENAME>rime-20240930_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://algoholdings.com/role/Cover" xlink:href="rime-20240930.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/BalanceSheets" xlink:href="rime-20240930.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/BalanceSheetsParenthetical" xlink:href="rime-20240930.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/StatementsOfOperations" xlink:href="rime-20240930.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/StatementsOfShareholdersDeficitEquity" xlink:href="rime-20240930.xsd#StatementsOfShareholdersDeficitEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/StatementsOfCashFlows" xlink:href="rime-20240930.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/NatureOfBusiness" xlink:href="rime-20240930.xsd#NatureOfBusiness" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/RecentDevelopments" xlink:href="rime-20240930.xsd#RecentDevelopments" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/LiquidityGoingConcernAndManagementPlans" xlink:href="rime-20240930.xsd#LiquidityGoingConcernAndManagementPlans" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="rime-20240930.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/AssetAcquisition" xlink:href="rime-20240930.xsd#AssetAcquisition" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/Financing" xlink:href="rime-20240930.xsd#Financing" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/LoansPayableRelatedParties" xlink:href="rime-20240930.xsd#LoansPayableRelatedParties" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/CommitmentsAndContingencies" xlink:href="rime-20240930.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/OperatingLeases" xlink:href="rime-20240930.xsd#OperatingLeases" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/IssuanceOfCommonStock" xlink:href="rime-20240930.xsd#IssuanceOfCommonStock" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/Warrants" xlink:href="rime-20240930.xsd#Warrants" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ComputationOfLossPerShare" xlink:href="rime-20240930.xsd#ComputationOfLossPerShare" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/IncomeTaxes" xlink:href="rime-20240930.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/RevenueDisaggregation" xlink:href="rime-20240930.xsd#RevenueDisaggregation" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ConcentrationsOfCreditRiskAndRevenue" xlink:href="rime-20240930.xsd#ConcentrationsOfCreditRiskAndRevenue" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/RelatedPartyTransactions" xlink:href="rime-20240930.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/SubsequentEvents" xlink:href="rime-20240930.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/PropertyAndEquipment" xlink:href="rime-20240930.xsd#PropertyAndEquipment" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/StockCompensationExpense" xlink:href="rime-20240930.xsd#StockCompensationExpense" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/PublicOfferingAndNasdaqUplisting" xlink:href="rime-20240930.xsd#PublicOfferingAndNasdaqUplisting" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/AtmOffering" xlink:href="rime-20240930.xsd#AtmOffering" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/PrivatePlacement" xlink:href="rime-20240930.xsd#PrivatePlacement" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/August2021StockRedemption" xlink:href="rime-20240930.xsd#August2021StockRedemption" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/August2021PrivatePlacement" xlink:href="rime-20240930.xsd#August2021PrivatePlacement" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/DamagedGoodsIncidentRecovery" xlink:href="rime-20240930.xsd#DamagedGoodsIncidentRecovery" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/SupplementalInformationCondensedFinancialInformation" xlink:href="rime-20240930.xsd#SupplementalInformationCondensedFinancialInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/AccountsReceivable" xlink:href="rime-20240930.xsd#AccountsReceivable" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/AccountsPayableAndAccruedExpenses" xlink:href="rime-20240930.xsd#AccountsPayableAndAccruedExpenses" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/NotesPayableAndFinaningArrangements" xlink:href="rime-20240930.xsd#NotesPayableAndFinaningArrangements" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/DueFromFactor" xlink:href="rime-20240930.xsd#DueFromFactor" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/StockholdersEquity" xlink:href="rime-20240930.xsd#StockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/SafePrivatePlacements" xlink:href="rime-20240930.xsd#SafePrivatePlacements" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/EmployeeBenefitPlans" xlink:href="rime-20240930.xsd#EmployeeBenefitPlans" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="rime-20240930.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/AssetAcquisitionTables" xlink:href="rime-20240930.xsd#AssetAcquisitionTables" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/LoansPayableRelatedPartiesTables" xlink:href="rime-20240930.xsd#LoansPayableRelatedPartiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/OperatingLeasesTables" xlink:href="rime-20240930.xsd#OperatingLeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/WarrantsTables" xlink:href="rime-20240930.xsd#WarrantsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ComputationOfLossPerShareTables" xlink:href="rime-20240930.xsd#ComputationOfLossPerShareTables" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/RevenueDisaggregationTables" xlink:href="rime-20240930.xsd#RevenueDisaggregationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/PropertyAndEquipmentTables" xlink:href="rime-20240930.xsd#PropertyAndEquipmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/StockCompensationExpenseTables" xlink:href="rime-20240930.xsd#StockCompensationExpenseTables" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/August2021PrivatePlacementTables" xlink:href="rime-20240930.xsd#August2021PrivatePlacementTables" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/SupplementalInformationCondensedFinancialInformationTables" xlink:href="rime-20240930.xsd#SupplementalInformationCondensedFinancialInformationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/NotesPayableAndFinaningArrangementsTables" xlink:href="rime-20240930.xsd#NotesPayableAndFinaningArrangementsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/StockholdersEquityTables" xlink:href="rime-20240930.xsd#StockholdersEquityTables" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/SafePrivatePlacementsTables" xlink:href="rime-20240930.xsd#SafePrivatePlacementsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/RecentDevelopmentsDetailsNarrative" xlink:href="rime-20240930.xsd#RecentDevelopmentsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/LiquidityGoingConcernAndManagementPlansDetailsNarrative" xlink:href="rime-20240930.xsd#LiquidityGoingConcernAndManagementPlansDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfConsiderationTransferredToAssetsAcquiredAndLiabilitiesAssumedDetails" xlink:href="rime-20240930.xsd#ScheduleOfConsiderationTransferredToAssetsAcquiredAndLiabilitiesAssumedDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfConsiderationTransferredToAssetsAcquiredAndLiabilitiesAssumedDetailsParenthetical" xlink:href="rime-20240930.xsd#ScheduleOfConsiderationTransferredToAssetsAcquiredAndLiabilitiesAssumedDetailsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfProFormaFinancialInformationDetails" xlink:href="rime-20240930.xsd#ScheduleOfProFormaFinancialInformationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/AssetAcquisitionDetailsNarrative" xlink:href="rime-20240930.xsd#AssetAcquisitionDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/FinancingDetailsNarrative" xlink:href="rime-20240930.xsd#FinancingDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfLoanDetails" xlink:href="rime-20240930.xsd#ScheduleOfLoanDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/LoansPayableRelatedPartiesDetailsNarrative" xlink:href="rime-20240930.xsd#LoansPayableRelatedPartiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="rime-20240930.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfSupplementalInformationRelatedToLeasesDetails" xlink:href="rime-20240930.xsd#ScheduleOfSupplementalInformationRelatedToLeasesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfLeaseTermAndDiscountRateDetails" xlink:href="rime-20240930.xsd#ScheduleOfLeaseTermAndDiscountRateDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfOperatingLeaseMinimumFuturePaymentsDetails" xlink:href="rime-20240930.xsd#ScheduleOfOperatingLeaseMinimumFuturePaymentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/OperatingLeasesDetailsNarrative" xlink:href="rime-20240930.xsd#OperatingLeasesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/IssuanceOfCommonStockDetailsNarrative" xlink:href="rime-20240930.xsd#IssuanceOfCommonStockDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfWarrantsExpirationDetails" xlink:href="rime-20240930.xsd#ScheduleOfWarrantsExpirationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/WarrantsDetailsNarrative" xlink:href="rime-20240930.xsd#WarrantsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfBasicAndDilutiveLossPerShareDetails" xlink:href="rime-20240930.xsd#ScheduleOfBasicAndDilutiveLossPerShareDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ComputationOfLossPerShareDetailsNarrative" xlink:href="rime-20240930.xsd#ComputationOfLossPerShareDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/IncomeTaxesDetailsNarrative" xlink:href="rime-20240930.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfRevenueByProductLineDetails" xlink:href="rime-20240930.xsd#ScheduleOfRevenueByProductLineDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfSalesByGeographicalRegionDetails" xlink:href="rime-20240930.xsd#ScheduleOfSalesByGeographicalRegionDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/RevenueDisaggregationDetailsNarrative" xlink:href="rime-20240930.xsd#RevenueDisaggregationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ConcentrationsOfCreditRiskAndRevenueDetailsNarrative" xlink:href="rime-20240930.xsd#ConcentrationsOfCreditRiskAndRevenueDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="rime-20240930.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/SubsequentEventsDetailsNarrative" xlink:href="rime-20240930.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="rime-20240930.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfPropertyAndEquipmentDetails" xlink:href="rime-20240930.xsd#ScheduleOfPropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/PropertyAndEquipmentDetailsNarrative" xlink:href="rime-20240930.xsd#PropertyAndEquipmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/SummaryOfStockOptionActivityDetails" xlink:href="rime-20240930.xsd#SummaryOfStockOptionActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfEmployeeStockOptionsOutstandingDetailsParenthetical" xlink:href="rime-20240930.xsd#ScheduleOfEmployeeStockOptionsOutstandingDetailsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfBasicAndDilutiveSharesDetails" xlink:href="rime-20240930.xsd#ScheduleOfBasicAndDilutiveSharesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/StockCompensationExpenseDetailsNarrative" xlink:href="rime-20240930.xsd#StockCompensationExpenseDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/PublicOfferingAndNasdaqUplistingDetailsNarrative" xlink:href="rime-20240930.xsd#PublicOfferingAndNasdaqUplistingDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/AtmOfferingDetailsNarrative" xlink:href="rime-20240930.xsd#AtmOfferingDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/PrivatePlacementDetailsNarrative" xlink:href="rime-20240930.xsd#PrivatePlacementDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/August2021StockRedemptionDetailsNarrative" xlink:href="rime-20240930.xsd#August2021StockRedemptionDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfLossBeforeIncomeTaxesDetails" xlink:href="rime-20240930.xsd#ScheduleOfLossBeforeIncomeTaxesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfProvisionForIncomeTaxesDetails" xlink:href="rime-20240930.xsd#ScheduleOfProvisionForIncomeTaxesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:href="rime-20240930.xsd#ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfTaxProvisionDetails" xlink:href="rime-20240930.xsd#ScheduleOfTaxProvisionDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfRevenueByGeographicalRegionDetails" xlink:href="rime-20240930.xsd#ScheduleOfRevenueByGeographicalRegionDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/August2021PrivatePlacementDetailsNarrative" xlink:href="rime-20240930.xsd#August2021PrivatePlacementDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/DamagedGoodsIncidentRecoveryDetailsNarrative" xlink:href="rime-20240930.xsd#DamagedGoodsIncidentRecoveryDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfOperationsDetails" xlink:href="rime-20240930.xsd#ScheduleOfCondensedConsolidatedStatementsOfOperationsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfCashFlowsDetails" xlink:href="rime-20240930.xsd#ScheduleOfCondensedConsolidatedStatementsOfCashFlowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfShareholdersEquityDetails" xlink:href="rime-20240930.xsd#ScheduleOfCondensedConsolidatedStatementsOfShareholdersEquityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfEstimatedUsefulLivesDetails" xlink:href="rime-20240930.xsd#ScheduleOfEstimatedUsefulLivesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/AccountsReceivableDetailsNarrative" xlink:href="rime-20240930.xsd#AccountsReceivableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/AccountsPayableAndAccruedExpensesDetailsNarrative" xlink:href="rime-20240930.xsd#AccountsPayableAndAccruedExpensesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfSpecificTermsDetails" xlink:href="rime-20240930.xsd#ScheduleOfSpecificTermsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/NotesPayableAndFinaningArrangementsDetailsNarrative" xlink:href="rime-20240930.xsd#NotesPayableAndFinaningArrangementsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/DueFromFactorDetailsNarrative" xlink:href="rime-20240930.xsd#DueFromFactorDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfStockOptionIssuedDuringYearDecember3120202021And2022Details" xlink:href="rime-20240930.xsd#ScheduleOfStockOptionIssuedDuringYearDecember3120202021And2022Details" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/StockholdersEquityDetailsNarrative" xlink:href="rime-20240930.xsd#StockholdersEquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfFirstTrancheOfSubscriptionsDetails" xlink:href="rime-20240930.xsd#ScheduleOfFirstTrancheOfSubscriptionsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/SummaryOfTerminatedImmediatelyAfterClosingOfTransactionDetails" xlink:href="rime-20240930.xsd#SummaryOfTerminatedImmediatelyAfterClosingOfTransactionDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/SafePrivatePlacementsDetailsNarrative" xlink:href="rime-20240930.xsd#SafePrivatePlacementsDetailsNarrative" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/BalanceSheets" xlink:title="00000002 - Statement - Condensed Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCash" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNet" xlink:label="loc_us-gaapAccountsReceivableNet" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAccountsReceivableNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DueFromBanks" xlink:label="loc_us-gaapDueFromBanks" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapDueFromBanks" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_RefundDueFromCustomer" xlink:label="loc_RIMERefundDueFromCustomer" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_RIMERefundDueFromCustomer" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ReturnsAsset" xlink:label="loc_RIMEReturnsAsset" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_RIMEReturnsAsset" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaapOtherAssetsNoncurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOtherAssetsNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaapNotesPayableCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapNotesPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LoansPayableCurrent" xlink:label="loc_us-gaapLoansPayableCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapLoansPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerRefundLiabilityCurrent" xlink:label="loc_us-gaapContractWithCustomerRefundLiabilityCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapContractWithCustomerRefundLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_CustomerPrepayments" xlink:label="loc_RIMECustomerPrepayments" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_RIMECustomerPrepayments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ReserveForSalesReturns" xlink:label="loc_RIMEReserveForSalesReturns" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_RIMEReserveForSalesReturns" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermBorrowings" xlink:label="loc_us-gaapShortTermBorrowings" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapShortTermBorrowings" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapOtherLiabilitiesNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapOtherLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermNotesPayable" xlink:label="loc_us-gaapLongTermNotesPayable" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLongTermNotesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermLoansPayable" xlink:label="loc_us-gaapLongTermLoansPayable" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLongTermLoansPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ProvisionForLegalLiability" xlink:label="loc_RIMEProvisionForLegalLiability" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCommitmentsAndContingencies" xlink:to="loc_RIMEProvisionForLegalLiability" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable" xlink:label="loc_us-gaapCommonStockShareSubscribedButUnissuedSubscriptionsReceivable" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockShareSubscribedButUnissuedSubscriptionsReceivable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaapMinorityInterest" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaapMinorityInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Condensed Consolidated Statements of Operations">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaapCostOfGoodsAndServicesSold" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapCostOfGoodsAndServicesSold" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingExpense" xlink:label="loc_us-gaapSellingExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapSellingExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnTerminationOfLease" xlink:label="loc_us-gaapGainLossOnTerminationOfLease" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapGainLossOnTerminationOfLease" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ProductDevelopmentExpense" xlink:label="loc_RIMEProductDevelopmentExpense" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_RIMEProductDevelopmentExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnDispositionOfAssets1" xlink:label="loc_us-gaapGainLossOnDispositionOfAssets1" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapGainLossOnDispositionOfAssets1" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_GainFromRelatedPartyDebt" xlink:label="loc_RIMEGainFromRelatedPartyDebt" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_RIMEGainFromRelatedPartyDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_GainFromPaycheckProtectionPlanLoanForgiveness" xlink:label="loc_RIMEGainFromPaycheckProtectionPlanLoanForgiveness" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_RIMEGainFromPaycheckProtectionPlanLoanForgiveness" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_GainFromSettlementOfAccountsPayable" xlink:label="loc_RIMEGainFromSettlementOfAccountsPayable" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_RIMEGainFromSettlementOfAccountsPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_GainFromEmployeeRetentionCreditProgramRefund" xlink:label="loc_RIMEGainFromEmployeeRetentionCreditProgramRefund" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_RIMEGainFromEmployeeRetentionCreditProgramRefund" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseDebtExcludingAmortization" xlink:label="loc_us-gaapInterestExpenseDebtExcludingAmortization" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInterestExpenseDebtExcludingAmortization" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapProfitLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapProfitLoss" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/StatementsOfShareholdersDeficitEquity" xlink:title="00000005 - Statement - Condensed Consolidated Statements of Shareholders&apos; (Deficit) Equity" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Condensed Consolidated Statements of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="loc_us-gaapAmortizationOfFinancingCosts" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapAmortizationOfFinancingCosts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredIncomeTaxExpenseBenefit" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDeferredIncomeTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ProvisionForEstimatedCostOfReturns" xlink:label="loc_RIMEProvisionForEstimatedCostOfReturns" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_RIMEProvisionForEstimatedCostOfReturns" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ProvisionForInventoryObsolescence" xlink:label="loc_RIMEProvisionForInventoryObsolescence" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_RIMEProvisionForInventoryObsolescence" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaapProvisionForDoubtfulAccounts" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapProvisionForDoubtfulAccounts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_GainOnTerminationOfOperatingLease" xlink:label="loc_RIMEGainOnTerminationOfOperatingLease" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_RIMEGainOnTerminationOfOperatingLease" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:label="loc_us-gaapGainLossOnSaleOfPropertyPlantEquipment" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapGainLossOnSaleOfPropertyPlantEquipment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAssetAmortizationExpense" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets" />
      <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" />
      <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_GainFromPaycheckProtectionPlanLoanForgiveness" xlink:label="loc_RIMEGainFromPaycheckProtectionPlanLoanForgiveness" />
      <link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_RIMEGainFromPaycheckProtectionPlanLoanForgiveness" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_GainFromRelatedPartyDebt" xlink:label="loc_RIMEGainFromRelatedPartyDebt" />
      <link:calculationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_RIMEGainFromRelatedPartyDebt" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_GainFromSettlementOfAccountsPayable" xlink:label="loc_RIMEGainFromSettlementOfAccountsPayable" />
      <link:calculationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_RIMEGainFromSettlementOfAccountsPayable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:calculationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseDueFromAffiliates" xlink:label="loc_us-gaapIncreaseDecreaseDueFromAffiliates" />
      <link:calculationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseDueFromAffiliates" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivableRelatedParties" />
      <link:calculationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivableRelatedParties" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:calculationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
      <link:calculationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherNoncurrentAssets" />
      <link:calculationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayable" />
      <link:calculationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" />
      <link:calculationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInDueToRelatedParties" xlink:label="loc_us-gaapIncreaseDecreaseInDueToRelatedParties" />
      <link:calculationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInDueToRelatedParties" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="loc_us-gaapIncreaseDecreaseInContractWithCustomerLiability" />
      <link:calculationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_IncreaseDecreaseInPrepaidsFromCustomers" xlink:label="loc_RIMEIncreaseDecreaseInPrepaidsFromCustomers" />
      <link:calculationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_RIMEIncreaseDecreaseInPrepaidsFromCustomers" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_IncreaseDecreaseInReserveForSalesReturns" xlink:label="loc_RIMEIncreaseDecreaseInReserveForSalesReturns" />
      <link:calculationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_RIMEIncreaseDecreaseInReserveForSalesReturns" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingLeaseLiability" />
      <link:calculationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingLeaseLiability" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_PaymentOfEarlyTerminationFeeOnOperatingLeaseTerminationSettlement" xlink:label="loc_RIMEPaymentOfEarlyTerminationFeeOnOperatingLeaseTerminationSettlement" />
      <link:calculationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_RIMEPaymentOfEarlyTerminationFeeOnOperatingLeaseTerminationSettlement" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromPreviousAcquisition" xlink:label="loc_us-gaapProceedsFromPreviousAcquisition" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapProceedsFromPreviousAcquisition" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="loc_us-gaapProceedsFromSaleOfPropertyPlantAndEquipment" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_PaymentOfRedemptionAndRetirementOfTreasuryStock" xlink:label="loc_RIMEPaymentOfRedemptionAndRetirementOfTreasuryStock" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_RIMEPaymentOfRedemptionAndRetirementOfTreasuryStock" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ProceedsFromCollectionOfSubscriptionsReceivable" xlink:label="loc_RIMEProceedsFromCollectionOfSubscriptionsReceivable" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_RIMEProceedsFromCollectionOfSubscriptionsReceivable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfSubordinatedDebt" xlink:label="loc_us-gaapRepaymentsOfSubordinatedDebt" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfSubordinatedDebt" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_PaymentOfDeferredFinancingCharges" xlink:label="loc_RIMEPaymentOfDeferredFinancingCharges" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_RIMEPaymentOfDeferredFinancingCharges" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_PaymentOfEarlyTerminationFeesOnRevolvingLinesOfCredit" xlink:label="loc_RIMEPaymentOfEarlyTerminationFeesOnRevolvingLinesOfCredit" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_RIMEPaymentOfEarlyTerminationFeesOnRevolvingLinesOfCredit" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_PaymentsOnInstallmentNote" xlink:label="loc_RIMEPaymentsOnInstallmentNote" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_RIMEPaymentsOnInstallmentNote" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaapProceedsFromStockOptionsExercised" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromStockOptionsExercised" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ProceedsFromExerciseOfCommonStockWarrants" xlink:label="loc_RIMEProceedsFromExerciseOfCommonStockWarrants" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_RIMEProceedsFromExerciseOfCommonStockWarrants" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaapProceedsFromWarrantExercises" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromWarrantExercises" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations" xlink:label="loc_us-gaapRepaymentsOfDebtAndCapitalLeaseObligations" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfDebtAndCapitalLeaseObligations" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfOtherDebt" xlink:label="loc_us-gaapRepaymentsOfOtherDebt" />
      <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfOtherDebt" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromRepaymentsOfLinesOfCredit" xlink:label="loc_us-gaapProceedsFromRepaymentsOfLinesOfCredit" />
      <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromRepaymentsOfLinesOfCredit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:label="loc_us-gaapProceedsFromPaymentsForOtherFinancingActivities" />
      <link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/NatureOfBusiness" xlink:title="00000007 - Disclosure - NATURE OF BUSINESS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/RecentDevelopments" xlink:title="00000008 - Disclosure - RECENT DEVELOPMENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/LiquidityGoingConcernAndManagementPlans" xlink:title="00000009 - Disclosure - LIQUIDITY, GOING CONCERN AND MANAGEMENT PLANS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000010 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/AssetAcquisition" xlink:title="00000011 - Disclosure - ASSET ACQUISITION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/Financing" xlink:title="00000012 - Disclosure - FINANCING" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/LoansPayableRelatedParties" xlink:title="00000013 - Disclosure - LOANS PAYABLE &#8211; RELATED PARTIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/CommitmentsAndContingencies" xlink:title="00000014 - Disclosure - COMMITMENTS AND CONTINGENCIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/OperatingLeases" xlink:title="00000015 - Disclosure - OPERATING LEASES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/IssuanceOfCommonStock" xlink:title="00000016 - Disclosure - ISSUANCE OF COMMON STOCK" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/Warrants" xlink:title="00000017 - Disclosure - WARRANTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ComputationOfLossPerShare" xlink:title="00000018 - Disclosure - COMPUTATION OF LOSS PER SHARE" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/IncomeTaxes" xlink:title="00000019 - Disclosure - INCOME TAXES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/RevenueDisaggregation" xlink:title="00000020 - Disclosure - REVENUE DISAGGREGATION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ConcentrationsOfCreditRiskAndRevenue" xlink:title="00000021 - Disclosure - CONCENTRATIONS OF CREDIT RISK AND REVENUE" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/RelatedPartyTransactions" xlink:title="00000022 - Disclosure - RELATED PARTY TRANSACTIONS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/SubsequentEvents" xlink:title="00000023 - Disclosure - SUBSEQUENT EVENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/PropertyAndEquipment" xlink:title="00000024 - Disclosure - PROPERTY AND EQUIPMENT" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/StockCompensationExpense" xlink:title="00000025 - Disclosure - STOCK COMPENSATION EXPENSE" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/PublicOfferingAndNasdaqUplisting" xlink:title="00000026 - Disclosure - PUBLIC OFFERING AND NASDAQ UPLISTING" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/AtmOffering" xlink:title="00000027 - Disclosure - ATM OFFERING" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/PrivatePlacement" xlink:title="00000028 - Disclosure - PRIVATE PLACEMENT" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/August2021StockRedemption" xlink:title="00000029 - Disclosure - AUGUST 2021 STOCK REDEMPTION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/August2021PrivatePlacement" xlink:title="00000030 - Disclosure - AUGUST 2021 PRIVATE PLACEMENT" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/DamagedGoodsIncidentRecovery" xlink:title="00000031 - Disclosure - DAMAGED GOODS INCIDENT RECOVERY" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/SupplementalInformationCondensedFinancialInformation" xlink:title="00000032 - Disclosure - SUPPLEMENTAL INFORMATION CONDENSED FINANCIAL INFORMATION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/AccountsReceivable" xlink:title="00000033 - Disclosure - ACCOUNTS RECEIVABLE" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/AccountsPayableAndAccruedExpenses" xlink:title="00000034 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/NotesPayableAndFinaningArrangements" xlink:title="00000035 - Disclosure - NOTES PAYABLE AND FINANING ARRANGEMENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/DueFromFactor" xlink:title="00000036 - Disclosure - DUE FROM FACTOR" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/StockholdersEquity" xlink:title="00000037 - Disclosure - STOCKHOLDERS&#8217; EQUITY" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/SafePrivatePlacements" xlink:title="00000038 - Disclosure - SAFE PRIVATE PLACEMENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/EmployeeBenefitPlans" xlink:title="00000039 - Disclosure - EMPLOYEE BENEFIT PLANS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000040 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/AssetAcquisitionTables" xlink:title="00000041 - Disclosure - ASSET ACQUISITION (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/LoansPayableRelatedPartiesTables" xlink:title="00000042 - Disclosure - LOANS PAYABLE &#8211; RELATED PARTIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/OperatingLeasesTables" xlink:title="00000043 - Disclosure - OPERATING LEASES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/WarrantsTables" xlink:title="00000044 - Disclosure - WARRANTS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ComputationOfLossPerShareTables" xlink:title="00000045 - Disclosure - COMPUTATION OF LOSS PER SHARE (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/RevenueDisaggregationTables" xlink:title="00000046 - Disclosure - REVENUE DISAGGREGATION (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/PropertyAndEquipmentTables" xlink:title="00000047 - Disclosure - PROPERTY AND EQUIPMENT (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/StockCompensationExpenseTables" xlink:title="00000048 - Disclosure - STOCK COMPENSATION EXPENSE (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/August2021PrivatePlacementTables" xlink:title="00000049 - Disclosure - AUGUST 2021 PRIVATE PLACEMENT (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/SupplementalInformationCondensedFinancialInformationTables" xlink:title="00000050 - Disclosure - SUPPLEMENTAL INFORMATION CONDENSED FINANCIAL INFORMATION (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/NotesPayableAndFinaningArrangementsTables" xlink:title="00000051 - Disclosure - NOTES PAYABLE AND FINANING ARRANGEMENTS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/StockholdersEquityTables" xlink:title="00000052 - Disclosure - STOCKHOLDERS&#8217; EQUITY (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/SafePrivatePlacementsTables" xlink:title="00000053 - Disclosure - SAFE PRIVATE PLACEMENTS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/RecentDevelopmentsDetailsNarrative" xlink:title="00000054 - Disclosure - RECENT DEVELOPMENTS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/LiquidityGoingConcernAndManagementPlansDetailsNarrative" xlink:title="00000055 - Disclosure - LIQUIDITY, GOING CONCERN AND MANAGEMENT PLANS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfConsiderationTransferredToAssetsAcquiredAndLiabilitiesAssumedDetails" xlink:title="00000056 - Disclosure - SCHEDULE OF CONSIDERATION TRANSFERRED TO THE ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfConsiderationTransferredToAssetsAcquiredAndLiabilitiesAssumedDetailsParenthetical" xlink:title="00000057 - Disclosure - SCHEDULE OF CONSIDERATION TRANSFERRED TO THE ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details) (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfProFormaFinancialInformationDetails" xlink:title="00000058 - Disclosure - SCHEDULE OF PRO FORMA FINANCIAL INFORMATION (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/AssetAcquisitionDetailsNarrative" xlink:title="00000059 - Disclosure - ASSET ACQUISITION (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/FinancingDetailsNarrative" xlink:title="00000060 - Disclosure - FINANCING (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfLoanDetails" xlink:title="00000061 - Disclosure - SCHEDULE OF LOAN (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/LoansPayableRelatedPartiesDetailsNarrative" xlink:title="00000062 - Disclosure - LOANS PAYABLE &#8211; RELATED PARTIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000063 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfSupplementalInformationRelatedToLeasesDetails" xlink:title="00000064 - Disclosure - SCHEDULE OF SUPPLEMENTAL INFORMATION RELATED TO LEASES (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfLeaseTermAndDiscountRateDetails" xlink:title="00000065 - Disclosure - SCHEDULE OF LEASE TERM AND DISCOUNT RATE (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfOperatingLeaseMinimumFuturePaymentsDetails" xlink:title="00000066 - Disclosure - SCHEDULE OF OPERATING LEASE MINIMUM FUTURE PAYMENTS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFive" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/OperatingLeasesDetailsNarrative" xlink:title="00000067 - Disclosure - OPERATING LEASES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/IssuanceOfCommonStockDetailsNarrative" xlink:title="00000068 - Disclosure - ISSUANCE OF COMMON STOCK (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfWarrantsExpirationDetails" xlink:title="00000069 - Disclosure - SCHEDULE OF WARRANTS EXPIRATION (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/WarrantsDetailsNarrative" xlink:title="00000070 - Disclosure - WARRANTS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfBasicAndDilutiveLossPerShareDetails" xlink:title="00000071 - Disclosure - SCHEDULE OF BASIC AND DILUTIVE LOSS PER SHARE (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ComputationOfLossPerShareDetailsNarrative" xlink:title="00000072 - Disclosure - COMPUTATION OF LOSS PER SHARE (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000073 - Disclosure - INCOME TAXES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfRevenueByProductLineDetails" xlink:title="00000074 - Disclosure - SCHEDULE OF REVENUE BY PRODUCT LINE (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfSalesByGeographicalRegionDetails" xlink:title="00000075 - Disclosure - SCHEDULE OF SALES BY GEOGRAPHICAL REGION (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/RevenueDisaggregationDetailsNarrative" xlink:title="00000076 - Disclosure - REVENUE DISAGGREGATION (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ConcentrationsOfCreditRiskAndRevenueDetailsNarrative" xlink:title="00000077 - Disclosure - CONCENTRATIONS OF CREDIT RISK AND REVENUE (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000078 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000079 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000080 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfPropertyAndEquipmentDetails" xlink:title="00000081 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/PropertyAndEquipmentDetailsNarrative" xlink:title="00000082 - Disclosure - PROPERTY AND EQUIPMENT (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/SummaryOfStockOptionActivityDetails" xlink:title="00000083 - Disclosure - SUMMARY OF STOCK OPTION ACTIVITY (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfEmployeeStockOptionsOutstandingDetailsParenthetical" xlink:title="00000084 - Disclosure - SCHEDULE OF EMPLOYEE STOCK OPTIONS OUTSTANDING (Details) (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfBasicAndDilutiveSharesDetails" xlink:title="00000085 - Disclosure - SCHEDULE OF BASIC AND DILUTIVE SHARES (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/StockCompensationExpenseDetailsNarrative" xlink:title="00000086 - Disclosure - STOCK COMPENSATION EXPENSE (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/PublicOfferingAndNasdaqUplistingDetailsNarrative" xlink:title="00000087 - Disclosure - PUBLIC OFFERING AND NASDAQ UPLISTING (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/AtmOfferingDetailsNarrative" xlink:title="00000088 - Disclosure - ATM OFFERING (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/PrivatePlacementDetailsNarrative" xlink:title="00000089 - Disclosure - PRIVATE PLACEMENT (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/August2021StockRedemptionDetailsNarrative" xlink:title="00000090 - Disclosure - AUGUST 2021 STOCK REDEMPTION (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfLossBeforeIncomeTaxesDetails" xlink:title="00000091 - Disclosure - SCHEDULE OF LOSS BEFORE INCOME TAXES (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfProvisionForIncomeTaxesDetails" xlink:title="00000092 - Disclosure - SCHEDULE OF PROVISION FOR INCOME TAXES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentFederalStateAndLocalTaxExpenseBenefit" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentFederalTaxExpenseBenefit" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCurrentFederalStateAndLocalTaxExpenseBenefit" xlink:to="loc_us-gaapCurrentFederalTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentStateAndLocalTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCurrentFederalStateAndLocalTaxExpenseBenefit" xlink:to="loc_us-gaapCurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_CurrentOtherTaxExpenseBenefit" xlink:label="loc_RIMECurrentOtherTaxExpenseBenefit" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCurrentFederalStateAndLocalTaxExpenseBenefit" xlink:to="loc_RIMECurrentOtherTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentForeignTaxExpenseBenefit" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCurrentFederalStateAndLocalTaxExpenseBenefit" xlink:to="loc_us-gaapCurrentForeignTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredFederalStateAndLocalTaxExpenseBenefit" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredFederalStateAndLocalTaxExpenseBenefit" xlink:to="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredStateAndLocalIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredFederalStateAndLocalTaxExpenseBenefit" xlink:to="loc_us-gaapDeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapCurrentFederalStateAndLocalTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapDeferredFederalStateAndLocalTaxExpenseBenefit" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:title="00000093 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaapDeferredTaxAssetsGross" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwardsDomestic" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsInventory" xlink:label="loc_us-gaapDeferredTaxAssetsInventory" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsInventory" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DeferredTaxAssetsRightUseOfLiability" xlink:label="loc_RIMEDeferredTaxAssetsRightUseOfLiability" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_RIMEDeferredTaxAssetsRightUseOfLiability" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DeferredTaxAssetsBusinessInterestLimitation" xlink:label="loc_RIMEDeferredTaxAssetsBusinessInterestLimitation" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_RIMEDeferredTaxAssetsBusinessInterestLimitation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DeferredTaxAssetsAllowanceForDoubtFulAccounts" xlink:label="loc_RIMEDeferredTaxAssetsAllowanceForDoubtFulAccounts" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_RIMEDeferredTaxAssetsAllowanceForDoubtFulAccounts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances" xlink:label="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:label="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsNet" xlink:to="loc_us-gaapDeferredTaxAssetsGross" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsNet" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="loc_us-gaapDeferredTaxLiabilities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:label="loc_us-gaapDeferredTaxLiabilitiesPropertyPlantAndEquipment" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxLiabilities" xlink:to="loc_us-gaapDeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DeferredTaxLiabilitiesRightUseOfAsset" xlink:label="loc_RIMEDeferredTaxLiabilitiesRightUseOfAsset" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxLiabilities" xlink:to="loc_RIMEDeferredTaxLiabilitiesRightUseOfAsset" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" xlink:label="loc_us-gaapDeferredTaxLiabilitiesPrepaidExpenses" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxLiabilities" xlink:to="loc_us-gaapDeferredTaxLiabilitiesPrepaidExpenses" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" xlink:to="loc_us-gaapDeferredTaxAssetsNet" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" xlink:to="loc_us-gaapDeferredTaxLiabilities" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfTaxProvisionDetails" xlink:title="00000094 - Disclosure - SCHEDULE OF TAX PROVISION (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapIncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapIncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="loc_us-gaapIncomeTaxReconciliationStateAndLocalIncomeTaxes" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapIncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:label="loc_us-gaapIncomeTaxReconciliationChangeInEnactedTaxRate" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapIncomeTaxReconciliationChangeInEnactedTaxRate" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_IncomeTaxReconciliationChangeInPermanentDifferencesERCIncome" xlink:label="loc_RIMEIncomeTaxReconciliationChangeInPermanentDifferencesERCIncome" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_RIMEIncomeTaxReconciliationChangeInPermanentDifferencesERCIncome" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:label="loc_us-gaapIncomeTaxReconciliationForeignIncomeTaxRateDifferential" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapIncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_IncomeTaxReconciliationChangeInExpirationOfNetOpretaingLossCarryforward" xlink:label="loc_RIMEIncomeTaxReconciliationChangeInExpirationOfNetOpretaingLossCarryforward" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_RIMEIncomeTaxReconciliationChangeInExpirationOfNetOpretaingLossCarryforward" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapIncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapIncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:label="loc_us-gaapIncomeTaxReconciliationOtherReconcilingItems" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapIncomeTaxReconciliationOtherReconcilingItems" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfRevenueByGeographicalRegionDetails" xlink:title="00000095 - Disclosure - SCHEDULE OF REVENUE BY GEOGRAPHICAL REGION (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/August2021PrivatePlacementDetailsNarrative" xlink:title="00000096 - Disclosure - AUGUST 2021 PRIVATE PLACEMENT (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/DamagedGoodsIncidentRecoveryDetailsNarrative" xlink:title="00000097 - Disclosure - DAMAGED GOODS INCIDENT RECOVERY (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfOperationsDetails" xlink:title="00000098 - Disclosure - SCHEDULE OF CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaapCostOfGoodsAndServicesSold" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapCostOfGoodsAndServicesSold" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapProfitLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapProfitLoss" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfCashFlowsDetails" xlink:title="00000099 - Disclosure - SCHEDULE OF CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapital" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingCapital" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingCapital" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfShareholdersEquityDetails" xlink:title="00000100 - Disclosure - SCHEDULE OF CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS? EQUITY (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfEstimatedUsefulLivesDetails" xlink:title="00000101 - Disclosure - SCHEDULE OF ESTIMATED USEFUL LIVES (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/AccountsReceivableDetailsNarrative" xlink:title="00000102 - Disclosure - ACCOUNTS RECEIVABLE (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/AccountsPayableAndAccruedExpensesDetailsNarrative" xlink:title="00000103 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfSpecificTermsDetails" xlink:title="00000104 - Disclosure - SCHEDULE OF SPECIFIC TERMS (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/NotesPayableAndFinaningArrangementsDetailsNarrative" xlink:title="00000105 - Disclosure - NOTES PAYABLE AND FINANING ARRANGEMENTS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/DueFromFactorDetailsNarrative" xlink:title="00000106 - Disclosure - DUE FROM FACTOR (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfStockOptionIssuedDuringYearDecember3120202021And2022Details" xlink:title="00000107 - Disclosure - SCHEDULE OF STOCK OPTION ISSUED DURING THE YEAR DECEMBER 31, 2020, 2021 AND 2022 (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/StockholdersEquityDetailsNarrative" xlink:title="00000108 - Disclosure - STOCKHOLDERS&#8217; EQUITY (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfFirstTrancheOfSubscriptionsDetails" xlink:title="00000109 - Disclosure - SCHEDULE OF FIRST TRANCHE OF SUBSCRIPTIONS (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/SummaryOfTerminatedImmediatelyAfterClosingOfTransactionDetails" xlink:title="00000110 - Disclosure - SUMMARY OF TERMINATED IMMEDIATELY AFTER CLOSING OF THE TRANSACTION (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/SafePrivatePlacementsDetailsNarrative" xlink:title="00000111 - Disclosure - SAFE PRIVATE PLACEMENTS (Details Narrative)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>18
<FILENAME>rime-20240930_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://algoholdings.com/role/Cover" xlink:href="rime-20240930.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/BalanceSheets" xlink:href="rime-20240930.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/BalanceSheetsParenthetical" xlink:href="rime-20240930.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/StatementsOfOperations" xlink:href="rime-20240930.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/StatementsOfShareholdersDeficitEquity" xlink:href="rime-20240930.xsd#StatementsOfShareholdersDeficitEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/StatementsOfCashFlows" xlink:href="rime-20240930.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/NatureOfBusiness" xlink:href="rime-20240930.xsd#NatureOfBusiness" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/RecentDevelopments" xlink:href="rime-20240930.xsd#RecentDevelopments" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/LiquidityGoingConcernAndManagementPlans" xlink:href="rime-20240930.xsd#LiquidityGoingConcernAndManagementPlans" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="rime-20240930.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/AssetAcquisition" xlink:href="rime-20240930.xsd#AssetAcquisition" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/Financing" xlink:href="rime-20240930.xsd#Financing" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/LoansPayableRelatedParties" xlink:href="rime-20240930.xsd#LoansPayableRelatedParties" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/CommitmentsAndContingencies" xlink:href="rime-20240930.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/OperatingLeases" xlink:href="rime-20240930.xsd#OperatingLeases" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/IssuanceOfCommonStock" xlink:href="rime-20240930.xsd#IssuanceOfCommonStock" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/Warrants" xlink:href="rime-20240930.xsd#Warrants" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ComputationOfLossPerShare" xlink:href="rime-20240930.xsd#ComputationOfLossPerShare" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/IncomeTaxes" xlink:href="rime-20240930.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/RevenueDisaggregation" xlink:href="rime-20240930.xsd#RevenueDisaggregation" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ConcentrationsOfCreditRiskAndRevenue" xlink:href="rime-20240930.xsd#ConcentrationsOfCreditRiskAndRevenue" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/RelatedPartyTransactions" xlink:href="rime-20240930.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/SubsequentEvents" xlink:href="rime-20240930.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/PropertyAndEquipment" xlink:href="rime-20240930.xsd#PropertyAndEquipment" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/StockCompensationExpense" xlink:href="rime-20240930.xsd#StockCompensationExpense" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/PublicOfferingAndNasdaqUplisting" xlink:href="rime-20240930.xsd#PublicOfferingAndNasdaqUplisting" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/AtmOffering" xlink:href="rime-20240930.xsd#AtmOffering" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/PrivatePlacement" xlink:href="rime-20240930.xsd#PrivatePlacement" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/August2021StockRedemption" xlink:href="rime-20240930.xsd#August2021StockRedemption" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/August2021PrivatePlacement" xlink:href="rime-20240930.xsd#August2021PrivatePlacement" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/DamagedGoodsIncidentRecovery" xlink:href="rime-20240930.xsd#DamagedGoodsIncidentRecovery" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/SupplementalInformationCondensedFinancialInformation" xlink:href="rime-20240930.xsd#SupplementalInformationCondensedFinancialInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/AccountsReceivable" xlink:href="rime-20240930.xsd#AccountsReceivable" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/AccountsPayableAndAccruedExpenses" xlink:href="rime-20240930.xsd#AccountsPayableAndAccruedExpenses" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/NotesPayableAndFinaningArrangements" xlink:href="rime-20240930.xsd#NotesPayableAndFinaningArrangements" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/DueFromFactor" xlink:href="rime-20240930.xsd#DueFromFactor" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/StockholdersEquity" xlink:href="rime-20240930.xsd#StockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/SafePrivatePlacements" xlink:href="rime-20240930.xsd#SafePrivatePlacements" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/EmployeeBenefitPlans" xlink:href="rime-20240930.xsd#EmployeeBenefitPlans" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="rime-20240930.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/AssetAcquisitionTables" xlink:href="rime-20240930.xsd#AssetAcquisitionTables" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/LoansPayableRelatedPartiesTables" xlink:href="rime-20240930.xsd#LoansPayableRelatedPartiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/OperatingLeasesTables" xlink:href="rime-20240930.xsd#OperatingLeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/WarrantsTables" xlink:href="rime-20240930.xsd#WarrantsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ComputationOfLossPerShareTables" xlink:href="rime-20240930.xsd#ComputationOfLossPerShareTables" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/RevenueDisaggregationTables" xlink:href="rime-20240930.xsd#RevenueDisaggregationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/PropertyAndEquipmentTables" xlink:href="rime-20240930.xsd#PropertyAndEquipmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/StockCompensationExpenseTables" xlink:href="rime-20240930.xsd#StockCompensationExpenseTables" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/August2021PrivatePlacementTables" xlink:href="rime-20240930.xsd#August2021PrivatePlacementTables" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/SupplementalInformationCondensedFinancialInformationTables" xlink:href="rime-20240930.xsd#SupplementalInformationCondensedFinancialInformationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/NotesPayableAndFinaningArrangementsTables" xlink:href="rime-20240930.xsd#NotesPayableAndFinaningArrangementsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/StockholdersEquityTables" xlink:href="rime-20240930.xsd#StockholdersEquityTables" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/SafePrivatePlacementsTables" xlink:href="rime-20240930.xsd#SafePrivatePlacementsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/RecentDevelopmentsDetailsNarrative" xlink:href="rime-20240930.xsd#RecentDevelopmentsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/LiquidityGoingConcernAndManagementPlansDetailsNarrative" xlink:href="rime-20240930.xsd#LiquidityGoingConcernAndManagementPlansDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfConsiderationTransferredToAssetsAcquiredAndLiabilitiesAssumedDetails" xlink:href="rime-20240930.xsd#ScheduleOfConsiderationTransferredToAssetsAcquiredAndLiabilitiesAssumedDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfConsiderationTransferredToAssetsAcquiredAndLiabilitiesAssumedDetailsParenthetical" xlink:href="rime-20240930.xsd#ScheduleOfConsiderationTransferredToAssetsAcquiredAndLiabilitiesAssumedDetailsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfProFormaFinancialInformationDetails" xlink:href="rime-20240930.xsd#ScheduleOfProFormaFinancialInformationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/AssetAcquisitionDetailsNarrative" xlink:href="rime-20240930.xsd#AssetAcquisitionDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/FinancingDetailsNarrative" xlink:href="rime-20240930.xsd#FinancingDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfLoanDetails" xlink:href="rime-20240930.xsd#ScheduleOfLoanDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/LoansPayableRelatedPartiesDetailsNarrative" xlink:href="rime-20240930.xsd#LoansPayableRelatedPartiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="rime-20240930.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfSupplementalInformationRelatedToLeasesDetails" xlink:href="rime-20240930.xsd#ScheduleOfSupplementalInformationRelatedToLeasesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfLeaseTermAndDiscountRateDetails" xlink:href="rime-20240930.xsd#ScheduleOfLeaseTermAndDiscountRateDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfOperatingLeaseMinimumFuturePaymentsDetails" xlink:href="rime-20240930.xsd#ScheduleOfOperatingLeaseMinimumFuturePaymentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/OperatingLeasesDetailsNarrative" xlink:href="rime-20240930.xsd#OperatingLeasesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/IssuanceOfCommonStockDetailsNarrative" xlink:href="rime-20240930.xsd#IssuanceOfCommonStockDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfWarrantsExpirationDetails" xlink:href="rime-20240930.xsd#ScheduleOfWarrantsExpirationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/WarrantsDetailsNarrative" xlink:href="rime-20240930.xsd#WarrantsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfBasicAndDilutiveLossPerShareDetails" xlink:href="rime-20240930.xsd#ScheduleOfBasicAndDilutiveLossPerShareDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ComputationOfLossPerShareDetailsNarrative" xlink:href="rime-20240930.xsd#ComputationOfLossPerShareDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/IncomeTaxesDetailsNarrative" xlink:href="rime-20240930.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfRevenueByProductLineDetails" xlink:href="rime-20240930.xsd#ScheduleOfRevenueByProductLineDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfSalesByGeographicalRegionDetails" xlink:href="rime-20240930.xsd#ScheduleOfSalesByGeographicalRegionDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/RevenueDisaggregationDetailsNarrative" xlink:href="rime-20240930.xsd#RevenueDisaggregationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ConcentrationsOfCreditRiskAndRevenueDetailsNarrative" xlink:href="rime-20240930.xsd#ConcentrationsOfCreditRiskAndRevenueDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="rime-20240930.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/SubsequentEventsDetailsNarrative" xlink:href="rime-20240930.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="rime-20240930.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfPropertyAndEquipmentDetails" xlink:href="rime-20240930.xsd#ScheduleOfPropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/PropertyAndEquipmentDetailsNarrative" xlink:href="rime-20240930.xsd#PropertyAndEquipmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/SummaryOfStockOptionActivityDetails" xlink:href="rime-20240930.xsd#SummaryOfStockOptionActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfEmployeeStockOptionsOutstandingDetailsParenthetical" xlink:href="rime-20240930.xsd#ScheduleOfEmployeeStockOptionsOutstandingDetailsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfBasicAndDilutiveSharesDetails" xlink:href="rime-20240930.xsd#ScheduleOfBasicAndDilutiveSharesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/StockCompensationExpenseDetailsNarrative" xlink:href="rime-20240930.xsd#StockCompensationExpenseDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/PublicOfferingAndNasdaqUplistingDetailsNarrative" xlink:href="rime-20240930.xsd#PublicOfferingAndNasdaqUplistingDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/AtmOfferingDetailsNarrative" xlink:href="rime-20240930.xsd#AtmOfferingDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/PrivatePlacementDetailsNarrative" xlink:href="rime-20240930.xsd#PrivatePlacementDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/August2021StockRedemptionDetailsNarrative" xlink:href="rime-20240930.xsd#August2021StockRedemptionDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfLossBeforeIncomeTaxesDetails" xlink:href="rime-20240930.xsd#ScheduleOfLossBeforeIncomeTaxesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfProvisionForIncomeTaxesDetails" xlink:href="rime-20240930.xsd#ScheduleOfProvisionForIncomeTaxesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:href="rime-20240930.xsd#ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfTaxProvisionDetails" xlink:href="rime-20240930.xsd#ScheduleOfTaxProvisionDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfRevenueByGeographicalRegionDetails" xlink:href="rime-20240930.xsd#ScheduleOfRevenueByGeographicalRegionDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/August2021PrivatePlacementDetailsNarrative" xlink:href="rime-20240930.xsd#August2021PrivatePlacementDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/DamagedGoodsIncidentRecoveryDetailsNarrative" xlink:href="rime-20240930.xsd#DamagedGoodsIncidentRecoveryDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfOperationsDetails" xlink:href="rime-20240930.xsd#ScheduleOfCondensedConsolidatedStatementsOfOperationsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfCashFlowsDetails" xlink:href="rime-20240930.xsd#ScheduleOfCondensedConsolidatedStatementsOfCashFlowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfShareholdersEquityDetails" xlink:href="rime-20240930.xsd#ScheduleOfCondensedConsolidatedStatementsOfShareholdersEquityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfEstimatedUsefulLivesDetails" xlink:href="rime-20240930.xsd#ScheduleOfEstimatedUsefulLivesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/AccountsReceivableDetailsNarrative" xlink:href="rime-20240930.xsd#AccountsReceivableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/AccountsPayableAndAccruedExpensesDetailsNarrative" xlink:href="rime-20240930.xsd#AccountsPayableAndAccruedExpensesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfSpecificTermsDetails" xlink:href="rime-20240930.xsd#ScheduleOfSpecificTermsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/NotesPayableAndFinaningArrangementsDetailsNarrative" xlink:href="rime-20240930.xsd#NotesPayableAndFinaningArrangementsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/DueFromFactorDetailsNarrative" xlink:href="rime-20240930.xsd#DueFromFactorDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfStockOptionIssuedDuringYearDecember3120202021And2022Details" xlink:href="rime-20240930.xsd#ScheduleOfStockOptionIssuedDuringYearDecember3120202021And2022Details" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/StockholdersEquityDetailsNarrative" xlink:href="rime-20240930.xsd#StockholdersEquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfFirstTrancheOfSubscriptionsDetails" xlink:href="rime-20240930.xsd#ScheduleOfFirstTrancheOfSubscriptionsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/SummaryOfTerminatedImmediatelyAfterClosingOfTransactionDetails" xlink:href="rime-20240930.xsd#SummaryOfTerminatedImmediatelyAfterClosingOfTransactionDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/SafePrivatePlacementsDetailsNarrative" xlink:href="rime-20240930.xsd#SafePrivatePlacementsDetailsNarrative" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesLineItems" xlink:label="loc_deiEntityAddressesLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesTable" xlink:label="loc_deiEntityAddressesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="loc_deiEntityAddressesAddressTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_deiEntityAddressesTable" xlink:to="loc_deiEntityAddressesAddressTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AddressTypeDomain" xlink:label="loc_deiAddressTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiEntityAddressesAddressTypeAxis" xlink:to="loc_deiAddressTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AddressTypeDomain" xlink:label="loc_deiAddressTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiEntityAddressesAddressTypeAxis" xlink:to="loc_deiAddressTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_BusinessContactMember" xlink:label="loc_deiBusinessContactMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiAddressTypeDomain" xlink:to="loc_deiBusinessContactMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentType_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAmendmentFlag_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAmendmentDescription_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentRegistrationStatement_30" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentAnnualReport_30" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentQuarterlyReport_30" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentTransitionReport_30" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentShellCompanyReport_30" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_30" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentPeriodStartDate_30" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentPeriodEndDate_30" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_30" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_30" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_30" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityFileNumber_30" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityRegistrantName_30" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCentralIndexKey_30" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityPrimarySicNumber_30" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_30" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_30" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine1_30" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine2_30" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine3_30" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressCityOrTown_30" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_30" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressCountry_30" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_30" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCountryRegion_30" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCityAreaCode_30" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiLocalPhoneNumber_30" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="loc_deiExtension_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiExtension_30" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiWrittenCommunications_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSolicitingMaterial_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiPreCommencementTenderOffer_30" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_30" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurity12bTitle_30" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiNoTradingSymbolFlag_30" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiTradingSymbol_30" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurityExchangeName_30" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurity12gTitle_30" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurityReportingObligation_30" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAnnualInformationForm_30" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_30" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_30" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityVoluntaryFilers_30" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_30" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_30" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityFilerCategory_30" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntitySmallBusiness_30" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_30" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityExTransitionPeriod_30" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentAccountingStandard_30" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_30" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityShellCompany_30" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityPublicFloat_30" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_30" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_30" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_30" xlink:type="arc" order="57" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_ContactPersonnelName" xlink:label="loc_deiContactPersonnelName_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiContactPersonnelName_30" xlink:type="arc" order="58" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/BalanceSheets" xlink:title="00000002 - Statement - Condensed Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonrelatedPartyMember" xlink:label="loc_us-gaapNonrelatedPartyMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapNonrelatedPartyMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember" xlink:label="loc_us-gaapRelatedPartyMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapRelatedPartyMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapAssetsAbstract_120" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_120" xlink:to="loc_us-gaapAssetsCurrentAbstract_120" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_120" xlink:to="loc_us-gaapCash_120" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNet" xlink:label="loc_us-gaapAccountsReceivableNet_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_120" xlink:to="loc_us-gaapAccountsReceivableNet_120" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DueFromBanks" xlink:label="loc_us-gaapDueFromBanks_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_120" xlink:to="loc_us-gaapDueFromBanks_120" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_RefundDueFromCustomer" xlink:label="loc_RIMERefundDueFromCustomer_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_120" xlink:to="loc_RIMERefundDueFromCustomer_120" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_120" xlink:to="loc_us-gaapInventoryNet_120" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ReturnsAsset" xlink:label="loc_RIMEReturnsAsset_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_120" xlink:to="loc_RIMEReturnsAsset_120" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_120" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent_120" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_120" xlink:to="loc_us-gaapAssetsCurrent_120" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_120" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_120" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_120" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset_120" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaapOtherAssetsNoncurrent_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_120" xlink:to="loc_us-gaapOtherAssetsNoncurrent_120" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_120" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill_120" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_120" xlink:to="loc_us-gaapGoodwill_120" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_120" xlink:to="loc_us-gaapAssets_120" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_120" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_120" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract_120" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_120" xlink:to="loc_us-gaapAccountsPayableCurrent_120" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_120" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent_120" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaapNotesPayableCurrent_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_120" xlink:to="loc_us-gaapNotesPayableCurrent_120" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LoansPayableCurrent" xlink:label="loc_us-gaapLoansPayableCurrent_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_120" xlink:to="loc_us-gaapLoansPayableCurrent_120" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerRefundLiabilityCurrent" xlink:label="loc_us-gaapContractWithCustomerRefundLiabilityCurrent_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_120" xlink:to="loc_us-gaapContractWithCustomerRefundLiabilityCurrent_120" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_CustomerPrepayments" xlink:label="loc_RIMECustomerPrepayments_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_120" xlink:to="loc_RIMECustomerPrepayments_120" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ReserveForSalesReturns" xlink:label="loc_RIMEReserveForSalesReturns_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_120" xlink:to="loc_RIMEReserveForSalesReturns_120" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermBorrowings" xlink:label="loc_us-gaapShortTermBorrowings_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_120" xlink:to="loc_us-gaapShortTermBorrowings_120" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_120" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent_120" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_120" xlink:to="loc_us-gaapOtherLiabilitiesCurrent_120" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_120" xlink:to="loc_us-gaapLiabilitiesCurrent_120" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapOtherLiabilitiesNoncurrent_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_120" xlink:to="loc_us-gaapOtherLiabilitiesNoncurrent_120" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermNotesPayable" xlink:label="loc_us-gaapLongTermNotesPayable_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_120" xlink:to="loc_us-gaapLongTermNotesPayable_120" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_120" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent_120" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermLoansPayable" xlink:label="loc_us-gaapLongTermLoansPayable_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_120" xlink:to="loc_us-gaapLongTermLoansPayable_120" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_120" xlink:to="loc_us-gaapLiabilities_120" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_CommitmentsAndContingenciesAbstract" xlink:label="loc_RIMECommitmentsAndContingenciesAbstract_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_RIMECommitmentsAndContingenciesAbstract_120" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ProvisionForLegalLiability" xlink:label="loc_RIMEProvisionForLegalLiability_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_RIMECommitmentsAndContingenciesAbstract_120" xlink:to="loc_RIMEProvisionForLegalLiability_120" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapCommitmentsAndContingencies_120" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapStockholdersEquityAbstract_120" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_120" xlink:to="loc_us-gaapPreferredStockValue_120" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_120" xlink:to="loc_us-gaapCommonStockValue_120" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_120" xlink:to="loc_us-gaapAdditionalPaidInCapital_120" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable" xlink:label="loc_us-gaapCommonStockShareSubscribedButUnissuedSubscriptionsReceivable_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_120" xlink:to="loc_us-gaapCommonStockShareSubscribedButUnissuedSubscriptionsReceivable_120" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_120" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit_120" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_120" xlink:to="loc_us-gaapStockholdersEquity_120" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaapMinorityInterest_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_120" xlink:to="loc_us-gaapMinorityInterest_120" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_120" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_120" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity_120" xlink:type="arc" order="46" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Condensed Consolidated Statements of Operations">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax_100" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaapCostOfGoodsAndServicesSold_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCostOfGoodsAndServicesSold_100" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGrossProfit_100" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaapOperatingExpensesAbstract_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingExpensesAbstract_100" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingExpense" xlink:label="loc_us-gaapSellingExpense_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingExpensesAbstract_100" xlink:to="loc_us-gaapSellingExpense_100" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingExpensesAbstract_100" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense_100" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnTerminationOfLease" xlink:label="loc_us-gaapGainLossOnTerminationOfLease_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingExpensesAbstract_100" xlink:to="loc_us-gaapGainLossOnTerminationOfLease_100" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ProductDevelopmentExpense" xlink:label="loc_RIMEProductDevelopmentExpense_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingExpensesAbstract_100" xlink:to="loc_RIMEProductDevelopmentExpense_100" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingExpensesAbstract_100" xlink:to="loc_us-gaapOperatingExpenses_100" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingIncomeLoss_100" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaapNonoperatingIncomeExpenseAbstract_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNonoperatingIncomeExpenseAbstract_100" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnDispositionOfAssets1" xlink:label="loc_us-gaapGainLossOnDispositionOfAssets1_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_100" xlink:to="loc_us-gaapGainLossOnDispositionOfAssets1_100" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_GainFromRelatedPartyDebt" xlink:label="loc_RIMEGainFromRelatedPartyDebt_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_100" xlink:to="loc_RIMEGainFromRelatedPartyDebt_100" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_GainFromPaycheckProtectionPlanLoanForgiveness" xlink:label="loc_RIMEGainFromPaycheckProtectionPlanLoanForgiveness_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_100" xlink:to="loc_RIMEGainFromPaycheckProtectionPlanLoanForgiveness_100" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_GainFromSettlementOfAccountsPayable" xlink:label="loc_RIMEGainFromSettlementOfAccountsPayable_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_100" xlink:to="loc_RIMEGainFromSettlementOfAccountsPayable_100" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_100" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt_100" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_GainFromEmployeeRetentionCreditProgramRefund" xlink:label="loc_RIMEGainFromEmployeeRetentionCreditProgramRefund_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_100" xlink:to="loc_RIMEGainFromEmployeeRetentionCreditProgramRefund_100" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseDebtExcludingAmortization" xlink:label="loc_us-gaapInterestExpenseDebtExcludingAmortization_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_100" xlink:to="loc_us-gaapInterestExpenseDebtExcludingAmortization_100" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_100" xlink:to="loc_us-gaapNonoperatingIncomeExpense_100" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_100" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit_100" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfitLoss_100" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest_100" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_100" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareAbstract_100" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareBasic_100" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareDiluted_100" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract" xlink:label="loc_us-gaapEarningsPerShareBasicOtherDisclosuresAbstract_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareBasicOtherDisclosuresAbstract_100" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_100" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_100" xlink:type="arc" order="29" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/StatementsOfShareholdersDeficitEquity" xlink:title="00000005 - Statement - Condensed Consolidated Statements of Shareholders&apos; (Deficit) Equity">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivablesFromStockholderMember" xlink:label="loc_us-gaapReceivablesFromStockholderMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapReceivablesFromStockholderMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaapNoncontrollingInterestMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapNoncontrollingInterestMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfitLoss_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_70" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_70" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation" xlink:label="loc_us-gaapStockGrantedDuringPeriodValueSharebasedCompensation_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockGrantedDuringPeriodValueSharebasedCompensation_70" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation_70" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueAcquisitions_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueAcquisitions_70" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions_70" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_70" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueOther_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueOther_70" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_StockIssuedDuringPeriodValueSaleOfCommonStockWarrants" xlink:label="loc_RIMEStockIssuedDuringPeriodValueSaleOfCommonStockWarrants_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMEStockIssuedDuringPeriodValueSaleOfCommonStockWarrants_70" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_StockIssuedDuringPeriodSharesSaleOfCommonStockWarrants" xlink:label="loc_RIMEStockIssuedDuringPeriodSharesSaleOfCommonStockWarrants_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMEStockIssuedDuringPeriodSharesSaleOfCommonStockWarrants_70" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalWarrantIssued_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalWarrantIssued_70" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesOther_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesOther_70" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:label="loc_us-gaapTreasuryStockRetiredCostMethodAmount_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTreasuryStockRetiredCostMethodAmount_70" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockSharesRetired" xlink:label="loc_us-gaapTreasuryStockSharesRetired_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTreasuryStockSharesRetired_70" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation_70" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised_70" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_70" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_StockIssuedDuringPeriodValueExerciseOfPrefundedAndCommonWarrants" xlink:label="loc_RIMEStockIssuedDuringPeriodValueExerciseOfPrefundedAndCommonWarrants_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMEStockIssuedDuringPeriodValueExerciseOfPrefundedAndCommonWarrants_70" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_StockIssuedDuringPeriodSharesExerciseOfPrefundedAndCommonWarrants" xlink:label="loc_RIMEStockIssuedDuringPeriodSharesExerciseOfPrefundedAndCommonWarrants_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMEStockIssuedDuringPeriodSharesExerciseOfPrefundedAndCommonWarrants_70" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_70" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_StockIssuedDuringPeriodValueReverseStockSplits" xlink:label="loc_RIMEStockIssuedDuringPeriodValueReverseStockSplits_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMEStockIssuedDuringPeriodValueReverseStockSplits_70" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesReverseStockSplits_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesReverseStockSplits_70" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_StockIssuedDuringPeriodValueIssuanceOfCommonStockAtMarketOffering" xlink:label="loc_RIMEStockIssuedDuringPeriodValueIssuanceOfCommonStockAtMarketOffering_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMEStockIssuedDuringPeriodValueIssuanceOfCommonStockAtMarketOffering_70" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_StockIssuedDuringPeriodSharesIssuanceOfCommonStockAtMarketOffering" xlink:label="loc_RIMEStockIssuedDuringPeriodSharesIssuanceOfCommonStockAtMarketOffering_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMEStockIssuedDuringPeriodSharesIssuanceOfCommonStockAtMarketOffering_70" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_StockIssuedDuringPeriodValueIssuanceOfCommonStockPrivatePlacement" xlink:label="loc_RIMEStockIssuedDuringPeriodValueIssuanceOfCommonStockPrivatePlacement_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMEStockIssuedDuringPeriodValueIssuanceOfCommonStockPrivatePlacement_70" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_StockIssuedDuringPeriodSharesIssuanceOfCommonStockPrivatePlacement" xlink:label="loc_RIMEStockIssuedDuringPeriodSharesIssuanceOfCommonStockPrivatePlacement_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMEStockIssuedDuringPeriodSharesIssuanceOfCommonStockPrivatePlacement_70" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalOther_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalOther_70" xlink:type="arc" order="32" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Condensed Consolidated Statements of Cash Flows" />
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/NatureOfBusiness" xlink:title="00000007 - Disclosure - NATURE OF BUSINESS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NatureOfOperations" xlink:label="loc_us-gaapNatureOfOperations_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNatureOfOperations_40" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/RecentDevelopments" xlink:title="00000008 - Disclosure - RECENT DEVELOPMENTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/LiquidityGoingConcernAndManagementPlans" xlink:title="00000009 - Disclosure - LIQUIDITY, GOING CONCERN AND MANAGEMENT PLANS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" xlink:label="loc_us-gaapSubstantialDoubtAboutGoingConcernTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSubstantialDoubtAboutGoingConcernTextBlock_40" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000010 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapSignificantAccountingPoliciesTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSignificantAccountingPoliciesTextBlock_40" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/AssetAcquisition" xlink:title="00000011 - Disclosure - ASSET ACQUISITION" />
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/Financing" xlink:title="00000012 - Disclosure - FINANCING" />
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/LoansPayableRelatedParties" xlink:title="00000013 - Disclosure - LOANS PAYABLE &#8211; RELATED PARTIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/CommitmentsAndContingencies" xlink:title="00000014 - Disclosure - COMMITMENTS AND CONTINGENCIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock_40" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/OperatingLeases" xlink:title="00000015 - Disclosure - OPERATING LEASES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/IssuanceOfCommonStock" xlink:title="00000016 - Disclosure - ISSUANCE OF COMMON STOCK" />
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/Warrants" xlink:title="00000017 - Disclosure - WARRANTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ComputationOfLossPerShare" xlink:title="00000018 - Disclosure - COMPUTATION OF LOSS PER SHARE" />
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/IncomeTaxes" xlink:title="00000019 - Disclosure - INCOME TAXES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaapIncomeTaxDisclosureTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxDisclosureTextBlock_40" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/RevenueDisaggregation" xlink:title="00000020 - Disclosure - REVENUE DISAGGREGATION" />
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ConcentrationsOfCreditRiskAndRevenue" xlink:title="00000021 - Disclosure - CONCENTRATIONS OF CREDIT RISK AND REVENUE">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:label="loc_us-gaapConcentrationRiskDisclosureTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConcentrationRiskDisclosureTextBlock_40" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/RelatedPartyTransactions" xlink:title="00000022 - Disclosure - RELATED PARTY TRANSACTIONS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock_40" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/SubsequentEvents" xlink:title="00000023 - Disclosure - SUBSEQUENT EVENTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/PropertyAndEquipment" xlink:title="00000024 - Disclosure - PROPERTY AND EQUIPMENT">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock_40" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/StockCompensationExpense" xlink:title="00000025 - Disclosure - STOCK COMPENSATION EXPENSE" />
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/PublicOfferingAndNasdaqUplisting" xlink:title="00000026 - Disclosure - PUBLIC OFFERING AND NASDAQ UPLISTING" />
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/AtmOffering" xlink:title="00000027 - Disclosure - ATM OFFERING" />
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/PrivatePlacement" xlink:title="00000028 - Disclosure - PRIVATE PLACEMENT" />
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/August2021StockRedemption" xlink:title="00000029 - Disclosure - AUGUST 2021 STOCK REDEMPTION" />
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/August2021PrivatePlacement" xlink:title="00000030 - Disclosure - AUGUST 2021 PRIVATE PLACEMENT" />
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/DamagedGoodsIncidentRecovery" xlink:title="00000031 - Disclosure - DAMAGED GOODS INCIDENT RECOVERY" />
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/SupplementalInformationCondensedFinancialInformation" xlink:title="00000032 - Disclosure - SUPPLEMENTAL INFORMATION CONDENSED FINANCIAL INFORMATION" />
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/AccountsReceivable" xlink:title="00000033 - Disclosure - ACCOUNTS RECEIVABLE">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsAndNontradeReceivableTextBlock" xlink:label="loc_us-gaapAccountsAndNontradeReceivableTextBlock_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccountsAndNontradeReceivableTextBlock_30" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/AccountsPayableAndAccruedExpenses" xlink:title="00000034 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_30" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/NotesPayableAndFinaningArrangements" xlink:title="00000035 - Disclosure - NOTES PAYABLE AND FINANING ARRANGEMENTS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_NotePayableAndFinancingArrangementsTextBlock" xlink:label="loc_RIMENotePayableAndFinancingArrangementsTextBlock_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMENotePayableAndFinancingArrangementsTextBlock_30" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/DueFromFactor" xlink:title="00000036 - Disclosure - DUE FROM FACTOR">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AccountsReceivableDisclosureTextBlock" xlink:label="loc_RIMEAccountsReceivableDisclosureTextBlock_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMEAccountsReceivableDisclosureTextBlock_30" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/StockholdersEquity" xlink:title="00000037 - Disclosure - STOCKHOLDERS&#8217; EQUITY">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock_30" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/SafePrivatePlacements" xlink:title="00000038 - Disclosure - SAFE PRIVATE PLACEMENTS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SafePrivatePlacementsTextBlock" xlink:label="loc_RIMESafePrivatePlacementsTextBlock_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMESafePrivatePlacementsTextBlock_30" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/EmployeeBenefitPlans" xlink:title="00000039 - Disclosure - EMPLOYEE BENEFIT PLANS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:label="loc_us-gaapCompensationAndEmployeeBenefitPlansTextBlock_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCompensationAndEmployeeBenefitPlansTextBlock_30" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000040 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaapConsolidationPolicyTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConsolidationPolicyTextBlock_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationsPolicy" xlink:label="loc_us-gaapBusinessCombinationsPolicy_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessCombinationsPolicy_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsPolicyTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGoodwillAndIntangibleAssetsPolicyTextBlock_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy_40" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="loc_us-gaapFairValueMeasurementPolicyPolicyTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFairValueMeasurementPolicyPolicyTextBlock_40" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock_40" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:label="loc_us-gaapPriorPeriodReclassificationAdjustmentDescription_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPriorPeriodReclassificationAdjustmentDescription_40" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaapUseOfEstimates_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapUseOfEstimates_40" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:label="loc_us-gaapTradeAndOtherAccountsReceivablePolicy_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTradeAndOtherAccountsReceivablePolicy_40" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="loc_us-gaapInventoryPolicyTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInventoryPolicyTextBlock_40" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_40" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock_40" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="loc_us-gaapLesseeLeasesPolicyTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeLeasesPolicyTextBlock_40" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="loc_us-gaapFairValueOfFinancialInstrumentsPolicy_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFairValueOfFinancialInstrumentsPolicy_40" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="loc_us-gaapRevenueFromContractWithCustomerPolicyTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenueFromContractWithCustomerPolicyTextBlock_40" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ShippingAndHandlingCostsPolicyTextBlock" xlink:label="loc_RIMEShippingAndHandlingCostsPolicyTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMEShippingAndHandlingCostsPolicyTextBlock_40" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="loc_us-gaapShareBasedCompensationOptionAndIncentivePlansPolicy_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationOptionAndIncentivePlansPolicy_40" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaapIncomeTaxPolicyTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxPolicyTextBlock_40" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountPolicy" xlink:label="loc_RIMEReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountPolicy_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMEReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountPolicy_40" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="loc_us-gaapForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_40" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaapConcentrationRiskCreditRisk_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConcentrationRiskCreditRisk_40" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_PrepaidExpensesPolicyTextBlock" xlink:label="loc_RIMEPrepaidExpensesPolicyTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMEPrepaidExpensesPolicyTextBlock_40" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:label="loc_us-gaapCompensationRelatedCostsPolicyTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCompensationRelatedCostsPolicyTextBlock_40" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="loc_us-gaapResearchAndDevelopmentExpensePolicy_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapResearchAndDevelopmentExpensePolicy_40" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaapEarningsPerSharePolicyTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerSharePolicyTextBlock_40" xlink:type="arc" order="25" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/AssetAcquisitionTables" xlink:title="00000041 - Disclosure - ASSET ACQUISITION (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/LoansPayableRelatedPartiesTables" xlink:title="00000042 - Disclosure - LOANS PAYABLE &#8211; RELATED PARTIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/OperatingLeasesTables" xlink:title="00000043 - Disclosure - OPERATING LEASES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/WarrantsTables" xlink:title="00000044 - Disclosure - WARRANTS (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ComputationOfLossPerShareTables" xlink:title="00000045 - Disclosure - COMPUTATION OF LOSS PER SHARE (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/RevenueDisaggregationTables" xlink:title="00000046 - Disclosure - REVENUE DISAGGREGATION (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/PropertyAndEquipmentTables" xlink:title="00000047 - Disclosure - PROPERTY AND EQUIPMENT (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/StockCompensationExpenseTables" xlink:title="00000048 - Disclosure - STOCK COMPENSATION EXPENSE (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/August2021PrivatePlacementTables" xlink:title="00000049 - Disclosure - AUGUST 2021 PRIVATE PLACEMENT (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/SupplementalInformationCondensedFinancialInformationTables" xlink:title="00000050 - Disclosure - SUPPLEMENTAL INFORMATION CONDENSED FINANCIAL INFORMATION (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfCondensedIncomeStatementTableTextBlock" xlink:label="loc_srtScheduleOfCondensedIncomeStatementTableTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_srtScheduleOfCondensedIncomeStatementTableTextBlock_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeStatementAbstract_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfCondensedCashFlowStatementTableTextBlock" xlink:label="loc_srtScheduleOfCondensedCashFlowStatementTableTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_srtScheduleOfCondensedCashFlowStatementTableTextBlock_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementOfCashFlowsAbstract_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:label="loc_us-gaapScheduleOfStockholdersEquityTableTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapScheduleOfStockholdersEquityTableTextBlock_40" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementOfStockholdersEquityAbstract_40" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaapScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock_40" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/NotesPayableAndFinaningArrangementsTables" xlink:title="00000051 - Disclosure - NOTES PAYABLE AND FINANING ARRANGEMENTS (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDebtTableTextBlock" xlink:label="loc_us-gaapScheduleOfDebtTableTextBlock_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapScheduleOfDebtTableTextBlock_30" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/StockholdersEquityTables" xlink:title="00000052 - Disclosure - STOCKHOLDERS&#8217; EQUITY (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ScheduleOfStockOptionIssuedTableTextBlock" xlink:label="loc_RIMEScheduleOfStockOptionIssuedTableTextBlock_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMEScheduleOfStockOptionIssuedTableTextBlock_30" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/SafePrivatePlacementsTables" xlink:title="00000053 - Disclosure - SAFE PRIVATE PLACEMENTS (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SafePrivatePlacementsTableTextBlock" xlink:label="loc_RIMESafePrivatePlacementsTableTextBlock_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMESafePrivatePlacementsTableTextBlock_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock" xlink:label="loc_us-gaapInvestmentHoldingsScheduleOfInvestmentsTableTextBlock_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInvestmentHoldingsScheduleOfInvestmentsTableTextBlock_30" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/RecentDevelopmentsDetailsNarrative" xlink:title="00000054 - Disclosure - RECENT DEVELOPMENTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AtTheMarketSalesAgreementMember" xlink:label="loc_RIMEAtTheMarketSalesAgreementMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMEAtTheMarketSalesAgreementMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AtTheMarketSalesAgreementAmendmentOneMember" xlink:label="loc_RIMEAtTheMarketSalesAgreementAmendmentOneMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMEAtTheMarketSalesAgreementAmendmentOneMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AtTheMarketSalesAgreementAmendmentTwoMember" xlink:label="loc_RIMEAtTheMarketSalesAgreementAmendmentTwoMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMEAtTheMarketSalesAgreementAmendmentTwoMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AssetPurchaseAgreementMember" xlink:label="loc_RIMEAssetPurchaseAgreementMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMEAssetPurchaseAgreementMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_LeaseAgreementMember" xlink:label="loc_RIMELeaseAgreementMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMELeaseAgreementMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SettlementAgreementMember" xlink:label="loc_RIMESettlementAgreementMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESettlementAgreementMember_110" xlink:type="arc" order="111" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SecuritiesPurchaseAgreementMember" xlink:label="loc_RIMESecuritiesPurchaseAgreementMember_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESecuritiesPurchaseAgreementMember_150" xlink:type="arc" order="153" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_LoanAgreementMember" xlink:label="loc_RIMELoanAgreementMember_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMELoanAgreementMember_170" xlink:type="arc" order="172" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_StockRepurchaseAgreementMember" xlink:label="loc_RIMEStockRepurchaseAgreementMember_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMEStockRepurchaseAgreementMember_190" xlink:type="arc" order="191" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="loc_srtEquityMethodInvesteeNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="loc_srtEquityMethodInvesteeNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="loc_srtEquityMethodInvesteeNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="loc_srtEquityMethodInvesteeNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabLLCMember" xlink:label="loc_RIMESemiCabLLCMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtEquityMethodInvesteeNameDomain" xlink:to="loc_RIMESemiCabLLCMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabLLCMember" xlink:label="loc_RIMESemiCabLLCMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RIMESemiCabLLCMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaapPrivatePlacementMember_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapPrivatePlacementMember_150" xlink:type="arc" order="151" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ATMOfferingMember" xlink:label="loc_RIMEATMOfferingMember_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_RIMEATMOfferingMember_230" xlink:type="arc" order="231" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityAxis" xlink:label="loc_us-gaapCreditFacilityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapCreditFacilityAxis" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaapCreditFacilityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapCreditFacilityAxis" xlink:to="loc_us-gaapCreditFacilityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaapCreditFacilityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapCreditFacilityAxis" xlink:to="loc_us-gaapCreditFacilityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="loc_us-gaapRevolvingCreditFacilityMember_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCreditFacilityDomain" xlink:to="loc_us-gaapRevolvingCreditFacilityMember_170" xlink:type="arc" order="171" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction_270" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LegalFees" xlink:label="loc_us-gaapLegalFees_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLegalFees_270" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_270" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity_270" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdministrativeFeesExpense" xlink:label="loc_us-gaapAdministrativeFeesExpense_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdministrativeFeesExpense_270" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesPurchaseOfAssets_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesPurchaseOfAssets_270" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_270" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AreaOfLand" xlink:label="loc_us-gaapAreaOfLand_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAreaOfLand_270" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AssetsWriteOff" xlink:label="loc_RIMEAssetsWriteOff_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMEAssetsWriteOff_270" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasePayments" xlink:label="loc_us-gaapOperatingLeasePayments_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeasePayments_270" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_OperatingLeasePeriodicPayments" xlink:label="loc_RIMEOperatingLeasePeriodicPayments_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMEOperatingLeasePeriodicPayments_270" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnTerminationOfLease" xlink:label="loc_us-gaapGainLossOnTerminationOfLease_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGainLossOnTerminationOfLease_270" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_LeaseSettlementExpense" xlink:label="loc_RIMELeaseSettlementExpense_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMELeaseSettlementExpense_270" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SecuredDebt" xlink:label="loc_us-gaapSecuredDebt_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSecuredDebt_270" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement_270" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_PrivatePlacementIssueDiscount" xlink:label="loc_RIMEPrivatePlacementIssueDiscount_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMEPrivatePlacementIssueDiscount_270" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaapLineOfCreditFacilityMaximumBorrowingCapacity_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityMaximumBorrowingCapacity_270" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:label="loc_us-gaapLineOfCreditFacilityCommitmentFeeAmount_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityCommitmentFeeAmount_270" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued_270" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_270" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_270" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare_270" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_TransactionFees" xlink:label="loc_RIMETransactionFees_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMETransactionFees_270" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="loc_us-gaapLesseeOperatingLeaseTermOfContract_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseTermOfContract_270" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRent" xlink:label="loc_us-gaapPaymentsForRent_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsForRent_270" xlink:type="arc" order="24" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/LiquidityGoingConcernAndManagementPlansDetailsNarrative" xlink:title="00000055 - Disclosure - LIQUIDITY, GOING CONCERN AND MANAGEMENT PLANS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_WorkingCapital" xlink:label="loc_RIMEWorkingCapital_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMEWorkingCapital_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit_40" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfConsiderationTransferredToAssetsAcquiredAndLiabilitiesAssumedDetails" xlink:title="00000056 - Disclosure - SCHEDULE OF CONSIDERATION TRANSFERRED TO THE ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionLineItems" xlink:label="loc_us-gaapAssetAcquisitionLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionTable" xlink:label="loc_us-gaapAssetAcquisitionTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapAssetAcquisitionTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionAxis" xlink:label="loc_us-gaapAssetAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapAssetAcquisitionTable" xlink:to="loc_us-gaapAssetAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionDomain" xlink:label="loc_us-gaapAssetAcquisitionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAssetAcquisitionAxis" xlink:to="loc_us-gaapAssetAcquisitionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionDomain" xlink:label="loc_us-gaapAssetAcquisitionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAssetAcquisitionAxis" xlink:to="loc_us-gaapAssetAcquisitionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionDomain" xlink:to="loc_RIMESemiCabIncMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapAssetAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RIMESemiCabIncMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" xlink:label="loc_us-gaapAssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapAssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AssetAcquisitionFairValueOfNonControllingInterest" xlink:label="loc_RIMEAssetAcquisitionFairValueOfNonControllingInterest_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_RIMEAssetAcquisitionFairValueOfNonControllingInterest_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration" xlink:label="loc_us-gaapAssetAcquisitionConsiderationTransferredContingentConsideration_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapAssetAcquisitionConsiderationTransferredContingentConsideration_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AssetAcquisitionDebtExtinguishment" xlink:label="loc_RIMEAssetAcquisitionDebtExtinguishment_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_RIMEAssetAcquisitionDebtExtinguishment_30" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionConsiderationTransferred" xlink:label="loc_us-gaapAssetAcquisitionConsiderationTransferred_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapAssetAcquisitionConsiderationTransferred_30" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_30" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_30" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_30" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_30" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_30" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCustomerRelationships" xlink:label="loc_RIMEBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCustomerRelationships_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_RIMEBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCustomerRelationships_30" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradeName" xlink:label="loc_RIMEBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradeName_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_RIMEBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradeName_30" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDevelopedTechnology" xlink:label="loc_RIMEBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDevelopedTechnology_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_RIMEBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDevelopedTechnology_30" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_30" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLoansPayable" xlink:label="loc_RIMEBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLoansPayable_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_RIMEBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLoansPayable_30" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt_30" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesNotesPayableRelatedParties" xlink:label="loc_RIMEBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesNotesPayableRelatedParties_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_RIMEBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesNotesPayableRelatedParties_30" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_30" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapGoodwill_30" xlink:type="arc" order="18" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfConsiderationTransferredToAssetsAcquiredAndLiabilitiesAssumedDetailsParenthetical" xlink:title="00000057 - Disclosure - SCHEDULE OF CONSIDERATION TRANSFERRED TO THE ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TradeNamesMember" xlink:label="loc_us-gaapTradeNamesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapTradeNamesMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DevelopedTechnologyRightsMember" xlink:label="loc_us-gaapDevelopedTechnologyRightsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapDevelopedTechnologyRightsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife_40" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfProFormaFinancialInformationDetails" xlink:title="00000058 - Disclosure - SCHEDULE OF PRO FORMA FINANCIAL INFORMATION (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/AssetAcquisitionDetailsNarrative" xlink:title="00000059 - Disclosure - ASSET ACQUISITION (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AssetPurchaseAgreementMember" xlink:label="loc_RIMEAssetPurchaseAgreementMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMEAssetPurchaseAgreementMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_EmploymentAgreementsMember" xlink:label="loc_RIMEEmploymentAgreementsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMEEmploymentAgreementsMember_30" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="loc_srtEquityMethodInvesteeNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="loc_srtEquityMethodInvesteeNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="loc_srtEquityMethodInvesteeNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="loc_srtEquityMethodInvesteeNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabLLCMember" xlink:label="loc_RIMESemiCabLLCMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtEquityMethodInvesteeNameDomain" xlink:to="loc_RIMESemiCabLLCMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtEquityMethodInvesteeNameDomain" xlink:to="loc_RIMESemiCabIncMember_140" xlink:type="arc" order="141" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AlgorhythmHoldingsIncMember" xlink:label="loc_RIMEAlgorhythmHoldingsIncMember_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtEquityMethodInvesteeNameDomain" xlink:to="loc_RIMEAlgorhythmHoldingsIncMember_150" xlink:type="arc" order="151" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionAxis" xlink:label="loc_us-gaapAssetAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAssetAcquisitionAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionDomain" xlink:label="loc_us-gaapAssetAcquisitionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAssetAcquisitionAxis" xlink:to="loc_us-gaapAssetAcquisitionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionDomain" xlink:label="loc_us-gaapAssetAcquisitionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAssetAcquisitionAxis" xlink:to="loc_us-gaapAssetAcquisitionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabLLCMember" xlink:label="loc_RIMESemiCabLLCMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionDomain" xlink:to="loc_RIMESemiCabLLCMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionDomain" xlink:to="loc_RIMESemiCabIncMember_110" xlink:type="arc" order="111" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementScenarioAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_TwoThousandTwentyFourMember" xlink:label="loc_RIMETwoThousandTwentyFourMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_RIMETwoThousandTwentyFourMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_TwoThousandTwentyFiveMember" xlink:label="loc_RIMETwoThousandTwentyFiveMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_RIMETwoThousandTwentyFiveMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SubsequentYearsMember" xlink:label="loc_RIMESubsequentYearsMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_RIMESubsequentYearsMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_TwoThousandTwentySixMember" xlink:label="loc_RIMETwoThousandTwentySixMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_RIMETwoThousandTwentySixMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_TwoThousandTwentySevenMember" xlink:label="loc_RIMETwoThousandTwentySevenMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_RIMETwoThousandTwentySevenMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_TwoThousandTwentyEightMember" xlink:label="loc_RIMETwoThousandTwentyEightMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_RIMETwoThousandTwentyEightMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AjeshKapoorMember" xlink:label="loc_RIMEAjeshKapoorMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_RIMEAjeshKapoorMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_VivekSehgalKapoorMember" xlink:label="loc_RIMEVivekSehgalKapoorMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_RIMEVivekSehgalKapoorMember_60" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_160" xlink:type="arc" order="161" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_170" xlink:type="arc" order="171" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesPurchaseOfAssets_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesPurchaseOfAssets_200" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets" xlink:label="loc_us-gaapStockIssuedDuringPeriodValuePurchaseOfAssets_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValuePurchaseOfAssets_200" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_200" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_200" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalariesAndWages" xlink:label="loc_us-gaapSalariesAndWages_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSalariesAndWages_200" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionConsiderationTransferred" xlink:label="loc_us-gaapAssetAcquisitionConsiderationTransferred_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetAcquisitionConsiderationTransferred_200" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetIncludingGoodwill_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIntangibleAssetsNetIncludingGoodwill_200" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_NonControllingInterestAtFairValue" xlink:label="loc_RIMENonControllingInterestAtFairValue_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMENonControllingInterestAtFairValue_200" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_RoyaltyRate" xlink:label="loc_RIMERoyaltyRate_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMERoyaltyRate_200" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DiscountOnRoyaltyRate" xlink:label="loc_RIMEDiscountOnRoyaltyRate_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMEDiscountOnRoyaltyRate_200" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_RoyaltyTerm" xlink:label="loc_RIMERoyaltyTerm_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMERoyaltyTerm_200" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_GrowthRateOfDevelopmentOfNewBusiness" xlink:label="loc_RIMEGrowthRateOfDevelopmentOfNewBusiness_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMEGrowthRateOfDevelopmentOfNewBusiness_200" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DiscountRateForWeightedAverageCost" xlink:label="loc_RIMEDiscountRateForWeightedAverageCost_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMEDiscountRateForWeightedAverageCost_200" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapital" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingCapital_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingCapital_200" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LegalFees" xlink:label="loc_us-gaapLegalFees_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLegalFees_200" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions_200" xlink:type="arc" order="15" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/FinancingDetailsNarrative" xlink:title="00000060 - Disclosure - FINANCING (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityLineItems" xlink:label="loc_us-gaapLineOfCreditFacilityLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityTable" xlink:label="loc_us-gaapLineOfCreditFacilityTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityAxis" xlink:label="loc_us-gaapCreditFacilityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapLineOfCreditFacilityTable" xlink:to="loc_us-gaapCreditFacilityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaapCreditFacilityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapCreditFacilityAxis" xlink:to="loc_us-gaapCreditFacilityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaapCreditFacilityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapCreditFacilityAxis" xlink:to="loc_us-gaapCreditFacilityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="loc_us-gaapRevolvingCreditFacilityMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCreditFacilityDomain" xlink:to="loc_us-gaapRevolvingCreditFacilityMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_RevolvingLoanAmendmentMember" xlink:label="loc_RIMERevolvingLoanAmendmentMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCreditFacilityDomain" xlink:to="loc_RIMERevolvingLoanAmendmentMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapLineOfCreditFacilityTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember" xlink:label="loc_us-gaapRelatedPartyMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapRelatedPartyMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapLineOfCreditFacilityTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_us-gaapShortTermDebtTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapLineOfCreditFacilityTable" xlink:to="loc_us-gaapShortTermDebtTypeAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaapShortTermDebtTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapShortTermDebtTypeAxis" xlink:to="loc_us-gaapShortTermDebtTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaapShortTermDebtTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShortTermDebtTypeAxis" xlink:to="loc_us-gaapShortTermDebtTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AgileCapilalFundingllcMember" xlink:label="loc_RIMEAgileCapilalFundingllcMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtTypeDomain" xlink:to="loc_RIMEAgileCapilalFundingllcMember_140" xlink:type="arc" order="141" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_CedarAdvancellcMember" xlink:label="loc_RIMECedarAdvancellcMember_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtTypeDomain" xlink:to="loc_RIMECedarAdvancellcMember_170" xlink:type="arc" order="171" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabInvestorMember" xlink:label="loc_RIMESemiCabInvestorMember_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtTypeDomain" xlink:to="loc_RIMESemiCabInvestorMember_200" xlink:type="arc" order="201" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapLineOfCreditFacilityTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_210" xlink:type="arc" order="212" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapLineOfCreditFacilityTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_TwoYearCreditAndSecurityAgreementMember" xlink:label="loc_RIMETwoYearCreditAndSecurityAgreementMember_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMETwoYearCreditAndSecurityAgreementMember_270" xlink:type="arc" order="271" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_TwoYearLoanAndSecurityAgreementMember" xlink:label="loc_RIMETwoYearLoanAndSecurityAgreementMember_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMETwoYearLoanAndSecurityAgreementMember_280" xlink:type="arc" order="281" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_CreditAndSecurityAgreementsMember" xlink:label="loc_RIMECreditAndSecurityAgreementsMember_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMECreditAndSecurityAgreementsMember_290" xlink:type="arc" order="291" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaapLineOfCreditFacilityMaximumBorrowingCapacity_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityMaximumBorrowingCapacity_340" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherReceivables" xlink:label="loc_us-gaapOtherReceivables_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapOtherReceivables_340" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:label="loc_us-gaapLineOfCreditFacilityInterestRateDuringPeriod_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityInterestRateDuringPeriod_340" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseDebt" xlink:label="loc_us-gaapInterestExpenseDebt_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapInterestExpenseDebt_340" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTerm" xlink:label="loc_us-gaapDebtInstrumentTerm_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapDebtInstrumentTerm_340" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityExpirationDate1" xlink:label="loc_us-gaapLineOfCreditFacilityExpirationDate1_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityExpirationDate1_340" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_PercentageOfExitFee" xlink:label="loc_RIMEPercentageOfExitFee_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_RIMEPercentageOfExitFee_340" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessExitCosts1" xlink:label="loc_us-gaapBusinessExitCosts1_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapBusinessExitCosts1_340" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfLinesOfCredit" xlink:label="loc_us-gaapRepaymentsOfLinesOfCredit_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapRepaymentsOfLinesOfCredit_340" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="loc_us-gaapAmortizationOfFinancingCosts_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapAmortizationOfFinancingCosts_340" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityInterestRateDescription" xlink:label="loc_us-gaapLineOfCreditFacilityInterestRateDescription_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityInterestRateDescription_340" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestAndDebtExpense" xlink:label="loc_us-gaapInterestAndDebtExpense_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapInterestAndDebtExpense_340" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount_340" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromShortTermDebt" xlink:label="loc_us-gaapProceedsFromShortTermDebt_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapProceedsFromShortTermDebt_340" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:label="loc_us-gaapDebtInstrumentPeriodicPayment_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapDebtInstrumentPeriodicPayment_340" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfShortTermDebt" xlink:label="loc_us-gaapRepaymentsOfShortTermDebt_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapRepaymentsOfShortTermDebt_340" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateEffectivePercentage_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateEffectivePercentage_340" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermBorrowings" xlink:label="loc_us-gaapShortTermBorrowings_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapShortTermBorrowings_340" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_LineOfCreditFacilityInterestRate" xlink:label="loc_RIMELineOfCreditFacilityInterestRate_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_RIMELineOfCreditFacilityInterestRate_340" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentForAmortization" xlink:label="loc_us-gaapAdjustmentForAmortization_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapAdjustmentForAmortization_340" xlink:type="arc" order="19" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfLoanDetails" xlink:title="00000061 - Disclosure - SCHEDULE OF LOAN (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AjeshKapoorOneMember" xlink:label="loc_RIMEAjeshKapoorOneMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_RIMEAjeshKapoorOneMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AjeshKapoorTwoMember" xlink:label="loc_RIMEAjeshKapoorTwoMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_RIMEAjeshKapoorTwoMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_VivekSeghalMember" xlink:label="loc_RIMEVivekSeghalMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_RIMEVivekSeghalMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AjeshKapoorThreeMember" xlink:label="loc_RIMEAjeshKapoorThreeMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_RIMEAjeshKapoorThreeMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AjeshKapoorFourMember" xlink:label="loc_RIMEAjeshKapoorFourMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_RIMEAjeshKapoorFourMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember" xlink:label="loc_us-gaapRelatedPartyMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapRelatedPartyMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentIssuanceDate1" xlink:label="loc_us-gaapDebtInstrumentIssuanceDate1_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDebtInstrumentIssuanceDate1_120" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate_120" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_120" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaapNotesPayable_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapNotesPayable_120" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaapNotesPayableCurrent_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapNotesPayableCurrent_120" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermNotesPayable" xlink:label="loc_us-gaapLongTermNotesPayable_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapLongTermNotesPayable_120" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/LoansPayableRelatedPartiesDetailsNarrative" xlink:title="00000062 - Disclosure - LOANS PAYABLE &#8211; RELATED PARTIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember" xlink:label="loc_us-gaapRelatedPartyMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapRelatedPartyMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPayableCurrentAndNoncurrent" xlink:label="loc_us-gaapInterestPayableCurrentAndNoncurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapInterestPayableCurrentAndNoncurrent_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapInterestExpense_40" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000063 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SettlementSumMember" xlink:label="loc_RIMESettlementSumMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_RIMESettlementSumMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_InitialPaymentMember" xlink:label="loc_RIMEInitialPaymentMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_RIMEInitialPaymentMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SecondPaymentMember" xlink:label="loc_RIMESecondPaymentMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_RIMESecondPaymentMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AdditionalPaymentMember" xlink:label="loc_RIMEAdditionalPaymentMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_RIMEAdditionalPaymentMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_PerYearMember" xlink:label="loc_RIMEPerYearMember_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_RIMEPerYearMember_170" xlink:type="arc" order="173" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_TwoSeparateMilestonePaymentMember" xlink:label="loc_RIMETwoSeparateMilestonePaymentMember_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_RIMETwoSeparateMilestonePaymentMember_200" xlink:type="arc" order="204" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_FirstMilestonePaymentMember" xlink:label="loc_RIMEFirstMilestonePaymentMember_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_RIMEFirstMilestonePaymentMember_210" xlink:type="arc" order="214" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SecondMilestonePaymentMember" xlink:label="loc_RIMESecondMilestonePaymentMember_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_RIMESecondMilestonePaymentMember_220" xlink:type="arc" order="224" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_BlueYonderIncMember" xlink:label="loc_RIMEBlueYonderIncMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMEBlueYonderIncMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember_170" xlink:type="arc" order="172" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_110" xlink:type="arc" order="112" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtStatementScenarioAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioForecastMember" xlink:label="loc_srtScenarioForecastMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_srtScenarioForecastMember_120" xlink:type="arc" order="122" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis" xlink:label="loc_us-gaapScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeAndTierIdentifierDomain" xlink:label="loc_us-gaapTypeAndTierIdentifierDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis" xlink:to="loc_us-gaapTypeAndTierIdentifierDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeAndTierIdentifierDomain" xlink:label="loc_us-gaapTypeAndTierIdentifierDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis" xlink:to="loc_us-gaapTypeAndTierIdentifierDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DirectorsAndOfficersLiabilityInsuranceMember" xlink:label="loc_us-gaapDirectorsAndOfficersLiabilityInsuranceMember_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTypeAndTierIdentifierDomain" xlink:to="loc_us-gaapDirectorsAndOfficersLiabilityInsuranceMember_150" xlink:type="arc" order="151" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ServiceContractAndAgreementMember" xlink:label="loc_RIMEServiceContractAndAgreementMember_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMEServiceContractAndAgreementMember_170" xlink:type="arc" order="171" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardDateAxis" xlink:label="loc_us-gaapAwardDateAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardDateAxis" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardDateDomain" xlink:label="loc_us-gaapAwardDateDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardDateAxis" xlink:to="loc_us-gaapAwardDateDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardDateDomain" xlink:label="loc_us-gaapAwardDateDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardDateAxis" xlink:to="loc_us-gaapAwardDateDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DueOnJulyOneTwoThousandTwentyFourMember" xlink:label="loc_RIMEDueOnJulyOneTwoThousandTwentyFourMember_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAwardDateDomain" xlink:to="loc_RIMEDueOnJulyOneTwoThousandTwentyFourMember_200" xlink:type="arc" order="203" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_OctoberOneTwoThousandTwentyFourMember" xlink:label="loc_RIMEOctoberOneTwoThousandTwentyFourMember_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAwardDateDomain" xlink:to="loc_RIMEOctoberOneTwoThousandTwentyFourMember_220" xlink:type="arc" order="223" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_JanuaryOneTwoThousandTwentyFiveMember" xlink:label="loc_RIMEJanuaryOneTwoThousandTwentyFiveMember_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAwardDateDomain" xlink:to="loc_RIMEJanuaryOneTwoThousandTwentyFiveMember_230" xlink:type="arc" order="233" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_WorkingCapital" xlink:label="loc_RIMEWorkingCapital_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_RIMEWorkingCapital_280" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTerm" xlink:label="loc_us-gaapDebtInstrumentTerm_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapDebtInstrumentTerm_280" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfDebt" xlink:label="loc_us-gaapRepaymentsOfDebt_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapRepaymentsOfDebt_280" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_280" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LitigationSettlementExpense" xlink:label="loc_us-gaapLitigationSettlementExpense_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapLitigationSettlementExpense_280" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrentAndNoncurrent_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapAccruedLiabilitiesCurrentAndNoncurrent_280" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_LossContingencyEstimateOfPossibleLossPerYear" xlink:label="loc_RIMELossContingencyEstimateOfPossibleLossPerYear_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_RIMELossContingencyEstimateOfPossibleLossPerYear_280" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:label="loc_us-gaapLossContingencyEstimateOfPossibleLoss_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapLossContingencyEstimateOfPossibleLoss_280" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyDamagesSoughtValue" xlink:label="loc_us-gaapLossContingencyDamagesSoughtValue_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapLossContingencyDamagesSoughtValue_280" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyDamagesAwardedValue" xlink:label="loc_us-gaapLossContingencyDamagesAwardedValue_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapLossContingencyDamagesAwardedValue_280" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyDamagesPaidValue" xlink:label="loc_us-gaapLossContingencyDamagesPaidValue_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapLossContingencyDamagesPaidValue_280" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseExpense" xlink:label="loc_us-gaapOperatingLeaseExpense_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapOperatingLeaseExpense_280" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_InsuranceLiabilities" xlink:label="loc_RIMEInsuranceLiabilities_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_RIMEInsuranceLiabilities_280" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MalpracticeInsuranceMaximumCoveragePerIncident" xlink:label="loc_us-gaapMalpracticeInsuranceMaximumCoveragePerIncident_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapMalpracticeInsuranceMaximumCoveragePerIncident_280" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_PaymentsForMilestone" xlink:label="loc_RIMEPaymentsForMilestone_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_RIMEPaymentsForMilestone_280" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForLegalSettlements" xlink:label="loc_us-gaapPaymentsForLegalSettlements_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapPaymentsForLegalSettlements_280" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapOtherLiabilitiesCurrent_280" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DisputeAmount" xlink:label="loc_RIMEDisputeAmount_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_RIMEDisputeAmount_280" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AccruedPotentialLiability" xlink:label="loc_RIMEAccruedPotentialLiability_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_RIMEAccruedPotentialLiability_280" xlink:type="arc" order="18" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfSupplementalInformationRelatedToLeasesDetails" xlink:title="00000064 - Disclosure - SCHEDULE OF SUPPLEMENTAL INFORMATION RELATED TO LEASES (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfLeaseTermAndDiscountRateDetails" xlink:title="00000065 - Disclosure - SCHEDULE OF LEASE TERM AND DISCOUNT RATE (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfOperatingLeaseMinimumFuturePaymentsDetails" xlink:title="00000066 - Disclosure - SCHEDULE OF OPERATING LEASE MINIMUM FUTURE PAYMENTS (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/OperatingLeasesDetailsNarrative" xlink:title="00000067 - Disclosure - OPERATING LEASES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_OperatingLeaseAgreementMember" xlink:label="loc_RIMEOperatingLeaseAgreementMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMEOperatingLeaseAgreementMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_50" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AreaOfLand" xlink:label="loc_us-gaapAreaOfLand_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapAreaOfLand_100" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseExpirationDate1" xlink:label="loc_us-gaapLeaseExpirationDate1_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapLeaseExpirationDate1_100" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:label="loc_us-gaapLesseeOperatingLeaseOptionToExtend_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseOptionToExtend_100" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasePayments" xlink:label="loc_us-gaapOperatingLeasePayments_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapOperatingLeasePayments_100" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRent" xlink:label="loc_us-gaapPaymentsForRent_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapPaymentsForRent_100" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TenantImprovements" xlink:label="loc_us-gaapTenantImprovements_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapTenantImprovements_100" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/IssuanceOfCommonStockDetailsNarrative" xlink:title="00000068 - Disclosure - ISSUANCE OF COMMON STOCK (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_TwoThousandTwentyTwoPlanMember" xlink:label="loc_RIMETwoThousandTwentyTwoPlanMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_RIMETwoThousandTwentyTwoPlanMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaapGeneralAndAdministrativeExpenseMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapGeneralAndAdministrativeExpenseMember_50" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_110" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_110" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensationForfeited_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensationForfeited_110" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_110" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeBenefitsAndShareBasedCompensation" xlink:label="loc_us-gaapEmployeeBenefitsAndShareBasedCompensation_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapEmployeeBenefitsAndShareBasedCompensation_110" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_110" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_110" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_110" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueRestrictedStockAwardGross_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueRestrictedStockAwardGross_110" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_110" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_110" xlink:type="arc" order="10" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfWarrantsExpirationDetails" xlink:title="00000069 - Disclosure - SCHEDULE OF WARRANTS EXPIRATION (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ExercisePriceRangeOneMember" xlink:label="loc_RIMEExercisePriceRangeOneMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_RIMEExercisePriceRangeOneMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ExercisePriceRangeTwoMember" xlink:label="loc_RIMEExercisePriceRangeTwoMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_RIMEExercisePriceRangeTwoMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingMaturityDate" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingMaturityDate_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingMaturityDate_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding_70" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/WarrantsDetailsNarrative" xlink:title="00000070 - Disclosure - WARRANTS (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfBasicAndDilutiveLossPerShareDetails" xlink:title="00000071 - Disclosure - SCHEDULE OF BASIC AND DILUTIVE LOSS PER SHARE (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ComputationOfLossPerShareDetailsNarrative" xlink:title="00000072 - Disclosure - COMPUTATION OF LOSS PER SHARE (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaapAntidilutiveSecuritiesNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaapAntidilutiveSecuritiesNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="loc_us-gaapAntidilutiveSecuritiesNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaapEmployeeStockOptionMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_us-gaapEmployeeStockOptionMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_us-gaapWarrantMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_CommonStockWarrantsMember" xlink:label="loc_RIMECommonStockWarrantsMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_RIMECommonStockWarrantsMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_PreFundedWarrantsMember" xlink:label="loc_RIMEPreFundedWarrantsMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_RIMEPreFundedWarrantsMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_OptionsAndWarrantsMember" xlink:label="loc_RIMEOptionsAndWarrantsMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_RIMEOptionsAndWarrantsMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_140" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000073 - Disclosure - INCOME TAXES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTable" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapEffectiveIncomeTaxRateReconciliationLineItems" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaapIncomeTaxAuthorityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapEffectiveIncomeTaxRateReconciliationTable" xlink:to="loc_us-gaapIncomeTaxAuthorityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeTaxAuthorityAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeTaxAuthorityAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DomesticCountryMember" xlink:label="loc_us-gaapDomesticCountryMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapDomesticCountryMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="loc_us-gaapStateAndLocalJurisdictionMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapStateAndLocalJurisdictionMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityNameAxis" xlink:label="loc_us-gaapIncomeTaxAuthorityNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapEffectiveIncomeTaxRateReconciliationTable" xlink:to="loc_us-gaapIncomeTaxAuthorityNameAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeTaxAuthorityNameAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeTaxAuthorityNameAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InternalRevenueServiceIRSMember" xlink:label="loc_us-gaapInternalRevenueServiceIRSMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeTaxAuthorityNameDomain" xlink:to="loc_us-gaapInternalRevenueServiceIRSMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEffectiveIncomeTaxRateReconciliationLineItems" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit_100" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaapOperatingLossCarryforwards_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEffectiveIncomeTaxRateReconciliationLineItems" xlink:to="loc_us-gaapOperatingLossCarryforwards_100" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEffectiveIncomeTaxRateReconciliationLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance_100" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfRevenueByProductLineDetails" xlink:title="00000074 - Disclosure - SCHEDULE OF REVENUE BY PRODUCT LINE (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:label="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:label="loc_us-gaapScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_us-gaapScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:to="loc_srtProductOrServiceAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ClassicKaraokeMachinesMember" xlink:label="loc_RIMEClassicKaraokeMachinesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_RIMEClassicKaraokeMachinesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_LicensedProductsMember" xlink:label="loc_RIMELicensedProductsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_RIMELicensedProductsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_KidsYouthElectronicsMember" xlink:label="loc_RIMEKidsYouthElectronicsMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_RIMEKidsYouthElectronicsMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_MicrophonesAndAccessoriesMember" xlink:label="loc_RIMEMicrophonesAndAccessoriesMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_RIMEMicrophonesAndAccessoriesMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_MusicSubscriptionsMember" xlink:label="loc_RIMEMusicSubscriptionsMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_RIMEMusicSubscriptionsMember_160" xlink:type="arc" order="161" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_LogisticsServicesMember" xlink:label="loc_RIMELogisticsServicesMember_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_RIMELogisticsServicesMember_200" xlink:type="arc" order="201" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_KaraokeMachinesMember" xlink:label="loc_RIMEKaraokeMachinesMember_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_RIMEKaraokeMachinesMember_280" xlink:type="arc" order="281" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues_470" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_us-gaapRevenues_470" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfSalesByGeographicalRegionDetails" xlink:title="00000075 - Disclosure - SCHEDULE OF SALES BY GEOGRAPHICAL REGION (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="loc_srtStatementGeographicalAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NorthAmericaMember" xlink:label="loc_srtNorthAmericaMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_srtNorthAmericaMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_AU" xlink:label="loc_countryAU_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryAU_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EuropeMember" xlink:label="loc_srtEuropeMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_srtEuropeMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapRevenues_170" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/RevenueDisaggregationDetailsNarrative" xlink:title="00000076 - Disclosure - REVENUE DISAGGREGATION (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ConcentrationsOfCreditRiskAndRevenueDetailsNarrative" xlink:title="00000077 - Disclosure - CONCENTRATIONS OF CREDIT RISK AND REVENUE (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="loc_us-gaapConcentrationRiskLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTable" xlink:label="loc_us-gaapConcentrationRiskTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskLineItems" xlink:to="loc_us-gaapConcentrationRiskTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaapAccountsReceivableMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapAccountsReceivableMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SalesRevenueMember" xlink:label="loc_RIMESalesRevenueMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_RIMESalesRevenueMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_PurchasesMember" xlink:label="loc_RIMEPurchasesMember_320" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_RIMEPurchasesMember_320" xlink:type="arc" order="321" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaapSalesRevenueNetMember_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapSalesRevenueNetMember_380" xlink:type="arc" order="381" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaapCustomerConcentrationRiskMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapCustomerConcentrationRiskMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ThreeCustomersMember" xlink:label="loc_RIMEThreeCustomersMember_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_RIMEThreeCustomersMember_180" xlink:type="arc" order="182" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_CustomersOneMember" xlink:label="loc_RIMECustomersOneMember_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_RIMECustomersOneMember_220" xlink:type="arc" order="222" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_CustomersTwoMember" xlink:label="loc_RIMECustomersTwoMember_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_RIMECustomersTwoMember_230" xlink:type="arc" order="232" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_CustomersThreeMember" xlink:label="loc_RIMECustomersThreeMember_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_RIMECustomersThreeMember_240" xlink:type="arc" order="242" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeographicConcentrationRiskMember" xlink:label="loc_us-gaapGeographicConcentrationRiskMember_320" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapGeographicConcentrationRiskMember_320" xlink:type="arc" order="322" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_RepublicOfChinaMember" xlink:label="loc_RIMERepublicOfChinaMember_350" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_RIMERepublicOfChinaMember_350" xlink:type="arc" order="351" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis" xlink:label="loc_srtMajorCustomersAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_srtMajorCustomersAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ThreeCustomersMember" xlink:label="loc_RIMEThreeCustomersMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_RIMEThreeCustomersMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_FourCustomersMember" xlink:label="loc_RIMEFourCustomersMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_RIMEFourCustomersMember_10" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_CustomerOneMember" xlink:label="loc_RIMECustomerOneMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_RIMECustomerOneMember_20" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_CustomersTwoMember" xlink:label="loc_RIMECustomersTwoMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_RIMECustomersTwoMember_30" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_CustomersThreeMember" xlink:label="loc_RIMECustomersThreeMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_RIMECustomersThreeMember_40" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_CustomersFourMember" xlink:label="loc_RIMECustomersFourMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_RIMECustomersFourMember_110" xlink:type="arc" order="113" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_CustomersConcentrationRiskMember" xlink:label="loc_RIMECustomersConcentrationRiskMember_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_RIMECustomersConcentrationRiskMember_180" xlink:type="arc" order="183" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_RepublicOfChinaMember" xlink:label="loc_RIMERepublicOfChinaMember_320" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_RIMERepublicOfChinaMember_320" xlink:type="arc" order="323" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_FourMember" xlink:label="loc_RIMEFourMember_360" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_RIMEFourMember_360" xlink:type="arc" order="363" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember_360" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember_360" xlink:type="arc" order="364" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1_410" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1_410" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentDescription" xlink:label="loc_us-gaapDebtInstrumentDescription_410" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskLineItems" xlink:to="loc_us-gaapDebtInstrumentDescription_410" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000078 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaapRelatedPartyTransactionLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember" xlink:label="loc_us-gaapRelatedPartyMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapRelatedPartyMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_StingrayMember" xlink:label="loc_RIMEStingrayMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_RIMEStingrayMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SMCBMember" xlink:label="loc_RIMESMCBMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_RIMESMCBMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AultAllianceIncMember" xlink:label="loc_RIMEAultAllianceIncMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_RIMEAultAllianceIncMember_140" xlink:type="arc" order="141" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AjeshKapoorMember" xlink:label="loc_RIMEAjeshKapoorMember_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_RIMEAjeshKapoorMember_150" xlink:type="arc" order="151" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:label="loc_us-gaapSoftwareAndSoftwareDevelopmentCostsMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapSoftwareAndSoftwareDevelopmentCostsMember_70" xlink:type="arc" order="72" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaapPrivatePlacementMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapPrivatePlacementMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember_150" xlink:type="arc" order="152" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapRevenues_190" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherReceivables" xlink:label="loc_us-gaapOtherReceivables_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapOtherReceivables_190" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilities" xlink:label="loc_us-gaapOtherLiabilities_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapOtherLiabilities_190" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaapProfessionalFees_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapProfessionalFees_190" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction_190" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount_190" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000079 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaapSubsequentEventLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaapSubsequentEventTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSubsequentEventTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SecuritiesPurchaseAgreementMember" xlink:label="loc_RIMESecuritiesPurchaseAgreementMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESecuritiesPurchaseAgreementMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSharePrice_80" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_80" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_80" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction_80" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity_80" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_PercentageOfPurchasersRightToParticipateOnIssuanceCompanyOfCommonStock" xlink:label="loc_RIMEPercentageOfPurchasersRightToParticipateOnIssuanceCompanyOfCommonStock_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_RIMEPercentageOfPurchasersRightToParticipateOnIssuanceCompanyOfCommonStock_80" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_PercentageOfGrossProceeds" xlink:label="loc_RIMEPercentageOfGrossProceeds_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_RIMEPercentageOfGrossProceeds_80" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_80" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount_80" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="loc_us-gaapProceedsFromIssuanceOfDebt_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfDebt_80" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionOriginalDebtAmount1" xlink:label="loc_us-gaapDebtConversionOriginalDebtAmount1_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtConversionOriginalDebtAmount1_80" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateEffectivePercentage_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateEffectivePercentage_80" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="loc_us-gaapDebtInstrumentInterestRateDuringPeriod_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateDuringPeriod_80" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentIssuanceDate1" xlink:label="loc_us-gaapDebtInstrumentIssuanceDate1_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentIssuanceDate1_80" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued_80" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_80" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdvertisingExpense" xlink:label="loc_us-gaapAdvertisingExpense_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapAdvertisingExpense_80" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement" xlink:label="loc_us-gaapIncomeTaxExaminationLikelihoodOfUnfavorableSettlement_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapIncomeTaxExaminationLikelihoodOfUnfavorableSettlement_80" xlink:type="arc" order="17" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000080 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdvertisingExpense" xlink:label="loc_us-gaapAdvertisingExpense_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdvertisingExpense_100" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ReserveForSalesReturn" xlink:label="loc_RIMEReserveForSalesReturn_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMEReserveForSalesReturn_100" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ReturnAssets" xlink:label="loc_RIMEReturnAssets_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMEReturnAssets_100" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ShippingAndHandlingExpenses" xlink:label="loc_RIMEShippingAndHandlingExpenses_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMEShippingAndHandlingExpenses_100" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignFinancialInstitutionsActualDeposits" xlink:label="loc_us-gaapForeignFinancialInstitutionsActualDeposits_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapForeignFinancialInstitutionsActualDeposits_100" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent_100" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapResearchAndDevelopmentExpense_100" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfPropertyAndEquipmentDetails" xlink:title="00000081 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ComputerAndOfficeEquipmentMember" xlink:label="loc_RIMEComputerAndOfficeEquipmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_RIMEComputerAndOfficeEquipmentMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_WarehouseEquipmentMember" xlink:label="loc_RIMEWarehouseEquipmentMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_RIMEWarehouseEquipmentMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_MoldsAndToolingMember" xlink:label="loc_RIMEMoldsAndToolingMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_RIMEMoldsAndToolingMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaapPropertyPlantAndEquipmentUsefulLife_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentUsefulLife_150" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross_150" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_150" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_150" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/PropertyAndEquipmentDetailsNarrative" xlink:title="00000082 - Disclosure - PROPERTY AND EQUIPMENT (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDepreciation_60" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/SummaryOfStockOptionActivityDetails" xlink:title="00000083 - Disclosure - SUMMARY OF STOCK OPTION ACTIVITY (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:label="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:label="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockOptionMember" xlink:label="loc_us-gaapStockOptionMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_us-gaapStockOptionMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_90" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_90" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_90" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_90" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_90" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_90" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_90" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_90" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_90" xlink:type="arc" order="13" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfEmployeeStockOptionsOutstandingDetailsParenthetical" xlink:title="00000084 - Disclosure - SCHEDULE OF EMPLOYEE STOCK OPTIONS OUTSTANDING (Details) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SixCurrentAndThreeFormerDirectorsMember" xlink:label="loc_RIMESixCurrentAndThreeFormerDirectorsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_RIMESixCurrentAndThreeFormerDirectorsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OfficerMember" xlink:label="loc_srtOfficerMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtOfficerMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_EmployeesMember" xlink:label="loc_RIMEEmployeesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_RIMEEmployeesMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_40" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfBasicAndDilutiveSharesDetails" xlink:title="00000085 - Disclosure - SCHEDULE OF BASIC AND DILUTIVE SHARES (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/StockCompensationExpenseDetailsNarrative" xlink:title="00000086 - Disclosure - STOCK COMPENSATION EXPENSE (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_TwoThousandTwentyTwoPlanMember" xlink:label="loc_RIMETwoThousandTwentyTwoPlanMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_RIMETwoThousandTwentyTwoPlanMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_DirectorMember" xlink:label="loc_srtDirectorMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtDirectorMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OfficerMember" xlink:label="loc_srtOfficerMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtOfficerMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_EmployeeMember" xlink:label="loc_RIMEEmployeeMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_RIMEEmployeeMember_70" xlink:type="arc" order="72" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_BoardOfDirectorsChairmanMember" xlink:label="loc_srtBoardOfDirectorsChairmanMember_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtBoardOfDirectorsChairmanMember_130" xlink:type="arc" order="131" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_20" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_30" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockDescriptionOfTransaction" xlink:label="loc_us-gaapSaleOfStockDescriptionOfTransaction_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSaleOfStockDescriptionOfTransaction_230" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_230" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_230" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockOptionPlanExpense" xlink:label="loc_us-gaapStockOptionPlanExpense_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockOptionPlanExpense_230" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_230" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_230" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_230" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_230" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_230" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_230" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_230" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_230" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding_230" xlink:type="arc" order="12" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/PublicOfferingAndNasdaqUplistingDetailsNarrative" xlink:title="00000087 - Disclosure - PUBLIC OFFERING AND NASDAQ UPLISTING (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_UnderwritingAgreementMember" xlink:label="loc_RIMEUnderwritingAgreementMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMEUnderwritingAgreementMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputExercisePriceMember" xlink:label="loc_us-gaapMeasurementInputExercisePriceMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExercisePriceMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="loc_us-gaapMeasurementInputExpectedTermMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedTermMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="loc_us-gaapMeasurementInputPriceVolatilityMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputPriceVolatilityMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="loc_us-gaapMeasurementInputExpectedDividendRateMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedDividendRateMember_50" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="loc_us-gaapMeasurementInputRiskFreeInterestRateMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputRiskFreeInterestRateMember_60" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_80" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_80" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock_80" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForCommissions" xlink:label="loc_us-gaapPaymentsForCommissions_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapPaymentsForCommissions_80" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare_80" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction_80" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_80" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SaleOfStockPercentage" xlink:label="loc_RIMESaleOfStockPercentage_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_RIMESaleOfStockPercentage_80" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_80" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingTerm_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingTerm_80" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaapFairValueAdjustmentOfWarrants_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapFairValueAdjustmentOfWarrants_80" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingMeasurementInput_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingMeasurementInput_80" xlink:type="arc" order="11" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/AtmOfferingDetailsNarrative" xlink:title="00000088 - Disclosure - ATM OFFERING (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaapSubsidiarySaleOfStockLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ATMOfferingMember" xlink:label="loc_RIMEATMOfferingMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_RIMEATMOfferingMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity_40" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/PrivatePlacementDetailsNarrative" xlink:title="00000089 - Disclosure - PRIVATE PLACEMENT (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaapSubsidiarySaleOfStockLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaapPrivatePlacementMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapPrivatePlacementMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity_30" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_TransactionFees" xlink:label="loc_RIMETransactionFees_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_RIMETransactionFees_30" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/August2021StockRedemptionDetailsNarrative" xlink:title="00000090 - Disclosure - AUGUST 2021 STOCK REDEMPTION (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_RedemptionAgreementMember" xlink:label="loc_RIMERedemptionAgreementMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMERedemptionAgreementMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_KonceptsandTreasureGreenMember" xlink:label="loc_RIMEKonceptsandTreasureGreenMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMEKonceptsandTreasureGreenMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodShares" xlink:label="loc_us-gaapStockRedeemedOrCalledDuringPeriodShares_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapStockRedeemedOrCalledDuringPeriodShares_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockAmountIssued1" xlink:label="loc_us-gaapConversionOfStockAmountIssued1_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapConversionOfStockAmountIssued1_30" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfLossBeforeIncomeTaxesDetails" xlink:title="00000091 - Disclosure - SCHEDULE OF LOSS BEFORE INCOME TAXES (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfProvisionForIncomeTaxesDetails" xlink:title="00000092 - Disclosure - SCHEDULE OF PROVISION FOR INCOME TAXES (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:title="00000093 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfTaxProvisionDetails" xlink:title="00000094 - Disclosure - SCHEDULE OF TAX PROVISION (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfRevenueByGeographicalRegionDetails" xlink:title="00000095 - Disclosure - SCHEDULE OF REVENUE BY GEOGRAPHICAL REGION (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementGeographicalAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NorthAmericaMember" xlink:label="loc_srtNorthAmericaMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_srtNorthAmericaMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_AU" xlink:label="loc_countryAU_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryAU_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_EuropeAndUnitedKingdomMember" xlink:label="loc_RIMEEuropeAndUnitedKingdomMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_RIMEEuropeAndUnitedKingdomMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_OthersMember" xlink:label="loc_RIMEOthersMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_RIMEOthersMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenues_160" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/August2021PrivatePlacementDetailsNarrative" xlink:title="00000096 - Disclosure - AUGUST 2021 PRIVATE PLACEMENT (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_PurchaseAgreementMember" xlink:label="loc_RIMEPurchaseAgreementMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMEPurchaseAgreementMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_RedemptionAgreementMember" xlink:label="loc_RIMERedemptionAgreementMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMERedemptionAgreementMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_PreFundedWarrantsMember" xlink:label="loc_RIMEPreFundedWarrantsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_RIMEPreFundedWarrantsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaapPrivatePlacementMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapPrivatePlacementMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_KonceptsandTreasureGreenMember" xlink:label="loc_RIMEKonceptsandTreasureGreenMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMEKonceptsandTreasureGreenMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AGPWarrantsMember" xlink:label="loc_RIMEAGPWarrantsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_RIMEAGPWarrantsMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued_100" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_100" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_100" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_100" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaapProceedsFromWarrantExercises_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromWarrantExercises_100" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockAmountIssued1" xlink:label="loc_us-gaapConversionOfStockAmountIssued1_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConversionOfStockAmountIssued1_100" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRepurchaseOfPrivatePlacement" xlink:label="loc_us-gaapPaymentsForRepurchaseOfPrivatePlacement_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsForRepurchaseOfPrivatePlacement_100" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeDescriptionOfTerms" xlink:label="loc_us-gaapDerivativeDescriptionOfTerms_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDerivativeDescriptionOfTerms_100" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AggregateNumberOfShares" xlink:label="loc_RIMEAggregateNumberOfShares_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMEAggregateNumberOfShares_100" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharePrice_100" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityFairValueDisclosure" xlink:label="loc_us-gaapEquityFairValueDisclosure_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityFairValueDisclosure_100" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SharePrice1" xlink:label="loc_RIMESharePrice1_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMESharePrice1_100" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingTerm_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingTerm_100" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_100" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_100" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_100" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LegalFees" xlink:label="loc_us-gaapLegalFees_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLegalFees_100" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross_100" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueRestrictedStockAwardGross_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueRestrictedStockAwardGross_100" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfStockIssuanceCosts_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsOfStockIssuanceCosts_100" xlink:type="arc" order="19" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/DamagedGoodsIncidentRecoveryDetailsNarrative" xlink:title="00000097 - Disclosure - DAMAGED GOODS INCIDENT RECOVERY (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfOperationsDetails" xlink:title="00000098 - Disclosure - SCHEDULE OF CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfCashFlowsDetails" xlink:title="00000099 - Disclosure - SCHEDULE OF CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfShareholdersEquityDetails" xlink:title="00000100 - Disclosure - SCHEDULE OF CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS? EQUITY (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivablesFromStockholderMember" xlink:label="loc_us-gaapReceivablesFromStockholderMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapReceivablesFromStockholderMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_310" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_310" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfitLoss_310" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_310" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_310" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensation_310" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation_310" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueOther_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueOther_310" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesOther_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesOther_310" xlink:type="arc" order="8" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfEstimatedUsefulLivesDetails" xlink:title="00000101 - Disclosure - SCHEDULE OF ESTIMATED USEFUL LIVES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaapPropertyPlantAndEquipmentUsefulLife_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentUsefulLife_30" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/AccountsReceivableDetailsNarrative" xlink:title="00000102 - Disclosure - ACCOUNTS RECEIVABLE (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNet" xlink:label="loc_us-gaapAccountsReceivableNet_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccountsReceivableNet_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaapProvisionForDoubtfulAccounts_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProvisionForDoubtfulAccounts_50" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/AccountsPayableAndAccruedExpensesDetailsNarrative" xlink:title="00000103 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccountsPayableCurrent_20" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent_20" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfSpecificTermsDetails" xlink:title="00000104 - Disclosure - SCHEDULE OF SPECIFIC TERMS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SixShareholderLoanAgreementsMember" xlink:label="loc_RIMESixShareholderLoanAgreementsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESixShareholderLoanAgreementsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AjeshKapoorMember" xlink:label="loc_RIMEAjeshKapoorMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_RIMEAjeshKapoorMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_VivekSehgalMember" xlink:label="loc_RIMEVivekSehgalMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_RIMEVivekSehgalMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_JaganReddyMember" xlink:label="loc_RIMEJaganReddyMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_RIMEJaganReddyMember_80" xlink:type="arc" order="82" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentIssuanceDate1" xlink:label="loc_us-gaapDebtInstrumentIssuanceDate1_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentIssuanceDate1_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:label="loc_us-gaapDebtInstrumentPeriodicPaymentPrincipal_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentPeriodicPaymentPrincipal_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_130" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentPeriodicPaymentInterest" xlink:label="loc_us-gaapDebtInstrumentPeriodicPaymentInterest_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentPeriodicPaymentInterest_130" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:label="loc_us-gaapDebtInstrumentPeriodicPayment_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentPeriodicPayment_130" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/NotesPayableAndFinaningArrangementsDetailsNarrative" xlink:title="00000105 - Disclosure - NOTES PAYABLE AND FINANING ARRANGEMENTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_EqualInstallmentsForThirteenMonthsMember" xlink:label="loc_RIMEEqualInstallmentsForThirteenMonthsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_RIMEEqualInstallmentsForThirteenMonthsMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_TwelveInstallmentsMember" xlink:label="loc_RIMETwelveInstallmentsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_RIMETwelveInstallmentsMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_FirstPaymentMember" xlink:label="loc_RIMEFirstPaymentMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_RIMEFirstPaymentMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SecondPaymentMember" xlink:label="loc_RIMESecondPaymentMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_RIMESecondPaymentMember_50" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_TenMonthlyPaymentsMember" xlink:label="loc_RIMETenMonthlyPaymentsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_RIMETenMonthlyPaymentsMember_60" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_WeeklyPaymentsForWeeksMember" xlink:label="loc_RIMEWeeklyPaymentsForWeeksMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_RIMEWeeklyPaymentsForWeeksMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_WeeklyPaymentsMember" xlink:label="loc_RIMEWeeklyPaymentsMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_RIMEWeeklyPaymentsMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SettlementAgreementMember" xlink:label="loc_RIMESettlementAgreementMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESettlementAgreementMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_30" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardDateAxis" xlink:label="loc_us-gaapAwardDateAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardDateAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardDateDomain" xlink:label="loc_us-gaapAwardDateDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardDateAxis" xlink:to="loc_us-gaapAwardDateDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardDateDomain" xlink:label="loc_us-gaapAwardDateDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardDateAxis" xlink:to="loc_us-gaapAwardDateDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DueAndPaidOnMayTwentyTwoThousandTwentyFourMember" xlink:label="loc_RIMEDueAndPaidOnMayTwentyTwoThousandTwentyFourMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAwardDateDomain" xlink:to="loc_RIMEDueAndPaidOnMayTwentyTwoThousandTwentyFourMember_40" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DueOnJuneThreeTwoThousandTwentyFourMember" xlink:label="loc_RIMEDueOnJuneThreeTwoThousandTwentyFourMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAwardDateDomain" xlink:to="loc_RIMEDueOnJuneThreeTwoThousandTwentyFourMember_50" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DueOnJulyOneTwoThousandTwentyFourMember" xlink:label="loc_RIMEDueOnJulyOneTwoThousandTwentyFourMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAwardDateDomain" xlink:to="loc_RIMEDueOnJulyOneTwoThousandTwentyFourMember_60" xlink:type="arc" order="63" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMaturityDateDescription" xlink:label="loc_us-gaapDebtInstrumentMaturityDateDescription_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDateDescription_140" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfDebt" xlink:label="loc_us-gaapRepaymentsOfDebt_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRepaymentsOfDebt_140" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_140" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermBorrowings" xlink:label="loc_us-gaapShortTermBorrowings_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShortTermBorrowings_140" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="loc_us-gaapProceedsFromIssuanceOfDebt_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfDebt_140" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateEffectivePercentage_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateEffectivePercentage_140" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/DueFromFactorDetailsNarrative" xlink:title="00000106 - Disclosure - DUE FROM FACTOR (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNet" xlink:label="loc_us-gaapAccountsReceivableNet_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccountsReceivableNet_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ForeignAndDomesticRateOfAccountsReceivable" xlink:label="loc_RIMEForeignAndDomesticRateOfAccountsReceivable_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMEForeignAndDomesticRateOfAccountsReceivable_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AdvanceFeeRate" xlink:label="loc_RIMEAdvanceFeeRate_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMEAdvanceFeeRate_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LegalFees" xlink:label="loc_us-gaapLegalFees_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLegalFees_60" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfStockOptionIssuedDuringYearDecember3120202021And2022Details" xlink:title="00000107 - Disclosure - SCHEDULE OF STOCK OPTION ISSUED DURING THE YEAR DECEMBER 31, 2020, 2021 AND 2022 (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SudhirNarasimhamurthyMember" xlink:label="loc_RIMESudhirNarasimhamurthyMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_RIMESudhirNarasimhamurthyMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_KadandaleSrinivasSudheerMember" xlink:label="loc_RIMEKadandaleSrinivasSudheerMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_RIMEKadandaleSrinivasSudheerMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_VivekSehgalMember" xlink:label="loc_RIMEVivekSehgalMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_RIMEVivekSehgalMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_RajivSaxenaMember" xlink:label="loc_RIMERajivSaxenaMember_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_RIMERajivSaxenaMember_180" xlink:type="arc" order="181" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_HarshaBhatMember" xlink:label="loc_RIMEHarshaBhatMember_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_RIMEHarshaBhatMember_200" xlink:type="arc" order="201" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_JaganReddyMember" xlink:label="loc_RIMEJaganReddyMember_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_RIMEJaganReddyMember_260" xlink:type="arc" order="261" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SiddayyaSGanjalMember" xlink:label="loc_RIMESiddayyaSGanjalMember_320" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_RIMESiddayyaSGanjalMember_320" xlink:type="arc" order="321" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SunilAroraMember" xlink:label="loc_RIMESunilAroraMember_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_RIMESunilAroraMember_380" xlink:type="arc" order="381" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_RajivVirmaniMember" xlink:label="loc_RIMERajivVirmaniMember_400" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_RIMERajivVirmaniMember_400" xlink:type="arc" order="401" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SudhindraShenoyMember" xlink:label="loc_RIMESudhindraShenoyMember_420" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_RIMESudhindraShenoyMember_420" xlink:type="arc" order="421" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AntonySunilMember" xlink:label="loc_RIMEAntonySunilMember_480" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_RIMEAntonySunilMember_480" xlink:type="arc" order="481" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_TuleekaNandyMember" xlink:label="loc_RIMETuleekaNandyMember_540" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_RIMETuleekaNandyMember_540" xlink:type="arc" order="541" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_RobelAtnafuMember" xlink:label="loc_RIMERobelAtnafuMember_580" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_RIMERobelAtnafuMember_580" xlink:type="arc" order="581" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_GuyPrimusMember" xlink:label="loc_RIMEGuyPrimusMember_600" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_RIMEGuyPrimusMember_600" xlink:type="arc" order="601" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SamarthaGowdaMember" xlink:label="loc_RIMESamarthaGowdaMember_620" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_RIMESamarthaGowdaMember_620" xlink:type="arc" order="621" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AlexandraAielloMember" xlink:label="loc_RIMEAlexandraAielloMember_640" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_RIMEAlexandraAielloMember_640" xlink:type="arc" order="641" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_StephenCabralMember" xlink:label="loc_RIMEStephenCabralMember_660" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_RIMEStephenCabralMember_660" xlink:type="arc" order="661" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_JonahPetiPerrinMember" xlink:label="loc_RIMEJonahPetiPerrinMember_680" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_RIMEJonahPetiPerrinMember_680" xlink:type="arc" order="681" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_BryanNellaMember" xlink:label="loc_RIMEBryanNellaMember_700" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_RIMEBryanNellaMember_700" xlink:type="arc" order="701" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_MarkSinkMember" xlink:label="loc_RIMEMarkSinkMember_720" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_RIMEMarkSinkMember_720" xlink:type="arc" order="721" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_KoustavChoudhuriMember" xlink:label="loc_RIMEKoustavChoudhuriMember_740" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_RIMEKoustavChoudhuriMember_740" xlink:type="arc" order="741" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaapDerivativeInstrumentRiskAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockOptionMember" xlink:label="loc_us-gaapStockOptionMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_us-gaapStockOptionMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_790" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_790" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_790" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_790" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TargetedOrTrackingStockIssuanceDates" xlink:label="loc_us-gaapTargetedOrTrackingStockIssuanceDates_790" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTargetedOrTrackingStockIssuanceDates_790" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_790" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_790" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate" xlink:label="loc_RIMEShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_790" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMEShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_790" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_790" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_790" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_790" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_790" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate" xlink:label="loc_RIMEShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_790" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMEShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_790" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate" xlink:label="loc_RIMEShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_790" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMEShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_790" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_790" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_790" xlink:type="arc" order="9" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/StockholdersEquityDetailsNarrative" xlink:title="00000108 - Disclosure - STOCKHOLDERS&#8217; EQUITY (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_FoundersMember" xlink:label="loc_RIMEFoundersMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_RIMEFoundersMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_20" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfFirstTrancheOfSubscriptionsDetails" xlink:title="00000109 - Disclosure - SCHEDULE OF FIRST TRANCHE OF SUBSCRIPTIONS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEOneMember" xlink:label="loc_RIMESAFEOneMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFEOneMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEThirtyEightMember" xlink:label="loc_RIMESAFEThirtyEightMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFEThirtyEightMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEFortyOneMember" xlink:label="loc_RIMESAFEFortyOneMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFEFortyOneMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEFortyTwoMember" xlink:label="loc_RIMESAFEFortyTwoMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFEFortyTwoMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEFortyFourMember" xlink:label="loc_RIMESAFEFortyFourMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFEFortyFourMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEFortyThreeMember" xlink:label="loc_RIMESAFEFortyThreeMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFEFortyThreeMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingAxis" xlink:label="loc_us-gaapVestingAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapVestingAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingDomain" xlink:label="loc_us-gaapVestingDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapVestingAxis" xlink:to="loc_us-gaapVestingDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingDomain" xlink:label="loc_us-gaapVestingDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapVestingAxis" xlink:to="loc_us-gaapVestingDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:label="loc_us-gaapShareBasedCompensationAwardTrancheOneMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapVestingDomain" xlink:to="loc_us-gaapShareBasedCompensationAwardTrancheOneMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ConvertibleHolderName" xlink:label="loc_RIMEConvertibleHolderName_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_RIMEConvertibleHolderName_140" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_InvestmentOfPrincipalAmount" xlink:label="loc_RIMEInvestmentOfPrincipalAmount_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_RIMEInvestmentOfPrincipalAmount_140" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_InvestmentIssueDate" xlink:label="loc_RIMEInvestmentIssueDate_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_RIMEInvestmentIssueDate_140" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ValuationCapitalOfInvestment" xlink:label="loc_RIMEValuationCapitalOfInvestment_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_RIMEValuationCapitalOfInvestment_140" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_InvestmentConvertedDate" xlink:label="loc_RIMEInvestmentConvertedDate_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_RIMEInvestmentConvertedDate_140" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/SummaryOfTerminatedImmediatelyAfterClosingOfTransactionDetails" xlink:title="00000110 - Disclosure - SUMMARY OF TERMINATED IMMEDIATELY AFTER CLOSING OF THE TRANSACTION (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEFortyMember" xlink:label="loc_RIMESAFEFortyMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFEFortyMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEThirtyNineMember" xlink:label="loc_RIMESAFEThirtyNineMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFEThirtyNineMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFETenMember" xlink:label="loc_RIMESAFETenMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFETenMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEElevenMember" xlink:label="loc_RIMESAFEElevenMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFEElevenMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFETwelveMember" xlink:label="loc_RIMESAFETwelveMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFETwelveMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEThirteenMember" xlink:label="loc_RIMESAFEThirteenMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFEThirteenMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEFourteenMember" xlink:label="loc_RIMESAFEFourteenMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFEFourteenMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEFifteenMember" xlink:label="loc_RIMESAFEFifteenMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFEFifteenMember_140" xlink:type="arc" order="141" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFESixteenMember" xlink:label="loc_RIMESAFESixteenMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFESixteenMember_160" xlink:type="arc" order="161" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFESeventeenMember" xlink:label="loc_RIMESAFESeventeenMember_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFESeventeenMember_180" xlink:type="arc" order="181" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEEighteenMember" xlink:label="loc_RIMESAFEEighteenMember_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFEEighteenMember_200" xlink:type="arc" order="201" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFENineteenMember" xlink:label="loc_RIMESAFENineteenMember_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFENineteenMember_220" xlink:type="arc" order="221" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFETwoMember" xlink:label="loc_RIMESAFETwoMember_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFETwoMember_240" xlink:type="arc" order="241" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFETwentyMember" xlink:label="loc_RIMESAFETwentyMember_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFETwentyMember_260" xlink:type="arc" order="261" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFETwentyOneMember" xlink:label="loc_RIMESAFETwentyOneMember_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFETwentyOneMember_280" xlink:type="arc" order="281" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFETwentyTwoMember" xlink:label="loc_RIMESAFETwentyTwoMember_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFETwentyTwoMember_300" xlink:type="arc" order="301" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFETwentyFourMember" xlink:label="loc_RIMESAFETwentyFourMember_320" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFETwentyFourMember_320" xlink:type="arc" order="321" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEThreeMember" xlink:label="loc_RIMESAFEThreeMember_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFEThreeMember_340" xlink:type="arc" order="341" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEFourMember" xlink:label="loc_RIMESAFEFourMember_360" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFEFourMember_360" xlink:type="arc" order="361" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEFortyFiveMember" xlink:label="loc_RIMESAFEFortyFiveMember_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFEFortyFiveMember_380" xlink:type="arc" order="381" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFESixMember" xlink:label="loc_RIMESAFESixMember_400" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFESixMember_400" xlink:type="arc" order="401" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFESevenMember" xlink:label="loc_RIMESAFESevenMember_420" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFESevenMember_420" xlink:type="arc" order="421" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEEightMember" xlink:label="loc_RIMESAFEEightMember_440" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFEEightMember_440" xlink:type="arc" order="441" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFENineMember" xlink:label="loc_RIMESAFENineMember_460" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFENineMember_460" xlink:type="arc" order="461" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEFiveMember" xlink:label="loc_RIMESAFEFiveMember_480" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFEFiveMember_480" xlink:type="arc" order="481" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFETwentyFiveMember" xlink:label="loc_RIMESAFETwentyFiveMember_500" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFETwentyFiveMember_500" xlink:type="arc" order="501" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFETwentySixMember" xlink:label="loc_RIMESAFETwentySixMember_520" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFETwentySixMember_520" xlink:type="arc" order="521" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFETwentySevenMember" xlink:label="loc_RIMESAFETwentySevenMember_540" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFETwentySevenMember_540" xlink:type="arc" order="541" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFETwentyEightMember" xlink:label="loc_RIMESAFETwentyEightMember_560" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFETwentyEightMember_560" xlink:type="arc" order="561" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFETwentyNineMember" xlink:label="loc_RIMESAFETwentyNineMember_580" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFETwentyNineMember_580" xlink:type="arc" order="581" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEThirtyMember" xlink:label="loc_RIMESAFEThirtyMember_600" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFEThirtyMember_600" xlink:type="arc" order="601" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEThirtyOneMember" xlink:label="loc_RIMESAFEThirtyOneMember_620" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFEThirtyOneMember_620" xlink:type="arc" order="621" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEThirtyTwoMember" xlink:label="loc_RIMESAFEThirtyTwoMember_640" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFEThirtyTwoMember_640" xlink:type="arc" order="641" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEThirtyThreeMember" xlink:label="loc_RIMESAFEThirtyThreeMember_660" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFEThirtyThreeMember_660" xlink:type="arc" order="661" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEThirtyFourMember" xlink:label="loc_RIMESAFEThirtyFourMember_680" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFEThirtyFourMember_680" xlink:type="arc" order="681" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEThirtyFiveMember" xlink:label="loc_RIMESAFEThirtyFiveMember_700" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFEThirtyFiveMember_700" xlink:type="arc" order="701" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEThirtySixMember" xlink:label="loc_RIMESAFEThirtySixMember_720" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFEThirtySixMember_720" xlink:type="arc" order="721" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEThirtySevenMember" xlink:label="loc_RIMESAFEThirtySevenMember_740" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFEThirtySevenMember_740" xlink:type="arc" order="741" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEFortySixMember" xlink:label="loc_RIMESAFEFortySixMember_760" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFEFortySixMember_760" xlink:type="arc" order="761" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEFiftyMember" xlink:label="loc_RIMESAFEFiftyMember_780" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFEFiftyMember_780" xlink:type="arc" order="781" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEFortyEightMember" xlink:label="loc_RIMESAFEFortyEightMember_800" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFEFortyEightMember_800" xlink:type="arc" order="801" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEFortySevenMember" xlink:label="loc_RIMESAFEFortySevenMember_820" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFEFortySevenMember_820" xlink:type="arc" order="821" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEFortyNineMember" xlink:label="loc_RIMESAFEFortyNineMember_840" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFEFortyNineMember_840" xlink:type="arc" order="841" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEFiftyOneMember" xlink:label="loc_RIMESAFEFiftyOneMember_860" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFEFiftyOneMember_860" xlink:type="arc" order="861" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ConvertibleHolderName" xlink:label="loc_RIMEConvertibleHolderName_900" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_RIMEConvertibleHolderName_900" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_InvestmentOfPrincipalAmount" xlink:label="loc_RIMEInvestmentOfPrincipalAmount_900" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_RIMEInvestmentOfPrincipalAmount_900" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_InvestmentIssueDate" xlink:label="loc_RIMEInvestmentIssueDate_900" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_RIMEInvestmentIssueDate_900" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ValuationCapitalOfInvestment" xlink:label="loc_RIMEValuationCapitalOfInvestment_900" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_RIMEValuationCapitalOfInvestment_900" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://algoholdings.com/role/SafePrivatePlacementsDetailsNarrative" xlink:title="00000111 - Disclosure - SAFE PRIVATE PLACEMENTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEAgreementsMember" xlink:label="loc_RIMESAFEAgreementsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFEAgreementsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_FortyFourSAFEAgreementsMember" xlink:label="loc_RIMEFortyFourSAFEAgreementsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMEFortyFourSAFEAgreementsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingAxis" xlink:label="loc_us-gaapVestingAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapVestingAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingDomain" xlink:label="loc_us-gaapVestingDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapVestingAxis" xlink:to="loc_us-gaapVestingDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingDomain" xlink:label="loc_us-gaapVestingDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapVestingAxis" xlink:to="loc_us-gaapVestingDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:label="loc_us-gaapShareBasedCompensationAwardTrancheOneMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapVestingDomain" xlink:to="loc_us-gaapShareBasedCompensationAwardTrancheOneMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:label="loc_us-gaapShareBasedCompensationAwardTrancheTwoMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapVestingDomain" xlink:to="loc_us-gaapShareBasedCompensationAwardTrancheTwoMember_50" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Investments" xlink:label="loc_us-gaapInvestments_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapInvestments_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_InvestedValuationOfAmount" xlink:label="loc_RIMEInvestedValuationOfAmount_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_RIMEInvestedValuationOfAmount_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount_70" xlink:type="arc" order="2" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>19
<FILENAME>rime-20240930_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="dei_EntityAddressesAddressTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_EntityAddressesAddressTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressesAddressTypeAxis_lbl" xml:lang="en-US">Entity Addresses, Address Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_BusinessContactMember" xlink:label="dei_BusinessContactMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_BusinessContactMember" xlink:to="dei_BusinessContactMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_BusinessContactMember_lbl" xml:lang="en-US">Business Contact [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US">Related and Nonrelated Parties [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonrelatedPartyMember" xlink:label="us-gaap_NonrelatedPartyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonrelatedPartyMember" xlink:to="us-gaap_NonrelatedPartyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonrelatedPartyMember_lbl" xml:lang="en-US">Nonrelated Party [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember" xlink:label="us-gaap_RelatedPartyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyMember" xlink:to="us-gaap_RelatedPartyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyMember_lbl" xml:lang="en-US">Related Party [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LegalEntityAxis_lbl" xml:lang="en-US">Legal Entity [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="RIME_SemiCabIncMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SemiCabIncMember" xlink:to="RIME_SemiCabIncMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_SemiCabIncMember_lbl" xml:lang="en-US">Semi Cab Inc [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivablesFromStockholderMember" xlink:label="us-gaap_ReceivablesFromStockholderMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReceivablesFromStockholderMember" xlink:to="us-gaap_ReceivablesFromStockholderMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ReceivablesFromStockholderMember_lbl" xml:lang="en-US">Receivables from Stockholder [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="us-gaap_NoncontrollingInterestMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncontrollingInterestMember" xlink:to="us-gaap_NoncontrollingInterestMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncontrollingInterestMember_lbl" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Retained Earnings [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AtTheMarketSalesAgreementMember" xlink:label="RIME_AtTheMarketSalesAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_AtTheMarketSalesAgreementMember" xlink:to="RIME_AtTheMarketSalesAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_AtTheMarketSalesAgreementMember_lbl" xml:lang="en-US">At The Market Sales Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AtTheMarketSalesAgreementAmendmentOneMember" xlink:label="RIME_AtTheMarketSalesAgreementAmendmentOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_AtTheMarketSalesAgreementAmendmentOneMember" xlink:to="RIME_AtTheMarketSalesAgreementAmendmentOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_AtTheMarketSalesAgreementAmendmentOneMember_lbl" xml:lang="en-US">At The Market Sales Agreement Amendment One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AtTheMarketSalesAgreementAmendmentTwoMember" xlink:label="RIME_AtTheMarketSalesAgreementAmendmentTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_AtTheMarketSalesAgreementAmendmentTwoMember" xlink:to="RIME_AtTheMarketSalesAgreementAmendmentTwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_AtTheMarketSalesAgreementAmendmentTwoMember_lbl" xml:lang="en-US">At The Market Sales Agreement Amendment Two [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US">Subsequent Event [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AssetPurchaseAgreementMember" xlink:label="RIME_AssetPurchaseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_AssetPurchaseAgreementMember" xlink:to="RIME_AssetPurchaseAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_AssetPurchaseAgreementMember_lbl" xml:lang="en-US">Asset Purchase Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl" xml:lang="en-US">Investment, Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabLLCMember" xlink:label="RIME_SemiCabLLCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SemiCabLLCMember" xlink:to="RIME_SemiCabLLCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_SemiCabLLCMember_lbl" xml:lang="en-US">Semi Cab LLC [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionAxis_lbl" xml:lang="en-US">Business Acquisition [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_LeaseAgreementMember" xlink:label="RIME_LeaseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_LeaseAgreementMember" xlink:to="RIME_LeaseAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_LeaseAgreementMember_lbl" xml:lang="en-US">Lease Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SettlementAgreementMember" xlink:label="RIME_SettlementAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SettlementAgreementMember" xlink:to="RIME_SettlementAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_SettlementAgreementMember_lbl" xml:lang="en-US">Settlement Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xml:lang="en-US">Sale of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrivatePlacementMember" xlink:to="us-gaap_PrivatePlacementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrivatePlacementMember_lbl" xml:lang="en-US">Private Placement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SecuritiesPurchaseAgreementMember" xlink:label="RIME_SecuritiesPurchaseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SecuritiesPurchaseAgreementMember" xlink:to="RIME_SecuritiesPurchaseAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_SecuritiesPurchaseAgreementMember_lbl" xml:lang="en-US">Securities Purchase Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityAxis" xlink:label="us-gaap_CreditFacilityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CreditFacilityAxis_lbl" xml:lang="en-US">Credit Facility [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="us-gaap_RevolvingCreditFacilityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevolvingCreditFacilityMember" xlink:to="us-gaap_RevolvingCreditFacilityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevolvingCreditFacilityMember_lbl" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_LoanAgreementMember" xlink:label="RIME_LoanAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_LoanAgreementMember" xlink:to="RIME_LoanAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_LoanAgreementMember_lbl" xml:lang="en-US">Loan Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_StockRepurchaseAgreementMember" xlink:label="RIME_StockRepurchaseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_StockRepurchaseAgreementMember" xlink:to="RIME_StockRepurchaseAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_StockRepurchaseAgreementMember_lbl" xml:lang="en-US">Stock Repurchase Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ATMOfferingMember" xlink:label="RIME_ATMOfferingMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_ATMOfferingMember" xlink:to="RIME_ATMOfferingMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_ATMOfferingMember_lbl" xml:lang="en-US">ATM Offering [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionAxis" xlink:label="us-gaap_AssetAcquisitionAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetAcquisitionAxis" xlink:to="us-gaap_AssetAcquisitionAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetAcquisitionAxis_lbl" xml:lang="en-US">Asset Acquisition [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_StatementScenarioAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementScenarioAxis_lbl" xml:lang="en-US">Scenario [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_TwoThousandTwentyFourMember" xlink:label="RIME_TwoThousandTwentyFourMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_TwoThousandTwentyFourMember" xlink:to="RIME_TwoThousandTwentyFourMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_TwoThousandTwentyFourMember_lbl" xml:lang="en-US">2024 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_TitleOfIndividualAxis_lbl" xml:lang="en-US">Title and Position [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AjeshKapoorMember" xlink:label="RIME_AjeshKapoorMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_AjeshKapoorMember" xlink:to="RIME_AjeshKapoorMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_AjeshKapoorMember_lbl" xml:lang="en-US">Ajesh Kapoor [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_EmploymentAgreementsMember" xlink:label="RIME_EmploymentAgreementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_EmploymentAgreementsMember" xlink:to="RIME_EmploymentAgreementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_EmploymentAgreementsMember_lbl" xml:lang="en-US">Employment Agreements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_TwoThousandTwentyFiveMember" xlink:label="RIME_TwoThousandTwentyFiveMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_TwoThousandTwentyFiveMember" xlink:to="RIME_TwoThousandTwentyFiveMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_TwoThousandTwentyFiveMember_lbl" xml:lang="en-US">2025 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SubsequentYearsMember" xlink:label="RIME_SubsequentYearsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SubsequentYearsMember" xlink:to="RIME_SubsequentYearsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_SubsequentYearsMember_lbl" xml:lang="en-US">Subsequent Years [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_VivekSehgalKapoorMember" xlink:label="RIME_VivekSehgalKapoorMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_VivekSehgalKapoorMember" xlink:to="RIME_VivekSehgalKapoorMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_VivekSehgalKapoorMember_lbl" xml:lang="en-US">Vivek Sehgal Kapoor [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_TwoThousandTwentySixMember" xlink:label="RIME_TwoThousandTwentySixMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_TwoThousandTwentySixMember" xlink:to="RIME_TwoThousandTwentySixMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_TwoThousandTwentySixMember_lbl" xml:lang="en-US">2026 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_TwoThousandTwentySevenMember" xlink:label="RIME_TwoThousandTwentySevenMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_TwoThousandTwentySevenMember" xlink:to="RIME_TwoThousandTwentySevenMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_TwoThousandTwentySevenMember_lbl" xml:lang="en-US">2027 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_TwoThousandTwentyEightMember" xlink:label="RIME_TwoThousandTwentyEightMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_TwoThousandTwentyEightMember" xlink:to="RIME_TwoThousandTwentyEightMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_TwoThousandTwentyEightMember_lbl" xml:lang="en-US">2028 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AlgorhythmHoldingsIncMember" xlink:label="RIME_AlgorhythmHoldingsIncMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_AlgorhythmHoldingsIncMember" xlink:to="RIME_AlgorhythmHoldingsIncMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_AlgorhythmHoldingsIncMember_lbl" xml:lang="en-US">Algorhythm Holdings Inc [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeAxis_lbl" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MinimumMember_lbl" xml:lang="en-US">Minimum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MaximumMember_lbl" xml:lang="en-US">Maximum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="us-gaap_CustomerRelationshipsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerRelationshipsMember" xlink:to="us-gaap_CustomerRelationshipsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CustomerRelationshipsMember_lbl" xml:lang="en-US">Customer Relationships [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TradeNamesMember" xlink:label="us-gaap_TradeNamesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TradeNamesMember" xlink:to="us-gaap_TradeNamesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TradeNamesMember_lbl" xml:lang="en-US">Trade Names [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DevelopedTechnologyRightsMember" xlink:label="us-gaap_DevelopedTechnologyRightsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DevelopedTechnologyRightsMember" xlink:to="us-gaap_DevelopedTechnologyRightsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DevelopedTechnologyRightsMember_lbl" xml:lang="en-US">Developed Technology Rights [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_RevolvingLoanAmendmentMember" xlink:label="RIME_RevolvingLoanAmendmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_RevolvingLoanAmendmentMember" xlink:to="RIME_RevolvingLoanAmendmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_RevolvingLoanAmendmentMember_lbl" xml:lang="en-US">Revolving Loan Amendment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="us-gaap_ShortTermDebtTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ShortTermDebtTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermDebtTypeAxis_lbl" xml:lang="en-US">Short-Term Debt, Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AgileCapilalFundingllcMember" xlink:label="RIME_AgileCapilalFundingllcMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_AgileCapilalFundingllcMember" xlink:to="RIME_AgileCapilalFundingllcMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_AgileCapilalFundingllcMember_lbl" xml:lang="en-US">Agile Capilal Fundingllc [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_CedarAdvancellcMember" xlink:label="RIME_CedarAdvancellcMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_CedarAdvancellcMember" xlink:to="RIME_CedarAdvancellcMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_CedarAdvancellcMember_lbl" xml:lang="en-US">Cedar Advancellc [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabInvestorMember" xlink:label="RIME_SemiCabInvestorMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SemiCabInvestorMember" xlink:to="RIME_SemiCabInvestorMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_SemiCabInvestorMember_lbl" xml:lang="en-US">Semi Cab Investor [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_TwoYearCreditAndSecurityAgreementMember" xlink:label="RIME_TwoYearCreditAndSecurityAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_TwoYearCreditAndSecurityAgreementMember" xlink:to="RIME_TwoYearCreditAndSecurityAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_TwoYearCreditAndSecurityAgreementMember_lbl" xml:lang="en-US">Two Year Credit and Security Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_TwoYearLoanAndSecurityAgreementMember" xlink:label="RIME_TwoYearLoanAndSecurityAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_TwoYearLoanAndSecurityAgreementMember" xlink:to="RIME_TwoYearLoanAndSecurityAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_TwoYearLoanAndSecurityAgreementMember_lbl" xml:lang="en-US">Two-Year Loan and Security Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_CreditAndSecurityAgreementsMember" xlink:label="RIME_CreditAndSecurityAgreementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_CreditAndSecurityAgreementsMember" xlink:to="RIME_CreditAndSecurityAgreementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_CreditAndSecurityAgreementsMember_lbl" xml:lang="en-US">Credit and Security Agreements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AjeshKapoorOneMember" xlink:label="RIME_AjeshKapoorOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_AjeshKapoorOneMember" xlink:to="RIME_AjeshKapoorOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_AjeshKapoorOneMember_lbl" xml:lang="en-US">Ajesh Kapoor One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AjeshKapoorTwoMember" xlink:label="RIME_AjeshKapoorTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_AjeshKapoorTwoMember" xlink:to="RIME_AjeshKapoorTwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_AjeshKapoorTwoMember_lbl" xml:lang="en-US">Ajesh Kapoor Two [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_VivekSeghalMember" xlink:label="RIME_VivekSeghalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_VivekSeghalMember" xlink:to="RIME_VivekSeghalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_VivekSeghalMember_lbl" xml:lang="en-US">Vivek Seghal [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AjeshKapoorThreeMember" xlink:label="RIME_AjeshKapoorThreeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_AjeshKapoorThreeMember" xlink:to="RIME_AjeshKapoorThreeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_AjeshKapoorThreeMember_lbl" xml:lang="en-US">Ajesh Kapoor Three [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AjeshKapoorFourMember" xlink:label="RIME_AjeshKapoorFourMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_AjeshKapoorFourMember" xlink:to="RIME_AjeshKapoorFourMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_AjeshKapoorFourMember_lbl" xml:lang="en-US">Ajesh Kapoor Four [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US">Award Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SettlementSumMember" xlink:label="RIME_SettlementSumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SettlementSumMember" xlink:to="RIME_SettlementSumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_SettlementSumMember_lbl" xml:lang="en-US">Settlement Sum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_InitialPaymentMember" xlink:label="RIME_InitialPaymentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_InitialPaymentMember" xlink:to="RIME_InitialPaymentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_InitialPaymentMember_lbl" xml:lang="en-US">Initial Payment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SecondPaymentMember" xlink:label="RIME_SecondPaymentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SecondPaymentMember" xlink:to="RIME_SecondPaymentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_SecondPaymentMember_lbl" xml:lang="en-US">Second Payment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AdditionalPaymentMember" xlink:label="RIME_AdditionalPaymentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_AdditionalPaymentMember" xlink:to="RIME_AdditionalPaymentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_AdditionalPaymentMember_lbl" xml:lang="en-US">Additional Payment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_BlueYonderIncMember" xlink:label="RIME_BlueYonderIncMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_BlueYonderIncMember" xlink:to="RIME_BlueYonderIncMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_BlueYonderIncMember_lbl" xml:lang="en-US">Blue Yonder Inc [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioForecastMember" xlink:label="srt_ScenarioForecastMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioForecastMember" xlink:to="srt_ScenarioForecastMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScenarioForecastMember_lbl" xml:lang="en-US">Forecast [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis" xlink:label="us-gaap_ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis" xlink:to="us-gaap_ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis_lbl" xml:lang="en-US">Insurance Type and Tier Identifier [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DirectorsAndOfficersLiabilityInsuranceMember" xlink:label="us-gaap_DirectorsAndOfficersLiabilityInsuranceMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DirectorsAndOfficersLiabilityInsuranceMember" xlink:to="us-gaap_DirectorsAndOfficersLiabilityInsuranceMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DirectorsAndOfficersLiabilityInsuranceMember_lbl" xml:lang="en-US">Directors and Officers Liability Insurance [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ServiceContractAndAgreementMember" xlink:label="RIME_ServiceContractAndAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_ServiceContractAndAgreementMember" xlink:to="RIME_ServiceContractAndAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_ServiceContractAndAgreementMember_lbl" xml:lang="en-US">Service Contract And Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_PerYearMember" xlink:label="RIME_PerYearMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_PerYearMember" xlink:to="RIME_PerYearMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_PerYearMember_lbl" xml:lang="en-US">Per Year [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardDateAxis" xlink:label="us-gaap_AwardDateAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardDateAxis" xlink:to="us-gaap_AwardDateAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardDateAxis_lbl" xml:lang="en-US">Award Date [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DueOnJulyOneTwoThousandTwentyFourMember" xlink:label="RIME_DueOnJulyOneTwoThousandTwentyFourMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_DueOnJulyOneTwoThousandTwentyFourMember" xlink:to="RIME_DueOnJulyOneTwoThousandTwentyFourMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_DueOnJulyOneTwoThousandTwentyFourMember_lbl" xml:lang="en-US">Due on July 1, 2024 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_TwoSeparateMilestonePaymentMember" xlink:label="RIME_TwoSeparateMilestonePaymentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_TwoSeparateMilestonePaymentMember" xlink:to="RIME_TwoSeparateMilestonePaymentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_TwoSeparateMilestonePaymentMember_lbl" xml:lang="en-US">Two Separate Milestone Payment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_FirstMilestonePaymentMember" xlink:label="RIME_FirstMilestonePaymentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_FirstMilestonePaymentMember" xlink:to="RIME_FirstMilestonePaymentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_FirstMilestonePaymentMember_lbl" xml:lang="en-US">First Milestone Payment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_OctoberOneTwoThousandTwentyFourMember" xlink:label="RIME_OctoberOneTwoThousandTwentyFourMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_OctoberOneTwoThousandTwentyFourMember" xlink:to="RIME_OctoberOneTwoThousandTwentyFourMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_OctoberOneTwoThousandTwentyFourMember_lbl" xml:lang="en-US">October 1 2024 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SecondMilestonePaymentMember" xlink:label="RIME_SecondMilestonePaymentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SecondMilestonePaymentMember" xlink:to="RIME_SecondMilestonePaymentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_SecondMilestonePaymentMember_lbl" xml:lang="en-US">Second Milestone Payment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_JanuaryOneTwoThousandTwentyFiveMember" xlink:label="RIME_JanuaryOneTwoThousandTwentyFiveMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_JanuaryOneTwoThousandTwentyFiveMember" xlink:to="RIME_JanuaryOneTwoThousandTwentyFiveMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_JanuaryOneTwoThousandTwentyFiveMember_lbl" xml:lang="en-US">January 1, 2025 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_OperatingLeaseAgreementMember" xlink:label="RIME_OperatingLeaseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_OperatingLeaseAgreementMember" xlink:to="RIME_OperatingLeaseAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_OperatingLeaseAgreementMember_lbl" xml:lang="en-US">Operating Lease Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PlanNameAxis_lbl" xml:lang="en-US">Plan Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_TwoThousandTwentyTwoPlanMember" xlink:label="RIME_TwoThousandTwentyTwoPlanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_TwoThousandTwentyTwoPlanMember" xlink:to="RIME_TwoThousandTwentyTwoPlanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_TwoThousandTwentyTwoPlanMember_lbl" xml:lang="en-US">2022 Plan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xml:lang="en-US">Statement of Income Location, Balance [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lbl" xml:lang="en-US">Exercise Price Range [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ExercisePriceRangeOneMember" xlink:label="RIME_ExercisePriceRangeOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_ExercisePriceRangeOneMember" xlink:to="RIME_ExercisePriceRangeOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_ExercisePriceRangeOneMember_lbl" xml:lang="en-US">Exercise Price Range One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ExercisePriceRangeTwoMember" xlink:label="RIME_ExercisePriceRangeTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_ExercisePriceRangeTwoMember" xlink:to="RIME_ExercisePriceRangeTwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_ExercisePriceRangeTwoMember_lbl" xml:lang="en-US">Exercise Price Range Two [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantMember_lbl" xml:lang="en-US">Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_CommonStockWarrantsMember" xlink:label="RIME_CommonStockWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_CommonStockWarrantsMember" xlink:to="RIME_CommonStockWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_CommonStockWarrantsMember_lbl" xml:lang="en-US">Common Stock Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_PreFundedWarrantsMember" xlink:label="RIME_PreFundedWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_PreFundedWarrantsMember" xlink:to="RIME_PreFundedWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_PreFundedWarrantsMember_lbl" xml:lang="en-US">Pre Funded Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_OptionsAndWarrantsMember" xlink:label="RIME_OptionsAndWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_OptionsAndWarrantsMember" xlink:to="RIME_OptionsAndWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_OptionsAndWarrantsMember_lbl" xml:lang="en-US">Options and Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxAuthorityAxis_lbl" xml:lang="en-US">Income Tax Jurisdiction [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DomesticCountryMember" xlink:to="us-gaap_DomesticCountryMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DomesticCountryMember_lbl" xml:lang="en-US">Domestic Tax Jurisdiction [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityNameAxis" xlink:label="us-gaap_IncomeTaxAuthorityNameAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="us-gaap_IncomeTaxAuthorityNameAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxAuthorityNameAxis_lbl" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InternalRevenueServiceIRSMember" xlink:label="us-gaap_InternalRevenueServiceIRSMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InternalRevenueServiceIRSMember" xlink:to="us-gaap_InternalRevenueServiceIRSMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InternalRevenueServiceIRSMember_lbl" xml:lang="en-US">Internal Revenue Service (IRS) [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StateAndLocalJurisdictionMember" xlink:to="us-gaap_StateAndLocalJurisdictionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StateAndLocalJurisdictionMember_lbl" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductOrServiceAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ProductOrServiceAxis_lbl" xml:lang="en-US">Product and Service [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ClassicKaraokeMachinesMember" xlink:label="RIME_ClassicKaraokeMachinesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_ClassicKaraokeMachinesMember" xlink:to="RIME_ClassicKaraokeMachinesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_ClassicKaraokeMachinesMember_lbl" xml:lang="en-US">Classic Karaoke Machines [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_LicensedProductsMember" xlink:label="RIME_LicensedProductsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_LicensedProductsMember" xlink:to="RIME_LicensedProductsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_LicensedProductsMember_lbl" xml:lang="en-US">Licensed Products [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_KidsYouthElectronicsMember" xlink:label="RIME_KidsYouthElectronicsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_KidsYouthElectronicsMember" xlink:to="RIME_KidsYouthElectronicsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_KidsYouthElectronicsMember_lbl" xml:lang="en-US">Kids Youth Electronics [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_MicrophonesAndAccessoriesMember" xlink:label="RIME_MicrophonesAndAccessoriesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_MicrophonesAndAccessoriesMember" xlink:to="RIME_MicrophonesAndAccessoriesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_MicrophonesAndAccessoriesMember_lbl" xml:lang="en-US">Microphones and Accessories [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_MusicSubscriptionsMember" xlink:label="RIME_MusicSubscriptionsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_MusicSubscriptionsMember" xlink:to="RIME_MusicSubscriptionsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_MusicSubscriptionsMember_lbl" xml:lang="en-US">Music Subscriptions [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_LogisticsServicesMember" xlink:label="RIME_LogisticsServicesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_LogisticsServicesMember" xlink:to="RIME_LogisticsServicesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_LogisticsServicesMember_lbl" xml:lang="en-US">Logistics Services [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_KaraokeMachinesMember" xlink:label="RIME_KaraokeMachinesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_KaraokeMachinesMember" xlink:to="RIME_KaraokeMachinesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_KaraokeMachinesMember_lbl" xml:lang="en-US">Karaoke Machines [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_StatementGeographicalAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementGeographicalAxis_lbl" xml:lang="en-US">Geographical [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NorthAmericaMember" xlink:label="srt_NorthAmericaMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_NorthAmericaMember" xlink:to="srt_NorthAmericaMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_NorthAmericaMember_lbl" xml:lang="en-US">North America [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_AU" xlink:label="country_AU" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_AU" xlink:to="country_AU_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_AU_lbl" xml:lang="en-US">AUSTRALIA</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EuropeMember" xlink:label="srt_EuropeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_EuropeMember" xlink:to="srt_EuropeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_EuropeMember_lbl" xml:lang="en-US">Europe [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableMember" xlink:label="us-gaap_AccountsReceivableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableMember" xlink:to="us-gaap_AccountsReceivableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableMember_lbl" xml:lang="en-US">Accounts Receivable [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByTypeAxis_lbl" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="us-gaap_CustomerConcentrationRiskMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerConcentrationRiskMember" xlink:to="us-gaap_CustomerConcentrationRiskMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CustomerConcentrationRiskMember_lbl" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis" xlink:label="srt_MajorCustomersAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_MajorCustomersAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MajorCustomersAxis_lbl" xml:lang="en-US">Customer [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ThreeCustomersMember" xlink:label="RIME_ThreeCustomersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_ThreeCustomersMember" xlink:to="RIME_ThreeCustomersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_ThreeCustomersMember_lbl" xml:lang="en-US">Three Customers [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_FourCustomersMember" xlink:label="RIME_FourCustomersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_FourCustomersMember" xlink:to="RIME_FourCustomersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_FourCustomersMember_lbl" xml:lang="en-US">Four Customers [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SalesRevenueMember" xlink:label="RIME_SalesRevenueMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SalesRevenueMember" xlink:to="RIME_SalesRevenueMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_SalesRevenueMember_lbl" xml:lang="en-US">Sales Revenue [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_CustomerOneMember" xlink:label="RIME_CustomerOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_CustomerOneMember" xlink:to="RIME_CustomerOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_CustomerOneMember_lbl" xml:lang="en-US">Customer One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_CustomersTwoMember" xlink:label="RIME_CustomersTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_CustomersTwoMember" xlink:to="RIME_CustomersTwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_CustomersTwoMember_lbl" xml:lang="en-US">Customers Two [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_CustomersThreeMember" xlink:label="RIME_CustomersThreeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_CustomersThreeMember" xlink:to="RIME_CustomersThreeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_CustomersThreeMember_lbl" xml:lang="en-US">Customers Three [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_CustomersFourMember" xlink:label="RIME_CustomersFourMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_CustomersFourMember" xlink:to="RIME_CustomersFourMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_CustomersFourMember_lbl" xml:lang="en-US">Customers Four [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_CustomersConcentrationRiskMember" xlink:label="RIME_CustomersConcentrationRiskMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_CustomersConcentrationRiskMember" xlink:to="RIME_CustomersConcentrationRiskMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_CustomersConcentrationRiskMember_lbl" xml:lang="en-US">Customers concentration risk [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_CustomersOneMember" xlink:label="RIME_CustomersOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_CustomersOneMember" xlink:to="RIME_CustomersOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_CustomersOneMember_lbl" xml:lang="en-US">Customers One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_PurchasesMember" xlink:label="RIME_PurchasesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_PurchasesMember" xlink:to="RIME_PurchasesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_PurchasesMember_lbl" xml:lang="en-US">Purchases [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeographicConcentrationRiskMember" xlink:label="us-gaap_GeographicConcentrationRiskMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeographicConcentrationRiskMember" xlink:to="us-gaap_GeographicConcentrationRiskMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeographicConcentrationRiskMember_lbl" xml:lang="en-US">Geographic Concentration Risk [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_RepublicOfChinaMember" xlink:label="RIME_RepublicOfChinaMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_RepublicOfChinaMember" xlink:to="RIME_RepublicOfChinaMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_RepublicOfChinaMember_lbl" xml:lang="en-US">Republic of China [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_FourMember" xlink:label="RIME_FourMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_FourMember" xlink:to="RIME_FourMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_FourMember_lbl" xml:lang="en-US">4 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesRevenueNetMember" xlink:label="us-gaap_SalesRevenueNetMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueNetMember" xlink:to="us-gaap_SalesRevenueNetMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesRevenueNetMember_lbl" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_StingrayMember" xlink:label="RIME_StingrayMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_StingrayMember" xlink:to="RIME_StingrayMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_StingrayMember_lbl" xml:lang="en-US">Stingray [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SMCBMember" xlink:label="RIME_SMCBMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SMCBMember" xlink:to="RIME_SMCBMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_SMCBMember_lbl" xml:lang="en-US">S M C B [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:label="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:to="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_lbl" xml:lang="en-US">Software and Software Development Costs [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AultAllianceIncMember" xlink:label="RIME_AultAllianceIncMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_AultAllianceIncMember" xlink:to="RIME_AultAllianceIncMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_AultAllianceIncMember_lbl" xml:lang="en-US">AultAlliance Inc [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ComputerAndOfficeEquipmentMember" xlink:label="RIME_ComputerAndOfficeEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_ComputerAndOfficeEquipmentMember" xlink:to="RIME_ComputerAndOfficeEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_ComputerAndOfficeEquipmentMember_lbl" xml:lang="en-US">Computer and Office Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FurnitureAndFixturesMember" xlink:to="us-gaap_FurnitureAndFixturesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_WarehouseEquipmentMember" xlink:label="RIME_WarehouseEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_WarehouseEquipmentMember" xlink:to="RIME_WarehouseEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_WarehouseEquipmentMember_lbl" xml:lang="en-US">Warehouse Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_MoldsAndToolingMember" xlink:label="RIME_MoldsAndToolingMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_MoldsAndToolingMember" xlink:to="RIME_MoldsAndToolingMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_MoldsAndToolingMember_lbl" xml:lang="en-US">Molds and tooling [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_DirectorMember" xlink:label="srt_DirectorMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_DirectorMember" xlink:to="srt_DirectorMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_DirectorMember_lbl" xml:lang="en-US">Director [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OfficerMember" xlink:label="srt_OfficerMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_OfficerMember" xlink:to="srt_OfficerMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_OfficerMember_lbl" xml:lang="en-US">Officer [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_EmployeeMember" xlink:label="RIME_EmployeeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_EmployeeMember" xlink:to="RIME_EmployeeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_EmployeeMember_lbl" xml:lang="en-US">Employee [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_BoardOfDirectorsChairmanMember" xlink:label="srt_BoardOfDirectorsChairmanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_BoardOfDirectorsChairmanMember" xlink:to="srt_BoardOfDirectorsChairmanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_BoardOfDirectorsChairmanMember_lbl" xml:lang="en-US">Board of Directors Chairman [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_FinancialInstrumentAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinancialInstrumentAxis_lbl" xml:lang="en-US">Financial Instrument [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockOptionMember" xlink:label="us-gaap_StockOptionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockOptionMember" xlink:to="us-gaap_StockOptionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockOptionMember_lbl" xml:lang="en-US">Equity Option [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SixCurrentAndThreeFormerDirectorsMember" xlink:label="RIME_SixCurrentAndThreeFormerDirectorsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SixCurrentAndThreeFormerDirectorsMember" xlink:to="RIME_SixCurrentAndThreeFormerDirectorsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_SixCurrentAndThreeFormerDirectorsMember_lbl" xml:lang="en-US">Six Current And Three Former Directors [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_EmployeesMember" xlink:label="RIME_EmployeesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_EmployeesMember" xlink:to="RIME_EmployeesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_EmployeesMember_lbl" xml:lang="en-US">Employees [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_UnderwritingAgreementMember" xlink:label="RIME_UnderwritingAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_UnderwritingAgreementMember" xlink:to="RIME_UnderwritingAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_UnderwritingAgreementMember_lbl" xml:lang="en-US">Underwriting Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="us-gaap_MeasurementInputTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputTypeAxis_lbl" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputExercisePriceMember" xlink:label="us-gaap_MeasurementInputExercisePriceMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputExercisePriceMember" xlink:to="us-gaap_MeasurementInputExercisePriceMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputExercisePriceMember_lbl" xml:lang="en-US">Measurement Input, Exercise Price [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="us-gaap_MeasurementInputExpectedTermMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputExpectedTermMember" xlink:to="us-gaap_MeasurementInputExpectedTermMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputExpectedTermMember_lbl" xml:lang="en-US">Measurement Input, Expected Term [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputPriceVolatilityMember" xlink:to="us-gaap_MeasurementInputPriceVolatilityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember_lbl" xml:lang="en-US">Measurement Input, Price Volatility [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="us-gaap_MeasurementInputExpectedDividendRateMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputExpectedDividendRateMember" xlink:to="us-gaap_MeasurementInputExpectedDividendRateMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputExpectedDividendRateMember_lbl" xml:lang="en-US">Measurement Input, Expected Dividend Rate [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:to="us-gaap_MeasurementInputRiskFreeInterestRateMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember_lbl" xml:lang="en-US">Measurement Input, Risk Free Interest Rate [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_RedemptionAgreementMember" xlink:label="RIME_RedemptionAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_RedemptionAgreementMember" xlink:to="RIME_RedemptionAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_RedemptionAgreementMember_lbl" xml:lang="en-US">Redemption Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_KonceptsandTreasureGreenMember" xlink:label="RIME_KonceptsandTreasureGreenMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_KonceptsandTreasureGreenMember" xlink:to="RIME_KonceptsandTreasureGreenMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_KonceptsandTreasureGreenMember_lbl" xml:lang="en-US">Koncepts and Treasure Green [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_PurchaseAgreementMember" xlink:label="RIME_PurchaseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_PurchaseAgreementMember" xlink:to="RIME_PurchaseAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_PurchaseAgreementMember_lbl" xml:lang="en-US">Purchase Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_lbl" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AGPWarrantsMember" xlink:label="RIME_AGPWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_AGPWarrantsMember" xlink:to="RIME_AGPWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_AGPWarrantsMember_lbl" xml:lang="en-US">AGP Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_EuropeAndUnitedKingdomMember" xlink:label="RIME_EuropeAndUnitedKingdomMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_EuropeAndUnitedKingdomMember" xlink:to="RIME_EuropeAndUnitedKingdomMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_EuropeAndUnitedKingdomMember_lbl" xml:lang="en-US">Europe and United Kingdom [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_OthersMember" xlink:label="RIME_OthersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_OthersMember" xlink:to="RIME_OthersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_OthersMember_lbl" xml:lang="en-US">Others [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xml:lang="en-US">Debt Instrument [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_EqualInstallmentsForThirteenMonthsMember" xlink:label="RIME_EqualInstallmentsForThirteenMonthsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_EqualInstallmentsForThirteenMonthsMember" xlink:to="RIME_EqualInstallmentsForThirteenMonthsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_EqualInstallmentsForThirteenMonthsMember_lbl" xml:lang="en-US">Equal installments for 13 months [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_TwelveInstallmentsMember" xlink:label="RIME_TwelveInstallmentsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_TwelveInstallmentsMember" xlink:to="RIME_TwelveInstallmentsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_TwelveInstallmentsMember_lbl" xml:lang="en-US">12 Installments [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_FirstPaymentMember" xlink:label="RIME_FirstPaymentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_FirstPaymentMember" xlink:to="RIME_FirstPaymentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_FirstPaymentMember_lbl" xml:lang="en-US">First Payment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DueAndPaidOnMayTwentyTwoThousandTwentyFourMember" xlink:label="RIME_DueAndPaidOnMayTwentyTwoThousandTwentyFourMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_DueAndPaidOnMayTwentyTwoThousandTwentyFourMember" xlink:to="RIME_DueAndPaidOnMayTwentyTwoThousandTwentyFourMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_DueAndPaidOnMayTwentyTwoThousandTwentyFourMember_lbl" xml:lang="en-US">Due and paid on May 20, 2024 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DueOnJuneThreeTwoThousandTwentyFourMember" xlink:label="RIME_DueOnJuneThreeTwoThousandTwentyFourMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_DueOnJuneThreeTwoThousandTwentyFourMember" xlink:to="RIME_DueOnJuneThreeTwoThousandTwentyFourMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_DueOnJuneThreeTwoThousandTwentyFourMember_lbl" xml:lang="en-US">Due on June 3, 2024 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_TenMonthlyPaymentsMember" xlink:label="RIME_TenMonthlyPaymentsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_TenMonthlyPaymentsMember" xlink:to="RIME_TenMonthlyPaymentsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_TenMonthlyPaymentsMember_lbl" xml:lang="en-US">Ten Monthly Payments [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_WeeklyPaymentsForWeeksMember" xlink:label="RIME_WeeklyPaymentsForWeeksMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_WeeklyPaymentsForWeeksMember" xlink:to="RIME_WeeklyPaymentsForWeeksMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_WeeklyPaymentsForWeeksMember_lbl" xml:lang="en-US">Weekly Payments For Weeks [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_WeeklyPaymentsMember" xlink:label="RIME_WeeklyPaymentsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_WeeklyPaymentsMember" xlink:to="RIME_WeeklyPaymentsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_WeeklyPaymentsMember_lbl" xml:lang="en-US">Weekly Payments [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SixShareholderLoanAgreementsMember" xlink:label="RIME_SixShareholderLoanAgreementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SixShareholderLoanAgreementsMember" xlink:to="RIME_SixShareholderLoanAgreementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_SixShareholderLoanAgreementsMember_lbl" xml:lang="en-US">Six Shareholder Loan Agreements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_VivekSehgalMember" xlink:label="RIME_VivekSehgalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_VivekSehgalMember" xlink:to="RIME_VivekSehgalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_VivekSehgalMember_lbl" xml:lang="en-US">Vivek Sehgal [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_JaganReddyMember" xlink:label="RIME_JaganReddyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_JaganReddyMember" xlink:to="RIME_JaganReddyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_JaganReddyMember_lbl" xml:lang="en-US">Jagan Reddy [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SudhirNarasimhamurthyMember" xlink:label="RIME_SudhirNarasimhamurthyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SudhirNarasimhamurthyMember" xlink:to="RIME_SudhirNarasimhamurthyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_SudhirNarasimhamurthyMember_lbl" xml:lang="en-US">Sudhir Narasimhamurthy [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="us-gaap_DerivativeInstrumentRiskAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentRiskAxis" xlink:to="us-gaap_DerivativeInstrumentRiskAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeInstrumentRiskAxis_lbl" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_KadandaleSrinivasSudheerMember" xlink:label="RIME_KadandaleSrinivasSudheerMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_KadandaleSrinivasSudheerMember" xlink:to="RIME_KadandaleSrinivasSudheerMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_KadandaleSrinivasSudheerMember_lbl" xml:lang="en-US">Kadandale Srinivas Sudheer [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_RajivSaxenaMember" xlink:label="RIME_RajivSaxenaMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_RajivSaxenaMember" xlink:to="RIME_RajivSaxenaMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_RajivSaxenaMember_lbl" xml:lang="en-US">Rajiv Saxena [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_HarshaBhatMember" xlink:label="RIME_HarshaBhatMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_HarshaBhatMember" xlink:to="RIME_HarshaBhatMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_HarshaBhatMember_lbl" xml:lang="en-US">Harsha Bhat [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SiddayyaSGanjalMember" xlink:label="RIME_SiddayyaSGanjalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SiddayyaSGanjalMember" xlink:to="RIME_SiddayyaSGanjalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_SiddayyaSGanjalMember_lbl" xml:lang="en-US">Siddayya S Ganjal [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SunilAroraMember" xlink:label="RIME_SunilAroraMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SunilAroraMember" xlink:to="RIME_SunilAroraMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_SunilAroraMember_lbl" xml:lang="en-US">Sunil Arora [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_RajivVirmaniMember" xlink:label="RIME_RajivVirmaniMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_RajivVirmaniMember" xlink:to="RIME_RajivVirmaniMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_RajivVirmaniMember_lbl" xml:lang="en-US">Rajiv Virmani [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SudhindraShenoyMember" xlink:label="RIME_SudhindraShenoyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SudhindraShenoyMember" xlink:to="RIME_SudhindraShenoyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_SudhindraShenoyMember_lbl" xml:lang="en-US">Sudhindra Shenoy [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AntonySunilMember" xlink:label="RIME_AntonySunilMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_AntonySunilMember" xlink:to="RIME_AntonySunilMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_AntonySunilMember_lbl" xml:lang="en-US">Antony Sunil [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_TuleekaNandyMember" xlink:label="RIME_TuleekaNandyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_TuleekaNandyMember" xlink:to="RIME_TuleekaNandyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_TuleekaNandyMember_lbl" xml:lang="en-US">Tuleeka Nandy [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_RobelAtnafuMember" xlink:label="RIME_RobelAtnafuMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_RobelAtnafuMember" xlink:to="RIME_RobelAtnafuMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_RobelAtnafuMember_lbl" xml:lang="en-US">Robel Atnafu [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_GuyPrimusMember" xlink:label="RIME_GuyPrimusMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_GuyPrimusMember" xlink:to="RIME_GuyPrimusMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_GuyPrimusMember_lbl" xml:lang="en-US">Guy Primus [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SamarthaGowdaMember" xlink:label="RIME_SamarthaGowdaMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SamarthaGowdaMember" xlink:to="RIME_SamarthaGowdaMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_SamarthaGowdaMember_lbl" xml:lang="en-US">Samartha Gowda [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AlexandraAielloMember" xlink:label="RIME_AlexandraAielloMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_AlexandraAielloMember" xlink:to="RIME_AlexandraAielloMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_AlexandraAielloMember_lbl" xml:lang="en-US">Alexandra Aiello [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_StephenCabralMember" xlink:label="RIME_StephenCabralMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_StephenCabralMember" xlink:to="RIME_StephenCabralMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_StephenCabralMember_lbl" xml:lang="en-US">Stephen Cabral [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_JonahPetiPerrinMember" xlink:label="RIME_JonahPetiPerrinMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_JonahPetiPerrinMember" xlink:to="RIME_JonahPetiPerrinMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_JonahPetiPerrinMember_lbl" xml:lang="en-US">Jonah Peti-Perrin [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_BryanNellaMember" xlink:label="RIME_BryanNellaMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_BryanNellaMember" xlink:to="RIME_BryanNellaMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_BryanNellaMember_lbl" xml:lang="en-US">Bryan Nella [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_MarkSinkMember" xlink:label="RIME_MarkSinkMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_MarkSinkMember" xlink:to="RIME_MarkSinkMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_MarkSinkMember_lbl" xml:lang="en-US">Mark Sink [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_KoustavChoudhuriMember" xlink:label="RIME_KoustavChoudhuriMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_KoustavChoudhuriMember" xlink:to="RIME_KoustavChoudhuriMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_KoustavChoudhuriMember_lbl" xml:lang="en-US">Koustav Choudhuri [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_FoundersMember" xlink:label="RIME_FoundersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_FoundersMember" xlink:to="RIME_FoundersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_FoundersMember_lbl" xml:lang="en-US">Founders [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEAgreementsMember" xlink:label="RIME_SAFEAgreementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFEAgreementsMember" xlink:to="RIME_SAFEAgreementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_SAFEAgreementsMember_lbl" xml:lang="en-US">SAFE Agreements[Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_FortyFourSAFEAgreementsMember" xlink:label="RIME_FortyFourSAFEAgreementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_FortyFourSAFEAgreementsMember" xlink:to="RIME_FortyFourSAFEAgreementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_FortyFourSAFEAgreementsMember_lbl" xml:lang="en-US">44 SAFE Agreements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingAxis" xlink:label="us-gaap_VestingAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_VestingAxis_lbl" xml:lang="en-US">Vesting [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Tranche One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheTwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheTwoMember_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Tranche Two [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEOneMember" xlink:label="RIME_SAFEOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFEOneMember" xlink:to="RIME_SAFEOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_SAFEOneMember_lbl" xml:lang="en-US">SAFE-1</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEThirtyEightMember" xlink:label="RIME_SAFEThirtyEightMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFEThirtyEightMember" xlink:to="RIME_SAFEThirtyEightMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_SAFEThirtyEightMember_lbl" xml:lang="en-US">SAFE-38 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEFortyOneMember" xlink:label="RIME_SAFEFortyOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFEFortyOneMember" xlink:to="RIME_SAFEFortyOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_SAFEFortyOneMember_lbl" xml:lang="en-US">SAFE-41 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEFortyTwoMember" xlink:label="RIME_SAFEFortyTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFEFortyTwoMember" xlink:to="RIME_SAFEFortyTwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_SAFEFortyTwoMember_lbl" xml:lang="en-US">SAFE-42 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEFortyFourMember" xlink:label="RIME_SAFEFortyFourMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFEFortyFourMember" xlink:to="RIME_SAFEFortyFourMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_SAFEFortyFourMember_lbl" xml:lang="en-US">SAFE Forty Four [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEFortyThreeMember" xlink:label="RIME_SAFEFortyThreeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFEFortyThreeMember" xlink:to="RIME_SAFEFortyThreeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_SAFEFortyThreeMember_lbl" xml:lang="en-US">SAFE-43 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEFortyMember" xlink:label="RIME_SAFEFortyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFEFortyMember" xlink:to="RIME_SAFEFortyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_SAFEFortyMember_lbl" xml:lang="en-US">SAFE-40 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEThirtyNineMember" xlink:label="RIME_SAFEThirtyNineMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFEThirtyNineMember" xlink:to="RIME_SAFEThirtyNineMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_SAFEThirtyNineMember_lbl" xml:lang="en-US">SAFE-39 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFETenMember" xlink:label="RIME_SAFETenMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFETenMember" xlink:to="RIME_SAFETenMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_SAFETenMember_lbl" xml:lang="en-US">SAFE-10 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEElevenMember" xlink:label="RIME_SAFEElevenMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFEElevenMember" xlink:to="RIME_SAFEElevenMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_SAFEElevenMember_lbl" xml:lang="en-US">SAFE-11 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFETwelveMember" xlink:label="RIME_SAFETwelveMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFETwelveMember" xlink:to="RIME_SAFETwelveMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_SAFETwelveMember_lbl" xml:lang="en-US">SAFE-12 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEThirteenMember" xlink:label="RIME_SAFEThirteenMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFEThirteenMember" xlink:to="RIME_SAFEThirteenMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_SAFEThirteenMember_lbl" xml:lang="en-US">SAFE-13 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEFourteenMember" xlink:label="RIME_SAFEFourteenMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFEFourteenMember" xlink:to="RIME_SAFEFourteenMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_SAFEFourteenMember_lbl" xml:lang="en-US">SAFE-14 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEFifteenMember" xlink:label="RIME_SAFEFifteenMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFEFifteenMember" xlink:to="RIME_SAFEFifteenMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_SAFEFifteenMember_lbl" xml:lang="en-US">SAFE-15 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFESixteenMember" xlink:label="RIME_SAFESixteenMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFESixteenMember" xlink:to="RIME_SAFESixteenMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_SAFESixteenMember_lbl" xml:lang="en-US">SAFE-16 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFESeventeenMember" xlink:label="RIME_SAFESeventeenMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFESeventeenMember" xlink:to="RIME_SAFESeventeenMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_SAFESeventeenMember_lbl" xml:lang="en-US">SAFE-17 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEEighteenMember" xlink:label="RIME_SAFEEighteenMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFEEighteenMember" xlink:to="RIME_SAFEEighteenMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_SAFEEighteenMember_lbl" xml:lang="en-US">SAFE-18 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFENineteenMember" xlink:label="RIME_SAFENineteenMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFENineteenMember" xlink:to="RIME_SAFENineteenMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_SAFENineteenMember_lbl" xml:lang="en-US">SAFE-19 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFETwoMember" xlink:label="RIME_SAFETwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFETwoMember" xlink:to="RIME_SAFETwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_SAFETwoMember_lbl" xml:lang="en-US">SAFE-20 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFETwentyMember" xlink:label="RIME_SAFETwentyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFETwentyMember" xlink:to="RIME_SAFETwentyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="RIME_SAFETwentyMember_lbl" xml:lang="en-US">SAFE-20 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFETwentyOneMember" xlink:label="RIME_SAFETwentyOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFETwentyOneMember" xlink:to="RIME_SAFETwentyOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_SAFETwentyOneMember_lbl" xml:lang="en-US">SAFE-21 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFETwentyTwoMember" xlink:label="RIME_SAFETwentyTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFETwentyTwoMember" xlink:to="RIME_SAFETwentyTwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_SAFETwentyTwoMember_lbl" xml:lang="en-US">SAFE-22 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFETwentyFourMember" xlink:label="RIME_SAFETwentyFourMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFETwentyFourMember" xlink:to="RIME_SAFETwentyFourMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_SAFETwentyFourMember_lbl" xml:lang="en-US">SAFE-24 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEThreeMember" xlink:label="RIME_SAFEThreeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFEThreeMember" xlink:to="RIME_SAFEThreeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_SAFEThreeMember_lbl" xml:lang="en-US">SAFE-3 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEFourMember" xlink:label="RIME_SAFEFourMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFEFourMember" xlink:to="RIME_SAFEFourMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_SAFEFourMember_lbl" xml:lang="en-US">SAFE-4 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEFortyFiveMember" xlink:label="RIME_SAFEFortyFiveMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFEFortyFiveMember" xlink:to="RIME_SAFEFortyFiveMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_SAFEFortyFiveMember_lbl" xml:lang="en-US">SAFE-45 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFESixMember" xlink:label="RIME_SAFESixMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFESixMember" xlink:to="RIME_SAFESixMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_SAFESixMember_lbl" xml:lang="en-US">SAFE-6 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFESevenMember" xlink:label="RIME_SAFESevenMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFESevenMember" xlink:to="RIME_SAFESevenMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_SAFESevenMember_lbl" xml:lang="en-US">SAFE-7 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEEightMember" xlink:label="RIME_SAFEEightMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFEEightMember" xlink:to="RIME_SAFEEightMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_SAFEEightMember_lbl" xml:lang="en-US">SAFE-8 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFENineMember" xlink:label="RIME_SAFENineMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFENineMember" xlink:to="RIME_SAFENineMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_SAFENineMember_lbl" xml:lang="en-US">SAFE-9 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEFiveMember" xlink:label="RIME_SAFEFiveMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFEFiveMember" xlink:to="RIME_SAFEFiveMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_SAFEFiveMember_lbl" xml:lang="en-US">SAFE-5 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFETwentyFiveMember" xlink:label="RIME_SAFETwentyFiveMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFETwentyFiveMember" xlink:to="RIME_SAFETwentyFiveMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_SAFETwentyFiveMember_lbl" xml:lang="en-US">SAFE-25 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFETwentySixMember" xlink:label="RIME_SAFETwentySixMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFETwentySixMember" xlink:to="RIME_SAFETwentySixMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_SAFETwentySixMember_lbl" xml:lang="en-US">SAFE-26 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFETwentySevenMember" xlink:label="RIME_SAFETwentySevenMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFETwentySevenMember" xlink:to="RIME_SAFETwentySevenMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_SAFETwentySevenMember_lbl" xml:lang="en-US">SAFE-27 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFETwentyEightMember" xlink:label="RIME_SAFETwentyEightMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFETwentyEightMember" xlink:to="RIME_SAFETwentyEightMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_SAFETwentyEightMember_lbl" xml:lang="en-US">SAFE-28 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFETwentyNineMember" xlink:label="RIME_SAFETwentyNineMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFETwentyNineMember" xlink:to="RIME_SAFETwentyNineMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_SAFETwentyNineMember_lbl" xml:lang="en-US">SAFE-29 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEThirtyMember" xlink:label="RIME_SAFEThirtyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFEThirtyMember" xlink:to="RIME_SAFEThirtyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_SAFEThirtyMember_lbl" xml:lang="en-US">SAFE-30 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEThirtyOneMember" xlink:label="RIME_SAFEThirtyOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFEThirtyOneMember" xlink:to="RIME_SAFEThirtyOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_SAFEThirtyOneMember_lbl" xml:lang="en-US">SAFE-31 [Member</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEThirtyTwoMember" xlink:label="RIME_SAFEThirtyTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFEThirtyTwoMember" xlink:to="RIME_SAFEThirtyTwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_SAFEThirtyTwoMember_lbl" xml:lang="en-US">SAFE-32 [Member</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEThirtyThreeMember" xlink:label="RIME_SAFEThirtyThreeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFEThirtyThreeMember" xlink:to="RIME_SAFEThirtyThreeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_SAFEThirtyThreeMember_lbl" xml:lang="en-US">SAFE-33 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEThirtyFourMember" xlink:label="RIME_SAFEThirtyFourMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFEThirtyFourMember" xlink:to="RIME_SAFEThirtyFourMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_SAFEThirtyFourMember_lbl" xml:lang="en-US">SAFE-34 [Member</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEThirtyFiveMember" xlink:label="RIME_SAFEThirtyFiveMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFEThirtyFiveMember" xlink:to="RIME_SAFEThirtyFiveMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_SAFEThirtyFiveMember_lbl" xml:lang="en-US">SAFE-35 [Member</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEThirtySixMember" xlink:label="RIME_SAFEThirtySixMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFEThirtySixMember" xlink:to="RIME_SAFEThirtySixMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_SAFEThirtySixMember_lbl" xml:lang="en-US">SAFE-36 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEThirtySevenMember" xlink:label="RIME_SAFEThirtySevenMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFEThirtySevenMember" xlink:to="RIME_SAFEThirtySevenMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_SAFEThirtySevenMember_lbl" xml:lang="en-US">SAFE-37 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEFortySixMember" xlink:label="RIME_SAFEFortySixMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFEFortySixMember" xlink:to="RIME_SAFEFortySixMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_SAFEFortySixMember_lbl" xml:lang="en-US">SAFE-46 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEFiftyMember" xlink:label="RIME_SAFEFiftyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFEFiftyMember" xlink:to="RIME_SAFEFiftyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_SAFEFiftyMember_lbl" xml:lang="en-US">SAFE-50 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEFortyEightMember" xlink:label="RIME_SAFEFortyEightMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFEFortyEightMember" xlink:to="RIME_SAFEFortyEightMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_SAFEFortyEightMember_lbl" xml:lang="en-US">SAFE-48 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEFortySevenMember" xlink:label="RIME_SAFEFortySevenMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFEFortySevenMember" xlink:to="RIME_SAFEFortySevenMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_SAFEFortySevenMember_lbl" xml:lang="en-US">SAFE-47 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEFortyNineMember" xlink:label="RIME_SAFEFortyNineMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFEFortyNineMember" xlink:to="RIME_SAFEFortyNineMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_SAFEFortyNineMember_lbl" xml:lang="en-US">SAFE-49 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEFiftyOneMember" xlink:label="RIME_SAFEFiftyOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFEFiftyOneMember" xlink:to="RIME_SAFEFiftyOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_SAFEFiftyOneMember_lbl" xml:lang="en-US">SAFE-51 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesTable" xlink:label="dei_EntityAddressesTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressesTable" xlink:to="dei_EntityAddressesTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressesTable_lbl" xml:lang="en-US">Entity Addresses [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesLineItems" xlink:label="dei_EntityAddressesLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_EntityAddressesLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressesLineItems_lbl" xml:lang="en-US">Entity Addresses [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_ContactPersonnelName" xlink:label="dei_ContactPersonnelName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_ContactPersonnelName" xlink:to="dei_ContactPersonnelName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_ContactPersonnelName_lbl" xml:lang="en-US">Contact Personnel Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_lbl" xml:lang="en-US">Defined Benefit Plan [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="us-gaap_DefinedBenefitPlanDisclosureLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="us-gaap_DefinedBenefitPlanDisclosureLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanDisclosureLineItems_lbl" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Cash" xlink:label="us-gaap_Cash" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Cash" xlink:to="us-gaap_Cash_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Cash_lbl" xml:lang="en-US">Cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNet" xlink:label="us-gaap_AccountsReceivableNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNet" xlink:to="us-gaap_AccountsReceivableNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableNet_lbl" xml:lang="en-US">Accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DueFromBanks" xlink:label="us-gaap_DueFromBanks" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueFromBanks" xlink:to="us-gaap_DueFromBanks_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DueFromBanks_lbl" xml:lang="en-US">Due from Banks</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_RefundDueFromCustomer" xlink:label="RIME_RefundDueFromCustomer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_RefundDueFromCustomer" xlink:to="RIME_RefundDueFromCustomer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_RefundDueFromCustomer_lbl" xml:lang="en-US">Refund due from customer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryNet_lbl" xml:lang="en-US">Inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ReturnsAsset" xlink:label="RIME_ReturnsAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_ReturnsAsset" xlink:to="RIME_ReturnsAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_ReturnsAsset_lbl" xml:lang="en-US">Returns asset</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US">Prepaid Expenses and other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total Current Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Property and equipment, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US">Operating leases - right of use assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xml:lang="en-US">Other non-current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xml:lang="en-US">Intangible assets, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_Goodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Goodwill_lbl" xml:lang="en-US">Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">Liabilities and Shareholders&#8217; Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayableCurrent" xlink:label="us-gaap_NotesPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayableCurrent" xlink:to="us-gaap_NotesPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesPayableCurrent_lbl" xml:lang="en-US">Notes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LoansPayableCurrent" xlink:label="us-gaap_LoansPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoansPayableCurrent" xlink:to="us-gaap_LoansPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LoansPayableCurrent_lbl" xml:lang="en-US">Loans from affiliates, current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerRefundLiabilityCurrent" xlink:label="us-gaap_ContractWithCustomerRefundLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerRefundLiabilityCurrent" xlink:to="us-gaap_ContractWithCustomerRefundLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractWithCustomerRefundLiabilityCurrent_lbl" xml:lang="en-US">Due to factor</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_CustomerPrepayments" xlink:label="RIME_CustomerPrepayments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_CustomerPrepayments" xlink:to="RIME_CustomerPrepayments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_CustomerPrepayments_lbl" xml:lang="en-US">Customer prepayments</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ReserveForSalesReturns" xlink:label="RIME_ReserveForSalesReturns" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_ReserveForSalesReturns" xlink:to="RIME_ReserveForSalesReturns_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_ReserveForSalesReturns_lbl" xml:lang="en-US">Reserve for sales returns</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermBorrowings" xlink:label="us-gaap_ShortTermBorrowings" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermBorrowings" xlink:to="us-gaap_ShortTermBorrowings_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermBorrowings_lbl" xml:lang="en-US">Merchant cash advances payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xml:lang="en-US">Current portion of operating lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl" xml:lang="en-US">Other current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total Current Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xml:lang="en-US">Other liabilities, net of current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermNotesPayable" xlink:label="us-gaap_LongTermNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermNotesPayable" xlink:to="us-gaap_LongTermNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermNotesPayable_lbl" xml:lang="en-US">Notes payable to related parties, net of current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xml:lang="en-US">Operating lease liabilities, net of current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermLoansPayable" xlink:label="us-gaap_LongTermLoansPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermLoansPayable" xlink:to="us-gaap_LongTermLoansPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermLoansPayable_lbl" xml:lang="en-US">Loans from affiliates, net of current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">Total Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_CommitmentsAndContingenciesAbstract" xlink:label="RIME_CommitmentsAndContingenciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_CommitmentsAndContingenciesAbstract" xlink:to="RIME_CommitmentsAndContingenciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_CommitmentsAndContingenciesAbstract_lbl" xml:lang="en-US">Commitments and Contingencies</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ProvisionForLegalLiability" xlink:label="RIME_ProvisionForLegalLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_ProvisionForLegalLiability" xlink:to="RIME_ProvisionForLegalLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_ProvisionForLegalLiability_lbl" xml:lang="en-US">Provision for legal liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US">Total Commitments and Contingencies</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">Shareholders&#8217; Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US">Preferred equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common stock $0.01 par value; 100,000,000 shares authorized; 6,418,061 issued and outstanding at December 31, 2023 and 3,184,439 issued and 3,167,489 outstanding at March 31, 2023</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Additional paid-in capital</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable" xlink:label="us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable" xlink:to="us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable_lbl" xml:lang="en-US">Subscriptions receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total Shareholders&#8217; Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterest" xlink:label="us-gaap_MinorityInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterest" xlink:to="us-gaap_MinorityInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterest_lbl" xml:lang="en-US">Non-controlling interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Total Algorhythm Holdings Shareholders&#8217; Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total Liabilities and Shareholders&#8217; Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" xml:lang="en-US">Allowance for doubtful accounts receivable, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Preferred stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Preferred stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xml:lang="en-US">Net Revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="us-gaap_CostOfGoodsAndServicesSold" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsAndServicesSold" xlink:to="us-gaap_CostOfGoodsAndServicesSold_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfGoodsAndServicesSold_lbl" xml:lang="en-US">Cost of Revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit" xlink:label="us-gaap_GrossProfit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_GrossProfit_lbl" xml:lang="en-US">Gross Profit (Loss)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US">Operating Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingExpense" xlink:label="us-gaap_SellingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingExpense" xlink:to="us-gaap_SellingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingExpense_lbl" xml:lang="en-US">Selling general and administrative expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US">General and administrative expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnTerminationOfLease" xlink:label="us-gaap_GainLossOnTerminationOfLease" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnTerminationOfLease" xlink:to="us-gaap_GainLossOnTerminationOfLease_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_GainLossOnTerminationOfLease_lbl" xml:lang="en-US">Net (gain) loss on early termination of operating lease</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ProductDevelopmentExpense" xlink:label="RIME_ProductDevelopmentExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_ProductDevelopmentExpense" xlink:to="RIME_ProductDevelopmentExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_ProductDevelopmentExpense_lbl" xml:lang="en-US">Product development</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingExpenses_lbl" xml:lang="en-US">Total Operating Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Loss from Operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xml:lang="en-US">Other Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnDispositionOfAssets1" xlink:label="us-gaap_GainLossOnDispositionOfAssets1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnDispositionOfAssets1" xlink:to="us-gaap_GainLossOnDispositionOfAssets1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnDispositionOfAssets1_lbl" xml:lang="en-US">Gain on disposal of fixed assets</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_GainFromRelatedPartyDebt" xlink:label="RIME_GainFromRelatedPartyDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_GainFromRelatedPartyDebt" xlink:to="RIME_GainFromRelatedPartyDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_GainFromRelatedPartyDebt_lbl" xml:lang="en-US">Gain - related party</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_GainFromPaycheckProtectionPlanLoanForgiveness" xlink:label="RIME_GainFromPaycheckProtectionPlanLoanForgiveness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_GainFromPaycheckProtectionPlanLoanForgiveness" xlink:to="RIME_GainFromPaycheckProtectionPlanLoanForgiveness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_GainFromPaycheckProtectionPlanLoanForgiveness_lbl" xml:lang="en-US">Gain from extinguishment of PPP loan forgiveness</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_GainFromSettlementOfAccountsPayable" xlink:label="RIME_GainFromSettlementOfAccountsPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_GainFromSettlementOfAccountsPayable" xlink:to="RIME_GainFromSettlementOfAccountsPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_GainFromSettlementOfAccountsPayable_lbl" xml:lang="en-US">Gain from settlement of accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xml:lang="en-US">Loss from extinguishment of debt</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_GainFromEmployeeRetentionCreditProgramRefund" xlink:label="RIME_GainFromEmployeeRetentionCreditProgramRefund" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_GainFromEmployeeRetentionCreditProgramRefund" xlink:to="RIME_GainFromEmployeeRetentionCreditProgramRefund_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_GainFromEmployeeRetentionCreditProgramRefund_lbl" xml:lang="en-US">Gain from Employee Retention Credit Program refund</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseDebtExcludingAmortization" xlink:label="us-gaap_InterestExpenseDebtExcludingAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseDebtExcludingAmortization" xlink:to="us-gaap_InterestExpenseDebtExcludingAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InterestExpenseDebtExcludingAmortization_lbl" xml:lang="en-US">Interest expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xml:lang="en-US">Total Other Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US">Loss Before Income Tax Benefit (Provision)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Income Tax Benefit (Provision)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_ProfitLoss_lbl" xml:lang="en-US">Net Loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Net (income) loss attributable to non-controlling interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xml:lang="en-US">Loss per Common Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US">Basic</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US">Diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract" xlink:label="us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract" xlink:to="us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract_lbl" xml:lang="en-US">Weighted Average Common and Common Equivalent Shares:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">Basic</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US">Diluted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2_lbl" xml:lang="en-US">Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US">Balance, shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfitLoss_2_lbl" xml:lang="en-US">Net income (Ioss)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US">Issuance of common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US">Issuance of common stock, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation" xlink:label="us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation" xlink:to="us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation_lbl" xml:lang="en-US">Stock based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl" xml:lang="en-US">Stock based compensation, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl" xml:lang="en-US">Common stock issued for purchase of SemiCab Inc</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl" xml:lang="en-US">Common stock issued for purchase of SemiCab Inc, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_lbl" xml:lang="en-US">Issuance of subsidiary stock to non-controlling interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueOther" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther_lbl" xml:lang="en-US">Issuance of common stock for stock offering costs</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_StockIssuedDuringPeriodValueSaleOfCommonStockWarrants" xlink:label="RIME_StockIssuedDuringPeriodValueSaleOfCommonStockWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_StockIssuedDuringPeriodValueSaleOfCommonStockWarrants" xlink:to="RIME_StockIssuedDuringPeriodValueSaleOfCommonStockWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_StockIssuedDuringPeriodValueSaleOfCommonStockWarrants_lbl" xml:lang="en-US">Sale of common stock warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_StockIssuedDuringPeriodSharesSaleOfCommonStockWarrants" xlink:label="RIME_StockIssuedDuringPeriodSharesSaleOfCommonStockWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_StockIssuedDuringPeriodSharesSaleOfCommonStockWarrants" xlink:to="RIME_StockIssuedDuringPeriodSharesSaleOfCommonStockWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_StockIssuedDuringPeriodSharesSaleOfCommonStockWarrants_lbl" xml:lang="en-US">Sale of common stock warrants, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl" xml:lang="en-US">Issuance of pre-funded warrants</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_2_lbl" xml:lang="en-US">Common stock offering costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther_lbl" xml:lang="en-US">Issuance of common stock for stock offering costs, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:label="us-gaap_TreasuryStockRetiredCostMethodAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:to="us-gaap_TreasuryStockRetiredCostMethodAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_TreasuryStockRetiredCostMethodAmount_lbl" xml:lang="en-US">Redemption and retirement of treasury shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockSharesRetired" xlink:label="us-gaap_TreasuryStockSharesRetired" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockSharesRetired" xlink:to="us-gaap_TreasuryStockSharesRetired_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_TreasuryStockSharesRetired_lbl" xml:lang="en-US">Redemption and retirement of treasury shares, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl" xml:lang="en-US">Stock based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xml:lang="en-US">Exercise of stock options</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US">Exercise of stock options, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_StockIssuedDuringPeriodValueExerciseOfPrefundedAndCommonWarrants" xlink:label="RIME_StockIssuedDuringPeriodValueExerciseOfPrefundedAndCommonWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_StockIssuedDuringPeriodValueExerciseOfPrefundedAndCommonWarrants" xlink:to="RIME_StockIssuedDuringPeriodValueExerciseOfPrefundedAndCommonWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_StockIssuedDuringPeriodValueExerciseOfPrefundedAndCommonWarrants_lbl" xml:lang="en-US">Exercise of pre-funded and common warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_StockIssuedDuringPeriodSharesExerciseOfPrefundedAndCommonWarrants" xlink:label="RIME_StockIssuedDuringPeriodSharesExerciseOfPrefundedAndCommonWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_StockIssuedDuringPeriodSharesExerciseOfPrefundedAndCommonWarrants" xlink:to="RIME_StockIssuedDuringPeriodSharesExerciseOfPrefundedAndCommonWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_StockIssuedDuringPeriodSharesExerciseOfPrefundedAndCommonWarrants_lbl" xml:lang="en-US">Exercise of pre-funded warrants, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xml:lang="en-US">Employee compensation - stock option</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_StockIssuedDuringPeriodValueReverseStockSplits" xlink:label="RIME_StockIssuedDuringPeriodValueReverseStockSplits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_StockIssuedDuringPeriodValueReverseStockSplits" xlink:to="RIME_StockIssuedDuringPeriodValueReverseStockSplits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_StockIssuedDuringPeriodValueReverseStockSplits_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits" xlink:label="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits" xlink:to="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits_lbl" xml:lang="en-US">Rounding of common stock issued due to reverse split, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_StockIssuedDuringPeriodValueIssuanceOfCommonStockAtMarketOffering" xlink:label="RIME_StockIssuedDuringPeriodValueIssuanceOfCommonStockAtMarketOffering" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_StockIssuedDuringPeriodValueIssuanceOfCommonStockAtMarketOffering" xlink:to="RIME_StockIssuedDuringPeriodValueIssuanceOfCommonStockAtMarketOffering_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_StockIssuedDuringPeriodValueIssuanceOfCommonStockAtMarketOffering_lbl" xml:lang="en-US">Issuance of common stock - at-the -market offering</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_StockIssuedDuringPeriodSharesIssuanceOfCommonStockAtMarketOffering" xlink:label="RIME_StockIssuedDuringPeriodSharesIssuanceOfCommonStockAtMarketOffering" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_StockIssuedDuringPeriodSharesIssuanceOfCommonStockAtMarketOffering" xlink:to="RIME_StockIssuedDuringPeriodSharesIssuanceOfCommonStockAtMarketOffering_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_StockIssuedDuringPeriodSharesIssuanceOfCommonStockAtMarketOffering_lbl" xml:lang="en-US">Issuance of common stock - at-the-market offering, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_StockIssuedDuringPeriodValueIssuanceOfCommonStockPrivatePlacement" xlink:label="RIME_StockIssuedDuringPeriodValueIssuanceOfCommonStockPrivatePlacement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_StockIssuedDuringPeriodValueIssuanceOfCommonStockPrivatePlacement" xlink:to="RIME_StockIssuedDuringPeriodValueIssuanceOfCommonStockPrivatePlacement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_StockIssuedDuringPeriodValueIssuanceOfCommonStockPrivatePlacement_lbl" xml:lang="en-US">Issuance of common stock - private placement</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_StockIssuedDuringPeriodSharesIssuanceOfCommonStockPrivatePlacement" xlink:label="RIME_StockIssuedDuringPeriodSharesIssuanceOfCommonStockPrivatePlacement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_StockIssuedDuringPeriodSharesIssuanceOfCommonStockPrivatePlacement" xlink:to="RIME_StockIssuedDuringPeriodSharesIssuanceOfCommonStockPrivatePlacement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_StockIssuedDuringPeriodSharesIssuanceOfCommonStockPrivatePlacement_lbl" xml:lang="en-US">Issuance of common stock - private placement, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_lbl" xml:lang="en-US">Other</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3_lbl" xml:lang="en-US">Balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesOutstanding_2_lbl" xml:lang="en-US">Balance, shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_3_lbl" xml:lang="en-US">Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from operating activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProfitLoss_3_lbl" xml:lang="en-US">Net (loss) income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net (loss) income to net cash provided by (used in) operating activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Depreciation_lbl" xml:lang="en-US">Depreciation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="us-gaap_AmortizationOfFinancingCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfFinancingCosts" xlink:to="us-gaap_AmortizationOfFinancingCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfFinancingCosts_lbl" xml:lang="en-US">Amortization of deferred financing costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Change in net deferred tax assets</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ProvisionForEstimatedCostOfReturns" xlink:label="RIME_ProvisionForEstimatedCostOfReturns" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_ProvisionForEstimatedCostOfReturns" xlink:to="RIME_ProvisionForEstimatedCostOfReturns_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="RIME_ProvisionForEstimatedCostOfReturns_lbl" xml:lang="en-US">Provision for estimated cost of returns</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ProvisionForInventoryObsolescence" xlink:label="RIME_ProvisionForInventoryObsolescence" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_ProvisionForInventoryObsolescence" xlink:to="RIME_ProvisionForInventoryObsolescence_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="RIME_ProvisionForInventoryObsolescence_lbl" xml:lang="en-US">Provision for inventory obsolesence</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="us-gaap_ProvisionForDoubtfulAccounts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProvisionForDoubtfulAccounts" xlink:to="us-gaap_ProvisionForDoubtfulAccounts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProvisionForDoubtfulAccounts_lbl" xml:lang="en-US">Credit losses</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_GainOnTerminationOfOperatingLease" xlink:label="RIME_GainOnTerminationOfOperatingLease" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_GainOnTerminationOfOperatingLease" xlink:to="RIME_GainOnTerminationOfOperatingLease_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="RIME_GainOnTerminationOfOperatingLease_lbl" xml:lang="en-US">Gain on termination of operating lease</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl" xml:lang="en-US">(Gain) loss from disposal of property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Stock based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" xml:lang="en-US">Amortization of right of use assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xml:lang="en-US">Change in net deferred tax assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_2_lbl" xml:lang="en-US">Loss on debt extinguishment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_GainFromPaycheckProtectionPlanLoanForgiveness" xlink:to="RIME_GainFromPaycheckProtectionPlanLoanForgiveness_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="RIME_GainFromPaycheckProtectionPlanLoanForgiveness_2_lbl" xml:lang="en-US">Paycheck Protection Plan loan forgiveness</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_GainFromRelatedPartyDebt" xlink:to="RIME_GainFromRelatedPartyDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="RIME_GainFromRelatedPartyDebt_2_lbl" xml:lang="en-US">Gain - related party</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_GainFromSettlementOfAccountsPayable" xlink:to="RIME_GainFromSettlementOfAccountsPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="RIME_GainFromSettlementOfAccountsPayable_2_lbl" xml:lang="en-US">Gain from extinguishment of accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US">Accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseDueFromAffiliates" xlink:label="us-gaap_IncreaseDecreaseDueFromAffiliates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseDueFromAffiliates" xlink:to="us-gaap_IncreaseDecreaseDueFromAffiliates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseDueFromAffiliates_lbl" xml:lang="en-US">Due from banks</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties_lbl" xml:lang="en-US">Accounts receivable &#8211; related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_lbl" xml:lang="en-US">Other non-current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xml:lang="en-US">Accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInDueToRelatedParties" xlink:label="us-gaap_IncreaseDecreaseInDueToRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDueToRelatedParties" xlink:to="us-gaap_IncreaseDecreaseInDueToRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInDueToRelatedParties_lbl" xml:lang="en-US">Due to related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_lbl" xml:lang="en-US">Refunds due to customer</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_IncreaseDecreaseInPrepaidsFromCustomers" xlink:label="RIME_IncreaseDecreaseInPrepaidsFromCustomers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_IncreaseDecreaseInPrepaidsFromCustomers" xlink:to="RIME_IncreaseDecreaseInPrepaidsFromCustomers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_IncreaseDecreaseInPrepaidsFromCustomers_lbl" xml:lang="en-US">Prepaids from customers</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_IncreaseDecreaseInReserveForSalesReturns" xlink:label="RIME_IncreaseDecreaseInReserveForSalesReturns" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_IncreaseDecreaseInReserveForSalesReturns" xlink:to="RIME_IncreaseDecreaseInReserveForSalesReturns_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="RIME_IncreaseDecreaseInReserveForSalesReturns_lbl" xml:lang="en-US">Reserve for sales returns</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl" xml:lang="en-US">Operating lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_PaymentOfEarlyTerminationFeeOnOperatingLeaseTerminationSettlement" xlink:label="RIME_PaymentOfEarlyTerminationFeeOnOperatingLeaseTerminationSettlement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_PaymentOfEarlyTerminationFeeOnOperatingLeaseTerminationSettlement" xlink:to="RIME_PaymentOfEarlyTerminationFeeOnOperatingLeaseTerminationSettlement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_PaymentOfEarlyTerminationFeeOnOperatingLeaseTerminationSettlement_lbl" xml:lang="en-US">Payment of early termination fee on operating lease termination settlement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash provided by (used in) operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Purchase of property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromPreviousAcquisition" xlink:label="us-gaap_ProceedsFromPreviousAcquisition" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromPreviousAcquisition" xlink:to="us-gaap_ProceedsFromPreviousAcquisition_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromPreviousAcquisition_lbl" xml:lang="en-US">Cash received from purchase of SemiCab Inc</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl" xml:lang="en-US">Disposal of property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash used in investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US">Proceeds from issuance of stock, net of offering costs</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_PaymentOfRedemptionAndRetirementOfTreasuryStock" xlink:label="RIME_PaymentOfRedemptionAndRetirementOfTreasuryStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_PaymentOfRedemptionAndRetirementOfTreasuryStock" xlink:to="RIME_PaymentOfRedemptionAndRetirementOfTreasuryStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="RIME_PaymentOfRedemptionAndRetirementOfTreasuryStock_lbl" xml:lang="en-US">Payment of redemption and retirement of treasury stock</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ProceedsFromCollectionOfSubscriptionsReceivable" xlink:label="RIME_ProceedsFromCollectionOfSubscriptionsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_ProceedsFromCollectionOfSubscriptionsReceivable" xlink:to="RIME_ProceedsFromCollectionOfSubscriptionsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_ProceedsFromCollectionOfSubscriptionsReceivable_lbl" xml:lang="en-US">Collection of subscriptions receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfSubordinatedDebt" xlink:label="us-gaap_RepaymentsOfSubordinatedDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfSubordinatedDebt" xlink:to="us-gaap_RepaymentsOfSubordinatedDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfSubordinatedDebt_lbl" xml:lang="en-US">Payment of subordinated note payable - Starlight Marketing Development, Ltd.</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_PaymentOfDeferredFinancingCharges" xlink:label="RIME_PaymentOfDeferredFinancingCharges" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_PaymentOfDeferredFinancingCharges" xlink:to="RIME_PaymentOfDeferredFinancingCharges_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="RIME_PaymentOfDeferredFinancingCharges_lbl" xml:lang="en-US">Payment of deferred financing charges</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_PaymentOfEarlyTerminationFeesOnRevolvingLinesOfCredit" xlink:label="RIME_PaymentOfEarlyTerminationFeesOnRevolvingLinesOfCredit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_PaymentOfEarlyTerminationFeesOnRevolvingLinesOfCredit" xlink:to="RIME_PaymentOfEarlyTerminationFeesOnRevolvingLinesOfCredit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="RIME_PaymentOfEarlyTerminationFeesOnRevolvingLinesOfCredit_lbl" xml:lang="en-US">Payment of early termination fees on revolving lines of credit</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_PaymentsOnInstallmentNote" xlink:label="RIME_PaymentsOnInstallmentNote" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_PaymentsOnInstallmentNote" xlink:to="RIME_PaymentsOnInstallmentNote_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="RIME_PaymentsOnInstallmentNote_lbl" xml:lang="en-US">Payments on installment notes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xml:lang="en-US">Proceeds from exercise of stock options</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ProceedsFromExerciseOfCommonStockWarrants" xlink:label="RIME_ProceedsFromExerciseOfCommonStockWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_ProceedsFromExerciseOfCommonStockWarrants" xlink:to="RIME_ProceedsFromExerciseOfCommonStockWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_ProceedsFromExerciseOfCommonStockWarrants_lbl" xml:lang="en-US">Proceeds from exercise of common stock warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="us-gaap_ProceedsFromWarrantExercises" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromWarrantExercises" xlink:to="us-gaap_ProceedsFromWarrantExercises_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromWarrantExercises_lbl" xml:lang="en-US">Proceeds from exercise of pre-funded warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations" xlink:label="us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations" xlink:to="us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_lbl" xml:lang="en-US">Payments on finance leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfOtherDebt" xlink:label="us-gaap_RepaymentsOfOtherDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfOtherDebt" xlink:to="us-gaap_RepaymentsOfOtherDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfOtherDebt_lbl" xml:lang="en-US">Payments on merchant cash advances payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromRepaymentsOfLinesOfCredit" xlink:label="us-gaap_ProceedsFromRepaymentsOfLinesOfCredit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRepaymentsOfLinesOfCredit" xlink:to="us-gaap_ProceedsFromRepaymentsOfLinesOfCredit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromRepaymentsOfLinesOfCredit_lbl" xml:lang="en-US">Net (payment) proceeds from revolving lines of credit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:label="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash provided by financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xml:lang="en-US">Net change in cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xml:lang="en-US">Cash at beginning of year</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_lbl" xml:lang="en-US">Cash at end of period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US">Supplemental disclosures of cash flow information:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaidNet_lbl" xml:lang="en-US">Cash paid for interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="us-gaap_IncomeTaxesPaidNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaidNet" xlink:to="us-gaap_IncomeTaxesPaidNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxesPaidNet_lbl" xml:lang="en-US">Cash paid for income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xml:lang="en-US">Non-Cash investing and financing cash flow information:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssued1" xlink:label="us-gaap_StockIssued1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssued1" xlink:to="us-gaap_StockIssued1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssued1_lbl" xml:lang="en-US">Common stock issued for purchase of SemiCab Inc</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalLeaseObligationsIncurred" xlink:label="us-gaap_CapitalLeaseObligationsIncurred" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalLeaseObligationsIncurred" xlink:to="us-gaap_CapitalLeaseObligationsIncurred_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalLeaseObligationsIncurred_lbl" xml:lang="en-US">Equipment purchased under capital lease</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl" xml:lang="en-US">Right of use assets exchanged for lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_IssuanceOfCommonStockAndWarrantsForOfferingCosts" xlink:label="RIME_IssuanceOfCommonStockAndWarrantsForOfferingCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_IssuanceOfCommonStockAndWarrantsForOfferingCosts" xlink:to="RIME_IssuanceOfCommonStockAndWarrantsForOfferingCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_IssuanceOfCommonStockAndWarrantsForOfferingCosts_lbl" xml:lang="en-US">Issuance of common stock and warrants for offering costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NatureOfOperations" xlink:label="us-gaap_NatureOfOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NatureOfOperations" xlink:to="us-gaap_NatureOfOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NatureOfOperations_lbl" xml:lang="en-US">NATURE OF BUSINESS</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DisclosureRecentDevelopmentsAbstract" xlink:label="RIME_DisclosureRecentDevelopmentsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_DisclosureRecentDevelopmentsAbstract" xlink:to="RIME_DisclosureRecentDevelopmentsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_DisclosureRecentDevelopmentsAbstract_lbl" xml:lang="en-US">Recent Developments</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_RecentDevelopmentsTextBlock" xlink:label="RIME_RecentDevelopmentsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_RecentDevelopmentsTextBlock" xlink:to="RIME_RecentDevelopmentsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_RecentDevelopmentsTextBlock_lbl" xml:lang="en-US">RECENT DEVELOPMENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" xlink:label="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" xlink:to="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock_lbl" xml:lang="en-US">LIQUIDITY, GOING CONCERN AND MANAGEMENT PLANS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_lbl" xml:lang="en-US">Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionTextBlock" xlink:label="us-gaap_AssetAcquisitionTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetAcquisitionTextBlock" xlink:to="us-gaap_AssetAcquisitionTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetAcquisitionTextBlock_lbl" xml:lang="en-US">ASSET ACQUISITION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xml:lang="en-US">FINANCING</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtTextBlock" xlink:label="us-gaap_LongTermDebtTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtTextBlock" xlink:to="us-gaap_LongTermDebtTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtTextBlock_lbl" xml:lang="en-US">LOANS PAYABLE &#8211; RELATED PARTIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DisclosureOperatingLeasesAbstract" xlink:label="RIME_DisclosureOperatingLeasesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_DisclosureOperatingLeasesAbstract" xlink:to="RIME_DisclosureOperatingLeasesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_DisclosureOperatingLeasesAbstract_lbl" xml:lang="en-US">Operating Leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xml:lang="en-US">OPERATING LEASES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityAbstract_lbl" xml:lang="en-US">Equity [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">ISSUANCE OF COMMON STOCK</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DisclosureWarrantsAbstract" xlink:label="RIME_DisclosureWarrantsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_DisclosureWarrantsAbstract" xlink:to="RIME_DisclosureWarrantsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_DisclosureWarrantsAbstract_lbl" xml:lang="en-US">Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_WarrantsDisclosureTextBlock" xlink:label="RIME_WarrantsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_WarrantsDisclosureTextBlock" xlink:to="RIME_WarrantsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_WarrantsDisclosureTextBlock_lbl" xml:lang="en-US">WARRANTS</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerShareAbstract_2_lbl" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xml:lang="en-US">COMPUTATION OF LOSS PER SHARE</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">INCOME TAXES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingAbstract_lbl" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xml:lang="en-US">REVENUE DISAGGREGATION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:label="us-gaap_ConcentrationRiskDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:to="us-gaap_ConcentrationRiskDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskDisclosureTextBlock_lbl" xml:lang="en-US">CONCENTRATIONS OF CREDIT RISK AND REVENUE</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US">RELATED PARTY TRANSACTIONS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">SUBSEQUENT EVENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xml:lang="en-US">PROPERTY AND EQUIPMENT</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xml:lang="en-US">STOCK COMPENSATION EXPENSE</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DisclosurePublicOfferingAndNasdaqUplistingAbstract" xlink:label="RIME_DisclosurePublicOfferingAndNasdaqUplistingAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_DisclosurePublicOfferingAndNasdaqUplistingAbstract" xlink:to="RIME_DisclosurePublicOfferingAndNasdaqUplistingAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_DisclosurePublicOfferingAndNasdaqUplistingAbstract_lbl" xml:lang="en-US">Public Offering And Nasdaq Uplisting</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_IssuanceOfPublicOfferingTextBlock" xlink:label="RIME_IssuanceOfPublicOfferingTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_IssuanceOfPublicOfferingTextBlock" xlink:to="RIME_IssuanceOfPublicOfferingTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_IssuanceOfPublicOfferingTextBlock_lbl" xml:lang="en-US">PUBLIC OFFERING AND NASDAQ UPLISTING</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DisclosureAtmOfferingAbstract" xlink:label="RIME_DisclosureAtmOfferingAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_DisclosureAtmOfferingAbstract" xlink:to="RIME_DisclosureAtmOfferingAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_DisclosureAtmOfferingAbstract_lbl" xml:lang="en-US">Atm Offering</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AtTheMarketPublicOfferingTextBlock" xlink:label="RIME_AtTheMarketPublicOfferingTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_AtTheMarketPublicOfferingTextBlock" xlink:to="RIME_AtTheMarketPublicOfferingTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_AtTheMarketPublicOfferingTextBlock_lbl" xml:lang="en-US">ATM OFFERING</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DisclosurePrivatePlacementAbstract" xlink:label="RIME_DisclosurePrivatePlacementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_DisclosurePrivatePlacementAbstract" xlink:to="RIME_DisclosurePrivatePlacementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_DisclosurePrivatePlacementAbstract_lbl" xml:lang="en-US">Private Placement</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_PrivatePlacementTextBlock" xlink:label="RIME_PrivatePlacementTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_PrivatePlacementTextBlock" xlink:to="RIME_PrivatePlacementTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_PrivatePlacementTextBlock_lbl" xml:lang="en-US">PRIVATE PLACEMENT</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DisclosureAugust2021StockRedemptionAbstract" xlink:label="RIME_DisclosureAugust2021StockRedemptionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_DisclosureAugust2021StockRedemptionAbstract" xlink:to="RIME_DisclosureAugust2021StockRedemptionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_DisclosureAugust2021StockRedemptionAbstract_lbl" xml:lang="en-US">August 2021 Stock Redemption</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_StockRedemptionTextBlock" xlink:label="RIME_StockRedemptionTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_StockRedemptionTextBlock" xlink:to="RIME_StockRedemptionTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_StockRedemptionTextBlock_lbl" xml:lang="en-US">AUGUST 2021 STOCK REDEMPTION</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DisclosureAugust2021PrivatePlacementAbstract" xlink:label="RIME_DisclosureAugust2021PrivatePlacementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_DisclosureAugust2021PrivatePlacementAbstract" xlink:to="RIME_DisclosureAugust2021PrivatePlacementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_DisclosureAugust2021PrivatePlacementAbstract_lbl" xml:lang="en-US">August 2021 Private Placement</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AugustTwentyTwentyOnePrivatePlacementTextBlock" xlink:label="RIME_AugustTwentyTwentyOnePrivatePlacementTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_AugustTwentyTwentyOnePrivatePlacementTextBlock" xlink:to="RIME_AugustTwentyTwentyOnePrivatePlacementTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_AugustTwentyTwentyOnePrivatePlacementTextBlock_lbl" xml:lang="en-US">AUGUST 2021 PRIVATE PLACEMENT</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InsuranceAbstract" xlink:label="us-gaap_InsuranceAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InsuranceAbstract" xlink:to="us-gaap_InsuranceAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InsuranceAbstract_lbl" xml:lang="en-US">Insurance [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InsuranceDisclosureTextBlock" xlink:label="us-gaap_InsuranceDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InsuranceDisclosureTextBlock" xlink:to="us-gaap_InsuranceDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InsuranceDisclosureTextBlock_lbl" xml:lang="en-US">DAMAGED GOODS INCIDENT RECOVERY</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DisclosureSupplementalInformationCondensedFinancialInformationAbstract" xlink:label="RIME_DisclosureSupplementalInformationCondensedFinancialInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_DisclosureSupplementalInformationCondensedFinancialInformationAbstract" xlink:to="RIME_DisclosureSupplementalInformationCondensedFinancialInformationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_DisclosureSupplementalInformationCondensedFinancialInformationAbstract_lbl" xml:lang="en-US">Supplemental Information Condensed Financial Information</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SupplementalInformationDisclosuresTextBlock" xlink:label="RIME_SupplementalInformationDisclosuresTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SupplementalInformationDisclosuresTextBlock" xlink:to="RIME_SupplementalInformationDisclosuresTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_SupplementalInformationDisclosuresTextBlock_lbl" xml:lang="en-US">SUPPLEMENTAL INFORMATION CONDENSED FINANCIAL INFORMATION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsAndNontradeReceivableTextBlock" xlink:label="us-gaap_AccountsAndNontradeReceivableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsAndNontradeReceivableTextBlock" xlink:to="us-gaap_AccountsAndNontradeReceivableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsAndNontradeReceivableTextBlock_lbl" xml:lang="en-US">ACCOUNTS RECEIVABLE</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xml:lang="en-US">ACCOUNTS PAYABLE AND ACCRUED EXPENSES</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_NotePayableAndFinancingArrangementsTextBlock" xlink:label="RIME_NotePayableAndFinancingArrangementsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_NotePayableAndFinancingArrangementsTextBlock" xlink:to="RIME_NotePayableAndFinancingArrangementsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_NotePayableAndFinancingArrangementsTextBlock_lbl" xml:lang="en-US">NOTES PAYABLE AND FINANING ARRANGEMENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AccountsReceivableDisclosureTextBlock" xlink:label="RIME_AccountsReceivableDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_AccountsReceivableDisclosureTextBlock" xlink:to="RIME_AccountsReceivableDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_AccountsReceivableDisclosureTextBlock_lbl" xml:lang="en-US">DUE FROM FACTOR</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_2_lbl" xml:lang="en-US">STOCKHOLDERS&#8217; EQUITY</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SafePrivatePlacementsTextBlock" xlink:label="RIME_SafePrivatePlacementsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SafePrivatePlacementsTextBlock" xlink:to="RIME_SafePrivatePlacementsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_SafePrivatePlacementsTextBlock_lbl" xml:lang="en-US">SAFE PRIVATE PLACEMENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:label="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:to="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_lbl" xml:lang="en-US">EMPLOYEE BENEFIT PLANS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US">BASIS OF PRESENTATION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xml:lang="en-US">PRINCIPLES OF CONSOLIDATION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationsPolicy" xlink:label="us-gaap_BusinessCombinationsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationsPolicy" xlink:to="us-gaap_BusinessCombinationsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationsPolicy_lbl" xml:lang="en-US">Business Combinations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl" xml:lang="en-US">Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy" xlink:label="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy" xlink:to="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy_lbl" xml:lang="en-US">Intangible Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl" xml:lang="en-US">Fair Value Measurements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">RECENT ACCOUNTING PRONOUNCEMENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:label="us-gaap_PriorPeriodReclassificationAdjustmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="us-gaap_PriorPeriodReclassificationAdjustmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PriorPeriodReclassificationAdjustmentDescription_lbl" xml:lang="en-US">RECLASSIFICATION OF PRIOR YEARS PRESENTATION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">USE OF ESTIMATES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:to="us-gaap_TradeAndOtherAccountsReceivablePolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy_lbl" xml:lang="en-US">ACCOUNTS RECEIVABLE AND ALLOWANCES FOR EXPECTED CREDIT LOSSES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="us-gaap_InventoryPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryPolicyTextBlock" xlink:to="us-gaap_InventoryPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryPolicyTextBlock_lbl" xml:lang="en-US">INVENTORY AND RETURNS ASSET</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xml:lang="en-US">LONG-LIVED ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xml:lang="en-US">PROPERTY AND EQUIPMENT</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xml:lang="en-US">LEASES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US">FAIR VALUE OF FINANCIAL INSTRUMENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xml:lang="en-US">REVENUE RECOGNITION AND RESERVE FOR SALES RETURNS</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ShippingAndHandlingCostsPolicyTextBlock" xlink:label="RIME_ShippingAndHandlingCostsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_ShippingAndHandlingCostsPolicyTextBlock" xlink:to="RIME_ShippingAndHandlingCostsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_ShippingAndHandlingCostsPolicyTextBlock_lbl" xml:lang="en-US">SHIPPING AND HANDLING COSTS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xml:lang="en-US">SHARE-BASED COMPENSATION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">INCOME TAXES</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountPolicy" xlink:label="RIME_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountPolicy" xlink:to="RIME_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountPolicy_lbl" xml:lang="en-US">ALLOWANCE FOR DOUBTFUL ACCOUNTS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xml:lang="en-US">FOREIGN CURRENCY TRANSLATION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xml:lang="en-US">Concentration of Credit Risk</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_PrepaidExpensesPolicyTextBlock" xlink:label="RIME_PrepaidExpensesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_PrepaidExpensesPolicyTextBlock" xlink:to="RIME_PrepaidExpensesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_PrepaidExpensesPolicyTextBlock_lbl" xml:lang="en-US">PREPAID EXPENSES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:to="us-gaap_CompensationRelatedCostsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock_lbl" xml:lang="en-US">STOCK-BASED COMPENSATION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xml:lang="en-US">RESEARCH AND DEVELOPMENT COSTS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">COMPUTATION OF EARNINGS (LOSS) PER SHARE</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF CONSIDERATION TRANSFERRED TO THE ASSETS ACQUIRED AND LIABILITIES ASSUMED</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ScheduleOfProFormaFinancialInformationTableTextBlock" xlink:label="RIME_ScheduleOfProFormaFinancialInformationTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_ScheduleOfProFormaFinancialInformationTableTextBlock" xlink:to="RIME_ScheduleOfProFormaFinancialInformationTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_ScheduleOfProFormaFinancialInformationTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF PRO FORMA FINANCIAL INFORMATION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF LOAN</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ScheduleOfSupplementalInformationRelatedToLeaseTableTextBlock" xlink:label="RIME_ScheduleOfSupplementalInformationRelatedToLeaseTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_ScheduleOfSupplementalInformationRelatedToLeaseTableTextBlock" xlink:to="RIME_ScheduleOfSupplementalInformationRelatedToLeaseTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_ScheduleOfSupplementalInformationRelatedToLeaseTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF SUPPLEMENTAL INFORMATION RELATED TO LEASES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="us-gaap_LeaseCostTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCostTableTextBlock" xlink:to="us-gaap_LeaseCostTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF LEASE TERM AND DISCOUNT RATE</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF OPERATING LEASE MINIMUM FUTURE PAYMENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xml:lang="en-US">SCHEDULE OF WARRANTS EXPIRATION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF BASIC AND DILUTIVE SHARES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF REVENUE BY PRODUCT LINE</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:label="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:to="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF REVENUE BY GEOGRAPHICAL REGION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US">SCHEDULE OF PROPERTY AND EQUIPMENT</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xml:lang="en-US">SUMMARY OF STOCK OPTION ACTIVITY</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ScheduleOfLossBeforeIncomeTaxTableTextBlock" xlink:label="RIME_ScheduleOfLossBeforeIncomeTaxTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_ScheduleOfLossBeforeIncomeTaxTableTextBlock" xlink:to="RIME_ScheduleOfLossBeforeIncomeTaxTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_ScheduleOfLossBeforeIncomeTaxTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF LOSS BEFORE INCOME TAXES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF PROVISION FOR INCOME TAXES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:to="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF TAX PROVISION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfCondensedIncomeStatementTableTextBlock" xlink:label="srt_ScheduleOfCondensedIncomeStatementTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScheduleOfCondensedIncomeStatementTableTextBlock" xlink:to="srt_ScheduleOfCondensedIncomeStatementTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScheduleOfCondensedIncomeStatementTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfCondensedCashFlowStatementTableTextBlock" xlink:label="srt_ScheduleOfCondensedCashFlowStatementTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScheduleOfCondensedCashFlowStatementTableTextBlock" xlink:to="srt_ScheduleOfCondensedCashFlowStatementTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScheduleOfCondensedCashFlowStatementTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:label="us-gaap_ScheduleOfStockholdersEquityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:to="us-gaap_ScheduleOfStockholdersEquityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfStockholdersEquityTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS&#8217; EQUITY</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US">SCHEDULE OF ESTIMATED USEFUL LIVES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDebtTableTextBlock" xlink:label="us-gaap_ScheduleOfDebtTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="us-gaap_ScheduleOfDebtTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDebtTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF SPECIFIC TERMS</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ScheduleOfStockOptionIssuedTableTextBlock" xlink:label="RIME_ScheduleOfStockOptionIssuedTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_ScheduleOfStockOptionIssuedTableTextBlock" xlink:to="RIME_ScheduleOfStockOptionIssuedTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_ScheduleOfStockOptionIssuedTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF STOCK OPTION ISSUED DURING THE YEAR DECEMBER 31, 2020, 2021 AND 2022</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SafePrivatePlacementsTableTextBlock" xlink:label="RIME_SafePrivatePlacementsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SafePrivatePlacementsTableTextBlock" xlink:to="RIME_SafePrivatePlacementsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_SafePrivatePlacementsTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF FIRST TRANCHE OF SUBSCRIPTIONS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock" xlink:label="us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock" xlink:to="us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock_lbl" xml:lang="en-US">SUMMARY OF TERMINATED IMMEDIATELY AFTER CLOSING OF THE TRANSACTION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl" xml:lang="en-US">Number of stock sold, value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LegalFees" xlink:label="us-gaap_LegalFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LegalFees" xlink:to="us-gaap_LegalFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LegalFees_lbl" xml:lang="en-US">Legal and administrative expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xml:lang="en-US">Number of shares sold</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl" xml:lang="en-US">Proceeds from sale of equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdministrativeFeesExpense" xlink:label="us-gaap_AdministrativeFeesExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdministrativeFeesExpense" xlink:to="us-gaap_AdministrativeFeesExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdministrativeFeesExpense_lbl" xml:lang="en-US">Brokerage commissions and administrative fees</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:label="us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:to="us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets_lbl" xml:lang="en-US">Shares purchase</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xml:lang="en-US">Membership percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AreaOfLand" xlink:label="us-gaap_AreaOfLand" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AreaOfLand" xlink:to="us-gaap_AreaOfLand_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AreaOfLand_lbl" xml:lang="en-US">Lease space</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AssetsWriteOff" xlink:label="RIME_AssetsWriteOff" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_AssetsWriteOff" xlink:to="RIME_AssetsWriteOff_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_AssetsWriteOff_lbl" xml:lang="en-US">Written off</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasePayments" xlink:label="us-gaap_OperatingLeasePayments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasePayments" xlink:to="us-gaap_OperatingLeasePayments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasePayments_lbl" xml:lang="en-US">Lease payments</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_OperatingLeasePeriodicPayments" xlink:label="RIME_OperatingLeasePeriodicPayments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_OperatingLeasePeriodicPayments" xlink:to="RIME_OperatingLeasePeriodicPayments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_OperatingLeasePeriodicPayments_lbl" xml:lang="en-US">periodic lease payments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnTerminationOfLease" xlink:to="us-gaap_GainLossOnTerminationOfLease_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnTerminationOfLease_2_lbl" xml:lang="en-US">Gain loss on termination of operating lease</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_LeaseSettlementExpense" xlink:label="RIME_LeaseSettlementExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_LeaseSettlementExpense" xlink:to="RIME_LeaseSettlementExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_LeaseSettlementExpense_lbl" xml:lang="en-US">Lease settlement expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SecuredDebt" xlink:label="us-gaap_SecuredDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecuredDebt" xlink:to="us-gaap_SecuredDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SecuredDebt_lbl" xml:lang="en-US">Secured note principal amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl" xml:lang="en-US">Proceeds from private placement</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_PrivatePlacementIssueDiscount" xlink:label="RIME_PrivatePlacementIssueDiscount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_PrivatePlacementIssueDiscount" xlink:to="RIME_PrivatePlacementIssueDiscount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_PrivatePlacementIssueDiscount_lbl" xml:lang="en-US">Private placement issue discount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" xml:lang="en-US">Revolving credit facility</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:label="us-gaap_LineOfCreditFacilityCommitmentFeeAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:to="us-gaap_LineOfCreditFacilityCommitmentFeeAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityCommitmentFeeAmount_lbl" xml:lang="en-US">Credit facility termination fee</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesIssued_2_lbl" xml:lang="en-US">Shares issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_2_lbl" xml:lang="en-US">Shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl" xml:lang="en-US">Commmon stock share per share</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_TransactionFees" xlink:label="RIME_TransactionFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_TransactionFees" xlink:to="RIME_TransactionFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_TransactionFees_lbl" xml:lang="en-US">Transaction fees</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" xml:lang="en-US">Lease term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRent" xlink:label="us-gaap_PaymentsForRent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRent" xlink:to="us-gaap_PaymentsForRent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForRent_lbl" xml:lang="en-US">Initial base rent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4_lbl" xml:lang="en-US">Stockholders equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_WorkingCapital" xlink:label="RIME_WorkingCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_WorkingCapital" xlink:to="RIME_WorkingCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_WorkingCapital_lbl" xml:lang="en-US">Working capital deficit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_2_lbl" xml:lang="en-US">Accumulated losses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionTable" xlink:label="us-gaap_AssetAcquisitionTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetAcquisitionTable" xlink:to="us-gaap_AssetAcquisitionTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetAcquisitionTable_lbl" xml:lang="en-US">Asset Acquisition [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionLineItems" xlink:label="us-gaap_AssetAcquisitionLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetAcquisitionLineItems" xlink:to="us-gaap_AssetAcquisitionLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetAcquisitionLineItems_lbl" xml:lang="en-US">Asset Acquisition [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" xlink:label="us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" xlink:to="us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable_lbl" xml:lang="en-US">Equity consideration</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AssetAcquisitionFairValueOfNonControllingInterest" xlink:label="RIME_AssetAcquisitionFairValueOfNonControllingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_AssetAcquisitionFairValueOfNonControllingInterest" xlink:to="RIME_AssetAcquisitionFairValueOfNonControllingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_AssetAcquisitionFairValueOfNonControllingInterest_lbl" xml:lang="en-US">Fair value of non-controlling interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration" xlink:label="us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration" xlink:to="us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration_lbl" xml:lang="en-US">Total Equity Consideration</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AssetAcquisitionDebtExtinguishment" xlink:label="RIME_AssetAcquisitionDebtExtinguishment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_AssetAcquisitionDebtExtinguishment" xlink:to="RIME_AssetAcquisitionDebtExtinguishment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_AssetAcquisitionDebtExtinguishment_lbl" xml:lang="en-US">Debt Extinguishment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionConsiderationTransferred" xlink:label="us-gaap_AssetAcquisitionConsiderationTransferred" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetAcquisitionConsiderationTransferred" xlink:to="us-gaap_AssetAcquisitionConsiderationTransferred_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetAcquisitionConsiderationTransferred_lbl" xml:lang="en-US">Total consideration</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_lbl" xml:lang="en-US">Cash and Cash Equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl" xml:lang="en-US">Accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_lbl" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_lbl" xml:lang="en-US">Property and equipment, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_lbl" xml:lang="en-US">Other Non-Current Operating Assets, Net</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCustomerRelationships" xlink:label="RIME_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCustomerRelationships" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCustomerRelationships" xlink:to="RIME_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCustomerRelationships_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCustomerRelationships_lbl" xml:lang="en-US">Customer Relationships (9 year estimated useful life)</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradeName" xlink:label="RIME_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradeName" xlink:to="RIME_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradeName_lbl" xml:lang="en-US">Trade Name (9 year estimated useful life)</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDevelopedTechnology" xlink:label="RIME_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDevelopedTechnology" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDevelopedTechnology" xlink:to="RIME_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDevelopedTechnology_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDevelopedTechnology_lbl" xml:lang="en-US">Developed Technology (6 year estimated useful life)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLoansPayable" xlink:label="RIME_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLoansPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLoansPayable" xlink:to="RIME_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLoansPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLoansPayable_lbl" xml:lang="en-US">Loans payable Merchant Cash Advances (MCA)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt_lbl" xml:lang="en-US">Note payable</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesNotesPayableRelatedParties" xlink:label="RIME_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesNotesPayableRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesNotesPayableRelatedParties" xlink:to="RIME_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesNotesPayableRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesNotesPayableRelatedParties_lbl" xml:lang="en-US">Notes payable Related Parties</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl" xml:lang="en-US">Net assets acquired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_Goodwill_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_Goodwill_2_lbl" xml:lang="en-US">Estimated Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_lbl" xml:lang="en-US">Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:label="us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_lbl" xml:lang="en-US">Acquired Finite-Lived Intangible Assets [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:label="us-gaap_BusinessAcquisitionsProFormaRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:to="us-gaap_BusinessAcquisitionsProFormaRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionsProFormaRevenue_lbl" xml:lang="en-US">Net revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax" xlink:label="us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax" xlink:to="us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax_lbl" xml:lang="en-US">Operating loss from continuing operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:label="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:to="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_lbl" xml:lang="en-US">Net loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets" xlink:label="us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets" xlink:to="us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets_lbl" xml:lang="en-US">Purchase of assets value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_2_lbl" xml:lang="en-US">Ownership percentage</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_2_lbl" xml:lang="en-US">Seller Consideration share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalariesAndWages" xlink:label="us-gaap_SalariesAndWages" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalariesAndWages" xlink:to="us-gaap_SalariesAndWages_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalariesAndWages_lbl" xml:lang="en-US">Salaries and wages</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetAcquisitionConsiderationTransferred" xlink:to="us-gaap_AssetAcquisitionConsiderationTransferred_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AssetAcquisitionConsiderationTransferred_2_lbl" xml:lang="en-US">Asset acquisition purchase price consideration</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetIncludingGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetIncludingGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsNetIncludingGoodwill_lbl" xml:lang="en-US">Identifiable intangible assets including goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_NonControllingInterestAtFairValue" xlink:label="RIME_NonControllingInterestAtFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_NonControllingInterestAtFairValue" xlink:to="RIME_NonControllingInterestAtFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_NonControllingInterestAtFairValue_lbl" xml:lang="en-US">Non-controlling interest at fair value</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_RoyaltyRate" xlink:label="RIME_RoyaltyRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_RoyaltyRate" xlink:to="RIME_RoyaltyRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_RoyaltyRate_lbl" xml:lang="en-US">Royalty rate</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DiscountOnRoyaltyRate" xlink:label="RIME_DiscountOnRoyaltyRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_DiscountOnRoyaltyRate" xlink:to="RIME_DiscountOnRoyaltyRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_DiscountOnRoyaltyRate_lbl" xml:lang="en-US">Discount on royalty rate</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_RoyaltyTerm" xlink:label="RIME_RoyaltyTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_RoyaltyTerm" xlink:to="RIME_RoyaltyTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_RoyaltyTerm_lbl" xml:lang="en-US">Royalty term</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_GrowthRateOfDevelopmentOfNewBusiness" xlink:label="RIME_GrowthRateOfDevelopmentOfNewBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_GrowthRateOfDevelopmentOfNewBusiness" xlink:to="RIME_GrowthRateOfDevelopmentOfNewBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_GrowthRateOfDevelopmentOfNewBusiness_lbl" xml:lang="en-US">Growth rate of development of new business</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DiscountRateForWeightedAverageCost" xlink:label="RIME_DiscountRateForWeightedAverageCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_DiscountRateForWeightedAverageCost" xlink:to="RIME_DiscountRateForWeightedAverageCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_DiscountRateForWeightedAverageCost_lbl" xml:lang="en-US">Discount rate for weighted average cost</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapital" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapital" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapital_lbl" xml:lang="en-US">Increase decrease in operating capital</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LegalFees" xlink:to="us-gaap_LegalFees_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LegalFees_2_lbl" xml:lang="en-US">Legal fees</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_2_lbl" xml:lang="en-US">Stock issued during period shares acquisitions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityTable" xlink:label="us-gaap_LineOfCreditFacilityTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityTable" xlink:to="us-gaap_LineOfCreditFacilityTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityTable_lbl" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityLineItems" xlink:label="us-gaap_LineOfCreditFacilityLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="us-gaap_LineOfCreditFacilityLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityLineItems_lbl" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_2_lbl" xml:lang="en-US">Line of credit facility, maximum borrowing amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherReceivables" xlink:label="us-gaap_OtherReceivables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherReceivables" xlink:to="us-gaap_OtherReceivables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherReceivables_lbl" xml:lang="en-US">Due from Oxford Bank</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:label="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:to="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_lbl" xml:lang="en-US">The Prime Rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseDebt" xlink:label="us-gaap_InterestExpenseDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseDebt" xlink:to="us-gaap_InterestExpenseDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpenseDebt_lbl" xml:lang="en-US">Interest expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTerm" xlink:label="us-gaap_DebtInstrumentTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentTerm" xlink:to="us-gaap_DebtInstrumentTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentTerm_lbl" xml:lang="en-US">Credit agreement term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityExpirationDate1" xlink:label="us-gaap_LineOfCreditFacilityExpirationDate1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityExpirationDate1" xlink:to="us-gaap_LineOfCreditFacilityExpirationDate1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityExpirationDate1_lbl" xml:lang="en-US">Revolving credit facility terminated date</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_PercentageOfExitFee" xlink:label="RIME_PercentageOfExitFee" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_PercentageOfExitFee" xlink:to="RIME_PercentageOfExitFee_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_PercentageOfExitFee_lbl" xml:lang="en-US">Percentage of exit fee</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessExitCosts1" xlink:label="us-gaap_BusinessExitCosts1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessExitCosts1" xlink:to="us-gaap_BusinessExitCosts1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessExitCosts1_lbl" xml:lang="en-US">Exit fee payable on termination of contract</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfLinesOfCredit" xlink:label="us-gaap_RepaymentsOfLinesOfCredit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfLinesOfCredit" xlink:to="us-gaap_RepaymentsOfLinesOfCredit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfLinesOfCredit_lbl" xml:lang="en-US">Costs associated with line of credit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityInterestRateDescription" xlink:label="us-gaap_LineOfCreditFacilityInterestRateDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityInterestRateDescription" xlink:to="us-gaap_LineOfCreditFacilityInterestRateDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityInterestRateDescription_lbl" xml:lang="en-US">Base rates of loan description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestAndDebtExpense" xlink:label="us-gaap_InterestAndDebtExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestAndDebtExpense" xlink:to="us-gaap_InterestAndDebtExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestAndDebtExpense_lbl" xml:lang="en-US">Interest expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xml:lang="en-US">Initial amount borrowed</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromShortTermDebt" xlink:label="us-gaap_ProceedsFromShortTermDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromShortTermDebt" xlink:to="us-gaap_ProceedsFromShortTermDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromShortTermDebt_lbl" xml:lang="en-US">Net proceeds from short term debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:label="us-gaap_DebtInstrumentPeriodicPayment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentPeriodicPayment" xlink:to="us-gaap_DebtInstrumentPeriodicPayment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentPeriodicPayment_lbl" xml:lang="en-US">Stipulated periodic payment of short term debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfShortTermDebt" xlink:label="us-gaap_RepaymentsOfShortTermDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfShortTermDebt" xlink:to="us-gaap_RepaymentsOfShortTermDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfShortTermDebt_lbl" xml:lang="en-US">Total short term debt to be repaid</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="us-gaap_DebtInstrumentInterestRateEffectivePercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage_lbl" xml:lang="en-US">Effective Interest rate</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermBorrowings" xlink:to="us-gaap_ShortTermBorrowings_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShortTermBorrowings_2_lbl" xml:lang="en-US">Amount outstanding for Agile Capital Funding,LLC</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_LineOfCreditFacilityInterestRate" xlink:label="RIME_LineOfCreditFacilityInterestRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_LineOfCreditFacilityInterestRate" xlink:to="RIME_LineOfCreditFacilityInterestRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="RIME_LineOfCreditFacilityInterestRate_lbl" xml:lang="en-US">The Prime Rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentForAmortization" xlink:label="us-gaap_AdjustmentForAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentForAmortization" xlink:to="us-gaap_AdjustmentForAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentForAmortization_lbl" xml:lang="en-US">Amortization expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentIssuanceDate1" xlink:label="us-gaap_DebtInstrumentIssuanceDate1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentIssuanceDate1" xlink:to="us-gaap_DebtInstrumentIssuanceDate1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentIssuanceDate1_lbl" xml:lang="en-US">Debt Instrument, Issuance Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMaturityDate" xlink:to="us-gaap_DebtInstrumentMaturityDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl" xml:lang="en-US">Debt Instrument, Maturity Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayable" xlink:label="us-gaap_NotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayable" xlink:to="us-gaap_NotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesPayable_lbl" xml:lang="en-US">Amount due as of September 30, 2024</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayableCurrent" xlink:to="us-gaap_NotesPayableCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NotesPayableCurrent_2_lbl" xml:lang="en-US">Less: Current portion of notes payable to related parties</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermNotesPayable" xlink:to="us-gaap_LongTermNotesPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LongTermNotesPayable_2_lbl" xml:lang="en-US">Notes payable to related parties, net of current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPayableCurrentAndNoncurrent" xlink:label="us-gaap_InterestPayableCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPayableCurrentAndNoncurrent" xlink:to="us-gaap_InterestPayableCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPayableCurrentAndNoncurrent_lbl" xml:lang="en-US">Accrued interest payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InterestExpense_lbl" xml:lang="en-US">Interest expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_WorkingCapital" xlink:to="RIME_WorkingCapital_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="RIME_WorkingCapital_2_lbl" xml:lang="en-US">Working capital</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentTerm" xlink:to="us-gaap_DebtInstrumentTerm_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentTerm_2_lbl" xml:lang="en-US">Maturity date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfDebt" xlink:label="us-gaap_RepaymentsOfDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfDebt" xlink:to="us-gaap_RepaymentsOfDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfDebt_lbl" xml:lang="en-US">Repayments of Debt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_2_lbl" xml:lang="en-US">Interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LitigationSettlementExpense" xlink:label="us-gaap_LitigationSettlementExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LitigationSettlementExpense" xlink:to="us-gaap_LitigationSettlementExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LitigationSettlementExpense_lbl" xml:lang="en-US">Payments of litigation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_lbl" xml:lang="en-US">Component of accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_LossContingencyEstimateOfPossibleLossPerYear" xlink:label="RIME_LossContingencyEstimateOfPossibleLossPerYear" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_LossContingencyEstimateOfPossibleLossPerYear" xlink:to="RIME_LossContingencyEstimateOfPossibleLossPerYear_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_LossContingencyEstimateOfPossibleLossPerYear_lbl" xml:lang="en-US">Loss contingency estimate of possible loss per year</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:label="us-gaap_LossContingencyEstimateOfPossibleLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:to="us-gaap_LossContingencyEstimateOfPossibleLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LossContingencyEstimateOfPossibleLoss_lbl" xml:lang="en-US">Loss contingency estimate of possible loss value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyDamagesSoughtValue" xlink:label="us-gaap_LossContingencyDamagesSoughtValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingencyDamagesSoughtValue" xlink:to="us-gaap_LossContingencyDamagesSoughtValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LossContingencyDamagesSoughtValue_lbl" xml:lang="en-US">Damages claimed</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyDamagesAwardedValue" xlink:label="us-gaap_LossContingencyDamagesAwardedValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingencyDamagesAwardedValue" xlink:to="us-gaap_LossContingencyDamagesAwardedValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LossContingencyDamagesAwardedValue_lbl" xml:lang="en-US">Loss contingency damages awarded value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyDamagesPaidValue" xlink:label="us-gaap_LossContingencyDamagesPaidValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingencyDamagesPaidValue" xlink:to="us-gaap_LossContingencyDamagesPaidValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LossContingencyDamagesPaidValue_lbl" xml:lang="en-US">First milestone payment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseExpense" xlink:label="us-gaap_OperatingLeaseExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseExpense" xlink:to="us-gaap_OperatingLeaseExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseExpense_lbl" xml:lang="en-US">Operating lease expense</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_InsuranceLiabilities" xlink:label="RIME_InsuranceLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_InsuranceLiabilities" xlink:to="RIME_InsuranceLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_InsuranceLiabilities_lbl" xml:lang="en-US">Insurance liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MalpracticeInsuranceMaximumCoveragePerIncident" xlink:label="us-gaap_MalpracticeInsuranceMaximumCoveragePerIncident" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MalpracticeInsuranceMaximumCoveragePerIncident" xlink:to="us-gaap_MalpracticeInsuranceMaximumCoveragePerIncident_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MalpracticeInsuranceMaximumCoveragePerIncident_lbl" xml:lang="en-US">Malpractice Insurance, Maximum Coverage Per Incident</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_PaymentsForMilestone" xlink:label="RIME_PaymentsForMilestone" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_PaymentsForMilestone" xlink:to="RIME_PaymentsForMilestone_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_PaymentsForMilestone_lbl" xml:lang="en-US">Payments for milestone</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForLegalSettlements" xlink:label="us-gaap_PaymentsForLegalSettlements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForLegalSettlements" xlink:to="us-gaap_PaymentsForLegalSettlements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForLegalSettlements_lbl" xml:lang="en-US">Remaining settlement</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherLiabilitiesCurrent_2_lbl" xml:lang="en-US">Other current liability</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DisputeAmount" xlink:label="RIME_DisputeAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_DisputeAmount" xlink:to="RIME_DisputeAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_DisputeAmount_lbl" xml:lang="en-US">Dispute. amount</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AccruedPotentialLiability" xlink:label="RIME_AccruedPotentialLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_AccruedPotentialLiability" xlink:to="RIME_AccruedPotentialLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_AccruedPotentialLiability_lbl" xml:lang="en-US">Accrued, potential liability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_DisclosureOperatingLeasesAbstract" xlink:to="RIME_DisclosureOperatingLeasesAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="RIME_DisclosureOperatingLeasesAbstract_2_lbl" xml:lang="en-US">Schedule Of Supplemental Information Related To Leases</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_2_lbl" xml:lang="en-US">Operating lease - right-of-use assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityAbstract" xlink:label="us-gaap_OperatingLeaseLiabilityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityAbstract_lbl" xml:lang="en-US">Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_2_lbl" xml:lang="en-US">Current portion of operating leases</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_DisclosureOperatingLeasesAbstract" xlink:to="RIME_DisclosureOperatingLeasesAbstract_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="RIME_DisclosureOperatingLeasesAbstract_3_lbl" xml:lang="en-US">Schedule Of Lease Term And Discount Rate</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseExpense" xlink:to="us-gaap_OperatingLeaseExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseExpense_2_lbl" xml:lang="en-US">Operating lease expense as a component of general and administrative expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFlowOperatingActivitiesLesseeAbstract" xlink:label="us-gaap_CashFlowOperatingActivitiesLesseeAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowOperatingActivitiesLesseeAbstract" xlink:to="us-gaap_CashFlowOperatingActivitiesLesseeAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFlowOperatingActivitiesLesseeAbstract_lbl" xml:lang="en-US">Supplemental cash flow information related to operating leases is as follows:</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasePayments" xlink:to="us-gaap_OperatingLeasePayments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeasePayments_2_lbl" xml:lang="en-US">Operating cash flow paid for operating leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCostAbstract" xlink:label="us-gaap_LeaseCostAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCostAbstract" xlink:to="us-gaap_LeaseCostAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseCostAbstract_lbl" xml:lang="en-US">Lease term and Discount Rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xml:lang="en-US">Weighted average remaining lease term (months)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xml:lang="en-US">Weighted average discount rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_lbl" xml:lang="en-US">2024 (remaining six months)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xml:lang="en-US">2024</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xml:lang="en-US">Total minimum future payments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xml:lang="en-US">Less: interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xml:lang="en-US">Total operating lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xml:lang="en-US">2025</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xml:lang="en-US">2026</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xml:lang="en-US">2027</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xml:lang="en-US">2028</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xml:lang="en-US">Thereafter</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_3_lbl" xml:lang="en-US">Less: current portion of lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseExpirationDate1" xlink:label="us-gaap_LeaseExpirationDate1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseExpirationDate1" xlink:to="us-gaap_LeaseExpirationDate1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseExpirationDate1_lbl" xml:lang="en-US">Lease expiration, date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:label="us-gaap_LesseeOperatingLeaseOptionToExtend" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:to="us-gaap_LesseeOperatingLeaseOptionToExtend_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseOptionToExtend_lbl" xml:lang="en-US">Lease extension, description</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasePayments" xlink:to="us-gaap_OperatingLeasePayments_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeasePayments_3_lbl" xml:lang="en-US">Operating lease payments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRent" xlink:to="us-gaap_PaymentsForRent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PaymentsForRent_2_lbl" xml:lang="en-US">Base rent payment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TenantImprovements" xlink:label="us-gaap_TenantImprovements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TenantImprovements" xlink:to="us-gaap_TenantImprovements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TenantImprovements_lbl" xml:lang="en-US">Reimbursement for tenant improvements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_lbl" xml:lang="en-US">Share base compensation issued shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted average grant date fair value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_lbl" xml:lang="en-US">Share base compensation forfeited shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xml:lang="en-US">Number of shares available to issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeBenefitsAndShareBasedCompensation" xlink:label="us-gaap_EmployeeBenefitsAndShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeBenefitsAndShareBasedCompensation" xlink:to="us-gaap_EmployeeBenefitsAndShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeBenefitsAndShareBasedCompensation_lbl" xml:lang="en-US">Equity compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xml:lang="en-US">Unrecognised expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xml:lang="en-US">Weighted average term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl" xml:lang="en-US">Vested options intrinsic value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_lbl" xml:lang="en-US">Stock Issued During Period, Value, Restricted Stock Award, Gross</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xml:lang="en-US">Stock Issued During Period, Shares, Issued for Services</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_2_lbl" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xml:lang="en-US">Number of common warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xml:lang="en-US">Warrant Exercise Price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingMaturityDate" xlink:label="us-gaap_WarrantsAndRightsOutstandingMaturityDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingMaturityDate" xlink:to="us-gaap_WarrantsAndRightsOutstandingMaturityDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsOutstandingMaturityDate_lbl" xml:lang="en-US">Expiration Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xml:lang="en-US">Number of Common Warrants</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_2_lbl" xml:lang="en-US">Class of Warrant or Right, Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xml:lang="en-US">Net income (loss) available to common stockholders</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2_lbl" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerShareDiluted_2_lbl" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xml:lang="en-US">Antidilutive Security, Excluded EPS Calculation [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xml:lang="en-US">Potentially dilutive securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTable" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationTable" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTable_lbl" xml:lang="en-US">Effective Income Tax Rate Reconciliation [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems_lbl" xml:lang="en-US">Effective Income Tax Rate Reconciliation [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Income Tax (benefit) provision</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xml:lang="en-US">Operating loss carryforwards</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Deferred tax asset valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:label="us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:to="us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_lbl" xml:lang="en-US">Segment Reporting, Revenue from External Customer, Product and Service [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:label="us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_lbl" xml:lang="en-US">Revenue from External Customer [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Revenues_lbl" xml:lang="en-US">Total Net Sales</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_lbl" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_lbl" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_Revenues_2_lbl" xml:lang="en-US">Total Net Sales&#160;</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdvertisingExpense" xlink:label="us-gaap_AdvertisingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdvertisingExpense" xlink:to="us-gaap_AdvertisingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdvertisingExpense_lbl" xml:lang="en-US">Co-op promotion incentives</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_EstimatedReserveOfAdvertisingExpense" xlink:label="RIME_EstimatedReserveOfAdvertisingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_EstimatedReserveOfAdvertisingExpense" xlink:to="RIME_EstimatedReserveOfAdvertisingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_EstimatedReserveOfAdvertisingExpense_lbl" xml:lang="en-US">Estimated reserve co-op promotion incentives</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_EstimatedCostOfReturns" xlink:label="RIME_EstimatedCostOfReturns" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_EstimatedCostOfReturns" xlink:to="RIME_EstimatedCostOfReturns_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_EstimatedCostOfReturns_lbl" xml:lang="en-US">Estimated costs of returns</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTable" xlink:label="us-gaap_ConcentrationRiskTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskTable" xlink:to="us-gaap_ConcentrationRiskTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskTable_lbl" xml:lang="en-US">Concentration Risk [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="us-gaap_ConcentrationRiskLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskLineItems" xlink:to="us-gaap_ConcentrationRiskLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskLineItems_lbl" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl" xml:lang="en-US">Concentration risk percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentDescription" xlink:label="us-gaap_DebtInstrumentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentDescription" xlink:to="us-gaap_DebtInstrumentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentDescription_lbl" xml:lang="en-US">Debt instrument, description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xml:lang="en-US">Related Party Transaction [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionLineItems_lbl" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_Revenues_3_lbl" xml:lang="en-US">Revenue from related parties</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherReceivables" xlink:to="us-gaap_OtherReceivables_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherReceivables_2_lbl" xml:lang="en-US">Other receivables</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilities" xlink:label="us-gaap_OtherLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilities" xlink:to="us-gaap_OtherLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherLiabilities_lbl" xml:lang="en-US">Due to related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfessionalFees" xlink:label="us-gaap_ProfessionalFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfessionalFees" xlink:to="us-gaap_ProfessionalFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfessionalFees_lbl" xml:lang="en-US">Software support service</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentFaceAmount_2_lbl" xml:lang="en-US">Principal amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTable_lbl" xml:lang="en-US">Subsequent Event [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharePrice_lbl" xml:lang="en-US">Share price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_2_lbl" xml:lang="en-US">Common stock par value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_3_lbl" xml:lang="en-US">Number of share sold</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_2_lbl" xml:lang="en-US">Number of shares sold, value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_2_lbl" xml:lang="en-US">Net proceeds</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_PercentageOfPurchasersRightToParticipateOnIssuanceCompanyOfCommonStock" xlink:label="RIME_PercentageOfPurchasersRightToParticipateOnIssuanceCompanyOfCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_PercentageOfPurchasersRightToParticipateOnIssuanceCompanyOfCommonStock" xlink:to="RIME_PercentageOfPurchasersRightToParticipateOnIssuanceCompanyOfCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_PercentageOfPurchasersRightToParticipateOnIssuanceCompanyOfCommonStock_lbl" xml:lang="en-US">Percentage of purchasers right to participate on issuance company of common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_PercentageOfGrossProceeds" xlink:label="RIME_PercentageOfGrossProceeds" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_PercentageOfGrossProceeds" xlink:to="RIME_PercentageOfGrossProceeds_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_PercentageOfGrossProceeds_lbl" xml:lang="en-US">Percentage of gross proceeds</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_2_lbl" xml:lang="en-US">Number of shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfDebt" xlink:to="us-gaap_ProceedsFromIssuanceOfDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt_lbl" xml:lang="en-US">Net proceeds</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionOriginalDebtAmount1" xlink:label="us-gaap_DebtConversionOriginalDebtAmount1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionOriginalDebtAmount1" xlink:to="us-gaap_DebtConversionOriginalDebtAmount1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtConversionOriginalDebtAmount1_lbl" xml:lang="en-US">Original issue discount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="us-gaap_DebtInstrumentInterestRateEffectivePercentage_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage_2_lbl" xml:lang="en-US">Original issue discount percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:to="us-gaap_DebtInstrumentInterestRateDuringPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod_lbl" xml:lang="en-US">Interest accrued rate percentage</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentIssuanceDate1" xlink:to="us-gaap_DebtInstrumentIssuanceDate1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentIssuanceDate1_2_lbl" xml:lang="en-US">Issuance date</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesIssued_3_lbl" xml:lang="en-US">Common stock shares issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_3_lbl" xml:lang="en-US">Common stock shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement" xlink:label="us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement" xlink:to="us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement_lbl" xml:lang="en-US">Income Tax Examination, Likelihood of Unfavorable Settlement</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ReserveForSalesReturn" xlink:label="RIME_ReserveForSalesReturn" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_ReserveForSalesReturn" xlink:to="RIME_ReserveForSalesReturn_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_ReserveForSalesReturn_lbl" xml:lang="en-US">Reserve for sales return</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ReturnAssets" xlink:label="RIME_ReturnAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_ReturnAssets" xlink:to="RIME_ReturnAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_ReturnAssets_lbl" xml:lang="en-US">Return assets</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ShippingAndHandlingExpenses" xlink:label="RIME_ShippingAndHandlingExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_ShippingAndHandlingExpenses" xlink:to="RIME_ShippingAndHandlingExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_ShippingAndHandlingExpenses_lbl" xml:lang="en-US">Shipping and handling expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignFinancialInstitutionsActualDeposits" xlink:label="us-gaap_ForeignFinancialInstitutionsActualDeposits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignFinancialInstitutionsActualDeposits" xlink:to="us-gaap_ForeignFinancialInstitutionsActualDeposits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignFinancialInstitutionsActualDeposits_lbl" xml:lang="en-US">Foreign financial institutions actual deposits</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_2_lbl" xml:lang="en-US">Prepaid expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Research and development costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xml:lang="en-US">Average useful life (in years)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xml:lang="en-US">Property and equipment, gross</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US">Less: Accumulated depreciation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:label="us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:to="us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable_lbl" xml:lang="en-US">Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:label="us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems_lbl" xml:lang="en-US">Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US">Number of Options, Balance at beginning of period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Balance at beginning of period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Weighted Average contractual life</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US">Number of Options, Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Granted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2_lbl" xml:lang="en-US">Number of Options, Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xml:lang="en-US">Number of Options, Forfeited</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Forfeited</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xml:lang="en-US">Number of Options, Balance at end of period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Weighted Average Exercise Price, Balance at end of period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Weighted Average contractual life</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xml:lang="en-US">Number of Options, exercisable at end of period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Options exercisable at end of period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xml:lang="en-US">Option issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2_lbl" xml:lang="en-US">Basic weighted average common shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:label="us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:to="us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_lbl" xml:lang="en-US">Effect of dilutive stock options</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3_lbl" xml:lang="en-US">Diluted weighted average of common shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockDescriptionOfTransaction" xlink:label="us-gaap_SaleOfStockDescriptionOfTransaction" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockDescriptionOfTransaction" xlink:to="us-gaap_SaleOfStockDescriptionOfTransaction_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockDescriptionOfTransaction_lbl" xml:lang="en-US">Sale of stock description</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_lbl" xml:lang="en-US">Common stock options grants</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Exercise price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockOptionPlanExpense" xlink:label="us-gaap_StockOptionPlanExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockOptionPlanExpense" xlink:to="us-gaap_StockOptionPlanExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockOptionPlanExpense_lbl" xml:lang="en-US">Stock option expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xml:lang="en-US">Stock option, expected dividend yield</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xml:lang="en-US">Stock option, risk free interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xml:lang="en-US">Stock option, volatility</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xml:lang="en-US">Stock option, expected term</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_2_lbl" xml:lang="en-US">Vested options</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_2_lbl" xml:lang="en-US">Number of shares available for issuance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_3_lbl" xml:lang="en-US">Warrants outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_2_lbl" xml:lang="en-US">Gross proceeds</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForCommissions" xlink:label="us-gaap_PaymentsForCommissions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForCommissions" xlink:to="us-gaap_PaymentsForCommissions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForCommissions_lbl" xml:lang="en-US">Underwriting discounts and commissions and other estimated offering expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SaleOfStockPricePerShare_2_lbl" xml:lang="en-US">Sale of stock, price per share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_3_lbl" xml:lang="en-US">Net proceeds</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_2_lbl" xml:lang="en-US">Underwriter warrants to purchase</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SaleOfStockPercentage" xlink:label="RIME_SaleOfStockPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SaleOfStockPercentage" xlink:to="RIME_SaleOfStockPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_SaleOfStockPercentage_lbl" xml:lang="en-US">Sale of stock, percentage</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2_lbl" xml:lang="en-US">Exercise price per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingTerm" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm_lbl" xml:lang="en-US">Warrant term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="us-gaap_FairValueAdjustmentOfWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAdjustmentOfWarrants" xlink:to="us-gaap_FairValueAdjustmentOfWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_lbl" xml:lang="en-US">Fair value adjustment of warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:label="us-gaap_WarrantsAndRightsOutstandingMeasurementInput" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:to="us-gaap_WarrantsAndRightsOutstandingMeasurementInput_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsOutstandingMeasurementInput_lbl" xml:lang="en-US">Warrant measurement input</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_lbl" xml:lang="en-US">Subsidiary or Equity Method Investee, Sale of Stock, Type [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_SubsidiarySaleOfStockLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems_lbl" xml:lang="en-US">Subsidiary, Sale of Stock [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodShares" xlink:label="us-gaap_StockRedeemedOrCalledDuringPeriodShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRedeemedOrCalledDuringPeriodShares" xlink:to="us-gaap_StockRedeemedOrCalledDuringPeriodShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRedeemedOrCalledDuringPeriodShares_lbl" xml:lang="en-US">Shares redeemed</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockAmountIssued1" xlink:label="us-gaap_ConversionOfStockAmountIssued1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockAmountIssued1" xlink:to="us-gaap_ConversionOfStockAmountIssued1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConversionOfStockAmountIssued1_lbl" xml:lang="en-US">Conversion of stock, amount issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_DisclosureAugust2021PrivatePlacementAbstract" xlink:to="RIME_DisclosureAugust2021PrivatePlacementAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="RIME_DisclosureAugust2021PrivatePlacementAbstract_2_lbl" xml:lang="en-US">Schedule Of Loss Before Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl" xml:lang="en-US">United States</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl" xml:lang="en-US">Foreign</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xml:lang="en-US">Loss before income taxes</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_DisclosureAugust2021PrivatePlacementAbstract" xlink:to="RIME_DisclosureAugust2021PrivatePlacementAbstract_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="RIME_DisclosureAugust2021PrivatePlacementAbstract_3_lbl" xml:lang="en-US">Schedule Of Provision For Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xml:lang="en-US">Federal</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xml:lang="en-US">State</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_CurrentOtherTaxExpenseBenefit" xlink:label="RIME_CurrentOtherTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_CurrentOtherTaxExpenseBenefit" xlink:to="RIME_CurrentOtherTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="RIME_CurrentOtherTaxExpenseBenefit_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="us-gaap_CurrentForeignTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit_lbl" xml:lang="en-US">Hong Kong</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit_lbl" xml:lang="en-US">Total current Federal and State</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Federal</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">State</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit_lbl" xml:lang="en-US">Total Deferred Federal and State</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_3_lbl" xml:lang="en-US">Total income tax provision</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_lbl" xml:lang="en-US">NOL Federal Carryforward</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_lbl" xml:lang="en-US">State NOL Carryforward</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsInventory" xlink:label="us-gaap_DeferredTaxAssetsInventory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsInventory" xlink:to="us-gaap_DeferredTaxAssetsInventory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsInventory_lbl" xml:lang="en-US">Inventory differences to inventory valuation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xml:lang="en-US">Stock option compensation expense</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DeferredTaxAssetsRightUseOfLiability" xlink:label="RIME_DeferredTaxAssetsRightUseOfLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_DeferredTaxAssetsRightUseOfLiability" xlink:to="RIME_DeferredTaxAssetsRightUseOfLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_DeferredTaxAssetsRightUseOfLiability_lbl" xml:lang="en-US">Right of use liability</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DeferredTaxAssetsBusinessInterestLimitation" xlink:label="RIME_DeferredTaxAssetsBusinessInterestLimitation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_DeferredTaxAssetsBusinessInterestLimitation" xlink:to="RIME_DeferredTaxAssetsBusinessInterestLimitation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_DeferredTaxAssetsBusinessInterestLimitation_lbl" xml:lang="en-US">Business interest limitation</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DeferredTaxAssetsAllowanceForDoubtFulAccounts" xlink:label="RIME_DeferredTaxAssetsAllowanceForDoubtFulAccounts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_DeferredTaxAssetsAllowanceForDoubtFulAccounts" xlink:to="RIME_DeferredTaxAssetsAllowanceForDoubtFulAccounts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_DeferredTaxAssetsAllowanceForDoubtFulAccounts_lbl" xml:lang="en-US">Allowance for doubtful accounts</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances_lbl" xml:lang="en-US">Reserve for estimated returns</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_lbl" xml:lang="en-US">Accrued vacation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xml:lang="en-US">Total</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xml:lang="en-US">Less: valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xml:lang="en-US">Net deferred tax asset</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:label="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_lbl" xml:lang="en-US">Depreciable and amortizable assets</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DeferredTaxLiabilitiesRightUseOfAsset" xlink:label="RIME_DeferredTaxLiabilitiesRightUseOfAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_DeferredTaxLiabilitiesRightUseOfAsset" xlink:to="RIME_DeferredTaxLiabilitiesRightUseOfAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="RIME_DeferredTaxLiabilitiesRightUseOfAsset_lbl" xml:lang="en-US">ROU Asset</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" xlink:label="us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" xlink:to="us-gaap_DeferredTaxLiabilitiesPrepaidExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxLiabilitiesPrepaidExpenses_lbl" xml:lang="en-US">Prepaid expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="us-gaap_DeferredTaxLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="us-gaap_DeferredTaxLiabilities_lbl" xml:lang="en-US">Net deferred tax liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US">Statutory federal tax rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl" xml:lang="en-US">Stater tax rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:label="us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:to="us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_lbl" xml:lang="en-US">Permanent differences</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_IncomeTaxReconciliationChangeInPermanentDifferencesERCIncome" xlink:label="RIME_IncomeTaxReconciliationChangeInPermanentDifferencesERCIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_IncomeTaxReconciliationChangeInPermanentDifferencesERCIncome" xlink:to="RIME_IncomeTaxReconciliationChangeInPermanentDifferencesERCIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_IncomeTaxReconciliationChangeInPermanentDifferencesERCIncome_lbl" xml:lang="en-US">Permanent difference in ERC income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:to="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_lbl" xml:lang="en-US">Tax rate differential on foreign earnings</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_IncomeTaxReconciliationChangeInExpirationOfNetOpretaingLossCarryforward" xlink:label="RIME_IncomeTaxReconciliationChangeInExpirationOfNetOpretaingLossCarryforward" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_IncomeTaxReconciliationChangeInExpirationOfNetOpretaingLossCarryforward" xlink:to="RIME_IncomeTaxReconciliationChangeInExpirationOfNetOpretaingLossCarryforward_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_IncomeTaxReconciliationChangeInExpirationOfNetOpretaingLossCarryforward_lbl" xml:lang="en-US">Expiration of net operating loss carryforward</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Change in valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:label="us-gaap_IncomeTaxReconciliationOtherReconcilingItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:to="us-gaap_IncomeTaxReconciliationOtherReconcilingItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncomeTaxReconciliationOtherReconcilingItems_lbl" xml:lang="en-US">Other</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_3_lbl" xml:lang="en-US">Issuance of warrant shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_3_lbl" xml:lang="en-US">Exercise price of warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl" xml:lang="en-US">Class of warrant or right, number of securities called by each warrant or right</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromWarrantExercises" xlink:to="us-gaap_ProceedsFromWarrantExercises_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromWarrantExercises_2_lbl" xml:lang="en-US">Proceeds from warrant exercises</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRepurchaseOfPrivatePlacement" xlink:label="us-gaap_PaymentsForRepurchaseOfPrivatePlacement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRepurchaseOfPrivatePlacement" xlink:to="us-gaap_PaymentsForRepurchaseOfPrivatePlacement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForRepurchaseOfPrivatePlacement_lbl" xml:lang="en-US">Cash payment for private placement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeDescriptionOfTerms" xlink:label="us-gaap_DerivativeDescriptionOfTerms" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeDescriptionOfTerms" xlink:to="us-gaap_DerivativeDescriptionOfTerms_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeDescriptionOfTerms_lbl" xml:lang="en-US">Derivative, Description of Terms</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AggregateNumberOfShares" xlink:label="RIME_AggregateNumberOfShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_AggregateNumberOfShares" xlink:to="RIME_AggregateNumberOfShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_AggregateNumberOfShares_lbl" xml:lang="en-US">Aggregate number of shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharePrice_2_lbl" xml:lang="en-US">Share Price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityFairValueDisclosure" xlink:label="us-gaap_EquityFairValueDisclosure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityFairValueDisclosure" xlink:to="us-gaap_EquityFairValueDisclosure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityFairValueDisclosure_lbl" xml:lang="en-US">Equity, Fair Value Disclosure</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SharePrice1" xlink:label="RIME_SharePrice1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SharePrice1" xlink:to="RIME_SharePrice1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_SharePrice1_lbl" xml:lang="en-US">Common stock price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingTerm" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm_2_lbl" xml:lang="en-US">Warrants and Rights Outstanding, Term</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl" xml:lang="en-US">Stock issued for restricted shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_2_lbl" xml:lang="en-US">Stock issued for restricted shares, value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xml:lang="en-US">Payment of stock issuance expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_GainFromSettlementOfAccountsPayable" xlink:to="RIME_GainFromSettlementOfAccountsPayable_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="RIME_GainFromSettlementOfAccountsPayable_3_lbl" xml:lang="en-US">Settlement of accounts payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_DisclosureSupplementalInformationCondensedFinancialInformationAbstract" xlink:to="RIME_DisclosureSupplementalInformationCondensedFinancialInformationAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="RIME_DisclosureSupplementalInformationCondensedFinancialInformationAbstract_2_lbl" xml:lang="en-US">Schedule Of Condensed Consolidated Statements Of Operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2_lbl" xml:lang="en-US">Net Sales</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsAndServicesSold" xlink:to="us-gaap_CostOfGoodsAndServicesSold_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CostOfGoodsAndServicesSold_2_lbl" xml:lang="en-US">Cost of Goods Sold</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingExpenses_2_lbl" xml:lang="en-US">Operating Expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpense_2_lbl" xml:lang="en-US">Other (Expenses) Income</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_4_lbl" xml:lang="en-US">Income Tax Benefit (Loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_DisclosureSupplementalInformationCondensedFinancialInformationAbstract" xlink:to="RIME_DisclosureSupplementalInformationCondensedFinancialInformationAbstract_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="RIME_DisclosureSupplementalInformationCondensedFinancialInformationAbstract_3_lbl" xml:lang="en-US">Schedule Of Condensed Consolidated Statements Of Cash Flows</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProfitLoss_4_lbl" xml:lang="en-US">Net loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapital" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapital_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapital_2_lbl" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_3_lbl" xml:lang="en-US">Issuance of common stock and warrants, net of stock offering costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_3_lbl" xml:lang="en-US">Issuance of common stock and warrants, net of stock offering costs, shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_2_lbl" xml:lang="en-US">Stock based compensation ,shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueOther" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther_2_lbl" xml:lang="en-US">Other</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther_2_lbl" xml:lang="en-US">Other, shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_2_lbl" xml:lang="en-US">Property plant and equipment useful life</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNet" xlink:to="us-gaap_AccountsReceivableNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AccountsReceivableNet_2_lbl" xml:lang="en-US">Accounts receivable, net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProvisionForDoubtfulAccounts" xlink:to="us-gaap_ProvisionForDoubtfulAccounts_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProvisionForDoubtfulAccounts_2_lbl" xml:lang="en-US">Allowance for doubtful accounts</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AccountsPayableCurrent_2_lbl" xml:lang="en-US">Vendors expenses payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentIssuanceDate1" xlink:to="us-gaap_DebtInstrumentIssuanceDate1_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentIssuanceDate1_3_lbl" xml:lang="en-US">Date</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMaturityDate" xlink:to="us-gaap_DebtInstrumentMaturityDate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentMaturityDate_2_lbl" xml:lang="en-US">Maturity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:label="us-gaap_DebtInstrumentPeriodicPaymentPrincipal" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:to="us-gaap_DebtInstrumentPeriodicPaymentPrincipal_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentPeriodicPaymentPrincipal_lbl" xml:lang="en-US">Principal</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_3_lbl" xml:lang="en-US">Rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentPeriodicPaymentInterest" xlink:label="us-gaap_DebtInstrumentPeriodicPaymentInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentPeriodicPaymentInterest" xlink:to="us-gaap_DebtInstrumentPeriodicPaymentInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentPeriodicPaymentInterest_lbl" xml:lang="en-US">Accrued Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentPeriodicPayment" xlink:to="us-gaap_DebtInstrumentPeriodicPayment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentPeriodicPayment_2_lbl" xml:lang="en-US">Current Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMaturityDateDescription" xlink:label="us-gaap_DebtInstrumentMaturityDateDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMaturityDateDescription" xlink:to="us-gaap_DebtInstrumentMaturityDateDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentMaturityDateDescription_lbl" xml:lang="en-US">Maturity date, description</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfDebt" xlink:to="us-gaap_RepaymentsOfDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_RepaymentsOfDebt_2_lbl" xml:lang="en-US">Repayment, debt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermBorrowings" xlink:to="us-gaap_ShortTermBorrowings_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShortTermBorrowings_3_lbl" xml:lang="en-US">Initial amount, borrowed</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="us-gaap_DebtInstrumentInterestRateEffectivePercentage_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage_3_lbl" xml:lang="en-US">Effective, interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ForeignAndDomesticRateOfAccountsReceivable" xlink:label="RIME_ForeignAndDomesticRateOfAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_ForeignAndDomesticRateOfAccountsReceivable" xlink:to="RIME_ForeignAndDomesticRateOfAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_ForeignAndDomesticRateOfAccountsReceivable_lbl" xml:lang="en-US">Accounts receivable rate, description</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AdvanceFeeRate" xlink:label="RIME_AdvanceFeeRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_AdvanceFeeRate" xlink:to="RIME_AdvanceFeeRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_AdvanceFeeRate_lbl" xml:lang="en-US">Advance fee, rate</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LegalFees" xlink:to="us-gaap_LegalFees_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LegalFees_3_lbl" xml:lang="en-US">Dispute, amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_lbl" xml:lang="en-US">Granted Shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4_lbl" xml:lang="en-US">Outstanding Awards</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TargetedOrTrackingStockIssuanceDates" xlink:label="us-gaap_TargetedOrTrackingStockIssuanceDates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TargetedOrTrackingStockIssuanceDates" xlink:to="us-gaap_TargetedOrTrackingStockIssuanceDates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TargetedOrTrackingStockIssuanceDates_lbl" xml:lang="en-US">Granted Date</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xml:lang="en-US">Exercise price</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate" xlink:label="RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate" xlink:to="RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_lbl" xml:lang="en-US">Vesting Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xml:lang="en-US">Vested Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_lbl" xml:lang="en-US">Unvested</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate" xlink:label="RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate" xlink:to="RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_lbl" xml:lang="en-US">Date Fully Vested</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate" xlink:label="RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate" xlink:to="RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_lbl" xml:lang="en-US">Board Approval Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_lbl" xml:lang="en-US">Expiration Date</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ConvertibleHolderName" xlink:label="RIME_ConvertibleHolderName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_ConvertibleHolderName" xlink:to="RIME_ConvertibleHolderName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_ConvertibleHolderName_lbl" xml:lang="en-US">Convertible Holder Name</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_InvestmentOfPrincipalAmount" xlink:label="RIME_InvestmentOfPrincipalAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_InvestmentOfPrincipalAmount" xlink:to="RIME_InvestmentOfPrincipalAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="RIME_InvestmentOfPrincipalAmount_lbl" xml:lang="en-US">Principal</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_InvestmentIssueDate" xlink:label="RIME_InvestmentIssueDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_InvestmentIssueDate" xlink:to="RIME_InvestmentIssueDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_InvestmentIssueDate_lbl" xml:lang="en-US">Issue Date</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ValuationCapitalOfInvestment" xlink:label="RIME_ValuationCapitalOfInvestment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_ValuationCapitalOfInvestment" xlink:to="RIME_ValuationCapitalOfInvestment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_ValuationCapitalOfInvestment_lbl" xml:lang="en-US">Valuation Cap</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_InvestmentConvertedDate" xlink:label="RIME_InvestmentConvertedDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_InvestmentConvertedDate" xlink:to="RIME_InvestmentConvertedDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_InvestmentConvertedDate_lbl" xml:lang="en-US">Converted Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Investments" xlink:label="us-gaap_Investments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Investments" xlink:to="us-gaap_Investments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Investments_lbl" xml:lang="en-US">Investments</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_InvestedValuationOfAmount" xlink:label="RIME_InvestedValuationOfAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_InvestedValuationOfAmount" xlink:to="RIME_InvestedValuationOfAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_InvestedValuationOfAmount_lbl" xml:lang="en-US">Invested valuation of amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_LeaseAgreementMember" xlink:to="RIME_LeaseAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_LeaseAgreementMember_doc" xml:lang="en-US">Lease Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_RecentDevelopmentsTextBlock" xlink:to="RIME_RecentDevelopmentsTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_RecentDevelopmentsTextBlock_doc" xml:lang="en-US">Recent Developments [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_ReturnsAsset" xlink:to="RIME_ReturnsAsset_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_ReturnsAsset_doc" xml:lang="en-US">Returns asset.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_CustomerPrepayments" xlink:to="RIME_CustomerPrepayments_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_CustomerPrepayments_doc" xml:lang="en-US">Customer prepayments.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_GainFromRelatedPartyDebt" xlink:to="RIME_GainFromRelatedPartyDebt_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_GainFromRelatedPartyDebt_doc" xml:lang="en-US">Gain from related party debt.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_GainFromPaycheckProtectionPlanLoanForgiveness" xlink:to="RIME_GainFromPaycheckProtectionPlanLoanForgiveness_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_GainFromPaycheckProtectionPlanLoanForgiveness_doc" xml:lang="en-US">Gain from paycheck protection plan loan forgiveness.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_ScheduleOfSupplementalInformationRelatedToLeaseTableTextBlock" xlink:to="RIME_ScheduleOfSupplementalInformationRelatedToLeaseTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_ScheduleOfSupplementalInformationRelatedToLeaseTableTextBlock_doc" xml:lang="en-US">Schedule Of Supplemental Information Related to Lease [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_ComputerAndOfficeEquipmentMember" xlink:to="RIME_ComputerAndOfficeEquipmentMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_ComputerAndOfficeEquipmentMember_doc" xml:lang="en-US">Computer and Office Equipment [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_WarehouseEquipmentMember" xlink:to="RIME_WarehouseEquipmentMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_WarehouseEquipmentMember_doc" xml:lang="en-US">Warehouse Equipment [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_MoldsAndToolingMember" xlink:to="RIME_MoldsAndToolingMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_MoldsAndToolingMember_doc" xml:lang="en-US">Molds and tooling [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_PaymentOfRedemptionAndRetirementOfTreasuryStock" xlink:to="RIME_PaymentOfRedemptionAndRetirementOfTreasuryStock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_PaymentOfRedemptionAndRetirementOfTreasuryStock_doc" xml:lang="en-US">Payment of redemption and retirement of treasury stock.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_ProceedsFromExerciseOfCommonStockWarrants" xlink:to="RIME_ProceedsFromExerciseOfCommonStockWarrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_ProceedsFromExerciseOfCommonStockWarrants_doc" xml:lang="en-US">Proceeds from exercise of common stock warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_PaymentOfDeferredFinancingCharges" xlink:to="RIME_PaymentOfDeferredFinancingCharges_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_PaymentOfDeferredFinancingCharges_doc" xml:lang="en-US">Payment of deferred financing charges.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_TwoThousandTwentyTwoPlanMember" xlink:to="RIME_TwoThousandTwentyTwoPlanMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_TwoThousandTwentyTwoPlanMember_doc" xml:lang="en-US">Two Thousand Twenty Two Plan [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_TwoYearCreditAndSecurityAgreementMember" xlink:to="RIME_TwoYearCreditAndSecurityAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_TwoYearCreditAndSecurityAgreementMember_doc" xml:lang="en-US">Two Year Credit and Security Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_TwoYearLoanAndSecurityAgreementMember" xlink:to="RIME_TwoYearLoanAndSecurityAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_TwoYearLoanAndSecurityAgreementMember_doc" xml:lang="en-US">Two-Year Loan and Security Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_CreditAndSecurityAgreementsMember" xlink:to="RIME_CreditAndSecurityAgreementsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_CreditAndSecurityAgreementsMember_doc" xml:lang="en-US">Credit and Security Agreements [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_ExercisePriceRangeOneMember" xlink:to="RIME_ExercisePriceRangeOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_ExercisePriceRangeOneMember_doc" xml:lang="en-US">Exercise Price Range One [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_ProceedsFromCollectionOfSubscriptionsReceivable" xlink:to="RIME_ProceedsFromCollectionOfSubscriptionsReceivable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_ProceedsFromCollectionOfSubscriptionsReceivable_doc" xml:lang="en-US">Proceeds from collection of subscriptions receivable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_IssuanceOfCommonStockAndWarrantsForOfferingCosts" xlink:to="RIME_IssuanceOfCommonStockAndWarrantsForOfferingCosts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_IssuanceOfCommonStockAndWarrantsForOfferingCosts_doc" xml:lang="en-US">Issuance of common stock and warrants for offering costs.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_StockIssuedDuringPeriodValueReverseStockSplits" xlink:to="RIME_StockIssuedDuringPeriodValueReverseStockSplits_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_StockIssuedDuringPeriodValueReverseStockSplits_doc" xml:lang="en-US">Stock issued during period value reverse stock splits.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_StockIssuedDuringPeriodValueIssuanceOfCommonStockAtMarketOffering" xlink:to="RIME_StockIssuedDuringPeriodValueIssuanceOfCommonStockAtMarketOffering_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_StockIssuedDuringPeriodValueIssuanceOfCommonStockAtMarketOffering_doc" xml:lang="en-US">Stock issued during period value issuance of common stock at market offering.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_EmployeesMember" xlink:to="RIME_EmployeesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_EmployeesMember_doc" xml:lang="en-US">Employees [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SixCurrentAndThreeFormerDirectorsMember" xlink:to="RIME_SixCurrentAndThreeFormerDirectorsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_SixCurrentAndThreeFormerDirectorsMember_doc" xml:lang="en-US">Six Current and Three Former Directors [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_StockIssuedDuringPeriodSharesIssuanceOfCommonStockAtMarketOffering" xlink:to="RIME_StockIssuedDuringPeriodSharesIssuanceOfCommonStockAtMarketOffering_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_StockIssuedDuringPeriodSharesIssuanceOfCommonStockAtMarketOffering_doc" xml:lang="en-US">Stock issued during period shares issuance of common stock at market offering.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_ExercisePriceRangeTwoMember" xlink:to="RIME_ExercisePriceRangeTwoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_ExercisePriceRangeTwoMember_doc" xml:lang="en-US">Exercise Price Range Two [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_StockIssuedDuringPeriodValueIssuanceOfCommonStockPrivatePlacement" xlink:to="RIME_StockIssuedDuringPeriodValueIssuanceOfCommonStockPrivatePlacement_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_StockIssuedDuringPeriodValueIssuanceOfCommonStockPrivatePlacement_doc" xml:lang="en-US">Issuance of common stock - private placement.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_StockIssuedDuringPeriodSharesIssuanceOfCommonStockPrivatePlacement" xlink:to="RIME_StockIssuedDuringPeriodSharesIssuanceOfCommonStockPrivatePlacement_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_StockIssuedDuringPeriodSharesIssuanceOfCommonStockPrivatePlacement_doc" xml:lang="en-US">Shares issuance of common stock - private placement.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_PreFundedWarrantsMember" xlink:to="RIME_PreFundedWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_PreFundedWarrantsMember_doc" xml:lang="en-US">Pre Funded Warrants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_IssuanceOfPublicOfferingTextBlock" xlink:to="RIME_IssuanceOfPublicOfferingTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_IssuanceOfPublicOfferingTextBlock_doc" xml:lang="en-US">Issuance of Public Offering [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_UnderwritingAgreementMember" xlink:to="RIME_UnderwritingAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_UnderwritingAgreementMember_doc" xml:lang="en-US">Underwriting Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SaleOfStockPercentage" xlink:to="RIME_SaleOfStockPercentage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_SaleOfStockPercentage_doc" xml:lang="en-US">Sale of stock percentage.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_AtTheMarketPublicOfferingTextBlock" xlink:to="RIME_AtTheMarketPublicOfferingTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_AtTheMarketPublicOfferingTextBlock_doc" xml:lang="en-US">At The Market Public Offering [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_PrivatePlacementTextBlock" xlink:to="RIME_PrivatePlacementTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_PrivatePlacementTextBlock_doc" xml:lang="en-US">Private Placement [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_ScheduleOfLossBeforeIncomeTaxTableTextBlock" xlink:to="RIME_ScheduleOfLossBeforeIncomeTaxTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_ScheduleOfLossBeforeIncomeTaxTableTextBlock_doc" xml:lang="en-US">Schedule of Loss Before Income Tax [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_IncreaseDecreaseInPrepaidsFromCustomers" xlink:to="RIME_IncreaseDecreaseInPrepaidsFromCustomers_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_IncreaseDecreaseInPrepaidsFromCustomers_doc" xml:lang="en-US">Prepaids from customers.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_ReserveForSalesReturns" xlink:to="RIME_ReserveForSalesReturns_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_ReserveForSalesReturns_doc" xml:lang="en-US">Reserve for sales returns.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_OperatingLeaseAgreementMember" xlink:to="RIME_OperatingLeaseAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_OperatingLeaseAgreementMember_doc" xml:lang="en-US">Operating Lease Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_TransactionFees" xlink:to="RIME_TransactionFees_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_TransactionFees_doc" xml:lang="en-US">Transaction fees.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_CurrentOtherTaxExpenseBenefit" xlink:to="RIME_CurrentOtherTaxExpenseBenefit_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_CurrentOtherTaxExpenseBenefit_doc" xml:lang="en-US">Current other tax expense benefit.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_ShippingAndHandlingCostsPolicyTextBlock" xlink:to="RIME_ShippingAndHandlingCostsPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_ShippingAndHandlingCostsPolicyTextBlock_doc" xml:lang="en-US">Shipping and Handling Costs [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_ReserveForSalesReturn" xlink:to="RIME_ReserveForSalesReturn_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_ReserveForSalesReturn_doc" xml:lang="en-US">Reserve for sales return.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_ReturnAssets" xlink:to="RIME_ReturnAssets_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_ReturnAssets_doc" xml:lang="en-US">Return assets.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_ShippingAndHandlingExpenses" xlink:to="RIME_ShippingAndHandlingExpenses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_ShippingAndHandlingExpenses_doc" xml:lang="en-US">Shipping and handling expenses.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_GainFromSettlementOfAccountsPayable" xlink:to="RIME_GainFromSettlementOfAccountsPayable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_GainFromSettlementOfAccountsPayable_doc" xml:lang="en-US">Gain from settlement of accounts payable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_IncreaseDecreaseInReserveForSalesReturns" xlink:to="RIME_IncreaseDecreaseInReserveForSalesReturns_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_IncreaseDecreaseInReserveForSalesReturns_doc" xml:lang="en-US">Reserve for sales returns.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_PaymentsOnInstallmentNote" xlink:to="RIME_PaymentsOnInstallmentNote_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_PaymentsOnInstallmentNote_doc" xml:lang="en-US">Payments on installment notes.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_PaymentOfEarlyTerminationFeesOnRevolvingLinesOfCredit" xlink:to="RIME_PaymentOfEarlyTerminationFeesOnRevolvingLinesOfCredit_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_PaymentOfEarlyTerminationFeesOnRevolvingLinesOfCredit_doc" xml:lang="en-US">Payment of early termination fees on revolving lines of credit.</link:label>
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AmortizationOfRightOfUseAssets" xlink:label="RIME_AmortizationOfRightOfUseAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_AmortizationOfRightOfUseAssets" xlink:to="RIME_AmortizationOfRightOfUseAssets_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_AmortizationOfRightOfUseAssets_doc" xml:lang="en-US">Amortization of right of use assets.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_EmployeeMember" xlink:to="RIME_EmployeeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_EmployeeMember_doc" xml:lang="en-US">Employee [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_PercentageOfExitFee" xlink:to="RIME_PercentageOfExitFee_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_PercentageOfExitFee_doc" xml:lang="en-US">Percentage of exit fee.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_ProvisionForEstimatedCostOfReturns" xlink:to="RIME_ProvisionForEstimatedCostOfReturns_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_ProvisionForEstimatedCostOfReturns_doc" xml:lang="en-US">Provision for estimated cost of returns.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_DeferredTaxAssetsRightUseOfLiability" xlink:to="RIME_DeferredTaxAssetsRightUseOfLiability_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_DeferredTaxAssetsRightUseOfLiability_doc" xml:lang="en-US">Deferred Tax Assets Right Use of Liability.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_DeferredTaxAssetsBusinessInterestLimitation" xlink:to="RIME_DeferredTaxAssetsBusinessInterestLimitation_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_DeferredTaxAssetsBusinessInterestLimitation_doc" xml:lang="en-US">Deferred Tax Assets Business Interest Limitation.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_DeferredTaxAssetsAllowanceForDoubtFulAccounts" xlink:to="RIME_DeferredTaxAssetsAllowanceForDoubtFulAccounts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_DeferredTaxAssetsAllowanceForDoubtFulAccounts_doc" xml:lang="en-US">Deferred tax assets allowance for doubtful accounts.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_DeferredTaxLiabilitiesRightUseOfAsset" xlink:to="RIME_DeferredTaxLiabilitiesRightUseOfAsset_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_DeferredTaxLiabilitiesRightUseOfAsset_doc" xml:lang="en-US">Deferred Tax Liabilities Right Use of Asset.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_IncomeTaxReconciliationChangeInPermanentDifferencesERCIncome" xlink:to="RIME_IncomeTaxReconciliationChangeInPermanentDifferencesERCIncome_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_IncomeTaxReconciliationChangeInPermanentDifferencesERCIncome_doc" xml:lang="en-US">Income tax reconciliation change in permanent difference in ERC income.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_IncomeTaxReconciliationChangeInExpirationOfNetOpretaingLossCarryforward" xlink:to="RIME_IncomeTaxReconciliationChangeInExpirationOfNetOpretaingLossCarryforward_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_IncomeTaxReconciliationChangeInExpirationOfNetOpretaingLossCarryforward_doc" xml:lang="en-US">Income tax reconciliation change in expiration of net opretaing loss carryforward.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_EuropeAndUnitedKingdomMember" xlink:to="RIME_EuropeAndUnitedKingdomMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_EuropeAndUnitedKingdomMember_doc" xml:lang="en-US">Europe and United Kingdom [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_KaraokeMachinesMember" xlink:to="RIME_KaraokeMachinesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_KaraokeMachinesMember_doc" xml:lang="en-US">Karaoke Machines [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_LicensedProductsMember" xlink:to="RIME_LicensedProductsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_LicensedProductsMember_doc" xml:lang="en-US">Licensed Products [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_KidsYouthElectronicsMember" xlink:to="RIME_KidsYouthElectronicsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_KidsYouthElectronicsMember_doc" xml:lang="en-US">Kids Youth Electronics [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_MicrophonesAndAccessoriesMember" xlink:to="RIME_MicrophonesAndAccessoriesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_MicrophonesAndAccessoriesMember_doc" xml:lang="en-US">Microphones and Accessories [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_MusicSubscriptionsMember" xlink:to="RIME_MusicSubscriptionsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_MusicSubscriptionsMember_doc" xml:lang="en-US">Music Subscriptions [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_ThreeCustomersMember" xlink:to="RIME_ThreeCustomersMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_ThreeCustomersMember_doc" xml:lang="en-US">Three Customers [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_FourCustomersMember" xlink:to="RIME_FourCustomersMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_FourCustomersMember_doc" xml:lang="en-US">Four Customers [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SalesRevenueMember" xlink:to="RIME_SalesRevenueMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_SalesRevenueMember_doc" xml:lang="en-US">Sales Revenue [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_CustomersConcentrationRiskMember" xlink:to="RIME_CustomersConcentrationRiskMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_CustomersConcentrationRiskMember_doc" xml:lang="en-US">Customers concentration risk [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_CustomersOneMember" xlink:to="RIME_CustomersOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_CustomersOneMember_doc" xml:lang="en-US">Customers One [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_CustomersTwoMember" xlink:to="RIME_CustomersTwoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_CustomersTwoMember_doc" xml:lang="en-US">Customers Two [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_CustomersThreeMember" xlink:to="RIME_CustomersThreeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_CustomersThreeMember_doc" xml:lang="en-US">Customers Three [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_PurchasesMember" xlink:to="RIME_PurchasesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_PurchasesMember_doc" xml:lang="en-US">Purchases [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_RepublicOfChinaMember" xlink:to="RIME_RepublicOfChinaMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_RepublicOfChinaMember_doc" xml:lang="en-US">Republic of China [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_StingrayMember" xlink:to="RIME_StingrayMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_StingrayMember_doc" xml:lang="en-US">Stingray [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_AultAllianceIncMember" xlink:to="RIME_AultAllianceIncMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_AultAllianceIncMember_doc" xml:lang="en-US">AultAlliance Inc [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SupplementalInformationDisclosuresTextBlock" xlink:to="RIME_SupplementalInformationDisclosuresTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_SupplementalInformationDisclosuresTextBlock_doc" xml:lang="en-US">Supplemental Information Disclosures [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_ATMOfferingMember" xlink:to="RIME_ATMOfferingMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_ATMOfferingMember_doc" xml:lang="en-US">ATM Offering [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_InsuranceLiabilities" xlink:to="RIME_InsuranceLiabilities_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_InsuranceLiabilities_doc" xml:lang="en-US">Insurance liabilities.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_CommonStockWarrantsMember" xlink:to="RIME_CommonStockWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_CommonStockWarrantsMember_doc" xml:lang="en-US">Common Stock Warrants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_OptionsAndWarrantsMember" xlink:to="RIME_OptionsAndWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_OptionsAndWarrantsMember_doc" xml:lang="en-US">Options and Warrants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_OthersMember" xlink:to="RIME_OthersMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_OthersMember_doc" xml:lang="en-US">Others [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_StockRedemptionTextBlock" xlink:to="RIME_StockRedemptionTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_StockRedemptionTextBlock_doc" xml:lang="en-US">Stock Redemption [TextBlock]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_KonceptsandTreasureGreenMember" xlink:to="RIME_KonceptsandTreasureGreenMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_KonceptsandTreasureGreenMember_doc" xml:lang="en-US">Koncepts and Treasure Green [Member].</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_RedemptionAgreementMember" xlink:to="RIME_RedemptionAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_RedemptionAgreementMember_doc" xml:lang="en-US">Redemption Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_PurchaseAgreementMember" xlink:to="RIME_PurchaseAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_PurchaseAgreementMember_doc" xml:lang="en-US">Purchase Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_AGPWarrantsMember" xlink:to="RIME_AGPWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_AGPWarrantsMember_doc" xml:lang="en-US">AGP Warrants [Member].</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_AggregateNumberOfShares" xlink:to="RIME_AggregateNumberOfShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_AggregateNumberOfShares_doc" xml:lang="en-US">Aggregate number of shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SharePrice1" xlink:to="RIME_SharePrice1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_SharePrice1_doc" xml:lang="en-US">Common stock price.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_AugustTwentyTwentyOnePrivatePlacementTextBlock" xlink:to="RIME_AugustTwentyTwentyOnePrivatePlacementTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_AugustTwentyTwentyOnePrivatePlacementTextBlock_doc" xml:lang="en-US">August 2021 Private Placement [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_StockIssuedDuringPeriodValueExerciseOfPrefundedAndCommonWarrants" xlink:to="RIME_StockIssuedDuringPeriodValueExerciseOfPrefundedAndCommonWarrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_StockIssuedDuringPeriodValueExerciseOfPrefundedAndCommonWarrants_doc" xml:lang="en-US">Exercise of prefunded and common warrants, value.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_StockIssuedDuringPeriodSharesExerciseOfPrefundedAndCommonWarrants" xlink:to="RIME_StockIssuedDuringPeriodSharesExerciseOfPrefundedAndCommonWarrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_StockIssuedDuringPeriodSharesExerciseOfPrefundedAndCommonWarrants_doc" xml:lang="en-US">Exercise of prefunded and common warrants, shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_RefundDueFromCustomer" xlink:to="RIME_RefundDueFromCustomer_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_RefundDueFromCustomer_doc" xml:lang="en-US">Refund due from customer.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_StockIssuedDuringPeriodValueSaleOfCommonStockWarrants" xlink:to="RIME_StockIssuedDuringPeriodValueSaleOfCommonStockWarrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_StockIssuedDuringPeriodValueSaleOfCommonStockWarrants_doc" xml:lang="en-US">Stock issued during period value sale of common stock warrants</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_GainFromEmployeeRetentionCreditProgramRefund" xlink:to="RIME_GainFromEmployeeRetentionCreditProgramRefund_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_GainFromEmployeeRetentionCreditProgramRefund_doc" xml:lang="en-US">Gain from employee retention credit program refund</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_ProvisionForLegalLiability" xlink:to="RIME_ProvisionForLegalLiability_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_ProvisionForLegalLiability_doc" xml:lang="en-US">Provision for legal liability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_CommitmentsAndContingenciesAbstract" xlink:to="RIME_CommitmentsAndContingenciesAbstract_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_CommitmentsAndContingenciesAbstract_doc" xml:lang="en-US">Commitments and contingencies abstract</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_StockIssuedDuringPeriodSharesSaleOfCommonStockWarrants" xlink:to="RIME_StockIssuedDuringPeriodSharesSaleOfCommonStockWarrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_StockIssuedDuringPeriodSharesSaleOfCommonStockWarrants_doc" xml:lang="en-US">Stock issued during period shares sale of common stock warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_ProvisionForInventoryObsolescence" xlink:to="RIME_ProvisionForInventoryObsolescence_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_ProvisionForInventoryObsolescence_doc" xml:lang="en-US">Provision for inventory obsolescence.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_AssetsWriteOff" xlink:to="RIME_AssetsWriteOff_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_AssetsWriteOff_doc" xml:lang="en-US">Assets write off.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_EstimatedCostOfReturns" xlink:to="RIME_EstimatedCostOfReturns_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_EstimatedCostOfReturns_doc" xml:lang="en-US">Estimated cost of returns.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_WorkingCapital" xlink:to="RIME_WorkingCapital_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_WorkingCapital_doc" xml:lang="en-US">Working capital.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_ScheduleOfProFormaFinancialInformationTableTextBlock" xlink:to="RIME_ScheduleOfProFormaFinancialInformationTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_ScheduleOfProFormaFinancialInformationTableTextBlock_doc" xml:lang="en-US">Schedule Of Pro Forma Financial Information [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_PrepaidExpensesPolicyTextBlock" xlink:to="RIME_PrepaidExpensesPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_PrepaidExpensesPolicyTextBlock_doc" xml:lang="en-US">Prepaid Expenses [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountPolicy" xlink:to="RIME_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountPolicy_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountPolicy_doc" xml:lang="en-US">Receivables Trade And Other Accounts Receivable Allowance For Doubtful Account Policy.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_EqualInstallmentsForThirteenMonthsMember" xlink:to="RIME_EqualInstallmentsForThirteenMonthsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_EqualInstallmentsForThirteenMonthsMember_doc" xml:lang="en-US">Equal Installments For Thirteen Months [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_TwelveInstallmentsMember" xlink:to="RIME_TwelveInstallmentsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_TwelveInstallmentsMember_doc" xml:lang="en-US">Twelve Installments [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SettlementAgreementMember" xlink:to="RIME_SettlementAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_SettlementAgreementMember_doc" xml:lang="en-US">Settlement Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_FirstPaymentMember" xlink:to="RIME_FirstPaymentMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_FirstPaymentMember_doc" xml:lang="en-US">First Payment [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_DueAndPaidOnMayTwentyTwoThousandTwentyFourMember" xlink:to="RIME_DueAndPaidOnMayTwentyTwoThousandTwentyFourMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_DueAndPaidOnMayTwentyTwoThousandTwentyFourMember_doc" xml:lang="en-US">Due And Paid On May Twenty Two Thousand Twenty Four [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SecondPaymentMember" xlink:to="RIME_SecondPaymentMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_SecondPaymentMember_doc" xml:lang="en-US">Second Payment [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_DueOnJuneThreeTwoThousandTwentyFourMember" xlink:to="RIME_DueOnJuneThreeTwoThousandTwentyFourMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_DueOnJuneThreeTwoThousandTwentyFourMember_doc" xml:lang="en-US">Due On June Three Two Thousand Twenty Four [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_TenMonthlyPaymentsMember" xlink:to="RIME_TenMonthlyPaymentsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_TenMonthlyPaymentsMember_doc" xml:lang="en-US">Ten Monthly Payments [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_DueOnJulyOneTwoThousandTwentyFourMember" xlink:to="RIME_DueOnJulyOneTwoThousandTwentyFourMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_DueOnJulyOneTwoThousandTwentyFourMember_doc" xml:lang="en-US">Due On July One Two Thousand Twenty Four [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_WeeklyPaymentsForWeeksMember" xlink:to="RIME_WeeklyPaymentsForWeeksMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_WeeklyPaymentsForWeeksMember_doc" xml:lang="en-US">Weekly Payments For Weeks [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SixShareholderLoanAgreementsMember" xlink:to="RIME_SixShareholderLoanAgreementsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_SixShareholderLoanAgreementsMember_doc" xml:lang="en-US">Six Shareholder Loan Agreements [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_AjeshKapoorMember" xlink:to="RIME_AjeshKapoorMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_AjeshKapoorMember_doc" xml:lang="en-US">Ajesh Kapoor [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_VivekSehgalMember" xlink:to="RIME_VivekSehgalMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_VivekSehgalMember_doc" xml:lang="en-US">Vivek Sehgal [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_JaganReddyMember" xlink:to="RIME_JaganReddyMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_JaganReddyMember_doc" xml:lang="en-US">Jagan Reddy [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SafePrivatePlacementsTextBlock" xlink:to="RIME_SafePrivatePlacementsTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_SafePrivatePlacementsTextBlock_doc" xml:lang="en-US">Safe Private Placements [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_ServiceContractAndAgreementMember" xlink:to="RIME_ServiceContractAndAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_ServiceContractAndAgreementMember_doc" xml:lang="en-US">Service Contract And Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_JanuaryOneTwoThousandTwentyFiveMember" xlink:to="RIME_JanuaryOneTwoThousandTwentyFiveMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_JanuaryOneTwoThousandTwentyFiveMember_doc" xml:lang="en-US">January 1, 2025 [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFEAgreementsMember" xlink:to="RIME_SAFEAgreementsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_SAFEAgreementsMember_doc" xml:lang="en-US">SAFE Agreements[Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_OctoberOneTwoThousandTwentyFourMember" xlink:to="RIME_OctoberOneTwoThousandTwentyFourMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_OctoberOneTwoThousandTwentyFourMember_doc" xml:lang="en-US">October One Two Thousand Twenty Four [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SafePrivatePlacementsTableTextBlock" xlink:to="RIME_SafePrivatePlacementsTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_SafePrivatePlacementsTableTextBlock_doc" xml:lang="en-US">Safe Private Placements [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFEOneMember" xlink:to="RIME_SAFEOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_SAFEOneMember_doc" xml:lang="en-US">SAFE One [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_PerYearMember" xlink:to="RIME_PerYearMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_PerYearMember_doc" xml:lang="en-US">Per Year [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_ConvertibleHolderName" xlink:to="RIME_ConvertibleHolderName_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_ConvertibleHolderName_doc" xml:lang="en-US">Convertible holder name.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_InvestmentIssueDate" xlink:to="RIME_InvestmentIssueDate_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_InvestmentIssueDate_doc" xml:lang="en-US">Investment issue date.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_InvestmentConvertedDate" xlink:to="RIME_InvestmentConvertedDate_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_InvestmentConvertedDate_doc" xml:lang="en-US">Investment converted date.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_AccruedPotentialLiability" xlink:to="RIME_AccruedPotentialLiability_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_AccruedPotentialLiability_doc" xml:lang="en-US">Accrued potential liability.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_DisputeAmount" xlink:to="RIME_DisputeAmount_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_DisputeAmount_doc" xml:lang="en-US">Dispute amount.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_ValuationCapitalOfInvestment" xlink:to="RIME_ValuationCapitalOfInvestment_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_ValuationCapitalOfInvestment_doc" xml:lang="en-US">Valuation capital of investment.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_WeeklyPaymentsMember" xlink:to="RIME_WeeklyPaymentsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_WeeklyPaymentsMember_doc" xml:lang="en-US">Weekly Payments [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_PaymentsForMilestone" xlink:to="RIME_PaymentsForMilestone_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_PaymentsForMilestone_doc" xml:lang="en-US">Payments for milestone.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_TwoSeparateMilestonePaymentMember" xlink:to="RIME_TwoSeparateMilestonePaymentMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_TwoSeparateMilestonePaymentMember_doc" xml:lang="en-US">Two Separate Milestone Payment [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_FirstMilestonePaymentMember" xlink:to="RIME_FirstMilestonePaymentMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_FirstMilestonePaymentMember_doc" xml:lang="en-US">First Milestone Payment [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SecondMilestonePaymentMember" xlink:to="RIME_SecondMilestonePaymentMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_SecondMilestonePaymentMember_doc" xml:lang="en-US">Second Milestone Payment [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFEFortyOneMember" xlink:to="RIME_SAFEFortyOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_SAFEFortyOneMember_doc" xml:lang="en-US">SAFE Forty One [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFEFortyTwoMember" xlink:to="RIME_SAFEFortyTwoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_SAFEFortyTwoMember_doc" xml:lang="en-US">SAFE Forty Two [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFEFortyThreeMember" xlink:to="RIME_SAFEFortyThreeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_SAFEFortyThreeMember_doc" xml:lang="en-US">SAFE Forty Three [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFEFortyMember" xlink:to="RIME_SAFEFortyMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_SAFEFortyMember_doc" xml:lang="en-US">SAFE Forty [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFEThirtyNineMember" xlink:to="RIME_SAFEThirtyNineMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_SAFEThirtyNineMember_doc" xml:lang="en-US">SAFE Thirty Nine [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFETenMember" xlink:to="RIME_SAFETenMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_SAFETenMember_doc" xml:lang="en-US">SAFE Ten [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFEElevenMember" xlink:to="RIME_SAFEElevenMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_SAFEElevenMember_doc" xml:lang="en-US">SAFE Eleven [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFETwelveMember" xlink:to="RIME_SAFETwelveMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_SAFETwelveMember_doc" xml:lang="en-US">SAFE Twelve [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFEThirteenMember" xlink:to="RIME_SAFEThirteenMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_SAFEThirteenMember_doc" xml:lang="en-US">SAFE Thirteen [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SudhirNarasimhamurthyMember" xlink:to="RIME_SudhirNarasimhamurthyMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_SudhirNarasimhamurthyMember_doc" xml:lang="en-US">Sudhir Narasimhamurthy [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate" xlink:to="RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_doc" xml:lang="en-US">Share based compensation arrangement by share based payment award vesting start date.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate" xlink:to="RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_doc" xml:lang="en-US">Share based compensation arrangement by share based payment award fully vested date.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate" xlink:to="RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_doc" xml:lang="en-US">Share based compensation arrangement by share based payment award board approval date.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_KadandaleSrinivasSudheerMember" xlink:to="RIME_KadandaleSrinivasSudheerMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_KadandaleSrinivasSudheerMember_doc" xml:lang="en-US">Kadandale Srinivas Sudheer [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFEFortyNineMember" xlink:to="RIME_SAFEFortyNineMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_SAFEFortyNineMember_doc" xml:lang="en-US">SAFE Forty Nine [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_RajivSaxenaMember" xlink:to="RIME_RajivSaxenaMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_RajivSaxenaMember_doc" xml:lang="en-US">Rajiv Saxena [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_HarshaBhatMember" xlink:to="RIME_HarshaBhatMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_HarshaBhatMember_doc" xml:lang="en-US">Harsha Bhat [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_InvestmentOfPrincipalAmount" xlink:to="RIME_InvestmentOfPrincipalAmount_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_InvestmentOfPrincipalAmount_doc" xml:lang="en-US">Investment of principal amount.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_InvestedValuationOfAmount" xlink:to="RIME_InvestedValuationOfAmount_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_InvestedValuationOfAmount_doc" xml:lang="en-US">Invested valuation of amount.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_FortyFourSAFEAgreementsMember" xlink:to="RIME_FortyFourSAFEAgreementsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_FortyFourSAFEAgreementsMember_doc" xml:lang="en-US">Forty Four SAFE Agreements [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SiddayyaSGanjalMember" xlink:to="RIME_SiddayyaSGanjalMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_SiddayyaSGanjalMember_doc" xml:lang="en-US">Siddayya S Ganjal [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SunilAroraMember" xlink:to="RIME_SunilAroraMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_SunilAroraMember_doc" xml:lang="en-US">Sunil Arora [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_RajivVirmaniMember" xlink:to="RIME_RajivVirmaniMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_RajivVirmaniMember_doc" xml:lang="en-US">Rajiv Virmani [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SudhindraShenoyMember" xlink:to="RIME_SudhindraShenoyMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_SudhindraShenoyMember_doc" xml:lang="en-US">Sudhindra Shenoy [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_AntonySunilMember" xlink:to="RIME_AntonySunilMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_AntonySunilMember_doc" xml:lang="en-US">Antony Sunil [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_TuleekaNandyMember" xlink:to="RIME_TuleekaNandyMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_TuleekaNandyMember_doc" xml:lang="en-US">Tuleeka Nandy [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SemiCabIncMember" xlink:to="RIME_SemiCabIncMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_SemiCabIncMember_doc" xml:lang="en-US">Semi Cab, Inc [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_AccountsReceivableDisclosureTextBlock" xlink:to="RIME_AccountsReceivableDisclosureTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_AccountsReceivableDisclosureTextBlock_doc" xml:lang="en-US">Accounts Receivable Disclosure [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_ProductDevelopmentExpense" xlink:to="RIME_ProductDevelopmentExpense_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_ProductDevelopmentExpense_doc" xml:lang="en-US">Product development expense.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_RobelAtnafuMember" xlink:to="RIME_RobelAtnafuMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_RobelAtnafuMember_doc" xml:lang="en-US">Robel Atnafu [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_GuyPrimusMember" xlink:to="RIME_GuyPrimusMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_GuyPrimusMember_doc" xml:lang="en-US">Guy Primus [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFEFiftyOneMember" xlink:to="RIME_SAFEFiftyOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_SAFEFiftyOneMember_doc" xml:lang="en-US">SAFE Fifty One [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_FourMember" xlink:to="RIME_FourMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_FourMember_doc" xml:lang="en-US">Four [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_ScheduleOfStockOptionIssuedTableTextBlock" xlink:to="RIME_ScheduleOfStockOptionIssuedTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_ScheduleOfStockOptionIssuedTableTextBlock_doc" xml:lang="en-US">Schedule Of Stock Option Issued [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFEThirtyEightMember" xlink:to="RIME_SAFEThirtyEightMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_SAFEThirtyEightMember_doc" xml:lang="en-US">SAFE Thirty Eight [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFEFourteenMember" xlink:to="RIME_SAFEFourteenMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_SAFEFourteenMember_doc" xml:lang="en-US">SAFE Fourteen [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFEFifteenMember" xlink:to="RIME_SAFEFifteenMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_SAFEFifteenMember_doc" xml:lang="en-US">SAFE Fifteen [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFESixteenMember" xlink:to="RIME_SAFESixteenMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_SAFESixteenMember_doc" xml:lang="en-US">SAFE Sixteen [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFESeventeenMember" xlink:to="RIME_SAFESeventeenMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_SAFESeventeenMember_doc" xml:lang="en-US">SAFE Seventeen [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFEEighteenMember" xlink:to="RIME_SAFEEighteenMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_SAFEEighteenMember_doc" xml:lang="en-US">SAFE Eighteen [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFENineteenMember" xlink:to="RIME_SAFENineteenMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_SAFENineteenMember_doc" xml:lang="en-US">SAFE Nineteen [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFETwoMember" xlink:to="RIME_SAFETwoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_SAFETwoMember_doc" xml:lang="en-US">SAFE Two [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFETwentyMember" xlink:to="RIME_SAFETwentyMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_SAFETwentyMember_doc" xml:lang="en-US">SAFE Twenty [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFETwentyOneMember" xlink:to="RIME_SAFETwentyOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_SAFETwentyOneMember_doc" xml:lang="en-US">SAFE Twenty One [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFETwentyTwoMember" xlink:to="RIME_SAFETwentyTwoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_SAFETwentyTwoMember_doc" xml:lang="en-US">SAFE Twenty Two [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFETwentyFourMember" xlink:to="RIME_SAFETwentyFourMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_SAFETwentyFourMember_doc" xml:lang="en-US">SAFE Twenty Four [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFEThreeMember" xlink:to="RIME_SAFEThreeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_SAFEThreeMember_doc" xml:lang="en-US">SAFE Three [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFEFourMember" xlink:to="RIME_SAFEFourMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_SAFEFourMember_doc" xml:lang="en-US">SAFE Four [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFEFortyFiveMember" xlink:to="RIME_SAFEFortyFiveMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_SAFEFortyFiveMember_doc" xml:lang="en-US">SAFE Forty Five [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFESixMember" xlink:to="RIME_SAFESixMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_SAFESixMember_doc" xml:lang="en-US">SAFE Six [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFESevenMember" xlink:to="RIME_SAFESevenMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_SAFESevenMember_doc" xml:lang="en-US">SAFE Seven [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFEEightMember" xlink:to="RIME_SAFEEightMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_SAFEEightMember_doc" xml:lang="en-US">SAFE Eight [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFENineMember" xlink:to="RIME_SAFENineMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_SAFENineMember_doc" xml:lang="en-US">SAFE Nine [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFEFiveMember" xlink:to="RIME_SAFEFiveMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_SAFEFiveMember_doc" xml:lang="en-US">SAFE Five [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFETwentyFiveMember" xlink:to="RIME_SAFETwentyFiveMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_SAFETwentyFiveMember_doc" xml:lang="en-US">SAFE Twenty Five [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFETwentySixMember" xlink:to="RIME_SAFETwentySixMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_SAFETwentySixMember_doc" xml:lang="en-US">SAFE Twenty Six [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFETwentySevenMember" xlink:to="RIME_SAFETwentySevenMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_SAFETwentySevenMember_doc" xml:lang="en-US">SAFE Twenty Seven [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFETwentyEightMember" xlink:to="RIME_SAFETwentyEightMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_SAFETwentyEightMember_doc" xml:lang="en-US">SAFE Twenty Eight [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFETwentyNineMember" xlink:to="RIME_SAFETwentyNineMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_SAFETwentyNineMember_doc" xml:lang="en-US">SAFE Twenty Nine [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFEThirtyMember" xlink:to="RIME_SAFEThirtyMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_SAFEThirtyMember_doc" xml:lang="en-US">SAFE Thirty [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFEThirtyOneMember" xlink:to="RIME_SAFEThirtyOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_SAFEThirtyOneMember_doc" xml:lang="en-US">SAFE Thirty One [Member</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFEThirtyTwoMember" xlink:to="RIME_SAFEThirtyTwoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_SAFEThirtyTwoMember_doc" xml:lang="en-US">SAFE Thirty Two [Member</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFEThirtyThreeMember" xlink:to="RIME_SAFEThirtyThreeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_SAFEThirtyThreeMember_doc" xml:lang="en-US">SAFE Thirty Three [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFEThirtyFourMember" xlink:to="RIME_SAFEThirtyFourMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_SAFEThirtyFourMember_doc" xml:lang="en-US">SAFE Thirty Four [Member</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFEThirtyFiveMember" xlink:to="RIME_SAFEThirtyFiveMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_SAFEThirtyFiveMember_doc" xml:lang="en-US">SAFE Thirty Five [Member</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFEThirtySixMember" xlink:to="RIME_SAFEThirtySixMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_SAFEThirtySixMember_doc" xml:lang="en-US">SAFE Thirty Six [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFEThirtySevenMember" xlink:to="RIME_SAFEThirtySevenMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_SAFEThirtySevenMember_doc" xml:lang="en-US">SAFE Thirty Seven [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFEFortySixMember" xlink:to="RIME_SAFEFortySixMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_SAFEFortySixMember_doc" xml:lang="en-US">SAFE Forty Six [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFEFiftyMember" xlink:to="RIME_SAFEFiftyMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_SAFEFiftyMember_doc" xml:lang="en-US">SAFE Fifty [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFEFortyEightMember" xlink:to="RIME_SAFEFortyEightMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_SAFEFortyEightMember_doc" xml:lang="en-US">SAFE Forty Eight [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFEFortySevenMember" xlink:to="RIME_SAFEFortySevenMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_SAFEFortySevenMember_doc" xml:lang="en-US">SAFE Forty Seven [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_ForeignAndDomesticRateOfAccountsReceivable" xlink:to="RIME_ForeignAndDomesticRateOfAccountsReceivable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_ForeignAndDomesticRateOfAccountsReceivable_doc" xml:lang="en-US">Foreign and domestic rate of accounts receivable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_AdvanceFeeRate" xlink:to="RIME_AdvanceFeeRate_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_AdvanceFeeRate_doc" xml:lang="en-US">Advance fee rate.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_FoundersMember" xlink:to="RIME_FoundersMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_FoundersMember_doc" xml:lang="en-US">Founders [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SamarthaGowdaMember" xlink:to="RIME_SamarthaGowdaMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_SamarthaGowdaMember_doc" xml:lang="en-US">Samartha Gowda [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_AlexandraAielloMember" xlink:to="RIME_AlexandraAielloMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_AlexandraAielloMember_doc" xml:lang="en-US">Alexandra Aiello [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_StephenCabralMember" xlink:to="RIME_StephenCabralMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_StephenCabralMember_doc" xml:lang="en-US">Stephen Cabral [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_JonahPetiPerrinMember" xlink:to="RIME_JonahPetiPerrinMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_JonahPetiPerrinMember_doc" xml:lang="en-US">Jonah Peti Perrin [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_BryanNellaMember" xlink:to="RIME_BryanNellaMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_BryanNellaMember_doc" xml:lang="en-US">Bryan Nella [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_MarkSinkMember" xlink:to="RIME_MarkSinkMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_MarkSinkMember_doc" xml:lang="en-US">Mark Sink [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_KoustavChoudhuriMember" xlink:to="RIME_KoustavChoudhuriMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_KoustavChoudhuriMember_doc" xml:lang="en-US">Koustav Choudhuri [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_NotePayableAndFinancingArrangementsTextBlock" xlink:to="RIME_NotePayableAndFinancingArrangementsTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_NotePayableAndFinancingArrangementsTextBlock_doc" xml:lang="en-US">Note Payable And Financing Arrangements [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_LineOfCreditFacilityInterestRate" xlink:to="RIME_LineOfCreditFacilityInterestRate_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_LineOfCreditFacilityInterestRate_doc" xml:lang="en-US">Line of credit facility interest rate.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SemiCabLLCMember" xlink:to="RIME_SemiCabLLCMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_SemiCabLLCMember_doc" xml:lang="en-US">Semi Cab LLC [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_RevolvingLoanAmendmentMember" xlink:to="RIME_RevolvingLoanAmendmentMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_RevolvingLoanAmendmentMember_doc" xml:lang="en-US">Revolving Loan Amendment [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_ClassicKaraokeMachinesMember" xlink:to="RIME_ClassicKaraokeMachinesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_ClassicKaraokeMachinesMember_doc" xml:lang="en-US">Classic Karaoke Machines [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_AssetPurchaseAgreementMember" xlink:to="RIME_AssetPurchaseAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_AssetPurchaseAgreementMember_doc" xml:lang="en-US">Asset Purchase Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_TwoThousandTwentyFourMember" xlink:to="RIME_TwoThousandTwentyFourMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_TwoThousandTwentyFourMember_doc" xml:lang="en-US">2024 [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_EmploymentAgreementsMember" xlink:to="RIME_EmploymentAgreementsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_EmploymentAgreementsMember_doc" xml:lang="en-US">Employment Agreements [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_TwoThousandTwentyFiveMember" xlink:to="RIME_TwoThousandTwentyFiveMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_TwoThousandTwentyFiveMember_doc" xml:lang="en-US">2025 [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SubsequentYearsMember" xlink:to="RIME_SubsequentYearsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_SubsequentYearsMember_doc" xml:lang="en-US">Subsequent Years [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_VivekSehgalKapoorMember" xlink:to="RIME_VivekSehgalKapoorMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_VivekSehgalKapoorMember_doc" xml:lang="en-US">Vivek Sehgal Kapoor [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_TwoThousandTwentySixMember" xlink:to="RIME_TwoThousandTwentySixMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_TwoThousandTwentySixMember_doc" xml:lang="en-US">2026 [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_TwoThousandTwentySevenMember" xlink:to="RIME_TwoThousandTwentySevenMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_TwoThousandTwentySevenMember_doc" xml:lang="en-US">2027 [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_TwoThousandTwentyEightMember" xlink:to="RIME_TwoThousandTwentyEightMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_TwoThousandTwentyEightMember_doc" xml:lang="en-US">2028 [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFEFortyFourMember" xlink:to="RIME_SAFEFortyFourMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_SAFEFortyFourMember_doc" xml:lang="en-US">SAFE Forty Four [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SecuritiesPurchaseAgreementMember" xlink:to="RIME_SecuritiesPurchaseAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_SecuritiesPurchaseAgreementMember_doc" xml:lang="en-US">Securities Purchase Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_BlueYonderIncMember" xlink:to="RIME_BlueYonderIncMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_BlueYonderIncMember_doc" xml:lang="en-US">Blue Yonder Inc [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_GainOnTerminationOfOperatingLease" xlink:to="RIME_GainOnTerminationOfOperatingLease_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_GainOnTerminationOfOperatingLease_doc" xml:lang="en-US">Gain on termination of operating lease.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_PaymentOfEarlyTerminationFeeOnOperatingLeaseTerminationSettlement" xlink:to="RIME_PaymentOfEarlyTerminationFeeOnOperatingLeaseTerminationSettlement_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_PaymentOfEarlyTerminationFeeOnOperatingLeaseTerminationSettlement_doc" xml:lang="en-US">Payment of early termination fee on operating lease termination settlement.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_OperatingLeasePeriodicPayments" xlink:to="RIME_OperatingLeasePeriodicPayments_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_OperatingLeasePeriodicPayments_doc" xml:lang="en-US">Operating lease periodic payments.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_LeaseSettlementExpense" xlink:to="RIME_LeaseSettlementExpense_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_LeaseSettlementExpense_doc" xml:lang="en-US">Lease settlement expense.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_PrivatePlacementIssueDiscount" xlink:to="RIME_PrivatePlacementIssueDiscount_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_PrivatePlacementIssueDiscount_doc" xml:lang="en-US">Private placement issue discount.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_NonControllingInterestAtFairValue" xlink:to="RIME_NonControllingInterestAtFairValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_NonControllingInterestAtFairValue_doc" xml:lang="en-US">Non controlling interest at fair value.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_RoyaltyRate" xlink:to="RIME_RoyaltyRate_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_RoyaltyRate_doc" xml:lang="en-US">Royalty rate.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_DiscountOnRoyaltyRate" xlink:to="RIME_DiscountOnRoyaltyRate_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_DiscountOnRoyaltyRate_doc" xml:lang="en-US">Discount on royalty rate.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_RoyaltyTerm" xlink:to="RIME_RoyaltyTerm_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_RoyaltyTerm_doc" xml:lang="en-US">Royalty term.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_GrowthRateOfDevelopmentOfNewBusiness" xlink:to="RIME_GrowthRateOfDevelopmentOfNewBusiness_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_GrowthRateOfDevelopmentOfNewBusiness_doc" xml:lang="en-US">Growth rate of development of new business.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_DiscountRateForWeightedAverageCost" xlink:to="RIME_DiscountRateForWeightedAverageCost_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_DiscountRateForWeightedAverageCost_doc" xml:lang="en-US">Discount rate for weighted average cost.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_AssetAcquisitionFairValueOfNonControllingInterest" xlink:to="RIME_AssetAcquisitionFairValueOfNonControllingInterest_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_AssetAcquisitionFairValueOfNonControllingInterest_doc" xml:lang="en-US">Asset acquisition fair value of non controlling interest.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_AssetAcquisitionDebtExtinguishment" xlink:to="RIME_AssetAcquisitionDebtExtinguishment_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_AssetAcquisitionDebtExtinguishment_doc" xml:lang="en-US">Asset acquisition debt extinguishment.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCustomerRelationships" xlink:to="RIME_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCustomerRelationships_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCustomerRelationships_doc" xml:lang="en-US">Business combination recognized identifiable assets acquired and liabilities assumed customer relationships.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradeName" xlink:to="RIME_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradeName_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradeName_doc" xml:lang="en-US">Business combination recognized identifiable assets acquired and liabilities assumed trade name.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDevelopedTechnology" xlink:to="RIME_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDevelopedTechnology_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDevelopedTechnology_doc" xml:lang="en-US">Business combination recognized identifiable assets acquired and liabilities assumed developed technology.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLoansPayable" xlink:to="RIME_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLoansPayable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLoansPayable_doc" xml:lang="en-US">Business combination recognized identifiable assets acquired and liabilities assumed current liabilities loans payable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesNotesPayableRelatedParties" xlink:to="RIME_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesNotesPayableRelatedParties_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesNotesPayableRelatedParties_doc" xml:lang="en-US">Business combination recognized identifiable assets acquired and liabilities assumed current liabilities notes payable related parties.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_LossContingencyEstimateOfPossibleLossPerYear" xlink:to="RIME_LossContingencyEstimateOfPossibleLossPerYear_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_LossContingencyEstimateOfPossibleLossPerYear_doc" xml:lang="en-US">Loss contingency estimate of possible loss per year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_WarrantsDisclosureTextBlock" xlink:to="RIME_WarrantsDisclosureTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_WarrantsDisclosureTextBlock_doc" xml:lang="en-US">Warrants Disclosure [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_EstimatedReserveOfAdvertisingExpense" xlink:to="RIME_EstimatedReserveOfAdvertisingExpense_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_EstimatedReserveOfAdvertisingExpense_doc" xml:lang="en-US">Estimated reserve of advertising expense.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_PercentageOfPurchasersRightToParticipateOnIssuanceCompanyOfCommonStock" xlink:to="RIME_PercentageOfPurchasersRightToParticipateOnIssuanceCompanyOfCommonStock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_PercentageOfPurchasersRightToParticipateOnIssuanceCompanyOfCommonStock_doc" xml:lang="en-US">Percentage of purchasers right to participate on issuance company of common stock.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_PercentageOfGrossProceeds" xlink:to="RIME_PercentageOfGrossProceeds_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RIME_PercentageOfGrossProceeds_doc" xml:lang="en-US">Percentage of gross proceeds.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_SAFETwentyMember" xlink:to="RIME_SAFETwentyMember_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_SAFETwentyMember_3_lbl" xml:lang="en-US">SAFE-20 [Member] [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Assets, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Assets [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_2_lbl" xml:lang="en-US">Liabilities [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_2_lbl" xml:lang="en-US">Commitments and Contingencies [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable" xlink:to="us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable_2_lbl" xml:lang="en-US">Common Stock, Share Subscribed but Unissued, Subscriptions Receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_4_lbl" xml:lang="en-US">Equity, Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GrossProfit_2_lbl" xml:lang="en-US">Gross Profit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpenses_3_lbl" xml:lang="en-US">Operating Expenses [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_2_lbl" xml:lang="en-US">Operating Income (Loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseDebtExcludingAmortization" xlink:to="us-gaap_InterestExpenseDebtExcludingAmortization_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpenseDebtExcludingAmortization_2_lbl" xml:lang="en-US">Interest Expense, Debt, Excluding Amortization</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2_lbl" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesOutstanding_3_lbl" xml:lang="en-US">Shares, Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:to="us-gaap_TreasuryStockRetiredCostMethodAmount_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockRetiredCostMethodAmount_2_lbl" xml:lang="en-US">Treasury Stock, Retired, Cost Method, Amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockSharesRetired" xlink:to="us-gaap_TreasuryStockSharesRetired_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockSharesRetired_2_lbl" xml:lang="en-US">Treasury Stock, Shares, Retired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_2_lbl" xml:lang="en-US">Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_2_lbl" xml:lang="en-US">Adjustments to Additional Paid in Capital, Other</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_ProvisionForEstimatedCostOfReturns" xlink:to="RIME_ProvisionForEstimatedCostOfReturns_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_ProvisionForEstimatedCostOfReturns_3_lbl" xml:lang="en-US">ProvisionForEstimatedCostOfReturns</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_ProvisionForInventoryObsolescence" xlink:to="RIME_ProvisionForInventoryObsolescence_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_ProvisionForInventoryObsolescence_3_lbl" xml:lang="en-US">ProvisionForInventoryObsolescence</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_GainOnTerminationOfOperatingLease" xlink:to="RIME_GainOnTerminationOfOperatingLease_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_GainOnTerminationOfOperatingLease_3_lbl" xml:lang="en-US">GainOnTerminationOfOperatingLease</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_2_lbl" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_2_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfIntangibleAssets_2_lbl" xml:lang="en-US">Amortization of Intangible Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseDueFromAffiliates" xlink:to="us-gaap_IncreaseDecreaseDueFromAffiliates_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseDueFromAffiliates_2_lbl" xml:lang="en-US">Increase (Decrease) Due from Affiliates</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Receivable, Related Parties</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInInventories_2_lbl" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_lbl" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_2_lbl" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_2_lbl" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_IncreaseDecreaseInReserveForSalesReturns" xlink:to="RIME_IncreaseDecreaseInReserveForSalesReturns_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_IncreaseDecreaseInReserveForSalesReturns_3_lbl" xml:lang="en-US">IncreaseDecreaseInReserveForSalesReturns</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_PaymentOfRedemptionAndRetirementOfTreasuryStock" xlink:to="RIME_PaymentOfRedemptionAndRetirementOfTreasuryStock_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_PaymentOfRedemptionAndRetirementOfTreasuryStock_3_lbl" xml:lang="en-US">PaymentOfRedemptionAndRetirementOfTreasuryStock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfSubordinatedDebt" xlink:to="us-gaap_RepaymentsOfSubordinatedDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfSubordinatedDebt_2_lbl" xml:lang="en-US">Repayments of Subordinated Debt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_PaymentOfDeferredFinancingCharges" xlink:to="RIME_PaymentOfDeferredFinancingCharges_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_PaymentOfDeferredFinancingCharges_3_lbl" xml:lang="en-US">PaymentOfDeferredFinancingCharges</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_PaymentOfEarlyTerminationFeesOnRevolvingLinesOfCredit" xlink:to="RIME_PaymentOfEarlyTerminationFeesOnRevolvingLinesOfCredit_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_PaymentOfEarlyTerminationFeesOnRevolvingLinesOfCredit_3_lbl" xml:lang="en-US">PaymentOfEarlyTerminationFeesOnRevolvingLinesOfCredit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_PaymentsOnInstallmentNote" xlink:to="RIME_PaymentsOnInstallmentNote_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_PaymentsOnInstallmentNote_3_lbl" xml:lang="en-US">PaymentsOnInstallmentNote</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations" xlink:to="us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_2_lbl" xml:lang="en-US">Repayments of Debt and Lease Obligation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfOtherDebt" xlink:to="us-gaap_RepaymentsOfOtherDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfOtherDebt_2_lbl" xml:lang="en-US">Repayments of Other Debt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_2_lbl" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssued1" xlink:to="us-gaap_StockIssued1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssued1_2_lbl" xml:lang="en-US">Stock Issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_2_lbl" xml:lang="en-US">Goodwill and Intangible Assets, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_2_lbl" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_2_lbl" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_2_lbl" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_2_lbl" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt_2_lbl" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Long-Term Debt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_LineOfCreditFacilityInterestRate" xlink:to="RIME_LineOfCreditFacilityInterestRate_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_LineOfCreditFacilityInterestRate_3_lbl" xml:lang="en-US">LineOfCreditFacilityInterestRate</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpense_2_lbl" xml:lang="en-US">Interest Expense, Operating and Nonoperating</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilities" xlink:to="us-gaap_OtherLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilities_2_lbl" xml:lang="en-US">Other Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_2_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_CurrentOtherTaxExpenseBenefit" xlink:to="RIME_CurrentOtherTaxExpenseBenefit_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_CurrentOtherTaxExpenseBenefit_3_lbl" xml:lang="en-US">CurrentOtherTaxExpenseBenefit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit_2_lbl" xml:lang="en-US">Current Federal, State and Local, Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit_2_lbl" xml:lang="en-US">Deferred Federal, State and Local, Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsGross_2_lbl" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsNet_2_lbl" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Deferred Tax Liabilities, Property, Plant and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_DeferredTaxLiabilitiesRightUseOfAsset" xlink:to="RIME_DeferredTaxLiabilitiesRightUseOfAsset_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_DeferredTaxLiabilitiesRightUseOfAsset_3_lbl" xml:lang="en-US">DeferredTaxLiabilitiesRightUseOfAsset</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" xlink:to="us-gaap_DeferredTaxLiabilitiesPrepaidExpenses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilitiesPrepaidExpenses_2_lbl" xml:lang="en-US">Deferred Tax Liabilities, Prepaid Expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilities_2_lbl" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_2_lbl" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:to="us-gaap_IncomeTaxReconciliationOtherReconcilingItems_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationOtherReconcilingItems_2_lbl" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Date</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RIME_InvestmentOfPrincipalAmount" xlink:to="RIME_InvestmentOfPrincipalAmount_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RIME_InvestmentOfPrincipalAmount_3_lbl" xml:lang="en-US">InvestmentOfPrincipalAmount</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>20
<FILENAME>rime-20240930_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://algoholdings.com/role/Cover" xlink:href="rime-20240930.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/BalanceSheets" xlink:href="rime-20240930.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/BalanceSheetsParenthetical" xlink:href="rime-20240930.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/StatementsOfOperations" xlink:href="rime-20240930.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/StatementsOfShareholdersDeficitEquity" xlink:href="rime-20240930.xsd#StatementsOfShareholdersDeficitEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/StatementsOfCashFlows" xlink:href="rime-20240930.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/NatureOfBusiness" xlink:href="rime-20240930.xsd#NatureOfBusiness" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/RecentDevelopments" xlink:href="rime-20240930.xsd#RecentDevelopments" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/LiquidityGoingConcernAndManagementPlans" xlink:href="rime-20240930.xsd#LiquidityGoingConcernAndManagementPlans" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="rime-20240930.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/AssetAcquisition" xlink:href="rime-20240930.xsd#AssetAcquisition" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/Financing" xlink:href="rime-20240930.xsd#Financing" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/LoansPayableRelatedParties" xlink:href="rime-20240930.xsd#LoansPayableRelatedParties" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/CommitmentsAndContingencies" xlink:href="rime-20240930.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/OperatingLeases" xlink:href="rime-20240930.xsd#OperatingLeases" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/IssuanceOfCommonStock" xlink:href="rime-20240930.xsd#IssuanceOfCommonStock" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/Warrants" xlink:href="rime-20240930.xsd#Warrants" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ComputationOfLossPerShare" xlink:href="rime-20240930.xsd#ComputationOfLossPerShare" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/IncomeTaxes" xlink:href="rime-20240930.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/RevenueDisaggregation" xlink:href="rime-20240930.xsd#RevenueDisaggregation" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ConcentrationsOfCreditRiskAndRevenue" xlink:href="rime-20240930.xsd#ConcentrationsOfCreditRiskAndRevenue" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/RelatedPartyTransactions" xlink:href="rime-20240930.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/SubsequentEvents" xlink:href="rime-20240930.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/PropertyAndEquipment" xlink:href="rime-20240930.xsd#PropertyAndEquipment" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/StockCompensationExpense" xlink:href="rime-20240930.xsd#StockCompensationExpense" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/PublicOfferingAndNasdaqUplisting" xlink:href="rime-20240930.xsd#PublicOfferingAndNasdaqUplisting" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/AtmOffering" xlink:href="rime-20240930.xsd#AtmOffering" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/PrivatePlacement" xlink:href="rime-20240930.xsd#PrivatePlacement" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/August2021StockRedemption" xlink:href="rime-20240930.xsd#August2021StockRedemption" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/August2021PrivatePlacement" xlink:href="rime-20240930.xsd#August2021PrivatePlacement" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/DamagedGoodsIncidentRecovery" xlink:href="rime-20240930.xsd#DamagedGoodsIncidentRecovery" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/SupplementalInformationCondensedFinancialInformation" xlink:href="rime-20240930.xsd#SupplementalInformationCondensedFinancialInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/AccountsReceivable" xlink:href="rime-20240930.xsd#AccountsReceivable" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/AccountsPayableAndAccruedExpenses" xlink:href="rime-20240930.xsd#AccountsPayableAndAccruedExpenses" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/NotesPayableAndFinaningArrangements" xlink:href="rime-20240930.xsd#NotesPayableAndFinaningArrangements" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/DueFromFactor" xlink:href="rime-20240930.xsd#DueFromFactor" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/StockholdersEquity" xlink:href="rime-20240930.xsd#StockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/SafePrivatePlacements" xlink:href="rime-20240930.xsd#SafePrivatePlacements" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/EmployeeBenefitPlans" xlink:href="rime-20240930.xsd#EmployeeBenefitPlans" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="rime-20240930.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/AssetAcquisitionTables" xlink:href="rime-20240930.xsd#AssetAcquisitionTables" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/LoansPayableRelatedPartiesTables" xlink:href="rime-20240930.xsd#LoansPayableRelatedPartiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/OperatingLeasesTables" xlink:href="rime-20240930.xsd#OperatingLeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/WarrantsTables" xlink:href="rime-20240930.xsd#WarrantsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ComputationOfLossPerShareTables" xlink:href="rime-20240930.xsd#ComputationOfLossPerShareTables" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/RevenueDisaggregationTables" xlink:href="rime-20240930.xsd#RevenueDisaggregationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/PropertyAndEquipmentTables" xlink:href="rime-20240930.xsd#PropertyAndEquipmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/StockCompensationExpenseTables" xlink:href="rime-20240930.xsd#StockCompensationExpenseTables" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/August2021PrivatePlacementTables" xlink:href="rime-20240930.xsd#August2021PrivatePlacementTables" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/SupplementalInformationCondensedFinancialInformationTables" xlink:href="rime-20240930.xsd#SupplementalInformationCondensedFinancialInformationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/NotesPayableAndFinaningArrangementsTables" xlink:href="rime-20240930.xsd#NotesPayableAndFinaningArrangementsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/StockholdersEquityTables" xlink:href="rime-20240930.xsd#StockholdersEquityTables" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/SafePrivatePlacementsTables" xlink:href="rime-20240930.xsd#SafePrivatePlacementsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/RecentDevelopmentsDetailsNarrative" xlink:href="rime-20240930.xsd#RecentDevelopmentsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/LiquidityGoingConcernAndManagementPlansDetailsNarrative" xlink:href="rime-20240930.xsd#LiquidityGoingConcernAndManagementPlansDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfConsiderationTransferredToAssetsAcquiredAndLiabilitiesAssumedDetails" xlink:href="rime-20240930.xsd#ScheduleOfConsiderationTransferredToAssetsAcquiredAndLiabilitiesAssumedDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfConsiderationTransferredToAssetsAcquiredAndLiabilitiesAssumedDetailsParenthetical" xlink:href="rime-20240930.xsd#ScheduleOfConsiderationTransferredToAssetsAcquiredAndLiabilitiesAssumedDetailsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfProFormaFinancialInformationDetails" xlink:href="rime-20240930.xsd#ScheduleOfProFormaFinancialInformationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/AssetAcquisitionDetailsNarrative" xlink:href="rime-20240930.xsd#AssetAcquisitionDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/FinancingDetailsNarrative" xlink:href="rime-20240930.xsd#FinancingDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfLoanDetails" xlink:href="rime-20240930.xsd#ScheduleOfLoanDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/LoansPayableRelatedPartiesDetailsNarrative" xlink:href="rime-20240930.xsd#LoansPayableRelatedPartiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="rime-20240930.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfSupplementalInformationRelatedToLeasesDetails" xlink:href="rime-20240930.xsd#ScheduleOfSupplementalInformationRelatedToLeasesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfLeaseTermAndDiscountRateDetails" xlink:href="rime-20240930.xsd#ScheduleOfLeaseTermAndDiscountRateDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfOperatingLeaseMinimumFuturePaymentsDetails" xlink:href="rime-20240930.xsd#ScheduleOfOperatingLeaseMinimumFuturePaymentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/OperatingLeasesDetailsNarrative" xlink:href="rime-20240930.xsd#OperatingLeasesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/IssuanceOfCommonStockDetailsNarrative" xlink:href="rime-20240930.xsd#IssuanceOfCommonStockDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfWarrantsExpirationDetails" xlink:href="rime-20240930.xsd#ScheduleOfWarrantsExpirationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/WarrantsDetailsNarrative" xlink:href="rime-20240930.xsd#WarrantsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfBasicAndDilutiveLossPerShareDetails" xlink:href="rime-20240930.xsd#ScheduleOfBasicAndDilutiveLossPerShareDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ComputationOfLossPerShareDetailsNarrative" xlink:href="rime-20240930.xsd#ComputationOfLossPerShareDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/IncomeTaxesDetailsNarrative" xlink:href="rime-20240930.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfRevenueByProductLineDetails" xlink:href="rime-20240930.xsd#ScheduleOfRevenueByProductLineDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfSalesByGeographicalRegionDetails" xlink:href="rime-20240930.xsd#ScheduleOfSalesByGeographicalRegionDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/RevenueDisaggregationDetailsNarrative" xlink:href="rime-20240930.xsd#RevenueDisaggregationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ConcentrationsOfCreditRiskAndRevenueDetailsNarrative" xlink:href="rime-20240930.xsd#ConcentrationsOfCreditRiskAndRevenueDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="rime-20240930.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/SubsequentEventsDetailsNarrative" xlink:href="rime-20240930.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="rime-20240930.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfPropertyAndEquipmentDetails" xlink:href="rime-20240930.xsd#ScheduleOfPropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/PropertyAndEquipmentDetailsNarrative" xlink:href="rime-20240930.xsd#PropertyAndEquipmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/SummaryOfStockOptionActivityDetails" xlink:href="rime-20240930.xsd#SummaryOfStockOptionActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfEmployeeStockOptionsOutstandingDetailsParenthetical" xlink:href="rime-20240930.xsd#ScheduleOfEmployeeStockOptionsOutstandingDetailsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfBasicAndDilutiveSharesDetails" xlink:href="rime-20240930.xsd#ScheduleOfBasicAndDilutiveSharesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/StockCompensationExpenseDetailsNarrative" xlink:href="rime-20240930.xsd#StockCompensationExpenseDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/PublicOfferingAndNasdaqUplistingDetailsNarrative" xlink:href="rime-20240930.xsd#PublicOfferingAndNasdaqUplistingDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/AtmOfferingDetailsNarrative" xlink:href="rime-20240930.xsd#AtmOfferingDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/PrivatePlacementDetailsNarrative" xlink:href="rime-20240930.xsd#PrivatePlacementDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/August2021StockRedemptionDetailsNarrative" xlink:href="rime-20240930.xsd#August2021StockRedemptionDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfLossBeforeIncomeTaxesDetails" xlink:href="rime-20240930.xsd#ScheduleOfLossBeforeIncomeTaxesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfProvisionForIncomeTaxesDetails" xlink:href="rime-20240930.xsd#ScheduleOfProvisionForIncomeTaxesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:href="rime-20240930.xsd#ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfTaxProvisionDetails" xlink:href="rime-20240930.xsd#ScheduleOfTaxProvisionDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfRevenueByGeographicalRegionDetails" xlink:href="rime-20240930.xsd#ScheduleOfRevenueByGeographicalRegionDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/August2021PrivatePlacementDetailsNarrative" xlink:href="rime-20240930.xsd#August2021PrivatePlacementDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/DamagedGoodsIncidentRecoveryDetailsNarrative" xlink:href="rime-20240930.xsd#DamagedGoodsIncidentRecoveryDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfOperationsDetails" xlink:href="rime-20240930.xsd#ScheduleOfCondensedConsolidatedStatementsOfOperationsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfCashFlowsDetails" xlink:href="rime-20240930.xsd#ScheduleOfCondensedConsolidatedStatementsOfCashFlowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfShareholdersEquityDetails" xlink:href="rime-20240930.xsd#ScheduleOfCondensedConsolidatedStatementsOfShareholdersEquityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfEstimatedUsefulLivesDetails" xlink:href="rime-20240930.xsd#ScheduleOfEstimatedUsefulLivesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/AccountsReceivableDetailsNarrative" xlink:href="rime-20240930.xsd#AccountsReceivableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/AccountsPayableAndAccruedExpensesDetailsNarrative" xlink:href="rime-20240930.xsd#AccountsPayableAndAccruedExpensesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfSpecificTermsDetails" xlink:href="rime-20240930.xsd#ScheduleOfSpecificTermsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/NotesPayableAndFinaningArrangementsDetailsNarrative" xlink:href="rime-20240930.xsd#NotesPayableAndFinaningArrangementsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/DueFromFactorDetailsNarrative" xlink:href="rime-20240930.xsd#DueFromFactorDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfStockOptionIssuedDuringYearDecember3120202021And2022Details" xlink:href="rime-20240930.xsd#ScheduleOfStockOptionIssuedDuringYearDecember3120202021And2022Details" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/StockholdersEquityDetailsNarrative" xlink:href="rime-20240930.xsd#StockholdersEquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/ScheduleOfFirstTrancheOfSubscriptionsDetails" xlink:href="rime-20240930.xsd#ScheduleOfFirstTrancheOfSubscriptionsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/SummaryOfTerminatedImmediatelyAfterClosingOfTransactionDetails" xlink:href="rime-20240930.xsd#SummaryOfTerminatedImmediatelyAfterClosingOfTransactionDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://algoholdings.com/role/SafePrivatePlacementsDetailsNarrative" xlink:href="rime-20240930.xsd#SafePrivatePlacementsDetailsNarrative" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesTable" xlink:label="loc_deiEntityAddressesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesLineItems" xlink:label="loc_deiEntityAddressesLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesTable" xlink:to="loc_deiEntityAddressesLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="loc_deiEntityAddressesAddressTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesTable" xlink:to="loc_deiEntityAddressesAddressTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AddressTypeDomain" xlink:label="loc_deiAddressTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesAddressTypeAxis" xlink:to="loc_deiAddressTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_BusinessContactMember" xlink:label="loc_deiBusinessContactMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiAddressTypeDomain" xlink:to="loc_deiBusinessContactMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_ContactPersonnelName" xlink:label="loc_deiContactPersonnelName" />
      <link:presentationArc order="580" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiContactPersonnelName" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/BalanceSheets" xlink:title="00000002 - Statement - Condensed Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonrelatedPartyMember" xlink:label="loc_us-gaapNonrelatedPartyMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapNonrelatedPartyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember" xlink:label="loc_us-gaapRelatedPartyMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapRelatedPartyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_deiLegalEntityAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCash" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNet" xlink:label="loc_us-gaapAccountsReceivableNet" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAccountsReceivableNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DueFromBanks" xlink:label="loc_us-gaapDueFromBanks" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapDueFromBanks" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_RefundDueFromCustomer" xlink:label="loc_RIMERefundDueFromCustomer" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_RIMERefundDueFromCustomer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ReturnsAsset" xlink:label="loc_RIMEReturnsAsset" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_RIMEReturnsAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaapOtherAssetsNoncurrent" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapOtherAssetsNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaapNotesPayableCurrent" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapNotesPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LoansPayableCurrent" xlink:label="loc_us-gaapLoansPayableCurrent" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLoansPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerRefundLiabilityCurrent" xlink:label="loc_us-gaapContractWithCustomerRefundLiabilityCurrent" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapContractWithCustomerRefundLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_CustomerPrepayments" xlink:label="loc_RIMECustomerPrepayments" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_RIMECustomerPrepayments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ReserveForSalesReturns" xlink:label="loc_RIMEReserveForSalesReturns" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_RIMEReserveForSalesReturns" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermBorrowings" xlink:label="loc_us-gaapShortTermBorrowings" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapShortTermBorrowings" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapOtherLiabilitiesNoncurrent" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapOtherLiabilitiesNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermNotesPayable" xlink:label="loc_us-gaapLongTermNotesPayable" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLongTermNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermLoansPayable" xlink:label="loc_us-gaapLongTermLoansPayable" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLongTermLoansPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_CommitmentsAndContingenciesAbstract" xlink:label="loc_RIMECommitmentsAndContingenciesAbstract" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_RIMECommitmentsAndContingenciesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ProvisionForLegalLiability" xlink:label="loc_RIMEProvisionForLegalLiability" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMECommitmentsAndContingenciesAbstract" xlink:to="loc_RIMEProvisionForLegalLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable" xlink:label="loc_us-gaapCommonStockShareSubscribedButUnissuedSubscriptionsReceivable" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockShareSubscribedButUnissuedSubscriptionsReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaapMinorityInterest" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapMinorityInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Condensed Consolidated Statements of Operations">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaapCostOfGoodsAndServicesSold" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCostOfGoodsAndServicesSold" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaapOperatingExpensesAbstract" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingExpensesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingExpense" xlink:label="loc_us-gaapSellingExpense" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapSellingExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnTerminationOfLease" xlink:label="loc_us-gaapGainLossOnTerminationOfLease" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapGainLossOnTerminationOfLease" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ProductDevelopmentExpense" xlink:label="loc_RIMEProductDevelopmentExpense" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_RIMEProductDevelopmentExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaapNonoperatingIncomeExpenseAbstract" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnDispositionOfAssets1" xlink:label="loc_us-gaapGainLossOnDispositionOfAssets1" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapGainLossOnDispositionOfAssets1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_GainFromRelatedPartyDebt" xlink:label="loc_RIMEGainFromRelatedPartyDebt" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_RIMEGainFromRelatedPartyDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_GainFromPaycheckProtectionPlanLoanForgiveness" xlink:label="loc_RIMEGainFromPaycheckProtectionPlanLoanForgiveness" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_RIMEGainFromPaycheckProtectionPlanLoanForgiveness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_GainFromSettlementOfAccountsPayable" xlink:label="loc_RIMEGainFromSettlementOfAccountsPayable" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_RIMEGainFromSettlementOfAccountsPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_GainFromEmployeeRetentionCreditProgramRefund" xlink:label="loc_RIMEGainFromEmployeeRetentionCreditProgramRefund" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_RIMEGainFromEmployeeRetentionCreditProgramRefund" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseDebtExcludingAmortization" xlink:label="loc_us-gaapInterestExpenseDebtExcludingAmortization" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapInterestExpenseDebtExcludingAmortization" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract" xlink:label="loc_us-gaapEarningsPerShareBasicOtherDisclosuresAbstract" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareBasicOtherDisclosuresAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/StatementsOfShareholdersDeficitEquity" xlink:title="00000005 - Statement - Condensed Consolidated Statements of Shareholders&apos; (Deficit) Equity">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivablesFromStockholderMember" xlink:label="loc_us-gaapReceivablesFromStockholderMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapReceivablesFromStockholderMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaapNoncontrollingInterestMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapNoncontrollingInterestMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation" xlink:label="loc_us-gaapStockGrantedDuringPeriodValueSharebasedCompensation" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockGrantedDuringPeriodValueSharebasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueAcquisitions" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueAcquisitions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueOther" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_StockIssuedDuringPeriodValueSaleOfCommonStockWarrants" xlink:label="loc_RIMEStockIssuedDuringPeriodValueSaleOfCommonStockWarrants" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMEStockIssuedDuringPeriodValueSaleOfCommonStockWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_StockIssuedDuringPeriodSharesSaleOfCommonStockWarrants" xlink:label="loc_RIMEStockIssuedDuringPeriodSharesSaleOfCommonStockWarrants" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMEStockIssuedDuringPeriodSharesSaleOfCommonStockWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalWarrantIssued" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_2" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesOther" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:label="loc_us-gaapTreasuryStockRetiredCostMethodAmount" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTreasuryStockRetiredCostMethodAmount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockSharesRetired" xlink:label="loc_us-gaapTreasuryStockSharesRetired" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTreasuryStockSharesRetired" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_StockIssuedDuringPeriodValueExerciseOfPrefundedAndCommonWarrants" xlink:label="loc_RIMEStockIssuedDuringPeriodValueExerciseOfPrefundedAndCommonWarrants" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMEStockIssuedDuringPeriodValueExerciseOfPrefundedAndCommonWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_StockIssuedDuringPeriodSharesExerciseOfPrefundedAndCommonWarrants" xlink:label="loc_RIMEStockIssuedDuringPeriodSharesExerciseOfPrefundedAndCommonWarrants" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMEStockIssuedDuringPeriodSharesExerciseOfPrefundedAndCommonWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_StockIssuedDuringPeriodValueReverseStockSplits" xlink:label="loc_RIMEStockIssuedDuringPeriodValueReverseStockSplits" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMEStockIssuedDuringPeriodValueReverseStockSplits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesReverseStockSplits" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesReverseStockSplits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_StockIssuedDuringPeriodValueIssuanceOfCommonStockAtMarketOffering" xlink:label="loc_RIMEStockIssuedDuringPeriodValueIssuanceOfCommonStockAtMarketOffering" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMEStockIssuedDuringPeriodValueIssuanceOfCommonStockAtMarketOffering" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_StockIssuedDuringPeriodSharesIssuanceOfCommonStockAtMarketOffering" xlink:label="loc_RIMEStockIssuedDuringPeriodSharesIssuanceOfCommonStockAtMarketOffering" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMEStockIssuedDuringPeriodSharesIssuanceOfCommonStockAtMarketOffering" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_StockIssuedDuringPeriodValueIssuanceOfCommonStockPrivatePlacement" xlink:label="loc_RIMEStockIssuedDuringPeriodValueIssuanceOfCommonStockPrivatePlacement" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMEStockIssuedDuringPeriodValueIssuanceOfCommonStockPrivatePlacement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_StockIssuedDuringPeriodSharesIssuanceOfCommonStockPrivatePlacement" xlink:label="loc_RIMEStockIssuedDuringPeriodSharesIssuanceOfCommonStockPrivatePlacement" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMEStockIssuedDuringPeriodSharesIssuanceOfCommonStockPrivatePlacement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalOther" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalOther" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_2" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_2" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Condensed Consolidated Statements of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="loc_us-gaapAmortizationOfFinancingCosts" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAmortizationOfFinancingCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredIncomeTaxExpenseBenefit" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDeferredIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ProvisionForEstimatedCostOfReturns" xlink:label="loc_RIMEProvisionForEstimatedCostOfReturns" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_RIMEProvisionForEstimatedCostOfReturns" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ProvisionForInventoryObsolescence" xlink:label="loc_RIMEProvisionForInventoryObsolescence" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_RIMEProvisionForInventoryObsolescence" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaapProvisionForDoubtfulAccounts" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapProvisionForDoubtfulAccounts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_GainOnTerminationOfOperatingLease" xlink:label="loc_RIMEGainOnTerminationOfOperatingLease" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_RIMEGainOnTerminationOfOperatingLease" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:label="loc_us-gaapGainLossOnSaleOfPropertyPlantEquipment" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapGainLossOnSaleOfPropertyPlantEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAssetAmortizationExpense" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_GainFromPaycheckProtectionPlanLoanForgiveness" xlink:label="loc_RIMEGainFromPaycheckProtectionPlanLoanForgiveness" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_RIMEGainFromPaycheckProtectionPlanLoanForgiveness" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_GainFromRelatedPartyDebt" xlink:label="loc_RIMEGainFromRelatedPartyDebt" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_RIMEGainFromRelatedPartyDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_GainFromSettlementOfAccountsPayable" xlink:label="loc_RIMEGainFromSettlementOfAccountsPayable" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_RIMEGainFromSettlementOfAccountsPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseDueFromAffiliates" xlink:label="loc_us-gaapIncreaseDecreaseDueFromAffiliates" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseDueFromAffiliates" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivableRelatedParties" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivableRelatedParties" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherNoncurrentAssets" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayable" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInDueToRelatedParties" xlink:label="loc_us-gaapIncreaseDecreaseInDueToRelatedParties" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInDueToRelatedParties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="loc_us-gaapIncreaseDecreaseInContractWithCustomerLiability" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_IncreaseDecreaseInPrepaidsFromCustomers" xlink:label="loc_RIMEIncreaseDecreaseInPrepaidsFromCustomers" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_RIMEIncreaseDecreaseInPrepaidsFromCustomers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_IncreaseDecreaseInReserveForSalesReturns" xlink:label="loc_RIMEIncreaseDecreaseInReserveForSalesReturns" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_RIMEIncreaseDecreaseInReserveForSalesReturns" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingLeaseLiability" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingLeaseLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_PaymentOfEarlyTerminationFeeOnOperatingLeaseTerminationSettlement" xlink:label="loc_RIMEPaymentOfEarlyTerminationFeeOnOperatingLeaseTerminationSettlement" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_RIMEPaymentOfEarlyTerminationFeeOnOperatingLeaseTerminationSettlement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromPreviousAcquisition" xlink:label="loc_us-gaapProceedsFromPreviousAcquisition" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromPreviousAcquisition" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="loc_us-gaapProceedsFromSaleOfPropertyPlantAndEquipment" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_PaymentOfRedemptionAndRetirementOfTreasuryStock" xlink:label="loc_RIMEPaymentOfRedemptionAndRetirementOfTreasuryStock" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_RIMEPaymentOfRedemptionAndRetirementOfTreasuryStock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ProceedsFromCollectionOfSubscriptionsReceivable" xlink:label="loc_RIMEProceedsFromCollectionOfSubscriptionsReceivable" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_RIMEProceedsFromCollectionOfSubscriptionsReceivable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfSubordinatedDebt" xlink:label="loc_us-gaapRepaymentsOfSubordinatedDebt" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapRepaymentsOfSubordinatedDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_PaymentOfDeferredFinancingCharges" xlink:label="loc_RIMEPaymentOfDeferredFinancingCharges" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_RIMEPaymentOfDeferredFinancingCharges" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_PaymentOfEarlyTerminationFeesOnRevolvingLinesOfCredit" xlink:label="loc_RIMEPaymentOfEarlyTerminationFeesOnRevolvingLinesOfCredit" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_RIMEPaymentOfEarlyTerminationFeesOnRevolvingLinesOfCredit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_PaymentsOnInstallmentNote" xlink:label="loc_RIMEPaymentsOnInstallmentNote" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_RIMEPaymentsOnInstallmentNote" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaapProceedsFromStockOptionsExercised" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ProceedsFromExerciseOfCommonStockWarrants" xlink:label="loc_RIMEProceedsFromExerciseOfCommonStockWarrants" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_RIMEProceedsFromExerciseOfCommonStockWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaapProceedsFromWarrantExercises" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromWarrantExercises" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations" xlink:label="loc_us-gaapRepaymentsOfDebtAndCapitalLeaseObligations" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapRepaymentsOfDebtAndCapitalLeaseObligations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfOtherDebt" xlink:label="loc_us-gaapRepaymentsOfOtherDebt" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapRepaymentsOfOtherDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromRepaymentsOfLinesOfCredit" xlink:label="loc_us-gaapProceedsFromRepaymentsOfLinesOfCredit" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromRepaymentsOfLinesOfCredit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:label="loc_us-gaapProceedsFromPaymentsForOtherFinancingActivities" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaapSupplementalCashFlowInformationAbstract" />
      <link:presentationArc order="580" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaidNet" xlink:label="loc_us-gaapInterestPaidNet" />
      <link:presentationArc order="590" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_us-gaapInterestPaidNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="loc_us-gaapIncomeTaxesPaidNet" />
      <link:presentationArc order="600" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_us-gaapIncomeTaxesPaidNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" />
      <link:presentationArc order="610" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssued1" xlink:label="loc_us-gaapStockIssued1" />
      <link:presentationArc order="620" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_us-gaapStockIssued1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalLeaseObligationsIncurred" xlink:label="loc_us-gaapCapitalLeaseObligationsIncurred" />
      <link:presentationArc order="630" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_us-gaapCapitalLeaseObligationsIncurred" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="loc_us-gaapRightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" />
      <link:presentationArc order="640" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_us-gaapRightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_IssuanceOfCommonStockAndWarrantsForOfferingCosts" xlink:label="loc_RIMEIssuanceOfCommonStockAndWarrantsForOfferingCosts" />
      <link:presentationArc order="650" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_RIMEIssuanceOfCommonStockAndWarrantsForOfferingCosts" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/NatureOfBusiness" xlink:title="00000007 - Disclosure - NATURE OF BUSINESS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NatureOfOperations" xlink:label="loc_us-gaapNatureOfOperations" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNatureOfOperations" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/RecentDevelopments" xlink:title="00000008 - Disclosure - RECENT DEVELOPMENTS">
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DisclosureRecentDevelopmentsAbstract" xlink:label="loc_RIMEDisclosureRecentDevelopmentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_RecentDevelopmentsTextBlock" xlink:label="loc_RIMERecentDevelopmentsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureRecentDevelopmentsAbstract" xlink:to="loc_RIMERecentDevelopmentsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/LiquidityGoingConcernAndManagementPlans" xlink:title="00000009 - Disclosure - LIQUIDITY, GOING CONCERN AND MANAGEMENT PLANS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" xlink:label="loc_us-gaapSubstantialDoubtAboutGoingConcernTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSubstantialDoubtAboutGoingConcernTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000010 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapSignificantAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSignificantAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/AssetAcquisition" xlink:title="00000011 - Disclosure - ASSET ACQUISITION">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionTextBlock" xlink:label="loc_us-gaapAssetAcquisitionTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapAssetAcquisitionTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/Financing" xlink:title="00000012 - Disclosure - FINANCING">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_us-gaapDebtDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/LoansPayableRelatedParties" xlink:title="00000013 - Disclosure - LOANS PAYABLE &#8211; RELATED PARTIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtTextBlock" xlink:label="loc_us-gaapLongTermDebtTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapLongTermDebtTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/CommitmentsAndContingencies" xlink:title="00000014 - Disclosure - COMMITMENTS AND CONTINGENCIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/OperatingLeases" xlink:title="00000015 - Disclosure - OPERATING LEASES">
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DisclosureOperatingLeasesAbstract" xlink:label="loc_RIMEDisclosureOperatingLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="loc_us-gaapLesseeOperatingLeasesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureOperatingLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeasesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/IssuanceOfCommonStock" xlink:title="00000016 - Disclosure - ISSUANCE OF COMMON STOCK">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/Warrants" xlink:title="00000017 - Disclosure - WARRANTS">
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DisclosureWarrantsAbstract" xlink:label="loc_RIMEDisclosureWarrantsAbstract" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_WarrantsDisclosureTextBlock" xlink:label="loc_RIMEWarrantsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureWarrantsAbstract" xlink:to="loc_RIMEWarrantsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ComputationOfLossPerShare" xlink:title="00000018 - Disclosure - COMPUTATION OF LOSS PER SHARE">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="loc_us-gaapEarningsPerShareTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapEarningsPerShareTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/IncomeTaxes" xlink:title="00000019 - Disclosure - INCOME TAXES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaapIncomeTaxDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/RevenueDisaggregation" xlink:title="00000020 - Disclosure - REVENUE DISAGGREGATION">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="loc_us-gaapSegmentReportingDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapSegmentReportingDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ConcentrationsOfCreditRiskAndRevenue" xlink:title="00000021 - Disclosure - CONCENTRATIONS OF CREDIT RISK AND REVENUE">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="loc_us-gaapRisksAndUncertaintiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRisksAndUncertaintiesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:label="loc_us-gaapConcentrationRiskDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConcentrationRiskDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/RelatedPartyTransactions" xlink:title="00000022 - Disclosure - RELATED PARTY TRANSACTIONS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/SubsequentEvents" xlink:title="00000023 - Disclosure - SUBSEQUENT EVENTS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/PropertyAndEquipment" xlink:title="00000024 - Disclosure - PROPERTY AND EQUIPMENT">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/StockCompensationExpense" xlink:title="00000025 - Disclosure - STOCK COMPENSATION EXPENSE">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/PublicOfferingAndNasdaqUplisting" xlink:title="00000026 - Disclosure - PUBLIC OFFERING AND NASDAQ UPLISTING">
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DisclosurePublicOfferingAndNasdaqUplistingAbstract" xlink:label="loc_RIMEDisclosurePublicOfferingAndNasdaqUplistingAbstract" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_IssuanceOfPublicOfferingTextBlock" xlink:label="loc_RIMEIssuanceOfPublicOfferingTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosurePublicOfferingAndNasdaqUplistingAbstract" xlink:to="loc_RIMEIssuanceOfPublicOfferingTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/AtmOffering" xlink:title="00000027 - Disclosure - ATM OFFERING">
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DisclosureAtmOfferingAbstract" xlink:label="loc_RIMEDisclosureAtmOfferingAbstract" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AtTheMarketPublicOfferingTextBlock" xlink:label="loc_RIMEAtTheMarketPublicOfferingTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureAtmOfferingAbstract" xlink:to="loc_RIMEAtTheMarketPublicOfferingTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/PrivatePlacement" xlink:title="00000028 - Disclosure - PRIVATE PLACEMENT">
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DisclosurePrivatePlacementAbstract" xlink:label="loc_RIMEDisclosurePrivatePlacementAbstract" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_PrivatePlacementTextBlock" xlink:label="loc_RIMEPrivatePlacementTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosurePrivatePlacementAbstract" xlink:to="loc_RIMEPrivatePlacementTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/August2021StockRedemption" xlink:title="00000029 - Disclosure - AUGUST 2021 STOCK REDEMPTION">
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DisclosureAugust2021StockRedemptionAbstract" xlink:label="loc_RIMEDisclosureAugust2021StockRedemptionAbstract" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_StockRedemptionTextBlock" xlink:label="loc_RIMEStockRedemptionTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureAugust2021StockRedemptionAbstract" xlink:to="loc_RIMEStockRedemptionTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/August2021PrivatePlacement" xlink:title="00000030 - Disclosure - AUGUST 2021 PRIVATE PLACEMENT">
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DisclosureAugust2021PrivatePlacementAbstract" xlink:label="loc_RIMEDisclosureAugust2021PrivatePlacementAbstract" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AugustTwentyTwentyOnePrivatePlacementTextBlock" xlink:label="loc_RIMEAugustTwentyTwentyOnePrivatePlacementTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureAugust2021PrivatePlacementAbstract" xlink:to="loc_RIMEAugustTwentyTwentyOnePrivatePlacementTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/DamagedGoodsIncidentRecovery" xlink:title="00000031 - Disclosure - DAMAGED GOODS INCIDENT RECOVERY">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InsuranceAbstract" xlink:label="loc_us-gaapInsuranceAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InsuranceDisclosureTextBlock" xlink:label="loc_us-gaapInsuranceDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInsuranceAbstract" xlink:to="loc_us-gaapInsuranceDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/SupplementalInformationCondensedFinancialInformation" xlink:title="00000032 - Disclosure - SUPPLEMENTAL INFORMATION CONDENSED FINANCIAL INFORMATION">
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DisclosureSupplementalInformationCondensedFinancialInformationAbstract" xlink:label="loc_RIMEDisclosureSupplementalInformationCondensedFinancialInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SupplementalInformationDisclosuresTextBlock" xlink:label="loc_RIMESupplementalInformationDisclosuresTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureSupplementalInformationCondensedFinancialInformationAbstract" xlink:to="loc_RIMESupplementalInformationDisclosuresTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/AccountsReceivable" xlink:title="00000033 - Disclosure - ACCOUNTS RECEIVABLE">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditLossAbstract" xlink:label="loc_us-gaapCreditLossAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCreditLossAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsAndNontradeReceivableTextBlock" xlink:label="loc_us-gaapAccountsAndNontradeReceivableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccountsAndNontradeReceivableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/AccountsPayableAndAccruedExpenses" xlink:title="00000034 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/NotesPayableAndFinaningArrangements" xlink:title="00000035 - Disclosure - NOTES PAYABLE AND FINANING ARRANGEMENTS">
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DisclosureNotesPayableAndFinaningArrangementsAbstract" xlink:label="loc_RIMEDisclosureNotesPayableAndFinaningArrangementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureNotesPayableAndFinaningArrangementsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_NotePayableAndFinancingArrangementsTextBlock" xlink:label="loc_RIMENotePayableAndFinancingArrangementsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMENotePayableAndFinancingArrangementsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/DueFromFactor" xlink:title="00000036 - Disclosure - DUE FROM FACTOR">
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DisclosureDueFromFactorAbstract" xlink:label="loc_RIMEDisclosureDueFromFactorAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureDueFromFactorAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AccountsReceivableDisclosureTextBlock" xlink:label="loc_RIMEAccountsReceivableDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMEAccountsReceivableDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/StockholdersEquity" xlink:title="00000037 - Disclosure - STOCKHOLDERS&#8217; EQUITY">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/SafePrivatePlacements" xlink:title="00000038 - Disclosure - SAFE PRIVATE PLACEMENTS">
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DisclosureSafePrivatePlacementsAbstract" xlink:label="loc_RIMEDisclosureSafePrivatePlacementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureSafePrivatePlacementsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SafePrivatePlacementsTextBlock" xlink:label="loc_RIMESafePrivatePlacementsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMESafePrivatePlacementsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/EmployeeBenefitPlans" xlink:title="00000039 - Disclosure - EMPLOYEE BENEFIT PLANS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="loc_us-gaapCompensationAndRetirementDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCompensationAndRetirementDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:label="loc_us-gaapCompensationAndEmployeeBenefitPlansTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCompensationAndEmployeeBenefitPlansTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000040 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaapConsolidationPolicyTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConsolidationPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationsPolicy" xlink:label="loc_us-gaapBusinessCombinationsPolicy" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessCombinationsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsPolicyTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGoodwillAndIntangibleAssetsPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="loc_us-gaapFairValueMeasurementPolicyPolicyTextBlock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:label="loc_us-gaapPriorPeriodReclassificationAdjustmentDescription" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaapUseOfEstimates" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapUseOfEstimates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:label="loc_us-gaapTradeAndOtherAccountsReceivablePolicy" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTradeAndOtherAccountsReceivablePolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="loc_us-gaapInventoryPolicyTextBlock" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInventoryPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="loc_us-gaapLesseeLeasesPolicyTextBlock" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeLeasesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="loc_us-gaapRevenueFromContractWithCustomerPolicyTextBlock" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ShippingAndHandlingCostsPolicyTextBlock" xlink:label="loc_RIMEShippingAndHandlingCostsPolicyTextBlock" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMEShippingAndHandlingCostsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="loc_us-gaapShareBasedCompensationOptionAndIncentivePlansPolicy" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaapIncomeTaxPolicyTextBlock" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountPolicy" xlink:label="loc_RIMEReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountPolicy" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMEReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="loc_us-gaapForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaapConcentrationRiskCreditRisk" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConcentrationRiskCreditRisk" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_PrepaidExpensesPolicyTextBlock" xlink:label="loc_RIMEPrepaidExpensesPolicyTextBlock" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMEPrepaidExpensesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:label="loc_us-gaapCompensationRelatedCostsPolicyTextBlock" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCompensationRelatedCostsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="loc_us-gaapResearchAndDevelopmentExpensePolicy" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapResearchAndDevelopmentExpensePolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaapEarningsPerSharePolicyTextBlock" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerSharePolicyTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/AssetAcquisitionTables" xlink:title="00000041 - Disclosure - ASSET ACQUISITION (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="loc_us-gaapScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ScheduleOfProFormaFinancialInformationTableTextBlock" xlink:label="loc_RIMEScheduleOfProFormaFinancialInformationTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_RIMEScheduleOfProFormaFinancialInformationTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/LoansPayableRelatedPartiesTables" xlink:title="00000042 - Disclosure - LOANS PAYABLE &#8211; RELATED PARTIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="loc_us-gaapScheduleOfMaturitiesOfLongTermDebtTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/OperatingLeasesTables" xlink:title="00000043 - Disclosure - OPERATING LEASES (Tables)">
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DisclosureOperatingLeasesAbstract" xlink:label="loc_RIMEDisclosureOperatingLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ScheduleOfSupplementalInformationRelatedToLeaseTableTextBlock" xlink:label="loc_RIMEScheduleOfSupplementalInformationRelatedToLeaseTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureOperatingLeasesAbstract" xlink:to="loc_RIMEScheduleOfSupplementalInformationRelatedToLeaseTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="loc_us-gaapLeaseCostTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureOperatingLeasesAbstract" xlink:to="loc_us-gaapLeaseCostTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureOperatingLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/WarrantsTables" xlink:title="00000044 - Disclosure - WARRANTS (Tables)">
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DisclosureWarrantsAbstract" xlink:label="loc_RIMEDisclosureWarrantsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureWarrantsAbstract" xlink:to="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ComputationOfLossPerShareTables" xlink:title="00000045 - Disclosure - COMPUTATION OF LOSS PER SHARE (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/RevenueDisaggregationTables" xlink:title="00000046 - Disclosure - REVENUE DISAGGREGATION (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="loc_us-gaapDisaggregationOfRevenueTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapDisaggregationOfRevenueTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:label="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/PropertyAndEquipmentTables" xlink:title="00000047 - Disclosure - PROPERTY AND EQUIPMENT (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/StockCompensationExpenseTables" xlink:title="00000048 - Disclosure - STOCK COMPENSATION EXPENSE (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/August2021PrivatePlacementTables" xlink:title="00000049 - Disclosure - AUGUST 2021 PRIVATE PLACEMENT (Tables)">
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DisclosureAugust2021PrivatePlacementAbstract" xlink:label="loc_RIMEDisclosureAugust2021PrivatePlacementAbstract" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ScheduleOfLossBeforeIncomeTaxTableTextBlock" xlink:label="loc_RIMEScheduleOfLossBeforeIncomeTaxTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureAugust2021PrivatePlacementAbstract" xlink:to="loc_RIMEScheduleOfLossBeforeIncomeTaxTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="loc_us-gaapScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureAugust2021PrivatePlacementAbstract" xlink:to="loc_us-gaapScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureAugust2021PrivatePlacementAbstract" xlink:to="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:label="loc_us-gaapScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureAugust2021PrivatePlacementAbstract" xlink:to="loc_us-gaapScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/SupplementalInformationCondensedFinancialInformationTables" xlink:title="00000050 - Disclosure - SUPPLEMENTAL INFORMATION CONDENSED FINANCIAL INFORMATION (Tables)">
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DisclosureSupplementalInformationCondensedFinancialInformationAbstract" xlink:label="loc_RIMEDisclosureSupplementalInformationCondensedFinancialInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureSupplementalInformationCondensedFinancialInformationAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfCondensedIncomeStatementTableTextBlock" xlink:label="loc_srtScheduleOfCondensedIncomeStatementTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_srtScheduleOfCondensedIncomeStatementTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeStatementAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfCondensedCashFlowStatementTableTextBlock" xlink:label="loc_srtScheduleOfCondensedCashFlowStatementTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_srtScheduleOfCondensedCashFlowStatementTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementOfCashFlowsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:label="loc_us-gaapScheduleOfStockholdersEquityTableTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapScheduleOfStockholdersEquityTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaapScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/NotesPayableAndFinaningArrangementsTables" xlink:title="00000051 - Disclosure - NOTES PAYABLE AND FINANING ARRANGEMENTS (Tables)">
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DisclosureNotesPayableAndFinaningArrangementsAbstract" xlink:label="loc_RIMEDisclosureNotesPayableAndFinaningArrangementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureNotesPayableAndFinaningArrangementsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDebtTableTextBlock" xlink:label="loc_us-gaapScheduleOfDebtTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapScheduleOfDebtTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/StockholdersEquityTables" xlink:title="00000052 - Disclosure - STOCKHOLDERS&#8217; EQUITY (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ScheduleOfStockOptionIssuedTableTextBlock" xlink:label="loc_RIMEScheduleOfStockOptionIssuedTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMEScheduleOfStockOptionIssuedTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/SafePrivatePlacementsTables" xlink:title="00000053 - Disclosure - SAFE PRIVATE PLACEMENTS (Tables)">
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DisclosureSafePrivatePlacementsAbstract" xlink:label="loc_RIMEDisclosureSafePrivatePlacementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureSafePrivatePlacementsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SafePrivatePlacementsTableTextBlock" xlink:label="loc_RIMESafePrivatePlacementsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMESafePrivatePlacementsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock" xlink:label="loc_us-gaapInvestmentHoldingsScheduleOfInvestmentsTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInvestmentHoldingsScheduleOfInvestmentsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/RecentDevelopmentsDetailsNarrative" xlink:title="00000054 - Disclosure - RECENT DEVELOPMENTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DisclosureRecentDevelopmentsAbstract" xlink:label="loc_RIMEDisclosureRecentDevelopmentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureRecentDevelopmentsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AtTheMarketSalesAgreementMember" xlink:label="loc_RIMEAtTheMarketSalesAgreementMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMEAtTheMarketSalesAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AtTheMarketSalesAgreementAmendmentOneMember" xlink:label="loc_RIMEAtTheMarketSalesAgreementAmendmentOneMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMEAtTheMarketSalesAgreementAmendmentOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AtTheMarketSalesAgreementAmendmentTwoMember" xlink:label="loc_RIMEAtTheMarketSalesAgreementAmendmentTwoMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMEAtTheMarketSalesAgreementAmendmentTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AssetPurchaseAgreementMember" xlink:label="loc_RIMEAssetPurchaseAgreementMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMEAssetPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_LeaseAgreementMember" xlink:label="loc_RIMELeaseAgreementMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMELeaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SettlementAgreementMember" xlink:label="loc_RIMESettlementAgreementMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESettlementAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SecuritiesPurchaseAgreementMember" xlink:label="loc_RIMESecuritiesPurchaseAgreementMember" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESecuritiesPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_LoanAgreementMember" xlink:label="loc_RIMELoanAgreementMember" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMELoanAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_StockRepurchaseAgreementMember" xlink:label="loc_RIMEStockRepurchaseAgreementMember" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMEStockRepurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="loc_srtEquityMethodInvesteeNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="loc_srtEquityMethodInvesteeNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabLLCMember" xlink:label="loc_RIMESemiCabLLCMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtEquityMethodInvesteeNameDomain" xlink:to="loc_RIMESemiCabLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabLLCMember" xlink:label="loc_RIMESemiCabLLCMember_2" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RIMESemiCabLLCMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaapPrivatePlacementMember" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapPrivatePlacementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ATMOfferingMember" xlink:label="loc_RIMEATMOfferingMember" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_RIMEATMOfferingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityAxis" xlink:label="loc_us-gaapCreditFacilityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapCreditFacilityAxis" order="70" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaapCreditFacilityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCreditFacilityAxis" xlink:to="loc_us-gaapCreditFacilityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="loc_us-gaapRevolvingCreditFacilityMember" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCreditFacilityDomain" xlink:to="loc_us-gaapRevolvingCreditFacilityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LegalFees" xlink:label="loc_us-gaapLegalFees" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLegalFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdministrativeFeesExpense" xlink:label="loc_us-gaapAdministrativeFeesExpense" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdministrativeFeesExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesPurchaseOfAssets" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AreaOfLand" xlink:label="loc_us-gaapAreaOfLand" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAreaOfLand" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AssetsWriteOff" xlink:label="loc_RIMEAssetsWriteOff" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMEAssetsWriteOff" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasePayments" xlink:label="loc_us-gaapOperatingLeasePayments" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeasePayments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_OperatingLeasePeriodicPayments" xlink:label="loc_RIMEOperatingLeasePeriodicPayments" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMEOperatingLeasePeriodicPayments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnTerminationOfLease" xlink:label="loc_us-gaapGainLossOnTerminationOfLease" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGainLossOnTerminationOfLease" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_LeaseSettlementExpense" xlink:label="loc_RIMELeaseSettlementExpense" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMELeaseSettlementExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SecuredDebt" xlink:label="loc_us-gaapSecuredDebt" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSecuredDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_PrivatePlacementIssueDiscount" xlink:label="loc_RIMEPrivatePlacementIssueDiscount" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMEPrivatePlacementIssueDiscount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaapLineOfCreditFacilityMaximumBorrowingCapacity" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:label="loc_us-gaapLineOfCreditFacilityCommitmentFeeAmount" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityCommitmentFeeAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_TransactionFees" xlink:label="loc_RIMETransactionFees" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMETransactionFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="loc_us-gaapLesseeOperatingLeaseTermOfContract" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseTermOfContract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRent" xlink:label="loc_us-gaapPaymentsForRent" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsForRent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/LiquidityGoingConcernAndManagementPlansDetailsNarrative" xlink:title="00000055 - Disclosure - LIQUIDITY, GOING CONCERN AND MANAGEMENT PLANS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_WorkingCapital" xlink:label="loc_RIMEWorkingCapital" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMEWorkingCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfConsiderationTransferredToAssetsAcquiredAndLiabilitiesAssumedDetails" xlink:title="00000056 - Disclosure - SCHEDULE OF CONSIDERATION TRANSFERRED TO THE ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionTable" xlink:label="loc_us-gaapAssetAcquisitionTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapAssetAcquisitionTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionLineItems" xlink:label="loc_us-gaapAssetAcquisitionLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionTable" xlink:to="loc_us-gaapAssetAcquisitionLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionAxis" xlink:label="loc_us-gaapAssetAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionTable" xlink:to="loc_us-gaapAssetAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionDomain" xlink:label="loc_us-gaapAssetAcquisitionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionAxis" xlink:to="loc_us-gaapAssetAcquisitionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionDomain" xlink:to="loc_RIMESemiCabIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember_2" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RIMESemiCabIncMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" xlink:label="loc_us-gaapAssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapAssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AssetAcquisitionFairValueOfNonControllingInterest" xlink:label="loc_RIMEAssetAcquisitionFairValueOfNonControllingInterest" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_RIMEAssetAcquisitionFairValueOfNonControllingInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration" xlink:label="loc_us-gaapAssetAcquisitionConsiderationTransferredContingentConsideration" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapAssetAcquisitionConsiderationTransferredContingentConsideration" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AssetAcquisitionDebtExtinguishment" xlink:label="loc_RIMEAssetAcquisitionDebtExtinguishment" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_RIMEAssetAcquisitionDebtExtinguishment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionConsiderationTransferred" xlink:label="loc_us-gaapAssetAcquisitionConsiderationTransferred" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapAssetAcquisitionConsiderationTransferred" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCustomerRelationships" xlink:label="loc_RIMEBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCustomerRelationships" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_RIMEBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCustomerRelationships" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradeName" xlink:label="loc_RIMEBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradeName" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_RIMEBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDevelopedTechnology" xlink:label="loc_RIMEBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDevelopedTechnology" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_RIMEBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDevelopedTechnology" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLoansPayable" xlink:label="loc_RIMEBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLoansPayable" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_RIMEBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLoansPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesNotesPayableRelatedParties" xlink:label="loc_RIMEBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesNotesPayableRelatedParties" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_RIMEBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesNotesPayableRelatedParties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfConsiderationTransferredToAssetsAcquiredAndLiabilitiesAssumedDetailsParenthetical" xlink:title="00000057 - Disclosure - SCHEDULE OF CONSIDERATION TRANSFERRED TO THE ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable" xlink:to="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TradeNamesMember" xlink:label="loc_us-gaapTradeNamesMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapTradeNamesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DevelopedTechnologyRightsMember" xlink:label="loc_us-gaapDevelopedTechnologyRightsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapDevelopedTechnologyRightsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfProFormaFinancialInformationDetails" xlink:title="00000058 - Disclosure - SCHEDULE OF PRO FORMA FINANCIAL INFORMATION (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:label="loc_us-gaapBusinessAcquisitionsProFormaRevenue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapBusinessAcquisitionsProFormaRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax" xlink:label="loc_us-gaapBusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapBusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:label="loc_us-gaapBusinessAcquisitionsProFormaNetIncomeLoss" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapBusinessAcquisitionsProFormaNetIncomeLoss" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/AssetAcquisitionDetailsNarrative" xlink:title="00000059 - Disclosure - ASSET ACQUISITION (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AssetPurchaseAgreementMember" xlink:label="loc_RIMEAssetPurchaseAgreementMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMEAssetPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_EmploymentAgreementsMember" xlink:label="loc_RIMEEmploymentAgreementsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMEEmploymentAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="loc_srtEquityMethodInvesteeNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="loc_srtEquityMethodInvesteeNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabLLCMember" xlink:label="loc_RIMESemiCabLLCMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtEquityMethodInvesteeNameDomain" xlink:to="loc_RIMESemiCabLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtEquityMethodInvesteeNameDomain" xlink:to="loc_RIMESemiCabIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AlgorhythmHoldingsIncMember" xlink:label="loc_RIMEAlgorhythmHoldingsIncMember" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtEquityMethodInvesteeNameDomain" xlink:to="loc_RIMEAlgorhythmHoldingsIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionAxis" xlink:label="loc_us-gaapAssetAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAssetAcquisitionAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionDomain" xlink:label="loc_us-gaapAssetAcquisitionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionAxis" xlink:to="loc_us-gaapAssetAcquisitionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabLLCMember" xlink:label="loc_RIMESemiCabLLCMember_2" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionDomain" xlink:to="loc_RIMESemiCabLLCMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember_2" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionDomain" xlink:to="loc_RIMESemiCabIncMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementScenarioAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_TwoThousandTwentyFourMember" xlink:label="loc_RIMETwoThousandTwentyFourMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_RIMETwoThousandTwentyFourMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_TwoThousandTwentyFiveMember" xlink:label="loc_RIMETwoThousandTwentyFiveMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_RIMETwoThousandTwentyFiveMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SubsequentYearsMember" xlink:label="loc_RIMESubsequentYearsMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_RIMESubsequentYearsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_TwoThousandTwentySixMember" xlink:label="loc_RIMETwoThousandTwentySixMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_RIMETwoThousandTwentySixMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_TwoThousandTwentySevenMember" xlink:label="loc_RIMETwoThousandTwentySevenMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_RIMETwoThousandTwentySevenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_TwoThousandTwentyEightMember" xlink:label="loc_RIMETwoThousandTwentyEightMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_RIMETwoThousandTwentyEightMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AjeshKapoorMember" xlink:label="loc_RIMEAjeshKapoorMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_RIMEAjeshKapoorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_VivekSehgalKapoorMember" xlink:label="loc_RIMEVivekSehgalKapoorMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_RIMEVivekSehgalKapoorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesPurchaseOfAssets" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets" xlink:label="loc_us-gaapStockIssuedDuringPeriodValuePurchaseOfAssets" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValuePurchaseOfAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalariesAndWages" xlink:label="loc_us-gaapSalariesAndWages" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSalariesAndWages" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionConsiderationTransferred" xlink:label="loc_us-gaapAssetAcquisitionConsiderationTransferred" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetAcquisitionConsiderationTransferred" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetIncludingGoodwill" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIntangibleAssetsNetIncludingGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_NonControllingInterestAtFairValue" xlink:label="loc_RIMENonControllingInterestAtFairValue" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMENonControllingInterestAtFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_RoyaltyRate" xlink:label="loc_RIMERoyaltyRate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMERoyaltyRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DiscountOnRoyaltyRate" xlink:label="loc_RIMEDiscountOnRoyaltyRate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMEDiscountOnRoyaltyRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_RoyaltyTerm" xlink:label="loc_RIMERoyaltyTerm" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMERoyaltyTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_GrowthRateOfDevelopmentOfNewBusiness" xlink:label="loc_RIMEGrowthRateOfDevelopmentOfNewBusiness" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMEGrowthRateOfDevelopmentOfNewBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DiscountRateForWeightedAverageCost" xlink:label="loc_RIMEDiscountRateForWeightedAverageCost" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMEDiscountRateForWeightedAverageCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapital" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingCapital" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LegalFees" xlink:label="loc_us-gaapLegalFees" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLegalFees" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/FinancingDetailsNarrative" xlink:title="00000060 - Disclosure - FINANCING (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityTable" xlink:label="loc_us-gaapLineOfCreditFacilityTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapLineOfCreditFacilityTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityLineItems" xlink:label="loc_us-gaapLineOfCreditFacilityLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityTable" xlink:to="loc_us-gaapLineOfCreditFacilityLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityAxis" xlink:label="loc_us-gaapCreditFacilityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityTable" xlink:to="loc_us-gaapCreditFacilityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaapCreditFacilityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCreditFacilityAxis" xlink:to="loc_us-gaapCreditFacilityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="loc_us-gaapRevolvingCreditFacilityMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCreditFacilityDomain" xlink:to="loc_us-gaapRevolvingCreditFacilityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_RevolvingLoanAmendmentMember" xlink:label="loc_RIMERevolvingLoanAmendmentMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCreditFacilityDomain" xlink:to="loc_RIMERevolvingLoanAmendmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember" xlink:label="loc_us-gaapRelatedPartyMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapRelatedPartyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityTable" xlink:to="loc_srtRangeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_us-gaapShortTermDebtTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityTable" xlink:to="loc_us-gaapShortTermDebtTypeAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaapShortTermDebtTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtTypeAxis" xlink:to="loc_us-gaapShortTermDebtTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AgileCapilalFundingllcMember" xlink:label="loc_RIMEAgileCapilalFundingllcMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtTypeDomain" xlink:to="loc_RIMEAgileCapilalFundingllcMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_CedarAdvancellcMember" xlink:label="loc_RIMECedarAdvancellcMember" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtTypeDomain" xlink:to="loc_RIMECedarAdvancellcMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabInvestorMember" xlink:label="loc_RIMESemiCabInvestorMember" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtTypeDomain" xlink:to="loc_RIMESemiCabInvestorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_TwoYearCreditAndSecurityAgreementMember" xlink:label="loc_RIMETwoYearCreditAndSecurityAgreementMember" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMETwoYearCreditAndSecurityAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_TwoYearLoanAndSecurityAgreementMember" xlink:label="loc_RIMETwoYearLoanAndSecurityAgreementMember" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMETwoYearLoanAndSecurityAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_CreditAndSecurityAgreementsMember" xlink:label="loc_RIMECreditAndSecurityAgreementsMember" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMECreditAndSecurityAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaapLineOfCreditFacilityMaximumBorrowingCapacity" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherReceivables" xlink:label="loc_us-gaapOtherReceivables" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapOtherReceivables" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:label="loc_us-gaapLineOfCreditFacilityInterestRateDuringPeriod" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityInterestRateDuringPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseDebt" xlink:label="loc_us-gaapInterestExpenseDebt" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapInterestExpenseDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTerm" xlink:label="loc_us-gaapDebtInstrumentTerm" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapDebtInstrumentTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityExpirationDate1" xlink:label="loc_us-gaapLineOfCreditFacilityExpirationDate1" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityExpirationDate1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_PercentageOfExitFee" xlink:label="loc_RIMEPercentageOfExitFee" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_RIMEPercentageOfExitFee" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessExitCosts1" xlink:label="loc_us-gaapBusinessExitCosts1" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapBusinessExitCosts1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfLinesOfCredit" xlink:label="loc_us-gaapRepaymentsOfLinesOfCredit" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapRepaymentsOfLinesOfCredit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="loc_us-gaapAmortizationOfFinancingCosts" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapAmortizationOfFinancingCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityInterestRateDescription" xlink:label="loc_us-gaapLineOfCreditFacilityInterestRateDescription" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityInterestRateDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestAndDebtExpense" xlink:label="loc_us-gaapInterestAndDebtExpense" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapInterestAndDebtExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromShortTermDebt" xlink:label="loc_us-gaapProceedsFromShortTermDebt" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapProceedsFromShortTermDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:label="loc_us-gaapDebtInstrumentPeriodicPayment" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapDebtInstrumentPeriodicPayment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfShortTermDebt" xlink:label="loc_us-gaapRepaymentsOfShortTermDebt" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapRepaymentsOfShortTermDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateEffectivePercentage" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateEffectivePercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermBorrowings" xlink:label="loc_us-gaapShortTermBorrowings" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapShortTermBorrowings" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_LineOfCreditFacilityInterestRate" xlink:label="loc_RIMELineOfCreditFacilityInterestRate" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_RIMELineOfCreditFacilityInterestRate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentForAmortization" xlink:label="loc_us-gaapAdjustmentForAmortization" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapAdjustmentForAmortization" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfLoanDetails" xlink:title="00000061 - Disclosure - SCHEDULE OF LOAN (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AjeshKapoorOneMember" xlink:label="loc_RIMEAjeshKapoorOneMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_RIMEAjeshKapoorOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AjeshKapoorTwoMember" xlink:label="loc_RIMEAjeshKapoorTwoMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_RIMEAjeshKapoorTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_VivekSeghalMember" xlink:label="loc_RIMEVivekSeghalMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_RIMEVivekSeghalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AjeshKapoorThreeMember" xlink:label="loc_RIMEAjeshKapoorThreeMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_RIMEAjeshKapoorThreeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AjeshKapoorFourMember" xlink:label="loc_RIMEAjeshKapoorFourMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_RIMEAjeshKapoorFourMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember" xlink:label="loc_us-gaapRelatedPartyMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapRelatedPartyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentIssuanceDate1" xlink:label="loc_us-gaapDebtInstrumentIssuanceDate1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDebtInstrumentIssuanceDate1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaapNotesPayable" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaapNotesPayableCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapNotesPayableCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermNotesPayable" xlink:label="loc_us-gaapLongTermNotesPayable" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapLongTermNotesPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/LoansPayableRelatedPartiesDetailsNarrative" xlink:title="00000062 - Disclosure - LOANS PAYABLE &#8211; RELATED PARTIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember" xlink:label="loc_us-gaapRelatedPartyMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapRelatedPartyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPayableCurrentAndNoncurrent" xlink:label="loc_us-gaapInterestPayableCurrentAndNoncurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapInterestPayableCurrentAndNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000063 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SettlementSumMember" xlink:label="loc_RIMESettlementSumMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_RIMESettlementSumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_InitialPaymentMember" xlink:label="loc_RIMEInitialPaymentMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_RIMEInitialPaymentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SecondPaymentMember" xlink:label="loc_RIMESecondPaymentMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_RIMESecondPaymentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AdditionalPaymentMember" xlink:label="loc_RIMEAdditionalPaymentMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_RIMEAdditionalPaymentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_PerYearMember" xlink:label="loc_RIMEPerYearMember" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_RIMEPerYearMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_TwoSeparateMilestonePaymentMember" xlink:label="loc_RIMETwoSeparateMilestonePaymentMember" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_RIMETwoSeparateMilestonePaymentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_FirstMilestonePaymentMember" xlink:label="loc_RIMEFirstMilestonePaymentMember" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_RIMEFirstMilestonePaymentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SecondMilestonePaymentMember" xlink:label="loc_RIMESecondMilestonePaymentMember" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_RIMESecondMilestonePaymentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_deiLegalEntityAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_BlueYonderIncMember" xlink:label="loc_RIMEBlueYonderIncMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMEBlueYonderIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtStatementScenarioAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioForecastMember" xlink:label="loc_srtScenarioForecastMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_srtScenarioForecastMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis" xlink:label="loc_us-gaapScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeAndTierIdentifierDomain" xlink:label="loc_us-gaapTypeAndTierIdentifierDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis" xlink:to="loc_us-gaapTypeAndTierIdentifierDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DirectorsAndOfficersLiabilityInsuranceMember" xlink:label="loc_us-gaapDirectorsAndOfficersLiabilityInsuranceMember" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeAndTierIdentifierDomain" xlink:to="loc_us-gaapDirectorsAndOfficersLiabilityInsuranceMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ServiceContractAndAgreementMember" xlink:label="loc_RIMEServiceContractAndAgreementMember" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMEServiceContractAndAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardDateAxis" xlink:label="loc_us-gaapAwardDateAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardDateAxis" order="70" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardDateDomain" xlink:label="loc_us-gaapAwardDateDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardDateAxis" xlink:to="loc_us-gaapAwardDateDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DueOnJulyOneTwoThousandTwentyFourMember" xlink:label="loc_RIMEDueOnJulyOneTwoThousandTwentyFourMember" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardDateDomain" xlink:to="loc_RIMEDueOnJulyOneTwoThousandTwentyFourMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_OctoberOneTwoThousandTwentyFourMember" xlink:label="loc_RIMEOctoberOneTwoThousandTwentyFourMember" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardDateDomain" xlink:to="loc_RIMEOctoberOneTwoThousandTwentyFourMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_JanuaryOneTwoThousandTwentyFiveMember" xlink:label="loc_RIMEJanuaryOneTwoThousandTwentyFiveMember" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardDateDomain" xlink:to="loc_RIMEJanuaryOneTwoThousandTwentyFiveMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_WorkingCapital" xlink:label="loc_RIMEWorkingCapital" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_RIMEWorkingCapital" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTerm" xlink:label="loc_us-gaapDebtInstrumentTerm" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapDebtInstrumentTerm" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfDebt" xlink:label="loc_us-gaapRepaymentsOfDebt" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapRepaymentsOfDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LitigationSettlementExpense" xlink:label="loc_us-gaapLitigationSettlementExpense" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapLitigationSettlementExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrentAndNoncurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapAccruedLiabilitiesCurrentAndNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_LossContingencyEstimateOfPossibleLossPerYear" xlink:label="loc_RIMELossContingencyEstimateOfPossibleLossPerYear" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_RIMELossContingencyEstimateOfPossibleLossPerYear" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:label="loc_us-gaapLossContingencyEstimateOfPossibleLoss" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapLossContingencyEstimateOfPossibleLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyDamagesSoughtValue" xlink:label="loc_us-gaapLossContingencyDamagesSoughtValue" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapLossContingencyDamagesSoughtValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyDamagesAwardedValue" xlink:label="loc_us-gaapLossContingencyDamagesAwardedValue" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapLossContingencyDamagesAwardedValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyDamagesPaidValue" xlink:label="loc_us-gaapLossContingencyDamagesPaidValue" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapLossContingencyDamagesPaidValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseExpense" xlink:label="loc_us-gaapOperatingLeaseExpense" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapOperatingLeaseExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_InsuranceLiabilities" xlink:label="loc_RIMEInsuranceLiabilities" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_RIMEInsuranceLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MalpracticeInsuranceMaximumCoveragePerIncident" xlink:label="loc_us-gaapMalpracticeInsuranceMaximumCoveragePerIncident" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapMalpracticeInsuranceMaximumCoveragePerIncident" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_PaymentsForMilestone" xlink:label="loc_RIMEPaymentsForMilestone" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_RIMEPaymentsForMilestone" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForLegalSettlements" xlink:label="loc_us-gaapPaymentsForLegalSettlements" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapPaymentsForLegalSettlements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DisputeAmount" xlink:label="loc_RIMEDisputeAmount" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_RIMEDisputeAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AccruedPotentialLiability" xlink:label="loc_RIMEAccruedPotentialLiability" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_RIMEAccruedPotentialLiability" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfSupplementalInformationRelatedToLeasesDetails" xlink:title="00000064 - Disclosure - SCHEDULE OF SUPPLEMENTAL INFORMATION RELATED TO LEASES (Details)">
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DisclosureOperatingLeasesAbstract" xlink:label="loc_RIMEDisclosureOperatingLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureOperatingLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityAbstract" xlink:label="loc_us-gaapOperatingLeaseLiabilityAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureOperatingLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLeaseLiabilityAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLeaseLiabilityAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfLeaseTermAndDiscountRateDetails" xlink:title="00000065 - Disclosure - SCHEDULE OF LEASE TERM AND DISCOUNT RATE (Details)">
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DisclosureOperatingLeasesAbstract" xlink:label="loc_RIMEDisclosureOperatingLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseExpense" xlink:label="loc_us-gaapOperatingLeaseExpense" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureOperatingLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFlowOperatingActivitiesLesseeAbstract" xlink:label="loc_us-gaapCashFlowOperatingActivitiesLesseeAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureOperatingLeasesAbstract" xlink:to="loc_us-gaapCashFlowOperatingActivitiesLesseeAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasePayments" xlink:label="loc_us-gaapOperatingLeasePayments" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowOperatingActivitiesLesseeAbstract" xlink:to="loc_us-gaapOperatingLeasePayments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCostAbstract" xlink:label="loc_us-gaapLeaseCostAbstract" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureOperatingLeasesAbstract" xlink:to="loc_us-gaapLeaseCostAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageRemainingLeaseTerm1" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeaseCostAbstract" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeaseCostAbstract" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfOperatingLeaseMinimumFuturePaymentsDetails" xlink:title="00000066 - Disclosure - SCHEDULE OF OPERATING LEASE MINIMUM FUTURE PAYMENTS (Details)">
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DisclosureOperatingLeasesAbstract" xlink:label="loc_RIMEDisclosureOperatingLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureOperatingLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureOperatingLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureOperatingLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureOperatingLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaapOperatingLeaseLiability" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureOperatingLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureOperatingLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureOperatingLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureOperatingLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFive" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureOperatingLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureOperatingLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureOperatingLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureOperatingLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/OperatingLeasesDetailsNarrative" xlink:title="00000067 - Disclosure - OPERATING LEASES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DisclosureOperatingLeasesAbstract" xlink:label="loc_RIMEDisclosureOperatingLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureOperatingLeasesAbstract" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_OperatingLeaseAgreementMember" xlink:label="loc_RIMEOperatingLeaseAgreementMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMEOperatingLeaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AreaOfLand" xlink:label="loc_us-gaapAreaOfLand" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapAreaOfLand" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseExpirationDate1" xlink:label="loc_us-gaapLeaseExpirationDate1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapLeaseExpirationDate1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:label="loc_us-gaapLesseeOperatingLeaseOptionToExtend" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseOptionToExtend" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasePayments" xlink:label="loc_us-gaapOperatingLeasePayments" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapOperatingLeasePayments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRent" xlink:label="loc_us-gaapPaymentsForRent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapPaymentsForRent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TenantImprovements" xlink:label="loc_us-gaapTenantImprovements" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapTenantImprovements" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/IssuanceOfCommonStockDetailsNarrative" xlink:title="00000068 - Disclosure - ISSUANCE OF COMMON STOCK (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_TwoThousandTwentyTwoPlanMember" xlink:label="loc_RIMETwoThousandTwentyTwoPlanMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_RIMETwoThousandTwentyTwoPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaapGeneralAndAdministrativeExpenseMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapGeneralAndAdministrativeExpenseMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensationForfeited" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeBenefitsAndShareBasedCompensation" xlink:label="loc_us-gaapEmployeeBenefitsAndShareBasedCompensation" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapEmployeeBenefitsAndShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueRestrictedStockAwardGross" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfWarrantsExpirationDetails" xlink:title="00000069 - Disclosure - SCHEDULE OF WARRANTS EXPIRATION (Details)">
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DisclosureWarrantsAbstract" xlink:label="loc_RIMEDisclosureWarrantsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureWarrantsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ExercisePriceRangeOneMember" xlink:label="loc_RIMEExercisePriceRangeOneMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_RIMEExercisePriceRangeOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ExercisePriceRangeTwoMember" xlink:label="loc_RIMEExercisePriceRangeTwoMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_RIMEExercisePriceRangeTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingMaturityDate" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingMaturityDate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingMaturityDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/WarrantsDetailsNarrative" xlink:title="00000070 - Disclosure - WARRANTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DisclosureWarrantsAbstract" xlink:label="loc_RIMEDisclosureWarrantsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureWarrantsAbstract" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfBasicAndDilutiveLossPerShareDetails" xlink:title="00000071 - Disclosure - SCHEDULE OF BASIC AND DILUTIVE LOSS PER SHARE (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ComputationOfLossPerShareDetailsNarrative" xlink:title="00000072 - Disclosure - COMPUTATION OF LOSS PER SHARE (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaapAntidilutiveSecuritiesNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="loc_us-gaapAntidilutiveSecuritiesNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaapEmployeeStockOptionMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_us-gaapEmployeeStockOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_CommonStockWarrantsMember" xlink:label="loc_RIMECommonStockWarrantsMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_RIMECommonStockWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_PreFundedWarrantsMember" xlink:label="loc_RIMEPreFundedWarrantsMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_RIMEPreFundedWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_OptionsAndWarrantsMember" xlink:label="loc_RIMEOptionsAndWarrantsMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_RIMEOptionsAndWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000073 - Disclosure - INCOME TAXES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTable" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEffectiveIncomeTaxRateReconciliationTable" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaapIncomeTaxAuthorityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEffectiveIncomeTaxRateReconciliationTable" xlink:to="loc_us-gaapIncomeTaxAuthorityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DomesticCountryMember" xlink:label="loc_us-gaapDomesticCountryMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapDomesticCountryMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="loc_us-gaapStateAndLocalJurisdictionMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapStateAndLocalJurisdictionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityNameAxis" xlink:label="loc_us-gaapIncomeTaxAuthorityNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEffectiveIncomeTaxRateReconciliationTable" xlink:to="loc_us-gaapIncomeTaxAuthorityNameAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityNameAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InternalRevenueServiceIRSMember" xlink:label="loc_us-gaapInternalRevenueServiceIRSMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityNameDomain" xlink:to="loc_us-gaapInternalRevenueServiceIRSMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEffectiveIncomeTaxRateReconciliationLineItems" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaapOperatingLossCarryforwards" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEffectiveIncomeTaxRateReconciliationLineItems" xlink:to="loc_us-gaapOperatingLossCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEffectiveIncomeTaxRateReconciliationLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfRevenueByProductLineDetails" xlink:title="00000074 - Disclosure - SCHEDULE OF REVENUE BY PRODUCT LINE (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:label="loc_us-gaapScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:label="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:to="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:to="loc_srtProductOrServiceAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ClassicKaraokeMachinesMember" xlink:label="loc_RIMEClassicKaraokeMachinesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_RIMEClassicKaraokeMachinesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_LicensedProductsMember" xlink:label="loc_RIMELicensedProductsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_RIMELicensedProductsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_KidsYouthElectronicsMember" xlink:label="loc_RIMEKidsYouthElectronicsMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_RIMEKidsYouthElectronicsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_MicrophonesAndAccessoriesMember" xlink:label="loc_RIMEMicrophonesAndAccessoriesMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_RIMEMicrophonesAndAccessoriesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_MusicSubscriptionsMember" xlink:label="loc_RIMEMusicSubscriptionsMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_RIMEMusicSubscriptionsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_LogisticsServicesMember" xlink:label="loc_RIMELogisticsServicesMember" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_RIMELogisticsServicesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_KaraokeMachinesMember" xlink:label="loc_RIMEKaraokeMachinesMember" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_RIMEKaraokeMachinesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_us-gaapRevenues" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfSalesByGeographicalRegionDetails" xlink:title="00000075 - Disclosure - SCHEDULE OF SALES BY GEOGRAPHICAL REGION (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="loc_srtStatementGeographicalAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NorthAmericaMember" xlink:label="loc_srtNorthAmericaMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_srtNorthAmericaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_AU" xlink:label="loc_countryAU" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryAU" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EuropeMember" xlink:label="loc_srtEuropeMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_srtEuropeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapRevenues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/RevenueDisaggregationDetailsNarrative" xlink:title="00000076 - Disclosure - REVENUE DISAGGREGATION (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdvertisingExpense" xlink:label="loc_us-gaapAdvertisingExpense" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapAdvertisingExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_EstimatedReserveOfAdvertisingExpense" xlink:label="loc_RIMEEstimatedReserveOfAdvertisingExpense" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_RIMEEstimatedReserveOfAdvertisingExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ReserveForSalesReturns" xlink:label="loc_RIMEReserveForSalesReturns" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_RIMEReserveForSalesReturns" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_EstimatedCostOfReturns" xlink:label="loc_RIMEEstimatedCostOfReturns" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_RIMEEstimatedCostOfReturns" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ConcentrationsOfCreditRiskAndRevenueDetailsNarrative" xlink:title="00000077 - Disclosure - CONCENTRATIONS OF CREDIT RISK AND REVENUE (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="loc_us-gaapRisksAndUncertaintiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTable" xlink:label="loc_us-gaapConcentrationRiskTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRisksAndUncertaintiesAbstract" xlink:to="loc_us-gaapConcentrationRiskTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="loc_us-gaapConcentrationRiskLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_us-gaapConcentrationRiskLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaapAccountsReceivableMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapAccountsReceivableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SalesRevenueMember" xlink:label="loc_RIMESalesRevenueMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_RIMESalesRevenueMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_PurchasesMember" xlink:label="loc_RIMEPurchasesMember" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_RIMEPurchasesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaapSalesRevenueNetMember" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapSalesRevenueNetMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaapCustomerConcentrationRiskMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapCustomerConcentrationRiskMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ThreeCustomersMember" xlink:label="loc_RIMEThreeCustomersMember" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_RIMEThreeCustomersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_CustomersOneMember" xlink:label="loc_RIMECustomersOneMember" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_RIMECustomersOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_CustomersTwoMember" xlink:label="loc_RIMECustomersTwoMember" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_RIMECustomersTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_CustomersThreeMember" xlink:label="loc_RIMECustomersThreeMember" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_RIMECustomersThreeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeographicConcentrationRiskMember" xlink:label="loc_us-gaapGeographicConcentrationRiskMember" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapGeographicConcentrationRiskMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_RepublicOfChinaMember" xlink:label="loc_RIMERepublicOfChinaMember" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_RIMERepublicOfChinaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis" xlink:label="loc_srtMajorCustomersAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_srtMajorCustomersAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ThreeCustomersMember" xlink:label="loc_RIMEThreeCustomersMember_2" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_RIMEThreeCustomersMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_FourCustomersMember" xlink:label="loc_RIMEFourCustomersMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_RIMEFourCustomersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_CustomerOneMember" xlink:label="loc_RIMECustomerOneMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_RIMECustomerOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_CustomersTwoMember" xlink:label="loc_RIMECustomersTwoMember_2" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_RIMECustomersTwoMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_CustomersThreeMember" xlink:label="loc_RIMECustomersThreeMember_2" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_RIMECustomersThreeMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_CustomersFourMember" xlink:label="loc_RIMECustomersFourMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_RIMECustomersFourMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_CustomersConcentrationRiskMember" xlink:label="loc_RIMECustomersConcentrationRiskMember" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_RIMECustomersConcentrationRiskMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_RepublicOfChinaMember" xlink:label="loc_RIMERepublicOfChinaMember_2" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_RIMERepublicOfChinaMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_FourMember" xlink:label="loc_RIMEFourMember" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_RIMEFourMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_deiLegalEntityAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentDescription" xlink:label="loc_us-gaapDebtInstrumentDescription" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskLineItems" xlink:to="loc_us-gaapDebtInstrumentDescription" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000078 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaapRelatedPartyTransactionLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedPartyTransactionLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember" xlink:label="loc_us-gaapRelatedPartyMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapRelatedPartyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_StingrayMember" xlink:label="loc_RIMEStingrayMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_RIMEStingrayMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SMCBMember" xlink:label="loc_RIMESMCBMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_RIMESMCBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AultAllianceIncMember" xlink:label="loc_RIMEAultAllianceIncMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_RIMEAultAllianceIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AjeshKapoorMember" xlink:label="loc_RIMEAjeshKapoorMember" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_RIMEAjeshKapoorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:label="loc_us-gaapSoftwareAndSoftwareDevelopmentCostsMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapSoftwareAndSoftwareDevelopmentCostsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaapPrivatePlacementMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapPrivatePlacementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_deiLegalEntityAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapRevenues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherReceivables" xlink:label="loc_us-gaapOtherReceivables" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapOtherReceivables" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilities" xlink:label="loc_us-gaapOtherLiabilities" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapOtherLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaapProfessionalFees" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapProfessionalFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000079 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaapSubsequentEventTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaapSubsequentEventLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SecuritiesPurchaseAgreementMember" xlink:label="loc_RIMESecuritiesPurchaseAgreementMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESecuritiesPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSharePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_PercentageOfPurchasersRightToParticipateOnIssuanceCompanyOfCommonStock" xlink:label="loc_RIMEPercentageOfPurchasersRightToParticipateOnIssuanceCompanyOfCommonStock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_RIMEPercentageOfPurchasersRightToParticipateOnIssuanceCompanyOfCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_PercentageOfGrossProceeds" xlink:label="loc_RIMEPercentageOfGrossProceeds" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_RIMEPercentageOfGrossProceeds" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="loc_us-gaapProceedsFromIssuanceOfDebt" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionOriginalDebtAmount1" xlink:label="loc_us-gaapDebtConversionOriginalDebtAmount1" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtConversionOriginalDebtAmount1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateEffectivePercentage" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateEffectivePercentage" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="loc_us-gaapDebtInstrumentInterestRateDuringPeriod" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateDuringPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentIssuanceDate1" xlink:label="loc_us-gaapDebtInstrumentIssuanceDate1" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentIssuanceDate1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdvertisingExpense" xlink:label="loc_us-gaapAdvertisingExpense" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapAdvertisingExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement" xlink:label="loc_us-gaapIncomeTaxExaminationLikelihoodOfUnfavorableSettlement" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapIncomeTaxExaminationLikelihoodOfUnfavorableSettlement" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000080 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdvertisingExpense" xlink:label="loc_us-gaapAdvertisingExpense" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdvertisingExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ReserveForSalesReturn" xlink:label="loc_RIMEReserveForSalesReturn" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMEReserveForSalesReturn" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ReturnAssets" xlink:label="loc_RIMEReturnAssets" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMEReturnAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ShippingAndHandlingExpenses" xlink:label="loc_RIMEShippingAndHandlingExpenses" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMEShippingAndHandlingExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignFinancialInstitutionsActualDeposits" xlink:label="loc_us-gaapForeignFinancialInstitutionsActualDeposits" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapForeignFinancialInstitutionsActualDeposits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfPropertyAndEquipmentDetails" xlink:title="00000081 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ComputerAndOfficeEquipmentMember" xlink:label="loc_RIMEComputerAndOfficeEquipmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_RIMEComputerAndOfficeEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_WarehouseEquipmentMember" xlink:label="loc_RIMEWarehouseEquipmentMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_RIMEWarehouseEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_MoldsAndToolingMember" xlink:label="loc_RIMEMoldsAndToolingMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_RIMEMoldsAndToolingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_srtRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaapPropertyPlantAndEquipmentUsefulLife" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentUsefulLife" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/PropertyAndEquipmentDetailsNarrative" xlink:title="00000082 - Disclosure - PROPERTY AND EQUIPMENT (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/SummaryOfStockOptionActivityDetails" xlink:title="00000083 - Disclosure - SUMMARY OF STOCK OPTION ACTIVITY (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:label="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:label="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:to="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockOptionMember" xlink:label="loc_us-gaapStockOptionMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_us-gaapStockOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfEmployeeStockOptionsOutstandingDetailsParenthetical" xlink:title="00000084 - Disclosure - SCHEDULE OF EMPLOYEE STOCK OPTIONS OUTSTANDING (Details) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SixCurrentAndThreeFormerDirectorsMember" xlink:label="loc_RIMESixCurrentAndThreeFormerDirectorsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_RIMESixCurrentAndThreeFormerDirectorsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OfficerMember" xlink:label="loc_srtOfficerMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtOfficerMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_EmployeesMember" xlink:label="loc_RIMEEmployeesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_RIMEEmployeesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfBasicAndDilutiveSharesDetails" xlink:title="00000085 - Disclosure - SCHEDULE OF BASIC AND DILUTIVE SHARES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:label="loc_us-gaapIncrementalCommonSharesAttributableToCallOptionsAndWarrants" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapIncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/StockCompensationExpenseDetailsNarrative" xlink:title="00000086 - Disclosure - STOCK COMPENSATION EXPENSE (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_TwoThousandTwentyTwoPlanMember" xlink:label="loc_RIMETwoThousandTwentyTwoPlanMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_RIMETwoThousandTwentyTwoPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtTitleOfIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_DirectorMember" xlink:label="loc_srtDirectorMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtDirectorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OfficerMember" xlink:label="loc_srtOfficerMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtOfficerMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_EmployeeMember" xlink:label="loc_RIMEEmployeeMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_RIMEEmployeeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_BoardOfDirectorsChairmanMember" xlink:label="loc_srtBoardOfDirectorsChairmanMember" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtBoardOfDirectorsChairmanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtRangeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockDescriptionOfTransaction" xlink:label="loc_us-gaapSaleOfStockDescriptionOfTransaction" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSaleOfStockDescriptionOfTransaction" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockOptionPlanExpense" xlink:label="loc_us-gaapStockOptionPlanExpense" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockOptionPlanExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/PublicOfferingAndNasdaqUplistingDetailsNarrative" xlink:title="00000087 - Disclosure - PUBLIC OFFERING AND NASDAQ UPLISTING (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DisclosurePublicOfferingAndNasdaqUplistingAbstract" xlink:label="loc_RIMEDisclosurePublicOfferingAndNasdaqUplistingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosurePublicOfferingAndNasdaqUplistingAbstract" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_UnderwritingAgreementMember" xlink:label="loc_RIMEUnderwritingAgreementMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMEUnderwritingAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputExercisePriceMember" xlink:label="loc_us-gaapMeasurementInputExercisePriceMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExercisePriceMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="loc_us-gaapMeasurementInputExpectedTermMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedTermMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="loc_us-gaapMeasurementInputPriceVolatilityMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputPriceVolatilityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="loc_us-gaapMeasurementInputExpectedDividendRateMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedDividendRateMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="loc_us-gaapMeasurementInputRiskFreeInterestRateMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputRiskFreeInterestRateMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForCommissions" xlink:label="loc_us-gaapPaymentsForCommissions" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapPaymentsForCommissions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SaleOfStockPercentage" xlink:label="loc_RIMESaleOfStockPercentage" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_RIMESaleOfStockPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingTerm" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaapFairValueAdjustmentOfWarrants" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapFairValueAdjustmentOfWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingMeasurementInput" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingMeasurementInput" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/AtmOfferingDetailsNarrative" xlink:title="00000088 - Disclosure - ATM OFFERING (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DisclosureAtmOfferingAbstract" xlink:label="loc_RIMEDisclosureAtmOfferingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureAtmOfferingAbstract" xlink:to="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaapSubsidiarySaleOfStockLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ATMOfferingMember" xlink:label="loc_RIMEATMOfferingMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_RIMEATMOfferingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/PrivatePlacementDetailsNarrative" xlink:title="00000089 - Disclosure - PRIVATE PLACEMENT (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DisclosurePrivatePlacementAbstract" xlink:label="loc_RIMEDisclosurePrivatePlacementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosurePrivatePlacementAbstract" xlink:to="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaapSubsidiarySaleOfStockLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaapPrivatePlacementMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapPrivatePlacementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_TransactionFees" xlink:label="loc_RIMETransactionFees" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_RIMETransactionFees" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/August2021StockRedemptionDetailsNarrative" xlink:title="00000090 - Disclosure - AUGUST 2021 STOCK REDEMPTION (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DisclosureAugust2021StockRedemptionAbstract" xlink:label="loc_RIMEDisclosureAugust2021StockRedemptionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureAugust2021StockRedemptionAbstract" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_RedemptionAgreementMember" xlink:label="loc_RIMERedemptionAgreementMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMERedemptionAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_deiLegalEntityAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_KonceptsandTreasureGreenMember" xlink:label="loc_RIMEKonceptsandTreasureGreenMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMEKonceptsandTreasureGreenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodShares" xlink:label="loc_us-gaapStockRedeemedOrCalledDuringPeriodShares" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapStockRedeemedOrCalledDuringPeriodShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockAmountIssued1" xlink:label="loc_us-gaapConversionOfStockAmountIssued1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapConversionOfStockAmountIssued1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfLossBeforeIncomeTaxesDetails" xlink:title="00000091 - Disclosure - SCHEDULE OF LOSS BEFORE INCOME TAXES (Details)">
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DisclosureAugust2021PrivatePlacementAbstract" xlink:label="loc_RIMEDisclosureAugust2021PrivatePlacementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureAugust2021PrivatePlacementAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureAugust2021PrivatePlacementAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureAugust2021PrivatePlacementAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfProvisionForIncomeTaxesDetails" xlink:title="00000092 - Disclosure - SCHEDULE OF PROVISION FOR INCOME TAXES (Details)">
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DisclosureAugust2021PrivatePlacementAbstract" xlink:label="loc_RIMEDisclosureAugust2021PrivatePlacementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentFederalTaxExpenseBenefit" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureAugust2021PrivatePlacementAbstract" xlink:to="loc_us-gaapCurrentFederalTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentStateAndLocalTaxExpenseBenefit" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureAugust2021PrivatePlacementAbstract" xlink:to="loc_us-gaapCurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_CurrentOtherTaxExpenseBenefit" xlink:label="loc_RIMECurrentOtherTaxExpenseBenefit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureAugust2021PrivatePlacementAbstract" xlink:to="loc_RIMECurrentOtherTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentForeignTaxExpenseBenefit" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureAugust2021PrivatePlacementAbstract" xlink:to="loc_us-gaapCurrentForeignTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentFederalStateAndLocalTaxExpenseBenefit" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureAugust2021PrivatePlacementAbstract" xlink:to="loc_us-gaapCurrentFederalStateAndLocalTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureAugust2021PrivatePlacementAbstract" xlink:to="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredStateAndLocalIncomeTaxExpenseBenefit" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureAugust2021PrivatePlacementAbstract" xlink:to="loc_us-gaapDeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredFederalStateAndLocalTaxExpenseBenefit" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureAugust2021PrivatePlacementAbstract" xlink:to="loc_us-gaapDeferredFederalStateAndLocalTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureAugust2021PrivatePlacementAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:title="00000093 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details)">
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DisclosureAugust2021PrivatePlacementAbstract" xlink:label="loc_RIMEDisclosureAugust2021PrivatePlacementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwardsDomestic" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureAugust2021PrivatePlacementAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureAugust2021PrivatePlacementAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsInventory" xlink:label="loc_us-gaapDeferredTaxAssetsInventory" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureAugust2021PrivatePlacementAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsInventory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureAugust2021PrivatePlacementAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DeferredTaxAssetsRightUseOfLiability" xlink:label="loc_RIMEDeferredTaxAssetsRightUseOfLiability" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureAugust2021PrivatePlacementAbstract" xlink:to="loc_RIMEDeferredTaxAssetsRightUseOfLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DeferredTaxAssetsBusinessInterestLimitation" xlink:label="loc_RIMEDeferredTaxAssetsBusinessInterestLimitation" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureAugust2021PrivatePlacementAbstract" xlink:to="loc_RIMEDeferredTaxAssetsBusinessInterestLimitation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DeferredTaxAssetsAllowanceForDoubtFulAccounts" xlink:label="loc_RIMEDeferredTaxAssetsAllowanceForDoubtFulAccounts" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureAugust2021PrivatePlacementAbstract" xlink:to="loc_RIMEDeferredTaxAssetsAllowanceForDoubtFulAccounts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances" xlink:label="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureAugust2021PrivatePlacementAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:label="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureAugust2021PrivatePlacementAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaapDeferredTaxAssetsGross" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureAugust2021PrivatePlacementAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureAugust2021PrivatePlacementAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureAugust2021PrivatePlacementAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:label="loc_us-gaapDeferredTaxLiabilitiesPropertyPlantAndEquipment" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureAugust2021PrivatePlacementAbstract" xlink:to="loc_us-gaapDeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DeferredTaxLiabilitiesRightUseOfAsset" xlink:label="loc_RIMEDeferredTaxLiabilitiesRightUseOfAsset" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureAugust2021PrivatePlacementAbstract" xlink:to="loc_RIMEDeferredTaxLiabilitiesRightUseOfAsset" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" xlink:label="loc_us-gaapDeferredTaxLiabilitiesPrepaidExpenses" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureAugust2021PrivatePlacementAbstract" xlink:to="loc_us-gaapDeferredTaxLiabilitiesPrepaidExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="loc_us-gaapDeferredTaxLiabilities" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureAugust2021PrivatePlacementAbstract" xlink:to="loc_us-gaapDeferredTaxLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureAugust2021PrivatePlacementAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfTaxProvisionDetails" xlink:title="00000094 - Disclosure - SCHEDULE OF TAX PROVISION (Details)">
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DisclosureAugust2021PrivatePlacementAbstract" xlink:label="loc_RIMEDisclosureAugust2021PrivatePlacementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapIncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureAugust2021PrivatePlacementAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="loc_us-gaapIncomeTaxReconciliationStateAndLocalIncomeTaxes" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureAugust2021PrivatePlacementAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:label="loc_us-gaapIncomeTaxReconciliationChangeInEnactedTaxRate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureAugust2021PrivatePlacementAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationChangeInEnactedTaxRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_IncomeTaxReconciliationChangeInPermanentDifferencesERCIncome" xlink:label="loc_RIMEIncomeTaxReconciliationChangeInPermanentDifferencesERCIncome" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureAugust2021PrivatePlacementAbstract" xlink:to="loc_RIMEIncomeTaxReconciliationChangeInPermanentDifferencesERCIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:label="loc_us-gaapIncomeTaxReconciliationForeignIncomeTaxRateDifferential" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureAugust2021PrivatePlacementAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_IncomeTaxReconciliationChangeInExpirationOfNetOpretaingLossCarryforward" xlink:label="loc_RIMEIncomeTaxReconciliationChangeInExpirationOfNetOpretaingLossCarryforward" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureAugust2021PrivatePlacementAbstract" xlink:to="loc_RIMEIncomeTaxReconciliationChangeInExpirationOfNetOpretaingLossCarryforward" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapIncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureAugust2021PrivatePlacementAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:label="loc_us-gaapIncomeTaxReconciliationOtherReconcilingItems" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureAugust2021PrivatePlacementAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationOtherReconcilingItems" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureAugust2021PrivatePlacementAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfRevenueByGeographicalRegionDetails" xlink:title="00000095 - Disclosure - SCHEDULE OF REVENUE BY GEOGRAPHICAL REGION (Details)">
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DisclosureAugust2021PrivatePlacementAbstract" xlink:label="loc_RIMEDisclosureAugust2021PrivatePlacementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureAugust2021PrivatePlacementAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementGeographicalAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NorthAmericaMember" xlink:label="loc_srtNorthAmericaMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_srtNorthAmericaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_AU" xlink:label="loc_countryAU" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryAU" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_EuropeAndUnitedKingdomMember" xlink:label="loc_RIMEEuropeAndUnitedKingdomMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_RIMEEuropeAndUnitedKingdomMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_OthersMember" xlink:label="loc_RIMEOthersMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_RIMEOthersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenues" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/August2021PrivatePlacementDetailsNarrative" xlink:title="00000096 - Disclosure - AUGUST 2021 PRIVATE PLACEMENT (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DisclosureAugust2021PrivatePlacementAbstract" xlink:label="loc_RIMEDisclosureAugust2021PrivatePlacementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureAugust2021PrivatePlacementAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_PurchaseAgreementMember" xlink:label="loc_RIMEPurchaseAgreementMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMEPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_RedemptionAgreementMember" xlink:label="loc_RIMERedemptionAgreementMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMERedemptionAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_PreFundedWarrantsMember" xlink:label="loc_RIMEPreFundedWarrantsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_RIMEPreFundedWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaapPrivatePlacementMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapPrivatePlacementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_KonceptsandTreasureGreenMember" xlink:label="loc_RIMEKonceptsandTreasureGreenMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMEKonceptsandTreasureGreenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AGPWarrantsMember" xlink:label="loc_RIMEAGPWarrantsMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_RIMEAGPWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaapProceedsFromWarrantExercises" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromWarrantExercises" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockAmountIssued1" xlink:label="loc_us-gaapConversionOfStockAmountIssued1" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConversionOfStockAmountIssued1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRepurchaseOfPrivatePlacement" xlink:label="loc_us-gaapPaymentsForRepurchaseOfPrivatePlacement" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsForRepurchaseOfPrivatePlacement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeDescriptionOfTerms" xlink:label="loc_us-gaapDerivativeDescriptionOfTerms" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDerivativeDescriptionOfTerms" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AggregateNumberOfShares" xlink:label="loc_RIMEAggregateNumberOfShares" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMEAggregateNumberOfShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityFairValueDisclosure" xlink:label="loc_us-gaapEquityFairValueDisclosure" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityFairValueDisclosure" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SharePrice1" xlink:label="loc_RIMESharePrice1" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMESharePrice1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingTerm" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingTerm" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LegalFees" xlink:label="loc_us-gaapLegalFees" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLegalFees" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueRestrictedStockAwardGross" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfStockIssuanceCosts" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsOfStockIssuanceCosts" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/DamagedGoodsIncidentRecoveryDetailsNarrative" xlink:title="00000097 - Disclosure - DAMAGED GOODS INCIDENT RECOVERY (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InsuranceAbstract" xlink:label="loc_us-gaapInsuranceAbstract" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_GainFromSettlementOfAccountsPayable" xlink:label="loc_RIMEGainFromSettlementOfAccountsPayable" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInsuranceAbstract" xlink:to="loc_RIMEGainFromSettlementOfAccountsPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfOperationsDetails" xlink:title="00000098 - Disclosure - SCHEDULE OF CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Details)">
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DisclosureSupplementalInformationCondensedFinancialInformationAbstract" xlink:label="loc_RIMEDisclosureSupplementalInformationCondensedFinancialInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureSupplementalInformationCondensedFinancialInformationAbstract" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaapCostOfGoodsAndServicesSold" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureSupplementalInformationCondensedFinancialInformationAbstract" xlink:to="loc_us-gaapCostOfGoodsAndServicesSold" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureSupplementalInformationCondensedFinancialInformationAbstract" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureSupplementalInformationCondensedFinancialInformationAbstract" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureSupplementalInformationCondensedFinancialInformationAbstract" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureSupplementalInformationCondensedFinancialInformationAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureSupplementalInformationCondensedFinancialInformationAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureSupplementalInformationCondensedFinancialInformationAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureSupplementalInformationCondensedFinancialInformationAbstract" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureSupplementalInformationCondensedFinancialInformationAbstract" xlink:to="loc_us-gaapEarningsPerShareAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureSupplementalInformationCondensedFinancialInformationAbstract" xlink:to="loc_us-gaapEarningsPerShareBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureSupplementalInformationCondensedFinancialInformationAbstract" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract" xlink:label="loc_us-gaapEarningsPerShareBasicOtherDisclosuresAbstract" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureSupplementalInformationCondensedFinancialInformationAbstract" xlink:to="loc_us-gaapEarningsPerShareBasicOtherDisclosuresAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureSupplementalInformationCondensedFinancialInformationAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureSupplementalInformationCondensedFinancialInformationAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfCashFlowsDetails" xlink:title="00000099 - Disclosure - SCHEDULE OF CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Details)">
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DisclosureSupplementalInformationCondensedFinancialInformationAbstract" xlink:label="loc_RIMEDisclosureSupplementalInformationCondensedFinancialInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureSupplementalInformationCondensedFinancialInformationAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapital" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingCapital" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingCapital" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureSupplementalInformationCondensedFinancialInformationAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureSupplementalInformationCondensedFinancialInformationAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureSupplementalInformationCondensedFinancialInformationAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureSupplementalInformationCondensedFinancialInformationAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureSupplementalInformationCondensedFinancialInformationAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfShareholdersEquityDetails" xlink:title="00000100 - Disclosure - SCHEDULE OF CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS? EQUITY (Details)">
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DisclosureSupplementalInformationCondensedFinancialInformationAbstract" xlink:label="loc_RIMEDisclosureSupplementalInformationCondensedFinancialInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureSupplementalInformationCondensedFinancialInformationAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivablesFromStockholderMember" xlink:label="loc_us-gaapReceivablesFromStockholderMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapReceivablesFromStockholderMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueOther" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueOther" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesOther" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesOther" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_2" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_2" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfEstimatedUsefulLivesDetails" xlink:title="00000101 - Disclosure - SCHEDULE OF ESTIMATED USEFUL LIVES (Details)">
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DisclosureSupplementalInformationCondensedFinancialInformationAbstract" xlink:label="loc_RIMEDisclosureSupplementalInformationCondensedFinancialInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureSupplementalInformationCondensedFinancialInformationAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaapPropertyPlantAndEquipmentUsefulLife" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentUsefulLife" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/AccountsReceivableDetailsNarrative" xlink:title="00000102 - Disclosure - ACCOUNTS RECEIVABLE (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditLossAbstract" xlink:label="loc_us-gaapCreditLossAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCreditLossAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNet" xlink:label="loc_us-gaapAccountsReceivableNet" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccountsReceivableNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaapProvisionForDoubtfulAccounts" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProvisionForDoubtfulAccounts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/AccountsPayableAndAccruedExpensesDetailsNarrative" xlink:title="00000103 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfSpecificTermsDetails" xlink:title="00000104 - Disclosure - SCHEDULE OF SPECIFIC TERMS (Details)">
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DisclosureNotesPayableAndFinaningArrangementsAbstract" xlink:label="loc_RIMEDisclosureNotesPayableAndFinaningArrangementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureNotesPayableAndFinaningArrangementsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SixShareholderLoanAgreementsMember" xlink:label="loc_RIMESixShareholderLoanAgreementsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESixShareholderLoanAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AjeshKapoorMember" xlink:label="loc_RIMEAjeshKapoorMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_RIMEAjeshKapoorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_VivekSehgalMember" xlink:label="loc_RIMEVivekSehgalMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_RIMEVivekSehgalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_JaganReddyMember" xlink:label="loc_RIMEJaganReddyMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_RIMEJaganReddyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentIssuanceDate1" xlink:label="loc_us-gaapDebtInstrumentIssuanceDate1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentIssuanceDate1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:label="loc_us-gaapDebtInstrumentPeriodicPaymentPrincipal" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentPeriodicPaymentPrincipal" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentPeriodicPaymentInterest" xlink:label="loc_us-gaapDebtInstrumentPeriodicPaymentInterest" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentPeriodicPaymentInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:label="loc_us-gaapDebtInstrumentPeriodicPayment" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentPeriodicPayment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/NotesPayableAndFinaningArrangementsDetailsNarrative" xlink:title="00000105 - Disclosure - NOTES PAYABLE AND FINANING ARRANGEMENTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DisclosureNotesPayableAndFinaningArrangementsAbstract" xlink:label="loc_RIMEDisclosureNotesPayableAndFinaningArrangementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureNotesPayableAndFinaningArrangementsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_EqualInstallmentsForThirteenMonthsMember" xlink:label="loc_RIMEEqualInstallmentsForThirteenMonthsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_RIMEEqualInstallmentsForThirteenMonthsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_TwelveInstallmentsMember" xlink:label="loc_RIMETwelveInstallmentsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_RIMETwelveInstallmentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_FirstPaymentMember" xlink:label="loc_RIMEFirstPaymentMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_RIMEFirstPaymentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SecondPaymentMember" xlink:label="loc_RIMESecondPaymentMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_RIMESecondPaymentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_TenMonthlyPaymentsMember" xlink:label="loc_RIMETenMonthlyPaymentsMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_RIMETenMonthlyPaymentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_WeeklyPaymentsForWeeksMember" xlink:label="loc_RIMEWeeklyPaymentsForWeeksMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_RIMEWeeklyPaymentsForWeeksMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_WeeklyPaymentsMember" xlink:label="loc_RIMEWeeklyPaymentsMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_RIMEWeeklyPaymentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SettlementAgreementMember" xlink:label="loc_RIMESettlementAgreementMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESettlementAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardDateAxis" xlink:label="loc_us-gaapAwardDateAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardDateAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardDateDomain" xlink:label="loc_us-gaapAwardDateDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardDateAxis" xlink:to="loc_us-gaapAwardDateDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DueAndPaidOnMayTwentyTwoThousandTwentyFourMember" xlink:label="loc_RIMEDueAndPaidOnMayTwentyTwoThousandTwentyFourMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardDateDomain" xlink:to="loc_RIMEDueAndPaidOnMayTwentyTwoThousandTwentyFourMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DueOnJuneThreeTwoThousandTwentyFourMember" xlink:label="loc_RIMEDueOnJuneThreeTwoThousandTwentyFourMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardDateDomain" xlink:to="loc_RIMEDueOnJuneThreeTwoThousandTwentyFourMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DueOnJulyOneTwoThousandTwentyFourMember" xlink:label="loc_RIMEDueOnJulyOneTwoThousandTwentyFourMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardDateDomain" xlink:to="loc_RIMEDueOnJulyOneTwoThousandTwentyFourMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMaturityDateDescription" xlink:label="loc_us-gaapDebtInstrumentMaturityDateDescription" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDateDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfDebt" xlink:label="loc_us-gaapRepaymentsOfDebt" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRepaymentsOfDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermBorrowings" xlink:label="loc_us-gaapShortTermBorrowings" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShortTermBorrowings" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="loc_us-gaapProceedsFromIssuanceOfDebt" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateEffectivePercentage" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateEffectivePercentage" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/DueFromFactorDetailsNarrative" xlink:title="00000106 - Disclosure - DUE FROM FACTOR (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DisclosureDueFromFactorAbstract" xlink:label="loc_RIMEDisclosureDueFromFactorAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureDueFromFactorAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNet" xlink:label="loc_us-gaapAccountsReceivableNet" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccountsReceivableNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ForeignAndDomesticRateOfAccountsReceivable" xlink:label="loc_RIMEForeignAndDomesticRateOfAccountsReceivable" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMEForeignAndDomesticRateOfAccountsReceivable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AdvanceFeeRate" xlink:label="loc_RIMEAdvanceFeeRate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMEAdvanceFeeRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LegalFees" xlink:label="loc_us-gaapLegalFees" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLegalFees" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfStockOptionIssuedDuringYearDecember3120202021And2022Details" xlink:title="00000107 - Disclosure - SCHEDULE OF STOCK OPTION ISSUED DURING THE YEAR DECEMBER 31, 2020, 2021 AND 2022 (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SudhirNarasimhamurthyMember" xlink:label="loc_RIMESudhirNarasimhamurthyMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_RIMESudhirNarasimhamurthyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_KadandaleSrinivasSudheerMember" xlink:label="loc_RIMEKadandaleSrinivasSudheerMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_RIMEKadandaleSrinivasSudheerMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_VivekSehgalMember" xlink:label="loc_RIMEVivekSehgalMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_RIMEVivekSehgalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_RajivSaxenaMember" xlink:label="loc_RIMERajivSaxenaMember" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_RIMERajivSaxenaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_HarshaBhatMember" xlink:label="loc_RIMEHarshaBhatMember" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_RIMEHarshaBhatMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_JaganReddyMember" xlink:label="loc_RIMEJaganReddyMember" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_RIMEJaganReddyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SiddayyaSGanjalMember" xlink:label="loc_RIMESiddayyaSGanjalMember" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_RIMESiddayyaSGanjalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SunilAroraMember" xlink:label="loc_RIMESunilAroraMember" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_RIMESunilAroraMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_RajivVirmaniMember" xlink:label="loc_RIMERajivVirmaniMember" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_RIMERajivVirmaniMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SudhindraShenoyMember" xlink:label="loc_RIMESudhindraShenoyMember" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_RIMESudhindraShenoyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AntonySunilMember" xlink:label="loc_RIMEAntonySunilMember" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_RIMEAntonySunilMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_TuleekaNandyMember" xlink:label="loc_RIMETuleekaNandyMember" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_RIMETuleekaNandyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_RobelAtnafuMember" xlink:label="loc_RIMERobelAtnafuMember" />
      <link:presentationArc order="590" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_RIMERobelAtnafuMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_GuyPrimusMember" xlink:label="loc_RIMEGuyPrimusMember" />
      <link:presentationArc order="610" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_RIMEGuyPrimusMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SamarthaGowdaMember" xlink:label="loc_RIMESamarthaGowdaMember" />
      <link:presentationArc order="630" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_RIMESamarthaGowdaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_AlexandraAielloMember" xlink:label="loc_RIMEAlexandraAielloMember" />
      <link:presentationArc order="650" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_RIMEAlexandraAielloMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_StephenCabralMember" xlink:label="loc_RIMEStephenCabralMember" />
      <link:presentationArc order="670" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_RIMEStephenCabralMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_JonahPetiPerrinMember" xlink:label="loc_RIMEJonahPetiPerrinMember" />
      <link:presentationArc order="690" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_RIMEJonahPetiPerrinMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_BryanNellaMember" xlink:label="loc_RIMEBryanNellaMember" />
      <link:presentationArc order="710" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_RIMEBryanNellaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_MarkSinkMember" xlink:label="loc_RIMEMarkSinkMember" />
      <link:presentationArc order="730" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_RIMEMarkSinkMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_KoustavChoudhuriMember" xlink:label="loc_RIMEKoustavChoudhuriMember" />
      <link:presentationArc order="750" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_RIMEKoustavChoudhuriMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaapDerivativeInstrumentRiskAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDerivativeInstrumentRiskAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockOptionMember" xlink:label="loc_us-gaapStockOptionMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_us-gaapStockOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TargetedOrTrackingStockIssuanceDates" xlink:label="loc_us-gaapTargetedOrTrackingStockIssuanceDates" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTargetedOrTrackingStockIssuanceDates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate" xlink:label="loc_RIMEShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMEShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate" xlink:label="loc_RIMEShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMEShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate" xlink:label="loc_RIMEShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RIMEShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/StockholdersEquityDetailsNarrative" xlink:title="00000108 - Disclosure - STOCKHOLDERS&#8217; EQUITY (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_FoundersMember" xlink:label="loc_RIMEFoundersMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_RIMEFoundersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/ScheduleOfFirstTrancheOfSubscriptionsDetails" xlink:title="00000109 - Disclosure - SCHEDULE OF FIRST TRANCHE OF SUBSCRIPTIONS (Details)">
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DisclosureSafePrivatePlacementsAbstract" xlink:label="loc_RIMEDisclosureSafePrivatePlacementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureSafePrivatePlacementsAbstract" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEOneMember" xlink:label="loc_RIMESAFEOneMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFEOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEThirtyEightMember" xlink:label="loc_RIMESAFEThirtyEightMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFEThirtyEightMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEFortyOneMember" xlink:label="loc_RIMESAFEFortyOneMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFEFortyOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEFortyTwoMember" xlink:label="loc_RIMESAFEFortyTwoMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFEFortyTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEFortyFourMember" xlink:label="loc_RIMESAFEFortyFourMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFEFortyFourMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEFortyThreeMember" xlink:label="loc_RIMESAFEFortyThreeMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFEFortyThreeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingAxis" xlink:label="loc_us-gaapVestingAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapVestingAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingDomain" xlink:label="loc_us-gaapVestingDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapVestingAxis" xlink:to="loc_us-gaapVestingDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:label="loc_us-gaapShareBasedCompensationAwardTrancheOneMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapVestingDomain" xlink:to="loc_us-gaapShareBasedCompensationAwardTrancheOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_deiLegalEntityAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ConvertibleHolderName" xlink:label="loc_RIMEConvertibleHolderName" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_RIMEConvertibleHolderName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_InvestmentOfPrincipalAmount" xlink:label="loc_RIMEInvestmentOfPrincipalAmount" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_RIMEInvestmentOfPrincipalAmount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_InvestmentIssueDate" xlink:label="loc_RIMEInvestmentIssueDate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_RIMEInvestmentIssueDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ValuationCapitalOfInvestment" xlink:label="loc_RIMEValuationCapitalOfInvestment" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_RIMEValuationCapitalOfInvestment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_InvestmentConvertedDate" xlink:label="loc_RIMEInvestmentConvertedDate" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_RIMEInvestmentConvertedDate" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/SummaryOfTerminatedImmediatelyAfterClosingOfTransactionDetails" xlink:title="00000110 - Disclosure - SUMMARY OF TERMINATED IMMEDIATELY AFTER CLOSING OF THE TRANSACTION (Details)">
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DisclosureSafePrivatePlacementsAbstract" xlink:label="loc_RIMEDisclosureSafePrivatePlacementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureSafePrivatePlacementsAbstract" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEFortyMember" xlink:label="loc_RIMESAFEFortyMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFEFortyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEThirtyNineMember" xlink:label="loc_RIMESAFEThirtyNineMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFEThirtyNineMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFETenMember" xlink:label="loc_RIMESAFETenMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFETenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEElevenMember" xlink:label="loc_RIMESAFEElevenMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFEElevenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFETwelveMember" xlink:label="loc_RIMESAFETwelveMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFETwelveMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEThirteenMember" xlink:label="loc_RIMESAFEThirteenMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFEThirteenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEFourteenMember" xlink:label="loc_RIMESAFEFourteenMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFEFourteenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEFifteenMember" xlink:label="loc_RIMESAFEFifteenMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFEFifteenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFESixteenMember" xlink:label="loc_RIMESAFESixteenMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFESixteenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFESeventeenMember" xlink:label="loc_RIMESAFESeventeenMember" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFESeventeenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEEighteenMember" xlink:label="loc_RIMESAFEEighteenMember" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFEEighteenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFENineteenMember" xlink:label="loc_RIMESAFENineteenMember" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFENineteenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFETwoMember" xlink:label="loc_RIMESAFETwoMember" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFETwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFETwentyMember" xlink:label="loc_RIMESAFETwentyMember" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFETwentyMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFETwentyOneMember" xlink:label="loc_RIMESAFETwentyOneMember" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFETwentyOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFETwentyTwoMember" xlink:label="loc_RIMESAFETwentyTwoMember" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFETwentyTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFETwentyFourMember" xlink:label="loc_RIMESAFETwentyFourMember" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFETwentyFourMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEThreeMember" xlink:label="loc_RIMESAFEThreeMember" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFEThreeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEFourMember" xlink:label="loc_RIMESAFEFourMember" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFEFourMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEFortyFiveMember" xlink:label="loc_RIMESAFEFortyFiveMember" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFEFortyFiveMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFESixMember" xlink:label="loc_RIMESAFESixMember" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFESixMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFESevenMember" xlink:label="loc_RIMESAFESevenMember" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFESevenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEEightMember" xlink:label="loc_RIMESAFEEightMember" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFEEightMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFENineMember" xlink:label="loc_RIMESAFENineMember" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFENineMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEFiveMember" xlink:label="loc_RIMESAFEFiveMember" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFEFiveMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFETwentyFiveMember" xlink:label="loc_RIMESAFETwentyFiveMember" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFETwentyFiveMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFETwentySixMember" xlink:label="loc_RIMESAFETwentySixMember" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFETwentySixMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFETwentySevenMember" xlink:label="loc_RIMESAFETwentySevenMember" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFETwentySevenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFETwentyEightMember" xlink:label="loc_RIMESAFETwentyEightMember" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFETwentyEightMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFETwentyNineMember" xlink:label="loc_RIMESAFETwentyNineMember" />
      <link:presentationArc order="590" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFETwentyNineMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEThirtyMember" xlink:label="loc_RIMESAFEThirtyMember" />
      <link:presentationArc order="610" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFEThirtyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEThirtyOneMember" xlink:label="loc_RIMESAFEThirtyOneMember" />
      <link:presentationArc order="630" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFEThirtyOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEThirtyTwoMember" xlink:label="loc_RIMESAFEThirtyTwoMember" />
      <link:presentationArc order="650" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFEThirtyTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEThirtyThreeMember" xlink:label="loc_RIMESAFEThirtyThreeMember" />
      <link:presentationArc order="670" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFEThirtyThreeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEThirtyFourMember" xlink:label="loc_RIMESAFEThirtyFourMember" />
      <link:presentationArc order="690" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFEThirtyFourMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEThirtyFiveMember" xlink:label="loc_RIMESAFEThirtyFiveMember" />
      <link:presentationArc order="710" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFEThirtyFiveMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEThirtySixMember" xlink:label="loc_RIMESAFEThirtySixMember" />
      <link:presentationArc order="730" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFEThirtySixMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEThirtySevenMember" xlink:label="loc_RIMESAFEThirtySevenMember" />
      <link:presentationArc order="750" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFEThirtySevenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEFortySixMember" xlink:label="loc_RIMESAFEFortySixMember" />
      <link:presentationArc order="770" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFEFortySixMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEFiftyMember" xlink:label="loc_RIMESAFEFiftyMember" />
      <link:presentationArc order="790" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFEFiftyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEFortyEightMember" xlink:label="loc_RIMESAFEFortyEightMember" />
      <link:presentationArc order="810" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFEFortyEightMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEFortySevenMember" xlink:label="loc_RIMESAFEFortySevenMember" />
      <link:presentationArc order="830" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFEFortySevenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEFortyNineMember" xlink:label="loc_RIMESAFEFortyNineMember" />
      <link:presentationArc order="850" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFEFortyNineMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEFiftyOneMember" xlink:label="loc_RIMESAFEFiftyOneMember" />
      <link:presentationArc order="870" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFEFiftyOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_deiLegalEntityAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ConvertibleHolderName" xlink:label="loc_RIMEConvertibleHolderName" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_RIMEConvertibleHolderName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_InvestmentOfPrincipalAmount" xlink:label="loc_RIMEInvestmentOfPrincipalAmount" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_RIMEInvestmentOfPrincipalAmount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_InvestmentIssueDate" xlink:label="loc_RIMEInvestmentIssueDate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_RIMEInvestmentIssueDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_ValuationCapitalOfInvestment" xlink:label="loc_RIMEValuationCapitalOfInvestment" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_RIMEValuationCapitalOfInvestment" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://algoholdings.com/role/SafePrivatePlacementsDetailsNarrative" xlink:title="00000111 - Disclosure - SAFE PRIVATE PLACEMENTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_DisclosureSafePrivatePlacementsAbstract" xlink:label="loc_RIMEDisclosureSafePrivatePlacementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RIMEDisclosureSafePrivatePlacementsAbstract" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SAFEAgreementsMember" xlink:label="loc_RIMESAFEAgreementsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMESAFEAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_FortyFourSAFEAgreementsMember" xlink:label="loc_RIMEFortyFourSAFEAgreementsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RIMEFortyFourSAFEAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_deiLegalEntityAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_SemiCabIncMember" xlink:label="loc_RIMESemiCabIncMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_RIMESemiCabIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingAxis" xlink:label="loc_us-gaapVestingAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapVestingAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingDomain" xlink:label="loc_us-gaapVestingDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapVestingAxis" xlink:to="loc_us-gaapVestingDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:label="loc_us-gaapShareBasedCompensationAwardTrancheOneMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapVestingDomain" xlink:to="loc_us-gaapShareBasedCompensationAwardTrancheOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:label="loc_us-gaapShareBasedCompensationAwardTrancheTwoMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapVestingDomain" xlink:to="loc_us-gaapShareBasedCompensationAwardTrancheTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Investments" xlink:label="loc_us-gaapInvestments" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rime-20240930.xsd#RIME_InvestedValuationOfAmount" xlink:label="loc_RIMEInvestedValuationOfAmount" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_RIMEInvestedValuationOfAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>133
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M[OY:IM1!XZBD<=22QC55@62)F;YU;)PP]2%[7C'5D73)E);$E@6E">2$L19
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MC<'\65:.2<(TX>Q_5L *<./MO,$UX^GVJ](NA"=JR!P$V0JK6DZUF;?0OF"
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MD1Q<(OV>1UEY5$?19B-FU*BJT\!&Y'_AP)-I5063!6T(DGIE<] PP>2<O?T
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MR453M5_J/TMT^D-7-_\#4$L#!!0    ( .XT>EF<CO?-: ,  + ,   8
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M+IJ_Z0+-A*->RE?YI_-Y\=QNOUFGW]+[);D@I8<^6OI0XP>*%IR"1DL?:OM
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MN8"*= 2UI9F*%*Y%R01J.Y&\#K'5-H;R)@3OWD[@H5)ZWXEKE_&O3U#'";X
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MP!ZSHA 3BF^IKRS!ZUZGJ,$$W0X"0#(%KS^%"#A!ST0A()F!,GP I+/^XL]
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M.$H>7*K;9>\:FT4;T2<=DSI732&"V!R>PVYFKLE'K8P4B-%X=,8N6V?%2.S
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M]VNY#>))I)W%6_,U?S2UT=NTSJ U4AJYX2*[LJC.8 'QRP!'1'+APG00BWE
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MO;"@YPSUFCFSSKCEGS]JM62:GH8T>N-\XU;#&IE3%(=6XZ[$.OOY_GQP?O/
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M1(.8J]V<)C;7#\PK->N"RVZA,F+%*HZ6H2PJ!!1TNU+[.8&"$R<0T$OD'(G
M9ZJH@!SW#KKQR7Z'N9'/3\W5E>[)27QR<LQNGY!=:32@GM*R"Y[X?A,.]*=5
MW:V'!8ZJW4JZ-*,:B-TO "W7 '-V#?/E!%JB5CD6J\U=,7NK02HZM+,H?67G
MYB16[@TQBD*,KE2C4VD4AL:M2H!/!D]W]V*AL@5I$DR]H8RK"Z$+U5)/.6]J
MKMOW+T,ZMHCNQ;PV.J]&]N^!FE7)(ZL)V&[2M@>:P+M'\,$'["ON !XF"F6K
M&G5?&;M?F6]?/[]:M6)ZI>#:I!@UP DL=N+VR3':U YKM_ /M28*IS^X"9U
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M:W-H965T<R]S:&5E=#$P+GAM;.U]67,;Q[7P>_^**>5^*:D*I$AJL2W9KH)
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M[?]9[N,=XBWL48.$U!9J,B,$M#533=V6^G_KM-5)@Q^0[6]0>RK;&NL.P>X
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M:$>+84,C((TQ"&HSNKZ\')^-?DJN+H=GD]/MW!)'!GC,R&5@#8*_L[M8D&U
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M7GU-D.L =;YE3)X,G>#\?1K^#U!+ P04    " #N-'I9?=_W# <%  !1#P
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M&(7,APO@_4H(7=S@!N47X(M_ U!+ P04    " #N-'I9++X6,; (   M%P
M&0   'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6SM6%MSZC@2?O>O4#%34S-5
MG&!LS"4G214!DE G@120F4IM[8.P!=8>8WDD$9)_O]V23)R$9$]FYG%?P++5
MK;Y\?=/)3LCO*F5,D\=-EJO36JIU<=QHJ#AE&ZJ.1,%R^+(2<D,U+.6ZH0K)
M:&*(-EDC\/UV8T-Y7CL[,>]NY=F)V.J,Y^Q6$K7=;*A\.F>9V)W6FK7RQ8RO
M4XTO&F<G!5VS.=-WQ:V$56//)>$;EBLN<B+9ZK36;QX/6KC?;/B=LYVJ/!/4
M9"G$=UR,D].:CP*QC,4:.5#X>V #EF7(",3XT_&L[8]$PNISR?W"Z ZZ+*EB
M Y']P1.=GM:Z-9*P%=UF>B9V5\SI$R&_6&3*_)*=W1OT:B3>*BTVCA@DV/#<
M_M-'9X<*0==_AR!P!,&/$H2.(#2*6LF,6D.JZ=F)%#LB<3=PPP=C&T,-VO <
MO3C7$KYRH--GL]'OH\G=B S'\_[EY6QTV5^,IY.3A@;>N*,1.S[GED_P#I\>
MN1&Y3A49Y0E+7M(W0*:]8$$IV'GP(<,Y*XY(Z-=)X >M _(,/B8?LAC(FX8\
M_$"<<&^GT/ +WQ5G#=C59,8*(37/U^1?_:72$F#X[T/6LMQ:A[EA:!ZK@L;L
MM :QIYA\8+6S7WYJMOVOAU3]AYB]4+RU5[SU$?=/ .1#/H>EG$P7(Z_9(K_\
MU V:S:_D\&%DD3)O(#8%S9](PA5=KR5;4\T4Y)$'EF_A8?E$"BF2;:P)GDQH
MGD"8_$=(LF9B+6F1<I"2K4WJ4&0CE"9B1;C>\R!<P=Z<26"<(#^=,J)H!LQA
MXW<JJ?C.O)3*9$>E/0!WE'*EP#471, ["2=K)CG-R'*K0!JEB++X4<> ('.<
M]UIB.!Y8K$0&B16VS0=7H^'=]<B;7NS-<GY/;F?3X=U@0:['DY&W2"5C7C7P
MR 18O7CCW;I#KO$0B"K--DLFO3*TWKX*?VR7-\BH4F#5;]8TY(;&*2I+?B;=
M>M#LUGW?A^=FJ]X.V^7"KT=!LUQTZF$[Q(5WS6.H#""_DU:19M<WVQQIV.G8
M_\#L_\831>ZA*J5DA!5!BIS'"G;US*Z@9W='+4O=BLR9W@V/I2A2@5*B _MQ
M#,X1DL.Z68]\>V37=V?6PZ#GGJ*6%?1FBRK/MTL52UY@)5*DU+496;JH:]=1
MY%OEQ)HKC?+- ?:@*1P66 &_/#]Y"Z$!,1.HW'.#.F.M=A"4UHKJO;#YO&AU
M2PN#07NA%;1_?3F=7=TOKFZ\J^GU<#RYG-?)>#(X,NK.[\[GX^&X/QN/Y@1C
M;^XMIF0PG0Q'D_EHB$_SZ?5XV%_ XF(\Z4\&X_XUF2_@Q<UHLI@?0@8R-JCY
M]2ZGVX1#]/QF-4"(OXT^Z#Q,X!00(0*\:+)!CC%GPNJ=$)CWKT%F"(#+T?1R
MUK^]&@] ,L@0D!]^+ [^2>A/H :D7G\#*L34.JK5;C_[)NQTGQ>!7W%4V#7;
MO/X6BT?&*;$@(8&-! B*5G7MC;: 6 8GM!VR[?97:PL>[^^!IYIF7:/UP#)(
M4Q0J7LP+DW$YY$]PI:8\8]+D[<Y716+Q1128SS;"=&<\AWA&\C(S/_ $BR9T
MBM^9*9^K+>"&HJ=ICA&AA4G&MN5A4AUY?84X4>P <ZXYM=P1,[G0(%.",99#
MHEL+D1  F;+!]B93QS1'"NAYE<CI$A1D0(DIVVQ;42[) \V@(HB5AV^64!56
M7(-\0!0S<^X*I''B42EIOF8FO=<-B]A5%_?]64FJS7<XS9SU9,07JQ63 %FP
M@"$N+6 ^PH%"(GPA,-#NF!S1!K Y!V>;^G1$+EQ,:0P$*&X&]LP$PAZ]Y$W$
MUC]RVXYA-!;P[='8!LST,^DY*#<AI7?<4Q"53SV_Z9ZZ85A^=7F[BJW2W K,
M#%5RF:'%8"Y(L/:B&  -D-?69KV5^;,)45;()QMET@AZNMP#JI8^V9N0[* 8
M,P @W1=YN]ES'0@6W=+"9AH X.0D!21!38CWIV_$UOA6%2SF*_B S+2IUR T
M&&S%,7V9EB.G%@K/6AZA\B7Z]A'C)/!0#]MEV-,,5\#..WZ#OM:]=;UMG>P0
M&J\<%4 !#LHB5J:,NM\M'=1KNGKA.1V=78U980JRL>\,#$;*V5I@S(&:.PY%
MET&M=PA_H]DN%: .S:I0QJZ+/#$JOVCQ!?_1VAQ,,RBW>";[HY]M*#BY7LN"
MIYL4Y'P!FVTA,=)@7-$5]%Y$I;PP;OAUR?2.L9PH_F@LF&,?9$/DMQ>N(8F
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MH&N9PU<]S=6<\]T.-I+:&(25KR)#.:<?P>K:(%&JF-;&!KSU3"1D'.80U%F
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MIL'1@&Y$MI-,NZ#8[3! Q*?1PHHY#7\HC0*=9T+HS<(XZ,;)\=]02P,$%
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M!?T^4)H-M+X30A\G)L#IAS3Y%U!+ P04    " #N-'I9>%(XF%$"   U!0
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MH/WUV@-5#6GE&%FZP5A)0V/FS(S>-50V@>)K*<W!L0<T+V7\!U!+ P04
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M7;C,LOLB%>FN?!^FM?8-&_L^#4\J_%4D/78^Z)*%YR?TG;?^GGM]Y\?\K18
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M[>+G6^ S"QQ]!SB,8,X;54J8-04MG@/XR')'->JIGD4'$<]I[D$<NA %47P
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MY#[(#!K!BQ#4XZ]B[=.CF6D0LF>J$W# &;QF$A,=;V)D9SCIJT?S^S'P*I9
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M51F6O>F,G/< 3#24Q&"(PM3\B&B:O(K)*]Y D-**=T':,!)X<B@R'=C?$^W
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M6[!E9=SNB K-9PPU11YL7HDCB["54V%\U0:IY25SELKES'(VS'$'EJ*!,I&
MWG61UVN+O OYF1SB#L3+($3@*-*M6A5,+TH^O9,0BPLIT@CL@6]B!'U,H'-A
M[W(XWXO2&RFE;*_(OYPO/8AX2&\^0K@7'H-) ^MU$9-HYDX[-*/OD3"P[S(&
M]OM3!LXOSL['%Y>L&(W_>G5\CARK]7 _)E)XM$UK9JPJ&.L@.@6EZ%P.')TR
M>^8:>@P'FPB)!!I/O:KYC,PU](&;2JZ&,=KA(.5JP7&A= /*$3A"3/E3C(?
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MW,3D>'%Z?QLR1$97&%=!B27)&'5H\L3\:)?U.-_D&*9AN(-S0\-L!I1NL+/
M"AUAN-]DC,T8$(?L(A.1IVA_.=,]9 5!5)^23Z)IJC-B65Y:!1T%C,D'0V-F
M5!"DP6R)9*1P-XW]5"W3\U;"+_G=M>;M"J4I<L5C#]OW4]3H<-:$#*E\T'G[
M<$@]#>C-QZ30I0D:5D3N4&$$B 4OA*TF&]:B![=6 EGT]QS;\=;?:\HFJ01D
M81&22+M$F"A8*' KE1S; -ZNV?#T6BQ&[XI&4J6?7#2,Q=V<.:E.K1-)I#Z2
M3R7?LBTRTR[B4!OK$NZA$2,!.V3.YXT3&RD21#PQQ74>.C<NGSBX(@C5EO>>
M+GV7N97DP7@[G:GW,;XH8'QR^J.[1*=^4NH&JJK9#2_!G<=,+//,<M<NL,J\
M;B)XW$F#J2VTP#8]KZ2RDH:U,9"SVKAA[<MT'X*] (L"?EAPANN4VLK?"//C
MG%B_+\F(%2,Y]YL-AJH\IE#YP]W85%-QW-XRT)DS*E)CPY(.ABADX*5-4'1)
M"HU0Y(7:V:61FK95NW?,,?4.Q9;OP2#=A((B?LD]5BM1\W0#I0L\3(0VS4NY
M@,<6E6QQG*Y6&-UAVFQ1*9JU.VU$^+[46\?F2"B4"31J7.Z"6!#MAS@<D"72
M JV=F9M300B8R%7+,->&IB55JUU65(@,9' N;S]OK&%VI/CD&>(G9#PNR8_M
MR[87/%59N>>;J3MV>6A ]RY11\%4%[4TLT5+>+;4<CD$_))H+FFAS U@\D3C
MEA1@5E.NQG;96GFY6OJ'I;15P5B]\FT))#\:DE-M3:Z#Q+Q(D?9P8*64KIKI
M-+4%NKGRG'-]UI0\A61OKQP,UU1L!^_V"_(!I@1G&#!VD:.,TE?$.V%PJG6F
M8W*\>;NAOCU7_+',YM#"=_4<#OKK.1R?@J4\CBZ'?V\'<_>__F"K?HO6>(2*
M1A@0&:,AS"4K4B& KZ,T\)8?7NQ9P]&A"I'X_7(NUIJ\LG:C5$+U[B^X,P<>
M[Q.;C!0T/2 O,4=:XJ\!9KH;+>UN*21NCR_B<2+AQ2$ZX-/36C E+*[X%P/"
MH[<MPM%& 5J 8*C.2='FKL%Q;#(IS"T#J'CBF*:$"3_ZMODI*T*86>HL9G4%
MWF)QYN-D\,+1.[+'XZ]2$8WV0E1ZC$*0)FX -U3*$>STO, RTOZ*F+K^TK)R
M%98ESJZQFMI\5S96*(*/OZW$\DV;R/A_OJ,4QVDG)BYRV5Q*S\3)F!N##'2.
MRG;Y]PO0$GE0^>.%P$6IZ'J:?-%4."_.Y HG>+_$1:(:4B8A87/D?*V9K3:-
M"9QZ/E"Q5W3,U14(QOZ?%?CIT G\^JEXD.K,^!EP!4S%Y9***+?_UBCY&GL_
MH*Q<H\J9UR562@%C#?0OW&D.=*#<=H\WD%]5_$4;#*P[V?*FJ=I&^V*TOUE*
M)8BPK$H6KZ;)=8WQ&7PKC6\Y[Y51Q A<(6":;A1J-6!4NI7+7N]A*IATD?)"
MKI7"6WYQ2GP'@&C-H;H.HM&!9EA'1]8@< 32H>/.A28%*+F?K$VS]D4B8;J1
MI.2:JHJ6.[9N&G&DP$O$V>H*ZS"P8 \L%ZHX3^HUWO_H[CDR/34FZ[OHO'D&
MN*$PWP2SR<K*+@A-ASRUH,-HK.&@:*HO]_X?3SU9YBQ IIH2(.1\4M$_5:=B
M,\,8\K3F 0X)(=T2>-@\/ /1E"CF )98Q]DP4$?T:@KD&YW,-CFFPU&JPAH\
M?J&<3DQG<$,BJ$!Q*@E,J:DB5&?>VOIK;H*X;;VJEE[E**0V0!QF3$D,<\'9
M,12@MX-#)%G[V(+ULPI&AQKW/4K^'+B2/P?])7\F>I5$HWB*>DWT/Y^(6OY_
MJS[WJ*5\'K6UH\=J+5Q#5W;DH+_LR /O7>UO[<$K^9BM'6W3VG>Z:,X<(CIO
MYI8W"W)I.BP2*KR1HTF>WZ*,/@9#./;OGU.33Z-WT40X9!F=%\D-<LV39(65
M*0<6---RL]WO>N%<2)6NE,-!?RF';2J<]C?Y8-)\S-:.MFGM6VIY]A7XHCJ>
M_UK1KJA9M"N&-^:V:*#M8N^0@P(KH FZ'\<4?65Z,P8A6Q\^@,Y(LJF^3C)R
M+ S719)&5KJ[$)#1WDR!"%M;&!UX28D*CT"Y_##R/*>;L[W%0#WF4WPG7;R0
MU-IY;IWH_K/S9"ZIGR91EC5$KE0E$RI-F9?[^4->6&'KDMPVA&MX:%R=A(/^
M.@G?4J6ROXD''Y)'O9EMF]8V:EZB3@ J@<(D\++G\D$Q54%%@GTJ\%J<NN!H
M6>/&;ZZ7R' LKXH:-VA!Q@-7KT?&QID8RGPRM[\R5ICR^AQRW)1 ^Z;*F*WN
M#"IZ18X>BM2V/JC$[C">Z&\C60/D;AM0:U5._T)$QPGXV.(=P%QF[L9O' M$
M\%$R./&I]FMT,3Q@2A:"%:[5W5M6_A%3-9!,C49@V^V_S7SET!)(Y:2DP(NY
MAGDW^N@Y_!'67-I;G,0\"*J:"H:YHB*WL>,)<JMX1QRI]0YL]3&_Q?CWH''K
M%B>KB@/&W2,)6CL&<]C@]N^MZN<CKLC%P3U%+KZECE)_&P]F)(]ZZ]TVK6U6
M93K-*X5>.\YB9CE!YCW8S"BJJ(I)L\"2H*;M'6S 9OB>9?%YH$>.:NNZ>@4#
MOI6:RQN039A1=A96NR<(Z9VB;K@ZAG/H2A8UES\P26%%+E48G4[73Q4N@_^@
M/X/_VZOP]#?T8-)XU-NCMFFMO:9/6,YGW%/.!SW*W[7$CD/!*X>"L#%\$XZC
MBCN#X)J3EO([D2V_0YB!KK(]["U@V(@.JA.9"])=22^<I.-[GD@P>?]<?MF$
M-MY$D]''\='522#9CR(0]>^O3B(\HQ/U*_K+5<<6'$8O>VG>)5<?W'/?UW95
M*_I;?? !>-1[*[9I[5MJ8%SZMZN8JZP[+U?ABJ#F,A4B&?H#A32\;!.+Z+J3
MP>9])SN=]YRH\&KF^Z\XJ=H+#(3=->Y5":/!L=Q7<AA<0:*&SN=.MM+#;FQ3
MC5NBE%P 1&?%W :VW651WG5J[C!20$;9VZ/.&7^HO"NZO*H7&Y<Z-0;AI_C(
MK5,#[Q*BWKNF_!N68ELJPVJ?'#AR%R;9Z!(&S-JIS29F$U68<)U<;H0 ,!J-
MBQ4Q!\1+6^EF+7NA46--6FX=W;CFJ)$)YTV-\UNH7A-EM?/=::9XOK3C7RK&
MGB)[39/RKFGRQ^M[NOFZ+9-]8G70*3J _=+8?@5"I'U_1FWWV'DW;JGV"WB(
M#+,<'=UUT;Q?;^63/72_J429I0U0L 11;KM_RI^^XGM8I6H4A4)^J_MN?VK%
ME/T;ZK"HEFHK7FF6*"S-8JJM6*U@RUHKS=HF:MM:*U6310Z:1;X8)0Z:4)H2
M1?#3?C46[RXJPQ&^9<RN/DQ>N$?]X$92VO6FE'<"KWFEQ.2*L<+AW\P456.*
M8.#FZ0V5 D/="*UL=I/UKOHW#I_!?HVQR\"5N\A0AMFGT+CDJX/[[@=ZA&HQ
M_7T\6+UYS-:.MFFMK?;,'_5HC'OHCWHT?]2C^;]9C^;?6UUA UNP;76%!]94
M:+O>U]L?]?UJ*C1/KP^)WZBIH/ZHJ?!_K:9"C\9RZ))Q#^]+QGU0NGA_:P_5
M31ZUM:-M6OL]D\]=]28YF_>DH&,8]%],07_/@=P0%MF?;NZ<J8202XJY8B<-
MUYLJ.HKQO!R\^O& JR;L#?9>_M"2C!Y2K .7'_YKX/+^UQ],HH_9VM$VK?T!
M5?\#JOX'5/W? 57_ Q[^GP$/=ZNO?C=X>!3"P]6_&1X>=<##U?WP\.C;X>%1
M#SR\*XGB>^+!0V2V^CWQX%ZOEBG\CGCP4%=R".[#>RYM-3>9DD/MZ.SJW27&
M>,W%IZWJTZ-BN1^UM:-M6K-+H%J7P #:K-L@O"%UGM?3"@/S-N3@9[*W!'\<
M@,FXI\BA?0MB:YF8FJ*-<G&&I[;<#:H:=0R\FP3(\S.P0#O0X$4NNE$-:+18
M+.+&"@TZB\:)T 1$E, 4Z,$,>TDM5D_YN<;>58/$[/?W@-<$.#S?10"KE7TI
MZG4UN_.J]'CE0WDUB1VU7JCJUT0(JD4D97 C"UW#-(UG7Z2.J1N$\]11I5%M
MJM^M27K>Y!SXI6@!WCQI^K;>G$7XZ*Z:R.5I!LGH7;=*WK\DIY (23J4:/_P
MU@3%9HS!0ZGEX;L?0ZZ(>AI5U# $B:(1KV?EG51>&#&]LRG%-@_]EL9(;JL8
M7KMFSX:#SW7?"1\R&Y?J<-B?Z@#G:WS\X30:75U<C$]'OT:7%\/3R4EGKD-_
M<P_F-(^:Z[!-:S)_U3;_0(Y87D+(G1P]6)DP@=E=F"ZPK@NLMT443A"'0X0X
MR"LC\\HGNL^G]*\PP2=-43$IX 2RAK&QRO85>E;-'1]7NY-=X'PIZ!H#JQ"*
M8R-\D2^<O7.<2V<W29%GYEI1>V4)$QL*U&,_4$,H<S>Q59[I"MNS%RW.-;9K
MLR3(RYI]X2.PL7(>-$RT,:Y+((,UL0JQ7%#MCI.4'#RL$3HTHAE 5"ZU-B;*
M^WMWJ^EZ=+9IX/<;M W'=:YL<#2%$38N39GSPP6C%G:C#^1?PG612[S]B[@,
MO%:&T^C1@QEP%ZF-1& !-Q5,+<Z\(J#HPG58!%G>YN;)VO&=M<VJS]>H\CS%
M,3^+6._J7E96PASY;E!A,YW'4"M]GT47]5IKWP8F6L/TFAZ/A5D05N)R.!/1
M9%?QH2B]\AU6=OMK:XK/2$$KBIQ(#H7!:5^T0KL;/;MN8BS?=>VV4#5I&)XJ
M\OIZ:2X7\MP9ULS":*9/2]=\/1W.GHG';G!C>_NV5C6.J+_HLNV>(=ES*B)3
M@Y7K%,&N>S3IW;.VX>3W[G%4<J$.XM_T$M84YX^3ZQ=Q+F_JL#]O:I135D%A
M#XID]5PDY9=6$?>H.5./VMK1-JT%\U?A_*-AI;#:TD8EE$3N021($>S7588Y
M=7@-5T7J7_;%242KJG%L6?1E;.^]GE-8Z(CA/)AA51=$C*.\0-^8.%3(#V=P
M)DW70C 4*V02QX!"/%)2U8X#6;=B7-WS.#ZQ49K 6=#M_O+77+9U_UY'N<M7
M.KSO7M?Q^?#X*!K_'8N6=CC+'S5?Z5%;.]JF-9FS,G..SNGJUKFR+-8$GUEU
MP?L&Z3X/>LH%]T6%%J^0O#PWV K[&$6 3'S$9,S=ZO3&%/FE"Q^\9/M-<AB(
MHN)NEF;%B@94FI/!1(-A%22/U_<2B4M&.>Q/1IE<GHW^\HW%>/N;>C"Q/&I.
MRC:M>7/O+NT;*.M4C2EJJ8W5 C_:#,N0_WW_]<[^GH4C^>76(LD4!<Z(!:S\
MGP:BRJO&-8,-.;U9 ]8D$C=K8OG52+-&.5:VA ,P2= PQA>4=PR,D]\K6N8[
MJK%2%C-0,H3%HJ9BG9TU[;S+1^A]+LL6HY*C.4)B:HRI<K8$J]TD$/D " [.
M]_7C2OJ"^""]GV-<QNJIT*-:MM8THT+TY&C&DZFDXJ74@W,UZ)IE7YME/;TD
M/*?LA24F/> T57_E[?&R[0@U3'=LF$MI71ZF 3R'J9D,VQ!7E>DUU=DUD"TR
M(+S)Q=8P9BY(E^AD$BLSQ<^"V7#\6TGNG[2Z8AB/4+LE"\D&QKD;(W702*OQ
M2X^*Q\RO^B?U 4TZ#C=HG7B-TK6TPQV5-#N::%:_;=RWL_F8Q#3"$IB[:A28
M8*4V+BM43/U-F<69S7%,@TS5=B2YI:;6\X/Y'B:H6J5W ^7C>,7WYU]<Q77
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M)%10@$*?E!/"24 ,+[$(0PXUS"5D@E2SZ<DP6$HC@ ,73[G,;S/F97@4\\P
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MIX!1?^!@7Z@Q/,(&]SD3$/NA@_6!HH7]QEPT=4Y3#G@JW, ?-+X#/[9&_/]
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MPS4E&'IR 7Y?,B;2%[E!=K78_A=02P,$%     @ [C1Z6;I=[AK3 @  F@<
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MJ&I#5C:JS#*>X$[P(8S@+0R"03\( BN=CJS4NZI5R4VMT+EE_-G*FHS#P!E
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M XWD!EA?,2;*B310?>3I_0-02P,$%     @ [C1Z6:>B-H@L!P  ^1<  !D
M  !X;"]W;W)K<VAE971S+W-H965T-3 N>&ULQ5AM;]LV$/ZN7T&XQ>8 2JQW
M2UD2P'&<Q8!C>Y'38ACV@9;H6*LD>B*=-/]^1U)2[%1VD]; 4*0FJ;OCO?">
M._+LB19?V)(0CKYF:<[.6TO.5Z>=#HN6),/LA*Y(#E\6M,@PAVGQT&&K@N!8
M,F5IQS(,KY/A)&]=G,FU:7%Q1M<\37(R+1!;9QDNGB])2I_.6V:K6KA+'I9<
M+'0NSE;X@82$WZ^F!<PZM90XR4C.$IJC@BS.6SWSM&\:@D%2?$K($]L8(V'*
MG-(O8C*,SUN&T(BD).)"!(:?1](G:2HD@1[_ED);]9Z"<7-<2;^6QH,Q<\Q(
MGZ:?DY@OSUM^"\5D@=<IOZ-/-Z0TR!7R(IHR^3]Z4K1=HX6B->,T*YE!@RS)
MU2_^6CIB@\'?Q6"5#-8K!L_?P6"7#+8T5&DFS;K"'%^<%?0)%8(:I(F!](WD
M!FN27(0QY 5\38"/7X3WT^EH<#L8SWHC-!Q?3^YN>[/A9(SZD_'58!P.KM#U
M<-P;]X>OOK=G>)X2=G36X:"&$-:)RBTOU9;6CBT#=$MSOF1HD,<D;N#O[^<W
MK3T".F!_[02K<L*EM5?B%8E.D&WJR#(LNTFA'V;?4L>N8V)+><ZNF/1O!E?W
MHP&:7&^$ 4;A9#2\ZLU@$L[@1T0M%$23Z>!.1B5LBL;>S01,G+(5CLAY"W"
MD>*1M&H-M/=KH($W2#8G1>T1]'K%TL:@Q%80W\357N=X'2><Q$?:&! NQ'
MT4=D!;H9^+IA&#"Q73TP/3'1^I1Q1!?H=TICAD*:QLBRX8LBM;JZXYN2\/>"
M,H:F!5TD''D@S) 4ONZ -$$P69$"\R1_0(.O * ,MC4MW;9M21?H@:]V;(]
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MB\[60K'8.\E(39D=MW>,CW_O4-%!-5334<U -1/5+%2S4<U!-1?5/%3S42U
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M?$.$N.<[\BORXG\HQO\!4$L#!!0    ( .XT>EGS26L&RP(  '0)   9
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M3/2S"(59H.=7G*N7CJG4Y4.K^Q=02P,$%     @ [C1Z6>]W4UW: @  -P<
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M)VW1HAFJF:AFH9J-:@ZJN:CFH9J/:@&JA:@6H5J,:@FJI9363MNF:*;)BV;
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M8,><S_>3^0^322],-A:<S;K^NA64]75YW3,^'!Y_^=KX9'B\.'H-2%\!I->
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MH?GYE\VF?OQB-\'W3?7/^Z=S]3]02P,$%     @ [C1Z62"^3%#1 @  &@D
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M&4U$ ?[]/(K89D%4L/W?$@;_ 5!+ P04    " #N-'I9Q6@O>-(&  #K.P
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M.:,3QE,#^?TTCL7K01I@L[]W\#]02P,$%     @ [C1Z67#%.$V6 P  SQ(
M !D   !X;"]W;W)K<VAE971S+W-H965T-CDN>&ULQ5AK3]LP%/TK5C9-F]21
M1Y^P-E*I04,:4!4V)J%],.EM&Y'$F>U2^/>SDQ#2+C5IB00?J)W<<Z[/J7UU
MZ_Z*LGN^ !#H,0PB/C 60L1'ILF]!82$'] 8(OEF1EE(A)RRN<EC!F2:@,+
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M=)3OD3PJO[:OQG9-N6=?!77EH=IUFN\BW(?=;5F]Q6P9R_R?D(5L@G71E:F
M[7:![DX$7>=["A^H$#3-#U<$SPE3%>3U!96O0'&B I1[<8<_ %!+ P04
M" #N-'I9Y_9!(OD$  "O)P  &0   'AL+W=O<FMS:&5E=',O<VAE970W,RYX
M;6R]FFMOHS@4AO^*Q:Y6K;13KKEUDTAM(<!J.E,U,[LKC?:#"R<)&L 9XR2=
M?[_F4IH4RB0[1_V2@/'['-N\F"/L\8[QK]D*0)#')$ZSB;(28GVIJEFP@H1F
M%VP-J;RR8#RA0I[RI9JM.="P$"6Q:FA:7TUHE"K3<5%VQZ=CMA%QE,(=)]DF
M22C_?@TQVTT477DJN(^6*Y$7J-/QFBYA#N+S^H[+,[6FA%$":1:QE'!83)0K
M_=+7K5Q0U/@K@EVV=TSRKCPP]C4_\<.)HN4M@A@"D2.H_-O"#<1Q3I+M^%9!
ME3IF+MP_?J+/BL[+SCS0#&Y8_'<4BM5$&2HDA 7=Q.*>[3RH.M3+>0&+L^*7
M[,JZ/4LAP283+*G$L@5)E);_]+$:B#V!Y+0+C$I@O!2\%L&L!.:Q$:Q*8!T;
MH5<)>L<*^I6@?ZQ@4 D&+P7]5P3#2C \-L*H$HP*.Y3WK[CY-A5T.N9L1WA>
M6]+R@\)!A5K>\RC-S3X77%Z-I$Y,_0\W'V\=\NGJ'V=.SFP0-(HS\H%R3G,7
MGI-WY//<)F>_GH]5(>/E*C6HV-<EVWB%;9);EHI51IPTA+!%;W?K1S_2>]UZ
MW>@ J'*@ZM$RGD;KVN@DSF%]04SM=V)HAM72H)OCY6;;>/Q<=*=;;D,@Y?JK
MT6<_UWCW^.A&V[WLEM]2WMEX_WBYT6$$LWYLS()GOL)S%@LHIFGBIP%+@'RB
MC^2>"B#W$+ TB.*(%I/YE_=227P!2?9OVQ-4AK':P^1ONLML30.8*/)5E@'?
M@C+][1>]K_W1YCY,F(T)<S!A,TR8BPGS,&$^$NS WU;M;ZN+/MUS]=D#I+"(
MQ#E9<[:-\BRGS<B=O/;6DC8/(W%L)(Z#Q)F5G%[!R3/0[53O:3(EU<;J=M^/
MS7KOK$&SGM?"TTRM4<]OUNL-]FL=V*-7VZ/7:0\;%L YA$1(@] LDTGYEL:;
M<LJCL<R@:1I FTTZN:?.=Y@P&Q/FE+#^WJB;?:UY=V:805U,F-?L@:%K5M-?
M2$$/;-BO;=C_P2PE@*<TEB_=+:0;(',9( J G/GW\W/RY1:2!^"M[]U.\*D^
MQ(39F# '$S;#A+F8, \3YB/!#AP]J!T]>)N\<H#I;TR8C0ES,&$S3)B+"?,P
M83X2[,#?P]K?P\X9^^,:\@\+Z9+$+,M(0#G_OF!\1WF8M=FXDW:JC3%A-B;,
M&39>MC(Y;&8+F#%=3)B'"?.18 <&'=4&'75GMG+2S404%!/OGQL>96%4?I;M
MRB8ZF:?:%!-F8\(<3-@,$^9BPCQ,F(\$.S"SKCU_W=7>)I^HXB!9')5FH](<
M5-H,E>:BTCQ4FH]%.W3ZWCJ&CII9=.-.-C0FS4:E.15M/[OHZ]:HF5Z@AG51
M:5Y+)RS=U)O?([#"'MK0>+:AT6G#N<@G5YJ&Y#T+:'Q\"M'-/=F/F#0;E>:@
MTF:H-!>5YJ'2?"S:H;.?5[ST-UKRTE'7O%!I-BK-0:7-4&DN*LU#I?E8M$.G
M/Z]]Z=V+7R>G$O]CC:C#T)@T&Y7FZ,W5),/JF2VI!&98%Y7FM77",(<MJ012
MV-*&ZMXFG03XLMCA)=W%-JDH%V;KTGH7V56Q=^I%^;5^>:.WE-OZI=M6[N6[
MT8K-0L]ARZULMY0OHS0C,2QD$[2+@1P37NX.*T\$6Q=;AQZ8$"PI#E= 0^!Y
M!7E]P9AX.LD#U'OTIO\!4$L#!!0    ( .XT>ED8L:,+C08  !DZ   9
M>&PO=V]R:W-H965T<R]S:&5E=#<T+GAM;+6;;7.;.!#'OXK&=W/3SMS52#P8
M<HEG&B.@T[C-Q$UO.IU[0; 2,\7(AW#2^_8'F!@3*8I]6;]) ._^5D@+?VLM
MG3[PXH=8,%:BG\LL%V>#15FN3H9#D2S8,A;O^(KEU2>WO%C&975:W W%JF#Q
MO'%:9D-B&,YP&:?Y8'S:7+LLQJ=\769ISBX+)-;+95S\>\XR_G VP(/'"U?I
MW:*L+PS'IZOXCLU8>;VZ+*JSX98R3Y<L%RG/4<%NSP;O\4E$[-JAL?B:L@>Q
M<XSJ6[GA_$=]\F%^-C#J%K&,)66-B*M_]VS"LJPF5>WXIX4.MC%KQ]WC1WK0
MW'QU,S>Q8!.>_97.R\79P!V@.;N-UUEYQ1\BUMY0T\"$9Z+YBQXVMK8S0,E:
ME'S9.E<M6*;YYG_\L^V('8>*HW8@K0-YZF ]XV"V#N:^$:S6P=HW@MTZV/LZ
M.*V#\]3AN5X:M0ZC?2.XK8/;C.YF.)JQ].,R'I\6_ $5M75%JP^:A&B\JR%,
M\SIW9V51?9I6?N5X-HFH?WU!T>< 7=&O]-,U1>??T.759_]Z\@5=?/A$T1N?
ME7&:B;?H#W0]\]&;7]^>#LLJ>(T8)FV@\TT@\DP@$TUY7BX$HOF<S17^OM[?
M>\D_U/MCH@$,JU[;=AUY[+ISHB7.V.H=,HW?$3&(I6C09']W4]4?KXM.]>X^
M2RIW_&STX'6-#_7NT[C01H_V=R>:D32W#X'9\,QG>%?LGN5KAFX+OD3T9\F*
M/,[0I'GZ6(&^7U3VZ$/)EN)O5>)OX)8:7HO/B5C%"3L;5.HB6''/!N/??L&.
M\:<J:2!A/B2,0L("2%@("8N 8+U$M+:):.GHXR^\K!+O4_65919G3*B2;0.P
M&T#]Q>1^C V'5%]5C-/A_6XB*0QMS\22H:\RM%Q7,J2R(?&P)QL&"D/LF9YD
M&,J&ID<\V3"2#:V1C7MWW>MP>]OAMK;#)UDL1)J@CW$1\Q\,3>-D49D(]'W*
MEC>L4#[O6N2ASSLDS(>$44A8  D+(6$1$*R7?LXV_9QC"H\#F8B0,!\21B%A
M 20LA(1%0+!>(HZVB3AZK?!L ,[.*]@E6'[Y3V0[;#FF(^N.PM"PB2Q05-OT
M0\=?$75D.J:L39!1(R!8;VS=[=BZVK&]2!.6"S9'EP6?KY-2+VY:UJ'O%$B8
M#PFCD+  $A9"PB(@6"_OO&W>><<4-P\R$2%A/B2,0L("2%@("8N 8+U$Q$97
MY#)>*V\MH2<,M;H]E3>%G4K<5&:CD:QM"CO;DB= @8HG3_I"A9EGR],IU<TZ
MEOWL= KOE!.QMJ<_IG.!OO%UN4"TKD\7/$\3O>+HB8<^Z: T'Y1&06D!*"T$
MI450M'X6DBX+R3&EIZ5#920DS0>E45!: $H+06D1%*V?D5V%&6OKAGLID*F0
M#%D*)@H[XLG2XBOL;$N6*JJR<V31"!1VEBU/UT*%'79'LEA%JALA?9'L]W97
M1L7Z.NHT30J^6O"ZDA?G<_0^29@0O$A?J.SIL0<_^) T'Y1&06D!*"T$I450
MM'XJ=@5F;!]5BD"+S: T'Y1&06D!*"T$I450M'Y&=C5GK*TD[B5%COP*KQ5!
MUB+9T#54TR'9SC2)+&Y494A<N3P7J QM2U''4QB.7$,E1[*AA5W-I*@KKF)]
M=76ZKG]CFJUO1%*DJWK-S@LR!%E[G(#2?% :!:4%H+00E!9!T?HIV-6 L7M4
M&0(M"X/2?% :!:4%H+00E!9!T?H9V56'L;;FMY<,>?($0?63D\(.VRH5DNUL
MU4('A9V#9<4(5#Q;5LE0Q1M9"@52\/K%Q?Y"M:[^2?3USPM^EXJR+L3-JG%,
MDQ>F07K:H4\[*,T'I5%06@!*"T%I$12MGX%=79C@8^H/ :T1@])\4!H%I06@
MM!"4%D'1^AG9U8B)MN*WC_ZTA-[2.")7VB;Z2.H[0<I4VB\@_3\!-4D"U/P0
MM%D1%*V?'UW%EN@KM@<M"=2S#GX_@2X"!J514%H 2@M!:1$4K9]_70V;6$=5
M3-!2-BC-!Z514%H 2@M!:1$4K9^172F;Z!=+[Z.8H.5J4)H/2J,MK;?(W<*N
M8ND&:-Q0%==U%;/=2&%INJ[CR?/)X<[^L>K=<M?L)10HX>N\W&Q>V%[=[E=\
MW^S2>W+]')],L.*ZCT\"U?40GT2;78I=V,VFR6E<W*6Y0!F[K9I@O!M5MU%L
M]B%N3DJ^:G:UW?"R>B$VAPL6SUE1&U2?WW)>/I[4 ;:[0<?_ 5!+ P04
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MIKE ?+XBA#_?Y 'J@_7A?U!+ P04    " #N-'I96B?\"KT#  "F$@  &0
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MP\>75*<B58/AHMPR/V/&-^#EY0'!&!$1P._O,&:O#2'0'$VY_P)02P,$%
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M_N&*T05+L@7B\\LXYD\/L@3[NS:._@=02P,$%     @ [C1Z64>9MMY;"0
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M<=/>V86^^PM4TZ":#M4,J&9"-0NJV5#-@6HN2FL&O)X&4@[##; KR!3HF]5
M-16J:5!-AVH&5#.AF@75;*CF0#47I36S6P\.*>+!H0M7D(FK>R?UH(FO1U.A
M/36HID,U ZJ94,V":C94<Z":B]*:":P'AI1+[]?3]0HR,=0[C'-.&%N#[=">
M&E33H9H!U4RH9D$U&ZHY4,U%:<TPUG-#BGANZ&2PG:1)R#^D"WVWH4J[.".O
M0MMJ4$V':@94,Z&:!=5LJ.9 -1>E-=\KOYX:&HFGAEJ7F11Q_'3^ 5+,]4UE
MI5U\2S85VE:#:CI4,Z":"=4LJ&9#-0>JN2BMF<IZ9&@D'AFZ-.$N+N^=0KEK
M"J$30E!-AVH&5#.AF@75;*CF0#47I1U2./SP85(199OR(])24D[)%DT^W'K\
M&+;/Y8=1G=RNRM>:S+E=EZ]-WNV6?&T?/GRM;GOX++@O'ML$<4I"^I*O@G0U
MRS/(#A^O=O@A2W;E1UP])UF61.6W6^JM*2L6R'__DB39^P]%@^.'W"W_"U!+
M P04    " #N-'I99\+.)A<%   2(@  &0   'AL+W=O<FMS:&5E=',O<VAE
M970X,"YX;6RMFFMOZC8<QK^*Q:;I'&FGY (!.D!JR85$HZW*Z:9IV@L7#$0G
MB3/;E.[;SPDAA<:D0?V_ 6+\_!['>>PXE^&.LA]\0XA KW&4\%%K(T1ZW6[S
MQ8;$F%_1E"3RGQ5E,19RDZW;/&4$+W-1'+4-3;/:,0Z3UGB8ESVP\9!N110F
MY($AOHUCS/Z[)1'=C5IZZU#P&*XW(BMHCX<I7I,Y$4_I Y-;[9*R#&.2\) F
MB)'5J'6C7P>ZD0GR&G^$9,>/?J-L5YXI_9%M^,M12\M:1"*R$!D"RZ\7,B%1
ME)%D._XMH*W2,Q,>_S[0W7SGY<X\8TXF-/HS7(K-J-5OH259X6TD'NEN2HH=
MZF:\!8UX_HEV^[H]LX466RYH7(AE"^(PV7_CUZ(CC@22HQ88A<!X+^B<$9B%
MP&SJT"D$G:8.W4+0;2JP"H'U7F"=$?0*0:^I0[\0])L*!H5@T%2@:X<CI^4)
MVA_R/"\V%G@\9'2'6%9?\K(?>>ARO8Q)F&3C8RZ8_#>4.C&>/\UF-X]_H7L7
MS7WOSG?]R<W==W0SF=P_W7WW[SST</^[/_&=.?IB$X'#B*,[S!C.8OT5?4-/
M<QM]^?GKL"UD:S)F>U$XW^Z=C3/.)IK11&PX<I(E62KT=KU^\)'>J]?K1@V@
M+;NQ[$OCT)>W1BUQ3M(K9&J_(D,S.HH&39K+355_?,[=J9?;9"'E^EEW]W.-
M]S[G/JV7SS"KE?O-W0V%/&CN;M3DR"S'I)GS.F=X$_J-IBAE-*;Y.21,%B3)
MQAM7C;(]JYNSLK/ARWB@]35-&[9?CK-7K:9;9J]2SU;4,[K5>DZUGF%I6J6>
MJ^ --+U2SZOMDFR5<,U3O""CEEP&<,)>2&O\RT^ZI?VF2HNB<::B<3ZD:: P
MU4Y-3]+0*=/0J4W#X]X9R;40XC@B7"Y+Q)8EJBS4DB[<GPDDS(:$.7N8==33
M9D>5/4A3KU,YO$K3:;5Q U7T(-L6 ,%.\MDM\]G]()]9&A'FG CE!%4KOS24
MD# ;$N9T*\==5QUX%]+4:V@ZK=933=8^9-L"(-A)**TRE%9M*.>;,$W#9(UP
MLD0;^1%E&^157E9R]6FTEG=I2B%A-B3,L1H%P87T]"!AT^H.=%5)AO0,+,42
MZ_R)O5=FM%>;T0=&4APN#ZE4A;)7,>Y;U;78I-;GTK@U\W1ZU9G'M*I!@FR:
MU\QS6MT#LUM=<?J030N 8"=!ZI=!ZM=/=B0.T00_(S]9H+]G)'XF[!]5G&HQ
ME\YQD# ;$N9 PEQ(F <)FT+"?$A8  0[&0R#<C ,@,_\M;Q+1P4DS(:$.9 P
M%Q+F#:JG=&M@5.=U2%-_4+TOH6F*&QT!D.M)F'7M[?:L5AMGES(2KA.T"A.<
M+$(<H3#A(A3;[,X0SQXO;&79DJ24A^K+KWJ#2_,-2K-!:4Y!.PE2]4Z8"VKJ
M-3.=@IKZ"M-!=8430)F>9O?HT8+^V05N/>'B<$+2;%":4]".)YRN(IN0GEY!
M>W^Q]#Z:D)Z^PK,Z' (HS]-D&F_)-#Z\IXK98I,O$I;DA40TC4DBT(+R,[-H
M+?#BH$+2;%": TIS06E>03NY..TH5@J@KK["U>I4[SD$4*[[4+>/'NK&A*WS
MEPBX3.@V$?NG!V5I^:+"3?YX_EWYK7X]T17EMG[MJLJ][(6'_.'RF^W^;8D9
M9FNY_$ 16<DF:%<]V25L_P+"?D/0-'_4_$R%H''^<T/PDK"L@OQ_1:DX;&0&
MY6L@X_\!4$L#!!0    ( .XT>EEKDE8W+P4  .(H   9    >&PO=V]R:W-H
M965T<R]S:&5E=#@Q+GAM;+6:;V^C.!#&OXJ5.YVZ4J]@DW_M)9&ZH=56:K:Y
M=GNKT^E>N(F3H 6<M4W32O?ASY 48@%NB29O6@B>'S-/,I8?S&##Q0^Y8DRA
MERB,Y;"U4FI]X3ARMF(1E6=\S6)]9<%%1)4^%4M'K@6C\RPH"AWBNETGHD'<
M&@VRSZ9B-.")"H.830622111\?J9A7PS;.'6VP?WP7*ET@^<T6!-E^R!J<?U
M5.@S)Z?,@XC%,N Q$FPQ;%WB"]_+ K(1?P5L(_>.45K*$^<_TI.;^;#EIAFQ
MD,U4BJ#ZWS,;LS!,23J/GSMH*[]G&KA__$:_SHK7Q3Q1R<8\_![,U6K8ZK?0
MG"UH$JI[OOG"=@5U4MZ,AS+[BS;;L1T]>)9(Q:-=L,X@"N+M?_JR$V(O +=K
M L@N@'PTP-L%>!\-:.\"VIDRVU(R'7RJZ&@@^ :)=+2FI0>9F%FT+C^(T^_]
M00E]-=!Q:O0P_G+E/]Y>H;MK-+V_FU[=?_L;77[UT=6?CS?3R=77;^C$9XH&
MH?R$?D>/#SXZ^?73P%'ZWBG!F>WN\WE['U)W'[8^0YY[BHA+VA7A8WNXSV8Z
M'&?A7D6X;P^?4%$7[FC!<M5(KAK)>%X-;RITXPGU>HJF(8T5HO$<7?U,@K7N
M"(7^N=7#T8UBD?RW2JDMNUW-3AO]0J[IC U;NI,E$\^L-?KM%]QU_ZC2#1+F
M \$,3;U<4\]&SS7-Q&1O8IZBI>!25LEHQ365<0OK9+!TKGP>D9YW[KKNP'G>
M5Z@\SG.Q,<XHOIT7W[86?\NDO$"7LUD2)2%5;*[G+IWV+*#I[%A5O977M/HM
MK+M?O>=URM57C>MW:ZOOY-5W#OKJ8Z:J2N^4OP/<+R4[[I22;;OM<DWE85W/
MJRVIFY?4M98TYM$Z44QD)=TM%L&,[<\0$Q8],5$Y.UBY3;]82)@/!#/T[.5Z
M]HXXX_8@-86$^4 P0]-^KFD?=L:UXIK*V"]U<65[]LM=?-ZK;<_SO/1S@/9$
M_Z%)$ =1$ED[UGJKIK) PGP@F"$Q=HNEI7O$GMW!@60%I?E0-%/8O34[MOYZ
M+Y^9T*8,)9(MDA"%P8*ADR!&KXP*6;TXMP(;BVE/K[--I%(XH#Q,X8IE.[:N
M8!NT/7UYM^WM]VJL*>A"'HIFZEPLY;%WS,X'7=F#TGPHFBEL81.PW2<<T/F@
M1N&=]'J6S@?*PQ2N<!C8;C&N$Q$'*A$L^RU>!R_IL;3WMY786#E(F@]%,]4L
MS WN'K._02T.*,V'HIG"%BX'6Q?\A_0WJ+=Y)SU;?Q_#R>#"RF!@+V/G-=:M
M[&:PVRN[&5RV,QCC6CN#"S^#[8;F.Q5LQ?7/YH-/&>RXQN6#NA8HFOEHM[ M
MY)BVA8#:%E":#T4SA2UL"X&V+79@8S'MZ5DF-Z@\3.'V=AOLMJ7QY&;G-=;M
M !JJE)&4GQ]WZF<_4O@-8M\[F/!P+C-U%.?ZXM(Z]]EAC=4!]1=0-%/(PE^0
M]C'G/E"O 4KSH6BFL(7_((=M<=2W,*C[(.4]$T)(>=/$KQJ(TQV>NAXM/ .Q
M[XC4]^@''[/:^8T5 ;4-4#13V\(VD&/NCA!0"P%*\Z%HIK"%K2!V6W' D@74
M5[R3GF=9L@#E80I7^!%B]R/V;O_ TU4[O[&.H 8%BF:^)U$8%.^8!L4#-2B@
M-!^*9@I;&!0/VJ#8@8W%/'A?!2J/K7#.WOMDZ=M_$RJ602Q1R!8:[Y[U]/)
M;%^HVYXHOLY>,7OB2O$H.UPQ.F<B':"O+SA7;R?I6VOY:XVC_P%02P,$%
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M&R'-'K0AOMUO'+20T7P72O.@- JE,2B-HVBZFNK\@?45$PC6;IS>:E0:-#D
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M\@+J_T])(E\/\@K6^PJ?_PM02P,$%     @ [C1Z62^;OLO  @  %@@  !D
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MA^:0U;&SNM%B7Y[<GH6&<V!YN8.C.I7& -YOA= ?-^8P6!_^)_\ 4$L#!!0
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MA]>!5H>[U0,CF_+D[XDP1O+R=HW@ E&1@?^_)(2]/H@ S1'[\']02P,$%
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M#:<"0]TS/<XPY U-S_!XPX@WM%Q;/QKU4<"M-N!69\ ?,:$;,,X02980_/6
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MI0%[OL*8OMV4#MKO(J/O4$L#!!0    ( .XT>EG<.5,P-@H  %AN   9
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M5@)A O3[%>=J/S$;-/=<]!M02P,$%     @ [C1Z62Q<3YO%!@  ,"4  !D
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MS0O0PZ/_]?9II@'DDR?S((RRS^2"?)M[Y-/OGZ_[N6Y40=U?5 T8[AK &AK
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M3#%#R"I5,:DD4@DJC8,T% G($8(S8+\]"+NPJ0,#UT> @IJ(,@C0-&TDER%
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MHW<^X4F:L??H GV=^^C=G^]'?2X*):7[B[H -U4!S!,%L- MS?F&H2!?DB7
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MV2IP!@"QZZBAP]97=:Y%@*BV:ZG%BU6@*<OV CMJ6*=I6*>U8:^7_XEICYB
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MI7;<30[V0O#Y\]G.?:55^^R^HE/-K]6.%@3*SZ;7V18 6N!,%@!>F)::TV8
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M L3_5Y3R_8T,T!S6&O\/4$L#!!0    ( .XT>EF(JI#RTPH  ,UJ   :
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M-T9#*-/OX2.DR"F,R!IF(H,?"^1K5#_[H;%*'%^8G;,.3UGC&UG'F#6@U?P
M<12W?H>'MH"JBKBJ(O9\[1M\"RHH+WFMHEH&=_=[NB 9#@)[N36J5PR2MV^:
MW>AKC;Y6I:]5JV^I[!0I<X2"$6& B W@2TD+>[L-E!KSD@&C.?Y)=SUS"XY(
ME*[1V*XTMNM[2 Y_[6$MPS_VL%/IZ_RW'M8S=V[W,+R:+/=(+8C:4J&!86ZI
MHL8GRZQ.@W]RC"S\L*VEL:/KS9U]*U&Y 'N>2VDNCIO?ZO5-?@%02P,$%
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M=V]R:W-H965T<R]S:&5E=#$P-2YX;6RUG%MOX[86A?\*X1X4+3"-=?$M<Y(
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MLS(HS8?2 BB-HVBZ3!M7RS;;6@>'6DB7Y!)*\VJ:[@(/G+<5%&IH06D^E!9
M:1Q%TZ79N%JVV=;J--2"6EM0FE?3S(,C"LW)H#0?2@N@-(ZBZ7?+-\Z58S9-
M]@VUZ->5ZORCM)!A')<7J06YSW)BNR19W[!O&GJ9<W95,Y3F06D42F-0F@^E
M!5 :1]%TU3<NE_/-+I>9T%G#4)<+2J-0&JMIXU9O4=W7?[)]:[\/S1M :1Q%
MT_79^%S.(9_KP/6".;ZS.J'F%I1&H316TPX^,0#-&D!I'$73M=F86X[9W-IW
MQ6 [:DOK<J$];RNDC$6YF4P?<K%^]=YY77/S.DL?:IY!:11*8U":#Z4%4!I'
MT?03I+'8'+/%=LS%!=19JVE:ESL8J9^3D5[6/&A>"J4Q*,V'T@(HC:-HNCX;
M=\UYG[O&HEQ=<5ROM0LIW^HS;R5(F"[(,HP6)$M)^92R4S\G;"[S4/L.2O.@
M- JE,2C-A]("*(VC:/IIU-AWSC?;=V9"9PV/WCH9;XT,#YJ40FD,2O.AM !*
MXRB:+L[&O7/,[MW>.RC$/%/5^%\H\JJV_[Q*!7&/J>U0OQ!*\Z T"J4Q*,V'
MT@(HC:-H^NG3N(J.V54\IK9#C<6:UJ[MXUVU'?J<')3&H#0?2@N@-(ZBZ>)L
M?$7G'8_+J2K\6:3KU93BE]<"CYF%:5=XQ;:/J?!0/Q-*\Z T"J4Q*,V'T@(H
MC:-H^OI0C>_IFGW/8U:(@KJ8-:T]23,95',TVY,TT+P42F-0F@^E!5 :1]%T
M?38.I6MV*/<5^=^%^-*N[RS+JVUF0]Z<K+.4H68FE$:A- :E^5!: *5Q%$V7
M>V-XNF;#\YAR#+4\H30/2J,UK7U?H#URWCPS!4WJ0VD!E,91-%V<K<4DW^=X
M;M?B]SJ:YO2=E8U=C!*[&B5V.4KL>I101Q-*XRB:?@(TCJ;[S8ZFF=!9PTB:
M5].T>FK;KKMU!RLT*8/2?"@M@-(XBK869[^UB'4B\H=J!?2"S,NG4-;K66^V
M;E99GU9KB_>;KZ^7:+\*\X<H+4@L[E6H=3)6"LC7JYZOW\AL62V)?9=)F275
MRT<1+D1>?D%]?I]E\O5-F6"S]OS%_P%02P,$%     @ [C1Z6;^0FT/W P
M3Q<  !H   !X;"]W;W)K<VAE971S+W-H965T,3 V+GAM;*V876_;-A2&_PJA
M=4,+=-&W/S+;0&)):"_<!O&R70R[H*5C6Z@D>B1MI\!^_$A)42Q;YJ*--[$H
M\7T.#U]^A9,CH=_8%H"CYSPKV-38<KZ[-4T6;R''[(;LH!!?UH3FF(LBW9AL
M1P$GI2C/3,>R!F:.T\*83<IW#W0V(7N>I04\4,3V>8[I]WO(R'%JV,;+B\=T
ML^7RA3F;[/ &EL"?=@]4E,R&DJ0Y%"PE!:*PGAIW]FUD.U)0UO@MA2,[>48R
ME14AWV3A<S(U+-DBR"#F$H'%SP'FD&62)-KQ5PTUFIA2>/K\0H_*Y$4R*\Q@
M3K+?TX1OI\;(0 FL\3[CC^3X">J$?,F+2<;*O^A8U?4&!HKWC).\%HL6Y&E1
M_>+GNB-.!+9[1>#4 N=,,+*N"-Q:X)Y'\*\(O%K@G0N\*P*_%OAO%0QJP:#L
M^ZJSRIX.,,>S"25'1&5M09,/I5VE6G1P6LB1M>14?$V%CL^"IQ!%CU\7*+J;
M__KU$;T/@.,T8^@+IA1+US^@G]'3,D#OWWV8F%R$E$(SKO'S"N]<P;MH00J^
M92@L$D@Z](%:/U;H39%JDZ_SDN^]HP0N\'?DC#XBQW*\KG3^34UOD&M?E0=J
M^1)V0FZ5<K=#'JKE <1-]"YY]':YH^A*MQDZ;LGSKO%2MMMS^(AP3O8%[VC0
MO1(@%\U;ML,Q3 VQ*C*@!S!F/_U@#ZQ?NJS1"0LJF%_"Y.I[F#FV;UG6Q#R<
M&J(S9J0)UC++:\SRE&8M(4_1'*_0YR)&?RP@7P']L\LR)::O93IA@4Y8J!,6
M:8*UC/4;8WVEL7=Q+&<?$]M\#.D!KS+HLE4)Z6NK3EB@$Q;Z%]/:&WL7TSJZ
MK#88#D^KM:P8-%8,^EJ!Q!XJ5L@$6$S3G3Q+=9FCQ/8U1]W&2!SE"!4MS%/1
M4-?_$9$UXEM XI J3F'BJ%<D:/CZ.B$Y,)[&X@AXF=P*9[B(N\9;H#.E4"<L
MT@1KC9!A,T*&_W?+'%X,S;%[,8#GRC!]9Z!.6*@3%FF"M;P:-5Z-E%XMTB+-
M]WFS6:*_T9LW426Y[X36"0MTPD*=L$@3K.7UN/%ZK&,354+ZVCJ^F.CE ?1L
MI@<Z8X8Z89$F6,LPVWK]O]526Y8<Y-Z#UB"64[G+=AFF9O1UK*:-3RRS;BQG
MZ)]9IC5JJ)46Z:*U73NY;;#5BRI^_L^+JAK=VTR=M$ K+=1*BW31VI8[KY8[
M&B:JDM';VXHV:DU4^V*:ZHP9:J5%NFB59^;)_6 .=%/>Y#)4[GG556'SMKDM
MOBOO2,W7ZM55\P+335HPE,%:2*V;H=C :'5[6Q4XV96WC2O".<G+QRW@!*BL
M(+ZO">$O!1F@N4.?_0-02P,$%     @ [C1Z63LG$:C.%@  7_\  !H   !X
M;"]W;W)K<VAE971S+W-H965T,3 W+GAM;+6=6W/;2)*%_PI".[&Q&S%CL8IW
MCZT(65"[/;V^A-7VQL;&/L B+'+,BP8D9>O?+RF1JB20R),E)OK!+<M5!Z@#
MH/@E6,!Y]7-1_%B.\WR5_)I-Y\O7)^/5ZO;EZ>GR>IS/LN6+Q6T^W_S+]T4Q
MRU:;OQ8WI\O;(L]&#YUFTU/?:O5.9]ED?G+VZN%WGXJS5XOU:CJ9YY^*9+F>
MS;+B_DT^7?Q\?>).]K_X/+D9K[:_.#U[=9O=Y%?YZLOMIV+SM],GE=%DEL^7
MD\4\*?+OKT_.W<O4M_VVQT.3KY/\YY+\G&S'\FVQ^+']R[O1ZY/6=I?R:7Z]
MVFIDF__=Y1?Y=+J5VNS(OW:J)T\;W7:D/^_5?WL8_68TW[)E?K&8_O=DM!J_
M/AF<)*/\>[:>KCXO?OZ>[T;4W>I=+Z;+AS^3G[NVK9/D>KU<+6:[SIL]F$WF
MC__/?NV<(!U<KZ:#WW7PV@[M78=VN4.WID-GUZ'SX,SC4!Y\2+-5=O:J6/Q,
MBFWKC=KVAP<S'WIOAC^9;P_\U:K8_.MDTV]U=G7Q^V7ZY;\NDX^_)5=_?KSX
M(_GXZ<]W'S\D[ZZNOERF2?KE\[L/;Y,_?[],_N?R_'.27EY<OG]S^3EIN[\F
MON5;#W^ZY/Q#NOW!)_^1YJML,EW^9_*WY/)?Z\GJ/OEX^W"(__=]/ON6%_^W
M^8>K?#9)+K)OR;OY-?W]7Y+39#G.BGSYZG2U&=UV'T^O=R-Y\S@27S,2YY/W
MB_EJO$PNYZ-\="APNK'ER1N_]^:-%Q73_/K%?IR>V:$+?7?'=$_UW5O":-I/
M1[K]H->IT7M;9/-5/DJN:OU][-][Z+^=,.[.G.N[S12RV?P=';>XH>U4]7)Y
MFUWGKT\V<]$R+^[RD[-__S?7:_V=<\%([,"3SI,G'=&3C^O5<I7-1Y/Y37+^
M,RM&K"\=QI?NL%_U1=Q8K"]&8@>^=)]\Z8J^7*U'XTF1?,B*;#F9C;/9NEB-
M[Y^N5,XD43!R[!>68JF1V(&1O2<C>T=>=+W*R>6[U3.KVFK;J-0JK;9R@X-F
M!V/H/XVA;W"1]%7CJ+;BQE%M)8UC\#2.@>I8;#XG<VX$<N_WV7V2M/Q?D]I/
M [G_^?KF1>)V_=F/ [G_57[[(O'#Q_[2Y\'PR8ZA*'CY*R^N)\L\N2TFUZPA
MC_W[Y#"T7K2ZI2/*-NJ5#BAH=+#_KA70I26.X&N^7&U/RKH#"KKC(PH$'@Y)
MTG+",=4H: ZJ(SSGH"F;DYQ<M*PUKGJ);:_7TL%EFK6W_Y4.+Z<F7+#.A\%X
M<3!?YG</PV&'X'5#8)KU>KU^>0C59G5['X#+R<2U/2^3W];3Z7WRM7X8LL;!
M2=IC3U)9X/ D[;(GJ4)A?Y*VI9,T8)>3N>O-8O,QDIS?WA:+NVQ:?P'+*HH+
M6!; <S(0>+1FH+A^ WDY&;TN?]U.BNRA8*JU159XM.7Q@+=Y6V2!1UMV KPM
M !^)+6W1EL!13@:I/[+19C;+IGER54SFD[MLF6PA-<\+D4IEU5@L-55+K=0.
M'0U4YV2LPVCJ5+1VP31S+8;JF':]EO I$;C.R6BD ]2="!Q-M1D_FFH[<30!
MRYS,90A307?%I"@+*"9%64 --3Z0GC^.]$!W[ D04)">1D%E2B ];T%ZOLIF
M7&'&-.MM_RN=]5PSX:SW@?3\\TG/5]F,'4*UV995.^4AJ$G/!]+S!J0'-##I
M 0$%Z6D4-*3G ^EY$](#*HH+^%C2 P)JTO.!]/S1I <4,.D! 4QZ0$!->CZ0
MGI=)[^OD+O^17.7CF\WY(K&=K!/+=J9JJ97:H8>![?RQ;.=UT';!M/,<#C'M
M.BWIDR'0G;>@.Z_#M@NF'3^>:CMY/('O_'%\![HKIL)C^0X(J%&F'?BN+=,1
MOA>Y$P W(_E698A!K0X'$7BL;<%C[2I!<64(T\QQM]Z8=N)YV@Y$UGX^D;6K
M#,4.HMJLQ]Q[8YK5[3WYLM. R( &)C(@H" RC8*&R-J!R-HF1 94\#0$!/ T
M! 341-8.1-8^FLB  B8R((")# BHB:P=B*PM$]GG[)^3N^0J^Y7/,Y'(9)U8
M(C-52ZW4#CT,1-8^ELAD@6CS+-72-J3%0UL"W+4MX$X6B;;&4BUM0_ \M"9P
M8OLX3I2[1YMBJ9:"H:D)LA,(LG,L0<H"L7Z9JJ6=&"+M!"+M8"*5;IO*W:,M
ML51+P=#TIU  WHX,O#I^ET6B/;-42SO,=]W"7-0)--V1,52J!>2NT8:8KBWL
M5)<TUGE!E@S*W*FJ+&2-:%,LU5(P/G7)T0E<W9&95%ERR"K1IIDN(@0C5!<C
MG4#='9FZ%<6(K!!MF"EO@]&IRY1.0.R.C-B_9\5RG"5OQME*K%)DF6C73$';
M2NW0PH#C'=T2R?HJI</</V6^BV.:<0L]F6;2PK%.@.>.3)C*A=U#W6"JS=C!
M5)M)@^D&MNW*;(LJ = =WZH! OA6#1!0PUHWH&U7YC_,^SL!<,>8;U6^8XQ:
M'0XB$&<7$Z?$YZ"[XL#* HIE#1H%U9$-K-F565.'X5WF815F]2?3C+N+SJE)
MEVZ Q:X,4Q(X[[K"(3#-F)OH3+.ZO2=/@<A4HT)=H(%OH@,!Q4UTC8*&:+L!
MSKHROBB)%J@H+F!90#$SZS%,OGX#AG5E#%-P*U# -]&! +Z)#@34=-H-:-65
MT>H?V4TV3S[GHQ%XCLKT7J>I6FJE=FAA@+JN[HYH/9UV&03C5@$P[=A5 $P[
M\=O57F"ZGHQ$.D#=B<#Q,.W8\3#MY/$$'NO)/(88%73',R$0P#,A$%"33"_@
M74^&(\RH.P' J'RK,J.B5H>#"#C6PS@F,2KHKCBP,=^A\T<VXCMT\<@&K.O)
M6*=CU%X5R;A5$DPS=JD'TTZ^> /G]61 DBAUUQ4.HMJ,6^K!-*O;>_*(K<PP
M*DH%&IA2@8""4C4*&DKM!13KR1BCI%2@HKB$-3@FSLUZ').OX(!C/1G'%)0*
M%#"E @%,J4! 3:F]@%@]\,WL9#3*[N^SY"IYF\W_"5;@RF*QK&JJEEJI'3XR
M'_BNK[MG5\^J?8;9N"?FJ\W81^894I2>_0]@UY>Y2/GTO^XI$Z89.YBXYXG[
M@<CZ,I$A2@7=\4P(!/!," 34+-,/@->7\0A3ZDX 4"K?JDRIJ-7A( *0]3&0
M290*NBL.K.)+4YE2-0JJ(QNPKB]CG8Y2^U4DXVY#,LTX2.74I$LW4%Y?QB.)
M4?O,BT^X(3#-&$9EFM7M/7F%BDPP*D8%&IA1@8""434*&D;M!Q#KRQ"C9%2@
MHKB CWT]"Q!0,VH_P%@?O:$%,BI0P(P*!#"C @$UHPX"6@W MXGK^62:G!>+
M0EZ-+,O$TJFI6FJE=FAA@+J![FY=/9W* M'FF2X-'%3Q<"B\'BK0X4"&*QWJ
MRB+1SI@N !RHGZ09!#X<Z-X;6/O:+-/U?Z9J*1B:FKD& 40',L9AFI8%HOVR
M5$MW:CHZ'P00'6 0E>A<[AYMB>G"/S T_2D42'< 'H!68;LL$NV9Z=J_@9J@
M!X&@!S)Z2OPO=XWVPG1%WZ#ZZ$R=%^1%AC)KJJH)62/:%-,ODL'XU&7&(+#T
M0.9099DAJT2;9GI'$XQ078 , VD/T4,UL "1%6(-,U5+P>C4I<DP</50YNK'
M)R6_3HI9-I^(Q8DL%.V;*5];J1V:&#!\J+M)6U^<R +1YIDB^+#FT?B:27\8
M.'PHPZJN.I%%HJTQI?%A=96E:$V [J$,W:A$D;M'FV**W&!H^M?^!AH?HJ?<
MX8M_37G<5"W=J>E*E&& [B&&;JE$D;M'6V**VV!H^E,HP/A0AG%=B2*+1'MF
MBN7#FG=;ULU%@<V',KM*=8K<-=H04R0?5A_%J?."O&%<1E)5G2)K1)MBBMQ@
M?/HW([?H2\UE+-6^&UF6B7ZUK:E<B@:I?W%RB[SYO(6>"<*O3I8EXETS!6\T
M0/U[E5N>N :6%&RS/N:C(ML =SY?R*O3@5B\?Z;L;297,I.\\;UU;,C.7@$M
ME>':<6MEN';BR_=;Y"WM+1D^E2]6WJG@$57;\2.JMI-'1%ZNWI+9%[Y<&?37
M9$9H7O DOEX9*.A#(UKD]>JMX_@7]=<8$[."ML89(])U+?*:])8%Z^Y58!P%
MTXZ-U.#TQ(N O"Z]]7Q$W??%XV#:<;D:3+O:(9!WI+<,R!*)*+(U@((F7$,C
MH6)(&HP#<F6T#'E\0@Y04,QVJH@<#2D>9.0<3XI 0I&R 104,1M 0<^#-'('
M9.Z<SU>+^7WRN,I&9$%9*)H%3>52,[F2D80%06Z.@@6=D@69=BPY,>V$E3&.
M!O: I!LE"CHE"C+M^ %5VXD#(B0(,FH@":I2=N2Y\6@25.7LJ.+#" F"I!U\
M>WBO !:$US0KKPB'S4HC(>0&$FX@TX+^FD,<L^*VYAA'++F5CS$A0)"8HPV)
M4[(@TXZ/B:NV$Z]FPH,@<T9$6L<\%<X.@VG'(2W3KC;ICC ;2(C1(6U,T@V/
MM%%1-SS2QF3=B$A+PFX<2+O1(BV045S30$$Q;0,%/=*2_!P' G0T2 LD%$@+
M%!1("Q3T2$O2>1S(M?ES/<WS'UGR83/7@?N;LE(TTYK*I69R)2<)!H(8' 73
M>N;N'8> NG8IV*-GCYF0(LBX4:*O9YY\8L<M/0*_'W,3F=6.9/ X$,(#Z1CT
MUTRSQ[[:""@\VR4"F"!F1X'*.P6$RGRS"BK+^_/L$1-P!&$\$*E!?\UYH5@;
M"I!:EGBV301'042.DJ]]%23[7(*QQ)O[(3?QN+LC"3X.1/B(!-ZN/IW.#91I
M5AFHO!O/'B@!41#SHTQUCL#0FEAG!42B7.<F%G(Z$B'D0(:0%MJ!C&+6  J*
M3Q-9X=EFT;1P]" ^)GA58I%(\$!!0?"RPK.-(A *DG\^+[[ET^1\-<^^KV6:
MEX6B:=Y4+C63*QE)R!9D!2EH7E:(=Y!_FU1EDF^$?TGBD0.11TKFMPT\VLO)
MGW^-0"\),G+*)*/Z.<ITV2?:'<W,W@@UDY C!U*.%'6";<317@[5$U9;+3E#
M0!DD <%ZPC;E".V.IKBPVJ-#STC2D0-11\KBPC;O:"\GSDU6FRQ90]@<I *)
M18AMVM%>3C:D$0 GD48.9!KIBA7;3".T3YK*Q6J/2L81& >)1]K*Q3;]".V5
MXL/.:H=*SA$Z!_E!FC+&-AX)[9&BIK':H9)K!,5!@-#;]7WRJ9C,UDNYHK'-
M2+*52\WD2C82;@>Q0HJ*QC8T:2]W\-UWCUO*8K7=DC<$W$$^DK*FL8U'VLLI
M_&F$TDGVD5.&']7/6K:,#G9',]<W@N\D9<F!F"5%82,KQ)LV5!4V5EL]=(9$
M-CD0>00+&[E_M"^:!"90V%CM4<DS0N\@TTE9V,@J\<XQKZ[M<!.4U79+_A"8
M!V%+8G4C]XUWA8D2]:PKC9 ZB8MR("]*5^+((O'VQ(06\"6.U1Z5C".@#K*I
MM"6.+!-OG0;6Q8\]JQTJ.4=@'01*:4H<62+>-<U:8K'$L=JADFN$S5'65#;+
MBM4X2]XN?H[D5W<"J7CW3-^W8"97LI*@/,BG4I0Y7>;Y,6XYDKRE>&L:H7@2
ML^5 SI:RRNDR2YM9>TQ?LF F5[*'$+LR0ZM^WHIX9H[_AEE6B+>L$90G25T.
M1'4IBIR= EKE)6\HVADKN9(S!-A!9A8L<HY._0(*\98UPO ]PO ]'/FJJ'%Z
M5?SF%DS)&XMWIQ&6)UEC#D1UB15.K_IP&^N)[9)K*[F2)P330=:8KKX!(HKU
M9K)"O&^-0#K)-',@U$Q;W@ 9S1QE>Q/=2J[D' %UD$2F*6]4>6KB0C19(=ZU
M1IB<9*TYE'(VS7]E#^_1.9_DT^E"+G!DL>@"QU0N-9,KF4DH'D2;*0J<7I7@
MN8?ZY W%.],(P). -@<2VI3U38])N.7<L67U1D+7'$E=<\K8M=IY"_17S/:R
M0K1E5G(ERPC$@X W17FS4T#EC;RA>&<:8742%N= V!HL;XZ.BP,*\98U O D
M2\Z!,#EE>=-GWEFVF9XJ)Y0MREO)E=PA* \RWL3R9M<7>F*+Z59R)4\(IH.0
M.EUY T04Y8VL$.];(Y!.XO <R,/3EC= 1C-'V8*ZE5S).0+J(,1.4]ZHHOC$
M\D96B'>M$2(G,7T.Y=NM\MMQ/D\NLF\%B 4&4M'%C:E<:B97LI(@/,C$4Q0W
M_2J^<]].R!N*=Z81?"?)?@Y$^RF+FP%<BWX!MA1M32.!?8XD]CEE9%_ME 7Z
M*R9ZVY0^,[F2983?09Z?HK+9*:#*QC:ESTRNY S!=!!\!RL;T%]S,MFRNY5<
MR3+"[B#83UG9#*H47YV:;!'>2JYD#4%XD($GEC4#^+J3"Z ?;T@C;$X"_!Q(
M\-/5-$!$4=/8IO:9R95\(V0.,OZT-0V0T<Q.MG1N)5=RCM Y2,S3U#1 0E'3
MV(8 FLF57",@#B+S_K&89^/D4[Z:_.U37A23N5S6V(8#VLJE9G*';I*P0 ?R
M]!1ES; *[MRW$K8Q@&9R)6<(NX-80&59,V16HG/NV&)Z(VE_CL3].67>7^W$
M!?HKIGO;B#\SN9)EA-]!%J"BLMDIH,K&-N'/3*[D#,%TD)<'*QO07W,RV>*[
ME5S),H+O( ]06=D,F?<;,M]/V*;]F<F5W"$L#]+SQ.)F6'WXD_7$EM.MY$J>
M$$X'\7^Z^@:(*.H;V\@_,[F2;X3203:@MKX!,IHYRI;4K>1*SA%2!TE[FOH&
M2"CJ&]OP0#.Y ]<\B1+T*$JPN,_FR8=\.I4?MP$ZL96-K5QJ)E?RT1$?=??>
MZRN;O0(*O@!;BK>F"7CW)#W0@_1 76FS5\'VF(*ZF5S)GC:Q1Y<!4S=IH?YX
MJ@<*\98U0?">A YZ$#J(:YN] JAMP(;BG6D"U#T)+_0@^ _5-JB_YF0RI7<S
MN9)E/6(9CC7$M<U>!26$@*W%V],$R'N2;>A!MJ%4W'AEHB'81KPI35"Z)_&(
M'L0CJJH;)(*K&Z 0[UL3C.Y))J,'28;*Z@;):&8I4TXWDSMTCL0U>I!QJ*AN
MD 2N;H!"M&M6<B77")7#!,;B1W(UF?^0:QM9);JV,95+S>1*+A* !W&/BMK&
M*>'=-L#13*YD#8%W$."HK&V4(8Y@:_'V- +J)!+2@TA(6-N _MLIR_6D>5X6
MB'>L$8 GF9,>Y#4J2IN= BIMY W%.],(IY/020]")V%I _HKSB5;=+>2*SE&
MT%T1;JFH;)P2XN6MQ=O3",23A$L/$B[%RD:9:PFV$6]*(X1.4C(]2,G4539
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M8VZ_,JA<@+U?2FEVADO0?K>2OU!+ P04    " #N-'I9Y3?(EM(%  #P(0
M&@   'AL+W=O<FMS:&5E=',O<VAE970Q,#DN>&ULQ9K?;^(X$,??[Z^PN--I
M5]IM$MO\VJ-(@1;!;ELJH-N'U3T8XC;1)C'KF+(]W1]_3D)CJL(DAQ;!0YN$
MS(QGL#_?V$YG+>3WQ.=<H9]1&"?G-5^IY2?+2A8^CUAR)I8\UM\\"!DQI4_E
MHY4L)6=>9A2%%K;MAA6Q(*YU.]FU6]GMB)4*@YC?2I2LHHC)YQX/Q?J\YM1>
M+DR"1U^E%ZQN9\D>^92KN^6MU&=6X<4+(AXG@8B1Y _G-=?YU*/MU""[XVO
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MO2 _46*9;>G/A5(BR@Y]SO3H2&_0WS\(H5Y.T@#%2Q[=_P!02P,$%     @
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M2+D'@#?/(&42^&8EHH8K;^()T,O6@Z;G+NQ[D ![\_;'O1&E/I1#_TYS;QX
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M(OM'7O^RN(4WO[\=VD*&I(CML%S^IEC>>V9Y'^YI+F(.=WF$40-^:L9[CH'
MEEY4AG@'0VX\(^,]85?@N^_ <[R@*2 S?+*1<,_3<-\0CE\]'U_S!:;G,UDS
M1%D[@A\\;W+:2*1>!]=\0T(<6;+>.;(=6N,_?G.[SI]-*ELBJVD.*LV!9O>?
MT2Q+,B5+6J0=3&3^Y6LM'T@>U<:?18P,1$QRJ(.^?92<,!.8\4:O@C:]:HFL
MYE6G\JICS(]9OD,N=&XTZ2S '0U6;_3=>!#X3N .[=VI@O-I'<?O]SVGFE<+
MKEL%UWU!<!C!CJ1;HE_;= 4DH]M<-$7;/0O#=8J_)_$:E_U%QWN5J)Y15!#
MDZ($4U4:R2[-M);(:KK[E>[^:U=EOTVO6B*K>36HO!JTFOA&MDN%%V3=DRH*
MG$&GUQLT%[/K'%L%YU<S'_Z#14P8OK^1+54$<_)39\))5KR#1WDNNU#X+'/
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MPS ,0'_%T)XP!] AB#-E\18$^0%6H@_8$@6*19V_K]JE<9 +&7D]/!+<'FE
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M%@FZ,F0&$A/)D%@DIXLN%^.(Z61(K)/CZL9%,'2K@WJO UOF8!\@)B:0(;%
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M;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ [C1Z698JO1_N    *P(  !$
M             ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @
M[C1Z69E<G",0!@  G"<  !,              ( !S $  'AL+W1H96UE+W1H
M96UE,2YX;6Q02P$"% ,4    " #N-'I9Q\7S\6X(  #N(   &
M    @($-"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @
M[C1Z64_Y?94*#0  ]&H  !@              ("!L1   'AL+W=O<FMS:&5E
M=',O<VAE970R+GAM;%!+ 0(4 Q0    ( .XT>EF<CO?-: ,  + ,   8
M          " @?$=  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"% ,4
M    " #N-'I9"E"3EO$,  !7>@  &               @(&/(0  >&PO=V]R
M:W-H965T<R]S:&5E=#0N>&UL4$L! A0#%     @ [C1Z60!BC&GL$P  !]P
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M965T.2YX;6Q02P$"% ,4    " #N-'I9$$C&=M$N   UI0  &0
M    @(%J<0  >&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    (
M .XT>EG**?/?/ L  .@:   9              " @7*@  !X;"]W;W)K<VAE
M971S+W-H965T,3$N>&UL4$L! A0#%     @ [C1Z6<.T/SH6"0  ^QX  !D
M             ("!Y:L  'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"
M% ,4    " #N-'I9#SB91"H$  #S"   &0              @($RM0  >&PO
M=V]R:W-H965T<R]S:&5E=#$S+GAM;%!+ 0(4 Q0    ( .XT>ED0(G_I9PL
M -D@   9              " @9.Y  !X;"]W;W)K<VAE971S+W-H965T,30N
M>&UL4$L! A0#%     @ [C1Z64YYX&54"   O1H  !D              ("!
M,<4  'AL+W=O<FMS:&5E=',O<VAE970Q-2YX;6Q02P$"% ,4    " #N-'I9
MFU$?DD\$  !'"0  &0              @(&\S0  >&PO=V]R:W-H965T<R]S
M:&5E=#$V+GAM;%!+ 0(4 Q0    ( .XT>EFCJ]0H+0,  *L&   9
M      " @4+2  !X;"]W;W)K<VAE971S+W-H965T,3<N>&UL4$L! A0#%
M  @ [C1Z67W?]PP'!0  40\  !D              ("!IM4  'AL+W=O<FMS
M:&5E=',O<VAE970Q."YX;6Q02P$"% ,4    " #N-'I9B]J!<P,*   -'@
M&0              @('DV@  >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+
M 0(4 Q0    ( .XT>EDLOA8QL @  "T7   9              " @1[E  !X
M;"]W;W)K<VAE971S+W-H965T,C N>&UL4$L! A0#%     @ [C1Z6;T\;P;A
M"   ;QD  !D              ("!!>X  'AL+W=O<FMS:&5E=',O<VAE970R
M,2YX;6Q02P$"% ,4    " #N-'I9T"/DX\@&  #?$@  &0
M@($=]P  >&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    ( .XT
M>ED:XS9N+08  ($/   9              " @1S^  !X;"]W;W)K<VAE971S
M+W-H965T,C,N>&UL4$L! A0#%     @ [C1Z6>\] _'/ P  6@H  !D
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M=#(X+GAM;%!+ 0(4 Q0    ( .XT>EGD32@HA@(  )<%   9
M  " @:X; 0!X;"]W;W)K<VAE971S+W-H965T,CDN>&UL4$L! A0#%     @
M[C1Z66700N $"   \!,  !D              ("!:QX! 'AL+W=O<FMS:&5E
M=',O<VAE970S,"YX;6Q02P$"% ,4    " #N-'I9C$/X;[@"  #;!0  &0
M            @(&F)@$ >&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4
M Q0    ( .XT>EGZM1P9_0X  /4I   9              " @94I 0!X;"]W
M;W)K<VAE971S+W-H965T,S(N>&UL4$L! A0#%     @ [C1Z656A$D:( P
MPP<  !D              ("!R3@! 'AL+W=O<FMS:&5E=',O<VAE970S,RYX
M;6Q02P$"% ,4    " #N-'I96*A_X&@"  !A!0  &0              @(&(
M/ $ >&PO=V]R:W-H965T<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    ( .XT>EGY
M9VOY+04  ,X+   9              " @2<_ 0!X;"]W;W)K<VAE971S+W-H
M965T,S4N>&UL4$L! A0#%     @ [C1Z6?7\H'Q,!   _0@  !D
M     ("!BT0! 'AL+W=O<FMS:&5E=',O<VAE970S-BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( .XT>EGXL*)"N 0  , *   9              "
M@6J0 0!X;"]W;W)K<VAE971S+W-H965T-#$N>&UL4$L! A0#%     @ [C1Z
M64Q<<>,[ P  % <  !D              ("!694! 'AL+W=O<FMS:&5E=',O
M<VAE970T,BYX;6Q02P$"% ,4    " #N-'I9W\UCM[T%  !F%   &0
M        @('+F $ >&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4 Q0
M   ( .XT>EFZ7>X:TP(  )H'   9              " @;^> 0!X;"]W;W)K
M<VAE971S+W-H965T-#0N>&UL4$L! A0#%     @ [C1Z6:MN>P// P  %PH
M !D              ("!R:$! 'AL+W=O<FMS:&5E=',O<VAE970T-2YX;6Q0
M2P$"% ,4    " #N-'I9W7TYQQ0%  "Y#@  &0              @('/I0$
M>&PO=V]R:W-H965T<R]S:&5E=#0V+GAM;%!+ 0(4 Q0    ( .XT>EG'WR^X
M[P(  %,&   9              " @1JK 0!X;"]W;W)K<VAE971S+W-H965T
M-#<N>&UL4$L! A0#%     @ [C1Z66==^5R+!   @PP  !D
M ("!0*X! 'AL+W=O<FMS:&5E=',O<VAE970T."YX;6Q02P$"% ,4    " #N
M-'I9>ZGBP&@&  #P$0  &0              @($"LP$ >&PO=V]R:W-H965T
M<R]S:&5E=#0Y+GAM;%!+ 0(4 Q0    ( .XT>EFGHC:(+ <  /D7   9
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M970U-"YX;6Q02P$"% ,4    " #N-'I9:I6T280$  "M'@  &0
M    @('1[ $ >&PO=V]R:W-H965T<R]S:&5E=#4U+GAM;%!+ 0(4 Q0    (
M .XT>EF0[[*PO 4  $\A   9              " @8SQ 0!X;"]W;W)K<VAE
M971S+W-H965T-38N>&UL4$L! A0#%     @ [C1Z6?-):P;+ @  = D  !D
M             ("!?_<! 'AL+W=O<FMS:&5E=',O<VAE970U-RYX;6Q02P$"
M% ,4    " #N-'I9[W=37=H"   W!P  &0              @(&!^@$ >&PO
M=V]R:W-H965T<R]S:&5E=#4X+GAM;%!+ 0(4 Q0    ( .XT>EG"J$"M! @
M ,!$   9              " @9+] 0!X;"]W;W)K<VAE971S+W-H965T-3DN
M>&UL4$L! A0#%     @ [C1Z66P&4+Z/%0  5(,! !D              ("!
MS04" 'AL+W=O<FMS:&5E=',O<VAE970V,"YX;6Q02P$"% ,4    " #N-'I9
MB9)T(CT&  "?,@  &0              @(&3&P( >&PO=V]R:W-H965T<R]S
M:&5E=#8Q+GAM;%!+ 0(4 Q0    ( .XT>EF$V-,"P0(  (T(   9
M      " @0<B @!X;"]W;W)K<VAE971S+W-H965T-C(N>&UL4$L! A0#%
M  @ [C1Z65R\G2]2&0  <@D" !D              ("!_R0" 'AL+W=O<FMS
M:&5E=',O<VAE970V,RYX;6Q02P$"% ,4    " #N-'I9(+Y,4-$"   :"0
M&0              @(&(/@( >&PO=V]R:W-H965T<R]S:&5E=#8T+GAM;%!+
M 0(4 Q0    ( .XT>ED6,67 ,P0  "H3   9              " @9!! @!X
M;"]W;W)K<VAE971S+W-H965T-C4N>&UL4$L! A0#%     @ [C1Z65X]CR31
M P  .A$  !D              ("!^D4" 'AL+W=O<FMS:&5E=',O<VAE970V
M-BYX;6Q02P$"% ,4    " #N-'I98^THA/ &   Y00  &0
M@($"2@( >&PO=V]R:W-H965T<R]S:&5E=#8W+GAM;%!+ 0(4 Q0    ( .XT
M>EG%:"]XT@8  .L[   9              " @2E1 @!X;"]W;W)K<VAE971S
M+W-H965T-C@N>&UL4$L! A0#%     @ [C1Z67#%.$V6 P  SQ(  !D
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M=#<S+GAM;%!+ 0(4 Q0    ( .XT>ED8L:,+C08  !DZ   9
M  " @>ML @!X;"]W;W)K<VAE971S+W-H965T-S0N>&UL4$L! A0#%     @
M[C1Z64U 6S>@!   9!\  !D              ("!KW," 'AL+W=O<FMS:&5E
M=',O<VAE970W-2YX;6Q02P$"% ,4    " #N-'I96B?\"KT#  "F$@  &0
M            @(&&> ( >&PO=V]R:W-H965T<R]S:&5E=#<V+GAM;%!+ 0(4
M Q0    ( .XT>EFW=-]320L  ":C   9              " @7I\ @!X;"]W
M;W)K<VAE971S+W-H965T-S<N>&UL4$L! A0#%     @ [C1Z65B?&H)C!P
MP5$  !D              ("!^H<" 'AL+W=O<FMS:&5E=',O<VAE970W."YX
M;6Q02P$"% ,4    " #N-'I91YFVWEL)  #P;@  &0              @(&4
MCP( >&PO=V]R:W-H965T<R]S:&5E=#<Y+GAM;%!+ 0(4 Q0    ( .XT>EEG
MPLXF%P4  !(B   9              " @2:9 @!X;"]W;W)K<VAE971S+W-H
M965T.# N>&UL4$L! A0#%     @ [C1Z66N25C<O!0  XB@  !D
M     ("!=)X" 'AL+W=O<FMS:&5E=',O<VAE970X,2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( .XT>EG,#I(WRPL  +:'   9              "
M@:*S @!X;"]W;W)K<VAE971S+W-H965T.#8N>&UL4$L! A0#%     @ [C1Z
M66'AO9!-"   8U@  !D              ("!I+\" 'AL+W=O<FMS:&5E=',O
M<VAE970X-RYX;6Q02P$"% ,4    " #N-'I9+YN^R\ "   6"   &0
M        @($HR ( >&PO=V]R:W-H965T<R]S:&5E=#@X+GAM;%!+ 0(4 Q0
M   ( .XT>EG5+["!J@(  '$&   9              " @1_+ @!X;"]W;W)K
M<VAE971S+W-H965T.#DN>&UL4$L! A0#%     @ [C1Z6:,>E427 @  >@8
M !D              ("! ,X" 'AL+W=O<FMS:&5E=',O<VAE970Y,"YX;6Q0
M2P$"% ,4    " #N-'I90RED<8@#  !*$   &0              @('.T (
M>&PO=V]R:W-H965T<R]S:&5E=#DQ+GAM;%!+ 0(4 Q0    ( .XT>ED#G7OO
MB00  !$@   9              " @8W4 @!X;"]W;W)K<VAE971S+W-H965T
M.3(N>&UL4$L! A0#%     @ [C1Z60_X@7-9!   "!   !D
M ("!3=D" 'AL+W=O<FMS:&5E=',O<VAE970Y,RYX;6Q02P$"% ,4    " #N
M-'I9LU,([.$$  !N'P  &0              @('=W0( >&PO=V]R:W-H965T
M<R]S:&5E=#DT+GAM;%!+ 0(4 Q0    ( .XT>EDRV#%!1 0  ",9   9
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M970Y.2YX;6Q02P$"% ,4    " #N-'I9B*J0\M,*  #-:@  &@
M    @(&A 0, >&PO=V]R:W-H965T<R]S:&5E=#$P,"YX;6Q02P$"% ,4
M" #N-'I9"N"4%S "  ")!0  &@              @(&L# , >&PO=V]R:W-H
M965T<R]S:&5E=#$P,2YX;6Q02P$"% ,4    " #N-'I9?-+RVT #  #D#@
M&@              @($4#P, >&PO=V]R:W-H965T<R]S:&5E=#$P,BYX;6Q0
M2P$"% ,4    " #N-'I9)0W3E]D"  "2"@  &@              @(&,$@,
M>&PO=V]R:W-H965T<R]S:&5E=#$P,RYX;6Q02P$"% ,4    " #N-'I9P;8$
MHB<&  !^-P  &@              @(&=%0, >&PO=V]R:W-H965T<R]S:&5E
M=#$P-"YX;6Q02P$"% ,4    " #N-'I9<;;>X4,(  "'7@  &@
M    @('\&P, >&PO=V]R:W-H965T<R]S:&5E=#$P-2YX;6Q02P$"% ,4
M" #N-'I9OY";0_<#  !/%P  &@              @(%W) , >&PO=V]R:W-H
M965T<R]S:&5E=#$P-BYX;6Q02P$"% ,4    " #N-'I9.R<1J,X6  !?_P
M&@              @(&F* , >&PO=V]R:W-H965T<R]S:&5E=#$P-RYX;6Q0
M2P$"% ,4    " #N-'I9J>14GD0"  ##!   &@              @(&L/P,
M>&PO=V]R:W-H965T<R]S:&5E=#$P."YX;6Q02P$"% ,4    " #N-'I9Y3?(
MEM(%  #P(0  &@              @($H0@, >&PO=V]R:W-H965T<R]S:&5E
M=#$P.2YX;6Q02P$"% ,4    " #N-'I9D46\,R,2   IJ   &@
M    @($R2 , >&PO=V]R:W-H965T<R]S:&5E=#$Q,"YX;6Q02P$"% ,4
M" #N-'I9+AP:*Z8#  ! $0  &@              @(&-6@, >&PO=V]R:W-H
M965T<R]S:&5E=#$Q,2YX;6Q02P$"% ,4    " #N-'I939T&*2,#  #L$0
M#0              @ %K7@, >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( .XT
M>EF7BKL<P    !,"   +              "  ;EA P!?<F5L<R\N<F5L<U!+
M 0(4 Q0    ( .XT>EECN>SM70@  +Y(   /              "  :)B P!X
M;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " #N-'I9?M8R)AX#   N00  &@
M            @ $L:P, >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"
M% ,4    " #N-'I94'Y NGP"  "Q/@  $P              @ &";@, 6T-O
F;G1E;G1?5'EP97-=+GAM;%!+!08     =P!W ,0@   O<0,    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>134
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>135
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>141
<FILENAME>0001493152-24-047703-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-24-047703-xbrl.zip
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MA\H7XB .HJ1D1+.JQIJ%BBWX4*;)\+&I.'R"43D\\!/84JG :]XO6(C;='&
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MY3$)/XSYI]SAJ^'ODMF14'R@V[%,_2'VT!E(_W6X&)>PJ?-B8Y^&?UZL,4:
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MVLZ('-(J-C6@63'J0XY9)=P?8D@EA1A01(<'?-^,+6HRD1,/>R@+K /'"N)
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MH9 8IB7"9+_IW.SIMJ5%><([0T\)K1HH(>//T$*HPBN$*&&-LO! ;CI?"2:
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M6)09"0VW"259!TZC+Q;PS;H3XN'&[]/1\M0/0[ZY(+>Q\@G?1AJ5:N5%+PA
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MZ,BC@OKE\YLCA49EFZOS7DCN9<M0*.8H);H9K"I\4\+."F'#OEVX5DI"@GS
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M <8?AQRCSIBFCL&XFG1+/0Z&20,&5F#"->%'OO\X.&VN/RZ/]#5P?N]\^+8
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M/B,?^VC8E)G;*G!;[EZ(B%'G[K/ID;K[T\+KGB3X"?+2!YGU1,S7:W2IW8K
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M0N;7U.;;+N**-NTXR$.Q4U;_INL]PPH:,=RX+'&O_G9D6I/E4CH";Z9X?3'
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M9&(DQBAX:=B&WPJ6YI .M05;C.F-=#<'QF ;>QA;,IR'.;EA?<PY[]:G$CB
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MWF-".)OFT:NYK6@PW=BFZR*#1.0E\N+*K].^1U%$$0LZ@T)1-#H5-:SX7@Y
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M.<5_@7\,(<K&^_4U"_VG8E5W\,I&;KMK5G?Y=[Z%K-(*P-F+->#L+@%G+]:
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MF:'(VW:JJO)X-!H(E[M1.=^&$6H@L'>=NRZJJ>*J]G??817K\?[.KHUSKD^
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M-S$=.45J 9Z%45&[X8"]-M+D@(*A%T3Q>X7LFLAB4#3.>\%5:HVC>(@:TPU
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M:8*R$P!44K <IP":.;OL5 S'6 2F>R_*?V-="":0ID4^Z<V_HW8FB:01 (>
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M%Y9@.UO6 KF!I 56TY%J5>SY^@$,YH_E&-"Z 5QWM';Q!JE::QT1FQ^^1LM
M]= U;FD![N28"DPT$6??@W$0D^2<YA?N_[E /%4I($\S@PDK<(/Y-C,5ULN;
M$;W=G>O^_;_90UD] ,B_,GJ0RB$;(-EQK_[C2547%ZA<TC.<G=:X"Z!4LE$,
MZ^1C]T_HR<4\PS $J^Y2;G QPP?ZOU4H,>)N)T(0;HI'T_-RG&;S;COZFGJ.
MA]_";_D.QHH5^7A7*=V'*)BNN$?).[9>< F!!9VB/2L\WGBL@Z5"'E</OV1_
M).A1[>''>2R1Z,EA-?KCR?N9-R^7TIIB3@BBDRD%(4%J*D.SJPY4T:)XI*&W
MZ;Z+DT=XL2+WQE@7HGQI"E^:S\3E]VM[>?D_AOTZ+^M;]0AL@54/'#24+R4Y
M*HRZ=A]!K#WLGH7=['ZZ#PJD]0C+%;]Q,)H\_T/)1:#O>+X:.U.]7;1V.N_^
M!C;@BGS:=^M\VEWFT[Y;Y]/^\C+^\8UVX\U/7V:#T@*XXT[LG)P=[![N#0?_
MVGK@/?GUX!3V[L[1WO'[TR_7ER]T;'Z%]?:%>K:]19459VQW%%Y9/@B5,<>(
MFB=C80RU2<%&05_=H($MG/,4[10?*)5:B2P'QNE^<)Y^4^68KV7@GWG(31I@
M3 :L7A%6JPDW$ZLH< 3"2V<6OE94"V214HQXFYC5B6J_L& 2:%.]FCM44ETF
M&]OMY:86_KW-@)-F.JT^B+=EP-(_)&[<A7P'!CV%7S 9(_[,&G8E#VKKYXB"
MTQF-DT?32AH;+2]&X..4Y,IVQ72)PO>JO5^@:\;CL/D-6#T/NTO;6X2^V!>*
MJSUF4PODIE!G79(GMW,X95_X5 RNET""EAF^A%X+'&Y/Y88:3F-GS^.^8^*V
M%!V&>=FJ6\VUG^Z+=4O[CJ/51&[M_XS/[?"(S9BO<H01<TT@"8"A($49"K\*
M-IJRF:GX\G1<=#P">^SU>6_0>_COF53>4B ;!V/#4I3UA<"Q/#TWD20B0',V
MXI-QMJ!04]-(13RF1S0 Y S4%H+E7D.^!\%A&3_XI!L.@F^8J/=F"N5%5[.D
MS?[,[;3XG\=S2K[DUP5%6?H*>'1 N=$FX,JKZ9L297S87=K>(C3%7MFZ!>KW
M@H]F+&$Q#XN6"4& :4*.HSEW?XS5\:U4JZEDIQ)8IY(FYKPTM2&$2D0XJKXZ
M-RER<%<U[!@N3N+7Z;^;.9#RYV/B*B "1T/]!A\)W@P1O0K4GSW18U>[7$24
M6CS^?-&--->DL"F?@Y8%5E&/J6J)"BO\N/:/XGH?W?,N;6^]9%5(%-5ANBLY
MIBD,2*5$$A$/I-@;9@2%@[6P%P98:2JW36P> 8DX&=:F(,'=1$Q"[T-^7N7W
MPKV V"\YBW^M$FYY5@-1"IB5KX7$EV+8U83R[,R1GZK,O4B$1YW!RB-_"P%1
MTR0;886/\@O[7PCM%.A\9,44>#V="4(9>^8BIM^/QY@;#L2:N.V-F^H,RU<@
M.M+P,R!EPF9QUA*2H2 *U.W7+YXFLZVKK60#IOCWJOXC38Y^Q^YNAD0CSJ@W
MW,.E6T2!O1\!$Y8-%21+EHU5\B6':CA8-E9:PPN]'V<+39)C #OH--"^9ZU4
M?*T>3 +X!L,))= ,;:@ -_&\'*]TI-S@0O<HN3_!!!:8..^W3K<2<I28LVE4
M791()PWYWQ)])2!<+7(DZ[CF>0"E*2@R0Q#?',EB2,!3DM$2T?YP65T%"[XP
M&Y3V).XKNB]E\)7K5G8^$30%F]Y7=C2HL'*[5<TS]?GT#Y'*5 405ZHY?E;]
M0[*L*;._MQOV9840XCG5NE')[5_307Q4=]6CO'XI+;<CE G-#\EO"/[W10D1
MW+\OX(6).4G4%? O3[O 9,I7!('GZBV4Q9%0$WEO1(X$>Q>^'X.02L_JT)$_
M@0/"Y/;)FA1LRQB.>%B\;;+]=.O9?R18VNA6+5W9M$$H34WES7"PX2_=_AO5
M!2GZ[3!;N#<=-J!86R]&;$X?6QR:# &P%HIT>T!65'*1!H<HZ'M1R24>I0'A
M-TL,PB:DT3?S!.6?*/80Z\4R:[49RK"^HY;*#X#_ VD'XHZPOH$5M<:P-*#<
MH7#]H[)=#P^#V!A5%P3E+9L"@J(*$ZV*[KR#'YJ/;_%,*>_#&A*#<< E*_4K
M$Z[4GV1 (A4[(4%2-?5RXD33A(]3%<EPV4?FH3!Z9\+5A@AQ:@-/-%<)(]]!
MV#I?J*L-[?F4E..O;"V9;B!B$<),D#;?ZCB%85 +B/'EN'ZY%R*;4);PDYNG
MHA;\.U?3FQ6)W]X:#G;L8O,* ;UX$%,9ZDXEH\A2D$.+=>U1<8Y(%M(XF8!*
MQ'2[OH?N>9>VM[[#>^@7TBLSH)!+_HTPRR,:F<PL9SH61&]00DW"N&+E)=4%
MRG!Q+RG,"-0FV,T#6!0&(G$+>AX4CW$3V =MLO6ZNN==VF8IY=/Y"$+&%>L$
M[#1@9S2].;S^@P=+^4ID9&4FC+S,)T4;Q]GXX"G0AS&O' Y\."*CMX=A<["D
MT&/$/\8+EGT"HM7&4[PW46BE5WJE5A +&1VBEH7D?,%4A9NQ$!.TC]LF3LI4
M]9ZX7;T",IV24[!EF+'"G.0T)@CNXI1!$T7)8V.&LGW\X3R7*A<C)TBW\KDS
MW<;=$"0Z]?)U\$CMF\0*B]1TEV:#T(442F#X'%.-F(@^\XL\JNWU*4"I?ZR!
M4G<)E/K'&BBUOOCZ+CY2$'>76SU^0OHY;_#*&E%(R5M8<;&1#Z[!4>Z^31["
MN7Y[F7XD05140C*NL;6%2"^VGJF-?JNG1#4$_CG/.Q=X7\4]W]9:"B#7M82Y
M]=8VY5WA!9YT[F\I[X=;.WI/(OX7WIH!=I<,1Q"X%7\>\LVI<?+HIE2BFZPQ
MW) !.L'(07$/ A_J^[5U>L^[M,U*,#]3O-U9+(?9!TZ!N2WHCO)&*S1'_ F)
MI C>(4VN7:/'!<@.V@ 1&:SNDG&;*Q!7Z#=A#%O2!;9&L&MCRS*!]>R\:)<4
M=:@,(W&]<X"MY3R$)#JXVIQ.%E.>/!Q (ZCFQVM'=@8@[%C3[;G(5 IZ_6/*
M7<%8#W0,>@R^#>%SZ^C%AK R*$Y"U+V>*IDI"C5EH[Z6M/%4GY!1@,>5^(>K
M'+)8ML14JTH;P_G") 44:YW.&_=23]=.RN0P0I,<J%BF)$G?)(T[VI@O!.,F
M7-FE\S4<F GCTL["F<W7U0@5"YKY^57A<5'Z:K>5ZJ(9%R.[ C^U%6XXWE1$
MX.]^^VM67D)JI]33-QNCZ)ZN=HQ[%<ULSFA"1E/6$4('_D3$ZXS*B,GJ@Q5#
MG<=4#] 4S)O&R]X9QIX^P$5/ />F/;E)V(^>T<;88)/R6J7MPP704"!:*U&,
MWT-TPZ 6,,>"-4DYPPL'<X"&]Q*:%4^>!OAPOHP4]G!@1=0;"!#6U8P'F]7.
M-6(#1<(E@RTCE=C@7%C:<6VQ3TM.!!5&<6IV=QOB)\0_,)$G2V$M40@&_S=C
M.0OWD-E"H3"08B;R9V%4 E(=8M3$Y#$XY9HV%:S7<+"!"R%'QD[6.>>_;2H0
MAH_!EA<QY4&52 ''29*AP+?=]CO:,=,#:\/B !FI+PF.7512WN3EJ;K#*6P5
MQ(Y*02\H-8S(*F+91XVG$:Z/AWLX^,#VD+(]XG3HRPJK(,.Q9F]WN<D!F4:1
M[[9@2SGT8*59S6&OVAI889X/8!E*ZQ)02Q%-98RMCB@%0N4KU.CDRM%K7E("
MQXR7G;E\5;%3<8N868V?,=&+1<NY1->U83"YUW45W$S31I+"BA?UDD>1I*H!
MAR8L3]08OIMX]SXJZ^Q1&IPL\G6*,B'9U'N!*[RP)5N=Y$9RF_]4O\[B7=N0
M8& "E--XV!D2$_?F.5F)'@N\!O#=]RYMB^K(GD#';ZJ,8<XN8A?X4*G,#:+>
MG4F?(<R=(\N4R/\@6EFEQ\X:8Y<X!3%OGWN)=B0<S'KR/>?Y" B\/8H/'V]?
M;_"F!$909C^^IM&]$.29$ ::$I$4>9'(VF!D+%RURKTCL8<R)SWHA /^2I.H
M;4&-<S0<O<H26BT*< I0<*Z='O-FX71HK$(OGJ"E$@#1)5*]-1M/.$2=$'X'
MP&,9XHJ8,\N_EB]=X"Z$,!%ZH#@PDC/QUZ1-D"R0= !6B?L(<AP X3X(?3(!
M7/2:HM$%L^D]3!PEN=3'*E?0*+S2#X)[14_W] 7@75VX)9#7:#@HCT.[SNX]
MB"YM"[OJ*3+5D2 <'3]L(T(Q6!K")IB)!U$31-?5#VTJ(#HXY6(0]'>(?NIJ
MEB-L,/"-('&,,&+<"LYRG&(,(TVNJP*=A7G)ABC<=2G'/8%UCK$+K?)A&"O5
M\NP1^;LVV")4[8T,E%M71-]..K#=C:)G80%5?L(EFC$X(V5P!_DXW*%,E3)[
M@J?TL+DRJ5@A4&A.GQ+HI"@YG(2Q#,1W&25:$N< ;W9T6>1L7^"^[\B6Z5]8
M*2YC[\?Z[&YN%KXX\#;KP2T@7@%$8M46LSFY_W3\ ^FL@E@E(E7&YYV*@;A?
M.-^UFD\!60W7B]Z#?B&@O_)1*T"RO2%-L)CES "%D^MUG:7I:.G?9JU^ X?@
MBH3E]^N$Y5TF++]?)RS7=WGO74X5=2=Y,V*$(@KSND-N7&<?G%EV D$C@24O
MX4^-ZG)#/M4-4T/OZ;W(HB89G3!"M&E#M#>D U SIL02_*#8WW!F913R2DF.
ME0MLKS+B7J]F7O.&2D:\B(46&D20QF1<2="W('U9*M'EL!!=5C9:!?WFN+J0
M:[5L.0BNAN)>,4&NNT.0VG144&L_\(Q@? S>YHZT'&/ASAR ?B#[*);UP&S
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M"S8BI%Q@>4V!M@OL@]D,##Y<+]Z"=I:HX8#F&Z(26J)9X7.(ON3$B(+YR&H
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M"">(1?0JA_2"Y.!T0F("CG9IBE[?55P!-H!H3I4V-M.BR8W6DX9!8C$8B>'
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M>]?8>[K*][,_7V^\VGZY2:W9?O7=D^=/OZ!5M#:Y'T6S_!KAX. :T/8YHHC
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MY1"8=]<0CK\,X7C^J1".!T63&N^2O[\Y?OL[0.#__LO9KX<__7]02P,$%
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M%UFGWDOM9"2=P9_#8M'\EC1$RB O&<TJWN%<^ ?6KS5C4E77VV-FWO@-3R.
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MU%1QDJ376G,X&F- A"K"@&-R!_UUU&G*HG%T'79S92&M+G]#HB6Z'?PUHW?
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M12%P'Q?6+U,W#$L8=E>Z>#@4-WQ(B[85D?_RQ]<GSH\;4!G[U*G,_-G35A)
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MAQW]@-VT.?0/]YZZ9@.UG2NY1),9,6\%2R39A%NLGD+ED<AJZ3JZ4VTQ:[%
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M9XFY.B)8MPG8'^1&]:VKH<F^*9IJYK& 47Z!=GY;W'FQ)3:0?W'.3^>YUW#
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MCGS#(AI-T5M-LIG/ZL9[URQ2EV3S6!B]#4I]''!:-WQ(&E9Y@L60W[R[VEG
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M5;@( ,TZ;%CK7M X=EI-14JAWK6M^3O*!,\="43W[8&MZ48K/IDRD3D6'%$
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M&WS)Q^-+]E<+7[)*@9RU"6M@'=>IQ\I=A[BU+\M%Y8<6,,^UJ%SLP3BVU((
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MVU!U?9+]\/"'7W_\$SS"A_]^^\O)=_\/4$L#!!0    ( .HT>EF4L&GMN0,
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ME]IXZ"X\D7NX".A-2NQ%.9#2<UJ6>OWWAL#CX]1SM[;R&N=N>W\"4$L#!!0
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M'R0.;#G.<_F2%0@KI&E4.M)6E>)6 O[4D7^=-%4N5K5I<B$_ %!+ P04
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M+ZME='3OH89^1GO?9WD:O2GO@R7V^-ZCOSY^^)>_3@:K\%9*#;-YC$?"%3D
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MZ6 "L!&$S\0"$-_$L?RXAE&7 /1I:!?@=0@%MVD'3:P065Z%/\RIL1WE]&1
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M.W*&;\=8_77 6%TGQNJO \9JP%C=<0M[*A;V>EJ3?#?242-Z"]H8^6;JWEX
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M7VORL\?*P)>2;6P)4% W5VI&<%:B99I+?9L;JHD3P B00A]_Q#:&N@.V#U:
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M;SM_T285N+.YGO("V%N<;_+!1=2DRS6"I1SJ8:&Y*?">EQNZ/>RXV_>YL>J
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M[&ZO^5WT_%#1A!R^<.,*I\:D4(0WW^UVO/C[O(1QN&7V>Z&Y22%-4U/@G[8
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M4/-53:</V@<=\G(9K7GKW1V(VM$G\T7P%=;PL,S^86TP'.I)O(^D>3!Y_VH
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M,PDD3KF@R=A\T\,TQ#I>+L[V7# P1>ZDG8-JQ2F261?C:=HU?[%MO<+)V-:
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M\7T=UW>F$6+!YI@#Q*>AODL+$';)<DDFW]2U2FX%#[?L+,O3D]2*HCE*^%3
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MX H<P*H:#EY%J^91R\&BE?B:]3DXB2=1O2QCA'"<+'/Z$ZPK_CU=J4(JF,=
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M=,J94Z4>OLB1BF[2.+AE<K >0?FH!TO>)%CR40^6[,&2OQ<MS27ZK3P"Q!8
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M&.5MA5)LYKVUN$O=.@!-,ZJ0*3 S#^#W#R@:GFCR3@L,_>[TD&E*_:8(PM'
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ME\S,)96^I,)+#"DD'O'-Z[2M(U8I'6^V(R%'DQ6QQU2BQ*G4\R2F0,&;1L"
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M<G?<QYHZJN'J;"$K;;NKP_<E4['#$L41=UG'H8'/>"YZP\[?SL"O4L(+D<5
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MA4/?^)9ZBC Q">O()D_;1"D4@_5)]GR'-MB,1EFKJK493VFBR-#H)Q@ %0[
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M]IE&[-<+^^+O!5VLYVQ]ES!E$E(K2#BJ,N&;1#O>CE?J46*O8\.RMAVW&C[
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M/- &N=7/2GDHG#Z59I&L9..$<11"VT2*39J:\DTK_AT'/X0?)YJIFS!S"X>
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MU^G'O+C,DO@LJ8RCXO?GF0I2K",T:5=&I#-RYTQ5@:%$5P6-"FJ(J6]L6]#
MT87D&@X'Q%936L-7: =JW #N="&5B,P,2-'")$;GTR\$[P7T-@KHN0*SYA1]
M8[C"T:=%@BQX+*IOL4QN659"M15ETL!%\,X16<<6B[P63).6-F7^(KQ,#35S
M:GF' ZR$%<[^*)#Q*$P$/TC!7"^Y67?RVS(6%C%YE,:EJQXJU*:XXMP#QAYP
M-O(VTJMHJMCD=7BIF^E*\8TENGW[J6$@$Q;/5J2K)OQO;T4=>BV'D0HARS@<
M@2N#F@(>A?SQ,.&5+F%<&2J&-<]FIXS=NDJ%LQ0W81!'\^C,4!]:\=9&2[-H
MY74,D3@7QH$HFJ>/4)=D +,QJFE+)2C]1(3-CMEB&!+5$TT=18%#*U*"34.X
MEK.2Y0:=0ST4<]U>\5P50BT6A+.AHUJ "7PE(H=\U@3JE)-E5@!/?5.\M*H+
M%2D#N[!&(-G0T$O-C*C=@FBVQ3WQ'.^!/G2:?*G6I[J[1*A(\ S>/I8NX@;+
MS8'W.58\JVX6S'Y7E%8CGD87P$;0@T*;YH8."]1N>['!$.U/X-LH<;\)+%6G
MIW !WZ0.^\[;PE+K*KHEK@"599H$3P3ZEOJ67.C$OZOCNLXT0CGHO+2'$E64
M>4D.PBZ9,=4*9N;D8_!P2R_2+,&C1'ZGCA(^%7 SP.65[K"0J8_51 *O.P@M
M%HHN$V]S6_64FTI>0MW%G@XK\]*4.XJ5=:-LF#0\_&@*^R_%9@W>(_L-=1LW
MU$?E<_$IZ_M;M'$4]2/K9V(0=?HZ*0O6,%4I,"6( W@SMJV!E>#4  G-8[:A
ME/?DM]]B*J&IGY@U9L)&>%.$RES<1)#^A!+#RG+CL+U">,9(PXLT[&@A@HG%
MNU;U,$&8MV,&L7W%-5@8/X0] C\UN'3_A/'R6]QJ3X^O8/M=] 9SBO(N8YQ4
M,D.C3]F@HJ@(W=(V1XS=8<.)FKT@G(B_UOK2?CO>QNV8"3(:<<%5591L]>\3
MVU'5()>[$I&<=>Y0OW0K#:F*+K1@BDF5YN*EXKV3)$]FJ6",2)0FN@FCN'65
M.VQCV#%=4Z/]IAK6IOLTKQPK)=[DZ[98F5#<,H^U4:E.1^<K5OKL]*DHVG:M
MT]>.@J0T\PTJ.7.@NG9!O^-NXXZ;"^Y;P4Y( G^A< KOMR/-K&,'4QQ09[A)
MYTL.E; M A7V\14(V^"LJNAWL1CAJ41CB(%)]*-@9]B( KE!7>TU!I2K^,Q*
MZY"CY6[4A(CE=#L#"F!X'5L,+;4\G&6]8F?/1>WXA- 6AK3)PN#K$)O !C&B
M5KM)&\?Y^VD#=@_V5RXG6G+AD:3^@B*+$:X%&%<IT4R2'=49DK.;!DA.RN*9
MY-X;0H UL1LNHJ11?FLX8(/115IS "V=K8\'FI>;#8F;BIL6X].#]H<SA:=^
MK E6P';30W31G4K<U9L$62GOH2R=PFG*SR(-9N-6!K$5"[;54FE=0XC.;IW5
MGU:W<3<5O)M>)X3WM]RU<_D)@N::[5S1(%(6$+7RSE,5!BG!N2CY'[G$S36(
M,S1-')G8*C0= N"LTHF)&Y6;NR8KW5B>75_P&9!QG=_R7RW_N]D%N?YON$_K
M\>+XY>B$N*^7""$D[,R/U/ZC&K]X>/SRNM?F6^/=GO9XMQO%NSWM\6X]WNT&
M;9QO8M4<OQT.?CD^?7MT<A+\\OKHP]&['\.&ATIM*SWB<['T+5)_J_"4@<;+
M'"[RBOK\IFBSM*S 1L(2#8QYQ53<=/W,WM_(D#&;UMZD_B:^\J<Y>[ASKW]'
M.\K:T=N_H&7O?Z?V)VQ>:Q_K'P:'[_ CW_[UNT=7_J+K6PA99ZY6*DK0GLO%
M(BFQ$@I><O!R/SLKRO-5?3[G@6,TA8$6Q_ET!YD>]1*:CT-5=4-3J9XG*_K4
MTY*-ZZXL(T__>(-2?BTC?/*5AGB#JW@M2W:M93.K9VL7:;V1QP_\VF/F.;R)
M__[.A8$,V6O9L_T^O>9).,6,^UU<&S'<[ZQEML&5_KYWI6_4E?Z^=Z5[5_I&
MTP4W'EP\>'GTC]?'!\>GP\&^XS?<D0^XL]..H.=WI\>'1\/!NQ^#HW\<?3@\
M/CG";,S-+\/MSX!\K6&?OGL&@O_F;^\^O/[U]/5/P>MW;U"3GH C_?;POH1O
M[F \;[0W'@XP*<E<,=QP3)!E"=:+,.F=PBG_K_RO05WOD? [C= =5I[$M !5
MSQAA-G,X2&<6\Z:T%11*7(*'E97N&:AIP^21&M?*.&K=9-%KUR9@%TGYNPU!
M0X$5]++X[63QT1C3;BL+FT0$.4+S,\?5'H'D($VC6<9)\6G\K%\T&_3P-4A8
M__1_?_CSDR?/,0B/X!G8;P3;UKQ,/^<$NSG!ZMGJ>5"4/5?.K5BMF5W#=9ZT
M4XMW,N!$2#9J^&7"KN(MW*[++'*)R[ KM&KDA>U*PNXR5'J08DJ40V0>?:*&
M3)V#DU/*:Y@H?=S\.G NFXPIU=\Q2NJITI\'W^X\>(SG0<;D:41?1KU9FPRA
M5"YHM3"T;1DN926IYKI&NI#EV'3 GB19<=F?(E]?L_[O^O_U*_*5W#.$DGL;
MRV*+\6I[9X2*HB[CO^P?!OMP "!/XEM2S/TNNO>[Z.Z;7OWB](O3GS^W9]C_
M/#G^V]O]TY\_<)06HX-''_YUYS[C9F;_NI/[5*)YG%\DW('J" NY5]=^;/^^
MYG6#'MGZ?[?Y&U\<O[3P\2!#=@,>^D7!9 &^;"%ZOI>OKRM?M_ECM!)J$Z!>
M4+ZU(KK-GT<(J%YV;JWLW&KAN?TK@ 2+MUJ(KT-$[JJD;  !_KD' =XH"/#/
M/0CP=H  V]YSU3V[MM+W]NO\KPD7/.CA@E\7+KA_@M&HGX[>PN3_^.[#3SU6
M\.L.&POQ3YE6#U[A=ODRG,]22LJX >%7BH-J26Q&FELIS8EK#]/Y.\&K@KGA
M*_LN&][&;5YW;J3<OU_M]F'##AL._K[_YN>CX,/1X='QWX]>A>UKSNTF,LU<
M::CP:D726"::K[$2 $!=W+DI^5;%P3=6 7SUY[7"3>RJU]M8[_95AWU%)TO9
M?+=DA6$F[N(VI*^]U8[J%U<%WOIE&3$DC+_Q?9GF]?@NKM%MVHTWOF;[<0R&
M576#:K97K7=I#]])U7I-8[SQR7U_7N2B'ML@>?U$7]? C^91FO%@&PKN;LQT
M;RW<_C6Z*[OA,[(^_>3WDW^7[.2[H/ PA1P_XT_TEA_^'09W5Q+N];+=28NX
MWZ"?,8MN/T_^5(VK?.;OV7ZSWL(E[#?K[WFS*E^O;:OV>_6VK>!]V*OWG#[O
M+\^#=PMJ;_8L>!-5=0^?NP'XW%\^%SYWAUGA'AZ\>_4K;IN'KT]_>O/R_P-0
M2P,$%     @ ZC1Z68;8JK/Y20  JQ8"  D   !E>#0M-"YH=&WMO7MOVU:V
M-_R_ 'T'/GWF#*0'C&LG::=-,@$<VYGX/6F2$[O3*0X.#BB)LME0I,J+'<VG
M?]=M7TG*<F/'ELL",TDDBONV]KJOWWKQYO2GMR^'@Q=OCO8/X<\ _WMQ>GSZ
M]NCEBV_Y3_CV6_GZQ:OWA[\&)Z>_OCWZ^S?S/*N>!7N[RRHX319Q&;R++X./
M^2+*0OX@#$[B(IE_ S^$GWZX[N^>!XNH.$NR9P$^JO_WS<N_9I-R^?S%MQ^\
M%U?QY^I1E"9G\),B.3NOG@=?/-:+5R^//I\GDZ0*GNX\??'MJY?-<;]PD.>!
M/?%IG%5Q 0._?O_NU![AT3Q:).GJV55CT+-E\N^8IT1+4#N&L\?W;N4B/GP\
M>O3ZYW>'1X?#P<'[GWYZ_P[>_/[@/X,//W\\>+-_<A3\LO_QX_Z[TQM=YZ,J
M7]):]0>3O*KRA7QVNZM6Y[:U9[;_]A_O/[[Y]?3-3\/!F_=O#X_?_>,D#([?
M'>QL,S&V'\OI_JNW1\'!T=NW)Q_V#V"E?_]F]QOZ]X?]PT/U[VNO\#*95>?X
MZ.Y_?$,<^L7IQS_"@IFS'UY_ O9>_E:753)?Z5E]AY.ZN8W])2J***MXLB?G
M41&7SX+_#OY';_7IX4VM1 3$[:SC.$NJ)$IYJL=E64?9- X.HRJFY83!X]W'
M3^U%P?]]Y,/]ELCH9<^RK)O=08/T89+-8GIEDMWD,D[?')\,!T;D!&LE3C"J
MSN/@K^GL]SI_#FQ/Z!AYW%\+^G ,6UW M!.8174>52$,600745K'01%/X^0B
MGH7!_SK_!?!$4I7#0526L/+2'^5-GL[BPADD*0/8C:1*\6WU,L\"_ D<\:(,
MHFP6E/7DMWA:!55.7Z3)(JFB*LGAY?!L_#DNIDD9TZ/X_33/9@E_?1X7<9)%
M<WC7<%#&%<Z_.@^B"AY>!17L)KX!9DR/T*]G0._TNWP>C,IZ>DZ?A(&["KDK
MP9$:'*^)LZ@:5I2:-U;GL$K-*7#%\LM9D&3!O$Y3?Z-.8?TP=UQ(\^V3N@JR
MO,+W%S%-/L3M@9TJIT4RB>F@<$.6=3$]CV""\R)?!/OI65Z<KZKS18#GD&1G
M93@<'&?3G3"(@L,XC2Z!?<$.%LN\X*&]61WDBR7LG3T9/#,<7,Z_) [805S"
M'YVUP$9/\\4BS^"(JGSZ*0R6D:*RO^SN[.X%2S@;>FV(#^.+91K!R)D9O",X
MP5>XT[/H)YKA15P N=$9UW /BYW@%-ZH-VI9)--X.("!\BSF87%4^_4!_<XY
M4WP0SA!V/OZ]!L(06M7T\0'?"IM<!K-XGF1\["]^?GD"$\-M?CR:C%]\^_/+
MG:^C7K2SH]V=Q]_=+$?ZFKI@^YIV;GA%YLR&@STZ,3S&0SQ49CK\V7$&M,9L
M2-$",S1U_'%:QI=(@T@(-B4QJYGG:9I?P@65GYU'%S%]L8BC#.\M_&R63($O
MS("=R!LL>I*I'41+X)4IS'\F+ZJ1Y2!G0/:1(_^X1/I4TV*.*=3<'-3P4!H3
M&"E*B C^ 0/7!:PW!M;_0=VE_;,BCNFV>>R@^81[99%GSHS6 1<'+M^9<_45
MNU<7MX#9 1U$55ZLF"]6^=>]3=MS<?!2;,80;IH?: K8G\^3-''EVG" A%:2
M</X !YIGHG;,$E WJG1%RD6F_U6=%WE]=DZ,&KY9Y'2;D,[C61(5"<X$M(&J
MR%/X&_ZV5/\&72.8K.0S9N<LA-0#P\%E@JJ"3(18-ZD#HI? 4+5(;Z1$^%59
M%35\P"_[6*=Q\'3W.RTJ8NN&!/O3ZK9(<].CO?&3O4V"O;-%&7)-X=R!N8!F
M< !'G<"ADGYD46\'TW1YIL6BGXQFMRKR>TJX'4JH*M"P:]8 /D0%7N@OH(+'
MH[BG@FT48*_B#'2F*7E,WE]F("7.DV7P5ANGVT@36T, =\\&7B6@>)-59Q\T
MZ2^A6-\KRW5 5B5HV159]:Q\D)Z?%&6EK%JC]$_3"+0+]KH$T7*9)NA4'"7C
M(-$&L#9'R9\ 'V9!FI2H-\/H,!OZ&V@GP6D1H:D?_!05GV*Q+R;)3.:4-U](
M\R>3!3TD0)N_UW')W@#Y(HO1C*_@%?$TII?C4L=@-K/SQAT2IW%YGJ#RY(_4
M.7-0MXIX"9>#]^I5FN>+25R<!:-)5/HK.XQ6[.#X\=F3W2#:6>P,!R,\U5_S
MXE,8J+_1>L9HCSU]MOLX6,)S0>=C8(6,$M[P]Z<'__4*YX9_^1?.&8VG]HV]
MR-,:-NTR1E<M&F=PZ8OH++YBM[6GZ:HMQH5[\X&M(A*91I,TIEG[=#(<Z-T6
MKU'+CM.ARXI:!@$E%]Y)JR@U@3CK0)V87JT/3JCA0Y)]"MXO8YB'$ 0N,@)[
M#6YA5, @9\ 0_\T.)_SF+,ZF*]R3:<Q+AR-+*ABVSJ;B^)O+*/@M3VK,![#(
M8=-PS\#J-%2N74CPR^&@,?4RUY,F0V&47(Q)M0>V349R, 6J*\4VCY("N1(N
MA-U4,)NHPU5$'A_[UD<9FC Q[ :R**"/Y;*(P 2'^<4I" "V*<[R?(8#@6P0
M3L&.TY+'6D2_Y6!+K/!1LGABPT7$CR 7*Z^KLH+#PWW",RSB",P9H!28"6SO
MLD*B@1W);>-:UAG'[("-/\-LD1W!"'R/M;=K&26:E\F/>TUF&Q9E!)GBK"V&
MN.&Z;W<^[-#-0+%&%[,LF0?<II^E5U1NX'SSJ)B1/_N0_"9Y438T%E8)\$&\
MXC/UG.=M[R_V-BS*''Q=@LPIR^$ U*/FD;-^NA+Q!HHF2*RHJ@OX#-Y>9_0G
M7''^GIY46AQZRC"N$8$(B+)/Z(NF&,H!2B2@&:U(H4",ZNH<9-6_41>"UQ7Q
M[S70%PF--+I$R5[$"_0@3],<%+N>R&XZ O+]WW:^H\C%K=#8ZM%QYDB.:]NZ
MLS%J6[T/9%L6Y45<Q;:XKKN#[ )01A>@?O;JP_4=73<:T_0F_W\>/0I>)W$Z
M>Q9\ %OL.?SP]QI,,OS!<S#DR 1[A@/(+7X>_!/M(/@Z>/1()3L='O]3S>ZJ
M%)_O\;-)7H"!HS][E49@/NW!)I1YFLQ@EB97S<Y-\W/79$AYVS1/TVA9PM34
MWYSDM+;-,)EJ%YC],HU2M?4P?_<LTGA.O]!I7<TT)2\7SMY;M:O/@]/5$L;?
M+Z)),GT>O(L6,>_\NQSW<\_^T;?J5_B-2<-2*5@OOH5M;SF!"5RU3X\F,=P_
M>/>23M4^E>_;$Z]@PA_<0Y2/33JS,Z(]45P D\.VW8<_$]\.CD ?NXA2&+/%
M+B!KS\0MO>P;<0*=U),RD8"K:(B7>9W.5%87/71.[@LV&/$U>1!-21,<#NQT
M+-MW$H*<F*8UNB[" *.Q>5U9V5\AJ[#QI K123:/"U0K)86(,B5!?UWRDY<J
MMT(KM G%:RDW 9VLY$.U)S+-,[K^()[0PY+C+R5G"STF_,\I:,UG,?T;+I9Y
M.Z54R.K+CN5+ EWH++G7@+8L"M3,A]M, _X:ZL]=60</FWL>)J4. '^)X?-D
M-+W[C+\M._W[<.,/?]D_^'*#]PZ.?FM.^>[O^)%(]N%@?UJU>TNM;"[U-*9U
MH8JT]^.3IY0O!GH\3'46ZES%HDXEI%+$9W4:<2QK6>2+.CVCE,?*I"4_M-U]
MZ"3#F=XM20'79A"WFPK>$\"M$,!K=)FC/8$)0:=@;931M,\0_'/J"(TBI]XH
M>.A'KJLGNTK"[HU7O*> VZ& =WFE*L<4#7R1%A#U.:#W_LRY.*2UA(4*52Z2
M&58#YH5=4TD%CI5D#(=!5<"LR=<ICW!67ITYGT1EF4\3^?UO>9)5P06LKL:B
M2/*)PC-I$DV2-*E6P\%4)7+QH^05#?2'9_E%7&1<F$4Y/2KECC(1)SCO,N'D
M/717CBV_*7DU*<J/KM)/L,B>0N\UA:;1E KLP);E,VXKN;,,VZ7Z@:*)2#VO
MRO(B"@18Q7D3KL:;Q-5E'&>-*KV?L^0"\Q.-R1P.!V_?'O2$<^\4\T:!)E)-
M"[E<4YCM]5;,MBRJA0(^8BSM2VJ<GO0>C2U:E*: C_$9QCHB+G4[J8#Y=XL-
M8?A_+4K\ HLWS(]!_9#?8@[AZ[Q8!">/]FP7:3!ZG:1Q\"[?"9X\>?+XAR=[
M?_MAW+O'[REAG!P=M*B\2 4@ZE%#(%HI;1\YZ@':3XX1[Z1$#;-7 >[Q*5N(
M#IN$04STXTD?\/@SF!8G6%=$Q04G<56ES.#!(D[RV1<Y/FX]/MISAQLX?)7T
MM>H \"CU W[:&&%Z(5&$ 2/@V-6+45KFDO<5<X(75:/8R!]K7@T$M9!" TDO
MF[5C>_7,9AL695&;5)P-!T?D@.JC:G\^>6,AXF%-TS9%5[;FG._^JDM1?5?5
MFEN)UH(UD)1!OHPSNYR]UR.VX+CY^-I3T!OX&%Q]7]I9V.5ZE(FKX Z4?D!H
M>@KOXAF5-;Z+REGTN\+2TV@/UE?_2//)VF].J+3? 8K019*2AB_+""6K?CAX
M]^O)4;"_@!V<XHZ._.+KDI+H[=T!&RN'Y=R:XV3[Z?W>U5,][DNG;K-TZG%?
M.O5U2?_A2ZNLG".:- 936Z35 ?PVR2@+4!B[^DGPUV@!=^ 4H_TNSLJT+@JJ
M0U)/8N"U\DQ;KH BZ)<D)3"7V:R@ZG[TN;''%?Z_B%&^/-F%1U^G.=8D*3D#
M?_L5;]+NTT=[WWV_1U9X%"S/$3PSJQ'E T<</=Y[/ Z^V_WQT5-XE#.7/<B/
MMEDB*N+=8$3TQ+LQ\?[SE_T/36?-UT8K\R"_R%=S%5K9#&A^Y4-K!3>,K-6#
ME_7@93UXV>V EYWWX&6]_/I2^:5HHS7V;+5BP%-GNO]0Q(^P+@/(TJ%KW>SA
M4I%;4I9U[!,#/H=M<'3K$3LC(M )$;TC>1L6Y9/1<,"GZ=1I7#>6\/26BW@?
M) G<AUB")@)J2(.M;Q)0=59_J&CC/A3W]N4;-TL1UTYWO%,\JYX;W+*;]DGO
MIKU--^V3WDU[]]?A[I$J;_R"6[VZ'NM>7:8X[^$A<-SC=J[/@Q9FHWJ\?D%_
M5)G;S?>NP_I+V=V;Z^!Z&]'&GRWP"9QD/@]T+T^D^1.W?Z9IK.EURLSGH>FF
M*?X8;2D3H!JY-4$Y0KXOQK)E=R^B%7I5%M$L#GDF";I.<T9+@[]CV6/H=M\L
MZ,^RT8:SM<$F6_;T)/-Y=M=ZC3)Q7C/1YWD:KG^(G5"S.EWA:J<UN0^C*?GS
M$/=M2660'PY?\]_+>K)(*EEO_ C#+^0!E+]&515-S]$-,%9[QH7 @54'S-/
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MEO>#[- R9,81"<?1KVY<= ',E&A4UX/H(A+U*+YK@@7&=N]DG@8V4 Y9W!!
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MM5X#*]8!6]O93,>HS3F54<J0658*O+NE,MOV#'_M/Y=H"4^#:RL8OZ2SKL(
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MFOLM?6J^9--W@-41C+S#&L77TXR@A6[>O)"$R$D[;R0>L^O(3)JFS/Q"^V]
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MB]%3BRBS='W+I%#YN7 "H'.DW)_3]Y@;\][J=V<^+%N,?O_DB!;9[P6OQ%G
M# Q>DLN8CET]%K[2SCQNH*T\.=* M\/Y?:5:BPT(4SC]#&64VW\P0:NVH0[<
M+>+TEB-TWGL8WK_UJ2:WF6KRMS[5Y$]_OV\Z\<06UD\XCHU9*$#PB)*UK[/1
MRSM'XMW=^7&+#G-3-.6;/L^(P919;3Y,J&QIQ@ZYDV6:M(-XA Y^%2A=J-)X
M3FU+L><&<DL$V(PX]XB;0\;9S$DL0)RL3^@-1&^],7%1<[+^35XOH_>CC>Q:
M%(45'I12IUS_S:IFM"QT50"6J#=34I/SVA'IEAQLBR[R9*9,D%E>3ZK0RL)0
M<6MQC719C4TXS=:HM>[G,!90U+*>\.Z5FYCRH.%2Z!/3\8N&D1P*%.HT7TQ
MFRR=8ETL@247*29_%7@\?'8ETL7X&H.7"X0,:AN=^KQ=C'D_".D7M/T4\\4)
M$$EB$>;ME4!76@X_9Y.GT3+!L@&>J.]W(8>1$[:HFM4MIIY!%\*PA\*N +(
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M^(&:#0G9'UA6XFNE>YH3.!Y.V?-;XT?B\-,;1 :>M4&-S2&_K&PJFM257?!
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M!^<$-*;NC:$[0][4/X,A$QKN4/4B,O7P55\_.Z*GP"N7M1 90*U;;5?'+TA
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MC601A6G3IMO,;G2<-=)+Q#VX1PE:,TMW]*_@LXN*;E&#SV[@)/21^A'O@:)
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M11!SF2R/AL9W5)M:NG+CI-0YQIXJ64I1"^=;PKH]]K>A>D&I"2N9= #+'ME
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M%0'IIKK*NHQZ'WS9QVGKVU/:A[!(RY3Y.8:E69;$-6V=L(>&@S)J.?I]*F-
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MRZ_=JD%LH:1248B%$4, \RI1&DS_]A]02P,$%     @ ZC1Z68W.3Q;Z5
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M5ZDJJ7=NQB!GOFJV%,U;62,&8*)LS,=B@C3=;KQC01+@?=#FO7@-F8_MC>^
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MF[GD$C9"!AQ+FMHW/H8&D!O$P+*!O%DQR=DAK]"PX%?(PJ3\0WNRB)3+L6B
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M&$7K>1^V)%B"S>QF=,3VFH@R'J,?D 52<%RUJV]!36K@JOW;-N#[K*'31Y*
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ME0$92\O.E+C(BJ'<S\)E<?>R5<?UZ3&QGZ!->T/8^4N[J: +30=]#+^AW:.
M=II=F=3KS/3]$:/-#\9<P[?,;X8-R6I1K1BM=3MC^4EH57*=KOUL1&K01D.K
MZF9M9A*VZE?TV(\7E8LLB#4."/6LCJK#]!FRZ9%&R"O3+GD0!M &Y9$9-ZTU
M>P3H<BU9MS@_77_;)[QBAL]VX@E%',#T-3YG)_B;)KP<7^EJ()UKPYRNWKG$
M]?M\S:^?#KF!Q]4MHUO\IV*MPZO'ZO0F[7+K*NJ^,>'C?]Y]/[,J^#WGUZ>6
M>]=I)I].N#K^J#Y:9?SE]*<(I9#(P@KCCA<6]RI$U+)MKJFZ[9]@L.<:TO0X
M)W,4(8OS@Q$LG1C-=,0R1I+.!V:2,&E.2V)X$P%_2<X$M'D=Z'0CWJ[H4FM7
M![6XH6YMWVIZT'=:N\)0+!TB7.1<@9'77KG$Y!UG0523&)W=3$64-KZ]#Y%X
MZ:ULP5J)+5R%<3/EH%(O1\)/SC>S_TPP?=&PE5.X]DA&3LEA%N17/NC@6JRD
M>LWNCO56;D,>"[*Z5T@$KC: "B5#6Z :"Y)E',5(7'ZA32+VLB )8?[W,<=B
MU7]%'^U1F_*A'L&)C/UX2L)P@+;G[2Y:A0UFK^4UKTNV;C);O<I1B.M%U[MZ
MD*.+"(O)+5QI.QLC1K'B#\=8$+XMJG0HD01/2/ER[A'U@.GJ2RGK4P<^?-S7
M9?(=;4_$W!0@'(Q(TM$CMG&F.;I</)GMD$SF[!M*N HNK MFPS6='Q<]>WTX
M%3:]-+T-??RRP/YU^62 XD8V"Y($^RC Y*EB\[$%9.>/0[4@D=R0A!"DP\O1
M%H# X!B'(]6\;RL]FO]I)'E=6SR@1[:G"8^V*0UD2G=W354"JQEHI;":G_"Z
M@,>_]I>>$_Q2C<]CO&H7I-9KSAON-3/YN!G5=*]*^FU&.>;6F)-#9S<80T$D
MC]*NH%2NOBN."J+K+,-YP?0!V2/4^;4;^3JNVIGA"!&4ZY;#9?LL-R)GWSVQ
M3;'(;*M?+ @0Y?JZA>UE]QY#Y/_NMMZX $DT8,= I*" N^AEQ7"EXSLVV"_C
MH-XLTS9S66B>*4ZC3(S@Z!HE<0HP]QMN=\+K-V,\_A$<_WFN_GU!=6->&Q_"
MT-2@0IQ,3\EN3#61+JC O,&@'<7,G:)R,FO'I9W^W4([L"#9S>SA^E/R()QQ
M79_MI78X4,Z<_HJV*\Z"-'E1H R78J.7ZNCCC!,L2'G)VP@F$@9$;-$KO*^R
M-V<*0EF0:A9DY"P+<BV0!=$O <_N,6V;RP7V6Z"/6) J+/.,'PMR$?JL8G[U
MGY Y6$/794$F7=:A0(@8_=D(7:R3^?D'D06QG]UT0GS2*=K8O_M.O<OTMI(:
MOV'4W2,<YSONFLLMMR'WV=$Q'H7[/LRV;.*N'[LQ^Y68P [F#2W<=^Y0%N1F
M-6;[R9L2./RO 9:JAIG'Y<!_PW:YV1?=-%&F&X!]- GFG##SF^?AZ6W$09#-
M.(%-)=@C.? \14K3W!;?HNG73Q1: 9Y+KH-,I%M,9SK*[5JZTP.MJ\=NY6.K
MHF+JS,D-=&DG-K&>,!IAZ^U],(;?5B)QM )36;71S8(H3]#8$_L<+VC!@KSF
M3%ZG?V(_@X+[=QV[F<J">/2PM[(.0VN56YTY8Y^[N%'HF>:(>#+,UA=Y' E;
M(LI>7,."",;*S?G+GI]D\J$E0!@TV7RP(:VP(?FWL0-ZGYC.7Z&=3)<@87C-
MJW_>0*4/&KK>SWP36#@T]*.S*J!8!.\$?S^5.3;<71JPC]V^303\! 8.'\:1
MNV,5'Y^V-CF,,K^O^S3)!+;^\3NUA*RPTL ^^_CS#N8;431W(P=^3.#\*?>3
M"Q?IXF!PB^@P12QF\Q YL@>R,,?L2N%\S?GKP,NT7.7*R?MM)2H-!<QK","A
M 532'H:#2O!A* ]*:J3XY&2L"ET7K*I %A+[6)!T@NB3*/('8QO.Q-_;-#;J
M(P=E);NZIQ4!8H:QCG+KJX5?CJ*$+^WEBVO1N]CJ@/W:)CBF:JVDE0CXMV\Z
M4<:/,B>)LC!O3;AC5P<80C4G)[*1%L+]L_ECV/G\Y!X5]-F9+B4R1FAQ[10G
MS:!XR0!P2JO#D4^\^S-"6 $XDVYIU$.*UAI XX)0,A94*8(<,;:@6;WN[9.8
M-.%\+F":>RCCSX7S2;"3_PGP @LR,+>=(<U!TZ6'?M@YR)Y3=W77X^[IFE;\
M>[U(V(W<L4*VY;\'S6FF+,C'WMBOT%T/IF[X=S;*>;6')!06[N\-Q;*!U:<$
M(RW"4J" K<##LMV78#YU&N-'C&<JS729DUF01,=HZ".GD5@#\"%:H19.)@JB
MFIQW9# #'=K)72>0%"N8&_ [^T>PM^M,ZWE.IPXDGYAE\M6I5ESO%H&3:2VP
M^Y!-RTUJ/@OBB$C#?-QIV-YE'V/D0QA@AOOV\C&WB338G&W&!F%&'-@2S;"
MV?ISCPWSYIO'NNTK$I=BV=K'7G]V#!NGOXZ+Q[3+_&BGRA(^Q6"/_L0<ZSGZ
M[6<QW\P6.94@H^(\2]=>UG1S ;8-\5$W9.[,7Z1RX9^4O]BVI'.-4!'+V,.H
M$C(Q@^X'$$<(BDP9:L/ E@CXM'=)#UCY.S\>\1)L[C\[O9?<95'F_A&I.5:.
M7RO\4O3 1V.F>3Q8O?=V7$!I>!B3T.DDMRDAPW_$'#^)&\$S>1Y#V!KX#--G
M>@%R@.;#G'@),>)@BE:E#D-^&D$>0&1>BTA\LJH^-Z?<0XN*A%G 2%BV=%Z
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M4;FU5*CM5902%SQ[73?'FFX.B#ZY(<^!0T[L:N8%8][J"G:A![BQ%R  > )
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MW;3AU/^$ 5E9-627 K*8_CDK9]2.B\ZHH3JA.I5#G>:Z^!2140MNXL+&GKN
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M'OS((VHO.B%[,1#?N\Z:T)#I'M4LMN899RGNQB/K]M_?/K]HPWQBBZ-Y0Y!
MT-[E^?%!Z_3\^ @28ZF, /U'+]:#9)%XKM$),YB,.DT7>N:8Z,)OEBX;DCP$
M%M*0Y>.S_L&F/V1IV?7Z2%3E?]C?/Q>EM9M555XH_>E1EVD,-V/T42&IDJA+
M5 *21:-'650$7RS7BF@8'N@%<'N"#7V42;XRZ1X^'?8/&7F=R5319D0/:$?(
M]@@/VN'/L3;E XN,+\L9U?-.<XS7.@IYK;8DZ<0PG/_<R2IIQ'NL3^V_K9?!
M4#PVC_+Q6,?S'BN&F+W+DU:](3Q\%8X_&M;TTAQ3 =#_"E_%68+WVA>B0VXN
M&7(S?LC#V[O3YYDN#M3UP_G0D$_2#+FY=]FW9),(S?-ZO3+3_A@@GL1)Y9I^
M[.D#[4V-E\EX-&Q\T3JCJ_9?^<CD-%$F/BE[EU#:6KL3+1JV2J*2-'F:1]YQ
MW!A9C-'3'^FD3E:'"7/);U?/>N]+RSK2Q'P&>I8XT @]=+1W"0.<&]]YW/@>
M-3II5?XM3Y-GRB\M26K5KU[_:.6D6N>)HPM1LW?9:K7JYU56JRM') #?MD[$
M9"$,OEX?__;[^TWSX307(33K02$$WT]C!3K?^#F![7/K$J[6W&ETWO XUE2R
M:"[5FNF/K]+P_;;7S&<8C> PHC3L71Z?GQPTZA6RS3\YFK)?H^JO6)",%/Z1
MIY1Y$MD7:*A-WZ^0*?! 4!D3]@7_2I'*V+DTE,_]G_\Z:S9.?S&$J4XOEJ<T
M1B?O9&B9\BMD?FE@2(P*Y'5YISG&0K1="T&OI9A_)+JAJ2I1$I="OL_;>.*&
M++!F",6JSD57ED%C&.H\[6<[==__M,A8_/9_C^I=N[&"COH:"@__'OOLB.Z&
MUECB!KAW^0FFD6WSAZS2;RNCQ%3.UV.9O-0ZGI+UF)+I0BD'TU9&FCZ>F>-)
M[;.F@*6AUW?5X6$I1[-XJ2'M)"R['EY_^??]WU?='[^MXO'74,.8=8G$R5TM
MV^1N&2OC)W?964E.?W3__OM;Z_SFN5A>QJ1V=WC6>+;&K#&[L+7CDW_NOIZT
M/[=7F8VM(>SDK$@>T]'3=:>CV3GX,O[SZK>[XZ/A/Z18#B8G63+,<V,S2,OG
MN=G9]O;\Z=^?_SSJ*%*K6+8EYT%V;0+=23N!SB[=;]_^[]/5X/Y-&YT5*]VS
M;<S,L_/'U([;O;?V[;MT7"Q_SG=MR@]3H?V:Z$S\A>P3?W%$B83J%<$@^BN=
M=^#<OGCC%7P2>Y5$ALYZ](5@J30\4"CT]RZOM:E,C!K4+K/Q791KG+M63[<R
MN4?G4.O"NQBIK_VD$SJMGP7VH"[_7U\>CHGZCRSN"QWC[[GY/^-="89^+^J
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MQ;3M/1<J;?WU4M9VZ 5V,SGK6]!W%Y[C9D6&Q$B&.!TAVS^EVUN28NBIK5
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M0$+J,(_#H=-^$^[R<$-%^=_UPV9KW^E6^.9T]%-$PW1Z&SL'9]7L-\7!G'X
MG#Z(AB3^+3@5RL*]J/\@K/_B@_;*SO<6FG4[(V3C>G[6Q' Z%N&L"M5O.<!>
M7*,O_F];>O:_T.S3&>Y/HBG <3NPJ\"_P/[W7Z[MO9=5>6)-:,@*PQ -^Y0
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MQEY4,L-:2F_ $@Q,]'X!TU TQA1 1D AI\$6#W.RAU-6'*@D7,)JJA@T8>7
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M$@]#FU56]23R$SE%7%.*U=H:W\80*TE++DS"W_#3Y=[1"N)7<@T,N-F=1WD
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M@L!W;R8=4@PI!NX@(:9I)D\AZ:KYABT^TUV"5'B4]5'6OUE9WS?XU?%6TEQ
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ML_.SJFR+%"Q*9?47%)@:<Y,/\.CX<73*Z?,M#UXK1=Q@7__E'C_CY0185^#
MN_I#=@BP0D:XHRTNOJ,.1=YU+<9UN*1  Y\5UZ2!UXM\>T3PQT<_H/MD+TJ'
M*S6B=AH26%T&-3 I&J^$49;;3A+73'\0-M-?]3\#+"P_'A[]X.O> S[/+4][
M^*P#^PV>T.^?3)X^>[+7:;CQO%)@^:_ZG[YTT.]-=6%2+C#,VZ:M@G9<J67
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M[>T3'067I&#U8VX@/S_*SJ*9V,',M&QIF!?LQ#PKR%$#)R$M4D:J<XEP31:
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M>'6\=81Z)X9UF9V\U.$7HG,Q1!DY2PJN;VO+/SYR& 6.B+NGMJPF<8= [O?
MC^OG7GIK8Z]P<'%R2/6T"SN!#%GAP\W=(:H$!\]X'([;"NDA4!P??AL!K(2O
MZ(8:<65\GER4E4TN<+.YBZ[[229R?L.9-3JNJSM)+4GI<43_)VE:X0Y=R=[R
M[R\?W,+CI.UFZBROW=7W8#1I-_G@'LI"-2[G)'AOC$\@S),91HPU60.B"04H
M,9(N;(3R8QH\A9^EFQV>RF /:6>B8!)?,K(&RNM045$HI:*T$C\?#=W7<-Q/
M4[P"85;H"^B83;]3-@5^?$=Y#@:_7;2=<TW]*( K^_$L^IVTP42]ERCA4Z-]
M4PKAFF75K%W"?>6QRWX=?7B@W,$U_TWT@YH,C75VZHQ>$;*= 3K(\N,DP8F%
MDO:#PQQI&_H+%99DPP1.M0?<58/O+DS8)_0&*FU*)L,B_83^UA(<"5,,6=[&
M3HJQ>?)+RE$/1JM=@E(X.1I1"M=&*3P=40KWTDI_I7"T6UW50FE04;(986CX
M7I(5.L[E,2RVRBERD$Q-?*"J(>YT@V8:09,Z8DOS<94)1FL,0>^@NX"_T8].
MM_-]^I>?XD^<H-S"_N4P!3%;_#XX6*=#!\O.<8XZ>;SQ?-R-\W$*P'S@T*CW
MW_,8^W'Z($AWGI=EI3] G,SSSYX=_<G^6@/"-SIBYVTE@Z=%DW!VXJ6=2#Y\
MJGYVP-^33UQU:NCU,CVO9C>N<.7Q2-Z5(]F9':S)4C% XH"[8R@3KXIRR?U-
M<O(X5'ERQ$.N;#Y$#AFI-4:'E&$$T$\_#<8QA]'K,'IQ'2<6Y](1DOZ(P09,
MA7FY#KAG0E;?KJ1Q'2.;#UX]VKIZ:AP9)#+/=)/+KVY9JIF-4\L;M<>0 )&C
M/]#(D6R[MPP2_D0H1;AR2X_X1I!*B7!)NH#)+D+U!G,53>2]=%Z_^AJ:A"K;
MYJ"<'] W#GCZLB.F)?G?E"TW(,P6)<KLRB835J:7WD?!T5DR/%Z\EU'0;[MV
M,NQVV.UC)W.=;)19*,D;$+]+4UA2+]@7\;F(+N8-/$FFZC1W?Z7B\\/;_B_>
M;WOSAP'IFJ4DHV<F6W&B:<C@3SJ*"1A$_8).AE<ZN,Z(GV91&;,K4P9+9!*Z
M9/]I!+;B5VB)UAWUGK8(0E&1:HK>MS-I==6Y-[R<(<X"E]+J4;*/VNV.A.*7
M0"J4)*/@L92TEQX!P9S-B277&?757=)7IT6T75C[% X-]@DS69CIV[,I2O'-
MCWF)GQX^?_ZG^!&ID>?\+_4!K76+:W)O&,_\./K$P1&(S'!]];)#2;IND4TS
M44W0B>0^JE;D$+[K&48.WF)A@L[[6O?@WKBA7L@O'1":-4=H,NL(GO'5WX$E
MQ0R1,EV_>[DT:::EVGFC':BAH9!+>;"/S8WU)H993;P%E13(NWOKD2/+7V2N
MX[4W2SE1VDV+6X?-"%S6L#B_&XT%K]G/'UN"U#])P?>5G)FRY?)=2M<ONQVC
MP13[L#;1@=B/EN,V>6L<<#8DHP6-)9WM>1MR?"0N/E:FW9T0M*]?NGUXF_VE
MK<I+\AJC[8UR*;8P$>OZGX0SN@P2[W$JC!6LSX3Y&.,>U+G4\V S)>)X=MAO
M^1 Y@&BOK\BVY?>/9UEMG=)KG,U1_]PV;U9_?Z^^FUM!W*AG[IB>H6C;CT7?
M$10/A^/J:GQN>L;Z(8H>=Y&VXV$'D42R4R<%U^+Q34)"[YQ,>1S^8M<+'02X
MV+*$<)A7);#B^/.CCX\E<^K(M3Z)C>'TYMK"^[I(F63[3>P4%.Z5>+1Y'!\?
M'NU0NTH8?[/2.4KE76 5^,TSX[/Q?N784%Y8-I2OI40%L3+NUI!A- 5SYF%$
MAVVF9E*Q&<\Q1? IA%6CU;MC5L_.5Z%@O2DKP+GRC=#35D80[:PRLRIEAFM,
MK:O.@PV-P61E0?65XA(!3C8Z0%R'C]NO=XC,=-))SIAHIF62 \-(:CTP\3\Y
M6_!)^*04VQC;:/,1N*!6OW/7*I4TF 8KXVEQ6Y"H^>&R?CAOY.?].MXEWYI2
M5@[]'4*^I:?3/8/)^/?\BI#+Z+P*=+)W$9\).*YD;)Z]1*1?MJ!+09]XU&4=
M;TVFMW'1$"1=J**,2[);&+UR[/&B,QX$6/.<&++^/'X1(P1HE:UT.B@I.N?1
M=$V<V!E8&'X5]$3H;2;;JY8L#+_O=<;T OG\ %:;UZ/SCZ. ;^L!*9#+ *+'
M(T#TV@#19R- ].$8Q"_BPK#>SH10-^V4(:"1<0G^AL[$E5",C-Q"J+!3CXCO
M%"#+EO2^4,2P;?/9;:>3>:J=S'97=O310[K- W';CMV'@*;7G<?"V'/(OD&G
MZ/[=#Y.3YR>3HZ,C/HC?/9L\>?HC_T]+FE1D!<H@1;, PW/*_-NKQG#T_N1H
M$H'*6S&#)T\FEDV#:2C91;%1=+>;<I&DS(BT;"542[ELU0RM\,F3R<G1]WZ)
M)\\FSX^?X7]CB#$ ".%Z8K>>GRF4ET^/)P.+$U<3[X;%L:VEST9=!#1FXHO"
M4+2F&]&;.OK^N=PV_*'ZKIRU^>Z'[X]VO#SU: ??87S9.XQ.=SQDYX6Z&EA;
M6+)AJVBF22Y8!SS$]R?'6.!A_)/M375SS? D_Y;13'4DH&+_+OP$XNZ;L05/
M1P!@[X9T#EUY$HQY8-2R\GBOLL)AV+KG IVCP30VR;RPIU^S!Q_0E3(\D6>X
MU8@S3+P!=Y,O1W+*WHZXD/'/.J.C&6J^7!K:4SJ#D<OJ!VSCX0NQI,Q^Q-&2
M%+O.)->BJGT@'8=N[Z%D8*BKHHO8OU,@?',%&$9NV/?EJMYO8L.D5])K6O<E
M;<BLR-1&K8(,W"/2>[B3W*Q-?N$4P;S$6FW<Y(JX_H6;H>GM;E1\&IN\-FNQ
M>D6X/X>L.^^/QG]P ?T'?_R<3K'#2.F FHM,V>.Z9U&''V2UTKX+F8F-^M;<
M4HAC5I7"].Q5BY\-(].35*F(H. DB@;0+@<1FYK\H9F8LXX$29-BPX,E,\Z8
M^S_[^8VVQ;&GF58-N6?TCF<DK AN88V\SQ6!*MUX=<2QY75UD?A]& 0Z-0/=
MD P40=R[I*NV8#+Q?0$<X<_;7- H_1T+?$59]U8N6TAB>% :%Q&0G9E8-+]>
MWB9!;"(_&!0;>1N@.1M.57 N0ACF7=)#GH7A&QXDP4E_"Y6H.L/N:6T ;R2U
MU6=.S^*U6ZTRB0W=HEQFLRC@!PQ3+4NNH,ZU/(+;3<VFM*,UY"S:',3 %M06
M8-TS12X_XL;Q,K(P8N"(XQO!\%#F?"2S+5\"7HBM S8VSWNEB. L+A(9=22*
MTEK(6F8".Y8P+XN!<H\T9N#S.^0=7#&&Z).1R]18(VDKY1J0,:GV@I)_\0SD
MD3*0=P Q ].R[Z6;?[]CE$Y!6@>$;"D)EV^UFJX[DH+V7\>GA,G2SOB)D</@
M5K/R+OI+7/QW:?07\ %^(N+3X -:EZ,X=_UH^_K?3YX\_W'H^@<2%'$Z7V82
M* NAW' K=K-C+7I\,:J7K"["A&IW2%UKTS4..3NRGSKH\2D9&@R-*>&->X\#
M]U:'-QHN<D^"XO>J,G,C^2,=06[Q >!9L'7['<5R-J&]WW/9P//28)H-@AL>
M-NU(8O@!R\J(_@^_K=4&#U]4'\P/E0GGQL-]*+CEJY(A&[2\:58D=OHIL/OR
MHOS[C_06W3<V#4('3'%G&#Z3NTT\/FMJ_!]X59C#Y;"ZM(5NI"Q^Q@0] 81?
MV2_@65F4OQOV&>3NA+[)%?TA8(Q7P._<FONT1FMCF:+8DPAY+7#&9%ARWX-@
M2 ,@L60XZ:X95Z;XW-("_L"(--T4<2L$>]SA7FH[OL58SKX]LPH-M3#)!6;
M^$'$I:6)XA%PWMO3<8A>/Y.O;X$Q@S^@YTB6G3$U[G1;=NY2N[1&"WS;:#">
M.<2ZPU07F4:L_X5)=*?->5;4S*L)A J9L7G\4L9YD=+Z#3&'J5C>?P+ZJR*O
M_PTIV_#K[S2X=E]>#U&*1<Q2SV:9C@?B!0H^\V1F_-PTU3RQ:AX[HRZ8NZH@
MK#Y5FDD/:55US:.\]8'XYUBJE#Q0[C=IE#36^>><%(+EXV>:\>1(N1Y*SD*4
M:-%+&:B$O\-VX;GF=H83731--@=->9"BK-Z;I^2RDOX/ECJ78Y]4Q]MV3)D(
MK;3<A^: S@N/,+3V@"Y)RUBR7\"KU1GFX<AT-;$UTEQ,Q=0F.<\]1_W\;($S
M(D.!P]&)9KG*2\E )G9RHG)5[WS;H>'ITA)V9W[9M$',TP!MBJ5_1 >6+.[7
MVDA R =;X^NM+^\XB?&G3F+4/8GN(.Z:8"4=,)*E\%Z;.ZV7</S1P?T:ND;J
MT[YP^XE:_<E8J[]VK?[[L5;?>=_WUT)_:60H=-[/7NU/XC=)T2+CR(&J&*#W
M%$VL-%*"/7DKB= O.(=J]+&OPG&PE0A0^TTATSH^)^M7GCOX>2T^DY8BZD'<
MW5E5KD?@Q!USH5&)LGM)-Z&;5EQ.G2T2S-RD7_U?J;I7R2HCD3:S15'FY1G,
MD"(%)_&\DD%1?#)L'2-#[E]I[+7T5"S@QXDG(A!4S8C3;<NEJ:+4T)I3J?.<
M\?CB*O0 !Z .Y-=5T/*U#C=U)#;PF^R#+9'"*@PG_3L86DL]D\I4CXPG8\W-
M)-+153JS2LH#E3JL]DQCT$CL!XT$-9PZ=,S@CIM&"F5"QXR<OU3PY V9\+W5
M6JG!OZ/.&Y,*#\KG!LW8X8N+]<5)G2KTL^E-="Z.K05\UGQT\[D&&9+QE:9S
MJ2@+HABZ6T&Q;_PA? K_!-OQ#NY#B_W+ Y+[O=R_JS]@QQL,?:&C+3?TZ#_@
M] 0.XM7O,N!*_H=Z4-Y[U*4<'9ZPUK$O@5R\_C?W?CQ[S9O<HN??__#<[]&U
M5OF%CY,=4Y=O>(D\PTSBV]0@&N[*K$7-:/E59/VO<?BD[')_D;-P$[O^K6ZS
M;"8O;T[&#. "T>*A6X1>' KX45IN3->*<-)=9G#YPBX;D[*JQP-P]P^ K[SQ
M$CN;2UL/*5^& 1'^*DTESL\RXT;?@XT&_3NNR0LD?PUF^JSG+;,#65O*G0;L
MA5:GCWM\#_88!4)..1M>HNW&HOVD?3UH:V/+PX:!3?VQAZR^U5\/.#U%&XS[
M?_?W?PH-S:OK>&;BE&V%/#&;>1_Z<6!:"_'GN-=W?:^E#):*.K>LRS)H>R@%
M$@;M,>I#K8O:IQM!;5)L/KCMFB:_Y['PO<Z!_6XBG6C6K>592%/HK6M&AK5Y
M+[U4:P#GDZ3N#_3#<V-6\2J925]O1S5P>T=XJJ(@[:+='QZ&I0I'4:]8"[)E
MH6N)RJ44Q#'4%TJ)\R_V<:ROTEFN((N=8I,9EPK7<1&*!"3]QQX!IK>6I?^M
MK2*W9TC6 YFULN,*7M#V)%(U+X#QJJMVY:;OU;;J(J5<.V,(TTA-CBI_X*Y8
M;R7@HP5BK4 W_IC1OWO:K(*I(H>C@+O*))4RM4X:8STI$./S 2"GH#-!DUI5
M98 7 MP$B%\ >D=5'U"0>4?S>4=(]6:V1,^%NKM,;,E-)"EPEF91MM(_)6AV
M<IQQ0LM)_(+>$"FQ(DL.XW? 2^2\"LZZ)^>&9PV2J[/IM4K4]A)(PMNGO$CH
M&9J-M,;)\X!-TBZ,DRF!HNP)!NB)53! /6E8*^(N;H6P]'S/B2##N#B2)U-
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MG[TW76X;R=9%_^,I$!U5$78$I-;@L6N?CE#)]FZ=]K0MUZ[H^^<&1"9%E$&
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M;.0/)HB@V!';%+SN@_84X3"N8H:MC-E42*YP0A-U2]-M.'M;-XB[P2PHDB-
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MF5B&$'0Z&FH\0RBG>P)5R9,\S1:NF6SE@M63$L8A@2J4)R "J=+W13:(=%;
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M+45E86*:8UEY;2 L@#1CRP/]6V@Y7(5ZP86M":6 FM 9Z.[W,C _#]7C<9I
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M,3!6$YG(<XK_[\P8YGJT1)=L[-Q%[>2O97I!6@5T3,N)Z_#N9(_9M61:H=K
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MXM?_;A$"?E1@G()TJQ_SM%B!@QUE_ '(^,N=O61W]WI"[ASS-3K:U\_G:86
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MK?O$-.?&R+(&VX*M?;73\X;;E5?=V_U^<&-UT[!_F;@::#BJ#AD<AXO_\).
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M95I-44F\ F^6<(W,X(R\\;X^(60GO]$+@_#@0L[DNQ1<UGA_%T^BAZ3<CC_
M+P;!10FXI/4\GN7E.7B Y./E.7OBJ4 IN6Q&Z74DT1$R&5$3RH,K0]\U#AW
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MA=5F49-VOZ16Y]ZK_:5;H [WTLY*>Y^$&B\:[(0F@"#E4E )X^+%V=">9RJ
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MY,MY1LWAX37A&W"0INM*8;I<%ZKFM)(PX\=D[G'][Y:(L8RAI^#3BO7_LA(
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M^.($C:,N0:.397^'!(VM/@PO,^-ZEM/:' <;)EZ=N;UW)'K!VL2,\-OCZ&C
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M6E/_8N2FR,>%J+#+Q_UY;L69=:1WDF5SCD1]+K"F11A71TX;HGVZZ4A?B':
ML% 2Z%,P O%U-Y'(KF@: R\)3.,/-6+FDBC-UN[BCFRQ&^).O--/$;T+"NU6
M/<^*2]A<."I(!1$8GFF/8.4JVX>-1;;.M-P;QIFUOVCDB-:=D]+&!E%:.8@N
MDK8<(8WK%O^9<!Y0U9S#RX5WQ.$($YHV)V[Y8R5\6#/*5\TN2RG>/Z^5+G")
M&;A,S#BYR!*,T-?3BZFBO(95@50<$6+ #>E<XN4-P7][OCXV--,:KU1,5"MB
MXB9N6PQE$4U=$>UX>PIG"^*BK=V C]?P! %;T71/.USFN^%3+]),!JJX0JJV
M),&.(K!:DXA/XXRHMQG6:_B.^T:@O^$@&"Y5=F&-SO,"<S7FJ#6ZW8;;I=$7
M(;KX E3."ZVR2EVR'Y@=Q/9\NBC05JS*BR!:J6140KK&)!AP$W -6C>6;PKN
MB^3":;\*F2X*M^^2W4&XC&4A.=J. 0G^&XC.NM?8=<+DA/LJ?$*H5!.7CD+C
M0K;H;*QRQ3AYLP(9YQ<^&5IN6!GWU +_FI&HY-PS)'DWPB\,[F%=!&4,%Y5E
M6I)@]X4<2W+V1K2[Q*SR BD>3<GTQE0LJOEH0OPKIC^H*F"B9MD[0I7>>9-U
M9+45JUI%5NYRA7*Y#!HA<5:Y9WS<B2*R@$Z7AS,NFM?Y1_H.L.NS*4V5)3U^
MH;)",C&=.(^</S( 4=9L1Q)%RA=UFA)$9WQ^SEH=OC")Z7IJ4Y2_4"%KJ.+R
M59(:&?Y7BR;?)VX%1!0J^D0Q!4W1Y[5MZ[X:!5/<<>21<B@3GQNJ>8&I-J5A
M&":NN().;'K5@E9AZ"2^B-/,9E;1[Q.5.]N>UE1PV$#-:E$55#FMC/9,W([,
MJM&H*.$OS.8MA6?"X1LC\W@2(JG!*\D4*T0WL QS64X+DUEA! 3>O;A21WA+
M6W1.ZR/.P-QY-('=B%4!R)6U$2G[-0..)-],C=G=0.8=$$[U65N'@VP\_.L!
M6QP=@]DD'_H_AO\\A1]H%&?!B<2[<">>ZWC3-B=F;?6Y$"T&7 *03E?KQYRN
MP&DC&E$X9L[B3/Q?\Q3L\ZSF3$O19#)&;01[@LO('?>L)!4KG668D7!.S=,\
M%L5V3_S1VNG0AA(UXE1;YN"D:5539<)K)F)9>8Q)B2A@KV1=(QM%U!+6[<&2
MN?"_ 3L"MV$G% >Q&O9_>4#'DA0+MCV=:2N+QS9VQA]-8C0Q&T!FS<?^ 5AM
M[/"$]")CI?07MD*CTUZTRCFDO:\'6()@)MA:0G9\T<;2'D00G V=G\&]T1X/
M[ \]@%.1?%I\B!$/;+Q7@O0C3:+^F7D;W-Z*8!)?*/%8N_%'-.J8#ET'20L$
M*1/$B\]3G;Q$;/H#R4!=6:F]YL:F:[G'ES.PVC&XKT5F$L3:3A9Q^W-OS_JJ
ML.=A%_;\TK#G?J\+>W9$N.*F\DAI\C_?Q-GL__5Z?4>7PW\^_?7LY9OG9V</
M,3'\'JQJ_C'-(;7HA=V#-+]MA<MSOVCW(XO%RTD!$5I<(G#F5YY$2. -7YD2
MPPCUX[LD['VL:5+*2)+RJ#;:36^],N%<'F/G=5.E(_U^$(<OZ-#29.W+KULO
MAX_^]<OC\%4ZA;Z'K_^K(/7@ET*'?6 0NW?_Y5Z%8G%&+!O*Q&L8>[DU'=U,
MGI$5CIK,U5-IO^V&?OWR](RF89MZT+\S2 MOBZX<>/%].W*P-/)KJZ)%X:M7
MIZVA,]D3K]_(XH9<,=S":M[0+4KD$\'-/_'F/S9\#VU-5^5ZVZ*G_D9=Q'3N
MGQ]5CV!&?4 I7-LS>6+Q;R^0GZ\N.S-Y<SCY238NRLF\GDR#-MN!5YZ^<?*2
M)C":Y"09QW.=0)N3]40&C<K(_BN+'/7B$WG74I[$S2\+BY$W))Z=PV':Y# '
MV=W6_]'2-M.Y,,A ,\A=^T<[$\4&8Q*.LV(( [\XKX6OV+IU^QF13NP=%!15
MR"8KCN9+3&5WD;L'^"K* ;+D$E&/3,6)J[N8P!C^&)=Q\5&Y'3%8>\;7RM9O
MH@#55QG(G+I,APT,4?.V?4E6E8E+6I%-GY'1SZ:[8L2<DE1H^*!S^KEC8?=3
MOWZJCSIX[EW^+2YG?W#\['<5J'P,NTY3JA>1B31=<@8@Z,I4(ED"-C09-TE:
M.%"-B/V 5564-I@SA0[*3BH=HD!@4QG'5WBIV,L5,]L 5]$LRW[ #!&RE04'
M'CO.1G[^$N(]:8QZ],JM!LR$7]=\0S=H^[,1E6SI X%AFLM<BJ.F"?O8F+%/
MTBPIE8YMV*=X'=-"^PH!+PT/ 0(8+KZSQ,OT=)E]\GC!-*T89T""U%HQ@[>Q
M5N$?Q=SR:9[TKE;5P@^2WG2A2@F\T=MZ(*[YP=S.BU'C 0.X%(HIL-=V:$I(
MK8%_D1C[#P^(3IU[R7<G+;J;;KS EK=IK5?J&[A3/-?3]<=?X:3Z1OMFG%]*
M3Z*W.V#^8)9?)TM/WGAA9LS;/)SCPR?'[G2^:)9?^2*]S'EJ$F NRGH'4=<(
ML<BRD&HH+V3)96A(S/BOES5BLK3\K$KU:8:?QCX\\X]XRM\3=OM]E5MS&_>C
MNQ#$69.=NMC)B&'J:['BC-.<_IW3\.9$C/N',QB;NI@6'.W25R1GH).=#[]!
M$'.QMKXHEZR1:[%H]6*Z73P=B":=A-"6S,MPUO[-TC[E+6?L6S-Y4HA/7@;6
MI=<IPAND"&L#5\S8458TB4:E/84$'[(3D<B4HYB(7HI/\5T6U^>HC1@V:5;[
MB2TL,8C<C6RP>3PUC'R5I"-==2D"0YG"!:1(!5D1ZPK829.3CIGHC.6BJ>)<
M_T?9C#Z2$DT:7U&.)HH8 E3#D9LM9PMI"9,WR'QJ2H6T7&LL1XZ1<+ZNSJ).
MB8_$)>GN])MI^RIP!J1^9CLT7\X0C"7>>_+NI=XIS)I."> 2)EF;5KHC6X-\
M@[&1A^SN^/#ZC)]Y_NJ9L].Q'KR0,%K3G,=42<#Q!EIS.N,C]*9T\O+[UZ_$
MYY+^V9B M4''T#N-D],;+1LS+4A-IJ^]%278C#C3QQF1L$]G,R01S&*:!#PD
M-&Y@MD5R%3BN+]FB"(A/X@N=V2GQ<'25GMQVF4%'XE] XJAB#P:]0<_=(:3&
M&8M/D$8\ZAB63&U,%FVZU\@#)1MG9#V4N"%".@M/YEP^;GQ5UDEG\^?>.N)M
M\9HBIT?VCP8_PI''UY7GRFIGWLI;7OC@*(9U4\^=DBK G0+5%DL#:6E>%*KI
MC%@3[29M6R ],19Z74?&=L9R0V#?#0W0I:[30YY'N32+7-6 !MD-7S.E07F^
ME 1^YQV=:. [S-BT;#\/*B$C2X#$4)CA#1U_#!/L4XF3R1MQ 1JOI4?DN^&+
MID0.:;2XZ2T7;585=B:S@G%%XPSY2,0,@.?]41'S+C+K(-&[FIA*$#-U.2-W
MT+8H@DLYY-B\9$ES.,S'_</1Z'4,>GIX\!U7:\">/^Y]%YF$;$GT05Y6F)3Q
M-*ZY0LJX-_1$B5D-&:BPJ)&"59N*"*(OFGDYE^R?%EODCBJZ@F9I8@%26NFN
M+U3=[?6^$T[(+V@L&+Z!S.:1GB7FM?<4)$\)+P4G]O(_<[F&)K=62$I9Q!OZ
M(M'HM KH5,:-K?C02PFS%+EC)'?I"S*RF&MP;'&)#$03*<? -90>H&:RK?5+
MSBE?"84P60Z1VE[N@(Z$;NGIVP%1C[A6Z![6(D5-\BY_[KQ4Z7ARIZ4DMUJ3
M^'E1\_GLH"===M 79P?UN^R@AZ/CW'9Z-6N:P!-ZD<+:"/^#0IXN8+PY2J=N
M.B.P6W#1/"WBD@&PGI':)-4H+&$$VT*;#CIG]EP.E:NS5*X3;%_'I#*&>WT(
M&B];MC,S[H<$P:\YZGPVGPZ++!22W&(2O#_,V:]+B<\EB?]">8AX!Q9^AJCM
M% (?+0*E^!$H\BY[C '$II*C#N^N5!OX!,O%!/'45AY;# T0K0[@>6EQP<JT
M.!/(<S$_EW&RD.AF'GV9VUJ\2,\+_@ZWR*,5R![6_B05YR.T9;F\6&4KF]_+
M,UN>VON7KY^;:727_3[7\)[AW8/G%[9$YIF+XW=U5O?8!>H3J=M)H-N4O-!M
M0CK'_^:(A;=Y(!K58!6?9%J20\1/R"I#K=P+KII#[57X.B4V/D:U;YR+^\-)
MC2A\5-JN"*@$-IQ31K1INVPKJB1@IUH<OBJ0O^= F3W,KO:?6GF_IJ;YO05[
MU+>.\9S]0?!#"_$K#K\=F !$X, B@1+I@43Z0^@M>:6?D"_9A&'XU=^2;LO
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M?XEG12&*XF\TO8_TQ0G$^*(ZO-!L-UZMJ?!#AEB6->%@M>8J,Y,Q=5N0+#-
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MBDLJMB@!+"X*,?M+529BW6&0DY"N-;W&W' [40*?H1(_ Y&.*R+Y4TY9G];
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M.GD5#)L:$5ST:<]2F@)+@Q\6C#!NH)K-O;@$&TDS#8L,+5O@4DSZCV=)?-Z
M(G:/<E"FFE$\2VM>%L*<Q*[QLP[).%A];>20$<45Y_2W1 UK#B-A!IIYB\VE
MYZQE(SO@W38NS\56J5NP RUGI,N(G8Z%T->!HG1D^N9PZ"H*_RA2>N&"WH+M
M$9%D+<=L\,4CFGV5>H$!)$O1]=</.KG#<MV-SYU88K9*._9^7ZU$@A?2L>F]
M'ZCL,I@VBL67*F"69KIK^4'ET$0<$9=R/:DY97NI+6"I-6S_60Y3+SMR[H0B
MN_S"18)\*8FB8,X!R>-3W>GUE1J3$'D'UP^W]>XH=(,H]/DG-( /(#O)%".U
M@=2F(8G82^G9Y=EJJZBRDCIF*"Q#T+%-%4YSOP6G0Y-! V'2))9Z>-*[W/6N
M@YEY:.TSMQ=[YFYGWM_]:K.^57#'?,YS&\;YQ[*9U2.@,]92I'6>9I+K ED]
M)M:/W!]HYCII2/<HM\H\<0=I=>X_)&TO#<*,W_YRD?E(D4'*AD4L 9.:)F^8
MCC=#>MLDAEX6NKWFK$R+4AQ>>)E>O*T"G;L@H2VBF6ZJW97:X',:;!??'17Y
M13HR<?,8OB<XMG5HE?5KL#O=S:KAT#E'+<*9]JJL>N.1^F3<.76)SJVC\"(M
M_'1YG:":YH7P7;A[\DI5C[LKOO%W9ZNGVEVI39SJWG9P36:#/#N?%<(PA=D4
MV28TW* ]48C,1FS-TN,5YV'6[++BH&,2T<\5I^\G_,)%/$*63<1Y133HB"QF
MFP+.">+T@3*M$F'8D6D*1C.7@:& *I3JQB5<8RJ'GUIZ:T_#\[*8X@GFO)?
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M_M_>H^73S[@81+\1(QS4X/+ ,U>>?EQ2\80% 9EH0_.K-0R'\2*8 >AD5..
M>I?K"&P4F3I89O!H6C:EFR%!*6+*PJTG(*!:O6[4Z_6\YV(Q R(]XWX[*G@A
M!0]($K[T&=[(K56SU^-^1>$ZY"Z]F"\QC<-]R^^*X S<#[M.F3>6(U*G&4YS
MEOAOP[LHT7G'VM4;/\A'NF'@ Y*3.IJ &Q40BA(] U78(5(7$*KEQ^!C3B\/
M,FLX9#U,G8;;D94P>@&'5T-X@<59  CMW8'8.TY5\#W\8,H4(W/HAE2E%O>]
M=IX+\N.2%C>(%G,HQ \[_\!I(:(FJL8F,O4!V#^4FPE"@K "<,V0Z6P@NE$4
MNLI[;Y =UD4ZMEE/0R/,(_+N,PM>80@:-!],()X.ZZ(-59P-E$BV04@6X8@9
M!@/7@Y][Q'55\1K@7[U2,2J5:HQG9[&3)!]7Z#"#0J$552C2^H0>UR=T7I(7
MU4O5*[)@*@8(&(<]13/59M.H'3?S2 [?=E@Q:HU:BNG+.N ,DH-G/ TL4!K%
MC:EX&98;/Y*S00-1\XCLOEDW#AI*,([3$RL)9SWVYT&ENO-EEXP*O30[-X=_
MM?M];OMHOYF@(WK/.I7!5>#?3Z@> K$A,],?71MT(OR=GZ0^0BFDMT"$*2XD
M2]:XXA=E?<?2?5 &,EB@);@:)?MTK1$R24P4#STM\?Q/#/;J"]P'_PG0HGW@
M;,KJA+([ !92T"M,&\'K8?\##_,M8]<!>QGAZ^ITY<@$.V]DA[[>*'"K1CY.
MN!/N;\C[HY 2?/# @$3KTW)%#CQ7((&; QMZX.T-8!\<\JWBC4G0B+ECQP1;
ME*:;/5 N++!U33*?J4Q0ZU$1HYXL8M3A&L>W>)$B 9!?U8A/IN/@5Q"7#=S
MM/%\T84 5@O7GM\>4 \0LB/>-H[P[U0I\[)6J<=6R1/\"5@M61I.MT^"__!
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M)5.FK1+#Z8O8ANI+0L(6]D18\MORD$0OE$:3<1!CQ[[<G+8,;.3+Q)]_TJT
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M4#GZXB5I88$/Z8OH5>Z(D@!LRV=11IYJ8\1KI%2$E]M;2-IO^?;P?_,JLK3
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MQ23!\2F$(K60BFEQ@_?$!FL2&CF6U6,<A_2AY5C#<!CO6QVKNO74[U$W[>C
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MY8]L\_DG'1;-\M.!%LP%%A=TE!LJM&*YJRFFO=+\YM6VLYA!TKTLFKTNOKD
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MT_^[\=LE^_+O;S@K5?#]^#LGVB^U^5\OQ,[@YOW-;R>=T>'=88'73^F;-Q6
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M3W. DK;B5 V_X3'-QOKIZDHV5P[76O$W&(YM[N8*)ZD0NS"_4MZHY8^$+!#
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M[S4T1!K#,!)TJ_6?O-&*T5F@GV&!_J7JZJYTU?F[_F2]@);8T.KU&_2LRL]
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MEDUA9Y*],D .'!@ZNR@6G@5))D<10^(GN*40#?-Y!EUZ1*H6'@"PD ( ;A(
ML)H" "85 )"4K[FO#O>,=K7Q?-.&UK@>/F#R^)Q\R,#D\:RS9Q3!Y'%D1\""
MR5OXMK &D[?2((.\[7(GGE\H=\*+E(;XO%4,2(W,R!CY:^QR#22D!Y4Z.9M?
MPKW@83YYD:Z_-W[V*M>/L<N<]G!50PJ9BMR)7PG374,K5-2GYN\S\=V7WMW5
M5?WF%]<]XWKM\T[[K-VH=VZY>J/1O>O<0DW3-;9I#6+/-UV_E* KK(U+[$*!
MWBDDV[I#C["]T?\?(+%%I\2&>\'#//?ZYZG:GU]\_S[:B<1:U):+#_-A_?=
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M-^FOI<.\;=^6B(YNZ@".&?QN&NFG=G("I:?/,9T^F]PV=HXY1/ HCK/")]_
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M5 <S N"$E_-BC!E0L0.8$7P\OW2^3;5UZ0)B*3VK1.@%,K^#U(TP=L!=_0#
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MXGK</<G9;,)N---'1@*IE0)HY 1*,6?"GX--W,7H1B<V:YPU?O\IG%G!3@R
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M9>CE* R,79G MC!(A[ GRE8=O^L;$<L&.7^CII/GK:NA?048#/%H3.MH+(@
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MNRZ7_@I5'<#@6PC(+2*O*%F[L#IKJQ@2_SLY]?)X+KU]_;V(PPL[4]T-61I
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M8Z!J9+2I < 1.V5X :-$8<!X4@1"$!:9.#=!YDX)DH$:8T0N5+,LY(F8X^B
M17QZ%8D4X7X/8@N"ATM5!\7X\Q>9$D68RQB'A0T03/-083,APZ;&,E3$RI)(
M$ BCAREM:I1 --D>9X]EA0%@ SS0  J<(T*Z)JPP5<ACH]>2ZIP-3-@3^-1#
MM<;$*8Y4HP"^8QZVC>,M*9AK\#XQI[,:IE@L"S4""\2QJL;T=3*&:_E^=C@7
M:#?C?W9CH)!!,.B#R*M?__V_TU.F)B"1_\'<L -L.7?0FXXP!_U@"OF?#.G:
MB]=D3D\-VY\7)JMZV?3DUN<YLJ^U9DHLGQ213"3^\3N^W07)Z\1I\MC/A'58
MR<X/87H]4ERO._E5.W7"S8383Z8['>,=E!3LQG,_20HUA6I3!O@E4\ZG_C4?
M@X]LR]DTF__[+P:T#\BQY'L][2'@EA_8/@>,&6#&YSH@&+O@Z74?_(#@!!W
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ML%46\Q7 *P9-C:9Q1M5[+Z0"5;;J/8W*'9XFUN*UL%'YC050]0F<C,I+[^8
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MR$'E/M&^3+AHGT%($9.4D+X=UGOCKOK&KA+,,ZAB??I8*YA7W"B8%S-,XW1
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MD]X_?&*+J  6T?KX#'WIM[13W5%=?8ZZLDI:S2RXT 4BT*K2^2@GZR)/^GA
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M>C]<5(>ZX*+#?^-!8_\BV_CO?O*]KRDC_:X0U0S M0<S+IQGGDR$CJ%$LNO
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MZ[:@M*Y2;7:JI,BNTVK4*Z4N_J56;Y::Y7JIP72Z^ ^D%.]K0\3*6XA9>0M
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M7'[ZJ+U]7/]NG]<O2Z4#VY4RM^@#;Z^QE@K_^.]_SLZX"QDHTC>N)0P@Q77
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MCL9/JYH)SR2AO<BJ:'(#39,X38=7P!N2\9!Z-+O:OIHHJ.@;:&JWID):G'(
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M]\SP_D/9*GVOM.VS*?HUALET;B6JO&D\&X;&%Z;JFF*FD-8JV7HCLU4:7V'
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M$:\3A#LVRD0Y39LP6_V[PNBA6_@CY4Z",&=W7Z#+F#PUWC\Z[-C#87KDXXC
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MF-4O+Q0;1G2=G[QV^@7^-;,59N4IF95Z-&$N%VF,:9?L";'8#O.3,TY+6)I
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MY+@)I,R$M>^/#.<7Q)<)1..":XUGZF-F6%A2@!)J>-8N? @\E[;HDV/:1^X
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MJA/=UK1!N;'$,I'**CY)((&Z=Y&V=*T/Y:.,%DA<@%C37AYT^N1^+[:>6Q
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MT:+.64L?N6I$K*=#OH?G@;2HZ=.E1Z.F:QP1'MO#G!:2[B3U9$4/X2< +FI
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M#_$S%XJT3=+'+.* ,?GU+,6&/CF$3\35.M^XS_P7=[%2@GS/.LA\G2P!G"+
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M()$+3002JH<F42$#H90T^QC/AB^+VO3DQ>"^[)O [)MT"Y?%(R 91,P&RU-
ME(Z/\I7KX []V8>=ZX!W"!H55SO@3BL3%?/@!LPD!U!'%A).Q/U =498GN%:
M%J((48<U=,&L9_I>B]@T!)+87YF]'Q5F"LYR3.^XT,2P*E5=GE_"WEF&;"<)
MCPN<V5"X/>P-+9F _UUX!>)2%%FS FZ".WCF??9'Y"8K,GBU!/U,?=A[@=&
MS)E4)_VK2.:X0G^,M_?L*M#%JB"33H3F81EC\Y9XU<S/VK^KH/"6:&'+XCT[
M!H*J"2<J_ -.<@!%>\.VQ"Q$(F,E[T0M[%6#5BC;L6-\;2[+N-/!W*L2N%%U
MSF&9.XF]3Q@_'OU%-E$+'O$2!).4<)*, UD&+!*IBCI+74(5O]RZ#U$EUH.=
MHR;<YB':29+^@I=?*Z^6I8N])AF'U454PPAPRL>9C2HC@X],4X7"]AUB3QI8
M@J\[=%_*DI/>:$@X:V@%!0U0M::YO@E3MQ"TW55OU6<*ST EL;&WH:8 HNTL
MVQ ^.HF$O.L\ED"?/U#"1CPFA:0EHG%K PIRXC(_<AAGS:0/86FZ>P^E)W)<
M;4M3"YE,SN_95?Z3YQ^&7R<!42-!WF_$OU!D%7SZT09X/BR.NJ$A]@;7!N9$
M5XUO#BCDX] -QY<-+T,9!'ES8ABN*'C6%I>!Z9"%-DK'N,3A $P*I/T)3=35
M-,E>C*MC^@!62E1#_H("Y0[VZ:'H&>C"B)B"Y$OS'R?J"(T01HZCAKJ4H$Z:
M&)8Q2;P!'> N<YV0)OX8.0]Y%FHC1$-M40FFY(3X$D,9/A8-]2"?LHUV*/61
M,H F-#2+B<J #T A-O@[R\B>F=$S,#"IMF=7>00)%]I&R[DC&W4>!(,UK*?2
ML[U.K*,%%&JU\H H%"3,;XRW[82$8P7-N6!+(=L1I&FH-?'?7)FBI%U. <\B
M6F%7')]Q5E(O4#OQ' V2JR2#W'$0)0&?8U,]F?B)HGVS2V/*1G@R\!(.7<:N
M+78MR5@.288?[T]0@[/]+60"R<2S14RD6/4?N.N%D\# BL1A$$(PVR!))AS;
M"@7O\>B$?A\M!D9FT7BL3&W;Q>62V]4GCNONNN!QL-\1ZAQ)LH*("6N.%+%]
M+>O;.U"#R6$6DR#\Y\1:2+&,"D@?'68B^QG8D+:B%WX&=6(A<$'"J%BR+P12
M7<>P:L<@5Z%^M]F4'8.$-+V"GS,%:>LMTC#@[@S\FD!1'_?-W:&?I#5W!&^L
M@3 F_I C!2P&<3._HP/G$EDZ!!U$&#RUS>K.B'?#Z<-%"R#PM#"@2DZF!DW[
M@9I6D3_PV1W]3K)VEJ(F>MMYHTO"D*/-Y(I+K'S'7MA"X&E%88" 1N:17CQ'
M;OO?WAJN@/OF9N?!16J6&6!]U-ET!47Y9-:%1AQ:*"[18CBR\"HA*@(D=:=7
M$[Y2D!6(%[(3\W,&9>D$9?J!WHD!B2D#_\O4\>XB*_QGGQ+3,3ZE8=.QCDP.
MI&!T>]E1?Z+C8*=-AZ[<B#OR[L"$[.>$)&:8J"Z$/!:!732%(Q*41V2G_&O\
MF[@5='$RXI8?BL4&NHTQ@O1[)@ICX],/11G/CRK8"P"XSQCBW4>%0_RD'Q86
M;VY:##U[A1Z[#'Q^M<VBPK9M5&BL0"LCSND)#(&Q\%=K*"N"!)3Q4!:2B190
M56.JO JJ+-B7[.G__DA85=<Y>P;FX3=_16XJSK.FXEB;BGG65+P/3<6L-=9J
MC=7!.,VZ8X\Y;F)UQWHTPR(/;ZYIEG7''M M-SAI<Q\N%JI=]HAN?40V]L9[
M9;'@<D]Q1LVSB97-L\BC'J[H0Z7KGDT$-,_:0YSQ.+4W$A;%+J.*@J- HNV'
M383IA^4VTP^;\$GOKFZ.]8/_W,-<;;+P;[*^V"A+?HEPD)BUR@;#>*XGEHNE
M)S9A]<0>ARHY(ME#E(='/Q=3%?MXE0/OZ3)84Q=KZCH-3O5NZC)85]=>='49
MK*V+M7[LY56<MBYCMWU="9N!CZ"ORSBFQBXC8>\C8XU=!W>5:/EP7(B=3O%Y
MQ%M[EQ:/%9^S])L[W;:8CHM\W;ELG&_6[A/*E[E2<^&?[Y'$^V0EWV9YNX6<
M;V\QYQOY.CETF\VWIJ#Z*'25FFRH0"^/T(QZ7&+CZC,QI:7K[N5U%FC.SIIN
M%._A'[>5(HY:O=.HM<NWK5K;JU)J+4PR[&WS\@=TU!/"$^&RN@&M-OAA]+V?
MT(D$4\9H!X+ GQ-ERO%D@W/FT-%EE0.=3+D/>>6JTKP"*\V+M30OS4KS-E":
M9^_A265S>!5A)I5%JPC1OWCXOZ>/WY5?CS_EZ]R?W\_4NWE.N61L"[LSTDYU
M8&!IU5)MQA$!I=)L=)HW]6JY6ZLFSLLWY4:EQG6N:K5NA]OQ-0\<LG[\$TY2
MVB(&BI8GGH<BY>^EU!3O&N6FF(,B93*"=YKBCWR;58]Q9V@BM@14%!:MN*M0
MSJV"I XJ2#(H9%(XD1U?D(;@RL\01?.=91%^2)$BFWAXK^*\ EA\?.CG6AAT
M*(L?SS_9.3V$%J*!__N4GJ$V6SIWJ8S4>\ULWZ32_-7SHI[TM78BGM:+Y)?&
M[6\8(CN#=07#.I5!L#;4U$6G-):JUW^W">OY>K%- SI.GW"GW!BEF\N/#M9R
M"A<=IQ@.>1J7=)&@PXBIE&O==]DPH#HJ]PP3[9]^DL^?/B:%*PF4^*+XV*.X
MD3?A0O4%N7F@:Q-50BI,TR'A#7J?TZEL,ITI)M.YW!<_XHY&U9YSH;P!3>X>
M+S6L10'$85H/_QM@[O@/R6"WDD&K2PQ:(2,/9WR:XB&GZNUQ_7'44DIE<:.<
M^CB431!72-**"D#'QQKC:+-A[P<C)\:*>\:*%RY6K C&$')>NO[T\3@>EQMW
MN>ZD7]P+'1G%7D4W)]]P/,?\8FZ90 ==F![:UK/3_\1$8K:7ZWG4_UW[G'S^
M'T^B^X\L ;] <A?5(ZG""#[>(HIO"$2?<*$A_&8;]/_O4]EH]I%W<<:GSS(\
M<8 NX'=3*3['9S[A65""^7^?Y'?SFSH929H)319Y)"B?..L?!HX_3%29//"^
M4_WT(Y\LI#+)5"IE+R6WST,M- , NBZOG3KV4YEE[&=IL9].%DNY76'?4RYF
MW":*-5RWC:=VH>!: YA$4(['J7'J:>A\M$T:TEJ";DZ[:.DCN89Q/G7_I?PN
M&T]/SI<:FJJ[_GJ+PR5/'Z\E_?WNZM>?FIG=;^O'2_ N@]R&HC7\#($QB0><
MH?&$]D127+OZO[,X.D)&*55P(\/^Z(6F5]%BL_Y$64:097L]R762/B$1L/R?
MWZ,KXR/S(3U_XDS91-=TGH>K)B7KB;.!R@NG#>*82,>+(%A+M*S%%[(^C(5#
MQCCSL 3PXMH )V&PFV*O,FE>O@SDP3X#W$.6I7EJ@.?SJP">M/N)<)?J*5BU
M ?CS$JZK&,.6FT^>8G.!;?+AL6A 80D\\%E(9E+%F'73*3LY\9$#9MM(Y%!8
MGQS2R50A;E.%PCXI;=$^:7L8)\WA\+)2^I-^%*2#=A!#V2G.G '408:S\XQ-
M::7V,C$M*-X(+J0OC^9+3&#O(27,"^Q 2HC@3OI20F:[E. IJ_D=RVIE=)<=
MEOF!?$V3\))D8ZP(TV\<A!_8E>A>. 2])*='_-P18N+?A6O%S\XK7K!K.1^#
M:1Z_G-\N0A@5K:TCXK#H8]<1D1""589_4J:NHBTXFCYU],3'1[XYN?QY7985
MX1@"@\X-F3'E1G;XX&":.CB83Q8+/#.5]P>['I'(3(H6NU"L%?<@5 &E&5DA
MAJQ3O/\$5T18PJQ;&V1^I:Z4NV;AR ();6>9%;SMZ5)_NWY;^^9&?'C!EDE3
M!^&3)9[% /8%M5Y2C;I2()?; YE6<5EH+1V,!5FJO8]16T19E9IHC,Y<79LE
MZ]3FW>BF:_Y^_% .WW#S*1"WH(%W'D%PD&$]>(.6L]=86*LN-4*=?J3"^SAY
M;3-O#&5DA*#&" (X1RV ,WY9T!BQO@GAQXAK(\3EI0(B1(#FB2N3B]MIH2"N
MP'+*)0W0A2K@XNZJ^D<6S<X=.%!S-^UC[O[7^]'53$'A3K/N.2 "1BE_B]05
M=9ED.A6W"&86\#KX]1*!]&5=.8C?U*X,X7VV7;?4^[>?5,JZ+_85=H&=BBT=
M[6TPIRU%4$UH6M5>)O(8]=R3P#\/C8?G/_61H15?!6.S_F.<QH.GH6#?E:QX
MMB^*ZSV9O4 ,;7]B"&\^9*F+6+,IOZIA)EGV -<>ID26.E::S\3=>$,A";,N
M2=@D^VO4P0T0#-!&,&SV[Z&_::4-D"@T[EIWVJ#1^?VXY\T1GO+/N2'\E8""
M9&>$5%#WP\0 3H2,B<+QMY74$$$64C<G99*E-/.D]AG=7N*0.G*9RV\W(QZ8
M7W#%V!J:*CKQ)"0&A^\-X;;W4?G3/EB#T"?DBJ0DSAI ')PM9@[HY2(+\*[F
M/B]:BR!D(Y1C+;:IQ9VN9?F"PR(G+R%.'_Z,/4D<5X8@LY0A0*(<I08^:F+J
M8W![:;8.*COLG0]8!ECZ:V[L3A.LGQ[P?4=4]L-?PZVH"EB/ Y<:]3?VO@AA
MZ?#R.T==:Y8N) O\IGD.PVT;0IS1400Z\A#<N36ZIY/Y[*9-@5!TM)UTQZ8L
M:Y;Y8![YGL NL'_Y1A;PPED9&&55ZIB:^&PM!Z_AI>!STQMYY>[^=UD< &&P
M.RMI8R,;7: @,\$]-J43H#"Z9#R]9SQ]X<W3WK,=>V+ISY]^^WJ@]0\V=#4W
MYM%UXU,)W#/^W%?8A9YIUA*F<^.;<)UZ_N6MH-R)[X]_]SRY%K$/?$PNNW?D
MM<9X/^I>W'G$1P@14)>L%9)Y_F3S:'N+8@_O/4\=!>*3A2V/7O$4=,5Y0:=/
M@+1LCUBR[NZ*?Y8R+S<7*LTBI7THR%XA]M#-G4Z<O>.)7<RJ\::%\.(O3UUF
MDX;BCQ55[2NJO<0@=8MB.IGV'0*Y13'H'IM:@2]"AWB4S6$%=V,#'1X8"B@;
M1--YN9BJI[K-J^;P_/THADR0NW+2!* MZJ(% <8GX>DB@HRD[QI,%K+;+48\
M<MR[U\V=&4 \D]_/AK(D ?@9*"32\GM/5R#&\I]^G,TMD-V2B,K/9D/8U(=[
M#*>H_M6P1-%[MWH%SK5^#AS;K$G[SMQX=NF3H$O_<0(>9!!!\E 7C.2+!29W
M]@N_7B89=? A5]R#(O=S]R0< ^BO:&AY1U" 80W1L 1>7[PJ=1Z5]%NM=!RV
M%[XKGO=NH-MR.KGNB;."-PV$EW8%ZBJ+3#)3VF[S*$-R&"1[B+P"=<"AM+O^
M8)^^'E0-ZA^(JXOF^ZNJ/%-M--]G*Z\Y-_U&<><)3Y4UY@J$UXG'%:C;>K8\
MQ9]A>8U07($ZHE#:@W1$VK>WT2?V]J)_3*^$H6I>Y [?_O-ID;#+)L::CBE&
MZW/:?%=D')*2]6=$:+:CC_@5J/M^BG&G1%C;SX&2E9?8IP[GY%)[T$X6./+#
MVQ9&O4!_:N=7J4DNU_B=/U!C./28L!.LFUO-/>N8PT7ZTHU\,AT[TS"3>&TD
M>XC%(G7<)Y_DMSS*X "'AIT:H;(JWGV%7; WN>!8+\V'R-Y=YJKYJ@G^'GB5
M/8FAN3Q"9W>P..](,AO"*^)",\RA2%W_Q$HX]A;/7N8$=0B5W_*4.$]Y6 N.
MKBV/S7EN/>I7/]O3P0Z;"&G@L6)8CG_P;!.BDD5 :"(@5&*8?DQZLI3>@S$H
MC+CVA+B\9#]]X#;NG>AQ!=BRW@$V>\J.<G4S:(S.[[OWA[IO*NS '7YNW$Y,
M83;&FF'#.A$D/'556SJ5Y#-Q%RXR$7\(=.0AS$O4P=]\,L/OESP_)*/\E-Q1
M%BS<5]@%9ALKVF@DF[CBNJQ*J/$'LB=019=QU&Q4KX9:37K/'/B" ===\1R=
MN=N>3(C0W?VSL),:/?BL+XQD!?XJX-'XLX;\ <A)PK<5E=+NMJ*-=A<Q3&X6
MDYFM8=+9A\Y,@)T?BYD !P6[P/CXJMEZ>"K7ZZ^+5&-Z<WXN'[;^7S4W[S24
M/^/2?85=F(72?:#K@(S"?!"4"; *PQ]?Q/;KF]@>=C;+GUMJ#'0N"E\ ;YKD
M_I?8(S982JFR+UA:@M[4.Z9@ @E#J 5TS/1/<OU)1!$2'O[OZ:/W_I[OOK5^
M75=ZGSA3-M$UEEX[%G3N%3W$-HAF![B@/T J@PX@BW]?2U?\Z%<C$^X 00MX
M0QPA=.@QGPI;2E9O7,P'C5KX3<9&#[P<X\JGPA8E^!^8_^H9YUKZA=O8G6'H
M.[=((@5?$B%O+$_,H:9#HUM:H$U5Y151_OMX)V7]2</ S^ $YR'+-)J+?@!"
MFZU;)2^_3]*I\C#: 2*@?/$($6@S;-///*IIZ#+D(;WH,6P"S?N0>-603^!U
M-4$NH669,/D NJ@;QH30A*2YZ7)0_IC^N<G__3E9(;*L]\OX&<LTF0EX=W-B
M&J:@(B6Q?(#T'6\^FN/?=5 */( V>]#R*;*1(4 88]S*O4\N/NI@\)<: D%<
MZ0,!<H!SR;QX;A>O\\U@%,Q#(#+5$QA$8,OY;!4*&B"J?]-TR0#J)OC2!:GP
MQ^3Y;1]S)2 ]1 >?V3] >ATSM]XQ52V,;(LF_;QE(>%$'.]U\<0I."RAPWC%
MS<]Y8I#&D"[M:*+6^4+&1U,7O<CQ.#5./7U(K6?M6M2:2B9],+&>D%.U\+6)
MEEQV*1=38A: 0OJ3^C1;*YZ_ZK_214<QN]^WTIG,4[Z:V 07K>K8E%\GQKL2
MXM4!4_\"7QY>TZ;#EAW0^I#TI_509^FP\U3\3YOZFN+C="!KWF01X#T:E?)C
M,]N4W\X%'W((X3KR$5]-*%$HGY=^3G\U7BY+$5X=%L?T'F,Z;"4[C4$5_81>
MU!>VF-?'723.XJ8<1A_=L>@KN8@P\R84Y,*?LO)<6$T)8;RDI5<NN$CNL-[E
MK\);]T%51_+J]T9PCGQN'('\PK:KQT)^5%Y1ADY6VT?,)[.H3BP?7?QYV^:<
M8')5(()1#^A<AD]RZ-SX0YDD7\PFLYF2^YN1B&>!7HGDZC=[RFWMHMO0_'1H
MA+A&*'HE[[W^*75YOC9YDZ4=T:N',,K0J<*-T:O7$=>3Z)"*\H5DMEB*3*\+
M1'HKZ.+0H="3<'3"8A?;81'B,A$Z#@SH8 "O<E4V1W_/$.T5-XHPO,4/T9GT
M[OL+W9G9,G0_T0D$I27(4EVM"&/9%!0K.RO\>90^RE5!_[G99NMMK4UR+@N_
M($MGLLJ)Y+Z,+7P((8(A1M_5ETEFTVQ0RWYBVLN$H6ZQ@U@NIO=  JZR>3N3
MGB'J<@](YQ/S7B5FL_7+,3JJT8;VO?R*%E$A,=FPXX^2_/31T0?--^U&RZ6*
M1Q:"G(, ISL@. E^"A<BSV>V$"(_;DA_CN:"1>'5\/(M&Z'KS->@W[B0^[)"
MOKEKO-K %&052#5!5R&;&V51G(PF"@HX5T%?%F5[1NMM_ES-I!_,L;%9V;7+
M&:VNRT,\XMNS?L_-\&HPW86W+;,11L8;\(Q02B^9'KEDB=_1[(@OC,;VC,:\
MI'Z$X5 ^-,:7DCE^1\WKJ]1!9F7#A#6AU4JBFYG1Z#E;U8K@<!HFXY@FL9G^
MBI-GX-7\NTR,$71"A GZ?E9:(9DK[,&4 $97NZ(K+ST0(8[E1U=\*IG)\+LG
MK$!MX)K*458E3]W SW1#\4*H"I?MEW%QLS.\8_80PBJ$]-><WX AG*S=EHJP
MSA&5F?'7.$F;0&=W/7Y>6NV^L?=%'1WC2:01=$8,&9QT(5G8N".!8;L-M<%H
M+19:\](C$69@^>J1?!(^9Q]HS=8D_YHHEO8CD?AO'/W-(T$?R.J9J8V_<5@F
M6[^P3[(DIT4 8:TO!&#7&@]AW\F*T8X/]R903?TG_^@ D% U$W[3U#AS"!!Y
M8OL*A[CZLBJHH@QUF8$J3*UMO/(/HJ^. @8V0A<NE/CO?\[.N L9*-(WKB4,
MH-3H@)<)4$7XY5+Q.X=S__ YW-F9)?(D^36LZ;IPTSP^"^8,>$E%L3@,,S3Z
M&9Y+M'^>?P,T>!1A;,"#V/_ZSKW)DCE$-TS]XW7EV1R118,*8L)S>,!,2"QC
M8^YUGWY<G+GA9D/L.]>=CN$)RCH4CN)WK@%%)H%J0T/P2V?<W_K7_AKZTTQZ
MV*+COW\AH#U K@/A^:P'H,B$SQYCC+DI[&!@/ ?/11'J!00WZ!!,,44>'T<>
M[H5F%9/]IU0J\\F^5W<($AU(<ZBB[E80A[(*N(HV@G^:)KFZ*GXE7L.D9\B2
M+.C.G*ZC $JEV>@T;^K5<K=6372Z\#^WM4:WPS4ON&:KUBYWZ_ #.[[O(8/8
MRU ))_UL3S^3*C[Q?.;IH]^[K;XH#Q]&#BU?G(S@9:;X(U#"VV8!=X8FRDE
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M<P^",D'/X<[.+-DER:_VH8)&7R[<-(_/@OD$7E)1+.L,SW!!/\-SB?;/\V^
MIJ$BC UX$/M?W[DW63*'Z(:I?[RN/*MW6C0](2:\F-HE&Y:Q,?>Z3S\NSMQP
MLR'VG>M.Q_ $95WHR>)WK@&%)X%J0T/P2V?=W_K7_AKZTTR6V(+DOW\AH#U
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MS\?=[L($9 SX7JT7BRGJ:I],<?.!-X;OR/A>K0"+*?I"GSU0?'F7XG,ZT6X
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M3%/-3?1!U8I-4F!5>P>Z*!M (I46TW*EW7LSF^/I9F?3[KIC"EC7=CJF.(W
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MZP"SJ*F%/3X.!"DEH':,)*R]8%7D<X!.:=-U&^DZ0BQ+3QF3I?IX[<X(_/B
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M=\-VI:IT"_.7,^ECPTO^H8D1L2U^Z")3+H4U.*,X!GBP=&7%S:\L[UQ9MI#
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M7ISEI,Y=)@C'C!Z6KVUOD]1'4IAG;",(S!'6K_-$'8UHSK:=:BNRW%93L2
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M)PU"CJ.@UR-B/7TWS5MHZB4I2^?U* M4+W"A#2RB29 N31E J$ART,1-J^J
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M"0I9@\9)23H$$[@!PAA) LP_!&R0:'.>2OA2AB8^X6=@())H%3Q 18)A0-S
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MX0=Z%!=".4XBB<YY7SV('%SK+04CCDGG?FG31_&MO=><I_K2?9W/'VX'FM-
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MD#FG\IP0XR%$VD8_UF67"\5R#.N.PV47);PV)'X\\RM^F/(+VTJH)\P"=3)
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M# 3[49'D2G?BV$CR[9=Z?8*3'#R:W9Y;_3+K7*%#<ZR/Q9,^AG7&'R%*P'2
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MW]44C3WH#Q3$ E+,LBF%SAY\XANU7__^S]D94>< S_X@VM!O_ F?]#8'T."
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M,_AK%#*','/Q+/2CL2I>(*%>:,P8]&<<VV=G_3E$,HA1],M,-O\'7-:ZG&?
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M=RE;OZA>\1[=?573+^U;N[LNW354Y;"'/=;H$(K;-6G.Y_VV:.841UV6K<
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MIWG)ND^@L3JZ;QYI?1 @FE$^Y&"1<N21V=NO(TP[>,#LR.Z2%9[6;IT]UC$
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M>QFT1OHM^8I!6[S[77RL?61Y^7AF4ZY2"6\477_/94#P^EZ_+F?A:8E^X!!
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MP5^Z/9X3\"QS3#)@,J'VC1GD<B )F$>@-$![T?XB ;@@&8JC%/J%)^^CC_)
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MWM($-R)&<PG%RBW+1V1U.7]C6Q#/'%S+!Z=,($GE&7HEW#^B,AX:D7*G4YH
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M7W@3OJ;@QU-_C4"Y.0(5XEW["H<H0S]I^)N,8/>FRI/P]/75],;@"O,AB[(
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M"*L&JX65AQ76W$2S- G-5B JA9]W))%\>+@XLN#2FBX8&P2<!8/(0MZ*_%K
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M8A54U;9IFSE E#X1#+A)YD'2\$JIF!>U1VTID5KXY$?B2PDX1@DX[F8O\UM
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M 3O1+E!4+0;*$&"$@N7=VAJ:LJ5PF7JMJ>*M0#3J8>&1M#2%Z4B M*(BT%6
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MOD!P=#--?V?YFN@;>E9HPCSN3<7OB?5N5UC8\]/S6)O%;&P;RH$.4\Y%+ Q
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MYB6<<H!+\B^\*K"9.TZ&B#E-D;H&5*N[TUS,Q[,P]EZ-N;H66*DD]%WL#>[
MWC/!UK#HN:<CD\U)&SAL@$+SS >:GKD&^#Q])P@7'&[ S'[Z,8H6S>P(Z0T,
M.@+GK?>PYMTT/89G_D667F?E3>LX2D%C 2KS?521[M-B-9PN(;)&"C%D ;(
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MUA=#4&T"!J*;WXF.8"TE+RI2K@]6"?!V^R;XKU9N:R,#) GV+^+:2$=GY&)
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M1D4^V^-F+3JZHGY9@Z :\].UZGPTTV.&LV?L^ZG8+.+$V^^[//$^LDZ"AU6
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MK%!)EFN/ML?[D [+?E5/R6PD$LN6D^\Q*I\.91_F"1_(<<$38NM48[BC!?=
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M.J^D7[@0G7L"R2 F^@61<60D-6,;8=X?T1K7\2\(#":Q\2\6L:2?_%AR?R<
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M5J$FNIF5X6AF%/2*%Z@!O44%)D+@Q '\EF6Z4L\VJE*A^_#D#&=!2HZVR1W
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M'1![7=F =V&Z<F[O4R+4&_!LC'XD.38&AM=Z_#8)N'%X7=W C3C$R$M%IMZ
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M6'RX#.2E<%-*%DI"TQ4,"$?P>%UAPHUXW-^E[WP&!&&>K_G)%%(?LNHK7LZ
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M*F TKF- $!4H8F1 V'$B3WZ<N%^=%1,#@C#++GV'FYFW[O"S>#4#@BC;QLB
MN*-ZG,-B%839]AOSUHN$PV$M)5S#@"#)K@6,# A@UW#59@_;M=?VX:Z+%?MH
M#\P2N@P)T)4FM7[C4Q^_\VZ@/3#+%89Q(/L1KJM',+S[MEE)H#T0@<M0*E\,
MOF=&GZF6*V@/CN#QNFJ$&_&X_\#N^;0'PCQ?)RJ,DOE4N<]V+J8]X/<G9T2L
ME](>^!>?E68QY*=9^VD/F/H!G4)[.,>:L=$>S'A[6*['"F:*=BGMX2<"<= >
M!"2T!][S(8BDEG?2'@CS,^;XM=P:QO.9\>5-'TCR,T%\M(>[\T2.-) \E_9
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M6X)>AP5GA>DP=EC 9.^E(!?Q57M384R[F;B W1$%KRLD!-QWL/O<LP]$M%C
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M(XN.@,.::8%M%KE^)YE0L)$1G+5GCXIPP**W8J-;4A%PV'.V51$3U>9;.-O
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M-_(9\,#1:]V [$R%0ZP&? #K9\URF$T4N%X /:\!F?F>$;RZFMF ,G##QVS
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M'QOCX2;6[3$?#M@W31+S 6>F(R<GU<K;-)3 (P)Q"\L67,*$.+7O0EU3I9/
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M4]JSG,[];RF39G-WIODKQWC_?N_O5=\?>[O!3F--+:( [4N2#=O"<AY A1O
M+. "[X?:9&3PD'@=C0_B<2@ZRL2 :H%I<_S+' R$8<)':\QX%WY@'<OQ<%1U
M-N*A[LE3]=4>:(4MQ3 ]4*1@DL"(HO"5I1'S[M[.O]_/!@>5R_LO%UZS'7%!
M:E*__7/]\>RL=75;NCAB[.;PZNSDO'5S>,!.SLX.#T[@X^DM:QW!#VS_].+Z
MY/R8P84W;P_9S57K_+JU?W-R<3X9"D1[FNL$R;[O/SYK=O$\6&P4TG2$4;:<
MF#8(K$Q^KY.#V3ZSC ,\$>Z7.!0+GO\3&7S+6A30 )+>__Y6RYFTE'DJLUR
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M[GNWYI>/1U^'XW6%BG.0V-Q>G:K.:%DN5$P3Z^TAW^L>UZQCJU,(4LQ&2CF
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M%T8_,Y3Y!KRAH4]/9M4R6T_QO<S*YE-$=/YU#,K?XX?+]?::YZ7,QMR^)HU
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M/T(SY]G^:6CGI#$VS@+/[*C[0=4_LAS7-)Z\^2QU,_OC[?L_V:DL?XI/?^L
M";['_W14ZE-\[]OX5O377 .U(L%B0B>0?Y@K%<_D ,C[01:YFS&5]-WQT&<G
M^]<P#8]<DU@4,.W7QDD^._#D_='(I:F1SZ(R?V5V>KJ?&CHL"6N9@.7HZLD-
M>6:XB=6< Q49\A&E_(\XOXUL["@X5,Y18EO4U,_%B,-[__&H:H3(6JY%S&HM
M!0#9!:@M(U,\:./&>IP 3P9XD='*9JT3F$"G;SN6TQM+SRZ<%)@@R BZN8X-
MAP#KRWLCCI7)!@].9"1N@ZRWA>=1'J07)1B',H'D@Q2L)258-Z,?HYD(&[&)
MP7J6T^86Z.]=7\JC\#"*'R-/-41_RLE-D"D\QL93PFAS\E0HD='NP7$MXP%+
M85N IT241MW'0MKWW.7.O8AW!!"0$6 )515&0#C4$!Z\4 5@PT@!>$?AW=%-
M<E5PYLK"VMQ$_WL);Q-H]L3Z2F0.M[73>_66 CK.OB*#TF&",3027@\Y^%F4
MA-U#RY#B< ,K-CM#B;$D/Y-'%?DQC(:)&#_D90Z*F\/$M\!4-_).!Z21(W$S
M97<AYJ6*8!V*Y$')\UFPMK!,>"![$"44:)S$#4HC)>JB!X1#R.+2J+Z18A;*
M79(X%&X#V_==>/%J4 BIC'"2-S)6B7T+) 2<>D I%+;3T@U#@K@16+X4:B N
M+<,5H#F#.A%?1>L8.$J/'3B>C\9(=-1SC+8B+7-*!JKIDMBE\4J)E#20BPH(
M=J@^&KMSQI%\ITG'P7X.+-DRL6*IH]+NU$!E]*_CW+H.Z,PRLE FS6.A;8H!
M@Y69&S E^$P^(S@0_GZU/*R3RQ+3Q1C/Q<J5B2W_J62L B?9W-YI+FB6!=/P
MB4U3HT"8ON/Z&^BT+6,50W3NHB3I@EJK%,CV&("@#WKE=XH&B"T="LB"2)=%
M-,3C$+_JN5A!47*F]P:OFIF!]N($NYH4JDD2#AD#1/R&!6>'(LP95&;:\-F&
MX4.:\!)&7Q[ <>#X,NF!B-0F"_G&S2?$)!27K$CU@90:A1"20<@T'3RE9?S+
M!$@)#]O-F;2]U.S*UX=3%ZQ3M$Y*D:55ZQ)KHDLHVX*T('0L)S V9(N6?80]
M;;+[ GM3O:PA'&'2#'QI<9^JL[4#TY*!R("L42F@LP[$1'BJN:A@N-*S-<0*
M;1WIF5%'G0@#4M%O5+(<;JC6+X$-,-U0\;A.X,&7\@\WZ-QC+H/#'+?3%Q2G
M)R1(:X=6:MY19Z,=8/Q=X K7*\=VBG(L@!Q7Z3HP;]-%'QJH/_!=*;2Y!!@4
M# C>VH#Y@F["?2Y]?JW+$[53.&MX2^C-(J%(>HO8D%N#);!ZX4E.EJ:;LVL9
M:GUZ$)M(<#UX@\&D"P_'%$;)Q>I8L&9S2*\P,:76R5]GI]+<97X+E)SEQ@B[
M[QCA3N.;4QLM-V;@@*8!3[NP5?"W''&H7F<98(J)/FL/0Z=!K_-HW%*X+0R;
MR,F4BP=0I 3Y-_M\1 Y 1Y4! 3H"'<;N:;//.K _'.8"H[0J,7UA.&*H4%/3
MJ"3GM%WB1&*9M$Q0??A<TGU!'7.1>B1;35QI4U1_:$*,;*=1=\&+F+%3<LBQ
MX9*MW=H;M*\2*=-<"4Q3(",L!EC5$Y,/['!4%_UQ#+VYYV$NG@]"2K(&B@=
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M0R=XIQ\%U<\B,-J R3)\+W?<:IG]LV5V2$:54B MG>\_"=144==Z>;?>*#>
M4&=7KDX6AYR0(!+T$H4:+%D+$<7$A.RKE9L[C?)VM3%=]#"N69JL53J#/T(V
MHL3ZGKI[4L;6ZN7*5D-3\KK@1PQQ*8%D[0!%"HT;UU@&A;BQ6GU*C\> FME5
M$*;31^?.92_!?:'Y5<9[6U98L#-NV149DA, 8B\8"S=1$T&.E['60#J3ON2X
MR9&QRG)RZ%0?89SD)YC>/3RQC]!@$F++,+"AXA'&9Z,?NBADI&ET79J-AN7,
MY)A&U'>,A*]'"6Y*WD;[I<)0X_<:W1E/4-X= (B.BN+*YY1+^,9]3J%:F+=F
MR39KM$(5LM:127AAB>O$*S>%ZL"@L!G>&:<G=Q//V6370?M.51\.!Q2/'2%+
MG95PJ[J."[00PKXG=D_2!P; 4NUAM59,"<3OB6#BU@IJS?A+<LKIF:T.^VOQ
MEE^\8=A<4KJ%E(%M$.+,QU19>.J5/!A*VZ"J9_T4N4UQ%Z"A0')73$*E/\P_
MV?96M;Q;V<ZA1K(_3+B/,_\!'C3&M@L=DB&URN]_L@%YOS!T,VJ'G&AJC*)8
M$^ZZ$FZHMI9"Z$S$QSO? E/U=IE09)-'MCH?)H\D9YB^,6V;EC].'4%EUG-1
M]-N]4BP]94FN7E_E9U >1JH*F>0 RL9(6)4[RC:4*MV-98SVV+5C!9+U+F7/
MAF11HR3\*"7@1TI(8\FPJ,*9LDO#05VO5<K-2OTI12G-@S)(-ZENX1$QAIT7
MC^C$\)3E7>ZDYJZU75^.J-1M'95:=%1J74>EKCS'O"X+1J+L6^E4O+01XQ6]
MIR4 >N63J$E,7P]K]-U.>[DBH .G/+WE=%2 F*ES2W/#16N?5:M5=H2:JXL>
M<X#3,JX!?FD9PAKVS3*:+=)CPA56(DAAEC\KG&ZLA%LTD[11M"H=$=ZW@*JT
M"$&KZ,FTS:[E1+ES# \(&;S)&::$J=0B4K1AW+A9D"VX,J0\.4S<0@6K1/B8
M+=HA'0B49]R.SZACU+;^ZP7#?_P^4!G\RZY]6 C 4'B+I5O'O:=/##^E]N;2
MQ10>X<4!#R?2\S)+"4*%Q@Z[" 3*%12.0)V-J'1 F,P_$G8@RG%O'1.#3CRT
M/X=73)1OHQ)%&R.3.G5%*7%4GRALA.3S )$O7=[F;C0XEGE[P.0G9LAZ!G3B
MPXYW X*Y*3Q>,FTS[#N6B)A0[T>^>-AS"J9Y'8$3KU\ D44A=K1G$Q7LQZ*B
M:UHRM-X< 3_R5'KA=3 $XD>R"ER4!+)'B*^\1A&_\1XW;6#1N&QI:)&=5IOV
MGR]6.FTU#"_$[PY$5]@&L$?$SB6*B0)-K$<M[<B9B5UXD,3+H/*)>YF5:(.X
M@4D8? ! *5GR([#)!>N22ML-,+<^_=V,GEIA^);2DNEAFZ4;ZCJ"YAM,Q)1S
MDF(FGK::HE+H(D8<<==T DQ'!W8UJ4(9N>)>L-1@T13]^ADVCA2O-7X<'@,C
M^;ZJ]!U#"!GQAR44D.A$:#(W3 ^]GSPR?<1TA^<(4%0C,G>7##Y^TNJ7\*W^
MI]90P0M):P3PLI#/CR[%-IB,R[,\C!P,5QAQ;RAG0O%2PC+I#E7CH: ?.NY
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M-8F #+4N0ORPYJQIAVW6E)$HT<B(F=W81(PR"F09<,X@[K:26E5>L8A^H@F
M@L+0IHXF3M?T0VMR' <?=,0OV'9-2RDMI99B5U+%K2EDQG0!=7#7QY!S; V
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M9WEK@"4!=M -QX_1AQ0"\EF1@*"GQX&)6CYH^:#EPQ+D@VF#&D'9X&09 =%
MME%DQY[C&%X88(<-L2U!\<MPN0>\3$I0.D18Y'/&A.))"1R2-R@5'JCP=N )
M+0:T&-!BH)ATA;#J Q6'$=PCCVM4,J;KJ!@^;MM!G#. C=N$!QJ(BL25L8%4
M!5^:4#%V.%\P<)C3SBU8KB&3)\A02P:5$<;XMD'_Z;(^AE5A?6R:K!8-6C1H
MT9 Q7@,0=3#(>3@;IM=Q!45B@'+@(9\C:Z(BKP!\9&107@VE,'B1EH\%\T?<
M->$H9Z+CV,[ [,1][_.;'#LR[D2SOF9]S?K%Q/I+XR Y*RGSYL&.T3A&2H!4
M\%VS3=TH&(!^M/YCQ@Y\PR@?!]T=,K=H0^8664X/N\IU<I:7<IV1B9UW &X,
M05:8R JHE(2S05E$%L_ Z@(2H91+G#"2L[?)3J1?-SF1<,@YK:]>*G];J2Z1
MQ8*RK'TOO3\R6%KZ7608"6TL!P$#WYO<RB<!#>SB*9A0YA,[5;RKG/ P12)6
MY6I)P(:N;FU@T3)4R]""-2OE="$)0)97Q$RF#6@*0%+"AYML\$DNW!A(2?F&
M$F:?DBX%NPVXG3/@UO,%-\)JZ!\WKS=!O -A_C)5NC3O:]Y_ =[OPFDO.2#T
M>AI"\K[!#%F1*10&A@P5H;/9Y0\1+H )):K#*.=-OF(P\B[/<P 1H"I&!1UB
MR:1E@)8!6@9DF^;/EF_#?M_"%V'MEZG8#*P,TR,/Z8\KI>3OEJ3+JFB>USR?
M=YIGW,[':V$F"_&ZB8T_9=TG](I(SR;I_CTX][&A1JRLD],3?2ZHJ,,0" ?\
M/BR#8K4TSVJ>U3Q;U#E-G3M3B1U4.!5K$1D"K6SP-!GAX-X+BID40S]9.C\5
M7RE/[V$@VX#.=5+WN3N0G<4G0K%4%IH0]U3?370PEU;U!Y<1&EZ84_*KB(PU
M7<HSE0E.0U-Y5)M ER/0<E_+_1],,V^G9PI@PW1BZ;DQ5>D/UC>Q83N^60OS
M];R$\\=@G7''PI]8UPJPME3<4"5"<LK1DL_A)@U"D7<<B_;*])TRH+\'&U,0
MZ3%1N Y.1%J,KL7 W.?MJ(IH,M$''4_"RY>GB.D J>65&?6=LCOCB:]CS!I-
M' , $?2VQ=C!?@'IN>6T7=F^ZZQ05[FX]L_2A>^/ZU1M572=*GE'<76J=G2=
MJO4!$AGH<TX@D5K[],HUG'@5<$(=7?G2XCB:;9+E2B)4$5J$?DFGB^9%S8O+
MYD574 UIK%<K.GW;L9P>M2N5P4^"PK1"-*TY4G.DYL@Y.'(NQ>ZI-A11/IKI
MQXQ*%R6B&J76:7"?8]#$B'?&,IM5L[!F8<W"RV+A1/OON'H[QGT#\.UV5;PQ
M.5#$8&@Y8R$HP<P<D+W-EBFGB0.8#1Q#K)"I1_.PYN$UXN&<O:&$LMUB7&*R
M0Z1X'%+JEH^1Q^C<+(?M7I@EN&N'R18<B*!KJBI6V&;![*$A+-<L_D"Y4ZN\
M:9W0A^J;/V.<CKB=^EU:)KHW<3Z><$<4(DDV9PWAM>S0LN,%S_]DUGBJ+SF?
M*NP;N:,TAVH.U1Q:].EN>LFR+AV+FP,,030IDXA"@_#4G/!]_\H)@9I)-9.^
M^#$JSU" W4/*%@2=V:3X0DK7L;%H Q9/F-TYXU=AV35=RJQ OQN'700N.TGV
MJ+M4/>I^H5@_+7JUZ/V9:>:L:C%T32 $DQIWR!(5 (,,;"*+%6XPB-L7<:5N
MV[$WL/B-Y5"M;]YSA4#1Z\G2WG1M&/P=-I3,Z0;I.NZ 9'@9R^IU^F20P<(;
M[;"\@SGZ!8O?:;&@Q<(2Q8+*S@9F[,@8?*QETT/[(II$;?J>:MZ(KE )&;.;
MR\INLF6\=K(#;=[D\>2 47,2LR-LS]&&%"T1M$0H7"*H8SA,WDX>^,]Q/W ^
MJ&H]:G.-0N#!<:U?)N-Z39<B-;1C80L7)#5J:NQ(IC%H74R+6"UB,TTS;X6<
MA/:3#-#TQIXO!A[A+>YS!:8<+TJU58[@J(P?71HGR#KY9A%X<59M.U40O3-N
M"W>#^S[OW-,S9*(3Z(J!BY$OIMTQT>GEA;I;1[5JP^0O^#5?^A>&LV%J2*<O
M5-K6] $#S^_Z9672+X<HE;1'90W$]@W8:,$+?_'RU6!.=+>$X56,3SF1S S3
MD5G&B=2OL!YA!QZG,F(T0M7B4XO/0L7GG/4^0V4WK#!FC4/^M<91O>9\$X'[
M;(#+ B7.2&"('Y=E21'^]BRG#3.3Z:%CU0QJ:/KPG2RFX*EY1MY)V:C&[H*V
MFR]MU;39QWN7F[*5+\Y)RJ>><(8."DO,VO5!@_Z5?"9:0&D!M9AIO@7U-B_
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M)@;V,T/+H+*WQ15LHZ@+0=B"JNUBW7,M(+2 T *B2(5>M1R4Z2QPQ+<%F=F
M4]L6^>4&0W2@HSW.\]&GKBSEJC%)&3 !D@!<8/,>#3-?%2$?)$3D(DQX_)+E
MA7R8 'R=*"D4VP#;#G<--A!8:V!E<,4;UN:=^YX+\M? VL>.^S>&B/EBH3&K
M+Q61NI35O:[@8H3N^PZ<@52TYB2VGKWJT.*ETB1]:5(5$CP&%GP*?!:E!^%B
M1D\G?(T8T6#(UBO,X@]>V%_UVL=W#'\<"/B:TTVLVFQN;5+&[]#%N-$AMV(8
M!$>_JRJI;-<K57;^F37^ZP7#?_P^;"C\RS[S,<PM !XKU9J52ID=.2![3WD
M$S"X)>"+4U:OURO-<M0RQA>6&/8=6X256&#X/YJ-K3]9H[F] =B@LLD^8QR8
M*?O<R*95(8T^B+8'CP/AR_YK_M/W_:'W]U]_F>XFMWI.W[$0K'B;<$R4,$+^
M#[\/HT?WQ.O!'(H(!8(L[P:VS*^$03FLG/7'0^%:IGU/\Y9)4[%M6?7@060J
M)Q@^8F+H$@R-J1H,&WS+%P%7 -+UAAA#Z_VYB;-,,M[D@(8CY) 8Q.J;?N G
MABO#+[1_II^F -.F,+,'?#TP%Z<T\5Q:E->7D2TRG82*TAHRS=^D%=HJY90R
M_0?\7M;84F&\E.IOB(Z)06OJA=W#U$8 S@D\=EU!U(;:?D_@LIYY67_)01UW
MHVMBIW3O?_XJT6EKVP$6UH1S%4T&UEB2D6SZ@*4&L%"()[_D,"4C2H.5D=GJ
M G2[PW[ =1[S'#S4,;B/>PZZW;'O.IH*,0B/=]$P\2"8P!AGU[%EKXT2S IM
MCI0'*\,3:5<H!KP;N+;I]65I4-F-Z?IP7VW)6(4. A?3K/!?9?=(E!R,DWD]
MV7Q5;H:'(8R@G_BJU?*@I$R8)^H"1EG[LD"I>EG*FJG(9U/+\-67X7@( P\,
M'!S.Z=PC0W\+'%]*%WS?Y]PS^+>$7/?&@[9C,56H[NKD[%"5JB.R(VK-RCI
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MYI^)>XG,_((2TSX653GN#]B NZG]M2!ES69A2$Y;C+-(0I$Z8:2?A.2!]IW
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MRX=F981Q]M0B@UIJ8)6(E"A3JBA6DJ$J*?@WDCT^;"BZ5&T*+U%T3@_'8E#
M"NG:YZG=SJB]GQ%9-#NARL3:6L[A2?N%YX]4!I!;;<U"FLARC)9A(Q8"(V@(
M'F2EM5QUGQP3!/V^Z&'E0#X: W)A76M=5'>*4^4/ND=,Q$.J]:/J06'M(552
M)<_<DB5E&#Q]#!9FP0+D0S&NV7\$ '\V5O]-0JJIG41Q5H:-HF/C4$BT"KG$
MP![#$"J5+M$UA=*RK'M9(2$&.QGZ?$)%BQO'[\GRW8=7)NY 5;/L ZJIVL$J
M'CYF0A5DCF-5EAS0.R%8DEX7ABC5];!<4B\)0^Y:JMR<7)EY%8^9;\LJ236
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M(A=;46=E&QW'G-DVVJS19DN%\1,#XQ6'<6<#,'Y83GS9 /FSTW@U1V6 ?.M
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M>(/P!N$WA/#F$';%$7ZE+'^-\%\2AGUN.'^.M'R#TP:G#4YO"*=/_FKH:4-
M+17I$\+9U1PENP5L>J-^BFY*>,@ZVYQ[7;47%WGS]*^[M;A3E']:I/QKC_6X
MZKL!^L)DFNPKOR55A+AJCLH(\NW2DSED44UKJW72IN-UJQ6\$E%,BP18&27=
M2+B"A:@GP-\=;Q"$PTD\'*6Y4H?J',4XY/<B2")O(LTG8QT91C"@6@:H-@\;
MQCC:G''D-%6(^<-9X$>J8P,6@4A&]N7EM8$Q0W<&QDJ!,<? V$9AS)F!L7,1
M^3SLC,8\-%AFB,]@66E8UC18ME$L:\Y@V<<D&MK_CXU@))TH"GJ"Q?#\L^L.
MYFD;9#.D:)"M%&1K&63;'+*UY]B:9T$"GSW,6[CAV/$54QPHP<%+7,I63O,9
MVH<-XU<SM&F@K@RH:QV:<$5UPQ7](!Q%$BW_DWGC_ZL[]<<B%]?! P\C';OH
MQ'$0^GQB0A,&0@V$;BAQRZ375A=!^8\#V*"5TFN%)_P!+=1GSNT[*EIO8-/
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M^V<?\>2 =LFS*F^?I\^;//-P/E/Q1RSXCGD<<TE*P^KF<%5O.,(@O.8_#@Y
M.'#/?4>2XST\Z\\$BUW"*]N-]_:_F)?@9_O@0(E$5]SKH4E\3)__T6.][W8#
M!AH%GG!7!?K5L+CXRE[@>6P<P<CTIRG$G5G\'%T_*J!1"\([4FK)_]BC6O^%
MUP&B7!SDEU(OXGO[;C*&(71"UA6]]_85&W&YT%<!KF@[?]-;?1?^DE&%IHE?
MWL+*S]F#D+/O!UT.LAT>/:8]7&W=4PI;DV[R \D/GS0/))-=4 I^Z:8SZGXH
MZ@:;&?Q<%?"]W066&81!XKM(TT'XSGX8BIB7/-6+F(^LQO&A_9L/W!.S[U1?
MZ>5/?9[JM]4YTI<"%AU?5;I:=3?D5H([&L%;0;2$V2$_E#+=B9VH_>;1NV=;
MA9>\H4[).[K7V+?N LJ*K]EN$F(_>FP?,X;K [+,@$=Z0SOH]V'7456-J"L9
M9HEV.5X]8B[<RNQQ$,4''"Z35B#+-SB+AR)*B84<75$,ZC#^;,AD!_A^3Q"5
MJ'.\DD#"(!K#7B>XL7\F(I2URR/<?MC?1GV/[>\U]_'X&A4>SXKT=GIT5KAQ
MVFS6T"] E )W[^%U6-/<J;\O7DY?-M[O/]\"&UI9@U8DL82\[P$QZ!3T'+T@
M^?3!\"4XX?<P#,03$1'V]$'7I1LR*,&^A9J.YH.(O1?(FT8 0G -JLQ3@&3E
M  EE5=#?E]!6@Q&"?BG<A'G>!(>D1LP& W@;O*$&3QQ++SW@7!]$'#X+^ROV
MALP?<'V#\*6_BX;&8UB:,![J'_,#M]*!'V(+%S3.,)$?31&Z%E7K00!_U6BM
M@.U YXXXCLWEZC,\]C[PDA&M3)2Q"P$U<I.0"Q8'.% 7C9;0OD?CJGB#I6]X
M"!+/I;,#_$>/<^P>QF*%_@],PS=>ND_N.QR9R^^%G&\_#$;T/B]XP'$.Q6!H
MPX+K?>- >R-J<#!B/\0H&<F!XHQ#7$-KQ"8@4#352*>@6@NJ=9RCG^F>!MGD
M<5SG/]2NG 6CD8@HQC).0NRI2;+H)@'CK^6T]KK[MNC79G?;PC_E,Z+<,N.S
MQZ'H\1PU^ %0'$A"6"H?2,.IH]PDXBM2AIYS^I)L]O*1,^2B<#"7J0@;E195
MH"7_S+D"1EM:M.K6C''F,\M[G,J+A9^7CZZSLA@9*Q3 YGD$(OX .D6FD3H8
M)\\B,I.+9"&Z"5V(+)\[( F_];P@RCAP >0&H55XMZ)X>%.4](:%H2Q]T'MD
M;8!?[M;L8?  \B"L2>P9LY -0C8>1C:HJ:"#U.2_0@*0_ RKP;H!2HE 'WR"
M22CPRP\BU5*H8:*=KTFR1'GM8L=$6(W\8$"7+<0N0FJ[$EDY7 ($[">A+Z*A
M?.&*.$5OXWFS*H]<MUJW:MJR!YC\J[WGSE&SK/3YF;[5DNN*NOOBGC-+-ZM&
M\G%J_FPA2%N+@)?&(61/RN6B_?#%LG+5D*ITT](!H()]KB%Y2/A)@.0B4D!<
M#K Q$KZV-SW!NL(3L?(@S+$9:C9G@"L$+@O9-1J"$H?L[6(?!,7K%K-]&/4"
M' LYRE?4O"2;SM&E2&$4?BUMJII*;RHLCJ/*\78LJ1OT'3X]'DMBCX0FN!Q@
MLQOXP#\ ?]E#E7[Z?)1OJ'P-*F\J:V>$0HC4X *A ;:../.IYOP2.8,\H' P
M1TO2PY)IWDH=AY<!^ *G1 &H[$1PW)+\)%^JGJ0IRE#23E!2:T6\?!PK$<O(
M2:/Z(87/YV6;6K:F<WC<WGRZQ0M2$_8Z^]8Y2KX9"WBYMIA3M] /-U<RKJ!_
MH8=.7F"1'X9L<GI];CSH'U#/U4]$49G7L9<9 ,]ICQI*7)T2/RZBQ$5J/LLT
M?+:*_D76J9198&F@'B1=*_-OC2RX=T)JF*]>VZQ_1 LE=VLV5JY'2R8;@"A:
M.[D[.[5'F.0QDK;F,(UT7@HR=OHBC&([0=-:NCE31<#G471H7R^P@_T@MUP8
M;I%&U_Q%L6#ZN?U9W=#"=<L>GE84*1B*Y("DE5EF/\:!M?PU3QO?@_ \"A@@
MH62B31K<3.K;\(0LK:IO8:P*/6PH3Y5?(MT$V.UDS$/8#7*LC@(76(BD9O9*
MZ0)E4;HPZ\WK0=&_M?K"X^MQF-GZCV"YL4"T-YF:B7:+IS,R:MY.J'EMJ>:M
MKN5-40\0Q<IZ7Q::D-9FWO%G%>( -;IN07 _B^HKAB6?62A@32=%8SAO/"][
MHI88UO+H,(9>!BQT/0#(PA,?\"T8?>;Q,' EJ")C<,#O*2-*^S[UFM2T=S 7
M!$&7F+;V,<:-=I7FLVPQ"[9<9K#U \\+'G TO6 T2GQ,]819+%]21#,4+HS&
MC+LI43-[&XH;?16 6@2B0;DO::0T3ISNM -B9MPFQ+X+RI78MSH45P?5! WY
ML!!C+TJ7Y;PU[='*(FU%%_A\W<T"W<T$VBLVE>(DEN;0.B:'=K,YM$<FA[9*
MK/'BY8(2#/V0<UNK/87LJP5H#Y($C ]IGJ%-[ /F@WW;?T1ZP*6D3<&_9-1I
M>3&Q%M_T,D#VY5,2I@Z@CAF$.DQ :BQY2]:F+Q4#ECF@<Q(06#=(XB64AIX*
M+#V:4UUU)L!Z)&L<B#M#@?<2RR3%%:REU!.D?8#:=$WIC7PDRN>] +NF33WC
M$=D!JKCPHZ#/0HMAMIW+1[[H:YI %XGV@U!L766)+O1_J"S",7I1Z-PQ4(0+
M)D\O#D(8 M"2Z&$>NSY_'((B2G@'7P9DV%M3KI:\>81@"805HN^6H J3=FI(
MDQY[2/W.#P*=BU./ 7*$@7% 11=NT]F5FL3' *-9V#:7Q+,H44BE6!57"YEG
MP+ H-(RZZXD> #W\[P1]IOP'YBSFLKJF%HY\V])C$9):6H-%YHCF/8Z:[*%U
MH;(+[U/'*+-['A,CVJ7IL>B!T$#S6[B7]\VS299D55@N6 D8,?<C2L&$D4K'
MC#5F@H0#2W<UW51YC'9Z2^<XS]0"P,AZL"+]Q+-=T'-\Z8'#+6:46(7^8:'=
MNI@0"P_=IS6&9002<*VN]M6N.!1X,7SKJ[RM-']U2;Q_AHRD#SSQR1\F)V+E
MJ ?%:4_WX**\TQAI-26^B,>QBAP6QH<9TRZYVZ*D"YPC7>SP)!7X&,,2C$/T
M0@,H  ^ZHJ<PF]M@_D3D3GP8<MK:N;0);Y1!D)^B4.T.&V#U 3\+@?:%#\H'
M<_](7/5"2V?F ,,DQC.^"W)@G<-E!$#&K[D3\8[&OO49452&.:*G9O]-Y_,&
M2L*G)P\6GA0H1.$6AAH*8>%DG \,SY8K69SRND)6AJ6R,AK[*"CV6O1/Z_1X
M;[B_6+-Y+']C\;RR6#2%2$6LTC5 >(.(L=(@M ')G6 G1[)36?FTBX]MHHJG
MB#Z:2_#6?)K<<K:MM3#;UC;9MA\>+;G1-.&"S88+CDVXX'66W)!$5/*$;B^^
M7'7N?KLYO]W6I%ZR<"Y9-E\7DEJXCK=3KN)C!^'G^(O<Q ,[G<G<%E3P"L<_
M;[,L-1)SRFI"/T,<*;^Y->LN52Z>Q$?/&+Z )?$P"&$6J>%]II*.0,V([4N6
MP+TNP_H0]$KZQ8,[7%;#MUV!+3[J@HKAM&NV4W=:+U:2YJ187FI-2[6G%L&3
M0FVA\'NS]4J=6ZIW"1/$;__VQGG"VFTZ[Z+[H7/YY=O-K_][]^M7&O&OWRX_
M75Q]N:W9%U=GQ8I&SU51M?K[]"++V"J>3U&I@:BD>+F-"F,UJ\7.'?9<8:GF
MTBQU*A\G[^38ETSF,9MC;6AM'9<ZAU_$A[?16QKU%\S3Z\3?P48&6?C+6_%J
MX.!%C&KC @3I@P:G:<20QVZ-JOI&U=E0\#[-\/P'&!?DQOLF Y%Y]966H/JS
MV;L.A=\38^;-G])^;DY;K1#^TCW7SY2NW#+^Q\WZ'T^,_[%"+CSC 5OB 5OL
MXLHR6*272^=]I">O= *7<F'U&+)UFD*E4E5<*L$O5#%^USBJ*NZH*MT.=%KE
MVH'=#XBVTTZ@S;@4G"U[%,I;_"62K7U4]H9<!Q%U/S6;\N1-:92^*9\ ;E^3
MJ_1%C.H9&I*]Y 7<N"Y9-D^5A37/XGDM%>ZK2EX;'NH2QU+-/ALR$8ZP[#'H
MUY]4!OQ.3&NKP93RN5['VVG0.N;^H@3K4I]Y%0983<&UNN>T(@,VDO9%+'XU
M1V6TU]?-4Q777F\$'B1U[6L>\G\;[759(LIF5-K/PF<@+9DW$RLUZV]TUR?/
M4/&U[(R-O/UR!<2&=->,,=&R[/3P/#.=&#)J;,5%[FXO?C5'9=38U\U3%5=C
M_VI4U^VKKC=8@R5)_3K& VNTV)(Y_",/?=!B QK+5^X%KT4^& '[V@3L;B]^
M-4=E>.IU\Y116JM(4L^AM!JUU*BEY<WP5Q;><YD:\/?$_1X\B/@%^U>-%'W=
M4G2W%[^:HS(\];IYRFBF520IHYE6:;&-9KK^#/\>1'P\I)'\ TMJOQ8!8"3H
M:Y.@N[WXU1R5X:G7S5-&*ZTB21FMM$J+;;32]6?XE<5#P1.5C.H%?R;B!9^E
M,E+T=4O1W5[\:H[*\-3KYBFCF5:1I(QF6J7%-IKI$_RE3(;Q/P<AA^M?"_X;
M ;I+ G2K!67US+(:F-NN<3E=.G"%2JFK#VNUFJH 3NO74)VFK&7UVK#^WU\_
M3MYIDEQ#U=%/H.)HI((42Q!)363FL8]V"= ;GE+>TU<@_RPYB@]30\Q^V.QK
MGTZY0*%O/G1@K4*?3PXN_(//K!<3;2X?O6;6%\>MI:K.J]=E;K^WOXVQD&+T
MSKYD46R*,V^B.//I$XLSEU<3>=[,GI,JMUV'5R)+-W G^.\P'GD?_C]02P,$
M%     @ ZC1Z6>#XV#F<2@  <DP  !    !F;W)M<RTQ85\P,#$N:G!GI+II
M.%1_'#<\0K(UV66;2E()D>Q,)8284LB2J52V- D9C)GL.T7(.DE(8I(UVV L
M22*[(;,(V<\4TXF9<<__?I[K?MX\+^[KOL]<\V*N<^9W?I_O^7Z6[URS.[E+
MA1RPMK"R@/#P\$!N<5^0W6F(V7^?_J^._Q;YOUV#9[<=(K8/8LMSBI?G"&2/
M& ^O&,]N%P0&@?#P_S\70/[?@V</+Q__7H%]@D+"W OJ#D#V\/#R[N'CY>?G
MX^.>#>>>A_")\8L?UCJ_5^+J;8$C_I+:$<^+]BE?J.Z0LO\.'#USYW&DH)"T
MC.Q!.95CJL=/G-0YJZNG;V!H=M'<PO*2E?6UZPZ.3C><73SNWKOOZ>7M$Q 8
M]"08'1(:%1T3&Q>?D)B>\2(S*_ME3N[KXC<EI65OR]]]K*FMJV]H_-342>KJ
M[NG]W/=E>&1T;'QB<HI,H\_]G%]8_+6TS/C]9W.+^1?\M_T?+AX([_^"_O^+
M2XR+:P\?'R^?P'^X>/8$_W>!&!__8:V]XN>O"MSVESBB';%/\L+SHNH.0>4S
M]H#4G<??A:2/ZM!4&/]!^Y_(_O> 1?X?(?M?P/X_7&2(""\/]^'QBD'@$ Z[
M)V20 +/^:7R3;J+<J:3 4$T*VLFL'<*HO_;A*$]HY$%<O0U54GI*PC4':F^?
M6KM_5.+/Z:L]OA6S ?D!4;T8".)R*AL'T4*F[4( E[2T8NK$ZCTZ7' I.':Z
MFZC88NX!$,U3#5HJ7@R5F%6AZ6PILTOC]6T*(Z7566[[QE><JAM"[NAY;0VD
M=IMI=M"KZQZ4TQZ-^>JL>1[O&7W]*;>EQ*%3R^K')W6F:</31DO%7I9_IYM4
MED5 C[]N>/;\H^MS)ZPE3XXQ&Y?7>B1>'([M!R97S:WS*RUTZ-,NR$4X> RZ
MUKKCS"$3:Q'=211IWUGY!I"'VJSHZ3 2**K7H6OHQY(Q/<D085*@++A>_+A-
M4E*"3J620=7Z_'[/EM2O5D]V(6TW*1_P-8-K4E08^1@T40_+FTF&QR!EC#V!
M8'?Q/H77X;X=>OXN[CZZ'R^^EBAS_WK?1CU-@__]NXU6H;+%;)98 )4/+XR[
MS5;M#D[P?X-N8,:-GL4E:/L\<GGMX^(4J[$V3=J%0(NCO]VSRJ*8?]B%1#<@
MM%V[(EAF\P,/=X0;%H@L,1P=FK +\1R<AL\MK@8S8%>?GT5(SX*=W^\6.D-:
MP1*@XL;HO3'-PS*:33C0ID6%75TY_941_GI9T7#XBK(5INC/I C6B#>.1G9.
M?C=>&&3LQM#/_?/P1NCDRU-V$D)%4I^+9,_::?DYUQ97>&[^33!5?&2IR) 9
M1IX%5O@S?S;">0$WU2A:E>+G1X$?KM>\3XNK$?HDH.!OH:&3/PZ7<I*PKE*6
M<+8:S\08,R223XSY9V\%&$R+;3F=[U"./*_PU,[TU:*B(*%]D(?S U<;V[P+
MX0]C9*_FX>B(_?#V-9FN-M41'6X5S&GJINJ/C4PT:549=%\MS?CQ^\W/)QQ;
M"KVA+Q1?HVITI=#LQ1?52=FJ+V8,(S\MZF]!HWK.*1H*<9S:I/? J=3!^.+D
M74CG[;EDB?Q=2)_$$,^V5H])WTR(JF(.\TB;=.G%MX[EMG?.?%41N1 ]H^RZ
M?^[J]6+]K>3\I2\_KM\D#W,WMAE*6XV*?TR$^7I^TG7*&SP$:"8&S*2'% JE
M:H<X!L1TT0['#6C_<TC/DH!9GU6WE+(U?,%,=O.Q@HUAZ1:(FY7@79[!\Y32
M\\NA0J7WY9GEWV8RTA-#C!6D^6M6H@I_0 A],/ $@25)[F>J#M?BXRC0P!18
M#Q&&\2S5K2AU7LGXUB8%AM.R<];2DHR=_6Z?TFNJFU]][G:>1A$V#W\C>C[=
MUO[OE881/SZYN#EH!(%(;8#5[\TGBK-DZ+N09$>LU$1+CD[_"NH &D>E1&VL
M";MIWT0'6#1RNG8<XMO%EJ49=AD60]GI#[H6JF?,HCOOS&?3@,:907F[DT&G
M_X7+CC*%K%?(HV]IUG*:<7DY3YKG0Q[!OI<E@KW1IV</>;(<VF=E'SF:OG][
M]]]B_,'^_GOX;^*9>L9EFJ2ZE(K83!>'I9$>AY_%[H%J_5"[>B7\^#P[3O#Q
M^R^/9B+WSB0?"/UY %%TZ,/2P/&@/]:+^GP?E"&WV*MO/YM<4CD_*)I*Z24F
MF!KO0CKN$6_E54 /LNZ,LH+H"'ZK$&_^1=:IFE*, ^@?_-$I1:?5LLM0LO<:
M4(,\\N^$OW>5MY[X&;-3&A.GJF&7=R&1..PLLA:UIL)]IF>!]Z;*8 &#UQ:T
M88AO<,L4_QI4#J$O!5'XP?OD"5IP?)W?&1)S>G--;XV,B]O*$PMY,ZA2D/_N
M=GW((2N/6R$G_._O+56#1E1$?GWT\JO=R50Y_0<.0H&>_*X_RN(7'O\LMRPP
M1$T97+<MZ_ORHPVOLWV(D240 ^:E/OYF#$PD@FJQC4@]NF471BU_+N"!K@?R
MR)6*5-JR;*BLU1W H'=T^52@9XZU@>>'-'4W6Z&QXYV$K>CE/9&?Y ,ZV@]^
M7FL424[^?2;51^">"*]$ON?1HD//]BE\0)W;"[4+72 J[D*HI7#@NJ_F9*>B
M$2V89*)IP>CMW1!?4KV1+NICDP402#"H6XC6TO9BHM^#6;4"5]?QI!DK&D'8
M+.S62(</N;[26'I/S[03*QGH0@)N%'(9 AE?J,C0Z_&#D@H/W]Q^7!!&PO.S
MC +N'_ODM1Z(@MXT37GTP*RG3[3_7(9;NWI.E<;PQ?0F_Q;SF$ZZ9P2)YO^O
M4".U,3$$J^B0(O#UQ6W']S/>)^I"&BT>7DG\^_K-J--70/-[<2+8$/W(+;P+
MX]3N+OWHB9_:W9"&^$^C']]-L3RPH?\LG"Y$,R:33_J7"^GG].@P[(N<:>6#
M4%GZ"@[Y=EDJUJHS-6^_ :^ @(EA.N3G_$>?GE6(Y66-@$F(X*!!KV)-QE/M
M1U#&-)T2CP-<89.O5< X!JP+)AF$W[OT]?GRA-))O!DX '!FR2J-2/#M_NQC
M)?Y%SGJ:&L6BS+PC;ZZ&-,44H0MP7!N@YB.!JP@A[ \EP7&_($7MD?9=B!Q&
M %76/[>QQQ5I$U[R8RF[\J<S>J(CX\=J:PO0ND67-^IWC3J[&+NE+!5;%/"X
MH<EO?J7_#TO#2!P(^@!^;8 =_S32N2 I=3)SJ1N9FW+)X&JY5^D_R9G5JK%O
MR .<5&/7]I93X)\3= U!QIF(XW=.W Y0.@YL&(;TR!PCN-<>'W+N$:J4TY^1
M$LI<_D[JE^JW3Y';\B*)6<<8;FI)X>Q(BA'Q:\\,/5(%]#NVYQ09 Z=/]]VL
MVN<>_B@,\ZF/]SE7*?<)^.\A?DWC"+5R60+GDB:%Q>5+9"9GFBC2)L.91M9:
M/L4J@K"Y^H97H%%'X4'&UW%#@=A M ZWGSI*O,;WCA775L>&+#Z_)7(M<#B]
M-TSK7PU]@R7SER.4.;<+X<'H J)I:X@YS>AM31*.[Q=6[M,$2["\MXQU$<R@
MJ\OU^(9[T 6Z\/'D?">E8^-!&V)N?2H_OCWWT$BC%6CKKYZJK.VOJ BI4QM\
MLDC%]E@=FU<JV&RMK,17-)2S$;B.;]SH<25M6I-Y8()XVP@QI3976 ?XP))<
M8&O( (:XNEXGAX\AAT['Q87&K?9"H][D@Q.='&5=U.ON.:+4&^04RDO#R?'Y
MQERCUYK+_F:.Z#-VVR[$=Q<RC3_'KM8D^FJFY#;TV*3%%AX!#;RIWD%(85"9
MY$=;08G_XNCAW1.E ,]8EF%#PEO;$N_?6:..\Z^DY_J\HOJ: 0^.\-1<FC3+
MAAU+I#YM,V5L)&SAY=']W92/&VMP CJO>_;(Z-&Q.J*8KUPTKOK!1%-5>?D7
M%YOIZ4]666%Q=VZ^S)C ]U,F@SE"#3MVN Y#4S$6%@S;T8 )@#;=1-@6A7>Y
MZ6_W#YQU5!?G$.">1C6!=>4^7BH4!MH(?&V2MI9.^"[M@0"ZIICK"O*6C2Q]
MI-8IB^JC>]N_;,"VPKP-E;B^;>+8='8,MI*O$$2>4U6=/QH^"VUL5]"P\W^>
MZ_"HZ^EIRRN/]VWV*D0-*C^U4&-%/^0RX0,.N"[_X_HRURP[+N"\<6O2806Q
MT_1 IN/W\"JG7*_*VA6O]$YAG+9%*GE*?4K]]0UJDI>Y.3N*VUAAN([OE+J-
M]C1Y-*X35[^UB:S=:%>\L($89IG-72WQ;A+HU8QM\LY5"TN363+,BBHC>R,E
M3M5.>XM^JZ;!Q;QUVPZ-7?0-*$%_&4>7C&R=B[.VJ0G/:&:E;3[L!3DO.=>=
M_BCO0@3$N5L[UV;,&8!7!Z]6,Q:91\$5>.1ML(^!LMQ1366=N$W#BSFC>VF]
M\6T'?;&GOM^K0QWP=FG-\";'_M"SK_]4'WMB"M,"S_I:":!8\D@N.?38S7 _
MU+31'(Z$(*<QHQD"W41>$,F\V\SHB7CE4Z@$N*>@RL J> )'X+N$4RIN/SKX
M4EM(MM68YONN,S\0OA_G<XK^7#",_AU6Y60]Z%"Y\Z1AJYS]X>J5G^4[71'2
MJT_T9;_9/;([,TQ,18$&Q1PADYV'V"X8#'YW4!#[A:*TM1%MJ@1& ,%T?#SF
M7LF2$@R(K=M?5^FEI M@<]Y0^C43,/ *!$HE,[4D[$&"K['_I8P:6^%+%2H\
MLI^LCOYU:JM'$@9@#5QYAY,%YE17";L0OB;V.U-3["!'KPGT9^#:=?$")4!P
MRJG:5F&7YN^P+B(,*P7";VHM%1X="4K9OT1@G27X;%\+;[9K.M"+^3/]S^F$
MR/==R!$B< D&GB*R)%>8W%D@,H/S!<^'U<..<909&YT$&-B+'&;=H^X0(9BC
MPVM!S?((/G2>8UT#_BJP"WFZV7IG3+GM0WTCU..MJW7/@738B:F;'$EV$Y=\
MTSC./GEN]>,FB#[$Y-S>'E$GVE_N+>ZJ0SLF0MM2: 4'-TTTG<$5(.SJ:.7A
M-)*+1IID7T#H\Z^#@1IW[?,<YBY<V85HX84Y)UA6H I7D:"8ZZ#)'$Z,I0=F
MTX3SDBC"Z+E.F5W(%%9YZ"'AP7K@2DYM,S7]Y=%/U<V?:E[&S]B(_.[IK_O
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M0.5&79Z)#/,#HZUA#@7J!G,$[Y W?_]P0QLQ"> *,(=HS/)>S&PQH<(5,#B
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MAO[3)$)XKNK<3:<<,#[ZSI090/+O"7MH I^@T"BKB!UYEI*I!HX;RS[B5Y>
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MB[5387HY]X?L.-?3C;7"3' FW"+84::_0&/P'Z$D&(_>:L1.()K=<K:*A?R
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MT''X*.4-\A]. 9]]L2Y9/'N^CP#9X^.LSNIR(&7QCT7]!72W82<N!3L]+HD
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M+Q:_?&S[B#1X,N]+MY7Q_P%02P,$%     @ ZC1Z64;*5BX!)   3+P! !$
M  !R:6UE+3(P,C0P.3,P+GAS9.U=ZY/;-I+_?E7W/_!\57?9NAW/P\[#WN2V
M*(D:,Y9$K2C9\7[9PI"0A#5%*GS,C/+77P,D)8H 2$@SCI%;)E6)!MT N_'#
MH]%H #_^]7$3&/<X3D@4_O3B^N75"P.'7N23</73BX5[8;I]VWYA_/5___W?
M#/CGQ_^XN#"&! ?^6V,0>1=VN(S^8DS0!K\U;G&(8Y1&\5^,#RC(:$HT) &.
MC7ZTV08XQ4#(O_36^/;ES>L[X^)"H=P/./2C>#&S]^6NTW2;O+V\?'AX>!E&
M]^@ABC\G+[UHHU:@FZ(T2_:E73U>%?^H91^3Q-MG?O/=>)M\_S@COZQP^$,V
M0.%#\A'UK?^YF[[Y[=N__W"#/Z_O/_9^NT,ANMR]#NV_+RX_D]7/]T'OXVLW
ML?-/_IAX:[Q!!H 1)C^]H/H5ZCV\>AG%J\N;JZOKRU_&(Y?QO<@9WSX&)/PL
M8K]^\^;-):.6K!SGXUT<E$6_NJ3D.Y3@?<E )0W\)$Q2%'I'_'ZZSU!E_O8R
M)QZQ$B'K=SDK*5E]7.-+L/=R%=U? @'X;UZ7C%ERL4)HNV=>HN2.%5H0CIB3
M..49(;'.=)'NMC@1LN:DHPQ^&M<R'-4:D"\IF>:YN;AZ=?'JNLPYL\?6/A,*
M5M$Z"FC_8RV:?>/JS2O:+P.\P6$ZC.+- "]1%H :OV8H($N"_1=&BN(53FD3
M3;;(PPHEEFT=A6$$70+Z99%"T[9; FU^GP!)M(V\C:, ST$/@_Z /BG_#&6X
M[$<PMKPPB/_3B_QGI<"R2!\O24C8YXM^>&U<T%Z7477A)\OYXV6=F2\I2[#O
MA/_+?F]CG$!VIM8($HK\!4MS7@\%7A:<E?4@7U/.(KVLS*?6<@\%M#.Z:XS3
M)*_MXR2E6K^!JJ9#(]Y7>^CC$$2GOY(H(#[0?*,HV<B+[F!1A&6*8M![C5,"
M:@@P.J8K ?;J',",;XZ^]*<.0#F ^\I-G*6SI<8-?+_H8!*:$G"OU8 [?,*(
MEL;A(QUD:I"Y:VCIE 6,3I@QB4=2Z]>,I#L>03FK$J#?G@-H]9O_;7Q3?/9/
M1O[A#F0UD/LH60^#Z$'0+0\D)1"_.P=$^@V#?:0#3 [8!!9<,7:6O2PA(4X*
MK+A4)9B^I\8A+,&"*('<\,?$G"]FEN$,C=["M2>6ZW90R*&880]4'>!['$1;
MUHQS, 3I2G#\4(=C9O6MR=P86!^LD3,=P^\.CP8\1@2&>Q\&_-L("##2>#@.
MS= ?HQ"MV#@S!?.M $F560FY-W7D1O;?%O; GG_ZLW'KV)-;H^],^M9L8IB3
M@3$V)^:M1>$TIB-STF':-#]EFPV*=V!6D%4(RW,/A:GI>5$6IL XA:G$([B<
ML-1X51"]OJHCZB[&8W/VB8Z-KGT[L8=VWP0 S7[?64SF%.*I,[+[MM7!V0"G
MF208,(&NE[!/Y\!QJ4H07=<A,EW7HHA UW/MN>U,.B3D2 Q)"$M92,LA./RI
M5/<W];H?VA-STH=NT-5YPP05P8PR13MT%^ 9#J@-/$5QNA_ &NA*J+SBIB$'
MIA=C:GXR>R/+^*___.'F^OHO8%:,S+DU@/39O!NO6IRNFPU)F0T'M@%8"70F
MP>%ASFEB4,+L=1VSOC,>VW-F[#%K 2P'.KU8DVYN:<:J\.J$JQ%&28E//5$)
MDV_KF#A3:V:R27YDF6X'0Q,,=I)DU$GJ+&G?B$(WC;S/.1ABDA(DW]4AL5UW
M 3,.6ZS2+N-,#'?N]-]WT,BA^8CB&.V7J?N_E #@? 4?S=G,[%:D;=/'-LM5
M=9:C*$FF.&:^ROWD(2$K0<+Y"Z ?3!=SDYJ^M%N,'!<F?VMFN._,F=7AU#!F
MA? 3S]%C.6U4$Y2PX#P ]@30L(RY^4LW730[T>YQF&&H.[1:Q7B%#LM",4D%
MCAMN^3ZS/EB3A64,;->\O9U9MV:W0&P;NT+JQBPVRF#*CK%/TAE)/H.A6T!3
M#F,*G$JP<4MZYC:;S&<,+9?-]3-K8,^-F>V^9^9Q 6R'9%,7VR\E=W.8\A/D
M579?I50EQ#A'0'5Q^<D Y":NV6?H=1 UN3GO$OQK!NI:]X>-!"Y5"1+."^ N
M>J[UMP7U-]/.TIEL34A,XPB6C.D.ABZZ>\SV;W(TA!0E1+@U_G1&5Y30/^@(
M!M#8;'.G@Z5IGQJ6BM1>QC! T6];C_0G+K>J)50E>+CE/EM(,FO:@M&+F=/6
M+_1W-\TT]9SL+B">LUSB& C02R8H\=&OBVU DG3O:&[E4H*,<P=,%[V1W0<#
M86C-J)^&=JR)Z0[,OQF+Z<AVYYUKNGEC)MV4F!1[,I4$)4@X!X$Y'^_QZ*J^
M:<8A]V"!30/DX>IL4TM5 H%S"4QG]@>PQ^A&<]_J)IF63I"MLB2]@74(FU!F
MV,>;;66;4DI6PH9S$9B+VX4[-VB!Q90#:QMK/.U6IJHPB;M. UT%J%><\Z *
M5->A3D!J@#9HA?W;*/(3._2(#XK/L$</(121HXT<2FAQ/H.!.39O805ZZS@#
ME_KA[ %=^LRLOO/!FGWJ\&I:AFZW^=$8%-!S6O&&R;X/WRRB!(Z(Y5+UC)Q*
M^'(>!G<QG8Y8US-' ._0F8US&[WO3 ;42!^4T0C'] [XAB$U#Y-*:.@B#)EW
M0;&P$J0K@<;Y((HX*9?%-,((VAMU:RD%/(I@$%@F04J<8;]8V";'\,C9E-#B
M_!-[M,K0$;J<@L39 CI7L13NO$A-4=I1BBNHL-&/+G?ICFL>75H&;BLP*F'(
M.3$FSMPZ!I"-BFQQ3'=N\PC4#L4F\R7#PSC:#)&71L71R^,D)60X7\5@81G#
MF3,VAF9_[LPZ!%K<?L7!GN,#1URZ$A:<DX*MN]XYHX$U<UE\W/=_80[9>6<G
M-L&"EKB^MBKW+(0D)7 XYX5K#BU^P=4-60W(6)MM$.TP[N$0/E\]\""D*.'"
M.2ZL\73D?+(LHV=-K*'='6-XIF,,YQQG..E8P^LG'&LPOBD_U1UT/N&$PYQ:
M=HGXG$-!4T*N_;2#\4U>7@?/62'X5:!:N90@XSP72N'X'8RGQWI7L1.3E #C
MO!;UN.\.FQ.BC*N@U-*4T."\$F7$<8?"4T*/J["T,2GAQ'D>&L.0._#.#8JM
M M?$H 0:YY00!\AV:)T9,E8%JX&NA!7GM!"'CW58/2&.K(I7"X\29KPO0QI3
MUN'VI#W_HP56&Y<2=HV!&IP[JH/O"VTL'W7)\_.K0/ZMP"]RWB9SUQJ>9W>L
M"KXZNQ+6G"=%<:>L@_:L#1MN9A51E8#C(T&DFS<=5N?NXAS!U<"@A!A_%$6\
MH]/!==9U8P.<(A(D$^I<2<D]EET_QO$I@<?Y7P37D=&[%EG9QK[P#L.G7U$F
M!O;<S$IH<UZ<DZXPZ]K!B4.OM\9^%K";,,*$^,5]M.S\Y1+',?;G$=LM2MAV
M$?P-.(\(NB,!H=L00,LVV"\JO1BMG[=,I5;#N9'<_CMKL!@5UW),7'M@Y8=W
M\Z.@0VLV ]-Y[ACS=U:^A>7F>U@TF;:LD6WV[)'-=D* OAA#>MFXNB;UNS4I
MP1W;7_(#2HV-#][YHHVMN][[G,8WC2/ZK (2K<@EPY5*%J4&PCO=*@UD.G,,
MMDR7+=R[0>;TZ :QH=+*I80F[X;C(QXZJ^.L.Q_%L,G)*GA]Q_G0]G="=CB=
M.YK20!3)J%DE*>'#^;VJHR,-3>F&P*=%$$E6;>K\2C">&U74=<%GNOA3#/,I
M&91PYGQGC1>#=OB>.\1*MI:*KCJ/\C RR2!\6F8EW#FW6W68EFY+E=T=%CME
MJ%HWF)\TTU*DYCC>0.^EU4_#K&< HFSV;6%7@IJ_>*8Z(U,8C;DU&[/>/K!=
M%I)MS*CKO /W)'"/8T+'(,HFVPPS^F8*S,Q5'WD=YQ-R*D'>Z#"KA9L:8WMB
MCQ=C8[A@S[+ %'_L=._05P\1%L_:;4Q*F')^*3YLN)N<GWR%M!A -58E&#GO
MD>R*Z0[.<\?A,@S<>MR2N,DE*&=4@I)S'55'V7T8N?7+U)YUSK^3 _O%/5%*
M54'L>\YY= CV[SK;>9VMAQ+B,?,TR&BU5>/[)=U.)8L2G(V^II[IVOW"J!TM
MYO8'BSLCT'7')YSPD#HH%-F5$.;<4"VG/KI>?.:%]!*[IX%!"3_.O52]L+Z#
MZ]Q!MSB8T]M-X\C/O!2$D VV3:Q*$#9ZBLKS/+U/=.=SL.C/C9$]Z8;64[V#
M*,!);W>+HU6,MFL:"###*[GAVLJOA&RC8\@U1]!# ==;R[F=F=-W=M\< =ZW
MG2'[E.-ULF!*%58E4)6/W'5C[W._4R&SB,[(J00UYQ%2?L>B0__4KBQ^O4+6
MFQ6YE5 6O-<L>_NB@_74\V+'+U^(X6SE4H*1=Q;5W\OHT#L5/96;BV28GI57
M!>D?GG3[4=<$S@X(Y4Z_RP-!I:Q* #>ZG62GYCN+^;PK#L3]5XE3"4S.P]0"
M8-<S3QR<Z5:9PQXP,,$,NB?I[KA?*C J 2EXD.HP[+(--8>]>6!08^D#.[W9
M]<E3AMCR:L<*4(F3I4F*0O\0SMMXI..<(I3 ;W12[2^2K#8#6!XMYNX<.GDU
M=+@[CO$LFT#,XR\+=FEF5H*[T7,EV/AANP-=1(L:JI)[:22&M"JW$JY\W%+#
M?3;=A/R<[Z9)[*Q3<RG!S%\UI?"N6@?XB8>H#D^K2<Y/-3 HP<AYIJIOL75P
MG;KV.;X!0[;N:>%2 H[S10FNF^K0>Y8WW21=3YE=!<\WC4^)U=]\ZZ ]_YA<
MDO3P,HHQ'Q?!GYMKX%4"M>4@G>L:/6OHS"QQ2$4'J:K;\)XD\/5A%+>#VL*M
M!"M_O=2Q\_"#[=)."LAVP#X!V $N+HM C\5M$4>W1$@ 5LRE!#3OCZH /;#*
M:R/,7_9W1M2NBN@0/PEQP&S?/R7PBEB4L&QT+U$(#QVW0^V\2#;EV">%'$J8
M-OJ0*G%M7?S3DVUBM;7-"?Q* '/.I)8+=CNS^*17ZQJ>U!7C>U(.)80Y/U++
MH[P=QN<.T_LKD.FE7%% ?!K@Y$(MY+=U[D^P'J*<!+=YG5J"4AMHO(WI<(TR
MO;C+&=D#%CGESN%_^2'7PWG8:OQ4URJ>IU7T4;(>!M'#V8V"*T"I330>S%-J
M$WW3?6<,1\['KDT\=YM@VWU'MS.?VSCD)2FTDNLK/D[KU%;"MA6+FZ'_NK\3
MNFLO)T45)"G94&07"5YFP0CF9-EHT<2JA'BC2\URY_:8@;QPK>%B!&OQ#]TJ
M7-'4YQYPEYCX[7Q*0').-,'#[YVQ=QZ&TE?>FR%5SZ:$,.<]4WHLOL/\[!-H
M6^S1.&AZV9#T&BH1CQ*:S;=-3:T^C8EFMQ!U ZX2< J/E8B[ZSD9E2#FW&G*
M[YUT7?8DOTN&AW&T&2(OC6*)HZ6110E-SG<V6%C&<.:,C:'9GSNS#K6S!]I#
MZ"N]50C[@XQ&X'S""*#R\.8.QZ^N;Z[8O]?00^%_-[+Q^ E%*;6"QJO0CV*J
MZ25&, \/%BSTAUZ$_LDR9\8 K+%QSYH9KZ[_3/VN5W_.O:]T-*#2=(/]>:\=
M-<1B-O,IP2Y^55#R E(W#IPW#@Q)G*3T="BDT!L^[Q(O)MLF#ZI"#B5X&[UC
M0WOFSMFA4DC,[P+MN?V9/>T<I*>??:&&,AA8*?;MS0;[!'X%.W.9XK@/E0^9
M@.5P/EA\+.:\,E0:PG73045JBX.Y1MTA]GAL#6SX.?IDF$,@&/V1X])QGO)!
M*ZD<0>X:R-E/HDG&="56);AY[Y?LF;1_\3&=_N<.)7B&E\8C2TF![:<7"=EL
M \ E3UO'>/G3BYAL\ 68,J^OWKRZ^@>H_?)Q$Y0L] O[IO#P\/#R\2X.7D;Q
MZO+FZNI5WA;J-55\N"P"Q1Y7RL,K5L;UFS=O+AD7%,*.0Q*<7);"EP6D)*79
MIY7/&/0[,,Y</J/F ;H[57/(@H,OJ/*(EO\E=(4&>JJNM3;]A33N'[[R)?2&
MWG6JWL<=\@NI/=A_A-?ZQTNTW9)P&14I\'<81GD_*)- \2A.C1!M<+*%,;9!
M*1+2LXH>2)" %;9!H\AC135DH7]=E/DN:-+%]<W%J^N7CXE_D/04(0[5<)H0
M9;XSA&"E)=A[N8KN 51R21N%^/N)C)W^8(U)]:-+E-PQ%;+D8H705N6CPCR7
M.$B3,N5L$6@W29XN ROF)"&.X/33^)(600N]N0 <7UW+Q6G+R?Y.SFH$S.L?
M[TYI"-4LY1_GH9'$Z4E E/PY"/#7V9\]HQ7P'Y<V 9R_\I#?(F2/K7^X>$/Z
MZ,X.O3'SY[Q@XH%9R*>3(*!.W9]>I'%&1TB0@;R%D9-$_IP-\'Z6Q]>\,/(!
M']I#+LE;/]H@$MHIWE!.T O6EC"V9I3[-HZR[4\O\N((L#2):Z;S-1ZC^#-.
MV15UYBK&C.58^G8VK94QX3\^_>&$6%$Q898_AI+SA^A4):M9M%"2QO)/L]A;
MP^PG:Y/-/#JH473ZT:@O' RJZ3J(RQX[D-2VA*:#V"Y.TSQ-(GL3@QX*>%G,
MSJNT-'D51AT4HF^;R=J1D*2#T,7!SFT+!&U<.JABSL?E0?':F"D@Z" PS#_S
M=90E*/3G#T#9#:,L/A:]F44')<Q_XF3]'FVCJ":ZB*"#P/GE/D?C8G(L>2.'
M#BKPK8+<X[:&4V7108G#?95T)[@&@8RH@^ ?H"8_NWB]0H&HW<O).@C/M0N7
M/+:TG"J'GBK0HW9M2ASQ:*F&15;KM$6-8QX=U#"#512O=^EZ\Z[80.*\ ,TL
M.B@QP_=1<$]?/J.&6KD^/-:BA4<'-<P5"7 ?;4F @F'&[JH+@CH8S3PZJ-''
M/HI-_YYZHCGY940=!-^[N^YQDM;G!1E1!\%AG*'S;'[GNQGZQ9)K)UD.J+-K
MI!SKMJJJM3+KH)B\_FO6E JC#@I5E@R\SU),TTQLW@LIIND@=F&HKM8H$%JP
M1P0=!*[6Y1H:L+RFCZB:B<XO\F5$'00_>!'=;"-S,%9).@AMTVUV%!1O$A]+
M+:'I(#:,SE'H"Z46DW00VO1]%M,@J6XY60?A>T&&/]'SNS&W:!&3=!#:Q?$]
M\7 _HJ_U>'1:ESK.VQEU4&B*8VIS'0M?3]1!T$&&G?#G+-B!!:+@O%5GUT$Y
MD-#%6P3?P6-8(L(:)<3"+JW"J(-"+!"]695F%AV4<+PT FG4&IPJLPZ*Y3-:
M,SPM/#JH\3,*,QH +ZIRSBFORJR#8L4]-^&J:7^\C4D'1;BJAH1I@-H<QG4N
M'52Q'G'LD81&VGMX1D_"<LOD9A8]E> 6S<TL.BC1CS:;*&3;XN53[S672P.#
M#@I,8TR]O]@7BR\GZR!\\20+&+1BZ1OH.HC?#U"2$.\]F%#19SQ&WIJ$N-Y^
MFGET4&,$G9/>>U2\V%Q30$K50?3WQ$\^15FZM@+LI7$4$J\F?B.'#BJ,B1='
MVS6814E^F0E.DB@F]7;4SJ:%,AFT]:.CHC4MY'0=Q!]%*_K.B)<4*^YZ5Y"2
M=1"^<1C2>?QA7MY^!DN##:['CTAH.HA-5V(2J<4D'81F$=3%E<:U-9J(HH/(
M945R)K*(H)/ "6</"REZB<SOQTAH6HG-NU#$)*V$/GJIG3[0+M% SJ>5.M+^
MF>C60<OP\_I:B4O605@:K9T_BM:'J1O58YG$1!T$Y_ND=EW1I2ZO&.WJ0?*U
M5"U$'?=[-3&K*3J(:&9!:@8!H1%=?.R@A*B#X/0]R2S%,2RLG.42#/O]&\^<
M+ZB-3P=U/K)KBK-$ID8#70?QQU'@TS7N/(H"[@B(C*B#X.5KPS4?:#U5!U%=
M\MC/8OKP,*U+:M<-HQBFZ@&),;W%KQ[%K\RN@W)EC0M/@V#-IO<%C4QXH,?B
MPI5D<Z:910<E#@\*2E1H8M!!@??4Q-ZF;-<HQHA>6'0+<M;VEEJY=%"EY1"F
MWD<OS=NI>"= 1-!!8"NCU\7 J+@(@=5_#UT4RJX-/,T\.JCAI&O.B55+TT%,
M,%A08-.[;8* 13T/:8PHB5/:":,P7=>'?'5^'=2;/^#@'E?EK>]M2^DZB,^"
M<.3A.3I&?0PRVB^GB/A..$:[?<2 0D38J?DT49<&LH68V7#JD6]*&710<%[T
MZV!7M+9Z#Y+3=1#_(\:?#Z+!8$43:BJT\.BG1I/X6HD-JYS*$S]'5SWPZZ%V
M3AU4JIQA/M9 1-!!X)_1"H6P6O!K/CE!N@[BNID/YL0$Q2@AFS7:9'&ZKGL3
M&UET4.(]\F%$1P%V8Q*2>Y10D3&N306M7#JH,D/_)/<N>L2<HUQ T$'@=RA.
MUJBW1C6+29"N@[@N\7VTVR'W%H7_K(\I,J(6@F<@AAE',:KW3BY=!W%9<_U
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M6#1M4;@[.H0FFI6?5)H6$U]5&\@($U9Q^%"D;IU!"PV$-P <(D+$1%V7J+F
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MT@_L(R=ZFGC!5R'"5B9U!]L,]&:(YMN[)')]%#6"11O?'4066@/68_2,O.!
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MT45Q3I('Y-Q-?HZ:I3ET?U-XTUN$Q7SK<?)>X<31=9147"@(Q.?7.L2E@+(
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M7Z0V+#D]Y8O?7PP\=X-[ ))HFG1^/KV]=&X$6(\T\]G \V.^^(7%^=0<D]:
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MPB)[1"" ([]G=502HW)K!]&T)(I.5)ZJ"C%E!<@4Z%H=G<GNY6[&B)A!7-J
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M=US8'?,1.=&GEJ0YW/I5\[0NTN4&F'0F+2]I/(&K>0=J$\T0G'ZQ.OY]A=V
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M@G%..X3'AV;QF"+/QC3CQA- XJ)Q2S#(HQJ2_D<9TM==2U3V2=-623Y-,RO
MW*3@A[:_,IV8OB'Y'1!&!INW!(!\NE4)Y,34T<0380B.C5L%P#G5H/@;\HK[
MH>>=D<9<?Z#6B@/ )!M$H"$_..:#/J<Y">&P\64KQ26>2RXHZ8:<WYBH0T#$
M#>B;H2QIG[=LA<1S2 :EWI#3&Q/6CR[U.R/70M]_1WN6V"^:MD+N>32#@F_(
MV8TIFWHV3;N;VRO^\G+9MA6BSR4:E'U#'FY,VL+\/J)7<**Z U1B? B +JU
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M,[>K^C@)LL *M,O>_@>VO\.^'>]_<?G &Q$#(*^?-,"*X0"9 C!+((!E@P*
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M$0"0'J^YY0&\Z-]6!//8@""4^\S0G6>Z08[Z11P\FCZRJ&6,7)]SXZ+$8.T
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M)]$NEM!8+*%Z25<?2V#)\4;>JU6)+4+]-DQSEBQT,DL$H@AB_9=YBJ)2_*
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MF>)5\X?[>VWVA;X*-Q_=34;#45^;+ [7P>F]FJDQ'O5'^KSWE\/0?^T,U,Y
M[0S4SD#M#%3E)-H9J%T58^6K&-^:ONT;ZPOC91__KX!I*M9?^<K%!=@0,$>;
M]C%<G]!I11:U,'"L7LK#Q26^UJVWU#P+?<*3[Q/OY]%VXZ>D8\(9<POLHSQ
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M'H@39J,?G?3YN,A)5-DAU=6%2C@#LPIDIN;07<2+:)[9_M>^ARP[H/]B9N9
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MHC;.IQ[:F;:55&PB[8W@"7F\"JQ2R/GAM90K'$AMI97$J%(44P_OD!?LZ>7
M(-DW=NR:48U\_D=42[8P(#645@"D2M:C.4<3.],SLQD5S/WTCZA^L" @U:NX
M[FFU2[P?X"WR9LB)!J(5HJ%B#K5_5WEM:DX*8+"QXD!QE=P0[]V*'G=O0'^.
MW_KA=.:<\\I/GQK0DP%Z1@[9PJT%6CVYV,&;O)*!5<LMYZL_G.Y ,@"U2'KF
M1H5N3/H/JZC8IC\U]^R3SD;)4%X=I0D%U,^R@?U&+*M+SL;8=!DJ5[UQP2)
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MR90%G_2->[VWT/ZETLO,^GJ-5O3[1P;I&^+T:JF[LAW;3.3'BY 6'$:2Z2Y
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M;W[GBC7=I :%OE:N&?)  UQF ?W\+>3!1^O0&=MK1E!2H+.T=YE+1Q^%F8+
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MB.4$%^T!FBIZ+PPFN)DC\Z)R_VP'3S/D1&N]_V3O%IASZ2F/0=X@S9?^86/
MP$I,'K)+!<F 4<DTS_J@;O8>G/T]*3E/BZN1IM1TVR)O8'MH10:!RRI&5\_$
M>DNH7%1V>N%2S"FQPL;E.SU6X:.S)C(*'UT)2RX+E0<\@*ER,,[94^*BU3)O
M>59;R! 7X ;4VL"2U+1D245GQ6WZ6CB&E$CF#=FC^TU8L5?TE0_;"6G-DSB
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MD\0$U+Z9GG6<W!JQW^/[ ;[^?8=6 ;(^88<,XY E8$;$Q]EAZOVX^IK3F!!
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MD712G\2KY41:S]HNWTA:XHJ%47-HAI"05U@G"N:G4E(X)Y3IIBV (9]DY<R
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M?0B @G1R*5DIAS<HJ[U&AZH.98IJ=@"$C]#?P=,8O> 0<0DOR?DG=K8I X"
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MUTF<4I0=-,6@.M\>@9XX1H6*0!8X=T'A"F^_I__<DV69_.;_ 5!+ P04
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MG0NL TG.J<\0,4.Y'6*&J+*\V(#5540C\A^?_F$>X1Z"$IF[%Y>\4GJA\;;
M12<EW$V 53&(E.->CNN7^!PYULP!R9&K5 <Y5K9?BQS;A/O*D90#QYU;'1]3
M_(\CW55^IG44!]9IT5:W]]64&QO[8JASQ9GQXPZ+*C1B\,%BZ"X@).7"4H)U
M*"+YLE((A"H@]5EC6SY#SXEIBK,%J>W.2[&)DZ_$VYOU#&B?ICD%V+E(3!ER
M$QDU0:7- #Z]>+!)DZPVT)"_G089\I>_T0M,_C$DR^#\4/,.9[O8GT;/.,U.
MIZ+U?\68WJ823&?G%V=#C9>J-!7KN64YU_*%*M"6^LGX';MZ9R749C8;:T-M
M:AC;H38<O7:H305PK@H5*VFH#0'"\;_+T/?1AH@W98>D"O];BK;I.FDHUYTG
M"=2Y;LSX2:\IU.###A@S;.8ZB7'6!@X5S6KP$(&<"T''C _+',8CDDX861;F
MNQ!Z$2C %J<0#>':7")!PM"$CAX_NY1X:_YRQ\5YX =>\D:WI>9;%@&AV>>1
MX&TOTI6TVPMU(=BYH$P9<IHB*!1OR[ \&/L\BR1X]C*\"+V-?#S2@6V*2$VX
MKB Q$HQ\E/3:VBG J$(//U5MCDE K\)UV/(Q,+(X=1E6H#:%:2R<2Z<337Y*
M*^WL[P5UB21/L!]DM]XF",47E%1 J['D4J*-8'(.Y5Q%6FI<! H#HA()9>I:
MXN<X? ZBIV9%-#%P2AN[H7 &])L1<0H#,*HR8<G'QQ4VB)/:L+/<+/8BD_6X
M"&9O.2XG>5J-\QCGBM 0X];B!&EQ*4Z=\"4^='!N-!;V/!LCZB>W1@F'H1(C
MCIQ#P]91)RN+T6KKN_EVBQ,R8BG./WF0O4-/&<'326<; 4,(,EK<F>;Z#I5
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MJK:'E7A[^\,&M$\;Q JP<YV8,N2VB*D)*FS0R6CH"6J,?2\9^<\>:2"E4B1
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MJ<1"I@.>J3+A@1+N4"OR] <*+%2MZ)(A"+5RR:0(Y\? 1%G@!^&1>AI%_I8
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M-4J_A-'EK;%/.'Y*O,,NV'BA9-=#@;66-EI'M\H<+0,Z%XP)._[RU DVZ*&
M1BWW<9+M1GN<$"+"X40&LJ4/.<%2&#P"A"*DM-I28$!4((<9.U*\^?8I?B:_
M-3L:S051_.6DA^(?_C9Z:%6G_H&-=N>)T+8^_:OS]N6H<#':#ZOU<C2;CIQT
MZLF1+&7$E[+XCVUU9!&IL@O7/W/>N!)"W$49!H%SK#:F/W_$;N#&T3)(OUR_
M7>-HL]M[R1=%U(#>S.;!FFDEZB=K.AOG@NI(E ^OK9DA:H<J,RCQ!*,-&Q+3
M)=[@X-E[#-47_N5PJ[>A-*0;5YDD6##BTA#D)J@"CDYXT$/9^DWY!*;2PO$
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M[52!#@J\U6SL.MJ-/.PRL',QF3(4OM5-(V@*"Q0GB-D,FW![]&E1?*'B<%$
MLG<M3$;P="6LC7"N 24M[BK8IT79YL,?)+/GED:1_Q %9+GWER!Z\F/Q7JD!
MWMX1LP'MTWFS @Q#&08,)>]D44<D-T*%U="*F6<[92;VYN?6%"&B52F@_B&,
M%A<PX@*L&02.%W&#'S.C.$D1T*;?("=:=QAXE'-E:*EQ=RX(\/+AD+*IXA_'
M/%33"T/Z;>EMG*QW09+155,<93M5,)*QK;TII&-U3M.)H:%S.?5A*XBE]$(4
MU.S1EOBA[S^B/3,>>K99O^#P&=?YRT4FQ]I[!D9#]_04C 0(0S0:=FV1O/^
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M1# 8;:_DQB<D8V!4H0>_>QL?Z2L'BA5[&V'OSJV0VNF^;>-C&&TMY,3=LRU
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M0U/WT*"IVS"[C2TFV6SN)@90@PN)B9O\]U866O3 3=OB;93=Q9:08G.YU8#
M:6XA+W%K6SG1I/LV^M9NHZRVMIABH[6;$#BM+>0E;FT[.V.ZPTQ7YYCJ(TR
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MNFNYU6HNZ*XE@1F"U54U'H_%Q< 2="_NIH*&-5)+W*+1ABQW\IOZ??S9ICD
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M.S"V!Z/)'J2Y!V:6-+R 3*#4U2-ZG;*[D,ZU6HO%H;D)#I@X",RYS=T&EHV
M[40^TN0PY0L/N@#U,PNU&H1\D1^@$:M\5HE@-'^1:G"#-36XNF:)ALI7@D?T
M..N)Y0^%Y T8U_^Z7G]MX/VYI8+L&^J?H%?G$!?Y]?4.93VX[D'#.&A,QV)"
M%EGL5&?R7_3/9^\*:&,[%L?',-B466C(''?OI;[WCX=#&*2*G?;>I3B(!>E:
M14&,B&D1SG5Z'F_.>6'FJ+1'I "4EX"J(@9/B-6L@S+JQ,#(0<HK304$.:XD
M%C#494J3$]/#]6PZ1O/;V\F2!MM2A_A^M+H9_2=Z6,RFJ_4%+D9IA[M1MJ]Z
M@]'()C1P,(@IB O&*P$:AGA,*'+7=K-]-00-))!1MM[A.R_Y@K,.PXV)E36I
MF%>ATHO>!(9HC'ERREG?5>/-\)Y4$CP3'W 1>ANVJ#'TG*16+CPE315$GI'$
M!(9RC'GR;Z,S.*KP \FG34LYWBC UL2B)5QI1(J$(0T=/7XC;_IYM)[0C%#C
MR27V\/2^RO'IF&8$\9[='%AB'^\/BC0ZW<U=^#&FE1)Y-3I;&,KJ3IB;MY@=
MHH:(6:*3Z4"R:Q%4CD-RK#5!Z>A6ZI$!84A%PX[3Q<.GA]6ZT 7;,UI.;B9W
MBTN$-748COIY.B;V3@>D'MZ/WAB&SGHP5HU)MKRC_#O7+^0;WO+_SB/.DU,O
MT3J68&^YUJMJIZ5;)W,8(NS%634$7MPEN\#-!]+'Z.:8YJ14@+-[QT%"LWFQ
MH05RKB(=,^X*0XF#=+Y8D>IR.49EXD0XQI=CY'AX<C*/ZK@9W8T^36[0I_G\
M9H6F]^/I#0U$6D[&\\^3Y2^#^V+UIS=K#W:.X\C'48K+5\P:'YIY:>>5[,!_
MN\1/(?#LSBG6N;(O7Q?EVZ\U,U05BJI2ZY\/M7H5U_#T$ZA?#.AD;F^-V[U2
MIV6ON2T,M78GS >$+A8SY@:.9F1(OITO[_)0BO'\_H;&4MR@(@%C\W/G'D&1
M&)SF6;N/Z2T3GSW&0?SBQU#K&Y@:6TTSW*E"C9S#1I;.%=N++K>2R=.XKZC7
M,"$+F>N9^SM 9846WANM DWTO=DD1^S/3B^@F?NMO4MS(=:>51:IMV-1X.3<
MC[]4WV424QKP0?YQ^4!&XB*\;:@DD#2QTJD6U9N^M9!3M4/0S=Z:1]"G6I5+
MT,78N23[,N:>.YNO)TT%,A^ Q1_1Y#CY,R]#R;#L4*=)P3!]DJ&AO=W*+A4Y
M;5*:6,&06A>JW&; PP3=+N=WZ'8T7L^7CK(M64JF!RX?4W?JPNCKG^:SF\ER
MQ1)M__Y/[*;.>JA]G)6WY?:]-0M4C86]-:D1]=,R5 F'T?6-.'*:&=U.^/,'
M]W<0ZW<2Z(6U_2&,WS"^QA'>!AF]QZ:]JM*M",O)V#M7KI6*W=C>N3;/(,UE
MH+M;S.:_3";H>G(_N9U">=7NVDN#=+YMO8OVEO]7IU)38ZMOA'6J4.-M,"-+
M,)KL1)=["VRTFK)$*(OE9$5WZT!LPHWC*"7T?=;/S"2H-K&<A$=+OI5\1XH'
M(S(#DH(8S?OQ=#&;Y(EVYO>K^6QZ T-@@G?TTKQ6LDZF,'#\\F&+N.:5PP(-
M1EA:BB:O%[I_A>)3'/LO01@2IV :981O0/=)Z)-XJ=GXU:4 FX+K7K&Z ,VM
MH:UD.S-OZ[0L +(T^;_[Q(^-@@S/@F?L*T?$\XL%(N-./X*AN(W*!#,&7Z@B
M?,17:9L_+NM^E+[U@N2S%Q[Q'?;H=A3=7>BRSNE@;U/<G:M55[&Q,1BY=F7,
MO?Q([!$K -5*<*_.>_Q26\0E<43^6.R =1%I]V)L:K5O)>N2[5H&&.7V),XG
M@Z193!M/SR_G]^3/4#8^%TD0)PM,_NLO\2;TTC38!IM\U\S_^S%E3QG>X'23
M!.RJC>3GZEZ,W21L_2K93,36K0PP2NY)7*#DV6BUFMY.Q]7["8OE=+Y$OTQ&
MRQ6L7:F'%,^WDS0+]EZ&4\D/TP;95*288%UO3008-0EIM;7RL&*/;4U6Z^G=
M: W@'80U#3$C/O,\V^&$/[-6KIX,;6VJIU-UZJ(R,@2CM2YL#:($\T"JV6S^
M,WT-;H5NR=A%XZG&-%MSD5V<O@@#0*_3B.9RC1-#/U(.MWO)14VZ><%%C 6C
M/0U!_M47FDMWOORE2$V_?EC>KQ"9+R< +M?M#V0916?Y>7(3I(<X]<+YECZJ
MSC8&NFQ]]BO*J@C/J&Q#H#W*@2/>_N3;PI[-[S]=S::?R1#)U.Q^;)0F%S:3
ML+DYB#31!E(UM86V;]^1]U>2(3I_2CM_0=M,D4H+^\^;*ZGS;YL+X6!&0CU'
M;L"#\99YM7,ZW]:N&:99<JSM0>EV7=6V3O:]3:HCW/-6&8*16Q>VW%[W:+I$
MGT>S![9VKE^Y6ZV7#S!V"Y>8>,5'?$O:=LPN;FVRGX-L-SZF6;S'B=EXU[40
MNR\>]:E@\]&C+B6 46XOVK*'X^A]_D_W4[9-F*^'5I/EYPE;<:]&-,RH6"$-
M%2B^"PZ'/''S3U[D$X,GEF%<K<]NIO9"Q[M5YA1#;F;G7($]R')1Y3]-%XLR
M-_)/Y#\S^I?Q? 5@R#QEM:]'),\/15SRE+V01U9E+")9.:WW*LGJRTK]J]JX
M5-.]&.<B/I\[K^G1<G)U/:+W[^LO'#@7=/4FLNG>I SNY'5JH[U),1;:^EG#
M<\B'J27S[FEO/M7LW8_",'ZAN8-NX^0F/CYFVV-8H(1CX.6+MS9_#_"C5'/\
M!<MV/H0.5"'N8*@\ &+>Z,W\X7I]^S K(S3<^PND.CAXBL;'),'1IO$&*?DQ
MV%_#>NRU-A"N?WE6-PC.K79CTZ!O8<X[P:5JP&TNS)>3Z:=[-'Y8+B?WX^)=
MVAD,CX)[)GJ<8#_(Z)\D/X_2PNDSWCQUY>O=)S@8Z>DY<F]UURU0O$6Y!:(F
M@^7_QP<O\">OU,?6;;0;65A\"<"$>NTY !7<N6K,.?+G-Y/%:'JYE#87O0->
M?Y?.]%:CH;6KF]\&59)=^E:8.A=@/[["7!805]M+G&+RB^[(K'^#GW$8LQ/2
MHJ<IMXN,+.WNK1M7I;FAKC4#(T)SKOS6^6HR6HY_8EN8-Y//D]F<G6<#V<6<
M>$D41$_I B=LB\ML3-1:V92?817JTM.8@)&=&4_.;2/CW,.Z"N8F\J/YO5;H
M-S0(\K=H,5DBM@GI7'RKS0[[QQ#/MV3Y'S]%P3^Q/_7I1NHV**.91IM_' /B
M=I*>5\NZ1SX[[K&_-LD(>O%OL;KU/LQ/U-B6O^Q7@.D\P]2+<S#&/TUN'F:3
M,L'"]&:RS+L>6XG?3LBZ_ :MYVC]TZ2(M$.C\7\^3.D_TSEA-AU=3V?3]73"
MXDH?[B8W0YV>5C_((HEO:49A4:)K99\ZHQQ[YZIG5/-TR-JC$.?*/Y>Y2MN+
MY1RQ%-% DT:?JGWG9<>$]>,\-':-D_T-?LPZ3A:FQ;B9#;I54CS<FY7A7-5G
M$E>)>C8?#?5.V(FM))-[L99=QRR(L<NHVZM !\/O&147C,,]2G,NW8M5025B
M:9[_Y60V6N?.!Y#@5U9!NGMC-!9+T79CIY64FW'30JAS%9KQ4XZ35#YH/5G>
MY=L8TQ4[5$7$TW6_BLQ#P><'3,\IHB=6R]*9?RNFBC=#P?4HR7X@?Z^J\@'^
MG8H!).*^W%4"IS=.1BR-0R[UN^G]].[A#MT^K!^6$YHO'4:<=FTN$:9Y_MFC
MN>"S=)XL@Z>=/(GR!<ISX_?VK+;8 >Y8&)@^<&X-5#WA9_8,P'I%C^^F2VAK
MN_:&*$V\NJ&;\D%XS#KO!W8LS8WB>U59K/=.10%4>Q_^*JW3S+OCPJ.9/:RG
MGR?YQKC[<?XF2+VGIP0_Y6'&V^(6AY&^#6UMJKE3=>K:-3($H]0N;%6Z+*_;
M7/]"M]UN'L9K-)O>N_>TZSOJK&8IO58T><UP$GEA>:6(!K*UKJ1?OWW"\5/B
M'7;!QB,B(TY;YZ.;2W^AJU.<87XXV8'.9;\-3$\;O(J&W?/39/YI.5K\-!V/
M9N3?/T'PEJ37[S5O<!O8@<B<H'JC6VL$1L&F3+GHNL+N'6*6R(M\5-E">M=;
M6L'>B3R@I?#HE[P#WF!J3%5S/@@Q:T=MJ2R\P<<6T/DUOG2TR8)GT[W"2Q3L
M: OES!]"LI?2LU0PO>!B5>'?8;Z[&RU_84<U-!H5S1?Y!?HQ67$.^*A:59]9
MG*;7>!LGN+I9V.6XT<#<P>&B<:4$1XE:6^>B[$E8?=:]6J'K";TPA"YY9?2"
M0S3M;G%$$ZK,MU5%BR#;XGVOCF-SCQ+=#,J]JRX>C3L7YUSQEZN#QDOY/%W1
MT9=>$@7:#6[P%B<)W<]\+:(4&]&)';M Q]+<R+]7E<72[U040-GWX:^2_,VD
MC$$=_5<5@-J,.P6D_8<HJ8)UR2]0]/-T&8?A;9R\>$G7,Y[N!;KI 7TK+NX$
M74L#V ]Z5D'5%6@/J&: 842?)EE-\.1O)[&3OS1FM\BG,YF?3VVKS,M89)A2
MWOV*L"'H<RI')=S'WKEHSR"MN49P0V_.WM1>;"1_6:W)_[ PE%K$RAS N[6M
M^FJVF:5H^VF#I)3YK$$<U+GXS/CQ#X)1-*K@@^\8=Q\0QUZZNPWCE[.&1&TA
M#@=%PPHJAD5-"<ZU>1;MLX?&\6CU$[J=S7]V/S2J(K6Z;C-K"X 2D==IVUAC
M[5S*O2F?+6,6BO33?'8S6:[^]5_^\.'][__$#E;.WS$^7]9E!Q;]&IKYW]#6
MJIB[5*>A8Q-#.!+NP)93;^4PQ%M4M_Y_4&X/Z>BY=@7R^!@&FX>,18?W/I$^
MHSPW8W+/:HN'Z(Z%P9'[F350#>#E"V@WZ&$UH6D&Z4LJD-R-'A=>X5QN[7J1
M]:NXM-KK@NIJ,1G3EQG9W:O!LJHW79O\C'N:ID=-0'U78Q=74,TJ)+INJK9T
M+K!>=)52J\<F3%>K!S*XW3PLZ9THFKJ"/@:*;B;CR=WU9(D^OG^'B)"^9_]]
MS\X3R!\^#"50;XL72?!,7! R:A>O]1I(T\3,GBC-*W&2H]X&B!"-B:HD>#M=
MKM8L;PKYQ_QJ\_5JO)PNH.QS/N/\5=V?B.]++Z*<^M_I,[/SV9YEV7[VL7=U
MVV]"=B[(N:XOP5X1"D8G].D]<R&G=W>3FRGYX^P7-+HE'Z#Q;+ZB R_%D9[
M,@G1<#$ T>4KKYINQG&4!CXN$LJR!-[8GT>UG,8RIZA;&5:=T#[5:WBE70H
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M$Z3L97;1B*LQL/@NKP'QVK.\"K1S_1A3Y#734@D*J!7R"S/G8]DLB.A50?;
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M]\'7%09='5^3X=NQVT"J[Y^+XL^DIB)[<(]EI%(VJ)%8YH3591+W[C*)YXS
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MI)"&1XL-2_:NU/^+;<>.>!.">ONEH'0]5?,)X#BC-GJ)>QX,N^$1";XW.2:
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M48GI)&G^[RR>!^(<W:2DDYCS(XN.P+U\@51&K+3=I)RKD>8G3C7C!?D0I6)
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M2\(92H^VVX9/]*OX9?)M2\N(Q;4Y#K3M >^F'TH(NFR>=U[(U!W-^7<.N6U
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M)R?0&X1)!K('#O%<-Z@Z[J/#YI5NOMRSO(1'CWD&R0SO\@BRL;TD;S2CA3I
M)G'C5-P4Z&9M[FLI?'@U8D1"1Y)R09":KI$41,E-G9#UUE"&I+;>IUPX)D_P
M]M#L!)PD#9<1S-$46U&6OE32$TMJN5"80/J"?Q.R26"' ^ZIJI*R51:OM]MD
M0]M,I@:OW,6 2]V>:-6C$\DFDK-*1M)R!O7=?X\8?<VKPJDG$R$N_3A0CO72
MDB/1QL<\%?4&G_*<__1B4(66"I<>;!"5G"] *T9&*:F#JJ"^15]O'VA,=R(0
MD;>#[S825M?P?8*R(Q4[B%=5BG(F\N-2VW'@+46G62M'*)BUDN#'LI8E2S8$
M\6NXS[:A-"[ CVL>(ZVWEZ+(A&CB[W5Y"57/OIS(-#P1MB;9N."73BMMWF^-
M*W,T53G"*+6QXBNZI8RUI?&RE\M7>!NI4::+ YD2/>%:!F9<<Y)MPTHVDC>(
MRIZ^YD^P$/-)XNDKAWC@?X!=E&$%M)/C4I87UK&F. UIN(AD(_ W8 RZ/'(0
M?Z41N^2FDY2B,O)&)&QS';Y[\J%3W030.AT".Y'\8@%L)" YN:\;"&<5TW5I
MYT*I22_(&CW^)/0(W!BU:+;/PK3I=G'@TIXO7&7;;1MX15"=#=['/T X[SJC
M!FU9:''IR0W4F ! L!#!0SA3V"U@ST>^S--4GL;""=]SFT;-EGAN(C\N'1X'
MWKY-V+1R1(&^OJ1>KKH@CF>3%66P!^(S3;,-NLG9NBXE> F5!-7(CHD"<&G[
M2/1'56@4]76&=1G#W&58RM8]T#=((R9('O=IHE'X-'9<ZCX*N[[J8B*DD%B(
M(7LA1X0#43ZDA:3:! HA"YVF]99??HS8%UHV-C])^5X2WX\]3&G.9!-)C!-&
M27;B"^U,$<1RKG?[-#]0:G*@1[_CTJH>G.)Z-51!?:W'Y%M==0!N"UZY;\Z7
MG!UE5PEW#,J<F13@R8=+,=- *X,J^4::"@WB6 @$$"F!M"+":M-6<736&7>"
M2&0V,%=[)LRYLHPK_DE7V3X^?<V]]\0M+2Y]NX%Z[8GA,!'AR#9["AS\6U32
M^S3:4.T[J9,EXM+S7,WQWEK]!$D300*$B4D1F)QLRX1VK&E,$/DN;&-Z>Y0Y
MWS&Q8[&1>T9OJBRF[;F"858WT.'2IAVD>A(&&7J G#3T02?RSMSNJ^<TV31>
MA3E:T\F!2SV^<&T3K>0D#6OP9QR?N?VPKRR!;*&NVSD++2Y%N8&J*=XZ#B1W
M;X^1B/T5<[:V&I*9"I<V;!"598?3BI-\L<CL6_(@:\NJ?'JE<H?D.Z.Y67#I
MQANO4B*F))R32%9TL]K8R3$KS$B)2T\NF)K<*L(Y:QF"JZ1[SG"7%\4'NLT9
MO<VX3TF?HF_>KSJ<O+C4-AVX\<4&GQ1!!I%"B)1"N!@DSS,X( BZI5=4_O,V
M$P__DOJ^MW[BI[GE]./#I==IH#6.NZ"MK[ ;ZB!KW ,M*'N#TV)8>HOZ[:NB
M)3T9+J58,:J/? 6QN#DN@!PBR($^B!;6W-.)P/?T2C=@I<:E$Q^H2JFBAH=@
M2D7PQ#?8121"3<85Z72_XU*#'IP2CMA10>F_,$.AOH=:EZ^4\=4-$N9G!?U
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M0>]'9-VN(E.Z6I"$SU_=5;6U>$T&0ER=[D"ISPW?T4O?)YSK\ZO\7=3$E$6
MZ2^,4E.Y3SLY+LUX856" 6HF6=>A9B."KQTU@9)>M'6@'>FNC)2XU.."J9YZ
MM&,&1X:KY@3,I0\#'2YMV$&:#O^0:&+UR[W#;U(H</6^"9ZR?_OE7O60PN3Z
M?>&:?XE*^JD"$.NM3("O=KR>#EGW6T$J2FBH22;(1?YEP1 H8P__M"A0\@?5
MA>I^P]7C*C##)JU.; V48>R\>JF*LBD7#O^[SJA_NN1I[+AT=!1V]0P7A) _
M_OS'/Q"$298MI6*:XC_K[3VC6U$W@F]HI5DV<[!^SW*"0%P6,%-KC&65^,2Y
M;YB%PUV73&GJE%[(&H7XBNG,:1O^$M^%<4QNS@G6$7#5?1# KBK:3V"MV8II
MJ'"IT091W8(!+8DK.DS%C6F BLE)EM#0G M/FK"-4G!I\)0F3"X76]0%1P;%
MK9H1&3(M8I/EYH&6O+/@/:+(2W7/\A<6[:3E*MJ?PHQ+Z4<@-V=,I$V&(-9(
MJ;-Z\0E8R"%R'@Z=ON:.;[M2<_(3,RDNW3EQVM/4I,#2WB(>0ETA)J7("BB6
M]0QB9&BV26BQ>BY*%FTTJ<?=/+C4Y ]8MW>M.6O'I<=+HIH9T:(IG;:35TV'
M&%SJ/:D-TTO^6A?.X(G!;K,WWE<Y.ZR?"\Y;;" Q@W6"U7+@TK O7/MTFS2<
M).^QACF,$KER?F=)R8USJQXV#7[&I0LM-N6P2.8"@KJ",%:V85(W^.7(>P]Y
M\2;EPKM&E?WN]YQ]@=(1T3XIHU3I_>'/N'I=BVW<VS41V4BJ,#OHMMH:G_%N
M(#+S)LDB[J0,@CV]:\WY"\&EKQ-:8*P^M]Y"?@<BI)%6W"  %D<9NKJV6E,.
MP562QDZ.2Z]>6 VUYDC#A:?JS(8F;V QQ1.+8LC!(V*YFE1[W>]*0KYMFY!/
M-D5S2CF;;%P6,'_#U!/1]@M$?(+P;Q#Q$=)\A71$I/T.3 VD^5)#2N2WPK@]
M_ZQ@OFO3^Q<<X--KPDJ(F.+[UU=3:(4O(R[3F(A:<9: G?3YA4(;"42*")L*
MXRM-WV@?HBD=AH$0E\(<*)6T&()\J*&@4:]M41I7N)B1$I<^7# 5UZBKRH,C
M:.PF8459%[TPY2I12'#IP(A/R50"A*2I\!&RUZ\J6(7ON8NUSCY&AR:Z)']Z
MS2L1J2O^ )E5##J9*@"7QHY$KR3=K:2C 8+(FB\W$7=0!:M(/-!(:_XF$M6$
MG?TX16P?;!H:7+HS U3G.J#$,M[6V7]7&15)$28.-#].7%J:"ELWM/B( @EU
M(@F4(^JI=E/30U.>R^3=&0AQ:<V!4O'N&A<[/9"V/!F"899"B.01@\S%ATM9
MTT ;!QC7'>0F0CF\?J?T2V>+?&L'?S -,1LQ+LUY(%4.J@5+-\I@FRNXPCH4
MR3=Q4?N:IS%E=WG4/2(R:<G-@DM7WG@5[R/Y1GJ<!%B[/5=8O:W^08O77Z-]
MGIMF1(4"EU9,\)2K3* CDC!HC_^6O-$OC_3U)4H-/:Y0X.IQ$[QQCPLZ(@F#
M]OA_1R]1]D#CV)02:4R J[\-Z,;=+<B(H N<^72K/$JQI>*QDN/2A!=6-3OJ
MEJHO;<+GV'FD["W94 BC@^ WR/SM/ AU<"#3EB=<];! \)&&41SLX#@B_>\H
MJR*F=_/Y;&N<WCRX<.EN"F1U(A2\Y \7\,KMW\-.AJN;:[<CK"'"I0X+0F7T
M<-*><QLT:\RFS.'U\+03 "\N7.J9 EE)0"-Y\>[\]8NN(P;*S8-+@_Z _=T+
M#-%,,!N8DWL/?D6F$ TT[507.IOW/65_I9%I,AO\BJN'== T5;L)$(7-W)UG
M;Y25"1].?Q$'.)\B325*+16N'K=!5%_,M+2D/K;*HF#%(-]H(5[OB-<A5WRF
M4[I?0X.K\\T U<24#:5\OT)B3ANXXVMSH+&C\P=T6!6@ VE1PJ8A#Z>(U6;#
M*AK?Y^(UJ.W)I9$2ES)<,)736TE/]@U#]]PR3"7JI-A7)5WM($I4O43L_XJK
MXW70E M!24,B012D?^&MO"QB*Y]CK+?=@%3/RRW$N'K? ZERBMZP-"]3X"%0
MTG*%>0LTN+7TNH3%Z(%:$+HN78-Z_-UM\<<DY7:09YJ7H1HB7+UO0:AL YIN
MA^>?NX8XB.D_?<T?Z3YBW!-H4=O#Z)P<N-3B"U>-[\Y)PTA:3A0A=R+8UE-;
M%EI<>G(#U<<<XU*-#,STU(V-&)=R/) :0E21J6=U<\WG9Y%HT'*&-R1!I@H3
M/NUIGJ ,?J;78C97Z%-)D':[JT)?K]M#E^CK,%M*].F(L':]LT1?O_.#U^AK
M<;MZ'G6G^_9WZ)X6+R,/GQ+KQ#XFPM?G!H3:CI>T!(C#=[^QHL/@5X0=[JC7
M('NZ5YPA5 ]?IU"0VM+)?0)\_:Q!I^UJ21>\M^7S7IM)]PCP];8&G=ZPY2OF
MX+W=/(QW3-U("\$8\9FG;1K:QJN8P_@4L:A(=J_1KF+EJ]%1,=,BTX,3J%H]
M$CC(B"6L9N!EQ8>H@*1:.\@1(YJ[@CQ^+R(6YL.A(ZDWU:NO$8M_XQOM)'MY
M+"-6:J\U9Y.,3.LS-TNQ$6 FS\ -R17;+Y"H^P1Y/L@\C#7=OC[LB. [Y$U^
MB!3PI7"WKD=WU$V5I@?H+<-]^5R"OQ.[TK=J?K/:PG>$<86\RS^ZFS[D_']6
M^SW+WZ)T7KM21'\GEF5JU_RV]0Q?(E']J7#6]6L41UD<I?21)5GR%A6P8E-J
MB@^TD^.R B^L2OG AHDT7*1F"^[$BW,@QP',B :70LP +>=>P4]?'J)_)&^/
MT3>:18:.5RAP=;L)GI(*#^B() S:XW^)&)\X/[Q&IHN],0&N_C:@&W>W)"-
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MBK ][[BM&-)@[7F_VPK9\[W;BL ][SPS'U&A[7W?\_,$3Y)M"<9U7S0BPJH
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M%D0Y"AJ_!%Y"&1:F<;2A,#E*I2F4^]@FJY!2G-#5+%+\<$ZQI<E[E"#N <4
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M75WJ-8'TA$*HS4?1Z+X53)Y6)U%:K3K*BD>D[S$/VR\'$5$'*!#M.R=4F1G
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M[+X0*1[2CMA.>E6 @)S 1XQJJ4.Z-=L^>X#M^BE#[67Z;%X E[ 7ME]>&2L
M#S"CZOGO;!?)/.Y19=0+TM(7_&66OTKEM<=VT(,1D]!AR**JD*.@%N"[WU67
M#Y?:]Z#@96Y4MCL ,"PVQJZ*I*[454F]8@!'@1^<$K:OP"75U %=T4LD@=$%
M\P%]TSR>PCTWVN;7??8R*Q?Q :*+U/=#KY8$AX"GEH@8HBF)!_LX\V]-2/K4
M;.R$\:Y'GGE)5?C-T4LC*;-?3,]%N#YV=O,UF7^FJDY,YHQ5[/T"2X]T3YE
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MXHSSR>TG+L[>*.@%!5.;QTK+"N1Q!QW"HK;/-'Q6]3H+X4CC+^QGSUVEO!<
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MJ%  U;"EX;'4J'PF,W'ZRW([V7JLR*^61=DJLA5=ZY3B8O%,9*SHFB;IG@/
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MR";%=$=WX3KACEV"YD_$Y/8EIXL9JP!L87*H*.CW2* <9\3./GM9<,9*C4U
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M^R(-+,MB@C7)=>FCZ:GDS@7<9KUDG=#?A<$$'T8[^D)X<%Q_&$21[<](2/7
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M74=LK_)9:Y7/B:M9G.>O0OP$:;J6FS%@UG@X)V0>K'SWWV0Q6% .N4N7G>D
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M]"@8>15F:'+=C5)YBREQM.V*3HA09L56?.^X8:K<<9QX@'[8)3+E,  )T0K
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MM.(N<=+3S(C"2VX(-8PT) /$7E!!21^^_[KL?#\XW"^6C?UJ_>T&K##-90R
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M',KP]J_!E!DN(5G7UAVL7'8]&NUG*-Z[>:VA_B/\8U)"L*[M6T$?.4\1^6C
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MB+RF?Q(YLX']L1]&JIZQ2FRYZL,5X<Y=VS,8190O?-=N@-*T9"0K*DMY'_3
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M*_-K0M@I17_?#?S4/DT<;T;"S4>)W%]Z,MC7_9K6  ZF5Z]D/-"&<33PL[3
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M[9V?S&.@3]W=:HT\L*WZ'VG@F/:^ZWTOL4RJ7R#OX7BN>W$BY#D/W/I@:)M
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MC@MT\8@6^:A0F\"%FM05HY!O19/417UHFRY"<D4!EVV_UFQ$X0I\!CH?VJW
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M5H5@<:70]Z;$+)_A7H>1<I6VMJ";/ S:P;*=\?W]J4BVH&61]LW6]E/3WA3
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M!L,F;DI]W%0[R;)-W)2)F[J'N*G%%K/VX,;(&X;[ PKB$USO:;0?CA>24S6
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MYBOR;,,W@7V]>OJ&_/,93][XD_\'4$L! A0#%     @ ZC1Z667;[AU)LP
MN44$  L              ( !     &5X,3 M,C@N:'1M4$L! A0#%     @
MZC1Z62%#::=!E@  IU,#  L              ( !<K,  &5X,3 M,CDN:'1M
M4$L! A0#%     @ ZC1Z692P:>VY P  00\   H              ( !W$D!
M &5X,C,M,2YH=&U02P$"% ,4    " #J-'I9%!+"N<(#  #T#0  "@
M        @ &]30$ 97@R,RTR+FAT;5!+ 0(4 Q0    ( .HT>EE#FMO=F $
M )<#   *              "  :=1 0!E>#(S+3,N:'1M4$L! A0#%     @
MZC1Z67&]K<UQ9@  L,\"  D              ( !9U,! &5X-"TR+FAT;5!+
M 0(4 Q0    ( .HT>EGZ'#%P#UD  +EV @ )              "  ?^Y 0!E
M>#0M,RYH=&U02P$"% ,4    " #J-'I9AMBJL_E)  "K%@( "0
M    @ $U$P( 97@T+30N:'1M4$L! A0#%     @ ZC1Z66B"\*6Y#@  1V@
M  D              ( !55T" &5X-2TQ+FAT;5!+ 0(4 Q0    ( .HT>EGY
M() U[0T  *0.   /              "  35L @!F;W)M<RTQ7S P,2YJ<&=0
M2P$"% ,4    " #J-'I9C<Y/%OI4   L5P  #P              @ %/>@(
M9F]R;7,M,5\P,#,N:G!G4$L! A0#%     @ ZC1Z67IET'.(L 4 AT-"  P
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M+3(P,C0P.3,P7V1E9BYX;6Q02P$"% ,4    " #J-'I9+ ?O;.C+  ""90L
M%0              @ %RF@D <FEM92TR,#(T,#DS,%]L86(N>&UL4$L! A0#
M%     @ ZC1Z6?Z=G%C=G   L:T* !4              ( !C68* ')I;64M
F,C R-# Y,S!?<')E+GAM;%!+!08     $@ 2 #,$  "= PL    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>144
<FILENAME>forms-1a_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:RIME="http://algoholdings.com/20240930"
  xmlns:country="http://xbrl.sec.gov/country/2024"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2024"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="rime-20240930.xsd" xlink:type="simple"/>
    <context id="From2024-01-01to2024-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_dei_BusinessContactMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_NonrelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_NonrelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_us-gaap_NonrelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2024-07-012024-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-04-012023-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2021-04-012022-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_ReceivablesFromStockholderMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ReceivablesFromStockholderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_ReceivablesFromStockholderMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ReceivablesFromStockholderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_ReceivablesFromStockholderMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ReceivablesFromStockholderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_ReceivablesFromStockholderMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ReceivablesFromStockholderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="AsOf2021-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="AsOf2021-03-31_us-gaap_ReceivablesFromStockholderMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ReceivablesFromStockholderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="AsOf2021-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="AsOf2021-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-03-31_us-gaap_ReceivablesFromStockholderMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ReceivablesFromStockholderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_us-gaap_ReceivablesFromStockholderMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ReceivablesFromStockholderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="From2024-07-012024-09-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-09-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-09-30_us-gaap_ReceivablesFromStockholderMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ReceivablesFromStockholderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-09-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-09-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_us-gaap_ReceivablesFromStockholderMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ReceivablesFromStockholderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_us-gaap_ReceivablesFromStockholderMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ReceivablesFromStockholderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_us-gaap_ReceivablesFromStockholderMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ReceivablesFromStockholderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2021-04-012022-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2021-04-012022-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2021-04-012022-03-31_us-gaap_ReceivablesFromStockholderMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ReceivablesFromStockholderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2021-04-012022-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2022-04-012023-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2022-04-012023-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2022-04-012023-03-31_us-gaap_ReceivablesFromStockholderMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ReceivablesFromStockholderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2022-04-012023-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-12-31_us-gaap_ReceivablesFromStockholderMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ReceivablesFromStockholderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_ReceivablesFromStockholderMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ReceivablesFromStockholderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_ReceivablesFromStockholderMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ReceivablesFromStockholderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="From2024-06-262024-06-26_custom_AtTheMarketSalesAgreementMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:AtTheMarketSalesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-26</startDate>
            <endDate>2024-06-26</endDate>
        </period>
    </context>
    <context id="From2024-06-262024-06-26_custom_AtTheMarketSalesAgreementAmendmentOneMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:AtTheMarketSalesAgreementAmendmentOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-26</startDate>
            <endDate>2024-06-26</endDate>
        </period>
    </context>
    <context id="From2024-06-262024-06-26_custom_AtTheMarketSalesAgreementAmendmentTwoMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:AtTheMarketSalesAgreementAmendmentTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-26</startDate>
            <endDate>2024-06-26</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-09-30_custom_AtTheMarketSalesAgreementMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:AtTheMarketSalesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_custom_AtTheMarketSalesAgreementMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:AtTheMarketSalesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-10-012024-11-18_us-gaap_SubsequentEventMember_custom_AtTheMarketSalesAgreementMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:AtTheMarketSalesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-11-18</endDate>
        </period>
    </context>
    <context id="From2024-07-032024-07-03_custom_AssetPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:AssetPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-03</startDate>
            <endDate>2024-07-03</endDate>
        </period>
    </context>
    <context id="AsOf2024-07-03_custom_SemiCabLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">RIME:SemiCabLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-03</instant>
        </period>
    </context>
    <context id="From2024-07-032024-07-03_custom_SemiCabLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RIME:SemiCabLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-03</startDate>
            <endDate>2024-07-03</endDate>
        </period>
    </context>
    <context id="AsOf2023-08-23_custom_LeaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:LeaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-23</instant>
        </period>
    </context>
    <context id="From2024-04-012024-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-09-252024-09-25_custom_SettlementAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SettlementAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-25</startDate>
            <endDate>2024-09-25</endDate>
        </period>
    </context>
    <context id="From2024-10-252024-10-25_custom_SettlementAgreementMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SettlementAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-25</startDate>
            <endDate>2024-10-25</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-09-30_custom_SettlementAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SettlementAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_custom_SettlementAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SettlementAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-10-22_us-gaap_PrivatePlacementMember_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-10-22</instant>
        </period>
    </context>
    <context id="From2024-10-222024-10-22_us-gaap_PrivatePlacementMember_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-22</startDate>
            <endDate>2024-10-22</endDate>
        </period>
    </context>
    <context id="AsOf2024-03-28_us-gaap_RevolvingCreditFacilityMember_custom_LoanAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:LoanAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-28</instant>
        </period>
    </context>
    <context id="From2024-10-172024-10-17_us-gaap_RevolvingCreditFacilityMember_us-gaap_SubsequentEventMember_custom_LoanAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:LoanAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-17</startDate>
            <endDate>2024-10-17</endDate>
        </period>
    </context>
    <context id="AsOf2024-11-01_custom_StockRepurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:StockRepurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-01</instant>
        </period>
    </context>
    <context id="From2023-11-202023-11-20_us-gaap_PrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-20</startDate>
            <endDate>2023-11-20</endDate>
        </period>
    </context>
    <context id="AsOf2023-11-20_us-gaap_PrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-20</instant>
        </period>
    </context>
    <context id="From2023-08-232023-08-23_custom_LeaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:LeaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-23</startDate>
            <endDate>2023-08-23</endDate>
        </period>
    </context>
    <context id="From2023-02-152023-02-15_custom_ATMOfferingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">RIME:ATMOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-15</startDate>
            <endDate>2023-02-15</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-12-31_custom_ATMOfferingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">RIME:ATMOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-04-012023-03-31_custom_ATMOfferingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">RIME:ATMOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_RetainedEarningsMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-07-032024-07-03_custom_SemiCabLLCMember249477656">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">RIME:SemiCabLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-03</startDate>
            <endDate>2024-07-03</endDate>
        </period>
    </context>
    <context id="From2024-07-032024-07-03_custom_TwoThousandTwentyFourMember_custom_AjeshKapoorMember_custom_EmploymentAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">RIME:TwoThousandTwentyFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:AjeshKapoorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:EmploymentAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-03</startDate>
            <endDate>2024-07-03</endDate>
        </period>
    </context>
    <context id="From2024-07-032024-07-03_custom_TwoThousandTwentyFiveMember_custom_AjeshKapoorMember_custom_EmploymentAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">RIME:TwoThousandTwentyFiveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:AjeshKapoorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:EmploymentAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-03</startDate>
            <endDate>2024-07-03</endDate>
        </period>
    </context>
    <context id="From2024-07-032024-07-03_custom_SubsequentYearsMember_custom_AjeshKapoorMember_custom_EmploymentAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">RIME:SubsequentYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:AjeshKapoorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:EmploymentAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-03</startDate>
            <endDate>2024-07-03</endDate>
        </period>
    </context>
    <context id="From2024-07-032024-07-03_custom_TwoThousandTwentyFourMember_custom_VivekSehgalKapoorMember_custom_EmploymentAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">RIME:TwoThousandTwentyFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:VivekSehgalKapoorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:EmploymentAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-03</startDate>
            <endDate>2024-07-03</endDate>
        </period>
    </context>
    <context id="From2024-07-032024-07-03_custom_TwoThousandTwentyFiveMember_custom_VivekSehgalKapoorMember_custom_EmploymentAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">RIME:TwoThousandTwentyFiveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:VivekSehgalKapoorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:EmploymentAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-03</startDate>
            <endDate>2024-07-03</endDate>
        </period>
    </context>
    <context id="From2024-07-032024-07-03_custom_TwoThousandTwentySixMember_custom_VivekSehgalKapoorMember_custom_EmploymentAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">RIME:TwoThousandTwentySixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:VivekSehgalKapoorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:EmploymentAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-03</startDate>
            <endDate>2024-07-03</endDate>
        </period>
    </context>
    <context id="From2024-07-032024-07-03_custom_TwoThousandTwentySevenMember_custom_VivekSehgalKapoorMember_custom_EmploymentAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">RIME:TwoThousandTwentySevenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:VivekSehgalKapoorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:EmploymentAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-03</startDate>
            <endDate>2024-07-03</endDate>
        </period>
    </context>
    <context id="From2024-07-032024-07-03_custom_TwoThousandTwentyEightMember_custom_VivekSehgalKapoorMember_custom_EmploymentAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">RIME:TwoThousandTwentyEightMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:VivekSehgalKapoorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:EmploymentAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-03</startDate>
            <endDate>2024-07-03</endDate>
        </period>
    </context>
    <context id="From2024-07-032024-07-03_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-03</startDate>
            <endDate>2024-07-03</endDate>
        </period>
    </context>
    <context id="AsOf2024-07-03">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
        </entity>
        <period>
            <instant>2024-07-03</instant>
        </period>
    </context>
    <context id="From2024-07-032024-07-03">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
        </entity>
        <period>
            <startDate>2024-07-03</startDate>
            <endDate>2024-07-03</endDate>
        </period>
    </context>
    <context id="AsOf2024-07-03_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-03</instant>
        </period>
    </context>
    <context id="AsOf2024-07-03_custom_AlgorhythmHoldingsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">RIME:AlgorhythmHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-03</instant>
        </period>
    </context>
    <context id="From2024-07-032024-07-03_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-03</startDate>
            <endDate>2024-07-03</endDate>
        </period>
    </context>
    <context id="From2024-07-032024-07-03_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-03</startDate>
            <endDate>2024-07-03</endDate>
        </period>
    </context>
    <context id="AsOf2024-07-03_custom_SemiCabIncMember249477843">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-03</instant>
        </period>
    </context>
    <context id="AsOf2024-07-03_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-03</instant>
        </period>
    </context>
    <context id="AsOf2024-07-03_us-gaap_TradeNamesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-03</instant>
        </period>
    </context>
    <context id="AsOf2024-07-03_us-gaap_DevelopedTechnologyRightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-03</instant>
        </period>
    </context>
    <context id="AsOf2024-03-28_us-gaap_RevolvingCreditFacilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-28</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_RevolvingCreditFacilityMember_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_RevolvingCreditFacilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="From2024-03-282024-03-28_us-gaap_RevolvingCreditFacilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-28</startDate>
            <endDate>2024-03-28</endDate>
        </period>
    </context>
    <context id="From2024-03-282024-03-28_us-gaap_RevolvingCreditFacilityMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-28</startDate>
            <endDate>2024-03-28</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-09-30_us-gaap_RevolvingCreditFacilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_us-gaap_RevolvingCreditFacilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-10-172024-10-17_us-gaap_RevolvingCreditFacilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-17</startDate>
            <endDate>2024-10-17</endDate>
        </period>
    </context>
    <context id="AsOf2022-10-14_us-gaap_RevolvingCreditFacilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-14</instant>
        </period>
    </context>
    <context id="From2022-10-142022-10-14_us-gaap_RevolvingCreditFacilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-14</startDate>
            <endDate>2022-10-14</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_us-gaap_RevolvingCreditFacilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_us-gaap_RevolvingCreditFacilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-10-14_custom_RevolvingLoanAmendmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">RIME:RevolvingLoanAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-14</instant>
        </period>
    </context>
    <context id="AsOf2023-08-30_custom_RevolvingLoanAmendmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">RIME:RevolvingLoanAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-30</instant>
        </period>
    </context>
    <context id="AsOf2024-03-22_custom_AgileCapilalFundingllcMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">RIME:AgileCapilalFundingllcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-22</instant>
        </period>
    </context>
    <context id="From2024-03-222024-03-22_custom_AgileCapilalFundingllcMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">RIME:AgileCapilalFundingllcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-22</startDate>
            <endDate>2024-03-22</endDate>
        </period>
    </context>
    <context id="AsOf2024-09-30_custom_AgileCapilalFundingllcMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">RIME:AgileCapilalFundingllcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-05-08_custom_CedarAdvancellcMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">RIME:CedarAdvancellcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-08</instant>
        </period>
    </context>
    <context id="From2024-05-082024-05-08_custom_CedarAdvancellcMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">RIME:CedarAdvancellcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-08</startDate>
            <endDate>2024-05-08</endDate>
        </period>
    </context>
    <context id="AsOf2024-09-30_custom_CedarAdvancellcMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">RIME:CedarAdvancellcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-03-22_custom_SemiCabInvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">RIME:SemiCabInvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-22</instant>
        </period>
    </context>
    <context id="AsOf2024-03-28_us-gaap_RevolvingCreditFacilityMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-28</instant>
        </period>
    </context>
    <context id="From2024-03-282024-03-28_us-gaap_SubsequentEventMember_us-gaap_RevolvingCreditFacilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-28</startDate>
            <endDate>2024-03-28</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-06-16_custom_TwoYearCreditAndSecurityAgreementMember_us-gaap_RevolvingCreditFacilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:TwoYearCreditAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-16</instant>
        </period>
    </context>
    <context id="AsOf2020-06-16_custom_TwoYearLoanAndSecurityAgreementMember_us-gaap_RevolvingCreditFacilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:TwoYearLoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-16</instant>
        </period>
    </context>
    <context id="From2023-04-012023-12-31_custom_CreditAndSecurityAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:CreditAndSecurityAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-12-31_custom_CreditAndSecurityAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:CreditAndSecurityAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-04-012023-03-31_custom_CreditAndSecurityAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:CreditAndSecurityAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2021-04-012022-03-31_custom_CreditAndSecurityAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:CreditAndSecurityAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-09-30_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_custom_AjeshKapoorOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">RIME:AjeshKapoorOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-09-30_custom_AjeshKapoorOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">RIME:AjeshKapoorOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_custom_AjeshKapoorTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">RIME:AjeshKapoorTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-09-30_custom_AjeshKapoorTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">RIME:AjeshKapoorTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_custom_VivekSeghalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">RIME:VivekSeghalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-09-30_custom_VivekSeghalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">RIME:VivekSeghalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_custom_AjeshKapoorThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">RIME:AjeshKapoorThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-09-30_custom_AjeshKapoorThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">RIME:AjeshKapoorThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_custom_AjeshKapoorFourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">RIME:AjeshKapoorFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-09-30_custom_AjeshKapoorFourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">RIME:AjeshKapoorFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-05-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
        </entity>
        <period>
            <instant>2023-05-18</instant>
        </period>
    </context>
    <context id="From2023-05-182023-05-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
        </entity>
        <period>
            <startDate>2023-05-18</startDate>
            <endDate>2023-05-18</endDate>
        </period>
    </context>
    <context id="From2023-06-012024-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
        </entity>
        <period>
            <startDate>2023-06-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-05-182024-05-18_custom_SettlementSumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">RIME:SettlementSumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-18</startDate>
            <endDate>2024-05-18</endDate>
        </period>
    </context>
    <context id="From2024-05-202024-05-20_custom_InitialPaymentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">RIME:InitialPaymentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-20</startDate>
            <endDate>2024-05-20</endDate>
        </period>
    </context>
    <context id="From2024-06-032024-06-03_custom_SecondPaymentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">RIME:SecondPaymentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-03</startDate>
            <endDate>2024-06-03</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-04-30_custom_AdditionalPaymentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">RIME:AdditionalPaymentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="AsOf2020-03-28_custom_BlueYonderIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:BlueYonderIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="From2023-06-212023-06-21_custom_BlueYonderIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:BlueYonderIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-21</startDate>
            <endDate>2023-06-21</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-07-01_custom_BlueYonderIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:BlueYonderIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-07-01</endDate>
        </period>
    </context>
    <context id="From2024-10-012024-10-01_custom_BlueYonderIncMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:BlueYonderIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-10-01</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-01-01_custom_BlueYonderIncMember_srt_ScenarioForecastMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:BlueYonderIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-01-01</endDate>
        </period>
    </context>
    <context id="AsOf2024-09-30_custom_BlueYonderIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:BlueYonderIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="From2024-07-012024-07-01_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-07-01</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-21_us-gaap_DirectorsAndOfficersLiabilityInsuranceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis">us-gaap:DirectorsAndOfficersLiabilityInsuranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-21</instant>
        </period>
    </context>
    <context id="From2023-12-212023-12-21_us-gaap_DirectorsAndOfficersLiabilityInsuranceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis">us-gaap:DirectorsAndOfficersLiabilityInsuranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-21</startDate>
            <endDate>2023-12-21</endDate>
        </period>
    </context>
    <context id="From2020-03-282020-03-28_custom_ServiceContractAndAgreementMember_custom_SemiCabIncMember_custom_PerYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">RIME:PerYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:ServiceContractAndAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-28</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="From2020-03-282020-03-28_custom_ServiceContractAndAgreementMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:ServiceContractAndAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-28</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="From2023-06-212023-06-21_custom_ServiceContractAndAgreementMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:ServiceContractAndAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-21</startDate>
            <endDate>2023-06-21</endDate>
        </period>
    </context>
    <context id="From2020-03-282020-03-28_custom_ServiceContractAndAgreementMember_custom_SemiCabIncMember_custom_DueOnJulyOneTwoThousandTwentyFourMember_custom_TwoSeparateMilestonePaymentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">RIME:DueOnJulyOneTwoThousandTwentyFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">RIME:TwoSeparateMilestonePaymentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:ServiceContractAndAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-28</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="From2020-03-282020-03-28_custom_ServiceContractAndAgreementMember_custom_SemiCabIncMember_custom_DueOnJulyOneTwoThousandTwentyFourMember_custom_FirstMilestonePaymentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">RIME:DueOnJulyOneTwoThousandTwentyFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">RIME:FirstMilestonePaymentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:ServiceContractAndAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-28</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="From2020-03-282020-03-28_custom_ServiceContractAndAgreementMember_custom_SemiCabIncMember_custom_OctoberOneTwoThousandTwentyFourMember_custom_SecondMilestonePaymentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">RIME:OctoberOneTwoThousandTwentyFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">RIME:SecondMilestonePaymentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:ServiceContractAndAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-28</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="From2020-03-282020-03-28_custom_ServiceContractAndAgreementMember_custom_SemiCabIncMember_custom_JanuaryOneTwoThousandTwentyFiveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">RIME:JanuaryOneTwoThousandTwentyFiveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:ServiceContractAndAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-28</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="AsOf2024-03-31_custom_ServiceContractAndAgreementMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:ServiceContractAndAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="From2024-05-282024-05-28_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-28</startDate>
            <endDate>2024-05-28</endDate>
        </period>
    </context>
    <context id="From2024-03-312024-03-31_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-31</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2017-10-01_custom_OperatingLeaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:OperatingLeaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-10-01</instant>
        </period>
    </context>
    <context id="From2017-10-012017-10-01_custom_OperatingLeaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:OperatingLeaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2017-10-01</endDate>
        </period>
    </context>
    <context id="From2024-02-222024-02-22_custom_OperatingLeaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:OperatingLeaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-22</startDate>
            <endDate>2024-02-22</endDate>
        </period>
    </context>
    <context id="AsOf2023-08-23_custom_OperatingLeaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:OperatingLeaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-23</instant>
        </period>
    </context>
    <context id="From2024-09-252024-09-25_custom_OperatingLeaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:OperatingLeaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-25</startDate>
            <endDate>2024-09-25</endDate>
        </period>
    </context>
    <context id="From2024-02-202024-02-22_custom_OperatingLeaseAgreementMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:OperatingLeaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-20</startDate>
            <endDate>2024-02-22</endDate>
        </period>
    </context>
    <context id="From2023-08-232023-08-23_custom_OperatingLeaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:OperatingLeaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-23</startDate>
            <endDate>2023-08-23</endDate>
        </period>
    </context>
    <context id="AsOf2022-10-15_custom_OperatingLeaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:OperatingLeaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-15</instant>
        </period>
    </context>
    <context id="From2022-10-152022-10-15_custom_OperatingLeaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:OperatingLeaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-15</startDate>
            <endDate>2022-10-15</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_custom_TwoThousandTwentyTwoPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">RIME:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-09-30_custom_TwoThousandTwentyTwoPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">RIME:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_custom_TwoThousandTwentyTwoPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">RIME:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_custom_TwoThousandTwentyTwoPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">RIME:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-09-30_custom_TwoThousandTwentyTwoPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">RIME:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="From2024-07-012024-09-30_custom_TwoThousandTwentyTwoPlanMember_us-gaap_GeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">RIME:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_custom_TwoThousandTwentyTwoPlanMember_us-gaap_GeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">RIME:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_us-gaap_GeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-09-30_custom_ExercisePriceRangeOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">RIME:ExercisePriceRangeOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_custom_ExercisePriceRangeTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">RIME:ExercisePriceRangeTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_ExercisePriceRangeOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">RIME:ExercisePriceRangeOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_ExercisePriceRangeTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">RIME:ExercisePriceRangeTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-07-012024-09-30_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-12-31_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-12-31_custom_CommonStockWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">RIME:CommonStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-04-012023-03-31_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2022-04-012023-03-31_custom_CommonStockWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">RIME:CommonStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2021-04-012022-03-31_custom_PreFundedWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">RIME:PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2021-04-012022-03-31_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2021-04-012022-03-31_custom_OptionsAndWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">RIME:OptionsAndWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_DomesticCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_us-gaap_DomesticCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_InternalRevenueServiceIRSMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_StateAndLocalJurisdictionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_us-gaap_StateAndLocalJurisdictionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="From2024-07-012024-09-30_custom_ClassicKaraokeMachinesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:ClassicKaraokeMachinesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_custom_ClassicKaraokeMachinesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:ClassicKaraokeMachinesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_custom_ClassicKaraokeMachinesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:ClassicKaraokeMachinesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_custom_ClassicKaraokeMachinesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:ClassicKaraokeMachinesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-09-30_custom_LicensedProductsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:LicensedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_custom_LicensedProductsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:LicensedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_custom_LicensedProductsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:LicensedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_custom_LicensedProductsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:LicensedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-09-30_custom_KidsYouthElectronicsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:KidsYouthElectronicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_custom_KidsYouthElectronicsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:KidsYouthElectronicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_custom_KidsYouthElectronicsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:KidsYouthElectronicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_custom_KidsYouthElectronicsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:KidsYouthElectronicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-09-30_custom_MicrophonesAndAccessoriesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:MicrophonesAndAccessoriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_custom_MicrophonesAndAccessoriesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:MicrophonesAndAccessoriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_custom_MicrophonesAndAccessoriesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:MicrophonesAndAccessoriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_custom_MicrophonesAndAccessoriesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:MicrophonesAndAccessoriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-09-30_custom_MusicSubscriptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:MusicSubscriptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_custom_MusicSubscriptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:MusicSubscriptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_custom_MusicSubscriptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:MusicSubscriptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_custom_MusicSubscriptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:MusicSubscriptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-09-30_custom_LogisticsServicesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:LogisticsServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_custom_LogisticsServicesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:LogisticsServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_custom_LogisticsServicesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:LogisticsServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_custom_LogisticsServicesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:LogisticsServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-12-31_custom_KaraokeMachinesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:KaraokeMachinesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-04-012023-03-31_custom_KaraokeMachinesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:KaraokeMachinesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2021-04-012022-03-31_custom_KaraokeMachinesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:KaraokeMachinesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-12-31_custom_LicensedProductsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:LicensedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-04-012023-03-31_custom_LicensedProductsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:LicensedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2021-04-012022-03-31_custom_LicensedProductsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:LicensedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-12-31_custom_KidsYouthElectronicsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:KidsYouthElectronicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-04-012023-03-31_custom_KidsYouthElectronicsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:KidsYouthElectronicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2021-04-012022-03-31_custom_KidsYouthElectronicsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:KidsYouthElectronicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-12-31_custom_MicrophonesAndAccessoriesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:MicrophonesAndAccessoriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-04-012023-03-31_custom_MicrophonesAndAccessoriesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:MicrophonesAndAccessoriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2021-04-012022-03-31_custom_MicrophonesAndAccessoriesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:MicrophonesAndAccessoriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-12-31_custom_MusicSubscriptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:MusicSubscriptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-04-012023-03-31_custom_MusicSubscriptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:MusicSubscriptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2021-04-012022-03-31_custom_MusicSubscriptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RIME:MusicSubscriptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-09-30_srt_NorthAmericaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_srt_NorthAmericaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_srt_NorthAmericaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_srt_NorthAmericaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-09-30_country_AU">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_country_AU">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_country_AU">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_country_AU">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-09-30_srt_EuropeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_srt_EuropeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_srt_EuropeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_srt_EuropeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_ThreeCustomersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:ThreeCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2023-12-312023-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_FourCustomersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:FourCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-09-30_custom_SalesRevenueMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:CustomerOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">RIME:SalesRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-09-30_custom_SalesRevenueMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomersTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:CustomersTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">RIME:SalesRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-09-30_custom_SalesRevenueMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomersThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:CustomersThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">RIME:SalesRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_custom_SalesRevenueMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:CustomerOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">RIME:SalesRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_custom_SalesRevenueMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomersTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:CustomersTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">RIME:SalesRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_custom_SalesRevenueMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomersThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:CustomersThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">RIME:SalesRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_custom_SalesRevenueMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:CustomerOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">RIME:SalesRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_custom_SalesRevenueMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomersTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:CustomersTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">RIME:SalesRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_custom_SalesRevenueMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomersThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:CustomersThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">RIME:SalesRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_custom_SalesRevenueMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomersFourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:CustomersFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">RIME:SalesRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_custom_SalesRevenueMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:CustomerOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">RIME:SalesRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_custom_SalesRevenueMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomersTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:CustomersTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">RIME:SalesRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_custom_SalesRevenueMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomersThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:CustomersThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">RIME:SalesRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_FourCustomersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:FourCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-04-012023-03-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_ThreeCustomersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:ThreeCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2021-04-012022-03-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_FourCustomersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:FourCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-12-31_custom_SalesRevenueMember_custom_ThreeCustomersMember_custom_CustomersConcentrationRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:CustomersConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">RIME:SalesRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">RIME:ThreeCustomersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-12-31_custom_SalesRevenueMember_custom_ThreeCustomersMember_custom_CustomersConcentrationRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:CustomersConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">RIME:SalesRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">RIME:ThreeCustomersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-04-012023-03-31_custom_SalesRevenueMember_custom_ThreeCustomersMember_custom_CustomersConcentrationRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:CustomersConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">RIME:SalesRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">RIME:ThreeCustomersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2021-04-012022-03-31_custom_SalesRevenueMember_custom_ThreeCustomersMember_custom_CustomersConcentrationRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:CustomersConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">RIME:SalesRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">RIME:ThreeCustomersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-12-31_custom_SalesRevenueMember_custom_CustomersOneMember_custom_CustomersConcentrationRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:CustomersConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">RIME:SalesRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">RIME:CustomersOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-12-31_custom_SalesRevenueMember_custom_CustomersTwoMember_custom_CustomersConcentrationRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:CustomersConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">RIME:SalesRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">RIME:CustomersTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-12-31_custom_SalesRevenueMember_custom_CustomersThreeMember_custom_CustomersConcentrationRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:CustomersConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">RIME:SalesRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">RIME:CustomersThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-12-31_custom_SalesRevenueMember_custom_CustomersOneMember_custom_CustomersConcentrationRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:CustomersConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">RIME:SalesRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">RIME:CustomersOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-12-31_custom_SalesRevenueMember_custom_CustomersTwoMember_custom_CustomersConcentrationRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:CustomersConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">RIME:SalesRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">RIME:CustomersTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-04-012023-03-31_custom_SalesRevenueMember_custom_CustomersOneMember_custom_CustomersConcentrationRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:CustomersConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">RIME:SalesRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">RIME:CustomersOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2022-04-012023-03-31_custom_SalesRevenueMember_custom_CustomersTwoMember_custom_CustomersConcentrationRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:CustomersConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">RIME:SalesRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">RIME:CustomersTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2021-04-012022-03-31_custom_SalesRevenueMember_custom_CustomersOneMember_custom_CustomersConcentrationRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:CustomersConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">RIME:SalesRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">RIME:CustomersOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2021-04-012022-03-31_custom_SalesRevenueMember_custom_CustomersTwoMember_custom_CustomersConcentrationRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:CustomersConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">RIME:SalesRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">RIME:CustomersTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2021-04-012022-03-31_custom_SalesRevenueMember_custom_CustomersThreeMember_custom_CustomersConcentrationRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:CustomersConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">RIME:SalesRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">RIME:CustomersThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-12-31_custom_PurchasesMember_us-gaap_GeographicConcentrationRiskMember_custom_RepublicOfChinaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:RepublicOfChinaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">RIME:PurchasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-04-012023-03-31_custom_PurchasesMember_us-gaap_GeographicConcentrationRiskMember_custom_RepublicOfChinaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:RepublicOfChinaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">RIME:PurchasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2021-04-012022-03-31_custom_PurchasesMember_us-gaap_GeographicConcentrationRiskMember_custom_RepublicOfChinaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:RepublicOfChinaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">RIME:PurchasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-12-31_custom_RepublicOfChinaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">RIME:RepublicOfChinaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_FourMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:FourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_FourMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:FourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_FourMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:FourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_FourMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RIME:FourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-09-30_custom_StingrayMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">RIME:StingrayMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_StingrayMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">RIME:StingrayMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_custom_SMCBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">RIME:SMCBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="From2024-07-012024-09-30_custom_SMCBMember_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">RIME:SMCBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-12-31_custom_StingrayMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">RIME:StingrayMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-12-31_custom_StingrayMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">RIME:StingrayMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-04-012023-03-31_custom_StingrayMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">RIME:StingrayMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2021-04-012022-03-31_custom_StingrayMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">RIME:StingrayMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-03-31_custom_StingrayMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">RIME:StingrayMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_custom_AultAllianceIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">RIME:AultAllianceIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_AjeshKapoorMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">RIME:AjeshKapoorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_AjeshKapoorMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">RIME:AjeshKapoorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_custom_AjeshKapoorMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">RIME:AjeshKapoorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-10-22_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-10-22</instant>
        </period>
    </context>
    <context id="From2024-10-222024-10-22_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-22</startDate>
            <endDate>2024-10-22</endDate>
        </period>
    </context>
    <context id="From2024-10-222024-10-22_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-22</startDate>
            <endDate>2024-10-22</endDate>
        </period>
    </context>
    <context id="From2024-10-242024-10-24_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-24</startDate>
            <endDate>2024-10-24</endDate>
        </period>
    </context>
    <context id="AsOf2024-10-24_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-10-24</instant>
        </period>
    </context>
    <context id="AsOf2024-11-01_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-01</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_ComputerAndOfficeEquipmentMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">RIME:ComputerAndOfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_ComputerAndOfficeEquipmentMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">RIME:ComputerAndOfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_ComputerAndOfficeEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">RIME:ComputerAndOfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_custom_ComputerAndOfficeEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">RIME:ComputerAndOfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_FurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_us-gaap_FurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_WarehouseEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">RIME:WarehouseEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_custom_WarehouseEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">RIME:WarehouseEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_MoldsAndToolingMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">RIME:MoldsAndToolingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_MoldsAndToolingMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">RIME:MoldsAndToolingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_MoldsAndToolingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">RIME:MoldsAndToolingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_custom_MoldsAndToolingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">RIME:MoldsAndToolingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="From2022-04-112022-04-12_custom_TwoThousandTwentyTwoPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">RIME:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-11</startDate>
            <endDate>2022-04-12</endDate>
        </period>
    </context>
    <context id="From2022-04-012023-03-31_custom_TwoThousandTwentyTwoPlanMember_srt_DirectorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">RIME:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2022-04-012023-03-31_custom_TwoThousandTwentyTwoPlanMember_srt_DirectorMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">RIME:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2022-04-012023-03-31_custom_TwoThousandTwentyTwoPlanMember_srt_DirectorMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">RIME:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2022-04-012023-03-31_custom_TwoThousandTwentyTwoPlanMember_srt_OfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:OfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">RIME:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2022-04-012023-03-31_custom_TwoThousandTwentyTwoPlanMember_srt_OfficerMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:OfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">RIME:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2022-04-012023-03-31_custom_TwoThousandTwentyTwoPlanMember_srt_OfficerMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:OfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">RIME:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2022-04-012023-03-31_custom_TwoThousandTwentyTwoPlanMember_custom_EmployeeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:EmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">RIME:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2022-04-012023-03-31_custom_TwoThousandTwentyTwoPlanMember_custom_EmployeeMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:EmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">RIME:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2022-04-012023-03-31_custom_TwoThousandTwentyTwoPlanMember_custom_EmployeeMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:EmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">RIME:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2021-04-012022-03-31_srt_BoardOfDirectorsChairmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2021-04-012022-03-31_srt_BoardOfDirectorsChairmanMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2021-04-012022-03-31_srt_BoardOfDirectorsChairmanMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2022-04-012023-03-31_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2022-04-012023-03-31_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2021-04-012022-03-31_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2021-04-012022-03-31_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-03-31_us-gaap_StockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="From2022-04-012023-03-31_us-gaap_StockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-03-31_us-gaap_StockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="From2021-04-012022-03-31_us-gaap_StockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-03-31_us-gaap_StockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="From2020-04-012021-03-31_us-gaap_StockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-12-31_us-gaap_StockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_StockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_SixCurrentAndThreeFormerDirectorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:SixCurrentAndThreeFormerDirectorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_srt_OfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:OfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_EmployeesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:EmployeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2022-05-232022-05-23_custom_UnderwritingAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:UnderwritingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-23</startDate>
            <endDate>2022-05-23</endDate>
        </period>
    </context>
    <context id="AsOf2022-05-23_custom_UnderwritingAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:UnderwritingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-23</instant>
        </period>
    </context>
    <context id="AsOf2022-05-23_custom_UnderwritingAgreementMember_us-gaap_MeasurementInputExercisePriceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:UnderwritingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-23</instant>
        </period>
    </context>
    <context id="AsOf2022-05-23_custom_UnderwritingAgreementMember_us-gaap_MeasurementInputExpectedTermMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:UnderwritingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-23</instant>
        </period>
    </context>
    <context id="AsOf2022-05-23_custom_UnderwritingAgreementMember_us-gaap_MeasurementInputPriceVolatilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:UnderwritingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-23</instant>
        </period>
    </context>
    <context id="AsOf2022-05-23_custom_UnderwritingAgreementMember_us-gaap_MeasurementInputExpectedDividendRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:UnderwritingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-23</instant>
        </period>
    </context>
    <context id="AsOf2022-05-23_custom_UnderwritingAgreementMember_us-gaap_MeasurementInputRiskFreeInterestRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:UnderwritingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-23</instant>
        </period>
    </context>
    <context id="From2021-08-012021-08-05_custom_RedemptionAgreementMember_custom_KonceptsandTreasureGreenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:RedemptionAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:KonceptsandTreasureGreenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-01</startDate>
            <endDate>2021-08-05</endDate>
        </period>
    </context>
    <context id="From2021-08-082021-08-10_custom_KonceptsandTreasureGreenMember_custom_RedemptionAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:RedemptionAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:KonceptsandTreasureGreenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-08</startDate>
            <endDate>2021-08-10</endDate>
        </period>
    </context>
    <context id="AsOf2021-08-05_custom_PurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:PurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-05</instant>
        </period>
    </context>
    <context id="AsOf2021-08-05_custom_PreFundedWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">RIME:PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-05</instant>
        </period>
    </context>
    <context id="AsOf2021-08-05_us-gaap_PrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-05</instant>
        </period>
    </context>
    <context id="From2021-07-012021-07-06_us-gaap_PrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-06</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-07-06">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-06</endDate>
        </period>
    </context>
    <context id="AsOf2021-07-06_custom_AGPWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">RIME:AGPWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-06</instant>
        </period>
    </context>
    <context id="AsOf2021-07-06">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
        </entity>
        <period>
            <instant>2021-07-06</instant>
        </period>
    </context>
    <context id="From2022-04-012022-12-31_us-gaap_PrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-12-31_srt_NorthAmericaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-04-012023-03-31_srt_NorthAmericaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2021-04-012022-03-31_srt_NorthAmericaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-12-31_country_AU">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-04-012023-03-31_country_AU">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2021-04-012022-03-31_country_AU">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-12-31_custom_EuropeAndUnitedKingdomMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">RIME:EuropeAndUnitedKingdomMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-04-012023-03-31_custom_EuropeAndUnitedKingdomMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">RIME:EuropeAndUnitedKingdomMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2021-04-012022-03-31_custom_EuropeAndUnitedKingdomMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">RIME:EuropeAndUnitedKingdomMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-12-31_custom_OthersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">RIME:OthersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-04-012023-03-31_custom_OthersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">RIME:OthersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2021-04-012022-03-31_custom_OthersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">RIME:OthersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-12-31_us-gaap_ReceivablesFromStockholderMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ReceivablesFromStockholderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_srt_MinimumMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_srt_MaximumMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-05-182023-05-18_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-18</startDate>
            <endDate>2023-05-18</endDate>
        </period>
    </context>
    <context id="From2023-05-182023-05-18_custom_SemiCabIncMember_custom_EqualInstallmentsForThirteenMonthsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RIME:EqualInstallmentsForThirteenMonthsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-18</startDate>
            <endDate>2023-05-18</endDate>
        </period>
    </context>
    <context id="AsOf2023-05-18_custom_SemiCabIncMember_custom_EqualInstallmentsForThirteenMonthsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RIME:EqualInstallmentsForThirteenMonthsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-18</instant>
        </period>
    </context>
    <context id="From2024-05-182024-05-18_custom_SettlementAgreementMember_custom_TwelveInstallmentsMember_us-gaap_SubsequentEventMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RIME:TwelveInstallmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SettlementAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-18</startDate>
            <endDate>2024-05-18</endDate>
        </period>
    </context>
    <context id="From2024-05-182024-05-18_custom_SettlementAgreementMember_custom_FirstPaymentMember_custom_DueAndPaidOnMayTwentyTwoThousandTwentyFourMember_us-gaap_SubsequentEventMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">RIME:DueAndPaidOnMayTwentyTwoThousandTwentyFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RIME:FirstPaymentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SettlementAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-18</startDate>
            <endDate>2024-05-18</endDate>
        </period>
    </context>
    <context id="From2024-05-182024-05-18_custom_SettlementAgreementMember_custom_SecondPaymentMember_custom_DueOnJuneThreeTwoThousandTwentyFourMember_us-gaap_SubsequentEventMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">RIME:DueOnJuneThreeTwoThousandTwentyFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RIME:SecondPaymentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SettlementAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-18</startDate>
            <endDate>2024-05-18</endDate>
        </period>
    </context>
    <context id="From2024-05-182024-05-18_custom_SettlementAgreementMember_custom_TenMonthlyPaymentsMember_custom_DueOnJulyOneTwoThousandTwentyFourMember_us-gaap_SubsequentEventMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">RIME:DueOnJulyOneTwoThousandTwentyFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RIME:TenMonthlyPaymentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SettlementAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-18</startDate>
            <endDate>2024-05-18</endDate>
        </period>
    </context>
    <context id="AsOf2024-03-22_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-22</instant>
        </period>
    </context>
    <context id="From2024-03-222024-03-22_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-22</startDate>
            <endDate>2024-03-22</endDate>
        </period>
    </context>
    <context id="From2024-03-222024-03-22_custom_WeeklyPaymentsForWeeksMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RIME:WeeklyPaymentsForWeeksMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-22</startDate>
            <endDate>2024-03-22</endDate>
        </period>
    </context>
    <context id="AsOf2024-05-08_custom_SemiCabIncMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-08</instant>
        </period>
    </context>
    <context id="From2024-05-082024-05-08_custom_SemiCabIncMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-08</startDate>
            <endDate>2024-05-08</endDate>
        </period>
    </context>
    <context id="From2024-05-082024-05-08_custom_WeeklyPaymentsMember_custom_SemiCabIncMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RIME:WeeklyPaymentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-08</startDate>
            <endDate>2024-05-08</endDate>
        </period>
    </context>
    <context id="From2021-07-102021-07-10_custom_SixShareholderLoanAgreementsMember_custom_AjeshKapoorMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:AjeshKapoorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SixShareholderLoanAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-10</startDate>
            <endDate>2021-07-10</endDate>
        </period>
    </context>
    <context id="AsOf2021-07-10_custom_SixShareholderLoanAgreementsMember_custom_AjeshKapoorMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:AjeshKapoorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SixShareholderLoanAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-10</instant>
        </period>
    </context>
    <context id="From2021-08-272021-08-27_custom_SixShareholderLoanAgreementsMember_custom_AjeshKapoorMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:AjeshKapoorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SixShareholderLoanAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-27</startDate>
            <endDate>2021-08-27</endDate>
        </period>
    </context>
    <context id="AsOf2021-08-27_custom_SixShareholderLoanAgreementsMember_custom_AjeshKapoorMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:AjeshKapoorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SixShareholderLoanAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-27</instant>
        </period>
    </context>
    <context id="From2023-04-172023-04-17_custom_SixShareholderLoanAgreementsMember_custom_VivekSehgalMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:VivekSehgalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SixShareholderLoanAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-17</startDate>
            <endDate>2023-04-17</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-17_custom_SixShareholderLoanAgreementsMember_custom_VivekSehgalMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:VivekSehgalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SixShareholderLoanAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-17</instant>
        </period>
    </context>
    <context id="From2023-05-052023-05-05_custom_SixShareholderLoanAgreementsMember_custom_AjeshKapoorMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:AjeshKapoorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SixShareholderLoanAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-05</startDate>
            <endDate>2023-05-05</endDate>
        </period>
    </context>
    <context id="AsOf2023-05-05_custom_SixShareholderLoanAgreementsMember_custom_AjeshKapoorMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:AjeshKapoorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SixShareholderLoanAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-05</instant>
        </period>
    </context>
    <context id="From2023-05-082023-05-08_custom_SixShareholderLoanAgreementsMember_custom_JaganReddyMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:JaganReddyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SixShareholderLoanAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-08</startDate>
            <endDate>2023-05-08</endDate>
        </period>
    </context>
    <context id="AsOf2023-05-08_custom_SixShareholderLoanAgreementsMember_custom_JaganReddyMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:JaganReddyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SixShareholderLoanAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-08</instant>
        </period>
    </context>
    <context id="From2023-05-172023-05-17_custom_SixShareholderLoanAgreementsMember_custom_AjeshKapoorMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:AjeshKapoorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SixShareholderLoanAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-17</startDate>
            <endDate>2023-05-17</endDate>
        </period>
    </context>
    <context id="AsOf2023-05-17_custom_SixShareholderLoanAgreementsMember_custom_AjeshKapoorMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:AjeshKapoorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SixShareholderLoanAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-17</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31_srt_MinimumMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-03-31_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-03-31_srt_MinimumMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-03-31_srt_MaximumMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:SudhirNarasimhamurthyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:SudhirNarasimhamurthyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:SudhirNarasimhamurthyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:SudhirNarasimhamurthyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:SudhirNarasimhamurthyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:SudhirNarasimhamurthyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_KadandaleSrinivasSudheerMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:KadandaleSrinivasSudheerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_KadandaleSrinivasSudheerMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:KadandaleSrinivasSudheerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_KadandaleSrinivasSudheerMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:KadandaleSrinivasSudheerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_KadandaleSrinivasSudheerMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:KadandaleSrinivasSudheerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_KadandaleSrinivasSudheerMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:KadandaleSrinivasSudheerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_KadandaleSrinivasSudheerMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:KadandaleSrinivasSudheerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_VivekSehgalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:VivekSehgalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_VivekSehgalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:VivekSehgalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_VivekSehgalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:VivekSehgalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_VivekSehgalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:VivekSehgalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_VivekSehgalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:VivekSehgalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_VivekSehgalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:VivekSehgalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_RajivSaxenaMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:RajivSaxenaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_RajivSaxenaMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:RajivSaxenaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_HarshaBhatMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:HarshaBhatMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_HarshaBhatMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:HarshaBhatMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_HarshaBhatMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:HarshaBhatMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_HarshaBhatMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:HarshaBhatMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_HarshaBhatMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:HarshaBhatMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_HarshaBhatMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:HarshaBhatMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_JaganReddyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:JaganReddyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_JaganReddyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:JaganReddyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_JaganReddyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:JaganReddyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_JaganReddyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:JaganReddyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_JaganReddyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:JaganReddyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_JaganReddyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:JaganReddyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:SiddayyaSGanjalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:SiddayyaSGanjalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:SiddayyaSGanjalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:SiddayyaSGanjalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:SiddayyaSGanjalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:SiddayyaSGanjalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_SunilAroraMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:SunilAroraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_SunilAroraMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:SunilAroraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_RajivVirmaniMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:RajivVirmaniMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_RajivVirmaniMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:RajivVirmaniMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_SudhindraShenoyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:SudhindraShenoyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_SudhindraShenoyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:SudhindraShenoyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_SudhindraShenoyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:SudhindraShenoyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_SudhindraShenoyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:SudhindraShenoyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_SudhindraShenoyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:SudhindraShenoyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_SudhindraShenoyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:SudhindraShenoyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_AntonySunilMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:AntonySunilMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_AntonySunilMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:AntonySunilMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_AntonySunilMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:AntonySunilMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_AntonySunilMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:AntonySunilMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_AntonySunilMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:AntonySunilMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_AntonySunilMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:AntonySunilMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_TuleekaNandyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:TuleekaNandyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_TuleekaNandyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:TuleekaNandyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_TuleekaNandyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:TuleekaNandyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_TuleekaNandyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:TuleekaNandyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_RobelAtnafuMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:RobelAtnafuMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_RobelAtnafuMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:RobelAtnafuMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_GuyPrimusMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:GuyPrimusMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_GuyPrimusMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:GuyPrimusMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_SamarthaGowdaMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:SamarthaGowdaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_SamarthaGowdaMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:SamarthaGowdaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_AlexandraAielloMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:AlexandraAielloMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_AlexandraAielloMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:AlexandraAielloMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_StephenCabralMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:StephenCabralMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_StephenCabralMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:StephenCabralMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_JonahPetiPerrinMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:JonahPetiPerrinMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_JonahPetiPerrinMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:JonahPetiPerrinMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_BryanNellaMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:BryanNellaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_BryanNellaMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:BryanNellaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_MarkSinkMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:MarkSinkMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_MarkSinkMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:MarkSinkMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_KoustavChoudhuriMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:KoustavChoudhuriMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_KoustavChoudhuriMember_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:KoustavChoudhuriMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_StockOptionMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-03-31_custom_FoundersMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RIME:FoundersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-22_custom_SAFEAgreementsMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-22</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31_custom_SAFEAgreementsMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-03-31_custom_SAFEAgreementsMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2021-08-122023-04-22_custom_FortyFourSAFEAgreementsMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:FortyFourSAFEAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-12</startDate>
            <endDate>2023-04-22</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-22_custom_FortyFourSAFEAgreementsMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:FortyFourSAFEAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-22</instant>
        </period>
    </context>
    <context id="From2021-08-122023-04-22_custom_FortyFourSAFEAgreementsMember_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:FortyFourSAFEAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-12</startDate>
            <endDate>2023-04-22</endDate>
        </period>
    </context>
    <context id="From2018-10-252023-04-22_custom_SAFEOneMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-10-25</startDate>
            <endDate>2023-04-22</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-22_custom_SAFEOneMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-22</instant>
        </period>
    </context>
    <context id="From2018-10-252023-04-22_custom_SAFEThirtyEightMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEThirtyEightMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-10-25</startDate>
            <endDate>2023-04-22</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-22_custom_SAFEThirtyEightMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEThirtyEightMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-22</instant>
        </period>
    </context>
    <context id="From2018-10-252023-04-22_custom_SAFEFortyOneMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEFortyOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-10-25</startDate>
            <endDate>2023-04-22</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-22_custom_SAFEFortyOneMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEFortyOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-22</instant>
        </period>
    </context>
    <context id="From2018-10-252023-04-22_custom_SAFEFortyTwoMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEFortyTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-10-25</startDate>
            <endDate>2023-04-22</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-22_custom_SAFEFortyTwoMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEFortyTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-22</instant>
        </period>
    </context>
    <context id="From2018-10-252023-04-22_custom_SAFEFortyFourMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEFortyFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-10-25</startDate>
            <endDate>2023-04-22</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-22_custom_SAFEFortyFourMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEFortyFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-22</instant>
        </period>
    </context>
    <context id="From2018-10-252023-04-22_custom_SAFEFortyThreeMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEFortyThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-10-25</startDate>
            <endDate>2023-04-22</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-22_custom_SAFEFortyThreeMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEFortyThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-22</instant>
        </period>
    </context>
    <context id="AsOf2023-04-22_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-22</instant>
        </period>
    </context>
    <context id="From2021-08-122023-04-22_custom_SAFEFortyMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEFortyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-12</startDate>
            <endDate>2023-04-22</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-22_custom_SAFEFortyMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEFortyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-22</instant>
        </period>
    </context>
    <context id="From2021-08-122023-04-22_custom_SAFEThirtyNineMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEThirtyNineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-12</startDate>
            <endDate>2023-04-22</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-22_custom_SAFEThirtyNineMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEThirtyNineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-22</instant>
        </period>
    </context>
    <context id="From2021-08-122023-04-22_custom_SAFETenMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFETenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-12</startDate>
            <endDate>2023-04-22</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-22_custom_SAFETenMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFETenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-22</instant>
        </period>
    </context>
    <context id="From2021-08-122023-04-22_custom_SAFEElevenMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEElevenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-12</startDate>
            <endDate>2023-04-22</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-22_custom_SAFEElevenMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEElevenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-22</instant>
        </period>
    </context>
    <context id="From2021-08-122023-04-22_custom_SAFETwelveMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFETwelveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-12</startDate>
            <endDate>2023-04-22</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-22_custom_SAFETwelveMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFETwelveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-22</instant>
        </period>
    </context>
    <context id="From2021-08-122023-04-22_custom_SAFEThirteenMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEThirteenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-12</startDate>
            <endDate>2023-04-22</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-22_custom_SAFEThirteenMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEThirteenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-22</instant>
        </period>
    </context>
    <context id="From2021-08-122023-04-22_custom_SAFEFourteenMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEFourteenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-12</startDate>
            <endDate>2023-04-22</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-22_custom_SAFEFourteenMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEFourteenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-22</instant>
        </period>
    </context>
    <context id="From2021-08-122023-04-22_custom_SAFEFifteenMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEFifteenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-12</startDate>
            <endDate>2023-04-22</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-22_custom_SAFEFifteenMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEFifteenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-22</instant>
        </period>
    </context>
    <context id="From2021-08-122023-04-22_custom_SAFESixteenMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFESixteenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-12</startDate>
            <endDate>2023-04-22</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-22_custom_SAFESixteenMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFESixteenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-22</instant>
        </period>
    </context>
    <context id="From2021-08-122023-04-22_custom_SAFESeventeenMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFESeventeenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-12</startDate>
            <endDate>2023-04-22</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-22_custom_SAFESeventeenMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFESeventeenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-22</instant>
        </period>
    </context>
    <context id="From2021-08-122023-04-22_custom_SAFEEighteenMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEEighteenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-12</startDate>
            <endDate>2023-04-22</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-22_custom_SAFEEighteenMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEEighteenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-22</instant>
        </period>
    </context>
    <context id="From2021-08-122023-04-22_custom_SAFENineteenMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFENineteenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-12</startDate>
            <endDate>2023-04-22</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-22_custom_SAFENineteenMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFENineteenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-22</instant>
        </period>
    </context>
    <context id="From2021-08-122023-04-22_custom_SAFETwoMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFETwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-12</startDate>
            <endDate>2023-04-22</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-22_custom_SAFETwoMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFETwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-22</instant>
        </period>
    </context>
    <context id="From2021-08-122023-04-22_custom_SAFETwentyMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFETwentyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-12</startDate>
            <endDate>2023-04-22</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-22_custom_SAFETwentyMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFETwentyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-22</instant>
        </period>
    </context>
    <context id="From2021-08-122023-04-22_custom_SAFETwentyOneMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFETwentyOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-12</startDate>
            <endDate>2023-04-22</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-22_custom_SAFETwentyOneMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFETwentyOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-22</instant>
        </period>
    </context>
    <context id="From2021-08-122023-04-22_custom_SAFETwentyTwoMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFETwentyTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-12</startDate>
            <endDate>2023-04-22</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-22_custom_SAFETwentyTwoMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFETwentyTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-22</instant>
        </period>
    </context>
    <context id="From2021-08-122023-04-22_custom_SAFETwentyFourMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFETwentyFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-12</startDate>
            <endDate>2023-04-22</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-22_custom_SAFETwentyFourMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFETwentyFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-22</instant>
        </period>
    </context>
    <context id="From2021-08-122023-04-22_custom_SAFEThreeMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-12</startDate>
            <endDate>2023-04-22</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-22_custom_SAFEThreeMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-22</instant>
        </period>
    </context>
    <context id="From2021-08-122023-04-22_custom_SAFEFourMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-12</startDate>
            <endDate>2023-04-22</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-22_custom_SAFEFourMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-22</instant>
        </period>
    </context>
    <context id="From2021-08-122023-04-22_custom_SAFEFortyFiveMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEFortyFiveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-12</startDate>
            <endDate>2023-04-22</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-22_custom_SAFEFortyFiveMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEFortyFiveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-22</instant>
        </period>
    </context>
    <context id="From2021-08-122023-04-22_custom_SAFESixMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFESixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-12</startDate>
            <endDate>2023-04-22</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-22_custom_SAFESixMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFESixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-22</instant>
        </period>
    </context>
    <context id="From2021-08-122023-04-22_custom_SAFESevenMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFESevenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-12</startDate>
            <endDate>2023-04-22</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-22_custom_SAFESevenMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFESevenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-22</instant>
        </period>
    </context>
    <context id="From2021-08-122023-04-22_custom_SAFEEightMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEEightMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-12</startDate>
            <endDate>2023-04-22</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-22_custom_SAFEEightMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEEightMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-22</instant>
        </period>
    </context>
    <context id="From2021-08-122023-04-22_custom_SAFENineMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFENineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-12</startDate>
            <endDate>2023-04-22</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-22_custom_SAFENineMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFENineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-22</instant>
        </period>
    </context>
    <context id="From2021-08-122023-04-22_custom_SAFEFiveMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEFiveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-12</startDate>
            <endDate>2023-04-22</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-22_custom_SAFEFiveMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEFiveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-22</instant>
        </period>
    </context>
    <context id="From2021-08-122023-04-22_custom_SAFETwentyFiveMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFETwentyFiveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-12</startDate>
            <endDate>2023-04-22</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-22_custom_SAFETwentyFiveMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFETwentyFiveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-22</instant>
        </period>
    </context>
    <context id="From2021-08-122023-04-22_custom_SAFETwentySixMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFETwentySixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-12</startDate>
            <endDate>2023-04-22</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-22_custom_SAFETwentySixMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFETwentySixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-22</instant>
        </period>
    </context>
    <context id="From2021-08-122023-04-22_custom_SAFETwentySevenMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFETwentySevenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-12</startDate>
            <endDate>2023-04-22</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-22_custom_SAFETwentySevenMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFETwentySevenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-22</instant>
        </period>
    </context>
    <context id="From2021-08-122023-04-22_custom_SAFETwentyEightMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFETwentyEightMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-12</startDate>
            <endDate>2023-04-22</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-22_custom_SAFETwentyEightMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFETwentyEightMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-22</instant>
        </period>
    </context>
    <context id="From2021-08-122023-04-22_custom_SAFETwentyNineMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFETwentyNineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-12</startDate>
            <endDate>2023-04-22</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-22_custom_SAFETwentyNineMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFETwentyNineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-22</instant>
        </period>
    </context>
    <context id="From2021-08-122023-04-22_custom_SAFEThirtyMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEThirtyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-12</startDate>
            <endDate>2023-04-22</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-22_custom_SAFEThirtyMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEThirtyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-22</instant>
        </period>
    </context>
    <context id="From2021-08-122023-04-22_custom_SAFEThirtyOneMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEThirtyOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-12</startDate>
            <endDate>2023-04-22</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-22_custom_SAFEThirtyOneMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEThirtyOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-22</instant>
        </period>
    </context>
    <context id="From2021-08-122023-04-22_custom_SAFEThirtyTwoMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEThirtyTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-12</startDate>
            <endDate>2023-04-22</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-22_custom_SAFEThirtyTwoMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEThirtyTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-22</instant>
        </period>
    </context>
    <context id="From2021-08-122023-04-22_custom_SAFEThirtyThreeMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEThirtyThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-12</startDate>
            <endDate>2023-04-22</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-22_custom_SAFEThirtyThreeMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEThirtyThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-22</instant>
        </period>
    </context>
    <context id="From2021-08-122023-04-22_custom_SAFEThirtyFourMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEThirtyFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-12</startDate>
            <endDate>2023-04-22</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-22_custom_SAFEThirtyFourMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEThirtyFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-22</instant>
        </period>
    </context>
    <context id="From2021-08-122023-04-22_custom_SAFEThirtyFiveMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEThirtyFiveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-12</startDate>
            <endDate>2023-04-22</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-22_custom_SAFEThirtyFiveMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEThirtyFiveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-22</instant>
        </period>
    </context>
    <context id="From2021-08-122023-04-22_custom_SAFEThirtySixMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEThirtySixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-12</startDate>
            <endDate>2023-04-22</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-22_custom_SAFEThirtySixMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEThirtySixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-22</instant>
        </period>
    </context>
    <context id="From2021-08-122023-04-22_custom_SAFEThirtySevenMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEThirtySevenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-12</startDate>
            <endDate>2023-04-22</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-22_custom_SAFEThirtySevenMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEThirtySevenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-22</instant>
        </period>
    </context>
    <context id="From2021-08-122023-04-22_custom_SAFEFortySixMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEFortySixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-12</startDate>
            <endDate>2023-04-22</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-22_custom_SAFEFortySixMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEFortySixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-22</instant>
        </period>
    </context>
    <context id="From2021-08-122023-04-22_custom_SAFEFiftyMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEFiftyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-12</startDate>
            <endDate>2023-04-22</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-22_custom_SAFEFiftyMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEFiftyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-22</instant>
        </period>
    </context>
    <context id="From2021-08-122023-04-22_custom_SAFEFortyEightMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEFortyEightMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-12</startDate>
            <endDate>2023-04-22</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-22_custom_SAFEFortyEightMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEFortyEightMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-22</instant>
        </period>
    </context>
    <context id="From2021-08-122023-04-22_custom_SAFEFortySevenMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEFortySevenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-12</startDate>
            <endDate>2023-04-22</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-22_custom_SAFEFortySevenMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEFortySevenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-22</instant>
        </period>
    </context>
    <context id="From2021-08-122023-04-22_custom_SAFEFortyNineMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEFortyNineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-12</startDate>
            <endDate>2023-04-22</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-22_custom_SAFEFortyNineMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEFortyNineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-22</instant>
        </period>
    </context>
    <context id="From2021-08-122023-04-22_custom_SAFEFiftyOneMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEFiftyOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-12</startDate>
            <endDate>2023-04-22</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-22_custom_SAFEFiftyOneMember_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RIME:SAFEFiftyOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-22</instant>
        </period>
    </context>
    <context id="AsOf2023-04-22_custom_SemiCabIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000923601</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RIME:SemiCabIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-22</instant>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <unit id="sqft">
        <measure>utr:sqft</measure>
    </unit>
    <dei:AmendmentFlag contextRef="From2024-01-01to2024-09-30" id="Fact000003">true</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="From2024-01-01to2024-09-30" id="Fact000004">0000923601</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="From2024-01-01to2024-09-30" id="xdx2ixbrl0011">S-1/A</dei:DocumentType>
    <us-gaap:DueFromBanks
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl0052"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl0085"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Goodwill
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl0088"
      unitRef="USD"
      xsi:nil="true"/>
    <RIME:CustomerPrepayments
      contextRef="AsOf2024-09-30"
      id="xdx2ixbrl0114"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShortTermBorrowings
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl0121"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NotesPayableCurrent
      contextRef="AsOf2023-12-31_us-gaap_NonrelatedPartyMember"
      id="xdx2ixbrl0124"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NotesPayableCurrent
      contextRef="AsOf2023-12-31_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl0127"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NotesPayableCurrent
      contextRef="AsOf2023-12-31_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl0130"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="AsOf2024-09-30"
      id="xdx2ixbrl0141"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LongTermNotesPayable
      contextRef="AsOf2023-12-31_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl0145"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="AsOf2024-09-30"
      id="xdx2ixbrl0147"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2024-09-30"
      id="xdx2ixbrl0162"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl0163"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2024-09-30"
      id="xdx2ixbrl0168"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl0169"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterest
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl0219"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GainLossOnTerminationOfLease
      contextRef="From2023-07-012023-09-30"
      id="xdx2ixbrl0258"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GainLossOnTerminationOfLease
      contextRef="From2023-01-012023-09-30"
      id="xdx2ixbrl0260"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GainLossOnDispositionOfAssets1
      contextRef="From2024-07-012024-09-30"
      id="xdx2ixbrl0282"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GainLossOnDispositionOfAssets1
      contextRef="From2024-01-01to2024-09-30"
      id="xdx2ixbrl0284"
      unitRef="USD"
      xsi:nil="true"/>
    <RIME:GainFromEmployeeRetentionCreditProgramRefund
      contextRef="From2024-07-012024-09-30"
      id="xdx2ixbrl0307"
      unitRef="USD"
      xsi:nil="true"/>
    <RIME:GainFromEmployeeRetentionCreditProgramRefund
      contextRef="From2023-07-012023-09-30"
      id="xdx2ixbrl0308"
      unitRef="USD"
      xsi:nil="true"/>
    <RIME:GainFromEmployeeRetentionCreditProgramRefund
      contextRef="From2024-01-01to2024-09-30"
      id="xdx2ixbrl0309"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2024-07-012024-09-30"
      id="xdx2ixbrl0327"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2023-07-012023-09-30"
      id="xdx2ixbrl0328"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2024-01-01to2024-09-30"
      id="xdx2ixbrl0329"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2023-07-012023-09-30"
      id="xdx2ixbrl0338"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2023-01-012023-09-30"
      id="xdx2ixbrl0340"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-06-30_us-gaap_ReceivablesFromStockholderMember"
      id="xdx2ixbrl0391"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-06-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0392"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0398"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2024-07-012024-09-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0399"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2024-07-012024-09-30_us-gaap_ReceivablesFromStockholderMember"
      id="xdx2ixbrl0400"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2024-07-012024-09-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0408"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2024-07-012024-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0409"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation
      contextRef="From2024-07-012024-09-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0417"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation
      contextRef="From2024-07-012024-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0418"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2024-07-012024-09-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0426"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2024-07-012024-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0427"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0432"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="From2024-07-012024-09-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0433"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="From2024-07-012024-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0436"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0439"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2024-07-012024-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0443"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-09-30_us-gaap_ReceivablesFromStockholderMember"
      id="xdx2ixbrl0448"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-06-30_us-gaap_ReceivablesFromStockholderMember"
      id="xdx2ixbrl0457"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-06-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0458"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0464"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2023-07-012023-09-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0465"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2023-07-012023-09-30_us-gaap_ReceivablesFromStockholderMember"
      id="xdx2ixbrl0466"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2023-07-012023-09-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0467"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation
      contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0471"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation
      contextRef="From2023-07-012023-09-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0474"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation
      contextRef="From2023-07-012023-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0475"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0478"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2023-07-012023-09-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0481"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2023-07-012023-09-30"
      id="xdx2ixbrl0483"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-09-30_us-gaap_ReceivablesFromStockholderMember"
      id="xdx2ixbrl0487"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-09-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0488"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-12-31_us-gaap_ReceivablesFromStockholderMember"
      id="xdx2ixbrl0496"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-12-31_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0497"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2024-01-012024-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0503"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2024-01-012024-09-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0504"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2024-01-012024-09-30_us-gaap_ReceivablesFromStockholderMember"
      id="xdx2ixbrl0505"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2024-01-012024-09-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0513"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2024-01-012024-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0514"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation
      contextRef="From2024-01-012024-09-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0522"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation
      contextRef="From2024-01-012024-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0523"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2024-01-012024-09-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0531"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2024-01-012024-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0532"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="From2024-01-012024-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0537"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="From2024-01-012024-09-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0538"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="From2024-01-012024-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0541"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2024-01-012024-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0544"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-09-30_us-gaap_ReceivablesFromStockholderMember"
      id="xdx2ixbrl0553"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-12-31_us-gaap_ReceivablesFromStockholderMember"
      id="xdx2ixbrl0562"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-12-31_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0563"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-12-31_us-gaap_ReceivablesFromStockholderMember"
      id="xdx2ixbrl0571"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-12-31_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0572"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2023-01-012023-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0578"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2023-01-012023-09-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0579"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2023-01-012023-09-30_us-gaap_ReceivablesFromStockholderMember"
      id="xdx2ixbrl0580"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2023-01-012023-09-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0581"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2023-01-012023-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0585"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2023-01-012023-09-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0586"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2023-01-012023-09-30_us-gaap_ReceivablesFromStockholderMember"
      id="xdx2ixbrl0587"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2023-01-012023-09-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0588"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-01-012023-09-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0595"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-01-012023-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0596"
      unitRef="USD"
      xsi:nil="true"/>
    <RIME:StockIssuedDuringPeriodValueSaleOfCommonStockWarrants
      contextRef="From2023-01-012023-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0601"
      unitRef="USD"
      xsi:nil="true"/>
    <RIME:StockIssuedDuringPeriodValueSaleOfCommonStockWarrants
      contextRef="From2023-01-012023-09-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0604"
      unitRef="USD"
      xsi:nil="true"/>
    <RIME:StockIssuedDuringPeriodValueSaleOfCommonStockWarrants
      contextRef="From2023-01-012023-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0605"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation
      contextRef="From2023-01-012023-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0610"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation
      contextRef="From2023-01-012023-09-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0613"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation
      contextRef="From2023-01-012023-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0614"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-09-30_us-gaap_ReceivablesFromStockholderMember"
      id="xdx2ixbrl0619"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-09-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0620"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-09-30_us-gaap_ReceivablesFromStockholderMember"
      id="xdx2ixbrl0628"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-09-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0629"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="From2023-01-012023-09-30"
      id="xdx2ixbrl0651"
      unitRef="USD"
      xsi:nil="true"/>
    <RIME:ProvisionForInventoryObsolescence
      contextRef="From2024-01-01to2024-09-30"
      id="xdx2ixbrl0656"
      unitRef="USD"
      xsi:nil="true"/>
    <RIME:GainOnTerminationOfOperatingLease
      contextRef="From2023-01-012023-09-30"
      id="xdx2ixbrl0663"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="From2024-01-01to2024-09-30"
      id="xdx2ixbrl0665"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2024-01-01to2024-09-30"
      id="xdx2ixbrl0674"
      unitRef="USD"
      xsi:nil="true"/>
    <RIME:PaymentOfEarlyTerminationFeeOnOperatingLeaseTerminationSettlement
      contextRef="From2023-01-012023-09-30"
      id="xdx2ixbrl0732"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromPreviousAcquisition
      contextRef="From2023-01-012023-09-30"
      id="xdx2ixbrl0744"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="From2024-01-01to2024-09-30"
      id="xdx2ixbrl0746"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RepaymentsOfOtherDebt
      contextRef="From2023-01-012023-09-30"
      id="xdx2ixbrl0789"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromRepaymentsOfLinesOfCredit
      contextRef="From2024-01-01to2024-09-30"
      id="xdx2ixbrl0791"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssued1
      contextRef="From2023-01-012023-09-30"
      id="xdx2ixbrl0822"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CapitalLeaseObligationsIncurred
      contextRef="From2024-01-01to2024-09-30"
      id="xdx2ixbrl0824"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DebtInstrumentTerm
      contextRef="From2024-03-282024-03-28_us-gaap_RevolvingCreditFacilityMember"
      id="xdx2ixbrl1051">P2Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="AsOf2024-09-30"
      id="xdx2ixbrl1204"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2024-07-012024-09-30"
      id="xdx2ixbrl1334"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2023-07-012023-09-30"
      id="xdx2ixbrl1336"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Revenues
      contextRef="From2023-07-012023-09-30_custom_LogisticsServicesMember"
      id="xdx2ixbrl1370"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Revenues
      contextRef="From2023-01-012023-09-30_custom_LogisticsServicesMember"
      id="xdx2ixbrl1372"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ContractWithCustomerRefundLiabilityCurrent
      contextRef="AsOf2023-03-31"
      id="xdx2ixbrl1566"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl1592"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2023-03-31"
      id="xdx2ixbrl1593"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl1598"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2023-03-31"
      id="xdx2ixbrl1599"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl1639"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GainLossOnDispositionOfAssets1
      contextRef="From2022-04-012023-03-31"
      id="xdx2ixbrl1688"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GainLossOnDispositionOfAssets1
      contextRef="From2021-04-012022-03-31"
      id="xdx2ixbrl1689"
      unitRef="USD"
      xsi:nil="true"/>
    <RIME:GainFromRelatedPartyDebt
      contextRef="From2023-04-012023-12-31"
      id="xdx2ixbrl1691"
      unitRef="USD"
      xsi:nil="true"/>
    <RIME:GainFromRelatedPartyDebt
      contextRef="From2022-04-012023-03-31"
      id="xdx2ixbrl1692"
      unitRef="USD"
      xsi:nil="true"/>
    <RIME:GainFromPaycheckProtectionPlanLoanForgiveness
      contextRef="From2023-04-012023-12-31"
      id="xdx2ixbrl1695"
      unitRef="USD"
      xsi:nil="true"/>
    <RIME:GainFromPaycheckProtectionPlanLoanForgiveness
      contextRef="From2022-04-012023-03-31"
      id="xdx2ixbrl1696"
      unitRef="USD"
      xsi:nil="true"/>
    <RIME:GainFromEmployeeRetentionCreditProgramRefund
      contextRef="From2023-04-012023-12-31"
      id="xdx2ixbrl1699"
      unitRef="USD"
      xsi:nil="true"/>
    <RIME:GainFromEmployeeRetentionCreditProgramRefund
      contextRef="From2021-04-012022-03-31"
      id="xdx2ixbrl1701"
      unitRef="USD"
      xsi:nil="true"/>
    <RIME:GainFromSettlementOfAccountsPayable
      contextRef="From2023-04-012023-12-31"
      id="xdx2ixbrl1703"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2023-04-012023-12-31"
      id="xdx2ixbrl1707"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2021-04-012022-03-31"
      id="xdx2ixbrl1709"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2023-04-012023-12-31"
      id="xdx2ixbrl1723"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="From2023-04-012023-12-31"
      id="xdx2ixbrl1779"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="From2023-04-012023-12-31"
      id="xdx2ixbrl1807"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2023-04-012023-12-31"
      id="xdx2ixbrl1811"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2021-04-012022-03-31"
      id="xdx2ixbrl1813"
      unitRef="USD"
      xsi:nil="true"/>
    <RIME:GainFromPaycheckProtectionPlanLoanForgiveness
      contextRef="From2023-04-012023-12-31"
      id="xdx2ixbrl1815"
      unitRef="USD"
      xsi:nil="true"/>
    <RIME:GainFromPaycheckProtectionPlanLoanForgiveness
      contextRef="From2022-04-012023-03-31"
      id="xdx2ixbrl1816"
      unitRef="USD"
      xsi:nil="true"/>
    <RIME:GainFromRelatedPartyDebt
      contextRef="From2023-04-012023-12-31"
      id="xdx2ixbrl1819"
      unitRef="USD"
      xsi:nil="true"/>
    <RIME:GainFromRelatedPartyDebt
      contextRef="From2022-04-012023-03-31"
      id="xdx2ixbrl1820"
      unitRef="USD"
      xsi:nil="true"/>
    <RIME:GainFromSettlementOfAccountsPayable
      contextRef="From2023-04-012023-12-31"
      id="xdx2ixbrl1823"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseDueFromAffiliates
      contextRef="From2023-04-012023-12-31"
      id="xdx2ixbrl1839"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInDueToRelatedParties
      contextRef="From2023-04-012023-12-31"
      id="xdx2ixbrl1863"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInDueToRelatedParties
      contextRef="From2021-04-012022-03-31"
      id="xdx2ixbrl1865"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="From2022-04-012023-03-31"
      id="xdx2ixbrl1868"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="From2022-04-012023-03-31"
      id="xdx2ixbrl1896"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="From2021-04-012022-03-31"
      id="xdx2ixbrl1897"
      unitRef="USD"
      xsi:nil="true"/>
    <RIME:PaymentOfRedemptionAndRetirementOfTreasuryStock
      contextRef="From2023-04-012023-12-31"
      id="xdx2ixbrl1911"
      unitRef="USD"
      xsi:nil="true"/>
    <RIME:PaymentOfRedemptionAndRetirementOfTreasuryStock
      contextRef="From2022-04-012023-03-31"
      id="xdx2ixbrl1912"
      unitRef="USD"
      xsi:nil="true"/>
    <RIME:ProceedsFromCollectionOfSubscriptionsReceivable
      contextRef="From2022-04-012023-03-31"
      id="xdx2ixbrl1916"
      unitRef="USD"
      xsi:nil="true"/>
    <RIME:ProceedsFromCollectionOfSubscriptionsReceivable
      contextRef="From2021-04-012022-03-31"
      id="xdx2ixbrl1917"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromRepaymentsOfLinesOfCredit
      contextRef="From2023-04-012023-12-31"
      id="xdx2ixbrl1919"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RepaymentsOfSubordinatedDebt
      contextRef="From2023-04-012023-12-31"
      id="xdx2ixbrl1923"
      unitRef="USD"
      xsi:nil="true"/>
    <RIME:PaymentOfDeferredFinancingCharges
      contextRef="From2023-04-012023-12-31"
      id="xdx2ixbrl1927"
      unitRef="USD"
      xsi:nil="true"/>
    <RIME:PaymentOfEarlyTerminationFeesOnRevolvingLinesOfCredit
      contextRef="From2023-04-012023-12-31"
      id="xdx2ixbrl1931"
      unitRef="USD"
      xsi:nil="true"/>
    <RIME:PaymentOfEarlyTerminationFeesOnRevolvingLinesOfCredit
      contextRef="From2021-04-012022-03-31"
      id="xdx2ixbrl1933"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="From2023-04-012023-12-31"
      id="xdx2ixbrl1939"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="From2022-04-012023-03-31"
      id="xdx2ixbrl1940"
      unitRef="USD"
      xsi:nil="true"/>
    <RIME:ProceedsFromExerciseOfCommonStockWarrants
      contextRef="From2023-04-012023-12-31"
      id="xdx2ixbrl1943"
      unitRef="USD"
      xsi:nil="true"/>
    <RIME:ProceedsFromExerciseOfCommonStockWarrants
      contextRef="From2021-04-012022-03-31"
      id="xdx2ixbrl1945"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="From2023-04-012023-12-31"
      id="xdx2ixbrl1947"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="From2021-04-012022-03-31"
      id="xdx2ixbrl1949"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations
      contextRef="From2023-04-012023-12-31"
      id="xdx2ixbrl1951"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="From2023-04-012023-12-31"
      id="xdx2ixbrl1979"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="From2021-04-012022-03-31"
      id="xdx2ixbrl1981"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CapitalLeaseObligationsIncurred
      contextRef="From2023-04-012023-12-31"
      id="xdx2ixbrl1987"
      unitRef="USD"
      xsi:nil="true"/>
    <RIME:IssuanceOfCommonStockAndWarrantsForOfferingCosts
      contextRef="From2023-04-012023-12-31"
      id="xdx2ixbrl1991"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-03-31_us-gaap_ReceivablesFromStockholderMember"
      id="xdx2ixbrl2001"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2021-04-012022-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl2007"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2021-04-012022-03-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl2008"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2021-04-012022-03-31_us-gaap_ReceivablesFromStockholderMember"
      id="xdx2ixbrl2009"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2021-04-012022-03-31_us-gaap_ReceivablesFromStockholderMember"
      id="xdx2ixbrl2015"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2021-04-012022-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl2016"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="From2021-04-012022-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl2021"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="From2021-04-012022-03-31_us-gaap_ReceivablesFromStockholderMember"
      id="xdx2ixbrl2023"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="From2021-04-012022-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl2024"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="From2021-04-012022-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl2027"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="From2021-04-012022-03-31_us-gaap_ReceivablesFromStockholderMember"
      id="xdx2ixbrl2029"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="From2021-04-012022-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl2030"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2021-04-012022-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl2033"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2021-04-012022-03-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl2034"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2021-04-012022-03-31_us-gaap_ReceivablesFromStockholderMember"
      id="xdx2ixbrl2035"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2021-04-012022-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl2036"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2021-04-012022-03-31"
      id="xdx2ixbrl2037"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="From2021-04-012022-03-31_us-gaap_ReceivablesFromStockholderMember"
      id="xdx2ixbrl2043"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2021-04-012022-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl2049"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2021-04-012022-03-31_us-gaap_ReceivablesFromStockholderMember"
      id="xdx2ixbrl2051"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2021-04-012022-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl2052"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2021-04-012022-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl2057"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2021-04-012022-03-31_us-gaap_ReceivablesFromStockholderMember"
      id="xdx2ixbrl2059"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2021-04-012022-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl2060"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-03-31_us-gaap_ReceivablesFromStockholderMember"
      id="xdx2ixbrl2067"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2022-04-012023-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl2073"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2022-04-012023-03-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl2074"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2022-04-012023-03-31_us-gaap_ReceivablesFromStockholderMember"
      id="xdx2ixbrl2075"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-04-012023-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl2082"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="From2022-04-012023-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl2087"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="From2022-04-012023-03-31_us-gaap_ReceivablesFromStockholderMember"
      id="xdx2ixbrl2089"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="From2022-04-012023-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl2090"
      unitRef="USD"
      xsi:nil="true"/>
    <RIME:StockIssuedDuringPeriodValueExerciseOfPrefundedAndCommonWarrants
      contextRef="From2022-04-012023-03-31_us-gaap_ReceivablesFromStockholderMember"
      id="xdx2ixbrl2095"
      unitRef="USD"
      xsi:nil="true"/>
    <RIME:StockIssuedDuringPeriodValueExerciseOfPrefundedAndCommonWarrants
      contextRef="From2022-04-012023-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl2096"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2022-04-012023-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl2101"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2022-04-012023-03-31_us-gaap_ReceivablesFromStockholderMember"
      id="xdx2ixbrl2103"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2022-04-012023-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl2104"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2022-04-012023-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl2109"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2022-04-012023-03-31_us-gaap_ReceivablesFromStockholderMember"
      id="xdx2ixbrl2111"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2022-04-012023-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl2112"
      unitRef="USD"
      xsi:nil="true"/>
    <RIME:StockIssuedDuringPeriodValueReverseStockSplits
      contextRef="From2022-04-012023-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl2115"
      unitRef="USD"
      xsi:nil="true"/>
    <RIME:StockIssuedDuringPeriodValueReverseStockSplits
      contextRef="From2022-04-012023-03-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl2116"
      unitRef="USD"
      xsi:nil="true"/>
    <RIME:StockIssuedDuringPeriodValueReverseStockSplits
      contextRef="From2022-04-012023-03-31_us-gaap_ReceivablesFromStockholderMember"
      id="xdx2ixbrl2117"
      unitRef="USD"
      xsi:nil="true"/>
    <RIME:StockIssuedDuringPeriodValueReverseStockSplits
      contextRef="From2022-04-012023-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl2118"
      unitRef="USD"
      xsi:nil="true"/>
    <RIME:StockIssuedDuringPeriodValueReverseStockSplits
      contextRef="From2022-04-012023-03-31"
      id="xdx2ixbrl2119"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2023-04-012023-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl2139"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2023-04-012023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl2140"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2023-04-012023-12-31_us-gaap_ReceivablesFromStockholderMember"
      id="xdx2ixbrl2141"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2023-04-012023-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl2145"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2023-04-012023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl2146"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2023-04-012023-12-31_us-gaap_ReceivablesFromStockholderMember"
      id="xdx2ixbrl2147"
      unitRef="USD"
      xsi:nil="true"/>
    <RIME:StockIssuedDuringPeriodValueIssuanceOfCommonStockAtMarketOffering
      contextRef="From2023-04-012023-12-31_us-gaap_ReceivablesFromStockholderMember"
      id="xdx2ixbrl2153"
      unitRef="USD"
      xsi:nil="true"/>
    <RIME:StockIssuedDuringPeriodValueIssuanceOfCommonStockAtMarketOffering
      contextRef="From2023-04-012023-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl2154"
      unitRef="USD"
      xsi:nil="true"/>
    <RIME:StockIssuedDuringPeriodValueIssuanceOfCommonStockPrivatePlacement
      contextRef="From2023-04-012023-12-31_us-gaap_ReceivablesFromStockholderMember"
      id="xdx2ixbrl2161"
      unitRef="USD"
      xsi:nil="true"/>
    <RIME:StockIssuedDuringPeriodValueIssuanceOfCommonStockPrivatePlacement
      contextRef="From2023-04-012023-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl2162"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="From2023-04-012023-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl2167"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="From2023-04-012023-12-31_us-gaap_ReceivablesFromStockholderMember"
      id="xdx2ixbrl2169"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="From2023-04-012023-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl2170"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2023-04-012023-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl2173"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2023-04-012023-12-31_us-gaap_ReceivablesFromStockholderMember"
      id="xdx2ixbrl2175"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2023-04-012023-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl2176"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="From2023-04-012023-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl2179"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="From2023-04-012023-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl2181"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="From2023-04-012023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl2182"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="From2023-04-012023-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl2184"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_ReceivablesFromStockholderMember"
      id="xdx2ixbrl2189"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_ReceivablesFromStockholderMember"
      id="xdx2ixbrl2197"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2023-12-31_custom_WarehouseEquipmentMember"
      id="xdx2ixbrl2305"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DebtInstrumentTerm
      contextRef="From2024-03-282024-03-28_us-gaap_SubsequentEventMember_us-gaap_RevolvingCreditFacilityMember"
      id="xdx2ixbrl2341">P2Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2023-04-012023-12-31_us-gaap_StockOptionMember"
      id="xdx2ixbrl2545"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2023-04-012023-12-31_us-gaap_StockOptionMember"
      id="xdx2ixbrl2547"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2023-04-012023-12-31_us-gaap_StockOptionMember"
      id="xdx2ixbrl2557"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="From2023-04-012023-12-31_us-gaap_StockOptionMember"
      id="xdx2ixbrl2559"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2022-04-012023-03-31_us-gaap_StockOptionMember"
      id="xdx2ixbrl2561"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="From2022-04-012023-03-31_us-gaap_StockOptionMember"
      id="xdx2ixbrl2563"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants
      contextRef="From2023-04-012023-12-31"
      id="xdx2ixbrl2654"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants
      contextRef="From2022-04-012023-03-31"
      id="xdx2ixbrl2655"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="From2023-04-012023-12-31"
      id="xdx2ixbrl2795"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="From2023-04-012023-12-31"
      id="xdx2ixbrl2799"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="From2022-04-012023-03-31"
      id="xdx2ixbrl2800"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="From2021-04-012022-03-31"
      id="xdx2ixbrl2801"
      unitRef="USD"
      xsi:nil="true"/>
    <RIME:CurrentOtherTaxExpenseBenefit
      contextRef="From2023-04-012023-12-31"
      id="xdx2ixbrl2803"
      unitRef="USD"
      xsi:nil="true"/>
    <RIME:CurrentOtherTaxExpenseBenefit
      contextRef="From2021-04-012022-03-31"
      id="xdx2ixbrl2805"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="From2023-04-012023-12-31"
      id="xdx2ixbrl2807"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="From2021-04-012022-03-31"
      id="xdx2ixbrl2809"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CurrentFederalStateAndLocalTaxExpenseBenefit
      contextRef="From2023-04-012023-12-31"
      id="xdx2ixbrl2811"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="From2023-04-012023-12-31"
      id="xdx2ixbrl2815"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="From2023-04-012023-12-31"
      id="xdx2ixbrl2819"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit
      contextRef="From2023-04-012023-12-31"
      id="xdx2ixbrl2823"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2023-04-012023-12-31"
      id="xdx2ixbrl2827"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl2881"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="AsOf2023-03-31"
      id="xdx2ixbrl2882"
      unitRef="USD"
      xsi:nil="true"/>
    <RIME:IncomeTaxReconciliationChangeInPermanentDifferencesERCIncome
      contextRef="From2023-04-012023-12-31"
      id="xdx2ixbrl2898"
      unitRef="USD"
      xsi:nil="true"/>
    <RIME:IncomeTaxReconciliationChangeInPermanentDifferencesERCIncome
      contextRef="From2021-04-012022-03-31"
      id="xdx2ixbrl2900"
      unitRef="USD"
      xsi:nil="true"/>
    <RIME:IncomeTaxReconciliationChangeInExpirationOfNetOpretaingLossCarryforward
      contextRef="From2022-04-012023-03-31"
      id="xdx2ixbrl2907"
      unitRef="USD"
      xsi:nil="true"/>
    <RIME:IncomeTaxReconciliationChangeInExpirationOfNetOpretaingLossCarryforward
      contextRef="From2021-04-012022-03-31"
      id="xdx2ixbrl2908"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2023-04-012023-12-31"
      id="xdx2ixbrl2918"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Revenues
      contextRef="From2022-04-012023-03-31_custom_OthersMember"
      id="xdx2ixbrl2977"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2023-04-012023-12-31"
      id="xdx2ixbrl3079"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2023-04-012023-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl3162"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2023-04-012023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl3163"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2023-04-012023-12-31_us-gaap_ReceivablesFromStockholderMember"
      id="xdx2ixbrl3164"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-04-012023-12-31_us-gaap_ReceivablesFromStockholderMember"
      id="xdx2ixbrl3170"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-04-012023-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl3171"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensation
      contextRef="From2023-04-012023-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl3176"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensation
      contextRef="From2023-04-012023-12-31_us-gaap_ReceivablesFromStockholderMember"
      id="xdx2ixbrl3178"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensation
      contextRef="From2023-04-012023-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl3179"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="From2023-04-012023-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl3182"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2023-04-012023-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl3184"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2023-04-012023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl3185"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2023-04-012023-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl3187"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="From2023-04-012023-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl3190"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_ReceivablesFromStockholderMember"
      id="xdx2ixbrl3194"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-03-31_us-gaap_ReceivablesFromStockholderMember"
      id="xdx2ixbrl3202"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-03-31_us-gaap_ReceivablesFromStockholderMember"
      id="xdx2ixbrl3210"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2022-04-012022-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl3216"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2022-04-012022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl3217"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2022-04-012022-12-31_us-gaap_ReceivablesFromStockholderMember"
      id="xdx2ixbrl3218"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-04-012022-12-31_us-gaap_ReceivablesFromStockholderMember"
      id="xdx2ixbrl3224"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-04-012022-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl3225"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensation
      contextRef="From2022-04-012022-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl3230"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensation
      contextRef="From2022-04-012022-12-31_us-gaap_ReceivablesFromStockholderMember"
      id="xdx2ixbrl3232"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensation
      contextRef="From2022-04-012022-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl3233"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2022-04-012022-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl3238"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2022-04-012022-12-31_us-gaap_ReceivablesFromStockholderMember"
      id="xdx2ixbrl3240"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2022-04-012022-12-31"
      id="xdx2ixbrl3242"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_ReceivablesFromStockholderMember"
      id="xdx2ixbrl3248"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_ReceivablesFromStockholderMember"
      id="xdx2ixbrl3256"
      unitRef="USD"
      xsi:nil="true"/>
    <RIME:RefundDueFromCustomer
      contextRef="AsOf2022-12-31_custom_SemiCabIncMember"
      id="xdx2ixbrl3275"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LoansPayableCurrent
      contextRef="AsOf2022-12-31_custom_SemiCabIncMember"
      id="xdx2ixbrl3308"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ContractWithCustomerRefundLiabilityCurrent
      contextRef="AsOf2022-12-31_custom_SemiCabIncMember"
      id="xdx2ixbrl3311"
      unitRef="USD"
      xsi:nil="true"/>
    <RIME:ProvisionForLegalLiability
      contextRef="AsOf2022-12-31_custom_SemiCabIncMember"
      id="xdx2ixbrl3329"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2022-12-31_custom_SemiCabIncMember"
      id="xdx2ixbrl3332"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember"
      id="xdx2ixbrl3385"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2022-01-012022-12-31_custom_SemiCabIncMember"
      id="xdx2ixbrl3386"
      unitRef="USD"
      xsi:nil="true"/>
    <dei:EntityRegistrantName contextRef="From2024-01-01to2024-09-30" id="Fact000012">ALGORHYTHM HOLDINGS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2024-01-01to2024-09-30" id="Fact000013">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="From2024-01-01to2024-09-30" id="Fact000014">95-3795478</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2024-01-01to2024-09-30" id="Fact000015">6301 NW 5th Way</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2024-01-01to2024-09-30" id="Fact000016">Suite 2900</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2024-01-01to2024-09-30" id="Fact000017">Fort Lauderdale</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2024-01-01to2024-09-30" id="Fact000018">FL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2024-01-01to2024-09-30" id="Fact000019">33309</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2024-01-01to2024-09-30" id="Fact000020">(954)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2024-01-01to2024-09-30" id="Fact000021">596-1000</dei:LocalPhoneNumber>
    <dei:ContactPersonnelName
      contextRef="From2024-01-012024-09-30_dei_BusinessContactMember"
      id="Fact000022">Gary Atkinson</dei:ContactPersonnelName>
    <dei:EntityAddressAddressLine1
      contextRef="From2024-01-012024-09-30_dei_BusinessContactMember"
      id="Fact000023">6301 NW 5th Way</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="From2024-01-012024-09-30_dei_BusinessContactMember"
      id="Fact000024">Suite 2900</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="From2024-01-012024-09-30_dei_BusinessContactMember"
      id="Fact000025">Fort Lauderdale</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="From2024-01-012024-09-30_dei_BusinessContactMember"
      id="Fact000026">FL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="From2024-01-012024-09-30_dei_BusinessContactMember"
      id="Fact000027">33309</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="From2024-01-012024-09-30_dei_BusinessContactMember"
      id="Fact000028">(954)</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="From2024-01-012024-09-30_dei_BusinessContactMember"
      id="Fact000029">596-1000</dei:LocalPhoneNumber>
    <dei:EntityFilerCategory contextRef="From2024-01-01to2024-09-30" id="Fact000030">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="From2024-01-01to2024-09-30" id="Fact000031">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2024-01-01to2024-09-30" id="Fact000032">false</dei:EntityEmergingGrowthCompany>
    <dei:AmendmentDescription contextRef="From2024-01-01to2024-09-30" id="Fact000035">This
registration statement contains two prospectuses, as set forth below.

    &#x25cf;
    Public
    Offering Prospectus. A prospectus to be used for the public offering (the &#x201c;Public Offering Prospectus&#x201d;) of up
    to 43,478,261 shares of common stock of Algorhythm Holdings, Inc. (the &#x201c;Company&#x201d;) or pre-funded warrants in lieu
    thereof, 43,478,261 Series A warrants (the &#x201c;Series A Warrants&#x201d;) and 43,478,261 Series B warrants (together
    with the Series A Warrants, the &#x201c;Warrants&#x201d;) with such securities being placed and sold through the placement agent named
    on the cover page of the Public Offering Prospectus. The Public Offering Prospectus also relates to the shares issuable upon the
    exercise of the Warrants, and the pre-funded warrants.

&#160;



    &#x25cf;
    Resale
    Prospectus. A prospectus to be used for the resale by the selling stockholders (the &#x201c;Selling Stockholders&#x201d; set
    forth in the section of the resale prospectus (the &#x201c;Resale Prospectus&#x201d;) entitled &#x201c;Selling Stockholders&#x201d; of
    an aggregate of 2,840,344 shares of common stock.

&#160;

The
Resale Prospectus is substantively identical to the Public Offering Prospectus, except for the following principal points:

&#160;



    &#x25cf;
    they
    contain different outside and inside front covers and back covers;

&#160;



    &#x25cf;
    they
    contain different &#x201c;Offering&#x201d; sections in the &#x201c;Prospectus Summary&#x201d; section beginning on page
    Altr 2;

&#160;



    &#x25cf;
    they
    contain different &#x201c;Use of Proceeds&#x201d; sections on page Altr 9;

&#160;



    &#x25cf;
    the
    &#x201c;Capitalization&#x201d; and &#x201c;Dilution&#x201d; sections from the Public Offering Prospectus are deleted from
    the Resale Prospectus;

&#160;



    &#x25cf;
    a
    &#x201c;Selling Stockholders&#x201d; section is included in the Resale Prospectus;

&#160;



    &#x25cf;
    the
    &#x201c;Plan of Distribution&#x201d; section from the Public Offering Prospectus is deleted from the Resale Prospectus and a
    &#x201c;Selling Stockholder Plan of Distribution&#x201d; is inserted in its place in the Resale Prospectus; and

&#160;



    &#x25cf;
    the
    &#x201c;Legal Matters&#x201d; section in the Resale Prospectus on page Altr 12 deletes the reference to counsel for the
    placement agent.

&#160;

The
Company has included in this registration statement a set of alternate pages after the back cover page of the Public Offering Prospectus
(the &#x201c;Alternate Pages&#x201d;) to reflect the foregoing differences in the Resale Prospectus as compared to the Public Offering
Prospectus. The Public Offering Prospectus will exclude the Alternate Pages and will be used for the public offering by the Company.
The Resale Prospectus will be substantively identical to the Public Offering Prospectus except for the addition or substitution of the
Alternate Pages, and such other changes as may be necessary to clarify references to the public offering or the resale offering and will
be used for the resale offering by the Selling Stockholders.

&#160;</dei:AmendmentDescription>
    <us-gaap:Cash
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact000043"
      unitRef="USD">621000</us-gaap:Cash>
    <us-gaap:Cash
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000044"
      unitRef="USD">6703000</us-gaap:Cash>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact000048"
      unitRef="USD">266000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000049"
      unitRef="USD">174000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNet
      contextRef="AsOf2024-09-30_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact000046"
      unitRef="USD">4330000</us-gaap:AccountsReceivableNet>
    <us-gaap:AccountsReceivableNet
      contextRef="AsOf2023-12-31_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact000047"
      unitRef="USD">7308000</us-gaap:AccountsReceivableNet>
    <us-gaap:DueFromBanks
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact000051"
      unitRef="USD">22000</us-gaap:DueFromBanks>
    <us-gaap:AccountsReceivableNet
      contextRef="AsOf2024-09-30_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000054"
      unitRef="USD">157000</us-gaap:AccountsReceivableNet>
    <us-gaap:AccountsReceivableNet
      contextRef="AsOf2023-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000055"
      unitRef="USD">269000</us-gaap:AccountsReceivableNet>
    <us-gaap:AccountsReceivableNet
      contextRef="AsOf2024-09-30_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000057"
      unitRef="USD">157000</us-gaap:AccountsReceivableNet>
    <us-gaap:AccountsReceivableNet
      contextRef="AsOf2023-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000058"
      unitRef="USD">269000</us-gaap:AccountsReceivableNet>
    <us-gaap:InventoryNet
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact000063"
      unitRef="USD">7328000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000064"
      unitRef="USD">6871000</us-gaap:InventoryNet>
    <RIME:ReturnsAsset
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact000066"
      unitRef="USD">1081000</RIME:ReturnsAsset>
    <RIME:ReturnsAsset
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000067"
      unitRef="USD">1919000</RIME:ReturnsAsset>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact000069"
      unitRef="USD">867000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000070"
      unitRef="USD">136000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact000072"
      unitRef="USD">14406000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000073"
      unitRef="USD">23206000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact000075"
      unitRef="USD">318000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000076"
      unitRef="USD">404000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact000078"
      unitRef="USD">137000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000079"
      unitRef="USD">3926000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact000081"
      unitRef="USD">41000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000082"
      unitRef="USD">179000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact000084"
      unitRef="USD">1356000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Goodwill
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact000087"
      unitRef="USD">3354000</us-gaap:Goodwill>
    <us-gaap:Assets
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact000090"
      unitRef="USD">19612000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000091"
      unitRef="USD">27715000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact000099"
      unitRef="USD">8743000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000100"
      unitRef="USD">7616000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact000102"
      unitRef="USD">4303000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000103"
      unitRef="USD">2614000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:ContractWithCustomerRefundLiabilityCurrent
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact000111"
      unitRef="USD">462000</us-gaap:ContractWithCustomerRefundLiabilityCurrent>
    <us-gaap:ContractWithCustomerRefundLiabilityCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000112"
      unitRef="USD">1743000</us-gaap:ContractWithCustomerRefundLiabilityCurrent>
    <RIME:CustomerPrepayments
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000115"
      unitRef="USD">687000</RIME:CustomerPrepayments>
    <RIME:ReserveForSalesReturns
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact000117"
      unitRef="USD">2212000</RIME:ReserveForSalesReturns>
    <RIME:ReserveForSalesReturns
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000118"
      unitRef="USD">3390000</RIME:ReserveForSalesReturns>
    <us-gaap:ShortTermBorrowings
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact000120"
      unitRef="USD">303000</us-gaap:ShortTermBorrowings>
    <us-gaap:NotesPayableCurrent
      contextRef="AsOf2024-09-30_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact000123"
      unitRef="USD">50000</us-gaap:NotesPayableCurrent>
    <us-gaap:NotesPayableCurrent
      contextRef="AsOf2024-09-30_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000126"
      unitRef="USD">265000</us-gaap:NotesPayableCurrent>
    <us-gaap:NotesPayableCurrent
      contextRef="AsOf2024-09-30_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000129"
      unitRef="USD">265000</us-gaap:NotesPayableCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact000132"
      unitRef="USD">135000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000133"
      unitRef="USD">84000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact000135"
      unitRef="USD">15000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000136"
      unitRef="USD">75000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact000138"
      unitRef="USD">16488000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000139"
      unitRef="USD">16209000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000142"
      unitRef="USD">3000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:LongTermNotesPayable
      contextRef="AsOf2024-09-30_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000144"
      unitRef="USD">385000</us-gaap:LongTermNotesPayable>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000148"
      unitRef="USD">3925000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:Liabilities
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact000153"
      unitRef="USD">16873000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000154"
      unitRef="USD">20137000</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2024-09-30"
      decimals="INF"
      id="Fact000171"
      unitRef="USDPShares">1.00</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000173"
      unitRef="USDPShares">1.00</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2024-09-30"
      decimals="INF"
      id="Fact000175"
      unitRef="Shares">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000177"
      unitRef="Shares">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2024-09-30"
      decimals="INF"
      id="Fact000179"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2024-09-30"
      decimals="INF"
      id="Fact000181"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000183"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000185"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2024-09-30"
      decimals="INF"
      id="Fact000190"
      unitRef="USDPShares">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000192"
      unitRef="USDPShares">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2024-09-30"
      decimals="INF"
      id="Fact000194"
      unitRef="Shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000196"
      unitRef="Shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2024-09-30"
      decimals="INF"
      id="Fact000198"
      unitRef="Shares">11079678</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2024-09-30"
      decimals="INF"
      id="Fact000200"
      unitRef="Shares">9752755</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000202"
      unitRef="Shares">6418061</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000204"
      unitRef="Shares">6418061</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact000187"
      unitRef="USD">98000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000188"
      unitRef="USD">64000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact000206"
      unitRef="USD">35995000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000207"
      unitRef="USD">33429000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact000212"
      unitRef="USD">-33206000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000213"
      unitRef="USD">-25915000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000216"
      unitRef="USD">7578000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact000218"
      unitRef="USD">-148000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact000221"
      unitRef="USD">2739000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000222"
      unitRef="USD">7578000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact000224"
      unitRef="USD">19612000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000225"
      unitRef="USD">27715000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2024-07-012024-09-30"
      decimals="0"
      id="Fact000227"
      unitRef="USD">10622000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2023-07-012023-09-30"
      decimals="0"
      id="Fact000228"
      unitRef="USD">15931000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact000229"
      unitRef="USD">15488000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact000230"
      unitRef="USD">21939000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="From2024-07-012024-09-30"
      decimals="0"
      id="Fact000232"
      unitRef="USD">8247000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="From2023-07-012023-09-30"
      decimals="0"
      id="Fact000233"
      unitRef="USD">12197000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact000234"
      unitRef="USD">12287000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact000235"
      unitRef="USD">16582000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="From2024-07-012024-09-30"
      decimals="0"
      id="Fact000237"
      unitRef="USD">2375000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2023-07-012023-09-30"
      decimals="0"
      id="Fact000238"
      unitRef="USD">3734000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact000239"
      unitRef="USD">3201000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact000240"
      unitRef="USD">5357000</us-gaap:GrossProfit>
    <us-gaap:SellingExpense
      contextRef="From2024-07-012024-09-30"
      decimals="0"
      id="Fact000247"
      unitRef="USD">653000</us-gaap:SellingExpense>
    <us-gaap:SellingExpense
      contextRef="From2023-07-012023-09-30"
      decimals="0"
      id="Fact000248"
      unitRef="USD">1169000</us-gaap:SellingExpense>
    <us-gaap:SellingExpense
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact000249"
      unitRef="USD">1830000</us-gaap:SellingExpense>
    <us-gaap:SellingExpense
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact000250"
      unitRef="USD">2426000</us-gaap:SellingExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2024-07-012024-09-30"
      decimals="0"
      id="Fact000252"
      unitRef="USD">4339000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2023-07-012023-09-30"
      decimals="0"
      id="Fact000253"
      unitRef="USD">2459000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact000254"
      unitRef="USD">8552000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact000255"
      unitRef="USD">7403000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GainLossOnTerminationOfLease
      contextRef="From2024-07-012024-09-30"
      decimals="0"
      id="Fact000257"
      unitRef="USD">3874000</us-gaap:GainLossOnTerminationOfLease>
    <us-gaap:GainLossOnTerminationOfLease
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact000259"
      unitRef="USD">-4000</us-gaap:GainLossOnTerminationOfLease>
    <us-gaap:OperatingExpenses
      contextRef="From2024-07-012024-09-30"
      decimals="0"
      id="Fact000267"
      unitRef="USD">1118000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2023-07-012023-09-30"
      decimals="0"
      id="Fact000268"
      unitRef="USD">3628000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact000269"
      unitRef="USD">10386000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact000270"
      unitRef="USD">9829000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2024-07-012024-09-30"
      decimals="0"
      id="Fact000272"
      unitRef="USD">1257000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2023-07-012023-09-30"
      decimals="0"
      id="Fact000273"
      unitRef="USD">106000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact000274"
      unitRef="USD">-7185000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact000275"
      unitRef="USD">-4472000</us-gaap:OperatingIncomeLoss>
    <us-gaap:GainLossOnDispositionOfAssets1
      contextRef="From2023-07-012023-09-30"
      decimals="0"
      id="Fact000283"
      unitRef="USD">44000</us-gaap:GainLossOnDispositionOfAssets1>
    <us-gaap:GainLossOnDispositionOfAssets1
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact000285"
      unitRef="USD">44000</us-gaap:GainLossOnDispositionOfAssets1>
    <RIME:GainFromEmployeeRetentionCreditProgramRefund
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact000310"
      unitRef="USD">704000</RIME:GainFromEmployeeRetentionCreditProgramRefund>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="From2024-07-012024-09-30"
      decimals="0"
      id="Fact000312"
      unitRef="USD">283000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="From2023-07-012023-09-30"
      decimals="0"
      id="Fact000313"
      unitRef="USD">53000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact000314"
      unitRef="USD">328000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact000315"
      unitRef="USD">122000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2024-07-012024-09-30"
      decimals="0"
      id="Fact000317"
      unitRef="USD">-283000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2023-07-012023-09-30"
      decimals="0"
      id="Fact000318"
      unitRef="USD">-9000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact000319"
      unitRef="USD">-328000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact000320"
      unitRef="USD">626000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2024-07-012024-09-30"
      decimals="0"
      id="Fact000322"
      unitRef="USD">974000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2023-07-012023-09-30"
      decimals="0"
      id="Fact000323"
      unitRef="USD">97000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact000324"
      unitRef="USD">-7513000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact000325"
      unitRef="USD">-3846000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact000330"
      unitRef="USD">1502000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="From2024-07-012024-09-30"
      decimals="0"
      id="Fact000332"
      unitRef="USD">974000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2023-07-012023-09-30"
      decimals="0"
      id="Fact000333"
      unitRef="USD">97000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact000334"
      unitRef="USD">-7513000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact000335"
      unitRef="USD">-5348000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2024-07-012024-09-30"
      decimals="0"
      id="Fact000337"
      unitRef="USD">-221000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact000339"
      unitRef="USD">-221000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-07-012024-09-30"
      decimals="0"
      id="Fact000342"
      unitRef="USD">1195000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-07-012023-09-30"
      decimals="0"
      id="Fact000343"
      unitRef="USD">97000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact000344"
      unitRef="USD">-7292000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact000345"
      unitRef="USD">-5348000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2024-07-012024-09-30"
      decimals="INF"
      id="Fact000352"
      unitRef="USDPShares">0.13</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2024-07-012024-09-30"
      decimals="INF"
      id="Fact000354"
      unitRef="USDPShares">0.13</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2023-07-012023-09-30"
      decimals="INF"
      id="Fact000356"
      unitRef="USDPShares">0.03</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-07-012023-09-30"
      decimals="INF"
      id="Fact000358"
      unitRef="USDPShares">0.03</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2024-01-01to2024-09-30"
      decimals="INF"
      id="Fact000360"
      unitRef="USDPShares">-0.99</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2024-01-01to2024-09-30"
      decimals="INF"
      id="Fact000362"
      unitRef="USDPShares">-0.99</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2023-01-012023-09-30"
      decimals="INF"
      id="Fact000364"
      unitRef="USDPShares">-1.44</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-01-012023-09-30"
      decimals="INF"
      id="Fact000366"
      unitRef="USDPShares">-1.44</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2024-07-012024-09-30"
      decimals="INF"
      id="Fact000373"
      unitRef="Shares">9095504</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2024-07-012024-09-30"
      decimals="INF"
      id="Fact000375"
      unitRef="Shares">9095504</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-07-012023-09-30"
      decimals="INF"
      id="Fact000377"
      unitRef="Shares">4220259</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-07-012023-09-30"
      decimals="INF"
      id="Fact000379"
      unitRef="Shares">4220259</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2024-01-01to2024-09-30"
      decimals="INF"
      id="Fact000381"
      unitRef="Shares">7341204</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2024-01-01to2024-09-30"
      decimals="INF"
      id="Fact000383"
      unitRef="Shares">7341204</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-01-012023-09-30"
      decimals="INF"
      id="Fact000385"
      unitRef="Shares">3726259</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-01-012023-09-30"
      decimals="INF"
      id="Fact000387"
      unitRef="Shares">3726259</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000396"
      unitRef="Shares">6418061</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-06-30_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000389"
      unitRef="USD">64000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000390"
      unitRef="USD">33465000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000393"
      unitRef="USD">-34401000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000394"
      unitRef="USD">-872000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="From2024-07-012024-09-30_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      id="Fact000401"
      unitRef="USD">-221000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2024-07-012024-09-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000402"
      unitRef="USD">1195000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2024-07-012024-09-30"
      decimals="0"
      id="Fact000403"
      unitRef="USD">974000</us-gaap:ProfitLoss>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000412"
      unitRef="Shares">1673077</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000405"
      unitRef="USD">18000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2024-07-012024-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000406"
      unitRef="USD">1471000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2024-07-012024-09-30"
      decimals="0"
      id="Fact000410"
      unitRef="USD">1489000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000421"
      unitRef="Shares">1019811</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation
      contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000414"
      unitRef="USD">10000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation
      contextRef="From2024-07-012024-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000415"
      unitRef="USD">569000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation
      contextRef="From2024-07-012024-09-30"
      decimals="0"
      id="Fact000419"
      unitRef="USD">579000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000430"
      unitRef="Shares">641806</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000423"
      unitRef="USD">6000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2024-07-012024-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000424"
      unitRef="USD">488000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2024-07-012024-09-30"
      decimals="0"
      id="Fact000428"
      unitRef="USD">494000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="From2024-07-012024-09-30_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      id="Fact000435"
      unitRef="USD">74000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="From2024-07-012024-09-30"
      decimals="0"
      id="Fact000437"
      unitRef="USD">74000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2024-07-012024-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000440"
      unitRef="USD">2000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2024-07-012024-09-30_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      id="Fact000442"
      unitRef="USD">-1000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2024-07-012024-09-30"
      decimals="0"
      id="Fact000444"
      unitRef="USD">1000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000453"
      unitRef="Shares">9752755</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-09-30_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000446"
      unitRef="USD">98000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000447"
      unitRef="USD">35995000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-09-30_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      id="Fact000449"
      unitRef="USD">-148000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-09-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000450"
      unitRef="USD">-33206000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact000451"
      unitRef="USD">2739000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000462"
      unitRef="Shares">4220259</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-06-30_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000455"
      unitRef="USD">42000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000456"
      unitRef="USD">31479000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000459"
      unitRef="USD">-21977000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000460"
      unitRef="USD">9544000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="From2023-07-012023-09-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000468"
      unitRef="USD">97000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2023-07-012023-09-30"
      decimals="0"
      id="Fact000469"
      unitRef="USD">97000</us-gaap:ProfitLoss>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation
      contextRef="From2023-07-012023-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000472"
      unitRef="USD">37000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation
      contextRef="From2023-07-012023-09-30"
      decimals="0"
      id="Fact000476"
      unitRef="USD">37000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2023-07-012023-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000479"
      unitRef="USD">-1000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2023-07-012023-09-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000482"
      unitRef="USD">1000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000492"
      unitRef="Shares">4220259</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-09-30_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000485"
      unitRef="USD">42000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000486"
      unitRef="USD">31515000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-09-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000489"
      unitRef="USD">-21879000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="Fact000490"
      unitRef="USD">9678000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000501"
      unitRef="Shares">6418061</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000494"
      unitRef="USD">64000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000495"
      unitRef="USD">33429000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000498"
      unitRef="USD">-25915000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000499"
      unitRef="USD">7578000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="From2024-01-012024-09-30_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      id="Fact000506"
      unitRef="USD">-221000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2024-01-012024-09-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000507"
      unitRef="USD">-7292000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact000508"
      unitRef="USD">-7513000</us-gaap:ProfitLoss>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-01-012024-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000517"
      unitRef="Shares">1673077</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2024-01-012024-09-30_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000510"
      unitRef="USD">18000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2024-01-012024-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000511"
      unitRef="USD">1471000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact000515"
      unitRef="USD">1489000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="From2024-01-012024-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000526"
      unitRef="Shares">1019811</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation
      contextRef="From2024-01-012024-09-30_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000519"
      unitRef="USD">10000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation
      contextRef="From2024-01-012024-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000520"
      unitRef="USD">606000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact000524"
      unitRef="USD">616000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2024-01-012024-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000535"
      unitRef="Shares">641806</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2024-01-012024-09-30_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000528"
      unitRef="USD">6000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2024-01-012024-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000529"
      unitRef="USD">488000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact000533"
      unitRef="USD">494000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="From2024-01-012024-09-30_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      id="Fact000540"
      unitRef="USD">74000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact000542"
      unitRef="USD">74000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2024-01-012024-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000545"
      unitRef="USD">1000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2024-01-012024-09-30_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      id="Fact000547"
      unitRef="USD">-1000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2024-01-012024-09-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000548"
      unitRef="USD">1000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact000549"
      unitRef="USD">1000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000558"
      unitRef="Shares">9752755</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-09-30_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000551"
      unitRef="USD">98000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000552"
      unitRef="USD">35995000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-09-30_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      id="Fact000554"
      unitRef="USD">-148000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-09-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000555"
      unitRef="USD">-33206000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact000556"
      unitRef="USD">2739000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000567"
      unitRef="Shares">3148219</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000560"
      unitRef="USD">31000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000561"
      unitRef="USD">29698000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000564"
      unitRef="USD">-16531000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact000565"
      unitRef="USD">13198000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000576"
      unitRef="Shares">3148219</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000569"
      unitRef="USD">31000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000570"
      unitRef="USD">29698000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000573"
      unitRef="USD">-16531000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact000574"
      unitRef="USD">13198000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="From2023-01-012023-09-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000582"
      unitRef="USD">-5348000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact000583"
      unitRef="USD">-5348000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2023-01-012023-09-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000589"
      unitRef="USD">-5348000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact000590"
      unitRef="USD">-5348000</us-gaap:ProfitLoss>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-01-012023-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000599"
      unitRef="Shares">1057810</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-01-012023-09-30_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000592"
      unitRef="USD">11000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-01-012023-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000593"
      unitRef="USD">1629000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact000597"
      unitRef="USD">1640000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <RIME:StockIssuedDuringPeriodSharesSaleOfCommonStockWarrants
      contextRef="From2023-01-012023-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000608"
      unitRef="Shares">14230</RIME:StockIssuedDuringPeriodSharesSaleOfCommonStockWarrants>
    <RIME:StockIssuedDuringPeriodValueSaleOfCommonStockWarrants
      contextRef="From2023-01-012023-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000602"
      unitRef="USD">14000</RIME:StockIssuedDuringPeriodValueSaleOfCommonStockWarrants>
    <RIME:StockIssuedDuringPeriodValueSaleOfCommonStockWarrants
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact000606"
      unitRef="USD">14000</RIME:StockIssuedDuringPeriodValueSaleOfCommonStockWarrants>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation
      contextRef="From2023-01-012023-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000611"
      unitRef="USD">174000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact000615"
      unitRef="USD">174000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000624"
      unitRef="Shares">4220259</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-09-30_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000617"
      unitRef="USD">42000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000618"
      unitRef="USD">31515000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-09-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000621"
      unitRef="USD">-21879000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="Fact000622"
      unitRef="USD">9678000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000633"
      unitRef="Shares">4220259</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-09-30_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000626"
      unitRef="USD">42000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000627"
      unitRef="USD">31515000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-09-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000630"
      unitRef="USD">-21879000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="Fact000631"
      unitRef="USD">9678000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact000638"
      unitRef="USD">-7513000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact000639"
      unitRef="USD">-5348000</us-gaap:ProfitLoss>
    <us-gaap:Depreciation
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact000644"
      unitRef="USD">159000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact000645"
      unitRef="USD">289000</us-gaap:Depreciation>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact000650"
      unitRef="USD">44000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <RIME:ProvisionForEstimatedCostOfReturns
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact000653"
      unitRef="USD">-839000</RIME:ProvisionForEstimatedCostOfReturns>
    <RIME:ProvisionForEstimatedCostOfReturns
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact000654"
      unitRef="USD">-1095000</RIME:ProvisionForEstimatedCostOfReturns>
    <RIME:ProvisionForInventoryObsolescence
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact000657"
      unitRef="USD">-271000</RIME:ProvisionForInventoryObsolescence>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact000659"
      unitRef="USD">92000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact000660"
      unitRef="USD">104000</us-gaap:ProvisionForDoubtfulAccounts>
    <RIME:GainOnTerminationOfOperatingLease
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact000662"
      unitRef="USD">246000</RIME:GainOnTerminationOfOperatingLease>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact000666"
      unitRef="USD">42000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:ShareBasedCompensation
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact000668"
      unitRef="USD">616000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact000669"
      unitRef="USD">174000</us-gaap:ShareBasedCompensation>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact000671"
      unitRef="USD">194000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact000672"
      unitRef="USD">520000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact000675"
      unitRef="USD">1399000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact000692"
      unitRef="USD">-3079000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact000693"
      unitRef="USD">3982000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseDueFromAffiliates
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact000695"
      unitRef="USD">22000</us-gaap:IncreaseDecreaseDueFromAffiliates>
    <us-gaap:IncreaseDecreaseDueFromAffiliates
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact000696"
      unitRef="USD">152000</us-gaap:IncreaseDecreaseDueFromAffiliates>
    <us-gaap:IncreaseDecreaseInAccountsReceivableRelatedParties
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact000698"
      unitRef="USD">303000</us-gaap:IncreaseDecreaseInAccountsReceivableRelatedParties>
    <us-gaap:IncreaseDecreaseInAccountsReceivableRelatedParties
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact000699"
      unitRef="USD">-117000</us-gaap:IncreaseDecreaseInAccountsReceivableRelatedParties>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact000701"
      unitRef="USD">456000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact000702"
      unitRef="USD">3424000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact000704"
      unitRef="USD">718000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact000705"
      unitRef="USD">-87000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact000707"
      unitRef="USD">-151000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact000708"
      unitRef="USD">248000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact000710"
      unitRef="USD">394000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact000711"
      unitRef="USD">10442000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact000713"
      unitRef="USD">-198000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact000714"
      unitRef="USD">-486000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact000719"
      unitRef="USD">-1967000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact000720"
      unitRef="USD">1212000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <RIME:IncreaseDecreaseInReserveForSalesReturns
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact000725"
      unitRef="USD">-1180000</RIME:IncreaseDecreaseInReserveForSalesReturns>
    <RIME:IncreaseDecreaseInReserveForSalesReturns
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact000726"
      unitRef="USD">-646000</RIME:IncreaseDecreaseInReserveForSalesReturns>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact000728"
      unitRef="USD">116000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact000729"
      unitRef="USD">-622000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <RIME:PaymentOfEarlyTerminationFeeOnOperatingLeaseTerminationSettlement
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact000731"
      unitRef="USD">-150000</RIME:PaymentOfEarlyTerminationFeeOnOperatingLeaseTerminationSettlement>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact000734"
      unitRef="USD">-7069000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact000735"
      unitRef="USD">760000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact000740"
      unitRef="USD">70000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact000741"
      unitRef="USD">163000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromPreviousAcquisition
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact000743"
      unitRef="USD">17000</us-gaap:ProceedsFromPreviousAcquisition>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact000747"
      unitRef="USD">55000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact000749"
      unitRef="USD">-53000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact000750"
      unitRef="USD">-108000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact000755"
      unitRef="USD">1489000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact000756"
      unitRef="USD">1640000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:RepaymentsOfOtherDebt
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact000788"
      unitRef="USD">327000</us-gaap:RepaymentsOfOtherDebt>
    <us-gaap:ProceedsFromRepaymentsOfLinesOfCredit
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact000792"
      unitRef="USD">-1761000</us-gaap:ProceedsFromRepaymentsOfLinesOfCredit>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact000794"
      unitRef="USD">-122000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact000795"
      unitRef="USD">-113000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact000797"
      unitRef="USD">1040000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact000798"
      unitRef="USD">-234000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact000800"
      unitRef="USD">-6082000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact000801"
      unitRef="USD">418000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000803"
      unitRef="USD">6703000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact000804"
      unitRef="USD">2795000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact000806"
      unitRef="USD">621000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="Fact000807"
      unitRef="USD">3213000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:InterestPaidNet
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact000812"
      unitRef="USD">320000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact000813"
      unitRef="USD">80000</us-gaap:InterestPaidNet>
    <us-gaap:StockIssued1
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact000821"
      unitRef="USD">569000</us-gaap:StockIssued1>
    <us-gaap:CapitalLeaseObligationsIncurred
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact000825"
      unitRef="USD">55000</us-gaap:CapitalLeaseObligationsIncurred>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact000827"
      unitRef="USD">136000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact000828"
      unitRef="USD">3874000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:NatureOfOperations contextRef="From2024-01-01to2024-09-30" id="Fact000833">&lt;p id="xdx_800_eus-gaap--NatureOfOperations_zVQtZY68gGpg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
1 &#x2013; &lt;span id="xdx_82F_zx0mRjbNBQk7"&gt;NATURE OF BUSINESS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Algorhythm
Holdings, Inc. (f/k/a The Singing machine Company, Inc.) (the &#x201c;Company&#x201d;) is a holding company for an AI enabled software
logistics business operated through our SemiCab Holding subsidiary and a home karaoke consumer products company that designs and distributes
karaoke products globally to retailers and ecommerce partners through our Singing Machine subsidiary.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Our
operations include our wholly owned subsidiaries, SMC Logistics, Inc., a California corporation (&#x201c;SMCL&#x201d;), SMC-Music, Inc.,
a Florida corporation (&#x201c;SMCM&#x201d;), SMC (HK) Limited, a Hong Kong company (&#x201c;SMH&#x201d;), MICS Hospitality Holdings, Inc.,
a Delaware corporation (&#x201c;MICS Hospitality&#x201d;), MICS Hospitality Management, LLC, a Delaware limited liability company (&#x201c;MICS
Hospitality Management&#x201d;), MICS Nomad, LLC, a Delaware limited liability company (&#x201c;MICS NY&#x201d;) and SemiCab Holdings, LLC,
a Nevada limited liability company (&#x201c;SemiCab&#x201d;).&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Singing
Machine is primarily engaged in the development, marketing, and sale of consumer karaoke audio equipment, accessories, and musical recordings.
We are a global karaoke and music entertainment company that specializes in the design and production of quality karaoke and music enabled
consumer products for adults and children.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;SemiCab
is a cloud-based collaborative transportation platform built to achieve the scalability required to predict and optimize full-truckload
transportation at enterprise-scale. To orchestrate collaboration across manufacturers, retailers, distributors, and their carriers, SemiCab
uses real-time data from API-based load tendering and pre-built integrations with TMS and ELD partners. To build fully loaded round trips,
SemiCab uses AI/ML techniques and advanced predictive optimization models.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:NatureOfOperations>
    <RIME:RecentDevelopmentsTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact000835">&lt;p id="xdx_800_ecustom--RecentDevelopmentsTextBlock_zkFtt4U165d6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
2 - &lt;span id="xdx_821_zyI5z6qQrEjb"&gt;RECENT DEVELOPMENTS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Name
and Symbol Change&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Effective
September 5, 2024, our Certificate of Incorporation was amended to effect a change in the name of the Company from &#x201c;The Singing
Machine Company, Inc.&#x201d; to &#x201c;Algorhythm Holdings, Inc.&#x201d; In addition, effective September 8, 2024, the Company&#x2019;s
ticker symbol was changed from &#x201c;MICS&#x201d; to &#x201c;RIME.&#x201d;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Change
in Fiscal Year&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
2023, our Board of Directors approved a change in our fiscal year end from March 31 to December 31. Our results of operations, cash flows,
and all transactions impacting shareholders&#x2019; equity presented in this Quarterly Report on Form 10-Q as of September 30, 2024 are
for the three and nine month periods ended September 30, 2024 and 2023.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;ATM
Offering&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;On
June 26, 2024, the Company entered into an At-The-Market Issuance Sales Agreement (the &#x201c;Sales Agreement&#x201d;) with Ascendiant
Capital markets, LLC, as sales agent (the &#x201c;Agent&#x201d;), pursuant to which the Company could offer and sell, from time to time,
through the Agent (the &#x201c;ATM Offering&#x201d;), up to approximately $&lt;span id="xdx_90F_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20240626__20240626__us-gaap--TypeOfArrangementAxis__custom--AtTheMarketSalesAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zxtaBAya9Lvj" title="Number of stock sold, value"&gt;1,100,000&lt;/span&gt; in shares of the Company&#x2019;s common stock. &lt;span style="background-color: white"&gt;On
July 8, 2024, the Company entered into the First Amendment to the Sales Agreement (the &#x201c;Amendment&#x201d;) to increase the number
of shares to be sold in the ATM Offering to $&lt;span id="xdx_900_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20240626__20240626__us-gaap--TypeOfArrangementAxis__custom--AtTheMarketSalesAgreementAmendmentOneMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zoysTChabrxh" title="Number of stock sold, value"&gt;2,020,000&lt;/span&gt;.&lt;/span&gt; On August 9, 2024, the Company entered into the Second Amendment to the
Sales Agreement (the &#x201c;Amendment&#x201d;) to increase the number of shares to be sold in the ATM Offering to $&lt;span id="xdx_90F_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20240626__20240626__us-gaap--TypeOfArrangementAxis__custom--AtTheMarketSalesAgreementAmendmentTwoMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zvJUvUD1rFs7" title="Number of stock sold, value"&gt;3,100,000&lt;/span&gt;. Pursuant
to the agreement, the Agent was paid $&lt;span id="xdx_90B_eus-gaap--LegalFees_c20240626__20240626__us-gaap--TypeOfArrangementAxis__custom--AtTheMarketSalesAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zKfOat8ljuk" title="Legal and administrative expenses"&gt;30,000&lt;/span&gt; in fees to cover legal and administrative expenses and will receive an amount equal to 3%
of the gross proceeds from each sale of the Company&#x2019;s share of common stock. For the three and nine months ended September 30,
2024, the Company sold &lt;span id="xdx_908_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20240701__20240930__us-gaap--TypeOfArrangementAxis__custom--AtTheMarketSalesAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zyUC7RsqduXe" title="Number of shares issued in transaction"&gt;&lt;span id="xdx_90D_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20240101__20240930__us-gaap--TypeOfArrangementAxis__custom--AtTheMarketSalesAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zFvQyJtmM7Ti" title="Number of shares issued in transaction"&gt;1,673,077&lt;/span&gt;&lt;/span&gt; shares of common stock under the ATM offering and received net proceeds of approximately &lt;span id="xdx_90D_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20240701__20240930__us-gaap--TypeOfArrangementAxis__custom--AtTheMarketSalesAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zR2iZTF6Ix6l" title="Net proceeds from sale of common stock"&gt;&lt;span id="xdx_907_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20240101__20240930__us-gaap--TypeOfArrangementAxis__custom--AtTheMarketSalesAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zYNNJ7hHnji1" title="Net proceeds from sale of common stock"&gt;$1,489,000&lt;/span&gt;&lt;/span&gt;
after payment of legal and accounting fees, brokerage commissions, and administrative fees to the agent of approximately $&lt;span id="xdx_909_eus-gaap--AdministrativeFeesExpense_c20240701__20240930__us-gaap--TypeOfArrangementAxis__custom--AtTheMarketSalesAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zm4Wo2dU9uAl" title="Brokerage commissions and administrative fees"&gt;&lt;span id="xdx_90D_eus-gaap--AdministrativeFeesExpense_c20240101__20240930__us-gaap--TypeOfArrangementAxis__custom--AtTheMarketSalesAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zIXp99kXkhu2" title="Brokerage commissions and administrative fees"&gt;189,000&lt;/span&gt;&lt;/span&gt;.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;ALGORHYTHM
                                            HOLDINGS, INC. and SUBSIDIARIES&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;September
30, 2024 and 2023&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;Subsequent
to September 30, 2024 and through November 18, 2024 (the last trading day prior to filing), the Company sold &lt;span id="xdx_904_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20241001__20241118__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--AtTheMarketSalesAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zbRTlgrIxpG5" title="Number of shares issued in transaction"&gt;2,162,423&lt;/span&gt; shares of common
stock under the ATM offering, and received net proceeds of approximately $&lt;span id="xdx_902_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20241001__20241118__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--AtTheMarketSalesAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zaeijgi8t6S2" title="Net proceeds from sale of common stock"&gt;1,372,000&lt;/span&gt; after payment of brokerage commissions and administrative
fees to the agent of approximately $&lt;span id="xdx_906_eus-gaap--AdministrativeFeesExpense_c20241001__20241118__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--AtTheMarketSalesAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z21YPIa7Stw8" title="Brokerage commissions and administrative fees"&gt;42,000&lt;/span&gt;.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Asset
Purchase&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
June 11, 2024, the Company and its wholly owned subsidiary SemiCab Holdings, LLC, a Nevada limited liability company (&#x201c;SemiCab
LLC&#x201d; and collectively with the Company, the &#x201c;Buyer&#x201d;), SemiCab, Inc., a Delaware corporation (&#x201c;SemiCab&#x201d;
or the &#x201c;Seller&#x201d;), Ajesh Kapoor and Vivek Sehgal entered into an asset purchase agreement (the &#x201c;Asset Purchase Agreement&#x201d;)
pursuant to which the Seller agreed to sell and assign to the Company, and the Company agreed to purchase and assume from the Seller,
substantially all the assets, and certain specified liabilities relating to the business of the Seller. Subject to certain exceptions
set forth in the Asset Purchase Agreement, the parties agreed that the Buyer will not assume the liabilities of the Seller. SemiCab is
an artificial intelligence, cloud-based collaborative transportation platform built to achieve the scalability required to predict and
optimize semi-tractor trailer load efficiency.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;On
July 3, 2024, the parties closed on the asset purchase whereby the Company issued to the Seller (i) &lt;span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesPurchaseOfAssets_c20240703__20240703__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember_zFfnE8f1OG65" title="Shares purchase"&gt;641,806&lt;/span&gt; shares of the Company&#x2019;s
common stock (ii) a twenty percent (&lt;span id="xdx_90A_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20240703__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SemiCabLLCMember_zXK3h5FiFzG" title="Membership percentage"&gt;20%&lt;/span&gt;) membership interest in SemiCab LLC.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;Pursuant
to the asset acquisition agreement, the Company and Seller entered into an option agreement (the &#x201c;Option Agreement&#x201d;), granting
the Buyer the right to acquire all of the issued and outstanding capital securities of SMCB Solutions Private Limited (&#x201c;SMCB&#x201d;),
a wholly owned subsidiary of the Seller, in consideration for &lt;span id="xdx_905_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20240703__20240703__us-gaap--BusinessAcquisitionAxis__custom--SemiCabLLCMember_zyur9xTrqKn2" title="Seller Consideration share"&gt;320,903&lt;/span&gt; shares of common stock of the Company. The Option Agreement expired
unexercised.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Hospitality
Lease&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;On
August 23, 2023, MICS NY entered into an Agreement of Lease (the &#x201c;Lease Agreement&#x201d;) with OAC 111 Flatiron, LLC and OAC Adelphi,
LLC (the &#x201c;Landlord&#x201d;), pursuant to which MICS NY agreed to lease approximately &lt;span id="xdx_90F_eus-gaap--AreaOfLand_iI_pid_usqft_c20230823__us-gaap--TypeOfArrangementAxis__custom--LeaseAgreementMember_zqAWQB20e3v7" title="Lease space"&gt;10,000&lt;/span&gt; square feet of ground floor retail space
and a portion of the basement underneath the ground floor retail space in the property located at 111 West 24&lt;sup&gt;th&lt;/sup&gt; Street, New
York, New York (the &#x201c;Premises&#x201d;).&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;During
the six months ended June 30, 2024, the Company abandoned its plans to continue use of the leased space and exercised its early termination
provision of the Lease Agreement which was not accepted by the Landlord. Due to the abandonment of the lease, all assets related to the
lease were impaired. Assets including security deposits, rent deposits and right of use assets of approximately $&lt;span id="xdx_907_ecustom--AssetsWriteOff_c20240401__20240630_ztwmvg2LeXnj" title="Written off"&gt;3,878,000&lt;/span&gt; were written
off during the three months ended June 30, 2024.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;On
July 26, 2024, OAC 111 Flatiron, LLC and OAC Adelphi, LLC (the &#x201c;Landlord&#x201d;), filed a civil action in the Supreme Court of
the State of New York against MICS Nomad LLC, a subsidiary of the Company (&#x201c;MICS NY&#x201d;), and the Company (&#x201c;the Defendants&#x201d;)
for alleged breach of lease, seeking monetary damages including unpaid rent, future unpaid rent, and other expenses related to the lease.
The complaint alleged the Defendants breached the lease in various material respects.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;On
September 25, 2024, the Company entered into a Settlement Agreement for a full release and dismissal of the complaint within 5 business
days of the Company&#x2019;s payment of $&lt;span id="xdx_90A_eus-gaap--OperatingLeasePayments_c20240925__20240925__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember_zZ2y4fwF9h9g" title="Lease payments"&gt;250,000&lt;/span&gt;. Pursuant to the Settlement Agreement, the Company made the first payment of $&lt;span id="xdx_901_ecustom--OperatingLeasePeriodicPayments_c20240925__20240925__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember_zIN3kvZetXY2" title="periodic lease payments"&gt;150,000&lt;/span&gt;
was made on September 25, 2024 and a final payment of $&lt;span id="xdx_903_ecustom--OperatingLeasePeriodicPayments_c20241025__20241025__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zpvyTYxHrUjl" title="periodic lease payments"&gt;100,000&lt;/span&gt; was due and paid on October 25, 2024. On October 29, 2024, the Landlord
filed a discontinuance with prejudice.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;As
a result of the settlement, during the three months ended September 30, 2024, the Company wrote off the remaining operating lease liability
on the Lease Agreement and recognized a gain on early termination of the operating lease of approximately $&lt;span id="xdx_909_eus-gaap--GainLossOnTerminationOfLease_c20240701__20240930__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember_zPsQEpDXHU5k" title="Gain loss on termination of operating lease"&gt;3,874,000&lt;/span&gt;. For the nine months
ended September 30, 2024, the Company recognized a loss on early termination of the operating lease of $&lt;span id="xdx_902_eus-gaap--GainLossOnTerminationOfLease_c20240101__20240930__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember_z7xMssUBS686" title="Gain loss on termination of operating lease"&gt;4,000&lt;/span&gt; which includes the $&lt;span id="xdx_90D_ecustom--LeaseSettlementExpense_c20240101__20240930__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember_ztKU1jVXs1V8" title="Lease settlement expense"&gt;250,000&lt;/span&gt;
termination settlement expense. The net loss on early termination of the Lease Agreement was recorded as a component of operating expenses
in the accompanying condensed consolidated statements of operations.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;ALGORHYTHM
                                            HOLDINGS, INC. and SUBSIDIARIES&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;September
30, 2024 and 2023&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Private
Placement&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;On
October 22, 2024, the Company entered into a Securities Purchase Agreement (the &#x201c;SPA&#x201d;) with investors pursuant to which we
sold, in a private placement (the &#x201c;Private Placement&#x201d;), secured notes with an aggregate principal amount of $&lt;span id="xdx_90A_eus-gaap--SecuredDebt_iI_c20241022__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zKfClgJze3ic" title="Secured note principal amount"&gt;2,352,941&lt;/span&gt; (the
&#x201c;Notes&#x201d;), for cash proceeds of $&lt;span id="xdx_903_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_c20241022__20241022__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z9OW4kOgoNOb" title="Proceeds from private placement"&gt;2,000,000&lt;/span&gt;, net of original issue discount of $&lt;span id="xdx_90D_ecustom--PrivatePlacementIssueDiscount_c20241022__20241022__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z2Pa41ldSTde" title="Private placement issue discount"&gt;352,941&lt;/span&gt;. As consideration for entering into
the SPA, we issued a total of &lt;span id="xdx_90C_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20241022__20241022__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_znpcyIVaHklf" title="Issuance of stock, shares"&gt;2,299,998&lt;/span&gt; shares of common stock of the Company to the investors on October 24, 2024 (See Note 17).&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Oxford
Credit Facility&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;On
March 28, 2024, the Company and Oxford Commercial Finance, a Michigan banking corporation, (referred to as &#x201c;Oxford&#x201d;) entered
into a Loan Agreement (the &#x201c;Loan Agreement&#x201d;) and related Revolving Credit Note (the &#x201c;Note&#x201d;) for a $&lt;span id="xdx_907_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_c20240328__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_za8wH2smkprd" title="Revolving credit facility"&gt;2,000,000&lt;/span&gt;
revolving line of credit (the &#x201c;Oxford Line of Credit&#x201d;). On October 17, 2024, the Company terminated the Loan Agreement and
the Note. As of the date of termination, the Company had no outstanding amounts owed to Oxford and paid a termination fee of $&lt;span id="xdx_90F_eus-gaap--LineOfCreditFacilityCommitmentFeeAmount_c20241017__20241017__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_z0YeidNVAw21" title="Credit facility termination fee"&gt;40,000&lt;/span&gt;.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Share
Repurchase&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;On
November 1, 2024, the Company entered into a Stock Repurchase Agreement (the &#x201c;Repurchase Agreement&#x201d;) with Regalia Ventures
LLC, a Delaware limited liability company (the &#x201c;Seller&#x201d;), pursuant to which the Company agreed to repurchase from the Seller
an aggregate of &lt;span id="xdx_902_eus-gaap--CommonStockSharesIssued_iI_c20241101__us-gaap--TypeOfArrangementAxis__custom--StockRepurchaseAgreementMember_ziY17tqiNoAi" title="Shares issued"&gt;&lt;span id="xdx_902_eus-gaap--CommonStockSharesOutstanding_iI_c20241101__us-gaap--TypeOfArrangementAxis__custom--StockRepurchaseAgreementMember_zA2Air1hO7Xl" title="Shares outstanding"&gt;1,098,901&lt;/span&gt;&lt;/span&gt; issued and outstanding shares of common stock, par value $&lt;span id="xdx_90C_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20241101__us-gaap--TypeOfArrangementAxis__custom--StockRepurchaseAgreementMember_zTpSErdqPVXh" title="Common stock, par value"&gt;0.01&lt;/span&gt; per share, of the Company (the &#x201c;Shares&#x201d;).
Pursuant to the terms of the Repurchase Agreement, the Company has agreed to repurchase from the Seller, and the Seller has agreed to
sell, assign and transfer to the Company, all of the Seller&#x2019;s right, title and interest in and to the Shares, at a price per Share
equal to the higher of: (1) the closing price of the common stock on the last trading day immediately preceding the date of the Repurchase
Agreement; or (2) the highest volume weighted average price (VWAP) of the common stock during a pricing period of ten (10) consecutive
trading days prior to the date of the Repurchase Agreement per share (the &#x201c;Purchase Price&#x201d;), and the Company shall issue
to the Seller a promissory note in the principal amount equal to the Purchase Price, substantially in the form attached to the Repurchase
Agreement as Exhibit A (the &#x201c;Note&#x201d;), and subject to terms and conditions therein.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
shares of common stock to be repurchased were originally issued to the Seller on November 21, 2023, pursuant to a certain stock purchase
agreement, dated November 20, 2023.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of the date of this filing, the repurchase of the shares has not yet closed.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

</RIME:RecentDevelopmentsTextBlock>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="From2024-06-262024-06-26_custom_AtTheMarketSalesAgreementMember_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000837"
      unitRef="USD">1100000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="From2024-06-262024-06-26_custom_AtTheMarketSalesAgreementAmendmentOneMember_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000839"
      unitRef="USD">2020000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="From2024-06-262024-06-26_custom_AtTheMarketSalesAgreementAmendmentTwoMember_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000841"
      unitRef="USD">3100000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:LegalFees
      contextRef="From2024-06-262024-06-26_custom_AtTheMarketSalesAgreementMember_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000843"
      unitRef="USD">30000</us-gaap:LegalFees>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2024-07-012024-09-30_custom_AtTheMarketSalesAgreementMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000845"
      unitRef="Shares">1673077</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2024-01-012024-09-30_custom_AtTheMarketSalesAgreementMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000847"
      unitRef="Shares">1673077</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity
      contextRef="From2024-07-012024-09-30_custom_AtTheMarketSalesAgreementMember_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000849"
      unitRef="USD">1489000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity
      contextRef="From2024-01-012024-09-30_custom_AtTheMarketSalesAgreementMember_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000851"
      unitRef="USD">1489000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <us-gaap:AdministrativeFeesExpense
      contextRef="From2024-07-012024-09-30_custom_AtTheMarketSalesAgreementMember_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000853"
      unitRef="USD">189000</us-gaap:AdministrativeFeesExpense>
    <us-gaap:AdministrativeFeesExpense
      contextRef="From2024-01-012024-09-30_custom_AtTheMarketSalesAgreementMember_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000855"
      unitRef="USD">189000</us-gaap:AdministrativeFeesExpense>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2024-10-012024-11-18_us-gaap_SubsequentEventMember_custom_AtTheMarketSalesAgreementMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000857"
      unitRef="Shares">2162423</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity
      contextRef="From2024-10-012024-11-18_us-gaap_SubsequentEventMember_custom_AtTheMarketSalesAgreementMember_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000859"
      unitRef="USD">1372000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <us-gaap:AdministrativeFeesExpense
      contextRef="From2024-10-012024-11-18_us-gaap_SubsequentEventMember_custom_AtTheMarketSalesAgreementMember_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000861"
      unitRef="USD">42000</us-gaap:AdministrativeFeesExpense>
    <us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets
      contextRef="From2024-07-032024-07-03_custom_AssetPurchaseAgreementMember"
      decimals="INF"
      id="Fact000863"
      unitRef="Shares">641806</us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2024-07-03_custom_SemiCabLLCMember"
      decimals="INF"
      id="Fact000865"
      unitRef="Pure">0.20</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2024-07-032024-07-03_custom_SemiCabLLCMember"
      decimals="INF"
      id="Fact000867"
      unitRef="Shares">320903</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:AreaOfLand
      contextRef="AsOf2023-08-23_custom_LeaseAgreementMember"
      decimals="INF"
      id="Fact000869"
      unitRef="sqft">10000</us-gaap:AreaOfLand>
    <RIME:AssetsWriteOff
      contextRef="From2024-04-012024-06-30"
      decimals="0"
      id="Fact000871"
      unitRef="USD">3878000</RIME:AssetsWriteOff>
    <us-gaap:OperatingLeasePayments
      contextRef="From2024-09-252024-09-25_custom_SettlementAgreementMember"
      decimals="0"
      id="Fact000873"
      unitRef="USD">250000</us-gaap:OperatingLeasePayments>
    <RIME:OperatingLeasePeriodicPayments
      contextRef="From2024-09-252024-09-25_custom_SettlementAgreementMember"
      decimals="0"
      id="Fact000875"
      unitRef="USD">150000</RIME:OperatingLeasePeriodicPayments>
    <RIME:OperatingLeasePeriodicPayments
      contextRef="From2024-10-252024-10-25_custom_SettlementAgreementMember_us-gaap_SubsequentEventMember"
      decimals="0"
      id="Fact000877"
      unitRef="USD">100000</RIME:OperatingLeasePeriodicPayments>
    <us-gaap:GainLossOnTerminationOfLease
      contextRef="From2024-07-012024-09-30_custom_SettlementAgreementMember"
      decimals="0"
      id="Fact000879"
      unitRef="USD">3874000</us-gaap:GainLossOnTerminationOfLease>
    <us-gaap:GainLossOnTerminationOfLease
      contextRef="From2024-01-012024-09-30_custom_SettlementAgreementMember"
      decimals="0"
      id="Fact000881"
      unitRef="USD">4000</us-gaap:GainLossOnTerminationOfLease>
    <RIME:LeaseSettlementExpense
      contextRef="From2024-01-012024-09-30_custom_SettlementAgreementMember"
      decimals="0"
      id="Fact000883"
      unitRef="USD">250000</RIME:LeaseSettlementExpense>
    <us-gaap:SecuredDebt
      contextRef="AsOf2024-10-22_us-gaap_PrivatePlacementMember_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="0"
      id="Fact000885"
      unitRef="USD">2352941</us-gaap:SecuredDebt>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="From2024-10-222024-10-22_us-gaap_PrivatePlacementMember_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="0"
      id="Fact000887"
      unitRef="USD">2000000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <RIME:PrivatePlacementIssueDiscount
      contextRef="From2024-10-222024-10-22_us-gaap_PrivatePlacementMember_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="0"
      id="Fact000889"
      unitRef="USD">352941</RIME:PrivatePlacementIssueDiscount>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2024-10-222024-10-22_us-gaap_PrivatePlacementMember_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      id="Fact000891"
      unitRef="Shares">2299998</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="AsOf2024-03-28_us-gaap_RevolvingCreditFacilityMember_custom_LoanAgreementMember"
      decimals="0"
      id="Fact000893"
      unitRef="USD">2000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityCommitmentFeeAmount
      contextRef="From2024-10-172024-10-17_us-gaap_RevolvingCreditFacilityMember_us-gaap_SubsequentEventMember_custom_LoanAgreementMember"
      decimals="0"
      id="Fact000895"
      unitRef="USD">40000</us-gaap:LineOfCreditFacilityCommitmentFeeAmount>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2024-11-01_custom_StockRepurchaseAgreementMember"
      decimals="INF"
      id="Fact000897"
      unitRef="Shares">1098901</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2024-11-01_custom_StockRepurchaseAgreementMember"
      decimals="INF"
      id="Fact000899"
      unitRef="Shares">1098901</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2024-11-01_custom_StockRepurchaseAgreementMember"
      decimals="INF"
      id="Fact000901"
      unitRef="USDPShares">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:SubstantialDoubtAboutGoingConcernTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact000903">&lt;p id="xdx_80A_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zySyMsRllmd3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
3 &#x2013; &lt;span id="xdx_82D_zcDEgntxp0m1"&gt;LIQUIDITY, GOING CONCERN AND MANAGEMENT PLANS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
previously reported on Form 8-K filed on August 30, 2024, on August 26, 2024, the Company received a notice from The Nasdaq Stock Market
LLC (&#x201c;NASDAQ&#x201d;) indicating that its stockholders&#x2019; equity as reported in its Quarterly Report on Form 10-Q for the quarterly
period ended June 30, 2024 did not meet the minimum of $2,500,000 in stockholders&#x2019; equity required by NASDAQ Listing Rule 5550(b)(1)
(the &#x201c;Equity Rule&#x201d;) for continued listing, or the alternatives of market value of listed securities or net income from continuing
operations. Pursuant to the Equity Rule, the Company submitted a plan to regain compliance with the Equity Rule.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;On
November 13, 2024, the Company filed a Form 8-K stating that it believed it regained compliance with the Equity Rule. As disclosed herein,
the Company reported stockholders&#x2019; equity of approximately $&lt;span id="xdx_906_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iI_pn5n6_c20240930_zRcLXPjwP0Ci" title="Stockholders equity"&gt;2.7&lt;/span&gt; million.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;NASDAQ
has advised the Company that it will continue to monitor the Company&#x2019;s ongoing compliance with the stockholders&#x2019; equity requirement
and, if at the time of its next periodic report the Company does not evidence compliance, that it may be subject to delisting.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;As
of September 30, 2024, the Company had cash on hand of approximately $&lt;span id="xdx_90A_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20240930_zizFOQSZoLX6" title="Cash and cash equivalents"&gt;621,000&lt;/span&gt; and deficit working capital of approximately $&lt;span id="xdx_90D_ecustom--WorkingCapital_iI_c20240930_zWBiJaK42awj" title="Working capital deficit"&gt;2,082,000&lt;/span&gt;
which is not sufficient to fund the Company&#x2019;s planned operations through one year after the date the consolidated financial statements
are issued. The Company has a recent history of recurring operating losses and decreases in working capital. These factors create substantial
doubt about the Company&#x2019;s ability to continue as a going concern for at least one year after the date that the Company&#x2019;s
audited consolidated financial statements are issued.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
condensed consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue
as a going concern. Accordingly, the condensed consolidated financial statements have been prepared on a basis that assumes the Company
will continue as a going concern and which contemplates the realization of assets and satisfaction of liabilities and commitments in
the ordinary course of business.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Management
intends to finance operations with future debt or equity financings, however, if and when such financings may occur are uncertain.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
making this assessment management performed a comprehensive analysis of the Company&#x2019;s current circumstances including: its financial
position, cash flow and cash usage forecasts, and obligations and debts. Although management has a recent history of successful capital
raises, the analysis used to determine the Company&#x2019;s ability as a going concern does not include cash sources outside the Company&#x2019;s
direct control that management expects to be available within the next 12 months.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;ALGORHYTHM
                                            HOLDINGS, INC. and SUBSIDIARIES&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;September
30, 2024 and 2023&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SubstantialDoubtAboutGoingConcernTextBlock>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-09-30"
      decimals="-5"
      id="Fact000905"
      unitRef="USD">2700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact000907"
      unitRef="USD">621000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <RIME:WorkingCapital
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact000909"
      unitRef="USD">2082000</RIME:WorkingCapital>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact000911">&lt;p id="xdx_802_eus-gaap--SignificantAccountingPoliciesTextBlock_zmwiPQCXS7Pj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
4 - &lt;span id="xdx_82D_zUCr37okDZFd"&gt;SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_842_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_z0xqk8bzKQQg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_864_zfAZcd39HU79" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Basis
of Presentation&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying unaudited financial statements for the three months ended September 30, 2024 and 2023 have been prepared in accordance with
accounting principles generally accepted in the United States of America (&#x201c;US GAAP&#x201d;) applicable to interim financial information
and the requirements of Form 10-Q and Article 8 of Regulation S-X of the Securities and Exchange Commission. Accordingly, they do not
include all of the information and disclosures required by US GAAP for complete consolidated financial statements.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;In the opinion of management, such
condensed consolidated financial statements include all adjustments (consisting of normal recurring accruals) necessary for the fair
presentation of the condensed consolidated financial position and the condensed consolidated results of operations. The condensed consolidated
results of operations for the periods presented are not necessarily indicative of the results to be expected for the full year. The condensed
consolidated balance sheet as of September 30, 2024 and condensed financial statements information for the three and nine months ended
September 30, 2024 and 2023 are unaudited whereas the condensed consolidated balance sheet as of December 31, 2023 is derived from the
audited consolidated balance sheet as of that date. The condensed consolidated financial statements and notes hereto should be read in
conjunction with the consolidated financial statements and notes thereto included in the Company&#x2019;s annual report on Form 10-KT
for the transition period ended December 31, 2023. There have been no changes to our significant accounting policies as disclosed on
the Company&#x2019;s annual report on Form 10-KT for the transition period ended December 31, 2023.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p id="xdx_848_eus-gaap--ConsolidationPolicyTextBlock_zG652AMbDIuc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_863_zrdDkiVdw3gl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Principles
of Consolidation&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company evaluates its business relationships with related parties to identify potential Variable Interest Entities (&#x201c;VIEs&#x201d;)
under Accounting Standards Codification (&#x201c;ASC&#x201d;) 810, Consolidation. The Company will consolidate any VIE in which it has
a controlling financial interest and is deemed to be the primary beneficiary. A controlling financial interest has both of the following
characteristics: (1) the power to direct the activities of the VIE that most significantly impact its economic performance; and (2) the
obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE
that could be significant to the VIE. If both characteristics are met, the Company is considered to be the primary beneficiary and therefore
will consolidate that VIE into its consolidated financial statements.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
prescribed by ASC 810, if the Company holds a variable interest in a VIE but is not the entity&#x2019;s primary beneficiary, it shall
disclose its methodology for determining if the Company is the primary beneficiary of the VIE, e.g., significant judgments and assumptions
made. Additional information required includes information about the types of involvement considered significant, and those considered
in the determination of whether the reporting entity is the primary beneficiary.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Furthermore,
if the Company provides or intends to provide financial or other support (explicitly or implicitly) to the VIE, when not contractually
required to, the Company shall disclose the type and amount of the support, along with the primary reasons for providing the support.
Both qualitative and quantitative information about the Company&#x2019;s involvement with the VIE, shall include the nature, purpose,
size, and activities of the VIE, including how the VIE is financed.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84D_eus-gaap--BusinessCombinationsPolicy_z8Zj4Utlqz7i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_86F_zifn80Cmun6f" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Business
Combinations&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company allocates the purchase price of an acquired business to the tangible and intangible assets acquired and liabilities assumed based
upon their estimated fair values on the acquisition date. Any excess of the purchase price over the fair value of the net assets acquired
is recorded as goodwill. The purchase price allocation process requires management to make significant estimates and assumptions at the
acquisition date with respect to intangible assets. The allocation of the consideration transferred in certain cases may be subject to
revision based on the final determination of fair values during the measurement period, which may be up to one year from the acquisition
date. Direct transaction costs associated with the business combination are expensed as incurred. The Company includes the results of
operations of the business that it has acquired in its consolidated results prospectively from the date of acquisition.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_841_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zvE70x651AHd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_86E_zdrnLExkCPR8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Goodwill&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company evaluates its goodwill for impairment in accordance with the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued
Accounting Standards Update (&#x201c;ASU&#x201d;) 350, &lt;i&gt;Intangibles &#x2013; Goodwill and Other&lt;/i&gt;. Goodwill is recorded when the purchase
price paid for an acquisition exceeds the estimated fair value of the net identified tangible and intangible assets acquired.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company tests the recorded amount of goodwill for impairment on an annual basis on December 31 or more frequently if there are indicators
that the carrying amount of the goodwill exceeds its carried value.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_845_eus-gaap--GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy_zcM29p0Vadpl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_867_zbvUCXbIw5xh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Intangible
Assets&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company acquired amortizable intangibles assets as part of asset purchase agreements consisting of customer relationships, trade names
and proprietary technology. Such intangibles are amortized over their useful lives on a straight-line basis.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company reviews intangible assets for impairment whenever events or changes in business circumstances indicate that the carrying amount
of the assets might not be recoverable. Factors that the Company considers in deciding when to perform an impairment review include significant
underperformance of the business in relation to expectations, significant negative industry or economic trends, and significant changes
or planned changes in the use of the assets. If an impairment review is performed to evaluate a long-lived asset for recoverability,
the Company compares forecasts of undiscounted cash flows expected to result from the use and eventual disposition of the long-lived
asset to its carrying value. An impairment loss would be recognized when estimated undiscounted future cash flows expected to result
from the use of an asset are less than its carrying amount. The impairment loss would be based on the excess of the carrying value of
the impaired asset over its fair value, determined based on discounted cash flows.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;ALGORHYTHM
                                            HOLDINGS, INC. and SUBSIDIARIES&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;September
30, 2024 and 2023&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_849_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_zopZkXAp8v6a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_86C_zixKQwzNxh5g" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Fair
Value Measurements&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
accordance with ASC 820, Fair Value Measurements and Disclosures, fair value is defined as the exit price, or the amount that would be
received for the sale of an asset or paid to transfer a liability in an orderly transaction between market participants as of the measurement
date.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
guidance also establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes
the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs include those that
market participants would use in valuing the asset or liability and are developed based on market data obtained from sources independent
of the Company. Unobservable inputs are inputs that reflect the Company&#x2019;s assumptions about the factors that market participants
would use in valuing the asset or liability. The guidance establishes three levels of inputs that may be used to measure fair value:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
                                            1: Quoted market prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
                                            2: Inputs other than Level 1 that are observable, either directly or indirectly, such as
                                            quoted prices for similar assets or liabilities; quoted prices in markets that are not active;
                                            or model-derived valuations. All significant inputs used in the Company&#x2019;s valuations
                                            are observable or can be derived principally from or corroborated with observable market
                                            data for substantially the full term of the assets or liabilities. Level 2 inputs also include
                                            quoted prices that were adjusted for security-specific restrictions which are compared to
                                            output from internally developed models such as a discounted cash flow model.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
                                            3: Unobservable inputs that are supported by little or no market activity and that are significant
                                            to the fair value of the assets or liabilities.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
carrying amounts of financial instruments carried at cost, including cash, accounts receivables and accounts and accounts receivable
&#x2013; related party, trade payables advances and notes payables and notes payable &#x2013; related party approximate their fair value
due to the short-term maturities of such instruments.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
categorization of a financial instrument within the valuation hierarchy is based upon the lowest level of input that is significant to
the fair value measurement.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_840_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zh67ficBlsJi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;R&lt;span id="xdx_865_zefuG9EEAdg4"&gt;ECENT
ACCOUNTING PRONOUNCEMENTS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
November 2023, the FASB issued ASU 2023-07, &lt;i&gt;Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures&lt;/i&gt;, that
requires disclosure of significant segment expenses that are regularly reviewed by the chief operating decision maker and included within
each reported measure of segment profit or loss. The standard also requires disclosure of the composition of other segment items included
in the measure of segment profit or loss that are not separately disclosed. All disclosure requirements under ASU 2023-07 are also required
for public entities with a single reportable segment. The ASU is effective for the Company&#x2019;s Annual Report on Form 10-K for the
year ended December 31, 2024, and subsequent interim periods, with early adoption permitted. The Company is currently evaluating the
impact of adopting this standard on our consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;ALGORHYTHM
                                            HOLDINGS, INC. and SUBSIDIARIES&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;September
30, 2024 and 2023&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
December 2023, the FASB issued ASU 2023-09, &lt;i&gt;Income Taxes (Topic 740): Improvements to Income Tax Disclosures&lt;/i&gt;. ASU 2023-09 is intended
to enhance the usefulness of income tax disclosures by requiring entities to disclose specific rate reconciliations, amount of income
taxes separate by federal and individual tax jurisdictions, and the amount of income or loss from continuing operations before income
tax expense or benefit disaggregated between federal, state and foreign. ASU 2023-09 is effective for the Company for its fiscal year
beginning January 1, 2025, with early adoption permitted. The Company is currently evaluating the impact of adopting this standard on
our consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_856_zundEyYyi8e5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact000913">&lt;p id="xdx_842_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_z0xqk8bzKQQg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_864_zfAZcd39HU79" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Basis
of Presentation&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying unaudited financial statements for the three months ended September 30, 2024 and 2023 have been prepared in accordance with
accounting principles generally accepted in the United States of America (&#x201c;US GAAP&#x201d;) applicable to interim financial information
and the requirements of Form 10-Q and Article 8 of Regulation S-X of the Securities and Exchange Commission. Accordingly, they do not
include all of the information and disclosures required by US GAAP for complete consolidated financial statements.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;In the opinion of management, such
condensed consolidated financial statements include all adjustments (consisting of normal recurring accruals) necessary for the fair
presentation of the condensed consolidated financial position and the condensed consolidated results of operations. The condensed consolidated
results of operations for the periods presented are not necessarily indicative of the results to be expected for the full year. The condensed
consolidated balance sheet as of September 30, 2024 and condensed financial statements information for the three and nine months ended
September 30, 2024 and 2023 are unaudited whereas the condensed consolidated balance sheet as of December 31, 2023 is derived from the
audited consolidated balance sheet as of that date. The condensed consolidated financial statements and notes hereto should be read in
conjunction with the consolidated financial statements and notes thereto included in the Company&#x2019;s annual report on Form 10-KT
for the transition period ended December 31, 2023. There have been no changes to our significant accounting policies as disclosed on
the Company&#x2019;s annual report on Form 10-KT for the transition period ended December 31, 2023.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact000915">&lt;p id="xdx_848_eus-gaap--ConsolidationPolicyTextBlock_zG652AMbDIuc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_863_zrdDkiVdw3gl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Principles
of Consolidation&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company evaluates its business relationships with related parties to identify potential Variable Interest Entities (&#x201c;VIEs&#x201d;)
under Accounting Standards Codification (&#x201c;ASC&#x201d;) 810, Consolidation. The Company will consolidate any VIE in which it has
a controlling financial interest and is deemed to be the primary beneficiary. A controlling financial interest has both of the following
characteristics: (1) the power to direct the activities of the VIE that most significantly impact its economic performance; and (2) the
obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE
that could be significant to the VIE. If both characteristics are met, the Company is considered to be the primary beneficiary and therefore
will consolidate that VIE into its consolidated financial statements.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
prescribed by ASC 810, if the Company holds a variable interest in a VIE but is not the entity&#x2019;s primary beneficiary, it shall
disclose its methodology for determining if the Company is the primary beneficiary of the VIE, e.g., significant judgments and assumptions
made. Additional information required includes information about the types of involvement considered significant, and those considered
in the determination of whether the reporting entity is the primary beneficiary.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Furthermore,
if the Company provides or intends to provide financial or other support (explicitly or implicitly) to the VIE, when not contractually
required to, the Company shall disclose the type and amount of the support, along with the primary reasons for providing the support.
Both qualitative and quantitative information about the Company&#x2019;s involvement with the VIE, shall include the nature, purpose,
size, and activities of the VIE, including how the VIE is financed.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:BusinessCombinationsPolicy contextRef="From2024-01-01to2024-09-30" id="Fact000917">&lt;p id="xdx_84D_eus-gaap--BusinessCombinationsPolicy_z8Zj4Utlqz7i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_86F_zifn80Cmun6f" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Business
Combinations&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company allocates the purchase price of an acquired business to the tangible and intangible assets acquired and liabilities assumed based
upon their estimated fair values on the acquisition date. Any excess of the purchase price over the fair value of the net assets acquired
is recorded as goodwill. The purchase price allocation process requires management to make significant estimates and assumptions at the
acquisition date with respect to intangible assets. The allocation of the consideration transferred in certain cases may be subject to
revision based on the final determination of fair values during the measurement period, which may be up to one year from the acquisition
date. Direct transaction costs associated with the business combination are expensed as incurred. The Company includes the results of
operations of the business that it has acquired in its consolidated results prospectively from the date of acquisition.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:BusinessCombinationsPolicy>
    <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact000919">&lt;p id="xdx_841_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zvE70x651AHd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_86E_zdrnLExkCPR8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Goodwill&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company evaluates its goodwill for impairment in accordance with the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued
Accounting Standards Update (&#x201c;ASU&#x201d;) 350, &lt;i&gt;Intangibles &#x2013; Goodwill and Other&lt;/i&gt;. Goodwill is recorded when the purchase
price paid for an acquisition exceeds the estimated fair value of the net identified tangible and intangible assets acquired.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company tests the recorded amount of goodwill for impairment on an annual basis on December 31 or more frequently if there are indicators
that the carrying amount of the goodwill exceeds its carried value.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
    <us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy contextRef="From2024-01-01to2024-09-30" id="Fact000921">&lt;p id="xdx_845_eus-gaap--GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy_zcM29p0Vadpl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_867_zbvUCXbIw5xh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Intangible
Assets&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company acquired amortizable intangibles assets as part of asset purchase agreements consisting of customer relationships, trade names
and proprietary technology. Such intangibles are amortized over their useful lives on a straight-line basis.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company reviews intangible assets for impairment whenever events or changes in business circumstances indicate that the carrying amount
of the assets might not be recoverable. Factors that the Company considers in deciding when to perform an impairment review include significant
underperformance of the business in relation to expectations, significant negative industry or economic trends, and significant changes
or planned changes in the use of the assets. If an impairment review is performed to evaluate a long-lived asset for recoverability,
the Company compares forecasts of undiscounted cash flows expected to result from the use and eventual disposition of the long-lived
asset to its carrying value. An impairment loss would be recognized when estimated undiscounted future cash flows expected to result
from the use of an asset are less than its carrying amount. The impairment loss would be based on the excess of the carrying value of
the impaired asset over its fair value, determined based on discounted cash flows.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;ALGORHYTHM
                                            HOLDINGS, INC. and SUBSIDIARIES&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;September
30, 2024 and 2023&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact000923">&lt;p id="xdx_849_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_zopZkXAp8v6a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_86C_zixKQwzNxh5g" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Fair
Value Measurements&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
accordance with ASC 820, Fair Value Measurements and Disclosures, fair value is defined as the exit price, or the amount that would be
received for the sale of an asset or paid to transfer a liability in an orderly transaction between market participants as of the measurement
date.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
guidance also establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes
the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs include those that
market participants would use in valuing the asset or liability and are developed based on market data obtained from sources independent
of the Company. Unobservable inputs are inputs that reflect the Company&#x2019;s assumptions about the factors that market participants
would use in valuing the asset or liability. The guidance establishes three levels of inputs that may be used to measure fair value:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
                                            1: Quoted market prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
                                            2: Inputs other than Level 1 that are observable, either directly or indirectly, such as
                                            quoted prices for similar assets or liabilities; quoted prices in markets that are not active;
                                            or model-derived valuations. All significant inputs used in the Company&#x2019;s valuations
                                            are observable or can be derived principally from or corroborated with observable market
                                            data for substantially the full term of the assets or liabilities. Level 2 inputs also include
                                            quoted prices that were adjusted for security-specific restrictions which are compared to
                                            output from internally developed models such as a discounted cash flow model.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
                                            3: Unobservable inputs that are supported by little or no market activity and that are significant
                                            to the fair value of the assets or liabilities.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
carrying amounts of financial instruments carried at cost, including cash, accounts receivables and accounts and accounts receivable
&#x2013; related party, trade payables advances and notes payables and notes payable &#x2013; related party approximate their fair value
due to the short-term maturities of such instruments.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
categorization of a financial instrument within the valuation hierarchy is based upon the lowest level of input that is significant to
the fair value measurement.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact000925">&lt;p id="xdx_840_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zh67ficBlsJi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;R&lt;span id="xdx_865_zefuG9EEAdg4"&gt;ECENT
ACCOUNTING PRONOUNCEMENTS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
November 2023, the FASB issued ASU 2023-07, &lt;i&gt;Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures&lt;/i&gt;, that
requires disclosure of significant segment expenses that are regularly reviewed by the chief operating decision maker and included within
each reported measure of segment profit or loss. The standard also requires disclosure of the composition of other segment items included
in the measure of segment profit or loss that are not separately disclosed. All disclosure requirements under ASU 2023-07 are also required
for public entities with a single reportable segment. The ASU is effective for the Company&#x2019;s Annual Report on Form 10-K for the
year ended December 31, 2024, and subsequent interim periods, with early adoption permitted. The Company is currently evaluating the
impact of adopting this standard on our consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;ALGORHYTHM
                                            HOLDINGS, INC. and SUBSIDIARIES&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;September
30, 2024 and 2023&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
December 2023, the FASB issued ASU 2023-09, &lt;i&gt;Income Taxes (Topic 740): Improvements to Income Tax Disclosures&lt;/i&gt;. ASU 2023-09 is intended
to enhance the usefulness of income tax disclosures by requiring entities to disclose specific rate reconciliations, amount of income
taxes separate by federal and individual tax jurisdictions, and the amount of income or loss from continuing operations before income
tax expense or benefit disaggregated between federal, state and foreign. ASU 2023-09 is effective for the Company for its fiscal year
beginning January 1, 2025, with early adoption permitted. The Company is currently evaluating the impact of adopting this standard on
our consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:AssetAcquisitionTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact000927">&lt;p id="xdx_80D_eus-gaap--AssetAcquisitionTextBlock_zMHVfCEgdIX6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
5 &#x2013; &lt;span id="xdx_827_zfEDbNuQdSbc"&gt;ASSET ACQUISITION&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
June 11, 2024, the Company and its wholly owned subsidiary SemiCab,LLC, SemiCab, Inc., Ajesh Kapoor and Vivek Sehgal entered into the
Asset Purchase Agreement pursuant to which the Seller agreed to sell and assign to the Company, and the Company agreed to purchase and
assume from the Seller, substantially all the assets, and certain specified liabilities relating to the business of the Seller.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="-sec-ix-redline: true"&gt;The Company
decided to acquire SemiCab as part of a strategic plan to diversify its business and reduce its reliance solely on retail and consumer
electronics and strategically focus on growth. The acquisition fit the Company&#x2019;s strategic decision to pivot to a holding company
structure.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;On
July 3, 2024, the parties completed the Asset Purchase Agreement whereby the Company issued to the Seller (i) &lt;span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesPurchaseOfAssets_c20240703__20240703__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember_z8gJnhFSCGJh" title="Shares purchase"&gt;641,806&lt;/span&gt; shares of the Company&#x2019;s
common stock with a value of approximately &lt;span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodValuePurchaseOfAssets_c20240703__20240703__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember_zkKseGqOtZG4" title="Purchase of assets value"&gt;$494,000&lt;/span&gt; (ii) a twenty percent (&lt;span id="xdx_90E_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_uPure_c20240703__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SemiCabLLCMember_zWKLnN6wxobe" title="Membership percentage"&gt;20%&lt;/span&gt;) membership interest in SemiCab LLC. (See Note 2).&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;Pursuant
to the asset acquisition agreement, the Company and Seller entered into an option agreement (the &#x201c;Option Agreement&#x201d;), granting
the Buyer the right to acquire all of the issued and outstanding capital securities of SMCB Solutions Private Limited (&#x201c;SMCB&#x201d;),
a wholly owned subsidiary of the Seller, in consideration for &lt;span id="xdx_90F_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20240703__20240703__us-gaap--AssetAcquisitionAxis__custom--SemiCabLLCMember_zKwvxynjL23g" title="Seller Consideration share"&gt;320,903&lt;/span&gt; shares of common stock of the Company. As of the date of this filing,
the Option Agreement expired unexercised.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;In
connection with the asset acquisition agreement, effective July 3, 2024, SemiCab, LLC entered into employment agreements (the &#x201c;Agreements&#x201d;)
with Ajesh Kapoor and Vivek Sehgal Kapoor&#x2019;s agreement spans three years with an annual base salary of $&lt;span id="xdx_903_eus-gaap--SalariesAndWages_c20240703__20240703__srt--StatementScenarioAxis__custom--TwoThousandTwentyFourMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementsMember_zlrl9eXOT6Yi" title="Salaries and wages"&gt;140,000&lt;/span&gt; for 2024, $&lt;span id="xdx_90C_eus-gaap--SalariesAndWages_c20240703__20240703__srt--StatementScenarioAxis__custom--TwoThousandTwentyFiveMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementsMember_zQ3IT5o38E12" title="Salaries and wages"&gt;240,000&lt;/span&gt;
for 2025, and $&lt;span id="xdx_90E_eus-gaap--SalariesAndWages_c20240703__20240703__srt--StatementScenarioAxis__custom--SubsequentYearsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementsMember_zWLBx1Ospq0a" title="Salaries and wages"&gt;300,000&lt;/span&gt; for subsequent years, and Sehgal&#x2019;s agreement also spans three years with an annual base salary of $&lt;span id="xdx_906_eus-gaap--SalariesAndWages_c20240703__20240703__srt--StatementScenarioAxis__custom--TwoThousandTwentyFourMember__srt--TitleOfIndividualAxis__custom--VivekSehgalKapoorMember__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementsMember_zxuUVyJG3Mdg" title="Salaries and wages"&gt;105,000&lt;/span&gt;
for 2024, $&lt;span id="xdx_90A_eus-gaap--SalariesAndWages_c20240703__20240703__srt--StatementScenarioAxis__custom--TwoThousandTwentyFiveMember__srt--TitleOfIndividualAxis__custom--VivekSehgalKapoorMember__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementsMember_z8a3AnH52brc" title="Salaries and wages"&gt;210,000&lt;/span&gt; for 2025, $&lt;span id="xdx_90A_eus-gaap--SalariesAndWages_c20240703__20240703__srt--StatementScenarioAxis__custom--TwoThousandTwentySixMember__srt--TitleOfIndividualAxis__custom--VivekSehgalKapoorMember__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementsMember_zbSowXnf3Axb" title="Salaries and wages"&gt;240,000&lt;/span&gt; for 2026, $&lt;span id="xdx_907_eus-gaap--SalariesAndWages_c20240703__20240703__srt--StatementScenarioAxis__custom--TwoThousandTwentySevenMember__srt--TitleOfIndividualAxis__custom--VivekSehgalKapoorMember__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementsMember_zvK7JhFkJkt6" title="Salaries and wages"&gt;270,000&lt;/span&gt; for 2027, and $&lt;span id="xdx_90E_eus-gaap--SalariesAndWages_c20240703__20240703__srt--StatementScenarioAxis__custom--TwoThousandTwentyEightMember__srt--TitleOfIndividualAxis__custom--VivekSehgalKapoorMember__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementsMember_zd2IGkiq341k" title="Salaries and wages"&gt;300,000&lt;/span&gt; for 2028. Both executives&#x2019; salaries are subject
to annual review by the Board. They are eligible for annual performance-based bonuses contingent on specific goals set by the Board and
will participate in the 2022 Equity Incentive Plan, receiving annual equity issuances and cash-based incentives tied to revenue milestones.
Both are entitled to standard employee benefits, including health insurance and retirement plans.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;ALGORHYTHM
                                            HOLDINGS, INC. and SUBSIDIARIES&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;September
30, 2024 and 2023&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;On
July 3, 2024, the (&#x201c;Acquisition Date&#x201d;), the Company acquired substantially all the assets and assumed certain liabilities
of SemiCab, Inc. in exchange for the purchase price consideration of approximately $&lt;span id="xdx_90F_eus-gaap--AssetAcquisitionConsiderationTransferred_c20240703__20240703__us-gaap--AssetAcquisitionAxis__custom--SemiCabIncMember_ztWenrSpEiKc" title="Asset acquisition purchase price consideration"&gt;983,000&lt;/span&gt;. On July 3, 2024, the value of the total
identifiable intangible assets, including goodwill was approximately &lt;span id="xdx_909_eus-gaap--IntangibleAssetsNetIncludingGoodwill_iI_c20240703_zGHnOvGlyX54" title="Identifiable intangible assets  including goodwill"&gt;$4,754,000&lt;/span&gt;, based on the restricted value of SMC common shares on
the date of acquisition. The Company also recognized non-controlling interest at fair value as of the Acquisition Date in the amount
of approximately $&lt;span id="xdx_90B_ecustom--NonControllingInterestAtFairValue_c20240703__20240703_zI0pHU3nzsZ6" title="Non-controlling interest at fair value"&gt;74,000&lt;/span&gt; representing &lt;span id="xdx_90C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20240703__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SemiCabIncMember_zqwasO0LjYX6" title="Ownership percentage"&gt;20&lt;/span&gt;% ownership in SemiCab Holdings, LLC, which is &lt;span id="xdx_90C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20240703__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlgorhythmHoldingsIncMember_z2rWftGzy9j5" title="Ownership percentage"&gt;80&lt;/span&gt;% owned by the Company.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;The
trade names and developed technology intangible assets were valued using the relief-from-royalty method. The relief-from-royalty method
is one of the methods under the income approach wherein estimates of a company&#x2019;s earnings attributable to the intangible asset
are based on the royalty rate the company would have paid for the use of the asset if it did not own it. Royalty payments are estimated
by applying royalty rates of &lt;span id="xdx_90A_ecustom--RoyaltyRate_pid_dp_uPure_c20240703__20240703_zax9QlMBHA1l" title="Royalty rate"&gt;0.5&lt;/span&gt;% to the prospective revenue attributable to the intangible asset. The resulting net annual royalty payments
are then discounted to present value using a discount factor of &lt;span id="xdx_90C_ecustom--DiscountOnRoyaltyRate_pid_dp_uPure_c20240703__20240703_zKVJtg7wctuf" title="Discount on royalty rate"&gt;33&lt;/span&gt;%, and the remaining economic life of &lt;span id="xdx_90D_ecustom--RoyaltyTerm_dc_c20240703__20240703_zu7yRrIFFDMi" title="Royalty term"&gt;nine years&lt;/span&gt;.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;The
Company determined an estimated fair value of customer relationships using multi-period excess earnings approach utilizing a discounted
cash flow methodology. The analysis included assumptions regarding the growth rate for the development of new businesses, concluding
between &lt;span id="xdx_904_ecustom--GrowthRateOfDevelopmentOfNewBusiness_pid_dp_c20240703__20240703__srt--RangeAxis__srt--MinimumMember_zgz8ADQQa8oc" title="Growth rate of development of new business"&gt;8&lt;/span&gt;% and &lt;span id="xdx_901_ecustom--GrowthRateOfDevelopmentOfNewBusiness_pid_dp_c20240703__20240703__srt--RangeAxis__srt--MaximumMember_z6imzS83qoid" title="Growth rate of development of new business"&gt;20&lt;/span&gt;% organic growth rates for revenue attributable to existing customers. A discount rate of &lt;span id="xdx_90B_ecustom--DiscountRateForWeightedAverageCost_pid_dp_c20240703__20240703_zdwxyxjh8GA5" title="Discount rate for weighted average cost"&gt;33&lt;/span&gt;% was used for the weighted
average cost of capital analysis, along with the evaluation of the capital expenditure requirements associated with any new initiatives
developed by SemiCab. The purchase accounting for this transaction is provisional and subject
to measurement period adjustments for one year following the date of acquisition.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
valuations for the above intangible assets require use of unobservable inputs that are classified as Level 3 on the fair value hierarchy.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
goodwill resulting from this acquisition is tax deductible.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_893_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_zqfSlXacSIQb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table presents the allocation of the consideration transferred to the assets acquired and liabilities assumed based on their
fair values:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_8B0_zqB8RjhO6SA" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;SCHEDULE
OF CONSIDERATION TRANSFERRED TO THE ASSETS ACQUIRED AND LIABILITIES ASSUMED&lt;/span&gt;&lt;/span&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_49E_20240703__us-gaap--BusinessAcquisitionAxis__custom--SemiCabIncMember_zh7pqoAcz5qf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Equity consideration"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 74%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;Equity consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable_c20240703__20240703__us-gaap--AssetAcquisitionAxis__custom--SemiCabIncMember_zlLgWxDyscff" style="font: 10pt Times New Roman, Times, Serif; width: 22%; text-align: right" title="Equity consideration"&gt;&lt;span style="-sec-ix-redline: true"&gt;494,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;Fair value of non-controlling interest&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--AssetAcquisitionFairValueOfNonControllingInterest_c20240703__20240703__us-gaap--AssetAcquisitionAxis__custom--SemiCabIncMember_z6LHfTO1zIf" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Fair value of non-controlling interest"&gt;&lt;span style="-sec-ix-redline: true"&gt;74,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;Total Equity Consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AssetAcquisitionConsiderationTransferredContingentConsideration_c20240703__20240703__us-gaap--AssetAcquisitionAxis__custom--SemiCabIncMember_zo7Ps31BOJhd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total Equity Consideration"&gt;&lt;span style="-sec-ix-redline: true"&gt;568,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;Debt Extinguishment&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--AssetAcquisitionDebtExtinguishment_c20240703__20240703__us-gaap--AssetAcquisitionAxis__custom--SemiCabIncMember_z02uvR7ZXrRk" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Debt Extinguishment"&gt;&lt;span style="-sec-ix-redline: true"&gt;415,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;Total Consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--AssetAcquisitionConsiderationTransferred_c20240703__20240703__us-gaap--AssetAcquisitionAxis__custom--SemiCabIncMember_zlZrKZvXompg" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Total consideration"&gt;&lt;span style="-sec-ix-redline: true"&gt;983,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;Identifiable net assets acquired:&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_iI_ziB7iOrglvn" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;17,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_iI_zia4FpE3NQVc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;193,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_iI_zDAJcMob9pAd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;13,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_zlTqy723kO5c" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;3,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_iI_z6siHi5SxsMl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;Other Non-Current Operating Assets, Net&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;14,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCustomerRelationships_iI_zUWvmGbp32t3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;Customer Relationships (&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlNJREVSQVRJT04gVFJBTlNGRVJSRUQgVE8gVEhFIEFTU0VUUyBBQ1FVSVJFRCBBTkQgTElBQklMSVRJRVMgQVNTVU1FRCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20240703__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zYg7VmAKamhf"&gt;9
    &lt;/span&gt;&lt;/span&gt;&lt;span style="-sec-ix-redline: true"&gt;year estimated useful life)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;747,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradeName_iI_z7vJ6LJn72h6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;Trade Name (&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlNJREVSQVRJT04gVFJBTlNGRVJSRUQgVE8gVEhFIEFTU0VUUyBBQ1FVSVJFRCBBTkQgTElBQklMSVRJRVMgQVNTVU1FRCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90F_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20240703__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_ziXcACBKrHC6"&gt;9
    &lt;/span&gt;&lt;/span&gt;&lt;span style="-sec-ix-redline: true"&gt;year estimated useful life)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;272,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDevelopedTechnology_iI_zUOYy8tjHF41" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;Developed Technology (&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlNJREVSQVRJT04gVFJBTlNGRVJSRUQgVE8gVEhFIEFTU0VUUyBBQ1FVSVJFRCBBTkQgTElBQklMSVRJRVMgQVNTVU1FRCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20240703__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DevelopedTechnologyRightsMember_zCx5Qsd9yz8l"&gt;6
    &lt;/span&gt;&lt;/span&gt;&lt;span style="-sec-ix-redline: true"&gt;year estimated useful life)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;381,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_iNI_di_zodX7BNLMoAd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;Accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;(2,680,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLoansPayable_iI_zMz2R2tKSr3l" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;Loans payable Merchant Cash Advances (MCA)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;(631,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt_iNI_di_zkoi1AVl10b8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;Note payable&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;(50,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesNotesPayableRelatedParties_iI_znAEmC4h6vsj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;Notes payable Related Parties&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;(650,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_z67ORAU3jxsf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;Net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;(2,371,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--Goodwill_iI_z56M72yov2Yk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;Estimated Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;3,354,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AF_zEtY1LGpkYD7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Pro
Forma Information&lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
unaudited pro forma financial information below presents the effects of the Asset Purchase Agreement as though it had been completed
on January 1, 2023. The pro forma adjustments are derived from the historically reported transactions of the respective companies. The
pro forma results do not include anticipated combined effects or other expected benefits of the acquisition. The pro forma results for
the nine months ended September 30, 2024 and 2023 reflect the combined performance of the Company and the SemiCab business for that period.
The unaudited pro forma information is based on available data and certain assumptions that the Company believes are reasonable given
the circumstances. However, actual results may differ materially from the assumptions used in the accompanying unaudited pro forma financial
information. This selected unaudited pro forma condensed combined financial information is presented for illustrative purposes only and
is not intended to represent what the actual consolidated results of operations would have been had the acquisition date occurred on
January 1, 2023, nor does it attempt to forecast future consolidated results of operations.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;ALGORHYTHM
                                            HOLDINGS, INC. and SUBSIDIARIES&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;September
30, 2024 and 2023&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_891_ecustom--ScheduleOfProFormaFinancialInformationTableTextBlock_zWwCnqTKNek9" style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_8BD_z3uB87DL9bu3" style="display: none"&gt;SCHEDULE
OF PRO FORMA FINANCIAL INFORMATION&lt;/span&gt;&lt;/span&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_497_20240101__20240930_z3drDoyCCjZd" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_499_20230101__20230930_z71B4uIUAeLi" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;September
    30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;September
    30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--BusinessAcquisitionsProFormaRevenue_zGU55vatkVmd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;Net revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;16,831,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;26,848,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax_zRTwvKp3syM2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;Operating loss from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;(8,093,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;(6,187,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_zBIixXJD0Vvd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;(8,451,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;(7,164,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;/p&gt;

&lt;p id="xdx_8A3_zO5F9SgOmRfa" style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="-sec-ix-redline: true"&gt;The pro forma results for
the nine months ended September 30, 2023, include a net increase in operating expenses of $&lt;span id="xdx_904_eus-gaap--IncreaseDecreaseInOperatingCapital_c20230101__20230930_z4qK0CSlK5Mb" title="Increase decrease in operating capital"&gt;265,000&lt;/span&gt;, consisting of legal and accounting
expenses of approximately $&lt;span id="xdx_905_eus-gaap--LegalFees_c20230101__20230930_z6F1WhjiJy07" title="Legal fees"&gt;215,000&lt;/span&gt;&#160;associated with the acquisition of SemiCab and $&lt;span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20230101__20230930_zYDqUrqyMfye" title="Stock issued during period shares acquisitions"&gt;50,000&lt;/span&gt;&#160;in shares of SMC common stock issued
to Vivek Sehgal as sign-on bonus.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:AssetAcquisitionTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets
      contextRef="From2024-07-032024-07-03_custom_AssetPurchaseAgreementMember"
      decimals="INF"
      id="Fact000929"
      unitRef="Shares">641806</us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets>
    <us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets
      contextRef="From2024-07-032024-07-03_custom_AssetPurchaseAgreementMember"
      decimals="0"
      id="Fact000931"
      unitRef="USD">494000</us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2024-07-03_custom_SemiCabLLCMember"
      decimals="INF"
      id="Fact000933"
      unitRef="Pure">0.20</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2024-07-032024-07-03_custom_SemiCabLLCMember249477656"
      decimals="INF"
      id="Fact000935"
      unitRef="Shares">320903</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SalariesAndWages
      contextRef="From2024-07-032024-07-03_custom_TwoThousandTwentyFourMember_custom_AjeshKapoorMember_custom_EmploymentAgreementsMember"
      decimals="0"
      id="Fact000937"
      unitRef="USD">140000</us-gaap:SalariesAndWages>
    <us-gaap:SalariesAndWages
      contextRef="From2024-07-032024-07-03_custom_TwoThousandTwentyFiveMember_custom_AjeshKapoorMember_custom_EmploymentAgreementsMember"
      decimals="0"
      id="Fact000939"
      unitRef="USD">240000</us-gaap:SalariesAndWages>
    <us-gaap:SalariesAndWages
      contextRef="From2024-07-032024-07-03_custom_SubsequentYearsMember_custom_AjeshKapoorMember_custom_EmploymentAgreementsMember"
      decimals="0"
      id="Fact000941"
      unitRef="USD">300000</us-gaap:SalariesAndWages>
    <us-gaap:SalariesAndWages
      contextRef="From2024-07-032024-07-03_custom_TwoThousandTwentyFourMember_custom_VivekSehgalKapoorMember_custom_EmploymentAgreementsMember"
      decimals="0"
      id="Fact000943"
      unitRef="USD">105000</us-gaap:SalariesAndWages>
    <us-gaap:SalariesAndWages
      contextRef="From2024-07-032024-07-03_custom_TwoThousandTwentyFiveMember_custom_VivekSehgalKapoorMember_custom_EmploymentAgreementsMember"
      decimals="0"
      id="Fact000945"
      unitRef="USD">210000</us-gaap:SalariesAndWages>
    <us-gaap:SalariesAndWages
      contextRef="From2024-07-032024-07-03_custom_TwoThousandTwentySixMember_custom_VivekSehgalKapoorMember_custom_EmploymentAgreementsMember"
      decimals="0"
      id="Fact000947"
      unitRef="USD">240000</us-gaap:SalariesAndWages>
    <us-gaap:SalariesAndWages
      contextRef="From2024-07-032024-07-03_custom_TwoThousandTwentySevenMember_custom_VivekSehgalKapoorMember_custom_EmploymentAgreementsMember"
      decimals="0"
      id="Fact000949"
      unitRef="USD">270000</us-gaap:SalariesAndWages>
    <us-gaap:SalariesAndWages
      contextRef="From2024-07-032024-07-03_custom_TwoThousandTwentyEightMember_custom_VivekSehgalKapoorMember_custom_EmploymentAgreementsMember"
      decimals="0"
      id="Fact000951"
      unitRef="USD">300000</us-gaap:SalariesAndWages>
    <us-gaap:AssetAcquisitionConsiderationTransferred
      contextRef="From2024-07-032024-07-03_custom_SemiCabIncMember"
      decimals="0"
      id="Fact000953"
      unitRef="USD">983000</us-gaap:AssetAcquisitionConsiderationTransferred>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill
      contextRef="AsOf2024-07-03"
      decimals="0"
      id="Fact000955"
      unitRef="USD">4754000</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <RIME:NonControllingInterestAtFairValue
      contextRef="From2024-07-032024-07-03"
      decimals="0"
      id="Fact000957"
      unitRef="USD">74000</RIME:NonControllingInterestAtFairValue>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2024-07-03_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact000959"
      unitRef="Pure">0.20</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2024-07-03_custom_AlgorhythmHoldingsIncMember"
      decimals="INF"
      id="Fact000961"
      unitRef="Pure">0.80</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <RIME:RoyaltyRate
      contextRef="From2024-07-032024-07-03"
      decimals="INF"
      id="Fact000963"
      unitRef="Pure">0.005</RIME:RoyaltyRate>
    <RIME:DiscountOnRoyaltyRate
      contextRef="From2024-07-032024-07-03"
      decimals="INF"
      id="Fact000965"
      unitRef="Pure">0.33</RIME:DiscountOnRoyaltyRate>
    <RIME:RoyaltyTerm contextRef="From2024-07-032024-07-03" id="Fact000967">P9Y</RIME:RoyaltyTerm>
    <RIME:GrowthRateOfDevelopmentOfNewBusiness
      contextRef="From2024-07-032024-07-03_srt_MinimumMember"
      decimals="INF"
      id="Fact000969"
      unitRef="Pure">0.08</RIME:GrowthRateOfDevelopmentOfNewBusiness>
    <RIME:GrowthRateOfDevelopmentOfNewBusiness
      contextRef="From2024-07-032024-07-03_srt_MaximumMember"
      decimals="INF"
      id="Fact000971"
      unitRef="Pure">0.20</RIME:GrowthRateOfDevelopmentOfNewBusiness>
    <RIME:DiscountRateForWeightedAverageCost
      contextRef="From2024-07-032024-07-03"
      decimals="INF"
      id="Fact000973"
      unitRef="Pure">0.33</RIME:DiscountRateForWeightedAverageCost>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact000975">&lt;p id="xdx_893_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_zqfSlXacSIQb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table presents the allocation of the consideration transferred to the assets acquired and liabilities assumed based on their
fair values:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_8B0_zqB8RjhO6SA" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;SCHEDULE
OF CONSIDERATION TRANSFERRED TO THE ASSETS ACQUIRED AND LIABILITIES ASSUMED&lt;/span&gt;&lt;/span&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_49E_20240703__us-gaap--BusinessAcquisitionAxis__custom--SemiCabIncMember_zh7pqoAcz5qf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Equity consideration"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 74%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;Equity consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable_c20240703__20240703__us-gaap--AssetAcquisitionAxis__custom--SemiCabIncMember_zlLgWxDyscff" style="font: 10pt Times New Roman, Times, Serif; width: 22%; text-align: right" title="Equity consideration"&gt;&lt;span style="-sec-ix-redline: true"&gt;494,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;Fair value of non-controlling interest&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--AssetAcquisitionFairValueOfNonControllingInterest_c20240703__20240703__us-gaap--AssetAcquisitionAxis__custom--SemiCabIncMember_z6LHfTO1zIf" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Fair value of non-controlling interest"&gt;&lt;span style="-sec-ix-redline: true"&gt;74,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;Total Equity Consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AssetAcquisitionConsiderationTransferredContingentConsideration_c20240703__20240703__us-gaap--AssetAcquisitionAxis__custom--SemiCabIncMember_zo7Ps31BOJhd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total Equity Consideration"&gt;&lt;span style="-sec-ix-redline: true"&gt;568,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;Debt Extinguishment&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--AssetAcquisitionDebtExtinguishment_c20240703__20240703__us-gaap--AssetAcquisitionAxis__custom--SemiCabIncMember_z02uvR7ZXrRk" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Debt Extinguishment"&gt;&lt;span style="-sec-ix-redline: true"&gt;415,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;Total Consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--AssetAcquisitionConsiderationTransferred_c20240703__20240703__us-gaap--AssetAcquisitionAxis__custom--SemiCabIncMember_zlZrKZvXompg" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Total consideration"&gt;&lt;span style="-sec-ix-redline: true"&gt;983,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;Identifiable net assets acquired:&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_iI_ziB7iOrglvn" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;17,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_iI_zia4FpE3NQVc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;193,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_iI_zDAJcMob9pAd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;13,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_zlTqy723kO5c" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;3,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_iI_z6siHi5SxsMl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;Other Non-Current Operating Assets, Net&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;14,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCustomerRelationships_iI_zUWvmGbp32t3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;Customer Relationships (&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlNJREVSQVRJT04gVFJBTlNGRVJSRUQgVE8gVEhFIEFTU0VUUyBBQ1FVSVJFRCBBTkQgTElBQklMSVRJRVMgQVNTVU1FRCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20240703__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zYg7VmAKamhf"&gt;9
    &lt;/span&gt;&lt;/span&gt;&lt;span style="-sec-ix-redline: true"&gt;year estimated useful life)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;747,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradeName_iI_z7vJ6LJn72h6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;Trade Name (&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlNJREVSQVRJT04gVFJBTlNGRVJSRUQgVE8gVEhFIEFTU0VUUyBBQ1FVSVJFRCBBTkQgTElBQklMSVRJRVMgQVNTVU1FRCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90F_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20240703__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_ziXcACBKrHC6"&gt;9
    &lt;/span&gt;&lt;/span&gt;&lt;span style="-sec-ix-redline: true"&gt;year estimated useful life)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;272,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDevelopedTechnology_iI_zUOYy8tjHF41" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;Developed Technology (&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlNJREVSQVRJT04gVFJBTlNGRVJSRUQgVE8gVEhFIEFTU0VUUyBBQ1FVSVJFRCBBTkQgTElBQklMSVRJRVMgQVNTVU1FRCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20240703__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DevelopedTechnologyRightsMember_zCx5Qsd9yz8l"&gt;6
    &lt;/span&gt;&lt;/span&gt;&lt;span style="-sec-ix-redline: true"&gt;year estimated useful life)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;381,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_iNI_di_zodX7BNLMoAd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;Accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;(2,680,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLoansPayable_iI_zMz2R2tKSr3l" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;Loans payable Merchant Cash Advances (MCA)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;(631,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt_iNI_di_zkoi1AVl10b8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;Note payable&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;(50,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesNotesPayableRelatedParties_iI_znAEmC4h6vsj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;Notes payable Related Parties&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;(650,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_z67ORAU3jxsf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;Net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;(2,371,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--Goodwill_iI_z56M72yov2Yk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;Estimated Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;3,354,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable
      contextRef="From2024-07-032024-07-03_custom_SemiCabIncMember"
      decimals="0"
      id="Fact000977"
      unitRef="USD">494000</us-gaap:AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable>
    <RIME:AssetAcquisitionFairValueOfNonControllingInterest
      contextRef="From2024-07-032024-07-03_custom_SemiCabIncMember"
      decimals="0"
      id="Fact000979"
      unitRef="USD">74000</RIME:AssetAcquisitionFairValueOfNonControllingInterest>
    <us-gaap:AssetAcquisitionConsiderationTransferredContingentConsideration
      contextRef="From2024-07-032024-07-03_custom_SemiCabIncMember"
      decimals="0"
      id="Fact000981"
      unitRef="USD">568000</us-gaap:AssetAcquisitionConsiderationTransferredContingentConsideration>
    <RIME:AssetAcquisitionDebtExtinguishment
      contextRef="From2024-07-032024-07-03_custom_SemiCabIncMember"
      decimals="0"
      id="Fact000983"
      unitRef="USD">415000</RIME:AssetAcquisitionDebtExtinguishment>
    <us-gaap:AssetAcquisitionConsiderationTransferred
      contextRef="From2024-07-032024-07-03_custom_SemiCabIncMember"
      decimals="0"
      id="Fact000985"
      unitRef="USD">983000</us-gaap:AssetAcquisitionConsiderationTransferred>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="AsOf2024-07-03_custom_SemiCabIncMember249477843"
      decimals="0"
      id="Fact000987"
      unitRef="USD">17000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="AsOf2024-07-03_custom_SemiCabIncMember249477843"
      decimals="0"
      id="Fact000989"
      unitRef="USD">193000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="AsOf2024-07-03_custom_SemiCabIncMember249477843"
      decimals="0"
      id="Fact000991"
      unitRef="USD">13000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="AsOf2024-07-03_custom_SemiCabIncMember249477843"
      decimals="0"
      id="Fact000993"
      unitRef="USD">3000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="AsOf2024-07-03_custom_SemiCabIncMember249477843"
      decimals="0"
      id="Fact000995"
      unitRef="USD">14000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="AsOf2024-07-03_us-gaap_CustomerRelationshipsMember"
      id="Fact000998">P9Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <RIME:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCustomerRelationships
      contextRef="AsOf2024-07-03_custom_SemiCabIncMember249477843"
      decimals="0"
      id="Fact000997"
      unitRef="USD">747000</RIME:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCustomerRelationships>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="AsOf2024-07-03_us-gaap_TradeNamesMember"
      id="Fact001001">P9Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <RIME:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradeName
      contextRef="AsOf2024-07-03_custom_SemiCabIncMember249477843"
      decimals="0"
      id="Fact001000"
      unitRef="USD">272000</RIME:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradeName>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="AsOf2024-07-03_us-gaap_DevelopedTechnologyRightsMember"
      id="Fact001004">P6Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <RIME:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDevelopedTechnology
      contextRef="AsOf2024-07-03_custom_SemiCabIncMember249477843"
      decimals="0"
      id="Fact001003"
      unitRef="USD">381000</RIME:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDevelopedTechnology>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="AsOf2024-07-03_custom_SemiCabIncMember249477843"
      decimals="0"
      id="Fact001006"
      unitRef="USD">2680000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <RIME:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLoansPayable
      contextRef="AsOf2024-07-03_custom_SemiCabIncMember249477843"
      decimals="0"
      id="Fact001008"
      unitRef="USD">-631000</RIME:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLoansPayable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt
      contextRef="AsOf2024-07-03_custom_SemiCabIncMember249477843"
      decimals="0"
      id="Fact001010"
      unitRef="USD">50000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt>
    <RIME:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesNotesPayableRelatedParties
      contextRef="AsOf2024-07-03_custom_SemiCabIncMember249477843"
      decimals="0"
      id="Fact001012"
      unitRef="USD">-650000</RIME:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesNotesPayableRelatedParties>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="AsOf2024-07-03_custom_SemiCabIncMember249477843"
      decimals="0"
      id="Fact001014"
      unitRef="USD">-2371000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:Goodwill
      contextRef="AsOf2024-07-03_custom_SemiCabIncMember249477843"
      decimals="0"
      id="Fact001016"
      unitRef="USD">3354000</us-gaap:Goodwill>
    <RIME:ScheduleOfProFormaFinancialInformationTableTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact001018">&lt;p id="xdx_891_ecustom--ScheduleOfProFormaFinancialInformationTableTextBlock_zWwCnqTKNek9" style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_8BD_z3uB87DL9bu3" style="display: none"&gt;SCHEDULE
OF PRO FORMA FINANCIAL INFORMATION&lt;/span&gt;&lt;/span&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_497_20240101__20240930_z3drDoyCCjZd" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_499_20230101__20230930_z71B4uIUAeLi" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;September
    30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;September
    30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--BusinessAcquisitionsProFormaRevenue_zGU55vatkVmd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;Net revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;16,831,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;26,848,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax_zRTwvKp3syM2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;Operating loss from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;(8,093,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;(6,187,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_zBIixXJD0Vvd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;(8,451,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;(7,164,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;/p&gt;

</RIME:ScheduleOfProFormaFinancialInformationTableTextBlock>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact001020"
      unitRef="USD">16831000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact001021"
      unitRef="USD">26848000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact001023"
      unitRef="USD">-8093000</us-gaap:BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax>
    <us-gaap:BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact001024"
      unitRef="USD">-6187000</us-gaap:BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact001026"
      unitRef="USD">-8451000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact001027"
      unitRef="USD">-7164000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:IncreaseDecreaseInOperatingCapital
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact001029"
      unitRef="USD">265000</us-gaap:IncreaseDecreaseInOperatingCapital>
    <us-gaap:LegalFees
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact001031"
      unitRef="USD">215000</us-gaap:LegalFees>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2023-01-012023-09-30"
      decimals="INF"
      id="Fact001033"
      unitRef="Shares">50000</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:DebtDisclosureTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact001035">&lt;p id="xdx_802_eus-gaap--DebtDisclosureTextBlock_z5HBU13PkCdh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
6 &#x2013; &lt;span id="xdx_82A_zC4jtxyBG7Zj"&gt;FINANCING&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Oxford
Credit Facility&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;On
March 28, 2024, the Company entered into a Loan and Security Agreement (the &#x201c;Credit Agreement&#x201d;) with Oxford Business Credit
&#x201c;Oxford&#x201d;), as Lender. The Credit Agreement established a secured asset-backed revolving credit facility which is comprised
of a maximum $&lt;span id="xdx_900_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_c20240328__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_zbETZNnun2y5" title="Revolving credit facility"&gt;2,000,000&lt;/span&gt; revolving credit facility (&#x201c;Credit Facility&#x201d;) (&#x201c;Revolving Loan Cap&#x201d;). Availability under
the Credit Facility is determined monthly by a borrowing base comprised of a percentage of eligible accounts receivable of the Borrowers.
The Company&#x2019;s obligations under the Credit Agreement are secured by a continuing security interest in all property of each Loan
Party, subject to certain excluded collateral (as defined in the Credit Agreement). As of September 30, 2024, there was approximately
$&lt;span id="xdx_901_eus-gaap--OtherReceivables_iI_c20240930__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zi86HMiOCY7e" title="Due from Oxford Bank"&gt;22,000&lt;/span&gt; due from Oxford for cash collections received that exceeded the amount due on the Credit Agreement. As of September 30, 2024,
there were &lt;span id="xdx_909_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_do_c20240930__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_zD9v6RKE6xid" title="Revolving credit facility"&gt;no&lt;/span&gt; funds available for borrowing under the Credit Facility.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;Borrowings
under the Credit Facility take the form of base rate loans at interest rates of the Wall Street Journal Prime Rate plus &lt;span id="xdx_90E_eus-gaap--LineOfCreditFacilityInterestRateDuringPeriod_dp_uPure_c20240328__20240328__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_z8W9XVN6ZVR5" title="The Prime Rate"&gt;2.5&lt;/span&gt;%, but in
any event no less than &lt;span id="xdx_906_eus-gaap--LineOfCreditFacilityInterestRateDuringPeriod_dp_uPure_c20240328__20240328__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember__srt--RangeAxis__srt--MaximumMember_z6rvZ1pGURj9" title="The Prime Rate"&gt;10&lt;/span&gt;%. The Credit Agreement includes certain covenants which include, but are not limited to restrictions on debt,
asset liens, capital expenditures, formation of new entities and financial covenants. For the three and nine months ended September 30,
2024, the Company incurred interest expense of approximately $&lt;span id="xdx_90B_eus-gaap--InterestExpenseDebt_c20240701__20240930__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_zjqw8BJS3Cn2" title="Interest expense"&gt;24,000&lt;/span&gt; and $&lt;span id="xdx_90C_eus-gaap--InterestExpenseDebt_c20240101__20240930__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_z5vOgQSpnoY3" title="Interest expense"&gt;66,000&lt;/span&gt;, respectively associated with financing costs from the
Credit Agreement.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;The
Credit Agreement is for a &lt;span id="xdx_908_eus-gaap--DebtInstrumentTerm_dxL_c20240328__20240328__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_z0ojmNaeWUz1" title="Credit agreement term::XDX::P2Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1051"&gt;two&lt;/span&gt;&lt;/span&gt;-year term that expires on &lt;span id="xdx_909_eus-gaap--LineOfCreditFacilityExpirationDate1_dd_c20240328__20240328__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_zFLDsF5PnHVf" title="Credit agreement expires"&gt;November 28, 2026&lt;/span&gt;, and automatically renews for an additional one-year term on
each anniversary of date of the agreement unless the Company notifies Oxford within 60 days before the anniversary date of its intention
to pay off the Credit Facility and terminate the Credit Agreement.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;The
Company is subject to a two percent (&lt;span id="xdx_90B_ecustom--PercentageOfExitFee_dp_uPure_c20240328__20240328__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_z2MYsdzqnlW1" title="Percentage of exit fee"&gt;2&lt;/span&gt;%) exit fee (&#x201c;Exit Fee&#x201d;) of the Revolving Loan Cap if the Company terminates the Credit
Agreement and repays the obligations under Credit Facility prior to the anniversary date of the Credit Agreement. The Exit Fee shall
automatically renew on the two-year anniversary date of the Loan Agreement for an additional one-year period unless the Company notifies
Lender in writing within sixty (60) days before such anniversary date of Borrower&#x2019;s intention to pay off this Credit Facility and
terminate the Credit Agreement and all obligations of the Credit Facility are paid in full by such anniversary date. There were
no draws against the Credit Facility since inception of the Credit Agreement.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;On
October 17, 2024, the Company voluntarily terminated the Credit Agreement. Pursuant to the terms of the Credit Agreement the Company
was obligated to pay a $&lt;span id="xdx_907_eus-gaap--BusinessExitCosts1_c20241017__20241017__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_zFX9RXPuMKRa" title="Exit fee payable on termination of contract"&gt;40,000&lt;/span&gt; Exit Fee due to termination prior to the anniversary date of the Credit Agreement.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Fifth
Third Bank Asset-backed Revolving Credit Facility&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
October 14, 2022, the Company entered into a Loan and Security Agreement with Fifth Third Financial Corporation (the &#x201c;Credit Agreement&#x201d;),
as Lender, replacing the Company&#x2019;s credit facilities with Crestmark and IHC that were terminated by the Company on October 13,
2022. The Credit Agreement established a secured asset-backed revolving credit facility which is comprised of a maximum $&lt;span id="xdx_902_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_c20221014__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_zCqs92yslYxi"&gt;15,000,000
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;revolving credit facility (&#x201c;Credit
Facility&#x201d;). The Credit Facility was terminated on &lt;span id="xdx_904_eus-gaap--LineOfCreditFacilityExpirationDate1_dd_c20221014__20221014__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_zi3QhIbpTsqa"&gt;November
17, 2023&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;. Availability under the Credit
Facility was determined monthly by a borrowing base comprised of a percentage of eligible accounts receivable and eligible inventory
of the Borrowers. The Company&#x2019;s obligations under the Credit Agreement are secured by a continuing security interest in all property
of each Loan Party, subject to certain excluded collateral (as defined in the Credit Facility).&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;Costs
associated with closing of the Credit Agreement of approximately $&lt;span id="xdx_905_eus-gaap--RepaymentsOfLinesOfCredit_c20221014__20221014__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_zn6BzuHVptCg" title="Costs associated with line of credit"&gt;254,000&lt;/span&gt; were deferred and being amortized over life of the loan. During
the three months and nine months ended September 30, 2023 the Company incurred approximately $&lt;span id="xdx_903_eus-gaap--AmortizationOfFinancingCosts_c20230701__20230930__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_zpJWNSfwFKE" title="Amortization of deferred financing costs"&gt;21,000&lt;/span&gt; and $&lt;span id="xdx_907_eus-gaap--AmortizationOfFinancingCosts_c20230101__20230930__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_zU2aQni4klSg" title="Amortization of deferred financing costs"&gt;63,000&lt;/span&gt;, respectively associated
with the amortization of deferred financing costs from the Credit Agreement.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;ALGORHYTHM
                                            HOLDINGS, INC. and SUBSIDIARIES&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;September
30, 2024 and 2023&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;Borrowings
under the Credit Facility took the form of base rate loans at interest rates of the greater of either &lt;span id="xdx_90A_eus-gaap--LineOfCreditFacilityInterestRateDescription_c20221014__20221014__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_z1IGRS2yb2R1" title="Base rates of loan description"&gt;(a) the Prime Rate plus 0.50% or (b) the Secured Overnight Financing Rate (&#x201c;SOFR&#x201d;) 30-day term rate plus 3%, subject to a minimum of 0.050% in either case.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;During
the three and nine months ended September 30, 2023, the Company incurred interest expense of approximately $&lt;span id="xdx_903_eus-gaap--InterestAndDebtExpense_c20230701__20230930__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_zTkl2YOWpDY3" title="Interest expense"&gt;19,000&lt;/span&gt; and $&lt;span id="xdx_903_eus-gaap--InterestAndDebtExpense_c20230101__20230930__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_zMatrRXg6Srd" title="Interest expense"&gt;59,000&lt;/span&gt; respectively,
associated with interest and financing costs from the Credit Agreement.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;On
May 19, 2023, the Company executed a Waiver and First Amendment agreement which provides for a waiver of previous defaults and instituted
new covenants.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;On
August 30, 2023, the Company entered into a Waiver and Second Amendment (the &#x201c;Revolving Loan Amendment&#x201d;) to the Credit Agreement.
The Revolving Loan Amendment provides for, among other things, (i) a waiver of all known existing defaults under the Credit Agreement
as of the date of the Revolving Loan Amendment and (ii) the amendment of the definition of &#x201c;Borrowing Base&#x201d; to reduce from
$&lt;span id="xdx_905_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_c20221014__us-gaap--CreditFacilityAxis__custom--RevolvingLoanAmendmentMember_zBTI0XrSvoJc" title="Revolving credit facility maximum amount"&gt;5,000,000&lt;/span&gt; to $&lt;span id="xdx_903_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_c20230830__us-gaap--CreditFacilityAxis__custom--RevolvingLoanAmendmentMember_zpT5JRSt3O43" title="Revolving credit facility maximum amount"&gt;2,000,000&lt;/span&gt;.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
November 17, 2023, the Company voluntarily terminated the Credit Agreement as the Company could not comply with the debt coverage financial
covenant effective September 30, 2023. There was no balance outstanding on the credit agreement as of the termination date.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Merchant
Cash Advance payable &#x2013; Agile Capital Funding, LLC&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;Pursuant to the acquisition of SemiCab, the Company assumed a Merchant
Cash Advance (&#x201c;MCA Financing&#x201d;) payable with Agile Capital Funding, LLC (&#x201c;Agile&#x201d;). On
March 22, 2024, SemiCab entered into a MCA Financing agreement with Agile. The initial
amount borrowed was $&lt;span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_iI_c20240322__us-gaap--ShortTermDebtTypeAxis__custom--AgileCapilalFundingllcMember_zVHMwas78f7j" title="Initial amount borrowed"&gt;315,000&lt;/span&gt;, with net proceeds to the Company in the amount of $&lt;span id="xdx_902_eus-gaap--ProceedsFromShortTermDebt_c20240322__20240322__us-gaap--ShortTermDebtTypeAxis__custom--AgileCapilalFundingllcMember_zGhiRuXtUIEe" title="Net proceeds from short term debt"&gt;300,000&lt;/span&gt;. Repayment terms stipulate weekly payments in
the amount of $&lt;span id="xdx_906_eus-gaap--DebtInstrumentPeriodicPayment_c20240322__20240322__us-gaap--ShortTermDebtTypeAxis__custom--AgileCapilalFundingllcMember_zyxbviYoc9R4" title="Stipulated periodic payment of short term debt"&gt;16,200&lt;/span&gt; for weeks, for a total of $&lt;span id="xdx_90B_eus-gaap--RepaymentsOfShortTermDebt_c20240322__20240322__us-gaap--ShortTermDebtTypeAxis__custom--AgileCapilalFundingllcMember_zy77m5cWfili" title="Total short term debt to be repaid"&gt;453,600&lt;/span&gt; repaid. The effective interest rate for the borrowings is &lt;span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_dp_c20240322__us-gaap--ShortTermDebtTypeAxis__custom--AgileCapilalFundingllcMember_ztwU3tLc9acj" title="Effective Interest rate"&gt;15&lt;/span&gt;%. As September
30, 2024 the amount due on this MCA Financing was approximately $&lt;span id="xdx_905_eus-gaap--ShortTermBorrowings_iI_c20240930__us-gaap--ShortTermDebtTypeAxis__custom--AgileCapilalFundingllcMember_zMer59dkaotf" title="Amount outstanding for Agile Capital Funding,LLC"&gt;146,500&lt;/span&gt;.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Merchant
Cash Advance payable &#x2013; Cedar Advance, LLC&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;Pursuant to the acquisition of SemiCab, the Company assumed a MCA Financing
payable with Cedar Advance, LLC (&#x201c;Cedar&#x201d;). On
May 8, 2024, SemiCab entered into an MCA Financing with Cedar. The initial amount borrowed was $&lt;span id="xdx_90C_eus-gaap--DebtInstrumentFaceAmount_iI_c20240508__us-gaap--ShortTermDebtTypeAxis__custom--CedarAdvancellcMember_zVO8oGJdlich" title="Initial amount borrowed"&gt;215,000&lt;/span&gt;, with net proceeds
to the Company in the amount of $&lt;span id="xdx_907_eus-gaap--ProceedsFromShortTermDebt_c20240508__20240508__us-gaap--ShortTermDebtTypeAxis__custom--CedarAdvancellcMember_z1Y9U30HxHM5" title="Net proceeds from short term debt"&gt;204,250&lt;/span&gt;. Repayment terms stipulate weekly payments in the amount of $&lt;span id="xdx_901_eus-gaap--DebtInstrumentPeriodicPayment_c20240508__20240508__us-gaap--ShortTermDebtTypeAxis__custom--CedarAdvancellcMember_z8OXvDjgdSck" title="Stipulated periodic payment of short term debt"&gt;11,133&lt;/span&gt; for 28 weeks, for a total
of $&lt;span id="xdx_90D_eus-gaap--RepaymentsOfShortTermDebt_c20240508__20240508__us-gaap--ShortTermDebtTypeAxis__custom--CedarAdvancellcMember_zVqczmkpevka" title="Total short term debt to be repaid"&gt;311,750&lt;/span&gt; repaid. The effective interest rate for the borrowings is &lt;span id="xdx_908_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_dp_c20240508__us-gaap--ShortTermDebtTypeAxis__custom--CedarAdvancellcMember_zvO8TZuqnv12" title="Effective Interest rate"&gt;18&lt;/span&gt;%. As September 30, 2024 the amount due on this MCA Financing
was approximately $&lt;span id="xdx_90F_eus-gaap--ShortTermBorrowings_iI_c20240930__us-gaap--ShortTermDebtTypeAxis__custom--CedarAdvancellcMember_zCpVVaWuplol" title="Amount outstanding for Agile Capital Funding,LLC"&gt;156,920&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Loan
Payable SemiCab Investor&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;SemiCab
maintains a loan from a SemiCab investor in the amount of $&lt;span id="xdx_90C_eus-gaap--DebtInstrumentFaceAmount_iI_c20240322__us-gaap--ShortTermDebtTypeAxis__custom--SemiCabInvestorMember_zZ0BzEWCRxDc" title="Initial amount borrowed"&gt;50,000&lt;/span&gt;. The loan bears interest at &lt;span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_dp_c20240322__us-gaap--ShortTermDebtTypeAxis__custom--SemiCabInvestorMember_ziiuETZmpLE4" title="Effective Interest rate"&gt;10%&lt;/span&gt; per annum and matured on May 15, 2024
and is unsecured. As of September 30, 2024 the loan had not been paid and is in default. The principal amount due is recorded as a component
of notes payable on the accompanying condensed consolidated balance sheets.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="AsOf2024-03-28_us-gaap_RevolvingCreditFacilityMember"
      decimals="0"
      id="Fact001037"
      unitRef="USD">2000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:OtherReceivables
      contextRef="AsOf2024-09-30_us-gaap_RevolvingCreditFacilityMember_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact001039"
      unitRef="USD">22000</us-gaap:OtherReceivables>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="AsOf2024-09-30_us-gaap_RevolvingCreditFacilityMember"
      decimals="0"
      id="Fact001041"
      unitRef="USD">0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod
      contextRef="From2024-03-282024-03-28_us-gaap_RevolvingCreditFacilityMember"
      decimals="INF"
      id="Fact001043"
      unitRef="Pure">0.025</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod
      contextRef="From2024-03-282024-03-28_us-gaap_RevolvingCreditFacilityMember_srt_MaximumMember"
      decimals="INF"
      id="Fact001045"
      unitRef="Pure">0.10</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:InterestExpenseDebt
      contextRef="From2024-07-012024-09-30_us-gaap_RevolvingCreditFacilityMember"
      decimals="0"
      id="Fact001047"
      unitRef="USD">24000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="From2024-01-012024-09-30_us-gaap_RevolvingCreditFacilityMember"
      decimals="0"
      id="Fact001049"
      unitRef="USD">66000</us-gaap:InterestExpenseDebt>
    <us-gaap:LineOfCreditFacilityExpirationDate1
      contextRef="From2024-03-282024-03-28_us-gaap_RevolvingCreditFacilityMember"
      id="Fact001053">2026-11-28</us-gaap:LineOfCreditFacilityExpirationDate1>
    <RIME:PercentageOfExitFee
      contextRef="From2024-03-282024-03-28_us-gaap_RevolvingCreditFacilityMember"
      decimals="INF"
      id="Fact001055"
      unitRef="Pure">0.02</RIME:PercentageOfExitFee>
    <us-gaap:BusinessExitCosts1
      contextRef="From2024-10-172024-10-17_us-gaap_RevolvingCreditFacilityMember"
      decimals="0"
      id="Fact001057"
      unitRef="USD">40000</us-gaap:BusinessExitCosts1>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="AsOf2022-10-14_us-gaap_RevolvingCreditFacilityMember"
      decimals="0"
      id="Fact001058"
      unitRef="USD">15000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityExpirationDate1
      contextRef="From2022-10-142022-10-14_us-gaap_RevolvingCreditFacilityMember"
      id="Fact001059">2023-11-17</us-gaap:LineOfCreditFacilityExpirationDate1>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="From2022-10-142022-10-14_us-gaap_RevolvingCreditFacilityMember"
      decimals="0"
      id="Fact001061"
      unitRef="USD">254000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="From2023-07-012023-09-30_us-gaap_RevolvingCreditFacilityMember"
      decimals="0"
      id="Fact001063"
      unitRef="USD">21000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="From2023-01-012023-09-30_us-gaap_RevolvingCreditFacilityMember"
      decimals="0"
      id="Fact001065"
      unitRef="USD">63000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:LineOfCreditFacilityInterestRateDescription
      contextRef="From2022-10-142022-10-14_us-gaap_RevolvingCreditFacilityMember"
      id="Fact001067">(a) the Prime Rate plus 0.50% or (b) the Secured Overnight Financing Rate (&#x201c;SOFR&#x201d;) 30-day term rate plus 3%, subject to a minimum of 0.050% in either case.</us-gaap:LineOfCreditFacilityInterestRateDescription>
    <us-gaap:InterestAndDebtExpense
      contextRef="From2023-07-012023-09-30_us-gaap_RevolvingCreditFacilityMember"
      decimals="0"
      id="Fact001069"
      unitRef="USD">19000</us-gaap:InterestAndDebtExpense>
    <us-gaap:InterestAndDebtExpense
      contextRef="From2023-01-012023-09-30_us-gaap_RevolvingCreditFacilityMember"
      decimals="0"
      id="Fact001071"
      unitRef="USD">59000</us-gaap:InterestAndDebtExpense>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="AsOf2022-10-14_custom_RevolvingLoanAmendmentMember"
      decimals="0"
      id="Fact001073"
      unitRef="USD">5000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="AsOf2023-08-30_custom_RevolvingLoanAmendmentMember"
      decimals="0"
      id="Fact001075"
      unitRef="USD">2000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2024-03-22_custom_AgileCapilalFundingllcMember"
      decimals="0"
      id="Fact001077"
      unitRef="USD">315000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ProceedsFromShortTermDebt
      contextRef="From2024-03-222024-03-22_custom_AgileCapilalFundingllcMember"
      decimals="0"
      id="Fact001079"
      unitRef="USD">300000</us-gaap:ProceedsFromShortTermDebt>
    <us-gaap:DebtInstrumentPeriodicPayment
      contextRef="From2024-03-222024-03-22_custom_AgileCapilalFundingllcMember"
      decimals="0"
      id="Fact001081"
      unitRef="USD">16200</us-gaap:DebtInstrumentPeriodicPayment>
    <us-gaap:RepaymentsOfShortTermDebt
      contextRef="From2024-03-222024-03-22_custom_AgileCapilalFundingllcMember"
      decimals="0"
      id="Fact001083"
      unitRef="USD">453600</us-gaap:RepaymentsOfShortTermDebt>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="AsOf2024-03-22_custom_AgileCapilalFundingllcMember"
      decimals="INF"
      id="Fact001085"
      unitRef="Pure">0.15</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:ShortTermBorrowings
      contextRef="AsOf2024-09-30_custom_AgileCapilalFundingllcMember"
      decimals="0"
      id="Fact001087"
      unitRef="USD">146500</us-gaap:ShortTermBorrowings>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2024-05-08_custom_CedarAdvancellcMember"
      decimals="0"
      id="Fact001089"
      unitRef="USD">215000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ProceedsFromShortTermDebt
      contextRef="From2024-05-082024-05-08_custom_CedarAdvancellcMember"
      decimals="0"
      id="Fact001091"
      unitRef="USD">204250</us-gaap:ProceedsFromShortTermDebt>
    <us-gaap:DebtInstrumentPeriodicPayment
      contextRef="From2024-05-082024-05-08_custom_CedarAdvancellcMember"
      decimals="0"
      id="Fact001093"
      unitRef="USD">11133</us-gaap:DebtInstrumentPeriodicPayment>
    <us-gaap:RepaymentsOfShortTermDebt
      contextRef="From2024-05-082024-05-08_custom_CedarAdvancellcMember"
      decimals="0"
      id="Fact001095"
      unitRef="USD">311750</us-gaap:RepaymentsOfShortTermDebt>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="AsOf2024-05-08_custom_CedarAdvancellcMember"
      decimals="INF"
      id="Fact001097"
      unitRef="Pure">0.18</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:ShortTermBorrowings
      contextRef="AsOf2024-09-30_custom_CedarAdvancellcMember"
      decimals="0"
      id="Fact001099"
      unitRef="USD">156920</us-gaap:ShortTermBorrowings>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2024-03-22_custom_SemiCabInvestorMember"
      decimals="0"
      id="Fact001101"
      unitRef="USD">50000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="AsOf2024-03-22_custom_SemiCabInvestorMember"
      decimals="INF"
      id="Fact001103"
      unitRef="Pure">0.10</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:LongTermDebtTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact001105">&lt;p id="xdx_808_eus-gaap--LongTermDebtTextBlock_zsaLNMlnhGfc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
7 &#x2013; &lt;span id="xdx_827_zR9yHGinEifc"&gt;LOANS PAYABLE &#x2013; RELATED PARTIES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;SemiCab
maintains several outstanding affiliate loans from Ajesh Kapoor and Vivek Sehgal, (current employees and original founders of SemiCab)
initially issued by SemiCab Holdings LLC. The notes are unsecured. There was accrued interest payable is approximately $&lt;span id="xdx_902_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20240930_zdbg0bp8AURb" title="Accrued interest payable"&gt;72,000&lt;/span&gt; that is
included as a component of accrued expenses on the accompanying condensed consolidated balance sheets. Interest expense on these related
party loans for the three and nine months ended September 30, 2024 was approximately $&lt;span id="xdx_90C_eus-gaap--InterestExpense_c20240701__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zVow8c7l1kVh" title="Interest expense"&gt;&lt;span id="xdx_907_eus-gaap--InterestExpense_c20240101__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zKf1wftrmuU8" title="Interest expense"&gt;28,000&lt;/span&gt;&lt;/span&gt;.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;ALGORHYTHM
                                            HOLDINGS, INC. and SUBSIDIARIES&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;September
30, 2024 and 2023&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89D_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_zNxrQIM0BEHi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
specific terms of each loan are summarized in the table below:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_8BE_zZepzgZY38Uh" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;SCHEDULE
OF LOAN&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;Issue&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;Maturity&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;Interest&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20240930_z8QaO2zgqSDi" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;Holder&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;Date&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;Date&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;Status&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;Rate&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;Principal&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 46%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;Ajesh Kapoor&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_905_eus-gaap--DebtInstrumentIssuanceDate1_dd_c20240101__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorOneMember_zAbJ9Nu4bt79"&gt;7/10/2021&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_908_eus-gaap--DebtInstrumentMaturityDate_dd_c20240101__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorOneMember_zH86iwv0hNs3"&gt;7/10/2026&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 8%"&gt;&lt;span style="-sec-ix-redline: true"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_905_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorOneMember_zkzfROuvp3Sh"&gt;9.0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--NotesPayable_iI_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorOneMember_zDGdI4auNRg3" style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: right" title="Principal amount"&gt;&lt;span style="-sec-ix-redline: true"&gt;150,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;Ajesh Kapoor&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_905_eus-gaap--DebtInstrumentIssuanceDate1_dd_c20240101__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorTwoMember_zHfH1bsvae54"&gt;8/27/2021&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_909_eus-gaap--DebtInstrumentMaturityDate_dd_c20240101__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorTwoMember_zZWTAcVYM0Hd"&gt;8/26/2026&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorTwoMember_zSoqUWHGGesh"&gt;9.0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--NotesPayable_iI_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorTwoMember_zVF13JLSDoK5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal amount"&gt;&lt;span style="-sec-ix-redline: true"&gt;235,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;Vivek Seghal&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_90C_eus-gaap--DebtInstrumentIssuanceDate1_dd_c20240101__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--VivekSeghalMember_z2KzwxE1Ipwh"&gt;4/17/2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_902_eus-gaap--DebtInstrumentMaturityDate_dd_c20240101__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--VivekSeghalMember_zpChU2QYiCFc"&gt;10/13/2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;Default&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_903_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--VivekSeghalMember_zXuIk9wWnLo2"&gt;10.0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--NotesPayable_iI_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--VivekSeghalMember_z5d53GLi5j8j" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal amount"&gt;&lt;span style="-sec-ix-redline: true"&gt;50,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;Ajesh Kapoor&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_903_eus-gaap--DebtInstrumentIssuanceDate1_dd_c20240101__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorThreeMember_zj6J3z4YGgq"&gt;5/5/2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_902_eus-gaap--DebtInstrumentMaturityDate_dd_c20240101__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorThreeMember_zz0koCJcw2L1"&gt;5/4/2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;Default&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_908_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorThreeMember_z0zCbAHnh0h4"&gt;10.0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--NotesPayable_iI_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorThreeMember_zqlhKpIoJK0k" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal amount"&gt;&lt;span style="-sec-ix-redline: true"&gt;50,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;Ajesh Kapoor&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_909_eus-gaap--DebtInstrumentIssuanceDate1_dd_c20240101__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorFourMember_zLCkZHT27tu6"&gt;5/17/2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_90D_eus-gaap--DebtInstrumentMaturityDate_dd_c20240101__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorFourMember_zetEGTdpidX7"&gt;5/16/2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;Default&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_909_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorFourMember_zLiWcQbjnTma"&gt;10.0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--NotesPayable_iI_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorFourMember_zI3MWIBNpu4a" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal amount"&gt;&lt;span style="-sec-ix-redline: true"&gt;165,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--NotesPayable_iI_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zkSNxspZRSGi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;Amount due as of September 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;650,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--NotesPayableCurrent_iI_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zzTUD2zbYcS1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;Less: Current portion of notes payable
    to related parties&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;265,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--LongTermNotesPayable_iTI_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zbbTuKSJbwdg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt; padding-left: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;Notes payable
    to related parties, net of current portion&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;385,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AC_zQshLb6Rbmlc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:LongTermDebtTextBlock>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact001107"
      unitRef="USD">72000</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:InterestExpense
      contextRef="From2024-07-012024-09-30_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact001109"
      unitRef="USD">28000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2024-01-012024-09-30_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact001111"
      unitRef="USD">28000</us-gaap:InterestExpense>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact001113">&lt;p id="xdx_89D_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_zNxrQIM0BEHi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
specific terms of each loan are summarized in the table below:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_8BE_zZepzgZY38Uh" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;SCHEDULE
OF LOAN&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;Issue&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;Maturity&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;Interest&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20240930_z8QaO2zgqSDi" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;Holder&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;Date&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;Date&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;Status&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;Rate&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;Principal&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 46%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;Ajesh Kapoor&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_905_eus-gaap--DebtInstrumentIssuanceDate1_dd_c20240101__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorOneMember_zAbJ9Nu4bt79"&gt;7/10/2021&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_908_eus-gaap--DebtInstrumentMaturityDate_dd_c20240101__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorOneMember_zH86iwv0hNs3"&gt;7/10/2026&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 8%"&gt;&lt;span style="-sec-ix-redline: true"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_905_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorOneMember_zkzfROuvp3Sh"&gt;9.0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--NotesPayable_iI_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorOneMember_zDGdI4auNRg3" style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: right" title="Principal amount"&gt;&lt;span style="-sec-ix-redline: true"&gt;150,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;Ajesh Kapoor&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_905_eus-gaap--DebtInstrumentIssuanceDate1_dd_c20240101__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorTwoMember_zHfH1bsvae54"&gt;8/27/2021&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_909_eus-gaap--DebtInstrumentMaturityDate_dd_c20240101__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorTwoMember_zZWTAcVYM0Hd"&gt;8/26/2026&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorTwoMember_zSoqUWHGGesh"&gt;9.0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--NotesPayable_iI_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorTwoMember_zVF13JLSDoK5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal amount"&gt;&lt;span style="-sec-ix-redline: true"&gt;235,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;Vivek Seghal&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_90C_eus-gaap--DebtInstrumentIssuanceDate1_dd_c20240101__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--VivekSeghalMember_z2KzwxE1Ipwh"&gt;4/17/2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_902_eus-gaap--DebtInstrumentMaturityDate_dd_c20240101__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--VivekSeghalMember_zpChU2QYiCFc"&gt;10/13/2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;Default&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_903_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--VivekSeghalMember_zXuIk9wWnLo2"&gt;10.0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--NotesPayable_iI_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--VivekSeghalMember_z5d53GLi5j8j" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal amount"&gt;&lt;span style="-sec-ix-redline: true"&gt;50,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;Ajesh Kapoor&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_903_eus-gaap--DebtInstrumentIssuanceDate1_dd_c20240101__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorThreeMember_zj6J3z4YGgq"&gt;5/5/2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_902_eus-gaap--DebtInstrumentMaturityDate_dd_c20240101__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorThreeMember_zz0koCJcw2L1"&gt;5/4/2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;Default&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_908_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorThreeMember_z0zCbAHnh0h4"&gt;10.0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--NotesPayable_iI_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorThreeMember_zqlhKpIoJK0k" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal amount"&gt;&lt;span style="-sec-ix-redline: true"&gt;50,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;Ajesh Kapoor&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_909_eus-gaap--DebtInstrumentIssuanceDate1_dd_c20240101__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorFourMember_zLCkZHT27tu6"&gt;5/17/2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_90D_eus-gaap--DebtInstrumentMaturityDate_dd_c20240101__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorFourMember_zetEGTdpidX7"&gt;5/16/2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;Default&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_909_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorFourMember_zLiWcQbjnTma"&gt;10.0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--NotesPayable_iI_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorFourMember_zI3MWIBNpu4a" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal amount"&gt;&lt;span style="-sec-ix-redline: true"&gt;165,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--NotesPayable_iI_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zkSNxspZRSGi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;Amount due as of September 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;650,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--NotesPayableCurrent_iI_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zzTUD2zbYcS1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;Less: Current portion of notes payable
    to related parties&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;265,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--LongTermNotesPayable_iTI_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zbbTuKSJbwdg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt; padding-left: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;Notes payable
    to related parties, net of current portion&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;385,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:DebtInstrumentIssuanceDate1
      contextRef="From2024-01-012024-09-30_custom_AjeshKapoorOneMember"
      id="Fact001114">2021-07-10</us-gaap:DebtInstrumentIssuanceDate1>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="From2024-01-012024-09-30_custom_AjeshKapoorOneMember"
      id="Fact001115">2026-07-10</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2024-09-30_custom_AjeshKapoorOneMember"
      decimals="INF"
      id="Fact001116"
      unitRef="Pure">0.090</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:NotesPayable
      contextRef="AsOf2024-09-30_custom_AjeshKapoorOneMember"
      decimals="0"
      id="Fact001118"
      unitRef="USD">150000</us-gaap:NotesPayable>
    <us-gaap:DebtInstrumentIssuanceDate1
      contextRef="From2024-01-012024-09-30_custom_AjeshKapoorTwoMember"
      id="Fact001119">2021-08-27</us-gaap:DebtInstrumentIssuanceDate1>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="From2024-01-012024-09-30_custom_AjeshKapoorTwoMember"
      id="Fact001120">2026-08-26</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2024-09-30_custom_AjeshKapoorTwoMember"
      decimals="INF"
      id="Fact001121"
      unitRef="Pure">0.090</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:NotesPayable
      contextRef="AsOf2024-09-30_custom_AjeshKapoorTwoMember"
      decimals="0"
      id="Fact001123"
      unitRef="USD">235000</us-gaap:NotesPayable>
    <us-gaap:DebtInstrumentIssuanceDate1
      contextRef="From2024-01-012024-09-30_custom_VivekSeghalMember"
      id="Fact001124">2023-04-17</us-gaap:DebtInstrumentIssuanceDate1>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="From2024-01-012024-09-30_custom_VivekSeghalMember"
      id="Fact001125">2023-10-13</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2024-09-30_custom_VivekSeghalMember"
      decimals="INF"
      id="Fact001126"
      unitRef="Pure">0.100</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:NotesPayable
      contextRef="AsOf2024-09-30_custom_VivekSeghalMember"
      decimals="0"
      id="Fact001128"
      unitRef="USD">50000</us-gaap:NotesPayable>
    <us-gaap:DebtInstrumentIssuanceDate1
      contextRef="From2024-01-012024-09-30_custom_AjeshKapoorThreeMember"
      id="Fact001129">2023-05-05</us-gaap:DebtInstrumentIssuanceDate1>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="From2024-01-012024-09-30_custom_AjeshKapoorThreeMember"
      id="Fact001130">2024-05-04</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2024-09-30_custom_AjeshKapoorThreeMember"
      decimals="INF"
      id="Fact001131"
      unitRef="Pure">0.100</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:NotesPayable
      contextRef="AsOf2024-09-30_custom_AjeshKapoorThreeMember"
      decimals="0"
      id="Fact001133"
      unitRef="USD">50000</us-gaap:NotesPayable>
    <us-gaap:DebtInstrumentIssuanceDate1
      contextRef="From2024-01-012024-09-30_custom_AjeshKapoorFourMember"
      id="Fact001134">2023-05-17</us-gaap:DebtInstrumentIssuanceDate1>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="From2024-01-012024-09-30_custom_AjeshKapoorFourMember"
      id="Fact001135">2024-05-16</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2024-09-30_custom_AjeshKapoorFourMember"
      decimals="INF"
      id="Fact001136"
      unitRef="Pure">0.100</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:NotesPayable
      contextRef="AsOf2024-09-30_custom_AjeshKapoorFourMember"
      decimals="0"
      id="Fact001138"
      unitRef="USD">165000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="AsOf2024-09-30_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact001140"
      unitRef="USD">650000</us-gaap:NotesPayable>
    <us-gaap:NotesPayableCurrent
      contextRef="AsOf2024-09-30_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact001142"
      unitRef="USD">265000</us-gaap:NotesPayableCurrent>
    <us-gaap:LongTermNotesPayable
      contextRef="AsOf2024-09-30_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact001144"
      unitRef="USD">385000</us-gaap:LongTermNotesPayable>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact001146">&lt;p id="xdx_806_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zKZ9TthlTebk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
8 - &lt;span id="xdx_821_z6J69pwYLUc3"&gt;COMMITMENTS AND CONTINGENCIES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Settlement
Agreement &#x2013; Efficient Capital Labs, Inc&lt;/i&gt;.&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;On
May 18, 2023 SemiCab entered into a Installment Business Loan Agreement (&#x201c;IBLA&#x201d;) with a principal balance of $&lt;span id="xdx_906_ecustom--WorkingCapital_c20230518_zoanr5wg0cw7" title="Working capital"&gt;1,000,000&lt;/span&gt; with
Efficient Capital Labs, Inc. (&#x201c;ECL&#x201d;) to finance working capital and product development. The loan had a &lt;span id="xdx_90D_eus-gaap--DebtInstrumentTerm_dtM_c20230518__20230518_zEbrhORQ7q53" title="Maturity date"&gt;12&lt;/span&gt;-month maturity
date. Repayments were originally scheduled to begin in June 2023, in equal installments of $&lt;span id="xdx_904_eus-gaap--RepaymentsOfDebt_c20230601__20240630_z1xMeZq6nSb5"&gt;91,667&lt;/span&gt; for 13 months, with an interest rate
of &lt;span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20230518_zAeVUxjjjha" title="Interest rate"&gt;17.97&lt;/span&gt;%. On May 18, 2024, SemiCab entered into a settlement agreement (&#x201c;Settlement&#x201d;) with ECL. The terms of repayment are
as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;Payment:
Semicab shall pay to ECL the sum of $&lt;span id="xdx_900_eus-gaap--LitigationSettlementExpense_c20240518__20240518__us-gaap--AwardTypeAxis__custom--SettlementSumMember_z9y9C5tjqpCj" title="Payments of litigation"&gt;946,666&lt;/span&gt;USD (the &#x201c;Settlement Sum&#x201d;) as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;(a)
On or before May 20, 2024, Semicab shall pay ECL $&lt;span id="xdx_90E_eus-gaap--LitigationSettlementExpense_pn2d_c20240520__20240520__us-gaap--AwardTypeAxis__custom--InitialPaymentMember_zIYh4DuuEbN" title="Payments of litigation"&gt;25,000.00&lt;/span&gt; USD (the &#x201c;Initial Payment&#x201d;);&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;(b)
On or before June 3, 2024, Semicab shall pay ECL $&lt;span id="xdx_902_eus-gaap--LitigationSettlementExpense_pn2d_c20240603__20240603__us-gaap--AwardTypeAxis__custom--SecondPaymentMember_zlZWQR4WNKkf" title="Payments of litigation"&gt;75,000.00&lt;/span&gt; USD (the &#x201c;Second Payment&#x201d;);&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;(c)
On or before the first business day of each of the following ten (10) calendar months, starting July 1, 2024 Semicab shall pay ECL $&lt;span id="xdx_907_eus-gaap--LitigationSettlementExpense_c20240701__20250430__us-gaap--AwardTypeAxis__custom--AdditionalPaymentMember_zusq0o76wl5b" title="Payments of litigation"&gt;84,666&lt;/span&gt;
USD (the &#x201c;Additional Payments,&#x201d; and each an &#x201c;Additional Payment&#x201d;).&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;As
of September 30, 2024 the amount payable on the Settlement is $&lt;span id="xdx_90B_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_iI_c20240930_zWPg9hqGCcAd" title="Settlement amount payable"&gt;578,917&lt;/span&gt; and recorded as a component accrued expenses on the accompanying
condensed consolidated balance sheets.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Blue
Yonder, Inc. Lawsuit&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;Pursuant
to the asset purchase agreement with SemiCab, the Company assumed a judgement against SemiCab regarding damages resulting from contract
breach for IT subscription-based services. On March 28, 2020, SemiCab entered into a service contract and agreement with Blue Yonder,
Inc. (&#x201c;Blue Yonder&#x201d;) for certain IT subscription-based services. The original term of the agreement was for three years,
at a price of $&lt;span id="xdx_90D_ecustom--LossContingencyEstimateOfPossibleLossPerYear_iI_c20200328__dei--LegalEntityAxis__custom--BlueYonderIncMember_zi0JtbEYp8G" title="Loss contingency estimate of possible loss per year"&gt;100,000&lt;/span&gt; per year, for a total of $&lt;span id="xdx_90A_eus-gaap--LossContingencyEstimateOfPossibleLoss_iI_c20200328__dei--LegalEntityAxis__custom--BlueYonderIncMember_zjWKWP9m8Fli" title="Loss contingency estimate of possible loss value"&gt;300,000&lt;/span&gt;. On June 21, 2023, Blue Yonder filed a lawsuit claiming damages in the
amount of $&lt;span id="xdx_907_eus-gaap--LossContingencyDamagesSoughtValue_c20230621__20230621__dei--LegalEntityAxis__custom--BlueYonderIncMember_zBZ9PN4w1q26" title="Lawsuit claiming damages in the amount"&gt;275,000&lt;/span&gt; with the Maricopa County Superior Court in Arizona (&#x201c;Lawsuit&#x201d;). The suit was found in favor of Blue Yonder
in the amount of $&lt;span id="xdx_90A_eus-gaap--LossContingencyDamagesAwardedValue_c20230621__20230621__dei--LegalEntityAxis__custom--BlueYonderIncMember_zeNSsGDcrRMd" title="Milestone payments"&gt;509,119&lt;/span&gt;, subject to two separate milestone payments that would otherwise deem the entire balance due satisfied if either
milestone payment is made by the Company. The first milestone payment for $&lt;span id="xdx_90D_eus-gaap--LossContingencyDamagesPaidValue_c20240701__20240701__dei--LegalEntityAxis__custom--BlueYonderIncMember_zFqEklauQcY4" title="First milestone payment"&gt;175,000&lt;/span&gt; and was due on July 1, 2024 and was not made.
In the event this payment is made, the remaining settlement shall be deemed satisfied. If this payment is not made, the Company shall
owe a total of $&lt;span id="xdx_900_eus-gaap--LossContingencyDamagesAwardedValue_c20241001__20241001__dei--LegalEntityAxis__custom--BlueYonderIncMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z28PkGYqoi01" title="Remaining settlement amount"&gt;225,000&lt;/span&gt; by October 1, 2024. In the event this payment is made, the remaining settlement shall be deemed satisfied. If
neither payment is made, Blue Yonder shall be entitled to execute the full $&lt;span id="xdx_901_eus-gaap--LossContingencyDamagesAwardedValue_c20250101__20250101__dei--LegalEntityAxis__custom--BlueYonderIncMember__srt--StatementScenarioAxis__srt--ScenarioForecastMember_z01y7RtbvXn6" title="Loss contingency damages awarded value"&gt;509,119&lt;/span&gt; beginning January 1, 2025. As of the date of this
filing, none of the scheduled payments have been made. A liability of $&lt;span id="xdx_906_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_iI_c20240930__dei--LegalEntityAxis__custom--BlueYonderIncMember_z0Yw3fRw2GBa" title="Component of accrued expenses"&gt;509,119&lt;/span&gt; has been recorded as a component of accrued expenses on
the accompanying condensed consolidated balance sheets.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;ALGORHYTHM
                                            HOLDINGS, INC. and SUBSIDIARIES&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;September
30, 2024 and 2023&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Derivative
Action&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 21, 2023, Ault Lending, LLC, a wholly owned subsidiary of Ault Alliance, Inc. (&#x201c;Ault&#x201d;), one of the Company&#x2019;s
largest shareholders, filed a derivative shareholder action in Delaware Chancery Court against the Company, its Directors, and other
Company shareholders (The Stingray Group, Inc. and Regalia Ventures) (&#x201c;the Defendants&#x201d;) for alleged breach of fiduciary duty
in approving a recent above-market private placement equity transaction. The complaint alleges the Company, and its directors followed
an inadequate process in evaluating the private placement transaction which occurred back in November 2023 and entered into the transaction
with an intent to dilute Ault&#x2019;s ownership stake in the Company. The Company filed a motion to dismiss the complaint. Based on the
Company&#x2019;s assessment of the facts underlying the claims, the uncertainty of the litigation and the preliminary stage of the case,
the Company cannot reasonably estimate the potential loss or range of loss that may result from this action.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is involved in litigation arising from other matters in the ordinary course of business. The Company is subject to claims, suits
and other proceedings that could result in fines, civil penalties, or other adverse consequences. The Company records a liability when
it believes that it is probable that a loss has been incurred and the amount can be reasonably estimated. If the Company determines that
a loss is reasonably possible and the loss or range of loss can be estimated, the Company discloses the reasonably possible loss. The
Company evaluates developments in its legal matters that could affect the amount of liability that has been previously accrued, and the
matters and related reasonably possible losses disclosed, and makes adjustments as appropriate. Significant judgment is required to determine
both likelihood of there being and the estimated amount of a loss related to such matters.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <RIME:WorkingCapital
      contextRef="AsOf2023-05-18"
      decimals="0"
      id="Fact001148"
      unitRef="USD">1000000</RIME:WorkingCapital>
    <us-gaap:DebtInstrumentTerm contextRef="From2023-05-182023-05-18" id="Fact001150">P12M</us-gaap:DebtInstrumentTerm>
    <us-gaap:RepaymentsOfDebt
      contextRef="From2023-06-012024-06-30"
      decimals="0"
      id="Fact001151"
      unitRef="USD">91667</us-gaap:RepaymentsOfDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2023-05-18"
      decimals="INF"
      id="Fact001153"
      unitRef="Pure">0.1797</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LitigationSettlementExpense
      contextRef="From2024-05-182024-05-18_custom_SettlementSumMember"
      decimals="0"
      id="Fact001155"
      unitRef="USD">946666</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="From2024-05-202024-05-20_custom_InitialPaymentMember"
      decimals="-2"
      id="Fact001157"
      unitRef="USD">25000.00</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="From2024-06-032024-06-03_custom_SecondPaymentMember"
      decimals="-2"
      id="Fact001159"
      unitRef="USD">75000.00</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="From2024-07-012025-04-30_custom_AdditionalPaymentMember"
      decimals="0"
      id="Fact001161"
      unitRef="USD">84666</us-gaap:LitigationSettlementExpense>
    <us-gaap:AccruedLiabilitiesCurrentAndNoncurrent
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact001163"
      unitRef="USD">578917</us-gaap:AccruedLiabilitiesCurrentAndNoncurrent>
    <RIME:LossContingencyEstimateOfPossibleLossPerYear
      contextRef="AsOf2020-03-28_custom_BlueYonderIncMember"
      decimals="0"
      id="Fact001165"
      unitRef="USD">100000</RIME:LossContingencyEstimateOfPossibleLossPerYear>
    <us-gaap:LossContingencyEstimateOfPossibleLoss
      contextRef="AsOf2020-03-28_custom_BlueYonderIncMember"
      decimals="0"
      id="Fact001167"
      unitRef="USD">300000</us-gaap:LossContingencyEstimateOfPossibleLoss>
    <us-gaap:LossContingencyDamagesSoughtValue
      contextRef="From2023-06-212023-06-21_custom_BlueYonderIncMember"
      decimals="0"
      id="Fact001169"
      unitRef="USD">275000</us-gaap:LossContingencyDamagesSoughtValue>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="From2023-06-212023-06-21_custom_BlueYonderIncMember"
      decimals="0"
      id="Fact001171"
      unitRef="USD">509119</us-gaap:LossContingencyDamagesAwardedValue>
    <us-gaap:LossContingencyDamagesPaidValue
      contextRef="From2024-07-012024-07-01_custom_BlueYonderIncMember"
      decimals="0"
      id="Fact001173"
      unitRef="USD">175000</us-gaap:LossContingencyDamagesPaidValue>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="From2024-10-012024-10-01_custom_BlueYonderIncMember_us-gaap_SubsequentEventMember"
      decimals="0"
      id="Fact001175"
      unitRef="USD">225000</us-gaap:LossContingencyDamagesAwardedValue>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="From2025-01-012025-01-01_custom_BlueYonderIncMember_srt_ScenarioForecastMember"
      decimals="0"
      id="Fact001177"
      unitRef="USD">509119</us-gaap:LossContingencyDamagesAwardedValue>
    <us-gaap:AccruedLiabilitiesCurrentAndNoncurrent
      contextRef="AsOf2024-09-30_custom_BlueYonderIncMember"
      decimals="0"
      id="Fact001179"
      unitRef="USD">509119</us-gaap:AccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact001181">&lt;p id="xdx_802_eus-gaap--LesseeOperatingLeasesTextBlock_zOlnHNjODPwi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
9 &#x2013; &lt;span id="xdx_827_zbQZ3ywRu1gc"&gt;OPERATING LEASES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
the time of this filing, the Company has operating lease agreements for offices in Florida and Hong Kong.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;The
Company entered into an operating lease agreement, effective October 1, 2017, for our corporate headquarters located in Fort Lauderdale,
Florida where we lease approximately &lt;span id="xdx_901_eus-gaap--AreaOfLand_iI_pid_usqft_c20171001__us-gaap--TypeOfArrangementAxis__custom--OperatingLeaseAgreementMember_zZQ9CI6QWpqh" title="Lease space"&gt;6,500&lt;/span&gt; square feet of office space which expired on &lt;span id="xdx_904_eus-gaap--LeaseExpirationDate1_dd_c20171001__20171001__us-gaap--TypeOfArrangementAxis__custom--OperatingLeaseAgreementMember_z3llofSlHtEh" title="Lease expiration, date"&gt;March 31, 2024&lt;/span&gt;. On February 22, 2024, &lt;span id="xdx_901_eus-gaap--LesseeOperatingLeaseOptionToExtend_c20240222__20240222__us-gaap--TypeOfArrangementAxis__custom--OperatingLeaseAgreementMember_zx0EQbpNl5J" title="Lease extension, description"&gt;the Company
executed a lease extension for 14 months effective April 1, 2024, and expires on May 31, 2025. The base rent on the extension is approximately
$10,000 per month subject to a 3% annual adjustment.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;The
Company entered into an operating lease on August 23, 2023, for approximately &lt;span id="xdx_904_eus-gaap--AreaOfLand_iI_pid_usqft_c20230823__us-gaap--TypeOfArrangementAxis__custom--OperatingLeaseAgreementMember_zP3fgZuw8Tfa" title="Lease space"&gt;10,000&lt;/span&gt; square feet of ground floor retail space and a portion
of the basement underneath the ground floor retail space. During the nine months ended September 30, 2024, the Company abandoned its
plans to continue use of the leased space. On September 25, 2024, the Company entered into a Settlement Agreement for a full release
and termination of the Lease Agreement in exchange for Company&#x2019;s payment of $&lt;span id="xdx_909_eus-gaap--OperatingLeasePayments_c20240925__20240925__us-gaap--TypeOfArrangementAxis__custom--OperatingLeaseAgreementMember_zkvfwxkBMgvh" title="Operating lease payments"&gt;250,000&lt;/span&gt;. (See Note 2).&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_895_ecustom--ScheduleOfSupplementalInformationRelatedToLeaseTableTextBlock_zF3exgsWDJJa" style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Supplemental
balance sheet information related to leases as of September 30, 2024 and December 31, 2023 is as follows:&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B8_zcEQMBbha7gg" style="display: none"&gt;SCHEDULE
OF SUPPLEMENTAL INFORMATION RELATED TO LEASES&lt;/span&gt;&lt;/span&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&#160;&lt;/b&gt;&#160;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20240930_zhpj8U3NHW9g" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;September
    30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20231231_zVjcjeS3yFkb" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;December
    31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pp0p0_zTnGXcLX8Yab" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;Operating lease - right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;137,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;3,926,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--OperatingLeaseLiabilityAbstract_iB_zcnf2xz6jF33" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--OperatingLeaseLiabilityCurrent_i01I_pp0p0_zlNcwoHuOZt9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;Current portion of operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;135,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;84,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--OperatingLeaseLiabilityNoncurrent_i01I_pp0p0_zaOP6csvSWB2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;Operating lease liabilities, net of
    current portion&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1204"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;3,925,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AD_z3JWMDPUr4Lf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;/p&gt;

&lt;p id="xdx_89F_eus-gaap--LeaseCostTableTextBlock_z1pV0GUJUfB1" style="font: bold 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;Supplemental
statement of operations information related to operating leases is as follows:&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B6_zif9s7e8i4Od" style="display: none"&gt;SCHEDULE
OF LEASE TERM AND DISCOUNT RATE&lt;/span&gt;&lt;/span&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20240701__20240930_zIaWt9EvW5ea" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;Three
    Months Ended September 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20230701__20230930_zkOg9rK0SLy4" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;Three
    Months Ended September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20240101__20240930_zXlYiL5chsM5" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;Nine
    Months Ended September 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20230101__20230930_zwFIrEm7eQNk" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;Nine
    Months Ended September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--OperatingLeaseExpense_zMgjefZg42ab" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 44%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;Operating lease expense as a component of general
    and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;45,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;279,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;444,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;762,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--CashFlowOperatingActivitiesLesseeAbstract_iB_zi0QkZuopnX1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;Supplemental cash flow information related to operating
    leases is as follows:&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;Cash paid for amounts included in the measurement of lease
    liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--OperatingLeasePayments_i01_zlWk7e7NPjg1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;Operating cash flow paid for operating
    leases&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;45,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;363,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;136,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;868,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--LeaseCostAbstract_iB_zVeWmJne5YQ6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;Lease term and Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;Weighted average remaining lease term
    (years)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_i01I_dtY_c20240930_zRklYVwN8Rk4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average remaining lease term (months)"&gt;&lt;span style="-sec-ix-redline: true"&gt;0.8&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_i01I_dtY_c20230930_zctYiIdy9umd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average remaining lease term (months)"&gt;&lt;span style="-sec-ix-redline: true"&gt;15.1&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_i01I_dp_uPure_c20240930_zoascLyeW4fc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average discount rate"&gt;&lt;span style="-sec-ix-redline: true"&gt;9.0&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_i01I_dp_uPure_c20230930_zhUaArmGSe5l" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average discount rate"&gt;&lt;span style="-sec-ix-redline: true"&gt;12.0&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AC_zAoXCi3OAC8b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;ALGORHYTHM
                                            HOLDINGS, INC. and SUBSIDIARIES&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;September
30, 2024 and 2023&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89D_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_z0VHfRfhtwL4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Minimum
future payments under all operating leases as of September 30, 2024, are as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;span id="xdx_8BC_zcqX8rDCZpgj" style="display: none"&gt;SCHEDULE
OF OPERATING LEASE MINIMUM FUTURE PAYMENTS&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;Payments due by period&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20240930_zHKj1Dre9ynh" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_iI_maLOLLPzbAO_zQ6I9RaOBx82" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 80%"&gt;&lt;span style="-sec-ix-redline: true"&gt;2024 (remaining six months)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;46,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_maLOLLPzbAO_zrNYz1Se4UA" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;94,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_mtLOLLPzbAO_zRAFXg7raWI5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;Total minimum future payments&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;140,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iI_zVxOUgnXjOb2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;Less: Interest&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;5,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--OperatingLeaseLiability_iI_zRgxvCoHTA8e" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt; padding-left: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;Total operating
    lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;135,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A1_zVBIIm1h7ry1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:AreaOfLand
      contextRef="AsOf2017-10-01_custom_OperatingLeaseAgreementMember"
      decimals="INF"
      id="Fact001183"
      unitRef="sqft">6500</us-gaap:AreaOfLand>
    <us-gaap:LeaseExpirationDate1
      contextRef="From2017-10-012017-10-01_custom_OperatingLeaseAgreementMember"
      id="Fact001185">2024-03-31</us-gaap:LeaseExpirationDate1>
    <us-gaap:LesseeOperatingLeaseOptionToExtend
      contextRef="From2024-02-222024-02-22_custom_OperatingLeaseAgreementMember"
      id="Fact001187">the Company
executed a lease extension for 14 months effective April 1, 2024, and expires on May 31, 2025. The base rent on the extension is approximately
$10,000 per month subject to a 3% annual adjustment.</us-gaap:LesseeOperatingLeaseOptionToExtend>
    <us-gaap:AreaOfLand
      contextRef="AsOf2023-08-23_custom_OperatingLeaseAgreementMember"
      decimals="INF"
      id="Fact001189"
      unitRef="sqft">10000</us-gaap:AreaOfLand>
    <us-gaap:OperatingLeasePayments
      contextRef="From2024-09-252024-09-25_custom_OperatingLeaseAgreementMember"
      decimals="0"
      id="Fact001191"
      unitRef="USD">250000</us-gaap:OperatingLeasePayments>
    <RIME:ScheduleOfSupplementalInformationRelatedToLeaseTableTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact001193">&lt;p id="xdx_895_ecustom--ScheduleOfSupplementalInformationRelatedToLeaseTableTextBlock_zF3exgsWDJJa" style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Supplemental
balance sheet information related to leases as of September 30, 2024 and December 31, 2023 is as follows:&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B8_zcEQMBbha7gg" style="display: none"&gt;SCHEDULE
OF SUPPLEMENTAL INFORMATION RELATED TO LEASES&lt;/span&gt;&lt;/span&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&#160;&lt;/b&gt;&#160;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20240930_zhpj8U3NHW9g" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;September
    30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20231231_zVjcjeS3yFkb" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;December
    31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pp0p0_zTnGXcLX8Yab" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;Operating lease - right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;137,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;3,926,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--OperatingLeaseLiabilityAbstract_iB_zcnf2xz6jF33" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--OperatingLeaseLiabilityCurrent_i01I_pp0p0_zlNcwoHuOZt9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;Current portion of operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;135,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;84,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--OperatingLeaseLiabilityNoncurrent_i01I_pp0p0_zaOP6csvSWB2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;Operating lease liabilities, net of
    current portion&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1204"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;3,925,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</RIME:ScheduleOfSupplementalInformationRelatedToLeaseTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact001195"
      unitRef="USD">137000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001196"
      unitRef="USD">3926000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact001201"
      unitRef="USD">135000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001202"
      unitRef="USD">84000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001205"
      unitRef="USD">3925000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LeaseCostTableTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact001207">&lt;p id="xdx_89F_eus-gaap--LeaseCostTableTextBlock_z1pV0GUJUfB1" style="font: bold 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;Supplemental
statement of operations information related to operating leases is as follows:&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B6_zif9s7e8i4Od" style="display: none"&gt;SCHEDULE
OF LEASE TERM AND DISCOUNT RATE&lt;/span&gt;&lt;/span&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20240701__20240930_zIaWt9EvW5ea" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;Three
    Months Ended September 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20230701__20230930_zkOg9rK0SLy4" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;Three
    Months Ended September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20240101__20240930_zXlYiL5chsM5" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;Nine
    Months Ended September 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20230101__20230930_zwFIrEm7eQNk" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;Nine
    Months Ended September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--OperatingLeaseExpense_zMgjefZg42ab" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 44%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;Operating lease expense as a component of general
    and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;45,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;279,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;444,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;762,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--CashFlowOperatingActivitiesLesseeAbstract_iB_zi0QkZuopnX1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;Supplemental cash flow information related to operating
    leases is as follows:&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;Cash paid for amounts included in the measurement of lease
    liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--OperatingLeasePayments_i01_zlWk7e7NPjg1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;Operating cash flow paid for operating
    leases&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;45,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;363,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;136,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;868,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--LeaseCostAbstract_iB_zVeWmJne5YQ6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;Lease term and Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;Weighted average remaining lease term
    (years)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_i01I_dtY_c20240930_zRklYVwN8Rk4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average remaining lease term (months)"&gt;&lt;span style="-sec-ix-redline: true"&gt;0.8&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_i01I_dtY_c20230930_zctYiIdy9umd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average remaining lease term (months)"&gt;&lt;span style="-sec-ix-redline: true"&gt;15.1&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_i01I_dp_uPure_c20240930_zoascLyeW4fc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average discount rate"&gt;&lt;span style="-sec-ix-redline: true"&gt;9.0&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_i01I_dp_uPure_c20230930_zhUaArmGSe5l" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average discount rate"&gt;&lt;span style="-sec-ix-redline: true"&gt;12.0&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseExpense
      contextRef="From2024-07-012024-09-30"
      decimals="0"
      id="Fact001209"
      unitRef="USD">45000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="From2023-07-012023-09-30"
      decimals="0"
      id="Fact001210"
      unitRef="USD">279000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact001211"
      unitRef="USD">444000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact001212"
      unitRef="USD">762000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeasePayments
      contextRef="From2024-07-012024-09-30"
      decimals="0"
      id="Fact001219"
      unitRef="USD">45000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="From2023-07-012023-09-30"
      decimals="0"
      id="Fact001220"
      unitRef="USD">363000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact001221"
      unitRef="USD">136000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact001222"
      unitRef="USD">868000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="AsOf2024-09-30" id="Fact001229">P0Y9M18D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="AsOf2023-09-30" id="Fact001231">P15Y1M6D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="AsOf2024-09-30"
      decimals="INF"
      id="Fact001233"
      unitRef="Pure">0.090</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="AsOf2023-09-30"
      decimals="INF"
      id="Fact001235"
      unitRef="Pure">0.120</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact001237">&lt;p id="xdx_89D_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_z0VHfRfhtwL4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Minimum
future payments under all operating leases as of September 30, 2024, are as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;span id="xdx_8BC_zcqX8rDCZpgj" style="display: none"&gt;SCHEDULE
OF OPERATING LEASE MINIMUM FUTURE PAYMENTS&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;Payments due by period&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20240930_zHKj1Dre9ynh" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_iI_maLOLLPzbAO_zQ6I9RaOBx82" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 80%"&gt;&lt;span style="-sec-ix-redline: true"&gt;2024 (remaining six months)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;46,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_maLOLLPzbAO_zrNYz1Se4UA" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;94,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_mtLOLLPzbAO_zRAFXg7raWI5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;Total minimum future payments&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;140,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iI_zVxOUgnXjOb2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;Less: Interest&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;5,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--OperatingLeaseLiability_iI_zRgxvCoHTA8e" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt; padding-left: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;Total operating
    lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;135,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact001239"
      unitRef="USD">46000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact001241"
      unitRef="USD">94000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact001243"
      unitRef="USD">140000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact001245"
      unitRef="USD">5000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact001247"
      unitRef="USD">135000</us-gaap:OperatingLeaseLiability>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact001249">&lt;p id="xdx_80E_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zG6alrsOQtU9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
10 &#x2013; &lt;span id="xdx_824_z8pagMj79AEl"&gt;ISSUANCE OF COMMON STOCK&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Equity
Incentive Plan&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;On
April 12, 2022, the Board of Directors approved The Singing Machine Company, Inc. 2022 Equity Incentive Plan, or the 2022 Plan. The 2022
Plan provides for the issuance of equity incentive awards, such as stock options, stock appreciation rights, stock awards, restricted
stock, stock units, performance awards and other stock or cash-based awards collectively, the &#x201c;Awards.&#x201d; Awards may be granted
under the 2022 Plan to the Company&#x2019;s employees, officers, directors, consultants, agents, advisors and independent contractors.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;There
were &lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20240101__20240930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zisABCkgWfN5" title="Share base compensation issued shares"&gt;&lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20240701__20240930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zYmZnZZSrlZa" title="Share base compensation issued shares"&gt;150,943&lt;/span&gt;&lt;/span&gt;
share base compensation awards issued under the 2022 Plan during the three and nine months ended September 30, 2024 with a weighted average grant date fair value of $&lt;span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20240701__20240930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zWCjtrAmtrV4" title="Weighted average grant date fair value"&gt;&lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20240101__20240930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zC5QGhT1F8Jl" title="Weighted average grant date fair value"&gt;0.55&lt;/span&gt;&lt;/span&gt; per share. There were &lt;span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_do_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zWOnrMwWdR3d" title="Share base compensation issued shares"&gt;&lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_do_c20230701__20230930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zeT29ymfHjz2" title="Share base compensation issued shares"&gt;no&lt;/span&gt;&lt;/span&gt;
share base compensation awards issued under the 2022 Plan during the three and nine months ended September 30, 2023. There were &lt;span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20240701__20240930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zOw3t9YtHrDd" title="Share base compensation forfeited shares"&gt;1,250&lt;/span&gt;
and &lt;span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20240101__20240930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zdE7JQ8gAsW6" title="Share base compensation forfeited shares"&gt;6,500&lt;/span&gt;
shares forfeited during the three and nine months ended September 30, 2024, respectively. There were &lt;span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_do_c20230701__20230930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zchqtSocrl0g" title="Share base compensation forfeited shares"&gt;&lt;span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_do_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zLyXbmnu4QZk" title="Share base compensation forfeited shares"&gt;no&lt;/span&gt;&lt;/span&gt;
shares forfeited during the three and nine months ended September 30, 2023. As of September 30, 2024, there were &lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20240930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zWe8aTwLyFg2" title="Number of shares available to issued"&gt;63,453&lt;/span&gt;
shares available to be issued under the 2022 Plan.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;Equity compensation under the 2022 Plan was approximately $&lt;span id="xdx_905_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_c20240701__20240930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zU3Fq1TyUcEg" title="Equity compensation"&gt;101,000&lt;/span&gt; and
$&lt;span id="xdx_90C_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_c20240101__20240930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zR5IFzmkKCO9" title="Equity compensation"&gt;138,000&lt;/span&gt; during the three and nine months ended September 30, 2024 and was expensed as a component of general administrative expenses
on the accompanying condensed consolidated statements of operations. As
of September 30, 2024, there was an unrecognized expense of approximately $&lt;span id="xdx_907_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_c20240930_zdxlVYPGXUuh" title="Unrecognised expense"&gt;50,000&lt;/span&gt; remaining on options currently vesting over time with
an approximate weighted average of &lt;span id="xdx_906_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dc_c20240101__20240930_z3BAvLIP2v1a" title="Weighted average term"&gt;twelve months&lt;/span&gt; remaining until these options are fully vested.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;The
vested options as of September 30, 2024, had &lt;span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_do_c20240930_zqMbKMC4BkHh" title="Vested options intrinsic value"&gt;no&lt;/span&gt; intrinsic value.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Other
Equity Compensation&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;During
the three and nine months ended September 30, 2024, the Company issued &lt;span id="xdx_902_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardGross_c20240101__20240930_zfCdjqI40XQk"&gt;774,528
&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of common stock to three vendors for payment
of consulting services rendered and &lt;span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20240101__20240930_zzHpMV3yOXU6"&gt;94,340
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;for restricted shares of common stock to Vivek
Sehgal (a related party) as bonus compensation (See Note 5). The grant date fair value for all of these share issuances was approximately
$&lt;span id="xdx_908_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20240101__20240930__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zSXLZymTeMUl"&gt;478,000
&lt;/span&gt;&lt;/span&gt;and were expensed as a component of general and
administrative expenses on the accompanying condensed consolidated statements of operations during the three and nine months ended September
30, 2024. These shares vest immediately but must be held for a minimum of six months in accordance with Securities Exchange Commission
Rule 144.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="From2024-01-012024-09-30_custom_TwoThousandTwentyTwoPlanMember"
      decimals="INF"
      id="Fact001251"
      unitRef="Shares">150943</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="From2024-07-012024-09-30_custom_TwoThousandTwentyTwoPlanMember"
      decimals="INF"
      id="Fact001253"
      unitRef="Shares">150943</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2024-07-012024-09-30_custom_TwoThousandTwentyTwoPlanMember"
      decimals="INF"
      id="Fact001255"
      unitRef="USDPShares">0.55</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2024-01-012024-09-30_custom_TwoThousandTwentyTwoPlanMember"
      decimals="INF"
      id="Fact001257"
      unitRef="USDPShares">0.55</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="From2023-01-012023-09-30_custom_TwoThousandTwentyTwoPlanMember"
      decimals="INF"
      id="Fact001259"
      unitRef="Shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="From2023-07-012023-09-30_custom_TwoThousandTwentyTwoPlanMember"
      decimals="INF"
      id="Fact001261"
      unitRef="Shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
      contextRef="From2024-07-012024-09-30_custom_TwoThousandTwentyTwoPlanMember"
      decimals="INF"
      id="Fact001263"
      unitRef="Shares">1250</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
      contextRef="From2024-01-012024-09-30_custom_TwoThousandTwentyTwoPlanMember"
      decimals="INF"
      id="Fact001265"
      unitRef="Shares">6500</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
      contextRef="From2023-07-012023-09-30_custom_TwoThousandTwentyTwoPlanMember"
      decimals="INF"
      id="Fact001267"
      unitRef="Shares">0</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
      contextRef="From2023-01-012023-09-30_custom_TwoThousandTwentyTwoPlanMember"
      decimals="INF"
      id="Fact001269"
      unitRef="Shares">0</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="AsOf2024-09-30_custom_TwoThousandTwentyTwoPlanMember"
      decimals="INF"
      id="Fact001271"
      unitRef="Shares">63453</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:EmployeeBenefitsAndShareBasedCompensation
      contextRef="From2024-07-012024-09-30_custom_TwoThousandTwentyTwoPlanMember_us-gaap_GeneralAndAdministrativeExpenseMember"
      decimals="0"
      id="Fact001273"
      unitRef="USD">101000</us-gaap:EmployeeBenefitsAndShareBasedCompensation>
    <us-gaap:EmployeeBenefitsAndShareBasedCompensation
      contextRef="From2024-01-012024-09-30_custom_TwoThousandTwentyTwoPlanMember_us-gaap_GeneralAndAdministrativeExpenseMember"
      decimals="0"
      id="Fact001275"
      unitRef="USD">138000</us-gaap:EmployeeBenefitsAndShareBasedCompensation>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact001277"
      unitRef="USD">50000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="From2024-01-01to2024-09-30" id="Fact001279">P12M</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact001281"
      unitRef="USD">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact001282"
      unitRef="USD">774528</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2024-01-01to2024-09-30"
      decimals="INF"
      id="Fact001283"
      unitRef="Shares">94340</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2024-01-012024-09-30_us-gaap_GeneralAndAdministrativeExpenseMember"
      decimals="0"
      id="Fact001284"
      unitRef="USD">478000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <RIME:WarrantsDisclosureTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact001286">&lt;p id="xdx_801_ecustom--WarrantsDisclosureTextBlock_zqaEvcPXt8Nh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
11 - &lt;span id="xdx_822_zsppuSeBjha3"&gt;WARRANTS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Common
warrants issued and outstanding as of September 30, 2024 and December 31, 2023, were &lt;span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20231231_zGakUkBcFVT5"&gt;902,113&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;.
There were no changes in the warrants outstanding during the period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_890_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zYYHPpTStg96" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of September 30, 2024, the Company&#x2019;s warrants by expiration date were as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_8B9_z53HeMr0u9Ue" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;SCHEDULE
OF WARRANTS EXPIRATION&lt;/span&gt;&lt;/span&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;Number of
    &lt;br/&gt;
    Common Warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;Exercise
    Price&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;Expiration Date&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zZ9riAbr0ne4" style="font: 10pt Times New Roman, Times, Serif; width: 30%; text-align: right" title="Number of common warrants"&gt;&lt;span style="-sec-ix-redline: true"&gt;802,113&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zQOms2NMpzql" style="font: 10pt Times New Roman, Times, Serif; width: 30%; text-align: right" title="Warrant exercise price"&gt;&lt;span style="-sec-ix-redline: true"&gt;2.80&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 32%"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_906_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zAhRqajSZPL5"&gt;September
    15, 2026&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zLaBM9JTpt0j" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of common warrants"&gt;&lt;span style="-sec-ix-redline: true"&gt;100,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zAKLtDoLbeSe" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right" title="Warrant Exercise Price"&gt;&lt;span style="-sec-ix-redline: true"&gt;5.00&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_902_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zF2QLVbDK9Ph"&gt;May
    23, 2027&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20240930_z94gW3N03BR7" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Common Warrants"&gt;&lt;span style="-sec-ix-redline: true"&gt;902,113&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A3_zU5PGS9xsu82" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;ALGORHYTHM
                                            HOLDINGS, INC. and SUBSIDIARIES&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;September
30, 2024 and 2023&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

</RIME:WarrantsDisclosureTextBlock>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact001287"
      unitRef="Shares">902113</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact001289">&lt;p id="xdx_890_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zYYHPpTStg96" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of September 30, 2024, the Company&#x2019;s warrants by expiration date were as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_8B9_z53HeMr0u9Ue" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;SCHEDULE
OF WARRANTS EXPIRATION&lt;/span&gt;&lt;/span&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;Number of
    &lt;br/&gt;
    Common Warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;Exercise
    Price&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;Expiration Date&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zZ9riAbr0ne4" style="font: 10pt Times New Roman, Times, Serif; width: 30%; text-align: right" title="Number of common warrants"&gt;&lt;span style="-sec-ix-redline: true"&gt;802,113&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zQOms2NMpzql" style="font: 10pt Times New Roman, Times, Serif; width: 30%; text-align: right" title="Warrant exercise price"&gt;&lt;span style="-sec-ix-redline: true"&gt;2.80&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 32%"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_906_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zAhRqajSZPL5"&gt;September
    15, 2026&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zLaBM9JTpt0j" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of common warrants"&gt;&lt;span style="-sec-ix-redline: true"&gt;100,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zAKLtDoLbeSe" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right" title="Warrant Exercise Price"&gt;&lt;span style="-sec-ix-redline: true"&gt;5.00&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_902_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zF2QLVbDK9Ph"&gt;May
    23, 2027&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20240930_z94gW3N03BR7" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Common Warrants"&gt;&lt;span style="-sec-ix-redline: true"&gt;902,113&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2024-09-30_custom_ExercisePriceRangeOneMember"
      decimals="INF"
      id="Fact001291"
      unitRef="Shares">802113</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-09-30_custom_ExercisePriceRangeOneMember"
      decimals="INF"
      id="Fact001293"
      unitRef="USDPShares">2.80</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingMaturityDate
      contextRef="AsOf2024-09-30_custom_ExercisePriceRangeOneMember"
      id="Fact001294">2026-09-15</us-gaap:WarrantsAndRightsOutstandingMaturityDate>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2024-09-30_custom_ExercisePriceRangeTwoMember"
      decimals="INF"
      id="Fact001296"
      unitRef="Shares">100000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-09-30_custom_ExercisePriceRangeTwoMember"
      decimals="INF"
      id="Fact001298"
      unitRef="USDPShares">5.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingMaturityDate
      contextRef="AsOf2024-09-30_custom_ExercisePriceRangeTwoMember"
      id="Fact001299">2027-05-23</us-gaap:WarrantsAndRightsOutstandingMaturityDate>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2024-09-30"
      decimals="INF"
      id="Fact001301"
      unitRef="Shares">902113</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:EarningsPerShareTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact001303">&lt;p id="xdx_80F_eus-gaap--EarningsPerShareTextBlock_zgLzrlm0sfe3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
12 - &lt;span id="xdx_825_zOxH3ZfwUyFc"&gt;COMPUTATION OF LOSS PER SHARE&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_896_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zjxa6pA9SB0j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Computation
of basic and dilutive loss per share for the three and nine months ended September 30, 2024 and 2023 are as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_8BA_z8u1VjiPbD3h" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;SCHEDULE
OF BASIC AND DILUTIVE LOSS PER SHARE&lt;/span&gt;&lt;/span&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20240701__20240930_zh24815XKJY7" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;For
    the three months ended September 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20230701__20230930_ziiKRIrQbrTa" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;For
    the three months ended September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20240101__20240930_zUVz7oKTpjE8" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;For
    the nine months ended September 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20230101__20230930_zUwyUSQWrji4" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;For
    the nine months ended September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_zMR8qGvPQ0Oh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;Net income (loss) available to common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;1,195,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;97,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;(7,292,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;(5,348,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;Weighted-average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_908_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240701__20240930_zjKkO8HXtnNg"&gt;9,095,504&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_90C_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230701__20230930_zLd81j8FJH4k"&gt;4,220,259&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_90E_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240101__20240930_zrFewd9yDsbh"&gt;7,341,204&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_902_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230101__20230930_zKs9K6QYqox3"&gt;3,726,259&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;Basic and diluted income (loss)
    per share&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_907_eus-gaap--EarningsPerShareDiluted_pid_c20240701__20240930_znNJ4haozmeg"&gt;0.13&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_90A_eus-gaap--EarningsPerShareDiluted_pid_c20230701__20230930_z2Ttkzw559F8"&gt;0.03&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_pid_c20240101__20240930_zSUx8zUrNY85"&gt;(0.99&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_907_eus-gaap--EarningsPerShareDiluted_pid_c20230101__20230930_zoHdFLPdoQJl"&gt;(1.44&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AA_zVzkdLWCH937" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Basic
net loss per share is based on the weighted average number of shares of common stock outstanding during the period. Diluted net loss
per share reflects the potential dilution assuming shares of common stock were issued upon the exercise of outstanding in-the-money options
and the proceeds thereof were used to purchase shares of the Company&#x2019;s common stock at the average market price during the period
using the treasury stock method.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;For
the three and nine months ended September 30, 2024 and 2023, options to purchase &lt;span id="xdx_906_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240701__20240930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zHUcVtTE0vN9" title="Potentially dilutive securities"&gt;&lt;span id="xdx_900_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240101__20240930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zveLJGSzuoq6" title="Potentially dilutive securities"&gt;98,178&lt;/span&gt;&lt;/span&gt; and &lt;span id="xdx_908_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230701__20230930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zJ3qTurI64Th" title="Potentially dilutive securities"&gt;&lt;span id="xdx_90C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20230930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zbzTFvh5tmxd" title="Potentially dilutive securities"&gt;91,261&lt;/span&gt;&lt;/span&gt; shares of common stock, respectively
and options to purchase &lt;span id="xdx_901_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240101__20240930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zprMrhM6lpa4" title="Potentially dilutive securities"&gt;&lt;span id="xdx_903_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20230930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zoT2RYqlWQM5" title="Potentially dilutive securities"&gt;902,113&lt;/span&gt;&lt;/span&gt; common stock warrants for both September 30, 2024 and 2023 were excluded in the calculation of diluted
net loss per share as the result would have been anti-dilutive.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact001305">&lt;p id="xdx_896_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zjxa6pA9SB0j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Computation
of basic and dilutive loss per share for the three and nine months ended September 30, 2024 and 2023 are as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_8BA_z8u1VjiPbD3h" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;SCHEDULE
OF BASIC AND DILUTIVE LOSS PER SHARE&lt;/span&gt;&lt;/span&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20240701__20240930_zh24815XKJY7" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;For
    the three months ended September 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20230701__20230930_ziiKRIrQbrTa" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;For
    the three months ended September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20240101__20240930_zUVz7oKTpjE8" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;For
    the nine months ended September 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20230101__20230930_zUwyUSQWrji4" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;For
    the nine months ended September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_zMR8qGvPQ0Oh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;Net income (loss) available to common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;1,195,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;97,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;(7,292,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;(5,348,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;Weighted-average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_908_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240701__20240930_zjKkO8HXtnNg"&gt;9,095,504&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_90C_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230701__20230930_zLd81j8FJH4k"&gt;4,220,259&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_90E_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240101__20240930_zrFewd9yDsbh"&gt;7,341,204&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_902_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230101__20230930_zKs9K6QYqox3"&gt;3,726,259&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;Basic and diluted income (loss)
    per share&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_907_eus-gaap--EarningsPerShareDiluted_pid_c20240701__20240930_znNJ4haozmeg"&gt;0.13&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_90A_eus-gaap--EarningsPerShareDiluted_pid_c20230701__20230930_z2Ttkzw559F8"&gt;0.03&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_pid_c20240101__20240930_zSUx8zUrNY85"&gt;(0.99&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_907_eus-gaap--EarningsPerShareDiluted_pid_c20230101__20230930_zoHdFLPdoQJl"&gt;(1.44&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2024-07-012024-09-30"
      decimals="0"
      id="Fact001307"
      unitRef="USD">1195000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2023-07-012023-09-30"
      decimals="0"
      id="Fact001308"
      unitRef="USD">97000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact001309"
      unitRef="USD">-7292000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact001310"
      unitRef="USD">-5348000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2024-07-012024-09-30"
      decimals="INF"
      id="Fact001311"
      unitRef="Shares">9095504</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-07-012023-09-30"
      decimals="INF"
      id="Fact001312"
      unitRef="Shares">4220259</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2024-01-01to2024-09-30"
      decimals="INF"
      id="Fact001313"
      unitRef="Shares">7341204</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-01-012023-09-30"
      decimals="INF"
      id="Fact001314"
      unitRef="Shares">3726259</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2024-07-012024-09-30"
      decimals="INF"
      id="Fact001315"
      unitRef="USDPShares">0.13</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-07-012023-09-30"
      decimals="INF"
      id="Fact001316"
      unitRef="USDPShares">0.03</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2024-01-01to2024-09-30"
      decimals="INF"
      id="Fact001317"
      unitRef="USDPShares">-0.99</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-01-012023-09-30"
      decimals="INF"
      id="Fact001318"
      unitRef="USDPShares">-1.44</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2024-07-012024-09-30_us-gaap_EmployeeStockOptionMember"
      decimals="INF"
      id="Fact001320"
      unitRef="Shares">98178</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2024-01-012024-09-30_us-gaap_EmployeeStockOptionMember"
      decimals="INF"
      id="Fact001322"
      unitRef="Shares">98178</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2023-07-012023-09-30_us-gaap_EmployeeStockOptionMember"
      decimals="INF"
      id="Fact001324"
      unitRef="Shares">91261</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2023-01-012023-09-30_us-gaap_EmployeeStockOptionMember"
      decimals="INF"
      id="Fact001326"
      unitRef="Shares">91261</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2024-01-012024-09-30_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact001328"
      unitRef="Shares">902113</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2023-01-012023-09-30_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact001330"
      unitRef="Shares">902113</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact001332">&lt;p id="xdx_802_eus-gaap--IncomeTaxDisclosureTextBlock_zZAI7n5zRZwk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
13 - &lt;span id="xdx_828_zkrkiJ97izB8"&gt;INCOME TAXES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;For
the three months ended September 30, 2024 and 2023 the Company did &lt;span id="xdx_908_eus-gaap--IncomeTaxExpenseBenefit_dxL_c20240701__20240930_z4gmrTXfCyZb" title="Income tax (benefit) provision::XDX::-"&gt;&lt;span id="xdx_900_eus-gaap--IncomeTaxExpenseBenefit_dxL_c20230701__20230930_zVhSk3kPnPua" title="Income tax (benefit) provision::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1334"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1336"&gt;no&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;t recognize income tax provision as the Company is not forecasting
any taxable income for the current year and had a loss before income tax benefit in the previous year. The Company&#x2019;s income tax
provision for the nine months ended September 30, 2023, was approximately $&lt;span id="xdx_905_eus-gaap--IncomeTaxExpenseBenefit_c20230101__20230930_zn4DY84d9sle" title="Income Tax (benefit) provision"&gt;1,502,000&lt;/span&gt; as the Company recognized a valuation reserve of
all of its deferred tax assets based on the recent history of losses and forecasts that suggested the Company would not be able to utilize
the deferred tax assets in the future.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s income tax expense differs from the expected tax benefit/expense based on statutory rates primarily due to full valuation
allowance for all of its subsidiaries for the three and nine months ended September 30, 2024 and 2023.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact001338"
      unitRef="USD">1502000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact001340">&lt;p id="xdx_80A_eus-gaap--SegmentReportingDisclosureTextBlock_zLcwUk2Rv7ei" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
14 &#x2013; &lt;span id="xdx_822_zubLELtErhoc"&gt;REVENUE DISAGGREGATION&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company disaggregates revenues by product line and major geographic region as most of its revenue is generated by the sales of karaoke
hardware and the Company has no other material business segments:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89C_eus-gaap--DisaggregationOfRevenueTableTextBlock_zWgjDe6nNgVk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;Revenue
by product line is as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_8B1_z1QfDZZPjWcj" style="display: none"&gt;SCHEDULE
OF REVENUE BY PRODUCT LINE&lt;/span&gt;&lt;/span&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; display: none"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_49C_20240701__20240930_zCzew3xSqc4e" style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; display: none"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_49D_20230701__20230930_zjZ5ZFJYFCAh" style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; display: none"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_496_20240101__20240930_zlQrx7BexgF8" style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; display: none"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_492_20230101__20230930_z8GQqm0u6BOa" style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="5" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;Three
                                            Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="5" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;Nine
                                            Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;Product Line&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;September
                                            30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="-sec-ix-redline: true"&gt;September
                                            30, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;September
                                            30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="-sec-ix-redline: true"&gt;September
                                            30, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--ClassicKaraokeMachinesMember_zvmUzb0BQWy8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 28%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;Classic Karaoke Machines&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;8,218,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;14,636,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;10,521,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;17,363,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--LicensedProductsMember_zcRM22HViYWg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;Licensed Products&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;180,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;36,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;377,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;32,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--KidsYouthElectronicsMember_zBaA3BsGGST6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;Kids Youth Electronics&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;379,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;297,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;546,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;451,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--MicrophonesAndAccessoriesMember_zlifGfjGdIQ3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;Microphones and Accessories&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;1,500,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;806,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;3,329,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;3,543,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--MusicSubscriptionsMember_z9JfG6qqdHl4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;Music Subscriptions&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;218,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;156,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;588,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;550,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--LogisticsServicesMember_zhP1KbZNMlna" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;Logistics Services&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;127,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1370"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;127,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1372"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--Revenues_z2nmXoH7wJHb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;Total Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;10,622,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;15,931,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;15,488,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;21,939,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AA_zEwzKYRBIG99" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;ALGORHYTHM
HOLDINGS, INC. and SUBSIDIARIES&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;September
30, 2024 and 2023&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_892_eus-gaap--ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_zUw7jGOtOBdj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Sales
by geographic region for the periods presented are as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_8BA_zyyjRYaDDCrk" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;SCHEDULE
OF SALES BY GEOGRAPHICAL REGION&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; display: none"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; display: none"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_496_20240701__20240930_z7UpUTsSdPv8" style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; display: none"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_497_20230701__20230930_zPB2ZINp0KB8" style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; display: none"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_497_20240101__20240930_zatNM73nEHe1" style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; display: none"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_498_20230101__20230930_zyDFJQGqHp6b" style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Three
    Months Ended&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Nine
    Months Ended&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;September
    30, 2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;September
    30, 2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;September
    30, 2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;September
    30, 2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--Revenues_hsrt--StatementGeographicalAxis__srt--NorthAmericaMember_z12ApUNYOplf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 28%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;North
    America&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10,466,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;15,378,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;15,208,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;21,386,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--Revenues_hsrt--StatementGeographicalAxis__country--AU_zeia9sW3VEha" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Australia&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;50,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;263,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;174,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;263,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--Revenues_hsrt--StatementGeographicalAxis__srt--EuropeMember_zLH57oVPdK82" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Europe&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;106,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;290,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;106,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;290,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--Revenues_zs8zxZUzacD" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total
    Net Sales&lt;/span&gt;&lt;/span&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10,622,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;15,931,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;15,488,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;21,939,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A9_zkuPpWT8a4K9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;The
Company selectively participates in a retailer&#x2019;s co-op promotion incentives by providing marketing fund allowances to its customers.
As these co-op promotion initiatives are not a distinct good or service and the Company cannot reasonably estimate the fair value of
the benefit it receives from these arrangements, the cost of these allowances at the time they are offered to the customers are recorded
as a reduction to net sales. For the three months ended September 30, 2024 and 2023, co-op promotion incentives were approximately $&lt;span id="xdx_90E_eus-gaap--AdvertisingExpense_c20240701__20240930_zxy9gNy5db17" title="Co-op promotion incentives"&gt;908,000&lt;/span&gt;
and $&lt;span id="xdx_901_eus-gaap--AdvertisingExpense_c20230701__20230930_zyjuFAXN4SA7" title="Co-op promotion incentives"&gt;1,637,000&lt;/span&gt;, respectively. For the nine months ended September 30, 2024 and 2023, co-op promotion incentives were approximately $&lt;span id="xdx_902_eus-gaap--AdvertisingExpense_c20240101__20240930_z1tFhax3hUzl" title="Co-op promotion incentives"&gt;1,257,000&lt;/span&gt;
and $&lt;span id="xdx_904_eus-gaap--AdvertisingExpense_c20230101__20230930_ztc372oC4IN3" title="Co-op promotion incentives"&gt;1,901,000&lt;/span&gt;, respectively. The Company&#x2019;s estimated reserve for co-op promotion incentives was approximately $&lt;span id="xdx_907_ecustom--EstimatedReserveOfAdvertisingExpense_c20240101__20240930_zFsA1DcJnyY6" title="Estimated reserve co-op promotion incentives"&gt;1,833,000&lt;/span&gt; and $&lt;span id="xdx_90A_ecustom--EstimatedReserveOfAdvertisingExpense_c20230101__20231231_zg2LUd5OvLU8" title="Estimated reserve co-op promotion incentives"&gt;1,277,000&lt;/span&gt;
as of September 30, 2024 and December 31, 2023, respectively. The estimated reserve for co-op promotions is a component of accrued expenses
on the accompanying condensed consolidated balance sheets.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;The
Company estimates variable consideration under its return allowance programs for goods returned from the customer whereby a revenue return
reserve is recorded based on historic return amounts, specific events as identified and management estimates. The Company&#x2019;s reserve
for sales returns as of September 30, 2024 and December 31, 2023, was approximately $&lt;span id="xdx_903_ecustom--ReserveForSalesReturns_iI_c20240930_zMfVMB75VpFj" title="Reserve for sales returns"&gt;2,212,000&lt;/span&gt; and $&lt;span id="xdx_90B_ecustom--ReserveForSalesReturns_iI_c20231231_zWOcGJHDikHf" title="Reserve for sales returns"&gt;3,390,000&lt;/span&gt;, respectively. In conjunction
with the recording of the revenue sales return reserve, the Company estimates the cost of products that are expected to be returned under
its return allowance program whereby the estimated cost of product returns is recorded as an asset. The asset is separately stated as
returns asset on the condensed consolidated balance sheets. The Company&#x2019;s estimated cost of returns as of September 30, 2024 and
December 31, 2023, was approximately $&lt;span id="xdx_90B_ecustom--EstimatedCostOfReturns_iI_c20240930_z9a8cZl4L3Yg" title="Estimated costs of returns"&gt;1,081,000&lt;/span&gt; and $&lt;span id="xdx_90A_ecustom--EstimatedCostOfReturns_iI_c20231231_zSEFlnJVlJj2" title="Estimated costs of returns"&gt;1,919,000&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
return program for defective goods is negotiated with each of the Company&#x2019;s wholesale customers on a year-to-year basis. Customers
are allowed to return defective goods within a specified period of time after shipment (between six and nine months). The Company does
make occasional exceptions to this return policy and accordingly records a sales return reserve based on historic return amounts, specific
exceptions as identified and management estimates.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company records a sales reserve for its return goods programs at the time of sale for estimated sales returns that may occur. The liability
for defective goods is included in the reserve for sales returns on the condensed consolidated balance sheets.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact001342">&lt;p id="xdx_89C_eus-gaap--DisaggregationOfRevenueTableTextBlock_zWgjDe6nNgVk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;Revenue
by product line is as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_8B1_z1QfDZZPjWcj" style="display: none"&gt;SCHEDULE
OF REVENUE BY PRODUCT LINE&lt;/span&gt;&lt;/span&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; display: none"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_49C_20240701__20240930_zCzew3xSqc4e" style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; display: none"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_49D_20230701__20230930_zjZ5ZFJYFCAh" style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; display: none"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_496_20240101__20240930_zlQrx7BexgF8" style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; display: none"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_492_20230101__20230930_z8GQqm0u6BOa" style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="5" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;Three
                                            Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="5" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;Nine
                                            Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;Product Line&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;September
                                            30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="-sec-ix-redline: true"&gt;September
                                            30, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;September
                                            30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="-sec-ix-redline: true"&gt;September
                                            30, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--ClassicKaraokeMachinesMember_zvmUzb0BQWy8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 28%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;Classic Karaoke Machines&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;8,218,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;14,636,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;10,521,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;17,363,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--LicensedProductsMember_zcRM22HViYWg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;Licensed Products&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;180,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;36,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;377,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;32,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--KidsYouthElectronicsMember_zBaA3BsGGST6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;Kids Youth Electronics&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;379,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;297,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;546,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;451,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--MicrophonesAndAccessoriesMember_zlifGfjGdIQ3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;Microphones and Accessories&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;1,500,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;806,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;3,329,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;3,543,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--MusicSubscriptionsMember_z9JfG6qqdHl4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;Music Subscriptions&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;218,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;156,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;588,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;550,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--LogisticsServicesMember_zhP1KbZNMlna" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;Logistics Services&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;127,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1370"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;127,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1372"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--Revenues_z2nmXoH7wJHb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;Total Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;10,622,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;15,931,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;15,488,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;21,939,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:Revenues
      contextRef="From2024-07-012024-09-30_custom_ClassicKaraokeMachinesMember"
      decimals="0"
      id="Fact001344"
      unitRef="USD">8218000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-07-012023-09-30_custom_ClassicKaraokeMachinesMember"
      decimals="0"
      id="Fact001345"
      unitRef="USD">14636000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2024-01-012024-09-30_custom_ClassicKaraokeMachinesMember"
      decimals="0"
      id="Fact001346"
      unitRef="USD">10521000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-01-012023-09-30_custom_ClassicKaraokeMachinesMember"
      decimals="0"
      id="Fact001347"
      unitRef="USD">17363000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2024-07-012024-09-30_custom_LicensedProductsMember"
      decimals="0"
      id="Fact001349"
      unitRef="USD">180000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-07-012023-09-30_custom_LicensedProductsMember"
      decimals="0"
      id="Fact001350"
      unitRef="USD">36000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2024-01-012024-09-30_custom_LicensedProductsMember"
      decimals="0"
      id="Fact001351"
      unitRef="USD">377000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-01-012023-09-30_custom_LicensedProductsMember"
      decimals="0"
      id="Fact001352"
      unitRef="USD">32000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2024-07-012024-09-30_custom_KidsYouthElectronicsMember"
      decimals="0"
      id="Fact001354"
      unitRef="USD">379000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-07-012023-09-30_custom_KidsYouthElectronicsMember"
      decimals="0"
      id="Fact001355"
      unitRef="USD">297000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2024-01-012024-09-30_custom_KidsYouthElectronicsMember"
      decimals="0"
      id="Fact001356"
      unitRef="USD">546000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-01-012023-09-30_custom_KidsYouthElectronicsMember"
      decimals="0"
      id="Fact001357"
      unitRef="USD">451000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2024-07-012024-09-30_custom_MicrophonesAndAccessoriesMember"
      decimals="0"
      id="Fact001359"
      unitRef="USD">1500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-07-012023-09-30_custom_MicrophonesAndAccessoriesMember"
      decimals="0"
      id="Fact001360"
      unitRef="USD">806000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2024-01-012024-09-30_custom_MicrophonesAndAccessoriesMember"
      decimals="0"
      id="Fact001361"
      unitRef="USD">3329000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-01-012023-09-30_custom_MicrophonesAndAccessoriesMember"
      decimals="0"
      id="Fact001362"
      unitRef="USD">3543000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2024-07-012024-09-30_custom_MusicSubscriptionsMember"
      decimals="0"
      id="Fact001364"
      unitRef="USD">218000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-07-012023-09-30_custom_MusicSubscriptionsMember"
      decimals="0"
      id="Fact001365"
      unitRef="USD">156000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2024-01-012024-09-30_custom_MusicSubscriptionsMember"
      decimals="0"
      id="Fact001366"
      unitRef="USD">588000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-01-012023-09-30_custom_MusicSubscriptionsMember"
      decimals="0"
      id="Fact001367"
      unitRef="USD">550000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2024-07-012024-09-30_custom_LogisticsServicesMember"
      decimals="0"
      id="Fact001369"
      unitRef="USD">127000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2024-01-012024-09-30_custom_LogisticsServicesMember"
      decimals="0"
      id="Fact001371"
      unitRef="USD">127000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2024-07-012024-09-30"
      decimals="0"
      id="Fact001374"
      unitRef="USD">10622000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-07-012023-09-30"
      decimals="0"
      id="Fact001375"
      unitRef="USD">15931000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact001376"
      unitRef="USD">15488000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact001377"
      unitRef="USD">21939000</us-gaap:Revenues>
    <us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact001379">&lt;p id="xdx_892_eus-gaap--ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_zUw7jGOtOBdj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Sales
by geographic region for the periods presented are as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_8BA_zyyjRYaDDCrk" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;SCHEDULE
OF SALES BY GEOGRAPHICAL REGION&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; display: none"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; display: none"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_496_20240701__20240930_z7UpUTsSdPv8" style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; display: none"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_497_20230701__20230930_zPB2ZINp0KB8" style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; display: none"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_497_20240101__20240930_zatNM73nEHe1" style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; display: none"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_498_20230101__20230930_zyDFJQGqHp6b" style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Three
    Months Ended&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Nine
    Months Ended&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;September
    30, 2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;September
    30, 2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;September
    30, 2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;September
    30, 2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--Revenues_hsrt--StatementGeographicalAxis__srt--NorthAmericaMember_z12ApUNYOplf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 28%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;North
    America&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10,466,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;15,378,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;15,208,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;21,386,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--Revenues_hsrt--StatementGeographicalAxis__country--AU_zeia9sW3VEha" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Australia&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;50,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;263,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;174,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;263,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--Revenues_hsrt--StatementGeographicalAxis__srt--EuropeMember_zLH57oVPdK82" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Europe&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;106,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;290,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;106,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;290,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--Revenues_zs8zxZUzacD" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total
    Net Sales&lt;/span&gt;&lt;/span&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10,622,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;15,931,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;15,488,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;21,939,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock>
    <us-gaap:Revenues
      contextRef="From2024-07-012024-09-30_srt_NorthAmericaMember"
      decimals="0"
      id="Fact001381"
      unitRef="USD">10466000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-07-012023-09-30_srt_NorthAmericaMember"
      decimals="0"
      id="Fact001382"
      unitRef="USD">15378000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2024-01-012024-09-30_srt_NorthAmericaMember"
      decimals="0"
      id="Fact001383"
      unitRef="USD">15208000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-01-012023-09-30_srt_NorthAmericaMember"
      decimals="0"
      id="Fact001384"
      unitRef="USD">21386000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2024-07-012024-09-30_country_AU"
      decimals="0"
      id="Fact001386"
      unitRef="USD">50000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-07-012023-09-30_country_AU"
      decimals="0"
      id="Fact001387"
      unitRef="USD">263000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2024-01-012024-09-30_country_AU"
      decimals="0"
      id="Fact001388"
      unitRef="USD">174000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-01-012023-09-30_country_AU"
      decimals="0"
      id="Fact001389"
      unitRef="USD">263000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2024-07-012024-09-30_srt_EuropeMember"
      decimals="0"
      id="Fact001391"
      unitRef="USD">106000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-07-012023-09-30_srt_EuropeMember"
      decimals="0"
      id="Fact001392"
      unitRef="USD">290000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2024-01-012024-09-30_srt_EuropeMember"
      decimals="0"
      id="Fact001393"
      unitRef="USD">106000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-01-012023-09-30_srt_EuropeMember"
      decimals="0"
      id="Fact001394"
      unitRef="USD">290000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2024-07-012024-09-30"
      decimals="0"
      id="Fact001396"
      unitRef="USD">10622000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-07-012023-09-30"
      decimals="0"
      id="Fact001397"
      unitRef="USD">15931000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact001398"
      unitRef="USD">15488000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact001399"
      unitRef="USD">21939000</us-gaap:Revenues>
    <us-gaap:AdvertisingExpense
      contextRef="From2024-07-012024-09-30"
      decimals="0"
      id="Fact001401"
      unitRef="USD">908000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="From2023-07-012023-09-30"
      decimals="0"
      id="Fact001403"
      unitRef="USD">1637000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact001405"
      unitRef="USD">1257000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact001407"
      unitRef="USD">1901000</us-gaap:AdvertisingExpense>
    <RIME:EstimatedReserveOfAdvertisingExpense
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact001409"
      unitRef="USD">1833000</RIME:EstimatedReserveOfAdvertisingExpense>
    <RIME:EstimatedReserveOfAdvertisingExpense
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact001411"
      unitRef="USD">1277000</RIME:EstimatedReserveOfAdvertisingExpense>
    <RIME:ReserveForSalesReturns
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact001413"
      unitRef="USD">2212000</RIME:ReserveForSalesReturns>
    <RIME:ReserveForSalesReturns
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001415"
      unitRef="USD">3390000</RIME:ReserveForSalesReturns>
    <RIME:EstimatedCostOfReturns
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact001417"
      unitRef="USD">1081000</RIME:EstimatedCostOfReturns>
    <RIME:EstimatedCostOfReturns
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001419"
      unitRef="USD">1919000</RIME:EstimatedCostOfReturns>
    <us-gaap:ConcentrationRiskDisclosureTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact001421">&lt;p id="xdx_800_eus-gaap--ConcentrationRiskDisclosureTextBlock_zHVwqT1O2d96" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
15 - &lt;span id="xdx_820_zJPDWPODbaIa"&gt;CONCENTRATIONS OF CREDIT RISK AND REVENUE&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;The
Company derives a majority of its revenues from retailers of products in the United States. The Company&#x2019;s allowance for credit
losses is based upon management&#x2019;s estimates and historical experience and reflects the fact that accounts receivable is concentrated
with several large customers. At September 30, 2024, &lt;span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240101__20240930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ThreeCustomersMember_zHxYTqJcGeY3"&gt;70&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%
of accounts receivable were due from three customers in North America that individually owed over 10% of total accounts receivable. On
December 31, 2023, &lt;/span&gt;&lt;span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20231231__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--FourCustomersMember_z8UER6VkXDVf" style="font-size: 10pt"&gt;82&lt;/span&gt;%
of accounts receivable were due from four customers in North America that individually owed over 10% of total accounts receivable.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;Revenues
from customers representing greater than 10% of total net sales derived from our top three customers as a percentage of net sales were
&lt;span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240701__20240930__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zNCPa1fwXXRj" title="Concentration of sales risk, percentage"&gt;41&lt;/span&gt;%, &lt;span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240701__20240930__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersTwoMember_zOHucgA96QX2" title="Concentration of sales risk, percentage"&gt;20&lt;/span&gt;%, and &lt;span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240701__20240930__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersThreeMember_zGUixm5jN6gb" title="Concentration of sales risk, percentage"&gt;13&lt;/span&gt;% for the three months ended September 30, 2024. Revenues from customers representing greater than 10% of total net sales
derived from three customers as a percentage of net sales were &lt;span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230701__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zRC4bYIqY1fc" title="Concentration of sales risk, percentage"&gt;28&lt;/span&gt;%, &lt;span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230701__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersTwoMember_zwAfdt9iNDb" title="Concentration of sales risk, percentage"&gt;22&lt;/span&gt;% and &lt;span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230701__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersThreeMember_z5Chl58wPjX1" title="Concentration of sales risk, percentage"&gt;21&lt;/span&gt;% for the three months ended September 30, 2023. Revenues
from customers representing greater than 10% of total net sales derived from our top four customers as a percentage of net sales were
&lt;span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240101__20240930__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerOneMember_z081AlpVUWSd" title="Concentration of sales risk, percentage"&gt;29&lt;/span&gt;%, &lt;span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240101__20240930__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersTwoMember_zpeU54RUqyo8" title="Concentration of sales risk, percentage"&gt;27&lt;/span&gt;%, &lt;span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240101__20240930__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersThreeMember_zd1CX4VBKbQ2" title="Concentration of sales risk, percentage"&gt;15&lt;/span&gt;% and &lt;span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240101__20240930__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersFourMember_zPfQ7mVT7Zd5" title="Concentration of sales risk, percentage"&gt;10&lt;/span&gt;% for the nine months ended September 30, 2024. Revenues from customers representing greater than 10% of total net
sales derived from our top three customers as a percentage of net sales were &lt;span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zAAabSqEP6sh" title="Concentration of sales risk, percentage"&gt;44&lt;/span&gt;%, &lt;span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersTwoMember_zTDI49ve7v16" title="Concentration of sales risk, percentage"&gt;13&lt;/span&gt;% and &lt;span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersThreeMember_z6GHLWXQemZd" title="Concentration of risk, percentage"&gt;12&lt;/span&gt;% for the nine months ended September 30,
2023. The loss of any of these customers could have an adverse impact on the Company.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;ALGORHYTHM
                                            HOLDINGS, INC. and SUBSIDIARIES&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;September
30, 2024 and 2023&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ConcentrationRiskDisclosureTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2024-01-012024-09-30_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_ThreeCustomersMember"
      decimals="INF"
      id="Fact001422"
      unitRef="Pure">0.70</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2023-12-312023-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_FourCustomersMember"
      decimals="INF"
      id="Fact001423"
      unitRef="Pure">0.82</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2024-07-012024-09-30_custom_SalesRevenueMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerOneMember"
      decimals="INF"
      id="Fact001425"
      unitRef="Pure">0.41</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2024-07-012024-09-30_custom_SalesRevenueMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomersTwoMember"
      decimals="INF"
      id="Fact001427"
      unitRef="Pure">0.20</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2024-07-012024-09-30_custom_SalesRevenueMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomersThreeMember"
      decimals="INF"
      id="Fact001429"
      unitRef="Pure">0.13</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2023-07-012023-09-30_custom_SalesRevenueMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerOneMember"
      decimals="INF"
      id="Fact001431"
      unitRef="Pure">0.28</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2023-07-012023-09-30_custom_SalesRevenueMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomersTwoMember"
      decimals="INF"
      id="Fact001433"
      unitRef="Pure">0.22</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2023-07-012023-09-30_custom_SalesRevenueMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomersThreeMember"
      decimals="INF"
      id="Fact001435"
      unitRef="Pure">0.21</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2024-01-012024-09-30_custom_SalesRevenueMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerOneMember"
      decimals="INF"
      id="Fact001437"
      unitRef="Pure">0.29</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2024-01-012024-09-30_custom_SalesRevenueMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomersTwoMember"
      decimals="INF"
      id="Fact001439"
      unitRef="Pure">0.27</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2024-01-012024-09-30_custom_SalesRevenueMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomersThreeMember"
      decimals="INF"
      id="Fact001441"
      unitRef="Pure">0.15</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2024-01-012024-09-30_custom_SalesRevenueMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomersFourMember"
      decimals="INF"
      id="Fact001443"
      unitRef="Pure">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2023-01-012023-09-30_custom_SalesRevenueMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerOneMember"
      decimals="INF"
      id="Fact001445"
      unitRef="Pure">0.44</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2023-01-012023-09-30_custom_SalesRevenueMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomersTwoMember"
      decimals="INF"
      id="Fact001447"
      unitRef="Pure">0.13</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2023-01-012023-09-30_custom_SalesRevenueMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomersThreeMember"
      decimals="INF"
      id="Fact001449"
      unitRef="Pure">0.12</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact001451">&lt;p id="xdx_808_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zBVfWm7UcGK3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
16 &#x2013; &lt;span id="xdx_82A_zpMy1wLIHqOi"&gt;RELATED PARTY TRANSACTIONS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Due
To/From Related Parties&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;b&gt;&lt;i&gt;Stingray&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;Stingray
Group, Inc. (&#x201c;Stingray&#x201d;) is an existing shareholder with board representation. The Company has a music subscription sharing
agreement with Stingray. For the three months ended September 30, 2024, and 2023, the amounts earned from the subscription agreement
were approximately $&lt;span id="xdx_907_eus-gaap--Revenues_c20240701__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zJJjH8r0nBq1" title="Revenue from related parties"&gt;218,000&lt;/span&gt; and $&lt;span id="xdx_904_eus-gaap--Revenues_c20230701__20230930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_z9RiTOnLgGwk" title="Revenue from related parties"&gt;156,000&lt;/span&gt;, respectively. For the nine months ended September 30, 2024, and 2023, the amounts earned from
the subscription agreement were approximately $&lt;span id="xdx_908_eus-gaap--Revenues_c20240101__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zuNB2Dfyr794" title="Revenue from related parties"&gt;567,000&lt;/span&gt; and $&lt;span id="xdx_90A_eus-gaap--Revenues_c20230101__20230930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zrr1uvSf71v3" title="Revenue from related parties"&gt;550,000&lt;/span&gt;, respectively. These amounts were included as a component of net
sales in the accompanying condensed consolidated statements of operations. On September 30, 2024, the Company had approximately $&lt;span id="xdx_900_eus-gaap--OtherReceivables_iI_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StingrayMember_zJfiaWl0n5sa" title="Due from related parties"&gt;157,000&lt;/span&gt;
due from Stingray. On December 31, 2023, the Company had approximately $&lt;span id="xdx_903_eus-gaap--OtherReceivables_iI_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StingrayMember_zPoqAjmRFuck" title="Due from related parties"&gt;269,000&lt;/span&gt; due from Stingray for music subscription reimbursement.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;SMCB&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;The
Company determined that SMCB is a VIE as the Company provides financial support to SMCB. While not contractually obligated, SMCB currently
relies on our reimbursement of certain costs under a Services Agreement (&#x201c;MSA&#x201d;) whereby SMCB agree to provide IT software
development services to support SemiCab&#x2019;s US operations. In exchange, under the MSA, the Company grants intellectual property rights
to SMCB to use the software platform in India. Compensation for services is invoiced and paid on a monthly or quarterly basis as agreed
by both parties, with rates subject to periodic review and revision. As a result of this relationship SMCB has been determined to be
a VIE.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;Pursuant
to the asset acquisition agreement of SemiCab, the Company entered into an option agreement granting the right to acquire all of the
issued and outstanding capital securities of SMCB, however the option agreement expired on August 31, 2024 unexercised.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;The
Company further determined that it is not the primary beneficiary of SMCB as the Company does not have the power to direct or control
SMCB&#x2019;s significant activities related to its business. Accordingly, the Company has not consolidated SMCB&#x2019;s results of operations
and financial position in the accompanying condensed consolidated financials presented for this period.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;As
of September 30, 2024, the Company has advanced approximately $&lt;span id="xdx_90F_eus-gaap--OtherLiabilities_iI_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SMCBMember_zBVvCBdJWnd7" title="Due to related parties"&gt;776,000&lt;/span&gt;
to SMCB for estimated prepaid services to be provided by SMCB in accordance with the MSA which are a component of prepaid expenses
and other current assets on the accompanying condensed consolidated balance sheets. During the three months ended September 30,
2024, the Company incurred approximately $&lt;span id="xdx_902_eus-gaap--ProfessionalFees_c20240701__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SMCBMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zZnAwKWBMABb" title="Software support service"&gt;422,000&lt;/span&gt;
in software support services under the MSA.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:Revenues
      contextRef="From2024-07-012024-09-30_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact001453"
      unitRef="USD">218000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-07-012023-09-30_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact001455"
      unitRef="USD">156000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2024-01-012024-09-30_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact001457"
      unitRef="USD">567000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-01-012023-09-30_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact001459"
      unitRef="USD">550000</us-gaap:Revenues>
    <us-gaap:OtherReceivables
      contextRef="AsOf2024-09-30_custom_StingrayMember"
      decimals="0"
      id="Fact001461"
      unitRef="USD">157000</us-gaap:OtherReceivables>
    <us-gaap:OtherReceivables
      contextRef="AsOf2023-12-31_custom_StingrayMember"
      decimals="0"
      id="Fact001463"
      unitRef="USD">269000</us-gaap:OtherReceivables>
    <us-gaap:OtherLiabilities
      contextRef="AsOf2024-09-30_custom_SMCBMember"
      decimals="0"
      id="Fact001465"
      unitRef="USD">776000</us-gaap:OtherLiabilities>
    <us-gaap:ProfessionalFees
      contextRef="From2024-07-012024-09-30_custom_SMCBMember_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"
      decimals="0"
      id="Fact001467"
      unitRef="USD">422000</us-gaap:ProfessionalFees>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact001469">&lt;p id="xdx_803_eus-gaap--SubsequentEventsTextBlock_zn3f20UwLxwa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
17 &#x2013; &lt;span id="xdx_82E_zgBcjXTSdma2"&gt;SUBSEQUENT EVENTS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Securities
Purchase Agreement&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;On
October 22, 2024, the Company entered into a Securities Purchase Agreement (the &#x201c;SPA&#x201d;), pursuant to which the Company agreed
to issue and sell to each purchaser (i) an Original Issue Discount Senior Secured Note with a principal amount equal to such purchaser&#x2019;s
subscription amount divided by &lt;span id="xdx_907_eus-gaap--SharePrice_iI_c20241022__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zEZHBXI6TvXh" title="Share price"&gt;0.85&lt;/span&gt; (each a &#x201c;Note&#x201d; and collectively, the &#x201c;Notes&#x201d;), and (ii) a number of shares
of common stock of the Company, par value $&lt;span id="xdx_902_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20241022__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zlZTSjAdp1ig" title="Common stock, par value"&gt;0.01&lt;/span&gt; equal to (i) &lt;span id="xdx_904_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20241022__20241022__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zlpqy9VjA3Pa" title="Number of share sold"&gt;2,300,000&lt;/span&gt; multiplied by (ii) such purchaser&#x2019;s subscription amount
divided by (iii) $&lt;span id="xdx_907_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20241022__20241022__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zoXhIDFdnyU8" title="Number of shares sold, value"&gt;2,000,000&lt;/span&gt; (the &#x201c;Shares&#x201d;) (the transactions contemplated under the SPA, the &#x201c;Offering&#x201d;).The
aggregate gross proceeds to the Company were approximately $&lt;span id="xdx_90B_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_pn5n6_c20241022__20241022__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zl2FZAMPD5S1" title="Net proceeds"&gt;2.0&lt;/span&gt; million, before deducting placement agent fees and expenses. The Company
intends to use the net proceeds from the Offering for working capital and other general corporate purposes.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;The
Company agreed to certain registration rights with respect to the Shares, as described in the SPA. The Company also granted the purchasers
a right to participate up to an amount of &lt;span id="xdx_90D_ecustom--PercentageOfPurchasersRightToParticipateOnIssuanceCompanyOfCommonStock_dp_c20241022__20241022__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zWsuSWAzHKp3" title="Percentage of purchasers right to participate on issuance company of common stock"&gt;20&lt;/span&gt;% in any issuance by the Company of common stock or common stock equivalents for cash, subject
to certain exceptions, during the 90 days after the closing of the Offering.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;Univest
Securities LLC served as the placement agent in the Offering and received &lt;span id="xdx_90B_ecustom--PercentageOfGrossProceeds_dp_uPure_c20241022__20241022__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zwhyZEqEsJ5e" title="Percentage of gross proceeds"&gt;7&lt;/span&gt;% of the gross proceeds received by the Company and reimbursement
of the legal fees of its counsel.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;The
Offering closed on October 24, 2024. At the closing, the Company issued to the purchasers an aggregate of &lt;span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20241024__20241024__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zifBkpKJ3aU9" title="Number of shares issued"&gt;2,300,000&lt;/span&gt; shares of its common
stock and Notes in the aggregate principal amount of $&lt;span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_iI_c20241024__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zSyE6GH6yrfb" title="Principal amount"&gt;2,352,941&lt;/span&gt;for total proceeds of $&lt;span id="xdx_90A_eus-gaap--ProceedsFromIssuanceOfDebt_c20241024__20241024__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zptQhopjOsD3" title="Net proceeds"&gt;2,000,000&lt;/span&gt; net of original issue discount of $&lt;span id="xdx_90D_eus-gaap--DebtConversionOriginalDebtAmount1_c20241024__20241024__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zk24LJlFQYOl" title="Original issue discount"&gt;352,941&lt;/span&gt;.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;At
the closing, the Company issued a Note to each purchaser equal to such purchaser&#x2019;s subscription amount divided by&lt;span id="xdx_901_eus-gaap--SharePrice_iI_c20241024__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zOVhV4wFOo7f" title="Share price"&gt; 0.85&lt;/span&gt;. The Notes
were issued with an original issue discount of &lt;span id="xdx_902_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_dp_c20241024__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z5XsBXUxrc49" title="Original issue discount percentage"&gt;15&lt;/span&gt;%. No interest shall accrue on the Notes unless and until an Event of Default (as defined
in the Notes) has occurred, upon which interest shall accrue at a rate of fourteen percent (&lt;span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20241024__20241024__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zhZ9dAyRbgai" title="Interest accrued rate percentage"&gt;14.0&lt;/span&gt;%) per annum and shall be computed on
the basis of a three hundred sixty (360)-day year and twelve (12) thirty (30)-day months and shall be payable on the maturity date, which
is ninety (90) days from the issuance date of &lt;span id="xdx_90B_eus-gaap--DebtInstrumentIssuanceDate1_dd_c20241024__20241024__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z7jNeTGUtGfk" title="Issuance date"&gt;October 24, 2024&lt;/span&gt;.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;The
Notes also provide for redemption upon a change of control, as such term is defined under the Notes and mandatory redemption upon the
receipt of net proceeds from any offering of equity or debt by the Company. The Company also has the right to prepay the Notes.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;The
Notes are secured by a security interest in the assets and property of the Company and its subsidiaries and guaranteed by the Company&#x2019;s
subsidiaries, pursuant to the terms of a Guarantee Agreement entered into among the purchasers and the Company and each of its subsidiaries.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Stock
Repurchase Agreement&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;On
November 1, 2024, the Company entered into Stock Repurchase Agreement (the &#x201c;Repurchase Agreement&#x201d;) with Regalia Ventures
LLC, a Delaware limited liability company (the &#x201c;Seller&#x201d;), pursuant to which the Company agreed to repurchase from the Seller
an aggregate of &lt;span id="xdx_906_eus-gaap--CommonStockSharesIssued_iI_c20241101__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zcKURhHgy414" title="Common stock shares issued"&gt;&lt;span id="xdx_904_eus-gaap--CommonStockSharesOutstanding_iI_c20241101__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zUig7kzsu433" title="Common stock shares outstanding"&gt;1,098,901&lt;/span&gt;&lt;/span&gt; issued and outstanding shares of common stock, par value $&lt;span id="xdx_909_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20241101__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zHlo0sa1f2C1" title="Common stock par value"&gt;0.01&lt;/span&gt; per share, of the Company (the &#x201c;Shares&#x201d;).
The shares of common stock to be repurchased were originally issued to the Seller on November 21, 2023, pursuant to a certain stock purchase
agreement, dated November 20, 2023.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;As
consideration for the transaction contemplated by the Repurchase Agreement (the &#x201c;Stock Repurchase&#x201d;), when the transaction
closes, the Company has agreed to repurchase from the Seller, and the Seller has agreed to sell, assign and transfer to the Company,
all of the Seller&#x2019;s right, title and interest in and to the Shares, at a price per Share equal to the higher of: (1) the closing
price of the common stock on the last trading day immediately preceding the date of the Repurchase Agreement; or (2) the highest volume
weighted average price (VWAP) of the common stock during a pricing period of ten (10) consecutive trading days prior to the date of the
Repurchase Agreement per share (the &#x201c;Purchase Price&#x201d;), and the Company shall issue to the Seller a promissory note in the
principal amount equal to the Purchase Price.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of the date of this filing, the repurchase of the shares has not yet closed.&lt;/span&gt;&lt;/p&gt;

</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:SharePrice
      contextRef="AsOf2024-10-22_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      id="Fact001471"
      unitRef="USDPShares">0.85</us-gaap:SharePrice>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2024-10-22_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      id="Fact001473"
      unitRef="USDPShares">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2024-10-222024-10-22_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      id="Fact001475"
      unitRef="Shares">2300000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="From2024-10-222024-10-22_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="0"
      id="Fact001477"
      unitRef="USD">2000000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity
      contextRef="From2024-10-222024-10-22_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="-5"
      id="Fact001479"
      unitRef="USD">2000000.0</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <RIME:PercentageOfPurchasersRightToParticipateOnIssuanceCompanyOfCommonStock
      contextRef="From2024-10-222024-10-22_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact001481"
      unitRef="Pure">0.20</RIME:PercentageOfPurchasersRightToParticipateOnIssuanceCompanyOfCommonStock>
    <RIME:PercentageOfGrossProceeds
      contextRef="From2024-10-222024-10-22_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact001483"
      unitRef="Pure">0.07</RIME:PercentageOfGrossProceeds>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-10-242024-10-24_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact001485"
      unitRef="Shares">2300000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2024-10-24_us-gaap_SubsequentEventMember"
      decimals="0"
      id="Fact001487"
      unitRef="USD">2352941</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="From2024-10-242024-10-24_us-gaap_SubsequentEventMember"
      decimals="0"
      id="Fact001489"
      unitRef="USD">2000000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:DebtConversionOriginalDebtAmount1
      contextRef="From2024-10-242024-10-24_us-gaap_SubsequentEventMember"
      decimals="0"
      id="Fact001491"
      unitRef="USD">352941</us-gaap:DebtConversionOriginalDebtAmount1>
    <us-gaap:SharePrice
      contextRef="AsOf2024-10-24_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact001493"
      unitRef="USDPShares">0.85</us-gaap:SharePrice>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="AsOf2024-10-24_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact001495"
      unitRef="Pure">0.15</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="From2024-10-242024-10-24_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact001497"
      unitRef="Pure">0.140</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentIssuanceDate1
      contextRef="From2024-10-242024-10-24_us-gaap_SubsequentEventMember"
      id="Fact001499">2024-10-24</us-gaap:DebtInstrumentIssuanceDate1>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2024-11-01_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact001501"
      unitRef="Shares">1098901</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2024-11-01_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact001503"
      unitRef="Shares">1098901</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2024-11-01_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact001505"
      unitRef="USDPShares">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:Cash
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001513"
      unitRef="USD">6703000</us-gaap:Cash>
    <us-gaap:Cash
      contextRef="AsOf2023-03-31"
      decimals="0"
      id="Fact001514"
      unitRef="USD">2895000</us-gaap:Cash>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001519"
      unitRef="USD">174000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="AsOf2023-03-31"
      decimals="0"
      id="Fact001521"
      unitRef="USD">166000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNet
      contextRef="AsOf2023-12-31_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact001516"
      unitRef="USD">7308000</us-gaap:AccountsReceivableNet>
    <us-gaap:AccountsReceivableNet
      contextRef="AsOf2023-03-31_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact001517"
      unitRef="USD">2075000</us-gaap:AccountsReceivableNet>
    <us-gaap:AccountsReceivableNet
      contextRef="AsOf2023-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact001523"
      unitRef="USD">269000</us-gaap:AccountsReceivableNet>
    <us-gaap:AccountsReceivableNet
      contextRef="AsOf2023-03-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact001524"
      unitRef="USD">239000</us-gaap:AccountsReceivableNet>
    <us-gaap:AccountsReceivableNet
      contextRef="AsOf2023-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact001526"
      unitRef="USD">269000</us-gaap:AccountsReceivableNet>
    <us-gaap:AccountsReceivableNet
      contextRef="AsOf2023-03-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact001527"
      unitRef="USD">239000</us-gaap:AccountsReceivableNet>
    <us-gaap:InventoryNet
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001529"
      unitRef="USD">6871000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="AsOf2023-03-31"
      decimals="0"
      id="Fact001530"
      unitRef="USD">9085000</us-gaap:InventoryNet>
    <RIME:ReturnsAsset
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001532"
      unitRef="USD">1919000</RIME:ReturnsAsset>
    <RIME:ReturnsAsset
      contextRef="AsOf2023-03-31"
      decimals="0"
      id="Fact001533"
      unitRef="USD">555000</RIME:ReturnsAsset>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001535"
      unitRef="USD">136000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2023-03-31"
      decimals="0"
      id="Fact001536"
      unitRef="USD">351000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001538"
      unitRef="USD">23206000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2023-03-31"
      decimals="0"
      id="Fact001539"
      unitRef="USD">15200000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001541"
      unitRef="USD">404000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2023-03-31"
      decimals="0"
      id="Fact001542"
      unitRef="USD">633000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001544"
      unitRef="USD">3926000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="AsOf2023-03-31"
      decimals="0"
      id="Fact001545"
      unitRef="USD">561000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001547"
      unitRef="USD">179000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="AsOf2023-03-31"
      decimals="0"
      id="Fact001548"
      unitRef="USD">255000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001550"
      unitRef="USD">27715000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2023-03-31"
      decimals="0"
      id="Fact001551"
      unitRef="USD">16649000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001559"
      unitRef="USD">7616000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="AsOf2023-03-31"
      decimals="0"
      id="Fact001560"
      unitRef="USD">1769000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001562"
      unitRef="USD">2614000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="AsOf2023-03-31"
      decimals="0"
      id="Fact001563"
      unitRef="USD">2266000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:ContractWithCustomerRefundLiabilityCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001565"
      unitRef="USD">1743000</us-gaap:ContractWithCustomerRefundLiabilityCurrent>
    <RIME:CustomerPrepayments
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001568"
      unitRef="USD">687000</RIME:CustomerPrepayments>
    <RIME:CustomerPrepayments
      contextRef="AsOf2023-03-31"
      decimals="0"
      id="Fact001569"
      unitRef="USD">583000</RIME:CustomerPrepayments>
    <RIME:ReserveForSalesReturns
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001571"
      unitRef="USD">3390000</RIME:ReserveForSalesReturns>
    <RIME:ReserveForSalesReturns
      contextRef="AsOf2023-03-31"
      decimals="0"
      id="Fact001572"
      unitRef="USD">900000</RIME:ReserveForSalesReturns>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001574"
      unitRef="USD">75000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="AsOf2023-03-31"
      decimals="0"
      id="Fact001575"
      unitRef="USD">99000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001577"
      unitRef="USD">84000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="AsOf2023-03-31"
      decimals="0"
      id="Fact001578"
      unitRef="USD">509000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001580"
      unitRef="USD">16209000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2023-03-31"
      decimals="0"
      id="Fact001581"
      unitRef="USD">6126000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001583"
      unitRef="USD">3000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="AsOf2023-03-31"
      decimals="0"
      id="Fact001584"
      unitRef="USD">104000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001586"
      unitRef="USD">3925000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="AsOf2023-03-31"
      decimals="0"
      id="Fact001587"
      unitRef="USD">88000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:Liabilities
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001589"
      unitRef="USD">20137000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="AsOf2023-03-31"
      decimals="0"
      id="Fact001590"
      unitRef="USD">6318000</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact001601"
      unitRef="USDPShares">1.00</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2023-03-31"
      decimals="INF"
      id="Fact001603"
      unitRef="USDPShares">1.00</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact001605"
      unitRef="Shares">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2023-03-31"
      decimals="INF"
      id="Fact001607"
      unitRef="Shares">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact001609"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact001611"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2023-03-31"
      decimals="INF"
      id="Fact001613"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2023-03-31"
      decimals="INF"
      id="Fact001615"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact001620"
      unitRef="USDPShares">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2023-03-31"
      decimals="INF"
      id="Fact001622"
      unitRef="USDPShares">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact001624"
      unitRef="Shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2023-03-31"
      decimals="INF"
      id="Fact001626"
      unitRef="Shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact001628"
      unitRef="Shares">6418061</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact001630"
      unitRef="Shares">6418061</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2023-03-31"
      decimals="INF"
      id="Fact001632"
      unitRef="Shares">3167489</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2023-03-31"
      decimals="INF"
      id="Fact001634"
      unitRef="Shares">3167489</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001617"
      unitRef="USD">64000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="AsOf2023-03-31"
      decimals="0"
      id="Fact001618"
      unitRef="USD">32000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001636"
      unitRef="USD">33429000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2023-03-31"
      decimals="0"
      id="Fact001637"
      unitRef="USD">29822000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
      contextRef="AsOf2023-03-31"
      decimals="0"
      id="Fact001640"
      unitRef="USD">6000</us-gaap:CommonStockShareSubscribedButUnissuedSubscriptionsReceivable>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001642"
      unitRef="USD">-25915000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2023-03-31"
      decimals="0"
      id="Fact001643"
      unitRef="USD">-19517000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001645"
      unitRef="USD">7578000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-31"
      decimals="0"
      id="Fact001646"
      unitRef="USD">10331000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001648"
      unitRef="USD">27715000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2023-03-31"
      decimals="0"
      id="Fact001649"
      unitRef="USD">16649000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact001651"
      unitRef="USD">29198000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact001652"
      unitRef="USD">39299000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact001653"
      unitRef="USD">47512000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact001655"
      unitRef="USD">23008000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact001656"
      unitRef="USD">30090000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact001657"
      unitRef="USD">36697000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact001659"
      unitRef="USD">6190000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact001660"
      unitRef="USD">9209000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact001661"
      unitRef="USD">10815000</us-gaap:GrossProfit>
    <us-gaap:SellingExpense
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact001667"
      unitRef="USD">3717000</us-gaap:SellingExpense>
    <us-gaap:SellingExpense
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact001668"
      unitRef="USD">3442000</us-gaap:SellingExpense>
    <us-gaap:SellingExpense
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact001669"
      unitRef="USD">3589000</us-gaap:SellingExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact001671"
      unitRef="USD">8616000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact001672"
      unitRef="USD">9465000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact001673"
      unitRef="USD">7157000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact001675"
      unitRef="USD">12333000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact001676"
      unitRef="USD">12907000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact001677"
      unitRef="USD">10746000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact001679"
      unitRef="USD">-6143000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact001680"
      unitRef="USD">-3698000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact001681"
      unitRef="USD">69000</us-gaap:OperatingIncomeLoss>
    <us-gaap:GainLossOnDispositionOfAssets1
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact001687"
      unitRef="USD">44000</us-gaap:GainLossOnDispositionOfAssets1>
    <RIME:GainFromRelatedPartyDebt
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact001693"
      unitRef="USD">11000</RIME:GainFromRelatedPartyDebt>
    <RIME:GainFromPaycheckProtectionPlanLoanForgiveness
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact001697"
      unitRef="USD">448000</RIME:GainFromPaycheckProtectionPlanLoanForgiveness>
    <RIME:GainFromEmployeeRetentionCreditProgramRefund
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact001700"
      unitRef="USD">704000</RIME:GainFromEmployeeRetentionCreditProgramRefund>
    <RIME:GainFromSettlementOfAccountsPayable
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact001704"
      unitRef="USD">48000</RIME:GainFromSettlementOfAccountsPayable>
    <RIME:GainFromSettlementOfAccountsPayable
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact001705"
      unitRef="USD">339000</RIME:GainFromSettlementOfAccountsPayable>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact001708"
      unitRef="USD">-183000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact001711"
      unitRef="USD">299000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact001712"
      unitRef="USD">479000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact001713"
      unitRef="USD">580000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact001715"
      unitRef="USD">-255000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact001716"
      unitRef="USD">90000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact001717"
      unitRef="USD">218000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact001719"
      unitRef="USD">-6398000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact001720"
      unitRef="USD">-3608000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact001721"
      unitRef="USD">287000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact001724"
      unitRef="USD">1030000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact001725"
      unitRef="USD">57000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact001727"
      unitRef="USD">-6398000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact001728"
      unitRef="USD">-4638000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact001729"
      unitRef="USD">230000</us-gaap:ProfitLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2023-04-012023-12-31"
      decimals="INF"
      id="Fact001735"
      unitRef="USDPShares">-1.32</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2022-04-012023-03-31"
      decimals="INF"
      id="Fact001736"
      unitRef="USDPShares">-1.65</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2021-04-012022-03-31"
      decimals="INF"
      id="Fact001737"
      unitRef="USDPShares">0.14</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-04-012023-12-31"
      decimals="INF"
      id="Fact001739"
      unitRef="USDPShares">-1.32</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2022-04-012023-03-31"
      decimals="INF"
      id="Fact001740"
      unitRef="USDPShares">-1.65</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2021-04-012022-03-31"
      decimals="INF"
      id="Fact001741"
      unitRef="USDPShares">0.14</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-04-012023-12-31"
      decimals="INF"
      id="Fact001751"
      unitRef="Shares">4864540</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2022-04-012023-03-31"
      decimals="INF"
      id="Fact001752"
      unitRef="Shares">2811872</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2021-04-012022-03-31"
      decimals="INF"
      id="Fact001753"
      unitRef="Shares">1614506</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-04-012023-12-31"
      decimals="INF"
      id="Fact001755"
      unitRef="Shares">4864540</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2022-04-012023-03-31"
      decimals="INF"
      id="Fact001756"
      unitRef="Shares">2811872</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2021-04-012022-03-31"
      decimals="INF"
      id="Fact001757"
      unitRef="Shares">1614506</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-04-012023-12-31"
      decimals="INF"
      id="Fact001759"
      unitRef="Shares">4864540</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2022-04-012023-03-31"
      decimals="INF"
      id="Fact001760"
      unitRef="Shares">2811872</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2021-04-012022-03-31"
      decimals="INF"
      id="Fact001761"
      unitRef="Shares">1623397</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ProfitLoss
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact001767"
      unitRef="USD">-6398000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact001768"
      unitRef="USD">-4638000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact001769"
      unitRef="USD">230000</us-gaap:ProfitLoss>
    <us-gaap:Depreciation
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact001775"
      unitRef="USD">287000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact001776"
      unitRef="USD">228000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact001777"
      unitRef="USD">246000</us-gaap:Depreciation>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact001780"
      unitRef="USD">47000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact001781"
      unitRef="USD">45000</us-gaap:AmortizationOfFinancingCosts>
    <RIME:ProvisionForEstimatedCostOfReturns
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact001783"
      unitRef="USD">1364000</RIME:ProvisionForEstimatedCostOfReturns>
    <RIME:ProvisionForEstimatedCostOfReturns
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact001784"
      unitRef="USD">-128000</RIME:ProvisionForEstimatedCostOfReturns>
    <RIME:ProvisionForEstimatedCostOfReturns
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact001785"
      unitRef="USD">156000</RIME:ProvisionForEstimatedCostOfReturns>
    <RIME:ProvisionForInventoryObsolescence
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact001787"
      unitRef="USD">-1798000</RIME:ProvisionForInventoryObsolescence>
    <RIME:ProvisionForInventoryObsolescence
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact001788"
      unitRef="USD">-536000</RIME:ProvisionForInventoryObsolescence>
    <RIME:ProvisionForInventoryObsolescence
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact001789"
      unitRef="USD">272000</RIME:ProvisionForInventoryObsolescence>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact001791"
      unitRef="USD">8000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact001792"
      unitRef="USD">43000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact001793"
      unitRef="USD">-16000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact001795"
      unitRef="USD">44000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact001796"
      unitRef="USD">-3000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact001797"
      unitRef="USD">-4000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:ShareBasedCompensation
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact001799"
      unitRef="USD">110000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact001800"
      unitRef="USD">382000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact001801"
      unitRef="USD">44000</us-gaap:ShareBasedCompensation>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact001803"
      unitRef="USD">510000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact001804"
      unitRef="USD">718000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact001805"
      unitRef="USD">795000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact001808"
      unitRef="USD">893000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact001809"
      unitRef="USD">-5000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact001812"
      unitRef="USD">-183000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <RIME:GainFromPaycheckProtectionPlanLoanForgiveness
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact001817"
      unitRef="USD">448000</RIME:GainFromPaycheckProtectionPlanLoanForgiveness>
    <RIME:GainFromRelatedPartyDebt
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact001821"
      unitRef="USD">11000</RIME:GainFromRelatedPartyDebt>
    <RIME:GainFromSettlementOfAccountsPayable
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact001824"
      unitRef="USD">48000</RIME:GainFromSettlementOfAccountsPayable>
    <RIME:GainFromSettlementOfAccountsPayable
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact001825"
      unitRef="USD">339000</RIME:GainFromSettlementOfAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact001831"
      unitRef="USD">5241000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact001832"
      unitRef="USD">-667000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact001833"
      unitRef="USD">558000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivableRelatedParties
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact001835"
      unitRef="USD">30000</us-gaap:IncreaseDecreaseInAccountsReceivableRelatedParties>
    <us-gaap:IncreaseDecreaseInAccountsReceivableRelatedParties
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact001836"
      unitRef="USD">87000</us-gaap:IncreaseDecreaseInAccountsReceivableRelatedParties>
    <us-gaap:IncreaseDecreaseInAccountsReceivableRelatedParties
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact001837"
      unitRef="USD">64000</us-gaap:IncreaseDecreaseInAccountsReceivableRelatedParties>
    <us-gaap:IncreaseDecreaseDueFromAffiliates
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact001840"
      unitRef="USD">-101000</us-gaap:IncreaseDecreaseDueFromAffiliates>
    <us-gaap:IncreaseDecreaseDueFromAffiliates
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact001841"
      unitRef="USD">-4456000</us-gaap:IncreaseDecreaseDueFromAffiliates>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact001843"
      unitRef="USD">-415000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact001844"
      unitRef="USD">-3858000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact001845"
      unitRef="USD">8244000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact001847"
      unitRef="USD">-215000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact001848"
      unitRef="USD">-78000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact001849"
      unitRef="USD">123000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact001851"
      unitRef="USD">-76000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact001852"
      unitRef="USD">38000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact001853"
      unitRef="USD">-61000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact001855"
      unitRef="USD">5847000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact001856"
      unitRef="USD">-3511000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact001857"
      unitRef="USD">3217000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact001859"
      unitRef="USD">348000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact001860"
      unitRef="USD">533000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact001861"
      unitRef="USD">77000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInDueToRelatedParties
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact001864"
      unitRef="USD">-63000</us-gaap:IncreaseDecreaseInDueToRelatedParties>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact001867"
      unitRef="USD">1743000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact001869"
      unitRef="USD">-139000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <RIME:IncreaseDecreaseInPrepaidsFromCustomers
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact001871"
      unitRef="USD">103000</RIME:IncreaseDecreaseInPrepaidsFromCustomers>
    <RIME:IncreaseDecreaseInPrepaidsFromCustomers
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact001872"
      unitRef="USD">485000</RIME:IncreaseDecreaseInPrepaidsFromCustomers>
    <RIME:IncreaseDecreaseInPrepaidsFromCustomers
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact001873"
      unitRef="USD">-47000</RIME:IncreaseDecreaseInPrepaidsFromCustomers>
    <RIME:IncreaseDecreaseInReserveForSalesReturns
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact001875"
      unitRef="USD">2490000</RIME:IncreaseDecreaseInReserveForSalesReturns>
    <RIME:IncreaseDecreaseInReserveForSalesReturns
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact001876"
      unitRef="USD">-90000</RIME:IncreaseDecreaseInReserveForSalesReturns>
    <RIME:IncreaseDecreaseInReserveForSalesReturns
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact001877"
      unitRef="USD">30000</RIME:IncreaseDecreaseInReserveForSalesReturns>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact001879"
      unitRef="USD">-462000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact001880"
      unitRef="USD">-738000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact001881"
      unitRef="USD">-795000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact001883"
      unitRef="USD">411000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact001884"
      unitRef="USD">-330000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact001885"
      unitRef="USD">-2012000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact001891"
      unitRef="USD">68000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact001892"
      unitRef="USD">244000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact001893"
      unitRef="USD">118000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact001895"
      unitRef="USD">54000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact001899"
      unitRef="USD">-14000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact001900"
      unitRef="USD">-244000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact001901"
      unitRef="USD">-118000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact001907"
      unitRef="USD">3529000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact001908"
      unitRef="USD">3393000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact001909"
      unitRef="USD">9001000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <RIME:PaymentOfRedemptionAndRetirementOfTreasuryStock
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact001913"
      unitRef="USD">7162000</RIME:PaymentOfRedemptionAndRetirementOfTreasuryStock>
    <RIME:ProceedsFromCollectionOfSubscriptionsReceivable
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact001915"
      unitRef="USD">6000</RIME:ProceedsFromCollectionOfSubscriptionsReceivable>
    <us-gaap:ProceedsFromRepaymentsOfLinesOfCredit
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact001920"
      unitRef="USD">-2500000</us-gaap:ProceedsFromRepaymentsOfLinesOfCredit>
    <us-gaap:ProceedsFromRepaymentsOfLinesOfCredit
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact001921"
      unitRef="USD">2435000</us-gaap:ProceedsFromRepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfSubordinatedDebt
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact001924"
      unitRef="USD">353000</us-gaap:RepaymentsOfSubordinatedDebt>
    <us-gaap:RepaymentsOfSubordinatedDebt
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact001925"
      unitRef="USD">150000</us-gaap:RepaymentsOfSubordinatedDebt>
    <RIME:PaymentOfDeferredFinancingCharges
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact001928"
      unitRef="USD">254000</RIME:PaymentOfDeferredFinancingCharges>
    <RIME:PaymentOfDeferredFinancingCharges
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact001929"
      unitRef="USD">38000</RIME:PaymentOfDeferredFinancingCharges>
    <RIME:PaymentOfEarlyTerminationFeesOnRevolvingLinesOfCredit
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact001932"
      unitRef="USD">183000</RIME:PaymentOfEarlyTerminationFeesOnRevolvingLinesOfCredit>
    <RIME:PaymentsOnInstallmentNote
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact001935"
      unitRef="USD">124000</RIME:PaymentsOnInstallmentNote>
    <RIME:PaymentsOnInstallmentNote
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact001936"
      unitRef="USD">74000</RIME:PaymentsOnInstallmentNote>
    <RIME:PaymentsOnInstallmentNote
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact001937"
      unitRef="USD">68000</RIME:PaymentsOnInstallmentNote>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact001941"
      unitRef="USD">14000</us-gaap:ProceedsFromStockOptionsExercised>
    <RIME:ProceedsFromExerciseOfCommonStockWarrants
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact001944"
      unitRef="USD">990000</RIME:ProceedsFromExerciseOfCommonStockWarrants>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact001948"
      unitRef="USD">168000</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact001952"
      unitRef="USD">9000</us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations>
    <us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact001953"
      unitRef="USD">8000</us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact001955"
      unitRef="USD">3411000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact001956"
      unitRef="USD">1178000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact001957"
      unitRef="USD">4024000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact001959"
      unitRef="USD">3808000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact001960"
      unitRef="USD">604000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact001961"
      unitRef="USD">1894000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2023-03-31"
      decimals="0"
      id="Fact001963"
      unitRef="USD">2895000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2022-03-31"
      decimals="0"
      id="Fact001964"
      unitRef="USD">2291000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2021-03-31"
      decimals="0"
      id="Fact001965"
      unitRef="USD">397000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001967"
      unitRef="USD">6703000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2023-03-31"
      decimals="0"
      id="Fact001968"
      unitRef="USD">2895000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2022-03-31"
      decimals="0"
      id="Fact001969"
      unitRef="USD">2291000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:InterestPaidNet
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact001975"
      unitRef="USD">44000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact001976"
      unitRef="USD">481000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact001977"
      unitRef="USD">547000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact001980"
      unitRef="USD">34000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:CapitalLeaseObligationsIncurred
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact001988"
      unitRef="USD">55000</us-gaap:CapitalLeaseObligationsIncurred>
    <us-gaap:CapitalLeaseObligationsIncurred
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact001989"
      unitRef="USD">24000</us-gaap:CapitalLeaseObligationsIncurred>
    <RIME:IssuanceOfCommonStockAndWarrantsForOfferingCosts
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact001992"
      unitRef="USD">244000</RIME:IssuanceOfCommonStockAndWarrantsForOfferingCosts>
    <RIME:IssuanceOfCommonStockAndWarrantsForOfferingCosts
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact001993"
      unitRef="USD">548000</RIME:IssuanceOfCommonStockAndWarrantsForOfferingCosts>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact001995"
      unitRef="USD">3874000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact001996"
      unitRef="USD">192000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact001997"
      unitRef="USD">16000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact002005"
      unitRef="Shares">1301358</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact001999"
      unitRef="USD">13000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact002000"
      unitRef="USD">20151000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact002002"
      unitRef="USD">-12254000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-03-31"
      decimals="0"
      id="Fact002003"
      unitRef="USD">7910000</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="From2021-04-012022-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact002010"
      unitRef="USD">230000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact002011"
      unitRef="USD">230000</us-gaap:ProfitLoss>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2021-04-012022-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact002019"
      unitRef="Shares">550000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2021-04-012022-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact002013"
      unitRef="USD">6000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2021-04-012022-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact002014"
      unitRef="USD">4944000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact002017"
      unitRef="USD">4950000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="From2021-04-012022-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact002022"
      unitRef="USD">4882000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact002025"
      unitRef="USD">4882000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="From2021-04-012022-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact002028"
      unitRef="USD">831000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact002031"
      unitRef="USD">831000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="From2021-04-012022-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact002039"
      unitRef="Shares">19047</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:TreasuryStockSharesRetired
      contextRef="From2021-04-012022-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact002047"
      unitRef="Shares">654105</us-gaap:TreasuryStockSharesRetired>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="From2021-04-012022-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact002041"
      unitRef="USD">7000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="From2021-04-012022-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact002042"
      unitRef="USD">4301000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="From2021-04-012022-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact002044"
      unitRef="USD">2855000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact002045"
      unitRef="USD">7163000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="From2021-04-012022-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact002055"
      unitRef="Shares">2242</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2021-04-012022-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact002050"
      unitRef="USD">44000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact002053"
      unitRef="USD">44000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2021-04-012022-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact002063"
      unitRef="Shares">2667</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2021-04-012022-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact002058"
      unitRef="USD">14000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact002061"
      unitRef="USD">14000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact002071"
      unitRef="Shares">1221209</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact002065"
      unitRef="USD">12000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact002066"
      unitRef="USD">24903000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact002068"
      unitRef="USD">-14879000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-03-31"
      decimals="0"
      id="Fact002069"
      unitRef="USD">10036000</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="From2022-04-012023-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact002076"
      unitRef="USD">-4638000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact002077"
      unitRef="USD">-4638000</us-gaap:ProfitLoss>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2022-04-012023-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact002085"
      unitRef="Shares">1014230</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-04-012023-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact002079"
      unitRef="USD">10000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-04-012023-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact002080"
      unitRef="USD">4026000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-04-012023-03-31_us-gaap_ReceivablesFromStockholderMember"
      decimals="0"
      id="Fact002081"
      unitRef="USD">-6000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact002083"
      unitRef="USD">4030000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="From2022-04-012023-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact002088"
      unitRef="USD">637000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact002091"
      unitRef="USD">637000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <RIME:StockIssuedDuringPeriodSharesExerciseOfPrefundedAndCommonWarrants
      contextRef="From2022-04-012023-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact002099"
      unitRef="Shares">914558</RIME:StockIssuedDuringPeriodSharesExerciseOfPrefundedAndCommonWarrants>
    <RIME:StockIssuedDuringPeriodValueExerciseOfPrefundedAndCommonWarrants
      contextRef="From2022-04-012023-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact002093"
      unitRef="USD">10000</RIME:StockIssuedDuringPeriodValueExerciseOfPrefundedAndCommonWarrants>
    <RIME:StockIssuedDuringPeriodValueExerciseOfPrefundedAndCommonWarrants
      contextRef="From2022-04-012023-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact002094"
      unitRef="USD">1148000</RIME:StockIssuedDuringPeriodValueExerciseOfPrefundedAndCommonWarrants>
    <RIME:StockIssuedDuringPeriodValueExerciseOfPrefundedAndCommonWarrants
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact002097"
      unitRef="USD">1158000</RIME:StockIssuedDuringPeriodValueExerciseOfPrefundedAndCommonWarrants>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="From2022-04-012023-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact002107"
      unitRef="Shares">15803</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2022-04-012023-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact002102"
      unitRef="USD">145000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact002105"
      unitRef="USD">145000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2022-04-012023-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact002110"
      unitRef="USD">237000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact002113"
      unitRef="USD">237000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesReverseStockSplits
      contextRef="From2022-04-012023-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact002121"
      unitRef="Shares">1688</us-gaap:StockIssuedDuringPeriodSharesReverseStockSplits>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact002129"
      unitRef="Shares">3167488</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact002123"
      unitRef="USD">32000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact002124"
      unitRef="USD">29822000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-31_us-gaap_ReceivablesFromStockholderMember"
      decimals="0"
      id="Fact002125"
      unitRef="USD">-6000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact002126"
      unitRef="USD">-19517000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-31"
      decimals="0"
      id="Fact002127"
      unitRef="USD">10331000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact002137"
      unitRef="Shares">3167488</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact002131"
      unitRef="USD">32000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact002132"
      unitRef="USD">29822000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-31_us-gaap_ReceivablesFromStockholderMember"
      decimals="0"
      id="Fact002133"
      unitRef="USD">-6000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact002134"
      unitRef="USD">-19517000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-31"
      decimals="0"
      id="Fact002135"
      unitRef="USD">10331000</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="From2023-04-012023-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact002142"
      unitRef="USD">-6398000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact002143"
      unitRef="USD">-6398000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2023-04-012023-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact002148"
      unitRef="USD">-6398000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact002149"
      unitRef="USD">-6398000</us-gaap:ProfitLoss>
    <RIME:StockIssuedDuringPeriodSharesIssuanceOfCommonStockAtMarketOffering
      contextRef="From2023-04-012023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact002157"
      unitRef="Shares">1052770</RIME:StockIssuedDuringPeriodSharesIssuanceOfCommonStockAtMarketOffering>
    <RIME:StockIssuedDuringPeriodValueIssuanceOfCommonStockAtMarketOffering
      contextRef="From2023-04-012023-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact002151"
      unitRef="USD">10000</RIME:StockIssuedDuringPeriodValueIssuanceOfCommonStockAtMarketOffering>
    <RIME:StockIssuedDuringPeriodValueIssuanceOfCommonStockAtMarketOffering
      contextRef="From2023-04-012023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact002152"
      unitRef="USD">1699000</RIME:StockIssuedDuringPeriodValueIssuanceOfCommonStockAtMarketOffering>
    <RIME:StockIssuedDuringPeriodValueIssuanceOfCommonStockAtMarketOffering
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact002155"
      unitRef="USD">1709000</RIME:StockIssuedDuringPeriodValueIssuanceOfCommonStockAtMarketOffering>
    <RIME:StockIssuedDuringPeriodSharesIssuanceOfCommonStockPrivatePlacement
      contextRef="From2023-04-012023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact002165"
      unitRef="Shares">2197803</RIME:StockIssuedDuringPeriodSharesIssuanceOfCommonStockPrivatePlacement>
    <RIME:StockIssuedDuringPeriodValueIssuanceOfCommonStockPrivatePlacement
      contextRef="From2023-04-012023-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact002159"
      unitRef="USD">22000</RIME:StockIssuedDuringPeriodValueIssuanceOfCommonStockPrivatePlacement>
    <RIME:StockIssuedDuringPeriodValueIssuanceOfCommonStockPrivatePlacement
      contextRef="From2023-04-012023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact002160"
      unitRef="USD">1977000</RIME:StockIssuedDuringPeriodValueIssuanceOfCommonStockPrivatePlacement>
    <RIME:StockIssuedDuringPeriodValueIssuanceOfCommonStockPrivatePlacement
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact002163"
      unitRef="USD">1999000</RIME:StockIssuedDuringPeriodValueIssuanceOfCommonStockPrivatePlacement>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="From2023-04-012023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact002168"
      unitRef="USD">179000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact002171"
      unitRef="USD">179000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2023-04-012023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact002174"
      unitRef="USD">110000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact002177"
      unitRef="USD">110000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="From2023-04-012023-12-31_us-gaap_ReceivablesFromStockholderMember"
      decimals="0"
      id="Fact002183"
      unitRef="USD">6000</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact002185"
      unitRef="USD">6000</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact002193"
      unitRef="Shares">6418061</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact002187"
      unitRef="USD">64000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact002188"
      unitRef="USD">33429000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact002190"
      unitRef="USD">-25915000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002191"
      unitRef="USD">7578000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact002201"
      unitRef="Shares">6418061</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact002195"
      unitRef="USD">64000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact002196"
      unitRef="USD">33429000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact002198"
      unitRef="USD">-25915000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002199"
      unitRef="USD">7578000</us-gaap:StockholdersEquity>
    <us-gaap:NatureOfOperations contextRef="From2023-04-012023-12-31" id="Fact002203">&lt;p id="xdx_800_eus-gaap--NatureOfOperations_zsL9fKGUJGMi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
1 &#x2013; &lt;span id="xdx_82A_zlzsnAE65cha"&gt;NATURE OF BUSINESS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;We
are primarily engaged in the development, marketing, and sale of consumer karaoke audio equipment, accessories, and musical recordings.
We believe we are a leading global karaoke and music entertainment company that specializes in the design and production of quality karaoke
and music enabled consumer products for adults and children. Our products are among the most widely available karaoke products in the
world.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Our
mission is to &#x201c;create joy through music.&#x201d;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Singing Machine&#x2019;s operations include its wholly owned subsidiaries, SMC Logistics, Inc., a California corporation (&#x201c;SMCL&#x201d;),
SMC-Music, Inc., a Florida corporation (&#x201c;SMCM&#x201d;), SMC (HK) Limited, a Hong Kong company (&#x201c;SMH&#x201d;), MICS Hospitality
Holdings, Inc., a Delaware corporation (&#x201c;MICS Hospitality&#x201d;), MICS Hospitality Management, LLC, a Delaware limited liability
company (&#x201c;MICS Hospitality Management&#x201d;) and MICS Nomad, LLC, a Delaware limited liability company (&#x201c;MICS NY&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:NatureOfOperations>
    <RIME:RecentDevelopmentsTextBlock contextRef="From2023-04-012023-12-31" id="Fact002205">&lt;p id="xdx_800_ecustom--RecentDevelopmentsTextBlock_zMDDr0ulIhw6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
2 - &lt;span id="xdx_82A_zi95aABtW9Vj"&gt;RECENT DEVELOPMENTS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Change
in Fiscal Year &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
2023, our Board of Directors approved a change in our fiscal year end from March 31 to December 31. Our results of operations, cash
flows, and all transactions impacting shareholders&#x2019; equity presented in this Transition Report on Table of Contents Form 10-KT
are for the nine-month period ended December 31, 2023 (&#x201c;transition period&#x201d;), and our fiscal years 2023 and 2022 are for
the twelve months ended March 31, 2023, and March 31, 2022, unless otherwise noted.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Private
Placement&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
November 20, 2023, the Company entered into an agreement to sell $&lt;span id="xdx_907_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20231120__20231120__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zfixydcjEL85" title="Number of stock sold, value"&gt;2,000,000&lt;/span&gt; in common stock through a private placement of common stock
(the &#x201c;Private Placement&#x201d;). The Private Placement was completed with two Affiliates, (Stingray Group, Inc. and Jay Foreman),
both of which were existing shareholders with Board representation. The Private Placement was completed at $&lt;span id="xdx_90C_eus-gaap--SaleOfStockPricePerShare_iI_c20231120__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zaWldYcI4yJ2" title="Commmon stock share per share"&gt;0.91&lt;/span&gt; per share of common
stock, with a total of approximately &lt;span id="xdx_90B_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20231120__20231120__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zQ19jELJcLse" title="Number of shares sold"&gt;2,198,000&lt;/span&gt; shares issued. Net proceeds from the transaction were approximately $&lt;span id="xdx_90D_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20231120__20231120__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zU7wJCVwJCGj" title="Proceeds from sale of equity"&gt;1,900,000&lt;/span&gt;, net of
transaction fees of approximately $&lt;span id="xdx_90E_ecustom--TransactionFees_iI_c20231120__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zmuLUdQlLQGk" title="Transaction fees"&gt;100,000&lt;/span&gt;. During the six-month period after the closing date, the purchasers may make a written request
for registration under the Securities Act of all or any portion of the shares purchased.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Hospitality
Lease&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
August 23, 2023, MICS NY entered into an Agreement of Lease (the &#x201c;Lease Agreement&#x201d;) with OAC 111 Flatiron, LLC and OAC Adelphi,
LLC (the &#x201c;Landlord&#x201d;), pursuant to which MICS NY agreed to lease approximately &lt;span id="xdx_904_eus-gaap--AreaOfLand_iI_pid_usqft_c20230823__us-gaap--TypeOfArrangementAxis__custom--LeaseAgreementMember_zC3lWaoT8JV7" title="Lease space"&gt;10,000&lt;/span&gt; square feet of ground floor retail space
and a portion of the basement underneath the ground floor retail space in the property located at 111 West 24&lt;sup&gt;th&lt;/sup&gt; Street, New
York, New York (the &#x201c;Premises&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
term of the Lease Agreement is for fifteen (&lt;span id="xdx_90E_eus-gaap--LesseeOperatingLeaseTermOfContract_iI_dtY_c20230823__us-gaap--TypeOfArrangementAxis__custom--LeaseAgreementMember_zTmVGdoOnDe" title="Lease term"&gt;15&lt;/span&gt;) years, or on such an earlier date upon which the term shall expire, be canceled or terminated
pursuant to any of the conditions or covenants of the Lease Agreement. Pursuant to the Lease Agreement, MICS NY is obligated to pay an
initial base rent in the amount of $&lt;span id="xdx_909_eus-gaap--PaymentsForRent_c20230823__20230823__us-gaap--TypeOfArrangementAxis__custom--LeaseAgreementMember_zV4WSxyON0lh" title="Initial base rent"&gt;30,000&lt;/span&gt; beginning August 1, 2024, with scheduled increases over the term, as set forth in the Lease
Agreement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
March 2024, the Company initiated the termination of this lease under certain provisions made available under the Lease Agreement. The
Landlord and the Company are in active discussions as to the terms of the lease termination however as of this filing, it is too early
in the negotiation process to estimate any potential loss, if any, related to the lease termination process.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;ATM
Offering&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;On
February 15, 2023, the Company entered into an At-The-Market Issuance Sales Agreement (the &#x201c;Sales Agreement&#x201d;) with Aegis
Capital Corp, as sales agent (the &#x201c;Agent&#x201d;), pursuant to which the Company could offer and sell, from time to time,
through the Agent (the &#x201c;ATM Offering&#x201d;), up to approximately $&lt;span id="xdx_909_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_pp0p0_c20230215__20230215__us-gaap--SubsidiarySaleOfStockAxis__custom--ATMOfferingMember_zWZ0xMZwEGnl" title="Number of stock sold, value"&gt;1,800,000&lt;/span&gt;
in shares of the Company&#x2019;s common stock. For the nine months ended December 31, 2023, and fiscal year ended March 31, 2023,
the Company received net proceeds of approximately $&lt;span id="xdx_901_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20230401__20231231__us-gaap--SubsidiarySaleOfStockAxis__custom--ATMOfferingMember_zcL78nR3yvDi" title="Proceeds from sale of equity"&gt;1,654,000&lt;/span&gt;
and $&lt;span id="xdx_904_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20220401__20230331__us-gaap--SubsidiarySaleOfStockAxis__custom--ATMOfferingMember_zd8C9KHbRXL" title="Proceeds from sale of equity"&gt;36,000&lt;/span&gt;,
respectively, after payment of brokerage commissions and administrative fees to the agent. As of May 12, 2023, the Company  terminated the Sales Agreement.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</RIME:RecentDevelopmentsTextBlock>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="From2023-11-202023-11-20_us-gaap_PrivatePlacementMember"
      decimals="0"
      id="Fact002207"
      unitRef="USD">2000000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2023-11-20_us-gaap_PrivatePlacementMember"
      decimals="INF"
      id="Fact002209"
      unitRef="USDPShares">0.91</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2023-11-202023-11-20_us-gaap_PrivatePlacementMember"
      decimals="INF"
      id="Fact002211"
      unitRef="Shares">2198000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity
      contextRef="From2023-11-202023-11-20_us-gaap_PrivatePlacementMember"
      decimals="0"
      id="Fact002213"
      unitRef="USD">1900000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <RIME:TransactionFees
      contextRef="AsOf2023-11-20_us-gaap_PrivatePlacementMember"
      decimals="0"
      id="Fact002215"
      unitRef="USD">100000</RIME:TransactionFees>
    <us-gaap:AreaOfLand
      contextRef="AsOf2023-08-23_custom_LeaseAgreementMember"
      decimals="INF"
      id="Fact002217"
      unitRef="sqft">10000</us-gaap:AreaOfLand>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="AsOf2023-08-23_custom_LeaseAgreementMember"
      id="Fact002219">P15Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:PaymentsForRent
      contextRef="From2023-08-232023-08-23_custom_LeaseAgreementMember"
      decimals="0"
      id="Fact002221"
      unitRef="USD">30000</us-gaap:PaymentsForRent>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="From2023-02-152023-02-15_custom_ATMOfferingMember"
      decimals="0"
      id="Fact002223"
      unitRef="USD">1800000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity
      contextRef="From2023-04-012023-12-31_custom_ATMOfferingMember"
      decimals="0"
      id="Fact002225"
      unitRef="USD">1654000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity
      contextRef="From2022-04-012023-03-31_custom_ATMOfferingMember"
      decimals="0"
      id="Fact002227"
      unitRef="USD">36000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <us-gaap:SubstantialDoubtAboutGoingConcernTextBlock contextRef="From2023-04-012023-12-31" id="Fact002229">&lt;p id="xdx_80A_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zi9CW53dKuY8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
3 &#x2013; &lt;span id="xdx_821_zZcFLFmmCccg"&gt;LIQUIDITY, GOING CONCERN AND MANAGEMENT PLANS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;As
of December 31, 2023, the Company had cash on hand of approximately $&lt;span id="xdx_904_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20231231_zszztNhTKdXa"&gt;6,703,000 &lt;/span&gt;which
is not sufficient to fund the Company&#x2019;s planned operations through one year after the date the consolidated financial
statements are issued. The Company has a recent history of recurring operating losses and decreases in working capital. These
factors create substantial doubt about the Company&#x2019;s ability to continue as a going concern for at least one year after the
date that the Company&#x2019;s audited consolidated financial statements are issued.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;The consolidated financial statements do not
include any adjustments that might be necessary if the Company is unable to continue as a going concern. Accordingly, the
consolidated financial statements have been prepared on a basis that assumes the Company will continue as a going concern and which
contemplates the realization of assets and satisfaction of liabilities and commitments in the ordinary course of business.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;Management
intends to finance operations with future debt or equity financings however, if and when such financings may occur are uncertain.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;In
making this assessment management performed a comprehensive analysis of the Company&#x2019;s current circumstances including: its
financial position, cash flow and cash usage forecasts, and obligations and debts. Although management has a recent history of
successful capital raises, the analysis used to determine the Company&#x2019;s ability as a going concern does not include cash
sources outside the Company&#x2019;s direct control that management expects to be available within the next 12 months.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;THE
SINGING MACHINE COMPANY, INC AND SUBSIDIARIES&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December
31, 2023, and March 31, 2023 and 2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SubstantialDoubtAboutGoingConcernTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002230"
      unitRef="USD">6703000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2023-04-012023-12-31" id="Fact002232">&lt;p id="xdx_804_eus-gaap--SignificantAccountingPoliciesTextBlock_zqNjTthj8LAf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
4 - &lt;span id="xdx_825_z04vsAxtg152"&gt;SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84C_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_z3YYmrJUWim1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;BASIS
OF PRESENTATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the
United States of America (&#x201c;GAAP&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_847_eus-gaap--ConsolidationPolicyTextBlock_zCa0IWp0mh3i" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;PRINCIPLES
OF CONSOLIDATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying consolidated financial statements include the accounts of the Company and its Hong Kong subsidiary, SMCL, SMCM, SMH, MICS
Hospitality, MICS Hospitality Management and MICS NY. All inter-company accounts and transactions have been eliminated in consolidation
for all periods presented.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_849_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zVl9t85L9Bml" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;RECLASSIFICATION
OF PRIOR YEARS PRESENTATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Certain
prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on
the reported results of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_841_eus-gaap--UseOfEstimates_zg7Fs5GiIx77" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;USE
OF ESTIMATES&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions. These estimates and
assumptions affect the reported amounts of assets, liabilities, revenues and expenses. Actual results could differ materially from these
estimates. Estimates are assessed each period and updated to reflect current information. Significant estimates include revenue recognition,
allowance for credit losses, provision for excess and obsolete inventory, reserve for sales returns, accruals relating to litigation,
income taxes and share-based compensation expense.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_848_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zKXhm8BV8qe8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;ACCOUNTS
RECEIVABLE AND ALLOWANCES FOR EXPECTED CREDIT LOSSES&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
June 2016, the FASB issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2016-13, &#x201c;Financial Instruments&#x2014;Credit Losses&#x201d;
&lt;i&gt;(Topic 326)&lt;/i&gt;. This ASU represents a significant change in the current accounting model by requiring immediate recognition of management&#x2019;s
estimates of current expected credit losses. Under the prior model, losses were recognized only as they were incurred, which delayed
recognition of expected losses that might not yet have met the threshold of being probable. The amendments in ASU 2016-03 were effective
for our fiscal year beginning April 1, 2023, including interim periods within that fiscal year. We adopted ASU 2016-03 on April 1, 2023,
and the adoption did not have any material effect on our consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognizes an allowance for credit losses at the time a receivable is recorded based on its estimate of expected credit losses
and adjusts this estimate over the life of the receivable as needed. The Company evaluates specific identified risks and the aggregation
and risk characteristics of a receivable pool and develops loss rates that reflect historical collections, current forecasts of future
economic conditions over the time horizon the Company is exposed to credit risk, and payment terms or conditions that may materially
affect future forecasts. As needed, amounts are written-off when determined to be uncollectible.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84D_eus-gaap--InventoryPolicyTextBlock_zt1zqrGxQzxj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;INVENTORY
AND RETURNS ASSET&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Inventory
is comprised primarily of electronic karaoke equipment, microphones, and accessories, and are stated at the lower of cost or net realizable
value, as determined using the first in, first out method. The Company reduces inventory on hand to its net realizable value on an item-by-item
basis when it is apparent that the expected realizable value of an inventory item falls below its original cost. A charge to cost of
sales results when the estimated net realizable value of specific inventory items declines below cost. Management regularly reviews the
Company&#x2019;s investment in inventories for such declines in value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
addition, the Company reports an estimated amount for the net realizable value of expected future inventory returns (returns asset) related
to the Company&#x2019;s defective allowance, overstock, and warranty policies.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;THE
SINGING MACHINE COMPANY, INC AND SUBSIDIARIES&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December
31, 2023, and March 31, 2023 and 2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_841_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zUAAmNvZLnp8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;LONG-LIVED
ASSETS &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company periodically evaluates the carrying value of the unamortized balances of its long-lived assets, including property, equipment
and rental assets, to determine whether impairment of these assets has occurred or whether a revision to the related amortization periods
should be made. If the carrying value of the long-lived asset group exceeds the estimated future undiscounted cash flows, an impairment
loss is recorded based on the amount by which the asset group&#x2019;s carrying amount exceeds its fair value. Fair value is determined
based on an evaluation of the assets&#x2019; associated discounted future cash flows or appraised value&lt;i&gt;.&lt;/i&gt; For the nine months ended
December 31, 2023 and fiscal year ended March 31, 2023, the Company had no impairment loss related to long-lived assets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84F_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_znvSDpwnKbKl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;PROPERTY
AND EQUIPMENT, NET &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Property
and equipment are stated at cost, less accumulated depreciation. Expenditures for repairs and maintenance are charged to expense as incurred.
Depreciation is provided for in amounts sufficient to relate the cost of depreciable assets to their estimated useful lives using straight-line
methods.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84F_eus-gaap--LesseeLeasesPolicyTextBlock_zJtEl5F2EXkj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;LEASES&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company determines if an arrangement contains a lease at the inception of a contract. Right-of-use assets represent the Company&#x2019;s
right to use an underlying asset for the lease term and lease liabilities represent the Company&#x2019;s obligation to make lease payments
arising from the lease. Right-of-use assets and lease liabilities are recognized at the commencement date. The liability is equal to
the present value of the remaining minimum lease payments. The asset is based on the liability, subject to certain adjustments. Operating
leases result in straight-line expense (similar to operating leases under the prior accounting standard) while finance leases result
in a front-loaded expense pattern (similar to capital leases under the prior accounting standard). As the interest rate implicit in the
Company&#x2019;s operating leases is not readily determinable, the Company utilizes its incremental borrowing rate to discount the lease
payments. The Company utilizes the implicit rate for its finance leases.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84F_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zO1xq9uamRK9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;FAIR
VALUE OF FINANCIAL INSTRUMENTS &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;We
follow Financial Accounting Standards Board (&#x201c;FASB&#x201d;) Accounting Standards Codification (&#x201c;ASC&#x201d;) 825, &#x201c;Financial
Instruments&#x201d;, which requires disclosure of information about the fair value of certain financial instruments for which it is practicable
to estimate that value. For the purposes of this disclosure, the fair value of a financial instrument is the amount at which the instrument
could be exchanged in a current transaction between willing parties, other than in a forced sale or liquidation. The carrying amounts
of the Company&#x2019;s short-term financial instruments, including accounts receivable, accounts payable, accrued expenses, refunds due
to customers, customer deposits, other current liabilities and due from related parties approximates fair value due to the relatively
short period to maturity for these instruments. The carrying amounts on other liabilities are approximate to fair value due to their
relatively short period to maturity.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_842_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_znmqBVe2Pvf5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;REVENUE
RECOGNITION AND RESERVE FOR SALES RETURNS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognizes revenue in accordance with FASB ASC 606, &#x201c;Revenue from Contracts with Customers&#x201d;. All revenue is generated
from contracts with customers. The Company recognizes revenue when the control of the goods sold is transferred to the customer, in an
amount, referred to as the transaction price, that reflects the consideration to which the Company is expected to be entitled in exchange
for those goods. The Company determines revenue recognition utilizing the following five steps: (1) identification of the contract with
a customer, (2) identification of the performance obligations in the contract (promised goods or services that are distinct), (3) determination
of the transaction price, (4) allocation of the transaction price to the performance obligations, and (5) recognition of revenue when,
or as, the Company transfers control of the product or service for each performance obligation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s performance obligations are established when a customer submits a purchase order notification, and the Company
accepts the order. The Company identifies performance obligations as the delivery of the requested product or service in appropriate
quantities and to the location specified in the customer&#x2019;s contract and/or purchase order. Revenue from sales of product is
recognized at a point in time when the Company transfers control to the customer, typically at the time when the product is
delivered or shipped, at which time, title passes to the customer and there are no further performance obligations with regards to
the product.&#x201d;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company selectively participates in a retailer&#x2019;s co-op promotion incentives to maximize sales of the Company&#x2019;s products on
the retail floor or to assist in developing consumer awareness of new product launches, by providing marketing fund allowances to our
customers. As these co-op promotion initiatives are not a distinct good or service and the Company cannot reasonably estimate the fair
value of the benefit it receives from these arrangements, the cost of these allowances at the time they are offered to the customers
are recorded as a reduction to net sales. Co-op promotion incentives were approximately $&lt;span id="xdx_907_eus-gaap--AdvertisingExpense_c20230401__20231231_zetgZ155fVu8" title="Co-op promotion incentives"&gt;2,600,000&lt;/span&gt; during the nine months ended December
31, 2023, $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_908_eus-gaap--AdvertisingExpense_c20220401__20230331_z7p1nzM50py8" title="Co-op promotion incentives"&gt;2,300,000&lt;/span&gt; during fiscal 2023 and $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_905_eus-gaap--AdvertisingExpense_c20210401__20220331_zys9xYLM0WY1" title="Co-op promotion incentives"&gt;2,000,000&lt;/span&gt; during fiscal 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s contracts with customers consist of one performance obligation (the sale of the Company&#x2019;s products). The
Company&#x2019;s contracts have no financing elements, payment terms are generally less than 120 days and have no further contract
asset or liability obligations once control of goods is transferred to the customer. Revenue is recorded in the amount of
consideration the Company expects to receive for the sale of these goods.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Costs
incurred in fulfilling contracts with customers include administrative costs associated with the procurement of goods are included in
general and administrative expenses, in-bound freight costs are included in the cost of goods sold and accrued sales representative commissions
are included in selling expenses in the accompanying consolidated statements of operations as our underlying customer agreements are
less than one year.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;THE
SINGING MACHINE COMPANY, INC AND SUBSIDIARIES&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December
31, 2023, and March 31, 2023 and 2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;While
the Company has no overstock return privileges in its vendor agreements with its customers, the Company does accept defective returns,
warranty exchanges and overstock from seasonal customers. The Company estimates the sales value of goods to be returned from our allowance
programs for goods returned from the customer for various reasons, whereby a reserve for sales returns is recorded based on historic
return amounts, specific events as identified and management estimates. The Company&#x2019;s reserve for sales returns was approximately
$&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_90E_ecustom--ReserveForSalesReturn_iI_c20231231_zUmZ1f0zmEhh" title="Reserve for sales return"&gt;3,400,000&lt;/span&gt; as of December 31, 2023, and $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_908_ecustom--ReserveForSalesReturn_iI_c20230331_zgqYZZmZeKTg" title="Reserve for sales return"&gt;900,000&lt;/span&gt; as of March 31, 2023. The Company estimates the net realizable value of these expected
future sales returns. The net realizable value of these estimated returns is classified as return assets as part of current assets on
the accompanying consolidated financial statements. The Company&#x2019;s return assets were approximately $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_905_ecustom--ReturnAssets_iI_c20231231_zlaEnHEG2wQf" title="Return assets"&gt;1,900,000&lt;/span&gt; and $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_90A_ecustom--ReturnAssets_iI_c20230331_zkNePkNTq8s5" title="Return assets"&gt;600,000&lt;/span&gt; as of
December 31, 2023, and March 31, 2023, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84B_ecustom--ShippingAndHandlingCostsPolicyTextBlock_zCeER69gCcLf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SHIPPING
AND HANDLING COSTS &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Shipping
and handling activities are performed before the customer obtains control of the goods sold to them and are considered activities to
fulfill the Company&#x2019;s promise to transfer the goods. For the nine months ended December 31, 2023, shipping and handling expenses
were approximately $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_901_ecustom--ShippingAndHandlingExpenses_c20230401__20231231_zAD9DO2uvUu3" title="Shipping and handling expenses"&gt;600,000&lt;/span&gt;. For Fiscal 2023 and 2022 shipping and handling expenses were approximately $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_90D_ecustom--ShippingAndHandlingExpenses_c20220401__20230331_zDKl0hYiF6Pl" title="Shipping and handling expenses"&gt;500,000&lt;/span&gt; and $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_90B_ecustom--ShippingAndHandlingExpenses_c20210401__20220331_zWcuHtKtohl5" title="Shipping and handling expenses"&gt;900,000&lt;/span&gt;, respectively.
These expenses are classified as a component of selling expenses in the accompanying consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_845_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zW3YbDrlpx7h" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SHARE-BASED
COMPENSATION &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has granted stock options and restricted stock units (&#x201c;RSUs&#x201d;) to employees, non-employee consultants and non-employee
members of our Board of Directors. The Company also has an equity incentive plan which provides for the issuance of equity incentive
awards, such as stock options, stock appreciation rights, stock awards, restricted stock, stock units, performance awards and other stock
or cash-based awards collectively, the &#x201c;Awards.&#x201d; Awards may be granted under the 2022 Plan to the Company&#x2019;s employees,
officers, directors, consultants, agents, advisors and independent contractors.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company measures the compensation cost associated with all share-based payments based on grant date fair values. The fair value of each
stock option and stock purchase right is estimated on the date of grant using an option pricing model that meets certain requirements.
The Company generally uses the Black-Scholes option pricing model to estimate the fair value of its stock options and stock purchase
rights. The determination of the fair value of share-based payment awards utilizing the Black-Scholes model is affected by the Company&#x2019;s
stock price and several assumptions, including expected volatility, expected term, risk-free interest rate and expected dividends.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
grants of stock options, the Company uses a blend of historical and implied volatility for traded options on its stock to estimate the
expected volatility assumption required in the Black-Scholes model. The Company&#x2019;s use of a blended volatility estimates in computing
the expected volatility assumption for stock options is based on its belief that while the implied volatility is representative of expected
future volatility, the historical volatility over the expected term of the award is also an indicator of expected future volatility.
The Company utilizes a blended volatility estimate that consists of implied volatility and historical volatility in order to estimate
the expected volatility assumption of the Black-Scholes model.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
expected term of stock options granted is estimated using historical experience. The risk-free interest rate assumption is based on observed
interest rates appropriate for the expected terms of the Company&#x2019;s stock options and stock purchase rights. The dividend yield
assumption is based on the Company&#x2019;s history and expectation of no dividend payouts. The Company estimates forfeitures at the time
of grant and revises these estimates, if necessary, in subsequent periods if actual forfeitures differ from those estimates. The Company
estimates its forfeiture rate assumption for all types of share-based compensation awards based on historical forfeiture rates related
to each category of award.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Compensation
costs associated with grants of restricted stock units are measured at fair value, which has historically been the closing price of the
Company&#x2019;s common stock on the date of grant.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognizes share-based compensation expense over the requisite service period of each individual award, which generally equals
the vesting period, using the straight-line method for awards that contain only service conditions. For awards that contain performance
conditions, the Company recognizes the share-based compensation expense on a straight-line basis for each vesting tranche, when achievement
of that tranche is considered probable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company evaluates the assumptions used to value stock awards at each grant date. If there are any modifications or cancellations of
the underlying unvested securities, the Company may be required to accelerate, increase or cancel any remaining unearned share-based
compensation expense.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_849_eus-gaap--IncomeTaxPolicyTextBlock_zXx5R89VEUIg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;INCOME
TAXES&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company follows the provisions of FASB ASC 740 &#x201c;Accounting for Income Taxes.&#x201d; Under the asset and liability method of ASC
740, deferred tax assets and liabilities are recognized for the future tax consequences attributed to differences between the financial
statement carrying amounts of existing assets and liabilities and their respective tax base. Deferred tax assets and liabilities are
measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to
be recovered or settled. Under ASC 740, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income
in the period that includes the enactment date. If it is more likely than not that some portion of a deferred tax asset will not be realized,
a valuation allowance is recognized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;THE
SINGING MACHINE COMPANY, INC AND SUBSIDIARIES&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December
31, 2023, and March 31, 2023 and 2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognizes a liability for uncertain tax positions. An uncertain tax position is defined as a position in a previously filed
tax return or a position expected to be taken in a future tax return that is not based on clear and unambiguous tax law and which is
reflected in measuring current or deferred income tax assets and liabilities for interim or annual periods. The Company may
recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained
on examination by the taxing authorities, based on the technical merits of the position. The Company measures the tax benefits
recognized based on the largest benefit that has a &lt;span id="xdx_90A_eus-gaap--IncomeTaxExaminationLikelihoodOfUnfavorableSettlement_c20230401__20231231_zrx94xkqnTv7"&gt;greater
than 50% likelihood&lt;/span&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;of being realized upon
ultimate resolution.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2023, and March 31, 2023, there were no uncertain tax positions that resulted in any adjustment to the Company&#x2019;s
provision for income taxes. The Company recognizes interest and penalties related to unrecognized tax benefits in its provision for income
taxes. The Company currently has no liabilities recorded for accrued interest or penalties related to uncertain tax provisions.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84B_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zlsiD5f9UQQb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;RECENT
ACCOUNTING PRONOUNCEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
December 2023, the FASB issued ASU 2023-09, &lt;i&gt;Income Taxes (Topic 740): Improvements to Income Tax Disclosures&lt;/i&gt;. ASU 2023-09 is intended
to enhance the usefulness of income tax disclosures by requiring entities to disclose specific rate reconciliations, amount of income
taxes separate by federal and individual tax jurisdictions, and the amount of income (loss) from continuing operations before income
tax expense (benefit) disaggregated between federal, state and foreign. ASU 2023-09 is effective for the Company for its fiscal year
beginning January 1, 2025, with early adoption permitted. The Company is currently evaluating the impact of adopting this standard on
our consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_85B_zW76W1xUgLok" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="From2023-04-012023-12-31" id="Fact002234">&lt;p id="xdx_84C_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_z3YYmrJUWim1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;BASIS
OF PRESENTATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the
United States of America (&#x201c;GAAP&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="From2023-04-012023-12-31" id="Fact002236">&lt;p id="xdx_847_eus-gaap--ConsolidationPolicyTextBlock_zCa0IWp0mh3i" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;PRINCIPLES
OF CONSOLIDATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying consolidated financial statements include the accounts of the Company and its Hong Kong subsidiary, SMCL, SMCM, SMH, MICS
Hospitality, MICS Hospitality Management and MICS NY. All inter-company accounts and transactions have been eliminated in consolidation
for all periods presented.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription contextRef="From2023-04-012023-12-31" id="Fact002238">&lt;p id="xdx_849_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zVl9t85L9Bml" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;RECLASSIFICATION
OF PRIOR YEARS PRESENTATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Certain
prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on
the reported results of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:UseOfEstimates contextRef="From2023-04-012023-12-31" id="Fact002240">&lt;p id="xdx_841_eus-gaap--UseOfEstimates_zg7Fs5GiIx77" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;USE
OF ESTIMATES&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions. These estimates and
assumptions affect the reported amounts of assets, liabilities, revenues and expenses. Actual results could differ materially from these
estimates. Estimates are assessed each period and updated to reflect current information. Significant estimates include revenue recognition,
allowance for credit losses, provision for excess and obsolete inventory, reserve for sales returns, accruals relating to litigation,
income taxes and share-based compensation expense.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:UseOfEstimates>
    <us-gaap:TradeAndOtherAccountsReceivablePolicy contextRef="From2023-04-012023-12-31" id="Fact002242">&lt;p id="xdx_848_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zKXhm8BV8qe8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;ACCOUNTS
RECEIVABLE AND ALLOWANCES FOR EXPECTED CREDIT LOSSES&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
June 2016, the FASB issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2016-13, &#x201c;Financial Instruments&#x2014;Credit Losses&#x201d;
&lt;i&gt;(Topic 326)&lt;/i&gt;. This ASU represents a significant change in the current accounting model by requiring immediate recognition of management&#x2019;s
estimates of current expected credit losses. Under the prior model, losses were recognized only as they were incurred, which delayed
recognition of expected losses that might not yet have met the threshold of being probable. The amendments in ASU 2016-03 were effective
for our fiscal year beginning April 1, 2023, including interim periods within that fiscal year. We adopted ASU 2016-03 on April 1, 2023,
and the adoption did not have any material effect on our consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognizes an allowance for credit losses at the time a receivable is recorded based on its estimate of expected credit losses
and adjusts this estimate over the life of the receivable as needed. The Company evaluates specific identified risks and the aggregation
and risk characteristics of a receivable pool and develops loss rates that reflect historical collections, current forecasts of future
economic conditions over the time horizon the Company is exposed to credit risk, and payment terms or conditions that may materially
affect future forecasts. As needed, amounts are written-off when determined to be uncollectible.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:TradeAndOtherAccountsReceivablePolicy>
    <us-gaap:InventoryPolicyTextBlock contextRef="From2023-04-012023-12-31" id="Fact002244">&lt;p id="xdx_84D_eus-gaap--InventoryPolicyTextBlock_zt1zqrGxQzxj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;INVENTORY
AND RETURNS ASSET&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Inventory
is comprised primarily of electronic karaoke equipment, microphones, and accessories, and are stated at the lower of cost or net realizable
value, as determined using the first in, first out method. The Company reduces inventory on hand to its net realizable value on an item-by-item
basis when it is apparent that the expected realizable value of an inventory item falls below its original cost. A charge to cost of
sales results when the estimated net realizable value of specific inventory items declines below cost. Management regularly reviews the
Company&#x2019;s investment in inventories for such declines in value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
addition, the Company reports an estimated amount for the net realizable value of expected future inventory returns (returns asset) related
to the Company&#x2019;s defective allowance, overstock, and warranty policies.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;THE
SINGING MACHINE COMPANY, INC AND SUBSIDIARIES&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December
31, 2023, and March 31, 2023 and 2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="From2023-04-012023-12-31" id="Fact002246">&lt;p id="xdx_841_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zUAAmNvZLnp8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;LONG-LIVED
ASSETS &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company periodically evaluates the carrying value of the unamortized balances of its long-lived assets, including property, equipment
and rental assets, to determine whether impairment of these assets has occurred or whether a revision to the related amortization periods
should be made. If the carrying value of the long-lived asset group exceeds the estimated future undiscounted cash flows, an impairment
loss is recorded based on the amount by which the asset group&#x2019;s carrying amount exceeds its fair value. Fair value is determined
based on an evaluation of the assets&#x2019; associated discounted future cash flows or appraised value&lt;i&gt;.&lt;/i&gt; For the nine months ended
December 31, 2023 and fiscal year ended March 31, 2023, the Company had no impairment loss related to long-lived assets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="From2023-04-012023-12-31" id="Fact002248">&lt;p id="xdx_84F_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_znvSDpwnKbKl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;PROPERTY
AND EQUIPMENT, NET &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Property
and equipment are stated at cost, less accumulated depreciation. Expenditures for repairs and maintenance are charged to expense as incurred.
Depreciation is provided for in amounts sufficient to relate the cost of depreciable assets to their estimated useful lives using straight-line
methods.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:LesseeLeasesPolicyTextBlock contextRef="From2023-04-012023-12-31" id="Fact002250">&lt;p id="xdx_84F_eus-gaap--LesseeLeasesPolicyTextBlock_zJtEl5F2EXkj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;LEASES&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company determines if an arrangement contains a lease at the inception of a contract. Right-of-use assets represent the Company&#x2019;s
right to use an underlying asset for the lease term and lease liabilities represent the Company&#x2019;s obligation to make lease payments
arising from the lease. Right-of-use assets and lease liabilities are recognized at the commencement date. The liability is equal to
the present value of the remaining minimum lease payments. The asset is based on the liability, subject to certain adjustments. Operating
leases result in straight-line expense (similar to operating leases under the prior accounting standard) while finance leases result
in a front-loaded expense pattern (similar to capital leases under the prior accounting standard). As the interest rate implicit in the
Company&#x2019;s operating leases is not readily determinable, the Company utilizes its incremental borrowing rate to discount the lease
payments. The Company utilizes the implicit rate for its finance leases.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2023-04-012023-12-31" id="Fact002252">&lt;p id="xdx_84F_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zO1xq9uamRK9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;FAIR
VALUE OF FINANCIAL INSTRUMENTS &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;We
follow Financial Accounting Standards Board (&#x201c;FASB&#x201d;) Accounting Standards Codification (&#x201c;ASC&#x201d;) 825, &#x201c;Financial
Instruments&#x201d;, which requires disclosure of information about the fair value of certain financial instruments for which it is practicable
to estimate that value. For the purposes of this disclosure, the fair value of a financial instrument is the amount at which the instrument
could be exchanged in a current transaction between willing parties, other than in a forced sale or liquidation. The carrying amounts
of the Company&#x2019;s short-term financial instruments, including accounts receivable, accounts payable, accrued expenses, refunds due
to customers, customer deposits, other current liabilities and due from related parties approximates fair value due to the relatively
short period to maturity for these instruments. The carrying amounts on other liabilities are approximate to fair value due to their
relatively short period to maturity.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock contextRef="From2023-04-012023-12-31" id="Fact002254">&lt;p id="xdx_842_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_znmqBVe2Pvf5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;REVENUE
RECOGNITION AND RESERVE FOR SALES RETURNS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognizes revenue in accordance with FASB ASC 606, &#x201c;Revenue from Contracts with Customers&#x201d;. All revenue is generated
from contracts with customers. The Company recognizes revenue when the control of the goods sold is transferred to the customer, in an
amount, referred to as the transaction price, that reflects the consideration to which the Company is expected to be entitled in exchange
for those goods. The Company determines revenue recognition utilizing the following five steps: (1) identification of the contract with
a customer, (2) identification of the performance obligations in the contract (promised goods or services that are distinct), (3) determination
of the transaction price, (4) allocation of the transaction price to the performance obligations, and (5) recognition of revenue when,
or as, the Company transfers control of the product or service for each performance obligation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s performance obligations are established when a customer submits a purchase order notification, and the Company
accepts the order. The Company identifies performance obligations as the delivery of the requested product or service in appropriate
quantities and to the location specified in the customer&#x2019;s contract and/or purchase order. Revenue from sales of product is
recognized at a point in time when the Company transfers control to the customer, typically at the time when the product is
delivered or shipped, at which time, title passes to the customer and there are no further performance obligations with regards to
the product.&#x201d;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company selectively participates in a retailer&#x2019;s co-op promotion incentives to maximize sales of the Company&#x2019;s products on
the retail floor or to assist in developing consumer awareness of new product launches, by providing marketing fund allowances to our
customers. As these co-op promotion initiatives are not a distinct good or service and the Company cannot reasonably estimate the fair
value of the benefit it receives from these arrangements, the cost of these allowances at the time they are offered to the customers
are recorded as a reduction to net sales. Co-op promotion incentives were approximately $&lt;span id="xdx_907_eus-gaap--AdvertisingExpense_c20230401__20231231_zetgZ155fVu8" title="Co-op promotion incentives"&gt;2,600,000&lt;/span&gt; during the nine months ended December
31, 2023, $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_908_eus-gaap--AdvertisingExpense_c20220401__20230331_z7p1nzM50py8" title="Co-op promotion incentives"&gt;2,300,000&lt;/span&gt; during fiscal 2023 and $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_905_eus-gaap--AdvertisingExpense_c20210401__20220331_zys9xYLM0WY1" title="Co-op promotion incentives"&gt;2,000,000&lt;/span&gt; during fiscal 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s contracts with customers consist of one performance obligation (the sale of the Company&#x2019;s products). The
Company&#x2019;s contracts have no financing elements, payment terms are generally less than 120 days and have no further contract
asset or liability obligations once control of goods is transferred to the customer. Revenue is recorded in the amount of
consideration the Company expects to receive for the sale of these goods.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Costs
incurred in fulfilling contracts with customers include administrative costs associated with the procurement of goods are included in
general and administrative expenses, in-bound freight costs are included in the cost of goods sold and accrued sales representative commissions
are included in selling expenses in the accompanying consolidated statements of operations as our underlying customer agreements are
less than one year.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;THE
SINGING MACHINE COMPANY, INC AND SUBSIDIARIES&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December
31, 2023, and March 31, 2023 and 2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;While
the Company has no overstock return privileges in its vendor agreements with its customers, the Company does accept defective returns,
warranty exchanges and overstock from seasonal customers. The Company estimates the sales value of goods to be returned from our allowance
programs for goods returned from the customer for various reasons, whereby a reserve for sales returns is recorded based on historic
return amounts, specific events as identified and management estimates. The Company&#x2019;s reserve for sales returns was approximately
$&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_90E_ecustom--ReserveForSalesReturn_iI_c20231231_zUmZ1f0zmEhh" title="Reserve for sales return"&gt;3,400,000&lt;/span&gt; as of December 31, 2023, and $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_908_ecustom--ReserveForSalesReturn_iI_c20230331_zgqYZZmZeKTg" title="Reserve for sales return"&gt;900,000&lt;/span&gt; as of March 31, 2023. The Company estimates the net realizable value of these expected
future sales returns. The net realizable value of these estimated returns is classified as return assets as part of current assets on
the accompanying consolidated financial statements. The Company&#x2019;s return assets were approximately $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_905_ecustom--ReturnAssets_iI_c20231231_zlaEnHEG2wQf" title="Return assets"&gt;1,900,000&lt;/span&gt; and $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_90A_ecustom--ReturnAssets_iI_c20230331_zkNePkNTq8s5" title="Return assets"&gt;600,000&lt;/span&gt; as of
December 31, 2023, and March 31, 2023, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:AdvertisingExpense
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact002256"
      unitRef="USD">2600000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact002258"
      unitRef="USD">2300000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact002260"
      unitRef="USD">2000000</us-gaap:AdvertisingExpense>
    <RIME:ReserveForSalesReturn
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002262"
      unitRef="USD">3400000</RIME:ReserveForSalesReturn>
    <RIME:ReserveForSalesReturn
      contextRef="AsOf2023-03-31"
      decimals="0"
      id="Fact002264"
      unitRef="USD">900000</RIME:ReserveForSalesReturn>
    <RIME:ReturnAssets
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002266"
      unitRef="USD">1900000</RIME:ReturnAssets>
    <RIME:ReturnAssets
      contextRef="AsOf2023-03-31"
      decimals="0"
      id="Fact002268"
      unitRef="USD">600000</RIME:ReturnAssets>
    <RIME:ShippingAndHandlingCostsPolicyTextBlock contextRef="From2023-04-012023-12-31" id="Fact002270">&lt;p id="xdx_84B_ecustom--ShippingAndHandlingCostsPolicyTextBlock_zCeER69gCcLf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SHIPPING
AND HANDLING COSTS &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Shipping
and handling activities are performed before the customer obtains control of the goods sold to them and are considered activities to
fulfill the Company&#x2019;s promise to transfer the goods. For the nine months ended December 31, 2023, shipping and handling expenses
were approximately $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_901_ecustom--ShippingAndHandlingExpenses_c20230401__20231231_zAD9DO2uvUu3" title="Shipping and handling expenses"&gt;600,000&lt;/span&gt;. For Fiscal 2023 and 2022 shipping and handling expenses were approximately $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_90D_ecustom--ShippingAndHandlingExpenses_c20220401__20230331_zDKl0hYiF6Pl" title="Shipping and handling expenses"&gt;500,000&lt;/span&gt; and $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_90B_ecustom--ShippingAndHandlingExpenses_c20210401__20220331_zWcuHtKtohl5" title="Shipping and handling expenses"&gt;900,000&lt;/span&gt;, respectively.
These expenses are classified as a component of selling expenses in the accompanying consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</RIME:ShippingAndHandlingCostsPolicyTextBlock>
    <RIME:ShippingAndHandlingExpenses
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact002272"
      unitRef="USD">600000</RIME:ShippingAndHandlingExpenses>
    <RIME:ShippingAndHandlingExpenses
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact002274"
      unitRef="USD">500000</RIME:ShippingAndHandlingExpenses>
    <RIME:ShippingAndHandlingExpenses
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact002276"
      unitRef="USD">900000</RIME:ShippingAndHandlingExpenses>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="From2023-04-012023-12-31" id="Fact002278">&lt;p id="xdx_845_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zW3YbDrlpx7h" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SHARE-BASED
COMPENSATION &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has granted stock options and restricted stock units (&#x201c;RSUs&#x201d;) to employees, non-employee consultants and non-employee
members of our Board of Directors. The Company also has an equity incentive plan which provides for the issuance of equity incentive
awards, such as stock options, stock appreciation rights, stock awards, restricted stock, stock units, performance awards and other stock
or cash-based awards collectively, the &#x201c;Awards.&#x201d; Awards may be granted under the 2022 Plan to the Company&#x2019;s employees,
officers, directors, consultants, agents, advisors and independent contractors.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company measures the compensation cost associated with all share-based payments based on grant date fair values. The fair value of each
stock option and stock purchase right is estimated on the date of grant using an option pricing model that meets certain requirements.
The Company generally uses the Black-Scholes option pricing model to estimate the fair value of its stock options and stock purchase
rights. The determination of the fair value of share-based payment awards utilizing the Black-Scholes model is affected by the Company&#x2019;s
stock price and several assumptions, including expected volatility, expected term, risk-free interest rate and expected dividends.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
grants of stock options, the Company uses a blend of historical and implied volatility for traded options on its stock to estimate the
expected volatility assumption required in the Black-Scholes model. The Company&#x2019;s use of a blended volatility estimates in computing
the expected volatility assumption for stock options is based on its belief that while the implied volatility is representative of expected
future volatility, the historical volatility over the expected term of the award is also an indicator of expected future volatility.
The Company utilizes a blended volatility estimate that consists of implied volatility and historical volatility in order to estimate
the expected volatility assumption of the Black-Scholes model.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
expected term of stock options granted is estimated using historical experience. The risk-free interest rate assumption is based on observed
interest rates appropriate for the expected terms of the Company&#x2019;s stock options and stock purchase rights. The dividend yield
assumption is based on the Company&#x2019;s history and expectation of no dividend payouts. The Company estimates forfeitures at the time
of grant and revises these estimates, if necessary, in subsequent periods if actual forfeitures differ from those estimates. The Company
estimates its forfeiture rate assumption for all types of share-based compensation awards based on historical forfeiture rates related
to each category of award.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Compensation
costs associated with grants of restricted stock units are measured at fair value, which has historically been the closing price of the
Company&#x2019;s common stock on the date of grant.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognizes share-based compensation expense over the requisite service period of each individual award, which generally equals
the vesting period, using the straight-line method for awards that contain only service conditions. For awards that contain performance
conditions, the Company recognizes the share-based compensation expense on a straight-line basis for each vesting tranche, when achievement
of that tranche is considered probable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company evaluates the assumptions used to value stock awards at each grant date. If there are any modifications or cancellations of
the underlying unvested securities, the Company may be required to accelerate, increase or cancel any remaining unearned share-based
compensation expense.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2023-04-012023-12-31" id="Fact002280">&lt;p id="xdx_849_eus-gaap--IncomeTaxPolicyTextBlock_zXx5R89VEUIg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;INCOME
TAXES&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company follows the provisions of FASB ASC 740 &#x201c;Accounting for Income Taxes.&#x201d; Under the asset and liability method of ASC
740, deferred tax assets and liabilities are recognized for the future tax consequences attributed to differences between the financial
statement carrying amounts of existing assets and liabilities and their respective tax base. Deferred tax assets and liabilities are
measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to
be recovered or settled. Under ASC 740, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income
in the period that includes the enactment date. If it is more likely than not that some portion of a deferred tax asset will not be realized,
a valuation allowance is recognized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;THE
SINGING MACHINE COMPANY, INC AND SUBSIDIARIES&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December
31, 2023, and March 31, 2023 and 2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognizes a liability for uncertain tax positions. An uncertain tax position is defined as a position in a previously filed
tax return or a position expected to be taken in a future tax return that is not based on clear and unambiguous tax law and which is
reflected in measuring current or deferred income tax assets and liabilities for interim or annual periods. The Company may
recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained
on examination by the taxing authorities, based on the technical merits of the position. The Company measures the tax benefits
recognized based on the largest benefit that has a &lt;span id="xdx_90A_eus-gaap--IncomeTaxExaminationLikelihoodOfUnfavorableSettlement_c20230401__20231231_zrx94xkqnTv7"&gt;greater
than 50% likelihood&lt;/span&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;of being realized upon
ultimate resolution.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2023, and March 31, 2023, there were no uncertain tax positions that resulted in any adjustment to the Company&#x2019;s
provision for income taxes. The Company recognizes interest and penalties related to unrecognized tax benefits in its provision for income
taxes. The Company currently has no liabilities recorded for accrued interest or penalties related to uncertain tax provisions.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:IncomeTaxExaminationLikelihoodOfUnfavorableSettlement contextRef="From2023-04-012023-12-31" id="Fact002281">greater
than 50% likelihood</us-gaap:IncomeTaxExaminationLikelihoodOfUnfavorableSettlement>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2023-04-012023-12-31" id="Fact002283">&lt;p id="xdx_84B_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zlsiD5f9UQQb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;RECENT
ACCOUNTING PRONOUNCEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
December 2023, the FASB issued ASU 2023-09, &lt;i&gt;Income Taxes (Topic 740): Improvements to Income Tax Disclosures&lt;/i&gt;. ASU 2023-09 is intended
to enhance the usefulness of income tax disclosures by requiring entities to disclose specific rate reconciliations, amount of income
taxes separate by federal and individual tax jurisdictions, and the amount of income (loss) from continuing operations before income
tax expense (benefit) disaggregated between federal, state and foreign. ASU 2023-09 is effective for the Company for its fiscal year
beginning January 1, 2025, with early adoption permitted. The Company is currently evaluating the impact of adopting this standard on
our consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/p&gt;

</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="From2023-04-012023-12-31" id="Fact002285">&lt;p id="xdx_80F_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_ztYxJTMrb7r3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
5 - &lt;span&gt;PROPERTY AND EQUIPMENT, NET&lt;/span&gt; &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_828_zEWoggtyJkS6" style="display: none"&gt;PROPERTY
AND EQUIPMENT&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_890_eus-gaap--PropertyPlantAndEquipmentTextBlock_zTLkenoLXW3g" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
summary of property and equipment is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BC_zAmQk0bKrwej" style="display: none"&gt;SCHEDULE
OF PROPERTY AND EQUIPMENT&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;Useful&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;March 31,&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;Life&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 48%; text-align: left"&gt;Computer and office equipment&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: left"&gt;&lt;span id="xdx_904_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerAndOfficeEquipmentMember__srt--RangeAxis__srt--MinimumMember_zZItq5y2jJK9" title="Average useful life (in years)"&gt;5&lt;/span&gt;-&lt;span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerAndOfficeEquipmentMember__srt--RangeAxis__srt--MaximumMember_zluvefZyvHkg" title="Average useful life (in years)"&gt;7&lt;/span&gt; years&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerAndOfficeEquipmentMember_zOJy9Ps5K0t7" style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right" title="Property and equipment, gross"&gt;404,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerAndOfficeEquipmentMember_zOOhCwIoh8B1" style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right" title="Property and equipment, gross"&gt;497,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Furniture and fixtures&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zsCYAHHPEDLe" title="Average useful life (in years)"&gt;7&lt;/span&gt; years&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zqHbKfyGTJuc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross"&gt;107,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zyk4EUB7BZyc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross"&gt;111,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Warehouse equipment&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_906_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--WarehouseEquipmentMember_zkZk2d4OMzV6" title="Average useful life (in years)"&gt;7&lt;/span&gt; years&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--WarehouseEquipmentMember_zU1a3Xgvuwmk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2305"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--WarehouseEquipmentMember_zZEuGuqIRqV1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross"&gt;251,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Molds and tooling&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;&lt;span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MoldsAndToolingMember__srt--RangeAxis__srt--MinimumMember_zXcDx8A9SzZb" title="Average useful life (in years)"&gt;3&lt;/span&gt;-&lt;span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MoldsAndToolingMember__srt--RangeAxis__srt--MaximumMember_zUNkbKrTalP5" title="Average useful life (in years)"&gt;5&lt;/span&gt; years&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MoldsAndToolingMember_zUTKwhQYnkq5" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross"&gt;2,228,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MoldsAndToolingMember_zL5n6RHOk1b4" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross"&gt;2,160,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20231231_zlU54n9m8uG6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross"&gt;2,739,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230331_zrs7FnVl2VLj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross"&gt;3,019,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Less: Accumulated depreciation&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pp0p0_c20231231_zH6PI5nPOcA7" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Less: Accumulated depreciation"&gt;2,335,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pp0p0_c20230331_z8dczwO11nca" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Less: Accumulated depreciation"&gt;2,386,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3p0_c20231231_z4mXyHYNYQZ3" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"&gt;404,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3p0_c20230331_zbbsJanErv32" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"&gt;633,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A4_zzdYpgc2Hfta" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Depreciation
expense for the nine months ended December 31, 2023 was approximately $&lt;span id="xdx_903_eus-gaap--Depreciation_c20230401__20231231_zAZmXlnANDS2" title="Depreciation expense"&gt;287,000&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Depreciation
expense for both fiscal years ended March 31, 2023, and 2022, was approximately $&lt;span id="xdx_907_eus-gaap--Depreciation_c20220401__20230331_z1M2ij933MBi" title="Depreciation expense"&gt;228,000&lt;/span&gt; and $&lt;span id="xdx_900_eus-gaap--Depreciation_c20210401__20220331_zJgXsnYaL1Ca" title="Depreciation expense"&gt;246,000&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="From2023-04-012023-12-31" id="Fact002287">&lt;p id="xdx_890_eus-gaap--PropertyPlantAndEquipmentTextBlock_zTLkenoLXW3g" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
summary of property and equipment is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BC_zAmQk0bKrwej" style="display: none"&gt;SCHEDULE
OF PROPERTY AND EQUIPMENT&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;Useful&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;March 31,&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;Life&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 48%; text-align: left"&gt;Computer and office equipment&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: left"&gt;&lt;span id="xdx_904_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerAndOfficeEquipmentMember__srt--RangeAxis__srt--MinimumMember_zZItq5y2jJK9" title="Average useful life (in years)"&gt;5&lt;/span&gt;-&lt;span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerAndOfficeEquipmentMember__srt--RangeAxis__srt--MaximumMember_zluvefZyvHkg" title="Average useful life (in years)"&gt;7&lt;/span&gt; years&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerAndOfficeEquipmentMember_zOJy9Ps5K0t7" style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right" title="Property and equipment, gross"&gt;404,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerAndOfficeEquipmentMember_zOOhCwIoh8B1" style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right" title="Property and equipment, gross"&gt;497,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Furniture and fixtures&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zsCYAHHPEDLe" title="Average useful life (in years)"&gt;7&lt;/span&gt; years&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zqHbKfyGTJuc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross"&gt;107,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zyk4EUB7BZyc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross"&gt;111,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Warehouse equipment&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_906_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--WarehouseEquipmentMember_zkZk2d4OMzV6" title="Average useful life (in years)"&gt;7&lt;/span&gt; years&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--WarehouseEquipmentMember_zU1a3Xgvuwmk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2305"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--WarehouseEquipmentMember_zZEuGuqIRqV1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross"&gt;251,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Molds and tooling&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;&lt;span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MoldsAndToolingMember__srt--RangeAxis__srt--MinimumMember_zXcDx8A9SzZb" title="Average useful life (in years)"&gt;3&lt;/span&gt;-&lt;span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MoldsAndToolingMember__srt--RangeAxis__srt--MaximumMember_zUNkbKrTalP5" title="Average useful life (in years)"&gt;5&lt;/span&gt; years&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MoldsAndToolingMember_zUTKwhQYnkq5" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross"&gt;2,228,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MoldsAndToolingMember_zL5n6RHOk1b4" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross"&gt;2,160,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20231231_zlU54n9m8uG6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross"&gt;2,739,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230331_zrs7FnVl2VLj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross"&gt;3,019,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Less: Accumulated depreciation&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pp0p0_c20231231_zH6PI5nPOcA7" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Less: Accumulated depreciation"&gt;2,335,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pp0p0_c20230331_z8dczwO11nca" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Less: Accumulated depreciation"&gt;2,386,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3p0_c20231231_z4mXyHYNYQZ3" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"&gt;404,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3p0_c20230331_zbbsJanErv32" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"&gt;633,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2023-12-31_custom_ComputerAndOfficeEquipmentMember_srt_MinimumMember"
      id="Fact002289">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2023-12-31_custom_ComputerAndOfficeEquipmentMember_srt_MaximumMember"
      id="Fact002291">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2023-12-31_custom_ComputerAndOfficeEquipmentMember"
      decimals="0"
      id="Fact002293"
      unitRef="USD">404000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2023-03-31_custom_ComputerAndOfficeEquipmentMember"
      decimals="0"
      id="Fact002295"
      unitRef="USD">497000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2023-12-31_us-gaap_FurnitureAndFixturesMember"
      id="Fact002297">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2023-12-31_us-gaap_FurnitureAndFixturesMember"
      decimals="0"
      id="Fact002299"
      unitRef="USD">107000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2023-03-31_us-gaap_FurnitureAndFixturesMember"
      decimals="0"
      id="Fact002301"
      unitRef="USD">111000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2023-12-31_custom_WarehouseEquipmentMember"
      id="Fact002303">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2023-03-31_custom_WarehouseEquipmentMember"
      decimals="0"
      id="Fact002307"
      unitRef="USD">251000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2023-12-31_custom_MoldsAndToolingMember_srt_MinimumMember"
      id="Fact002309">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2023-12-31_custom_MoldsAndToolingMember_srt_MaximumMember"
      id="Fact002311">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2023-12-31_custom_MoldsAndToolingMember"
      decimals="0"
      id="Fact002313"
      unitRef="USD">2228000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2023-03-31_custom_MoldsAndToolingMember"
      decimals="0"
      id="Fact002315"
      unitRef="USD">2160000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002317"
      unitRef="USD">2739000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2023-03-31"
      decimals="0"
      id="Fact002319"
      unitRef="USD">3019000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002321"
      unitRef="USD">2335000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2023-03-31"
      decimals="0"
      id="Fact002323"
      unitRef="USD">2386000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002325"
      unitRef="USD">404000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2023-03-31"
      decimals="-3"
      id="Fact002327"
      unitRef="USD">633000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact002329"
      unitRef="USD">287000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact002331"
      unitRef="USD">228000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact002333"
      unitRef="USD">246000</us-gaap:Depreciation>
    <us-gaap:DebtDisclosureTextBlock contextRef="From2023-04-012023-12-31" id="Fact002335">&lt;p id="xdx_802_eus-gaap--DebtDisclosureTextBlock_zoegaCnoZlqf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
6 &#x2013; &lt;span id="xdx_828_znhlSSPeKUJ2"&gt;FINANCING&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Oxford
Credit Facility&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March 28, 2024, the Company entered into a Loan and Security Agreement with Oxford Business Credit (the &#x201c;Credit Agreement&#x201d;),
as Lender. The Credit Agreement established a secured asset-backed revolving credit facility which is comprised of a maximum $&lt;span id="xdx_90B_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_c20240328__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zQk4m4U3gg33" title="Revolving credit facility"&gt;2,000,000&lt;/span&gt;
revolving credit facility (&#x201c;Credit Facility&#x201d;). Availability under the Credit Facility is determined monthly by a borrowing
base comprised of a percentage of eligible accounts receivable of the Borrowers. The Company&#x2019;s obligations under the Credit Agreement
are secured by a continuing security interest in all property of each Loan Party, subject to certain excluded collateral (as defined
in the Credit Agreement).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;THE
SINGING MACHINE COMPANY, INC AND SUBSIDIARIES&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December
31, 2023, and March 31, 2023 and 2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Borrowings
under the Credit Facility take the form of base rate loans at interest rates of the greater of either (a) the Prime Rate plus &lt;span id="xdx_907_ecustom--LineOfCreditFacilityInterestRate_dp_uPure_c20240328__20240328__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_zpUeUt4O9lV5" title="The Prime Rate"&gt;2.5&lt;/span&gt;% The
Credit agreement includes certain covenants which include, but are not limited to restrictions on debt, asset liens, capital expenditures,
formation of new entities and financial covenants.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Credit Agreement is for a &lt;span id="xdx_90A_eus-gaap--DebtInstrumentTerm_dxL_c20240328__20240328__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_z8vRwyyYUbrb" title="Credit agreement term::XDX::P2Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2341"&gt;two&lt;/span&gt;&lt;/span&gt;-year term that expires on &lt;span id="xdx_908_eus-gaap--LineOfCreditFacilityExpirationDate1_dd_c20240328__20240328__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_zvE5JZcsnlB5" title="Credit agreement expires"&gt;November 28, 2026&lt;/span&gt;, and automatically renews for an additional one-year term on
each anniversary of date of the agreement unless the Company notifies Oxford within 60 days before the anniversary date of its intention
to pay off the Credit Facility and terminate the Credit Agreement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is subject to a two percent (&lt;span id="xdx_907_ecustom--PercentageOfExitFee_dp_uPure_c20240328__20240328__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_zrDXecF6lhGe" title="Percentage of exit fee"&gt;2&lt;/span&gt;%) Exit Fee if the Company terminates the Credit Agreement and repays the obligations under Credit
Facility prior to the anniversary date of the Credit Agreement. The Exit Fee shall automatically renew on the two-year anniversary date
of the Loan Agreement for an additional one-year period unless the Company notifies Lender in writing within sixty (60) days before such
anniversary date of Borrower&#x2019;s intention to pay off this Credit Facility and terminate the Credit Agreement and all obligations
of the Credit Facility are paid in full by such anniversary date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Fifth
Third Bank Asset-backed Revolving Credit Facility&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
October 14, 2022, the Company entered into a Loan and Security Agreement with Fifth Third Financial Corporation (the &#x201c;Credit Agreement&#x201d;),
as Lender, replacing the Company&#x2019;s credit facilities with Crestmark and IHC that were terminated by the Company on October 13,
2022. The Credit Agreement established a secured asset-backed revolving credit facility which is comprised of a maximum $&lt;span id="xdx_902_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_c20221014__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_zj8BYhItFPY5" title="Revolving credit facility maximum amount"&gt;15,000,000&lt;/span&gt; revolving
credit facility (&#x201c;Credit Facility&#x201d;). The Credit Facility was terminated on &lt;span id="xdx_904_eus-gaap--LineOfCreditFacilityExpirationDate1_dd_c20221014__20221014__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_zUBMDHAdT2ed" title="Revolving credit facility terminated date"&gt;November 17, 2023&lt;/span&gt;. Availability under the Credit
Facility was determined monthly by a borrowing base comprised of a percentage of eligible accounts receivable and eligible inventory
of the Borrowers. The Company&#x2019;s obligations under the Credit Agreement are secured by a continuing security interest in all property
of each Loan Party, subject to certain excluded collateral (as defined in the Credit Agreement).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Costs
associated with closing of the Credit Agreement of approximately $&lt;span id="xdx_902_eus-gaap--RepaymentsOfLinesOfCredit_c20221014__20221014__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_zl2w5WVzF013" title="Costs associated with line of credit"&gt;254,000&lt;/span&gt; were deferred and being amortized over life of the loan. During
the nine months ended December 31, 2023, and 2022, the Company incurred amortization expenses of approximately $&lt;span id="xdx_909_eus-gaap--AdjustmentForAmortization_c20230401__20231231_zkE9VC4x4R5k" title="Amortization expense"&gt;215,000&lt;/span&gt; and $&lt;span id="xdx_90D_eus-gaap--AdjustmentForAmortization_c20220401__20221231_z1ylOAExJwd9" title="Amortization expense"&gt;18,000&lt;/span&gt; respectively
associated with the amortization of deferred financing costs from the Credit Agreement. During the fiscal years ended March 31, 2023,
and 2022, the Company incurred amortization expense of approximately $&lt;span id="xdx_906_eus-gaap--AdjustmentForAmortization_c20220401__20230331_zgZgKCRmzEcf" title="Amortization expense"&gt;39,000&lt;/span&gt; and $&lt;span id="xdx_90A_eus-gaap--AdjustmentForAmortization_c20210401__20220331_zLZLz0yNvpQl" title="Amortization expense"&gt;0&lt;/span&gt;, respectively, associated with the amortization of
deferred financing costs from the Credit Agreement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Borrowings
under the Credit Facility took the form of base rate loans at interest rates of the greater of either &lt;span id="xdx_907_eus-gaap--LineOfCreditFacilityInterestRateDescription_c20221014__20221014__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_zWOWVwwlxQEc" title="Base rates of loan description"&gt;(a) the Prime Rate plus 0.50% or (b) the Secured Overnight Financing Rate (&#x201c;SOFR&#x201d;) 30-day term rate plus 3%, subject to a minimum of 0.050% in either case.&lt;/span&gt;
For the nine months ended December 31, 2023, and 2022, the Company incurred interest expense of approximately $&lt;span id="xdx_90A_eus-gaap--InterestAndDebtExpense_c20230401__20231231_zT1dJ4T4Lski" title="Interest expense"&gt;28,000&lt;/span&gt; and $&lt;span id="xdx_900_eus-gaap--InterestAndDebtExpense_c20220401__20221231_zEf4bGqscgW6" title="Interest expense"&gt;19,000&lt;/span&gt;, respectively.
For the fiscal years ended March 31, 2023, and 2022, the Company incurred interest expense of approximately $&lt;span id="xdx_909_eus-gaap--InterestAndDebtExpense_c20220401__20230331_zuIsnGIR9zM" title="Interest expense"&gt;33,000&lt;/span&gt; and $&lt;span id="xdx_90F_eus-gaap--InterestAndDebtExpense_c20210401__20220331_zQSAmhQeeXf2" title="Interest expense"&gt;0&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
May 19, 2023, the Company executed a Waiver and First Amendment agreement which provides for a waiver of previous defaults and
instituted new covenants. On November 17, 2023, the Company voluntarily terminated the Credit Agreement as the
Company could not comply with the debt coverage financial covenant effective September 30, 2023. There was no balance outstanding on
the credit agreement as of the termination date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Intercreditor
Revolving Credit Facility Crestmark Bank and Iron Horse Credit&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
June 16, 2020, the Company entered into a two-year Credit and Security Agreement for a $&lt;span id="xdx_90B_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_c20200616__us-gaap--TypeOfArrangementAxis__custom--TwoYearCreditAndSecurityAgreementMember__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_z2Di9oZsjNdh" title="Line of credit facility, maximum borrowing amount"&gt;2,500,000&lt;/span&gt; financing facility, with Iron Horse
Credit (&#x201c;IHC&#x201d;) on eligible accounts receivable and inventory. Also, on June 16, 2020, the Company entered into a two-year
Loan and Security Agreement for a $&lt;span id="xdx_90C_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_c20200616__us-gaap--TypeOfArrangementAxis__custom--TwoYearLoanAndSecurityAgreementMember__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_zSKFgqhR76M3" title="Line of credit facility, maximum borrowing amount"&gt;10,000,000&lt;/span&gt; financing facility with Crestmark Bank (&#x201c;Crestmark&#x201d;) on eligible accounts receivable.
For the nine months ended December 31, 2023, and 2022, the Company incurred approximately $&lt;span id="xdx_90E_eus-gaap--AdjustmentForAmortization_c20230401__20231231__us-gaap--TypeOfArrangementAxis__custom--CreditAndSecurityAgreementsMember_zTgv0ThgPB2l" title="Amortization expense"&gt;0&lt;/span&gt; and $&lt;span id="xdx_904_eus-gaap--AdjustmentForAmortization_c20220401__20221231__us-gaap--TypeOfArrangementAxis__custom--CreditAndSecurityAgreementsMember_z36h7xfRpnNf" title="Amortization expense"&gt;8,000&lt;/span&gt;, respectively, in amortization
costs for deferred financing charges associated with the credit and security agreements with Crestmark and IHC. The Company also incurred
interest expense of approximately $&lt;span id="xdx_90C_eus-gaap--InterestAndDebtExpense_c20220401__20230331__us-gaap--TypeOfArrangementAxis__custom--CreditAndSecurityAgreementsMember_zG7CviMNZYY1" title="Interest expenses"&gt;400,000&lt;/span&gt; and $&lt;span id="xdx_908_eus-gaap--InterestAndDebtExpense_c20210401__20220331__us-gaap--TypeOfArrangementAxis__custom--CreditAndSecurityAgreementsMember_zq3KNQdq2gy8" title="Interest expenses"&gt;500,000&lt;/span&gt; for the fiscal years ended March 31, 2023, and 2022, respectively, associated
with the credit and security agreements with Crestmark and IHC.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;THE
SINGING MACHINE COMPANY, INC AND SUBSIDIARIES&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December
31, 2023, and March 31, 2023 and 2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="AsOf2024-03-28_us-gaap_RevolvingCreditFacilityMember_us-gaap_SubsequentEventMember"
      decimals="0"
      id="Fact002337"
      unitRef="USD">2000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <RIME:LineOfCreditFacilityInterestRate
      contextRef="From2024-03-282024-03-28_us-gaap_SubsequentEventMember_us-gaap_RevolvingCreditFacilityMember"
      decimals="INF"
      id="Fact002339"
      unitRef="Pure">0.025</RIME:LineOfCreditFacilityInterestRate>
    <us-gaap:LineOfCreditFacilityExpirationDate1
      contextRef="From2024-03-282024-03-28_us-gaap_SubsequentEventMember_us-gaap_RevolvingCreditFacilityMember"
      id="Fact002343">2026-11-28</us-gaap:LineOfCreditFacilityExpirationDate1>
    <RIME:PercentageOfExitFee
      contextRef="From2024-03-282024-03-28_us-gaap_SubsequentEventMember_us-gaap_RevolvingCreditFacilityMember"
      decimals="INF"
      id="Fact002345"
      unitRef="Pure">0.02</RIME:PercentageOfExitFee>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="AsOf2022-10-14_us-gaap_RevolvingCreditFacilityMember"
      decimals="0"
      id="Fact002347"
      unitRef="USD">15000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityExpirationDate1
      contextRef="From2022-10-142022-10-14_us-gaap_RevolvingCreditFacilityMember"
      id="Fact002349">2023-11-17</us-gaap:LineOfCreditFacilityExpirationDate1>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="From2022-10-142022-10-14_us-gaap_RevolvingCreditFacilityMember"
      decimals="0"
      id="Fact002351"
      unitRef="USD">254000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:AdjustmentForAmortization
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact002353"
      unitRef="USD">215000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="From2022-04-012022-12-31"
      decimals="0"
      id="Fact002355"
      unitRef="USD">18000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact002357"
      unitRef="USD">39000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact002359"
      unitRef="USD">0</us-gaap:AdjustmentForAmortization>
    <us-gaap:LineOfCreditFacilityInterestRateDescription
      contextRef="From2022-10-142022-10-14_us-gaap_RevolvingCreditFacilityMember"
      id="Fact002361">(a) the Prime Rate plus 0.50% or (b) the Secured Overnight Financing Rate (&#x201c;SOFR&#x201d;) 30-day term rate plus 3%, subject to a minimum of 0.050% in either case.</us-gaap:LineOfCreditFacilityInterestRateDescription>
    <us-gaap:InterestAndDebtExpense
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact002363"
      unitRef="USD">28000</us-gaap:InterestAndDebtExpense>
    <us-gaap:InterestAndDebtExpense
      contextRef="From2022-04-012022-12-31"
      decimals="0"
      id="Fact002365"
      unitRef="USD">19000</us-gaap:InterestAndDebtExpense>
    <us-gaap:InterestAndDebtExpense
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact002367"
      unitRef="USD">33000</us-gaap:InterestAndDebtExpense>
    <us-gaap:InterestAndDebtExpense
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact002369"
      unitRef="USD">0</us-gaap:InterestAndDebtExpense>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="AsOf2020-06-16_custom_TwoYearCreditAndSecurityAgreementMember_us-gaap_RevolvingCreditFacilityMember"
      decimals="0"
      id="Fact002371"
      unitRef="USD">2500000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="AsOf2020-06-16_custom_TwoYearLoanAndSecurityAgreementMember_us-gaap_RevolvingCreditFacilityMember"
      decimals="0"
      id="Fact002373"
      unitRef="USD">10000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:AdjustmentForAmortization
      contextRef="From2023-04-012023-12-31_custom_CreditAndSecurityAgreementsMember"
      decimals="0"
      id="Fact002375"
      unitRef="USD">0</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="From2022-04-012022-12-31_custom_CreditAndSecurityAgreementsMember"
      decimals="0"
      id="Fact002377"
      unitRef="USD">8000</us-gaap:AdjustmentForAmortization>
    <us-gaap:InterestAndDebtExpense
      contextRef="From2022-04-012023-03-31_custom_CreditAndSecurityAgreementsMember"
      decimals="0"
      id="Fact002379"
      unitRef="USD">400000</us-gaap:InterestAndDebtExpense>
    <us-gaap:InterestAndDebtExpense
      contextRef="From2021-04-012022-03-31_custom_CreditAndSecurityAgreementsMember"
      decimals="0"
      id="Fact002381"
      unitRef="USD">500000</us-gaap:InterestAndDebtExpense>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2023-04-012023-12-31" id="Fact002383">&lt;p id="xdx_80A_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zIa6MsNQNNqj" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;NOTE
7 - &lt;span id="xdx_824_zJJZMc7y3cr9"&gt;COMMITMENTS AND CONTINGENCIES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Hospitality
Lease&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
August 23, 2023, MICS NY entered into an Agreement of Lease (the &#x201c;Lease Agreement&#x201d;) with OAC 111 Flatiron, LLC and OAC Adelphi,
LLC (the &#x201c;Landlord&#x201d;), pursuant to which MICS NY agreed to lease approximately 10,000 square feet of ground floor retail space
and a portion of the basement underneath the ground floor retail space in the property located at 111 West 24&lt;sup&gt;th&lt;/sup&gt; Street, New
York, New York (the &#x201c;Premises&#x201d;). It was the Company&#x2019;s intention to use the Premises as a new karaoke venue, offering
immersive karaoke technology and audio-visual capabilities, with restaurant and bar offerings however due to lack of funding, the Company
initiated termination of the lease in March 2024 (See Note 8 - Operating Leases).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
term of the Lease Agreement is for fifteen (15) years, or on such an earlier date upon which the term shall expire, be canceled, or terminated
pursuant to any of the conditions or covenants of the Lease Agreement. Pursuant to the Lease Agreement, MICS NY is obligated to pay an
initial base rent in the amount of $&lt;span id="xdx_90B_eus-gaap--OperatingLeaseExpense_c20240701__20240701__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zY2Htcevq7v9" title="Operating lease expense"&gt;30,000&lt;/span&gt; beginning July 1, 2024, with scheduled increases over the term, as set forth in the Lease
Agreement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
March 2024, the Company initiated the termination of this lease under certain provisions made available under the Lease Agreement. The
Landlord and the Company are in active discussions as to the terms of the lease termination however as of this filing, it is too early
in the negotiation process to estimate any potential loss, if any, related to the lease termination process.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Derivative
Litigation&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 21, 2023, Ault Lending, LLC, a wholly owned subsidiary of Ault Alliance, Inc. (&#x201c;Ault&#x201d;), one of the Company&#x2019;s
largest shareholders, filed a derivative shareholder action in Delaware Chancery Court against the Company, its Directors, and other
Company shareholders (The Stingray Group, Inc. and Regalia Ventures) (&#x201c;the Defendants&#x201d;) for alleged breach of fiduciary duty
in approving a recent above-market private placement equity transaction. The Complaint alleges the Company, and its Directors followed
an inadequate process in evaluating the private placement transaction which occurred back in November 2023 and entered into the transaction
with an intent to dilute Ault&#x2019;s ownership stake in the Company. The Defendants have retained Delaware counsel to represent them
in this matter and the Company has filed a motion to dismiss the suit. The Company has Director &amp;amp; Officer liability insurance for
up to $&lt;span id="xdx_90C_ecustom--InsuranceLiabilities_iI_c20231221__us-gaap--ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis__us-gaap--DirectorsAndOfficersLiabilityInsuranceMember_zWY8fcSPZEQ8" title="Insurance liabilities"&gt;5,000,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;with a retention of $&lt;span id="xdx_904_eus-gaap--MalpracticeInsuranceMaximumCoveragePerIncident_c20231221__20231221__us-gaap--ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis__us-gaap--DirectorsAndOfficersLiabilityInsuranceMember_zP4GhMz6qIV4"&gt;250,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;for derivative claims.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other
than what is disclosed above, we are not a party to, and our property is not the subject of, any pending material legal proceedings.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:OperatingLeaseExpense
      contextRef="From2024-07-012024-07-01_us-gaap_SubsequentEventMember"
      decimals="0"
      id="Fact002385"
      unitRef="USD">30000</us-gaap:OperatingLeaseExpense>
    <RIME:InsuranceLiabilities
      contextRef="AsOf2023-12-21_us-gaap_DirectorsAndOfficersLiabilityInsuranceMember"
      decimals="0"
      id="Fact002387"
      unitRef="USD">5000000</RIME:InsuranceLiabilities>
    <us-gaap:MalpracticeInsuranceMaximumCoveragePerIncident
      contextRef="From2023-12-212023-12-21_us-gaap_DirectorsAndOfficersLiabilityInsuranceMember"
      decimals="0"
      id="Fact002388"
      unitRef="USD">250000</us-gaap:MalpracticeInsuranceMaximumCoveragePerIncident>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="From2023-04-012023-12-31" id="Fact002390">&lt;p id="xdx_802_eus-gaap--LesseeOperatingLeasesTextBlock_z2S3jesDU2Of" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
8 &#x2013; &lt;span id="xdx_822_z7PIQGxfbp87"&gt;OPERATING LEASES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
the time of this filing, the Company has operating lease agreements for offices in Florida and Hong Kong and a retail location in New
York expiring in various years through 2038. The Company entered into an operating lease agreement, effective October 1, 2017, for our
corporate headquarters located in Fort Lauderdale, Florida where we lease approximately &lt;span id="xdx_909_eus-gaap--AreaOfLand_iI_pid_usqft_c20171001__us-gaap--TypeOfArrangementAxis__custom--OperatingLeaseAgreementMember_z5QYnhZlBjAd" title="Lease space"&gt;6,500&lt;/span&gt; square feet of office space. The lease
expired on &lt;span id="xdx_901_eus-gaap--LeaseExpirationDate1_dd_c20171001__20171001__us-gaap--TypeOfArrangementAxis__custom--OperatingLeaseAgreementMember_zZPQQUCnUqY3" title="Lease expiration, date"&gt;March 31, 2024&lt;/span&gt;. The base rent payment is approximately $&lt;span id="xdx_901_eus-gaap--PaymentsForRent_c20171001__20171001__us-gaap--TypeOfArrangementAxis__custom--OperatingLeaseAgreementMember_ztyn6TshNWF2" title="Base rent payment"&gt;9,950&lt;/span&gt; per month, subject to annual adjustments. On February 22, 2024,
&lt;span id="xdx_90D_eus-gaap--LesseeOperatingLeaseOptionToExtend_c20240220__20240222__us-gaap--TypeOfArrangementAxis__custom--OperatingLeaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_znUBhqeiqPDd" title="Lease extension, description"&gt;the Company executed a lease extension for 14 months effective April 1, 2024, and expires on May 31, 2025. The base rent on the extension
is approximately $&lt;span id="xdx_90E_eus-gaap--PaymentsForRent_c20240220__20240222__us-gaap--TypeOfArrangementAxis__custom--OperatingLeaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z9leSZpZRE72" title="Base rent payment"&gt;10,553&lt;/span&gt; per month subject to a 3% annual adjustment.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company entered into an operating lease on August 23, 2023, for approximately &lt;span id="xdx_904_eus-gaap--AreaOfLand_iI_pid_usqft_c20230823__us-gaap--TypeOfArrangementAxis__custom--OperatingLeaseAgreementMember_zKLb1vxeC867" title="Lease space"&gt;10,000&lt;/span&gt; square feet of ground floor retail space and a portion
of the basement underneath the ground floor retail space. The lease expires &lt;span id="xdx_909_eus-gaap--LeaseExpirationDate1_dd_c20230823__20230823__us-gaap--TypeOfArrangementAxis__custom--OperatingLeaseAgreementMember_zWsj6gYbLEug" title="Lease expiration, date"&gt;August 22, 2038&lt;/span&gt;, and the monthly base rent is $&lt;span id="xdx_901_eus-gaap--PaymentsForRent_c20230823__20230823__us-gaap--TypeOfArrangementAxis__custom--OperatingLeaseAgreementMember_zNQPTSZhW5p7" title="Base rent"&gt;30,000&lt;/span&gt;, subject
to annual increases. The lease includes a 11-month free rent period between July 1, 2023, and June 30, 2024 and also includes a $&lt;span id="xdx_906_eus-gaap--TenantImprovements_iI_pp0p0_c20230823__us-gaap--TypeOfArrangementAxis__custom--OperatingLeaseAgreementMember_zvx16rWpdwGk" title="Reimbursement for tenant improvements"&gt;700,000&lt;/span&gt;
reimbursement for tenant improvements upon completion of construction milestones as defined in the lease. Due to uncertainties as to
whether these milestones will be met timely, the Company has not recorded any amounts related to the tenant improvement allowance in
our consolidated financial statements for the nine months ended December 31, 2023, at lease inception in the balance sheet of our consolidated
financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
August 31, 2023, our Ontario, California operating lease agreement for our primary warehouse expired. The Company did not renew the lease
and instead transferred all of its warehousing and logistics operations to a third-party logistics facility.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;We
entered into an operating lease agreement, effective October 15, 2022, for our administrative office located in Hong Kong where we lease
approximately &lt;span id="xdx_903_eus-gaap--AreaOfLand_iI_pid_usqft_c20221015__us-gaap--TypeOfArrangementAxis__custom--OperatingLeaseAgreementMember_zLtdlyRbCAph" title="Lease space"&gt;1,890&lt;/span&gt; square feet of office space. The lease expires on &lt;span id="xdx_909_eus-gaap--LeaseExpirationDate1_dd_c20221015__20221015__us-gaap--TypeOfArrangementAxis__custom--OperatingLeaseAgreementMember_zX31giI38MOh" title="Lease expiration, date"&gt;October 14, 2025&lt;/span&gt;. The base rent payment is approximately $&lt;span id="xdx_904_eus-gaap--PaymentsForRent_c20221015__20221015__us-gaap--TypeOfArrangementAxis__custom--OperatingLeaseAgreementMember_zvdhvfgd9BLj" title="Base rent payment"&gt;4,900&lt;/span&gt;
per month for the entire term of the lease.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;THE
SINGING MACHINE COMPANY, INC AND SUBSIDIARIES&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December
31, 2023, and March 31, 2023 and 2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Lease
expense for our operating leases is recognized on a straight-line basis over the lease terms.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_895_ecustom--ScheduleOfSupplementalInformationRelatedToLeaseTableTextBlock_zWjmbd3bVcm2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Supplemental
balance sheet information related to leases as of December 31, 2023 and March 31, 2023 is as follows:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B0_za7kMDxbRY3d" style="display: none"&gt;SCHEDULE OF SUPPLEMENTAL INFORMATION RELATED TO LEASES&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49C_20231231_zDcPHGudyeXj" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_498_20230331_zHS0qcvQ2ZEf" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;December 31, 2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;March 31, 2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Assets:&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pp0p0_z1RqJbrrnIY7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"&gt;Operating lease - right-of-use assets&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;3,926,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;561,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;Liabilities&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--OperatingLeaseLiabilityCurrent_iI_pp0p0_z2SRaJwowWSb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;Current portion of operating leases&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;84,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;509,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pp0p0_zwkV7Yqg0h92" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;Operating lease liabilities, net of current portion&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;3,925,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;88,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AC_zgIRmhowRwrj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89F_eus-gaap--LeaseCostTableTextBlock_zOFvpHZmMXH9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Supplemental
statement of operations information related to leases for the nine months ended December 31, 2023 and fiscal year ended March 31, 2023
is as follows:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BD_zMH17NPEuaWc" style="display: none"&gt;SCHEDULE OF LEASE TERM AND DISCOUNT RATE&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49E_20230401__20231231_zWqyUUsNndN5" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49E_20220401__20230331_zzVpriL4SWkl" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Nine Months Ended&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Fiscal Year Ended&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;December 31 2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;March 31, 2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--OperatingLeaseExpense_zG1MRiSO8EQl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"&gt;Operating lease expense as a component of general and administrative expenses&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;717,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;1,058,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;Supplemental cash flow information related to leases for the nine months ended December 31, 2023 and fiscal year ended March 31, 2023 is as follows:&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--OperatingLeasePayments_zdqWnEkPiF56" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;Operating cash flow paid for operating leases&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;858,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;960,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;Lease term and Discount Rate&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Weighted average remaining lease term (months)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;Operating leases&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtM_c20231231_zKkjermhv1xa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average remaining lease term (months)"&gt;15.0&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtM_c20230331_zfICcyELPeRk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average remaining lease term (months)"&gt;12.4&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Weighted average discount rate&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;Operating leases&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_uPure_c20231231_zpUFwiwx61Pj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average discount rate"&gt;12.0&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;%&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_uPure_c20230331_zBY1LEPGSq5g" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average discount rate"&gt;6.5&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A9_zVeywgAg1hie" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89D_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zp4IXSDZzVy1" style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Minimum future payments under all operating leases as of December 31, 2023, are as follows:&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;span id="xdx_8B3_zrBTJWYRyf78" style="display: none"&gt;SCHEDULE
OF OPERATING LEASE MINIMUM FUTURE PAYMENTS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Payments due by period&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20231231_zeoiT9zTEqfl" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_maLOLLPzbAO_zO5vCyfHAU33" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 78%; text-align: left"&gt;2024&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"&gt;269,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_maLOLLPzbAO_zTdNecW50r51" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;2025&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;355,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_maLOLLPzbAO_zTKJSwNDSsnk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;2026&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;529,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_maLOLLPzbAO_zbN8Kl94jvk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;2027&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;585,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_maLOLLPzbAO_zo5OU1FlIcmk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;2028&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;610,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_maLOLLPzbAO_zUA0M4XIYggd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Thereafter&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;7,555,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_mtLOLLPzbAO_zZ7pqYo4GpEl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Total minimum future payments&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;9,903,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iI_zgWxyK52Qum9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Less: interest&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;5,894,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--OperatingLeaseLiability_iI_zVOVB7QGOcuf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;Total operating lease liabilities&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;4,009,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--OperatingLeaseLiabilityCurrent_iI_zIJhnVEt2fy5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Less: current portion of lease liabilities&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;84,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_zHQbvNKnJDIh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;Operating lease liabilities, net of current portion&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;3,925,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A7_zAEaWhvEnV36" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:AreaOfLand
      contextRef="AsOf2017-10-01_custom_OperatingLeaseAgreementMember"
      decimals="INF"
      id="Fact002392"
      unitRef="sqft">6500</us-gaap:AreaOfLand>
    <us-gaap:LeaseExpirationDate1
      contextRef="From2017-10-012017-10-01_custom_OperatingLeaseAgreementMember"
      id="Fact002394">2024-03-31</us-gaap:LeaseExpirationDate1>
    <us-gaap:PaymentsForRent
      contextRef="From2017-10-012017-10-01_custom_OperatingLeaseAgreementMember"
      decimals="0"
      id="Fact002396"
      unitRef="USD">9950</us-gaap:PaymentsForRent>
    <us-gaap:LesseeOperatingLeaseOptionToExtend
      contextRef="From2024-02-202024-02-22_custom_OperatingLeaseAgreementMember_us-gaap_SubsequentEventMember"
      id="Fact002398">the Company executed a lease extension for 14 months effective April 1, 2024, and expires on May 31, 2025. The base rent on the extension
is approximately $10,553 per month subject to a 3% annual adjustment.</us-gaap:LesseeOperatingLeaseOptionToExtend>
    <us-gaap:PaymentsForRent
      contextRef="From2024-02-202024-02-22_custom_OperatingLeaseAgreementMember_us-gaap_SubsequentEventMember"
      decimals="0"
      id="Fact002400"
      unitRef="USD">10553</us-gaap:PaymentsForRent>
    <us-gaap:AreaOfLand
      contextRef="AsOf2023-08-23_custom_OperatingLeaseAgreementMember"
      decimals="INF"
      id="Fact002402"
      unitRef="sqft">10000</us-gaap:AreaOfLand>
    <us-gaap:LeaseExpirationDate1
      contextRef="From2023-08-232023-08-23_custom_OperatingLeaseAgreementMember"
      id="Fact002404">2038-08-22</us-gaap:LeaseExpirationDate1>
    <us-gaap:PaymentsForRent
      contextRef="From2023-08-232023-08-23_custom_OperatingLeaseAgreementMember"
      decimals="0"
      id="Fact002406"
      unitRef="USD">30000</us-gaap:PaymentsForRent>
    <us-gaap:TenantImprovements
      contextRef="AsOf2023-08-23_custom_OperatingLeaseAgreementMember"
      decimals="0"
      id="Fact002408"
      unitRef="USD">700000</us-gaap:TenantImprovements>
    <us-gaap:AreaOfLand
      contextRef="AsOf2022-10-15_custom_OperatingLeaseAgreementMember"
      decimals="INF"
      id="Fact002410"
      unitRef="sqft">1890</us-gaap:AreaOfLand>
    <us-gaap:LeaseExpirationDate1
      contextRef="From2022-10-152022-10-15_custom_OperatingLeaseAgreementMember"
      id="Fact002412">2025-10-14</us-gaap:LeaseExpirationDate1>
    <us-gaap:PaymentsForRent
      contextRef="From2022-10-152022-10-15_custom_OperatingLeaseAgreementMember"
      decimals="0"
      id="Fact002414"
      unitRef="USD">4900</us-gaap:PaymentsForRent>
    <RIME:ScheduleOfSupplementalInformationRelatedToLeaseTableTextBlock contextRef="From2023-04-012023-12-31" id="Fact002416">&lt;p id="xdx_895_ecustom--ScheduleOfSupplementalInformationRelatedToLeaseTableTextBlock_zWjmbd3bVcm2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Supplemental
balance sheet information related to leases as of December 31, 2023 and March 31, 2023 is as follows:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B0_za7kMDxbRY3d" style="display: none"&gt;SCHEDULE OF SUPPLEMENTAL INFORMATION RELATED TO LEASES&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49C_20231231_zDcPHGudyeXj" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_498_20230331_zHS0qcvQ2ZEf" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;December 31, 2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;March 31, 2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Assets:&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pp0p0_z1RqJbrrnIY7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"&gt;Operating lease - right-of-use assets&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;3,926,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;561,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;Liabilities&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--OperatingLeaseLiabilityCurrent_iI_pp0p0_z2SRaJwowWSb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;Current portion of operating leases&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;84,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;509,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pp0p0_zwkV7Yqg0h92" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;Operating lease liabilities, net of current portion&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;3,925,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;88,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</RIME:ScheduleOfSupplementalInformationRelatedToLeaseTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002418"
      unitRef="USD">3926000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="AsOf2023-03-31"
      decimals="0"
      id="Fact002419"
      unitRef="USD">561000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002421"
      unitRef="USD">84000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="AsOf2023-03-31"
      decimals="0"
      id="Fact002422"
      unitRef="USD">509000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002424"
      unitRef="USD">3925000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="AsOf2023-03-31"
      decimals="0"
      id="Fact002425"
      unitRef="USD">88000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LeaseCostTableTextBlock contextRef="From2023-04-012023-12-31" id="Fact002427">&lt;p id="xdx_89F_eus-gaap--LeaseCostTableTextBlock_zOFvpHZmMXH9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Supplemental
statement of operations information related to leases for the nine months ended December 31, 2023 and fiscal year ended March 31, 2023
is as follows:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BD_zMH17NPEuaWc" style="display: none"&gt;SCHEDULE OF LEASE TERM AND DISCOUNT RATE&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49E_20230401__20231231_zWqyUUsNndN5" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49E_20220401__20230331_zzVpriL4SWkl" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Nine Months Ended&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Fiscal Year Ended&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;December 31 2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;March 31, 2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--OperatingLeaseExpense_zG1MRiSO8EQl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"&gt;Operating lease expense as a component of general and administrative expenses&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;717,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;1,058,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;Supplemental cash flow information related to leases for the nine months ended December 31, 2023 and fiscal year ended March 31, 2023 is as follows:&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--OperatingLeasePayments_zdqWnEkPiF56" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;Operating cash flow paid for operating leases&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;858,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;960,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;Lease term and Discount Rate&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Weighted average remaining lease term (months)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;Operating leases&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtM_c20231231_zKkjermhv1xa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average remaining lease term (months)"&gt;15.0&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtM_c20230331_zfICcyELPeRk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average remaining lease term (months)"&gt;12.4&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Weighted average discount rate&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;Operating leases&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_uPure_c20231231_zpUFwiwx61Pj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average discount rate"&gt;12.0&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;%&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_uPure_c20230331_zBY1LEPGSq5g" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average discount rate"&gt;6.5&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseExpense
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact002429"
      unitRef="USD">717000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact002430"
      unitRef="USD">1058000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeasePayments
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact002432"
      unitRef="USD">858000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact002433"
      unitRef="USD">960000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="AsOf2023-12-31" id="Fact002435">P15M</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="AsOf2023-03-31" id="Fact002437">P12M12D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact002439"
      unitRef="Pure">0.120</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="AsOf2023-03-31"
      decimals="INF"
      id="Fact002441"
      unitRef="Pure">0.065</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="From2023-04-012023-12-31" id="Fact002443">&lt;p id="xdx_89D_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zp4IXSDZzVy1" style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Minimum future payments under all operating leases as of December 31, 2023, are as follows:&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;span id="xdx_8B3_zrBTJWYRyf78" style="display: none"&gt;SCHEDULE
OF OPERATING LEASE MINIMUM FUTURE PAYMENTS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Payments due by period&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20231231_zeoiT9zTEqfl" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_maLOLLPzbAO_zO5vCyfHAU33" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 78%; text-align: left"&gt;2024&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"&gt;269,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_maLOLLPzbAO_zTdNecW50r51" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;2025&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;355,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_maLOLLPzbAO_zTKJSwNDSsnk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;2026&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;529,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_maLOLLPzbAO_zbN8Kl94jvk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;2027&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;585,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_maLOLLPzbAO_zo5OU1FlIcmk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;2028&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;610,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_maLOLLPzbAO_zUA0M4XIYggd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Thereafter&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;7,555,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_mtLOLLPzbAO_zZ7pqYo4GpEl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Total minimum future payments&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;9,903,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iI_zgWxyK52Qum9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Less: interest&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;5,894,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--OperatingLeaseLiability_iI_zVOVB7QGOcuf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;Total operating lease liabilities&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;4,009,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--OperatingLeaseLiabilityCurrent_iI_zIJhnVEt2fy5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Less: current portion of lease liabilities&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;84,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_zHQbvNKnJDIh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;Operating lease liabilities, net of current portion&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;3,925,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002445"
      unitRef="USD">269000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002447"
      unitRef="USD">355000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002449"
      unitRef="USD">529000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002451"
      unitRef="USD">585000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002453"
      unitRef="USD">610000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002455"
      unitRef="USD">7555000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002457"
      unitRef="USD">9903000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002459"
      unitRef="USD">5894000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002461"
      unitRef="USD">4009000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002463"
      unitRef="USD">84000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002465"
      unitRef="USD">3925000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="From2023-04-012023-12-31" id="Fact002467">&lt;p id="xdx_80D_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_z5GkWyKWz7u9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
9 &#x2013; &lt;span id="xdx_82C_zz4hmLHo5Qhg"&gt;STOCK COMPENSATION EXPENSE&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;EQUITY
INCENTIVE PLAN&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
April 12, 2022, the Board of Directors approved The Singing Machine Company, Inc. 2022 Equity Incentive Plan, or the 2022 Plan. The 2022
Plan provides for the issuance of equity incentive awards, such as stock options, stock appreciation rights, stock awards, restricted
stock, stock units, performance awards and other stock or cash-based awards collectively, the &#x201c;Awards.&#x201d; Awards may be granted
under the 2022 Plan to the Company&#x2019;s employees, officers, directors, consultants, agents, advisors and independent contractors.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_eus-gaap--SaleOfStockDescriptionOfTransaction_c20220411__20220412__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zekDRupXv7Ej" title="Sale of stock description"&gt;The
maximum number of shares of common stock initially available for issuance under the 2022 Plan is 233,334 shares of common stock and
thereafter an annual increase shall be added as of the first day of the Company&#x2019;s fiscal year beginning in 2023, equal to the
least of (i) 5% of the outstanding common stock on a fully diluted basis as of the end of the Company&#x2019;s immediately preceding
fiscal year, (ii) 33,334 shares, and (iii) a lesser amount as determined by the Board of Directors.&lt;/span&gt; The shares of common stock
subject to stock awards granted under the 2022 Plan that lapse, terminate, expire prior to exercise, are canceled, or are forfeited,
shall again become available for issuance under the 2022 Plan. Shares subject to a stock award under the 2022 Plan shall not again
be made available for issuance or delivery under the 2022 Plan if such shares are (i) shares tendered by a participant or retained
by the Company as full or partial payment to the Company for the exercise or purchase price of an award or (ii) shares used to
satisfy tax withholding obligations in connection with an award.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Board of Directors may amend, suspend or terminate the 2022 Plan or a portion of it at any time; however, to the extent required by applicable
law, regulation or stock exchange rule, stockholder approval shall be required for any amendment to the 2022 Plan. The 2022 Plan is scheduled
to terminate automatically in ten (10) years following the earlier of (a) the date the Board of Directors adopted the 2022 Plan and (b)
the date the stockholders approved the 2022 Plan.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;THE
SINGING MACHINE COMPANY, INC AND SUBSIDIARIES&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December
31, 2023, and March 31, 2023 and 2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;COMMON
STOCK OPTIONS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the nine months ended December 31, 2023, the Company did not issue any stock options. During the fiscal years ended March 31, 2023, the
Company issued the following stock options:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fiscal
2023:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the fiscal year ended March 31, 2023, the Company issued &lt;span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220401__20230331__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zhYKPx7FRuG7" title="Common stock options grants"&gt;6,001&lt;/span&gt; stock options under the 2022 Plan at an exercise price ranging from $&lt;span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220401__20230331__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__srt--TitleOfIndividualAxis__srt--DirectorMember__srt--RangeAxis__srt--MinimumMember_zfKtS8MEOK35" title="Exercise price"&gt;2.35&lt;/span&gt;
to $&lt;span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220401__20230331__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__srt--TitleOfIndividualAxis__srt--DirectorMember__srt--RangeAxis__srt--MaximumMember_zBltLXSALflb" title="Exercise price"&gt;8.11&lt;/span&gt; per share to directors as compensation for their service.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the fiscal year ended March 31, 2023, the Company issued &lt;span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220401__20230331__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__srt--TitleOfIndividualAxis__srt--OfficerMember_zIirfgi9Svy1" title="Common stock options grants"&gt;37,001 &lt;/span&gt;stock
options from the 2022 Plan at an exercise price ranging from $&lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220401__20230331__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__srt--TitleOfIndividualAxis__srt--OfficerMember__srt--RangeAxis__srt--MinimumMember_zrjgVp5Wyuzf" title="Exercise price"&gt;4.00&lt;/span&gt;
to $&lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220401__20230331__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__srt--TitleOfIndividualAxis__srt--OfficerMember__srt--RangeAxis__srt--MaximumMember_z0xBID13UDZ6" title="Exercise price"&gt;8.65&lt;/span&gt;
per share to the Company&#x2019;s officers as incentive compensation for the successful up-listing of the Company&#x2019;s common
stock on the Nasdaq Capital Market and compensation related to their Fiscal 2022 annual incentive plan.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the fiscal year ended March 31, 2023, the Company issued &lt;span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220401__20230331__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__srt--TitleOfIndividualAxis__custom--EmployeeMember_z4xSXPO0ahl4" title="Common stock options grants"&gt;64,750&lt;/span&gt; stock options from the 2022 Plan to all employees (excluding Company
officers) who had one year or more of service to the Company under an Employee Incentive Plan at an exercise price ranging from $&lt;span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220401__20230331__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__srt--TitleOfIndividualAxis__custom--EmployeeMember__srt--RangeAxis__srt--MinimumMember_zN0Y1fCGx21g" title="Exercise price"&gt;8.11&lt;/span&gt;
to $&lt;span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220401__20230331__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__srt--TitleOfIndividualAxis__custom--EmployeeMember__srt--RangeAxis__srt--MaximumMember_zZe98hshSP07" title="Exercise price"&gt;8.65&lt;/span&gt; per share.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Employee
stock option compensation expense for the nine months ended December 31, 2023, and in fiscal years ended March 31, 2023, and 2022 includes
the estimated fair value of options granted, amortized on a straight-line basis over the requisite service period for the entire portion
of the award. For the nine months ended December 31, 2023, the stock option expense was approximately $&lt;span id="xdx_90A_eus-gaap--StockOptionPlanExpense_c20230401__20231231_zRDg86rXewH5" title="Stock option expense"&gt;110,000&lt;/span&gt;. For the fiscal years
ended March 31, 2023, and 2022, the stock option expense was approximately $&lt;span id="xdx_90B_eus-gaap--StockOptionPlanExpense_c20220401__20230331_zfc9hwTbnooh" title="Stock option expense"&gt;237,000&lt;/span&gt; and $&lt;span id="xdx_901_eus-gaap--StockOptionPlanExpense_c20210401__20220331_zzGZkuXxuiw3" title="Stock option expense"&gt;22,000&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fiscal
2022:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the fiscal year ended March 31, 2022, the Company issued &lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210401__20220331__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember_zKGFIfAPybk8" title="Common stock options grants"&gt;2,001&lt;/span&gt; Board approved options three members of our Board of Directors at an exercise
price ranging from $&lt;span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210401__20220331__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember__srt--RangeAxis__srt--MinimumMember_zmfTXfAfdLjd" title="Exercise price"&gt;8.10&lt;/span&gt; and $&lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210401__20220331__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember__srt--RangeAxis__srt--MaximumMember_zOAUKVkhGR0b" title="Exercise price"&gt;8.70&lt;/span&gt; per share pursuant to our annual director compensation plan for the fiscal year ended March 31, 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of each option grant was estimated on the date of the grant using the Black-Scholes option-pricing model with the assumptions
outlined below. The expected volatility is based upon the historical volatility of our stock and other contributing factors. The expected
term is based upon observation of actual time elapsed between date of grant and exercise of options for all employees.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
    the year ended March 31, 2023: expected dividend yield of &lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20220401__20230331_zAwJHiDdPak2" title="Stock option, expected dividend yield"&gt;0&lt;/span&gt;%, risk-free interest rate between &lt;span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20220401__20230331__srt--RangeAxis__srt--MinimumMember_zVvIIspQ1oHe" title="Stock option, risk free interest rate"&gt;2.63&lt;/span&gt;% and &lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20220401__20230331__srt--RangeAxis__srt--MaximumMember_zEQwQQUSYlxb" title="Stock option, risk free interest rate"&gt;3.21&lt;/span&gt;%, respectively, with
    volatility between &lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20220401__20230331__srt--RangeAxis__srt--MinimumMember_zCEZh59Ffih7" title="Stock option, volatility"&gt;166.1&lt;/span&gt;% and &lt;span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20220401__20230331__srt--RangeAxis__srt--MaximumMember_zC5exglHaUV" title="Stock option, volatility"&gt;196.3&lt;/span&gt;%, respectively with an expected term of &lt;span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dc_c20220401__20230331_zjVgIJiZ7k8l" title="Stock option, expected term"&gt;three years&lt;/span&gt;.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
    the fiscal year ended March 31, 2022: expected dividend yield of &lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20210401__20220331_zNwaweCTsHp8" title="Stock option, expected dividend yield"&gt;0&lt;/span&gt;%, risk-free interest rate between &lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20210401__20220331__srt--RangeAxis__srt--MinimumMember_zApapyrpAuW6" title="Stock option, risk free interest rate"&gt;0.43&lt;/span&gt;% and &lt;span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20210401__20220331__srt--RangeAxis__srt--MaximumMember_zjW8pkHro0Ab" title="Stock option, risk free interest rate"&gt;0.96&lt;/span&gt;%, respectively
    with volatility between &lt;span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20210401__20220331__srt--RangeAxis__srt--MinimumMember_zzGMD5kpB1Ql" title="Stock option, volatility"&gt;149.5&lt;/span&gt;% and &lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20210401__20220331__srt--RangeAxis__srt--MaximumMember_zcm7CXKI6d5l" title="Stock option, volatility"&gt;157.0&lt;/span&gt;% respectively with an expected term of &lt;span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dc_c20210401__20220331_zPjyUS7j10Ii" title="Stock option, expected term"&gt;three years&lt;/span&gt;.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_894_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zwSZRhkkVd2i" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
summary of stock option activity for each of the years presented is summarized below.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span id="xdx_8BB_zxjo8GHyYRrc" style="display: none"&gt;SUMMARY OF STOCK OPTION ACTIVITY&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;Nine Months Ended&lt;/p&gt;
                                                                                &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;December 31, 2023&lt;/p&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;Fiscal Year Ended&lt;/p&gt;
                                                                                &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;March 31, 2023&lt;/p&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;Fiscal Year Ended&lt;/p&gt;
                                                                                &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;March 31, 2022&lt;/p&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;Number of&lt;/p&gt;
                                                                                &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;Options&lt;/p&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;Weighted&lt;/p&gt;
                                                                                &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;Average Exercise&lt;/p&gt;
                                                                                &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;Price&lt;/p&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;Weighted&lt;/p&gt;
                                                                                &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;Average Contractual&lt;/p&gt;
                                                                                &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;Life&lt;/p&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;Number of&lt;/p&gt;
                                                                                &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;Options&lt;/p&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;Weighted&lt;/p&gt;
                                                                                &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;Average Exercise&lt;/p&gt;
                                                                                &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;Price&lt;/p&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;Weighted&lt;/p&gt;
                                                                                &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;Average Contractual&lt;/p&gt;
                                                                                &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;Life&lt;/p&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;Number of&lt;/p&gt;
                                                                                &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;Options&lt;/p&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;Weighted&lt;/p&gt;
                                                                                &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;Average Exercise&lt;/p&gt;
                                                                                &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;Price&lt;/p&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;Weighted&lt;/p&gt;
                                                                                &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;Average Contractual&lt;/p&gt;
                                                                                &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;Life&lt;/p&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;Stock Options:&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; width: 28%; text-align: left"&gt;Balance at beginning of year&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20230401__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zuSR13e2AEoi" style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: right" title="Number of Options, Balance at beginning of period"&gt;161,427&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20230401__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zM4jL2mKz5ye" style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: right" title="Weighted Average Exercise Price, Balance at beginning of period"&gt;7.90&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220401__20230331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_z4VT6tWjrgqi" title="Weighted Average contractual life"&gt;6.6&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220401__20230331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_z8dASt4qV4ne" style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: right" title="Number of Options, Balance at beginning of period"&gt;56,343&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20220401__20230331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zKgXaYCHT0o2" style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: right" title="Weighted Average Exercise Price, Balance at beginning of period"&gt;9.90&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210401__20220331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zWny3OKkJnFk" title="Weighted Average contractual life"&gt;4.1&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20210401__20220331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zec1i6Kv76M9" style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: right" title="Number of Options, Balance at beginning of period"&gt;56,010&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20210401__20220331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zjjPY4f494Lk" style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: right" title="Weighted Average Exercise Price, Balance at beginning of period"&gt;9.90&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20200401__20210331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zt6XjHfdLmUi" title="Weighted Average contractual life"&gt;5.4&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;Granted&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230401__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zUkFlbAFEZug" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2545"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20230401__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zunSwWVnfai3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2547"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;-&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220401__20230331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zfBOrO3XLqfi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Granted"&gt;107,752&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220401__20230331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_z1nbqACPRrm4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Granted"&gt;6.83&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;-&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210401__20220331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_z1T5Xzj2wjN7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Granted"&gt;3,667&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210401__20220331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zcgNdOMVzf3d" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Granted"&gt;7.80&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;-&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;Exercised&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20230401__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zPs1yMi1yQV8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2557"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20230401__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zApJ6Jrqzn57" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2559"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;-&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20220401__20230331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zT42hGb2aNR" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2561"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20220401__20230331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_z37yoMd6Q3Ti" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2563"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;-&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20210401__20220331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zKwYoyq3KHh7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Exercised"&gt;(2,667&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20210401__20220331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zKk6OPn2Fa7k" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercised"&gt;5.40&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;-&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Forfeited&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20230401__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zM53IbfCe9X3" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Forfeited"&gt;(47,666&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20230401__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zcSqnMymjpzh" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right" title="Weighted Average Exercise Price, Forfeited"&gt;7.48&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;-&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20220401__20230331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zOaq83fvBo2h" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Forfeited"&gt;(2,668&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20220401__20230331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zzIPkkG9V76j" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right" title="Weighted Average Exercise Price, Forfeited"&gt;5.63&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;-&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20210401__20220331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zMtnNIMFxgt9" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Forfeited"&gt;(667&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20210401__20220331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zsZN6Kzaabge" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right" title="Weighted Average Exercise Price, Forfeited"&gt;3.60&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;-&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;Balance at end of year *&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20230401__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_fKCop_z6HwM5zINEc7" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Balance at end of period"&gt;113,761&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20230401__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_fKCop_zT3QNP0Qe0E1" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Balance at end of period"&gt;8.08&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230401__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_fKCop_zOPu4ZtADzIj" title="Weighted Average contractual life"&gt;4.2&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20220401__20230331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_fKCop_zD4igbxPj4V7" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Balance at end of period"&gt;161,427&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20220401__20230331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_fKCop_z28dSgXsk8W1" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Balance at end of period"&gt;7.90&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220401__20230331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_fKCop_zCIRXJCsJF4i" title="Weighted Average contractual life"&gt;6.6&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20210401__20220331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_fKCop_zBve8WxqYidb" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Balance at end of period"&gt;56,343&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20210401__20220331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_fKCop_z2odeywZpLlh" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Balance at end of period"&gt;9.90&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210401__20220331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_fKCop_zUxCdhfq8POk" title="Weighted Average contractual life"&gt;4.1&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;Options exercisable at end of year&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20230401__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_z3jhMdDLOEjd" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, exercisable at end of period"&gt;91,261&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20230401__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zPdnz0W0BGpa" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Options exercisable at end of period"&gt;8.06&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20220401__20230331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zYb8ze7xDAZ1" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, exercisable at end of period"&gt;53,675&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20220401__20230331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zeZztL05GLB6" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Options exercisable at end of period"&gt;9.90&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20210401__20220331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zU3UfCKF5SS4" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, exercisable at end of period"&gt;52,667&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20210401__20220331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zTpFTVGB4XQe" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Options exercisable at end of period"&gt;9.90&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 15pt; text-align: right"&gt;&lt;span id="xdx_F03_zMJ9yCxd4dyi" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F11_ztjnMqHqnwl5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total number of
options outstanding as of December 31, 2023, includes &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEVNUExPWUVFIFNUT0NLIE9QVElPTlMgT1VUU1RBTkRJTkcgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20231231__srt--TitleOfIndividualAxis__custom--SixCurrentAndThreeFormerDirectorsMember_ziDf0VRBSP8d" title="Option issued"&gt;23,343&lt;/span&gt; options issued to six current and three former directors as compensation,
&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEVNUExPWUVFIFNUT0NLIE9QVElPTlMgT1VUU1RBTkRJTkcgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20231231__srt--TitleOfIndividualAxis__srt--OfficerMember_zlaFmcYLufcb" title="Option issued"&gt;56,668&lt;/span&gt; options issued to Company officers as compensation and &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEVNUExPWUVFIFNUT0NLIE9QVElPTlMgT1VUU1RBTkRJTkcgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20231231__srt--TitleOfIndividualAxis__custom--EmployeesMember_zMTAts14yJF3" title="Option issued"&gt;33,750&lt;/span&gt; options issued to employees as part of an Employee Stock Incentive
Plan.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_8A3_zIYp4RC0vqbi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2023, there was an unrecognized expense of approximately $&lt;span id="xdx_904_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_c20231231_zgCDisISYLPc" title="Unrecognised expense"&gt;122,000&lt;/span&gt; remaining on options currently vesting over time with
approximate weighted average of &lt;span id="xdx_905_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dc_c20230401__20231231_z5eipgicKVjg" title="Weighted average term"&gt;eighteen months&lt;/span&gt; remaining until these options are fully vested.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
vested options as of December 31, 2023, had &lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_do_c20231231_z5Y582EQZRv3" title="Vested options"&gt;no&lt;/span&gt; intrinsic value. As of December 31, 2023, there were &lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20231231_zNn4FSuDIj9a" title="Number of shares available for issuance"&gt;165,469&lt;/span&gt; shares under the 2022 Plan
available to be issued.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;WARRANTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Common
warrants issued and outstanding as of December 31, 2023 and March 31, 2023, were &lt;span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20231231_zpFvGKoQgIz3" title="Warrants outstanding"&gt;&lt;span id="xdx_904_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20230331_zaAapAmp1i4e" title="Warrants outstanding"&gt;902,113&lt;/span&gt;&lt;/span&gt;.
There were no changes in the warrants outstanding during the period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;THE
SINGING MACHINE COMPANY, INC AND SUBSIDIARIES&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December
31, 2023, and March 31, 2023 and 2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_894_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zAXu7qMU6Qxd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2023, the Company&#x2019;s warrants by expiration date were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B2_z4dc31X58bna" style="display: none"&gt;SCHEDULE
OF WARRANTS EXPIRATION&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;Number of&lt;/p&gt;
                                                                                &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;Common&lt;/p&gt;
                                                                                &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;Warrants&lt;/p&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;Exercise Price&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;Expiration Date&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_z1p7O41GDgqk" style="font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: right" title="Number of common warrants"&gt;802,113&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zzlnpwNolV4l" style="font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: right" title="Warrant Exercise Price"&gt;2.80&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 52%; text-align: left"&gt;&lt;span id="xdx_90F_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zeQZylxWsLCl" title="Expiration Date"&gt;September 15, 2026&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zUrmgJ8OuzZa" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of common warrants"&gt;100,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_z2GYeW1cdQR6" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right" title="Warrant Exercise Price"&gt;5.00&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;&lt;span id="xdx_905_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zvU7gahreCL4" title="Expiration Date"&gt;May 23, 2027&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20231231_zX2rc3VxQHeg" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of common warrants"&gt;902,113&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A0_zc9F3jST1XBg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:SaleOfStockDescriptionOfTransaction
      contextRef="From2022-04-112022-04-12_custom_TwoThousandTwentyTwoPlanMember"
      id="Fact002469">The
maximum number of shares of common stock initially available for issuance under the 2022 Plan is 233,334 shares of common stock and
thereafter an annual increase shall be added as of the first day of the Company&#x2019;s fiscal year beginning in 2023, equal to the
least of (i) 5% of the outstanding common stock on a fully diluted basis as of the end of the Company&#x2019;s immediately preceding
fiscal year, (ii) 33,334 shares, and (iii) a lesser amount as determined by the Board of Directors.</us-gaap:SaleOfStockDescriptionOfTransaction>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2022-04-012023-03-31_custom_TwoThousandTwentyTwoPlanMember_srt_DirectorMember"
      decimals="INF"
      id="Fact002471"
      unitRef="Shares">6001</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2022-04-012023-03-31_custom_TwoThousandTwentyTwoPlanMember_srt_DirectorMember_srt_MinimumMember"
      decimals="INF"
      id="Fact002473"
      unitRef="USDPShares">2.35</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2022-04-012023-03-31_custom_TwoThousandTwentyTwoPlanMember_srt_DirectorMember_srt_MaximumMember"
      decimals="INF"
      id="Fact002475"
      unitRef="USDPShares">8.11</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2022-04-012023-03-31_custom_TwoThousandTwentyTwoPlanMember_srt_OfficerMember"
      decimals="INF"
      id="Fact002477"
      unitRef="Shares">37001</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2022-04-012023-03-31_custom_TwoThousandTwentyTwoPlanMember_srt_OfficerMember_srt_MinimumMember"
      decimals="INF"
      id="Fact002479"
      unitRef="USDPShares">4.00</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2022-04-012023-03-31_custom_TwoThousandTwentyTwoPlanMember_srt_OfficerMember_srt_MaximumMember"
      decimals="INF"
      id="Fact002481"
      unitRef="USDPShares">8.65</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2022-04-012023-03-31_custom_TwoThousandTwentyTwoPlanMember_custom_EmployeeMember"
      decimals="INF"
      id="Fact002483"
      unitRef="Shares">64750</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2022-04-012023-03-31_custom_TwoThousandTwentyTwoPlanMember_custom_EmployeeMember_srt_MinimumMember"
      decimals="INF"
      id="Fact002485"
      unitRef="USDPShares">8.11</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2022-04-012023-03-31_custom_TwoThousandTwentyTwoPlanMember_custom_EmployeeMember_srt_MaximumMember"
      decimals="INF"
      id="Fact002487"
      unitRef="USDPShares">8.65</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockOptionPlanExpense
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact002489"
      unitRef="USD">110000</us-gaap:StockOptionPlanExpense>
    <us-gaap:StockOptionPlanExpense
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact002491"
      unitRef="USD">237000</us-gaap:StockOptionPlanExpense>
    <us-gaap:StockOptionPlanExpense
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact002493"
      unitRef="USD">22000</us-gaap:StockOptionPlanExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2021-04-012022-03-31_srt_BoardOfDirectorsChairmanMember"
      decimals="INF"
      id="Fact002495"
      unitRef="Shares">2001</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2021-04-012022-03-31_srt_BoardOfDirectorsChairmanMember_srt_MinimumMember"
      decimals="INF"
      id="Fact002497"
      unitRef="USDPShares">8.10</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2021-04-012022-03-31_srt_BoardOfDirectorsChairmanMember_srt_MaximumMember"
      decimals="INF"
      id="Fact002499"
      unitRef="USDPShares">8.70</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2022-04-012023-03-31"
      decimals="INF"
      id="Fact002501"
      unitRef="Pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2022-04-012023-03-31_srt_MinimumMember"
      decimals="INF"
      id="Fact002503"
      unitRef="Pure">0.0263</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2022-04-012023-03-31_srt_MaximumMember"
      decimals="INF"
      id="Fact002505"
      unitRef="Pure">0.0321</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2022-04-012023-03-31_srt_MinimumMember"
      decimals="INF"
      id="Fact002507"
      unitRef="Pure">1.661</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2022-04-012023-03-31_srt_MaximumMember"
      decimals="INF"
      id="Fact002509"
      unitRef="Pure">1.963</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2022-04-012023-03-31" id="Fact002511">P3Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2021-04-012022-03-31"
      decimals="INF"
      id="Fact002513"
      unitRef="Pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2021-04-012022-03-31_srt_MinimumMember"
      decimals="INF"
      id="Fact002515"
      unitRef="Pure">0.0043</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2021-04-012022-03-31_srt_MaximumMember"
      decimals="INF"
      id="Fact002517"
      unitRef="Pure">0.0096</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2021-04-012022-03-31_srt_MinimumMember"
      decimals="INF"
      id="Fact002519"
      unitRef="Pure">1.495</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2021-04-012022-03-31_srt_MaximumMember"
      decimals="INF"
      id="Fact002521"
      unitRef="Pure">1.570</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2021-04-012022-03-31" id="Fact002523">P3Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="From2023-04-012023-12-31" id="Fact002525">&lt;p id="xdx_894_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zwSZRhkkVd2i" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
summary of stock option activity for each of the years presented is summarized below.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span id="xdx_8BB_zxjo8GHyYRrc" style="display: none"&gt;SUMMARY OF STOCK OPTION ACTIVITY&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;Nine Months Ended&lt;/p&gt;
                                                                                &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;December 31, 2023&lt;/p&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;Fiscal Year Ended&lt;/p&gt;
                                                                                &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;March 31, 2023&lt;/p&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;Fiscal Year Ended&lt;/p&gt;
                                                                                &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;March 31, 2022&lt;/p&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;Number of&lt;/p&gt;
                                                                                &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;Options&lt;/p&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;Weighted&lt;/p&gt;
                                                                                &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;Average Exercise&lt;/p&gt;
                                                                                &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;Price&lt;/p&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;Weighted&lt;/p&gt;
                                                                                &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;Average Contractual&lt;/p&gt;
                                                                                &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;Life&lt;/p&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;Number of&lt;/p&gt;
                                                                                &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;Options&lt;/p&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;Weighted&lt;/p&gt;
                                                                                &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;Average Exercise&lt;/p&gt;
                                                                                &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;Price&lt;/p&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;Weighted&lt;/p&gt;
                                                                                &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;Average Contractual&lt;/p&gt;
                                                                                &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;Life&lt;/p&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;Number of&lt;/p&gt;
                                                                                &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;Options&lt;/p&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;Weighted&lt;/p&gt;
                                                                                &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;Average Exercise&lt;/p&gt;
                                                                                &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;Price&lt;/p&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;Weighted&lt;/p&gt;
                                                                                &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;Average Contractual&lt;/p&gt;
                                                                                &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;Life&lt;/p&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;Stock Options:&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; width: 28%; text-align: left"&gt;Balance at beginning of year&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20230401__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zuSR13e2AEoi" style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: right" title="Number of Options, Balance at beginning of period"&gt;161,427&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20230401__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zM4jL2mKz5ye" style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: right" title="Weighted Average Exercise Price, Balance at beginning of period"&gt;7.90&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220401__20230331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_z4VT6tWjrgqi" title="Weighted Average contractual life"&gt;6.6&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220401__20230331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_z8dASt4qV4ne" style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: right" title="Number of Options, Balance at beginning of period"&gt;56,343&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20220401__20230331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zKgXaYCHT0o2" style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: right" title="Weighted Average Exercise Price, Balance at beginning of period"&gt;9.90&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210401__20220331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zWny3OKkJnFk" title="Weighted Average contractual life"&gt;4.1&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20210401__20220331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zec1i6Kv76M9" style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: right" title="Number of Options, Balance at beginning of period"&gt;56,010&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20210401__20220331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zjjPY4f494Lk" style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: right" title="Weighted Average Exercise Price, Balance at beginning of period"&gt;9.90&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20200401__20210331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zt6XjHfdLmUi" title="Weighted Average contractual life"&gt;5.4&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;Granted&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230401__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zUkFlbAFEZug" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2545"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20230401__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zunSwWVnfai3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2547"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;-&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220401__20230331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zfBOrO3XLqfi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Granted"&gt;107,752&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220401__20230331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_z1nbqACPRrm4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Granted"&gt;6.83&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;-&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210401__20220331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_z1T5Xzj2wjN7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Granted"&gt;3,667&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210401__20220331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zcgNdOMVzf3d" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Granted"&gt;7.80&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;-&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;Exercised&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20230401__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zPs1yMi1yQV8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2557"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20230401__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zApJ6Jrqzn57" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2559"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;-&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20220401__20230331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zT42hGb2aNR" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2561"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20220401__20230331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_z37yoMd6Q3Ti" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2563"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;-&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20210401__20220331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zKwYoyq3KHh7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Exercised"&gt;(2,667&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20210401__20220331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zKk6OPn2Fa7k" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercised"&gt;5.40&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;-&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Forfeited&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20230401__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zM53IbfCe9X3" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Forfeited"&gt;(47,666&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20230401__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zcSqnMymjpzh" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right" title="Weighted Average Exercise Price, Forfeited"&gt;7.48&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;-&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20220401__20230331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zOaq83fvBo2h" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Forfeited"&gt;(2,668&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20220401__20230331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zzIPkkG9V76j" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right" title="Weighted Average Exercise Price, Forfeited"&gt;5.63&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;-&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20210401__20220331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zMtnNIMFxgt9" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Forfeited"&gt;(667&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20210401__20220331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zsZN6Kzaabge" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right" title="Weighted Average Exercise Price, Forfeited"&gt;3.60&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;-&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;Balance at end of year *&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20230401__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_fKCop_z6HwM5zINEc7" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Balance at end of period"&gt;113,761&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20230401__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_fKCop_zT3QNP0Qe0E1" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Balance at end of period"&gt;8.08&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230401__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_fKCop_zOPu4ZtADzIj" title="Weighted Average contractual life"&gt;4.2&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20220401__20230331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_fKCop_zD4igbxPj4V7" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Balance at end of period"&gt;161,427&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20220401__20230331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_fKCop_z28dSgXsk8W1" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Balance at end of period"&gt;7.90&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220401__20230331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_fKCop_zCIRXJCsJF4i" title="Weighted Average contractual life"&gt;6.6&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20210401__20220331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_fKCop_zBve8WxqYidb" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Balance at end of period"&gt;56,343&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20210401__20220331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_fKCop_z2odeywZpLlh" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Balance at end of period"&gt;9.90&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210401__20220331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_fKCop_zUxCdhfq8POk" title="Weighted Average contractual life"&gt;4.1&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;Options exercisable at end of year&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20230401__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_z3jhMdDLOEjd" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, exercisable at end of period"&gt;91,261&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20230401__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zPdnz0W0BGpa" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Options exercisable at end of period"&gt;8.06&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20220401__20230331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zYb8ze7xDAZ1" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, exercisable at end of period"&gt;53,675&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20220401__20230331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zeZztL05GLB6" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Options exercisable at end of period"&gt;9.90&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20210401__20220331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zU3UfCKF5SS4" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, exercisable at end of period"&gt;52,667&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20210401__20220331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zTpFTVGB4XQe" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Options exercisable at end of period"&gt;9.90&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 15pt; text-align: right"&gt;&lt;span id="xdx_F03_zMJ9yCxd4dyi" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F11_ztjnMqHqnwl5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total number of
options outstanding as of December 31, 2023, includes &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEVNUExPWUVFIFNUT0NLIE9QVElPTlMgT1VUU1RBTkRJTkcgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20231231__srt--TitleOfIndividualAxis__custom--SixCurrentAndThreeFormerDirectorsMember_ziDf0VRBSP8d" title="Option issued"&gt;23,343&lt;/span&gt; options issued to six current and three former directors as compensation,
&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEVNUExPWUVFIFNUT0NLIE9QVElPTlMgT1VUU1RBTkRJTkcgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20231231__srt--TitleOfIndividualAxis__srt--OfficerMember_zlaFmcYLufcb" title="Option issued"&gt;56,668&lt;/span&gt; options issued to Company officers as compensation and &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEVNUExPWUVFIFNUT0NLIE9QVElPTlMgT1VUU1RBTkRJTkcgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20231231__srt--TitleOfIndividualAxis__custom--EmployeesMember_zMTAts14yJF3" title="Option issued"&gt;33,750&lt;/span&gt; options issued to employees as part of an Employee Stock Incentive
Plan.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2023-03-31_us-gaap_StockOptionMember"
      decimals="INF"
      id="Fact002527"
      unitRef="Shares">161427</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2023-03-31_us-gaap_StockOptionMember"
      decimals="INF"
      id="Fact002529"
      unitRef="USDPShares">7.90</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="From2022-04-012023-03-31_us-gaap_StockOptionMember"
      id="Fact002531">P6Y7M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2022-03-31_us-gaap_StockOptionMember"
      decimals="INF"
      id="Fact002533"
      unitRef="Shares">56343</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2022-03-31_us-gaap_StockOptionMember"
      decimals="INF"
      id="Fact002535"
      unitRef="USDPShares">9.90</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="From2021-04-012022-03-31_us-gaap_StockOptionMember"
      id="Fact002537">P4Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2021-03-31_us-gaap_StockOptionMember"
      decimals="INF"
      id="Fact002539"
      unitRef="Shares">56010</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2021-03-31_us-gaap_StockOptionMember"
      decimals="INF"
      id="Fact002541"
      unitRef="USDPShares">9.90</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="From2020-04-012021-03-31_us-gaap_StockOptionMember"
      id="Fact002543">P5Y4M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2022-04-012023-03-31_us-gaap_StockOptionMember"
      decimals="INF"
      id="Fact002549"
      unitRef="Shares">107752</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2022-04-012023-03-31_us-gaap_StockOptionMember"
      decimals="INF"
      id="Fact002551"
      unitRef="USDPShares">6.83</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2021-04-012022-03-31_us-gaap_StockOptionMember"
      decimals="INF"
      id="Fact002553"
      unitRef="Shares">3667</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2021-04-012022-03-31_us-gaap_StockOptionMember"
      decimals="INF"
      id="Fact002555"
      unitRef="USDPShares">7.80</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2021-04-012022-03-31_us-gaap_StockOptionMember"
      decimals="INF"
      id="Fact002565"
      unitRef="Shares">2667</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="From2021-04-012022-03-31_us-gaap_StockOptionMember"
      decimals="INF"
      id="Fact002567"
      unitRef="USDPShares">5.40</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="From2023-04-012023-12-31_us-gaap_StockOptionMember"
      decimals="INF"
      id="Fact002569"
      unitRef="Shares">47666</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="From2023-04-012023-12-31_us-gaap_StockOptionMember"
      decimals="INF"
      id="Fact002571"
      unitRef="USDPShares">7.48</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="From2022-04-012023-03-31_us-gaap_StockOptionMember"
      decimals="INF"
      id="Fact002573"
      unitRef="Shares">2668</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="From2022-04-012023-03-31_us-gaap_StockOptionMember"
      decimals="INF"
      id="Fact002575"
      unitRef="USDPShares">5.63</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="From2021-04-012022-03-31_us-gaap_StockOptionMember"
      decimals="INF"
      id="Fact002577"
      unitRef="Shares">667</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="From2021-04-012022-03-31_us-gaap_StockOptionMember"
      decimals="INF"
      id="Fact002579"
      unitRef="USDPShares">3.60</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2023-12-31_us-gaap_StockOptionMember"
      decimals="INF"
      id="Fact002581"
      unitRef="Shares">113761</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2023-12-31_us-gaap_StockOptionMember"
      decimals="INF"
      id="Fact002583"
      unitRef="USDPShares">8.08</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="From2023-04-012023-12-31_us-gaap_StockOptionMember"
      id="Fact002585">P4Y2M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2023-03-31_us-gaap_StockOptionMember"
      decimals="INF"
      id="Fact002587"
      unitRef="Shares">161427</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2023-03-31_us-gaap_StockOptionMember"
      decimals="INF"
      id="Fact002589"
      unitRef="USDPShares">7.90</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="From2022-04-012023-03-31_us-gaap_StockOptionMember"
      id="Fact002591">P6Y7M6D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2022-03-31_us-gaap_StockOptionMember"
      decimals="INF"
      id="Fact002593"
      unitRef="Shares">56343</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2022-03-31_us-gaap_StockOptionMember"
      decimals="INF"
      id="Fact002595"
      unitRef="USDPShares">9.90</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="From2021-04-012022-03-31_us-gaap_StockOptionMember"
      id="Fact002597">P4Y1M6D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="AsOf2023-12-31_us-gaap_StockOptionMember"
      decimals="INF"
      id="Fact002599"
      unitRef="Shares">91261</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="AsOf2023-12-31_us-gaap_StockOptionMember"
      decimals="INF"
      id="Fact002601"
      unitRef="USDPShares">8.06</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="AsOf2023-03-31_us-gaap_StockOptionMember"
      decimals="INF"
      id="Fact002603"
      unitRef="Shares">53675</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="AsOf2023-03-31_us-gaap_StockOptionMember"
      decimals="INF"
      id="Fact002605"
      unitRef="USDPShares">9.90</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="AsOf2022-03-31_us-gaap_StockOptionMember"
      decimals="INF"
      id="Fact002607"
      unitRef="Shares">52667</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="AsOf2022-03-31_us-gaap_StockOptionMember"
      decimals="INF"
      id="Fact002609"
      unitRef="USDPShares">9.90</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2023-12-31_custom_SixCurrentAndThreeFormerDirectorsMember"
      decimals="INF"
      id="Fact002612"
      unitRef="Shares">23343</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2023-12-31_srt_OfficerMember"
      decimals="INF"
      id="Fact002614"
      unitRef="Shares">56668</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2023-12-31_custom_EmployeesMember"
      decimals="INF"
      id="Fact002616"
      unitRef="Shares">33750</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002618"
      unitRef="USD">122000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="From2023-04-012023-12-31" id="Fact002620">P18M</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002622"
      unitRef="USD">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact002624"
      unitRef="Shares">165469</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact002626"
      unitRef="Shares">902113</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2023-03-31"
      decimals="INF"
      id="Fact002628"
      unitRef="Shares">902113</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="From2023-04-012023-12-31" id="Fact002630">&lt;p id="xdx_894_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zAXu7qMU6Qxd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2023, the Company&#x2019;s warrants by expiration date were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B2_z4dc31X58bna" style="display: none"&gt;SCHEDULE
OF WARRANTS EXPIRATION&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;Number of&lt;/p&gt;
                                                                                &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;Common&lt;/p&gt;
                                                                                &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;Warrants&lt;/p&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;Exercise Price&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;Expiration Date&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_z1p7O41GDgqk" style="font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: right" title="Number of common warrants"&gt;802,113&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zzlnpwNolV4l" style="font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: right" title="Warrant Exercise Price"&gt;2.80&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 52%; text-align: left"&gt;&lt;span id="xdx_90F_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zeQZylxWsLCl" title="Expiration Date"&gt;September 15, 2026&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zUrmgJ8OuzZa" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of common warrants"&gt;100,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_z2GYeW1cdQR6" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right" title="Warrant Exercise Price"&gt;5.00&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;&lt;span id="xdx_905_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zvU7gahreCL4" title="Expiration Date"&gt;May 23, 2027&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20231231_zX2rc3VxQHeg" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of common warrants"&gt;902,113&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2023-12-31_custom_ExercisePriceRangeOneMember"
      decimals="INF"
      id="Fact002632"
      unitRef="Shares">802113</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2023-12-31_custom_ExercisePriceRangeOneMember"
      decimals="INF"
      id="Fact002634"
      unitRef="USDPShares">2.80</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingMaturityDate
      contextRef="AsOf2023-12-31_custom_ExercisePriceRangeOneMember"
      id="Fact002636">2026-09-15</us-gaap:WarrantsAndRightsOutstandingMaturityDate>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2023-12-31_custom_ExercisePriceRangeTwoMember"
      decimals="INF"
      id="Fact002638"
      unitRef="Shares">100000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2023-12-31_custom_ExercisePriceRangeTwoMember"
      decimals="INF"
      id="Fact002640"
      unitRef="USDPShares">5.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingMaturityDate
      contextRef="AsOf2023-12-31_custom_ExercisePriceRangeTwoMember"
      id="Fact002642">2027-05-23</us-gaap:WarrantsAndRightsOutstandingMaturityDate>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact002644"
      unitRef="Shares">902113</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:EarningsPerShareTextBlock contextRef="From2023-04-012023-12-31" id="Fact002646">&lt;p id="xdx_809_eus-gaap--EarningsPerShareTextBlock_zG4iKg7KSqD" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
10 - &lt;span&gt;COMPUTATION OF (LOSS) EARNINGS PER SHARE&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_823_zrvuvKyHQPu4" style="display: none"&gt;COMPUTATION
OF LOSS PER SHARE&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_894_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zkkcrU1UzQx7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Computation
of dilutive shares for the nine months ended December 31, 2023 and fiscal years ended March 31, 2023 and 2022 are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B1_zwv1HLg3C7Jd" style="display: none"&gt;SCHEDULE
OF BASIC AND DILUTIVE SHARES&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20230401__20231231_zMhBsn563Tz9" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;Nine months ended&lt;/p&gt;
                                               &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;December 31, 2023&lt;/p&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20220401__20230331_zwsIj5F43kF6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;Fiscal year ended&lt;/p&gt;
                                               &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;March 31, 2023&lt;/p&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20210401__20220331_zOYnLVamqU39" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;Fiscal year ended&lt;/p&gt;
                                               &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;March 31, 2022&lt;/p&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_zC8SvzUsAmnc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 43%; text-align: left"&gt;Basic weighted average common shares outstanding&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right"&gt;4,864,540&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right"&gt;2,811,872&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right"&gt;1,614,506&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_zA0NI4Fna3t" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Effect of dilutive stock options&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2654"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2655"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;8,891&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_zJVYATuS89pb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;Diluted weighted average of common shares outstanding&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;4,864,540&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;2,811,872&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,623,397&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A0_z7bKfIsBccWj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Basic
net (loss) income per share is based on the weighted average number of shares of common stock outstanding during the period. Diluted
net (loss) income per share reflects the potential dilution assuming shares of common stock were issued upon the exercise of
outstanding in-the-money options and the proceeds thereof were used to purchase shares of the Company&#x2019;s common stock at the
average market price during the period using the treasury stock method. For the nine months ended December 31, 2023, options to
purchase &lt;span id="xdx_903_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230401__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zaRa7ZNjzhsg" title="Potentially dilutive securities"&gt;113,761&lt;/span&gt;
shares of common stock and &lt;span id="xdx_90D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230401__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--CommonStockWarrantsMember_zAJM7dzAOuSh" title="Potentially dilutive securities"&gt;902,113&lt;/span&gt;
common stock warrants were excluded in the calculation of diluted net (loss) income per share as the result would have been
anti-dilutive. For the fiscal year ended March 31, 2023, options to purchase &lt;span id="xdx_90E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220401__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zsg8lIyWdJw6" title="Potentially dilutive securities"&gt;53,675&lt;/span&gt;
shares of common stock and &lt;span id="xdx_909_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220401__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--CommonStockWarrantsMember_zbOFlAyYQ4Dk" title="Potentially dilutive securities"&gt;902,113&lt;/span&gt;
common stock warrants were excluded in the calculation of diluted net (loss) income per share as the result would have been
anti-dilutive.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
the fiscal year ended March 31, 2022, pre-funded warrants to purchase &lt;span id="xdx_903_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210401__20220331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--PreFundedWarrantsMember_zDbzGVgB9NFe" title="Potentially dilutive securities"&gt;561,111&lt;/span&gt; shares of common stock were included in basic weighted
average shares outstanding as deemed outstanding. Options to purchase &lt;span id="xdx_909_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210401__20220331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_z3fL6IOMWC2h" title="Potentially dilutive securities"&gt;8,891&lt;/span&gt; shares of common stock were included in the calculation of
diluted net income per share. For the fiscal year ended March 31, 2022, options and warrants to purchase approximately &lt;span id="xdx_900_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210401__20220331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--OptionsAndWarrantsMember_zoEguhA4bOS9" title="Potentially dilutive securities"&gt;56,000&lt;/span&gt; shares
of common stock were excluded in the calculation of diluted net (loss) income per share as the result would have been anti-dilutive.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="From2023-04-012023-12-31" id="Fact002648">&lt;p id="xdx_894_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zkkcrU1UzQx7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Computation
of dilutive shares for the nine months ended December 31, 2023 and fiscal years ended March 31, 2023 and 2022 are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B1_zwv1HLg3C7Jd" style="display: none"&gt;SCHEDULE
OF BASIC AND DILUTIVE SHARES&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20230401__20231231_zMhBsn563Tz9" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;Nine months ended&lt;/p&gt;
                                               &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;December 31, 2023&lt;/p&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20220401__20230331_zwsIj5F43kF6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;Fiscal year ended&lt;/p&gt;
                                               &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;March 31, 2023&lt;/p&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20210401__20220331_zOYnLVamqU39" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;Fiscal year ended&lt;/p&gt;
                                               &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;March 31, 2022&lt;/p&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_zC8SvzUsAmnc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 43%; text-align: left"&gt;Basic weighted average common shares outstanding&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right"&gt;4,864,540&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right"&gt;2,811,872&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right"&gt;1,614,506&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_zA0NI4Fna3t" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Effect of dilutive stock options&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2654"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2655"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;8,891&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_zJVYATuS89pb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;Diluted weighted average of common shares outstanding&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;4,864,540&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;2,811,872&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,623,397&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-04-012023-12-31"
      decimals="INF"
      id="Fact002650"
      unitRef="Shares">4864540</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2022-04-012023-03-31"
      decimals="INF"
      id="Fact002651"
      unitRef="Shares">2811872</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2021-04-012022-03-31"
      decimals="INF"
      id="Fact002652"
      unitRef="Shares">1614506</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants
      contextRef="From2021-04-012022-03-31"
      decimals="INF"
      id="Fact002656"
      unitRef="Shares">8891</us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-04-012023-12-31"
      decimals="INF"
      id="Fact002658"
      unitRef="Shares">4864540</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2022-04-012023-03-31"
      decimals="INF"
      id="Fact002659"
      unitRef="Shares">2811872</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2021-04-012022-03-31"
      decimals="INF"
      id="Fact002660"
      unitRef="Shares">1623397</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2023-04-012023-12-31_us-gaap_EmployeeStockOptionMember"
      decimals="INF"
      id="Fact002662"
      unitRef="Shares">113761</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2023-04-012023-12-31_custom_CommonStockWarrantsMember"
      decimals="INF"
      id="Fact002664"
      unitRef="Shares">902113</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2022-04-012023-03-31_us-gaap_EmployeeStockOptionMember"
      decimals="INF"
      id="Fact002666"
      unitRef="Shares">53675</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2022-04-012023-03-31_custom_CommonStockWarrantsMember"
      decimals="INF"
      id="Fact002668"
      unitRef="Shares">902113</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2021-04-012022-03-31_custom_PreFundedWarrantsMember"
      decimals="INF"
      id="Fact002670"
      unitRef="Shares">561111</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2021-04-012022-03-31_us-gaap_EmployeeStockOptionMember"
      decimals="INF"
      id="Fact002672"
      unitRef="Shares">8891</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2021-04-012022-03-31_custom_OptionsAndWarrantsMember"
      decimals="INF"
      id="Fact002674"
      unitRef="Shares">56000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <RIME:IssuanceOfPublicOfferingTextBlock contextRef="From2023-04-012023-12-31" id="Fact002676">&lt;p id="xdx_803_ecustom--IssuanceOfPublicOfferingTextBlock_zbLN8k1uirYh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
11 &#x2013; &lt;span id="xdx_828_z0aE5XohnvDf"&gt;PUBLIC OFFERING AND NASDAQ UPLISTING&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
May 23, 2022, the Company entered into the Underwriting Agreement with Aegis Capital Corp., who acted as the sole Underwriter, in a firm
commitment underwritten public offering pursuant to which the Company sold to the Underwriter &lt;span id="xdx_902_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20220523__20220523__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_zfDp2eI7R9x3" title="Sale of stock, number of shares issued in transaction"&gt;1,000,000&lt;/span&gt; shares of common stock, par value
$&lt;span id="xdx_902_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20220523__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_zBOCML0XZEO5" title="Common stock, par value"&gt;0.01&lt;/span&gt; per share for gross proceeds of $&lt;span id="xdx_904_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20220523__20220523__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_zdekSTM9f1kf" title="Gross proceeds"&gt;4,000,000&lt;/span&gt; prior to deducting underwriting discounts and commissions and other estimated offering
expenses of approximately $&lt;span id="xdx_901_eus-gaap--PaymentsForCommissions_c20220523__20220523__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_zF0zNDjHjaoe" title="Underwriting discounts and commissions and other estimated offering expenses"&gt;600,000&lt;/span&gt;. The price to the public in the offering was $&lt;span id="xdx_90D_eus-gaap--SaleOfStockPricePerShare_iI_c20220523__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_zaFjRu0c4M3h" title="Sale of stock, price per share"&gt;4.00&lt;/span&gt; per Share, before underwriting discounts and commissions.
The offering closed on May 26, 2022. The Company received net proceeds of approximately &lt;span id="xdx_902_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20220523__20220523__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_ztQFgvfbn5t" title="Net proceeds"&gt;3,400,000&lt;/span&gt; which was used for working capital.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pursuant
to the terms of the Underwriting Agreement, the Company agreed to issue to the Underwriter warrants to purchase up to &lt;span id="xdx_901_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220523__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_zWnqf8ePdVYi" title="Underwriter warrants to purchase"&gt;100,000&lt;/span&gt; shares
of Common Stock representing &lt;span id="xdx_904_ecustom--SaleOfStockPercentage_pid_dp_uPure_c20220523__20220523__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_zsa35ZeGESi3" title="Sale of stock, percentage"&gt;10.0&lt;/span&gt;% of the Shares sold in this offering, excluding any Shares sold through the over-allotment option.
The warrants are exercisable for six months from the commencement of sales under the offering, have an exercise price of $&lt;span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220523__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_z7qG3UCt2qw9" title="Exercise price per share"&gt;5.00&lt;/span&gt; per share
and expire &lt;span id="xdx_909_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_c20220523__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_zWsbtxhGBZS1" title="Warrant term"&gt;five years&lt;/span&gt; from the date of issuance. The Company estimated the fair value of these warrants to be approximately $&lt;span id="xdx_906_eus-gaap--FairValueAdjustmentOfWarrants_pp0p0_c20220523__20220523__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_zdzZOfjpolz" title="Fair value adjustment of warrants"&gt;244,000&lt;/span&gt;
using the Black-Scholes Model based on the following input assumptions: common stock price of $&lt;span id="xdx_906_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220523__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember_zhaLW2eVYTDk" title="Warrant measurement input"&gt;2.90&lt;/span&gt;, expected life of the warrants of
&lt;span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20220523__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_z17ADdJpzU7l" title="Warrant term"&gt;3&lt;/span&gt; years; stock price volatility of &lt;span id="xdx_902_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220523__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zCP8iv4WwsJb" title="Warrant measurement input"&gt;176&lt;/span&gt;%; dividend yield of &lt;span id="xdx_90E_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220523__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zRpbMe0Ug4eb" title="Warrant measurement input"&gt;0&lt;/span&gt;%; and the risk-free interest rate of &lt;span id="xdx_900_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220523__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zrt05B5RPxX4" title="Warrant measurement input"&gt;2.63&lt;/span&gt;%.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
May 24, 2022, the Company&#x2019;s common stock was approved to list on the Nasdaq Capital Market under the symbol &#x201c;MICS&#x201d;
and began trading on the Nasdaq Capital Market on May 24, 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</RIME:IssuanceOfPublicOfferingTextBlock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2022-05-232022-05-23_custom_UnderwritingAgreementMember"
      decimals="INF"
      id="Fact002678"
      unitRef="Shares">1000000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-05-23_custom_UnderwritingAgreementMember"
      decimals="INF"
      id="Fact002680"
      unitRef="USDPShares">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2022-05-232022-05-23_custom_UnderwritingAgreementMember"
      decimals="0"
      id="Fact002682"
      unitRef="USD">4000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:PaymentsForCommissions
      contextRef="From2022-05-232022-05-23_custom_UnderwritingAgreementMember"
      decimals="0"
      id="Fact002684"
      unitRef="USD">600000</us-gaap:PaymentsForCommissions>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2022-05-23_custom_UnderwritingAgreementMember"
      decimals="INF"
      id="Fact002686"
      unitRef="USDPShares">4.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="From2022-05-232022-05-23_custom_UnderwritingAgreementMember"
      decimals="0"
      id="Fact002688"
      unitRef="USD">3400000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2022-05-23_custom_UnderwritingAgreementMember"
      decimals="INF"
      id="Fact002690"
      unitRef="Shares">100000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <RIME:SaleOfStockPercentage
      contextRef="From2022-05-232022-05-23_custom_UnderwritingAgreementMember"
      decimals="INF"
      id="Fact002692"
      unitRef="Pure">0.100</RIME:SaleOfStockPercentage>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2022-05-23_custom_UnderwritingAgreementMember"
      decimals="INF"
      id="Fact002694"
      unitRef="USDPShares">5.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingTerm
      contextRef="AsOf2022-05-23_custom_UnderwritingAgreementMember"
      id="Fact002696">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2022-05-232022-05-23_custom_UnderwritingAgreementMember"
      decimals="0"
      id="Fact002698"
      unitRef="USD">244000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2022-05-23_custom_UnderwritingAgreementMember_us-gaap_MeasurementInputExercisePriceMember"
      decimals="INF"
      id="Fact002700"
      unitRef="Pure">2.90</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingTerm
      contextRef="AsOf2022-05-23_custom_UnderwritingAgreementMember_us-gaap_MeasurementInputExpectedTermMember"
      id="Fact002702">P3Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2022-05-23_custom_UnderwritingAgreementMember_us-gaap_MeasurementInputPriceVolatilityMember"
      decimals="INF"
      id="Fact002704"
      unitRef="Pure">176</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2022-05-23_custom_UnderwritingAgreementMember_us-gaap_MeasurementInputExpectedDividendRateMember"
      decimals="INF"
      id="Fact002706"
      unitRef="Pure">0</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2022-05-23_custom_UnderwritingAgreementMember_us-gaap_MeasurementInputRiskFreeInterestRateMember"
      decimals="INF"
      id="Fact002708"
      unitRef="Pure">2.63</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <RIME:AtTheMarketPublicOfferingTextBlock contextRef="From2023-04-012023-12-31" id="Fact002710">&lt;p id="xdx_80D_ecustom--AtTheMarketPublicOfferingTextBlock_zBPwJg5r8tR2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
12 &#x2013; &lt;span id="xdx_82E_z1zXFm5G0Zvc"&gt;ATM OFFERING&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 15, 2023, the Company entered into an At-The-Market Issuance Sales Agreement (the &#x201c;Sales Agreement&#x201d;) with Aegis
Capital Corp, as sales agent (the &#x201c;Agent&#x201d;), pursuant to which the Company could offer and sell, from time to time, through
the Agent (the &#x201c;ATM Offering&#x201d;), up to approximately $&lt;span id="xdx_903_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_pp0p0_c20230215__20230215__us-gaap--SubsidiarySaleOfStockAxis__custom--ATMOfferingMember_z8sylrixdvOg" title="Number of stock sold, value"&gt;1,800,000&lt;/span&gt; in shares of the Company&#x2019;s common stock. For the nine
months ended December 31, 2023, and fiscal year ended March 31, 2023, the Company received net proceeds of approximately $&lt;span id="xdx_90F_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20230401__20231231__us-gaap--SubsidiarySaleOfStockAxis__custom--ATMOfferingMember_z5j0sPe6ajV7" title="Proceeds from sale of equity"&gt;1,654,000&lt;/span&gt; and
$&lt;span id="xdx_907_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20220401__20230331__us-gaap--SubsidiarySaleOfStockAxis__custom--ATMOfferingMember_zmbXx5bjFuh3" title="Proceeds from sale of equity"&gt;36,000&lt;/span&gt;, respectively, after payment of brokerage commissions and administrative fees to the agent. The ATM Offering was terminated on May 12, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;THE
SINGING MACHINE COMPANY, INC AND SUBSIDIARIES&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December
31, 2023, and March 31, 2023 and 2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</RIME:AtTheMarketPublicOfferingTextBlock>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="From2023-02-152023-02-15_custom_ATMOfferingMember"
      decimals="0"
      id="Fact002712"
      unitRef="USD">1800000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity
      contextRef="From2023-04-012023-12-31_custom_ATMOfferingMember"
      decimals="0"
      id="Fact002714"
      unitRef="USD">1654000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity
      contextRef="From2022-04-012023-03-31_custom_ATMOfferingMember"
      decimals="0"
      id="Fact002716"
      unitRef="USD">36000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <RIME:PrivatePlacementTextBlock contextRef="From2023-04-012023-12-31" id="Fact002718">&lt;p id="xdx_804_ecustom--PrivatePlacementTextBlock_zEGmTkIFWoac" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
13 &#x2013; &lt;span id="xdx_827_zVjf19s2AIXd"&gt;PRIVATE PLACEMENT&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
November 20, 2023, the Company the Company entered into an agreement to sell $&lt;span id="xdx_90F_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20231120__20231120__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zIlmqJmcjBP6" title="Number of stock sold, value"&gt;2,000,000&lt;/span&gt; in common stock through a private placement of
common stock (the &#x201c;Private Placement&#x201d;). The Private Placement was completed with two Affiliates, (Stingray Group, Inc. and
Jay Foreman), both of which were existing shareholders with Board representation. The Private Placement was completed at $&lt;span id="xdx_902_eus-gaap--SaleOfStockPricePerShare_iI_c20231120__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zF8MvgiOJe45" title="Commmon stock share per share"&gt;0.91&lt;/span&gt; per share
of common stock, with a total of approximately &lt;span id="xdx_901_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20231120__20231120__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zA4yjRNzWoKa" title="Number of stock sold"&gt;2,198,000&lt;/span&gt; shares issued. Net proceeds from the transaction were approximately $&lt;span id="xdx_903_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20231120__20231120__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zIODCkO1j2nc" title="Proceeds from sale of equity"&gt;1,900,000&lt;/span&gt;,
net of transaction fees of approximately $&lt;span id="xdx_90E_ecustom--TransactionFees_iI_c20231120__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zBW9bXe0xPO7" title="Transaction fees"&gt;100,000&lt;/span&gt;. During the six-month period after the closing date, the purchasers may make a written
request for registration under the Securities Act of all or any portion of the shares purchased.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</RIME:PrivatePlacementTextBlock>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="From2023-11-202023-11-20_us-gaap_PrivatePlacementMember"
      decimals="0"
      id="Fact002720"
      unitRef="USD">2000000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2023-11-20_us-gaap_PrivatePlacementMember"
      decimals="INF"
      id="Fact002722"
      unitRef="USDPShares">0.91</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2023-11-202023-11-20_us-gaap_PrivatePlacementMember"
      decimals="INF"
      id="Fact002724"
      unitRef="Shares">2198000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity
      contextRef="From2023-11-202023-11-20_us-gaap_PrivatePlacementMember"
      decimals="0"
      id="Fact002726"
      unitRef="USD">1900000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <RIME:TransactionFees
      contextRef="AsOf2023-11-20_us-gaap_PrivatePlacementMember"
      decimals="0"
      id="Fact002728"
      unitRef="USD">100000</RIME:TransactionFees>
    <RIME:StockRedemptionTextBlock contextRef="From2023-04-012023-12-31" id="Fact002730">&lt;p id="xdx_805_ecustom--StockRedemptionTextBlock_zv7yitEIiMih" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
14 - &lt;span id="xdx_82C_zOJYSrS3MzGj"&gt;AUGUST 2021 STOCK REDEMPTION&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
August 5, 2021, the Company entered into the Redemption Agreement with koncepts and Treasure Green (former majority shareholders), pursuant
to which the Company redeemed &lt;span id="xdx_903_eus-gaap--StockRedeemedOrCalledDuringPeriodShares_c20210801__20210805__us-gaap--TypeOfArrangementAxis__custom--RedemptionAgreementMember__dei--LegalEntityAxis__custom--KonceptsandTreasureGreenMember_zdillBIFb94g" title="Shares redeemed"&gt;654,105&lt;/span&gt; shares of common stock of the Company. The closing of the transaction set forth in the Redemption
Agreement took place on August 10, 2021, at which time the Redeemed Shares were assigned and transferred back to the Company in consideration
of a payment by the Company of approximately $&lt;span id="xdx_901_eus-gaap--ConversionOfStockAmountIssued1_pn5n6_c20210808__20210810__dei--LegalEntityAxis__custom--KonceptsandTreasureGreenMember__us-gaap--TypeOfArrangementAxis__custom--RedemptionAgreementMember_zXLU89EnUN45" title="Conversion of stock, amount issued"&gt;7.2 &lt;/span&gt;million to koncepts and Treasure Green. The Redeemed Shares were retired and returned
to the unissued authorized capital of the Company. Pursuant to the Redemption Agreement, neither koncepts nor Treasure Green remained
stockholders of the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</RIME:StockRedemptionTextBlock>
    <us-gaap:StockRedeemedOrCalledDuringPeriodShares
      contextRef="From2021-08-012021-08-05_custom_RedemptionAgreementMember_custom_KonceptsandTreasureGreenMember"
      decimals="INF"
      id="Fact002732"
      unitRef="Shares">654105</us-gaap:StockRedeemedOrCalledDuringPeriodShares>
    <us-gaap:ConversionOfStockAmountIssued1
      contextRef="From2021-08-082021-08-10_custom_KonceptsandTreasureGreenMember_custom_RedemptionAgreementMember"
      decimals="-5"
      id="Fact002734"
      unitRef="USD">7200000</us-gaap:ConversionOfStockAmountIssued1>
    <RIME:AugustTwentyTwentyOnePrivatePlacementTextBlock contextRef="From2023-04-012023-12-31" id="Fact002736">&lt;p id="xdx_809_ecustom--AugustTwentyTwentyOnePrivatePlacementTextBlock_zk73zIeNXpC" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
15 &#x2013; &lt;span id="xdx_82A_zSd0GOr2ugal"&gt;AUGUST 2021 PRIVATE PLACEMENT&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
August 5, 2021, the Company entered into a securities purchase agreement (the &#x201c;Purchase Agreement&#x201d;) with large institutional
investors and the strategic investor for private placement of (i) &lt;span id="xdx_903_eus-gaap--CommonStockSharesIssued_iI_pid_c20210805__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember_zQszQ83FBDHl" title="Common stock, shares, issued"&gt;550,000&lt;/span&gt; shares of its common stock (the &#x201c;Shares&#x201d;) together
with Common Warrants to purchase up to &lt;span id="xdx_908_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20210805__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember_zOGBglabIYcb" title="Warrants to purchase common stock"&gt;550,000&lt;/span&gt; shares of common stock with an exercise price of $&lt;span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20210805__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember_zhmhLP6uuLbc" title="Exercise price of warrants"&gt;10.50&lt;/span&gt; per share, and (ii) &lt;span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_pid_c20210805__us-gaap--StatementEquityComponentsAxis__custom--PreFundedWarrantsMember_zKwi0Gu6w8Si" title="Class of warrant or right, number of securities called by each warrant or right"&gt;561,111&lt;/span&gt; pre-funded
warrants (&#x201c;Pre-Funded Warrants&#x201d;) with each Pre-Funded Warrant exercisable for one share of common stock at an exercise price
of $&lt;span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20210805__us-gaap--StatementEquityComponentsAxis__custom--PreFundedWarrantsMember_z5nmqbZW8u2b" title="Exercise price of warrants"&gt;0.01&lt;/span&gt; per share, together with Common Warrants to purchase up to &lt;span id="xdx_900_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20210805__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zdAko8gD2IWj" title="Issuance of warrant shares"&gt;561,111&lt;/span&gt; shares of common stock at an exercise price of $&lt;span id="xdx_901_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20210805__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zkpDamcxzt56" title="Exercise price of warrants"&gt;10.50&lt;/span&gt; per
share (the &#x201c;Private Placement&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Common Warrants and Pre-Funded Warrants are collectively referred to as (the &#x201c;Warrants&#x201d;). The Warrants are exercisable at
any time at the option of the holder, have a term of 5 years from the issuance date and provide for cashless exercise under certain conditions.
The Company determined that the Warrants meet the conditions for equity classification. Shares issuable upon exercise of the Warrants
are hereinafter referred to as the &#x201c;Warrant Shares&#x201d;. The exercise price and number of the Warrant Shares are subject to anti-dilution
and other adjustments for certain stock dividends, stock splits, subsequent rights offerings, pro rata distributions or certain equity
structure changes.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pursuant
to the terms of the Purchase Agreement, on September 3, 2021, the Company filed a registration statement providing for the resale by
the purchasers of the Shares and Warrant Shares sold in the Private Placement, which registration statement became effective on September
15, 2021. Additionally, under the terms of the Purchase Agreement, the Company was obligated to use its reasonable best efforts to submit
an application to have the Company&#x2019;s common stock listed on a national exchange by December 31, 2021, and to use its reasonable
best efforts to have the Shares and Warrant Shares listed on such national exchange as soon as practicable following the submission of
such application. As indicated, the Common Stock was approved to list on the Nasdaq Capital Market under the symbol &#x201c;MICS&#x201d;
and began trading on the Nasdaq Capital Market on May 24, 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
closing of the Private Placement took place on August 10, 2021, when the Shares and Warrants were delivered to the purchasers and
funds, in the amount of approximately $&lt;span id="xdx_90C_eus-gaap--ProceedsFromWarrantExercises_c20210808__20210810__dei--LegalEntityAxis__custom--KonceptsandTreasureGreenMember__us-gaap--TypeOfArrangementAxis__custom--RedemptionAgreementMember_zXFTAqhoUydc" title="Proceeds from warrant exercises"&gt;9,800,000&lt;/span&gt;,
were received by the Company. Approximately $&lt;span id="xdx_903_eus-gaap--ConversionOfStockAmountIssued1_c20210808__20210810__dei--LegalEntityAxis__custom--KonceptsandTreasureGreenMember__us-gaap--TypeOfArrangementAxis__custom--RedemptionAgreementMember_zf46bgR4qsre" title="Conversion of stock, amount issued"&gt;7,200,000&lt;/span&gt;
of the funds was used to execute the Redemption Agreement (See Note 14 &#x2013; August 2021 Stock Redemption).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Stingray
is part of the group of investors who participated in the Private Placement and have acquired a minority interest in the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with the Private Placement, on July 6, 2021, the Company entered into a Placement Agency Agreement with A.G.P./Alliance Global
Partners (&#x201c;AGP&#x201d;), which provided for AGP to serve as the exclusive placement agent, advisor or underwriter (the &#x201c;placement
agent services&#x201d;). Pursuant to the Placement Agency Agreement, upon closing of the Private Placement, the Company paid AGP placement
fees of approximately $&lt;span id="xdx_909_eus-gaap--PaymentsForRepurchaseOfPrivatePlacement_pn5n6_c20210701__20210706__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zSfjuAhNJ6la"&gt;600,000
&lt;/span&gt;&lt;/span&gt;&lt;span id="xdx_90A_eus-gaap--DerivativeDescriptionOfTerms_c20210701__20210706_zrQlLm8Y9Om9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(representing
7% of the gross proceeds raised in the Private Placement excluding proceeds raised from the strategic investor, plus 3.5% of the aggregate
gross proceeds raised from the strategic investor),&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;and
issued AGP warrants to purchase &lt;span id="xdx_905_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20210706__us-gaap--ClassOfWarrantOrRightAxis__custom--AGPWarrantsMember_zWSmk3I0WCM"&gt;44,445
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of the Company&#x2019;s common stock (the
&#x201c;Advisor Warrants&#x201d;) (representing &lt;span id="xdx_90A_ecustom--AggregateNumberOfShares_iI_pid_dp_uPure_c20210706_z7VXqDZ67cXc"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%
of the aggregate number of Shares and Pre-Funded Warrants sold in the Private Placement, excluding the Shares sold to the strategic investor).
The Advisor Warrants have the same exercise price ($&lt;span id="xdx_900_eus-gaap--SharePrice_iI_pid_c20210706_z4jvEi89V5mb"&gt;10.50&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)
and terms as the Common Warrants issued in the Private Placement. The Company estimated the fair value of the Advisor Warrants to be
approximately $&lt;span id="xdx_901_eus-gaap--EquityFairValueDisclosure_iI_c20210706_zTL6IvK3uL4d"&gt;400,000&lt;/span&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;using
the Black-Scholes Model based on the following input assumptions: common stock price of $&lt;span id="xdx_90B_ecustom--SharePrice1_iI_c20210706_zdtHJ2Nhqef7"&gt;9.90&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;,
expected life of the warrants of &lt;span id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20210706_zRtNseODzXP2"&gt;2.5&lt;/span&gt;&lt;/span&gt;
&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;years; stock price volatility of &lt;span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20210701__20210706_zlAYuLDmTNxl"&gt;168&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%;
dividend yield of &lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20210701__20210706_zC3fSB4cE5T6"&gt;0&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%;
and the risk-free interest rate of &lt;span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20210701__20210706_zrPYJK9QSeN"&gt;2.65&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
addition to the placement fees paid to AGP, the Company incurred additional offering costs for direct incremental legal, consulting,
accounting and filing fees related to the Private Placement of approximately $&lt;span id="xdx_90E_eus-gaap--LegalFees_c20220401__20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zcj2kH3dj1nl" title="Legal fees"&gt;400,000&lt;/span&gt;
of which one consultant was issued &lt;span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20220401__20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zbhW3MNW1d2i" title="Stock issued for restricted shares"&gt;1,905&lt;/span&gt;
shares of restricted common stock with an aggregate fair value of approximately $&lt;span id="xdx_905_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardGross_c20220401__20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zzHoiZJpNOPb" title="Stock issued for restricted shares, value"&gt;200,000&lt;/span&gt;
and a cash payment of approximately $&lt;span id="xdx_90A_eus-gaap--PaymentsForRepurchaseOfPrivatePlacement_c20220401__20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zKH1tG8nZTLj" title="Cash payment for private placement"&gt;100,000&lt;/span&gt;.
Total offering costs related to the Private Placement amounted approximately $&lt;span id="xdx_90D_eus-gaap--PaymentsOfStockIssuanceCosts_c20220401__20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zcNcIzRf9hHj" title="Payment of stock issuance expenses"&gt;800,000&lt;/span&gt;
of which was payment of stock issuance expenses, which is recorded as an offset to additional paid in capital in the accompanying
consolidated statements of shareholders&#x2019; equity.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</RIME:AugustTwentyTwentyOnePrivatePlacementTextBlock>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2021-08-05_custom_PurchaseAgreementMember"
      decimals="INF"
      id="Fact002738"
      unitRef="Shares">550000</us-gaap:CommonStockSharesIssued>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2021-08-05_custom_PurchaseAgreementMember"
      decimals="INF"
      id="Fact002740"
      unitRef="Shares">550000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2021-08-05_custom_PurchaseAgreementMember"
      decimals="INF"
      id="Fact002742"
      unitRef="USDPShares">10.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="AsOf2021-08-05_custom_PreFundedWarrantsMember"
      decimals="INF"
      id="Fact002744"
      unitRef="Shares">561111</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2021-08-05_custom_PreFundedWarrantsMember"
      decimals="INF"
      id="Fact002746"
      unitRef="USDPShares">0.01</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2021-08-05_us-gaap_PrivatePlacementMember"
      decimals="INF"
      id="Fact002748"
      unitRef="Shares">561111</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2021-08-05_us-gaap_PrivatePlacementMember"
      decimals="INF"
      id="Fact002750"
      unitRef="USDPShares">10.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="From2021-08-082021-08-10_custom_KonceptsandTreasureGreenMember_custom_RedemptionAgreementMember"
      decimals="0"
      id="Fact002752"
      unitRef="USD">9800000</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ConversionOfStockAmountIssued1
      contextRef="From2021-08-082021-08-10_custom_KonceptsandTreasureGreenMember_custom_RedemptionAgreementMember"
      decimals="0"
      id="Fact002754"
      unitRef="USD">7200000</us-gaap:ConversionOfStockAmountIssued1>
    <us-gaap:PaymentsForRepurchaseOfPrivatePlacement
      contextRef="From2021-07-012021-07-06_us-gaap_PrivatePlacementMember"
      decimals="-5"
      id="Fact002755"
      unitRef="USD">600000000000</us-gaap:PaymentsForRepurchaseOfPrivatePlacement>
    <us-gaap:DerivativeDescriptionOfTerms contextRef="From2021-07-012021-07-06" id="Fact002756">(representing
7% of the gross proceeds raised in the Private Placement excluding proceeds raised from the strategic investor, plus 3.5% of the aggregate
gross proceeds raised from the strategic investor),</us-gaap:DerivativeDescriptionOfTerms>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2021-07-06_custom_AGPWarrantsMember"
      decimals="INF"
      id="Fact002757"
      unitRef="Shares">44445</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <RIME:AggregateNumberOfShares
      contextRef="AsOf2021-07-06"
      decimals="INF"
      id="Fact002758"
      unitRef="Pure">0.05</RIME:AggregateNumberOfShares>
    <us-gaap:SharePrice
      contextRef="AsOf2021-07-06"
      decimals="INF"
      id="Fact002759"
      unitRef="USDPShares">10.50</us-gaap:SharePrice>
    <us-gaap:EquityFairValueDisclosure
      contextRef="AsOf2021-07-06"
      decimals="0"
      id="Fact002760"
      unitRef="USD">400000</us-gaap:EquityFairValueDisclosure>
    <RIME:SharePrice1
      contextRef="AsOf2021-07-06"
      decimals="INF"
      id="Fact002761"
      unitRef="USDPShares">9.90</RIME:SharePrice1>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="AsOf2021-07-06" id="Fact002762">P2Y6M</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2021-07-012021-07-06"
      decimals="INF"
      id="Fact002763"
      unitRef="Pure">1.68</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2021-07-012021-07-06"
      decimals="INF"
      id="Fact002764"
      unitRef="Pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2021-07-012021-07-06"
      decimals="INF"
      id="Fact002765"
      unitRef="Pure">0.0265</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:LegalFees
      contextRef="From2022-04-012022-12-31_us-gaap_PrivatePlacementMember"
      decimals="0"
      id="Fact002767"
      unitRef="USD">400000</us-gaap:LegalFees>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="From2022-04-012022-12-31_us-gaap_PrivatePlacementMember"
      decimals="INF"
      id="Fact002769"
      unitRef="Shares">1905</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="From2022-04-012022-12-31_us-gaap_PrivatePlacementMember"
      decimals="0"
      id="Fact002771"
      unitRef="USD">200000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:PaymentsForRepurchaseOfPrivatePlacement
      contextRef="From2022-04-012022-12-31_us-gaap_PrivatePlacementMember"
      decimals="0"
      id="Fact002773"
      unitRef="USD">100000</us-gaap:PaymentsForRepurchaseOfPrivatePlacement>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="From2022-04-012022-12-31_us-gaap_PrivatePlacementMember"
      decimals="0"
      id="Fact002775"
      unitRef="USD">800000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2023-04-012023-12-31" id="Fact002777">&lt;p id="xdx_800_eus-gaap--IncomeTaxDisclosureTextBlock_zs4A8cVjmsH8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
16 - &lt;span id="xdx_82A_zgbCidzNUWFd"&gt;INCOME TAXES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89C_ecustom--ScheduleOfLossBeforeIncomeTaxTableTextBlock_zcKIvPBKU3z8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s loss before income taxes for the nine months ended December 31, 2023, and fiscal years ended March 31, 2023, and 2022
is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span id="xdx_8BE_z3CzUrwMDpU2" style="display: none"&gt;SCHEDULE OF LOSS BEFORE INCOME TAXES&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20230401__20231231_z3gv4sBqTotb" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;December 31, 2023&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20220401__20230331_zFivyGNqlKJl" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;March 31, 2023&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20210401__20220331_zHzf2VMRhQWe" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;March 31, 2023&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;Nine months ended&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;Fiscal years ended&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;December 31, 2023&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;March 31, 2023&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;March 31, 2023&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_zwVDB3c5KXVc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 34%; text-align: left"&gt;United States&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"&gt;(6,173,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"&gt;(3,526,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"&gt;(261,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_zeCEGkZB61cj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Foreign&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(225,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(82,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;548,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_zs8t6xUY4trg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-bottom: 2.5pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Loss
    before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(6,398,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(3,608,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;287,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A9_zartpE47oyA7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89B_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zwnpNk4VM3Al" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
provision for income taxes for the nine months ended December 31, 2023, and fiscal years ended March 31, 2023, and 2022 is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"&gt;&lt;span id="xdx_8BF_z3RkLhSRENai" style="display: none"&gt;SCHEDULE OF PROVISION FOR INCOME TAXES&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20230401__20231231_zMrKuEIP6l78" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;December 31, 2023&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20220401__20230331_zVWJ0jALdzn2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;March 31, 2023&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20210401__20220331_zRwAoTfR3pM" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;March 31, 2023&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;Nine months ended&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;Fiscal years ended&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;December 31, 2023&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;March 31, 2023&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;March 31, 2022&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Income tax provision:&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Current:&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--CurrentFederalTaxExpenseBenefit_maCFSALz48L_zePw4gom3VJj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 34%; text-align: left"&gt;Federal&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2795"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"&gt;109,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"&gt;63,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_maCFSALz48L_zJtMCKdI8mt1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;State&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2799"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2800"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2801"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--CurrentOtherTaxExpenseBenefit_maCFSALz48L_z2xFJgRqIO7e" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;Other&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2803"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(5,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2805"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--CurrentForeignTaxExpenseBenefit_maCFSALz48L_z4wliGmmM3v9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Hong Kong&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2807"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;34,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2809"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--CurrentFederalStateAndLocalTaxExpenseBenefit_iT_mtCFSALz48L_maITEBzBKD_zObMMc8g0sfj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;Total current Federal and State&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2811"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;138,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;63,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Deferred:&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_maDFSALzMsp_z5wMSFShEQaj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;Federal&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2815"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;686,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(60,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_maDFSALzMsp_zikmZFKcqwX9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;State&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2819"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;206,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;54,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--DeferredFederalStateAndLocalTaxExpenseBenefit_iT_mtDFSALzMsp_maITEBzBKD_zc0coHnpCFEh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Total Deferred Federal and State&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2823"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;892,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(6,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--IncomeTaxExpenseBenefit_iT_mtITEBzBKD_zlOwdZewRqMb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;Total income tax provision&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2827"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,030,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;57,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A2_zKtIcvYIOfN8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;THE
SINGING MACHINE COMPANY, INC AND SUBSIDIARIES&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December
31, 2023, and March 31, 2023 and 2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_893_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zKyasForL40c" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s net deferred tax assets as of December 31, 2023, and ended March 31, 2023 are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B3_zyy9lBaEuoLj" style="display: none"&gt;SCHEDULE
OF DEFERRED TAX ASSETS AND LIABILITIES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20231231_znTKkDMvVGEk" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20230331_zsJ6V8SEPaQ7" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;March 31,&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsDomestic_iI_maDTAGzkTe_zJcF4AE0oCF9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"&gt;NOL Federal Carryforward&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;1,291,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;868,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_iI_maDTAGzkTe_zfbMU0Jdv45i" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;State NOL Carryforward&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;470,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;341,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--DeferredTaxAssetsInventory_iI_maDTAGzkTe_zqMAT95bmnSd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Inventory differences to inventory valuation&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,173,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;623,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_iI_maDTAGzkTe_z18znzqFGylg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Stock option compensation expense&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;159,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;184,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--DeferredTaxAssetsRightUseOfLiability_iI_maDTAGzkTe_z7MQ7WEw3lse" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Right of use liability&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,022,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;118,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--DeferredTaxAssetsBusinessInterestLimitation_iI_maDTAGzkTe_z04oHutDkea3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Business interest limitation&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;151,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;138,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--DeferredTaxAssetsAllowanceForDoubtFulAccounts_iI_maDTAGzkTe_zg3VHHmlvoMb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Allowance for doubtful accounts&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;45,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;43,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances_iI_maDTAGzkTe_zwTm6k5Oi3b2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Reserve for estimated returns&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;384,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;89,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_iI_maDTAGzkTe_zLsHZcgvuira" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Accrued vacation&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;7,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;14,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--DeferredTaxAssetsGross_iTI_mtDTAGzkTe_maDTANzmdy_zgDA8p5rs8gh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;4,702,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;2,418,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_msDTANzmdy_zH2zn2oTD532" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Less: valuation allowance&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(3,600,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(2,104,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--DeferredTaxAssetsNet_iTI_maDTALNzWnn_mtDTANzmdy_zq4JfvbOkoL" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Net deferred tax asset&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,102,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;314,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--DeferredTaxLiabilitiesPropertyPlantAndEquipment_iNI_di_maDTLzkol_zQU1KPUgfPJk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Depreciable and amortizable assets&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(67,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(134,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--DeferredTaxLiabilitiesRightUseOfAsset_iNI_di_maDTLzkol_zCoA2j3XFaBd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;ROU Asset&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(1,000,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(111,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--DeferredTaxLiabilitiesPrepaidExpenses_iNI_di_maDTLzkol_zlE04no3wyIe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Prepaid expenses&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(35,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(69,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--DeferredTaxLiabilities_iNTI_di_msDTALNzWnn_mtDTLzkol_zlWlWrLvQpIb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Net deferred tax liability&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(1,102,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(314,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTI_mtDTALNzWnn_zIj3UIbrG3df" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2881"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2882"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AC_zzsckDqAScVa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognizes federal, state and foreign current tax liabilities or assets based on its estimate of taxes payable to or refundable
by tax authorities in the current fiscal year. The Company also recognizes federal, state and foreign deferred tax liabilities or assets
based on the Company&#x2019;s estimate of future tax effects attributable to temporary differences and carryforwards. The Company records
a valuation allowance to reduce any deferred tax assets by the amount of any tax benefits that, based on available evidence and judgment,
are not expected to be realized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company performed an analysis in accordance with the provisions of ASC 740, which requires an assessment of both positive and
negative evidence when determining whether it is more likely than not that deferred tax assets are recoverable. The analysis
performed to assess the realizability of the deferred tax assets included an evaluation of the pattern and timing of the reversals
of temporary differences and the length of carryback and carryforward periods available under the applicable federal, state and
foreign laws; and the amount and timing of future taxable income. The Company evaluated the realizability of its deferred tax assets
as of December 31, 2023 and March 31, 2023 in accordance with accounting principles generally accepted in the United States of
America and concluded that valuation allowance against all of our deferred tax assets was necessary based upon the Company&#x2019;s
conclusions regarding, among other considerations, the Company&#x2019;s recent history of losses and projected earnings for fiscal
year 2024 and in the future.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89F_eus-gaap--ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_zXpACVfvQcl4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
actual tax provision differs from the &#x201c;expected&#x201d; tax for the nine-month transition period ended December 31, 2023, and
the years ended March 31, 2023, and 2022 (computed by applying the U.S. Federal Corporate tax rate of 21 percent to income before
taxes) as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BB_zcJhmqf1s41b" style="display: none"&gt;SCHEDULE
OF TAX PROVISION&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20230401__20231231_z8vkNy8O8w6l" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;December 31, 2023&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20220401__20230331_zp2XvTg004g7" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;March 31, 2023&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20210401__20220331_zQ3piCOGCKQi" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;March 31, 2022&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_maITEBzmuZ_zqhaPji5LA26" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 43%; text-align: left"&gt;Statutory federal tax rate&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: right"&gt;(1,344,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;(758,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;60,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_maITEBzmuZ_znWhJFW0VkI7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Stater tax rate&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(326,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(174,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;14,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--IncomeTaxReconciliationChangeInEnactedTaxRate_maITEBzmuZ_zbpaBJyHD3V3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Permanent differences&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;15,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;13,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;10,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--IncomeTaxReconciliationChangeInPermanentDifferencesERCIncome_maITEBzmuZ_z0sxIegNnU8g" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Permanent difference in ERC income&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2898"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(99,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2900"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--IncomeTaxReconciliationForeignIncomeTaxRateDifferential_maITEBzmuZ_zxM7CBG0rctj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Tax rate differential on foreign earnings&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;59,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;21,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(84,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--IncomeTaxReconciliationChangeInExpirationOfNetOpretaingLossCarryforward_maITEBzmuZ_z3bxgbF9SVQd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Expiration of net operating loss carryforward&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;89,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2907"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2908"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_maITEBzmuZ_zDX1hCDEpzVk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Change in valuation allowance&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,495,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;2,026,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;55,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--IncomeTaxReconciliationOtherReconcilingItems_maITEBzmuZ_zzR1Oatq5DS4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Other&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;12,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;2,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--IncomeTaxExpenseBenefit_iT_mtITEBzmuZ_zX0jsMOAbHnd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Tax
    provision&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2918"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,030,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;57,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A5_znnnZIzJLiE6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;THE
SINGING MACHINE COMPANY, INC AND SUBSIDIARIES&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December
31, 2023, and March 31, 2023 and 2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
December 31, 2023, and March 31, 2023, the Company had federal tax net operating loss carryforwards in the amount of approximately $&lt;span id="xdx_909_eus-gaap--OperatingLossCarryforwards_iI_c20231231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zJ5oiD2W6Bj" title="Federal tax net operating loss carryforwards"&gt;6,149,000&lt;/span&gt;
and $&lt;span id="xdx_90C_eus-gaap--OperatingLossCarryforwards_iI_c20230331__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zjVbPDDceWL2" title="Federal tax net operating loss carryforwards"&gt;4,131,000&lt;/span&gt;, respectively that begin to expire in the year 2025. The net operating loss carryforward is subject to an IRS Section
382 limitation that limited the amount available to use beginning in Fiscal 2020 to approximately $&lt;span id="xdx_909_eus-gaap--OperatingLossCarryforwards_iI_c20231231__us-gaap--IncomeTaxAuthorityNameAxis__us-gaap--InternalRevenueServiceIRSMember_zh8ZzfUJAkZe" title="Net operating loss"&gt;150,000 &lt;/span&gt;per year. In addition, the
Company had state tax net operating loss carryforwards of approximately $&lt;span id="xdx_907_eus-gaap--OperatingLossCarryforwards_iI_c20231231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--StateAndLocalJurisdictionMember_z2zZTFLTI0U3" title="Operating loss carryforwards"&gt;2,453,000&lt;/span&gt; and $&lt;span id="xdx_90F_eus-gaap--OperatingLossCarryforwards_iI_c20230331__us-gaap--IncomeTaxAuthorityAxis__us-gaap--StateAndLocalJurisdictionMember_zcn95fYK8YPf" title="Operating loss carryforwards"&gt;2,238,000&lt;/span&gt;, respectively that will begin to expire
beginning in 2024. These tax net operating loss carryforwards may be subject to adjustment based on future changes in ownership.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
December 31, 2023, the Company evaluated the realizability of its deferred tax assets in accordance with GAAP and concluded that a valuation
allowance of approximately $&lt;span id="xdx_90E_eus-gaap--DeferredTaxAssetsValuationAllowance_iI_c20231231_z0JfsW10Zare" title="Deferred tax asset valuation allowance"&gt;3,600,000&lt;/span&gt; against deferred tax assets is necessary. The recognition of the remaining net deferred
tax asset and corresponding tax benefit is based upon the Company&#x2019;s conclusions regarding, among other considerations, the Company&#x2019;s
current and anticipated customers, contracts and product introductions, and recent operating results.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxDisclosureTextBlock>
    <RIME:ScheduleOfLossBeforeIncomeTaxTableTextBlock contextRef="From2023-04-012023-12-31" id="Fact002779">&lt;p id="xdx_89C_ecustom--ScheduleOfLossBeforeIncomeTaxTableTextBlock_zcKIvPBKU3z8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s loss before income taxes for the nine months ended December 31, 2023, and fiscal years ended March 31, 2023, and 2022
is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span id="xdx_8BE_z3CzUrwMDpU2" style="display: none"&gt;SCHEDULE OF LOSS BEFORE INCOME TAXES&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20230401__20231231_z3gv4sBqTotb" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;December 31, 2023&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20220401__20230331_zFivyGNqlKJl" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;March 31, 2023&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20210401__20220331_zHzf2VMRhQWe" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;March 31, 2023&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;Nine months ended&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;Fiscal years ended&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;December 31, 2023&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;March 31, 2023&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;March 31, 2023&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_zwVDB3c5KXVc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 34%; text-align: left"&gt;United States&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"&gt;(6,173,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"&gt;(3,526,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"&gt;(261,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_zeCEGkZB61cj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Foreign&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(225,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(82,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;548,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_zs8t6xUY4trg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-bottom: 2.5pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Loss
    before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(6,398,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(3,608,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;287,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</RIME:ScheduleOfLossBeforeIncomeTaxTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact002781"
      unitRef="USD">-6173000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact002782"
      unitRef="USD">-3526000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact002783"
      unitRef="USD">-261000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact002785"
      unitRef="USD">-225000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact002786"
      unitRef="USD">-82000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact002787"
      unitRef="USD">548000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact002789"
      unitRef="USD">-6398000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact002790"
      unitRef="USD">-3608000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact002791"
      unitRef="USD">287000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="From2023-04-012023-12-31" id="Fact002793">&lt;p id="xdx_89B_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zwnpNk4VM3Al" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
provision for income taxes for the nine months ended December 31, 2023, and fiscal years ended March 31, 2023, and 2022 is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"&gt;&lt;span id="xdx_8BF_z3RkLhSRENai" style="display: none"&gt;SCHEDULE OF PROVISION FOR INCOME TAXES&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20230401__20231231_zMrKuEIP6l78" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;December 31, 2023&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20220401__20230331_zVWJ0jALdzn2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;March 31, 2023&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20210401__20220331_zRwAoTfR3pM" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;March 31, 2023&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;Nine months ended&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;Fiscal years ended&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;December 31, 2023&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;March 31, 2023&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;March 31, 2022&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Income tax provision:&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Current:&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--CurrentFederalTaxExpenseBenefit_maCFSALz48L_zePw4gom3VJj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 34%; text-align: left"&gt;Federal&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2795"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"&gt;109,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"&gt;63,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_maCFSALz48L_zJtMCKdI8mt1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;State&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2799"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2800"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2801"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--CurrentOtherTaxExpenseBenefit_maCFSALz48L_z2xFJgRqIO7e" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;Other&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2803"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(5,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2805"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--CurrentForeignTaxExpenseBenefit_maCFSALz48L_z4wliGmmM3v9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Hong Kong&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2807"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;34,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2809"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--CurrentFederalStateAndLocalTaxExpenseBenefit_iT_mtCFSALz48L_maITEBzBKD_zObMMc8g0sfj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;Total current Federal and State&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2811"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;138,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;63,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Deferred:&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_maDFSALzMsp_z5wMSFShEQaj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;Federal&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2815"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;686,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(60,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_maDFSALzMsp_zikmZFKcqwX9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;State&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2819"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;206,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;54,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--DeferredFederalStateAndLocalTaxExpenseBenefit_iT_mtDFSALzMsp_maITEBzBKD_zc0coHnpCFEh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Total Deferred Federal and State&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2823"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;892,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(6,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--IncomeTaxExpenseBenefit_iT_mtITEBzBKD_zlOwdZewRqMb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;Total income tax provision&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2827"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,030,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;57,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact002796"
      unitRef="USD">109000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact002797"
      unitRef="USD">63000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <RIME:CurrentOtherTaxExpenseBenefit
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact002804"
      unitRef="USD">-5000</RIME:CurrentOtherTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact002808"
      unitRef="USD">34000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentFederalStateAndLocalTaxExpenseBenefit
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact002812"
      unitRef="USD">138000</us-gaap:CurrentFederalStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentFederalStateAndLocalTaxExpenseBenefit
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact002813"
      unitRef="USD">63000</us-gaap:CurrentFederalStateAndLocalTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact002816"
      unitRef="USD">686000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact002817"
      unitRef="USD">-60000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact002820"
      unitRef="USD">206000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact002821"
      unitRef="USD">54000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact002824"
      unitRef="USD">892000</us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit>
    <us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact002825"
      unitRef="USD">-6000</us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact002828"
      unitRef="USD">1030000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact002829"
      unitRef="USD">57000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="From2023-04-012023-12-31" id="Fact002831">&lt;p id="xdx_893_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zKyasForL40c" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s net deferred tax assets as of December 31, 2023, and ended March 31, 2023 are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B3_zyy9lBaEuoLj" style="display: none"&gt;SCHEDULE
OF DEFERRED TAX ASSETS AND LIABILITIES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20231231_znTKkDMvVGEk" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20230331_zsJ6V8SEPaQ7" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;March 31,&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsDomestic_iI_maDTAGzkTe_zJcF4AE0oCF9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"&gt;NOL Federal Carryforward&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;1,291,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;868,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_iI_maDTAGzkTe_zfbMU0Jdv45i" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;State NOL Carryforward&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;470,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;341,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--DeferredTaxAssetsInventory_iI_maDTAGzkTe_zqMAT95bmnSd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Inventory differences to inventory valuation&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,173,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;623,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_iI_maDTAGzkTe_z18znzqFGylg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Stock option compensation expense&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;159,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;184,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--DeferredTaxAssetsRightUseOfLiability_iI_maDTAGzkTe_z7MQ7WEw3lse" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Right of use liability&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,022,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;118,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--DeferredTaxAssetsBusinessInterestLimitation_iI_maDTAGzkTe_z04oHutDkea3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Business interest limitation&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;151,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;138,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--DeferredTaxAssetsAllowanceForDoubtFulAccounts_iI_maDTAGzkTe_zg3VHHmlvoMb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Allowance for doubtful accounts&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;45,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;43,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances_iI_maDTAGzkTe_zwTm6k5Oi3b2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Reserve for estimated returns&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;384,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;89,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_iI_maDTAGzkTe_zLsHZcgvuira" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Accrued vacation&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;7,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;14,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--DeferredTaxAssetsGross_iTI_mtDTAGzkTe_maDTANzmdy_zgDA8p5rs8gh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;4,702,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;2,418,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_msDTANzmdy_zH2zn2oTD532" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Less: valuation allowance&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(3,600,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(2,104,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--DeferredTaxAssetsNet_iTI_maDTALNzWnn_mtDTANzmdy_zq4JfvbOkoL" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Net deferred tax asset&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,102,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;314,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--DeferredTaxLiabilitiesPropertyPlantAndEquipment_iNI_di_maDTLzkol_zQU1KPUgfPJk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Depreciable and amortizable assets&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(67,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(134,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--DeferredTaxLiabilitiesRightUseOfAsset_iNI_di_maDTLzkol_zCoA2j3XFaBd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;ROU Asset&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(1,000,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(111,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--DeferredTaxLiabilitiesPrepaidExpenses_iNI_di_maDTLzkol_zlE04no3wyIe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Prepaid expenses&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(35,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(69,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--DeferredTaxLiabilities_iNTI_di_msDTALNzWnn_mtDTLzkol_zlWlWrLvQpIb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Net deferred tax liability&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(1,102,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(314,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTI_mtDTALNzWnn_zIj3UIbrG3df" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2881"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2882"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002833"
      unitRef="USD">1291000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic
      contextRef="AsOf2023-03-31"
      decimals="0"
      id="Fact002834"
      unitRef="USD">868000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002836"
      unitRef="USD">470000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
      contextRef="AsOf2023-03-31"
      decimals="0"
      id="Fact002837"
      unitRef="USD">341000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal>
    <us-gaap:DeferredTaxAssetsInventory
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002839"
      unitRef="USD">1173000</us-gaap:DeferredTaxAssetsInventory>
    <us-gaap:DeferredTaxAssetsInventory
      contextRef="AsOf2023-03-31"
      decimals="0"
      id="Fact002840"
      unitRef="USD">623000</us-gaap:DeferredTaxAssetsInventory>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002842"
      unitRef="USD">159000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="AsOf2023-03-31"
      decimals="0"
      id="Fact002843"
      unitRef="USD">184000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <RIME:DeferredTaxAssetsRightUseOfLiability
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002845"
      unitRef="USD">1022000</RIME:DeferredTaxAssetsRightUseOfLiability>
    <RIME:DeferredTaxAssetsRightUseOfLiability
      contextRef="AsOf2023-03-31"
      decimals="0"
      id="Fact002846"
      unitRef="USD">118000</RIME:DeferredTaxAssetsRightUseOfLiability>
    <RIME:DeferredTaxAssetsBusinessInterestLimitation
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002848"
      unitRef="USD">151000</RIME:DeferredTaxAssetsBusinessInterestLimitation>
    <RIME:DeferredTaxAssetsBusinessInterestLimitation
      contextRef="AsOf2023-03-31"
      decimals="0"
      id="Fact002849"
      unitRef="USD">138000</RIME:DeferredTaxAssetsBusinessInterestLimitation>
    <RIME:DeferredTaxAssetsAllowanceForDoubtFulAccounts
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002851"
      unitRef="USD">45000</RIME:DeferredTaxAssetsAllowanceForDoubtFulAccounts>
    <RIME:DeferredTaxAssetsAllowanceForDoubtFulAccounts
      contextRef="AsOf2023-03-31"
      decimals="0"
      id="Fact002852"
      unitRef="USD">43000</RIME:DeferredTaxAssetsAllowanceForDoubtFulAccounts>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002854"
      unitRef="USD">384000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances
      contextRef="AsOf2023-03-31"
      decimals="0"
      id="Fact002855"
      unitRef="USD">89000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002857"
      unitRef="USD">7000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
      contextRef="AsOf2023-03-31"
      decimals="0"
      id="Fact002858"
      unitRef="USD">14000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002860"
      unitRef="USD">4702000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="AsOf2023-03-31"
      decimals="0"
      id="Fact002861"
      unitRef="USD">2418000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002863"
      unitRef="USD">3600000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="AsOf2023-03-31"
      decimals="0"
      id="Fact002864"
      unitRef="USD">2104000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002866"
      unitRef="USD">1102000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="AsOf2023-03-31"
      decimals="0"
      id="Fact002867"
      unitRef="USD">314000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002869"
      unitRef="USD">67000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="AsOf2023-03-31"
      decimals="0"
      id="Fact002870"
      unitRef="USD">134000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <RIME:DeferredTaxLiabilitiesRightUseOfAsset
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002872"
      unitRef="USD">1000000</RIME:DeferredTaxLiabilitiesRightUseOfAsset>
    <RIME:DeferredTaxLiabilitiesRightUseOfAsset
      contextRef="AsOf2023-03-31"
      decimals="0"
      id="Fact002873"
      unitRef="USD">111000</RIME:DeferredTaxLiabilitiesRightUseOfAsset>
    <us-gaap:DeferredTaxLiabilitiesPrepaidExpenses
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002875"
      unitRef="USD">35000</us-gaap:DeferredTaxLiabilitiesPrepaidExpenses>
    <us-gaap:DeferredTaxLiabilitiesPrepaidExpenses
      contextRef="AsOf2023-03-31"
      decimals="0"
      id="Fact002876"
      unitRef="USD">69000</us-gaap:DeferredTaxLiabilitiesPrepaidExpenses>
    <us-gaap:DeferredTaxLiabilities
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002878"
      unitRef="USD">1102000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="AsOf2023-03-31"
      decimals="0"
      id="Fact002879"
      unitRef="USD">314000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock contextRef="From2023-04-012023-12-31" id="Fact002884">&lt;p id="xdx_89F_eus-gaap--ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_zXpACVfvQcl4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
actual tax provision differs from the &#x201c;expected&#x201d; tax for the nine-month transition period ended December 31, 2023, and
the years ended March 31, 2023, and 2022 (computed by applying the U.S. Federal Corporate tax rate of 21 percent to income before
taxes) as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BB_zcJhmqf1s41b" style="display: none"&gt;SCHEDULE
OF TAX PROVISION&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20230401__20231231_z8vkNy8O8w6l" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;December 31, 2023&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20220401__20230331_zp2XvTg004g7" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;March 31, 2023&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20210401__20220331_zQ3piCOGCKQi" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;March 31, 2022&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_maITEBzmuZ_zqhaPji5LA26" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 43%; text-align: left"&gt;Statutory federal tax rate&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: right"&gt;(1,344,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;(758,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;60,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_maITEBzmuZ_znWhJFW0VkI7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Stater tax rate&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(326,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(174,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;14,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--IncomeTaxReconciliationChangeInEnactedTaxRate_maITEBzmuZ_zbpaBJyHD3V3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Permanent differences&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;15,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;13,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;10,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--IncomeTaxReconciliationChangeInPermanentDifferencesERCIncome_maITEBzmuZ_z0sxIegNnU8g" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Permanent difference in ERC income&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2898"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(99,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2900"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--IncomeTaxReconciliationForeignIncomeTaxRateDifferential_maITEBzmuZ_zxM7CBG0rctj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Tax rate differential on foreign earnings&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;59,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;21,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(84,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--IncomeTaxReconciliationChangeInExpirationOfNetOpretaingLossCarryforward_maITEBzmuZ_z3bxgbF9SVQd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Expiration of net operating loss carryforward&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;89,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2907"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2908"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_maITEBzmuZ_zDX1hCDEpzVk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Change in valuation allowance&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,495,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;2,026,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;55,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--IncomeTaxReconciliationOtherReconcilingItems_maITEBzmuZ_zzR1Oatq5DS4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Other&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;12,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;2,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--IncomeTaxExpenseBenefit_iT_mtITEBzmuZ_zX0jsMOAbHnd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Tax
    provision&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2918"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,030,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;57,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact002886"
      unitRef="USD">-1344000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact002887"
      unitRef="USD">-758000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact002888"
      unitRef="USD">60000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact002890"
      unitRef="USD">-326000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact002891"
      unitRef="USD">-174000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact002892"
      unitRef="USD">14000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact002894"
      unitRef="USD">15000</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact002895"
      unitRef="USD">13000</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact002896"
      unitRef="USD">10000</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <RIME:IncomeTaxReconciliationChangeInPermanentDifferencesERCIncome
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact002899"
      unitRef="USD">-99000</RIME:IncomeTaxReconciliationChangeInPermanentDifferencesERCIncome>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact002902"
      unitRef="USD">59000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact002903"
      unitRef="USD">21000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact002904"
      unitRef="USD">-84000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <RIME:IncomeTaxReconciliationChangeInExpirationOfNetOpretaingLossCarryforward
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact002906"
      unitRef="USD">89000</RIME:IncomeTaxReconciliationChangeInExpirationOfNetOpretaingLossCarryforward>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact002910"
      unitRef="USD">1495000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact002911"
      unitRef="USD">2026000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact002912"
      unitRef="USD">55000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationOtherReconcilingItems
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact002914"
      unitRef="USD">12000</us-gaap:IncomeTaxReconciliationOtherReconcilingItems>
    <us-gaap:IncomeTaxReconciliationOtherReconcilingItems
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact002915"
      unitRef="USD">1000</us-gaap:IncomeTaxReconciliationOtherReconcilingItems>
    <us-gaap:IncomeTaxReconciliationOtherReconcilingItems
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact002916"
      unitRef="USD">2000</us-gaap:IncomeTaxReconciliationOtherReconcilingItems>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact002919"
      unitRef="USD">1030000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact002920"
      unitRef="USD">57000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2023-12-31_us-gaap_DomesticCountryMember"
      decimals="0"
      id="Fact002922"
      unitRef="USD">6149000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2023-03-31_us-gaap_DomesticCountryMember"
      decimals="0"
      id="Fact002924"
      unitRef="USD">4131000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2023-12-31_us-gaap_InternalRevenueServiceIRSMember"
      decimals="0"
      id="Fact002926"
      unitRef="USD">150000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2023-12-31_us-gaap_StateAndLocalJurisdictionMember"
      decimals="0"
      id="Fact002928"
      unitRef="USD">2453000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2023-03-31_us-gaap_StateAndLocalJurisdictionMember"
      decimals="0"
      id="Fact002930"
      unitRef="USD">2238000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002932"
      unitRef="USD">3600000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="From2023-04-012023-12-31" id="Fact002934">&lt;p id="xdx_809_eus-gaap--SegmentReportingDisclosureTextBlock_z4oc9irSX5Ib" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
17 &#x2013; &lt;span id="xdx_826_zJf6TZ2q0cba"&gt;REVENUE DISAGGREGATION &lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company disaggregates revenues by product line and major geographic region as most of its revenue is generated by the sales of karaoke
hardware and the Company has no other material business segments:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_896_eus-gaap--DisaggregationOfRevenueTableTextBlock_z5e4ksowGI86" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Revenue
by product line is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BE_z3cwErgWkoab" style="display: none"&gt;SCHEDULE
OF REVENUE BY PRODUCT LINE&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20230401__20231231_zcvFlwHSoYL9" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;December 31,2023&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20220401__20230331_zlXsNzH4TLT2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;March 31, 2023&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20210401__20220331_z5WtX8zdZ96k" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;March 31, 2022&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;Nine Months Ended&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;Fiscal Years Ended&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;December 31,2023&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;March 31, 2023&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;March 31, 2022&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-decoration: underline; text-align: left"&gt;Product Line&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--KaraokeMachinesMember_z0vcexDTdO97" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 43%; text-align: left"&gt;Karaoke Machines&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: right"&gt;24,189,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;28,856,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;38,869,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--LicensedProductsMember_zsLnmKlMotNd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Licensed Products&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;549,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;95,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,645,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--KidsYouthElectronicsMember_zXQuyMEB1F5d" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Kids Youth Electronics&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;565,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,872,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;2,277,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--MicrophonesAndAccessoriesMember_zehC3h1wXjc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Microphones and Accessories&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;3,283,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;7,802,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;4,185,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--MusicSubscriptionsMember_z6b5M8pZNNNg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Music Subscriptions&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;612,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;674,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;536,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--Revenues_z187dA9Sthlj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;Total Net Sales&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;29,198,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;39,299,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;47,512,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AD_zJJzZMbCd3Oe" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_890_eus-gaap--ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_zo4TbTIXPNVd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Revenue
by geographic region is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BD_zhNkzveFBU0e" style="display: none"&gt;SCHEDULE OF REVENUE BY GEOGRAPHICAL REGION&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20230401__20231231_zNrLZbPbyV8c" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;December 31, 2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20220401__20230331_zqervhkGBDRc" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;March 31, 2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20210401__20220331_zb4vNjlif2K4" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;March 31, 2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;FOR THE NINE MONTHS ENDED&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;FOR THE FISCAL YEARS ENDED&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;December 31, 2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;March 31, 2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;March 31, 2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--Revenues_hsrt--StatementGeographicalAxis__srt--NorthAmericaMember_z3SHp5Gxhxz6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 43%; text-align: left"&gt;North America&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: right"&gt;28,763,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;38,298,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;46,396,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--Revenues_hsrt--StatementGeographicalAxis__country--AU_zI0fmWTEjNM4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Australia&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;205,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;670,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;679,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--Revenues_hsrt--StatementGeographicalAxis__custom--EuropeAndUnitedKingdomMember_z2qxcwIIbrjj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Europe and United Kingdom&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;226,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;331,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;359,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--Revenues_hsrt--StatementGeographicalAxis__custom--OthersMember_ztrJtqC9geC2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;All Others&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;4,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2977"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;78,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--Revenues_z1XP4QOH1mTj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;29,198,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;39,299,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;47,512,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A9_zgOtFMZeeo0e" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
geographic area of sales is based primarily on where the product was delivered.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock contextRef="From2023-04-012023-12-31" id="Fact002936">&lt;p id="xdx_896_eus-gaap--DisaggregationOfRevenueTableTextBlock_z5e4ksowGI86" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Revenue
by product line is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BE_z3cwErgWkoab" style="display: none"&gt;SCHEDULE
OF REVENUE BY PRODUCT LINE&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20230401__20231231_zcvFlwHSoYL9" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;December 31,2023&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20220401__20230331_zlXsNzH4TLT2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;March 31, 2023&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20210401__20220331_z5WtX8zdZ96k" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;March 31, 2022&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;Nine Months Ended&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;Fiscal Years Ended&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;December 31,2023&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;March 31, 2023&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;March 31, 2022&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-decoration: underline; text-align: left"&gt;Product Line&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--KaraokeMachinesMember_z0vcexDTdO97" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 43%; text-align: left"&gt;Karaoke Machines&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: right"&gt;24,189,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;28,856,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;38,869,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--LicensedProductsMember_zsLnmKlMotNd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Licensed Products&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;549,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;95,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,645,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--KidsYouthElectronicsMember_zXQuyMEB1F5d" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Kids Youth Electronics&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;565,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,872,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;2,277,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--MicrophonesAndAccessoriesMember_zehC3h1wXjc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Microphones and Accessories&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;3,283,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;7,802,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;4,185,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--MusicSubscriptionsMember_z6b5M8pZNNNg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Music Subscriptions&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;612,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;674,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;536,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--Revenues_z187dA9Sthlj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;Total Net Sales&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;29,198,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;39,299,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;47,512,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:Revenues
      contextRef="From2023-04-012023-12-31_custom_KaraokeMachinesMember"
      decimals="0"
      id="Fact002938"
      unitRef="USD">24189000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2022-04-012023-03-31_custom_KaraokeMachinesMember"
      decimals="0"
      id="Fact002939"
      unitRef="USD">28856000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2021-04-012022-03-31_custom_KaraokeMachinesMember"
      decimals="0"
      id="Fact002940"
      unitRef="USD">38869000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-04-012023-12-31_custom_LicensedProductsMember"
      decimals="0"
      id="Fact002942"
      unitRef="USD">549000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2022-04-012023-03-31_custom_LicensedProductsMember"
      decimals="0"
      id="Fact002943"
      unitRef="USD">95000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2021-04-012022-03-31_custom_LicensedProductsMember"
      decimals="0"
      id="Fact002944"
      unitRef="USD">1645000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-04-012023-12-31_custom_KidsYouthElectronicsMember"
      decimals="0"
      id="Fact002946"
      unitRef="USD">565000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2022-04-012023-03-31_custom_KidsYouthElectronicsMember"
      decimals="0"
      id="Fact002947"
      unitRef="USD">1872000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2021-04-012022-03-31_custom_KidsYouthElectronicsMember"
      decimals="0"
      id="Fact002948"
      unitRef="USD">2277000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-04-012023-12-31_custom_MicrophonesAndAccessoriesMember"
      decimals="0"
      id="Fact002950"
      unitRef="USD">3283000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2022-04-012023-03-31_custom_MicrophonesAndAccessoriesMember"
      decimals="0"
      id="Fact002951"
      unitRef="USD">7802000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2021-04-012022-03-31_custom_MicrophonesAndAccessoriesMember"
      decimals="0"
      id="Fact002952"
      unitRef="USD">4185000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-04-012023-12-31_custom_MusicSubscriptionsMember"
      decimals="0"
      id="Fact002954"
      unitRef="USD">612000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2022-04-012023-03-31_custom_MusicSubscriptionsMember"
      decimals="0"
      id="Fact002955"
      unitRef="USD">674000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2021-04-012022-03-31_custom_MusicSubscriptionsMember"
      decimals="0"
      id="Fact002956"
      unitRef="USD">536000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact002958"
      unitRef="USD">29198000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact002959"
      unitRef="USD">39299000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact002960"
      unitRef="USD">47512000</us-gaap:Revenues>
    <us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock contextRef="From2023-04-012023-12-31" id="Fact002962">&lt;p id="xdx_890_eus-gaap--ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_zo4TbTIXPNVd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Revenue
by geographic region is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BD_zhNkzveFBU0e" style="display: none"&gt;SCHEDULE OF REVENUE BY GEOGRAPHICAL REGION&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20230401__20231231_zNrLZbPbyV8c" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;December 31, 2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20220401__20230331_zqervhkGBDRc" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;March 31, 2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20210401__20220331_zb4vNjlif2K4" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;March 31, 2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;FOR THE NINE MONTHS ENDED&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;FOR THE FISCAL YEARS ENDED&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;December 31, 2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;March 31, 2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;March 31, 2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--Revenues_hsrt--StatementGeographicalAxis__srt--NorthAmericaMember_z3SHp5Gxhxz6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 43%; text-align: left"&gt;North America&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: right"&gt;28,763,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;38,298,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;46,396,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--Revenues_hsrt--StatementGeographicalAxis__country--AU_zI0fmWTEjNM4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Australia&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;205,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;670,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;679,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--Revenues_hsrt--StatementGeographicalAxis__custom--EuropeAndUnitedKingdomMember_z2qxcwIIbrjj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Europe and United Kingdom&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;226,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;331,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;359,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--Revenues_hsrt--StatementGeographicalAxis__custom--OthersMember_ztrJtqC9geC2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;All Others&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;4,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2977"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;78,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--Revenues_z1XP4QOH1mTj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;29,198,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;39,299,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;47,512,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock>
    <us-gaap:Revenues
      contextRef="From2023-04-012023-12-31_srt_NorthAmericaMember"
      decimals="0"
      id="Fact002964"
      unitRef="USD">28763000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2022-04-012023-03-31_srt_NorthAmericaMember"
      decimals="0"
      id="Fact002965"
      unitRef="USD">38298000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2021-04-012022-03-31_srt_NorthAmericaMember"
      decimals="0"
      id="Fact002966"
      unitRef="USD">46396000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-04-012023-12-31_country_AU"
      decimals="0"
      id="Fact002968"
      unitRef="USD">205000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2022-04-012023-03-31_country_AU"
      decimals="0"
      id="Fact002969"
      unitRef="USD">670000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2021-04-012022-03-31_country_AU"
      decimals="0"
      id="Fact002970"
      unitRef="USD">679000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-04-012023-12-31_custom_EuropeAndUnitedKingdomMember"
      decimals="0"
      id="Fact002972"
      unitRef="USD">226000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2022-04-012023-03-31_custom_EuropeAndUnitedKingdomMember"
      decimals="0"
      id="Fact002973"
      unitRef="USD">331000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2021-04-012022-03-31_custom_EuropeAndUnitedKingdomMember"
      decimals="0"
      id="Fact002974"
      unitRef="USD">359000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-04-012023-12-31_custom_OthersMember"
      decimals="0"
      id="Fact002976"
      unitRef="USD">4000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2021-04-012022-03-31_custom_OthersMember"
      decimals="0"
      id="Fact002978"
      unitRef="USD">78000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact002980"
      unitRef="USD">29198000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact002981"
      unitRef="USD">39299000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact002982"
      unitRef="USD">47512000</us-gaap:Revenues>
    <us-gaap:ConcentrationRiskDisclosureTextBlock contextRef="From2023-04-012023-12-31" id="Fact002984">&lt;p id="xdx_800_eus-gaap--ConcentrationRiskDisclosureTextBlock_znfs8FWL4Ul5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
18 - &lt;span id="xdx_82E_zSrhmbvWQBFk"&gt;CONCENTRATIONS OF CREDIT RISK AND REVENUE&lt;/span&gt; &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
times, the Company maintains cash in United States bank accounts that are more than the Federal Deposit Insurance Corporation insured
amounts. The Company maintains cash balances in foreign financial institutions. The Company regularly monitors the financial stability
of this financial institution and believes that it is not exposed to any significant credit risk in cash and cash equivalents. However,
in March and April 2023, certain U.S. government banking regulators took steps to intervene in the operations of certain financial institutions
due to liquidity concerns, which caused general heightened uncertainties in financial markets. While these events have not had a material
direct impact on the Company&#x2019;s operations, if further liquidity and financial stability concerns arise with respect to banks and
financial institutions, either nationally or in specific regions, the Company&#x2019;s ability to access cash or enter into new financing
arrangements may be threatened, which could have a material adverse effect on its business, financial condition and results of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company derives most of its revenues from retailers in the United States. The Company&#x2019;s allowance for credit losses is based upon
management&#x2019;s estimates and historical experience and reflects the fact that accounts receivable is concentrated with several large
customers. On December 31, 2023, &lt;span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230401__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--FourCustomersMember_zdPKSNZ3Ms3c" title="Concentration of sales risk, percentage"&gt;82&lt;/span&gt;% of accounts receivable were due from four customers in North America that individually owed over
10% of total accounts receivable. On March 31, 2023, &lt;span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220401__20230331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ThreeCustomersMember_zcQN8fDaDZW1" title="Concentration of sales risk, percentage"&gt;79&lt;/span&gt;% of accounts receivable were due from three customers in North America that individually
owed over 10% of total accounts receivable. On March 31, 2022, &lt;span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210401__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--FourCustomersMember_zFSXapnxAiv5" title="Concentration of sales risk, percentage"&gt;53&lt;/span&gt;% of accounts receivable were due from four customers in North America
that individually owed over 10% of total accounts receivable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Revenues
derived from our top three customers for the nine months ended December 31, 2023, and 2022, were &lt;span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230401__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__custom--ThreeCustomersMember__srt--MajorCustomersAxis__custom--CustomersConcentrationRiskMember_zOW0Mk4toyx6" title="Concentration of sales risk, percentage"&gt;81&lt;/span&gt;% and &lt;span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220401__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__custom--ThreeCustomersMember__srt--MajorCustomersAxis__custom--CustomersConcentrationRiskMember_zozBkQYinFl9" title="Concentration of sales risk, percentage"&gt;77&lt;/span&gt;% of total revenue, respectively.
Revenues derived from our top three customers for the fiscal years ended March 31, 2023, and 2022 were &lt;span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220401__20230331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__custom--ThreeCustomersMember__srt--MajorCustomersAxis__custom--CustomersConcentrationRiskMember_zFXh5VZLs1x1" title="Concentration of sales risk, percentage"&gt;69&lt;/span&gt;% and &lt;span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210401__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__custom--ThreeCustomersMember__srt--MajorCustomersAxis__custom--CustomersConcentrationRiskMember_zmSuTByUV0x7" title="Concentration of sales risk, percentage"&gt;72&lt;/span&gt;% of total revenue,
respectively. Revenues from customers representing greater than 10% of total net sales were derived from top three customers for the
nine months ended December 31, 2023, and top two customers for the nine months ended December 31, 2022, as percentage of the net sales
were &lt;span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230401__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomersOneMember__srt--MajorCustomersAxis__custom--CustomersConcentrationRiskMember_zdGtBbk808Kh" title="Concentration of sales risk, percentage"&gt;48&lt;/span&gt;%, &lt;span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230401__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomersTwoMember__srt--MajorCustomersAxis__custom--CustomersConcentrationRiskMember_zvVJk8ALlRLc" title="Concentration of sales risk, percentage"&gt;21&lt;/span&gt;% and &lt;span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230401__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomersThreeMember__srt--MajorCustomersAxis__custom--CustomersConcentrationRiskMember_zpe8ODKWIO53" title="Concentration of sales risk, percentage"&gt;12&lt;/span&gt;% and &lt;span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220401__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomersOneMember__srt--MajorCustomersAxis__custom--CustomersConcentrationRiskMember_z3mQnf61ln43" title="Concentration of sales risk, percentage"&gt;46&lt;/span&gt;% and, &lt;span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220401__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomersTwoMember__srt--MajorCustomersAxis__custom--CustomersConcentrationRiskMember_z0VYpnq06jgc" title="Concentration of sales risk, percentage"&gt;22&lt;/span&gt;%, respectively. Revenues from customers representing greater than 10% of total net sales were derived
from our top two customers in Fiscal 2023 and top three customers in Fiscal 2022 as percentage of the net sales were &lt;span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220401__20230331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomersOneMember__srt--MajorCustomersAxis__custom--CustomersConcentrationRiskMember_zT7KGAJqPvv9" title="Concentration of sales risk, percentage"&gt;48&lt;/span&gt;% and &lt;span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220401__20230331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomersTwoMember__srt--MajorCustomersAxis__custom--CustomersConcentrationRiskMember_zMLs58p2um1d" title="Concentration of sales risk, percentage"&gt;21&lt;/span&gt;% and
&lt;span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210401__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomersOneMember__srt--MajorCustomersAxis__custom--CustomersConcentrationRiskMember_zDmwTLyzkI3d" title="Concentration of sales risk, percentage"&gt;37&lt;/span&gt;%, &lt;span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210401__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomersTwoMember__srt--MajorCustomersAxis__custom--CustomersConcentrationRiskMember_zeeHNC9oX279" title="Concentration of sales risk, percentage"&gt;18&lt;/span&gt;%, and &lt;span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210401__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomersThreeMember__srt--MajorCustomersAxis__custom--CustomersConcentrationRiskMember_ziPVXjAekhGk" title="Concentration of sales risk, percentage"&gt;17&lt;/span&gt;%, respectively. The loss of any of these customers could have an adverse impact on the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;THE
SINGING MACHINE COMPANY, INC AND SUBSIDIARIES&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December
31, 2023, and March 31, 2023 and 2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is dependent upon foreign companies for the manufacture of all its electronic products. The Company&#x2019;s arrangements with
manufacturers are subject to the risk of doing business abroad, such as import duties, trade restrictions, work stoppages, foreign currency
fluctuations, political instability, and other factors, which could have an adverse impact on its business. The Company believes that
the loss of any one or more of their suppliers would not have a long-term material adverse effect because other manufacturers with whom
the Company does business would be able to increase production to fulfill their requirements. However, the loss of certain suppliers
in the short term could adversely affect business until alternative supply arrangements are secured.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the nine months ended December 31, 2023, and fiscal years 2023 and 2022, manufacturers in the People&#x2019;s Republic of China accounted
for &lt;span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230401__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--GeographicConcentrationRiskMember__srt--MajorCustomersAxis__custom--RepublicOfChinaMember_zq4PtJ0ODRV6" title="Concentration of sales risk, percentage"&gt;&lt;span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220401__20230331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--GeographicConcentrationRiskMember__srt--MajorCustomersAxis__custom--RepublicOfChinaMember_zvKD5hLm5NGg" title="Concentration of sales risk, percentage"&gt;&lt;span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210401__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--GeographicConcentrationRiskMember__srt--MajorCustomersAxis__custom--RepublicOfChinaMember_zvJ9DP33MIKa" title="Concentration of sales risk, percentage"&gt;100&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;% of the Company&#x2019;s total product purchases, including all the Company&#x2019;s hardware purchases. In 2018 &lt;span id="xdx_900_eus-gaap--DebtInstrumentDescription_pid_c20230401__20231231__us-gaap--ConcentrationRiskByTypeAxis__custom--RepublicOfChinaMember_zCksFkuHY0Dk" title="Debt instrument, description"&gt;the U.S. government-imposed
tariffs of up to 25% on certain goods imported from China. All our products are manufactured and imported from China however, only our
microphones are currently subject to a 7.5% tariff currently in place&lt;/span&gt;. Should the government decide to expand its list of products to
include our karaoke products that would subject our products to tariffs in the future, there could be a significant increase in the landed
cost of our products. If we are unable to mitigate these increased costs through price increases, we could experience reductions in revenues,
gross profit margin and results from operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ConcentrationRiskDisclosureTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2023-04-012023-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_FourCustomersMember"
      decimals="INF"
      id="Fact002986"
      unitRef="Pure">0.82</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2022-04-012023-03-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_ThreeCustomersMember"
      decimals="INF"
      id="Fact002988"
      unitRef="Pure">0.79</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2021-04-012022-03-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_FourCustomersMember"
      decimals="INF"
      id="Fact002990"
      unitRef="Pure">0.53</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2023-04-012023-12-31_custom_SalesRevenueMember_custom_ThreeCustomersMember_custom_CustomersConcentrationRiskMember"
      decimals="INF"
      id="Fact002992"
      unitRef="Pure">0.81</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2022-04-012022-12-31_custom_SalesRevenueMember_custom_ThreeCustomersMember_custom_CustomersConcentrationRiskMember"
      decimals="INF"
      id="Fact002994"
      unitRef="Pure">0.77</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2022-04-012023-03-31_custom_SalesRevenueMember_custom_ThreeCustomersMember_custom_CustomersConcentrationRiskMember"
      decimals="INF"
      id="Fact002996"
      unitRef="Pure">0.69</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2021-04-012022-03-31_custom_SalesRevenueMember_custom_ThreeCustomersMember_custom_CustomersConcentrationRiskMember"
      decimals="INF"
      id="Fact002998"
      unitRef="Pure">0.72</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2023-04-012023-12-31_custom_SalesRevenueMember_custom_CustomersOneMember_custom_CustomersConcentrationRiskMember"
      decimals="INF"
      id="Fact003000"
      unitRef="Pure">0.48</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2023-04-012023-12-31_custom_SalesRevenueMember_custom_CustomersTwoMember_custom_CustomersConcentrationRiskMember"
      decimals="INF"
      id="Fact003002"
      unitRef="Pure">0.21</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2023-04-012023-12-31_custom_SalesRevenueMember_custom_CustomersThreeMember_custom_CustomersConcentrationRiskMember"
      decimals="INF"
      id="Fact003004"
      unitRef="Pure">0.12</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2022-04-012022-12-31_custom_SalesRevenueMember_custom_CustomersOneMember_custom_CustomersConcentrationRiskMember"
      decimals="INF"
      id="Fact003006"
      unitRef="Pure">0.46</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2022-04-012022-12-31_custom_SalesRevenueMember_custom_CustomersTwoMember_custom_CustomersConcentrationRiskMember"
      decimals="INF"
      id="Fact003008"
      unitRef="Pure">0.22</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2022-04-012023-03-31_custom_SalesRevenueMember_custom_CustomersOneMember_custom_CustomersConcentrationRiskMember"
      decimals="INF"
      id="Fact003010"
      unitRef="Pure">0.48</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2022-04-012023-03-31_custom_SalesRevenueMember_custom_CustomersTwoMember_custom_CustomersConcentrationRiskMember"
      decimals="INF"
      id="Fact003012"
      unitRef="Pure">0.21</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2021-04-012022-03-31_custom_SalesRevenueMember_custom_CustomersOneMember_custom_CustomersConcentrationRiskMember"
      decimals="INF"
      id="Fact003014"
      unitRef="Pure">0.37</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2021-04-012022-03-31_custom_SalesRevenueMember_custom_CustomersTwoMember_custom_CustomersConcentrationRiskMember"
      decimals="INF"
      id="Fact003016"
      unitRef="Pure">0.18</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2021-04-012022-03-31_custom_SalesRevenueMember_custom_CustomersThreeMember_custom_CustomersConcentrationRiskMember"
      decimals="INF"
      id="Fact003018"
      unitRef="Pure">0.17</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2023-04-012023-12-31_custom_PurchasesMember_us-gaap_GeographicConcentrationRiskMember_custom_RepublicOfChinaMember"
      decimals="INF"
      id="Fact003020"
      unitRef="Pure">1</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2022-04-012023-03-31_custom_PurchasesMember_us-gaap_GeographicConcentrationRiskMember_custom_RepublicOfChinaMember"
      decimals="INF"
      id="Fact003022"
      unitRef="Pure">1</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2021-04-012022-03-31_custom_PurchasesMember_us-gaap_GeographicConcentrationRiskMember_custom_RepublicOfChinaMember"
      decimals="INF"
      id="Fact003024"
      unitRef="Pure">1</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:DebtInstrumentDescription
      contextRef="From2023-04-012023-12-31_custom_RepublicOfChinaMember"
      id="Fact003026">the U.S. government-imposed
tariffs of up to 25% on certain goods imported from China. All our products are manufactured and imported from China however, only our
microphones are currently subject to a 7.5% tariff currently in place</us-gaap:DebtInstrumentDescription>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2023-04-012023-12-31" id="Fact003028">&lt;p id="xdx_805_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zpzov70XlNqd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
19 &#x2013; &lt;span id="xdx_826_zIqD0Wxtzpf2"&gt;RELATED PARTY TRANSACTIONS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Financing&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
November 20, 2023, the Company the Company entered into an agreement to sell $&lt;span id="xdx_90C_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20231120__20231120__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zHp8xmDlvEdd" title="Number of stock sold, value"&gt;2,000,000&lt;/span&gt; in common stock through a private placement of
common stock (the &#x201c;Private Placement&#x201d;). The Private Placement was completed with two Affiliates, (Stingray Group, Inc. and
Jay Foreman), both of which were existing shareholders with Board representation (See Note 13 &#x2013; November 2023 Private Placement).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Due
To/From Related Parties&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has a music subscription sharing agreement with Stingray. For the transition year ended December 31, 2023, and 2022, the Company
received music subscription revenue of approximately $&lt;span id="xdx_909_eus-gaap--Revenues_c20230401__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StingrayMember_zbGwyH4zwAD7" title="Revenue from related parties"&gt;600,000&lt;/span&gt; and $&lt;span id="xdx_90C_eus-gaap--Revenues_c20220401__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StingrayMember_zYr9SNNglQt4" title="Revenue from related parties"&gt;500,000&lt;/span&gt;, respectively. For the fiscal years ended March 31, 2023,
and 2022, this amount was approximately $&lt;span id="xdx_905_eus-gaap--Revenues_c20220401__20230331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StingrayMember_zh4tfxEtKxBe" title="Revenue from related parties"&gt;700,000&lt;/span&gt; and $&lt;span id="xdx_908_eus-gaap--Revenues_c20210401__20220331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StingrayMember_zRqvXqUDZUGg" title="Revenue from related parties"&gt;500,000&lt;/span&gt;, respectively. This amount was included as a component of net sales in
the accompanying consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 31, 2023, and March 31, 2023, the Company had approximately $&lt;span id="xdx_906_eus-gaap--OtherReceivables_iI_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StingrayMember_zRMFezJhOQqk" title="Due from related parties"&gt;269,000&lt;/span&gt; and $&lt;span id="xdx_90C_eus-gaap--OtherReceivables_iI_c20230331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StingrayMember_zqiC6Tg9gLq7" title="Due from related parties"&gt;218,000&lt;/span&gt;, respectively, due from Stingray for music
subscription reimbursement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
March 31, 2023, the Company had travel and entertainment expense reimbursements due from Ault Alliance, Inc., a former parent company,
of approximately $&lt;span id="xdx_905_eus-gaap--OtherReceivables_iI_c20230331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AultAllianceIncMember_ztpvUOwheBG4" title="Due from related parties"&gt;21,000&lt;/span&gt;. There was nothing due to or from Ault Alliance, Inc. on December 31, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="From2023-11-202023-11-20_us-gaap_PrivatePlacementMember"
      decimals="0"
      id="Fact003030"
      unitRef="USD">2000000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:Revenues
      contextRef="From2023-04-012023-12-31_custom_StingrayMember"
      decimals="0"
      id="Fact003032"
      unitRef="USD">600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2022-04-012022-12-31_custom_StingrayMember"
      decimals="0"
      id="Fact003034"
      unitRef="USD">500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2022-04-012023-03-31_custom_StingrayMember"
      decimals="0"
      id="Fact003036"
      unitRef="USD">700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2021-04-012022-03-31_custom_StingrayMember"
      decimals="0"
      id="Fact003038"
      unitRef="USD">500000</us-gaap:Revenues>
    <us-gaap:OtherReceivables
      contextRef="AsOf2023-12-31_custom_StingrayMember"
      decimals="0"
      id="Fact003040"
      unitRef="USD">269000</us-gaap:OtherReceivables>
    <us-gaap:OtherReceivables
      contextRef="AsOf2023-03-31_custom_StingrayMember"
      decimals="0"
      id="Fact003042"
      unitRef="USD">218000</us-gaap:OtherReceivables>
    <us-gaap:OtherReceivables
      contextRef="AsOf2023-03-31_custom_AultAllianceIncMember"
      decimals="0"
      id="Fact003044"
      unitRef="USD">21000</us-gaap:OtherReceivables>
    <us-gaap:InsuranceDisclosureTextBlock contextRef="From2023-04-012023-12-31" id="Fact003046">&lt;p id="xdx_80C_eus-gaap--InsuranceDisclosureTextBlock_z6jsZOuvGBe6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
20 &#x2013; &lt;span id="xdx_827_zXdX0YYy0v1h"&gt;DAMAGED GOODS INCIDENT RECOVERY&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For the fiscal years ended March 31, 2023 and 2022 we recognized a gain of approximately $&lt;span id="xdx_90E_ecustom--GainFromSettlementOfAccountsPayable_c20220401__20230331_zzEK73FtAMDc" title="Settlement of accounts payable"&gt;48,000&lt;/span&gt; and $&lt;span id="xdx_900_ecustom--GainFromSettlementOfAccountsPayable_c20210401__20220331_zzcZCRRDYSg6" title="Settlement of accounts payable"&gt;339,000&lt;/span&gt; as other income on the accompanying
consolidated statements of operations due to settlement of accounts payable by a manufacturer&#x2019;s representative of a factory that
caused a damaged goods incident in Fiscal 2020.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;THE
SINGING MACHINE COMPANY, INC AND SUBSIDIARIES&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December
31, 2023, and March 31, 2023 and 2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:InsuranceDisclosureTextBlock>
    <RIME:GainFromSettlementOfAccountsPayable
      contextRef="From2022-04-012023-03-31"
      decimals="0"
      id="Fact003048"
      unitRef="USD">48000</RIME:GainFromSettlementOfAccountsPayable>
    <RIME:GainFromSettlementOfAccountsPayable
      contextRef="From2021-04-012022-03-31"
      decimals="0"
      id="Fact003050"
      unitRef="USD">339000</RIME:GainFromSettlementOfAccountsPayable>
    <RIME:SupplementalInformationDisclosuresTextBlock contextRef="From2023-04-012023-12-31" id="Fact003052">&lt;p id="xdx_806_ecustom--SupplementalInformationDisclosuresTextBlock_zGt64f89haC8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
21 &#x2013; &lt;span id="xdx_82D_zUPxBfovsTDj"&gt;SUPPLEMENTAL INFORMATION CONDENSED FINANCIAL INFORMATION&lt;/span&gt; FOR THE NINE MONTHS ENDED DECEMBER 31, 2023, AND 2022.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;The
Singing Machine Company, Inc. and Subsidiaries&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;CONDENSED
CONSOLIDATED STATEMENTS OF OPERATIONS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;For
the nine months ended December 31, 2023 and 2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;/p&gt;

&lt;p id="xdx_894_esrt--ScheduleOfCondensedIncomeStatementTableTextBlock_zRwUdi7R88z1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B2_z6ajTb0E5juc"&gt;SCHEDULE
OF CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--IncomeStatementAbstract_pn3n3_zk1596I4Wbc4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SCHEDULE OF CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Details)"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20230401__20231231_zUw8GwXOeui" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;December 31, 2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20220401__20221231_zXvi6m7zAge8" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;December 31, 2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Nine Months Ended&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;December 31, 2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;December 31, 2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;(unaudited)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_maGPzmfg_z9MVSYgGPy5h" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"&gt;Net Sales&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;29,198,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;35,916,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--CostOfGoodsAndServicesSold_msGPzmfg_zJLNOOQwROW3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Cost of Goods Sold&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;23,008,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;27,481,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--GrossProfit_iT_pp0p0_mtGPzmfg_maOILzsGr_za4kC8gX327g" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;Gross Profit&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;6,190,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;8,435,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--OperatingExpenses_pp0p0_msOILzsGr_zE9QVe01jj7h" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Operating Expenses&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;12,333,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;9,986,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--OperatingIncomeLoss_iT_pp0p0_mtOILzsGr_maILFCOzzC2_zHJguttX6boe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;(Loss) Income from Operations&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(6,143,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(1,551,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--NonoperatingIncomeExpense_pp0p0_maILFCOzzC2_zp1msKve4kq6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Other (Expenses) Income&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(255,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(574,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iT_pp0p0_mtILFCOzzC2_maNILzRTS_ztxzDGaPsQV9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;(Loss) Income Before Income Tax Benefit&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(6,398,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(2,125,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--IncomeTaxExpenseBenefit_iN_pp0p0_di_msNILzRTS_zcGL0bqOzrla" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Income Tax Benefit (Loss)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3079"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;472,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--ProfitLoss_iT_pp0p0_mtNILzRTS_zMycqg2Gmiql" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;Net (Loss) Income&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(6,398,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(1,653,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--EarningsPerShareAbstract_iB_z7JAa0AK9DI6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;Loss per Common Share&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;Basic and Diluted&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTkRFTlNFRCBDT05TT0xJREFURUQgU1RBVEVNRU5UUyBPRiBPUEVSQVRJT05TIChEZXRhaWxzKQA_" id="xdx_900_eus-gaap--EarningsPerShareBasic_pid_c20230401__20231231_zFisDk6vXfV5" title="Basic"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTkRFTlNFRCBDT05TT0xJREFURUQgU1RBVEVNRU5UUyBPRiBPUEVSQVRJT05TIChEZXRhaWxzKQA_" id="xdx_900_eus-gaap--EarningsPerShareDiluted_pid_c20230401__20231231_zrfoP03g4xC9" title="Diluted"&gt;(1.32&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTkRFTlNFRCBDT05TT0xJREFURUQgU1RBVEVNRU5UUyBPRiBPUEVSQVRJT05TIChEZXRhaWxzKQA_" id="xdx_905_eus-gaap--EarningsPerShareBasic_pid_c20220401__20221231_zigRinIATjdk" title="Basic"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTkRFTlNFRCBDT05TT0xJREFURUQgU1RBVEVNRU5UUyBPRiBPUEVSQVRJT05TIChEZXRhaWxzKQA_" id="xdx_906_eus-gaap--EarningsPerShareDiluted_pid_c20220401__20221231_z6xAmVxVcGn1" title="Diluted"&gt;(0.61&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--EarningsPerShareBasicOtherDisclosuresAbstract_iB" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;Weighted Average Common and Common&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;Equivalent Shares:&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--EarningsPerShareBasicOtherDisclosuresAbstract_iB_z4AL99Y9uNWh" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;Weighted Average Common and Common Equivalent Shares:&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;Basic and Diluted&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTkRFTlNFRCBDT05TT0xJREFURUQgU1RBVEVNRU5UUyBPRiBPUEVSQVRJT05TIChEZXRhaWxzKQA_" id="xdx_904_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20230401__20231231_z62xNBARsPq1" title="Basic"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTkRFTlNFRCBDT05TT0xJREFURUQgU1RBVEVNRU5UUyBPRiBPUEVSQVRJT05TIChEZXRhaWxzKQA_" id="xdx_907_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20230401__20231231_znDWmOHXgU81" title="Diluted"&gt;4,864,540&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTkRFTlNFRCBDT05TT0xJREFURUQgU1RBVEVNRU5UUyBPRiBPUEVSQVRJT05TIChEZXRhaWxzKQA_" id="xdx_908_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20220401__20221231_zzFnOlShhQ4g" title="Basic"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTkRFTlNFRCBDT05TT0xJREFURUQgU1RBVEVNRU5UUyBPRiBPUEVSQVRJT05TIChEZXRhaWxzKQA_" id="xdx_907_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20220401__20221231_zfWTnrupW0d3" title="Diluted"&gt;2,699,210&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A4_zwQ08z2eSbPg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;THE
SINGING MACHINE COMPANY, INC AND SUBSIDIARIES&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December
31, 2023, and March 31, 2023 and 2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;The
Singing Machine Company, Inc. and Subsidiaries&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;CONDENSED
CONSOLIDATED STATEMENTS OF CASH FLOWS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;For
the nine months ended December 31, 2023 and 2022 (unaudited)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;/p&gt;

&lt;p id="xdx_898_esrt--ScheduleOfCondensedCashFlowStatementTableTextBlock_zzJFFZvUv7P4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B9_zq2esEfyrJUc"&gt;SCHEDULE
OF CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--StatementOfCashFlowsAbstract_pn3n3_z5qt6cR0g2Kd" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SCHEDULE OF CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Details)"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20230401__20231231_zN3BV2OvRkHe" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;December 31, 2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20220401__20221231_zWPEFIOYuZP4" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;December 31, 2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;For the Nine Months Ended&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;December 31, 2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;December 31, 2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;(unaudited)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;Cash flows from operating activities&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--ProfitLoss_i01_pp0p0_maNCPBUzVoD_zRbqIkluj2xg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 60%; text-align: left"&gt;Net loss&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;(6,398,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;(1,653,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_i01_maNCPBUzVoD_z2q9M7Aaj0rc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;Adjustments to reconcile net loss to net cash used in operating activities:&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,305,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(73,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--IncreaseDecreaseInOperatingCapital_i02N_di_msNCPBUzVoD_zycYRO5ECe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Changes in operating assets and liabilities:&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;5,504,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="letter-spacing: -0.1pt"&gt;(538,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i01T_pp0p0_maCCERCzHgo_mtNCPBUzVoD_z5HCjOq13Pf2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left; padding-bottom: 1pt"&gt;Net cash provided by (used in) operating activities&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;411,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="letter-spacing: -0.1pt"&gt;(2,264,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Cash flows from investing activities&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--NetCashProvidedByUsedInInvestingActivities_i01T_pp0p0_maCCERCzHgo_mtNCPBUzYTF_zu7TLVNtK3H" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left; padding-bottom: 1pt"&gt;Net cash used in investing activities&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(14,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(149,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Cash flows from financing activities&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_pp0p0_mtNCPBUz2nB_maCCERCzHgo_zNUUYQjGsFo4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left; padding-bottom: 1pt"&gt;Net cash provided by financing activities&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;3,411,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;2,917,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_iT_pp0p0_mtCCERCzHgo_zLQk8dYsgvM2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;Net change in cash&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;3,808,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="letter-spacing: -0.1pt"&gt;504,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;-&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;-&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iS_zYLw7ZXMPcnj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Cash at beginning of year&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;2,895,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="letter-spacing: -0.1pt"&gt;2,291,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iE_pp0p0" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;Cash at end of period&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;6,703,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;2,795,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AE_zOCpvyu6hNq8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;THE
SINGING MACHINE COMPANY, INC AND SUBSIDIARIES&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December
31, 2023, and March 31, 2023 and 2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;The
Singing Machine Company, Inc. and Subsidiaries&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;CONDENSED
CONSOLIDATED STATEMENTS OF SHAREHOLDERS&#x2019; EQUITY &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;For
the nine months ended December 31, 2023 and 2022 (unaudited) &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;/p&gt;

&lt;p id="xdx_896_eus-gaap--ScheduleOfStockholdersEquityTableTextBlock_zCW1DqARj325" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BE_zvYf1K7G3G04"&gt;SCHEDULE
OF CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS&#x2019; EQUITY &lt;/span&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--StatementOfStockholdersEquityAbstract_pn3n3_zxyrKaMhy6f1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SCHEDULE OF CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS? EQUITY (Details)"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Shares&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B2_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zEtMtgSm2zZ8" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B5_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_zAxMPGS8fGRg" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Capital&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4BB_us-gaap--StatementEquityComponentsAxis_us-gaap--ReceivablesFromStockholderMember_zCLULKo1u7T5" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Receivable&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B2_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zuAhdj1FY41h" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Deficit&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4BC_zScqmt4y1DSg" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Common Stock&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;Additional Paid in&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;Subscriptions&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;Accumulated&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Shares&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Capital&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Receivable&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Deficit&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_430_c20230401__20231231_eus-gaap--StockholdersEquity_iS_z15MFfvx8tte" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; width: 40%; text-align: left"&gt;Balance at March 31, 2023&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--SharesOutstanding_iS_c20230401__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zowtBJASZVCh" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Balance, shares"&gt;3,167,488&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"&gt;&lt;span style="letter-spacing: -0.1pt"&gt;32,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"&gt;&lt;span style="letter-spacing: -0.1pt"&gt;29,822,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"&gt;(6,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"&gt;(19,517,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"&gt;10,331,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--ProfitLoss_zljSGiBzflMd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Net loss&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;-&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3162"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3163"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3164"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(6,398,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(6,398,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--StockIssuedDuringPeriodValueNewIssues_zuXpPoKfvDuh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Issuance of common stock, net of stock offering costs&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230401__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zHs66oERJF77" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Issuance of common stock, net of stock offering costs, shares"&gt;3,250,573&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;32,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;3,497,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3170"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3171"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;3,529,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--ShareBasedCompensation_zAD96sTcLV4c" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Stock based compensation&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensation_c20230401__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zetVtSdvzZK1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock based compensation ,shares"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3182"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3176"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;110,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3178"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3179"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;110,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--StockIssuedDuringPeriodValueOther_zwMG12wIkAC4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Other&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesOther_c20230401__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zVRpaFXW54eb" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Other, shares"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3190"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3184"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3185"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;6,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3187"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;6,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43A_c20230401__20231231_eus-gaap--StockholdersEquity_iE_z9PBjMd6zXs8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;&#160;Balance at December 31, 2023&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--SharesOutstanding_iE_c20230401__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zoqWMShhrePd" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Balance, shares"&gt;6,418,061&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;64,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;33,429,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3194"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(25,915,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;7,578,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Common Stock&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;Additional Paid in&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;Subscriptions&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;Accumulated&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Shares&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;Capital&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;Receivable&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;Deficit&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_430_c20220401__20221231_eus-gaap--StockholdersEquity_iS_zycTCV8uqA29" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; width: 40%; text-align: left"&gt;Balance at March 31, 2022&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--SharesOutstanding_iS_c20220401__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zdlm0MkAosCh" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Balance, shares"&gt;1,221,209&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"&gt;12,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"&gt;24,903,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"&gt;&#160;&#160;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl3202"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"&gt;(14,879,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"&gt;10,036,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_436_c20220401__20221231_eus-gaap--StockholdersEquity_iS_zojW5XrXZ977" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;Balance, value&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--SharesOutstanding_iS_c20220401__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zwTA0nkfmV2a" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Balance, shares"&gt;1,221,209&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;12,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;24,903,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&#160;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl3210"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(14,879,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;10,036,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--ProfitLoss_zkUmFtmEA8h2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Net loss&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;-&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3216"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3217"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3218"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(1,653,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(1,653,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--StockIssuedDuringPeriodValueNewIssues_zqnTAwvBYPt5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Issuance of common stock and warrants, net of stock offering costs&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220401__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zJ1CYS2FTsP5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Issuance of common stock and warrants, net of stock offering costs, shares"&gt;1,909,519&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;19,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;4,489,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3224"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3225"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;4,508,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--ShareBasedCompensation_z20q0lgt0B88" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Stock based compensation&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensation_c20220401__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zDSwTyperGsd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock based compensation ,shares"&gt;15,803&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3230"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;307,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3232"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3233"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;307,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--StockIssuedDuringPeriodValueOther_zVfoPv7TlHG9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Other&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--StockIssuedDuringPeriodSharesOther_c20220401__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zqFQDez6fl4" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Other, shares"&gt;1,688&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3238"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(1,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3240"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;1,000&lt;/p&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3242"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_430_c20220401__20221231_eus-gaap--StockholdersEquity_iE_zuIEPlPLRTZe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;Balance at December 31, 2022 (unaudited)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--SharesOutstanding_iE_c20220401__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zVm7Ha1dRStd" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Balance, shares"&gt;3,148,219&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;31,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;29,698,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3248"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(16,531,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;13,198,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43D_c20220401__20221231_eus-gaap--StockholdersEquity_iE_z9aej9Q95ur6" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;Balance, value&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--SharesOutstanding_iE_c20220401__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zsOmskrUNKS" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Balance, shares"&gt;3,148,219&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;31,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;29,698,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3256"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(16,531,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;13,198,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AF_zjOG8MKLoXzl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="a_003"&gt;&lt;/span&gt;Report
of Independent Registered Public Accounting Firm&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;To
the Shareholder and the Board of Directors of&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;SemiCab,
Inc.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Opinion
on the Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;We
have audited the accompanying consolidated balance sheet of SemiCab, Inc. (the &#x201c;Company&#x201d;) as of December 31, 2023 and 2022,
and the related consolidated statements of operations and comprehensive loss, stockholders&#x2019; equity and cash flows for the years
then ended, and the related notes (collectively referred to as the &#x201c;financial statements&#x201d;). In our opinion, the financial
statements present fairly, in all material respects, the financial position of the Company as of December 31, 2023 and 2022, and the
results of its operations and its cash flows for the years then ended in conformity with accounting principles generally accepted in
the United States of America.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;GOING
CONCERN&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying financial statements have been prepared assuming that the Company will continue as a going concern. The Company has suffered
substantial net losses and negative cash flows from operations in recent years and is dependent on debt and equity financing to fund
its operations, all of which raise substantial doubt about the Company&#x2019;s ability to continue as a going concern. Management&#x2019;s
plans regarding these matters have also been reviewed and considered. The consolidated financial statements do not include any adjustments
that might result from the outcome of this uncertainty.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;BASIS
FOR OPINION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;These
financial statements are the responsibility of the Company&#x2019;s management. Our responsibility is to express an opinion on these financial
statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United
States) (&#x201c;PCAOB&#x201d;) and are required to be independent with respect to the Company in accordance with the U.S. federal securities
laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;We
conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company
is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits,
we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion
on the effectiveness of the Company&#x2019;s internal control over financial reporting. Accordingly, we express no such opinion.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Our
audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or
fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding
the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant
estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides
a reasonable basis for our opinion.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Critical
Audit Matters&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Critical
audit matters are matters arising from the current period audit of the financial statements that were communicated or required to be
communicated to the audit committee and that (1) relate to accounts or disclosures that are material to the financial statements and
(2) involved our especially challenging, subjective, or complex judgements. We determined that there are no critical audit matters.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;/s/Bush
&amp;amp; Associates CPA LLC&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;We
have served as the Company&#x2019;s auditor since 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Henderson,
Nevada&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;June
11, 2024&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p id="xdx_04C_c20230101__20231231_zrvfceZOHjc8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_119_hdei--LegalEntityAxis__custom--SemiCabIncMember_zGg4NCqpbXSb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SemiCab,
Inc. &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="a_001"&gt;&lt;/span&gt;CONSOLIDATED
BALANCE SHEETS &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_30A_111_zPmv06O0r6Pa" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Statement - Condensed Consolidated Balance Sheets"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20231231_zrE5FecPErqb" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;December 31, 2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20221231_z8DHPHx0oLB6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;December 31, 2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--AssetsAbstract_iB_zKIBsk4SAO89" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-decoration: underline; text-align: center"&gt;Assets&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--AssetsCurrentAbstract_i01B_zK9yhLCH8r7h" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;Current Assets&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--Cash_i02I_zb6S1TMj4vcj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 60%; padding-left: 10pt"&gt;Cash&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;72,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;881,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--AccountsReceivableNet_i02I_zKQWliMrvw1h" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"&gt;Accounts receivable&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;494,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;677,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--RefundDueFromCustomer_i02I_zCarpsXD6RFj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"&gt;Refund due from customer&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;143,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3275"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_i02I_zI047hNyjXYf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 10pt"&gt;Prepaid Expenses and other current assets&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;5,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;8,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--AssetsCurrent_i02TI_zJuxdfOibgel" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 20pt"&gt;Total Current Assets&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;714,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,566,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--PropertyPlantAndEquipmentNet_i01I_zHyFNFQjvHmi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;Property and equipment, net&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;3,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;4,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--OtherAssetsNoncurrent_i01I_z0EeEEGUzOJ2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Other non-current assets&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;14,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;14,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--Assets_i01TI_z8ZMyA5JgxRb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt; padding-left: 20pt"&gt;Total Assets&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;731,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,584,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--LiabilitiesAndStockholdersEquityAbstract_iB_z2iSexEs1oO" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-decoration: underline; text-align: center"&gt;Liabilities and Shareholders&#x2019; Equity&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--LiabilitiesCurrentAbstract_i01B_zbAZzCqRzV8b" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;Current Liabilities&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--AccountsPayableCurrent_i02I_z1i9d2bKJjfj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"&gt;Accounts payable&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;668,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;810,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--AccruedLiabilitiesCurrent_i02I_zsOCocUIMzxc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"&gt;Accrued expenses&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;149,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;151,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--NotesPayableCurrent_i02I_zgOgEjgiKXa3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"&gt;Notes payable&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;833,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;579,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--LoansPayableCurrent_i02I_z8yBfgcYEyh4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"&gt;Loans from affiliates, current portion&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;315,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3308"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--ContractWithCustomerRefundLiabilityCurrent_i02I_zWHPZlDVxlE4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"&gt;Due to factor&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;231,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3311"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--OtherLiabilitiesCurrent_i02I_zoxTabAfqCl8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 10pt"&gt;Other current liabilities&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;45,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;108,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--LiabilitiesCurrent_i02TI_zNvoUx6cSBC3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 20pt"&gt;Total Current Liabilities&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;2,241,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,648,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--LongTermLoansPayable_i01I_zJGecqNnFaX7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Loans from affiliates, net of current portion&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;385,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;385,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--Liabilities_i01TI_z2iisP21K2f6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 20pt"&gt;Total Liabilities&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;2,626,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;2,033,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--CommitmentsAndContingenciesAbstract_i01B_zaSounIA6tR7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;Commitments and Contingencies&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--ProvisionForLegalLiability_i02I_zkIvvdnfpUfa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"&gt;Provision for legal liability&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;275,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3329"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--CommitmentsAndContingencies_i02TI_zmnccElb5Bmc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 20pt"&gt;Total Commitments and Contingencies&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;275,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3332"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--StockholdersEquityAbstract_i01B_zIshhRihLkT7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;Shareholders&#x2019; Equity&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--PreferredStockValue_i02I_zdpWeDq6BjDe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"&gt;Preferred equity&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;5,969,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;5,543,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--RetainedEarningsAccumulatedDeficit_i02I_zc4U46jdpzCl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 10pt"&gt;Accumulated deficit&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(8,139,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(5,992,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--StockholdersEquity_i02TI_z52VlWxqUVJi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 20pt"&gt;Total Shareholders&#x2019; Equity&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(2,170,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(449,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--LiabilitiesAndStockholdersEquity_i01TI_zh8uMqYx0Yu" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt; padding-left: 20pt"&gt;Total Liabilities and Shareholders&#x2019; Equity&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;731,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,584,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;See
notes to condensed consolidated statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SemiCab,
Inc. &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="a_002"&gt;&lt;/span&gt;CONDENSED
CONSOLIDATED STATEMENTS OF OPERATIONS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_30F_113_zJtpNz3FXg4b" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Statement - Condensed Consolidated Statements of Operations"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20230101__20231231_zCEXlSlfj0Ih" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;December 31, 2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20220101__20221231_zF3FdCZxDmBh" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;December 31, 2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Years Ended&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;December 31, 2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;December 31, 2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zg3FPhfgl7kk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"&gt;Net Revenue&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;6,036,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;9,655,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;-&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--CostOfGoodsAndServicesSold_zq51xC47RFmi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;Cost of Revenue&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;5,853,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;10,108,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--GrossProfit_iT_zCZYLWrSxx37" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;Gross Profit (Loss)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;183,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(453,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--OperatingExpensesAbstract_iB_zAjFbtufdk9d" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;Operating Expenses&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--SellingExpense_i01_zrhAAMCV0484" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;Selling general and administrative expenses&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,333,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,511,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--ProductDevelopmentExpense_i01_zGDS6aa3SYBb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; padding-left: 10pt; text-align: left"&gt;Product development&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;852,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;640,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--OperatingExpenses_i01T_zMpafX2Fbt5l" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;Total Operating Expenses&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;2,185,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;2,151,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--OperatingIncomeLoss_iT_za4ce2RczYDl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;Loss from Operations&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(2,002,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(2,604,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--NonoperatingIncomeExpenseAbstract_iB_zUIlgAQLBRR3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;Other Expenses&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--InterestExpenseDebtExcludingAmortization_i01N_di_zprLXpXrW1Aj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; padding-left: 10pt; text-align: left"&gt;Interest expense&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(145,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(63,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--NonoperatingIncomeExpense_i01T_zjtmmPcki4Mg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;Total Other Expenses&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(145,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(63,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iT_zc5Yt981FuBl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;Loss Before Income Tax Benefit (Provision)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(2,147,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(2,667,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--IncomeTaxExpenseBenefit_iN_di_zSUE7npCtSBh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;Income Tax Benefit (Provision)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3385"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3386"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--ProfitLoss_iT_zLvmfvvdseZ6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;Net Loss&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(2,147,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(2,667,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;See
notes to condensed consolidated statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</RIME:SupplementalInformationDisclosuresTextBlock>
    <srt:ScheduleOfCondensedIncomeStatementTableTextBlock contextRef="From2023-04-012023-12-31" id="Fact003054">&lt;p id="xdx_894_esrt--ScheduleOfCondensedIncomeStatementTableTextBlock_zRwUdi7R88z1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B2_z6ajTb0E5juc"&gt;SCHEDULE
OF CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--IncomeStatementAbstract_pn3n3_zk1596I4Wbc4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SCHEDULE OF CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Details)"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20230401__20231231_zUw8GwXOeui" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;December 31, 2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20220401__20221231_zXvi6m7zAge8" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;December 31, 2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Nine Months Ended&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;December 31, 2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;December 31, 2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;(unaudited)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_maGPzmfg_z9MVSYgGPy5h" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"&gt;Net Sales&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;29,198,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;35,916,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--CostOfGoodsAndServicesSold_msGPzmfg_zJLNOOQwROW3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Cost of Goods Sold&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;23,008,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;27,481,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--GrossProfit_iT_pp0p0_mtGPzmfg_maOILzsGr_za4kC8gX327g" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;Gross Profit&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;6,190,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;8,435,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--OperatingExpenses_pp0p0_msOILzsGr_zE9QVe01jj7h" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Operating Expenses&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;12,333,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;9,986,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--OperatingIncomeLoss_iT_pp0p0_mtOILzsGr_maILFCOzzC2_zHJguttX6boe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;(Loss) Income from Operations&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(6,143,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(1,551,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--NonoperatingIncomeExpense_pp0p0_maILFCOzzC2_zp1msKve4kq6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Other (Expenses) Income&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(255,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(574,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iT_pp0p0_mtILFCOzzC2_maNILzRTS_ztxzDGaPsQV9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;(Loss) Income Before Income Tax Benefit&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(6,398,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(2,125,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--IncomeTaxExpenseBenefit_iN_pp0p0_di_msNILzRTS_zcGL0bqOzrla" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Income Tax Benefit (Loss)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3079"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;472,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--ProfitLoss_iT_pp0p0_mtNILzRTS_zMycqg2Gmiql" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;Net (Loss) Income&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(6,398,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(1,653,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--EarningsPerShareAbstract_iB_z7JAa0AK9DI6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;Loss per Common Share&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;Basic and Diluted&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTkRFTlNFRCBDT05TT0xJREFURUQgU1RBVEVNRU5UUyBPRiBPUEVSQVRJT05TIChEZXRhaWxzKQA_" id="xdx_900_eus-gaap--EarningsPerShareBasic_pid_c20230401__20231231_zFisDk6vXfV5" title="Basic"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTkRFTlNFRCBDT05TT0xJREFURUQgU1RBVEVNRU5UUyBPRiBPUEVSQVRJT05TIChEZXRhaWxzKQA_" id="xdx_900_eus-gaap--EarningsPerShareDiluted_pid_c20230401__20231231_zrfoP03g4xC9" title="Diluted"&gt;(1.32&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTkRFTlNFRCBDT05TT0xJREFURUQgU1RBVEVNRU5UUyBPRiBPUEVSQVRJT05TIChEZXRhaWxzKQA_" id="xdx_905_eus-gaap--EarningsPerShareBasic_pid_c20220401__20221231_zigRinIATjdk" title="Basic"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTkRFTlNFRCBDT05TT0xJREFURUQgU1RBVEVNRU5UUyBPRiBPUEVSQVRJT05TIChEZXRhaWxzKQA_" id="xdx_906_eus-gaap--EarningsPerShareDiluted_pid_c20220401__20221231_z6xAmVxVcGn1" title="Diluted"&gt;(0.61&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--EarningsPerShareBasicOtherDisclosuresAbstract_iB" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;Weighted Average Common and Common&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;Equivalent Shares:&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--EarningsPerShareBasicOtherDisclosuresAbstract_iB_z4AL99Y9uNWh" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;Weighted Average Common and Common Equivalent Shares:&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;Basic and Diluted&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTkRFTlNFRCBDT05TT0xJREFURUQgU1RBVEVNRU5UUyBPRiBPUEVSQVRJT05TIChEZXRhaWxzKQA_" id="xdx_904_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20230401__20231231_z62xNBARsPq1" title="Basic"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTkRFTlNFRCBDT05TT0xJREFURUQgU1RBVEVNRU5UUyBPRiBPUEVSQVRJT05TIChEZXRhaWxzKQA_" id="xdx_907_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20230401__20231231_znDWmOHXgU81" title="Diluted"&gt;4,864,540&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTkRFTlNFRCBDT05TT0xJREFURUQgU1RBVEVNRU5UUyBPRiBPUEVSQVRJT05TIChEZXRhaWxzKQA_" id="xdx_908_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20220401__20221231_zzFnOlShhQ4g" title="Basic"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTkRFTlNFRCBDT05TT0xJREFURUQgU1RBVEVNRU5UUyBPRiBPUEVSQVRJT05TIChEZXRhaWxzKQA_" id="xdx_907_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20220401__20221231_zfWTnrupW0d3" title="Diluted"&gt;2,699,210&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</srt:ScheduleOfCondensedIncomeStatementTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact003058"
      unitRef="USD">29198000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-04-012022-12-31"
      decimals="0"
      id="Fact003059"
      unitRef="USD">35916000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact003061"
      unitRef="USD">23008000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="From2022-04-012022-12-31"
      decimals="0"
      id="Fact003062"
      unitRef="USD">27481000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact003064"
      unitRef="USD">6190000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2022-04-012022-12-31"
      decimals="0"
      id="Fact003065"
      unitRef="USD">8435000</us-gaap:GrossProfit>
    <us-gaap:OperatingExpenses
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact003067"
      unitRef="USD">12333000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2022-04-012022-12-31"
      decimals="0"
      id="Fact003068"
      unitRef="USD">9986000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact003070"
      unitRef="USD">-6143000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2022-04-012022-12-31"
      decimals="0"
      id="Fact003071"
      unitRef="USD">-1551000</us-gaap:OperatingIncomeLoss>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact003073"
      unitRef="USD">-255000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2022-04-012022-12-31"
      decimals="0"
      id="Fact003074"
      unitRef="USD">-574000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact003076"
      unitRef="USD">-6398000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2022-04-012022-12-31"
      decimals="0"
      id="Fact003077"
      unitRef="USD">-2125000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2022-04-012022-12-31"
      decimals="0"
      id="Fact003080"
      unitRef="USD">-472000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact003082"
      unitRef="USD">-6398000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2022-04-012022-12-31"
      decimals="0"
      id="Fact003083"
      unitRef="USD">-1653000</us-gaap:ProfitLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2023-04-012023-12-31"
      decimals="INF"
      id="Fact003088"
      unitRef="USDPShares">-1.32</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-04-012023-12-31"
      decimals="INF"
      id="Fact003090"
      unitRef="USDPShares">-1.32</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2022-04-012022-12-31"
      decimals="INF"
      id="Fact003092"
      unitRef="USDPShares">-0.61</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2022-04-012022-12-31"
      decimals="INF"
      id="Fact003094"
      unitRef="USDPShares">-0.61</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-04-012023-12-31"
      decimals="INF"
      id="Fact003102"
      unitRef="Shares">4864540</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-04-012023-12-31"
      decimals="INF"
      id="Fact003104"
      unitRef="Shares">4864540</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2022-04-012022-12-31"
      decimals="INF"
      id="Fact003106"
      unitRef="Shares">2699210</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2022-04-012022-12-31"
      decimals="INF"
      id="Fact003108"
      unitRef="Shares">2699210</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <srt:ScheduleOfCondensedCashFlowStatementTableTextBlock contextRef="From2023-04-012023-12-31" id="Fact003110">&lt;p id="xdx_898_esrt--ScheduleOfCondensedCashFlowStatementTableTextBlock_zzJFFZvUv7P4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B9_zq2esEfyrJUc"&gt;SCHEDULE
OF CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--StatementOfCashFlowsAbstract_pn3n3_z5qt6cR0g2Kd" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SCHEDULE OF CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Details)"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20230401__20231231_zN3BV2OvRkHe" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;December 31, 2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20220401__20221231_zWPEFIOYuZP4" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;December 31, 2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;For the Nine Months Ended&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;December 31, 2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;December 31, 2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;(unaudited)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;Cash flows from operating activities&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--ProfitLoss_i01_pp0p0_maNCPBUzVoD_zRbqIkluj2xg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 60%; text-align: left"&gt;Net loss&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;(6,398,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;(1,653,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_i01_maNCPBUzVoD_z2q9M7Aaj0rc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;Adjustments to reconcile net loss to net cash used in operating activities:&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,305,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(73,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--IncreaseDecreaseInOperatingCapital_i02N_di_msNCPBUzVoD_zycYRO5ECe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Changes in operating assets and liabilities:&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;5,504,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="letter-spacing: -0.1pt"&gt;(538,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i01T_pp0p0_maCCERCzHgo_mtNCPBUzVoD_z5HCjOq13Pf2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left; padding-bottom: 1pt"&gt;Net cash provided by (used in) operating activities&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;411,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="letter-spacing: -0.1pt"&gt;(2,264,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Cash flows from investing activities&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--NetCashProvidedByUsedInInvestingActivities_i01T_pp0p0_maCCERCzHgo_mtNCPBUzYTF_zu7TLVNtK3H" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left; padding-bottom: 1pt"&gt;Net cash used in investing activities&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(14,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(149,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Cash flows from financing activities&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_pp0p0_mtNCPBUz2nB_maCCERCzHgo_zNUUYQjGsFo4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left; padding-bottom: 1pt"&gt;Net cash provided by financing activities&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;3,411,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;2,917,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_iT_pp0p0_mtCCERCzHgo_zLQk8dYsgvM2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;Net change in cash&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;3,808,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="letter-spacing: -0.1pt"&gt;504,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;-&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;-&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iS_zYLw7ZXMPcnj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Cash at beginning of year&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;2,895,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="letter-spacing: -0.1pt"&gt;2,291,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iE_pp0p0" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;Cash at end of period&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;6,703,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;2,795,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</srt:ScheduleOfCondensedCashFlowStatementTableTextBlock>
    <us-gaap:ProfitLoss
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact003117"
      unitRef="USD">-6398000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2022-04-012022-12-31"
      decimals="0"
      id="Fact003118"
      unitRef="USD">-1653000</us-gaap:ProfitLoss>
    <us-gaap:AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact003120"
      unitRef="USD">1305000</us-gaap:AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities>
    <us-gaap:AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
      contextRef="From2022-04-012022-12-31"
      decimals="0"
      id="Fact003121"
      unitRef="USD">-73000</us-gaap:AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities>
    <us-gaap:IncreaseDecreaseInOperatingCapital
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact003123"
      unitRef="USD">-5504000</us-gaap:IncreaseDecreaseInOperatingCapital>
    <us-gaap:IncreaseDecreaseInOperatingCapital
      contextRef="From2022-04-012022-12-31"
      decimals="0"
      id="Fact003124"
      unitRef="USD">538000</us-gaap:IncreaseDecreaseInOperatingCapital>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact003126"
      unitRef="USD">411000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2022-04-012022-12-31"
      decimals="0"
      id="Fact003127"
      unitRef="USD">-2264000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact003132"
      unitRef="USD">-14000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2022-04-012022-12-31"
      decimals="0"
      id="Fact003133"
      unitRef="USD">-149000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact003138"
      unitRef="USD">3411000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2022-04-012022-12-31"
      decimals="0"
      id="Fact003139"
      unitRef="USD">2917000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact003141"
      unitRef="USD">3808000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2022-04-012022-12-31"
      decimals="0"
      id="Fact003142"
      unitRef="USD">504000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2023-03-31"
      decimals="0"
      id="Fact003144"
      unitRef="USD">2895000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2022-03-31"
      decimals="0"
      id="Fact003145"
      unitRef="USD">2291000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact003147"
      unitRef="USD">6703000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact003148"
      unitRef="USD">2795000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:ScheduleOfStockholdersEquityTableTextBlock contextRef="From2023-04-012023-12-31" id="Fact003150">&lt;p id="xdx_896_eus-gaap--ScheduleOfStockholdersEquityTableTextBlock_zCW1DqARj325" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BE_zvYf1K7G3G04"&gt;SCHEDULE
OF CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS&#x2019; EQUITY &lt;/span&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--StatementOfStockholdersEquityAbstract_pn3n3_zxyrKaMhy6f1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SCHEDULE OF CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS? EQUITY (Details)"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Shares&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B2_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zEtMtgSm2zZ8" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B5_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_zAxMPGS8fGRg" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Capital&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4BB_us-gaap--StatementEquityComponentsAxis_us-gaap--ReceivablesFromStockholderMember_zCLULKo1u7T5" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Receivable&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B2_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zuAhdj1FY41h" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Deficit&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4BC_zScqmt4y1DSg" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Common Stock&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;Additional Paid in&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;Subscriptions&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;Accumulated&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Shares&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Capital&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Receivable&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Deficit&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_430_c20230401__20231231_eus-gaap--StockholdersEquity_iS_z15MFfvx8tte" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; width: 40%; text-align: left"&gt;Balance at March 31, 2023&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--SharesOutstanding_iS_c20230401__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zowtBJASZVCh" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Balance, shares"&gt;3,167,488&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"&gt;&lt;span style="letter-spacing: -0.1pt"&gt;32,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"&gt;&lt;span style="letter-spacing: -0.1pt"&gt;29,822,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"&gt;(6,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"&gt;(19,517,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"&gt;10,331,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--ProfitLoss_zljSGiBzflMd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Net loss&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;-&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3162"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3163"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3164"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(6,398,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(6,398,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--StockIssuedDuringPeriodValueNewIssues_zuXpPoKfvDuh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Issuance of common stock, net of stock offering costs&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230401__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zHs66oERJF77" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Issuance of common stock, net of stock offering costs, shares"&gt;3,250,573&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;32,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;3,497,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3170"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3171"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;3,529,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--ShareBasedCompensation_zAD96sTcLV4c" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Stock based compensation&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensation_c20230401__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zetVtSdvzZK1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock based compensation ,shares"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3182"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3176"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;110,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3178"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3179"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;110,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--StockIssuedDuringPeriodValueOther_zwMG12wIkAC4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Other&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesOther_c20230401__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zVRpaFXW54eb" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Other, shares"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3190"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3184"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3185"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;6,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3187"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;6,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43A_c20230401__20231231_eus-gaap--StockholdersEquity_iE_z9PBjMd6zXs8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;&#160;Balance at December 31, 2023&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--SharesOutstanding_iE_c20230401__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zoqWMShhrePd" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Balance, shares"&gt;6,418,061&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;64,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;33,429,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3194"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(25,915,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;7,578,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Common Stock&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;Additional Paid in&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;Subscriptions&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;Accumulated&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Shares&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;Capital&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;Receivable&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;Deficit&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_430_c20220401__20221231_eus-gaap--StockholdersEquity_iS_zycTCV8uqA29" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; width: 40%; text-align: left"&gt;Balance at March 31, 2022&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--SharesOutstanding_iS_c20220401__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zdlm0MkAosCh" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Balance, shares"&gt;1,221,209&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"&gt;12,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"&gt;24,903,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"&gt;&#160;&#160;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl3202"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"&gt;(14,879,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"&gt;10,036,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_436_c20220401__20221231_eus-gaap--StockholdersEquity_iS_zojW5XrXZ977" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;Balance, value&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--SharesOutstanding_iS_c20220401__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zwTA0nkfmV2a" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Balance, shares"&gt;1,221,209&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;12,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;24,903,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&#160;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl3210"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(14,879,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;10,036,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--ProfitLoss_zkUmFtmEA8h2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Net loss&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;-&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3216"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3217"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3218"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(1,653,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(1,653,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--StockIssuedDuringPeriodValueNewIssues_zqnTAwvBYPt5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Issuance of common stock and warrants, net of stock offering costs&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220401__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zJ1CYS2FTsP5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Issuance of common stock and warrants, net of stock offering costs, shares"&gt;1,909,519&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;19,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;4,489,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3224"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3225"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;4,508,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--ShareBasedCompensation_z20q0lgt0B88" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Stock based compensation&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensation_c20220401__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zDSwTyperGsd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock based compensation ,shares"&gt;15,803&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3230"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;307,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3232"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3233"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;307,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--StockIssuedDuringPeriodValueOther_zVfoPv7TlHG9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Other&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--StockIssuedDuringPeriodSharesOther_c20220401__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zqFQDez6fl4" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Other, shares"&gt;1,688&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3238"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(1,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3240"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;1,000&lt;/p&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3242"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_430_c20220401__20221231_eus-gaap--StockholdersEquity_iE_zuIEPlPLRTZe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;Balance at December 31, 2022 (unaudited)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--SharesOutstanding_iE_c20220401__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zVm7Ha1dRStd" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Balance, shares"&gt;3,148,219&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;31,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;29,698,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3248"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(16,531,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;13,198,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43D_c20220401__20221231_eus-gaap--StockholdersEquity_iE_z9aej9Q95ur6" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;Balance, value&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--SharesOutstanding_iE_c20220401__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zsOmskrUNKS" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Balance, shares"&gt;3,148,219&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;31,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;29,698,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3256"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(16,531,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;13,198,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfStockholdersEquityTableTextBlock>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact003160"
      unitRef="Shares">3167488</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact003154"
      unitRef="USD">32000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact003155"
      unitRef="USD">29822000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-31_us-gaap_ReceivablesFromStockholderMember"
      decimals="0"
      id="Fact003156"
      unitRef="USD">-6000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact003157"
      unitRef="USD">-19517000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-31"
      decimals="0"
      id="Fact003158"
      unitRef="USD">10331000</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="From2023-04-012023-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact003165"
      unitRef="USD">-6398000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact003166"
      unitRef="USD">-6398000</us-gaap:ProfitLoss>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-04-012023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact003174"
      unitRef="Shares">3250573</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-04-012023-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact003168"
      unitRef="USD">32000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-04-012023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact003169"
      unitRef="USD">3497000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact003172"
      unitRef="USD">3529000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:ShareBasedCompensation
      contextRef="From2023-04-012023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact003177"
      unitRef="USD">110000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact003180"
      unitRef="USD">110000</us-gaap:ShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2023-04-012023-12-31_us-gaap_ReceivablesFromStockholderMember"
      decimals="0"
      id="Fact003186"
      unitRef="USD">6000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2023-04-012023-12-31"
      decimals="0"
      id="Fact003188"
      unitRef="USD">6000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact003198"
      unitRef="Shares">6418061</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact003192"
      unitRef="USD">64000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact003193"
      unitRef="USD">33429000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact003195"
      unitRef="USD">-25915000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact003196"
      unitRef="USD">7578000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact003206"
      unitRef="Shares">1221209</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact003200"
      unitRef="USD">12000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact003201"
      unitRef="USD">24903000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact003203"
      unitRef="USD">-14879000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-03-31"
      decimals="0"
      id="Fact003204"
      unitRef="USD">10036000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact003214"
      unitRef="Shares">1221209</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact003208"
      unitRef="USD">12000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact003209"
      unitRef="USD">24903000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact003211"
      unitRef="USD">-14879000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-03-31"
      decimals="0"
      id="Fact003212"
      unitRef="USD">10036000</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="From2022-04-012022-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact003219"
      unitRef="USD">-1653000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2022-04-012022-12-31"
      decimals="0"
      id="Fact003220"
      unitRef="USD">-1653000</us-gaap:ProfitLoss>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2022-04-012022-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact003228"
      unitRef="Shares">1909519</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-04-012022-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact003222"
      unitRef="USD">19000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-04-012022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact003223"
      unitRef="USD">4489000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-04-012022-12-31"
      decimals="0"
      id="Fact003226"
      unitRef="USD">4508000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="From2022-04-012022-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact003236"
      unitRef="Shares">15803</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2022-04-012022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact003231"
      unitRef="USD">307000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2022-04-012022-12-31"
      decimals="0"
      id="Fact003234"
      unitRef="USD">307000</us-gaap:ShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="From2022-04-012022-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact003244"
      unitRef="Shares">1688</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2022-04-012022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact003239"
      unitRef="USD">-1000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2022-04-012022-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact003241"
      unitRef="USD">1000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact003252"
      unitRef="Shares">3148219</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact003246"
      unitRef="USD">31000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact003247"
      unitRef="USD">29698000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact003249"
      unitRef="USD">-16531000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact003250"
      unitRef="USD">13198000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact003260"
      unitRef="Shares">3148219</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact003254"
      unitRef="USD">31000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact003255"
      unitRef="USD">29698000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact003257"
      unitRef="USD">-16531000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact003258"
      unitRef="USD">13198000</us-gaap:StockholdersEquity>
    <us-gaap:Cash
      contextRef="AsOf2023-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003268"
      unitRef="USD">72000</us-gaap:Cash>
    <us-gaap:Cash
      contextRef="AsOf2022-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003269"
      unitRef="USD">881000</us-gaap:Cash>
    <us-gaap:AccountsReceivableNet
      contextRef="AsOf2023-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003271"
      unitRef="USD">494000</us-gaap:AccountsReceivableNet>
    <us-gaap:AccountsReceivableNet
      contextRef="AsOf2022-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003272"
      unitRef="USD">677000</us-gaap:AccountsReceivableNet>
    <RIME:RefundDueFromCustomer
      contextRef="AsOf2023-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003274"
      unitRef="USD">143000</RIME:RefundDueFromCustomer>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2023-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003277"
      unitRef="USD">5000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2022-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003278"
      unitRef="USD">8000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2023-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003280"
      unitRef="USD">714000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2022-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003281"
      unitRef="USD">1566000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2023-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003283"
      unitRef="USD">3000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2022-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003284"
      unitRef="USD">4000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="AsOf2023-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003286"
      unitRef="USD">14000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="AsOf2022-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003287"
      unitRef="USD">14000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="AsOf2023-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003289"
      unitRef="USD">731000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2022-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003290"
      unitRef="USD">1584000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="AsOf2023-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003298"
      unitRef="USD">668000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="AsOf2022-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003299"
      unitRef="USD">810000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="AsOf2023-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003301"
      unitRef="USD">149000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="AsOf2022-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003302"
      unitRef="USD">151000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:NotesPayableCurrent
      contextRef="AsOf2023-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003304"
      unitRef="USD">833000</us-gaap:NotesPayableCurrent>
    <us-gaap:NotesPayableCurrent
      contextRef="AsOf2022-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003305"
      unitRef="USD">579000</us-gaap:NotesPayableCurrent>
    <us-gaap:LoansPayableCurrent
      contextRef="AsOf2023-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003307"
      unitRef="USD">315000</us-gaap:LoansPayableCurrent>
    <us-gaap:ContractWithCustomerRefundLiabilityCurrent
      contextRef="AsOf2023-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003310"
      unitRef="USD">231000</us-gaap:ContractWithCustomerRefundLiabilityCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="AsOf2023-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003313"
      unitRef="USD">45000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="AsOf2022-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003314"
      unitRef="USD">108000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2023-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003316"
      unitRef="USD">2241000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2022-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003317"
      unitRef="USD">1648000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermLoansPayable
      contextRef="AsOf2023-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003319"
      unitRef="USD">385000</us-gaap:LongTermLoansPayable>
    <us-gaap:LongTermLoansPayable
      contextRef="AsOf2022-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003320"
      unitRef="USD">385000</us-gaap:LongTermLoansPayable>
    <us-gaap:Liabilities
      contextRef="AsOf2023-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003322"
      unitRef="USD">2626000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="AsOf2022-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003323"
      unitRef="USD">2033000</us-gaap:Liabilities>
    <RIME:ProvisionForLegalLiability
      contextRef="AsOf2023-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003328"
      unitRef="USD">275000</RIME:ProvisionForLegalLiability>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2023-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003331"
      unitRef="USD">275000</us-gaap:CommitmentsAndContingencies>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2023-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003337"
      unitRef="USD">5969000</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2022-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003338"
      unitRef="USD">5543000</us-gaap:PreferredStockValue>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2023-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003340"
      unitRef="USD">-8139000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2022-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003341"
      unitRef="USD">-5992000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003343"
      unitRef="USD">-2170000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003344"
      unitRef="USD">-449000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2023-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003346"
      unitRef="USD">731000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2022-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003347"
      unitRef="USD">1584000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003349"
      unitRef="USD">6036000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-01-012022-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003350"
      unitRef="USD">9655000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003352"
      unitRef="USD">5853000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="From2022-01-012022-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003353"
      unitRef="USD">10108000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003355"
      unitRef="USD">183000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2022-01-012022-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003356"
      unitRef="USD">-453000</us-gaap:GrossProfit>
    <us-gaap:SellingExpense
      contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003361"
      unitRef="USD">1333000</us-gaap:SellingExpense>
    <us-gaap:SellingExpense
      contextRef="From2022-01-012022-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003362"
      unitRef="USD">1511000</us-gaap:SellingExpense>
    <RIME:ProductDevelopmentExpense
      contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003364"
      unitRef="USD">852000</RIME:ProductDevelopmentExpense>
    <RIME:ProductDevelopmentExpense
      contextRef="From2022-01-012022-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003365"
      unitRef="USD">640000</RIME:ProductDevelopmentExpense>
    <us-gaap:OperatingExpenses
      contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003367"
      unitRef="USD">2185000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2022-01-012022-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003368"
      unitRef="USD">2151000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003370"
      unitRef="USD">-2002000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2022-01-012022-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003371"
      unitRef="USD">-2604000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003376"
      unitRef="USD">145000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="From2022-01-012022-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003377"
      unitRef="USD">63000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003379"
      unitRef="USD">-145000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2022-01-012022-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003380"
      unitRef="USD">-63000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003382"
      unitRef="USD">-2147000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2022-01-012022-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003383"
      unitRef="USD">-2667000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003388"
      unitRef="USD">-2147000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2022-01-012022-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003389"
      unitRef="USD">-2667000</us-gaap:ProfitLoss>
    <us-gaap:NatureOfOperations
      contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember"
      id="Fact003391">&lt;p id="xdx_801_eus-gaap--NatureOfOperations_zFnSd0WXeqg9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span id="alp_014"&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
1 - &lt;span&gt;BASIS OF PRESENTATION&lt;/span&gt; &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;span id="xdx_829_z3u6FIzulgK1"&gt;NATURE OF BUSINESS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;OVERVIEW&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
SemiCab, Inc., a Delaware corporation (the &#x201c;Company,&#x201d; &#x201c;SemiCab&#x201d;) is primarily engaged in the development, marketing,
and sale of logistics optimization services for enterprise-level dedicated freight and shipping customers in The United States and India.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Basis
of Presentation&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States
of America (&#x201c;GAAP&#x201d;), which contemplate continuation of the Company as a going concern, and assumes continuity of operations,
realization of assets and the satisfaction of liabilities and commitments in the normal course of business. The Company has suffered
substantial net losses and negative cash flows from operations in recent years and is dependent on debt and equity financing to fund
its operations all of which raise substantial doubt about the Company&#x2019;s ability to continue as a going concern. Recoverability
of a major portion of the recorded asset amounts shown in the accompanying balance sheet is dependent upon the Company&#x2019;s ability
to increase its revenue and meet its financing requirements on a continuing basis and become profitable in its future operations. The
accompanying consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded
assets or the amounts and classification of liabilities that might be necessary should the Company be unable to continue in existence.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:NatureOfOperations>
    <us-gaap:SubstantialDoubtAboutGoingConcernTextBlock
      contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember"
      id="Fact003393">&lt;p id="xdx_80E_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zY1NS1InFa3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
2 &#x2013; &lt;span&gt;GOING CONCERN&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_82D_zmLRHaxfVLM3" style="display: none"&gt;LIQUIDITY,
GOING CONCERN AND MANAGEMENT PLANS&lt;/span&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s financial statements as of December 31, 2023 and 2022 have been prepared using generally accepted accounting principles
in the United States of America applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities
in the normal course of business. The Company has not yet established an ongoing source of revenue sufficient to cover its operating
costs and allow it to continue as a going concern. The Company has accumulated losses from 2022 to 2023 of $&lt;span id="xdx_90E_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_c20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zzCd79lKYFP4" title="Accumulated losses"&gt;4,814,000&lt;/span&gt;. These factors
among others raise substantial doubt about the ability of the company to continue as a going concern for a reasonable period of time.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
order to continue as a going concern, the Company will need, among other things, additional capital resources. Management&#x2019;s plan
is to obtain such resources for the Company by obtaining capital from management and significant shareholders sufficient to meet its
minimal operating expenses and seeking third party equity and/or debt financing. However, management cannot provide any assurances that
the Company will be successful in accomplishing any of its plans. These financial statements do not include any adjustments related to
the recoverability and classification of assets or the amounts and classification of liabilities that might be necessary should the Company
be unable to continue as a going concern.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SubstantialDoubtAboutGoingConcernTextBlock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2023-12-31_us-gaap_RetainedEarningsMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003395"
      unitRef="USD">4814000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember"
      id="Fact003397">&lt;p id="xdx_805_eus-gaap--SignificantAccountingPoliciesTextBlock_zz3tgt0GCdw9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
3 - &lt;span id="xdx_829_z65a3VHgP1y3"&gt;SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84A_eus-gaap--ConsolidationPolicyTextBlock_zt14LqVxqMS1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_868_z460VSZ58tEi"&gt;PRINCIPLES
OF CONSOLIDATION&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying consolidated financial statements include certain intercompany expenses associated with its wholly owned India subsidiary,
SMCB Solutions Private Limited, the accounts of the Company. All inter-company accounts and transactions have been eliminated in consolidation
for all periods presented.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_845_eus-gaap--UseOfEstimates_z7bKEnQYdoBc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_860_zbZQlUmRLS03"&gt;USE
OF ESTIMATES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;SemiCab
makes estimates and assumptions in the ordinary course of business relating to sales collections and allowances, warranty reserves, and
reserves for promotional incentives that may affect the reported amounts of assets and liabilities and of contingent assets and liabilities
at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Future
events and their effects cannot be determined with absolute certainty; therefore, the determination of estimates requires the exercise
of judgment. Historically, past changes to these estimates have not had a material impact on the Company&#x2019;s financial statements.
However, circumstances could change which may alter future expectations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_848_ecustom--ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountPolicy_z1ejGJPCZPgi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_862_zmLkW7LMOPD3"&gt;ALLOWANCE
FOR DOUBTFUL ACCOUNTS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;SemiCab&#x2019;s
allowance for doubtful accounts is based on management&#x2019;s estimates of the creditworthiness of its customers, current economic conditions
and historical information, and, in the opinion of management, is believed to be in an amount sufficient to respond to normal business
conditions. Management sets 100% reserves for customers in bankruptcy and other allowances based upon historical collection experience.
The Company is subject to chargebacks from customers that are deducted from open invoices and reduce collectability of open invoices.
Should business conditions deteriorate or any major customer default on its obligations to the Company, this allowance may need to be
significantly increased, which would have a negative impact on operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84D_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zLndMT9h1Rrb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_864_zIH83l1KnwYc"&gt;FOREIGN
CURRENCY TRANSLATION&lt;/span&gt; &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for foreign currency transactions pursuant to ASC 830, Foreign Currency Matters (&#x201c;ASC 830&#x201d;). The functional
currency of the Company is the U.S. dollar, which is the currency of the primary economic environment in which it operates. In accordance
with ASC 830, monetary balances denominated in or linked to foreign currency are stated on the basis of the exchange rates prevailing
at the applicable balance sheet date. For foreign currency transactions included in the statement of operations, the exchange rates applicable
on the relevant transaction dates are used. Gains or losses arising from changes in the exchange rates used in the translation of such
transactions and from the remeasurement of the monetary balance sheet items are recorded as gain (loss) on foreign currency transactions.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
functional currency of the India subsidiary is the Indian Rupee. Under ASC 830, all assets and liabilities are translated into U. S.
dollars using the current exchange rate at the end of each fiscal period. Revenues and expenses are translated using the average exchange
rates prevailing throughout the respective periods. All transaction gains and losses from the measurement of monetary balance sheet items
denominated in Indian Rupee are reflected in the statement of operations as appropriate. Translation adjustments are included in accumulated
other comprehensive loss.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84F_eus-gaap--ConcentrationRiskCreditRisk_zuOr9O0PwYm5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"&gt;&lt;b&gt;&lt;span id="xdx_86E_zcJuM1Yy4mYi"&gt;Concentration
of Credit Risk&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
times, the Company maintains cash in United States bank accounts that are in excess of the Federal Deposit Insurance Corporation insured
amounts. The Company maintains cash balances in foreign financial institutions. The amounts at foreign financial institutions at December
31, 2023 and 2022 were approximately $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_90D_eus-gaap--ForeignFinancialInstitutionsActualDeposits_iI_c20231231_za9UvT4LO8nh" title="Foreign financial institutions actual deposits"&gt;58,000&lt;/span&gt; and $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_906_eus-gaap--ForeignFinancialInstitutionsActualDeposits_iI_c20221231_zwMgn0t9uMXb" title="Foreign financial institutions actual deposits"&gt;91,000&lt;/span&gt;, respectively. The Company regularly monitors the financial stability of this
financial institution and believes that it is not exposed to any significant credit risk in cash and cash equivalents. However, in March
and April 2023, certain U.S. government banking regulators took steps to intervene in the operations of certain financial institutions
due to liquidity concerns, which caused general heightened uncertainties in financial markets. While these events have not had a material
direct impact on the Company&#x2019;s operations, if further liquidity and financial stability concerns arise with respect to banks and
financial institutions, either nationally or in specific regions, the Company&#x2019;s ability to access cash or enter into new financing
arrangements may be threatened, which could have a material adverse effect on its business, financial condition and results of operations.
Financial instruments, which potentially subject the Company to concentrations of credit risk, consist of accounts receivable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_843_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zBaPdFhl2PSl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86C_zwUgYWEk8UX9"&gt;LONG-LIVED
ASSETS&lt;/span&gt; &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Not
applicable. The only meaningful long-lived assets are intangible in nature and under GAAP accounting, not capitalized nor assigned any
long-term accounting value. prior to the proposed transaction.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84E_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zzUXSum9Vgah" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_866_zwN1Jzo3psEk"&gt;PROPERTY
AND EQUIPMENT&lt;/span&gt; &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Property
and Equipment are stated at cost. Depreciation is provided for in amounts sufficient to relate the cost of depreciable assets to operations
over the estimated service lives, principally using straight-line methods.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
estimated useful lives used to compute depreciation and amortization for financial reporting purposes are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_897_eus-gaap--ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock_z2dJnq9UqxD5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BC_zmYEfXhjCFr5" style="display: none"&gt;SCHEDULE
OF ESTIMATED USEFUL LIVES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
  &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify"&gt;&#160;&lt;/td&gt;
  &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;Years&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
  &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 70%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Property
  and Equipment&lt;/span&gt;&lt;/td&gt;
  &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 30%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__srt--RangeAxis__srt--MinimumMember_zhbOAT3stvZh" title="Property plant and equipment useful life"&gt;3&lt;/span&gt; - &lt;span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__srt--RangeAxis__srt--MaximumMember_zqn6PxRDpa4c" title="Property plant and equipment useful life"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p id="xdx_8A6_zWlb9Wnx0g7h" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_845_ecustom--PrepaidExpensesPolicyTextBlock_zkvjbZ0xjxoj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_867_zagvPAZT0yLk"&gt;PREPAID
EXPENSES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Prepaid
expenses consist primarily of prepaid services which will be expensed as the services are provided within twelve months. As of December
31, 2023 and 2022, the balances of the prepaids account were $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_90F_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iI_c20231231_z7bl03q6wx8h" title="Prepaid expense"&gt;5,000&lt;/span&gt; and $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_90F_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iI_c20221231_znLDu8J88Lbf" title="Prepaid expense"&gt;8,000&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_849_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zHRLmSf1tBl5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_869_zz0MwxDff286"&gt;FAIR
VALUE OF FINANCIAL INSTRUMENTS&lt;/span&gt; &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
carrying values of financial instruments comprising cash and cash equivalents, payables, and notes payable-related party approximate
fair values due to the short-term maturities of these instruments. The notes payable- related party is considered a level 3 measurement.
As defined in ASC 820, &lt;i&gt;Fair Value Measurements and Disclosures&lt;/i&gt;, fair value is the price that would be received to sell an asset
or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). The Company
utilizes market data or assumptions that market participants would use in pricing the asset or liability, including assumptions about
risk and the risks inherent in the inputs to the valuation technique. These inputs can be readily observable, market corroborated, or
generally unobservable. ASC 820 establishes a fair value hierarchy that prioritizes the inputs used to measure fair value. The hierarchy
gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and
the lowest priority to unobservable inputs (Level 3 measurement). This fair value measurement framework applies to both initial and subsequent
measurement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    1:&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 92%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Quoted
    prices are available in active markets for identical assets or liabilities as of the reporting date.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    2:&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pricing
    inputs are other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as
    of the reported date. Level 2 includes those financial instruments that are valued using models or other valuation methodologies.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    3:&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pricing
inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally
developed methodologies that result in management&#x2019;s best estimate of fair value. The significant unobservable inputs used in the
fair value measurement for nonrecurring fair value measurements of long-lived assets include pricing models, discounted cash flow methodologies
and similar techniques.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
carrying amounts of the Company&#x2019;s short-term financial instruments, including accounts receivable, accounts payable, accrued expenses,
customer deposits, refunds due to customers, and due to related parties approximates fair value due to the relatively short period to
maturity for these instruments. The carrying amounts on the notes payable, finance leases and installment notes approximate fair value
either due to the relatively short period to maturity or the related interest is accrued at a rate similar to market rates. The carrying
amounts on the revolving line of credit approximates fair value due the relatively short period to maturity and related interest accrued
at market rates.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_841_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_z6gJVLCEEyt9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span&gt;REVENUE
RECOGNITION&lt;/span&gt; &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_869_ziYHCZqBAts2" style="display: none"&gt;REVENUE
RECOGNITION AND RESERVE FOR SALES RETURNS&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognizes revenue in accordance with FASB ASC 606, &#x201c;Revenue from Contracts with Customers&#x201d;. All revenue is generated
from contracts with customers. The Company recognizes revenue when the control of the goods sold is transferred to the customer, in an
amount, referred to as the transaction price, that reflects the consideration to which the Company is expected to be entitled in exchange
for those goods. The Company determines revenue recognition utilizing the following five steps: (1) identification of the contract with
a customer, (2) identification of the performance obligations in the contract (promised goods or services that are distinct), (3) determination
of the transaction price, (4) allocation of the transaction price to the performance obligations, and (5) recognition of revenue when,
or as, the Company transfers control of the product or service for each performance obligation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s contracts with customers consist of one performance obligation (the sale of the Company&#x2019;s products). The Company&#x2019;s
contracts have no financing elements, payment terms are less than 120 days and have no further contract asset or liability obligations
once control of goods is transferred to the customer. Revenue is recorded in the amount of consideration the Company expects to receive
for the sale of these goods.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Costs
incurred in fulfilling contracts with customers include administrative costs associated with the procurement of goods are included in
general and administrative expenses, in-bound freight costs are included in the cost of goods sold and accrued sales representative commissions
are included in selling expenses in the accompanying consolidated statements of operations as our underlying customer agreements are
less than one year.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84D_ecustom--ShippingAndHandlingCostsPolicyTextBlock_zUMy4fBOf0a2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_862_zJNalzNaVDh9"&gt;SHIPPING
AND HANDLING COSTS&lt;/span&gt; &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Shipping
and handling activities are performed before the customer obtains control of the goods delivered for them and are considered activities
to fulfill the Company&#x2019;s promise to transfer the goods. For Fiscal 2023 and 2022 shipping and handling expenses provided by third
party shippers were approximately $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_90F_ecustom--ShippingAndHandlingExpenses_c20230101__20231231_zlhIbVOmmoij" title="Shipping and handling expenses"&gt;5,692,000&lt;/span&gt; and $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_908_ecustom--ShippingAndHandlingExpenses_c20220101__20221231_zYqwgyDuxhu8" title="Shipping and handling expenses"&gt;10,057,000&lt;/span&gt;, respectively. These expenses are classified as a component of selling
expenses in the accompanying consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_849_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zi5KOh9YHNHf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86B_z18aPM8fpv76"&gt;STOCK-BASED
COMPENSATION&lt;/span&gt; &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for share based compensation in accordance with the provisions of ASC 718-10, &#x201c;Compensation &#x2014; Stock Compensation,&#x201d;
which requires measurement of compensation cost for all stock awards at fair value on date of grant and recognition of compensation over
the service period for awards expected to vest. The majority of its share-based compensation arrangements vest over a three year vesting
schedule. The Company expenses its share-based compensation under the ratable method, which treats each vesting tranche as if it were
an individual grant. The fair value of stock options is determined using the Black-Scholes valuation model and requires the input of
certain assumptions. These assumptions include estimating the length of time employees will retain their vested stock options before
exercising them (the &#x201c;expected option term&#x201d;), the estimated volatility of its common stock price over the option&#x2019;s
expected term, the risk-free interest rate over the option&#x2019;s expected term, and the Company&#x2019;s expected annual dividend yield.
Changes in these subjective assumptions can materially affect the estimate of fair value of stock-based compensation and consequently,
the related amount recognized as an expense in the consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
required under the accounting rules, the Company reviews its valuation assumptions at each grant date and, as a result, the Company is
likely to change its valuation assumptions used to value employee stock-based awards granted in future periods. The values derived from
using the Black-Scholes model are recognized as expense over the service period, net of estimated forfeitures (the number of individuals
that will ultimately not complete their vesting requirements). The estimation of stock awards that will ultimately vest requires significant
judgment. The Company considers many factors when estimating expected forfeitures, including types of awards, employee class, and historical
experience. Actual results, and future changes in estimates, may differ substantially from current estimates. Options and warrants to
outsiders are accounted for under ASC 718.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_848_eus-gaap--ResearchAndDevelopmentExpensePolicy_zbNgN3QOxfw7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_864_z0hSPZtChHU4"&gt;RESEARCH
AND DEVELOPMENT COSTS&lt;/span&gt; &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;All
research and development costs are charged to results of operations as incurred. These expenses are shown as a component of general and
administrative expenses in the consolidated statements of operations. For the years ended December 31, 2023 and 2022, these amounts totaled
approximately $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_907_eus-gaap--ResearchAndDevelopmentExpense_c20230101__20231231_z00keplmHzVi" title="Research and development costs"&gt;842,000&lt;/span&gt; and $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_904_eus-gaap--ResearchAndDevelopmentExpense_c20220101__20221231_zP8VEPPMhMm1" title="Research and development costs"&gt;640,000&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_849_eus-gaap--IncomeTaxPolicyTextBlock_zTed47CBFWAh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_869_zOUw1hxTBww3"&gt;INCOME
TAXES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company follows the provisions of FASB ASC 740 &#x201c;Accounting for Income Taxes.&#x201d; Under the asset and liability method of ASC
740, deferred tax assets and liabilities are recognized for the future tax consequences attributed to differences between the financial
statement carrying amounts of existing assets and liabilities and their respective tax base. Deferred tax assets and liabilities are
measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to
be recovered or settled. Under ASC 740, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income
in the period that includes the enactment date. If it is more likely than not that some portion of a deferred tax asset will not be realized,
a valuation allowance is recognized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognizes a liability for uncertain tax positions. An uncertain tax position is defined as a position in a previously filed
tax return or a position expected to be taken in a future tax return that is not based on clear and unambiguous tax law and which is
reflected in measuring current or deferred income tax assets and liabilities for interim or annual periods. The Company may recognize
the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination
by the taxing authorities, based on the technical merits of the position. The Company measures the tax benefits recognized based on the
largest benefit that has a greater than 50% likelihood of being realized upon ultimate resolution.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of March 31, 2023 and 2022 there were no uncertain tax positions that resulted in any adjustment to the Company&#x2019;s provision for
income taxes. The Company recognizes interest and penalties related to unrecognized tax benefits in its provision for income taxes. The
Company currently has no liabilities recorded for accrued interest or penalties related to uncertain tax provisions.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84A_eus-gaap--EarningsPerSharePolicyTextBlock_zAb0q9XUEOti" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_863_zz3yTyIaMu27"&gt;COMPUTATION
OF EARNINGS (LOSS) PER SHARE&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Not
applicable. This is not required.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84B_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zSuculTGSwrj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_866_zSh71TqczAL7"&gt;RECENT
ACCOUNTING PRONOUNCEMENTS&lt;/span&gt;:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;In
June 2016, the FASB issued ASU 2016-13, &#x201c;Financial Instruments&#x2014;Credit Losses&#x201d; &lt;i&gt;(Topic 326)&lt;/i&gt;. This ASU represents
a significant change in the current accounting model by requiring immediate recognition of management&#x2019;s estimates of current expected
credit losses. Under the prior model, losses were recognized only as they were incurred, which delayed recognition of expected losses
that might not yet have met the threshold of being probable. &lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
amendments in ASU 2016-03 for smaller reporting companies are effective for the Company beginning April 1, 2023, including interim periods
within that fiscal year. The Company adopted ASU 2016-13 on May 1, 2024. The adoption of ASU 2016-13 did not result in any material effects
to the consolidated financial statements or related disclosures.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember"
      id="Fact003399">&lt;p id="xdx_84A_eus-gaap--ConsolidationPolicyTextBlock_zt14LqVxqMS1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_868_z460VSZ58tEi"&gt;PRINCIPLES
OF CONSOLIDATION&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying consolidated financial statements include certain intercompany expenses associated with its wholly owned India subsidiary,
SMCB Solutions Private Limited, the accounts of the Company. All inter-company accounts and transactions have been eliminated in consolidation
for all periods presented.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember"
      id="Fact003401">&lt;p id="xdx_845_eus-gaap--UseOfEstimates_z7bKEnQYdoBc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_860_zbZQlUmRLS03"&gt;USE
OF ESTIMATES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;SemiCab
makes estimates and assumptions in the ordinary course of business relating to sales collections and allowances, warranty reserves, and
reserves for promotional incentives that may affect the reported amounts of assets and liabilities and of contingent assets and liabilities
at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Future
events and their effects cannot be determined with absolute certainty; therefore, the determination of estimates requires the exercise
of judgment. Historically, past changes to these estimates have not had a material impact on the Company&#x2019;s financial statements.
However, circumstances could change which may alter future expectations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:UseOfEstimates>
    <RIME:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountPolicy
      contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember"
      id="Fact003403">&lt;p id="xdx_848_ecustom--ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountPolicy_z1ejGJPCZPgi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_862_zmLkW7LMOPD3"&gt;ALLOWANCE
FOR DOUBTFUL ACCOUNTS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;SemiCab&#x2019;s
allowance for doubtful accounts is based on management&#x2019;s estimates of the creditworthiness of its customers, current economic conditions
and historical information, and, in the opinion of management, is believed to be in an amount sufficient to respond to normal business
conditions. Management sets 100% reserves for customers in bankruptcy and other allowances based upon historical collection experience.
The Company is subject to chargebacks from customers that are deducted from open invoices and reduce collectability of open invoices.
Should business conditions deteriorate or any major customer default on its obligations to the Company, this allowance may need to be
significantly increased, which would have a negative impact on operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</RIME:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountPolicy>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock
      contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember"
      id="Fact003405">&lt;p id="xdx_84D_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zLndMT9h1Rrb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_864_zIH83l1KnwYc"&gt;FOREIGN
CURRENCY TRANSLATION&lt;/span&gt; &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for foreign currency transactions pursuant to ASC 830, Foreign Currency Matters (&#x201c;ASC 830&#x201d;). The functional
currency of the Company is the U.S. dollar, which is the currency of the primary economic environment in which it operates. In accordance
with ASC 830, monetary balances denominated in or linked to foreign currency are stated on the basis of the exchange rates prevailing
at the applicable balance sheet date. For foreign currency transactions included in the statement of operations, the exchange rates applicable
on the relevant transaction dates are used. Gains or losses arising from changes in the exchange rates used in the translation of such
transactions and from the remeasurement of the monetary balance sheet items are recorded as gain (loss) on foreign currency transactions.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
functional currency of the India subsidiary is the Indian Rupee. Under ASC 830, all assets and liabilities are translated into U. S.
dollars using the current exchange rate at the end of each fiscal period. Revenues and expenses are translated using the average exchange
rates prevailing throughout the respective periods. All transaction gains and losses from the measurement of monetary balance sheet items
denominated in Indian Rupee are reflected in the statement of operations as appropriate. Translation adjustments are included in accumulated
other comprehensive loss.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember"
      id="Fact003407">&lt;p id="xdx_84F_eus-gaap--ConcentrationRiskCreditRisk_zuOr9O0PwYm5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"&gt;&lt;b&gt;&lt;span id="xdx_86E_zcJuM1Yy4mYi"&gt;Concentration
of Credit Risk&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
times, the Company maintains cash in United States bank accounts that are in excess of the Federal Deposit Insurance Corporation insured
amounts. The Company maintains cash balances in foreign financial institutions. The amounts at foreign financial institutions at December
31, 2023 and 2022 were approximately $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_90D_eus-gaap--ForeignFinancialInstitutionsActualDeposits_iI_c20231231_za9UvT4LO8nh" title="Foreign financial institutions actual deposits"&gt;58,000&lt;/span&gt; and $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_906_eus-gaap--ForeignFinancialInstitutionsActualDeposits_iI_c20221231_zwMgn0t9uMXb" title="Foreign financial institutions actual deposits"&gt;91,000&lt;/span&gt;, respectively. The Company regularly monitors the financial stability of this
financial institution and believes that it is not exposed to any significant credit risk in cash and cash equivalents. However, in March
and April 2023, certain U.S. government banking regulators took steps to intervene in the operations of certain financial institutions
due to liquidity concerns, which caused general heightened uncertainties in financial markets. While these events have not had a material
direct impact on the Company&#x2019;s operations, if further liquidity and financial stability concerns arise with respect to banks and
financial institutions, either nationally or in specific regions, the Company&#x2019;s ability to access cash or enter into new financing
arrangements may be threatened, which could have a material adverse effect on its business, financial condition and results of operations.
Financial instruments, which potentially subject the Company to concentrations of credit risk, consist of accounts receivable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:ForeignFinancialInstitutionsActualDeposits
      contextRef="AsOf2023-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003409"
      unitRef="USD">58000</us-gaap:ForeignFinancialInstitutionsActualDeposits>
    <us-gaap:ForeignFinancialInstitutionsActualDeposits
      contextRef="AsOf2022-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003411"
      unitRef="USD">91000</us-gaap:ForeignFinancialInstitutionsActualDeposits>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock
      contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember"
      id="Fact003413">&lt;p id="xdx_843_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zBaPdFhl2PSl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86C_zwUgYWEk8UX9"&gt;LONG-LIVED
ASSETS&lt;/span&gt; &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Not
applicable. The only meaningful long-lived assets are intangible in nature and under GAAP accounting, not capitalized nor assigned any
long-term accounting value. prior to the proposed transaction.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember"
      id="Fact003415">&lt;p id="xdx_84E_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zzUXSum9Vgah" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_866_zwN1Jzo3psEk"&gt;PROPERTY
AND EQUIPMENT&lt;/span&gt; &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Property
and Equipment are stated at cost. Depreciation is provided for in amounts sufficient to relate the cost of depreciable assets to operations
over the estimated service lives, principally using straight-line methods.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
estimated useful lives used to compute depreciation and amortization for financial reporting purposes are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_897_eus-gaap--ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock_z2dJnq9UqxD5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BC_zmYEfXhjCFr5" style="display: none"&gt;SCHEDULE
OF ESTIMATED USEFUL LIVES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
  &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify"&gt;&#160;&lt;/td&gt;
  &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;Years&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
  &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 70%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Property
  and Equipment&lt;/span&gt;&lt;/td&gt;
  &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 30%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__srt--RangeAxis__srt--MinimumMember_zhbOAT3stvZh" title="Property plant and equipment useful life"&gt;3&lt;/span&gt; - &lt;span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__srt--RangeAxis__srt--MaximumMember_zqn6PxRDpa4c" title="Property plant and equipment useful life"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p id="xdx_8A6_zWlb9Wnx0g7h" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock
      contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember"
      id="Fact003417">&lt;p id="xdx_897_eus-gaap--ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock_z2dJnq9UqxD5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BC_zmYEfXhjCFr5" style="display: none"&gt;SCHEDULE
OF ESTIMATED USEFUL LIVES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
  &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify"&gt;&#160;&lt;/td&gt;
  &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;Years&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
  &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 70%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Property
  and Equipment&lt;/span&gt;&lt;/td&gt;
  &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 30%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__srt--RangeAxis__srt--MinimumMember_zhbOAT3stvZh" title="Property plant and equipment useful life"&gt;3&lt;/span&gt; - &lt;span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__srt--RangeAxis__srt--MaximumMember_zqn6PxRDpa4c" title="Property plant and equipment useful life"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


</us-gaap:ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2023-12-31_srt_MinimumMember_custom_SemiCabIncMember"
      id="Fact003419">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2023-12-31_srt_MaximumMember_custom_SemiCabIncMember"
      id="Fact003421">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <RIME:PrepaidExpensesPolicyTextBlock
      contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember"
      id="Fact003423">&lt;p id="xdx_845_ecustom--PrepaidExpensesPolicyTextBlock_zkvjbZ0xjxoj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_867_zagvPAZT0yLk"&gt;PREPAID
EXPENSES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Prepaid
expenses consist primarily of prepaid services which will be expensed as the services are provided within twelve months. As of December
31, 2023 and 2022, the balances of the prepaids account were $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_90F_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iI_c20231231_z7bl03q6wx8h" title="Prepaid expense"&gt;5,000&lt;/span&gt; and $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_90F_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iI_c20221231_znLDu8J88Lbf" title="Prepaid expense"&gt;8,000&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</RIME:PrepaidExpensesPolicyTextBlock>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2023-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003425"
      unitRef="USD">5000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2022-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003427"
      unitRef="USD">8000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy
      contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember"
      id="Fact003429">&lt;p id="xdx_849_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zHRLmSf1tBl5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_869_zz0MwxDff286"&gt;FAIR
VALUE OF FINANCIAL INSTRUMENTS&lt;/span&gt; &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
carrying values of financial instruments comprising cash and cash equivalents, payables, and notes payable-related party approximate
fair values due to the short-term maturities of these instruments. The notes payable- related party is considered a level 3 measurement.
As defined in ASC 820, &lt;i&gt;Fair Value Measurements and Disclosures&lt;/i&gt;, fair value is the price that would be received to sell an asset
or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). The Company
utilizes market data or assumptions that market participants would use in pricing the asset or liability, including assumptions about
risk and the risks inherent in the inputs to the valuation technique. These inputs can be readily observable, market corroborated, or
generally unobservable. ASC 820 establishes a fair value hierarchy that prioritizes the inputs used to measure fair value. The hierarchy
gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and
the lowest priority to unobservable inputs (Level 3 measurement). This fair value measurement framework applies to both initial and subsequent
measurement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    1:&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 92%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Quoted
    prices are available in active markets for identical assets or liabilities as of the reporting date.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    2:&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pricing
    inputs are other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as
    of the reported date. Level 2 includes those financial instruments that are valued using models or other valuation methodologies.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    3:&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pricing
inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally
developed methodologies that result in management&#x2019;s best estimate of fair value. The significant unobservable inputs used in the
fair value measurement for nonrecurring fair value measurements of long-lived assets include pricing models, discounted cash flow methodologies
and similar techniques.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
carrying amounts of the Company&#x2019;s short-term financial instruments, including accounts receivable, accounts payable, accrued expenses,
customer deposits, refunds due to customers, and due to related parties approximates fair value due to the relatively short period to
maturity for these instruments. The carrying amounts on the notes payable, finance leases and installment notes approximate fair value
either due to the relatively short period to maturity or the related interest is accrued at a rate similar to market rates. The carrying
amounts on the revolving line of credit approximates fair value due the relatively short period to maturity and related interest accrued
at market rates.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember"
      id="Fact003431">&lt;p id="xdx_841_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_z6gJVLCEEyt9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span&gt;REVENUE
RECOGNITION&lt;/span&gt; &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_869_ziYHCZqBAts2" style="display: none"&gt;REVENUE
RECOGNITION AND RESERVE FOR SALES RETURNS&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognizes revenue in accordance with FASB ASC 606, &#x201c;Revenue from Contracts with Customers&#x201d;. All revenue is generated
from contracts with customers. The Company recognizes revenue when the control of the goods sold is transferred to the customer, in an
amount, referred to as the transaction price, that reflects the consideration to which the Company is expected to be entitled in exchange
for those goods. The Company determines revenue recognition utilizing the following five steps: (1) identification of the contract with
a customer, (2) identification of the performance obligations in the contract (promised goods or services that are distinct), (3) determination
of the transaction price, (4) allocation of the transaction price to the performance obligations, and (5) recognition of revenue when,
or as, the Company transfers control of the product or service for each performance obligation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s contracts with customers consist of one performance obligation (the sale of the Company&#x2019;s products). The Company&#x2019;s
contracts have no financing elements, payment terms are less than 120 days and have no further contract asset or liability obligations
once control of goods is transferred to the customer. Revenue is recorded in the amount of consideration the Company expects to receive
for the sale of these goods.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Costs
incurred in fulfilling contracts with customers include administrative costs associated with the procurement of goods are included in
general and administrative expenses, in-bound freight costs are included in the cost of goods sold and accrued sales representative commissions
are included in selling expenses in the accompanying consolidated statements of operations as our underlying customer agreements are
less than one year.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <RIME:ShippingAndHandlingCostsPolicyTextBlock
      contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember"
      id="Fact003433">&lt;p id="xdx_84D_ecustom--ShippingAndHandlingCostsPolicyTextBlock_zUMy4fBOf0a2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_862_zJNalzNaVDh9"&gt;SHIPPING
AND HANDLING COSTS&lt;/span&gt; &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Shipping
and handling activities are performed before the customer obtains control of the goods delivered for them and are considered activities
to fulfill the Company&#x2019;s promise to transfer the goods. For Fiscal 2023 and 2022 shipping and handling expenses provided by third
party shippers were approximately $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_90F_ecustom--ShippingAndHandlingExpenses_c20230101__20231231_zlhIbVOmmoij" title="Shipping and handling expenses"&gt;5,692,000&lt;/span&gt; and $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_908_ecustom--ShippingAndHandlingExpenses_c20220101__20221231_zYqwgyDuxhu8" title="Shipping and handling expenses"&gt;10,057,000&lt;/span&gt;, respectively. These expenses are classified as a component of selling
expenses in the accompanying consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</RIME:ShippingAndHandlingCostsPolicyTextBlock>
    <RIME:ShippingAndHandlingExpenses
      contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003435"
      unitRef="USD">5692000</RIME:ShippingAndHandlingExpenses>
    <RIME:ShippingAndHandlingExpenses
      contextRef="From2022-01-012022-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003437"
      unitRef="USD">10057000</RIME:ShippingAndHandlingExpenses>
    <us-gaap:CompensationRelatedCostsPolicyTextBlock
      contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember"
      id="Fact003439">&lt;p id="xdx_849_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zi5KOh9YHNHf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86B_z18aPM8fpv76"&gt;STOCK-BASED
COMPENSATION&lt;/span&gt; &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for share based compensation in accordance with the provisions of ASC 718-10, &#x201c;Compensation &#x2014; Stock Compensation,&#x201d;
which requires measurement of compensation cost for all stock awards at fair value on date of grant and recognition of compensation over
the service period for awards expected to vest. The majority of its share-based compensation arrangements vest over a three year vesting
schedule. The Company expenses its share-based compensation under the ratable method, which treats each vesting tranche as if it were
an individual grant. The fair value of stock options is determined using the Black-Scholes valuation model and requires the input of
certain assumptions. These assumptions include estimating the length of time employees will retain their vested stock options before
exercising them (the &#x201c;expected option term&#x201d;), the estimated volatility of its common stock price over the option&#x2019;s
expected term, the risk-free interest rate over the option&#x2019;s expected term, and the Company&#x2019;s expected annual dividend yield.
Changes in these subjective assumptions can materially affect the estimate of fair value of stock-based compensation and consequently,
the related amount recognized as an expense in the consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
required under the accounting rules, the Company reviews its valuation assumptions at each grant date and, as a result, the Company is
likely to change its valuation assumptions used to value employee stock-based awards granted in future periods. The values derived from
using the Black-Scholes model are recognized as expense over the service period, net of estimated forfeitures (the number of individuals
that will ultimately not complete their vesting requirements). The estimation of stock awards that will ultimately vest requires significant
judgment. The Company considers many factors when estimating expected forfeitures, including types of awards, employee class, and historical
experience. Actual results, and future changes in estimates, may differ substantially from current estimates. Options and warrants to
outsiders are accounted for under ASC 718.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CompensationRelatedCostsPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy
      contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember"
      id="Fact003441">&lt;p id="xdx_848_eus-gaap--ResearchAndDevelopmentExpensePolicy_zbNgN3QOxfw7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_864_z0hSPZtChHU4"&gt;RESEARCH
AND DEVELOPMENT COSTS&lt;/span&gt; &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;All
research and development costs are charged to results of operations as incurred. These expenses are shown as a component of general and
administrative expenses in the consolidated statements of operations. For the years ended December 31, 2023 and 2022, these amounts totaled
approximately $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_907_eus-gaap--ResearchAndDevelopmentExpense_c20230101__20231231_z00keplmHzVi" title="Research and development costs"&gt;842,000&lt;/span&gt; and $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_904_eus-gaap--ResearchAndDevelopmentExpense_c20220101__20221231_zP8VEPPMhMm1" title="Research and development costs"&gt;640,000&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003443"
      unitRef="USD">842000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2022-01-012022-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003445"
      unitRef="USD">640000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember"
      id="Fact003447">&lt;p id="xdx_849_eus-gaap--IncomeTaxPolicyTextBlock_zTed47CBFWAh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_869_zOUw1hxTBww3"&gt;INCOME
TAXES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company follows the provisions of FASB ASC 740 &#x201c;Accounting for Income Taxes.&#x201d; Under the asset and liability method of ASC
740, deferred tax assets and liabilities are recognized for the future tax consequences attributed to differences between the financial
statement carrying amounts of existing assets and liabilities and their respective tax base. Deferred tax assets and liabilities are
measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to
be recovered or settled. Under ASC 740, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income
in the period that includes the enactment date. If it is more likely than not that some portion of a deferred tax asset will not be realized,
a valuation allowance is recognized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognizes a liability for uncertain tax positions. An uncertain tax position is defined as a position in a previously filed
tax return or a position expected to be taken in a future tax return that is not based on clear and unambiguous tax law and which is
reflected in measuring current or deferred income tax assets and liabilities for interim or annual periods. The Company may recognize
the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination
by the taxing authorities, based on the technical merits of the position. The Company measures the tax benefits recognized based on the
largest benefit that has a greater than 50% likelihood of being realized upon ultimate resolution.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of March 31, 2023 and 2022 there were no uncertain tax positions that resulted in any adjustment to the Company&#x2019;s provision for
income taxes. The Company recognizes interest and penalties related to unrecognized tax benefits in its provision for income taxes. The
Company currently has no liabilities recorded for accrued interest or penalties related to uncertain tax provisions.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember"
      id="Fact003449">&lt;p id="xdx_84A_eus-gaap--EarningsPerSharePolicyTextBlock_zAb0q9XUEOti" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_863_zz3yTyIaMu27"&gt;COMPUTATION
OF EARNINGS (LOSS) PER SHARE&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Not
applicable. This is not required.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember"
      id="Fact003451">&lt;p id="xdx_84B_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zSuculTGSwrj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_866_zSh71TqczAL7"&gt;RECENT
ACCOUNTING PRONOUNCEMENTS&lt;/span&gt;:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;In
June 2016, the FASB issued ASU 2016-13, &#x201c;Financial Instruments&#x2014;Credit Losses&#x201d; &lt;i&gt;(Topic 326)&lt;/i&gt;. This ASU represents
a significant change in the current accounting model by requiring immediate recognition of management&#x2019;s estimates of current expected
credit losses. Under the prior model, losses were recognized only as they were incurred, which delayed recognition of expected losses
that might not yet have met the threshold of being probable. &lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
amendments in ASU 2016-03 for smaller reporting companies are effective for the Company beginning April 1, 2023, including interim periods
within that fiscal year. The Company adopted ASU 2016-13 on May 1, 2024. The adoption of ASU 2016-13 did not result in any material effects
to the consolidated financial statements or related disclosures.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:AccountsAndNontradeReceivableTextBlock
      contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember"
      id="Fact003453">&lt;p id="xdx_80F_eus-gaap--AccountsAndNontradeReceivableTextBlock_zVpryh8ylkhh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
4 &#x2013; &lt;span id="xdx_822_zeyZTwlK6GR9"&gt;ACCOUNTS RECEIVABLE&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accounts
receivable are carried at original amount less an estimate made for doubtful receivables based on a review of all outstanding amounts
on a monthly basis. Management determines the allowance for doubtful receivables by regularly evaluating individual customer receivables
and considering a customer&#x2019;s financial condition, credit history, and current economic conditions. Accounts receivable are written
off when deemed uncollectible. Accounts receivable at December 31, 2023 and 2022 consisted of the following: $&lt;span id="xdx_906_eus-gaap--AccountsReceivableNet_iI_c20231231_zlNbTT3bb76h" title="Accounts receivable, net"&gt;494,000&lt;/span&gt; and $&lt;span id="xdx_908_eus-gaap--AccountsReceivableNet_iI_c20221231_zU2dKl4oUvqh" title="Accounts receivable, net"&gt;677,000&lt;/span&gt;, all
due from large, US-based manufacturers for shipping services provided by the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Bad
debt expenses (if any) are recorded in selling, general, and administrative expense.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
allowance for doubtful accounts for the years ended December 31, 2023 and 2022 is as follows: This has historically been set at $&lt;span id="xdx_901_eus-gaap--ProvisionForDoubtfulAccounts_c20230101__20231231_zfOdHeazxahe" title="Allowance for doubtful accounts"&gt;&lt;span id="xdx_901_eus-gaap--ProvisionForDoubtfulAccounts_c20220101__20221231_zhDsyhw7b8th" title="Allowance for doubtful accounts"&gt;0&lt;/span&gt;&lt;/span&gt;, as
the Company has not previously recorded any losses due to bad debt.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:AccountsAndNontradeReceivableTextBlock>
    <us-gaap:AccountsReceivableNet
      contextRef="AsOf2023-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003455"
      unitRef="USD">494000</us-gaap:AccountsReceivableNet>
    <us-gaap:AccountsReceivableNet
      contextRef="AsOf2022-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003457"
      unitRef="USD">677000</us-gaap:AccountsReceivableNet>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003459"
      unitRef="USD">0</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="From2022-01-012022-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003461"
      unitRef="USD">0</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember"
      id="Fact003463">&lt;p id="xdx_80B_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_z8UFEgXSL1xf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
5 - &lt;span id="xdx_829_zP6e4Hs3BiIl"&gt;PROPERTY AND EQUIPMENT &lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Equipment
and leasehold improvements consisted of the following as of December 31: Miscellaneous office equipment, including desktop computers,
laptop computers, and printers.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Depreciation
was $&lt;span id="xdx_905_eus-gaap--Depreciation_c20230101__20231231_zAhYcoIwJFqh" title="Depreciation"&gt;1,000&lt;/span&gt; and $&lt;span id="xdx_90A_eus-gaap--Depreciation_c20220101__20221231_z4Rd6P30Jwp7" title="Depreciation"&gt;2,000&lt;/span&gt; for 2023 and 2022, respectively. Amounts are recorded in selling, general, and administrative expenses as well
as in cost of services.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:Depreciation
      contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003465"
      unitRef="USD">1000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="From2022-01-012022-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003467"
      unitRef="USD">2000</us-gaap:Depreciation>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
      contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember"
      id="Fact003469">&lt;p id="xdx_80F_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_z2UNyz13Ru0f" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
6 &#x2013; &lt;span id="xdx_823_zcUwkXLrXqm2"&gt;ACCOUNTS PAYABLE AND ACCRUED EXPENSES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accounts
payable and accrued liabilities consisted of the following as of December 31: $&lt;span id="xdx_908_eus-gaap--AccountsPayableCurrent_iI_c20231231_zGXzS11qlwt3" title="Vendors expenses payable"&gt;668,000&lt;/span&gt; in vendors expenses payable, primarily for shipping
services, and $&lt;span id="xdx_900_eus-gaap--AccruedLiabilitiesCurrent_iI_c20231231_zdzT7CfE9he8" title="Accrued expenses"&gt;149,000&lt;/span&gt; in accrued expenses, primarily for accrued payroll and interest expenses payable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:AccountsPayableCurrent
      contextRef="AsOf2023-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003471"
      unitRef="USD">668000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="AsOf2023-12-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003473"
      unitRef="USD">149000</us-gaap:AccruedLiabilitiesCurrent>
    <RIME:NotePayableAndFinancingArrangementsTextBlock
      contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember"
      id="Fact003475">&lt;p id="xdx_80A_ecustom--NotePayableAndFinancingArrangementsTextBlock_zN22Pp3Pw6p5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
7 &#x2013; &lt;span id="xdx_82A_z0pezUGdYowb"&gt;NOTES PAYABLE AND FINANING ARRANGEMENTS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Efficient
Capital Labs Installment Note &amp;amp; Settlement&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
May 18, 2023 the Company entered into a financing arrangement with Efficient Capital Labs, Inc. (&#x201c;ECL&#x201d;) to finance working
capital and product development. The loan had a &lt;span id="xdx_901_eus-gaap--DebtInstrumentMaturityDateDescription_c20230518__20230518__dei--LegalEntityAxis__custom--EfficientCapitalLabsIncMember_ztGUt31qVFR1" title="Maturity date, description"&gt;12-month maturity date&lt;/span&gt;. Repayments were originally scheduled to begin in June 2023, in
equal installments of $&lt;span id="xdx_90A_eus-gaap--RepaymentsOfDebt_pp2d_c20230518__20230518__dei--LegalEntityAxis__custom--EfficientCapitalLabsIncMember__us-gaap--DebtInstrumentAxis__custom--EqualInstallmentsForThirteenMonthsMember_zD2EaSEjCYT9" title="Repayment, debt"&gt;91,667.67&lt;/span&gt; for 13 months, with an interest rate of &lt;span id="xdx_906_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20230518__dei--LegalEntityAxis__custom--EfficientCapitalLabsIncMember__us-gaap--DebtInstrumentAxis__custom--EqualInstallmentsForThirteenMonthsMember_zQ9V9sZX9UMc" title="Interest rate"&gt;17.97&lt;/span&gt;%.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
May 18, 2024, the Company entered into a Settlement Agreement (&#x201c;Settlement&#x201d;) with ECL. In the Settlement, the Company agreed
to repay a total of $&lt;span id="xdx_905_eus-gaap--RepaymentsOfDebt_pp2d_c20240518__20240518__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember__us-gaap--DebtInstrumentAxis__custom--TwelveInstallmentsMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zKLZ4acK3Bl7" title="Repayment, debt"&gt;946,666.60&lt;/span&gt; in 12 installments. The first payment in the amount of $&lt;span id="xdx_909_eus-gaap--RepaymentsOfDebt_c20240518__20240518__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember__us-gaap--DebtInstrumentAxis__custom--FirstPaymentMember__us-gaap--AwardDateAxis__custom--DueAndPaidOnMayTwentyTwoThousandTwentyFourMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_za7rIbSzBCD3" title="Repayment, debt"&gt;25,000&lt;/span&gt; was due and paid on May 20, 2024. A second
payment in the amount of $&lt;span id="xdx_902_eus-gaap--RepaymentsOfDebt_c20240518__20240518__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember__us-gaap--DebtInstrumentAxis__custom--SecondPaymentMember__us-gaap--AwardDateAxis__custom--DueOnJuneThreeTwoThousandTwentyFourMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zZSHUAGoYguf" title="Repayment, debt"&gt;75,000&lt;/span&gt; is due on June 3, 2024. Thereafter, ten monthly payments are due on the first day of each month starting
on July 1, 2024 in the amount of $&lt;span id="xdx_90C_eus-gaap--RepaymentsOfDebt_pp2d_c20240518__20240518__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember__us-gaap--DebtInstrumentAxis__custom--TenMonthlyPaymentsMember__us-gaap--AwardDateAxis__custom--DueOnJulyOneTwoThousandTwentyFourMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zSnWPftc6NPh" title="Repayment, debt"&gt;84,666.66&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Shareholder
Notes &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_890_eus-gaap--ScheduleOfDebtTableTextBlock_zjVs3uuodTWd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Beginning
in July of 2021, and ending in May of 2023, the Company entered into a total of six shareholder loan agreements with a total of three
shareholders. These notes are all unsecured with limited rights of recourse. The specific terms of each note are summarized on the table
below.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span id="xdx_8B6_zpz2rEc3RS87" style="display: none"&gt;SCHEDULE OF SPECIFIC TERMS&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif"&gt;Date&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Maturity&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Holder&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Principal&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Rate&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Accrued Interest&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Current Balance&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 12%"&gt;&lt;span id="xdx_909_eus-gaap--DebtInstrumentIssuanceDate1_c20210710__20210710__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zMxeSg9oDMpc" title="Date"&gt;7/10/2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: center"&gt;&lt;span id="xdx_90D_eus-gaap--DebtInstrumentMaturityDate_c20210710__20210710__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zF3FgAPQLLs" title="Maturity"&gt;7/10/2026&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: center"&gt;Ajesh Kapoor&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pp2d_c20210710__20210710__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zZUUQwVGwcHh" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Principal"&gt;150,000.00&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20210710__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zvdo8UoOZZx9" title="Rate"&gt;9.0&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--DebtInstrumentPeriodicPaymentInterest_pp2d_c20210710__20210710__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zbXg08gQ3suc" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Accrued Interest"&gt;36,838.36&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--DebtInstrumentPeriodicPayment_pp2d_c20210710__20210710__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zsCuIFPy3W18" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Current Balance"&gt;186,838.36&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_eus-gaap--DebtInstrumentIssuanceDate1_c20210827__20210827__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_z3zQ7dE44r28" title="Date"&gt;8/27/2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_90B_eus-gaap--DebtInstrumentMaturityDate_c20210827__20210827__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_z82UfKP6YOJ5" title="Maturity"&gt;8/26/2026&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;Ajesh Kapoor&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pp2d_c20210827__20210827__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zc0bFz2i6mR2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;235,000.00&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20210827__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zSkUfAtXdMv4" title="Rate"&gt;9.0&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;%&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--DebtInstrumentPeriodicPaymentInterest_pp2d_c20210827__20210827__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zyMUpXy8YYF9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accrued Interest"&gt;54,932.05&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DebtInstrumentPeriodicPayment_pp2d_c20210827__20210827__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zZio3ImCnja9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Current Balance"&gt;289,932.05&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_eus-gaap--DebtInstrumentIssuanceDate1_c20230417__20230417__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--VivekSehgalMember_zuBVgiyGuJ15" title="Date"&gt;4/17/2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_c20230417__20230417__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--VivekSehgalMember_zL93Kx1OE147" title="Maturity"&gt;10/16/2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;Vivek Sehgal&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pp2d_c20230417__20230417__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--VivekSehgalMember_zDVy2qwrrGsl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;50,000.00&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20230417__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--VivekSehgalMember_zTOgp5Ja2CT5" title="Rate"&gt;10.0&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;%&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--DebtInstrumentPeriodicPaymentInterest_pp2d_c20230417__20230417__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--VivekSehgalMember_zJpj5JUzaJu9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accrued Interest"&gt;4,794.52&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DebtInstrumentPeriodicPayment_pp2d_c20230417__20230417__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--VivekSehgalMember_zh9u9wekat1l" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Current Balance"&gt;54,794.52&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_eus-gaap--DebtInstrumentIssuanceDate1_c20230505__20230505__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zMh3trEJXS61" title="Date"&gt;5/5/2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_907_eus-gaap--DebtInstrumentMaturityDate_c20230505__20230505__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_z7GsuQ7ZTXE6" title="Maturity"&gt;5/4/2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;Ajesh Kapoor&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pp2d_c20230505__20230505__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zHucpzqngjnf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;50,000.00&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20230505__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_z9J0SLMyNfyj" title="Rate"&gt;10.0&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;%&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--DebtInstrumentPeriodicPaymentInterest_pp2d_c20230505__20230505__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zBd3J4sMd0gj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accrued Interest"&gt;4,547.95&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--DebtInstrumentPeriodicPayment_pp2d_c20230505__20230505__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zKRkUjy3cc0d" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Current Balance"&gt;54,547.95&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_eus-gaap--DebtInstrumentIssuanceDate1_c20230508__20230508__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--JaganReddyMember_zLITNj5tRMZa" title="Date"&gt;5/8/2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_902_eus-gaap--DebtInstrumentMaturityDate_c20230508__20230508__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--JaganReddyMember_zydI6JVpUaEg" title="Maturity"&gt;5/7/2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;Jagan Reddy&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pp2d_c20230508__20230508__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--JaganReddyMember_z1dk5xlV6Vwg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;50,000.00&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20230508__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--JaganReddyMember_zz4lr1bk8xv9" title="Rate"&gt;10.0&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;%&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--DebtInstrumentPeriodicPaymentInterest_pp2d_c20230508__20230508__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--JaganReddyMember_zf95chdqpBLk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accrued Interest"&gt;4,506.85&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--DebtInstrumentPeriodicPayment_pp2d_c20230508__20230508__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--JaganReddyMember_zSau5oqdc87g" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Current Balance"&gt;54,506.85&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_eus-gaap--DebtInstrumentIssuanceDate1_c20230517__20230517__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zsEPMwAukQa6" title="Date"&gt;5/17/2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_c20230517__20230517__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zeLWdCc3sYbj" title="Maturity"&gt;5/16/2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;Ajesh Kapoor&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pp2d_c20230517__20230517__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zHrzrv6MhQhj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;165,000.00&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20230517__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zNKVAz1OIPvb" title="Rate"&gt;10.0&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;%&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DebtInstrumentPeriodicPaymentInterest_pp2d_c20230517__20230517__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_z286zhnhOtD3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accrued Interest"&gt;14,465.75&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--DebtInstrumentPeriodicPayment_pp2d_c20230517__20230517__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zxgJ2W2cOTQ6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Current Balance"&gt;179,465.75&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A5_zSrte5fz5LGf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;MCA-Agile
Capital Funding, LLC&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March 22, 2024, the Company entered into a Merchant Cash Advance (&#x201c;MCA Financing&#x201d;) with Agile Capital Funding, LLC. The initial
amount borrowed was $&lt;span id="xdx_90D_eus-gaap--ShortTermBorrowings_iI_c20240322__dei--LegalEntityAxis__custom--AgileCapitalFundingLLCMember_zPJrmtBqeIZd" title="Initial amount, borrowed"&gt;315,000&lt;/span&gt;, with net proceeds to the Company in the amount of $&lt;span id="xdx_90C_eus-gaap--ProceedsFromIssuanceOfDebt_c20240322__20240322__dei--LegalEntityAxis__custom--AgileCapitalFundingLLCMember_ztfDwHiB7NTa" title="Net proceeds"&gt;300,000&lt;/span&gt;. Repayment terms stipulate weekly payments in
the amount of $&lt;span id="xdx_906_eus-gaap--RepaymentsOfDebt_c20240322__20240322__us-gaap--DebtInstrumentAxis__custom--WeeklyPaymentsForWeeksMember__dei--LegalEntityAxis__custom--AgileCapitalFundingLLCMember_zkIqnUbeukB7" title="Repayment, debt"&gt;16,200&lt;/span&gt; for weeks, for a total of $&lt;span id="xdx_90A_eus-gaap--RepaymentsOfDebt_c20240322__20240322__dei--LegalEntityAxis__custom--AgileCapitalFundingLLCMember_zWKYumNYiJ98" title="Repayment, debt"&gt;453,600&lt;/span&gt; repaid. The effective interest rate for the borrowings is &lt;span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_uPure_c20240322__dei--LegalEntityAxis__custom--AgileCapitalFundingLLCMember_z3G1Hwg6XVU2" title="Effective, interest rate"&gt;18&lt;/span&gt;%.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;MCA-Huson
Cedar Advance, LLC&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
May 8, 2024, the Company entered into an MCA Financing with Cedar Advance, LLC. The initial amount borrowed was $&lt;span id="xdx_90D_eus-gaap--ShortTermBorrowings_iI_c20240508__dei--LegalEntityAxis__custom--HusonCedarAdvanceLLCMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zmsFCSFX66nh" title="Initial amount, borrowed"&gt;215,000&lt;/span&gt;, with net proceeds
to the Company in the amount of $&lt;span id="xdx_903_eus-gaap--ProceedsFromIssuanceOfDebt_c20240508__20240508__dei--LegalEntityAxis__custom--AgileCapitalFundingLLCMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zWf6Gw7Kh7sk" title="Net proceeds"&gt;204,250&lt;/span&gt;. Repayment terms stipulate weekly payments in the amount of $&lt;span id="xdx_901_eus-gaap--RepaymentsOfDebt_c20240508__20240508__us-gaap--DebtInstrumentAxis__custom--WeeklyPaymentsMember__dei--LegalEntityAxis__custom--HusonCedarAdvanceLLCMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zvIZ99bgwdBc" title="Repayment, debt"&gt;11,133&lt;/span&gt; for 28 weeks, for a total
of $&lt;span id="xdx_904_eus-gaap--RepaymentsOfDebt_c20240508__20240508__dei--LegalEntityAxis__custom--HusonCedarAdvanceLLCMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zyqCIgiTHWP1" title="Repayment, debt"&gt;311,750&lt;/span&gt; repaid. The effective interest rate for the borrowings is &lt;span id="xdx_903_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_uPure_c20240508__dei--LegalEntityAxis__custom--AgileCapitalFundingLLCMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z12Z4Wp4lZii" title="Effective, interest rate"&gt;18&lt;/span&gt;%.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</RIME:NotePayableAndFinancingArrangementsTextBlock>
    <us-gaap:DebtInstrumentMaturityDateDescription
      contextRef="From2023-05-182023-05-18_custom_SemiCabIncMember"
      id="Fact003477">12-month maturity date</us-gaap:DebtInstrumentMaturityDateDescription>
    <us-gaap:RepaymentsOfDebt
      contextRef="From2023-05-182023-05-18_custom_SemiCabIncMember_custom_EqualInstallmentsForThirteenMonthsMember"
      decimals="2"
      id="Fact003479"
      unitRef="USD">91667.67</us-gaap:RepaymentsOfDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2023-05-18_custom_SemiCabIncMember_custom_EqualInstallmentsForThirteenMonthsMember"
      decimals="INF"
      id="Fact003481"
      unitRef="Pure">0.1797</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:RepaymentsOfDebt
      contextRef="From2024-05-182024-05-18_custom_SettlementAgreementMember_custom_TwelveInstallmentsMember_us-gaap_SubsequentEventMember_custom_SemiCabIncMember"
      decimals="2"
      id="Fact003483"
      unitRef="USD">946666.60</us-gaap:RepaymentsOfDebt>
    <us-gaap:RepaymentsOfDebt
      contextRef="From2024-05-182024-05-18_custom_SettlementAgreementMember_custom_FirstPaymentMember_custom_DueAndPaidOnMayTwentyTwoThousandTwentyFourMember_us-gaap_SubsequentEventMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003485"
      unitRef="USD">25000</us-gaap:RepaymentsOfDebt>
    <us-gaap:RepaymentsOfDebt
      contextRef="From2024-05-182024-05-18_custom_SettlementAgreementMember_custom_SecondPaymentMember_custom_DueOnJuneThreeTwoThousandTwentyFourMember_us-gaap_SubsequentEventMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003487"
      unitRef="USD">75000</us-gaap:RepaymentsOfDebt>
    <us-gaap:RepaymentsOfDebt
      contextRef="From2024-05-182024-05-18_custom_SettlementAgreementMember_custom_TenMonthlyPaymentsMember_custom_DueOnJulyOneTwoThousandTwentyFourMember_us-gaap_SubsequentEventMember_custom_SemiCabIncMember"
      decimals="2"
      id="Fact003489"
      unitRef="USD">84666.66</us-gaap:RepaymentsOfDebt>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember"
      id="Fact003491">&lt;p id="xdx_890_eus-gaap--ScheduleOfDebtTableTextBlock_zjVs3uuodTWd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Beginning
in July of 2021, and ending in May of 2023, the Company entered into a total of six shareholder loan agreements with a total of three
shareholders. These notes are all unsecured with limited rights of recourse. The specific terms of each note are summarized on the table
below.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span id="xdx_8B6_zpz2rEc3RS87" style="display: none"&gt;SCHEDULE OF SPECIFIC TERMS&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif"&gt;Date&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Maturity&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Holder&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Principal&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Rate&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Accrued Interest&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Current Balance&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 12%"&gt;&lt;span id="xdx_909_eus-gaap--DebtInstrumentIssuanceDate1_c20210710__20210710__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zMxeSg9oDMpc" title="Date"&gt;7/10/2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: center"&gt;&lt;span id="xdx_90D_eus-gaap--DebtInstrumentMaturityDate_c20210710__20210710__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zF3FgAPQLLs" title="Maturity"&gt;7/10/2026&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: center"&gt;Ajesh Kapoor&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pp2d_c20210710__20210710__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zZUUQwVGwcHh" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Principal"&gt;150,000.00&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20210710__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zvdo8UoOZZx9" title="Rate"&gt;9.0&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--DebtInstrumentPeriodicPaymentInterest_pp2d_c20210710__20210710__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zbXg08gQ3suc" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Accrued Interest"&gt;36,838.36&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--DebtInstrumentPeriodicPayment_pp2d_c20210710__20210710__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zsCuIFPy3W18" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Current Balance"&gt;186,838.36&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_eus-gaap--DebtInstrumentIssuanceDate1_c20210827__20210827__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_z3zQ7dE44r28" title="Date"&gt;8/27/2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_90B_eus-gaap--DebtInstrumentMaturityDate_c20210827__20210827__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_z82UfKP6YOJ5" title="Maturity"&gt;8/26/2026&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;Ajesh Kapoor&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pp2d_c20210827__20210827__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zc0bFz2i6mR2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;235,000.00&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20210827__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zSkUfAtXdMv4" title="Rate"&gt;9.0&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;%&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--DebtInstrumentPeriodicPaymentInterest_pp2d_c20210827__20210827__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zyMUpXy8YYF9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accrued Interest"&gt;54,932.05&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DebtInstrumentPeriodicPayment_pp2d_c20210827__20210827__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zZio3ImCnja9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Current Balance"&gt;289,932.05&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_eus-gaap--DebtInstrumentIssuanceDate1_c20230417__20230417__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--VivekSehgalMember_zuBVgiyGuJ15" title="Date"&gt;4/17/2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_c20230417__20230417__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--VivekSehgalMember_zL93Kx1OE147" title="Maturity"&gt;10/16/2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;Vivek Sehgal&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pp2d_c20230417__20230417__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--VivekSehgalMember_zDVy2qwrrGsl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;50,000.00&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20230417__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--VivekSehgalMember_zTOgp5Ja2CT5" title="Rate"&gt;10.0&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;%&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--DebtInstrumentPeriodicPaymentInterest_pp2d_c20230417__20230417__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--VivekSehgalMember_zJpj5JUzaJu9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accrued Interest"&gt;4,794.52&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DebtInstrumentPeriodicPayment_pp2d_c20230417__20230417__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--VivekSehgalMember_zh9u9wekat1l" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Current Balance"&gt;54,794.52&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_eus-gaap--DebtInstrumentIssuanceDate1_c20230505__20230505__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zMh3trEJXS61" title="Date"&gt;5/5/2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_907_eus-gaap--DebtInstrumentMaturityDate_c20230505__20230505__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_z7GsuQ7ZTXE6" title="Maturity"&gt;5/4/2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;Ajesh Kapoor&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pp2d_c20230505__20230505__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zHucpzqngjnf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;50,000.00&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20230505__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_z9J0SLMyNfyj" title="Rate"&gt;10.0&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;%&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--DebtInstrumentPeriodicPaymentInterest_pp2d_c20230505__20230505__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zBd3J4sMd0gj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accrued Interest"&gt;4,547.95&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--DebtInstrumentPeriodicPayment_pp2d_c20230505__20230505__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zKRkUjy3cc0d" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Current Balance"&gt;54,547.95&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_eus-gaap--DebtInstrumentIssuanceDate1_c20230508__20230508__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--JaganReddyMember_zLITNj5tRMZa" title="Date"&gt;5/8/2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_902_eus-gaap--DebtInstrumentMaturityDate_c20230508__20230508__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--JaganReddyMember_zydI6JVpUaEg" title="Maturity"&gt;5/7/2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;Jagan Reddy&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pp2d_c20230508__20230508__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--JaganReddyMember_z1dk5xlV6Vwg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;50,000.00&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20230508__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--JaganReddyMember_zz4lr1bk8xv9" title="Rate"&gt;10.0&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;%&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--DebtInstrumentPeriodicPaymentInterest_pp2d_c20230508__20230508__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--JaganReddyMember_zf95chdqpBLk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accrued Interest"&gt;4,506.85&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--DebtInstrumentPeriodicPayment_pp2d_c20230508__20230508__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--JaganReddyMember_zSau5oqdc87g" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Current Balance"&gt;54,506.85&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_eus-gaap--DebtInstrumentIssuanceDate1_c20230517__20230517__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zsEPMwAukQa6" title="Date"&gt;5/17/2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_c20230517__20230517__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zeLWdCc3sYbj" title="Maturity"&gt;5/16/2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;Ajesh Kapoor&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pp2d_c20230517__20230517__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zHrzrv6MhQhj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;165,000.00&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20230517__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zNKVAz1OIPvb" title="Rate"&gt;10.0&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;%&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DebtInstrumentPeriodicPaymentInterest_pp2d_c20230517__20230517__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_z286zhnhOtD3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accrued Interest"&gt;14,465.75&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--DebtInstrumentPeriodicPayment_pp2d_c20230517__20230517__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zxgJ2W2cOTQ6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Current Balance"&gt;179,465.75&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:DebtInstrumentIssuanceDate1
      contextRef="From2021-07-102021-07-10_custom_SixShareholderLoanAgreementsMember_custom_AjeshKapoorMember_custom_SemiCabIncMember"
      id="Fact003493">2021-07-10</us-gaap:DebtInstrumentIssuanceDate1>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="From2021-07-102021-07-10_custom_SixShareholderLoanAgreementsMember_custom_AjeshKapoorMember_custom_SemiCabIncMember"
      id="Fact003495">2026-07-10</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal
      contextRef="From2021-07-102021-07-10_custom_SixShareholderLoanAgreementsMember_custom_AjeshKapoorMember_custom_SemiCabIncMember"
      decimals="2"
      id="Fact003497"
      unitRef="USD">150000.00</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2021-07-10_custom_SixShareholderLoanAgreementsMember_custom_AjeshKapoorMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003499"
      unitRef="Pure">0.090</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentPeriodicPaymentInterest
      contextRef="From2021-07-102021-07-10_custom_SixShareholderLoanAgreementsMember_custom_AjeshKapoorMember_custom_SemiCabIncMember"
      decimals="2"
      id="Fact003501"
      unitRef="USD">36838.36</us-gaap:DebtInstrumentPeriodicPaymentInterest>
    <us-gaap:DebtInstrumentPeriodicPayment
      contextRef="From2021-07-102021-07-10_custom_SixShareholderLoanAgreementsMember_custom_AjeshKapoorMember_custom_SemiCabIncMember"
      decimals="2"
      id="Fact003503"
      unitRef="USD">186838.36</us-gaap:DebtInstrumentPeriodicPayment>
    <us-gaap:DebtInstrumentIssuanceDate1
      contextRef="From2021-08-272021-08-27_custom_SixShareholderLoanAgreementsMember_custom_AjeshKapoorMember_custom_SemiCabIncMember"
      id="Fact003505">2021-08-27</us-gaap:DebtInstrumentIssuanceDate1>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="From2021-08-272021-08-27_custom_SixShareholderLoanAgreementsMember_custom_AjeshKapoorMember_custom_SemiCabIncMember"
      id="Fact003507">2026-08-26</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal
      contextRef="From2021-08-272021-08-27_custom_SixShareholderLoanAgreementsMember_custom_AjeshKapoorMember_custom_SemiCabIncMember"
      decimals="2"
      id="Fact003509"
      unitRef="USD">235000.00</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2021-08-27_custom_SixShareholderLoanAgreementsMember_custom_AjeshKapoorMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003511"
      unitRef="Pure">0.090</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentPeriodicPaymentInterest
      contextRef="From2021-08-272021-08-27_custom_SixShareholderLoanAgreementsMember_custom_AjeshKapoorMember_custom_SemiCabIncMember"
      decimals="2"
      id="Fact003513"
      unitRef="USD">54932.05</us-gaap:DebtInstrumentPeriodicPaymentInterest>
    <us-gaap:DebtInstrumentPeriodicPayment
      contextRef="From2021-08-272021-08-27_custom_SixShareholderLoanAgreementsMember_custom_AjeshKapoorMember_custom_SemiCabIncMember"
      decimals="2"
      id="Fact003515"
      unitRef="USD">289932.05</us-gaap:DebtInstrumentPeriodicPayment>
    <us-gaap:DebtInstrumentIssuanceDate1
      contextRef="From2023-04-172023-04-17_custom_SixShareholderLoanAgreementsMember_custom_VivekSehgalMember_custom_SemiCabIncMember"
      id="Fact003517">2023-04-17</us-gaap:DebtInstrumentIssuanceDate1>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="From2023-04-172023-04-17_custom_SixShareholderLoanAgreementsMember_custom_VivekSehgalMember_custom_SemiCabIncMember"
      id="Fact003519">2023-10-16</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal
      contextRef="From2023-04-172023-04-17_custom_SixShareholderLoanAgreementsMember_custom_VivekSehgalMember_custom_SemiCabIncMember"
      decimals="2"
      id="Fact003521"
      unitRef="USD">50000.00</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2023-04-17_custom_SixShareholderLoanAgreementsMember_custom_VivekSehgalMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003523"
      unitRef="Pure">0.100</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentPeriodicPaymentInterest
      contextRef="From2023-04-172023-04-17_custom_SixShareholderLoanAgreementsMember_custom_VivekSehgalMember_custom_SemiCabIncMember"
      decimals="2"
      id="Fact003525"
      unitRef="USD">4794.52</us-gaap:DebtInstrumentPeriodicPaymentInterest>
    <us-gaap:DebtInstrumentPeriodicPayment
      contextRef="From2023-04-172023-04-17_custom_SixShareholderLoanAgreementsMember_custom_VivekSehgalMember_custom_SemiCabIncMember"
      decimals="2"
      id="Fact003527"
      unitRef="USD">54794.52</us-gaap:DebtInstrumentPeriodicPayment>
    <us-gaap:DebtInstrumentIssuanceDate1
      contextRef="From2023-05-052023-05-05_custom_SixShareholderLoanAgreementsMember_custom_AjeshKapoorMember_custom_SemiCabIncMember"
      id="Fact003529">2023-05-05</us-gaap:DebtInstrumentIssuanceDate1>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="From2023-05-052023-05-05_custom_SixShareholderLoanAgreementsMember_custom_AjeshKapoorMember_custom_SemiCabIncMember"
      id="Fact003531">2024-05-04</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal
      contextRef="From2023-05-052023-05-05_custom_SixShareholderLoanAgreementsMember_custom_AjeshKapoorMember_custom_SemiCabIncMember"
      decimals="2"
      id="Fact003533"
      unitRef="USD">50000.00</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2023-05-05_custom_SixShareholderLoanAgreementsMember_custom_AjeshKapoorMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003535"
      unitRef="Pure">0.100</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentPeriodicPaymentInterest
      contextRef="From2023-05-052023-05-05_custom_SixShareholderLoanAgreementsMember_custom_AjeshKapoorMember_custom_SemiCabIncMember"
      decimals="2"
      id="Fact003537"
      unitRef="USD">4547.95</us-gaap:DebtInstrumentPeriodicPaymentInterest>
    <us-gaap:DebtInstrumentPeriodicPayment
      contextRef="From2023-05-052023-05-05_custom_SixShareholderLoanAgreementsMember_custom_AjeshKapoorMember_custom_SemiCabIncMember"
      decimals="2"
      id="Fact003539"
      unitRef="USD">54547.95</us-gaap:DebtInstrumentPeriodicPayment>
    <us-gaap:DebtInstrumentIssuanceDate1
      contextRef="From2023-05-082023-05-08_custom_SixShareholderLoanAgreementsMember_custom_JaganReddyMember_custom_SemiCabIncMember"
      id="Fact003541">2023-05-08</us-gaap:DebtInstrumentIssuanceDate1>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="From2023-05-082023-05-08_custom_SixShareholderLoanAgreementsMember_custom_JaganReddyMember_custom_SemiCabIncMember"
      id="Fact003543">2024-05-07</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal
      contextRef="From2023-05-082023-05-08_custom_SixShareholderLoanAgreementsMember_custom_JaganReddyMember_custom_SemiCabIncMember"
      decimals="2"
      id="Fact003545"
      unitRef="USD">50000.00</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2023-05-08_custom_SixShareholderLoanAgreementsMember_custom_JaganReddyMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003547"
      unitRef="Pure">0.100</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentPeriodicPaymentInterest
      contextRef="From2023-05-082023-05-08_custom_SixShareholderLoanAgreementsMember_custom_JaganReddyMember_custom_SemiCabIncMember"
      decimals="2"
      id="Fact003549"
      unitRef="USD">4506.85</us-gaap:DebtInstrumentPeriodicPaymentInterest>
    <us-gaap:DebtInstrumentPeriodicPayment
      contextRef="From2023-05-082023-05-08_custom_SixShareholderLoanAgreementsMember_custom_JaganReddyMember_custom_SemiCabIncMember"
      decimals="2"
      id="Fact003551"
      unitRef="USD">54506.85</us-gaap:DebtInstrumentPeriodicPayment>
    <us-gaap:DebtInstrumentIssuanceDate1
      contextRef="From2023-05-172023-05-17_custom_SixShareholderLoanAgreementsMember_custom_AjeshKapoorMember_custom_SemiCabIncMember"
      id="Fact003553">2023-05-17</us-gaap:DebtInstrumentIssuanceDate1>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="From2023-05-172023-05-17_custom_SixShareholderLoanAgreementsMember_custom_AjeshKapoorMember_custom_SemiCabIncMember"
      id="Fact003555">2024-05-16</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal
      contextRef="From2023-05-172023-05-17_custom_SixShareholderLoanAgreementsMember_custom_AjeshKapoorMember_custom_SemiCabIncMember"
      decimals="2"
      id="Fact003557"
      unitRef="USD">165000.00</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2023-05-17_custom_SixShareholderLoanAgreementsMember_custom_AjeshKapoorMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003559"
      unitRef="Pure">0.100</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentPeriodicPaymentInterest
      contextRef="From2023-05-172023-05-17_custom_SixShareholderLoanAgreementsMember_custom_AjeshKapoorMember_custom_SemiCabIncMember"
      decimals="2"
      id="Fact003561"
      unitRef="USD">14465.75</us-gaap:DebtInstrumentPeriodicPaymentInterest>
    <us-gaap:DebtInstrumentPeriodicPayment
      contextRef="From2023-05-172023-05-17_custom_SixShareholderLoanAgreementsMember_custom_AjeshKapoorMember_custom_SemiCabIncMember"
      decimals="2"
      id="Fact003563"
      unitRef="USD">179465.75</us-gaap:DebtInstrumentPeriodicPayment>
    <us-gaap:ShortTermBorrowings
      contextRef="AsOf2024-03-22_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003565"
      unitRef="USD">315000</us-gaap:ShortTermBorrowings>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="From2024-03-222024-03-22_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003567"
      unitRef="USD">300000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:RepaymentsOfDebt
      contextRef="From2024-03-222024-03-22_custom_WeeklyPaymentsForWeeksMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003569"
      unitRef="USD">16200</us-gaap:RepaymentsOfDebt>
    <us-gaap:RepaymentsOfDebt
      contextRef="From2024-03-222024-03-22_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003571"
      unitRef="USD">453600</us-gaap:RepaymentsOfDebt>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="AsOf2024-03-22_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003573"
      unitRef="Pure">0.18</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:ShortTermBorrowings
      contextRef="AsOf2024-05-08_custom_SemiCabIncMember_us-gaap_SubsequentEventMember"
      decimals="0"
      id="Fact003575"
      unitRef="USD">215000</us-gaap:ShortTermBorrowings>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="From2024-05-082024-05-08_custom_SemiCabIncMember_us-gaap_SubsequentEventMember"
      decimals="0"
      id="Fact003577"
      unitRef="USD">204250</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:RepaymentsOfDebt
      contextRef="From2024-05-082024-05-08_custom_WeeklyPaymentsMember_custom_SemiCabIncMember_us-gaap_SubsequentEventMember"
      decimals="0"
      id="Fact003579"
      unitRef="USD">11133</us-gaap:RepaymentsOfDebt>
    <us-gaap:RepaymentsOfDebt
      contextRef="From2024-05-082024-05-08_custom_SemiCabIncMember_us-gaap_SubsequentEventMember"
      decimals="0"
      id="Fact003581"
      unitRef="USD">311750</us-gaap:RepaymentsOfDebt>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="AsOf2024-05-08_custom_SemiCabIncMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact003583"
      unitRef="Pure">0.18</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember"
      id="Fact003585">&lt;p id="xdx_802_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_z1Sc4s1zMWhj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
8 - &lt;span id="xdx_825_zuTW9foaJel9"&gt;COMMITMENTS AND CONTINGENCIES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March 28, 2020 the Company entered into a service contract and agreement with Blue Yonder, Inc. (&#x201c;Blue Yonder&#x201d;) for certain
IT subscription based services. The original term of the agreement was for three years, at a price of $&lt;span id="xdx_900_eus-gaap--LossContingencyDamagesSoughtValue_c20200328__20200328__us-gaap--TypeOfArrangementAxis__custom--ServiceContractAndAgreementMember__dei--LegalEntityAxis__custom--BlueYonderIncMember__us-gaap--AwardTypeAxis__custom--PerYearMember_zxTJyLDdZEl2" title="Sought, value"&gt;100,000&lt;/span&gt; per year, for a total
of $&lt;span id="xdx_90B_eus-gaap--LossContingencyDamagesSoughtValue_c20200328__20200328__us-gaap--TypeOfArrangementAxis__custom--ServiceContractAndAgreementMember__dei--LegalEntityAxis__custom--BlueYonderIncMember_zfh0uA2XoVL7" title="Sought value, total"&gt;300,000&lt;/span&gt;. On June 21, 2023, Blue Yonder filed a lawsuit claiming damages in the amount of $&lt;span id="xdx_902_eus-gaap--LossContingencyDamagesSoughtValue_c20230621__20230621__us-gaap--TypeOfArrangementAxis__custom--ServiceContractAndAgreementMember__dei--LegalEntityAxis__custom--BlueYonderIncMember_z0wLk7FoqZv9" title="Damages claimed"&gt;275,000&lt;/span&gt; with the Maricopa County Superior
Court in Arizona (&#x201c;Lawsuit&#x201d;). The suit was found in favor of Blue Yonder in the amount of $&lt;span id="xdx_905_ecustom--PaymentsForMilestone_c20200328__20200328__us-gaap--TypeOfArrangementAxis__custom--ServiceContractAndAgreementMember__dei--LegalEntityAxis__custom--BlueYonderIncMember__us-gaap--AwardDateAxis__custom--DueOnJulyOneTwoThousandTwentyFourMember__us-gaap--AwardTypeAxis__custom--TwoSeparateMilestonePaymentMember_zUZFK17p3Kye" title="Payments for milestone"&gt;509,119&lt;/span&gt;, subject to two separate
milestone payments that would otherwise deem the entire balance due satisfied if either milestone payment is made by the Company. The
first milestone payment if for $&lt;span id="xdx_906_ecustom--PaymentsForMilestone_c20200328__20200328__us-gaap--TypeOfArrangementAxis__custom--ServiceContractAndAgreementMember__dei--LegalEntityAxis__custom--BlueYonderIncMember__us-gaap--AwardDateAxis__custom--DueOnJulyOneTwoThousandTwentyFourMember__us-gaap--AwardTypeAxis__custom--FirstMilestonePaymentMember_z8YTp3WxJoU5" title="Remaining settlement"&gt;175,000&lt;/span&gt; and is due on July 1, 2024. In the event this payment is made, the remaining settlement shall
be deemed satisfied. If this payment is not made, the Company shall owe a total of $&lt;span id="xdx_90C_ecustom--PaymentsForMilestone_c20200328__20200328__us-gaap--TypeOfArrangementAxis__custom--ServiceContractAndAgreementMember__dei--LegalEntityAxis__custom--BlueYonderIncMember__us-gaap--AwardDateAxis__custom--OctoberOneTwoThousandTwentyFourMember__us-gaap--AwardTypeAxis__custom--SecondMilestonePaymentMember_zXzVpZbuL0Oi" title="Payments for milestone"&gt;225,000&lt;/span&gt; by October 1, 2024. In the event this payment
is made, the remaining settlement shall be deemed satisfied. If neither payment s made, Blue Yonder shall be entitled to execute the
full $&lt;span id="xdx_909_eus-gaap--PaymentsForLegalSettlements_c20200328__20200328__us-gaap--TypeOfArrangementAxis__custom--ServiceContractAndAgreementMember__dei--LegalEntityAxis__custom--BlueYonderIncMember__us-gaap--AwardDateAxis__custom--JanuaryOneTwoThousandTwentyFiveMember_zFzUDECfAmrb" title="Remaining settlement"&gt;509,119&lt;/span&gt; beginning January 1, 2025. As of March 31, 2024, the Company has accrued $&lt;span id="xdx_907_eus-gaap--OtherLiabilitiesCurrent_iI_c20240331__us-gaap--TypeOfArrangementAxis__custom--ServiceContractAndAgreementMember_zuR5Nm4zg1Dk" title="Other current liability"&gt;225,000&lt;/span&gt; on its balance sheet as an other current
liability to account for the expected payment of this amount required to settle this dispute on or before October 1, 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On May 28, 2024, SemiCab was sued by a Baxter Bailey, collection agency acting on behalf of a domestic freight shipper. The shipper claims
is was underpaid for services rendered, and SemiCab has disputed the claim. The total amount in dispute is approximately $&lt;span id="xdx_90E_ecustom--DisputeAmount_c20240528__20240528_zYFvGN8bXUmj" title="Dispute. amount"&gt;93,000&lt;/span&gt;. SemiCab
intends to dispute the claim. As such, this litigation has been excluded from liabilities assumed as part of this transaction. $&lt;span id="xdx_900_ecustom--AccruedPotentialLiability_c20240331__20240331_zC34jPhewe5j" title="Accrued, potential liability"&gt;100,000&lt;/span&gt;
has been accrued on the March 31, 2024 balance sheet to account for this potential liability.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LossContingencyDamagesSoughtValue
      contextRef="From2020-03-282020-03-28_custom_ServiceContractAndAgreementMember_custom_SemiCabIncMember_custom_PerYearMember"
      decimals="0"
      id="Fact003587"
      unitRef="USD">100000</us-gaap:LossContingencyDamagesSoughtValue>
    <us-gaap:LossContingencyDamagesSoughtValue
      contextRef="From2020-03-282020-03-28_custom_ServiceContractAndAgreementMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003589"
      unitRef="USD">300000</us-gaap:LossContingencyDamagesSoughtValue>
    <us-gaap:LossContingencyDamagesSoughtValue
      contextRef="From2023-06-212023-06-21_custom_ServiceContractAndAgreementMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003591"
      unitRef="USD">275000</us-gaap:LossContingencyDamagesSoughtValue>
    <RIME:PaymentsForMilestone
      contextRef="From2020-03-282020-03-28_custom_ServiceContractAndAgreementMember_custom_SemiCabIncMember_custom_DueOnJulyOneTwoThousandTwentyFourMember_custom_TwoSeparateMilestonePaymentMember"
      decimals="0"
      id="Fact003593"
      unitRef="USD">509119</RIME:PaymentsForMilestone>
    <RIME:PaymentsForMilestone
      contextRef="From2020-03-282020-03-28_custom_ServiceContractAndAgreementMember_custom_SemiCabIncMember_custom_DueOnJulyOneTwoThousandTwentyFourMember_custom_FirstMilestonePaymentMember"
      decimals="0"
      id="Fact003595"
      unitRef="USD">175000</RIME:PaymentsForMilestone>
    <RIME:PaymentsForMilestone
      contextRef="From2020-03-282020-03-28_custom_ServiceContractAndAgreementMember_custom_SemiCabIncMember_custom_OctoberOneTwoThousandTwentyFourMember_custom_SecondMilestonePaymentMember"
      decimals="0"
      id="Fact003597"
      unitRef="USD">225000</RIME:PaymentsForMilestone>
    <us-gaap:PaymentsForLegalSettlements
      contextRef="From2020-03-282020-03-28_custom_ServiceContractAndAgreementMember_custom_SemiCabIncMember_custom_JanuaryOneTwoThousandTwentyFiveMember"
      decimals="0"
      id="Fact003599"
      unitRef="USD">509119</us-gaap:PaymentsForLegalSettlements>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="AsOf2024-03-31_custom_ServiceContractAndAgreementMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003601"
      unitRef="USD">225000</us-gaap:OtherLiabilitiesCurrent>
    <RIME:DisputeAmount
      contextRef="From2024-05-282024-05-28_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003603"
      unitRef="USD">93000</RIME:DisputeAmount>
    <RIME:AccruedPotentialLiability
      contextRef="From2024-03-312024-03-31_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003605"
      unitRef="USD">100000</RIME:AccruedPotentialLiability>
    <RIME:AccountsReceivableDisclosureTextBlock
      contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember"
      id="Fact003607">&lt;p id="xdx_807_ecustom--AccountsReceivableDisclosureTextBlock_z2TQ6gZjtLQa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
9 - &lt;span id="xdx_822_z9VUFgefS8i7"&gt;DUE FROM FACTOR&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;We
entered into an accounts receivable factoring arrangement with a financial institution (the &#x201c;Factor&#x201d;) which has been extended
to October 31, 2024 and may be discontinued at that time. Pursuant to the terms of the arrangement, from time to time, we sell to the
Factor a minimum of $&lt;span id="xdx_902_eus-gaap--AccountsReceivableNet_iI_c20240331__srt--RangeAxis__srt--MinimumMember_zMEZ7d7jYdLc" title="Accounts receivable"&gt;150,000&lt;/span&gt; per quarter of certain of our accounts receivable balances on a non-recourse basis for credit approved accounts.
The &lt;span id="xdx_902_ecustom--ForeignAndDomesticRateOfAccountsReceivable_c20240101__20240331_zcUMJeQOsJbb" title="Accounts receivable rate, description"&gt;Factor remits 35% of the foreign and 75% of the domestic accounts receivable balance&lt;/span&gt; to us (the &#x201c;Advance Amount&#x201d;), with
the remaining balance, less fees, forwarded to us once the Factor collects the full accounts receivable balance from the customer. In
addition, from time to time, we receive over advances from the Factor. Factoring fees range from &lt;span id="xdx_906_ecustom--AdvanceFeeRate_pid_dp_uPure_c20240101__20240331__srt--RangeAxis__srt--MinimumMember_zM84KYSyuAt7" title="Advance fee, rate"&gt;2.75&lt;/span&gt;% to &lt;span id="xdx_906_ecustom--AdvanceFeeRate_pid_dp_uPure_c20240101__20240331__srt--RangeAxis__srt--MaximumMember_zh6r6lG6zNmh" title="Advance fee, rate"&gt;15&lt;/span&gt;% of the face value of the
invoice factored and are determined by the number of days required for collection of the invoice. We expect to continue to use this factoring
arrangement periodically to assist with our general working capital requirements due to contractual requirements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;LEGAL
MATTERS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On May 28, 2024, SemiCab was sued by a Baxter Bailey, collection agency acting on behalf of a domestic freight shipper. The shipper claims
is was underpaid for services rendered, and SemiCab has disputed the claim. The total amount in dispute is approximately $&lt;span id="xdx_90C_eus-gaap--LegalFees_c20240528__20240528_zq4v3oh80Beg" title="Dispute, amount"&gt;93,000&lt;/span&gt;. SemiCab
intends to dispute the claim. As such, this litigation has been excluded from liabilities assumed as part of this transaction.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;LEASES&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Operating
Leases&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Not
applicable. The Company currently utilizes a work-from-home model for its US operations, and a month-to-month shared office space in
Bangalore that expires in June. At that time 100% of the current employees will adopt a work-from-home model.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Finance
Leases&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Not
applicable. The Company does not have any material financial leases at this time, or any of the periods presented in this Report.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</RIME:AccountsReceivableDisclosureTextBlock>
    <us-gaap:AccountsReceivableNet
      contextRef="AsOf2024-03-31_srt_MinimumMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003609"
      unitRef="USD">150000</us-gaap:AccountsReceivableNet>
    <RIME:ForeignAndDomesticRateOfAccountsReceivable
      contextRef="From2024-01-012024-03-31_custom_SemiCabIncMember"
      id="Fact003611">Factor remits 35% of the foreign and 75% of the domestic accounts receivable balance</RIME:ForeignAndDomesticRateOfAccountsReceivable>
    <RIME:AdvanceFeeRate
      contextRef="From2024-01-012024-03-31_srt_MinimumMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003613"
      unitRef="Pure">0.0275</RIME:AdvanceFeeRate>
    <RIME:AdvanceFeeRate
      contextRef="From2024-01-012024-03-31_srt_MaximumMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003615"
      unitRef="Pure">0.15</RIME:AdvanceFeeRate>
    <us-gaap:LegalFees
      contextRef="From2024-05-282024-05-28_custom_SemiCabIncMember"
      decimals="0"
      id="Fact003617"
      unitRef="USD">93000</us-gaap:LegalFees>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember"
      id="Fact003619">&lt;p id="xdx_809_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zPE0SCL9ZdW" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
10 &#x2013; &lt;span id="xdx_82B_zxYWXgk2KtZj"&gt;STOCKHOLDERS&#x2019; EQUITY&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;EQUITY
INCCENTIVE PLAN&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has maintained an equity incentive plan since 2020. Under this plan, all employees have been eligible to received common stock
options as a part of their performance-based incentive compensation plan.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;COMMON
STOCK OPTIONS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89D_ecustom--ScheduleOfStockOptionIssuedTableTextBlock_zS4MKNLnlLo3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the years ended Dember 31, 2020, 2021 and 2022 the Company issued the following stock options, as shown below. No options were issued
in 2023 or 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span id="xdx_8B5_zQna3u5WPUSa" style="display: none"&gt;SCHEDULE OF STOCK OPTION ISSUED
DURING THE YEAR DECEMBER 31, 2020, 2021 AND 2022&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif"&gt;Holder&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;Granted Shares&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;Outstanding Awards&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;Grant Date&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;Exercise Price&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;Vesting Start Date&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;Vested Outstanding&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;Unvested&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;Date Fully Vested&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;Board Approval Date&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;Expiration Date&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: left"&gt;Sudhir Narasimhamurthy&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zkaVwWdoGg3" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Granted Shares"&gt;180,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zcr2MKz1AwFg" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Outstanding Awards"&gt;180,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z1PCe2WkmQMa" title="Granted Date"&gt;09-29-2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20201231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zEwHsyzEa6K4" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Exercise price"&gt;0.06&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"&gt;&lt;span id="xdx_904_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z5ZXzIUpv5v2" title="Vesting Date"&gt;09-29-2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z1y1z4fUkMd9" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Vested Outstanding"&gt;180,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20201231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zjAJBNToTHb9" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Unvested"&gt;0&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zc9gMLKiRMSi" title="Date Fully Vested"&gt;09-29-2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"&gt;&lt;span id="xdx_908_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z6c6IllFXpx7" title="Board Approval Date"&gt;09-28-2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zdfXa5VRylw9" title="Expiration Date"&gt;09-28-2030&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Sudhir Narasimhamurthy&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z3uCfygXvbR4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;50,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zQtKppP6tag2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;50,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_znDPUpqUbYw1" title="Granted Date"&gt;08-12-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20211231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zjCZBQdsmS37" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"&gt;0.06&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z5Wb3cLxzFP2" title="Vesting Date"&gt;09-01-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zvRymfYhav79" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding"&gt;33,333&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20211231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z430AXwdWbqa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"&gt;16,667&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_905_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_ztFM8AbGO4z" title="Date Fully Vested"&gt;09-01-2025&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z8DY2FENLkba" title="Board Approval Date"&gt;08-12-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zaVtrIbr1jSa" title="Expiration Date"&gt;08-11-2031&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Sudhir Narasimhamurthy&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zdQxKgnCNhYl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;25,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zpCDH1mvMsFb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;25,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zOpcXghoINqd" title="Granted Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zkXP0xggFfQ4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"&gt;0.05&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zSKiAJqKuqb1" title="Vesting Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zNyEIkIRBfme" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding"&gt;12,500&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zbeugqboZ186" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"&gt;12,500&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_909_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zCJz3cB56Coc" title="Date Fully Vested"&gt;05-02-2026&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_900_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zr8EiANorbQf" title="Board Approval Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z6JDYzFtRMFg" title="Expiration Date"&gt;05-01-2032&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Kadandale Srinivas Sudheer&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zQXre4LkNdsg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;600,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zZEPsi2Skxqd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;600,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20200101__20201231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zEog8Y6iMuMb" title="Granted Date"&gt;09-29-2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20201231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z8wAPlyTERF9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"&gt;0.06&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zZ1kQQCQyof3" title="Vesting Date"&gt;09-29-2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z19ywhQYgQYa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding"&gt;600,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20201231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zTe1UbNcWdQk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"&gt;0&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zbxETfbMaBLd" title="Date Fully Vested"&gt;09-29-2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_900_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z7eACM5ED3Ci" title="Board Approval Date"&gt;09-28-2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z0JG5iPR3Z17" title="Expiration Date"&gt;09-28-2030&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Kadandale Srinivas Sudheer&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20211231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_za98zzoEujK9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;100,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zE3JVBLazA0a" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;100,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20210101__20211231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z6eOXUUTjNrk" title="Granted Date"&gt;08-12-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20211231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zg6Nmo40glYd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"&gt;0.06&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_907_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zFeRQu9z9nq" title="Vesting Date"&gt;09-01-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z8tDJidvYA8g" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding"&gt;66,666&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20211231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zODHT2K3W2L3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"&gt;33,334&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_900_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zJAqgSZbew21" title="Date Fully Vested"&gt;09-01-2025&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_909_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zMLmVAewjCL5" title="Board Approval Date"&gt;08-12-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zU0PUmZ171j1" title="Expiration Date"&gt;08-11-2031&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Kadandale Srinivas Sudheer&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zytGZ9hbU7ja" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;50,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zF4FHf7SRPXe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;50,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z8UbrhZ7O8t1" title="Granted Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zSYMGd9uqPca" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"&gt;0.05&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zbDudXMOICq9" title="Vesting Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zhW8YXZAWDZd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding"&gt;25,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zZRwBgBVHrud" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"&gt;25,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_909_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z88nzqafXHq3" title="Date Fully Vested"&gt;05-02-2026&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_903_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zlGP0zcOyh0i" title="Board Approval Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zCz9iQ9aDTn8" title="Expiration Date"&gt;05-01-2032&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Vivek Sehgal&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zRpjmlZTOGX3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;4,000,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zcQvVn88Xlzd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;4,000,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20200101__20201231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zYn1HvGb2uE3" title="Granted Date"&gt;09-29-2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20201231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zwj20RpZTZ3l" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"&gt;0.06&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zcOJJxYF28v4" title="Vesting Date"&gt;09-29-2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zXMwES9jBJyk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding"&gt;4,000,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20201231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zR4OKdEJGYAe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"&gt;0&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_903_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zmG35jgQubc4" title="Date Fully Vested"&gt;09-29-2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_905_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z157ujDnNYy8" title="Board Approval Date"&gt;09-28-2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zGq4oFwd78C8" title="Expiration Date"&gt;09-28-2030&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Vivek Sehgal&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20211231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zhGKq280Xs45" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;200,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zO4iwkQvJbya" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;200,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20210101__20211231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zR91Gan7PQ68" title="Granted Date"&gt;08-12-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20211231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zv711yflLHw9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"&gt;0.06&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zv58Z1jTHlu2" title="Vesting Date"&gt;09-01-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zYD54Fb54DUi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding"&gt;133,333&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20211231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zvLyxMREXQyd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"&gt;66,667&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zDqisXKWh0Ik" title="Date Fully Vested"&gt;09-01-2025&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_907_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z6BxPFgVriA2" title="Board Approval Date"&gt;08-12-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zVnMcREQ1i55" title="Expiration Date"&gt;08-11-2031&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Vivek Sehgal&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zDDZm2IDXNL3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;100,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zRghaqfb8pch" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;100,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zEAqpKDIUl87" title="Granted Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zqs3KXmqO1ua" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"&gt;0.05&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_901_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zZxxyoqlsdBi" title="Vesting Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zBKaGub0LWD9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding"&gt;50,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zfyYDo512rMa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"&gt;50,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_906_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zGWF9B3Fc3tc" title="Date Fully Vested"&gt;05-02-2026&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zNCmcVOAIY4j" title="Board Approval Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zMd2fAXZF2Q1" title="Expiration Date"&gt;05-01-2032&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Rajiv Saxena&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__srt--TitleOfIndividualAxis__custom--RajivSaxenaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_znQO4mVSpOjk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;100,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--RajivSaxenaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zhBE7ZJA66Uh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;100,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20200101__20201231__srt--TitleOfIndividualAxis__custom--RajivSaxenaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zfqtIuMocDq4" title="Granted Date"&gt;09-29-2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20201231__srt--TitleOfIndividualAxis__custom--RajivSaxenaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z0V8spZqH7ca" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"&gt;0.06&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_904_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--RajivSaxenaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zOTob9Ez0zb3" title="Vesting Date"&gt;09-29-2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--RajivSaxenaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zAVzgpY3COkg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding"&gt;100,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20201231__srt--TitleOfIndividualAxis__custom--RajivSaxenaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zhi2QrpZRBBd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"&gt;0&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_905_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--RajivSaxenaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_ztcI3kL5i449" title="Date Fully Vested"&gt;09-29-2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--RajivSaxenaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zoEfGqJJHtcg" title="Board Approval Date"&gt;09-28-2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--RajivSaxenaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zXH5b5Qf8pAh" title="Expiration Date"&gt;09-28-2030&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Harsha Bhat&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z08HbgZ0X45g" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;180,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zbwUA0GCQ80h" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;180,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20200101__20201231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zXXdHjVSoRFj" title="Granted Date"&gt;09-29-2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20201231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zSUxLUAAlsU4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"&gt;0.06&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_902_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zoVMaEcY1RVj" title="Vesting Date"&gt;09-29-2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zrzYnC0SL8qb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding"&gt;180,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20201231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zzsVwuUkeghi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"&gt;0&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_909_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z8sd1sUXMfJ2" title="Date Fully Vested"&gt;09-29-2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zmgIWsiO9eX5" title="Board Approval Date"&gt;09-28-2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z2dyEezFF0Fa" title="Expiration Date"&gt;09-28-2030&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Harsha Bhat&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20211231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zDsyymcL05z2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;50,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z6wgdxcyHxT1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;50,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20210101__20211231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z9QO3uaAaEOh" title="Granted Date"&gt;08-12-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20211231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zaUkaL5fUYPe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"&gt;0.06&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_ze5s6G3w3q4f" title="Vesting Date"&gt;09-01-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zfoMrlWA3YA7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding"&gt;33,333&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20211231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zUgMjGfU0RTi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"&gt;16,667&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_905_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_za3qr7dQi3Wa" title="Date Fully Vested"&gt;09-01-2025&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zsnSa1PIg8Te" title="Board Approval Date"&gt;08-12-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zskswrzDKQ09" title="Expiration Date"&gt;08-11-2031&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Harsha Bhat&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zNmCBODP5IDj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;25,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zMpSnEP1ymzd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;25,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zOzdi7J0AsDh" title="Granted Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zBKdxDK5waRe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"&gt;0.05&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zOv44xxlwtEl" title="Vesting Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z90kaRIoIGpc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding"&gt;12,500&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zztgEunYXoFa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"&gt;12,500&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_903_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zMLrqEeSJIT1" title="Date Fully Vested"&gt;05-02-2026&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_900_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zM7zJ4LAPqY1" title="Board Approval Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z7W4b76MIqI5" title="Expiration Date"&gt;05-01-2032&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Jagan Reddy&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zKxeqlsABfBj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;4,000,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zCX04OMzsbj2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;4,000,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20200101__20201231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zOBUo3w8GC44" title="Granted Date"&gt;09-29-2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20201231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zLcOa2wApEZb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"&gt;0.06&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zKGRKrSA53dl" title="Vesting Date"&gt;09-29-2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zx3OEy8qgdm1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding"&gt;4,000,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20201231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zAjEkAZ5A27l" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"&gt;0&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zzqPH1Zy89ud" title="Date Fully Vested"&gt;09-29-2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zzxwfJY1pVfc" title="Board Approval Date"&gt;09-28-2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zBJeqN0tpsA5" title="Expiration Date"&gt;09-28-2030&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Jagan Reddy&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20211231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z1QNcWlp7339" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;200,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zBOhrCUX2hWh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;200,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20210101__20211231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z77tWXOWvbQf" title="Granted Date"&gt;08-12-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20211231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zWjsNE1gxH6a" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"&gt;0.06&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_900_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z3VGSbXqfnHd" title="Vesting Date"&gt;09-01-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zJnYSjGUYRq9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding"&gt;133,333&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20211231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zXigKW9A6dBd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"&gt;66,667&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z2AXveCbVYM1" title="Date Fully Vested"&gt;09-01-2025&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_909_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zGx1kMBN6qMk" title="Board Approval Date"&gt;08-12-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_znMp1jOUxMRi" title="Expiration Date"&gt;08-11-2031&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Jagan Reddy&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zWnM7OtIcJl5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;100,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z3CLUQbelsd5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;100,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zaFrPzj34uy1" title="Granted Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zx2CNpSmQoI2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"&gt;0.05&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zSms9MSXoam1" title="Vesting Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zdyEfY0hMI0j" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding"&gt;50,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z2XI43Etedgl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"&gt;50,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_900_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zTeiOccr6De4" title="Date Fully Vested"&gt;05-02-2026&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_901_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zTIQbZj7izOk" title="Board Approval Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zhcIPo9lJrnb" title="Expiration Date"&gt;05-01-2032&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Siddayya S Ganjal&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zLtHZXLIYXT2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;180,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zidPZtDo9f2l" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;180,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z64CelNZxK28" title="Granted Date"&gt;09-29-2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20201231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zZJN9c6A2Xz8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"&gt;0.06&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_900_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zji5tD9IWLJ7" title="Vesting Date"&gt;09-29-2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zEbslEd6W4Uk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding"&gt;180,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20201231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zC47cn7xpmB5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"&gt;0&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_903_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z81CfIvqcg07" title="Date Fully Vested"&gt;09-29-2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_908_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zZhwhGG9ylSl" title="Board Approval Date"&gt;09-28-2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zlETeoQnlBD6" title="Expiration Date"&gt;09-28-2030&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Siddayya S Ganjal&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zOeVWgDLd6bd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;50,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zO52qNDAB4j1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;50,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zQiPa3xVsHL6" title="Granted Date"&gt;08-12-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20211231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zp1TIwkcXPli" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"&gt;0.06&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_906_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zi1FCNFDnJ4a" title="Vesting Date"&gt;09-01-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zCxAMtrNrbwi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding"&gt;33,333&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20211231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zODWxdOOSXZ7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"&gt;16,667&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_907_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zUelF2aoLGV" title="Date Fully Vested"&gt;09-01-2025&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zYRo89dsMIXc" title="Board Approval Date"&gt;08-12-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z26RMcgHAkZ2" title="Expiration Date"&gt;08-11-2031&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Siddayya S Ganjal&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z8GrwY1ZeiA8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;25,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z7PdBfdIQS8f" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;25,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zfZ2QJXel0R6" title="Granted Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zOLPYJnpSyB4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"&gt;0.05&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_908_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zDdmnDMrgNB1" title="Vesting Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z9jAQSeoce1j" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding"&gt;12,500&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zEU7k2yN2rrl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"&gt;12,500&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_901_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zmKgANLDQ4C8" title="Date Fully Vested"&gt;05-02-2026&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_903_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zbrXvmpsk0o4" title="Board Approval Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zSN3SC32THb8" title="Expiration Date"&gt;05-01-2032&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Sunil Arora&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SunilAroraMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z7m9enW4i5Zi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;90,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--SunilAroraMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zsezXG1Sejg5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;0&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SunilAroraMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zkoYykwWriM4" title="Granted Date"&gt;09-29-2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20201231__srt--TitleOfIndividualAxis__custom--SunilAroraMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zPcaRvcX5Ww6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"&gt;0.06&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SunilAroraMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zLPcUvlsIyVc" title="Vesting Date"&gt;09-29-2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--SunilAroraMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zP0MdBecOlJ3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding"&gt;0&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20201231__srt--TitleOfIndividualAxis__custom--SunilAroraMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zjtyFMbmjjM1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"&gt;0&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_900_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SunilAroraMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_znYKA3dyYKOa" title="Date Fully Vested"&gt;09-29-2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SunilAroraMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zfFmNNsb1id8" title="Board Approval Date"&gt;09-28-2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SunilAroraMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z5q5eI77xCTf" title="Expiration Date"&gt;09-28-2030&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Rajiv Virmani&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__srt--TitleOfIndividualAxis__custom--RajivVirmaniMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zAvTpweQTCkk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;500,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--RajivVirmaniMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zsPUxo7rXUVi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;500,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20200101__20201231__srt--TitleOfIndividualAxis__custom--RajivVirmaniMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zUixUnpBEey" title="Granted Date"&gt;09-29-2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20201231__srt--TitleOfIndividualAxis__custom--RajivVirmaniMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zYa1tFm2h7r2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"&gt;0.06&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--RajivVirmaniMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zGdB8F8Vpkw9" title="Vesting Date"&gt;09-29-2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--RajivVirmaniMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zzuDeP7iTWBh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding"&gt;500,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20201231__srt--TitleOfIndividualAxis__custom--RajivVirmaniMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_znbKyxGWlMO4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"&gt;0&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--RajivVirmaniMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z1ZhutZcDpOl" title="Date Fully Vested"&gt;09-29-2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--RajivVirmaniMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zHE0MGI0XA6c" title="Board Approval Date"&gt;09-28-2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--RajivVirmaniMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zrxbrYtV69t1" title="Expiration Date"&gt;09-28-2030&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Sudhindra Shenoy&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zJ4QWiC4caWb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;180,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zgmeBkw8F8j5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;180,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zv4BBKrvS86k" title="Granted Date"&gt;09-29-2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20201231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z9PEv9VWomrf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"&gt;0.06&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zcTu02LTXQD6" title="Vesting Date"&gt;09-29-2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zED81jMp6uo1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding"&gt;180,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20201231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zSpk753JhlNa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"&gt;0&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zDYoF6saLzQ6" title="Date Fully Vested"&gt;09-29-2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zRxbgV6riQIi" title="Board Approval Date"&gt;09-28-2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zSWz0ilcoDn9" title="Expiration Date"&gt;09-28-2030&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Sudhindra Shenoy&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zHiLjzV9s139" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;50,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zqncTIeeYlMi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;50,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z3Q7dMpXuPQl" title="Granted Date"&gt;08-12-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20211231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zqtXw6he9koe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"&gt;0.06&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_905_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z3EiXnMZUPVg" title="Vesting Date"&gt;09-01-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z4TqSghQCWf5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding"&gt;33,333&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20211231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zl9Dk6iCfNUc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"&gt;16,667&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z3cBvBXDJ7sc" title="Date Fully Vested"&gt;09-01-2025&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_909_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zSxBfMKkqZRi" title="Board Approval Date"&gt;08-12-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zK2KmCBBBoJ8" title="Expiration Date"&gt;08-11-2031&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Sudhindra Shenoy&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zdwYncZrvV59" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;25,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zAJPR9VMuZJg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;25,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zjD8uIPJTn3j" title="Granted Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_ztFhqTbEQtJ1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"&gt;0.05&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_900_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_ztvHTgqFPMv6" title="Vesting Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zN9xWBjDSpSb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding"&gt;12,500&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z6ZIFhqGT8j9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"&gt;12,500&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zKWPeT8HF9z5" title="Date Fully Vested"&gt;05-02-2026&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z8YAQ8UQsU22" title="Board Approval Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zSlZ99QVHP9b" title="Expiration Date"&gt;05-01-2032&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Antony Sunil&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zmI8FhHvmypd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;90,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zS427y4oyIgh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;90,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20200101__20201231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zS4jXqRIxdNa" title="Granted Date"&gt;09-29-2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20201231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zCK1E38zUGB9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"&gt;0.06&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_909_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zUchczNYa5jk" title="Vesting Date"&gt;09-29-2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zE9ia44VfIm6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding"&gt;90,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20201231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zx8POfK8Rcw6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"&gt;0&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_905_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zRbZddjh8Aue" title="Date Fully Vested"&gt;09-29-2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_902_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zszioAjv8Bqe" title="Board Approval Date"&gt;09-28-2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zDdDEeTDGbhi" title="Expiration Date"&gt;09-28-2030&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Antony Sunil&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20211231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zStQjTpTmw22" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;50,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zW3X4WBNgYxh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;50,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20210101__20211231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zLfMcMLcTXGh" title="Granted Date"&gt;08-12-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20211231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zkXLwkFMIA5d" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"&gt;0.06&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_905_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zPPj5PC7Ix7c" title="Vesting Date"&gt;09-01-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zliNQG0mUou2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding"&gt;33,333&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20211231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zpy0i9DTWivi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"&gt;16,667&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zf06eLernOX8" title="Date Fully Vested"&gt;09-01-2025&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zMHa6AstZAy7" title="Board Approval Date"&gt;08-12-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z8VDq4AdhNN4" title="Expiration Date"&gt;08-11-2031&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Antony Sunil&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zt6Tew4XYJvg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;25,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zqEbpMITIlH1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;25,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zjQHGf6zSV6k" title="Granted Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zrl3HOXAcou1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"&gt;0.05&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_903_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zRPrkULN2mnh" title="Vesting Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zwE2jHb87Abd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding"&gt;12,500&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zodw1uxPgGnj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"&gt;12,500&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_904_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zHnvDmjt5DJk" title="Date Fully Vested"&gt;05-02-2026&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_908_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zuQqZZQ4Bec5" title="Board Approval Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zyH5egEJfptj" title="Expiration Date"&gt;05-01-2032&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Tuleeka Nandy&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20211231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zGeQUPGVcqC9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;15,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zWREe5GJFG32" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;0&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20210101__20211231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zPlyc3UbVQ68" title="Granted Date"&gt;08-12-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20211231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zyg4qZYrT9Wa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"&gt;0.06&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_904_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z9Tm46w78EVl" title="Vesting Date"&gt;09-01-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zciUSx4cEKVe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding"&gt;0&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20211231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zc5DVfnr44za" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"&gt;0&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_906_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zk9oh7ar75S1" title="Date Fully Vested"&gt;09-01-2025&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zqQR8gFyZZEa" title="Board Approval Date"&gt;08-12-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zCBYtFP5vVA1" title="Expiration Date"&gt;08-11-2031&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Tuleeka Nandy&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zbzyE7DKx0n5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;15,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zyPGwPl4LmOl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;15,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zNOHxOGAM5ql" title="Granted Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zIL7zRdfFmqg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"&gt;0.05&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zFT85c9TDdK8" title="Vesting Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zS94C0Wmy8v1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding"&gt;7,500&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zKYh7zntYvEb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"&gt;7,500&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_906_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zB6HsCjNmSfc" title="Date Fully Vested"&gt;05-02-2026&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_904_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zW0Qw50fnqOg" title="Board Approval Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zu3PueADS1Nf" title="Expiration Date"&gt;05-01-2032&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Robel Atnafu&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20211231__srt--TitleOfIndividualAxis__custom--RobelAtnafuMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zMYN4j4zbw27" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;5,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--RobelAtnafuMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zkaOlGc6QBKd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;0&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20210101__20211231__srt--TitleOfIndividualAxis__custom--RobelAtnafuMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zCAg44aRCXz9" title="Granted Date"&gt;08-12-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20211231__srt--TitleOfIndividualAxis__custom--RobelAtnafuMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zQlITQRRVHT5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"&gt;0.06&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_902_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--RobelAtnafuMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zrgD9NvzmkK5" title="Vesting Date"&gt;09-01-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--RobelAtnafuMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zD3QUtoWzBOj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding"&gt;0&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20211231__srt--TitleOfIndividualAxis__custom--RobelAtnafuMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zmr99hzbrwbb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"&gt;0&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_903_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--RobelAtnafuMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zYaOQ001KYc5" title="Date Fully Vested"&gt;09-01-2025&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_902_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--RobelAtnafuMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zRYd7sPNM6ne" title="Board Approval Date"&gt;08-12-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--RobelAtnafuMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zE0Thm3B4a73" title="Expiration Date"&gt;08-11-2031&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Guy Primus&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20211231__srt--TitleOfIndividualAxis__custom--GuyPrimusMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zv7tnKkLurq3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;360,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--GuyPrimusMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z5lsCpiRMGT7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;360,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20210101__20211231__srt--TitleOfIndividualAxis__custom--GuyPrimusMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z27yWlq2iEZh" title="Granted Date"&gt;08-12-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20211231__srt--TitleOfIndividualAxis__custom--GuyPrimusMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z4LI0glhB5K7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"&gt;0.06&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_909_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--GuyPrimusMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z6R8fWq0gQKb" title="Vesting Date"&gt;09-01-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--GuyPrimusMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zJHAcSIrs837" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding"&gt;240,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20211231__srt--TitleOfIndividualAxis__custom--GuyPrimusMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zshUiCy9NTE" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"&gt;120,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_905_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--GuyPrimusMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z0v50qGwDqbi" title="Date Fully Vested"&gt;09-01-2025&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_900_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--GuyPrimusMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z183fR4njIGi" title="Board Approval Date"&gt;08-12-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--GuyPrimusMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zNgUaGWfKBNc" title="Expiration Date"&gt;08-11-2031&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Samartha Gowda&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SamarthaGowdaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zx41vfeTjDK1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;15,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--SamarthaGowdaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z5mVmuym9a7e" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;15,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SamarthaGowdaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zA9b1GaOT6Tl" title="Granted Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--SamarthaGowdaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zP7eRx49hXbl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"&gt;0.05&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_908_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SamarthaGowdaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zMkuWD2OKVUg" title="Vesting Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--SamarthaGowdaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z2pjFHsTgYjk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding"&gt;7,500&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--SamarthaGowdaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zOeHdHRImpt4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"&gt;7,500&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SamarthaGowdaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z6p852xmFNl8" title="Date Fully Vested"&gt;05-02-2026&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SamarthaGowdaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zRKoBC1L5T74" title="Board Approval Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SamarthaGowdaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zCrDWd7dOoo2" title="Expiration Date"&gt;05-01-2032&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Alexandra Aiello&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--AlexandraAielloMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zos3ZTwgdgpd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;2,500&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--AlexandraAielloMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zkLf5NC3A9F8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;2,500&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--AlexandraAielloMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zUOXKuHn8bJ2" title="Granted Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--AlexandraAielloMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zMlDopmU4nMk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"&gt;0.05&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--AlexandraAielloMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zMO4Wx2Wxqsb" title="Vesting Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--AlexandraAielloMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zj0DmFR2Hmfl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding"&gt;1,250&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--AlexandraAielloMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zMKrN3i8HUx1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"&gt;1,250&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_907_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--AlexandraAielloMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zZ1BzH0xur41" title="Date Fully Vested"&gt;05-02-2026&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--AlexandraAielloMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z4rVg0eKPw0i" title="Board Approval Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--AlexandraAielloMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zMmyOdwnl6bf" title="Expiration Date"&gt;05-01-2032&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Stephen Cabral&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--StephenCabralMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zlO4ZVDea3Y4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;5,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--StephenCabralMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z5AJCEHMgIm8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;0&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--StephenCabralMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zKMERKWPDCo2" title="Granted Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--StephenCabralMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zpoidDGY1po6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"&gt;0.05&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_908_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--StephenCabralMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_ziPZldaQahO" title="Vesting Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--StephenCabralMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z7mtBjLCWCOg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding"&gt;0&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--StephenCabralMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zvGzB6e10LIj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"&gt;0&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--StephenCabralMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zuwBeWx1OgTj" title="Date Fully Vested"&gt;05-02-2026&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_908_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--StephenCabralMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z06wjmJJL7j" title="Board Approval Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--StephenCabralMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zf0KWNyJqW24" title="Expiration Date"&gt;05-01-2032&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Jonah Petit-Perrin&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--JonahPetiPerrinMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zjUdsZpRym9c" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;2,500&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--JonahPetiPerrinMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z5ByE1Z1QMa3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;2,500&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--JonahPetiPerrinMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_znNtTB3GQ4m7" title="Granted Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--JonahPetiPerrinMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zBS4tPH6taid" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"&gt;0.05&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--JonahPetiPerrinMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z1Z9cejRmEwh" title="Vesting Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--JonahPetiPerrinMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zee8GqimbV64" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding"&gt;1,250&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--JonahPetiPerrinMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_ziQtB8JotaV4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"&gt;1,250&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_902_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--JonahPetiPerrinMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zhtHlmhSqBV1" title="Date Fully Vested"&gt;05-02-2026&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--JonahPetiPerrinMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zjdz5sN18x0g" title="Board Approval Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--JonahPetiPerrinMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z4ipI8GLHwP8" title="Expiration Date"&gt;05-01-2032&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Bryan Nella&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--BryanNellaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zbPLsMrTyCA2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;25,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--BryanNellaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zeur895jwiSe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;25,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--BryanNellaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zmLZTBTnQtG2" title="Granted Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--BryanNellaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zUc14HjWkwyg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"&gt;0.05&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_900_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--BryanNellaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zONYjSE3kgmd" title="Vesting Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--BryanNellaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zhwvJLEBGex1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding"&gt;12,500&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--BryanNellaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z1WjMt58CFUg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"&gt;12,500&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_908_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--BryanNellaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z96tWHUjxNeg" title="Date Fully Vested"&gt;05-02-2026&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--BryanNellaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zMwCQJm0JADe" title="Board Approval Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--BryanNellaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zdDDHYmYKT2i" title="Expiration Date"&gt;05-01-2032&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Mark Sink&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--MarkSinkMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zimf9Ch28Wui" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;25,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--MarkSinkMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zZLocIrhgjk2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;25,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--MarkSinkMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zGFaccnau9le" title="Granted Date"&gt;05-16-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--MarkSinkMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zu7z4rcHGuCc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"&gt;0.05&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_906_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--MarkSinkMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zabNGQ8A0Kj6" title="Vesting Date"&gt;05-16-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--MarkSinkMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zlle8gf7Tndd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding"&gt;12,500&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--MarkSinkMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zTZuKBOkJng2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"&gt;12,500&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--MarkSinkMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zFMW3LGvFmH1" title="Date Fully Vested"&gt;05-16-2026&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--MarkSinkMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zJLhpuc0V4h" title="Board Approval Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--MarkSinkMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zvLkBOKkgj1b" title="Expiration Date"&gt;05-15-2032&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Koustav Choudhuri&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--KoustavChoudhuriMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zbh9U6pV5q3c" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;17,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--KoustavChoudhuriMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zqKUHN23zawa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;17,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--KoustavChoudhuriMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zFze2Pe8pvWc" title="Granted Date"&gt;05-16-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--KoustavChoudhuriMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zCR3ZuuzNtj9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"&gt;0.05&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--KoustavChoudhuriMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z8f5vWaGbzx2" title="Vesting Date"&gt;05-16-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--KoustavChoudhuriMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zHFzmum5KYR8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding"&gt;8,500&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--KoustavChoudhuriMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zA3MVoCaVxUa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"&gt;8,500&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_907_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--KoustavChoudhuriMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z7Qdji6G9dJ3" title="Date Fully Vested"&gt;05-16-2026&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_909_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--KoustavChoudhuriMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z9Z9FMLzPlT6" title="Board Approval Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--KoustavChoudhuriMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zHeIwWUKyAG8" title="Expiration Date"&gt;05-15-2032&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;Total&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zbm3KvbNqxJi" style="font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;11,712,000&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zbFqwBe0pozj" style="font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;11,597,000&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A7_zOfGtJ9Lfm38" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;WARRANTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Not
applicable. The Company has not issued any form of a warrant.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;COMMON
STOCK ISSUANCES &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Not
applicable other than founders shares in the amount of &lt;span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240101__20240331__srt--TitleOfIndividualAxis__custom--FoundersMember_zW90DaQyoT2d" title="Common stock, issuance"&gt;25,000,000&lt;/span&gt;. The Company has only used SAFE convertible notes convertible into
preferred equity, and common stock options to date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <RIME:ScheduleOfStockOptionIssuedTableTextBlock
      contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember"
      id="Fact003621">&lt;p id="xdx_89D_ecustom--ScheduleOfStockOptionIssuedTableTextBlock_zS4MKNLnlLo3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the years ended Dember 31, 2020, 2021 and 2022 the Company issued the following stock options, as shown below. No options were issued
in 2023 or 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span id="xdx_8B5_zQna3u5WPUSa" style="display: none"&gt;SCHEDULE OF STOCK OPTION ISSUED
DURING THE YEAR DECEMBER 31, 2020, 2021 AND 2022&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif"&gt;Holder&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;Granted Shares&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;Outstanding Awards&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;Grant Date&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;Exercise Price&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;Vesting Start Date&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;Vested Outstanding&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;Unvested&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;Date Fully Vested&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;Board Approval Date&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;Expiration Date&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: left"&gt;Sudhir Narasimhamurthy&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zkaVwWdoGg3" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Granted Shares"&gt;180,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zcr2MKz1AwFg" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Outstanding Awards"&gt;180,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z1PCe2WkmQMa" title="Granted Date"&gt;09-29-2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20201231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zEwHsyzEa6K4" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Exercise price"&gt;0.06&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"&gt;&lt;span id="xdx_904_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z5ZXzIUpv5v2" title="Vesting Date"&gt;09-29-2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z1y1z4fUkMd9" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Vested Outstanding"&gt;180,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20201231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zjAJBNToTHb9" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Unvested"&gt;0&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zc9gMLKiRMSi" title="Date Fully Vested"&gt;09-29-2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"&gt;&lt;span id="xdx_908_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z6c6IllFXpx7" title="Board Approval Date"&gt;09-28-2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zdfXa5VRylw9" title="Expiration Date"&gt;09-28-2030&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Sudhir Narasimhamurthy&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z3uCfygXvbR4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;50,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zQtKppP6tag2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;50,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_znDPUpqUbYw1" title="Granted Date"&gt;08-12-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20211231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zjCZBQdsmS37" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"&gt;0.06&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z5Wb3cLxzFP2" title="Vesting Date"&gt;09-01-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zvRymfYhav79" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding"&gt;33,333&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20211231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z430AXwdWbqa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"&gt;16,667&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_905_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_ztFM8AbGO4z" title="Date Fully Vested"&gt;09-01-2025&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z8DY2FENLkba" title="Board Approval Date"&gt;08-12-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zaVtrIbr1jSa" title="Expiration Date"&gt;08-11-2031&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Sudhir Narasimhamurthy&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zdQxKgnCNhYl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;25,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zpCDH1mvMsFb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;25,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zOpcXghoINqd" title="Granted Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zkXP0xggFfQ4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"&gt;0.05&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zSKiAJqKuqb1" title="Vesting Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zNyEIkIRBfme" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding"&gt;12,500&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zbeugqboZ186" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"&gt;12,500&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_909_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zCJz3cB56Coc" title="Date Fully Vested"&gt;05-02-2026&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_900_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zr8EiANorbQf" title="Board Approval Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z6JDYzFtRMFg" title="Expiration Date"&gt;05-01-2032&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Kadandale Srinivas Sudheer&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zQXre4LkNdsg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;600,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zZEPsi2Skxqd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;600,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20200101__20201231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zEog8Y6iMuMb" title="Granted Date"&gt;09-29-2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20201231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z8wAPlyTERF9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"&gt;0.06&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zZ1kQQCQyof3" title="Vesting Date"&gt;09-29-2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z19ywhQYgQYa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding"&gt;600,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20201231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zTe1UbNcWdQk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"&gt;0&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zbxETfbMaBLd" title="Date Fully Vested"&gt;09-29-2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_900_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z7eACM5ED3Ci" title="Board Approval Date"&gt;09-28-2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z0JG5iPR3Z17" title="Expiration Date"&gt;09-28-2030&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Kadandale Srinivas Sudheer&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20211231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_za98zzoEujK9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;100,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zE3JVBLazA0a" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;100,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20210101__20211231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z6eOXUUTjNrk" title="Granted Date"&gt;08-12-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20211231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zg6Nmo40glYd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"&gt;0.06&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_907_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zFeRQu9z9nq" title="Vesting Date"&gt;09-01-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z8tDJidvYA8g" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding"&gt;66,666&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20211231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zODHT2K3W2L3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"&gt;33,334&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_900_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zJAqgSZbew21" title="Date Fully Vested"&gt;09-01-2025&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_909_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zMLmVAewjCL5" title="Board Approval Date"&gt;08-12-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zU0PUmZ171j1" title="Expiration Date"&gt;08-11-2031&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Kadandale Srinivas Sudheer&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zytGZ9hbU7ja" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;50,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zF4FHf7SRPXe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;50,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z8UbrhZ7O8t1" title="Granted Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zSYMGd9uqPca" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"&gt;0.05&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zbDudXMOICq9" title="Vesting Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zhW8YXZAWDZd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding"&gt;25,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zZRwBgBVHrud" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"&gt;25,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_909_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z88nzqafXHq3" title="Date Fully Vested"&gt;05-02-2026&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_903_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zlGP0zcOyh0i" title="Board Approval Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zCz9iQ9aDTn8" title="Expiration Date"&gt;05-01-2032&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Vivek Sehgal&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zRpjmlZTOGX3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;4,000,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zcQvVn88Xlzd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;4,000,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20200101__20201231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zYn1HvGb2uE3" title="Granted Date"&gt;09-29-2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20201231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zwj20RpZTZ3l" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"&gt;0.06&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zcOJJxYF28v4" title="Vesting Date"&gt;09-29-2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zXMwES9jBJyk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding"&gt;4,000,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20201231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zR4OKdEJGYAe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"&gt;0&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_903_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zmG35jgQubc4" title="Date Fully Vested"&gt;09-29-2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_905_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z157ujDnNYy8" title="Board Approval Date"&gt;09-28-2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zGq4oFwd78C8" title="Expiration Date"&gt;09-28-2030&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Vivek Sehgal&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20211231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zhGKq280Xs45" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;200,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zO4iwkQvJbya" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;200,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20210101__20211231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zR91Gan7PQ68" title="Granted Date"&gt;08-12-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20211231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zv711yflLHw9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"&gt;0.06&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zv58Z1jTHlu2" title="Vesting Date"&gt;09-01-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zYD54Fb54DUi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding"&gt;133,333&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20211231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zvLyxMREXQyd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"&gt;66,667&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zDqisXKWh0Ik" title="Date Fully Vested"&gt;09-01-2025&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_907_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z6BxPFgVriA2" title="Board Approval Date"&gt;08-12-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zVnMcREQ1i55" title="Expiration Date"&gt;08-11-2031&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Vivek Sehgal&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zDDZm2IDXNL3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;100,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zRghaqfb8pch" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;100,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zEAqpKDIUl87" title="Granted Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zqs3KXmqO1ua" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"&gt;0.05&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_901_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zZxxyoqlsdBi" title="Vesting Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zBKaGub0LWD9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding"&gt;50,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zfyYDo512rMa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"&gt;50,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_906_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zGWF9B3Fc3tc" title="Date Fully Vested"&gt;05-02-2026&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zNCmcVOAIY4j" title="Board Approval Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zMd2fAXZF2Q1" title="Expiration Date"&gt;05-01-2032&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Rajiv Saxena&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__srt--TitleOfIndividualAxis__custom--RajivSaxenaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_znQO4mVSpOjk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;100,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--RajivSaxenaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zhBE7ZJA66Uh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;100,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20200101__20201231__srt--TitleOfIndividualAxis__custom--RajivSaxenaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zfqtIuMocDq4" title="Granted Date"&gt;09-29-2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20201231__srt--TitleOfIndividualAxis__custom--RajivSaxenaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z0V8spZqH7ca" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"&gt;0.06&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_904_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--RajivSaxenaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zOTob9Ez0zb3" title="Vesting Date"&gt;09-29-2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--RajivSaxenaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zAVzgpY3COkg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding"&gt;100,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20201231__srt--TitleOfIndividualAxis__custom--RajivSaxenaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zhi2QrpZRBBd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"&gt;0&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_905_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--RajivSaxenaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_ztcI3kL5i449" title="Date Fully Vested"&gt;09-29-2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--RajivSaxenaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zoEfGqJJHtcg" title="Board Approval Date"&gt;09-28-2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--RajivSaxenaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zXH5b5Qf8pAh" title="Expiration Date"&gt;09-28-2030&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Harsha Bhat&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z08HbgZ0X45g" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;180,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zbwUA0GCQ80h" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;180,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20200101__20201231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zXXdHjVSoRFj" title="Granted Date"&gt;09-29-2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20201231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zSUxLUAAlsU4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"&gt;0.06&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_902_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zoVMaEcY1RVj" title="Vesting Date"&gt;09-29-2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zrzYnC0SL8qb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding"&gt;180,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20201231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zzsVwuUkeghi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"&gt;0&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_909_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z8sd1sUXMfJ2" title="Date Fully Vested"&gt;09-29-2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zmgIWsiO9eX5" title="Board Approval Date"&gt;09-28-2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z2dyEezFF0Fa" title="Expiration Date"&gt;09-28-2030&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Harsha Bhat&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20211231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zDsyymcL05z2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;50,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z6wgdxcyHxT1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;50,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20210101__20211231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z9QO3uaAaEOh" title="Granted Date"&gt;08-12-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20211231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zaUkaL5fUYPe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"&gt;0.06&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_ze5s6G3w3q4f" title="Vesting Date"&gt;09-01-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zfoMrlWA3YA7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding"&gt;33,333&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20211231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zUgMjGfU0RTi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"&gt;16,667&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_905_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_za3qr7dQi3Wa" title="Date Fully Vested"&gt;09-01-2025&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zsnSa1PIg8Te" title="Board Approval Date"&gt;08-12-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zskswrzDKQ09" title="Expiration Date"&gt;08-11-2031&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Harsha Bhat&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zNmCBODP5IDj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;25,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zMpSnEP1ymzd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;25,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zOzdi7J0AsDh" title="Granted Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zBKdxDK5waRe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"&gt;0.05&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zOv44xxlwtEl" title="Vesting Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z90kaRIoIGpc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding"&gt;12,500&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zztgEunYXoFa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"&gt;12,500&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_903_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zMLrqEeSJIT1" title="Date Fully Vested"&gt;05-02-2026&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_900_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zM7zJ4LAPqY1" title="Board Approval Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z7W4b76MIqI5" title="Expiration Date"&gt;05-01-2032&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Jagan Reddy&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zKxeqlsABfBj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;4,000,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zCX04OMzsbj2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;4,000,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20200101__20201231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zOBUo3w8GC44" title="Granted Date"&gt;09-29-2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20201231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zLcOa2wApEZb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"&gt;0.06&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zKGRKrSA53dl" title="Vesting Date"&gt;09-29-2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zx3OEy8qgdm1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding"&gt;4,000,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20201231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zAjEkAZ5A27l" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"&gt;0&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zzqPH1Zy89ud" title="Date Fully Vested"&gt;09-29-2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zzxwfJY1pVfc" title="Board Approval Date"&gt;09-28-2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zBJeqN0tpsA5" title="Expiration Date"&gt;09-28-2030&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Jagan Reddy&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20211231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z1QNcWlp7339" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;200,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zBOhrCUX2hWh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;200,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20210101__20211231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z77tWXOWvbQf" title="Granted Date"&gt;08-12-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20211231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zWjsNE1gxH6a" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"&gt;0.06&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_900_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z3VGSbXqfnHd" title="Vesting Date"&gt;09-01-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zJnYSjGUYRq9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding"&gt;133,333&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20211231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zXigKW9A6dBd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"&gt;66,667&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z2AXveCbVYM1" title="Date Fully Vested"&gt;09-01-2025&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_909_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zGx1kMBN6qMk" title="Board Approval Date"&gt;08-12-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_znMp1jOUxMRi" title="Expiration Date"&gt;08-11-2031&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Jagan Reddy&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zWnM7OtIcJl5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;100,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z3CLUQbelsd5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;100,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zaFrPzj34uy1" title="Granted Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zx2CNpSmQoI2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"&gt;0.05&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zSms9MSXoam1" title="Vesting Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zdyEfY0hMI0j" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding"&gt;50,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z2XI43Etedgl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"&gt;50,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_900_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zTeiOccr6De4" title="Date Fully Vested"&gt;05-02-2026&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_901_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zTIQbZj7izOk" title="Board Approval Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zhcIPo9lJrnb" title="Expiration Date"&gt;05-01-2032&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Siddayya S Ganjal&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zLtHZXLIYXT2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;180,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zidPZtDo9f2l" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;180,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z64CelNZxK28" title="Granted Date"&gt;09-29-2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20201231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zZJN9c6A2Xz8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"&gt;0.06&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_900_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zji5tD9IWLJ7" title="Vesting Date"&gt;09-29-2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zEbslEd6W4Uk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding"&gt;180,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20201231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zC47cn7xpmB5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"&gt;0&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_903_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z81CfIvqcg07" title="Date Fully Vested"&gt;09-29-2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_908_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zZhwhGG9ylSl" title="Board Approval Date"&gt;09-28-2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zlETeoQnlBD6" title="Expiration Date"&gt;09-28-2030&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Siddayya S Ganjal&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zOeVWgDLd6bd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;50,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zO52qNDAB4j1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;50,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zQiPa3xVsHL6" title="Granted Date"&gt;08-12-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20211231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zp1TIwkcXPli" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"&gt;0.06&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_906_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zi1FCNFDnJ4a" title="Vesting Date"&gt;09-01-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zCxAMtrNrbwi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding"&gt;33,333&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20211231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zODWxdOOSXZ7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"&gt;16,667&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_907_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zUelF2aoLGV" title="Date Fully Vested"&gt;09-01-2025&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zYRo89dsMIXc" title="Board Approval Date"&gt;08-12-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z26RMcgHAkZ2" title="Expiration Date"&gt;08-11-2031&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Siddayya S Ganjal&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z8GrwY1ZeiA8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;25,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z7PdBfdIQS8f" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;25,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zfZ2QJXel0R6" title="Granted Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zOLPYJnpSyB4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"&gt;0.05&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_908_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zDdmnDMrgNB1" title="Vesting Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z9jAQSeoce1j" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding"&gt;12,500&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zEU7k2yN2rrl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"&gt;12,500&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_901_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zmKgANLDQ4C8" title="Date Fully Vested"&gt;05-02-2026&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_903_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zbrXvmpsk0o4" title="Board Approval Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zSN3SC32THb8" title="Expiration Date"&gt;05-01-2032&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Sunil Arora&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SunilAroraMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z7m9enW4i5Zi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;90,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--SunilAroraMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zsezXG1Sejg5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;0&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SunilAroraMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zkoYykwWriM4" title="Granted Date"&gt;09-29-2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20201231__srt--TitleOfIndividualAxis__custom--SunilAroraMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zPcaRvcX5Ww6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"&gt;0.06&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SunilAroraMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zLPcUvlsIyVc" title="Vesting Date"&gt;09-29-2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--SunilAroraMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zP0MdBecOlJ3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding"&gt;0&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20201231__srt--TitleOfIndividualAxis__custom--SunilAroraMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zjtyFMbmjjM1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"&gt;0&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_900_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SunilAroraMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_znYKA3dyYKOa" title="Date Fully Vested"&gt;09-29-2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SunilAroraMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zfFmNNsb1id8" title="Board Approval Date"&gt;09-28-2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SunilAroraMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z5q5eI77xCTf" title="Expiration Date"&gt;09-28-2030&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Rajiv Virmani&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__srt--TitleOfIndividualAxis__custom--RajivVirmaniMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zAvTpweQTCkk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;500,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--RajivVirmaniMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zsPUxo7rXUVi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;500,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20200101__20201231__srt--TitleOfIndividualAxis__custom--RajivVirmaniMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zUixUnpBEey" title="Granted Date"&gt;09-29-2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20201231__srt--TitleOfIndividualAxis__custom--RajivVirmaniMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zYa1tFm2h7r2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"&gt;0.06&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--RajivVirmaniMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zGdB8F8Vpkw9" title="Vesting Date"&gt;09-29-2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--RajivVirmaniMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zzuDeP7iTWBh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding"&gt;500,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20201231__srt--TitleOfIndividualAxis__custom--RajivVirmaniMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_znbKyxGWlMO4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"&gt;0&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--RajivVirmaniMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z1ZhutZcDpOl" title="Date Fully Vested"&gt;09-29-2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--RajivVirmaniMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zHE0MGI0XA6c" title="Board Approval Date"&gt;09-28-2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--RajivVirmaniMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zrxbrYtV69t1" title="Expiration Date"&gt;09-28-2030&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Sudhindra Shenoy&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zJ4QWiC4caWb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;180,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zgmeBkw8F8j5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;180,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zv4BBKrvS86k" title="Granted Date"&gt;09-29-2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20201231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z9PEv9VWomrf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"&gt;0.06&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zcTu02LTXQD6" title="Vesting Date"&gt;09-29-2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zED81jMp6uo1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding"&gt;180,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20201231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zSpk753JhlNa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"&gt;0&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zDYoF6saLzQ6" title="Date Fully Vested"&gt;09-29-2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zRxbgV6riQIi" title="Board Approval Date"&gt;09-28-2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zSWz0ilcoDn9" title="Expiration Date"&gt;09-28-2030&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Sudhindra Shenoy&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zHiLjzV9s139" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;50,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zqncTIeeYlMi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;50,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z3Q7dMpXuPQl" title="Granted Date"&gt;08-12-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20211231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zqtXw6he9koe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"&gt;0.06&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_905_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z3EiXnMZUPVg" title="Vesting Date"&gt;09-01-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z4TqSghQCWf5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding"&gt;33,333&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20211231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zl9Dk6iCfNUc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"&gt;16,667&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z3cBvBXDJ7sc" title="Date Fully Vested"&gt;09-01-2025&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_909_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zSxBfMKkqZRi" title="Board Approval Date"&gt;08-12-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zK2KmCBBBoJ8" title="Expiration Date"&gt;08-11-2031&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Sudhindra Shenoy&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zdwYncZrvV59" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;25,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zAJPR9VMuZJg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;25,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zjD8uIPJTn3j" title="Granted Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_ztFhqTbEQtJ1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"&gt;0.05&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_900_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_ztvHTgqFPMv6" title="Vesting Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zN9xWBjDSpSb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding"&gt;12,500&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z6ZIFhqGT8j9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"&gt;12,500&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zKWPeT8HF9z5" title="Date Fully Vested"&gt;05-02-2026&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z8YAQ8UQsU22" title="Board Approval Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zSlZ99QVHP9b" title="Expiration Date"&gt;05-01-2032&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Antony Sunil&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zmI8FhHvmypd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;90,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zS427y4oyIgh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;90,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20200101__20201231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zS4jXqRIxdNa" title="Granted Date"&gt;09-29-2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20201231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zCK1E38zUGB9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"&gt;0.06&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_909_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zUchczNYa5jk" title="Vesting Date"&gt;09-29-2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zE9ia44VfIm6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding"&gt;90,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20201231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zx8POfK8Rcw6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"&gt;0&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_905_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zRbZddjh8Aue" title="Date Fully Vested"&gt;09-29-2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_902_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zszioAjv8Bqe" title="Board Approval Date"&gt;09-28-2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zDdDEeTDGbhi" title="Expiration Date"&gt;09-28-2030&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Antony Sunil&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20211231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zStQjTpTmw22" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;50,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zW3X4WBNgYxh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;50,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20210101__20211231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zLfMcMLcTXGh" title="Granted Date"&gt;08-12-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20211231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zkXLwkFMIA5d" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"&gt;0.06&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_905_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zPPj5PC7Ix7c" title="Vesting Date"&gt;09-01-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zliNQG0mUou2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding"&gt;33,333&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20211231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zpy0i9DTWivi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"&gt;16,667&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zf06eLernOX8" title="Date Fully Vested"&gt;09-01-2025&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zMHa6AstZAy7" title="Board Approval Date"&gt;08-12-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z8VDq4AdhNN4" title="Expiration Date"&gt;08-11-2031&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Antony Sunil&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zt6Tew4XYJvg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;25,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zqEbpMITIlH1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;25,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zjQHGf6zSV6k" title="Granted Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zrl3HOXAcou1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"&gt;0.05&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_903_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zRPrkULN2mnh" title="Vesting Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zwE2jHb87Abd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding"&gt;12,500&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zodw1uxPgGnj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"&gt;12,500&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_904_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zHnvDmjt5DJk" title="Date Fully Vested"&gt;05-02-2026&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_908_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zuQqZZQ4Bec5" title="Board Approval Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zyH5egEJfptj" title="Expiration Date"&gt;05-01-2032&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Tuleeka Nandy&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20211231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zGeQUPGVcqC9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;15,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zWREe5GJFG32" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;0&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20210101__20211231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zPlyc3UbVQ68" title="Granted Date"&gt;08-12-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20211231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zyg4qZYrT9Wa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"&gt;0.06&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_904_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z9Tm46w78EVl" title="Vesting Date"&gt;09-01-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zciUSx4cEKVe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding"&gt;0&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20211231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zc5DVfnr44za" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"&gt;0&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_906_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zk9oh7ar75S1" title="Date Fully Vested"&gt;09-01-2025&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zqQR8gFyZZEa" title="Board Approval Date"&gt;08-12-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zCBYtFP5vVA1" title="Expiration Date"&gt;08-11-2031&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Tuleeka Nandy&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zbzyE7DKx0n5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;15,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zyPGwPl4LmOl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;15,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zNOHxOGAM5ql" title="Granted Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zIL7zRdfFmqg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"&gt;0.05&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zFT85c9TDdK8" title="Vesting Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zS94C0Wmy8v1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding"&gt;7,500&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zKYh7zntYvEb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"&gt;7,500&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_906_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zB6HsCjNmSfc" title="Date Fully Vested"&gt;05-02-2026&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_904_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zW0Qw50fnqOg" title="Board Approval Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zu3PueADS1Nf" title="Expiration Date"&gt;05-01-2032&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Robel Atnafu&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20211231__srt--TitleOfIndividualAxis__custom--RobelAtnafuMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zMYN4j4zbw27" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;5,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--RobelAtnafuMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zkaOlGc6QBKd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;0&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20210101__20211231__srt--TitleOfIndividualAxis__custom--RobelAtnafuMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zCAg44aRCXz9" title="Granted Date"&gt;08-12-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20211231__srt--TitleOfIndividualAxis__custom--RobelAtnafuMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zQlITQRRVHT5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"&gt;0.06&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_902_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--RobelAtnafuMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zrgD9NvzmkK5" title="Vesting Date"&gt;09-01-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--RobelAtnafuMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zD3QUtoWzBOj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding"&gt;0&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20211231__srt--TitleOfIndividualAxis__custom--RobelAtnafuMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zmr99hzbrwbb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"&gt;0&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_903_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--RobelAtnafuMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zYaOQ001KYc5" title="Date Fully Vested"&gt;09-01-2025&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_902_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--RobelAtnafuMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zRYd7sPNM6ne" title="Board Approval Date"&gt;08-12-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--RobelAtnafuMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zE0Thm3B4a73" title="Expiration Date"&gt;08-11-2031&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Guy Primus&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20211231__srt--TitleOfIndividualAxis__custom--GuyPrimusMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zv7tnKkLurq3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;360,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--GuyPrimusMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z5lsCpiRMGT7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;360,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20210101__20211231__srt--TitleOfIndividualAxis__custom--GuyPrimusMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z27yWlq2iEZh" title="Granted Date"&gt;08-12-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20211231__srt--TitleOfIndividualAxis__custom--GuyPrimusMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z4LI0glhB5K7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"&gt;0.06&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_909_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--GuyPrimusMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z6R8fWq0gQKb" title="Vesting Date"&gt;09-01-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--GuyPrimusMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zJHAcSIrs837" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding"&gt;240,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20211231__srt--TitleOfIndividualAxis__custom--GuyPrimusMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zshUiCy9NTE" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"&gt;120,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_905_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--GuyPrimusMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z0v50qGwDqbi" title="Date Fully Vested"&gt;09-01-2025&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_900_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--GuyPrimusMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z183fR4njIGi" title="Board Approval Date"&gt;08-12-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--GuyPrimusMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zNgUaGWfKBNc" title="Expiration Date"&gt;08-11-2031&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Samartha Gowda&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SamarthaGowdaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zx41vfeTjDK1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;15,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--SamarthaGowdaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z5mVmuym9a7e" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;15,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SamarthaGowdaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zA9b1GaOT6Tl" title="Granted Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--SamarthaGowdaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zP7eRx49hXbl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"&gt;0.05&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_908_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SamarthaGowdaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zMkuWD2OKVUg" title="Vesting Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--SamarthaGowdaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z2pjFHsTgYjk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding"&gt;7,500&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--SamarthaGowdaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zOeHdHRImpt4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"&gt;7,500&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SamarthaGowdaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z6p852xmFNl8" title="Date Fully Vested"&gt;05-02-2026&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SamarthaGowdaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zRKoBC1L5T74" title="Board Approval Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SamarthaGowdaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zCrDWd7dOoo2" title="Expiration Date"&gt;05-01-2032&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Alexandra Aiello&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--AlexandraAielloMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zos3ZTwgdgpd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;2,500&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--AlexandraAielloMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zkLf5NC3A9F8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;2,500&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--AlexandraAielloMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zUOXKuHn8bJ2" title="Granted Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--AlexandraAielloMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zMlDopmU4nMk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"&gt;0.05&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--AlexandraAielloMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zMO4Wx2Wxqsb" title="Vesting Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--AlexandraAielloMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zj0DmFR2Hmfl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding"&gt;1,250&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--AlexandraAielloMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zMKrN3i8HUx1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"&gt;1,250&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_907_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--AlexandraAielloMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zZ1BzH0xur41" title="Date Fully Vested"&gt;05-02-2026&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--AlexandraAielloMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z4rVg0eKPw0i" title="Board Approval Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--AlexandraAielloMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zMmyOdwnl6bf" title="Expiration Date"&gt;05-01-2032&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Stephen Cabral&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--StephenCabralMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zlO4ZVDea3Y4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;5,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--StephenCabralMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z5AJCEHMgIm8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;0&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--StephenCabralMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zKMERKWPDCo2" title="Granted Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--StephenCabralMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zpoidDGY1po6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"&gt;0.05&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_908_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--StephenCabralMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_ziPZldaQahO" title="Vesting Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--StephenCabralMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z7mtBjLCWCOg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding"&gt;0&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--StephenCabralMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zvGzB6e10LIj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"&gt;0&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--StephenCabralMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zuwBeWx1OgTj" title="Date Fully Vested"&gt;05-02-2026&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_908_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--StephenCabralMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z06wjmJJL7j" title="Board Approval Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--StephenCabralMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zf0KWNyJqW24" title="Expiration Date"&gt;05-01-2032&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Jonah Petit-Perrin&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--JonahPetiPerrinMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zjUdsZpRym9c" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;2,500&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--JonahPetiPerrinMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z5ByE1Z1QMa3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;2,500&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--JonahPetiPerrinMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_znNtTB3GQ4m7" title="Granted Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--JonahPetiPerrinMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zBS4tPH6taid" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"&gt;0.05&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--JonahPetiPerrinMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z1Z9cejRmEwh" title="Vesting Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--JonahPetiPerrinMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zee8GqimbV64" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding"&gt;1,250&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--JonahPetiPerrinMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_ziQtB8JotaV4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"&gt;1,250&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_902_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--JonahPetiPerrinMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zhtHlmhSqBV1" title="Date Fully Vested"&gt;05-02-2026&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--JonahPetiPerrinMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zjdz5sN18x0g" title="Board Approval Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--JonahPetiPerrinMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z4ipI8GLHwP8" title="Expiration Date"&gt;05-01-2032&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Bryan Nella&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--BryanNellaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zbPLsMrTyCA2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;25,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--BryanNellaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zeur895jwiSe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;25,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--BryanNellaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zmLZTBTnQtG2" title="Granted Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--BryanNellaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zUc14HjWkwyg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"&gt;0.05&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_900_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--BryanNellaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zONYjSE3kgmd" title="Vesting Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--BryanNellaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zhwvJLEBGex1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding"&gt;12,500&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--BryanNellaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z1WjMt58CFUg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"&gt;12,500&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_908_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--BryanNellaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z96tWHUjxNeg" title="Date Fully Vested"&gt;05-02-2026&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--BryanNellaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zMwCQJm0JADe" title="Board Approval Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--BryanNellaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zdDDHYmYKT2i" title="Expiration Date"&gt;05-01-2032&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Mark Sink&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--MarkSinkMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zimf9Ch28Wui" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;25,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--MarkSinkMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zZLocIrhgjk2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;25,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--MarkSinkMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zGFaccnau9le" title="Granted Date"&gt;05-16-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--MarkSinkMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zu7z4rcHGuCc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"&gt;0.05&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_906_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--MarkSinkMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zabNGQ8A0Kj6" title="Vesting Date"&gt;05-16-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--MarkSinkMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zlle8gf7Tndd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding"&gt;12,500&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--MarkSinkMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zTZuKBOkJng2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"&gt;12,500&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--MarkSinkMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zFMW3LGvFmH1" title="Date Fully Vested"&gt;05-16-2026&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--MarkSinkMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zJLhpuc0V4h" title="Board Approval Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--MarkSinkMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zvLkBOKkgj1b" title="Expiration Date"&gt;05-15-2032&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Koustav Choudhuri&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--KoustavChoudhuriMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zbh9U6pV5q3c" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;17,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--KoustavChoudhuriMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zqKUHN23zawa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;17,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--KoustavChoudhuriMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zFze2Pe8pvWc" title="Granted Date"&gt;05-16-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--KoustavChoudhuriMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zCR3ZuuzNtj9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"&gt;0.05&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--KoustavChoudhuriMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z8f5vWaGbzx2" title="Vesting Date"&gt;05-16-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--KoustavChoudhuriMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zHFzmum5KYR8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding"&gt;8,500&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--KoustavChoudhuriMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zA3MVoCaVxUa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"&gt;8,500&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_907_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--KoustavChoudhuriMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z7Qdji6G9dJ3" title="Date Fully Vested"&gt;05-16-2026&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_909_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--KoustavChoudhuriMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z9Z9FMLzPlT6" title="Board Approval Date"&gt;05-02-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--KoustavChoudhuriMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zHeIwWUKyAG8" title="Expiration Date"&gt;05-15-2032&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;Total&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zbm3KvbNqxJi" style="font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares"&gt;11,712,000&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zbFqwBe0pozj" style="font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards"&gt;11,597,000&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</RIME:ScheduleOfStockOptionIssuedTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2020-01-012020-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003623"
      unitRef="Shares">180000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2020-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003625"
      unitRef="Shares">180000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:TargetedOrTrackingStockIssuanceDates
      contextRef="From2020-01-012020-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003627">2020-09-29</us-gaap:TargetedOrTrackingStockIssuanceDates>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2020-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003629"
      unitRef="USDPShares">0.06</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate
      contextRef="From2020-01-012020-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003631">2020-09-29</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="AsOf2020-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003633"
      unitRef="Shares">180000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="AsOf2020-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003635"
      unitRef="Shares">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate
      contextRef="From2020-01-012020-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003637">2023-09-29</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate
      contextRef="From2020-01-012020-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003639">2020-09-28</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="From2020-01-012020-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003641">2030-09-28</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2021-01-012021-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003643"
      unitRef="Shares">50000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2021-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003645"
      unitRef="Shares">50000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:TargetedOrTrackingStockIssuanceDates
      contextRef="From2021-01-012021-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003647">2021-08-12</us-gaap:TargetedOrTrackingStockIssuanceDates>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2021-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003649"
      unitRef="USDPShares">0.06</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate
      contextRef="From2021-01-012021-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003651">2021-09-01</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="AsOf2021-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003653"
      unitRef="Shares">33333</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="AsOf2021-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003655"
      unitRef="Shares">16667</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate
      contextRef="From2021-01-012021-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003657">2025-09-01</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate
      contextRef="From2021-01-012021-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003659">2021-08-12</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="From2021-01-012021-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003661">2031-08-11</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2022-01-012022-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003663"
      unitRef="Shares">25000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2022-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003665"
      unitRef="Shares">25000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:TargetedOrTrackingStockIssuanceDates
      contextRef="From2022-01-012022-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003667">2022-05-02</us-gaap:TargetedOrTrackingStockIssuanceDates>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2022-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003669"
      unitRef="USDPShares">0.05</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate
      contextRef="From2022-01-012022-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003671">2022-05-02</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="AsOf2022-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003673"
      unitRef="Shares">12500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="AsOf2022-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003675"
      unitRef="Shares">12500</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate
      contextRef="From2022-01-012022-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003677">2026-05-02</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate
      contextRef="From2022-01-012022-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003679">2022-05-02</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="From2022-01-012022-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003681">2032-05-01</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2020-01-012020-12-31_custom_KadandaleSrinivasSudheerMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003683"
      unitRef="Shares">600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2020-12-31_custom_KadandaleSrinivasSudheerMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003685"
      unitRef="Shares">600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:TargetedOrTrackingStockIssuanceDates
      contextRef="From2020-01-012020-12-31_custom_KadandaleSrinivasSudheerMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003687">2020-09-29</us-gaap:TargetedOrTrackingStockIssuanceDates>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2020-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003689"
      unitRef="USDPShares">0.06</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate
      contextRef="From2020-01-012020-12-31_custom_KadandaleSrinivasSudheerMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003691">2020-09-29</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="AsOf2020-12-31_custom_KadandaleSrinivasSudheerMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003693"
      unitRef="Shares">600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="AsOf2020-12-31_custom_KadandaleSrinivasSudheerMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003695"
      unitRef="Shares">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate
      contextRef="From2020-01-012020-12-31_custom_KadandaleSrinivasSudheerMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003697">2023-09-29</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate
      contextRef="From2020-01-012020-12-31_custom_KadandaleSrinivasSudheerMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003699">2020-09-28</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="From2020-01-012020-12-31_custom_KadandaleSrinivasSudheerMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003701">2030-09-28</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2021-01-012021-12-31_custom_KadandaleSrinivasSudheerMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003703"
      unitRef="Shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2021-12-31_custom_KadandaleSrinivasSudheerMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003705"
      unitRef="Shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:TargetedOrTrackingStockIssuanceDates
      contextRef="From2021-01-012021-12-31_custom_KadandaleSrinivasSudheerMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003707">2021-08-12</us-gaap:TargetedOrTrackingStockIssuanceDates>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2021-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003709"
      unitRef="USDPShares">0.06</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate
      contextRef="From2021-01-012021-12-31_custom_KadandaleSrinivasSudheerMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003711">2021-09-01</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="AsOf2021-12-31_custom_KadandaleSrinivasSudheerMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003713"
      unitRef="Shares">66666</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="AsOf2021-12-31_custom_KadandaleSrinivasSudheerMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003715"
      unitRef="Shares">33334</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate
      contextRef="From2021-01-012021-12-31_custom_KadandaleSrinivasSudheerMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003717">2025-09-01</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate
      contextRef="From2021-01-012021-12-31_custom_KadandaleSrinivasSudheerMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003719">2021-08-12</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="From2021-01-012021-12-31_custom_KadandaleSrinivasSudheerMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003721">2031-08-11</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2022-01-012022-12-31_custom_KadandaleSrinivasSudheerMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003723"
      unitRef="Shares">50000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2022-12-31_custom_KadandaleSrinivasSudheerMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003725"
      unitRef="Shares">50000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:TargetedOrTrackingStockIssuanceDates
      contextRef="From2022-01-012022-12-31_custom_KadandaleSrinivasSudheerMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003727">2022-05-02</us-gaap:TargetedOrTrackingStockIssuanceDates>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2022-12-31_custom_SudhirNarasimhamurthyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003729"
      unitRef="USDPShares">0.05</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate
      contextRef="From2022-01-012022-12-31_custom_KadandaleSrinivasSudheerMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003731">2022-05-02</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="AsOf2022-12-31_custom_KadandaleSrinivasSudheerMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003733"
      unitRef="Shares">25000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="AsOf2022-12-31_custom_KadandaleSrinivasSudheerMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003735"
      unitRef="Shares">25000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate
      contextRef="From2022-01-012022-12-31_custom_KadandaleSrinivasSudheerMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003737">2026-05-02</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate
      contextRef="From2022-01-012022-12-31_custom_KadandaleSrinivasSudheerMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003739">2022-05-02</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="From2022-01-012022-12-31_custom_KadandaleSrinivasSudheerMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003741">2032-05-01</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2020-01-012020-12-31_custom_VivekSehgalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003743"
      unitRef="Shares">4000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2020-12-31_custom_VivekSehgalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003745"
      unitRef="Shares">4000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:TargetedOrTrackingStockIssuanceDates
      contextRef="From2020-01-012020-12-31_custom_VivekSehgalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003747">2020-09-29</us-gaap:TargetedOrTrackingStockIssuanceDates>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2020-12-31_custom_VivekSehgalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003749"
      unitRef="USDPShares">0.06</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate
      contextRef="From2020-01-012020-12-31_custom_KadandaleSrinivasSudheerMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003751">2020-09-29</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="AsOf2020-12-31_custom_VivekSehgalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003753"
      unitRef="Shares">4000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="AsOf2020-12-31_custom_VivekSehgalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003755"
      unitRef="Shares">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate
      contextRef="From2020-01-012020-12-31_custom_VivekSehgalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003757">2023-09-29</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate
      contextRef="From2020-01-012020-12-31_custom_VivekSehgalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003759">2020-09-28</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="From2020-01-012020-12-31_custom_VivekSehgalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003761">2030-09-28</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2021-01-012021-12-31_custom_VivekSehgalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003763"
      unitRef="Shares">200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2021-12-31_custom_VivekSehgalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003765"
      unitRef="Shares">200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:TargetedOrTrackingStockIssuanceDates
      contextRef="From2021-01-012021-12-31_custom_VivekSehgalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003767">2021-08-12</us-gaap:TargetedOrTrackingStockIssuanceDates>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2021-12-31_custom_VivekSehgalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003769"
      unitRef="USDPShares">0.06</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate
      contextRef="From2021-01-012021-12-31_custom_KadandaleSrinivasSudheerMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003771">2021-09-01</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="AsOf2021-12-31_custom_VivekSehgalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003773"
      unitRef="Shares">133333</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="AsOf2021-12-31_custom_VivekSehgalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003775"
      unitRef="Shares">66667</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate
      contextRef="From2021-01-012021-12-31_custom_VivekSehgalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003777">2025-09-01</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate
      contextRef="From2021-01-012021-12-31_custom_VivekSehgalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003779">2021-08-12</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="From2021-01-012021-12-31_custom_VivekSehgalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003781">2031-08-11</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2022-01-012022-12-31_custom_VivekSehgalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003783"
      unitRef="Shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2022-12-31_custom_VivekSehgalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003785"
      unitRef="Shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:TargetedOrTrackingStockIssuanceDates
      contextRef="From2022-01-012022-12-31_custom_VivekSehgalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003787">2022-05-02</us-gaap:TargetedOrTrackingStockIssuanceDates>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2022-12-31_custom_VivekSehgalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003789"
      unitRef="USDPShares">0.05</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate
      contextRef="From2022-01-012022-12-31_custom_KadandaleSrinivasSudheerMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003791">2022-05-02</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="AsOf2022-12-31_custom_VivekSehgalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003793"
      unitRef="Shares">50000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="AsOf2022-12-31_custom_VivekSehgalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003795"
      unitRef="Shares">50000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate
      contextRef="From2022-01-012022-12-31_custom_VivekSehgalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003797">2026-05-02</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate
      contextRef="From2022-01-012022-12-31_custom_VivekSehgalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003799">2022-05-02</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="From2022-01-012022-12-31_custom_VivekSehgalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003801">2032-05-01</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2020-01-012020-12-31_custom_RajivSaxenaMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003803"
      unitRef="Shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2020-12-31_custom_RajivSaxenaMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003805"
      unitRef="Shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:TargetedOrTrackingStockIssuanceDates
      contextRef="From2020-01-012020-12-31_custom_RajivSaxenaMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003807">2020-09-29</us-gaap:TargetedOrTrackingStockIssuanceDates>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2020-12-31_custom_RajivSaxenaMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003809"
      unitRef="USDPShares">0.06</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate
      contextRef="From2020-01-012020-12-31_custom_RajivSaxenaMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003811">2020-09-29</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="AsOf2020-12-31_custom_RajivSaxenaMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003813"
      unitRef="Shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="AsOf2020-12-31_custom_RajivSaxenaMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003815"
      unitRef="Shares">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate
      contextRef="From2020-01-012020-12-31_custom_RajivSaxenaMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003817">2023-09-29</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate
      contextRef="From2020-01-012020-12-31_custom_RajivSaxenaMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003819">2020-09-28</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="From2020-01-012020-12-31_custom_RajivSaxenaMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003821">2030-09-28</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2020-01-012020-12-31_custom_HarshaBhatMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003823"
      unitRef="Shares">180000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2020-12-31_custom_HarshaBhatMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003825"
      unitRef="Shares">180000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:TargetedOrTrackingStockIssuanceDates
      contextRef="From2020-01-012020-12-31_custom_HarshaBhatMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003827">2020-09-29</us-gaap:TargetedOrTrackingStockIssuanceDates>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2020-12-31_custom_HarshaBhatMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003829"
      unitRef="USDPShares">0.06</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate
      contextRef="From2020-01-012020-12-31_custom_HarshaBhatMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003831">2020-09-29</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="AsOf2020-12-31_custom_HarshaBhatMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003833"
      unitRef="Shares">180000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="AsOf2020-12-31_custom_HarshaBhatMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003835"
      unitRef="Shares">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate
      contextRef="From2020-01-012020-12-31_custom_HarshaBhatMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003837">2023-09-29</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate
      contextRef="From2020-01-012020-12-31_custom_HarshaBhatMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003839">2020-09-28</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="From2020-01-012020-12-31_custom_HarshaBhatMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003841">2030-09-28</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2021-01-012021-12-31_custom_HarshaBhatMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003843"
      unitRef="Shares">50000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2021-12-31_custom_HarshaBhatMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003845"
      unitRef="Shares">50000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:TargetedOrTrackingStockIssuanceDates
      contextRef="From2021-01-012021-12-31_custom_HarshaBhatMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003847">2021-08-12</us-gaap:TargetedOrTrackingStockIssuanceDates>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2021-12-31_custom_HarshaBhatMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003849"
      unitRef="USDPShares">0.06</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate
      contextRef="From2021-01-012021-12-31_custom_HarshaBhatMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003851">2021-09-01</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="AsOf2021-12-31_custom_HarshaBhatMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003853"
      unitRef="Shares">33333</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="AsOf2021-12-31_custom_HarshaBhatMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003855"
      unitRef="Shares">16667</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate
      contextRef="From2021-01-012021-12-31_custom_HarshaBhatMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003857">2025-09-01</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate
      contextRef="From2021-01-012021-12-31_custom_HarshaBhatMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003859">2021-08-12</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="From2021-01-012021-12-31_custom_HarshaBhatMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003861">2031-08-11</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2022-01-012022-12-31_custom_HarshaBhatMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003863"
      unitRef="Shares">25000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2022-12-31_custom_HarshaBhatMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003865"
      unitRef="Shares">25000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:TargetedOrTrackingStockIssuanceDates
      contextRef="From2022-01-012022-12-31_custom_HarshaBhatMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003867">2022-05-02</us-gaap:TargetedOrTrackingStockIssuanceDates>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2022-12-31_custom_HarshaBhatMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003869"
      unitRef="USDPShares">0.05</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate
      contextRef="From2022-01-012022-12-31_custom_HarshaBhatMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003871">2022-05-02</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="AsOf2022-12-31_custom_HarshaBhatMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003873"
      unitRef="Shares">12500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="AsOf2022-12-31_custom_HarshaBhatMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003875"
      unitRef="Shares">12500</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate
      contextRef="From2022-01-012022-12-31_custom_HarshaBhatMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003877">2026-05-02</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate
      contextRef="From2022-01-012022-12-31_custom_HarshaBhatMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003879">2022-05-02</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="From2022-01-012022-12-31_custom_HarshaBhatMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003881">2032-05-01</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2020-01-012020-12-31_custom_JaganReddyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003883"
      unitRef="Shares">4000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2020-12-31_custom_JaganReddyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003885"
      unitRef="Shares">4000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:TargetedOrTrackingStockIssuanceDates
      contextRef="From2020-01-012020-12-31_custom_JaganReddyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003887">2020-09-29</us-gaap:TargetedOrTrackingStockIssuanceDates>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2020-12-31_custom_JaganReddyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003889"
      unitRef="USDPShares">0.06</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate
      contextRef="From2020-01-012020-12-31_custom_JaganReddyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003891">2020-09-29</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="AsOf2020-12-31_custom_JaganReddyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003893"
      unitRef="Shares">4000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="AsOf2020-12-31_custom_JaganReddyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003895"
      unitRef="Shares">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate
      contextRef="From2020-01-012020-12-31_custom_JaganReddyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003897">2023-09-29</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate
      contextRef="From2020-01-012020-12-31_custom_JaganReddyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003899">2020-09-28</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="From2020-01-012020-12-31_custom_JaganReddyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003901">2030-09-28</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2021-01-012021-12-31_custom_JaganReddyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003903"
      unitRef="Shares">200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2021-12-31_custom_JaganReddyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003905"
      unitRef="Shares">200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:TargetedOrTrackingStockIssuanceDates
      contextRef="From2021-01-012021-12-31_custom_JaganReddyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003907">2021-08-12</us-gaap:TargetedOrTrackingStockIssuanceDates>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2021-12-31_custom_JaganReddyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003909"
      unitRef="USDPShares">0.06</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate
      contextRef="From2021-01-012021-12-31_custom_JaganReddyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003911">2021-09-01</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="AsOf2021-12-31_custom_JaganReddyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003913"
      unitRef="Shares">133333</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="AsOf2021-12-31_custom_JaganReddyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003915"
      unitRef="Shares">66667</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate
      contextRef="From2021-01-012021-12-31_custom_JaganReddyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003917">2025-09-01</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate
      contextRef="From2021-01-012021-12-31_custom_JaganReddyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003919">2021-08-12</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="From2021-01-012021-12-31_custom_JaganReddyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003921">2031-08-11</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2022-01-012022-12-31_custom_JaganReddyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003923"
      unitRef="Shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2022-12-31_custom_JaganReddyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003925"
      unitRef="Shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:TargetedOrTrackingStockIssuanceDates
      contextRef="From2022-01-012022-12-31_custom_JaganReddyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003927">2022-05-02</us-gaap:TargetedOrTrackingStockIssuanceDates>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2022-12-31_custom_JaganReddyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003929"
      unitRef="USDPShares">0.05</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate
      contextRef="From2022-01-012022-12-31_custom_JaganReddyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003931">2022-05-02</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="AsOf2022-12-31_custom_JaganReddyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003933"
      unitRef="Shares">50000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="AsOf2022-12-31_custom_JaganReddyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003935"
      unitRef="Shares">50000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate
      contextRef="From2022-01-012022-12-31_custom_JaganReddyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003937">2026-05-02</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate
      contextRef="From2022-01-012022-12-31_custom_JaganReddyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003939">2022-05-02</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="From2022-01-012022-12-31_custom_JaganReddyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003941">2032-05-01</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2020-01-012020-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003943"
      unitRef="Shares">180000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2020-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003945"
      unitRef="Shares">180000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:TargetedOrTrackingStockIssuanceDates
      contextRef="From2020-01-012020-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003947">2020-09-29</us-gaap:TargetedOrTrackingStockIssuanceDates>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2020-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003949"
      unitRef="USDPShares">0.06</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate
      contextRef="From2020-01-012020-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003951">2020-09-29</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="AsOf2020-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003953"
      unitRef="Shares">180000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="AsOf2020-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003955"
      unitRef="Shares">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate
      contextRef="From2020-01-012020-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003957">2023-09-29</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate
      contextRef="From2020-01-012020-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003959">2020-09-28</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="From2020-01-012020-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003961">2030-09-28</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2021-01-012021-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003963"
      unitRef="Shares">50000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2021-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003965"
      unitRef="Shares">50000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:TargetedOrTrackingStockIssuanceDates
      contextRef="From2021-01-012021-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003967">2021-08-12</us-gaap:TargetedOrTrackingStockIssuanceDates>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2021-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003969"
      unitRef="USDPShares">0.06</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate
      contextRef="From2021-01-012021-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003971">2021-09-01</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="AsOf2021-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003973"
      unitRef="Shares">33333</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="AsOf2021-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003975"
      unitRef="Shares">16667</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate
      contextRef="From2021-01-012021-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003977">2025-09-01</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate
      contextRef="From2021-01-012021-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003979">2021-08-12</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="From2021-01-012021-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003981">2031-08-11</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2022-01-012022-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003983"
      unitRef="Shares">25000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2022-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003985"
      unitRef="Shares">25000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:TargetedOrTrackingStockIssuanceDates
      contextRef="From2022-01-012022-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003987">2022-05-02</us-gaap:TargetedOrTrackingStockIssuanceDates>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2022-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003989"
      unitRef="USDPShares">0.05</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate
      contextRef="From2022-01-012022-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003991">2022-05-02</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="AsOf2022-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003993"
      unitRef="Shares">12500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="AsOf2022-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact003995"
      unitRef="Shares">12500</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate
      contextRef="From2022-01-012022-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003997">2026-05-02</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate
      contextRef="From2022-01-012022-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact003999">2022-05-02</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="From2022-01-012022-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004001">2032-05-01</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2020-01-012020-12-31_custom_SunilAroraMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004003"
      unitRef="Shares">90000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2020-12-31_custom_SunilAroraMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004005"
      unitRef="Shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:TargetedOrTrackingStockIssuanceDates
      contextRef="From2020-01-012020-12-31_custom_SunilAroraMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004007">2020-09-29</us-gaap:TargetedOrTrackingStockIssuanceDates>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2020-12-31_custom_SunilAroraMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004009"
      unitRef="USDPShares">0.06</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate
      contextRef="From2020-01-012020-12-31_custom_SunilAroraMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004011">2020-09-29</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="AsOf2020-12-31_custom_SunilAroraMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004013"
      unitRef="Shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="AsOf2020-12-31_custom_SunilAroraMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004015"
      unitRef="Shares">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate
      contextRef="From2020-01-012020-12-31_custom_SunilAroraMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004017">2023-09-29</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate
      contextRef="From2020-01-012020-12-31_custom_SunilAroraMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004019">2020-09-28</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="From2020-01-012020-12-31_custom_SunilAroraMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004021">2030-09-28</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2020-01-012020-12-31_custom_RajivVirmaniMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004023"
      unitRef="Shares">500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2020-12-31_custom_RajivVirmaniMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004025"
      unitRef="Shares">500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:TargetedOrTrackingStockIssuanceDates
      contextRef="From2020-01-012020-12-31_custom_RajivVirmaniMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004027">2020-09-29</us-gaap:TargetedOrTrackingStockIssuanceDates>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2020-12-31_custom_RajivVirmaniMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004029"
      unitRef="USDPShares">0.06</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate
      contextRef="From2020-01-012020-12-31_custom_RajivVirmaniMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004031">2020-09-29</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="AsOf2020-12-31_custom_RajivVirmaniMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004033"
      unitRef="Shares">500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="AsOf2020-12-31_custom_RajivVirmaniMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004035"
      unitRef="Shares">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate
      contextRef="From2020-01-012020-12-31_custom_RajivVirmaniMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004037">2023-09-29</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate
      contextRef="From2020-01-012020-12-31_custom_RajivVirmaniMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004039">2020-09-28</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="From2020-01-012020-12-31_custom_RajivVirmaniMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004041">2030-09-28</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2020-01-012020-12-31_custom_SudhindraShenoyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004043"
      unitRef="Shares">180000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2020-12-31_custom_SudhindraShenoyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004045"
      unitRef="Shares">180000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:TargetedOrTrackingStockIssuanceDates
      contextRef="From2020-01-012020-12-31_custom_SudhindraShenoyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004047">2020-09-29</us-gaap:TargetedOrTrackingStockIssuanceDates>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2020-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004049"
      unitRef="USDPShares">0.06</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate
      contextRef="From2020-01-012020-12-31_custom_SudhindraShenoyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004051">2020-09-29</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="AsOf2020-12-31_custom_SudhindraShenoyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004053"
      unitRef="Shares">180000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="AsOf2020-12-31_custom_SudhindraShenoyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004055"
      unitRef="Shares">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate
      contextRef="From2020-01-012020-12-31_custom_SudhindraShenoyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004057">2023-09-29</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate
      contextRef="From2020-01-012020-12-31_custom_SudhindraShenoyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004059">2020-09-28</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="From2020-01-012020-12-31_custom_SudhindraShenoyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004061">2030-09-28</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2021-01-012021-12-31_custom_SudhindraShenoyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004063"
      unitRef="Shares">50000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2021-12-31_custom_SudhindraShenoyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004065"
      unitRef="Shares">50000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:TargetedOrTrackingStockIssuanceDates
      contextRef="From2021-01-012021-12-31_custom_SudhindraShenoyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004067">2021-08-12</us-gaap:TargetedOrTrackingStockIssuanceDates>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2021-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004069"
      unitRef="USDPShares">0.06</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate
      contextRef="From2021-01-012021-12-31_custom_SudhindraShenoyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004071">2021-09-01</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="AsOf2021-12-31_custom_SudhindraShenoyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004073"
      unitRef="Shares">33333</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="AsOf2021-12-31_custom_SudhindraShenoyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004075"
      unitRef="Shares">16667</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate
      contextRef="From2021-01-012021-12-31_custom_SudhindraShenoyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004077">2025-09-01</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate
      contextRef="From2021-01-012021-12-31_custom_SudhindraShenoyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004079">2021-08-12</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="From2021-01-012021-12-31_custom_SudhindraShenoyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004081">2031-08-11</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2022-01-012022-12-31_custom_SudhindraShenoyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004083"
      unitRef="Shares">25000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2022-12-31_custom_SudhindraShenoyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004085"
      unitRef="Shares">25000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:TargetedOrTrackingStockIssuanceDates
      contextRef="From2022-01-012022-12-31_custom_SudhindraShenoyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004087">2022-05-02</us-gaap:TargetedOrTrackingStockIssuanceDates>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2022-12-31_custom_SiddayyaSGanjalMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004089"
      unitRef="USDPShares">0.05</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate
      contextRef="From2022-01-012022-12-31_custom_SudhindraShenoyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004091">2022-05-02</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="AsOf2022-12-31_custom_SudhindraShenoyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004093"
      unitRef="Shares">12500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="AsOf2022-12-31_custom_SudhindraShenoyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004095"
      unitRef="Shares">12500</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate
      contextRef="From2022-01-012022-12-31_custom_SudhindraShenoyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004097">2026-05-02</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate
      contextRef="From2022-01-012022-12-31_custom_SudhindraShenoyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004099">2022-05-02</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="From2022-01-012022-12-31_custom_SudhindraShenoyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004101">2032-05-01</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2020-01-012020-12-31_custom_AntonySunilMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004103"
      unitRef="Shares">90000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2020-12-31_custom_AntonySunilMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004105"
      unitRef="Shares">90000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:TargetedOrTrackingStockIssuanceDates
      contextRef="From2020-01-012020-12-31_custom_AntonySunilMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004107">2020-09-29</us-gaap:TargetedOrTrackingStockIssuanceDates>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2020-12-31_custom_AntonySunilMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004109"
      unitRef="USDPShares">0.06</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate
      contextRef="From2020-01-012020-12-31_custom_AntonySunilMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004111">2020-09-29</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="AsOf2020-12-31_custom_AntonySunilMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004113"
      unitRef="Shares">90000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="AsOf2020-12-31_custom_AntonySunilMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004115"
      unitRef="Shares">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate
      contextRef="From2020-01-012020-12-31_custom_AntonySunilMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004117">2023-09-29</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate
      contextRef="From2020-01-012020-12-31_custom_AntonySunilMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004119">2020-09-28</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="From2020-01-012020-12-31_custom_AntonySunilMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004121">2030-09-28</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2021-01-012021-12-31_custom_AntonySunilMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004123"
      unitRef="Shares">50000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2021-12-31_custom_AntonySunilMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004125"
      unitRef="Shares">50000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:TargetedOrTrackingStockIssuanceDates
      contextRef="From2021-01-012021-12-31_custom_AntonySunilMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004127">2021-08-12</us-gaap:TargetedOrTrackingStockIssuanceDates>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2021-12-31_custom_AntonySunilMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004129"
      unitRef="USDPShares">0.06</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate
      contextRef="From2021-01-012021-12-31_custom_AntonySunilMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004131">2021-09-01</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="AsOf2021-12-31_custom_AntonySunilMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004133"
      unitRef="Shares">33333</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="AsOf2021-12-31_custom_AntonySunilMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004135"
      unitRef="Shares">16667</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate
      contextRef="From2021-01-012021-12-31_custom_AntonySunilMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004137">2025-09-01</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate
      contextRef="From2021-01-012021-12-31_custom_AntonySunilMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004139">2021-08-12</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="From2021-01-012021-12-31_custom_AntonySunilMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004141">2031-08-11</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2022-01-012022-12-31_custom_AntonySunilMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004143"
      unitRef="Shares">25000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2022-12-31_custom_AntonySunilMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004145"
      unitRef="Shares">25000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:TargetedOrTrackingStockIssuanceDates
      contextRef="From2022-01-012022-12-31_custom_AntonySunilMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004147">2022-05-02</us-gaap:TargetedOrTrackingStockIssuanceDates>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2022-12-31_custom_AntonySunilMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004149"
      unitRef="USDPShares">0.05</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate
      contextRef="From2022-01-012022-12-31_custom_AntonySunilMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004151">2022-05-02</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="AsOf2022-12-31_custom_AntonySunilMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004153"
      unitRef="Shares">12500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="AsOf2022-12-31_custom_AntonySunilMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004155"
      unitRef="Shares">12500</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate
      contextRef="From2022-01-012022-12-31_custom_AntonySunilMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004157">2026-05-02</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate
      contextRef="From2022-01-012022-12-31_custom_AntonySunilMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004159">2022-05-02</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="From2022-01-012022-12-31_custom_AntonySunilMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004161">2032-05-01</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2021-01-012021-12-31_custom_TuleekaNandyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004163"
      unitRef="Shares">15000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2021-12-31_custom_TuleekaNandyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004165"
      unitRef="Shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:TargetedOrTrackingStockIssuanceDates
      contextRef="From2021-01-012021-12-31_custom_TuleekaNandyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004167">2021-08-12</us-gaap:TargetedOrTrackingStockIssuanceDates>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2021-12-31_custom_TuleekaNandyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004169"
      unitRef="USDPShares">0.06</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate
      contextRef="From2021-01-012021-12-31_custom_TuleekaNandyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004171">2021-09-01</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="AsOf2021-12-31_custom_TuleekaNandyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004173"
      unitRef="Shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="AsOf2021-12-31_custom_TuleekaNandyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004175"
      unitRef="Shares">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate
      contextRef="From2021-01-012021-12-31_custom_TuleekaNandyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004177">2025-09-01</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate
      contextRef="From2021-01-012021-12-31_custom_TuleekaNandyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004179">2021-08-12</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="From2021-01-012021-12-31_custom_TuleekaNandyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004181">2031-08-11</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2022-01-012022-12-31_custom_TuleekaNandyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004183"
      unitRef="Shares">15000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2022-12-31_custom_TuleekaNandyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004185"
      unitRef="Shares">15000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:TargetedOrTrackingStockIssuanceDates
      contextRef="From2022-01-012022-12-31_custom_TuleekaNandyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004187">2022-05-02</us-gaap:TargetedOrTrackingStockIssuanceDates>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2022-12-31_custom_TuleekaNandyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004189"
      unitRef="USDPShares">0.05</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate
      contextRef="From2022-01-012022-12-31_custom_TuleekaNandyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004191">2022-05-02</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="AsOf2022-12-31_custom_TuleekaNandyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004193"
      unitRef="Shares">7500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="AsOf2022-12-31_custom_TuleekaNandyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004195"
      unitRef="Shares">7500</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate
      contextRef="From2022-01-012022-12-31_custom_TuleekaNandyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004197">2026-05-02</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate
      contextRef="From2022-01-012022-12-31_custom_TuleekaNandyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004199">2022-05-02</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="From2022-01-012022-12-31_custom_TuleekaNandyMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004201">2032-05-01</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2021-01-012021-12-31_custom_RobelAtnafuMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004203"
      unitRef="Shares">5000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2021-12-31_custom_RobelAtnafuMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004205"
      unitRef="Shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:TargetedOrTrackingStockIssuanceDates
      contextRef="From2021-01-012021-12-31_custom_RobelAtnafuMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004207">2021-08-12</us-gaap:TargetedOrTrackingStockIssuanceDates>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2021-12-31_custom_RobelAtnafuMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004209"
      unitRef="USDPShares">0.06</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate
      contextRef="From2021-01-012021-12-31_custom_RobelAtnafuMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004211">2021-09-01</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="AsOf2021-12-31_custom_RobelAtnafuMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004213"
      unitRef="Shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="AsOf2021-12-31_custom_RobelAtnafuMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004215"
      unitRef="Shares">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate
      contextRef="From2021-01-012021-12-31_custom_RobelAtnafuMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004217">2025-09-01</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate
      contextRef="From2021-01-012021-12-31_custom_RobelAtnafuMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004219">2021-08-12</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="From2021-01-012021-12-31_custom_RobelAtnafuMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004221">2031-08-11</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2021-01-012021-12-31_custom_GuyPrimusMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004223"
      unitRef="Shares">360000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2021-12-31_custom_GuyPrimusMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004225"
      unitRef="Shares">360000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:TargetedOrTrackingStockIssuanceDates
      contextRef="From2021-01-012021-12-31_custom_GuyPrimusMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004227">2021-08-12</us-gaap:TargetedOrTrackingStockIssuanceDates>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2021-12-31_custom_GuyPrimusMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004229"
      unitRef="USDPShares">0.06</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate
      contextRef="From2021-01-012021-12-31_custom_GuyPrimusMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004231">2021-09-01</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="AsOf2021-12-31_custom_GuyPrimusMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004233"
      unitRef="Shares">240000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="AsOf2021-12-31_custom_GuyPrimusMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004235"
      unitRef="Shares">120000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate
      contextRef="From2021-01-012021-12-31_custom_GuyPrimusMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004237">2025-09-01</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate
      contextRef="From2021-01-012021-12-31_custom_GuyPrimusMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004239">2021-08-12</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="From2021-01-012021-12-31_custom_GuyPrimusMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004241">2031-08-11</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2022-01-012022-12-31_custom_SamarthaGowdaMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004243"
      unitRef="Shares">15000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2022-12-31_custom_SamarthaGowdaMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004245"
      unitRef="Shares">15000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:TargetedOrTrackingStockIssuanceDates
      contextRef="From2022-01-012022-12-31_custom_SamarthaGowdaMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004247">2022-05-02</us-gaap:TargetedOrTrackingStockIssuanceDates>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2022-12-31_custom_SamarthaGowdaMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004249"
      unitRef="USDPShares">0.05</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate
      contextRef="From2022-01-012022-12-31_custom_SamarthaGowdaMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004251">2022-05-02</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="AsOf2022-12-31_custom_SamarthaGowdaMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004253"
      unitRef="Shares">7500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="AsOf2022-12-31_custom_SamarthaGowdaMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004255"
      unitRef="Shares">7500</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate
      contextRef="From2022-01-012022-12-31_custom_SamarthaGowdaMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004257">2026-05-02</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate
      contextRef="From2022-01-012022-12-31_custom_SamarthaGowdaMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004259">2022-05-02</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="From2022-01-012022-12-31_custom_SamarthaGowdaMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004261">2032-05-01</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2022-01-012022-12-31_custom_AlexandraAielloMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004263"
      unitRef="Shares">2500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2022-12-31_custom_AlexandraAielloMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004265"
      unitRef="Shares">2500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:TargetedOrTrackingStockIssuanceDates
      contextRef="From2022-01-012022-12-31_custom_AlexandraAielloMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004267">2022-05-02</us-gaap:TargetedOrTrackingStockIssuanceDates>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2022-12-31_custom_AlexandraAielloMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004269"
      unitRef="USDPShares">0.05</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate
      contextRef="From2022-01-012022-12-31_custom_AlexandraAielloMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004271">2022-05-02</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="AsOf2022-12-31_custom_AlexandraAielloMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004273"
      unitRef="Shares">1250</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="AsOf2022-12-31_custom_AlexandraAielloMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004275"
      unitRef="Shares">1250</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate
      contextRef="From2022-01-012022-12-31_custom_AlexandraAielloMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004277">2026-05-02</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate
      contextRef="From2022-01-012022-12-31_custom_AlexandraAielloMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004279">2022-05-02</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="From2022-01-012022-12-31_custom_AlexandraAielloMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004281">2032-05-01</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2022-01-012022-12-31_custom_StephenCabralMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004283"
      unitRef="Shares">5000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2022-12-31_custom_StephenCabralMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004285"
      unitRef="Shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:TargetedOrTrackingStockIssuanceDates
      contextRef="From2022-01-012022-12-31_custom_StephenCabralMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004287">2022-05-02</us-gaap:TargetedOrTrackingStockIssuanceDates>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2022-12-31_custom_StephenCabralMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004289"
      unitRef="USDPShares">0.05</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate
      contextRef="From2022-01-012022-12-31_custom_StephenCabralMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004291">2022-05-02</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="AsOf2022-12-31_custom_StephenCabralMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004293"
      unitRef="Shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="AsOf2022-12-31_custom_StephenCabralMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004295"
      unitRef="Shares">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate
      contextRef="From2022-01-012022-12-31_custom_StephenCabralMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004297">2026-05-02</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate
      contextRef="From2022-01-012022-12-31_custom_StephenCabralMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004299">2022-05-02</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="From2022-01-012022-12-31_custom_StephenCabralMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004301">2032-05-01</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2022-01-012022-12-31_custom_JonahPetiPerrinMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004303"
      unitRef="Shares">2500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2022-12-31_custom_JonahPetiPerrinMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004305"
      unitRef="Shares">2500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:TargetedOrTrackingStockIssuanceDates
      contextRef="From2022-01-012022-12-31_custom_JonahPetiPerrinMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004307">2022-05-02</us-gaap:TargetedOrTrackingStockIssuanceDates>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2022-12-31_custom_JonahPetiPerrinMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004309"
      unitRef="USDPShares">0.05</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate
      contextRef="From2022-01-012022-12-31_custom_JonahPetiPerrinMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004311">2022-05-02</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="AsOf2022-12-31_custom_JonahPetiPerrinMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004313"
      unitRef="Shares">1250</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="AsOf2022-12-31_custom_JonahPetiPerrinMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004315"
      unitRef="Shares">1250</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate
      contextRef="From2022-01-012022-12-31_custom_JonahPetiPerrinMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004317">2026-05-02</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate
      contextRef="From2022-01-012022-12-31_custom_JonahPetiPerrinMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004319">2022-05-02</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="From2022-01-012022-12-31_custom_JonahPetiPerrinMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004321">2032-05-01</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2022-01-012022-12-31_custom_BryanNellaMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004323"
      unitRef="Shares">25000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2022-12-31_custom_BryanNellaMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004325"
      unitRef="Shares">25000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:TargetedOrTrackingStockIssuanceDates
      contextRef="From2022-01-012022-12-31_custom_BryanNellaMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004327">2022-05-02</us-gaap:TargetedOrTrackingStockIssuanceDates>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2022-12-31_custom_BryanNellaMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004329"
      unitRef="USDPShares">0.05</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate
      contextRef="From2022-01-012022-12-31_custom_BryanNellaMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004331">2022-05-02</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="AsOf2022-12-31_custom_BryanNellaMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004333"
      unitRef="Shares">12500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="AsOf2022-12-31_custom_BryanNellaMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004335"
      unitRef="Shares">12500</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate
      contextRef="From2022-01-012022-12-31_custom_BryanNellaMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004337">2026-05-02</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate
      contextRef="From2022-01-012022-12-31_custom_BryanNellaMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004339">2022-05-02</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="From2022-01-012022-12-31_custom_BryanNellaMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004341">2032-05-01</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2022-01-012022-12-31_custom_MarkSinkMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004343"
      unitRef="Shares">25000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2022-12-31_custom_MarkSinkMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004345"
      unitRef="Shares">25000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:TargetedOrTrackingStockIssuanceDates
      contextRef="From2022-01-012022-12-31_custom_MarkSinkMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004347">2022-05-16</us-gaap:TargetedOrTrackingStockIssuanceDates>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2022-12-31_custom_MarkSinkMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004349"
      unitRef="USDPShares">0.05</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate
      contextRef="From2022-01-012022-12-31_custom_MarkSinkMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004351">2022-05-16</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="AsOf2022-12-31_custom_MarkSinkMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004353"
      unitRef="Shares">12500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="AsOf2022-12-31_custom_MarkSinkMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004355"
      unitRef="Shares">12500</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate
      contextRef="From2022-01-012022-12-31_custom_MarkSinkMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004357">2026-05-16</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate
      contextRef="From2022-01-012022-12-31_custom_MarkSinkMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004359">2022-05-02</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="From2022-01-012022-12-31_custom_MarkSinkMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004361">2032-05-15</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2022-01-012022-12-31_custom_KoustavChoudhuriMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004363"
      unitRef="Shares">17000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2022-12-31_custom_KoustavChoudhuriMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004365"
      unitRef="Shares">17000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:TargetedOrTrackingStockIssuanceDates
      contextRef="From2022-01-012022-12-31_custom_KoustavChoudhuriMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004367">2022-05-16</us-gaap:TargetedOrTrackingStockIssuanceDates>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2022-12-31_custom_KoustavChoudhuriMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004369"
      unitRef="USDPShares">0.05</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate
      contextRef="From2022-01-012022-12-31_custom_KoustavChoudhuriMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004371">2022-05-16</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="AsOf2022-12-31_custom_KoustavChoudhuriMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004373"
      unitRef="Shares">8500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="AsOf2022-12-31_custom_KoustavChoudhuriMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004375"
      unitRef="Shares">8500</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate
      contextRef="From2022-01-012022-12-31_custom_KoustavChoudhuriMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004377">2026-05-16</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate>
    <RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate
      contextRef="From2022-01-012022-12-31_custom_KoustavChoudhuriMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004379">2022-05-02</RIME:ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="From2022-01-012022-12-31_custom_KoustavChoudhuriMember_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      id="Fact004381">2032-05-15</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2022-01-012022-12-31_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004383"
      unitRef="Shares">11712000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2022-12-31_us-gaap_StockOptionMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004385"
      unitRef="Shares">11597000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-01-012024-03-31_custom_FoundersMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004387"
      unitRef="Shares">25000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <RIME:SafePrivatePlacementsTextBlock
      contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember"
      id="Fact004389">&lt;p id="xdx_80D_ecustom--SafePrivatePlacementsTextBlock_zkMoV0TaqySi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
11 &#x2013;&lt;span id="xdx_82E_zqzxCowkNyk7"&gt;SAFE PRIVATE PLACEMENTS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Beginning
on October 25, 2018 through April 22, 2023, the Company entered into a total of 50 separate Simple Agreements for Future Equity (&#x201c;SAFE
Agreements&#x201d;). 45 distinct counterparties entered into subscription agreements with the Company, investing a total of $&lt;span id="xdx_908_eus-gaap--Investments_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEAgreementsMember_zw8qc4vbx8mb"&gt;5,038,820
&lt;/span&gt;during this period. The terms of these SAFE Agreements varied slightly over the course of this time frame. All of these investments were
made in the form of a private placement under Reg D and were considered exempt from registration at that time.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_892_ecustom--SafePrivatePlacementsTableTextBlock_zMdTYM5IwPF4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
table below summarizes the first tranche of subscriptions, all with the same terms and conditions.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; display: none; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BA_zbXdLJs5wjXa"&gt;SCHEDULE
OF FIRST TRANCHE OF SUBSCRIPTIONS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;


&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ID&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Convertible
    Holder Name&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Principal&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Issue
    Date&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Valuation
    Cap&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Converted
    Date&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 12%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;SAFE-1&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 23%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_905_ecustom--ConvertibleHolderName_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEOneMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zmBU6yAqD2Hi" title="Convertible Holder Name"&gt;Ardhendu
    Haldar&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEOneMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zliJ96O3eCyd" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Principal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;250,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 12%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_905_ecustom--InvestmentIssueDate_dd_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEOneMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zVsRHCePLDrl" title="Issue Date"&gt;10-25-2018&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_907_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEOneMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zF51JYfcVegi" title="Valuation Cap"&gt;10,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 15%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_907_ecustom--InvestmentConvertedDate_dd_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEOneMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zhQqLyTc9ISi" title="Converted Date"&gt;12-25-2020&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;SAFE-38&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_ecustom--ConvertibleHolderName_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyEightMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zsp0Xg3OZ17g" title="Convertible Holder Name"&gt;Praveen
    Kaza&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyEightMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zwKlJexkQVYc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90F_ecustom--InvestmentIssueDate_dd_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyEightMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zWVwrA2aR1ll" title="Issue Date"&gt;10-25-2018&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_905_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyEightMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zHCIbpCX9oTh" title="Valuation Cap"&gt;13,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90D_ecustom--InvestmentConvertedDate_dd_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyEightMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zcY9jTwULxIl" title="Converted Date"&gt;12-25-2020&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;SAFE-41&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_907_ecustom--ConvertibleHolderName_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyOneMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zNbrREaH5yVg" title="Convertible Holder Name"&gt;Kurt
    W Mattson&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyOneMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zjQUbNow8tH" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;50,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_ecustom--InvestmentIssueDate_dd_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyOneMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zeZsrnt9se8h" title="Issue Date"&gt;03-27-2019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_903_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyOneMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_z7scvcwKhoc2" title="Valuation Cap"&gt;20,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_ecustom--InvestmentConvertedDate_dd_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyOneMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zKL4FKO1Fmnc" title="Converted Date"&gt;12-25-2020&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;SAFE-42&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_908_ecustom--ConvertibleHolderName_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyTwoMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_z2dvffhkCpyh" title="Convertible Holder Name"&gt;Wendy
    A Thompson&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyTwoMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zOCnPEcTXJRe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;50,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90C_ecustom--InvestmentIssueDate_dd_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyTwoMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_z40PYKq7EC3c" title="Issue Date"&gt;03-27-2019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90E_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyTwoMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zVijYLn5dR3" title="Valuation Cap"&gt;20,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90E_ecustom--InvestmentConvertedDate_dd_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyTwoMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zOBbF9N3JDhc" title="Converted Date"&gt;12-25-2020&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;SAFE-44&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_907_ecustom--ConvertibleHolderName_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyFourMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zdE9XHWYEDdh" title="Convertible Holder Name"&gt;Sonata
    Software North America Inc&lt;/span&gt;.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyFourMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zVGewTXRhwrb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;468,041&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90B_ecustom--InvestmentIssueDate_dd_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyFourMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zNPuc9NcMVa2" title="Issue Date"&gt;02-24-2020&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90D_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyFourMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zmbPCN5pvDx3" title="Valuation Cap"&gt;10,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_ecustom--InvestmentConvertedDate_dd_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyFourMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zRDcr11ljCIl" title="Converted Date"&gt;12-25-2020&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;SAFE-43&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90C_ecustom--ConvertibleHolderName_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyThreeMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zkUUt1YUMlSf" title="Convertible Holder Name"&gt;THE
    IRA CLUB F/B/O RANJU MAHESHWARI ROTH IRA 2000201&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyThreeMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zUJGoISJZdW4" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;25,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90C_ecustom--InvestmentIssueDate_dd_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyThreeMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_z2hw2WkOElA7" title="Issue Date"&gt;06-15-2020&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_908_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyThreeMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zRWIOgb9n6o6" title="Valuation Cap"&gt;10,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_ecustom--InvestmentConvertedDate_dd_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyThreeMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zLBBYOIrIXTk" title="Converted Date"&gt;12-25-2020&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zSss5sYwsHj4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;943,041&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AE_zYrpx0ld86fe" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
total of six investors subscribed for a total of $&lt;span id="xdx_90E_eus-gaap--Investments_iI_c20240331__us-gaap--TypeOfArrangementAxis__custom--SAFEAgreementsMember_zNsFTh2bWTS3" title="Investments"&gt;943,041&lt;/span&gt; was invested at a valuation of $&lt;span id="xdx_904_ecustom--InvestedValuationOfAmount_c20240101__20240331__us-gaap--TypeOfArrangementAxis__custom--SAFEAgreementsMember_zbaKohTz30c2" title="Invested valuation of value"&gt;10,000,000&lt;/span&gt;. On December 25, 2020, all of these
SAFE Agreements were converted to preferred equity and the underlying subscription agreements were cancelled. These are the only SAFE
Agreements converted to date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;From
August 12, 2021 to April 22, 2023, the Company entered into the remaining 44 SAFE Agreements with a total of 39 individual counterparties.
The total amount of capital invested under these subscriptions was $&lt;span id="xdx_90E_ecustom--InvestedValuationOfAmount_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--FortyFourSAFEAgreementsMember_zWF5ApTWeWQa" title="Invested valuation of amount"&gt;4,095,779&lt;/span&gt;. The primary difference in the terms of this tranche of
capital raised was the valuation placed on the Company, which increased from a valuation of $&lt;span id="xdx_902_eus-gaap--DebtInstrumentFaceAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--FortyFourSAFEAgreementsMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zqKhmi8O6bRd" title="Principal amount"&gt;10,000,000&lt;/span&gt; under the first tranche to $&lt;span id="xdx_902_ecustom--InvestedValuationOfAmount_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--FortyFourSAFEAgreementsMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheTwoMember_z1Y1jTBvFU4c" title="Invested valuation of amount"&gt;35,000,000&lt;/span&gt;
under the second tranche. None of the second tranche of SAFE Agreements have been converted, cancelled, or otherwise amended.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_898_eus-gaap--InvestmentHoldingsScheduleOfInvestmentsTableTextBlock_zhB1KGs8u75" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
table below summarizes the remaining 44 SAFE Agreements, all of which are expected to terminated immediately after closing of the Transaction.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; display: none; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B7_zMmD0PkXOs9b" style="display: none"&gt;SUMMARY
OF  TERMINATED IMMEDIATELY AFTER CLOSING OF THE TRANSACTION&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif"&gt;ID&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif"&gt;Convertible Holder Name&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Principal&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Issue Date&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Valuation Cap&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 15%"&gt;SAFE-40&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 29%; text-align: left"&gt;&lt;span id="xdx_90A_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyMember_zNnWrhDBldck" title="Convertible Holder Name"&gt;Sunil Bhatia&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyMember_zEKBp996pwHi" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Principal"&gt;250,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: center"&gt;&lt;span id="xdx_902_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyMember_zPaiFTX2BXk8" title="Issue Date"&gt;08-12-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right"&gt;&lt;span id="xdx_901_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyMember_zI3TIfkGu0t2" title="Valuation Cap"&gt;15,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-39&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_90D_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyNineMember_z2xekIuZFKYe" title="Convertible Holder Name"&gt;Pallav Gupta&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyNineMember_zrn49RYrIbR3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;15,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_909_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyNineMember_z96jMvjVktAj" title="Issue Date"&gt;08-12-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_902_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyNineMember_zKrr458gx533" title="Valuation Cap"&gt;15,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-10&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_907_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETenMember_zkAQ4JGsh2K9" title="Convertible Holder Name"&gt;The Bhardwaj 2003 Revocable Trust&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETenMember_zxPlTIta7LCg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;200,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_90E_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETenMember_zPpAgbPO2igf" title="Issue Date"&gt;12-31-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_908_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETenMember_zvAiK7JMG6Ck" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-11&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_909_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEElevenMember_zx29Iq8xxFvf" title="Convertible Holder Name"&gt;Praveen Kaza&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEElevenMember_zDgGtuZ5Xpt2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;50,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_90C_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEElevenMember_zjMRPuI8Pqei" title="Issue Date"&gt;12-31-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_908_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEElevenMember_zuk39vaK0GIi" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-12&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_901_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwelveMember_zvucg5fvnDKk" title="Convertible Holder Name"&gt;Pallav Gupta&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwelveMember_zM4GJPvEhpF1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;20,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_905_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwelveMember_zsihZaL9rFLg" title="Issue Date"&gt;12-31-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwelveMember_zU3JDnKOLoMg" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-13&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_902_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirteenMember_zRj99Hawz5vj" title="Convertible Holder Name"&gt;Amit and Anju Bhardwaj&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirteenMember_zdS4E6YfSQa7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;50,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_900_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirteenMember_zuxmOK3Tw1Vj" title="Issue Date"&gt;12-31-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirteenMember_z7gdaPTaMrxh" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-14&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_908_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFourteenMember_zZRo7rH88Jk6" title="Convertible Holder Name"&gt;Komal Bajaj&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFourteenMember_zA4UOoq9A4G1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;50,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_900_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFourteenMember_zKCanzlfUdsg" title="Issue Date"&gt;12-31-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_907_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFourteenMember_zIKvaYNdkdMh" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-15&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFifteenMember_zj7F5dwItiYc" title="Convertible Holder Name"&gt;Goel Trust, Dated Aug 2, 2000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFifteenMember_zkgYiXUFZpy1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;100,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_900_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFifteenMember_zYEaBfG2lGlc" title="Issue Date"&gt;12-31-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFifteenMember_zPtrjrMBMVR" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-16&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_902_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESixteenMember_zjmnovNVUREh" title="Convertible Holder Name"&gt;Sanjiva Singh&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESixteenMember_zPbhZDlGti9i" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;100,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_90B_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESixteenMember_zmtZT7WmxGWd" title="Issue Date"&gt;12-31-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_908_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESixteenMember_zeXEnVfzKFOc" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-17&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_908_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESeventeenMember_zPT0HF6QbXz2" title="Convertible Holder Name"&gt;Rajeev Agarwal&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESeventeenMember_zWAgY5GiRFPd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;25,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_902_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESeventeenMember_zlWqcPmnUMm1" title="Issue Date"&gt;12-31-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_907_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESeventeenMember_zLISUGvFYJE1" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-18&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_900_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEEighteenMember_zvb6oFeoq7dc" title="Convertible Holder Name"&gt;Sanyogita and Sunil Gupta&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEEighteenMember_zlSZj5xmK85i" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;25,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_909_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEEighteenMember_zw4aZodHxbsd" title="Issue Date"&gt;12-31-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEEighteenMember_z0zCJl2UxNzh" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-19&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_902_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFENineteenMember_z5gYmgIRZC2j" title="Convertible Holder Name"&gt;SEM Gaingels Fund I, a series of JMWTX Investments, LP&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFENineteenMember_zHLtC1f3hJTb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;300,279&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_904_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFENineteenMember_zvUnvJTA2m74" title="Issue Date"&gt;12-31-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_902_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFENineteenMember_zcTAUrLJsjy3" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-2&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwoMember_ztzlSQofB838" title="Convertible Holder Name"&gt;FVI Fund LLC&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwoMember_z6Pm4zfQYkv4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;50,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_90F_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwoMember_z7SmG95GTUB7" title="Issue Date"&gt;12-31-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_902_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwoMember_z7obRtEGSim1" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-20&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_901_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyMember_zYy69ZruVOce" title="Convertible Holder Name"&gt;JWass PT Investors, LP - B2&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyMember_zlKjHaqejOWd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;10,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_902_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyMember_zOclF6NkOzk5" title="Issue Date"&gt;12-31-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_908_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyMember_zOpn12QWZsu" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-21&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_90C_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyOneMember_z9fzyC7DZ3d4" title="Convertible Holder Name"&gt;Medhavi Gupta&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyOneMember_zdvRuVWHS8D" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;20,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_902_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyOneMember_znwAza1j5Ujc" title="Issue Date"&gt;12-31-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_908_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyOneMember_znzs75RnW6Cl" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-22&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_90D_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyTwoMember_z144al2WrGR1" title="Convertible Holder Name"&gt;Sundeep Sibal&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyTwoMember_zhtfycm9WdOe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;50,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_908_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyTwoMember_zKn85GJ5Z0zi" title="Issue Date"&gt;12-31-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyTwoMember_zPfMSm9t0Xmf" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-24&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_901_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyFourMember_zAEqTQvKbuf2" title="Convertible Holder Name"&gt;Jolly Gupta&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyFourMember_zjmTFdn1ZnFl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;35,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_908_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyFourMember_zK104COnc0R2" title="Issue Date"&gt;12-31-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_907_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyFourMember_zfJ9p1jroqjj" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-3&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_908_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThreeMember_zRjjC2OLq2rk" title="Convertible Holder Name"&gt;Ashutosh Malaviya&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThreeMember_zZBAbKZN1IC6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;50,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_902_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThreeMember_zm1Tm30R8FY4" title="Issue Date"&gt;12-31-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_907_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThreeMember_zKftjrrX15b8" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-4&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_905_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFourMember_zG7nyP7UGV85" title="Convertible Holder Name"&gt;Consensia Inc&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFourMember_z9rqcLReDAC6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;50,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_903_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFourMember_zUV3DxTSvFXa" title="Issue Date"&gt;12-31-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFourMember_zOM7HbVmx624" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-45&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_902_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyFiveMember_z8Zwm7gyGDm9" title="Convertible Holder Name"&gt;Atula Sibal&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyFiveMember_zWwxjlxJtFG1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;50,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_90A_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyFiveMember_z1J2fHmUTJZ2" title="Issue Date"&gt;12-31-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyFiveMember_zovVeA5NUiI5" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-6&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_904_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESixMember_zAORJfg9xmPk" title="Convertible Holder Name"&gt;Ajay Bhatnagar&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESixMember_zMVvItr25CU3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;100,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_908_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESixMember_zCY7GJBRuXOa" title="Issue Date"&gt;12-31-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESixMember_zrmlbLeHoiRe" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-7&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_902_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESevenMember_zsXtuX1hlU3i" title="Convertible Holder Name"&gt;Pankaj Sinha&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESevenMember_zVEoAVhg3is6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;50,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_90D_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESevenMember_z6qqVZlPTGq2" title="Issue Date"&gt;12-31-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESevenMember_zCX9sTubOrif" title="Valuation Cap"&gt;35,000,00&lt;/span&gt;0&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-8&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_908_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEEightMember_z3FLJBYSju17" title="Convertible Holder Name"&gt;Bakulesh Adya&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEEightMember_za1ogWXLzuG" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;35,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_907_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEEightMember_zUf4NUgc5ltl" title="Issue Date"&gt;12-31-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_901_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEEightMember_z0GeTzCjdZ8a" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-9&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_90D_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFENineMember_zxkc6bd9qW14" title="Convertible Holder Name"&gt;Alok Mahajan&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFENineMember_zTrQ9S5ulMkj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;50,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_906_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFENineMember_zwEodwKJgPy3" title="Issue Date"&gt;12-31-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_909_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFENineMember_zAzDeee9QL8l" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-5&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_901_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFiveMember_zNIRhPwRjDqf" title="Convertible Holder Name"&gt;BANSAL GARG FAMILY TRUST AMIT BANSAL TRTEE KARUNA GARG TRTEE U/A 11/07/2017&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFiveMember_zTo0BWVT15Q2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;100,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_909_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFiveMember_zqdqxPgiq1Uh" title="Issue Date"&gt;12-31-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_901_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFiveMember_zoiEi4vFMMQ" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-25&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_901_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyFiveMember_z87GVP2Kr487" title="Convertible Holder Name"&gt;Disrupt Fund XVIII, LLC&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyFiveMember_zpDXoAkIL7gc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;50,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_906_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyFiveMember_z2iip7EJy5Zc" title="Issue Date"&gt;01-24-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_902_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyFiveMember_zIGi98eBjik8" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-26&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_903_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentySixMember_z5qk6UtZVyma" title="Convertible Holder Name"&gt;Ajatshatru and Manju Dhawal&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentySixMember_zwq5d84kJyqj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;25,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_90B_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentySixMember_zvXbDAVLuwEb" title="Issue Date"&gt;01-31-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_907_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentySixMember_z3QGORJeh0w7" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-27&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_908_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentySevenMember_zQISQihhra6h" title="Convertible Holder Name"&gt;Mrityunjay Dhawal&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentySevenMember_zaoVassLtjEc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;25,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_90A_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentySevenMember_z7BJQdSejaS9" title="Issue Date"&gt;01-31-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_909_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentySevenMember_zBfracneXCt3" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-28&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_90D_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyEightMember_zs6p2mtqhsyf" title="Convertible Holder Name"&gt;You Sexy Dawg, LLC&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyEightMember_zDaYJfvx0zr3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;50,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_90F_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyEightMember_zaxRpdVeNIgk" title="Issue Date"&gt;01-31-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyEightMember_zxC1LXiYo3fa" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-29&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_908_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyNineMember_zzINvLOaD5A2" title="Convertible Holder Name"&gt;Elisa deLaet&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyNineMember_zV3qmc05prX3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;25,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_90D_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyNineMember_zcqM2qkRQRdl" title="Issue Date"&gt;01-31-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_904_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyNineMember_zNdG7c4Mgh9i" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-30&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_90C_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyMember_z9A7xdcWrMck" title="Convertible Holder Name"&gt;Ardhendu Haldar&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyMember_zrWXHC3A6nAc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;100,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_90E_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyMember_zx4eM6Tyeixi" title="Issue Date"&gt;02-28-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_908_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyMember_zxHAEZ4L86Rf" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-31&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_90B_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyOneMember_z9s03pEKaLbc" title="Convertible Holder Name"&gt;Suzanne and Tom Lambert&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyOneMember_zUSy1B6ET8G8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;250,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_90D_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyOneMember_zju0awdaGHx9" title="Issue Date"&gt;02-28-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_900_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyOneMember_zkh6ooAfsSMf" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-32&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_90A_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyTwoMember_zCzp2jV9ZjNh" title="Convertible Holder Name"&gt;Nidus Capital Holdings, LLC&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyTwoMember_zC8z68bxng7l" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;250,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_908_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyTwoMember_zDDJO5nh0IJb" title="Issue Date"&gt;02-28-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyTwoMember_zoKzpsL4Pm31" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-33&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_909_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyThreeMember_za1CM0HpvT88" title="Convertible Holder Name"&gt;Compelling Natural Health II, LLC&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyThreeMember_zV625NkkSqAb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;250,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_90A_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyThreeMember_zhEHULcGdxie" title="Issue Date"&gt;02-28-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_905_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyThreeMember_zrlOk9avlmYb" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-34&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_901_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyFourMember_zxbogyxpmin4" title="Convertible Holder Name"&gt;Birch Hill Capital Group, LLC&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyFourMember_zjvNqbGpxkxe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;250,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_905_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyFourMember_zAy1t63ty99e" title="Issue Date"&gt;02-28-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_900_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyFourMember_zraxNBVKnfM2" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-35&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_90F_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyFiveMember_zwI3xKp4Nco2" title="Convertible Holder Name"&gt;Ingrid P. Maes as Trustee of The IPM Irrevocable Trust dated September 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyFiveMember_zNZy204xQP7l" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;250,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_90A_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyFiveMember_zSQoyF6nupMl" title="Issue Date"&gt;02-28-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyFiveMember_zJbWSxvp90Nd" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-36&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_90C_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtySixMember_ztVM9pdodOB7" title="Convertible Holder Name"&gt;Nattoceuticals, LLC&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtySixMember_z7ApdaQb37vc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;250,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_905_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtySixMember_zxEZbdt2Z7j1" title="Issue Date"&gt;02-28-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_902_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtySixMember_zvYBBuwLA0N4" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-37&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_905_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtySevenMember_zZRPNNnL8Vm7" title="Convertible Holder Name"&gt;Pallav Gupta&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtySevenMember_zH0Gh5Fm4rEe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;60,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_90A_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtySevenMember_zjBpxNYCNpA" title="Issue Date"&gt;02-28-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_902_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtySevenMember_zpcCwMgPJ0Jl" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-46&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_905_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortySixMember_z0Il1LOBPbM" title="Convertible Holder Name"&gt;Gaingels Semicab LLC&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortySixMember_zXe3YnldJGN8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;130,500&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_907_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortySixMember_z17TXVfMMkii" title="Issue Date"&gt;03-21-2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_905_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortySixMember_zJTaJaq4HfWh" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-50&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_90F_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFiftyMember_zkcNU8cVCKb3" title="Convertible Holder Name"&gt;Pankaj Sinha&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFiftyMember_zi2KO9kkOGtl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;50,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_90B_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFiftyMember_zZycYQjTglz3" title="Issue Date"&gt;04-04-2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_907_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFiftyMember_zvYcYOEtMBL5" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-48&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_901_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyEightMember_zYF6mij4ytgk" title="Convertible Holder Name"&gt;Lucy Holifield&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyEightMember_zT8XYsub1pkc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;70,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_906_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyEightMember_zaWFVEcDEAFf" title="Issue Date"&gt;04-14-2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_900_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyEightMember_zbigYlXvlFvg" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-47&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_902_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortySevenMember_zEYHNK6zi5Pf" title="Convertible Holder Name"&gt;Corvus Albus LLC&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortySevenMember_zgs3uoustsvc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;100,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_909_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortySevenMember_zNhU2aMYEqHa" title="Issue Date"&gt;04-19-2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortySevenMember_zW3XBIzILQ86" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-49&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_904_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyNineMember_zexIdYj1LXzg" title="Convertible Holder Name"&gt;David Friedland&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyNineMember_zAWqjBWO3Cvi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;50,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_90B_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyNineMember_zFXk85gUHVD2" title="Issue Date"&gt;04-19-2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyNineMember_z5oxexiVv7Y8" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;SAFE-51&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;&lt;span id="xdx_90E_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFiftyOneMember_zA1pnuTTL2zd" title="Convertible Holder Name"&gt;Kapil K Gupta&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFiftyOneMember_zAXtWhB2dFJ9" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;25,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"&gt;&lt;span id="xdx_908_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFiftyOneMember_zhQKwfvu2dNl" title="Issue Date"&gt;04-22-2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFiftyOneMember_zRFGcdWSHWK" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;TOTAL&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_ecustom--InvestmentOfPrincipalAmount_iI_c20230422_zZM1IaDPyD56" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;4,095,779&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p id="xdx_8AE_zZxvnaJE3qIk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</RIME:SafePrivatePlacementsTextBlock>
    <us-gaap:Investments
      contextRef="AsOf2023-04-22_custom_SAFEAgreementsMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004390"
      unitRef="USD">5038820</us-gaap:Investments>
    <RIME:SafePrivatePlacementsTableTextBlock
      contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember"
      id="Fact004392">&lt;p id="xdx_892_ecustom--SafePrivatePlacementsTableTextBlock_zMdTYM5IwPF4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
table below summarizes the first tranche of subscriptions, all with the same terms and conditions.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; display: none; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BA_zbXdLJs5wjXa"&gt;SCHEDULE
OF FIRST TRANCHE OF SUBSCRIPTIONS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;


&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ID&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Convertible
    Holder Name&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Principal&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Issue
    Date&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Valuation
    Cap&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Converted
    Date&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 12%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;SAFE-1&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 23%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_905_ecustom--ConvertibleHolderName_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEOneMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zmBU6yAqD2Hi" title="Convertible Holder Name"&gt;Ardhendu
    Haldar&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEOneMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zliJ96O3eCyd" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Principal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;250,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 12%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_905_ecustom--InvestmentIssueDate_dd_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEOneMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zVsRHCePLDrl" title="Issue Date"&gt;10-25-2018&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_907_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEOneMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zF51JYfcVegi" title="Valuation Cap"&gt;10,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 15%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_907_ecustom--InvestmentConvertedDate_dd_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEOneMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zhQqLyTc9ISi" title="Converted Date"&gt;12-25-2020&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;SAFE-38&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_ecustom--ConvertibleHolderName_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyEightMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zsp0Xg3OZ17g" title="Convertible Holder Name"&gt;Praveen
    Kaza&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyEightMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zwKlJexkQVYc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90F_ecustom--InvestmentIssueDate_dd_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyEightMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zWVwrA2aR1ll" title="Issue Date"&gt;10-25-2018&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_905_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyEightMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zHCIbpCX9oTh" title="Valuation Cap"&gt;13,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90D_ecustom--InvestmentConvertedDate_dd_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyEightMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zcY9jTwULxIl" title="Converted Date"&gt;12-25-2020&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;SAFE-41&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_907_ecustom--ConvertibleHolderName_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyOneMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zNbrREaH5yVg" title="Convertible Holder Name"&gt;Kurt
    W Mattson&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyOneMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zjQUbNow8tH" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;50,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_ecustom--InvestmentIssueDate_dd_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyOneMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zeZsrnt9se8h" title="Issue Date"&gt;03-27-2019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_903_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyOneMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_z7scvcwKhoc2" title="Valuation Cap"&gt;20,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_ecustom--InvestmentConvertedDate_dd_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyOneMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zKL4FKO1Fmnc" title="Converted Date"&gt;12-25-2020&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;SAFE-42&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_908_ecustom--ConvertibleHolderName_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyTwoMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_z2dvffhkCpyh" title="Convertible Holder Name"&gt;Wendy
    A Thompson&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyTwoMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zOCnPEcTXJRe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;50,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90C_ecustom--InvestmentIssueDate_dd_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyTwoMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_z40PYKq7EC3c" title="Issue Date"&gt;03-27-2019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90E_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyTwoMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zVijYLn5dR3" title="Valuation Cap"&gt;20,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90E_ecustom--InvestmentConvertedDate_dd_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyTwoMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zOBbF9N3JDhc" title="Converted Date"&gt;12-25-2020&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;SAFE-44&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_907_ecustom--ConvertibleHolderName_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyFourMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zdE9XHWYEDdh" title="Convertible Holder Name"&gt;Sonata
    Software North America Inc&lt;/span&gt;.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyFourMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zVGewTXRhwrb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;468,041&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90B_ecustom--InvestmentIssueDate_dd_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyFourMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zNPuc9NcMVa2" title="Issue Date"&gt;02-24-2020&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90D_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyFourMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zmbPCN5pvDx3" title="Valuation Cap"&gt;10,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_ecustom--InvestmentConvertedDate_dd_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyFourMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zRDcr11ljCIl" title="Converted Date"&gt;12-25-2020&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;SAFE-43&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90C_ecustom--ConvertibleHolderName_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyThreeMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zkUUt1YUMlSf" title="Convertible Holder Name"&gt;THE
    IRA CLUB F/B/O RANJU MAHESHWARI ROTH IRA 2000201&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyThreeMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zUJGoISJZdW4" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;25,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90C_ecustom--InvestmentIssueDate_dd_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyThreeMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_z2hw2WkOElA7" title="Issue Date"&gt;06-15-2020&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_908_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyThreeMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zRWIOgb9n6o6" title="Valuation Cap"&gt;10,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_ecustom--InvestmentConvertedDate_dd_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyThreeMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zLBBYOIrIXTk" title="Converted Date"&gt;12-25-2020&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zSss5sYwsHj4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;943,041&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</RIME:SafePrivatePlacementsTableTextBlock>
    <RIME:ConvertibleHolderName
      contextRef="From2018-10-252023-04-22_custom_SAFEOneMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember"
      id="Fact004394">Ardhendu
    Haldar</RIME:ConvertibleHolderName>
    <RIME:InvestmentOfPrincipalAmount
      contextRef="AsOf2023-04-22_custom_SAFEOneMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004396"
      unitRef="USD">250000</RIME:InvestmentOfPrincipalAmount>
    <RIME:InvestmentIssueDate
      contextRef="From2018-10-252023-04-22_custom_SAFEOneMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember"
      id="Fact004398">2018-10-25</RIME:InvestmentIssueDate>
    <RIME:ValuationCapitalOfInvestment
      contextRef="AsOf2023-04-22_custom_SAFEOneMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004400"
      unitRef="USD">10000000</RIME:ValuationCapitalOfInvestment>
    <RIME:InvestmentConvertedDate
      contextRef="From2018-10-252023-04-22_custom_SAFEOneMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember"
      id="Fact004402">2020-12-25</RIME:InvestmentConvertedDate>
    <RIME:ConvertibleHolderName
      contextRef="From2018-10-252023-04-22_custom_SAFEThirtyEightMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember"
      id="Fact004404">Praveen
    Kaza</RIME:ConvertibleHolderName>
    <RIME:InvestmentOfPrincipalAmount
      contextRef="AsOf2023-04-22_custom_SAFEThirtyEightMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004406"
      unitRef="USD">100000</RIME:InvestmentOfPrincipalAmount>
    <RIME:InvestmentIssueDate
      contextRef="From2018-10-252023-04-22_custom_SAFEThirtyEightMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember"
      id="Fact004408">2018-10-25</RIME:InvestmentIssueDate>
    <RIME:ValuationCapitalOfInvestment
      contextRef="AsOf2023-04-22_custom_SAFEThirtyEightMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004410"
      unitRef="USD">13000000</RIME:ValuationCapitalOfInvestment>
    <RIME:InvestmentConvertedDate
      contextRef="From2018-10-252023-04-22_custom_SAFEThirtyEightMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember"
      id="Fact004412">2020-12-25</RIME:InvestmentConvertedDate>
    <RIME:ConvertibleHolderName
      contextRef="From2018-10-252023-04-22_custom_SAFEFortyOneMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember"
      id="Fact004414">Kurt
    W Mattson</RIME:ConvertibleHolderName>
    <RIME:InvestmentOfPrincipalAmount
      contextRef="AsOf2023-04-22_custom_SAFEFortyOneMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004416"
      unitRef="USD">50000</RIME:InvestmentOfPrincipalAmount>
    <RIME:InvestmentIssueDate
      contextRef="From2018-10-252023-04-22_custom_SAFEFortyOneMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember"
      id="Fact004418">2019-03-27</RIME:InvestmentIssueDate>
    <RIME:ValuationCapitalOfInvestment
      contextRef="AsOf2023-04-22_custom_SAFEFortyOneMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004420"
      unitRef="USD">20000000</RIME:ValuationCapitalOfInvestment>
    <RIME:InvestmentConvertedDate
      contextRef="From2018-10-252023-04-22_custom_SAFEFortyOneMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember"
      id="Fact004422">2020-12-25</RIME:InvestmentConvertedDate>
    <RIME:ConvertibleHolderName
      contextRef="From2018-10-252023-04-22_custom_SAFEFortyTwoMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember"
      id="Fact004424">Wendy
    A Thompson</RIME:ConvertibleHolderName>
    <RIME:InvestmentOfPrincipalAmount
      contextRef="AsOf2023-04-22_custom_SAFEFortyTwoMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004426"
      unitRef="USD">50000</RIME:InvestmentOfPrincipalAmount>
    <RIME:InvestmentIssueDate
      contextRef="From2018-10-252023-04-22_custom_SAFEFortyTwoMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember"
      id="Fact004428">2019-03-27</RIME:InvestmentIssueDate>
    <RIME:ValuationCapitalOfInvestment
      contextRef="AsOf2023-04-22_custom_SAFEFortyTwoMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004430"
      unitRef="USD">20000000</RIME:ValuationCapitalOfInvestment>
    <RIME:InvestmentConvertedDate
      contextRef="From2018-10-252023-04-22_custom_SAFEFortyTwoMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember"
      id="Fact004432">2020-12-25</RIME:InvestmentConvertedDate>
    <RIME:ConvertibleHolderName
      contextRef="From2018-10-252023-04-22_custom_SAFEFortyFourMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember"
      id="Fact004434">Sonata
    Software North America Inc</RIME:ConvertibleHolderName>
    <RIME:InvestmentOfPrincipalAmount
      contextRef="AsOf2023-04-22_custom_SAFEFortyFourMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004436"
      unitRef="USD">468041</RIME:InvestmentOfPrincipalAmount>
    <RIME:InvestmentIssueDate
      contextRef="From2018-10-252023-04-22_custom_SAFEFortyFourMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember"
      id="Fact004438">2020-02-24</RIME:InvestmentIssueDate>
    <RIME:ValuationCapitalOfInvestment
      contextRef="AsOf2023-04-22_custom_SAFEFortyFourMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004440"
      unitRef="USD">10000000</RIME:ValuationCapitalOfInvestment>
    <RIME:InvestmentConvertedDate
      contextRef="From2018-10-252023-04-22_custom_SAFEFortyFourMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember"
      id="Fact004442">2020-12-25</RIME:InvestmentConvertedDate>
    <RIME:ConvertibleHolderName
      contextRef="From2018-10-252023-04-22_custom_SAFEFortyThreeMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember"
      id="Fact004444">THE
    IRA CLUB F/B/O RANJU MAHESHWARI ROTH IRA 2000201</RIME:ConvertibleHolderName>
    <RIME:InvestmentOfPrincipalAmount
      contextRef="AsOf2023-04-22_custom_SAFEFortyThreeMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004446"
      unitRef="USD">25000</RIME:InvestmentOfPrincipalAmount>
    <RIME:InvestmentIssueDate
      contextRef="From2018-10-252023-04-22_custom_SAFEFortyThreeMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember"
      id="Fact004448">2020-06-15</RIME:InvestmentIssueDate>
    <RIME:ValuationCapitalOfInvestment
      contextRef="AsOf2023-04-22_custom_SAFEFortyThreeMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004450"
      unitRef="USD">10000000</RIME:ValuationCapitalOfInvestment>
    <RIME:InvestmentConvertedDate
      contextRef="From2018-10-252023-04-22_custom_SAFEFortyThreeMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember"
      id="Fact004452">2020-12-25</RIME:InvestmentConvertedDate>
    <RIME:InvestmentOfPrincipalAmount
      contextRef="AsOf2023-04-22_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004454"
      unitRef="USD">943041</RIME:InvestmentOfPrincipalAmount>
    <us-gaap:Investments
      contextRef="AsOf2024-03-31_custom_SAFEAgreementsMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004456"
      unitRef="USD">943041</us-gaap:Investments>
    <RIME:InvestedValuationOfAmount
      contextRef="From2024-01-012024-03-31_custom_SAFEAgreementsMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004458"
      unitRef="USD">10000000</RIME:InvestedValuationOfAmount>
    <RIME:InvestedValuationOfAmount
      contextRef="From2021-08-122023-04-22_custom_FortyFourSAFEAgreementsMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004460"
      unitRef="USD">4095779</RIME:InvestedValuationOfAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2023-04-22_custom_FortyFourSAFEAgreementsMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004462"
      unitRef="USD">10000000</us-gaap:DebtInstrumentFaceAmount>
    <RIME:InvestedValuationOfAmount
      contextRef="From2021-08-122023-04-22_custom_FortyFourSAFEAgreementsMember_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004464"
      unitRef="USD">35000000</RIME:InvestedValuationOfAmount>
    <us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock
      contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember"
      id="Fact004466">&lt;p id="xdx_898_eus-gaap--InvestmentHoldingsScheduleOfInvestmentsTableTextBlock_zhB1KGs8u75" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
table below summarizes the remaining 44 SAFE Agreements, all of which are expected to terminated immediately after closing of the Transaction.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; display: none; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B7_zMmD0PkXOs9b" style="display: none"&gt;SUMMARY
OF  TERMINATED IMMEDIATELY AFTER CLOSING OF THE TRANSACTION&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif"&gt;ID&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif"&gt;Convertible Holder Name&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Principal&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Issue Date&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Valuation Cap&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 15%"&gt;SAFE-40&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 29%; text-align: left"&gt;&lt;span id="xdx_90A_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyMember_zNnWrhDBldck" title="Convertible Holder Name"&gt;Sunil Bhatia&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyMember_zEKBp996pwHi" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Principal"&gt;250,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: center"&gt;&lt;span id="xdx_902_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyMember_zPaiFTX2BXk8" title="Issue Date"&gt;08-12-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right"&gt;&lt;span id="xdx_901_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyMember_zI3TIfkGu0t2" title="Valuation Cap"&gt;15,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-39&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_90D_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyNineMember_z2xekIuZFKYe" title="Convertible Holder Name"&gt;Pallav Gupta&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyNineMember_zrn49RYrIbR3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;15,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_909_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyNineMember_z96jMvjVktAj" title="Issue Date"&gt;08-12-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_902_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyNineMember_zKrr458gx533" title="Valuation Cap"&gt;15,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-10&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_907_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETenMember_zkAQ4JGsh2K9" title="Convertible Holder Name"&gt;The Bhardwaj 2003 Revocable Trust&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETenMember_zxPlTIta7LCg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;200,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_90E_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETenMember_zPpAgbPO2igf" title="Issue Date"&gt;12-31-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_908_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETenMember_zvAiK7JMG6Ck" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-11&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_909_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEElevenMember_zx29Iq8xxFvf" title="Convertible Holder Name"&gt;Praveen Kaza&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEElevenMember_zDgGtuZ5Xpt2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;50,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_90C_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEElevenMember_zjMRPuI8Pqei" title="Issue Date"&gt;12-31-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_908_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEElevenMember_zuk39vaK0GIi" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-12&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_901_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwelveMember_zvucg5fvnDKk" title="Convertible Holder Name"&gt;Pallav Gupta&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwelveMember_zM4GJPvEhpF1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;20,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_905_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwelveMember_zsihZaL9rFLg" title="Issue Date"&gt;12-31-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwelveMember_zU3JDnKOLoMg" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-13&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_902_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirteenMember_zRj99Hawz5vj" title="Convertible Holder Name"&gt;Amit and Anju Bhardwaj&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirteenMember_zdS4E6YfSQa7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;50,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_900_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirteenMember_zuxmOK3Tw1Vj" title="Issue Date"&gt;12-31-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirteenMember_z7gdaPTaMrxh" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-14&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_908_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFourteenMember_zZRo7rH88Jk6" title="Convertible Holder Name"&gt;Komal Bajaj&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFourteenMember_zA4UOoq9A4G1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;50,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_900_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFourteenMember_zKCanzlfUdsg" title="Issue Date"&gt;12-31-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_907_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFourteenMember_zIKvaYNdkdMh" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-15&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFifteenMember_zj7F5dwItiYc" title="Convertible Holder Name"&gt;Goel Trust, Dated Aug 2, 2000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFifteenMember_zkgYiXUFZpy1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;100,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_900_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFifteenMember_zYEaBfG2lGlc" title="Issue Date"&gt;12-31-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFifteenMember_zPtrjrMBMVR" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-16&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_902_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESixteenMember_zjmnovNVUREh" title="Convertible Holder Name"&gt;Sanjiva Singh&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESixteenMember_zPbhZDlGti9i" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;100,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_90B_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESixteenMember_zmtZT7WmxGWd" title="Issue Date"&gt;12-31-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_908_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESixteenMember_zeXEnVfzKFOc" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-17&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_908_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESeventeenMember_zPT0HF6QbXz2" title="Convertible Holder Name"&gt;Rajeev Agarwal&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESeventeenMember_zWAgY5GiRFPd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;25,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_902_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESeventeenMember_zlWqcPmnUMm1" title="Issue Date"&gt;12-31-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_907_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESeventeenMember_zLISUGvFYJE1" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-18&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_900_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEEighteenMember_zvb6oFeoq7dc" title="Convertible Holder Name"&gt;Sanyogita and Sunil Gupta&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEEighteenMember_zlSZj5xmK85i" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;25,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_909_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEEighteenMember_zw4aZodHxbsd" title="Issue Date"&gt;12-31-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEEighteenMember_z0zCJl2UxNzh" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-19&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_902_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFENineteenMember_z5gYmgIRZC2j" title="Convertible Holder Name"&gt;SEM Gaingels Fund I, a series of JMWTX Investments, LP&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFENineteenMember_zHLtC1f3hJTb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;300,279&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_904_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFENineteenMember_zvUnvJTA2m74" title="Issue Date"&gt;12-31-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_902_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFENineteenMember_zcTAUrLJsjy3" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-2&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwoMember_ztzlSQofB838" title="Convertible Holder Name"&gt;FVI Fund LLC&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwoMember_z6Pm4zfQYkv4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;50,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_90F_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwoMember_z7SmG95GTUB7" title="Issue Date"&gt;12-31-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_902_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwoMember_z7obRtEGSim1" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-20&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_901_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyMember_zYy69ZruVOce" title="Convertible Holder Name"&gt;JWass PT Investors, LP - B2&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyMember_zlKjHaqejOWd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;10,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_902_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyMember_zOclF6NkOzk5" title="Issue Date"&gt;12-31-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_908_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyMember_zOpn12QWZsu" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-21&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_90C_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyOneMember_z9fzyC7DZ3d4" title="Convertible Holder Name"&gt;Medhavi Gupta&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyOneMember_zdvRuVWHS8D" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;20,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_902_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyOneMember_znwAza1j5Ujc" title="Issue Date"&gt;12-31-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_908_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyOneMember_znzs75RnW6Cl" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-22&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_90D_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyTwoMember_z144al2WrGR1" title="Convertible Holder Name"&gt;Sundeep Sibal&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyTwoMember_zhtfycm9WdOe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;50,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_908_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyTwoMember_zKn85GJ5Z0zi" title="Issue Date"&gt;12-31-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyTwoMember_zPfMSm9t0Xmf" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-24&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_901_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyFourMember_zAEqTQvKbuf2" title="Convertible Holder Name"&gt;Jolly Gupta&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyFourMember_zjmTFdn1ZnFl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;35,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_908_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyFourMember_zK104COnc0R2" title="Issue Date"&gt;12-31-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_907_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyFourMember_zfJ9p1jroqjj" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-3&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_908_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThreeMember_zRjjC2OLq2rk" title="Convertible Holder Name"&gt;Ashutosh Malaviya&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThreeMember_zZBAbKZN1IC6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;50,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_902_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThreeMember_zm1Tm30R8FY4" title="Issue Date"&gt;12-31-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_907_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThreeMember_zKftjrrX15b8" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-4&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_905_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFourMember_zG7nyP7UGV85" title="Convertible Holder Name"&gt;Consensia Inc&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFourMember_z9rqcLReDAC6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;50,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_903_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFourMember_zUV3DxTSvFXa" title="Issue Date"&gt;12-31-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFourMember_zOM7HbVmx624" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-45&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_902_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyFiveMember_z8Zwm7gyGDm9" title="Convertible Holder Name"&gt;Atula Sibal&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyFiveMember_zWwxjlxJtFG1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;50,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_90A_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyFiveMember_z1J2fHmUTJZ2" title="Issue Date"&gt;12-31-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyFiveMember_zovVeA5NUiI5" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-6&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_904_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESixMember_zAORJfg9xmPk" title="Convertible Holder Name"&gt;Ajay Bhatnagar&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESixMember_zMVvItr25CU3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;100,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_908_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESixMember_zCY7GJBRuXOa" title="Issue Date"&gt;12-31-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESixMember_zrmlbLeHoiRe" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-7&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_902_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESevenMember_zsXtuX1hlU3i" title="Convertible Holder Name"&gt;Pankaj Sinha&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESevenMember_zVEoAVhg3is6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;50,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_90D_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESevenMember_z6qqVZlPTGq2" title="Issue Date"&gt;12-31-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESevenMember_zCX9sTubOrif" title="Valuation Cap"&gt;35,000,00&lt;/span&gt;0&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-8&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_908_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEEightMember_z3FLJBYSju17" title="Convertible Holder Name"&gt;Bakulesh Adya&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEEightMember_za1ogWXLzuG" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;35,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_907_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEEightMember_zUf4NUgc5ltl" title="Issue Date"&gt;12-31-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_901_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEEightMember_z0GeTzCjdZ8a" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-9&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_90D_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFENineMember_zxkc6bd9qW14" title="Convertible Holder Name"&gt;Alok Mahajan&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFENineMember_zTrQ9S5ulMkj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;50,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_906_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFENineMember_zwEodwKJgPy3" title="Issue Date"&gt;12-31-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_909_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFENineMember_zAzDeee9QL8l" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-5&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_901_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFiveMember_zNIRhPwRjDqf" title="Convertible Holder Name"&gt;BANSAL GARG FAMILY TRUST AMIT BANSAL TRTEE KARUNA GARG TRTEE U/A 11/07/2017&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFiveMember_zTo0BWVT15Q2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;100,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_909_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFiveMember_zqdqxPgiq1Uh" title="Issue Date"&gt;12-31-2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_901_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFiveMember_zoiEi4vFMMQ" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-25&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_901_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyFiveMember_z87GVP2Kr487" title="Convertible Holder Name"&gt;Disrupt Fund XVIII, LLC&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyFiveMember_zpDXoAkIL7gc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;50,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_906_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyFiveMember_z2iip7EJy5Zc" title="Issue Date"&gt;01-24-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_902_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyFiveMember_zIGi98eBjik8" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-26&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_903_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentySixMember_z5qk6UtZVyma" title="Convertible Holder Name"&gt;Ajatshatru and Manju Dhawal&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentySixMember_zwq5d84kJyqj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;25,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_90B_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentySixMember_zvXbDAVLuwEb" title="Issue Date"&gt;01-31-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_907_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentySixMember_z3QGORJeh0w7" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-27&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_908_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentySevenMember_zQISQihhra6h" title="Convertible Holder Name"&gt;Mrityunjay Dhawal&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentySevenMember_zaoVassLtjEc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;25,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_90A_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentySevenMember_z7BJQdSejaS9" title="Issue Date"&gt;01-31-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_909_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentySevenMember_zBfracneXCt3" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-28&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_90D_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyEightMember_zs6p2mtqhsyf" title="Convertible Holder Name"&gt;You Sexy Dawg, LLC&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyEightMember_zDaYJfvx0zr3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;50,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_90F_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyEightMember_zaxRpdVeNIgk" title="Issue Date"&gt;01-31-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyEightMember_zxC1LXiYo3fa" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-29&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_908_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyNineMember_zzINvLOaD5A2" title="Convertible Holder Name"&gt;Elisa deLaet&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyNineMember_zV3qmc05prX3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;25,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_90D_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyNineMember_zcqM2qkRQRdl" title="Issue Date"&gt;01-31-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_904_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyNineMember_zNdG7c4Mgh9i" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-30&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_90C_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyMember_z9A7xdcWrMck" title="Convertible Holder Name"&gt;Ardhendu Haldar&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyMember_zrWXHC3A6nAc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;100,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_90E_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyMember_zx4eM6Tyeixi" title="Issue Date"&gt;02-28-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_908_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyMember_zxHAEZ4L86Rf" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-31&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_90B_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyOneMember_z9s03pEKaLbc" title="Convertible Holder Name"&gt;Suzanne and Tom Lambert&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyOneMember_zUSy1B6ET8G8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;250,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_90D_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyOneMember_zju0awdaGHx9" title="Issue Date"&gt;02-28-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_900_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyOneMember_zkh6ooAfsSMf" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-32&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_90A_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyTwoMember_zCzp2jV9ZjNh" title="Convertible Holder Name"&gt;Nidus Capital Holdings, LLC&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyTwoMember_zC8z68bxng7l" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;250,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_908_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyTwoMember_zDDJO5nh0IJb" title="Issue Date"&gt;02-28-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyTwoMember_zoKzpsL4Pm31" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-33&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_909_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyThreeMember_za1CM0HpvT88" title="Convertible Holder Name"&gt;Compelling Natural Health II, LLC&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyThreeMember_zV625NkkSqAb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;250,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_90A_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyThreeMember_zhEHULcGdxie" title="Issue Date"&gt;02-28-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_905_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyThreeMember_zrlOk9avlmYb" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-34&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_901_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyFourMember_zxbogyxpmin4" title="Convertible Holder Name"&gt;Birch Hill Capital Group, LLC&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyFourMember_zjvNqbGpxkxe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;250,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_905_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyFourMember_zAy1t63ty99e" title="Issue Date"&gt;02-28-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_900_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyFourMember_zraxNBVKnfM2" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-35&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_90F_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyFiveMember_zwI3xKp4Nco2" title="Convertible Holder Name"&gt;Ingrid P. Maes as Trustee of The IPM Irrevocable Trust dated September 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyFiveMember_zNZy204xQP7l" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;250,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_90A_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyFiveMember_zSQoyF6nupMl" title="Issue Date"&gt;02-28-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyFiveMember_zJbWSxvp90Nd" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-36&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_90C_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtySixMember_ztVM9pdodOB7" title="Convertible Holder Name"&gt;Nattoceuticals, LLC&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtySixMember_z7ApdaQb37vc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;250,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_905_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtySixMember_zxEZbdt2Z7j1" title="Issue Date"&gt;02-28-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_902_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtySixMember_zvYBBuwLA0N4" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-37&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_905_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtySevenMember_zZRPNNnL8Vm7" title="Convertible Holder Name"&gt;Pallav Gupta&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtySevenMember_zH0Gh5Fm4rEe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;60,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_90A_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtySevenMember_zjBpxNYCNpA" title="Issue Date"&gt;02-28-2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_902_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtySevenMember_zpcCwMgPJ0Jl" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-46&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_905_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortySixMember_z0Il1LOBPbM" title="Convertible Holder Name"&gt;Gaingels Semicab LLC&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortySixMember_zXe3YnldJGN8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;130,500&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_907_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortySixMember_z17TXVfMMkii" title="Issue Date"&gt;03-21-2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_905_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortySixMember_zJTaJaq4HfWh" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-50&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_90F_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFiftyMember_zkcNU8cVCKb3" title="Convertible Holder Name"&gt;Pankaj Sinha&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFiftyMember_zi2KO9kkOGtl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;50,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_90B_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFiftyMember_zZycYQjTglz3" title="Issue Date"&gt;04-04-2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_907_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFiftyMember_zvYcYOEtMBL5" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-48&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_901_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyEightMember_zYF6mij4ytgk" title="Convertible Holder Name"&gt;Lucy Holifield&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyEightMember_zT8XYsub1pkc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;70,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_906_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyEightMember_zaWFVEcDEAFf" title="Issue Date"&gt;04-14-2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_900_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyEightMember_zbigYlXvlFvg" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-47&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_902_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortySevenMember_zEYHNK6zi5Pf" title="Convertible Holder Name"&gt;Corvus Albus LLC&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortySevenMember_zgs3uoustsvc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;100,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_909_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortySevenMember_zNhU2aMYEqHa" title="Issue Date"&gt;04-19-2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortySevenMember_zW3XBIzILQ86" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;SAFE-49&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_904_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyNineMember_zexIdYj1LXzg" title="Convertible Holder Name"&gt;David Friedland&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyNineMember_zAWqjBWO3Cvi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;50,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_90B_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyNineMember_zFXk85gUHVD2" title="Issue Date"&gt;04-19-2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyNineMember_z5oxexiVv7Y8" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;SAFE-51&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;&lt;span id="xdx_90E_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFiftyOneMember_zA1pnuTTL2zd" title="Convertible Holder Name"&gt;Kapil K Gupta&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFiftyOneMember_zAXtWhB2dFJ9" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;25,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"&gt;&lt;span id="xdx_908_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFiftyOneMember_zhQKwfvu2dNl" title="Issue Date"&gt;04-22-2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFiftyOneMember_zRFGcdWSHWK" title="Valuation Cap"&gt;35,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;TOTAL&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_ecustom--InvestmentOfPrincipalAmount_iI_c20230422_zZM1IaDPyD56" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"&gt;4,095,779&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


</us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock>
    <RIME:ConvertibleHolderName
      contextRef="From2021-08-122023-04-22_custom_SAFEFortyMember_custom_SemiCabIncMember"
      id="Fact004468">Sunil Bhatia</RIME:ConvertibleHolderName>
    <RIME:InvestmentOfPrincipalAmount
      contextRef="AsOf2023-04-22_custom_SAFEFortyMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004470"
      unitRef="USD">250000</RIME:InvestmentOfPrincipalAmount>
    <RIME:InvestmentIssueDate
      contextRef="From2021-08-122023-04-22_custom_SAFEFortyMember_custom_SemiCabIncMember"
      id="Fact004472">2021-08-12</RIME:InvestmentIssueDate>
    <RIME:ValuationCapitalOfInvestment
      contextRef="AsOf2023-04-22_custom_SAFEFortyMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004474"
      unitRef="USD">15000000</RIME:ValuationCapitalOfInvestment>
    <RIME:ConvertibleHolderName
      contextRef="From2021-08-122023-04-22_custom_SAFEThirtyNineMember_custom_SemiCabIncMember"
      id="Fact004476">Pallav Gupta</RIME:ConvertibleHolderName>
    <RIME:InvestmentOfPrincipalAmount
      contextRef="AsOf2023-04-22_custom_SAFEThirtyNineMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004478"
      unitRef="USD">15000</RIME:InvestmentOfPrincipalAmount>
    <RIME:InvestmentIssueDate
      contextRef="From2021-08-122023-04-22_custom_SAFEThirtyNineMember_custom_SemiCabIncMember"
      id="Fact004480">2021-08-12</RIME:InvestmentIssueDate>
    <RIME:ValuationCapitalOfInvestment
      contextRef="AsOf2023-04-22_custom_SAFEThirtyNineMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004482"
      unitRef="USD">15000000</RIME:ValuationCapitalOfInvestment>
    <RIME:ConvertibleHolderName
      contextRef="From2021-08-122023-04-22_custom_SAFETenMember_custom_SemiCabIncMember"
      id="Fact004484">The Bhardwaj 2003 Revocable Trust</RIME:ConvertibleHolderName>
    <RIME:InvestmentOfPrincipalAmount
      contextRef="AsOf2023-04-22_custom_SAFETenMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004486"
      unitRef="USD">200000</RIME:InvestmentOfPrincipalAmount>
    <RIME:InvestmentIssueDate
      contextRef="From2021-08-122023-04-22_custom_SAFETenMember_custom_SemiCabIncMember"
      id="Fact004488">2021-12-31</RIME:InvestmentIssueDate>
    <RIME:ValuationCapitalOfInvestment
      contextRef="AsOf2023-04-22_custom_SAFETenMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004490"
      unitRef="USD">35000000</RIME:ValuationCapitalOfInvestment>
    <RIME:ConvertibleHolderName
      contextRef="From2021-08-122023-04-22_custom_SAFEElevenMember_custom_SemiCabIncMember"
      id="Fact004492">Praveen Kaza</RIME:ConvertibleHolderName>
    <RIME:InvestmentOfPrincipalAmount
      contextRef="AsOf2023-04-22_custom_SAFEElevenMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004494"
      unitRef="USD">50000</RIME:InvestmentOfPrincipalAmount>
    <RIME:InvestmentIssueDate
      contextRef="From2021-08-122023-04-22_custom_SAFEElevenMember_custom_SemiCabIncMember"
      id="Fact004496">2021-12-31</RIME:InvestmentIssueDate>
    <RIME:ValuationCapitalOfInvestment
      contextRef="AsOf2023-04-22_custom_SAFEElevenMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004498"
      unitRef="USD">35000000</RIME:ValuationCapitalOfInvestment>
    <RIME:ConvertibleHolderName
      contextRef="From2021-08-122023-04-22_custom_SAFETwelveMember_custom_SemiCabIncMember"
      id="Fact004500">Pallav Gupta</RIME:ConvertibleHolderName>
    <RIME:InvestmentOfPrincipalAmount
      contextRef="AsOf2023-04-22_custom_SAFETwelveMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004502"
      unitRef="USD">20000</RIME:InvestmentOfPrincipalAmount>
    <RIME:InvestmentIssueDate
      contextRef="From2021-08-122023-04-22_custom_SAFETwelveMember_custom_SemiCabIncMember"
      id="Fact004504">2021-12-31</RIME:InvestmentIssueDate>
    <RIME:ValuationCapitalOfInvestment
      contextRef="AsOf2023-04-22_custom_SAFETwelveMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004506"
      unitRef="USD">35000000</RIME:ValuationCapitalOfInvestment>
    <RIME:ConvertibleHolderName
      contextRef="From2021-08-122023-04-22_custom_SAFEThirteenMember_custom_SemiCabIncMember"
      id="Fact004508">Amit and Anju Bhardwaj</RIME:ConvertibleHolderName>
    <RIME:InvestmentOfPrincipalAmount
      contextRef="AsOf2023-04-22_custom_SAFEThirteenMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004510"
      unitRef="USD">50000</RIME:InvestmentOfPrincipalAmount>
    <RIME:InvestmentIssueDate
      contextRef="From2021-08-122023-04-22_custom_SAFEThirteenMember_custom_SemiCabIncMember"
      id="Fact004512">2021-12-31</RIME:InvestmentIssueDate>
    <RIME:ValuationCapitalOfInvestment
      contextRef="AsOf2023-04-22_custom_SAFEThirteenMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004514"
      unitRef="USD">35000000</RIME:ValuationCapitalOfInvestment>
    <RIME:ConvertibleHolderName
      contextRef="From2021-08-122023-04-22_custom_SAFEFourteenMember_custom_SemiCabIncMember"
      id="Fact004516">Komal Bajaj</RIME:ConvertibleHolderName>
    <RIME:InvestmentOfPrincipalAmount
      contextRef="AsOf2023-04-22_custom_SAFEFourteenMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004518"
      unitRef="USD">50000</RIME:InvestmentOfPrincipalAmount>
    <RIME:InvestmentIssueDate
      contextRef="From2021-08-122023-04-22_custom_SAFEFourteenMember_custom_SemiCabIncMember"
      id="Fact004520">2021-12-31</RIME:InvestmentIssueDate>
    <RIME:ValuationCapitalOfInvestment
      contextRef="AsOf2023-04-22_custom_SAFEFourteenMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004522"
      unitRef="USD">35000000</RIME:ValuationCapitalOfInvestment>
    <RIME:ConvertibleHolderName
      contextRef="From2021-08-122023-04-22_custom_SAFEFifteenMember_custom_SemiCabIncMember"
      id="Fact004524">Goel Trust, Dated Aug 2, 2000</RIME:ConvertibleHolderName>
    <RIME:InvestmentOfPrincipalAmount
      contextRef="AsOf2023-04-22_custom_SAFEFifteenMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004526"
      unitRef="USD">100000</RIME:InvestmentOfPrincipalAmount>
    <RIME:InvestmentIssueDate
      contextRef="From2021-08-122023-04-22_custom_SAFEFifteenMember_custom_SemiCabIncMember"
      id="Fact004528">2021-12-31</RIME:InvestmentIssueDate>
    <RIME:ValuationCapitalOfInvestment
      contextRef="AsOf2023-04-22_custom_SAFEFifteenMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004530"
      unitRef="USD">35000000</RIME:ValuationCapitalOfInvestment>
    <RIME:ConvertibleHolderName
      contextRef="From2021-08-122023-04-22_custom_SAFESixteenMember_custom_SemiCabIncMember"
      id="Fact004532">Sanjiva Singh</RIME:ConvertibleHolderName>
    <RIME:InvestmentOfPrincipalAmount
      contextRef="AsOf2023-04-22_custom_SAFESixteenMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004534"
      unitRef="USD">100000</RIME:InvestmentOfPrincipalAmount>
    <RIME:InvestmentIssueDate
      contextRef="From2021-08-122023-04-22_custom_SAFESixteenMember_custom_SemiCabIncMember"
      id="Fact004536">2021-12-31</RIME:InvestmentIssueDate>
    <RIME:ValuationCapitalOfInvestment
      contextRef="AsOf2023-04-22_custom_SAFESixteenMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004538"
      unitRef="USD">35000000</RIME:ValuationCapitalOfInvestment>
    <RIME:ConvertibleHolderName
      contextRef="From2021-08-122023-04-22_custom_SAFESeventeenMember_custom_SemiCabIncMember"
      id="Fact004540">Rajeev Agarwal</RIME:ConvertibleHolderName>
    <RIME:InvestmentOfPrincipalAmount
      contextRef="AsOf2023-04-22_custom_SAFESeventeenMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004542"
      unitRef="USD">25000</RIME:InvestmentOfPrincipalAmount>
    <RIME:InvestmentIssueDate
      contextRef="From2021-08-122023-04-22_custom_SAFESeventeenMember_custom_SemiCabIncMember"
      id="Fact004544">2021-12-31</RIME:InvestmentIssueDate>
    <RIME:ValuationCapitalOfInvestment
      contextRef="AsOf2023-04-22_custom_SAFESeventeenMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004546"
      unitRef="USD">35000000</RIME:ValuationCapitalOfInvestment>
    <RIME:ConvertibleHolderName
      contextRef="From2021-08-122023-04-22_custom_SAFEEighteenMember_custom_SemiCabIncMember"
      id="Fact004548">Sanyogita and Sunil Gupta</RIME:ConvertibleHolderName>
    <RIME:InvestmentOfPrincipalAmount
      contextRef="AsOf2023-04-22_custom_SAFEEighteenMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004550"
      unitRef="USD">25000</RIME:InvestmentOfPrincipalAmount>
    <RIME:InvestmentIssueDate
      contextRef="From2021-08-122023-04-22_custom_SAFEEighteenMember_custom_SemiCabIncMember"
      id="Fact004552">2021-12-31</RIME:InvestmentIssueDate>
    <RIME:ValuationCapitalOfInvestment
      contextRef="AsOf2023-04-22_custom_SAFEEighteenMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004554"
      unitRef="USD">35000000</RIME:ValuationCapitalOfInvestment>
    <RIME:ConvertibleHolderName
      contextRef="From2021-08-122023-04-22_custom_SAFENineteenMember_custom_SemiCabIncMember"
      id="Fact004556">SEM Gaingels Fund I, a series of JMWTX Investments, LP</RIME:ConvertibleHolderName>
    <RIME:InvestmentOfPrincipalAmount
      contextRef="AsOf2023-04-22_custom_SAFENineteenMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004558"
      unitRef="USD">300279</RIME:InvestmentOfPrincipalAmount>
    <RIME:InvestmentIssueDate
      contextRef="From2021-08-122023-04-22_custom_SAFENineteenMember_custom_SemiCabIncMember"
      id="Fact004560">2021-12-31</RIME:InvestmentIssueDate>
    <RIME:ValuationCapitalOfInvestment
      contextRef="AsOf2023-04-22_custom_SAFENineteenMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004562"
      unitRef="USD">35000000</RIME:ValuationCapitalOfInvestment>
    <RIME:ConvertibleHolderName
      contextRef="From2021-08-122023-04-22_custom_SAFETwoMember_custom_SemiCabIncMember"
      id="Fact004564">FVI Fund LLC</RIME:ConvertibleHolderName>
    <RIME:InvestmentOfPrincipalAmount
      contextRef="AsOf2023-04-22_custom_SAFETwoMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004566"
      unitRef="USD">50000</RIME:InvestmentOfPrincipalAmount>
    <RIME:InvestmentIssueDate
      contextRef="From2021-08-122023-04-22_custom_SAFETwoMember_custom_SemiCabIncMember"
      id="Fact004568">2021-12-31</RIME:InvestmentIssueDate>
    <RIME:ValuationCapitalOfInvestment
      contextRef="AsOf2023-04-22_custom_SAFETwoMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004570"
      unitRef="USD">35000000</RIME:ValuationCapitalOfInvestment>
    <RIME:ConvertibleHolderName
      contextRef="From2021-08-122023-04-22_custom_SAFETwentyMember_custom_SemiCabIncMember"
      id="Fact004572">JWass PT Investors, LP - B2</RIME:ConvertibleHolderName>
    <RIME:InvestmentOfPrincipalAmount
      contextRef="AsOf2023-04-22_custom_SAFETwentyMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004574"
      unitRef="USD">10000</RIME:InvestmentOfPrincipalAmount>
    <RIME:InvestmentIssueDate
      contextRef="From2021-08-122023-04-22_custom_SAFETwentyMember_custom_SemiCabIncMember"
      id="Fact004576">2021-12-31</RIME:InvestmentIssueDate>
    <RIME:ValuationCapitalOfInvestment
      contextRef="AsOf2023-04-22_custom_SAFETwentyMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004578"
      unitRef="USD">35000000</RIME:ValuationCapitalOfInvestment>
    <RIME:ConvertibleHolderName
      contextRef="From2021-08-122023-04-22_custom_SAFETwentyOneMember_custom_SemiCabIncMember"
      id="Fact004580">Medhavi Gupta</RIME:ConvertibleHolderName>
    <RIME:InvestmentOfPrincipalAmount
      contextRef="AsOf2023-04-22_custom_SAFETwentyOneMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004582"
      unitRef="USD">20000</RIME:InvestmentOfPrincipalAmount>
    <RIME:InvestmentIssueDate
      contextRef="From2021-08-122023-04-22_custom_SAFETwentyOneMember_custom_SemiCabIncMember"
      id="Fact004584">2021-12-31</RIME:InvestmentIssueDate>
    <RIME:ValuationCapitalOfInvestment
      contextRef="AsOf2023-04-22_custom_SAFETwentyOneMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004586"
      unitRef="USD">35000000</RIME:ValuationCapitalOfInvestment>
    <RIME:ConvertibleHolderName
      contextRef="From2021-08-122023-04-22_custom_SAFETwentyTwoMember_custom_SemiCabIncMember"
      id="Fact004588">Sundeep Sibal</RIME:ConvertibleHolderName>
    <RIME:InvestmentOfPrincipalAmount
      contextRef="AsOf2023-04-22_custom_SAFETwentyTwoMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004590"
      unitRef="USD">50000</RIME:InvestmentOfPrincipalAmount>
    <RIME:InvestmentIssueDate
      contextRef="From2021-08-122023-04-22_custom_SAFETwentyTwoMember_custom_SemiCabIncMember"
      id="Fact004592">2021-12-31</RIME:InvestmentIssueDate>
    <RIME:ValuationCapitalOfInvestment
      contextRef="AsOf2023-04-22_custom_SAFETwentyTwoMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004594"
      unitRef="USD">35000000</RIME:ValuationCapitalOfInvestment>
    <RIME:ConvertibleHolderName
      contextRef="From2021-08-122023-04-22_custom_SAFETwentyFourMember_custom_SemiCabIncMember"
      id="Fact004596">Jolly Gupta</RIME:ConvertibleHolderName>
    <RIME:InvestmentOfPrincipalAmount
      contextRef="AsOf2023-04-22_custom_SAFETwentyFourMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004598"
      unitRef="USD">35000</RIME:InvestmentOfPrincipalAmount>
    <RIME:InvestmentIssueDate
      contextRef="From2021-08-122023-04-22_custom_SAFETwentyFourMember_custom_SemiCabIncMember"
      id="Fact004600">2021-12-31</RIME:InvestmentIssueDate>
    <RIME:ValuationCapitalOfInvestment
      contextRef="AsOf2023-04-22_custom_SAFETwentyFourMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004602"
      unitRef="USD">35000000</RIME:ValuationCapitalOfInvestment>
    <RIME:ConvertibleHolderName
      contextRef="From2021-08-122023-04-22_custom_SAFEThreeMember_custom_SemiCabIncMember"
      id="Fact004604">Ashutosh Malaviya</RIME:ConvertibleHolderName>
    <RIME:InvestmentOfPrincipalAmount
      contextRef="AsOf2023-04-22_custom_SAFEThreeMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004606"
      unitRef="USD">50000</RIME:InvestmentOfPrincipalAmount>
    <RIME:InvestmentIssueDate
      contextRef="From2021-08-122023-04-22_custom_SAFEThreeMember_custom_SemiCabIncMember"
      id="Fact004608">2021-12-31</RIME:InvestmentIssueDate>
    <RIME:ValuationCapitalOfInvestment
      contextRef="AsOf2023-04-22_custom_SAFEThreeMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004610"
      unitRef="USD">35000000</RIME:ValuationCapitalOfInvestment>
    <RIME:ConvertibleHolderName
      contextRef="From2021-08-122023-04-22_custom_SAFEFourMember_custom_SemiCabIncMember"
      id="Fact004612">Consensia Inc</RIME:ConvertibleHolderName>
    <RIME:InvestmentOfPrincipalAmount
      contextRef="AsOf2023-04-22_custom_SAFEFourMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004614"
      unitRef="USD">50000</RIME:InvestmentOfPrincipalAmount>
    <RIME:InvestmentIssueDate
      contextRef="From2021-08-122023-04-22_custom_SAFEFourMember_custom_SemiCabIncMember"
      id="Fact004616">2021-12-31</RIME:InvestmentIssueDate>
    <RIME:ValuationCapitalOfInvestment
      contextRef="AsOf2023-04-22_custom_SAFEFourMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004618"
      unitRef="USD">35000000</RIME:ValuationCapitalOfInvestment>
    <RIME:ConvertibleHolderName
      contextRef="From2021-08-122023-04-22_custom_SAFEFortyFiveMember_custom_SemiCabIncMember"
      id="Fact004620">Atula Sibal</RIME:ConvertibleHolderName>
    <RIME:InvestmentOfPrincipalAmount
      contextRef="AsOf2023-04-22_custom_SAFEFortyFiveMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004622"
      unitRef="USD">50000</RIME:InvestmentOfPrincipalAmount>
    <RIME:InvestmentIssueDate
      contextRef="From2021-08-122023-04-22_custom_SAFEFortyFiveMember_custom_SemiCabIncMember"
      id="Fact004624">2021-12-31</RIME:InvestmentIssueDate>
    <RIME:ValuationCapitalOfInvestment
      contextRef="AsOf2023-04-22_custom_SAFEFortyFiveMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004626"
      unitRef="USD">35000000</RIME:ValuationCapitalOfInvestment>
    <RIME:ConvertibleHolderName
      contextRef="From2021-08-122023-04-22_custom_SAFESixMember_custom_SemiCabIncMember"
      id="Fact004628">Ajay Bhatnagar</RIME:ConvertibleHolderName>
    <RIME:InvestmentOfPrincipalAmount
      contextRef="AsOf2023-04-22_custom_SAFESixMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004630"
      unitRef="USD">100000</RIME:InvestmentOfPrincipalAmount>
    <RIME:InvestmentIssueDate
      contextRef="From2021-08-122023-04-22_custom_SAFESixMember_custom_SemiCabIncMember"
      id="Fact004632">2021-12-31</RIME:InvestmentIssueDate>
    <RIME:ValuationCapitalOfInvestment
      contextRef="AsOf2023-04-22_custom_SAFESixMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004634"
      unitRef="USD">35000000</RIME:ValuationCapitalOfInvestment>
    <RIME:ConvertibleHolderName
      contextRef="From2021-08-122023-04-22_custom_SAFESevenMember_custom_SemiCabIncMember"
      id="Fact004636">Pankaj Sinha</RIME:ConvertibleHolderName>
    <RIME:InvestmentOfPrincipalAmount
      contextRef="AsOf2023-04-22_custom_SAFESevenMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004638"
      unitRef="USD">50000</RIME:InvestmentOfPrincipalAmount>
    <RIME:InvestmentIssueDate
      contextRef="From2021-08-122023-04-22_custom_SAFESevenMember_custom_SemiCabIncMember"
      id="Fact004640">2021-12-31</RIME:InvestmentIssueDate>
    <RIME:ValuationCapitalOfInvestment
      contextRef="AsOf2023-04-22_custom_SAFESevenMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004642"
      unitRef="USD">35000.00</RIME:ValuationCapitalOfInvestment>
    <RIME:ConvertibleHolderName
      contextRef="From2021-08-122023-04-22_custom_SAFEEightMember_custom_SemiCabIncMember"
      id="Fact004644">Bakulesh Adya</RIME:ConvertibleHolderName>
    <RIME:InvestmentOfPrincipalAmount
      contextRef="AsOf2023-04-22_custom_SAFEEightMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004646"
      unitRef="USD">35000</RIME:InvestmentOfPrincipalAmount>
    <RIME:InvestmentIssueDate
      contextRef="From2021-08-122023-04-22_custom_SAFEEightMember_custom_SemiCabIncMember"
      id="Fact004648">2021-12-31</RIME:InvestmentIssueDate>
    <RIME:ValuationCapitalOfInvestment
      contextRef="AsOf2023-04-22_custom_SAFEEightMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004650"
      unitRef="USD">35000000</RIME:ValuationCapitalOfInvestment>
    <RIME:ConvertibleHolderName
      contextRef="From2021-08-122023-04-22_custom_SAFENineMember_custom_SemiCabIncMember"
      id="Fact004652">Alok Mahajan</RIME:ConvertibleHolderName>
    <RIME:InvestmentOfPrincipalAmount
      contextRef="AsOf2023-04-22_custom_SAFENineMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004654"
      unitRef="USD">50000</RIME:InvestmentOfPrincipalAmount>
    <RIME:InvestmentIssueDate
      contextRef="From2021-08-122023-04-22_custom_SAFENineMember_custom_SemiCabIncMember"
      id="Fact004656">2021-12-31</RIME:InvestmentIssueDate>
    <RIME:ValuationCapitalOfInvestment
      contextRef="AsOf2023-04-22_custom_SAFENineMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004658"
      unitRef="USD">35000000</RIME:ValuationCapitalOfInvestment>
    <RIME:ConvertibleHolderName
      contextRef="From2021-08-122023-04-22_custom_SAFEFiveMember_custom_SemiCabIncMember"
      id="Fact004660">BANSAL GARG FAMILY TRUST AMIT BANSAL TRTEE KARUNA GARG TRTEE U/A 11/07/2017</RIME:ConvertibleHolderName>
    <RIME:InvestmentOfPrincipalAmount
      contextRef="AsOf2023-04-22_custom_SAFEFiveMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004662"
      unitRef="USD">100000</RIME:InvestmentOfPrincipalAmount>
    <RIME:InvestmentIssueDate
      contextRef="From2021-08-122023-04-22_custom_SAFEFiveMember_custom_SemiCabIncMember"
      id="Fact004664">2021-12-31</RIME:InvestmentIssueDate>
    <RIME:ValuationCapitalOfInvestment
      contextRef="AsOf2023-04-22_custom_SAFEFiveMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004666"
      unitRef="USD">35000000</RIME:ValuationCapitalOfInvestment>
    <RIME:ConvertibleHolderName
      contextRef="From2021-08-122023-04-22_custom_SAFETwentyFiveMember_custom_SemiCabIncMember"
      id="Fact004668">Disrupt Fund XVIII, LLC</RIME:ConvertibleHolderName>
    <RIME:InvestmentOfPrincipalAmount
      contextRef="AsOf2023-04-22_custom_SAFETwentyFiveMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004670"
      unitRef="USD">50000</RIME:InvestmentOfPrincipalAmount>
    <RIME:InvestmentIssueDate
      contextRef="From2021-08-122023-04-22_custom_SAFETwentyFiveMember_custom_SemiCabIncMember"
      id="Fact004672">2022-01-24</RIME:InvestmentIssueDate>
    <RIME:ValuationCapitalOfInvestment
      contextRef="AsOf2023-04-22_custom_SAFETwentyFiveMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004674"
      unitRef="USD">35000000</RIME:ValuationCapitalOfInvestment>
    <RIME:ConvertibleHolderName
      contextRef="From2021-08-122023-04-22_custom_SAFETwentySixMember_custom_SemiCabIncMember"
      id="Fact004676">Ajatshatru and Manju Dhawal</RIME:ConvertibleHolderName>
    <RIME:InvestmentOfPrincipalAmount
      contextRef="AsOf2023-04-22_custom_SAFETwentySixMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004678"
      unitRef="USD">25000</RIME:InvestmentOfPrincipalAmount>
    <RIME:InvestmentIssueDate
      contextRef="From2021-08-122023-04-22_custom_SAFETwentySixMember_custom_SemiCabIncMember"
      id="Fact004680">2022-01-31</RIME:InvestmentIssueDate>
    <RIME:ValuationCapitalOfInvestment
      contextRef="AsOf2023-04-22_custom_SAFETwentySixMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004682"
      unitRef="USD">35000000</RIME:ValuationCapitalOfInvestment>
    <RIME:ConvertibleHolderName
      contextRef="From2021-08-122023-04-22_custom_SAFETwentySevenMember_custom_SemiCabIncMember"
      id="Fact004684">Mrityunjay Dhawal</RIME:ConvertibleHolderName>
    <RIME:InvestmentOfPrincipalAmount
      contextRef="AsOf2023-04-22_custom_SAFETwentySevenMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004686"
      unitRef="USD">25000</RIME:InvestmentOfPrincipalAmount>
    <RIME:InvestmentIssueDate
      contextRef="From2021-08-122023-04-22_custom_SAFETwentySevenMember_custom_SemiCabIncMember"
      id="Fact004688">2022-01-31</RIME:InvestmentIssueDate>
    <RIME:ValuationCapitalOfInvestment
      contextRef="AsOf2023-04-22_custom_SAFETwentySevenMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004690"
      unitRef="USD">35000000</RIME:ValuationCapitalOfInvestment>
    <RIME:ConvertibleHolderName
      contextRef="From2021-08-122023-04-22_custom_SAFETwentyEightMember_custom_SemiCabIncMember"
      id="Fact004692">You Sexy Dawg, LLC</RIME:ConvertibleHolderName>
    <RIME:InvestmentOfPrincipalAmount
      contextRef="AsOf2023-04-22_custom_SAFETwentyEightMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004694"
      unitRef="USD">50000</RIME:InvestmentOfPrincipalAmount>
    <RIME:InvestmentIssueDate
      contextRef="From2021-08-122023-04-22_custom_SAFETwentyEightMember_custom_SemiCabIncMember"
      id="Fact004696">2022-01-31</RIME:InvestmentIssueDate>
    <RIME:ValuationCapitalOfInvestment
      contextRef="AsOf2023-04-22_custom_SAFETwentyEightMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004698"
      unitRef="USD">35000000</RIME:ValuationCapitalOfInvestment>
    <RIME:ConvertibleHolderName
      contextRef="From2021-08-122023-04-22_custom_SAFETwentyNineMember_custom_SemiCabIncMember"
      id="Fact004700">Elisa deLaet</RIME:ConvertibleHolderName>
    <RIME:InvestmentOfPrincipalAmount
      contextRef="AsOf2023-04-22_custom_SAFETwentyNineMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004702"
      unitRef="USD">25000</RIME:InvestmentOfPrincipalAmount>
    <RIME:InvestmentIssueDate
      contextRef="From2021-08-122023-04-22_custom_SAFETwentyNineMember_custom_SemiCabIncMember"
      id="Fact004704">2022-01-31</RIME:InvestmentIssueDate>
    <RIME:ValuationCapitalOfInvestment
      contextRef="AsOf2023-04-22_custom_SAFETwentyNineMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004706"
      unitRef="USD">35000000</RIME:ValuationCapitalOfInvestment>
    <RIME:ConvertibleHolderName
      contextRef="From2021-08-122023-04-22_custom_SAFEThirtyMember_custom_SemiCabIncMember"
      id="Fact004708">Ardhendu Haldar</RIME:ConvertibleHolderName>
    <RIME:InvestmentOfPrincipalAmount
      contextRef="AsOf2023-04-22_custom_SAFEThirtyMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004710"
      unitRef="USD">100000</RIME:InvestmentOfPrincipalAmount>
    <RIME:InvestmentIssueDate
      contextRef="From2021-08-122023-04-22_custom_SAFEThirtyMember_custom_SemiCabIncMember"
      id="Fact004712">2022-02-28</RIME:InvestmentIssueDate>
    <RIME:ValuationCapitalOfInvestment
      contextRef="AsOf2023-04-22_custom_SAFEThirtyMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004714"
      unitRef="USD">35000000</RIME:ValuationCapitalOfInvestment>
    <RIME:ConvertibleHolderName
      contextRef="From2021-08-122023-04-22_custom_SAFEThirtyOneMember_custom_SemiCabIncMember"
      id="Fact004716">Suzanne and Tom Lambert</RIME:ConvertibleHolderName>
    <RIME:InvestmentOfPrincipalAmount
      contextRef="AsOf2023-04-22_custom_SAFEThirtyOneMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004718"
      unitRef="USD">250000</RIME:InvestmentOfPrincipalAmount>
    <RIME:InvestmentIssueDate
      contextRef="From2021-08-122023-04-22_custom_SAFEThirtyOneMember_custom_SemiCabIncMember"
      id="Fact004720">2022-02-28</RIME:InvestmentIssueDate>
    <RIME:ValuationCapitalOfInvestment
      contextRef="AsOf2023-04-22_custom_SAFEThirtyOneMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004722"
      unitRef="USD">35000000</RIME:ValuationCapitalOfInvestment>
    <RIME:ConvertibleHolderName
      contextRef="From2021-08-122023-04-22_custom_SAFEThirtyTwoMember_custom_SemiCabIncMember"
      id="Fact004724">Nidus Capital Holdings, LLC</RIME:ConvertibleHolderName>
    <RIME:InvestmentOfPrincipalAmount
      contextRef="AsOf2023-04-22_custom_SAFEThirtyTwoMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004726"
      unitRef="USD">250000</RIME:InvestmentOfPrincipalAmount>
    <RIME:InvestmentIssueDate
      contextRef="From2021-08-122023-04-22_custom_SAFEThirtyTwoMember_custom_SemiCabIncMember"
      id="Fact004728">2022-02-28</RIME:InvestmentIssueDate>
    <RIME:ValuationCapitalOfInvestment
      contextRef="AsOf2023-04-22_custom_SAFEThirtyTwoMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004730"
      unitRef="USD">35000000</RIME:ValuationCapitalOfInvestment>
    <RIME:ConvertibleHolderName
      contextRef="From2021-08-122023-04-22_custom_SAFEThirtyThreeMember_custom_SemiCabIncMember"
      id="Fact004732">Compelling Natural Health II, LLC</RIME:ConvertibleHolderName>
    <RIME:InvestmentOfPrincipalAmount
      contextRef="AsOf2023-04-22_custom_SAFEThirtyThreeMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004734"
      unitRef="USD">250000</RIME:InvestmentOfPrincipalAmount>
    <RIME:InvestmentIssueDate
      contextRef="From2021-08-122023-04-22_custom_SAFEThirtyThreeMember_custom_SemiCabIncMember"
      id="Fact004736">2022-02-28</RIME:InvestmentIssueDate>
    <RIME:ValuationCapitalOfInvestment
      contextRef="AsOf2023-04-22_custom_SAFEThirtyThreeMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004738"
      unitRef="USD">35000000</RIME:ValuationCapitalOfInvestment>
    <RIME:ConvertibleHolderName
      contextRef="From2021-08-122023-04-22_custom_SAFEThirtyFourMember_custom_SemiCabIncMember"
      id="Fact004740">Birch Hill Capital Group, LLC</RIME:ConvertibleHolderName>
    <RIME:InvestmentOfPrincipalAmount
      contextRef="AsOf2023-04-22_custom_SAFEThirtyFourMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004742"
      unitRef="USD">250000</RIME:InvestmentOfPrincipalAmount>
    <RIME:InvestmentIssueDate
      contextRef="From2021-08-122023-04-22_custom_SAFEThirtyFourMember_custom_SemiCabIncMember"
      id="Fact004744">2022-02-28</RIME:InvestmentIssueDate>
    <RIME:ValuationCapitalOfInvestment
      contextRef="AsOf2023-04-22_custom_SAFEThirtyFourMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004746"
      unitRef="USD">35000000</RIME:ValuationCapitalOfInvestment>
    <RIME:ConvertibleHolderName
      contextRef="From2021-08-122023-04-22_custom_SAFEThirtyFiveMember_custom_SemiCabIncMember"
      id="Fact004748">Ingrid P. Maes as Trustee of The IPM Irrevocable Trust dated September 1, 2022</RIME:ConvertibleHolderName>
    <RIME:InvestmentOfPrincipalAmount
      contextRef="AsOf2023-04-22_custom_SAFEThirtyFiveMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004750"
      unitRef="USD">250000</RIME:InvestmentOfPrincipalAmount>
    <RIME:InvestmentIssueDate
      contextRef="From2021-08-122023-04-22_custom_SAFEThirtyFiveMember_custom_SemiCabIncMember"
      id="Fact004752">2022-02-28</RIME:InvestmentIssueDate>
    <RIME:ValuationCapitalOfInvestment
      contextRef="AsOf2023-04-22_custom_SAFEThirtyFiveMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004754"
      unitRef="USD">35000000</RIME:ValuationCapitalOfInvestment>
    <RIME:ConvertibleHolderName
      contextRef="From2021-08-122023-04-22_custom_SAFEThirtySixMember_custom_SemiCabIncMember"
      id="Fact004756">Nattoceuticals, LLC</RIME:ConvertibleHolderName>
    <RIME:InvestmentOfPrincipalAmount
      contextRef="AsOf2023-04-22_custom_SAFEThirtySixMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004758"
      unitRef="USD">250000</RIME:InvestmentOfPrincipalAmount>
    <RIME:InvestmentIssueDate
      contextRef="From2021-08-122023-04-22_custom_SAFEThirtySixMember_custom_SemiCabIncMember"
      id="Fact004760">2022-02-28</RIME:InvestmentIssueDate>
    <RIME:ValuationCapitalOfInvestment
      contextRef="AsOf2023-04-22_custom_SAFEThirtySixMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004762"
      unitRef="USD">35000000</RIME:ValuationCapitalOfInvestment>
    <RIME:ConvertibleHolderName
      contextRef="From2021-08-122023-04-22_custom_SAFEThirtySevenMember_custom_SemiCabIncMember"
      id="Fact004764">Pallav Gupta</RIME:ConvertibleHolderName>
    <RIME:InvestmentOfPrincipalAmount
      contextRef="AsOf2023-04-22_custom_SAFEThirtySevenMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004766"
      unitRef="USD">60000</RIME:InvestmentOfPrincipalAmount>
    <RIME:InvestmentIssueDate
      contextRef="From2021-08-122023-04-22_custom_SAFEThirtySevenMember_custom_SemiCabIncMember"
      id="Fact004768">2022-02-28</RIME:InvestmentIssueDate>
    <RIME:ValuationCapitalOfInvestment
      contextRef="AsOf2023-04-22_custom_SAFEThirtySevenMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004770"
      unitRef="USD">35000000</RIME:ValuationCapitalOfInvestment>
    <RIME:ConvertibleHolderName
      contextRef="From2021-08-122023-04-22_custom_SAFEFortySixMember_custom_SemiCabIncMember"
      id="Fact004772">Gaingels Semicab LLC</RIME:ConvertibleHolderName>
    <RIME:InvestmentOfPrincipalAmount
      contextRef="AsOf2023-04-22_custom_SAFEFortySixMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004774"
      unitRef="USD">130500</RIME:InvestmentOfPrincipalAmount>
    <RIME:InvestmentIssueDate
      contextRef="From2021-08-122023-04-22_custom_SAFEFortySixMember_custom_SemiCabIncMember"
      id="Fact004776">2023-03-21</RIME:InvestmentIssueDate>
    <RIME:ValuationCapitalOfInvestment
      contextRef="AsOf2023-04-22_custom_SAFEFortySixMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004778"
      unitRef="USD">35000000</RIME:ValuationCapitalOfInvestment>
    <RIME:ConvertibleHolderName
      contextRef="From2021-08-122023-04-22_custom_SAFEFiftyMember_custom_SemiCabIncMember"
      id="Fact004780">Pankaj Sinha</RIME:ConvertibleHolderName>
    <RIME:InvestmentOfPrincipalAmount
      contextRef="AsOf2023-04-22_custom_SAFEFiftyMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004782"
      unitRef="USD">50000</RIME:InvestmentOfPrincipalAmount>
    <RIME:InvestmentIssueDate
      contextRef="From2021-08-122023-04-22_custom_SAFEFiftyMember_custom_SemiCabIncMember"
      id="Fact004784">2023-04-04</RIME:InvestmentIssueDate>
    <RIME:ValuationCapitalOfInvestment
      contextRef="AsOf2023-04-22_custom_SAFEFiftyMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004786"
      unitRef="USD">35000000</RIME:ValuationCapitalOfInvestment>
    <RIME:ConvertibleHolderName
      contextRef="From2021-08-122023-04-22_custom_SAFEFortyEightMember_custom_SemiCabIncMember"
      id="Fact004788">Lucy Holifield</RIME:ConvertibleHolderName>
    <RIME:InvestmentOfPrincipalAmount
      contextRef="AsOf2023-04-22_custom_SAFEFortyEightMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004790"
      unitRef="USD">70000</RIME:InvestmentOfPrincipalAmount>
    <RIME:InvestmentIssueDate
      contextRef="From2021-08-122023-04-22_custom_SAFEFortyEightMember_custom_SemiCabIncMember"
      id="Fact004792">2023-04-14</RIME:InvestmentIssueDate>
    <RIME:ValuationCapitalOfInvestment
      contextRef="AsOf2023-04-22_custom_SAFEFortyEightMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004794"
      unitRef="USD">35000000</RIME:ValuationCapitalOfInvestment>
    <RIME:ConvertibleHolderName
      contextRef="From2021-08-122023-04-22_custom_SAFEFortySevenMember_custom_SemiCabIncMember"
      id="Fact004796">Corvus Albus LLC</RIME:ConvertibleHolderName>
    <RIME:InvestmentOfPrincipalAmount
      contextRef="AsOf2023-04-22_custom_SAFEFortySevenMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004798"
      unitRef="USD">100000</RIME:InvestmentOfPrincipalAmount>
    <RIME:InvestmentIssueDate
      contextRef="From2021-08-122023-04-22_custom_SAFEFortySevenMember_custom_SemiCabIncMember"
      id="Fact004800">2023-04-19</RIME:InvestmentIssueDate>
    <RIME:ValuationCapitalOfInvestment
      contextRef="AsOf2023-04-22_custom_SAFEFortySevenMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004802"
      unitRef="USD">35000000</RIME:ValuationCapitalOfInvestment>
    <RIME:ConvertibleHolderName
      contextRef="From2021-08-122023-04-22_custom_SAFEFortyNineMember_custom_SemiCabIncMember"
      id="Fact004804">David Friedland</RIME:ConvertibleHolderName>
    <RIME:InvestmentOfPrincipalAmount
      contextRef="AsOf2023-04-22_custom_SAFEFortyNineMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004806"
      unitRef="USD">50000</RIME:InvestmentOfPrincipalAmount>
    <RIME:InvestmentIssueDate
      contextRef="From2021-08-122023-04-22_custom_SAFEFortyNineMember_custom_SemiCabIncMember"
      id="Fact004808">2023-04-19</RIME:InvestmentIssueDate>
    <RIME:ValuationCapitalOfInvestment
      contextRef="AsOf2023-04-22_custom_SAFEFortyNineMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004810"
      unitRef="USD">35000000</RIME:ValuationCapitalOfInvestment>
    <RIME:ConvertibleHolderName
      contextRef="From2021-08-122023-04-22_custom_SAFEFiftyOneMember_custom_SemiCabIncMember"
      id="Fact004812">Kapil K Gupta</RIME:ConvertibleHolderName>
    <RIME:InvestmentOfPrincipalAmount
      contextRef="AsOf2023-04-22_custom_SAFEFiftyOneMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004814"
      unitRef="USD">25000</RIME:InvestmentOfPrincipalAmount>
    <RIME:InvestmentIssueDate
      contextRef="From2021-08-122023-04-22_custom_SAFEFiftyOneMember_custom_SemiCabIncMember"
      id="Fact004816">2023-04-22</RIME:InvestmentIssueDate>
    <RIME:ValuationCapitalOfInvestment
      contextRef="AsOf2023-04-22_custom_SAFEFiftyOneMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004818"
      unitRef="USD">35000000</RIME:ValuationCapitalOfInvestment>
    <RIME:InvestmentOfPrincipalAmount
      contextRef="AsOf2023-04-22_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004820"
      unitRef="USD">4095779</RIME:InvestmentOfPrincipalAmount>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember"
      id="Fact004822">&lt;p id="xdx_808_eus-gaap--IncomeTaxDisclosureTextBlock_zvGJHFazOHq3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
12- &lt;span id="xdx_82C_zVZbS042zD3f"&gt;INCOME TAXES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company files separate tax returns in the United States and India. &lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:CompensationAndEmployeeBenefitPlansTextBlock
      contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember"
      id="Fact004824">&lt;p id="xdx_804_eus-gaap--CompensationAndEmployeeBenefitPlansTextBlock_zzSRH9xpIi5h" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
13 - &lt;span id="xdx_827_zXf3uxo7lr86"&gt;EMPLOYEE BENEFIT PLANS &lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has a 401(k) plan for its employees to which the Company makes contributions at rates dependent on the level of each employee&#x2019;s
contributions. Contributions made by the Company are limited to the maximum allowable for federal income tax purposes. The Company does
not provide any post-employment benefits to retirees.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CompensationAndEmployeeBenefitPlansTextBlock>
    <us-gaap:ConcentrationRiskDisclosureTextBlock
      contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember"
      id="Fact004826">&lt;p id="xdx_803_eus-gaap--ConcentrationRiskDisclosureTextBlock_z41cxMIkSk6l" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
14 &#x2013; &lt;span&gt;CONCENTRATIONS OF CREDIT RISK, CUSTOMERS, AND SUPPLIERS&lt;/span&gt; &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_82A_zmX6yOVKuvE6" style="display: none"&gt;CONCENTRATIONS
OF CREDIT RISK AND REVENUE&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company derives a majority of its revenues from enterprise-level customers in the United States. The Company&#x2019;s allowance for doubtful
accounts is based upon management&#x2019;s estimates and historical experience and reflects the fact that accounts receivable are concentrated
with several large customers. At both December 31, 2023 and 2022, &lt;span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--FourMember_zTzp1lWG4aC6" title="Concentration risk percentage"&gt;&lt;span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--FourMember_zYj9y70UmWYk" title="Concentration risk percentage"&gt;100&lt;/span&gt;&lt;/span&gt;% of accounts receivable were due from four customers in North America,
all of which that individually owed over 10% of total accounts receivable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Revenues
derived from our top four US customers in 2023 and 2022 were &lt;span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--FourMember_ziRbky3oJY12" title="Concentration risk percentage"&gt;100&lt;/span&gt;% and &lt;span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--FourMember_z4sOhNOxvzV1" title="Concentration risk percentage"&gt;100&lt;/span&gt;% of total revenue, respectively, all of which represented greater
than 10% of total net sales in both years. The loss of any of these customers could have an adverse impact on the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ConcentrationRiskDisclosureTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2023-01-012023-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_FourMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004828"
      unitRef="Pure">1</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2022-01-012022-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_FourMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004830"
      unitRef="Pure">1</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2023-01-012023-12-31_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_FourMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004832"
      unitRef="Pure">1</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2022-01-012022-12-31_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_FourMember_custom_SemiCabIncMember"
      decimals="INF"
      id="Fact004834"
      unitRef="Pure">1</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock
      contextRef="From2023-01-012023-12-31_custom_SemiCabIncMember"
      id="Fact004836">&lt;p id="xdx_80C_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zRpnRjhHeWVj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
15 &#x2013; &lt;span id="xdx_822_zFYfQv2wehN2"&gt;RELATED PARTY TRANSACTIONS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;DUE
TO/FROM RELATED PARTIES&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the years ended December 31, 2023 and 2022, the Company owed $&lt;span id="xdx_90F_eus-gaap--OtherReceivables_iI_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorMember_z2L6PZMach09" title="Other receivables"&gt;712,000&lt;/span&gt; and $&lt;span id="xdx_908_eus-gaap--OtherReceivables_iI_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorMember_zkBoktVALhQ6" title="Other receivables"&gt;385,000&lt;/span&gt;, respectively, to Ajesh Kapoor in the form of shareholder
notes. see Note 6 &#x2013; Credit Arrangements&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March 31, 2023, the Company had approximately $&lt;span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_c20230331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorMember_z7QgPyDMmQhi" title="Principal amount"&gt;712,000&lt;/span&gt; in principal plus accrued interest, due to Ajesh Kapoor, the founder and primary
shareholder in SemiCab.&lt;/span&gt;&lt;/p&gt;

</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:OtherReceivables
      contextRef="AsOf2023-12-31_custom_AjeshKapoorMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004838"
      unitRef="USD">712000</us-gaap:OtherReceivables>
    <us-gaap:OtherReceivables
      contextRef="AsOf2022-12-31_custom_AjeshKapoorMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004840"
      unitRef="USD">385000</us-gaap:OtherReceivables>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2023-03-31_custom_AjeshKapoorMember_custom_SemiCabIncMember"
      decimals="0"
      id="Fact004842"
      unitRef="USD">712000</us-gaap:DebtInstrumentFaceAmount>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fact002581"
          xlink:label="Fact002581"
          xlink:type="locator"/>
        <link:footnote id="Footnote002610" xlink:label="Footnote002610" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Total number of
options outstanding as of December 31, 2023, includes <xhtml:span
  class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEVNUExPWUVFIFNUT0NLIE9QVElPTlMgT1VUU1RBTkRJTkcgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"
  id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20231231__srt--TitleOfIndividualAxis__custom--SixCurrentAndThreeFormerDirectorsMember_ziDf0VRBSP8d"
  title="Option issued">23,343</xhtml:span> options issued to six current and three former directors as compensation,
<xhtml:span
  class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEVNUExPWUVFIFNUT0NLIE9QVElPTlMgT1VUU1RBTkRJTkcgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"
  id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20231231__srt--TitleOfIndividualAxis__srt--OfficerMember_zlaFmcYLufcb"
  title="Option issued">56,668</xhtml:span> options issued to Company officers as compensation and <xhtml:span
  class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEVNUExPWUVFIFNUT0NLIE9QVElPTlMgT1VUU1RBTkRJTkcgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"
  id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20231231__srt--TitleOfIndividualAxis__custom--EmployeesMember_zMTAts14yJF3"
  title="Option issued">33,750</xhtml:span> options issued to employees as part of an Employee Stock Incentive
Plan.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002581"
          xlink:to="Footnote002610"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002583"
          xlink:label="Fact002583"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002583"
          xlink:to="Footnote002610"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002585"
          xlink:label="Fact002585"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002585"
          xlink:to="Footnote002610"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002587"
          xlink:label="Fact002587"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002587"
          xlink:to="Footnote002610"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002589"
          xlink:label="Fact002589"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002589"
          xlink:to="Footnote002610"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002591"
          xlink:label="Fact002591"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002591"
          xlink:to="Footnote002610"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002593"
          xlink:label="Fact002593"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002593"
          xlink:to="Footnote002610"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002595"
          xlink:label="Fact002595"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002595"
          xlink:to="Footnote002610"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002597"
          xlink:label="Fact002597"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002597"
          xlink:to="Footnote002610"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>145
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035114352800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressesLineItems', window );"><strong>Entity Addresses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">S-1/A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentDescription', window );">Amendment Description</a></td>
<td class="text">This
registration statement contains two prospectuses, as set forth below.

    &#9679;
    Public
    Offering Prospectus. A prospectus to be used for the public offering (the &#8220;Public Offering Prospectus&#8221;) of up
    to 43,478,261 shares of common stock of Algorhythm Holdings, Inc. (the &#8220;Company&#8221;) or pre-funded warrants in lieu
    thereof, 43,478,261 Series A warrants (the &#8220;Series A Warrants&#8221;) and 43,478,261 Series B warrants (together
    with the Series A Warrants, the &#8220;Warrants&#8221;) with such securities being placed and sold through the placement agent named
    on the cover page of the Public Offering Prospectus. The Public Offering Prospectus also relates to the shares issuable upon the
    exercise of the Warrants, and the pre-funded warrants.

&#160;



    &#9679;
    Resale
    Prospectus. A prospectus to be used for the resale by the selling stockholders (the &#8220;Selling Stockholders&#8221; set
    forth in the section of the resale prospectus (the &#8220;Resale Prospectus&#8221;) entitled &#8220;Selling Stockholders&#8221; of
    an aggregate of 2,840,344 shares of common stock.

&#160;

The
Resale Prospectus is substantively identical to the Public Offering Prospectus, except for the following principal points:

&#160;



    &#9679;
    they
    contain different outside and inside front covers and back covers;

&#160;



    &#9679;
    they
    contain different &#8220;Offering&#8221; sections in the &#8220;Prospectus Summary&#8221; section beginning on page
    Altr 2;

&#160;



    &#9679;
    they
    contain different &#8220;Use of Proceeds&#8221; sections on page Altr 9;

&#160;



    &#9679;
    the
    &#8220;Capitalization&#8221; and &#8220;Dilution&#8221; sections from the Public Offering Prospectus are deleted from
    the Resale Prospectus;

&#160;



    &#9679;
    a
    &#8220;Selling Stockholders&#8221; section is included in the Resale Prospectus;

&#160;



    &#9679;
    the
    &#8220;Plan of Distribution&#8221; section from the Public Offering Prospectus is deleted from the Resale Prospectus and a
    &#8220;Selling Stockholder Plan of Distribution&#8221; is inserted in its place in the Resale Prospectus; and

&#160;



    &#9679;
    the
    &#8220;Legal Matters&#8221; section in the Resale Prospectus on page Altr 12 deletes the reference to counsel for the
    placement agent.

&#160;

The
Company has included in this registration statement a set of alternate pages after the back cover page of the Public Offering Prospectus
(the &#8220;Alternate Pages&#8221;) to reflect the foregoing differences in the Resale Prospectus as compared to the Public Offering
Prospectus. The Public Offering Prospectus will exclude the Alternate Pages and will be used for the public offering by the Company.
The Resale Prospectus will be substantively identical to the Public Offering Prospectus except for the addition or substitution of the
Alternate Pages, and such other changes as may be necessary to clarify references to the public offering or the resale offering and will
be used for the resale offering by the Selling Stockholders.

&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ALGORHYTHM
HOLDINGS, INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000923601<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">95-3795478<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">6301 NW 5th Way<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 2900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Fort
Lauderdale<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">FL<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">33309<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(954)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">596-1000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember', window );">Business Contact [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressesLineItems', window );"><strong>Entity Addresses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">6301
NW 5th Way<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 2900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Fort
Lauderdale<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">FL<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">33309<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(954)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">596-1000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_ContactPersonnelName', window );">Contact Personnel Name</a></td>
<td class="text">Gary
Atkinson<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of changes contained within amended document.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of contact personnel</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>146
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035102539344">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="nump">$ 621,000<span></span>
</td>
<td class="nump">$ 6,703,000<span></span>
</td>
<td class="nump">$ 2,895,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueFromBanks', window );">Due from Banks</a></td>
<td class="nump">22,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="nump">7,328,000<span></span>
</td>
<td class="nump">6,871,000<span></span>
</td>
<td class="nump">9,085,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ReturnsAsset', window );">Returns asset</a></td>
<td class="nump">1,081,000<span></span>
</td>
<td class="nump">1,919,000<span></span>
</td>
<td class="nump">555,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid Expenses and other current assets</a></td>
<td class="nump">867,000<span></span>
</td>
<td class="nump">136,000<span></span>
</td>
<td class="nump">351,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total Current Assets</a></td>
<td class="nump">14,406,000<span></span>
</td>
<td class="nump">23,206,000<span></span>
</td>
<td class="nump">15,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">318,000<span></span>
</td>
<td class="nump">404,000<span></span>
</td>
<td class="nump">633,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating leases - right of use assets</a></td>
<td class="nump">137,000<span></span>
</td>
<td class="nump">3,926,000<span></span>
</td>
<td class="nump">561,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other non-current assets</a></td>
<td class="nump">41,000<span></span>
</td>
<td class="nump">179,000<span></span>
</td>
<td class="nump">255,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">1,356,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">3,354,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">19,612,000<span></span>
</td>
<td class="nump">27,715,000<span></span>
</td>
<td class="nump">16,649,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">8,743,000<span></span>
</td>
<td class="nump">7,616,000<span></span>
</td>
<td class="nump">1,769,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">4,303,000<span></span>
</td>
<td class="nump">2,614,000<span></span>
</td>
<td class="nump">2,266,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerRefundLiabilityCurrent', window );">Due to factor</a></td>
<td class="nump">462,000<span></span>
</td>
<td class="nump">1,743,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_CustomerPrepayments', window );">Customer prepayments</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">687,000<span></span>
</td>
<td class="nump">583,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ReserveForSalesReturns', window );">Reserve for sales returns</a></td>
<td class="nump">2,212,000<span></span>
</td>
<td class="nump">3,390,000<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Merchant cash advances payable</a></td>
<td class="nump">303,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liabilities</a></td>
<td class="nump">135,000<span></span>
</td>
<td class="nump">84,000<span></span>
</td>
<td class="nump">509,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">15,000<span></span>
</td>
<td class="nump">75,000<span></span>
</td>
<td class="nump">99,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total Current Liabilities</a></td>
<td class="nump">16,488,000<span></span>
</td>
<td class="nump">16,209,000<span></span>
</td>
<td class="nump">6,126,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities, net of current portion</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">3,000<span></span>
</td>
<td class="nump">104,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, net of current portion</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">3,925,000<span></span>
</td>
<td class="nump">88,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total Liabilities</a></td>
<td class="nump">16,873,000<span></span>
</td>
<td class="nump">20,137,000<span></span>
</td>
<td class="nump">6,318,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_CommitmentsAndContingenciesAbstract', window );"><strong>Commitments and Contingencies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Total Commitments and Contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders&#8217; Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred equity</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock $0.01 par value; 100,000,000 shares authorized; 6,418,061 issued and outstanding at December 31, 2023 and 3,184,439 issued and 3,167,489 outstanding at March 31, 2023</a></td>
<td class="nump">98,000<span></span>
</td>
<td class="nump">64,000<span></span>
</td>
<td class="nump">32,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">35,995,000<span></span>
</td>
<td class="nump">33,429,000<span></span>
</td>
<td class="nump">29,822,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable', window );">Subscriptions receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(6,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(33,206,000)<span></span>
</td>
<td class="num">(25,915,000)<span></span>
</td>
<td class="num">(19,517,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Shareholders&#8217; Equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,578,000<span></span>
</td>
<td class="nump">10,331,000<span></span>
</td>
<td class="nump">$ 13,198,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Non-controlling interest</a></td>
<td class="num">(148,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total Algorhythm Holdings Shareholders&#8217; Equity</a></td>
<td class="nump">2,739,000<span></span>
</td>
<td class="nump">7,578,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,198,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities and Shareholders&#8217; Equity</a></td>
<td class="nump">19,612,000<span></span>
</td>
<td class="nump">27,715,000<span></span>
</td>
<td class="nump">16,649,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=RIME_SemiCabIncMember', window );">Semi Cab Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">72,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">881,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNet', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">494,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">677,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_RefundDueFromCustomer', window );">Refund due from customer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">143,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid Expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total Current Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">714,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,566,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other non-current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">731,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,584,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">668,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">810,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">149,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">151,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableCurrent', window );">Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">833,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">579,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LoansPayableCurrent', window );">Loans from affiliates, current portion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">315,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerRefundLiabilityCurrent', window );">Due to factor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">231,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">108,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total Current Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,241,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,648,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermLoansPayable', window );">Loans from affiliates, net of current portion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">385,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">385,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,626,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,033,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_CommitmentsAndContingenciesAbstract', window );"><strong>Commitments and Contingencies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ProvisionForLegalLiability', window );">Provision for legal liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">275,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Total Commitments and Contingencies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">275,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders&#8217; Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,969,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,543,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,139,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,992,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Shareholders&#8217; Equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,170,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(449,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities and Shareholders&#8217; Equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">731,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,584,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_NonrelatedPartyMember', window );">Nonrelated Party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNet', window );">Accounts receivable</a></td>
<td class="nump">4,330,000<span></span>
</td>
<td class="nump">7,308,000<span></span>
</td>
<td class="nump">2,075,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableCurrent', window );">Notes payable</a></td>
<td class="nump">50,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">Related Party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNet', window );">Accounts receivable</a></td>
<td class="nump">157,000<span></span>
</td>
<td class="nump">269,000<span></span>
</td>
<td class="nump">$ 239,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableCurrent', window );">Notes payable</a></td>
<td class="nump">265,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermNotesPayable', window );">Notes payable to related parties, net of current portion</a></td>
<td class="nump">$ 385,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_CommitmentsAndContingenciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commitments and contingencies abstract</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_CommitmentsAndContingenciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_CustomerPrepayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Customer prepayments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_CustomerPrepayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_ProvisionForLegalLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Provision for legal liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_ProvisionForLegalLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_RefundDueFromCustomer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refund due from customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_RefundDueFromCustomer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_ReserveForSalesReturns">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reserve for sales returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_ReserveForSalesReturns</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_ReturnsAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Returns asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_ReturnsAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477802/946-310-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(5)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479196/954-310-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 30: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477796/946-210-45-21<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 210<br> -Topic 946<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477796/946-210-45-20<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of subscription receivable from investors who have been allocated common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477802/946-310-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(5)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerRefundLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability for consideration received or receivable from customer which is not included in transaction price, when consideration is expected to be refunded to customer, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 27<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerRefundLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueFromBanks">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A bank's noninterest bearing demand deposits in other banks (such as correspondents).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueFromBanks</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482598/350-20-45-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of portion of long-term loans payable due within one year or the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermLoansPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermLoansPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479832/842-10-65-8<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-24<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-23<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-5<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-5<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-8<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-8<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-5<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-17<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 39: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 43: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 44: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 45: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 46: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-15<br><br>Reference 47: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-16<br><br>Reference 48: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4I<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476166/350-60-65-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=RIME_SemiCabIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=RIME_SemiCabIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_NonrelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_NonrelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>147
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035125757152">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for doubtful accounts receivable, net</a></td>
<td class="nump">$ 266,000<span></span>
</td>
<td class="nump">$ 174,000<span></span>
</td>
<td class="nump">$ 166,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">11,079,678<span></span>
</td>
<td class="nump">6,418,061<span></span>
</td>
<td class="nump">3,167,489<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">9,752,755<span></span>
</td>
<td class="nump">6,418,061<span></span>
</td>
<td class="nump">3,167,489<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479344/326-20-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>148
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035112523744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="3">9 Months Ended</th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net Revenue</a></td>
<td class="nump">$ 10,622,000<span></span>
</td>
<td class="nump">$ 15,931,000<span></span>
</td>
<td class="nump">$ 15,488,000<span></span>
</td>
<td class="nump">$ 29,198,000<span></span>
</td>
<td class="nump">$ 21,939,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 39,299,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 47,512,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of Revenue</a></td>
<td class="nump">8,247,000<span></span>
</td>
<td class="nump">12,197,000<span></span>
</td>
<td class="nump">12,287,000<span></span>
</td>
<td class="nump">23,008,000<span></span>
</td>
<td class="nump">16,582,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,090,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,697,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross Profit (Loss)</a></td>
<td class="nump">2,375,000<span></span>
</td>
<td class="nump">3,734,000<span></span>
</td>
<td class="nump">3,201,000<span></span>
</td>
<td class="nump">6,190,000<span></span>
</td>
<td class="nump">5,357,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,209,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,815,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingExpense', window );">Selling general and administrative expenses</a></td>
<td class="nump">653,000<span></span>
</td>
<td class="nump">1,169,000<span></span>
</td>
<td class="nump">1,830,000<span></span>
</td>
<td class="nump">3,717,000<span></span>
</td>
<td class="nump">2,426,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,442,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,589,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="nump">4,339,000<span></span>
</td>
<td class="nump">2,459,000<span></span>
</td>
<td class="nump">8,552,000<span></span>
</td>
<td class="nump">8,616,000<span></span>
</td>
<td class="nump">7,403,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,465,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,157,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnTerminationOfLease', window );">Net (gain) loss on early termination of operating lease</a></td>
<td class="num">(3,874,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total Operating Expenses</a></td>
<td class="nump">1,118,000<span></span>
</td>
<td class="nump">3,628,000<span></span>
</td>
<td class="nump">10,386,000<span></span>
</td>
<td class="nump">12,333,000<span></span>
</td>
<td class="nump">9,829,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,907,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,746,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from Operations</a></td>
<td class="nump">1,257,000<span></span>
</td>
<td class="nump">106,000<span></span>
</td>
<td class="num">(7,185,000)<span></span>
</td>
<td class="num">(6,143,000)<span></span>
</td>
<td class="num">(4,472,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,698,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets1', window );">Gain on disposal of fixed assets</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">44,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">44,000<span></span>
</td>
<td class="nump">44,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_GainFromRelatedPartyDebt', window );">Gain - related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_GainFromPaycheckProtectionPlanLoanForgiveness', window );">Gain from extinguishment of PPP loan forgiveness</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">448,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_GainFromSettlementOfAccountsPayable', window );">Gain from settlement of accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">339,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss from extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(183,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_GainFromEmployeeRetentionCreditProgramRefund', window );">Gain from Employee Retention Credit Program refund</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">704,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">704,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebtExcludingAmortization', window );">Interest expense</a></td>
<td class="num">(283,000)<span></span>
</td>
<td class="num">(53,000)<span></span>
</td>
<td class="num">(328,000)<span></span>
</td>
<td class="num">(299,000)<span></span>
</td>
<td class="num">(122,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(479,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(580,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total Other Expenses</a></td>
<td class="num">(283,000)<span></span>
</td>
<td class="num">(9,000)<span></span>
</td>
<td class="num">(328,000)<span></span>
</td>
<td class="num">(255,000)<span></span>
</td>
<td class="nump">626,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">218,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss Before Income Tax Benefit (Provision)</a></td>
<td class="nump">974,000<span></span>
</td>
<td class="nump">97,000<span></span>
</td>
<td class="num">(7,513,000)<span></span>
</td>
<td class="num">(6,398,000)<span></span>
</td>
<td class="num">(3,846,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,608,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">287,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income Tax Benefit (Provision)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,502,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,030,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(57,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Loss</a></td>
<td class="nump">974,000<span></span>
</td>
<td class="nump">97,000<span></span>
</td>
<td class="num">(7,513,000)<span></span>
</td>
<td class="num">$ (6,398,000)<span></span>
</td>
<td class="num">(5,348,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (4,638,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 230,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net (income) loss attributable to non-controlling interest</a></td>
<td class="nump">221,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">221,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss) Available to Common Stockholders</a></td>
<td class="nump">$ 1,195,000<span></span>
</td>
<td class="nump">$ 97,000<span></span>
</td>
<td class="num">$ (7,292,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (5,348,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Loss per Common Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic</a></td>
<td class="nump">$ 0.13<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
<td class="num">$ (0.99)<span></span>
</td>
<td class="num">$ (1.32)<span></span>
</td>
<td class="num">$ (1.44)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1.65)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.14<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted</a></td>
<td class="nump">$ 0.13<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
<td class="num">$ (0.99)<span></span>
</td>
<td class="num">$ (1.32)<span></span>
</td>
<td class="num">$ (1.44)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1.65)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.14<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract', window );"><strong>Weighted Average Common and Common Equivalent Shares:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic</a></td>
<td class="nump">9,095,504<span></span>
</td>
<td class="nump">4,220,259<span></span>
</td>
<td class="nump">7,341,204<span></span>
</td>
<td class="nump">4,864,540<span></span>
</td>
<td class="nump">3,726,259<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,811,872<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,614,506<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted</a></td>
<td class="nump">9,095,504<span></span>
</td>
<td class="nump">4,220,259<span></span>
</td>
<td class="nump">7,341,204<span></span>
</td>
<td class="nump">4,864,540<span></span>
</td>
<td class="nump">3,726,259<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,811,872<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,623,397<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=RIME_SemiCabIncMember', window );">Semi Cab Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,036,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,655,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,853,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,108,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross Profit (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">183,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(453,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingExpense', window );">Selling general and administrative expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,333,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,511,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ProductDevelopmentExpense', window );">Product development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">852,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">640,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total Operating Expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,185,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,151,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,002,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,604,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebtExcludingAmortization', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(145,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(63,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total Other Expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(145,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(63,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss Before Income Tax Benefit (Provision)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,147,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,667,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income Tax Benefit (Provision)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2,147,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2,667,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_GainFromEmployeeRetentionCreditProgramRefund">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain from employee retention credit program refund</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_GainFromEmployeeRetentionCreditProgramRefund</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_GainFromPaycheckProtectionPlanLoanForgiveness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain from paycheck protection plan loan forgiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_GainFromPaycheckProtectionPlanLoanForgiveness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_GainFromRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain from related party debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_GainFromRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_GainFromSettlementOfAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain from settlement of accounts payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_GainFromSettlementOfAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_ProductDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Product development expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_ProductDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnTerminationOfLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on termination of lease before expiration of lease term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 40<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479092/842-20-40-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnTerminationOfLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481303/470-50-40-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481303/470-50-40-4<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebtExcludingAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebtExcludingAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4K<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-2<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expenses recognized in the period that are directly related to the selling and distribution of products or services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=RIME_SemiCabIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=RIME_SemiCabIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>149
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035114443264">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Shareholders' (Deficit) Equity - USD ($)<br></strong></div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Receivables from Stockholder [Member]</div></th>
<th class="th"><div>Noncontrolling Interest [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Mar. 31, 2021</a></td>
<td class="nump">1,301,358<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Mar. 31, 2021</a></td>
<td class="nump">$ 13,000<span></span>
</td>
<td class="nump">$ 20,151,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (12,254,000)<span></span>
</td>
<td class="nump">$ 7,910,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (Ioss)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">230,000<span></span>
</td>
<td class="nump">230,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock</a></td>
<td class="nump">$ 6,000<span></span>
</td>
<td class="nump">4,944,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">4,950,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, shares</a></td>
<td class="nump">550,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Stock based compensation, shares</a></td>
<td class="nump">2,242<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Issuance of subsidiary stock to non-controlling interest</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">831,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">831,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Issuance of common stock for stock offering costs</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Issuance of pre-funded warrants</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">4,882,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">4,882,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Common stock offering costs</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(831,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(831,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Issuance of common stock for stock offering costs, shares</a></td>
<td class="nump">19,047<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockRetiredCostMethodAmount', window );">Redemption and retirement of treasury shares</a></td>
<td class="num">$ (7,000)<span></span>
</td>
<td class="num">(4,301,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,855,000)<span></span>
</td>
<td class="num">(7,163,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesRetired', window );">Redemption and retirement of treasury shares, shares</a></td>
<td class="num">(654,105)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock based compensation</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">44,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">44,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">14,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">14,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options, shares</a></td>
<td class="nump">2,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Mar. 31, 2022</a></td>
<td class="nump">1,221,209<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Mar. 31, 2022</a></td>
<td class="nump">$ 12,000<span></span>
</td>
<td class="nump">24,903,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,879,000)<span></span>
</td>
<td class="nump">10,036,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (Ioss)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,653,000)<span></span>
</td>
<td class="num">(1,653,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock</a></td>
<td class="nump">$ 19,000<span></span>
</td>
<td class="nump">4,489,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">4,508,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, shares</a></td>
<td class="nump">1,909,519<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Stock based compensation, shares</a></td>
<td class="nump">15,803<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Issuance of common stock for stock offering costs</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(1,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Issuance of common stock for stock offering costs, shares</a></td>
<td class="nump">1,688<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Dec. 31, 2022</a></td>
<td class="nump">$ 31,000<span></span>
</td>
<td class="nump">29,698,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(16,531,000)<span></span>
</td>
<td class="nump">13,198,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2022</a></td>
<td class="nump">3,148,219<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2022</a></td>
<td class="nump">$ 31,000<span></span>
</td>
<td class="nump">29,698,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16,531,000)<span></span>
</td>
<td class="nump">13,198,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Mar. 31, 2022</a></td>
<td class="nump">1,221,209<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Mar. 31, 2022</a></td>
<td class="nump">$ 12,000<span></span>
</td>
<td class="nump">24,903,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,879,000)<span></span>
</td>
<td class="nump">10,036,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (Ioss)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,638,000)<span></span>
</td>
<td class="num">(4,638,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock</a></td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="nump">4,026,000<span></span>
</td>
<td class="num">(6,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">4,030,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, shares</a></td>
<td class="nump">1,014,230<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Stock based compensation, shares</a></td>
<td class="nump">15,803<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Issuance of subsidiary stock to non-controlling interest</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">637,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">637,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Common stock offering costs</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(637,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(637,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock based compensation</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">145,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">145,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_StockIssuedDuringPeriodValueExerciseOfPrefundedAndCommonWarrants', window );">Exercise of pre-funded and common warrants</a></td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="nump">1,148,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,158,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_StockIssuedDuringPeriodSharesExerciseOfPrefundedAndCommonWarrants', window );">Exercise of pre-funded warrants, shares</a></td>
<td class="nump">914,558<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Employee compensation - stock option</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">237,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">237,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_StockIssuedDuringPeriodValueReverseStockSplits', window );">Other</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits', window );">Rounding of common stock issued due to reverse split, shares</a></td>
<td class="nump">1,688<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Mar. 31, 2023</a></td>
<td class="nump">3,167,488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Mar. 31, 2023</a></td>
<td class="nump">$ 32,000<span></span>
</td>
<td class="nump">29,822,000<span></span>
</td>
<td class="num">(6,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19,517,000)<span></span>
</td>
<td class="nump">10,331,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2022</a></td>
<td class="nump">3,148,219<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2022</a></td>
<td class="nump">$ 31,000<span></span>
</td>
<td class="nump">29,698,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16,531,000)<span></span>
</td>
<td class="nump">13,198,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (Ioss)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(5,348,000)<span></span>
</td>
<td class="num">(5,348,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock</a></td>
<td class="nump">$ 11,000<span></span>
</td>
<td class="nump">1,629,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,640,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, shares</a></td>
<td class="nump">1,057,810<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation', window );">Stock based compensation</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">174,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 174,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Common stock issued for purchase of SemiCab Inc, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_StockIssuedDuringPeriodValueSaleOfCommonStockWarrants', window );">Sale of common stock warrants</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">14,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 14,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_StockIssuedDuringPeriodSharesSaleOfCommonStockWarrants', window );">Sale of common stock warrants, shares</a></td>
<td class="nump">14,230<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Sep. 30, 2023</a></td>
<td class="nump">$ 42,000<span></span>
</td>
<td class="nump">31,515,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(21,879,000)<span></span>
</td>
<td class="nump">9,678,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Sep. 30, 2023</a></td>
<td class="nump">4,220,259<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Dec. 31, 2022</a></td>
<td class="nump">$ 31,000<span></span>
</td>
<td class="nump">29,698,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(16,531,000)<span></span>
</td>
<td class="nump">13,198,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2022</a></td>
<td class="nump">3,148,219<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2022</a></td>
<td class="nump">$ 31,000<span></span>
</td>
<td class="nump">29,698,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16,531,000)<span></span>
</td>
<td class="nump">13,198,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Dec. 31, 2023</a></td>
<td class="nump">$ 64,000<span></span>
</td>
<td class="nump">33,429,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(25,915,000)<span></span>
</td>
<td class="nump">7,578,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2023</a></td>
<td class="nump">6,418,061<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2023</a></td>
<td class="nump">$ 64,000<span></span>
</td>
<td class="nump">33,429,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(25,915,000)<span></span>
</td>
<td class="nump">7,578,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Mar. 31, 2023</a></td>
<td class="nump">3,167,488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Mar. 31, 2023</a></td>
<td class="nump">$ 32,000<span></span>
</td>
<td class="nump">29,822,000<span></span>
</td>
<td class="num">(6,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19,517,000)<span></span>
</td>
<td class="nump">10,331,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (Ioss)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,398,000)<span></span>
</td>
<td class="num">(6,398,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock</a></td>
<td class="nump">$ 32,000<span></span>
</td>
<td class="nump">3,497,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">3,529,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, shares</a></td>
<td class="nump">3,250,573<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Stock based compensation, shares</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Issuance of subsidiary stock to non-controlling interest</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">179,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">179,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Issuance of common stock for stock offering costs</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">6,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Common stock offering costs</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(179,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(179,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Issuance of common stock for stock offering costs, shares</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock based compensation</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">110,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">110,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_StockIssuedDuringPeriodValueIssuanceOfCommonStockAtMarketOffering', window );">Issuance of common stock - at-the -market offering</a></td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="nump">1,699,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,709,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_StockIssuedDuringPeriodSharesIssuanceOfCommonStockAtMarketOffering', window );">Issuance of common stock - at-the-market offering, shares</a></td>
<td class="nump">1,052,770<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_StockIssuedDuringPeriodValueIssuanceOfCommonStockPrivatePlacement', window );">Issuance of common stock - private placement</a></td>
<td class="nump">$ 22,000<span></span>
</td>
<td class="nump">1,977,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,999,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_StockIssuedDuringPeriodSharesIssuanceOfCommonStockPrivatePlacement', window );">Issuance of common stock - private placement, shares</a></td>
<td class="nump">2,197,803<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther', window );">Other</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">6,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Dec. 31, 2023</a></td>
<td class="nump">$ 64,000<span></span>
</td>
<td class="nump">33,429,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(25,915,000)<span></span>
</td>
<td class="nump">7,578,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2023</a></td>
<td class="nump">6,418,061<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2023</a></td>
<td class="nump">$ 64,000<span></span>
</td>
<td class="nump">33,429,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(25,915,000)<span></span>
</td>
<td class="nump">7,578,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Jun. 30, 2023</a></td>
<td class="nump">$ 42,000<span></span>
</td>
<td class="nump">31,479,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(21,977,000)<span></span>
</td>
<td class="nump">9,544,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Jun. 30, 2023</a></td>
<td class="nump">4,220,259<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (Ioss)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">97,000<span></span>
</td>
<td class="nump">97,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation', window );">Stock based compensation</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">37,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">37,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Issuance of common stock for stock offering costs</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(1,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Sep. 30, 2023</a></td>
<td class="nump">$ 42,000<span></span>
</td>
<td class="nump">31,515,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(21,879,000)<span></span>
</td>
<td class="nump">9,678,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Sep. 30, 2023</a></td>
<td class="nump">4,220,259<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Dec. 31, 2023</a></td>
<td class="nump">$ 64,000<span></span>
</td>
<td class="nump">33,429,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(25,915,000)<span></span>
</td>
<td class="nump">7,578,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2023</a></td>
<td class="nump">6,418,061<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (Ioss)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(221,000)<span></span>
</td>
<td class="num">(7,292,000)<span></span>
</td>
<td class="num">(7,513,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock</a></td>
<td class="nump">$ 18,000<span></span>
</td>
<td class="nump">1,471,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,489,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, shares</a></td>
<td class="nump">1,673,077<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation', window );">Stock based compensation</a></td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="nump">606,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">616,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Stock based compensation, shares</a></td>
<td class="nump">1,019,811<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Common stock issued for purchase of SemiCab Inc</a></td>
<td class="nump">$ 6,000<span></span>
</td>
<td class="nump">488,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">494,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Common stock issued for purchase of SemiCab Inc, shares</a></td>
<td class="nump">641,806<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Issuance of subsidiary stock to non-controlling interest</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">74,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Issuance of common stock for stock offering costs</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,000)<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Common stock offering costs</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(74,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(74,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Sep. 30, 2024</a></td>
<td class="nump">$ 98,000<span></span>
</td>
<td class="nump">35,995,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(148,000)<span></span>
</td>
<td class="num">(33,206,000)<span></span>
</td>
<td class="nump">2,739,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Sep. 30, 2024</a></td>
<td class="nump">9,752,755<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Jun. 30, 2024</a></td>
<td class="nump">$ 64,000<span></span>
</td>
<td class="nump">33,465,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(34,401,000)<span></span>
</td>
<td class="num">(872,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Jun. 30, 2024</a></td>
<td class="nump">6,418,061<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (Ioss)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(221,000)<span></span>
</td>
<td class="nump">1,195,000<span></span>
</td>
<td class="nump">974,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock</a></td>
<td class="nump">$ 18,000<span></span>
</td>
<td class="nump">1,471,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,489,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, shares</a></td>
<td class="nump">1,673,077<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation', window );">Stock based compensation</a></td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="nump">569,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">579,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Stock based compensation, shares</a></td>
<td class="nump">1,019,811<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Common stock issued for purchase of SemiCab Inc</a></td>
<td class="nump">$ 6,000<span></span>
</td>
<td class="nump">488,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">494,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Common stock issued for purchase of SemiCab Inc, shares</a></td>
<td class="nump">641,806<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Issuance of subsidiary stock to non-controlling interest</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">74,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Issuance of common stock for stock offering costs</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Common stock offering costs</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(74,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(74,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Sep. 30, 2024</a></td>
<td class="nump">$ 98,000<span></span>
</td>
<td class="nump">$ 35,995,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">$ (148,000)<span></span>
</td>
<td class="num">$ (33,206,000)<span></span>
</td>
<td class="nump">$ 2,739,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Sep. 30, 2024</a></td>
<td class="nump">9,752,755<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_StockIssuedDuringPeriodSharesExerciseOfPrefundedAndCommonWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise of prefunded and common warrants, shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_StockIssuedDuringPeriodSharesExerciseOfPrefundedAndCommonWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_StockIssuedDuringPeriodSharesIssuanceOfCommonStockAtMarketOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares issuance of common stock at market offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_StockIssuedDuringPeriodSharesIssuanceOfCommonStockAtMarketOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_StockIssuedDuringPeriodSharesIssuanceOfCommonStockPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Shares issuance of common stock - private placement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_StockIssuedDuringPeriodSharesIssuanceOfCommonStockPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_StockIssuedDuringPeriodSharesSaleOfCommonStockWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares sale of common stock warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_StockIssuedDuringPeriodSharesSaleOfCommonStockWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_StockIssuedDuringPeriodValueExerciseOfPrefundedAndCommonWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise of prefunded and common warrants, value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_StockIssuedDuringPeriodValueExerciseOfPrefundedAndCommonWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_StockIssuedDuringPeriodValueIssuanceOfCommonStockAtMarketOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period value issuance of common stock at market offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_StockIssuedDuringPeriodValueIssuanceOfCommonStockAtMarketOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_StockIssuedDuringPeriodValueIssuanceOfCommonStockPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Issuance of common stock - private placement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_StockIssuedDuringPeriodValueIssuanceOfCommonStockPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_StockIssuedDuringPeriodValueReverseStockSplits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period value reverse stock splits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_StockIssuedDuringPeriodValueReverseStockSplits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_StockIssuedDuringPeriodValueSaleOfCommonStockWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period value sale of common stock warrants</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_StockIssuedDuringPeriodValueSaleOfCommonStockWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other increase (decrease) in additional paid in capital (APIC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481089/718-20-55-13<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481089/718-20-55-12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481284/470-20-25-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4K<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-2<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares granted under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 30<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480513/718-10-30-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480843/718-30-35-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reduction in the number of shares during the period as a result of a reverse stock split.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479832/842-10-65-8<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-24<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-23<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-5<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-5<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-8<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-8<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-5<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-17<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 39: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 43: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 44: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 45: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 46: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-15<br><br>Reference 47: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-16<br><br>Reference 48: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4I<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476166/350-60-65-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockRetiredCostMethodAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease of par value, additional paid in capital (APIC) and retained earnings of common and preferred stock retired from treasury when treasury stock is accounted for under the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockRetiredCostMethodAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesRetired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common and preferred stock retired from treasury during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesRetired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>150
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035118415856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows - USD ($)<br></strong></div></th>
<th class="th" colspan="3">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net (loss) income</a></td>
<td class="num">$ (7,513,000)<span></span>
</td>
<td class="num">$ (6,398,000)<span></span>
</td>
<td class="num">$ (5,348,000)<span></span>
</td>
<td class="num">$ (4,638,000)<span></span>
</td>
<td class="nump">$ 230,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net (loss) income to net cash provided by (used in) operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">159,000<span></span>
</td>
<td class="nump">287,000<span></span>
</td>
<td class="nump">289,000<span></span>
</td>
<td class="nump">228,000<span></span>
</td>
<td class="nump">246,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of deferred financing costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47,000<span></span>
</td>
<td class="nump">45,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Change in net deferred tax assets</a></td>
<td class="nump">44,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">893,000<span></span>
</td>
<td class="num">(5,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ProvisionForEstimatedCostOfReturns', window );">Provision for estimated cost of returns</a></td>
<td class="nump">839,000<span></span>
</td>
<td class="num">(1,364,000)<span></span>
</td>
<td class="nump">1,095,000<span></span>
</td>
<td class="nump">128,000<span></span>
</td>
<td class="num">(156,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ProvisionForInventoryObsolescence', window );">Provision for inventory obsolesence</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,798,000<span></span>
</td>
<td class="nump">271,000<span></span>
</td>
<td class="nump">536,000<span></span>
</td>
<td class="num">(272,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Credit losses</a></td>
<td class="nump">92,000<span></span>
</td>
<td class="nump">8,000<span></span>
</td>
<td class="nump">104,000<span></span>
</td>
<td class="nump">43,000<span></span>
</td>
<td class="num">(16,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_GainOnTerminationOfOperatingLease', window );">Gain on termination of operating lease</a></td>
<td class="num">(246,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">(Gain) loss from disposal of property and equipment</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(44,000)<span></span>
</td>
<td class="num">(42,000)<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock based compensation</a></td>
<td class="nump">616,000<span></span>
</td>
<td class="nump">110,000<span></span>
</td>
<td class="nump">174,000<span></span>
</td>
<td class="nump">382,000<span></span>
</td>
<td class="nump">44,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Amortization of right of use assets</a></td>
<td class="nump">194,000<span></span>
</td>
<td class="nump">510,000<span></span>
</td>
<td class="nump">520,000<span></span>
</td>
<td class="nump">718,000<span></span>
</td>
<td class="nump">795,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Change in net deferred tax assets</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,399,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on debt extinguishment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">183,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_GainFromPaycheckProtectionPlanLoanForgiveness', window );">Paycheck Protection Plan loan forgiveness</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(448,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_GainFromRelatedPartyDebt', window );">Gain - related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(11,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_GainFromSettlementOfAccountsPayable', window );">Gain from extinguishment of accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(48,000)<span></span>
</td>
<td class="num">(339,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">3,079,000<span></span>
</td>
<td class="num">(5,241,000)<span></span>
</td>
<td class="num">(3,982,000)<span></span>
</td>
<td class="nump">667,000<span></span>
</td>
<td class="num">(558,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseDueFromAffiliates', window );">Due from banks</a></td>
<td class="num">(22,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(152,000)<span></span>
</td>
<td class="nump">101,000<span></span>
</td>
<td class="nump">4,456,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties', window );">Accounts receivable &#8211; related parties</a></td>
<td class="num">(303,000)<span></span>
</td>
<td class="num">(30,000)<span></span>
</td>
<td class="nump">117,000<span></span>
</td>
<td class="num">(87,000)<span></span>
</td>
<td class="num">(64,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(456,000)<span></span>
</td>
<td class="nump">415,000<span></span>
</td>
<td class="num">(3,424,000)<span></span>
</td>
<td class="nump">3,858,000<span></span>
</td>
<td class="num">(8,244,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="num">(718,000)<span></span>
</td>
<td class="nump">215,000<span></span>
</td>
<td class="nump">87,000<span></span>
</td>
<td class="nump">78,000<span></span>
</td>
<td class="num">(123,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets', window );">Other non-current assets</a></td>
<td class="nump">151,000<span></span>
</td>
<td class="nump">76,000<span></span>
</td>
<td class="num">(248,000)<span></span>
</td>
<td class="num">(38,000)<span></span>
</td>
<td class="nump">61,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">394,000<span></span>
</td>
<td class="nump">5,847,000<span></span>
</td>
<td class="nump">10,442,000<span></span>
</td>
<td class="num">(3,511,000)<span></span>
</td>
<td class="nump">3,217,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses</a></td>
<td class="num">(198,000)<span></span>
</td>
<td class="nump">348,000<span></span>
</td>
<td class="num">(486,000)<span></span>
</td>
<td class="nump">533,000<span></span>
</td>
<td class="nump">77,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDueToRelatedParties', window );">Due to related parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(63,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Refunds due to customer</a></td>
<td class="num">(1,967,000)<span></span>
</td>
<td class="nump">1,743,000<span></span>
</td>
<td class="nump">1,212,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(139,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_IncreaseDecreaseInPrepaidsFromCustomers', window );">Prepaids from customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">485,000<span></span>
</td>
<td class="num">(47,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_IncreaseDecreaseInReserveForSalesReturns', window );">Reserve for sales returns</a></td>
<td class="num">(1,180,000)<span></span>
</td>
<td class="nump">2,490,000<span></span>
</td>
<td class="num">(646,000)<span></span>
</td>
<td class="num">(90,000)<span></span>
</td>
<td class="nump">30,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="nump">116,000<span></span>
</td>
<td class="num">(462,000)<span></span>
</td>
<td class="num">(622,000)<span></span>
</td>
<td class="num">(738,000)<span></span>
</td>
<td class="num">(795,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_PaymentOfEarlyTerminationFeeOnOperatingLeaseTerminationSettlement', window );">Payment of early termination fee on operating lease termination settlement</a></td>
<td class="num">(150,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by (used in) operating activities</a></td>
<td class="num">(7,069,000)<span></span>
</td>
<td class="nump">411,000<span></span>
</td>
<td class="nump">760,000<span></span>
</td>
<td class="num">(330,000)<span></span>
</td>
<td class="num">(2,012,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="num">(70,000)<span></span>
</td>
<td class="num">(68,000)<span></span>
</td>
<td class="num">(163,000)<span></span>
</td>
<td class="num">(244,000)<span></span>
</td>
<td class="num">(118,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPreviousAcquisition', window );">Cash received from purchase of SemiCab Inc</a></td>
<td class="nump">17,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Disposal of property and equipment</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">54,000<span></span>
</td>
<td class="nump">55,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(53,000)<span></span>
</td>
<td class="num">(14,000)<span></span>
</td>
<td class="num">(108,000)<span></span>
</td>
<td class="num">(244,000)<span></span>
</td>
<td class="num">(118,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of stock, net of offering costs</a></td>
<td class="nump">1,489,000<span></span>
</td>
<td class="nump">3,529,000<span></span>
</td>
<td class="nump">1,640,000<span></span>
</td>
<td class="nump">3,393,000<span></span>
</td>
<td class="nump">9,001,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_PaymentOfRedemptionAndRetirementOfTreasuryStock', window );">Payment of redemption and retirement of treasury stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(7,162,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ProceedsFromCollectionOfSubscriptionsReceivable', window );">Collection of subscriptions receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfSubordinatedDebt', window );">Payment of subordinated note payable - Starlight Marketing Development, Ltd.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(353,000)<span></span>
</td>
<td class="num">(150,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_PaymentOfDeferredFinancingCharges', window );">Payment of deferred financing charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(254,000)<span></span>
</td>
<td class="num">(38,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_PaymentOfEarlyTerminationFeesOnRevolvingLinesOfCredit', window );">Payment of early termination fees on revolving lines of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(183,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_PaymentsOnInstallmentNote', window );">Payments on installment notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(124,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(74,000)<span></span>
</td>
<td class="num">(68,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">14,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ProceedsFromExerciseOfCommonStockWarrants', window );">Proceeds from exercise of common stock warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">990,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Proceeds from exercise of pre-funded warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">168,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations', window );">Payments on finance leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,000)<span></span>
</td>
<td class="num">(8,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfOtherDebt', window );">Payments on merchant cash advances payable</a></td>
<td class="num">(327,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit', window );">Net (payment) proceeds from revolving lines of credit</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,761,000)<span></span>
</td>
<td class="num">(2,500,000)<span></span>
</td>
<td class="nump">2,435,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other</a></td>
<td class="num">(122,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(113,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">1,040,000<span></span>
</td>
<td class="nump">3,411,000<span></span>
</td>
<td class="num">(234,000)<span></span>
</td>
<td class="nump">1,178,000<span></span>
</td>
<td class="nump">4,024,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net change in cash</a></td>
<td class="num">(6,082,000)<span></span>
</td>
<td class="nump">3,808,000<span></span>
</td>
<td class="nump">418,000<span></span>
</td>
<td class="nump">604,000<span></span>
</td>
<td class="nump">1,894,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash at beginning of year</a></td>
<td class="nump">6,703,000<span></span>
</td>
<td class="nump">2,895,000<span></span>
</td>
<td class="nump">2,795,000<span></span>
</td>
<td class="nump">2,291,000<span></span>
</td>
<td class="nump">397,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash at end of period</a></td>
<td class="nump">621,000<span></span>
</td>
<td class="nump">6,703,000<span></span>
</td>
<td class="nump">3,213,000<span></span>
</td>
<td class="nump">2,895,000<span></span>
</td>
<td class="nump">2,291,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosures of cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">320,000<span></span>
</td>
<td class="nump">44,000<span></span>
</td>
<td class="nump">80,000<span></span>
</td>
<td class="nump">481,000<span></span>
</td>
<td class="nump">547,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Cash paid for income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Non-Cash investing and financing cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssued1', window );">Common stock issued for purchase of SemiCab Inc</a></td>
<td class="nump">569,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeaseObligationsIncurred', window );">Equipment purchased under capital lease</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">55,000<span></span>
</td>
<td class="nump">55,000<span></span>
</td>
<td class="nump">24,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right of use assets exchanged for lease liabilities</a></td>
<td class="nump">$ 136,000<span></span>
</td>
<td class="nump">3,874,000<span></span>
</td>
<td class="nump">$ 3,874,000<span></span>
</td>
<td class="nump">192,000<span></span>
</td>
<td class="nump">16,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_IssuanceOfCommonStockAndWarrantsForOfferingCosts', window );">Issuance of common stock and warrants for offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 244,000<span></span>
</td>
<td class="nump">$ 548,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_GainFromPaycheckProtectionPlanLoanForgiveness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain from paycheck protection plan loan forgiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_GainFromPaycheckProtectionPlanLoanForgiveness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_GainFromRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain from related party debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_GainFromRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_GainFromSettlementOfAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain from settlement of accounts payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_GainFromSettlementOfAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_GainOnTerminationOfOperatingLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain on termination of operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_GainOnTerminationOfOperatingLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_IncreaseDecreaseInPrepaidsFromCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Prepaids from customers.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_IncreaseDecreaseInPrepaidsFromCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_IncreaseDecreaseInReserveForSalesReturns">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reserve for sales returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_IncreaseDecreaseInReserveForSalesReturns</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_IssuanceOfCommonStockAndWarrantsForOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Issuance of common stock and warrants for offering costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_IssuanceOfCommonStockAndWarrantsForOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_PaymentOfDeferredFinancingCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payment of deferred financing charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_PaymentOfDeferredFinancingCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_PaymentOfEarlyTerminationFeeOnOperatingLeaseTerminationSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payment of early termination fee on operating lease termination settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_PaymentOfEarlyTerminationFeeOnOperatingLeaseTerminationSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_PaymentOfEarlyTerminationFeesOnRevolvingLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payment of early termination fees on revolving lines of credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_PaymentOfEarlyTerminationFeesOnRevolvingLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_PaymentOfRedemptionAndRetirementOfTreasuryStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payment of redemption and retirement of treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_PaymentOfRedemptionAndRetirementOfTreasuryStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_PaymentsOnInstallmentNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments on installment notes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_PaymentsOnInstallmentNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_ProceedsFromCollectionOfSubscriptionsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from collection of subscriptions receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_ProceedsFromCollectionOfSubscriptionsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_ProceedsFromExerciseOfCommonStockWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from exercise of common stock warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_ProceedsFromExerciseOfCommonStockWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_ProvisionForEstimatedCostOfReturns">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Provision for estimated cost of returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_ProvisionForEstimatedCostOfReturns</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_ProvisionForInventoryObsolescence">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Provision for inventory obsolescence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_ProvisionForInventoryObsolescence</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeaseObligationsIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in lease obligation from new lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalLeaseObligationsIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481303/470-50-40-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481303/470-50-40-4<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 23<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-22<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseDueFromAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in receivables to be collected from an entity that is controlling, under the control of, or within the same control group as the reporting entity by means of direct or indirect ownership.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseDueFromAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount due to the reporting entity for good and services provided to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management, an entity and its principal owners, management, member of their immediate families, affiliates, or other parties with the ability to exert significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478345/912-310-45-11<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDueToRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations to be paid to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management; an entity and its principal owners, management, or member of their immediate families; affiliates; or other parties with the ability to exert significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDueToRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPreviousAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash inflow representing an adjustment to the purchase price of a previous acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPreviousAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or cash outflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with either short term or long term maturity that is collateralized (backed by pledge, mortgage or other lien in the entity's assets).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromWarrantExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromWarrantExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4K<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-2<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for short-term and long-term debt and lease obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfOtherDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for the payment of debt classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfOtherDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfSubordinatedDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow from the repayment of long-term borrowing where a lender is placed in a lien position behind debt having a higher priority of repayment (senior) in case of liquidation of the entity's assets or underlying collateral.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfSubordinatedDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of stock issued in noncash financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>151
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035114245072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NATURE OF BUSINESS<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">NATURE OF BUSINESS</a></td>
<td class="text"><p id="xdx_800_eus-gaap--NatureOfOperations_zVQtZY68gGpg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
1 &#8211; <span id="xdx_82F_zx0mRjbNBQk7">NATURE OF BUSINESS</span></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Algorhythm
Holdings, Inc. (f/k/a The Singing machine Company, Inc.) (the &#8220;Company&#8221;) is a holding company for an AI enabled software
logistics business operated through our SemiCab Holding subsidiary and a home karaoke consumer products company that designs and distributes
karaoke products globally to retailers and ecommerce partners through our Singing Machine subsidiary.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
operations include our wholly owned subsidiaries, SMC Logistics, Inc., a California corporation (&#8220;SMCL&#8221;), SMC-Music, Inc.,
a Florida corporation (&#8220;SMCM&#8221;), SMC (HK) Limited, a Hong Kong company (&#8220;SMH&#8221;), MICS Hospitality Holdings, Inc.,
a Delaware corporation (&#8220;MICS Hospitality&#8221;), MICS Hospitality Management, LLC, a Delaware limited liability company (&#8220;MICS
Hospitality Management&#8221;), MICS Nomad, LLC, a Delaware limited liability company (&#8220;MICS NY&#8221;) and SemiCab Holdings, LLC,
a Nevada limited liability company (&#8220;SemiCab&#8221;).</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Singing
Machine is primarily engaged in the development, marketing, and sale of consumer karaoke audio equipment, accessories, and musical recordings.
We are a global karaoke and music entertainment company that specializes in the design and production of quality karaoke and music enabled
consumer products for adults and children.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SemiCab
is a cloud-based collaborative transportation platform built to achieve the scalability required to predict and optimize full-truckload
transportation at enterprise-scale. To orchestrate collaboration across manufacturers, retailers, distributors, and their carriers, SemiCab
uses real-time data from API-based load tendering and pre-built integrations with TMS and ELD partners. To build fully loaded round trips,
SemiCab uses AI/ML techniques and advanced predictive optimization models.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<span></span>
</td>
<td class="text"><p id="xdx_800_eus-gaap--NatureOfOperations_zsL9fKGUJGMi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
1 &#8211; <span id="xdx_82A_zlzsnAE65cha">NATURE OF BUSINESS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are primarily engaged in the development, marketing, and sale of consumer karaoke audio equipment, accessories, and musical recordings.
We believe we are a leading global karaoke and music entertainment company that specializes in the design and production of quality karaoke
and music enabled consumer products for adults and children. Our products are among the most widely available karaoke products in the
world.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
mission is to &#8220;create joy through music.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Singing Machine&#8217;s operations include its wholly owned subsidiaries, SMC Logistics, Inc., a California corporation (&#8220;SMCL&#8221;),
SMC-Music, Inc., a Florida corporation (&#8220;SMCM&#8221;), SMC (HK) Limited, a Hong Kong company (&#8220;SMH&#8221;), MICS Hospitality
Holdings, Inc., a Delaware corporation (&#8220;MICS Hospitality&#8221;), MICS Hospitality Management, LLC, a Delaware limited liability
company (&#8220;MICS Hospitality Management&#8221;) and MICS Nomad, LLC, a Delaware limited liability company (&#8220;MICS NY&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=RIME_SemiCabIncMember', window );">Semi Cab Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">NATURE OF BUSINESS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_801_eus-gaap--NatureOfOperations_zFnSd0WXeqg9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span id="alp_014"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
1 - <span>BASIS OF PRESENTATION</span> </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;<span id="xdx_829_z3u6FIzulgK1">NATURE OF BUSINESS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>OVERVIEW</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
SemiCab, Inc., a Delaware corporation (the &#8220;Company,&#8221; &#8220;SemiCab&#8221;) is primarily engaged in the development, marketing,
and sale of logistics optimization services for enterprise-level dedicated freight and shipping customers in The United States and India.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Basis
of Presentation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States
of America (&#8220;GAAP&#8221;), which contemplate continuation of the Company as a going concern, and assumes continuity of operations,
realization of assets and the satisfaction of liabilities and commitments in the normal course of business. The Company has suffered
substantial net losses and negative cash flows from operations in recent years and is dependent on debt and equity financing to fund
its operations all of which raise substantial doubt about the Company&#8217;s ability to continue as a going concern. Recoverability
of a major portion of the recorded asset amounts shown in the accompanying balance sheet is dependent upon the Company&#8217;s ability
to increase its revenue and meet its financing requirements on a continuing basis and become profitable in its future operations. The
accompanying consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded
assets or the amounts and classification of liabilities that might be necessary should the Company be unable to continue in existence.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/275/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=RIME_SemiCabIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=RIME_SemiCabIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>152
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035105201888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RECENT DEVELOPMENTS<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_DisclosureRecentDevelopmentsAbstract', window );"><strong>Recent Developments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_RecentDevelopmentsTextBlock', window );">RECENT DEVELOPMENTS</a></td>
<td class="text"><p id="xdx_800_ecustom--RecentDevelopmentsTextBlock_zkFtt4U165d6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
2 - <span id="xdx_821_zyI5z6qQrEjb">RECENT DEVELOPMENTS</span></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Name
and Symbol Change</i></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
September 5, 2024, our Certificate of Incorporation was amended to effect a change in the name of the Company from &#8220;The Singing
Machine Company, Inc.&#8221; to &#8220;Algorhythm Holdings, Inc.&#8221; In addition, effective September 8, 2024, the Company&#8217;s
ticker symbol was changed from &#8220;MICS&#8221; to &#8220;RIME.&#8221;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Change
in Fiscal Year</i></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
2023, our Board of Directors approved a change in our fiscal year end from March 31 to December 31. Our results of operations, cash flows,
and all transactions impacting shareholders&#8217; equity presented in this Quarterly Report on Form 10-Q as of September 30, 2024 are
for the three and nine month periods ended September 30, 2024 and 2023.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>ATM
Offering</i></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-redline: true">On
June 26, 2024, the Company entered into an At-The-Market Issuance Sales Agreement (the &#8220;Sales Agreement&#8221;) with Ascendiant
Capital markets, LLC, as sales agent (the &#8220;Agent&#8221;), pursuant to which the Company could offer and sell, from time to time,
through the Agent (the &#8220;ATM Offering&#8221;), up to approximately $<span id="xdx_90F_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20240626__20240626__us-gaap--TypeOfArrangementAxis__custom--AtTheMarketSalesAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zxtaBAya9Lvj" title="Number of stock sold, value">1,100,000</span> in shares of the Company&#8217;s common stock. <span style="background-color: white">On
July 8, 2024, the Company entered into the First Amendment to the Sales Agreement (the &#8220;Amendment&#8221;) to increase the number
of shares to be sold in the ATM Offering to $<span id="xdx_900_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20240626__20240626__us-gaap--TypeOfArrangementAxis__custom--AtTheMarketSalesAgreementAmendmentOneMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zoysTChabrxh" title="Number of stock sold, value">2,020,000</span>.</span> On August 9, 2024, the Company entered into the Second Amendment to the
Sales Agreement (the &#8220;Amendment&#8221;) to increase the number of shares to be sold in the ATM Offering to $<span id="xdx_90F_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20240626__20240626__us-gaap--TypeOfArrangementAxis__custom--AtTheMarketSalesAgreementAmendmentTwoMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zvJUvUD1rFs7" title="Number of stock sold, value">3,100,000</span>. Pursuant
to the agreement, the Agent was paid $<span id="xdx_90B_eus-gaap--LegalFees_c20240626__20240626__us-gaap--TypeOfArrangementAxis__custom--AtTheMarketSalesAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zKfOat8ljuk" title="Legal and administrative expenses">30,000</span> in fees to cover legal and administrative expenses and will receive an amount equal to 3%
of the gross proceeds from each sale of the Company&#8217;s share of common stock. For the three and nine months ended September 30,
2024, the Company sold <span id="xdx_908_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20240701__20240930__us-gaap--TypeOfArrangementAxis__custom--AtTheMarketSalesAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zyUC7RsqduXe" title="Number of shares issued in transaction"><span id="xdx_90D_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20240101__20240930__us-gaap--TypeOfArrangementAxis__custom--AtTheMarketSalesAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zFvQyJtmM7Ti" title="Number of shares issued in transaction">1,673,077</span></span> shares of common stock under the ATM offering and received net proceeds of approximately <span id="xdx_90D_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20240701__20240930__us-gaap--TypeOfArrangementAxis__custom--AtTheMarketSalesAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zR2iZTF6Ix6l" title="Net proceeds from sale of common stock"><span id="xdx_907_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20240101__20240930__us-gaap--TypeOfArrangementAxis__custom--AtTheMarketSalesAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zYNNJ7hHnji1" title="Net proceeds from sale of common stock">$1,489,000</span></span>
after payment of legal and accounting fees, brokerage commissions, and administrative fees to the agent of approximately $<span id="xdx_909_eus-gaap--AdministrativeFeesExpense_c20240701__20240930__us-gaap--TypeOfArrangementAxis__custom--AtTheMarketSalesAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zm4Wo2dU9uAl" title="Brokerage commissions and administrative fees"><span id="xdx_90D_eus-gaap--AdministrativeFeesExpense_c20240101__20240930__us-gaap--TypeOfArrangementAxis__custom--AtTheMarketSalesAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zIXp99kXkhu2" title="Brokerage commissions and administrative fees">189,000</span></span>.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALGORHYTHM
                                            HOLDINGS, INC. and SUBSIDIARIES</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September
30, 2024 and 2023</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-redline: true">Subsequent
to September 30, 2024 and through November 18, 2024 (the last trading day prior to filing), the Company sold <span id="xdx_904_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20241001__20241118__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--AtTheMarketSalesAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zbRTlgrIxpG5" title="Number of shares issued in transaction">2,162,423</span> shares of common
stock under the ATM offering, and received net proceeds of approximately $<span id="xdx_902_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20241001__20241118__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--AtTheMarketSalesAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zaeijgi8t6S2" title="Net proceeds from sale of common stock">1,372,000</span> after payment of brokerage commissions and administrative
fees to the agent of approximately $<span id="xdx_906_eus-gaap--AdministrativeFeesExpense_c20241001__20241118__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--AtTheMarketSalesAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z21YPIa7Stw8" title="Brokerage commissions and administrative fees">42,000</span>.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Asset
Purchase</i></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 11, 2024, the Company and its wholly owned subsidiary SemiCab Holdings, LLC, a Nevada limited liability company (&#8220;SemiCab
LLC&#8221; and collectively with the Company, the &#8220;Buyer&#8221;), SemiCab, Inc., a Delaware corporation (&#8220;SemiCab&#8221;
or the &#8220;Seller&#8221;), Ajesh Kapoor and Vivek Sehgal entered into an asset purchase agreement (the &#8220;Asset Purchase Agreement&#8221;)
pursuant to which the Seller agreed to sell and assign to the Company, and the Company agreed to purchase and assume from the Seller,
substantially all the assets, and certain specified liabilities relating to the business of the Seller. Subject to certain exceptions
set forth in the Asset Purchase Agreement, the parties agreed that the Buyer will not assume the liabilities of the Seller. SemiCab is
an artificial intelligence, cloud-based collaborative transportation platform built to achieve the scalability required to predict and
optimize semi-tractor trailer load efficiency.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-redline: true">On
July 3, 2024, the parties closed on the asset purchase whereby the Company issued to the Seller (i) <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesPurchaseOfAssets_c20240703__20240703__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember_zFfnE8f1OG65" title="Shares purchase">641,806</span> shares of the Company&#8217;s
common stock (ii) a twenty percent (<span id="xdx_90A_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20240703__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SemiCabLLCMember_zXK3h5FiFzG" title="Membership percentage">20%</span>) membership interest in SemiCab LLC.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-redline: true">Pursuant
to the asset acquisition agreement, the Company and Seller entered into an option agreement (the &#8220;Option Agreement&#8221;), granting
the Buyer the right to acquire all of the issued and outstanding capital securities of SMCB Solutions Private Limited (&#8220;SMCB&#8221;),
a wholly owned subsidiary of the Seller, in consideration for <span id="xdx_905_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20240703__20240703__us-gaap--BusinessAcquisitionAxis__custom--SemiCabLLCMember_zyur9xTrqKn2" title="Seller Consideration share">320,903</span> shares of common stock of the Company. The Option Agreement expired
unexercised.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Hospitality
Lease</i></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-redline: true">On
August 23, 2023, MICS NY entered into an Agreement of Lease (the &#8220;Lease Agreement&#8221;) with OAC 111 Flatiron, LLC and OAC Adelphi,
LLC (the &#8220;Landlord&#8221;), pursuant to which MICS NY agreed to lease approximately <span id="xdx_90F_eus-gaap--AreaOfLand_iI_pid_usqft_c20230823__us-gaap--TypeOfArrangementAxis__custom--LeaseAgreementMember_zqAWQB20e3v7" title="Lease space">10,000</span> square feet of ground floor retail space
and a portion of the basement underneath the ground floor retail space in the property located at 111 West 24<sup>th</sup> Street, New
York, New York (the &#8220;Premises&#8221;).</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-redline: true">During
the six months ended June 30, 2024, the Company abandoned its plans to continue use of the leased space and exercised its early termination
provision of the Lease Agreement which was not accepted by the Landlord. Due to the abandonment of the lease, all assets related to the
lease were impaired. Assets including security deposits, rent deposits and right of use assets of approximately $<span id="xdx_907_ecustom--AssetsWriteOff_c20240401__20240630_ztwmvg2LeXnj" title="Written off">3,878,000</span> were written
off during the three months ended June 30, 2024.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-redline: true">On
July 26, 2024, OAC 111 Flatiron, LLC and OAC Adelphi, LLC (the &#8220;Landlord&#8221;), filed a civil action in the Supreme Court of
the State of New York against MICS Nomad LLC, a subsidiary of the Company (&#8220;MICS NY&#8221;), and the Company (&#8220;the Defendants&#8221;)
for alleged breach of lease, seeking monetary damages including unpaid rent, future unpaid rent, and other expenses related to the lease.
The complaint alleged the Defendants breached the lease in various material respects.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-redline: true">On
September 25, 2024, the Company entered into a Settlement Agreement for a full release and dismissal of the complaint within 5 business
days of the Company&#8217;s payment of $<span id="xdx_90A_eus-gaap--OperatingLeasePayments_c20240925__20240925__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember_zZ2y4fwF9h9g" title="Lease payments">250,000</span>. Pursuant to the Settlement Agreement, the Company made the first payment of $<span id="xdx_901_ecustom--OperatingLeasePeriodicPayments_c20240925__20240925__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember_zIN3kvZetXY2" title="periodic lease payments">150,000</span>
was made on September 25, 2024 and a final payment of $<span id="xdx_903_ecustom--OperatingLeasePeriodicPayments_c20241025__20241025__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zpvyTYxHrUjl" title="periodic lease payments">100,000</span> was due and paid on October 25, 2024. On October 29, 2024, the Landlord
filed a discontinuance with prejudice.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-redline: true">As
a result of the settlement, during the three months ended September 30, 2024, the Company wrote off the remaining operating lease liability
on the Lease Agreement and recognized a gain on early termination of the operating lease of approximately $<span id="xdx_909_eus-gaap--GainLossOnTerminationOfLease_c20240701__20240930__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember_zPsQEpDXHU5k" title="Gain loss on termination of operating lease">3,874,000</span>. For the nine months
ended September 30, 2024, the Company recognized a loss on early termination of the operating lease of $<span id="xdx_902_eus-gaap--GainLossOnTerminationOfLease_c20240101__20240930__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember_z7xMssUBS686" title="Gain loss on termination of operating lease">4,000</span> which includes the $<span id="xdx_90D_ecustom--LeaseSettlementExpense_c20240101__20240930__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember_ztKU1jVXs1V8" title="Lease settlement expense">250,000</span>
termination settlement expense. The net loss on early termination of the Lease Agreement was recorded as a component of operating expenses
in the accompanying condensed consolidated statements of operations.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALGORHYTHM
                                            HOLDINGS, INC. and SUBSIDIARIES</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September
30, 2024 and 2023</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Private
Placement</i></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-redline: true">On
October 22, 2024, the Company entered into a Securities Purchase Agreement (the &#8220;SPA&#8221;) with investors pursuant to which we
sold, in a private placement (the &#8220;Private Placement&#8221;), secured notes with an aggregate principal amount of $<span id="xdx_90A_eus-gaap--SecuredDebt_iI_c20241022__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zKfClgJze3ic" title="Secured note principal amount">2,352,941</span> (the
&#8220;Notes&#8221;), for cash proceeds of $<span id="xdx_903_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_c20241022__20241022__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z9OW4kOgoNOb" title="Proceeds from private placement">2,000,000</span>, net of original issue discount of $<span id="xdx_90D_ecustom--PrivatePlacementIssueDiscount_c20241022__20241022__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z2Pa41ldSTde" title="Private placement issue discount">352,941</span>. As consideration for entering into
the SPA, we issued a total of <span id="xdx_90C_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20241022__20241022__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_znpcyIVaHklf" title="Issuance of stock, shares">2,299,998</span> shares of common stock of the Company to the investors on October 24, 2024 (See Note 17).</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Oxford
Credit Facility</i></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-redline: true">On
March 28, 2024, the Company and Oxford Commercial Finance, a Michigan banking corporation, (referred to as &#8220;Oxford&#8221;) entered
into a Loan Agreement (the &#8220;Loan Agreement&#8221;) and related Revolving Credit Note (the &#8220;Note&#8221;) for a $<span id="xdx_907_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_c20240328__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_za8wH2smkprd" title="Revolving credit facility">2,000,000</span>
revolving line of credit (the &#8220;Oxford Line of Credit&#8221;). On October 17, 2024, the Company terminated the Loan Agreement and
the Note. As of the date of termination, the Company had no outstanding amounts owed to Oxford and paid a termination fee of $<span id="xdx_90F_eus-gaap--LineOfCreditFacilityCommitmentFeeAmount_c20241017__20241017__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_z0YeidNVAw21" title="Credit facility termination fee">40,000</span>.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Share
Repurchase</i></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-redline: true">On
November 1, 2024, the Company entered into a Stock Repurchase Agreement (the &#8220;Repurchase Agreement&#8221;) with Regalia Ventures
LLC, a Delaware limited liability company (the &#8220;Seller&#8221;), pursuant to which the Company agreed to repurchase from the Seller
an aggregate of <span id="xdx_902_eus-gaap--CommonStockSharesIssued_iI_c20241101__us-gaap--TypeOfArrangementAxis__custom--StockRepurchaseAgreementMember_ziY17tqiNoAi" title="Shares issued"><span id="xdx_902_eus-gaap--CommonStockSharesOutstanding_iI_c20241101__us-gaap--TypeOfArrangementAxis__custom--StockRepurchaseAgreementMember_zA2Air1hO7Xl" title="Shares outstanding">1,098,901</span></span> issued and outstanding shares of common stock, par value $<span id="xdx_90C_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20241101__us-gaap--TypeOfArrangementAxis__custom--StockRepurchaseAgreementMember_zTpSErdqPVXh" title="Common stock, par value">0.01</span> per share, of the Company (the &#8220;Shares&#8221;).
Pursuant to the terms of the Repurchase Agreement, the Company has agreed to repurchase from the Seller, and the Seller has agreed to
sell, assign and transfer to the Company, all of the Seller&#8217;s right, title and interest in and to the Shares, at a price per Share
equal to the higher of: (1) the closing price of the common stock on the last trading day immediately preceding the date of the Repurchase
Agreement; or (2) the highest volume weighted average price (VWAP) of the common stock during a pricing period of ten (10) consecutive
trading days prior to the date of the Repurchase Agreement per share (the &#8220;Purchase Price&#8221;), and the Company shall issue
to the Seller a promissory note in the principal amount equal to the Purchase Price, substantially in the form attached to the Repurchase
Agreement as Exhibit A (the &#8220;Note&#8221;), and subject to terms and conditions therein.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
shares of common stock to be repurchased were originally issued to the Seller on November 21, 2023, pursuant to a certain stock purchase
agreement, dated November 20, 2023.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the date of this filing, the repurchase of the shares has not yet closed.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<span></span>
</td>
<td class="text"><p id="xdx_800_ecustom--RecentDevelopmentsTextBlock_zMDDr0ulIhw6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
2 - <span id="xdx_82A_zi95aABtW9Vj">RECENT DEVELOPMENTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Change
in Fiscal Year </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
2023, our Board of Directors approved a change in our fiscal year end from March 31 to December 31. Our results of operations, cash
flows, and all transactions impacting shareholders&#8217; equity presented in this Transition Report on Table of Contents Form 10-KT
are for the nine-month period ended December 31, 2023 (&#8220;transition period&#8221;), and our fiscal years 2023 and 2022 are for
the twelve months ended March 31, 2023, and March 31, 2022, unless otherwise noted.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Private
Placement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 20, 2023, the Company entered into an agreement to sell $<span id="xdx_907_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20231120__20231120__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zfixydcjEL85" title="Number of stock sold, value">2,000,000</span> in common stock through a private placement of common stock
(the &#8220;Private Placement&#8221;). The Private Placement was completed with two Affiliates, (Stingray Group, Inc. and Jay Foreman),
both of which were existing shareholders with Board representation. The Private Placement was completed at $<span id="xdx_90C_eus-gaap--SaleOfStockPricePerShare_iI_c20231120__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zaWldYcI4yJ2" title="Commmon stock share per share">0.91</span> per share of common
stock, with a total of approximately <span id="xdx_90B_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20231120__20231120__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zQ19jELJcLse" title="Number of shares sold">2,198,000</span> shares issued. Net proceeds from the transaction were approximately $<span id="xdx_90D_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20231120__20231120__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zU7wJCVwJCGj" title="Proceeds from sale of equity">1,900,000</span>, net of
transaction fees of approximately $<span id="xdx_90E_ecustom--TransactionFees_iI_c20231120__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zmuLUdQlLQGk" title="Transaction fees">100,000</span>. During the six-month period after the closing date, the purchasers may make a written request
for registration under the Securities Act of all or any portion of the shares purchased.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Hospitality
Lease</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 23, 2023, MICS NY entered into an Agreement of Lease (the &#8220;Lease Agreement&#8221;) with OAC 111 Flatiron, LLC and OAC Adelphi,
LLC (the &#8220;Landlord&#8221;), pursuant to which MICS NY agreed to lease approximately <span id="xdx_904_eus-gaap--AreaOfLand_iI_pid_usqft_c20230823__us-gaap--TypeOfArrangementAxis__custom--LeaseAgreementMember_zC3lWaoT8JV7" title="Lease space">10,000</span> square feet of ground floor retail space
and a portion of the basement underneath the ground floor retail space in the property located at 111 West 24<sup>th</sup> Street, New
York, New York (the &#8220;Premises&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
term of the Lease Agreement is for fifteen (<span id="xdx_90E_eus-gaap--LesseeOperatingLeaseTermOfContract_iI_dtY_c20230823__us-gaap--TypeOfArrangementAxis__custom--LeaseAgreementMember_zTmVGdoOnDe" title="Lease term">15</span>) years, or on such an earlier date upon which the term shall expire, be canceled or terminated
pursuant to any of the conditions or covenants of the Lease Agreement. Pursuant to the Lease Agreement, MICS NY is obligated to pay an
initial base rent in the amount of $<span id="xdx_909_eus-gaap--PaymentsForRent_c20230823__20230823__us-gaap--TypeOfArrangementAxis__custom--LeaseAgreementMember_zV4WSxyON0lh" title="Initial base rent">30,000</span> beginning August 1, 2024, with scheduled increases over the term, as set forth in the Lease
Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
March 2024, the Company initiated the termination of this lease under certain provisions made available under the Lease Agreement. The
Landlord and the Company are in active discussions as to the terms of the lease termination however as of this filing, it is too early
in the negotiation process to estimate any potential loss, if any, related to the lease termination process.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>ATM
Offering</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">On
February 15, 2023, the Company entered into an At-The-Market Issuance Sales Agreement (the &#8220;Sales Agreement&#8221;) with Aegis
Capital Corp, as sales agent (the &#8220;Agent&#8221;), pursuant to which the Company could offer and sell, from time to time,
through the Agent (the &#8220;ATM Offering&#8221;), up to approximately $<span id="xdx_909_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_pp0p0_c20230215__20230215__us-gaap--SubsidiarySaleOfStockAxis__custom--ATMOfferingMember_zWZ0xMZwEGnl" title="Number of stock sold, value">1,800,000</span>
in shares of the Company&#8217;s common stock. For the nine months ended December 31, 2023, and fiscal year ended March 31, 2023,
the Company received net proceeds of approximately $<span id="xdx_901_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20230401__20231231__us-gaap--SubsidiarySaleOfStockAxis__custom--ATMOfferingMember_zcL78nR3yvDi" title="Proceeds from sale of equity">1,654,000</span>
and $<span id="xdx_904_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20220401__20230331__us-gaap--SubsidiarySaleOfStockAxis__custom--ATMOfferingMember_zd8C9KHbRXL" title="Proceeds from sale of equity">36,000</span>,
respectively, after payment of brokerage commissions and administrative fees to the agent. As of May 12, 2023, the Company  terminated the Sales Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_DisclosureRecentDevelopmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_DisclosureRecentDevelopmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_RecentDevelopmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Recent Developments [Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_RecentDevelopmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>153
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035310495856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LIQUIDITY, GOING CONCERN AND MANAGEMENT PLANS<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubstantialDoubtAboutGoingConcernTextBlock', window );">LIQUIDITY, GOING CONCERN AND MANAGEMENT PLANS</a></td>
<td class="text"><p id="xdx_80A_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zySyMsRllmd3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
3 &#8211; <span id="xdx_82D_zcDEgntxp0m1">LIQUIDITY, GOING CONCERN AND MANAGEMENT PLANS</span></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
previously reported on Form 8-K filed on August 30, 2024, on August 26, 2024, the Company received a notice from The Nasdaq Stock Market
LLC (&#8220;NASDAQ&#8221;) indicating that its stockholders&#8217; equity as reported in its Quarterly Report on Form 10-Q for the quarterly
period ended June 30, 2024 did not meet the minimum of $2,500,000 in stockholders&#8217; equity required by NASDAQ Listing Rule 5550(b)(1)
(the &#8220;Equity Rule&#8221;) for continued listing, or the alternatives of market value of listed securities or net income from continuing
operations. Pursuant to the Equity Rule, the Company submitted a plan to regain compliance with the Equity Rule.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-redline: true">On
November 13, 2024, the Company filed a Form 8-K stating that it believed it regained compliance with the Equity Rule. As disclosed herein,
the Company reported stockholders&#8217; equity of approximately $<span id="xdx_906_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iI_pn5n6_c20240930_zRcLXPjwP0Ci" title="Stockholders equity">2.7</span> million.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NASDAQ
has advised the Company that it will continue to monitor the Company&#8217;s ongoing compliance with the stockholders&#8217; equity requirement
and, if at the time of its next periodic report the Company does not evidence compliance, that it may be subject to delisting.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-redline: true">As
of September 30, 2024, the Company had cash on hand of approximately $<span id="xdx_90A_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20240930_zizFOQSZoLX6" title="Cash and cash equivalents">621,000</span> and deficit working capital of approximately $<span id="xdx_90D_ecustom--WorkingCapital_iI_c20240930_zWBiJaK42awj" title="Working capital deficit">2,082,000</span>
which is not sufficient to fund the Company&#8217;s planned operations through one year after the date the consolidated financial statements
are issued. The Company has a recent history of recurring operating losses and decreases in working capital. These factors create substantial
doubt about the Company&#8217;s ability to continue as a going concern for at least one year after the date that the Company&#8217;s
audited consolidated financial statements are issued.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
condensed consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue
as a going concern. Accordingly, the condensed consolidated financial statements have been prepared on a basis that assumes the Company
will continue as a going concern and which contemplates the realization of assets and satisfaction of liabilities and commitments in
the ordinary course of business.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
intends to finance operations with future debt or equity financings, however, if and when such financings may occur are uncertain.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
making this assessment management performed a comprehensive analysis of the Company&#8217;s current circumstances including: its financial
position, cash flow and cash usage forecasts, and obligations and debts. Although management has a recent history of successful capital
raises, the analysis used to determine the Company&#8217;s ability as a going concern does not include cash sources outside the Company&#8217;s
direct control that management expects to be available within the next 12 months.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALGORHYTHM
                                            HOLDINGS, INC. and SUBSIDIARIES</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September
30, 2024 and 2023</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></span></p>

<span></span>
</td>
<td class="text"><p id="xdx_80A_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zi9CW53dKuY8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
3 &#8211; <span id="xdx_821_zZcFLFmmCccg">LIQUIDITY, GOING CONCERN AND MANAGEMENT PLANS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">As
of December 31, 2023, the Company had cash on hand of approximately $<span id="xdx_904_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20231231_zszztNhTKdXa">6,703,000 </span>which
is not sufficient to fund the Company&#8217;s planned operations through one year after the date the consolidated financial
statements are issued. The Company has a recent history of recurring operating losses and decreases in working capital. These
factors create substantial doubt about the Company&#8217;s ability to continue as a going concern for at least one year after the
date that the Company&#8217;s audited consolidated financial statements are issued.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The consolidated financial statements do not
include any adjustments that might be necessary if the Company is unable to continue as a going concern. Accordingly, the
consolidated financial statements have been prepared on a basis that assumes the Company will continue as a going concern and which
contemplates the realization of assets and satisfaction of liabilities and commitments in the ordinary course of business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Management
intends to finance operations with future debt or equity financings however, if and when such financings may occur are uncertain.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">In
making this assessment management performed a comprehensive analysis of the Company&#8217;s current circumstances including: its
financial position, cash flow and cash usage forecasts, and obligations and debts. Although management has a recent history of
successful capital raises, the analysis used to determine the Company&#8217;s ability as a going concern does not include cash
sources outside the Company&#8217;s direct control that management expects to be available within the next 12 months.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
SINGING MACHINE COMPANY, INC AND SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
31, 2023, and March 31, 2023 and 2022</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=RIME_SemiCabIncMember', window );">Semi Cab Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubstantialDoubtAboutGoingConcernTextBlock', window );">LIQUIDITY, GOING CONCERN AND MANAGEMENT PLANS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_80E_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zY1NS1InFa3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
2 &#8211; <span>GOING CONCERN</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_82D_zmLRHaxfVLM3" style="display: none">LIQUIDITY,
GOING CONCERN AND MANAGEMENT PLANS</span><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s financial statements as of December 31, 2023 and 2022 have been prepared using generally accepted accounting principles
in the United States of America applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities
in the normal course of business. The Company has not yet established an ongoing source of revenue sufficient to cover its operating
costs and allow it to continue as a going concern. The Company has accumulated losses from 2022 to 2023 of $<span id="xdx_90E_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_c20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zzCd79lKYFP4" title="Accumulated losses">4,814,000</span>. These factors
among others raise substantial doubt about the ability of the company to continue as a going concern for a reasonable period of time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to continue as a going concern, the Company will need, among other things, additional capital resources. Management&#8217;s plan
is to obtain such resources for the Company by obtaining capital from management and significant shareholders sufficient to meet its
minimal operating expenses and seeking third party equity and/or debt financing. However, management cannot provide any assurances that
the Company will be successful in accomplishing any of its plans. These financial statements do not include any adjustments related to
the recoverability and classification of assets or the amounts and classification of liabilities that might be necessary should the Company
be unable to continue as a going concern.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubstantialDoubtAboutGoingConcernTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/205-40/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubstantialDoubtAboutGoingConcernTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=RIME_SemiCabIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=RIME_SemiCabIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>154
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035034141584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text"><p id="xdx_802_eus-gaap--SignificantAccountingPoliciesTextBlock_zmwiPQCXS7Pj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
4 - <span id="xdx_82D_zUCr37okDZFd">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></span></p>

<p id="xdx_842_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_z0xqk8bzKQQg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_864_zfAZcd39HU79" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Basis
of Presentation</i></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying unaudited financial statements for the three months ended September 30, 2024 and 2023 have been prepared in accordance with
accounting principles generally accepted in the United States of America (&#8220;US GAAP&#8221;) applicable to interim financial information
and the requirements of Form 10-Q and Article 8 of Regulation S-X of the Securities and Exchange Commission. Accordingly, they do not
include all of the information and disclosures required by US GAAP for complete consolidated financial statements.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true">In the opinion of management, such
condensed consolidated financial statements include all adjustments (consisting of normal recurring accruals) necessary for the fair
presentation of the condensed consolidated financial position and the condensed consolidated results of operations. The condensed consolidated
results of operations for the periods presented are not necessarily indicative of the results to be expected for the full year. The condensed
consolidated balance sheet as of September 30, 2024 and condensed financial statements information for the three and nine months ended
September 30, 2024 and 2023 are unaudited whereas the condensed consolidated balance sheet as of December 31, 2023 is derived from the
audited consolidated balance sheet as of that date. The condensed consolidated financial statements and notes hereto should be read in
conjunction with the consolidated financial statements and notes thereto included in the Company&#8217;s annual report on Form 10-KT
for the transition period ended December 31, 2023. There have been no changes to our significant accounting policies as disclosed on
the Company&#8217;s annual report on Form 10-KT for the transition period ended December 31, 2023.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p id="xdx_848_eus-gaap--ConsolidationPolicyTextBlock_zG652AMbDIuc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_863_zrdDkiVdw3gl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Principles
of Consolidation</i></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company evaluates its business relationships with related parties to identify potential Variable Interest Entities (&#8220;VIEs&#8221;)
under Accounting Standards Codification (&#8220;ASC&#8221;) 810, Consolidation. The Company will consolidate any VIE in which it has
a controlling financial interest and is deemed to be the primary beneficiary. A controlling financial interest has both of the following
characteristics: (1) the power to direct the activities of the VIE that most significantly impact its economic performance; and (2) the
obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE
that could be significant to the VIE. If both characteristics are met, the Company is considered to be the primary beneficiary and therefore
will consolidate that VIE into its consolidated financial statements.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
prescribed by ASC 810, if the Company holds a variable interest in a VIE but is not the entity&#8217;s primary beneficiary, it shall
disclose its methodology for determining if the Company is the primary beneficiary of the VIE, e.g., significant judgments and assumptions
made. Additional information required includes information about the types of involvement considered significant, and those considered
in the determination of whether the reporting entity is the primary beneficiary.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
if the Company provides or intends to provide financial or other support (explicitly or implicitly) to the VIE, when not contractually
required to, the Company shall disclose the type and amount of the support, along with the primary reasons for providing the support.
Both qualitative and quantitative information about the Company&#8217;s involvement with the VIE, shall include the nature, purpose,
size, and activities of the VIE, including how the VIE is financed.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p id="xdx_84D_eus-gaap--BusinessCombinationsPolicy_z8Zj4Utlqz7i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_86F_zifn80Cmun6f" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Business
Combinations</i></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company allocates the purchase price of an acquired business to the tangible and intangible assets acquired and liabilities assumed based
upon their estimated fair values on the acquisition date. Any excess of the purchase price over the fair value of the net assets acquired
is recorded as goodwill. The purchase price allocation process requires management to make significant estimates and assumptions at the
acquisition date with respect to intangible assets. The allocation of the consideration transferred in certain cases may be subject to
revision based on the final determination of fair values during the measurement period, which may be up to one year from the acquisition
date. Direct transaction costs associated with the business combination are expensed as incurred. The Company includes the results of
operations of the business that it has acquired in its consolidated results prospectively from the date of acquisition.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p id="xdx_841_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zvE70x651AHd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_86E_zdrnLExkCPR8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Goodwill</i></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company evaluates its goodwill for impairment in accordance with the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued
Accounting Standards Update (&#8220;ASU&#8221;) 350, <i>Intangibles &#8211; Goodwill and Other</i>. Goodwill is recorded when the purchase
price paid for an acquisition exceeds the estimated fair value of the net identified tangible and intangible assets acquired.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company tests the recorded amount of goodwill for impairment on an annual basis on December 31 or more frequently if there are indicators
that the carrying amount of the goodwill exceeds its carried value.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p id="xdx_845_eus-gaap--GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy_zcM29p0Vadpl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_867_zbvUCXbIw5xh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Intangible
Assets</i></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company acquired amortizable intangibles assets as part of asset purchase agreements consisting of customer relationships, trade names
and proprietary technology. Such intangibles are amortized over their useful lives on a straight-line basis.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company reviews intangible assets for impairment whenever events or changes in business circumstances indicate that the carrying amount
of the assets might not be recoverable. Factors that the Company considers in deciding when to perform an impairment review include significant
underperformance of the business in relation to expectations, significant negative industry or economic trends, and significant changes
or planned changes in the use of the assets. If an impairment review is performed to evaluate a long-lived asset for recoverability,
the Company compares forecasts of undiscounted cash flows expected to result from the use and eventual disposition of the long-lived
asset to its carrying value. An impairment loss would be recognized when estimated undiscounted future cash flows expected to result
from the use of an asset are less than its carrying amount. The impairment loss would be based on the excess of the carrying value of
the impaired asset over its fair value, determined based on discounted cash flows.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALGORHYTHM
                                            HOLDINGS, INC. and SUBSIDIARIES</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September
30, 2024 and 2023</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></span></p>

<p id="xdx_849_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_zopZkXAp8v6a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_86C_zixKQwzNxh5g" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Fair
Value Measurements</i></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with ASC 820, Fair Value Measurements and Disclosures, fair value is defined as the exit price, or the amount that would be
received for the sale of an asset or paid to transfer a liability in an orderly transaction between market participants as of the measurement
date.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
guidance also establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes
the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs include those that
market participants would use in valuing the asset or liability and are developed based on market data obtained from sources independent
of the Company. Unobservable inputs are inputs that reflect the Company&#8217;s assumptions about the factors that market participants
would use in valuing the asset or liability. The guidance establishes three levels of inputs that may be used to measure fair value:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="-sec-ix-redline: true">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
                                            1: Quoted market prices in active markets for identical assets or liabilities.</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="-sec-ix-redline: true">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
                                            2: Inputs other than Level 1 that are observable, either directly or indirectly, such as
                                            quoted prices for similar assets or liabilities; quoted prices in markets that are not active;
                                            or model-derived valuations. All significant inputs used in the Company&#8217;s valuations
                                            are observable or can be derived principally from or corroborated with observable market
                                            data for substantially the full term of the assets or liabilities. Level 2 inputs also include
                                            quoted prices that were adjusted for security-specific restrictions which are compared to
                                            output from internally developed models such as a discounted cash flow model.</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
                                            3: Unobservable inputs that are supported by little or no market activity and that are significant
                                            to the fair value of the assets or liabilities.</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
carrying amounts of financial instruments carried at cost, including cash, accounts receivables and accounts and accounts receivable
&#8211; related party, trade payables advances and notes payables and notes payable &#8211; related party approximate their fair value
due to the short-term maturities of such instruments.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
categorization of a financial instrument within the valuation hierarchy is based upon the lowest level of input that is significant to
the fair value measurement.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p id="xdx_840_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zh67ficBlsJi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>R<span id="xdx_865_zefuG9EEAdg4">ECENT
ACCOUNTING PRONOUNCEMENTS</span></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
November 2023, the FASB issued ASU 2023-07, <i>Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures</i>, that
requires disclosure of significant segment expenses that are regularly reviewed by the chief operating decision maker and included within
each reported measure of segment profit or loss. The standard also requires disclosure of the composition of other segment items included
in the measure of segment profit or loss that are not separately disclosed. All disclosure requirements under ASU 2023-07 are also required
for public entities with a single reportable segment. The ASU is effective for the Company&#8217;s Annual Report on Form 10-K for the
year ended December 31, 2024, and subsequent interim periods, with early adoption permitted. The Company is currently evaluating the
impact of adopting this standard on our consolidated financial statements and related disclosures.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALGORHYTHM
                                            HOLDINGS, INC. and SUBSIDIARIES</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September
30, 2024 and 2023</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2023, the FASB issued ASU 2023-09, <i>Income Taxes (Topic 740): Improvements to Income Tax Disclosures</i>. ASU 2023-09 is intended
to enhance the usefulness of income tax disclosures by requiring entities to disclose specific rate reconciliations, amount of income
taxes separate by federal and individual tax jurisdictions, and the amount of income or loss from continuing operations before income
tax expense or benefit disaggregated between federal, state and foreign. ASU 2023-09 is effective for the Company for its fiscal year
beginning January 1, 2025, with early adoption permitted. The Company is currently evaluating the impact of adopting this standard on
our consolidated financial statements and related disclosures.</span></span></p>

<p id="xdx_856_zundEyYyi8e5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></span></p>

<span></span>
</td>
<td class="text"><p id="xdx_804_eus-gaap--SignificantAccountingPoliciesTextBlock_zqNjTthj8LAf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
4 - <span id="xdx_825_z04vsAxtg152">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p id="xdx_84C_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_z3YYmrJUWim1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>BASIS
OF PRESENTATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the
United States of America (&#8220;GAAP&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p id="xdx_847_eus-gaap--ConsolidationPolicyTextBlock_zCa0IWp0mh3i" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PRINCIPLES
OF CONSOLIDATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements include the accounts of the Company and its Hong Kong subsidiary, SMCL, SMCM, SMH, MICS
Hospitality, MICS Hospitality Management and MICS NY. All inter-company accounts and transactions have been eliminated in consolidation
for all periods presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_849_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zVl9t85L9Bml" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RECLASSIFICATION
OF PRIOR YEARS PRESENTATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on
the reported results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p id="xdx_841_eus-gaap--UseOfEstimates_zg7Fs5GiIx77" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>USE
OF ESTIMATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions. These estimates and
assumptions affect the reported amounts of assets, liabilities, revenues and expenses. Actual results could differ materially from these
estimates. Estimates are assessed each period and updated to reflect current information. Significant estimates include revenue recognition,
allowance for credit losses, provision for excess and obsolete inventory, reserve for sales returns, accruals relating to litigation,
income taxes and share-based compensation expense.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p id="xdx_848_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zKXhm8BV8qe8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ACCOUNTS
RECEIVABLE AND ALLOWANCES FOR EXPECTED CREDIT LOSSES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2016, the FASB issued Accounting Standards Update (&#8220;ASU&#8221;) 2016-13, &#8220;Financial Instruments&#8212;Credit Losses&#8221;
<i>(Topic 326)</i>. This ASU represents a significant change in the current accounting model by requiring immediate recognition of management&#8217;s
estimates of current expected credit losses. Under the prior model, losses were recognized only as they were incurred, which delayed
recognition of expected losses that might not yet have met the threshold of being probable. The amendments in ASU 2016-03 were effective
for our fiscal year beginning April 1, 2023, including interim periods within that fiscal year. We adopted ASU 2016-03 on April 1, 2023,
and the adoption did not have any material effect on our consolidated financial statements and related disclosures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes an allowance for credit losses at the time a receivable is recorded based on its estimate of expected credit losses
and adjusts this estimate over the life of the receivable as needed. The Company evaluates specific identified risks and the aggregation
and risk characteristics of a receivable pool and develops loss rates that reflect historical collections, current forecasts of future
economic conditions over the time horizon the Company is exposed to credit risk, and payment terms or conditions that may materially
affect future forecasts. As needed, amounts are written-off when determined to be uncollectible.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84D_eus-gaap--InventoryPolicyTextBlock_zt1zqrGxQzxj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INVENTORY
AND RETURNS ASSET</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory
is comprised primarily of electronic karaoke equipment, microphones, and accessories, and are stated at the lower of cost or net realizable
value, as determined using the first in, first out method. The Company reduces inventory on hand to its net realizable value on an item-by-item
basis when it is apparent that the expected realizable value of an inventory item falls below its original cost. A charge to cost of
sales results when the estimated net realizable value of specific inventory items declines below cost. Management regularly reviews the
Company&#8217;s investment in inventories for such declines in value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the Company reports an estimated amount for the net realizable value of expected future inventory returns (returns asset) related
to the Company&#8217;s defective allowance, overstock, and warranty policies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
SINGING MACHINE COMPANY, INC AND SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
31, 2023, and March 31, 2023 and 2022</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p id="xdx_841_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zUAAmNvZLnp8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>LONG-LIVED
ASSETS </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company periodically evaluates the carrying value of the unamortized balances of its long-lived assets, including property, equipment
and rental assets, to determine whether impairment of these assets has occurred or whether a revision to the related amortization periods
should be made. If the carrying value of the long-lived asset group exceeds the estimated future undiscounted cash flows, an impairment
loss is recorded based on the amount by which the asset group&#8217;s carrying amount exceeds its fair value. Fair value is determined
based on an evaluation of the assets&#8217; associated discounted future cash flows or appraised value<i>.</i> For the nine months ended
December 31, 2023 and fiscal year ended March 31, 2023, the Company had no impairment loss related to long-lived assets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84F_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_znvSDpwnKbKl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PROPERTY
AND EQUIPMENT, NET </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and equipment are stated at cost, less accumulated depreciation. Expenditures for repairs and maintenance are charged to expense as incurred.
Depreciation is provided for in amounts sufficient to relate the cost of depreciable assets to their estimated useful lives using straight-line
methods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84F_eus-gaap--LesseeLeasesPolicyTextBlock_zJtEl5F2EXkj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>LEASES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company determines if an arrangement contains a lease at the inception of a contract. Right-of-use assets represent the Company&#8217;s
right to use an underlying asset for the lease term and lease liabilities represent the Company&#8217;s obligation to make lease payments
arising from the lease. Right-of-use assets and lease liabilities are recognized at the commencement date. The liability is equal to
the present value of the remaining minimum lease payments. The asset is based on the liability, subject to certain adjustments. Operating
leases result in straight-line expense (similar to operating leases under the prior accounting standard) while finance leases result
in a front-loaded expense pattern (similar to capital leases under the prior accounting standard). As the interest rate implicit in the
Company&#8217;s operating leases is not readily determinable, the Company utilizes its incremental borrowing rate to discount the lease
payments. The Company utilizes the implicit rate for its finance leases.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84F_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zO1xq9uamRK9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FAIR
VALUE OF FINANCIAL INSTRUMENTS </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
follow Financial Accounting Standards Board (&#8220;FASB&#8221;) Accounting Standards Codification (&#8220;ASC&#8221;) 825, &#8220;Financial
Instruments&#8221;, which requires disclosure of information about the fair value of certain financial instruments for which it is practicable
to estimate that value. For the purposes of this disclosure, the fair value of a financial instrument is the amount at which the instrument
could be exchanged in a current transaction between willing parties, other than in a forced sale or liquidation. The carrying amounts
of the Company&#8217;s short-term financial instruments, including accounts receivable, accounts payable, accrued expenses, refunds due
to customers, customer deposits, other current liabilities and due from related parties approximates fair value due to the relatively
short period to maturity for these instruments. The carrying amounts on other liabilities are approximate to fair value due to their
relatively short period to maturity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p id="xdx_842_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_znmqBVe2Pvf5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>REVENUE
RECOGNITION AND RESERVE FOR SALES RETURNS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes revenue in accordance with FASB ASC 606, &#8220;Revenue from Contracts with Customers&#8221;. All revenue is generated
from contracts with customers. The Company recognizes revenue when the control of the goods sold is transferred to the customer, in an
amount, referred to as the transaction price, that reflects the consideration to which the Company is expected to be entitled in exchange
for those goods. The Company determines revenue recognition utilizing the following five steps: (1) identification of the contract with
a customer, (2) identification of the performance obligations in the contract (promised goods or services that are distinct), (3) determination
of the transaction price, (4) allocation of the transaction price to the performance obligations, and (5) recognition of revenue when,
or as, the Company transfers control of the product or service for each performance obligation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s performance obligations are established when a customer submits a purchase order notification, and the Company
accepts the order. The Company identifies performance obligations as the delivery of the requested product or service in appropriate
quantities and to the location specified in the customer&#8217;s contract and/or purchase order. Revenue from sales of product is
recognized at a point in time when the Company transfers control to the customer, typically at the time when the product is
delivered or shipped, at which time, title passes to the customer and there are no further performance obligations with regards to
the product.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company selectively participates in a retailer&#8217;s co-op promotion incentives to maximize sales of the Company&#8217;s products on
the retail floor or to assist in developing consumer awareness of new product launches, by providing marketing fund allowances to our
customers. As these co-op promotion initiatives are not a distinct good or service and the Company cannot reasonably estimate the fair
value of the benefit it receives from these arrangements, the cost of these allowances at the time they are offered to the customers
are recorded as a reduction to net sales. Co-op promotion incentives were approximately $<span id="xdx_907_eus-gaap--AdvertisingExpense_c20230401__20231231_zetgZ155fVu8" title="Co-op promotion incentives">2,600,000</span> during the nine months ended December
31, 2023, $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_908_eus-gaap--AdvertisingExpense_c20220401__20230331_z7p1nzM50py8" title="Co-op promotion incentives">2,300,000</span> during fiscal 2023 and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_905_eus-gaap--AdvertisingExpense_c20210401__20220331_zys9xYLM0WY1" title="Co-op promotion incentives">2,000,000</span> during fiscal 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s contracts with customers consist of one performance obligation (the sale of the Company&#8217;s products). The
Company&#8217;s contracts have no financing elements, payment terms are generally less than 120 days and have no further contract
asset or liability obligations once control of goods is transferred to the customer. Revenue is recorded in the amount of
consideration the Company expects to receive for the sale of these goods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Costs
incurred in fulfilling contracts with customers include administrative costs associated with the procurement of goods are included in
general and administrative expenses, in-bound freight costs are included in the cost of goods sold and accrued sales representative commissions
are included in selling expenses in the accompanying consolidated statements of operations as our underlying customer agreements are
less than one year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
SINGING MACHINE COMPANY, INC AND SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
31, 2023, and March 31, 2023 and 2022</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
the Company has no overstock return privileges in its vendor agreements with its customers, the Company does accept defective returns,
warranty exchanges and overstock from seasonal customers. The Company estimates the sales value of goods to be returned from our allowance
programs for goods returned from the customer for various reasons, whereby a reserve for sales returns is recorded based on historic
return amounts, specific events as identified and management estimates. The Company&#8217;s reserve for sales returns was approximately
$<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_90E_ecustom--ReserveForSalesReturn_iI_c20231231_zUmZ1f0zmEhh" title="Reserve for sales return">3,400,000</span> as of December 31, 2023, and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_908_ecustom--ReserveForSalesReturn_iI_c20230331_zgqYZZmZeKTg" title="Reserve for sales return">900,000</span> as of March 31, 2023. The Company estimates the net realizable value of these expected
future sales returns. The net realizable value of these estimated returns is classified as return assets as part of current assets on
the accompanying consolidated financial statements. The Company&#8217;s return assets were approximately $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_905_ecustom--ReturnAssets_iI_c20231231_zlaEnHEG2wQf" title="Return assets">1,900,000</span> and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_90A_ecustom--ReturnAssets_iI_c20230331_zkNePkNTq8s5" title="Return assets">600,000</span> as of
December 31, 2023, and March 31, 2023, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84B_ecustom--ShippingAndHandlingCostsPolicyTextBlock_zCeER69gCcLf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHIPPING
AND HANDLING COSTS </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shipping
and handling activities are performed before the customer obtains control of the goods sold to them and are considered activities to
fulfill the Company&#8217;s promise to transfer the goods. For the nine months ended December 31, 2023, shipping and handling expenses
were approximately $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_901_ecustom--ShippingAndHandlingExpenses_c20230401__20231231_zAD9DO2uvUu3" title="Shipping and handling expenses">600,000</span>. For Fiscal 2023 and 2022 shipping and handling expenses were approximately $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_90D_ecustom--ShippingAndHandlingExpenses_c20220401__20230331_zDKl0hYiF6Pl" title="Shipping and handling expenses">500,000</span> and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_90B_ecustom--ShippingAndHandlingExpenses_c20210401__20220331_zWcuHtKtohl5" title="Shipping and handling expenses">900,000</span>, respectively.
These expenses are classified as a component of selling expenses in the accompanying consolidated statements of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_845_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zW3YbDrlpx7h" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARE-BASED
COMPENSATION </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has granted stock options and restricted stock units (&#8220;RSUs&#8221;) to employees, non-employee consultants and non-employee
members of our Board of Directors. The Company also has an equity incentive plan which provides for the issuance of equity incentive
awards, such as stock options, stock appreciation rights, stock awards, restricted stock, stock units, performance awards and other stock
or cash-based awards collectively, the &#8220;Awards.&#8221; Awards may be granted under the 2022 Plan to the Company&#8217;s employees,
officers, directors, consultants, agents, advisors and independent contractors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company measures the compensation cost associated with all share-based payments based on grant date fair values. The fair value of each
stock option and stock purchase right is estimated on the date of grant using an option pricing model that meets certain requirements.
The Company generally uses the Black-Scholes option pricing model to estimate the fair value of its stock options and stock purchase
rights. The determination of the fair value of share-based payment awards utilizing the Black-Scholes model is affected by the Company&#8217;s
stock price and several assumptions, including expected volatility, expected term, risk-free interest rate and expected dividends.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
grants of stock options, the Company uses a blend of historical and implied volatility for traded options on its stock to estimate the
expected volatility assumption required in the Black-Scholes model. The Company&#8217;s use of a blended volatility estimates in computing
the expected volatility assumption for stock options is based on its belief that while the implied volatility is representative of expected
future volatility, the historical volatility over the expected term of the award is also an indicator of expected future volatility.
The Company utilizes a blended volatility estimate that consists of implied volatility and historical volatility in order to estimate
the expected volatility assumption of the Black-Scholes model.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
expected term of stock options granted is estimated using historical experience. The risk-free interest rate assumption is based on observed
interest rates appropriate for the expected terms of the Company&#8217;s stock options and stock purchase rights. The dividend yield
assumption is based on the Company&#8217;s history and expectation of no dividend payouts. The Company estimates forfeitures at the time
of grant and revises these estimates, if necessary, in subsequent periods if actual forfeitures differ from those estimates. The Company
estimates its forfeiture rate assumption for all types of share-based compensation awards based on historical forfeiture rates related
to each category of award.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compensation
costs associated with grants of restricted stock units are measured at fair value, which has historically been the closing price of the
Company&#8217;s common stock on the date of grant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes share-based compensation expense over the requisite service period of each individual award, which generally equals
the vesting period, using the straight-line method for awards that contain only service conditions. For awards that contain performance
conditions, the Company recognizes the share-based compensation expense on a straight-line basis for each vesting tranche, when achievement
of that tranche is considered probable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company evaluates the assumptions used to value stock awards at each grant date. If there are any modifications or cancellations of
the underlying unvested securities, the Company may be required to accelerate, increase or cancel any remaining unearned share-based
compensation expense.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_849_eus-gaap--IncomeTaxPolicyTextBlock_zXx5R89VEUIg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INCOME
TAXES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company follows the provisions of FASB ASC 740 &#8220;Accounting for Income Taxes.&#8221; Under the asset and liability method of ASC
740, deferred tax assets and liabilities are recognized for the future tax consequences attributed to differences between the financial
statement carrying amounts of existing assets and liabilities and their respective tax base. Deferred tax assets and liabilities are
measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to
be recovered or settled. Under ASC 740, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income
in the period that includes the enactment date. If it is more likely than not that some portion of a deferred tax asset will not be realized,
a valuation allowance is recognized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
SINGING MACHINE COMPANY, INC AND SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
31, 2023, and March 31, 2023 and 2022</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes a liability for uncertain tax positions. An uncertain tax position is defined as a position in a previously filed
tax return or a position expected to be taken in a future tax return that is not based on clear and unambiguous tax law and which is
reflected in measuring current or deferred income tax assets and liabilities for interim or annual periods. The Company may
recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained
on examination by the taxing authorities, based on the technical merits of the position. The Company measures the tax benefits
recognized based on the largest benefit that has a <span id="xdx_90A_eus-gaap--IncomeTaxExaminationLikelihoodOfUnfavorableSettlement_c20230401__20231231_zrx94xkqnTv7">greater
than 50% likelihood</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of being realized upon
ultimate resolution.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2023, and March 31, 2023, there were no uncertain tax positions that resulted in any adjustment to the Company&#8217;s
provision for income taxes. The Company recognizes interest and penalties related to unrecognized tax benefits in its provision for income
taxes. The Company currently has no liabilities recorded for accrued interest or penalties related to uncertain tax provisions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p id="xdx_84B_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zlsiD5f9UQQb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RECENT
ACCOUNTING PRONOUNCEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2023, the FASB issued ASU 2023-09, <i>Income Taxes (Topic 740): Improvements to Income Tax Disclosures</i>. ASU 2023-09 is intended
to enhance the usefulness of income tax disclosures by requiring entities to disclose specific rate reconciliations, amount of income
taxes separate by federal and individual tax jurisdictions, and the amount of income (loss) from continuing operations before income
tax expense (benefit) disaggregated between federal, state and foreign. ASU 2023-09 is effective for the Company for its fiscal year
beginning January 1, 2025, with early adoption permitted. The Company is currently evaluating the impact of adopting this standard on
our consolidated financial statements and related disclosures.</span></p>

<p id="xdx_85B_zW76W1xUgLok" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=RIME_SemiCabIncMember', window );">Semi Cab Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_805_eus-gaap--SignificantAccountingPoliciesTextBlock_zz3tgt0GCdw9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
3 - <span id="xdx_829_z65a3VHgP1y3">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p id="xdx_84A_eus-gaap--ConsolidationPolicyTextBlock_zt14LqVxqMS1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_z460VSZ58tEi">PRINCIPLES
OF CONSOLIDATION</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements include certain intercompany expenses associated with its wholly owned India subsidiary,
SMCB Solutions Private Limited, the accounts of the Company. All inter-company accounts and transactions have been eliminated in consolidation
for all periods presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p id="xdx_845_eus-gaap--UseOfEstimates_z7bKEnQYdoBc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_860_zbZQlUmRLS03">USE
OF ESTIMATES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SemiCab
makes estimates and assumptions in the ordinary course of business relating to sales collections and allowances, warranty reserves, and
reserves for promotional incentives that may affect the reported amounts of assets and liabilities and of contingent assets and liabilities
at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Future
events and their effects cannot be determined with absolute certainty; therefore, the determination of estimates requires the exercise
of judgment. Historically, past changes to these estimates have not had a material impact on the Company&#8217;s financial statements.
However, circumstances could change which may alter future expectations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p id="xdx_848_ecustom--ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountPolicy_z1ejGJPCZPgi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_862_zmLkW7LMOPD3">ALLOWANCE
FOR DOUBTFUL ACCOUNTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SemiCab&#8217;s
allowance for doubtful accounts is based on management&#8217;s estimates of the creditworthiness of its customers, current economic conditions
and historical information, and, in the opinion of management, is believed to be in an amount sufficient to respond to normal business
conditions. Management sets 100% reserves for customers in bankruptcy and other allowances based upon historical collection experience.
The Company is subject to chargebacks from customers that are deducted from open invoices and reduce collectability of open invoices.
Should business conditions deteriorate or any major customer default on its obligations to the Company, this allowance may need to be
significantly increased, which would have a negative impact on operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p id="xdx_84D_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zLndMT9h1Rrb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_zIH83l1KnwYc">FOREIGN
CURRENCY TRANSLATION</span> </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for foreign currency transactions pursuant to ASC 830, Foreign Currency Matters (&#8220;ASC 830&#8221;). The functional
currency of the Company is the U.S. dollar, which is the currency of the primary economic environment in which it operates. In accordance
with ASC 830, monetary balances denominated in or linked to foreign currency are stated on the basis of the exchange rates prevailing
at the applicable balance sheet date. For foreign currency transactions included in the statement of operations, the exchange rates applicable
on the relevant transaction dates are used. Gains or losses arising from changes in the exchange rates used in the translation of such
transactions and from the remeasurement of the monetary balance sheet items are recorded as gain (loss) on foreign currency transactions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
functional currency of the India subsidiary is the Indian Rupee. Under ASC 830, all assets and liabilities are translated into U. S.
dollars using the current exchange rate at the end of each fiscal period. Revenues and expenses are translated using the average exchange
rates prevailing throughout the respective periods. All transaction gains and losses from the measurement of monetary balance sheet items
denominated in Indian Rupee are reflected in the statement of operations as appropriate. Translation adjustments are included in accumulated
other comprehensive loss.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84F_eus-gaap--ConcentrationRiskCreditRisk_zuOr9O0PwYm5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b><span id="xdx_86E_zcJuM1Yy4mYi">Concentration
of Credit Risk</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
times, the Company maintains cash in United States bank accounts that are in excess of the Federal Deposit Insurance Corporation insured
amounts. The Company maintains cash balances in foreign financial institutions. The amounts at foreign financial institutions at December
31, 2023 and 2022 were approximately $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_90D_eus-gaap--ForeignFinancialInstitutionsActualDeposits_iI_c20231231_za9UvT4LO8nh" title="Foreign financial institutions actual deposits">58,000</span> and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_906_eus-gaap--ForeignFinancialInstitutionsActualDeposits_iI_c20221231_zwMgn0t9uMXb" title="Foreign financial institutions actual deposits">91,000</span>, respectively. The Company regularly monitors the financial stability of this
financial institution and believes that it is not exposed to any significant credit risk in cash and cash equivalents. However, in March
and April 2023, certain U.S. government banking regulators took steps to intervene in the operations of certain financial institutions
due to liquidity concerns, which caused general heightened uncertainties in financial markets. While these events have not had a material
direct impact on the Company&#8217;s operations, if further liquidity and financial stability concerns arise with respect to banks and
financial institutions, either nationally or in specific regions, the Company&#8217;s ability to access cash or enter into new financing
arrangements may be threatened, which could have a material adverse effect on its business, financial condition and results of operations.
Financial instruments, which potentially subject the Company to concentrations of credit risk, consist of accounts receivable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p id="xdx_843_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zBaPdFhl2PSl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86C_zwUgYWEk8UX9">LONG-LIVED
ASSETS</span> </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable. The only meaningful long-lived assets are intangible in nature and under GAAP accounting, not capitalized nor assigned any
long-term accounting value. prior to the proposed transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p id="xdx_84E_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zzUXSum9Vgah" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_zwN1Jzo3psEk">PROPERTY
AND EQUIPMENT</span> </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and Equipment are stated at cost. Depreciation is provided for in amounts sufficient to relate the cost of depreciable assets to operations
over the estimated service lives, principally using straight-line methods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
estimated useful lives used to compute depreciation and amortization for financial reporting purposes are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_897_eus-gaap--ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock_z2dJnq9UqxD5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zmYEfXhjCFr5" style="display: none">SCHEDULE
OF ESTIMATED USEFUL LIVES</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></p>

<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify">&#160;</td>
  <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Years</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 70%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
  and Equipment</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 30%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__srt--RangeAxis__srt--MinimumMember_zhbOAT3stvZh" title="Property plant and equipment useful life">3</span> - <span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__srt--RangeAxis__srt--MaximumMember_zqn6PxRDpa4c" title="Property plant and equipment useful life">5</span></span></td></tr>
</table>


<p id="xdx_8A6_zWlb9Wnx0g7h" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p id="xdx_845_ecustom--PrepaidExpensesPolicyTextBlock_zkvjbZ0xjxoj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_867_zagvPAZT0yLk">PREPAID
EXPENSES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid
expenses consist primarily of prepaid services which will be expensed as the services are provided within twelve months. As of December
31, 2023 and 2022, the balances of the prepaids account were $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_90F_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iI_c20231231_z7bl03q6wx8h" title="Prepaid expense">5,000</span> and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_90F_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iI_c20221231_znLDu8J88Lbf" title="Prepaid expense">8,000</span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p id="xdx_849_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zHRLmSf1tBl5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_869_zz0MwxDff286">FAIR
VALUE OF FINANCIAL INSTRUMENTS</span> </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
carrying values of financial instruments comprising cash and cash equivalents, payables, and notes payable-related party approximate
fair values due to the short-term maturities of these instruments. The notes payable- related party is considered a level 3 measurement.
As defined in ASC 820, <i>Fair Value Measurements and Disclosures</i>, fair value is the price that would be received to sell an asset
or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). The Company
utilizes market data or assumptions that market participants would use in pricing the asset or liability, including assumptions about
risk and the risks inherent in the inputs to the valuation technique. These inputs can be readily observable, market corroborated, or
generally unobservable. ASC 820 establishes a fair value hierarchy that prioritizes the inputs used to measure fair value. The hierarchy
gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and
the lowest priority to unobservable inputs (Level 3 measurement). This fair value measurement framework applies to both initial and subsequent
measurement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    1:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 92%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quoted
    prices are available in active markets for identical assets or liabilities as of the reporting date.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    2:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pricing
    inputs are other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as
    of the reported date. Level 2 includes those financial instruments that are valued using models or other valuation methodologies.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    3:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pricing
inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally
developed methodologies that result in management&#8217;s best estimate of fair value. The significant unobservable inputs used in the
fair value measurement for nonrecurring fair value measurements of long-lived assets include pricing models, discounted cash flow methodologies
and similar techniques.</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
carrying amounts of the Company&#8217;s short-term financial instruments, including accounts receivable, accounts payable, accrued expenses,
customer deposits, refunds due to customers, and due to related parties approximates fair value due to the relatively short period to
maturity for these instruments. The carrying amounts on the notes payable, finance leases and installment notes approximate fair value
either due to the relatively short period to maturity or the related interest is accrued at a rate similar to market rates. The carrying
amounts on the revolving line of credit approximates fair value due the relatively short period to maturity and related interest accrued
at market rates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p id="xdx_841_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_z6gJVLCEEyt9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span>REVENUE
RECOGNITION</span> </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_869_ziYHCZqBAts2" style="display: none">REVENUE
RECOGNITION AND RESERVE FOR SALES RETURNS</span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes revenue in accordance with FASB ASC 606, &#8220;Revenue from Contracts with Customers&#8221;. All revenue is generated
from contracts with customers. The Company recognizes revenue when the control of the goods sold is transferred to the customer, in an
amount, referred to as the transaction price, that reflects the consideration to which the Company is expected to be entitled in exchange
for those goods. The Company determines revenue recognition utilizing the following five steps: (1) identification of the contract with
a customer, (2) identification of the performance obligations in the contract (promised goods or services that are distinct), (3) determination
of the transaction price, (4) allocation of the transaction price to the performance obligations, and (5) recognition of revenue when,
or as, the Company transfers control of the product or service for each performance obligation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s contracts with customers consist of one performance obligation (the sale of the Company&#8217;s products). The Company&#8217;s
contracts have no financing elements, payment terms are less than 120 days and have no further contract asset or liability obligations
once control of goods is transferred to the customer. Revenue is recorded in the amount of consideration the Company expects to receive
for the sale of these goods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Costs
incurred in fulfilling contracts with customers include administrative costs associated with the procurement of goods are included in
general and administrative expenses, in-bound freight costs are included in the cost of goods sold and accrued sales representative commissions
are included in selling expenses in the accompanying consolidated statements of operations as our underlying customer agreements are
less than one year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p id="xdx_84D_ecustom--ShippingAndHandlingCostsPolicyTextBlock_zUMy4fBOf0a2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_862_zJNalzNaVDh9">SHIPPING
AND HANDLING COSTS</span> </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shipping
and handling activities are performed before the customer obtains control of the goods delivered for them and are considered activities
to fulfill the Company&#8217;s promise to transfer the goods. For Fiscal 2023 and 2022 shipping and handling expenses provided by third
party shippers were approximately $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_90F_ecustom--ShippingAndHandlingExpenses_c20230101__20231231_zlhIbVOmmoij" title="Shipping and handling expenses">5,692,000</span> and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_908_ecustom--ShippingAndHandlingExpenses_c20220101__20221231_zYqwgyDuxhu8" title="Shipping and handling expenses">10,057,000</span>, respectively. These expenses are classified as a component of selling
expenses in the accompanying consolidated statements of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p id="xdx_849_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zi5KOh9YHNHf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86B_z18aPM8fpv76">STOCK-BASED
COMPENSATION</span> </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for share based compensation in accordance with the provisions of ASC 718-10, &#8220;Compensation &#8212; Stock Compensation,&#8221;
which requires measurement of compensation cost for all stock awards at fair value on date of grant and recognition of compensation over
the service period for awards expected to vest. The majority of its share-based compensation arrangements vest over a three year vesting
schedule. The Company expenses its share-based compensation under the ratable method, which treats each vesting tranche as if it were
an individual grant. The fair value of stock options is determined using the Black-Scholes valuation model and requires the input of
certain assumptions. These assumptions include estimating the length of time employees will retain their vested stock options before
exercising them (the &#8220;expected option term&#8221;), the estimated volatility of its common stock price over the option&#8217;s
expected term, the risk-free interest rate over the option&#8217;s expected term, and the Company&#8217;s expected annual dividend yield.
Changes in these subjective assumptions can materially affect the estimate of fair value of stock-based compensation and consequently,
the related amount recognized as an expense in the consolidated statements of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
required under the accounting rules, the Company reviews its valuation assumptions at each grant date and, as a result, the Company is
likely to change its valuation assumptions used to value employee stock-based awards granted in future periods. The values derived from
using the Black-Scholes model are recognized as expense over the service period, net of estimated forfeitures (the number of individuals
that will ultimately not complete their vesting requirements). The estimation of stock awards that will ultimately vest requires significant
judgment. The Company considers many factors when estimating expected forfeitures, including types of awards, employee class, and historical
experience. Actual results, and future changes in estimates, may differ substantially from current estimates. Options and warrants to
outsiders are accounted for under ASC 718.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_848_eus-gaap--ResearchAndDevelopmentExpensePolicy_zbNgN3QOxfw7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_z0hSPZtChHU4">RESEARCH
AND DEVELOPMENT COSTS</span> </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
research and development costs are charged to results of operations as incurred. These expenses are shown as a component of general and
administrative expenses in the consolidated statements of operations. For the years ended December 31, 2023 and 2022, these amounts totaled
approximately $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_907_eus-gaap--ResearchAndDevelopmentExpense_c20230101__20231231_z00keplmHzVi" title="Research and development costs">842,000</span> and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_904_eus-gaap--ResearchAndDevelopmentExpense_c20220101__20221231_zP8VEPPMhMm1" title="Research and development costs">640,000</span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p id="xdx_849_eus-gaap--IncomeTaxPolicyTextBlock_zTed47CBFWAh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_869_zOUw1hxTBww3">INCOME
TAXES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company follows the provisions of FASB ASC 740 &#8220;Accounting for Income Taxes.&#8221; Under the asset and liability method of ASC
740, deferred tax assets and liabilities are recognized for the future tax consequences attributed to differences between the financial
statement carrying amounts of existing assets and liabilities and their respective tax base. Deferred tax assets and liabilities are
measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to
be recovered or settled. Under ASC 740, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income
in the period that includes the enactment date. If it is more likely than not that some portion of a deferred tax asset will not be realized,
a valuation allowance is recognized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes a liability for uncertain tax positions. An uncertain tax position is defined as a position in a previously filed
tax return or a position expected to be taken in a future tax return that is not based on clear and unambiguous tax law and which is
reflected in measuring current or deferred income tax assets and liabilities for interim or annual periods. The Company may recognize
the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination
by the taxing authorities, based on the technical merits of the position. The Company measures the tax benefits recognized based on the
largest benefit that has a greater than 50% likelihood of being realized upon ultimate resolution.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of March 31, 2023 and 2022 there were no uncertain tax positions that resulted in any adjustment to the Company&#8217;s provision for
income taxes. The Company recognizes interest and penalties related to unrecognized tax benefits in its provision for income taxes. The
Company currently has no liabilities recorded for accrued interest or penalties related to uncertain tax provisions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p id="xdx_84A_eus-gaap--EarningsPerSharePolicyTextBlock_zAb0q9XUEOti" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_863_zz3yTyIaMu27">COMPUTATION
OF EARNINGS (LOSS) PER SHARE</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable. This is not required.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p id="xdx_84B_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zSuculTGSwrj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_zSh71TqczAL7">RECENT
ACCOUNTING PRONOUNCEMENTS</span>:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">In
June 2016, the FASB issued ASU 2016-13, &#8220;Financial Instruments&#8212;Credit Losses&#8221; <i>(Topic 326)</i>. This ASU represents
a significant change in the current accounting model by requiring immediate recognition of management&#8217;s estimates of current expected
credit losses. Under the prior model, losses were recognized only as they were incurred, which delayed recognition of expected losses
that might not yet have met the threshold of being probable. </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
amendments in ASU 2016-03 for smaller reporting companies are effective for the Company beginning April 1, 2023, including interim periods
within that fiscal year. The Company adopted ASU 2016-13 on May 1, 2024. The adoption of ASU 2016-13 did not result in any material effects
to the consolidated financial statements or related disclosures.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=RIME_SemiCabIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=RIME_SemiCabIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>155
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035118290640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ASSET ACQUISITION<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetAcquisitionTextBlock', window );">ASSET ACQUISITION</a></td>
<td class="text"><p id="xdx_80D_eus-gaap--AssetAcquisitionTextBlock_zMHVfCEgdIX6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
5 &#8211; <span id="xdx_827_zfEDbNuQdSbc">ASSET ACQUISITION</span></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 11, 2024, the Company and its wholly owned subsidiary SemiCab,LLC, SemiCab, Inc., Ajesh Kapoor and Vivek Sehgal entered into the
Asset Purchase Agreement pursuant to which the Seller agreed to sell and assign to the Company, and the Company agreed to purchase and
assume from the Seller, substantially all the assets, and certain specified liabilities relating to the business of the Seller.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="-sec-ix-redline: true">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="-sec-ix-redline: true">The Company
decided to acquire SemiCab as part of a strategic plan to diversify its business and reduce its reliance solely on retail and consumer
electronics and strategically focus on growth. The acquisition fit the Company&#8217;s strategic decision to pivot to a holding company
structure.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-redline: true">On
July 3, 2024, the parties completed the Asset Purchase Agreement whereby the Company issued to the Seller (i) <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesPurchaseOfAssets_c20240703__20240703__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember_z8gJnhFSCGJh" title="Shares purchase">641,806</span> shares of the Company&#8217;s
common stock with a value of approximately <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodValuePurchaseOfAssets_c20240703__20240703__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember_zkKseGqOtZG4" title="Purchase of assets value">$494,000</span> (ii) a twenty percent (<span id="xdx_90E_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_uPure_c20240703__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SemiCabLLCMember_zWKLnN6wxobe" title="Membership percentage">20%</span>) membership interest in SemiCab LLC. (See Note 2).</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-redline: true">Pursuant
to the asset acquisition agreement, the Company and Seller entered into an option agreement (the &#8220;Option Agreement&#8221;), granting
the Buyer the right to acquire all of the issued and outstanding capital securities of SMCB Solutions Private Limited (&#8220;SMCB&#8221;),
a wholly owned subsidiary of the Seller, in consideration for <span id="xdx_90F_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20240703__20240703__us-gaap--AssetAcquisitionAxis__custom--SemiCabLLCMember_zKwvxynjL23g" title="Seller Consideration share">320,903</span> shares of common stock of the Company. As of the date of this filing,
the Option Agreement expired unexercised.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-redline: true">In
connection with the asset acquisition agreement, effective July 3, 2024, SemiCab, LLC entered into employment agreements (the &#8220;Agreements&#8221;)
with Ajesh Kapoor and Vivek Sehgal Kapoor&#8217;s agreement spans three years with an annual base salary of $<span id="xdx_903_eus-gaap--SalariesAndWages_c20240703__20240703__srt--StatementScenarioAxis__custom--TwoThousandTwentyFourMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementsMember_zlrl9eXOT6Yi" title="Salaries and wages">140,000</span> for 2024, $<span id="xdx_90C_eus-gaap--SalariesAndWages_c20240703__20240703__srt--StatementScenarioAxis__custom--TwoThousandTwentyFiveMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementsMember_zQ3IT5o38E12" title="Salaries and wages">240,000</span>
for 2025, and $<span id="xdx_90E_eus-gaap--SalariesAndWages_c20240703__20240703__srt--StatementScenarioAxis__custom--SubsequentYearsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementsMember_zWLBx1Ospq0a" title="Salaries and wages">300,000</span> for subsequent years, and Sehgal&#8217;s agreement also spans three years with an annual base salary of $<span id="xdx_906_eus-gaap--SalariesAndWages_c20240703__20240703__srt--StatementScenarioAxis__custom--TwoThousandTwentyFourMember__srt--TitleOfIndividualAxis__custom--VivekSehgalKapoorMember__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementsMember_zxuUVyJG3Mdg" title="Salaries and wages">105,000</span>
for 2024, $<span id="xdx_90A_eus-gaap--SalariesAndWages_c20240703__20240703__srt--StatementScenarioAxis__custom--TwoThousandTwentyFiveMember__srt--TitleOfIndividualAxis__custom--VivekSehgalKapoorMember__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementsMember_z8a3AnH52brc" title="Salaries and wages">210,000</span> for 2025, $<span id="xdx_90A_eus-gaap--SalariesAndWages_c20240703__20240703__srt--StatementScenarioAxis__custom--TwoThousandTwentySixMember__srt--TitleOfIndividualAxis__custom--VivekSehgalKapoorMember__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementsMember_zbSowXnf3Axb" title="Salaries and wages">240,000</span> for 2026, $<span id="xdx_907_eus-gaap--SalariesAndWages_c20240703__20240703__srt--StatementScenarioAxis__custom--TwoThousandTwentySevenMember__srt--TitleOfIndividualAxis__custom--VivekSehgalKapoorMember__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementsMember_zvK7JhFkJkt6" title="Salaries and wages">270,000</span> for 2027, and $<span id="xdx_90E_eus-gaap--SalariesAndWages_c20240703__20240703__srt--StatementScenarioAxis__custom--TwoThousandTwentyEightMember__srt--TitleOfIndividualAxis__custom--VivekSehgalKapoorMember__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementsMember_zd2IGkiq341k" title="Salaries and wages">300,000</span> for 2028. Both executives&#8217; salaries are subject
to annual review by the Board. They are eligible for annual performance-based bonuses contingent on specific goals set by the Board and
will participate in the 2022 Equity Incentive Plan, receiving annual equity issuances and cash-based incentives tied to revenue milestones.
Both are entitled to standard employee benefits, including health insurance and retirement plans.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALGORHYTHM
                                            HOLDINGS, INC. and SUBSIDIARIES</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September
30, 2024 and 2023</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-redline: true">On
July 3, 2024, the (&#8220;Acquisition Date&#8221;), the Company acquired substantially all the assets and assumed certain liabilities
of SemiCab, Inc. in exchange for the purchase price consideration of approximately $<span id="xdx_90F_eus-gaap--AssetAcquisitionConsiderationTransferred_c20240703__20240703__us-gaap--AssetAcquisitionAxis__custom--SemiCabIncMember_ztWenrSpEiKc" title="Asset acquisition purchase price consideration">983,000</span>. On July 3, 2024, the value of the total
identifiable intangible assets, including goodwill was approximately <span id="xdx_909_eus-gaap--IntangibleAssetsNetIncludingGoodwill_iI_c20240703_zGHnOvGlyX54" title="Identifiable intangible assets  including goodwill">$4,754,000</span>, based on the restricted value of SMC common shares on
the date of acquisition. The Company also recognized non-controlling interest at fair value as of the Acquisition Date in the amount
of approximately $<span id="xdx_90B_ecustom--NonControllingInterestAtFairValue_c20240703__20240703_zI0pHU3nzsZ6" title="Non-controlling interest at fair value">74,000</span> representing <span id="xdx_90C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20240703__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SemiCabIncMember_zqwasO0LjYX6" title="Ownership percentage">20</span>% ownership in SemiCab Holdings, LLC, which is <span id="xdx_90C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20240703__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlgorhythmHoldingsIncMember_z2rWftGzy9j5" title="Ownership percentage">80</span>% owned by the Company.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-redline: true">The
trade names and developed technology intangible assets were valued using the relief-from-royalty method. The relief-from-royalty method
is one of the methods under the income approach wherein estimates of a company&#8217;s earnings attributable to the intangible asset
are based on the royalty rate the company would have paid for the use of the asset if it did not own it. Royalty payments are estimated
by applying royalty rates of <span id="xdx_90A_ecustom--RoyaltyRate_pid_dp_uPure_c20240703__20240703_zax9QlMBHA1l" title="Royalty rate">0.5</span>% to the prospective revenue attributable to the intangible asset. The resulting net annual royalty payments
are then discounted to present value using a discount factor of <span id="xdx_90C_ecustom--DiscountOnRoyaltyRate_pid_dp_uPure_c20240703__20240703_zKVJtg7wctuf" title="Discount on royalty rate">33</span>%, and the remaining economic life of <span id="xdx_90D_ecustom--RoyaltyTerm_dc_c20240703__20240703_zu7yRrIFFDMi" title="Royalty term">nine years</span>.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-redline: true">The
Company determined an estimated fair value of customer relationships using multi-period excess earnings approach utilizing a discounted
cash flow methodology. The analysis included assumptions regarding the growth rate for the development of new businesses, concluding
between <span id="xdx_904_ecustom--GrowthRateOfDevelopmentOfNewBusiness_pid_dp_c20240703__20240703__srt--RangeAxis__srt--MinimumMember_zgz8ADQQa8oc" title="Growth rate of development of new business">8</span>% and <span id="xdx_901_ecustom--GrowthRateOfDevelopmentOfNewBusiness_pid_dp_c20240703__20240703__srt--RangeAxis__srt--MaximumMember_z6imzS83qoid" title="Growth rate of development of new business">20</span>% organic growth rates for revenue attributable to existing customers. A discount rate of <span id="xdx_90B_ecustom--DiscountRateForWeightedAverageCost_pid_dp_c20240703__20240703_zdwxyxjh8GA5" title="Discount rate for weighted average cost">33</span>% was used for the weighted
average cost of capital analysis, along with the evaluation of the capital expenditure requirements associated with any new initiatives
developed by SemiCab. The purchase accounting for this transaction is provisional and subject
to measurement period adjustments for one year following the date of acquisition.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
valuations for the above intangible assets require use of unobservable inputs that are classified as Level 3 on the fair value hierarchy.</span></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
goodwill resulting from this acquisition is tax deductible.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p id="xdx_893_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_zqfSlXacSIQb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents the allocation of the consideration transferred to the assets acquired and liabilities assumed based on their
fair values:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="-sec-ix-redline: true"><span id="xdx_8B0_zqB8RjhO6SA" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE
OF CONSIDERATION TRANSFERRED TO THE ASSETS ACQUIRED AND LIABILITIES ASSUMED</span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td id="xdx_49E_20240703__us-gaap--BusinessAcquisitionAxis__custom--SemiCabIncMember_zh7pqoAcz5qf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Equity consideration"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 74%; text-align: left"><span style="-sec-ix-redline: true">Equity consideration</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_98A_eus-gaap--AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable_c20240703__20240703__us-gaap--AssetAcquisitionAxis__custom--SemiCabIncMember_zlLgWxDyscff" style="font: 10pt Times New Roman, Times, Serif; width: 22%; text-align: right" title="Equity consideration"><span style="-sec-ix-redline: true">494,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">Fair value of non-controlling interest</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td id="xdx_98E_ecustom--AssetAcquisitionFairValueOfNonControllingInterest_c20240703__20240703__us-gaap--AssetAcquisitionAxis__custom--SemiCabIncMember_z6LHfTO1zIf" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Fair value of non-controlling interest"><span style="-sec-ix-redline: true">74,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">Total Equity Consideration</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td id="xdx_983_eus-gaap--AssetAcquisitionConsiderationTransferredContingentConsideration_c20240703__20240703__us-gaap--AssetAcquisitionAxis__custom--SemiCabIncMember_zo7Ps31BOJhd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total Equity Consideration"><span style="-sec-ix-redline: true">568,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="-sec-ix-redline: true">Debt Extinguishment</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td id="xdx_981_ecustom--AssetAcquisitionDebtExtinguishment_c20240703__20240703__us-gaap--AssetAcquisitionAxis__custom--SemiCabIncMember_z02uvR7ZXrRk" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Debt Extinguishment"><span style="-sec-ix-redline: true">415,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">Total Consideration</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_980_eus-gaap--AssetAcquisitionConsiderationTransferred_c20240703__20240703__us-gaap--AssetAcquisitionAxis__custom--SemiCabIncMember_zlZrKZvXompg" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Total consideration"><span style="-sec-ix-redline: true">983,000</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">Identifiable net assets acquired:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_iI_ziB7iOrglvn" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">Cash and Cash Equivalents</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">17,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_iI_zia4FpE3NQVc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">Accounts receivable</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">193,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_iI_zDAJcMob9pAd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">Prepaid expenses and other current assets</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">13,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_zlTqy723kO5c" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">Property and equipment, net</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">3,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_iI_z6siHi5SxsMl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">Other Non-Current Operating Assets, Net</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">14,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr id="xdx_40C_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCustomerRelationships_iI_zUWvmGbp32t3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">Customer Relationships (<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlNJREVSQVRJT04gVFJBTlNGRVJSRUQgVE8gVEhFIEFTU0VUUyBBQ1FVSVJFRCBBTkQgTElBQklMSVRJRVMgQVNTVU1FRCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20240703__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zYg7VmAKamhf">9
    </span></span><span style="-sec-ix-redline: true">year estimated useful life)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">747,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr id="xdx_401_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradeName_iI_z7vJ6LJn72h6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">Trade Name (<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlNJREVSQVRJT04gVFJBTlNGRVJSRUQgVE8gVEhFIEFTU0VUUyBBQ1FVSVJFRCBBTkQgTElBQklMSVRJRVMgQVNTVU1FRCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90F_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20240703__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_ziXcACBKrHC6">9
    </span></span><span style="-sec-ix-redline: true">year estimated useful life)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">272,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr id="xdx_409_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDevelopedTechnology_iI_zUOYy8tjHF41" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">Developed Technology (<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlNJREVSQVRJT04gVFJBTlNGRVJSRUQgVE8gVEhFIEFTU0VUUyBBQ1FVSVJFRCBBTkQgTElBQklMSVRJRVMgQVNTVU1FRCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20240703__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DevelopedTechnologyRightsMember_zCx5Qsd9yz8l">6
    </span></span><span style="-sec-ix-redline: true">year estimated useful life)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">381,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_iNI_di_zodX7BNLMoAd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">Accounts payable and accrued expenses</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">(2,680,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">)</span></td></tr>
  <tr id="xdx_40B_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLoansPayable_iI_zMz2R2tKSr3l" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">Loans payable Merchant Cash Advances (MCA)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">(631,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">)</span></td></tr>
  <tr id="xdx_408_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt_iNI_di_zkoi1AVl10b8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">Note payable</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">(50,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">)</span></td></tr>
  <tr id="xdx_404_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesNotesPayableRelatedParties_iI_znAEmC4h6vsj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="-sec-ix-redline: true">Notes payable Related Parties</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">(650,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="-sec-ix-redline: true">)</span></td></tr>
  <tr id="xdx_400_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_z67ORAU3jxsf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="-sec-ix-redline: true">Net assets acquired</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">(2,371,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="-sec-ix-redline: true">)</span></td></tr>
  <tr id="xdx_40E_eus-gaap--Goodwill_iI_z56M72yov2Yk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">Estimated Goodwill</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">3,354,000</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  </table>

<p id="xdx_8AF_zEtY1LGpkYD7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Pro
Forma Information</i></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
unaudited pro forma financial information below presents the effects of the Asset Purchase Agreement as though it had been completed
on January 1, 2023. The pro forma adjustments are derived from the historically reported transactions of the respective companies. The
pro forma results do not include anticipated combined effects or other expected benefits of the acquisition. The pro forma results for
the nine months ended September 30, 2024 and 2023 reflect the combined performance of the Company and the SemiCab business for that period.
The unaudited pro forma information is based on available data and certain assumptions that the Company believes are reasonable given
the circumstances. However, actual results may differ materially from the assumptions used in the accompanying unaudited pro forma financial
information. This selected unaudited pro forma condensed combined financial information is presented for illustrative purposes only and
is not intended to represent what the actual consolidated results of operations would have been had the acquisition date occurred on
January 1, 2023, nor does it attempt to forecast future consolidated results of operations.</span></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALGORHYTHM
                                            HOLDINGS, INC. and SUBSIDIARIES</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September
30, 2024 and 2023</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></span></p>

<p id="xdx_891_ecustom--ScheduleOfProFormaFinancialInformationTableTextBlock_zWwCnqTKNek9" style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span id="xdx_8BD_z3uB87DL9bu3" style="display: none">SCHEDULE
OF PRO FORMA FINANCIAL INFORMATION</span></span><span style="-sec-ix-redline: true">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td id="xdx_497_20240101__20240930_z3drDoyCCjZd" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td id="xdx_499_20230101__20230930_z71B4uIUAeLi" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">Nine Months Ended</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">September
    30, 2024</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">September
    30, 2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--BusinessAcquisitionsProFormaRevenue_zGU55vatkVmd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="-sec-ix-redline: true">Net revenue</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="-sec-ix-redline: true">16,831,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="-sec-ix-redline: true">26,848,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax_zRTwvKp3syM2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">Operating loss from continuing operations</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">(8,093,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">(6,187,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">)</span></td></tr>
  <tr id="xdx_400_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_zBIixXJD0Vvd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">Net loss</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">(8,451,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">(7,164,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">)</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<p id="xdx_8A3_zO5F9SgOmRfa" style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="-sec-ix-redline: true">The pro forma results for
the nine months ended September 30, 2023, include a net increase in operating expenses of $<span id="xdx_904_eus-gaap--IncreaseDecreaseInOperatingCapital_c20230101__20230930_z4qK0CSlK5Mb" title="Increase decrease in operating capital">265,000</span>, consisting of legal and accounting
expenses of approximately $<span id="xdx_905_eus-gaap--LegalFees_c20230101__20230930_z6F1WhjiJy07" title="Legal fees">215,000</span>&#160;associated with the acquisition of SemiCab and $<span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20230101__20230930_zYDqUrqyMfye" title="Stock issued during period shares acquisitions">50,000</span>&#160;in shares of SMC common stock issued
to Vivek Sehgal as sign-on bonus.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for asset acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 15<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480123/805-50-15-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>156
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035112739776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCING<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">FINANCING</a></td>
<td class="text"><p id="xdx_802_eus-gaap--DebtDisclosureTextBlock_z5HBU13PkCdh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
6 &#8211; <span id="xdx_82A_zC4jtxyBG7Zj">FINANCING</span></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Oxford
Credit Facility</i></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-redline: true">On
March 28, 2024, the Company entered into a Loan and Security Agreement (the &#8220;Credit Agreement&#8221;) with Oxford Business Credit
&#8220;Oxford&#8221;), as Lender. The Credit Agreement established a secured asset-backed revolving credit facility which is comprised
of a maximum $<span id="xdx_900_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_c20240328__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_zbETZNnun2y5" title="Revolving credit facility">2,000,000</span> revolving credit facility (&#8220;Credit Facility&#8221;) (&#8220;Revolving Loan Cap&#8221;). Availability under
the Credit Facility is determined monthly by a borrowing base comprised of a percentage of eligible accounts receivable of the Borrowers.
The Company&#8217;s obligations under the Credit Agreement are secured by a continuing security interest in all property of each Loan
Party, subject to certain excluded collateral (as defined in the Credit Agreement). As of September 30, 2024, there was approximately
$<span id="xdx_901_eus-gaap--OtherReceivables_iI_c20240930__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zi86HMiOCY7e" title="Due from Oxford Bank">22,000</span> due from Oxford for cash collections received that exceeded the amount due on the Credit Agreement. As of September 30, 2024,
there were <span id="xdx_909_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_do_c20240930__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_zD9v6RKE6xid" title="Revolving credit facility">no</span> funds available for borrowing under the Credit Facility.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-redline: true">Borrowings
under the Credit Facility take the form of base rate loans at interest rates of the Wall Street Journal Prime Rate plus <span id="xdx_90E_eus-gaap--LineOfCreditFacilityInterestRateDuringPeriod_dp_uPure_c20240328__20240328__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_z8W9XVN6ZVR5" title="The Prime Rate">2.5</span>%, but in
any event no less than <span id="xdx_906_eus-gaap--LineOfCreditFacilityInterestRateDuringPeriod_dp_uPure_c20240328__20240328__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember__srt--RangeAxis__srt--MaximumMember_z6rvZ1pGURj9" title="The Prime Rate">10</span>%. The Credit Agreement includes certain covenants which include, but are not limited to restrictions on debt,
asset liens, capital expenditures, formation of new entities and financial covenants. For the three and nine months ended September 30,
2024, the Company incurred interest expense of approximately $<span id="xdx_90B_eus-gaap--InterestExpenseDebt_c20240701__20240930__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_zjqw8BJS3Cn2" title="Interest expense">24,000</span> and $<span id="xdx_90C_eus-gaap--InterestExpenseDebt_c20240101__20240930__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_z5vOgQSpnoY3" title="Interest expense">66,000</span>, respectively associated with financing costs from the
Credit Agreement.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-redline: true">The
Credit Agreement is for a <span id="xdx_908_eus-gaap--DebtInstrumentTerm_dxL_c20240328__20240328__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_z0ojmNaeWUz1" title="Credit agreement term::XDX::P2Y"><span style="-sec-ix-hidden: xdx2ixbrl1051">two</span></span>-year term that expires on <span id="xdx_909_eus-gaap--LineOfCreditFacilityExpirationDate1_dd_c20240328__20240328__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_zFLDsF5PnHVf" title="Credit agreement expires">November 28, 2026</span>, and automatically renews for an additional one-year term on
each anniversary of date of the agreement unless the Company notifies Oxford within 60 days before the anniversary date of its intention
to pay off the Credit Facility and terminate the Credit Agreement.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-redline: true">The
Company is subject to a two percent (<span id="xdx_90B_ecustom--PercentageOfExitFee_dp_uPure_c20240328__20240328__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_z2MYsdzqnlW1" title="Percentage of exit fee">2</span>%) exit fee (&#8220;Exit Fee&#8221;) of the Revolving Loan Cap if the Company terminates the Credit
Agreement and repays the obligations under Credit Facility prior to the anniversary date of the Credit Agreement. The Exit Fee shall
automatically renew on the two-year anniversary date of the Loan Agreement for an additional one-year period unless the Company notifies
Lender in writing within sixty (60) days before such anniversary date of Borrower&#8217;s intention to pay off this Credit Facility and
terminate the Credit Agreement and all obligations of the Credit Facility are paid in full by such anniversary date. There were
no draws against the Credit Facility since inception of the Credit Agreement.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-redline: true">On
October 17, 2024, the Company voluntarily terminated the Credit Agreement. Pursuant to the terms of the Credit Agreement the Company
was obligated to pay a $<span id="xdx_907_eus-gaap--BusinessExitCosts1_c20241017__20241017__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_zFX9RXPuMKRa" title="Exit fee payable on termination of contract">40,000</span> Exit Fee due to termination prior to the anniversary date of the Credit Agreement.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Fifth
Third Bank Asset-backed Revolving Credit Facility</i></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 14, 2022, the Company entered into a Loan and Security Agreement with Fifth Third Financial Corporation (the &#8220;Credit Agreement&#8221;),
as Lender, replacing the Company&#8217;s credit facilities with Crestmark and IHC that were terminated by the Company on October 13,
2022. The Credit Agreement established a secured asset-backed revolving credit facility which is comprised of a maximum $<span id="xdx_902_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_c20221014__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_zCqs92yslYxi">15,000,000
</span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">revolving credit facility (&#8220;Credit
Facility&#8221;). The Credit Facility was terminated on <span id="xdx_904_eus-gaap--LineOfCreditFacilityExpirationDate1_dd_c20221014__20221014__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_zi3QhIbpTsqa">November
17, 2023</span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. Availability under the Credit
Facility was determined monthly by a borrowing base comprised of a percentage of eligible accounts receivable and eligible inventory
of the Borrowers. The Company&#8217;s obligations under the Credit Agreement are secured by a continuing security interest in all property
of each Loan Party, subject to certain excluded collateral (as defined in the Credit Facility).</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-redline: true">Costs
associated with closing of the Credit Agreement of approximately $<span id="xdx_905_eus-gaap--RepaymentsOfLinesOfCredit_c20221014__20221014__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_zn6BzuHVptCg" title="Costs associated with line of credit">254,000</span> were deferred and being amortized over life of the loan. During
the three months and nine months ended September 30, 2023 the Company incurred approximately $<span id="xdx_903_eus-gaap--AmortizationOfFinancingCosts_c20230701__20230930__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_zpJWNSfwFKE" title="Amortization of deferred financing costs">21,000</span> and $<span id="xdx_907_eus-gaap--AmortizationOfFinancingCosts_c20230101__20230930__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_zU2aQni4klSg" title="Amortization of deferred financing costs">63,000</span>, respectively associated
with the amortization of deferred financing costs from the Credit Agreement.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALGORHYTHM
                                            HOLDINGS, INC. and SUBSIDIARIES</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September
30, 2024 and 2023</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-redline: true">Borrowings
under the Credit Facility took the form of base rate loans at interest rates of the greater of either <span id="xdx_90A_eus-gaap--LineOfCreditFacilityInterestRateDescription_c20221014__20221014__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_z1IGRS2yb2R1" title="Base rates of loan description">(a) the Prime Rate plus 0.50% or (b) the Secured Overnight Financing Rate (&#8220;SOFR&#8221;) 30-day term rate plus 3%, subject to a minimum of 0.050% in either case.</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-redline: true">During
the three and nine months ended September 30, 2023, the Company incurred interest expense of approximately $<span id="xdx_903_eus-gaap--InterestAndDebtExpense_c20230701__20230930__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_zTkl2YOWpDY3" title="Interest expense">19,000</span> and $<span id="xdx_903_eus-gaap--InterestAndDebtExpense_c20230101__20230930__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_zMatrRXg6Srd" title="Interest expense">59,000</span> respectively,
associated with interest and financing costs from the Credit Agreement.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-redline: true">On
May 19, 2023, the Company executed a Waiver and First Amendment agreement which provides for a waiver of previous defaults and instituted
new covenants.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-redline: true">On
August 30, 2023, the Company entered into a Waiver and Second Amendment (the &#8220;Revolving Loan Amendment&#8221;) to the Credit Agreement.
The Revolving Loan Amendment provides for, among other things, (i) a waiver of all known existing defaults under the Credit Agreement
as of the date of the Revolving Loan Amendment and (ii) the amendment of the definition of &#8220;Borrowing Base&#8221; to reduce from
$<span id="xdx_905_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_c20221014__us-gaap--CreditFacilityAxis__custom--RevolvingLoanAmendmentMember_zBTI0XrSvoJc" title="Revolving credit facility maximum amount">5,000,000</span> to $<span id="xdx_903_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_c20230830__us-gaap--CreditFacilityAxis__custom--RevolvingLoanAmendmentMember_zpT5JRSt3O43" title="Revolving credit facility maximum amount">2,000,000</span>.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 17, 2023, the Company voluntarily terminated the Credit Agreement as the Company could not comply with the debt coverage financial
covenant effective September 30, 2023. There was no balance outstanding on the credit agreement as of the termination date.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Merchant
Cash Advance payable &#8211; Agile Capital Funding, LLC</i></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-redline: true">Pursuant to the acquisition of SemiCab, the Company assumed a Merchant
Cash Advance (&#8220;MCA Financing&#8221;) payable with Agile Capital Funding, LLC (&#8220;Agile&#8221;). On
March 22, 2024, SemiCab entered into a MCA Financing agreement with Agile. The initial
amount borrowed was $<span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_iI_c20240322__us-gaap--ShortTermDebtTypeAxis__custom--AgileCapilalFundingllcMember_zVHMwas78f7j" title="Initial amount borrowed">315,000</span>, with net proceeds to the Company in the amount of $<span id="xdx_902_eus-gaap--ProceedsFromShortTermDebt_c20240322__20240322__us-gaap--ShortTermDebtTypeAxis__custom--AgileCapilalFundingllcMember_zGhiRuXtUIEe" title="Net proceeds from short term debt">300,000</span>. Repayment terms stipulate weekly payments in
the amount of $<span id="xdx_906_eus-gaap--DebtInstrumentPeriodicPayment_c20240322__20240322__us-gaap--ShortTermDebtTypeAxis__custom--AgileCapilalFundingllcMember_zyxbviYoc9R4" title="Stipulated periodic payment of short term debt">16,200</span> for weeks, for a total of $<span id="xdx_90B_eus-gaap--RepaymentsOfShortTermDebt_c20240322__20240322__us-gaap--ShortTermDebtTypeAxis__custom--AgileCapilalFundingllcMember_zy77m5cWfili" title="Total short term debt to be repaid">453,600</span> repaid. The effective interest rate for the borrowings is <span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_dp_c20240322__us-gaap--ShortTermDebtTypeAxis__custom--AgileCapilalFundingllcMember_ztwU3tLc9acj" title="Effective Interest rate">15</span>%. As September
30, 2024 the amount due on this MCA Financing was approximately $<span id="xdx_905_eus-gaap--ShortTermBorrowings_iI_c20240930__us-gaap--ShortTermDebtTypeAxis__custom--AgileCapilalFundingllcMember_zMer59dkaotf" title="Amount outstanding for Agile Capital Funding,LLC">146,500</span>.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Merchant
Cash Advance payable &#8211; Cedar Advance, LLC</i></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true">Pursuant to the acquisition of SemiCab, the Company assumed a MCA Financing
payable with Cedar Advance, LLC (&#8220;Cedar&#8221;). On
May 8, 2024, SemiCab entered into an MCA Financing with Cedar. The initial amount borrowed was $<span id="xdx_90C_eus-gaap--DebtInstrumentFaceAmount_iI_c20240508__us-gaap--ShortTermDebtTypeAxis__custom--CedarAdvancellcMember_zVO8oGJdlich" title="Initial amount borrowed">215,000</span>, with net proceeds
to the Company in the amount of $<span id="xdx_907_eus-gaap--ProceedsFromShortTermDebt_c20240508__20240508__us-gaap--ShortTermDebtTypeAxis__custom--CedarAdvancellcMember_z1Y9U30HxHM5" title="Net proceeds from short term debt">204,250</span>. Repayment terms stipulate weekly payments in the amount of $<span id="xdx_901_eus-gaap--DebtInstrumentPeriodicPayment_c20240508__20240508__us-gaap--ShortTermDebtTypeAxis__custom--CedarAdvancellcMember_z8OXvDjgdSck" title="Stipulated periodic payment of short term debt">11,133</span> for 28 weeks, for a total
of $<span id="xdx_90D_eus-gaap--RepaymentsOfShortTermDebt_c20240508__20240508__us-gaap--ShortTermDebtTypeAxis__custom--CedarAdvancellcMember_zVqczmkpevka" title="Total short term debt to be repaid">311,750</span> repaid. The effective interest rate for the borrowings is <span id="xdx_908_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_dp_c20240508__us-gaap--ShortTermDebtTypeAxis__custom--CedarAdvancellcMember_zvO8TZuqnv12" title="Effective Interest rate">18</span>%. As September 30, 2024 the amount due on this MCA Financing
was approximately $<span id="xdx_90F_eus-gaap--ShortTermBorrowings_iI_c20240930__us-gaap--ShortTermDebtTypeAxis__custom--CedarAdvancellcMember_zCpVVaWuplol" title="Amount outstanding for Agile Capital Funding,LLC">156,920</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Loan
Payable SemiCab Investor</i></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-redline: true">SemiCab
maintains a loan from a SemiCab investor in the amount of $<span id="xdx_90C_eus-gaap--DebtInstrumentFaceAmount_iI_c20240322__us-gaap--ShortTermDebtTypeAxis__custom--SemiCabInvestorMember_zZ0BzEWCRxDc" title="Initial amount borrowed">50,000</span>. The loan bears interest at <span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_dp_c20240322__us-gaap--ShortTermDebtTypeAxis__custom--SemiCabInvestorMember_ziiuETZmpLE4" title="Effective Interest rate">10%</span> per annum and matured on May 15, 2024
and is unsecured. As of September 30, 2024 the loan had not been paid and is in default. The principal amount due is recorded as a component
of notes payable on the accompanying condensed consolidated balance sheets.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></span></p>

<span></span>
</td>
<td class="text"><p id="xdx_802_eus-gaap--DebtDisclosureTextBlock_zoegaCnoZlqf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
6 &#8211; <span id="xdx_828_znhlSSPeKUJ2">FINANCING</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Oxford
Credit Facility</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 28, 2024, the Company entered into a Loan and Security Agreement with Oxford Business Credit (the &#8220;Credit Agreement&#8221;),
as Lender. The Credit Agreement established a secured asset-backed revolving credit facility which is comprised of a maximum $<span id="xdx_90B_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_c20240328__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zQk4m4U3gg33" title="Revolving credit facility">2,000,000</span>
revolving credit facility (&#8220;Credit Facility&#8221;). Availability under the Credit Facility is determined monthly by a borrowing
base comprised of a percentage of eligible accounts receivable of the Borrowers. The Company&#8217;s obligations under the Credit Agreement
are secured by a continuing security interest in all property of each Loan Party, subject to certain excluded collateral (as defined
in the Credit Agreement).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
SINGING MACHINE COMPANY, INC AND SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
31, 2023, and March 31, 2023 and 2022</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Borrowings
under the Credit Facility take the form of base rate loans at interest rates of the greater of either (a) the Prime Rate plus <span id="xdx_907_ecustom--LineOfCreditFacilityInterestRate_dp_uPure_c20240328__20240328__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_zpUeUt4O9lV5" title="The Prime Rate">2.5</span>% The
Credit agreement includes certain covenants which include, but are not limited to restrictions on debt, asset liens, capital expenditures,
formation of new entities and financial covenants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Credit Agreement is for a <span id="xdx_90A_eus-gaap--DebtInstrumentTerm_dxL_c20240328__20240328__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_z8vRwyyYUbrb" title="Credit agreement term::XDX::P2Y"><span style="-sec-ix-hidden: xdx2ixbrl2341">two</span></span>-year term that expires on <span id="xdx_908_eus-gaap--LineOfCreditFacilityExpirationDate1_dd_c20240328__20240328__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_zvE5JZcsnlB5" title="Credit agreement expires">November 28, 2026</span>, and automatically renews for an additional one-year term on
each anniversary of date of the agreement unless the Company notifies Oxford within 60 days before the anniversary date of its intention
to pay off the Credit Facility and terminate the Credit Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is subject to a two percent (<span id="xdx_907_ecustom--PercentageOfExitFee_dp_uPure_c20240328__20240328__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_zrDXecF6lhGe" title="Percentage of exit fee">2</span>%) Exit Fee if the Company terminates the Credit Agreement and repays the obligations under Credit
Facility prior to the anniversary date of the Credit Agreement. The Exit Fee shall automatically renew on the two-year anniversary date
of the Loan Agreement for an additional one-year period unless the Company notifies Lender in writing within sixty (60) days before such
anniversary date of Borrower&#8217;s intention to pay off this Credit Facility and terminate the Credit Agreement and all obligations
of the Credit Facility are paid in full by such anniversary date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fifth
Third Bank Asset-backed Revolving Credit Facility</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 14, 2022, the Company entered into a Loan and Security Agreement with Fifth Third Financial Corporation (the &#8220;Credit Agreement&#8221;),
as Lender, replacing the Company&#8217;s credit facilities with Crestmark and IHC that were terminated by the Company on October 13,
2022. The Credit Agreement established a secured asset-backed revolving credit facility which is comprised of a maximum $<span id="xdx_902_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_c20221014__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_zj8BYhItFPY5" title="Revolving credit facility maximum amount">15,000,000</span> revolving
credit facility (&#8220;Credit Facility&#8221;). The Credit Facility was terminated on <span id="xdx_904_eus-gaap--LineOfCreditFacilityExpirationDate1_dd_c20221014__20221014__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_zUBMDHAdT2ed" title="Revolving credit facility terminated date">November 17, 2023</span>. Availability under the Credit
Facility was determined monthly by a borrowing base comprised of a percentage of eligible accounts receivable and eligible inventory
of the Borrowers. The Company&#8217;s obligations under the Credit Agreement are secured by a continuing security interest in all property
of each Loan Party, subject to certain excluded collateral (as defined in the Credit Agreement).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Costs
associated with closing of the Credit Agreement of approximately $<span id="xdx_902_eus-gaap--RepaymentsOfLinesOfCredit_c20221014__20221014__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_zl2w5WVzF013" title="Costs associated with line of credit">254,000</span> were deferred and being amortized over life of the loan. During
the nine months ended December 31, 2023, and 2022, the Company incurred amortization expenses of approximately $<span id="xdx_909_eus-gaap--AdjustmentForAmortization_c20230401__20231231_zkE9VC4x4R5k" title="Amortization expense">215,000</span> and $<span id="xdx_90D_eus-gaap--AdjustmentForAmortization_c20220401__20221231_z1ylOAExJwd9" title="Amortization expense">18,000</span> respectively
associated with the amortization of deferred financing costs from the Credit Agreement. During the fiscal years ended March 31, 2023,
and 2022, the Company incurred amortization expense of approximately $<span id="xdx_906_eus-gaap--AdjustmentForAmortization_c20220401__20230331_zgZgKCRmzEcf" title="Amortization expense">39,000</span> and $<span id="xdx_90A_eus-gaap--AdjustmentForAmortization_c20210401__20220331_zLZLz0yNvpQl" title="Amortization expense">0</span>, respectively, associated with the amortization of
deferred financing costs from the Credit Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Borrowings
under the Credit Facility took the form of base rate loans at interest rates of the greater of either <span id="xdx_907_eus-gaap--LineOfCreditFacilityInterestRateDescription_c20221014__20221014__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_zWOWVwwlxQEc" title="Base rates of loan description">(a) the Prime Rate plus 0.50% or (b) the Secured Overnight Financing Rate (&#8220;SOFR&#8221;) 30-day term rate plus 3%, subject to a minimum of 0.050% in either case.</span>
For the nine months ended December 31, 2023, and 2022, the Company incurred interest expense of approximately $<span id="xdx_90A_eus-gaap--InterestAndDebtExpense_c20230401__20231231_zT1dJ4T4Lski" title="Interest expense">28,000</span> and $<span id="xdx_900_eus-gaap--InterestAndDebtExpense_c20220401__20221231_zEf4bGqscgW6" title="Interest expense">19,000</span>, respectively.
For the fiscal years ended March 31, 2023, and 2022, the Company incurred interest expense of approximately $<span id="xdx_909_eus-gaap--InterestAndDebtExpense_c20220401__20230331_zuIsnGIR9zM" title="Interest expense">33,000</span> and $<span id="xdx_90F_eus-gaap--InterestAndDebtExpense_c20210401__20220331_zQSAmhQeeXf2" title="Interest expense">0</span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 19, 2023, the Company executed a Waiver and First Amendment agreement which provides for a waiver of previous defaults and
instituted new covenants. On November 17, 2023, the Company voluntarily terminated the Credit Agreement as the
Company could not comply with the debt coverage financial covenant effective September 30, 2023. There was no balance outstanding on
the credit agreement as of the termination date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Intercreditor
Revolving Credit Facility Crestmark Bank and Iron Horse Credit</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 16, 2020, the Company entered into a two-year Credit and Security Agreement for a $<span id="xdx_90B_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_c20200616__us-gaap--TypeOfArrangementAxis__custom--TwoYearCreditAndSecurityAgreementMember__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_z2Di9oZsjNdh" title="Line of credit facility, maximum borrowing amount">2,500,000</span> financing facility, with Iron Horse
Credit (&#8220;IHC&#8221;) on eligible accounts receivable and inventory. Also, on June 16, 2020, the Company entered into a two-year
Loan and Security Agreement for a $<span id="xdx_90C_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_c20200616__us-gaap--TypeOfArrangementAxis__custom--TwoYearLoanAndSecurityAgreementMember__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_zSKFgqhR76M3" title="Line of credit facility, maximum borrowing amount">10,000,000</span> financing facility with Crestmark Bank (&#8220;Crestmark&#8221;) on eligible accounts receivable.
For the nine months ended December 31, 2023, and 2022, the Company incurred approximately $<span id="xdx_90E_eus-gaap--AdjustmentForAmortization_c20230401__20231231__us-gaap--TypeOfArrangementAxis__custom--CreditAndSecurityAgreementsMember_zTgv0ThgPB2l" title="Amortization expense">0</span> and $<span id="xdx_904_eus-gaap--AdjustmentForAmortization_c20220401__20221231__us-gaap--TypeOfArrangementAxis__custom--CreditAndSecurityAgreementsMember_z36h7xfRpnNf" title="Amortization expense">8,000</span>, respectively, in amortization
costs for deferred financing charges associated with the credit and security agreements with Crestmark and IHC. The Company also incurred
interest expense of approximately $<span id="xdx_90C_eus-gaap--InterestAndDebtExpense_c20220401__20230331__us-gaap--TypeOfArrangementAxis__custom--CreditAndSecurityAgreementsMember_zG7CviMNZYY1" title="Interest expenses">400,000</span> and $<span id="xdx_908_eus-gaap--InterestAndDebtExpense_c20210401__20220331__us-gaap--TypeOfArrangementAxis__custom--CreditAndSecurityAgreementsMember_zq3KNQdq2gy8" title="Interest expenses">500,000</span> for the fiscal years ended March 31, 2023, and 2022, respectively, associated
with the credit and security agreements with Crestmark and IHC.</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
SINGING MACHINE COMPANY, INC AND SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
31, 2023, and March 31, 2023 and 2022</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/470/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>157
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035116980192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LOANS PAYABLE &#8211; RELATED PARTIES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtTextBlock', window );">LOANS PAYABLE &#8211; RELATED PARTIES</a></td>
<td class="text"><p id="xdx_808_eus-gaap--LongTermDebtTextBlock_zsaLNMlnhGfc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
7 &#8211; <span id="xdx_827_zR9yHGinEifc">LOANS PAYABLE &#8211; RELATED PARTIES</span></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-redline: true">SemiCab
maintains several outstanding affiliate loans from Ajesh Kapoor and Vivek Sehgal, (current employees and original founders of SemiCab)
initially issued by SemiCab Holdings LLC. The notes are unsecured. There was accrued interest payable is approximately $<span id="xdx_902_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20240930_zdbg0bp8AURb" title="Accrued interest payable">72,000</span> that is
included as a component of accrued expenses on the accompanying condensed consolidated balance sheets. Interest expense on these related
party loans for the three and nine months ended September 30, 2024 was approximately $<span id="xdx_90C_eus-gaap--InterestExpense_c20240701__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zVow8c7l1kVh" title="Interest expense"><span id="xdx_907_eus-gaap--InterestExpense_c20240101__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zKf1wftrmuU8" title="Interest expense">28,000</span></span>.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALGORHYTHM
                                            HOLDINGS, INC. and SUBSIDIARIES</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September
30, 2024 and 2023</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p id="xdx_89D_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_zNxrQIM0BEHi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
specific terms of each loan are summarized in the table below:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_8BE_zZepzgZY38Uh" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE
OF LOAN</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">Issue</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">Maturity</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">Interest</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td colspan="2" id="xdx_49C_20240930_z8QaO2zgqSDi" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">Holder</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">Date</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">Date</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">Status</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">Rate</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">Principal</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 46%; text-align: left"><span style="-sec-ix-redline: true">Ajesh Kapoor</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_905_eus-gaap--DebtInstrumentIssuanceDate1_dd_c20240101__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorOneMember_zAbJ9Nu4bt79">7/10/2021</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_908_eus-gaap--DebtInstrumentMaturityDate_dd_c20240101__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorOneMember_zH86iwv0hNs3">7/10/2026</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 8%"><span style="-sec-ix-redline: true">Current</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_905_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorOneMember_zkzfROuvp3Sh">9.0</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">%</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_984_eus-gaap--NotesPayable_iI_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorOneMember_zDGdI4auNRg3" style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: right" title="Principal amount"><span style="-sec-ix-redline: true">150,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">Ajesh Kapoor</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_905_eus-gaap--DebtInstrumentIssuanceDate1_dd_c20240101__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorTwoMember_zHfH1bsvae54">8/27/2021</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_909_eus-gaap--DebtInstrumentMaturityDate_dd_c20240101__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorTwoMember_zZWTAcVYM0Hd">8/26/2026</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">Current</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorTwoMember_zSoqUWHGGesh">9.0</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td id="xdx_982_eus-gaap--NotesPayable_iI_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorTwoMember_zVF13JLSDoK5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal amount"><span style="-sec-ix-redline: true">235,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">Vivek Seghal</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_90C_eus-gaap--DebtInstrumentIssuanceDate1_dd_c20240101__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--VivekSeghalMember_z2KzwxE1Ipwh">4/17/2023</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_902_eus-gaap--DebtInstrumentMaturityDate_dd_c20240101__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--VivekSeghalMember_zpChU2QYiCFc">10/13/2023</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">Default</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_903_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--VivekSeghalMember_zXuIk9wWnLo2">10.0</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td id="xdx_986_eus-gaap--NotesPayable_iI_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--VivekSeghalMember_z5d53GLi5j8j" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal amount"><span style="-sec-ix-redline: true">50,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">Ajesh Kapoor</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_903_eus-gaap--DebtInstrumentIssuanceDate1_dd_c20240101__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorThreeMember_zj6J3z4YGgq">5/5/2023</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_902_eus-gaap--DebtInstrumentMaturityDate_dd_c20240101__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorThreeMember_zz0koCJcw2L1">5/4/2024</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">Default</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_908_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorThreeMember_z0zCbAHnh0h4">10.0</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td id="xdx_989_eus-gaap--NotesPayable_iI_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorThreeMember_zqlhKpIoJK0k" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal amount"><span style="-sec-ix-redline: true">50,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="-sec-ix-redline: true">Ajesh Kapoor</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-bottom: 1pt"><span style="-sec-ix-redline: true"><span id="xdx_909_eus-gaap--DebtInstrumentIssuanceDate1_dd_c20240101__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorFourMember_zLCkZHT27tu6">5/17/2023</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-bottom: 1pt"><span style="-sec-ix-redline: true"><span id="xdx_90D_eus-gaap--DebtInstrumentMaturityDate_dd_c20240101__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorFourMember_zetEGTdpidX7">5/16/2024</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">Default</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_909_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorFourMember_zLiWcQbjnTma">10.0</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="-sec-ix-redline: true">%</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td id="xdx_98E_eus-gaap--NotesPayable_iI_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorFourMember_zI3MWIBNpu4a" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal amount"><span style="-sec-ix-redline: true">165,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--NotesPayable_iI_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zkSNxspZRSGi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="-sec-ix-redline: true">Amount due as of September 30, 2024</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">650,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--NotesPayableCurrent_iI_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zzTUD2zbYcS1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="-sec-ix-redline: true">Less: Current portion of notes payable
    to related parties</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">265,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--LongTermNotesPayable_iTI_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zbbTuKSJbwdg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt; padding-left: 10pt"><span style="-sec-ix-redline: true">Notes payable
    to related parties, net of current portion</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">385,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  </table>

<p id="xdx_8AC_zQshLb6Rbmlc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/470/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>158
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035310887504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text"><p id="xdx_806_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zKZ9TthlTebk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
8 - <span id="xdx_821_z6J69pwYLUc3">COMMITMENTS AND CONTINGENCIES</span></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Settlement
Agreement &#8211; Efficient Capital Labs, Inc</i>.</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-redline: true">On
May 18, 2023 SemiCab entered into a Installment Business Loan Agreement (&#8220;IBLA&#8221;) with a principal balance of $<span id="xdx_906_ecustom--WorkingCapital_c20230518_zoanr5wg0cw7" title="Working capital">1,000,000</span> with
Efficient Capital Labs, Inc. (&#8220;ECL&#8221;) to finance working capital and product development. The loan had a <span id="xdx_90D_eus-gaap--DebtInstrumentTerm_dtM_c20230518__20230518_zEbrhORQ7q53" title="Maturity date">12</span>-month maturity
date. Repayments were originally scheduled to begin in June 2023, in equal installments of $<span id="xdx_904_eus-gaap--RepaymentsOfDebt_c20230601__20240630_z1xMeZq6nSb5">91,667</span> for 13 months, with an interest rate
of <span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20230518_zAeVUxjjjha" title="Interest rate">17.97</span>%. On May 18, 2024, SemiCab entered into a settlement agreement (&#8220;Settlement&#8221;) with ECL. The terms of repayment are
as follows:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-redline: true">Payment:
Semicab shall pay to ECL the sum of $<span id="xdx_900_eus-gaap--LitigationSettlementExpense_c20240518__20240518__us-gaap--AwardTypeAxis__custom--SettlementSumMember_z9y9C5tjqpCj" title="Payments of litigation">946,666</span>USD (the &#8220;Settlement Sum&#8221;) as follows:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-redline: true">(a)
On or before May 20, 2024, Semicab shall pay ECL $<span id="xdx_90E_eus-gaap--LitigationSettlementExpense_pn2d_c20240520__20240520__us-gaap--AwardTypeAxis__custom--InitialPaymentMember_zIYh4DuuEbN" title="Payments of litigation">25,000.00</span> USD (the &#8220;Initial Payment&#8221;);</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-redline: true">(b)
On or before June 3, 2024, Semicab shall pay ECL $<span id="xdx_902_eus-gaap--LitigationSettlementExpense_pn2d_c20240603__20240603__us-gaap--AwardTypeAxis__custom--SecondPaymentMember_zlZWQR4WNKkf" title="Payments of litigation">75,000.00</span> USD (the &#8220;Second Payment&#8221;);</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-redline: true">(c)
On or before the first business day of each of the following ten (10) calendar months, starting July 1, 2024 Semicab shall pay ECL $<span id="xdx_907_eus-gaap--LitigationSettlementExpense_c20240701__20250430__us-gaap--AwardTypeAxis__custom--AdditionalPaymentMember_zusq0o76wl5b" title="Payments of litigation">84,666</span>
USD (the &#8220;Additional Payments,&#8221; and each an &#8220;Additional Payment&#8221;).</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-redline: true">As
of September 30, 2024 the amount payable on the Settlement is $<span id="xdx_90B_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_iI_c20240930_zWPg9hqGCcAd" title="Settlement amount payable">578,917</span> and recorded as a component accrued expenses on the accompanying
condensed consolidated balance sheets.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Blue
Yonder, Inc. Lawsuit</i></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-redline: true">Pursuant
to the asset purchase agreement with SemiCab, the Company assumed a judgement against SemiCab regarding damages resulting from contract
breach for IT subscription-based services. On March 28, 2020, SemiCab entered into a service contract and agreement with Blue Yonder,
Inc. (&#8220;Blue Yonder&#8221;) for certain IT subscription-based services. The original term of the agreement was for three years,
at a price of $<span id="xdx_90D_ecustom--LossContingencyEstimateOfPossibleLossPerYear_iI_c20200328__dei--LegalEntityAxis__custom--BlueYonderIncMember_zi0JtbEYp8G" title="Loss contingency estimate of possible loss per year">100,000</span> per year, for a total of $<span id="xdx_90A_eus-gaap--LossContingencyEstimateOfPossibleLoss_iI_c20200328__dei--LegalEntityAxis__custom--BlueYonderIncMember_zjWKWP9m8Fli" title="Loss contingency estimate of possible loss value">300,000</span>. On June 21, 2023, Blue Yonder filed a lawsuit claiming damages in the
amount of $<span id="xdx_907_eus-gaap--LossContingencyDamagesSoughtValue_c20230621__20230621__dei--LegalEntityAxis__custom--BlueYonderIncMember_zBZ9PN4w1q26" title="Lawsuit claiming damages in the amount">275,000</span> with the Maricopa County Superior Court in Arizona (&#8220;Lawsuit&#8221;). The suit was found in favor of Blue Yonder
in the amount of $<span id="xdx_90A_eus-gaap--LossContingencyDamagesAwardedValue_c20230621__20230621__dei--LegalEntityAxis__custom--BlueYonderIncMember_zeNSsGDcrRMd" title="Milestone payments">509,119</span>, subject to two separate milestone payments that would otherwise deem the entire balance due satisfied if either
milestone payment is made by the Company. The first milestone payment for $<span id="xdx_90D_eus-gaap--LossContingencyDamagesPaidValue_c20240701__20240701__dei--LegalEntityAxis__custom--BlueYonderIncMember_zFqEklauQcY4" title="First milestone payment">175,000</span> and was due on July 1, 2024 and was not made.
In the event this payment is made, the remaining settlement shall be deemed satisfied. If this payment is not made, the Company shall
owe a total of $<span id="xdx_900_eus-gaap--LossContingencyDamagesAwardedValue_c20241001__20241001__dei--LegalEntityAxis__custom--BlueYonderIncMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z28PkGYqoi01" title="Remaining settlement amount">225,000</span> by October 1, 2024. In the event this payment is made, the remaining settlement shall be deemed satisfied. If
neither payment is made, Blue Yonder shall be entitled to execute the full $<span id="xdx_901_eus-gaap--LossContingencyDamagesAwardedValue_c20250101__20250101__dei--LegalEntityAxis__custom--BlueYonderIncMember__srt--StatementScenarioAxis__srt--ScenarioForecastMember_z01y7RtbvXn6" title="Loss contingency damages awarded value">509,119</span> beginning January 1, 2025. As of the date of this
filing, none of the scheduled payments have been made. A liability of $<span id="xdx_906_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_iI_c20240930__dei--LegalEntityAxis__custom--BlueYonderIncMember_z0Yw3fRw2GBa" title="Component of accrued expenses">509,119</span> has been recorded as a component of accrued expenses on
the accompanying condensed consolidated balance sheets.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALGORHYTHM
                                            HOLDINGS, INC. and SUBSIDIARIES</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September
30, 2024 and 2023</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Derivative
Action</i></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 21, 2023, Ault Lending, LLC, a wholly owned subsidiary of Ault Alliance, Inc. (&#8220;Ault&#8221;), one of the Company&#8217;s
largest shareholders, filed a derivative shareholder action in Delaware Chancery Court against the Company, its Directors, and other
Company shareholders (The Stingray Group, Inc. and Regalia Ventures) (&#8220;the Defendants&#8221;) for alleged breach of fiduciary duty
in approving a recent above-market private placement equity transaction. The complaint alleges the Company, and its directors followed
an inadequate process in evaluating the private placement transaction which occurred back in November 2023 and entered into the transaction
with an intent to dilute Ault&#8217;s ownership stake in the Company. The Company filed a motion to dismiss the complaint. Based on the
Company&#8217;s assessment of the facts underlying the claims, the uncertainty of the litigation and the preliminary stage of the case,
the Company cannot reasonably estimate the potential loss or range of loss that may result from this action.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is involved in litigation arising from other matters in the ordinary course of business. The Company is subject to claims, suits
and other proceedings that could result in fines, civil penalties, or other adverse consequences. The Company records a liability when
it believes that it is probable that a loss has been incurred and the amount can be reasonably estimated. If the Company determines that
a loss is reasonably possible and the loss or range of loss can be estimated, the Company discloses the reasonably possible loss. The
Company evaluates developments in its legal matters that could affect the amount of liability that has been previously accrued, and the
matters and related reasonably possible losses disclosed, and makes adjustments as appropriate. Significant judgment is required to determine
both likelihood of there being and the estimated amount of a loss related to such matters.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></span></p>

<span></span>
</td>
<td class="text"><p id="xdx_80A_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zIa6MsNQNNqj" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTE
7 - <span id="xdx_824_zJJZMc7y3cr9">COMMITMENTS AND CONTINGENCIES</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Hospitality
Lease</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 23, 2023, MICS NY entered into an Agreement of Lease (the &#8220;Lease Agreement&#8221;) with OAC 111 Flatiron, LLC and OAC Adelphi,
LLC (the &#8220;Landlord&#8221;), pursuant to which MICS NY agreed to lease approximately 10,000 square feet of ground floor retail space
and a portion of the basement underneath the ground floor retail space in the property located at 111 West 24<sup>th</sup> Street, New
York, New York (the &#8220;Premises&#8221;). It was the Company&#8217;s intention to use the Premises as a new karaoke venue, offering
immersive karaoke technology and audio-visual capabilities, with restaurant and bar offerings however due to lack of funding, the Company
initiated termination of the lease in March 2024 (See Note 8 - Operating Leases).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
term of the Lease Agreement is for fifteen (15) years, or on such an earlier date upon which the term shall expire, be canceled, or terminated
pursuant to any of the conditions or covenants of the Lease Agreement. Pursuant to the Lease Agreement, MICS NY is obligated to pay an
initial base rent in the amount of $<span id="xdx_90B_eus-gaap--OperatingLeaseExpense_c20240701__20240701__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zY2Htcevq7v9" title="Operating lease expense">30,000</span> beginning July 1, 2024, with scheduled increases over the term, as set forth in the Lease
Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
March 2024, the Company initiated the termination of this lease under certain provisions made available under the Lease Agreement. The
Landlord and the Company are in active discussions as to the terms of the lease termination however as of this filing, it is too early
in the negotiation process to estimate any potential loss, if any, related to the lease termination process.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Derivative
Litigation</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 21, 2023, Ault Lending, LLC, a wholly owned subsidiary of Ault Alliance, Inc. (&#8220;Ault&#8221;), one of the Company&#8217;s
largest shareholders, filed a derivative shareholder action in Delaware Chancery Court against the Company, its Directors, and other
Company shareholders (The Stingray Group, Inc. and Regalia Ventures) (&#8220;the Defendants&#8221;) for alleged breach of fiduciary duty
in approving a recent above-market private placement equity transaction. The Complaint alleges the Company, and its Directors followed
an inadequate process in evaluating the private placement transaction which occurred back in November 2023 and entered into the transaction
with an intent to dilute Ault&#8217;s ownership stake in the Company. The Defendants have retained Delaware counsel to represent them
in this matter and the Company has filed a motion to dismiss the suit. The Company has Director &amp; Officer liability insurance for
up to $<span id="xdx_90C_ecustom--InsuranceLiabilities_iI_c20231221__us-gaap--ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis__us-gaap--DirectorsAndOfficersLiabilityInsuranceMember_zWY8fcSPZEQ8" title="Insurance liabilities">5,000,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">with a retention of $<span id="xdx_904_eus-gaap--MalpracticeInsuranceMaximumCoveragePerIncident_c20231221__20231221__us-gaap--ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis__us-gaap--DirectorsAndOfficersLiabilityInsuranceMember_zP4GhMz6qIV4">250,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">for derivative claims.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
than what is disclosed above, we are not a party to, and our property is not the subject of, any pending material legal proceedings.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=RIME_SemiCabIncMember', window );">Semi Cab Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_802_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_z1Sc4s1zMWhj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
8 - <span id="xdx_825_zuTW9foaJel9">COMMITMENTS AND CONTINGENCIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 28, 2020 the Company entered into a service contract and agreement with Blue Yonder, Inc. (&#8220;Blue Yonder&#8221;) for certain
IT subscription based services. The original term of the agreement was for three years, at a price of $<span id="xdx_900_eus-gaap--LossContingencyDamagesSoughtValue_c20200328__20200328__us-gaap--TypeOfArrangementAxis__custom--ServiceContractAndAgreementMember__dei--LegalEntityAxis__custom--BlueYonderIncMember__us-gaap--AwardTypeAxis__custom--PerYearMember_zxTJyLDdZEl2" title="Sought, value">100,000</span> per year, for a total
of $<span id="xdx_90B_eus-gaap--LossContingencyDamagesSoughtValue_c20200328__20200328__us-gaap--TypeOfArrangementAxis__custom--ServiceContractAndAgreementMember__dei--LegalEntityAxis__custom--BlueYonderIncMember_zfh0uA2XoVL7" title="Sought value, total">300,000</span>. On June 21, 2023, Blue Yonder filed a lawsuit claiming damages in the amount of $<span id="xdx_902_eus-gaap--LossContingencyDamagesSoughtValue_c20230621__20230621__us-gaap--TypeOfArrangementAxis__custom--ServiceContractAndAgreementMember__dei--LegalEntityAxis__custom--BlueYonderIncMember_z0wLk7FoqZv9" title="Damages claimed">275,000</span> with the Maricopa County Superior
Court in Arizona (&#8220;Lawsuit&#8221;). The suit was found in favor of Blue Yonder in the amount of $<span id="xdx_905_ecustom--PaymentsForMilestone_c20200328__20200328__us-gaap--TypeOfArrangementAxis__custom--ServiceContractAndAgreementMember__dei--LegalEntityAxis__custom--BlueYonderIncMember__us-gaap--AwardDateAxis__custom--DueOnJulyOneTwoThousandTwentyFourMember__us-gaap--AwardTypeAxis__custom--TwoSeparateMilestonePaymentMember_zUZFK17p3Kye" title="Payments for milestone">509,119</span>, subject to two separate
milestone payments that would otherwise deem the entire balance due satisfied if either milestone payment is made by the Company. The
first milestone payment if for $<span id="xdx_906_ecustom--PaymentsForMilestone_c20200328__20200328__us-gaap--TypeOfArrangementAxis__custom--ServiceContractAndAgreementMember__dei--LegalEntityAxis__custom--BlueYonderIncMember__us-gaap--AwardDateAxis__custom--DueOnJulyOneTwoThousandTwentyFourMember__us-gaap--AwardTypeAxis__custom--FirstMilestonePaymentMember_z8YTp3WxJoU5" title="Remaining settlement">175,000</span> and is due on July 1, 2024. In the event this payment is made, the remaining settlement shall
be deemed satisfied. If this payment is not made, the Company shall owe a total of $<span id="xdx_90C_ecustom--PaymentsForMilestone_c20200328__20200328__us-gaap--TypeOfArrangementAxis__custom--ServiceContractAndAgreementMember__dei--LegalEntityAxis__custom--BlueYonderIncMember__us-gaap--AwardDateAxis__custom--OctoberOneTwoThousandTwentyFourMember__us-gaap--AwardTypeAxis__custom--SecondMilestonePaymentMember_zXzVpZbuL0Oi" title="Payments for milestone">225,000</span> by October 1, 2024. In the event this payment
is made, the remaining settlement shall be deemed satisfied. If neither payment s made, Blue Yonder shall be entitled to execute the
full $<span id="xdx_909_eus-gaap--PaymentsForLegalSettlements_c20200328__20200328__us-gaap--TypeOfArrangementAxis__custom--ServiceContractAndAgreementMember__dei--LegalEntityAxis__custom--BlueYonderIncMember__us-gaap--AwardDateAxis__custom--JanuaryOneTwoThousandTwentyFiveMember_zFzUDECfAmrb" title="Remaining settlement">509,119</span> beginning January 1, 2025. As of March 31, 2024, the Company has accrued $<span id="xdx_907_eus-gaap--OtherLiabilitiesCurrent_iI_c20240331__us-gaap--TypeOfArrangementAxis__custom--ServiceContractAndAgreementMember_zuR5Nm4zg1Dk" title="Other current liability">225,000</span> on its balance sheet as an other current
liability to account for the expected payment of this amount required to settle this dispute on or before October 1, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 28, 2024, SemiCab was sued by a Baxter Bailey, collection agency acting on behalf of a domestic freight shipper. The shipper claims
is was underpaid for services rendered, and SemiCab has disputed the claim. The total amount in dispute is approximately $<span id="xdx_90E_ecustom--DisputeAmount_c20240528__20240528_zYFvGN8bXUmj" title="Dispute. amount">93,000</span>. SemiCab
intends to dispute the claim. As such, this litigation has been excluded from liabilities assumed as part of this transaction. $<span id="xdx_900_ecustom--AccruedPotentialLiability_c20240331__20240331_zC34jPhewe5j" title="Accrued, potential liability">100,000</span>
has been accrued on the March 31, 2024 balance sheet to account for this potential liability.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 405<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/405-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/450/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478522/954-440-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=RIME_SemiCabIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=RIME_SemiCabIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>159
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035116611536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OPERATING LEASES<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_DisclosureOperatingLeasesAbstract', window );"><strong>Operating Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">OPERATING LEASES</a></td>
<td class="text"><p id="xdx_802_eus-gaap--LesseeOperatingLeasesTextBlock_zOlnHNjODPwi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
9 &#8211; <span id="xdx_827_zbQZ3ywRu1gc">OPERATING LEASES</span></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the time of this filing, the Company has operating lease agreements for offices in Florida and Hong Kong.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-redline: true">The
Company entered into an operating lease agreement, effective October 1, 2017, for our corporate headquarters located in Fort Lauderdale,
Florida where we lease approximately <span id="xdx_901_eus-gaap--AreaOfLand_iI_pid_usqft_c20171001__us-gaap--TypeOfArrangementAxis__custom--OperatingLeaseAgreementMember_zZQ9CI6QWpqh" title="Lease space">6,500</span> square feet of office space which expired on <span id="xdx_904_eus-gaap--LeaseExpirationDate1_dd_c20171001__20171001__us-gaap--TypeOfArrangementAxis__custom--OperatingLeaseAgreementMember_z3llofSlHtEh" title="Lease expiration, date">March 31, 2024</span>. On February 22, 2024, <span id="xdx_901_eus-gaap--LesseeOperatingLeaseOptionToExtend_c20240222__20240222__us-gaap--TypeOfArrangementAxis__custom--OperatingLeaseAgreementMember_zx0EQbpNl5J" title="Lease extension, description">the Company
executed a lease extension for 14 months effective April 1, 2024, and expires on May 31, 2025. The base rent on the extension is approximately
$10,000 per month subject to a 3% annual adjustment.</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-redline: true">The
Company entered into an operating lease on August 23, 2023, for approximately <span id="xdx_904_eus-gaap--AreaOfLand_iI_pid_usqft_c20230823__us-gaap--TypeOfArrangementAxis__custom--OperatingLeaseAgreementMember_zP3fgZuw8Tfa" title="Lease space">10,000</span> square feet of ground floor retail space and a portion
of the basement underneath the ground floor retail space. During the nine months ended September 30, 2024, the Company abandoned its
plans to continue use of the leased space. On September 25, 2024, the Company entered into a Settlement Agreement for a full release
and termination of the Lease Agreement in exchange for Company&#8217;s payment of $<span id="xdx_909_eus-gaap--OperatingLeasePayments_c20240925__20240925__us-gaap--TypeOfArrangementAxis__custom--OperatingLeaseAgreementMember_zkvfwxkBMgvh" title="Operating lease payments">250,000</span>. (See Note 2).</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_895_ecustom--ScheduleOfSupplementalInformationRelatedToLeaseTableTextBlock_zF3exgsWDJJa" style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Supplemental
balance sheet information related to leases as of September 30, 2024 and December 31, 2023 is as follows:</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span><span id="xdx_8B8_zcEQMBbha7gg" style="display: none">SCHEDULE
OF SUPPLEMENTAL INFORMATION RELATED TO LEASES</span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;&#160;</b>&#160;<b>&#160;</b></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">Assets:</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td colspan="2" id="xdx_49E_20240930_zhpj8U3NHW9g" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">September
    30, 2024</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td colspan="2" id="xdx_49C_20231231_zVjcjeS3yFkb" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">December
    31, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pp0p0_zTnGXcLX8Yab" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="-sec-ix-redline: true">Operating lease - right-of-use assets</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="-sec-ix-redline: true">137,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="-sec-ix-redline: true">3,926,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--OperatingLeaseLiabilityAbstract_iB_zcnf2xz6jF33" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">Liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">Current</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--OperatingLeaseLiabilityCurrent_i01I_pp0p0_zlNcwoHuOZt9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"><span style="-sec-ix-redline: true">Current portion of operating leases</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">135,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">84,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--OperatingLeaseLiabilityNoncurrent_i01I_pp0p0_zaOP6csvSWB2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"><span style="-sec-ix-redline: true">Operating lease liabilities, net of
    current portion</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl1204">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">3,925,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  </table>

<p id="xdx_8AD_z3JWMDPUr4Lf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<p id="xdx_89F_eus-gaap--LeaseCostTableTextBlock_z1pV0GUJUfB1" style="font: bold 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="-sec-ix-redline: true">Supplemental
statement of operations information related to operating leases is as follows:</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B6_zif9s7e8i4Od" style="display: none">SCHEDULE
OF LEASE TERM AND DISCOUNT RATE</span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td colspan="2" id="xdx_490_20240701__20240930_zIaWt9EvW5ea" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">Three
    Months Ended September 30, 2024</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td colspan="2" id="xdx_49F_20230701__20230930_zkOg9rK0SLy4" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">Three
    Months Ended September 30, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td colspan="2" id="xdx_497_20240101__20240930_zXlYiL5chsM5" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">Nine
    Months Ended September 30, 2024</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td colspan="2" id="xdx_49B_20230101__20230930_zwFIrEm7eQNk" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">Nine
    Months Ended September 30, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--OperatingLeaseExpense_zMgjefZg42ab" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 44%; text-align: left"><span style="-sec-ix-redline: true">Operating lease expense as a component of general
    and administrative expenses</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="-sec-ix-redline: true">45,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="-sec-ix-redline: true">279,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="-sec-ix-redline: true">444,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="-sec-ix-redline: true">762,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--CashFlowOperatingActivitiesLesseeAbstract_iB_zi0QkZuopnX1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">Supplemental cash flow information related to operating
    leases is as follows:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">Cash paid for amounts included in the measurement of lease
    liabilities:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--OperatingLeasePayments_i01_zlWk7e7NPjg1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"><span style="-sec-ix-redline: true">Operating cash flow paid for operating
    leases</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">45,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">363,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">136,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">868,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--LeaseCostAbstract_iB_zVeWmJne5YQ6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">Lease term and Discount Rate</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"><span style="-sec-ix-redline: true">Weighted average remaining lease term
    (years)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td id="xdx_983_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_i01I_dtY_c20240930_zRklYVwN8Rk4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average remaining lease term (months)"><span style="-sec-ix-redline: true">0.8</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td id="xdx_983_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_i01I_dtY_c20230930_zctYiIdy9umd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average remaining lease term (months)"><span style="-sec-ix-redline: true">15.1</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="-sec-ix-redline: true">Weighted average discount rate</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td id="xdx_983_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_i01I_dp_uPure_c20240930_zoascLyeW4fc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average discount rate"><span style="-sec-ix-redline: true">9.0</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td id="xdx_988_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_i01I_dp_uPure_c20230930_zhUaArmGSe5l" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average discount rate"><span style="-sec-ix-redline: true">12.0</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  </table>

<p id="xdx_8AC_zAoXCi3OAC8b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALGORHYTHM
                                            HOLDINGS, INC. and SUBSIDIARIES</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September
30, 2024 and 2023</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p id="xdx_89D_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_z0VHfRfhtwL4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Minimum
future payments under all operating leases as of September 30, 2024, are as follows:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b><span id="xdx_8BC_zcqX8rDCZpgj" style="display: none">SCHEDULE
OF OPERATING LEASE MINIMUM FUTURE PAYMENTS</span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;&#160;</b></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">Payments due by period</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td colspan="2" id="xdx_497_20240930_zHKj1Dre9ynh" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">Amount</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_iI_maLOLLPzbAO_zQ6I9RaOBx82" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 80%"><span style="-sec-ix-redline: true">2024 (remaining six months)</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="-sec-ix-redline: true">46,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_maLOLLPzbAO_zrNYz1Se4UA" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="-sec-ix-redline: true">2025</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">94,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_mtLOLLPzbAO_zRAFXg7raWI5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">Total minimum future payments</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">140,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iI_zVxOUgnXjOb2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="-sec-ix-redline: true">Less: Interest</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">5,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--OperatingLeaseLiability_iI_zRgxvCoHTA8e" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt; padding-left: 10pt"><span style="-sec-ix-redline: true">Total operating
    lease liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">135,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  </table>

<p id="xdx_8A1_zVBIIm1h7ry1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></span></p>

<span></span>
</td>
<td class="text"><p id="xdx_802_eus-gaap--LesseeOperatingLeasesTextBlock_z2S3jesDU2Of" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
8 &#8211; <span id="xdx_822_z7PIQGxfbp87">OPERATING LEASES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the time of this filing, the Company has operating lease agreements for offices in Florida and Hong Kong and a retail location in New
York expiring in various years through 2038. The Company entered into an operating lease agreement, effective October 1, 2017, for our
corporate headquarters located in Fort Lauderdale, Florida where we lease approximately <span id="xdx_909_eus-gaap--AreaOfLand_iI_pid_usqft_c20171001__us-gaap--TypeOfArrangementAxis__custom--OperatingLeaseAgreementMember_z5QYnhZlBjAd" title="Lease space">6,500</span> square feet of office space. The lease
expired on <span id="xdx_901_eus-gaap--LeaseExpirationDate1_dd_c20171001__20171001__us-gaap--TypeOfArrangementAxis__custom--OperatingLeaseAgreementMember_zZPQQUCnUqY3" title="Lease expiration, date">March 31, 2024</span>. The base rent payment is approximately $<span id="xdx_901_eus-gaap--PaymentsForRent_c20171001__20171001__us-gaap--TypeOfArrangementAxis__custom--OperatingLeaseAgreementMember_ztyn6TshNWF2" title="Base rent payment">9,950</span> per month, subject to annual adjustments. On February 22, 2024,
<span id="xdx_90D_eus-gaap--LesseeOperatingLeaseOptionToExtend_c20240220__20240222__us-gaap--TypeOfArrangementAxis__custom--OperatingLeaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_znUBhqeiqPDd" title="Lease extension, description">the Company executed a lease extension for 14 months effective April 1, 2024, and expires on May 31, 2025. The base rent on the extension
is approximately $<span id="xdx_90E_eus-gaap--PaymentsForRent_c20240220__20240222__us-gaap--TypeOfArrangementAxis__custom--OperatingLeaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z9leSZpZRE72" title="Base rent payment">10,553</span> per month subject to a 3% annual adjustment.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company entered into an operating lease on August 23, 2023, for approximately <span id="xdx_904_eus-gaap--AreaOfLand_iI_pid_usqft_c20230823__us-gaap--TypeOfArrangementAxis__custom--OperatingLeaseAgreementMember_zKLb1vxeC867" title="Lease space">10,000</span> square feet of ground floor retail space and a portion
of the basement underneath the ground floor retail space. The lease expires <span id="xdx_909_eus-gaap--LeaseExpirationDate1_dd_c20230823__20230823__us-gaap--TypeOfArrangementAxis__custom--OperatingLeaseAgreementMember_zWsj6gYbLEug" title="Lease expiration, date">August 22, 2038</span>, and the monthly base rent is $<span id="xdx_901_eus-gaap--PaymentsForRent_c20230823__20230823__us-gaap--TypeOfArrangementAxis__custom--OperatingLeaseAgreementMember_zNQPTSZhW5p7" title="Base rent">30,000</span>, subject
to annual increases. The lease includes a 11-month free rent period between July 1, 2023, and June 30, 2024 and also includes a $<span id="xdx_906_eus-gaap--TenantImprovements_iI_pp0p0_c20230823__us-gaap--TypeOfArrangementAxis__custom--OperatingLeaseAgreementMember_zvx16rWpdwGk" title="Reimbursement for tenant improvements">700,000</span>
reimbursement for tenant improvements upon completion of construction milestones as defined in the lease. Due to uncertainties as to
whether these milestones will be met timely, the Company has not recorded any amounts related to the tenant improvement allowance in
our consolidated financial statements for the nine months ended December 31, 2023, at lease inception in the balance sheet of our consolidated
financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 31, 2023, our Ontario, California operating lease agreement for our primary warehouse expired. The Company did not renew the lease
and instead transferred all of its warehousing and logistics operations to a third-party logistics facility.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
entered into an operating lease agreement, effective October 15, 2022, for our administrative office located in Hong Kong where we lease
approximately <span id="xdx_903_eus-gaap--AreaOfLand_iI_pid_usqft_c20221015__us-gaap--TypeOfArrangementAxis__custom--OperatingLeaseAgreementMember_zLtdlyRbCAph" title="Lease space">1,890</span> square feet of office space. The lease expires on <span id="xdx_909_eus-gaap--LeaseExpirationDate1_dd_c20221015__20221015__us-gaap--TypeOfArrangementAxis__custom--OperatingLeaseAgreementMember_zX31giI38MOh" title="Lease expiration, date">October 14, 2025</span>. The base rent payment is approximately $<span id="xdx_904_eus-gaap--PaymentsForRent_c20221015__20221015__us-gaap--TypeOfArrangementAxis__custom--OperatingLeaseAgreementMember_zvdhvfgd9BLj" title="Base rent payment">4,900</span>
per month for the entire term of the lease.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
SINGING MACHINE COMPANY, INC AND SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
31, 2023, and March 31, 2023 and 2022</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease
expense for our operating leases is recognized on a straight-line basis over the lease terms.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p id="xdx_895_ecustom--ScheduleOfSupplementalInformationRelatedToLeaseTableTextBlock_zWjmbd3bVcm2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Supplemental
balance sheet information related to leases as of December 31, 2023 and March 31, 2023 is as follows:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span><span id="xdx_8B0_za7kMDxbRY3d" style="display: none">SCHEDULE OF SUPPLEMENTAL INFORMATION RELATED TO LEASES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_49C_20231231_zDcPHGudyeXj" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_498_20230331_zHS0qcvQ2ZEf" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Assets:</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pp0p0_z1RqJbrrnIY7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left">Operating lease - right-of-use assets</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">3,926,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">561,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Liabilities</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--OperatingLeaseLiabilityCurrent_iI_pp0p0_z2SRaJwowWSb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Current portion of operating leases</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">84,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">509,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pp0p0_zwkV7Yqg0h92" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Operating lease liabilities, net of current portion</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3,925,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">88,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AC_zgIRmhowRwrj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89F_eus-gaap--LeaseCostTableTextBlock_zOFvpHZmMXH9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Supplemental
statement of operations information related to leases for the nine months ended December 31, 2023 and fiscal year ended March 31, 2023
is as follows:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BD_zMH17NPEuaWc" style="display: none">SCHEDULE OF LEASE TERM AND DISCOUNT RATE</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_49E_20230401__20231231_zWqyUUsNndN5" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_49E_20220401__20230331_zzVpriL4SWkl" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Nine Months Ended</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Fiscal Year Ended</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--OperatingLeaseExpense_zG1MRiSO8EQl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left">Operating lease expense as a component of general and administrative expenses</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">717,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">1,058,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Supplemental cash flow information related to leases for the nine months ended December 31, 2023 and fiscal year ended March 31, 2023 is as follows:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Cash paid for amounts included in the measurement of lease liabilities:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--OperatingLeasePayments_zdqWnEkPiF56" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Operating cash flow paid for operating leases</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">858,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">960,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Lease term and Discount Rate</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Weighted average remaining lease term (months)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Operating leases</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtM_c20231231_zKkjermhv1xa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average remaining lease term (months)">15.0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtM_c20230331_zfICcyELPeRk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average remaining lease term (months)">12.4</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Weighted average discount rate</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Operating leases</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_uPure_c20231231_zpUFwiwx61Pj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average discount rate">12.0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_uPure_c20230331_zBY1LEPGSq5g" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average discount rate">6.5</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  </table>

<p id="xdx_8A9_zVeywgAg1hie" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p id="xdx_89D_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zp4IXSDZzVy1" style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Minimum future payments under all operating leases as of December 31, 2023, are as follows:</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b><span id="xdx_8B3_zrBTJWYRyf78" style="display: none">SCHEDULE
OF OPERATING LEASE MINIMUM FUTURE PAYMENTS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">Payments due by period</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_495_20231231_zeoiT9zTEqfl" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Amount</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_maLOLLPzbAO_zO5vCyfHAU33" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 78%; text-align: left">2024</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right">269,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_maLOLLPzbAO_zTdNecW50r51" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">2025</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">355,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_maLOLLPzbAO_zTKJSwNDSsnk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">2026</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">529,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_maLOLLPzbAO_zbN8Kl94jvk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">2027</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">585,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_maLOLLPzbAO_zo5OU1FlIcmk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">2028</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">610,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_maLOLLPzbAO_zUA0M4XIYggd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Thereafter</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">7,555,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_mtLOLLPzbAO_zZ7pqYo4GpEl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Total minimum future payments</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">9,903,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iI_zgWxyK52Qum9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Less: interest</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">5,894,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--OperatingLeaseLiability_iI_zVOVB7QGOcuf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Total operating lease liabilities</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">4,009,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--OperatingLeaseLiabilityCurrent_iI_zIJhnVEt2fy5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Less: current portion of lease liabilities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">84,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_zHQbvNKnJDIh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Operating lease liabilities, net of current portion</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">3,925,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A7_zAEaWhvEnV36" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_DisclosureOperatingLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_DisclosureOperatingLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/842-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>160
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035119539424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ISSUANCE OF COMMON STOCK<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">ISSUANCE OF COMMON STOCK</a></td>
<td class="text"><p id="xdx_80E_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zG6alrsOQtU9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
10 &#8211; <span id="xdx_824_z8pagMj79AEl">ISSUANCE OF COMMON STOCK</span></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Equity
Incentive Plan</i></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-redline: true">On
April 12, 2022, the Board of Directors approved The Singing Machine Company, Inc. 2022 Equity Incentive Plan, or the 2022 Plan. The 2022
Plan provides for the issuance of equity incentive awards, such as stock options, stock appreciation rights, stock awards, restricted
stock, stock units, performance awards and other stock or cash-based awards collectively, the &#8220;Awards.&#8221; Awards may be granted
under the 2022 Plan to the Company&#8217;s employees, officers, directors, consultants, agents, advisors and independent contractors.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-redline: true">There
were <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20240101__20240930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zisABCkgWfN5" title="Share base compensation issued shares"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20240701__20240930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zYmZnZZSrlZa" title="Share base compensation issued shares">150,943</span></span>
share base compensation awards issued under the 2022 Plan during the three and nine months ended September 30, 2024 with a weighted average grant date fair value of $<span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20240701__20240930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zWCjtrAmtrV4" title="Weighted average grant date fair value"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20240101__20240930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zC5QGhT1F8Jl" title="Weighted average grant date fair value">0.55</span></span> per share. There were <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_do_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zWOnrMwWdR3d" title="Share base compensation issued shares"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_do_c20230701__20230930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zeT29ymfHjz2" title="Share base compensation issued shares">no</span></span>
share base compensation awards issued under the 2022 Plan during the three and nine months ended September 30, 2023. There were <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20240701__20240930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zOw3t9YtHrDd" title="Share base compensation forfeited shares">1,250</span>
and <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20240101__20240930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zdE7JQ8gAsW6" title="Share base compensation forfeited shares">6,500</span>
shares forfeited during the three and nine months ended September 30, 2024, respectively. There were <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_do_c20230701__20230930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zchqtSocrl0g" title="Share base compensation forfeited shares"><span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_do_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zLyXbmnu4QZk" title="Share base compensation forfeited shares">no</span></span>
shares forfeited during the three and nine months ended September 30, 2023. As of September 30, 2024, there were <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20240930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zWe8aTwLyFg2" title="Number of shares available to issued">63,453</span>
shares available to be issued under the 2022 Plan.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-redline: true">Equity compensation under the 2022 Plan was approximately $<span id="xdx_905_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_c20240701__20240930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zU3Fq1TyUcEg" title="Equity compensation">101,000</span> and
$<span id="xdx_90C_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_c20240101__20240930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zR5IFzmkKCO9" title="Equity compensation">138,000</span> during the three and nine months ended September 30, 2024 and was expensed as a component of general administrative expenses
on the accompanying condensed consolidated statements of operations. As
of September 30, 2024, there was an unrecognized expense of approximately $<span id="xdx_907_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_c20240930_zdxlVYPGXUuh" title="Unrecognised expense">50,000</span> remaining on options currently vesting over time with
an approximate weighted average of <span id="xdx_906_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dc_c20240101__20240930_z3BAvLIP2v1a" title="Weighted average term">twelve months</span> remaining until these options are fully vested.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-redline: true">The
vested options as of September 30, 2024, had <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_do_c20240930_zqMbKMC4BkHh" title="Vested options intrinsic value">no</span> intrinsic value.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Other
Equity Compensation</i></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true">During
the three and nine months ended September 30, 2024, the Company issued <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardGross_c20240101__20240930_zfCdjqI40XQk">774,528
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock to three vendors for payment
of consulting services rendered and <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20240101__20240930_zzHpMV3yOXU6">94,340
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">for restricted shares of common stock to Vivek
Sehgal (a related party) as bonus compensation (See Note 5). The grant date fair value for all of these share issuances was approximately
$<span id="xdx_908_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20240101__20240930__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zSXLZymTeMUl">478,000
</span></span>and were expensed as a component of general and
administrative expenses on the accompanying condensed consolidated statements of operations during the three and nine months ended September
30, 2024. These shares vest immediately but must be held for a minimum of six months in accordance with Securities Exchange Commission
Rule 144.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>161
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035118040960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>WARRANTS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_DisclosureWarrantsAbstract', window );"><strong>Warrants</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_WarrantsDisclosureTextBlock', window );">WARRANTS</a></td>
<td class="text"><p id="xdx_801_ecustom--WarrantsDisclosureTextBlock_zqaEvcPXt8Nh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
11 - <span id="xdx_822_zsppuSeBjha3">WARRANTS</span></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
warrants issued and outstanding as of September 30, 2024 and December 31, 2023, were <span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20231231_zGakUkBcFVT5">902,113</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
There were no changes in the warrants outstanding during the period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p id="xdx_890_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zYYHPpTStg96" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 30, 2024, the Company&#8217;s warrants by expiration date were as follows:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="-sec-ix-redline: true"><span id="xdx_8B9_z53HeMr0u9Ue" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE
OF WARRANTS EXPIRATION</span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">Number of
    <br/>
    Common Warrants</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">Exercise
    Price</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">Expiration Date</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zZ9riAbr0ne4" style="font: 10pt Times New Roman, Times, Serif; width: 30%; text-align: right" title="Number of common warrants"><span style="-sec-ix-redline: true">802,113</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_988_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zQOms2NMpzql" style="font: 10pt Times New Roman, Times, Serif; width: 30%; text-align: right" title="Warrant exercise price"><span style="-sec-ix-redline: true">2.80</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32%"><span style="-sec-ix-redline: true"><span id="xdx_906_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zAhRqajSZPL5">September
    15, 2026</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zLaBM9JTpt0j" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of common warrants"><span style="-sec-ix-redline: true">100,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_987_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zAKLtDoLbeSe" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right" title="Warrant Exercise Price"><span style="-sec-ix-redline: true">5.00</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true"><span id="xdx_902_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zF2QLVbDK9Ph">May
    23, 2027</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td id="xdx_98C_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20240930_z94gW3N03BR7" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Common Warrants"><span style="-sec-ix-redline: true">902,113</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  </table>

<p id="xdx_8A3_zU5PGS9xsu82" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALGORHYTHM
                                            HOLDINGS, INC. and SUBSIDIARIES</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September
30, 2024 and 2023</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_DisclosureWarrantsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_DisclosureWarrantsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_WarrantsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants Disclosure [Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_WarrantsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>162
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035119419328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMPUTATION OF LOSS PER SHARE<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Loss per Common Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">COMPUTATION OF LOSS PER SHARE</a></td>
<td class="text"><p id="xdx_80F_eus-gaap--EarningsPerShareTextBlock_zgLzrlm0sfe3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
12 - <span id="xdx_825_zOxH3ZfwUyFc">COMPUTATION OF LOSS PER SHARE</span></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p id="xdx_896_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zjxa6pA9SB0j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computation
of basic and dilutive loss per share for the three and nine months ended September 30, 2024 and 2023 are as follows:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="-sec-ix-redline: true"><span id="xdx_8BA_z8u1VjiPbD3h" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE
OF BASIC AND DILUTIVE LOSS PER SHARE</span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td colspan="2" id="xdx_499_20240701__20240930_zh24815XKJY7" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">For
    the three months ended September 30, 2024</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td colspan="2" id="xdx_498_20230701__20230930_ziiKRIrQbrTa" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">For
    the three months ended September 30, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td colspan="2" id="xdx_498_20240101__20240930_zUVz7oKTpjE8" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">For
    the nine months ended September 30, 2024</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td colspan="2" id="xdx_49A_20230101__20230930_zUwyUSQWrji4" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">For
    the nine months ended September 30, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_zMR8qGvPQ0Oh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: left"><span style="-sec-ix-redline: true">Net income (loss) available to common stockholders</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="-sec-ix-redline: true">1,195,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="-sec-ix-redline: true">97,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="-sec-ix-redline: true">(7,292,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="-sec-ix-redline: true">(5,348,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="-sec-ix-redline: true">Weighted-average common shares outstanding</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_908_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240701__20240930_zjKkO8HXtnNg">9,095,504</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_90C_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230701__20230930_zLd81j8FJH4k">4,220,259</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_90E_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240101__20240930_zrFewd9yDsbh">7,341,204</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_902_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230101__20230930_zKs9K6QYqox3">3,726,259</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">Basic and diluted income (loss)
    per share</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_907_eus-gaap--EarningsPerShareDiluted_pid_c20240701__20240930_znNJ4haozmeg">0.13</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_90A_eus-gaap--EarningsPerShareDiluted_pid_c20230701__20230930_z2Ttkzw559F8">0.03</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_pid_c20240101__20240930_zSUx8zUrNY85">(0.99</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_907_eus-gaap--EarningsPerShareDiluted_pid_c20230101__20230930_zoHdFLPdoQJl">(1.44</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true">)</span></td></tr>
  </table>

<p id="xdx_8AA_zVzkdLWCH937" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
net loss per share is based on the weighted average number of shares of common stock outstanding during the period. Diluted net loss
per share reflects the potential dilution assuming shares of common stock were issued upon the exercise of outstanding in-the-money options
and the proceeds thereof were used to purchase shares of the Company&#8217;s common stock at the average market price during the period
using the treasury stock method.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-redline: true">For
the three and nine months ended September 30, 2024 and 2023, options to purchase <span id="xdx_906_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240701__20240930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zHUcVtTE0vN9" title="Potentially dilutive securities"><span id="xdx_900_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240101__20240930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zveLJGSzuoq6" title="Potentially dilutive securities">98,178</span></span> and <span id="xdx_908_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230701__20230930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zJ3qTurI64Th" title="Potentially dilutive securities"><span id="xdx_90C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20230930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zbzTFvh5tmxd" title="Potentially dilutive securities">91,261</span></span> shares of common stock, respectively
and options to purchase <span id="xdx_901_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240101__20240930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zprMrhM6lpa4" title="Potentially dilutive securities"><span id="xdx_903_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20230930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zoT2RYqlWQM5" title="Potentially dilutive securities">902,113</span></span> common stock warrants for both September 30, 2024 and 2023 were excluded in the calculation of diluted
net loss per share as the result would have been anti-dilutive.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
<td class="text"><p id="xdx_809_eus-gaap--EarningsPerShareTextBlock_zG4iKg7KSqD" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
10 - <span>COMPUTATION OF (LOSS) EARNINGS PER SHARE</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_823_zrvuvKyHQPu4" style="display: none">COMPUTATION
OF LOSS PER SHARE</span>&#160;</span></p>

<p id="xdx_894_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zkkcrU1UzQx7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computation
of dilutive shares for the nine months ended December 31, 2023 and fiscal years ended March 31, 2023 and 2022 are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B1_zwv1HLg3C7Jd" style="display: none">SCHEDULE
OF BASIC AND DILUTIVE SHARES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_492_20230401__20231231_zMhBsn563Tz9" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Nine months ended</p>
                                               <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">December 31, 2023</p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_499_20220401__20230331_zwsIj5F43kF6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Fiscal year ended</p>
                                               <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">March 31, 2023</p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20210401__20220331_zOYnLVamqU39" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Fiscal year ended</p>
                                               <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">March 31, 2022</p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_zC8SvzUsAmnc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 43%; text-align: left">Basic weighted average common shares outstanding</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right">4,864,540</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right">2,811,872</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right">1,614,506</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_zA0NI4Fna3t" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Effect of dilutive stock options</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2654">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2655">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">8,891</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_zJVYATuS89pb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Diluted weighted average of common shares outstanding</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">4,864,540</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">2,811,872</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">1,623,397</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A0_z7bKfIsBccWj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
net (loss) income per share is based on the weighted average number of shares of common stock outstanding during the period. Diluted
net (loss) income per share reflects the potential dilution assuming shares of common stock were issued upon the exercise of
outstanding in-the-money options and the proceeds thereof were used to purchase shares of the Company&#8217;s common stock at the
average market price during the period using the treasury stock method. For the nine months ended December 31, 2023, options to
purchase <span id="xdx_903_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230401__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zaRa7ZNjzhsg" title="Potentially dilutive securities">113,761</span>
shares of common stock and <span id="xdx_90D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230401__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--CommonStockWarrantsMember_zAJM7dzAOuSh" title="Potentially dilutive securities">902,113</span>
common stock warrants were excluded in the calculation of diluted net (loss) income per share as the result would have been
anti-dilutive. For the fiscal year ended March 31, 2023, options to purchase <span id="xdx_90E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220401__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zsg8lIyWdJw6" title="Potentially dilutive securities">53,675</span>
shares of common stock and <span id="xdx_909_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220401__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--CommonStockWarrantsMember_zbOFlAyYQ4Dk" title="Potentially dilutive securities">902,113</span>
common stock warrants were excluded in the calculation of diluted net (loss) income per share as the result would have been
anti-dilutive.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the fiscal year ended March 31, 2022, pre-funded warrants to purchase <span id="xdx_903_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210401__20220331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--PreFundedWarrantsMember_zDbzGVgB9NFe" title="Potentially dilutive securities">561,111</span> shares of common stock were included in basic weighted
average shares outstanding as deemed outstanding. Options to purchase <span id="xdx_909_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210401__20220331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_z3fL6IOMWC2h" title="Potentially dilutive securities">8,891</span> shares of common stock were included in the calculation of
diluted net income per share. For the fiscal year ended March 31, 2022, options and warrants to purchase approximately <span id="xdx_900_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210401__20220331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--OptionsAndWarrantsMember_zoEguhA4bOS9" title="Potentially dilutive securities">56,000</span> shares
of common stock were excluded in the calculation of diluted net (loss) income per share as the result would have been anti-dilutive.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/260/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>163
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035317159280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text"><p id="xdx_802_eus-gaap--IncomeTaxDisclosureTextBlock_zZAI7n5zRZwk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
13 - <span id="xdx_828_zkrkiJ97izB8">INCOME TAXES</span></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-redline: true">For
the three months ended September 30, 2024 and 2023 the Company did <span id="xdx_908_eus-gaap--IncomeTaxExpenseBenefit_dxL_c20240701__20240930_z4gmrTXfCyZb" title="Income tax (benefit) provision::XDX::-"><span id="xdx_900_eus-gaap--IncomeTaxExpenseBenefit_dxL_c20230701__20230930_zVhSk3kPnPua" title="Income tax (benefit) provision::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl1334"><span style="-sec-ix-hidden: xdx2ixbrl1336">no</span></span></span></span>t recognize income tax provision as the Company is not forecasting
any taxable income for the current year and had a loss before income tax benefit in the previous year. The Company&#8217;s income tax
provision for the nine months ended September 30, 2023, was approximately $<span id="xdx_905_eus-gaap--IncomeTaxExpenseBenefit_c20230101__20230930_zn4DY84d9sle" title="Income Tax (benefit) provision">1,502,000</span> as the Company recognized a valuation reserve of
all of its deferred tax assets based on the recent history of losses and forecasts that suggested the Company would not be able to utilize
the deferred tax assets in the future.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s income tax expense differs from the expected tax benefit/expense based on statutory rates primarily due to full valuation
allowance for all of its subsidiaries for the three and nine months ended September 30, 2024 and 2023.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<span></span>
</td>
<td class="text"><p id="xdx_800_eus-gaap--IncomeTaxDisclosureTextBlock_zs4A8cVjmsH8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
16 - <span id="xdx_82A_zgbCidzNUWFd">INCOME TAXES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89C_ecustom--ScheduleOfLossBeforeIncomeTaxTableTextBlock_zcKIvPBKU3z8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s loss before income taxes for the nine months ended December 31, 2023, and fiscal years ended March 31, 2023, and 2022
is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span id="xdx_8BE_z3CzUrwMDpU2" style="display: none">SCHEDULE OF LOSS BEFORE INCOME TAXES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_491_20230401__20231231_z3gv4sBqTotb" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20220401__20230331_zFivyGNqlKJl" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_492_20210401__20220331_zHzf2VMRhQWe" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">Nine months ended</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Fiscal years ended</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_zwVDB3c5KXVc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 34%; text-align: left">United States</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right">(6,173,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right">(3,526,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right">(261,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_404_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_zeCEGkZB61cj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Foreign</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(225,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(82,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">548,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_zs8t6xUY4trg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss
    before income taxes</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(6,398,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(3,608,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">287,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A9_zartpE47oyA7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89B_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zwnpNk4VM3Al" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
provision for income taxes for the nine months ended December 31, 2023, and fiscal years ended March 31, 2023, and 2022 is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span id="xdx_8BF_z3RkLhSRENai" style="display: none">SCHEDULE OF PROVISION FOR INCOME TAXES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_496_20230401__20231231_zMrKuEIP6l78" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_496_20220401__20230331_zVWJ0jALdzn2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_499_20210401__20220331_zRwAoTfR3pM" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">Nine months ended</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Fiscal years ended</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2022</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Income tax provision:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Current:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--CurrentFederalTaxExpenseBenefit_maCFSALz48L_zePw4gom3VJj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 34%; text-align: left">Federal</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2795">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right">109,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right">63,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_maCFSALz48L_zJtMCKdI8mt1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">State</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2799">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2800">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2801">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--CurrentOtherTaxExpenseBenefit_maCFSALz48L_z2xFJgRqIO7e" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Other</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2803">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(5,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2805">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--CurrentForeignTaxExpenseBenefit_maCFSALz48L_z4wliGmmM3v9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1pt">Hong Kong</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2807">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">34,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2809">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--CurrentFederalStateAndLocalTaxExpenseBenefit_iT_mtCFSALz48L_maITEBzBKD_zObMMc8g0sfj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Total current Federal and State</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2811">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">138,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">63,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Deferred:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_maDFSALzMsp_z5wMSFShEQaj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Federal</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2815">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">686,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(60,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_40E_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_maDFSALzMsp_zikmZFKcqwX9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1pt">State</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2819">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">206,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">54,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--DeferredFederalStateAndLocalTaxExpenseBenefit_iT_mtDFSALzMsp_maITEBzBKD_zc0coHnpCFEh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Total Deferred Federal and State</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2823">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">892,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(6,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--IncomeTaxExpenseBenefit_iT_mtITEBzBKD_zlOwdZewRqMb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Total income tax provision</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2827">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">1,030,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">57,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A2_zKtIcvYIOfN8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
SINGING MACHINE COMPANY, INC AND SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
31, 2023, and March 31, 2023 and 2022</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_893_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zKyasForL40c" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s net deferred tax assets as of December 31, 2023, and ended March 31, 2023 are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B3_zyy9lBaEuoLj" style="display: none">SCHEDULE
OF DEFERRED TAX ASSETS AND LIABILITIES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" id="xdx_49A_20231231_znTKkDMvVGEk" style="font: 10pt Times New Roman, Times, Serif; text-align: center">December 31,</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" id="xdx_494_20230331_zsJ6V8SEPaQ7" style="font: 10pt Times New Roman, Times, Serif; text-align: center">March 31,</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsDomestic_iI_maDTAGzkTe_zJcF4AE0oCF9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left">NOL Federal Carryforward</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">1,291,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">868,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_iI_maDTAGzkTe_zfbMU0Jdv45i" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">State NOL Carryforward</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">470,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">341,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsInventory_iI_maDTAGzkTe_zqMAT95bmnSd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Inventory differences to inventory valuation</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,173,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">623,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_iI_maDTAGzkTe_z18znzqFGylg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Stock option compensation expense</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">159,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">184,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--DeferredTaxAssetsRightUseOfLiability_iI_maDTAGzkTe_z7MQ7WEw3lse" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Right of use liability</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,022,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">118,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--DeferredTaxAssetsBusinessInterestLimitation_iI_maDTAGzkTe_z04oHutDkea3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Business interest limitation</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">151,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">138,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--DeferredTaxAssetsAllowanceForDoubtFulAccounts_iI_maDTAGzkTe_zg3VHHmlvoMb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Allowance for doubtful accounts</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">45,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">43,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances_iI_maDTAGzkTe_zwTm6k5Oi3b2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Reserve for estimated returns</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">384,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">89,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_iI_maDTAGzkTe_zLsHZcgvuira" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Accrued vacation</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">7,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">14,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--DeferredTaxAssetsGross_iTI_mtDTAGzkTe_maDTANzmdy_zgDA8p5rs8gh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">4,702,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2,418,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_msDTANzmdy_zH2zn2oTD532" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Less: valuation allowance</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(3,600,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(2,104,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40B_eus-gaap--DeferredTaxAssetsNet_iTI_maDTALNzWnn_mtDTANzmdy_zq4JfvbOkoL" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Net deferred tax asset</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1,102,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">314,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--DeferredTaxLiabilitiesPropertyPlantAndEquipment_iNI_di_maDTLzkol_zQU1KPUgfPJk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Depreciable and amortizable assets</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(67,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(134,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_40C_ecustom--DeferredTaxLiabilitiesRightUseOfAsset_iNI_di_maDTLzkol_zCoA2j3XFaBd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">ROU Asset</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(1,000,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(111,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_403_eus-gaap--DeferredTaxLiabilitiesPrepaidExpenses_iNI_di_maDTLzkol_zlE04no3wyIe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Prepaid expenses</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(35,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(69,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--DeferredTaxLiabilities_iNTI_di_msDTALNzWnn_mtDTLzkol_zlWlWrLvQpIb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Net deferred tax liability</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(1,102,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(314,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTI_mtDTALNzWnn_zIj3UIbrG3df" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2881">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2882">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AC_zzsckDqAScVa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes federal, state and foreign current tax liabilities or assets based on its estimate of taxes payable to or refundable
by tax authorities in the current fiscal year. The Company also recognizes federal, state and foreign deferred tax liabilities or assets
based on the Company&#8217;s estimate of future tax effects attributable to temporary differences and carryforwards. The Company records
a valuation allowance to reduce any deferred tax assets by the amount of any tax benefits that, based on available evidence and judgment,
are not expected to be realized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company performed an analysis in accordance with the provisions of ASC 740, which requires an assessment of both positive and
negative evidence when determining whether it is more likely than not that deferred tax assets are recoverable. The analysis
performed to assess the realizability of the deferred tax assets included an evaluation of the pattern and timing of the reversals
of temporary differences and the length of carryback and carryforward periods available under the applicable federal, state and
foreign laws; and the amount and timing of future taxable income. The Company evaluated the realizability of its deferred tax assets
as of December 31, 2023 and March 31, 2023 in accordance with accounting principles generally accepted in the United States of
America and concluded that valuation allowance against all of our deferred tax assets was necessary based upon the Company&#8217;s
conclusions regarding, among other considerations, the Company&#8217;s recent history of losses and projected earnings for fiscal
year 2024 and in the future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89F_eus-gaap--ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_zXpACVfvQcl4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
actual tax provision differs from the &#8220;expected&#8221; tax for the nine-month transition period ended December 31, 2023, and
the years ended March 31, 2023, and 2022 (computed by applying the U.S. Federal Corporate tax rate of 21 percent to income before
taxes) as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BB_zcJhmqf1s41b" style="display: none">SCHEDULE
OF TAX PROVISION</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20230401__20231231_z8vkNy8O8w6l" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_495_20220401__20230331_zp2XvTg004g7" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_490_20210401__20220331_zQ3piCOGCKQi" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2022</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_maITEBzmuZ_zqhaPji5LA26" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 43%; text-align: left">Statutory federal tax rate</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: right">(1,344,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">(758,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">60,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_maITEBzmuZ_znWhJFW0VkI7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Stater tax rate</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(326,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(174,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">14,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--IncomeTaxReconciliationChangeInEnactedTaxRate_maITEBzmuZ_zbpaBJyHD3V3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Permanent differences</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">15,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">13,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">10,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecustom--IncomeTaxReconciliationChangeInPermanentDifferencesERCIncome_maITEBzmuZ_z0sxIegNnU8g" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Permanent difference in ERC income</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2898">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(99,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2900">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--IncomeTaxReconciliationForeignIncomeTaxRateDifferential_maITEBzmuZ_zxM7CBG0rctj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Tax rate differential on foreign earnings</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">59,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">21,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(84,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_404_ecustom--IncomeTaxReconciliationChangeInExpirationOfNetOpretaingLossCarryforward_maITEBzmuZ_z3bxgbF9SVQd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Expiration of net operating loss carryforward</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">89,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2907">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2908">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_maITEBzmuZ_zDX1hCDEpzVk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Change in valuation allowance</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,495,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2,026,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">55,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--IncomeTaxReconciliationOtherReconcilingItems_maITEBzmuZ_zzR1Oatq5DS4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Other</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">12,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">2,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--IncomeTaxExpenseBenefit_iT_mtITEBzmuZ_zX0jsMOAbHnd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax
    provision</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2918">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">1,030,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">57,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A5_znnnZIzJLiE6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
SINGING MACHINE COMPANY, INC AND SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
31, 2023, and March 31, 2023 and 2022</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
December 31, 2023, and March 31, 2023, the Company had federal tax net operating loss carryforwards in the amount of approximately $<span id="xdx_909_eus-gaap--OperatingLossCarryforwards_iI_c20231231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zJ5oiD2W6Bj" title="Federal tax net operating loss carryforwards">6,149,000</span>
and $<span id="xdx_90C_eus-gaap--OperatingLossCarryforwards_iI_c20230331__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zjVbPDDceWL2" title="Federal tax net operating loss carryforwards">4,131,000</span>, respectively that begin to expire in the year 2025. The net operating loss carryforward is subject to an IRS Section
382 limitation that limited the amount available to use beginning in Fiscal 2020 to approximately $<span id="xdx_909_eus-gaap--OperatingLossCarryforwards_iI_c20231231__us-gaap--IncomeTaxAuthorityNameAxis__us-gaap--InternalRevenueServiceIRSMember_zh8ZzfUJAkZe" title="Net operating loss">150,000 </span>per year. In addition, the
Company had state tax net operating loss carryforwards of approximately $<span id="xdx_907_eus-gaap--OperatingLossCarryforwards_iI_c20231231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--StateAndLocalJurisdictionMember_z2zZTFLTI0U3" title="Operating loss carryforwards">2,453,000</span> and $<span id="xdx_90F_eus-gaap--OperatingLossCarryforwards_iI_c20230331__us-gaap--IncomeTaxAuthorityAxis__us-gaap--StateAndLocalJurisdictionMember_zcn95fYK8YPf" title="Operating loss carryforwards">2,238,000</span>, respectively that will begin to expire
beginning in 2024. These tax net operating loss carryforwards may be subject to adjustment based on future changes in ownership.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
December 31, 2023, the Company evaluated the realizability of its deferred tax assets in accordance with GAAP and concluded that a valuation
allowance of approximately $<span id="xdx_90E_eus-gaap--DeferredTaxAssetsValuationAllowance_iI_c20231231_z0JfsW10Zare" title="Deferred tax asset valuation allowance">3,600,000</span> against deferred tax assets is necessary. The recognition of the remaining net deferred
tax asset and corresponding tax benefit is based upon the Company&#8217;s conclusions regarding, among other considerations, the Company&#8217;s
current and anticipated customers, contracts and product introductions, and recent operating results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=RIME_SemiCabIncMember', window );">Semi Cab Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_808_eus-gaap--IncomeTaxDisclosureTextBlock_zvGJHFazOHq3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
12- <span id="xdx_82C_zVZbS042zD3f">INCOME TAXES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company files separate tax returns in the United States and India. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income tax.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477891/740-270-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/740/tableOfContent<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-14<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-21<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=RIME_SemiCabIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=RIME_SemiCabIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>164
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035115209920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE DISAGGREGATION<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">REVENUE DISAGGREGATION</a></td>
<td class="text"><p id="xdx_80A_eus-gaap--SegmentReportingDisclosureTextBlock_zLcwUk2Rv7ei" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
14 &#8211; <span id="xdx_822_zubLELtErhoc">REVENUE DISAGGREGATION</span></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company disaggregates revenues by product line and major geographic region as most of its revenue is generated by the sales of karaoke
hardware and the Company has no other material business segments:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p id="xdx_89C_eus-gaap--DisaggregationOfRevenueTableTextBlock_zWgjDe6nNgVk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;Revenue
by product line is as follows:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_8B1_z1QfDZZPjWcj" style="display: none">SCHEDULE
OF REVENUE BY PRODUCT LINE</span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; display: none"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td id="xdx_49C_20240701__20240930_zCzew3xSqc4e" style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; display: none"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td id="xdx_49D_20230701__20230930_zjZ5ZFJYFCAh" style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; display: none"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td id="xdx_496_20240101__20240930_zlQrx7BexgF8" style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; display: none"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td id="xdx_492_20230101__20230930_z8GQqm0u6BOa" style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td colspan="5" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">Three
                                            Months Ended</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td colspan="5" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">Nine
                                            Months Ended</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">Product Line</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">September
                                            30, 2024</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="-sec-ix-redline: true">September
                                            30, 2023</span></p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">September
                                            30, 2024</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="-sec-ix-redline: true">September
                                            30, 2023</span></p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--ClassicKaraokeMachinesMember_zvmUzb0BQWy8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 28%; text-align: left"><span style="-sec-ix-redline: true">Classic Karaoke Machines</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="-sec-ix-redline: true">8,218,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="-sec-ix-redline: true">14,636,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="-sec-ix-redline: true">10,521,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="-sec-ix-redline: true">17,363,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--LicensedProductsMember_zcRM22HViYWg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">Licensed Products</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">180,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">36,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">377,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">32,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--KidsYouthElectronicsMember_zBaA3BsGGST6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">Kids Youth Electronics</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">379,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">297,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">546,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">451,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--MicrophonesAndAccessoriesMember_zlifGfjGdIQ3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">Microphones and Accessories</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">1,500,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">806,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">3,329,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">3,543,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--MusicSubscriptionsMember_z9JfG6qqdHl4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">Music Subscriptions</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">218,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">156,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">588,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">550,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--LogisticsServicesMember_zhP1KbZNMlna" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="-sec-ix-redline: true">Logistics Services</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">127,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl1370">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">127,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl1372">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--Revenues_z2nmXoH7wJHb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">Total Net Sales</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">10,622,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">15,931,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">15,488,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">21,939,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  </table>

<p id="xdx_8AA_zEwzKYRBIG99" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALGORHYTHM
HOLDINGS, INC. and SUBSIDIARIES</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September
30, 2024 and 2023</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></span></p>

<p id="xdx_892_eus-gaap--ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_zUw7jGOtOBdj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales
by geographic region for the periods presented are as follows:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_8BA_zyyjRYaDDCrk" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE
OF SALES BY GEOGRAPHICAL REGION</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; display: none"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; display: none"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td id="xdx_496_20240701__20240930_z7UpUTsSdPv8" style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; display: none"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td id="xdx_497_20230701__20230930_zPB2ZINp0KB8" style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; display: none"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td id="xdx_497_20240101__20240930_zatNM73nEHe1" style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; display: none"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td id="xdx_498_20230101__20230930_zyDFJQGqHp6b" style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">Three
    Months Ended</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">Nine
    Months Ended</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">September
    30, 2024</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">September
    30, 2023</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">September
    30, 2024</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">September
    30, 2023</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td></tr>
  <tr id="xdx_40D_eus-gaap--Revenues_hsrt--StatementGeographicalAxis__srt--NorthAmericaMember_z12ApUNYOplf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 28%; text-align: left"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">North
    America</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">$</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">10,466,000</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">$</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">15,378,000</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">$</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">15,208,000</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">$</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">21,386,000</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td></tr>
  <tr id="xdx_406_eus-gaap--Revenues_hsrt--StatementGeographicalAxis__country--AU_zeia9sW3VEha" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">Australia</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">50,000</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">263,000</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">174,000</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">263,000</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td></tr>
  <tr id="xdx_40C_eus-gaap--Revenues_hsrt--StatementGeographicalAxis__srt--EuropeMember_zLH57oVPdK82" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">Europe</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">106,000</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">290,000</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">106,000</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">290,000</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td></tr>
  <tr id="xdx_40B_eus-gaap--Revenues_zs8zxZUzacD" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Net Sales</span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">$</span></span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">10,622,000</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">$</span></span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">15,931,000</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">$</span></span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">15,488,000</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">$</span></span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">21,939,000</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td></tr>
  </table>

<p id="xdx_8A9_zkuPpWT8a4K9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-redline: true">The
Company selectively participates in a retailer&#8217;s co-op promotion incentives by providing marketing fund allowances to its customers.
As these co-op promotion initiatives are not a distinct good or service and the Company cannot reasonably estimate the fair value of
the benefit it receives from these arrangements, the cost of these allowances at the time they are offered to the customers are recorded
as a reduction to net sales. For the three months ended September 30, 2024 and 2023, co-op promotion incentives were approximately $<span id="xdx_90E_eus-gaap--AdvertisingExpense_c20240701__20240930_zxy9gNy5db17" title="Co-op promotion incentives">908,000</span>
and $<span id="xdx_901_eus-gaap--AdvertisingExpense_c20230701__20230930_zyjuFAXN4SA7" title="Co-op promotion incentives">1,637,000</span>, respectively. For the nine months ended September 30, 2024 and 2023, co-op promotion incentives were approximately $<span id="xdx_902_eus-gaap--AdvertisingExpense_c20240101__20240930_z1tFhax3hUzl" title="Co-op promotion incentives">1,257,000</span>
and $<span id="xdx_904_eus-gaap--AdvertisingExpense_c20230101__20230930_ztc372oC4IN3" title="Co-op promotion incentives">1,901,000</span>, respectively. The Company&#8217;s estimated reserve for co-op promotion incentives was approximately $<span id="xdx_907_ecustom--EstimatedReserveOfAdvertisingExpense_c20240101__20240930_zFsA1DcJnyY6" title="Estimated reserve co-op promotion incentives">1,833,000</span> and $<span id="xdx_90A_ecustom--EstimatedReserveOfAdvertisingExpense_c20230101__20231231_zg2LUd5OvLU8" title="Estimated reserve co-op promotion incentives">1,277,000</span>
as of September 30, 2024 and December 31, 2023, respectively. The estimated reserve for co-op promotions is a component of accrued expenses
on the accompanying condensed consolidated balance sheets.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-redline: true">The
Company estimates variable consideration under its return allowance programs for goods returned from the customer whereby a revenue return
reserve is recorded based on historic return amounts, specific events as identified and management estimates. The Company&#8217;s reserve
for sales returns as of September 30, 2024 and December 31, 2023, was approximately $<span id="xdx_903_ecustom--ReserveForSalesReturns_iI_c20240930_zMfVMB75VpFj" title="Reserve for sales returns">2,212,000</span> and $<span id="xdx_90B_ecustom--ReserveForSalesReturns_iI_c20231231_zWOcGJHDikHf" title="Reserve for sales returns">3,390,000</span>, respectively. In conjunction
with the recording of the revenue sales return reserve, the Company estimates the cost of products that are expected to be returned under
its return allowance program whereby the estimated cost of product returns is recorded as an asset. The asset is separately stated as
returns asset on the condensed consolidated balance sheets. The Company&#8217;s estimated cost of returns as of September 30, 2024 and
December 31, 2023, was approximately $<span id="xdx_90B_ecustom--EstimatedCostOfReturns_iI_c20240930_z9a8cZl4L3Yg" title="Estimated costs of returns">1,081,000</span> and $<span id="xdx_90A_ecustom--EstimatedCostOfReturns_iI_c20231231_zSEFlnJVlJj2" title="Estimated costs of returns">1,919,000</span>, respectively.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
return program for defective goods is negotiated with each of the Company&#8217;s wholesale customers on a year-to-year basis. Customers
are allowed to return defective goods within a specified period of time after shipment (between six and nine months). The Company does
make occasional exceptions to this return policy and accordingly records a sales return reserve based on historic return amounts, specific
exceptions as identified and management estimates.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company records a sales reserve for its return goods programs at the time of sale for estimated sales returns that may occur. The liability
for defective goods is included in the reserve for sales returns on the condensed consolidated balance sheets.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<span></span>
</td>
<td class="text"><p id="xdx_809_eus-gaap--SegmentReportingDisclosureTextBlock_z4oc9irSX5Ib" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
17 &#8211; <span id="xdx_826_zJf6TZ2q0cba">REVENUE DISAGGREGATION </span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company disaggregates revenues by product line and major geographic region as most of its revenue is generated by the sales of karaoke
hardware and the Company has no other material business segments:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p id="xdx_896_eus-gaap--DisaggregationOfRevenueTableTextBlock_z5e4ksowGI86" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue
by product line is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BE_z3cwErgWkoab" style="display: none">SCHEDULE
OF REVENUE BY PRODUCT LINE</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_490_20230401__20231231_zcvFlwHSoYL9" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">December 31,2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_495_20220401__20230331_zlXsNzH4TLT2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_495_20210401__20220331_z5WtX8zdZ96k" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2022</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center">Nine Months Ended</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Fiscal Years Ended</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">December 31,2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2022</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-decoration: underline; text-align: left">Product Line</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--KaraokeMachinesMember_z0vcexDTdO97" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 43%; text-align: left">Karaoke Machines</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: right">24,189,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">28,856,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">38,869,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--LicensedProductsMember_zsLnmKlMotNd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Licensed Products</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">549,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">95,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,645,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--KidsYouthElectronicsMember_zXQuyMEB1F5d" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Kids Youth Electronics</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">565,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,872,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2,277,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--MicrophonesAndAccessoriesMember_zehC3h1wXjc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Microphones and Accessories</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3,283,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">7,802,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">4,185,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--MusicSubscriptionsMember_z6b5M8pZNNNg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Music Subscriptions</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">612,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">674,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">536,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--Revenues_z187dA9Sthlj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Total Net Sales</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">29,198,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">39,299,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">47,512,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AD_zJJzZMbCd3Oe" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_890_eus-gaap--ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_zo4TbTIXPNVd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue
by geographic region is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BD_zhNkzveFBU0e" style="display: none">SCHEDULE OF REVENUE BY GEOGRAPHICAL REGION</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_490_20230401__20231231_zNrLZbPbyV8c" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_495_20220401__20230331_zqervhkGBDRc" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_495_20210401__20220331_zb4vNjlif2K4" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">FOR THE NINE MONTHS ENDED</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">FOR THE FISCAL YEARS ENDED</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--Revenues_hsrt--StatementGeographicalAxis__srt--NorthAmericaMember_z3SHp5Gxhxz6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 43%; text-align: left">North America</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: right">28,763,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">38,298,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">46,396,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--Revenues_hsrt--StatementGeographicalAxis__country--AU_zI0fmWTEjNM4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Australia</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">205,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">670,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">679,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--Revenues_hsrt--StatementGeographicalAxis__custom--EuropeAndUnitedKingdomMember_z2qxcwIIbrjj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Europe and United Kingdom</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">226,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">331,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">359,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--Revenues_hsrt--StatementGeographicalAxis__custom--OthersMember_ztrJtqC9geC2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">All Others</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">4,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2977">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">78,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--Revenues_z1XP4QOH1mTj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Net sales</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">29,198,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">39,299,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">47,512,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A9_zgOtFMZeeo0e" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
geographic area of sales is based primarily on where the product was delivered.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/280/tableOfContent<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>165
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035117302992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONCENTRATIONS OF CREDIT RISK AND REVENUE<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskDisclosureTextBlock', window );">CONCENTRATIONS OF CREDIT RISK AND REVENUE</a></td>
<td class="text"><p id="xdx_800_eus-gaap--ConcentrationRiskDisclosureTextBlock_zHVwqT1O2d96" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
15 - <span id="xdx_820_zJPDWPODbaIa">CONCENTRATIONS OF CREDIT RISK AND REVENUE</span></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-redline: true">The
Company derives a majority of its revenues from retailers of products in the United States. The Company&#8217;s allowance for credit
losses is based upon management&#8217;s estimates and historical experience and reflects the fact that accounts receivable is concentrated
with several large customers. At September 30, 2024, <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240101__20240930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ThreeCustomersMember_zHxYTqJcGeY3">70</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
of accounts receivable were due from three customers in North America that individually owed over 10% of total accounts receivable. On
December 31, 2023, </span><span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20231231__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--FourCustomersMember_z8UER6VkXDVf" style="font-size: 10pt">82</span>%
of accounts receivable were due from four customers in North America that individually owed over 10% of total accounts receivable.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-redline: true">Revenues
from customers representing greater than 10% of total net sales derived from our top three customers as a percentage of net sales were
<span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240701__20240930__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zNCPa1fwXXRj" title="Concentration of sales risk, percentage">41</span>%, <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240701__20240930__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersTwoMember_zOHucgA96QX2" title="Concentration of sales risk, percentage">20</span>%, and <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240701__20240930__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersThreeMember_zGUixm5jN6gb" title="Concentration of sales risk, percentage">13</span>% for the three months ended September 30, 2024. Revenues from customers representing greater than 10% of total net sales
derived from three customers as a percentage of net sales were <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230701__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zRC4bYIqY1fc" title="Concentration of sales risk, percentage">28</span>%, <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230701__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersTwoMember_zwAfdt9iNDb" title="Concentration of sales risk, percentage">22</span>% and <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230701__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersThreeMember_z5Chl58wPjX1" title="Concentration of sales risk, percentage">21</span>% for the three months ended September 30, 2023. Revenues
from customers representing greater than 10% of total net sales derived from our top four customers as a percentage of net sales were
<span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240101__20240930__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerOneMember_z081AlpVUWSd" title="Concentration of sales risk, percentage">29</span>%, <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240101__20240930__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersTwoMember_zpeU54RUqyo8" title="Concentration of sales risk, percentage">27</span>%, <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240101__20240930__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersThreeMember_zd1CX4VBKbQ2" title="Concentration of sales risk, percentage">15</span>% and <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240101__20240930__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersFourMember_zPfQ7mVT7Zd5" title="Concentration of sales risk, percentage">10</span>% for the nine months ended September 30, 2024. Revenues from customers representing greater than 10% of total net
sales derived from our top three customers as a percentage of net sales were <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zAAabSqEP6sh" title="Concentration of sales risk, percentage">44</span>%, <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersTwoMember_zTDI49ve7v16" title="Concentration of sales risk, percentage">13</span>% and <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersThreeMember_z6GHLWXQemZd" title="Concentration of risk, percentage">12</span>% for the nine months ended September 30,
2023. The loss of any of these customers could have an adverse impact on the Company.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALGORHYTHM
                                            HOLDINGS, INC. and SUBSIDIARIES</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September
30, 2024 and 2023</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<span></span>
</td>
<td class="text"><p id="xdx_800_eus-gaap--ConcentrationRiskDisclosureTextBlock_znfs8FWL4Ul5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
18 - <span id="xdx_82E_zSrhmbvWQBFk">CONCENTRATIONS OF CREDIT RISK AND REVENUE</span> </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
times, the Company maintains cash in United States bank accounts that are more than the Federal Deposit Insurance Corporation insured
amounts. The Company maintains cash balances in foreign financial institutions. The Company regularly monitors the financial stability
of this financial institution and believes that it is not exposed to any significant credit risk in cash and cash equivalents. However,
in March and April 2023, certain U.S. government banking regulators took steps to intervene in the operations of certain financial institutions
due to liquidity concerns, which caused general heightened uncertainties in financial markets. While these events have not had a material
direct impact on the Company&#8217;s operations, if further liquidity and financial stability concerns arise with respect to banks and
financial institutions, either nationally or in specific regions, the Company&#8217;s ability to access cash or enter into new financing
arrangements may be threatened, which could have a material adverse effect on its business, financial condition and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company derives most of its revenues from retailers in the United States. The Company&#8217;s allowance for credit losses is based upon
management&#8217;s estimates and historical experience and reflects the fact that accounts receivable is concentrated with several large
customers. On December 31, 2023, <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230401__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--FourCustomersMember_zdPKSNZ3Ms3c" title="Concentration of sales risk, percentage">82</span>% of accounts receivable were due from four customers in North America that individually owed over
10% of total accounts receivable. On March 31, 2023, <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220401__20230331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ThreeCustomersMember_zcQN8fDaDZW1" title="Concentration of sales risk, percentage">79</span>% of accounts receivable were due from three customers in North America that individually
owed over 10% of total accounts receivable. On March 31, 2022, <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210401__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--FourCustomersMember_zFSXapnxAiv5" title="Concentration of sales risk, percentage">53</span>% of accounts receivable were due from four customers in North America
that individually owed over 10% of total accounts receivable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues
derived from our top three customers for the nine months ended December 31, 2023, and 2022, were <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230401__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__custom--ThreeCustomersMember__srt--MajorCustomersAxis__custom--CustomersConcentrationRiskMember_zOW0Mk4toyx6" title="Concentration of sales risk, percentage">81</span>% and <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220401__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__custom--ThreeCustomersMember__srt--MajorCustomersAxis__custom--CustomersConcentrationRiskMember_zozBkQYinFl9" title="Concentration of sales risk, percentage">77</span>% of total revenue, respectively.
Revenues derived from our top three customers for the fiscal years ended March 31, 2023, and 2022 were <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220401__20230331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__custom--ThreeCustomersMember__srt--MajorCustomersAxis__custom--CustomersConcentrationRiskMember_zFXh5VZLs1x1" title="Concentration of sales risk, percentage">69</span>% and <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210401__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__custom--ThreeCustomersMember__srt--MajorCustomersAxis__custom--CustomersConcentrationRiskMember_zmSuTByUV0x7" title="Concentration of sales risk, percentage">72</span>% of total revenue,
respectively. Revenues from customers representing greater than 10% of total net sales were derived from top three customers for the
nine months ended December 31, 2023, and top two customers for the nine months ended December 31, 2022, as percentage of the net sales
were <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230401__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomersOneMember__srt--MajorCustomersAxis__custom--CustomersConcentrationRiskMember_zdGtBbk808Kh" title="Concentration of sales risk, percentage">48</span>%, <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230401__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomersTwoMember__srt--MajorCustomersAxis__custom--CustomersConcentrationRiskMember_zvVJk8ALlRLc" title="Concentration of sales risk, percentage">21</span>% and <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230401__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomersThreeMember__srt--MajorCustomersAxis__custom--CustomersConcentrationRiskMember_zpe8ODKWIO53" title="Concentration of sales risk, percentage">12</span>% and <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220401__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomersOneMember__srt--MajorCustomersAxis__custom--CustomersConcentrationRiskMember_z3mQnf61ln43" title="Concentration of sales risk, percentage">46</span>% and, <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220401__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomersTwoMember__srt--MajorCustomersAxis__custom--CustomersConcentrationRiskMember_z0VYpnq06jgc" title="Concentration of sales risk, percentage">22</span>%, respectively. Revenues from customers representing greater than 10% of total net sales were derived
from our top two customers in Fiscal 2023 and top three customers in Fiscal 2022 as percentage of the net sales were <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220401__20230331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomersOneMember__srt--MajorCustomersAxis__custom--CustomersConcentrationRiskMember_zT7KGAJqPvv9" title="Concentration of sales risk, percentage">48</span>% and <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220401__20230331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomersTwoMember__srt--MajorCustomersAxis__custom--CustomersConcentrationRiskMember_zMLs58p2um1d" title="Concentration of sales risk, percentage">21</span>% and
<span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210401__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomersOneMember__srt--MajorCustomersAxis__custom--CustomersConcentrationRiskMember_zDmwTLyzkI3d" title="Concentration of sales risk, percentage">37</span>%, <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210401__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomersTwoMember__srt--MajorCustomersAxis__custom--CustomersConcentrationRiskMember_zeeHNC9oX279" title="Concentration of sales risk, percentage">18</span>%, and <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210401__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomersThreeMember__srt--MajorCustomersAxis__custom--CustomersConcentrationRiskMember_ziPVXjAekhGk" title="Concentration of sales risk, percentage">17</span>%, respectively. The loss of any of these customers could have an adverse impact on the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
SINGING MACHINE COMPANY, INC AND SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
31, 2023, and March 31, 2023 and 2022</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is dependent upon foreign companies for the manufacture of all its electronic products. The Company&#8217;s arrangements with
manufacturers are subject to the risk of doing business abroad, such as import duties, trade restrictions, work stoppages, foreign currency
fluctuations, political instability, and other factors, which could have an adverse impact on its business. The Company believes that
the loss of any one or more of their suppliers would not have a long-term material adverse effect because other manufacturers with whom
the Company does business would be able to increase production to fulfill their requirements. However, the loss of certain suppliers
in the short term could adversely affect business until alternative supply arrangements are secured.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the nine months ended December 31, 2023, and fiscal years 2023 and 2022, manufacturers in the People&#8217;s Republic of China accounted
for <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230401__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--GeographicConcentrationRiskMember__srt--MajorCustomersAxis__custom--RepublicOfChinaMember_zq4PtJ0ODRV6" title="Concentration of sales risk, percentage"><span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220401__20230331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--GeographicConcentrationRiskMember__srt--MajorCustomersAxis__custom--RepublicOfChinaMember_zvKD5hLm5NGg" title="Concentration of sales risk, percentage"><span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210401__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--GeographicConcentrationRiskMember__srt--MajorCustomersAxis__custom--RepublicOfChinaMember_zvJ9DP33MIKa" title="Concentration of sales risk, percentage">100</span></span></span>% of the Company&#8217;s total product purchases, including all the Company&#8217;s hardware purchases. In 2018 <span id="xdx_900_eus-gaap--DebtInstrumentDescription_pid_c20230401__20231231__us-gaap--ConcentrationRiskByTypeAxis__custom--RepublicOfChinaMember_zCksFkuHY0Dk" title="Debt instrument, description">the U.S. government-imposed
tariffs of up to 25% on certain goods imported from China. All our products are manufactured and imported from China however, only our
microphones are currently subject to a 7.5% tariff currently in place</span>. Should the government decide to expand its list of products to
include our karaoke products that would subject our products to tariffs in the future, there could be a significant increase in the landed
cost of our products. If we are unable to mitigate these increased costs through price increases, we could experience reductions in revenues,
gross profit margin and results from operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=RIME_SemiCabIncMember', window );">Semi Cab Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskDisclosureTextBlock', window );">CONCENTRATIONS OF CREDIT RISK AND REVENUE</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_803_eus-gaap--ConcentrationRiskDisclosureTextBlock_z41cxMIkSk6l" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
14 &#8211; <span>CONCENTRATIONS OF CREDIT RISK, CUSTOMERS, AND SUPPLIERS</span> </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_82A_zmX6yOVKuvE6" style="display: none">CONCENTRATIONS
OF CREDIT RISK AND REVENUE</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company derives a majority of its revenues from enterprise-level customers in the United States. The Company&#8217;s allowance for doubtful
accounts is based upon management&#8217;s estimates and historical experience and reflects the fact that accounts receivable are concentrated
with several large customers. At both December 31, 2023 and 2022, <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--FourMember_zTzp1lWG4aC6" title="Concentration risk percentage"><span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--FourMember_zYj9y70UmWYk" title="Concentration risk percentage">100</span></span>% of accounts receivable were due from four customers in North America,
all of which that individually owed over 10% of total accounts receivable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues
derived from our top four US customers in 2023 and 2022 were <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--FourMember_ziRbky3oJY12" title="Concentration risk percentage">100</span>% and <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--FourMember_z4sOhNOxvzV1" title="Concentration risk percentage">100</span>% of total revenue, respectively, all of which represented greater
than 10% of total net sales in both years. The loss of any of these customers could have an adverse impact on the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 275<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/275/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=RIME_SemiCabIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=RIME_SemiCabIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>166
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035112721888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">RELATED PARTY TRANSACTIONS</a></td>
<td class="text"><p id="xdx_808_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zBVfWm7UcGK3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
16 &#8211; <span id="xdx_82A_zpMy1wLIHqOi">RELATED PARTY TRANSACTIONS</span></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Due
To/From Related Parties</i></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><b><i>Stingray</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-redline: true">Stingray
Group, Inc. (&#8220;Stingray&#8221;) is an existing shareholder with board representation. The Company has a music subscription sharing
agreement with Stingray. For the three months ended September 30, 2024, and 2023, the amounts earned from the subscription agreement
were approximately $<span id="xdx_907_eus-gaap--Revenues_c20240701__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zJJjH8r0nBq1" title="Revenue from related parties">218,000</span> and $<span id="xdx_904_eus-gaap--Revenues_c20230701__20230930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_z9RiTOnLgGwk" title="Revenue from related parties">156,000</span>, respectively. For the nine months ended September 30, 2024, and 2023, the amounts earned from
the subscription agreement were approximately $<span id="xdx_908_eus-gaap--Revenues_c20240101__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zuNB2Dfyr794" title="Revenue from related parties">567,000</span> and $<span id="xdx_90A_eus-gaap--Revenues_c20230101__20230930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zrr1uvSf71v3" title="Revenue from related parties">550,000</span>, respectively. These amounts were included as a component of net
sales in the accompanying condensed consolidated statements of operations. On September 30, 2024, the Company had approximately $<span id="xdx_900_eus-gaap--OtherReceivables_iI_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StingrayMember_zJfiaWl0n5sa" title="Due from related parties">157,000</span>
due from Stingray. On December 31, 2023, the Company had approximately $<span id="xdx_903_eus-gaap--OtherReceivables_iI_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StingrayMember_zPoqAjmRFuck" title="Due from related parties">269,000</span> due from Stingray for music subscription reimbursement.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>SMCB</i></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-redline: true">The
Company determined that SMCB is a VIE as the Company provides financial support to SMCB. While not contractually obligated, SMCB currently
relies on our reimbursement of certain costs under a Services Agreement (&#8220;MSA&#8221;) whereby SMCB agree to provide IT software
development services to support SemiCab&#8217;s US operations. In exchange, under the MSA, the Company grants intellectual property rights
to SMCB to use the software platform in India. Compensation for services is invoiced and paid on a monthly or quarterly basis as agreed
by both parties, with rates subject to periodic review and revision. As a result of this relationship SMCB has been determined to be
a VIE.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-redline: true">Pursuant
to the asset acquisition agreement of SemiCab, the Company entered into an option agreement granting the right to acquire all of the
issued and outstanding capital securities of SMCB, however the option agreement expired on August 31, 2024 unexercised.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-redline: true">The
Company further determined that it is not the primary beneficiary of SMCB as the Company does not have the power to direct or control
SMCB&#8217;s significant activities related to its business. Accordingly, the Company has not consolidated SMCB&#8217;s results of operations
and financial position in the accompanying condensed consolidated financials presented for this period.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-redline: true">As
of September 30, 2024, the Company has advanced approximately $<span id="xdx_90F_eus-gaap--OtherLiabilities_iI_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SMCBMember_zBVvCBdJWnd7" title="Due to related parties">776,000</span>
to SMCB for estimated prepaid services to be provided by SMCB in accordance with the MSA which are a component of prepaid expenses
and other current assets on the accompanying condensed consolidated balance sheets. During the three months ended September 30,
2024, the Company incurred approximately $<span id="xdx_902_eus-gaap--ProfessionalFees_c20240701__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SMCBMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zZnAwKWBMABb" title="Software support service">422,000</span>
in software support services under the MSA.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_805_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zpzov70XlNqd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
19 &#8211; <span id="xdx_826_zIqD0Wxtzpf2">RELATED PARTY TRANSACTIONS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Financing</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 20, 2023, the Company the Company entered into an agreement to sell $<span id="xdx_90C_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20231120__20231120__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zHp8xmDlvEdd" title="Number of stock sold, value">2,000,000</span> in common stock through a private placement of
common stock (the &#8220;Private Placement&#8221;). The Private Placement was completed with two Affiliates, (Stingray Group, Inc. and
Jay Foreman), both of which were existing shareholders with Board representation (See Note 13 &#8211; November 2023 Private Placement).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Due
To/From Related Parties</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has a music subscription sharing agreement with Stingray. For the transition year ended December 31, 2023, and 2022, the Company
received music subscription revenue of approximately $<span id="xdx_909_eus-gaap--Revenues_c20230401__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StingrayMember_zbGwyH4zwAD7" title="Revenue from related parties">600,000</span> and $<span id="xdx_90C_eus-gaap--Revenues_c20220401__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StingrayMember_zYr9SNNglQt4" title="Revenue from related parties">500,000</span>, respectively. For the fiscal years ended March 31, 2023,
and 2022, this amount was approximately $<span id="xdx_905_eus-gaap--Revenues_c20220401__20230331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StingrayMember_zh4tfxEtKxBe" title="Revenue from related parties">700,000</span> and $<span id="xdx_908_eus-gaap--Revenues_c20210401__20220331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StingrayMember_zRqvXqUDZUGg" title="Revenue from related parties">500,000</span>, respectively. This amount was included as a component of net sales in
the accompanying consolidated statements of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 31, 2023, and March 31, 2023, the Company had approximately $<span id="xdx_906_eus-gaap--OtherReceivables_iI_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StingrayMember_zRMFezJhOQqk" title="Due from related parties">269,000</span> and $<span id="xdx_90C_eus-gaap--OtherReceivables_iI_c20230331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StingrayMember_zqiC6Tg9gLq7" title="Due from related parties">218,000</span>, respectively, due from Stingray for music
subscription reimbursement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
March 31, 2023, the Company had travel and entertainment expense reimbursements due from Ault Alliance, Inc., a former parent company,
of approximately $<span id="xdx_905_eus-gaap--OtherReceivables_iI_c20230331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AultAllianceIncMember_ztpvUOwheBG4" title="Due from related parties">21,000</span>. There was nothing due to or from Ault Alliance, Inc. on December 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=RIME_SemiCabIncMember', window );">Semi Cab Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">RELATED PARTY TRANSACTIONS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_80C_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zRpnRjhHeWVj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
15 &#8211; <span id="xdx_822_zFYfQv2wehN2">RELATED PARTY TRANSACTIONS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DUE
TO/FROM RELATED PARTIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the years ended December 31, 2023 and 2022, the Company owed $<span id="xdx_90F_eus-gaap--OtherReceivables_iI_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorMember_z2L6PZMach09" title="Other receivables">712,000</span> and $<span id="xdx_908_eus-gaap--OtherReceivables_iI_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorMember_zkBoktVALhQ6" title="Other receivables">385,000</span>, respectively, to Ajesh Kapoor in the form of shareholder
notes. see Note 6 &#8211; Credit Arrangements</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 31, 2023, the Company had approximately $<span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_c20230331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorMember_z7QgPyDMmQhi" title="Principal amount">712,000</span> in principal plus accrued interest, due to Ajesh Kapoor, the founder and primary
shareholder in SemiCab.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/850/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-6<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=RIME_SemiCabIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=RIME_SemiCabIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>167
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035113049248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENTS</a></td>
<td class="text"><p id="xdx_803_eus-gaap--SubsequentEventsTextBlock_zn3f20UwLxwa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
17 &#8211; <span id="xdx_82E_zgBcjXTSdma2">SUBSEQUENT EVENTS</span></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Securities
Purchase Agreement</i></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-redline: true">On
October 22, 2024, the Company entered into a Securities Purchase Agreement (the &#8220;SPA&#8221;), pursuant to which the Company agreed
to issue and sell to each purchaser (i) an Original Issue Discount Senior Secured Note with a principal amount equal to such purchaser&#8217;s
subscription amount divided by <span id="xdx_907_eus-gaap--SharePrice_iI_c20241022__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zEZHBXI6TvXh" title="Share price">0.85</span> (each a &#8220;Note&#8221; and collectively, the &#8220;Notes&#8221;), and (ii) a number of shares
of common stock of the Company, par value $<span id="xdx_902_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20241022__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zlZTSjAdp1ig" title="Common stock, par value">0.01</span> equal to (i) <span id="xdx_904_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20241022__20241022__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zlpqy9VjA3Pa" title="Number of share sold">2,300,000</span> multiplied by (ii) such purchaser&#8217;s subscription amount
divided by (iii) $<span id="xdx_907_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20241022__20241022__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zoXhIDFdnyU8" title="Number of shares sold, value">2,000,000</span> (the &#8220;Shares&#8221;) (the transactions contemplated under the SPA, the &#8220;Offering&#8221;).The
aggregate gross proceeds to the Company were approximately $<span id="xdx_90B_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_pn5n6_c20241022__20241022__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zl2FZAMPD5S1" title="Net proceeds">2.0</span> million, before deducting placement agent fees and expenses. The Company
intends to use the net proceeds from the Offering for working capital and other general corporate purposes.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-redline: true">The
Company agreed to certain registration rights with respect to the Shares, as described in the SPA. The Company also granted the purchasers
a right to participate up to an amount of <span id="xdx_90D_ecustom--PercentageOfPurchasersRightToParticipateOnIssuanceCompanyOfCommonStock_dp_c20241022__20241022__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zWsuSWAzHKp3" title="Percentage of purchasers right to participate on issuance company of common stock">20</span>% in any issuance by the Company of common stock or common stock equivalents for cash, subject
to certain exceptions, during the 90 days after the closing of the Offering.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-redline: true">Univest
Securities LLC served as the placement agent in the Offering and received <span id="xdx_90B_ecustom--PercentageOfGrossProceeds_dp_uPure_c20241022__20241022__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zwhyZEqEsJ5e" title="Percentage of gross proceeds">7</span>% of the gross proceeds received by the Company and reimbursement
of the legal fees of its counsel.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-redline: true">The
Offering closed on October 24, 2024. At the closing, the Company issued to the purchasers an aggregate of <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20241024__20241024__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zifBkpKJ3aU9" title="Number of shares issued">2,300,000</span> shares of its common
stock and Notes in the aggregate principal amount of $<span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_iI_c20241024__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zSyE6GH6yrfb" title="Principal amount">2,352,941</span>for total proceeds of $<span id="xdx_90A_eus-gaap--ProceedsFromIssuanceOfDebt_c20241024__20241024__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zptQhopjOsD3" title="Net proceeds">2,000,000</span> net of original issue discount of $<span id="xdx_90D_eus-gaap--DebtConversionOriginalDebtAmount1_c20241024__20241024__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zk24LJlFQYOl" title="Original issue discount">352,941</span>.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-redline: true">At
the closing, the Company issued a Note to each purchaser equal to such purchaser&#8217;s subscription amount divided by<span id="xdx_901_eus-gaap--SharePrice_iI_c20241024__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zOVhV4wFOo7f" title="Share price"> 0.85</span>. The Notes
were issued with an original issue discount of <span id="xdx_902_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_dp_c20241024__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z5XsBXUxrc49" title="Original issue discount percentage">15</span>%. No interest shall accrue on the Notes unless and until an Event of Default (as defined
in the Notes) has occurred, upon which interest shall accrue at a rate of fourteen percent (<span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20241024__20241024__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zhZ9dAyRbgai" title="Interest accrued rate percentage">14.0</span>%) per annum and shall be computed on
the basis of a three hundred sixty (360)-day year and twelve (12) thirty (30)-day months and shall be payable on the maturity date, which
is ninety (90) days from the issuance date of <span id="xdx_90B_eus-gaap--DebtInstrumentIssuanceDate1_dd_c20241024__20241024__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z7jNeTGUtGfk" title="Issuance date">October 24, 2024</span>.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-redline: true">The
Notes also provide for redemption upon a change of control, as such term is defined under the Notes and mandatory redemption upon the
receipt of net proceeds from any offering of equity or debt by the Company. The Company also has the right to prepay the Notes.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-redline: true">The
Notes are secured by a security interest in the assets and property of the Company and its subsidiaries and guaranteed by the Company&#8217;s
subsidiaries, pursuant to the terms of a Guarantee Agreement entered into among the purchasers and the Company and each of its subsidiaries.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Stock
Repurchase Agreement</i></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-redline: true">On
November 1, 2024, the Company entered into Stock Repurchase Agreement (the &#8220;Repurchase Agreement&#8221;) with Regalia Ventures
LLC, a Delaware limited liability company (the &#8220;Seller&#8221;), pursuant to which the Company agreed to repurchase from the Seller
an aggregate of <span id="xdx_906_eus-gaap--CommonStockSharesIssued_iI_c20241101__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zcKURhHgy414" title="Common stock shares issued"><span id="xdx_904_eus-gaap--CommonStockSharesOutstanding_iI_c20241101__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zUig7kzsu433" title="Common stock shares outstanding">1,098,901</span></span> issued and outstanding shares of common stock, par value $<span id="xdx_909_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20241101__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zHlo0sa1f2C1" title="Common stock par value">0.01</span> per share, of the Company (the &#8220;Shares&#8221;).
The shares of common stock to be repurchased were originally issued to the Seller on November 21, 2023, pursuant to a certain stock purchase
agreement, dated November 20, 2023.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-redline: true">As
consideration for the transaction contemplated by the Repurchase Agreement (the &#8220;Stock Repurchase&#8221;), when the transaction
closes, the Company has agreed to repurchase from the Seller, and the Seller has agreed to sell, assign and transfer to the Company,
all of the Seller&#8217;s right, title and interest in and to the Shares, at a price per Share equal to the higher of: (1) the closing
price of the common stock on the last trading day immediately preceding the date of the Repurchase Agreement; or (2) the highest volume
weighted average price (VWAP) of the common stock during a pricing period of ten (10) consecutive trading days prior to the date of the
Repurchase Agreement per share (the &#8220;Purchase Price&#8221;), and the Company shall issue to the Seller a promissory note in the
principal amount equal to the Purchase Price.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the date of this filing, the repurchase of the shares has not yet closed.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>168
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035115294720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">PROPERTY AND EQUIPMENT</a></td>
<td class="text"><p id="xdx_80F_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_ztYxJTMrb7r3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
5 - <span>PROPERTY AND EQUIPMENT, NET</span> </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_828_zEWoggtyJkS6" style="display: none">PROPERTY
AND EQUIPMENT</span></span></p>

<p id="xdx_890_eus-gaap--PropertyPlantAndEquipmentTextBlock_zTLkenoLXW3g" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of property and equipment is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zAmQk0bKrwej" style="display: none">SCHEDULE
OF PROPERTY AND EQUIPMENT</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">Useful</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">December 31,</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">March 31,</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Life</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48%; text-align: left">Computer and office equipment</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: left"><span id="xdx_904_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerAndOfficeEquipmentMember__srt--RangeAxis__srt--MinimumMember_zZItq5y2jJK9" title="Average useful life (in years)">5</span>-<span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerAndOfficeEquipmentMember__srt--RangeAxis__srt--MaximumMember_zluvefZyvHkg" title="Average useful life (in years)">7</span> years</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerAndOfficeEquipmentMember_zOJy9Ps5K0t7" style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right" title="Property and equipment, gross">404,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerAndOfficeEquipmentMember_zOOhCwIoh8B1" style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right" title="Property and equipment, gross">497,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Furniture and fixtures</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zsCYAHHPEDLe" title="Average useful life (in years)">7</span> years</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zqHbKfyGTJuc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross">107,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zyk4EUB7BZyc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross">111,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Warehouse equipment</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_906_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--WarehouseEquipmentMember_zkZk2d4OMzV6" title="Average useful life (in years)">7</span> years</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--WarehouseEquipmentMember_zU1a3Xgvuwmk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross"><span style="-sec-ix-hidden: xdx2ixbrl2305">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--WarehouseEquipmentMember_zZEuGuqIRqV1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross">251,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Molds and tooling</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MoldsAndToolingMember__srt--RangeAxis__srt--MinimumMember_zXcDx8A9SzZb" title="Average useful life (in years)">3</span>-<span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MoldsAndToolingMember__srt--RangeAxis__srt--MaximumMember_zUNkbKrTalP5" title="Average useful life (in years)">5</span> years</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MoldsAndToolingMember_zUTKwhQYnkq5" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross">2,228,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MoldsAndToolingMember_zL5n6RHOk1b4" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross">2,160,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20231231_zlU54n9m8uG6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross">2,739,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230331_zrs7FnVl2VLj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross">3,019,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Less: Accumulated depreciation</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pp0p0_c20231231_zH6PI5nPOcA7" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Less: Accumulated depreciation">2,335,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pp0p0_c20230331_z8dczwO11nca" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Less: Accumulated depreciation">2,386,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-bottom: 2.5pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-bottom: 2.5pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3p0_c20231231_z4mXyHYNYQZ3" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net">404,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3p0_c20230331_zbbsJanErv32" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net">633,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A4_zzdYpgc2Hfta" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
expense for the nine months ended December 31, 2023 was approximately $<span id="xdx_903_eus-gaap--Depreciation_c20230401__20231231_zAZmXlnANDS2" title="Depreciation expense">287,000</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
expense for both fiscal years ended March 31, 2023, and 2022, was approximately $<span id="xdx_907_eus-gaap--Depreciation_c20220401__20230331_z1M2ij933MBi" title="Depreciation expense">228,000</span> and $<span id="xdx_900_eus-gaap--Depreciation_c20210401__20220331_zJgXsnYaL1Ca" title="Depreciation expense">246,000</span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=RIME_SemiCabIncMember', window );">Semi Cab Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">PROPERTY AND EQUIPMENT</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_80B_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_z8UFEgXSL1xf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
5 - <span id="xdx_829_zP6e4Hs3BiIl">PROPERTY AND EQUIPMENT </span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equipment
and leasehold improvements consisted of the following as of December 31: Miscellaneous office equipment, including desktop computers,
laptop computers, and printers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
was $<span id="xdx_905_eus-gaap--Depreciation_c20230101__20231231_zAhYcoIwJFqh" title="Depreciation">1,000</span> and $<span id="xdx_90A_eus-gaap--Depreciation_c20220101__20221231_z4Rd6P30Jwp7" title="Depreciation">2,000</span> for 2023 and 2022, respectively. Amounts are recorded in selling, general, and administrative expenses as well
as in cost of services.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/360/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-7<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=RIME_SemiCabIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=RIME_SemiCabIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>169
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035115296832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK COMPENSATION EXPENSE<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">STOCK COMPENSATION EXPENSE</a></td>
<td class="text"><p id="xdx_80D_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_z5GkWyKWz7u9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
9 &#8211; <span id="xdx_82C_zz4hmLHo5Qhg">STOCK COMPENSATION EXPENSE</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>EQUITY
INCENTIVE PLAN</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 12, 2022, the Board of Directors approved The Singing Machine Company, Inc. 2022 Equity Incentive Plan, or the 2022 Plan. The 2022
Plan provides for the issuance of equity incentive awards, such as stock options, stock appreciation rights, stock awards, restricted
stock, stock units, performance awards and other stock or cash-based awards collectively, the &#8220;Awards.&#8221; Awards may be granted
under the 2022 Plan to the Company&#8217;s employees, officers, directors, consultants, agents, advisors and independent contractors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--SaleOfStockDescriptionOfTransaction_c20220411__20220412__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zekDRupXv7Ej" title="Sale of stock description">The
maximum number of shares of common stock initially available for issuance under the 2022 Plan is 233,334 shares of common stock and
thereafter an annual increase shall be added as of the first day of the Company&#8217;s fiscal year beginning in 2023, equal to the
least of (i) 5% of the outstanding common stock on a fully diluted basis as of the end of the Company&#8217;s immediately preceding
fiscal year, (ii) 33,334 shares, and (iii) a lesser amount as determined by the Board of Directors.</span> The shares of common stock
subject to stock awards granted under the 2022 Plan that lapse, terminate, expire prior to exercise, are canceled, or are forfeited,
shall again become available for issuance under the 2022 Plan. Shares subject to a stock award under the 2022 Plan shall not again
be made available for issuance or delivery under the 2022 Plan if such shares are (i) shares tendered by a participant or retained
by the Company as full or partial payment to the Company for the exercise or purchase price of an award or (ii) shares used to
satisfy tax withholding obligations in connection with an award.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board of Directors may amend, suspend or terminate the 2022 Plan or a portion of it at any time; however, to the extent required by applicable
law, regulation or stock exchange rule, stockholder approval shall be required for any amendment to the 2022 Plan. The 2022 Plan is scheduled
to terminate automatically in ten (10) years following the earlier of (a) the date the Board of Directors adopted the 2022 Plan and (b)
the date the stockholders approved the 2022 Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
SINGING MACHINE COMPANY, INC AND SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
31, 2023, and March 31, 2023 and 2022</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>COMMON
STOCK OPTIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the nine months ended December 31, 2023, the Company did not issue any stock options. During the fiscal years ended March 31, 2023, the
Company issued the following stock options:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fiscal
2023:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the fiscal year ended March 31, 2023, the Company issued <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220401__20230331__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zhYKPx7FRuG7" title="Common stock options grants">6,001</span> stock options under the 2022 Plan at an exercise price ranging from $<span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220401__20230331__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__srt--TitleOfIndividualAxis__srt--DirectorMember__srt--RangeAxis__srt--MinimumMember_zfKtS8MEOK35" title="Exercise price">2.35</span>
to $<span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220401__20230331__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__srt--TitleOfIndividualAxis__srt--DirectorMember__srt--RangeAxis__srt--MaximumMember_zBltLXSALflb" title="Exercise price">8.11</span> per share to directors as compensation for their service.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the fiscal year ended March 31, 2023, the Company issued <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220401__20230331__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__srt--TitleOfIndividualAxis__srt--OfficerMember_zIirfgi9Svy1" title="Common stock options grants">37,001 </span>stock
options from the 2022 Plan at an exercise price ranging from $<span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220401__20230331__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__srt--TitleOfIndividualAxis__srt--OfficerMember__srt--RangeAxis__srt--MinimumMember_zrjgVp5Wyuzf" title="Exercise price">4.00</span>
to $<span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220401__20230331__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__srt--TitleOfIndividualAxis__srt--OfficerMember__srt--RangeAxis__srt--MaximumMember_z0xBID13UDZ6" title="Exercise price">8.65</span>
per share to the Company&#8217;s officers as incentive compensation for the successful up-listing of the Company&#8217;s common
stock on the Nasdaq Capital Market and compensation related to their Fiscal 2022 annual incentive plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the fiscal year ended March 31, 2023, the Company issued <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220401__20230331__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__srt--TitleOfIndividualAxis__custom--EmployeeMember_z4xSXPO0ahl4" title="Common stock options grants">64,750</span> stock options from the 2022 Plan to all employees (excluding Company
officers) who had one year or more of service to the Company under an Employee Incentive Plan at an exercise price ranging from $<span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220401__20230331__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__srt--TitleOfIndividualAxis__custom--EmployeeMember__srt--RangeAxis__srt--MinimumMember_zN0Y1fCGx21g" title="Exercise price">8.11</span>
to $<span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220401__20230331__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__srt--TitleOfIndividualAxis__custom--EmployeeMember__srt--RangeAxis__srt--MaximumMember_zZe98hshSP07" title="Exercise price">8.65</span> per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employee
stock option compensation expense for the nine months ended December 31, 2023, and in fiscal years ended March 31, 2023, and 2022 includes
the estimated fair value of options granted, amortized on a straight-line basis over the requisite service period for the entire portion
of the award. For the nine months ended December 31, 2023, the stock option expense was approximately $<span id="xdx_90A_eus-gaap--StockOptionPlanExpense_c20230401__20231231_zRDg86rXewH5" title="Stock option expense">110,000</span>. For the fiscal years
ended March 31, 2023, and 2022, the stock option expense was approximately $<span id="xdx_90B_eus-gaap--StockOptionPlanExpense_c20220401__20230331_zfc9hwTbnooh" title="Stock option expense">237,000</span> and $<span id="xdx_901_eus-gaap--StockOptionPlanExpense_c20210401__20220331_zzGZkuXxuiw3" title="Stock option expense">22,000</span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fiscal
2022:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the fiscal year ended March 31, 2022, the Company issued <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210401__20220331__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember_zKGFIfAPybk8" title="Common stock options grants">2,001</span> Board approved options three members of our Board of Directors at an exercise
price ranging from $<span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210401__20220331__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember__srt--RangeAxis__srt--MinimumMember_zmfTXfAfdLjd" title="Exercise price">8.10</span> and $<span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210401__20220331__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember__srt--RangeAxis__srt--MaximumMember_zOAUKVkhGR0b" title="Exercise price">8.70</span> per share pursuant to our annual director compensation plan for the fiscal year ended March 31, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of each option grant was estimated on the date of the grant using the Black-Scholes option-pricing model with the assumptions
outlined below. The expected volatility is based upon the historical volatility of our stock and other contributing factors. The expected
term is based upon observation of actual time elapsed between date of grant and exercise of options for all employees.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the year ended March 31, 2023: expected dividend yield of <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20220401__20230331_zAwJHiDdPak2" title="Stock option, expected dividend yield">0</span>%, risk-free interest rate between <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20220401__20230331__srt--RangeAxis__srt--MinimumMember_zVvIIspQ1oHe" title="Stock option, risk free interest rate">2.63</span>% and <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20220401__20230331__srt--RangeAxis__srt--MaximumMember_zEQwQQUSYlxb" title="Stock option, risk free interest rate">3.21</span>%, respectively, with
    volatility between <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20220401__20230331__srt--RangeAxis__srt--MinimumMember_zCEZh59Ffih7" title="Stock option, volatility">166.1</span>% and <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20220401__20230331__srt--RangeAxis__srt--MaximumMember_zC5exglHaUV" title="Stock option, volatility">196.3</span>%, respectively with an expected term of <span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dc_c20220401__20230331_zjVgIJiZ7k8l" title="Stock option, expected term">three years</span>.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the fiscal year ended March 31, 2022: expected dividend yield of <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20210401__20220331_zNwaweCTsHp8" title="Stock option, expected dividend yield">0</span>%, risk-free interest rate between <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20210401__20220331__srt--RangeAxis__srt--MinimumMember_zApapyrpAuW6" title="Stock option, risk free interest rate">0.43</span>% and <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20210401__20220331__srt--RangeAxis__srt--MaximumMember_zjW8pkHro0Ab" title="Stock option, risk free interest rate">0.96</span>%, respectively
    with volatility between <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20210401__20220331__srt--RangeAxis__srt--MinimumMember_zzGMD5kpB1Ql" title="Stock option, volatility">149.5</span>% and <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20210401__20220331__srt--RangeAxis__srt--MaximumMember_zcm7CXKI6d5l" title="Stock option, volatility">157.0</span>% respectively with an expected term of <span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dc_c20210401__20220331_zPjyUS7j10Ii" title="Stock option, expected term">three years</span>.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_894_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zwSZRhkkVd2i" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of stock option activity for each of the years presented is summarized below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span id="xdx_8BB_zxjo8GHyYRrc" style="display: none">SUMMARY OF STOCK OPTION ACTIVITY</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Nine Months Ended</p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">December 31, 2023</p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Fiscal Year Ended</p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">March 31, 2023</p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Fiscal Year Ended</p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">March 31, 2022</p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Number of</p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Options</p></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Weighted</p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Average Exercise</p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Price</p></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Weighted</p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Average Contractual</p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Life</p></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Number of</p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Options</p></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Weighted</p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Average Exercise</p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Price</p></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Weighted</p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Average Contractual</p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Life</p></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Number of</p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Options</p></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Weighted</p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Average Exercise</p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Price</p></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Weighted</p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Average Contractual</p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Life</p></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Stock Options:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; width: 28%; text-align: left">Balance at beginning of year</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20230401__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zuSR13e2AEoi" style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: right" title="Number of Options, Balance at beginning of period">161,427</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20230401__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zM4jL2mKz5ye" style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: right" title="Weighted Average Exercise Price, Balance at beginning of period">7.90</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: right"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220401__20230331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_z4VT6tWjrgqi" title="Weighted Average contractual life">6.6</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220401__20230331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_z8dASt4qV4ne" style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: right" title="Number of Options, Balance at beginning of period">56,343</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20220401__20230331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zKgXaYCHT0o2" style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: right" title="Weighted Average Exercise Price, Balance at beginning of period">9.90</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210401__20220331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zWny3OKkJnFk" title="Weighted Average contractual life">4.1</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20210401__20220331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zec1i6Kv76M9" style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: right" title="Number of Options, Balance at beginning of period">56,010</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20210401__20220331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zjjPY4f494Lk" style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: right" title="Weighted Average Exercise Price, Balance at beginning of period">9.90</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: right"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20200401__20210331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zt6XjHfdLmUi" title="Weighted Average contractual life">5.4</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Granted</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230401__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zUkFlbAFEZug" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Granted"><span style="-sec-ix-hidden: xdx2ixbrl2545">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20230401__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zunSwWVnfai3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Granted"><span style="-sec-ix-hidden: xdx2ixbrl2547">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220401__20230331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zfBOrO3XLqfi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Granted">107,752</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220401__20230331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_z1nbqACPRrm4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Granted">6.83</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210401__20220331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_z1T5Xzj2wjN7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Granted">3,667</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210401__20220331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zcgNdOMVzf3d" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Granted">7.80</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Exercised</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20230401__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zPs1yMi1yQV8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl2557">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20230401__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zApJ6Jrqzn57" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl2559">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20220401__20230331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zT42hGb2aNR" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl2561">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20220401__20230331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_z37yoMd6Q3Ti" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl2563">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20210401__20220331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zKwYoyq3KHh7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Exercised">(2,667</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20210401__20220331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zKk6OPn2Fa7k" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercised">5.40</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Forfeited</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20230401__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zM53IbfCe9X3" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Forfeited">(47,666</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20230401__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zcSqnMymjpzh" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right" title="Weighted Average Exercise Price, Forfeited">7.48</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20220401__20230331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zOaq83fvBo2h" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Forfeited">(2,668</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20220401__20230331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zzIPkkG9V76j" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right" title="Weighted Average Exercise Price, Forfeited">5.63</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20210401__20220331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zMtnNIMFxgt9" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Forfeited">(667</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20210401__20220331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zsZN6Kzaabge" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right" title="Weighted Average Exercise Price, Forfeited">3.60</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Balance at end of year *</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20230401__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_fKCop_z6HwM5zINEc7" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Balance at end of period">113,761</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20230401__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_fKCop_zT3QNP0Qe0E1" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Balance at end of period">8.08</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230401__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_fKCop_zOPu4ZtADzIj" title="Weighted Average contractual life">4.2</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20220401__20230331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_fKCop_zD4igbxPj4V7" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Balance at end of period">161,427</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20220401__20230331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_fKCop_z28dSgXsk8W1" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Balance at end of period">7.90</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span id="xdx_90C_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220401__20230331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_fKCop_zCIRXJCsJF4i" title="Weighted Average contractual life">6.6</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20210401__20220331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_fKCop_zBve8WxqYidb" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Balance at end of period">56,343</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20210401__20220331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_fKCop_z2odeywZpLlh" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Balance at end of period">9.90</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span id="xdx_90A_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210401__20220331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_fKCop_zUxCdhfq8POk" title="Weighted Average contractual life">4.1</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Options exercisable at end of year</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20230401__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_z3jhMdDLOEjd" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, exercisable at end of period">91,261</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20230401__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zPdnz0W0BGpa" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Options exercisable at end of period">8.06</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20220401__20230331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zYb8ze7xDAZ1" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, exercisable at end of period">53,675</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20220401__20230331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zeZztL05GLB6" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Options exercisable at end of period">9.90</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20210401__20220331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zU3UfCKF5SS4" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, exercisable at end of period">52,667</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20210401__20220331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zTpFTVGB4XQe" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Options exercisable at end of period">9.90</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font: 10pt Times New Roman, Times, Serif; width: 15pt; text-align: right"><span id="xdx_F03_zMJ9yCxd4dyi" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F11_ztjnMqHqnwl5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total number of
options outstanding as of December 31, 2023, includes <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEVNUExPWUVFIFNUT0NLIE9QVElPTlMgT1VUU1RBTkRJTkcgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20231231__srt--TitleOfIndividualAxis__custom--SixCurrentAndThreeFormerDirectorsMember_ziDf0VRBSP8d" title="Option issued">23,343</span> options issued to six current and three former directors as compensation,
<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEVNUExPWUVFIFNUT0NLIE9QVElPTlMgT1VUU1RBTkRJTkcgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20231231__srt--TitleOfIndividualAxis__srt--OfficerMember_zlaFmcYLufcb" title="Option issued">56,668</span> options issued to Company officers as compensation and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEVNUExPWUVFIFNUT0NLIE9QVElPTlMgT1VUU1RBTkRJTkcgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20231231__srt--TitleOfIndividualAxis__custom--EmployeesMember_zMTAts14yJF3" title="Option issued">33,750</span> options issued to employees as part of an Employee Stock Incentive
Plan.</span></td>
</tr></table>

<p id="xdx_8A3_zIYp4RC0vqbi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2023, there was an unrecognized expense of approximately $<span id="xdx_904_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_c20231231_zgCDisISYLPc" title="Unrecognised expense">122,000</span> remaining on options currently vesting over time with
approximate weighted average of <span id="xdx_905_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dc_c20230401__20231231_z5eipgicKVjg" title="Weighted average term">eighteen months</span> remaining until these options are fully vested.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
vested options as of December 31, 2023, had <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_do_c20231231_z5Y582EQZRv3" title="Vested options">no</span> intrinsic value. As of December 31, 2023, there were <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20231231_zNn4FSuDIj9a" title="Number of shares available for issuance">165,469</span> shares under the 2022 Plan
available to be issued.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WARRANTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
warrants issued and outstanding as of December 31, 2023 and March 31, 2023, were <span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20231231_zpFvGKoQgIz3" title="Warrants outstanding"><span id="xdx_904_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20230331_zaAapAmp1i4e" title="Warrants outstanding">902,113</span></span>.
There were no changes in the warrants outstanding during the period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
SINGING MACHINE COMPANY, INC AND SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
31, 2023, and March 31, 2023 and 2022</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_894_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zAXu7qMU6Qxd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2023, the Company&#8217;s warrants by expiration date were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B2_z4dc31X58bna" style="display: none">SCHEDULE
OF WARRANTS EXPIRATION</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Number of</p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Common</p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Warrants</p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Exercise Price</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Expiration Date</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_z1p7O41GDgqk" style="font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: right" title="Number of common warrants">802,113</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zzlnpwNolV4l" style="font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: right" title="Warrant Exercise Price">2.80</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 52%; text-align: left"><span id="xdx_90F_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zeQZylxWsLCl" title="Expiration Date">September 15, 2026</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zUrmgJ8OuzZa" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of common warrants">100,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">$</td><td id="xdx_980_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_z2GYeW1cdQR6" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right" title="Warrant Exercise Price">5.00</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span id="xdx_905_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zvU7gahreCL4" title="Expiration Date">May 23, 2027</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20231231_zX2rc3VxQHeg" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of common warrants">902,113</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-bottom: 2.5pt">&#160;</td></tr>
  </table>

<p id="xdx_8A0_zc9F3jST1XBg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>170
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035112739776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PUBLIC OFFERING AND NASDAQ UPLISTING<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_DisclosurePublicOfferingAndNasdaqUplistingAbstract', window );"><strong>Public Offering And Nasdaq Uplisting</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_IssuanceOfPublicOfferingTextBlock', window );">PUBLIC OFFERING AND NASDAQ UPLISTING</a></td>
<td class="text"><p id="xdx_803_ecustom--IssuanceOfPublicOfferingTextBlock_zbLN8k1uirYh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
11 &#8211; <span id="xdx_828_z0aE5XohnvDf">PUBLIC OFFERING AND NASDAQ UPLISTING</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 23, 2022, the Company entered into the Underwriting Agreement with Aegis Capital Corp., who acted as the sole Underwriter, in a firm
commitment underwritten public offering pursuant to which the Company sold to the Underwriter <span id="xdx_902_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20220523__20220523__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_zfDp2eI7R9x3" title="Sale of stock, number of shares issued in transaction">1,000,000</span> shares of common stock, par value
$<span id="xdx_902_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20220523__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_zBOCML0XZEO5" title="Common stock, par value">0.01</span> per share for gross proceeds of $<span id="xdx_904_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20220523__20220523__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_zdekSTM9f1kf" title="Gross proceeds">4,000,000</span> prior to deducting underwriting discounts and commissions and other estimated offering
expenses of approximately $<span id="xdx_901_eus-gaap--PaymentsForCommissions_c20220523__20220523__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_zF0zNDjHjaoe" title="Underwriting discounts and commissions and other estimated offering expenses">600,000</span>. The price to the public in the offering was $<span id="xdx_90D_eus-gaap--SaleOfStockPricePerShare_iI_c20220523__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_zaFjRu0c4M3h" title="Sale of stock, price per share">4.00</span> per Share, before underwriting discounts and commissions.
The offering closed on May 26, 2022. The Company received net proceeds of approximately <span id="xdx_902_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20220523__20220523__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_ztQFgvfbn5t" title="Net proceeds">3,400,000</span> which was used for working capital.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the terms of the Underwriting Agreement, the Company agreed to issue to the Underwriter warrants to purchase up to <span id="xdx_901_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220523__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_zWnqf8ePdVYi" title="Underwriter warrants to purchase">100,000</span> shares
of Common Stock representing <span id="xdx_904_ecustom--SaleOfStockPercentage_pid_dp_uPure_c20220523__20220523__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_zsa35ZeGESi3" title="Sale of stock, percentage">10.0</span>% of the Shares sold in this offering, excluding any Shares sold through the over-allotment option.
The warrants are exercisable for six months from the commencement of sales under the offering, have an exercise price of $<span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220523__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_z7qG3UCt2qw9" title="Exercise price per share">5.00</span> per share
and expire <span id="xdx_909_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_c20220523__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_zWsbtxhGBZS1" title="Warrant term">five years</span> from the date of issuance. The Company estimated the fair value of these warrants to be approximately $<span id="xdx_906_eus-gaap--FairValueAdjustmentOfWarrants_pp0p0_c20220523__20220523__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_zdzZOfjpolz" title="Fair value adjustment of warrants">244,000</span>
using the Black-Scholes Model based on the following input assumptions: common stock price of $<span id="xdx_906_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220523__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember_zhaLW2eVYTDk" title="Warrant measurement input">2.90</span>, expected life of the warrants of
<span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20220523__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_z17ADdJpzU7l" title="Warrant term">3</span> years; stock price volatility of <span id="xdx_902_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220523__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zCP8iv4WwsJb" title="Warrant measurement input">176</span>%; dividend yield of <span id="xdx_90E_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220523__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zRpbMe0Ug4eb" title="Warrant measurement input">0</span>%; and the risk-free interest rate of <span id="xdx_900_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220523__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zrt05B5RPxX4" title="Warrant measurement input">2.63</span>%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 24, 2022, the Company&#8217;s common stock was approved to list on the Nasdaq Capital Market under the symbol &#8220;MICS&#8221;
and began trading on the Nasdaq Capital Market on May 24, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_DisclosurePublicOfferingAndNasdaqUplistingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_DisclosurePublicOfferingAndNasdaqUplistingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_IssuanceOfPublicOfferingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Issuance of Public Offering [Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_IssuanceOfPublicOfferingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>171
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035117324784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ATM OFFERING<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_DisclosureAtmOfferingAbstract', window );"><strong>Atm Offering</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_AtTheMarketPublicOfferingTextBlock', window );">ATM OFFERING</a></td>
<td class="text"><p id="xdx_80D_ecustom--AtTheMarketPublicOfferingTextBlock_zBPwJg5r8tR2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
12 &#8211; <span id="xdx_82E_z1zXFm5G0Zvc">ATM OFFERING</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 15, 2023, the Company entered into an At-The-Market Issuance Sales Agreement (the &#8220;Sales Agreement&#8221;) with Aegis
Capital Corp, as sales agent (the &#8220;Agent&#8221;), pursuant to which the Company could offer and sell, from time to time, through
the Agent (the &#8220;ATM Offering&#8221;), up to approximately $<span id="xdx_903_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_pp0p0_c20230215__20230215__us-gaap--SubsidiarySaleOfStockAxis__custom--ATMOfferingMember_z8sylrixdvOg" title="Number of stock sold, value">1,800,000</span> in shares of the Company&#8217;s common stock. For the nine
months ended December 31, 2023, and fiscal year ended March 31, 2023, the Company received net proceeds of approximately $<span id="xdx_90F_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20230401__20231231__us-gaap--SubsidiarySaleOfStockAxis__custom--ATMOfferingMember_z5j0sPe6ajV7" title="Proceeds from sale of equity">1,654,000</span> and
$<span id="xdx_907_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20220401__20230331__us-gaap--SubsidiarySaleOfStockAxis__custom--ATMOfferingMember_zmbXx5bjFuh3" title="Proceeds from sale of equity">36,000</span>, respectively, after payment of brokerage commissions and administrative fees to the agent. The ATM Offering was terminated on May 12, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
SINGING MACHINE COMPANY, INC AND SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
31, 2023, and March 31, 2023 and 2022</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_AtTheMarketPublicOfferingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>At The Market Public Offering [Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_AtTheMarketPublicOfferingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_DisclosureAtmOfferingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_DisclosureAtmOfferingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>172
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035121909520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PRIVATE PLACEMENT<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_DisclosurePrivatePlacementAbstract', window );"><strong>Private Placement</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_PrivatePlacementTextBlock', window );">PRIVATE PLACEMENT</a></td>
<td class="text"><p id="xdx_804_ecustom--PrivatePlacementTextBlock_zEGmTkIFWoac" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
13 &#8211; <span id="xdx_827_zVjf19s2AIXd">PRIVATE PLACEMENT</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 20, 2023, the Company the Company entered into an agreement to sell $<span id="xdx_90F_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20231120__20231120__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zIlmqJmcjBP6" title="Number of stock sold, value">2,000,000</span> in common stock through a private placement of
common stock (the &#8220;Private Placement&#8221;). The Private Placement was completed with two Affiliates, (Stingray Group, Inc. and
Jay Foreman), both of which were existing shareholders with Board representation. The Private Placement was completed at $<span id="xdx_902_eus-gaap--SaleOfStockPricePerShare_iI_c20231120__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zF8MvgiOJe45" title="Commmon stock share per share">0.91</span> per share
of common stock, with a total of approximately <span id="xdx_901_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20231120__20231120__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zA4yjRNzWoKa" title="Number of stock sold">2,198,000</span> shares issued. Net proceeds from the transaction were approximately $<span id="xdx_903_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20231120__20231120__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zIODCkO1j2nc" title="Proceeds from sale of equity">1,900,000</span>,
net of transaction fees of approximately $<span id="xdx_90E_ecustom--TransactionFees_iI_c20231120__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zBW9bXe0xPO7" title="Transaction fees">100,000</span>. During the six-month period after the closing date, the purchasers may make a written
request for registration under the Securities Act of all or any portion of the shares purchased.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_DisclosurePrivatePlacementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_DisclosurePrivatePlacementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_PrivatePlacementTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Private Placement [Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_PrivatePlacementTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>173
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035125774224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>AUGUST 2021 STOCK REDEMPTION<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_DisclosureAugust2021StockRedemptionAbstract', window );"><strong>August 2021 Stock Redemption</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_StockRedemptionTextBlock', window );">AUGUST 2021 STOCK REDEMPTION</a></td>
<td class="text"><p id="xdx_805_ecustom--StockRedemptionTextBlock_zv7yitEIiMih" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
14 - <span id="xdx_82C_zOJYSrS3MzGj">AUGUST 2021 STOCK REDEMPTION</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 5, 2021, the Company entered into the Redemption Agreement with koncepts and Treasure Green (former majority shareholders), pursuant
to which the Company redeemed <span id="xdx_903_eus-gaap--StockRedeemedOrCalledDuringPeriodShares_c20210801__20210805__us-gaap--TypeOfArrangementAxis__custom--RedemptionAgreementMember__dei--LegalEntityAxis__custom--KonceptsandTreasureGreenMember_zdillBIFb94g" title="Shares redeemed">654,105</span> shares of common stock of the Company. The closing of the transaction set forth in the Redemption
Agreement took place on August 10, 2021, at which time the Redeemed Shares were assigned and transferred back to the Company in consideration
of a payment by the Company of approximately $<span id="xdx_901_eus-gaap--ConversionOfStockAmountIssued1_pn5n6_c20210808__20210810__dei--LegalEntityAxis__custom--KonceptsandTreasureGreenMember__us-gaap--TypeOfArrangementAxis__custom--RedemptionAgreementMember_zXLU89EnUN45" title="Conversion of stock, amount issued">7.2 </span>million to koncepts and Treasure Green. The Redeemed Shares were retired and returned
to the unissued authorized capital of the Company. Pursuant to the Redemption Agreement, neither koncepts nor Treasure Green remained
stockholders of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_DisclosureAugust2021StockRedemptionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_DisclosureAugust2021StockRedemptionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_StockRedemptionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Redemption [TextBlock]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_StockRedemptionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>174
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035115296448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>AUGUST 2021 PRIVATE PLACEMENT<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_DisclosureAugust2021PrivatePlacementAbstract', window );"><strong>August 2021 Private Placement</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_AugustTwentyTwentyOnePrivatePlacementTextBlock', window );">AUGUST 2021 PRIVATE PLACEMENT</a></td>
<td class="text"><p id="xdx_809_ecustom--AugustTwentyTwentyOnePrivatePlacementTextBlock_zk73zIeNXpC" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
15 &#8211; <span id="xdx_82A_zSd0GOr2ugal">AUGUST 2021 PRIVATE PLACEMENT</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 5, 2021, the Company entered into a securities purchase agreement (the &#8220;Purchase Agreement&#8221;) with large institutional
investors and the strategic investor for private placement of (i) <span id="xdx_903_eus-gaap--CommonStockSharesIssued_iI_pid_c20210805__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember_zQszQ83FBDHl" title="Common stock, shares, issued">550,000</span> shares of its common stock (the &#8220;Shares&#8221;) together
with Common Warrants to purchase up to <span id="xdx_908_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20210805__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember_zOGBglabIYcb" title="Warrants to purchase common stock">550,000</span> shares of common stock with an exercise price of $<span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20210805__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember_zhmhLP6uuLbc" title="Exercise price of warrants">10.50</span> per share, and (ii) <span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_pid_c20210805__us-gaap--StatementEquityComponentsAxis__custom--PreFundedWarrantsMember_zKwi0Gu6w8Si" title="Class of warrant or right, number of securities called by each warrant or right">561,111</span> pre-funded
warrants (&#8220;Pre-Funded Warrants&#8221;) with each Pre-Funded Warrant exercisable for one share of common stock at an exercise price
of $<span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20210805__us-gaap--StatementEquityComponentsAxis__custom--PreFundedWarrantsMember_z5nmqbZW8u2b" title="Exercise price of warrants">0.01</span> per share, together with Common Warrants to purchase up to <span id="xdx_900_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20210805__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zdAko8gD2IWj" title="Issuance of warrant shares">561,111</span> shares of common stock at an exercise price of $<span id="xdx_901_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20210805__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zkpDamcxzt56" title="Exercise price of warrants">10.50</span> per
share (the &#8220;Private Placement&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Common Warrants and Pre-Funded Warrants are collectively referred to as (the &#8220;Warrants&#8221;). The Warrants are exercisable at
any time at the option of the holder, have a term of 5 years from the issuance date and provide for cashless exercise under certain conditions.
The Company determined that the Warrants meet the conditions for equity classification. Shares issuable upon exercise of the Warrants
are hereinafter referred to as the &#8220;Warrant Shares&#8221;. The exercise price and number of the Warrant Shares are subject to anti-dilution
and other adjustments for certain stock dividends, stock splits, subsequent rights offerings, pro rata distributions or certain equity
structure changes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the terms of the Purchase Agreement, on September 3, 2021, the Company filed a registration statement providing for the resale by
the purchasers of the Shares and Warrant Shares sold in the Private Placement, which registration statement became effective on September
15, 2021. Additionally, under the terms of the Purchase Agreement, the Company was obligated to use its reasonable best efforts to submit
an application to have the Company&#8217;s common stock listed on a national exchange by December 31, 2021, and to use its reasonable
best efforts to have the Shares and Warrant Shares listed on such national exchange as soon as practicable following the submission of
such application. As indicated, the Common Stock was approved to list on the Nasdaq Capital Market under the symbol &#8220;MICS&#8221;
and began trading on the Nasdaq Capital Market on May 24, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
closing of the Private Placement took place on August 10, 2021, when the Shares and Warrants were delivered to the purchasers and
funds, in the amount of approximately $<span id="xdx_90C_eus-gaap--ProceedsFromWarrantExercises_c20210808__20210810__dei--LegalEntityAxis__custom--KonceptsandTreasureGreenMember__us-gaap--TypeOfArrangementAxis__custom--RedemptionAgreementMember_zXFTAqhoUydc" title="Proceeds from warrant exercises">9,800,000</span>,
were received by the Company. Approximately $<span id="xdx_903_eus-gaap--ConversionOfStockAmountIssued1_c20210808__20210810__dei--LegalEntityAxis__custom--KonceptsandTreasureGreenMember__us-gaap--TypeOfArrangementAxis__custom--RedemptionAgreementMember_zf46bgR4qsre" title="Conversion of stock, amount issued">7,200,000</span>
of the funds was used to execute the Redemption Agreement (See Note 14 &#8211; August 2021 Stock Redemption).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stingray
is part of the group of investors who participated in the Private Placement and have acquired a minority interest in the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Private Placement, on July 6, 2021, the Company entered into a Placement Agency Agreement with A.G.P./Alliance Global
Partners (&#8220;AGP&#8221;), which provided for AGP to serve as the exclusive placement agent, advisor or underwriter (the &#8220;placement
agent services&#8221;). Pursuant to the Placement Agency Agreement, upon closing of the Private Placement, the Company paid AGP placement
fees of approximately $<span id="xdx_909_eus-gaap--PaymentsForRepurchaseOfPrivatePlacement_pn5n6_c20210701__20210706__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zSfjuAhNJ6la">600,000
</span></span><span id="xdx_90A_eus-gaap--DerivativeDescriptionOfTerms_c20210701__20210706_zrQlLm8Y9Om9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(representing
7% of the gross proceeds raised in the Private Placement excluding proceeds raised from the strategic investor, plus 3.5% of the aggregate
gross proceeds raised from the strategic investor),</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and
issued AGP warrants to purchase <span id="xdx_905_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20210706__us-gaap--ClassOfWarrantOrRightAxis__custom--AGPWarrantsMember_zWSmk3I0WCM">44,445
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of the Company&#8217;s common stock (the
&#8220;Advisor Warrants&#8221;) (representing <span id="xdx_90A_ecustom--AggregateNumberOfShares_iI_pid_dp_uPure_c20210706_z7VXqDZ67cXc">5</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
of the aggregate number of Shares and Pre-Funded Warrants sold in the Private Placement, excluding the Shares sold to the strategic investor).
The Advisor Warrants have the same exercise price ($<span id="xdx_900_eus-gaap--SharePrice_iI_pid_c20210706_z4jvEi89V5mb">10.50</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)
and terms as the Common Warrants issued in the Private Placement. The Company estimated the fair value of the Advisor Warrants to be
approximately $<span id="xdx_901_eus-gaap--EquityFairValueDisclosure_iI_c20210706_zTL6IvK3uL4d">400,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">using
the Black-Scholes Model based on the following input assumptions: common stock price of $<span id="xdx_90B_ecustom--SharePrice1_iI_c20210706_zdtHJ2Nhqef7">9.90</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
expected life of the warrants of <span id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20210706_zRtNseODzXP2">2.5</span></span>
<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">years; stock price volatility of <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20210701__20210706_zlAYuLDmTNxl">168</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%;
dividend yield of <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20210701__20210706_zC3fSB4cE5T6">0</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%;
and the risk-free interest rate of <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20210701__20210706_zrPYJK9QSeN">2.65</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to the placement fees paid to AGP, the Company incurred additional offering costs for direct incremental legal, consulting,
accounting and filing fees related to the Private Placement of approximately $<span id="xdx_90E_eus-gaap--LegalFees_c20220401__20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zcj2kH3dj1nl" title="Legal fees">400,000</span>
of which one consultant was issued <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20220401__20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zbhW3MNW1d2i" title="Stock issued for restricted shares">1,905</span>
shares of restricted common stock with an aggregate fair value of approximately $<span id="xdx_905_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardGross_c20220401__20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zzHoiZJpNOPb" title="Stock issued for restricted shares, value">200,000</span>
and a cash payment of approximately $<span id="xdx_90A_eus-gaap--PaymentsForRepurchaseOfPrivatePlacement_c20220401__20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zKH1tG8nZTLj" title="Cash payment for private placement">100,000</span>.
Total offering costs related to the Private Placement amounted approximately $<span id="xdx_90D_eus-gaap--PaymentsOfStockIssuanceCosts_c20220401__20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zcNcIzRf9hHj" title="Payment of stock issuance expenses">800,000</span>
of which was payment of stock issuance expenses, which is recorded as an offset to additional paid in capital in the accompanying
consolidated statements of shareholders&#8217; equity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_AugustTwentyTwentyOnePrivatePlacementTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>August 2021 Private Placement [Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_AugustTwentyTwentyOnePrivatePlacementTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_DisclosureAugust2021PrivatePlacementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_DisclosureAugust2021PrivatePlacementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>175
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035034147296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DAMAGED GOODS INCIDENT RECOVERY<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InsuranceAbstract', window );"><strong>Insurance [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InsuranceDisclosureTextBlock', window );">DAMAGED GOODS INCIDENT RECOVERY</a></td>
<td class="text"><p id="xdx_80C_eus-gaap--InsuranceDisclosureTextBlock_z6jsZOuvGBe6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
20 &#8211; <span id="xdx_827_zXdX0YYy0v1h">DAMAGED GOODS INCIDENT RECOVERY</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the fiscal years ended March 31, 2023 and 2022 we recognized a gain of approximately $<span id="xdx_90E_ecustom--GainFromSettlementOfAccountsPayable_c20220401__20230331_zzEK73FtAMDc" title="Settlement of accounts payable">48,000</span> and $<span id="xdx_900_ecustom--GainFromSettlementOfAccountsPayable_c20210401__20220331_zzcZCRRDYSg6" title="Settlement of accounts payable">339,000</span> as other income on the accompanying
consolidated statements of operations due to settlement of accounts payable by a manufacturer&#8217;s representative of a factory that
caused a damaged goods incident in Fiscal 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
SINGING MACHINE COMPANY, INC AND SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
31, 2023, and March 31, 2023 and 2022</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the types of coverages and products sold, and the assets, obligations, recorded liabilities, revenues and expenses arising therefrom, and the amounts of and methodologies and assumptions used in determining the amounts of such items.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479838/944-20-50-7<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/944/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)(4)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477363/944-310-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)(4)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477363/944-310-50-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>176
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035112907040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL INFORMATION CONDENSED FINANCIAL INFORMATION<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_DisclosureSupplementalInformationCondensedFinancialInformationAbstract', window );"><strong>Supplemental Information Condensed Financial Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_SupplementalInformationDisclosuresTextBlock', window );">SUPPLEMENTAL INFORMATION CONDENSED FINANCIAL INFORMATION</a></td>
<td class="text"><p id="xdx_806_ecustom--SupplementalInformationDisclosuresTextBlock_zGt64f89haC8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
21 &#8211; <span id="xdx_82D_zUPxBfovsTDj">SUPPLEMENTAL INFORMATION CONDENSED FINANCIAL INFORMATION</span> FOR THE NINE MONTHS ENDED DECEMBER 31, 2023, AND 2022.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
Singing Machine Company, Inc. and Subsidiaries</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONDENSED
CONSOLIDATED STATEMENTS OF OPERATIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For
the nine months ended December 31, 2023 and 2022</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<p id="xdx_894_esrt--ScheduleOfCondensedIncomeStatementTableTextBlock_zRwUdi7R88z1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B2_z6ajTb0E5juc">SCHEDULE
OF CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS&#160;</span></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--IncomeStatementAbstract_pn3n3_zk1596I4Wbc4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SCHEDULE OF CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Details)">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_494_20230401__20231231_zUw8GwXOeui" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_490_20220401__20221231_zXvi6m7zAge8" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Nine Months Ended</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">(unaudited)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_maGPzmfg_z9MVSYgGPy5h" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; width: 60%; text-align: left">Net Sales</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">29,198,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">35,916,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--CostOfGoodsAndServicesSold_msGPzmfg_zJLNOOQwROW3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Cost of Goods Sold</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">23,008,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">27,481,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--GrossProfit_iT_pp0p0_mtGPzmfg_maOILzsGr_za4kC8gX327g" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Gross Profit</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">6,190,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">8,435,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--OperatingExpenses_pp0p0_msOILzsGr_zE9QVe01jj7h" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Operating Expenses</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">12,333,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">9,986,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--OperatingIncomeLoss_iT_pp0p0_mtOILzsGr_maILFCOzzC2_zHJguttX6boe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">(Loss) Income from Operations</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(6,143,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(1,551,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--NonoperatingIncomeExpense_pp0p0_maILFCOzzC2_zp1msKve4kq6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Other (Expenses) Income</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(255,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(574,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iT_pp0p0_mtILFCOzzC2_maNILzRTS_ztxzDGaPsQV9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">(Loss) Income Before Income Tax Benefit</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(6,398,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(2,125,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--IncomeTaxExpenseBenefit_iN_pp0p0_di_msNILzRTS_zcGL0bqOzrla" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Income Tax Benefit (Loss)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3079">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">472,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--ProfitLoss_iT_pp0p0_mtNILzRTS_zMycqg2Gmiql" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Net (Loss) Income</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(6,398,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(1,653,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--EarningsPerShareAbstract_iB_z7JAa0AK9DI6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Loss per Common Share</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Basic and Diluted</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTkRFTlNFRCBDT05TT0xJREFURUQgU1RBVEVNRU5UUyBPRiBPUEVSQVRJT05TIChEZXRhaWxzKQA_" id="xdx_900_eus-gaap--EarningsPerShareBasic_pid_c20230401__20231231_zFisDk6vXfV5" title="Basic"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTkRFTlNFRCBDT05TT0xJREFURUQgU1RBVEVNRU5UUyBPRiBPUEVSQVRJT05TIChEZXRhaWxzKQA_" id="xdx_900_eus-gaap--EarningsPerShareDiluted_pid_c20230401__20231231_zrfoP03g4xC9" title="Diluted">(1.32</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTkRFTlNFRCBDT05TT0xJREFURUQgU1RBVEVNRU5UUyBPRiBPUEVSQVRJT05TIChEZXRhaWxzKQA_" id="xdx_905_eus-gaap--EarningsPerShareBasic_pid_c20220401__20221231_zigRinIATjdk" title="Basic"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTkRFTlNFRCBDT05TT0xJREFURUQgU1RBVEVNRU5UUyBPRiBPUEVSQVRJT05TIChEZXRhaWxzKQA_" id="xdx_906_eus-gaap--EarningsPerShareDiluted_pid_c20220401__20221231_z6xAmVxVcGn1" title="Diluted">(0.61</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--EarningsPerShareBasicOtherDisclosuresAbstract_iB" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Weighted Average Common and Common</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Equivalent Shares:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--EarningsPerShareBasicOtherDisclosuresAbstract_iB_z4AL99Y9uNWh" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Weighted Average Common and Common Equivalent Shares:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Basic and Diluted</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTkRFTlNFRCBDT05TT0xJREFURUQgU1RBVEVNRU5UUyBPRiBPUEVSQVRJT05TIChEZXRhaWxzKQA_" id="xdx_904_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20230401__20231231_z62xNBARsPq1" title="Basic"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTkRFTlNFRCBDT05TT0xJREFURUQgU1RBVEVNRU5UUyBPRiBPUEVSQVRJT05TIChEZXRhaWxzKQA_" id="xdx_907_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20230401__20231231_znDWmOHXgU81" title="Diluted">4,864,540</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTkRFTlNFRCBDT05TT0xJREFURUQgU1RBVEVNRU5UUyBPRiBPUEVSQVRJT05TIChEZXRhaWxzKQA_" id="xdx_908_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20220401__20221231_zzFnOlShhQ4g" title="Basic"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTkRFTlNFRCBDT05TT0xJREFURUQgU1RBVEVNRU5UUyBPRiBPUEVSQVRJT05TIChEZXRhaWxzKQA_" id="xdx_907_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20220401__20221231_zfWTnrupW0d3" title="Diluted">2,699,210</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A4_zwQ08z2eSbPg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
SINGING MACHINE COMPANY, INC AND SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
31, 2023, and March 31, 2023 and 2022</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
Singing Machine Company, Inc. and Subsidiaries</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONDENSED
CONSOLIDATED STATEMENTS OF CASH FLOWS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For
the nine months ended December 31, 2023 and 2022 (unaudited)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<p id="xdx_898_esrt--ScheduleOfCondensedCashFlowStatementTableTextBlock_zzJFFZvUv7P4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B9_zq2esEfyrJUc">SCHEDULE
OF CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</span></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--StatementOfCashFlowsAbstract_pn3n3_z5qt6cR0g2Kd" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SCHEDULE OF CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Details)">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_494_20230401__20231231_zN3BV2OvRkHe" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20220401__20221231_zWPEFIOYuZP4" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">For the Nine Months Ended</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">(unaudited)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Cash flows from operating activities</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--ProfitLoss_i01_pp0p0_maNCPBUzVoD_zRbqIkluj2xg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 60%; text-align: left">Net loss</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">(6,398,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">(1,653,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_405_eus-gaap--AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_i01_maNCPBUzVoD_z2q9M7Aaj0rc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Adjustments to reconcile net loss to net cash used in operating activities:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,305,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(73,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_40C_eus-gaap--IncreaseDecreaseInOperatingCapital_i02N_di_msNCPBUzVoD_zycYRO5ECe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1pt">Changes in operating assets and liabilities:</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">5,504,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="letter-spacing: -0.1pt">(538,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_405_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i01T_pp0p0_maCCERCzHgo_mtNCPBUzVoD_z5HCjOq13Pf2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left; padding-bottom: 1pt">Net cash provided by (used in) operating activities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">411,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="letter-spacing: -0.1pt">(2,264,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40E_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Cash flows from investing activities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--NetCashProvidedByUsedInInvestingActivities_i01T_pp0p0_maCCERCzHgo_mtNCPBUzYTF_zu7TLVNtK3H" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left; padding-bottom: 1pt">Net cash used in investing activities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(14,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(149,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40F_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Cash flows from financing activities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_pp0p0_mtNCPBUz2nB_maCCERCzHgo_zNUUYQjGsFo4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left; padding-bottom: 1pt">Net cash provided by financing activities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">3,411,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">2,917,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_iT_pp0p0_mtCCERCzHgo_zLQk8dYsgvM2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Net change in cash</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3,808,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="letter-spacing: -0.1pt">504,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iS_zYLw7ZXMPcnj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Cash at beginning of year</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">2,895,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="letter-spacing: -0.1pt">2,291,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iE_pp0p0" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Cash at end of period</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">6,703,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">2,795,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AE_zOCpvyu6hNq8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
SINGING MACHINE COMPANY, INC AND SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
31, 2023, and March 31, 2023 and 2022</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
Singing Machine Company, Inc. and Subsidiaries</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONDENSED
CONSOLIDATED STATEMENTS OF SHAREHOLDERS&#8217; EQUITY </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For
the nine months ended December 31, 2023 and 2022 (unaudited) </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<p id="xdx_896_eus-gaap--ScheduleOfStockholdersEquityTableTextBlock_zCW1DqARj325" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BE_zvYf1K7G3G04">SCHEDULE
OF CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS&#8217; EQUITY </span><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--StatementOfStockholdersEquityAbstract_pn3n3_zxyrKaMhy6f1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SCHEDULE OF CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS? EQUITY (Details)">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Shares</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B2_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zEtMtgSm2zZ8" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Amount</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B5_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_zAxMPGS8fGRg" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Capital</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4BB_us-gaap--StatementEquityComponentsAxis_us-gaap--ReceivablesFromStockholderMember_zCLULKo1u7T5" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Receivable</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B2_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zuAhdj1FY41h" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Deficit</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4BC_zScqmt4y1DSg" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Total</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Common Stock</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center">Additional Paid in</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center">Subscriptions</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center">Accumulated</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Shares</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Amount</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Capital</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Receivable</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Deficit</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Total</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_430_c20230401__20231231_eus-gaap--StockholdersEquity_iS_z15MFfvx8tte" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; width: 40%; text-align: left">Balance at March 31, 2023</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--SharesOutstanding_iS_c20230401__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zowtBJASZVCh" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Balance, shares">3,167,488</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span style="letter-spacing: -0.1pt">32,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span style="letter-spacing: -0.1pt">29,822,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right">(6,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right">(19,517,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right">10,331,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--ProfitLoss_zljSGiBzflMd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Net loss</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3162">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3163">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3164">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(6,398,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(6,398,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_408_eus-gaap--StockIssuedDuringPeriodValueNewIssues_zuXpPoKfvDuh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Issuance of common stock, net of stock offering costs</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230401__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zHs66oERJF77" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Issuance of common stock, net of stock offering costs, shares">3,250,573</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">32,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3,497,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3170">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3171">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3,529,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--ShareBasedCompensation_zAD96sTcLV4c" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Stock based compensation</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensation_c20230401__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zetVtSdvzZK1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock based compensation ,shares"><span style="-sec-ix-hidden: xdx2ixbrl3182">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3176">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">110,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3178">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3179">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">110,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--StockIssuedDuringPeriodValueOther_zwMG12wIkAC4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Other</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesOther_c20230401__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zVRpaFXW54eb" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Other, shares"><span style="-sec-ix-hidden: xdx2ixbrl3190">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3184">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3185">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">6,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3187">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">6,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_43A_c20230401__20231231_eus-gaap--StockholdersEquity_iE_z9PBjMd6zXs8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">&#160;Balance at December 31, 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--SharesOutstanding_iE_c20230401__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zoqWMShhrePd" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Balance, shares">6,418,061</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">64,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">33,429,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3194">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(25,915,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">7,578,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Common Stock</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center">Additional Paid in</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center">Subscriptions</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center">Accumulated</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Shares</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Amount</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Capital</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Receivable</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Deficit</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Total</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_430_c20220401__20221231_eus-gaap--StockholdersEquity_iS_zycTCV8uqA29" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; width: 40%; text-align: left">Balance at March 31, 2022</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--SharesOutstanding_iS_c20220401__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zdlm0MkAosCh" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Balance, shares">1,221,209</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right">12,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right">24,903,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right">&#160;&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl3202">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right">(14,879,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right">10,036,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_436_c20220401__20221231_eus-gaap--StockholdersEquity_iS_zojW5XrXZ977" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Balance, value</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--SharesOutstanding_iS_c20220401__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zwTA0nkfmV2a" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Balance, shares">1,221,209</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">12,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">24,903,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl3210">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(14,879,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">10,036,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--ProfitLoss_zkUmFtmEA8h2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Net loss</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3216">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3217">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3218">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(1,653,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(1,653,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_408_eus-gaap--StockIssuedDuringPeriodValueNewIssues_zqnTAwvBYPt5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Issuance of common stock and warrants, net of stock offering costs</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220401__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zJ1CYS2FTsP5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Issuance of common stock and warrants, net of stock offering costs, shares">1,909,519</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">19,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">4,489,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3224">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3225">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">4,508,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--ShareBasedCompensation_z20q0lgt0B88" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Stock based compensation</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensation_c20220401__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zDSwTyperGsd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock based compensation ,shares">15,803</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3230">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">307,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3232">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3233">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">307,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--StockIssuedDuringPeriodValueOther_zVfoPv7TlHG9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Other</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--StockIssuedDuringPeriodSharesOther_c20220401__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zqFQDez6fl4" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Other, shares">1,688</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3238">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(1,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3240">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">1,000</p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3242">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_430_c20220401__20221231_eus-gaap--StockholdersEquity_iE_zuIEPlPLRTZe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Balance at December 31, 2022 (unaudited)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--SharesOutstanding_iE_c20220401__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zVm7Ha1dRStd" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Balance, shares">3,148,219</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">31,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">29,698,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3248">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(16,531,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">13,198,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_43D_c20220401__20221231_eus-gaap--StockholdersEquity_iE_z9aej9Q95ur6" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Balance, value</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--SharesOutstanding_iE_c20220401__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zsOmskrUNKS" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Balance, shares">3,148,219</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">31,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">29,698,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3256">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(16,531,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">13,198,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8AF_zjOG8MKLoXzl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_003"></span>Report
of Independent Registered Public Accounting Firm</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the Shareholder and the Board of Directors of</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SemiCab,
Inc.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Opinion
on the Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have audited the accompanying consolidated balance sheet of SemiCab, Inc. (the &#8220;Company&#8221;) as of December 31, 2023 and 2022,
and the related consolidated statements of operations and comprehensive loss, stockholders&#8217; equity and cash flows for the years
then ended, and the related notes (collectively referred to as the &#8220;financial statements&#8221;). In our opinion, the financial
statements present fairly, in all material respects, the financial position of the Company as of December 31, 2023 and 2022, and the
results of its operations and its cash flows for the years then ended in conformity with accounting principles generally accepted in
the United States of America.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GOING
CONCERN</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying financial statements have been prepared assuming that the Company will continue as a going concern. The Company has suffered
substantial net losses and negative cash flows from operations in recent years and is dependent on debt and equity financing to fund
its operations, all of which raise substantial doubt about the Company&#8217;s ability to continue as a going concern. Management&#8217;s
plans regarding these matters have also been reviewed and considered. The consolidated financial statements do not include any adjustments
that might result from the outcome of this uncertainty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>BASIS
FOR OPINION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on these financial
statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United
States) (&#8220;PCAOB&#8221;) and are required to be independent with respect to the Company in accordance with the U.S. federal securities
laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company
is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits,
we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion
on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or
fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding
the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant
estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides
a reasonable basis for our opinion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Critical
Audit Matters</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Critical
audit matters are matters arising from the current period audit of the financial statements that were communicated or required to be
communicated to the audit committee and that (1) relate to accounts or disclosures that are material to the financial statements and
(2) involved our especially challenging, subjective, or complex judgements. We determined that there are no critical audit matters.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/Bush
&amp; Associates CPA LLC</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have served as the Company&#8217;s auditor since 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Henderson,
Nevada</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
11, 2024</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p id="xdx_04C_c20230101__20231231_zrvfceZOHjc8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_119_hdei--LegalEntityAxis__custom--SemiCabIncMember_zGg4NCqpbXSb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SemiCab,
Inc. </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_001"></span>CONSOLIDATED
BALANCE SHEETS </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30A_111_zPmv06O0r6Pa" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Statement - Condensed Consolidated Balance Sheets">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_492_20231231_zrE5FecPErqb" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20221231_z8DHPHx0oLB6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--AssetsAbstract_iB_zKIBsk4SAO89" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-decoration: underline; text-align: center">Assets</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--AssetsCurrentAbstract_i01B_zK9yhLCH8r7h" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Current Assets</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--Cash_i02I_zb6S1TMj4vcj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; padding-left: 10pt">Cash</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">72,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">881,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--AccountsReceivableNet_i02I_zKQWliMrvw1h" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt">Accounts receivable</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">494,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">677,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--RefundDueFromCustomer_i02I_zCarpsXD6RFj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt">Refund due from customer</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">143,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3275">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_i02I_zI047hNyjXYf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 10pt">Prepaid Expenses and other current assets</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">5,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">8,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--AssetsCurrent_i02TI_zJuxdfOibgel" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 20pt">Total Current Assets</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">714,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,566,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--PropertyPlantAndEquipmentNet_i01I_zHyFNFQjvHmi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Property and equipment, net</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">4,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--OtherAssetsNoncurrent_i01I_z0EeEEGUzOJ2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Other non-current assets</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">14,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">14,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--Assets_i01TI_z8ZMyA5JgxRb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt; padding-left: 20pt">Total Assets</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">731,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">1,584,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--LiabilitiesAndStockholdersEquityAbstract_iB_z2iSexEs1oO" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-decoration: underline; text-align: center">Liabilities and Shareholders&#8217; Equity</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--LiabilitiesCurrentAbstract_i01B_zbAZzCqRzV8b" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Current Liabilities</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--AccountsPayableCurrent_i02I_z1i9d2bKJjfj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt">Accounts payable</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">668,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">810,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--AccruedLiabilitiesCurrent_i02I_zsOCocUIMzxc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt">Accrued expenses</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">149,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">151,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--NotesPayableCurrent_i02I_zgOgEjgiKXa3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt">Notes payable</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">833,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">579,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--LoansPayableCurrent_i02I_z8yBfgcYEyh4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt">Loans from affiliates, current portion</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">315,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3308">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--ContractWithCustomerRefundLiabilityCurrent_i02I_zWHPZlDVxlE4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt">Due to factor</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">231,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3311">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--OtherLiabilitiesCurrent_i02I_zoxTabAfqCl8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 10pt">Other current liabilities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">45,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">108,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--LiabilitiesCurrent_i02TI_zNvoUx6cSBC3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 20pt">Total Current Liabilities</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2,241,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,648,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--LongTermLoansPayable_i01I_zJGecqNnFaX7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Loans from affiliates, net of current portion</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">385,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">385,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--Liabilities_i01TI_z2iisP21K2f6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 20pt">Total Liabilities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">2,626,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">2,033,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--CommitmentsAndContingenciesAbstract_i01B_zaSounIA6tR7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Commitments and Contingencies</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--ProvisionForLegalLiability_i02I_zkIvvdnfpUfa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt">Provision for legal liability</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">275,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3329">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--CommitmentsAndContingencies_i02TI_zmnccElb5Bmc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 20pt">Total Commitments and Contingencies</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">275,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3332">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--StockholdersEquityAbstract_i01B_zIshhRihLkT7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Shareholders&#8217; Equity</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--PreferredStockValue_i02I_zdpWeDq6BjDe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt">Preferred equity</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">5,969,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">5,543,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--RetainedEarningsAccumulatedDeficit_i02I_zc4U46jdpzCl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 10pt">Accumulated deficit</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(8,139,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(5,992,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_408_eus-gaap--StockholdersEquity_i02TI_z52VlWxqUVJi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 20pt">Total Shareholders&#8217; Equity</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(2,170,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(449,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_407_eus-gaap--LiabilitiesAndStockholdersEquity_i01TI_zh8uMqYx0Yu" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt; padding-left: 20pt">Total Liabilities and Shareholders&#8217; Equity</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">731,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">1,584,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>See
notes to condensed consolidated statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SemiCab,
Inc. </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_002"></span>CONDENSED
CONSOLIDATED STATEMENTS OF OPERATIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30F_113_zJtpNz3FXg4b" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Statement - Condensed Consolidated Statements of Operations">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49A_20230101__20231231_zCEXlSlfj0Ih" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_494_20220101__20221231_zF3FdCZxDmBh" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Years Ended</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zg3FPhfgl7kk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; width: 60%; text-align: left">Net Revenue</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">6,036,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">9,655,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--CostOfGoodsAndServicesSold_zq51xC47RFmi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">Cost of Revenue</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">5,853,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">10,108,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--GrossProfit_iT_zCZYLWrSxx37" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Gross Profit (Loss)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">183,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(453,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--OperatingExpensesAbstract_iB_zAjFbtufdk9d" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Operating Expenses</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--SellingExpense_i01_zrhAAMCV0484" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Selling general and administrative expenses</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,333,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,511,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--ProductDevelopmentExpense_i01_zGDS6aa3SYBb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; padding-left: 10pt; text-align: left">Product development</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">852,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">640,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--OperatingExpenses_i01T_zMpafX2Fbt5l" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">Total Operating Expenses</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">2,185,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">2,151,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--OperatingIncomeLoss_iT_za4ce2RczYDl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Loss from Operations</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(2,002,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(2,604,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--NonoperatingIncomeExpenseAbstract_iB_zUIlgAQLBRR3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Other Expenses</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--InterestExpenseDebtExcludingAmortization_i01N_di_zprLXpXrW1Aj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; padding-left: 10pt; text-align: left">Interest expense</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(145,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(63,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_403_eus-gaap--NonoperatingIncomeExpense_i01T_zjtmmPcki4Mg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">Total Other Expenses</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(145,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(63,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iT_zc5Yt981FuBl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Loss Before Income Tax Benefit (Provision)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(2,147,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(2,667,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--IncomeTaxExpenseBenefit_iN_di_zSUE7npCtSBh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">Income Tax Benefit (Provision)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3385">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3386">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--ProfitLoss_iT_zLvmfvvdseZ6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">Net Loss</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(2,147,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(2,667,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>See
notes to condensed consolidated statements</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_DisclosureSupplementalInformationCondensedFinancialInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_DisclosureSupplementalInformationCondensedFinancialInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_SupplementalInformationDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Supplemental Information Disclosures [Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_SupplementalInformationDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>177
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035311335936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTS RECEIVABLE<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=RIME_SemiCabIncMember', window );">Semi Cab Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsAndNontradeReceivableTextBlock', window );">ACCOUNTS RECEIVABLE</a></td>
<td class="text"><p id="xdx_80F_eus-gaap--AccountsAndNontradeReceivableTextBlock_zVpryh8ylkhh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
4 &#8211; <span id="xdx_822_zeyZTwlK6GR9">ACCOUNTS RECEIVABLE</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
receivable are carried at original amount less an estimate made for doubtful receivables based on a review of all outstanding amounts
on a monthly basis. Management determines the allowance for doubtful receivables by regularly evaluating individual customer receivables
and considering a customer&#8217;s financial condition, credit history, and current economic conditions. Accounts receivable are written
off when deemed uncollectible. Accounts receivable at December 31, 2023 and 2022 consisted of the following: $<span id="xdx_906_eus-gaap--AccountsReceivableNet_iI_c20231231_zlNbTT3bb76h" title="Accounts receivable, net">494,000</span> and $<span id="xdx_908_eus-gaap--AccountsReceivableNet_iI_c20221231_zU2dKl4oUvqh" title="Accounts receivable, net">677,000</span>, all
due from large, US-based manufacturers for shipping services provided by the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bad
debt expenses (if any) are recorded in selling, general, and administrative expense.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
allowance for doubtful accounts for the years ended December 31, 2023 and 2022 is as follows: This has historically been set at $<span id="xdx_901_eus-gaap--ProvisionForDoubtfulAccounts_c20230101__20231231_zfOdHeazxahe" title="Allowance for doubtful accounts"><span id="xdx_901_eus-gaap--ProvisionForDoubtfulAccounts_c20220101__20221231_zhDsyhw7b8th" title="Allowance for doubtful accounts">0</span></span>, as
the Company has not previously recorded any losses due to bad debt.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsAndNontradeReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts receivable, contract receivable, receivable held-for-sale, and nontrade receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/310/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/326/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsAndNontradeReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=RIME_SemiCabIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=RIME_SemiCabIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>178
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035033241840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTS PAYABLE AND ACCRUED EXPENSES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=RIME_SemiCabIncMember', window );">Semi Cab Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">ACCOUNTS PAYABLE AND ACCRUED EXPENSES</a></td>
<td class="text"><p id="xdx_80F_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_z2UNyz13Ru0f" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
6 &#8211; <span id="xdx_823_zcUwkXLrXqm2">ACCOUNTS PAYABLE AND ACCRUED EXPENSES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
payable and accrued liabilities consisted of the following as of December 31: $<span id="xdx_908_eus-gaap--AccountsPayableCurrent_iI_c20231231_zGXzS11qlwt3" title="Vendors expenses payable">668,000</span> in vendors expenses payable, primarily for shipping
services, and $<span id="xdx_900_eus-gaap--AccruedLiabilitiesCurrent_iI_c20231231_zdzT7CfE9he8" title="Accrued expenses">149,000</span> in accrued expenses, primarily for accrued payroll and interest expenses payable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 720<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483384/720-30-45-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=RIME_SemiCabIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=RIME_SemiCabIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>179
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035125254352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTES PAYABLE AND FINANING ARRANGEMENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=RIME_SemiCabIncMember', window );">Semi Cab Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_NotePayableAndFinancingArrangementsTextBlock', window );">NOTES PAYABLE AND FINANING ARRANGEMENTS</a></td>
<td class="text"><p id="xdx_80A_ecustom--NotePayableAndFinancingArrangementsTextBlock_zN22Pp3Pw6p5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
7 &#8211; <span id="xdx_82A_z0pezUGdYowb">NOTES PAYABLE AND FINANING ARRANGEMENTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Efficient
Capital Labs Installment Note &amp; Settlement</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 18, 2023 the Company entered into a financing arrangement with Efficient Capital Labs, Inc. (&#8220;ECL&#8221;) to finance working
capital and product development. The loan had a <span id="xdx_901_eus-gaap--DebtInstrumentMaturityDateDescription_c20230518__20230518__dei--LegalEntityAxis__custom--EfficientCapitalLabsIncMember_ztGUt31qVFR1" title="Maturity date, description">12-month maturity date</span>. Repayments were originally scheduled to begin in June 2023, in
equal installments of $<span id="xdx_90A_eus-gaap--RepaymentsOfDebt_pp2d_c20230518__20230518__dei--LegalEntityAxis__custom--EfficientCapitalLabsIncMember__us-gaap--DebtInstrumentAxis__custom--EqualInstallmentsForThirteenMonthsMember_zD2EaSEjCYT9" title="Repayment, debt">91,667.67</span> for 13 months, with an interest rate of <span id="xdx_906_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20230518__dei--LegalEntityAxis__custom--EfficientCapitalLabsIncMember__us-gaap--DebtInstrumentAxis__custom--EqualInstallmentsForThirteenMonthsMember_zQ9V9sZX9UMc" title="Interest rate">17.97</span>%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 18, 2024, the Company entered into a Settlement Agreement (&#8220;Settlement&#8221;) with ECL. In the Settlement, the Company agreed
to repay a total of $<span id="xdx_905_eus-gaap--RepaymentsOfDebt_pp2d_c20240518__20240518__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember__us-gaap--DebtInstrumentAxis__custom--TwelveInstallmentsMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zKLZ4acK3Bl7" title="Repayment, debt">946,666.60</span> in 12 installments. The first payment in the amount of $<span id="xdx_909_eus-gaap--RepaymentsOfDebt_c20240518__20240518__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember__us-gaap--DebtInstrumentAxis__custom--FirstPaymentMember__us-gaap--AwardDateAxis__custom--DueAndPaidOnMayTwentyTwoThousandTwentyFourMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_za7rIbSzBCD3" title="Repayment, debt">25,000</span> was due and paid on May 20, 2024. A second
payment in the amount of $<span id="xdx_902_eus-gaap--RepaymentsOfDebt_c20240518__20240518__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember__us-gaap--DebtInstrumentAxis__custom--SecondPaymentMember__us-gaap--AwardDateAxis__custom--DueOnJuneThreeTwoThousandTwentyFourMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zZSHUAGoYguf" title="Repayment, debt">75,000</span> is due on June 3, 2024. Thereafter, ten monthly payments are due on the first day of each month starting
on July 1, 2024 in the amount of $<span id="xdx_90C_eus-gaap--RepaymentsOfDebt_pp2d_c20240518__20240518__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember__us-gaap--DebtInstrumentAxis__custom--TenMonthlyPaymentsMember__us-gaap--AwardDateAxis__custom--DueOnJulyOneTwoThousandTwentyFourMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zSnWPftc6NPh" title="Repayment, debt">84,666.66</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shareholder
Notes </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_890_eus-gaap--ScheduleOfDebtTableTextBlock_zjVs3uuodTWd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beginning
in July of 2021, and ending in May of 2023, the Company entered into a total of six shareholder loan agreements with a total of three
shareholders. These notes are all unsecured with limited rights of recourse. The specific terms of each note are summarized on the table
below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span id="xdx_8B6_zpz2rEc3RS87" style="display: none">SCHEDULE OF SPECIFIC TERMS</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif">Date</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Maturity</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Holder</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Principal</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Rate</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Accrued Interest</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Current Balance</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 12%"><span id="xdx_909_eus-gaap--DebtInstrumentIssuanceDate1_c20210710__20210710__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zMxeSg9oDMpc" title="Date">7/10/2021</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: center"><span id="xdx_90D_eus-gaap--DebtInstrumentMaturityDate_c20210710__20210710__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zF3FgAPQLLs" title="Maturity">7/10/2026</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: center">Ajesh Kapoor</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pp2d_c20210710__20210710__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zZUUQwVGwcHh" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Principal">150,000.00</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span id="xdx_908_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20210710__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zvdo8UoOZZx9" title="Rate">9.0</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--DebtInstrumentPeriodicPaymentInterest_pp2d_c20210710__20210710__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zbXg08gQ3suc" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Accrued Interest">36,838.36</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--DebtInstrumentPeriodicPayment_pp2d_c20210710__20210710__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zsCuIFPy3W18" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Current Balance">186,838.36</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90E_eus-gaap--DebtInstrumentIssuanceDate1_c20210827__20210827__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_z3zQ7dE44r28" title="Date">8/27/2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90B_eus-gaap--DebtInstrumentMaturityDate_c20210827__20210827__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_z82UfKP6YOJ5" title="Maturity">8/26/2026</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">Ajesh Kapoor</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98C_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pp2d_c20210827__20210827__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zc0bFz2i6mR2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">235,000.00</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20210827__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zSkUfAtXdMv4" title="Rate">9.0</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_986_eus-gaap--DebtInstrumentPeriodicPaymentInterest_pp2d_c20210827__20210827__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zyMUpXy8YYF9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accrued Interest">54,932.05</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_984_eus-gaap--DebtInstrumentPeriodicPayment_pp2d_c20210827__20210827__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zZio3ImCnja9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Current Balance">289,932.05</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90B_eus-gaap--DebtInstrumentIssuanceDate1_c20230417__20230417__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--VivekSehgalMember_zuBVgiyGuJ15" title="Date">4/17/2023</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_c20230417__20230417__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--VivekSehgalMember_zL93Kx1OE147" title="Maturity">10/16/2023</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">Vivek Sehgal</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98C_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pp2d_c20230417__20230417__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--VivekSehgalMember_zDVy2qwrrGsl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">50,000.00</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20230417__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--VivekSehgalMember_zTOgp5Ja2CT5" title="Rate">10.0</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_980_eus-gaap--DebtInstrumentPeriodicPaymentInterest_pp2d_c20230417__20230417__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--VivekSehgalMember_zJpj5JUzaJu9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accrued Interest">4,794.52</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_983_eus-gaap--DebtInstrumentPeriodicPayment_pp2d_c20230417__20230417__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--VivekSehgalMember_zh9u9wekat1l" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Current Balance">54,794.52</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_905_eus-gaap--DebtInstrumentIssuanceDate1_c20230505__20230505__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zMh3trEJXS61" title="Date">5/5/2023</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_907_eus-gaap--DebtInstrumentMaturityDate_c20230505__20230505__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_z7GsuQ7ZTXE6" title="Maturity">5/4/2024</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">Ajesh Kapoor</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_983_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pp2d_c20230505__20230505__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zHucpzqngjnf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">50,000.00</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20230505__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_z9J0SLMyNfyj" title="Rate">10.0</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_989_eus-gaap--DebtInstrumentPeriodicPaymentInterest_pp2d_c20230505__20230505__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zBd3J4sMd0gj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accrued Interest">4,547.95</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_986_eus-gaap--DebtInstrumentPeriodicPayment_pp2d_c20230505__20230505__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zKRkUjy3cc0d" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Current Balance">54,547.95</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90E_eus-gaap--DebtInstrumentIssuanceDate1_c20230508__20230508__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--JaganReddyMember_zLITNj5tRMZa" title="Date">5/8/2023</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_902_eus-gaap--DebtInstrumentMaturityDate_c20230508__20230508__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--JaganReddyMember_zydI6JVpUaEg" title="Maturity">5/7/2024</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">Jagan Reddy</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98E_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pp2d_c20230508__20230508__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--JaganReddyMember_z1dk5xlV6Vwg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">50,000.00</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_906_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20230508__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--JaganReddyMember_zz4lr1bk8xv9" title="Rate">10.0</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_982_eus-gaap--DebtInstrumentPeriodicPaymentInterest_pp2d_c20230508__20230508__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--JaganReddyMember_zf95chdqpBLk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accrued Interest">4,506.85</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_985_eus-gaap--DebtInstrumentPeriodicPayment_pp2d_c20230508__20230508__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--JaganReddyMember_zSau5oqdc87g" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Current Balance">54,506.85</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_906_eus-gaap--DebtInstrumentIssuanceDate1_c20230517__20230517__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zsEPMwAukQa6" title="Date">5/17/2023</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_c20230517__20230517__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zeLWdCc3sYbj" title="Maturity">5/16/2024</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">Ajesh Kapoor</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_980_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pp2d_c20230517__20230517__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zHrzrv6MhQhj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">165,000.00</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20230517__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zNKVAz1OIPvb" title="Rate">10.0</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_984_eus-gaap--DebtInstrumentPeriodicPaymentInterest_pp2d_c20230517__20230517__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_z286zhnhOtD3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accrued Interest">14,465.75</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98E_eus-gaap--DebtInstrumentPeriodicPayment_pp2d_c20230517__20230517__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zxgJ2W2cOTQ6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Current Balance">179,465.75</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A5_zSrte5fz5LGf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>MCA-Agile
Capital Funding, LLC</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 22, 2024, the Company entered into a Merchant Cash Advance (&#8220;MCA Financing&#8221;) with Agile Capital Funding, LLC. The initial
amount borrowed was $<span id="xdx_90D_eus-gaap--ShortTermBorrowings_iI_c20240322__dei--LegalEntityAxis__custom--AgileCapitalFundingLLCMember_zPJrmtBqeIZd" title="Initial amount, borrowed">315,000</span>, with net proceeds to the Company in the amount of $<span id="xdx_90C_eus-gaap--ProceedsFromIssuanceOfDebt_c20240322__20240322__dei--LegalEntityAxis__custom--AgileCapitalFundingLLCMember_ztfDwHiB7NTa" title="Net proceeds">300,000</span>. Repayment terms stipulate weekly payments in
the amount of $<span id="xdx_906_eus-gaap--RepaymentsOfDebt_c20240322__20240322__us-gaap--DebtInstrumentAxis__custom--WeeklyPaymentsForWeeksMember__dei--LegalEntityAxis__custom--AgileCapitalFundingLLCMember_zkIqnUbeukB7" title="Repayment, debt">16,200</span> for weeks, for a total of $<span id="xdx_90A_eus-gaap--RepaymentsOfDebt_c20240322__20240322__dei--LegalEntityAxis__custom--AgileCapitalFundingLLCMember_zWKYumNYiJ98" title="Repayment, debt">453,600</span> repaid. The effective interest rate for the borrowings is <span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_uPure_c20240322__dei--LegalEntityAxis__custom--AgileCapitalFundingLLCMember_z3G1Hwg6XVU2" title="Effective, interest rate">18</span>%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>MCA-Huson
Cedar Advance, LLC</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 8, 2024, the Company entered into an MCA Financing with Cedar Advance, LLC. The initial amount borrowed was $<span id="xdx_90D_eus-gaap--ShortTermBorrowings_iI_c20240508__dei--LegalEntityAxis__custom--HusonCedarAdvanceLLCMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zmsFCSFX66nh" title="Initial amount, borrowed">215,000</span>, with net proceeds
to the Company in the amount of $<span id="xdx_903_eus-gaap--ProceedsFromIssuanceOfDebt_c20240508__20240508__dei--LegalEntityAxis__custom--AgileCapitalFundingLLCMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zWf6Gw7Kh7sk" title="Net proceeds">204,250</span>. Repayment terms stipulate weekly payments in the amount of $<span id="xdx_901_eus-gaap--RepaymentsOfDebt_c20240508__20240508__us-gaap--DebtInstrumentAxis__custom--WeeklyPaymentsMember__dei--LegalEntityAxis__custom--HusonCedarAdvanceLLCMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zvIZ99bgwdBc" title="Repayment, debt">11,133</span> for 28 weeks, for a total
of $<span id="xdx_904_eus-gaap--RepaymentsOfDebt_c20240508__20240508__dei--LegalEntityAxis__custom--HusonCedarAdvanceLLCMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zyqCIgiTHWP1" title="Repayment, debt">311,750</span> repaid. The effective interest rate for the borrowings is <span id="xdx_903_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_uPure_c20240508__dei--LegalEntityAxis__custom--AgileCapitalFundingLLCMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z12Z4Wp4lZii" title="Effective, interest rate">18</span>%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_NotePayableAndFinancingArrangementsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Note Payable And Financing Arrangements [Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_NotePayableAndFinancingArrangementsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=RIME_SemiCabIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=RIME_SemiCabIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>180
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035117037328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DUE FROM FACTOR<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=RIME_SemiCabIncMember', window );">Semi Cab Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_AccountsReceivableDisclosureTextBlock', window );">DUE FROM FACTOR</a></td>
<td class="text"><p id="xdx_807_ecustom--AccountsReceivableDisclosureTextBlock_z2TQ6gZjtLQa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
9 - <span id="xdx_822_z9VUFgefS8i7">DUE FROM FACTOR</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
entered into an accounts receivable factoring arrangement with a financial institution (the &#8220;Factor&#8221;) which has been extended
to October 31, 2024 and may be discontinued at that time. Pursuant to the terms of the arrangement, from time to time, we sell to the
Factor a minimum of $<span id="xdx_902_eus-gaap--AccountsReceivableNet_iI_c20240331__srt--RangeAxis__srt--MinimumMember_zMEZ7d7jYdLc" title="Accounts receivable">150,000</span> per quarter of certain of our accounts receivable balances on a non-recourse basis for credit approved accounts.
The <span id="xdx_902_ecustom--ForeignAndDomesticRateOfAccountsReceivable_c20240101__20240331_zcUMJeQOsJbb" title="Accounts receivable rate, description">Factor remits 35% of the foreign and 75% of the domestic accounts receivable balance</span> to us (the &#8220;Advance Amount&#8221;), with
the remaining balance, less fees, forwarded to us once the Factor collects the full accounts receivable balance from the customer. In
addition, from time to time, we receive over advances from the Factor. Factoring fees range from <span id="xdx_906_ecustom--AdvanceFeeRate_pid_dp_uPure_c20240101__20240331__srt--RangeAxis__srt--MinimumMember_zM84KYSyuAt7" title="Advance fee, rate">2.75</span>% to <span id="xdx_906_ecustom--AdvanceFeeRate_pid_dp_uPure_c20240101__20240331__srt--RangeAxis__srt--MaximumMember_zh6r6lG6zNmh" title="Advance fee, rate">15</span>% of the face value of the
invoice factored and are determined by the number of days required for collection of the invoice. We expect to continue to use this factoring
arrangement periodically to assist with our general working capital requirements due to contractual requirements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>LEGAL
MATTERS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 28, 2024, SemiCab was sued by a Baxter Bailey, collection agency acting on behalf of a domestic freight shipper. The shipper claims
is was underpaid for services rendered, and SemiCab has disputed the claim. The total amount in dispute is approximately $<span id="xdx_90C_eus-gaap--LegalFees_c20240528__20240528_zq4v3oh80Beg" title="Dispute, amount">93,000</span>. SemiCab
intends to dispute the claim. As such, this litigation has been excluded from liabilities assumed as part of this transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>LEASES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Operating
Leases</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable. The Company currently utilizes a work-from-home model for its US operations, and a month-to-month shared office space in
Bangalore that expires in June. At that time 100% of the current employees will adopt a work-from-home model.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Finance
Leases</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable. The Company does not have any material financial leases at this time, or any of the periods presented in this Report.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_AccountsReceivableDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accounts Receivable Disclosure [Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_AccountsReceivableDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=RIME_SemiCabIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=RIME_SemiCabIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>181
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035112437152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS&#8217; EQUITY<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">STOCKHOLDERS&#8217; EQUITY</a></td>
<td class="text"><p id="xdx_80E_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zG6alrsOQtU9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
10 &#8211; <span id="xdx_824_z8pagMj79AEl">ISSUANCE OF COMMON STOCK</span></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Equity
Incentive Plan</i></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-redline: true">On
April 12, 2022, the Board of Directors approved The Singing Machine Company, Inc. 2022 Equity Incentive Plan, or the 2022 Plan. The 2022
Plan provides for the issuance of equity incentive awards, such as stock options, stock appreciation rights, stock awards, restricted
stock, stock units, performance awards and other stock or cash-based awards collectively, the &#8220;Awards.&#8221; Awards may be granted
under the 2022 Plan to the Company&#8217;s employees, officers, directors, consultants, agents, advisors and independent contractors.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-redline: true">There
were <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20240101__20240930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zisABCkgWfN5" title="Share base compensation issued shares"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20240701__20240930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zYmZnZZSrlZa" title="Share base compensation issued shares">150,943</span></span>
share base compensation awards issued under the 2022 Plan during the three and nine months ended September 30, 2024 with a weighted average grant date fair value of $<span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20240701__20240930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zWCjtrAmtrV4" title="Weighted average grant date fair value"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20240101__20240930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zC5QGhT1F8Jl" title="Weighted average grant date fair value">0.55</span></span> per share. There were <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_do_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zWOnrMwWdR3d" title="Share base compensation issued shares"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_do_c20230701__20230930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zeT29ymfHjz2" title="Share base compensation issued shares">no</span></span>
share base compensation awards issued under the 2022 Plan during the three and nine months ended September 30, 2023. There were <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20240701__20240930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zOw3t9YtHrDd" title="Share base compensation forfeited shares">1,250</span>
and <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20240101__20240930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zdE7JQ8gAsW6" title="Share base compensation forfeited shares">6,500</span>
shares forfeited during the three and nine months ended September 30, 2024, respectively. There were <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_do_c20230701__20230930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zchqtSocrl0g" title="Share base compensation forfeited shares"><span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_do_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zLyXbmnu4QZk" title="Share base compensation forfeited shares">no</span></span>
shares forfeited during the three and nine months ended September 30, 2023. As of September 30, 2024, there were <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20240930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zWe8aTwLyFg2" title="Number of shares available to issued">63,453</span>
shares available to be issued under the 2022 Plan.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-redline: true">Equity compensation under the 2022 Plan was approximately $<span id="xdx_905_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_c20240701__20240930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zU3Fq1TyUcEg" title="Equity compensation">101,000</span> and
$<span id="xdx_90C_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_c20240101__20240930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zR5IFzmkKCO9" title="Equity compensation">138,000</span> during the three and nine months ended September 30, 2024 and was expensed as a component of general administrative expenses
on the accompanying condensed consolidated statements of operations. As
of September 30, 2024, there was an unrecognized expense of approximately $<span id="xdx_907_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_c20240930_zdxlVYPGXUuh" title="Unrecognised expense">50,000</span> remaining on options currently vesting over time with
an approximate weighted average of <span id="xdx_906_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dc_c20240101__20240930_z3BAvLIP2v1a" title="Weighted average term">twelve months</span> remaining until these options are fully vested.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-redline: true">The
vested options as of September 30, 2024, had <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_do_c20240930_zqMbKMC4BkHh" title="Vested options intrinsic value">no</span> intrinsic value.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Other
Equity Compensation</i></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true">During
the three and nine months ended September 30, 2024, the Company issued <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardGross_c20240101__20240930_zfCdjqI40XQk">774,528
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock to three vendors for payment
of consulting services rendered and <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20240101__20240930_zzHpMV3yOXU6">94,340
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">for restricted shares of common stock to Vivek
Sehgal (a related party) as bonus compensation (See Note 5). The grant date fair value for all of these share issuances was approximately
$<span id="xdx_908_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20240101__20240930__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zSXLZymTeMUl">478,000
</span></span>and were expensed as a component of general and
administrative expenses on the accompanying condensed consolidated statements of operations during the three and nine months ended September
30, 2024. These shares vest immediately but must be held for a minimum of six months in accordance with Securities Exchange Commission
Rule 144.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=RIME_SemiCabIncMember', window );">Semi Cab Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">STOCKHOLDERS&#8217; EQUITY</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_809_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zPE0SCL9ZdW" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
10 &#8211; <span id="xdx_82B_zxYWXgk2KtZj">STOCKHOLDERS&#8217; EQUITY</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>EQUITY
INCCENTIVE PLAN</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has maintained an equity incentive plan since 2020. Under this plan, all employees have been eligible to received common stock
options as a part of their performance-based incentive compensation plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>COMMON
STOCK OPTIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89D_ecustom--ScheduleOfStockOptionIssuedTableTextBlock_zS4MKNLnlLo3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the years ended Dember 31, 2020, 2021 and 2022 the Company issued the following stock options, as shown below. No options were issued
in 2023 or 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span id="xdx_8B5_zQna3u5WPUSa" style="display: none">SCHEDULE OF STOCK OPTION ISSUED
DURING THE YEAR DECEMBER 31, 2020, 2021 AND 2022</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif">Holder</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">Granted Shares</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">Outstanding Awards</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">Grant Date</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">Exercise Price</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">Vesting Start Date</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">Vested Outstanding</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">Unvested</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">Date Fully Vested</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">Board Approval Date</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">Expiration Date</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: left">Sudhir Narasimhamurthy</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zkaVwWdoGg3" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Granted Shares">180,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zcr2MKz1AwFg" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Outstanding Awards">180,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span id="xdx_901_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z1PCe2WkmQMa" title="Granted Date">09-29-2020</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20201231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zEwHsyzEa6K4" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Exercise price">0.06</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span id="xdx_904_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z5ZXzIUpv5v2" title="Vesting Date">09-29-2020</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z1y1z4fUkMd9" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Vested Outstanding">180,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20201231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zjAJBNToTHb9" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Unvested">0</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zc9gMLKiRMSi" title="Date Fully Vested">09-29-2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span id="xdx_908_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z6c6IllFXpx7" title="Board Approval Date">09-28-2020</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zdfXa5VRylw9" title="Expiration Date">09-28-2030</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Sudhir Narasimhamurthy</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z3uCfygXvbR4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">50,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zQtKppP6tag2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">50,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_znDPUpqUbYw1" title="Granted Date">08-12-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20211231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zjCZBQdsmS37" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.06</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z5Wb3cLxzFP2" title="Vesting Date">09-01-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zvRymfYhav79" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding">33,333</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20211231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z430AXwdWbqa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested">16,667</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_ztFM8AbGO4z" title="Date Fully Vested">09-01-2025</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z8DY2FENLkba" title="Board Approval Date">08-12-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zaVtrIbr1jSa" title="Expiration Date">08-11-2031</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Sudhir Narasimhamurthy</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zdQxKgnCNhYl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">25,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zpCDH1mvMsFb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">25,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zOpcXghoINqd" title="Granted Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zkXP0xggFfQ4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.05</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zSKiAJqKuqb1" title="Vesting Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zNyEIkIRBfme" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding">12,500</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zbeugqboZ186" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested">12,500</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zCJz3cB56Coc" title="Date Fully Vested">05-02-2026</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zr8EiANorbQf" title="Board Approval Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z6JDYzFtRMFg" title="Expiration Date">05-01-2032</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Kadandale Srinivas Sudheer</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zQXre4LkNdsg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">600,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zZEPsi2Skxqd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">600,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20200101__20201231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zEog8Y6iMuMb" title="Granted Date">09-29-2020</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20201231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z8wAPlyTERF9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.06</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zZ1kQQCQyof3" title="Vesting Date">09-29-2020</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z19ywhQYgQYa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding">600,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20201231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zTe1UbNcWdQk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zbxETfbMaBLd" title="Date Fully Vested">09-29-2023</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z7eACM5ED3Ci" title="Board Approval Date">09-28-2020</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z0JG5iPR3Z17" title="Expiration Date">09-28-2030</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Kadandale Srinivas Sudheer</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20211231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_za98zzoEujK9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">100,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zE3JVBLazA0a" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">100,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90F_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20210101__20211231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z6eOXUUTjNrk" title="Granted Date">08-12-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20211231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zg6Nmo40glYd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.06</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zFeRQu9z9nq" title="Vesting Date">09-01-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z8tDJidvYA8g" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding">66,666</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20211231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zODHT2K3W2L3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested">33,334</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zJAqgSZbew21" title="Date Fully Vested">09-01-2025</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zMLmVAewjCL5" title="Board Approval Date">08-12-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zU0PUmZ171j1" title="Expiration Date">08-11-2031</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Kadandale Srinivas Sudheer</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zytGZ9hbU7ja" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">50,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zF4FHf7SRPXe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">50,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_904_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z8UbrhZ7O8t1" title="Granted Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zSYMGd9uqPca" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.05</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zbDudXMOICq9" title="Vesting Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zhW8YXZAWDZd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding">25,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zZRwBgBVHrud" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested">25,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z88nzqafXHq3" title="Date Fully Vested">05-02-2026</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_903_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zlGP0zcOyh0i" title="Board Approval Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zCz9iQ9aDTn8" title="Expiration Date">05-01-2032</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Vivek Sehgal</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zRpjmlZTOGX3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">4,000,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zcQvVn88Xlzd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">4,000,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20200101__20201231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zYn1HvGb2uE3" title="Granted Date">09-29-2020</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20201231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zwj20RpZTZ3l" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.06</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zcOJJxYF28v4" title="Vesting Date">09-29-2020</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zXMwES9jBJyk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding">4,000,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20201231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zR4OKdEJGYAe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_903_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zmG35jgQubc4" title="Date Fully Vested">09-29-2023</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z157ujDnNYy8" title="Board Approval Date">09-28-2020</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zGq4oFwd78C8" title="Expiration Date">09-28-2030</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Vivek Sehgal</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20211231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zhGKq280Xs45" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">200,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zO4iwkQvJbya" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">200,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90F_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20210101__20211231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zR91Gan7PQ68" title="Granted Date">08-12-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20211231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zv711yflLHw9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.06</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zv58Z1jTHlu2" title="Vesting Date">09-01-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zYD54Fb54DUi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding">133,333</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20211231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zvLyxMREXQyd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested">66,667</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zDqisXKWh0Ik" title="Date Fully Vested">09-01-2025</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z6BxPFgVriA2" title="Board Approval Date">08-12-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zVnMcREQ1i55" title="Expiration Date">08-11-2031</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Vivek Sehgal</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zDDZm2IDXNL3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">100,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zRghaqfb8pch" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">100,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90D_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zEAqpKDIUl87" title="Granted Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zqs3KXmqO1ua" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.05</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_901_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zZxxyoqlsdBi" title="Vesting Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zBKaGub0LWD9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding">50,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zfyYDo512rMa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested">50,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_906_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zGWF9B3Fc3tc" title="Date Fully Vested">05-02-2026</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zNCmcVOAIY4j" title="Board Approval Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zMd2fAXZF2Q1" title="Expiration Date">05-01-2032</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Rajiv Saxena</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__srt--TitleOfIndividualAxis__custom--RajivSaxenaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_znQO4mVSpOjk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">100,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--RajivSaxenaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zhBE7ZJA66Uh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">100,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20200101__20201231__srt--TitleOfIndividualAxis__custom--RajivSaxenaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zfqtIuMocDq4" title="Granted Date">09-29-2020</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20201231__srt--TitleOfIndividualAxis__custom--RajivSaxenaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z0V8spZqH7ca" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.06</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_904_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--RajivSaxenaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zOTob9Ez0zb3" title="Vesting Date">09-29-2020</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--RajivSaxenaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zAVzgpY3COkg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding">100,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20201231__srt--TitleOfIndividualAxis__custom--RajivSaxenaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zhi2QrpZRBBd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--RajivSaxenaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_ztcI3kL5i449" title="Date Fully Vested">09-29-2023</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--RajivSaxenaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zoEfGqJJHtcg" title="Board Approval Date">09-28-2020</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--RajivSaxenaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zXH5b5Qf8pAh" title="Expiration Date">09-28-2030</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Harsha Bhat</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z08HbgZ0X45g" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">180,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zbwUA0GCQ80h" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">180,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_906_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20200101__20201231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zXXdHjVSoRFj" title="Granted Date">09-29-2020</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20201231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zSUxLUAAlsU4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.06</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zoVMaEcY1RVj" title="Vesting Date">09-29-2020</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zrzYnC0SL8qb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding">180,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20201231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zzsVwuUkeghi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z8sd1sUXMfJ2" title="Date Fully Vested">09-29-2023</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zmgIWsiO9eX5" title="Board Approval Date">09-28-2020</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z2dyEezFF0Fa" title="Expiration Date">09-28-2030</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Harsha Bhat</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20211231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zDsyymcL05z2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">50,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z6wgdxcyHxT1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">50,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20210101__20211231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z9QO3uaAaEOh" title="Granted Date">08-12-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20211231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zaUkaL5fUYPe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.06</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_ze5s6G3w3q4f" title="Vesting Date">09-01-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zfoMrlWA3YA7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding">33,333</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20211231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zUgMjGfU0RTi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested">16,667</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_za3qr7dQi3Wa" title="Date Fully Vested">09-01-2025</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zsnSa1PIg8Te" title="Board Approval Date">08-12-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zskswrzDKQ09" title="Expiration Date">08-11-2031</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Harsha Bhat</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zNmCBODP5IDj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">25,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zMpSnEP1ymzd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">25,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zOzdi7J0AsDh" title="Granted Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zBKdxDK5waRe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.05</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zOv44xxlwtEl" title="Vesting Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z90kaRIoIGpc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding">12,500</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zztgEunYXoFa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested">12,500</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_903_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zMLrqEeSJIT1" title="Date Fully Vested">05-02-2026</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zM7zJ4LAPqY1" title="Board Approval Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z7W4b76MIqI5" title="Expiration Date">05-01-2032</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Jagan Reddy</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zKxeqlsABfBj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">4,000,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zCX04OMzsbj2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">4,000,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20200101__20201231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zOBUo3w8GC44" title="Granted Date">09-29-2020</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20201231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zLcOa2wApEZb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.06</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zKGRKrSA53dl" title="Vesting Date">09-29-2020</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zx3OEy8qgdm1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding">4,000,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20201231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zAjEkAZ5A27l" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zzqPH1Zy89ud" title="Date Fully Vested">09-29-2023</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zzxwfJY1pVfc" title="Board Approval Date">09-28-2020</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zBJeqN0tpsA5" title="Expiration Date">09-28-2030</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Jagan Reddy</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20211231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z1QNcWlp7339" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">200,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zBOhrCUX2hWh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">200,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20210101__20211231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z77tWXOWvbQf" title="Granted Date">08-12-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20211231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zWjsNE1gxH6a" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.06</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z3VGSbXqfnHd" title="Vesting Date">09-01-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zJnYSjGUYRq9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding">133,333</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20211231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zXigKW9A6dBd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested">66,667</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z2AXveCbVYM1" title="Date Fully Vested">09-01-2025</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zGx1kMBN6qMk" title="Board Approval Date">08-12-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_znMp1jOUxMRi" title="Expiration Date">08-11-2031</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Jagan Reddy</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zWnM7OtIcJl5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">100,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z3CLUQbelsd5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">100,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zaFrPzj34uy1" title="Granted Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zx2CNpSmQoI2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.05</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zSms9MSXoam1" title="Vesting Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zdyEfY0hMI0j" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding">50,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z2XI43Etedgl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested">50,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zTeiOccr6De4" title="Date Fully Vested">05-02-2026</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_901_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zTIQbZj7izOk" title="Board Approval Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zhcIPo9lJrnb" title="Expiration Date">05-01-2032</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Siddayya S Ganjal</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zLtHZXLIYXT2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">180,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zidPZtDo9f2l" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">180,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90D_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z64CelNZxK28" title="Granted Date">09-29-2020</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20201231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zZJN9c6A2Xz8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.06</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zji5tD9IWLJ7" title="Vesting Date">09-29-2020</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zEbslEd6W4Uk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding">180,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20201231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zC47cn7xpmB5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_903_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z81CfIvqcg07" title="Date Fully Vested">09-29-2023</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zZhwhGG9ylSl" title="Board Approval Date">09-28-2020</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zlETeoQnlBD6" title="Expiration Date">09-28-2030</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Siddayya S Ganjal</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zOeVWgDLd6bd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">50,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zO52qNDAB4j1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">50,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zQiPa3xVsHL6" title="Granted Date">08-12-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20211231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zp1TIwkcXPli" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.06</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_906_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zi1FCNFDnJ4a" title="Vesting Date">09-01-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zCxAMtrNrbwi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding">33,333</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20211231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zODWxdOOSXZ7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested">16,667</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zUelF2aoLGV" title="Date Fully Vested">09-01-2025</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zYRo89dsMIXc" title="Board Approval Date">08-12-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z26RMcgHAkZ2" title="Expiration Date">08-11-2031</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Siddayya S Ganjal</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z8GrwY1ZeiA8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">25,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z7PdBfdIQS8f" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">25,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_901_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zfZ2QJXel0R6" title="Granted Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zOLPYJnpSyB4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.05</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zDdmnDMrgNB1" title="Vesting Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z9jAQSeoce1j" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding">12,500</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zEU7k2yN2rrl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested">12,500</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_901_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zmKgANLDQ4C8" title="Date Fully Vested">05-02-2026</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_903_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zbrXvmpsk0o4" title="Board Approval Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zSN3SC32THb8" title="Expiration Date">05-01-2032</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Sunil Arora</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SunilAroraMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z7m9enW4i5Zi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">90,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--SunilAroraMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zsezXG1Sejg5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SunilAroraMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zkoYykwWriM4" title="Granted Date">09-29-2020</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20201231__srt--TitleOfIndividualAxis__custom--SunilAroraMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zPcaRvcX5Ww6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.06</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SunilAroraMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zLPcUvlsIyVc" title="Vesting Date">09-29-2020</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--SunilAroraMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zP0MdBecOlJ3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20201231__srt--TitleOfIndividualAxis__custom--SunilAroraMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zjtyFMbmjjM1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SunilAroraMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_znYKA3dyYKOa" title="Date Fully Vested">09-29-2023</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SunilAroraMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zfFmNNsb1id8" title="Board Approval Date">09-28-2020</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SunilAroraMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z5q5eI77xCTf" title="Expiration Date">09-28-2030</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Rajiv Virmani</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__srt--TitleOfIndividualAxis__custom--RajivVirmaniMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zAvTpweQTCkk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">500,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--RajivVirmaniMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zsPUxo7rXUVi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">500,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20200101__20201231__srt--TitleOfIndividualAxis__custom--RajivVirmaniMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zUixUnpBEey" title="Granted Date">09-29-2020</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20201231__srt--TitleOfIndividualAxis__custom--RajivVirmaniMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zYa1tFm2h7r2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.06</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--RajivVirmaniMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zGdB8F8Vpkw9" title="Vesting Date">09-29-2020</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--RajivVirmaniMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zzuDeP7iTWBh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding">500,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20201231__srt--TitleOfIndividualAxis__custom--RajivVirmaniMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_znbKyxGWlMO4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--RajivVirmaniMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z1ZhutZcDpOl" title="Date Fully Vested">09-29-2023</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--RajivVirmaniMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zHE0MGI0XA6c" title="Board Approval Date">09-28-2020</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--RajivVirmaniMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zrxbrYtV69t1" title="Expiration Date">09-28-2030</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Sudhindra Shenoy</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zJ4QWiC4caWb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">180,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zgmeBkw8F8j5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">180,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zv4BBKrvS86k" title="Granted Date">09-29-2020</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20201231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z9PEv9VWomrf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.06</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zcTu02LTXQD6" title="Vesting Date">09-29-2020</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zED81jMp6uo1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding">180,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20201231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zSpk753JhlNa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zDYoF6saLzQ6" title="Date Fully Vested">09-29-2023</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zRxbgV6riQIi" title="Board Approval Date">09-28-2020</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zSWz0ilcoDn9" title="Expiration Date">09-28-2030</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Sudhindra Shenoy</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zHiLjzV9s139" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">50,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zqncTIeeYlMi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">50,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z3Q7dMpXuPQl" title="Granted Date">08-12-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20211231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zqtXw6he9koe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.06</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z3EiXnMZUPVg" title="Vesting Date">09-01-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z4TqSghQCWf5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding">33,333</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20211231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zl9Dk6iCfNUc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested">16,667</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z3cBvBXDJ7sc" title="Date Fully Vested">09-01-2025</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zSxBfMKkqZRi" title="Board Approval Date">08-12-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zK2KmCBBBoJ8" title="Expiration Date">08-11-2031</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Sudhindra Shenoy</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zdwYncZrvV59" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">25,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zAJPR9VMuZJg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">25,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90B_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zjD8uIPJTn3j" title="Granted Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_ztFhqTbEQtJ1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.05</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_ztvHTgqFPMv6" title="Vesting Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zN9xWBjDSpSb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding">12,500</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z6ZIFhqGT8j9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested">12,500</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zKWPeT8HF9z5" title="Date Fully Vested">05-02-2026</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z8YAQ8UQsU22" title="Board Approval Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zSlZ99QVHP9b" title="Expiration Date">05-01-2032</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Antony Sunil</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zmI8FhHvmypd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">90,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zS427y4oyIgh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">90,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20200101__20201231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zS4jXqRIxdNa" title="Granted Date">09-29-2020</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20201231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zCK1E38zUGB9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.06</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zUchczNYa5jk" title="Vesting Date">09-29-2020</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zE9ia44VfIm6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding">90,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20201231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zx8POfK8Rcw6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zRbZddjh8Aue" title="Date Fully Vested">09-29-2023</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zszioAjv8Bqe" title="Board Approval Date">09-28-2020</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zDdDEeTDGbhi" title="Expiration Date">09-28-2030</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Antony Sunil</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20211231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zStQjTpTmw22" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">50,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zW3X4WBNgYxh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">50,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_906_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20210101__20211231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zLfMcMLcTXGh" title="Granted Date">08-12-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20211231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zkXLwkFMIA5d" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.06</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zPPj5PC7Ix7c" title="Vesting Date">09-01-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zliNQG0mUou2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding">33,333</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20211231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zpy0i9DTWivi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested">16,667</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zf06eLernOX8" title="Date Fully Vested">09-01-2025</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zMHa6AstZAy7" title="Board Approval Date">08-12-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z8VDq4AdhNN4" title="Expiration Date">08-11-2031</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Antony Sunil</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zt6Tew4XYJvg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">25,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zqEbpMITIlH1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">25,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90B_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zjQHGf6zSV6k" title="Granted Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zrl3HOXAcou1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.05</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_903_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zRPrkULN2mnh" title="Vesting Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zwE2jHb87Abd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding">12,500</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zodw1uxPgGnj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested">12,500</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_904_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zHnvDmjt5DJk" title="Date Fully Vested">05-02-2026</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zuQqZZQ4Bec5" title="Board Approval Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zyH5egEJfptj" title="Expiration Date">05-01-2032</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Tuleeka Nandy</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20211231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zGeQUPGVcqC9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">15,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zWREe5GJFG32" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20210101__20211231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zPlyc3UbVQ68" title="Granted Date">08-12-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20211231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zyg4qZYrT9Wa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.06</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_904_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z9Tm46w78EVl" title="Vesting Date">09-01-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zciUSx4cEKVe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20211231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zc5DVfnr44za" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_906_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zk9oh7ar75S1" title="Date Fully Vested">09-01-2025</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zqQR8gFyZZEa" title="Board Approval Date">08-12-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zCBYtFP5vVA1" title="Expiration Date">08-11-2031</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Tuleeka Nandy</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zbzyE7DKx0n5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">15,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zyPGwPl4LmOl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">15,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zNOHxOGAM5ql" title="Granted Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zIL7zRdfFmqg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.05</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zFT85c9TDdK8" title="Vesting Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zS94C0Wmy8v1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding">7,500</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zKYh7zntYvEb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested">7,500</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_906_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zB6HsCjNmSfc" title="Date Fully Vested">05-02-2026</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_904_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zW0Qw50fnqOg" title="Board Approval Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zu3PueADS1Nf" title="Expiration Date">05-01-2032</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Robel Atnafu</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20211231__srt--TitleOfIndividualAxis__custom--RobelAtnafuMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zMYN4j4zbw27" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">5,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--RobelAtnafuMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zkaOlGc6QBKd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_906_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20210101__20211231__srt--TitleOfIndividualAxis__custom--RobelAtnafuMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zCAg44aRCXz9" title="Granted Date">08-12-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20211231__srt--TitleOfIndividualAxis__custom--RobelAtnafuMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zQlITQRRVHT5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.06</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--RobelAtnafuMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zrgD9NvzmkK5" title="Vesting Date">09-01-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--RobelAtnafuMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zD3QUtoWzBOj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20211231__srt--TitleOfIndividualAxis__custom--RobelAtnafuMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zmr99hzbrwbb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_903_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--RobelAtnafuMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zYaOQ001KYc5" title="Date Fully Vested">09-01-2025</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--RobelAtnafuMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zRYd7sPNM6ne" title="Board Approval Date">08-12-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--RobelAtnafuMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zE0Thm3B4a73" title="Expiration Date">08-11-2031</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Guy Primus</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20211231__srt--TitleOfIndividualAxis__custom--GuyPrimusMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zv7tnKkLurq3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">360,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--GuyPrimusMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z5lsCpiRMGT7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">360,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_904_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20210101__20211231__srt--TitleOfIndividualAxis__custom--GuyPrimusMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z27yWlq2iEZh" title="Granted Date">08-12-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20211231__srt--TitleOfIndividualAxis__custom--GuyPrimusMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z4LI0glhB5K7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.06</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--GuyPrimusMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z6R8fWq0gQKb" title="Vesting Date">09-01-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--GuyPrimusMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zJHAcSIrs837" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding">240,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20211231__srt--TitleOfIndividualAxis__custom--GuyPrimusMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zshUiCy9NTE" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested">120,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--GuyPrimusMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z0v50qGwDqbi" title="Date Fully Vested">09-01-2025</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--GuyPrimusMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z183fR4njIGi" title="Board Approval Date">08-12-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--GuyPrimusMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zNgUaGWfKBNc" title="Expiration Date">08-11-2031</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Samartha Gowda</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SamarthaGowdaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zx41vfeTjDK1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">15,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--SamarthaGowdaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z5mVmuym9a7e" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">15,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SamarthaGowdaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zA9b1GaOT6Tl" title="Granted Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--SamarthaGowdaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zP7eRx49hXbl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.05</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SamarthaGowdaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zMkuWD2OKVUg" title="Vesting Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--SamarthaGowdaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z2pjFHsTgYjk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding">7,500</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--SamarthaGowdaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zOeHdHRImpt4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested">7,500</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SamarthaGowdaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z6p852xmFNl8" title="Date Fully Vested">05-02-2026</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SamarthaGowdaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zRKoBC1L5T74" title="Board Approval Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SamarthaGowdaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zCrDWd7dOoo2" title="Expiration Date">05-01-2032</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Alexandra Aiello</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--AlexandraAielloMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zos3ZTwgdgpd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">2,500</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--AlexandraAielloMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zkLf5NC3A9F8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">2,500</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--AlexandraAielloMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zUOXKuHn8bJ2" title="Granted Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--AlexandraAielloMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zMlDopmU4nMk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.05</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--AlexandraAielloMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zMO4Wx2Wxqsb" title="Vesting Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--AlexandraAielloMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zj0DmFR2Hmfl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding">1,250</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--AlexandraAielloMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zMKrN3i8HUx1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested">1,250</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--AlexandraAielloMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zZ1BzH0xur41" title="Date Fully Vested">05-02-2026</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--AlexandraAielloMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z4rVg0eKPw0i" title="Board Approval Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--AlexandraAielloMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zMmyOdwnl6bf" title="Expiration Date">05-01-2032</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Stephen Cabral</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--StephenCabralMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zlO4ZVDea3Y4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">5,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--StephenCabralMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z5AJCEHMgIm8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_903_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--StephenCabralMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zKMERKWPDCo2" title="Granted Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--StephenCabralMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zpoidDGY1po6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.05</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--StephenCabralMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_ziPZldaQahO" title="Vesting Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--StephenCabralMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z7mtBjLCWCOg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--StephenCabralMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zvGzB6e10LIj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--StephenCabralMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zuwBeWx1OgTj" title="Date Fully Vested">05-02-2026</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--StephenCabralMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z06wjmJJL7j" title="Board Approval Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--StephenCabralMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zf0KWNyJqW24" title="Expiration Date">05-01-2032</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Jonah Petit-Perrin</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--JonahPetiPerrinMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zjUdsZpRym9c" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">2,500</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--JonahPetiPerrinMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z5ByE1Z1QMa3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">2,500</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--JonahPetiPerrinMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_znNtTB3GQ4m7" title="Granted Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--JonahPetiPerrinMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zBS4tPH6taid" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.05</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--JonahPetiPerrinMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z1Z9cejRmEwh" title="Vesting Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--JonahPetiPerrinMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zee8GqimbV64" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding">1,250</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--JonahPetiPerrinMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_ziQtB8JotaV4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested">1,250</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--JonahPetiPerrinMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zhtHlmhSqBV1" title="Date Fully Vested">05-02-2026</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--JonahPetiPerrinMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zjdz5sN18x0g" title="Board Approval Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--JonahPetiPerrinMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z4ipI8GLHwP8" title="Expiration Date">05-01-2032</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Bryan Nella</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--BryanNellaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zbPLsMrTyCA2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">25,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--BryanNellaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zeur895jwiSe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">25,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90B_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--BryanNellaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zmLZTBTnQtG2" title="Granted Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--BryanNellaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zUc14HjWkwyg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.05</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--BryanNellaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zONYjSE3kgmd" title="Vesting Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--BryanNellaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zhwvJLEBGex1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding">12,500</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--BryanNellaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z1WjMt58CFUg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested">12,500</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--BryanNellaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z96tWHUjxNeg" title="Date Fully Vested">05-02-2026</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--BryanNellaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zMwCQJm0JADe" title="Board Approval Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--BryanNellaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zdDDHYmYKT2i" title="Expiration Date">05-01-2032</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Mark Sink</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--MarkSinkMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zimf9Ch28Wui" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">25,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--MarkSinkMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zZLocIrhgjk2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">25,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_906_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--MarkSinkMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zGFaccnau9le" title="Granted Date">05-16-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--MarkSinkMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zu7z4rcHGuCc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.05</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_906_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--MarkSinkMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zabNGQ8A0Kj6" title="Vesting Date">05-16-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--MarkSinkMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zlle8gf7Tndd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding">12,500</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--MarkSinkMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zTZuKBOkJng2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested">12,500</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--MarkSinkMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zFMW3LGvFmH1" title="Date Fully Vested">05-16-2026</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--MarkSinkMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zJLhpuc0V4h" title="Board Approval Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--MarkSinkMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zvLkBOKkgj1b" title="Expiration Date">05-15-2032</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Koustav Choudhuri</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--KoustavChoudhuriMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zbh9U6pV5q3c" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">17,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--KoustavChoudhuriMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zqKUHN23zawa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">17,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--KoustavChoudhuriMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zFze2Pe8pvWc" title="Granted Date">05-16-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--KoustavChoudhuriMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zCR3ZuuzNtj9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.05</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--KoustavChoudhuriMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z8f5vWaGbzx2" title="Vesting Date">05-16-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--KoustavChoudhuriMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zHFzmum5KYR8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding">8,500</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--KoustavChoudhuriMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zA3MVoCaVxUa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested">8,500</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--KoustavChoudhuriMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z7Qdji6G9dJ3" title="Date Fully Vested">05-16-2026</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--KoustavChoudhuriMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z9Z9FMLzPlT6" title="Board Approval Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--KoustavChoudhuriMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zHeIwWUKyAG8" title="Expiration Date">05-15-2032</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif">Total</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zbm3KvbNqxJi" style="font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">11,712,000</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zbFqwBe0pozj" style="font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">11,597,000</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  </table>

<p id="xdx_8A7_zOfGtJ9Lfm38" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WARRANTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable. The Company has not issued any form of a warrant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>COMMON
STOCK ISSUANCES </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable other than founders shares in the amount of <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240101__20240331__srt--TitleOfIndividualAxis__custom--FoundersMember_zW90DaQyoT2d" title="Common stock, issuance">25,000,000</span>. The Company has only used SAFE convertible notes convertible into
preferred equity, and common stock options to date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=RIME_SemiCabIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=RIME_SemiCabIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>182
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035316672176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SAFE PRIVATE PLACEMENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=RIME_SemiCabIncMember', window );">Semi Cab Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_SafePrivatePlacementsTextBlock', window );">SAFE PRIVATE PLACEMENTS</a></td>
<td class="text"><p id="xdx_80D_ecustom--SafePrivatePlacementsTextBlock_zkMoV0TaqySi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
11 &#8211;<span id="xdx_82E_zqzxCowkNyk7">SAFE PRIVATE PLACEMENTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beginning
on October 25, 2018 through April 22, 2023, the Company entered into a total of 50 separate Simple Agreements for Future Equity (&#8220;SAFE
Agreements&#8221;). 45 distinct counterparties entered into subscription agreements with the Company, investing a total of $<span id="xdx_908_eus-gaap--Investments_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEAgreementsMember_zw8qc4vbx8mb">5,038,820
</span>during this period. The terms of these SAFE Agreements varied slightly over the course of this time frame. All of these investments were
made in the form of a private placement under Reg D and were considered exempt from registration at that time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_892_ecustom--SafePrivatePlacementsTableTextBlock_zMdTYM5IwPF4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table below summarizes the first tranche of subscriptions, all with the same terms and conditions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; display: none; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BA_zbXdLJs5wjXa">SCHEDULE
OF FIRST TRANCHE OF SUBSCRIPTIONS</span></span></p>


<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ID</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible
    Holder Name</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue
    Date</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Valuation
    Cap</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Converted
    Date</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 12%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SAFE-1</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 23%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_ecustom--ConvertibleHolderName_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEOneMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zmBU6yAqD2Hi" title="Convertible Holder Name">Ardhendu
    Haldar</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_980_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEOneMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zliJ96O3eCyd" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Principal"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">250,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 12%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_ecustom--InvestmentIssueDate_dd_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEOneMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zVsRHCePLDrl" title="Issue Date">10-25-2018</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEOneMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zF51JYfcVegi" title="Valuation Cap">10,000,000</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--InvestmentConvertedDate_dd_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEOneMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zhQqLyTc9ISi" title="Converted Date">12-25-2020</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SAFE-38</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--ConvertibleHolderName_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyEightMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zsp0Xg3OZ17g" title="Convertible Holder Name">Praveen
    Kaza</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98B_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyEightMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zwKlJexkQVYc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_ecustom--InvestmentIssueDate_dd_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyEightMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zWVwrA2aR1ll" title="Issue Date">10-25-2018</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyEightMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zHCIbpCX9oTh" title="Valuation Cap">13,000,000</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_ecustom--InvestmentConvertedDate_dd_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyEightMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zcY9jTwULxIl" title="Converted Date">12-25-2020</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SAFE-41</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--ConvertibleHolderName_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyOneMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zNbrREaH5yVg" title="Convertible Holder Name">Kurt
    W Mattson</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98E_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyOneMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zjQUbNow8tH" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecustom--InvestmentIssueDate_dd_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyOneMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zeZsrnt9se8h" title="Issue Date">03-27-2019</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyOneMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_z7scvcwKhoc2" title="Valuation Cap">20,000,000</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecustom--InvestmentConvertedDate_dd_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyOneMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zKL4FKO1Fmnc" title="Converted Date">12-25-2020</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SAFE-42</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--ConvertibleHolderName_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyTwoMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_z2dvffhkCpyh" title="Convertible Holder Name">Wendy
    A Thompson</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_986_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyTwoMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zOCnPEcTXJRe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_ecustom--InvestmentIssueDate_dd_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyTwoMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_z40PYKq7EC3c" title="Issue Date">03-27-2019</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyTwoMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zVijYLn5dR3" title="Valuation Cap">20,000,000</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_ecustom--InvestmentConvertedDate_dd_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyTwoMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zOBbF9N3JDhc" title="Converted Date">12-25-2020</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SAFE-44</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--ConvertibleHolderName_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyFourMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zdE9XHWYEDdh" title="Convertible Holder Name">Sonata
    Software North America Inc</span>.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98A_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyFourMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zVGewTXRhwrb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">468,041</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_ecustom--InvestmentIssueDate_dd_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyFourMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zNPuc9NcMVa2" title="Issue Date">02-24-2020</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyFourMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zmbPCN5pvDx3" title="Valuation Cap">10,000,000</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--InvestmentConvertedDate_dd_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyFourMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zRDcr11ljCIl" title="Converted Date">12-25-2020</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SAFE-43</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_ecustom--ConvertibleHolderName_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyThreeMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zkUUt1YUMlSf" title="Convertible Holder Name">THE
    IRA CLUB F/B/O RANJU MAHESHWARI ROTH IRA 2000201</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_983_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyThreeMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zUJGoISJZdW4" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_ecustom--InvestmentIssueDate_dd_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyThreeMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_z2hw2WkOElA7" title="Issue Date">06-15-2020</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyThreeMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zRWIOgb9n6o6" title="Valuation Cap">10,000,000</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--InvestmentConvertedDate_dd_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyThreeMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zLBBYOIrIXTk" title="Converted Date">12-25-2020</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_984_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zSss5sYwsHj4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">943,041</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p id="xdx_8AE_zYrpx0ld86fe" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
total of six investors subscribed for a total of $<span id="xdx_90E_eus-gaap--Investments_iI_c20240331__us-gaap--TypeOfArrangementAxis__custom--SAFEAgreementsMember_zNsFTh2bWTS3" title="Investments">943,041</span> was invested at a valuation of $<span id="xdx_904_ecustom--InvestedValuationOfAmount_c20240101__20240331__us-gaap--TypeOfArrangementAxis__custom--SAFEAgreementsMember_zbaKohTz30c2" title="Invested valuation of value">10,000,000</span>. On December 25, 2020, all of these
SAFE Agreements were converted to preferred equity and the underlying subscription agreements were cancelled. These are the only SAFE
Agreements converted to date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
August 12, 2021 to April 22, 2023, the Company entered into the remaining 44 SAFE Agreements with a total of 39 individual counterparties.
The total amount of capital invested under these subscriptions was $<span id="xdx_90E_ecustom--InvestedValuationOfAmount_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--FortyFourSAFEAgreementsMember_zWF5ApTWeWQa" title="Invested valuation of amount">4,095,779</span>. The primary difference in the terms of this tranche of
capital raised was the valuation placed on the Company, which increased from a valuation of $<span id="xdx_902_eus-gaap--DebtInstrumentFaceAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--FortyFourSAFEAgreementsMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zqKhmi8O6bRd" title="Principal amount">10,000,000</span> under the first tranche to $<span id="xdx_902_ecustom--InvestedValuationOfAmount_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--FortyFourSAFEAgreementsMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheTwoMember_z1Y1jTBvFU4c" title="Invested valuation of amount">35,000,000</span>
under the second tranche. None of the second tranche of SAFE Agreements have been converted, cancelled, or otherwise amended.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_898_eus-gaap--InvestmentHoldingsScheduleOfInvestmentsTableTextBlock_zhB1KGs8u75" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table below summarizes the remaining 44 SAFE Agreements, all of which are expected to terminated immediately after closing of the Transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; display: none; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B7_zMmD0PkXOs9b" style="display: none">SUMMARY
OF  TERMINATED IMMEDIATELY AFTER CLOSING OF THE TRANSACTION</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif">ID</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif">Convertible Holder Name</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Principal</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Issue Date</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Valuation Cap</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 15%">SAFE-40</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 29%; text-align: left"><span id="xdx_90A_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyMember_zNnWrhDBldck" title="Convertible Holder Name">Sunil Bhatia</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98F_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyMember_zEKBp996pwHi" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Principal">250,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: center"><span id="xdx_902_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyMember_zPaiFTX2BXk8" title="Issue Date">08-12-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right"><span id="xdx_901_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyMember_zI3TIfkGu0t2" title="Valuation Cap">15,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-39</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_90D_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyNineMember_z2xekIuZFKYe" title="Convertible Holder Name">Pallav Gupta</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98D_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyNineMember_zrn49RYrIbR3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">15,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_909_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyNineMember_z96jMvjVktAj" title="Issue Date">08-12-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyNineMember_zKrr458gx533" title="Valuation Cap">15,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-10</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_907_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETenMember_zkAQ4JGsh2K9" title="Convertible Holder Name">The Bhardwaj 2003 Revocable Trust</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98A_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETenMember_zxPlTIta7LCg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">200,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90E_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETenMember_zPpAgbPO2igf" title="Issue Date">12-31-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETenMember_zvAiK7JMG6Ck" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-11</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_909_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEElevenMember_zx29Iq8xxFvf" title="Convertible Holder Name">Praveen Kaza</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_989_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEElevenMember_zDgGtuZ5Xpt2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">50,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90C_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEElevenMember_zjMRPuI8Pqei" title="Issue Date">12-31-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEElevenMember_zuk39vaK0GIi" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-12</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_901_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwelveMember_zvucg5fvnDKk" title="Convertible Holder Name">Pallav Gupta</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_981_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwelveMember_zM4GJPvEhpF1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">20,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_905_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwelveMember_zsihZaL9rFLg" title="Issue Date">12-31-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90B_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwelveMember_zU3JDnKOLoMg" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-13</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_902_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirteenMember_zRj99Hawz5vj" title="Convertible Holder Name">Amit and Anju Bhardwaj</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_987_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirteenMember_zdS4E6YfSQa7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">50,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_900_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirteenMember_zuxmOK3Tw1Vj" title="Issue Date">12-31-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90F_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirteenMember_z7gdaPTaMrxh" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-14</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_908_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFourteenMember_zZRo7rH88Jk6" title="Convertible Holder Name">Komal Bajaj</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98C_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFourteenMember_zA4UOoq9A4G1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">50,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_900_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFourteenMember_zKCanzlfUdsg" title="Issue Date">12-31-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFourteenMember_zIKvaYNdkdMh" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-15</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90C_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFifteenMember_zj7F5dwItiYc" title="Convertible Holder Name">Goel Trust, Dated Aug 2, 2000</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98E_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFifteenMember_zkgYiXUFZpy1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">100,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_900_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFifteenMember_zYEaBfG2lGlc" title="Issue Date">12-31-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90D_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFifteenMember_zPtrjrMBMVR" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-16</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_902_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESixteenMember_zjmnovNVUREh" title="Convertible Holder Name">Sanjiva Singh</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98F_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESixteenMember_zPbhZDlGti9i" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">100,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90B_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESixteenMember_zmtZT7WmxGWd" title="Issue Date">12-31-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESixteenMember_zeXEnVfzKFOc" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-17</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_908_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESeventeenMember_zPT0HF6QbXz2" title="Convertible Holder Name">Rajeev Agarwal</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_986_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESeventeenMember_zWAgY5GiRFPd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">25,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_902_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESeventeenMember_zlWqcPmnUMm1" title="Issue Date">12-31-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESeventeenMember_zLISUGvFYJE1" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-18</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_900_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEEighteenMember_zvb6oFeoq7dc" title="Convertible Holder Name">Sanyogita and Sunil Gupta</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_984_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEEighteenMember_zlSZj5xmK85i" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">25,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_909_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEEighteenMember_zw4aZodHxbsd" title="Issue Date">12-31-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90D_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEEighteenMember_z0zCJl2UxNzh" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-19</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_902_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFENineteenMember_z5gYmgIRZC2j" title="Convertible Holder Name">SEM Gaingels Fund I, a series of JMWTX Investments, LP</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_985_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFENineteenMember_zHLtC1f3hJTb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">300,279</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_904_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFENineteenMember_zvUnvJTA2m74" title="Issue Date">12-31-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFENineteenMember_zcTAUrLJsjy3" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-2</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_901_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwoMember_ztzlSQofB838" title="Convertible Holder Name">FVI Fund LLC</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98C_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwoMember_z6Pm4zfQYkv4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">50,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90F_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwoMember_z7SmG95GTUB7" title="Issue Date">12-31-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwoMember_z7obRtEGSim1" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-20</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_901_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyMember_zYy69ZruVOce" title="Convertible Holder Name">JWass PT Investors, LP - B2</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_987_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyMember_zlKjHaqejOWd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">10,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_902_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyMember_zOclF6NkOzk5" title="Issue Date">12-31-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyMember_zOpn12QWZsu" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-21</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_90C_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyOneMember_z9fzyC7DZ3d4" title="Convertible Holder Name">Medhavi Gupta</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_982_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyOneMember_zdvRuVWHS8D" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">20,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_902_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyOneMember_znwAza1j5Ujc" title="Issue Date">12-31-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyOneMember_znzs75RnW6Cl" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-22</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_90D_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyTwoMember_z144al2WrGR1" title="Convertible Holder Name">Sundeep Sibal</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_988_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyTwoMember_zhtfycm9WdOe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">50,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_908_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyTwoMember_zKn85GJ5Z0zi" title="Issue Date">12-31-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyTwoMember_zPfMSm9t0Xmf" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-24</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_901_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyFourMember_zAEqTQvKbuf2" title="Convertible Holder Name">Jolly Gupta</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98F_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyFourMember_zjmTFdn1ZnFl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">35,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_908_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyFourMember_zK104COnc0R2" title="Issue Date">12-31-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyFourMember_zfJ9p1jroqjj" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-3</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_908_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThreeMember_zRjjC2OLq2rk" title="Convertible Holder Name">Ashutosh Malaviya</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98B_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThreeMember_zZBAbKZN1IC6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">50,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_902_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThreeMember_zm1Tm30R8FY4" title="Issue Date">12-31-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThreeMember_zKftjrrX15b8" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-4</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_905_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFourMember_zG7nyP7UGV85" title="Convertible Holder Name">Consensia Inc</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98A_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFourMember_z9rqcLReDAC6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">50,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_903_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFourMember_zUV3DxTSvFXa" title="Issue Date">12-31-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90F_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFourMember_zOM7HbVmx624" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-45</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_902_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyFiveMember_z8Zwm7gyGDm9" title="Convertible Holder Name">Atula Sibal</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_987_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyFiveMember_zWwxjlxJtFG1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">50,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90A_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyFiveMember_z1J2fHmUTJZ2" title="Issue Date">12-31-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyFiveMember_zovVeA5NUiI5" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-6</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_904_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESixMember_zAORJfg9xmPk" title="Convertible Holder Name">Ajay Bhatnagar</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98B_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESixMember_zMVvItr25CU3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">100,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_908_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESixMember_zCY7GJBRuXOa" title="Issue Date">12-31-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90F_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESixMember_zrmlbLeHoiRe" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-7</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_902_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESevenMember_zsXtuX1hlU3i" title="Convertible Holder Name">Pankaj Sinha</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_981_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESevenMember_zVEoAVhg3is6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">50,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90D_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESevenMember_z6qqVZlPTGq2" title="Issue Date">12-31-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESevenMember_zCX9sTubOrif" title="Valuation Cap">35,000,00</span>0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-8</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_908_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEEightMember_z3FLJBYSju17" title="Convertible Holder Name">Bakulesh Adya</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_982_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEEightMember_za1ogWXLzuG" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">35,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_907_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEEightMember_zUf4NUgc5ltl" title="Issue Date">12-31-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_901_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEEightMember_z0GeTzCjdZ8a" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-9</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_90D_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFENineMember_zxkc6bd9qW14" title="Convertible Holder Name">Alok Mahajan</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98B_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFENineMember_zTrQ9S5ulMkj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">50,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_906_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFENineMember_zwEodwKJgPy3" title="Issue Date">12-31-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFENineMember_zAzDeee9QL8l" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-5</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_901_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFiveMember_zNIRhPwRjDqf" title="Convertible Holder Name">BANSAL GARG FAMILY TRUST AMIT BANSAL TRTEE KARUNA GARG TRTEE U/A 11/07/2017</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_980_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFiveMember_zTo0BWVT15Q2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">100,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_909_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFiveMember_zqdqxPgiq1Uh" title="Issue Date">12-31-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_901_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFiveMember_zoiEi4vFMMQ" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-25</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_901_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyFiveMember_z87GVP2Kr487" title="Convertible Holder Name">Disrupt Fund XVIII, LLC</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_988_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyFiveMember_zpDXoAkIL7gc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">50,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_906_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyFiveMember_z2iip7EJy5Zc" title="Issue Date">01-24-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyFiveMember_zIGi98eBjik8" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-26</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_903_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentySixMember_z5qk6UtZVyma" title="Convertible Holder Name">Ajatshatru and Manju Dhawal</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_989_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentySixMember_zwq5d84kJyqj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">25,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90B_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentySixMember_zvXbDAVLuwEb" title="Issue Date">01-31-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentySixMember_z3QGORJeh0w7" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-27</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_908_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentySevenMember_zQISQihhra6h" title="Convertible Holder Name">Mrityunjay Dhawal</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_981_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentySevenMember_zaoVassLtjEc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">25,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90A_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentySevenMember_z7BJQdSejaS9" title="Issue Date">01-31-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentySevenMember_zBfracneXCt3" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-28</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_90D_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyEightMember_zs6p2mtqhsyf" title="Convertible Holder Name">You Sexy Dawg, LLC</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_983_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyEightMember_zDaYJfvx0zr3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">50,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90F_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyEightMember_zaxRpdVeNIgk" title="Issue Date">01-31-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyEightMember_zxC1LXiYo3fa" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-29</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_908_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyNineMember_zzINvLOaD5A2" title="Convertible Holder Name">Elisa deLaet</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_984_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyNineMember_zV3qmc05prX3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">25,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90D_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyNineMember_zcqM2qkRQRdl" title="Issue Date">01-31-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_904_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyNineMember_zNdG7c4Mgh9i" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-30</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_90C_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyMember_z9A7xdcWrMck" title="Convertible Holder Name">Ardhendu Haldar</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98A_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyMember_zrWXHC3A6nAc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">100,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90E_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyMember_zx4eM6Tyeixi" title="Issue Date">02-28-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyMember_zxHAEZ4L86Rf" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-31</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_90B_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyOneMember_z9s03pEKaLbc" title="Convertible Holder Name">Suzanne and Tom Lambert</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98A_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyOneMember_zUSy1B6ET8G8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">250,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90D_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyOneMember_zju0awdaGHx9" title="Issue Date">02-28-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyOneMember_zkh6ooAfsSMf" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-32</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_90A_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyTwoMember_zCzp2jV9ZjNh" title="Convertible Holder Name">Nidus Capital Holdings, LLC</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_987_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyTwoMember_zC8z68bxng7l" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">250,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_908_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyTwoMember_zDDJO5nh0IJb" title="Issue Date">02-28-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyTwoMember_zoKzpsL4Pm31" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-33</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_909_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyThreeMember_za1CM0HpvT88" title="Convertible Holder Name">Compelling Natural Health II, LLC</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_986_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyThreeMember_zV625NkkSqAb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">250,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90A_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyThreeMember_zhEHULcGdxie" title="Issue Date">02-28-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyThreeMember_zrlOk9avlmYb" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-34</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_901_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyFourMember_zxbogyxpmin4" title="Convertible Holder Name">Birch Hill Capital Group, LLC</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_983_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyFourMember_zjvNqbGpxkxe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">250,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_905_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyFourMember_zAy1t63ty99e" title="Issue Date">02-28-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyFourMember_zraxNBVKnfM2" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-35</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_90F_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyFiveMember_zwI3xKp4Nco2" title="Convertible Holder Name">Ingrid P. Maes as Trustee of The IPM Irrevocable Trust dated September 1, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_989_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyFiveMember_zNZy204xQP7l" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">250,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90A_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyFiveMember_zSQoyF6nupMl" title="Issue Date">02-28-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyFiveMember_zJbWSxvp90Nd" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-36</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_90C_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtySixMember_ztVM9pdodOB7" title="Convertible Holder Name">Nattoceuticals, LLC</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_989_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtySixMember_z7ApdaQb37vc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">250,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_905_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtySixMember_zxEZbdt2Z7j1" title="Issue Date">02-28-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtySixMember_zvYBBuwLA0N4" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-37</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_905_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtySevenMember_zZRPNNnL8Vm7" title="Convertible Holder Name">Pallav Gupta</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98D_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtySevenMember_zH0Gh5Fm4rEe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">60,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90A_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtySevenMember_zjBpxNYCNpA" title="Issue Date">02-28-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtySevenMember_zpcCwMgPJ0Jl" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-46</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_905_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortySixMember_z0Il1LOBPbM" title="Convertible Holder Name">Gaingels Semicab LLC</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_985_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortySixMember_zXe3YnldJGN8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">130,500</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_907_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortySixMember_z17TXVfMMkii" title="Issue Date">03-21-2023</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortySixMember_zJTaJaq4HfWh" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-50</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_90F_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFiftyMember_zkcNU8cVCKb3" title="Convertible Holder Name">Pankaj Sinha</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98F_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFiftyMember_zi2KO9kkOGtl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">50,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90B_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFiftyMember_zZycYQjTglz3" title="Issue Date">04-04-2023</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFiftyMember_zvYcYOEtMBL5" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-48</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_901_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyEightMember_zYF6mij4ytgk" title="Convertible Holder Name">Lucy Holifield</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_987_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyEightMember_zT8XYsub1pkc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">70,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_906_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyEightMember_zaWFVEcDEAFf" title="Issue Date">04-14-2023</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyEightMember_zbigYlXvlFvg" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-47</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_902_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortySevenMember_zEYHNK6zi5Pf" title="Convertible Holder Name">Corvus Albus LLC</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_986_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortySevenMember_zgs3uoustsvc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">100,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_909_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortySevenMember_zNhU2aMYEqHa" title="Issue Date">04-19-2023</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortySevenMember_zW3XBIzILQ86" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-49</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_904_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyNineMember_zexIdYj1LXzg" title="Convertible Holder Name">David Friedland</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98D_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyNineMember_zAWqjBWO3Cvi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">50,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90B_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyNineMember_zFXk85gUHVD2" title="Issue Date">04-19-2023</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyNineMember_z5oxexiVv7Y8" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">SAFE-51</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span id="xdx_90E_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFiftyOneMember_zA1pnuTTL2zd" title="Convertible Holder Name">Kapil K Gupta</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_984_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFiftyOneMember_zAXtWhB2dFJ9" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">25,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><span id="xdx_908_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFiftyOneMember_zhQKwfvu2dNl" title="Issue Date">04-22-2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"><span id="xdx_90A_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFiftyOneMember_zRFGcdWSHWK" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">TOTAL</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_989_ecustom--InvestmentOfPrincipalAmount_iI_c20230422_zZM1IaDPyD56" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">4,095,779</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  </table>


<p id="xdx_8AE_zZxvnaJE3qIk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_SafePrivatePlacementsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Safe Private Placements [Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_SafePrivatePlacementsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=RIME_SemiCabIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=RIME_SemiCabIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>183
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035115279936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYEE BENEFIT PLANS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=RIME_SemiCabIncMember', window );">Semi Cab Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock', window );">EMPLOYEE BENEFIT PLANS</a></td>
<td class="text"><p id="xdx_804_eus-gaap--CompensationAndEmployeeBenefitPlansTextBlock_zzSRH9xpIi5h" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
13 - <span id="xdx_827_zXf3uxo7lr86">EMPLOYEE BENEFIT PLANS </span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has a 401(k) plan for its employees to which the Company makes contributions at rates dependent on the level of each employee&#8217;s
contributions. Contributions made by the Company are limited to the maximum allowable for federal income tax purposes. The Company does
not provide any post-employment benefits to retirees.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 710<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/710/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 712<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/712/tableOfContent<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 715<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/715/tableOfContent<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndEmployeeBenefitPlansTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=RIME_SemiCabIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=RIME_SemiCabIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>184
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035124597984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">BASIS OF PRESENTATION</a></td>
<td class="text"><p id="xdx_842_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_z0xqk8bzKQQg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_864_zfAZcd39HU79" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Basis
of Presentation</i></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying unaudited financial statements for the three months ended September 30, 2024 and 2023 have been prepared in accordance with
accounting principles generally accepted in the United States of America (&#8220;US GAAP&#8221;) applicable to interim financial information
and the requirements of Form 10-Q and Article 8 of Regulation S-X of the Securities and Exchange Commission. Accordingly, they do not
include all of the information and disclosures required by US GAAP for complete consolidated financial statements.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true">In the opinion of management, such
condensed consolidated financial statements include all adjustments (consisting of normal recurring accruals) necessary for the fair
presentation of the condensed consolidated financial position and the condensed consolidated results of operations. The condensed consolidated
results of operations for the periods presented are not necessarily indicative of the results to be expected for the full year. The condensed
consolidated balance sheet as of September 30, 2024 and condensed financial statements information for the three and nine months ended
September 30, 2024 and 2023 are unaudited whereas the condensed consolidated balance sheet as of December 31, 2023 is derived from the
audited consolidated balance sheet as of that date. The condensed consolidated financial statements and notes hereto should be read in
conjunction with the consolidated financial statements and notes thereto included in the Company&#8217;s annual report on Form 10-KT
for the transition period ended December 31, 2023. There have been no changes to our significant accounting policies as disclosed on
the Company&#8217;s annual report on Form 10-KT for the transition period ended December 31, 2023.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<span></span>
</td>
<td class="text"><p id="xdx_84C_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_z3YYmrJUWim1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>BASIS
OF PRESENTATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the
United States of America (&#8220;GAAP&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">PRINCIPLES OF CONSOLIDATION</a></td>
<td class="text"><p id="xdx_848_eus-gaap--ConsolidationPolicyTextBlock_zG652AMbDIuc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_863_zrdDkiVdw3gl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Principles
of Consolidation</i></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company evaluates its business relationships with related parties to identify potential Variable Interest Entities (&#8220;VIEs&#8221;)
under Accounting Standards Codification (&#8220;ASC&#8221;) 810, Consolidation. The Company will consolidate any VIE in which it has
a controlling financial interest and is deemed to be the primary beneficiary. A controlling financial interest has both of the following
characteristics: (1) the power to direct the activities of the VIE that most significantly impact its economic performance; and (2) the
obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE
that could be significant to the VIE. If both characteristics are met, the Company is considered to be the primary beneficiary and therefore
will consolidate that VIE into its consolidated financial statements.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
prescribed by ASC 810, if the Company holds a variable interest in a VIE but is not the entity&#8217;s primary beneficiary, it shall
disclose its methodology for determining if the Company is the primary beneficiary of the VIE, e.g., significant judgments and assumptions
made. Additional information required includes information about the types of involvement considered significant, and those considered
in the determination of whether the reporting entity is the primary beneficiary.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
if the Company provides or intends to provide financial or other support (explicitly or implicitly) to the VIE, when not contractually
required to, the Company shall disclose the type and amount of the support, along with the primary reasons for providing the support.
Both qualitative and quantitative information about the Company&#8217;s involvement with the VIE, shall include the nature, purpose,
size, and activities of the VIE, including how the VIE is financed.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<span></span>
</td>
<td class="text"><p id="xdx_847_eus-gaap--ConsolidationPolicyTextBlock_zCa0IWp0mh3i" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PRINCIPLES
OF CONSOLIDATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements include the accounts of the Company and its Hong Kong subsidiary, SMCL, SMCM, SMH, MICS
Hospitality, MICS Hospitality Management and MICS NY. All inter-company accounts and transactions have been eliminated in consolidation
for all periods presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsPolicy', window );">Business Combinations</a></td>
<td class="text"><p id="xdx_84D_eus-gaap--BusinessCombinationsPolicy_z8Zj4Utlqz7i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_86F_zifn80Cmun6f" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Business
Combinations</i></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company allocates the purchase price of an acquired business to the tangible and intangible assets acquired and liabilities assumed based
upon their estimated fair values on the acquisition date. Any excess of the purchase price over the fair value of the net assets acquired
is recorded as goodwill. The purchase price allocation process requires management to make significant estimates and assumptions at the
acquisition date with respect to intangible assets. The allocation of the consideration transferred in certain cases may be subject to
revision based on the final determination of fair values during the measurement period, which may be up to one year from the acquisition
date. Direct transaction costs associated with the business combination are expensed as incurred. The Company includes the results of
operations of the business that it has acquired in its consolidated results prospectively from the date of acquisition.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock', window );">Goodwill</a></td>
<td class="text"><p id="xdx_841_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zvE70x651AHd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_86E_zdrnLExkCPR8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Goodwill</i></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company evaluates its goodwill for impairment in accordance with the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued
Accounting Standards Update (&#8220;ASU&#8221;) 350, <i>Intangibles &#8211; Goodwill and Other</i>. Goodwill is recorded when the purchase
price paid for an acquisition exceeds the estimated fair value of the net identified tangible and intangible assets acquired.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company tests the recorded amount of goodwill for impairment on an annual basis on December 31 or more frequently if there are indicators
that the carrying amount of the goodwill exceeds its carried value.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy', window );">Intangible Assets</a></td>
<td class="text"><p id="xdx_845_eus-gaap--GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy_zcM29p0Vadpl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_867_zbvUCXbIw5xh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Intangible
Assets</i></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company acquired amortizable intangibles assets as part of asset purchase agreements consisting of customer relationships, trade names
and proprietary technology. Such intangibles are amortized over their useful lives on a straight-line basis.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company reviews intangible assets for impairment whenever events or changes in business circumstances indicate that the carrying amount
of the assets might not be recoverable. Factors that the Company considers in deciding when to perform an impairment review include significant
underperformance of the business in relation to expectations, significant negative industry or economic trends, and significant changes
or planned changes in the use of the assets. If an impairment review is performed to evaluate a long-lived asset for recoverability,
the Company compares forecasts of undiscounted cash flows expected to result from the use and eventual disposition of the long-lived
asset to its carrying value. An impairment loss would be recognized when estimated undiscounted future cash flows expected to result
from the use of an asset are less than its carrying amount. The impairment loss would be based on the excess of the carrying value of
the impaired asset over its fair value, determined based on discounted cash flows.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALGORHYTHM
                                            HOLDINGS, INC. and SUBSIDIARIES</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September
30, 2024 and 2023</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></span></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><p id="xdx_849_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_zopZkXAp8v6a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_86C_zixKQwzNxh5g" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Fair
Value Measurements</i></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with ASC 820, Fair Value Measurements and Disclosures, fair value is defined as the exit price, or the amount that would be
received for the sale of an asset or paid to transfer a liability in an orderly transaction between market participants as of the measurement
date.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
guidance also establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes
the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs include those that
market participants would use in valuing the asset or liability and are developed based on market data obtained from sources independent
of the Company. Unobservable inputs are inputs that reflect the Company&#8217;s assumptions about the factors that market participants
would use in valuing the asset or liability. The guidance establishes three levels of inputs that may be used to measure fair value:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="-sec-ix-redline: true">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
                                            1: Quoted market prices in active markets for identical assets or liabilities.</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="-sec-ix-redline: true">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
                                            2: Inputs other than Level 1 that are observable, either directly or indirectly, such as
                                            quoted prices for similar assets or liabilities; quoted prices in markets that are not active;
                                            or model-derived valuations. All significant inputs used in the Company&#8217;s valuations
                                            are observable or can be derived principally from or corroborated with observable market
                                            data for substantially the full term of the assets or liabilities. Level 2 inputs also include
                                            quoted prices that were adjusted for security-specific restrictions which are compared to
                                            output from internally developed models such as a discounted cash flow model.</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
                                            3: Unobservable inputs that are supported by little or no market activity and that are significant
                                            to the fair value of the assets or liabilities.</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
carrying amounts of financial instruments carried at cost, including cash, accounts receivables and accounts and accounts receivable
&#8211; related party, trade payables advances and notes payables and notes payable &#8211; related party approximate their fair value
due to the short-term maturities of such instruments.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
categorization of a financial instrument within the valuation hierarchy is based upon the lowest level of input that is significant to
the fair value measurement.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">RECENT ACCOUNTING PRONOUNCEMENTS</a></td>
<td class="text"><p id="xdx_840_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zh67ficBlsJi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>R<span id="xdx_865_zefuG9EEAdg4">ECENT
ACCOUNTING PRONOUNCEMENTS</span></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
November 2023, the FASB issued ASU 2023-07, <i>Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures</i>, that
requires disclosure of significant segment expenses that are regularly reviewed by the chief operating decision maker and included within
each reported measure of segment profit or loss. The standard also requires disclosure of the composition of other segment items included
in the measure of segment profit or loss that are not separately disclosed. All disclosure requirements under ASU 2023-07 are also required
for public entities with a single reportable segment. The ASU is effective for the Company&#8217;s Annual Report on Form 10-K for the
year ended December 31, 2024, and subsequent interim periods, with early adoption permitted. The Company is currently evaluating the
impact of adopting this standard on our consolidated financial statements and related disclosures.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALGORHYTHM
                                            HOLDINGS, INC. and SUBSIDIARIES</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September
30, 2024 and 2023</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2023, the FASB issued ASU 2023-09, <i>Income Taxes (Topic 740): Improvements to Income Tax Disclosures</i>. ASU 2023-09 is intended
to enhance the usefulness of income tax disclosures by requiring entities to disclose specific rate reconciliations, amount of income
taxes separate by federal and individual tax jurisdictions, and the amount of income or loss from continuing operations before income
tax expense or benefit disaggregated between federal, state and foreign. ASU 2023-09 is effective for the Company for its fiscal year
beginning January 1, 2025, with early adoption permitted. The Company is currently evaluating the impact of adopting this standard on
our consolidated financial statements and related disclosures.</span></span></p>

<span></span>
</td>
<td class="text"><p id="xdx_84B_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zlsiD5f9UQQb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RECENT
ACCOUNTING PRONOUNCEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2023, the FASB issued ASU 2023-09, <i>Income Taxes (Topic 740): Improvements to Income Tax Disclosures</i>. ASU 2023-09 is intended
to enhance the usefulness of income tax disclosures by requiring entities to disclose specific rate reconciliations, amount of income
taxes separate by federal and individual tax jurisdictions, and the amount of income (loss) from continuing operations before income
tax expense (benefit) disaggregated between federal, state and foreign. ASU 2023-09 is effective for the Company for its fiscal year
beginning January 1, 2025, with early adoption permitted. The Company is currently evaluating the impact of adopting this standard on
our consolidated financial statements and related disclosures.</span></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">RECLASSIFICATION OF PRIOR YEARS PRESENTATION</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_849_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zVl9t85L9Bml" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RECLASSIFICATION
OF PRIOR YEARS PRESENTATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on
the reported results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">USE OF ESTIMATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_841_eus-gaap--UseOfEstimates_zg7Fs5GiIx77" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>USE
OF ESTIMATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions. These estimates and
assumptions affect the reported amounts of assets, liabilities, revenues and expenses. Actual results could differ materially from these
estimates. Estimates are assessed each period and updated to reflect current information. Significant estimates include revenue recognition,
allowance for credit losses, provision for excess and obsolete inventory, reserve for sales returns, accruals relating to litigation,
income taxes and share-based compensation expense.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradeAndOtherAccountsReceivablePolicy', window );">ACCOUNTS RECEIVABLE AND ALLOWANCES FOR EXPECTED CREDIT LOSSES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_848_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zKXhm8BV8qe8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ACCOUNTS
RECEIVABLE AND ALLOWANCES FOR EXPECTED CREDIT LOSSES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2016, the FASB issued Accounting Standards Update (&#8220;ASU&#8221;) 2016-13, &#8220;Financial Instruments&#8212;Credit Losses&#8221;
<i>(Topic 326)</i>. This ASU represents a significant change in the current accounting model by requiring immediate recognition of management&#8217;s
estimates of current expected credit losses. Under the prior model, losses were recognized only as they were incurred, which delayed
recognition of expected losses that might not yet have met the threshold of being probable. The amendments in ASU 2016-03 were effective
for our fiscal year beginning April 1, 2023, including interim periods within that fiscal year. We adopted ASU 2016-03 on April 1, 2023,
and the adoption did not have any material effect on our consolidated financial statements and related disclosures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes an allowance for credit losses at the time a receivable is recorded based on its estimate of expected credit losses
and adjusts this estimate over the life of the receivable as needed. The Company evaluates specific identified risks and the aggregation
and risk characteristics of a receivable pool and develops loss rates that reflect historical collections, current forecasts of future
economic conditions over the time horizon the Company is exposed to credit risk, and payment terms or conditions that may materially
affect future forecasts. As needed, amounts are written-off when determined to be uncollectible.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">INVENTORY AND RETURNS ASSET</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_84D_eus-gaap--InventoryPolicyTextBlock_zt1zqrGxQzxj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INVENTORY
AND RETURNS ASSET</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory
is comprised primarily of electronic karaoke equipment, microphones, and accessories, and are stated at the lower of cost or net realizable
value, as determined using the first in, first out method. The Company reduces inventory on hand to its net realizable value on an item-by-item
basis when it is apparent that the expected realizable value of an inventory item falls below its original cost. A charge to cost of
sales results when the estimated net realizable value of specific inventory items declines below cost. Management regularly reviews the
Company&#8217;s investment in inventories for such declines in value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the Company reports an estimated amount for the net realizable value of expected future inventory returns (returns asset) related
to the Company&#8217;s defective allowance, overstock, and warranty policies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
SINGING MACHINE COMPANY, INC AND SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
31, 2023, and March 31, 2023 and 2022</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">LONG-LIVED ASSETS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_841_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zUAAmNvZLnp8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>LONG-LIVED
ASSETS </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company periodically evaluates the carrying value of the unamortized balances of its long-lived assets, including property, equipment
and rental assets, to determine whether impairment of these assets has occurred or whether a revision to the related amortization periods
should be made. If the carrying value of the long-lived asset group exceeds the estimated future undiscounted cash flows, an impairment
loss is recorded based on the amount by which the asset group&#8217;s carrying amount exceeds its fair value. Fair value is determined
based on an evaluation of the assets&#8217; associated discounted future cash flows or appraised value<i>.</i> For the nine months ended
December 31, 2023 and fiscal year ended March 31, 2023, the Company had no impairment loss related to long-lived assets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">PROPERTY AND EQUIPMENT</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_84F_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_znvSDpwnKbKl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PROPERTY
AND EQUIPMENT, NET </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and equipment are stated at cost, less accumulated depreciation. Expenditures for repairs and maintenance are charged to expense as incurred.
Depreciation is provided for in amounts sufficient to relate the cost of depreciable assets to their estimated useful lives using straight-line
methods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">LEASES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_84F_eus-gaap--LesseeLeasesPolicyTextBlock_zJtEl5F2EXkj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>LEASES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company determines if an arrangement contains a lease at the inception of a contract. Right-of-use assets represent the Company&#8217;s
right to use an underlying asset for the lease term and lease liabilities represent the Company&#8217;s obligation to make lease payments
arising from the lease. Right-of-use assets and lease liabilities are recognized at the commencement date. The liability is equal to
the present value of the remaining minimum lease payments. The asset is based on the liability, subject to certain adjustments. Operating
leases result in straight-line expense (similar to operating leases under the prior accounting standard) while finance leases result
in a front-loaded expense pattern (similar to capital leases under the prior accounting standard). As the interest rate implicit in the
Company&#8217;s operating leases is not readily determinable, the Company utilizes its incremental borrowing rate to discount the lease
payments. The Company utilizes the implicit rate for its finance leases.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">FAIR VALUE OF FINANCIAL INSTRUMENTS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_84F_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zO1xq9uamRK9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FAIR
VALUE OF FINANCIAL INSTRUMENTS </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
follow Financial Accounting Standards Board (&#8220;FASB&#8221;) Accounting Standards Codification (&#8220;ASC&#8221;) 825, &#8220;Financial
Instruments&#8221;, which requires disclosure of information about the fair value of certain financial instruments for which it is practicable
to estimate that value. For the purposes of this disclosure, the fair value of a financial instrument is the amount at which the instrument
could be exchanged in a current transaction between willing parties, other than in a forced sale or liquidation. The carrying amounts
of the Company&#8217;s short-term financial instruments, including accounts receivable, accounts payable, accrued expenses, refunds due
to customers, customer deposits, other current liabilities and due from related parties approximates fair value due to the relatively
short period to maturity for these instruments. The carrying amounts on other liabilities are approximate to fair value due to their
relatively short period to maturity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">REVENUE RECOGNITION AND RESERVE FOR SALES RETURNS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_842_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_znmqBVe2Pvf5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>REVENUE
RECOGNITION AND RESERVE FOR SALES RETURNS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes revenue in accordance with FASB ASC 606, &#8220;Revenue from Contracts with Customers&#8221;. All revenue is generated
from contracts with customers. The Company recognizes revenue when the control of the goods sold is transferred to the customer, in an
amount, referred to as the transaction price, that reflects the consideration to which the Company is expected to be entitled in exchange
for those goods. The Company determines revenue recognition utilizing the following five steps: (1) identification of the contract with
a customer, (2) identification of the performance obligations in the contract (promised goods or services that are distinct), (3) determination
of the transaction price, (4) allocation of the transaction price to the performance obligations, and (5) recognition of revenue when,
or as, the Company transfers control of the product or service for each performance obligation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s performance obligations are established when a customer submits a purchase order notification, and the Company
accepts the order. The Company identifies performance obligations as the delivery of the requested product or service in appropriate
quantities and to the location specified in the customer&#8217;s contract and/or purchase order. Revenue from sales of product is
recognized at a point in time when the Company transfers control to the customer, typically at the time when the product is
delivered or shipped, at which time, title passes to the customer and there are no further performance obligations with regards to
the product.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company selectively participates in a retailer&#8217;s co-op promotion incentives to maximize sales of the Company&#8217;s products on
the retail floor or to assist in developing consumer awareness of new product launches, by providing marketing fund allowances to our
customers. As these co-op promotion initiatives are not a distinct good or service and the Company cannot reasonably estimate the fair
value of the benefit it receives from these arrangements, the cost of these allowances at the time they are offered to the customers
are recorded as a reduction to net sales. Co-op promotion incentives were approximately $<span id="xdx_907_eus-gaap--AdvertisingExpense_c20230401__20231231_zetgZ155fVu8" title="Co-op promotion incentives">2,600,000</span> during the nine months ended December
31, 2023, $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_908_eus-gaap--AdvertisingExpense_c20220401__20230331_z7p1nzM50py8" title="Co-op promotion incentives">2,300,000</span> during fiscal 2023 and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_905_eus-gaap--AdvertisingExpense_c20210401__20220331_zys9xYLM0WY1" title="Co-op promotion incentives">2,000,000</span> during fiscal 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s contracts with customers consist of one performance obligation (the sale of the Company&#8217;s products). The
Company&#8217;s contracts have no financing elements, payment terms are generally less than 120 days and have no further contract
asset or liability obligations once control of goods is transferred to the customer. Revenue is recorded in the amount of
consideration the Company expects to receive for the sale of these goods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Costs
incurred in fulfilling contracts with customers include administrative costs associated with the procurement of goods are included in
general and administrative expenses, in-bound freight costs are included in the cost of goods sold and accrued sales representative commissions
are included in selling expenses in the accompanying consolidated statements of operations as our underlying customer agreements are
less than one year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
SINGING MACHINE COMPANY, INC AND SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
31, 2023, and March 31, 2023 and 2022</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
the Company has no overstock return privileges in its vendor agreements with its customers, the Company does accept defective returns,
warranty exchanges and overstock from seasonal customers. The Company estimates the sales value of goods to be returned from our allowance
programs for goods returned from the customer for various reasons, whereby a reserve for sales returns is recorded based on historic
return amounts, specific events as identified and management estimates. The Company&#8217;s reserve for sales returns was approximately
$<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_90E_ecustom--ReserveForSalesReturn_iI_c20231231_zUmZ1f0zmEhh" title="Reserve for sales return">3,400,000</span> as of December 31, 2023, and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_908_ecustom--ReserveForSalesReturn_iI_c20230331_zgqYZZmZeKTg" title="Reserve for sales return">900,000</span> as of March 31, 2023. The Company estimates the net realizable value of these expected
future sales returns. The net realizable value of these estimated returns is classified as return assets as part of current assets on
the accompanying consolidated financial statements. The Company&#8217;s return assets were approximately $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_905_ecustom--ReturnAssets_iI_c20231231_zlaEnHEG2wQf" title="Return assets">1,900,000</span> and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_90A_ecustom--ReturnAssets_iI_c20230331_zkNePkNTq8s5" title="Return assets">600,000</span> as of
December 31, 2023, and March 31, 2023, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ShippingAndHandlingCostsPolicyTextBlock', window );">SHIPPING AND HANDLING COSTS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_84B_ecustom--ShippingAndHandlingCostsPolicyTextBlock_zCeER69gCcLf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHIPPING
AND HANDLING COSTS </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shipping
and handling activities are performed before the customer obtains control of the goods sold to them and are considered activities to
fulfill the Company&#8217;s promise to transfer the goods. For the nine months ended December 31, 2023, shipping and handling expenses
were approximately $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_901_ecustom--ShippingAndHandlingExpenses_c20230401__20231231_zAD9DO2uvUu3" title="Shipping and handling expenses">600,000</span>. For Fiscal 2023 and 2022 shipping and handling expenses were approximately $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_90D_ecustom--ShippingAndHandlingExpenses_c20220401__20230331_zDKl0hYiF6Pl" title="Shipping and handling expenses">500,000</span> and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_90B_ecustom--ShippingAndHandlingExpenses_c20210401__20220331_zWcuHtKtohl5" title="Shipping and handling expenses">900,000</span>, respectively.
These expenses are classified as a component of selling expenses in the accompanying consolidated statements of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">SHARE-BASED COMPENSATION</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_845_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zW3YbDrlpx7h" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARE-BASED
COMPENSATION </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has granted stock options and restricted stock units (&#8220;RSUs&#8221;) to employees, non-employee consultants and non-employee
members of our Board of Directors. The Company also has an equity incentive plan which provides for the issuance of equity incentive
awards, such as stock options, stock appreciation rights, stock awards, restricted stock, stock units, performance awards and other stock
or cash-based awards collectively, the &#8220;Awards.&#8221; Awards may be granted under the 2022 Plan to the Company&#8217;s employees,
officers, directors, consultants, agents, advisors and independent contractors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company measures the compensation cost associated with all share-based payments based on grant date fair values. The fair value of each
stock option and stock purchase right is estimated on the date of grant using an option pricing model that meets certain requirements.
The Company generally uses the Black-Scholes option pricing model to estimate the fair value of its stock options and stock purchase
rights. The determination of the fair value of share-based payment awards utilizing the Black-Scholes model is affected by the Company&#8217;s
stock price and several assumptions, including expected volatility, expected term, risk-free interest rate and expected dividends.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
grants of stock options, the Company uses a blend of historical and implied volatility for traded options on its stock to estimate the
expected volatility assumption required in the Black-Scholes model. The Company&#8217;s use of a blended volatility estimates in computing
the expected volatility assumption for stock options is based on its belief that while the implied volatility is representative of expected
future volatility, the historical volatility over the expected term of the award is also an indicator of expected future volatility.
The Company utilizes a blended volatility estimate that consists of implied volatility and historical volatility in order to estimate
the expected volatility assumption of the Black-Scholes model.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
expected term of stock options granted is estimated using historical experience. The risk-free interest rate assumption is based on observed
interest rates appropriate for the expected terms of the Company&#8217;s stock options and stock purchase rights. The dividend yield
assumption is based on the Company&#8217;s history and expectation of no dividend payouts. The Company estimates forfeitures at the time
of grant and revises these estimates, if necessary, in subsequent periods if actual forfeitures differ from those estimates. The Company
estimates its forfeiture rate assumption for all types of share-based compensation awards based on historical forfeiture rates related
to each category of award.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compensation
costs associated with grants of restricted stock units are measured at fair value, which has historically been the closing price of the
Company&#8217;s common stock on the date of grant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes share-based compensation expense over the requisite service period of each individual award, which generally equals
the vesting period, using the straight-line method for awards that contain only service conditions. For awards that contain performance
conditions, the Company recognizes the share-based compensation expense on a straight-line basis for each vesting tranche, when achievement
of that tranche is considered probable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company evaluates the assumptions used to value stock awards at each grant date. If there are any modifications or cancellations of
the underlying unvested securities, the Company may be required to accelerate, increase or cancel any remaining unearned share-based
compensation expense.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">INCOME TAXES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_849_eus-gaap--IncomeTaxPolicyTextBlock_zXx5R89VEUIg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INCOME
TAXES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company follows the provisions of FASB ASC 740 &#8220;Accounting for Income Taxes.&#8221; Under the asset and liability method of ASC
740, deferred tax assets and liabilities are recognized for the future tax consequences attributed to differences between the financial
statement carrying amounts of existing assets and liabilities and their respective tax base. Deferred tax assets and liabilities are
measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to
be recovered or settled. Under ASC 740, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income
in the period that includes the enactment date. If it is more likely than not that some portion of a deferred tax asset will not be realized,
a valuation allowance is recognized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
SINGING MACHINE COMPANY, INC AND SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
31, 2023, and March 31, 2023 and 2022</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes a liability for uncertain tax positions. An uncertain tax position is defined as a position in a previously filed
tax return or a position expected to be taken in a future tax return that is not based on clear and unambiguous tax law and which is
reflected in measuring current or deferred income tax assets and liabilities for interim or annual periods. The Company may
recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained
on examination by the taxing authorities, based on the technical merits of the position. The Company measures the tax benefits
recognized based on the largest benefit that has a <span id="xdx_90A_eus-gaap--IncomeTaxExaminationLikelihoodOfUnfavorableSettlement_c20230401__20231231_zrx94xkqnTv7">greater
than 50% likelihood</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of being realized upon
ultimate resolution.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2023, and March 31, 2023, there were no uncertain tax positions that resulted in any adjustment to the Company&#8217;s
provision for income taxes. The Company recognizes interest and penalties related to unrecognized tax benefits in its provision for income
taxes. The Company currently has no liabilities recorded for accrued interest or penalties related to uncertain tax provisions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=RIME_SemiCabIncMember', window );">Semi Cab Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">PRINCIPLES OF CONSOLIDATION</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_84A_eus-gaap--ConsolidationPolicyTextBlock_zt14LqVxqMS1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_z460VSZ58tEi">PRINCIPLES
OF CONSOLIDATION</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements include certain intercompany expenses associated with its wholly owned India subsidiary,
SMCB Solutions Private Limited, the accounts of the Company. All inter-company accounts and transactions have been eliminated in consolidation
for all periods presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">RECENT ACCOUNTING PRONOUNCEMENTS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_84B_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zSuculTGSwrj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_zSh71TqczAL7">RECENT
ACCOUNTING PRONOUNCEMENTS</span>:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">In
June 2016, the FASB issued ASU 2016-13, &#8220;Financial Instruments&#8212;Credit Losses&#8221; <i>(Topic 326)</i>. This ASU represents
a significant change in the current accounting model by requiring immediate recognition of management&#8217;s estimates of current expected
credit losses. Under the prior model, losses were recognized only as they were incurred, which delayed recognition of expected losses
that might not yet have met the threshold of being probable. </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
amendments in ASU 2016-03 for smaller reporting companies are effective for the Company beginning April 1, 2023, including interim periods
within that fiscal year. The Company adopted ASU 2016-13 on May 1, 2024. The adoption of ASU 2016-13 did not result in any material effects
to the consolidated financial statements or related disclosures.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">USE OF ESTIMATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_845_eus-gaap--UseOfEstimates_z7bKEnQYdoBc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_860_zbZQlUmRLS03">USE
OF ESTIMATES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SemiCab
makes estimates and assumptions in the ordinary course of business relating to sales collections and allowances, warranty reserves, and
reserves for promotional incentives that may affect the reported amounts of assets and liabilities and of contingent assets and liabilities
at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Future
events and their effects cannot be determined with absolute certainty; therefore, the determination of estimates requires the exercise
of judgment. Historically, past changes to these estimates have not had a material impact on the Company&#8217;s financial statements.
However, circumstances could change which may alter future expectations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">LONG-LIVED ASSETS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_843_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zBaPdFhl2PSl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86C_zwUgYWEk8UX9">LONG-LIVED
ASSETS</span> </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable. The only meaningful long-lived assets are intangible in nature and under GAAP accounting, not capitalized nor assigned any
long-term accounting value. prior to the proposed transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">PROPERTY AND EQUIPMENT</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_84E_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zzUXSum9Vgah" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_zwN1Jzo3psEk">PROPERTY
AND EQUIPMENT</span> </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and Equipment are stated at cost. Depreciation is provided for in amounts sufficient to relate the cost of depreciable assets to operations
over the estimated service lives, principally using straight-line methods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
estimated useful lives used to compute depreciation and amortization for financial reporting purposes are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_897_eus-gaap--ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock_z2dJnq9UqxD5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zmYEfXhjCFr5" style="display: none">SCHEDULE
OF ESTIMATED USEFUL LIVES</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></p>

<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify">&#160;</td>
  <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Years</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 70%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
  and Equipment</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 30%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__srt--RangeAxis__srt--MinimumMember_zhbOAT3stvZh" title="Property plant and equipment useful life">3</span> - <span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__srt--RangeAxis__srt--MaximumMember_zqn6PxRDpa4c" title="Property plant and equipment useful life">5</span></span></td></tr>
</table>


<p id="xdx_8A6_zWlb9Wnx0g7h" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">FAIR VALUE OF FINANCIAL INSTRUMENTS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_849_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zHRLmSf1tBl5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_869_zz0MwxDff286">FAIR
VALUE OF FINANCIAL INSTRUMENTS</span> </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
carrying values of financial instruments comprising cash and cash equivalents, payables, and notes payable-related party approximate
fair values due to the short-term maturities of these instruments. The notes payable- related party is considered a level 3 measurement.
As defined in ASC 820, <i>Fair Value Measurements and Disclosures</i>, fair value is the price that would be received to sell an asset
or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). The Company
utilizes market data or assumptions that market participants would use in pricing the asset or liability, including assumptions about
risk and the risks inherent in the inputs to the valuation technique. These inputs can be readily observable, market corroborated, or
generally unobservable. ASC 820 establishes a fair value hierarchy that prioritizes the inputs used to measure fair value. The hierarchy
gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and
the lowest priority to unobservable inputs (Level 3 measurement). This fair value measurement framework applies to both initial and subsequent
measurement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    1:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 92%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quoted
    prices are available in active markets for identical assets or liabilities as of the reporting date.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    2:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pricing
    inputs are other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as
    of the reported date. Level 2 includes those financial instruments that are valued using models or other valuation methodologies.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    3:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pricing
inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally
developed methodologies that result in management&#8217;s best estimate of fair value. The significant unobservable inputs used in the
fair value measurement for nonrecurring fair value measurements of long-lived assets include pricing models, discounted cash flow methodologies
and similar techniques.</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
carrying amounts of the Company&#8217;s short-term financial instruments, including accounts receivable, accounts payable, accrued expenses,
customer deposits, refunds due to customers, and due to related parties approximates fair value due to the relatively short period to
maturity for these instruments. The carrying amounts on the notes payable, finance leases and installment notes approximate fair value
either due to the relatively short period to maturity or the related interest is accrued at a rate similar to market rates. The carrying
amounts on the revolving line of credit approximates fair value due the relatively short period to maturity and related interest accrued
at market rates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">REVENUE RECOGNITION AND RESERVE FOR SALES RETURNS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_841_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_z6gJVLCEEyt9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span>REVENUE
RECOGNITION</span> </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_869_ziYHCZqBAts2" style="display: none">REVENUE
RECOGNITION AND RESERVE FOR SALES RETURNS</span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes revenue in accordance with FASB ASC 606, &#8220;Revenue from Contracts with Customers&#8221;. All revenue is generated
from contracts with customers. The Company recognizes revenue when the control of the goods sold is transferred to the customer, in an
amount, referred to as the transaction price, that reflects the consideration to which the Company is expected to be entitled in exchange
for those goods. The Company determines revenue recognition utilizing the following five steps: (1) identification of the contract with
a customer, (2) identification of the performance obligations in the contract (promised goods or services that are distinct), (3) determination
of the transaction price, (4) allocation of the transaction price to the performance obligations, and (5) recognition of revenue when,
or as, the Company transfers control of the product or service for each performance obligation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s contracts with customers consist of one performance obligation (the sale of the Company&#8217;s products). The Company&#8217;s
contracts have no financing elements, payment terms are less than 120 days and have no further contract asset or liability obligations
once control of goods is transferred to the customer. Revenue is recorded in the amount of consideration the Company expects to receive
for the sale of these goods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Costs
incurred in fulfilling contracts with customers include administrative costs associated with the procurement of goods are included in
general and administrative expenses, in-bound freight costs are included in the cost of goods sold and accrued sales representative commissions
are included in selling expenses in the accompanying consolidated statements of operations as our underlying customer agreements are
less than one year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ShippingAndHandlingCostsPolicyTextBlock', window );">SHIPPING AND HANDLING COSTS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_84D_ecustom--ShippingAndHandlingCostsPolicyTextBlock_zUMy4fBOf0a2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_862_zJNalzNaVDh9">SHIPPING
AND HANDLING COSTS</span> </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shipping
and handling activities are performed before the customer obtains control of the goods delivered for them and are considered activities
to fulfill the Company&#8217;s promise to transfer the goods. For Fiscal 2023 and 2022 shipping and handling expenses provided by third
party shippers were approximately $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_90F_ecustom--ShippingAndHandlingExpenses_c20230101__20231231_zlhIbVOmmoij" title="Shipping and handling expenses">5,692,000</span> and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_908_ecustom--ShippingAndHandlingExpenses_c20220101__20221231_zYqwgyDuxhu8" title="Shipping and handling expenses">10,057,000</span>, respectively. These expenses are classified as a component of selling
expenses in the accompanying consolidated statements of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">INCOME TAXES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_849_eus-gaap--IncomeTaxPolicyTextBlock_zTed47CBFWAh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_869_zOUw1hxTBww3">INCOME
TAXES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company follows the provisions of FASB ASC 740 &#8220;Accounting for Income Taxes.&#8221; Under the asset and liability method of ASC
740, deferred tax assets and liabilities are recognized for the future tax consequences attributed to differences between the financial
statement carrying amounts of existing assets and liabilities and their respective tax base. Deferred tax assets and liabilities are
measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to
be recovered or settled. Under ASC 740, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income
in the period that includes the enactment date. If it is more likely than not that some portion of a deferred tax asset will not be realized,
a valuation allowance is recognized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes a liability for uncertain tax positions. An uncertain tax position is defined as a position in a previously filed
tax return or a position expected to be taken in a future tax return that is not based on clear and unambiguous tax law and which is
reflected in measuring current or deferred income tax assets and liabilities for interim or annual periods. The Company may recognize
the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination
by the taxing authorities, based on the technical merits of the position. The Company measures the tax benefits recognized based on the
largest benefit that has a greater than 50% likelihood of being realized upon ultimate resolution.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of March 31, 2023 and 2022 there were no uncertain tax positions that resulted in any adjustment to the Company&#8217;s provision for
income taxes. The Company recognizes interest and penalties related to unrecognized tax benefits in its provision for income taxes. The
Company currently has no liabilities recorded for accrued interest or penalties related to uncertain tax provisions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountPolicy', window );">ALLOWANCE FOR DOUBTFUL ACCOUNTS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_848_ecustom--ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountPolicy_z1ejGJPCZPgi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_862_zmLkW7LMOPD3">ALLOWANCE
FOR DOUBTFUL ACCOUNTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SemiCab&#8217;s
allowance for doubtful accounts is based on management&#8217;s estimates of the creditworthiness of its customers, current economic conditions
and historical information, and, in the opinion of management, is believed to be in an amount sufficient to respond to normal business
conditions. Management sets 100% reserves for customers in bankruptcy and other allowances based upon historical collection experience.
The Company is subject to chargebacks from customers that are deducted from open invoices and reduce collectability of open invoices.
Should business conditions deteriorate or any major customer default on its obligations to the Company, this allowance may need to be
significantly increased, which would have a negative impact on operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">FOREIGN CURRENCY TRANSLATION</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_84D_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zLndMT9h1Rrb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_zIH83l1KnwYc">FOREIGN
CURRENCY TRANSLATION</span> </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for foreign currency transactions pursuant to ASC 830, Foreign Currency Matters (&#8220;ASC 830&#8221;). The functional
currency of the Company is the U.S. dollar, which is the currency of the primary economic environment in which it operates. In accordance
with ASC 830, monetary balances denominated in or linked to foreign currency are stated on the basis of the exchange rates prevailing
at the applicable balance sheet date. For foreign currency transactions included in the statement of operations, the exchange rates applicable
on the relevant transaction dates are used. Gains or losses arising from changes in the exchange rates used in the translation of such
transactions and from the remeasurement of the monetary balance sheet items are recorded as gain (loss) on foreign currency transactions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
functional currency of the India subsidiary is the Indian Rupee. Under ASC 830, all assets and liabilities are translated into U. S.
dollars using the current exchange rate at the end of each fiscal period. Revenues and expenses are translated using the average exchange
rates prevailing throughout the respective periods. All transaction gains and losses from the measurement of monetary balance sheet items
denominated in Indian Rupee are reflected in the statement of operations as appropriate. Translation adjustments are included in accumulated
other comprehensive loss.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_84F_eus-gaap--ConcentrationRiskCreditRisk_zuOr9O0PwYm5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b><span id="xdx_86E_zcJuM1Yy4mYi">Concentration
of Credit Risk</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
times, the Company maintains cash in United States bank accounts that are in excess of the Federal Deposit Insurance Corporation insured
amounts. The Company maintains cash balances in foreign financial institutions. The amounts at foreign financial institutions at December
31, 2023 and 2022 were approximately $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_90D_eus-gaap--ForeignFinancialInstitutionsActualDeposits_iI_c20231231_za9UvT4LO8nh" title="Foreign financial institutions actual deposits">58,000</span> and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_906_eus-gaap--ForeignFinancialInstitutionsActualDeposits_iI_c20221231_zwMgn0t9uMXb" title="Foreign financial institutions actual deposits">91,000</span>, respectively. The Company regularly monitors the financial stability of this
financial institution and believes that it is not exposed to any significant credit risk in cash and cash equivalents. However, in March
and April 2023, certain U.S. government banking regulators took steps to intervene in the operations of certain financial institutions
due to liquidity concerns, which caused general heightened uncertainties in financial markets. While these events have not had a material
direct impact on the Company&#8217;s operations, if further liquidity and financial stability concerns arise with respect to banks and
financial institutions, either nationally or in specific regions, the Company&#8217;s ability to access cash or enter into new financing
arrangements may be threatened, which could have a material adverse effect on its business, financial condition and results of operations.
Financial instruments, which potentially subject the Company to concentrations of credit risk, consist of accounts receivable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_PrepaidExpensesPolicyTextBlock', window );">PREPAID EXPENSES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_845_ecustom--PrepaidExpensesPolicyTextBlock_zkvjbZ0xjxoj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_867_zagvPAZT0yLk">PREPAID
EXPENSES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid
expenses consist primarily of prepaid services which will be expensed as the services are provided within twelve months. As of December
31, 2023 and 2022, the balances of the prepaids account were $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_90F_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iI_c20231231_z7bl03q6wx8h" title="Prepaid expense">5,000</span> and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_90F_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iI_c20221231_znLDu8J88Lbf" title="Prepaid expense">8,000</span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationRelatedCostsPolicyTextBlock', window );">STOCK-BASED COMPENSATION</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_849_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zi5KOh9YHNHf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86B_z18aPM8fpv76">STOCK-BASED
COMPENSATION</span> </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for share based compensation in accordance with the provisions of ASC 718-10, &#8220;Compensation &#8212; Stock Compensation,&#8221;
which requires measurement of compensation cost for all stock awards at fair value on date of grant and recognition of compensation over
the service period for awards expected to vest. The majority of its share-based compensation arrangements vest over a three year vesting
schedule. The Company expenses its share-based compensation under the ratable method, which treats each vesting tranche as if it were
an individual grant. The fair value of stock options is determined using the Black-Scholes valuation model and requires the input of
certain assumptions. These assumptions include estimating the length of time employees will retain their vested stock options before
exercising them (the &#8220;expected option term&#8221;), the estimated volatility of its common stock price over the option&#8217;s
expected term, the risk-free interest rate over the option&#8217;s expected term, and the Company&#8217;s expected annual dividend yield.
Changes in these subjective assumptions can materially affect the estimate of fair value of stock-based compensation and consequently,
the related amount recognized as an expense in the consolidated statements of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
required under the accounting rules, the Company reviews its valuation assumptions at each grant date and, as a result, the Company is
likely to change its valuation assumptions used to value employee stock-based awards granted in future periods. The values derived from
using the Black-Scholes model are recognized as expense over the service period, net of estimated forfeitures (the number of individuals
that will ultimately not complete their vesting requirements). The estimation of stock awards that will ultimately vest requires significant
judgment. The Company considers many factors when estimating expected forfeitures, including types of awards, employee class, and historical
experience. Actual results, and future changes in estimates, may differ substantially from current estimates. Options and warrants to
outsiders are accounted for under ASC 718.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">RESEARCH AND DEVELOPMENT COSTS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_848_eus-gaap--ResearchAndDevelopmentExpensePolicy_zbNgN3QOxfw7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_z0hSPZtChHU4">RESEARCH
AND DEVELOPMENT COSTS</span> </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
research and development costs are charged to results of operations as incurred. These expenses are shown as a component of general and
administrative expenses in the consolidated statements of operations. For the years ended December 31, 2023 and 2022, these amounts totaled
approximately $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_907_eus-gaap--ResearchAndDevelopmentExpense_c20230101__20231231_z00keplmHzVi" title="Research and development costs">842,000</span> and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgU0lHTklGSUNBTlQgQUNDT1VOVElORyBQT0xJQ0lFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_904_eus-gaap--ResearchAndDevelopmentExpense_c20220101__20221231_zP8VEPPMhMm1" title="Research and development costs">640,000</span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">COMPUTATION OF EARNINGS (LOSS) PER SHARE</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_84A_eus-gaap--EarningsPerSharePolicyTextBlock_zAb0q9XUEOti" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_863_zz3yTyIaMu27">COMPUTATION
OF EARNINGS (LOSS) PER SHARE</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable. This is not required.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_PrepaidExpensesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Prepaid Expenses [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_PrepaidExpensesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Receivables Trade And Other Accounts Receivable Allowance For Doubtful Account Policy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_ShippingAndHandlingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Shipping and Handling Costs [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_ShippingAndHandlingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479515/805-10-05-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479515/805-10-05-4<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479515/805-10-05-4<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479515/805-10-05-4<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationRelatedCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationRelatedCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478898/942-825-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 825<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/830/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for indefinite-lived intangible assets (that is, those intangible assets not subject to amortization). This accounting policy also may address how the entity assesses whether events and circumstances continue to support an indefinite useful life and how the entity assesses and measures impairment of such assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-30/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480091/360-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 4<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482338/360-10-05-4<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-20<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483080/330-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483489/210-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 330<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478411/912-330-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/330/tableOfContent<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483080/330-10-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 270<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482989/270-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 205<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483504/205-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483044/730-10-05-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-18<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org/606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.C.Q3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.1.Q5)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.3.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradeAndOtherAccountsReceivablePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-6<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481569/310-20-50-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-15<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-11B<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradeAndOtherAccountsReceivablePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=RIME_SemiCabIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=RIME_SemiCabIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>185
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035313197696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ASSET ACQUISITION (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">SCHEDULE OF CONSIDERATION TRANSFERRED TO THE ASSETS ACQUIRED AND LIABILITIES ASSUMED</a></td>
<td class="text"><p id="xdx_893_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_zqfSlXacSIQb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents the allocation of the consideration transferred to the assets acquired and liabilities assumed based on their
fair values:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="-sec-ix-redline: true"><span id="xdx_8B0_zqB8RjhO6SA" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE
OF CONSIDERATION TRANSFERRED TO THE ASSETS ACQUIRED AND LIABILITIES ASSUMED</span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td id="xdx_49E_20240703__us-gaap--BusinessAcquisitionAxis__custom--SemiCabIncMember_zh7pqoAcz5qf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Equity consideration"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 74%; text-align: left"><span style="-sec-ix-redline: true">Equity consideration</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_98A_eus-gaap--AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable_c20240703__20240703__us-gaap--AssetAcquisitionAxis__custom--SemiCabIncMember_zlLgWxDyscff" style="font: 10pt Times New Roman, Times, Serif; width: 22%; text-align: right" title="Equity consideration"><span style="-sec-ix-redline: true">494,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">Fair value of non-controlling interest</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td id="xdx_98E_ecustom--AssetAcquisitionFairValueOfNonControllingInterest_c20240703__20240703__us-gaap--AssetAcquisitionAxis__custom--SemiCabIncMember_z6LHfTO1zIf" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Fair value of non-controlling interest"><span style="-sec-ix-redline: true">74,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">Total Equity Consideration</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td id="xdx_983_eus-gaap--AssetAcquisitionConsiderationTransferredContingentConsideration_c20240703__20240703__us-gaap--AssetAcquisitionAxis__custom--SemiCabIncMember_zo7Ps31BOJhd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total Equity Consideration"><span style="-sec-ix-redline: true">568,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="-sec-ix-redline: true">Debt Extinguishment</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td id="xdx_981_ecustom--AssetAcquisitionDebtExtinguishment_c20240703__20240703__us-gaap--AssetAcquisitionAxis__custom--SemiCabIncMember_z02uvR7ZXrRk" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Debt Extinguishment"><span style="-sec-ix-redline: true">415,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">Total Consideration</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_980_eus-gaap--AssetAcquisitionConsiderationTransferred_c20240703__20240703__us-gaap--AssetAcquisitionAxis__custom--SemiCabIncMember_zlZrKZvXompg" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Total consideration"><span style="-sec-ix-redline: true">983,000</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">Identifiable net assets acquired:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_iI_ziB7iOrglvn" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">Cash and Cash Equivalents</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">17,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_iI_zia4FpE3NQVc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">Accounts receivable</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">193,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_iI_zDAJcMob9pAd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">Prepaid expenses and other current assets</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">13,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_zlTqy723kO5c" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">Property and equipment, net</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">3,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_iI_z6siHi5SxsMl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">Other Non-Current Operating Assets, Net</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">14,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr id="xdx_40C_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCustomerRelationships_iI_zUWvmGbp32t3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">Customer Relationships (<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlNJREVSQVRJT04gVFJBTlNGRVJSRUQgVE8gVEhFIEFTU0VUUyBBQ1FVSVJFRCBBTkQgTElBQklMSVRJRVMgQVNTVU1FRCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20240703__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zYg7VmAKamhf">9
    </span></span><span style="-sec-ix-redline: true">year estimated useful life)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">747,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr id="xdx_401_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradeName_iI_z7vJ6LJn72h6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">Trade Name (<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlNJREVSQVRJT04gVFJBTlNGRVJSRUQgVE8gVEhFIEFTU0VUUyBBQ1FVSVJFRCBBTkQgTElBQklMSVRJRVMgQVNTVU1FRCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90F_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20240703__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_ziXcACBKrHC6">9
    </span></span><span style="-sec-ix-redline: true">year estimated useful life)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">272,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr id="xdx_409_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDevelopedTechnology_iI_zUOYy8tjHF41" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">Developed Technology (<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlNJREVSQVRJT04gVFJBTlNGRVJSRUQgVE8gVEhFIEFTU0VUUyBBQ1FVSVJFRCBBTkQgTElBQklMSVRJRVMgQVNTVU1FRCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20240703__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DevelopedTechnologyRightsMember_zCx5Qsd9yz8l">6
    </span></span><span style="-sec-ix-redline: true">year estimated useful life)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">381,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_iNI_di_zodX7BNLMoAd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">Accounts payable and accrued expenses</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">(2,680,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">)</span></td></tr>
  <tr id="xdx_40B_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLoansPayable_iI_zMz2R2tKSr3l" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">Loans payable Merchant Cash Advances (MCA)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">(631,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">)</span></td></tr>
  <tr id="xdx_408_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt_iNI_di_zkoi1AVl10b8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">Note payable</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">(50,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">)</span></td></tr>
  <tr id="xdx_404_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesNotesPayableRelatedParties_iI_znAEmC4h6vsj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="-sec-ix-redline: true">Notes payable Related Parties</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">(650,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="-sec-ix-redline: true">)</span></td></tr>
  <tr id="xdx_400_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_z67ORAU3jxsf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="-sec-ix-redline: true">Net assets acquired</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">(2,371,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="-sec-ix-redline: true">)</span></td></tr>
  <tr id="xdx_40E_eus-gaap--Goodwill_iI_z56M72yov2Yk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">Estimated Goodwill</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">3,354,000</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ScheduleOfProFormaFinancialInformationTableTextBlock', window );">SCHEDULE OF PRO FORMA FINANCIAL INFORMATION</a></td>
<td class="text"><p id="xdx_891_ecustom--ScheduleOfProFormaFinancialInformationTableTextBlock_zWwCnqTKNek9" style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="-sec-ix-redline: true"><span id="xdx_8BD_z3uB87DL9bu3" style="display: none">SCHEDULE
OF PRO FORMA FINANCIAL INFORMATION</span></span><span style="-sec-ix-redline: true">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td id="xdx_497_20240101__20240930_z3drDoyCCjZd" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td id="xdx_499_20230101__20230930_z71B4uIUAeLi" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">Nine Months Ended</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">September
    30, 2024</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">September
    30, 2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--BusinessAcquisitionsProFormaRevenue_zGU55vatkVmd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="-sec-ix-redline: true">Net revenue</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="-sec-ix-redline: true">16,831,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="-sec-ix-redline: true">26,848,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax_zRTwvKp3syM2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">Operating loss from continuing operations</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">(8,093,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">(6,187,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">)</span></td></tr>
  <tr id="xdx_400_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_zBIixXJD0Vvd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">Net loss</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">(8,451,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">(7,164,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">)</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_ScheduleOfProFormaFinancialInformationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Pro Forma Financial Information [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_ScheduleOfProFormaFinancialInformationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Paragraph 1<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>186
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035113105616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LOANS PAYABLE &#8211; RELATED PARTIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">SCHEDULE OF LOAN</a></td>
<td class="text"><p id="xdx_89D_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_zNxrQIM0BEHi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
specific terms of each loan are summarized in the table below:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_8BE_zZepzgZY38Uh" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE
OF LOAN</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">Issue</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">Maturity</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">Interest</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td colspan="2" id="xdx_49C_20240930_z8QaO2zgqSDi" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">Holder</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">Date</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">Date</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">Status</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">Rate</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">Principal</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 46%; text-align: left"><span style="-sec-ix-redline: true">Ajesh Kapoor</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_905_eus-gaap--DebtInstrumentIssuanceDate1_dd_c20240101__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorOneMember_zAbJ9Nu4bt79">7/10/2021</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_908_eus-gaap--DebtInstrumentMaturityDate_dd_c20240101__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorOneMember_zH86iwv0hNs3">7/10/2026</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 8%"><span style="-sec-ix-redline: true">Current</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_905_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorOneMember_zkzfROuvp3Sh">9.0</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">%</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_984_eus-gaap--NotesPayable_iI_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorOneMember_zDGdI4auNRg3" style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: right" title="Principal amount"><span style="-sec-ix-redline: true">150,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">Ajesh Kapoor</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_905_eus-gaap--DebtInstrumentIssuanceDate1_dd_c20240101__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorTwoMember_zHfH1bsvae54">8/27/2021</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_909_eus-gaap--DebtInstrumentMaturityDate_dd_c20240101__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorTwoMember_zZWTAcVYM0Hd">8/26/2026</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">Current</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorTwoMember_zSoqUWHGGesh">9.0</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td id="xdx_982_eus-gaap--NotesPayable_iI_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorTwoMember_zVF13JLSDoK5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal amount"><span style="-sec-ix-redline: true">235,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">Vivek Seghal</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_90C_eus-gaap--DebtInstrumentIssuanceDate1_dd_c20240101__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--VivekSeghalMember_z2KzwxE1Ipwh">4/17/2023</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_902_eus-gaap--DebtInstrumentMaturityDate_dd_c20240101__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--VivekSeghalMember_zpChU2QYiCFc">10/13/2023</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">Default</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_903_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--VivekSeghalMember_zXuIk9wWnLo2">10.0</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td id="xdx_986_eus-gaap--NotesPayable_iI_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--VivekSeghalMember_z5d53GLi5j8j" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal amount"><span style="-sec-ix-redline: true">50,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">Ajesh Kapoor</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_903_eus-gaap--DebtInstrumentIssuanceDate1_dd_c20240101__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorThreeMember_zj6J3z4YGgq">5/5/2023</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_902_eus-gaap--DebtInstrumentMaturityDate_dd_c20240101__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorThreeMember_zz0koCJcw2L1">5/4/2024</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">Default</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_908_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorThreeMember_z0zCbAHnh0h4">10.0</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td id="xdx_989_eus-gaap--NotesPayable_iI_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorThreeMember_zqlhKpIoJK0k" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal amount"><span style="-sec-ix-redline: true">50,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="-sec-ix-redline: true">Ajesh Kapoor</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-bottom: 1pt"><span style="-sec-ix-redline: true"><span id="xdx_909_eus-gaap--DebtInstrumentIssuanceDate1_dd_c20240101__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorFourMember_zLCkZHT27tu6">5/17/2023</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-bottom: 1pt"><span style="-sec-ix-redline: true"><span id="xdx_90D_eus-gaap--DebtInstrumentMaturityDate_dd_c20240101__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorFourMember_zetEGTdpidX7">5/16/2024</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">Default</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_909_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorFourMember_zLiWcQbjnTma">10.0</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="-sec-ix-redline: true">%</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td id="xdx_98E_eus-gaap--NotesPayable_iI_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AjeshKapoorFourMember_zI3MWIBNpu4a" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal amount"><span style="-sec-ix-redline: true">165,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--NotesPayable_iI_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zkSNxspZRSGi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="-sec-ix-redline: true">Amount due as of September 30, 2024</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">650,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--NotesPayableCurrent_iI_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zzTUD2zbYcS1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="-sec-ix-redline: true">Less: Current portion of notes payable
    to related parties</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">265,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--LongTermNotesPayable_iTI_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zbbTuKSJbwdg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt; padding-left: 10pt"><span style="-sec-ix-redline: true">Notes payable
    to related parties, net of current portion</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">385,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>187
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035117786208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OPERATING LEASES (Tables)<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_DisclosureOperatingLeasesAbstract', window );"><strong>Operating Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ScheduleOfSupplementalInformationRelatedToLeaseTableTextBlock', window );">SCHEDULE OF SUPPLEMENTAL INFORMATION RELATED TO LEASES</a></td>
<td class="text"><p id="xdx_895_ecustom--ScheduleOfSupplementalInformationRelatedToLeaseTableTextBlock_zF3exgsWDJJa" style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Supplemental
balance sheet information related to leases as of September 30, 2024 and December 31, 2023 is as follows:</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span><span id="xdx_8B8_zcEQMBbha7gg" style="display: none">SCHEDULE
OF SUPPLEMENTAL INFORMATION RELATED TO LEASES</span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;&#160;</b>&#160;<b>&#160;</b></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">Assets:</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td colspan="2" id="xdx_49E_20240930_zhpj8U3NHW9g" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">September
    30, 2024</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td colspan="2" id="xdx_49C_20231231_zVjcjeS3yFkb" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">December
    31, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pp0p0_zTnGXcLX8Yab" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="-sec-ix-redline: true">Operating lease - right-of-use assets</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="-sec-ix-redline: true">137,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="-sec-ix-redline: true">3,926,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--OperatingLeaseLiabilityAbstract_iB_zcnf2xz6jF33" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">Liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">Current</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--OperatingLeaseLiabilityCurrent_i01I_pp0p0_zlNcwoHuOZt9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"><span style="-sec-ix-redline: true">Current portion of operating leases</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">135,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">84,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--OperatingLeaseLiabilityNoncurrent_i01I_pp0p0_zaOP6csvSWB2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"><span style="-sec-ix-redline: true">Operating lease liabilities, net of
    current portion</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl1204">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">3,925,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  </table>

<span></span>
</td>
<td class="text"><p id="xdx_895_ecustom--ScheduleOfSupplementalInformationRelatedToLeaseTableTextBlock_zWjmbd3bVcm2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Supplemental
balance sheet information related to leases as of December 31, 2023 and March 31, 2023 is as follows:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span><span id="xdx_8B0_za7kMDxbRY3d" style="display: none">SCHEDULE OF SUPPLEMENTAL INFORMATION RELATED TO LEASES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_49C_20231231_zDcPHGudyeXj" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_498_20230331_zHS0qcvQ2ZEf" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Assets:</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pp0p0_z1RqJbrrnIY7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left">Operating lease - right-of-use assets</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">3,926,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">561,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Liabilities</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--OperatingLeaseLiabilityCurrent_iI_pp0p0_z2SRaJwowWSb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Current portion of operating leases</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">84,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">509,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pp0p0_zwkV7Yqg0h92" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Operating lease liabilities, net of current portion</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3,925,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">88,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">SCHEDULE OF LEASE TERM AND DISCOUNT RATE</a></td>
<td class="text"><p id="xdx_89F_eus-gaap--LeaseCostTableTextBlock_z1pV0GUJUfB1" style="font: bold 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="-sec-ix-redline: true">Supplemental
statement of operations information related to operating leases is as follows:</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B6_zif9s7e8i4Od" style="display: none">SCHEDULE
OF LEASE TERM AND DISCOUNT RATE</span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td colspan="2" id="xdx_490_20240701__20240930_zIaWt9EvW5ea" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">Three
    Months Ended September 30, 2024</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td colspan="2" id="xdx_49F_20230701__20230930_zkOg9rK0SLy4" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">Three
    Months Ended September 30, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td colspan="2" id="xdx_497_20240101__20240930_zXlYiL5chsM5" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">Nine
    Months Ended September 30, 2024</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td colspan="2" id="xdx_49B_20230101__20230930_zwFIrEm7eQNk" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">Nine
    Months Ended September 30, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--OperatingLeaseExpense_zMgjefZg42ab" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 44%; text-align: left"><span style="-sec-ix-redline: true">Operating lease expense as a component of general
    and administrative expenses</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="-sec-ix-redline: true">45,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="-sec-ix-redline: true">279,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="-sec-ix-redline: true">444,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="-sec-ix-redline: true">762,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--CashFlowOperatingActivitiesLesseeAbstract_iB_zi0QkZuopnX1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">Supplemental cash flow information related to operating
    leases is as follows:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">Cash paid for amounts included in the measurement of lease
    liabilities:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--OperatingLeasePayments_i01_zlWk7e7NPjg1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"><span style="-sec-ix-redline: true">Operating cash flow paid for operating
    leases</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">45,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">363,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">136,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">868,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--LeaseCostAbstract_iB_zVeWmJne5YQ6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">Lease term and Discount Rate</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"><span style="-sec-ix-redline: true">Weighted average remaining lease term
    (years)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td id="xdx_983_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_i01I_dtY_c20240930_zRklYVwN8Rk4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average remaining lease term (months)"><span style="-sec-ix-redline: true">0.8</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td id="xdx_983_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_i01I_dtY_c20230930_zctYiIdy9umd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average remaining lease term (months)"><span style="-sec-ix-redline: true">15.1</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="-sec-ix-redline: true">Weighted average discount rate</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td id="xdx_983_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_i01I_dp_uPure_c20240930_zoascLyeW4fc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average discount rate"><span style="-sec-ix-redline: true">9.0</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td id="xdx_988_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_i01I_dp_uPure_c20230930_zhUaArmGSe5l" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average discount rate"><span style="-sec-ix-redline: true">12.0</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  </table>

<span></span>
</td>
<td class="text"><p id="xdx_89F_eus-gaap--LeaseCostTableTextBlock_zOFvpHZmMXH9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Supplemental
statement of operations information related to leases for the nine months ended December 31, 2023 and fiscal year ended March 31, 2023
is as follows:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BD_zMH17NPEuaWc" style="display: none">SCHEDULE OF LEASE TERM AND DISCOUNT RATE</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_49E_20230401__20231231_zWqyUUsNndN5" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_49E_20220401__20230331_zzVpriL4SWkl" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Nine Months Ended</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Fiscal Year Ended</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--OperatingLeaseExpense_zG1MRiSO8EQl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left">Operating lease expense as a component of general and administrative expenses</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">717,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">1,058,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Supplemental cash flow information related to leases for the nine months ended December 31, 2023 and fiscal year ended March 31, 2023 is as follows:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Cash paid for amounts included in the measurement of lease liabilities:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--OperatingLeasePayments_zdqWnEkPiF56" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Operating cash flow paid for operating leases</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">858,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">960,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Lease term and Discount Rate</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Weighted average remaining lease term (months)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Operating leases</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtM_c20231231_zKkjermhv1xa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average remaining lease term (months)">15.0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtM_c20230331_zfICcyELPeRk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average remaining lease term (months)">12.4</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Weighted average discount rate</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Operating leases</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_uPure_c20231231_zpUFwiwx61Pj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average discount rate">12.0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_uPure_c20230331_zBY1LEPGSq5g" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average discount rate">6.5</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">SCHEDULE OF OPERATING LEASE MINIMUM FUTURE PAYMENTS</a></td>
<td class="text"><p id="xdx_89D_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_z0VHfRfhtwL4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Minimum
future payments under all operating leases as of September 30, 2024, are as follows:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b><span id="xdx_8BC_zcqX8rDCZpgj" style="display: none">SCHEDULE
OF OPERATING LEASE MINIMUM FUTURE PAYMENTS</span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;&#160;</b></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">Payments due by period</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td colspan="2" id="xdx_497_20240930_zHKj1Dre9ynh" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">Amount</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_iI_maLOLLPzbAO_zQ6I9RaOBx82" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 80%"><span style="-sec-ix-redline: true">2024 (remaining six months)</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="-sec-ix-redline: true">46,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_maLOLLPzbAO_zrNYz1Se4UA" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="-sec-ix-redline: true">2025</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">94,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_mtLOLLPzbAO_zRAFXg7raWI5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">Total minimum future payments</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">140,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iI_zVxOUgnXjOb2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="-sec-ix-redline: true">Less: Interest</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">5,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--OperatingLeaseLiability_iI_zRgxvCoHTA8e" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt; padding-left: 10pt"><span style="-sec-ix-redline: true">Total operating
    lease liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">135,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  </table>

<span></span>
</td>
<td class="text"><p id="xdx_89D_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zp4IXSDZzVy1" style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Minimum future payments under all operating leases as of December 31, 2023, are as follows:</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b><span id="xdx_8B3_zrBTJWYRyf78" style="display: none">SCHEDULE
OF OPERATING LEASE MINIMUM FUTURE PAYMENTS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">Payments due by period</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_495_20231231_zeoiT9zTEqfl" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Amount</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_maLOLLPzbAO_zO5vCyfHAU33" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 78%; text-align: left">2024</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right">269,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_maLOLLPzbAO_zTdNecW50r51" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">2025</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">355,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_maLOLLPzbAO_zTKJSwNDSsnk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">2026</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">529,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_maLOLLPzbAO_zbN8Kl94jvk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">2027</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">585,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_maLOLLPzbAO_zo5OU1FlIcmk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">2028</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">610,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_maLOLLPzbAO_zUA0M4XIYggd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Thereafter</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">7,555,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_mtLOLLPzbAO_zZ7pqYo4GpEl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Total minimum future payments</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">9,903,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iI_zgWxyK52Qum9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Less: interest</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">5,894,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--OperatingLeaseLiability_iI_zVOVB7QGOcuf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Total operating lease liabilities</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">4,009,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--OperatingLeaseLiabilityCurrent_iI_zIJhnVEt2fy5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Less: current portion of lease liabilities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">84,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_zHQbvNKnJDIh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Operating lease liabilities, net of current portion</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">3,925,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_DisclosureOperatingLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_DisclosureOperatingLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_ScheduleOfSupplementalInformationRelatedToLeaseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Supplemental Information Related to Lease [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_ScheduleOfSupplementalInformationRelatedToLeaseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>188
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035311487136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>WARRANTS (Tables)<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_DisclosureWarrantsAbstract', window );"><strong>Warrants</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">SCHEDULE OF WARRANTS EXPIRATION</a></td>
<td class="text"><p id="xdx_890_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zYYHPpTStg96" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 30, 2024, the Company&#8217;s warrants by expiration date were as follows:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="-sec-ix-redline: true"><span id="xdx_8B9_z53HeMr0u9Ue" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE
OF WARRANTS EXPIRATION</span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">Number of
    <br/>
    Common Warrants</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">Exercise
    Price</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">Expiration Date</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zZ9riAbr0ne4" style="font: 10pt Times New Roman, Times, Serif; width: 30%; text-align: right" title="Number of common warrants"><span style="-sec-ix-redline: true">802,113</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_988_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zQOms2NMpzql" style="font: 10pt Times New Roman, Times, Serif; width: 30%; text-align: right" title="Warrant exercise price"><span style="-sec-ix-redline: true">2.80</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32%"><span style="-sec-ix-redline: true"><span id="xdx_906_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zAhRqajSZPL5">September
    15, 2026</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zLaBM9JTpt0j" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of common warrants"><span style="-sec-ix-redline: true">100,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_987_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zAKLtDoLbeSe" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right" title="Warrant Exercise Price"><span style="-sec-ix-redline: true">5.00</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true"><span id="xdx_902_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zF2QLVbDK9Ph">May
    23, 2027</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td id="xdx_98C_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20240930_z94gW3N03BR7" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Common Warrants"><span style="-sec-ix-redline: true">902,113</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  </table>

<span></span>
</td>
<td class="text"><p id="xdx_894_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zAXu7qMU6Qxd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2023, the Company&#8217;s warrants by expiration date were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B2_z4dc31X58bna" style="display: none">SCHEDULE
OF WARRANTS EXPIRATION</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Number of</p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Common</p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Warrants</p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Exercise Price</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Expiration Date</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_z1p7O41GDgqk" style="font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: right" title="Number of common warrants">802,113</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zzlnpwNolV4l" style="font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: right" title="Warrant Exercise Price">2.80</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 52%; text-align: left"><span id="xdx_90F_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zeQZylxWsLCl" title="Expiration Date">September 15, 2026</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zUrmgJ8OuzZa" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of common warrants">100,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">$</td><td id="xdx_980_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_z2GYeW1cdQR6" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right" title="Warrant Exercise Price">5.00</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span id="xdx_905_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zvU7gahreCL4" title="Expiration Date">May 23, 2027</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20231231_zX2rc3VxQHeg" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of common warrants">902,113</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-bottom: 2.5pt">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_DisclosureWarrantsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_DisclosureWarrantsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>189
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035297560144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMPUTATION OF LOSS PER SHARE (Tables)<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Loss per Common Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">SCHEDULE OF BASIC AND DILUTIVE SHARES</a></td>
<td class="text"><p id="xdx_896_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zjxa6pA9SB0j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computation
of basic and dilutive loss per share for the three and nine months ended September 30, 2024 and 2023 are as follows:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="-sec-ix-redline: true"><span id="xdx_8BA_z8u1VjiPbD3h" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE
OF BASIC AND DILUTIVE LOSS PER SHARE</span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td colspan="2" id="xdx_499_20240701__20240930_zh24815XKJY7" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">For
    the three months ended September 30, 2024</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td colspan="2" id="xdx_498_20230701__20230930_ziiKRIrQbrTa" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">For
    the three months ended September 30, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td colspan="2" id="xdx_498_20240101__20240930_zUVz7oKTpjE8" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">For
    the nine months ended September 30, 2024</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td colspan="2" id="xdx_49A_20230101__20230930_zUwyUSQWrji4" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">For
    the nine months ended September 30, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_zMR8qGvPQ0Oh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: left"><span style="-sec-ix-redline: true">Net income (loss) available to common stockholders</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="-sec-ix-redline: true">1,195,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="-sec-ix-redline: true">97,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="-sec-ix-redline: true">(7,292,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="-sec-ix-redline: true">(5,348,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="-sec-ix-redline: true">Weighted-average common shares outstanding</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_908_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240701__20240930_zjKkO8HXtnNg">9,095,504</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_90C_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230701__20230930_zLd81j8FJH4k">4,220,259</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_90E_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240101__20240930_zrFewd9yDsbh">7,341,204</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_902_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230101__20230930_zKs9K6QYqox3">3,726,259</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">Basic and diluted income (loss)
    per share</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_907_eus-gaap--EarningsPerShareDiluted_pid_c20240701__20240930_znNJ4haozmeg">0.13</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_90A_eus-gaap--EarningsPerShareDiluted_pid_c20230701__20230930_z2Ttkzw559F8">0.03</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_pid_c20240101__20240930_zSUx8zUrNY85">(0.99</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_907_eus-gaap--EarningsPerShareDiluted_pid_c20230101__20230930_zoHdFLPdoQJl">(1.44</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true">)</span></td></tr>
  </table>

<span></span>
</td>
<td class="text"><p id="xdx_894_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zkkcrU1UzQx7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computation
of dilutive shares for the nine months ended December 31, 2023 and fiscal years ended March 31, 2023 and 2022 are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B1_zwv1HLg3C7Jd" style="display: none">SCHEDULE
OF BASIC AND DILUTIVE SHARES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_492_20230401__20231231_zMhBsn563Tz9" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Nine months ended</p>
                                               <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">December 31, 2023</p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_499_20220401__20230331_zwsIj5F43kF6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Fiscal year ended</p>
                                               <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">March 31, 2023</p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20210401__20220331_zOYnLVamqU39" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Fiscal year ended</p>
                                               <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">March 31, 2022</p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_zC8SvzUsAmnc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 43%; text-align: left">Basic weighted average common shares outstanding</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right">4,864,540</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right">2,811,872</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right">1,614,506</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_zA0NI4Fna3t" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Effect of dilutive stock options</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2654">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2655">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">8,891</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_zJVYATuS89pb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Diluted weighted average of common shares outstanding</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">4,864,540</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">2,811,872</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">1,623,397</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>190
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035116297424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE DISAGGREGATION (Tables)<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">SCHEDULE OF REVENUE BY PRODUCT LINE</a></td>
<td class="text"><p id="xdx_89C_eus-gaap--DisaggregationOfRevenueTableTextBlock_zWgjDe6nNgVk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;Revenue
by product line is as follows:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_8B1_z1QfDZZPjWcj" style="display: none">SCHEDULE
OF REVENUE BY PRODUCT LINE</span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; display: none"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td id="xdx_49C_20240701__20240930_zCzew3xSqc4e" style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; display: none"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td id="xdx_49D_20230701__20230930_zjZ5ZFJYFCAh" style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; display: none"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td id="xdx_496_20240101__20240930_zlQrx7BexgF8" style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; display: none"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td id="xdx_492_20230101__20230930_z8GQqm0u6BOa" style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td colspan="5" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">Three
                                            Months Ended</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td colspan="5" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">Nine
                                            Months Ended</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">Product Line</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">September
                                            30, 2024</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="-sec-ix-redline: true">September
                                            30, 2023</span></p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">September
                                            30, 2024</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="-sec-ix-redline: true">September
                                            30, 2023</span></p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--ClassicKaraokeMachinesMember_zvmUzb0BQWy8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 28%; text-align: left"><span style="-sec-ix-redline: true">Classic Karaoke Machines</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="-sec-ix-redline: true">8,218,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="-sec-ix-redline: true">14,636,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="-sec-ix-redline: true">10,521,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="-sec-ix-redline: true">17,363,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--LicensedProductsMember_zcRM22HViYWg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">Licensed Products</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">180,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">36,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">377,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">32,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--KidsYouthElectronicsMember_zBaA3BsGGST6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">Kids Youth Electronics</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">379,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">297,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">546,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">451,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--MicrophonesAndAccessoriesMember_zlifGfjGdIQ3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">Microphones and Accessories</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">1,500,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">806,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">3,329,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">3,543,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--MusicSubscriptionsMember_z9JfG6qqdHl4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">Music Subscriptions</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">218,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">156,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">588,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">550,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--LogisticsServicesMember_zhP1KbZNMlna" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="-sec-ix-redline: true">Logistics Services</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">127,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl1370">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">127,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl1372">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--Revenues_z2nmXoH7wJHb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">Total Net Sales</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">10,622,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">15,931,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">15,488,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true">21,939,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  </table>

<span></span>
</td>
<td class="text"><p id="xdx_896_eus-gaap--DisaggregationOfRevenueTableTextBlock_z5e4ksowGI86" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue
by product line is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BE_z3cwErgWkoab" style="display: none">SCHEDULE
OF REVENUE BY PRODUCT LINE</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_490_20230401__20231231_zcvFlwHSoYL9" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">December 31,2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_495_20220401__20230331_zlXsNzH4TLT2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_495_20210401__20220331_z5WtX8zdZ96k" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2022</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center">Nine Months Ended</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Fiscal Years Ended</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">December 31,2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2022</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-decoration: underline; text-align: left">Product Line</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--KaraokeMachinesMember_z0vcexDTdO97" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 43%; text-align: left">Karaoke Machines</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: right">24,189,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">28,856,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">38,869,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--LicensedProductsMember_zsLnmKlMotNd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Licensed Products</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">549,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">95,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,645,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--KidsYouthElectronicsMember_zXQuyMEB1F5d" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Kids Youth Electronics</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">565,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,872,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2,277,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--MicrophonesAndAccessoriesMember_zehC3h1wXjc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Microphones and Accessories</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3,283,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">7,802,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">4,185,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--MusicSubscriptionsMember_z6b5M8pZNNNg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Music Subscriptions</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">612,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">674,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">536,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--Revenues_z187dA9Sthlj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Total Net Sales</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">29,198,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">39,299,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">47,512,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock', window );">SCHEDULE OF REVENUE BY GEOGRAPHICAL REGION</a></td>
<td class="text"><p id="xdx_892_eus-gaap--ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_zUw7jGOtOBdj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales
by geographic region for the periods presented are as follows:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_8BA_zyyjRYaDDCrk" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE
OF SALES BY GEOGRAPHICAL REGION</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; display: none"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; display: none"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td id="xdx_496_20240701__20240930_z7UpUTsSdPv8" style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; display: none"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td id="xdx_497_20230701__20230930_zPB2ZINp0KB8" style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; display: none"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td id="xdx_497_20240101__20240930_zatNM73nEHe1" style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; display: none"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td id="xdx_498_20230101__20230930_zyDFJQGqHp6b" style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">Three
    Months Ended</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">Nine
    Months Ended</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">September
    30, 2024</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">September
    30, 2023</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">September
    30, 2024</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">September
    30, 2023</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td></tr>
  <tr id="xdx_40D_eus-gaap--Revenues_hsrt--StatementGeographicalAxis__srt--NorthAmericaMember_z12ApUNYOplf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 28%; text-align: left"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">North
    America</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">$</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">10,466,000</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">$</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">15,378,000</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">$</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">15,208,000</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">$</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">21,386,000</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td></tr>
  <tr id="xdx_406_eus-gaap--Revenues_hsrt--StatementGeographicalAxis__country--AU_zeia9sW3VEha" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">Australia</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">50,000</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">263,000</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">174,000</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">263,000</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td></tr>
  <tr id="xdx_40C_eus-gaap--Revenues_hsrt--StatementGeographicalAxis__srt--EuropeMember_zLH57oVPdK82" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">Europe</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">106,000</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">290,000</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">106,000</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">290,000</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td></tr>
  <tr id="xdx_40B_eus-gaap--Revenues_zs8zxZUzacD" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Net Sales</span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">$</span></span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">10,622,000</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">$</span></span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">15,931,000</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">$</span></span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">15,488,000</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">$</span></span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">21,939,000</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td></tr>
  </table>

<span></span>
</td>
<td class="text"><p id="xdx_890_eus-gaap--ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_zo4TbTIXPNVd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue
by geographic region is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BD_zhNkzveFBU0e" style="display: none">SCHEDULE OF REVENUE BY GEOGRAPHICAL REGION</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_490_20230401__20231231_zNrLZbPbyV8c" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_495_20220401__20230331_zqervhkGBDRc" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_495_20210401__20220331_zb4vNjlif2K4" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">FOR THE NINE MONTHS ENDED</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">FOR THE FISCAL YEARS ENDED</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--Revenues_hsrt--StatementGeographicalAxis__srt--NorthAmericaMember_z3SHp5Gxhxz6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 43%; text-align: left">North America</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: right">28,763,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">38,298,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">46,396,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--Revenues_hsrt--StatementGeographicalAxis__country--AU_zI0fmWTEjNM4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Australia</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">205,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">670,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">679,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--Revenues_hsrt--StatementGeographicalAxis__custom--EuropeAndUnitedKingdomMember_z2qxcwIIbrjj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Europe and United Kingdom</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">226,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">331,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">359,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--Revenues_hsrt--StatementGeographicalAxis__custom--OthersMember_ztrJtqC9geC2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">All Others</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">4,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2977">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">78,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--Revenues_z1XP4QOH1mTj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Net sales</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">29,198,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">39,299,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">47,512,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>191
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035118235152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">SCHEDULE OF PROPERTY AND EQUIPMENT</a></td>
<td class="text"><p id="xdx_890_eus-gaap--PropertyPlantAndEquipmentTextBlock_zTLkenoLXW3g" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of property and equipment is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zAmQk0bKrwej" style="display: none">SCHEDULE
OF PROPERTY AND EQUIPMENT</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">Useful</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">December 31,</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">March 31,</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Life</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48%; text-align: left">Computer and office equipment</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: left"><span id="xdx_904_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerAndOfficeEquipmentMember__srt--RangeAxis__srt--MinimumMember_zZItq5y2jJK9" title="Average useful life (in years)">5</span>-<span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerAndOfficeEquipmentMember__srt--RangeAxis__srt--MaximumMember_zluvefZyvHkg" title="Average useful life (in years)">7</span> years</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerAndOfficeEquipmentMember_zOJy9Ps5K0t7" style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right" title="Property and equipment, gross">404,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerAndOfficeEquipmentMember_zOOhCwIoh8B1" style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right" title="Property and equipment, gross">497,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Furniture and fixtures</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zsCYAHHPEDLe" title="Average useful life (in years)">7</span> years</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zqHbKfyGTJuc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross">107,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zyk4EUB7BZyc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross">111,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Warehouse equipment</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_906_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--WarehouseEquipmentMember_zkZk2d4OMzV6" title="Average useful life (in years)">7</span> years</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--WarehouseEquipmentMember_zU1a3Xgvuwmk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross"><span style="-sec-ix-hidden: xdx2ixbrl2305">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--WarehouseEquipmentMember_zZEuGuqIRqV1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross">251,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Molds and tooling</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MoldsAndToolingMember__srt--RangeAxis__srt--MinimumMember_zXcDx8A9SzZb" title="Average useful life (in years)">3</span>-<span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MoldsAndToolingMember__srt--RangeAxis__srt--MaximumMember_zUNkbKrTalP5" title="Average useful life (in years)">5</span> years</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MoldsAndToolingMember_zUTKwhQYnkq5" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross">2,228,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MoldsAndToolingMember_zL5n6RHOk1b4" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross">2,160,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20231231_zlU54n9m8uG6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross">2,739,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230331_zrs7FnVl2VLj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross">3,019,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Less: Accumulated depreciation</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pp0p0_c20231231_zH6PI5nPOcA7" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Less: Accumulated depreciation">2,335,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pp0p0_c20230331_z8dczwO11nca" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Less: Accumulated depreciation">2,386,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-bottom: 2.5pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-bottom: 2.5pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3p0_c20231231_z4mXyHYNYQZ3" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net">404,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3p0_c20230331_zbbsJanErv32" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net">633,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>192
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035115304192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK COMPENSATION EXPENSE (Tables)<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">SUMMARY OF STOCK OPTION ACTIVITY</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_894_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zwSZRhkkVd2i" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of stock option activity for each of the years presented is summarized below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span id="xdx_8BB_zxjo8GHyYRrc" style="display: none">SUMMARY OF STOCK OPTION ACTIVITY</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Nine Months Ended</p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">December 31, 2023</p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Fiscal Year Ended</p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">March 31, 2023</p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Fiscal Year Ended</p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">March 31, 2022</p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Number of</p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Options</p></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Weighted</p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Average Exercise</p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Price</p></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Weighted</p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Average Contractual</p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Life</p></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Number of</p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Options</p></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Weighted</p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Average Exercise</p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Price</p></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Weighted</p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Average Contractual</p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Life</p></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Number of</p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Options</p></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Weighted</p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Average Exercise</p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Price</p></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Weighted</p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Average Contractual</p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Life</p></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Stock Options:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; width: 28%; text-align: left">Balance at beginning of year</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20230401__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zuSR13e2AEoi" style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: right" title="Number of Options, Balance at beginning of period">161,427</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20230401__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zM4jL2mKz5ye" style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: right" title="Weighted Average Exercise Price, Balance at beginning of period">7.90</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: right"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220401__20230331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_z4VT6tWjrgqi" title="Weighted Average contractual life">6.6</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220401__20230331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_z8dASt4qV4ne" style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: right" title="Number of Options, Balance at beginning of period">56,343</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20220401__20230331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zKgXaYCHT0o2" style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: right" title="Weighted Average Exercise Price, Balance at beginning of period">9.90</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210401__20220331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zWny3OKkJnFk" title="Weighted Average contractual life">4.1</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20210401__20220331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zec1i6Kv76M9" style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: right" title="Number of Options, Balance at beginning of period">56,010</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20210401__20220331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zjjPY4f494Lk" style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: right" title="Weighted Average Exercise Price, Balance at beginning of period">9.90</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: right"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20200401__20210331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zt6XjHfdLmUi" title="Weighted Average contractual life">5.4</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Granted</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230401__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zUkFlbAFEZug" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Granted"><span style="-sec-ix-hidden: xdx2ixbrl2545">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20230401__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zunSwWVnfai3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Granted"><span style="-sec-ix-hidden: xdx2ixbrl2547">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220401__20230331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zfBOrO3XLqfi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Granted">107,752</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220401__20230331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_z1nbqACPRrm4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Granted">6.83</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210401__20220331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_z1T5Xzj2wjN7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Granted">3,667</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210401__20220331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zcgNdOMVzf3d" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Granted">7.80</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Exercised</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20230401__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zPs1yMi1yQV8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl2557">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20230401__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zApJ6Jrqzn57" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl2559">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20220401__20230331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zT42hGb2aNR" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl2561">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20220401__20230331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_z37yoMd6Q3Ti" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl2563">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20210401__20220331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zKwYoyq3KHh7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Exercised">(2,667</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20210401__20220331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zKk6OPn2Fa7k" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercised">5.40</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Forfeited</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20230401__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zM53IbfCe9X3" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Forfeited">(47,666</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20230401__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zcSqnMymjpzh" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right" title="Weighted Average Exercise Price, Forfeited">7.48</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20220401__20230331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zOaq83fvBo2h" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Forfeited">(2,668</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20220401__20230331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zzIPkkG9V76j" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right" title="Weighted Average Exercise Price, Forfeited">5.63</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20210401__20220331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zMtnNIMFxgt9" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Forfeited">(667</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20210401__20220331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zsZN6Kzaabge" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right" title="Weighted Average Exercise Price, Forfeited">3.60</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Balance at end of year *</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20230401__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_fKCop_z6HwM5zINEc7" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Balance at end of period">113,761</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20230401__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_fKCop_zT3QNP0Qe0E1" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Balance at end of period">8.08</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230401__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_fKCop_zOPu4ZtADzIj" title="Weighted Average contractual life">4.2</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20220401__20230331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_fKCop_zD4igbxPj4V7" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Balance at end of period">161,427</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20220401__20230331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_fKCop_z28dSgXsk8W1" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Balance at end of period">7.90</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span id="xdx_90C_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220401__20230331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_fKCop_zCIRXJCsJF4i" title="Weighted Average contractual life">6.6</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20210401__20220331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_fKCop_zBve8WxqYidb" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Balance at end of period">56,343</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20210401__20220331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_fKCop_z2odeywZpLlh" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Balance at end of period">9.90</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span id="xdx_90A_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210401__20220331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_fKCop_zUxCdhfq8POk" title="Weighted Average contractual life">4.1</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Options exercisable at end of year</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20230401__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_z3jhMdDLOEjd" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, exercisable at end of period">91,261</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20230401__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zPdnz0W0BGpa" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Options exercisable at end of period">8.06</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20220401__20230331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zYb8ze7xDAZ1" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, exercisable at end of period">53,675</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20220401__20230331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zeZztL05GLB6" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Options exercisable at end of period">9.90</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20210401__20220331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zU3UfCKF5SS4" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, exercisable at end of period">52,667</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20210401__20220331__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zTpFTVGB4XQe" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Options exercisable at end of period">9.90</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font: 10pt Times New Roman, Times, Serif; width: 15pt; text-align: right"><span id="xdx_F03_zMJ9yCxd4dyi" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F11_ztjnMqHqnwl5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total number of
options outstanding as of December 31, 2023, includes <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEVNUExPWUVFIFNUT0NLIE9QVElPTlMgT1VUU1RBTkRJTkcgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20231231__srt--TitleOfIndividualAxis__custom--SixCurrentAndThreeFormerDirectorsMember_ziDf0VRBSP8d" title="Option issued">23,343</span> options issued to six current and three former directors as compensation,
<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEVNUExPWUVFIFNUT0NLIE9QVElPTlMgT1VUU1RBTkRJTkcgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20231231__srt--TitleOfIndividualAxis__srt--OfficerMember_zlaFmcYLufcb" title="Option issued">56,668</span> options issued to Company officers as compensation and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEVNUExPWUVFIFNUT0NLIE9QVElPTlMgT1VUU1RBTkRJTkcgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20231231__srt--TitleOfIndividualAxis__custom--EmployeesMember_zMTAts14yJF3" title="Option issued">33,750</span> options issued to employees as part of an Employee Stock Incentive
Plan.</span></td>
</tr></table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">SCHEDULE OF WARRANTS EXPIRATION</a></td>
<td class="text"><p id="xdx_890_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zYYHPpTStg96" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 30, 2024, the Company&#8217;s warrants by expiration date were as follows:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="-sec-ix-redline: true"><span id="xdx_8B9_z53HeMr0u9Ue" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE
OF WARRANTS EXPIRATION</span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">Number of
    <br/>
    Common Warrants</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">Exercise
    Price</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="-sec-ix-redline: true">Expiration Date</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zZ9riAbr0ne4" style="font: 10pt Times New Roman, Times, Serif; width: 30%; text-align: right" title="Number of common warrants"><span style="-sec-ix-redline: true">802,113</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_988_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zQOms2NMpzql" style="font: 10pt Times New Roman, Times, Serif; width: 30%; text-align: right" title="Warrant exercise price"><span style="-sec-ix-redline: true">2.80</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32%"><span style="-sec-ix-redline: true"><span id="xdx_906_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zAhRqajSZPL5">September
    15, 2026</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zLaBM9JTpt0j" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of common warrants"><span style="-sec-ix-redline: true">100,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_987_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zAKLtDoLbeSe" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right" title="Warrant Exercise Price"><span style="-sec-ix-redline: true">5.00</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="-sec-ix-redline: true"><span id="xdx_902_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zF2QLVbDK9Ph">May
    23, 2027</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td id="xdx_98C_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20240930_z94gW3N03BR7" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Common Warrants"><span style="-sec-ix-redline: true">902,113</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">&#160;</span></td></tr>
  </table>

<span></span>
</td>
<td class="text"><p id="xdx_894_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zAXu7qMU6Qxd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2023, the Company&#8217;s warrants by expiration date were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B2_z4dc31X58bna" style="display: none">SCHEDULE
OF WARRANTS EXPIRATION</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Number of</p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Common</p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Warrants</p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Exercise Price</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Expiration Date</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_z1p7O41GDgqk" style="font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: right" title="Number of common warrants">802,113</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zzlnpwNolV4l" style="font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: right" title="Warrant Exercise Price">2.80</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 52%; text-align: left"><span id="xdx_90F_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zeQZylxWsLCl" title="Expiration Date">September 15, 2026</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zUrmgJ8OuzZa" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of common warrants">100,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">$</td><td id="xdx_980_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_z2GYeW1cdQR6" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right" title="Warrant Exercise Price">5.00</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span id="xdx_905_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zvU7gahreCL4" title="Expiration Date">May 23, 2027</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20231231_zX2rc3VxQHeg" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of common warrants">902,113</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-bottom: 2.5pt">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>193
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035116978128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>AUGUST 2021 PRIVATE PLACEMENT (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_DisclosureAugust2021PrivatePlacementAbstract', window );"><strong>August 2021 Private Placement</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ScheduleOfLossBeforeIncomeTaxTableTextBlock', window );">SCHEDULE OF LOSS BEFORE INCOME TAXES</a></td>
<td class="text"><p id="xdx_89C_ecustom--ScheduleOfLossBeforeIncomeTaxTableTextBlock_zcKIvPBKU3z8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s loss before income taxes for the nine months ended December 31, 2023, and fiscal years ended March 31, 2023, and 2022
is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span id="xdx_8BE_z3CzUrwMDpU2" style="display: none">SCHEDULE OF LOSS BEFORE INCOME TAXES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_491_20230401__20231231_z3gv4sBqTotb" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20220401__20230331_zFivyGNqlKJl" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_492_20210401__20220331_zHzf2VMRhQWe" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">Nine months ended</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Fiscal years ended</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_zwVDB3c5KXVc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 34%; text-align: left">United States</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right">(6,173,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right">(3,526,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right">(261,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_404_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_zeCEGkZB61cj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Foreign</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(225,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(82,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">548,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_zs8t6xUY4trg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss
    before income taxes</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(6,398,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(3,608,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">287,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">SCHEDULE OF PROVISION FOR INCOME TAXES</a></td>
<td class="text"><p id="xdx_89B_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zwnpNk4VM3Al" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
provision for income taxes for the nine months ended December 31, 2023, and fiscal years ended March 31, 2023, and 2022 is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span id="xdx_8BF_z3RkLhSRENai" style="display: none">SCHEDULE OF PROVISION FOR INCOME TAXES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_496_20230401__20231231_zMrKuEIP6l78" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_496_20220401__20230331_zVWJ0jALdzn2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_499_20210401__20220331_zRwAoTfR3pM" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">Nine months ended</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Fiscal years ended</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2022</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Income tax provision:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Current:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--CurrentFederalTaxExpenseBenefit_maCFSALz48L_zePw4gom3VJj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 34%; text-align: left">Federal</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2795">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right">109,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right">63,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_maCFSALz48L_zJtMCKdI8mt1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">State</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2799">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2800">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2801">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--CurrentOtherTaxExpenseBenefit_maCFSALz48L_z2xFJgRqIO7e" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Other</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2803">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(5,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2805">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--CurrentForeignTaxExpenseBenefit_maCFSALz48L_z4wliGmmM3v9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1pt">Hong Kong</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2807">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">34,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2809">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--CurrentFederalStateAndLocalTaxExpenseBenefit_iT_mtCFSALz48L_maITEBzBKD_zObMMc8g0sfj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Total current Federal and State</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2811">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">138,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">63,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Deferred:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_maDFSALzMsp_z5wMSFShEQaj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Federal</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2815">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">686,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(60,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_40E_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_maDFSALzMsp_zikmZFKcqwX9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1pt">State</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2819">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">206,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">54,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--DeferredFederalStateAndLocalTaxExpenseBenefit_iT_mtDFSALzMsp_maITEBzBKD_zc0coHnpCFEh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Total Deferred Federal and State</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2823">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">892,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(6,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--IncomeTaxExpenseBenefit_iT_mtITEBzBKD_zlOwdZewRqMb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Total income tax provision</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2827">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">1,030,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">57,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES</a></td>
<td class="text"><p id="xdx_893_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zKyasForL40c" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s net deferred tax assets as of December 31, 2023, and ended March 31, 2023 are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B3_zyy9lBaEuoLj" style="display: none">SCHEDULE
OF DEFERRED TAX ASSETS AND LIABILITIES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" id="xdx_49A_20231231_znTKkDMvVGEk" style="font: 10pt Times New Roman, Times, Serif; text-align: center">December 31,</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" id="xdx_494_20230331_zsJ6V8SEPaQ7" style="font: 10pt Times New Roman, Times, Serif; text-align: center">March 31,</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsDomestic_iI_maDTAGzkTe_zJcF4AE0oCF9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left">NOL Federal Carryforward</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">1,291,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">868,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_iI_maDTAGzkTe_zfbMU0Jdv45i" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">State NOL Carryforward</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">470,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">341,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsInventory_iI_maDTAGzkTe_zqMAT95bmnSd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Inventory differences to inventory valuation</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,173,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">623,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_iI_maDTAGzkTe_z18znzqFGylg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Stock option compensation expense</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">159,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">184,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--DeferredTaxAssetsRightUseOfLiability_iI_maDTAGzkTe_z7MQ7WEw3lse" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Right of use liability</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,022,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">118,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--DeferredTaxAssetsBusinessInterestLimitation_iI_maDTAGzkTe_z04oHutDkea3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Business interest limitation</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">151,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">138,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--DeferredTaxAssetsAllowanceForDoubtFulAccounts_iI_maDTAGzkTe_zg3VHHmlvoMb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Allowance for doubtful accounts</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">45,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">43,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances_iI_maDTAGzkTe_zwTm6k5Oi3b2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Reserve for estimated returns</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">384,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">89,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_iI_maDTAGzkTe_zLsHZcgvuira" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Accrued vacation</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">7,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">14,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--DeferredTaxAssetsGross_iTI_mtDTAGzkTe_maDTANzmdy_zgDA8p5rs8gh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">4,702,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2,418,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_msDTANzmdy_zH2zn2oTD532" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Less: valuation allowance</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(3,600,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(2,104,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40B_eus-gaap--DeferredTaxAssetsNet_iTI_maDTALNzWnn_mtDTANzmdy_zq4JfvbOkoL" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Net deferred tax asset</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1,102,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">314,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--DeferredTaxLiabilitiesPropertyPlantAndEquipment_iNI_di_maDTLzkol_zQU1KPUgfPJk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Depreciable and amortizable assets</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(67,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(134,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_40C_ecustom--DeferredTaxLiabilitiesRightUseOfAsset_iNI_di_maDTLzkol_zCoA2j3XFaBd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">ROU Asset</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(1,000,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(111,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_403_eus-gaap--DeferredTaxLiabilitiesPrepaidExpenses_iNI_di_maDTLzkol_zlE04no3wyIe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Prepaid expenses</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(35,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(69,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--DeferredTaxLiabilities_iNTI_di_msDTALNzWnn_mtDTLzkol_zlWlWrLvQpIb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Net deferred tax liability</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(1,102,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(314,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTI_mtDTALNzWnn_zIj3UIbrG3df" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2881">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2882">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock', window );">SCHEDULE OF TAX PROVISION</a></td>
<td class="text"><p id="xdx_89F_eus-gaap--ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_zXpACVfvQcl4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
actual tax provision differs from the &#8220;expected&#8221; tax for the nine-month transition period ended December 31, 2023, and
the years ended March 31, 2023, and 2022 (computed by applying the U.S. Federal Corporate tax rate of 21 percent to income before
taxes) as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BB_zcJhmqf1s41b" style="display: none">SCHEDULE
OF TAX PROVISION</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20230401__20231231_z8vkNy8O8w6l" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_495_20220401__20230331_zp2XvTg004g7" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_490_20210401__20220331_zQ3piCOGCKQi" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2022</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_maITEBzmuZ_zqhaPji5LA26" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 43%; text-align: left">Statutory federal tax rate</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: right">(1,344,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">(758,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">60,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_maITEBzmuZ_znWhJFW0VkI7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Stater tax rate</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(326,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(174,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">14,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--IncomeTaxReconciliationChangeInEnactedTaxRate_maITEBzmuZ_zbpaBJyHD3V3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Permanent differences</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">15,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">13,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">10,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecustom--IncomeTaxReconciliationChangeInPermanentDifferencesERCIncome_maITEBzmuZ_z0sxIegNnU8g" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Permanent difference in ERC income</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2898">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(99,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2900">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--IncomeTaxReconciliationForeignIncomeTaxRateDifferential_maITEBzmuZ_zxM7CBG0rctj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Tax rate differential on foreign earnings</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">59,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">21,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(84,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_404_ecustom--IncomeTaxReconciliationChangeInExpirationOfNetOpretaingLossCarryforward_maITEBzmuZ_z3bxgbF9SVQd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Expiration of net operating loss carryforward</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">89,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2907">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2908">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_maITEBzmuZ_zDX1hCDEpzVk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Change in valuation allowance</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,495,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2,026,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">55,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--IncomeTaxReconciliationOtherReconcilingItems_maITEBzmuZ_zzR1Oatq5DS4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Other</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">12,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">2,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--IncomeTaxExpenseBenefit_iT_mtITEBzmuZ_zX0jsMOAbHnd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax
    provision</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2918">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">1,030,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">57,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_DisclosureAugust2021PrivatePlacementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_DisclosureAugust2021PrivatePlacementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_ScheduleOfLossBeforeIncomeTaxTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Loss Before Income Tax [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_ScheduleOfLossBeforeIncomeTaxTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>194
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035117434736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL INFORMATION CONDENSED FINANCIAL INFORMATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfCondensedIncomeStatementTableTextBlock', window );">SCHEDULE OF CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</a></td>
<td class="text"><p id="xdx_894_esrt--ScheduleOfCondensedIncomeStatementTableTextBlock_zRwUdi7R88z1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B2_z6ajTb0E5juc">SCHEDULE
OF CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS&#160;</span></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--IncomeStatementAbstract_pn3n3_zk1596I4Wbc4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SCHEDULE OF CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Details)">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_494_20230401__20231231_zUw8GwXOeui" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_490_20220401__20221231_zXvi6m7zAge8" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Nine Months Ended</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">(unaudited)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_maGPzmfg_z9MVSYgGPy5h" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; width: 60%; text-align: left">Net Sales</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">29,198,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">35,916,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--CostOfGoodsAndServicesSold_msGPzmfg_zJLNOOQwROW3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Cost of Goods Sold</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">23,008,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">27,481,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--GrossProfit_iT_pp0p0_mtGPzmfg_maOILzsGr_za4kC8gX327g" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Gross Profit</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">6,190,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">8,435,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--OperatingExpenses_pp0p0_msOILzsGr_zE9QVe01jj7h" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Operating Expenses</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">12,333,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">9,986,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--OperatingIncomeLoss_iT_pp0p0_mtOILzsGr_maILFCOzzC2_zHJguttX6boe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">(Loss) Income from Operations</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(6,143,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(1,551,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--NonoperatingIncomeExpense_pp0p0_maILFCOzzC2_zp1msKve4kq6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Other (Expenses) Income</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(255,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(574,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iT_pp0p0_mtILFCOzzC2_maNILzRTS_ztxzDGaPsQV9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">(Loss) Income Before Income Tax Benefit</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(6,398,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(2,125,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--IncomeTaxExpenseBenefit_iN_pp0p0_di_msNILzRTS_zcGL0bqOzrla" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Income Tax Benefit (Loss)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3079">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">472,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--ProfitLoss_iT_pp0p0_mtNILzRTS_zMycqg2Gmiql" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Net (Loss) Income</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(6,398,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(1,653,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--EarningsPerShareAbstract_iB_z7JAa0AK9DI6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Loss per Common Share</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Basic and Diluted</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTkRFTlNFRCBDT05TT0xJREFURUQgU1RBVEVNRU5UUyBPRiBPUEVSQVRJT05TIChEZXRhaWxzKQA_" id="xdx_900_eus-gaap--EarningsPerShareBasic_pid_c20230401__20231231_zFisDk6vXfV5" title="Basic"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTkRFTlNFRCBDT05TT0xJREFURUQgU1RBVEVNRU5UUyBPRiBPUEVSQVRJT05TIChEZXRhaWxzKQA_" id="xdx_900_eus-gaap--EarningsPerShareDiluted_pid_c20230401__20231231_zrfoP03g4xC9" title="Diluted">(1.32</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTkRFTlNFRCBDT05TT0xJREFURUQgU1RBVEVNRU5UUyBPRiBPUEVSQVRJT05TIChEZXRhaWxzKQA_" id="xdx_905_eus-gaap--EarningsPerShareBasic_pid_c20220401__20221231_zigRinIATjdk" title="Basic"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTkRFTlNFRCBDT05TT0xJREFURUQgU1RBVEVNRU5UUyBPRiBPUEVSQVRJT05TIChEZXRhaWxzKQA_" id="xdx_906_eus-gaap--EarningsPerShareDiluted_pid_c20220401__20221231_z6xAmVxVcGn1" title="Diluted">(0.61</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--EarningsPerShareBasicOtherDisclosuresAbstract_iB" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Weighted Average Common and Common</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Equivalent Shares:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--EarningsPerShareBasicOtherDisclosuresAbstract_iB_z4AL99Y9uNWh" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Weighted Average Common and Common Equivalent Shares:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Basic and Diluted</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTkRFTlNFRCBDT05TT0xJREFURUQgU1RBVEVNRU5UUyBPRiBPUEVSQVRJT05TIChEZXRhaWxzKQA_" id="xdx_904_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20230401__20231231_z62xNBARsPq1" title="Basic"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTkRFTlNFRCBDT05TT0xJREFURUQgU1RBVEVNRU5UUyBPRiBPUEVSQVRJT05TIChEZXRhaWxzKQA_" id="xdx_907_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20230401__20231231_znDWmOHXgU81" title="Diluted">4,864,540</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTkRFTlNFRCBDT05TT0xJREFURUQgU1RBVEVNRU5UUyBPRiBPUEVSQVRJT05TIChEZXRhaWxzKQA_" id="xdx_908_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20220401__20221231_zzFnOlShhQ4g" title="Basic"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTkRFTlNFRCBDT05TT0xJREFURUQgU1RBVEVNRU5UUyBPRiBPUEVSQVRJT05TIChEZXRhaWxzKQA_" id="xdx_907_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20220401__20221231_zfWTnrupW0d3" title="Diluted">2,699,210</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfCondensedCashFlowStatementTableTextBlock', window );">SCHEDULE OF CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</a></td>
<td class="text"><p id="xdx_898_esrt--ScheduleOfCondensedCashFlowStatementTableTextBlock_zzJFFZvUv7P4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B9_zq2esEfyrJUc">SCHEDULE
OF CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</span></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--StatementOfCashFlowsAbstract_pn3n3_z5qt6cR0g2Kd" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SCHEDULE OF CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Details)">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_494_20230401__20231231_zN3BV2OvRkHe" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20220401__20221231_zWPEFIOYuZP4" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">For the Nine Months Ended</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">(unaudited)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Cash flows from operating activities</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--ProfitLoss_i01_pp0p0_maNCPBUzVoD_zRbqIkluj2xg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 60%; text-align: left">Net loss</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">(6,398,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">(1,653,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_405_eus-gaap--AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_i01_maNCPBUzVoD_z2q9M7Aaj0rc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Adjustments to reconcile net loss to net cash used in operating activities:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,305,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(73,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_40C_eus-gaap--IncreaseDecreaseInOperatingCapital_i02N_di_msNCPBUzVoD_zycYRO5ECe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1pt">Changes in operating assets and liabilities:</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">5,504,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="letter-spacing: -0.1pt">(538,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_405_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i01T_pp0p0_maCCERCzHgo_mtNCPBUzVoD_z5HCjOq13Pf2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left; padding-bottom: 1pt">Net cash provided by (used in) operating activities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">411,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="letter-spacing: -0.1pt">(2,264,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40E_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Cash flows from investing activities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--NetCashProvidedByUsedInInvestingActivities_i01T_pp0p0_maCCERCzHgo_mtNCPBUzYTF_zu7TLVNtK3H" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left; padding-bottom: 1pt">Net cash used in investing activities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(14,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(149,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40F_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Cash flows from financing activities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_pp0p0_mtNCPBUz2nB_maCCERCzHgo_zNUUYQjGsFo4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left; padding-bottom: 1pt">Net cash provided by financing activities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">3,411,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">2,917,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_iT_pp0p0_mtCCERCzHgo_zLQk8dYsgvM2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Net change in cash</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3,808,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="letter-spacing: -0.1pt">504,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iS_zYLw7ZXMPcnj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Cash at beginning of year</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">2,895,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="letter-spacing: -0.1pt">2,291,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iE_pp0p0" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Cash at end of period</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">6,703,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">2,795,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfCashFlowsAbstract', window );"><strong>Statement of Cash Flows [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityTableTextBlock', window );">SCHEDULE OF CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS&#8217; EQUITY</a></td>
<td class="text"><p id="xdx_896_eus-gaap--ScheduleOfStockholdersEquityTableTextBlock_zCW1DqARj325" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BE_zvYf1K7G3G04">SCHEDULE
OF CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS&#8217; EQUITY </span><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--StatementOfStockholdersEquityAbstract_pn3n3_zxyrKaMhy6f1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SCHEDULE OF CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS? EQUITY (Details)">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Shares</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B2_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zEtMtgSm2zZ8" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Amount</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B5_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_zAxMPGS8fGRg" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Capital</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4BB_us-gaap--StatementEquityComponentsAxis_us-gaap--ReceivablesFromStockholderMember_zCLULKo1u7T5" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Receivable</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B2_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zuAhdj1FY41h" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Deficit</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4BC_zScqmt4y1DSg" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Total</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Common Stock</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center">Additional Paid in</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center">Subscriptions</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center">Accumulated</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Shares</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Amount</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Capital</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Receivable</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Deficit</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Total</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_430_c20230401__20231231_eus-gaap--StockholdersEquity_iS_z15MFfvx8tte" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; width: 40%; text-align: left">Balance at March 31, 2023</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--SharesOutstanding_iS_c20230401__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zowtBJASZVCh" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Balance, shares">3,167,488</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span style="letter-spacing: -0.1pt">32,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span style="letter-spacing: -0.1pt">29,822,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right">(6,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right">(19,517,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right">10,331,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--ProfitLoss_zljSGiBzflMd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Net loss</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3162">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3163">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3164">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(6,398,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(6,398,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_408_eus-gaap--StockIssuedDuringPeriodValueNewIssues_zuXpPoKfvDuh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Issuance of common stock, net of stock offering costs</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230401__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zHs66oERJF77" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Issuance of common stock, net of stock offering costs, shares">3,250,573</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">32,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3,497,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3170">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3171">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3,529,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--ShareBasedCompensation_zAD96sTcLV4c" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Stock based compensation</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensation_c20230401__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zetVtSdvzZK1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock based compensation ,shares"><span style="-sec-ix-hidden: xdx2ixbrl3182">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3176">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">110,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3178">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3179">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">110,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--StockIssuedDuringPeriodValueOther_zwMG12wIkAC4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Other</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesOther_c20230401__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zVRpaFXW54eb" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Other, shares"><span style="-sec-ix-hidden: xdx2ixbrl3190">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3184">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3185">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">6,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3187">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">6,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_43A_c20230401__20231231_eus-gaap--StockholdersEquity_iE_z9PBjMd6zXs8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">&#160;Balance at December 31, 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--SharesOutstanding_iE_c20230401__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zoqWMShhrePd" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Balance, shares">6,418,061</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">64,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">33,429,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3194">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(25,915,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">7,578,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Common Stock</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center">Additional Paid in</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center">Subscriptions</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center">Accumulated</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Shares</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Amount</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Capital</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Receivable</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Deficit</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Total</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_430_c20220401__20221231_eus-gaap--StockholdersEquity_iS_zycTCV8uqA29" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; width: 40%; text-align: left">Balance at March 31, 2022</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--SharesOutstanding_iS_c20220401__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zdlm0MkAosCh" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Balance, shares">1,221,209</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right">12,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right">24,903,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right">&#160;&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl3202">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right">(14,879,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right">10,036,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_436_c20220401__20221231_eus-gaap--StockholdersEquity_iS_zojW5XrXZ977" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Balance, value</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--SharesOutstanding_iS_c20220401__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zwTA0nkfmV2a" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Balance, shares">1,221,209</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">12,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">24,903,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl3210">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(14,879,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">10,036,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--ProfitLoss_zkUmFtmEA8h2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Net loss</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3216">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3217">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3218">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(1,653,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(1,653,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_408_eus-gaap--StockIssuedDuringPeriodValueNewIssues_zqnTAwvBYPt5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Issuance of common stock and warrants, net of stock offering costs</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220401__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zJ1CYS2FTsP5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Issuance of common stock and warrants, net of stock offering costs, shares">1,909,519</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">19,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">4,489,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3224">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3225">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">4,508,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--ShareBasedCompensation_z20q0lgt0B88" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Stock based compensation</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensation_c20220401__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zDSwTyperGsd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock based compensation ,shares">15,803</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3230">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">307,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3232">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3233">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">307,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--StockIssuedDuringPeriodValueOther_zVfoPv7TlHG9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Other</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--StockIssuedDuringPeriodSharesOther_c20220401__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zqFQDez6fl4" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Other, shares">1,688</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3238">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(1,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3240">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">1,000</p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3242">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_430_c20220401__20221231_eus-gaap--StockholdersEquity_iE_zuIEPlPLRTZe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Balance at December 31, 2022 (unaudited)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--SharesOutstanding_iE_c20220401__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zVm7Ha1dRStd" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Balance, shares">3,148,219</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">31,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">29,698,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3248">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(16,531,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">13,198,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_43D_c20220401__20221231_eus-gaap--StockholdersEquity_iE_z9aej9Q95ur6" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Balance, value</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--SharesOutstanding_iE_c20220401__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zsOmskrUNKS" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Balance, shares">3,148,219</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">31,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">29,698,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3256">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(16,531,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">13,198,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=RIME_SemiCabIncMember', window );">Semi Cab Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock', window );">SCHEDULE OF ESTIMATED USEFUL LIVES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_897_eus-gaap--ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock_z2dJnq9UqxD5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zmYEfXhjCFr5" style="display: none">SCHEDULE
OF ESTIMATED USEFUL LIVES</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></p>

<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify">&#160;</td>
  <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Years</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 70%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
  and Equipment</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 30%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__srt--RangeAxis__srt--MinimumMember_zhbOAT3stvZh" title="Property plant and equipment useful life">3</span> - <span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__srt--RangeAxis__srt--MaximumMember_zqn6PxRDpa4c" title="Property plant and equipment useful life">5</span></span></td></tr>
</table>


<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfCondensedCashFlowStatementTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of condensed cash flow statement, including, but not limited to, cash flow statements of consolidated entities and consolidation eliminations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 04<br> -Paragraph a<br> -Publisher SEC<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfCondensedCashFlowStatementTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfCondensedIncomeStatementTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of condensed income statement, including, but not limited to, income statements of consolidated entities and consolidation eliminations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 04<br> -Paragraph a<br> -Publisher SEC<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfCondensedIncomeStatementTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of public utility physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation expense and method used, including composite depreciation, and accumulated depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 980<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481834/980-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of changes in the separate accounts comprising stockholders' equity (in addition to retained earnings) and of the changes in the number of shares of equity securities during at least the most recent annual fiscal period and any subsequent interim period presented is required to make the financial statements sufficiently informative if both financial position and results of operations are presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfCashFlowsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfCashFlowsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=RIME_SemiCabIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=RIME_SemiCabIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>195
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035119155696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTES PAYABLE AND FINANING ARRANGEMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=RIME_SemiCabIncMember', window );">Semi Cab Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">SCHEDULE OF SPECIFIC TERMS</a></td>
<td class="text"><p id="xdx_890_eus-gaap--ScheduleOfDebtTableTextBlock_zjVs3uuodTWd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beginning
in July of 2021, and ending in May of 2023, the Company entered into a total of six shareholder loan agreements with a total of three
shareholders. These notes are all unsecured with limited rights of recourse. The specific terms of each note are summarized on the table
below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span id="xdx_8B6_zpz2rEc3RS87" style="display: none">SCHEDULE OF SPECIFIC TERMS</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif">Date</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Maturity</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Holder</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Principal</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Rate</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Accrued Interest</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Current Balance</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 12%"><span id="xdx_909_eus-gaap--DebtInstrumentIssuanceDate1_c20210710__20210710__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zMxeSg9oDMpc" title="Date">7/10/2021</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: center"><span id="xdx_90D_eus-gaap--DebtInstrumentMaturityDate_c20210710__20210710__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zF3FgAPQLLs" title="Maturity">7/10/2026</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: center">Ajesh Kapoor</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pp2d_c20210710__20210710__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zZUUQwVGwcHh" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Principal">150,000.00</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span id="xdx_908_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20210710__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zvdo8UoOZZx9" title="Rate">9.0</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--DebtInstrumentPeriodicPaymentInterest_pp2d_c20210710__20210710__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zbXg08gQ3suc" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Accrued Interest">36,838.36</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--DebtInstrumentPeriodicPayment_pp2d_c20210710__20210710__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zsCuIFPy3W18" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Current Balance">186,838.36</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90E_eus-gaap--DebtInstrumentIssuanceDate1_c20210827__20210827__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_z3zQ7dE44r28" title="Date">8/27/2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90B_eus-gaap--DebtInstrumentMaturityDate_c20210827__20210827__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_z82UfKP6YOJ5" title="Maturity">8/26/2026</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">Ajesh Kapoor</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98C_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pp2d_c20210827__20210827__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zc0bFz2i6mR2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">235,000.00</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20210827__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zSkUfAtXdMv4" title="Rate">9.0</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_986_eus-gaap--DebtInstrumentPeriodicPaymentInterest_pp2d_c20210827__20210827__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zyMUpXy8YYF9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accrued Interest">54,932.05</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_984_eus-gaap--DebtInstrumentPeriodicPayment_pp2d_c20210827__20210827__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zZio3ImCnja9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Current Balance">289,932.05</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90B_eus-gaap--DebtInstrumentIssuanceDate1_c20230417__20230417__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--VivekSehgalMember_zuBVgiyGuJ15" title="Date">4/17/2023</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_c20230417__20230417__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--VivekSehgalMember_zL93Kx1OE147" title="Maturity">10/16/2023</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">Vivek Sehgal</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98C_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pp2d_c20230417__20230417__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--VivekSehgalMember_zDVy2qwrrGsl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">50,000.00</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20230417__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--VivekSehgalMember_zTOgp5Ja2CT5" title="Rate">10.0</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_980_eus-gaap--DebtInstrumentPeriodicPaymentInterest_pp2d_c20230417__20230417__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--VivekSehgalMember_zJpj5JUzaJu9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accrued Interest">4,794.52</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_983_eus-gaap--DebtInstrumentPeriodicPayment_pp2d_c20230417__20230417__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--VivekSehgalMember_zh9u9wekat1l" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Current Balance">54,794.52</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_905_eus-gaap--DebtInstrumentIssuanceDate1_c20230505__20230505__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zMh3trEJXS61" title="Date">5/5/2023</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_907_eus-gaap--DebtInstrumentMaturityDate_c20230505__20230505__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_z7GsuQ7ZTXE6" title="Maturity">5/4/2024</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">Ajesh Kapoor</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_983_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pp2d_c20230505__20230505__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zHucpzqngjnf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">50,000.00</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20230505__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_z9J0SLMyNfyj" title="Rate">10.0</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_989_eus-gaap--DebtInstrumentPeriodicPaymentInterest_pp2d_c20230505__20230505__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zBd3J4sMd0gj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accrued Interest">4,547.95</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_986_eus-gaap--DebtInstrumentPeriodicPayment_pp2d_c20230505__20230505__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zKRkUjy3cc0d" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Current Balance">54,547.95</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90E_eus-gaap--DebtInstrumentIssuanceDate1_c20230508__20230508__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--JaganReddyMember_zLITNj5tRMZa" title="Date">5/8/2023</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_902_eus-gaap--DebtInstrumentMaturityDate_c20230508__20230508__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--JaganReddyMember_zydI6JVpUaEg" title="Maturity">5/7/2024</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">Jagan Reddy</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98E_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pp2d_c20230508__20230508__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--JaganReddyMember_z1dk5xlV6Vwg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">50,000.00</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_906_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20230508__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--JaganReddyMember_zz4lr1bk8xv9" title="Rate">10.0</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_982_eus-gaap--DebtInstrumentPeriodicPaymentInterest_pp2d_c20230508__20230508__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--JaganReddyMember_zf95chdqpBLk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accrued Interest">4,506.85</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_985_eus-gaap--DebtInstrumentPeriodicPayment_pp2d_c20230508__20230508__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--JaganReddyMember_zSau5oqdc87g" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Current Balance">54,506.85</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_906_eus-gaap--DebtInstrumentIssuanceDate1_c20230517__20230517__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zsEPMwAukQa6" title="Date">5/17/2023</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_c20230517__20230517__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zeLWdCc3sYbj" title="Maturity">5/16/2024</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">Ajesh Kapoor</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_980_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pp2d_c20230517__20230517__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zHrzrv6MhQhj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">165,000.00</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20230517__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zNKVAz1OIPvb" title="Rate">10.0</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_984_eus-gaap--DebtInstrumentPeriodicPaymentInterest_pp2d_c20230517__20230517__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_z286zhnhOtD3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accrued Interest">14,465.75</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98E_eus-gaap--DebtInstrumentPeriodicPayment_pp2d_c20230517__20230517__us-gaap--TypeOfArrangementAxis__custom--SixShareholderLoanAgreementsMember__srt--TitleOfIndividualAxis__custom--AjeshKapoorMember_zxgJ2W2cOTQ6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Current Balance">179,465.75</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=RIME_SemiCabIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=RIME_SemiCabIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>196
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035112434688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS&#8217; EQUITY (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=RIME_SemiCabIncMember', window );">Semi Cab Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ScheduleOfStockOptionIssuedTableTextBlock', window );">SCHEDULE OF STOCK OPTION ISSUED DURING THE YEAR DECEMBER 31, 2020, 2021 AND 2022</a></td>
<td class="text"><p id="xdx_89D_ecustom--ScheduleOfStockOptionIssuedTableTextBlock_zS4MKNLnlLo3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the years ended Dember 31, 2020, 2021 and 2022 the Company issued the following stock options, as shown below. No options were issued
in 2023 or 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span id="xdx_8B5_zQna3u5WPUSa" style="display: none">SCHEDULE OF STOCK OPTION ISSUED
DURING THE YEAR DECEMBER 31, 2020, 2021 AND 2022</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif">Holder</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">Granted Shares</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">Outstanding Awards</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">Grant Date</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">Exercise Price</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">Vesting Start Date</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">Vested Outstanding</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">Unvested</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">Date Fully Vested</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">Board Approval Date</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">Expiration Date</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: left">Sudhir Narasimhamurthy</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zkaVwWdoGg3" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Granted Shares">180,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zcr2MKz1AwFg" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Outstanding Awards">180,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span id="xdx_901_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z1PCe2WkmQMa" title="Granted Date">09-29-2020</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20201231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zEwHsyzEa6K4" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Exercise price">0.06</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span id="xdx_904_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z5ZXzIUpv5v2" title="Vesting Date">09-29-2020</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z1y1z4fUkMd9" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Vested Outstanding">180,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20201231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zjAJBNToTHb9" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Unvested">0</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zc9gMLKiRMSi" title="Date Fully Vested">09-29-2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span id="xdx_908_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z6c6IllFXpx7" title="Board Approval Date">09-28-2020</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zdfXa5VRylw9" title="Expiration Date">09-28-2030</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Sudhir Narasimhamurthy</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z3uCfygXvbR4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">50,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zQtKppP6tag2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">50,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_znDPUpqUbYw1" title="Granted Date">08-12-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20211231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zjCZBQdsmS37" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.06</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z5Wb3cLxzFP2" title="Vesting Date">09-01-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zvRymfYhav79" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding">33,333</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20211231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z430AXwdWbqa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested">16,667</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_ztFM8AbGO4z" title="Date Fully Vested">09-01-2025</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z8DY2FENLkba" title="Board Approval Date">08-12-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zaVtrIbr1jSa" title="Expiration Date">08-11-2031</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Sudhir Narasimhamurthy</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zdQxKgnCNhYl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">25,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zpCDH1mvMsFb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">25,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zOpcXghoINqd" title="Granted Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zkXP0xggFfQ4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.05</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zSKiAJqKuqb1" title="Vesting Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zNyEIkIRBfme" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding">12,500</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zbeugqboZ186" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested">12,500</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zCJz3cB56Coc" title="Date Fully Vested">05-02-2026</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zr8EiANorbQf" title="Board Approval Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z6JDYzFtRMFg" title="Expiration Date">05-01-2032</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Kadandale Srinivas Sudheer</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zQXre4LkNdsg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">600,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zZEPsi2Skxqd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">600,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20200101__20201231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zEog8Y6iMuMb" title="Granted Date">09-29-2020</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20201231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z8wAPlyTERF9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.06</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zZ1kQQCQyof3" title="Vesting Date">09-29-2020</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z19ywhQYgQYa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding">600,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20201231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zTe1UbNcWdQk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zbxETfbMaBLd" title="Date Fully Vested">09-29-2023</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z7eACM5ED3Ci" title="Board Approval Date">09-28-2020</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z0JG5iPR3Z17" title="Expiration Date">09-28-2030</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Kadandale Srinivas Sudheer</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20211231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_za98zzoEujK9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">100,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zE3JVBLazA0a" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">100,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90F_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20210101__20211231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z6eOXUUTjNrk" title="Granted Date">08-12-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20211231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zg6Nmo40glYd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.06</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zFeRQu9z9nq" title="Vesting Date">09-01-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z8tDJidvYA8g" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding">66,666</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20211231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zODHT2K3W2L3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested">33,334</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zJAqgSZbew21" title="Date Fully Vested">09-01-2025</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zMLmVAewjCL5" title="Board Approval Date">08-12-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zU0PUmZ171j1" title="Expiration Date">08-11-2031</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Kadandale Srinivas Sudheer</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zytGZ9hbU7ja" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">50,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zF4FHf7SRPXe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">50,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_904_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z8UbrhZ7O8t1" title="Granted Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--SudhirNarasimhamurthyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zSYMGd9uqPca" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.05</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zbDudXMOICq9" title="Vesting Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zhW8YXZAWDZd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding">25,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zZRwBgBVHrud" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested">25,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z88nzqafXHq3" title="Date Fully Vested">05-02-2026</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_903_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zlGP0zcOyh0i" title="Board Approval Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zCz9iQ9aDTn8" title="Expiration Date">05-01-2032</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Vivek Sehgal</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zRpjmlZTOGX3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">4,000,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zcQvVn88Xlzd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">4,000,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20200101__20201231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zYn1HvGb2uE3" title="Granted Date">09-29-2020</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20201231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zwj20RpZTZ3l" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.06</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zcOJJxYF28v4" title="Vesting Date">09-29-2020</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zXMwES9jBJyk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding">4,000,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20201231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zR4OKdEJGYAe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_903_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zmG35jgQubc4" title="Date Fully Vested">09-29-2023</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z157ujDnNYy8" title="Board Approval Date">09-28-2020</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zGq4oFwd78C8" title="Expiration Date">09-28-2030</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Vivek Sehgal</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20211231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zhGKq280Xs45" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">200,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zO4iwkQvJbya" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">200,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90F_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20210101__20211231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zR91Gan7PQ68" title="Granted Date">08-12-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20211231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zv711yflLHw9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.06</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zv58Z1jTHlu2" title="Vesting Date">09-01-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zYD54Fb54DUi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding">133,333</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20211231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zvLyxMREXQyd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested">66,667</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zDqisXKWh0Ik" title="Date Fully Vested">09-01-2025</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z6BxPFgVriA2" title="Board Approval Date">08-12-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zVnMcREQ1i55" title="Expiration Date">08-11-2031</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Vivek Sehgal</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zDDZm2IDXNL3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">100,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zRghaqfb8pch" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">100,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90D_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zEAqpKDIUl87" title="Granted Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zqs3KXmqO1ua" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.05</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_901_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--KadandaleSrinivasSudheerMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zZxxyoqlsdBi" title="Vesting Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zBKaGub0LWD9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding">50,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zfyYDo512rMa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested">50,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_906_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zGWF9B3Fc3tc" title="Date Fully Vested">05-02-2026</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zNCmcVOAIY4j" title="Board Approval Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--VivekSehgalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zMd2fAXZF2Q1" title="Expiration Date">05-01-2032</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Rajiv Saxena</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__srt--TitleOfIndividualAxis__custom--RajivSaxenaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_znQO4mVSpOjk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">100,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--RajivSaxenaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zhBE7ZJA66Uh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">100,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20200101__20201231__srt--TitleOfIndividualAxis__custom--RajivSaxenaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zfqtIuMocDq4" title="Granted Date">09-29-2020</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20201231__srt--TitleOfIndividualAxis__custom--RajivSaxenaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z0V8spZqH7ca" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.06</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_904_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--RajivSaxenaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zOTob9Ez0zb3" title="Vesting Date">09-29-2020</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--RajivSaxenaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zAVzgpY3COkg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding">100,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20201231__srt--TitleOfIndividualAxis__custom--RajivSaxenaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zhi2QrpZRBBd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--RajivSaxenaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_ztcI3kL5i449" title="Date Fully Vested">09-29-2023</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--RajivSaxenaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zoEfGqJJHtcg" title="Board Approval Date">09-28-2020</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--RajivSaxenaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zXH5b5Qf8pAh" title="Expiration Date">09-28-2030</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Harsha Bhat</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z08HbgZ0X45g" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">180,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zbwUA0GCQ80h" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">180,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_906_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20200101__20201231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zXXdHjVSoRFj" title="Granted Date">09-29-2020</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20201231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zSUxLUAAlsU4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.06</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zoVMaEcY1RVj" title="Vesting Date">09-29-2020</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zrzYnC0SL8qb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding">180,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20201231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zzsVwuUkeghi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z8sd1sUXMfJ2" title="Date Fully Vested">09-29-2023</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zmgIWsiO9eX5" title="Board Approval Date">09-28-2020</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z2dyEezFF0Fa" title="Expiration Date">09-28-2030</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Harsha Bhat</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20211231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zDsyymcL05z2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">50,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z6wgdxcyHxT1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">50,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20210101__20211231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z9QO3uaAaEOh" title="Granted Date">08-12-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20211231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zaUkaL5fUYPe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.06</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_ze5s6G3w3q4f" title="Vesting Date">09-01-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zfoMrlWA3YA7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding">33,333</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20211231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zUgMjGfU0RTi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested">16,667</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_za3qr7dQi3Wa" title="Date Fully Vested">09-01-2025</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zsnSa1PIg8Te" title="Board Approval Date">08-12-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zskswrzDKQ09" title="Expiration Date">08-11-2031</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Harsha Bhat</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zNmCBODP5IDj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">25,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zMpSnEP1ymzd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">25,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zOzdi7J0AsDh" title="Granted Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zBKdxDK5waRe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.05</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zOv44xxlwtEl" title="Vesting Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z90kaRIoIGpc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding">12,500</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zztgEunYXoFa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested">12,500</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_903_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zMLrqEeSJIT1" title="Date Fully Vested">05-02-2026</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zM7zJ4LAPqY1" title="Board Approval Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--HarshaBhatMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z7W4b76MIqI5" title="Expiration Date">05-01-2032</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Jagan Reddy</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zKxeqlsABfBj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">4,000,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zCX04OMzsbj2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">4,000,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20200101__20201231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zOBUo3w8GC44" title="Granted Date">09-29-2020</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20201231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zLcOa2wApEZb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.06</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zKGRKrSA53dl" title="Vesting Date">09-29-2020</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zx3OEy8qgdm1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding">4,000,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20201231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zAjEkAZ5A27l" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zzqPH1Zy89ud" title="Date Fully Vested">09-29-2023</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zzxwfJY1pVfc" title="Board Approval Date">09-28-2020</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zBJeqN0tpsA5" title="Expiration Date">09-28-2030</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Jagan Reddy</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20211231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z1QNcWlp7339" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">200,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zBOhrCUX2hWh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">200,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20210101__20211231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z77tWXOWvbQf" title="Granted Date">08-12-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20211231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zWjsNE1gxH6a" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.06</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z3VGSbXqfnHd" title="Vesting Date">09-01-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zJnYSjGUYRq9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding">133,333</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20211231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zXigKW9A6dBd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested">66,667</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z2AXveCbVYM1" title="Date Fully Vested">09-01-2025</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zGx1kMBN6qMk" title="Board Approval Date">08-12-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_znMp1jOUxMRi" title="Expiration Date">08-11-2031</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Jagan Reddy</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zWnM7OtIcJl5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">100,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z3CLUQbelsd5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">100,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zaFrPzj34uy1" title="Granted Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zx2CNpSmQoI2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.05</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zSms9MSXoam1" title="Vesting Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zdyEfY0hMI0j" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding">50,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z2XI43Etedgl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested">50,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zTeiOccr6De4" title="Date Fully Vested">05-02-2026</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_901_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zTIQbZj7izOk" title="Board Approval Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--JaganReddyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zhcIPo9lJrnb" title="Expiration Date">05-01-2032</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Siddayya S Ganjal</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zLtHZXLIYXT2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">180,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zidPZtDo9f2l" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">180,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90D_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z64CelNZxK28" title="Granted Date">09-29-2020</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20201231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zZJN9c6A2Xz8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.06</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zji5tD9IWLJ7" title="Vesting Date">09-29-2020</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zEbslEd6W4Uk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding">180,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20201231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zC47cn7xpmB5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_903_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z81CfIvqcg07" title="Date Fully Vested">09-29-2023</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zZhwhGG9ylSl" title="Board Approval Date">09-28-2020</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zlETeoQnlBD6" title="Expiration Date">09-28-2030</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Siddayya S Ganjal</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zOeVWgDLd6bd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">50,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zO52qNDAB4j1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">50,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zQiPa3xVsHL6" title="Granted Date">08-12-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20211231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zp1TIwkcXPli" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.06</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_906_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zi1FCNFDnJ4a" title="Vesting Date">09-01-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zCxAMtrNrbwi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding">33,333</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20211231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zODWxdOOSXZ7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested">16,667</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zUelF2aoLGV" title="Date Fully Vested">09-01-2025</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zYRo89dsMIXc" title="Board Approval Date">08-12-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z26RMcgHAkZ2" title="Expiration Date">08-11-2031</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Siddayya S Ganjal</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z8GrwY1ZeiA8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">25,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z7PdBfdIQS8f" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">25,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_901_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zfZ2QJXel0R6" title="Granted Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zOLPYJnpSyB4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.05</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zDdmnDMrgNB1" title="Vesting Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z9jAQSeoce1j" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding">12,500</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zEU7k2yN2rrl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested">12,500</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_901_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zmKgANLDQ4C8" title="Date Fully Vested">05-02-2026</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_903_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zbrXvmpsk0o4" title="Board Approval Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zSN3SC32THb8" title="Expiration Date">05-01-2032</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Sunil Arora</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SunilAroraMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z7m9enW4i5Zi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">90,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--SunilAroraMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zsezXG1Sejg5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SunilAroraMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zkoYykwWriM4" title="Granted Date">09-29-2020</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20201231__srt--TitleOfIndividualAxis__custom--SunilAroraMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zPcaRvcX5Ww6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.06</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SunilAroraMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zLPcUvlsIyVc" title="Vesting Date">09-29-2020</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--SunilAroraMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zP0MdBecOlJ3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20201231__srt--TitleOfIndividualAxis__custom--SunilAroraMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zjtyFMbmjjM1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SunilAroraMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_znYKA3dyYKOa" title="Date Fully Vested">09-29-2023</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SunilAroraMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zfFmNNsb1id8" title="Board Approval Date">09-28-2020</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SunilAroraMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z5q5eI77xCTf" title="Expiration Date">09-28-2030</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Rajiv Virmani</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__srt--TitleOfIndividualAxis__custom--RajivVirmaniMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zAvTpweQTCkk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">500,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--RajivVirmaniMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zsPUxo7rXUVi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">500,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20200101__20201231__srt--TitleOfIndividualAxis__custom--RajivVirmaniMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zUixUnpBEey" title="Granted Date">09-29-2020</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20201231__srt--TitleOfIndividualAxis__custom--RajivVirmaniMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zYa1tFm2h7r2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.06</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--RajivVirmaniMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zGdB8F8Vpkw9" title="Vesting Date">09-29-2020</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--RajivVirmaniMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zzuDeP7iTWBh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding">500,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20201231__srt--TitleOfIndividualAxis__custom--RajivVirmaniMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_znbKyxGWlMO4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--RajivVirmaniMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z1ZhutZcDpOl" title="Date Fully Vested">09-29-2023</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--RajivVirmaniMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zHE0MGI0XA6c" title="Board Approval Date">09-28-2020</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--RajivVirmaniMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zrxbrYtV69t1" title="Expiration Date">09-28-2030</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Sudhindra Shenoy</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zJ4QWiC4caWb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">180,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zgmeBkw8F8j5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">180,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zv4BBKrvS86k" title="Granted Date">09-29-2020</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20201231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z9PEv9VWomrf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.06</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zcTu02LTXQD6" title="Vesting Date">09-29-2020</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zED81jMp6uo1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding">180,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20201231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zSpk753JhlNa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zDYoF6saLzQ6" title="Date Fully Vested">09-29-2023</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zRxbgV6riQIi" title="Board Approval Date">09-28-2020</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zSWz0ilcoDn9" title="Expiration Date">09-28-2030</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Sudhindra Shenoy</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zHiLjzV9s139" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">50,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zqncTIeeYlMi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">50,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z3Q7dMpXuPQl" title="Granted Date">08-12-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20211231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zqtXw6he9koe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.06</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z3EiXnMZUPVg" title="Vesting Date">09-01-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z4TqSghQCWf5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding">33,333</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20211231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zl9Dk6iCfNUc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested">16,667</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z3cBvBXDJ7sc" title="Date Fully Vested">09-01-2025</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zSxBfMKkqZRi" title="Board Approval Date">08-12-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zK2KmCBBBoJ8" title="Expiration Date">08-11-2031</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Sudhindra Shenoy</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zdwYncZrvV59" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">25,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zAJPR9VMuZJg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">25,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90B_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zjD8uIPJTn3j" title="Granted Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--SiddayyaSGanjalMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_ztFhqTbEQtJ1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.05</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_ztvHTgqFPMv6" title="Vesting Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zN9xWBjDSpSb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding">12,500</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z6ZIFhqGT8j9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested">12,500</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zKWPeT8HF9z5" title="Date Fully Vested">05-02-2026</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z8YAQ8UQsU22" title="Board Approval Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SudhindraShenoyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zSlZ99QVHP9b" title="Expiration Date">05-01-2032</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Antony Sunil</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zmI8FhHvmypd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">90,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zS427y4oyIgh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">90,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20200101__20201231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zS4jXqRIxdNa" title="Granted Date">09-29-2020</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20201231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zCK1E38zUGB9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.06</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zUchczNYa5jk" title="Vesting Date">09-29-2020</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20201231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zE9ia44VfIm6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding">90,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20201231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zx8POfK8Rcw6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zRbZddjh8Aue" title="Date Fully Vested">09-29-2023</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zszioAjv8Bqe" title="Board Approval Date">09-28-2020</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20200101__20201231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zDdDEeTDGbhi" title="Expiration Date">09-28-2030</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Antony Sunil</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20211231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zStQjTpTmw22" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">50,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zW3X4WBNgYxh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">50,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_906_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20210101__20211231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zLfMcMLcTXGh" title="Granted Date">08-12-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20211231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zkXLwkFMIA5d" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.06</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zPPj5PC7Ix7c" title="Vesting Date">09-01-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zliNQG0mUou2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding">33,333</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20211231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zpy0i9DTWivi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested">16,667</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zf06eLernOX8" title="Date Fully Vested">09-01-2025</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zMHa6AstZAy7" title="Board Approval Date">08-12-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z8VDq4AdhNN4" title="Expiration Date">08-11-2031</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Antony Sunil</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zt6Tew4XYJvg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">25,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zqEbpMITIlH1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">25,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90B_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zjQHGf6zSV6k" title="Granted Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zrl3HOXAcou1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.05</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_903_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zRPrkULN2mnh" title="Vesting Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zwE2jHb87Abd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding">12,500</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zodw1uxPgGnj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested">12,500</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_904_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zHnvDmjt5DJk" title="Date Fully Vested">05-02-2026</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zuQqZZQ4Bec5" title="Board Approval Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--AntonySunilMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zyH5egEJfptj" title="Expiration Date">05-01-2032</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Tuleeka Nandy</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20211231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zGeQUPGVcqC9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">15,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zWREe5GJFG32" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20210101__20211231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zPlyc3UbVQ68" title="Granted Date">08-12-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20211231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zyg4qZYrT9Wa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.06</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_904_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z9Tm46w78EVl" title="Vesting Date">09-01-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zciUSx4cEKVe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20211231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zc5DVfnr44za" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_906_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zk9oh7ar75S1" title="Date Fully Vested">09-01-2025</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zqQR8gFyZZEa" title="Board Approval Date">08-12-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zCBYtFP5vVA1" title="Expiration Date">08-11-2031</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Tuleeka Nandy</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zbzyE7DKx0n5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">15,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zyPGwPl4LmOl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">15,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zNOHxOGAM5ql" title="Granted Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zIL7zRdfFmqg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.05</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zFT85c9TDdK8" title="Vesting Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zS94C0Wmy8v1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding">7,500</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zKYh7zntYvEb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested">7,500</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_906_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zB6HsCjNmSfc" title="Date Fully Vested">05-02-2026</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_904_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zW0Qw50fnqOg" title="Board Approval Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--TuleekaNandyMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zu3PueADS1Nf" title="Expiration Date">05-01-2032</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Robel Atnafu</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20211231__srt--TitleOfIndividualAxis__custom--RobelAtnafuMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zMYN4j4zbw27" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">5,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--RobelAtnafuMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zkaOlGc6QBKd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_906_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20210101__20211231__srt--TitleOfIndividualAxis__custom--RobelAtnafuMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zCAg44aRCXz9" title="Granted Date">08-12-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20211231__srt--TitleOfIndividualAxis__custom--RobelAtnafuMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zQlITQRRVHT5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.06</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--RobelAtnafuMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zrgD9NvzmkK5" title="Vesting Date">09-01-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--RobelAtnafuMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zD3QUtoWzBOj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20211231__srt--TitleOfIndividualAxis__custom--RobelAtnafuMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zmr99hzbrwbb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_903_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--RobelAtnafuMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zYaOQ001KYc5" title="Date Fully Vested">09-01-2025</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--RobelAtnafuMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zRYd7sPNM6ne" title="Board Approval Date">08-12-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--RobelAtnafuMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zE0Thm3B4a73" title="Expiration Date">08-11-2031</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Guy Primus</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20211231__srt--TitleOfIndividualAxis__custom--GuyPrimusMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zv7tnKkLurq3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">360,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--GuyPrimusMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z5lsCpiRMGT7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">360,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_904_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20210101__20211231__srt--TitleOfIndividualAxis__custom--GuyPrimusMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z27yWlq2iEZh" title="Granted Date">08-12-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20211231__srt--TitleOfIndividualAxis__custom--GuyPrimusMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z4LI0glhB5K7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.06</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--GuyPrimusMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z6R8fWq0gQKb" title="Vesting Date">09-01-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211231__srt--TitleOfIndividualAxis__custom--GuyPrimusMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zJHAcSIrs837" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding">240,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20211231__srt--TitleOfIndividualAxis__custom--GuyPrimusMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zshUiCy9NTE" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested">120,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--GuyPrimusMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z0v50qGwDqbi" title="Date Fully Vested">09-01-2025</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--GuyPrimusMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z183fR4njIGi" title="Board Approval Date">08-12-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20210101__20211231__srt--TitleOfIndividualAxis__custom--GuyPrimusMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zNgUaGWfKBNc" title="Expiration Date">08-11-2031</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Samartha Gowda</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SamarthaGowdaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zx41vfeTjDK1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">15,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--SamarthaGowdaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z5mVmuym9a7e" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">15,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SamarthaGowdaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zA9b1GaOT6Tl" title="Granted Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--SamarthaGowdaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zP7eRx49hXbl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.05</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SamarthaGowdaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zMkuWD2OKVUg" title="Vesting Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--SamarthaGowdaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z2pjFHsTgYjk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding">7,500</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--SamarthaGowdaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zOeHdHRImpt4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested">7,500</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SamarthaGowdaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z6p852xmFNl8" title="Date Fully Vested">05-02-2026</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SamarthaGowdaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zRKoBC1L5T74" title="Board Approval Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SamarthaGowdaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zCrDWd7dOoo2" title="Expiration Date">05-01-2032</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Alexandra Aiello</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--AlexandraAielloMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zos3ZTwgdgpd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">2,500</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--AlexandraAielloMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zkLf5NC3A9F8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">2,500</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--AlexandraAielloMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zUOXKuHn8bJ2" title="Granted Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--AlexandraAielloMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zMlDopmU4nMk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.05</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--AlexandraAielloMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zMO4Wx2Wxqsb" title="Vesting Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--AlexandraAielloMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zj0DmFR2Hmfl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding">1,250</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--AlexandraAielloMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zMKrN3i8HUx1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested">1,250</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--AlexandraAielloMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zZ1BzH0xur41" title="Date Fully Vested">05-02-2026</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--AlexandraAielloMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z4rVg0eKPw0i" title="Board Approval Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--AlexandraAielloMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zMmyOdwnl6bf" title="Expiration Date">05-01-2032</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Stephen Cabral</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--StephenCabralMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zlO4ZVDea3Y4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">5,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--StephenCabralMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z5AJCEHMgIm8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_903_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--StephenCabralMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zKMERKWPDCo2" title="Granted Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--StephenCabralMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zpoidDGY1po6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.05</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--StephenCabralMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_ziPZldaQahO" title="Vesting Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--StephenCabralMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z7mtBjLCWCOg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--StephenCabralMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zvGzB6e10LIj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--StephenCabralMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zuwBeWx1OgTj" title="Date Fully Vested">05-02-2026</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--StephenCabralMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z06wjmJJL7j" title="Board Approval Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--StephenCabralMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zf0KWNyJqW24" title="Expiration Date">05-01-2032</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Jonah Petit-Perrin</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--JonahPetiPerrinMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zjUdsZpRym9c" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">2,500</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--JonahPetiPerrinMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z5ByE1Z1QMa3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">2,500</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--JonahPetiPerrinMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_znNtTB3GQ4m7" title="Granted Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--JonahPetiPerrinMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zBS4tPH6taid" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.05</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--JonahPetiPerrinMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z1Z9cejRmEwh" title="Vesting Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--JonahPetiPerrinMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zee8GqimbV64" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding">1,250</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--JonahPetiPerrinMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_ziQtB8JotaV4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested">1,250</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--JonahPetiPerrinMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zhtHlmhSqBV1" title="Date Fully Vested">05-02-2026</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--JonahPetiPerrinMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zjdz5sN18x0g" title="Board Approval Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--JonahPetiPerrinMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z4ipI8GLHwP8" title="Expiration Date">05-01-2032</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Bryan Nella</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--BryanNellaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zbPLsMrTyCA2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">25,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--BryanNellaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zeur895jwiSe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">25,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90B_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--BryanNellaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zmLZTBTnQtG2" title="Granted Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--BryanNellaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zUc14HjWkwyg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.05</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--BryanNellaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zONYjSE3kgmd" title="Vesting Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--BryanNellaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zhwvJLEBGex1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding">12,500</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--BryanNellaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z1WjMt58CFUg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested">12,500</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--BryanNellaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z96tWHUjxNeg" title="Date Fully Vested">05-02-2026</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--BryanNellaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zMwCQJm0JADe" title="Board Approval Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--BryanNellaMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zdDDHYmYKT2i" title="Expiration Date">05-01-2032</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Mark Sink</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--MarkSinkMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zimf9Ch28Wui" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">25,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--MarkSinkMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zZLocIrhgjk2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">25,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_906_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--MarkSinkMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zGFaccnau9le" title="Granted Date">05-16-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--MarkSinkMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zu7z4rcHGuCc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.05</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_906_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--MarkSinkMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zabNGQ8A0Kj6" title="Vesting Date">05-16-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--MarkSinkMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zlle8gf7Tndd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding">12,500</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--MarkSinkMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zTZuKBOkJng2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested">12,500</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--MarkSinkMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zFMW3LGvFmH1" title="Date Fully Vested">05-16-2026</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--MarkSinkMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zJLhpuc0V4h" title="Board Approval Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--MarkSinkMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zvLkBOKkgj1b" title="Expiration Date">05-15-2032</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Koustav Choudhuri</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--KoustavChoudhuriMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zbh9U6pV5q3c" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">17,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--KoustavChoudhuriMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zqKUHN23zawa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">17,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_eus-gaap--TargetedOrTrackingStockIssuanceDates_c20220101__20221231__srt--TitleOfIndividualAxis__custom--KoustavChoudhuriMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zFze2Pe8pvWc" title="Granted Date">05-16-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__srt--TitleOfIndividualAxis__custom--KoustavChoudhuriMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zCR3ZuuzNtj9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.05</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--KoustavChoudhuriMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z8f5vWaGbzx2" title="Vesting Date">05-16-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20221231__srt--TitleOfIndividualAxis__custom--KoustavChoudhuriMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zHFzmum5KYR8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Outstanding">8,500</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__srt--TitleOfIndividualAxis__custom--KoustavChoudhuriMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zA3MVoCaVxUa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested">8,500</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--KoustavChoudhuriMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z7Qdji6G9dJ3" title="Date Fully Vested">05-16-2026</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--KoustavChoudhuriMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z9Z9FMLzPlT6" title="Board Approval Date">05-02-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__srt--TitleOfIndividualAxis__custom--KoustavChoudhuriMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zHeIwWUKyAG8" title="Expiration Date">05-15-2032</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif">Total</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zbm3KvbNqxJi" style="font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Granted Shares">11,712,000</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zbFqwBe0pozj" style="font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Outstanding Awards">11,597,000</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_ScheduleOfStockOptionIssuedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Stock Option Issued [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_ScheduleOfStockOptionIssuedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=RIME_SemiCabIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=RIME_SemiCabIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>197
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035118296224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SAFE PRIVATE PLACEMENTS (Tables) - Semi Cab Inc [Member]<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_SafePrivatePlacementsTableTextBlock', window );">SCHEDULE OF FIRST TRANCHE OF SUBSCRIPTIONS</a></td>
<td class="text"><p id="xdx_892_ecustom--SafePrivatePlacementsTableTextBlock_zMdTYM5IwPF4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table below summarizes the first tranche of subscriptions, all with the same terms and conditions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; display: none; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BA_zbXdLJs5wjXa">SCHEDULE
OF FIRST TRANCHE OF SUBSCRIPTIONS</span></span></p>


<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ID</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible
    Holder Name</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue
    Date</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Valuation
    Cap</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Converted
    Date</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 12%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SAFE-1</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 23%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_ecustom--ConvertibleHolderName_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEOneMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zmBU6yAqD2Hi" title="Convertible Holder Name">Ardhendu
    Haldar</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_980_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEOneMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zliJ96O3eCyd" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Principal"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">250,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 12%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_ecustom--InvestmentIssueDate_dd_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEOneMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zVsRHCePLDrl" title="Issue Date">10-25-2018</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEOneMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zF51JYfcVegi" title="Valuation Cap">10,000,000</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--InvestmentConvertedDate_dd_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEOneMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zhQqLyTc9ISi" title="Converted Date">12-25-2020</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SAFE-38</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--ConvertibleHolderName_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyEightMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zsp0Xg3OZ17g" title="Convertible Holder Name">Praveen
    Kaza</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98B_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyEightMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zwKlJexkQVYc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_ecustom--InvestmentIssueDate_dd_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyEightMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zWVwrA2aR1ll" title="Issue Date">10-25-2018</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyEightMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zHCIbpCX9oTh" title="Valuation Cap">13,000,000</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_ecustom--InvestmentConvertedDate_dd_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyEightMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zcY9jTwULxIl" title="Converted Date">12-25-2020</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SAFE-41</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--ConvertibleHolderName_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyOneMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zNbrREaH5yVg" title="Convertible Holder Name">Kurt
    W Mattson</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98E_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyOneMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zjQUbNow8tH" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecustom--InvestmentIssueDate_dd_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyOneMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zeZsrnt9se8h" title="Issue Date">03-27-2019</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyOneMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_z7scvcwKhoc2" title="Valuation Cap">20,000,000</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecustom--InvestmentConvertedDate_dd_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyOneMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zKL4FKO1Fmnc" title="Converted Date">12-25-2020</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SAFE-42</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--ConvertibleHolderName_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyTwoMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_z2dvffhkCpyh" title="Convertible Holder Name">Wendy
    A Thompson</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_986_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyTwoMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zOCnPEcTXJRe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_ecustom--InvestmentIssueDate_dd_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyTwoMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_z40PYKq7EC3c" title="Issue Date">03-27-2019</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyTwoMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zVijYLn5dR3" title="Valuation Cap">20,000,000</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_ecustom--InvestmentConvertedDate_dd_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyTwoMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zOBbF9N3JDhc" title="Converted Date">12-25-2020</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SAFE-44</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--ConvertibleHolderName_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyFourMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zdE9XHWYEDdh" title="Convertible Holder Name">Sonata
    Software North America Inc</span>.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98A_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyFourMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zVGewTXRhwrb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">468,041</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_ecustom--InvestmentIssueDate_dd_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyFourMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zNPuc9NcMVa2" title="Issue Date">02-24-2020</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyFourMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zmbPCN5pvDx3" title="Valuation Cap">10,000,000</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--InvestmentConvertedDate_dd_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyFourMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zRDcr11ljCIl" title="Converted Date">12-25-2020</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SAFE-43</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_ecustom--ConvertibleHolderName_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyThreeMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zkUUt1YUMlSf" title="Convertible Holder Name">THE
    IRA CLUB F/B/O RANJU MAHESHWARI ROTH IRA 2000201</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_983_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyThreeMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zUJGoISJZdW4" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_ecustom--InvestmentIssueDate_dd_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyThreeMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_z2hw2WkOElA7" title="Issue Date">06-15-2020</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyThreeMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zRWIOgb9n6o6" title="Valuation Cap">10,000,000</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--InvestmentConvertedDate_dd_c20181025__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyThreeMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zLBBYOIrIXTk" title="Converted Date">12-25-2020</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_984_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zSss5sYwsHj4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">943,041</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock', window );">SUMMARY OF TERMINATED IMMEDIATELY AFTER CLOSING OF THE TRANSACTION</a></td>
<td class="text"><p id="xdx_898_eus-gaap--InvestmentHoldingsScheduleOfInvestmentsTableTextBlock_zhB1KGs8u75" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table below summarizes the remaining 44 SAFE Agreements, all of which are expected to terminated immediately after closing of the Transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; display: none; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B7_zMmD0PkXOs9b" style="display: none">SUMMARY
OF  TERMINATED IMMEDIATELY AFTER CLOSING OF THE TRANSACTION</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif">ID</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif">Convertible Holder Name</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Principal</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Issue Date</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Valuation Cap</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 15%">SAFE-40</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 29%; text-align: left"><span id="xdx_90A_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyMember_zNnWrhDBldck" title="Convertible Holder Name">Sunil Bhatia</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98F_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyMember_zEKBp996pwHi" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Principal">250,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: center"><span id="xdx_902_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyMember_zPaiFTX2BXk8" title="Issue Date">08-12-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right"><span id="xdx_901_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyMember_zI3TIfkGu0t2" title="Valuation Cap">15,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-39</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_90D_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyNineMember_z2xekIuZFKYe" title="Convertible Holder Name">Pallav Gupta</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98D_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyNineMember_zrn49RYrIbR3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">15,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_909_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyNineMember_z96jMvjVktAj" title="Issue Date">08-12-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyNineMember_zKrr458gx533" title="Valuation Cap">15,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-10</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_907_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETenMember_zkAQ4JGsh2K9" title="Convertible Holder Name">The Bhardwaj 2003 Revocable Trust</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98A_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETenMember_zxPlTIta7LCg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">200,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90E_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETenMember_zPpAgbPO2igf" title="Issue Date">12-31-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETenMember_zvAiK7JMG6Ck" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-11</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_909_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEElevenMember_zx29Iq8xxFvf" title="Convertible Holder Name">Praveen Kaza</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_989_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEElevenMember_zDgGtuZ5Xpt2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">50,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90C_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEElevenMember_zjMRPuI8Pqei" title="Issue Date">12-31-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEElevenMember_zuk39vaK0GIi" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-12</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_901_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwelveMember_zvucg5fvnDKk" title="Convertible Holder Name">Pallav Gupta</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_981_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwelveMember_zM4GJPvEhpF1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">20,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_905_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwelveMember_zsihZaL9rFLg" title="Issue Date">12-31-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90B_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwelveMember_zU3JDnKOLoMg" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-13</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_902_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirteenMember_zRj99Hawz5vj" title="Convertible Holder Name">Amit and Anju Bhardwaj</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_987_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirteenMember_zdS4E6YfSQa7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">50,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_900_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirteenMember_zuxmOK3Tw1Vj" title="Issue Date">12-31-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90F_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirteenMember_z7gdaPTaMrxh" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-14</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_908_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFourteenMember_zZRo7rH88Jk6" title="Convertible Holder Name">Komal Bajaj</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98C_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFourteenMember_zA4UOoq9A4G1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">50,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_900_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFourteenMember_zKCanzlfUdsg" title="Issue Date">12-31-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFourteenMember_zIKvaYNdkdMh" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-15</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90C_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFifteenMember_zj7F5dwItiYc" title="Convertible Holder Name">Goel Trust, Dated Aug 2, 2000</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98E_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFifteenMember_zkgYiXUFZpy1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">100,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_900_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFifteenMember_zYEaBfG2lGlc" title="Issue Date">12-31-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90D_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFifteenMember_zPtrjrMBMVR" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-16</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_902_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESixteenMember_zjmnovNVUREh" title="Convertible Holder Name">Sanjiva Singh</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98F_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESixteenMember_zPbhZDlGti9i" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">100,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90B_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESixteenMember_zmtZT7WmxGWd" title="Issue Date">12-31-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESixteenMember_zeXEnVfzKFOc" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-17</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_908_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESeventeenMember_zPT0HF6QbXz2" title="Convertible Holder Name">Rajeev Agarwal</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_986_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESeventeenMember_zWAgY5GiRFPd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">25,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_902_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESeventeenMember_zlWqcPmnUMm1" title="Issue Date">12-31-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESeventeenMember_zLISUGvFYJE1" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-18</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_900_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEEighteenMember_zvb6oFeoq7dc" title="Convertible Holder Name">Sanyogita and Sunil Gupta</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_984_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEEighteenMember_zlSZj5xmK85i" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">25,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_909_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEEighteenMember_zw4aZodHxbsd" title="Issue Date">12-31-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90D_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEEighteenMember_z0zCJl2UxNzh" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-19</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_902_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFENineteenMember_z5gYmgIRZC2j" title="Convertible Holder Name">SEM Gaingels Fund I, a series of JMWTX Investments, LP</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_985_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFENineteenMember_zHLtC1f3hJTb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">300,279</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_904_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFENineteenMember_zvUnvJTA2m74" title="Issue Date">12-31-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFENineteenMember_zcTAUrLJsjy3" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-2</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_901_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwoMember_ztzlSQofB838" title="Convertible Holder Name">FVI Fund LLC</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98C_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwoMember_z6Pm4zfQYkv4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">50,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90F_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwoMember_z7SmG95GTUB7" title="Issue Date">12-31-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwoMember_z7obRtEGSim1" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-20</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_901_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyMember_zYy69ZruVOce" title="Convertible Holder Name">JWass PT Investors, LP - B2</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_987_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyMember_zlKjHaqejOWd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">10,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_902_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyMember_zOclF6NkOzk5" title="Issue Date">12-31-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyMember_zOpn12QWZsu" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-21</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_90C_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyOneMember_z9fzyC7DZ3d4" title="Convertible Holder Name">Medhavi Gupta</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_982_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyOneMember_zdvRuVWHS8D" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">20,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_902_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyOneMember_znwAza1j5Ujc" title="Issue Date">12-31-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyOneMember_znzs75RnW6Cl" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-22</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_90D_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyTwoMember_z144al2WrGR1" title="Convertible Holder Name">Sundeep Sibal</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_988_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyTwoMember_zhtfycm9WdOe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">50,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_908_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyTwoMember_zKn85GJ5Z0zi" title="Issue Date">12-31-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyTwoMember_zPfMSm9t0Xmf" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-24</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_901_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyFourMember_zAEqTQvKbuf2" title="Convertible Holder Name">Jolly Gupta</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98F_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyFourMember_zjmTFdn1ZnFl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">35,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_908_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyFourMember_zK104COnc0R2" title="Issue Date">12-31-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyFourMember_zfJ9p1jroqjj" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-3</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_908_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThreeMember_zRjjC2OLq2rk" title="Convertible Holder Name">Ashutosh Malaviya</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98B_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThreeMember_zZBAbKZN1IC6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">50,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_902_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThreeMember_zm1Tm30R8FY4" title="Issue Date">12-31-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThreeMember_zKftjrrX15b8" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-4</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_905_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFourMember_zG7nyP7UGV85" title="Convertible Holder Name">Consensia Inc</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98A_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFourMember_z9rqcLReDAC6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">50,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_903_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFourMember_zUV3DxTSvFXa" title="Issue Date">12-31-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90F_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFourMember_zOM7HbVmx624" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-45</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_902_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyFiveMember_z8Zwm7gyGDm9" title="Convertible Holder Name">Atula Sibal</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_987_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyFiveMember_zWwxjlxJtFG1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">50,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90A_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyFiveMember_z1J2fHmUTJZ2" title="Issue Date">12-31-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyFiveMember_zovVeA5NUiI5" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-6</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_904_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESixMember_zAORJfg9xmPk" title="Convertible Holder Name">Ajay Bhatnagar</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98B_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESixMember_zMVvItr25CU3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">100,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_908_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESixMember_zCY7GJBRuXOa" title="Issue Date">12-31-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90F_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESixMember_zrmlbLeHoiRe" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-7</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_902_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESevenMember_zsXtuX1hlU3i" title="Convertible Holder Name">Pankaj Sinha</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_981_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESevenMember_zVEoAVhg3is6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">50,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90D_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESevenMember_z6qqVZlPTGq2" title="Issue Date">12-31-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFESevenMember_zCX9sTubOrif" title="Valuation Cap">35,000,00</span>0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-8</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_908_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEEightMember_z3FLJBYSju17" title="Convertible Holder Name">Bakulesh Adya</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_982_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEEightMember_za1ogWXLzuG" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">35,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_907_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEEightMember_zUf4NUgc5ltl" title="Issue Date">12-31-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_901_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEEightMember_z0GeTzCjdZ8a" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-9</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_90D_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFENineMember_zxkc6bd9qW14" title="Convertible Holder Name">Alok Mahajan</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98B_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFENineMember_zTrQ9S5ulMkj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">50,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_906_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFENineMember_zwEodwKJgPy3" title="Issue Date">12-31-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFENineMember_zAzDeee9QL8l" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-5</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_901_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFiveMember_zNIRhPwRjDqf" title="Convertible Holder Name">BANSAL GARG FAMILY TRUST AMIT BANSAL TRTEE KARUNA GARG TRTEE U/A 11/07/2017</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_980_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFiveMember_zTo0BWVT15Q2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">100,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_909_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFiveMember_zqdqxPgiq1Uh" title="Issue Date">12-31-2021</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_901_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFiveMember_zoiEi4vFMMQ" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-25</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_901_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyFiveMember_z87GVP2Kr487" title="Convertible Holder Name">Disrupt Fund XVIII, LLC</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_988_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyFiveMember_zpDXoAkIL7gc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">50,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_906_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyFiveMember_z2iip7EJy5Zc" title="Issue Date">01-24-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyFiveMember_zIGi98eBjik8" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-26</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_903_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentySixMember_z5qk6UtZVyma" title="Convertible Holder Name">Ajatshatru and Manju Dhawal</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_989_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentySixMember_zwq5d84kJyqj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">25,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90B_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentySixMember_zvXbDAVLuwEb" title="Issue Date">01-31-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentySixMember_z3QGORJeh0w7" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-27</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_908_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentySevenMember_zQISQihhra6h" title="Convertible Holder Name">Mrityunjay Dhawal</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_981_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentySevenMember_zaoVassLtjEc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">25,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90A_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentySevenMember_z7BJQdSejaS9" title="Issue Date">01-31-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentySevenMember_zBfracneXCt3" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-28</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_90D_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyEightMember_zs6p2mtqhsyf" title="Convertible Holder Name">You Sexy Dawg, LLC</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_983_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyEightMember_zDaYJfvx0zr3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">50,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90F_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyEightMember_zaxRpdVeNIgk" title="Issue Date">01-31-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyEightMember_zxC1LXiYo3fa" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-29</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_908_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyNineMember_zzINvLOaD5A2" title="Convertible Holder Name">Elisa deLaet</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_984_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyNineMember_zV3qmc05prX3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">25,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90D_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyNineMember_zcqM2qkRQRdl" title="Issue Date">01-31-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_904_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFETwentyNineMember_zNdG7c4Mgh9i" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-30</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_90C_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyMember_z9A7xdcWrMck" title="Convertible Holder Name">Ardhendu Haldar</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98A_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyMember_zrWXHC3A6nAc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">100,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90E_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyMember_zx4eM6Tyeixi" title="Issue Date">02-28-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyMember_zxHAEZ4L86Rf" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-31</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_90B_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyOneMember_z9s03pEKaLbc" title="Convertible Holder Name">Suzanne and Tom Lambert</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98A_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyOneMember_zUSy1B6ET8G8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">250,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90D_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyOneMember_zju0awdaGHx9" title="Issue Date">02-28-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyOneMember_zkh6ooAfsSMf" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-32</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_90A_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyTwoMember_zCzp2jV9ZjNh" title="Convertible Holder Name">Nidus Capital Holdings, LLC</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_987_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyTwoMember_zC8z68bxng7l" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">250,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_908_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyTwoMember_zDDJO5nh0IJb" title="Issue Date">02-28-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyTwoMember_zoKzpsL4Pm31" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-33</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_909_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyThreeMember_za1CM0HpvT88" title="Convertible Holder Name">Compelling Natural Health II, LLC</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_986_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyThreeMember_zV625NkkSqAb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">250,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90A_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyThreeMember_zhEHULcGdxie" title="Issue Date">02-28-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyThreeMember_zrlOk9avlmYb" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-34</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_901_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyFourMember_zxbogyxpmin4" title="Convertible Holder Name">Birch Hill Capital Group, LLC</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_983_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyFourMember_zjvNqbGpxkxe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">250,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_905_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyFourMember_zAy1t63ty99e" title="Issue Date">02-28-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyFourMember_zraxNBVKnfM2" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-35</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_90F_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyFiveMember_zwI3xKp4Nco2" title="Convertible Holder Name">Ingrid P. Maes as Trustee of The IPM Irrevocable Trust dated September 1, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_989_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyFiveMember_zNZy204xQP7l" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">250,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90A_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyFiveMember_zSQoyF6nupMl" title="Issue Date">02-28-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtyFiveMember_zJbWSxvp90Nd" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-36</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_90C_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtySixMember_ztVM9pdodOB7" title="Convertible Holder Name">Nattoceuticals, LLC</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_989_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtySixMember_z7ApdaQb37vc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">250,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_905_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtySixMember_zxEZbdt2Z7j1" title="Issue Date">02-28-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtySixMember_zvYBBuwLA0N4" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-37</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_905_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtySevenMember_zZRPNNnL8Vm7" title="Convertible Holder Name">Pallav Gupta</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98D_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtySevenMember_zH0Gh5Fm4rEe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">60,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90A_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtySevenMember_zjBpxNYCNpA" title="Issue Date">02-28-2022</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEThirtySevenMember_zpcCwMgPJ0Jl" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-46</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_905_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortySixMember_z0Il1LOBPbM" title="Convertible Holder Name">Gaingels Semicab LLC</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_985_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortySixMember_zXe3YnldJGN8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">130,500</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_907_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortySixMember_z17TXVfMMkii" title="Issue Date">03-21-2023</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortySixMember_zJTaJaq4HfWh" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-50</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_90F_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFiftyMember_zkcNU8cVCKb3" title="Convertible Holder Name">Pankaj Sinha</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98F_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFiftyMember_zi2KO9kkOGtl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">50,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90B_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFiftyMember_zZycYQjTglz3" title="Issue Date">04-04-2023</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFiftyMember_zvYcYOEtMBL5" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-48</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_901_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyEightMember_zYF6mij4ytgk" title="Convertible Holder Name">Lucy Holifield</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_987_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyEightMember_zT8XYsub1pkc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">70,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_906_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyEightMember_zaWFVEcDEAFf" title="Issue Date">04-14-2023</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyEightMember_zbigYlXvlFvg" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-47</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_902_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortySevenMember_zEYHNK6zi5Pf" title="Convertible Holder Name">Corvus Albus LLC</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_986_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortySevenMember_zgs3uoustsvc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">100,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_909_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortySevenMember_zNhU2aMYEqHa" title="Issue Date">04-19-2023</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortySevenMember_zW3XBIzILQ86" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">SAFE-49</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_904_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyNineMember_zexIdYj1LXzg" title="Convertible Holder Name">David Friedland</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98D_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyNineMember_zAWqjBWO3Cvi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">50,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90B_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyNineMember_zFXk85gUHVD2" title="Issue Date">04-19-2023</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFortyNineMember_z5oxexiVv7Y8" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">SAFE-51</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span id="xdx_90E_ecustom--ConvertibleHolderName_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFiftyOneMember_zA1pnuTTL2zd" title="Convertible Holder Name">Kapil K Gupta</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_984_ecustom--InvestmentOfPrincipalAmount_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFiftyOneMember_zAXtWhB2dFJ9" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">25,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><span id="xdx_908_ecustom--InvestmentIssueDate_dd_c20210812__20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFiftyOneMember_zhQKwfvu2dNl" title="Issue Date">04-22-2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"><span id="xdx_90A_ecustom--ValuationCapitalOfInvestment_iI_c20230422__us-gaap--TypeOfArrangementAxis__custom--SAFEFiftyOneMember_zRFGcdWSHWK" title="Valuation Cap">35,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">TOTAL</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_989_ecustom--InvestmentOfPrincipalAmount_iI_c20230422_zZM1IaDPyD56" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">4,095,779</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  </table>


<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_SafePrivatePlacementsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Safe Private Placements [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_SafePrivatePlacementsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of data and information required in the supplementary schedule applicable to management investment companies listing holdings of unaffiliated investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=RIME_SemiCabIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=RIME_SemiCabIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>198
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035105527328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RECENT DEVELOPMENTS (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="4">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Oct. 25, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 22, 2024 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Oct. 17, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 25, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 03, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 26, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 20, 2023 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 23, 2023 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Feb. 15, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 18, 2024 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2024 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2024 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Nov. 01, 2024 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 28, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 14, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LegalFees', window );">Legal and administrative expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 215,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_AssetsWriteOff', window );">Written off</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,878,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Lease payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 363,000<span></span>
</td>
<td class="nump">$ 136,000<span></span>
</td>
<td class="nump">$ 858,000<span></span>
</td>
<td class="nump">868,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 960,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnTerminationOfLease', window );">Gain loss on termination of operating lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,874,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">$ (4,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Shares issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,079,678<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,079,678<span></span>
</td>
<td class="nump">6,418,061<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,167,489<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Shares outstanding | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,752,755<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,752,755<span></span>
</td>
<td class="nump">6,418,061<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,167,489<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Revolving credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="nump">$ 15,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Number of stock sold, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LegalFees', window );">Legal and administrative expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares sold | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,198,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Proceeds from sale of equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Commmon stock share per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.91<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_TransactionFees', window );">Transaction fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=RIME_ATMOfferingMember', window );">ATM Offering [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Number of stock sold, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Proceeds from sale of equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,654,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 36,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=RIME_SemiCabLLCMember', window );">Semi Cab LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares sold | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">320,903<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=RIME_SemiCabLLCMember', window );">Semi Cab LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Membership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Shares issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,098,901<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Shares outstanding | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,098,901<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Revolving Credit Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Revolving credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_AtTheMarketSalesAgreementMember', window );">At The Market Sales Agreement [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Number of stock sold, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LegalFees', window );">Legal and administrative expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares sold | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,673,077<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,673,077<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Proceeds from sale of equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,489,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,489,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdministrativeFeesExpense', window );">Brokerage commissions and administrative fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">189,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">189,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_AtTheMarketSalesAgreementMember', window );">At The Market Sales Agreement [Member] | Common Stock [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares sold | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,162,423<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Proceeds from sale of equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,372,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdministrativeFeesExpense', window );">Brokerage commissions and administrative fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 42,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_AtTheMarketSalesAgreementAmendmentOneMember', window );">At The Market Sales Agreement Amendment One [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Number of stock sold, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,020,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_AtTheMarketSalesAgreementAmendmentTwoMember', window );">At The Market Sales Agreement Amendment Two [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Number of stock sold, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_AssetPurchaseAgreementMember', window );">Asset Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets', window );">Shares purchase | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">641,806<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_LeaseAgreementMember', window );">Lease Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AreaOfLand', window );">Lease space | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRent', window );">Initial base rent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_SettlementAgreementMember', window );">Settlement Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Lease payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_OperatingLeasePeriodicPayments', window );">periodic lease payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnTerminationOfLease', window );">Gain loss on termination of operating lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,874,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_LeaseSettlementExpense', window );">Lease settlement expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_SettlementAgreementMember', window );">Settlement Agreement [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_OperatingLeasePeriodicPayments', window );">periodic lease payments</a></td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Number of stock sold, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares sold | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Proceeds from sale of equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | Subsequent Event [Member] | Private Placement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares sold | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,299,998<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuredDebt', window );">Secured note principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,352,941<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Proceeds from private placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_PrivatePlacementIssueDiscount', window );">Private placement issue discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 352,941<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_LoanAgreementMember', window );">Loan Agreement [Member] | Revolving Credit Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Revolving credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_LoanAgreementMember', window );">Loan Agreement [Member] | Subsequent Event [Member] | Revolving Credit Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeeAmount', window );">Credit facility termination fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_StockRepurchaseAgreementMember', window );">Stock Repurchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Shares issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,098,901<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Shares outstanding | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,098,901<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_AssetsWriteOff">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Assets write off.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_AssetsWriteOff</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_LeaseSettlementExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease settlement expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_LeaseSettlementExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_OperatingLeasePeriodicPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating lease periodic payments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_OperatingLeasePeriodicPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_PrivatePlacementIssueDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Private placement issue discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_PrivatePlacementIssueDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_TransactionFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Transaction fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_TransactionFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdministrativeFeesExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for administrative fee from service provided, including, but not limited to, salary, rent, or overhead cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-3<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdministrativeFeesExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AreaOfLand">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area of land held.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AreaOfLand</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnTerminationOfLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on termination of lease before expiration of lease term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 40<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479092/842-20-40-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnTerminationOfLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LegalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(6))<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LegalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCommitmentFeeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the fee for available but unused credit capacity under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCommitmentFeeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash payments to lessor's for use of assets under operating leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOrSaleOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date, including the current and noncurrent portions, of collateralized debt obligations (with maturities initially due after one year or beyond the operating cycle, if longer). Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=RIME_ATMOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=RIME_ATMOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=RIME_SemiCabLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=RIME_SemiCabLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=RIME_SemiCabLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=RIME_SemiCabLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RIME_AtTheMarketSalesAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RIME_AtTheMarketSalesAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RIME_AtTheMarketSalesAgreementAmendmentOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RIME_AtTheMarketSalesAgreementAmendmentOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RIME_AtTheMarketSalesAgreementAmendmentTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RIME_AtTheMarketSalesAgreementAmendmentTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RIME_AssetPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RIME_AssetPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RIME_LeaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RIME_LeaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RIME_SettlementAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RIME_SettlementAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RIME_SecuritiesPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RIME_SecuritiesPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RIME_LoanAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RIME_LoanAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RIME_StockRepurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RIME_StockRepurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>199
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035105464000">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LIQUIDITY, GOING CONCERN AND MANAGEMENT PLANS (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>May 18, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders equity</a></td>
<td class="nump">$ 2,739,000<span></span>
</td>
<td class="num">$ (872,000)<span></span>
</td>
<td class="nump">$ 7,578,000<span></span>
</td>
<td class="nump">$ 9,678,000<span></span>
</td>
<td class="nump">$ 9,544,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,198,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">621,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,703,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_WorkingCapital', window );">Working capital deficit</a></td>
<td class="nump">2,082,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated losses</a></td>
<td class="num">(33,206,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(25,915,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (19,517,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=RIME_SemiCabIncMember', window );">Semi Cab Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,139,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,992,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Retained Earnings [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders equity</a></td>
<td class="num">$ (33,206,000)<span></span>
</td>
<td class="num">$ (34,401,000)<span></span>
</td>
<td class="num">(25,915,000)<span></span>
</td>
<td class="num">$ (21,879,000)<span></span>
</td>
<td class="num">$ (21,977,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (16,531,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Retained Earnings [Member] | Semi Cab Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,814,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_WorkingCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Working capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_WorkingCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479832/842-10-65-8<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-24<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-23<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-5<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-5<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-8<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-8<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-5<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-17<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 39: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 43: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 44: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 45: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 46: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-15<br><br>Reference 47: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-16<br><br>Reference 48: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4I<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476166/350-60-65-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=RIME_SemiCabIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=RIME_SemiCabIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>200
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035102129296">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF CONSIDERATION TRANSFERRED TO THE ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jul. 03, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetAcquisitionLineItems', window );"><strong>Asset Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Estimated Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,354,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=RIME_SemiCabIncMember', window );">Semi Cab Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetAcquisitionLineItems', window );"><strong>Asset Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash and Cash Equivalents</a></td>
<td class="nump">$ 17,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="nump">193,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">13,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment, net</a></td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Other Non-Current Operating Assets, Net</a></td>
<td class="nump">14,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCustomerRelationships', window );">Customer Relationships (9 year estimated useful life)</a></td>
<td class="nump">747,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradeName', window );">Trade Name (9 year estimated useful life)</a></td>
<td class="nump">272,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDevelopedTechnology', window );">Developed Technology (6 year estimated useful life)</a></td>
<td class="nump">381,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable and accrued expenses</a></td>
<td class="num">(2,680,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLoansPayable', window );">Loans payable Merchant Cash Advances (MCA)</a></td>
<td class="num">(631,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt', window );">Note payable</a></td>
<td class="num">(50,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesNotesPayableRelatedParties', window );">Notes payable Related Parties</a></td>
<td class="num">(650,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Net assets acquired</a></td>
<td class="num">(2,371,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Estimated Goodwill</a></td>
<td class="nump">3,354,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=RIME_SemiCabIncMember', window );">Semi Cab Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetAcquisitionLineItems', window );"><strong>Asset Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable', window );">Equity consideration</a></td>
<td class="nump">494,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_AssetAcquisitionFairValueOfNonControllingInterest', window );">Fair value of non-controlling interest</a></td>
<td class="nump">74,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration', window );">Total Equity Consideration</a></td>
<td class="nump">568,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_AssetAcquisitionDebtExtinguishment', window );">Debt Extinguishment</a></td>
<td class="nump">415,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetAcquisitionConsiderationTransferred', window );">Total consideration</a></td>
<td class="nump">$ 983,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_AssetAcquisitionDebtExtinguishment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset acquisition debt extinguishment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_AssetAcquisitionDebtExtinguishment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_AssetAcquisitionFairValueOfNonControllingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset acquisition fair value of non controlling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_AssetAcquisitionFairValueOfNonControllingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLoansPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business combination recognized identifiable assets acquired and liabilities assumed current liabilities loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLoansPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesNotesPayableRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business combination recognized identifiable assets acquired and liabilities assumed current liabilities notes payable related parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesNotesPayableRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCustomerRelationships">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business combination recognized identifiable assets acquired and liabilities assumed customer relationships.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCustomerRelationships</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDevelopedTechnology">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business combination recognized identifiable assets acquired and liabilities assumed developed technology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDevelopedTechnology</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business combination recognized identifiable assets acquired and liabilities assumed trade name.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionConsiderationTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479908/805-50-55-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480060/805-50-25-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480027/805-50-30-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480027/805-50-30-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionConsiderationTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contingent consideration recognized as part of consideration transferred in asset acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480060/805-50-25-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480027/805-50-30-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480027/805-50-30-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of acquirer's equity interest issued and issuable as part of consideration transferred in asset acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480060/805-50-25-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480027/805-50-30-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480027/805-50-30-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 15<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480123/805-50-15-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-37<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-37<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482598/350-20-45-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=RIME_SemiCabIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=RIME_SemiCabIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=RIME_SemiCabIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=RIME_SemiCabIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>201
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035033745680">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF CONSIDERATION TRANSFERRED TO THE ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details) (Parenthetical)<br></strong></div></th>
<th class="th"><div>Jul. 03, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">9 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade Names [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">9 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Developed Technology Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">6 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>202
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035119344224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF PRO FORMA FINANCIAL INFORMATION (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Net revenue</a></td>
<td class="nump">$ 16,831,000<span></span>
</td>
<td class="nump">$ 26,848,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax', window );">Operating loss from continuing operations</a></td>
<td class="num">(8,093,000)<span></span>
</td>
<td class="num">(6,187,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (8,451,000)<span></span>
</td>
<td class="num">$ (7,164,000)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of pro forma income from continuing operations as if the business combination had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>203
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035111808320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ASSET ACQUISITION (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 03, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwill', window );">Identifiable intangible assets including goodwill</a></td>
<td class="nump">$ 4,754,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_NonControllingInterestAtFairValue', window );">Non-controlling interest at fair value</a></td>
<td class="nump">$ 74,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_RoyaltyRate', window );">Royalty rate</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_DiscountOnRoyaltyRate', window );">Discount on royalty rate</a></td>
<td class="nump">33.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_RoyaltyTerm', window );">Royalty term</a></td>
<td class="text">9 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_DiscountRateForWeightedAverageCost', window );">Discount rate for weighted average cost</a></td>
<td class="nump">33.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapital', window );">Increase decrease in operating capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (5,504,000)<span></span>
</td>
<td class="nump">$ 265,000<span></span>
</td>
<td class="nump">$ 538,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LegalFees', window );">Legal fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 215,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Stock issued during period shares acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_GrowthRateOfDevelopmentOfNewBusiness', window );">Growth rate of development of new business</a></td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_GrowthRateOfDevelopmentOfNewBusiness', window );">Growth rate of development of new business</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=RIME_SemiCabLLCMember', window );">Semi Cab LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Seller Consideration share</a></td>
<td class="nump">320,903<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=RIME_SemiCabIncMember', window );">Semi Cab Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetAcquisitionConsiderationTransferred', window );">Asset acquisition purchase price consideration</a></td>
<td class="nump">$ 983,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=RIME_SemiCabLLCMember', window );">Semi Cab LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership percentage</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=RIME_SemiCabIncMember', window );">Semi Cab Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership percentage</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=RIME_AlgorhythmHoldingsIncMember', window );">Algorhythm Holdings Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership percentage</a></td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_AssetPurchaseAgreementMember', window );">Asset Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets', window );">Shares purchase</a></td>
<td class="nump">641,806<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets', window );">Purchase of assets value</a></td>
<td class="nump">$ 494,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_EmploymentAgreementsMember', window );">Employment Agreements [Member] | 2024 [Member] | Ajesh Kapoor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalariesAndWages', window );">Salaries and wages</a></td>
<td class="nump">140,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_EmploymentAgreementsMember', window );">Employment Agreements [Member] | 2024 [Member] | Vivek Sehgal Kapoor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalariesAndWages', window );">Salaries and wages</a></td>
<td class="nump">105,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_EmploymentAgreementsMember', window );">Employment Agreements [Member] | 2025 [Member] | Ajesh Kapoor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalariesAndWages', window );">Salaries and wages</a></td>
<td class="nump">240,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_EmploymentAgreementsMember', window );">Employment Agreements [Member] | 2025 [Member] | Vivek Sehgal Kapoor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalariesAndWages', window );">Salaries and wages</a></td>
<td class="nump">210,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_EmploymentAgreementsMember', window );">Employment Agreements [Member] | Subsequent Years [Member] | Ajesh Kapoor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalariesAndWages', window );">Salaries and wages</a></td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_EmploymentAgreementsMember', window );">Employment Agreements [Member] | 2026 [Member] | Vivek Sehgal Kapoor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalariesAndWages', window );">Salaries and wages</a></td>
<td class="nump">240,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_EmploymentAgreementsMember', window );">Employment Agreements [Member] | 2027 [Member] | Vivek Sehgal Kapoor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalariesAndWages', window );">Salaries and wages</a></td>
<td class="nump">270,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_EmploymentAgreementsMember', window );">Employment Agreements [Member] | 2028 [Member] | Vivek Sehgal Kapoor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalariesAndWages', window );">Salaries and wages</a></td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_DiscountOnRoyaltyRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discount on royalty rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_DiscountOnRoyaltyRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_DiscountRateForWeightedAverageCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discount rate for weighted average cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_DiscountRateForWeightedAverageCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_GrowthRateOfDevelopmentOfNewBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Growth rate of development of new business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_GrowthRateOfDevelopmentOfNewBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_NonControllingInterestAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Non controlling interest at fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_NonControllingInterestAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_RoyaltyRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Royalty rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_RoyaltyRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_RoyaltyTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Royalty term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_RoyaltyTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionConsiderationTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479908/805-50-55-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480060/805-50-25-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480027/805-50-30-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480027/805-50-30-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionConsiderationTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period of all assets and liabilities used in operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetIncludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after impairment and amortization, of goodwill, indefinite-lived, and finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480265/350-10-S45-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetIncludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LegalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(6))<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LegalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalariesAndWages">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for salary and wage arising from service rendered by nonofficer employee. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalariesAndWages</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=RIME_SemiCabLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=RIME_SemiCabLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=RIME_SemiCabIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=RIME_SemiCabIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=RIME_SemiCabLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=RIME_SemiCabLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=RIME_SemiCabIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=RIME_SemiCabIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=RIME_AlgorhythmHoldingsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=RIME_AlgorhythmHoldingsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RIME_AssetPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RIME_AssetPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RIME_EmploymentAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RIME_EmploymentAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=RIME_TwoThousandTwentyFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=RIME_TwoThousandTwentyFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=RIME_AjeshKapoorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=RIME_AjeshKapoorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=RIME_VivekSehgalKapoorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=RIME_VivekSehgalKapoorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=RIME_TwoThousandTwentyFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=RIME_TwoThousandTwentyFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=RIME_SubsequentYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=RIME_SubsequentYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=RIME_TwoThousandTwentySixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=RIME_TwoThousandTwentySixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=RIME_TwoThousandTwentySevenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=RIME_TwoThousandTwentySevenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=RIME_TwoThousandTwentyEightMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=RIME_TwoThousandTwentyEightMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>204
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035114647104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCING (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="4">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Oct. 17, 2024</div></th>
<th class="th"><div>May 08, 2024</div></th>
<th class="th"><div>Mar. 28, 2024</div></th>
<th class="th"><div>Mar. 22, 2024</div></th>
<th class="th"><div>May 18, 2023</div></th>
<th class="th"><div>Oct. 14, 2022</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Oct. 24, 2024</div></th>
<th class="th"><div>Aug. 30, 2023</div></th>
<th class="th"><div>Jun. 16, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Credit agreement term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of deferred financing costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 47,000<span></span>
</td>
<td class="nump">$ 45,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestAndDebtExpense', window );">Interest expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,000<span></span>
</td>
<td class="nump">33,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Amount outstanding for Agile Capital Funding,LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 303,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 303,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortization', window );">Amortization expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">215,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,000<span></span>
</td>
<td class="nump">39,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_CreditAndSecurityAgreementsMember', window );">Credit and Security Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestAndDebtExpense', window );">Interest expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortization', window );">Amortization expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Initial amount borrowed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,352,941<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=RIME_AgileCapilalFundingllcMember', window );">Agile Capilal Fundingllc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Initial amount borrowed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 315,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromShortTermDebt', window );">Net proceeds from short term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPayment', window );">Stipulated periodic payment of short term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfShortTermDebt', window );">Total short term debt to be repaid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 453,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Amount outstanding for Agile Capital Funding,LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">146,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">146,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=RIME_CedarAdvancellcMember', window );">Cedar Advancellc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Initial amount borrowed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 215,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromShortTermDebt', window );">Net proceeds from short term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">204,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPayment', window );">Stipulated periodic payment of short term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfShortTermDebt', window );">Total short term debt to be repaid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 311,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Amount outstanding for Agile Capital Funding,LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">156,920<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">156,920<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=RIME_SemiCabInvestorMember', window );">Semi Cab Investor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Initial amount borrowed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, maximum borrowing amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod', window );">The Prime Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Credit agreement term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityExpirationDate1', window );">Revolving credit facility terminated date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Nov. 28,  2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Nov. 17,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_PercentageOfExitFee', window );">Percentage of exit fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessExitCosts1', window );">Exit fee payable on termination of contract</a></td>
<td class="nump">$ 40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLinesOfCredit', window );">Costs associated with line of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 254,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of deferred financing costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 63,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateDescription', window );">Base rates of loan description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">(a) the Prime Rate plus 0.50% or (b) the Secured Overnight Financing Rate (&#8220;SOFR&#8221;) 30-day term rate plus 3%, subject to a minimum of 0.050% in either case.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestAndDebtExpense', window );">Interest expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 59,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility [Member] | Two Year Credit and Security Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, maximum borrowing amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility [Member] | Two-Year Loan and Security Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, maximum borrowing amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, maximum borrowing amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Credit agreement term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityExpirationDate1', window );">Revolving credit facility terminated date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Nov. 28,  2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_PercentageOfExitFee', window );">Percentage of exit fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_LineOfCreditFacilityInterestRate', window );">The Prime Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod', window );">The Prime Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility [Member] | Related Party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherReceivables', window );">Due from Oxford Bank</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=RIME_RevolvingLoanAmendmentMember', window );">Revolving Loan Amendment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, maximum borrowing amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_LineOfCreditFacilityInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line of credit facility interest rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_LineOfCreditFacilityInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_PercentageOfExitFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of exit fee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_PercentageOfExitFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentForAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentForAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessExitCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Includes, but is not limited to, one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and termination benefits associated with an ongoing benefit arrangement. Excludes expenses associated with special or contractual termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessExitCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments including both interest and principal payments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477734/942-470-50-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndDebtExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest and debt related expenses associated with nonoperating financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestAndDebtExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityExpirationDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date the credit facility terminates, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityExpirationDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityInterestRateDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of interest rate for borrowing under credit facility. Includes, but is not limited to, terms and method for determining interest rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityInterestRateDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from parties in nontrade transactions, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(5)(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RIME_CreditAndSecurityAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RIME_CreditAndSecurityAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=RIME_AgileCapilalFundingllcMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=RIME_AgileCapilalFundingllcMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=RIME_CedarAdvancellcMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=RIME_CedarAdvancellcMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=RIME_SemiCabInvestorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=RIME_SemiCabInvestorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RIME_TwoYearCreditAndSecurityAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RIME_TwoYearCreditAndSecurityAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RIME_TwoYearLoanAndSecurityAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RIME_TwoYearLoanAndSecurityAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=RIME_RevolvingLoanAmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=RIME_RevolvingLoanAmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>205
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035117818416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF LOAN (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>May 18, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.97%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=RIME_AjeshKapoorOneMember', window );">Ajesh Kapoor One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentIssuanceDate1', window );">Debt Instrument, Issuance Date</a></td>
<td class="text">Jul. 10,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt Instrument, Maturity Date</a></td>
<td class="text">Jul. 10,  2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">9.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Amount due as of September 30, 2024</a></td>
<td class="nump">$ 150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=RIME_AjeshKapoorTwoMember', window );">Ajesh Kapoor Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentIssuanceDate1', window );">Debt Instrument, Issuance Date</a></td>
<td class="text">Aug. 27,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt Instrument, Maturity Date</a></td>
<td class="text">Aug. 26,  2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">9.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Amount due as of September 30, 2024</a></td>
<td class="nump">$ 235,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=RIME_VivekSeghalMember', window );">Vivek Seghal [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentIssuanceDate1', window );">Debt Instrument, Issuance Date</a></td>
<td class="text">Apr. 17,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt Instrument, Maturity Date</a></td>
<td class="text">Oct. 13,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Amount due as of September 30, 2024</a></td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=RIME_AjeshKapoorThreeMember', window );">Ajesh Kapoor Three [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentIssuanceDate1', window );">Debt Instrument, Issuance Date</a></td>
<td class="text">May  05,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt Instrument, Maturity Date</a></td>
<td class="text">May  04,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Amount due as of September 30, 2024</a></td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=RIME_AjeshKapoorFourMember', window );">Ajesh Kapoor Four [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentIssuanceDate1', window );">Debt Instrument, Issuance Date</a></td>
<td class="text">May 17,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt Instrument, Maturity Date</a></td>
<td class="text">May 16,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Amount due as of September 30, 2024</a></td>
<td class="nump">$ 165,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">Related Party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Amount due as of September 30, 2024</a></td>
<td class="nump">650,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableCurrent', window );">Less: Current portion of notes payable to related parties</a></td>
<td class="nump">265,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermNotesPayable', window );">Notes payable to related parties, net of current portion</a></td>
<td class="nump">$ 385,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentIssuanceDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date the debt instrument was issued, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentIssuanceDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=RIME_AjeshKapoorOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=RIME_AjeshKapoorOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=RIME_AjeshKapoorTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=RIME_AjeshKapoorTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=RIME_VivekSeghalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=RIME_VivekSeghalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=RIME_AjeshKapoorThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=RIME_AjeshKapoorThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=RIME_AjeshKapoorFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=RIME_AjeshKapoorFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>206
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035115596656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LOANS PAYABLE &#8211; RELATED PARTIES (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrentAndNoncurrent', window );">Accrued interest payable</a></td>
<td class="nump">$ 72,000<span></span>
</td>
<td class="nump">$ 72,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">Related Party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">$ 28,000<span></span>
</td>
<td class="nump">$ 28,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-24<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest payable on debt, including, but not limited to, trade payables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>207
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035033644272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="3">9 Months Ended</th>
<th class="th" colspan="1">10 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1">13 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jan. 01, 2025</div></th>
<th class="th"><div>Oct. 01, 2024</div></th>
<th class="th"><div>Jul. 01, 2024</div></th>
<th class="th"><div>Jun. 03, 2024</div></th>
<th class="th"><div>May 28, 2024</div></th>
<th class="th"><div>May 20, 2024</div></th>
<th class="th"><div>May 18, 2024</div></th>
<th class="th"><div>May 08, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Mar. 22, 2024</div></th>
<th class="th"><div>Dec. 21, 2023</div></th>
<th class="th"><div>Jun. 21, 2023</div></th>
<th class="th"><div>May 18, 2023</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2025</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_WorkingCapital', window );">Working capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,082,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,082,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 91,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.97%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent', window );">Component of accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">578,917<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">578,917<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Operating lease expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,000<span></span>
</td>
<td class="nump">$ 279,000<span></span>
</td>
<td class="nump">444,000<span></span>
</td>
<td class="nump">$ 717,000<span></span>
</td>
<td class="nump">$ 762,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,058,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
<td class="nump">75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 99,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis=us-gaap_DirectorsAndOfficersLiabilityInsuranceMember', window );">Directors and Officers Liability Insurance [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InsuranceLiabilities', window );">Insurance liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MalpracticeInsuranceMaximumCoveragePerIncident', window );">Malpractice Insurance, Maximum Coverage Per Incident</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Operating lease expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=RIME_BlueYonderIncMember', window );">Blue Yonder Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent', window );">Component of accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 509,119<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 509,119<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_LossContingencyEstimateOfPossibleLossPerYear', window );">Loss contingency estimate of possible loss per year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyEstimateOfPossibleLoss', window );">Loss contingency estimate of possible loss value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesSoughtValue', window );">Damages claimed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 275,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Loss contingency damages awarded value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">509,119<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesPaidValue', window );">First milestone payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 175,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=RIME_BlueYonderIncMember', window );">Blue Yonder Inc [Member] | Forecast [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Loss contingency damages awarded value</a></td>
<td class="nump">$ 509,119<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=RIME_BlueYonderIncMember', window );">Blue Yonder Inc [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Loss contingency damages awarded value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 225,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=RIME_SemiCabIncMember', window );">Semi Cab Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 453,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 108,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_DisputeAmount', window );">Dispute. amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 93,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_AccruedPotentialLiability', window );">Accrued, potential liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=RIME_SemiCabIncMember', window );">Semi Cab Inc [Member] | Service Contract And Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesSoughtValue', window );">Damages claimed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 275,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 225,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=RIME_SemiCabIncMember', window );">Semi Cab Inc [Member] | Service Contract And Agreement [Member] | January 1, 2025 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForLegalSettlements', window );">Remaining settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">509,119<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=RIME_SemiCabIncMember', window );">Semi Cab Inc [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 311,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=RIME_SettlementSumMember', window );">Settlement Sum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementExpense', window );">Payments of litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 946,666<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=RIME_InitialPaymentMember', window );">Initial Payment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementExpense', window );">Payments of litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=RIME_SecondPaymentMember', window );">Second Payment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementExpense', window );">Payments of litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=RIME_AdditionalPaymentMember', window );">Additional Payment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementExpense', window );">Payments of litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 84,666<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=RIME_PerYearMember', window );">Per Year [Member] | Semi Cab Inc [Member] | Service Contract And Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesSoughtValue', window );">Damages claimed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=RIME_TwoSeparateMilestonePaymentMember', window );">Two Separate Milestone Payment [Member] | Semi Cab Inc [Member] | Service Contract And Agreement [Member] | Due on July 1, 2024 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_PaymentsForMilestone', window );">Payments for milestone</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">509,119<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=RIME_FirstMilestonePaymentMember', window );">First Milestone Payment [Member] | Semi Cab Inc [Member] | Service Contract And Agreement [Member] | Due on July 1, 2024 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_PaymentsForMilestone', window );">Payments for milestone</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">175,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=RIME_SecondMilestonePaymentMember', window );">Second Milestone Payment [Member] | Semi Cab Inc [Member] | Service Contract And Agreement [Member] | October 1 2024 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_PaymentsForMilestone', window );">Payments for milestone</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 225,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_AccruedPotentialLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued potential liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_AccruedPotentialLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_DisputeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Dispute amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_DisputeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_InsuranceLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Insurance liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_InsuranceLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_LossContingencyEstimateOfPossibleLossPerYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss contingency estimate of possible loss per year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_LossContingencyEstimateOfPossibleLossPerYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_PaymentsForMilestone">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments for milestone.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_PaymentsForMilestone</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_WorkingCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Working capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_WorkingCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(6))<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesAwardedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of damages awarded to the plaintiff in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-9<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesAwardedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesPaidValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of damages paid to the plaintiff in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-9<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesPaidValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesSoughtValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value (monetary amount) of the award the plaintiff seeks in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-9<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesSoughtValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyEstimateOfPossibleLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the estimated amount of loss from the specified contingency as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 720<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483359/720-20-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 27<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482395/460-10-55-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-9<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482425/460-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482425/460-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyEstimateOfPossibleLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MalpracticeInsuranceMaximumCoveragePerIncident">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum coverage per malpractice claim provided by the insurance arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 954<br> -SubTopic 450<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477850/954-450-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MalpracticeInsuranceMaximumCoveragePerIncident</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-4<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForLegalSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid for the settlement of litigation or for other legal issues during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForLegalSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for short-term and long-term debt. Excludes payment of lease obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis=us-gaap_DirectorsAndOfficersLiabilityInsuranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis=us-gaap_DirectorsAndOfficersLiabilityInsuranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=RIME_BlueYonderIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=RIME_BlueYonderIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=RIME_SemiCabIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=RIME_SemiCabIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RIME_ServiceContractAndAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RIME_ServiceContractAndAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=RIME_JanuaryOneTwoThousandTwentyFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=RIME_JanuaryOneTwoThousandTwentyFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=RIME_SettlementSumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=RIME_SettlementSumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=RIME_InitialPaymentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=RIME_InitialPaymentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=RIME_SecondPaymentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=RIME_SecondPaymentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=RIME_AdditionalPaymentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=RIME_AdditionalPaymentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=RIME_PerYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=RIME_PerYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=RIME_TwoSeparateMilestonePaymentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=RIME_TwoSeparateMilestonePaymentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=RIME_DueOnJulyOneTwoThousandTwentyFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=RIME_DueOnJulyOneTwoThousandTwentyFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=RIME_FirstMilestonePaymentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=RIME_FirstMilestonePaymentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=RIME_SecondMilestonePaymentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=RIME_SecondMilestonePaymentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=RIME_OctoberOneTwoThousandTwentyFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=RIME_OctoberOneTwoThousandTwentyFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>208
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035032889936">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF SUPPLEMENTAL INFORMATION RELATED TO LEASES (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_DisclosureOperatingLeasesAbstract', window );"><strong>Operating Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease - right-of-use assets</a></td>
<td class="nump">$ 137,000<span></span>
</td>
<td class="nump">$ 3,926,000<span></span>
</td>
<td class="nump">$ 561,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of operating leases</a></td>
<td class="nump">135,000<span></span>
</td>
<td class="nump">84,000<span></span>
</td>
<td class="nump">509,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, net of current portion</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 3,925,000<span></span>
</td>
<td class="nump">$ 88,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_DisclosureOperatingLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_DisclosureOperatingLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>209
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035032733328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF LEASE TERM AND DISCOUNT RATE (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="3">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_DisclosureOperatingLeasesAbstract', window );"><strong>Operating Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Operating lease expense as a component of general and administrative expenses</a></td>
<td class="nump">$ 45,000<span></span>
</td>
<td class="nump">$ 279,000<span></span>
</td>
<td class="nump">$ 444,000<span></span>
</td>
<td class="nump">$ 717,000<span></span>
</td>
<td class="nump">$ 762,000<span></span>
</td>
<td class="nump">$ 1,058,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowOperatingActivitiesLesseeAbstract', window );"><strong>Supplemental cash flow information related to operating leases is as follows:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flow paid for operating leases</a></td>
<td class="nump">$ 45,000<span></span>
</td>
<td class="nump">$ 363,000<span></span>
</td>
<td class="nump">$ 136,000<span></span>
</td>
<td class="nump">$ 858,000<span></span>
</td>
<td class="nump">$ 868,000<span></span>
</td>
<td class="nump">$ 960,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostAbstract', window );"><strong>Lease term and Discount Rate</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term (months)</a></td>
<td class="text">9 months 18 days<span></span>
</td>
<td class="text">15 years 1 month 6 days<span></span>
</td>
<td class="text">9 months 18 days<span></span>
</td>
<td class="text">15 months<span></span>
</td>
<td class="text">15 years 1 month 6 days<span></span>
</td>
<td class="text">12 months 12 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate</a></td>
<td class="nump">9.00%<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">6.50%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_DisclosureOperatingLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_DisclosureOperatingLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowOperatingActivitiesLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowOperatingActivitiesLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-4<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>210
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035032425680">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF OPERATING LEASE MINIMUM FUTURE PAYMENTS (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_DisclosureOperatingLeasesAbstract', window );"><strong>Operating Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">2024 (remaining six months)</a></td>
<td class="nump">$ 46,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2024</a></td>
<td class="nump">94,000<span></span>
</td>
<td class="nump">$ 269,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total minimum future payments</a></td>
<td class="nump">140,000<span></span>
</td>
<td class="nump">9,903,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: interest</a></td>
<td class="nump">5,000<span></span>
</td>
<td class="nump">5,894,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">135,000<span></span>
</td>
<td class="nump">4,009,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">355,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">529,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">585,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">610,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,555,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Less: current portion of lease liabilities</a></td>
<td class="nump">135,000<span></span>
</td>
<td class="nump">84,000<span></span>
</td>
<td class="nump">$ 509,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, net of current portion</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 3,925,000<span></span>
</td>
<td class="nump">$ 88,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_DisclosureOperatingLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_DisclosureOperatingLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>211
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035102163360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OPERATING LEASES (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="3">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 25, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 22, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Feb. 22, 2024</div></th>
<th class="th">
<div>Aug. 23, 2023 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Oct. 15, 2022 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Oct. 01, 2017 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Sep. 30, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating lease payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45,000<span></span>
</td>
<td class="nump">$ 363,000<span></span>
</td>
<td class="nump">$ 136,000<span></span>
</td>
<td class="nump">$ 858,000<span></span>
</td>
<td class="nump">$ 868,000<span></span>
</td>
<td class="nump">$ 960,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_OperatingLeaseAgreementMember', window );">Operating Lease Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AreaOfLand', window );">Lease space | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">1,890<span></span>
</td>
<td class="nump">6,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseExpirationDate1', window );">Lease expiration, date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug. 22,  2038<span></span>
</td>
<td class="text">Oct. 14,  2025<span></span>
</td>
<td class="text">Mar. 31,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseOptionToExtend', window );">Lease extension, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">the Company
executed a lease extension for 14 months effective April 1, 2024, and expires on May 31, 2025. The base rent on the extension is approximately
$10,000 per month subject to a 3% annual adjustment.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating lease payments</a></td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRent', window );">Base rent payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000<span></span>
</td>
<td class="nump">$ 4,900<span></span>
</td>
<td class="nump">$ 9,950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TenantImprovements', window );">Reimbursement for tenant improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_OperatingLeaseAgreementMember', window );">Operating Lease Agreement [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseOptionToExtend', window );">Lease extension, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">the Company executed a lease extension for 14 months effective April 1, 2024, and expires on May 31, 2025. The base rent on the extension
is approximately $10,553 per month subject to a 3% annual adjustment.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRent', window );">Base rent payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,553<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AreaOfLand">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area of land held.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AreaOfLand</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 808<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseExpirationDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date which lease or group of leases is set to expire, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseExpirationDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseOptionToExtend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of terms and conditions of option to extend lessee's operating lease. Includes, but is not limited to, information about option recognized as part of right-of-use asset and lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseOptionToExtend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash payments to lessor's for use of assets under operating leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TenantImprovements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of improvements having a life longer than one year that were made for the benefit of one or more tenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TenantImprovements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RIME_OperatingLeaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RIME_OperatingLeaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>212
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035125833088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ISSUANCE OF COMMON STOCK (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="4">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available to issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">165,469<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognised expense</a></td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="nump">$ 122,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted average term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">18 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Vested options intrinsic value</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross', window );">Stock Issued During Period, Value, Restricted Stock Award, Gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 774,528<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Stock Issued During Period, Shares, Issued for Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">94,340<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Stock Issued During Period, Value, New Issues</a></td>
<td class="nump">$ 1,489,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,489,000<span></span>
</td>
<td class="nump">$ 3,529,000<span></span>
</td>
<td class="nump">$ 1,640,000<span></span>
</td>
<td class="nump">$ 4,508,000<span></span>
</td>
<td class="nump">$ 4,030,000<span></span>
</td>
<td class="nump">$ 4,950,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and Administrative Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Stock Issued During Period, Value, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 478,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=RIME_TwoThousandTwentyTwoPlanMember', window );">2022 Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">Share base compensation issued shares</a></td>
<td class="nump">150,943<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">150,943<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value</a></td>
<td class="nump">$ 0.55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited', window );">Share base compensation forfeited shares</a></td>
<td class="nump">1,250<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available to issued</a></td>
<td class="nump">63,453<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63,453<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=RIME_TwoThousandTwentyTwoPlanMember', window );">2022 Plan [Member] | General and Administrative Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeBenefitsAndShareBasedCompensation', window );">Equity compensation</a></td>
<td class="nump">$ 101,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 138,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeBenefitsAndShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for employee benefit and equity-based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeBenefitsAndShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares (or other type of equity) forfeited during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate value of stock related to Restricted Stock Awards issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=RIME_TwoThousandTwentyTwoPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=RIME_TwoThousandTwentyTwoPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>213
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035125720848">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF WARRANTS EXPIRATION (Details) - $ / shares<br></strong></div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of common warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">902,113<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of Common Warrants</a></td>
<td class="nump">902,113<span></span>
</td>
<td class="nump">902,113<span></span>
</td>
<td class="nump">902,113<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=RIME_ExercisePriceRangeOneMember', window );">Exercise Price Range One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of common warrants</a></td>
<td class="nump">802,113<span></span>
</td>
<td class="nump">802,113<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant Exercise Price</a></td>
<td class="nump">$ 2.80<span></span>
</td>
<td class="nump">$ 2.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate', window );">Expiration Date</a></td>
<td class="text">Sep. 15,  2026<span></span>
</td>
<td class="text">Sep. 15,  2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=RIME_ExercisePriceRangeTwoMember', window );">Exercise Price Range Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of common warrants</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant Exercise Price</a></td>
<td class="nump">$ 5.00<span></span>
</td>
<td class="nump">$ 5.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate', window );">Expiration Date</a></td>
<td class="text">May 23,  2027<span></span>
</td>
<td class="text">May 23,  2027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expiration date of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=RIME_ExercisePriceRangeOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=RIME_ExercisePriceRangeOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=RIME_ExercisePriceRangeTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=RIME_ExercisePriceRangeTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>214
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035033193312">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>WARRANTS (Details Narrative) - shares<br></strong></div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_DisclosureWarrantsAbstract', window );"><strong>Warrants</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Class of Warrant or Right, Outstanding</a></td>
<td class="nump">902,113<span></span>
</td>
<td class="nump">902,113<span></span>
</td>
<td class="nump">902,113<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_DisclosureWarrantsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_DisclosureWarrantsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>215
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035116104144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF BASIC AND DILUTIVE LOSS PER SHARE (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="4">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Loss per Common Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net income (loss) available to common stockholders</a></td>
<td class="nump">$ 1,195,000<span></span>
</td>
<td class="nump">$ 97,000<span></span>
</td>
<td class="num">$ (7,292,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (5,348,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted Average Number of Shares Outstanding, Diluted</a></td>
<td class="nump">9,095,504<span></span>
</td>
<td class="nump">4,220,259<span></span>
</td>
<td class="nump">7,341,204<span></span>
</td>
<td class="nump">4,864,540<span></span>
</td>
<td class="nump">3,726,259<span></span>
</td>
<td class="nump">2,699,210<span></span>
</td>
<td class="nump">2,811,872<span></span>
</td>
<td class="nump">1,623,397<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Earnings Per Share, Diluted</a></td>
<td class="nump">$ 0.13<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
<td class="num">$ (0.99)<span></span>
</td>
<td class="num">$ (1.32)<span></span>
</td>
<td class="num">$ (1.44)<span></span>
</td>
<td class="num">$ (0.61)<span></span>
</td>
<td class="num">$ (1.65)<span></span>
</td>
<td class="nump">$ 0.14<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-5<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>216
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035034144448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMPUTATION OF LOSS PER SHARE (Details Narrative) - shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="3">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Share-Based Payment Arrangement, Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive securities</a></td>
<td class="nump">98,178<span></span>
</td>
<td class="nump">91,261<span></span>
</td>
<td class="nump">98,178<span></span>
</td>
<td class="nump">113,761<span></span>
</td>
<td class="nump">91,261<span></span>
</td>
<td class="nump">53,675<span></span>
</td>
<td class="nump">8,891<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">902,113<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">902,113<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=RIME_CommonStockWarrantsMember', window );">Common Stock Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">902,113<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">902,113<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=RIME_PreFundedWarrantsMember', window );">Pre Funded Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">561,111<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=RIME_OptionsAndWarrantsMember', window );">Options and Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=RIME_CommonStockWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=RIME_CommonStockWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=RIME_PreFundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=RIME_PreFundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=RIME_OptionsAndWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=RIME_OptionsAndWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>217
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035119532624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="4">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationLineItems', window );"><strong>Effective Income Tax Rate Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income Tax (benefit) provision</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 1,502,000<span></span>
</td>
<td class="num">$ (472,000)<span></span>
</td>
<td class="nump">$ 1,030,000<span></span>
</td>
<td class="nump">$ 57,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Deferred tax asset valuation allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,104,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_InternalRevenueServiceIRSMember', window );">Internal Revenue Service (IRS) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationLineItems', window );"><strong>Effective Income Tax Rate Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Tax Jurisdiction [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationLineItems', window );"><strong>Effective Income Tax Rate Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,149,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,131,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local Jurisdiction [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationLineItems', window );"><strong>Effective Income Tax Rate Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,453,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,238,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_InternalRevenueServiceIRSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_InternalRevenueServiceIRSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>218
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035033981264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF REVENUE BY PRODUCT LINE (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="3">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Net Sales</a></td>
<td class="nump">$ 10,622,000<span></span>
</td>
<td class="nump">$ 15,931,000<span></span>
</td>
<td class="nump">$ 15,488,000<span></span>
</td>
<td class="nump">$ 29,198,000<span></span>
</td>
<td class="nump">$ 21,939,000<span></span>
</td>
<td class="nump">$ 39,299,000<span></span>
</td>
<td class="nump">$ 47,512,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=RIME_ClassicKaraokeMachinesMember', window );">Classic Karaoke Machines [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Net Sales</a></td>
<td class="nump">8,218,000<span></span>
</td>
<td class="nump">14,636,000<span></span>
</td>
<td class="nump">10,521,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,363,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=RIME_LicensedProductsMember', window );">Licensed Products [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Net Sales</a></td>
<td class="nump">180,000<span></span>
</td>
<td class="nump">36,000<span></span>
</td>
<td class="nump">377,000<span></span>
</td>
<td class="nump">549,000<span></span>
</td>
<td class="nump">32,000<span></span>
</td>
<td class="nump">95,000<span></span>
</td>
<td class="nump">1,645,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=RIME_KidsYouthElectronicsMember', window );">Kids Youth Electronics [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Net Sales</a></td>
<td class="nump">379,000<span></span>
</td>
<td class="nump">297,000<span></span>
</td>
<td class="nump">546,000<span></span>
</td>
<td class="nump">565,000<span></span>
</td>
<td class="nump">451,000<span></span>
</td>
<td class="nump">1,872,000<span></span>
</td>
<td class="nump">2,277,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=RIME_MicrophonesAndAccessoriesMember', window );">Microphones and Accessories [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Net Sales</a></td>
<td class="nump">1,500,000<span></span>
</td>
<td class="nump">806,000<span></span>
</td>
<td class="nump">3,329,000<span></span>
</td>
<td class="nump">3,283,000<span></span>
</td>
<td class="nump">3,543,000<span></span>
</td>
<td class="nump">7,802,000<span></span>
</td>
<td class="nump">4,185,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=RIME_MusicSubscriptionsMember', window );">Music Subscriptions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Net Sales</a></td>
<td class="nump">218,000<span></span>
</td>
<td class="nump">156,000<span></span>
</td>
<td class="nump">588,000<span></span>
</td>
<td class="nump">612,000<span></span>
</td>
<td class="nump">550,000<span></span>
</td>
<td class="nump">674,000<span></span>
</td>
<td class="nump">536,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=RIME_LogisticsServicesMember', window );">Logistics Services [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Net Sales</a></td>
<td class="nump">$ 127,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 127,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=RIME_KaraokeMachinesMember', window );">Karaoke Machines [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Net Sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,189,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 28,856,000<span></span>
</td>
<td class="nump">$ 38,869,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=RIME_ClassicKaraokeMachinesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=RIME_ClassicKaraokeMachinesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=RIME_LicensedProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=RIME_LicensedProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=RIME_KidsYouthElectronicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=RIME_KidsYouthElectronicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=RIME_MicrophonesAndAccessoriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=RIME_MicrophonesAndAccessoriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=RIME_MusicSubscriptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=RIME_MusicSubscriptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=RIME_LogisticsServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=RIME_LogisticsServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=RIME_KaraokeMachinesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=RIME_KaraokeMachinesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>219
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035121983264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF SALES BY GEOGRAPHICAL REGION (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="3">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Net Sales&#160;</a></td>
<td class="nump">$ 10,622,000<span></span>
</td>
<td class="nump">$ 15,931,000<span></span>
</td>
<td class="nump">$ 15,488,000<span></span>
</td>
<td class="nump">$ 29,198,000<span></span>
</td>
<td class="nump">$ 21,939,000<span></span>
</td>
<td class="nump">$ 39,299,000<span></span>
</td>
<td class="nump">$ 47,512,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_NorthAmericaMember', window );">North America [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Net Sales&#160;</a></td>
<td class="nump">10,466,000<span></span>
</td>
<td class="nump">15,378,000<span></span>
</td>
<td class="nump">15,208,000<span></span>
</td>
<td class="nump">28,763,000<span></span>
</td>
<td class="nump">21,386,000<span></span>
</td>
<td class="nump">38,298,000<span></span>
</td>
<td class="nump">46,396,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_AU', window );">AUSTRALIA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Net Sales&#160;</a></td>
<td class="nump">50,000<span></span>
</td>
<td class="nump">263,000<span></span>
</td>
<td class="nump">174,000<span></span>
</td>
<td class="nump">$ 205,000<span></span>
</td>
<td class="nump">263,000<span></span>
</td>
<td class="nump">$ 670,000<span></span>
</td>
<td class="nump">$ 679,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Net Sales&#160;</a></td>
<td class="nump">$ 106,000<span></span>
</td>
<td class="nump">$ 290,000<span></span>
</td>
<td class="nump">$ 106,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 290,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_NorthAmericaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_NorthAmericaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_AU">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_AU</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>220
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035119817856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE DISAGGREGATION (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="3">9 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvertisingExpense', window );">Co-op promotion incentives</a></td>
<td class="nump">$ 908,000<span></span>
</td>
<td class="nump">$ 1,637,000<span></span>
</td>
<td class="nump">$ 1,257,000<span></span>
</td>
<td class="nump">$ 2,600,000<span></span>
</td>
<td class="nump">$ 1,901,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,300,000<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_EstimatedReserveOfAdvertisingExpense', window );">Estimated reserve co-op promotion incentives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,833,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,277,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ReserveForSalesReturns', window );">Reserve for sales returns</a></td>
<td class="nump">2,212,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,212,000<span></span>
</td>
<td class="nump">3,390,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,390,000<span></span>
</td>
<td class="nump">$ 900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_EstimatedCostOfReturns', window );">Estimated costs of returns</a></td>
<td class="nump">$ 1,081,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,081,000<span></span>
</td>
<td class="nump">$ 1,919,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,919,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_EstimatedCostOfReturns">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Estimated cost of returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_EstimatedCostOfReturns</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_EstimatedReserveOfAdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Estimated reserve of advertising expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_EstimatedReserveOfAdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_ReserveForSalesReturns">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reserve for sales returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_ReserveForSalesReturns</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 720<br> -SubTopic 35<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483385/720-35-55-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 720<br> -SubTopic 35<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483406/720-35-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>221
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035117944096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONCENTRATIONS OF CREDIT RISK AND REVENUE (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="4">9 Months Ended</th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=RIME_RepublicOfChinaMember', window );">Republic of China [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentDescription', window );">Debt instrument, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">the U.S. government-imposed
tariffs of up to 25% on certain goods imported from China. All our products are manufactured and imported from China however, only our
microphones are currently subject to a 7.5% tariff currently in place<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Accounts Receivable [Member] | Customer Concentration Risk [Member] | Three Customers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">79.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Accounts Receivable [Member] | Customer Concentration Risk [Member] | Four Customers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">82.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">82.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Accounts Receivable [Member] | Customer Concentration Risk [Member] | 4 [Member] | Semi Cab Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=RIME_SalesRevenueMember', window );">Sales Revenue [Member] | Customer Concentration Risk [Member] | Customer One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41.00%<span></span>
</td>
<td class="nump">28.00%<span></span>
</td>
<td class="nump">29.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=RIME_SalesRevenueMember', window );">Sales Revenue [Member] | Customer Concentration Risk [Member] | Customers Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="nump">22.00%<span></span>
</td>
<td class="nump">27.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=RIME_SalesRevenueMember', window );">Sales Revenue [Member] | Customer Concentration Risk [Member] | Customers Three [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=RIME_SalesRevenueMember', window );">Sales Revenue [Member] | Customer Concentration Risk [Member] | Customers Four [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=RIME_SalesRevenueMember', window );">Sales Revenue [Member] | Three Customers [Member] | Customers concentration risk [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">81.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">77.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">72.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=RIME_SalesRevenueMember', window );">Sales Revenue [Member] | Customers One [Member] | Customers concentration risk [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=RIME_SalesRevenueMember', window );">Sales Revenue [Member] | Customers Two [Member] | Customers concentration risk [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=RIME_SalesRevenueMember', window );">Sales Revenue [Member] | Customers Three [Member] | Customers concentration risk [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=RIME_PurchasesMember', window );">Purchases [Member] | Geographic Concentration Risk [Member] | Republic of China [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue Benchmark [Member] | Customer Concentration Risk [Member] | 4 [Member] | Semi Cab Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478785/954-310-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-20<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Identification of the lender and information about a contractual promise to repay a short-term or long-term obligation, which includes borrowings under lines of credit, notes payable, commercial paper, bonds payable, debentures, and other contractual obligations for payment. This may include rationale for entering into the arrangement, significant terms of the arrangement, which may include amount, repayment terms, priority, collateral required, debt covenants, borrowing capacity, call features, participation rights, conversion provisions, sinking-fund requirements, voting rights, basis for conversion if convertible and remarketing provisions. The description may be provided for individual debt instruments, rational groupings of debt instruments, or by debt in total.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477734/942-470-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=RIME_RepublicOfChinaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=RIME_RepublicOfChinaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=RIME_ThreeCustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=RIME_ThreeCustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=RIME_FourCustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=RIME_FourCustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=RIME_FourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=RIME_FourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=RIME_SemiCabIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=RIME_SemiCabIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=RIME_SalesRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=RIME_SalesRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=RIME_CustomerOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=RIME_CustomerOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=RIME_CustomersTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=RIME_CustomersTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=RIME_CustomersThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=RIME_CustomersThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=RIME_CustomersFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=RIME_CustomersFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=RIME_ThreeCustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=RIME_ThreeCustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=RIME_CustomersConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=RIME_CustomersConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=RIME_CustomersOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=RIME_CustomersOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=RIME_CustomersTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=RIME_CustomersTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=RIME_CustomersThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=RIME_CustomersThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=RIME_PurchasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=RIME_PurchasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=RIME_RepublicOfChinaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=RIME_RepublicOfChinaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>222
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035113557472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="4">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 20, 2023</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue from related parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,622,000<span></span>
</td>
<td class="nump">$ 15,931,000<span></span>
</td>
<td class="nump">$ 15,488,000<span></span>
</td>
<td class="nump">$ 29,198,000<span></span>
</td>
<td class="nump">$ 21,939,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 39,299,000<span></span>
</td>
<td class="nump">$ 47,512,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Number of stock sold, value</a></td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">Related Party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue from related parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">218,000<span></span>
</td>
<td class="nump">$ 156,000<span></span>
</td>
<td class="nump">567,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 550,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=RIME_StingrayMember', window );">Stingray [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue from related parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="nump">700,000<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherReceivables', window );">Other receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">157,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">157,000<span></span>
</td>
<td class="nump">269,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">218,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=RIME_SMCBMember', window );">S M C B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilities', window );">Due to related parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">776,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 776,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=RIME_SMCBMember', window );">S M C B [Member] | Software and Software Development Costs [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfessionalFees', window );">Software support service</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 422,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=RIME_AultAllianceIncMember', window );">AultAlliance Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherReceivables', window );">Other receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=RIME_AjeshKapoorMember', window );">Ajesh Kapoor [Member] | Semi Cab Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherReceivables', window );">Other receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 712,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 385,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 712,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from parties in nontrade transactions, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(5)(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfessionalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (k)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-3<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfessionalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=RIME_StingrayMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=RIME_StingrayMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=RIME_SMCBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=RIME_SMCBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=RIME_AultAllianceIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=RIME_AultAllianceIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=RIME_AjeshKapoorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=RIME_AjeshKapoorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=RIME_SemiCabIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=RIME_SemiCabIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>223
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035033078896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="3">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Oct. 24, 2024</div></th>
<th class="th"><div>Oct. 22, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Nov. 01, 2024</div></th>
<th class="th"><div>Jul. 06, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,079,678<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,079,678<span></span>
</td>
<td class="nump">6,418,061<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,167,489<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,752,755<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,752,755<span></span>
</td>
<td class="nump">6,418,061<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,167,489<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvertisingExpense', window );">Co-op promotion incentives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 908,000<span></span>
</td>
<td class="nump">$ 1,637,000<span></span>
</td>
<td class="nump">$ 1,257,000<span></span>
</td>
<td class="nump">$ 2,600,000<span></span>
</td>
<td class="nump">$ 1,901,000<span></span>
</td>
<td class="nump">$ 2,300,000<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement', window );">Income Tax Examination, Likelihood of Unfavorable Settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">greater
than 50% likelihood<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price</a></td>
<td class="nump">$ 0.85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_PercentageOfPurchasersRightToParticipateOnIssuanceCompanyOfCommonStock', window );">Percentage of purchasers right to participate on issuance company of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_PercentageOfGrossProceeds', window );">Percentage of gross proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of shares issued</a></td>
<td class="nump">2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="nump">$ 2,352,941<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Net proceeds</a></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionOriginalDebtAmount1', window );">Original issue discount</a></td>
<td class="nump">$ 352,941<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Original issue discount percentage</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Interest accrued rate percentage</a></td>
<td class="nump">14.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentIssuanceDate1', window );">Issuance date</a></td>
<td class="text">Oct. 24,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,098,901<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,098,901<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Securities Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of share sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Number of shares sold, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Net proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_PercentageOfGrossProceeds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of gross proceeds.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_PercentageOfGrossProceeds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_PercentageOfPurchasersRightToParticipateOnIssuanceCompanyOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of purchasers right to participate on issuance company of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_PercentageOfPurchasersRightToParticipateOnIssuanceCompanyOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 720<br> -SubTopic 35<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483385/720-35-55-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 720<br> -SubTopic 35<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483406/720-35-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionOriginalDebtAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionOriginalDebtAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentIssuanceDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date the debt instrument was issued, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentIssuanceDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the likelihood that an uncertainty in income taxes will not be sustained as a result of the examination by the taxing authority.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOrSaleOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RIME_SecuritiesPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RIME_SecuritiesPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>224
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035119935376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="3">9 Months Ended</th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvertisingExpense', window );">Co-op promotion incentives</a></td>
<td class="nump">$ 908,000<span></span>
</td>
<td class="nump">$ 1,637,000<span></span>
</td>
<td class="nump">$ 1,257,000<span></span>
</td>
<td class="nump">$ 2,600,000<span></span>
</td>
<td class="nump">$ 1,901,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ReserveForSalesReturn', window );">Reserve for sales return</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,400,000<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ReturnAssets', window );">Return assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,900,000<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ShippingAndHandlingExpenses', window );">Shipping and handling expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 900,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expense</a></td>
<td class="nump">$ 867,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 867,000<span></span>
</td>
<td class="nump">136,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">136,000<span></span>
</td>
<td class="nump">$ 351,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=RIME_SemiCabIncMember', window );">Semi Cab Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ShippingAndHandlingExpenses', window );">Shipping and handling expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,692,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,057,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignFinancialInstitutionsActualDeposits', window );">Foreign financial institutions actual deposits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">91,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 842,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 640,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_ReserveForSalesReturn">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reserve for sales return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_ReserveForSalesReturn</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_ReturnAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Return assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_ReturnAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_ShippingAndHandlingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Shipping and handling expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_ShippingAndHandlingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 720<br> -SubTopic 35<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483385/720-35-55-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 720<br> -SubTopic 35<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483406/720-35-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignFinancialInstitutionsActualDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of deposits held by branches of foreign institutions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 505<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477270/942-505-50-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignFinancialInstitutionsActualDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=RIME_SemiCabIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=RIME_SemiCabIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>225
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035107244400">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF PROPERTY AND EQUIPMENT (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,739,000<span></span>
</td>
<td class="nump">$ 3,019,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: Accumulated depreciation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,335,000<span></span>
</td>
<td class="nump">2,386,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">$ 318,000<span></span>
</td>
<td class="nump">404,000<span></span>
</td>
<td class="nump">633,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=RIME_ComputerAndOfficeEquipmentMember', window );">Computer and Office Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 404,000<span></span>
</td>
<td class="nump">497,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=RIME_ComputerAndOfficeEquipmentMember', window );">Computer and Office Equipment [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Average useful life (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=RIME_ComputerAndOfficeEquipmentMember', window );">Computer and Office Equipment [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Average useful life (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Fixtures [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Average useful life (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 107,000<span></span>
</td>
<td class="nump">111,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=RIME_WarehouseEquipmentMember', window );">Warehouse Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Average useful life (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">251,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=RIME_MoldsAndToolingMember', window );">Molds and tooling [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,228,000<span></span>
</td>
<td class="nump">$ 2,160,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=RIME_MoldsAndToolingMember', window );">Molds and tooling [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Average useful life (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=RIME_MoldsAndToolingMember', window );">Molds and tooling [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Average useful life (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=RIME_ComputerAndOfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=RIME_ComputerAndOfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=RIME_WarehouseEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=RIME_WarehouseEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=RIME_MoldsAndToolingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=RIME_MoldsAndToolingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>226
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035034143968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">9 Months Ended</th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">$ 159,000<span></span>
</td>
<td class="nump">$ 287,000<span></span>
</td>
<td class="nump">$ 289,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 228,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 246,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=RIME_SemiCabIncMember', window );">Semi Cab Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=RIME_SemiCabIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=RIME_SemiCabIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>227
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035033251968">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF STOCK OPTION ACTIVITY (Details) - Equity Option [Member] - $ / shares<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="5">12 Months Ended</th>
</tr>
<tr>
<th class="th" colspan="2"><div>Dec. 31, 2023</div></th>
<th class="th" colspan="2"><div>Mar. 31, 2023</div></th>
<th class="th" colspan="2"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems', window );"><strong>Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Options, Balance at beginning of period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">161,427<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">56,343<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">56,010<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Balance at beginning of period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 7.90<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 9.90<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 9.90<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average contractual life</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">4 years 2 months 12 days<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">6 years 7 months 6 days<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">4 years 1 month 6 days<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">5 years 4 months 24 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of Options, Granted</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">107,752<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,667<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Granted</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 6.83<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 7.80<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Number of Options, Exercised</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(2,667)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Exercised</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 5.40<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Number of Options, Forfeited</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(47,666)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(2,668)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(667)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Forfeited</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 7.48<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 5.63<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 3.60<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Options, Balance at end of period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">113,761<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">161,427<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">56,343<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">56,010<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Balance at end of period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 8.08<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 7.90<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 9.90<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 9.90<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Weighted Average contractual life</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">6 years 7 months 6 days<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">4 years 1 month 6 days<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Number of Options, exercisable at end of period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">91,261<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">53,675<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">52,667<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Options exercisable at end of period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 8.06<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 9.90<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 9.90<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="8"></td></tr>
<tr><td colspan="8"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Total number of
options outstanding as of December 31, 2023, includes <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEVNUExPWUVFIFNUT0NLIE9QVElPTlMgT1VUU1RBTkRJTkcgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20231231__srt--TitleOfIndividualAxis__custom--SixCurrentAndThreeFormerDirectorsMember_ziDf0VRBSP8d" title="Option issued">23,343</span> options issued to six current and three former directors as compensation,
<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEVNUExPWUVFIFNUT0NLIE9QVElPTlMgT1VUU1RBTkRJTkcgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20231231__srt--TitleOfIndividualAxis__srt--OfficerMember_zlaFmcYLufcb" title="Option issued">56,668</span> options issued to Company officers as compensation and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEVNUExPWUVFIFNUT0NLIE9QVElPTlMgT1VUU1RBTkRJTkcgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20231231__srt--TitleOfIndividualAxis__custom--EmployeesMember_zMTAts14yJF3" title="Option issued">33,750</span> options issued to employees as part of an Employee Stock Incentive
Plan.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_StockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_StockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>228
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035124583840">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF EMPLOYEE STOCK OPTIONS OUTSTANDING (Details) (Parenthetical)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=RIME_SixCurrentAndThreeFormerDirectorsMember', window );">Six Current And Three Former Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Option issued</a></td>
<td class="nump">23,343<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_OfficerMember', window );">Officer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Option issued</a></td>
<td class="nump">56,668<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=RIME_EmployeesMember', window );">Employees [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Option issued</a></td>
<td class="nump">33,750<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=RIME_SixCurrentAndThreeFormerDirectorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=RIME_SixCurrentAndThreeFormerDirectorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_OfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_OfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=RIME_EmployeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=RIME_EmployeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>229
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035117976240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF BASIC AND DILUTIVE SHARES (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="4">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic weighted average common shares outstanding</a></td>
<td class="nump">9,095,504<span></span>
</td>
<td class="nump">4,220,259<span></span>
</td>
<td class="nump">7,341,204<span></span>
</td>
<td class="nump">4,864,540<span></span>
</td>
<td class="nump">3,726,259<span></span>
</td>
<td class="nump">2,699,210<span></span>
</td>
<td class="nump">2,811,872<span></span>
</td>
<td class="nump">1,614,506<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants', window );">Effect of dilutive stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">8,891<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted weighted average of common shares outstanding</a></td>
<td class="nump">9,095,504<span></span>
</td>
<td class="nump">4,220,259<span></span>
</td>
<td class="nump">7,341,204<span></span>
</td>
<td class="nump">4,864,540<span></span>
</td>
<td class="nump">3,726,259<span></span>
</td>
<td class="nump">2,699,210<span></span>
</td>
<td class="nump">2,811,872<span></span>
</td>
<td class="nump">1,623,397<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-26<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>230
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035033035408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK COMPENSATION EXPENSE (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 12, 2022</div></th>
<th class="th"><div>Jul. 06, 2021</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockOptionPlanExpense', window );">Stock option expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 110,000<span></span>
</td>
<td class="nump">$ 237,000<span></span>
</td>
<td class="nump">$ 22,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Stock option, expected dividend yield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Stock option, risk free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.65%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Stock option, volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">168.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Stock option, expected term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognised expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="nump">$ 122,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted average term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">18 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Vested options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available for issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">165,469<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">902,113<span></span>
</td>
<td class="nump">902,113<span></span>
</td>
<td class="nump">902,113<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Stock option, risk free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.63%<span></span>
</td>
<td class="nump">0.43%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Stock option, volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">166.10%<span></span>
</td>
<td class="nump">149.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Stock option, risk free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.21%<span></span>
</td>
<td class="nump">0.96%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Stock option, volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">196.30%<span></span>
</td>
<td class="nump">157.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_BoardOfDirectorsChairmanMember', window );">Board of Directors Chairman [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Common stock options grants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,001<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_BoardOfDirectorsChairmanMember', window );">Board of Directors Chairman [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.10<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_BoardOfDirectorsChairmanMember', window );">Board of Directors Chairman [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.70<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=RIME_TwoThousandTwentyTwoPlanMember', window );">2022 Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockDescriptionOfTransaction', window );">Sale of stock description</a></td>
<td class="text">The
maximum number of shares of common stock initially available for issuance under the 2022 Plan is 233,334 shares of common stock and
thereafter an annual increase shall be added as of the first day of the Company&#8217;s fiscal year beginning in 2023, equal to the
least of (i) 5% of the outstanding common stock on a fully diluted basis as of the end of the Company&#8217;s immediately preceding
fiscal year, (ii) 33,334 shares, and (iii) a lesser amount as determined by the Board of Directors.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available for issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63,453<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=RIME_TwoThousandTwentyTwoPlanMember', window );">2022 Plan [Member] | Director [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Common stock options grants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=RIME_TwoThousandTwentyTwoPlanMember', window );">2022 Plan [Member] | Director [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=RIME_TwoThousandTwentyTwoPlanMember', window );">2022 Plan [Member] | Director [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=RIME_TwoThousandTwentyTwoPlanMember', window );">2022 Plan [Member] | Officer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Common stock options grants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=RIME_TwoThousandTwentyTwoPlanMember', window );">2022 Plan [Member] | Officer [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=RIME_TwoThousandTwentyTwoPlanMember', window );">2022 Plan [Member] | Officer [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=RIME_TwoThousandTwentyTwoPlanMember', window );">2022 Plan [Member] | Employee [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Common stock options grants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=RIME_TwoThousandTwentyTwoPlanMember', window );">2022 Plan [Member] | Employee [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=RIME_TwoThousandTwentyTwoPlanMember', window );">2022 Plan [Member] | Employee [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockDescriptionOfTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of stock transaction which may include details of the offering (IPO, private placement), a description of the stock sold, percentage of subsidiary's or equity investee's stock sold, a description of the investors and whether the stock was issued in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-23<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockDescriptionOfTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockOptionPlanExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockOptionPlanExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_BoardOfDirectorsChairmanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_BoardOfDirectorsChairmanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=RIME_TwoThousandTwentyTwoPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=RIME_TwoThousandTwentyTwoPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_OfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_OfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=RIME_EmployeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=RIME_EmployeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>231
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035117551328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PUBLIC OFFERING AND NASDAQ UPLISTING (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>May 23, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2024 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Jul. 06, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Gross proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,489,000<span></span>
</td>
<td class="nump">$ 3,529,000<span></span>
</td>
<td class="nump">$ 1,640,000<span></span>
</td>
<td class="nump">$ 3,393,000<span></span>
</td>
<td class="nump">$ 9,001,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Underwriter warrants to purchase | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">902,113<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrant term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 6 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_UnderwritingAgreementMember', window );">Underwriting Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares sold | shares</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value | $ / shares</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Gross proceeds</a></td>
<td class="nump">$ 4,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForCommissions', window );">Underwriting discounts and commissions and other estimated offering expenses</a></td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, price per share | $ / shares</a></td>
<td class="nump">$ 4.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Net proceeds</a></td>
<td class="nump">$ 3,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Underwriter warrants to purchase | shares</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_SaleOfStockPercentage', window );">Sale of stock, percentage</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price per share | $ / shares</a></td>
<td class="nump">$ 5.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrant term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Fair value adjustment of warrants</a></td>
<td class="nump">$ 244,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_UnderwritingAgreementMember', window );">Underwriting Agreement [Member] | Measurement Input, Exercise Price [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrant measurement input</a></td>
<td class="nump">2.90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_UnderwritingAgreementMember', window );">Underwriting Agreement [Member] | Measurement Input, Expected Term [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrant term</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_UnderwritingAgreementMember', window );">Underwriting Agreement [Member] | Measurement Input, Price Volatility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrant measurement input</a></td>
<td class="nump">176<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_UnderwritingAgreementMember', window );">Underwriting Agreement [Member] | Measurement Input, Expected Dividend Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrant measurement input</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_UnderwritingAgreementMember', window );">Underwriting Agreement [Member] | Measurement Input, Risk Free Interest Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrant measurement input</a></td>
<td class="nump">2.63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_SaleOfStockPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sale of stock percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_SaleOfStockPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 808<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 13<br> -SubTopic 10<br> -Topic 480<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481766/480-10-25-13<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForCommissions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid for commissions during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForCommissions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RIME_UnderwritingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RIME_UnderwritingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>232
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035112705904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ATM OFFERING (Details Narrative) - ATM Offering [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 15, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Number of stock sold, value</a></td>
<td class="nump">$ 1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Proceeds from sale of equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,654,000<span></span>
</td>
<td class="nump">$ 36,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOrSaleOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=RIME_ATMOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=RIME_ATMOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>233
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035298433696">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>PRIVATE PLACEMENT (Details Narrative) - Private Placement [Member]<br></strong></div></th>
<th class="th">
<div>Nov. 20, 2023 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Number of stock sold, value</a></td>
<td class="nump">$ 2,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Commmon stock share per share | $ / shares</a></td>
<td class="nump">$ 0.91<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares sold | shares</a></td>
<td class="nump">2,198,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Proceeds from sale of equity</a></td>
<td class="nump">$ 1,900,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_TransactionFees', window );">Transaction fees</a></td>
<td class="nump">$ 100,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_TransactionFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Transaction fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_TransactionFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOrSaleOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>234
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035118290640">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>AUGUST 2021 STOCK REDEMPTION (Details Narrative) - Redemption Agreement [Member] - Koncepts and Treasure Green [Member] - USD ($)<br></strong></div></th>
<th class="th"><div>Aug. 10, 2021</div></th>
<th class="th"><div>Aug. 05, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRedeemedOrCalledDuringPeriodShares', window );">Shares redeemed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">654,105<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockAmountIssued1', window );">Conversion of stock, amount issued</a></td>
<td class="nump">$ 7,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 808<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockAmountIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of the financial instrument issued [noncash or part noncash] in the conversion of stock. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockAmountIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRedeemedOrCalledDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of stock bought back by the entity at the exercise price or redemption price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRedeemedOrCalledDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RIME_RedemptionAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RIME_RedemptionAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=RIME_KonceptsandTreasureGreenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=RIME_KonceptsandTreasureGreenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>235
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035314588560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF LOSS BEFORE INCOME TAXES (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="4">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_DisclosureAugust2021PrivatePlacementAbstract', window );"><strong>August 2021 Private Placement</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (6,173,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (3,526,000)<span></span>
</td>
<td class="num">$ (261,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Foreign</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(225,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(82,000)<span></span>
</td>
<td class="nump">548,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income taxes</a></td>
<td class="nump">$ 974,000<span></span>
</td>
<td class="nump">$ 97,000<span></span>
</td>
<td class="num">$ (7,513,000)<span></span>
</td>
<td class="num">$ (6,398,000)<span></span>
</td>
<td class="num">$ (3,846,000)<span></span>
</td>
<td class="num">$ (2,125,000)<span></span>
</td>
<td class="num">$ (3,608,000)<span></span>
</td>
<td class="nump">$ 287,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_DisclosureAugust2021PrivatePlacementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_DisclosureAugust2021PrivatePlacementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>236
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035033237920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF PROVISION FOR INCOME TAXES (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="4">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_DisclosureAugust2021PrivatePlacementAbstract', window );"><strong>August 2021 Private Placement</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 109,000<span></span>
</td>
<td class="nump">$ 63,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_CurrentOtherTaxExpenseBenefit', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Hong Kong</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit', window );">Total current Federal and State</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">138,000<span></span>
</td>
<td class="nump">63,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">686,000<span></span>
</td>
<td class="num">(60,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">206,000<span></span>
</td>
<td class="nump">54,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit', window );">Total Deferred Federal and State</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">892,000<span></span>
</td>
<td class="num">(6,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total income tax provision</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 1,502,000<span></span>
</td>
<td class="num">$ (472,000)<span></span>
</td>
<td class="nump">$ 1,030,000<span></span>
</td>
<td class="nump">$ 57,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_CurrentOtherTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Current other tax expense benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_CurrentOtherTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_DisclosureAugust2021PrivatePlacementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_DisclosureAugust2021PrivatePlacementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal, state, and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national, regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal, state, and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national, regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>237
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035119409056">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_DisclosureAugust2021PrivatePlacementAbstract', window );"><strong>August 2021 Private Placement</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic', window );">NOL Federal Carryforward</a></td>
<td class="nump">$ 1,291,000<span></span>
</td>
<td class="nump">$ 868,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal', window );">State NOL Carryforward</a></td>
<td class="nump">470,000<span></span>
</td>
<td class="nump">341,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInventory', window );">Inventory differences to inventory valuation</a></td>
<td class="nump">1,173,000<span></span>
</td>
<td class="nump">623,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Stock option compensation expense</a></td>
<td class="nump">159,000<span></span>
</td>
<td class="nump">184,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_DeferredTaxAssetsRightUseOfLiability', window );">Right of use liability</a></td>
<td class="nump">1,022,000<span></span>
</td>
<td class="nump">118,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_DeferredTaxAssetsBusinessInterestLimitation', window );">Business interest limitation</a></td>
<td class="nump">151,000<span></span>
</td>
<td class="nump">138,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_DeferredTaxAssetsAllowanceForDoubtFulAccounts', window );">Allowance for doubtful accounts</a></td>
<td class="nump">45,000<span></span>
</td>
<td class="nump">43,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances', window );">Reserve for estimated returns</a></td>
<td class="nump">384,000<span></span>
</td>
<td class="nump">89,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals', window );">Accrued vacation</a></td>
<td class="nump">7,000<span></span>
</td>
<td class="nump">14,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total</a></td>
<td class="nump">4,702,000<span></span>
</td>
<td class="nump">2,418,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Less: valuation allowance</a></td>
<td class="num">(3,600,000)<span></span>
</td>
<td class="num">(2,104,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Net deferred tax asset</a></td>
<td class="nump">1,102,000<span></span>
</td>
<td class="nump">314,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Depreciable and amortizable assets</a></td>
<td class="num">(67,000)<span></span>
</td>
<td class="num">(134,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_DeferredTaxLiabilitiesRightUseOfAsset', window );">ROU Asset</a></td>
<td class="num">(1,000,000)<span></span>
</td>
<td class="num">(111,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses', window );">Prepaid expenses</a></td>
<td class="num">(35,000)<span></span>
</td>
<td class="num">(69,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Net deferred tax liability</a></td>
<td class="num">(1,102,000)<span></span>
</td>
<td class="num">(314,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Total</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_DeferredTaxAssetsAllowanceForDoubtFulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets allowance for doubtful accounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_DeferredTaxAssetsAllowanceForDoubtFulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_DeferredTaxAssetsBusinessInterestLimitation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets Business Interest Limitation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_DeferredTaxAssetsBusinessInterestLimitation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_DeferredTaxAssetsRightUseOfLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets Right Use of Liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_DeferredTaxAssetsRightUseOfLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_DeferredTaxLiabilitiesRightUseOfAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liabilities Right Use of Asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_DeferredTaxLiabilitiesRightUseOfAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_DisclosureAugust2021PrivatePlacementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_DisclosureAugust2021PrivatePlacementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from estimated returns and sales allowances.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax consequences attributable to taxable temporary differences derived from prepaid expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPrepaidExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>238
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035112914080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF TAX PROVISION (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="4">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_DisclosureAugust2021PrivatePlacementAbstract', window );"><strong>August 2021 Private Placement</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Statutory federal tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,344,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (758,000)<span></span>
</td>
<td class="nump">$ 60,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes', window );">Stater tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(326,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(174,000)<span></span>
</td>
<td class="nump">14,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate', window );">Permanent differences</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,000<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_IncomeTaxReconciliationChangeInPermanentDifferencesERCIncome', window );">Permanent difference in ERC income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(99,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential', window );">Tax rate differential on foreign earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,000<span></span>
</td>
<td class="num">(84,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_IncomeTaxReconciliationChangeInExpirationOfNetOpretaingLossCarryforward', window );">Expiration of net operating loss carryforward</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">89,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,495,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,026,000<span></span>
</td>
<td class="nump">55,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherReconcilingItems', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total income tax provision</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 1,502,000<span></span>
</td>
<td class="num">$ (472,000)<span></span>
</td>
<td class="nump">$ 1,030,000<span></span>
</td>
<td class="nump">$ 57,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_DisclosureAugust2021PrivatePlacementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_DisclosureAugust2021PrivatePlacementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_IncomeTaxReconciliationChangeInExpirationOfNetOpretaingLossCarryforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income tax reconciliation change in expiration of net opretaing loss carryforward.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_IncomeTaxReconciliationChangeInExpirationOfNetOpretaingLossCarryforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_IncomeTaxReconciliationChangeInPermanentDifferencesERCIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income tax reconciliation change in permanent difference in ERC income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_IncomeTaxReconciliationChangeInPermanentDifferencesERCIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherReconcilingItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying statutory federal (national) tax rate to pretax income (loss) from continuing operation attributable to other reconciling item. Excludes state and local income tax expense (benefit), federal tax expense (benefit), statutory income tax expense (benefit) outside of country of domicile, tax credit, nondeductible expense, deduction, income tax settlement, income tax contingency, and cross-border tax law.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherReconcilingItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>239
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035125727200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF REVENUE BY GEOGRAPHICAL REGION (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="3">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Net Sales</a></td>
<td class="nump">$ 10,622,000<span></span>
</td>
<td class="nump">$ 15,931,000<span></span>
</td>
<td class="nump">$ 15,488,000<span></span>
</td>
<td class="nump">$ 29,198,000<span></span>
</td>
<td class="nump">$ 21,939,000<span></span>
</td>
<td class="nump">$ 39,299,000<span></span>
</td>
<td class="nump">$ 47,512,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_NorthAmericaMember', window );">North America [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Net Sales</a></td>
<td class="nump">10,466,000<span></span>
</td>
<td class="nump">15,378,000<span></span>
</td>
<td class="nump">15,208,000<span></span>
</td>
<td class="nump">28,763,000<span></span>
</td>
<td class="nump">21,386,000<span></span>
</td>
<td class="nump">38,298,000<span></span>
</td>
<td class="nump">46,396,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_AU', window );">AUSTRALIA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Net Sales</a></td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="nump">$ 263,000<span></span>
</td>
<td class="nump">$ 174,000<span></span>
</td>
<td class="nump">205,000<span></span>
</td>
<td class="nump">$ 263,000<span></span>
</td>
<td class="nump">670,000<span></span>
</td>
<td class="nump">679,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=RIME_EuropeAndUnitedKingdomMember', window );">Europe and United Kingdom [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Net Sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">226,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">331,000<span></span>
</td>
<td class="nump">359,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=RIME_OthersMember', window );">Others [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Net Sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 78,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_NorthAmericaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_NorthAmericaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_AU">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_AU</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=RIME_EuropeAndUnitedKingdomMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=RIME_EuropeAndUnitedKingdomMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=RIME_OthersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=RIME_OthersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>240
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035114621376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>AUGUST 2021 PRIVATE PLACEMENT (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="4">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Aug. 10, 2021</div></th>
<th class="th"><div>Jul. 06, 2021</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Aug. 05, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,079,678<span></span>
</td>
<td class="nump">6,418,061<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,167,489<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Issuance of warrant shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">902,113<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Proceeds from warrant exercises</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 168,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeDescriptionOfTerms', window );">Derivative, Description of Terms</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">(representing
7% of the gross proceeds raised in the Private Placement excluding proceeds raised from the strategic investor, plus 3.5% of the aggregate
gross proceeds raised from the strategic investor),<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_AggregateNumberOfShares', window );">Aggregate number of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityFairValueDisclosure', window );">Equity, Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_SharePrice1', window );">Common stock price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants and Rights Outstanding, Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">168.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.65%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LegalFees', window );">Legal fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 215,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross', window );">Stock issued for restricted shares, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 774,528<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=RIME_AGPWarrantsMember', window );">AGP Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Issuance of warrant shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,445<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Issuance of warrant shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">561,111<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfPrivatePlacement', window );">Cash payment for private placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LegalFees', window );">Legal fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Stock issued for restricted shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,905<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross', window );">Stock issued for restricted shares, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Payment of stock issuance expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=RIME_PreFundedWarrantsMember', window );">Pre Funded Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Class of warrant or right, number of securities called by each warrant or right</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">561,111<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_PurchaseAgreementMember', window );">Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">550,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Issuance of warrant shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">550,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_RedemptionAgreementMember', window );">Redemption Agreement [Member] | Koncepts and Treasure Green [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Proceeds from warrant exercises</a></td>
<td class="nump">$ 9,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockAmountIssued1', window );">Conversion of stock, amount issued</a></td>
<td class="nump">$ 7,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_AggregateNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_AggregateNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_SharePrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common stock price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_SharePrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockAmountIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of the financial instrument issued [noncash or part noncash] in the conversion of stock. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockAmountIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeDescriptionOfTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the relevant terms of the derivative. Includes the type of instrument, risk being hedged, notional amount, counterparty, inception date, maturity date, relevant interest rates, strike price, cap price, and floor price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeDescriptionOfTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of the entity's equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LegalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(6))<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LegalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the repurchase of amount received from entity's raising of capital via private rather than public placement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromWarrantExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromWarrantExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate value of stock related to Restricted Stock Awards issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=RIME_AGPWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=RIME_AGPWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=RIME_PreFundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=RIME_PreFundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RIME_PurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RIME_PurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RIME_RedemptionAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RIME_RedemptionAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=RIME_KonceptsandTreasureGreenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=RIME_KonceptsandTreasureGreenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>241
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035297842624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DAMAGED GOODS INCIDENT RECOVERY (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InsuranceAbstract', window );"><strong>Insurance [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_GainFromSettlementOfAccountsPayable', window );">Settlement of accounts payable</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 48,000<span></span>
</td>
<td class="nump">$ 339,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_GainFromSettlementOfAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain from settlement of accounts payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_GainFromSettlementOfAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>242
<FILENAME>R98.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035102547072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="4">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_DisclosureSupplementalInformationCondensedFinancialInformationAbstract', window );"><strong>Supplemental Information Condensed Financial Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net Sales</a></td>
<td class="nump">$ 10,622,000<span></span>
</td>
<td class="nump">$ 15,931,000<span></span>
</td>
<td class="nump">$ 15,488,000<span></span>
</td>
<td class="nump">$ 29,198,000<span></span>
</td>
<td class="nump">$ 21,939,000<span></span>
</td>
<td class="nump">$ 35,916,000<span></span>
</td>
<td class="nump">$ 39,299,000<span></span>
</td>
<td class="nump">$ 47,512,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of Goods Sold</a></td>
<td class="nump">8,247,000<span></span>
</td>
<td class="nump">12,197,000<span></span>
</td>
<td class="nump">12,287,000<span></span>
</td>
<td class="nump">23,008,000<span></span>
</td>
<td class="nump">16,582,000<span></span>
</td>
<td class="nump">27,481,000<span></span>
</td>
<td class="nump">30,090,000<span></span>
</td>
<td class="nump">36,697,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross Profit (Loss)</a></td>
<td class="nump">2,375,000<span></span>
</td>
<td class="nump">3,734,000<span></span>
</td>
<td class="nump">3,201,000<span></span>
</td>
<td class="nump">6,190,000<span></span>
</td>
<td class="nump">5,357,000<span></span>
</td>
<td class="nump">8,435,000<span></span>
</td>
<td class="nump">9,209,000<span></span>
</td>
<td class="nump">10,815,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Operating Expenses</a></td>
<td class="nump">1,118,000<span></span>
</td>
<td class="nump">3,628,000<span></span>
</td>
<td class="nump">10,386,000<span></span>
</td>
<td class="nump">12,333,000<span></span>
</td>
<td class="nump">9,829,000<span></span>
</td>
<td class="nump">9,986,000<span></span>
</td>
<td class="nump">12,907,000<span></span>
</td>
<td class="nump">10,746,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from Operations</a></td>
<td class="nump">1,257,000<span></span>
</td>
<td class="nump">106,000<span></span>
</td>
<td class="num">(7,185,000)<span></span>
</td>
<td class="num">(6,143,000)<span></span>
</td>
<td class="num">(4,472,000)<span></span>
</td>
<td class="num">(1,551,000)<span></span>
</td>
<td class="num">(3,698,000)<span></span>
</td>
<td class="nump">69,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other (Expenses) Income</a></td>
<td class="num">(283,000)<span></span>
</td>
<td class="num">(9,000)<span></span>
</td>
<td class="num">(328,000)<span></span>
</td>
<td class="num">(255,000)<span></span>
</td>
<td class="nump">626,000<span></span>
</td>
<td class="num">(574,000)<span></span>
</td>
<td class="nump">90,000<span></span>
</td>
<td class="nump">218,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss Before Income Tax Benefit (Provision)</a></td>
<td class="nump">974,000<span></span>
</td>
<td class="nump">97,000<span></span>
</td>
<td class="num">(7,513,000)<span></span>
</td>
<td class="num">(6,398,000)<span></span>
</td>
<td class="num">(3,846,000)<span></span>
</td>
<td class="num">(2,125,000)<span></span>
</td>
<td class="num">(3,608,000)<span></span>
</td>
<td class="nump">287,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income Tax Benefit (Loss)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,502,000)<span></span>
</td>
<td class="nump">472,000<span></span>
</td>
<td class="num">(1,030,000)<span></span>
</td>
<td class="num">(57,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Loss</a></td>
<td class="nump">$ 974,000<span></span>
</td>
<td class="nump">$ 97,000<span></span>
</td>
<td class="num">$ (7,513,000)<span></span>
</td>
<td class="num">$ (6,398,000)<span></span>
</td>
<td class="num">$ (5,348,000)<span></span>
</td>
<td class="num">$ (1,653,000)<span></span>
</td>
<td class="num">$ (4,638,000)<span></span>
</td>
<td class="nump">$ 230,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Loss per Common Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic</a></td>
<td class="nump">$ 0.13<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
<td class="num">$ (0.99)<span></span>
</td>
<td class="num">$ (1.32)<span></span>
</td>
<td class="num">$ (1.44)<span></span>
</td>
<td class="num">$ (0.61)<span></span>
</td>
<td class="num">$ (1.65)<span></span>
</td>
<td class="nump">$ 0.14<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted</a></td>
<td class="nump">$ 0.13<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
<td class="num">$ (0.99)<span></span>
</td>
<td class="num">$ (1.32)<span></span>
</td>
<td class="num">$ (1.44)<span></span>
</td>
<td class="num">$ (0.61)<span></span>
</td>
<td class="num">$ (1.65)<span></span>
</td>
<td class="nump">$ 0.14<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract', window );"><strong>Weighted Average Common and Common Equivalent Shares:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic</a></td>
<td class="nump">9,095,504<span></span>
</td>
<td class="nump">4,220,259<span></span>
</td>
<td class="nump">7,341,204<span></span>
</td>
<td class="nump">4,864,540<span></span>
</td>
<td class="nump">3,726,259<span></span>
</td>
<td class="nump">2,699,210<span></span>
</td>
<td class="nump">2,811,872<span></span>
</td>
<td class="nump">1,614,506<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted</a></td>
<td class="nump">9,095,504<span></span>
</td>
<td class="nump">4,220,259<span></span>
</td>
<td class="nump">7,341,204<span></span>
</td>
<td class="nump">4,864,540<span></span>
</td>
<td class="nump">3,726,259<span></span>
</td>
<td class="nump">2,699,210<span></span>
</td>
<td class="nump">2,811,872<span></span>
</td>
<td class="nump">1,623,397<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_DisclosureSupplementalInformationCondensedFinancialInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_DisclosureSupplementalInformationCondensedFinancialInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4K<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-2<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>243
<FILENAME>R99.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035033634368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="4">9 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="nump">$ 974,000<span></span>
</td>
<td class="nump">$ 97,000<span></span>
</td>
<td class="num">$ (7,513,000)<span></span>
</td>
<td class="num">$ (6,398,000)<span></span>
</td>
<td class="num">$ (5,348,000)<span></span>
</td>
<td class="num">$ (1,653,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (4,638,000)<span></span>
</td>
<td class="nump">$ 230,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities', window );">Adjustments to reconcile net loss to net cash used in operating activities:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,305,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(73,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapital', window );">Changes in operating assets and liabilities:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,504,000<span></span>
</td>
<td class="num">(265,000)<span></span>
</td>
<td class="num">(538,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by (used in) operating activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,069,000)<span></span>
</td>
<td class="nump">411,000<span></span>
</td>
<td class="nump">760,000<span></span>
</td>
<td class="num">(2,264,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(330,000)<span></span>
</td>
<td class="num">(2,012,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(53,000)<span></span>
</td>
<td class="num">(14,000)<span></span>
</td>
<td class="num">(108,000)<span></span>
</td>
<td class="num">(149,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(244,000)<span></span>
</td>
<td class="num">(118,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,040,000<span></span>
</td>
<td class="nump">3,411,000<span></span>
</td>
<td class="num">(234,000)<span></span>
</td>
<td class="nump">2,917,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,178,000<span></span>
</td>
<td class="nump">4,024,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net change in cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,082,000)<span></span>
</td>
<td class="nump">3,808,000<span></span>
</td>
<td class="nump">418,000<span></span>
</td>
<td class="nump">504,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">604,000<span></span>
</td>
<td class="nump">1,894,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash at beginning of year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,703,000<span></span>
</td>
<td class="nump">2,895,000<span></span>
</td>
<td class="nump">2,795,000<span></span>
</td>
<td class="nump">2,291,000<span></span>
</td>
<td class="nump">$ 2,795,000<span></span>
</td>
<td class="nump">2,291,000<span></span>
</td>
<td class="nump">397,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash at end of period</a></td>
<td class="nump">$ 621,000<span></span>
</td>
<td class="nump">$ 3,213,000<span></span>
</td>
<td class="nump">$ 621,000<span></span>
</td>
<td class="nump">$ 6,703,000<span></span>
</td>
<td class="nump">$ 3,213,000<span></span>
</td>
<td class="nump">$ 2,795,000<span></span>
</td>
<td class="nump">$ 6,703,000<span></span>
</td>
<td class="nump">$ 2,895,000<span></span>
</td>
<td class="nump">$ 2,291,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of adjustments to net income or loss necessary to remove the effects of all items whose cash effects are investing or financing cash flows. The aggregate amount also includes all noncash expenses and income items which reduce or increase net income and are thus added back or deducted when calculating cash provided by or used in operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period of all assets and liabilities used in operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4K<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-2<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>244
<FILENAME>R100.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035106198560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS? EQUITY (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="4">9 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,578,000<span></span>
</td>
<td class="nump">$ 10,331,000<span></span>
</td>
<td class="nump">$ 13,198,000<span></span>
</td>
<td class="nump">$ 10,036,000<span></span>
</td>
<td class="nump">$ 13,198,000<span></span>
</td>
<td class="nump">$ 10,036,000<span></span>
</td>
<td class="nump">$ 7,910,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="nump">$ 974,000<span></span>
</td>
<td class="nump">$ 97,000<span></span>
</td>
<td class="num">(7,513,000)<span></span>
</td>
<td class="num">(6,398,000)<span></span>
</td>
<td class="num">(5,348,000)<span></span>
</td>
<td class="num">(1,653,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,638,000)<span></span>
</td>
<td class="nump">230,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock and warrants, net of stock offering costs</a></td>
<td class="nump">1,489,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,489,000<span></span>
</td>
<td class="nump">3,529,000<span></span>
</td>
<td class="nump">1,640,000<span></span>
</td>
<td class="nump">4,508,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,030,000<span></span>
</td>
<td class="nump">4,950,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">616,000<span></span>
</td>
<td class="nump">110,000<span></span>
</td>
<td class="nump">174,000<span></span>
</td>
<td class="nump">307,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">382,000<span></span>
</td>
<td class="nump">44,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Other</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="nump">6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,578,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,198,000<span></span>
</td>
<td class="nump">7,578,000<span></span>
</td>
<td class="nump">10,331,000<span></span>
</td>
<td class="nump">10,036,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 64,000<span></span>
</td>
<td class="nump">$ 32,000<span></span>
</td>
<td class="nump">$ 31,000<span></span>
</td>
<td class="nump">$ 12,000<span></span>
</td>
<td class="nump">$ 31,000<span></span>
</td>
<td class="nump">$ 12,000<span></span>
</td>
<td class="nump">$ 13,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares</a></td>
<td class="nump">6,418,061<span></span>
</td>
<td class="nump">4,220,259<span></span>
</td>
<td class="nump">6,418,061<span></span>
</td>
<td class="nump">3,167,488<span></span>
</td>
<td class="nump">3,148,219<span></span>
</td>
<td class="nump">1,221,209<span></span>
</td>
<td class="nump">3,148,219<span></span>
</td>
<td class="nump">1,221,209<span></span>
</td>
<td class="nump">1,301,358<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock and warrants, net of stock offering costs</a></td>
<td class="nump">$ 18,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,000<span></span>
</td>
<td class="nump">$ 32,000<span></span>
</td>
<td class="nump">$ 11,000<span></span>
</td>
<td class="nump">$ 19,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="nump">$ 6,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock and warrants, net of stock offering costs, shares</a></td>
<td class="nump">1,673,077<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,673,077<span></span>
</td>
<td class="nump">3,250,573<span></span>
</td>
<td class="nump">1,057,810<span></span>
</td>
<td class="nump">1,909,519<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,014,230<span></span>
</td>
<td class="nump">550,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Stock based compensation ,shares</a></td>
<td class="nump">1,019,811<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,019,811<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,803<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,803<span></span>
</td>
<td class="nump">2,242<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Other</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Other, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,688<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,047<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 64,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 31,000<span></span>
</td>
<td class="nump">$ 64,000<span></span>
</td>
<td class="nump">$ 32,000<span></span>
</td>
<td class="nump">$ 12,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares</a></td>
<td class="nump">9,752,755<span></span>
</td>
<td class="nump">4,220,259<span></span>
</td>
<td class="nump">9,752,755<span></span>
</td>
<td class="nump">6,418,061<span></span>
</td>
<td class="nump">4,220,259<span></span>
</td>
<td class="nump">3,148,219<span></span>
</td>
<td class="nump">6,418,061<span></span>
</td>
<td class="nump">3,167,488<span></span>
</td>
<td class="nump">1,221,209<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional Paid-in Capital [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33,429,000<span></span>
</td>
<td class="nump">$ 29,822,000<span></span>
</td>
<td class="nump">$ 29,698,000<span></span>
</td>
<td class="nump">$ 24,903,000<span></span>
</td>
<td class="nump">$ 29,698,000<span></span>
</td>
<td class="nump">$ 24,903,000<span></span>
</td>
<td class="nump">$ 20,151,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock and warrants, net of stock offering costs</a></td>
<td class="nump">1,471,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,471,000<span></span>
</td>
<td class="nump">3,497,000<span></span>
</td>
<td class="nump">1,629,000<span></span>
</td>
<td class="nump">4,489,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,026,000<span></span>
</td>
<td class="nump">4,944,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">307,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Other</a></td>
<td class="nump">2,000<span></span>
</td>
<td class="num">(1,000)<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,429,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,698,000<span></span>
</td>
<td class="nump">33,429,000<span></span>
</td>
<td class="nump">29,822,000<span></span>
</td>
<td class="nump">24,903,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_ReceivablesFromStockholderMember', window );">Receivables from Stockholder [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(6,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock and warrants, net of stock offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(6,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Retained Earnings [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(25,915,000)<span></span>
</td>
<td class="num">(19,517,000)<span></span>
</td>
<td class="num">(16,531,000)<span></span>
</td>
<td class="num">(14,879,000)<span></span>
</td>
<td class="num">(16,531,000)<span></span>
</td>
<td class="num">(14,879,000)<span></span>
</td>
<td class="num">(12,254,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="nump">1,195,000<span></span>
</td>
<td class="nump">97,000<span></span>
</td>
<td class="num">(7,292,000)<span></span>
</td>
<td class="num">(6,398,000)<span></span>
</td>
<td class="num">(5,348,000)<span></span>
</td>
<td class="num">(1,653,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,638,000)<span></span>
</td>
<td class="nump">230,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock and warrants, net of stock offering costs</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Other</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (25,915,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (16,531,000)<span></span>
</td>
<td class="num">$ (25,915,000)<span></span>
</td>
<td class="num">$ (19,517,000)<span></span>
</td>
<td class="num">$ (14,879,000)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4K<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-2<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_ReceivablesFromStockholderMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_ReceivablesFromStockholderMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>245
<FILENAME>R101.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035111296112">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF ESTIMATED USEFUL LIVES (Details) - Semi Cab Inc [Member]<br></strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property plant and equipment useful life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property plant and equipment useful life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=RIME_SemiCabIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=RIME_SemiCabIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>246
<FILENAME>R102.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035316224048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTS RECEIVABLE (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">9 Months Ended</th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Allowance for doubtful accounts</a></td>
<td class="nump">$ 92,000<span></span>
</td>
<td class="nump">$ 8,000<span></span>
</td>
<td class="nump">$ 104,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 43,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (16,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=RIME_SemiCabIncMember', window );">Semi Cab Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNet', window );">Accounts receivable, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 494,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 494,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 677,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Allowance for doubtful accounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477802/946-310-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(5)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479196/954-310-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=RIME_SemiCabIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=RIME_SemiCabIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>247
<FILENAME>R103.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035033443920">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Vendors expenses payable</a></td>
<td class="nump">$ 8,743,000<span></span>
</td>
<td class="nump">$ 7,616,000<span></span>
</td>
<td class="nump">$ 1,769,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">$ 4,303,000<span></span>
</td>
<td class="nump">2,614,000<span></span>
</td>
<td class="nump">$ 2,266,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=RIME_SemiCabIncMember', window );">Semi Cab Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Vendors expenses payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">668,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 810,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 149,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 151,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=RIME_SemiCabIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=RIME_SemiCabIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>248
<FILENAME>R104.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035124947008">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF SPECIFIC TERMS (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>May 17, 2023</div></th>
<th class="th"><div>May 08, 2023</div></th>
<th class="th"><div>May 05, 2023</div></th>
<th class="th"><div>Apr. 17, 2023</div></th>
<th class="th"><div>Aug. 27, 2021</div></th>
<th class="th"><div>Jul. 10, 2021</div></th>
<th class="th"><div>May 18, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.97%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_SixShareholderLoanAgreementsMember', window );">Six Shareholder Loan Agreements [Member] | Ajesh Kapoor [Member] | Semi Cab Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentIssuanceDate1', window );">Date</a></td>
<td class="text">May 17,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">May  05,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug. 27,  2021<span></span>
</td>
<td class="text">Jul. 10,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Maturity</a></td>
<td class="text">May 16,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">May  04,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug. 26,  2026<span></span>
</td>
<td class="text">Jul. 10,  2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal', window );">Principal</a></td>
<td class="nump">$ 165,000.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 235,000.00<span></span>
</td>
<td class="nump">$ 150,000.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Rate</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentInterest', window );">Accrued Interest</a></td>
<td class="nump">$ 14,465.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,547.95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 54,932.05<span></span>
</td>
<td class="nump">$ 36,838.36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPayment', window );">Current Balance</a></td>
<td class="nump">$ 179,465.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 54,547.95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 289,932.05<span></span>
</td>
<td class="nump">$ 186,838.36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_SixShareholderLoanAgreementsMember', window );">Six Shareholder Loan Agreements [Member] | Vivek Sehgal [Member] | Semi Cab Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentIssuanceDate1', window );">Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Apr. 17,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Maturity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Oct. 16,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal', window );">Principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentInterest', window );">Accrued Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,794.52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPayment', window );">Current Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 54,794.52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_SixShareholderLoanAgreementsMember', window );">Six Shareholder Loan Agreements [Member] | Jagan Reddy [Member] | Semi Cab Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentIssuanceDate1', window );">Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">May  08,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Maturity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">May  07,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal', window );">Principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentInterest', window );">Accrued Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,506.85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPayment', window );">Current Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 54,506.85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentIssuanceDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date the debt instrument was issued, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentIssuanceDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments including both interest and principal payments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477734/942-470-50-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPaymentInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments applied to interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPaymentInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments applied to principal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPaymentPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RIME_SixShareholderLoanAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RIME_SixShareholderLoanAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=RIME_AjeshKapoorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=RIME_AjeshKapoorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=RIME_SemiCabIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=RIME_SemiCabIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=RIME_VivekSehgalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=RIME_VivekSehgalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=RIME_JaganReddyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=RIME_JaganReddyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>249
<FILENAME>R105.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035114582352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTES PAYABLE AND FINANING ARRANGEMENTS (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">13 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Oct. 24, 2024</div></th>
<th class="th"><div>May 18, 2024</div></th>
<th class="th"><div>May 08, 2024</div></th>
<th class="th"><div>Mar. 22, 2024</div></th>
<th class="th"><div>May 18, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayment, debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 91,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.97%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Initial amount, borrowed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 303,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Net proceeds</a></td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective, interest rate</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=RIME_SemiCabIncMember', window );">Semi Cab Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDateDescription', window );">Maturity date, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12-month maturity date<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayment, debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 453,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Initial amount, borrowed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">315,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Net proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective, interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=RIME_SemiCabIncMember', window );">Semi Cab Inc [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayment, debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 311,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Initial amount, borrowed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">215,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Net proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 204,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective, interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=RIME_SemiCabIncMember', window );">Semi Cab Inc [Member] | Equal installments for 13 months [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayment, debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 91,667.67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.97%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=RIME_SemiCabIncMember', window );">Semi Cab Inc [Member] | 12 Installments [Member] | Settlement Agreement [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayment, debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 946,666.60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=RIME_SemiCabIncMember', window );">Semi Cab Inc [Member] | First Payment [Member] | Settlement Agreement [Member] | Subsequent Event [Member] | Due and paid on May 20, 2024 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayment, debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=RIME_SemiCabIncMember', window );">Semi Cab Inc [Member] | Second Payment [Member] | Settlement Agreement [Member] | Subsequent Event [Member] | Due on June 3, 2024 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayment, debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=RIME_SemiCabIncMember', window );">Semi Cab Inc [Member] | Ten Monthly Payments [Member] | Settlement Agreement [Member] | Subsequent Event [Member] | Due on July 1, 2024 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayment, debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 84,666.66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=RIME_SemiCabIncMember', window );">Semi Cab Inc [Member] | Weekly Payments For Weeks [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayment, debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=RIME_SemiCabIncMember', window );">Semi Cab Inc [Member] | Weekly Payments [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayment, debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDateDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the maturity date of the debt instrument including whether the debt matures serially and, if so, a brief description of the serial maturities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDateDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for short-term and long-term debt. Excludes payment of lease obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=RIME_SemiCabIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=RIME_SemiCabIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=RIME_EqualInstallmentsForThirteenMonthsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=RIME_EqualInstallmentsForThirteenMonthsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=RIME_TwelveInstallmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=RIME_TwelveInstallmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RIME_SettlementAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RIME_SettlementAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=RIME_FirstPaymentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=RIME_FirstPaymentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=RIME_DueAndPaidOnMayTwentyTwoThousandTwentyFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=RIME_DueAndPaidOnMayTwentyTwoThousandTwentyFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=RIME_SecondPaymentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=RIME_SecondPaymentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=RIME_DueOnJuneThreeTwoThousandTwentyFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=RIME_DueOnJuneThreeTwoThousandTwentyFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=RIME_TenMonthlyPaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=RIME_TenMonthlyPaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=RIME_DueOnJulyOneTwoThousandTwentyFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=RIME_DueOnJulyOneTwoThousandTwentyFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=RIME_WeeklyPaymentsForWeeksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=RIME_WeeklyPaymentsForWeeksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=RIME_WeeklyPaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=RIME_WeeklyPaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>250
<FILENAME>R106.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035101352528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DUE FROM FACTOR (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>May 28, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LegalFees', window );">Dispute, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 215,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=RIME_SemiCabIncMember', window );">Semi Cab Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNet', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 494,000<span></span>
</td>
<td class="nump">$ 677,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ForeignAndDomesticRateOfAccountsReceivable', window );">Accounts receivable rate, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Factor remits 35% of the foreign and 75% of the domestic accounts receivable balance<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LegalFees', window );">Dispute, amount</a></td>
<td class="nump">$ 93,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Semi Cab Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNet', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_AdvanceFeeRate', window );">Advance fee, rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Semi Cab Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_AdvanceFeeRate', window );">Advance fee, rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_AdvanceFeeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Advance fee rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_AdvanceFeeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_ForeignAndDomesticRateOfAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Foreign and domestic rate of accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_ForeignAndDomesticRateOfAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477802/946-310-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(5)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479196/954-310-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LegalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(6))<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LegalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=RIME_SemiCabIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=RIME_SemiCabIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>251
<FILENAME>R107.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035105476912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF STOCK OPTION ISSUED DURING THE YEAR DECEMBER 31, 2020, 2021 AND 2022 (Details) - Equity Option [Member] - Semi Cab Inc [Member] - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted Shares</a></td>
<td class="nump">11,712,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding Awards</a></td>
<td class="nump">11,597,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=RIME_SudhirNarasimhamurthyMember', window );">Sudhir Narasimhamurthy [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted Shares</a></td>
<td class="nump">25,000<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="nump">180,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding Awards</a></td>
<td class="nump">25,000<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="nump">180,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TargetedOrTrackingStockIssuanceDates', window );">Granted Date</a></td>
<td class="text">May  02,  2022<span></span>
</td>
<td class="text">Aug. 12,  2021<span></span>
</td>
<td class="text">Sep. 29,  2020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Exercise price</a></td>
<td class="nump">$ 0.05<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate', window );">Vesting Date</a></td>
<td class="text">May  02,  2022<span></span>
</td>
<td class="text">Sep.  01,  2021<span></span>
</td>
<td class="text">Sep. 29,  2020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Vested Outstanding</a></td>
<td class="nump">12,500<span></span>
</td>
<td class="nump">33,333<span></span>
</td>
<td class="nump">180,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Unvested</a></td>
<td class="nump">12,500<span></span>
</td>
<td class="nump">16,667<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate', window );">Date Fully Vested</a></td>
<td class="text">May  02,  2026<span></span>
</td>
<td class="text">Sep.  01,  2025<span></span>
</td>
<td class="text">Sep. 29,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate', window );">Board Approval Date</a></td>
<td class="text">May  02,  2022<span></span>
</td>
<td class="text">Aug. 12,  2021<span></span>
</td>
<td class="text">Sep. 28,  2020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate', window );">Expiration Date</a></td>
<td class="text">May  01,  2032<span></span>
</td>
<td class="text">Aug. 11,  2031<span></span>
</td>
<td class="text">Sep. 28,  2030<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=RIME_KadandaleSrinivasSudheerMember', window );">Kadandale Srinivas Sudheer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted Shares</a></td>
<td class="nump">50,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding Awards</a></td>
<td class="nump">50,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TargetedOrTrackingStockIssuanceDates', window );">Granted Date</a></td>
<td class="text">May  02,  2022<span></span>
</td>
<td class="text">Aug. 12,  2021<span></span>
</td>
<td class="text">Sep. 29,  2020<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate', window );">Vesting Date</a></td>
<td class="text">May  02,  2022<span></span>
</td>
<td class="text">Sep.  01,  2021<span></span>
</td>
<td class="text">Sep. 29,  2020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Vested Outstanding</a></td>
<td class="nump">25,000<span></span>
</td>
<td class="nump">66,666<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Unvested</a></td>
<td class="nump">25,000<span></span>
</td>
<td class="nump">33,334<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate', window );">Date Fully Vested</a></td>
<td class="text">May  02,  2026<span></span>
</td>
<td class="text">Sep.  01,  2025<span></span>
</td>
<td class="text">Sep. 29,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate', window );">Board Approval Date</a></td>
<td class="text">May  02,  2022<span></span>
</td>
<td class="text">Aug. 12,  2021<span></span>
</td>
<td class="text">Sep. 28,  2020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate', window );">Expiration Date</a></td>
<td class="text">May  01,  2032<span></span>
</td>
<td class="text">Aug. 11,  2031<span></span>
</td>
<td class="text">Sep. 28,  2030<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=RIME_VivekSehgalMember', window );">Vivek Sehgal [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted Shares</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="nump">4,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding Awards</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="nump">4,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TargetedOrTrackingStockIssuanceDates', window );">Granted Date</a></td>
<td class="text">May  02,  2022<span></span>
</td>
<td class="text">Aug. 12,  2021<span></span>
</td>
<td class="text">Sep. 29,  2020<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Exercise price</a></td>
<td class="nump">$ 0.05<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Vested Outstanding</a></td>
<td class="nump">50,000<span></span>
</td>
<td class="nump">133,333<span></span>
</td>
<td class="nump">4,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Unvested</a></td>
<td class="nump">50,000<span></span>
</td>
<td class="nump">66,667<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate', window );">Date Fully Vested</a></td>
<td class="text">May  02,  2026<span></span>
</td>
<td class="text">Sep.  01,  2025<span></span>
</td>
<td class="text">Sep. 29,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate', window );">Board Approval Date</a></td>
<td class="text">May  02,  2022<span></span>
</td>
<td class="text">Aug. 12,  2021<span></span>
</td>
<td class="text">Sep. 28,  2020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate', window );">Expiration Date</a></td>
<td class="text">May  01,  2032<span></span>
</td>
<td class="text">Aug. 11,  2031<span></span>
</td>
<td class="text">Sep. 28,  2030<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=RIME_RajivSaxenaMember', window );">Rajiv Saxena [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TargetedOrTrackingStockIssuanceDates', window );">Granted Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sep. 29,  2020<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate', window );">Vesting Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sep. 29,  2020<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Vested Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate', window );">Date Fully Vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sep. 29,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate', window );">Board Approval Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sep. 28,  2020<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate', window );">Expiration Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sep. 28,  2030<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=RIME_HarshaBhatMember', window );">Harsha Bhat [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted Shares</a></td>
<td class="nump">25,000<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="nump">180,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding Awards</a></td>
<td class="nump">25,000<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="nump">180,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TargetedOrTrackingStockIssuanceDates', window );">Granted Date</a></td>
<td class="text">May  02,  2022<span></span>
</td>
<td class="text">Aug. 12,  2021<span></span>
</td>
<td class="text">Sep. 29,  2020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Exercise price</a></td>
<td class="nump">$ 0.05<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate', window );">Vesting Date</a></td>
<td class="text">May  02,  2022<span></span>
</td>
<td class="text">Sep.  01,  2021<span></span>
</td>
<td class="text">Sep. 29,  2020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Vested Outstanding</a></td>
<td class="nump">12,500<span></span>
</td>
<td class="nump">33,333<span></span>
</td>
<td class="nump">180,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Unvested</a></td>
<td class="nump">12,500<span></span>
</td>
<td class="nump">16,667<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate', window );">Date Fully Vested</a></td>
<td class="text">May  02,  2026<span></span>
</td>
<td class="text">Sep.  01,  2025<span></span>
</td>
<td class="text">Sep. 29,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate', window );">Board Approval Date</a></td>
<td class="text">May  02,  2022<span></span>
</td>
<td class="text">Aug. 12,  2021<span></span>
</td>
<td class="text">Sep. 28,  2020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate', window );">Expiration Date</a></td>
<td class="text">May  01,  2032<span></span>
</td>
<td class="text">Aug. 11,  2031<span></span>
</td>
<td class="text">Sep. 28,  2030<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=RIME_JaganReddyMember', window );">Jagan Reddy [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted Shares</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="nump">4,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding Awards</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="nump">4,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TargetedOrTrackingStockIssuanceDates', window );">Granted Date</a></td>
<td class="text">May  02,  2022<span></span>
</td>
<td class="text">Aug. 12,  2021<span></span>
</td>
<td class="text">Sep. 29,  2020<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Exercise price</a></td>
<td class="nump">$ 0.05<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate', window );">Vesting Date</a></td>
<td class="text">May  02,  2022<span></span>
</td>
<td class="text">Sep.  01,  2021<span></span>
</td>
<td class="text">Sep. 29,  2020<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Vested Outstanding</a></td>
<td class="nump">50,000<span></span>
</td>
<td class="nump">133,333<span></span>
</td>
<td class="nump">4,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Unvested</a></td>
<td class="nump">50,000<span></span>
</td>
<td class="nump">66,667<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate', window );">Date Fully Vested</a></td>
<td class="text">May  02,  2026<span></span>
</td>
<td class="text">Sep.  01,  2025<span></span>
</td>
<td class="text">Sep. 29,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate', window );">Board Approval Date</a></td>
<td class="text">May  02,  2022<span></span>
</td>
<td class="text">Aug. 12,  2021<span></span>
</td>
<td class="text">Sep. 28,  2020<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate', window );">Expiration Date</a></td>
<td class="text">May  01,  2032<span></span>
</td>
<td class="text">Aug. 11,  2031<span></span>
</td>
<td class="text">Sep. 28,  2030<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=RIME_SiddayyaSGanjalMember', window );">Siddayya S Ganjal [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted Shares</a></td>
<td class="nump">25,000<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="nump">180,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding Awards</a></td>
<td class="nump">25,000<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="nump">180,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TargetedOrTrackingStockIssuanceDates', window );">Granted Date</a></td>
<td class="text">May  02,  2022<span></span>
</td>
<td class="text">Aug. 12,  2021<span></span>
</td>
<td class="text">Sep. 29,  2020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Exercise price</a></td>
<td class="nump">$ 0.05<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate', window );">Vesting Date</a></td>
<td class="text">May  02,  2022<span></span>
</td>
<td class="text">Sep.  01,  2021<span></span>
</td>
<td class="text">Sep. 29,  2020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Vested Outstanding</a></td>
<td class="nump">12,500<span></span>
</td>
<td class="nump">33,333<span></span>
</td>
<td class="nump">180,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Unvested</a></td>
<td class="nump">12,500<span></span>
</td>
<td class="nump">16,667<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate', window );">Date Fully Vested</a></td>
<td class="text">May  02,  2026<span></span>
</td>
<td class="text">Sep.  01,  2025<span></span>
</td>
<td class="text">Sep. 29,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate', window );">Board Approval Date</a></td>
<td class="text">May  02,  2022<span></span>
</td>
<td class="text">Aug. 12,  2021<span></span>
</td>
<td class="text">Sep. 28,  2020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate', window );">Expiration Date</a></td>
<td class="text">May  01,  2032<span></span>
</td>
<td class="text">Aug. 11,  2031<span></span>
</td>
<td class="text">Sep. 28,  2030<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=RIME_SunilAroraMember', window );">Sunil Arora [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TargetedOrTrackingStockIssuanceDates', window );">Granted Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sep. 29,  2020<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate', window );">Vesting Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sep. 29,  2020<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Vested Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate', window );">Date Fully Vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sep. 29,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate', window );">Board Approval Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sep. 28,  2020<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate', window );">Expiration Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sep. 28,  2030<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=RIME_RajivVirmaniMember', window );">Rajiv Virmani [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TargetedOrTrackingStockIssuanceDates', window );">Granted Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sep. 29,  2020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate', window );">Vesting Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sep. 29,  2020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Vested Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate', window );">Date Fully Vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sep. 29,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate', window );">Board Approval Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sep. 28,  2020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate', window );">Expiration Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sep. 28,  2030<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=RIME_SudhindraShenoyMember', window );">Sudhindra Shenoy [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted Shares</a></td>
<td class="nump">25,000<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="nump">180,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding Awards</a></td>
<td class="nump">25,000<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="nump">180,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TargetedOrTrackingStockIssuanceDates', window );">Granted Date</a></td>
<td class="text">May  02,  2022<span></span>
</td>
<td class="text">Aug. 12,  2021<span></span>
</td>
<td class="text">Sep. 29,  2020<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate', window );">Vesting Date</a></td>
<td class="text">May  02,  2022<span></span>
</td>
<td class="text">Sep.  01,  2021<span></span>
</td>
<td class="text">Sep. 29,  2020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Vested Outstanding</a></td>
<td class="nump">12,500<span></span>
</td>
<td class="nump">33,333<span></span>
</td>
<td class="nump">180,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Unvested</a></td>
<td class="nump">12,500<span></span>
</td>
<td class="nump">16,667<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate', window );">Date Fully Vested</a></td>
<td class="text">May  02,  2026<span></span>
</td>
<td class="text">Sep.  01,  2025<span></span>
</td>
<td class="text">Sep. 29,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate', window );">Board Approval Date</a></td>
<td class="text">May  02,  2022<span></span>
</td>
<td class="text">Aug. 12,  2021<span></span>
</td>
<td class="text">Sep. 28,  2020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate', window );">Expiration Date</a></td>
<td class="text">May  01,  2032<span></span>
</td>
<td class="text">Aug. 11,  2031<span></span>
</td>
<td class="text">Sep. 28,  2030<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=RIME_AntonySunilMember', window );">Antony Sunil [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted Shares</a></td>
<td class="nump">25,000<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="nump">90,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding Awards</a></td>
<td class="nump">25,000<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="nump">90,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TargetedOrTrackingStockIssuanceDates', window );">Granted Date</a></td>
<td class="text">May  02,  2022<span></span>
</td>
<td class="text">Aug. 12,  2021<span></span>
</td>
<td class="text">Sep. 29,  2020<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Exercise price</a></td>
<td class="nump">$ 0.05<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate', window );">Vesting Date</a></td>
<td class="text">May  02,  2022<span></span>
</td>
<td class="text">Sep.  01,  2021<span></span>
</td>
<td class="text">Sep. 29,  2020<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Vested Outstanding</a></td>
<td class="nump">12,500<span></span>
</td>
<td class="nump">33,333<span></span>
</td>
<td class="nump">90,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Unvested</a></td>
<td class="nump">12,500<span></span>
</td>
<td class="nump">16,667<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate', window );">Date Fully Vested</a></td>
<td class="text">May  02,  2026<span></span>
</td>
<td class="text">Sep.  01,  2025<span></span>
</td>
<td class="text">Sep. 29,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate', window );">Board Approval Date</a></td>
<td class="text">May  02,  2022<span></span>
</td>
<td class="text">Aug. 12,  2021<span></span>
</td>
<td class="text">Sep. 28,  2020<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate', window );">Expiration Date</a></td>
<td class="text">May  01,  2032<span></span>
</td>
<td class="text">Aug. 11,  2031<span></span>
</td>
<td class="text">Sep. 28,  2030<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=RIME_TuleekaNandyMember', window );">Tuleeka Nandy [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted Shares</a></td>
<td class="nump">15,000<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding Awards</a></td>
<td class="nump">15,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TargetedOrTrackingStockIssuanceDates', window );">Granted Date</a></td>
<td class="text">May  02,  2022<span></span>
</td>
<td class="text">Aug. 12,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Exercise price</a></td>
<td class="nump">$ 0.05<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate', window );">Vesting Date</a></td>
<td class="text">May  02,  2022<span></span>
</td>
<td class="text">Sep.  01,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Vested Outstanding</a></td>
<td class="nump">7,500<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Unvested</a></td>
<td class="nump">7,500<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate', window );">Date Fully Vested</a></td>
<td class="text">May  02,  2026<span></span>
</td>
<td class="text">Sep.  01,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate', window );">Board Approval Date</a></td>
<td class="text">May  02,  2022<span></span>
</td>
<td class="text">Aug. 12,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate', window );">Expiration Date</a></td>
<td class="text">May  01,  2032<span></span>
</td>
<td class="text">Aug. 11,  2031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=RIME_RobelAtnafuMember', window );">Robel Atnafu [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TargetedOrTrackingStockIssuanceDates', window );">Granted Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug. 12,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate', window );">Vesting Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sep.  01,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Vested Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate', window );">Date Fully Vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sep.  01,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate', window );">Board Approval Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug. 12,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate', window );">Expiration Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug. 11,  2031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=RIME_GuyPrimusMember', window );">Guy Primus [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">360,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">360,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TargetedOrTrackingStockIssuanceDates', window );">Granted Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug. 12,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate', window );">Vesting Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sep.  01,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Vested Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">240,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">120,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate', window );">Date Fully Vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sep.  01,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate', window );">Board Approval Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug. 12,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate', window );">Expiration Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug. 11,  2031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=RIME_SamarthaGowdaMember', window );">Samartha Gowda [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted Shares</a></td>
<td class="nump">15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding Awards</a></td>
<td class="nump">15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TargetedOrTrackingStockIssuanceDates', window );">Granted Date</a></td>
<td class="text">May  02,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Exercise price</a></td>
<td class="nump">$ 0.05<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate', window );">Vesting Date</a></td>
<td class="text">May  02,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Vested Outstanding</a></td>
<td class="nump">7,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Unvested</a></td>
<td class="nump">7,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate', window );">Date Fully Vested</a></td>
<td class="text">May  02,  2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate', window );">Board Approval Date</a></td>
<td class="text">May  02,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate', window );">Expiration Date</a></td>
<td class="text">May  01,  2032<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=RIME_AlexandraAielloMember', window );">Alexandra Aiello [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted Shares</a></td>
<td class="nump">2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding Awards</a></td>
<td class="nump">2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TargetedOrTrackingStockIssuanceDates', window );">Granted Date</a></td>
<td class="text">May  02,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Exercise price</a></td>
<td class="nump">$ 0.05<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate', window );">Vesting Date</a></td>
<td class="text">May  02,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Vested Outstanding</a></td>
<td class="nump">1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Unvested</a></td>
<td class="nump">1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate', window );">Date Fully Vested</a></td>
<td class="text">May  02,  2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate', window );">Board Approval Date</a></td>
<td class="text">May  02,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate', window );">Expiration Date</a></td>
<td class="text">May  01,  2032<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=RIME_StephenCabralMember', window );">Stephen Cabral [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted Shares</a></td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding Awards</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TargetedOrTrackingStockIssuanceDates', window );">Granted Date</a></td>
<td class="text">May  02,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Exercise price</a></td>
<td class="nump">$ 0.05<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate', window );">Vesting Date</a></td>
<td class="text">May  02,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Vested Outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Unvested</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate', window );">Date Fully Vested</a></td>
<td class="text">May  02,  2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate', window );">Board Approval Date</a></td>
<td class="text">May  02,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate', window );">Expiration Date</a></td>
<td class="text">May  01,  2032<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=RIME_JonahPetiPerrinMember', window );">Jonah Peti-Perrin [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted Shares</a></td>
<td class="nump">2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding Awards</a></td>
<td class="nump">2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TargetedOrTrackingStockIssuanceDates', window );">Granted Date</a></td>
<td class="text">May  02,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Exercise price</a></td>
<td class="nump">$ 0.05<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate', window );">Vesting Date</a></td>
<td class="text">May  02,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Vested Outstanding</a></td>
<td class="nump">1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Unvested</a></td>
<td class="nump">1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate', window );">Date Fully Vested</a></td>
<td class="text">May  02,  2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate', window );">Board Approval Date</a></td>
<td class="text">May  02,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate', window );">Expiration Date</a></td>
<td class="text">May  01,  2032<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=RIME_BryanNellaMember', window );">Bryan Nella [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted Shares</a></td>
<td class="nump">25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding Awards</a></td>
<td class="nump">25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TargetedOrTrackingStockIssuanceDates', window );">Granted Date</a></td>
<td class="text">May  02,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Exercise price</a></td>
<td class="nump">$ 0.05<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate', window );">Vesting Date</a></td>
<td class="text">May  02,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Vested Outstanding</a></td>
<td class="nump">12,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Unvested</a></td>
<td class="nump">12,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate', window );">Date Fully Vested</a></td>
<td class="text">May  02,  2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate', window );">Board Approval Date</a></td>
<td class="text">May  02,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate', window );">Expiration Date</a></td>
<td class="text">May  01,  2032<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=RIME_MarkSinkMember', window );">Mark Sink [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted Shares</a></td>
<td class="nump">25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding Awards</a></td>
<td class="nump">25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TargetedOrTrackingStockIssuanceDates', window );">Granted Date</a></td>
<td class="text">May 16,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Exercise price</a></td>
<td class="nump">$ 0.05<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate', window );">Vesting Date</a></td>
<td class="text">May 16,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Vested Outstanding</a></td>
<td class="nump">12,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Unvested</a></td>
<td class="nump">12,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate', window );">Date Fully Vested</a></td>
<td class="text">May 16,  2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate', window );">Board Approval Date</a></td>
<td class="text">May  02,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate', window );">Expiration Date</a></td>
<td class="text">May 15,  2032<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=RIME_KoustavChoudhuriMember', window );">Koustav Choudhuri [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted Shares</a></td>
<td class="nump">17,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding Awards</a></td>
<td class="nump">17,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TargetedOrTrackingStockIssuanceDates', window );">Granted Date</a></td>
<td class="text">May 16,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Exercise price</a></td>
<td class="nump">$ 0.05<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate', window );">Vesting Date</a></td>
<td class="text">May 16,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Vested Outstanding</a></td>
<td class="nump">8,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Unvested</a></td>
<td class="nump">8,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate', window );">Date Fully Vested</a></td>
<td class="text">May 16,  2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate', window );">Board Approval Date</a></td>
<td class="text">May  02,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate', window );">Expiration Date</a></td>
<td class="text">May 15,  2032<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award board approval date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award fully vested date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award vesting start date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date the equity-based award expires, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TargetedOrTrackingStockIssuanceDates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date the targeted stock was issued, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TargetedOrTrackingStockIssuanceDates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_StockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_StockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=RIME_SemiCabIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=RIME_SemiCabIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=RIME_SudhirNarasimhamurthyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=RIME_SudhirNarasimhamurthyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=RIME_KadandaleSrinivasSudheerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=RIME_KadandaleSrinivasSudheerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=RIME_VivekSehgalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=RIME_VivekSehgalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=RIME_RajivSaxenaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=RIME_RajivSaxenaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=RIME_HarshaBhatMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=RIME_HarshaBhatMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=RIME_JaganReddyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=RIME_JaganReddyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=RIME_SiddayyaSGanjalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=RIME_SiddayyaSGanjalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=RIME_SunilAroraMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=RIME_SunilAroraMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=RIME_RajivVirmaniMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=RIME_RajivVirmaniMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=RIME_SudhindraShenoyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=RIME_SudhindraShenoyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=RIME_AntonySunilMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=RIME_AntonySunilMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=RIME_TuleekaNandyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=RIME_TuleekaNandyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=RIME_RobelAtnafuMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=RIME_RobelAtnafuMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=RIME_GuyPrimusMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=RIME_GuyPrimusMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=RIME_SamarthaGowdaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=RIME_SamarthaGowdaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=RIME_AlexandraAielloMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=RIME_AlexandraAielloMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=RIME_StephenCabralMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=RIME_StephenCabralMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=RIME_JonahPetiPerrinMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=RIME_JonahPetiPerrinMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=RIME_BryanNellaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=RIME_BryanNellaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=RIME_MarkSinkMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=RIME_MarkSinkMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=RIME_KoustavChoudhuriMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=RIME_KoustavChoudhuriMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>252
<FILENAME>R108.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035105098368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS&#8217; EQUITY (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2024 </div>
<div>shares</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=RIME_FoundersMember', window );">Founders [Member] | Semi Cab Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, shares</a></td>
<td class="nump">25,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=RIME_FoundersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=RIME_FoundersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=RIME_SemiCabIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=RIME_SemiCabIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>253
<FILENAME>R109.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035032353776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF FIRST TRANCHE OF SUBSCRIPTIONS (Details) - Semi Cab Inc [Member]<br></strong></div></th>
<th class="th" colspan="1">54 Months Ended</th>
</tr>
<tr><th class="th">
<div>Apr. 22, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentOfPrincipalAmount', window );">Principal</a></td>
<td class="nump">$ 4,095,779<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember', window );">Share-Based Payment Arrangement, Tranche One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentOfPrincipalAmount', window );">Principal</a></td>
<td class="nump">$ 943,041<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_SAFEOneMember', window );">SAFE-1 | Share-Based Payment Arrangement, Tranche One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ConvertibleHolderName', window );">Convertible Holder Name</a></td>
<td class="text">Ardhendu
    Haldar<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentOfPrincipalAmount', window );">Principal</a></td>
<td class="nump">$ 250,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentIssueDate', window );">Issue Date</a></td>
<td class="text">Oct. 25,  2018<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ValuationCapitalOfInvestment', window );">Valuation Cap</a></td>
<td class="nump">$ 10,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentConvertedDate', window );">Converted Date</a></td>
<td class="text">Dec. 25,  2020<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_SAFEThirtyEightMember', window );">SAFE-38 [Member] | Share-Based Payment Arrangement, Tranche One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ConvertibleHolderName', window );">Convertible Holder Name</a></td>
<td class="text">Praveen
    Kaza<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentOfPrincipalAmount', window );">Principal</a></td>
<td class="nump">$ 100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentIssueDate', window );">Issue Date</a></td>
<td class="text">Oct. 25,  2018<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ValuationCapitalOfInvestment', window );">Valuation Cap</a></td>
<td class="nump">$ 13,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentConvertedDate', window );">Converted Date</a></td>
<td class="text">Dec. 25,  2020<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_SAFEFortyOneMember', window );">SAFE-41 [Member] | Share-Based Payment Arrangement, Tranche One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ConvertibleHolderName', window );">Convertible Holder Name</a></td>
<td class="text">Kurt
    W Mattson<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentOfPrincipalAmount', window );">Principal</a></td>
<td class="nump">$ 50,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentIssueDate', window );">Issue Date</a></td>
<td class="text">Mar. 27,  2019<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ValuationCapitalOfInvestment', window );">Valuation Cap</a></td>
<td class="nump">$ 20,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentConvertedDate', window );">Converted Date</a></td>
<td class="text">Dec. 25,  2020<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_SAFEFortyTwoMember', window );">SAFE-42 [Member] | Share-Based Payment Arrangement, Tranche One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ConvertibleHolderName', window );">Convertible Holder Name</a></td>
<td class="text">Wendy
    A Thompson<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentOfPrincipalAmount', window );">Principal</a></td>
<td class="nump">$ 50,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentIssueDate', window );">Issue Date</a></td>
<td class="text">Mar. 27,  2019<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ValuationCapitalOfInvestment', window );">Valuation Cap</a></td>
<td class="nump">$ 20,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentConvertedDate', window );">Converted Date</a></td>
<td class="text">Dec. 25,  2020<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_SAFEFortyFourMember', window );">SAFE Forty Four [Member] | Share-Based Payment Arrangement, Tranche One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ConvertibleHolderName', window );">Convertible Holder Name</a></td>
<td class="text">Sonata
    Software North America Inc<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentOfPrincipalAmount', window );">Principal</a></td>
<td class="nump">$ 468,041<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentIssueDate', window );">Issue Date</a></td>
<td class="text">Feb. 24,  2020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ValuationCapitalOfInvestment', window );">Valuation Cap</a></td>
<td class="nump">$ 10,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentConvertedDate', window );">Converted Date</a></td>
<td class="text">Dec. 25,  2020<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_SAFEFortyThreeMember', window );">SAFE-43 [Member] | Share-Based Payment Arrangement, Tranche One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ConvertibleHolderName', window );">Convertible Holder Name</a></td>
<td class="text">THE
    IRA CLUB F/B/O RANJU MAHESHWARI ROTH IRA 2000201<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentOfPrincipalAmount', window );">Principal</a></td>
<td class="nump">$ 25,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentIssueDate', window );">Issue Date</a></td>
<td class="text">Jun. 15,  2020<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ValuationCapitalOfInvestment', window );">Valuation Cap</a></td>
<td class="nump">$ 10,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentConvertedDate', window );">Converted Date</a></td>
<td class="text">Dec. 25,  2020<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_ConvertibleHolderName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Convertible holder name.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_ConvertibleHolderName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_InvestmentConvertedDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investment converted date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_InvestmentConvertedDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_InvestmentIssueDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investment issue date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_InvestmentIssueDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_InvestmentOfPrincipalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investment of principal amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_InvestmentOfPrincipalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_ValuationCapitalOfInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Valuation capital of investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_ValuationCapitalOfInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 808<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=RIME_SemiCabIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=RIME_SemiCabIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RIME_SAFEOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RIME_SAFEOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RIME_SAFEThirtyEightMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RIME_SAFEThirtyEightMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RIME_SAFEFortyOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RIME_SAFEFortyOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RIME_SAFEFortyTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RIME_SAFEFortyTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RIME_SAFEFortyFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RIME_SAFEFortyFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RIME_SAFEFortyThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RIME_SAFEFortyThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>254
<FILENAME>R110.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035119851504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF TERMINATED IMMEDIATELY AFTER CLOSING OF THE TRANSACTION (Details) - Semi Cab Inc [Member]<br></strong></div></th>
<th class="th" colspan="1">20 Months Ended</th>
</tr>
<tr><th class="th">
<div>Apr. 22, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentOfPrincipalAmount', window );">Principal</a></td>
<td class="nump">$ 4,095,779<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_SAFEFortyMember', window );">SAFE-40 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ConvertibleHolderName', window );">Convertible Holder Name</a></td>
<td class="text">Sunil Bhatia<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentOfPrincipalAmount', window );">Principal</a></td>
<td class="nump">$ 250,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentIssueDate', window );">Issue Date</a></td>
<td class="text">Aug. 12,  2021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ValuationCapitalOfInvestment', window );">Valuation Cap</a></td>
<td class="nump">$ 15,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_SAFEThirtyNineMember', window );">SAFE-39 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ConvertibleHolderName', window );">Convertible Holder Name</a></td>
<td class="text">Pallav Gupta<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentOfPrincipalAmount', window );">Principal</a></td>
<td class="nump">$ 15,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentIssueDate', window );">Issue Date</a></td>
<td class="text">Aug. 12,  2021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ValuationCapitalOfInvestment', window );">Valuation Cap</a></td>
<td class="nump">$ 15,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_SAFETenMember', window );">SAFE-10 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ConvertibleHolderName', window );">Convertible Holder Name</a></td>
<td class="text">The Bhardwaj 2003 Revocable Trust<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentOfPrincipalAmount', window );">Principal</a></td>
<td class="nump">$ 200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentIssueDate', window );">Issue Date</a></td>
<td class="text">Dec. 31,  2021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ValuationCapitalOfInvestment', window );">Valuation Cap</a></td>
<td class="nump">$ 35,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_SAFEElevenMember', window );">SAFE-11 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ConvertibleHolderName', window );">Convertible Holder Name</a></td>
<td class="text">Praveen Kaza<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentOfPrincipalAmount', window );">Principal</a></td>
<td class="nump">$ 50,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentIssueDate', window );">Issue Date</a></td>
<td class="text">Dec. 31,  2021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ValuationCapitalOfInvestment', window );">Valuation Cap</a></td>
<td class="nump">$ 35,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_SAFETwelveMember', window );">SAFE-12 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ConvertibleHolderName', window );">Convertible Holder Name</a></td>
<td class="text">Pallav Gupta<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentOfPrincipalAmount', window );">Principal</a></td>
<td class="nump">$ 20,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentIssueDate', window );">Issue Date</a></td>
<td class="text">Dec. 31,  2021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ValuationCapitalOfInvestment', window );">Valuation Cap</a></td>
<td class="nump">$ 35,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_SAFEThirteenMember', window );">SAFE-13 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ConvertibleHolderName', window );">Convertible Holder Name</a></td>
<td class="text">Amit and Anju Bhardwaj<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentOfPrincipalAmount', window );">Principal</a></td>
<td class="nump">$ 50,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentIssueDate', window );">Issue Date</a></td>
<td class="text">Dec. 31,  2021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ValuationCapitalOfInvestment', window );">Valuation Cap</a></td>
<td class="nump">$ 35,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_SAFEFourteenMember', window );">SAFE-14 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ConvertibleHolderName', window );">Convertible Holder Name</a></td>
<td class="text">Komal Bajaj<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentOfPrincipalAmount', window );">Principal</a></td>
<td class="nump">$ 50,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentIssueDate', window );">Issue Date</a></td>
<td class="text">Dec. 31,  2021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ValuationCapitalOfInvestment', window );">Valuation Cap</a></td>
<td class="nump">$ 35,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_SAFEFifteenMember', window );">SAFE-15 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ConvertibleHolderName', window );">Convertible Holder Name</a></td>
<td class="text">Goel Trust, Dated Aug 2, 2000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentOfPrincipalAmount', window );">Principal</a></td>
<td class="nump">$ 100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentIssueDate', window );">Issue Date</a></td>
<td class="text">Dec. 31,  2021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ValuationCapitalOfInvestment', window );">Valuation Cap</a></td>
<td class="nump">$ 35,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_SAFESixteenMember', window );">SAFE-16 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ConvertibleHolderName', window );">Convertible Holder Name</a></td>
<td class="text">Sanjiva Singh<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentOfPrincipalAmount', window );">Principal</a></td>
<td class="nump">$ 100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentIssueDate', window );">Issue Date</a></td>
<td class="text">Dec. 31,  2021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ValuationCapitalOfInvestment', window );">Valuation Cap</a></td>
<td class="nump">$ 35,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_SAFESeventeenMember', window );">SAFE-17 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ConvertibleHolderName', window );">Convertible Holder Name</a></td>
<td class="text">Rajeev Agarwal<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentOfPrincipalAmount', window );">Principal</a></td>
<td class="nump">$ 25,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentIssueDate', window );">Issue Date</a></td>
<td class="text">Dec. 31,  2021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ValuationCapitalOfInvestment', window );">Valuation Cap</a></td>
<td class="nump">$ 35,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_SAFEEighteenMember', window );">SAFE-18 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ConvertibleHolderName', window );">Convertible Holder Name</a></td>
<td class="text">Sanyogita and Sunil Gupta<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentOfPrincipalAmount', window );">Principal</a></td>
<td class="nump">$ 25,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentIssueDate', window );">Issue Date</a></td>
<td class="text">Dec. 31,  2021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ValuationCapitalOfInvestment', window );">Valuation Cap</a></td>
<td class="nump">$ 35,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_SAFENineteenMember', window );">SAFE-19 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ConvertibleHolderName', window );">Convertible Holder Name</a></td>
<td class="text">SEM Gaingels Fund I, a series of JMWTX Investments, LP<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentOfPrincipalAmount', window );">Principal</a></td>
<td class="nump">$ 300,279<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentIssueDate', window );">Issue Date</a></td>
<td class="text">Dec. 31,  2021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ValuationCapitalOfInvestment', window );">Valuation Cap</a></td>
<td class="nump">$ 35,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_SAFETwoMember', window );">SAFE-20 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ConvertibleHolderName', window );">Convertible Holder Name</a></td>
<td class="text">FVI Fund LLC<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentOfPrincipalAmount', window );">Principal</a></td>
<td class="nump">$ 50,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentIssueDate', window );">Issue Date</a></td>
<td class="text">Dec. 31,  2021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ValuationCapitalOfInvestment', window );">Valuation Cap</a></td>
<td class="nump">$ 35,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_SAFETwentyMember', window );">SAFE-20 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ConvertibleHolderName', window );">Convertible Holder Name</a></td>
<td class="text">JWass PT Investors, LP - B2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentOfPrincipalAmount', window );">Principal</a></td>
<td class="nump">$ 10,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentIssueDate', window );">Issue Date</a></td>
<td class="text">Dec. 31,  2021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ValuationCapitalOfInvestment', window );">Valuation Cap</a></td>
<td class="nump">$ 35,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_SAFETwentyOneMember', window );">SAFE-21 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ConvertibleHolderName', window );">Convertible Holder Name</a></td>
<td class="text">Medhavi Gupta<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentOfPrincipalAmount', window );">Principal</a></td>
<td class="nump">$ 20,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentIssueDate', window );">Issue Date</a></td>
<td class="text">Dec. 31,  2021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ValuationCapitalOfInvestment', window );">Valuation Cap</a></td>
<td class="nump">$ 35,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_SAFETwentyTwoMember', window );">SAFE-22 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ConvertibleHolderName', window );">Convertible Holder Name</a></td>
<td class="text">Sundeep Sibal<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentOfPrincipalAmount', window );">Principal</a></td>
<td class="nump">$ 50,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentIssueDate', window );">Issue Date</a></td>
<td class="text">Dec. 31,  2021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ValuationCapitalOfInvestment', window );">Valuation Cap</a></td>
<td class="nump">$ 35,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_SAFETwentyFourMember', window );">SAFE-24 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ConvertibleHolderName', window );">Convertible Holder Name</a></td>
<td class="text">Jolly Gupta<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentOfPrincipalAmount', window );">Principal</a></td>
<td class="nump">$ 35,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentIssueDate', window );">Issue Date</a></td>
<td class="text">Dec. 31,  2021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ValuationCapitalOfInvestment', window );">Valuation Cap</a></td>
<td class="nump">$ 35,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_SAFEThreeMember', window );">SAFE-3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ConvertibleHolderName', window );">Convertible Holder Name</a></td>
<td class="text">Ashutosh Malaviya<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentOfPrincipalAmount', window );">Principal</a></td>
<td class="nump">$ 50,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentIssueDate', window );">Issue Date</a></td>
<td class="text">Dec. 31,  2021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ValuationCapitalOfInvestment', window );">Valuation Cap</a></td>
<td class="nump">$ 35,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_SAFEFourMember', window );">SAFE-4 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ConvertibleHolderName', window );">Convertible Holder Name</a></td>
<td class="text">Consensia Inc<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentOfPrincipalAmount', window );">Principal</a></td>
<td class="nump">$ 50,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentIssueDate', window );">Issue Date</a></td>
<td class="text">Dec. 31,  2021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ValuationCapitalOfInvestment', window );">Valuation Cap</a></td>
<td class="nump">$ 35,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_SAFEFortyFiveMember', window );">SAFE-45 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ConvertibleHolderName', window );">Convertible Holder Name</a></td>
<td class="text">Atula Sibal<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentOfPrincipalAmount', window );">Principal</a></td>
<td class="nump">$ 50,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentIssueDate', window );">Issue Date</a></td>
<td class="text">Dec. 31,  2021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ValuationCapitalOfInvestment', window );">Valuation Cap</a></td>
<td class="nump">$ 35,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_SAFESixMember', window );">SAFE-6 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ConvertibleHolderName', window );">Convertible Holder Name</a></td>
<td class="text">Ajay Bhatnagar<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentOfPrincipalAmount', window );">Principal</a></td>
<td class="nump">$ 100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentIssueDate', window );">Issue Date</a></td>
<td class="text">Dec. 31,  2021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ValuationCapitalOfInvestment', window );">Valuation Cap</a></td>
<td class="nump">$ 35,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_SAFESevenMember', window );">SAFE-7 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ConvertibleHolderName', window );">Convertible Holder Name</a></td>
<td class="text">Pankaj Sinha<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentOfPrincipalAmount', window );">Principal</a></td>
<td class="nump">$ 50,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentIssueDate', window );">Issue Date</a></td>
<td class="text">Dec. 31,  2021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ValuationCapitalOfInvestment', window );">Valuation Cap</a></td>
<td class="nump">$ 35,000.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_SAFEEightMember', window );">SAFE-8 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ConvertibleHolderName', window );">Convertible Holder Name</a></td>
<td class="text">Bakulesh Adya<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentOfPrincipalAmount', window );">Principal</a></td>
<td class="nump">$ 35,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentIssueDate', window );">Issue Date</a></td>
<td class="text">Dec. 31,  2021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ValuationCapitalOfInvestment', window );">Valuation Cap</a></td>
<td class="nump">$ 35,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_SAFENineMember', window );">SAFE-9 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ConvertibleHolderName', window );">Convertible Holder Name</a></td>
<td class="text">Alok Mahajan<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentOfPrincipalAmount', window );">Principal</a></td>
<td class="nump">$ 50,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentIssueDate', window );">Issue Date</a></td>
<td class="text">Dec. 31,  2021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ValuationCapitalOfInvestment', window );">Valuation Cap</a></td>
<td class="nump">$ 35,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_SAFEFiveMember', window );">SAFE-5 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ConvertibleHolderName', window );">Convertible Holder Name</a></td>
<td class="text">BANSAL GARG FAMILY TRUST AMIT BANSAL TRTEE KARUNA GARG TRTEE U/A 11/07/2017<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentOfPrincipalAmount', window );">Principal</a></td>
<td class="nump">$ 100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentIssueDate', window );">Issue Date</a></td>
<td class="text">Dec. 31,  2021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ValuationCapitalOfInvestment', window );">Valuation Cap</a></td>
<td class="nump">$ 35,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_SAFETwentyFiveMember', window );">SAFE-25 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ConvertibleHolderName', window );">Convertible Holder Name</a></td>
<td class="text">Disrupt Fund XVIII, LLC<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentOfPrincipalAmount', window );">Principal</a></td>
<td class="nump">$ 50,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentIssueDate', window );">Issue Date</a></td>
<td class="text">Jan. 24,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ValuationCapitalOfInvestment', window );">Valuation Cap</a></td>
<td class="nump">$ 35,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_SAFETwentySixMember', window );">SAFE-26 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ConvertibleHolderName', window );">Convertible Holder Name</a></td>
<td class="text">Ajatshatru and Manju Dhawal<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentOfPrincipalAmount', window );">Principal</a></td>
<td class="nump">$ 25,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentIssueDate', window );">Issue Date</a></td>
<td class="text">Jan. 31,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ValuationCapitalOfInvestment', window );">Valuation Cap</a></td>
<td class="nump">$ 35,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_SAFETwentySevenMember', window );">SAFE-27 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ConvertibleHolderName', window );">Convertible Holder Name</a></td>
<td class="text">Mrityunjay Dhawal<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentOfPrincipalAmount', window );">Principal</a></td>
<td class="nump">$ 25,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentIssueDate', window );">Issue Date</a></td>
<td class="text">Jan. 31,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ValuationCapitalOfInvestment', window );">Valuation Cap</a></td>
<td class="nump">$ 35,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_SAFETwentyEightMember', window );">SAFE-28 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ConvertibleHolderName', window );">Convertible Holder Name</a></td>
<td class="text">You Sexy Dawg, LLC<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentOfPrincipalAmount', window );">Principal</a></td>
<td class="nump">$ 50,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentIssueDate', window );">Issue Date</a></td>
<td class="text">Jan. 31,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ValuationCapitalOfInvestment', window );">Valuation Cap</a></td>
<td class="nump">$ 35,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_SAFETwentyNineMember', window );">SAFE-29 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ConvertibleHolderName', window );">Convertible Holder Name</a></td>
<td class="text">Elisa deLaet<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentOfPrincipalAmount', window );">Principal</a></td>
<td class="nump">$ 25,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentIssueDate', window );">Issue Date</a></td>
<td class="text">Jan. 31,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ValuationCapitalOfInvestment', window );">Valuation Cap</a></td>
<td class="nump">$ 35,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_SAFEThirtyMember', window );">SAFE-30 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ConvertibleHolderName', window );">Convertible Holder Name</a></td>
<td class="text">Ardhendu Haldar<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentOfPrincipalAmount', window );">Principal</a></td>
<td class="nump">$ 100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentIssueDate', window );">Issue Date</a></td>
<td class="text">Feb. 28,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ValuationCapitalOfInvestment', window );">Valuation Cap</a></td>
<td class="nump">$ 35,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_SAFEThirtyOneMember', window );">SAFE-31 [Member</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ConvertibleHolderName', window );">Convertible Holder Name</a></td>
<td class="text">Suzanne and Tom Lambert<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentOfPrincipalAmount', window );">Principal</a></td>
<td class="nump">$ 250,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentIssueDate', window );">Issue Date</a></td>
<td class="text">Feb. 28,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ValuationCapitalOfInvestment', window );">Valuation Cap</a></td>
<td class="nump">$ 35,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_SAFEThirtyTwoMember', window );">SAFE-32 [Member</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ConvertibleHolderName', window );">Convertible Holder Name</a></td>
<td class="text">Nidus Capital Holdings, LLC<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentOfPrincipalAmount', window );">Principal</a></td>
<td class="nump">$ 250,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentIssueDate', window );">Issue Date</a></td>
<td class="text">Feb. 28,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ValuationCapitalOfInvestment', window );">Valuation Cap</a></td>
<td class="nump">$ 35,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_SAFEThirtyThreeMember', window );">SAFE-33 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ConvertibleHolderName', window );">Convertible Holder Name</a></td>
<td class="text">Compelling Natural Health II, LLC<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentOfPrincipalAmount', window );">Principal</a></td>
<td class="nump">$ 250,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentIssueDate', window );">Issue Date</a></td>
<td class="text">Feb. 28,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ValuationCapitalOfInvestment', window );">Valuation Cap</a></td>
<td class="nump">$ 35,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_SAFEThirtyFourMember', window );">SAFE-34 [Member</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ConvertibleHolderName', window );">Convertible Holder Name</a></td>
<td class="text">Birch Hill Capital Group, LLC<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentOfPrincipalAmount', window );">Principal</a></td>
<td class="nump">$ 250,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentIssueDate', window );">Issue Date</a></td>
<td class="text">Feb. 28,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ValuationCapitalOfInvestment', window );">Valuation Cap</a></td>
<td class="nump">$ 35,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_SAFEThirtyFiveMember', window );">SAFE-35 [Member</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ConvertibleHolderName', window );">Convertible Holder Name</a></td>
<td class="text">Ingrid P. Maes as Trustee of The IPM Irrevocable Trust dated September 1, 2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentOfPrincipalAmount', window );">Principal</a></td>
<td class="nump">$ 250,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentIssueDate', window );">Issue Date</a></td>
<td class="text">Feb. 28,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ValuationCapitalOfInvestment', window );">Valuation Cap</a></td>
<td class="nump">$ 35,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_SAFEThirtySixMember', window );">SAFE-36 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ConvertibleHolderName', window );">Convertible Holder Name</a></td>
<td class="text">Nattoceuticals, LLC<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentOfPrincipalAmount', window );">Principal</a></td>
<td class="nump">$ 250,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentIssueDate', window );">Issue Date</a></td>
<td class="text">Feb. 28,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ValuationCapitalOfInvestment', window );">Valuation Cap</a></td>
<td class="nump">$ 35,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_SAFEThirtySevenMember', window );">SAFE-37 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ConvertibleHolderName', window );">Convertible Holder Name</a></td>
<td class="text">Pallav Gupta<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentOfPrincipalAmount', window );">Principal</a></td>
<td class="nump">$ 60,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentIssueDate', window );">Issue Date</a></td>
<td class="text">Feb. 28,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ValuationCapitalOfInvestment', window );">Valuation Cap</a></td>
<td class="nump">$ 35,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_SAFEFortySixMember', window );">SAFE-46 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ConvertibleHolderName', window );">Convertible Holder Name</a></td>
<td class="text">Gaingels Semicab LLC<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentOfPrincipalAmount', window );">Principal</a></td>
<td class="nump">$ 130,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentIssueDate', window );">Issue Date</a></td>
<td class="text">Mar. 21,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ValuationCapitalOfInvestment', window );">Valuation Cap</a></td>
<td class="nump">$ 35,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_SAFEFiftyMember', window );">SAFE-50 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ConvertibleHolderName', window );">Convertible Holder Name</a></td>
<td class="text">Pankaj Sinha<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentOfPrincipalAmount', window );">Principal</a></td>
<td class="nump">$ 50,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentIssueDate', window );">Issue Date</a></td>
<td class="text">Apr.  04,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ValuationCapitalOfInvestment', window );">Valuation Cap</a></td>
<td class="nump">$ 35,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_SAFEFortyEightMember', window );">SAFE-48 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ConvertibleHolderName', window );">Convertible Holder Name</a></td>
<td class="text">Lucy Holifield<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentOfPrincipalAmount', window );">Principal</a></td>
<td class="nump">$ 70,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentIssueDate', window );">Issue Date</a></td>
<td class="text">Apr. 14,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ValuationCapitalOfInvestment', window );">Valuation Cap</a></td>
<td class="nump">$ 35,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_SAFEFortySevenMember', window );">SAFE-47 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ConvertibleHolderName', window );">Convertible Holder Name</a></td>
<td class="text">Corvus Albus LLC<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentOfPrincipalAmount', window );">Principal</a></td>
<td class="nump">$ 100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentIssueDate', window );">Issue Date</a></td>
<td class="text">Apr. 19,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ValuationCapitalOfInvestment', window );">Valuation Cap</a></td>
<td class="nump">$ 35,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_SAFEFortyNineMember', window );">SAFE-49 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ConvertibleHolderName', window );">Convertible Holder Name</a></td>
<td class="text">David Friedland<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentOfPrincipalAmount', window );">Principal</a></td>
<td class="nump">$ 50,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentIssueDate', window );">Issue Date</a></td>
<td class="text">Apr. 19,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ValuationCapitalOfInvestment', window );">Valuation Cap</a></td>
<td class="nump">$ 35,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_SAFEFiftyOneMember', window );">SAFE-51 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ConvertibleHolderName', window );">Convertible Holder Name</a></td>
<td class="text">Kapil K Gupta<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentOfPrincipalAmount', window );">Principal</a></td>
<td class="nump">$ 25,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestmentIssueDate', window );">Issue Date</a></td>
<td class="text">Apr. 22,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_ValuationCapitalOfInvestment', window );">Valuation Cap</a></td>
<td class="nump">$ 35,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_ConvertibleHolderName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Convertible holder name.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_ConvertibleHolderName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_InvestmentIssueDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investment issue date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_InvestmentIssueDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_InvestmentOfPrincipalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investment of principal amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_InvestmentOfPrincipalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_ValuationCapitalOfInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Valuation capital of investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_ValuationCapitalOfInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 808<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=RIME_SemiCabIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=RIME_SemiCabIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RIME_SAFEFortyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RIME_SAFEFortyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RIME_SAFEThirtyNineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RIME_SAFEThirtyNineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RIME_SAFETenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RIME_SAFETenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RIME_SAFEElevenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RIME_SAFEElevenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RIME_SAFETwelveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RIME_SAFETwelveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RIME_SAFEThirteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RIME_SAFEThirteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RIME_SAFEFourteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RIME_SAFEFourteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RIME_SAFEFifteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RIME_SAFEFifteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RIME_SAFESixteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RIME_SAFESixteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RIME_SAFESeventeenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RIME_SAFESeventeenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RIME_SAFEEighteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RIME_SAFEEighteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RIME_SAFENineteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RIME_SAFENineteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RIME_SAFETwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RIME_SAFETwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RIME_SAFETwentyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RIME_SAFETwentyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RIME_SAFETwentyOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RIME_SAFETwentyOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RIME_SAFETwentyTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RIME_SAFETwentyTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RIME_SAFETwentyFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RIME_SAFETwentyFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RIME_SAFEThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RIME_SAFEThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RIME_SAFEFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RIME_SAFEFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RIME_SAFEFortyFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RIME_SAFEFortyFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RIME_SAFESixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RIME_SAFESixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RIME_SAFESevenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RIME_SAFESevenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RIME_SAFEEightMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RIME_SAFEEightMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RIME_SAFENineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RIME_SAFENineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RIME_SAFEFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RIME_SAFEFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RIME_SAFETwentyFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RIME_SAFETwentyFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RIME_SAFETwentySixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RIME_SAFETwentySixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RIME_SAFETwentySevenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RIME_SAFETwentySevenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RIME_SAFETwentyEightMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RIME_SAFETwentyEightMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RIME_SAFETwentyNineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RIME_SAFETwentyNineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RIME_SAFEThirtyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RIME_SAFEThirtyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RIME_SAFEThirtyOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RIME_SAFEThirtyOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RIME_SAFEThirtyTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RIME_SAFEThirtyTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RIME_SAFEThirtyThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RIME_SAFEThirtyThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RIME_SAFEThirtyFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RIME_SAFEThirtyFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RIME_SAFEThirtyFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RIME_SAFEThirtyFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RIME_SAFEThirtySixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RIME_SAFEThirtySixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RIME_SAFEThirtySevenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RIME_SAFEThirtySevenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RIME_SAFEFortySixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RIME_SAFEFortySixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RIME_SAFEFiftyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RIME_SAFEFiftyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RIME_SAFEFortyEightMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RIME_SAFEFortyEightMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RIME_SAFEFortySevenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RIME_SAFEFortySevenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RIME_SAFEFortyNineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RIME_SAFEFortyNineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RIME_SAFEFiftyOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RIME_SAFEFiftyOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>255
<FILENAME>R111.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45035111740384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SAFE PRIVATE PLACEMENTS (Details Narrative) - Semi Cab Inc [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">20 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Apr. 22, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_SAFEAgreementsMember', window );">SAFE Agreements[Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Investments', window );">Investments</a></td>
<td class="nump">$ 943,041<span></span>
</td>
<td class="nump">$ 5,038,820<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestedValuationOfAmount', window );">Invested valuation of amount</a></td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_FortyFourSAFEAgreementsMember', window );">44 SAFE Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestedValuationOfAmount', window );">Invested valuation of amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,095,779<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_FortyFourSAFEAgreementsMember', window );">44 SAFE Agreements [Member] | Share-Based Payment Arrangement, Tranche One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RIME_FortyFourSAFEAgreementsMember', window );">44 SAFE Agreements [Member] | Share-Based Payment Arrangement, Tranche Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_RIME_InvestedValuationOfAmount', window );">Invested valuation of amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RIME_InvestedValuationOfAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Invested valuation of amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RIME_InvestedValuationOfAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RIME_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 808<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Investments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 80<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480078/944-80-55-14<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 80<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480078/944-80-55-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(h))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Investments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RIME_SAFEAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RIME_SAFEAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=RIME_SemiCabIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=RIME_SemiCabIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RIME_FortyFourSAFEAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RIME_FortyFourSAFEAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>256
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>659</ContextCount>
  <ElementCount>493</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>229</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - Condensed Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/BalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/BalanceSheetsParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - Condensed Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/StatementsOfOperations</Role>
      <ShortName>Condensed Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - Condensed Consolidated Statements of Shareholders' (Deficit) Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/StatementsOfShareholdersDeficitEquity</Role>
      <ShortName>Condensed Consolidated Statements of Shareholders' (Deficit) Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Statement - Condensed Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/StatementsOfCashFlows</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Disclosure - NATURE OF BUSINESS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/NatureOfBusiness</Role>
      <ShortName>NATURE OF BUSINESS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00000008 - Disclosure - RECENT DEVELOPMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/RecentDevelopments</Role>
      <ShortName>RECENT DEVELOPMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00000009 - Disclosure - LIQUIDITY, GOING CONCERN AND MANAGEMENT PLANS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/LiquidityGoingConcernAndManagementPlans</Role>
      <ShortName>LIQUIDITY, GOING CONCERN AND MANAGEMENT PLANS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00000010 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/SummaryOfSignificantAccountingPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00000011 - Disclosure - ASSET ACQUISITION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/AssetAcquisition</Role>
      <ShortName>ASSET ACQUISITION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00000012 - Disclosure - FINANCING</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/Financing</Role>
      <ShortName>FINANCING</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00000013 - Disclosure - LOANS PAYABLE ??? RELATED PARTIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/LoansPayableRelatedParties</Role>
      <ShortName>LOANS PAYABLE ??? RELATED PARTIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00000014 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/CommitmentsAndContingencies</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00000015 - Disclosure - OPERATING LEASES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/OperatingLeases</Role>
      <ShortName>OPERATING LEASES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00000016 - Disclosure - ISSUANCE OF COMMON STOCK</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/IssuanceOfCommonStock</Role>
      <ShortName>ISSUANCE OF COMMON STOCK</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00000017 - Disclosure - WARRANTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/Warrants</Role>
      <ShortName>WARRANTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>00000018 - Disclosure - COMPUTATION OF LOSS PER SHARE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/ComputationOfLossPerShare</Role>
      <ShortName>COMPUTATION OF LOSS PER SHARE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>00000019 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/IncomeTaxes</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>00000020 - Disclosure - REVENUE DISAGGREGATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/RevenueDisaggregation</Role>
      <ShortName>REVENUE DISAGGREGATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>00000021 - Disclosure - CONCENTRATIONS OF CREDIT RISK AND REVENUE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/ConcentrationsOfCreditRiskAndRevenue</Role>
      <ShortName>CONCENTRATIONS OF CREDIT RISK AND REVENUE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>00000022 - Disclosure - RELATED PARTY TRANSACTIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/RelatedPartyTransactions</Role>
      <ShortName>RELATED PARTY TRANSACTIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>00000023 - Disclosure - SUBSEQUENT EVENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/SubsequentEvents</Role>
      <ShortName>SUBSEQUENT EVENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>00000024 - Disclosure - PROPERTY AND EQUIPMENT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/PropertyAndEquipment</Role>
      <ShortName>PROPERTY AND EQUIPMENT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>00000025 - Disclosure - STOCK COMPENSATION EXPENSE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/StockCompensationExpense</Role>
      <ShortName>STOCK COMPENSATION EXPENSE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>00000026 - Disclosure - PUBLIC OFFERING AND NASDAQ UPLISTING</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/PublicOfferingAndNasdaqUplisting</Role>
      <ShortName>PUBLIC OFFERING AND NASDAQ UPLISTING</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>00000027 - Disclosure - ATM OFFERING</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/AtmOffering</Role>
      <ShortName>ATM OFFERING</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>00000028 - Disclosure - PRIVATE PLACEMENT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/PrivatePlacement</Role>
      <ShortName>PRIVATE PLACEMENT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>00000029 - Disclosure - AUGUST 2021 STOCK REDEMPTION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/August2021StockRedemption</Role>
      <ShortName>AUGUST 2021 STOCK REDEMPTION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>00000030 - Disclosure - AUGUST 2021 PRIVATE PLACEMENT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/August2021PrivatePlacement</Role>
      <ShortName>AUGUST 2021 PRIVATE PLACEMENT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>00000031 - Disclosure - DAMAGED GOODS INCIDENT RECOVERY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/DamagedGoodsIncidentRecovery</Role>
      <ShortName>DAMAGED GOODS INCIDENT RECOVERY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>00000032 - Disclosure - SUPPLEMENTAL INFORMATION CONDENSED FINANCIAL INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/SupplementalInformationCondensedFinancialInformation</Role>
      <ShortName>SUPPLEMENTAL INFORMATION CONDENSED FINANCIAL INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>00000033 - Disclosure - ACCOUNTS RECEIVABLE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/AccountsReceivable</Role>
      <ShortName>ACCOUNTS RECEIVABLE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>00000034 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/AccountsPayableAndAccruedExpenses</Role>
      <ShortName>ACCOUNTS PAYABLE AND ACCRUED EXPENSES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>00000035 - Disclosure - NOTES PAYABLE AND FINANING ARRANGEMENTS</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://algoholdings.com/role/NotesPayableAndFinaningArrangements</Role>
      <ShortName>NOTES PAYABLE AND FINANING ARRANGEMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>00000036 - Disclosure - DUE FROM FACTOR</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/DueFromFactor</Role>
      <ShortName>DUE FROM FACTOR</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>00000037 - Disclosure - STOCKHOLDERS??? EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/StockholdersEquity</Role>
      <ShortName>STOCKHOLDERS??? EQUITY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>00000038 - Disclosure - SAFE PRIVATE PLACEMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/SafePrivatePlacements</Role>
      <ShortName>SAFE PRIVATE PLACEMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>00000039 - Disclosure - EMPLOYEE BENEFIT PLANS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/EmployeeBenefitPlans</Role>
      <ShortName>EMPLOYEE BENEFIT PLANS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>00000040 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/SummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>00000041 - Disclosure - ASSET ACQUISITION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/AssetAcquisitionTables</Role>
      <ShortName>ASSET ACQUISITION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://algoholdings.com/role/AssetAcquisition</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>00000042 - Disclosure - LOANS PAYABLE ??? RELATED PARTIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/LoansPayableRelatedPartiesTables</Role>
      <ShortName>LOANS PAYABLE ??? RELATED PARTIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://algoholdings.com/role/LoansPayableRelatedParties</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>00000043 - Disclosure - OPERATING LEASES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/OperatingLeasesTables</Role>
      <ShortName>OPERATING LEASES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://algoholdings.com/role/OperatingLeases</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>00000044 - Disclosure - WARRANTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/WarrantsTables</Role>
      <ShortName>WARRANTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://algoholdings.com/role/Warrants</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>00000045 - Disclosure - COMPUTATION OF LOSS PER SHARE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/ComputationOfLossPerShareTables</Role>
      <ShortName>COMPUTATION OF LOSS PER SHARE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://algoholdings.com/role/ComputationOfLossPerShare</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>00000046 - Disclosure - REVENUE DISAGGREGATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/RevenueDisaggregationTables</Role>
      <ShortName>REVENUE DISAGGREGATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://algoholdings.com/role/RevenueDisaggregation</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>00000047 - Disclosure - PROPERTY AND EQUIPMENT (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/PropertyAndEquipmentTables</Role>
      <ShortName>PROPERTY AND EQUIPMENT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://algoholdings.com/role/PropertyAndEquipment</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>00000048 - Disclosure - STOCK COMPENSATION EXPENSE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/StockCompensationExpenseTables</Role>
      <ShortName>STOCK COMPENSATION EXPENSE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://algoholdings.com/role/StockCompensationExpense</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>00000049 - Disclosure - AUGUST 2021 PRIVATE PLACEMENT (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/August2021PrivatePlacementTables</Role>
      <ShortName>AUGUST 2021 PRIVATE PLACEMENT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://algoholdings.com/role/August2021PrivatePlacement</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>00000050 - Disclosure - SUPPLEMENTAL INFORMATION CONDENSED FINANCIAL INFORMATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/SupplementalInformationCondensedFinancialInformationTables</Role>
      <ShortName>SUPPLEMENTAL INFORMATION CONDENSED FINANCIAL INFORMATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://algoholdings.com/role/SupplementalInformationCondensedFinancialInformation</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>00000051 - Disclosure - NOTES PAYABLE AND FINANING ARRANGEMENTS (Tables)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://algoholdings.com/role/NotesPayableAndFinaningArrangementsTables</Role>
      <ShortName>NOTES PAYABLE AND FINANING ARRANGEMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://algoholdings.com/role/NotesPayableAndFinaningArrangements</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>00000052 - Disclosure - STOCKHOLDERS??? EQUITY (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/StockholdersEquityTables</Role>
      <ShortName>STOCKHOLDERS??? EQUITY (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://algoholdings.com/role/StockholdersEquity</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>00000053 - Disclosure - SAFE PRIVATE PLACEMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/SafePrivatePlacementsTables</Role>
      <ShortName>SAFE PRIVATE PLACEMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://algoholdings.com/role/SafePrivatePlacements</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>00000054 - Disclosure - RECENT DEVELOPMENTS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/RecentDevelopmentsDetailsNarrative</Role>
      <ShortName>RECENT DEVELOPMENTS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://algoholdings.com/role/RecentDevelopments</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>00000055 - Disclosure - LIQUIDITY, GOING CONCERN AND MANAGEMENT PLANS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/LiquidityGoingConcernAndManagementPlansDetailsNarrative</Role>
      <ShortName>LIQUIDITY, GOING CONCERN AND MANAGEMENT PLANS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://algoholdings.com/role/LiquidityGoingConcernAndManagementPlans</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>00000056 - Disclosure - SCHEDULE OF CONSIDERATION TRANSFERRED TO THE ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/ScheduleOfConsiderationTransferredToAssetsAcquiredAndLiabilitiesAssumedDetails</Role>
      <ShortName>SCHEDULE OF CONSIDERATION TRANSFERRED TO THE ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>00000057 - Disclosure - SCHEDULE OF CONSIDERATION TRANSFERRED TO THE ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/ScheduleOfConsiderationTransferredToAssetsAcquiredAndLiabilitiesAssumedDetailsParenthetical</Role>
      <ShortName>SCHEDULE OF CONSIDERATION TRANSFERRED TO THE ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details) (Parenthetical)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>00000058 - Disclosure - SCHEDULE OF PRO FORMA FINANCIAL INFORMATION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/ScheduleOfProFormaFinancialInformationDetails</Role>
      <ShortName>SCHEDULE OF PRO FORMA FINANCIAL INFORMATION (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>00000059 - Disclosure - ASSET ACQUISITION (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/AssetAcquisitionDetailsNarrative</Role>
      <ShortName>ASSET ACQUISITION (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://algoholdings.com/role/AssetAcquisitionTables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>00000060 - Disclosure - FINANCING (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/FinancingDetailsNarrative</Role>
      <ShortName>FINANCING (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://algoholdings.com/role/Financing</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>00000061 - Disclosure - SCHEDULE OF LOAN (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/ScheduleOfLoanDetails</Role>
      <ShortName>SCHEDULE OF LOAN (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>00000062 - Disclosure - LOANS PAYABLE ??? RELATED PARTIES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/LoansPayableRelatedPartiesDetailsNarrative</Role>
      <ShortName>LOANS PAYABLE ??? RELATED PARTIES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://algoholdings.com/role/LoansPayableRelatedPartiesTables</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>00000063 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/CommitmentsAndContingenciesDetailsNarrative</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://algoholdings.com/role/CommitmentsAndContingencies</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>00000064 - Disclosure - SCHEDULE OF SUPPLEMENTAL INFORMATION RELATED TO LEASES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/ScheduleOfSupplementalInformationRelatedToLeasesDetails</Role>
      <ShortName>SCHEDULE OF SUPPLEMENTAL INFORMATION RELATED TO LEASES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>00000065 - Disclosure - SCHEDULE OF LEASE TERM AND DISCOUNT RATE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/ScheduleOfLeaseTermAndDiscountRateDetails</Role>
      <ShortName>SCHEDULE OF LEASE TERM AND DISCOUNT RATE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>00000066 - Disclosure - SCHEDULE OF OPERATING LEASE MINIMUM FUTURE PAYMENTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/ScheduleOfOperatingLeaseMinimumFuturePaymentsDetails</Role>
      <ShortName>SCHEDULE OF OPERATING LEASE MINIMUM FUTURE PAYMENTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>00000067 - Disclosure - OPERATING LEASES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/OperatingLeasesDetailsNarrative</Role>
      <ShortName>OPERATING LEASES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://algoholdings.com/role/OperatingLeasesTables</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>00000068 - Disclosure - ISSUANCE OF COMMON STOCK (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/IssuanceOfCommonStockDetailsNarrative</Role>
      <ShortName>ISSUANCE OF COMMON STOCK (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://algoholdings.com/role/IssuanceOfCommonStock</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>00000069 - Disclosure - SCHEDULE OF WARRANTS EXPIRATION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/ScheduleOfWarrantsExpirationDetails</Role>
      <ShortName>SCHEDULE OF WARRANTS EXPIRATION (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>00000070 - Disclosure - WARRANTS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/WarrantsDetailsNarrative</Role>
      <ShortName>WARRANTS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://algoholdings.com/role/WarrantsTables</ParentRole>
      <Position>70</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>00000071 - Disclosure - SCHEDULE OF BASIC AND DILUTIVE LOSS PER SHARE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/ScheduleOfBasicAndDilutiveLossPerShareDetails</Role>
      <ShortName>SCHEDULE OF BASIC AND DILUTIVE LOSS PER SHARE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>00000072 - Disclosure - COMPUTATION OF LOSS PER SHARE (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/ComputationOfLossPerShareDetailsNarrative</Role>
      <ShortName>COMPUTATION OF LOSS PER SHARE (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://algoholdings.com/role/ComputationOfLossPerShareTables</ParentRole>
      <Position>72</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>00000073 - Disclosure - INCOME TAXES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/IncomeTaxesDetailsNarrative</Role>
      <ShortName>INCOME TAXES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://algoholdings.com/role/IncomeTaxes</ParentRole>
      <Position>73</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>00000074 - Disclosure - SCHEDULE OF REVENUE BY PRODUCT LINE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/ScheduleOfRevenueByProductLineDetails</Role>
      <ShortName>SCHEDULE OF REVENUE BY PRODUCT LINE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>00000075 - Disclosure - SCHEDULE OF SALES BY GEOGRAPHICAL REGION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/ScheduleOfSalesByGeographicalRegionDetails</Role>
      <ShortName>SCHEDULE OF SALES BY GEOGRAPHICAL REGION (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>00000076 - Disclosure - REVENUE DISAGGREGATION (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/RevenueDisaggregationDetailsNarrative</Role>
      <ShortName>REVENUE DISAGGREGATION (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://algoholdings.com/role/RevenueDisaggregationTables</ParentRole>
      <Position>76</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>00000077 - Disclosure - CONCENTRATIONS OF CREDIT RISK AND REVENUE (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/ConcentrationsOfCreditRiskAndRevenueDetailsNarrative</Role>
      <ShortName>CONCENTRATIONS OF CREDIT RISK AND REVENUE (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://algoholdings.com/role/ConcentrationsOfCreditRiskAndRevenue</ParentRole>
      <Position>77</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>00000078 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/RelatedPartyTransactionsDetailsNarrative</Role>
      <ShortName>RELATED PARTY TRANSACTIONS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://algoholdings.com/role/RelatedPartyTransactions</ParentRole>
      <Position>78</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>00000079 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/SubsequentEventsDetailsNarrative</Role>
      <ShortName>SUBSEQUENT EVENTS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://algoholdings.com/role/SubsequentEvents</ParentRole>
      <Position>79</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>00000080 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://algoholdings.com/role/SummaryOfSignificantAccountingPoliciesPolicies</ParentRole>
      <Position>80</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>00000081 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/ScheduleOfPropertyAndEquipmentDetails</Role>
      <ShortName>SCHEDULE OF PROPERTY AND EQUIPMENT (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>00000082 - Disclosure - PROPERTY AND EQUIPMENT (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/PropertyAndEquipmentDetailsNarrative</Role>
      <ShortName>PROPERTY AND EQUIPMENT (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://algoholdings.com/role/PropertyAndEquipmentTables</ParentRole>
      <Position>82</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>00000083 - Disclosure - SUMMARY OF STOCK OPTION ACTIVITY (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/SummaryOfStockOptionActivityDetails</Role>
      <ShortName>SUMMARY OF STOCK OPTION ACTIVITY (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>00000084 - Disclosure - SCHEDULE OF EMPLOYEE STOCK OPTIONS OUTSTANDING (Details) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/ScheduleOfEmployeeStockOptionsOutstandingDetailsParenthetical</Role>
      <ShortName>SCHEDULE OF EMPLOYEE STOCK OPTIONS OUTSTANDING (Details) (Parenthetical)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>84</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>00000085 - Disclosure - SCHEDULE OF BASIC AND DILUTIVE SHARES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/ScheduleOfBasicAndDilutiveSharesDetails</Role>
      <ShortName>SCHEDULE OF BASIC AND DILUTIVE SHARES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>85</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>00000086 - Disclosure - STOCK COMPENSATION EXPENSE (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/StockCompensationExpenseDetailsNarrative</Role>
      <ShortName>STOCK COMPENSATION EXPENSE (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://algoholdings.com/role/StockCompensationExpenseTables</ParentRole>
      <Position>86</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>00000087 - Disclosure - PUBLIC OFFERING AND NASDAQ UPLISTING (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/PublicOfferingAndNasdaqUplistingDetailsNarrative</Role>
      <ShortName>PUBLIC OFFERING AND NASDAQ UPLISTING (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://algoholdings.com/role/PublicOfferingAndNasdaqUplisting</ParentRole>
      <Position>87</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>00000088 - Disclosure - ATM OFFERING (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/AtmOfferingDetailsNarrative</Role>
      <ShortName>ATM OFFERING (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://algoholdings.com/role/AtmOffering</ParentRole>
      <Position>88</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>00000089 - Disclosure - PRIVATE PLACEMENT (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/PrivatePlacementDetailsNarrative</Role>
      <ShortName>PRIVATE PLACEMENT (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://algoholdings.com/role/PrivatePlacement</ParentRole>
      <Position>89</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>00000090 - Disclosure - AUGUST 2021 STOCK REDEMPTION (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/August2021StockRedemptionDetailsNarrative</Role>
      <ShortName>AUGUST 2021 STOCK REDEMPTION (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://algoholdings.com/role/August2021StockRedemption</ParentRole>
      <Position>90</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>00000091 - Disclosure - SCHEDULE OF LOSS BEFORE INCOME TAXES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/ScheduleOfLossBeforeIncomeTaxesDetails</Role>
      <ShortName>SCHEDULE OF LOSS BEFORE INCOME TAXES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>91</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>00000092 - Disclosure - SCHEDULE OF PROVISION FOR INCOME TAXES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/ScheduleOfProvisionForIncomeTaxesDetails</Role>
      <ShortName>SCHEDULE OF PROVISION FOR INCOME TAXES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>92</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>00000093 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails</Role>
      <ShortName>SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>93</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>00000094 - Disclosure - SCHEDULE OF TAX PROVISION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/ScheduleOfTaxProvisionDetails</Role>
      <ShortName>SCHEDULE OF TAX PROVISION (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>94</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>00000095 - Disclosure - SCHEDULE OF REVENUE BY GEOGRAPHICAL REGION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/ScheduleOfRevenueByGeographicalRegionDetails</Role>
      <ShortName>SCHEDULE OF REVENUE BY GEOGRAPHICAL REGION (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>95</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>00000096 - Disclosure - AUGUST 2021 PRIVATE PLACEMENT (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/August2021PrivatePlacementDetailsNarrative</Role>
      <ShortName>AUGUST 2021 PRIVATE PLACEMENT (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://algoholdings.com/role/August2021PrivatePlacementTables</ParentRole>
      <Position>96</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>00000097 - Disclosure - DAMAGED GOODS INCIDENT RECOVERY (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/DamagedGoodsIncidentRecoveryDetailsNarrative</Role>
      <ShortName>DAMAGED GOODS INCIDENT RECOVERY (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://algoholdings.com/role/DamagedGoodsIncidentRecovery</ParentRole>
      <Position>97</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R98.htm</HtmlFileName>
      <LongName>00000098 - Disclosure - SCHEDULE OF CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfOperationsDetails</Role>
      <ShortName>SCHEDULE OF CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>98</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R99.htm</HtmlFileName>
      <LongName>00000099 - Disclosure - SCHEDULE OF CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfCashFlowsDetails</Role>
      <ShortName>SCHEDULE OF CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>99</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R100.htm</HtmlFileName>
      <LongName>00000100 - Disclosure - SCHEDULE OF CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS? EQUITY (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfShareholdersEquityDetails</Role>
      <ShortName>SCHEDULE OF CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS? EQUITY (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>100</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R101.htm</HtmlFileName>
      <LongName>00000101 - Disclosure - SCHEDULE OF ESTIMATED USEFUL LIVES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/ScheduleOfEstimatedUsefulLivesDetails</Role>
      <ShortName>SCHEDULE OF ESTIMATED USEFUL LIVES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>101</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R102.htm</HtmlFileName>
      <LongName>00000102 - Disclosure - ACCOUNTS RECEIVABLE (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/AccountsReceivableDetailsNarrative</Role>
      <ShortName>ACCOUNTS RECEIVABLE (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://algoholdings.com/role/AccountsReceivable</ParentRole>
      <Position>102</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R103.htm</HtmlFileName>
      <LongName>00000103 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/AccountsPayableAndAccruedExpensesDetailsNarrative</Role>
      <ShortName>ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://algoholdings.com/role/AccountsPayableAndAccruedExpenses</ParentRole>
      <Position>103</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R104.htm</HtmlFileName>
      <LongName>00000104 - Disclosure - SCHEDULE OF SPECIFIC TERMS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/ScheduleOfSpecificTermsDetails</Role>
      <ShortName>SCHEDULE OF SPECIFIC TERMS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>104</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R105.htm</HtmlFileName>
      <LongName>00000105 - Disclosure - NOTES PAYABLE AND FINANING ARRANGEMENTS (Details Narrative)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://algoholdings.com/role/NotesPayableAndFinaningArrangementsDetailsNarrative</Role>
      <ShortName>NOTES PAYABLE AND FINANING ARRANGEMENTS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://algoholdings.com/role/NotesPayableAndFinaningArrangementsTables</ParentRole>
      <Position>105</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R106.htm</HtmlFileName>
      <LongName>00000106 - Disclosure - DUE FROM FACTOR (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/DueFromFactorDetailsNarrative</Role>
      <ShortName>DUE FROM FACTOR (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://algoholdings.com/role/DueFromFactor</ParentRole>
      <Position>106</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R107.htm</HtmlFileName>
      <LongName>00000107 - Disclosure - SCHEDULE OF STOCK OPTION ISSUED DURING THE YEAR DECEMBER 31, 2020, 2021 AND 2022 (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/ScheduleOfStockOptionIssuedDuringYearDecember3120202021And2022Details</Role>
      <ShortName>SCHEDULE OF STOCK OPTION ISSUED DURING THE YEAR DECEMBER 31, 2020, 2021 AND 2022 (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>107</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R108.htm</HtmlFileName>
      <LongName>00000108 - Disclosure - STOCKHOLDERS??? EQUITY (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/StockholdersEquityDetailsNarrative</Role>
      <ShortName>STOCKHOLDERS??? EQUITY (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://algoholdings.com/role/StockholdersEquityTables</ParentRole>
      <Position>108</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R109.htm</HtmlFileName>
      <LongName>00000109 - Disclosure - SCHEDULE OF FIRST TRANCHE OF SUBSCRIPTIONS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/ScheduleOfFirstTrancheOfSubscriptionsDetails</Role>
      <ShortName>SCHEDULE OF FIRST TRANCHE OF SUBSCRIPTIONS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>109</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R110.htm</HtmlFileName>
      <LongName>00000110 - Disclosure - SUMMARY OF TERMINATED IMMEDIATELY AFTER CLOSING OF THE TRANSACTION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/SummaryOfTerminatedImmediatelyAfterClosingOfTransactionDetails</Role>
      <ShortName>SUMMARY OF TERMINATED IMMEDIATELY AFTER CLOSING OF THE TRANSACTION (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>110</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R111.htm</HtmlFileName>
      <LongName>00000111 - Disclosure - SAFE PRIVATE PLACEMENTS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://algoholdings.com/role/SafePrivatePlacementsDetailsNarrative</Role>
      <ShortName>SAFE PRIVATE PLACEMENTS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://algoholdings.com/role/SafePrivatePlacementsTables</ParentRole>
      <Position>111</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="S-1/A" isDefinitelyFs="true" isUsgaap="true" original="forms-1a.htm">forms-1a.htm</File>
    <File>rime-20240930.xsd</File>
    <File>rime-20240930_cal.xml</File>
    <File>rime-20240930_def.xml</File>
    <File>rime-20240930_lab.xml</File>
    <File>rime-20240930_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>forms-1_001.jpg</File>
    <File>forms-1_003.jpg</File>
    <File>forms-1a_001.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://fasb.org/srt/2024</BaseTaxonomy>
    <BaseTaxonomy items="2145">http://fasb.org/us-gaap/2024</BaseTaxonomy>
    <BaseTaxonomy items="25">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>258
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "forms-1a.htm": {
   "nsprefix": "RIME",
   "nsuri": "http://algoholdings.com/20240930",
   "dts": {
    "inline": {
     "local": [
      "forms-1a.htm"
     ]
    },
    "schema": {
     "local": [
      "rime-20240930.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "rime-20240930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "rime-20240930_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "rime-20240930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "rime-20240930_pre.xml"
     ]
    }
   },
   "keyStandard": 388,
   "keyCustom": 105,
   "axisStandard": 37,
   "axisCustom": 0,
   "memberStandard": 44,
   "memberCustom": 172,
   "hidden": {
    "total": 308,
    "http://fasb.org/us-gaap/2024": 254,
    "http://algoholdings.com/20240930": 51,
    "http://xbrl.sec.gov/dei/2024": 3
   },
   "contextCount": 659,
   "entityCount": 1,
   "segmentCount": 229,
   "elementCount": 916,
   "unitCount": 5,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2024": 2145,
    "http://xbrl.sec.gov/dei/2024": 25,
    "http://fasb.org/srt/2024": 2
   },
   "report": {
    "R1": {
     "role": "http://algoholdings.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "dei:AmendmentDescription",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "dei:AmendmentDescription",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://algoholdings.com/role/BalanceSheets",
     "longName": "00000002 - Statement - Condensed Consolidated Balance Sheets",
     "shortName": "Condensed Consolidated Balance Sheets",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "AsOf2024-09-30",
      "name": "us-gaap:Cash",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-09-30",
      "name": "us-gaap:Cash",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://algoholdings.com/role/BalanceSheetsParenthetical",
     "longName": "00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)",
     "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "AsOf2024-09-30",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-09-30",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R4": {
     "role": "http://algoholdings.com/role/StatementsOfOperations",
     "longName": "00000004 - Statement - Condensed Consolidated Statements of Operations",
     "shortName": "Condensed Consolidated Statements of Operations",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "From2024-07-012024-09-30",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-012024-09-30",
      "name": "us-gaap:SellingExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R5": {
     "role": "http://algoholdings.com/role/StatementsOfShareholdersDeficitEquity",
     "longName": "00000005 - Statement - Condensed Consolidated Statements of Shareholders' (Deficit) Equity",
     "shortName": "Condensed Consolidated Statements of Shareholders' (Deficit) Equity",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "AsOf2021-03-31_us-gaap_CommonStockMember",
      "name": "us-gaap:SharesOutstanding",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2021-04-012022-03-31_us-gaap_AdditionalPaidInCapitalMember",
      "name": "us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R6": {
     "role": "http://algoholdings.com/role/StatementsOfCashFlows",
     "longName": "00000006 - Statement - Condensed Consolidated Statements of Cash Flows",
     "shortName": "Condensed Consolidated Statements of Cash Flows",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:ProfitLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:DeferredIncomeTaxExpenseBenefit",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R7": {
     "role": "http://algoholdings.com/role/NatureOfBusiness",
     "longName": "00000007 - Disclosure - NATURE OF BUSINESS",
     "shortName": "NATURE OF BUSINESS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "7",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:NatureOfOperations",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:NatureOfOperations",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R8": {
     "role": "http://algoholdings.com/role/RecentDevelopments",
     "longName": "00000008 - Disclosure - RECENT DEVELOPMENTS",
     "shortName": "RECENT DEVELOPMENTS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "RIME:RecentDevelopmentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "RIME:RecentDevelopmentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://algoholdings.com/role/LiquidityGoingConcernAndManagementPlans",
     "longName": "00000009 - Disclosure - LIQUIDITY, GOING CONCERN AND MANAGEMENT PLANS",
     "shortName": "LIQUIDITY, GOING CONCERN AND MANAGEMENT PLANS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://algoholdings.com/role/SummaryOfSignificantAccountingPolicies",
     "longName": "00000010 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://algoholdings.com/role/AssetAcquisition",
     "longName": "00000011 - Disclosure - ASSET ACQUISITION",
     "shortName": "ASSET ACQUISITION",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:AssetAcquisitionTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:AssetAcquisitionTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://algoholdings.com/role/Financing",
     "longName": "00000012 - Disclosure - FINANCING",
     "shortName": "FINANCING",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://algoholdings.com/role/LoansPayableRelatedParties",
     "longName": "00000013 - Disclosure - LOANS PAYABLE \u2013 RELATED PARTIES",
     "shortName": "LOANS PAYABLE \u2013 RELATED PARTIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:LongTermDebtTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:LongTermDebtTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://algoholdings.com/role/CommitmentsAndContingencies",
     "longName": "00000014 - Disclosure - COMMITMENTS AND CONTINGENCIES",
     "shortName": "COMMITMENTS AND CONTINGENCIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://algoholdings.com/role/OperatingLeases",
     "longName": "00000015 - Disclosure - OPERATING LEASES",
     "shortName": "OPERATING LEASES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://algoholdings.com/role/IssuanceOfCommonStock",
     "longName": "00000016 - Disclosure - ISSUANCE OF COMMON STOCK",
     "shortName": "ISSUANCE OF COMMON STOCK",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R17": {
     "role": "http://algoholdings.com/role/Warrants",
     "longName": "00000017 - Disclosure - WARRANTS",
     "shortName": "WARRANTS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "RIME:WarrantsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "RIME:WarrantsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://algoholdings.com/role/ComputationOfLossPerShare",
     "longName": "00000018 - Disclosure - COMPUTATION OF LOSS PER SHARE",
     "shortName": "COMPUTATION OF LOSS PER SHARE",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://algoholdings.com/role/IncomeTaxes",
     "longName": "00000019 - Disclosure - INCOME TAXES",
     "shortName": "INCOME TAXES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://algoholdings.com/role/RevenueDisaggregation",
     "longName": "00000020 - Disclosure - REVENUE DISAGGREGATION",
     "shortName": "REVENUE DISAGGREGATION",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://algoholdings.com/role/ConcentrationsOfCreditRiskAndRevenue",
     "longName": "00000021 - Disclosure - CONCENTRATIONS OF CREDIT RISK AND REVENUE",
     "shortName": "CONCENTRATIONS OF CREDIT RISK AND REVENUE",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:ConcentrationRiskDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:ConcentrationRiskDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://algoholdings.com/role/RelatedPartyTransactions",
     "longName": "00000022 - Disclosure - RELATED PARTY TRANSACTIONS",
     "shortName": "RELATED PARTY TRANSACTIONS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://algoholdings.com/role/SubsequentEvents",
     "longName": "00000023 - Disclosure - SUBSEQUENT EVENTS",
     "shortName": "SUBSEQUENT EVENTS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://algoholdings.com/role/PropertyAndEquipment",
     "longName": "00000024 - Disclosure - PROPERTY AND EQUIPMENT",
     "shortName": "PROPERTY AND EQUIPMENT",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "From2023-04-012023-12-31",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-04-012023-12-31",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://algoholdings.com/role/StockCompensationExpense",
     "longName": "00000025 - Disclosure - STOCK COMPENSATION EXPENSE",
     "shortName": "STOCK COMPENSATION EXPENSE",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "25",
     "firstAnchor": {
      "contextRef": "From2023-04-012023-12-31",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-04-012023-12-31",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://algoholdings.com/role/PublicOfferingAndNasdaqUplisting",
     "longName": "00000026 - Disclosure - PUBLIC OFFERING AND NASDAQ UPLISTING",
     "shortName": "PUBLIC OFFERING AND NASDAQ UPLISTING",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "26",
     "firstAnchor": {
      "contextRef": "From2023-04-012023-12-31",
      "name": "RIME:IssuanceOfPublicOfferingTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-04-012023-12-31",
      "name": "RIME:IssuanceOfPublicOfferingTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://algoholdings.com/role/AtmOffering",
     "longName": "00000027 - Disclosure - ATM OFFERING",
     "shortName": "ATM OFFERING",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "27",
     "firstAnchor": {
      "contextRef": "From2023-04-012023-12-31",
      "name": "RIME:AtTheMarketPublicOfferingTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-04-012023-12-31",
      "name": "RIME:AtTheMarketPublicOfferingTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://algoholdings.com/role/PrivatePlacement",
     "longName": "00000028 - Disclosure - PRIVATE PLACEMENT",
     "shortName": "PRIVATE PLACEMENT",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "28",
     "firstAnchor": {
      "contextRef": "From2023-04-012023-12-31",
      "name": "RIME:PrivatePlacementTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-04-012023-12-31",
      "name": "RIME:PrivatePlacementTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://algoholdings.com/role/August2021StockRedemption",
     "longName": "00000029 - Disclosure - AUGUST 2021 STOCK REDEMPTION",
     "shortName": "AUGUST 2021 STOCK REDEMPTION",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "29",
     "firstAnchor": {
      "contextRef": "From2023-04-012023-12-31",
      "name": "RIME:StockRedemptionTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-04-012023-12-31",
      "name": "RIME:StockRedemptionTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://algoholdings.com/role/August2021PrivatePlacement",
     "longName": "00000030 - Disclosure - AUGUST 2021 PRIVATE PLACEMENT",
     "shortName": "AUGUST 2021 PRIVATE PLACEMENT",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "30",
     "firstAnchor": {
      "contextRef": "From2023-04-012023-12-31",
      "name": "RIME:AugustTwentyTwentyOnePrivatePlacementTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-04-012023-12-31",
      "name": "RIME:AugustTwentyTwentyOnePrivatePlacementTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://algoholdings.com/role/DamagedGoodsIncidentRecovery",
     "longName": "00000031 - Disclosure - DAMAGED GOODS INCIDENT RECOVERY",
     "shortName": "DAMAGED GOODS INCIDENT RECOVERY",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "31",
     "firstAnchor": {
      "contextRef": "From2023-04-012023-12-31",
      "name": "us-gaap:InsuranceDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-04-012023-12-31",
      "name": "us-gaap:InsuranceDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://algoholdings.com/role/SupplementalInformationCondensedFinancialInformation",
     "longName": "00000032 - Disclosure - SUPPLEMENTAL INFORMATION CONDENSED FINANCIAL INFORMATION",
     "shortName": "SUPPLEMENTAL INFORMATION CONDENSED FINANCIAL INFORMATION",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "32",
     "firstAnchor": {
      "contextRef": "From2023-04-012023-12-31",
      "name": "RIME:SupplementalInformationDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-04-012023-12-31",
      "name": "RIME:SupplementalInformationDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://algoholdings.com/role/AccountsReceivable",
     "longName": "00000033 - Disclosure - ACCOUNTS RECEIVABLE",
     "shortName": "ACCOUNTS RECEIVABLE",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "33",
     "firstAnchor": {
      "contextRef": "From2023-01-012023-12-31_custom_SemiCabIncMember",
      "name": "us-gaap:AccountsAndNontradeReceivableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-012023-12-31_custom_SemiCabIncMember",
      "name": "us-gaap:AccountsAndNontradeReceivableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://algoholdings.com/role/AccountsPayableAndAccruedExpenses",
     "longName": "00000034 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES",
     "shortName": "ACCOUNTS PAYABLE AND ACCRUED EXPENSES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "34",
     "firstAnchor": {
      "contextRef": "From2023-01-012023-12-31_custom_SemiCabIncMember",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-012023-12-31_custom_SemiCabIncMember",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://algoholdings.com/role/NotesPayableAndFinaningArrangements",
     "longName": "00000035 - Disclosure - NOTES PAYABLE AND FINANING ARRANGEMENTS",
     "shortName": "NOTES PAYABLE AND FINANING ARRANGEMENTS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "35",
     "firstAnchor": {
      "contextRef": "From2023-01-012023-12-31_custom_SemiCabIncMember",
      "name": "RIME:NotePayableAndFinancingArrangementsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-012023-12-31_custom_SemiCabIncMember",
      "name": "RIME:NotePayableAndFinancingArrangementsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://algoholdings.com/role/DueFromFactor",
     "longName": "00000036 - Disclosure - DUE FROM FACTOR",
     "shortName": "DUE FROM FACTOR",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "36",
     "firstAnchor": {
      "contextRef": "From2023-01-012023-12-31_custom_SemiCabIncMember",
      "name": "RIME:AccountsReceivableDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-012023-12-31_custom_SemiCabIncMember",
      "name": "RIME:AccountsReceivableDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://algoholdings.com/role/StockholdersEquity",
     "longName": "00000037 - Disclosure - STOCKHOLDERS\u2019 EQUITY",
     "shortName": "STOCKHOLDERS\u2019 EQUITY",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "37",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-012023-12-31_custom_SemiCabIncMember",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R38": {
     "role": "http://algoholdings.com/role/SafePrivatePlacements",
     "longName": "00000038 - Disclosure - SAFE PRIVATE PLACEMENTS",
     "shortName": "SAFE PRIVATE PLACEMENTS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "38",
     "firstAnchor": {
      "contextRef": "From2023-01-012023-12-31_custom_SemiCabIncMember",
      "name": "RIME:SafePrivatePlacementsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-012023-12-31_custom_SemiCabIncMember",
      "name": "RIME:SafePrivatePlacementsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://algoholdings.com/role/EmployeeBenefitPlans",
     "longName": "00000039 - Disclosure - EMPLOYEE BENEFIT PLANS",
     "shortName": "EMPLOYEE BENEFIT PLANS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "39",
     "firstAnchor": {
      "contextRef": "From2023-01-012023-12-31_custom_SemiCabIncMember",
      "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-012023-12-31_custom_SemiCabIncMember",
      "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://algoholdings.com/role/SummaryOfSignificantAccountingPoliciesPolicies",
     "longName": "00000040 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "40",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://algoholdings.com/role/AssetAcquisitionTables",
     "longName": "00000041 - Disclosure - ASSET ACQUISITION (Tables)",
     "shortName": "ASSET ACQUISITION (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "41",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:AssetAcquisitionTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:AssetAcquisitionTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://algoholdings.com/role/LoansPayableRelatedPartiesTables",
     "longName": "00000042 - Disclosure - LOANS PAYABLE \u2013 RELATED PARTIES (Tables)",
     "shortName": "LOANS PAYABLE \u2013 RELATED PARTIES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "42",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://algoholdings.com/role/OperatingLeasesTables",
     "longName": "00000043 - Disclosure - OPERATING LEASES (Tables)",
     "shortName": "OPERATING LEASES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "43",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "RIME:ScheduleOfSupplementalInformationRelatedToLeaseTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "RIME:ScheduleOfSupplementalInformationRelatedToLeaseTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R44": {
     "role": "http://algoholdings.com/role/WarrantsTables",
     "longName": "00000044 - Disclosure - WARRANTS (Tables)",
     "shortName": "WARRANTS (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "44",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "RIME:WarrantsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R45": {
     "role": "http://algoholdings.com/role/ComputationOfLossPerShareTables",
     "longName": "00000045 - Disclosure - COMPUTATION OF LOSS PER SHARE (Tables)",
     "shortName": "COMPUTATION OF LOSS PER SHARE (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "45",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://algoholdings.com/role/RevenueDisaggregationTables",
     "longName": "00000046 - Disclosure - REVENUE DISAGGREGATION (Tables)",
     "shortName": "REVENUE DISAGGREGATION (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "46",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://algoholdings.com/role/PropertyAndEquipmentTables",
     "longName": "00000047 - Disclosure - PROPERTY AND EQUIPMENT (Tables)",
     "shortName": "PROPERTY AND EQUIPMENT (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "47",
     "firstAnchor": {
      "contextRef": "From2023-04-012023-12-31",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-04-012023-12-31",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R48": {
     "role": "http://algoholdings.com/role/StockCompensationExpenseTables",
     "longName": "00000048 - Disclosure - STOCK COMPENSATION EXPENSE (Tables)",
     "shortName": "STOCK COMPENSATION EXPENSE (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "48",
     "firstAnchor": {
      "contextRef": "From2023-04-012023-12-31",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-04-012023-12-31",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R49": {
     "role": "http://algoholdings.com/role/August2021PrivatePlacementTables",
     "longName": "00000049 - Disclosure - AUGUST 2021 PRIVATE PLACEMENT (Tables)",
     "shortName": "AUGUST 2021 PRIVATE PLACEMENT (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "49",
     "firstAnchor": {
      "contextRef": "From2023-04-012023-12-31",
      "name": "RIME:ScheduleOfLossBeforeIncomeTaxTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-04-012023-12-31",
      "name": "RIME:ScheduleOfLossBeforeIncomeTaxTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R50": {
     "role": "http://algoholdings.com/role/SupplementalInformationCondensedFinancialInformationTables",
     "longName": "00000050 - Disclosure - SUPPLEMENTAL INFORMATION CONDENSED FINANCIAL INFORMATION (Tables)",
     "shortName": "SUPPLEMENTAL INFORMATION CONDENSED FINANCIAL INFORMATION (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "50",
     "firstAnchor": {
      "contextRef": "From2023-04-012023-12-31",
      "name": "srt:ScheduleOfCondensedIncomeStatementTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "RIME:SupplementalInformationDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-04-012023-12-31",
      "name": "srt:ScheduleOfCondensedIncomeStatementTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "RIME:SupplementalInformationDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R51": {
     "role": "http://algoholdings.com/role/NotesPayableAndFinaningArrangementsTables",
     "longName": "00000051 - Disclosure - NOTES PAYABLE AND FINANING ARRANGEMENTS (Tables)",
     "shortName": "NOTES PAYABLE AND FINANING ARRANGEMENTS (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "51",
     "firstAnchor": {
      "contextRef": "From2023-01-012023-12-31_custom_SemiCabIncMember",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "RIME:NotePayableAndFinancingArrangementsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-012023-12-31_custom_SemiCabIncMember",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "RIME:NotePayableAndFinancingArrangementsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R52": {
     "role": "http://algoholdings.com/role/StockholdersEquityTables",
     "longName": "00000052 - Disclosure - STOCKHOLDERS\u2019 EQUITY (Tables)",
     "shortName": "STOCKHOLDERS\u2019 EQUITY (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "52",
     "firstAnchor": {
      "contextRef": "From2023-01-012023-12-31_custom_SemiCabIncMember",
      "name": "RIME:ScheduleOfStockOptionIssuedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-012023-12-31_custom_SemiCabIncMember",
      "name": "RIME:ScheduleOfStockOptionIssuedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R53": {
     "role": "http://algoholdings.com/role/SafePrivatePlacementsTables",
     "longName": "00000053 - Disclosure - SAFE PRIVATE PLACEMENTS (Tables)",
     "shortName": "SAFE PRIVATE PLACEMENTS (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "53",
     "firstAnchor": {
      "contextRef": "From2023-01-012023-12-31_custom_SemiCabIncMember",
      "name": "RIME:SafePrivatePlacementsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "RIME:SafePrivatePlacementsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-012023-12-31_custom_SemiCabIncMember",
      "name": "RIME:SafePrivatePlacementsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "RIME:SafePrivatePlacementsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R54": {
     "role": "http://algoholdings.com/role/RecentDevelopmentsDetailsNarrative",
     "longName": "00000054 - Disclosure - RECENT DEVELOPMENTS (Details Narrative)",
     "shortName": "RECENT DEVELOPMENTS (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "From2023-01-012023-09-30",
      "name": "us-gaap:LegalFees",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:AssetAcquisitionTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-04-012024-06-30",
      "name": "RIME:AssetsWriteOff",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "RIME:RecentDevelopmentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R55": {
     "role": "http://algoholdings.com/role/LiquidityGoingConcernAndManagementPlansDetailsNarrative",
     "longName": "00000055 - Disclosure - LIQUIDITY, GOING CONCERN AND MANAGEMENT PLANS (Details Narrative)",
     "shortName": "LIQUIDITY, GOING CONCERN AND MANAGEMENT PLANS (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "AsOf2024-09-30",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-09-30",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R56": {
     "role": "http://algoholdings.com/role/ScheduleOfConsiderationTransferredToAssetsAcquiredAndLiabilitiesAssumedDetails",
     "longName": "00000056 - Disclosure - SCHEDULE OF CONSIDERATION TRANSFERRED TO THE ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details)",
     "shortName": "SCHEDULE OF CONSIDERATION TRANSFERRED TO THE ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "AsOf2024-09-30",
      "name": "us-gaap:Goodwill",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-07-03_custom_SemiCabIncMember249477843",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
       "us-gaap:AssetAcquisitionTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R57": {
     "role": "http://algoholdings.com/role/ScheduleOfConsiderationTransferredToAssetsAcquiredAndLiabilitiesAssumedDetailsParenthetical",
     "longName": "00000057 - Disclosure - SCHEDULE OF CONSIDERATION TRANSFERRED TO THE ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details) (Parenthetical)",
     "shortName": "SCHEDULE OF CONSIDERATION TRANSFERRED TO THE ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details) (Parenthetical)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "parenthetical",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "AsOf2024-07-03_us-gaap_CustomerRelationshipsMember",
      "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
       "us-gaap:AssetAcquisitionTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-07-03_us-gaap_CustomerRelationshipsMember",
      "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
       "us-gaap:AssetAcquisitionTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R58": {
     "role": "http://algoholdings.com/role/ScheduleOfProFormaFinancialInformationDetails",
     "longName": "00000058 - Disclosure - SCHEDULE OF PRO FORMA FINANCIAL INFORMATION (Details)",
     "shortName": "SCHEDULE OF PRO FORMA FINANCIAL INFORMATION (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "RIME:ScheduleOfProFormaFinancialInformationTableTextBlock",
       "us-gaap:AssetAcquisitionTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "RIME:ScheduleOfProFormaFinancialInformationTableTextBlock",
       "us-gaap:AssetAcquisitionTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R59": {
     "role": "http://algoholdings.com/role/AssetAcquisitionDetailsNarrative",
     "longName": "00000059 - Disclosure - ASSET ACQUISITION (Details Narrative)",
     "shortName": "ASSET ACQUISITION (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "AsOf2024-07-03",
      "name": "us-gaap:IntangibleAssetsNetIncludingGoodwill",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:AssetAcquisitionTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-07-03",
      "name": "us-gaap:IntangibleAssetsNetIncludingGoodwill",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:AssetAcquisitionTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R60": {
     "role": "http://algoholdings.com/role/FinancingDetailsNarrative",
     "longName": "00000060 - Disclosure - FINANCING (Details Narrative)",
     "shortName": "FINANCING (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "From2023-05-182023-05-18",
      "name": "us-gaap:DebtInstrumentTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-04-012023-12-31",
      "name": "us-gaap:InterestAndDebtExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R61": {
     "role": "http://algoholdings.com/role/ScheduleOfLoanDetails",
     "longName": "00000061 - Disclosure - SCHEDULE OF LOAN (Details)",
     "shortName": "SCHEDULE OF LOAN (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "AsOf2023-05-18",
      "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-012024-09-30_custom_AjeshKapoorOneMember",
      "name": "us-gaap:DebtInstrumentIssuanceDate1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R62": {
     "role": "http://algoholdings.com/role/LoansPayableRelatedPartiesDetailsNarrative",
     "longName": "00000062 - Disclosure - LOANS PAYABLE \u2013 RELATED PARTIES (Details Narrative)",
     "shortName": "LOANS PAYABLE \u2013 RELATED PARTIES (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "AsOf2024-09-30",
      "name": "us-gaap:InterestPayableCurrentAndNoncurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-012024-09-30_us-gaap_RelatedPartyMember",
      "name": "us-gaap:InterestExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "span",
       "p",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R63": {
     "role": "http://algoholdings.com/role/CommitmentsAndContingenciesDetailsNarrative",
     "longName": "00000063 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)",
     "shortName": "COMMITMENTS AND CONTINGENCIES (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "AsOf2023-05-18",
      "name": "RIME:WorkingCapital",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-21_us-gaap_DirectorsAndOfficersLiabilityInsuranceMember",
      "name": "RIME:InsuranceLiabilities",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R64": {
     "role": "http://algoholdings.com/role/ScheduleOfSupplementalInformationRelatedToLeasesDetails",
     "longName": "00000064 - Disclosure - SCHEDULE OF SUPPLEMENTAL INFORMATION RELATED TO LEASES (Details)",
     "shortName": "SCHEDULE OF SUPPLEMENTAL INFORMATION RELATED TO LEASES (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "AsOf2024-09-30",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R65": {
     "role": "http://algoholdings.com/role/ScheduleOfLeaseTermAndDiscountRateDetails",
     "longName": "00000065 - Disclosure - SCHEDULE OF LEASE TERM AND DISCOUNT RATE (Details)",
     "shortName": "SCHEDULE OF LEASE TERM AND DISCOUNT RATE (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "From2024-07-012024-09-30",
      "name": "us-gaap:OperatingLeaseExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R66": {
     "role": "http://algoholdings.com/role/ScheduleOfOperatingLeaseMinimumFuturePaymentsDetails",
     "longName": "00000066 - Disclosure - SCHEDULE OF OPERATING LEASE MINIMUM FUTURE PAYMENTS (Details)",
     "shortName": "SCHEDULE OF OPERATING LEASE MINIMUM FUTURE PAYMENTS (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "AsOf2024-09-30",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-09-30",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R67": {
     "role": "http://algoholdings.com/role/OperatingLeasesDetailsNarrative",
     "longName": "00000067 - Disclosure - OPERATING LEASES (Details Narrative)",
     "shortName": "OPERATING LEASES (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "From2024-07-012024-09-30",
      "name": "us-gaap:OperatingLeasePayments",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-08-23_custom_OperatingLeaseAgreementMember",
      "name": "us-gaap:AreaOfLand",
      "unitRef": "sqft",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R68": {
     "role": "http://algoholdings.com/role/IssuanceOfCommonStockDetailsNarrative",
     "longName": "00000068 - Disclosure - ISSUANCE OF COMMON STOCK (Details Narrative)",
     "shortName": "ISSUANCE OF COMMON STOCK (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:StockIssuedDuringPeriodSharesIssuedForServices",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R69": {
     "role": "http://algoholdings.com/role/ScheduleOfWarrantsExpirationDetails",
     "longName": "00000069 - Disclosure - SCHEDULE OF WARRANTS EXPIRATION (Details)",
     "shortName": "SCHEDULE OF WARRANTS EXPIRATION (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "69",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-09-30_custom_ExercisePriceRangeOneMember",
      "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "RIME:WarrantsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R70": {
     "role": "http://algoholdings.com/role/WarrantsDetailsNarrative",
     "longName": "00000070 - Disclosure - WARRANTS (Details Narrative)",
     "shortName": "WARRANTS (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "70",
     "firstAnchor": {
      "contextRef": "AsOf2024-09-30",
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "RIME:WarrantsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R71": {
     "role": "http://algoholdings.com/role/ScheduleOfBasicAndDilutiveLossPerShareDetails",
     "longName": "00000071 - Disclosure - SCHEDULE OF BASIC AND DILUTIVE LOSS PER SHARE (Details)",
     "shortName": "SCHEDULE OF BASIC AND DILUTIVE LOSS PER SHARE (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "71",
     "firstAnchor": {
      "contextRef": "From2024-07-012024-09-30",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-012024-09-30",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R72": {
     "role": "http://algoholdings.com/role/ComputationOfLossPerShareDetailsNarrative",
     "longName": "00000072 - Disclosure - COMPUTATION OF LOSS PER SHARE (Details Narrative)",
     "shortName": "COMPUTATION OF LOSS PER SHARE (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "72",
     "firstAnchor": {
      "contextRef": "From2024-07-012024-09-30_us-gaap_EmployeeStockOptionMember",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "span",
       "p",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-012024-09-30_us-gaap_EmployeeStockOptionMember",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "span",
       "p",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R73": {
     "role": "http://algoholdings.com/role/IncomeTaxesDetailsNarrative",
     "longName": "00000073 - Disclosure - INCOME TAXES (Details Narrative)",
     "shortName": "INCOME TAXES (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "73",
     "firstAnchor": {
      "contextRef": "From2023-01-012023-09-30",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-31_us-gaap_InternalRevenueServiceIRSMember",
      "name": "us-gaap:OperatingLossCarryforwards",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R74": {
     "role": "http://algoholdings.com/role/ScheduleOfRevenueByProductLineDetails",
     "longName": "00000074 - Disclosure - SCHEDULE OF REVENUE BY PRODUCT LINE (Details)",
     "shortName": "SCHEDULE OF REVENUE BY PRODUCT LINE (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "74",
     "firstAnchor": {
      "contextRef": "From2024-07-012024-09-30",
      "name": "us-gaap:Revenues",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-012024-09-30_custom_ClassicKaraokeMachinesMember",
      "name": "us-gaap:Revenues",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R75": {
     "role": "http://algoholdings.com/role/ScheduleOfSalesByGeographicalRegionDetails",
     "longName": "00000075 - Disclosure - SCHEDULE OF SALES BY GEOGRAPHICAL REGION (Details)",
     "shortName": "SCHEDULE OF SALES BY GEOGRAPHICAL REGION (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "75",
     "firstAnchor": {
      "contextRef": "From2024-07-012024-09-30",
      "name": "us-gaap:Revenues",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-012024-09-30_srt_EuropeMember",
      "name": "us-gaap:Revenues",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R76": {
     "role": "http://algoholdings.com/role/RevenueDisaggregationDetailsNarrative",
     "longName": "00000076 - Disclosure - REVENUE DISAGGREGATION (Details Narrative)",
     "shortName": "REVENUE DISAGGREGATION (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "76",
     "firstAnchor": {
      "contextRef": "From2024-07-012024-09-30",
      "name": "us-gaap:AdvertisingExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "RIME:EstimatedReserveOfAdvertisingExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R77": {
     "role": "http://algoholdings.com/role/ConcentrationsOfCreditRiskAndRevenueDetailsNarrative",
     "longName": "00000077 - Disclosure - CONCENTRATIONS OF CREDIT RISK AND REVENUE (Details Narrative)",
     "shortName": "CONCENTRATIONS OF CREDIT RISK AND REVENUE (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "77",
     "firstAnchor": {
      "contextRef": "From2023-04-012023-12-31_custom_RepublicOfChinaMember",
      "name": "us-gaap:DebtInstrumentDescription",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:ConcentrationRiskDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-04-012023-12-31_custom_RepublicOfChinaMember",
      "name": "us-gaap:DebtInstrumentDescription",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:ConcentrationRiskDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R78": {
     "role": "http://algoholdings.com/role/RelatedPartyTransactionsDetailsNarrative",
     "longName": "00000078 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)",
     "shortName": "RELATED PARTY TRANSACTIONS (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "78",
     "firstAnchor": {
      "contextRef": "From2024-07-012024-09-30",
      "name": "us-gaap:Revenues",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-012024-09-30_us-gaap_RelatedPartyMember",
      "name": "us-gaap:Revenues",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R79": {
     "role": "http://algoholdings.com/role/SubsequentEventsDetailsNarrative",
     "longName": "00000079 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)",
     "shortName": "SUBSEQUENT EVENTS (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "79",
     "firstAnchor": {
      "contextRef": "AsOf2021-07-06",
      "name": "us-gaap:SharePrice",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "RIME:AugustTwentyTwentyOnePrivatePlacementTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-04-012023-12-31",
      "name": "us-gaap:IncomeTaxExaminationLikelihoodOfUnfavorableSettlement",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IncomeTaxPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R80": {
     "role": "http://algoholdings.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
     "longName": "00000080 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "80",
     "firstAnchor": {
      "contextRef": "From2024-07-012024-09-30",
      "name": "us-gaap:AdvertisingExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-03-31",
      "name": "RIME:ReserveForSalesReturn",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R81": {
     "role": "http://algoholdings.com/role/ScheduleOfPropertyAndEquipmentDetails",
     "longName": "00000081 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT (Details)",
     "shortName": "SCHEDULE OF PROPERTY AND EQUIPMENT (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "81",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R82": {
     "role": "http://algoholdings.com/role/PropertyAndEquipmentDetailsNarrative",
     "longName": "00000082 - Disclosure - PROPERTY AND EQUIPMENT (Details Narrative)",
     "shortName": "PROPERTY AND EQUIPMENT (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "82",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:Depreciation",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-012023-12-31_custom_SemiCabIncMember",
      "name": "us-gaap:Depreciation",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R83": {
     "role": "http://algoholdings.com/role/SummaryOfStockOptionActivityDetails",
     "longName": "00000083 - Disclosure - SUMMARY OF STOCK OPTION ACTIVITY (Details)",
     "shortName": "SUMMARY OF STOCK OPTION ACTIVITY (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "83",
     "firstAnchor": {
      "contextRef": "AsOf2023-03-31_us-gaap_StockOptionMember",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-04-012023-12-31_us-gaap_StockOptionMember",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R84": {
     "role": "http://algoholdings.com/role/ScheduleOfEmployeeStockOptionsOutstandingDetailsParenthetical",
     "longName": "00000084 - Disclosure - SCHEDULE OF EMPLOYEE STOCK OPTIONS OUTSTANDING (Details) (Parenthetical)",
     "shortName": "SCHEDULE OF EMPLOYEE STOCK OPTIONS OUTSTANDING (Details) (Parenthetical)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "parenthetical",
     "menuCat": "Details",
     "order": "84",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31_custom_SixCurrentAndThreeFormerDirectorsMember",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "link:footnote",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-31_custom_SixCurrentAndThreeFormerDirectorsMember",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "link:footnote",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R85": {
     "role": "http://algoholdings.com/role/ScheduleOfBasicAndDilutiveSharesDetails",
     "longName": "00000085 - Disclosure - SCHEDULE OF BASIC AND DILUTIVE SHARES (Details)",
     "shortName": "SCHEDULE OF BASIC AND DILUTIVE SHARES (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "85",
     "firstAnchor": {
      "contextRef": "From2024-07-012024-09-30",
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2021-04-012022-03-31",
      "name": "us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R86": {
     "role": "http://algoholdings.com/role/StockCompensationExpenseDetailsNarrative",
     "longName": "00000086 - Disclosure - STOCK COMPENSATION EXPENSE (Details Narrative)",
     "shortName": "STOCK COMPENSATION EXPENSE (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "86",
     "firstAnchor": {
      "contextRef": "From2023-04-012023-12-31",
      "name": "us-gaap:StockOptionPlanExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-04-012023-12-31",
      "name": "us-gaap:StockOptionPlanExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R87": {
     "role": "http://algoholdings.com/role/PublicOfferingAndNasdaqUplistingDetailsNarrative",
     "longName": "00000087 - Disclosure - PUBLIC OFFERING AND NASDAQ UPLISTING (Details Narrative)",
     "shortName": "PUBLIC OFFERING AND NASDAQ UPLISTING (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "87",
     "firstAnchor": {
      "contextRef": "AsOf2024-09-30",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-05-232022-05-23_custom_UnderwritingAgreementMember",
      "name": "us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "RIME:IssuanceOfPublicOfferingTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R88": {
     "role": "http://algoholdings.com/role/AtmOfferingDetailsNarrative",
     "longName": "00000088 - Disclosure - ATM OFFERING (Details Narrative)",
     "shortName": "ATM OFFERING (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "88",
     "firstAnchor": {
      "contextRef": "From2023-02-152023-02-15_custom_ATMOfferingMember",
      "name": "us-gaap:SaleOfStockConsiderationReceivedOnTransaction",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "RIME:RecentDevelopmentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R89": {
     "role": "http://algoholdings.com/role/PrivatePlacementDetailsNarrative",
     "longName": "00000089 - Disclosure - PRIVATE PLACEMENT (Details Narrative)",
     "shortName": "PRIVATE PLACEMENT (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "89",
     "firstAnchor": {
      "contextRef": "From2023-11-202023-11-20_us-gaap_PrivatePlacementMember",
      "name": "us-gaap:SaleOfStockConsiderationReceivedOnTransaction",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "RIME:RecentDevelopmentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R90": {
     "role": "http://algoholdings.com/role/August2021StockRedemptionDetailsNarrative",
     "longName": "00000090 - Disclosure - AUGUST 2021 STOCK REDEMPTION (Details Narrative)",
     "shortName": "AUGUST 2021 STOCK REDEMPTION (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "90",
     "firstAnchor": {
      "contextRef": "From2021-08-012021-08-05_custom_RedemptionAgreementMember_custom_KonceptsandTreasureGreenMember",
      "name": "us-gaap:StockRedeemedOrCalledDuringPeriodShares",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "RIME:StockRedemptionTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2021-08-012021-08-05_custom_RedemptionAgreementMember_custom_KonceptsandTreasureGreenMember",
      "name": "us-gaap:StockRedeemedOrCalledDuringPeriodShares",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "RIME:StockRedemptionTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R91": {
     "role": "http://algoholdings.com/role/ScheduleOfLossBeforeIncomeTaxesDetails",
     "longName": "00000091 - Disclosure - SCHEDULE OF LOSS BEFORE INCOME TAXES (Details)",
     "shortName": "SCHEDULE OF LOSS BEFORE INCOME TAXES (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "91",
     "firstAnchor": {
      "contextRef": "From2023-04-012023-12-31",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "RIME:ScheduleOfLossBeforeIncomeTaxTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-04-012023-12-31",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "RIME:ScheduleOfLossBeforeIncomeTaxTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R92": {
     "role": "http://algoholdings.com/role/ScheduleOfProvisionForIncomeTaxesDetails",
     "longName": "00000092 - Disclosure - SCHEDULE OF PROVISION FOR INCOME TAXES (Details)",
     "shortName": "SCHEDULE OF PROVISION FOR INCOME TAXES (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "92",
     "firstAnchor": {
      "contextRef": "From2022-04-012023-03-31",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-04-012023-03-31",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R93": {
     "role": "http://algoholdings.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails",
     "longName": "00000093 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details)",
     "shortName": "SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "93",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R94": {
     "role": "http://algoholdings.com/role/ScheduleOfTaxProvisionDetails",
     "longName": "00000094 - Disclosure - SCHEDULE OF TAX PROVISION (Details)",
     "shortName": "SCHEDULE OF TAX PROVISION (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "94",
     "firstAnchor": {
      "contextRef": "From2023-04-012023-12-31",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-04-012023-12-31",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R95": {
     "role": "http://algoholdings.com/role/ScheduleOfRevenueByGeographicalRegionDetails",
     "longName": "00000095 - Disclosure - SCHEDULE OF REVENUE BY GEOGRAPHICAL REGION (Details)",
     "shortName": "SCHEDULE OF REVENUE BY GEOGRAPHICAL REGION (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "95",
     "firstAnchor": {
      "contextRef": "From2024-07-012024-09-30",
      "name": "us-gaap:Revenues",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-04-012023-12-31_custom_EuropeAndUnitedKingdomMember",
      "name": "us-gaap:Revenues",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R96": {
     "role": "http://algoholdings.com/role/August2021PrivatePlacementDetailsNarrative",
     "longName": "00000096 - Disclosure - AUGUST 2021 PRIVATE PLACEMENT (Details Narrative)",
     "shortName": "AUGUST 2021 PRIVATE PLACEMENT (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "96",
     "firstAnchor": {
      "contextRef": "AsOf2024-09-30",
      "name": "us-gaap:CommonStockSharesIssued",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2021-07-012021-07-06",
      "name": "us-gaap:DerivativeDescriptionOfTerms",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "RIME:AugustTwentyTwentyOnePrivatePlacementTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R97": {
     "role": "http://algoholdings.com/role/DamagedGoodsIncidentRecoveryDetailsNarrative",
     "longName": "00000097 - Disclosure - DAMAGED GOODS INCIDENT RECOVERY (Details Narrative)",
     "shortName": "DAMAGED GOODS INCIDENT RECOVERY (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "97",
     "firstAnchor": {
      "contextRef": "From2022-04-012023-03-31",
      "name": "RIME:GainFromSettlementOfAccountsPayable",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R98": {
     "role": "http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfOperationsDetails",
     "longName": "00000098 - Disclosure - SCHEDULE OF CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Details)",
     "shortName": "SCHEDULE OF CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "98",
     "firstAnchor": {
      "contextRef": "From2024-07-012024-09-30",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-04-012022-12-31",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "srt:ScheduleOfCondensedIncomeStatementTableTextBlock",
       "RIME:SupplementalInformationDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R99": {
     "role": "http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfCashFlowsDetails",
     "longName": "00000099 - Disclosure - SCHEDULE OF CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Details)",
     "shortName": "SCHEDULE OF CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "99",
     "firstAnchor": {
      "contextRef": "From2024-07-012024-09-30",
      "name": "us-gaap:ProfitLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-04-012023-12-31",
      "name": "us-gaap:AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "srt:ScheduleOfCondensedCashFlowStatementTableTextBlock",
       "RIME:SupplementalInformationDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R100": {
     "role": "http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfShareholdersEquityDetails",
     "longName": "00000100 - Disclosure - SCHEDULE OF CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS? EQUITY (Details)",
     "shortName": "SCHEDULE OF CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS? EQUITY (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "100",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-04-012022-12-31",
      "name": "us-gaap:ShareBasedCompensation",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
       "RIME:SupplementalInformationDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R101": {
     "role": "http://algoholdings.com/role/ScheduleOfEstimatedUsefulLivesDetails",
     "longName": "00000101 - Disclosure - SCHEDULE OF ESTIMATED USEFUL LIVES (Details)",
     "shortName": "SCHEDULE OF ESTIMATED USEFUL LIVES (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "101",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31_srt_MinimumMember_custom_SemiCabIncMember",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-31_srt_MinimumMember_custom_SemiCabIncMember",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R102": {
     "role": "http://algoholdings.com/role/AccountsReceivableDetailsNarrative",
     "longName": "00000102 - Disclosure - ACCOUNTS RECEIVABLE (Details Narrative)",
     "shortName": "ACCOUNTS RECEIVABLE (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "102",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:ProvisionForDoubtfulAccounts",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-012023-12-31_custom_SemiCabIncMember",
      "name": "us-gaap:ProvisionForDoubtfulAccounts",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "span",
       "p",
       "us-gaap:AccountsAndNontradeReceivableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R103": {
     "role": "http://algoholdings.com/role/AccountsPayableAndAccruedExpensesDetailsNarrative",
     "longName": "00000103 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details Narrative)",
     "shortName": "ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "103",
     "firstAnchor": {
      "contextRef": "AsOf2024-09-30",
      "name": "us-gaap:AccountsPayableCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R104": {
     "role": "http://algoholdings.com/role/ScheduleOfSpecificTermsDetails",
     "longName": "00000104 - Disclosure - SCHEDULE OF SPECIFIC TERMS (Details)",
     "shortName": "SCHEDULE OF SPECIFIC TERMS (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "104",
     "firstAnchor": {
      "contextRef": "AsOf2023-05-18",
      "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-172023-05-17_custom_SixShareholderLoanAgreementsMember_custom_AjeshKapoorMember_custom_SemiCabIncMember",
      "name": "us-gaap:DebtInstrumentIssuanceDate1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "RIME:NotePayableAndFinancingArrangementsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R105": {
     "role": "http://algoholdings.com/role/NotesPayableAndFinaningArrangementsDetailsNarrative",
     "longName": "00000105 - Disclosure - NOTES PAYABLE AND FINANING ARRANGEMENTS (Details Narrative)",
     "shortName": "NOTES PAYABLE AND FINANING ARRANGEMENTS (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "105",
     "firstAnchor": {
      "contextRef": "From2023-06-012024-06-30",
      "name": "us-gaap:RepaymentsOfDebt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-182023-05-18_custom_SemiCabIncMember",
      "name": "us-gaap:DebtInstrumentMaturityDateDescription",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "RIME:NotePayableAndFinancingArrangementsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R106": {
     "role": "http://algoholdings.com/role/DueFromFactorDetailsNarrative",
     "longName": "00000106 - Disclosure - DUE FROM FACTOR (Details Narrative)",
     "shortName": "DUE FROM FACTOR (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "106",
     "firstAnchor": {
      "contextRef": "From2023-01-012023-09-30",
      "name": "us-gaap:LegalFees",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:AssetAcquisitionTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-012024-03-31_custom_SemiCabIncMember",
      "name": "RIME:ForeignAndDomesticRateOfAccountsReceivable",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "RIME:AccountsReceivableDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R107": {
     "role": "http://algoholdings.com/role/ScheduleOfStockOptionIssuedDuringYearDecember3120202021And2022Details",
     "longName": "00000107 - Disclosure - SCHEDULE OF STOCK OPTION ISSUED DURING THE YEAR DECEMBER 31, 2020, 2021 AND 2022 (Details)",
     "shortName": "SCHEDULE OF STOCK OPTION ISSUED DURING THE YEAR DECEMBER 31, 2020, 2021 AND 2022 (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "107",
     "firstAnchor": {
      "contextRef": "From2022-01-012022-12-31_us-gaap_StockOptionMember_custom_SemiCabIncMember",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "RIME:ScheduleOfStockOptionIssuedTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-01-012022-12-31_us-gaap_StockOptionMember_custom_SemiCabIncMember",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "RIME:ScheduleOfStockOptionIssuedTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R108": {
     "role": "http://algoholdings.com/role/StockholdersEquityDetailsNarrative",
     "longName": "00000108 - Disclosure - STOCKHOLDERS\u2019 EQUITY (Details Narrative)",
     "shortName": "STOCKHOLDERS\u2019 EQUITY (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "108",
     "firstAnchor": {
      "contextRef": "From2024-01-012024-03-31_custom_FoundersMember_custom_SemiCabIncMember",
      "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-012024-03-31_custom_FoundersMember_custom_SemiCabIncMember",
      "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R109": {
     "role": "http://algoholdings.com/role/ScheduleOfFirstTrancheOfSubscriptionsDetails",
     "longName": "00000109 - Disclosure - SCHEDULE OF FIRST TRANCHE OF SUBSCRIPTIONS (Details)",
     "shortName": "SCHEDULE OF FIRST TRANCHE OF SUBSCRIPTIONS (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "109",
     "firstAnchor": {
      "contextRef": "AsOf2023-04-22_custom_SemiCabIncMember",
      "name": "RIME:InvestmentOfPrincipalAmount",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock",
       "RIME:SafePrivatePlacementsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-04-22_us-gaap_ShareBasedCompensationAwardTrancheOneMember_custom_SemiCabIncMember",
      "name": "RIME:InvestmentOfPrincipalAmount",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "RIME:SafePrivatePlacementsTableTextBlock",
       "RIME:SafePrivatePlacementsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R110": {
     "role": "http://algoholdings.com/role/SummaryOfTerminatedImmediatelyAfterClosingOfTransactionDetails",
     "longName": "00000110 - Disclosure - SUMMARY OF TERMINATED IMMEDIATELY AFTER CLOSING OF THE TRANSACTION (Details)",
     "shortName": "SUMMARY OF TERMINATED IMMEDIATELY AFTER CLOSING OF THE TRANSACTION (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "110",
     "firstAnchor": {
      "contextRef": "AsOf2023-04-22_custom_SemiCabIncMember",
      "name": "RIME:InvestmentOfPrincipalAmount",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock",
       "RIME:SafePrivatePlacementsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2021-08-122023-04-22_custom_SAFEFortyMember_custom_SemiCabIncMember",
      "name": "RIME:ConvertibleHolderName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock",
       "RIME:SafePrivatePlacementsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R111": {
     "role": "http://algoholdings.com/role/SafePrivatePlacementsDetailsNarrative",
     "longName": "00000111 - Disclosure - SAFE PRIVATE PLACEMENTS (Details Narrative)",
     "shortName": "SAFE PRIVATE PLACEMENTS (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "111",
     "firstAnchor": {
      "contextRef": "AsOf2024-03-31_custom_SAFEAgreementsMember_custom_SemiCabIncMember",
      "name": "us-gaap:Investments",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "RIME:SafePrivatePlacementsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-03-31_custom_SAFEAgreementsMember_custom_SemiCabIncMember",
      "name": "us-gaap:Investments",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "RIME:SafePrivatePlacementsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "RIME_AGPWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "AGPWarrantsMember",
     "presentation": [
      "http://algoholdings.com/role/August2021PrivatePlacementDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "AGP Warrants [Member]",
        "documentation": "AGP Warrants [Member]."
       }
      }
     },
     "auth_ref": []
    },
    "RIME_ATMOfferingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "ATMOfferingMember",
     "presentation": [
      "http://algoholdings.com/role/AtmOfferingDetailsNarrative",
      "http://algoholdings.com/role/RecentDevelopmentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ATM Offering [Member]",
        "documentation": "ATM Offering [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "country_AU": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2024",
     "localname": "AU",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfRevenueByGeographicalRegionDetails",
      "http://algoholdings.com/role/ScheduleOfSalesByGeographicalRegionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "AUSTRALIA"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountingPoliciesAbstract",
     "auth_ref": []
    },
    "us-gaap_AccountsAndNontradeReceivableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsAndNontradeReceivableTextBlock",
     "presentation": [
      "http://algoholdings.com/role/AccountsReceivable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ACCOUNTS RECEIVABLE",
        "documentation": "The entire disclosure for accounts receivable, contract receivable, receivable held-for-sale, and nontrade receivable."
       }
      }
     },
     "auth_ref": [
      "r315",
      "r352"
     ]
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
     "presentation": [
      "http://algoholdings.com/role/AccountsPayableAndAccruedExpenses"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ACCOUNTS PAYABLE AND ACCRUED EXPENSES",
        "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period."
       }
      }
     },
     "auth_ref": [
      "r82",
      "r85",
      "r92",
      "r1088"
     ]
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://algoholdings.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/AccountsPayableAndAccruedExpensesDetailsNarrative",
      "http://algoholdings.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts payable",
        "verboseLabel": "Vendors expenses payable",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r82",
      "r911"
     ]
    },
    "RIME_AccountsReceivableDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "AccountsReceivableDisclosureTextBlock",
     "presentation": [
      "http://algoholdings.com/role/DueFromFactor"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "DUE FROM FACTOR",
        "documentation": "Accounts Receivable Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsReceivableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsReceivableMember",
     "presentation": [
      "http://algoholdings.com/role/ConcentrationsOfCreditRiskAndRevenueDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Receivable [Member]",
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold."
       }
      }
     },
     "auth_ref": [
      "r841"
     ]
    },
    "us-gaap_AccountsReceivableNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsReceivableNet",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/AccountsReceivableDetailsNarrative",
      "http://algoholdings.com/role/BalanceSheets",
      "http://algoholdings.com/role/DueFromFactorDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts receivable",
        "verboseLabel": "Accounts receivable, net",
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business."
       }
      }
     },
     "auth_ref": [
      "r779",
      "r840",
      "r934",
      "r1149",
      "r1150"
     ]
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://algoholdings.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/AccountsPayableAndAccruedExpensesDetailsNarrative",
      "http://algoholdings.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued expenses",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r85"
     ]
    },
    "us-gaap_AccruedLiabilitiesCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccruedLiabilitiesCurrentAndNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://algoholdings.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Component of accrued expenses",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities."
       }
      }
     },
     "auth_ref": [
      "r150"
     ]
    },
    "RIME_AccruedPotentialLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "AccruedPotentialLiability",
     "crdr": "credit",
     "presentation": [
      "http://algoholdings.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued, potential liability",
        "documentation": "Accrued potential liability."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "crdr": "credit",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Less: Accumulated depreciation",
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r219",
      "r711"
     ]
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AcquiredFiniteLivedIntangibleAssetsLineItems",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfConsiderationTransferredToAssetsAcquiredAndLiabilitiesAssumedDetailsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Finite-Lived Intangible Assets [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r371",
      "r372",
      "r373",
      "r375",
      "r854"
     ]
    },
    "us-gaap_AdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapital",
     "crdr": "credit",
     "calculation": {
      "http://algoholdings.com/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional paid-in capital",
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r97",
      "r911",
      "r1189"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfShareholdersEquityDetails",
      "http://algoholdings.com/role/StatementsOfShareholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r751",
      "r1007",
      "r1008",
      "r1009",
      "r1011",
      "r1107",
      "r1192"
     ]
    },
    "RIME_AdditionalPaymentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "AdditionalPaymentMember",
     "presentation": [
      "http://algoholdings.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Payment [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://algoholdings.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdjustmentForAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentForAmortization",
     "crdr": "debit",
     "presentation": [
      "http://algoholdings.com/role/FinancingDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amortization expense",
        "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfCashFlowsDetails": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to reconcile net loss to net cash used in operating activities:",
        "documentation": "The aggregate amount of adjustments to net income or loss necessary to remove the effects of all items whose cash effects are investing or financing cash flows. The aggregate amount also includes all noncash expenses and income items which reduce or increase net income and are thus added back or deducted when calculating cash provided by or used in operating activities."
       }
      }
     },
     "auth_ref": [
      "r1000"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToAdditionalPaidInCapitalOther",
     "crdr": "credit",
     "presentation": [
      "http://algoholdings.com/role/StatementsOfShareholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other",
        "label": "Adjustments to Additional Paid in Capital, Other",
        "documentation": "Amount of other increase (decrease) in additional paid in capital (APIC)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "crdr": "credit",
     "presentation": [
      "http://algoholdings.com/role/StatementsOfShareholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee compensation - stock option",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r54",
      "r55",
      "r469"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts",
     "crdr": "debit",
     "presentation": [
      "http://algoholdings.com/role/StatementsOfShareholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of subsidiary stock to non-controlling interest",
        "negatedLabel": "Common stock offering costs",
        "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r128"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantIssued",
     "crdr": "credit",
     "presentation": [
      "http://algoholdings.com/role/StatementsOfShareholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of pre-funded warrants",
        "documentation": "Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r39",
      "r128"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://algoholdings.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to reconcile net (loss) income to net cash provided by (used in) operating activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdministrativeFeesExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdministrativeFeesExpense",
     "crdr": "debit",
     "presentation": [
      "http://algoholdings.com/role/RecentDevelopmentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Brokerage commissions and administrative fees",
        "documentation": "Amount of expense for administrative fee from service provided, including, but not limited to, salary, rent, or overhead cost."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r791",
      "r1191"
     ]
    },
    "RIME_AdvanceFeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "AdvanceFeeRate",
     "presentation": [
      "http://algoholdings.com/role/DueFromFactorDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Advance fee, rate",
        "documentation": "Advance fee rate."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdvertisingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdvertisingExpense",
     "crdr": "debit",
     "presentation": [
      "http://algoholdings.com/role/RevenueDisaggregationDetailsNarrative",
      "http://algoholdings.com/role/SubsequentEventsDetailsNarrative",
      "http://algoholdings.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Co-op promotion incentives",
        "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line."
       }
      }
     },
     "auth_ref": [
      "r510",
      "r892"
     ]
    },
    "RIME_AggregateNumberOfShares": {
     "xbrltype": "percentItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "AggregateNumberOfShares",
     "presentation": [
      "http://algoholdings.com/role/August2021PrivatePlacementDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate number of shares",
        "documentation": "Aggregate number of shares."
       }
      }
     },
     "auth_ref": []
    },
    "RIME_AgileCapilalFundingllcMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "AgileCapilalFundingllcMember",
     "presentation": [
      "http://algoholdings.com/role/FinancingDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Agile Capilal Fundingllc [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_AjeshKapoorFourMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "AjeshKapoorFourMember",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfLoanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ajesh Kapoor Four [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_AjeshKapoorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "AjeshKapoorMember",
     "presentation": [
      "http://algoholdings.com/role/AssetAcquisitionDetailsNarrative",
      "http://algoholdings.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://algoholdings.com/role/ScheduleOfSpecificTermsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ajesh Kapoor [Member]",
        "documentation": "Ajesh Kapoor [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_AjeshKapoorOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "AjeshKapoorOneMember",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfLoanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ajesh Kapoor One [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_AjeshKapoorThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "AjeshKapoorThreeMember",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfLoanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ajesh Kapoor Three [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_AjeshKapoorTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "AjeshKapoorTwoMember",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfLoanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ajesh Kapoor Two [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_AlexandraAielloMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "AlexandraAielloMember",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfStockOptionIssuedDuringYearDecember3120202021And2022Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Alexandra Aiello [Member]",
        "documentation": "Alexandra Aiello [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_AlgorhythmHoldingsIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "AlgorhythmHoldingsIncMember",
     "presentation": [
      "http://algoholdings.com/role/AssetAcquisitionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Algorhythm Holdings Inc [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "crdr": "credit",
     "presentation": [
      "http://algoholdings.com/role/BalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Allowance for doubtful accounts receivable, net",
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r225",
      "r317",
      "r355"
     ]
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://algoholdings.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://algoholdings.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AmortizationOfFinancingCosts",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/FinancingDetailsNarrative",
      "http://algoholdings.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amortization of deferred financing costs",
        "documentation": "Amount of amortization expense attributable to debt issuance costs."
       }
      }
     },
     "auth_ref": [
      "r110",
      "r430",
      "r1000",
      "r1126"
     ]
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AmortizationOfIntangibleAssets",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Change in net deferred tax assets",
        "label": "Amortization of Intangible Assets",
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r370",
      "r377",
      "r877"
     ]
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://algoholdings.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r956"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://algoholdings.com/role/ComputationOfLossPerShareDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Potentially dilutive securities",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r283"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "presentation": [
      "http://algoholdings.com/role/ComputationOfLossPerShareDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities [Axis]",
        "documentation": "Information by type of antidilutive security."
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "presentation": [
      "http://algoholdings.com/role/ComputationOfLossPerShareDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesNameDomain",
     "presentation": [
      "http://algoholdings.com/role/ComputationOfLossPerShareDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "RIME_AntonySunilMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "AntonySunilMember",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfStockOptionIssuedDuringYearDecember3120202021And2022Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antony Sunil [Member]",
        "documentation": "Antony Sunil [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AreaOfLand": {
     "xbrltype": "areaItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AreaOfLand",
     "presentation": [
      "http://algoholdings.com/role/OperatingLeasesDetailsNarrative",
      "http://algoholdings.com/role/RecentDevelopmentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease space",
        "documentation": "Area of land held."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "presentation": [
      "http://algoholdings.com/role/AssetAcquisitionDetailsNarrative",
      "http://algoholdings.com/role/August2021PrivatePlacementDetailsNarrative",
      "http://algoholdings.com/role/August2021StockRedemptionDetailsNarrative",
      "http://algoholdings.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://algoholdings.com/role/FinancingDetailsNarrative",
      "http://algoholdings.com/role/NotesPayableAndFinaningArrangementsDetailsNarrative",
      "http://algoholdings.com/role/OperatingLeasesDetailsNarrative",
      "http://algoholdings.com/role/PublicOfferingAndNasdaqUplistingDetailsNarrative",
      "http://algoholdings.com/role/RecentDevelopmentsDetailsNarrative",
      "http://algoholdings.com/role/SafePrivatePlacementsDetailsNarrative",
      "http://algoholdings.com/role/ScheduleOfFirstTrancheOfSubscriptionsDetails",
      "http://algoholdings.com/role/ScheduleOfSpecificTermsDetails",
      "http://algoholdings.com/role/SubsequentEventsDetailsNarrative",
      "http://algoholdings.com/role/SummaryOfTerminatedImmediatelyAfterClosingOfTransactionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r558"
     ]
    },
    "us-gaap_AssetAcquisitionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetAcquisitionAxis",
     "presentation": [
      "http://algoholdings.com/role/AssetAcquisitionDetailsNarrative",
      "http://algoholdings.com/role/ScheduleOfConsiderationTransferredToAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asset Acquisition [Axis]",
        "documentation": "Information by asset acquisition."
       }
      }
     },
     "auth_ref": [
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r1103"
     ]
    },
    "us-gaap_AssetAcquisitionConsiderationTransferred": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetAcquisitionConsiderationTransferred",
     "crdr": "credit",
     "presentation": [
      "http://algoholdings.com/role/AssetAcquisitionDetailsNarrative",
      "http://algoholdings.com/role/ScheduleOfConsiderationTransferredToAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total consideration",
        "verboseLabel": "Asset acquisition purchase price consideration",
        "documentation": "Amount of consideration transferred in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer."
       }
      }
     },
     "auth_ref": [
      "r895",
      "r1104",
      "r1105",
      "r1106"
     ]
    },
    "us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetAcquisitionConsiderationTransferredContingentConsideration",
     "crdr": "credit",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfConsiderationTransferredToAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Equity Consideration",
        "documentation": "Amount of contingent consideration recognized as part of consideration transferred in asset acquisition."
       }
      }
     },
     "auth_ref": [
      "r1104",
      "r1105",
      "r1106"
     ]
    },
    "us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable",
     "crdr": "credit",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfConsiderationTransferredToAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity consideration",
        "documentation": "Amount of acquirer's equity interest issued and issuable as part of consideration transferred in asset acquisition."
       }
      }
     },
     "auth_ref": [
      "r1104",
      "r1105",
      "r1106"
     ]
    },
    "RIME_AssetAcquisitionDebtExtinguishment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "AssetAcquisitionDebtExtinguishment",
     "crdr": "credit",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfConsiderationTransferredToAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Extinguishment",
        "documentation": "Asset acquisition debt extinguishment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetAcquisitionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetAcquisitionDomain",
     "presentation": [
      "http://algoholdings.com/role/AssetAcquisitionDetailsNarrative",
      "http://algoholdings.com/role/ScheduleOfConsiderationTransferredToAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset acquisition."
       }
      }
     },
     "auth_ref": [
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r1103"
     ]
    },
    "RIME_AssetAcquisitionFairValueOfNonControllingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "AssetAcquisitionFairValueOfNonControllingInterest",
     "crdr": "credit",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfConsiderationTransferredToAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair value of non-controlling interest",
        "documentation": "Asset acquisition fair value of non controlling interest."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetAcquisitionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetAcquisitionLineItems",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfConsiderationTransferredToAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asset Acquisition [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r1103"
     ]
    },
    "us-gaap_AssetAcquisitionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetAcquisitionTable",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfConsiderationTransferredToAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asset Acquisition [Table]",
        "documentation": "Disclosure of information about asset acquisition."
       }
      }
     },
     "auth_ref": [
      "r1103"
     ]
    },
    "us-gaap_AssetAcquisitionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetAcquisitionTextBlock",
     "presentation": [
      "http://algoholdings.com/role/AssetAcquisition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ASSET ACQUISITION",
        "documentation": "The entire disclosure for asset acquisition."
       }
      }
     },
     "auth_ref": [
      "r1103"
     ]
    },
    "RIME_AssetPurchaseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "AssetPurchaseAgreementMember",
     "presentation": [
      "http://algoholdings.com/role/AssetAcquisitionDetailsNarrative",
      "http://algoholdings.com/role/RecentDevelopmentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asset Purchase Agreement [Member]",
        "documentation": "Asset Purchase Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/BalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://algoholdings.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Assets",
        "label": "Assets [Default Label]",
        "documentation": "Amount of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r148",
      "r162",
      "r222",
      "r249",
      "r288",
      "r294",
      "r304",
      "r307",
      "r351",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r560",
      "r564",
      "r584",
      "r699",
      "r784",
      "r869",
      "r870",
      "r911",
      "r941",
      "r1056",
      "r1057",
      "r1134"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://algoholdings.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Current Assets",
        "label": "Assets, Current",
        "documentation": "Amount of asset recognized for present right to economic benefit, classified as current."
       }
      }
     },
     "auth_ref": [
      "r214",
      "r228",
      "r249",
      "r351",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r560",
      "r564",
      "r584",
      "r911",
      "r1056",
      "r1057",
      "r1134"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://algoholdings.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Assets"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_AssetsWriteOff": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "AssetsWriteOff",
     "crdr": "debit",
     "presentation": [
      "http://algoholdings.com/role/RecentDevelopmentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written off",
        "documentation": "Assets write off."
       }
      }
     },
     "auth_ref": []
    },
    "RIME_AtTheMarketPublicOfferingTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "AtTheMarketPublicOfferingTextBlock",
     "presentation": [
      "http://algoholdings.com/role/AtmOffering"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ATM OFFERING",
        "documentation": "At The Market Public Offering [Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_AtTheMarketSalesAgreementAmendmentOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "AtTheMarketSalesAgreementAmendmentOneMember",
     "presentation": [
      "http://algoholdings.com/role/RecentDevelopmentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "At The Market Sales Agreement Amendment One [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_AtTheMarketSalesAgreementAmendmentTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "AtTheMarketSalesAgreementAmendmentTwoMember",
     "presentation": [
      "http://algoholdings.com/role/RecentDevelopmentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "At The Market Sales Agreement Amendment Two [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_AtTheMarketSalesAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "AtTheMarketSalesAgreementMember",
     "presentation": [
      "http://algoholdings.com/role/RecentDevelopmentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "At The Market Sales Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://algoholdings.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r956"
     ]
    },
    "RIME_AugustTwentyTwentyOnePrivatePlacementTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "AugustTwentyTwentyOnePrivatePlacementTextBlock",
     "presentation": [
      "http://algoholdings.com/role/August2021PrivatePlacement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "AUGUST 2021 PRIVATE PLACEMENT",
        "documentation": "August 2021 Private Placement [Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_AultAllianceIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "AultAllianceIncMember",
     "presentation": [
      "http://algoholdings.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "AultAlliance Inc [Member]",
        "documentation": "AultAlliance Inc [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AwardDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AwardDateAxis",
     "presentation": [
      "http://algoholdings.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://algoholdings.com/role/NotesPayableAndFinaningArrangementsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Date [Axis]",
        "documentation": "Information by date or year award under share-based payment arrangement is granted."
       }
      }
     },
     "auth_ref": [
      "r1061",
      "r1062",
      "r1063",
      "r1064",
      "r1065",
      "r1066",
      "r1067",
      "r1068",
      "r1069",
      "r1070",
      "r1071",
      "r1072",
      "r1073",
      "r1074",
      "r1075",
      "r1076",
      "r1077",
      "r1078",
      "r1079",
      "r1080",
      "r1081",
      "r1082",
      "r1083",
      "r1084",
      "r1085",
      "r1086"
     ]
    },
    "us-gaap_AwardDateDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AwardDateDomain",
     "presentation": [
      "http://algoholdings.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://algoholdings.com/role/NotesPayableAndFinaningArrangementsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date or year award under share-based payment arrangement is granted."
       }
      }
     },
     "auth_ref": [
      "r1061",
      "r1062",
      "r1063",
      "r1064",
      "r1065",
      "r1066",
      "r1067",
      "r1068",
      "r1069",
      "r1070",
      "r1071",
      "r1072",
      "r1073",
      "r1074",
      "r1075",
      "r1076",
      "r1077",
      "r1078",
      "r1079",
      "r1080",
      "r1081",
      "r1082",
      "r1083",
      "r1084",
      "r1085",
      "r1086"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://algoholdings.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r472",
      "r473",
      "r474",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500"
     ]
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "BASIS OF PRESENTATION",
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": []
    },
    "RIME_BlueYonderIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "BlueYonderIncMember",
     "presentation": [
      "http://algoholdings.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Blue Yonder Inc [Member]",
        "documentation": "Blue Yonder Inc [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_BoardOfDirectorsChairmanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "BoardOfDirectorsChairmanMember",
     "presentation": [
      "http://algoholdings.com/role/StockCompensationExpenseDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Board of Directors Chairman [Member]",
        "documentation": "Leader of board of directors."
       }
      }
     },
     "auth_ref": [
      "r1018"
     ]
    },
    "RIME_BryanNellaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "BryanNellaMember",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfStockOptionIssuedDuringYearDecember3120202021And2022Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Bryan Nella [Member]",
        "documentation": "Bryan Nella [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionAcquireeDomain",
     "presentation": [
      "http://algoholdings.com/role/RecentDevelopmentsDetailsNarrative",
      "http://algoholdings.com/role/ScheduleOfConsiderationTransferredToAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree."
       }
      }
     },
     "auth_ref": [
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r555",
      "r888",
      "r889"
     ]
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionAxis",
     "presentation": [
      "http://algoholdings.com/role/RecentDevelopmentsDetailsNarrative",
      "http://algoholdings.com/role/ScheduleOfConsiderationTransferredToAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition [Axis]",
        "documentation": "Information by business combination or series of individually immaterial business combinations."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r58",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r555",
      "r888",
      "r889"
     ]
    },
    "us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax",
     "crdr": "credit",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfProFormaFinancialInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating loss from continuing operations",
        "documentation": "Amount after tax of pro forma income from continuing operations as if the business combination had been completed at the beginning of a period."
       }
      }
     },
     "auth_ref": [
      "r553",
      "r554"
     ]
    },
    "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionsProFormaNetIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfProFormaFinancialInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net loss",
        "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period."
       }
      }
     },
     "auth_ref": [
      "r553",
      "r554"
     ]
    },
    "us-gaap_BusinessAcquisitionsProFormaRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionsProFormaRevenue",
     "crdr": "credit",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfProFormaFinancialInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net revenue",
        "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period."
       }
      }
     },
     "auth_ref": [
      "r553",
      "r554"
     ]
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfConsiderationTransferredToAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets",
     "crdr": "debit",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfConsiderationTransferredToAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid expenses and other current assets",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "crdr": "debit",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfConsiderationTransferredToAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accounts receivable",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables",
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable",
     "crdr": "credit",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfConsiderationTransferredToAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accounts payable and accrued expenses",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable",
        "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "RIME_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLoansPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLoansPayable",
     "crdr": "credit",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfConsiderationTransferredToAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loans payable Merchant Cash Advances (MCA)",
        "documentation": "Business combination recognized identifiable assets acquired and liabilities assumed current liabilities loans payable."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt",
     "crdr": "credit",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfConsiderationTransferredToAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Note payable",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Long-Term Debt",
        "documentation": "Amount of long-term debt due within one year or within the normal operating cycle, if longer, assumed at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "RIME_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesNotesPayableRelatedParties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesNotesPayableRelatedParties",
     "crdr": "credit",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfConsiderationTransferredToAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Notes payable Related Parties",
        "documentation": "Business combination recognized identifiable assets acquired and liabilities assumed current liabilities notes payable related parties."
       }
      }
     },
     "auth_ref": []
    },
    "RIME_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCustomerRelationships": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCustomerRelationships",
     "crdr": "debit",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfConsiderationTransferredToAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer Relationships (9 year estimated useful life)",
        "documentation": "Business combination recognized identifiable assets acquired and liabilities assumed customer relationships."
       }
      }
     },
     "auth_ref": []
    },
    "RIME_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDevelopedTechnology": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDevelopedTechnology",
     "crdr": "debit",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfConsiderationTransferredToAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Developed Technology (6 year estimated useful life)",
        "documentation": "Business combination recognized identifiable assets acquired and liabilities assumed developed technology."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
     "crdr": "debit",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfConsiderationTransferredToAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net assets acquired",
        "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r60"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets",
     "crdr": "debit",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfConsiderationTransferredToAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Non-Current Operating Assets, Net",
        "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "crdr": "debit",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfConsiderationTransferredToAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Property and equipment, net",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r60"
     ]
    },
    "RIME_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradeName": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradeName",
     "crdr": "debit",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfConsiderationTransferredToAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade Name (9 year estimated useful life)",
        "documentation": "Business combination recognized identifiable assets acquired and liabilities assumed trade name."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationsPolicy",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combinations",
        "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy."
       }
      }
     },
     "auth_ref": [
      "r137",
      "r138",
      "r139",
      "r140"
     ]
    },
    "dei_BusinessContactMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "BusinessContactMember",
     "presentation": [
      "http://algoholdings.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Contact [Member]",
        "documentation": "Business contact for the entity"
       }
      }
     },
     "auth_ref": [
      "r955",
      "r956"
     ]
    },
    "us-gaap_BusinessExitCosts1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessExitCosts1",
     "crdr": "debit",
     "presentation": [
      "http://algoholdings.com/role/FinancingDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exit fee payable on termination of contract",
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Includes, but is not limited to, one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and termination benefits associated with an ongoing benefit arrangement. Excludes expenses associated with special or contractual termination benefits, a discontinued operation or an asset retirement obligation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_CapitalLeaseObligationsIncurred": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CapitalLeaseObligationsIncurred",
     "crdr": "credit",
     "presentation": [
      "http://algoholdings.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equipment purchased under capital lease",
        "documentation": "Amount of increase in lease obligation from new lease."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r22"
     ]
    },
    "us-gaap_Cash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Cash",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r167",
      "r703",
      "r752",
      "r776",
      "r911",
      "r941",
      "r990"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "presentation": [
      "http://algoholdings.com/role/LiquidityGoingConcernAndManagementPlansDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and cash equivalents",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r217",
      "r858"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "crdr": "debit",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfCashFlowsDetails",
      "http://algoholdings.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cash at beginning of year",
        "periodEndLabel": "Cash at end of period",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r115",
      "r245"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/StatementsOfCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfCashFlowsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfCashFlowsDetails",
      "http://algoholdings.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net change in cash",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r115"
     ]
    },
    "us-gaap_CashFlowOperatingActivitiesLesseeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashFlowOperatingActivitiesLesseeAbstract",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfLeaseTermAndDiscountRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental cash flow information related to operating leases is as follows:"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_CedarAdvancellcMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "CedarAdvancellcMember",
     "presentation": [
      "http://algoholdings.com/role/FinancingDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cedar Advancellc [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://algoholdings.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightAxis",
     "presentation": [
      "http://algoholdings.com/role/August2021PrivatePlacementDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Axis]",
        "documentation": "Information by type of warrant or right issued."
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightDomain",
     "presentation": [
      "http://algoholdings.com/role/August2021PrivatePlacementDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "presentation": [
      "http://algoholdings.com/role/August2021PrivatePlacementDetailsNarrative",
      "http://algoholdings.com/role/PublicOfferingAndNasdaqUplistingDetailsNarrative",
      "http://algoholdings.com/role/ScheduleOfWarrantsExpirationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant Exercise Price",
        "verboseLabel": "Exercise price per share",
        "terseLabel": "Exercise price of warrants",
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": [
      "r451"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight",
     "presentation": [
      "http://algoholdings.com/role/August2021PrivatePlacementDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of warrant or right, number of securities called by each warrant or right",
        "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "presentation": [
      "http://algoholdings.com/role/August2021PrivatePlacementDetailsNarrative",
      "http://algoholdings.com/role/PublicOfferingAndNasdaqUplistingDetailsNarrative",
      "http://algoholdings.com/role/ScheduleOfWarrantsExpirationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of common warrants",
        "verboseLabel": "Underwriter warrants to purchase",
        "terseLabel": "Issuance of warrant shares",
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares."
       }
      }
     },
     "auth_ref": [
      "r451"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightOutstanding",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfWarrantsExpirationDetails",
      "http://algoholdings.com/role/StockCompensationExpenseDetailsNarrative",
      "http://algoholdings.com/role/WarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of Common Warrants",
        "verboseLabel": "Class of Warrant or Right, Outstanding",
        "terseLabel": "Warrants outstanding",
        "documentation": "Number of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "RIME_ClassicKaraokeMachinesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "ClassicKaraokeMachinesMember",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfRevenueByProductLineDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classic Karaoke Machines [Member]",
        "documentation": "Classic Karaoke Machines [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems",
     "presentation": [
      "http://algoholdings.com/role/August2021StockRedemptionDetailsNarrative",
      "http://algoholdings.com/role/OperatingLeasesDetailsNarrative",
      "http://algoholdings.com/role/PublicOfferingAndNasdaqUplistingDetailsNarrative",
      "http://algoholdings.com/role/SafePrivatePlacementsDetailsNarrative",
      "http://algoholdings.com/role/ScheduleOfFirstTrancheOfSubscriptionsDetails",
      "http://algoholdings.com/role/SummaryOfTerminatedImmediatelyAfterClosingOfTransactionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r558"
     ]
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://algoholdings.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Commitments and Contingencies",
        "label": "Commitments and Contingencies [Default Label]",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r93",
      "r153",
      "r702",
      "r767"
     ]
    },
    "RIME_CommitmentsAndContingenciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "CommitmentsAndContingenciesAbstract",
     "presentation": [
      "http://algoholdings.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies",
        "documentation": "Commitments and contingencies abstract"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://algoholdings.com/role/CommitmentsAndContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "COMMITMENTS AND CONTINGENCIES",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r125",
      "r389",
      "r390",
      "r842",
      "r1043",
      "r1048"
     ]
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockMember",
     "presentation": [
      "http://algoholdings.com/role/RecentDevelopmentsDetailsNarrative",
      "http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfShareholdersEquityDetails",
      "http://algoholdings.com/role/StatementsOfShareholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r931",
      "r932",
      "r933",
      "r935",
      "r936",
      "r937",
      "r938",
      "r1007",
      "r1008",
      "r1011",
      "r1107",
      "r1181",
      "r1192"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://algoholdings.com/role/BalanceSheetsParenthetical",
      "http://algoholdings.com/role/PublicOfferingAndNasdaqUplistingDetailsNarrative",
      "http://algoholdings.com/role/RecentDevelopmentsDetailsNarrative",
      "http://algoholdings.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, par value",
        "verboseLabel": "Common stock par value",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r96"
     ]
    },
    "us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockShareSubscribedButUnissuedSubscriptionsReceivable",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Subscriptions receivable",
        "label": "Common Stock, Share Subscribed but Unissued, Subscriptions Receivable",
        "documentation": "Amount of subscription receivable from investors who have been allocated common stock."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r777",
      "r821"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://algoholdings.com/role/BalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, shares authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r768"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://algoholdings.com/role/August2021PrivatePlacementDetailsNarrative",
      "http://algoholdings.com/role/BalanceSheetsParenthetical",
      "http://algoholdings.com/role/RecentDevelopmentsDetailsNarrative",
      "http://algoholdings.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, shares issued",
        "verboseLabel": "Shares issued",
        "terseLabel": "Common stock shares issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r96"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://algoholdings.com/role/BalanceSheetsParenthetical",
      "http://algoholdings.com/role/RecentDevelopmentsDetailsNarrative",
      "http://algoholdings.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, shares outstanding",
        "verboseLabel": "Shares outstanding",
        "terseLabel": "Common stock shares outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r96",
      "r768",
      "r790",
      "r1192",
      "r1193"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://algoholdings.com/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock $0.01 par value; 100,000,000 shares authorized; 6,418,061 issued and outstanding at December 31, 2023 and 3,184,439 issued and 3,167,489 outstanding at March 31, 2023",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r705",
      "r911"
     ]
    },
    "RIME_CommonStockWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "CommonStockWarrantsMember",
     "presentation": [
      "http://algoholdings.com/role/ComputationOfLossPerShareDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock Warrants [Member]",
        "documentation": "Common Stock Warrants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CompensationAndEmployeeBenefitPlansTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CompensationAndEmployeeBenefitPlansTextBlock",
     "presentation": [
      "http://algoholdings.com/role/EmployeeBenefitPlans"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "EMPLOYEE BENEFIT PLANS",
        "documentation": "The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans."
       }
      }
     },
     "auth_ref": [
      "r129",
      "r130",
      "r131",
      "r132"
     ]
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "auth_ref": []
    },
    "us-gaap_CompensationRelatedCostsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CompensationRelatedCostsPolicyTextBlock",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "STOCK-BASED COMPENSATION",
        "documentation": "Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense."
       }
      }
     },
     "auth_ref": [
      "r133",
      "r135"
     ]
    },
    "RIME_ComputerAndOfficeEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "ComputerAndOfficeEquipmentMember",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Computer and Office Equipment [Member]",
        "documentation": "Computer and Office Equipment [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskBenchmarkDomain",
     "presentation": [
      "http://algoholdings.com/role/ConcentrationsOfCreditRiskAndRevenueDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r29",
      "r72",
      "r73",
      "r314",
      "r841"
     ]
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "presentation": [
      "http://algoholdings.com/role/ConcentrationsOfCreditRiskAndRevenueDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk Benchmark [Axis]",
        "documentation": "Information by benchmark of concentration risk."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r29",
      "r72",
      "r73",
      "r314",
      "r740",
      "r841"
     ]
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskByTypeAxis",
     "presentation": [
      "http://algoholdings.com/role/ConcentrationsOfCreditRiskAndRevenueDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk Type [Axis]",
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r29",
      "r72",
      "r73",
      "r314",
      "r841",
      "r970"
     ]
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskCreditRisk",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration of Credit Risk",
        "documentation": "Disclosure of accounting policy for credit risk."
       }
      }
     },
     "auth_ref": [
      "r79",
      "r172"
     ]
    },
    "us-gaap_ConcentrationRiskDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskDisclosureTextBlock",
     "presentation": [
      "http://algoholdings.com/role/ConcentrationsOfCreditRiskAndRevenue"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CONCENTRATIONS OF CREDIT RISK AND REVENUE",
        "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "us-gaap_ConcentrationRiskLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskLineItems",
     "presentation": [
      "http://algoholdings.com/role/ConcentrationsOfCreditRiskAndRevenueDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r841"
     ]
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskPercentage1",
     "presentation": [
      "http://algoholdings.com/role/ConcentrationsOfCreditRiskAndRevenueDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration risk percentage",
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r29",
      "r72",
      "r73",
      "r314"
     ]
    },
    "us-gaap_ConcentrationRiskTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskTable",
     "presentation": [
      "http://algoholdings.com/role/ConcentrationsOfCreditRiskAndRevenueDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk [Table]",
        "documentation": "Disclosure of information about concentration risk. Includes, but is not limited to, percentage of concentration risk and benchmark serving as denominator in calculation of percentage of concentration risk."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r27",
      "r29",
      "r30",
      "r72",
      "r146",
      "r841"
     ]
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskTypeDomain",
     "presentation": [
      "http://algoholdings.com/role/ConcentrationsOfCreditRiskAndRevenueDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r29",
      "r72",
      "r73",
      "r314",
      "r841"
     ]
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConsolidationPolicyTextBlock",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PRINCIPLES OF CONSOLIDATION",
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary."
       }
      }
     },
     "auth_ref": [
      "r65",
      "r861"
     ]
    },
    "dei_ContactPersonnelName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContactPersonnelName",
     "presentation": [
      "http://algoholdings.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Name",
        "documentation": "Name of contact personnel"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ContractWithCustomerRefundLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContractWithCustomerRefundLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://algoholdings.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Due to factor",
        "documentation": "Amount of liability for consideration received or receivable from customer which is not included in transaction price, when consideration is expected to be refunded to customer, classified as current."
       }
      }
     },
     "auth_ref": [
      "r1060"
     ]
    },
    "us-gaap_ConversionOfStockAmountIssued1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConversionOfStockAmountIssued1",
     "crdr": "credit",
     "presentation": [
      "http://algoholdings.com/role/August2021PrivatePlacementDetailsNarrative",
      "http://algoholdings.com/role/August2021StockRedemptionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of stock, amount issued",
        "documentation": "The value of the financial instrument issued [noncash or part noncash] in the conversion of stock. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r22",
      "r23"
     ]
    },
    "RIME_ConvertibleHolderName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "ConvertibleHolderName",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfFirstTrancheOfSubscriptionsDetails",
      "http://algoholdings.com/role/SummaryOfTerminatedImmediatelyAfterClosingOfTransactionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Holder Name",
        "documentation": "Convertible holder name."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CostOfGoodsAndServicesSold",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0,
       "order": 2.0
      },
      "http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfOperationsDetails": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfOperationsDetails",
      "http://algoholdings.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of Revenue",
        "verboseLabel": "Cost of Goods Sold",
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities."
       }
      }
     },
     "auth_ref": [
      "r104",
      "r105",
      "r658"
     ]
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CountryRegion",
     "presentation": [
      "http://algoholdings.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "RIME_CreditAndSecurityAgreementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "CreditAndSecurityAgreementsMember",
     "presentation": [
      "http://algoholdings.com/role/FinancingDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Credit and Security Agreements [Member]",
        "documentation": "Credit and Security Agreements [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CreditFacilityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CreditFacilityAxis",
     "presentation": [
      "http://algoholdings.com/role/FinancingDetailsNarrative",
      "http://algoholdings.com/role/RecentDevelopmentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Credit Facility [Axis]",
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing."
       }
      }
     },
     "auth_ref": [
      "r398",
      "r1054"
     ]
    },
    "us-gaap_CreditFacilityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CreditFacilityDomain",
     "presentation": [
      "http://algoholdings.com/role/FinancingDetailsNarrative",
      "http://algoholdings.com/role/RecentDevelopmentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing."
       }
      }
     },
     "auth_ref": [
      "r398",
      "r1054",
      "r1055"
     ]
    },
    "us-gaap_CreditLossAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CreditLossAbstract",
     "auth_ref": []
    },
    "us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CurrentFederalStateAndLocalTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/ScheduleOfProvisionForIncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current Federal and State",
        "label": "Current Federal, State and Local, Tax Expense (Benefit)",
        "documentation": "Amount of current federal, state, and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national, regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r972"
     ]
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CurrentFederalTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/ScheduleOfProvisionForIncomeTaxesDetails": {
       "parentTag": "us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Federal",
        "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r972",
      "r1003",
      "r1098"
     ]
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://algoholdings.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CurrentForeignTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/ScheduleOfProvisionForIncomeTaxesDetails": {
       "parentTag": "us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Hong Kong",
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r972",
      "r1003"
     ]
    },
    "RIME_CurrentOtherTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "CurrentOtherTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/ScheduleOfProvisionForIncomeTaxesDetails": {
       "parentTag": "us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other",
        "documentation": "Current other tax expense benefit.",
        "label": "CurrentOtherTaxExpenseBenefit"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/ScheduleOfProvisionForIncomeTaxesDetails": {
       "parentTag": "us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "State",
        "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r972",
      "r1003",
      "r1098"
     ]
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CustomerConcentrationRiskMember",
     "presentation": [
      "http://algoholdings.com/role/ConcentrationsOfCreditRiskAndRevenueDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer Concentration Risk [Member]",
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer."
       }
      }
     },
     "auth_ref": [
      "r120",
      "r314"
     ]
    },
    "RIME_CustomerOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "CustomerOneMember",
     "presentation": [
      "http://algoholdings.com/role/ConcentrationsOfCreditRiskAndRevenueDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer One [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_CustomerPrepayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "CustomerPrepayments",
     "crdr": "credit",
     "calculation": {
      "http://algoholdings.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer prepayments",
        "documentation": "Customer prepayments."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CustomerRelationshipsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CustomerRelationshipsMember",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfConsiderationTransferredToAssetsAcquiredAndLiabilitiesAssumedDetailsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer Relationships [Member]",
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r1033",
      "r1034",
      "r1035",
      "r1036",
      "r1038",
      "r1039",
      "r1041",
      "r1042"
     ]
    },
    "RIME_CustomersConcentrationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "CustomersConcentrationRiskMember",
     "presentation": [
      "http://algoholdings.com/role/ConcentrationsOfCreditRiskAndRevenueDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customers concentration risk [Member]",
        "documentation": "Customers concentration risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_CustomersFourMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "CustomersFourMember",
     "presentation": [
      "http://algoholdings.com/role/ConcentrationsOfCreditRiskAndRevenueDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customers Four [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_CustomersOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "CustomersOneMember",
     "presentation": [
      "http://algoholdings.com/role/ConcentrationsOfCreditRiskAndRevenueDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customers One [Member]",
        "documentation": "Customers One [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_CustomersThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "CustomersThreeMember",
     "presentation": [
      "http://algoholdings.com/role/ConcentrationsOfCreditRiskAndRevenueDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customers Three [Member]",
        "documentation": "Customers Three [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_CustomersTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "CustomersTwoMember",
     "presentation": [
      "http://algoholdings.com/role/ConcentrationsOfCreditRiskAndRevenueDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customers Two [Member]",
        "documentation": "Customers Two [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtConversionOriginalDebtAmount1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtConversionOriginalDebtAmount1",
     "crdr": "credit",
     "presentation": [
      "http://algoholdings.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Original issue discount",
        "documentation": "The amount of the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r23"
     ]
    },
    "us-gaap_DebtDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtDisclosureTextBlock",
     "presentation": [
      "http://algoholdings.com/role/Financing"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "FINANCING",
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants."
       }
      }
     },
     "auth_ref": [
      "r126",
      "r247",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r397",
      "r398",
      "r408",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r424",
      "r431",
      "r432",
      "r434",
      "r594"
     ]
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://algoholdings.com/role/NotesPayableAndFinaningArrangementsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r84",
      "r85",
      "r149",
      "r152",
      "r254",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r415",
      "r420",
      "r421",
      "r422",
      "r423",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r879",
      "r880",
      "r881",
      "r882",
      "r883",
      "r909",
      "r1001",
      "r1044",
      "r1045",
      "r1046",
      "r1125",
      "r1127"
     ]
    },
    "us-gaap_DebtInstrumentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentDescription",
     "presentation": [
      "http://algoholdings.com/role/ConcentrationsOfCreditRiskAndRevenueDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt instrument, description",
        "documentation": "Identification of the lender and information about a contractual promise to repay a short-term or long-term obligation, which includes borrowings under lines of credit, notes payable, commercial paper, bonds payable, debentures, and other contractual obligations for payment. This may include rationale for entering into the arrangement, significant terms of the arrangement, which may include amount, repayment terms, priority, collateral required, debt covenants, borrowing capacity, call features, participation rights, conversion provisions, sinking-fund requirements, voting rights, basis for conversion if convertible and remarketing provisions. The description may be provided for individual debt instruments, rational groupings of debt instruments, or by debt in total."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r42",
      "r76",
      "r84",
      "r149",
      "r152",
      "r594"
     ]
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentFaceAmount",
     "crdr": "credit",
     "presentation": [
      "http://algoholdings.com/role/FinancingDetailsNarrative",
      "http://algoholdings.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://algoholdings.com/role/SafePrivatePlacementsDetailsNarrative",
      "http://algoholdings.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Initial amount borrowed",
        "verboseLabel": "Principal amount",
        "documentation": "Face (par) amount of debt instrument at time of issuance."
       }
      }
     },
     "auth_ref": [
      "r409",
      "r594",
      "r595",
      "r880",
      "r881",
      "r909"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateDuringPeriod": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentInterestRateDuringPeriod",
     "presentation": [
      "http://algoholdings.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest accrued rate percentage",
        "documentation": "The average effective interest rate during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r87",
      "r427",
      "r1125"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "presentation": [
      "http://algoholdings.com/role/FinancingDetailsNarrative",
      "http://algoholdings.com/role/NotesPayableAndFinaningArrangementsDetailsNarrative",
      "http://algoholdings.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Interest rate",
        "verboseLabel": "Original issue discount percentage",
        "terseLabel": "Effective, interest rate",
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium."
       }
      }
     },
     "auth_ref": [
      "r87",
      "r435",
      "r594",
      "r595",
      "r909"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "presentation": [
      "http://algoholdings.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://algoholdings.com/role/NotesPayableAndFinaningArrangementsDetailsNarrative",
      "http://algoholdings.com/role/ScheduleOfLoanDetails",
      "http://algoholdings.com/role/ScheduleOfSpecificTermsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "verboseLabel": "Interest rate",
        "terseLabel": "Rate",
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement."
       }
      }
     },
     "auth_ref": [
      "r87",
      "r410"
     ]
    },
    "us-gaap_DebtInstrumentIssuanceDate1": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentIssuanceDate1",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfLoanDetails",
      "http://algoholdings.com/role/ScheduleOfSpecificTermsDetails",
      "http://algoholdings.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Issuance Date",
        "verboseLabel": "Issuance date",
        "terseLabel": "Date",
        "documentation": "Date the debt instrument was issued, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": [
      "r89",
      "r1058"
     ]
    },
    "us-gaap_DebtInstrumentMaturityDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentMaturityDate",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfLoanDetails",
      "http://algoholdings.com/role/ScheduleOfSpecificTermsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Maturity Date",
        "verboseLabel": "Maturity",
        "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": [
      "r223",
      "r879",
      "r1112",
      "r1113"
     ]
    },
    "us-gaap_DebtInstrumentMaturityDateDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentMaturityDateDescription",
     "presentation": [
      "http://algoholdings.com/role/NotesPayableAndFinaningArrangementsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maturity date, description",
        "documentation": "Description of the maturity date of the debt instrument including whether the debt matures serially and, if so, a brief description of the serial maturities."
       }
      }
     },
     "auth_ref": [
      "r88"
     ]
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://algoholdings.com/role/NotesPayableAndFinaningArrangementsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r254",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r415",
      "r420",
      "r421",
      "r422",
      "r423",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r879",
      "r880",
      "r881",
      "r882",
      "r883",
      "r909",
      "r1001",
      "r1044",
      "r1045",
      "r1046",
      "r1125",
      "r1127"
     ]
    },
    "us-gaap_DebtInstrumentPeriodicPayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentPeriodicPayment",
     "crdr": "debit",
     "presentation": [
      "http://algoholdings.com/role/FinancingDetailsNarrative",
      "http://algoholdings.com/role/ScheduleOfSpecificTermsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stipulated periodic payment of short term debt",
        "verboseLabel": "Current Balance",
        "documentation": "Amount of the required periodic payments including both interest and principal payments."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r77"
     ]
    },
    "us-gaap_DebtInstrumentPeriodicPaymentInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentPeriodicPaymentInterest",
     "crdr": "debit",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfSpecificTermsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Interest",
        "documentation": "Amount of the required periodic payments applied to interest."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "us-gaap_DebtInstrumentPeriodicPaymentPrincipal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentPeriodicPaymentPrincipal",
     "crdr": "debit",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfSpecificTermsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Principal",
        "documentation": "Amount of the required periodic payments applied to principal."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "us-gaap_DebtInstrumentTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentTerm",
     "presentation": [
      "http://algoholdings.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://algoholdings.com/role/FinancingDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Credit agreement term",
        "verboseLabel": "Maturity date",
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Table]",
        "documentation": "Disclosure of information about allowance for credit loss on investment in debt security measured at amortized cost (held-to-maturity)."
       }
      }
     },
     "auth_ref": [
      "r1027"
     ]
    },
    "us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r1027"
     ]
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/ScheduleOfProvisionForIncomeTaxesDetails": {
       "parentTag": "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Federal",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r1003",
      "r1097",
      "r1098"
     ]
    },
    "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredFederalStateAndLocalTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/ScheduleOfProvisionForIncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Deferred Federal and State",
        "label": "Deferred Federal, State and Local, Tax Expense (Benefit)",
        "documentation": "Amount of deferred federal, state, and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national, regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r1089"
     ]
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in net deferred tax assets",
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r178",
      "r1003"
     ]
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/ScheduleOfProvisionForIncomeTaxesDetails": {
       "parentTag": "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "State",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r1003",
      "r1097",
      "r1098"
     ]
    },
    "RIME_DeferredTaxAssetsAllowanceForDoubtFulAccounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "DeferredTaxAssetsAllowanceForDoubtFulAccounts",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Allowance for doubtful accounts",
        "documentation": "Deferred tax assets allowance for doubtful accounts."
       }
      }
     },
     "auth_ref": []
    },
    "RIME_DeferredTaxAssetsBusinessInterestLimitation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "DeferredTaxAssetsBusinessInterestLimitation",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business interest limitation",
        "documentation": "Deferred Tax Assets Business Interest Limitation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsGross",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "label": "Deferred Tax Assets, Gross",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r532"
     ]
    },
    "us-gaap_DeferredTaxAssetsInventory": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsInventory",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory differences to inventory valuation",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory."
       }
      }
     },
     "auth_ref": [
      "r1095"
     ]
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "label": "Deferred Tax Assets, Net",
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r1093"
     ]
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net deferred tax asset",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1093"
     ]
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsDomestic",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "NOL Federal Carryforward",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1095"
     ]
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "State NOL Carryforward",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1095"
     ]
    },
    "RIME_DeferredTaxAssetsRightUseOfLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "DeferredTaxAssetsRightUseOfLiability",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right of use liability",
        "documentation": "Deferred Tax Assets Right Use of Liability."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock option compensation expense",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation."
       }
      }
     },
     "auth_ref": [
      "r1095"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued vacation",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals."
       }
      }
     },
     "auth_ref": [
      "r1095"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reserve for estimated returns",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from estimated returns and sales allowances."
       }
      }
     },
     "auth_ref": [
      "r1095"
     ]
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsValuationAllowance",
     "crdr": "credit",
     "calculation": {
      "http://algoholdings.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/IncomeTaxesDetailsNarrative",
      "http://algoholdings.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred tax asset valuation allowance",
        "negatedLabel": "Less: valuation allowance",
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized."
       }
      }
     },
     "auth_ref": [
      "r533"
     ]
    },
    "us-gaap_DeferredTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://algoholdings.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Net deferred tax liability",
        "label": "Deferred Tax Liabilities, Net",
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r1093"
     ]
    },
    "us-gaap_DeferredTaxLiabilitiesPrepaidExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxLiabilitiesPrepaidExpenses",
     "crdr": "credit",
     "calculation": {
      "http://algoholdings.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Prepaid expenses",
        "label": "Deferred Tax Liabilities, Prepaid Expenses",
        "documentation": "Amount of deferred tax consequences attributable to taxable temporary differences derived from prepaid expenses."
       }
      }
     },
     "auth_ref": [
      "r1095"
     ]
    },
    "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://algoholdings.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Depreciable and amortizable assets",
        "label": "Deferred Tax Liabilities, Property, Plant and Equipment",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment."
       }
      }
     },
     "auth_ref": [
      "r1095"
     ]
    },
    "RIME_DeferredTaxLiabilitiesRightUseOfAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "DeferredTaxLiabilitiesRightUseOfAsset",
     "crdr": "credit",
     "calculation": {
      "http://algoholdings.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "ROU Asset",
        "documentation": "Deferred Tax Liabilities Right Use of Asset.",
        "label": "DeferredTaxLiabilitiesRightUseOfAsset"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "presentation": [
      "http://algoholdings.com/role/BalanceSheets",
      "http://algoholdings.com/role/LoansPayableRelatedPartiesDetailsNarrative",
      "http://algoholdings.com/role/ScheduleOfLoanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan Disclosure [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Depreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Depreciation",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/PropertyAndEquipmentDetailsNarrative",
      "http://algoholdings.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation",
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r37"
     ]
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeContractTypeDomain",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfStockOptionIssuedDuringYearDecember3120202021And2022Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset."
       }
      }
     },
     "auth_ref": [
      "r757",
      "r759",
      "r773",
      "r774",
      "r775",
      "r780",
      "r781",
      "r782",
      "r783",
      "r785",
      "r786",
      "r787",
      "r788",
      "r802",
      "r803",
      "r804",
      "r805",
      "r808",
      "r809",
      "r810",
      "r811",
      "r830",
      "r831",
      "r832",
      "r833",
      "r931",
      "r933",
      "r1114",
      "r1115",
      "r1116",
      "r1117",
      "r1118",
      "r1119",
      "r1121",
      "r1122"
     ]
    },
    "us-gaap_DerivativeDescriptionOfTerms": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeDescriptionOfTerms",
     "presentation": [
      "http://algoholdings.com/role/August2021PrivatePlacementDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative, Description of Terms",
        "documentation": "Description of the relevant terms of the derivative. Includes the type of instrument, risk being hedged, notional amount, counterparty, inception date, maturity date, relevant interest rates, strike price, cap price, and floor price."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeInstrumentRiskAxis",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfStockOptionIssuedDuringYearDecember3120202021And2022Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instrument [Axis]",
        "documentation": "Information by type of derivative contract."
       }
      }
     },
     "auth_ref": [
      "r69",
      "r70",
      "r71",
      "r145",
      "r757",
      "r759",
      "r773",
      "r774",
      "r775",
      "r780",
      "r781",
      "r782",
      "r783",
      "r785",
      "r786",
      "r787",
      "r788",
      "r802",
      "r803",
      "r804",
      "r805",
      "r808",
      "r809",
      "r810",
      "r811",
      "r830",
      "r831",
      "r832",
      "r833",
      "r860",
      "r931",
      "r933",
      "r1114",
      "r1115",
      "r1116",
      "r1117",
      "r1118",
      "r1119",
      "r1121",
      "r1122"
     ]
    },
    "us-gaap_DevelopedTechnologyRightsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DevelopedTechnologyRightsMember",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfConsiderationTransferredToAssetsAcquiredAndLiabilitiesAssumedDetailsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Developed Technology Rights [Member]",
        "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property."
       }
      }
     },
     "auth_ref": [
      "r142",
      "r1033",
      "r1034",
      "r1035",
      "r1036",
      "r1038",
      "r1039",
      "r1041",
      "r1042"
     ]
    },
    "srt_DirectorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "DirectorMember",
     "presentation": [
      "http://algoholdings.com/role/StockCompensationExpenseDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Director [Member]",
        "documentation": "Person serving on board of directors."
       }
      }
     },
     "auth_ref": [
      "r987",
      "r1018",
      "r1188"
     ]
    },
    "us-gaap_DirectorsAndOfficersLiabilityInsuranceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DirectorsAndOfficersLiabilityInsuranceMember",
     "presentation": [
      "http://algoholdings.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Directors and Officers Liability Insurance [Member]",
        "documentation": "Professional liability coverage for legal expenses and liability to shareholders, bondholders, creditors or others due to actions or omissions by a director or officer of a corporation or nonprofit organization."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "presentation": [
      "http://algoholdings.com/role/RevenueDisaggregationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF REVENUE BY PRODUCT LINE",
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor."
       }
      }
     },
     "auth_ref": [
      "r1059"
     ]
    },
    "RIME_DisclosureAtmOfferingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "DisclosureAtmOfferingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Atm Offering"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_DisclosureAugust2021PrivatePlacementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "DisclosureAugust2021PrivatePlacementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "August 2021 Private Placement",
        "verboseLabel": "Schedule Of Loss Before Income Taxes",
        "terseLabel": "Schedule Of Provision For Income Taxes"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_DisclosureAugust2021StockRedemptionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "DisclosureAugust2021StockRedemptionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "August 2021 Stock Redemption"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_DisclosureDueFromFactorAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "DisclosureDueFromFactorAbstract",
     "auth_ref": []
    },
    "RIME_DisclosureNotesPayableAndFinaningArrangementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "DisclosureNotesPayableAndFinaningArrangementsAbstract",
     "auth_ref": []
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "presentation": [
      "http://algoholdings.com/role/StockCompensationExpense"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "STOCK COMPENSATION EXPENSE",
        "documentation": "The entire disclosure for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r467",
      "r471",
      "r501",
      "r502",
      "r504",
      "r891"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_DisclosureOperatingLeasesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "DisclosureOperatingLeasesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Leases",
        "verboseLabel": "Schedule Of Supplemental Information Related To Leases",
        "terseLabel": "Schedule Of Lease Term And Discount Rate"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_DisclosurePrivatePlacementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "DisclosurePrivatePlacementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Private Placement"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_DisclosurePublicOfferingAndNasdaqUplistingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "DisclosurePublicOfferingAndNasdaqUplistingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Public Offering And Nasdaq Uplisting"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_DisclosureRecentDevelopmentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "DisclosureRecentDevelopmentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recent Developments"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_DisclosureSafePrivatePlacementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "DisclosureSafePrivatePlacementsAbstract",
     "auth_ref": []
    },
    "RIME_DisclosureSupplementalInformationCondensedFinancialInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "DisclosureSupplementalInformationCondensedFinancialInformationAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Information Condensed Financial Information",
        "verboseLabel": "Schedule Of Condensed Consolidated Statements Of Operations",
        "terseLabel": "Schedule Of Condensed Consolidated Statements Of Cash Flows"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_DisclosureWarrantsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "DisclosureWarrantsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_DiscountOnRoyaltyRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "DiscountOnRoyaltyRate",
     "presentation": [
      "http://algoholdings.com/role/AssetAcquisitionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Discount on royalty rate",
        "documentation": "Discount on royalty rate."
       }
      }
     },
     "auth_ref": []
    },
    "RIME_DiscountRateForWeightedAverageCost": {
     "xbrltype": "percentItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "DiscountRateForWeightedAverageCost",
     "presentation": [
      "http://algoholdings.com/role/AssetAcquisitionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Discount rate for weighted average cost",
        "documentation": "Discount rate for weighted average cost."
       }
      }
     },
     "auth_ref": []
    },
    "RIME_DisputeAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "DisputeAmount",
     "crdr": "credit",
     "presentation": [
      "http://algoholdings.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dispute. amount",
        "documentation": "Dispute amount."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://algoholdings.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r955"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://algoholdings.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r953",
      "r955",
      "r956"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://algoholdings.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://algoholdings.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://algoholdings.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://algoholdings.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://algoholdings.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r954"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://algoholdings.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r942"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://algoholdings.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r955"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://algoholdings.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r955"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://algoholdings.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r957"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://algoholdings.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://algoholdings.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r945"
     ]
    },
    "us-gaap_DomesticCountryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DomesticCountryMember",
     "presentation": [
      "http://algoholdings.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Domestic Tax Jurisdiction [Member]",
        "documentation": "Designated federal jurisdiction entitled to levy and collect income tax in country of domicile. Includes, but is not limited to, national jurisdiction for non-U.S. jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r519"
     ]
    },
    "RIME_DueAndPaidOnMayTwentyTwoThousandTwentyFourMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "DueAndPaidOnMayTwentyTwoThousandTwentyFourMember",
     "presentation": [
      "http://algoholdings.com/role/NotesPayableAndFinaningArrangementsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Due and paid on May 20, 2024 [Member]",
        "documentation": "Due And Paid On May Twenty Two Thousand Twenty Four [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DueFromBanks": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DueFromBanks",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Due from Banks",
        "documentation": "A bank's noninterest bearing demand deposits in other banks (such as correspondents)."
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "RIME_DueOnJulyOneTwoThousandTwentyFourMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "DueOnJulyOneTwoThousandTwentyFourMember",
     "presentation": [
      "http://algoholdings.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://algoholdings.com/role/NotesPayableAndFinaningArrangementsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Due on July 1, 2024 [Member]",
        "documentation": "Due On July One Two Thousand Twenty Four [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_DueOnJuneThreeTwoThousandTwentyFourMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "DueOnJuneThreeTwoThousandTwentyFourMember",
     "presentation": [
      "http://algoholdings.com/role/NotesPayableAndFinaningArrangementsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Due on June 3, 2024 [Member]",
        "documentation": "Due On June Three Two Thousand Twenty Four [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareAbstract",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfOperationsDetails",
      "http://algoholdings.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss per Common Share",
        "verboseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfOperationsDetails",
      "http://algoholdings.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r236",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r271",
      "r274",
      "r280",
      "r281",
      "r282",
      "r287",
      "r551",
      "r557",
      "r575",
      "r576",
      "r692",
      "r719",
      "r863"
     ]
    },
    "us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareBasicOtherDisclosuresAbstract",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfOperationsDetails",
      "http://algoholdings.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Common and Common Equivalent Shares:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfBasicAndDilutiveLossPerShareDetails",
      "http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfOperationsDetails",
      "http://algoholdings.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Diluted",
        "verboseLabel": "Earnings Per Share, Diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r236",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r274",
      "r280",
      "r281",
      "r282",
      "r287",
      "r551",
      "r557",
      "r575",
      "r576",
      "r692",
      "r719",
      "r863"
     ]
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerSharePolicyTextBlock",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "COMPUTATION OF EARNINGS (LOSS) PER SHARE",
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r25",
      "r284"
     ]
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareTextBlock",
     "presentation": [
      "http://algoholdings.com/role/ComputationOfLossPerShare"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "COMPUTATION OF LOSS PER SHARE",
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r270",
      "r283",
      "r285",
      "r286"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationLineItems",
     "presentation": [
      "http://algoholdings.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r519",
      "r520",
      "r894"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationTable",
     "presentation": [
      "http://algoholdings.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation [Table]",
        "documentation": "Disclosure of information about income tax rate reconciliation between amount of reported income tax expense (benefit) attributable to continuing operation to amount of income tax expense(benefit) that would result from applying statutory federal (national) tax rate to pretax income (loss) from continuing operation."
       }
      }
     },
     "auth_ref": [
      "r519",
      "r520",
      "r894"
     ]
    },
    "us-gaap_EmployeeBenefitsAndShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeBenefitsAndShareBasedCompensation",
     "crdr": "debit",
     "presentation": [
      "http://algoholdings.com/role/IssuanceOfCommonStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity compensation",
        "documentation": "Amount of expense for employee benefit and equity-based compensation."
       }
      }
     },
     "auth_ref": []
    },
    "RIME_EmployeeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "EmployeeMember",
     "presentation": [
      "http://algoholdings.com/role/StockCompensationExpenseDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee [Member]",
        "documentation": "Employee [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "presentation": [
      "http://algoholdings.com/role/IssuanceOfCommonStockDetailsNarrative",
      "http://algoholdings.com/role/StockCompensationExpenseDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average term",
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r503"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "crdr": "debit",
     "presentation": [
      "http://algoholdings.com/role/IssuanceOfCommonStockDetailsNarrative",
      "http://algoholdings.com/role/StockCompensationExpenseDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrecognised expense",
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1087"
     ]
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://algoholdings.com/role/ComputationOfLossPerShareDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": []
    },
    "RIME_EmployeesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "EmployeesMember",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfEmployeeStockOptionsOutstandingDetailsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employees [Member]",
        "documentation": "Employees [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_EmploymentAgreementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "EmploymentAgreementsMember",
     "presentation": [
      "http://algoholdings.com/role/AssetAcquisitionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employment Agreements [Member]",
        "documentation": "Employment Agreements [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://algoholdings.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://algoholdings.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://algoholdings.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://algoholdings.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://algoholdings.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://algoholdings.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://algoholdings.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://algoholdings.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesLineItems",
     "presentation": [
      "http://algoholdings.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesTable",
     "presentation": [
      "http://algoholdings.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Table]",
        "documentation": "Container of address information for the entity"
       }
      }
     },
     "auth_ref": [
      "r944"
     ]
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://algoholdings.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r948"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://algoholdings.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r944"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://algoholdings.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://algoholdings.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityDomain",
     "presentation": [
      "http://algoholdings.com/role/AccountsPayableAndAccruedExpenses",
      "http://algoholdings.com/role/AccountsPayableAndAccruedExpensesDetailsNarrative",
      "http://algoholdings.com/role/AccountsReceivable",
      "http://algoholdings.com/role/AccountsReceivableDetailsNarrative",
      "http://algoholdings.com/role/August2021PrivatePlacementDetailsNarrative",
      "http://algoholdings.com/role/August2021StockRedemptionDetailsNarrative",
      "http://algoholdings.com/role/BalanceSheets",
      "http://algoholdings.com/role/CommitmentsAndContingencies",
      "http://algoholdings.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://algoholdings.com/role/ConcentrationsOfCreditRiskAndRevenue",
      "http://algoholdings.com/role/ConcentrationsOfCreditRiskAndRevenueDetailsNarrative",
      "http://algoholdings.com/role/DueFromFactor",
      "http://algoholdings.com/role/DueFromFactorDetailsNarrative",
      "http://algoholdings.com/role/EmployeeBenefitPlans",
      "http://algoholdings.com/role/IncomeTaxes",
      "http://algoholdings.com/role/LiquidityGoingConcernAndManagementPlans",
      "http://algoholdings.com/role/LiquidityGoingConcernAndManagementPlansDetailsNarrative",
      "http://algoholdings.com/role/NatureOfBusiness",
      "http://algoholdings.com/role/NotesPayableAndFinaningArrangements",
      "http://algoholdings.com/role/NotesPayableAndFinaningArrangementsDetailsNarrative",
      "http://algoholdings.com/role/NotesPayableAndFinaningArrangementsTables",
      "http://algoholdings.com/role/PropertyAndEquipment",
      "http://algoholdings.com/role/PropertyAndEquipmentDetailsNarrative",
      "http://algoholdings.com/role/RelatedPartyTransactions",
      "http://algoholdings.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://algoholdings.com/role/SafePrivatePlacements",
      "http://algoholdings.com/role/SafePrivatePlacementsDetailsNarrative",
      "http://algoholdings.com/role/SafePrivatePlacementsTables",
      "http://algoholdings.com/role/ScheduleOfEstimatedUsefulLivesDetails",
      "http://algoholdings.com/role/ScheduleOfFirstTrancheOfSubscriptionsDetails",
      "http://algoholdings.com/role/ScheduleOfSpecificTermsDetails",
      "http://algoholdings.com/role/ScheduleOfStockOptionIssuedDuringYearDecember3120202021And2022Details",
      "http://algoholdings.com/role/StatementsOfOperations",
      "http://algoholdings.com/role/StockholdersEquity",
      "http://algoholdings.com/role/StockholdersEquityDetailsNarrative",
      "http://algoholdings.com/role/StockholdersEquityTables",
      "http://algoholdings.com/role/SummaryOfSignificantAccountingPolicies",
      "http://algoholdings.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://algoholdings.com/role/SummaryOfSignificantAccountingPoliciesPolicies",
      "http://algoholdings.com/role/SummaryOfTerminatedImmediatelyAfterClosingOfTransactionDetails",
      "http://algoholdings.com/role/SupplementalInformationCondensedFinancialInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://algoholdings.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r944"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://algoholdings.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r961"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://algoholdings.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://algoholdings.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r944"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://algoholdings.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://algoholdings.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r958"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://algoholdings.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r956"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://algoholdings.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://algoholdings.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r944"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://algoholdings.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r944"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://algoholdings.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r944"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://algoholdings.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r944"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://algoholdings.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://algoholdings.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r959"
     ]
    },
    "us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EntityWideInformationRevenueFromExternalCustomerLineItems",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfRevenueByProductLineDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from External Customer [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "RIME_EqualInstallmentsForThirteenMonthsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "EqualInstallmentsForThirteenMonthsMember",
     "presentation": [
      "http://algoholdings.com/role/NotesPayableAndFinaningArrangementsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equal installments for 13 months [Member]",
        "documentation": "Equal Installments For Thirteen Months [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://algoholdings.com/role/August2021PrivatePlacementDetailsNarrative",
      "http://algoholdings.com/role/LiquidityGoingConcernAndManagementPlansDetailsNarrative",
      "http://algoholdings.com/role/RecentDevelopmentsDetailsNarrative",
      "http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfShareholdersEquityDetails",
      "http://algoholdings.com/role/StatementsOfShareholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r211",
      "r232",
      "r233",
      "r234",
      "r255",
      "r256",
      "r257",
      "r259",
      "r264",
      "r266",
      "r268",
      "r289",
      "r353",
      "r354",
      "r380",
      "r452",
      "r540",
      "r541",
      "r548",
      "r549",
      "r550",
      "r552",
      "r556",
      "r557",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r574",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r596",
      "r599",
      "r612",
      "r717",
      "r734",
      "r735",
      "r736",
      "r751",
      "r814"
     ]
    },
    "us-gaap_EquityFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityFairValueDisclosure",
     "crdr": "credit",
     "presentation": [
      "http://algoholdings.com/role/August2021PrivatePlacementDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity, Fair Value Disclosure",
        "documentation": "Fair value of the entity's equity."
       }
      }
     },
     "auth_ref": [
      "r1109",
      "r1110",
      "r1120"
     ]
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "EquityMethodInvesteeNameDomain",
     "presentation": [
      "http://algoholdings.com/role/AssetAcquisitionDetailsNarrative",
      "http://algoholdings.com/role/RecentDevelopmentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of investment including named security. Excludes entity that is consolidated."
       }
      }
     },
     "auth_ref": [
      "r348",
      "r349",
      "r350",
      "r547",
      "r963",
      "r964",
      "r965",
      "r1099",
      "r1100",
      "r1101",
      "r1102"
     ]
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "presentation": [
      "http://algoholdings.com/role/AssetAcquisitionDetailsNarrative",
      "http://algoholdings.com/role/RecentDevelopmentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Membership percentage",
        "verboseLabel": "Ownership percentage",
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting."
       }
      }
     },
     "auth_ref": [
      "r348"
     ]
    },
    "RIME_EstimatedCostOfReturns": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "EstimatedCostOfReturns",
     "crdr": "debit",
     "presentation": [
      "http://algoholdings.com/role/RevenueDisaggregationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Estimated costs of returns",
        "documentation": "Estimated cost of returns."
       }
      }
     },
     "auth_ref": []
    },
    "RIME_EstimatedReserveOfAdvertisingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "EstimatedReserveOfAdvertisingExpense",
     "crdr": "debit",
     "presentation": [
      "http://algoholdings.com/role/RevenueDisaggregationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Estimated reserve co-op promotion incentives",
        "documentation": "Estimated reserve of advertising expense."
       }
      }
     },
     "auth_ref": []
    },
    "RIME_EuropeAndUnitedKingdomMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "EuropeAndUnitedKingdomMember",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfRevenueByGeographicalRegionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Europe and United Kingdom [Member]",
        "documentation": "Europe and United Kingdom [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_EuropeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "EuropeMember",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfSalesByGeographicalRegionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Europe [Member]",
        "documentation": "Continent of Europe."
       }
      }
     },
     "auth_ref": [
      "r983",
      "r984",
      "r985",
      "r986",
      "r1194",
      "r1195",
      "r1196",
      "r1197"
     ]
    },
    "RIME_ExercisePriceRangeOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "ExercisePriceRangeOneMember",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfWarrantsExpirationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price Range One [Member]",
        "documentation": "Exercise Price Range One [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_ExercisePriceRangeTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "ExercisePriceRangeTwoMember",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfWarrantsExpirationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price Range Two [Member]",
        "documentation": "Exercise Price Range Two [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Extension",
     "presentation": [
      "http://algoholdings.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueAdjustmentOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAdjustmentOfWarrants",
     "crdr": "debit",
     "presentation": [
      "http://algoholdings.com/role/PublicOfferingAndNasdaqUplistingDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair value adjustment of warrants",
        "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r6"
     ]
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurements",
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "FAIR VALUE OF FINANCIAL INSTRUMENTS",
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "us-gaap_FinancialInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinancialInstrumentAxis",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instrument [Axis]",
        "documentation": "Information by type of financial instrument."
       }
      }
     },
     "auth_ref": [
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r356",
      "r357",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r433",
      "r449",
      "r572",
      "r583",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r718",
      "r875",
      "r898",
      "r900",
      "r902",
      "r903",
      "r904",
      "r905",
      "r906",
      "r907",
      "r908",
      "r912",
      "r974",
      "r975",
      "r976",
      "r977",
      "r978",
      "r979",
      "r980",
      "r1022",
      "r1023",
      "r1024",
      "r1025",
      "r1108",
      "r1111",
      "r1112",
      "r1113",
      "r1120",
      "r1123"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfConsiderationTransferredToAssetsAcquiredAndLiabilitiesAssumedDetailsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfConsiderationTransferredToAssetsAcquiredAndLiabilitiesAssumedDetailsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table]",
        "documentation": "Disclosure of information about finite-lived intangible asset acquired in business combination."
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfConsiderationTransferredToAssetsAcquiredAndLiabilitiesAssumedDetailsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "documentation": "Information by major type or class of finite-lived intangible assets."
       }
      }
     },
     "auth_ref": [
      "r369",
      "r371",
      "r372",
      "r373",
      "r375",
      "r376",
      "r378",
      "r379",
      "r659",
      "r660",
      "r854"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfConsiderationTransferredToAssetsAcquiredAndLiabilitiesAssumedDetailsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company."
       }
      }
     },
     "auth_ref": [
      "r369",
      "r371",
      "r372",
      "r373",
      "r375",
      "r376",
      "r378",
      "r379",
      "r854"
     ]
    },
    "RIME_FirstMilestonePaymentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "FirstMilestonePaymentMember",
     "presentation": [
      "http://algoholdings.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "First Milestone Payment [Member]",
        "documentation": "First Milestone Payment [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_FirstPaymentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "FirstPaymentMember",
     "presentation": [
      "http://algoholdings.com/role/NotesPayableAndFinaningArrangementsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "First Payment [Member]",
        "documentation": "First Payment [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_ForeignAndDomesticRateOfAccountsReceivable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "ForeignAndDomesticRateOfAccountsReceivable",
     "presentation": [
      "http://algoholdings.com/role/DueFromFactorDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts receivable rate, description",
        "documentation": "Foreign and domestic rate of accounts receivable."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "FOREIGN CURRENCY TRANSLATION",
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy."
       }
      }
     },
     "auth_ref": [
      "r585"
     ]
    },
    "us-gaap_ForeignFinancialInstitutionsActualDeposits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ForeignFinancialInstitutionsActualDeposits",
     "crdr": "debit",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign financial institutions actual deposits",
        "documentation": "The amount of deposits held by branches of foreign institutions."
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "RIME_FortyFourSAFEAgreementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "FortyFourSAFEAgreementsMember",
     "presentation": [
      "http://algoholdings.com/role/SafePrivatePlacementsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "44 SAFE Agreements [Member]",
        "documentation": "Forty Four SAFE Agreements [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_FoundersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "FoundersMember",
     "presentation": [
      "http://algoholdings.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Founders [Member]",
        "documentation": "Founders [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_FourCustomersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "FourCustomersMember",
     "presentation": [
      "http://algoholdings.com/role/ConcentrationsOfCreditRiskAndRevenueDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Four Customers [Member]",
        "documentation": "Four Customers [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_FourMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "FourMember",
     "presentation": [
      "http://algoholdings.com/role/ConcentrationsOfCreditRiskAndRevenueDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "4 [Member]",
        "documentation": "Four [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FurnitureAndFixturesMember",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Furniture and Fixtures [Member]",
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases."
       }
      }
     },
     "auth_ref": []
    },
    "RIME_GainFromEmployeeRetentionCreditProgramRefund": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "GainFromEmployeeRetentionCreditProgramRefund",
     "crdr": "credit",
     "calculation": {
      "http://algoholdings.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gain from Employee Retention Credit Program refund",
        "documentation": "Gain from employee retention credit program refund"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_GainFromPaycheckProtectionPlanLoanForgiveness": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "GainFromPaycheckProtectionPlanLoanForgiveness",
     "crdr": "credit",
     "calculation": {
      "http://algoholdings.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 3.0
      },
      "http://algoholdings.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/StatementsOfCashFlows",
      "http://algoholdings.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gain from extinguishment of PPP loan forgiveness",
        "negatedLabel": "Paycheck Protection Plan loan forgiveness",
        "documentation": "Gain from paycheck protection plan loan forgiveness."
       }
      }
     },
     "auth_ref": []
    },
    "RIME_GainFromRelatedPartyDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "GainFromRelatedPartyDebt",
     "crdr": "credit",
     "calculation": {
      "http://algoholdings.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 2.0
      },
      "http://algoholdings.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/StatementsOfCashFlows",
      "http://algoholdings.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gain - related party",
        "negatedLabel": "Gain - related party",
        "documentation": "Gain from related party debt."
       }
      }
     },
     "auth_ref": []
    },
    "RIME_GainFromSettlementOfAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "GainFromSettlementOfAccountsPayable",
     "crdr": "credit",
     "calculation": {
      "http://algoholdings.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 4.0
      },
      "http://algoholdings.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 16.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/DamagedGoodsIncidentRecoveryDetailsNarrative",
      "http://algoholdings.com/role/StatementsOfCashFlows",
      "http://algoholdings.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gain from settlement of accounts payable",
        "negatedLabel": "Gain from extinguishment of accounts payable",
        "verboseLabel": "Settlement of accounts payable",
        "documentation": "Gain from settlement of accounts payable."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GainLossOnDispositionOfAssets1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GainLossOnDispositionOfAssets1",
     "crdr": "credit",
     "calculation": {
      "http://algoholdings.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gain on disposal of fixed assets",
        "documentation": "Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee."
       }
      }
     },
     "auth_ref": [
      "r1000"
     ]
    },
    "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GainLossOnSaleOfPropertyPlantEquipment",
     "crdr": "credit",
     "calculation": {
      "http://algoholdings.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "(Gain) loss from disposal of property and equipment",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment",
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_GainLossOnTerminationOfLease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GainLossOnTerminationOfLease",
     "crdr": "credit",
     "calculation": {
      "http://algoholdings.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/RecentDevelopmentsDetailsNarrative",
      "http://algoholdings.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Net (gain) loss on early termination of operating lease",
        "label": "Gain loss on termination of operating lease",
        "documentation": "Amount of gain (loss) on termination of lease before expiration of lease term."
       }
      }
     },
     "auth_ref": [
      "r600"
     ]
    },
    "RIME_GainOnTerminationOfOperatingLease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "GainOnTerminationOfOperatingLease",
     "crdr": "credit",
     "calculation": {
      "http://algoholdings.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Gain on termination of operating lease",
        "documentation": "Gain on termination of operating lease.",
        "label": "GainOnTerminationOfOperatingLease"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "crdr": "credit",
     "calculation": {
      "http://algoholdings.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 5.0
      },
      "http://algoholdings.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/StatementsOfCashFlows",
      "http://algoholdings.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss from extinguishment of debt",
        "negatedLabel": "Loss on debt extinguishment",
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r40",
      "r41"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General and administrative expenses",
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": [
      "r108",
      "r794"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GeneralAndAdministrativeExpenseMember",
     "presentation": [
      "http://algoholdings.com/role/IssuanceOfCommonStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General and Administrative Expense [Member]",
        "documentation": "Primary financial statement caption encompassing general and administrative expense."
       }
      }
     },
     "auth_ref": [
      "r108"
     ]
    },
    "us-gaap_GeographicConcentrationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GeographicConcentrationRiskMember",
     "presentation": [
      "http://algoholdings.com/role/ConcentrationsOfCreditRiskAndRevenueDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographic Concentration Risk [Member]",
        "documentation": "Reflects the percentage that a specified dollar value on the balance sheet or income statement in the period from one or more specified geographic areas is to a corresponding consolidated, segment, or product line amount. Risk is the materially adverse effects of economic decline or antagonistic political actions resulting in loss of assets, sales volume, labor supply, or source of materials and supplies in a US state or a specified country, continent, or region such as EMEA (Europe, Middle East, Africa)."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r841"
     ]
    },
    "us-gaap_Goodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Goodwill",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/BalanceSheets",
      "http://algoholdings.com/role/ScheduleOfConsiderationTransferredToAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill",
        "verboseLabel": "Estimated Goodwill",
        "documentation": "Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r220",
      "r368",
      "r691",
      "r870",
      "r876",
      "r899",
      "r911",
      "r1030",
      "r1031"
     ]
    },
    "us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Assets",
        "documentation": "Disclosure of accounting policy for indefinite-lived intangible assets (that is, those intangible assets not subject to amortization). This accounting policy also may address how the entity assesses whether events and circumstances continue to support an indefinite useful life and how the entity assesses and measures impairment of such assets."
       }
      }
     },
     "auth_ref": [
      "r1032"
     ]
    },
    "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Goodwill",
        "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r1029",
      "r1032"
     ]
    },
    "us-gaap_GrossProfit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GrossProfit",
     "crdr": "credit",
     "calculation": {
      "http://algoholdings.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      },
      "http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfOperationsDetails": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfOperationsDetails",
      "http://algoholdings.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Gross Profit (Loss)",
        "label": "Gross Profit",
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r106",
      "r161",
      "r249",
      "r351",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r584",
      "r865",
      "r869",
      "r1013",
      "r1014",
      "r1015",
      "r1016",
      "r1017",
      "r1056"
     ]
    },
    "RIME_GrowthRateOfDevelopmentOfNewBusiness": {
     "xbrltype": "percentItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "GrowthRateOfDevelopmentOfNewBusiness",
     "presentation": [
      "http://algoholdings.com/role/AssetAcquisitionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Growth rate of development of new business",
        "documentation": "Growth rate of development of new business."
       }
      }
     },
     "auth_ref": []
    },
    "RIME_GuyPrimusMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "GuyPrimusMember",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfStockOptionIssuedDuringYearDecember3120202021And2022Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Guy Primus [Member]",
        "documentation": "Guy Primus [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_HarshaBhatMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "HarshaBhatMember",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfStockOptionIssuedDuringYearDecember3120202021And2022Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Harsha Bhat [Member]",
        "documentation": "Harsha Bhat [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "LONG-LIVED ASSETS",
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r124"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "crdr": "credit",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfLossBeforeIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "United States",
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations."
       }
      }
     },
     "auth_ref": [
      "r250",
      "r518"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://algoholdings.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0,
       "order": 1.0
      },
      "http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfOperationsDetails": {
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfOperationsDetails",
      "http://algoholdings.com/role/ScheduleOfLossBeforeIncomeTaxesDetails",
      "http://algoholdings.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Loss Before Income Tax Benefit (Provision)",
        "label": "Loss before income taxes",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r103",
      "r156",
      "r161",
      "r693",
      "r713",
      "r865",
      "r869",
      "r1013",
      "r1014",
      "r1015",
      "r1016",
      "r1017"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "crdr": "credit",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfLossBeforeIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign",
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile."
       }
      }
     },
     "auth_ref": [
      "r250",
      "r518"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementAbstract",
     "presentation": [
      "http://algoholdings.com/role/SupplementalInformationCondensedFinancialInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://algoholdings.com/role/IssuanceOfCommonStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Income Location, Balance [Axis]",
        "documentation": "Information by location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r381",
      "r387",
      "r388",
      "r580",
      "r581",
      "r582",
      "r731",
      "r733",
      "r799",
      "r854",
      "r901",
      "r1152"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://algoholdings.com/role/IssuanceOfCommonStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r387",
      "r388",
      "r580",
      "r581",
      "r582",
      "r731",
      "r733",
      "r799",
      "r854",
      "r901",
      "r1152"
     ]
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxAuthorityAxis",
     "presentation": [
      "http://algoholdings.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Jurisdiction [Axis]",
        "documentation": "Information by income tax jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r244",
      "r519",
      "r520",
      "r528",
      "r537",
      "r894",
      "r1094"
     ]
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxAuthorityDomain",
     "presentation": [
      "http://algoholdings.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income tax jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r244",
      "r519",
      "r520",
      "r528",
      "r537",
      "r894",
      "r1094"
     ]
    },
    "us-gaap_IncomeTaxAuthorityNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxAuthorityNameAxis",
     "presentation": [
      "http://algoholdings.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Authority, Name [Axis]",
        "documentation": "Information by name of taxing authority."
       }
      }
     },
     "auth_ref": [
      "r528",
      "r1094"
     ]
    },
    "us-gaap_IncomeTaxAuthorityNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxAuthorityNameDomain",
     "presentation": [
      "http://algoholdings.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes."
       }
      }
     },
     "auth_ref": [
      "r528",
      "r1094"
     ]
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureAbstract",
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://algoholdings.com/role/IncomeTaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "INCOME TAXES",
        "documentation": "The entire disclosure for income tax."
       }
      }
     },
     "auth_ref": [
      "r251",
      "r513",
      "r519",
      "r525",
      "r526",
      "r527",
      "r530",
      "r535",
      "r542",
      "r544",
      "r545",
      "r546",
      "r745",
      "r894"
     ]
    },
    "us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxExaminationLikelihoodOfUnfavorableSettlement",
     "presentation": [
      "http://algoholdings.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Examination, Likelihood of Unfavorable Settlement",
        "documentation": "Description of the likelihood that an uncertainty in income taxes will not be sustained as a result of the examination by the taxing authority."
       }
      }
     },
     "auth_ref": [
      "r1092"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0,
       "order": 2.0
      },
      "http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfOperationsDetails": {
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0,
       "order": 2.0
      },
      "http://algoholdings.com/role/ScheduleOfProvisionForIncomeTaxesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://algoholdings.com/role/ScheduleOfTaxProvisionDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://algoholdings.com/role/IncomeTaxesDetailsNarrative",
      "http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfOperationsDetails",
      "http://algoholdings.com/role/ScheduleOfProvisionForIncomeTaxesDetails",
      "http://algoholdings.com/role/ScheduleOfTaxProvisionDetails",
      "http://algoholdings.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Income Tax Benefit (Provision)",
        "label": "Income Tax (benefit) provision",
        "totalLabel": "Total income tax provision",
        "negatedTerseLabel": "Income Tax Benefit (Loss)",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r166",
      "r179",
      "r267",
      "r268",
      "r288",
      "r298",
      "r307",
      "r517",
      "r519",
      "r543",
      "r720",
      "r894"
     ]
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxPolicyTextBlock",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "INCOME TAXES",
        "label": "Income Tax, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
       }
      }
     },
     "auth_ref": [
      "r231",
      "r515",
      "r516",
      "r530",
      "r531",
      "r534",
      "r539",
      "r742"
     ]
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/ScheduleOfTaxProvisionDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfTaxProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in valuation allowance",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r524",
      "r894",
      "r1090"
     ]
    },
    "us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationChangeInEnactedTaxRate",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/ScheduleOfTaxProvisionDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfTaxProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Permanent differences",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates."
       }
      }
     },
     "auth_ref": [
      "r514",
      "r519",
      "r523",
      "r894"
     ]
    },
    "RIME_IncomeTaxReconciliationChangeInExpirationOfNetOpretaingLossCarryforward": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "IncomeTaxReconciliationChangeInExpirationOfNetOpretaingLossCarryforward",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/ScheduleOfTaxProvisionDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfTaxProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expiration of net operating loss carryforward",
        "documentation": "Income tax reconciliation change in expiration of net opretaing loss carryforward."
       }
      }
     },
     "auth_ref": []
    },
    "RIME_IncomeTaxReconciliationChangeInPermanentDifferencesERCIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "IncomeTaxReconciliationChangeInPermanentDifferencesERCIncome",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/ScheduleOfTaxProvisionDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfTaxProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Permanent difference in ERC income",
        "documentation": "Income tax reconciliation change in permanent difference in ERC income."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/ScheduleOfTaxProvisionDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfTaxProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tax rate differential on foreign earnings",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r520",
      "r522",
      "r894",
      "r1090"
     ]
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/ScheduleOfTaxProvisionDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfTaxProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statutory federal tax rate",
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r519",
      "r894"
     ]
    },
    "us-gaap_IncomeTaxReconciliationOtherReconcilingItems": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationOtherReconcilingItems",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/ScheduleOfTaxProvisionDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfTaxProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other",
        "label": "Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount",
        "documentation": "Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying statutory federal (national) tax rate to pretax income (loss) from continuing operation attributable to other reconciling item. Excludes state and local income tax expense (benefit), federal tax expense (benefit), statutory income tax expense (benefit) outside of country of domicile, tax credit, nondeductible expense, deduction, income tax settlement, income tax contingency, and cross-border tax law."
       }
      }
     },
     "auth_ref": [
      "r1090",
      "r1091"
     ]
    },
    "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/ScheduleOfTaxProvisionDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfTaxProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stater tax rate",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r521",
      "r894",
      "r1090"
     ]
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxesPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://algoholdings.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash paid for income taxes",
        "documentation": "Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r244",
      "r536",
      "r537"
     ]
    },
    "us-gaap_IncreaseDecreaseDueFromAffiliates": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseDueFromAffiliates",
     "crdr": "credit",
     "calculation": {
      "http://algoholdings.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 18.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Due from banks",
        "label": "Increase (Decrease) Due from Affiliates",
        "documentation": "The increase (decrease) during the reporting period in receivables to be collected from an entity that is controlling, under the control of, or within the same control group as the reporting entity by means of direct or indirect ownership."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccountsPayable",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 23.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accounts payable",
        "label": "Increase (Decrease) in Accounts Payable",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "crdr": "credit",
     "calculation": {
      "http://algoholdings.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 17.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accounts receivable",
        "label": "Increase (Decrease) in Accounts Receivable",
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccountsReceivableRelatedParties",
     "crdr": "credit",
     "calculation": {
      "http://algoholdings.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 19.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accounts receivable \u2013 related parties",
        "label": "Increase (Decrease) in Accounts Receivable, Related Parties",
        "documentation": "The increase (decrease) during the reporting period in the amount due to the reporting entity for good and services provided to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management, an entity and its principal owners, management, member of their immediate families, affiliates, or other parties with the ability to exert significant influence."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 24.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accrued expenses",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 26.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Refunds due to customer",
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r656",
      "r999"
     ]
    },
    "us-gaap_IncreaseDecreaseInDueToRelatedParties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInDueToRelatedParties",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 25.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Due to related parties",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations to be paid to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management; an entity and its principal owners, management, or member of their immediate families; affiliates; or other parties with the ability to exert significant influence."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInInventories",
     "crdr": "credit",
     "calculation": {
      "http://algoholdings.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Inventories",
        "label": "Increase (Decrease) in Inventories",
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOperatingCapital",
     "crdr": "credit",
     "calculation": {
      "http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfCashFlowsDetails": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/AssetAcquisitionDetailsNarrative",
      "http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase decrease in operating capital",
        "negatedLabel": "Changes in operating assets and liabilities:",
        "documentation": "The increase (decrease) during the reporting period of all assets and liabilities used in operating activities."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://algoholdings.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in operating assets and liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 29.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating lease liabilities",
        "documentation": "Amount of increase (decrease) in obligation for operating lease."
       }
      }
     },
     "auth_ref": [
      "r971",
      "r999"
     ]
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOtherNoncurrentAssets",
     "crdr": "credit",
     "calculation": {
      "http://algoholdings.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 22.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other non-current assets",
        "label": "Increase (Decrease) in Other Noncurrent Assets",
        "documentation": "Amount of increase (decrease) in noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r999"
     ]
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "crdr": "credit",
     "calculation": {
      "http://algoholdings.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 21.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Prepaid expenses and other current assets",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "RIME_IncreaseDecreaseInPrepaidsFromCustomers": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "IncreaseDecreaseInPrepaidsFromCustomers",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 27.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaids from customers",
        "documentation": "Prepaids from customers."
       }
      }
     },
     "auth_ref": []
    },
    "RIME_IncreaseDecreaseInReserveForSalesReturns": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "IncreaseDecreaseInReserveForSalesReturns",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 28.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Reserve for sales returns",
        "documentation": "Reserve for sales returns.",
        "label": "IncreaseDecreaseInReserveForSalesReturns"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncrementalCommonSharesAttributableToCallOptionsAndWarrants",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfBasicAndDilutiveSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effect of dilutive stock options",
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method."
       }
      }
     },
     "auth_ref": [
      "r275",
      "r276",
      "r277",
      "r282"
     ]
    },
    "RIME_InitialPaymentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "InitialPaymentMember",
     "presentation": [
      "http://algoholdings.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Initial Payment [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InsuranceAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InsuranceAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insurance [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InsuranceDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InsuranceDisclosureTextBlock",
     "presentation": [
      "http://algoholdings.com/role/DamagedGoodsIncidentRecovery"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "DAMAGED GOODS INCIDENT RECOVERY",
        "documentation": "The entire disclosure for the types of coverages and products sold, and the assets, obligations, recorded liabilities, revenues and expenses arising therefrom, and the amounts of and methodologies and assumptions used in determining the amounts of such items."
       }
      }
     },
     "auth_ref": [
      "r695",
      "r696",
      "r727",
      "r728"
     ]
    },
    "RIME_InsuranceLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "InsuranceLiabilities",
     "crdr": "debit",
     "presentation": [
      "http://algoholdings.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insurance liabilities",
        "documentation": "Insurance liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible assets, net",
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges."
       }
      }
     },
     "auth_ref": [
      "r369",
      "r1039",
      "r1040"
     ]
    },
    "us-gaap_IntangibleAssetsNetIncludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IntangibleAssetsNetIncludingGoodwill",
     "crdr": "debit",
     "presentation": [
      "http://algoholdings.com/role/AssetAcquisitionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Identifiable intangible assets including goodwill",
        "documentation": "Amount, after impairment and amortization, of goodwill, indefinite-lived, and finite-lived intangible assets."
       }
      }
     },
     "auth_ref": [
      "r1028"
     ]
    },
    "us-gaap_InterestAndDebtExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestAndDebtExpense",
     "crdr": "debit",
     "presentation": [
      "http://algoholdings.com/role/FinancingDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest expenses",
        "documentation": "Interest and debt related expenses associated with nonoperating financing activities of the entity."
       }
      }
     },
     "auth_ref": [
      "r994"
     ]
    },
    "us-gaap_InterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestExpense",
     "crdr": "debit",
     "presentation": [
      "http://algoholdings.com/role/LoansPayableRelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Interest expense",
        "label": "Interest Expense, Operating and Nonoperating",
        "documentation": "Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense."
       }
      }
     },
     "auth_ref": [
      "r288",
      "r294",
      "r297",
      "r299",
      "r307",
      "r593",
      "r869",
      "r870"
     ]
    },
    "us-gaap_InterestExpenseDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestExpenseDebt",
     "crdr": "debit",
     "presentation": [
      "http://algoholdings.com/role/FinancingDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest expense",
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt."
       }
      }
     },
     "auth_ref": [
      "r110",
      "r428",
      "r436",
      "r882",
      "r883"
     ]
    },
    "us-gaap_InterestExpenseDebtExcludingAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestExpenseDebtExcludingAmortization",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Interest expense",
        "label": "Interest Expense, Debt, Excluding Amortization",
        "documentation": "Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs."
       }
      }
     },
     "auth_ref": [
      "r110",
      "r429",
      "r882",
      "r883"
     ]
    },
    "us-gaap_InterestPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://algoholdings.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash paid for interest",
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount."
       }
      }
     },
     "auth_ref": [
      "r239",
      "r242",
      "r243"
     ]
    },
    "us-gaap_InterestPayableCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestPayableCurrentAndNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://algoholdings.com/role/LoansPayableRelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued interest payable",
        "documentation": "Amount of interest payable on debt, including, but not limited to, trade payables."
       }
      }
     },
     "auth_ref": [
      "r150",
      "r1145"
     ]
    },
    "us-gaap_InternalRevenueServiceIRSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InternalRevenueServiceIRSMember",
     "presentation": [
      "http://algoholdings.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Internal Revenue Service (IRS) [Member]",
        "documentation": "Designated tax department of the United States of America government entitled to levy and collect income taxes from the entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InventoryNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryNet",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory",
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r227",
      "r859",
      "r911"
     ]
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryPolicyTextBlock",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "INVENTORY AND RETURNS ASSET",
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost."
       }
      }
     },
     "auth_ref": [
      "r168",
      "r216",
      "r226",
      "r365",
      "r366",
      "r367",
      "r657",
      "r862"
     ]
    },
    "RIME_InvestedValuationOfAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "InvestedValuationOfAmount",
     "crdr": "credit",
     "presentation": [
      "http://algoholdings.com/role/SafePrivatePlacementsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Invested valuation of amount",
        "documentation": "Invested valuation of amount."
       }
      }
     },
     "auth_ref": []
    },
    "RIME_InvestmentConvertedDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "InvestmentConvertedDate",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfFirstTrancheOfSubscriptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Converted Date",
        "documentation": "Investment converted date."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentHoldingsScheduleOfInvestmentsTableTextBlock",
     "presentation": [
      "http://algoholdings.com/role/SafePrivatePlacementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SUMMARY OF TERMINATED IMMEDIATELY AFTER CLOSING OF THE TRANSACTION",
        "documentation": "Tabular disclosure of data and information required in the supplementary schedule applicable to management investment companies listing holdings of unaffiliated investments."
       }
      }
     },
     "auth_ref": [
      "r1182",
      "r1183",
      "r1184",
      "r1185",
      "r1186",
      "r1187"
     ]
    },
    "RIME_InvestmentIssueDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "InvestmentIssueDate",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfFirstTrancheOfSubscriptionsDetails",
      "http://algoholdings.com/role/SummaryOfTerminatedImmediatelyAfterClosingOfTransactionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issue Date",
        "documentation": "Investment issue date."
       }
      }
     },
     "auth_ref": []
    },
    "RIME_InvestmentOfPrincipalAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "InvestmentOfPrincipalAmount",
     "crdr": "debit",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfFirstTrancheOfSubscriptionsDetails",
      "http://algoholdings.com/role/SummaryOfTerminatedImmediatelyAfterClosingOfTransactionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Principal",
        "documentation": "Investment of principal amount.",
        "label": "InvestmentOfPrincipalAmount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Investments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Investments",
     "crdr": "debit",
     "presentation": [
      "http://algoholdings.com/role/SafePrivatePlacementsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments."
       }
      }
     },
     "auth_ref": [
      "r697",
      "r698",
      "r928",
      "r930"
     ]
    },
    "RIME_IssuanceOfCommonStockAndWarrantsForOfferingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "IssuanceOfCommonStockAndWarrantsForOfferingCosts",
     "crdr": "credit",
     "presentation": [
      "http://algoholdings.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of common stock and warrants for offering costs",
        "documentation": "Issuance of common stock and warrants for offering costs."
       }
      }
     },
     "auth_ref": []
    },
    "RIME_IssuanceOfPublicOfferingTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "IssuanceOfPublicOfferingTextBlock",
     "presentation": [
      "http://algoholdings.com/role/PublicOfferingAndNasdaqUplisting"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PUBLIC OFFERING AND NASDAQ UPLISTING",
        "documentation": "Issuance of Public Offering [Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_JaganReddyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "JaganReddyMember",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfSpecificTermsDetails",
      "http://algoholdings.com/role/ScheduleOfStockOptionIssuedDuringYearDecember3120202021And2022Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Jagan Reddy [Member]",
        "documentation": "Jagan Reddy [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_JanuaryOneTwoThousandTwentyFiveMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "JanuaryOneTwoThousandTwentyFiveMember",
     "presentation": [
      "http://algoholdings.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "January 1, 2025 [Member]",
        "documentation": "January 1, 2025 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_JonahPetiPerrinMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "JonahPetiPerrinMember",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfStockOptionIssuedDuringYearDecember3120202021And2022Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Jonah Peti-Perrin [Member]",
        "documentation": "Jonah Peti Perrin [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_KadandaleSrinivasSudheerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "KadandaleSrinivasSudheerMember",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfStockOptionIssuedDuringYearDecember3120202021And2022Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Kadandale Srinivas Sudheer [Member]",
        "documentation": "Kadandale Srinivas Sudheer [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_KaraokeMachinesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "KaraokeMachinesMember",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfRevenueByProductLineDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Karaoke Machines [Member]",
        "documentation": "Karaoke Machines [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_KidsYouthElectronicsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "KidsYouthElectronicsMember",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfRevenueByProductLineDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Kids Youth Electronics [Member]",
        "documentation": "Kids Youth Electronics [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_KonceptsandTreasureGreenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "KonceptsandTreasureGreenMember",
     "presentation": [
      "http://algoholdings.com/role/August2021PrivatePlacementDetailsNarrative",
      "http://algoholdings.com/role/August2021StockRedemptionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Koncepts and Treasure Green [Member]",
        "documentation": "Koncepts and Treasure Green [Member]."
       }
      }
     },
     "auth_ref": []
    },
    "RIME_KoustavChoudhuriMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "KoustavChoudhuriMember",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfStockOptionIssuedDuringYearDecember3120202021And2022Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Koustav Choudhuri [Member]",
        "documentation": "Koustav Choudhuri [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_LeaseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "LeaseAgreementMember",
     "presentation": [
      "http://algoholdings.com/role/RecentDevelopmentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease Agreement [Member]",
        "documentation": "Lease Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseCostAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseCostAbstract",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfLeaseTermAndDiscountRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease term and Discount Rate"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseCostTableTextBlock",
     "presentation": [
      "http://algoholdings.com/role/OperatingLeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF LEASE TERM AND DISCOUNT RATE",
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income."
       }
      }
     },
     "auth_ref": [
      "r1130"
     ]
    },
    "us-gaap_LeaseExpirationDate1": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseExpirationDate1",
     "presentation": [
      "http://algoholdings.com/role/OperatingLeasesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease expiration, date",
        "documentation": "Date which lease or group of leases is set to expire, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "RIME_LeaseSettlementExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "LeaseSettlementExpense",
     "crdr": "debit",
     "presentation": [
      "http://algoholdings.com/role/RecentDevelopmentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease settlement expense",
        "documentation": "Lease settlement expense."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://algoholdings.com/role/AccountsPayableAndAccruedExpenses",
      "http://algoholdings.com/role/AccountsPayableAndAccruedExpensesDetailsNarrative",
      "http://algoholdings.com/role/AccountsReceivable",
      "http://algoholdings.com/role/AccountsReceivableDetailsNarrative",
      "http://algoholdings.com/role/August2021PrivatePlacementDetailsNarrative",
      "http://algoholdings.com/role/August2021StockRedemptionDetailsNarrative",
      "http://algoholdings.com/role/BalanceSheets",
      "http://algoholdings.com/role/CommitmentsAndContingencies",
      "http://algoholdings.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://algoholdings.com/role/ConcentrationsOfCreditRiskAndRevenue",
      "http://algoholdings.com/role/ConcentrationsOfCreditRiskAndRevenueDetailsNarrative",
      "http://algoholdings.com/role/DueFromFactor",
      "http://algoholdings.com/role/DueFromFactorDetailsNarrative",
      "http://algoholdings.com/role/EmployeeBenefitPlans",
      "http://algoholdings.com/role/IncomeTaxes",
      "http://algoholdings.com/role/LiquidityGoingConcernAndManagementPlans",
      "http://algoholdings.com/role/LiquidityGoingConcernAndManagementPlansDetailsNarrative",
      "http://algoholdings.com/role/NatureOfBusiness",
      "http://algoholdings.com/role/NotesPayableAndFinaningArrangements",
      "http://algoholdings.com/role/NotesPayableAndFinaningArrangementsDetailsNarrative",
      "http://algoholdings.com/role/NotesPayableAndFinaningArrangementsTables",
      "http://algoholdings.com/role/PropertyAndEquipment",
      "http://algoholdings.com/role/PropertyAndEquipmentDetailsNarrative",
      "http://algoholdings.com/role/RelatedPartyTransactions",
      "http://algoholdings.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://algoholdings.com/role/SafePrivatePlacements",
      "http://algoholdings.com/role/SafePrivatePlacementsDetailsNarrative",
      "http://algoholdings.com/role/SafePrivatePlacementsTables",
      "http://algoholdings.com/role/ScheduleOfEstimatedUsefulLivesDetails",
      "http://algoholdings.com/role/ScheduleOfFirstTrancheOfSubscriptionsDetails",
      "http://algoholdings.com/role/ScheduleOfSpecificTermsDetails",
      "http://algoholdings.com/role/ScheduleOfStockOptionIssuedDuringYearDecember3120202021And2022Details",
      "http://algoholdings.com/role/StatementsOfOperations",
      "http://algoholdings.com/role/StockholdersEquity",
      "http://algoholdings.com/role/StockholdersEquityDetailsNarrative",
      "http://algoholdings.com/role/StockholdersEquityTables",
      "http://algoholdings.com/role/SummaryOfSignificantAccountingPolicies",
      "http://algoholdings.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://algoholdings.com/role/SummaryOfSignificantAccountingPoliciesPolicies",
      "http://algoholdings.com/role/SummaryOfTerminatedImmediatelyAfterClosingOfTransactionDetails",
      "http://algoholdings.com/role/SupplementalInformationCondensedFinancialInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LegalFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LegalFees",
     "crdr": "debit",
     "presentation": [
      "http://algoholdings.com/role/AssetAcquisitionDetailsNarrative",
      "http://algoholdings.com/role/August2021PrivatePlacementDetailsNarrative",
      "http://algoholdings.com/role/DueFromFactorDetailsNarrative",
      "http://algoholdings.com/role/RecentDevelopmentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal and administrative expenses",
        "verboseLabel": "Legal fees",
        "terseLabel": "Dispute, amount",
        "documentation": "The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings."
       }
      }
     },
     "auth_ref": [
      "r973"
     ]
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeLeasesPolicyTextBlock",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "LEASES",
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee."
       }
      }
     },
     "auth_ref": [
      "r604"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://algoholdings.com/role/OperatingLeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF OPERATING LEASE MINIMUM FUTURE PAYMENTS",
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r1131"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "calculation": {
      "http://algoholdings.com/role/ScheduleOfOperatingLeaseMinimumFuturePaymentsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfOperatingLeaseMinimumFuturePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total minimum future payments",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease."
       }
      }
     },
     "auth_ref": [
      "r610"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "crdr": "credit",
     "calculation": {
      "http://algoholdings.com/role/ScheduleOfOperatingLeaseMinimumFuturePaymentsDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfOperatingLeaseMinimumFuturePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Thereafter",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r610"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://algoholdings.com/role/ScheduleOfOperatingLeaseMinimumFuturePaymentsDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfOperatingLeaseMinimumFuturePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2024",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r610"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "crdr": "credit",
     "calculation": {
      "http://algoholdings.com/role/ScheduleOfOperatingLeaseMinimumFuturePaymentsDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfOperatingLeaseMinimumFuturePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2028",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r610"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "crdr": "credit",
     "calculation": {
      "http://algoholdings.com/role/ScheduleOfOperatingLeaseMinimumFuturePaymentsDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfOperatingLeaseMinimumFuturePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2027",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r610"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "calculation": {
      "http://algoholdings.com/role/ScheduleOfOperatingLeaseMinimumFuturePaymentsDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfOperatingLeaseMinimumFuturePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2026",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r610"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://algoholdings.com/role/ScheduleOfOperatingLeaseMinimumFuturePaymentsDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfOperatingLeaseMinimumFuturePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2025",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r610"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "crdr": "credit",
     "calculation": {
      "http://algoholdings.com/role/ScheduleOfOperatingLeaseMinimumFuturePaymentsDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfOperatingLeaseMinimumFuturePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2024 (remaining six months)",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year."
       }
      }
     },
     "auth_ref": [
      "r1131"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfOperatingLeaseMinimumFuturePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Less: interest",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease."
       }
      }
     },
     "auth_ref": [
      "r610"
     ]
    },
    "us-gaap_LesseeOperatingLeaseOptionToExtend": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseOptionToExtend",
     "presentation": [
      "http://algoholdings.com/role/OperatingLeasesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease extension, description",
        "documentation": "Description of terms and conditions of option to extend lessee's operating lease. Includes, but is not limited to, information about option recognized as part of right-of-use asset and lease liability."
       }
      }
     },
     "auth_ref": [
      "r605"
     ]
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseTermOfContract",
     "presentation": [
      "http://algoholdings.com/role/RecentDevelopmentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease term",
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r1129"
     ]
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeasesTextBlock",
     "presentation": [
      "http://algoholdings.com/role/OperatingLeases"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "OPERATING LEASES",
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r598"
     ]
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://algoholdings.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Liabilities",
        "label": "Liabilities [Default Label]",
        "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r84",
      "r85",
      "r86",
      "r91",
      "r92",
      "r93",
      "r94",
      "r249",
      "r351",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r561",
      "r564",
      "r565",
      "r584",
      "r766",
      "r864",
      "r941",
      "r1056",
      "r1134",
      "r1135"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://algoholdings.com/role/BalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://algoholdings.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Liabilities and Shareholders\u2019 Equity",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r101",
      "r155",
      "r708",
      "r911",
      "r1002",
      "r1026",
      "r1124"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://algoholdings.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Shareholders\u2019 Equity"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://algoholdings.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Current Liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r86",
      "r215",
      "r249",
      "r351",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r561",
      "r564",
      "r565",
      "r584",
      "r911",
      "r1056",
      "r1134",
      "r1135"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://algoholdings.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_LicensedProductsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "LicensedProductsMember",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfRevenueByProductLineDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Licensed Products [Member]",
        "documentation": "Licensed Products [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LineOfCreditFacilityCommitmentFeeAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityCommitmentFeeAmount",
     "crdr": "debit",
     "presentation": [
      "http://algoholdings.com/role/RecentDevelopmentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Credit facility termination fee",
        "documentation": "Amount of the fee for available but unused credit capacity under the credit facility."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r90",
      "r398"
     ]
    },
    "us-gaap_LineOfCreditFacilityExpirationDate1": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityExpirationDate1",
     "presentation": [
      "http://algoholdings.com/role/FinancingDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revolving credit facility terminated date",
        "documentation": "Date the credit facility terminates, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r90"
     ]
    },
    "RIME_LineOfCreditFacilityInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "LineOfCreditFacilityInterestRate",
     "presentation": [
      "http://algoholdings.com/role/FinancingDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "The Prime Rate",
        "documentation": "Line of credit facility interest rate.",
        "label": "LineOfCreditFacilityInterestRate"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LineOfCreditFacilityInterestRateDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityInterestRateDescription",
     "presentation": [
      "http://algoholdings.com/role/FinancingDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Base rates of loan description",
        "documentation": "Description of interest rate for borrowing under credit facility. Includes, but is not limited to, terms and method for determining interest rate."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r90"
     ]
    },
    "us-gaap_LineOfCreditFacilityInterestRateDuringPeriod": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityInterestRateDuringPeriod",
     "presentation": [
      "http://algoholdings.com/role/FinancingDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "The Prime Rate",
        "documentation": "The effective interest rate during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r90"
     ]
    },
    "us-gaap_LineOfCreditFacilityLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityLineItems",
     "presentation": [
      "http://algoholdings.com/role/FinancingDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Line of Credit Facility [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r398",
      "r1001",
      "r1054"
     ]
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "crdr": "credit",
     "presentation": [
      "http://algoholdings.com/role/FinancingDetailsNarrative",
      "http://algoholdings.com/role/RecentDevelopmentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revolving credit facility",
        "verboseLabel": "Line of credit facility, maximum borrowing amount",
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r90"
     ]
    },
    "us-gaap_LineOfCreditFacilityTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityTable",
     "presentation": [
      "http://algoholdings.com/role/FinancingDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Line of Credit Facility [Table]",
        "documentation": "Disclosure of information about short-term and long-term contractual arrangements with lender under which borrowing can occur up to maximum amount. Includes, but is not limited to, letter of credit, standby letter of credit, and revolving credit arrangement."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r90",
      "r398",
      "r1001",
      "r1054"
     ]
    },
    "us-gaap_LitigationSettlementExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LitigationSettlementExpense",
     "crdr": "debit",
     "presentation": [
      "http://algoholdings.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments of litigation",
        "documentation": "Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees."
       }
      }
     },
     "auth_ref": [
      "r973"
     ]
    },
    "RIME_LoanAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "LoanAgreementMember",
     "presentation": [
      "http://algoholdings.com/role/RecentDevelopmentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loan Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LoansPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LoansPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://algoholdings.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loans from affiliates, current portion",
        "documentation": "Carrying value as of the balance sheet date of portion of long-term loans payable due within one year or the operating cycle if longer."
       }
      }
     },
     "auth_ref": [
      "r85"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://algoholdings.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "RIME_LogisticsServicesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "LogisticsServicesMember",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfRevenueByProductLineDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Logistics Services [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebtTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtTextBlock",
     "presentation": [
      "http://algoholdings.com/role/LoansPayableRelatedParties"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "LOANS PAYABLE \u2013 RELATED PARTIES",
        "documentation": "The entire disclosure for long-term debt."
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "us-gaap_LongTermLoansPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermLoansPayable",
     "crdr": "credit",
     "calculation": {
      "http://algoholdings.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loans from affiliates, net of current portion",
        "documentation": "Carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "us-gaap_LongTermNotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermNotesPayable",
     "crdr": "credit",
     "calculation": {
      "http://algoholdings.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/BalanceSheets",
      "http://algoholdings.com/role/ScheduleOfLoanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Notes payable to related parties, net of current portion",
        "totalLabel": "Notes payable to related parties, net of current portion",
        "documentation": "Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "us-gaap_LossContingencyDamagesAwardedValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LossContingencyDamagesAwardedValue",
     "crdr": "debit",
     "presentation": [
      "http://algoholdings.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss contingency damages awarded value",
        "documentation": "Amount of damages awarded to the plaintiff in the legal matter."
       }
      }
     },
     "auth_ref": [
      "r1049",
      "r1050",
      "r1051"
     ]
    },
    "us-gaap_LossContingencyDamagesPaidValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LossContingencyDamagesPaidValue",
     "crdr": "credit",
     "presentation": [
      "http://algoholdings.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "First milestone payment",
        "documentation": "Amount of damages paid to the plaintiff in the legal matter."
       }
      }
     },
     "auth_ref": [
      "r1049",
      "r1050",
      "r1051"
     ]
    },
    "us-gaap_LossContingencyDamagesSoughtValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LossContingencyDamagesSoughtValue",
     "crdr": "debit",
     "presentation": [
      "http://algoholdings.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Damages claimed",
        "documentation": "The value (monetary amount) of the award the plaintiff seeks in the legal matter."
       }
      }
     },
     "auth_ref": [
      "r1049",
      "r1050",
      "r1051"
     ]
    },
    "us-gaap_LossContingencyEstimateOfPossibleLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LossContingencyEstimateOfPossibleLoss",
     "crdr": "debit",
     "presentation": [
      "http://algoholdings.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss contingency estimate of possible loss value",
        "documentation": "Reflects the estimated amount of loss from the specified contingency as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r391",
      "r392",
      "r395",
      "r396",
      "r509",
      "r878"
     ]
    },
    "RIME_LossContingencyEstimateOfPossibleLossPerYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "LossContingencyEstimateOfPossibleLossPerYear",
     "crdr": "debit",
     "presentation": [
      "http://algoholdings.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss contingency estimate of possible loss per year",
        "documentation": "Loss contingency estimate of possible loss per year."
       }
      }
     },
     "auth_ref": []
    },
    "srt_MajorCustomersAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MajorCustomersAxis",
     "presentation": [
      "http://algoholdings.com/role/ConcentrationsOfCreditRiskAndRevenueDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]",
        "documentation": "Information by name or description of a single external customer or a group of external customers."
       }
      }
     },
     "auth_ref": [
      "r314",
      "r887",
      "r922",
      "r926",
      "r1059",
      "r1151",
      "r1153",
      "r1154",
      "r1156",
      "r1157",
      "r1158",
      "r1159",
      "r1160",
      "r1161",
      "r1162",
      "r1163",
      "r1164",
      "r1165",
      "r1166",
      "r1167",
      "r1168",
      "r1169",
      "r1170",
      "r1171",
      "r1172",
      "r1173",
      "r1174",
      "r1175",
      "r1176",
      "r1177",
      "r1178",
      "r1179",
      "r1180"
     ]
    },
    "us-gaap_MalpracticeInsuranceMaximumCoveragePerIncident": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MalpracticeInsuranceMaximumCoveragePerIncident",
     "crdr": "debit",
     "presentation": [
      "http://algoholdings.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Malpractice Insurance, Maximum Coverage Per Incident",
        "documentation": "Maximum coverage per malpractice claim provided by the insurance arrangement."
       }
      }
     },
     "auth_ref": [
      "r158"
     ]
    },
    "RIME_MarkSinkMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "MarkSinkMember",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfStockOptionIssuedDuringYearDecember3120202021And2022Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Mark Sink [Member]",
        "documentation": "Mark Sink [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MaximumMember",
     "presentation": [
      "http://algoholdings.com/role/AssetAcquisitionDetailsNarrative",
      "http://algoholdings.com/role/DueFromFactorDetailsNarrative",
      "http://algoholdings.com/role/FinancingDetailsNarrative",
      "http://algoholdings.com/role/ScheduleOfEstimatedUsefulLivesDetails",
      "http://algoholdings.com/role/ScheduleOfPropertyAndEquipmentDetails",
      "http://algoholdings.com/role/StockCompensationExpenseDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "documentation": "Upper limit of the provided range."
       }
      }
     },
     "auth_ref": [
      "r182",
      "r184",
      "r186",
      "r187",
      "r189",
      "r209",
      "r210",
      "r391",
      "r392",
      "r393",
      "r394",
      "r465",
      "r509",
      "r579",
      "r655",
      "r730",
      "r732",
      "r739",
      "r758",
      "r759",
      "r823",
      "r825",
      "r827",
      "r828",
      "r834",
      "r852",
      "r853",
      "r874",
      "r884",
      "r890",
      "r902",
      "r903",
      "r907",
      "r908",
      "r923",
      "r1058",
      "r1136",
      "r1137",
      "r1138",
      "r1139",
      "r1140",
      "r1141"
     ]
    },
    "us-gaap_MeasurementInputExercisePriceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MeasurementInputExercisePriceMember",
     "presentation": [
      "http://algoholdings.com/role/PublicOfferingAndNasdaqUplistingDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input, Exercise Price [Member]",
        "documentation": "Measurement input using agreed upon price for exchange of underlying asset."
       }
      }
     },
     "auth_ref": [
      "r1111",
      "r1112",
      "r1113"
     ]
    },
    "us-gaap_MeasurementInputExpectedDividendRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MeasurementInputExpectedDividendRateMember",
     "presentation": [
      "http://algoholdings.com/role/PublicOfferingAndNasdaqUplistingDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input, Expected Dividend Rate [Member]",
        "documentation": "Measurement input using expected dividend rate to be paid to holder of share per year."
       }
      }
     },
     "auth_ref": [
      "r1111",
      "r1112",
      "r1113"
     ]
    },
    "us-gaap_MeasurementInputExpectedTermMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MeasurementInputExpectedTermMember",
     "presentation": [
      "http://algoholdings.com/role/PublicOfferingAndNasdaqUplistingDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input, Expected Term [Member]",
        "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date."
       }
      }
     },
     "auth_ref": [
      "r1111",
      "r1112",
      "r1113"
     ]
    },
    "us-gaap_MeasurementInputPriceVolatilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MeasurementInputPriceVolatilityMember",
     "presentation": [
      "http://algoholdings.com/role/PublicOfferingAndNasdaqUplistingDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input, Price Volatility [Member]",
        "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns."
       }
      }
     },
     "auth_ref": [
      "r902",
      "r1111",
      "r1112",
      "r1113"
     ]
    },
    "us-gaap_MeasurementInputRiskFreeInterestRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MeasurementInputRiskFreeInterestRateMember",
     "presentation": [
      "http://algoholdings.com/role/PublicOfferingAndNasdaqUplistingDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input, Risk Free Interest Rate [Member]",
        "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss."
       }
      }
     },
     "auth_ref": [
      "r1111",
      "r1112",
      "r1113"
     ]
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MeasurementInputTypeAxis",
     "presentation": [
      "http://algoholdings.com/role/PublicOfferingAndNasdaqUplistingDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input Type [Axis]",
        "documentation": "Information by type of measurement input used to determine value of asset and liability."
       }
      }
     },
     "auth_ref": [
      "r577",
      "r578",
      "r579",
      "r902"
     ]
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MeasurementInputTypeDomain",
     "presentation": [
      "http://algoholdings.com/role/PublicOfferingAndNasdaqUplistingDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability."
       }
      }
     },
     "auth_ref": [
      "r577",
      "r578",
      "r579",
      "r902"
     ]
    },
    "RIME_MicrophonesAndAccessoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "MicrophonesAndAccessoriesMember",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfRevenueByProductLineDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Microphones and Accessories [Member]",
        "documentation": "Microphones and Accessories [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MinimumMember",
     "presentation": [
      "http://algoholdings.com/role/AssetAcquisitionDetailsNarrative",
      "http://algoholdings.com/role/DueFromFactorDetailsNarrative",
      "http://algoholdings.com/role/ScheduleOfEstimatedUsefulLivesDetails",
      "http://algoholdings.com/role/ScheduleOfPropertyAndEquipmentDetails",
      "http://algoholdings.com/role/StockCompensationExpenseDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "documentation": "Lower limit of the provided range."
       }
      }
     },
     "auth_ref": [
      "r182",
      "r184",
      "r186",
      "r187",
      "r189",
      "r209",
      "r210",
      "r391",
      "r392",
      "r393",
      "r394",
      "r465",
      "r509",
      "r579",
      "r655",
      "r730",
      "r732",
      "r739",
      "r758",
      "r759",
      "r823",
      "r825",
      "r827",
      "r828",
      "r834",
      "r852",
      "r853",
      "r874",
      "r884",
      "r890",
      "r902",
      "r903",
      "r907",
      "r923",
      "r1058",
      "r1136",
      "r1137",
      "r1138",
      "r1139",
      "r1140",
      "r1141"
     ]
    },
    "us-gaap_MinorityInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MinorityInterest",
     "crdr": "credit",
     "calculation": {
      "http://algoholdings.com/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-controlling interest",
        "documentation": "Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity."
       }
      }
     },
     "auth_ref": [
      "r100",
      "r154",
      "r249",
      "r351",
      "r399",
      "r401",
      "r402",
      "r403",
      "r406",
      "r407",
      "r584",
      "r707",
      "r770"
     ]
    },
    "RIME_MoldsAndToolingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "MoldsAndToolingMember",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Molds and tooling [Member]",
        "documentation": "Molds and tooling [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_MusicSubscriptionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "MusicSubscriptionsMember",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfRevenueByProductLineDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Music Subscriptions [Member]",
        "documentation": "Music Subscriptions [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_NameOfMajorCustomerDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "NameOfMajorCustomerDomain",
     "presentation": [
      "http://algoholdings.com/role/ConcentrationsOfCreditRiskAndRevenueDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Single external customer or group of external customers."
       }
      }
     },
     "auth_ref": [
      "r314",
      "r887",
      "r922",
      "r926",
      "r1059",
      "r1151",
      "r1153",
      "r1154",
      "r1156",
      "r1157",
      "r1158",
      "r1159",
      "r1160",
      "r1161",
      "r1162",
      "r1163",
      "r1164",
      "r1165",
      "r1166",
      "r1167",
      "r1168",
      "r1169",
      "r1170",
      "r1171",
      "r1172",
      "r1173",
      "r1174",
      "r1175",
      "r1176",
      "r1177",
      "r1178",
      "r1179",
      "r1180"
     ]
    },
    "us-gaap_NatureOfOperations": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NatureOfOperations",
     "presentation": [
      "http://algoholdings.com/role/NatureOfBusiness"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "NATURE OF BUSINESS",
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward."
       }
      }
     },
     "auth_ref": [
      "r169",
      "r180"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      },
      "http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfCashFlowsDetails": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfCashFlowsDetails",
      "http://algoholdings.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by financing activities",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r241"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfCashFlowsDetails",
      "http://algoholdings.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from financing activities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      },
      "http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfCashFlowsDetails": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfCashFlowsDetails",
      "http://algoholdings.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in investing activities",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r241"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfCashFlowsDetails",
      "http://algoholdings.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from investing activities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://algoholdings.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      },
      "http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfCashFlowsDetails": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfCashFlowsDetails",
      "http://algoholdings.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by (used in) operating activities",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r115",
      "r116",
      "r117"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfCashFlowsDetails",
      "http://algoholdings.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from operating activities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://algoholdings.com/role/StatementsOfOperations": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://algoholdings.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net Income (Loss) Available to Common Stockholders",
        "label": "Net Income (Loss) Attributable to Parent",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r107",
      "r117",
      "r157",
      "r213",
      "r229",
      "r230",
      "r234",
      "r249",
      "r258",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r267",
      "r268",
      "r278",
      "r351",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r551",
      "r557",
      "r576",
      "r584",
      "r716",
      "r792",
      "r812",
      "r813",
      "r939",
      "r1056"
     ]
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Net (income) loss attributable to non-controlling interest",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r68",
      "r144",
      "r229",
      "r230",
      "r264",
      "r267",
      "r268",
      "r715",
      "r992"
     ]
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "crdr": "credit",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfBasicAndDilutiveLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net income (loss) available to common stockholders",
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders."
       }
      }
     },
     "auth_ref": [
      "r238",
      "r260",
      "r261",
      "r262",
      "r263",
      "r271",
      "r272",
      "r279",
      "r282",
      "r557"
     ]
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "RECENT ACCOUNTING PRONOUNCEMENTS",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://algoholdings.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "RIME_NonControllingInterestAtFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "NonControllingInterestAtFairValue",
     "crdr": "credit",
     "presentation": [
      "http://algoholdings.com/role/AssetAcquisitionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-controlling interest at fair value",
        "documentation": "Non controlling interest at fair value."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "presentation": [
      "http://algoholdings.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Cash investing and financing cash flow information:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NoncontrollingInterestMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NoncontrollingInterestMember",
     "presentation": [
      "http://algoholdings.com/role/StatementsOfShareholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncontrolling Interest [Member]",
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest."
       }
      }
     },
     "auth_ref": [
      "r63",
      "r452",
      "r1007",
      "r1008",
      "r1009",
      "r1011",
      "r1192"
     ]
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://algoholdings.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      },
      "http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfOperationsDetails": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfOperationsDetails",
      "http://algoholdings.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Other Expenses",
        "label": "Other (Expenses) Income",
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)."
       }
      }
     },
     "auth_ref": [
      "r109"
     ]
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NonoperatingIncomeExpenseAbstract",
     "presentation": [
      "http://algoholdings.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NonrelatedPartyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NonrelatedPartyMember",
     "presentation": [
      "http://algoholdings.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonrelated Party [Member]",
        "documentation": "Party not related to reporting entity."
       }
      }
     },
     "auth_ref": [
      "r1004",
      "r1005"
     ]
    },
    "srt_NorthAmericaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "NorthAmericaMember",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfRevenueByGeographicalRegionDetails",
      "http://algoholdings.com/role/ScheduleOfSalesByGeographicalRegionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "North America [Member]",
        "documentation": "Continent of North America."
       }
      }
     },
     "auth_ref": [
      "r983",
      "r984",
      "r985",
      "r986",
      "r1194",
      "r1195",
      "r1196",
      "r1197"
     ]
    },
    "RIME_NotePayableAndFinancingArrangementsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "NotePayableAndFinancingArrangementsTextBlock",
     "presentation": [
      "http://algoholdings.com/role/NotesPayableAndFinaningArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "NOTES PAYABLE AND FINANING ARRANGEMENTS",
        "documentation": "Note Payable And Financing Arrangements [Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NotesPayable",
     "crdr": "credit",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfLoanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount due as of September 30, 2024",
        "documentation": "Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r152",
      "r1147",
      "r1148"
     ]
    },
    "us-gaap_NotesPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NotesPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://algoholdings.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/BalanceSheets",
      "http://algoholdings.com/role/ScheduleOfLoanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Notes payable",
        "verboseLabel": "Less: Current portion of notes payable to related parties",
        "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer."
       }
      }
     },
     "auth_ref": [
      "r84",
      "r85"
     ]
    },
    "RIME_OctoberOneTwoThousandTwentyFourMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "OctoberOneTwoThousandTwentyFourMember",
     "presentation": [
      "http://algoholdings.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "October 1 2024 [Member]",
        "documentation": "October One Two Thousand Twenty Four [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_OfficerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "OfficerMember",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfEmployeeStockOptionsOutstandingDetailsParenthetical",
      "http://algoholdings.com/role/StockCompensationExpenseDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Officer [Member]",
        "documentation": "Person with designation of officer."
       }
      }
     },
     "auth_ref": [
      "r316",
      "r987",
      "r1188"
     ]
    },
    "us-gaap_OperatingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingExpenses",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      },
      "http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfOperationsDetails": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfOperationsDetails",
      "http://algoholdings.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Operating Expenses",
        "verboseLabel": "Operating Expenses",
        "label": "Operating Expenses [Default Label]",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingExpensesAbstract",
     "presentation": [
      "http://algoholdings.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://algoholdings.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      },
      "http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfOperationsDetails": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfOperationsDetails",
      "http://algoholdings.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Loss from Operations",
        "label": "Operating Income (Loss)",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r161",
      "r865",
      "r1013",
      "r1014",
      "r1015",
      "r1016",
      "r1017"
     ]
    },
    "RIME_OperatingLeaseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "OperatingLeaseAgreementMember",
     "presentation": [
      "http://algoholdings.com/role/OperatingLeasesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease Agreement [Member]",
        "documentation": "Operating Lease Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseExpense",
     "crdr": "debit",
     "presentation": [
      "http://algoholdings.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://algoholdings.com/role/ScheduleOfLeaseTermAndDiscountRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating lease expense",
        "verboseLabel": "Operating lease expense as a component of general and administrative expenses",
        "documentation": "Amount of operating lease expense. Excludes sublease income."
       }
      }
     },
     "auth_ref": [
      "r1128"
     ]
    },
    "us-gaap_OperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiability",
     "crdr": "credit",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfOperatingLeaseMinimumFuturePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total operating lease liabilities",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease."
       }
      }
     },
     "auth_ref": [
      "r602"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityAbstract",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfSupplementalInformationRelatedToLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://algoholdings.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/BalanceSheets",
      "http://algoholdings.com/role/ScheduleOfOperatingLeaseMinimumFuturePaymentsDetails",
      "http://algoholdings.com/role/ScheduleOfSupplementalInformationRelatedToLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current portion of operating lease liabilities",
        "verboseLabel": "Current portion of operating leases",
        "terseLabel": "Less: current portion of lease liabilities",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r602"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://algoholdings.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/BalanceSheets",
      "http://algoholdings.com/role/ScheduleOfOperatingLeaseMinimumFuturePaymentsDetails",
      "http://algoholdings.com/role/ScheduleOfSupplementalInformationRelatedToLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating lease liabilities, net of current portion",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r602"
     ]
    },
    "us-gaap_OperatingLeasePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeasePayments",
     "crdr": "credit",
     "presentation": [
      "http://algoholdings.com/role/OperatingLeasesDetailsNarrative",
      "http://algoholdings.com/role/RecentDevelopmentsDetailsNarrative",
      "http://algoholdings.com/role/ScheduleOfLeaseTermAndDiscountRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease payments",
        "verboseLabel": "Operating cash flow paid for operating leases",
        "terseLabel": "Operating lease payments",
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use."
       }
      }
     },
     "auth_ref": [
      "r603",
      "r606"
     ]
    },
    "RIME_OperatingLeasePeriodicPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "OperatingLeasePeriodicPayments",
     "crdr": "credit",
     "presentation": [
      "http://algoholdings.com/role/RecentDevelopmentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "periodic lease payments",
        "documentation": "Operating lease periodic payments."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/BalanceSheets",
      "http://algoholdings.com/role/ScheduleOfSupplementalInformationRelatedToLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating leases - right of use assets",
        "verboseLabel": "Operating lease - right-of-use assets",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r601"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amortization of right of use assets",
        "documentation": "Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease."
       }
      }
     },
     "auth_ref": [
      "r1000"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfLeaseTermAndDiscountRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average discount rate",
        "documentation": "Weighted average discount rate for operating lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r609",
      "r910"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfLeaseTermAndDiscountRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average remaining lease term (months)",
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r608",
      "r910"
     ]
    },
    "us-gaap_OperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLossCarryforwards",
     "crdr": "debit",
     "presentation": [
      "http://algoholdings.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating loss carryforwards",
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws."
       }
      }
     },
     "auth_ref": [
      "r538"
     ]
    },
    "RIME_OptionsAndWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "OptionsAndWarrantsMember",
     "presentation": [
      "http://algoholdings.com/role/ComputationOfLossPerShareDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options and Warrants [Member]",
        "documentation": "Options and Warrants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "auth_ref": []
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other non-current assets",
        "documentation": "Amount of noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r221"
     ]
    },
    "us-gaap_OtherLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://algoholdings.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Due to related parties",
        "label": "Other Liabilities",
        "documentation": "Amount of liabilities classified as other."
       }
      }
     },
     "auth_ref": [
      "r151",
      "r700",
      "r762",
      "r763",
      "r941",
      "r1148",
      "r1188"
     ]
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://algoholdings.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/BalanceSheets",
      "http://algoholdings.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other current liabilities",
        "verboseLabel": "Other current liability",
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r85",
      "r911"
     ]
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://algoholdings.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other liabilities, net of current portion",
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r92"
     ]
    },
    "us-gaap_OtherReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherReceivables",
     "crdr": "debit",
     "presentation": [
      "http://algoholdings.com/role/FinancingDetailsNarrative",
      "http://algoholdings.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Due from Oxford Bank",
        "verboseLabel": "Other receivables",
        "documentation": "Amount due from parties in nontrade transactions, classified as other."
       }
      }
     },
     "auth_ref": [
      "r224",
      "r778",
      "r870",
      "r1149"
     ]
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://algoholdings.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r955"
     ]
    },
    "RIME_OthersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "OthersMember",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfRevenueByGeographicalRegionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Others [Member]",
        "documentation": "Others [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PayablesAndAccrualsAbstract",
     "auth_ref": []
    },
    "RIME_PaymentOfDeferredFinancingCharges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "PaymentOfDeferredFinancingCharges",
     "crdr": "credit",
     "calculation": {
      "http://algoholdings.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payment of deferred financing charges",
        "documentation": "Payment of deferred financing charges.",
        "label": "PaymentOfDeferredFinancingCharges"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_PaymentOfEarlyTerminationFeeOnOperatingLeaseTerminationSettlement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "PaymentOfEarlyTerminationFeeOnOperatingLeaseTerminationSettlement",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payment of early termination fee on operating lease termination settlement",
        "documentation": "Payment of early termination fee on operating lease termination settlement."
       }
      }
     },
     "auth_ref": []
    },
    "RIME_PaymentOfEarlyTerminationFeesOnRevolvingLinesOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "PaymentOfEarlyTerminationFeesOnRevolvingLinesOfCredit",
     "crdr": "credit",
     "calculation": {
      "http://algoholdings.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payment of early termination fees on revolving lines of credit",
        "documentation": "Payment of early termination fees on revolving lines of credit.",
        "label": "PaymentOfEarlyTerminationFeesOnRevolvingLinesOfCredit"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_PaymentOfRedemptionAndRetirementOfTreasuryStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "PaymentOfRedemptionAndRetirementOfTreasuryStock",
     "crdr": "credit",
     "calculation": {
      "http://algoholdings.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payment of redemption and retirement of treasury stock",
        "documentation": "Payment of redemption and retirement of treasury stock.",
        "label": "PaymentOfRedemptionAndRetirementOfTreasuryStock"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsForCommissions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsForCommissions",
     "crdr": "credit",
     "presentation": [
      "http://algoholdings.com/role/PublicOfferingAndNasdaqUplistingDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underwriting discounts and commissions and other estimated offering expenses",
        "documentation": "The amount of cash paid for commissions during the current period."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_PaymentsForLegalSettlements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsForLegalSettlements",
     "crdr": "credit",
     "presentation": [
      "http://algoholdings.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Remaining settlement",
        "documentation": "The amount of cash paid for the settlement of litigation or for other legal issues during the period."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "RIME_PaymentsForMilestone": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "PaymentsForMilestone",
     "crdr": "credit",
     "presentation": [
      "http://algoholdings.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments for milestone",
        "documentation": "Payments for milestone."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsForRent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsForRent",
     "crdr": "credit",
     "presentation": [
      "http://algoholdings.com/role/OperatingLeasesDetailsNarrative",
      "http://algoholdings.com/role/RecentDevelopmentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Initial base rent",
        "verboseLabel": "Base rent payment",
        "documentation": "Cash payments to lessor's for use of assets under operating leases."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_PaymentsForRepurchaseOfPrivatePlacement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsForRepurchaseOfPrivatePlacement",
     "crdr": "credit",
     "presentation": [
      "http://algoholdings.com/role/August2021PrivatePlacementDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash payment for private placement",
        "documentation": "The cash outflow associated with the repurchase of amount received from entity's raising of capital via private rather than public placement."
       }
      }
     },
     "auth_ref": [
      "r113"
     ]
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsOfStockIssuanceCosts",
     "crdr": "credit",
     "presentation": [
      "http://algoholdings.com/role/August2021PrivatePlacementDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payment of stock issuance expenses",
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    },
    "RIME_PaymentsOnInstallmentNote": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "PaymentsOnInstallmentNote",
     "crdr": "credit",
     "calculation": {
      "http://algoholdings.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payments on installment notes",
        "documentation": "Payments on installment notes.",
        "label": "PaymentsOnInstallmentNote"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://algoholdings.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchase of property and equipment",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r112"
     ]
    },
    "RIME_PerYearMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "PerYearMember",
     "presentation": [
      "http://algoholdings.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Per Year [Member]",
        "documentation": "Per Year [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_PercentageOfExitFee": {
     "xbrltype": "percentItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "PercentageOfExitFee",
     "presentation": [
      "http://algoholdings.com/role/FinancingDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage of exit fee",
        "documentation": "Percentage of exit fee."
       }
      }
     },
     "auth_ref": []
    },
    "RIME_PercentageOfGrossProceeds": {
     "xbrltype": "percentItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "PercentageOfGrossProceeds",
     "presentation": [
      "http://algoholdings.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage of gross proceeds",
        "documentation": "Percentage of gross proceeds."
       }
      }
     },
     "auth_ref": []
    },
    "RIME_PercentageOfPurchasersRightToParticipateOnIssuanceCompanyOfCommonStock": {
     "xbrltype": "percentItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "PercentageOfPurchasersRightToParticipateOnIssuanceCompanyOfCommonStock",
     "presentation": [
      "http://algoholdings.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage of purchasers right to participate on issuance company of common stock",
        "documentation": "Percentage of purchasers right to participate on issuance company of common stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PlanNameAxis",
     "presentation": [
      "http://algoholdings.com/role/IssuanceOfCommonStockDetailsNarrative",
      "http://algoholdings.com/role/StockCompensationExpenseDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Plan Name [Axis]",
        "documentation": "Information by plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1061",
      "r1062",
      "r1063",
      "r1064",
      "r1065",
      "r1066",
      "r1067",
      "r1068",
      "r1069",
      "r1070",
      "r1071",
      "r1072",
      "r1073",
      "r1074",
      "r1075",
      "r1076",
      "r1077",
      "r1078",
      "r1079",
      "r1080",
      "r1081",
      "r1082",
      "r1083",
      "r1084",
      "r1085",
      "r1086"
     ]
    },
    "us-gaap_PlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PlanNameDomain",
     "presentation": [
      "http://algoholdings.com/role/IssuanceOfCommonStockDetailsNarrative",
      "http://algoholdings.com/role/StockCompensationExpenseDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1061",
      "r1062",
      "r1063",
      "r1064",
      "r1065",
      "r1066",
      "r1067",
      "r1068",
      "r1069",
      "r1070",
      "r1071",
      "r1072",
      "r1073",
      "r1074",
      "r1075",
      "r1076",
      "r1077",
      "r1078",
      "r1079",
      "r1080",
      "r1081",
      "r1082",
      "r1083",
      "r1084",
      "r1085",
      "r1086"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://algoholdings.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r949"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://algoholdings.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r951"
     ]
    },
    "RIME_PreFundedWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "PreFundedWarrantsMember",
     "presentation": [
      "http://algoholdings.com/role/August2021PrivatePlacementDetailsNarrative",
      "http://algoholdings.com/role/ComputationOfLossPerShareDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Funded Warrants [Member]",
        "documentation": "Pre Funded Warrants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockParOrStatedValuePerShare",
     "presentation": [
      "http://algoholdings.com/role/BalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock, par value",
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer."
       }
      }
     },
     "auth_ref": [
      "r95",
      "r438"
     ]
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesAuthorized",
     "presentation": [
      "http://algoholdings.com/role/BalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock, shares authorized",
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r95",
      "r768"
     ]
    },
    "us-gaap_PreferredStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesIssued",
     "presentation": [
      "http://algoholdings.com/role/BalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock, shares issued",
        "documentation": "Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt."
       }
      }
     },
     "auth_ref": [
      "r95",
      "r438"
     ]
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesOutstanding",
     "presentation": [
      "http://algoholdings.com/role/BalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock, shares outstanding",
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased."
       }
      }
     },
     "auth_ref": [
      "r95",
      "r768",
      "r790",
      "r1192",
      "r1193"
     ]
    },
    "us-gaap_PreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockValue",
     "crdr": "credit",
     "calculation": {
      "http://algoholdings.com/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred equity",
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r95",
      "r704",
      "r911"
     ]
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/BalanceSheets",
      "http://algoholdings.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid Expenses and other current assets",
        "verboseLabel": "Prepaid expense",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r991"
     ]
    },
    "RIME_PrepaidExpensesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "PrepaidExpensesPolicyTextBlock",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PREPAID EXPENSES",
        "documentation": "Prepaid Expenses [Policy Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "RECLASSIFICATION OF PRIOR YEARS PRESENTATION",
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error."
       }
      }
     },
     "auth_ref": [
      "r989"
     ]
    },
    "RIME_PrivatePlacementIssueDiscount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "PrivatePlacementIssueDiscount",
     "crdr": "credit",
     "presentation": [
      "http://algoholdings.com/role/RecentDevelopmentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Private placement issue discount",
        "documentation": "Private placement issue discount."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrivatePlacementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrivatePlacementMember",
     "presentation": [
      "http://algoholdings.com/role/August2021PrivatePlacementDetailsNarrative",
      "http://algoholdings.com/role/PrivatePlacementDetailsNarrative",
      "http://algoholdings.com/role/RecentDevelopmentsDetailsNarrative",
      "http://algoholdings.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Private Placement [Member]",
        "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts."
       }
      }
     },
     "auth_ref": []
    },
    "RIME_PrivatePlacementTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "PrivatePlacementTextBlock",
     "presentation": [
      "http://algoholdings.com/role/PrivatePlacement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PRIVATE PLACEMENT",
        "documentation": "Private Placement [Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_ProceedsFromCollectionOfSubscriptionsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "ProceedsFromCollectionOfSubscriptionsReceivable",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collection of subscriptions receivable",
        "documentation": "Proceeds from collection of subscriptions receivable."
       }
      }
     },
     "auth_ref": []
    },
    "RIME_ProceedsFromExerciseOfCommonStockWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "ProceedsFromExerciseOfCommonStockWarrants",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from exercise of common stock warrants",
        "documentation": "Proceeds from exercise of common stock warrants."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/PublicOfferingAndNasdaqUplistingDetailsNarrative",
      "http://algoholdings.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from issuance of stock, net of offering costs",
        "verboseLabel": "Gross proceeds",
        "documentation": "The cash inflow from the additional capital contribution to the entity."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfDebt",
     "crdr": "debit",
     "presentation": [
      "http://algoholdings.com/role/NotesPayableAndFinaningArrangementsDetailsNarrative",
      "http://algoholdings.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net proceeds",
        "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt."
       }
      }
     },
     "auth_ref": [
      "r997"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfPrivatePlacement",
     "crdr": "debit",
     "presentation": [
      "http://algoholdings.com/role/RecentDevelopmentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from private placement",
        "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOrSaleOfEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOrSaleOfEquity",
     "crdr": "debit",
     "presentation": [
      "http://algoholdings.com/role/AtmOfferingDetailsNarrative",
      "http://algoholdings.com/role/PrivatePlacementDetailsNarrative",
      "http://algoholdings.com/role/RecentDevelopmentsDetailsNarrative",
      "http://algoholdings.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from sale of equity",
        "verboseLabel": "Net proceeds",
        "documentation": "The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r743"
     ]
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other."
       }
      }
     },
     "auth_ref": [
      "r968",
      "r995"
     ]
    },
    "us-gaap_ProceedsFromPreviousAcquisition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromPreviousAcquisition",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash received from purchase of SemiCab Inc",
        "documentation": "Cash inflow representing an adjustment to the purchase price of a previous acquisition."
       }
      }
     },
     "auth_ref": [
      "r967"
     ]
    },
    "us-gaap_ProceedsFromRepaymentsOfLinesOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromRepaymentsOfLinesOfCredit",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net (payment) proceeds from revolving lines of credit",
        "documentation": "The net cash inflow or cash outflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with either short term or long term maturity that is collateralized (backed by pledge, mortgage or other lien in the entity's assets)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disposal of property and equipment",
        "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r111"
     ]
    },
    "us-gaap_ProceedsFromShortTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromShortTermDebt",
     "crdr": "debit",
     "presentation": [
      "http://algoholdings.com/role/FinancingDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net proceeds from short term debt",
        "documentation": "The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromStockOptionsExercised",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from exercise of stock options",
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r15"
     ]
    },
    "us-gaap_ProceedsFromWarrantExercises": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromWarrantExercises",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/August2021PrivatePlacementDetailsNarrative",
      "http://algoholdings.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from exercise of pre-funded warrants",
        "verboseLabel": "Proceeds from warrant exercises",
        "documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants."
       }
      }
     },
     "auth_ref": [
      "r996"
     ]
    },
    "RIME_ProductDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "ProductDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product development",
        "documentation": "Product development expense."
       }
      }
     },
     "auth_ref": []
    },
    "srt_ProductOrServiceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ProductOrServiceAxis",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfRevenueByProductLineDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "documentation": "Information by product and service, or group of similar products and similar services."
       }
      }
     },
     "auth_ref": [
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r207",
      "r310",
      "r658",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r729",
      "r856",
      "r885",
      "r921",
      "r923",
      "r924",
      "r927",
      "r929",
      "r988",
      "r1052",
      "r1053",
      "r1059",
      "r1151",
      "r1153",
      "r1154",
      "r1155",
      "r1156",
      "r1157",
      "r1158",
      "r1159",
      "r1160",
      "r1161",
      "r1162",
      "r1163",
      "r1164",
      "r1165",
      "r1166",
      "r1167",
      "r1168",
      "r1169",
      "r1170",
      "r1171",
      "r1172",
      "r1173",
      "r1174",
      "r1175",
      "r1176",
      "r1177",
      "r1178",
      "r1179",
      "r1180"
     ]
    },
    "srt_ProductsAndServicesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ProductsAndServicesDomain",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfRevenueByProductLineDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product or service, or a group of similar products or similar services."
       }
      }
     },
     "auth_ref": [
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r207",
      "r310",
      "r658",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r729",
      "r856",
      "r885",
      "r921",
      "r923",
      "r924",
      "r927",
      "r929",
      "r988",
      "r1052",
      "r1053",
      "r1059",
      "r1151",
      "r1153",
      "r1154",
      "r1155",
      "r1156",
      "r1157",
      "r1158",
      "r1159",
      "r1160",
      "r1161",
      "r1162",
      "r1163",
      "r1164",
      "r1165",
      "r1166",
      "r1167",
      "r1168",
      "r1169",
      "r1170",
      "r1171",
      "r1172",
      "r1173",
      "r1174",
      "r1175",
      "r1176",
      "r1177",
      "r1178",
      "r1179",
      "r1180"
     ]
    },
    "us-gaap_ProfessionalFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProfessionalFees",
     "crdr": "debit",
     "presentation": [
      "http://algoholdings.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Software support service",
        "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer."
       }
      }
     },
     "auth_ref": [
      "r869",
      "r939",
      "r1190",
      "r1191"
     ]
    },
    "us-gaap_ProfitLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProfitLoss",
     "crdr": "credit",
     "calculation": {
      "http://algoholdings.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      },
      "http://algoholdings.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      },
      "http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfCashFlowsDetails": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      },
      "http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfOperationsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfCashFlowsDetails",
      "http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfOperationsDetails",
      "http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfShareholdersEquityDetails",
      "http://algoholdings.com/role/StatementsOfCashFlows",
      "http://algoholdings.com/role/StatementsOfOperations",
      "http://algoholdings.com/role/StatementsOfShareholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net Loss",
        "label": "Net income (Ioss)",
        "verboseLabel": "Net (loss) income",
        "terseLabel": "Net loss",
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r213",
      "r229",
      "r230",
      "r240",
      "r249",
      "r258",
      "r264",
      "r267",
      "r268",
      "r351",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r551",
      "r557",
      "r559",
      "r562",
      "r563",
      "r576",
      "r584",
      "r693",
      "r714",
      "r750",
      "r792",
      "r812",
      "r813",
      "r896",
      "r897",
      "r940",
      "r992",
      "r1056"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "presentation": [
      "http://algoholdings.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://algoholdings.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Lived Tangible Asset [Axis]",
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r611"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "presentation": [
      "http://algoholdings.com/role/PropertyAndEquipment"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PROPERTY AND EQUIPMENT",
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r122",
      "r173",
      "r176",
      "r177"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentGross",
     "crdr": "debit",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property and equipment, gross",
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r123",
      "r218",
      "r712"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r611"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/BalanceSheets",
      "http://algoholdings.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property and equipment, net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r611",
      "r694",
      "r712",
      "r911"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "PROPERTY AND EQUIPMENT",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r173",
      "r176",
      "r710"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "presentation": [
      "http://algoholdings.com/role/PropertyAndEquipmentTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF PROPERTY AND EQUIPMENT",
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "presentation": [
      "http://algoholdings.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://algoholdings.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "auth_ref": [
      "r123",
      "r611"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfEstimatedUsefulLivesDetails",
      "http://algoholdings.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Average useful life (in years)",
        "verboseLabel": "Property plant and equipment useful life",
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProvisionForDoubtfulAccounts",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/AccountsReceivableDetailsNarrative",
      "http://algoholdings.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Credit losses",
        "verboseLabel": "Allowance for doubtful accounts",
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r237",
      "r358"
     ]
    },
    "RIME_ProvisionForEstimatedCostOfReturns": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "ProvisionForEstimatedCostOfReturns",
     "crdr": "credit",
     "calculation": {
      "http://algoholdings.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Provision for estimated cost of returns",
        "documentation": "Provision for estimated cost of returns.",
        "label": "ProvisionForEstimatedCostOfReturns"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_ProvisionForInventoryObsolescence": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "ProvisionForInventoryObsolescence",
     "crdr": "credit",
     "calculation": {
      "http://algoholdings.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Provision for inventory obsolesence",
        "documentation": "Provision for inventory obsolescence.",
        "label": "ProvisionForInventoryObsolescence"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_ProvisionForLegalLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "ProvisionForLegalLiability",
     "crdr": "credit",
     "calculation": {
      "http://algoholdings.com/role/BalanceSheets": {
       "parentTag": "us-gaap_CommitmentsAndContingencies",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Provision for legal liability",
        "documentation": "Provision for legal liability"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_PurchaseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "PurchaseAgreementMember",
     "presentation": [
      "http://algoholdings.com/role/August2021PrivatePlacementDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchase Agreement [Member]",
        "documentation": "Purchase Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_PurchasesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "PurchasesMember",
     "presentation": [
      "http://algoholdings.com/role/ConcentrationsOfCreditRiskAndRevenueDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchases [Member]",
        "documentation": "Purchases [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_RajivSaxenaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "RajivSaxenaMember",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfStockOptionIssuedDuringYearDecember3120202021And2022Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rajiv Saxena [Member]",
        "documentation": "Rajiv Saxena [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_RajivVirmaniMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "RajivVirmaniMember",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfStockOptionIssuedDuringYearDecember3120202021And2022Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rajiv Virmani [Member]",
        "documentation": "Rajiv Virmani [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeAxis",
     "presentation": [
      "http://algoholdings.com/role/AssetAcquisitionDetailsNarrative",
      "http://algoholdings.com/role/DueFromFactorDetailsNarrative",
      "http://algoholdings.com/role/FinancingDetailsNarrative",
      "http://algoholdings.com/role/ScheduleOfEstimatedUsefulLivesDetails",
      "http://algoholdings.com/role/ScheduleOfPropertyAndEquipmentDetails",
      "http://algoholdings.com/role/StockCompensationExpenseDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median."
       }
      }
     },
     "auth_ref": [
      "r182",
      "r184",
      "r186",
      "r187",
      "r189",
      "r209",
      "r210",
      "r391",
      "r392",
      "r393",
      "r394",
      "r463",
      "r465",
      "r497",
      "r498",
      "r499",
      "r509",
      "r579",
      "r630",
      "r639",
      "r655",
      "r730",
      "r732",
      "r739",
      "r758",
      "r759",
      "r823",
      "r825",
      "r827",
      "r828",
      "r834",
      "r852",
      "r853",
      "r874",
      "r884",
      "r890",
      "r902",
      "r903",
      "r907",
      "r908",
      "r923",
      "r933",
      "r1047",
      "r1058",
      "r1112",
      "r1137",
      "r1138",
      "r1139",
      "r1140",
      "r1141"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeMember",
     "presentation": [
      "http://algoholdings.com/role/AssetAcquisitionDetailsNarrative",
      "http://algoholdings.com/role/DueFromFactorDetailsNarrative",
      "http://algoholdings.com/role/FinancingDetailsNarrative",
      "http://algoholdings.com/role/ScheduleOfEstimatedUsefulLivesDetails",
      "http://algoholdings.com/role/ScheduleOfPropertyAndEquipmentDetails",
      "http://algoholdings.com/role/StockCompensationExpenseDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median."
       }
      }
     },
     "auth_ref": [
      "r182",
      "r184",
      "r186",
      "r187",
      "r189",
      "r209",
      "r210",
      "r391",
      "r392",
      "r393",
      "r394",
      "r463",
      "r465",
      "r497",
      "r498",
      "r499",
      "r509",
      "r579",
      "r630",
      "r639",
      "r655",
      "r730",
      "r732",
      "r739",
      "r758",
      "r759",
      "r823",
      "r825",
      "r827",
      "r828",
      "r834",
      "r852",
      "r853",
      "r874",
      "r884",
      "r890",
      "r902",
      "r903",
      "r907",
      "r908",
      "r923",
      "r933",
      "r1047",
      "r1058",
      "r1112",
      "r1137",
      "r1138",
      "r1139",
      "r1140",
      "r1141"
     ]
    },
    "us-gaap_ReceivablesFromStockholderMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ReceivablesFromStockholderMember",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfShareholdersEquityDetails",
      "http://algoholdings.com/role/StatementsOfShareholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Receivables from Stockholder [Member]",
        "documentation": "Category of equity that is due from owners or affiliates of the reporting entity (including due from officers or directors) resulting from the sale of stock before the cash payment is received."
       }
      }
     },
     "auth_ref": []
    },
    "RIME_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountPolicy",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ALLOWANCE FOR DOUBTFUL ACCOUNTS",
        "documentation": "Receivables Trade And Other Accounts Receivable Allowance For Doubtful Account Policy."
       }
      }
     },
     "auth_ref": []
    },
    "RIME_RecentDevelopmentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "RecentDevelopmentsTextBlock",
     "presentation": [
      "http://algoholdings.com/role/RecentDevelopments"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "RECENT DEVELOPMENTS",
        "documentation": "Recent Developments [Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_RedemptionAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "RedemptionAgreementMember",
     "presentation": [
      "http://algoholdings.com/role/August2021PrivatePlacementDetailsNarrative",
      "http://algoholdings.com/role/August2021StockRedemptionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Redemption Agreement [Member]",
        "documentation": "Redemption Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_RefundDueFromCustomer": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "RefundDueFromCustomer",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Refund due from customer",
        "documentation": "Refund due from customer."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyDomain",
     "presentation": [
      "http://algoholdings.com/role/BalanceSheets",
      "http://algoholdings.com/role/FinancingDetailsNarrative",
      "http://algoholdings.com/role/LoansPayableRelatedPartiesDetailsNarrative",
      "http://algoholdings.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://algoholdings.com/role/ScheduleOfLoanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r316",
      "r464",
      "r616",
      "r617",
      "r701",
      "r709",
      "r761",
      "r762",
      "r763",
      "r764",
      "r765",
      "r789",
      "r791",
      "r822"
     ]
    },
    "us-gaap_RelatedPartyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyMember",
     "presentation": [
      "http://algoholdings.com/role/BalanceSheets",
      "http://algoholdings.com/role/FinancingDetailsNarrative",
      "http://algoholdings.com/role/LoansPayableRelatedPartiesDetailsNarrative",
      "http://algoholdings.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://algoholdings.com/role/ScheduleOfLoanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party [Member]",
        "documentation": "Party related to reporting entity. Includes, but is not limited to, affiliate, entity for which investment is accounted for by equity method, trust for benefit of employees, and principal owner, management, and members of immediate family."
       }
      }
     },
     "auth_ref": [
      "r252",
      "r253",
      "r616",
      "r617",
      "r618",
      "r619",
      "r701",
      "r709",
      "r761",
      "r762",
      "r763",
      "r764",
      "r765",
      "r789",
      "r791",
      "r822"
     ]
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionLineItems",
     "presentation": [
      "http://algoholdings.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transaction [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r316",
      "r795",
      "r796",
      "r799"
     ]
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsAbstract",
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "presentation": [
      "http://algoholdings.com/role/BalanceSheets",
      "http://algoholdings.com/role/FinancingDetailsNarrative",
      "http://algoholdings.com/role/LoansPayableRelatedPartiesDetailsNarrative",
      "http://algoholdings.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://algoholdings.com/role/ScheduleOfLoanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related and Nonrelated Parties [Axis]",
        "documentation": "Information by related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r316",
      "r464",
      "r616",
      "r617",
      "r701",
      "r709",
      "r761",
      "r762",
      "r763",
      "r764",
      "r765",
      "r789",
      "r791",
      "r822",
      "r1133"
     ]
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "presentation": [
      "http://algoholdings.com/role/RelatedPartyTransactions"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "RELATED PARTY TRANSACTIONS",
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r613",
      "r614",
      "r615",
      "r617",
      "r620",
      "r746",
      "r747",
      "r748",
      "r797",
      "r798",
      "r799",
      "r818",
      "r820"
     ]
    },
    "us-gaap_RepaymentsOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RepaymentsOfDebt",
     "crdr": "credit",
     "presentation": [
      "http://algoholdings.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://algoholdings.com/role/NotesPayableAndFinaningArrangementsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Repayments of Debt",
        "verboseLabel": "Repayment, debt",
        "documentation": "Amount of cash outflow for short-term and long-term debt. Excludes payment of lease obligation."
       }
      }
     },
     "auth_ref": [
      "r998"
     ]
    },
    "us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RepaymentsOfDebtAndCapitalLeaseObligations",
     "crdr": "credit",
     "calculation": {
      "http://algoholdings.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payments on finance leases",
        "label": "Repayments of Debt and Lease Obligation",
        "documentation": "Amount of cash outflow for short-term and long-term debt and lease obligation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RepaymentsOfLinesOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RepaymentsOfLinesOfCredit",
     "crdr": "credit",
     "presentation": [
      "http://algoholdings.com/role/FinancingDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs associated with line of credit",
        "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements."
       }
      }
     },
     "auth_ref": [
      "r114",
      "r1001"
     ]
    },
    "us-gaap_RepaymentsOfOtherDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RepaymentsOfOtherDebt",
     "crdr": "credit",
     "calculation": {
      "http://algoholdings.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payments on merchant cash advances payable",
        "label": "Repayments of Other Debt",
        "documentation": "Amount of cash outflow for the payment of debt classified as other."
       }
      }
     },
     "auth_ref": [
      "r114"
     ]
    },
    "us-gaap_RepaymentsOfShortTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RepaymentsOfShortTermDebt",
     "crdr": "credit",
     "presentation": [
      "http://algoholdings.com/role/FinancingDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total short term debt to be repaid",
        "documentation": "The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r114"
     ]
    },
    "us-gaap_RepaymentsOfSubordinatedDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RepaymentsOfSubordinatedDebt",
     "crdr": "credit",
     "calculation": {
      "http://algoholdings.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payment of subordinated note payable - Starlight Marketing Development, Ltd.",
        "label": "Repayments of Subordinated Debt",
        "documentation": "The cash outflow from the repayment of long-term borrowing where a lender is placed in a lien position behind debt having a higher priority of repayment (senior) in case of liquidation of the entity's assets or underlying collateral."
       }
      }
     },
     "auth_ref": [
      "r114"
     ]
    },
    "RIME_RepublicOfChinaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "RepublicOfChinaMember",
     "presentation": [
      "http://algoholdings.com/role/ConcentrationsOfCreditRiskAndRevenueDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Republic of China [Member]",
        "documentation": "Republic of China [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and development costs",
        "documentation": "Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity."
       }
      }
     },
     "auth_ref": [
      "r512",
      "r854",
      "r869",
      "r1142"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "RESEARCH AND DEVELOPMENT COSTS",
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process."
       }
      }
     },
     "auth_ref": [
      "r511"
     ]
    },
    "RIME_ReserveForSalesReturn": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "ReserveForSalesReturn",
     "crdr": "credit",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reserve for sales return",
        "documentation": "Reserve for sales return."
       }
      }
     },
     "auth_ref": []
    },
    "RIME_ReserveForSalesReturns": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "ReserveForSalesReturns",
     "crdr": "credit",
     "calculation": {
      "http://algoholdings.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/BalanceSheets",
      "http://algoholdings.com/role/RevenueDisaggregationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reserve for sales returns",
        "documentation": "Reserve for sales returns."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://algoholdings.com/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/BalanceSheets",
      "http://algoholdings.com/role/LiquidityGoingConcernAndManagementPlansDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated deficit",
        "verboseLabel": "Accumulated losses",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r98",
      "r128",
      "r706",
      "r737",
      "r738",
      "r744",
      "r769",
      "r911"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://algoholdings.com/role/LiquidityGoingConcernAndManagementPlansDetailsNarrative",
      "http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfShareholdersEquityDetails",
      "http://algoholdings.com/role/StatementsOfShareholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r211",
      "r255",
      "r256",
      "r257",
      "r259",
      "r264",
      "r266",
      "r268",
      "r353",
      "r354",
      "r380",
      "r540",
      "r541",
      "r548",
      "r549",
      "r550",
      "r552",
      "r556",
      "r557",
      "r566",
      "r568",
      "r569",
      "r571",
      "r574",
      "r596",
      "r599",
      "r734",
      "r736",
      "r751",
      "r1192"
     ]
    },
    "RIME_ReturnAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "ReturnAssets",
     "crdr": "debit",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return assets",
        "documentation": "Return assets."
       }
      }
     },
     "auth_ref": []
    },
    "RIME_ReturnsAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "ReturnsAsset",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Returns asset",
        "documentation": "Returns asset."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "crdr": "credit",
     "calculation": {
      "http://algoholdings.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0,
       "order": 1.0
      },
      "http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfOperationsDetails": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfOperationsDetails",
      "http://algoholdings.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Revenue",
        "verboseLabel": "Net Sales",
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise."
       }
      }
     },
     "auth_ref": [
      "r159",
      "r160",
      "r288",
      "r295",
      "r296",
      "r303",
      "r307",
      "r310",
      "r312",
      "r314",
      "r461",
      "r462",
      "r658"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "REVENUE RECOGNITION AND RESERVE FOR SALES RETURNS",
        "documentation": "Disclosure of accounting policy for revenue from contract with customer."
       }
      }
     },
     "auth_ref": [
      "r181",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r855"
     ]
    },
    "us-gaap_Revenues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Revenues",
     "crdr": "credit",
     "presentation": [
      "http://algoholdings.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://algoholdings.com/role/ScheduleOfRevenueByGeographicalRegionDetails",
      "http://algoholdings.com/role/ScheduleOfRevenueByProductLineDetails",
      "http://algoholdings.com/role/ScheduleOfSalesByGeographicalRegionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Net Sales",
        "verboseLabel": "Total Net Sales",
        "terseLabel": "Revenue from related parties",
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)."
       }
      }
     },
     "auth_ref": [
      "r159",
      "r160",
      "r235",
      "r249",
      "r288",
      "r295",
      "r296",
      "r303",
      "r307",
      "r310",
      "r312",
      "r314",
      "r351",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r584",
      "r693",
      "r869",
      "r1056"
     ]
    },
    "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfSalesByGeographicalRegionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues from External Customers and Long-Lived Assets [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevolvingCreditFacilityMember",
     "presentation": [
      "http://algoholdings.com/role/FinancingDetailsNarrative",
      "http://algoholdings.com/role/RecentDevelopmentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revolving Credit Facility [Member]",
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount."
       }
      }
     },
     "auth_ref": []
    },
    "RIME_RevolvingLoanAmendmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "RevolvingLoanAmendmentMember",
     "presentation": [
      "http://algoholdings.com/role/FinancingDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revolving Loan Amendment [Member]",
        "documentation": "Revolving Loan Amendment [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "crdr": "debit",
     "presentation": [
      "http://algoholdings.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right of use assets exchanged for lease liabilities",
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r607",
      "r910"
     ]
    },
    "us-gaap_RisksAndUncertaintiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RisksAndUncertaintiesAbstract",
     "auth_ref": []
    },
    "RIME_RobelAtnafuMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "RobelAtnafuMember",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfStockOptionIssuedDuringYearDecember3120202021And2022Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Robel Atnafu [Member]",
        "documentation": "Robel Atnafu [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_RoyaltyRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "RoyaltyRate",
     "presentation": [
      "http://algoholdings.com/role/AssetAcquisitionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Royalty rate",
        "documentation": "Royalty rate."
       }
      }
     },
     "auth_ref": []
    },
    "RIME_RoyaltyTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "RoyaltyTerm",
     "presentation": [
      "http://algoholdings.com/role/AssetAcquisitionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Royalty term",
        "documentation": "Royalty term."
       }
      }
     },
     "auth_ref": []
    },
    "RIME_SAFEAgreementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "SAFEAgreementsMember",
     "presentation": [
      "http://algoholdings.com/role/SafePrivatePlacementsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SAFE Agreements[Member]",
        "documentation": "SAFE Agreements[Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_SAFEEightMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "SAFEEightMember",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfTerminatedImmediatelyAfterClosingOfTransactionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SAFE-8 [Member]",
        "documentation": "SAFE Eight [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_SAFEEighteenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "SAFEEighteenMember",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfTerminatedImmediatelyAfterClosingOfTransactionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SAFE-18 [Member]",
        "documentation": "SAFE Eighteen [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_SAFEElevenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "SAFEElevenMember",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfTerminatedImmediatelyAfterClosingOfTransactionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SAFE-11 [Member]",
        "documentation": "SAFE Eleven [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_SAFEFifteenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "SAFEFifteenMember",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfTerminatedImmediatelyAfterClosingOfTransactionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SAFE-15 [Member]",
        "documentation": "SAFE Fifteen [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_SAFEFiftyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "SAFEFiftyMember",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfTerminatedImmediatelyAfterClosingOfTransactionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SAFE-50 [Member]",
        "documentation": "SAFE Fifty [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_SAFEFiftyOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "SAFEFiftyOneMember",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfTerminatedImmediatelyAfterClosingOfTransactionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SAFE-51 [Member]",
        "documentation": "SAFE Fifty One [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_SAFEFiveMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "SAFEFiveMember",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfTerminatedImmediatelyAfterClosingOfTransactionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SAFE-5 [Member]",
        "documentation": "SAFE Five [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_SAFEFortyEightMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "SAFEFortyEightMember",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfTerminatedImmediatelyAfterClosingOfTransactionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SAFE-48 [Member]",
        "documentation": "SAFE Forty Eight [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_SAFEFortyFiveMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "SAFEFortyFiveMember",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfTerminatedImmediatelyAfterClosingOfTransactionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SAFE-45 [Member]",
        "documentation": "SAFE Forty Five [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_SAFEFortyFourMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "SAFEFortyFourMember",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfFirstTrancheOfSubscriptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SAFE Forty Four [Member]",
        "documentation": "SAFE Forty Four [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_SAFEFortyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "SAFEFortyMember",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfTerminatedImmediatelyAfterClosingOfTransactionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SAFE-40 [Member]",
        "documentation": "SAFE Forty [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_SAFEFortyNineMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "SAFEFortyNineMember",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfTerminatedImmediatelyAfterClosingOfTransactionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SAFE-49 [Member]",
        "documentation": "SAFE Forty Nine [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_SAFEFortyOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "SAFEFortyOneMember",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfFirstTrancheOfSubscriptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SAFE-41 [Member]",
        "documentation": "SAFE Forty One [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_SAFEFortySevenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "SAFEFortySevenMember",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfTerminatedImmediatelyAfterClosingOfTransactionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SAFE-47 [Member]",
        "documentation": "SAFE Forty Seven [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_SAFEFortySixMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "SAFEFortySixMember",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfTerminatedImmediatelyAfterClosingOfTransactionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SAFE-46 [Member]",
        "documentation": "SAFE Forty Six [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_SAFEFortyThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "SAFEFortyThreeMember",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfFirstTrancheOfSubscriptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SAFE-43 [Member]",
        "documentation": "SAFE Forty Three [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_SAFEFortyTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "SAFEFortyTwoMember",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfFirstTrancheOfSubscriptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SAFE-42 [Member]",
        "documentation": "SAFE Forty Two [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_SAFEFourMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "SAFEFourMember",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfTerminatedImmediatelyAfterClosingOfTransactionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SAFE-4 [Member]",
        "documentation": "SAFE Four [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_SAFEFourteenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "SAFEFourteenMember",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfTerminatedImmediatelyAfterClosingOfTransactionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SAFE-14 [Member]",
        "documentation": "SAFE Fourteen [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_SAFENineMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "SAFENineMember",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfTerminatedImmediatelyAfterClosingOfTransactionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SAFE-9 [Member]",
        "documentation": "SAFE Nine [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_SAFENineteenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "SAFENineteenMember",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfTerminatedImmediatelyAfterClosingOfTransactionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SAFE-19 [Member]",
        "documentation": "SAFE Nineteen [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_SAFEOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "SAFEOneMember",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfFirstTrancheOfSubscriptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SAFE-1",
        "documentation": "SAFE One [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_SAFESevenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "SAFESevenMember",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfTerminatedImmediatelyAfterClosingOfTransactionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SAFE-7 [Member]",
        "documentation": "SAFE Seven [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_SAFESeventeenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "SAFESeventeenMember",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfTerminatedImmediatelyAfterClosingOfTransactionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SAFE-17 [Member]",
        "documentation": "SAFE Seventeen [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_SAFESixMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "SAFESixMember",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfTerminatedImmediatelyAfterClosingOfTransactionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SAFE-6 [Member]",
        "documentation": "SAFE Six [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_SAFESixteenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "SAFESixteenMember",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfTerminatedImmediatelyAfterClosingOfTransactionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SAFE-16 [Member]",
        "documentation": "SAFE Sixteen [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_SAFETenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "SAFETenMember",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfTerminatedImmediatelyAfterClosingOfTransactionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SAFE-10 [Member]",
        "documentation": "SAFE Ten [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_SAFEThirteenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "SAFEThirteenMember",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfTerminatedImmediatelyAfterClosingOfTransactionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SAFE-13 [Member]",
        "documentation": "SAFE Thirteen [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_SAFEThirtyEightMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "SAFEThirtyEightMember",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfFirstTrancheOfSubscriptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SAFE-38 [Member]",
        "documentation": "SAFE Thirty Eight [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_SAFEThirtyFiveMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "SAFEThirtyFiveMember",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfTerminatedImmediatelyAfterClosingOfTransactionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SAFE-35 [Member",
        "documentation": "SAFE Thirty Five [Member"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_SAFEThirtyFourMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "SAFEThirtyFourMember",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfTerminatedImmediatelyAfterClosingOfTransactionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SAFE-34 [Member",
        "documentation": "SAFE Thirty Four [Member"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_SAFEThirtyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "SAFEThirtyMember",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfTerminatedImmediatelyAfterClosingOfTransactionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SAFE-30 [Member]",
        "documentation": "SAFE Thirty [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_SAFEThirtyNineMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "SAFEThirtyNineMember",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfTerminatedImmediatelyAfterClosingOfTransactionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SAFE-39 [Member]",
        "documentation": "SAFE Thirty Nine [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_SAFEThirtyOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "SAFEThirtyOneMember",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfTerminatedImmediatelyAfterClosingOfTransactionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SAFE-31 [Member",
        "documentation": "SAFE Thirty One [Member"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_SAFEThirtySevenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "SAFEThirtySevenMember",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfTerminatedImmediatelyAfterClosingOfTransactionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SAFE-37 [Member]",
        "documentation": "SAFE Thirty Seven [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_SAFEThirtySixMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "SAFEThirtySixMember",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfTerminatedImmediatelyAfterClosingOfTransactionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SAFE-36 [Member]",
        "documentation": "SAFE Thirty Six [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_SAFEThirtyThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "SAFEThirtyThreeMember",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfTerminatedImmediatelyAfterClosingOfTransactionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SAFE-33 [Member]",
        "documentation": "SAFE Thirty Three [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_SAFEThirtyTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "SAFEThirtyTwoMember",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfTerminatedImmediatelyAfterClosingOfTransactionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SAFE-32 [Member",
        "documentation": "SAFE Thirty Two [Member"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_SAFEThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "SAFEThreeMember",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfTerminatedImmediatelyAfterClosingOfTransactionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SAFE-3 [Member]",
        "documentation": "SAFE Three [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_SAFETwelveMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "SAFETwelveMember",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfTerminatedImmediatelyAfterClosingOfTransactionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SAFE-12 [Member]",
        "documentation": "SAFE Twelve [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_SAFETwentyEightMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "SAFETwentyEightMember",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfTerminatedImmediatelyAfterClosingOfTransactionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SAFE-28 [Member]",
        "documentation": "SAFE Twenty Eight [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_SAFETwentyFiveMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "SAFETwentyFiveMember",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfTerminatedImmediatelyAfterClosingOfTransactionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SAFE-25 [Member]",
        "documentation": "SAFE Twenty Five [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_SAFETwentyFourMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "SAFETwentyFourMember",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfTerminatedImmediatelyAfterClosingOfTransactionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SAFE-24 [Member]",
        "documentation": "SAFE Twenty Four [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_SAFETwentyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "SAFETwentyMember",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfTerminatedImmediatelyAfterClosingOfTransactionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "SAFE-20 [Member]",
        "documentation": "SAFE Twenty [Member]",
        "label": "SAFE-20 [Member] [Default Label]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_SAFETwentyNineMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "SAFETwentyNineMember",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfTerminatedImmediatelyAfterClosingOfTransactionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SAFE-29 [Member]",
        "documentation": "SAFE Twenty Nine [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_SAFETwentyOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "SAFETwentyOneMember",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfTerminatedImmediatelyAfterClosingOfTransactionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SAFE-21 [Member]",
        "documentation": "SAFE Twenty One [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_SAFETwentySevenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "SAFETwentySevenMember",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfTerminatedImmediatelyAfterClosingOfTransactionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SAFE-27 [Member]",
        "documentation": "SAFE Twenty Seven [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_SAFETwentySixMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "SAFETwentySixMember",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfTerminatedImmediatelyAfterClosingOfTransactionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SAFE-26 [Member]",
        "documentation": "SAFE Twenty Six [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_SAFETwentyTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "SAFETwentyTwoMember",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfTerminatedImmediatelyAfterClosingOfTransactionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SAFE-22 [Member]",
        "documentation": "SAFE Twenty Two [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_SAFETwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "SAFETwoMember",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfTerminatedImmediatelyAfterClosingOfTransactionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SAFE-20 [Member]",
        "documentation": "SAFE Two [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_SMCBMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "SMCBMember",
     "presentation": [
      "http://algoholdings.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "S M C B [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_SafePrivatePlacementsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "SafePrivatePlacementsTableTextBlock",
     "presentation": [
      "http://algoholdings.com/role/SafePrivatePlacementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF FIRST TRANCHE OF SUBSCRIPTIONS",
        "documentation": "Safe Private Placements [Table Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_SafePrivatePlacementsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "SafePrivatePlacementsTextBlock",
     "presentation": [
      "http://algoholdings.com/role/SafePrivatePlacements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SAFE PRIVATE PLACEMENTS",
        "documentation": "Safe Private Placements [Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SalariesAndWages": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SalariesAndWages",
     "crdr": "debit",
     "presentation": [
      "http://algoholdings.com/role/AssetAcquisitionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Salaries and wages",
        "documentation": "Amount of expense for salary and wage arising from service rendered by nonofficer employee. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold."
       }
      }
     },
     "auth_ref": [
      "r993"
     ]
    },
    "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockConsiderationReceivedOnTransaction",
     "crdr": "debit",
     "presentation": [
      "http://algoholdings.com/role/AtmOfferingDetailsNarrative",
      "http://algoholdings.com/role/PrivatePlacementDetailsNarrative",
      "http://algoholdings.com/role/PublicOfferingAndNasdaqUplistingDetailsNarrative",
      "http://algoholdings.com/role/RecentDevelopmentsDetailsNarrative",
      "http://algoholdings.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://algoholdings.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of stock sold, value",
        "verboseLabel": "Number of shares sold, value",
        "terseLabel": "Net proceeds",
        "documentation": "Cash received on stock transaction after deduction of issuance costs."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockDescriptionOfTransaction": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockDescriptionOfTransaction",
     "presentation": [
      "http://algoholdings.com/role/StockCompensationExpenseDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of stock description",
        "documentation": "Description of stock transaction which may include details of the offering (IPO, private placement), a description of the stock sold, percentage of subsidiary's or equity investee's stock sold, a description of the investors and whether the stock was issued in a business combination."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r66",
      "r143"
     ]
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockNameOfTransactionDomain",
     "presentation": [
      "http://algoholdings.com/role/AtmOfferingDetailsNarrative",
      "http://algoholdings.com/role/August2021PrivatePlacementDetailsNarrative",
      "http://algoholdings.com/role/PrivatePlacementDetailsNarrative",
      "http://algoholdings.com/role/RecentDevelopmentsDetailsNarrative",
      "http://algoholdings.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "presentation": [
      "http://algoholdings.com/role/AssetAcquisitionDetailsNarrative",
      "http://algoholdings.com/role/PrivatePlacementDetailsNarrative",
      "http://algoholdings.com/role/PublicOfferingAndNasdaqUplistingDetailsNarrative",
      "http://algoholdings.com/role/RecentDevelopmentsDetailsNarrative",
      "http://algoholdings.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of shares sold",
        "verboseLabel": "Seller Consideration share",
        "terseLabel": "Number of share sold",
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "RIME_SaleOfStockPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "SaleOfStockPercentage",
     "presentation": [
      "http://algoholdings.com/role/PublicOfferingAndNasdaqUplistingDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of stock, percentage",
        "documentation": "Sale of stock percentage."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockPricePerShare",
     "presentation": [
      "http://algoholdings.com/role/PrivatePlacementDetailsNarrative",
      "http://algoholdings.com/role/PublicOfferingAndNasdaqUplistingDetailsNarrative",
      "http://algoholdings.com/role/RecentDevelopmentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commmon stock share per share",
        "verboseLabel": "Sale of stock, price per share",
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "RIME_SalesRevenueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "SalesRevenueMember",
     "presentation": [
      "http://algoholdings.com/role/ConcentrationsOfCreditRiskAndRevenueDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sales Revenue [Member]",
        "documentation": "Sales Revenue [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SalesRevenueNetMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SalesRevenueNetMember",
     "presentation": [
      "http://algoholdings.com/role/ConcentrationsOfCreditRiskAndRevenueDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue Benchmark [Member]",
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation."
       }
      }
     },
     "auth_ref": [
      "r314",
      "r969"
     ]
    },
    "RIME_SamarthaGowdaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "SamarthaGowdaMember",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfStockOptionIssuedDuringYearDecember3120202021And2022Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Samartha Gowda [Member]",
        "documentation": "Samartha Gowda [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_ScenarioForecastMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ScenarioForecastMember",
     "presentation": [
      "http://algoholdings.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forecast [Member]",
        "documentation": "Information reported for future period. Excludes information expected to be reported in future period for effect on historical fact."
       }
      }
     },
     "auth_ref": [
      "r466",
      "r981",
      "r1010"
     ]
    },
    "srt_ScenarioUnspecifiedDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ScenarioUnspecifiedDomain",
     "presentation": [
      "http://algoholdings.com/role/AssetAcquisitionDetailsNarrative",
      "http://algoholdings.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts."
       }
      }
     },
     "auth_ref": [
      "r208",
      "r269",
      "r466",
      "r962",
      "r1010"
     ]
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "presentation": [
      "http://algoholdings.com/role/ComputationOfLossPerShareDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Security, Excluded EPS Calculation [Table]",
        "documentation": "Disclosure of information about security that could potentially dilute basic earnings per share (EPS) in future that was not included in calculation of diluted EPS."
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable",
     "presentation": [
      "http://algoholdings.com/role/August2021StockRedemptionDetailsNarrative",
      "http://algoholdings.com/role/OperatingLeasesDetailsNarrative",
      "http://algoholdings.com/role/PublicOfferingAndNasdaqUplistingDetailsNarrative",
      "http://algoholdings.com/role/SafePrivatePlacementsDetailsNarrative",
      "http://algoholdings.com/role/ScheduleOfFirstTrancheOfSubscriptionsDetails",
      "http://algoholdings.com/role/SummaryOfTerminatedImmediatelyAfterClosingOfTransactionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]",
        "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r558"
     ]
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "presentation": [
      "http://algoholdings.com/role/August2021PrivatePlacementTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF PROVISION FOR INCOME TAXES",
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years."
       }
      }
     },
     "auth_ref": [
      "r1096"
     ]
    },
    "srt_ScheduleOfCondensedCashFlowStatementTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ScheduleOfCondensedCashFlowStatementTableTextBlock",
     "presentation": [
      "http://algoholdings.com/role/SupplementalInformationCondensedFinancialInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
        "documentation": "Tabular disclosure of condensed cash flow statement, including, but not limited to, cash flow statements of consolidated entities and consolidation eliminations."
       }
      }
     },
     "auth_ref": [
      "r982",
      "r1006"
     ]
    },
    "srt_ScheduleOfCondensedIncomeStatementTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ScheduleOfCondensedIncomeStatementTableTextBlock",
     "presentation": [
      "http://algoholdings.com/role/SupplementalInformationCondensedFinancialInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
        "documentation": "Tabular disclosure of condensed income statement, including, but not limited to, income statements of consolidated entities and consolidation eliminations."
       }
      }
     },
     "auth_ref": [
      "r982",
      "r1006"
     ]
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfDebtTableTextBlock",
     "presentation": [
      "http://algoholdings.com/role/NotesPayableAndFinaningArrangementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF SPECIFIC TERMS",
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "presentation": [
      "http://algoholdings.com/role/August2021PrivatePlacementTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES",
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r1093"
     ]
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "presentation": [
      "http://algoholdings.com/role/BalanceSheets",
      "http://algoholdings.com/role/LoansPayableRelatedPartiesDetailsNarrative",
      "http://algoholdings.com/role/ScheduleOfLoanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan [Table]",
        "documentation": "Disclosure of information about individual defined benefit pension plan or other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r44",
      "r45",
      "r46",
      "r47"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://algoholdings.com/role/ComputationOfLossPerShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF BASIC AND DILUTIVE SHARES",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r1012"
     ]
    },
    "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfRevenueByProductLineDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting, Revenue from External Customer, Product and Service [Table]",
        "documentation": "Disclosure of information about revenue from external customer by product and service when not provided as part of reportable operating segment information."
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "presentation": [
      "http://algoholdings.com/role/AssetAcquisitionDetailsNarrative",
      "http://algoholdings.com/role/RecentDevelopmentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Axis]",
        "documentation": "Information by name of investment including named security. Excludes entity that is consolidated."
       }
      }
     },
     "auth_ref": [
      "r348",
      "r349",
      "r350",
      "r547",
      "r963",
      "r964",
      "r965",
      "r1099",
      "r1100",
      "r1101",
      "r1102"
     ]
    },
    "RIME_ScheduleOfLossBeforeIncomeTaxTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "ScheduleOfLossBeforeIncomeTaxTableTextBlock",
     "presentation": [
      "http://algoholdings.com/role/August2021PrivatePlacementTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF LOSS BEFORE INCOME TAXES",
        "documentation": "Schedule of Loss Before Income Tax [Table Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis",
     "presentation": [
      "http://algoholdings.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insurance Type and Tier Identifier [Axis]",
        "documentation": "Information by type of insurance coverage or layer of insurance that covers malpractice claims."
       }
      }
     },
     "auth_ref": [
      "r158"
     ]
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "presentation": [
      "http://algoholdings.com/role/LoansPayableRelatedPartiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF LOAN",
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "RIME_ScheduleOfProFormaFinancialInformationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "ScheduleOfProFormaFinancialInformationTableTextBlock",
     "presentation": [
      "http://algoholdings.com/role/AssetAcquisitionTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF PRO FORMA FINANCIAL INFORMATION",
        "documentation": "Schedule Of Pro Forma Financial Information [Table Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Table]",
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r611"
     ]
    },
    "us-gaap_ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock",
     "presentation": [
      "http://algoholdings.com/role/SupplementalInformationCondensedFinancialInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF ESTIMATED USEFUL LIVES",
        "documentation": "Tabular disclosure of public utility physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation expense and method used, including composite depreciation, and accumulated depreciation."
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "presentation": [
      "http://algoholdings.com/role/AssetAcquisitionTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF CONSIDERATION TRANSFERRED TO THE ASSETS ACQUIRED AND LIABILITIES ASSUMED",
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree."
       }
      }
     },
     "auth_ref": [
      "r141"
     ]
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "presentation": [
      "http://algoholdings.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transaction [Table]",
        "documentation": "Disclosure of information about related party transaction."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r75",
      "r795",
      "r796",
      "r799"
     ]
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
     "presentation": [
      "http://algoholdings.com/role/RevenueDisaggregationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF REVENUE BY GEOGRAPHICAL REGION",
        "documentation": "Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r102"
     ]
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfSalesByGeographicalRegionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]",
        "documentation": "Disclosure of information about revenue from external customer and long-lived asset by geographical area. Long-lived asset excludes financial instrument, customer relationship with financial institution, mortgage and other servicing right, deferred policy acquisition cost, and deferred tax asset."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r102"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "presentation": [
      "http://algoholdings.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://algoholdings.com/role/IssuanceOfCommonStockDetailsNarrative",
      "http://algoholdings.com/role/StockCompensationExpenseDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r468",
      "r470",
      "r472",
      "r473",
      "r474",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfWarrantsExpirationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement by range of exercise prices."
       }
      }
     },
     "auth_ref": [
      "r50"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "presentation": [
      "http://algoholdings.com/role/StockCompensationExpenseTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SUMMARY OF STOCK OPTION ACTIVITY",
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r14",
      "r134"
     ]
    },
    "RIME_ScheduleOfStockOptionIssuedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "ScheduleOfStockOptionIssuedTableTextBlock",
     "presentation": [
      "http://algoholdings.com/role/StockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF STOCK OPTION ISSUED DURING THE YEAR DECEMBER 31, 2020, 2021 AND 2022",
        "documentation": "Schedule Of Stock Option Issued [Table Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
     "presentation": [
      "http://algoholdings.com/role/StockCompensationExpenseTables",
      "http://algoholdings.com/role/WarrantsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF WARRANTS EXPIRATION",
        "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable."
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "us-gaap_ScheduleOfStockholdersEquityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfStockholdersEquityTableTextBlock",
     "presentation": [
      "http://algoholdings.com/role/SupplementalInformationCondensedFinancialInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS\u2019 EQUITY",
        "documentation": "Tabular disclosure of changes in the separate accounts comprising stockholders' equity (in addition to retained earnings) and of the changes in the number of shares of equity securities during at least the most recent annual fiscal period and any subsequent interim period presented is required to make the financial statements sufficiently informative if both financial position and results of operations are presented."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "RIME_ScheduleOfSupplementalInformationRelatedToLeaseTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "ScheduleOfSupplementalInformationRelatedToLeaseTableTextBlock",
     "presentation": [
      "http://algoholdings.com/role/OperatingLeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF SUPPLEMENTAL INFORMATION RELATED TO LEASES",
        "documentation": "Schedule Of Supplemental Information Related to Lease [Table Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
     "presentation": [
      "http://algoholdings.com/role/August2021PrivatePlacementTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF TAX PROVISION",
        "documentation": "Tabular disclosure of the change in unrecognized tax benefits."
       }
      }
     },
     "auth_ref": [
      "r529",
      "r893"
     ]
    },
    "RIME_SecondMilestonePaymentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "SecondMilestonePaymentMember",
     "presentation": [
      "http://algoholdings.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Second Milestone Payment [Member]",
        "documentation": "Second Milestone Payment [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_SecondPaymentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "SecondPaymentMember",
     "presentation": [
      "http://algoholdings.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://algoholdings.com/role/NotesPayableAndFinaningArrangementsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Second Payment [Member]",
        "documentation": "Second Payment [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SecuredDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SecuredDebt",
     "crdr": "credit",
     "presentation": [
      "http://algoholdings.com/role/RecentDevelopmentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Secured note principal amount",
        "documentation": "Carrying value as of the balance sheet date, including the current and noncurrent portions, of collateralized debt obligations (with maturities initially due after one year or beyond the operating cycle, if longer). Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r152",
      "r1147"
     ]
    },
    "RIME_SecuritiesPurchaseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "SecuritiesPurchaseAgreementMember",
     "presentation": [
      "http://algoholdings.com/role/RecentDevelopmentsDetailsNarrative",
      "http://algoholdings.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities Purchase Agreement [Member]",
        "documentation": "Securities Purchase Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://algoholdings.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r943"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12gTitle",
     "presentation": [
      "http://algoholdings.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r947"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://algoholdings.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r946"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://algoholdings.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r952"
     ]
    },
    "srt_SegmentGeographicalDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "SegmentGeographicalDomain",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfRevenueByGeographicalRegionDetails",
      "http://algoholdings.com/role/ScheduleOfSalesByGeographicalRegionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Geographical area."
       }
      }
     },
     "auth_ref": [
      "r183",
      "r185",
      "r188",
      "r190",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r312",
      "r313",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r754",
      "r755",
      "r756",
      "r824",
      "r826",
      "r829",
      "r835",
      "r839",
      "r843",
      "r844",
      "r845",
      "r846",
      "r847",
      "r848",
      "r849",
      "r850",
      "r851",
      "r857",
      "r886",
      "r913",
      "r914",
      "r915",
      "r916",
      "r917",
      "r918",
      "r919",
      "r920",
      "r925",
      "r933",
      "r1059",
      "r1151",
      "r1153",
      "r1154",
      "r1156",
      "r1157",
      "r1158",
      "r1159",
      "r1160",
      "r1161",
      "r1162",
      "r1163",
      "r1164",
      "r1165",
      "r1166",
      "r1167",
      "r1168",
      "r1169",
      "r1170",
      "r1171",
      "r1172",
      "r1173",
      "r1174",
      "r1175",
      "r1176",
      "r1177",
      "r1178",
      "r1179",
      "r1180"
     ]
    },
    "us-gaap_SegmentReportingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingDisclosureTextBlock",
     "presentation": [
      "http://algoholdings.com/role/RevenueDisaggregation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "REVENUE DISAGGREGATION",
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments."
       }
      }
     },
     "auth_ref": [
      "r162",
      "r288",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r300",
      "r301",
      "r302",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r314",
      "r866",
      "r867",
      "r868",
      "r869",
      "r871",
      "r872",
      "r873"
     ]
    },
    "us-gaap_SellingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SellingExpense",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Selling general and administrative expenses",
        "documentation": "Expenses recognized in the period that are directly related to the selling and distribution of products or services."
       }
      }
     },
     "auth_ref": [
      "r108"
     ]
    },
    "RIME_SemiCabIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "SemiCabIncMember",
     "presentation": [
      "http://algoholdings.com/role/AccountsPayableAndAccruedExpenses",
      "http://algoholdings.com/role/AccountsPayableAndAccruedExpensesDetailsNarrative",
      "http://algoholdings.com/role/AccountsReceivable",
      "http://algoholdings.com/role/AccountsReceivableDetailsNarrative",
      "http://algoholdings.com/role/AssetAcquisitionDetailsNarrative",
      "http://algoholdings.com/role/BalanceSheets",
      "http://algoholdings.com/role/CommitmentsAndContingencies",
      "http://algoholdings.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://algoholdings.com/role/ConcentrationsOfCreditRiskAndRevenue",
      "http://algoholdings.com/role/ConcentrationsOfCreditRiskAndRevenueDetailsNarrative",
      "http://algoholdings.com/role/DueFromFactor",
      "http://algoholdings.com/role/DueFromFactorDetailsNarrative",
      "http://algoholdings.com/role/EmployeeBenefitPlans",
      "http://algoholdings.com/role/IncomeTaxes",
      "http://algoholdings.com/role/LiquidityGoingConcernAndManagementPlans",
      "http://algoholdings.com/role/LiquidityGoingConcernAndManagementPlansDetailsNarrative",
      "http://algoholdings.com/role/NatureOfBusiness",
      "http://algoholdings.com/role/NotesPayableAndFinaningArrangements",
      "http://algoholdings.com/role/NotesPayableAndFinaningArrangementsDetailsNarrative",
      "http://algoholdings.com/role/NotesPayableAndFinaningArrangementsTables",
      "http://algoholdings.com/role/PropertyAndEquipment",
      "http://algoholdings.com/role/PropertyAndEquipmentDetailsNarrative",
      "http://algoholdings.com/role/RelatedPartyTransactions",
      "http://algoholdings.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://algoholdings.com/role/SafePrivatePlacements",
      "http://algoholdings.com/role/SafePrivatePlacementsDetailsNarrative",
      "http://algoholdings.com/role/SafePrivatePlacementsTables",
      "http://algoholdings.com/role/ScheduleOfConsiderationTransferredToAssetsAcquiredAndLiabilitiesAssumedDetails",
      "http://algoholdings.com/role/ScheduleOfEstimatedUsefulLivesDetails",
      "http://algoholdings.com/role/ScheduleOfFirstTrancheOfSubscriptionsDetails",
      "http://algoholdings.com/role/ScheduleOfSpecificTermsDetails",
      "http://algoholdings.com/role/ScheduleOfStockOptionIssuedDuringYearDecember3120202021And2022Details",
      "http://algoholdings.com/role/StatementsOfOperations",
      "http://algoholdings.com/role/StockholdersEquity",
      "http://algoholdings.com/role/StockholdersEquityDetailsNarrative",
      "http://algoholdings.com/role/StockholdersEquityTables",
      "http://algoholdings.com/role/SummaryOfSignificantAccountingPolicies",
      "http://algoholdings.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://algoholdings.com/role/SummaryOfSignificantAccountingPoliciesPolicies",
      "http://algoholdings.com/role/SummaryOfTerminatedImmediatelyAfterClosingOfTransactionDetails",
      "http://algoholdings.com/role/SupplementalInformationCondensedFinancialInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Semi Cab Inc [Member]",
        "documentation": "Semi Cab, Inc [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_SemiCabInvestorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "SemiCabInvestorMember",
     "presentation": [
      "http://algoholdings.com/role/FinancingDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Semi Cab Investor [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_SemiCabLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "SemiCabLLCMember",
     "presentation": [
      "http://algoholdings.com/role/AssetAcquisitionDetailsNarrative",
      "http://algoholdings.com/role/RecentDevelopmentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Semi Cab LLC [Member]",
        "documentation": "Semi Cab LLC [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_ServiceContractAndAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "ServiceContractAndAgreementMember",
     "presentation": [
      "http://algoholdings.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Service Contract And Agreement [Member]",
        "documentation": "Service Contract And Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_SettlementAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "SettlementAgreementMember",
     "presentation": [
      "http://algoholdings.com/role/NotesPayableAndFinaningArrangementsDetailsNarrative",
      "http://algoholdings.com/role/RecentDevelopmentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Settlement Agreement [Member]",
        "documentation": "Settlement Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_SettlementSumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "SettlementSumMember",
     "presentation": [
      "http://algoholdings.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Settlement Sum [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://algoholdings.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfShareholdersEquityDetails",
      "http://algoholdings.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Stock based compensation",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardBoardApprovalDate",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfStockOptionIssuedDuringYearDecember3120202021And2022Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Board Approval Date",
        "documentation": "Share based compensation arrangement by share based payment award board approval date."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfStockOptionIssuedDuringYearDecember3120202021And2022Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Expiration Date",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Date",
        "documentation": "Date the equity-based award expires, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": [
      "r1062"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "presentation": [
      "http://algoholdings.com/role/August2021PrivatePlacementDetailsNarrative",
      "http://algoholdings.com/role/StockCompensationExpenseDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock option, expected dividend yield",
        "verboseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term."
       }
      }
     },
     "auth_ref": [
      "r498"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "presentation": [
      "http://algoholdings.com/role/August2021PrivatePlacementDetailsNarrative",
      "http://algoholdings.com/role/StockCompensationExpenseDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock option, volatility",
        "verboseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": [
      "r497"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "presentation": [
      "http://algoholdings.com/role/August2021PrivatePlacementDetailsNarrative",
      "http://algoholdings.com/role/StockCompensationExpenseDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock option, risk free interest rate",
        "verboseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": [
      "r499"
     ]
    },
    "RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFullyVestedDate",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfStockOptionIssuedDuringYearDecember3120202021And2022Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Date Fully Vested",
        "documentation": "Share based compensation arrangement by share based payment award fully vested date."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://algoholdings.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://algoholdings.com/role/IssuanceOfCommonStockDetailsNarrative",
      "http://algoholdings.com/role/StockCompensationExpenseDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r468",
      "r470",
      "r472",
      "r473",
      "r474",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "presentation": [
      "http://algoholdings.com/role/IssuanceOfCommonStockDetailsNarrative",
      "http://algoholdings.com/role/StockCompensationExpenseDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of shares available to issued",
        "verboseLabel": "Number of shares available for issuance",
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable."
       }
      }
     },
     "auth_ref": [
      "r50"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Number of Options, exercisable at end of period",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan."
       }
      }
     },
     "auth_ref": [
      "r478"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Weighted Average Exercise Price, Options exercisable at end of period",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r478"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Number of Options, Forfeited",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r482"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfStockOptionIssuedDuringYearDecember3120202021And2022Details",
      "http://algoholdings.com/role/StockCompensationExpenseDetailsNarrative",
      "http://algoholdings.com/role/SummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of Options, Granted",
        "verboseLabel": "Common stock options grants",
        "terseLabel": "Granted Shares",
        "documentation": "Gross number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r480"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://algoholdings.com/role/IssuanceOfCommonStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average grant date fair value",
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology."
       }
      }
     },
     "auth_ref": [
      "r490"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfEmployeeStockOptionsOutstandingDetailsParenthetical",
      "http://algoholdings.com/role/ScheduleOfStockOptionIssuedDuringYearDecember3120202021And2022Details",
      "http://algoholdings.com/role/SummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Number of Options, Balance at beginning of period",
        "periodEndLabel": "Number of Options, Balance at end of period",
        "label": "Option issued",
        "verboseLabel": "Outstanding Awards",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r476",
      "r477"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfStockOptionIssuedDuringYearDecember3120202021And2022Details",
      "http://algoholdings.com/role/SummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Weighted Average Exercise Price, Balance at beginning of period",
        "periodEndLabel": "Weighted Average Exercise Price, Balance at end of period",
        "label": "Exercise price",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r476",
      "r477"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://algoholdings.com/role/IssuanceOfCommonStockDetailsNarrative",
      "http://algoholdings.com/role/StockCompensationExpenseDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vested options intrinsic value",
        "verboseLabel": "Vested options",
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r492"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfStockOptionIssuedDuringYearDecember3120202021And2022Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vested Outstanding",
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r492"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod",
     "presentation": [
      "http://algoholdings.com/role/IssuanceOfCommonStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share base compensation issued shares",
        "documentation": "Number of shares issued under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r50"
     ]
    },
    "RIME_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingStartDate",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfStockOptionIssuedDuringYearDecember3120202021And2022Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting Date",
        "documentation": "Share based compensation arrangement by share based payment award vesting start date."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://algoholdings.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r472",
      "r473",
      "r474",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Exercise Price, Exercised",
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares."
       }
      }
     },
     "auth_ref": [
      "r481"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Exercise Price, Forfeited",
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated."
       }
      }
     },
     "auth_ref": [
      "r482"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://algoholdings.com/role/StockCompensationExpenseDetailsNarrative",
      "http://algoholdings.com/role/SummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Exercise Price, Granted",
        "verboseLabel": "Exercise price",
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
       }
      }
     },
     "auth_ref": [
      "r480"
     ]
    },
    "us-gaap_ShareBasedCompensationAwardTrancheOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationAwardTrancheOneMember",
     "presentation": [
      "http://algoholdings.com/role/SafePrivatePlacementsDetailsNarrative",
      "http://algoholdings.com/role/ScheduleOfFirstTrancheOfSubscriptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Tranche One [Member]",
        "documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationAwardTrancheTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationAwardTrancheTwoMember",
     "presentation": [
      "http://algoholdings.com/role/SafePrivatePlacementsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Tranche Two [Member]",
        "documentation": "Second portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SHARE-BASED COMPENSATION",
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost."
       }
      }
     },
     "auth_ref": [
      "r467",
      "r475",
      "r494",
      "r495",
      "r496",
      "r497",
      "r500",
      "r505",
      "r506",
      "r507",
      "r508"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfWarrantsExpirationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price Range [Axis]",
        "documentation": "Information by range of option prices pertaining to options granted."
       }
      }
     },
     "auth_ref": [
      "r52"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfWarrantsExpirationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices."
       }
      }
     },
     "auth_ref": [
      "r53"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfWarrantsExpirationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharePrice",
     "presentation": [
      "http://algoholdings.com/role/August2021PrivatePlacementDetailsNarrative",
      "http://algoholdings.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share price",
        "verboseLabel": "Share Price",
        "documentation": "Price of a single share of a number of saleable stocks of a company."
       }
      }
     },
     "auth_ref": []
    },
    "RIME_SharePrice1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "SharePrice1",
     "presentation": [
      "http://algoholdings.com/role/August2021PrivatePlacementDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock price",
        "documentation": "Common stock price."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "presentation": [
      "http://algoholdings.com/role/StockCompensationExpenseDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock option, expected term",
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r496"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfStockOptionIssuedDuringYearDecember3120202021And2022Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unvested",
        "documentation": "Number of non-vested options outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average contractual life",
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r136"
     ]
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Weighted Average contractual life",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r136"
     ]
    },
    "us-gaap_SharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharesOutstanding",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfShareholdersEquityDetails",
      "http://algoholdings.com/role/StatementsOfShareholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance, shares",
        "periodEndLabel": "Balance, shares",
        "label": "Shares, Outstanding",
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury."
       }
      }
     },
     "auth_ref": []
    },
    "RIME_ShippingAndHandlingCostsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "ShippingAndHandlingCostsPolicyTextBlock",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SHIPPING AND HANDLING COSTS",
        "documentation": "Shipping and Handling Costs [Policy Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_ShippingAndHandlingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "ShippingAndHandlingExpenses",
     "crdr": "debit",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shipping and handling expenses",
        "documentation": "Shipping and handling expenses."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShortTermBorrowings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShortTermBorrowings",
     "crdr": "credit",
     "calculation": {
      "http://algoholdings.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/BalanceSheets",
      "http://algoholdings.com/role/FinancingDetailsNarrative",
      "http://algoholdings.com/role/NotesPayableAndFinaningArrangementsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Merchant cash advances payable",
        "verboseLabel": "Amount outstanding for Agile Capital Funding,LLC",
        "terseLabel": "Initial amount, borrowed",
        "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r82",
      "r149",
      "r911",
      "r1146"
     ]
    },
    "us-gaap_ShortTermDebtTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShortTermDebtTypeAxis",
     "presentation": [
      "http://algoholdings.com/role/FinancingDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-Term Debt, Type [Axis]",
        "documentation": "Information by type of short-term debt arrangement."
       }
      }
     },
     "auth_ref": [
      "r84",
      "r1044",
      "r1045",
      "r1046"
     ]
    },
    "us-gaap_ShortTermDebtTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShortTermDebtTypeDomain",
     "presentation": [
      "http://algoholdings.com/role/FinancingDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing."
       }
      }
     },
     "auth_ref": [
      "r82",
      "r1044",
      "r1045",
      "r1046"
     ]
    },
    "RIME_SiddayyaSGanjalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "SiddayyaSGanjalMember",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfStockOptionIssuedDuringYearDecember3120202021And2022Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Siddayya S Ganjal [Member]",
        "documentation": "Siddayya S Ganjal [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r118",
      "r246"
     ]
    },
    "RIME_SixCurrentAndThreeFormerDirectorsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "SixCurrentAndThreeFormerDirectorsMember",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfEmployeeStockOptionsOutstandingDetailsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Six Current And Three Former Directors [Member]",
        "documentation": "Six Current and Three Former Directors [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_SixShareholderLoanAgreementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "SixShareholderLoanAgreementsMember",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfSpecificTermsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Six Shareholder Loan Agreements [Member]",
        "documentation": "Six Shareholder Loan Agreements [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SoftwareAndSoftwareDevelopmentCostsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SoftwareAndSoftwareDevelopmentCostsMember",
     "presentation": [
      "http://algoholdings.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Software and Software Development Costs [Member]",
        "documentation": "Purchased software applications and internally developed software for sale, licensing or long-term internal use."
       }
      }
     },
     "auth_ref": []
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://algoholdings.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r950"
     ]
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StateAndLocalJurisdictionMember",
     "presentation": [
      "http://algoholdings.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "State and Local Jurisdiction [Member]",
        "documentation": "Designated state or local jurisdiction entitled to levy and collect income tax."
       }
      }
     },
     "auth_ref": [
      "r519"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://algoholdings.com/role/August2021PrivatePlacementDetailsNarrative",
      "http://algoholdings.com/role/LiquidityGoingConcernAndManagementPlansDetailsNarrative",
      "http://algoholdings.com/role/RecentDevelopmentsDetailsNarrative",
      "http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfShareholdersEquityDetails",
      "http://algoholdings.com/role/StatementsOfShareholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r96",
      "r99",
      "r100",
      "r211",
      "r232",
      "r233",
      "r234",
      "r255",
      "r256",
      "r257",
      "r259",
      "r264",
      "r266",
      "r268",
      "r289",
      "r353",
      "r354",
      "r380",
      "r452",
      "r540",
      "r541",
      "r548",
      "r549",
      "r550",
      "r552",
      "r556",
      "r557",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r574",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r596",
      "r599",
      "r612",
      "r717",
      "r734",
      "r735",
      "r736",
      "r751",
      "r814"
     ]
    },
    "srt_StatementGeographicalAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "StatementGeographicalAxis",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfRevenueByGeographicalRegionDetails",
      "http://algoholdings.com/role/ScheduleOfSalesByGeographicalRegionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "documentation": "Information by geographical components."
       }
      }
     },
     "auth_ref": [
      "r183",
      "r185",
      "r188",
      "r190",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r312",
      "r313",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r754",
      "r755",
      "r756",
      "r824",
      "r826",
      "r829",
      "r835",
      "r839",
      "r843",
      "r844",
      "r845",
      "r846",
      "r847",
      "r848",
      "r849",
      "r850",
      "r851",
      "r857",
      "r886",
      "r913",
      "r914",
      "r915",
      "r916",
      "r917",
      "r918",
      "r919",
      "r920",
      "r925",
      "r933",
      "r1059",
      "r1151",
      "r1153",
      "r1154",
      "r1156",
      "r1157",
      "r1158",
      "r1159",
      "r1160",
      "r1161",
      "r1162",
      "r1163",
      "r1164",
      "r1165",
      "r1166",
      "r1167",
      "r1168",
      "r1169",
      "r1170",
      "r1171",
      "r1172",
      "r1173",
      "r1174",
      "r1175",
      "r1176",
      "r1177",
      "r1178",
      "r1179",
      "r1180"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementLineItems",
     "presentation": [
      "http://algoholdings.com/role/AccountsPayableAndAccruedExpenses",
      "http://algoholdings.com/role/AccountsPayableAndAccruedExpensesDetailsNarrative",
      "http://algoholdings.com/role/AccountsReceivable",
      "http://algoholdings.com/role/AccountsReceivableDetailsNarrative",
      "http://algoholdings.com/role/AssetAcquisitionDetailsNarrative",
      "http://algoholdings.com/role/August2021PrivatePlacementDetailsNarrative",
      "http://algoholdings.com/role/CommitmentsAndContingencies",
      "http://algoholdings.com/role/ConcentrationsOfCreditRiskAndRevenue",
      "http://algoholdings.com/role/DueFromFactor",
      "http://algoholdings.com/role/DueFromFactorDetailsNarrative",
      "http://algoholdings.com/role/EmployeeBenefitPlans",
      "http://algoholdings.com/role/IncomeTaxes",
      "http://algoholdings.com/role/LiquidityGoingConcernAndManagementPlans",
      "http://algoholdings.com/role/LiquidityGoingConcernAndManagementPlansDetailsNarrative",
      "http://algoholdings.com/role/NatureOfBusiness",
      "http://algoholdings.com/role/NotesPayableAndFinaningArrangements",
      "http://algoholdings.com/role/NotesPayableAndFinaningArrangementsDetailsNarrative",
      "http://algoholdings.com/role/NotesPayableAndFinaningArrangementsTables",
      "http://algoholdings.com/role/PropertyAndEquipment",
      "http://algoholdings.com/role/PropertyAndEquipmentDetailsNarrative",
      "http://algoholdings.com/role/RecentDevelopmentsDetailsNarrative",
      "http://algoholdings.com/role/RelatedPartyTransactions",
      "http://algoholdings.com/role/SafePrivatePlacements",
      "http://algoholdings.com/role/SafePrivatePlacementsTables",
      "http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfShareholdersEquityDetails",
      "http://algoholdings.com/role/ScheduleOfEmployeeStockOptionsOutstandingDetailsParenthetical",
      "http://algoholdings.com/role/ScheduleOfEstimatedUsefulLivesDetails",
      "http://algoholdings.com/role/ScheduleOfRevenueByGeographicalRegionDetails",
      "http://algoholdings.com/role/ScheduleOfSpecificTermsDetails",
      "http://algoholdings.com/role/ScheduleOfStockOptionIssuedDuringYearDecember3120202021And2022Details",
      "http://algoholdings.com/role/StatementsOfOperations",
      "http://algoholdings.com/role/StatementsOfShareholdersDeficitEquity",
      "http://algoholdings.com/role/StockholdersEquity",
      "http://algoholdings.com/role/StockholdersEquityDetailsNarrative",
      "http://algoholdings.com/role/StockholdersEquityTables",
      "http://algoholdings.com/role/SummaryOfSignificantAccountingPolicies",
      "http://algoholdings.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://algoholdings.com/role/SummaryOfSignificantAccountingPoliciesPolicies",
      "http://algoholdings.com/role/SupplementalInformationCondensedFinancialInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r255",
      "r256",
      "r257",
      "r289",
      "r599",
      "r658",
      "r741",
      "r753",
      "r760",
      "r761",
      "r762",
      "r763",
      "r764",
      "r765",
      "r768",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r780",
      "r781",
      "r782",
      "r783",
      "r785",
      "r786",
      "r787",
      "r788",
      "r789",
      "r791",
      "r793",
      "r794",
      "r800",
      "r801",
      "r802",
      "r803",
      "r804",
      "r805",
      "r806",
      "r807",
      "r808",
      "r809",
      "r810",
      "r811",
      "r814",
      "r934"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfCashFlowsAbstract",
     "presentation": [
      "http://algoholdings.com/role/SupplementalInformationCondensedFinancialInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfStockholdersEquityAbstract",
     "presentation": [
      "http://algoholdings.com/role/SupplementalInformationCondensedFinancialInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_StatementScenarioAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "StatementScenarioAxis",
     "presentation": [
      "http://algoholdings.com/role/AssetAcquisitionDetailsNarrative",
      "http://algoholdings.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]",
        "documentation": "Information by scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts."
       }
      }
     },
     "auth_ref": [
      "r208",
      "r269",
      "r466",
      "r962",
      "r966",
      "r1010"
     ]
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementTable",
     "presentation": [
      "http://algoholdings.com/role/AccountsPayableAndAccruedExpenses",
      "http://algoholdings.com/role/AccountsPayableAndAccruedExpensesDetailsNarrative",
      "http://algoholdings.com/role/AccountsReceivable",
      "http://algoholdings.com/role/AccountsReceivableDetailsNarrative",
      "http://algoholdings.com/role/AssetAcquisitionDetailsNarrative",
      "http://algoholdings.com/role/August2021PrivatePlacementDetailsNarrative",
      "http://algoholdings.com/role/CommitmentsAndContingencies",
      "http://algoholdings.com/role/ConcentrationsOfCreditRiskAndRevenue",
      "http://algoholdings.com/role/DueFromFactor",
      "http://algoholdings.com/role/DueFromFactorDetailsNarrative",
      "http://algoholdings.com/role/EmployeeBenefitPlans",
      "http://algoholdings.com/role/IncomeTaxes",
      "http://algoholdings.com/role/LiquidityGoingConcernAndManagementPlans",
      "http://algoholdings.com/role/LiquidityGoingConcernAndManagementPlansDetailsNarrative",
      "http://algoholdings.com/role/NatureOfBusiness",
      "http://algoholdings.com/role/NotesPayableAndFinaningArrangements",
      "http://algoholdings.com/role/NotesPayableAndFinaningArrangementsDetailsNarrative",
      "http://algoholdings.com/role/NotesPayableAndFinaningArrangementsTables",
      "http://algoholdings.com/role/PropertyAndEquipment",
      "http://algoholdings.com/role/PropertyAndEquipmentDetailsNarrative",
      "http://algoholdings.com/role/RecentDevelopmentsDetailsNarrative",
      "http://algoholdings.com/role/RelatedPartyTransactions",
      "http://algoholdings.com/role/SafePrivatePlacements",
      "http://algoholdings.com/role/SafePrivatePlacementsTables",
      "http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfShareholdersEquityDetails",
      "http://algoholdings.com/role/ScheduleOfEmployeeStockOptionsOutstandingDetailsParenthetical",
      "http://algoholdings.com/role/ScheduleOfEstimatedUsefulLivesDetails",
      "http://algoholdings.com/role/ScheduleOfRevenueByGeographicalRegionDetails",
      "http://algoholdings.com/role/ScheduleOfSpecificTermsDetails",
      "http://algoholdings.com/role/ScheduleOfStockOptionIssuedDuringYearDecember3120202021And2022Details",
      "http://algoholdings.com/role/StatementsOfOperations",
      "http://algoholdings.com/role/StatementsOfShareholdersDeficitEquity",
      "http://algoholdings.com/role/StockholdersEquity",
      "http://algoholdings.com/role/StockholdersEquityDetailsNarrative",
      "http://algoholdings.com/role/StockholdersEquityTables",
      "http://algoholdings.com/role/SummaryOfSignificantAccountingPolicies",
      "http://algoholdings.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://algoholdings.com/role/SummaryOfSignificantAccountingPoliciesPolicies",
      "http://algoholdings.com/role/SupplementalInformationCondensedFinancialInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]",
        "documentation": "Disclosure of information about statement of comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r255",
      "r256",
      "r257",
      "r289",
      "r316",
      "r599",
      "r658",
      "r741",
      "r753",
      "r760",
      "r761",
      "r762",
      "r763",
      "r764",
      "r765",
      "r768",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r780",
      "r781",
      "r782",
      "r783",
      "r785",
      "r786",
      "r787",
      "r788",
      "r789",
      "r791",
      "r793",
      "r794",
      "r800",
      "r801",
      "r802",
      "r803",
      "r804",
      "r805",
      "r806",
      "r807",
      "r808",
      "r809",
      "r810",
      "r811",
      "r814",
      "r934"
     ]
    },
    "RIME_StephenCabralMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "StephenCabralMember",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfStockOptionIssuedDuringYearDecember3120202021And2022Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stephen Cabral [Member]",
        "documentation": "Stephen Cabral [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_StingrayMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "StingrayMember",
     "presentation": [
      "http://algoholdings.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stingray [Member]",
        "documentation": "Stingray [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockGrantedDuringPeriodValueSharebasedCompensation",
     "crdr": "credit",
     "presentation": [
      "http://algoholdings.com/role/StatementsOfShareholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock based compensation",
        "documentation": "Value, after forfeiture, of shares granted under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": [
      "r48",
      "r56"
     ]
    },
    "us-gaap_StockIssued1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssued1",
     "crdr": "credit",
     "presentation": [
      "http://algoholdings.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Common stock issued for purchase of SemiCab Inc",
        "label": "Stock Issued",
        "documentation": "The fair value of stock issued in noncash financing activities."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r22",
      "r23"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesAcquisitions",
     "presentation": [
      "http://algoholdings.com/role/AssetAcquisitionDetailsNarrative",
      "http://algoholdings.com/role/StatementsOfShareholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock issued for purchase of SemiCab Inc, shares",
        "verboseLabel": "Stock issued during period shares acquisitions",
        "documentation": "Number of shares of stock issued during the period pursuant to acquisitions."
       }
      }
     },
     "auth_ref": [
      "r95",
      "r96",
      "r128"
     ]
    },
    "RIME_StockIssuedDuringPeriodSharesExerciseOfPrefundedAndCommonWarrants": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "StockIssuedDuringPeriodSharesExerciseOfPrefundedAndCommonWarrants",
     "presentation": [
      "http://algoholdings.com/role/StatementsOfShareholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise of pre-funded warrants, shares",
        "documentation": "Exercise of prefunded and common warrants, shares."
       }
      }
     },
     "auth_ref": []
    },
    "RIME_StockIssuedDuringPeriodSharesIssuanceOfCommonStockAtMarketOffering": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "StockIssuedDuringPeriodSharesIssuanceOfCommonStockAtMarketOffering",
     "presentation": [
      "http://algoholdings.com/role/StatementsOfShareholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of common stock - at-the-market offering, shares",
        "documentation": "Stock issued during period shares issuance of common stock at market offering."
       }
      }
     },
     "auth_ref": []
    },
    "RIME_StockIssuedDuringPeriodSharesIssuanceOfCommonStockPrivatePlacement": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "StockIssuedDuringPeriodSharesIssuanceOfCommonStockPrivatePlacement",
     "presentation": [
      "http://algoholdings.com/role/StatementsOfShareholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of common stock - private placement, shares",
        "documentation": "Shares issuance of common stock - private placement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesIssuedForServices",
     "presentation": [
      "http://algoholdings.com/role/IssuanceOfCommonStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Issued During Period, Shares, Issued for Services",
        "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfShareholdersEquityDetails",
      "http://algoholdings.com/role/StatementsOfShareholdersDeficitEquity",
      "http://algoholdings.com/role/StockholdersEquityDetailsNarrative",
      "http://algoholdings.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of common stock, shares",
        "verboseLabel": "Number of shares issued",
        "terseLabel": "Issuance of common stock and warrants, net of stock offering costs, shares",
        "documentation": "Number of new stock issued during the period."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r95",
      "r96",
      "r128",
      "r743",
      "r814",
      "r836"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesOther": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesOther",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfShareholdersEquityDetails",
      "http://algoholdings.com/role/StatementsOfShareholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of common stock for stock offering costs, shares",
        "verboseLabel": "Other, shares",
        "documentation": "Number of shares of stock issued attributable to transactions classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesPurchaseOfAssets",
     "presentation": [
      "http://algoholdings.com/role/AssetAcquisitionDetailsNarrative",
      "http://algoholdings.com/role/RecentDevelopmentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares purchase",
        "documentation": "Number of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross",
     "presentation": [
      "http://algoholdings.com/role/August2021PrivatePlacementDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock issued for restricted shares",
        "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r128"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesReverseStockSplits",
     "presentation": [
      "http://algoholdings.com/role/StatementsOfShareholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rounding of common stock issued due to reverse split, shares",
        "documentation": "Reduction in the number of shares during the period as a result of a reverse stock split."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "RIME_StockIssuedDuringPeriodSharesSaleOfCommonStockWarrants": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "StockIssuedDuringPeriodSharesSaleOfCommonStockWarrants",
     "presentation": [
      "http://algoholdings.com/role/StatementsOfShareholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of common stock warrants, shares",
        "documentation": "Stock issued during period shares sale of common stock warrants."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfShareholdersEquityDetails",
      "http://algoholdings.com/role/StatementsOfShareholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock based compensation, shares",
        "verboseLabel": "Stock based compensation ,shares",
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r95",
      "r96",
      "r128"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensationForfeited",
     "presentation": [
      "http://algoholdings.com/role/IssuanceOfCommonStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share base compensation forfeited shares",
        "documentation": "Number of shares (or other type of equity) forfeited during the period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://algoholdings.com/role/StatementsOfShareholdersDeficitEquity",
      "http://algoholdings.com/role/SummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise of stock options, shares",
        "negatedLabel": "Number of Options, Exercised",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r95",
      "r96",
      "r128",
      "r481"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueAcquisitions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueAcquisitions",
     "crdr": "credit",
     "presentation": [
      "http://algoholdings.com/role/StatementsOfShareholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock issued for purchase of SemiCab Inc",
        "documentation": "Value of stock issued pursuant to acquisitions during the period."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r96",
      "r99",
      "r100",
      "r128"
     ]
    },
    "RIME_StockIssuedDuringPeriodValueExerciseOfPrefundedAndCommonWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "StockIssuedDuringPeriodValueExerciseOfPrefundedAndCommonWarrants",
     "crdr": "credit",
     "presentation": [
      "http://algoholdings.com/role/StatementsOfShareholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise of pre-funded and common warrants",
        "documentation": "Exercise of prefunded and common warrants, value."
       }
      }
     },
     "auth_ref": []
    },
    "RIME_StockIssuedDuringPeriodValueIssuanceOfCommonStockAtMarketOffering": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "StockIssuedDuringPeriodValueIssuanceOfCommonStockAtMarketOffering",
     "crdr": "credit",
     "presentation": [
      "http://algoholdings.com/role/StatementsOfShareholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of common stock - at-the -market offering",
        "documentation": "Stock issued during period value issuance of common stock at market offering."
       }
      }
     },
     "auth_ref": []
    },
    "RIME_StockIssuedDuringPeriodValueIssuanceOfCommonStockPrivatePlacement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "StockIssuedDuringPeriodValueIssuanceOfCommonStockPrivatePlacement",
     "crdr": "credit",
     "presentation": [
      "http://algoholdings.com/role/StatementsOfShareholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of common stock - private placement",
        "documentation": "Issuance of common stock - private placement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://algoholdings.com/role/IssuanceOfCommonStockDetailsNarrative",
      "http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfShareholdersEquityDetails",
      "http://algoholdings.com/role/StatementsOfShareholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of common stock",
        "verboseLabel": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Issuance of common stock and warrants, net of stock offering costs",
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r95",
      "r96",
      "r128",
      "r751",
      "r814",
      "r836",
      "r940"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueOther",
     "crdr": "credit",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfShareholdersEquityDetails",
      "http://algoholdings.com/role/StatementsOfShareholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of common stock for stock offering costs",
        "verboseLabel": "Other",
        "documentation": "Value of shares of stock issued attributable to transactions classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValuePurchaseOfAssets",
     "crdr": "credit",
     "presentation": [
      "http://algoholdings.com/role/AssetAcquisitionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchase of assets value",
        "documentation": "Value of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardGross",
     "crdr": "credit",
     "presentation": [
      "http://algoholdings.com/role/August2021PrivatePlacementDetailsNarrative",
      "http://algoholdings.com/role/IssuanceOfCommonStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Issued During Period, Value, Restricted Stock Award, Gross",
        "verboseLabel": "Stock issued for restricted shares, value",
        "documentation": "Aggregate value of stock related to Restricted Stock Awards issued during the period."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r95",
      "r96",
      "r128"
     ]
    },
    "RIME_StockIssuedDuringPeriodValueReverseStockSplits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "StockIssuedDuringPeriodValueReverseStockSplits",
     "crdr": "credit",
     "presentation": [
      "http://algoholdings.com/role/StatementsOfShareholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other",
        "documentation": "Stock issued during period value reverse stock splits."
       }
      }
     },
     "auth_ref": []
    },
    "RIME_StockIssuedDuringPeriodValueSaleOfCommonStockWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "StockIssuedDuringPeriodValueSaleOfCommonStockWarrants",
     "crdr": "credit",
     "presentation": [
      "http://algoholdings.com/role/StatementsOfShareholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of common stock warrants",
        "documentation": "Stock issued during period value sale of common stock warrants"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "crdr": "credit",
     "presentation": [
      "http://algoholdings.com/role/StatementsOfShareholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Stock based compensation",
        "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture",
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": [
      "r51",
      "r95",
      "r96",
      "r128"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "crdr": "credit",
     "presentation": [
      "http://algoholdings.com/role/StatementsOfShareholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise of stock options",
        "documentation": "Value of stock issued as a result of the exercise of stock options."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r96",
      "r99",
      "r100",
      "r128"
     ]
    },
    "us-gaap_StockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockOptionMember",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfStockOptionIssuedDuringYearDecember3120202021And2022Details",
      "http://algoholdings.com/role/SummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Option [Member]",
        "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option)."
       }
      }
     },
     "auth_ref": [
      "r933"
     ]
    },
    "us-gaap_StockOptionPlanExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockOptionPlanExpense",
     "crdr": "debit",
     "presentation": [
      "http://algoholdings.com/role/StockCompensationExpenseDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock option expense",
        "documentation": "Amount of noncash expense for option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_StockRedeemedOrCalledDuringPeriodShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockRedeemedOrCalledDuringPeriodShares",
     "presentation": [
      "http://algoholdings.com/role/August2021StockRedemptionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares redeemed",
        "documentation": "Number of stock bought back by the entity at the exercise price or redemption price."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "RIME_StockRedemptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "StockRedemptionTextBlock",
     "presentation": [
      "http://algoholdings.com/role/August2021StockRedemption"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "AUGUST 2021 STOCK REDEMPTION",
        "documentation": "Stock Redemption [TextBlock]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_StockRepurchaseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "StockRepurchaseAgreementMember",
     "presentation": [
      "http://algoholdings.com/role/RecentDevelopmentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Repurchase Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://algoholdings.com/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/BalanceSheets",
      "http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfShareholdersEquityDetails",
      "http://algoholdings.com/role/StatementsOfShareholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Shareholders\u2019 Equity",
        "periodStartLabel": "Balance",
        "periodEndLabel": "Balance",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r99",
      "r100",
      "r121",
      "r770",
      "r790",
      "r815",
      "r816",
      "r911",
      "r941",
      "r1002",
      "r1026",
      "r1124",
      "r1192"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://algoholdings.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholders\u2019 Equity"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://algoholdings.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://algoholdings.com/role/BalanceSheets",
      "http://algoholdings.com/role/LiquidityGoingConcernAndManagementPlansDetailsNarrative",
      "http://algoholdings.com/role/StatementsOfShareholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Algorhythm Holdings Shareholders\u2019 Equity",
        "periodStartLabel": "Balance",
        "periodEndLabel": "Balance",
        "label": "Stockholders equity",
        "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity."
       }
      }
     },
     "auth_ref": [
      "r63",
      "r64",
      "r67",
      "r211",
      "r212",
      "r233",
      "r255",
      "r256",
      "r257",
      "r259",
      "r264",
      "r266",
      "r353",
      "r354",
      "r380",
      "r452",
      "r540",
      "r541",
      "r548",
      "r549",
      "r550",
      "r552",
      "r556",
      "r557",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r574",
      "r586",
      "r587",
      "r591",
      "r597",
      "r612",
      "r735",
      "r736",
      "r749",
      "r770",
      "r790",
      "r815",
      "r816",
      "r837",
      "r940",
      "r1002",
      "r1026",
      "r1124",
      "r1192"
     ]
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://algoholdings.com/role/IssuanceOfCommonStock",
      "http://algoholdings.com/role/StockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ISSUANCE OF COMMON STOCK",
        "verboseLabel": "STOCKHOLDERS\u2019 EQUITY",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r127",
      "r248",
      "r437",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r450",
      "r452",
      "r573",
      "r817",
      "r819",
      "r838"
     ]
    },
    "us-gaap_SubsequentEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventLineItems",
     "presentation": [
      "http://algoholdings.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Line Items]",
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event."
       }
      }
     },
     "auth_ref": [
      "r592",
      "r622"
     ]
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://algoholdings.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://algoholdings.com/role/FinancingDetailsNarrative",
      "http://algoholdings.com/role/NotesPayableAndFinaningArrangementsDetailsNarrative",
      "http://algoholdings.com/role/OperatingLeasesDetailsNarrative",
      "http://algoholdings.com/role/RecentDevelopmentsDetailsNarrative",
      "http://algoholdings.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Member]",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r592",
      "r622"
     ]
    },
    "us-gaap_SubsequentEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTable",
     "presentation": [
      "http://algoholdings.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Table]",
        "documentation": "Disclosure of information about significant event or transaction occurring between statement of financial position date and date when financial statements were issued."
       }
      }
     },
     "auth_ref": [
      "r592",
      "r622"
     ]
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://algoholdings.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://algoholdings.com/role/FinancingDetailsNarrative",
      "http://algoholdings.com/role/NotesPayableAndFinaningArrangementsDetailsNarrative",
      "http://algoholdings.com/role/OperatingLeasesDetailsNarrative",
      "http://algoholdings.com/role/RecentDevelopmentsDetailsNarrative",
      "http://algoholdings.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event Type [Axis]",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r592",
      "r622"
     ]
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://algoholdings.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://algoholdings.com/role/FinancingDetailsNarrative",
      "http://algoholdings.com/role/NotesPayableAndFinaningArrangementsDetailsNarrative",
      "http://algoholdings.com/role/OperatingLeasesDetailsNarrative",
      "http://algoholdings.com/role/RecentDevelopmentsDetailsNarrative",
      "http://algoholdings.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r592",
      "r622"
     ]
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://algoholdings.com/role/SubsequentEvents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SUBSEQUENT EVENTS",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r621",
      "r623"
     ]
    },
    "RIME_SubsequentYearsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "SubsequentYearsMember",
     "presentation": [
      "http://algoholdings.com/role/AssetAcquisitionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Years [Member]",
        "documentation": "Subsequent Years [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable",
     "presentation": [
      "http://algoholdings.com/role/AtmOfferingDetailsNarrative",
      "http://algoholdings.com/role/PrivatePlacementDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsidiary or Equity Method Investee, Sale of Stock, Type [Table]",
        "documentation": "Disclosure of information about sale of stock made by subsidiary or equity method investee to investor outside consolidated group by type of sale. Includes, but is not limited to, stock issued in business combination in exchange for share of acquired entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsidiarySaleOfStockAxis",
     "presentation": [
      "http://algoholdings.com/role/AtmOfferingDetailsNarrative",
      "http://algoholdings.com/role/August2021PrivatePlacementDetailsNarrative",
      "http://algoholdings.com/role/PrivatePlacementDetailsNarrative",
      "http://algoholdings.com/role/RecentDevelopmentsDetailsNarrative",
      "http://algoholdings.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock [Axis]",
        "documentation": "Information by type of sale of the entity's stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsidiarySaleOfStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsidiarySaleOfStockLineItems",
     "presentation": [
      "http://algoholdings.com/role/AtmOfferingDetailsNarrative",
      "http://algoholdings.com/role/PrivatePlacementDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsidiary, Sale of Stock [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubstantialDoubtAboutGoingConcernTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubstantialDoubtAboutGoingConcernTextBlock",
     "presentation": [
      "http://algoholdings.com/role/LiquidityGoingConcernAndManagementPlans"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "LIQUIDITY, GOING CONCERN AND MANAGEMENT PLANS",
        "documentation": "The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern."
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "RIME_SudhindraShenoyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "SudhindraShenoyMember",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfStockOptionIssuedDuringYearDecember3120202021And2022Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sudhindra Shenoy [Member]",
        "documentation": "Sudhindra Shenoy [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_SudhirNarasimhamurthyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "SudhirNarasimhamurthyMember",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfStockOptionIssuedDuringYearDecember3120202021And2022Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sudhir Narasimhamurthy [Member]",
        "documentation": "Sudhir Narasimhamurthy [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_SunilAroraMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "SunilAroraMember",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfStockOptionIssuedDuringYearDecember3120202021And2022Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sunil Arora [Member]",
        "documentation": "Sunil Arora [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SupplementalCashFlowInformationAbstract",
     "presentation": [
      "http://algoholdings.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental disclosures of cash flow information:"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_SupplementalInformationDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "SupplementalInformationDisclosuresTextBlock",
     "presentation": [
      "http://algoholdings.com/role/SupplementalInformationCondensedFinancialInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SUPPLEMENTAL INFORMATION CONDENSED FINANCIAL INFORMATION",
        "documentation": "Supplemental Information Disclosures [Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TargetedOrTrackingStockIssuanceDates": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TargetedOrTrackingStockIssuanceDates",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfStockOptionIssuedDuringYearDecember3120202021And2022Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Granted Date",
        "documentation": "Date the targeted stock was issued, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "RIME_TenMonthlyPaymentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "TenMonthlyPaymentsMember",
     "presentation": [
      "http://algoholdings.com/role/NotesPayableAndFinaningArrangementsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ten Monthly Payments [Member]",
        "documentation": "Ten Monthly Payments [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TenantImprovements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TenantImprovements",
     "crdr": "debit",
     "presentation": [
      "http://algoholdings.com/role/OperatingLeasesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reimbursement for tenant improvements",
        "documentation": "Carrying amount as of the balance sheet date of improvements having a life longer than one year that were made for the benefit of one or more tenants."
       }
      }
     },
     "auth_ref": [
      "r1143",
      "r1144"
     ]
    },
    "RIME_ThreeCustomersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "ThreeCustomersMember",
     "presentation": [
      "http://algoholdings.com/role/ConcentrationsOfCreditRiskAndRevenueDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Three Customers [Member]",
        "documentation": "Three Customers [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_TitleOfIndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "TitleOfIndividualAxis",
     "presentation": [
      "http://algoholdings.com/role/AssetAcquisitionDetailsNarrative",
      "http://algoholdings.com/role/ScheduleOfEmployeeStockOptionsOutstandingDetailsParenthetical",
      "http://algoholdings.com/role/ScheduleOfSpecificTermsDetails",
      "http://algoholdings.com/role/ScheduleOfStockOptionIssuedDuringYearDecember3120202021And2022Details",
      "http://algoholdings.com/role/StockCompensationExpenseDetailsNarrative",
      "http://algoholdings.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title and Position [Axis]",
        "documentation": "Information by title and position of individual or group within organization."
       }
      }
     },
     "auth_ref": [
      "r1018",
      "r1132"
     ]
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "presentation": [
      "http://algoholdings.com/role/AssetAcquisitionDetailsNarrative",
      "http://algoholdings.com/role/ScheduleOfEmployeeStockOptionsOutstandingDetailsParenthetical",
      "http://algoholdings.com/role/ScheduleOfSpecificTermsDetails",
      "http://algoholdings.com/role/ScheduleOfStockOptionIssuedDuringYearDecember3120202021And2022Details",
      "http://algoholdings.com/role/StockCompensationExpenseDetailsNarrative",
      "http://algoholdings.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title and position of individual or group within organization."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TradeAndOtherAccountsReceivablePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TradeAndOtherAccountsReceivablePolicy",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ACCOUNTS RECEIVABLE AND ALLOWANCES FOR EXPECTED CREDIT LOSSES",
        "documentation": "Disclosure of accounting policy for accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r163",
      "r164",
      "r165",
      "r1019",
      "r1020",
      "r1021"
     ]
    },
    "us-gaap_TradeNamesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TradeNamesMember",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfConsiderationTransferredToAssetsAcquiredAndLiabilitiesAssumedDetailsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade Names [Member]",
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof."
       }
      }
     },
     "auth_ref": [
      "r61",
      "r1033",
      "r1034",
      "r1035",
      "r1036",
      "r1037",
      "r1038",
      "r1039",
      "r1040",
      "r1041",
      "r1042"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://algoholdings.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "RIME_TransactionFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "TransactionFees",
     "crdr": "debit",
     "presentation": [
      "http://algoholdings.com/role/PrivatePlacementDetailsNarrative",
      "http://algoholdings.com/role/RecentDevelopmentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction fees",
        "documentation": "Transaction fees."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms."
       }
      }
     },
     "auth_ref": [
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r433",
      "r449",
      "r572",
      "r583",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r718",
      "r898",
      "r900",
      "r902",
      "r903",
      "r904",
      "r905",
      "r906",
      "r907",
      "r908",
      "r912",
      "r974",
      "r975",
      "r976",
      "r977",
      "r978",
      "r979",
      "r980",
      "r1022",
      "r1023",
      "r1024",
      "r1025",
      "r1108",
      "r1111",
      "r1112",
      "r1113",
      "r1120",
      "r1123"
     ]
    },
    "us-gaap_TreasuryStockRetiredCostMethodAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TreasuryStockRetiredCostMethodAmount",
     "crdr": "debit",
     "presentation": [
      "http://algoholdings.com/role/StatementsOfShareholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Redemption and retirement of treasury shares",
        "label": "Treasury Stock, Retired, Cost Method, Amount",
        "documentation": "Amount of decrease of par value, additional paid in capital (APIC) and retained earnings of common and preferred stock retired from treasury when treasury stock is accounted for under the cost method."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r43",
      "r96"
     ]
    },
    "us-gaap_TreasuryStockSharesRetired": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TreasuryStockSharesRetired",
     "presentation": [
      "http://algoholdings.com/role/StatementsOfShareholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Redemption and retirement of treasury shares, shares",
        "label": "Treasury Stock, Shares, Retired",
        "documentation": "Number of shares of common and preferred stock retired from treasury during the period."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r96",
      "r128"
     ]
    },
    "RIME_TuleekaNandyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "TuleekaNandyMember",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfStockOptionIssuedDuringYearDecember3120202021And2022Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tuleeka Nandy [Member]",
        "documentation": "Tuleeka Nandy [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_TwelveInstallmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "TwelveInstallmentsMember",
     "presentation": [
      "http://algoholdings.com/role/NotesPayableAndFinaningArrangementsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "12 Installments [Member]",
        "documentation": "Twelve Installments [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_TwoSeparateMilestonePaymentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "TwoSeparateMilestonePaymentMember",
     "presentation": [
      "http://algoholdings.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Two Separate Milestone Payment [Member]",
        "documentation": "Two Separate Milestone Payment [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_TwoThousandTwentyEightMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "TwoThousandTwentyEightMember",
     "presentation": [
      "http://algoholdings.com/role/AssetAcquisitionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2028 [Member]",
        "documentation": "2028 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_TwoThousandTwentyFiveMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "TwoThousandTwentyFiveMember",
     "presentation": [
      "http://algoholdings.com/role/AssetAcquisitionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2025 [Member]",
        "documentation": "2025 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_TwoThousandTwentyFourMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "TwoThousandTwentyFourMember",
     "presentation": [
      "http://algoholdings.com/role/AssetAcquisitionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2024 [Member]",
        "documentation": "2024 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_TwoThousandTwentySevenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "TwoThousandTwentySevenMember",
     "presentation": [
      "http://algoholdings.com/role/AssetAcquisitionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2027 [Member]",
        "documentation": "2027 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_TwoThousandTwentySixMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "TwoThousandTwentySixMember",
     "presentation": [
      "http://algoholdings.com/role/AssetAcquisitionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2026 [Member]",
        "documentation": "2026 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_TwoThousandTwentyTwoPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "TwoThousandTwentyTwoPlanMember",
     "presentation": [
      "http://algoholdings.com/role/IssuanceOfCommonStockDetailsNarrative",
      "http://algoholdings.com/role/StockCompensationExpenseDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2022 Plan [Member]",
        "documentation": "Two Thousand Twenty Two Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_TwoYearCreditAndSecurityAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "TwoYearCreditAndSecurityAgreementMember",
     "presentation": [
      "http://algoholdings.com/role/FinancingDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Two Year Credit and Security Agreement [Member]",
        "documentation": "Two Year Credit and Security Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_TwoYearLoanAndSecurityAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "TwoYearLoanAndSecurityAgreementMember",
     "presentation": [
      "http://algoholdings.com/role/FinancingDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Two-Year Loan and Security Agreement [Member]",
        "documentation": "Two-Year Loan and Security Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TypeAndTierIdentifierDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TypeAndTierIdentifierDomain",
     "presentation": [
      "http://algoholdings.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the type of insurance coverage or layer of insurance that covers malpractice claims."
       }
      }
     },
     "auth_ref": [
      "r158"
     ]
    },
    "us-gaap_TypeOfArrangementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TypeOfArrangementAxis",
     "presentation": [
      "http://algoholdings.com/role/AssetAcquisitionDetailsNarrative",
      "http://algoholdings.com/role/August2021PrivatePlacementDetailsNarrative",
      "http://algoholdings.com/role/August2021StockRedemptionDetailsNarrative",
      "http://algoholdings.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://algoholdings.com/role/FinancingDetailsNarrative",
      "http://algoholdings.com/role/NotesPayableAndFinaningArrangementsDetailsNarrative",
      "http://algoholdings.com/role/OperatingLeasesDetailsNarrative",
      "http://algoholdings.com/role/PublicOfferingAndNasdaqUplistingDetailsNarrative",
      "http://algoholdings.com/role/RecentDevelopmentsDetailsNarrative",
      "http://algoholdings.com/role/SafePrivatePlacementsDetailsNarrative",
      "http://algoholdings.com/role/ScheduleOfFirstTrancheOfSubscriptionsDetails",
      "http://algoholdings.com/role/ScheduleOfSpecificTermsDetails",
      "http://algoholdings.com/role/SubsequentEventsDetailsNarrative",
      "http://algoholdings.com/role/SummaryOfTerminatedImmediatelyAfterClosingOfTransactionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r558"
     ]
    },
    "RIME_UnderwritingAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "UnderwritingAgreementMember",
     "presentation": [
      "http://algoholdings.com/role/PublicOfferingAndNasdaqUplistingDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underwriting Agreement [Member]",
        "documentation": "Underwriting Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://algoholdings.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "USE OF ESTIMATES",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r32",
      "r33",
      "r170",
      "r171",
      "r174",
      "r175"
     ]
    },
    "RIME_ValuationCapitalOfInvestment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "ValuationCapitalOfInvestment",
     "crdr": "credit",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfFirstTrancheOfSubscriptionsDetails",
      "http://algoholdings.com/role/SummaryOfTerminatedImmediatelyAfterClosingOfTransactionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Valuation Cap",
        "documentation": "Valuation capital of investment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_VestingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "VestingAxis",
     "presentation": [
      "http://algoholdings.com/role/SafePrivatePlacementsDetailsNarrative",
      "http://algoholdings.com/role/ScheduleOfFirstTrancheOfSubscriptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting [Axis]",
        "documentation": "Information by vesting schedule of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1061",
      "r1062",
      "r1063",
      "r1064",
      "r1065",
      "r1066",
      "r1067",
      "r1068",
      "r1069",
      "r1070",
      "r1071",
      "r1072",
      "r1073",
      "r1074",
      "r1075",
      "r1076",
      "r1077",
      "r1078",
      "r1079",
      "r1080",
      "r1081",
      "r1082",
      "r1083",
      "r1084",
      "r1085",
      "r1086"
     ]
    },
    "us-gaap_VestingDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "VestingDomain",
     "presentation": [
      "http://algoholdings.com/role/SafePrivatePlacementsDetailsNarrative",
      "http://algoholdings.com/role/ScheduleOfFirstTrancheOfSubscriptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vesting schedule of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1061",
      "r1062",
      "r1063",
      "r1064",
      "r1065",
      "r1066",
      "r1067",
      "r1068",
      "r1069",
      "r1070",
      "r1071",
      "r1072",
      "r1073",
      "r1074",
      "r1075",
      "r1076",
      "r1077",
      "r1078",
      "r1079",
      "r1080",
      "r1081",
      "r1082",
      "r1083",
      "r1084",
      "r1085",
      "r1086"
     ]
    },
    "RIME_VivekSeghalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "VivekSeghalMember",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfLoanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vivek Seghal [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_VivekSehgalKapoorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "VivekSehgalKapoorMember",
     "presentation": [
      "http://algoholdings.com/role/AssetAcquisitionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vivek Sehgal Kapoor [Member]",
        "documentation": "Vivek Sehgal Kapoor [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_VivekSehgalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "VivekSehgalMember",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfSpecificTermsDetails",
      "http://algoholdings.com/role/ScheduleOfStockOptionIssuedDuringYearDecember3120202021And2022Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vivek Sehgal [Member]",
        "documentation": "Vivek Sehgal [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_WarehouseEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "WarehouseEquipmentMember",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warehouse Equipment [Member]",
        "documentation": "Warehouse Equipment [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WarrantMember",
     "presentation": [
      "http://algoholdings.com/role/ComputationOfLossPerShareDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant [Member]",
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount."
       }
      }
     },
     "auth_ref": [
      "r931",
      "r932",
      "r935",
      "r936",
      "r937",
      "r938"
     ]
    },
    "us-gaap_WarrantsAndRightsOutstandingMaturityDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WarrantsAndRightsOutstandingMaturityDate",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfWarrantsExpirationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expiration Date",
        "documentation": "Expiration date of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": [
      "r1111",
      "r1112",
      "r1113"
     ]
    },
    "us-gaap_WarrantsAndRightsOutstandingMeasurementInput": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WarrantsAndRightsOutstandingMeasurementInput",
     "presentation": [
      "http://algoholdings.com/role/PublicOfferingAndNasdaqUplistingDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant measurement input",
        "documentation": "Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur."
       }
      }
     },
     "auth_ref": [
      "r1111",
      "r1112",
      "r1113"
     ]
    },
    "us-gaap_WarrantsAndRightsOutstandingTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WarrantsAndRightsOutstandingTerm",
     "presentation": [
      "http://algoholdings.com/role/August2021PrivatePlacementDetailsNarrative",
      "http://algoholdings.com/role/PublicOfferingAndNasdaqUplistingDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant term",
        "verboseLabel": "Warrants and Rights Outstanding, Term",
        "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r1111",
      "r1112",
      "r1113"
     ]
    },
    "RIME_WarrantsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "WarrantsDisclosureTextBlock",
     "presentation": [
      "http://algoholdings.com/role/Warrants"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "WARRANTS",
        "documentation": "Warrants Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_WeeklyPaymentsForWeeksMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "WeeklyPaymentsForWeeksMember",
     "presentation": [
      "http://algoholdings.com/role/NotesPayableAndFinaningArrangementsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weekly Payments For Weeks [Member]",
        "documentation": "Weekly Payments For Weeks [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RIME_WeeklyPaymentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "WeeklyPaymentsMember",
     "presentation": [
      "http://algoholdings.com/role/NotesPayableAndFinaningArrangementsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weekly Payments [Member]",
        "documentation": "Weekly Payments [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfBasicAndDilutiveLossPerShareDetails",
      "http://algoholdings.com/role/ScheduleOfBasicAndDilutiveSharesDetails",
      "http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfOperationsDetails",
      "http://algoholdings.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Diluted",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted weighted average of common shares outstanding",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r273",
      "r282"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "presentation": [
      "http://algoholdings.com/role/ScheduleOfBasicAndDilutiveSharesDetails",
      "http://algoholdings.com/role/ScheduleOfCondensedConsolidatedStatementsOfOperationsDetails",
      "http://algoholdings.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Basic",
        "label": "Basic weighted average common shares outstanding",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r271",
      "r282"
     ]
    },
    "RIME_WorkingCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://algoholdings.com/20240930",
     "localname": "WorkingCapital",
     "crdr": "debit",
     "presentation": [
      "http://algoholdings.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://algoholdings.com/role/LiquidityGoingConcernAndManagementPlansDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Working capital deficit",
        "verboseLabel": "Working capital",
        "documentation": "Working capital."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://algoholdings.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r960"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482338/360-10-05-4"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "13",
   "SubTopic": "10",
   "Topic": "480",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481766/480-10-25-13"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(g)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "470",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-1"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "825",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-1"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "20",
   "Topic": "715",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1B"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2A"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-3"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-4"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-5"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-16"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-20"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-21"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-8"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "20",
   "Section": "25",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481284/470-20-25-2"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "50",
   "Section": "40",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481303/470-50-40-2"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "50",
   "Section": "40",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481303/470-50-40-4"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-2"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-3"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-4"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "30",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480513/718-10-30-3"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-1"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481089/718-20-55-12"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481089/718-20-55-13"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "30",
   "Section": "35",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480843/718-30-35-1"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-3"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "37",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-37"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-14"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-20"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-15"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-16"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4I"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4J"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-20"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "505",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477270/942-505-50-3"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "825",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478898/942-825-50-1"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "980",
   "SubTopic": "20",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481834/980-20-45-1"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/205-40/tableOfContent"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r106": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r107": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r108": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r109": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r110": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r111": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12"
  },
  "r112": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r113": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r114": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r115": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r116": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r117": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r118": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/235/tableOfContent"
  },
  "r119": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "275",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/275/tableOfContent"
  },
  "r120": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r121": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2"
  },
  "r122": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/360/tableOfContent"
  },
  "r123": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r124": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480091/360-10-S99-2"
  },
  "r125": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/440/tableOfContent"
  },
  "r126": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/470/tableOfContent"
  },
  "r127": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/505/tableOfContent"
  },
  "r128": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r129": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "710",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/710/tableOfContent"
  },
  "r130": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "712",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/712/tableOfContent"
  },
  "r131": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "715",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/715/tableOfContent"
  },
  "r132": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/718/tableOfContent"
  },
  "r133": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r134": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r135": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r136": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r137": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479515/805-10-05-4"
  },
  "r138": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479515/805-10-05-4"
  },
  "r139": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479515/805-10-05-4"
  },
  "r140": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479515/805-10-05-4"
  },
  "r141": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r142": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "38",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38"
  },
  "r143": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-23"
  },
  "r144": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r145": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r146": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21"
  },
  "r147": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r148": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r149": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r150": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r151": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r152": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r153": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r154": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r155": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r156": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r157": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r158": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "954",
   "SubTopic": "450",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477850/954-450-50-1"
  },
  "r159": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r160": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r161": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r162": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r163": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-11B"
  },
  "r164": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-15"
  },
  "r165": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-6"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "SubTopic": "210",
   "Topic": "946",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-20"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "270",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482989/270-10-45-6"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-1"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-11"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-6"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-7"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/275/tableOfContent"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/606/tableOfContent"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12",
   "Paragraph": "Column C",
   "Footnote": "5",
   "Publisher": "SEC"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12A",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12A",
   "Paragraph": "Column C",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12B",
   "Paragraph": "Column A",
   "Subparagraph": "(a)",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12B",
   "Paragraph": "Column A",
   "Subparagraph": "(b)",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12B",
   "Paragraph": "Column C",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "14",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "14",
   "Paragraph": "Column F",
   "Footnote": "7",
   "Publisher": "SEC"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column A",
   "Publisher": "SEC"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column B",
   "Publisher": "SEC"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column C",
   "Publisher": "SEC"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column D",
   "Publisher": "SEC"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column E",
   "Publisher": "SEC"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column F",
   "Publisher": "SEC"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column B",
   "Publisher": "SEC"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column C",
   "Publisher": "SEC"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column D",
   "Publisher": "SEC"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column E",
   "Publisher": "SEC"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column F",
   "Publisher": "SEC"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column G",
   "Publisher": "SEC"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column H",
   "Publisher": "SEC"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column I",
   "Publisher": "SEC"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "29",
   "Paragraph": "Column A",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 11",
   "Section": "L",
   "Publisher": "SEC"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 11",
   "Section": "M",
   "Paragraph": "Question 2",
   "Publisher": "SEC"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 5",
   "Section": "Y",
   "Paragraph": "Question 2",
   "Publisher": "SEC"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 5",
   "Section": "Y",
   "Paragraph": "Question 4",
   "Publisher": "SEC"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483489/210-10-50-1"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-1"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 6.B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-5"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-2"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2A"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480530/250-10-S99-5"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/260/tableOfContent"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-11"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-22"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-23"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-26"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-3"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/280/tableOfContent"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-15"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-24"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26B"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26C"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/310/tableOfContent"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-4"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/326/tableOfContent"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479344/326-20-45-1"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-11"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-14"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-16"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-5"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-4"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-7"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-9"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/330/tableOfContent"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483080/330-10-50-1"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483080/330-10-50-4"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482598/350-20-45-1"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-2"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-2"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-3"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-6"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-6"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-17"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-18"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-18"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-19"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-4"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/718/tableOfContent"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-1D"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-2"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-3"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.C.Q3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.1.Q5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.3.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "35",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483406/720-35-50-1"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483044/730-10-05-1"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482916/730-10-50-1"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/740/tableOfContent"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-15"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-25"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-28"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10A"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12B"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12C"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-14"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-19"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-20"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-21"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-22"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-23"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-3"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-2"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477891/740-270-50-1"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482603/740-30-50-2"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478758/740-323-25-1"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-5"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "808",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-5"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-6"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6B"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/830/tableOfContent"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-2"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483013/835-20-50-1"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/842-20/tableOfContent"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "12A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "40",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479092/842-20-40-1"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-5"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-1"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/850/tableOfContent"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-6"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/855/tableOfContent"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481444/860-30-45-1"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(4)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "912",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478345/912-310-45-11"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "912",
   "SubTopic": "330",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478411/912-330-50-1"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483154/926-20-50-5"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "928",
   "SubTopic": "340",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478859/928-340-50-1"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478934/932-220-50-1"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-19"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-6"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-7"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "280",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478657/932-280-50-1"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478988/932-323-50-1"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/944/tableOfContent"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479838/944-20-50-7"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1)(h))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(4)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(4)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4E"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-9"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.W.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "825",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-13"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-2"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-5"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-6"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-3"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-3"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-21"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-2"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(5)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(5)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(5)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r789": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r790": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r791": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r792": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r793": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r794": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r795": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r796": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r797": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r798": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r799": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r800": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r801": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r802": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r803": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r804": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r805": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r806": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r807": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r808": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r809": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r810": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r811": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r812": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r813": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r814": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r815": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r816": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r817": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r818": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r819": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r820": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r821": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r822": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r823": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r824": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r825": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r826": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r827": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r828": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r829": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r830": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5"
  },
  "r831": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5"
  },
  "r832": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5B"
  },
  "r833": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5C"
  },
  "r834": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r835": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r836": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r837": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-3"
  },
  "r838": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-6"
  },
  "r839": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column A)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r840": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479196/954-310-45-1"
  },
  "r841": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478785/954-310-50-2"
  },
  "r842": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1"
  },
  "r843": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r844": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r845": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r846": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r847": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r848": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r849": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r850": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r851": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r852": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1"
  },
  "r853": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1"
  },
  "r854": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2"
  },
  "r855": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r856": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r857": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(b)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r858": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r859": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r860": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-22"
  },
  "r861": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r862": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r863": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r864": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r865": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r866": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r867": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r868": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r869": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "48",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48"
  },
  "r870": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "49",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49"
  },
  "r871": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r872": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r873": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r874": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A"
  },
  "r875": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479081/326-30-55-8"
  },
  "r876": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482548/350-20-55-24"
  },
  "r877": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482640/350-30-55-40"
  },
  "r878": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482395/460-10-55-27"
  },
  "r879": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r880": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B"
  },
  "r881": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C"
  },
  "r882": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69E"
  },
  "r883": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69F"
  },
  "r884": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r885": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r886": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r887": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r888": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-11"
  },
  "r889": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-6"
  },
  "r890": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8"
  },
  "r891": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r892": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "720",
   "SubTopic": "35",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483385/720-35-55-1"
  },
  "r893": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "217",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-217"
  },
  "r894": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "231",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231"
  },
  "r895": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479908/805-50-55-1"
  },
  "r896": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4J"
  },
  "r897": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4K"
  },
  "r898": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r899": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r900": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "101",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-101"
  },
  "r901": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "102",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-102"
  },
  "r902": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "103",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103"
  },
  "r903": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r904": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r905": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r906": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r907": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r908": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r909": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482949/835-30-55-8"
  },
  "r910": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479589/842-20-55-53"
  },
  "r911": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10"
  },
  "r912": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481395/860-30-55-4"
  },
  "r913": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-17"
  },
  "r914": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-21"
  },
  "r915": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-29"
  },
  "r916": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-3"
  },
  "r917": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-2"
  },
  "r918": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-4"
  },
  "r919": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-5"
  },
  "r920": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-6"
  },
  "r921": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479401/944-30-55-2"
  },
  "r922": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r923": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F"
  },
  "r924": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r925": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r926": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r927": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9E"
  },
  "r928": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-14"
  },
  "r929": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-18"
  },
  "r930": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-9"
  },
  "r931": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r932": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r933": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1"
  },
  "r934": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r935": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r936": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r937": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r938": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r939": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r940": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11"
  },
  "r941": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12"
  },
  "r942": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r943": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r944": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r945": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r946": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r947": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r948": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r949": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r950": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r951": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r952": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r953": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r954": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r955": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r956": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r957": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r958": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r959": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r960": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r961": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r962": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-10"
  },
  "r963": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2"
  },
  "r964": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2"
  },
  "r965": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2"
  },
  "r966": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-3"
  },
  "r967": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12"
  },
  "r968": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r969": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r970": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "SubTopic": "825",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B"
  },
  "r971": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "SubTopic": "20",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r972": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r973": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(6))",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r974": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r975": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(1)",
   "Publisher": "SEC"
  },
  "r976": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(2)",
   "Publisher": "SEC"
  },
  "r977": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(3)",
   "Publisher": "SEC"
  },
  "r978": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(i)",
   "Publisher": "SEC"
  },
  "r979": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(ii)",
   "Publisher": "SEC"
  },
  "r980": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(iii)",
   "Publisher": "SEC"
  },
  "r981": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "11",
   "Subsection": "03",
   "Publisher": "SEC"
  },
  "r982": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "04",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r983": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12",
   "Paragraph": "Column A",
   "Subparagraph": "(ii)",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r984": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12A",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r985": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12B",
   "Paragraph": "Column A",
   "Subparagraph": "(b)",
   "Footnote": "1",
   "Publisher": "SEC"
  },
  "r986": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "14",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r987": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "6",
   "Subsection": "04",
   "Paragraph": "12",
   "Subparagraph": "(b)(1)",
   "Publisher": "SEC"
  },
  "r988": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 5",
   "Section": "Y",
   "Paragraph": "Question 2",
   "Publisher": "SEC"
  },
  "r989": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "205",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483504/205-10-50-1"
  },
  "r990": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r991": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r992": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r993": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r994": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r995": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r996": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r997": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r998": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r999": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r1000": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r1001": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1002": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1003": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1004": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1005": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1006": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r1007": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r1008": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r1009": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r1010": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r1011": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r1012": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r1013": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r1014": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r1015": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r1016": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r1017": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r1018": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r1019": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2"
  },
  "r1020": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2"
  },
  "r1021": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481569/310-20-50-1"
  },
  "r1022": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-9"
  },
  "r1023": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r1024": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r1025": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r1026": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r1027": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r1028": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480265/350-10-S45-1"
  },
  "r1029": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/350-20/tableOfContent"
  },
  "r1030": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1031": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1032": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/350-30/tableOfContent"
  },
  "r1033": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1"
  },
  "r1034": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1035": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1036": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1037": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1038": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1039": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1040": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1041": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1042": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1043": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/405-30/tableOfContent"
  },
  "r1044": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r1045": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r1046": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r1047": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10"
  },
  "r1048": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/450/tableOfContent"
  },
  "r1049": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-1"
  },
  "r1050": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r1051": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r1052": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r1053": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r1054": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r1055": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r1056": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1057": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1058": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r1059": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r1060": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-27"
  },
  "r1061": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1062": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1063": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1064": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1065": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1066": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1067": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1068": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1069": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1070": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1071": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1072": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1073": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1074": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1075": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1076": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1077": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1078": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1079": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1080": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1081": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1082": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1083": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1084": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1085": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1086": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1087": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1088": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "720",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483384/720-30-45-1"
  },
  "r1089": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10"
  },
  "r1090": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r1091": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r1092": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15"
  },
  "r1093": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r1094": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-3"
  },
  "r1095": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-6"
  },
  "r1096": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r1097": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r1098": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r1099": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r1100": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r1101": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r1102": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r1103": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "15",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480123/805-50-15-3"
  },
  "r1104": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480060/805-50-25-1"
  },
  "r1105": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480027/805-50-30-1"
  },
  "r1106": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480027/805-50-30-2"
  },
  "r1107": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r1108": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r1109": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1110": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1111": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1112": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1113": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1114": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1115": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1116": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1117": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1118": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1119": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1120": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r1121": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r1122": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r1123": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r1124": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r1125": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r1126": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-3"
  },
  "r1127": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r1128": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-4"
  },
  "r1129": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r1130": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r1131": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r1132": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2"
  },
  "r1133": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r1134": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1135": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1136": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1137": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1138": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1139": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1140": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1141": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1142": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "912",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479532/912-730-25-1"
  },
  "r1143": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1144": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1145": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(15)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1146": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1147": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1148": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1149": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1150": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1151": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B"
  },
  "r1152": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r1153": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1154": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1155": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4C"
  },
  "r1156": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D"
  },
  "r1157": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4G",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G"
  },
  "r1158": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1159": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1160": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1161": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1162": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1163": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1164": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1165": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1166": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1167": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1168": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1169": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1170": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1171": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1172": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1173": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1174": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1175": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1176": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1177": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1178": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1179": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1180": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1181": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r1182": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r1183": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r1184": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r1185": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r1186": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r1187": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r1188": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r1189": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r1190": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(k)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r1191": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r1192": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1193": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1194": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r1195": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r1196": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r1197": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  }
 }
}
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
